PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Chen, YC; Semenova, S; Rozov, S; Sundvik, M; Bonkowsky, JL; Panula, P				Chen, Yu-Chia; Semenova, Svetlana; Rozov, Stanislav; Sundvik, Maria; Bonkowsky, Joshua L.; Panula, Pertti			A Novel Developmental Role for Dopaminergic Signaling to Specify Hypothalamic Neurotransmitter Identity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dopamine; dopamine receptor; histamine; hypothalamus; zebrafish; morpholino; orexin	PRECURSOR CELL-PROLIFERATION; IN-SITU HYBRIDIZATION; TYROSINE-HYDROXYLASE; NEURON DEVELOPMENT; ZEBRAFISH BRAIN; VENTRAL TELENCEPHALON; SUBVENTRICULAR ZONE; SUBSTANTIA-NIGRA; HISTAMINE; SYSTEM	Hypothalamic neurons expressing histamine and orexin/hypocretin (hcrt) are necessary for normal regulation of wakefulness. In Parkinson's disease, the loss of dopaminergic neurons is associated with elevated histamine levels and disrupted sleep/wake cycles, but the mechanism is not understood. To characterize the role of dopamine in the development of histamine neurons, we inhibited the translation of the two non-allelic forms of tyrosine hydroxylase (th1 and th2) in zebrafish larvae. We found that dopamine levels were reduced in both th1 and th2 knockdown, but the serotonin level and number of serotonin neurons remained unchanged. Further, we demonstrated that th2 knockdown increased histamine neuron number and histamine levels, whereas increased dopaminergic signaling using the dopamine precursor l-DOPA (l-3,4-dihydroxyphenylalanine) or dopamine receptor agonists reduced the number of histaminergic neurons. Increases in the number of histaminergic neurons were paralleled by matching increases in the numbers of hcrt neurons, supporting observations that histamine regulates hcrt neuron development. Finally, we show that histaminergic neurons surround th2-expressing neurons in the hypothalamus, and we suggest that dopamine regulates the terminal differentiation of histamine neurons via paracrine actions or direct synaptic neurotransmission. These results reveal a role for dopaminergic signaling in the regulation of neurotransmitter identity and a potential mechanism contributing to sleep disturbances in Parkinson's disease.	[Chen, Yu-Chia; Semenova, Svetlana; Rozov, Stanislav; Sundvik, Maria; Panula, Pertti] Univ Helsinki, Neurosci Ctr, FIN-00290 Helsinki, Finland; [Chen, Yu-Chia; Semenova, Svetlana; Rozov, Stanislav; Sundvik, Maria; Panula, Pertti] Univ Helsinki, Dept Anat, Helsinki 00290, Finland; [Bonkowsky, Joshua L.] Univ Utah, Dept Pediat, Sch Med, Salt Lake City, UT 84113 USA	University of Helsinki; University of Helsinki; Utah System of Higher Education; University of Utah	Panula, P (corresponding author), Univ Helsinki, Neurosci Ctr, POB 63,Haartmaninkatu 8, FIN-00014 Helsinki, Finland.; Panula, P (corresponding author), Univ Helsinki, Dept Anat, POB 63,Haartmaninkatu 8, FIN-00014 Helsinki, Finland.	pertti.panula@helsinki.fi		Panula, Pertti/0000-0002-1189-5132; Rozov, Stanislav/0000-0002-0352-5502	Academy of Finland; Sigrid Juselius Foundation;  [DP2 MH100008]; NATIONAL INSTITUTE OF MENTAL HEALTH [DP2MH100008] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Academy of Finland and Sigrid Juselius Foundation (to P. P.) and DP2 MH100008 (to J. L. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Anichtchik OV, 2000, EXP NEUROL, V163, P20, DOI 10.1006/exnr.2000.7362; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Candy J, 2005, BBA-GENE STRUCT EXPR, V1727, P35, DOI 10.1016/j.bbaexp.2004.11.005; Chen YC, 2012, DEV BIOL, V370, P237, DOI 10.1016/j.ydbio.2012.07.030; Chen YC, 2009, HISTOCHEM CELL BIOL, V132, P375, DOI 10.1007/s00418-009-0619-8; Eiden LE, 2011, ANN NY ACAD SCI, V1216, P86, DOI 10.1111/j.1749-6632.2010.05906.x; Filippi A, 2010, J COMP NEUROL, V518, P423, DOI 10.1002/cne.22213; Fink M, 2006, DEV DYNAM, V235, P3370, DOI 10.1002/dvdy.20995; Freundlieb N, 2006, J NEUROSCI, V26, P2321, DOI 10.1523/JNEUROSCI.4859-05.2006; Fujimoto E, 2011, DEV BIOL, V352, P393, DOI 10.1016/j.ydbio.2011.01.023; Haas H, 2003, NAT REV NEUROSCI, V4, P121, DOI 10.1038/nrn1034; Holzschuh J, 2001, MECH DEVELOP, V101, P237, DOI 10.1016/S0925-4773(01)00287-8; Irons TD, 2013, PHARMACOL BIOCHEM BE, V103, P792, DOI 10.1016/j.pbb.2012.12.010; John J, 2013, ANN NEUROL, V74, P786, DOI 10.1002/ana.23968; Kaslin J, 2004, J NEUROSCI, V24, P2678, DOI 10.1523/JNEUROSCI.4908-03.2004; Kaslin J, 2001, J COMP NEUROL, V440, P342, DOI 10.1002/cne.1390; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KOBAYASHI K, 1995, J BIOL CHEM, V270, P27235, DOI 10.1074/jbc.270.45.27235; Kukko-Lukjanov TK, 2003, J CHEM NEUROANAT, V25, P279, DOI 10.1016/S0891-0618(03)00043-7; Lauter G, 2014, METHODS MOL BIOL, V1082, P175, DOI 10.1007/978-1-62703-655-9_12; Lindholm P, 2010, DEV NEUROBIOL, V70, P360, DOI 10.1002/dneu.20760; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Machluf Y, 2011, ANN NY ACAD SCI, V1220, P93, DOI 10.1111/j.1749-6632.2010.05945.x; Maggi R, 2015, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00440; McLean DL, 2004, J COMP NEUROL, V480, P57, DOI 10.1002/cne.20281; McPherson AD, 2016, CURR BIOL, V26, P263, DOI 10.1016/j.cub.2015.11.064; Mu Y, 2012, NEURON, V75, P688, DOI 10.1016/j.neuron.2012.05.035; Nyholm MK, 2007, DEVELOPMENT, V134, P735, DOI 10.1242/dev.02756; O'Keeffe GC, 2009, CELL CYCLE, V8, P2888, DOI 10.4161/cc.8.18.9512; PANULA P, 1990, NEUROSCIENCE, V34, P127, DOI 10.1016/0306-4522(90)90307-P; Panula P, 2014, TRENDS NEUROSCI, V37, P159, DOI 10.1016/j.tins.2014.01.001; Panula P, 2013, NAT REV NEUROSCI, V14, P472, DOI 10.1038/nrn3526; Popolo M, 2004, DEV NEUROSCI-BASEL, V26, P229, DOI 10.1159/000082140; PRELL GD, 1995, SCHIZOPHR RES, V14, P93, DOI 10.1016/0920-9964(94)00034-6; Reimer MM, 2013, DEV CELL, V25, P478, DOI 10.1016/j.devcel.2013.04.012; Ren GQ, 2013, J BIOL CHEM, V288, P22451, DOI 10.1074/jbc.M113.485227; Rink E, 2004, BRAIN RES, V1011, P206, DOI 10.1016/j.brainres.2004.03.027; Rink E, 2002, BRAIN RES BULL, V57, P385, DOI 10.1016/S0361-9230(01)00696-7; Rink E, 2002, DEV BRAIN RES, V137, P89, DOI 10.1016/S0165-3806(02)00354-1; Rinne JO, 2002, J NEUROCHEM, V81, P954, DOI 10.1046/j.1471-4159.2002.00871.x; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Russek-Blum N, 2008, DEVELOPMENT, V135, P3401, DOI 10.1242/dev.024232; Sallinen V, 2009, J NEUROCHEM, V108, P719, DOI 10.1111/j.1471-4159.2008.05793.x; Sallinen V, 2010, NEUROBIOL DIS, V40, P93, DOI 10.1016/j.nbd.2010.06.001; Sallinen V, 2009, J NEUROCHEM, V109, P403, DOI 10.1111/j.1471-4159.2009.05986.x; Schmidt U, 1996, NEUROSCIENCE, V74, P453, DOI 10.1016/0306-4522(96)00201-1; Schweitzer J, 2009, ADV EXP MED BIOL, V651, P1; Semenova SA, 2014, HISTOCHEM CELL BIOL, V142, P619, DOI 10.1007/s00418-014-1240-z; Sundvik M, 2015, ACTA PHYSIOL, V213, P321, DOI 10.1111/apha.12432; Sundvik M, 2013, J NEUROSCI, V33, P1589, DOI 10.1523/JNEUROSCI.1802-12.2013; Sundvik M, 2011, FASEB J, V25, P4338, DOI 10.1096/fj.11-188268; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; TODD RD, 1992, BIOL PSYCHIAT, V31, P794, DOI 10.1016/0006-3223(92)90311-M; Valko PO, 2013, ANN NEUROL, V74, P794, DOI 10.1002/ana.24019; Wang X, 2012, DEV CELL, V23, P624, DOI 10.1016/j.devcel.2012.07.012; Winterer G, 2004, TRENDS NEUROSCI, V27, P683, DOI 10.1016/j.tins.2004.08.002; Yamamoto K, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00021; Yamamoto K, 2011, J COMP NEUROL, V519, P576, DOI 10.1002/cne.22535; Yamamoto K, 2010, MOL CELL NEUROSCI, V43, P394, DOI 10.1016/j.mcn.2010.01.006; Yanovsky Y, 2011, J PHYSIOL-LONDON, V589, P1349, DOI 10.1113/jphysiol.2010.203257; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0	61	17	17	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					21880	21892		10.1074/jbc.M115.697466	http://dx.doi.org/10.1074/jbc.M115.697466			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27539857	hybrid, Green Published			2022-12-26	WOS:000386332600005
J	Lakhter, AJ; Hamilton, J; Konger, RL; Brustovetsky, N; Broxmeyer, HE; Naidu, SR				Lakhter, Alexander J.; Hamilton, James; Konger, Raymond L.; Brustovetsky, Nickolay; Broxmeyer, Hal E.; Naidu, Samisubbu R.			Glucose-independent Acetate Metabolism Promotes Melanoma Cell Survival and Tumor Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetyl-CoA synthetase; bioenergetics; glucose metabolism; glutamine; glycolysis; melanoma; mitochondria; acetate metabolism; glycolysis; melanoma; ACSS1; ACSS2	MITOCHONDRIAL PYRUVATE CARRIER; OXIDATIVE-METABOLISM; CANCER-CELLS; SYNTHETASE; BRAF; EXPRESSION; COLON; SUPPLEMENTATION; PROLIFERATION; CONTRIBUTES	Tumors rely on multiple nutrients to meet cellular bioenergetics and macromolecular synthesis demands of rapidly dividing cells. Although the role of glucose and glutamine in cancer metabolism is well understood, the relative contribution of acetate metabolism remains to be clarified. We show that glutamine supplementation is not sufficient to prevent loss of cell viability in a subset of glucose-deprived melanoma cells, but synergizes with acetate to support cell survival. Glucose-deprived melanoma cells depend on both oxidative phosphorylation and acetate metabolism for cell survival. Acetate supplementation significantly contributed to maintenance of ATP levels in glucose-starved cells. Unlike acetate, short chain fatty acids such as butyrate and propionate failed to prevent loss of cell viability from glucose deprivation. In vivo studies revealed that in addition to nucleo-cytoplasmic acetate assimilating enzyme ACSS2, mitochondrial ACSS1 was critical for melanoma tumor growth in mice. Our data indicate that acetate metabolism may be a potential therapeutic target for BRAF mutant melanoma.	[Lakhter, Alexander J.; Broxmeyer, Hal E.; Naidu, Samisubbu R.] Indiana Univ Sch Med, Dept Immunol & Microbiol, Indianapolis, IN 46202 USA; [Hamilton, James; Brustovetsky, Nickolay] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Konger, Raymond L.] Indiana Univ Sch Med, Dept Pathol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Naidu, SR (corresponding author), Indiana Univ Sch Med, Dept Immunol & Microbiol, Indianapolis, IN 46202 USA.	naidus@iu.edu		Naidu, Samisubbu/0000-0001-9411-660X	Indiana CTSI Independent Scientist Award; Indiana CTSI Core awards; Showalter award; National Institutes of Health [NS078008]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078008] Funding Source: NIH RePORTER	Indiana CTSI Independent Scientist Award; Indiana CTSI Core awards; Showalter award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the Indiana CTSI Independent Scientist Award, Indiana CTSI Core awards, and the Showalter award (to S. R. N.) and National Institutes of Health Grant NS078008 (to N. B.). Hal Broxmeyer committed significant financial resources for completion of this project. The authors declare that they have no conflicts of interest with the content of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Balsa-Martinez E, 2015, MOL CELL, V60, P509, DOI 10.1016/j.molcel.2015.11.005; Birsoy K, 2014, NATURE, V508, P108, DOI 10.1038/nature13110; Bjornson E, 2015, CELL REP, V13, P2014, DOI 10.1016/j.celrep.2015.10.045; Bollag G, 2012, NAT REV DRUG DISCOV, V11, P873, DOI 10.1038/nrd3847; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Bricker DK, 2012, SCIENCE, V337, P96, DOI 10.1126/science.1218099; Brogsitter C, 2013, EUR J NUCL MED MOL I, V40, pS18, DOI 10.1007/s00259-013-2358-2; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Comerford SA, 2014, CELL, V159, P1591, DOI 10.1016/j.cell.2014.11.020; Cresci GA, 2014, ALCOHOL CLIN EXP RES, V38, P1489, DOI 10.1111/acer.12428; Fedorenko IV, 2015, BRIT J CANCER, V112, P217, DOI 10.1038/bjc.2014.476; Fujino T, 2001, J BIOL CHEM, V276, P11420, DOI 10.1074/jbc.M008782200; Gu JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005767; Haq R, 2013, CANCER CELL, V23, P302, DOI 10.1016/j.ccr.2013.02.003; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hensley CT, 2016, CELL, V164, P681, DOI 10.1016/j.cell.2015.12.034; Herzig S, 2012, SCIENCE, V337, P93, DOI 10.1126/science.1218530; Hill EW, 2010, ANIM GENET, V41, P56, DOI 10.1111/j.1365-2052.2010.02104.x; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; Kaplon J, 2013, NATURE, V498, P109, DOI 10.1038/nature12154; Kluza J, 2012, CANCER RES, V72, P5035, DOI 10.1158/0008-5472.CAN-12-0979; Lakhter AJ, 2014, ONCOTARGET, V5, P12694, DOI 10.18632/oncotarget.3031; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Liang XY, 2012, CANCER RES, V72, P2791, DOI 10.1158/0008-5472.CAN-12-0320; MARAGOS CM, 1993, CANCER RES, V53, P564; Mashimo T, 2014, CELL, V159, P1603, DOI 10.1016/j.cell.2014.11.025; Miller MA, 2016, VET PATHOL, V53, P390, DOI 10.1177/0300985815608674; NUUTINEN H, 1985, ALCOHOL, V2, P623, DOI 10.1016/0741-8329(85)90090-4; Olson KA, 2016, TRENDS BIOCHEM SCI, V41, P219, DOI 10.1016/j.tibs.2016.01.002; Oyama N, 2002, J NUCL MED, V43, P181; Parmenter TJ, 2014, CANCER DISCOV, V4, P423, DOI 10.1158/2159-8290.CD-13-0440; Perry RJ, 2016, NATURE, V534, P213, DOI 10.1038/nature18309; Phillips JC, 2013, VET CLIN N AM-EQUINE, V29, P673, DOI 10.1016/j.cveq.2013.08.008; Pollak M, 2013, CANCER CELL, V23, P263, DOI 10.1016/j.ccr.2013.02.015; POMARE EW, 1985, J CLIN INVEST, V75, P1448, DOI 10.1172/JCI111847; Reijnders D, 2016, CELL METAB, V24, P63, DOI [10.1016/j.cmet.2016.06.016, 10.1016/j.cmet.2016.07.008]; Richards R H, 1976, Proc Clin Dial Transplant Forum, V6, P73; Roesch A, 2013, CANCER CELL, V23, P811, DOI 10.1016/j.ccr.2013.05.003; Sakakibara I, 2009, CELL METAB, V9, P191, DOI 10.1016/j.cmet.2008.12.008; Schell JC, 2014, MOL CELL, V56, P400, DOI 10.1016/j.molcel.2014.09.026; Schug ZT, 2015, CANCER CELL, V27, P57, DOI 10.1016/j.ccell.2014.12.002; Segel R, 2011, MOL GENET METAB, V103, P203, DOI 10.1016/j.ymgme.2011.03.012; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Tan AS, 2015, CELL METAB, V21, P81, DOI 10.1016/j.cmet.2014.12.003; Trajkovski M, 2016, NATURE, V534, P185, DOI 10.1038/534185a; Tsen AR, 2014, INT J CANCER, V134, P1300, DOI 10.1002/ijc.28465; Tsuchida T, 2008, NUCL MED BIOL, V35, P171, DOI 10.1016/j.nucmedbio.2007.11.004; Vazquez F, 2013, CANCER CELL, V23, P287, DOI 10.1016/j.ccr.2012.11.020; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Xu M, 2014, NAT MED, V20, P1018, DOI 10.1038/nm.3587; Yamamoto J, 2004, J BIOL CHEM, V279, P16954, DOI 10.1074/jbc.M312079200; Yu Y, 2015, J DRUGS DERMATOL, V14, P461; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229; Yun M, 2009, J NUCL MED, V50, P1222, DOI 10.2967/jnumed.109.062703; ZAKUT R, 1993, CANCER RES, V53, P5; Zietak M, 2016, CELL METAB, V23, P1216, DOI 10.1016/j.cmet.2016.05.001	59	37	39	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					21869	21879		10.1074/jbc.M115.712166	http://dx.doi.org/10.1074/jbc.M115.712166			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27539851	Green Published, hybrid			2022-12-26	WOS:000386332600004
J	Dukel, M; Streitfeld, WS; Tang, TCC; Backman, LRF; Ai, LB; May, WS; Brown, KD				Dukel, Muzaffer; Streitfeld, W. Scott; Tang, Tsz Ching Chloe; Backman, Lindsey R. F.; Ai, Lingbao; May, W. Stratford; Brown, Kevin D.			The Breast Cancer Tumor Suppressor TRIM29 Is Expressed via ATM-dependent Signaling in Response to Hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						breast cancer; cell signaling; hypoxia; hypoxia-inducible factor (HIF); tumor suppressor gene	UBIQUITIN-PROTEASOME PATHWAY; DOUBLE-STRAND BREAKS; NF-KAPPA-B; ATAXIA-TELANGIECTASIA; GENE-EXPRESSION; INDUCIBLE FACTOR-1; OXIDATIVE STRESS; PANCREATIC-CANCER; FACTOR 1-ALPHA; DNA-DAMAGE	Reduced ATM function has been linked to breast cancer risk, and the TRIM29 protein is an emerging breast cancer tumor suppressor. Here we show that, in cultured breast tumor and non-tumorigenic mammary epithelial cells, TRIM29 is up-regulated in response to hypoxic stress but not DNA damage. Hypoxia-induced up-regulation of TRIM29 is dependent upon ATM and HIF1 and occurs through increased transcription of the TRIM29 gene. Basal expression of TRIM29 is also down-regulated in cells expressing diminished levels of ATM, and findings suggest that this occurs through basal NF-B activity as knockdown of the NF-B subunit RelA suppresses TRIM29 abundance. We have previously shown that the activity of the TWIST1 oncogene is antagonized by TRIM29 and now show that TRIM29 is necessary to block the up-regulation of TWIST1 that occurs in response to hypoxic stress. This study establishes TRIM29 as a hypoxia-induced tumor suppressor gene and provides a novel molecular mechanism for ATM-dependent breast cancer suppression.	[Dukel, Muzaffer; Backman, Lindsey R. F.; Ai, Lingbao; Brown, Kevin D.] Univ Florida, Coll Med, Dept Biochem & Mol Biol, 1200 Newell Dr,Box 1000245, Gainesville, FL 32610 USA; [Streitfeld, W. Scott; Tang, Tsz Ching Chloe; May, W. Stratford] Univ Florida, Coll Med, Dept Med, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Brown, KD (corresponding author), Univ Florida, Coll Med, Dept Biochem & Mol Biol, 1200 Newell Dr,Box 1000245, Gainesville, FL 32610 USA.	kdbrown1@ufl.edu			National Institutes of Health [R03 CA12582]; Florida Department of Health; Violet Brownhill Trust; Scientific and Technological Research Council of Turkey (TUBITAK); NATIONAL CANCER INSTITUTE [P01CA012582] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Department of Health; Violet Brownhill Trust; Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant R03 CA12582 and funds from the Florida Department of Health and the Violet Brownhill Trust (to K. D. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a research fellowship from the Scientific and Technological Research Council of Turkey (TUBITAK). Present address: Dept. of Biology, Mehmet Akif Ersoy University, Burdur, Turkey.	Ai LB, 2008, CARCINOGENESIS, V29, P510, DOI 10.1093/carcin/bgm280; Ai LB, 2014, CANCER RES, V74, P4875, DOI 10.1158/0008-5472.CAN-13-3579; Ai LB, 2012, J BIOL CHEM, V287, P18330, DOI 10.1074/jbc.M112.339317; Alpay M, 2015, BREAST CANCER RES TR, V151, P75, DOI 10.1007/s10549-015-3368-5; Angele S, 2000, CLIN CANCER RES, V6, P3536; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bebb DG, 1999, BRIT J CANCER, V80, P1979, DOI 10.1038/sj.bjc.6690630; BelAiba RS, 2007, MOL BIOL CELL, V18, P4691, DOI 10.1091/mbc.E07-04-0391; Bencokova Z, 2009, MOL CELL BIOL, V29, P526, DOI 10.1128/MCB.01301-08; Bernstein JL, 2006, HUM MUTAT, V27, P1122, DOI 10.1002/humu.20415; Bernstein JL, 2003, BRIT J CANCER, V89, P1513, DOI 10.1038/sj.bjc.6601289; Broeks A, 2000, AM J HUM GENET, V66, P494, DOI 10.1086/302746; Buchler P, 2003, PANCREAS, V26, P56, DOI 10.1097/00006676-200301000-00010; Cam H, 2010, MOL CELL, V40, P509, DOI 10.1016/j.molcel.2010.10.030; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chan DA, 2007, CANCER METAST REV, V26, P333, DOI 10.1007/s10555-007-9063-1; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chenevix-Trench G, 2002, JNCI-J NATL CANCER I, V94, P205, DOI 10.1093/jnci/94.3.205; CORTESSIS V, 1993, CANCER RES, V53, P5083; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; FitzGerald MG, 1997, NAT GENET, V15, P307, DOI 10.1038/ng0397-307; Freiberg RA, 2006, MOL CELL BIOL, V26, P1598, DOI 10.1128/MCB.26.5.1598-1609.2006; Fristrup N, 2013, AM J PATHOL, V182, P339, DOI 10.1016/j.ajpath.2012.10.017; Gerald D, 2004, CELL, V118, P781, DOI 10.1016/j.cell.2004.08.025; Gibson SL, 2005, CANCER RES, V65, P10734, DOI 10.1158/0008-5472.CAN-05-1160; Gilkes DM, 2013, FUTURE ONCOL, V9, P1623, DOI [10.2217/fon.13.92, 10.2217/FON.13.92]; Glebov OK, 2006, CANCER EPIDEM BIOMAR, V15, P2253, DOI 10.1158/1055-9965.EPI-05-0694; Golding SE, 2011, CELL CYCLE, V10, P3227, DOI 10.4161/cc.10.19.17048; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Hatakeyama S, 2011, NAT REV CANCER, V11, P792, DOI 10.1038/nrc3139; Hosoi Y, 2006, BIOCHEM BIOPH RES CO, V348, P728, DOI 10.1016/j.bbrc.2006.07.115; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Iacobuzio-Donahue CA, 2003, CANCER RES, V63, P8614; Iwai K, 1999, P NATL ACAD SCI USA, V96, P12436, DOI 10.1073/pnas.96.22.12436; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kairouz R, 1999, J CLIN PATHOL-MOL PA, V52, P252, DOI 10.1136/mp.52.5.252; Kallio PJ, 1999, J BIOL CHEM, V274, P6519, DOI 10.1074/jbc.274.10.6519; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Kim W, 2003, CURR OPIN GENET DEV, V13, P55, DOI 10.1016/S0959-437X(02)00010-2; Kosaka Y, 2007, ANN SURG ONCOL, V14, P2543, DOI 10.1245/s10434-007-9461-1; Langholz B, 2006, INT J CANCER, V119, P724, DOI 10.1002/ijc.21876; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Liu J, 2012, AM J PATHOL, V180, P839, DOI 10.1016/j.ajpath.2011.10.020; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu HS, 2005, J BIOL CHEM, V280, P41928, DOI 10.1074/jbc.M508718200; Masuda Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8299; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Pilch DR, 2003, BIOCHEM CELL BIOL, V81, P123, DOI 10.1139/o03-042; PIPPARD EC, 1988, CANCER RES, V48, P2929; Rashi-Elkeles S, 2006, ONCOGENE, V25, P1584, DOI 10.1038/sj.onc.1209189; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Shafman TD, 2000, GENE CHROMOSOME CANC, V27, P124, DOI 10.1002/(SICI)1098-2264(200002)27:2<124::AID-GCC2>3.0.CO;2-M; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Stankovic T, 1998, AM J HUM GENET, V62, P334, DOI 10.1086/301706; SWIFT M, 1987, NEW ENGL J MED, V316, P1289, DOI 10.1056/NEJM198705213162101; SWIFT M, 1991, NEW ENGL J MED, V325, P1831, DOI 10.1056/NEJM199112263252602; Tang ZP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063676; Taylor AMR, 1996, BLOOD, V87, P423, DOI 10.1182/blood.V87.2.423.bloodjournal872423; Thompson D, 2005, JNCI-J NATL CANCER I, V97, P813, DOI 10.1093/jnci/dji141; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; Veuger SJ, 2011, DNA REPAIR, V10, P235, DOI 10.1016/j.dnarep.2010.11.005; Vo QN, 2004, ONCOGENE, V23, P9432, DOI 10.1038/sj.onc.1208092; Wang LD, 2015, GENE DEV, V29, P171, DOI 10.1101/gad.253591.114; Wang LD, 2009, CANCER CELL, V15, P207, DOI 10.1016/j.ccr.2009.01.018; WOOSTER R, 1993, HUM GENET, V92, P91, DOI 10.1007/BF00216153; Xiao ZX, 2013, CANCER CELL, V23, P527, DOI 10.1016/j.ccr.2013.03.009; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Zundel W, 2000, GENE DEV, V14, P391	73	15	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21541	21552		10.1074/jbc.M116.730960	http://dx.doi.org/10.1074/jbc.M116.730960			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27535224	Green Published, hybrid			2022-12-26	WOS:000385999200021
J	Hashimoto, M; Ozono, M; Furuyashiki, M; Baba, R; Hashiguchi, S; Suda, Y; Fukase, K; Fujimoto, Y				Hashimoto, Masahito; Ozono, Mami; Furuyashiki, Maiko; Baba, Risako; Hashiguchi, Shuhei; Suda, Yasuo; Fukase, Koichi; Fujimoto, Yukari			Characterization of a Novel D-Glycero-D-talo-oct-2-ulosonic acid-substituted Lipid A Moiety in the Lipopolysaccharide Produced by the Acetic Acid Bacterium Acetobacter pasteurianus NBRC 3283	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIA; PROTON COUPLING-CONSTANTS; CALCOACETICUS NCTC 10305; MASS-SPECTROMETRY; STRUCTURAL-CHARACTERIZATION; CARBOHYDRATE BACKBONE; FATTY-ACIDS; MESORHIZOBIUM; CHROMATOGRAPHY; SEPARATION	Acetobacter pasteurianus is an aerobic Gram-negative rod that is used in the fermentation process used to produce the traditional Japanese black rice vinegar kurozu. Previously, we found that a hydrophobic fraction derived from kurozu stimulates Toll-like receptors to produce cytokines. LPSs, particularly LPS from A. pasteurianus, are strong candidates for the immunostimulatory component of kurozu. The LPS of A. pasteurianus remains stable in acidic conditions during the 2 years of the abovementioned fermentation process. Thus, we hypothesized that its stability results from its structure. In this study, we isolated the LPS produced by A. pasteurianus NBRC 3283 bacterial cells and characterized the structure of its lipid A component. The lipid A moiety was obtained by standard weak acid hydrolysis of the LPS. However, the hydrolysis was incomplete because a certain proportion of the LPS contained acid-stable D-glycero-D-talo-oct-2-ulosonic acid (Ko) residues instead of the acid-labile 3-deoxy-D-manno-oct-2-ulosonic acid residues that are normally found in typical LPS. Even so, we obtained a Ko-substituted lipid A with a novel sugar backbone, alpha-Man(14)[alpha-Ko(2-6)]beta-GlcN3N(1-6)alpha-GlcN(1-1)alpha-GlcA. Its reducing end GlcN(1-1) GlcA bond was also found to be quite acid-stable. Six fatty acids were attached to the backbone. Both the whole LPS and the lipid A moiety induced TNF-alpha production in murine cells via Toll-like receptor 4, although their activity was weaker than those of Escherichia coli LPS and lipid A. These results suggest that the structurally atypical A. pasteurianus lipid A found in this study remains stable and, hence, retains its immunostimulatory activity during acetic acid fermentation.	[Hashimoto, Masahito; Ozono, Mami; Furuyashiki, Maiko; Baba, Risako; Hashiguchi, Shuhei; Suda, Yasuo] Kagoshima Univ, Dept Chem Biotechnol & Chem Engn, Korimoto 1-21-40, Kagoshima 8900065, Japan; [Fukase, Koichi] Osaka Univ, Grad Sch Sci, Dept Chem, Osaka 5600043, Japan; [Fujimoto, Yukari] Keio Univ, Fac Sci & Technol, Yokohama, Kanagawa 2238522, Japan	Kagoshima University; Osaka University; Keio University	Hashimoto, M (corresponding author), Kagoshima Univ, Dept Chem Biotechnol & Chem Engn, Korimoto 1-21-40, Kagoshima 8900065, Japan.	hassy@eng.kagoshima-u.ac.jp	Fujimoto, Yukari/M-7282-2014	Fujimoto, Yukari/0000-0001-5320-3192	Adaptable and Seamless Technology Transfer Program through Japan Science and Technology Agency [AS2111291E]; Japan Society for the Promotion of Science [23510259, 26350961]; Grants-in-Aid for Scientific Research [15H05836] Funding Source: KAKEN	Adaptable and Seamless Technology Transfer Program through Japan Science and Technology Agency; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Adaptable and Seamless Technology Transfer Program through Grant AS2111291E from the Japan Science and Technology Agency and Grants-in-Aid for Scientific Research 23510259 and 26350961 from the Japan Society for the Promotion of Science. The authors declare that they have no conflicts of interest with the contents of this article.	ALTONA C, 1980, ORG MAGN RESONANCE, V13, P417, DOI 10.1002/mrc.1270130606; ASHWELL G, 1957, METHOD ENZYMOL, V3, P73, DOI 10.1016/S0076-6879(57)03350-9; Azuma Y, 2009, NUCLEIC ACIDS RES, V37, P5768, DOI 10.1093/nar/gkp612; Choma A, 2004, EUR J BIOCHEM, V271, P1310, DOI 10.1111/j.1432-1033.2004.04038.x; Choma A, 2012, CARBOHYD RES, V352, P126, DOI 10.1016/j.carres.2012.03.003; Chung HS, 2011, P NATL ACAD SCI USA, V108, P510, DOI 10.1073/pnas.1016462108; El-Samalouti VT, 2000, METH MOL B, V145, P287; FISCHER W, 1990, EUR J BIOCHEM, V194, P655, DOI 10.1111/j.1432-1033.1990.tb15665.x; Fujimoto Y, 2005, J ENDOTOXIN RES, V11, P340, DOI 10.1179/096805105X76841; Fukase Y, 2001, SYNLETT, P1693; GASS J, 1993, CARBOHYD RES, V244, P69, DOI 10.1016/0008-6215(93)80005-Y; GERWIG GJ, 1978, CARBOHYD RES, V62, P349, DOI 10.1016/S0008-6215(00)80881-2; GRADOWSKA W, 1994, J MICROBIOL METH, V20, P55, DOI 10.1016/0167-7012(94)90064-7; HAISHIMA Y, 1992, EUR J BIOCHEM, V203, P127, DOI 10.1111/j.1432-1033.1992.tb19837.x; Hashimoto M, 2006, INT IMMUNOL, V18, P355, DOI 10.1093/intimm/dxh374; Hashimoto M, 2004, INT IMMUNOL, V16, P1431, DOI 10.1093/intimm/dxh146; Hashimoto M, 2013, J BIOSCI BIOENG, V116, P688, DOI 10.1016/j.jbiosc.2013.05.029; Hashimoto M, 2012, MICROBES ENVIRON, V27, P490, DOI 10.1264/jsme2.ME12103; Holst O, 2011, BACTERIAL LIPOPOLYSACCHARIDES: STRUCTURE, CHEMICAL SYNTHESIS, BIOGENESIS AND INTERACTION WITH HOST CELLS, P21, DOI 10.1007/978-3-7091-0733-1_2; IKEMOTO S, 1978, J GEN APPL MICROBIOL, V24, P41, DOI 10.2323/jgam.24.41; Kabanov DS, 2010, BIOCHEMISTRY-MOSCOW+, V75, P383, DOI 10.1134/S0006297910040012; Kato H, 1998, J BACTERIOL, V180, P3891, DOI 10.1128/JB.180.15.3891-3899.1998; Komaniecka I, 2010, MICROBIOL IMMUNOL, V54, P717, DOI 10.1111/j.1348-0421.2010.00269.x; Komaniecka I, 2010, CHEM-EUR J, V16, P2922, DOI 10.1002/chem.200902390; Kussak A, 2002, ANAL BIOCHEM, V307, P131, DOI 10.1016/S0003-2697(02)00004-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mayer H., 1985, METH MICROBIOL, V18, P157, DOI [10.1016/S0580-9517(08)70475-6, DOI 10.1016/S0580-9517(08)70475-6]; Murooka Yoshikatsu, 2009, P121, DOI 10.1007/978-88-470-0866-3_7; Nanda K, 2001, APPL ENVIRON MICROB, V67, P986, DOI 10.1128/AEM.67.2.986-990.2001; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; Seydel U, 2005, FEBS J, V272, P327, DOI 10.1111/j.1742-4658.2004.04471.x; Shaffer SA, 2007, J AM SOC MASS SPECTR, V18, P1080, DOI 10.1016/j.jasms.2007.03.008; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Silipo A, 2005, CARBOHYD RES, V340, P2540, DOI 10.1016/j.carres.2005.08.021; Taniguchi Y, 2006, ANTICANCER RES, V26, P3997; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Tsukushi Y, 2004, J ENDOTOXIN RES, V10, P25, DOI 10.1179/096805104225003799; Tvaroska I, 1995, ADV CARBOHYD CHEM BI, V51, P15, DOI 10.1016/S0065-2318(08)60191-2; Velasco J, 1998, CARBOHYD RES, V306, P283, DOI 10.1016/S0008-6215(97)10029-5; Vinogradov EV, 1998, J BIOL CHEM, V273, P28122, DOI 10.1074/jbc.273.43.28122; Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030; Yasuno S, 1999, BIOSCI BIOTECH BIOCH, V63, P1353, DOI 10.1271/bbb.63.1353; Zahringer U, 2013, CARBOHYD RES, V378, P63, DOI 10.1016/j.carres.2013.05.003	43	17	17	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					21184	21194		10.1074/jbc.M116.751271	http://dx.doi.org/10.1074/jbc.M116.751271			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27539854	Green Published, hybrid			2022-12-26	WOS:000385406200032
J	Abnousi, A; Broschat, SL; Kalyanaraman, A				Abnousi, Armen; Broschat, Shira L.; Kalyanaraman, Ananth			A Fast Alignment-Free Approach for De Novo Detection of Protein Conserved Regions	PLOS ONE			English	Article							DOMAIN PREDICTION; IDENTIFICATION; DATABASE; TOOL	Background Identifying conserved regions in protein sequences is a fundamental operation, occurring in numerous sequence-driven analysis pipelines. It is used as a way to decode domain-rich regions within proteins, to compute protein clusters, to annotate sequence function, and to compute evolutionary relationships among protein sequences. A number of approaches exist for identifying and characterizing protein families based on their domains, and because domains represent conserved portions of a protein sequence, the primary computation involved in protein family characterization is identification of such conserved regions. However, identifying conserved regions from large collections (millions) of protein sequences presents significant challenges. Methods In this paper we present a new, alignment-free method for detecting conserved regions in protein sequences called NADDA (No-Alignment Domain Detection Algorithm). Our method exploits the abundance of exact matching short subsequences (k-mers) to quickly detect conserved regions, and the power of machine learning is used to improve the prediction accuracy of detection. We present a parallel implementation of NADDA using the MapReduce framework and show that our method is highly scalable. Results We have compared NADDA with Pfam and InterPro databases. For known domains annotated by Pfam, accuracy is 83%, sensitivity 96%, and specificity 44%. For sequences with new domains not present in the training set an average accuracy of 63% is achieved when compared to Pfam. A boost in results in comparison with InterPro demonstrates the ability of NADDA to capture conserved regions beyond those present in Pfam. We have also compared NADDA with ADDA and MKDOM2, assuming Pfam as ground-truth. On average NADDA shows comparable accuracy, more balanced sensitivity and specificity, and being alignment-free, is significantly faster. Excluding the one-time cost of training, runtimes on a single processor were 49s, 10,566s, and 456s for NADDA, ADDA, and MKDOM2, respectively, for a data set comprised of approximately 2500 sequences.	[Abnousi, Armen; Broschat, Shira L.; Kalyanaraman, Ananth] Washington State Univ, Sch EECS, Pullman, WA 99164 USA; [Broschat, Shira L.; Kalyanaraman, Ananth] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA; [Broschat, Shira L.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA	Washington State University; Washington State University; Washington State University	Abnousi, A (corresponding author), Washington State Univ, Sch EECS, Pullman, WA 99164 USA.	aabnousi@eecs.wsu.edu			National Science Foundation under the Advances in Biological Informatics program (NSF ABI) [1262664]; U.S. National Science Foundation under the Advances in Biological Informatics program [DBI 1262664]; Div Of Biological Infrastructure [1262664] Funding Source: National Science Foundation	National Science Foundation under the Advances in Biological Informatics program (NSF ABI); U.S. National Science Foundation under the Advances in Biological Informatics program; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded by support from the National Science Foundation under the Advances in Biological Informatics program (NSF ABI), Award #1262664 (URL: http://nsf.gov/awardsearch/showAward?AWD_ID=1262664&HistoricalAwards=false). Award is received by SLB and AK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Prof. Janardhan (Jana) Rao Doppa (Washington State University) for his advice on the use of machine learning algorithms. This work was funded by support from the U.S. National Science Foundation under the Advances in Biological Informatics program, Award DBI 1262664.	Abnousi A, 2015, P 6 ACM C BIOINF COM, P597; Agrawal R, 1999, METHOD SYSTEM GENERA; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Breiman L., 2017, CLASSIFICATION REGRE; Bru C, 2005, NUCLEIC ACIDS RES, V33, pD212, DOI 10.1093/nar/gki034; Consortium U, 2014, NUCLEIC ACIDS RES; DOOLITTLE RF, 1993, SCI AM, V269, P50, DOI 10.1038/scientificamerican1093-50; Eickholt J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-43; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Gouzy J, 1997, COMPUT APPL BIOSCI, V13, P601; Gouzy J, 1999, COMPUT CHEM, V23, P333, DOI 10.1016/S0097-8485(99)00011-X; Haft DH, 2012, NUCLEIC ACIDS RES; Heger A, 2003, J MOL BIOL, V328, P749, DOI 10.1016/S0022-2836(03)00269-9; Ho TK, 1998, IEEE T PATTERN ANAL, V20, P832, DOI 10.1109/34.709601; Jin RM, 2003, SIAM PROC S, P119; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kahn D, 2008, PROCEEDINGS OF THE 2008 14TH IEEE INTERNATIONAL CONFERENCE ON PARALLEL AND DISTRIBUTED SYSTEMS, P72, DOI 10.1109/ICPADS.2008.115; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Plimpton SJ, 2011, PARALLEL COMPUT, V37, P610, DOI 10.1016/j.parco.2011.02.004; Portugaly E, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-277; Quinlan J. R., 1983, MACHINE LEARNING ART, P463, DOI [DOI 10.1007/978-3-662-12405-5_15, 10.1007/978-3-662-12405-5_15]; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; SONNHAMMER ELL, 1994, PROTEIN SCI, V3, P482; Srivastava A, 1999, PARALLEL FORMULATION; Tai CH, 2005, PROTEINS, V61, P183, DOI 10.1002/prot.20736; Tress M, 2007, PROTEINS, V69, P137, DOI 10.1002/prot.21675; Zaharia M., 2010, P 2 USENIX C HOT TOP, P10, DOI DOI 10.HTTP://DL.ACM.0RG/CITATI0N.CFM?	31	1	2	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0161338	10.1371/journal.pone.0161338	http://dx.doi.org/10.1371/journal.pone.0161338			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27552220	Green Published, Green Submitted, gold			2022-12-26	WOS:000381768800031
J	Koob, M; Viola, A; Le Fur, Y; Viout, P; Ratiney, H; Confort-Gouny, S; Cozzone, PJ; Girard, N				Koob, Meriam; Viola, Angele; Le Fur, Yann; Viout, Patrick; Ratiney, Helene; Confort-Gouny, Sylviane; Cozzone, Patrick J.; Girard, Nadine			Creatine, Glutamine plus Glutamate, and Macromolecules Are Decreased in the Central White Matter of Premature Neonates around Term	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; CENTRAL-NERVOUS-SYSTEM; EXTREMELY PRETERM INFANTS; PROTON MR SPECTROSCOPY; T-2 RELAXATION-TIMES; BRAIN IN-VIVO; EQUIVALENT AGE; CEREBRAL METABOLITES; LANGUAGE-DEVELOPMENT; DEFICIENCY SYNDROMES	Preterm birth represents a high risk of neurodevelopmental disabilities when associated with white-matter damage. Recent studies have reported cognitive deficits in children born preterm without brain injury on MRI at term-equivalent age. Understanding the microstructural and metabolic underpinnings of these deficits is essential for their early detection. Here, we used diffusion-weighted imaging and single-voxel H-1 magnetic resonance spectroscopy (MRS) to compare brain maturation at term-equivalent age in premature neonates with no evidence of white matter injury on conventional MRI except diffuse excessive highsignal intensity, and normal term neonates. Thirty-two infants, 16 term neonates (mean post-conceptional age at scan: 39.8 +/- 1 weeks) and 16 premature neonates (mean gestational age at birth: 29.1 +/- 2 weeks, mean post-conceptional age at scan: 39.2 +/- 1 weeks) were investigated. The MRI/MRS protocol performed at 1.5T involved diffusion-weighted MRI and localized H-1-MRS with the Point RESolved Spectroscopy (PRESS) sequence. Preterm neonates showed significantly higher ADC values in the temporal white matter (P<0.05), the occipital white matter (P<0.005) and the thalamus (P<0.05). The proton spectrum of the centrum semiovale was characterized by significantly lower taurine/H2O and macromolecules/ H2O ratios (P<0.05) at a TE of 30 ms, and reduced (creatine+phosphocreatine)/H2O and (glutamine+ glutamate)/H2O ratios (P<0.05) at a TE of 135 ms in the preterm neonates than in full-term neonates. Our findings indicate that premature neonates with normal conventional MRI present a delay in brain maturation affecting the white matter and the thalamus. Their brain metabolic profile is characterized by lower levels of creatine, glutamine plus glutamate, and macromolecules in the centrum semiovale, a finding suggesting altered energy metabolism and protein synthesis.	[Koob, Meriam; Girard, Nadine] Aix Marseille Univ, AP HM Timone, Serv Neuroradiol, Marseille, France; [Koob, Meriam] CHU Strasbourg, Hop Hautepierre, Serv Radiopediat Imagerie 2, Strasbourg, France; [Koob, Meriam] Univ Strasbourg, CNRS, Lab ICube, UMR 7357,FMTS, Strasbourg, France; [Viola, Angele; Le Fur, Yann; Viout, Patrick; Confort-Gouny, Sylviane; Cozzone, Patrick J.; Girard, Nadine] Aix Marseille Univ, CNRS, Ctr Resonance Magnet Biol & Med, Fac Med Timone,UMR 7339, Marseille, France; [Ratiney, Helene] Univ Lyon 1, INSA Lyon, Lab CREATIS, CNRS UMR 5220,Inserm U1044, Lyon, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Girard, N (corresponding author), Aix Marseille Univ, AP HM Timone, Serv Neuroradiol, Marseille, France.; Viola, A; Girard, N (corresponding author), Aix Marseille Univ, CNRS, Ctr Resonance Magnet Biol & Med, Fac Med Timone,UMR 7339, Marseille, France.	angele.viola@univ-amu.fr; Nadine.girard@ap-hm.fr	, Girard/E-8537-2013; Ratiney, Helene/K-9503-2019; Ratiney, Helene/H-4186-2014; Girard, Nadine/B-7109-2017	, Girard/0000-0001-8639-9275; Ratiney, Helene/0000-0002-0662-2172; Ratiney, Helene/0000-0002-0662-2172; 				Aeby A, 2013, NEUROIMAGE, V78, P145, DOI 10.1016/j.neuroimage.2013.03.076; Andres RH, 2008, BRAIN RES BULL, V76, P329, DOI 10.1016/j.brainresbull.2008.02.035; Anjari M, 2007, NEUROIMAGE, V35, P1021, DOI 10.1016/j.neuroimage.2007.01.035; Back SA, 2007, STROKE, V38, P724, DOI 10.1161/01.STR.0000254729.27386.05; Ball G, 2013, CORTEX, V49, P1711, DOI 10.1016/j.cortex.2012.07.006; Bapat R, 2014, PEDIATR NEUROL, V51, P53, DOI 10.1016/j.pediatrneurol.2014.03.011; Beard E, 2010, J NEUROCHEM, V115, P297, DOI 10.1111/j.1471-4159.2010.06935.x; BEHAR KL, 1993, MAGNET RESON MED, V30, P38, DOI 10.1002/mrm.1910300107; BEHAR KL, 1994, MAGNET RESON MED, V32, P294, DOI 10.1002/mrm.1910320304; Bianchi MC, 2007, AM J NEURORADIOL, V28, P548; Bluml S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085829; Braissant O, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-9; Braissant O, 2012, J INHERIT METAB DIS, V35, P655, DOI 10.1007/s10545-011-9433-2; Braissant O, 2011, AMINO ACIDS, V40, P1315, DOI 10.1007/s00726-011-0852-z; Braissant O, 2010, NEUROBIOL DIS, V37, P423, DOI 10.1016/j.nbd.2009.10.022; Brand A, 1998, J NEUROCHEM, V71, P827; Brekke E, 2015, NEUROCHEM INT, V82, P33, DOI 10.1016/j.neuint.2015.02.002; Choi CH, 2006, MAGN RESON MED, V56, P971, DOI 10.1002/mrm.21055; Constable RT, 2008, PEDIATRICS, V121, P306, DOI 10.1542/peds.2007-0414; de Graaf-Peters VB, 2006, EARLY HUM DEV, V82, P257, DOI 10.1016/j.earlhumdev.2005.10.013; Fulford J, 2009, SEMIN PERINATOL, V33, P281, DOI 10.1053/j.semperi.2009.04.006; Girard N, 2006, EUR J RADIOL, V57, P217, DOI 10.1016/j.ejrad.2005.11.021; Girard N, 2006, MAGN RESON MED, V56, P768, DOI 10.1002/mrm.21017; Huppi PS, 1996, PEDIATR RES, V39, P895; Huppi PS, 1998, PEDIATR RES, V44, P584; Ireland Z, 2011, NEUROSCIENCE, V194, P372, DOI 10.1016/j.neuroscience.2011.05.012; Iwata S, 2012, PEDIATRICS, V129, pE1138, DOI 10.1542/peds.2011-1735; Ke Y, 2002, MAGNET RESON MED, V47, P232, DOI 10.1002/mrm.10063; Kidokoro H, 2011, AM J NEURORADIOL, V32, P2005, DOI 10.3174/ajnr.A2703; KINNEY HC, 1994, NEUROCHEM RES, V19, P983, DOI 10.1007/BF00968708; Kirov II, 2008, MAGN RESON MED, V60, P790, DOI 10.1002/mrm.21715; Kreis R, 2002, MAGNET RESON MED, V48, P949, DOI 10.1002/mrm.10304; KREIS R, 1993, MAGNET RESON MED, V30, P424, DOI 10.1002/mrm.1910300405; Krishnan ML, 2007, PEDIATRICS, V120, pE604, DOI 10.1542/peds.2006-3054; Kugel H, 2003, J MAGN RESON IMAGING, V17, P634, DOI 10.1002/jmri.10315; Kwon HB, 2011, NATURE, V474, P100, DOI 10.1038/nature09986; Kwon SH, 2014, NEONATOLOGY, V106, P149, DOI 10.1159/000362433; Lage S, 2013, J PEDIATR ENDOCR MET, V26, P53, DOI 10.1515/jpem-2012-0293; Laigle C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053266; Le Fur Y, 2010, MAGN RESON MATER PHY, V23, P23, DOI 10.1007/s10334-009-0186-y; Leuzzi V, 2013, EPILEPSIA, V54, P217, DOI 10.1111/epi.12020; Ling XY, 2013, EUR J RADIOL, V82, pE476, DOI 10.1016/j.ejrad.2013.04.003; Mader I, 2001, BRAIN, V124, P953, DOI 10.1093/brain/124.5.953; Manent JB, 2007, NEUROSCIENTIST, V13, P268, DOI 10.1177/1073858406298918; Marjanska M, 2012, NMR BIOMED, V25, P332, DOI 10.1002/nbm.1754; Mathur AM, 2010, SEMIN PERINATOL, V34, P57, DOI 10.1053/j.semperi.2009.10.006; Ment LR, 2009, LANCET NEUROL, V8, P1042, DOI 10.1016/S1474-4422(09)70257-1; Mewes AUJ, 2006, PEDIATRICS, V118, P23, DOI 10.1542/peds.2005-2675; Miller TJ, 2000, COMP BIOCHEM PHYS A, V125, P45, DOI 10.1016/S1095-6433(99)00160-9; Mullen KM, 2011, NEUROIMAGE, V54, P2563, DOI 10.1016/j.neuroimage.2010.11.019; Nagy Z, 2011, CEREB CORTEX, V21, P300, DOI 10.1093/cercor/bhq095; Nguyen L, 2001, CELL TISSUE RES, V305, P187, DOI 10.1007/s004410000343; Pannek K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068593; Phillips JP, 2011, PEDIATR RES, V69, P224, DOI 10.1203/PDR.0b013e3182091d52; Ratiney H, 2005, NMR BIOMED, V18, P1, DOI 10.1002/nbm.895; Ratiney H, 2010, P INT SOC MAGN RESON, V18, P322; Ratiney H, 2010, NMR BIOMED, V23, P1146, DOI 10.1002/nbm.1541; Rees S, 2011, INT J DEV NEUROSCI, V29, P551, DOI 10.1016/j.ijdevneu.2011.04.004; Rutherford MA, 2010, NEURORADIOLOGY, V52, P505, DOI 10.1007/s00234-010-0700-y; Saransaari P, 2000, AMINO ACIDS, V19, P509, DOI 10.1007/s007260070003; Saunders DE, 1997, JMRI-J MAGN RESON IM, V7, P1116, DOI 10.1002/jmri.1880070626; Schaffer S, 2000, AMINO ACIDS, V19, P527, DOI 10.1007/s007260070004; Seeger U, 2003, MAGNET RESON MED, V49, P19, DOI 10.1002/mrm.10332; Shim SY, 2012, NEONATOLOGY, V102, P309, DOI 10.1159/000341867; Skiold B, 2012, J PEDIATR-US, V160, P559, DOI 10.1016/j.jpeds.2011.09.053; Stockler S, 1996, LANCET, V348, P789, DOI 10.1016/S0140-6736(96)04116-5; STURMAN JA, 1993, PHYSIOL REV, V73, P119, DOI 10.1152/physrev.1993.73.1.119; Viola A, 2011, AM J NEURORADIOL, V32, P1451, DOI 10.3174/ajnr.A2555; Vitvitsky V, 2011, J BIOL CHEM, V286, P32002, DOI 10.1074/jbc.M111.253344; Volpe JJ, 2005, PEDIATRICS, V116, P221, DOI 10.1542/peds.2005-0191; Walls AB, 2015, NEUROCHEM RES, V40, P402, DOI 10.1007/s11064-014-1473-1; Weindling M, 2010, ACTA PAEDIATR, V99, P961, DOI 10.1111/j.1651-2227.2010.01785.x; Wisnowski JL, 2014, NEURORADIOLOGY, V56, P771, DOI 10.1007/s00234-014-1380-9; Woodward LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051879; Woodward LJ, 2011, DEV NEUROPSYCHOL, V36, P22, DOI 10.1080/87565641.2011.540530; Xin L, 2008, NMR BIOMED, V21, P396, DOI 10.1002/nbm.1205; Yao FS, 1999, NMR BIOMED, V12, P463, DOI 10.1002/(SICI)1099-1492(199911)12:7<463::AID-NBM586>3.0.CO;2-S; Zhang Y, 2016, MAGN RESON MED, V76, P725, DOI 10.1002/mrm.25922	78	17	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0160990	10.1371/journal.pone.0160990	http://dx.doi.org/10.1371/journal.pone.0160990			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27547969	Green Submitted, Green Published, gold			2022-12-26	WOS:000381768400027
J	Fan, XF; Gu, XJ; Zhao, R; Zheng, QQ; Li, L; Yang, WB; Ding, L; Xue, F; Fan, JM; Gong, YS; Wang, YY				Fan, Xiaofang; Gu, Xuejiang; Zhao, Ru; Zheng, Qingqing; Li, Lan; Yang, Wenbing; Ding, Lu; Xue, Feng; Fan, Junming; Gong, Yongsheng; Wang, Yongyu			Cardiac beta(2)-Adrenergic Receptor Phosphorylation at Ser(355/356) Regulates Receptor Internalization and Functional Resensitization	PLOS ONE			English	Article							PROTEIN-KINASE-A; BETA-ARRESTIN; MYOCYTES; BINDING; MICE	Previous studies have demonstrated that beta(2)-adrenergic receptors (beta(2)ARs) can be phosphorylated by G protein-coupled receptor kinases (GRKs) and protein kinase A (PKA), affecting beta(2)AR internalization and desensitization. However, the exact physiological function of beta(2)ARs in cardiomyocytes is unknown. In this study, we showed that neonatal mouse cardiomyocytes had different contraction and internalization responses to sustained or repeated, transient agonist stimulation. Specifically, short-time stimulation (10 min) with epinephrine or norepinephrine increased the cardiomyocyte contraction rate, reaching a maximum at 5 min, followed by a slow decline. When the agonist was re-added after a 60-min wash-out period, the increase in the cardiomyocyte contraction rate was similar to the initial response. In contrast, when cardiomyocytes were exposed continuously to epinephrine or norepinephrine for 60 min, the second agonist stimulation did not increase the contraction response. These results indicated that continuous beta(2)AR stimulation caused functional desensitization. Phosphorylation of beta(2)ARs at serine (Ser)(355/356) GRK phosphorylation sites, but not at Ser(345/346) PKA phosphorylation sites increased with continuous epinephrine stimulation for 60 min. Accordingly, beta(2)AR internalization increased. Interestingly, beta(2)AR internalization was blocked by mutations at the GRK phosphorylation sites, but not by mutations at the PKA phosphorylation sites. Furthermore, inhibition of beta(2)AR dephosphorylation by okadaic acid, a phosphatase 2A inhibitor, impaired the recovery of internalized beta(2)ARs and reduced the cardiomyocyte contraction rate in response to epinephrine. Finally, epinephrine treatment induced the physical interaction of beta-arrestin with internalized beta(2)ARs in cardiomyocytes. Together, these data revealed the essential role of the Ser(355/356) phosphorylation status of beta(2)ARs in regulating receptor internalization and physiological resensitization in neonatal cardiomyocytes to contraction functions.	[Fan, Xiaofang; Zhao, Ru; Zheng, Qingqing; Ding, Lu; Xue, Feng; Fan, Junming; Gong, Yongsheng; Wang, Yongyu] Wenzhou Med Univ, Inst Hypoxia Med, Wenzhou, Zhejiang, Peoples R China; [Gu, Xuejiang] Wenzhou Med Univ, Dept Endocrine & Metab Dis, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China; [Li, Lan; Yang, Wenbing] Shantou Univ, Dept Pathol, Coll Med, Shantou, Guangdong, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Shantou University	Gong, YS; Wang, YY (corresponding author), Wenzhou Med Univ, Inst Hypoxia Med, Wenzhou, Zhejiang, Peoples R China.	fxb@wmu.edu.cn; yywangut@163.com	Yang, Wenbing/AAH-5134-2021	Wang, Yongyu/0000-0002-6088-8887	National Natural Science Foundation of China [81270321, 81200576]; Natural Science Foundation of Zhejiang Province [LY16H010005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This work was supported by the National Natural Science Foundation of China (81270321, 81200576) and Natural Science Foundation of Zhejiang Province (LY16H010005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cong M, 2001, J BIOL CHEM, V276, P15192, DOI 10.1074/jbc.M009130200; Devic E, 2001, MOL PHARMACOL, V60, P577; Gupta MK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125803; Krueger KM, 1997, J BIOL CHEM, V272, P5; Liu RJ, 2009, J BIOL CHEM, V284, P32279, DOI 10.1074/jbc.M109.021428; McGraw Dennis W, 2005, Proc Am Thorac Soc, V2, P292, DOI 10.1513/pats.200504-027SR; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Rohrer DK, 1999, J BIOL CHEM, V274, P16701, DOI 10.1074/jbc.274.24.16701; Rohrer DK, 1996, P NATL ACAD SCI USA, V93, P7375, DOI 10.1073/pnas.93.14.7375; Shenoy Sudha K, 2005, Sci STKE, V2005, pcm10, DOI 10.1126/stke.2005/308/cm10; Swaminath G, 2004, J BIOL CHEM, V279, P686, DOI 10.1074/jbc.M310888200; Tao JC, 2003, EMBO J, V22, P6419, DOI 10.1093/emboj/cdg628; Tobin AB, 2008, BRIT J PHARMACOL, V153, pS167, DOI 10.1038/sj.bjp.0707662; Tobin AB, 2008, TRENDS PHARMACOL SCI, V29, P413, DOI 10.1016/j.tips.2008.05.006; Vasudevan NT, 2011, CELL CYCLE, V10, P3684, DOI 10.4161/cc.10.21.18042; Vaughan DJ, 2006, J BIOL CHEM, V281, P7684, DOI 10.1074/jbc.M500328200; Wang Y, 2008, J BIOL CHEM, V283, P1799, DOI 10.1074/jbc.M705747200; Xiang Y, 2002, J BIOL CHEM, V277, P34280, DOI 10.1074/jbc.M201644200; Zhang J, 1997, J BIOL CHEM, V272, P27005, DOI 10.1074/jbc.272.43.27005	21	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2016	11	8							e0161373	10.1371/journal.pone.0161373	http://dx.doi.org/10.1371/journal.pone.0161373			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6UQ	27541735	Green Published, Green Submitted, gold			2022-12-26	WOS:000381620200005
J	Ogasawara, S; Chiba, T; Ooka, Y; Suzuki, E; Inoue, M; Wakamatsu, T; Tawada, A; Yokosuka, O				Ogasawara, Sadahisa; Chiba, Tetsuhiro; Ooka, Yoshihiko; Suzuki, Eiichiro; Inoue, Masanori; Wakamatsu, Toru; Tawada, Akinobu; Yokosuka, Osamu			Analysis of Sorafenib Outcome: Focusing on the Clinical Course in Patients with Hepatocellular Carcinoma	PLOS ONE			English	Article							TRANSARTERIAL CHEMOEMBOLIZATION; CHILD-PUGH; EFFICACY; SURVIVAL; PROPOSAL; THERAPY; SUBCLASSIFICATION; PROGNOSIS; ABLATION; CRITERIA	Background Treatment outcomes of sorafenib therapy may greatly vary depending not only on tumor spread but also on past clinical processes prior to sorafenib therapy and timing of sorafenib administration in the past clinical course of hepatocellular carcinoma (HCC). We evaluated the efficacy of sorafenib in patients with HCC, taking into account of their past clinical courses. Methods Patients with HCC treated with sorafenib as a first-line systemic therapy, whose courses documented from the time of the initial diagnosis, were retrospectively analyzed. Results Of the 123 patients receiving sorafenib therapy at an advanced-stage, baseline characteristics differed including the rate of hepatitis C virus, Child-Pugh class, and status of intrahepatic lesions according to stage progression processes. Overall survival (OS) in patients progressed directly from the early-stage (15.3 months) was significantly longer than that in patients diagnosed at the advanced-stage (5.3 months, P = 0.022) and progressed from the intermediate-stages (6.0 months, P = 0.041). Of 105 patients diagnosed at the intermediate-stage on past clinical courses, OS of starting sorafenib therapy before progression to the advanced-stage (6 patients) was significantly longer than for patients starting sorafenib therapy only after progression to the advanced-stage (38 patients) (P = 0.015). Conclusion Characteristic differences between past stage progression processes might affect prognosis in advanced-stage HCC patients receiving sorafenib. Switching to sorafenib therapy before progression to the advanced-stage appears more effective than that after progression to the advanced-stage in patients diagnosed in the intermediate-stage on past clinical courses prior to sorafenib administration.	[Ogasawara, Sadahisa; Chiba, Tetsuhiro; Ooka, Yoshihiko; Suzuki, Eiichiro; Inoue, Masanori; Wakamatsu, Toru; Tawada, Akinobu; Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba, Japan	Chiba University	Chiba, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba, Japan.	techiba@faculty.chiba-u.jp	Ogasawara, Sadahisa/GRF-7061-2022	Ogasawara, Sadahisa/0000-0002-6540-9064				Arizumi T, 2015, LIVER CANCER, V4, P253, DOI 10.1159/000367743; Arizumi T, 2015, DIGEST DIS, V33, P728, DOI 10.1159/000439079; Bolondi L, 2012, SEMIN LIVER DIS, V32, P348, DOI 10.1055/s-0032-1329906; Bruix J, 2012, J HEPATOL, V57, P821, DOI 10.1016/j.jhep.2012.06.014; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Hasegawa K, 2013, J HEPATOL, V58, P724, DOI 10.1016/j.jhep.2012.11.009; Iavarone M, 2011, HEPATOLOGY, V54, P2055, DOI 10.1002/hep.24644; Jung SM, 2012, J GASTROEN HEPATOL, V27, P684, DOI 10.1111/j.1440-1746.2011.06917.x; Kadalayil L, 2013, ANN ONCOL, V24, P2565, DOI 10.1093/annonc/mdt247; Kudo M, 2015, DIGEST DIS, V33, P751, DOI 10.1159/000439290; Kudo M, 2014, ONCOLOGY-BASEL, V87, P22, DOI 10.1159/000368142; Kudo M, 2014, HEPATOLOGY, V60, P1697, DOI 10.1002/hep.27290; Kudo M, 2011, DIGEST DIS, V29, P339, DOI 10.1159/000327577; Lee IC, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000688; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Ogasawara S, 2016, INVEST NEW DRUG, V34, P255, DOI 10.1007/s10637-016-0323-1; Ogasawara S, 2015, INVEST NEW DRUG, V33, P729, DOI 10.1007/s10637-015-0237-3; Ogasawara S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125244; Ogasawara S, 2014, ONCOLOGY-BASEL, V87, P330, DOI 10.1159/000365993; Raoul JL, 2011, CANCER TREAT REV, V37, P212, DOI 10.1016/j.ctrv.2010.07.006; Reig M, 2014, J HEPATOL, V61, P318, DOI 10.1016/j.jhep.2014.03.030; Reig M, 2013, HEPATOLOGY, V58, P2023, DOI 10.1002/hep.26586; Shao YY, 2015, ONCOLOGY-BASEL, V88, P345, DOI 10.1159/000369559; Sherman M, 2008, NEW ENGL J MED, V359, P2045, DOI 10.1056/NEJMe0807581; Shiina S, 2012, AM J GASTROENTEROL, V107, P569, DOI 10.1038/ajg.2011.425; Sohn W, 2015, J HEPATOL, V62, P1112, DOI 10.1016/j.jhep.2014.12.009; Takeda H, 2015, HEPATOL RES, V45, pE130, DOI 10.1111/hepr.12480; Uchino K, 2011, CANCER-AM CANCER SOC, V117, P4475, DOI 10.1002/cncr.25960; Yamakado K, 2014, JPN J RADIOL, V32, P260, DOI 10.1007/s11604-014-0298-9	36	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161303	10.1371/journal.pone.0161303	http://dx.doi.org/10.1371/journal.pone.0161303			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537374	Green Submitted, Green Published, gold			2022-12-26	WOS:000381577000086
J	Wang, FBA; Liu, JC; Chen, MX; Zhou, LJ; Li, ZW; Zhao, Q; Pan, G; Zaidi, SHR; Cheng, FM				Wang, Fubiao; Liu, Jianchao; Chen, Minxue; Zhou, Lujian; Li, Zhaowei; Zhao, Qian; Pan, Gang; Zaidi, Syed-Hassan-Raza; Cheng, Fangmin			Involvement of Abscisic Acid in PSII Photodamage and D1 Protein Turnover for Light-Induced Premature Senescence of Rice Flag Leaves	PLOS ONE			English	Article							DARK-INDUCED SENESCENCE; LEAF SENESCENCE; PHOTOSYSTEM-II; ARABIDOPSIS-THALIANA; CARBON RESERVES; FTSH PROTEASE; WATER-STRESS; WHEAT; CHLOROPLAST; REMOBILIZATION	D1 protein in the PSII reaction center is the major target of photodamage, and it exhibits the highest turnover rate among all the thylakoid proteins. In this paper, rice psf (premature senescence of flag leaves) mutant and its wild type were used to investigate the genotype-dependent alteration in PSII photo-damage and D1 protein turnover during leaf senescence and its relation to ABA accumulation in senescent leaves. The symptom and extent of leaf senescence of the psf mutant appeared to be sunlight-dependent under natural field condition. The psf also displayed significantly higher levels of ABA accumulation in senescent leaves than the wild type. However, the premature senescence lesion of psf leaves could be alleviated by shaded treatment, concomitantly with the strikingly suppressed ABA level in the shaded areas of flag leaves. The change in ABA concentration contributed to the regulation of shade-delayed leaf senescence. The participation of ABA in the timing of senescence initiation and in the subsequent rate of leaf senescence was closely associated with PSII photodamage and D1 protein turnover during leaf senescence, in which the transcriptional expression of several key genes (psbA, psbB, psbC and OsFtsH2) involved in D1 protein biosynthesis and PSII repair cycle was seriously suppressed by the significantly increased ABA level. This response resulted in the low rate of D1 protein synthesis and impaired repair recovery in the presence of ABA. The psf showed evidently decreased D1 protein amount in the senescent leaves. Both the inhibition of de novo synthesized D1 protein and the slow rate of proteolytic removal for the photodamaged D1 protein was among the most crucial steps for the linkage between light-dependent leaf senescence and the varying ABA concentration in psf mutant leaves. OsFtsH2 transcriptional expression possibly played an important role in the regulation of D1 protein turnover and PSII repair cycle in relation to ABA mediated leaf senescence.	[Wang, Fubiao; Liu, Jianchao; Zhou, Lujian; Li, Zhaowei; Zhao, Qian; Pan, Gang; Zaidi, Syed-Hassan-Raza; Cheng, Fangmin] Zhejiang Univ, Inst Crop Sci, Coll Agr & Biotechnol, Hangzhou 310058, Zhejiang, Peoples R China; [Chen, Minxue] China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou 310006, Zhejiang, Peoples R China; [Liu, Jianchao; Li, Zhaowei; Cheng, Fangmin] Jiangsu Collaborat Innovat Ctr Modern Crop Prod, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Zhejiang University; Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS	Cheng, FM (corresponding author), Zhejiang Univ, Inst Crop Sci, Coll Agr & Biotechnol, Hangzhou 310058, Zhejiang, Peoples R China.; Cheng, FM (corresponding author), Jiangsu Collaborat Innovat Ctr Modern Crop Prod, Nanjing, Jiangsu, Peoples R China.	chengfm@zju.edu.cn	Zaidi, Syed Hassan Raza/AAB-6307-2019	Zaidi, Syed Hassan Raza/0000-0003-0093-1481; Zhao, Qian/0000-0001-9238-0810	National Natural Science Foundation of China [31271655, 31571602]; National Key Research and Development Plan of China [2016YFD0300500]; Zhejiang Provincial Natural Science Foundation of China [LZ15C130001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Plan of China; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	The authors are deeply indebted to National Natural Science Foundation of China (No. 31271655 and 31571602), National Key Research and Development Plan of China (No 2016YFD0300500) and Zhejiang Provincial Natural Science Foundation of China (LZ15C130001) for their financial support to this research project.	Adam Z, 2006, CURR OPIN PLANT BIOL, V9, P234, DOI 10.1016/j.pbi.2006.03.010; Allakhverdiev SI, 2002, PLANT PHYSIOL, V130, P1443, DOI 10.1104/pp.011114; Almoguera C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051443; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; BARBER J, 1992, TRENDS BIOCHEM SCI, V17, P61, DOI 10.1016/0968-0004(92)90503-2; Brouwer B, 2012, PLANT CELL ENVIRON, V35, P1084, DOI 10.1111/j.1365-3040.2011.02474.x; Buchanan-Wollaston V, 2005, PLANT J, V42, P567, DOI 10.1111/j.1365-313X.2005.02399.x; Carrion CA, 2013, J EXP BOT, V64, P4967, DOI 10.1093/jxb/ert285; Causin HF, 2006, PLANT SCI, V171, P24, DOI 10.1016/j.plantsci.2006.02.009; Chen M, 2000, PLANT J, V22, P303, DOI 10.1046/j.1365-313x.2000.00738.x; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Distelfeld A, 2014, J EXP BOT, V65, P3783, DOI 10.1093/jxb/ert477; DUNGEY NO, 1982, J EXP BOT, V33, P12, DOI 10.1093/jxb/33.1.12; Fischer AM, 2012, CRIT REV PLANT SCI, V31, P124, DOI 10.1080/07352689.2011.616065; Fujiki Y, 2001, PHYSIOL PLANTARUM, V111, P345, DOI 10.1034/j.1399-3054.2001.1110312.x; Gan SS, 1997, PLANT PHYSIOL, V113, P313, DOI 10.1104/pp.113.2.313; Hankamer B, 1997, ANNU REV PLANT PHYS, V48, P641, DOI 10.1146/annurev.arplant.48.1.641; Hung KT, 2004, J PLANT PHYSIOL, V161, P1347, DOI 10.1016/j.jplph.2004.05.011; Jia YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065687; Jiang MY, 2001, PLANT CELL PHYSIOL, V42, P1265, DOI 10.1093/pcp/pce162; Jibran R, 2013, PLANT MOL BIOL, V82, P547, DOI 10.1007/s11103-013-0043-2; Kato Y, 2009, J BIOCHEM, V146, P463, DOI 10.1093/jb/mvp073; Keech O, 2007, PLANT CELL ENVIRON, V30, P1523, DOI 10.1111/j.1365-3040.2007.01724.x; Kempa S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003935; Kojima M, 2009, PLANT CELL PHYSIOL, V50, P1201, DOI 10.1093/pcp/pcp057; Kusaba M, 2007, PLANT CELL, V19, P1362, DOI 10.1105/tpc.106.042911; Li ZW, 2015, J PLANT PHYSIOL, V176, P1, DOI 10.1016/j.jplph.2014.09.020; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Lim PO, 2003, TRENDS PLANT SCI, V8, P272, DOI 10.1016/S1360-1385(03)00103-1; Lim PO, 2007, J PLANT BIOL, V50, P291, DOI 10.1007/BF03030657; Lindahl M, 2000, PLANT CELL, V12, P419, DOI 10.1105/tpc.12.3.419; Lu S, 2008, J AM SOC HORTIC SCI, V133, P360, DOI 10.21273/JASHS.133.3.360; Luo PG, 2013, PLANT CELL ENVIRON, V36, P683, DOI 10.1111/pce.12006; Martinez DE, 2008, PLANT BIOLOGY, V10, P15, DOI 10.1111/j.1438-8677.2008.00089.x; Murata N, 2007, BBA-BIOENERGETICS, V1767, P414, DOI 10.1016/j.bbabio.2006.11.019; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; Nixon PJ, 2005, J EXP BOT, V56, P357, DOI 10.1093/jxb/eri021; Nooden LD, 1996, PHYSIOL PLANTARUM, V96, P491, DOI 10.1111/j.1399-3054.1996.tb00463.x; Prochazkova D, 2004, BIOL PLANTARUM, V48, P33, DOI 10.1023/B:BIOP.0000024272.98338.5b; Quirino BF, 2000, TRENDS PLANT SCI, V5, P278, DOI 10.1016/S1360-1385(00)01655-1; Roberts IN, 2012, PHYSIOL PLANTARUM, V145, P130, DOI 10.1111/j.1399-3054.2012.01574.x; Sakamoto W, 2003, PLANT CELL, V15, P2843, DOI 10.1105/tpc.017319; Shaik R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077261; Sinvany-Villalobo G, 2004, PLANT PHYSIOL, V135, P1336, DOI 10.1104/pp.104.043299; Takahashi S, 2011, TRENDS PLANT SCI, V16, P53, DOI 10.1016/j.tplants.2010.10.001; Takechi K, 2000, PLANT CELL PHYSIOL, V41, P1334, DOI 10.1093/pcp/pcd067; Tyystjarvi E, 1996, P NATL ACAD SCI USA, V93, P2213, DOI 10.1073/pnas.93.5.2213; Weaver LM, 2001, PLANT PHYSIOL, V127, P876, DOI 10.1104/pp.010312; Wingler A, 2006, J EXP BOT, V57, P391, DOI 10.1093/jxb/eri279; Wu XY, 2012, J INTEGR PLANT BIOL, V54, P936, DOI 10.1111/jipb.12005; Yang JC, 2003, PLANT CELL ENVIRON, V26, P1621, DOI 10.1046/j.1365-3040.2003.01081.x; Yang JC, 2002, PLANTA, V215, P645, DOI 10.1007/s00425-002-0789-2; Yang JC, 2001, AGRON J, V93, P196, DOI 10.2134/agronj2001.931196x; Yu F, 2005, PLANT PHYSIOL, V138, P1957, DOI 10.1104/pp.105.061234; Zhang KW, 2012, PLANT J, V69, P667, DOI 10.1111/j.1365-313X.2011.04821.x; Zhao LF, 2012, J INTEGR PLANT BIOL, V54, P567, DOI 10.1111/j.1744-7909.2012.01139.x	56	26	33	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161203	10.1371/journal.pone.0161203	http://dx.doi.org/10.1371/journal.pone.0161203			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532299	Green Published, gold, Green Submitted			2022-12-26	WOS:000381487600074
J	Davies, HN; Beckley, LE; Kobryn, HT; Lombard, AT; Radford, B; Heyward, A				Davies, Harriet N.; Beckley, Lynnath E.; Kobryn, Halina T.; Lombard, Amanda T.; Radford, Ben; Heyward, Andrew			Integrating Climate Change Resilience Features into the Incremental Refinement of an Existing Marine Park	PLOS ONE			English	Article							CORAL-REEFS; BIODIVERSITY CONSERVATION; PROTECTED AREAS; RESERVE DESIGN; PHASE-SHIFTS; TRADE-OFFS; NINGALOO; SYSTEM; COMMUNITIES; TEMPERATURE	Marine protected area (MPA) designs are likely to require iterative refinement as new knowledge is gained. In particular, there is an increasing need to consider the effects of climate change, especially the ability of ecosystems to resist and/or recover from climate-related disturbances, within the MPA planning process. However, there has been limited research addressing the incorporation of climate change resilience into MPA design. This study used Marxan conservation planning software with fine-scale shallow water (<20 m) bathymetry and habitat maps, models of major benthic communities for deeper water, and comprehensive human use information from Ningaloo Marine Park in Western Australia to identify climate change resilience features to integrate into the incremental refinement of the marine park. The study assessed the representation of benthic habitats within the current marine park zones, identified priority areas of high resilience for inclusion within no-take zones and examined if any iterative refinements to the current no-take zones are necessary. Of the 65 habitat classes, 16 did not meet representation targets within the current no-take zones, most of which were in deeper offshore waters. These deeper areas also demonstrated the highest resilience values and, as such, Marxan outputs suggested minor increases to the current no-take zones in the deeper offshore areas. This work demonstrates that inclusion of fine-scale climate change resilience features within the design process for MPAs is feasible, and can be applied to future marine spatial planning practices globally.	[Davies, Harriet N.; Beckley, Lynnath E.; Kobryn, Halina T.] Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia; [Lombard, Amanda T.] Nelson Mandela Metropolitan Univ, Inst Coastal & Marine Res, Port Elizabeth, South Africa; [Radford, Ben; Heyward, Andrew] Australian Inst Marine Sci, Perth, WA, Australia	Murdoch University; Nelson Mandela University; Australian Institute of Marine Science	Davies, HN (corresponding author), Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia.	Harriet_Davies@hotmail.com	Lombard, Mandy/AAE-4649-2019; Kobryn, Halina/E-5051-2012	Lombard, Mandy/0000-0002-4323-1170; Kobryn, Halina/0000-0003-1004-7593	Murdoch University	Murdoch University	H.D. received scholarship funding through Murdoch University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABPmer (ABP Marine Environmental Research Limited), 2011, ARCGIS 10 BOUNDARY T; Airame S, 2003, ECOL APPL, V13, pS170; Anthony KRN, 2015, GLOBAL CHANGE BIOL, V21, P48, DOI 10.1111/gcb.12700; Ardron J. A., 2010, MARXAN GOOD PRACTICE; Aronson RB, 2000, NATURE, V405, P36, DOI 10.1038/35011132; Babcock R, 2008, CSIRO MARINE AND ATM; Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; Beckley LE, 2012, MAR FRESHWATER RES, V63, P17, DOI 10.1071/MF11074; Brown K, 2001, ECOL ECON, V37, P417, DOI 10.1016/S0921-8009(00)00293-7; Cassata L, 2008, J COASTAL RES, V24, P139, DOI 10.2112/05-0623.1; Cheung WWL, 2012, MAR FRESHWATER RES, V63, P415, DOI 10.1071/MF11205; Chollett I, 2013, BIOL CONSERV, V167, P179, DOI 10.1016/j.biocon.2013.08.010; Colquhoun J., 2007, NINGALOO REEF MARINE; Depczynski M, 2013, CORAL REEFS, V32, P233, DOI 10.1007/s00338-012-0974-0; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; Edinger EN, 1998, MAR POLLUT BULL, V36, P617, DOI 10.1016/S0025-326X(98)00047-2; Fabricius KE, 2004, MOL ECOL, V13, P2445, DOI 10.1111/j.1365-294X.2004.02230.x; Falter JL, 2014, LIMNOL OCEANOGR, V59, P1241, DOI 10.4319/lo.2014.59.4.1241; Feng M, 2015, GEOPHYS RES LETT, V42, P104, DOI 10.1002/2014GL062509; Feng M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01277; Fox NJ, 2005, BIOL CONSERV, V125, P399, DOI 10.1016/j.biocon.2005.02.006; Game ET, 2008, ECOL APPL, V18, P670, DOI 10.1890/07-1027.1; Game ET, 2008, CONSERV BIOL, V22, P1619, DOI 10.1111/j.1523-1739.2008.01037.x; Game ET, 2009, TRENDS ECOL EVOL, V24, P360, DOI 10.1016/j.tree.2009.01.011; Game ET, 2008, MARXAN USER MANUAL F; Geoscience Australia, 2004, GEODATA COAST 100K D; Gilmour JP, 2013, SCIENCE, V340, P69, DOI 10.1126/science.1232310; Graham NAJ, 2015, NATURE, V518, P94, DOI 10.1038/nature14140; Graham NAJ, 2011, OCEANOGR MAR BIOL, V49, P105; Grantham HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016552; Green AL, 2014, COAST MANAGE, V42, P143, DOI 10.1080/08920753.2014.877763; Groves CR, 2012, BIODIVERS CONSERV, V21, P1651, DOI 10.1007/s10531-012-0269-3; Guidetti P, 2013, AQUAT CONSERV, V23, P179, DOI 10.1002/aqc.2314; Hansen GJA, 2011, BIOL CONSERV, V144, P1866, DOI 10.1016/j.biocon.2011.04.002; Harris LR, 2014, J APPL ECOL, V51, P1504, DOI 10.1111/1365-2664.12345; Harrison HB, 2012, CURR BIOL, V22, P1023, DOI 10.1016/j.cub.2012.04.008; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; IUCN (International Union for the Conservation of Nature), 2014, THE PROMISE OF SYDNE; Januchowski-Hartley FA, 2013, ECOL LETT, V16, P191, DOI 10.1111/ele.12028; Jennings S, 1996, BIOL CONSERV, V75, P201, DOI 10.1016/0006-3207(95)00081-X; Johansson CL, 2010, MAR ECOL PROG SER, V414, P65, DOI 10.3354/meps08730; Jones KR, 2016, BIOL CONSERV, V194, P121, DOI 10.1016/j.biocon.2015.12.008; Keller BD, 2009, ENVIRON MANAGE, V44, P1069, DOI 10.1007/s00267-009-9346-0; Klein CJ, 2008, CONSERV BIOL, V22, P691, DOI 10.1111/j.1523-1739.2008.00896.x; Kobryn HT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070105; Ledlie MH, 2007, CORAL REEFS, V26, P641, DOI 10.1007/s00338-007-0230-1; Levy JS, 2013, MAR POLICY, V38, P16, DOI 10.1016/j.marpol.2012.05.015; Magris RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140828; Magris RA, 2014, BIOL CONSERV, V170, P207, DOI 10.1016/j.biocon.2013.12.032; Maina JM, 2015, REMOTE SENS-BASEL, V7, P16571, DOI 10.3390/rs71215849; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Maynard JA, 2010, CORAL REEFS, V29, P381, DOI 10.1007/s00338-010-0603-8; McClanahan T, 2002, CONSERV ECOL, V6; McClanahan TR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042884; McClanahan TR, 2009, MAR ECOL PROG SER, V396, P99, DOI 10.3354/meps08279; McCook LJ, 2010, P NATL ACAD SCI USA, V107, P18278, DOI 10.1073/pnas.0909335107; McLeod E, 2010, COAST MANAGE, V38, P518, DOI 10.1080/08920753.2010.509466; McLeod E, 2009, FRONT ECOL ENVIRON, V7, P362, DOI 10.1890/070211; Mcmanus JW, 1997, ENVIRON MANAGE, V21, P69, DOI 10.1007/s002679900006; Mellin C, 2016, ECOL LETT, V19, P629, DOI 10.1111/ele.12598; Moore JAY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051807; MPRA (Marine Parks and Reserves Authority), 2013, NINGALOO MARINE PARK; Mumby PJ, 2008, J APPL ECOL, V45, P854, DOI 10.1111/j.1365-2664.2008.01459.x; Mumby PJ, 2011, ECOL LETT, V14, P132, DOI 10.1111/j.1461-0248.2010.01562.x; Mumby PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008657; Mumby PJ, 2006, ECOL APPL, V16, P747, DOI 10.1890/1051-0761(2006)016[0747:TIOEGS]2.0.CO;2; Obura D, 2011, CORAL REEFS, V30, P607, DOI 10.1007/s00338-011-0741-7; Olds AD, 2014, GLOBAL CHANGE BIOL, V20, P3050, DOI 10.1111/gcb.12606; Onton K, 2011, MAR ECOL PROG SER, V433, P75, DOI 10.3354/meps09156; Palumbi SR, 2014, SCIENCE, V344, P895, DOI 10.1126/science.1251336; Pearce AF, 2013, J MARINE SYST, V111, P139, DOI 10.1016/j.jmarsys.2012.10.009; Possingham H, 2000, MARINE RESERVE DESIG; Pressey RL, 2003, BIOL CONSERV, V112, P99, DOI 10.1016/S0006-3207(02)00424-X; Rowlands G, 2012, MAR POLLUT BULL, V64, P1222, DOI 10.1016/j.marpolbul.2012.03.003; Santoro K, 2014, STATUS REPORT OF THE; Selig ER, 2012, GLOBAL CHANGE BIOL, V18, P1561, DOI 10.1111/j.1365-2486.2012.02658.x; Selig ER, 2010, GLOBAL ECOL BIOGEOGR, V19, P397, DOI 10.1111/j.1466-8238.2009.00522.x; Smallwood CB, 2012, TOURISM MANAGE, V33, P517, DOI 10.1016/j.tourman.2011.06.001; Smallwood CB, 2011, OCEAN COAST MANAGE, V54, P330, DOI 10.1016/j.ocecoaman.2010.11.007; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Speed CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069863; Spencer T, 2000, MAR POLLUT BULL, V40, P569, DOI 10.1016/S0025-326X(00)00026-6; Stewart RR, 2007, CONSERV BIOL, V21, P346, DOI 10.1111/j.1523-1739.2006.00618.x; Stewart RR, 2005, ENVIRON MODEL ASSESS, V10, P203, DOI 10.1007/s10666-005-9001-y; Szmant AM, 2002, ESTUARIES, V25, P743, DOI 10.1007/BF02804903; Taebi S, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006439; van Woesik R, 2011, MAR ECOL PROG SER, V434, P67, DOI 10.3354/meps09203; Webster FJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124162; Weeks R, 2013, CONSERV BIOL, V27, P1234, DOI 10.1111/cobi.12153; Weeks R, 2010, BIOL CONSERV, V143, P1236, DOI 10.1016/j.biocon.2010.02.031; West JM, 2003, CONSERV BIOL, V17, P956, DOI 10.1046/j.1523-1739.2003.02055.x; Wilkinson C., 2008, STATUS OF CORAL REEF; Williams ID, 2001, CORAL REEFS, V19, P358, DOI 10.1007/s003380000121; Wilson SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015185; Yates KK, 2014, BIOGEOSCIENCES, V11, P4321, DOI 10.5194/bg-11-4321-2014; Zinke J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4607	102	13	13	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161094	10.1371/journal.pone.0161094	http://dx.doi.org/10.1371/journal.pone.0161094			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529820	Green Submitted, Green Published, gold			2022-12-26	WOS:000381476700046
J	Loreto, RG; Hughes, DP				Loreto, Raquel G.; Hughes, David P.			Disease in the Society: Infectious Cadavers Result in Collapse of Ant Sub-Colonies	PLOS ONE			English	Article							HONEY-BEE; RESISTANCE; NESTS; RESIN; TRANSMISSION; ARCHITECTURE; PROPHYLAXIS; HYMENOPTERA; DIVERSITY; IMMUNITY	Despite the growing number of experimental studies on mechanisms of social immunity in ant societies, little is known about how social behavior relates to disease progression within the nests of ants. In fact, when empirically studying disease in ant societies, it is common to remove dead ants from experiments to confirm infection by the studied parasite. This unfortunately does not allow disease to progress within the nest as it may be assumed would happen under natural conditions. Therefore, the approach taken so far has resulted in a limited knowledge of diseases dynamics within the nest environment. Here we introduced a single infectious cadaver killed by the fungus Beauveria bassiana into small nests of the ant Camponotus castaneus. We then observed the natural progression of the disease by not removing the corpses of the ants that died following the first entry of the disease. Because some behaviors such as social isolation of sick individuals or the removal of cadavers by nestmates are considered social immune functions and thus adaptations at the colony level that reduce disease spread, we also experimentally confined some sub-colonies to one or two chamber nests to prevent the expression of such behaviors. Based on 51 small nests and survival studies in 1,003 ants we found that a single introduced infectious cadaver was able to transmit within the nest, and social immunity did not prevent the collapse of the small sub-colonies here tested. This was true whether ants did or did not have the option to remove the infectious cadaver. Therefore, we found no evidence that the typically studied social immunity behaviors can reduce disease spread in the conditions here tested.	[Loreto, Raquel G.; Hughes, David P.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Loreto, Raquel G.; Hughes, David P.] Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Loreto, Raquel G.] Minist Educ Brazil, CAPES Fdn, BR-70040020 Brasilia, DF, Brazil; [Hughes, David P.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Loreto, RG; Hughes, DP (corresponding author), Penn State Univ, Dept Entomol, University Pk, PA 16802 USA.; Loreto, RG; Hughes, DP (corresponding author), Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA.; Loreto, RG (corresponding author), Minist Educ Brazil, CAPES Fdn, BR-70040020 Brasilia, DF, Brazil.; Hughes, DP (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.	raquelgloreto@gmail.com; dph14@psu.edu			Coordernacao de Aperfeicoamento de Pessoa de Nivea Superior (CAPES-Brazil) [6203-10-8]; Pennsylvania State University; National Science Foundation as part of the joint NSF-NIH-USDA Ecology and Evolution of Infectious Diseases program [1414296]	Coordernacao de Aperfeicoamento de Pessoa de Nivea Superior (CAPES-Brazil); Pennsylvania State University; National Science Foundation as part of the joint NSF-NIH-USDA Ecology and Evolution of Infectious Diseases program	RGL was funded by Coordernacao de Aperfeicoamento de Pessoa de Nivea Superior (CAPES-Brazil), grant # 6203-10-8) and by The Pennsylvania State University. DPH is funded by The Pennsylvania State University. Part of this work was funded by National Science Foundation (grant # 1414296) as part of the joint NSF-NIH-USDA Ecology and Evolution of Infectious Diseases program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1971, INSECT SOC; Boomsma J.J., 2005, P139, DOI 10.1079/9780851998121.0139; Bos N, 2012, J EVOLUTION BIOL, V25, P342, DOI 10.1111/j.1420-9101.2011.02425.x; Brown MJF, 2009, APIDOLOGIE, V40, P410, DOI 10.1051/apido/2009019; Castella G, 2008, ANIM BEHAV, V75, P1591, DOI 10.1016/j.anbehav.2007.10.014; Chapuisat M, 2007, P ROY SOC B-BIOL SCI, V274, P2013, DOI 10.1098/rspb.2007.0531; Chouvenc T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034484; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Cremer S, 2007, CURR BIOL, V17, pR693, DOI 10.1016/j.cub.2007.06.008; Graystock P, 2011, BEHAV ECOL SOCIOBIOL, V65, P2319, DOI 10.1007/s00265-011-1242-y; Heinze J, 2010, CURR BIOL, V20, P249, DOI 10.1016/j.cub.2009.12.031; Holldobler B., 1990, pi; Holldobler B., 2009, SUPERORGANISM; Hughes DP, 2016, ADV GENETIC IN PRESS; Hughes WOH, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-45; Hughes WOH, 2004, J INVERTEBR PATHOL, V85, P46, DOI 10.1016/j.jip.2003.12.005; Hughes WOH, 2002, P ROY SOC B-BIOL SCI, V269, P1811, DOI 10.1098/rspb.2002.2113; Humber RA, 2011, CATALOG SPECIES ARSE; Jaccoud DB, 1999, ENTOMOL EXP APPL, V93, P51, DOI 10.1023/A:1003830625680; Keller S, 2003, BIOCONTROL, V48, P307, DOI 10.1023/A:1023646207455; Konrad M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001300; Lach L, 2010, ANT ECOLOGY, P1; McMenamin AJ, 2015, CURR OPIN INSECT SCI, V8, P121, DOI 10.1016/j.cois.2015.01.015; Moreau SJM, 2013, J INSECT PHYSIOL, V59, P186, DOI 10.1016/j.jinsphys.2012.10.005; Okuno M, 2012, J ETHOL, V30, P23, DOI 10.1007/s10164-011-0285-x; PENG YS, 1987, J INVERTEBR PATHOL, V49, P54, DOI 10.1016/0022-2011(87)90125-X; PEREIRA RM, 1992, ENVIRON ENTOMOL, V21, P1427, DOI 10.1093/ee/21.6.1427; Pettis JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070182; Pinter-Wollman N, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0695; Qiu HL, 2014, J INSECT BEHAV, V27, P678, DOI 10.1007/s10905-014-9459-z; Reber A, 2011, J EVOLUTION BIOL, V24, P954, DOI 10.1111/j.1420-9101.2011.02230.x; Reber A, 2008, ECOL LETT, V11, P682, DOI 10.1111/j.1461-0248.2008.01177.x; Reber A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035372; Rosengaus RB, 1998, BEHAV ECOL SOCIOBIOL, V44, P125, DOI 10.1007/s002650050523; Schmid-Hempel P., 1998, Parasites in social insects.; Simone M, 2009, EVOLUTION, V63, P3016, DOI 10.1111/j.1558-5646.2009.00772.x; Steinhauer NA, 2014, J APICULT RES, V53, P1, DOI 10.3896/IBRA.1.53.1.01; Stokstad E, 2007, SCIENCE, V316, P970, DOI 10.1126/science.316.5827.970; Tobin JE, 1991, ANT PLANT INTERACTIO; Tragust S, 2013, CURR BIOL, V23, P76, DOI 10.1016/j.cub.2012.11.034; Tranter C, 2015, BEHAV ECOL, V26, P396, DOI 10.1093/beheco/aru203; Tschinkel Walter R., 2015, Journal of Bioeconomics, V17, P271; Ugelvig LV, 2007, CURR BIOL, V17, P1967, DOI 10.1016/j.cub.2007.10.029; Westhus C, 2014, BEHAV ECOL SOCIOBIOL, V68, P1701, DOI 10.1007/s00265-014-1778-8; Wilfert L, 2016, SCIENCE, V351, P594, DOI 10.1126/science.aac9976; Williams GR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099465	46	9	10	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160820	10.1371/journal.pone.0160820	http://dx.doi.org/10.1371/journal.pone.0160820			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529548	Green Submitted, Green Published, gold			2022-12-26	WOS:000381476700024
J	Park, CK; Oh, HJ; Choi, HY; Shin, HJ; Lim, JH; Oh, IJ; Kim, YI; Lim, SC; Kim, YC; Kwon, YS				Park, Cheol-Kyu; Oh, Hyoung-Joo; Choi, Ha-Young; Shin, Hong-Joon; Lim, Jung Hwan; Oh, In-Jae; Kim, Yu-Il; Lim, Sung-Chul; Kim, Young-Chul; Kwon, Yong-Soo			Microbiological Characteristics and Predictive Factors for Mortality in Pleural Infection: A Single-Center Cohort Study in Korea	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; COMPLICATED PARAPNEUMONIC EFFUSIONS; INTENSIVE-CARE-UNIT; THORACIC EMPYEMA; BACTERIOLOGY; ADULTS; MANAGEMENT; GUIDELINE; CRITERIA; OUTCOMES	Background Identification and understanding of the pathogens responsible for pleural infection is critical for appropriate antibiotic treatment. This study sought to determine the microbiological characteristics of pleural infection and to identify potential predictive factors associated with mortality. Methods In this retrospective study, we analyzed patient data from 421 cases of parapneumonic effusion. A total of 184 microorganisms were isolated from 164 patients, using two culture systems: a standard method and a method using pairs of aerobic and anaerobic blood culture bottles. Results The most frequently isolated microorganisms were streptococci (31.5%), followed by staphylococci (23.4%), gram-negative bacteria (18.5%) and anaerobes (10.3%). Streptococci were the main microorganisms found in standard culture (41.9%) and community-acquired infections (52.2%), and were susceptible to all antimicrobial agents in drug sensitivity testing. Staphylococci were the most frequently isolated pathogens in blood cultures (30.8%) and hospital-acquired infections (38.3%), and were primarily multidrug-resistant (61.8%). In multivariate analysis, the following were significant predictive factors for 30-day mortality among the total population: CURB-65 >= 2 (aOR 5.549, 95% CI 2.296-13.407, p<0.001), structural lung disease (aOR 2.708, 95% CI 1.346-5.379, p = 0.004), PSI risk class IV-V (aOR 4.714, 95% CI 1.530-14.524, p = 0.007), no use of intrapleural fibrinolytics (aOR 3.062, 95% CI 1.102-8.511, p = 0.014), hospital-acquired infection (aOR 2.205, 95% CI 1.165-4.172, p = 0.015), age (aOR 0.964, 95% CI 0.935-0.994, p = 0.018), and SOFA score >= 2 (aOR 2.361, 95% CI 1.134-4.916, p = 0.022). Conclusion In this study, common pathogens causing pleural infection were comparable to previous studies, and consisted of streptococci, staphylococci, and anaerobes. CURB-65 >= 2, structural lung disease, PSI risk class IV-V, no use of intrapleural fibrinolytics, hospital-acquired infection, older age, and SOFA score >= 2 are potential predictors of mortality in pleural infection.	[Park, Cheol-Kyu; Oh, Hyoung-Joo; Choi, Ha-Young; Shin, Hong-Joon; Lim, Jung Hwan; Oh, In-Jae; Kim, Yu-Il; Lim, Sung-Chul; Kim, Young-Chul; Kwon, Yong-Soo] Chonnam Natl Univ Hosp, Dept Internal Med, Gwangju, South Korea	Chonnam National University; Chonnam National University Hospital	Kwon, YS (corresponding author), Chonnam Natl Univ Hosp, Dept Internal Med, Gwangju, South Korea.	yskwon@jnu.ac.kr	Oh, In-Jae/AAG-5919-2020; Kwon, Yong-Soo/AAH-6718-2019; Park, Cheol-Kyu/AAT-9872-2021	Oh, In-Jae/0000-0003-4837-1321; Park, Cheol-Kyu/0000-0001-8701-0786; Kwon, Yong-Soo/0000-0001-5121-4488	Chonnam National University Hospital [CRI16011-1]	Chonnam National University Hospital	This study was supported by a grant (CRI16011-1) from Chonnam National University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burgos J, 2013, CURR OPIN PULM MED, V19, P350, DOI 10.1097/MCP.0b013e3283606ab5; Capelastegul A, 2006, EUR RESPIR J, V27, P151, DOI 10.1183/09031936.06.00062505; Chen CH, 2007, CHEST, V132, P532, DOI 10.1378/chest.07-0005; Chen W, 2009, SOUTH MED J, V102, P909, DOI 10.1097/SMJ.0b013e3181b22c52; Chi SY, 2012, TUBERC RESPIR DIS, V73, P32, DOI 10.4046/trd.2012.73.1.32; Colicc GL, 2000, CHEST, V118, P1158, DOI 10.1378/chest.118.4.1158; Davies CWH, 2003, THORAX, V58, pII18, DOI 10.1136/thorax.58.suppl_2.ii18; Davies HE, 2010, THORAX, V65, P41, DOI 10.1136/thx.2010.137000; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Foster S, 2007, CURR OPIN PULM MED, V13, P319, DOI 10.1097/MCP.0b013e3281864691; Janda S, 2012, CHEST, V142, P401, DOI 10.1378/chest.11-3071; Jang HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099192; Kim SK, 2014, KOREAN J INTERN MED, V29, P603, DOI 10.3904/kjim.2014.29.5.603; Kim YJ, 2007, TUBERC RESPIR DIS, V63, P24, DOI 10.4046/trd.2007.63.1.24; Liang SJ, 2007, SOUTH MED J, V100, P1075, DOI 10.1097/SMJ.0b013e318158ba49; LIGHT RW, 1980, AM J MED, V69, P507, DOI 10.1016/0002-9343(80)90460-X; Lin YC, 2008, SOUTH MED J, V101, P484, DOI 10.1097/SMJ.0b013e31816c00fa; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Malhotra P, 2007, RESP MED, V101, P423, DOI 10.1016/j.rmed.2006.07.016; Marks DJB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030074; Maskell NA, 2005, NEW ENGL J MED, V352, P865, DOI 10.1056/NEJMoa042473; Maskell NA, 2006, AM J RESP CRIT CARE, V174, P817, DOI 10.1164/rccm.200601-074OC; Menzies SM, 2011, THORAX, V66, P658, DOI 10.1136/thx.2010.157842; Meyer CN, 2011, SCAND J INFECT DIS, V43, P165, DOI 10.3109/00365548.2010.536162; Neill AM, 1996, THORAX, V51, P1010, DOI 10.1136/thx.51.10.1010; Okiror L, 2014, EUR J CARDIO-THORAC, V46, P901, DOI 10.1093/ejcts/ezu104; 염정숙, 2006, Clinical and Experimental Pediatrics, V49, P56; Rahman NM, 2011, NEW ENGL J MED, V365, P518, DOI 10.1056/NEJMoa1012740; Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288; Tsang K. Y., 2007, Hong Kong Medical Journal, V13, P178; Tu CY, 2006, INTENS CARE MED, V32, P570, DOI 10.1007/s00134-005-0064-7	31	12	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161280	10.1371/journal.pone.0161280	http://dx.doi.org/10.1371/journal.pone.0161280			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529628	Green Published, Green Submitted, gold			2022-12-26	WOS:000381476700061
J	Qin, C; Sun, YQ; Dong, YD				Qin, Chao; Sun, Yongqi; Dong, Yadong			A New Method for Identifying Essential Proteins Based on Network Topology Properties and Protein Complexes	PLOS ONE			English	Article							ESSENTIAL GENES; CENTRALITY; IDENTIFICATION; GENOME; INTERACTOME; DISCOVERY; DATABASE	Essential proteins are indispensable to the viability and reproduction of an organism. The identification of essential proteins is necessary not only for understanding the molecular mechanisms of cellular life but also for disease diagnosis, medical treatments and drug design. Many computational methods have been proposed for discovering essential proteins, but the precision of the prediction of essential proteins remains to be improved. In this paper, we propose a new method, LBCC, which is based on the combination of local density, betweenness centrality (BC) and in-degree centrality of complex (IDC). First, we introduce the common centrality measures; second, we propose the densities Den1(v) and Den2(v) of a node v to describe its local properties in the network; and finally, the combined strategy of Den1, Den2, BC and IDC is developed to improve the prediction precision. The experimental results demonstrate that LBCC outperforms traditional topological measures for predicting essential proteins, including degree centrality (DC), BC, subgraph centrality (SC), eigenvector centrality (EC), network centrality (NC), and the local average connectivity- based method (LAC). LBCC also improves the prediction precision by approximately 10 percent on the YMIPS and YMBD datasets compared to the most recently developed method, LIDC.	[Qin, Chao; Sun, Yongqi; Dong, Yadong] Beijing Jiaotong Univ, Beijing Key Lab Traff Data Anal & Min, Beijing, Peoples R China	Beijing Jiaotong University	Sun, YQ (corresponding author), Beijing Jiaotong Univ, Beijing Key Lab Traff Data Anal & Min, Beijing, Peoples R China.	yqsun@bjtu.edu.cn	Dong, Yadong/GXG-3093-2022		National Natural Science Foundation of China [61572005, 61562066, 61272004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by NO. 61572005, National Natural Science Foundation of China, www.nsfc.gov.cn, YQS CQ; NO. 61562066, National Natural Science Foundation of China, www.nsfc.gov.cn, YQS; and NO. 61272004, National Natural Science Foundation of China, www.nsfc.gov.cn, YQS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Cole ST, 2002, EUR RESPIR J, V20, p78S, DOI 10.1183/09031936.02.00400202; Cullen LM, 2005, IMMUNOL CELL BIOL, V83, P217, DOI 10.1111/j.1440-1711.2005.01332.x; del Rio G, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-102; Estrada E, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.056103; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Friedel CC, 2009, J COMPUT BIOL, V16, P971, DOI 10.1089/cmb.2009.0023; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Holman AG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-243; Issel-Tarver L, 2002, METHOD ENZYMOL, V350, P329, DOI 10.1016/S0076-6879(02)50972-1; Li M, 2017, IEEE ACM T COMPUT BI, V14, P370, DOI 10.1109/TCBB.2015.2394487; Li M, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-15; Li M, 2011, COMPUT BIOL CHEM, V35, P143, DOI 10.1016/j.compbiolchem.2011.04.002; Luo JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131418; Mewes HW, 2006, NUCLEIC ACIDS RES, V34, pD169, DOI 10.1093/nar/gkj148; Pal C, 2003, NATURE, V421, P496, DOI 10.1038/421496b; Park K, 2009, PROTEOMICS, V9, P5143, DOI 10.1002/pmic.200900357; Peng W, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-87; Proctor C.H., 1951, RES METHODS SOCIAL R, P561; Pu SY, 2007, PROTEOMICS, V7, P944, DOI 10.1002/pmic.200600636; Pu SY, 2009, NUCLEIC ACIDS RES, V37, P825, DOI 10.1093/nar/gkn1005; Roemer T, 2003, MOL MICROBIOL, V50, P167, DOI 10.1046/j.1365-2958.2003.03697.x; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Tang XW, 2014, IEEE ACM T COMPUT BI, V11, P407, DOI 10.1109/TCBB.2013.2295318; Tang Y, 2015, BIOSYSTEMS, V127, P67, DOI 10.1016/j.biosystems.2014.11.005; Wang JX, 2012, IEEE ACM T COMPUT BI, V9, P1070, DOI 10.1109/TCBB.2011.147; Wang Y., 2014, INT J DISTRIB SENS N, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0110024; Watts D.J., 1999, SMALL WORLDS DYNAMIC; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Yu HY, 2004, TRENDS GENET, V20, P227, DOI 10.1016/j.tig.2004.04.008; Zhang R, 2009, NUCLEIC ACIDS RES, V37, pD455, DOI 10.1093/nar/gkn858; Zhang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058763; Zotenko E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000140	35	28	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161042	10.1371/journal.pone.0161042	http://dx.doi.org/10.1371/journal.pone.0161042			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529423	Green Published, gold, Green Submitted			2022-12-26	WOS:000381476700040
J	Fernandez, O; Arroyo, R; Martinez-Yelamos, S; Marco, M; Merino, JAG; Munoz, D; Merino, E; Roque, A				Fernandez, O.; Arroyo, R.; Martinez-Yelamos, S.; Marco, M.; Garcia Merino, J. A.; Munoz, D.; Merino, E.; Roque, A.		RELOAD Study Grp	Long-Term Adherence to IFN Beta-1 alpha Treatment when Using RebiSmart (R) Device in Patients with Relapsing-Remitting Multiple Sclerosis	PLOS ONE			English	Article							DISEASE-MODIFYING THERAPIES; INJECTION-SITE REACTIONS; MS; MULTICENTER; TOLERABILITY; INTERFERONS; PROGRESSION; PREVALENCE; TRIAL; DRUGS	The effectiveness of disease-modifying drugs in the treatment of multiple sclerosis is associated with adherence. RebiSmart (R) electronic device provides useful information about adherence to the treatment with subcutaneous (sc) interferon (IFN) beta-1 alpha (Rebif (R)). The aim of the study was to determine long-term adherence to this treatment in patients with relapsing-remitting multiple sclerosis (RRMS). This retrospective multicentre observational study analysed 258 patients with RRMS who were receiving sc IFN beta-1 alpha (Rebif (R)) treatment by using RebiSmart (R) until replacement (36 months maximum lifetime) or treatment discontinuation. Adherence was calculated with data (injection dosage, time, and date) automatically recorded by RebiSmart (R). Patients in the study had a mean age of 41 years with a female proportion of 68%. Mean EDSS score at start of treatment was 1.8 (95% CI, 1.6-1.9). Overall adherence was 92.6%(95% CI, 90.6-94.5%). A total of 30.2% of patients achieved an adherence rate of 100%, 80.6% at least 90%, and only 13.2% of patients showed a suboptimal adherence (<80%). A total of 59.9% of subjects were relapse-free after treatment initiation. Among 106 subjects (41.1%) who experienced, on average, 1.4 relapses, the majority were mild (40.6%) or moderate (47.2%). Having experienced relapses from the beginning of the treatment was the only variable significantly related to achieving an adherence of at least 80% (OR = 3.06, 1.28-7.31). Results of this study indicate that sc IFN beta-1 alpha administration facilitated by RebiSmart (R) could lead to high rates of adherence to a prescribed dose regimen over 36 months.	[Fernandez, O.] Univ Malaga, Hosp Univ Reg Malaga & Virgen Victoria, IBIMA, E-29071 Malaga, Spain; [Arroyo, R.] Hosp Univ Clin San Carlos, Madrid, Spain; [Martinez-Yelamos, S.] Hosp Univ Bellvitge, Barcelona, Spain; [Marco, M.] Corporacio Sanitaria Parc Tauli, Barcelona, Spain; [Garcia Merino, J. A.] Hosp Univ Puerta de Hierro, Madrid, Spain; [Munoz, D.] Hosp Xeral Cies, Vigo, Spain; [Merino, E.; Roque, A.] Merck SL, Dept Med, Barcelona, Spain	Universidad de Malaga; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Hospital Puerta de Hierro-Majadahonda; Complexo Hospitalario Universitario de Vigo	Fernandez, O (corresponding author), Univ Malaga, Hosp Univ Reg Malaga & Virgen Victoria, IBIMA, E-29071 Malaga, Spain.	oscar.fernandez.sspa@gmail.com	MARTÍNEZ-YÉLAMOS, Sergio/ABH-3087-2020; Merino, Esperanza/AAV-3244-2021; Merino de Lucas, Esperanza/AFQ-1126-2022	Merino de Lucas, Esperanza/0000-0003-3854-4874	Biogen Idec; Teva; Sanofi-Aventis; Merck-Serono; Novartis; Bayer-Schering	Biogen Idec(Biogen); Teva(Teva Pharmaceutical Industries); Sanofi-Aventis(Sanofi-Aventis); Merck-Serono(Merck & Company); Novartis(Novartis); Bayer-Schering(Bayer AG)	OF and RA have received honoraria as consultants in advisory boards, and as chairmen or lecturer in meetings, and have also participated in clinical trials and other research projects promoted by Biogen-Idec, Bayer-Schering, Merck-Serono, Teva, Novartis, Genzyme, Roche, Allergan, and Almirall; SM-Y has received honoraria compensation to participate in advisory boards, collaborations as a consultant and scientific communications from Biogen-Idec, Teva, Sanofi-Aventis, Merck-Serono, Novartis, and Bayer-Schering, and has received research support, funding for travel, and congress expenses from Biogen Idec, Teva, Sanofi-Aventis, Merck-Serono, Novartis, and Bayer-Schering; MM declares no conflict of interest; JAGM has received compensations for travel, lecturing or advisory work from Merck-Serono, Biogen-Idec, Bayer, Novartis, Almirall, Sanofi-Aventis, and research grants from Novartis and Biogen-Idec; DM has received honoraria as consultant in advisory boards, has participated and collaborated in meetings, and has also participated in clinical trials and other research projects promoted by Bayer-Schering, Merck-Serono, Novartis, Biogen-Idec, and Genzyme; EM and AR are employees at Merck-Serono. The authors received no specific funding for this work. The funder provided support in the form of salaries for authors [EM and AR], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AL-Sabbagh A, 2008, J NEUROL, V255, P79; Bartulos Iglesias M, 2014, NEUROLOGIA; Bayas A, 2013, EXPERT OPIN DRUG DEL, V10, P285, DOI 10.1517/17425247.2013.763793; Beer K, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-144; Brochet B, 2006, REV NEUROL-FRANCE, V162, P735, DOI 10.1016/S0035-3787(06)75071-8; Brown MG, 2007, NEUROLOGY, V69, P1498, DOI 10.1212/01.wnl.0000271884.11129.f3; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Costello Kathleen, 2008, Medscape J Med, V10, P225; Cox Darcy, 2006, J Neurosci Nurs, V38, P167; Cramer JA, 2006, ACTA NEUROL SCAND, V113, P156, DOI 10.1111/j.1600-0404.2005.00568.x; de Sa J, 2010, CURR MED RES OPIN, V26, P2237, DOI 10.1185/03007995.2010.508688; Devonshire V, 2011, EUR J NEUROL, V18, P69, DOI 10.1111/j.1468-1331.2010.03110.x; Ebers GC, 1998, LANCET, V352, P1498, DOI 10.1016/S0140-6736(98)03334-0; Exell S, 2011, EXPERT REV MED DEVIC, V8, P543, DOI [10.1586/ERD.11.29, 10.1586/erd.11.29]; Fernandez O, 2012, MULT SCLER J, V18, P372, DOI 10.1177/1352458511421917; Fernandez O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035600; IFNB Multiple Sclerosis Study Group, 1993, NEUROLOGY, V43, P655; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; JOHNSON KP, 1995, NEUROLOGY, V45, P1268, DOI 10.1212/WNL.45.7.1268; Lugaresi A, 2013, EXPERT OPIN DRUG DEL, V10, P273, DOI 10.1517/17425247.2013.746311; Lugaresi A, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-7; Mikol D, 2005, MULT SCLER J, V11, P585, DOI 10.1191/1352458505ms1197oa; Mohr DC, 2001, ANN BEHAV MED, V23, P125, DOI 10.1207/S15324796ABM2302_7; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Seddighzadeh A, 2014, EXPERT OPIN DRUG DEL, V11, P1713, DOI 10.1517/17425247.2014.944159; Steinberg SC, 2010, CLIN DRUG INVEST, V30, P89, DOI 10.2165/11533330-000000000-00000; Treadaway K, 2009, J NEUROL, V256, P568, DOI 10.1007/s00415-009-0096-y; Tremlett HL, 2003, NEUROLOGY, V61, P551, DOI 10.1212/01.WNL.0000078885.05053.7D; WEINSHENKER BG, 1989, BRAIN, V112, P133, DOI 10.1093/brain/112.1.133; Willis H, 2014, PATIENT PREFER ADHER, V8, P843, DOI 10.2147/PPA.S54986	30	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0160313	10.1371/journal.pone.0160313	http://dx.doi.org/10.1371/journal.pone.0160313			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27526201	Green Published, gold, Green Submitted			2022-12-26	WOS:000381471100013
J	Deng, X; Shao, G; Zhang, HT; Li, C; Zhang, D; Cheng, L; Elzey, BD; Pili, R; Ratliff, TL; Huang, J; Hu, CD				Deng, X.; Shao, G.; Zhang, H-T; Li, C.; Zhang, D.; Cheng, L.; Elzey, B. D.; Pili, R.; Ratliff, T. L.; Huang, J.; Hu, C-D			Protein arginine methyltransferase 5 functions as an epigenetic activator of the androgen receptor to promote prostate cancer cell growth	ONCOGENE			English	Article							SPLICE VARIANTS; GENE-EXPRESSION; IN-VITRO; PRMT5; TARGET; METHYLATION; TRANSCRIPTION; COMPLEX; RESISTANCE; INITIATION	Protein arginine methyltransferase 5 (PRMT5) is an emerging epigenetic enzyme that mainly represses transcription of target genes via symmetric dimethylation of arginine residues on histones H4R3, H3R8 and H2AR3. Accumulating evidence suggests that PRMT5 may function as an oncogene to drive cancer cell growth by epigenetic inactivation of several tumor suppressors. Here, we provide evidence that PRMT5 promotes prostate cancer cell growth by epigenetically activating transcription of the androgen receptor (AR) in prostate cancer cells. Knockdown of PRMT5 or inhibition of PRMT5 by a specific inhibitor reduces the expression of AR and suppresses the growth of multiple AR-positive, but not AR-negative, prostate cancer cells. Significantly, knockdown of PRMT5 in AR-positive LNCaP cells completely suppresses the growth of xenograft tumors in mice. Molecular analysis reveals that PRMT5 binds to the proximal promoter region of the AR gene and contributes mainly to the enriched symmetric dimethylation of H4R3 in the same region. Mechanistically, PRMT5 is recruited to the AR promoter by its interaction with Sp1, the major transcription factor responsible for AR transcription, and forms a complex with Brg1, an ATP-dependent chromatin remodeler, on the proximal promoter region of the AR gene. Furthermore, PRMT5 expression in prostate cancer tissues is significantly higher than that in benign prostatic hyperplasia tissues, and PRMT5 expression correlates positively with AR expression at both the protein and mRNA levels. Taken together, our results identify PRMT5 as a novel epigenetic activator of AR in prostate cancer. Given that inhibiting AR transcriptional activity or androgen synthesis remains the major mechanism of action for most existing anti-androgen agents, our findings also raise an interesting possibility that targeting PRMT5 may represent a novel approach for prostate cancer treatment by eliminating AR expression.	[Deng, X.; Shao, G.; Zhang, H-T; Hu, C-D] Purdue Univ, Dept Med Chem & Mol Pharmacol, 575 Stadium Mall Dr, W Lafayette, IN 47907 USA; [Shao, G.] Jiangsu Univ, Sch Med, Dept Bas Med Sci, Zhenjiang, Peoples R China; [Zhang, H-T] Jinan Univ, First Affiliated Hosp, Inst Orthoped Dis, Dept Orthoped, Guangzhou, Peoples R China; [Li, C.] Ohio State Univ, Div Med Chem & Pharmacognosy, Columbus, OH USA; [Zhang, D.] Purdue Univ, Dept Stat, W Lafayette, IN USA; [Cheng, L.] Indiana Univ, Dept Pathol, Indianapolis, IN USA; [Cheng, L.] Indiana Univ, Lab Med, Indianapolis, IN USA; [Elzey, B. D.; Ratliff, T. L.] Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN USA; [Pili, R.] Indiana Univ, Simon Canc Ctr, Dept Med Oncol, Indianapolis, IN USA; [Ratliff, T. L.; Hu, C-D] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA; [Huang, J.] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Jiangsu University; Jinan University; University System of Ohio; Ohio State University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indiana University System; Indiana University-Purdue University Indianapolis; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of California System; University of California Los Angeles	Hu, CD (corresponding author), Purdue Univ, Dept Med Chem & Mol Pharmacol, 575 Stadium Mall Dr, W Lafayette, IN 47907 USA.	hu1@purdue.edu		Cheng, Liang/0000-0001-6049-5293	U.S. Army Medical Research Acquisition Activity; Prostate Cancer Research Program [PC11190, PC120512, PC150697]; Purdue University Center for Cancer Research Small Grants; NCI CCSG; China Scholarship Council; NATIONAL CANCER INSTITUTE [P30CA023168, R01CA212403] Funding Source: NIH RePORTER	U.S. Army Medical Research Acquisition Activity; Prostate Cancer Research Program; Purdue University Center for Cancer Research Small Grants; NCI CCSG; China Scholarship Council(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was partially supported by grants from U.S. Army Medical Research Acquisition Activity, Prostate Cancer Research Program (PC11190, PC120512, and PC150697) to C-D Hu, and Purdue University Center for Cancer Research Small Grants. DNA sequencing and animal experiments were conducted in Genomic Core facility and the Biological Evaluation Shared Resource facility, respectively, supported by NCI CCSG CA23168 to Purdue University Center for Cancer Research. Genbao Shao and Huan-Tian Zhang were visiting scholars supported by the China Scholarship Council.	Agoulnik IU, 2008, ADV EXP MED BIOL, V617, P245, DOI 10.1007/978-0-387-69080-3_23; Alinari L, 2015, BLOOD, V125, P2530, DOI 10.1182/blood-2014-12-619783; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bello D, 1997, CARCINOGENESIS, V18, P1215, DOI 10.1093/carcin/18.6.1215; Cai CM, 2013, TRANSL ANDROL UROL, V2, P148, DOI 10.3978/j.issn.2223-4683.2013.09.02; Chan-Penebre E, 2015, NAT CHEM BIOL, V11, P432, DOI [10.1038/NCHEMBIO.1810, 10.1038/nchembio.1810]; Chandrasekar T, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0457-6; Chmelar R, 2007, INT J CANCER, V120, P719, DOI 10.1002/ijc.22365; Cho EC, 2012, EMBO J, V31, P1785, DOI 10.1038/emboj.2012.17; Dacwag CS, 2007, MOL CELL BIOL, V27, P384, DOI 10.1128/MCB.01528-06; Dehm SM, 2006, J CELL BIOCHEM, V99, P333, DOI 10.1002/jcb.20794; Deng XH, 2011, AM J CANCER RES, V1, P834; Dutt SS, 2009, FUTURE ONCOL, V5, P1403, DOI 10.2217/FON.09.117; FABER PW, 1993, J BIOL CHEM, V268, P9296; Gao L, 2010, EPIGENETICS-US, V5, P100, DOI 10.4161/epi.5.2.10778; Giacinti S, 2014, ANTICANCER RES, V34, P6265; Gu ZP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044033; Gu ZP, 2012, BIOCHEM J, V446, P235, DOI 10.1042/BJ20120768; Guo ZY, 2011, INT J BIOL SCI, V7, P815, DOI 10.7150/ijbs.7.815; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; Hay CW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139990; Hedges LV, 1998, PSYCHOL METHODS, V3, P486, DOI 10.1037/1082-989X.3.4.486; Hedges LV, 1985, STATISCAL METHODS ME; Hosohata K, 2003, MOL CELL BIOL, V23, P7019, DOI 10.1128/MCB.23.19.7019-7029.2003; Hsu CC, 2013, MOL CELL ENDOCRINOL, V372, P12, DOI 10.1016/j.mce.2013.03.004; Jeronimo C, 2011, EUR UROL, V60, P753, DOI 10.1016/j.eururo.2011.06.035; Karkhanis V, 2011, TRENDS BIOCHEM SCI, V36, P633, DOI 10.1016/j.tibs.2011.09.001; Ke N, 2004, BIOTECHNIQUES, V36, P826, DOI 10.2144/04365ST07; Krause CD, 2007, PHARMACOL THERAPEUT, V113, P50, DOI 10.1016/j.pharmthera.2006.06.007; LeBlanc SE, 2012, MOL ENDOCRINOL, V26, P583, DOI 10.1210/me.2011-1162; Liu C, 2013, JNCI-J NATL CANCER I, V105, P1719, DOI 10.1093/jnci/djt304; Mirochnik Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031052; Nakazawa M, 2014, HORM CANCER-US, V5, P265, DOI 10.1007/s12672-014-0190-1; Nelson JD, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj004; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Pal S, 2003, MOL CELL BIOL, V23, P7475, DOI 10.1128/MCB.23.21.7475-7487.2003; Powers MA, 2011, CANCER RES, V71, P5579, DOI 10.1158/0008-5472.CAN-11-0458; Ryan CJ, 2011, J CLIN ONCOL, V29, P3651, DOI 10.1200/JCO.2011.35.2005; Seth-Vollenweider T, 2014, J BIOL CHEM, V289, P33958, DOI 10.1074/jbc.M114.583302; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Stopa N, 2015, CELL MOL LIFE SCI, V72, P2041, DOI 10.1007/s00018-015-1847-9; Tarighat SS, 2016, LEUKEMIA, V30, P789, DOI 10.1038/leu.2015.308; Tee WW, 2010, GENE DEV, V24, P2772, DOI 10.1101/gad.606110; Teng Y, 2007, CANCER RES, V67, P10491, DOI 10.1158/0008-5472.CAN-06-4206; TILLEY WD, 1990, CANCER RES, V50, P5382; TILLEY WD, 1990, J BIOL CHEM, V265, P13776; Wang J, 2010, CANCER RES, V70, P10182, DOI 10.1158/0008-5472.CAN-10-2414; Wang L, 2005, PROSTATE, V63, P117, DOI 10.1002/pros.20170; Wang L, 2008, MOL CELL BIOL, V28, P6262, DOI 10.1128/MCB.00923-08; Wei TYW, 2012, CANCER SCI, V103, P1640, DOI 10.1111/j.1349-7006.2012.02367.x; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701; Yan FT, 2014, CANCER RES, V74, P1752, DOI 10.1158/0008-5472.CAN-13-0884; Zhang HT, 2014, BBA-GENE REGUL MECH, V1839, P1330, DOI 10.1016/j.bbagrm.2014.09.015	53	70	73	2	19	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2017	36	9					1223	1231		10.1038/onc.2016.287	http://dx.doi.org/10.1038/onc.2016.287			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EN2SV	27546619	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000395861300006
J	O'Dowd, EL; McKeever, TM; Baldwin, DR; Hubbard, RB				O'Dowd, Emma L.; McKeever, Tricia M.; Baldwin, David R.; Hubbard, Richard B.			Place of Death in Patients with Lung Cancer: A Retrospective Cohort Study from 2004-2013	PLOS ONE			English	Article							OF-LIFE CARE; RANDOMIZED-TRIAL; PALLIATIVE-CARE; MENTAL-HEALTH; ENGLAND; DISCUSSIONS; PREDICTORS; HOME	Introduction Many patients with cancer die in an acute hospital bed, which has been frequently identified as the least preferred location, with psychological and financial implications. This study looks at place and cause of death in patients with lung cancer and identifies which factors are associated with dying in an acute hospital bed versus at home. Methods and Findings We used the National Lung Cancer Audit linked to Hospital Episode Statistics and Office for National Statistics data to determine cause and place of death in those with lung cancer; both overall and by cancer Network. We used multivariate logistic regression to compare features of those who died in an acute hospital versus those who died at home. Results Of 143627 patients identified 40% (57678) died in an acute hospital, 29% (41957) died at home and 17% (24108) died in a hospice. Individual factors associated with death in an acute hospital bed compared to home were male sex, increasing age, poor performance status, social deprivation and diagnosis via an emergency route. There was marked variation between cancer Networks in place of death. The proportion of patients dying in an acute hospital ranged from 28% to 48%, with variation most notable in provision of hospice care (9% versus 33%). Cause of death in the majority was lung cancer (86%), with other malignancies, chronic obstructive pulmonary disease (COPD) and ischaemic heart disease (IHD) comprising 9% collectively. Conclusions A substantial proportion of patients with lung cancer die in acute hospital beds and this is more likely with increasing age, male sex, social deprivation and in those with poor performance status. There is marked variation between Networks, suggesting a need to improve end-of-life planning in those at greatest risk, and to review the allocation of resources to provide more hospice beds, enhanced community support and ensure equal access.	[O'Dowd, Emma L.; McKeever, Tricia M.; Hubbard, Richard B.] Div Publ Hlth & Epidemiol, Clin Sci Bldg,Nottingham City Campus,Hucknall Rd, Nottingham, England; [Baldwin, David R.] City Hosp Nottingham, Dept Resp Med, David Evans Bldg,Hucknall Rd, Nottingham, England	Nottingham University Hospital NHS Trust; Nottingham City Hospital; Nottingham University Hospital NHS Trust; Nottingham City Hospital	O'Dowd, EL (corresponding author), Div Publ Hlth & Epidemiol, Clin Sci Bldg,Nottingham City Campus,Hucknall Rd, Nottingham, England.	emma.o'dowd@nottingham.ac.uk		McKeever, Tricia/0000-0003-0914-0416	Roy Castle Lung Cancer Foundation [RB08F1]; British Lung Foundation [C05/01] Funding Source: researchfish	Roy Castle Lung Cancer Foundation; British Lung Foundation	This work was supported by the Roy Castle Lung Cancer Foundation, grant number RB08F1. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brumley R, 2007, J AM GERIATR SOC, V55, P993, DOI 10.1111/j.1532-5415.2007.01234.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Coupland VH, 2011, PALLIATIVE MED, V25, P314, DOI 10.1177/0269216310395986; Davies E, 2006, BRIT J CANCER, V95, P593, DOI 10.1038/sj.bjc.6603305; Elliss-Brookes L, 2012, BRIT J CANCER, V107, P1220, DOI 10.1038/bjc.2012.408; Gao W, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001410; Gatrell AC, 2012, HEALTH PLACE, V18, P832, DOI 10.1016/j.healthplace.2012.03.009; Gomes B, 2012, ANN ONCOL, V23, P2006, DOI 10.1093/annonc/mdr602; Gomes B, 2012, PALLIATIVE MED, V26, P102, DOI 10.1177/0269216311432329; Jordhoy MS, 2000, LANCET, V356, P888, DOI 10.1016/S0140-6736(00)02678-7; Kawaguchi T, 2010, J THORAC ONCOL, V5, P620, DOI 10.1097/JTO.0b013e3181d2dcd9; Mack JW, 2012, ANN INTERN MED, V156, P204, DOI 10.7326/0003-4819-156-3-201202070-00008; Macmillan Cancer Support, 2014, CANC UN BURD REAL IM; Marie Curie Cancer Care, 2012, UND COST END LIF CAR; Mitchell AJ, 2011, LANCET ONCOL, V12, P160, DOI 10.1016/S1470-2045(11)70002-X; Morden NE, 2012, HEALTH AFFAIR, V31, P786, DOI 10.1377/hlthaff.2011.0650; O'Dowd E, 2014, LUNG CANCER, V83, pS34, DOI 10.1016/S0169-5002(14)70092-3; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Prigerson H G, 1991, Home Health Care Serv Q, V12, P81; Rich AL, 2011, LUNG CANCER, V72, P16, DOI 10.1016/j.lungcan.2010.07.002; Sleeman KE, 2016, PALLIATIVE MED, V30, P45, DOI DOI 10.1177/0269216315585064; Townsend PP., 1988, HLTH DEPRIVATION INE; World Health Organization, 2010, INT STAT CLASS DIS R, V2; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665; Wright AA, 2010, J CLIN ONCOL, V28, P4457, DOI 10.1200/JCO.2009.26.3863	25	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0161399	10.1371/journal.pone.0161399	http://dx.doi.org/10.1371/journal.pone.0161399			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27551922	Green Published, gold, Green Submitted			2022-12-26	WOS:000381768800037
J	Banerjee, A; Preiser, AL; Sharkey, TD				Banerjee, Aparajita; Preiser, Alyssa L.; Sharkey, Thomas D.			Engineering of Recombinant Poplar Deoxy-D-Xylulose-5-Phosphate Synthase (PtDXS) by Site-Directed Mutagenesis Improves Its Activity	PLOS ONE			English	Article							1-DEOXY-D-XYLULOSE 5-PHOSPHATE SYNTHASE; ESCHERICHIA-COLI; ISOPRENOID BIOSYNTHESIS; ISOPENTENYL DIPHOSPHATE; PHOSPHATE-PATHWAY; SUBSTRATE-BINDING; HIGHER-PLANTS; INTERMEDIATE; EXPRESSION; TERPENOIDS	Deoxyxylulose 5-phosphate synthase (DXS), a thiamine diphosphate (ThDP) dependent enzyme, plays a regulatory role in the methylerythritol 4-phosphate (MEP) pathway. Isopentenyl diphosphate (IDP) and dimethylallyl diphosphate (DMADP), the end products of this pathway, inhibit DXS by competing with ThDP. Feedback inhibition of DXS by IDP and DMADP constitutes a significant metabolic regulation of this pathway. The aim of this work was to experimentally test the effect of key residues of recombinant poplar DXS (PtDXS) in binding both ThDP and IDP. This work also described the engineering of PtDXS to improve the enzymatic activity by reducing its inhibition by IDP and DMADP. We have designed and tested modifications of PtDXS in an attempt to reduce inhibition by IDP. This could possibly be valuable by removing a feedback that limits the usefulness of the MEP pathway in biotechnological applications. Both ThDP and IDP use similar interactions for binding at the active site of the enzyme, however, ThDP being a larger molecule has more anchoring sites at the active site of the enzyme as compared to the inhibitors. A predicted enzyme structure was examined to find ligand-enzyme interactions, which are relatively more important for inhibitor-enzyme binding than ThDP-enzyme binding, followed by their modifications so that the binding of the inhibitors can be selectively affected compared to ThDP. Two alanine residues important for binding ThDP and the inhibitors were mutated to glycine. In two of the cases, both the IDP inhibition and the overall activity were increased. In another case, both the IDP inhibition and the overall activity were reduced. This provides proof of concept that it is possible to reduce the feedback from IDP on DXS activity.	[Banerjee, Aparajita; Preiser, Alyssa L.; Sharkey, Thomas D.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University	Sharkey, TD (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	tsharkey@msu.edu	Banerjee, Aparajita/ABC-8383-2020; Sharkey, Thomas/ABF-1317-2020; Sharkey, Thomas D/B-4032-2009	Banerjee, Aparajita/0000-0001-5711-4998; Sharkey, Thomas/0000-0002-4423-3223; Sharkey, Thomas D/0000-0002-4423-3223	National Science Foundation [IOS-0950574]; Michigan AgBioResearch	National Science Foundation(National Science Foundation (NSF)); Michigan AgBioResearch	This work was supported by the National Science Foundation Grant No. IOS-0950574 to TDS provided salary for AB and supplies. Salary for TDS was provided in part by Michigan AgBioResearch.	Albrecht M, 1999, BIOTECHNOL LETT, V21, P791, DOI 10.1023/A:1005547827380; Banerjee A, 2013, J BIOL CHEM, V288, P16926, DOI 10.1074/jbc.M113.464636; Basta LAB, 2014, FEBS J, V281, P2820, DOI 10.1111/febs.12823; Brammer LA, 2011, J BIOL CHEM, V286, P36522, DOI 10.1074/jbc.M111.259747; Eisenreich W, 1998, CHEM BIOL, V5, pR221, DOI 10.1016/S1074-5521(98)90002-3; Eubanks LM, 2003, BIOCHEMISTRY-US, V42, P1140, DOI 10.1021/bi0205303; Ghirardo A, 2014, PLANT PHYSIOL, V165, P37, DOI 10.1104/pp.114.236018; Harker M, 1999, FEBS LETT, V448, P115, DOI 10.1016/S0014-5793(99)00360-9; Huang QL, 2001, BIOORGAN MED CHEM, V9, P2237, DOI 10.1016/S0968-0896(01)00072-4; Kim SW, 2001, BIOTECHNOL BIOENG, V72, P408, DOI 10.1002/1097-0290(20000220)72:4<408::AID-BIT1003>3.0.CO;2-H; Klein-Marcuschamer D, 2007, TRENDS BIOTECHNOL, V25, P417, DOI 10.1016/j.tibtech.2007.07.006; Lehninger AL, 1993, PRINCIPLES BIOCH, P408; Lichtenthaler HK, 1997, PHYSIOL PLANTARUM, V101, P643, DOI 10.1111/j.1399-3054.1997.tb01049.x; Lichtenthaler HK, 1999, ANNU REV PLANT PHYS, V50, P47, DOI 10.1146/annurev.arplant.50.1.47; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Martin VJJ, 2001, BIOTECHNOL BIOENG, V75, P497, DOI 10.1002/bit.10037; Matthews PD, 2000, APPL MICROBIOL BIOT, V53, P396, DOI 10.1007/s002530051632; Maury J, 2005, ADV BIOCHEM ENG BIOT, V100, P19, DOI 10.1007/b136410; Misawa N, 2011, CURR OPIN BIOTECH, V22, P627, DOI 10.1016/j.copbio.2011.01.002; Patel H, 2012, J AM CHEM SOC, V134, P18374, DOI 10.1021/ja307315u; Phillips MA, 2008, TRENDS PLANT SCI, V13, P619, DOI 10.1016/j.tplants.2008.09.003; Reiling KK, 2004, BIOTECHNOL BIOENG, V87, P200, DOI 10.1002/bit.20128; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Roberts SC, 2007, NAT CHEM BIOL, V3, P387, DOI 10.1038/nchembio.2007.8; Rodriguez-Concepcion M, 2002, PLANT PHYSIOL, V130, P1079, DOI 10.1104/pp.007138; Rodriguez-Concepcion Manuel, 2006, Phytochemistry Reviews, V5, P1, DOI 10.1007/s11101-005-3130-4; Rohmer M, 1999, NAT PROD REP, V16, P565, DOI 10.1039/a709175c; Rude MA, 2009, CURR OPIN MICROBIOL, V12, P274, DOI 10.1016/j.mib.2009.04.004; Vickers CE, 2014, PLANT CELL ENVIRON, V37, P1753, DOI 10.1111/pce.12316; Wang CW, 2000, BIOTECHNOL PROGR, V16, P922, DOI 10.1021/bp000124f	30	11	14	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161534	10.1371/journal.pone.0161534	http://dx.doi.org/10.1371/journal.pone.0161534			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548482	gold, Green Submitted, Green Published			2022-12-26	WOS:000381768400068
J	Cho, KI; Cho, SH; Her, AY; Singh, GB; Shin, ES				Cho, Kyoung Im; Cho, Sang Hoon; Her, Ae-Young; Singh, Gillian Balbir; Shin, Eun-Seok			Prognostic Utility of Neutrophil-to-Lymphocyte Ratio on Adverse Clinical Outcomes in Patients with Severe Calcific Aortic Stenosis	PLOS ONE			English	Article							C-REACTIVE PROTEIN; ELEVATION MYOCARDIAL-INFARCTION; RISK-EVALUATION EUROSCORE; VALVE STENOSIS; NEUTROPHIL/LYMPHOCYTE RATIO; EUROPEAN SYSTEM; CARDIAC-SURGERY; DISEASE; INFLAMMATION; PROGRESSION	Background Inflammation is an important factor in the pathogenesis of calcific aortic stenosis (AS). We aimed to evaluate the association between an inflammatory marker, neutrophil-to-lymphocyte ratio (NLR) and major adverse cardiovascular events (MACE) in patients with severe calcific AS. Methods A total of 336 patients with isolated severe calcific AS newly diagnosed between 2010 and 2015 were enrolled in this study. Using Cox proportional hazards (PH) regression models, we investigated the prognostic value of NLR adjusted for baseline covariates including logistic European System for Cardiac Operative Risk Evaluation score (EuroSCORE-I) and undergoing aortic valve replacement (AVR). We also evaluated the clinical relevance of NLR risk groups (divided into low, intermediate, high risk) as categorized by NLR cutoff values. MACE was defined as a composite of all-cause mortality, cardiac death and non-fatal myocardial infarction during the follow-up period. Results The inflammatory marker NLR was an independent prognostic factor most significantly associated with MACE [hazard ratio (HR), 1.06; 95% confidence interval (CI), 1.04-1.09; pvalue < 0.001]. The goodness-of-fit and discriminability of the model including EuroSCOREI and AVR (loglikelihood difference, 15.49; p-value < 0.001; c-index difference, 0.035; pvalue = 0.03) were significantly improved when NLR was incorporated into the model. The estimated Kaplan-Meier survival rates at 5 years for the NLR risk groups were 84.6% for the low risk group (NLR <= 2), 67.7% for the intermediate risk group ( 2 < NLR <= 9), and 42.6% for the high risk group ( NLR > 9), respectively. Conclusion The findings of the present study demonstrate the potential utility of NLR in risk stratification of patients with severe calcific AS.	[Cho, Kyoung Im] Kosin Univ, Sch Med, Dept Cardiol, Busan, South Korea; [Cho, Sang Hoon] Soongsil Univ, Dept Stat & Actuarial Sci, Seoul, South Korea; [Her, Ae-Young] Kangwon Natl Univ, Sch Med, Dept Internal Med, Div Cardiol, Chunchon, South Korea; [Singh, Gillian Balbir; Shin, Eun-Seok] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Cardiol, Ulsan, South Korea	Soongsil University; Kangwon National University; University of Ulsan; Ulsan University Hospital	Shin, ES (corresponding author), Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Cardiol, Ulsan, South Korea.	sesim1989@gmail.com						Arangalage D, 2014, ARCH CARDIOVASC DIS, V107, P353, DOI 10.1016/j.acvd.2014.05.002; Avci A, 2014, ECHOCARDIOGR-J CARD, V31, P1031, DOI 10.1111/echo.12534; Azab B, 2010, AM J CARDIOL, V106, P470, DOI 10.1016/j.amjcard.2010.03.062; Baumgartner H, 2009, J AM SOC ECHOCARDIOG, V22, P1, DOI 10.1016/j.echo.2008.11.029; Bergler-Klein J, 2004, CIRCULATION, V109, P2302, DOI 10.1161/01.CIR.0000126825.50903.18; Chan KL, 2011, AM HEART J, V161, P1133, DOI 10.1016/j.ahj.2011.03.016; Cho KI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133934; Cote N, 2013, INFLAMMATION, V36, P573, DOI 10.1007/s10753-012-9579-6; Fowler AJ, 2013, ATHEROSCLEROSIS, V228, P44, DOI 10.1016/j.atherosclerosis.2013.02.008; Hamirani YS, 2008, ATHEROSCLEROSIS, V201, P1, DOI 10.1016/j.atherosclerosis.2008.04.045; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Heymans S, 2009, EUR J HEART FAIL, V11, P119, DOI 10.1093/eurjhf/hfn043; Imai K, 2008, AM HEART J, V156, P713, DOI 10.1016/j.ahj.2008.04.011; Jander N, 2011, CIRCULATION, V123, P887, DOI 10.1161/CIRCULATIONAHA.110.983510; Jeevanantham V, 2007, MAYO CLIN PROC, V82, P171; Kim SI, 2013, BRIT J CANCER, V109, P1165, DOI 10.1038/bjc.2013.465; Lindman BR, 2013, CIRC RES, V113, P223, DOI 10.1161/CIRCRESAHA.111.300084; Nashef SAM, 2002, EUR J CARDIO-THORAC, V22, P101, DOI 10.1016/S1010-7940(02)00208-7; Novaro GM, 2007, J AM COLL CARDIOL, V50, P1992, DOI 10.1016/j.jacc.2007.07.064; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; Otto CM, 2014, NEW ENGL J MED, V371, P744, DOI 10.1056/NEJMra1313875; Park BJ, 2011, CLIN CHIM ACTA, V412, P925, DOI 10.1016/j.cca.2011.01.021; Poludasu Shyam, 2009, Clin Cardiol, V32, pE6, DOI 10.1002/clc.20503; Schemper M, 1996, CONTROL CLIN TRIALS, V17, P343, DOI 10.1016/0197-2456(96)00075-X; Wang C, 2010, J HEART VALVE DIS, V19, P21; Wang XD, 2014, ATHEROSCLEROSIS, V234, P206, DOI 10.1016/j.atherosclerosis.2014.03.003; Wendt D, 2015, J CARDIOL, V66, P292, DOI 10.1016/j.jjcc.2015.04.003; Wiegers SE, 2013, CIRCULATION, V128, P576, DOI 10.1161/CIRCULATIONAHA.113.004193	28	12	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161530	10.1371/journal.pone.0161530	http://dx.doi.org/10.1371/journal.pone.0161530			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548384	Green Published, gold, Green Submitted			2022-12-26	WOS:000381768400067
J	Georgiadis, M; Guizar-Sicairos, M; Gschwend, O; Hangartner, P; Bunk, O; Muller, R; Schneider, P				Georgiadis, Marios; Guizar-Sicairos, Manuel; Gschwend, Oliver; Hangartner, Peter; Bunk, Oliver; Mueller, Ralph; Schneider, Philipp			Ultrastructure Organization of Human Trabeculae Assessed by 3D sSAXS and Relation to Bone Microarchitecture	PLOS ONE			English	Article							COLLAGEN FIBER ORIENTATION; SCANNING ELECTRON-MICROSCOPY; POLARIZED-LIGHT MICROSCOPY; PHASE NANO-TOMOGRAPHY; HUMAN LAMELLAR BONE; COMPACT-BONE; 2ND-HARMONIC GENERATION; COMPUTED-TOMOGRAPHY; ELASTIC-ANISOTROPY; SINGLE OSTEONS	Although the organization of bone ultrastructure, i.e. the orientation and arrangement of the mineralized collagen fibrils, has been in the focus of research for many years for cortical bone, and many models on the osteonal arrangement have been proposed, limited attention has been paid to trabecular bone ultrastructure. This is surprising because trabeculae play a crucial role for the mechanical strength of several bone sites, including the vertebrae and the femoral head. On this account, we first validated a recently developed method (3D sSAXS or 3D scanning small-angle X-ray scattering) for investigating bone ultrastructure in a quantitative and spatially resolved way, using conventional linearly polarized light microscopy as a gold standard. While both methods are used to analyze thin tissue sections, in contrast to polarized light microscopy, 3D sSAXS has the important advantage that it provides 3D information on the orientation and arrangement of bone ultrastructure. In this first study of its kind, we used 3D sSAXS to investigate the ultrastructural organization of 22 vertebral trabeculae of different alignment, types and sizes, obtained from 4 subjects of different ages. Maps of ultrastructure orientation and arrangement of the trabeculae were retrieved by stacking information from consecutive 20-mu m-thick bone sections. The organization of the ultrastructure was analyzed in relation to trabecular microarchitecture obtained from computed tomography and to relevant parameters such as distance to trabecular surface, local curvature or local bone mineralization. We found that (i) ultrastructure organization is similar for all investigated trabeculae independent of their particular characteristics, (ii) bone ultrastructure exhibiting a high degree of orientation was arranged in domains, (iii) highly oriented ultrastructural areas were located closer to the bone surface, (iv) the ultrastructure of the human trabecular bone specimens followed the microarchitecture, being oriented mostly parallel to bone surface, and (v) local surface curvature seems to have an effect on the ultrastructure organization. Further studies that investigate bone ultrastructure orientation and arrangement are needed in order to understand its organization and consequently its relation to bone biology and mechanics.	[Georgiadis, Marios; Gschwend, Oliver; Hangartner, Peter; Mueller, Ralph; Schneider, Philipp] ETH, Inst Biomech, Zurich, Switzerland; [Guizar-Sicairos, Manuel; Bunk, Oliver] Paul Scherrer Inst, Villigen, Switzerland; [Schneider, Philipp] Univ Southampton, Fac Engn & Environm, Bioengn Sci Res Grp, Southampton, Hants, England	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Southampton	Schneider, P (corresponding author), ETH, Inst Biomech, Zurich, Switzerland.; Schneider, P (corresponding author), Univ Southampton, Fac Engn & Environm, Bioengn Sci Res Grp, Southampton, Hants, England.	p.schneider@soton.ac.uk	Bunk, Oliver/B-7602-2013; Schneider, Philipp/AAP-6133-2021; Müller, Ralph/A-1198-2008; Guizar-Sicairos, Manuel/AAB-3793-2019; Guizar-Sicairos, Manuel/I-4899-2013	Bunk, Oliver/0000-0001-6563-4053; Schneider, Philipp/0000-0001-7499-3576; Müller, Ralph/0000-0002-5811-7725; Guizar-Sicairos, Manuel/0000-0002-8293-3634; Guizar-Sicairos, Manuel/0000-0002-8293-3634; Georgiadis, Marios/0000-0003-0733-4559	ETH Research Grant [ETH-39 11-1]	ETH Research Grant	This work was supported by ETH Research Grant ETH-39 11-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, RADIONUCLIDE HYBRID; ASCENZI A, 1967, ANAT REC, V158, P375, DOI 10.1002/ar.1091580403; ASCENZI A, 1968, ANAT REC, V161, P377, DOI 10.1002/ar.1091610309; Ascenzi MG, 2003, J STRUCT BIOL, V141, P22, DOI 10.1016/S1047-8477(02)00578-6; ATKINSON P. J., 1967, CALCIFIED TISSUE RES, V1, P24, DOI 10.1007/BF02008071; Bi X, 2005, OSTEOARTHR CARTILAGE, V13, P1050, DOI 10.1016/j.joca.2005.07.008; Bidan CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036336; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; BOYDE A, 1969, Z ZELLFORSCH MIK ANA, V93, P213; BOYDE A, 1990, BONE, V11, P35, DOI 10.1016/8756-3282(90)90069-B; BOYDE A, 1984, METAB BONE DIS RELAT, V5, P299, DOI 10.1016/0221-8747(84)90017-1; Bromage Timothy G., 2003, Anatomical Record, V274B, P157, DOI 10.1002/ar.b.10031; Bunk O, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/12/123016; Chen XY, 2012, NAT PROTOC, V7, P654, DOI 10.1038/nprot.2012.009; Cotter MM, 2009, ANAT REC, V292, P1098, DOI 10.1002/ar.20932; Dierolf M, 2010, NATURE, V467, P436, DOI 10.1038/nature09419; Donnelly E, 2006, J MATER RES, V21, P2106, DOI 10.1557/JMR.2006.0259; Faingold A, 2013, ACTA BIOMATER, V9, P5956, DOI 10.1016/j.actbio.2012.11.032; Galvis L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063518; Gautieri A, 2011, NANO LETT, V11, P757, DOI 10.1021/nl103943u; Georgiadis M, 2016, J ROYAL SOC IN PRESS; Georgiadis M, 2015, BONE, V71, P42, DOI 10.1016/j.bone.2014.10.002; Giannini C, 2012, SCI REP-UK, V2, DOI 10.1038/srep00435; GIRAUDGUILLE MM, 1988, CALCIFIED TISSUE INT, V42, P167, DOI 10.1007/BF02556330; Granke M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058043; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; Hofmann T, 2006, J BIOMECH, V39, P2282, DOI 10.1016/j.jbiomech.2005.07.009; Holler M, 2014, SCI REP, P4; JAYASINGHE JAP, 1993, VIRCHOWS ARCH A, V422, P25, DOI 10.1007/BF01605129; Kagias M, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.093902; Karunaratne A, 2012, BONE, V51, P553, DOI 10.1016/j.bone.2012.04.021; Langer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035691; Liebi M, 2015, NATURE, V527, P349, DOI 10.1038/nature16056; MARTIN RB, 1989, J BIOMECH, V22, P419, DOI 10.1016/0021-9290(89)90202-9; Meek KM, 2009, PROG RETIN EYE RES, V28, P369, DOI 10.1016/j.preteyeres.2009.06.005; MOSEKILDE L, 1990, BONE MINER, V10, P13, DOI 10.1016/0169-6009(90)90046-I; Reisinger AG, 2011, BIOMECH MODEL MECHAN, V10, P67, DOI 10.1007/s10237-010-0218-6; Reznikov N, 2015, BONE, V71, P189, DOI 10.1016/j.bone.2014.10.017; Reznikov N, 2014, BONE, V59, P93, DOI 10.1016/j.bone.2013.10.023; Reznikov N, 2013, BONE, V52, P676, DOI 10.1016/j.bone.2012.10.034; Rieppo J, 2008, MICROSC RES TECHNIQ, V71, P279, DOI 10.1002/jemt.20551; RIGGS CM, 1993, ANAT EMBRYOL, V187, P239; RIGGS CM, 1993, ANAT EMBRYOL, V187, P231; Rinnerthaler S, 1999, CALCIFIED TISSUE INT, V64, P422, DOI 10.1007/PL00005824; Ripamonti U, 2009, J CELL MOL MED, V13, P2953, DOI 10.1111/j.1582-4934.2008.00562.x; Rumpler M, 2008, J R SOC INTERFACE, V5, P1173, DOI 10.1098/rsif.2008.0064; Schaff F, 2015, NATURE, V527, P353, DOI 10.1038/nature16060; Stoller P, 2002, BIOPHYS J, V82, P3330, DOI 10.1016/S0006-3495(02)75673-7; Takano Y, 1999, J ORTHOP RES, V17, P59, DOI 10.1002/jor.1100170110; Thomsen JS, 2002, BONE, V31, P136, DOI 10.1016/S8756-3282(02)00801-3; Trussel A.J., 2012, J BIOMECH, V45, pS108; Varga P, 2015, BIOMECH MODEL MECHAN, V14, P267, DOI 10.1007/s10237-014-0601-9; Varga P, 2013, ACTA BIOMATER, V9, P8118, DOI 10.1016/j.actbio.2013.05.015; Wagermaier W, 2006, BIOINTERPHASES, V1, P1, DOI 10.1116/1.2178386; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271; WEINER S, 1991, FEBS LETT, V285, P49, DOI 10.1016/0014-5793(91)80722-F; Wenk HR, 1999, BONE, V24, P361, DOI 10.1016/S8756-3282(98)00192-6; WOLMAN M, 1986, HISTOCHEMISTRY, V85, P41, DOI 10.1007/BF00508652; Zwahlen A, 2015, J BIOMECHANICAL ENG, V137, P9	59	18	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0159838	10.1371/journal.pone.0159838	http://dx.doi.org/10.1371/journal.pone.0159838			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27547973	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000381768400009
J	Hokke, S; Puelles, VG; Armitage, JA; Fong, K; Bertram, JF; Cullen-McEwen, LA				Hokke, Stacey; Puelles, Victor G.; Armitage, James A.; Fong, Karen; Bertram, John F.; Cullen-McEwen, Luise A.			Maternal Fat Feeding Augments Offspring Nephron Endowment in Mice	PLOS ONE			English	Article							DIET-INDUCED OBESITY; RENAL-FUNCTION; INSULIN-RESISTANCE; ANIMAL-MODELS; RICH DIET; HYPERTENSION; PREGNANCY; FETAL; NUMBER; RAT	Increasing consumption of a high fat 'Western' diet has led to a growing number of pregnancies complicated by maternal obesity. Maternal overnutrition and obesity have health implications for offspring, yet little is known about their effects on offspring kidney development and renal function. Female C57B16 mice were fed a high fat diet (HFD, 21% fat) or matched normal fat diet (NFD, 6% fat) for 6 weeks prior to pregnancy and throughout gestation and lactation. HFD dams were overweight and glucose intolerant prior to mating but not in late gestation. Offspring of NFD and HFD dams had similar body weights at embryonic day (E) 15.5, E18.5 and at postnatal day (PN)21. HFD offspring had normal ureteric tree development and nephron number at E15.5. However, using unbiased stereology, kidneys of HFD offspring were found to have 20-25% more nephrons than offspring of NFD dams at E18.5 and PN21. Offspring of HFD dams with body weight and glucose profiles similar to NFD dams prior to pregnancy also had an elevated nephron endowment. At 9 months of age, adult offspring of HFD dams displayed mild fasting hyperglycaemia but similar body weights to NFD offspring. Renal function and morphology, measured by transcutaneous clearance of FITC-sinistrin and stereology respectively, were normal. This study demonstrates that maternal fat feeding augments offspring nephron endowment with no long-term consequences for offspring renal health. Future studies assessing the effects of a chronic stressor on adult mice with augmented nephron number are warranted, as are studies investigating the molecular mechanisms that result in high nephron endowment.	[Hokke, Stacey; Puelles, Victor G.; Armitage, James A.; Fong, Karen; Bertram, John F.; Cullen-McEwen, Luise A.] Monash Univ, Monash Biomed Discovery Inst, Dev & Stem Cells Program, Melbourne, Vic, Australia; [Hokke, Stacey; Puelles, Victor G.; Armitage, James A.; Fong, Karen; Bertram, John F.; Cullen-McEwen, Luise A.] Monash Univ, Dept Anat & Dev Biol, Melbourne, Vic, Australia; [Armitage, James A.] Deakin Univ, Sch Med Optometry, Waurn Ponds, Vic, Australia	Monash University; Monash University; Deakin University	Cullen-McEwen, LA (corresponding author), Monash Univ, Monash Biomed Discovery Inst, Dev & Stem Cells Program, Melbourne, Vic, Australia.; Cullen-McEwen, LA (corresponding author), Monash Univ, Dept Anat & Dev Biol, Melbourne, Vic, Australia.	luise.cullen-mcewen@monash.edu	Armitage, James/AAX-1294-2021; Bertram, John/I-2588-2014	Puelles, Victor/0000-0002-7735-5462; Armitage, James/0000-0002-3762-0911; Bertram, John/0000-0001-5863-6464; Hokke, Stacey/0000-0003-1338-0156; Cullen-McEwen, Luise/0000-0003-2229-5762	Diabetes Australia Research Trust [Y13G-CULL]	Diabetes Australia Research Trust	LACM received funding by Diabetes Australia Research Trust to support this work (www.diabelesaustralia.com.au/current-research-projects; Y13G-CULL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainge H, 2011, INT J OBESITY, V35, P325, DOI 10.1038/ijo.2010.149; American College of Obstetricians and Gynecologists, 2013, Obstet Gynecol, V121, P213, DOI http://10.1097/01.AOG.0000425667.10377.60; Armitage JA, 2005, J PHYSIOL-LONDON, V565, P171, DOI 10.1113/jphysiol.2005.084947; Ashino NG, 2012, J NUTR BIOCHEM, V23, P341, DOI 10.1016/j.jnutbio.2010.12.011; Avci ME, 2015, J MATERN-FETAL NEO M, V28, P2080, DOI 10.3109/14767058.2014.978279; Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019; Boubred F, 2007, AM J PHYSIOL-RENAL, V293, pF1944, DOI 10.1152/ajprenal.00141.2007; BRENNER BM, 1988, AM J HYPERTENS, V1, P335, DOI 10.1093/ajh/1.4.335; Bruce KD, 2009, HEPATOLOGY, V50, P1796, DOI 10.1002/hep.23205; Catalano PM, 2009, AM J CLIN NUTR, V90, P1303, DOI 10.3945/ajcn.2008.27416; Cullen LA, 2000, NEPHROLOGY, V5, P115, DOI 10.1046/j.1440-1797.2000.00512.x; Cullen-McEwen LA, 2003, HYPERTENSION, V41, P335, DOI 10.1161/01.HYP.0000050961.70182.56; Cullen-McEwen Luise A, 2012, Methods Mol Biol, V886, P109, DOI 10.1007/978-1-61779-851-1_10; Cullen-McEwen LA, 2011, AM J PHYSIOL-RENAL, V300, pF1448, DOI 10.1152/ajprenal.00055.2011; Dunn GA, 2009, ENDOCRINOLOGY, V150, P4999, DOI 10.1210/en.2009-0500; Elahi MM, 2009, BRIT J NUTR, V102, P514, DOI 10.1017/S000711450820749X; Ferezou-Viala J, 2007, AM J PHYSIOL-REG I, V293, pR1056, DOI 10.1152/ajpregu.00117.2007; Festing MFW, 2006, ILAR J, V47, P5, DOI 10.1093/ilar.47.1.5; Franco MDP, 2002, J CARDIOVASC PHARM, V39, P369, DOI 10.1097/00005344-200203000-00008; Hanson MA, 2014, PHYSIOL REV, V94, P1027, DOI 10.1152/physrev.00029.2013; Hokke SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058243; Holemans K, 2004, AM J OBSTET GYNECOL, V190, P858, DOI 10.1016/j.ajog.2003.09.025; Hoppe CC, 2007, AM J PHYSIOL-REG I, V292, pR1768, DOI 10.1152/ajpregu.00442.2006; Jackson CM, 2012, AM J PHYSIOL-RENAL, V302, pF774, DOI 10.1152/ajprenal.00491.2011; Jones HN, 2009, FASEB J, V23, P271, DOI 10.1096/fj.08-116889; Khan LY, 2003, HYPERTENSION, V41, P168, DOI 10.1161/01.HYP.0000047511.97879.FC; Lagisz M, 2015, INT J OBESITY, V39, P1669, DOI 10.1038/ijo.2015.160; Langley-Evans SC, 1999, LIFE SCI, V64, P965, DOI 10.1016/S0024-3205(99)00022-3; Lelievre-Pegorier M, 1998, KIDNEY INT, V54, P1455, DOI 10.1046/j.1523-1755.1998.00151.x; Li HP, 2013, INT J CLIN EXP PATHO, V6, P650; Liang CY, 2010, METABOLISM, V59, P943, DOI 10.1016/j.metabol.2009.10.015; Lin Y, 2012, NUTRITION, V28, P1037, DOI 10.1016/j.nut.2012.01.002; Luyckx VA, 2013, LANCET, V382, P273, DOI 10.1016/S0140-6736(13)60311-6; Magliano DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064258; Main ML, 2010, JAMA-J AM MED ASSOC, V303, P1695, DOI 10.1001/jama.2010.517; Maka N, 2008, PEDIATR NEPHROL, V23, P55, DOI 10.1007/s00467-007-0641-9; Mansano R, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2007.02.008; Masuyama H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092805; Mazzucco MB, 2013, J ENDOCRINOL, V217, P303, DOI 10.1530/JOE-13-0021; Nicholas LM, 2016, INT J OBESITY, V40, P229, DOI 10.1038/ijo.2015.178; Nivoit P, 2009, DIABETOLOGIA, V52, P1133, DOI 10.1007/s00125-009-1316-9; Ornellas F, 2013, LIFE SCI, V93, P454, DOI 10.1016/j.lfs.2013.08.005; Owens LA, 2010, DIABETES CARE, V33, P577, DOI 10.2337/dc09-0911; Reynolds RM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4539; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Schock-Kusch D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071519; Schreiber A, 2012, AM J PHYSIOL-RENAL, V303, pF783, DOI 10.1152/ajprenal.00279.2012; Short K, 2013, DEVELOPMENT, V140, P471, DOI 10.1242/dev.088500; Shweta A, 2009, AM J PHYSIOL-RENAL, V296, pF583, DOI 10.1152/ajprenal.90359.2008; Sims-Lucas S, 2008, PEDIATR RES, V63, P607, DOI 10.1203/PDR.0b013e31816d9130; Srinivasan M, 2006, AM J PHYSIOL-ENDOC M, V291, pE792, DOI 10.1152/ajpendo.00078.2006; Taylor PD, 2005, AM J PHYSIOL-REG I, V288, pR134, DOI 10.1152/ajpregu.00355.2004; Vehaskari VM, 2001, KIDNEY INT, V59, P238, DOI 10.1046/j.1523-1755.2001.00484.x; Walker KA, 2012, AM J PHYSIOL-RENAL, V303, pF253, DOI 10.1152/ajprenal.00028.2012; Walls HL, 2010, PUBLIC HEALTH NUTR, V13, P631, DOI 10.1017/S1368980009991455; Woods LL, 2001, HYPERTENSION, V38, P337, DOI 10.1161/01.HYP.38.3.337	56	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161578	10.1371/journal.pone.0161578	http://dx.doi.org/10.1371/journal.pone.0161578			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27547968	Green Published, Green Submitted, gold			2022-12-26	WOS:000381768400072
J	Rega, D; Pecori, B; Scala, D; Avallone, A; Pace, U; Petrillo, A; Aloj, L; Tatangelo, F; Delrio, P				Rega, Daniela; Pecori, Biagio; Scala, Dario; Avallone, Antonio; Pace, Ugo; Petrillo, Antonella; Aloj, Luigi; Tatangelo, Fabiana; Delrio, Paolo			Evaluation of Tumor Response after Short-Course Radiotherapy and Delayed Surgery for Rectal Cancer	PLOS ONE			English	Article							PREOPERATIVE RADIOTHERAPY; RADIATION-THERAPY; RANDOMIZED-TRIAL; CHEMORADIOTHERAPY; INTERVAL	Purpose Neoadjuvant therapy is able to reduce local recurrence in rectal cancer. Immediate surgery after short course radiotherapy allows only for minimal downstaging. We investigated the effect of delayed surgery after short-course radiotherapy at different time intervals before surgery, in patients affected by rectal cancer. Methods From January 2003 to December 2013 sixty-seven patients with the following characteristics have been selected: clinical (c) stage T3N0 <= 12 cm from the anal verge and with circumferential resection margin >5 mm (by magnetic resonance imaging); cT2, any N, <5 cm from anal verge; and patients facing tumors with enlarged nodes and/or CRM+ve who resulted unfit for chemo-radiation, were also included. Patients underwent preoperative short-course radiotherapy with different interval to surgery were divided in three groups: A (within 6 weeks), B (between 6 and 8 weeks) and C (after more than 8 weeks). Hystopatolgical response to radiotherapy was measured by Mandard's modified tumor regression grade (TRG). Results All patients completed the scheduled treatment. Sixty-six patients underwent surgery. Fifty-three of which (80.3%) received a sphincter saving procedure. Downstaging occurred in 41 cases (62.1%). The analysis of subgroups showed an increasing prevalence of TRG 1-2 prolonging the interval to surgery (group A-16.7%, group B-36.8% and 54.3% in group C; p value 0.023). Conclusions Preoperative short-course radiotherapy is able to downstage rectal cancer if surgery is delayed. A higher rate of TRG 1-2 can be obtained if interval to surgery is prolonged to more than 8 weeks.	[Rega, Daniela; Scala, Dario; Pace, Ugo; Delrio, Paolo] Fdn Giovanni Pascale IRCCS, Ist Nazl Studio & Cura Tumori, Colorectal Surg Oncol, Naples, Italy; [Pecori, Biagio] Fdn Giovanni Pascale IRCCS, Ist Nazl Studio & Cura Tumori, Div Radiotherapy, Dept Diagnost Imaging Radiant & Metab Therapy, Naples, Italy; [Avallone, Antonio] Fdn Giovanni Pascale IRCCS, Ist Nazl Studio & Cura Tumori, Div Gastrointestinal Med Oncol, Naples, Italy; [Petrillo, Antonella] Fdn Giovanni Pascale IRCCS, Ist Nazl Studio & Cura Tumori, Div Radiol, Dept Diagnost Imaging Radiant & Metab Therapy, Naples, Italy; [Aloj, Luigi] Fdn Giovanni Pascale IRCCS, Ist Nazl Studio & Cura Tumori, Nucl Med Unit, Naples, Italy; [Tatangelo, Fabiana] Fdn Giovanni Pascale IRCCS, Ist Nazl Studio & Cura Tumori, Pathol Unit, Naples, Italy	IRCCS Fondazione Pascale; IRCCS Fondazione Pascale; IRCCS Fondazione Pascale; IRCCS Fondazione Pascale; IRCCS Fondazione Pascale; IRCCS Fondazione Pascale	Rega, D (corresponding author), Fdn Giovanni Pascale IRCCS, Ist Nazl Studio & Cura Tumori, Colorectal Surg Oncol, Naples, Italy.	daniela.rega@gmail.com	Tatangelo, Fabiana/AAA-8413-2020; Aloj, Luigi/AAK-5104-2020; Rega, Daniela/K-4876-2018; Scala, Dario/ABA-3610-2020; Petrillo, Antonella/J-5450-2018; Avallone, Antonio/K-4662-2016	Tatangelo, Fabiana/0000-0002-9943-6079; Petrillo, Antonella/0000-0003-2465-5370; Rega, Daniela/0000-0001-8326-050X; Avallone, Antonio/0000-0001-6188-5664; Aloj, Luigi/0000-0002-7452-4961				Avallone A, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-875; Avallone A, 2011, INT J RADIAT ONCOL, V79, P670, DOI 10.1016/j.ijrobp.2009.12.007; Berger C, 1997, INT J RADIAT ONCOL, V37, P619, DOI 10.1016/S0360-3016(96)00577-9; Bosset JF, 2006, NEW ENGL J MED, V355, P1114, DOI 10.1056/NEJMoa060829; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; COX JD, 1995, INT J RADIAT ONCOL, V31, P1341, DOI 10.1016/0360-3016(95)00060-C; de Campos-Lobato LF, 2011, J GASTROINTEST SURG, V15, P444, DOI 10.1007/s11605-010-1197-8; Evans J, 2011, DIS COLON RECTUM, V54, P1251, DOI 10.1097/DCR.0b013e3182281f4b; Foster JD, 2013, DIS COLON RECTUM, V56, P921, DOI 10.1097/DCR.0b013e31828aedcb; Francois Y, 1999, J CLIN ONCOL, V17, P2396, DOI 10.1200/JCO.1999.17.8.2396; Gerard JP, 2006, J CLIN ONCOL, V24, P4620, DOI 10.1200/JCO.2006.06.7629; Graf W, 1997, RADIOTHER ONCOL, V43, P133, DOI 10.1016/S0167-8140(96)01867-1; Guillerme F, 2014, INT J COLORECTAL DIS, V29, P157, DOI 10.1007/s00384-013-1778-6; Hatfield P, 2009, RADIOTHER ONCOL, V92, P210, DOI 10.1016/j.radonc.2009.04.007; Latkauskas T, 2012, COLORECTAL DIS, V14, P294, DOI 10.1111/j.1463-1318.2011.02815.x; MANDARD AM, 1994, CANCER, V73, P2680, DOI 10.1002/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C; Pach R, 2012, LANGENBECK ARCH SURG, V397, P801, DOI 10.1007/s00423-011-0890-8; Petrelli F, 2016, ANN SURG, V263, P458, DOI 10.1097/SLA.0000000000000368; Pettersson D, 2012, BRIT J SURG, V99, P577, DOI 10.1002/bjs.7796; Pettersson D, 2010, BRIT J SURG, V97, P580, DOI 10.1002/bjs.6914; Radu C, 2008, RADIOTHER ONCOL, V87, P343, DOI 10.1016/j.radonc.2007.11.025; Tulchinsky H, 2008, ANN SURG ONCOL, V15, P2661, DOI 10.1245/s10434-008-9892-3; Wasserberg N, 2014, WORLD J GASTROENTERO, V20, P4256, DOI 10.3748/wjg.v20.i15.4256; Yeo SG, 2013, INT J RADIAT ONCOL, V86, P34, DOI 10.1016/j.ijrobp.2012.11.018; 1997, SWEDISH RECTAL CANC, V336, P980	25	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0160732	10.1371/journal.pone.0160732	http://dx.doi.org/10.1371/journal.pone.0160732			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548058	gold, Green Published, Green Submitted			2022-12-26	WOS:000381768400019
J	Ceacero, TM; Mercadante, MEZ; Cyrillo, JNDG; Canesin, RC; Bonilha, SFM; de Albuquerque, LG				Ceacero, Thais Matos; Zerlotti Mercadante, Maria Eugenia; dos Santos Goncalves Cyrillo, Joslaine Noely; Canesin, Roberta Carrilho; Martins Bonilha, Sarah Figueiredo; de Albuquerque, Lucia Galvao			Phenotypic and Genetic Correlations of Feed Efficiency Traits with Growth and Carcass Traits in Nellore Cattle Selected for Postweaning Weight	PLOS ONE			English	Article							BEEF-CATTLE; BODY-WEIGHT; MUSCLE AREA; PERFORMANCE; PARAMETERS; BEHAVIOR; BULLS; ANGUS; ULTRASOUND; THICKNESS	This study evaluated phenotypic (r(ph)) and genetic correlations (r(g)) between 8 feed efficiency traits and other traits of economic interest including weight at selection (WS), loin-eye area (LEA), backfat thickness (BF), and rump fat thickness (RF) in Nellore cattle. Feed efficiency traits were gain: feed, residual feed intake (RFI), residual feed intake adjusted for backfat thickness (RFIb) and for backfat and rump fat thickness (RFIsf), residual body weight gain (RG), residual intake and body weight gain (RIG), and residual intake and body weight gain using RFIb (RIG(b)) and RFIsf (RIG(sf)). The variance components were estimated by the restricted maximum likelihood method using a two-trait animal model. The heritability estimates (h(2)) were 0.14, 0.24, 0.20, 0.22, 0.19, 0.15, 0.11 and 0.11 for gain: feed, RFI, RFIb, RFIsf, RG, RIG, RIG(b) and RIG(sf), respectively. All r(ph) values between traits were close to zero, except for the correlation of feed efficiency traits with dry matter intake and average daily gain. High r(g) values were observed for the correlation of dry matter intake, average daily gain and metabolic weight with WS and hip height (>0.61) and low to medium values (0.15 to 0.48) with the carcass traits (LEA, BF, RF). Among the feed efficiency traits, RG showed the highest r(g) with WS and hip height (0.34 and 0.25) and the lowest r(g) with subcutaneous fat thickness (-0.17 to 0.18). The r(g) values of RFI, RFIb and RFIsf with WS (0.17, 0.23 and 0.22), BF (0.37, 0.33 and 0.33) and RF (0.30, 0.31 and 0.32) were unfavorable. The r(g) values of gain: feed, RIG, RIG(b) and RIG(sf) with WS were low and favorable (0.07 to 0.22), while medium and unfavorable (-0.22 to -0.45) correlations were observed with fat thickness. The inclusion of subcutaneous fat thickness in the models used to calculate RFI did not reduce the r(g) between these traits. Selecting animals for higher feed efficiency will result in little or no genetic change in growth and will decrease subcutaneous fat thickness in the carcass.	[Ceacero, Thais Matos; Zerlotti Mercadante, Maria Eugenia; dos Santos Goncalves Cyrillo, Joslaine Noely; Canesin, Roberta Carrilho; Martins Bonilha, Sarah Figueiredo] Ctr APTA Bovinos Corte, Sertaozinho, SP, Brazil; [de Albuquerque, Lucia Galvao] Univ Paulista Julio de Mesquita Filho, Fac Ciencias Agr & Vet, Jaboticabal, SP, Brazil	Universidade Estadual Paulista	Mercadante, MEZ (corresponding author), Ctr APTA Bovinos Corte, Sertaozinho, SP, Brazil.	mercadante@iz.sp.gov.br	Canesin, Roberta C/A-5548-2015; Bonilha, Sarah F M/D-1043-2012; Mercadante, Maria Eugenia/C-9536-2012; Albuquerque, Lucia/A-7402-2013; Cyrillo, Joslaine/S-2637-2019; Canesin, Roberta Carrilho/AAH-1806-2019	Bonilha, Sarah F M/0000-0002-8055-4112; Mercadante, Maria Eugenia/0000-0002-1218-5378; Albuquerque, Lucia/0000-0002-2030-7590; Cyrillo, Joslaine/0000-0002-4390-630X; Carrilho Canesin, Roberta/0000-0003-1938-4596	Sao Paulo Research Foundation (FAPESP) [2009/16118-5]; National Council of Technological and Scientific Development of Brazil (CNPq); Coordination for the Improvement of Higher Education Personnel (CAPES)	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council of Technological and Scientific Development of Brazil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Sao Paulo Research Foundation (FAPESP, grant #2009/16118-5) for financial support, National Council of Technological and Scientific Development of Brazil (CNPq) for providing research grants to MEZM SFMB LGA, and Coordination for the Improvement of Higher Education Personnel (CAPES) for providing grants to TMC RCC.	Albuquerque LG, 2006, P 8 WORLD C GEN APPL, P1; [Anonymous], 2014, BMC GENET, DOI DOI 10.1186/S12863-014-0100-0.W0S:000343677100001; Arthur PF, 2001, J ANIM SCI, V79, P2805; Berry DP, 2013, J ANIM SCI, V91, P1594, DOI 10.2527/jas.2012-5862; Berry DP, 2012, J ANIM SCI, V90, P109, DOI 10.2527/jas.2011-4245; Chizzotti ML, 2007, J ANIM SCI, V85, P1971, DOI 10.2527/jas.2006-632; Coutinho CC, 2015, GENET MOL RES, V14, P14076, DOI 10.4238/2015.October.29.27; Crews DH, 2005, GENETICS OF EFFICIEN, V4, P14; Del Claro AC, 2012, PESQUI AGROPECU BRAS, V47, P302, DOI 10.1590/S0100-204X2012000200020; Grion AL, 2014, J ANIM SCI, V92, P955, DOI 10.2527/jas.2013-6682; Karin Meyer, 2007, Journal of Zhejiang University-Science B, V8, P815, DOI 10.1631/jzus.2007.B0815; KOCH RM, 1963, J ANIM SCI, V22, P486, DOI 10.2527/jas1963.222486x; Lancaster PA, 2009, J ANIM SCI, V87, P1528, DOI 10.2527/jas.2008-1352; Sobrinho TL, 2013, REV BRAS ZOOTECN, V42, P125, DOI 10.1590/S1516-35982013000200007; Malheiros JM, 2015, B IND ANIM, V72, P341, DOI 10.17523/bia.v72n4p341; Mao F, 2013, J ANIM SCI, V91, P2067, DOI 10.2527/jas.2012-5470; Bonilha SFM, 2015, TROP ANIM HEALTH PRO, V47, P1381, DOI 10.1007/s11250-015-0875-7; Mercadante MEZ, 2003, J ANIM SCI, V81, P376; Nkrumah JD, 2007, J ANIM SCI, V85, P2711, DOI 10.2527/jas.2006-767; Parnell PF, 1994, 20TH BIENNIAL CONFER; Pinheiro TR, 2012, REV BRAS ZOOTECN, V41, P1426, DOI 10.1590/S1516-35982012000600016; Robinson DL, 2004, LIVEST PROD SCI, V90, P255, DOI 10.1016/j.livprodsci.2004.06.011; Rolfe KM, 2011, J ANIM SCI, V89, P3452, DOI 10.2527/jas.2011-3961; Sakamoto LS, 2014, J ANIM SCI, V92, P5230, DOI 10.2527/jas.2012-6065; Santana MHA, 2014, LIVEST SCI, V167, P80, DOI 10.1016/j.livsci.2014.06.002; Schenkel FS, 2004, CAN J ANIM SCI, V84, P177, DOI 10.4141/A03-085; Yokoo MJ, 2010, J ANIM SCI, V88, P52, DOI 10.2527/jas.2008-1028	27	39	39	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161366	10.1371/journal.pone.0161366	http://dx.doi.org/10.1371/journal.pone.0161366			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537268	Green Published, Green Submitted, gold			2022-12-26	WOS:000381577000094
J	Song, LP; Wang, HY				Song, Li-Peng; Wang, Hao-Yu			Modeling and Control of Colorectal Cancer	PLOS ONE			English	Article							SCREENING STRATEGIES	Colorectal Cancer (CRC) is becoming a major threat to people's life in China. Screening methods adopted by many other countries as effective counter-cancer methods have not been explicitly explored for people there. Thus, we present a Markov model with detailed precancerous adenoma states and then evaluate various screening strategies in this paper. Different from current researches, our model considers the population's heterogeneous risk of developing adenomas and observation-based screening strategies. Furthermore, we also give a new cost-effectiveness metric. After calibrating, the model is simulated using the Monte Carlo method. Numerical results show that there are threshold values of compliance rates below which strategy with every ten-year colonoscopy becomes the most cost-effective method; otherwise, an observation-based screening strategy is the most cost-effective. We also find that strategy with single colonoscopy for adenoma-free individuals and every three-year colonoscopy for those with adenoma is recommended when the observation-based strategy is not considered. Our findings give an explicit and complete instruction in CRC screening protocol in average-risk Chinese.	[Song, Li-Peng; Wang, Hao-Yu] North Univ China, Dept Comp Sci & Technol, Taiyuan, Shanxi, Peoples R China	North University of China	Song, LP (corresponding author), North Univ China, Dept Comp Sci & Technol, Taiyuan, Shanxi, Peoples R China.	slp880@nuc.edu.cn						Chen WQ, 2015, CHIN J CANCER, V34, DOI 10.1186/s40880-015-0042-6; Greuter MJE, 2014, RISK ANAL, V34, P889, DOI 10.1111/risa.12137; Guy GP, 2014, CANCER-AM CANCER SOC, V120, P2308, DOI 10.1002/cncr.28724; Howlader N, 2012, SEER CANCER STATISTI; Huang WD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109150; Li L, 2016, APPL MATH MODEL, V40, P4765, DOI 10.1016/j.apm.2015.12.003; Li Y, 2014, EUR J OPER RES, V238, P313, DOI 10.1016/j.ejor.2014.03.004; Rex DK, 1997, GASTROENTEROLOGY, V112, P24, DOI 10.1016/S0016-5085(97)70214-2; Rubinstein R., 2007, SIMULATION AND THE M; Rutter CM, 2007, STAT MED, V26, P98, DOI 10.1002/sim.2460; Schreuders EH, 2015, GUT, V64, P1637, DOI 10.1136/gutjnl-2014-309086; Sun GQ, 2016, NONLINEAR DYNAM, V85, P1, DOI 10.1007/s11071-016-2671-y; Sun GQ, 2016, NONLINEAR DYNAM, V83, P811, DOI 10.1007/s11071-015-2369-6; Sun GQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11246; Sun GQ, 2014, APPL MATH COMPUT, V246, P336, DOI 10.1016/j.amc.2014.08.028; Sun GQ, 2014, COMMUN NONLINEAR SCI, V19, P1507, DOI 10.1016/j.cnsns.2013.09.016; Sung JJY, 2015, GUT, V64, P121, DOI 10.1136/gutjnl-2013-306503; Tafazzoli A, 2009, ACM T MODEL COMPUT S, V19, DOI 10.1145/1502787.1502789; Wang ZH, 2012, ASIAN PAC J CANCER P, V13, P1761, DOI 10.7314/APJCP.2012.13.5.1761; Zhao P, 2010, CHINESE CANC REGISTR, P110; Zheng S, 2003, DIS COLON RECTUM, V46, P51, DOI 10.1007/s10350-004-6496-2; Zheng S, 2009, CHINA CANC, V18, P700	22	3	3	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161349	10.1371/journal.pone.0161349	http://dx.doi.org/10.1371/journal.pone.0161349			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536786	Green Submitted, gold, Green Published			2022-12-26	WOS:000381577000090
J	Vink, MA; Berkhof, J; van de Kassteele, J; van Boven, M; Bogaards, JA				Vink, Margaretha A.; Berkhof, Johannes; van de Kassteele, Jan; van Boven, Michiel; Bogaards, Johannes A.			A Bivariate Mixture Model for Natural Antibody Levels to Human Papillomavirus Types 16 and 18: Baseline Estimates for Monitoring the Herd Effects of Immunization	PLOS ONE			English	Article							HIGH-RISK HPV; INTRAEPITHELIAL NEOPLASIA; VACCINATION PROGRAMS; CERVICAL-CANCER; PREVALENCE; SEROPREVALENCE; POPULATION; INFECTIONS; IMPACT	Post-vaccine monitoring programs for human papillomavirus (HPV) have been introduced in many countries, but HPV serology is still an underutilized tool, partly owing to the weak antibody response to HPV infection. Changes in antibody levels among non-vaccinated individuals could be employed to monitor herd effects of immunization against HPV vaccine types 16 and 18, but inference requires an appropriate statistical model. The authors developed a four-component bivariate mixture model for jointly estimating vaccine-type seroprevalence from correlated antibody responses against HPV16 and -18 infections. This model takes account of the correlation between HPV16 and -18 antibody concentrations within subjects, caused e.g. by heterogeneity in exposure level and immune response. The model was fitted to HPV16 and -18 antibody concentrations as measured by a multiplex immunoassay in a large serological survey (3,875 females) carried out in the Netherlands in 2006/2007, before the introduction of mass immunization. Parameters were estimated by Bayesian analysis. We used the deviance information criterion for model selection; performance of the preferred model was assessed through simulation. Our analysis uncovered elevated antibody concentrations in doubly as compared to singly seropositive individuals, and a strong clustering of HPV16 and -18 seropositivity, particularly around the age of sexual debut. The bivariate model resulted in a more reliable classification of singly and doubly seropositive individuals than achieved by a combination of two univariate models, and suggested a higher pre-vaccine HPV16 seroprevalence than previously estimated. The bivariate mixture model provides valuable baseline estimates of vaccine-type seroprevalence and may prove useful in seroepidemiologic assessment of the herd effects of HPV vaccination.	[Vink, Margaretha A.; van Boven, Michiel; Bogaards, Johannes A.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Bilthoven, Netherlands; [Vink, Margaretha A.; Berkhof, Johannes] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [van de Kassteele, Jan] Natl Inst Publ Hlth & Environm, Dept Stat Informat & Modelling, Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment; Vrije Universiteit Amsterdam; Netherlands National Institute for Public Health & the Environment	Bogaards, JA (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Bilthoven, Netherlands.	hans.bogaards@rivm.nl		van de Kassteele, Jan/0000-0001-5926-6709; Bogaards, Johannes/0000-0002-3389-5141	Dutch Ministry of Health, Welfare and Sports; National Institute for Public Health and the Environment (RIVM) [S/113005/01/PT]	Dutch Ministry of Health, Welfare and Sports; National Institute for Public Health and the Environment (RIVM)	This research was supported by the Dutch Ministry of Health, Welfare and Sports, and carried out within the framework of RIVM Strategic Programme (SPR grant number S/113005/01/PT), preparing the National Institute for Public Health and the Environment (RIVM) to respond to future issues in health and sustainability. See http://www.rivm.nl/en/About_RIVM/Mission_and_strategy/RIVM_s_Strategic_Programme.	Abogunrin S, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-968; Bogaards JA, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2016; Bogaards JA, 2011, EPIDEMIOLOGY, V22, P505, DOI 10.1097/EDE.0b013e31821d107b; Bogaards JA, 2010, AM J EPIDEMIOL, V171, P817, DOI 10.1093/aje/kwp466; Bosch FX, 2013, VACCINE, V31, pF1, DOI [10.1016/j.vaccine.2013.10.001, 10.1016/j.vaccine.2013.07.026, 10.1016/j.vaccine.2013.10.003]; Brisson M, 2011, SEX TRANSM INFECT, V87, P41, DOI 10.1136/sti.2010.044412; Combes JD, 2014, INT J CANCER, V135, P2453, DOI 10.1002/ijc.28888; DALE JR, 1986, BIOMETRICS, V42, P909, DOI 10.2307/2530704; de Graaf H, 2005, SEX AGE 25 SEXUAL HL; de Koning L, 2012, CLIN BIOCHEM, V45, P848, DOI 10.1016/j.clinbiochem.2012.04.006; De Vuyst H, 2009, INT J CANCER, V124, P1626, DOI 10.1002/ijc.24116; Drolet M, 2015, LANCET INFECT DIS, V15, P565, DOI 10.1016/S1473-3099(14)71073-4; Farrington CP, 2013, AM J EPIDEMIOL, V177, P474, DOI 10.1093/aje/kws260; Farrington CP, 2001, J R STAT SOC C-APPL, V50, P251, DOI 10.1111/1467-9876.00233; GELFAND AE, 1990, J AM STAT ASSOC, V85, P398, DOI 10.2307/2289776; Gelman A., 2004, BAYESIAN DATA ANAL; Hariri S, 2015, EMERG INFECT DIS, V21, P1557, DOI 10.3201/eid2109.141841; Hens N, 2008, STAT MED, V27, P2651, DOI 10.1002/sim.3089; Hens N, 2009, STAT MED, V28, P2785, DOI 10.1002/sim.3660; Hens N., 2012, MODELING INFECT DIS; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Miralles-Guri C, 2009, J CLIN PATHOL, V62, P870, DOI 10.1136/jcp.2008.063149; Mooij SH, 2013, CANCER EPIDEM BIOMAR, V22, P1698, DOI 10.1158/1055-9965.EPI-13-0460; Plummer M, 2008, BIOSTATISTICS, V9, P523, DOI 10.1093/biostatistics/kxm049; Scherpenisse M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074797; Scherpenisse M, 2012, VACCINE, V30, P6686, DOI 10.1016/j.vaccine.2012.08.068; Schiffman M, 2015, CANCER EPIDEM BIOMAR, V24, P1304, DOI 10.1158/1055-9965.EPI-14-1353; Schurink-van't Klooster TM, 2014, NATL IMMUNISATION PR; Schwarz TF, 2008, GYNECOL ONCOL, V110, pS1, DOI 10.1016/j.ygyno.2008.05.036; Smits G, 2014, VACCINE, V32, P1890, DOI 10.1016/j.vaccine.2014.01.066; Smits G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058234; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Stanley M, 2008, GYNECOL ONCOL, V109, pS15, DOI 10.1016/j.ygyno.2008.02.003; Vaccarella S, 2010, CANCER EPIDEM BIOMAR, V19, P2379, DOI 10.1158/1055-9965.EPI-10-0336; Vaccarella S, 2010, CANCER EPIDEM BIOMAR, V19, P503, DOI 10.1158/1055-9965.EPI-09-0983; Vink MA, 2015, EPIDEMIOLOGY, V26, P8, DOI 10.1097/EDE.0000000000000196; Vink MA, 2013, AM J EPIDEMIOL, V178, P1161, DOI 10.1093/aje/kwt077; Vriend HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060696; Yee TW, 1996, J ROY STAT SOC B MET, V58, P481	40	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161109	10.1371/journal.pone.0161109	http://dx.doi.org/10.1371/journal.pone.0161109			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537200	Green Published, Green Submitted, gold			2022-12-26	WOS:000381577000054
J	Christman, MC; Doctor, DH; Niemiller, ML; Weary, DJ; Young, JA; Zigler, KS; Culver, DC				Christman, Mary C.; Doctor, Daniel H.; Niemiller, Matthew L.; Weary, David J.; Young, John A.; Zigler, Kirk S.; Culver, David C.			Predicting the Occurrence of Cave-Inhabiting Fauna Based on Features of the Earth Surface Environment	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; TELEOSTEI AMBLYOPSIDAE; COMMUNITY-LEVEL; BIODIVERSITY; PATTERNS; DIVERSITY; FUTURE; CRUSTACEANS; TENNESSEE; ECOLOGY	One of the most challenging fauna to study in situ is the obligate cave fauna because of the difficulty of sampling. Cave-limited species display patchy and restricted distributions, but it is often unclear whether the observed distribution is a sampling artifact or a true restriction in range. Further, the drivers of the distribution could be local environmental conditions, such as cave humidity, or they could be associated with surface features that are surrogates for cave conditions. If surface features can be used to predict the distribution of important cave taxa, then conservation management is more easily obtained. We examined the hypothesis that the presence of major faunal groups of cave obligate species could be predicted based on features of the earth surface. Georeferenced records of cave obligate amphipods, crayfish, fish, isopods, beetles, millipedes, pseudoscorpions, spiders, and springtails within the area of Appalachian Landscape Conservation Cooperative in the eastern United States (Illinois to Virginia and New York to Alabama) were assigned to 20 x 20 km grid cells. Habitat suitability for these faunal groups was modeled using logistic regression with twenty predictor variables within each grid cell, such as percent karst, soil features, temperature, precipitation, and elevation. Models successfully predicted the presence of a group greater than 65% of the time (mean = 88%) for the presence of single grid cell endemics, and for all faunal groups except pseudoscorpions. The most common predictor variables were latitude, percent karst, and the standard deviation of the Topographic Position Index (TPI), a measure of landscape rugosity within each grid cell. The overall success of these models points to a number of important connections between the surface and cave environments, and some of these, especially soil features and topographic variability, suggest new research directions. These models should prove to be useful tools in predicting the presence of species in understudied areas.	[Christman, Mary C.] Univ Florida, Dept Biol & Stat, Gainesville, FL USA; [Christman, Mary C.] MCC Stat Consulting LLC, Gainesville, FL USA; [Doctor, Daniel H.; Weary, David J.] US Geol Survey, Reston, VA 22092 USA; [Niemiller, Matthew L.] Univ Illinois, Illinois Nat Hist Survey, Prairie Res Inst, Champaign, IL USA; [Young, John A.] US Geol Survey, Leetown Sci Ctr, Kearneysville, WV USA; [Zigler, Kirk S.] Univ South, Dept Biol, Sewanee, TN USA; [Culver, David C.] Amer Univ, Dept Environm Sci, Washington, DC 20016 USA	State University System of Florida; University of Florida; United States Department of the Interior; United States Geological Survey; Illinois Natural History Survey; University of Illinois System; University of Illinois Urbana-Champaign; United States Department of the Interior; United States Geological Survey; Sewanee: University of the South; American University	Culver, DC (corresponding author), Amer Univ, Dept Environm Sci, Washington, DC 20016 USA.	dculver@american.edu	Zigler, Kirk S./GZM-2049-2022; Niemiller, Matthew L./B-2454-2012	Niemiller, Matthew L./0000-0001-6353-8797; Young, John/0000-0002-4500-3673	Wildlife Management Institute through the Appalachian Land Conservation Cooperative (ALCC); commercial company, MCC Statistical Consulting LCC	Wildlife Management Institute through the Appalachian Land Conservation Cooperative (ALCC); commercial company, MCC Statistical Consulting LCC	This work was supported by the Wildlife Management Institute through the Appalachian Land Conservation Cooperative (ALCC 2013-4) to DCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. One author (MCC) is employed by a commercial company, MCC Statistical Consulting LCC. The funder provided support in the form of salaries for an author [MCC], but did not have any additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.; We thank the Alabama and Tennessee Cave Surveys and the Georgia, Illinois, Kentucky, Virginia, and West Virginia Speleological Surveys for assistance with georeferencing data. We thank D. Feller, E. Hazelton, G. Moni, J. Lewis, Alabama Natural Heritage Program, Georgia Natural Heritage Program, Kentucky State Nature Preserves Commission, Maryland Natural Heritage Program, Tennessee Chapter of The Nature Conservancy, Tennessee Natural Heritage Program, Virginia Natural Heritage Program, and West Virginia Natural Heritage Program for providing biological data. Funding for this work was provided by the Wildlife Management Institute through the Appalachian Land Conservation Cooperative (ALCC 2013-4). The data used for this work are available online through the USGS ScienceBase system [48]. Any use of trade, firm, or productnames is for descriptive purposes only and does not imply endorsement by the U.S. Government.	BARR TC, 1967, AM NAT, V101, P475, DOI 10.1086/282512; BARR THOMAS C., 1968, P35; BARR THOMAS C., 1960, AMER MIDLAND NAT, V63, P307, DOI 10.2307/2422794; Christman MC, 2005, J BIOGEOGR, V32, P1441, DOI 10.1111/j.1365-2699.2005.01263.x; Christman MC, 2001, J BIOGEOGR, V28, P367, DOI 10.1046/j.1365-2699.2001.00549.x; Corrigan LJ, 2014, EVOL BIOL, V41, P154, DOI 10.1007/s11692-013-9255-2; Culver DC, 2006, ECOGRAPHY, V29, P120; Culver DC, 2004, BIODIVERS CONSERV, V13, P1209, DOI 10.1023/B:BIOC.0000018153.49280.89; Culver DC, 2003, BIODIVERS CONSERV, V12, P441, DOI 10.1023/A:1022425908017; Doctor DH, 2016, GIS DATA PREDICTING; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Eme D, 2015, ECOGRAPHY, V38, P531, DOI 10.1111/ecog.01092; Engel A. S., 2012, ENCY CAVES, V2nd, P125, DOI DOI 10.1016/B978-0-12-383832-2.00019-0; Faille A, 2014, J BIOGEOGR, V41, P1979, DOI 10.1111/jbi.12349; Farlow JO, 2010, INDIANA GEOLOGICAL S, V69, P1; Ferrier S, 2002, BIODIVERS CONSERV, V11, P2309, DOI 10.1023/A:1021374009951; Ferrier S, 2006, J APPL ECOL, V43, P393, DOI 10.1111/j.1365-2664.2006.01149.x; Gers C, 1998, ACTA OECOL, V19, P205, DOI 10.1016/S1146-609X(98)80025-8; Gibert J, 2002, BIOSCIENCE, V52, P473, DOI 10.1641/0006-3568(2002)052[0473:SEATFB]2.0.CO;2; Graening GO, 2011, 2011 CAVE LIFE OKLAH; Guillera-Arroita G, 2015, GLOBAL ECOL BIOGEOGR, V24, P276, DOI 10.1111/geb.12268; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hawes RS, 1939, J ANIM ECOL, V8, P1, DOI 10.2307/1248; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Jeannel R., 1943, FOSSILES VIVANTS CAV; Jenness J., 2013, LAND FACET CORRIDOR; Loarie SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002502; Malard F, 2009, FRESHWATER BIOL, V54, P756, DOI 10.1111/j.1365-2427.2009.02180.x; Morvan C, 2013, SYST BIOL, V62, P512, DOI 10.1093/sysbio/syt015; Niemiller ML, 2008, MOL ECOL, V17, P2258, DOI 10.1111/j.1365-294X.2008.03750.x; Niemiller ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064177; Niemiller ML, 2013, EVOLUTION, V67, P1011, DOI 10.1111/evo.12017; Niemiller ML, 2013, EVOLUTION, V67, P732, DOI 10.1111/j.1558-5646.2012.01822.x; Niemiller ML, 2009, P 15 INT C SPEL, V15, P242; Ovaskainen O, 2011, ECOLOGY, V92, P289, DOI 10.1890/10-1251.1; Palmer AN., 2009, CAVES KARST US; Peck S.B., 1980, Bulletin of the National Speleological Society, V42, P53; Platts PJ, 2014, DIVERS DISTRIB, V20, P1307, DOI 10.1111/ddi.12244; Shunk AJ, 2009, PALAEOGEOGR PALAEOCL, V274, P173, DOI 10.1016/j.palaeo.2009.01.008; Simon KS, 2010, FUND APPL LIMNOL, V177, P81, DOI 10.1127/1863-9135/2010/0177-0081; Sinclair SJ, 2010, ECOL SOC, V15, DOI 10.5751/ES-03089-150108; Taylor Steven J., 2016, Subterranean Biology, V17, P1, DOI 10.3897/subtbiol.17.7298; Tschudy RH, 1965, US GEOL SURVEY PROF, V525-B, pB64; Weary DJ, 2014, 20141156 USGS; WOLOCK DM, 2003, 03146 USGS; Zagmajster M, 2007, THESIS; Zagmajster M, 2014, GLOBAL ECOL BIOGEOGR, V23, P1135, DOI 10.1111/geb.12200; Zobaa MK, 2011, PALAEOGEOGR PALAEOCL, V308, P433, DOI 10.1016/j.palaeo.2011.05.051	48	32	32	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160408	10.1371/journal.pone.0160408	http://dx.doi.org/10.1371/journal.pone.0160408			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532611	Green Submitted, gold, Green Published			2022-12-26	WOS:000381487600029
J	Gardner, B; Gruning, A				Gardner, Brian; Gruning, Andre			Supervised Learning in Spiking Neural Networks for Precise Temporal Encoding	PLOS ONE			English	Article							BACKPROPAGATION; REINFORCEMENT; NEURONS; TRAINS	Precise spike timing as a means to encode information in neural networks is biologically supported, and is advantageous over frequency-based codes by processing input features on a much shorter time-scale. For these reasons, much recent attention has been focused on the development of supervised learning rules for spiking neural networks that utilise a temporal coding scheme. However, despite significant progress in this area, there still lack rules that have a theoretical basis, and yet can be considered biologically relevant. Here we examine the general conditions under which synaptic plasticity most effectively takes place to support the supervised learning of a precise temporal code. As part of our analysis we examine two spike-based learning methods: one of which relies on an instantaneous error signal to modify synaptic weights in a network (INST rule), and the other one relying on a filtered error signal for smoother synaptic weight modifications (FILT rule). We test the accuracy of the solutions provided by each rule with respect to their temporal encoding precision, and then measure the maximum number of input patterns they can learn to memorise using the precise timings of individual spikes as an indication of their storage capacity. Our results demonstrate the high performance of the FILT rule in most cases, underpinned by the rule's error-filtering mechanism, which is predicted to provide smooth convergence towards a desired solution during learning. We also find the FILT rule to be most efficient at performing input pattern memorisations, and most noticeably when patterns are identified using spikes with sub-millisecond temporal precision. In comparison with existing work, we determine the performance of the FILT rule to be consistent with that of the highly efficient E-learning Chronotron rule, but with the distinct advantage that our FILT rule is also implementable as an online method for increased biological realism.	[Gardner, Brian; Gruning, Andre] Univ Surrey, Dept Comp Sci, Guildford, Surrey, England	University of Surrey	Gardner, B (corresponding author), Univ Surrey, Dept Comp Sci, Guildford, Surrey, England.	b.gardner@surrey.ac.uk			Engineering and Physical Sciences Research Council [EP/J500562/1]; European Community [604102]; Horizon [284941]	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Community(European Commission); Horizon	BG was supported by the Engineering and Physical Sciences Research Council (grant no. EP/J500562/1, http://www.epsrc.ac.uk/). AG and BG were supported by the European Community's Seventh Framework Programme (grant no. 604102, The Human Brain Project, http://cordis.europa.eu/fp7/). AG and BG were supported by Horizon 2020 (grant no. 284941, The Human Brain Project, https://ec.europa.eu/programmes/horizon2020/).	Albers C., 2013, ADV NEURAL INFORM PR, P1709; Albers C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148948; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Bohte SM, 2002, NEUROCOMPUTING, V48, P17, DOI 10.1016/S0925-2312(01)00658-0; Brea J, 2013, J NEUROSCI, V33, P9565, DOI 10.1523/JNEUROSCI.4098-12.2013; Bush D, 2012, J COMPUT NEUROSCI, V33, P495, DOI 10.1007/s10827-012-0397-5; Farries MA, 2007, J NEUROPHYSIOL, V98, P3648, DOI 10.1152/jn.00364.2007; Florian RV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040233; Fremaux N, 2010, J NEUROSCI, V30, P13326, DOI 10.1523/JNEUROSCI.6249-09.2010; Furber SB, 2014, P IEEE, V102, P652, DOI 10.1109/JPROC.2014.2304638; Gardner B, 2015, NEURAL COMPUT, V27, P2548, DOI 10.1162/NECO_a_00790; Gardner B, 2013, LECT NOTES COMPUT SC, V8131, P256, DOI 10.1007/978-3-642-40728-4_32; Gerstner W, 2002, SPIKING NEURON MODEL; Gollisch T, 2008, SCIENCE, V319, P1108, DOI 10.1126/science.1149639; Gruning A, 2007, NEURAL COMPUT, V19, P3108, DOI 10.1162/neco.2007.19.11.3108; Gutig R, 2014, CURR OPIN NEUROBIOL, V25, P134, DOI 10.1016/j.conb.2014.01.004; Gutig R, 2006, NAT NEUROSCI, V9, P420, DOI 10.1038/nn1643; Izhikevich EM, 2007, CEREB CORTEX, V17, P2443, DOI 10.1093/cercor/bhl152; Johansson RS, 2004, NAT NEUROSCI, V7, P170, DOI 10.1038/nn1177; Jolivet R, 2006, J COMPUT NEUROSCI, V21, P35, DOI 10.1007/s10827-006-7074-5; Kasinski A., 2006, International Journal of Applied Mathematics and Computer Science, V16, P101; KNUDSEN EI, 1994, J NEUROSCI, V14, P3985; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Memmesheimer RM, 2014, NEURON, V82, P925, DOI 10.1016/j.neuron.2014.03.026; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Mohemmed A, 2012, INT J NEURAL SYST, V22, DOI 10.1142/S0129065712500128; Nichols E, 2016, SUPERVISED IN PRESS; Paninski L, 2004, NETWORK-COMP NEURAL, V15, P243, DOI 10.1088/0954-898X/15/4/002; Pfister JP, 2006, NEURAL COMPUT, V18, P1318, DOI 10.1162/neco.2006.18.6.1318; Ponulak F, 2010, NEURAL COMPUT, V22, P467, DOI 10.1162/neco.2009.11-08-901; Reich DS, 1997, J NEUROPHYSIOL, V77, P2836, DOI 10.1152/jn.1997.77.5.2836; Rezende DJ, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00038; Sporea I, 2013, NEURAL COMPUT, V25, P473, DOI 10.1162/NECO_a_00396; Urbanczik R, 2014, NEURON, V81, P521, DOI 10.1016/j.neuron.2013.11.030; Uzzell VJ, 2004, J NEUROPHYSIOL, V92, P780, DOI 10.1152/jn.01171.2003; van Rossum MCW, 2001, NEURAL COMPUT, V13, P751, DOI 10.1162/089976601300014321; VanRullen R, 2005, TRENDS NEUROSCI, V28, P1, DOI 10.1016/j.tins.2004.10.010; Victor JD, 1996, J NEUROPHYSIOL, V76, P1310, DOI 10.1152/jn.1996.76.2.1310; Yu Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078318	40	33	35	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161335	10.1371/journal.pone.0161335	http://dx.doi.org/10.1371/journal.pone.0161335			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532262	gold, Green Published, Green Submitted			2022-12-26	WOS:000381487600086
J	Benedet, M; Falchi, FA; Puccio, S; Di Benedetto, C; Peano, C; Polissi, A; Deho, G				Benedet, Mattia; Falchi, Federica A.; Puccio, Simone; Di Benedetto, Cristiano; Peano, Clelia; Polissi, Alessandra; Deho, Gianni			The Lack of the Essential LptC Protein in the Trans-Envelope Lipopolysaccharide Transport Machine Is Circumvented by Suppressor Mutations in LptF, an Inner Membrane Component of the Escherichia coli Transporter	PLOS ONE			English	Article							OUTER-MEMBRANE; FUNCTIONAL-ANALYSIS; STRUCTURAL BASIS; ESSENTIAL GENES; COMPLEX; IDENTIFICATION; OLIGOMERIZATION; MUTAGENESIS; ASSEMBLES; REGION	The lipopolysaccharide (LPS) transport (Lpt) system is responsible for transferring LPS from the periplasmic surface of the inner membrane (IM) to the outer leaflet of the outer membrane (OM), where it plays a crucial role in OM selective permeability. In E. coli seven essential proteins are assembled in an Lpt trans-envelope complex, which is conserved in gamma-Proteobacteria. LptBFG constitute the IMABC transporter, LptDE form the OM translocon for final LPS delivery, whereas LptC, an IM-anchored protein with a periplasmic domain, interacts with the IM ABC transporter, the periplasmic protein LptA, and LPS. Although essential, LptC can tolerate several mutations and its role in LPS transport is unclear. To get insights into the functional role of LptC in the Lpt machine we searched for viable mutants lacking LptC by applying a strong double selection for lptC deletion mutants. Genome sequencing of viable Delta lptC mutants revealed single amino acid substitutions at a unique position in the predicted large periplasmic domain of the IM component LptF (LptF(SupC)). In complementation tests, lptF(SupC) mutants suppress lethality of both Delta lptC and lptC conditional expressionmutants. Our data show that mutations in a specific residue of the predicted LptF periplasmic domain can compensate the lack of the essential protein LptC, implicate such LptF domain in the formation of the periplasmic bridge between the IM and OM complexes, and suggest that LptC may have evolved to improve the performance of an ancestral six-component Lpt machine.	[Benedet, Mattia; Falchi, Federica A.; Di Benedetto, Cristiano; Deho, Gianni] Univ Milan, Dipartimento Biosci, Milan, Italy; [Puccio, Simone] Univ Milan, Scuola Dottorato Med Mol & Traslaz, Segrate, Italy; [Puccio, Simone; Peano, Clelia] CNR, Ist Tecnol Biomed, Milan, Italy; [Polissi, Alessandra] Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, Milan, Italy; [Benedet, Mattia] Univ Trento, Ctr Integrat Biol, Trento, Italy; [Di Benedetto, Cristiano] King Abdullah Univ Sci & Technol, Biol & Environm Sci & Engn Div, Thuwal, Saudi Arabia; [Polissi, Alessandra] Univ Milan, Dipartimento Sci Farmacol & Biomol, Milan, Italy	University of Milan; University of Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Milano-Bicocca; University of Trento; King Abdullah University of Science & Technology; University of Milan	Deho, G (corresponding author), Univ Milan, Dipartimento Biosci, Milan, Italy.	gianni.deho@unimi.it	Puccio, Simone/P-9571-2018; Peano, Clelia/C-4015-2018	Puccio, Simone/0000-0003-4007-4365; Peano, Clelia/0000-0001-7055-3629; POLISSI, ALESSANDRA/0000-0003-0903-8024; DEHO', GIOVANNI/0000-0001-5492-7766; FALCHI, FEDERICA ANNA/0000-0002-1692-8167	Fondazione per la Ricerca sulla Fibrosi Cistica [13/2010]; Regione Lombardia-MIUR [30190679]	Fondazione per la Ricerca sulla Fibrosi Cistica(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation); Regione Lombardia-MIUR(Regione Lombardia)	This work was supported by Fondazione per la Ricerca sulla Fibrosi Cistica (http://www.fibrosicisticaricerca.it/) (grant FFC#13/2010 to AP) and by Regione Lombardia-MIUR (http://www.regione.lombardia.it; http://www.istruzione.it), project ID 30190679 (to GD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Bollati M, 2015, FEBS J, V282, P1980, DOI 10.1111/febs.13254; Bos MP, 2004, P NATL ACAD SCI USA, V101, P9417, DOI 10.1073/pnas.0402340101; Chimalakonda G, 2011, P NATL ACAD SCI USA, V108, P2492, DOI 10.1073/pnas.1019089108; Chng SS, 2010, BIOCHEMISTRY-US, V49, P4565, DOI 10.1021/bi100493e; Chng SS, 2010, P NATL ACAD SCI USA, V107, P5363, DOI 10.1073/pnas.0912872107; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; De Baets G, 2012, NUCLEIC ACIDS RES, V40, pD935, DOI 10.1093/nar/gkr996; Dong HH, 2014, NATURE, V511, P52, DOI 10.1038/nature13464; Ferenci T, 2009, J BACTERIOL, V191, P4025, DOI 10.1128/JB.00118-09; Freinkman E, 2012, BIOCHEMISTRY; Freinkman E, 2011, P NATL ACAD SCI USA, V108, P2486, DOI 10.1073/pnas.1015617108; Gerdes S, 2006, CURR OPIN BIOTECH, V17, P448, DOI 10.1016/j.copbio.2006.08.006; GHISOTTI D, 1992, MOL MICROBIOL, V6, P3405, DOI 10.1111/j.1365-2958.1992.tb02208.x; Gu Y, 2015, STRUCTURE; LEDERBERG J, 1951, J BACTERIOL, V61, P549, DOI 10.1128/JB.61.5.549-550.1951; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lima S, 2013, SCIENCE, V340, P837, DOI 10.1126/science.1235358; Ma B, 2008, P NATL ACAD SCI USA, V105, P13823, DOI 10.1073/pnas.0807028105; Martorana AM, 2011, RES MICROBIOL, V162, P470, DOI 10.1016/j.resmic.2011.03.007; Martorana AM, 2016, J BACTERIOL IN PRESS; Merten JA, 2012, PROTEIN SCI, V21, P211, DOI 10.1002/pro.2004; Narita S, 2009, FEBS LETT, V583, P2160, DOI 10.1016/j.febslet.2009.05.051; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Okuda S, 2016, NAT REV MICROBIOL; Okuda S, 2012, SCIENCE, V338, P1214, DOI 10.1126/science.1228984; Qiao S, 2014, NATURE, V511, P108, DOI 10.1038/nature13484; Ruiz N, 2008, P NATL ACAD SCI USA, V105, P5537, DOI 10.1073/pnas.0801196105; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SAMPSON BA, 1989, GENETICS, V122, P491; Santambrogio C, 2013, J AM SOC MASS SPECTR, V24, P1593, DOI 10.1007/s13361-013-0687-9; Schultz KM, 2013, PROTEIN SCI, V22, P1639, DOI 10.1002/pro.2369; Serina S, 2004, RES MICROBIOL, V155, P692, DOI 10.1016/j.resmic.2004.05.006; Sestito SE, 2014, CHEMBIOCHEM, V15, P734, DOI 10.1002/cbic.201300805; Sherman DJ, 2014, P NATL ACAD SCI USA, V111, P4982, DOI 10.1073/pnas.1323516111; Sperandeo P, 2014, BACTERIAL MEMBRANES, P55; Sperandeo P, 2008, J BACTERIOL, V190, P4460, DOI 10.1128/JB.00270-08; Sperandeo P, 2007, J BACTERIOL, V189, P244, DOI 10.1128/JB.01126-06; Sperandeo P, 2006, RES MICROBIOL, V157, P547, DOI 10.1016/j.resmic.2005.11.014; Sperandeo P, 2011, J BACTERIOL, V193, P1042, DOI 10.1128/JB.01037-10; Stenberg F, 2005, J BIOL CHEM, V280, P34409, DOI 10.1074/jbc.M506479200; Suits MDL, 2008, J MOL BIOL, V380, P476, DOI 10.1016/j.jmb.2008.04.045; TAKASE I, 1987, J BACTERIOL, V169, P5692, DOI 10.1128/jb.169.12.5692-5699.1987; Tran AX, 2010, J BIOL CHEM, V285, P33529, DOI 10.1074/jbc.M110.144709; Tran AX, 2008, JBIOLCHEM; Villa R, 2013, J BACTERIOL, V195, P1100, DOI 10.1128/JB.02057-12; Wang ZS, 2014, BIOCHEM BIOPH RES CO, V452, P443, DOI 10.1016/j.bbrc.2014.08.094; Wu T, 2006, P NATL ACAD SCI USA, V103, P11754, DOI 10.1073/pnas.0604744103; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zerbino DR, 2010, CURR PROTOC BIOINFOR, V11, P11	52	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161354	10.1371/journal.pone.0161354	http://dx.doi.org/10.1371/journal.pone.0161354			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529623	gold, Green Published, Green Submitted			2022-12-26	WOS:000381476700070
J	Kunyanee, C; Kamjumphol, W; Taweechaisupapong, S; Kanthawong, S; Wongwajana, S; Wongratanacheewin, S; Hahnvajanawong, C; Chareonsudjai, S				Kunyanee, Chanikarn; Kamjumphol, Watcharaporn; Taweechaisupapong, Suwimol; Kanthawong, Sakawrat; Wongwajana, Suwin; Wongratanacheewin, Surasak; Hahnvajanawong, Chariya; Chareonsudjai, Sorujsiri			Burkholderia pseudomallei Biofilm Promotes Adhesion, Internalization and Stimulates Proinflammatory Cytokines in Human Epithelial A549 Cells	PLOS ONE			English	Article							INTRACELLULAR SURVIVAL; MOUSE MACROPHAGES; IN-VIVO; MELIOIDOSIS; INFECTION; APOPTOSIS; INVASION; INDUCTION; BACTERIA; DEATH	Burkholderia pseudomallei is a Gram-negative bacterium that causes melioidosis. Inhalational exposure leading to pulmonary melioidosis is the most common clinical manifestation with significant mortality. However, the role of B. pseudomallei biofilm phenotype during bacterial-host interaction remains unclear. We hypothesize that biofilm phenotype may play a role in such interactions. In this study, B. pseudomallei H777 (biofilm wild type), B. pseudomallei M10 (biofilm mutant) and B. pseudomallei C17 (biofilm-complemented) strains were used to assess the contribution of biofilm to adhesion to human lung epithelial cells (A549), intracellular interactions, apoptosis/necrosis and impact on proinflammatory responses. Confocal laser scanning microscopy demonstrated that B. pseudomallei H777 and C17 produced biofilm, whereas M10 did not. To determine the role of biofilm in host interaction, we assessed the ability of each of the three strains to interact with the A549 cells at MOI 10. Strain H777 exhibited higher levels of attachment and invasion compared to strain M10 (p < 0.05). In addition, the biofilm-complemented strain, C17 exhibited restored bacterial invasion ability. Flow cytometry combined with a double-staining assay using annexin V and propidium iodide revealed significantly higher numbers of early apoptotic and late apoptotic A549 cells when these were infected with strain H777 (1.52%) and C17 (1.43%) compared to strain M10 (0.85%) (p < 0.05). Strains H777 and C17 were able to stimulate significant secretion of IL-6 and IL-8 compared with the biofilm mutant (p < 0.05). Together, these findings demonstrated the role of biofilm-associated phenotypes of B. pseudomallei in cellular pathogenesis of human lung epithelial cells with respect to initial attachment and invasion, apoptosis and proinflammatory responses.	[Kunyanee, Chanikarn; Kamjumphol, Watcharaporn; Kanthawong, Sakawrat; Wongwajana, Suwin; Wongratanacheewin, Surasak; Hahnvajanawong, Chariya; Chareonsudjai, Sorujsiri] Khon Kaen Univ, Dept Microbiol, Fac Med, Khon Kaen, Thailand; [Taweechaisupapong, Suwimol] Khon Kaen Univ, Dept Oral Diag, Fac Dent, Khon Kaen, Thailand; [Kunyanee, Chanikarn; Kamjumphol, Watcharaporn; Taweechaisupapong, Suwimol; Kanthawong, Sakawrat; Wongratanacheewin, Surasak; Chareonsudjai, Sorujsiri] Khon Kaen Univ, Melioidosis Res Ctr, Khon Kaen, Thailand; [Taweechaisupapong, Suwimol; Kanthawong, Sakawrat; Chareonsudjai, Sorujsiri] Khon Kaen Univ, Biofilm Res Grp, Khon Kaen, Thailand	Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University	Chareonsudjai, S (corresponding author), Khon Kaen Univ, Dept Microbiol, Fac Med, Khon Kaen, Thailand.; Chareonsudjai, S (corresponding author), Khon Kaen Univ, Melioidosis Res Ctr, Khon Kaen, Thailand.; Chareonsudjai, S (corresponding author), Khon Kaen Univ, Biofilm Res Grp, Khon Kaen, Thailand.	sorujsr@kku.ac.th	Chareonsudjai, Sorujsiri/AFM-5607-2022; Taweechaisupapong, suwimol/F-6759-2010; Wongratanacheewin, Surasakdi/F-7324-2010	Chareonsudjai, Sorujsiri/0000-0001-7176-2924; Wongratanacheewin, Surasakdi/0000-0003-2921-2536	Higher Education Research Promotion; National Research University Project of Thailand; Office of the Higher Education Commission through Center of Excellence in Specific Health Problems in the Greater Mekong Sub-Region Cluster (SHeP-GMS), Khon Kaen University, Thailand; Office of the Higher Education Commission through the Center of Excellence in Specific Health Problems in the Greater Mekong Sub-Region Cluster (SHeP-GMS), Khon Kaen University	Higher Education Research Promotion; National Research University Project of Thailand; Office of the Higher Education Commission through Center of Excellence in Specific Health Problems in the Greater Mekong Sub-Region Cluster (SHeP-GMS), Khon Kaen University, Thailand; Office of the Higher Education Commission through the Center of Excellence in Specific Health Problems in the Greater Mekong Sub-Region Cluster (SHeP-GMS), Khon Kaen University	The Higher Education Research Promotion and National Research University Project of Thailand and the Office of the Higher Education Commission through the Center of Excellence in Specific Health Problems in the Greater Mekong Sub-Region Cluster (SHeP-GMS), Khon Kaen University, Thailand.; This study was supported by the Higher Education Research Promotion and National Research University Project of Thailand and the Office of the Higher Education Commission through the Center of Excellence in Specific Health Problems in the Greater Mekong Sub-Region Cluster (SHeP-GMS), Khon Kaen University. We would like to acknowledge Prof. David Blair for editing the manuscript via the Publication Clinic of KKU, Thailand. We would like to acknowledge Mr. Chaiwat Pongtornprid for the B. pseudomallei H777 and M10 images using Zeiss 500 CLSM.	Adler NRL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079461; Ahmed K, 1999, AM J TROP MED HYG, V60, P90, DOI 10.4269/ajtmh.1999.60.90; Anutrakunchai C, 2015, TROP BIOMED, V32, P300; Byrd MS, 2010, MBIO, V1, DOI 10.1128/mBio.00140-10; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Cheng Allen C, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS26, DOI 10.1016/S0035-9203(08)70008-7; Cheung KJ, 2007, MICROBES INFECT, V9, P829, DOI 10.1016/j.micinf.2007.03.001; Currie BJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000900; Currie BJ, 2003, EMERG INFECT DIS, V9, P1538, DOI 10.3201/eid0912.020750; Ereshefsky M, 2015, P NATL ACAD SCI USA, V112, P10126, DOI 10.1073/pnas.1421377112; Essex-Lopresti AE, 2005, INFECT IMMUN, V73, P1260, DOI 10.1128/IAI.73.2.1260-1264.2005; Garcia-Medina R, 2005, INFECT IMMUN, V73, P8298, DOI 10.1128/IAI.73.12.8298-8305.2005; Grassme H, 2001, APOPTOSIS, V6, P441, DOI 10.1023/A:1012485506972; Herigstad B, 2001, J MICROBIOL METH, V44, P121, DOI 10.1016/S0167-7012(00)00241-4; Hii CS, 2008, J INFECT DIS, V197, P1537, DOI 10.1086/587905; Hseu YC, 2014, J MICROBIOL IMMUNOL, V47, P394, DOI 10.1016/j.jmii.2013.03.011; Jones AL, 1997, INFECT IMMUN, V65, P4972, DOI 10.1128/IAI.65.12.4972-4977.1997; Kamjumphol W, 2015, AM J TROP MED HYG, V93, P1058, DOI 10.4269/ajtmh.15-0177; Kamjumphol W, 2013, SE ASIAN J TROP MED, V44, P72; Kespichayawattana W, 2000, INFECT IMMUN, V68, P5377, DOI 10.1128/IAI.68.9.5377-5384.2000; Korbsrisate S, 2007, MICROBIOL-SGM, V153, P1907, DOI 10.1099/mic.0.2006/003004-0; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; Lee HS, 2010, INFECT IMMUN, V78, P1832, DOI 10.1128/IAI.00446-09; Lengwehasatit I, 2008, MICROB PATHOGENESIS, V44, P238, DOI 10.1016/j.micpath.2007.08.017; Limmathurotsakul D, 2014, CLIN MICROBIOL INFEC, V20, pO854, DOI 10.1111/1469-0691.12614; Limmathurotsakul D, 2011, BRIT MED BULL, V99, P125, DOI 10.1093/bmb/ldr007; Parker D, 2011, AM J RESP CELL MOL, V45, P189, DOI 10.1165/rcmb.2011-0011RT; Pease James E, 2002, Am J Respir Med, V1, P19; Phewkliang A, 2010, SE ASIAN J TROP MED, V41, P1164; Pumirat P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096298; Ramli NSK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044104; Rammaert B, 2014, AM J TROP MED HYG, V90, P383, DOI 10.4269/ajtmh.13-0657a; Rammaert B, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-126; Reechaipichitkul Wipa, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P664; Savoia D, 2007, CURR MICROBIOL, V54, P440, DOI 10.1007/s00284-006-0601-9; Sim SH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007308; Simpson AJH, 2000, J INFECT DIS, V181, P621, DOI 10.1086/315271; Spiliopoulou AI, 2012, FEMS MICROBIOL LETT, V330, P56, DOI 10.1111/j.1574-6968.2012.02533.x; Stevens MP, 2003, J BACTERIOL, V185, P4992, DOI 10.1128/JB.185.16.4992-4996.2003; Sun GW, 2005, CELL MICROBIOL, V7, P1447, DOI 10.1111/j.1462-5822.2005.00569.x; Suparak S, 2005, J BACTERIOL, V187, P6556, DOI 10.1128/JB.187.18.6556-6560.2005; Suzuki T, 2008, INT J BIOCHEM CELL B, V40, P1348, DOI 10.1016/j.biocel.2008.01.003; Takenaka S, 2001, J Infect Chemother, V7, P87, DOI 10.1007/s101560100014; Taweechaisupapong S, 2005, MICROB PATHOGENESIS, V39, P77, DOI 10.1016/j.micpath.2005.06.001; Techawiwattanaboon T, 2015, J MICROBIOL, V53, P134, DOI 10.1007/s12275-015-4522-9; Utaisincharoen P, 2004, CLIN EXP IMMUNOL, V138, P61, DOI 10.1111/j.1365-2249.2004.02601.x; Vorachit M, 1995, J TROP MED HYG, V98, P379; Warawa JM, 2009, INFECT IMMUN, V77, P5252, DOI 10.1128/IAI.00824-09; West TE, 2012, INT J EXP PATHOL, V93, P421, DOI 10.1111/j.1365-2613.2012.00842.x; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; Wiersinga WJ, 2008, CELL MICROBIOL, V10, P81, DOI 10.1111/j.1462-5822.2007.01016.x; Wiersinga WJ, 2007, INFECT IMMUN, V75, P3074, DOI 10.1128/IAI.01733-06; Wiersinga WJ, 2012, NEW ENGL J MED, V367, P1035, DOI 10.1056/NEJMra1204699; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; Wonprompitak P, 2009, ASIAN PAC J ALLERGY, V27, P59; Yeager JJ, 2012, INFECT IMMUN, V80, P3332, DOI 10.1128/IAI.00675-12	56	20	20	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160741	10.1371/journal.pone.0160741	http://dx.doi.org/10.1371/journal.pone.0160741			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529172	Green Submitted, gold, Green Published			2022-12-26	WOS:000381476700020
J	Liu, TK; Wang, YC; Chuang, LZH; Chen, CH				Liu, Ta-Kang; Wang, Yu-Cheng; Chuang, Laurence Zsu-Hsin; Chen, Chih-How			Conservation of the Eastern Taiwan Strait Chinese White Dolphin (Sousa chinensis): Fishers' Perspectives and Management Implications	PLOS ONE			English	Article							PACIFIC HUMPBACK DOLPHINS; PEARL RIVER ESTUARY; FINLESS PORPOISES; RISK-ASSESSMENT; SMALL CETACEANS; POPULATION; ABUNDANCE; WATERS; BAY	The abundance of the eastern Taiwan Strait (ETS) population of the Chinese white dolphin (Sousa chinensis) has been estimated to be less than 100 individuals. It is categorized as critically endangered in the IUCN Red List of Threatened Species. Thus, immediate measures of conservation should be taken to protect it from extinction. Currently, the Taiwanese government plans to designate its habitat as a Major Wildlife Habitat (MWH), a type of marine protected area (MPA) for conservation of wildlife species. Although the designation allows continuing the current exploitation, however, it may cause conflicts among multiple stakeholders with competing interests. The study is to explore the attitude and opinions among the stakeholders in order to better manage the MPA. This study employs a semistructured interview and a questionnaire survey of local fishers. Results from interviews indicated that the subsistence of fishers remains a major problem. It was found that stakeholders have different perceptions of the fishers' attitude towards conservation and also thought that the fishery-related law enforcement could be difficult. Quantitative survey showed that fishers are generally positive towards the conservation of the Chinese white dolphin but are less willing to participate in the planning process. Most fishers considered temporary fishing closure as feasible for conservation. The results of this study provide recommendations for future efforts towards the goal of better conservation for this endangered species.	[Liu, Ta-Kang; Chuang, Laurence Zsu-Hsin; Chen, Chih-How] Natl Cheng Kung Univ, Inst Ocean Technol & Marine Affairs, Tainan, Taiwan; [Wang, Yu-Cheng] Natl Cheng Kung Univ, Dept Law, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University	Liu, TK (corresponding author), Natl Cheng Kung Univ, Inst Ocean Technol & Marine Affairs, Tainan, Taiwan.	tkliu@mail.ncku.edu.tw	Liu, Ta-Kang/A-7941-2010	Liu, Ta-Kang/0000-0002-8375-3934	Taiwan's Forestry Bureau [100-FD-07.1-C-33]; Forestry Bureau [100-FD-07.1-C-33]	Taiwan's Forestry Bureau; Forestry Bureau	TKL received the funding from Taiwan's Forestry Bureau. The grant number is 100-FD-07.1-C-33. Their website is: http://www.forest.gov.tw/mp.asp?mp=204. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to express sincere thanks to the officers from Forestry Bureau and Fisheries Agency for providing valuable information and assistance. The research was partially funded by Forestry Bureau contract 100-FD-07.1-C-33. The authors are grateful for their financial support. The opinions expressed therein are of the authors only and any error remains the sole responsibility of the authors.	Agency Fishery, 2011, FISH STAT YB; Chang W.-L., 2011, THESIS; Chen B, 2006, MAMM BIOL, V73, P156; Chen BY, 2009, INTEGR ZOOL, V4, P240, DOI 10.1111/j.1749-4877.2009.00160.x; Chen T, 2011, MAMM BIOL, V76, P93, DOI 10.1016/j.mambio.2010.01.001; Chen T, 2010, MAMMALIA, V74, P117, DOI 10.1515/MAMM.2010.024; Chilvers BL, 2005, BIOL CONSERV, V122, P559, DOI 10.1016/j.biocon.2004.08.013; Chou LS, 2011, CHINESE WHITE DOLPHI; Creswell J. W., 2014, RES DESIGN QUALITATI; Gleason M, 2010, OCEAN COAST MANAGE, V53, P52, DOI 10.1016/j.ocecoaman.2009.12.001; Guo XH, 2011, AQUAT ECOSYST HEALTH, V14, P298, DOI 10.1080/14634988.2011.598111; Hennink M., 2020, QUALITATIVE RES METH; Hung CLH, 2007, CHEMOSPHERE, V66, P1175, DOI 10.1016/j.chemosphere.2006.08.005; Jefferson TA, 2000, WILDLIFE MONOGR, P1; Jefferson Thomas A., 2004, Aquatic Mammals, V30, P149, DOI 10.1578/AM.30.1.2004.149; Jefferson Thomas A., 2004, Aquatic Mammals, V30, P3, DOI 10.1578/AM.30.1.2004.3; Jefferson Thomas A., 2001, Mammalian Species, V655, P1, DOI 10.1644/1545-1410(2001)655<0001:SC>2.0.CO;2; Jefferson TA, 2009, MAR POLICY, V33, P305, DOI 10.1016/j.marpol.2008.07.011; Karczmarski L, 2000, MAR MAMMAL SCI, V16, P65, DOI 10.1111/j.1748-7692.2000.tb00904.x; Ko M.-C., 2011, THESIS; Liu TK, 2015, MAR POLICY, V61, P113, DOI 10.1016/j.marpol.2015.06.023; Minh TB, 2000, ENVIRON POLLUT, V110, P459, DOI 10.1016/S0269-7491(99)00316-4; Ng SL, 2003, MAR ENVIRON RES, V56, P555, DOI 10.1016/S0141-1136(03)00041-2; Osmond M, 2010, OCEAN COAST MANAGE, V53, P41, DOI 10.1016/j.ocecoaman.2010.01.002; Parra GJ, 2006, BIOL CONSERV, V129, P167, DOI 10.1016/j.biocon.2005.10.031; Parsons ECM, 1999, ENVIRON CONSERV, V26, P30, DOI 10.1017/S0376892999000065; Pomeroy R, 2008, MAR POLICY, V32, P816, DOI 10.1016/j.marpol.2008.03.017; Ramu K, 2005, MAR POLLUT BULL, V51, P669, DOI 10.1016/j.marpolbul.2005.02.041; Reeves RR, 2008, IUCN RED LIST THREAT; Wang JY, 2007, MAMMALIA, V71, P157, DOI 10.1515/MAMM.2007.032; Wang JY, 2011, MAR MAMMAL SCI, V27, P652, DOI 10.1111/j.1748-7692.2010.00422.x; Wang JY, 2008, MAMMALIA, V72, P302, DOI 10.1515/MAMM.2008.030; WANG JY, 2004, 1 WORKSH CONS RES NE; Wang JY, 2007, 2 INT WORKSH CONS RE; Wang XY, 2016, MAR MAMMAL SCI, V32, P390, DOI 10.1111/mms.12257; Yeh CA, 2004, THESIS; Yeung LWY, 2009, ENVIRON POLLUT, V157, P17, DOI 10.1016/j.envpol.2008.08.005; Yu SY, 2010, INT C CONS CHIN WHIT; Zhang Li-feng, 2008, Journal of Oceanography in Taiwan Strait, V27, P79	39	4	5	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0161321	10.1371/journal.pone.0161321	http://dx.doi.org/10.1371/journal.pone.0161321			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27526102	Green Published, Green Submitted, gold			2022-12-26	WOS:000381471100054
J	Chung, H; Ko, H; Thap, T; Jeong, C; Noh, SE; Yoon, KH; Lee, J				Chung, Heewon; Ko, Hoon; Thap, Tharoeun; Jeong, Changwon; Noh, Se-Eung; Yoon, Kwon-Ha; Lee, Jinseok			Smartphone-Based Cardiac Rehabilitation Program: Feasibility Study	PLOS ONE			English	Article								We introduce a cardiac rehabilitation program (CRP) that utilizes only a smartphone, with no external devices. As an efficient guide for cardiac rehabilitation exercise, we developed an application to automatically indicate the exercise intensity by comparing the estimated heart rate (HR) with the target heart rate zone (THZ). The HR is estimated using video images of a fingertip taken by the smartphone's built-in camera. The introduced CRP app includes pre-exercise, exercise with intensity guidance, and post-exercise. In the pre-exercise period, information such as THZ, exercise type, exercise stage order, and duration of each stage are set up. In the exercise with intensity guidance, the app estimates HR from the pulse obtained using the smartphone's built-in camera and compares the estimated HR with the THZ. Based on this comparison, the app adjusts the exercise intensity to shift the patient's HR to the THZ during exercise. In the post-exercise period, the app manages the ratio of the estimated HR to the THZ and provides a questionnaire on factors such as chest pain, shortness of breath, and leg pain during exercise, as objective and subjective evaluation indicators. As a key issue, HR estimation upon signal corruption due to motion artifacts is also considered. Through the smartphone-based CRP, we estimated the HR accuracy as mean absolute error and root mean squared error of 6.16 and 4.30bpm, respectively, with signal corruption due to motion artifacts being detected by combining the turning point ratio and kurtosis.	[Chung, Heewon; Ko, Hoon; Thap, Tharoeun; Lee, Jinseok] Wonkwang Univ, Coll Med, Dept Biomed Engn, Iksan 54538, South Korea; [Jeong, Changwon] Wonkwang Univ, Imaging Sci Based Lung & Bone Dis Res Ctr, 460 Iksandeaero, Iksan 54538, Jeonbuk, South Korea; [Noh, Se-Eung] Wonkwang Univ, Colledge Med, Dept Rehabil Med, Iksan 54538, South Korea; [Yoon, Kwon-Ha] Wonkwang Univ, Colledge Med, Dept Radiol, Iksan 54538, South Korea	Wonkwang University; Wonkwang University; Wonkwang University; Wonkwang University	Lee, J (corresponding author), Wonkwang Univ, Coll Med, Dept Biomed Engn, Iksan 54538, South Korea.; Yoon, KH (corresponding author), Wonkwang Univ, Colledge Med, Dept Radiol, Iksan 54538, South Korea.	khy1646@wku.ac.kr; gonasago@wku.ac.kr	Lee, Jinseok/AAV-7182-2021; Ko, Hoon/J-4612-2013; Lee, Jinseok/GRR-6086-2022	Lee, Jinseok/0000-0002-8580-490X; Ko, Hoon/0000-0002-4604-1735; Lee, Jinseok/0000-0002-8580-490X	Korean Health Technology RAMP;D Project, Ministry of Health and Welfare, Republic of Korea [HI12C0110]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT AMP; Future Planning [NRF-2013R1A1A1005775, NRF-2015M3A9D7067215]	Korean Health Technology RAMP;D Project, Ministry of Health and Welfare, Republic of Korea; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT AMP; Future Planning	This work was supported by Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (HI12C0110), K-HY; and Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2013R1A1A1005775 and NRF-2015M3A9D7067215), JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboy M, 2005, IEEE T BIO-MED ENG, V52, P1662, DOI 10.1109/TBME.2005.855725; Allen Jerilyn K, 2003, J Cardiovasc Nurs, V18, P150; Arrigo I, 2008, EUR J CARDIOV PREV R, V15, P306, DOI 10.1097/HJR.0b013e3282f40e01; de la Cuerda RC, 2012, REV ESP CARDIOL, V65, P72, DOI [10.1016/j.recesp.2011.07.016, 10.1016/j.rec.2011.07.015]; Dalal HM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5631; Dash S, 2009, ANN BIOMED ENG, V37, P1701, DOI 10.1007/s10439-009-9740-z; Doukas Charalampos, 2010, 2010 32nd Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC 2010), P1037, DOI 10.1109/IEMBS.2010.5628061; Gellish RL, 2007, MED SCI SPORT EXER, V39, P822, DOI 10.1097/mss.0b013e31803349c6; JETTE M, 1990, CLIN CARDIOL, V13, P555, DOI 10.1002/clc.4960130809; Jolly K, 2007, BIRMINGHAM REHABILIT; Lee J, 2013, IEEE T BIO-MED ENG, V60, P203, DOI 10.1109/TBME.2012.2208112; Mackinnon L.T., 2003, EXERCISE MANAGEMENT; Maddison R, 2015, EUR J PREV CARDIOL, V22, P701, DOI 10.1177/2047487314535076; Medicine ACoS, 2013, ACSMS GUIDELINES EXE, V9th ed.; Noonan V, 2000, PHYS THER, V80, P782, DOI 10.1093/ptj/80.8.782; Pasquali SK, 2003, AM HEART J, V145, P445, DOI 10.1067/mhj.2003.172; Roy SJ, 2009, VALIDATION MAXIMAL H; Sarela A, 2009, HOME BASED CARE MODE, P1; Varnfield M, 2014, SMARTPHONE BASED HOM; Whaley M H, 1997, J Cardiopulm Rehabil, V17, P261, DOI 10.1097/00008483-199707000-00007	20	11	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0161268	10.1371/journal.pone.0161268	http://dx.doi.org/10.1371/journal.pone.0161268			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27551969	gold, Green Published, Green Submitted			2022-12-26	WOS:000381768800028
J	Cavallo, JS; Mayo, LM; de Wit, H				Cavallo, Joel S.; Mayo, Leah M.; de Wit, Harriet			Acquisition of Conditioning between Methamphetamine and Cues in Healthy Humans	PLOS ONE			English	Article							DRUG-SEEKING BEHAVIOR; D-AMPHETAMINE; COCAINE ADDICTION; ATTENTIONAL BIAS; PLACE PREFERENCE; C57BL/6J MICE; SELF-REPORT; FOOD CUES; RESPONSES; SMOKING	Environmental stimuli repeatedly paired with drugs of abuse can elicit conditioned responses that are thought to promote future drug seeking. We recently showed that healthy volunteers acquired conditioned responses to auditory and visual stimuli after just two pairings with methamphetamine (MA, 20 mg, oral). This study extended these findings by systematically varying the number of drug-stimuli pairings. We expected that more pairings would result in stronger conditioning. Three groups of healthy adults were randomly assigned to receive 1, 2 or 4 pairings (Groups P1, P2 and P4, Ns = 13, 16, 16, respectively) of an auditory-visual stimulus with MA, and another stimulus with placebo (PBO). Drug-cue pairings were administered in an alternating, counterbalanced order, under double-blind conditions, during 4 hr sessions. MA produced prototypic subjective effects (mood, ratings of drug effects) and alterations in physiology (heart rate, blood pressure). Although subjects did not exhibit increased behavioral preference for, or emotional reactivity to, the MA-paired cue after conditioning, they did exhibit an increase in attentional bias (initial gaze) toward the drug-paired stimulus. Further, subjects who had four pairings reported " liking" the MApaired cue more than the PBO cue after conditioning. Thus, the number of drug-stimulus pairings, varying from one to four, had only modest effects on the strength of conditioned responses. Further studies investigating the parameters under which drug conditioning occurs will help to identify risk factors for developing drug abuse, and provide new treatment strategies.	[Cavallo, Joel S.; de Wit, Harriet] Univ Chicago, Dept Psychiat & Behav Neurosci, 5841 S Maryland Ave,MC3077, Chicago, IL 60637 USA; [Mayo, Leah M.] Linkoping Univ, Dept Clin & Expt Med, Ctr Social & Affect Neurosci, SE-58183 Linkoping, Sweden	University of Chicago; Linkoping University	de Wit, H (corresponding author), Univ Chicago, Dept Psychiat & Behav Neurosci, 5841 S Maryland Ave,MC3077, Chicago, IL 60637 USA.	hdew@uchicago.edu	Mayo, Leah/AAX-5320-2020	Mayo, Leah/0000-0002-0645-4869	National Institute on Drug Abuse [R01DA037011]; Clinical Pharmacology Fellowship Program in the University of Chicago Division of Biological Sciences	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Clinical Pharmacology Fellowship Program in the University of Chicago Division of Biological Sciences	This research was supported by a grant from the National Institute on Drug Abuse, R01DA037011. HDW received this funding (https://www.drugabuse.gov/). JSC was supported in part by a fellowship from the Clinical Pharmacology Fellowship Program in the University of Chicago Division of Biological Sciences (https://ccpp.uchicago.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED SH, 1995, BEHAV NEUROSCI, V109, P723, DOI 10.1037/0735-7044.109.4.723; American Psychiatric Association, 2000, DIAGNOSTIC AND STATI; Anderson J, 2000, LEARNING MEMORY; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; Brabant C, 2005, PSYCHOPHARMACOLOGY, V180, P33, DOI 10.1007/s00213-004-2138-6; Bradley BP, 2003, PSYCHOL ADDICT BEHAV, V17, P66, DOI 10.1037/0893-164X.17.1.66; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Carter BL, 1999, ADDICTION, V94, P327, DOI 10.1046/j.1360-0443.1999.9433273.x; CHAIT LD, 1985, DRUG ALCOHOL DEPEN, V15, P229, DOI 10.1016/0376-8716(85)90002-X; Childress AR, 1999, AM J PSYCHIAT, V156, P11, DOI 10.1176/ajp.156.1.11; Conklin CA, 2002, ADDICTION, V97, P155, DOI 10.1046/j.1360-0443.2002.00014.x; COOK CE, 1992, DRUG METAB DISPOS, V20, P856; Cooney NL, 1997, J ABNORM PSYCHOL, V106, P243, DOI 10.1037/0021-843X.106.2.243; Cunningham CL, 2011, NEUROMETHODS, V53, P167, DOI 10.1007/978-1-60761-934-5_6; Dols M, 2000, ADDICT BEHAV, V25, P103, DOI 10.1016/S0306-4603(98)00115-4; Drobes DJ, 1997, J ABNORM PSYCHOL, V106, P15, DOI 10.1037/0021-843X.106.1.15; Drummond DC, 2001, ADDICTION, V96, P33, DOI 10.1046/j.1360-0443.2001.961333.x; Ehrman RN, 1996, DRUG ALCOHOL DEPEN, V42, P167, DOI 10.1016/S0376-8716(96)01278-1; EHRMAN RN, 1992, PSYCHOPHARMACOLOGY, V107, P523, DOI 10.1007/BF02245266; Ferguson SG, 2009, J SUBST ABUSE TREAT, V36, P235, DOI 10.1016/j.jsat.2008.06.005; Foltin RW, 2000, PSYCHOPHARMACOLOGY, V149, P24, DOI 10.1007/s002139900340; Geier A, 2000, PSYCHOPHARMACOLOGY, V150, P283, DOI 10.1007/s002130000404; GREELEY JD, 1993, J STUD ALCOHOL, V54, P359, DOI 10.15288/jsa.1993.54.359; Hogarth L, 2009, EXP CLIN PSYCHOPHARM, V17, P21, DOI 10.1037/a0014957; JOHANSON CE, 1980, PSYCHOPHARMACOLOGY, V71, P275, DOI 10.1007/BF00433062; Kilts CD, 2001, ARCH GEN PSYCHIAT, V58, P334, DOI 10.1001/archpsyc.58.4.334; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; Lazev AB, 1999, EXP CLIN PSYCHOPHARM, V7, P56, DOI 10.1037/1064-1297.7.1.56; Lejuez CW, 2007, J CLIN CHILD ADOLESC, V36, P106, DOI 10.1207/s15374424jccp3601_11; Leth-Steensen C, 2000, ACTA PSYCHOL, V104, P167, DOI 10.1016/S0001-6918(00)00019-6; MacKillop J, 2008, EXP CLIN PSYCHOPHARM, V16, P322, DOI 10.1037/a0012686; MARTIN WR, 1971, CLIN PHARMACOL THER, V12, P245; Mayo LM, 2016, J STUD ALCOHOL DRUGS, V77, P317, DOI 10.15288/jsad.2016.77.317; Mayo LM, 2015, NEUROPSYCHOPHARMACOL, V40, P1734, DOI 10.1038/npp.2015.21; Mayo LM, 2013, NEUROPSYCHOPHARMACOL, V38, P921, DOI 10.1038/npp.2013.3; MAZURSKI EJ, 1991, PSYCHOPHARMACOLOGY, V105, P107, DOI 10.1007/BF02316871; McNair DM, 1971, PROFILE OF MOOD STAT; Michel A, 2003, BEHAV BRAIN RES, V145, P113, DOI 10.1016/S0166-4328(03)00106-2; Mucha RF, 1998, CAN J PHYSIOL PHARM, V76, P259, DOI 10.1139/cjpp-76-3-259; NOMIKOS GG, 1988, PSYCHOPHARMACOLOGY, V94, P119, DOI 10.1007/BF00735892; OBRIEN CP, 1992, ANN NY ACAD SCI, V654, P400, DOI 10.1111/j.1749-6632.1992.tb25984.x; Papachristou H, 2013, APPETITE, V69, P46, DOI 10.1016/j.appet.2013.05.011; Powell J, 2010, PSYCHOPHARMACOLOGY, V212, P537, DOI 10.1007/s00213-010-1975-8; Risinger FO, 1996, PHARMACOL BIOCHEM BE, V55, P117, DOI 10.1016/0091-3057(96)00069-X; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; See RE, 2002, PHARMACOL BIOCHEM BE, V71, P517, DOI 10.1016/S0091-3057(01)00682-7; Sell LA, 2000, DRUG ALCOHOL DEPEN, V60, P207, DOI 10.1016/S0376-8716(99)00158-1; Sheynin J, 2013, STRESS, V16, P289, DOI 10.3109/10253890.2012.744391; Spear NE, 1978, THE PROCESSING OF ME; STEWART J, 1984, PSYCHOL REV, V91, P251, DOI 10.1037/0033-295X.91.2.251; Thewissen R, 2006, BEHAV RES THER, V44, P1441, DOI 10.1016/j.brat.2005.10.010; Tolliver BK, 2010, AM J DRUG ALCOHOL AB, V36, P106, DOI 10.3109/00952991003686402; van den Akker K, 2015, J BEHAV THER EXP PSY, V48, P50, DOI 10.1016/j.jbtep.2015.02.001; van den Akker K, 2014, APPETITE, V81, P242, DOI 10.1016/j.appet.2014.06.024; Van Gucht D, 2008, BEHAV RES THER, V46, P375, DOI 10.1016/j.brat.2008.01.003; Volkow ND, 2006, J NEUROSCI, V26, P6583, DOI 10.1523/JNEUROSCI.1544-06.2006; Wardle MC, 2012, PSYCHOPHARMACOLOGY, V223, P199, DOI 10.1007/s00213-012-2708-y; Waters AJ, 2009, EXP CLIN PSYCHOPHARM, V17, P247, DOI 10.1037/a0016658; White TL, 2002, PHARMACOL BIOCHEM BE, V73, P729, DOI 10.1016/S0091-3057(02)00818-3; Wikler A, 1965, NARCOTICS, P85; Winkler MH, 2011, PSYCHOPHARMACOLOGY, V213, P781, DOI 10.1007/s00213-010-2033-2	62	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161541	10.1371/journal.pone.0161541	http://dx.doi.org/10.1371/journal.pone.0161541			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548681	Green Published, Green Submitted, gold			2022-12-26	WOS:000381768400070
J	Goupil, S; Marechal, L; El Hajj, H; Tremblay, ME; Richard, FJ; Leclerc, P				Goupil, Serge; Marechal, Loize; El Hajj, Hassan; Tremblay, Marie-Eve; Richard, Francois J.; Leclerc, Pierre			Identification and Localization of the Cyclic Nucleotide Phosphodiesterase 10A in Bovine Testis and Mature Spermatozoa	PLOS ONE			English	Article							PROTEIN-TYROSINE PHOSPHORYLATION; SOLUBLE ADENYLYL-CYCLASE; HUMAN SPERM CAPACITATION; CAMP-DEPENDENT PATHWAY; ACROSOME REACTION; SIGNALING PATHWAYS; MAMMALIAN SPERM; INTRACELLULAR PARAMETERS; POLYACRYLAMIDE-GELS; MOUSE SPERMATOZOA	In mammals, adenosine 3', 5'-cyclic monophosphate (cAMP) is known to play highly important roles in sperm motility and acrosomal exocytosis. It is known to act through protein phosphorylation via PRKA and through the activation of guanine nucleotide exchange factors like EPAC. Sperm intracellular cAMP levels depend on the activity of adenylyl cyclases, mostly SACY, though transmembrane-containing adenylyl cyclases are also present, and on the activity of cyclic nucleotide phosphodiesterases (PDE) whose role is to degrade cAMP into 5'-AMP. The PDE superfamily is subdivided into 11 families (PDE1 to 11), which act on either cAMP or cGMP, or on both cAMP and cGMP although with different enzymatic properties. PDE10, which is more effective on cAMP than cGMP, has been known for almost 15 years and is mostly studied in the brain where it is associated with neurological disorders. Although a high level of PDE10A gene expression is observed in the testis, information on the identity of the isoforms or on the cell type that express the PDE10 protein is lacking. The objective of this study was to identify the PDE10A isoforms expressed in the testis and germ cells, and to determine the presence and localization of PDE10A in mature spermatozoa. As a sub-objective, since PDE10A transcript variants were reported strictly through analyses of bovine genomic sequence, we also wanted to determine the nucleotide and amino acid sequences by experimental evidence. Using RT-PCR, 5'-and 3'-RACE approaches we clearly show that PDE10A transcript variants X3 and X5 are expressed in bovine testis as well as in primary spermatocytes and spermatids. We also reveal using a combination of immunological techniques and proteomics analytical tools that the PDE10A isoform X4 is present in the area of the developing acrosome of spermatids and of the acrosome of mature spermatozoa.	[Goupil, Serge; Marechal, Loize; Leclerc, Pierre] Univ Laval, Dept Obstet Gynecol & Reprod, Quebec City, PQ G1K 7P4, Canada; [Goupil, Serge; Marechal, Loize; El Hajj, Hassan; Tremblay, Marie-Eve; Richard, Francois J.; Leclerc, Pierre] Univ Laval, CHU Quebec, Ctr Rech, Quebec City, PQ G1V 4G2, Canada; [El Hajj, Hassan; Tremblay, Marie-Eve] Univ Laval, Dept Mol Med, Quebec City, PQ G1K 7P4, Canada; [Richard, Francois J.] Univ Laval, Dept Sci Anim, Quebec City, PQ G1K 7P4, Canada; [Leclerc, Pierre] Univ Laval, CRDSI, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University; Laval University; Laval University; Laval University	Leclerc, P (corresponding author), Univ Laval, Dept Obstet Gynecol & Reprod, Quebec City, PQ G1K 7P4, Canada.; Leclerc, P (corresponding author), Univ Laval, CRDSI, Quebec City, PQ G1K 7P4, Canada.	pierre.leclerc@crchudequebec.ulaval.ca		Tremblay, Marie-Eve/0000-0003-2863-9626; Richard, Francois J./0000-0003-0226-2971; Leclerc, Pierre/0000-0003-2053-3958	Natural Science and Engineering Research Council of Canada (NSERC) [435507]	Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by the Natural Science and Engineering Research Council of Canada (NSERC; Collaborative Research & Development grant, project #435507; http://www.nserc-crsng.gc.ca) to FJR and PL. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was also supported by L'Alliance Boviteq Inc (St- Hyacinthe, QC, Canada; http://www.boviteq.com) to FJR and PL. This funder had no role in study	Bajpai M, 2006, BIOL REPROD, V74, P109, DOI 10.1095/biolreprod.105.043588; Baker MA, 2006, J CELL SCI, V119, P3182, DOI 10.1242/jcs.03055; Baxendale RW, 2005, MOL REPROD DEV, V71, P495, DOI 10.1002/mrd.20265; Bisht K, 2016, JOVE-J VIS EXP, DOI 10.3791/54060; Branham MT, 2009, J BIOL CHEM, V284, P24825, DOI 10.1074/jbc.M109.015362; Branham MAT, 2006, J BIOL CHEM, V281, P8656, DOI 10.1074/jbc.M508854200; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; Buffone MG, 2014, BBA-MOL BASIS DIS, V1842, P2610, DOI 10.1016/j.bbadis.2014.07.013; Charych EI, 2010, J NEUROSCI, V30, P9027, DOI 10.1523/JNEUROSCI.1635-10.2010; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Coskran TM, 2006, J HISTOCHEM CYTOCHEM, V54, P1205, DOI 10.1369/JHC.6A6930.2006; DEJONGE CJ, 1991, J EXP ZOOL, V258, P113, DOI 10.1002/jez.1402580113; DOHERTY CM, 1995, J ANDROL, V16, P36; Ebner T, 2011, FERTIL STERIL, V96, P1331, DOI 10.1016/j.fertnstert.2011.08.041; Fisch JD, 1998, HUM REPROD, V13, P1248, DOI 10.1093/humrep/13.5.1248; Fournier V, 2003, J ANDROL, V24, P104; FRASER LR, 1979, J REPROD FERTIL, V57, P377, DOI 10.1530/jrf.0.0570377; FRASER LR, 1981, J REPROD FERTIL, V62, P63, DOI 10.1530/jrf.0.0620063; Fujishige K, 1999, EUR J BIOCHEM, V266, P1118, DOI 10.1046/j.1432-1327.1999.00963.x; Fujishige K, 2000, EUR J BIOCHEM, V267, P5943, DOI 10.1046/j.1432-1327.2000.01661.x; Fujishige K, 1999, J BIOL CHEM, V274, P18438, DOI 10.1074/jbc.274.26.18438; GARBERS DL, 1971, BIOL REPROD, V5, P336, DOI 10.1093/biolreprod/5.3.336; Havlis J, 2003, ANAL CHEM, V75, P1300, DOI 10.1021/ac026136s; Herrero MB, 2000, FREE RADICAL BIO MED, V29, P522, DOI 10.1016/S0891-5849(00)00339-7; HOSKINS DD, 1975, BIOL REPROD, V13, P168, DOI 10.1095/biolreprod13.2.168; HYNE RV, 1979, P NATL ACAD SCI USA, V76, P5699, DOI 10.1073/pnas.76.11.5699; Kehler J, 2011, BIOORG MED CHEM LETT, V21, P3738, DOI 10.1016/j.bmcl.2011.04.067; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kleiman RJ, 2011, J PHARMACOL EXP THER, V336, P64, DOI 10.1124/jpet.110.173294; Kotera J, 2004, J BIOL CHEM, V279, P4366, DOI 10.1074/jbc.M308471200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lalancette C, 2006, MOL REPROD DEV, V73, P520, DOI 10.1002/mrd.20422; Lawson C, 2008, BIOL REPROD, V79, P657, DOI 10.1095/biolreprod.108.070367; Leclerc P, 1999, J ANDROL, V20, P126; LECLERC P, 1995, BIOL REPROD, V52, P1227, DOI 10.1095/biolreprod52.6.1227; Leclerc P, 1996, BIOL REPROD, V55, P684, DOI 10.1095/biolreprod55.3.684; Leclerc P, 2002, BIOL REPROD, V67, P301, DOI 10.1095/biolreprod67.1.301; Lefievre L, 2002, BIOL REPROD, V67, P423, DOI 10.1095/biolreprod67.2.423; Livera G, 2005, MOL ENDOCRINOL, V19, P1277, DOI 10.1210/me.2004-0318; McPartlin LA, 2011, BIOL REPROD, V85, P179, DOI 10.1095/biolreprod.110.085555; Melo RCN, 2014, NAT PROTOC, V9, P2382, DOI 10.1038/nprot.2014.163; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; PARRISH JJ, 1995, THERIOGENOLOGY, V44, P859, DOI 10.1016/0093-691X(95)00271-9; Pons-Rejraji H, 2009, REPROD FERT DEVELOP, V21, P525, DOI 10.1071/RD07170; Pons-Rejraji H, 2009, REPROD FERT DEVELOP, V21, P511, DOI 10.1071/RD07169; Richter W, 1999, MOL HUM REPROD, V5, P732, DOI 10.1093/molehr/5.8.732; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sinclair ML, 2000, MOL REPROD DEV, V56, P6, DOI 10.1002/(SICI)1098-2795(200005)56:1&lt;6::AID-MRD2&gt;3.0.CO;2-M; Siuciak JA, 2006, NEUROPHARMACOLOGY, V51, P386, DOI 10.1016/j.neuropharm.2006.04.013; Siuciak JA, 2008, CNS DRUGS, V22, P983, DOI 10.2165/0023210-200822120-00002; Soderling SH, 1999, P NATL ACAD SCI USA, V96, P7071, DOI 10.1073/pnas.96.12.7071; TASH JS, 1976, J REPROD FERTIL, V47, P63, DOI 10.1530/jrf.0.0470063; Thundathil J, 2002, MOL HUM REPROD, V8, P811, DOI 10.1093/molehr/8.9.811; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Visconti PE, 1999, BIOL REPROD, V61, P76, DOI 10.1095/biolreprod61.1.76; VISCONTI PE, 1995, DEVELOPMENT, V121, P1139; WASCO WM, 1984, BIOCHEM BIOPH RES CO, V118, P636, DOI 10.1016/0006-291X(84)91350-0; Wayman C, 2005, INT J IMPOT RES, V17, P216, DOI 10.1038/sj.ijir.3901307; Wertheimer E, 2013, J BIOL CHEM, V288, P35307, DOI 10.1074/jbc.M113.489476	59	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161035	10.1371/journal.pone.0161035	http://dx.doi.org/10.1371/journal.pone.0161035			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548062	gold, Green Submitted, Green Published			2022-12-26	WOS:000381768400028
J	Silva, VL; Ferreira, D; Nobrega, FL; Martins, IM; Kluskens, LD; Rodrigues, LR				Silva, Vera L.; Ferreira, Debora; Nobrega, Franklin L.; Martins, Ivone M.; Kluskens, Leon D.; Rodrigues, Ligia R.			Selection of Novel Peptides Homing the 4T1 CELL Line: Exploring Alternative Targets for Triple Negative Breast Cancer	PLOS ONE			English	Article							PHAGE DISPLAY; MOUSE MODELS; IDENTIFICATION; LIBRARIES; METASTASIS; DIVERSITY; DELIVERY; DATABASE; FUTURE; TUMORS	The use of bacteriophages to select novel ligands has been widely explored for cancer therapy. Their application is most warranted in cancer subtypes lacking knowledge on how to target the cancer cells in question, such as the triple negative breast cancer, eventually leading to the development of alternative nanomedicines for cancer therapeutics. Therefore, the following study aimed to select and characterize novel peptides for a triple negative breast cancer murine mammary carcinoma cell line-4T1. Using phage display, 7 and 12 amino acid random peptide libraries were screened against the 4T1 cell line. A total of four rounds, plus a counter-selection round using the 3T3 murine fibroblast cell line, was performed. The enriched selective peptides were characterized and their binding capacity towards 4T1 tissue samples was confirmed by immunofluorescence and flow cytometry analysis. The selected peptides (4T1pep1 -CPTASNTSC and 4T1pep2-EVQSSKF-PAHVS) were enriched over few rounds of selection and exhibited specific binding to the 4T1 cell line. Interestingly, affinity to the human MDA-MB-231 cell line was also observed for both peptides, promoting the translational application of these novel ligands between species. Additionally, bioinformatics analysis suggested that both peptides target human Mucin-16. This protein has been implicated in different types of cancer, as it is involved in many important cellular functions. This study strongly supports the need of finding alternative targeting systems for TNBC and the peptides herein selected exhibit promising future application as novel homing peptides for breast cancer therapy.	[Silva, Vera L.; Ferreira, Debora; Nobrega, Franklin L.; Martins, Ivone M.; Kluskens, Leon D.; Rodrigues, Ligia R.] Univ Minho, CEB, Campus Gualtar, Braga, Portugal; [Silva, Vera L.] Univ East Anglia, Sch Pharm, Norwich Res Pk, Norwich, Norfolk, England	Universidade do Minho; University of East Anglia	Rodrigues, LR (corresponding author), Univ Minho, CEB, Campus Gualtar, Braga, Portugal.	lrmr@deb.uminho.pt	Ferreira, Débora/AAA-6991-2022; Nobrega, Franklin L./J-3094-2019; Ferreira, Débora/T-1353-2017; Martins, Ivone M/G-1752-2012; Rodrigues, Ligia R/C-3151-2009	Ferreira, Débora/0000-0002-0937-4047; Nobrega, Franklin L./0000-0002-8238-1083; Ferreira, Débora/0000-0002-0937-4047; Martins, Ivone M/0000-0002-3412-9377; Rodrigues, Ligia R/0000-0001-9265-0630	Portuguese Foundation for Science and Technology (FCT) [SFRH/BD/86462/2012]; FCT; European Community fund FEDER, through Program COMPETE [FCOMP-01-0124-FEDER-021053 (PTDC/SAU-BMA/121028/2010), RECI/BBB-EBI/0179/2012 (FCOMP-01-0124-FEDER-027462), UID/BIO/04469/2013]; Programa Operacional Regional do Norte (ON.2 - O Novo Norte), QREN, FEDER; Fundação para a Ciência e a Tecnologia [PTDC/SAU-BMA/121028/2010] Funding Source: FCT	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); European Community fund FEDER, through Program COMPETE; Programa Operacional Regional do Norte (ON.2 - O Novo Norte), QREN, FEDER; Fundação para a Ciência e a Tecnologia	Franklin L. Nobrega acknowledges the Portuguese Foundation for Science and Technology (FCT) for the grant SFRH/BD/86462/2012. This study was supported by FCT and the European Community fund FEDER, through Program COMPETE, under the scope of the Projects FCOMP-01-0124-FEDER-021053 (PTDC/SAU-BMA/121028/2010), RECI/BBB-EBI/0179/2012 (FCOMP-01-0124-FEDER-027462), the strategic funding of UID/BIO/04469/2013 unit, co-funded by the Programa Operacional Regional do Norte (ON.2 - O Novo Norte), QREN, FEDER.	Adochite RC, 2014, MOL PHARMACEUT, V11, P2896, DOI 10.1021/mp5002526; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2014, IHC PARAFFIN STAININ; Bar H, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-37; Bedi D, 2011, NANOMED-NANOTECHNOL, V7, P315, DOI 10.1016/j.nano.2010.10.004; Bignone PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058200; Budynek P, 2010, ARCH MICROBIOL, V192, P315, DOI 10.1007/s00203-010-0559-7; Dai XY, 2014, BIOCHEM BIOPH RES CO, V445, P795, DOI 10.1016/j.bbrc.2014.02.022; Derda R, 2011, MOLECULES, V16, P1776, DOI 10.3390/molecules16021776; Dong J, 2008, CHINESE SCI BULL, V53, P860, DOI 10.1007/s11434-008-0162-3; Eckhardt BL, 2005, MOL CANCER RES, V3, P1; Fantozzi A, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1530; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Filfil R, 2012, INT J CANCER, V131, pE681, DOI 10.1002/ijc.27368; Francia G, 2011, NAT REV CANCER, V11, P135, DOI 10.1038/nrc3001; Fu B, 2014, BIOTECHNOL LETT, V36, P2291, DOI 10.1007/s10529-014-1608-0; Giordano RJ, 2001, NAT MED, V7, P1249, DOI 10.1038/nm1101-1249; Gluz O, 2009, ANN ONCOL, V20, P1913, DOI 10.1093/annonc/mdp492; Gray BP, 2014, CHEM REV, V114, P1020, DOI 10.1021/cr400166n; Gray BP, 2013, BIOCONJUGATE CHEM, V24, P85, DOI 10.1021/bc300498d; Hong HY, 2008, J CELL MOL MED, V12, P2003, DOI 10.1111/j.1582-4934.2008.00189.x; Huang J, 2012, NUCLEIC ACIDS RES, V40, pD271, DOI 10.1093/nar/gkr922; Huang J, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/101932; Ismail-Khan R, 2010, CANCER CONTROL, V17, P173, DOI 10.1177/107327481001700305; Jiao QL, 2014, J THORAC DIS, V6, P1329, DOI 10.3978/j.issn.2072-1439.2014.08.13; Kau P, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-120; Kong M., 2013, CHIN GER J CLIN ONCO, V12, P246, DOI [10.1007/s10330-013-1141-y, DOI 10.1007/S10330-013-1141-Y]; Krag DN, 2006, CANCER RES, V66, P7724, DOI 10.1158/0008-5472.CAN-05-4441; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Lakshmanan I, 2012, ONCOGENE, V31, P805, DOI 10.1038/onc.2011.297; Le Du F, 2015, ONCOTARGET, V6, P12890, DOI 10.18632/oncotarget.3849; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Li X, 2014, METHODS MOL BIOL, V1108, P57, DOI 10.1007/978-1-62703-751-8_4; Lu RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066128; Matochko WL, 2012, METHODS, V58, P47, DOI 10.1016/j.ymeth.2012.07.006; Mendes TFS, 2015, ADV SCI, V2, DOI 10.1002/advs.201500053; Menendez A, 2005, ANAL BIOCHEM, V336, P145, DOI 10.1016/j.ab.2004.09.048; Molek P, 2011, MOLECULES, V16, P857, DOI 10.3390/molecules16010857; Nowakowski GS, 2004, STEM CELLS, V22, P1030, DOI 10.1634/stemcells.22-6-1030; Petrenko VA, 2014, FEBS LETT, V588, P341, DOI 10.1016/j.febslet.2013.11.011; Reinartz S, 2012, EUR J CANCER, V48, P1558, DOI 10.1016/j.ejca.2011.07.004; Shtatland T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-280; Smith Temple F., 2008, V48, P20, DOI 10.1007/978-0-387-09595-0_3; 't Hoen PAC, 2012, ANAL BIOCHEM, V421, P622, DOI 10.1016/j.ab.2011.11.005; Tao K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-228; Umlauf BJ, 2015, BIOTECHNIQUES, V58, P81, DOI 10.2144/000114256; Vodnik M, 2011, MOLECULES, V16, P790, DOI 10.3390/molecules16010790; Yildiz I, 2011, CURR OPIN BIOTECH, V22, P901, DOI 10.1016/j.copbio.2011.04.020; Zhang BH, 2007, MOL MED, V13, P246, DOI 10.2119/2006-00115.Zhang	50	16	16	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161290	10.1371/journal.pone.0161290	http://dx.doi.org/10.1371/journal.pone.0161290			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548261	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000381768400038
J	Deng, LT; Wu, YL; Li, JC; OuYang, KX; Ding, MM; Zhang, JJ; Li, SQ; Lin, MF; Chen, HB; Hu, XS; Chen, XY				Deng, Li-Ting; Wu, Yu-Ling; Li, Jun-Cheng; OuYang, Kun-Xi; Ding, Mei-Mei; Zhang, Jun-Jie; Li, Shu-Qi; Lin, Meng-Fei; Chen, Han-Bin; Hu, Xin-Sheng; Chen, Xiao-Yang			Screening Reliable Reference Genes for RT-qPCR Analysis of Gene Expression in Moringa oleifera	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; HOUSEKEEPING GENES; SUPEROXIDE-DISMUTASE; PCR NORMALIZATION; OXIDATIVE STRESS; QUANTITATIVE-PCR; RNA EXPRESSION; SELECTION; IDENTIFICATION; VALIDATION	Moringa oleifera is a promising plant species for oil and forage, but its genetic improvement is limited. Our current breeding program in this species focuses on exploiting the functional genes associated with important agronomical traits. Here, we screened reliable reference genes for accurately quantifying the expression of target genes using the technique of real-time quantitative polymerase chain reaction (RT-qPCR) in M. oleifera. Eighteen candidate reference genes were selected from a transcriptome database, and their expression stabilities were examined in 90 samples collected from the pods in different developmental stages, various tissues, and the roots and leaves under different conditions (low or high temperature, sodium chloride (NaCl)-or polyethyleneglycol (PEG)-simulated water stress). Analyses with geNorm, NormFinder and BestKeeper algorithms revealed that the reliable reference genes differed across sample designs and that ribosomal protein L1 (RPL1) and acyl carrier protein 2 (ACP2) were the most suitable reference genes in all tested samples. The experiment results demonstrated the significance of using the properly validated reference genes and suggested the use of more than one reference gene to achieve reliable expression profiles. In addition, we applied three isotypes of the superoxide dismutase (SOD) gene that are associated with plant adaptation to abiotic stress to confirm the efficacy of the validated reference genes under NaCl and PEG water stresses. Our results provide a valuable reference for future studies on identifying important functional genes from their transcriptional expressions via RT-qPCR technique in M. oleifera.	[Deng, Li-Ting; Wu, Yu-Ling; Li, Jun-Cheng; OuYang, Kun-Xi; Ding, Mei-Mei; Zhang, Jun-Jie; Li, Shu-Qi; Lin, Meng-Fei; Chen, Han-Bin; Hu, Xin-Sheng; Chen, Xiao-Yang] South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou 510642, Guangdong, Peoples R China; [Deng, Li-Ting; Wu, Yu-Ling; Li, Jun-Cheng; OuYang, Kun-Xi; Ding, Mei-Mei; Zhang, Jun-Jie; Li, Shu-Qi; Lin, Meng-Fei; Chen, Han-Bin; Hu, Xin-Sheng; Chen, Xiao-Yang] South China Agr Univ, Guangdong Key Lab Innovat Dev & Utilizat Forest P, Guangzhou 510642, Guangdong, Peoples R China; [Deng, Li-Ting; Wu, Yu-Ling; Li, Jun-Cheng; OuYang, Kun-Xi; Ding, Mei-Mei; Zhang, Jun-Jie; Li, Shu-Qi; Lin, Meng-Fei; Chen, Han-Bin; Hu, Xin-Sheng; Chen, Xiao-Yang] South China Agr Univ, Guangdong Prov Res Ctr Woody Forage Engn Technol, Guangzhou 510642, Guangdong, Peoples R China; [Deng, Li-Ting; Wu, Yu-Ling; Li, Jun-Cheng; OuYang, Kun-Xi; Ding, Mei-Mei; Zhang, Jun-Jie; Li, Shu-Qi; Lin, Meng-Fei; Chen, Han-Bin; Hu, Xin-Sheng; Chen, Xiao-Yang] South China Agr Univ, Coll Forestry & Landscape Architecture, Guangzhou 510642, Guangdong, Peoples R China	South China Agricultural University; South China Agricultural University; South China Agricultural University; South China Agricultural University	Hu, XS; Chen, XY (corresponding author), South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou 510642, Guangdong, Peoples R China.; Hu, XS; Chen, XY (corresponding author), South China Agr Univ, Guangdong Key Lab Innovat Dev & Utilizat Forest P, Guangzhou 510642, Guangdong, Peoples R China.; Hu, XS; Chen, XY (corresponding author), South China Agr Univ, Guangdong Prov Res Ctr Woody Forage Engn Technol, Guangzhou 510642, Guangdong, Peoples R China.; Hu, XS; Chen, XY (corresponding author), South China Agr Univ, Coll Forestry & Landscape Architecture, Guangzhou 510642, Guangdong, Peoples R China.	xinsheng@scau.edu.cn; xychen@scau.edu.cn			Forestry Sciences and Technology Innovation Project in Guangdong Province, P.R. China [2015KJCX009]; Department of Tropical crops, State Bureau for Land-Reclamation, P.R. China [15RZNJ-62]	Forestry Sciences and Technology Innovation Project in Guangdong Province, P.R. China; Department of Tropical crops, State Bureau for Land-Reclamation, P.R. China	This work was supported by the Forestry Sciences and Technology Innovation Project in Guangdong Province (2015KJCX009) and the Department of Tropical crops, State Bureau for Land-Reclamation (15RZNJ-62), P.R. China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We appreciate the Academic Editor and two anonymous reviewers for helpful comments on an earlier version of this article. We would like to thank Yong-shun Gao, Ai-min Wu and Chang-Cao Peng for helpful advices on this research work. This work was supported by the Forestry Sciences and Technology Innovation Project in Guangdong Province (2015KJCX009) and the Department of Tropical crops, State Bureau for Land-Reclamation (15RZNJ-62), P.R. China.	Alscher RG, 2002, J EXP BOT, V53, P1331, DOI 10.1093/jexbot/53.372.1331; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Ando H, 2016, J PHARMACOL SCI, V131, P138, DOI 10.1016/j.jphs.2016.03.002; Anwar F, 2007, PHYTOTHER RES, V21, P17, DOI 10.1002/ptr.2023; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Buckland PR, 2006, BBA-MOL BASIS DIS, V1762, P17, DOI 10.1016/j.bbadis.2005.10.004; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen L, 2011, PLANTA, V234, P377, DOI 10.1007/s00425-011-1410-3; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Die JV, 2010, PLANTA, V232, P145, DOI 10.1007/s00425-010-1158-1; Ellis Danielle R., 2004, BMC Plant Biology, V4, P1, DOI 10.1186/1471-2229-4-1; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Foidl N., 2001, WHAT DEV POTENTIAL M, V20, P1; Gill SS, 2015, ENVIRON SCI POLLUT R, V22, P10375, DOI 10.1007/s11356-015-4532-5; Gismondi A, 2013, INT J ONCOL, V43, P956, DOI 10.3892/ijo.2013.2001; Gomez JM, 2004, J EXP BOT, V55, P119, DOI 10.1093/jxb/erh013; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Kim BR, 2003, BIOTECHNOL LETT, V25, P1869, DOI 10.1023/A:1026298032009; KIMURA M, 1974, P NATL ACAD SCI USA, V71, P2848, DOI 10.1073/pnas.71.7.2848; Kumar V, 2011, AUST J CROP SCI, V5, P1455; Lee PD, 2002, GENOME RES, V12, P292, DOI 10.1101/gr.217802; Libault M, 2008, PLANT GENOME-US, V1, P44, DOI 10.3835/plantgenome2008.02.0091; Lovdal T, 2009, ANAL BIOCHEM, V387, P238, DOI 10.1016/j.ab.2009.01.024; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Mohamed E, 2015, PLANT CELL REP, V34, P2099, DOI 10.1007/s00299-015-1854-1; Neuvians TAP, 2005, J BIOTECHNOL, V117, P163, DOI 10.1016/j.jbiotec.2005.01.011; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Saini RK, 2014, ACTA PHYSIOL PLANT, V36, P2695, DOI 10.1007/s11738-014-1640-7; Schmid H, 2003, KIDNEY INT, V64, P356, DOI 10.1046/j.1523-1755.2003.00074.x; Schmidt GW, 2010, MOL GENET GENOMICS, V283, P233, DOI 10.1007/s00438-010-0511-1; Shivhare R, 2016, SCI REP-UK, V6, DOI 10.1038/srep23036; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Smit R, 2013, S AFR J BOT, V86, P182, DOI 10.1016/j.sajb.2013.02.162; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Tian Y, 2015, SCI CHINA LIFE SCI, V58, P627, DOI 10.1007/s11427-015-4872-x; Tricarico C, 2002, ANAL BIOCHEM, V309, P293, DOI 10.1016/S0003-2697(02)00311-1; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verma AR, 2009, FOOD CHEM TOXICOL, V47, P2196, DOI 10.1016/j.fct.2009.06.005; Volkov RA, 2003, J EXP BOT, V54, P2343, DOI 10.1093/jxb/erg244; Wan HJ, 2010, ANAL BIOCHEM, V399, P257, DOI 10.1016/j.ab.2009.12.008; Xu M, 2011, ANAL BIOCHEM, V408, P337, DOI 10.1016/j.ab.2010.08.044; Zhang L, 2013, INT J MOL SCI, V14, P24338, DOI 10.3390/ijms141224338; Zhu XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033013	49	73	84	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2016	11	8							e0159458	10.1371/journal.pone.0159458	http://dx.doi.org/10.1371/journal.pone.0159458			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6UQ	27541138	Green Published, Green Submitted, gold			2022-12-26	WOS:000381620200001
J	Marini, F; Squeri, V; Morasso, P; Konczak, J; Masia, L				Marini, Francesca; Squeri, Valentina; Morasso, Pietro; Konczak, Juergen; Masia, Lorenzo			Robot-Aided Mapping of Wrist Proprioceptive Acuity across a 3D Workspace	PLOS ONE			English	Article							JOINT POSITION SENSE; SENSORIMOTOR SYSTEM; UPPER EXTREMITY; MUSCLE; SHOULDER; RELIABILITY; MOVEMENT; RECOVERY; STROKE; MECHANORECEPTORS	Proprioceptive signals from peripheral mechanoreceptors form the basis for bodily perception and are known to be essential for motor control. However we still have an incomplete understanding of how proprioception differs between joints, whether it differs among the various degrees-of-freedom (DoFs) within a particular joint, and how such differences affect motor control and learning. We here introduce a robot-aided method to objectively measure proprioceptive function: specifically, we systematically mapped wrist proprioceptive acuity across the three DoFs of the wrist/hand complex with the aim to characterize the wrist position sense. Thirty healthy young adults performed an ipsilateral active joint position matching task with their dominant wrist using a haptic robotic exoskeleton. Our results indicate that the active wrist position sense acuity is anisotropic across the joint, with the abduction/adduction DoF having the highest acuity (the error of acuity for flexion/extension is 4.64 +/- 0.24 degrees; abduction/adduction: 3.68 +/- 0.32 degrees; supination/pronation: 5.15 +/- 0.37 degrees) and they also revealed that proprioceptive acuity decreases for smaller joint displacements. We believe this knowledge is imperative in a clinical scenario when assessing proprioceptive deficits and for understanding how such sensory deficits relate to observable motor impairments.	[Marini, Francesca; Squeri, Valentina; Morasso, Pietro] Ist Italiano Tecnol, Dept Robot Brain & Cognit Sci, Motor Learning & Robot Rehabil Lab, Genoa, Italy; [Konczak, Juergen] Univ Minnesota, Human Sensorimotor Control Lab, Sch Kinesiol, Minneapolis, MN USA; [Konczak, Juergen] Univ Minnesota, Ctr Clin Movement Sci, Minneapolis, MN USA; [Masia, Lorenzo] Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore, Singapore	Istituto Italiano di Tecnologia - IIT; University of Genoa; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Masia, L (corresponding author), Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore, Singapore.	lorenzo.masia@ntu.edu.sg	Konczak, Jürgen/J-4001-2019	Konczak, Jürgen/0000-0002-4422-5610	RBCS Dept. of the Istituto Italiano di Tecnologia	RBCS Dept. of the Istituto Italiano di Tecnologia	This research was supported by the RBCS Dept. of the Istituto Italiano di Tecnologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEGRUCCI M, 1995, J ORTHOP SPORT PHYS, V21, P220, DOI 10.2519/jospt.1995.21.4.220; Brindle TJ, 2004, J ORTHOP SPORT PHYS, V34, P468, DOI 10.2519/jospt.2004.34.8.468; BURKE D, 1988, J PHYSIOL-LONDON, V402, P347, DOI 10.1113/jphysiol.1988.sp017208; Cappello L, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00198; Coupar F, 2012, CLIN REHABIL, V26, P291, DOI 10.1177/0269215511420305; De Santis D, 2015, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01037; Debert CT, 2012, J NEUROL PHYS THER, V36, P58, DOI 10.1097/NPT.0b013e318254bd4f; Domingo A, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-167; Dukelow SP, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-72; Dukelow SP, 2010, NEUROREHAB NEURAL RE, V24, P178, DOI 10.1177/1545968309345267; Elangovan N, 2014, PHYS THER, V94, P553, DOI 10.2522/ptj.20130103; Erickson RIC, 2012, J ORTHOP RES, V30, P787, DOI 10.1002/jor.22007; Fuentes CT, 2010, J NEUROPHYSIOL, V103, P164, DOI 10.1152/jn.00494.2009; Gay A, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-5; Goble DJ, 2012, EXP BRAIN RES, V216, P35, DOI 10.1007/s00221-011-2904-8; Goble DJ, 2010, PHYS THER, V90, P1176, DOI 10.2522/ptj.20090399; Goble DJ, 2009, BEHAV BRAIN RES, V200, P7, DOI 10.1016/j.bbr.2008.11.034; Hagert E, 2005, J ORTHOP RES, V23, P757, DOI 10.1016/j.orthres.2005.01.011; Hagert E., 2008, WRIST LIGAMENTS INNE; Herter TM, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-43; Hospod V, 2007, J NEUROSCI, V27, P5172, DOI 10.1523/JNEUROSCI.0572-07.2007; Janwantanakul P, 2001, ARCH PHYS MED REHAB, V82, P840, DOI 10.1053/apmr.2001.21865; JOHANSSON H, 1991, J ELECTROMYOGR KINES, V1, P158, DOI 10.1016/1050-6411(91)90032-Z; King J, 2013, J MOTOR BEHAV, V45, P479, DOI 10.1080/00222895.2013.832136; Knoop J, 2011, OSTEOARTHR CARTILAGE, V19, P381, DOI 10.1016/j.joca.2011.01.003; Konczak J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002625; Langhorne P, 2009, LANCET NEUROL, V8, P741, DOI 10.1016/S1474-4422(09)70150-4; Lephart S M, 1994, J Shoulder Elbow Surg, V3, P371, DOI 10.1016/S1058-2746(09)80022-0; Lincoln NB, 1998, PHYSIOTHERAPY, V84, P358, DOI [10.1016/S0031-9406(05)61454-X, DOI 10.1016/S0031-9406(05)61454-X]; Lonn J, 2000, CLIN PHYSIOL, V20, P30; Masia L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007004; MATTHEWS PBC, 1988, CAN J PHYSIOL PHARM, V66, P430, DOI 10.1139/y88-073; MCCLOSKEY DI, 1978, PHYSIOL REV, V58, P763, DOI 10.1152/physrev.1978.58.4.763; NEUFELD SD, 1981, PHYS THER, V61, P1147, DOI 10.1093/ptj/61.8.1147; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Petrie S, 1997, J BONE JOINT SURG BR, V79B, P494, DOI 10.1302/0301-620X.79B3.7439; Proske U, 2012, PHYSIOL REV, V92, P1651, DOI 10.1152/physrev.00048.2011; PRUDHOMME MJL, 1994, J NEUROPHYSIOL, V72, P2280, DOI 10.1152/jn.1994.72.5.2280; Rand D, 1999, NEUROREHAB NEURAL RE, V13, P15, DOI 10.1177/154596839901300104; Riemann BL, 2002, J ATHL TRAINING, V37, P85; Riemann BL, 2002, J ATHL TRAINING, V37, P71; SANES JN, 1985, HUM NEUROBIOL, V4, P101; Schabrun SM, 2009, CLIN REHABIL, V23, P27, DOI 10.1177/0269215508098897; Schmidt RA, 1988, MOTOR CONTROL AND LE; Sjolander Per, 2002, J Electromyogr Kinesiol, V12, P167, DOI 10.1016/S1050-6411(02)00017-2; Squeri Valentina, 2011, IEEE Int Conf Rehabil Robot, V2011, P5975500, DOI 10.1109/ICORR.2011.5975500; Swinkels A, 2000, SPINE, V25, P98, DOI 10.1097/00007632-200001010-00017; WEI JY, 1986, BRAIN RES, V370, P108; Wilson ET, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011851; Windhorst U, 2007, BRAIN RES BULL, V73, P155, DOI 10.1016/j.brainresbull.2007.03.010; Winward CE, 2002, CLIN REHABIL, V16, P523, DOI 10.1191/0269215502cr522oa	51	24	24	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161155	10.1371/journal.pone.0161155	http://dx.doi.org/10.1371/journal.pone.0161155			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536882	Green Submitted, Green Published, gold			2022-12-26	WOS:000381577000061
J	Shu, XM; Peng, QL; Lu, X; Wang, GC				Shu, Xiaoming; Peng, Qinglin; Lu, Xin; Wang, Guochun			HMGB1 May Be a Biomarker for Predicting the Outcome in Patients with Polymyositis/Dermatomyositis with Interstitial Lung Disease	PLOS ONE			English	Article							IDIOPATHIC INFLAMMATORY MYOPATHIES; GROUP BOX PROTEIN-1; MYOCARDIAL-INFARCTION; MUSCLE REGENERATION; DERMATOMYOSITIS; POLYMYOSITIS; MYOSITIS; ANTIBODY; EXPRESSION; RECEPTOR	Objective To investigate the significance of high mobility group box 1 (HMGB1) levels in polymyositis (PM) and dermatomyositis (DM) patients with interstitial lung disease and whether HMGB1 levels could predict disease outcome. Methods HMGB1 levels were measured in sera from 34 patients with PM/DM and from 34 healthy controls by ELISA. Results Significantly higher serum levels of HMGB1 were found in patients with PM [12.75 ng/ml (4.34-25.07 ng/ml), p < 0.001] and DM [20.75 ng/ml (3.80-124.88 ng/ml), p < 0.001] than in healthy controls [5.64 ng/ml (2.71-8.71 ng/ml)]. Importantly, the average HMGB1 level in PM/DM patients with interstitial lung disease (ILD) was 25.84 ng/ml, which is significantly higher than that in PM/DM patients without ILD [12.68 ng/ml] (p < 0.05). A receiver operating characteristic (ROC) curve analysis revealed that the serum HMGB1 cutoff value that best discriminated PM/DM patients with ILD from those without ILD was 14.5ng/ml. The area under the curve was 0.87 +/- 0.05, and the 95% Confidence interval (CI) was 0.77-0.98. The diagnostic sensitivity and specificity of this serum HMGB1 cutoff level was 84.6% and 89% respectively. Patients with higher levels of HMGB1 expression had lower overall survival rates and disease-free survival rates, whereas patients with lower levels of HMGB1 expression had higher survival rates. Conclusion Multivariate analysis showed that HMGB1 expression is a prognostic indicator for patient survival. These data support the notion that HMGB1 overexpression is involved in PM/DM progression for patients with ILD and is relative to its poor clinical outcomes.	[Shu, Xiaoming; Peng, Qinglin; Lu, Xin; Wang, Guochun] China Japan Friendship Hosp, Dept Rheumatol, YingHua East Rd, Beijing 100029, Peoples R China	China-Japan Friendship Hospital	Wang, GC (corresponding author), China Japan Friendship Hosp, Dept Rheumatol, YingHua East Rd, Beijing 100029, Peoples R China.	guochunwang@hotmail.com	Ming, Shu Xiao/AAF-3356-2019	Shu, Xiao ming/0000-0001-5425-6157	General Program of the National Natural Science Foundation of China [81571603]; Major Research Plan of the National Natural Science of China [91542121]; Youth Program of the National Natural Science Foundation of China [81401363]; Capital Health Research and Development of Special Programs [2014-4-4062]; International Cooperation Project from State Ministry of Science and Technology of China [2014DFA31490]	General Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Research Plan of the National Natural Science of China(National Natural Science Foundation of China (NSFC)); Youth Program of the National Natural Science Foundation of China; Capital Health Research and Development of Special Programs; International Cooperation Project from State Ministry of Science and Technology of China	This study was funded by the General Program of the National Natural Science Foundation of China (Grant No. 81571603), the Major Research Plan of the National Natural Science of China (Grant No. 91542121), the Youth Program of the National Natural Science Foundation of China (Grant No. 81401363), the Capital Health Research and Development of Special Programs (Grant No. 2014-4-4062), and the International Cooperation Project from State Ministry of Science and Technology of China (Grant No. 2014DFA31490).	Abdulahad DA, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3332; Abeyama K, 2005, J CLIN INVEST, V115, P1267, DOI 10.1172/JCI200522782; Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; ARAHATA K, 1986, ANN NEUROL, V19, P112, DOI 10.1002/ana.410190203; Barnay-Verdier S, 2011, INTENS CARE MED, V37, P957, DOI 10.1007/s00134-011-2192-6; BOHAN A, 1975, NEW ENGL J MED, V292, P403, DOI 10.1056/NEJM197502202920807; Chauhan AK, 2015, J BIOL CHEM; Cseri K, 2015, J MUSCLE RES CELL M, V36, P255, DOI 10.1007/s10974-015-9411-7; Dalakas MC, 2003, LANCET, V362, P971, DOI 10.1016/S0140-6736(03)14368-1; DALAKAS MC, 1991, NEW ENGL J MED, V325, P1487, DOI 10.1056/NEJM199111213252107; De Mori R, 2007, ARTERIOSCL THROM VAS, V27, P2377, DOI 10.1161/ATVBAHA.107.153429; EMSLIESMITH AM, 1990, ANN NEUROL, V27, P343, DOI 10.1002/ana.410270402; Gono T, 2010, RHEUMATOLOGY, V49, P1713, DOI 10.1093/rheumatology/keq149; Grundtman C, 2010, FASEB J, V24, P570, DOI 10.1096/fj.09-144782; Harris HE, 2012, NAT REV RHEUMATOL, V8, P195, DOI 10.1038/nrrheum.2011.222; Hoshino K, 2010, RHEUMATOLOGY, V49, P1726, DOI 10.1093/rheumatology/keq153; Huh JW, 2007, RESP MED, V101, P1761, DOI 10.1016/j.rmed.2007.02.017; Ichikado K, 1997, AM J ROENTGENOL, V168, P333, DOI 10.2214/ajr.168.2.9016201; Kang R, 2011, AUTOPHAGY, V7, P904, DOI 10.4161/auto.7.8.15704; KISSEL JT, 1991, ARCH NEUROL-CHICAGO, V48, P26, DOI 10.1001/archneur.1991.00530130034016; Li CKC, 2004, J RHEUMATOL, V31, P605; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Marie I, 2002, ARTHRIT RHEUM-ARTHR, V47, P614, DOI 10.1002/art.10794; Marie I, 2011, ARTHRITIS RHEUM-US, V63, P3439, DOI 10.1002/art.30513; Muller S, 2001, EMBO J, V20, P4337, DOI 10.1093/emboj/20.16.4337; Nakamura Y, 2015, J ATHEROSCLER THROMB, V22, P570, DOI 10.5551/jat.27235; Nakashima R, 2010, RHEUMATOLOGY, V49, P433, DOI 10.1093/rheumatology/kep375; Pisetsky DS, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2440; Sundaram C, 2008, NEUROL INDIA, V56, P363, DOI 10.4103/0028-3886.43457; Takahashi M, 2015, J ATHEROSCLER THROMB, V22, P553, DOI 10.5551/jat.ED008; Tanizawa K, 2013, RESP MED, V107, P745, DOI 10.1016/j.rmed.2013.01.014; Vincze M, 2012, BEST PRACT RES CL RH, V26, P25, DOI 10.1016/j.berh.2012.01.013; Vitadello M, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2963; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Zong M, 2013, ANN RHEUM DIS, V72, P1390, DOI 10.1136/annrheumdis-2012-202207	35	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161436	10.1371/journal.pone.0161436	http://dx.doi.org/10.1371/journal.pone.0161436			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537498	Green Published, Green Submitted, gold			2022-12-26	WOS:000381577000107
J	Wang, XF; Wang, Y; Feng, LF; Tong, Y; Chen, ZJ; Ying, SB; Chen, TH; Li, T; Xia, HL; Jiang, ZQ; Shang, Q; Lou, XM; Lou, JL				Wang, Xiaofeng; Wang, Yu; Feng, Lingfang; Tong, Yan; Chen, Zhijian; Ying, Shibo; Chen, Tianhui; Li, Tao; Xia, Hailing; Jiang, Zhaoqiang; Shang, Qi; Lou, Xiaoming; Lou, Jianlin			Application of the Benchmark Dose (BMD) Method to Identify Thresholds of Cadmium-Induced Renal Effects in Non-Polluted Areas in China	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; URINARY CADMIUM; HYBRID APPROACH; REFERENCE LEVEL; EXPOSURE; DYSFUNCTION; BETA(2)-MICROGLOBULIN; POPULATION; EXCRETION; REGIONS	The benchmark dose (BMD) method has been increasingly used to assess the health risks of cadmium (Cd) in epidemiological studies. The aim of our study was to estimate the threshold levels of urinary Cd (UCd) using the BMD method in a general population of Jiangshan City, Zhejiang Province of China. In our study, a total of 934 people (469 men, 465 women) were recruited and morning urine samples were collected from all the participants. Levels of Cd, creatinine, and renal dysfunction indicators such as retinol binding protein (RBP), beta 2-microglobulin (beta 2-MG), and N-acetyl-b-glucosaminidase (NAG) in urine were detected for analysis of BMD and BMD low (BMDL) of UCd. RBP, beta 2-MG, and NAG in urine all correlated significantly (P < 0.001) with UCd except of age (P = 0.767). When the benchmark response (BMR) was 5%, the BMD/BMDL of UCd for RBP, beta 2-MG, and NAG was 1.69/0.89, 1.24/0.62, 0.85/0.49 mu g/g Cr in men and 1.70/0.76, 1.35/0.64, 1.36/0.65 mu g/g Cr in women, respectively. If the BMR was set at 10%, the BMD/BMDL of UCd for RBP, beta 2-MG, and NAG was 2.44/1.59, 2.09/1.30, 1.80/1.04 mu g/g Cr in men and 2.43/1.53, 2.10/1.34, 2.31/1.37 mu g/g Cr in women, respectively. Our results provided evidence for Cd-induced tubular effects in cadmium non-polluted areas in China. Both beta 2-MG and NAG were more sensitive than RBP in response to Cd exposure. But beta 2-MG was the most sensitive indicator in women, and NAG was the most sensitive one in men.	[Wang, Xiaofeng; Lou, Xiaoming] Zhejiang Prov Ctr Dis Control & Prevent, Dept Environm & Occupat Hlth, Hangzhou 310051, Zhejiang, Peoples R China; [Wang, Yu; Feng, Lingfang; Tong, Yan; Chen, Zhijian; Ying, Shibo; Chen, Tianhui; Li, Tao; Xia, Hailing; Jiang, Zhaoqiang; Lou, Jianlin] Zhejiang Acad Med Sci, Inst Occupat Dis, Hangzhou 310013, Zhejiang, Peoples R China; [Shang, Qi] Chinese Ctr Dis Control & Prevent, Inst Environm Hlth & Related Prod Safety, Beijing 100050, Peoples R China	Zhejiang Provincial Center for Disease Control & Prevention; Zhejiang Academy of Medical Sciences; Chinese Center for Disease Control & Prevention; National Institute of Environmental Health, Chinese Center for Disease Control & Prevention	Lou, XM (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Dept Environm & Occupat Hlth, Hangzhou 310051, Zhejiang, Peoples R China.; Lou, JL (corresponding author), Zhejiang Acad Med Sci, Inst Occupat Dis, Hangzhou 310013, Zhejiang, Peoples R China.	xmlou@cdc.zj.cn; jianlinlou@163.com	Chen, Tianhui/Y-3500-2018; Ying, Shibo/K-2514-2016	Chen, Tianhui/0000-0003-4677-0361; Ying, Shibo/0000-0001-5275-9383	National Natural Science Foundation of China [81472960, 81001242]; Medical Scientific Research of Zhejiang Province [2009A044]; Zhejiang Provincial Natural Science [LQ14H260003]; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents; Zhejiang Committee of Science and Technology [2015F10013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Scientific Research of Zhejiang Province; Zhejiang Provincial Natural Science; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents; Zhejiang Committee of Science and Technology	The authors acknowledge funding by the National Natural Science Foundation of China (81472960, 81001242), the Medical Scientific Research of Zhejiang Province (2009A044), the Zhejiang Provincial Natural Science (LQ14H260003), the Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents (2014), and the Zhejiang Committee of Science and Technology (2015F10013).	Akesson AA, 2005, ENVIRON HEALTH PERSP, V113, P1627, DOI 10.1289/ehp.8033; BERNARD A, 1995, OCCUP ENVIRON MED, V52, P177, DOI 10.1136/oem.52.3.177; BERNARD AM, 1987, CLIN CHEM, V33, P775; Boonprasert K, 2011, ENVIRON TOXICOL PHAR, V31, P416, DOI 10.1016/j.etap.2011.02.003; Chen L, 2006, TOXICOL APPL PHARM, V215, P93, DOI 10.1016/j.taap.2006.01.013; Chen X, 2013, FOOD CHEM TOXICOL, V55, P592, DOI 10.1016/j.fct.2013.01.044; CRUMP KS, 1984, FUND APPL TOXICOL, V4, P854, DOI 10.1016/0272-0590(84)90107-6; EFSA, 2009, SCI OP PAN CONT FOOD, V980; El Nahas AM, 2005, LANCET, V365, P331, DOI 10.1016/S0140-6736(05)17789-7; Environmental Protection Administration of China (EPAC), 1995, GB156181995 EPAC; *EPA, 1995, US BENCHM DOS APPR H; Ferguson MA, 2008, TOXICOLOGY, V245, P182, DOI 10.1016/j.tox.2007.12.024; Filipsson AF, 2003, CRIT REV TOXICOL, V33, P505, DOI 10.1080/10408440390242360; Hong F, 2004, BIOMETALS, V17, P573, DOI 10.1023/B:BIOM.0000045741.22924.d8; Ikeda M, 1992, IARC Sci Publ, P65; Jarup L, 2000, OCCUP ENVIRON MED, V57, P668, DOI 10.1136/oem.57.10.668; Jarup Lars, 1998, Scandinavian Journal of Work Environment and Health, V24, P1; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Jin TY, 2004, BIOMETALS, V17, P525, DOI 10.1023/B:BIOM.0000045732.91261.e2; Kim NH, 2015, J KOREAN MED SCI, V30, P272, DOI 10.3346/jkms.2015.30.3.272; Kobayashi E, 2008, TOXICOL LETT, V179, P108, DOI 10.1016/j.toxlet.2008.04.013; Kobayashi E, 2006, J APPL TOXICOL, V26, P351, DOI 10.1002/jat.1147; Liang YH, 2012, ENVIRON HEALTH PERSP, V120, P223, DOI 10.1289/ehp.1103699; Ministry of Health of the People's Republic of China (MOHC), 2012, GB27622012 MOHC; Miyata T, 1998, J AM SOC NEPHROL, V9, P1723; Moriguchi J, 2004, TOXICOL LETT, V148, P11, DOI 10.1016/j.toxlet.2003.11.009; Moriguchi J, 2003, TOXICOL LETT, V143, P279, DOI 10.1016/S0378-4274(03)00181-4; Moriguchi Jiro, 2005, Toxicological and Environmental Chemistry, V87, P119, DOI 10.1080/02772240400010389; Moriguchi J, 2009, TOXICOL LETT, V190, P1, DOI 10.1016/j.toxlet.2009.05.009; Oo YK, 2000, ARCH ENVIRON HEALTH, V55, P98, DOI 10.1080/00039890009603394; Rong Li-Ping, 2014, Zhongguo Dang Dai Er Ke Za Zhi, V16, P325; Sakuragi S, 2012, INT ARCH OCC ENV HEA, V85, P941, DOI 10.1007/s00420-012-0734-z; Sand S, 2008, J APPL TOXICOL, V28, P405, DOI 10.1002/jat.1298; Shao B, 2007, BIOMED ENVIRON SCI, V20, P460; Shimizu A, 2006, INT J ENVIRON HEAL R, V16, P329, DOI 10.1080/09603120600869174; Soderland P, 2010, ADV CHRONIC KIDNEY D, V17, P254, DOI 10.1053/j.ackd.2010.03.011; Suwazono Y, 2006, ENVIRON HEALTH PERSP, V114, P1072, DOI 10.1289/ehp.9028; Suwazono Y, 2011, INT J HYG ENVIR HEAL, V214, P175, DOI 10.1016/j.ijheh.2010.09.002; Suwazono Y, 2011, ENVIRON RES, V111, P312, DOI 10.1016/j.envres.2010.11.013; Suwazono Y, 2010, TOXICOL LETT, V198, P40, DOI 10.1016/j.toxlet.2010.04.015; TREVISAN A, 1994, INT ARCH OCC ENV HEA, V65, P373, DOI 10.1007/BF00383246; Van Vleet TR, 2003, SEMIN NEPHROL, V23, P500, DOI 10.1016/S0270-9295(03)00094-9; Wang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087817; Woo HD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126680; Zheng Laura, 2014, Curr Environ Health Rep, V1, P192	45	9	11	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161240	10.1371/journal.pone.0161240	http://dx.doi.org/10.1371/journal.pone.0161240			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537182	Green Published, Green Submitted, gold			2022-12-26	WOS:000381577000074
J	Caceres, PS; Mendez, M; Haque, MZ; Ortiz, PA				Caceres, Paulo S.; Mendez, Mariela; Haque, Mohammed Z.; Ortiz, Pablo A.			Vesicle-associated Membrane Protein 3 (VAMP3) Mediates Constitutive Trafficking of the Renal Co-transporter NKCC2 in Thick Ascending Limbs ROLE IN RENAL FUNCTION AND BLOOD PRESSURE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epithelial cell; exocytosis; kidney; membrane transport; Na-K-Cl cotransporter (NKCC); renal physiology; SNARE proteins; apical surface; blood pressure; urine excretion	NA-K-2CL COTRANSPORTER; BARTTERS-SYNDROME; COLLECTING DUCT; NA+-K+-2CL(-) COTRANSPORTER; SYNAPTIC VESICLES; TETANUS-TOXIN; HYPOKALEMIC ALKALOSIS; RECYCLING ENDOSOMES; SURFACE EXPRESSION; V-SNARES	Renal cells of the thick ascending limb (TAL) reabsorb NaCl via the apical Na+/K+/2Cl(-) co-transporter NKCC2. Trafficking of NKCC2 to the apical surface regulates NKCC2-mediated NaCl absorption and blood pressure. The molecular mechanisms by which NKCC2 reaches the apical surface and their role in renal function and maintenance of blood pressure are poorly characterized. Here we report that NKCC2 interacts with the vesicle fusion protein VAMP3, and they co-localize at the TAL apical surface. We observed that silencing VAMP3 in vivo blocks constitutive NKCC2 exocytic delivery, decreasing the amount of NKCC2 at the TAL apical surface. VAMP3 is not required for cAMP-stimulated NKCC2 exocytic delivery. Additionally, genetic deletion of VAMP3 in mice decreased total expression of NKCC2 in the TAL and lowered blood pressure. Consistent with these results, urinary excretion of water and electrolytes was higher in VAMP3 knock-out mice, which produced more diluted urine. We conclude that VAMP3 interacts with NKCC2 and mediates its constitutive exocytic delivery to the apical surface. Additionally, VAMP3 is required for normal NKCC2 expression, renal function, and blood pressure.	[Caceres, Paulo S.; Mendez, Mariela; Haque, Mohammed Z.; Ortiz, Pablo A.] Henry Ford Hosp, Hypertens & Vasc Res Div, Dept Internal Med, 2799 W Grand Blvd,E&R 7044, Detroit, MI 48202 USA; [Caceres, Paulo S.; Ortiz, Pablo A.] Wayne State Univ, Dept Psychol, 71 W Warren Ave, Detroit, MI 48202 USA; [Haque, Mohammed Z.] Hamad Med Corp, Acad Hlth Syst, Interim Translat Res Inst, Doha 16060, Qatar	Henry Ford Health System; Henry Ford Hospital; Wayne State University; Hamad Medical Corporation	Ortiz, PA (corresponding author), Henry Ford Hosp, Hypertens & Vasc Res Div, Dept Internal Med, 2799 W Grand Blvd,E&R 7044, Detroit, MI 48202 USA.	portiz1@hfhs.org	Mendez, Mariela/D-7033-2019	Mendez, Mariela/0000-0002-2537-7272; Ortiz, Pablo/0000-0002-7512-7255; Caceres, Paulo/0000-0003-0197-8177	National Institutes of Health [RO1 HL080409]; NRSA [F32 HL096346-01]; American Heart Association [13IRG14770033, 10PRE3710001, 12PRE12070224]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080409, F32HL096346, R01HL070985] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants RO1 HL080409 (to P. A. O.) and NRSA F32 HL096346-01 (to M. M.), American Heart Association Grant 13IRG14770033 (to P. A. O.), and American Heart Association predoctoral fellowships 10PRE3710001 and 12PRE12070224 (to P. S. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acuna R, 2011, J HYPERTENS, V29, P475, DOI 10.1097/HJH.0b013e328341d0fd; Adachi M, 2007, ENDOCR J, V54, P1003, DOI 10.1507/endocrj.K06-204; Advani RJ, 1999, J CELL BIOL, V146, P765, DOI 10.1083/jcb.146.4.765; Allen LAH, 2002, J LEUKOCYTE BIOL, V72, P217; Antonin W, 2000, MOL BIOL CELL, V11, P3289, DOI 10.1091/mbc.11.10.3289; Ares GR, 2008, AM J PHYSIOL-RENAL, V295, pF877, DOI 10.1152/ajprenal.00449.2007; Ares GR, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.386425; Ares GR, 2010, AM J PHYSIOL-RENAL, V299, pF1193, DOI 10.1152/ajprenal.00307.2010; Barile M, 2005, MOL CELL PROTEOMICS, V4, P1095, DOI 10.1074/mcp.M500049-MCP200; Bettinelli A, 2000, PEDIATR NEPHROL, V14, P940, DOI 10.1007/PL00013418; BETTINELLI A, 1992, J PEDIATR-US, V120, P38, DOI 10.1016/S0022-3476(05)80594-3; Bhattacharya S, 2002, P NATL ACAD SCI USA, V99, P13867, DOI 10.1073/pnas.202335999; Borisovska M, 2005, EMBO J, V24, P2114, DOI 10.1038/sj.emboj.7600696; Bugaj V, 2009, AM J PHYSIOL-RENAL, V297, pF1411, DOI 10.1152/ajprenal.00371.2009; Caceres PS, 2014, J BIOL CHEM, V289, P23951, DOI 10.1074/jbc.M114.589333; Caceres PS, 2009, J BIOL CHEM, V284, P24965, DOI 10.1074/jbc.M109.037135; Daro E, 1996, P NATL ACAD SCI USA, V93, P9559, DOI 10.1073/pnas.93.18.9559; Deak F, 2006, J NEUROSCI, V26, P6668, DOI 10.1523/JNEUROSCI.5272-05.2006; ELLISON DH, 1989, J CLIN INVEST, V83, P113, DOI 10.1172/JCI113847; FRANKI N, 1995, AM J PHYSIOL-CELL PH, V269, pC797, DOI 10.1152/ajpcell.1995.269.3.C797; Fredj NB, 2009, NAT NEUROSCI, V12, P751, DOI 10.1038/nn.2317; Fukuyama S, 2003, KIDNEY INT, V64, P808, DOI 10.1046/j.1523-1755.2003.00163.x; GALLI T, 1994, J CELL BIOL, V125, P1015, DOI 10.1083/jcb.125.5.1015; GAMBA G, 1993, P NATL ACAD SCI USA, V90, P2749, DOI 10.1073/pnas.90.7.2749; Gouraud S, 2002, J CELL SCI, V115, P3667, DOI 10.1242/jcs.00053; Groemer TW, 2007, NAT NEUROSCI, V10, P145, DOI 10.1038/nn1831; Haque MZ, 2011, AM J PHYSIOL-RENAL, V300, pF1096, DOI 10.1152/ajprenal.00600.2010; Hua YF, 2010, NAT NEUROSCI, V13, P1451, DOI 10.1038/nn.2695; Jaykumar AB, 2016, AM J PHYSIOL-RENAL, V310, pF183, DOI 10.1152/ajprenal.00104.2015; Kim GH, 1999, AM J PHYSIOL-RENAL, V276, pF96, DOI 10.1152/ajprenal.1999.276.1.F96; Kurtz CL, 1997, J AM SOC NEPHROL, V8, P1706; LINK E, 1993, J BIOL CHEM, V268, P18423; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Martin S, 1996, J CELL BIOL, V134, P625, DOI 10.1083/jcb.134.3.625; MATSUMOTO J, 1989, AM J ROENTGENOL, V152, P1251, DOI 10.2214/ajr.152.6.1251; MCCREDIE DA, 1974, AUST PAEDIATR J, V10, P286; MCMAHON HT, 1993, NATURE, V364, P346, DOI 10.1038/364346a0; Mendez M, 2011, J BIOL CHEM, V286, P28608, DOI 10.1074/jbc.M111.225839; Millar CA, 1999, MOL BIOL CELL, V10, P3675, DOI 10.1091/mbc.10.11.3675; Monette MY, 2011, AM J PHYSIOL-RENAL, V300, pF840, DOI 10.1152/ajprenal.00552.2010; Nielsen S, 1998, AM J PHYSIOL-RENAL, V275, pF885, DOI 10.1152/ajprenal.1998.275.6.F885; OHLSSON A, 1984, ACTA PAEDIATR SCAND, V73, P868, DOI 10.1111/j.1651-2227.1984.tb17793.x; Ortiz PA, 2006, AM J PHYSIOL-RENAL, V290, pF608, DOI 10.1152/ajprenal.00248.2005; Ortiz PA, 2003, KIDNEY INT, V63, P1141, DOI 10.1046/j.1523-1755.2003.00827.x; Paredes A, 2006, AM J PHYSIOL-RENAL, V290, pF1094, DOI 10.1152/ajprenal.00071.2005; Procino G, 2008, J CELL SCI, V121, P2097, DOI 10.1242/jcs.022210; Puri C, 2013, CELL, V154, P1285, DOI 10.1016/j.cell.2013.08.044; Randhawa VK, 2000, MOL BIOL CELL, V11, P2403, DOI 10.1091/mbc.11.7.2403; REIF MC, 1986, J CLIN INVEST, V77, P1291, DOI 10.1172/JCI112433; Riggs KA, 2012, J CELL SCI, V125, P3827, DOI 10.1242/jcs.102566; Sara Y, 2005, NEURON, V45, P563, DOI 10.1016/j.neuron.2004.12.056; Schraw TD, 2003, BLOOD, V102, P1716, DOI 10.1182/blood-2003-01-0331; Schwenk RW, 2010, DIABETOLOGIA, V53, P2209, DOI 10.1007/s00125-010-1832-7; Sevilla L, 1997, ENDOCRINOLOGY, V138, P3006, DOI 10.1210/en.138.7.3006; Simon DB, 1996, NAT GENET, V13, P183, DOI 10.1038/ng0696-183; Starremans PGJF, 2003, J AM SOC NEPHROL, V14, P1419, DOI 10.1097/01.ASN.0000064948.39199.A0; Takahashi N, 2000, P NATL ACAD SCI USA, V97, P5434, DOI 10.1073/pnas.090091297; Vargas-Poussou R, 1998, AM J HUM GENET, V62, P1332, DOI 10.1086/301872; Wang CC, 2010, MOL CELL BIOL, V30, P333, DOI 10.1128/MCB.00814-09; Wilhelm BG, 2010, NAT NEUROSCI, V13, P1454, DOI 10.1038/nn.2690; Yamazaki Y, 2013, EMBO J, V32, P524, DOI 10.1038/emboj.2013.1; Yang CM, 2001, MOL CELL BIOL, V21, P1573, DOI 10.1128/MCB.21.5.1573-1580.2001; Zaarour N, 2009, J BIOL CHEM, V284, P21752, DOI 10.1074/jbc.M109.000679; Zhao P, 2009, J CELL SCI, V122, P3472, DOI 10.1242/jcs.047449	64	13	15	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22063	22073		10.1074/jbc.M116.735167	http://dx.doi.org/10.1074/jbc.M116.735167			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27551042	Green Published, hybrid			2022-12-26	WOS:000386332600021
J	Cheng, YF; Tong, MJ; Edge, ASB				Cheng, Yen-Fu; Tong, Mingjie; Edge, Albert S. B.			Destabilization of Atoh1 by E3 Ubiquitin Ligase Huwe1 and Casein Kinase 1 Is Essential for Normal Sensory Hair Cell Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN INNER-EAR; BETA-CATENIN; NEURAL DIFFERENTIATION; PROGENITOR CELLS; STEM-CELLS; NULL MICE; PROLIFERATION; DEGRADATION; EPITHELIA; PROTEIN	Proneural basic helix-loop-helix transcription factor, Atoh1, plays a key role in the development of sensory hair cells. We show here that the level of Atoh1 must be accurately controlled by degradation of the protein in addition to the regulation of Atoh1 gene expression to achieve normal cellular patterning during development of the cochlear sensory epithelium. The stability of Atoh1 was regulated by the ubiquitin proteasome system through the action of Huwe1, a HECT-domain, E3 ubiquitin ligase. An interaction between Huwe1 and Atoh1 could be visualized by a proximity ligation assay and was confirmed by co-immunoprecipitation and mass spectrometry. Transfer of a lysine 48-linked polyubiquitin chain to Atoh1 by Huwe1 could be demonstrated both in intact cells and in a cell-free system, and proteasome inhibition or Huwe1 silencing increased Atoh1 levels. The interaction with Huwe1 and polyubiquitylation were blocked by disruption of casein kinase 1 (CK1) activity, and mass spectrometry and mutational analysis identified serine 334 as an important phosphorylation site for Atoh1 ubiquitylation and subsequent degradation. Phosphorylation by CK1 thus targeted the protein for degradation. Development of an extra row of inner hair cells in the cochlea and an approximate doubling in the number of afferent synapses was observed after embryonic or early postnatal deletion of Huwe1 in cochlear-supporting cells, and hair cells died in the early postnatal period when Huwe1 was knocked out in the developing cochlea. These data indicate that the regulation of Atoh1 by the ubiquitin proteasome pathway is necessary for hair cell fate determination and survival.	[Cheng, Yen-Fu; Edge, Albert S. B.] Harvard Univ, Program Speech & Hearing Biosci & Technol, Cambridge, MA 02138 USA; [Cheng, Yen-Fu; Edge, Albert S. B.] MIT, Cambridge, MA 02138 USA; [Cheng, Yen-Fu; Tong, Mingjie; Edge, Albert S. B.] Massachusetts Eye & Ear Infirm, Eaton Peabody Lab, Boston, MA 02114 USA; [Cheng, Yen-Fu; Tong, Mingjie; Edge, Albert S. B.] Harvard Med Sch, Dept Otol & Laryngol, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School	Edge, ASB (corresponding author), Harvard Med Sch, Massachusetts Eye & Ear Infirm, Eaton Peabody Lab, 243 Charles St, Boston, MA 02114 USA.	albert_edge@meei.harvard.edu	Edge, Albert/Q-5448-2019	Cheng, Yen-Fu/0000-0003-1995-5854	National Institutes of Health [RO1 DC007174, P30 DC005209]; American Hearing Research Foundation; Yen Tjing Ling Medical Foundation (Taiwan); Amelia-Peabody Foundation; Shulsky Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC005209, R01DC007174] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Hearing Research Foundation; Yen Tjing Ling Medical Foundation (Taiwan); Amelia-Peabody Foundation; Shulsky Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DC007174 and P30 DC005209 (NIDCD). This work was also supported by the American Hearing Research Foundation, the Yen Tjing Ling Medical Foundation (Taiwan), the Amelia-Peabody Foundation, the Shulsky Foundation, David H. Koch, and Robert Boucai. The authors declare that they have no conflicts of interest with the contents of this paper. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adhikary S, 2005, CELL, V123, P409, DOI 10.1016/j.cell.2005.08.016; Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Basch ML, 2011, J NEUROSCI, V31, P8046, DOI 10.1523/JNEUROSCI.6671-10.2011; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Bossuyt W, 2009, PLOS BIOL, V7, P301, DOI 10.1371/journal.pbio.1000040; Bramhall NF, 2014, STEM CELL REP, V2, P311, DOI 10.1016/j.stemcr.2014.01.008; Cai TT, 2013, J NEUROSCI, V33, P10110, DOI 10.1523/JNEUROSCI.5606-12.2013; Chen DL, 2010, NATURE, V464, P624, DOI 10.1038/nature08820; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Chen P, 2002, DEVELOPMENT, V129, P2495; de Groot REA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004985; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; FORGE A, 1993, SCIENCE, V259, P1616, DOI 10.1126/science.8456284; Forget A, 2014, DEV CELL, V29, P649, DOI 10.1016/j.devcel.2014.05.014; Fritzsch B, 2005, DEV DYNAM, V233, P570, DOI 10.1002/dvdy.20370; Froyen G, 2012, AM J HUM GENET, V91, P252, DOI 10.1016/j.ajhg.2012.06.010; Hall JR, 2007, MOL BIOL CELL, V18, P3340, DOI 10.1091/mbc.E07-02-0173; Hao ZY, 2012, J EXP MED, V209, P173, DOI 10.1084/jem.20111363; Herold S, 2008, EMBO J, V27, P2851, DOI 10.1038/emboj.2008.200; Inoue S, 2013, GENE DEV, V27, P1101, DOI 10.1101/gad.214577.113; Jeon SJ, 2011, J NEUROSCI, V31, P8351, DOI 10.1523/JNEUROSCI.6366-10.2011; Kalinec GM, 2003, AUDIOL NEURO-OTOL, V8, P177, DOI 10.1159/000071059; Kelley MW, 2006, NAT REV NEUROSCI, V7, P837, DOI 10.1038/nrn1987; Kelly MC, 2012, J NEUROSCI, V32, P6699, DOI 10.1523/JNEUROSCI.5420-11.2012; Matei V, 2005, DEV DYNAM, V234, P633, DOI 10.1002/dvdy.20551; Millimaki BB, 2007, DEVELOPMENT, V134, P295, DOI 10.1242/dev.02734; Naujokat C, 2007, STEM CELLS, V25, P2408, DOI 10.1634/stemcells.2007-0255; Noy T, 2012, BIOCHEM BIOPH RES CO, V418, P408, DOI 10.1016/j.bbrc.2012.01.045; Parker MA, 2014, HUM GENE THER METHOD, V25, P1, DOI 10.1089/hgtb.2013.014; Parsons JL, 2009, EMBO J, V28, P3207, DOI 10.1038/emboj.2009.243; Shi FX, 2013, P NATL ACAD SCI USA, V110, P13851, DOI 10.1073/pnas.1219952110; Shi FX, 2010, J BIOL CHEM, V285, P392, DOI 10.1074/jbc.M109.059055; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stegmuller Judith, 2010, F1000 Biol Rep, V2, DOI 10.3410/B2-38; Tai HC, 2008, NAT REV NEUROSCI, V9, P826, DOI 10.1038/nrn2499; Tan MKM, 2013, MOL CELL, V52, P9, DOI 10.1016/j.molcel.2013.08.018; Tsuchiya K, 2007, GASTROENTEROLOGY, V132, P208, DOI 10.1053/j.gastro.2006.10.031; van Noort M, 2007, BLOOD, V110, P2778, DOI 10.1182/blood-2007-05-092445; Wang XZ, 2014, BIOCHEM BIOPH RES CO, V444, P549, DOI 10.1016/j.bbrc.2014.01.075; WARCHOL ME, 1993, SCIENCE, V259, P1619, DOI 10.1126/science.8456285; Westbrook TF, 2008, NATURE, V452, P370, DOI 10.1038/nature06780; Yamamoto N, 2011, DEV BIOL, V353, P367, DOI 10.1016/j.ydbio.2011.03.016; Yuan YS, 2014, JARO-J ASSOC RES OTO, V15, P31, DOI 10.1007/s10162-013-0419-7; Zhang J, 2011, GENE DEV, V25, P2610, DOI 10.1101/gad.170605.111; Zhang XX, 2013, STEM CELLS, V31, P2667, DOI 10.1002/stem.1371; Zhao XD, 2008, NAT CELL BIOL, V10, P643, DOI 10.1038/ncb1727; Zhao X, 2009, DEV CELL, V17, P210, DOI 10.1016/j.devcel.2009.07.009; Zheng JL, 2000, NAT NEUROSCI, V3, P580, DOI 10.1038/75753; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	51	16	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					21096	21109		10.1074/jbc.M116.722124	http://dx.doi.org/10.1074/jbc.M116.722124			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27542412	Green Published, hybrid			2022-12-26	WOS:000385406200025
J	Liu, QY; Liu, F; Yu, KL; Tas, R; Grigoriev, I; Remmelzwaal, S; Serra-Marques, A; Kapitein, LC; Heck, AJR; Akhmanova, A				Liu, Qingyang; Liu, Fan; Yu, Ka Lou; Tas, Roderick; Grigoriev, Ilya; Remmelzwaal, Sanne; Serra-Marques, Andrea; Kapitein, Lukas C.; Heck, Albert J. R.; Akhmanova, Anna			MICAL3 Flavoprotein Monooxygenase Forms a Complex with Centralspindlin and Regulates Cytokinesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; cytokinesis; mass spectrometry (MS); microtubule; protein cross-linking; centralspindlin; flavoprotein monooxygenase; midbody; vesicle transport	RAB8; MEMBRANE; MIDBODY; TRANSPORT; ABSCISSION; GTPASE; ACTIN; CELLS; MICROTUBULES; SPECTRIN	During cytokinesis, the antiparallel array of microtubules forming the central spindle organizes the midbody, a structure that anchors the ingressed cleavage furrow and guides the assembly of abscission machinery. Here, we identified a role for the flavoprotein monooxygenase MICAL3, an actin disassembly factor, in organizing midbody-associated protein complexes. By combining cell biological assays with cross-linking mass spectrometry, we show that MICAL3 is recruited to the central spindle and the midbody through a direct interaction with the centralspindlin component MKLP1. Knock-out of MICAL3 leads to an increased frequency of cytokinetic failure and a delayed abscission. In a mechanism independent of its enzymatic activity, MICAL3 targets the adaptor protein ELKS and Rab8A-positive vesicles to the midbody, and the depletion of ELKS and Rab8A also leads to cytokinesis defects. We propose that MICAL3 acts as a midbody-associated scaffold for vesicle targeting, which promotes maturation of the intercellular bridge and abscission.	[Liu, Qingyang; Yu, Ka Lou; Tas, Roderick; Grigoriev, Ilya; Remmelzwaal, Sanne; Serra-Marques, Andrea; Kapitein, Lukas C.; Akhmanova, Anna] Univ Utrecht, Fac Sci, Cell Biol, Padualaan 8, NL-3584 CH Utrecht, Netherlands; [Liu, Fan; Heck, Albert J. R.] Univ Utrecht, Bijvoet Ctr Biomol Res, Biomol Mass Spectrometry & Prote, NL-3584 CH Utrecht, Netherlands; [Liu, Fan; Heck, Albert J. R.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CH Utrecht, Netherlands; [Yu, Ka Lou] Agcy Sci Technol & Res, Inst Med Biol, 8a Biomed Grove,06-06 Immunos, Singapore 138648, Singapore; [Serra-Marques, Andrea] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA	Utrecht University; Utrecht University; Utrecht University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); University of California System; University of California San Francisco	Akhmanova, A (corresponding author), Univ Utrecht, Fac Sci, Cell Biol, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	a.akhmanova@uu.nl	Kapitein, Lukas C/J-4776-2016; Heck, Albert/D-7098-2011	Kapitein, Lukas C/0000-0001-9418-6739; Heck, Albert/0000-0002-2405-4404; Liu, Fan/0000-0002-2358-549X; Yu, Ka Lou (Carol)/0000-0002-4960-5399; Tas, Roderick/0000-0003-3111-8784	Netherlands Organization for Scientific Research Grant CW ECHO [711.011.005]; Proteins@Work, a program of the Netherlands Proteomics Centre - Netherlands Organization for Scientific Research (NWO) [184.032.201]	Netherlands Organization for Scientific Research Grant CW ECHO; Proteins@Work, a program of the Netherlands Proteomics Centre - Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by Netherlands Organization for Scientific Research Grant CW ECHO 711.011.005 (to A. A. and A. J. R. H.) and Proteins@Work, a program of the Netherlands Proteomics Centre financed by the Netherlands Organization for Scientific Research (NWO) as part of the National Roadmap Large-scale Research Facilities of the Netherlands Project Number 184.032.201. The authors declare that they have no conflicts of interest with the contents of this article.	Albertson R, 2005, TRENDS CELL BIOL, V15, P92, DOI 10.1016/j.tcb.2004.12.008; Ang AL, 2003, J CELL BIOL, V163, P339, DOI 10.1083/jcb.200307046; Baines AJ, 2009, BIOCHEM SOC T, V37, P796, DOI 10.1042/BST0370796; Bassi ZI, 2013, P NATL ACAD SCI USA, V110, P9782, DOI 10.1073/pnas.1301328110; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bennett V, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003012; Dambournet D, 2011, NAT CELL BIOL, V13, P981, DOI 10.1038/ncb2279; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; Fukuda M, 2008, MOL CELL PROTEOMICS, V7, P1031, DOI 10.1074/mcp.M700569-MCP200; Giridharan SSP, 2014, ANTIOXID REDOX SIGN, V20, P2059, DOI 10.1089/ars.2013.5487; Glotzer M, 2009, NAT REV MOL CELL BIO, V10, P9, DOI 10.1038/nrm2609; Goss JW, 2008, J CELL BIOL, V181, P1047, DOI 10.1083/jcb.200712137; Gould GW, 2016, SEMIN CELL DEV BIOL, V53, P64, DOI 10.1016/j.semcdb.2015.12.012; Green RA, 2012, ANNU REV CELL DEV BI, V28, P29, DOI 10.1146/annurev-cellbio-101011-155718; Grigoriev I, 2007, DEV CELL, V13, P305, DOI 10.1016/j.devcel.2007.06.010; Grigoriev I, 2011, CURR BIOL, V21, P967, DOI 10.1016/j.cub.2011.04.030; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; Guizetti J, 2011, SCIENCE, V331, P1616, DOI 10.1126/science.1201847; Henry L, 2008, MOL BIOL CELL, V19, P2059, DOI 10.1091/mbc.E07-09-0902; Hida Y, 2010, J BIOCHEM, V148, P131, DOI 10.1093/jb/mvq065; Joseph N, 2012, EMBO J, V31, P2604, DOI 10.1038/emboj.2012.139; Kao AH, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002212; Kaplan A, 2011, J CELL SCI, V124, P3989, DOI 10.1242/jcs.085407; Knodler A, 2010, P NATL ACAD SCI USA, V107, P6346, DOI 10.1073/pnas.1002401107; Kolk SM, 2007, ADV EXP MED BIOL, V600, P38; Kouranti I, 2006, CURR BIOL, V16, P1719, DOI 10.1016/j.cub.2006.07.020; Liu F, 2015, NAT METHODS, V12, P1179, DOI 10.1038/nmeth.3603; Makyio H, 2012, EMBO J, V31, P2590, DOI 10.1038/emboj.2012.89; Maliga Z, 2013, NAT CELL BIOL, V15, P325, DOI 10.1038/ncb2689; Mierzwa B, 2014, DEV CELL, V31, P525, DOI 10.1016/j.devcel.2014.11.006; Neef R, 2006, CURR BIOL, V16, P301, DOI 10.1016/j.cub.2005.12.030; Peranen J, 1996, J CELL BIOL, V135, P153, DOI 10.1083/jcb.135.1.153; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reinecke JB, 2015, TRAFFIC, V16, P48, DOI 10.1111/tra.12234; Schiel JA, 2013, CURR OPIN CELL BIOL, V25, P92, DOI 10.1016/j.ceb.2012.10.012; Schiel JA, 2012, NAT CELL BIOL, V14, P1068, DOI 10.1038/ncb2577; Schmidt EF, 2008, J NEUROSCI, V28, P2287, DOI 10.1523/JNEUROSCI.5646-07.2008; Terman JR, 2002, CELL, V109, P887, DOI 10.1016/S0092-8674(02)00794-8; White EA, 2012, CYTOSKELETON, V69, P882, DOI 10.1002/cm.21065; Zhao WM, 2006, MOL BIOL CELL, V17, P3881, DOI 10.1091/mbc.E06-01-0015	41	17	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20617	20629		10.1074/jbc.M116.748186	http://dx.doi.org/10.1074/jbc.M116.748186			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27528609	Green Published, hybrid			2022-12-26	WOS:000384574800026
J	Jatoba, LD; Varela, RM; Molinillo, JMG; Din, ZU; Gualtieri, SCJ; Rodrigues, E; Macias, FA				Jatoba, Luciana de Jesus; Maria Varela, Rosa; Gonzalez Molinillo, Jose Maria; Din, Zia Ud; Juliano Gualtieri, Sonia Cristina; Rodrigues-Filho, Edson; Antonio Macias, Francisco			Allelopathy of Bracken Fern (Pteridium arachnoideum): New Evidence from Green Fronds, Litter, and Soil	PLOS ONE			English	Article							RAIN-FOREST; CONDENSED TANNINS; PROANTHOCYANIDIN; AQUILINUM; DYNAMICS; DECOMPOSITION; PHENOLICS; ALTITUDE	The neotropical bracken fern Pteridium arachnoideum (Kaulf.) Maxon. (Dennstaedtiaceae) is described as an aggressive pioneer plant species. It invades abandoned or newly burned areas and represents a management challenge at these invaded sites. Native to the Atlantic Forest and Cerrado (Tropical Savanna) Brazilian biomes, P. arachnoideum has nevertheless become very problematic in these conservation hotspots. Despite some reports suggesting a possible role of allelopathy in this plant's dominance, until now there has been little evidence of isolated and individually identified compounds with phytotoxic activities present in its tissues or in the surrounding environment. Thus, the aim of this study was to investigate the allelopathic potential of P. arachnoideum by isolating and identifying any secondary metabolites with phytotoxic activity in its tissues, litter, and soil. Bioguided phytochemical investigation led to the isolation and identification of the proanthocyanidin selligueain A as the major secondary compound in the green fronds and litter of this fern. It is produced by P. arachnoideum in its green fronds, remains unaltered during the senescence process, and is the major secondary compound present in litter. Selligueain A showed phytotoxic activity against the selected target species sesame (Sesamum indicum) early development. In particular, the compound inhibited root and stem growth, and root metaxylem cell size but did not affect chlorophyll content. This compound can be considered as an allelochemical because it is present in the soil under P. arachnoideum patches as one of the major compounds in the soil solution. This is the first report of the presence of selligueain A in any member of the Dennstaedtiaceae family and the first time an isolated and identified allelochemical produced by members of the Pteridium species complex has been described. This evidence of selligueain A as a putative allelochemical of P. arachnoideum reinforces the role of allelopathy in the dominance processes of this plant in the areas where it occurs.	[Jatoba, Luciana de Jesus; Juliano Gualtieri, Sonia Cristina; Antonio Macias, Francisco] Univ Fed Sao Carlos UFSCar, Dept Bot, Lab Plant Phytochem & Reprod Ecophysiol Studies, Sao Carlos, SP, Brazil; [Maria Varela, Rosa; Gonzalez Molinillo, Jose Maria; Antonio Macias, Francisco] Univ Cadiz UCA, Fac Ciencias, Dept Organ Chem, Cadiz Allelopathy Grp GAC, Cadiz, Spain; [Din, Zia Ud; Rodrigues-Filho, Edson] Univ Fed Sao Carlos UFSCar, Dept Chem, Lab Micromol Biochem Microorganisms LaBioMMi, Sao Carlos, SP, Brazil	Universidade Federal de Sao Carlos; Universidad de Cadiz; Universidade Federal de Sao Carlos	Jatoba, LD (corresponding author), Univ Fed Sao Carlos UFSCar, Dept Bot, Lab Plant Phytochem & Reprod Ecophysiol Studies, Sao Carlos, SP, Brazil.	lujatoba.bio@gmail.com	Rodrigues-Filho, Edson/M-7657-2019; Macias, Francisco A./W-2568-2018; Molinillo, José María González/B-9373-2013	Macias, Francisco A./0000-0001-8862-2864; Molinillo, José María González/0000-0002-7844-9401; Ud Din, Zia/0000-0002-1491-7149	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [BEX 13753/12-6]; Ministerio de Economia y Competitividad [AGL2013-42238-R]; Consejeria de Economia Innovacion y Ciencia, Junta de Andalucia [DP12-TEP-725]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Ministerio de Economia y Competitividad(Spanish Government); Consejeria de Economia Innovacion y Ciencia, Junta de Andalucia(Junta de Andalucia); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was possible thanks to Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (http://www.capes.gov.br/) funding awarded to LJJ (Social Demand and Abroad Doctoral Internship - BEX 13753/12-6). All analyses performed in Spain were funded by Ministerio de Economia y Competitividad (http://www.mineco.gob.es/; AGL2013-42238-R) and Consejeria de Economia Innovacion y Ciencia, Junta de Andalucia (http://www.juntadeandalucia.es/organismos/empleoempresaycomercio.html; DP12-TEP-725) grants awarded to FAM. Analyses performed in Brazil were funded by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (http://www.capes.gov.br/), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://cnpq.br/), and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (http://www.fapesp.br/) grants awarded to SCJG and ERF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adie H, 2011, PLANT ECOL, V212, P2013, DOI 10.1007/s11258-011-9945-8; Alonso-Amelot ME, 2004, BIOCHEM SYST ECOL, V32, P969, DOI 10.1016/j.bse.2004.03.005; Alonso-Amelot ME, 2001, PURE APPL CHEM, V73, P549, DOI 10.1351/pac200173030549; Alonso-Amelot ME, 2007, BIOCHEM SYST ECOL, V35, P1, DOI 10.1016/j.bse.2006.04.013; Anese S, 2015, IND CROP PROD, V74, P28, DOI 10.1016/j.indcrop.2015.04.042; BAEK NI, 1993, J NAT PROD, V56, P1532, DOI 10.1021/np50099a011; BARNES JD, 1992, ENVIRON EXP BOT, V32, P85, DOI 10.1016/0098-8472(92)90034-Y; Blair AC, 2009, BIOL INVASIONS, V11, P325, DOI 10.1007/s10530-008-9250-1; Catford JA, 2009, DIVERS DISTRIB, V15, P22, DOI 10.1111/j.1472-4642.2008.00521.x; Cipollini D, 2012, J CHEM ECOL, V38, P714, DOI 10.1007/s10886-012-0133-7; Coq S, 2010, ECOLOGY, V91, P2080, DOI 10.1890/09-1076.1; da Costa RMG, 2012, J HAZARD MATER, V203, P1, DOI 10.1016/j.jhazmat.2011.12.046; DeLuca TH, 2013, PLANT SOIL, V367, P521, DOI 10.1007/s11104-012-1484-0; Der JP, 2009, AM J BOT, V96, P1041, DOI 10.3732/ajb.0800333; Dolan L, 2004, CURR OPIN PLANT BIOL, V7, P33, DOI 10.1016/j.pbi.2003.11.006; Duke SO, 2015, WEED SCI, V63, P121, DOI 10.1614/WS-D-13-00130.1; Ebrahimnejad H., 2014, RECENT ADV REDOX ACT, P211, DOI [10.1007/978-94-017-8953-0_8, DOI 10.1007/978-94-017-8953-0_8]; Einhellig F. A., 1986, The science of allelopathy, P171; Flores-De-Santiago F, 2012, MAR ECOL PROG SER, V444, P57, DOI 10.3354/meps09474; Fridley JD, 2014, GLOBAL ECOL BIOGEOGR, V23, P1157, DOI 10.1111/geb.12221; Fu CL, 2013, MOLECULES, V18, P4282, DOI 10.3390/molecules18044282; Gatti AB, 2010, ACTA BOT BRAS, V24, P454, DOI 10.1590/S0102-33062010000200016; Ghorbani J, 2007, LAND DEGRAD DEV, V18, P659, DOI 10.1002/ldr.804; Ghorbani J, 2006, APPL VEG SCI, V9, P127, DOI 10.1111/j.1654-109X.2006.tb00662.x; GLASS ADM, 1976, CAN J BOT, V54, P2440, DOI 10.1139/b76-259; Greer MJ, 2014, PLANT SOIL, V385, P165, DOI 10.1007/s11104-014-2209-3; Grossnickle SC, 2012, NEW FOREST, V43, P711, DOI 10.1007/s11056-012-9336-6; Hattenschwiler S, 2010, J ECOL, V98, P754, DOI 10.1111/j.1365-2745.2010.01671.x; Kraus TEC, 2003, PLANT SOIL, V256, P41, DOI 10.1023/A:1026206511084; Lohbeck M, 2014, FUNCT ECOL, V28, P1052, DOI 10.1111/1365-2435.12240; Macias FA, 2000, J AGR FOOD CHEM, V48, P2512, DOI 10.1021/jf9903051; Maren IE, 2008, BIOL CONSERV, V141, P1032, DOI 10.1016/j.biocon.2008.01.012; Miatto RC, 2011, FLORA, V206, P757, DOI 10.1016/j.flora.2010.12.001; Miranda MAFM, 2015, J NAT PROD, V78, P1083, DOI 10.1021/acs.jnatprod.5b00040; Moctezuma C, 2014, J CHEM ECOL, V40, P458, DOI 10.1007/s10886-014-0431-3; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nakashima S, 2012, PHYTOCHEMISTRY, V83, P144, DOI 10.1016/j.phytochem.2012.07.011; Orrock JL, 2015, ECOLOGY, V96, P1052, DOI 10.1890/14-0732.1; Parry C, 2014, PLANT CELL ENVIRON, V37, P2508, DOI 10.1111/pce.12324; Prakash AS, 2006, NAT TOXINS, V4, P221, DOI [10.1002/(SICI)(1996)4:5&LT;221::AID-NT4&GT;3.0.CO;2-Q, DOI 10.1002/(SICI)(1996)4:5&LT;221::AID-NT4&GT;3.0.CO;2-Q, DOI 10.1002/(SICI)(1996)4:5<221::AID-NT4>3.0.CO;2-Q]; Rice E. L., 1984, Allelopathy.; Rodrigues Da Silva UDS, 2006, BIODIVERS CONSERV, V15, P3035, DOI 10.1007/s10531-005-4877-z; Sampietro DA, 2009, ISOLATION IDENTIFICA, P7; Sarg T.M., 2011, J PHARMACOG PHYTOTHE, V3, P89; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Matos DMS, 2010, BRAZ J BIOL, V70, P311, DOI 10.1590/S1519-69842010000200012; Smolander A, 2012, PLANT SOIL, V350, P1, DOI 10.1007/s11104-011-0895-7; Stewart G, 2008, ANN BOT-LONDON, V101, P957, DOI 10.1093/aob/mcn020; Suazo-Ortuno I, 2015, BIOTROPICA, V47, P18, DOI 10.1111/btp.12181; Subarnas A, 2000, PHYTOMEDICINE, V7, P401, DOI 10.1016/S0944-7113(00)80061-6; TAYLOR JE, 1990, AIAS OC PUB, P203; Wang HH, 2011, ALLELOPATHY J, V27, P97; Zeng RS, 2014, J CHEM ECOL, V40, P515, DOI 10.1007/s10886-014-0464-7	53	22	23	0	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0161670	10.1371/journal.pone.0161670	http://dx.doi.org/10.1371/journal.pone.0161670			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27552161	Green Submitted, Green Published, gold			2022-12-26	WOS:000381768800066
J	Rezzoug, F; Thomas, SD; Rouchka, EC; Miller, DM				Rezzoug, Francine; Thomas, Shelia D.; Rouchka, Eric C.; Miller, Donald M.			Discovery of a Family of Genomic Sequences Which Interact Specifically with the c-MYC Promoter to Regulate c-MYC Expression	PLOS ONE			English	Article							G-QUADRUPLEX DNA; NUCLEASE-HYPERSENSITIVE ELEMENT; CROSS-LINKING REACTION; EMBRYONIC STEM-CELLS; GENE IN-VITRO; BURKITT-LYMPHOMA; COLORECTAL-CANCER; PROTEIN-BINDING; DOWN-REGULATION; POOR-PROGNOSIS	G-quadruplex forming sequences are particularly enriched in the promoter regions of eukaryotic genes, especially of oncogenes. One of the most well studied G-quadruplex forming sequences is located in the nuclease hypersensitive element (NHE) III1 of the c-MYC promoter region. The oncoprotein c-MYC regulates a large array of genes which play important roles in growth regulation and metabolism. It is dysregulated in >70% of human cancers. The silencer NHEIII1 located upstream of the P1 promoter regulates up-to 80% of c-MYC transcription and includes a G-quadruplex structure (Pu27) that is required for promoter inhibition. We have identified, for the first time, a family of seventeen G-quadruplexforming motifs with >90% identity with Pu27, located on different chromosomes throughout the human genome, some found near or within genes involved in stem cell maintenance or neural cell development. Notably, all members of the Pu27 family interact specifically with NHEIII1 sequence, in vitro. Crosslinking studies demonstrate that Pu27 oligonucleotide binds specifically to the C-rich strand of the NHEIII1 resulting in the G-quadruplex structure stabilization. Pu27 homologous sequences (Pu27-HS) significantly inhibit leukemic cell lines proliferation in culture. Exposure of U937 cells to the Pu27-HS induces cell growth inhibition associated with cell cycle arrest that is most likely due to downregulation of c-MYC expression at the RNA and/or protein levels. Expression of SOX2, another gene containing a Pu27-HS, was affected by Pu27-HS treatment as well. Our data suggest that the oligonucleotides encoding the Pu27 family target complementary DNA sequences in the genome, including those of the c-MYC and SOX2 promoters. This effect is most likely cell type and cell growth condition dependent. The presence of genomic G-quadruplex-forming sequences homologous to Pu27 of c-MYC silencer and the fact that they interact specifically with the parent sequence suggest a common regulatory mechanism for genes whose promoters contain these sequences.	[Rezzoug, Francine; Thomas, Shelia D.; Miller, Donald M.] Univ Louisville, Dept Med, James Graham Brown Canc Ctr, Louisville, KY 40292 USA; [Rouchka, Eric C.] Univ Louisville, Speed Sch Engn, Dept Comp Engn & Comp Sci, Louisville, KY 40292 USA	University of Louisville; University of Louisville	Rezzoug, F; Miller, DM (corresponding author), Univ Louisville, Dept Med, James Graham Brown Canc Ctr, Louisville, KY 40292 USA.	f0rezz01@louisville.edu; donaldmi@ulh.org			National Institute of Health and National Center for Research Resources [5P20RR18733-09]; National Institute of Health and National Cancer Institute [1R21CA191663-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103436] Funding Source: NIH RePORTER	National Institute of Health and National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Health and National Cancer Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported from the National Institute of Health and National Center for Research Resources (www.nih.gov) Grant #5P20RR18733-09 to DMM and from National Institute of Health and National Cancer Institute (www.nih.gov) Grant #1R21CA191663-01A1 to DMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Andorf CM, 2014, J GENET GENOMICS, V41, P627, DOI 10.1016/j.jgg.2014.10.004; Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428; Bates PJ, 2009, EXP MOL PATHOL, V86, P151, DOI 10.1016/j.yexmp.2009.01.004; Bates PJ, 1999, J BIOL CHEM, V274, P26369, DOI 10.1074/jbc.274.37.26369; BATTEY J, 1983, CELL, V34, P779, DOI 10.1016/0092-8674(83)90534-2; Beckett J, 2012, BIOCHEMISTRY-US, V51, P5257, DOI 10.1021/bi300304k; BENTLEY DL, 1986, MOL CELL BIOL, V6, P3481, DOI 10.1128/MCB.6.10.3481; Blume SW, 2003, EXP CELL RES, V288, P131, DOI 10.1016/S0014-4827(03)00182-4; BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Bretones G, 2015, BBA-GENE REGUL MECH, V1849, P506, DOI 10.1016/j.bbagrm.2014.03.013; Capra JA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000861; Chambers VS, 2015, NAT BIOTECHNOL, V33, P877, DOI 10.1038/nbt.3295; Chappell J, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014381; Cogoi S, 2006, NUCLEIC ACIDS RES, V34, P2536, DOI 10.1093/nar/gkl286; COONEY M, 1988, SCIENCE, V241, P456, DOI 10.1126/science.3293213; Dai JX, 2006, J AM CHEM SOC, V128, P1096, DOI 10.1021/ja055636a; DALLAFAVERA R, 1982, NATURE, V299, P61; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; DAVIS TL, 1989, P NATL ACAD SCI USA, V86, P9682, DOI 10.1073/pnas.86.24.9682; Eddy J, 2006, NUCLEIC ACIDS RES, V34, P3887, DOI 10.1093/nar/gkl529; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Fujimoto K, 2013, J AM CHEM SOC, V135, P16161, DOI 10.1021/ja406965f; Gonzalez V, 2009, J BIOL CHEM, V284, P23622, DOI 10.1074/jbc.M109.018028; Gregory MA, 2000, MOL CELL BIOL, V20, P2423, DOI 10.1128/MCB.20.7.2423-2435.2000; Halder K, 2009, NUCLEIC ACIDS RES, V37, P6811, DOI 10.1093/nar/gkp696; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Huang MJ, 2006, EXP HEMATOL, V34, P1480, DOI 10.1016/j.exphem.2006.06.019; Huang YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035256; Huppert JL, 2008, BIOCHIMIE, V90, P1140, DOI 10.1016/j.biochi.2008.01.014; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Hurley LH, 2006, SEMIN ONCOL, V33, P498, DOI 10.1053/j.seminoncol.2006.04.012; Jenkins RB, 1997, CANCER RES, V57, P524; Kim HG, 1998, BIOCHEMISTRY-US, V37, P2299, DOI 10.1021/bi9718191; KOHLHUBER F, 1995, J BIOL CHEM, V270, P28797, DOI 10.1074/jbc.270.48.28797; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Kwan KY, 2015, STEM CELL REP, V4, P47, DOI 10.1016/j.stemcr.2014.11.001; Laing AF, 2015, DEV BIOL, V397, P56, DOI 10.1016/j.ydbio.2014.10.007; Lee JY, 2002, CANCER GENET CYTOGEN, V137, P124, DOI 10.1016/S0165-4608(02)00565-4; Lin P, 2012, CANCER-AM CANCER SOC, V118, P1566, DOI 10.1002/cncr.26433; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma Y, 2008, BIOORGAN MED CHEM, V16, P7582, DOI 10.1016/j.bmc.2008.07.029; McNeill EM, 2011, DEV BIOL, V353, P331, DOI 10.1016/j.ydbio.2011.03.008; McNeill EM, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-6; Miller DM, 2012, CLIN CANCER RES, V18, P5546, DOI 10.1158/1078-0432.CCR-12-0977; Nass SJ, 1998, CLIN CANCER RES, V4, P1813; Ou TM, 2008, CHEMMEDCHEM, V3, P690, DOI 10.1002/cmdc.200700300; Ou TM, 2007, J MED CHEM, V50, P1465, DOI 10.1021/jm0610088; Park SB, 2012, CELL DEATH DIFFER, V19, P534, DOI 10.1038/cdd.2011.137; PERROTTI D, 1995, MOL CELL BIOL, V15, P6075; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; POSTEL EH, 1989, MOL CELL BIOL, V9, P5123, DOI 10.1128/MCB.9.11.5123; PROCHOWNIK EV, 1986, NATURE, V322, P848, DOI 10.1038/322848a0; RABBITTS PH, 1985, EMBO J, V4, P2009, DOI 10.1002/j.1460-2075.1985.tb03885.x; Rankin S, 2005, J AM CHEM SOC, V127, P10584, DOI 10.1021/ja050823u; Redies C, 2003, J PHYSIOL-PARIS, V97, P5, DOI 10.1016/j.jphysparis.2003.10.002; Robinson K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005951; Rotthier A, 2010, AM J HUM GENET, V87, P513, DOI 10.1016/j.ajhg.2010.09.010; Sedoris KC, 2012, MOL CANCER THER, V11, P66, DOI 10.1158/1535-7163.MCT-11-0515; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; Shou YP, 2000, P NATL ACAD SCI USA, V97, P228, DOI 10.1073/pnas.97.1.228; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; SIEBENLIST U, 1984, CELL, V37, P381, DOI 10.1016/0092-8674(84)90368-4; Simonsson T, 1998, NUCLEIC ACIDS RES, V26, P1167, DOI 10.1093/nar/26.5.1167; Simonsson T, 2002, BIOCHEM BIOPH RES CO, V290, P11, DOI 10.1006/bbrc.2001.6096; Smith KN, 2010, CELL STEM CELL, V7, P343, DOI 10.1016/j.stem.2010.06.023; SNYDER RC, 1991, BIOCHEMISTRY-US, V30, P4290, DOI 10.1021/bi00231a027; Sotelo J, 2010, P NATL ACAD SCI USA, V107, P3001, DOI 10.1073/pnas.0906067107; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; SUNDQUIST WI, 1989, NATURE, V342, P825, DOI 10.1038/342825a0; Tan FB, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0237-3; Tang SJ, 2012, GENES-BASEL, V3, P167, DOI 10.3390/genes3010167; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Tsai LH, 2015, ONCOGENE, V34, P1641, DOI 10.1038/onc.2014.118; Verma A, 2008, J MED CHEM, V51, P5641, DOI 10.1021/jm800448a; Vieregg JR, 2013, J AM CHEM SOC, V135, P9691, DOI 10.1021/ja4009216; Weina K, 2014, CLIN TRANSL MED, V3, DOI 10.1186/2001-1326-3-19; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Wolfer A, 2010, P NATL ACAD SCI USA, V107, P3698, DOI 10.1073/pnas.0914203107; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Yochum GS, 2008, MOL CELL BIOL, V28, P7368, DOI 10.1128/MCB.00744-08; Yoshimura Y, 2008, ORG LETT, V10, P3227, DOI 10.1021/ol801112j	86	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0161588	10.1371/journal.pone.0161588	http://dx.doi.org/10.1371/journal.pone.0161588			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27551915	gold, Green Submitted, Green Published			2022-12-26	WOS:000381768800054
J	Tamibmaniam, J; Hussin, N; Cheah, WK; Ng, KS; Muninathan, P				Tamibmaniam, Jayashamani; Hussin, Narwani; Cheah, Wee Kooi; Ng, Kee Sing; Muninathan, Prema			Proposal of a Clinical Decision Tree Algorithm Using Factors Associated with Severe Dengue Infection	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; CLASSIFICATION	Background WHO's new classification in 2009: dengue with or without warning signs and severe dengue, has necessitated large numbers of admissions to hospitals of dengue patients which in turn has been imposing a huge economical and physical burden on many hospitals around the globe, particularly South East Asia and Malaysia where the disease has seen a rapid surge in numbers in recent years. Lack of a simple tool to differentiate mild from life threatening infection has led to unnecessary hospitalization of dengue patients. Methods We conducted a single-centre, retrospective study involving serologically confirmed dengue fever patients, admitted in a single ward, in Hospital Kuala Lumpur, Malaysia. Data was collected for 4 months from February to May 2014. Socio demography, co-morbidity, days of illness before admission, symptoms, warning signs, vital signs and laboratory result were all recorded. Descriptive statistics was tabulated and simple and multiple logistic regression analysis was done to determine significant risk factors associated with severe dengue. Results 657 patients with confirmed dengue were analysed, of which 59 (9.0%) had severe dengue. Overall, the commonest warning sign were vomiting (36.1%) and abdominal pain (32.1%). Previous co-morbid, vomiting, diarrhoea, pleural effusion, low systolic blood pressure, high haematocrit, low albumin and high urea were found as significant risk factors for severe dengue using simple logistic regression. However the significant risk factors for severe dengue with multiple logistic regressions were only vomiting, pleural effusion, and low systolic blood pressure. Using those 3 risk factors, we plotted an algorithm for predicting severe dengue. When compared to the classification of severe dengue based on the WHO criteria, the decision tree algorithm had a sensitivity of 0.81, specificity of 0.54, positive predictive value of 0.16 and negative predictive of 0.96. Conclusion The decision tree algorithm proposed in this study showed high sensitivity and NPV in predicting patients with severe dengue that may warrant admission. This tool upon further validation study can be used to help clinicians decide on further managing a patient upon first encounter. It also will have a substantial impact on health resources as low risk patients can be managed as outpatients hence reserving the scarce hospital beds and medical	[Tamibmaniam, Jayashamani; Cheah, Wee Kooi] Taiping Hosp, Dept Med, Perak, Malaysia; [Hussin, Narwani; Muninathan, Prema] Taiping Hosp, Clin Res Ctr, Perak, Malaysia; [Ng, Kee Sing] Kuala Lumpur Hosp, Dept Med, Kuala Lumpur, Malaysia		Tamibmaniam, J (corresponding author), Taiping Hosp, Dept Med, Perak, Malaysia.; Hussin, N (corresponding author), Taiping Hosp, Clin Res Ctr, Perak, Malaysia.	jayashamani@hotmail.com; narwani@crc.gov.my						Ahmed S, 2013, JCPSP-J COLL PHYSICI, V23, P463, DOI 07.2013/JCPSP.463467; Anders Katherine L., AM SOC TROPICAL MED, V84, P127; Barniol J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-106; Breen Emer, 2012, DENGUE B; Carrasco Luis R., 2014, PLOS NEGLECTED TROPI; Cavalcanti LPD, 2014, MEM I OSWALDO CRUZ, V109, P93, DOI 10.1590/0074-0276140384; Hadinegoro RS, 2012, PAEDIATR INT CHILD H, V32, P33, DOI 10.1179/2046904712Z.00000000052; Hussain Mallhi Tauqeer, 2015, BIOMED CENTRAL INFEC; Kalayanarooj S., 2011, J MED ASS THAILAND; Lee VJ, 2009, TROP MED INT HEALTH, V14, P1154, DOI 10.1111/j.1365-3156.2009.02337.x; Malavige G.N., 2006, QJM INT J MED; Malaysia M.o.H., 2015, MALAYSIA DENGUE INCI; Huy NT, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002412; Nursing_Directorate, 2014, COMP PRACT 22 YEARS; Organisation W.H, 2009, DENGUE GUIDELINES DI; Organisation W.H., 2015, DENGUE SEVERE DENGUE; Sellahewa K.H, 2013, INT SCHOLARLY RES NO; Srikiatkhachorn A, 2010, CLIN INFECT DIS OXFO; Suaya JA, 2009, AM J TROP MED HYG, V80, P846, DOI 10.4269/ajtmh.2009.80.846; Thanachartwet V, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1150-2; Thein Tun-Linn G V.C., 2013, PLOS NEGLECTED TROPI; Zhang H., 2014, BIOMED RES INT, V2014	22	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0161696	10.1371/journal.pone.0161696	http://dx.doi.org/10.1371/journal.pone.0161696			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27551776	Green Published, gold, Green Submitted			2022-12-26	WOS:000381768800070
J	Tang, YJ; Wang, RP; Gong, PJ; Li, SX; Wang, YJ; Zhang, CH				Tang, Yujin; Wang, Ruipu; Gong, Peijie; Li, Shuxiu; Wang, Yuejin; Zhang, Chaohong			Gene Cloning, Expression and Enzyme Activity of Vitis vinifera Vacuolar Processing Enzymes (VvVPEs)	PLOS ONE			English	Article							SEED STORAGE PROTEINS; MALUS-HUPEHENSIS; MHVPE-GAMMA; CELL-DEATH; ARABIDOPSIS; FAMILY; VPE; LEGUMAINS; ACCUMULATION; GLUTELIN	Vacuolar processing enzymes (VPEs) have received considerable attention due to their caspase-1-like activity and ability to regulate programmed cell death (PCD), which plays an essential role in the development of stenospermocarpic seedless grapes ovules. To characterize VPEs and the relationship between stenospermocarpic grapes and the VPE gene family, we identified 3 Vitis vinifera VPE genes (Vv beta VPE, Vv gamma VPE, and Vv delta VPE) from the PN40024 grape genome and cloned the full-length complementary DNAs (cDNAs) from the 'Vitis vinifera cv. Pinot Noir' and 'Vitis vinifera cv. Thompson Seedless' varietals. Each of the VPEs contained a typical catalytic dyad [His (177), Cys (219)] and substrate binding pocket [Arg (112), Arg (389), Ser (395)], except that Ser (395) in the Vv gamma VPE protein sequence was replaced with alanine. Phylogenetic analysis of 4 Arabidopsis thaliana and 6 Vitis vinifera VPEs revealed that the 10 VPEs form 3 major branches. Furthermore, the 6 grapevine VPEs share a similar gene structure, with 9 exons and 8 introns. The 6 grapevine VPEs are located on 3 different chromosomes. We also tested the enzymatic activity of recombinant VPEs expressed in the Pichia Pastoris expression system and found that the VvVPEs exhibit cysteine peptidase activity. Tissue-specific expression analysis showed that VvdVPE is only expressed in flowers, buds and ovules, that Vv gamma VPE is expressed in various tissues, and that Vv beta VPE was expressed in roots, flowers, buds and ovules. The results of quantitative real-time PCR (qRT-PCR) suggested that Vv beta VPE in seeded grapes increased significantly at 30 days after full-bloom (DAF), close to the timing of endosperm abortion at 32 DAF. These results suggested that Vv beta VPE is related to ovule abortion in seedless grapes. Our experiments provide a new perspective for understanding the mechanism of stenospermocarpic seedlessness and represent a useful reference for the further study of VPEs.	[Tang, Yujin; Wang, Ruipu; Gong, Peijie; Li, Shuxiu; Wang, Yuejin; Zhang, Chaohong] Northwest A&F Univ, Coll Hort, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China; [Tang, Yujin; Wang, Ruipu; Gong, Peijie; Li, Shuxiu; Wang, Yuejin; Zhang, Chaohong] Minist Agr, Key Lab Biol & Genet Improvement Hort Crops North, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China; Ministry of Agriculture & Rural Affairs	Zhang, CH (corresponding author), Northwest A&F Univ, Coll Hort, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China.; Zhang, CH (corresponding author), Minist Agr, Key Lab Biol & Genet Improvement Hort Crops North, Yangling 712100, Shaanxi, Peoples R China.	zhangchaohong@nwsuaf.edu.cn	Gong, Peijie/ABI-7200-2020	Peijie, Gong/0000-0002-3866-2013	Natural Science Foundation of China [3117 1926]; Modern Agro-industry Technology Research System [CARS-30-yz-7]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Modern Agro-industry Technology Research System	This work was supported by Natural Science Foundation of China (No.3117 1926) http://www.nsfc.gov.cn/, Modern Agro-industry Technology Research System (No. CARS-30-yz-7) http://119.253.58.231/login.do?method=log&loginType=cookie&requestUrl=%2Findex.do%3Fmethod%3Dcenter%26product%3D%25C6%25CF%25CC%25D1%26productId%3D030.	Albertini A, 2014, BIOL PLANTARUM, V58, P531, DOI 10.1007/s10535-014-0417-6; Ariizumi T, 2011, J EXP BOT, V62, P2773, DOI 10.1093/jxb/erq451; Barrett AJ, 1998, HDB PROTEOLYTIC ENZY; Christoff AP, 2014, PLANT SCI, V215, P100, DOI 10.1016/j.plantsci.2013.11.005; Gruis D, 2002, PLANT CELL, V14, P2863, DOI 10.1105/tpc.005009; Gruis DF, 2004, PLANT CELL, V16, P270, DOI 10.1105/tpc.016378; HALBROOKS MC, 1988, HORTSCIENCE, V23, P409; Hara-Nishimura I, 2005, CURR OPIN PLANT BIOL, V8, P404, DOI 10.1016/j.pbi.2005.05.016; HARANISHIMURA I, 1987, PLANT PHYSIOL, V85, P440, DOI 10.1104/pp.85.2.440; HARANISHIMURA I, 1991, FEBS LETT, V294, P89, DOI 10.1016/0014-5793(91)81349-D; Hatsugai N, 2006, APOPTOSIS, V11, P905, DOI 10.1007/s10495-006-6601-1; Julian I, 2013, J EXP BOT, V64, P2929, DOI 10.1093/jxb/ert132; Kinoshita T, 1999, PLANT J, V19, P43, DOI 10.1046/j.1365-313X.1999.00497.x; KINOSHITA T, 1995, PLANT MOL BIOL, V29, P81, DOI 10.1007/BF00019120; Kumamaru T, 2010, PLANT CELL PHYSIOL, V51, P38, DOI 10.1093/pcp/pcp165; Kumar D, 2015, PLANT MOL BIOL, V88, P177, DOI 10.1007/s11103-015-0318-x; Kuroyanagi M, 2005, J BIOL CHEM, V280, P32914, DOI 10.1074/jbc.M504476200; Kuroyanagi M, 2002, PLANT CELL PHYSIOL, V43, P143, DOI 10.1093/pcp/pcf035; Li XQ, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-014-0808-z; Li Z, 2012, NEW PHYTOL, V195, P85, DOI 10.1111/j.1469-8137.2012.04131.x; Misas-Villamil JC, 2013, PLANT J, V73, P689, DOI 10.1111/tpj.12062; Muntz K, 2002, J PLANT PHYSIOL, V159, P1281, DOI 10.1078/0176-1617-00853; Muntz K, 2002, TRENDS PLANT SCI, V7, P340, DOI 10.1016/S1360-1385(02)02298-7; Muntz K, 1998, PLANT MOL BIOL, V38, P77, DOI 10.1023/A:1006020208380; Nakaune S, 2005, PLANT CELL, V17, P876, DOI 10.1105/tpc.104.026872; Piszczek E, 2007, ACTA PHYSIOL PLANT, V29, P391, DOI 10.1007/s11738-007-0086-6; Qiang XY, 2012, PLANT CELL, V24, P794, DOI 10.1105/tpc.111.093260; Radchuk V, 2011, J EXP BOT, V62, P1217, DOI 10.1093/jxb/erq348; Ramming DW, 2000, HORTSCIENCE, V35, P732, DOI 10.21273/HORTSCI.35.4.732; Ran K, 2014, APPL BIOCHEM BIOTECH, V173, P579, DOI 10.1007/s12010-014-0867-5; Robinson ADG, 2000, HDB PRETEOLYTIC ENZY; Robinson DG, 1998, J PLANT PHYSIOL, V152, P659, DOI 10.1016/S0176-1617(98)80027-8; Rojo E, 2004, CURR BIOL, V14, P1897, DOI 10.1016/j.cub.2004.09.056; Shimada T, 2003, J BIOL CHEM, V278, P32292, DOI 10.1074/jbc.M305740200; Su Q, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-015-1830-y; WANG JW, 1990, J JPN SOC HORTIC SCI, V59, P455, DOI 10.2503/jjshs.59.455; Wang YH, 2009, PLANT J, V58, P606, DOI 10.1111/j.1365-313X.2009.03801.x; Yamada K, 2005, PHYSIOL PLANTARUM, V123, P369, DOI 10.1111/j.1399-3054.2005.00464.x; Yamada K, 2004, PLANTA, V218, P599, DOI 10.1007/s00425-003-1131-3; Zhang CH, 2013, GENE, V528, P267, DOI 10.1016/j.gene.2013.06.062; Zhang J, 2013, INT J MOL SCI, V14, P13346, DOI 10.3390/ijms140713346; Zhang JinJin, 2003, Journal of Fruit Science, V20, P178; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044593	43	33	34	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0160945	10.1371/journal.pone.0160945	http://dx.doi.org/10.1371/journal.pone.0160945			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27551866	Green Published, gold, Green Submitted			2022-12-26	WOS:000381768800018
J	Collins, CC; Villa-Torres, L; Sams, LD; Zeldin, LP; Divaris, K				Collins, Chimere C.; Villa-Torres, Laura; Sams, Lattice D.; Zeldin, Leslie P.; Divaris, Kimon			Framing Young Childrens Oral Health: A Participatory Action Research Project	PLOS ONE			English	Article							EARLY-CHILDHOOD CARIES; AFRICAN-AMERICAN CHILDREN; SOCIAL DETERMINANTS; QUALITATIVE RESEARCH; DENTAL-CARE; DISPARITIES; PHOTOVOICE; PARENTS; ACCESS; FAMILY	Background and Objectives Despite the widespread acknowledgement of the importance of childhood oral health, little progress has been made in preventing early childhood caries. Limited information exists regarding specific daily-life and community-related factors that impede optimal oral hygiene, diet, care, and ultimately oral health for children. We sought to understand what parents of young children consider important and potentially modifiable factors and resources influencing their children's oral health, within the contexts of the family and the community. Methods This qualitative study employed Photovoice among 10 English-speaking parents of infants and toddlers who were clients of an urban WIC clinic in North Carolina. The primary research question was: "What do you consider as important behaviors, as well as family and community resources to prevent cavities among young children?" Five group sessions were conducted and they were recorded, transcribed verbatim and analyzed using qualitative research methodology. Inductive analyses were based on analytical summaries, double-coding, and summary matrices and were done using Atlas.ti.7.5.9 software. Findings Good oral health was associated with avoidance of problems or restorations for the participants. Financial constraints affected healthy food and beverage choices, as well as access to oral health care. Time constraints and occasional frustration related to children's oral hygiene emerged as additional barriers. Establishment of rules/routines and commitment to them was a successful strategy to promote their children's oral health, as well as modeling of older siblings, cooperation among caregivers and peer support. Community programs and organizations, social hubs including playgrounds, grocery stores and social media emerged as promising avenues for gaining support and sharing resources. Conclusions Low-income parents of young children are faced with daily life struggles that interfere with oral health and care. Financial constraints are pervasive, but parents identified several strategies involving home care and community agents that can be helpful. Future interventions aimed to improve children's oral health must take into consideration the role of families and the communities in which they live.	[Collins, Chimere C.; Sams, Lattice D.] Univ North Carolina Chapel Hill, Sch Dent, Dept Dent Ecol, Chapel Hill, NC USA; [Villa-Torres, Laura] Univ North Carolina Chapel Hill, UNC Gillings Sch Global Publ Hlth, Dept Hlth Behav, Chapel Hill, NC USA; [Zeldin, Leslie P.] Univ North Carolina Chapel Hill, Oral & Craniofacial Hlth Sci, Sch Dent, Chapel Hill, NC USA; [Divaris, Kimon] Univ North Carolina Chapel Hill, Sch Dent, Dept Pediat Dent, Chapel Hill, NC 27599 USA; [Divaris, Kimon] Univ North Carolina Chapel Hill, Dept Epidemiol, UNC Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Divaris, K (corresponding author), Univ North Carolina Chapel Hill, Sch Dent, Dept Pediat Dent, Chapel Hill, NC 27599 USA.; Divaris, K (corresponding author), Univ North Carolina Chapel Hill, Dept Epidemiol, UNC Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA.	Kimon_Divaris@unc.edu	Divaris, Kimon/E-4706-2011; Divaris, Kimon/AAU-8735-2021	Divaris, Kimon/0000-0003-1290-7251; Divaris, Kimon/0000-0003-1290-7251	Dora Lee & John C. Brauer Dental Research Fund; Dental Foundation of North Carolina, Inc.; National Institute of Dental and Craniofacial Research, National Institutes of Health [U01DE025046]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [U01DE025046] Funding Source: NIH RePORTER	Dora Lee & John C. Brauer Dental Research Fund; Dental Foundation of North Carolina, Inc.; National Institute of Dental and Craniofacial Research, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	A M.S. Research Support grant from the Dora Lee & John C. Brauer Dental Research Fund and the Dental Foundation of North Carolina, Inc. to Ms. Chimere Collins and a grant from the National Institute of Dental and Craniofacial Research, National Institutes of Health (U01DE025046) to Dr. Kimon Divans. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida J, 2008, COMMUNITY DENT ORAL, V36, P149, DOI 10.1111/j.1600-0528.2007.00380.x; Akpabio Aisha, 2008, J Dent Hyg, V82, P12; Albino J, 2016, J DENT RES, V95, P35, DOI 10.1177/0022034515609034; Amin MS, 2009, QUAL HEALTH RES, V19, P116, DOI 10.1177/1049732308327243; Amsden J., 2005, ACTION RES-LONDON, V3, P357, DOI [DOI 10.1177/1476750305058487, 10.1177/1476750305058487]; [Anonymous], 2009, PRACT GUID PHOT SHAR; BARENIE JT, 1977, J AM DENT ASSOC, V94, P329, DOI 10.14219/jada.archive.1977.0273; Carbone ET, 2016, INT Q COMMUNITY HEAL, V36, P177, DOI 10.1177/0272684X16637722; Casamassimo PS, 2014, J DENT RES, V93, P938, DOI 10.1177/0022034514547273; Casamassimo PS, 2009, J AM DENT ASSOC, V140, P650, DOI 10.14219/jada.archive.2009.0250; Chilton Mariana, 2009, Health Hum Rights, V11, P73; Colak Hakan, 2013, J Nat Sci Biol Med, V4, P29, DOI 10.4103/0976-9668.107257; CONNORS DD, 1988, ADV NURS SCI, V10, P32, DOI 10.1097/00012272-198807000-00006; Cornwall A, 1995, SOC SCI MED, V41, P1667, DOI 10.1016/0277-9536(95)00127-S; Divaris K, 2014, PEDIATRICS, V133, pE1268, DOI 10.1542/peds.2013-2932; Duijster D, 2015, BMC ORAL HEALTH, V15, DOI 10.1186/s12903-015-0145-0; Dye Bruce A, 2012, NCHS Data Brief, P1; Edelstein BL, 2009, ACAD PEDIATR, V9, P415, DOI 10.1016/j.acap.2009.09.010; Elison S, 2014, INT J ENV RES PUB HE, V11, P6808, DOI 10.3390/ijerph110706808; Ersin NK, 2006, J DENT CHILD, V73, P105; Evans-Agnew RA, 2016, QUAL HEALTH RES, V26, P1019, DOI 10.1177/1049732315624223; Finlayson TL, 2007, COMMUNITY DENT ORAL, V35, P272, DOI 10.1111/j.1600-0528.2007.00313.x; Finlayson TL, 2007, COMMUNITY DENT ORAL, V35, P439, DOI 10.1111/j.1600-0528.2006.00352.x; Fisher-Owens SA, 2016, PUBLIC HEALTH, V134, P54, DOI 10.1016/j.puhe.2015.04.024; Fisher-Owens SA, 2007, PEDIATRICS, V120, pE510, DOI 10.1542/peds.2006-3084; Castilho ARF, 2013, J PEDIAT-BRAZIL, V89, P116, DOI 10.1016/j.jped.2013.03.014; Garcia R, 2015, PEDIATR DENT, V37, P294; Ghazal T, 2015, J PUBLIC HEALTH DENT, V75, P42, DOI 10.1111/jphd.12069; Gill R, 2016, J PEDIATR ADOLESC GY; Gold JT, 2016, J COMMUN HEALTH, V41, P612, DOI 10.1007/s10900-015-0136-8; Han DH, 2014, COMMUNITY DENT ORAL, V42, P70, DOI 10.1111/cdoe.12065; Jain Mitali, 2015, J Dent Res Dent Clin Dent Prospects, V9, P115, DOI 10.15171/joddd.2014.023; Kerber KJ, 2007, LANCET, V370, P1358, DOI 10.1016/S0140-6736(07)61578-5; Kuper A, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1035; Lee JY, 2014, J DENT RES, V93, P224, DOI 10.1177/0022034513511821; Lee JY, 2004, J PUBLIC HEALTH DENT, V64, P76, DOI 10.1111/j.1752-7325.2004.tb02731.x; Lee JY, 2004, AM J PUBLIC HEALTH, V94, P772, DOI 10.2105/AJPH.94.5.772; Lewis CW, 2010, PEDIATR DENT, V32, P518; Li Y, 2011, INT J PAEDIATR DENT, V21, P103, DOI 10.1111/j.1365-263X.2010.01093.x; Link BG, 1996, AM J PUBLIC HEALTH, V86, P471, DOI 10.2105/AJPH.86.4.471; Martens L, 2006, QUINTESSENCE INT, V37, P527; Mouradian W E, 2001, J Dent Educ, V65, P821; Mouradian WE, 2000, JAMA-J AM MED ASSOC, V284, P2625, DOI 10.1001/jama.284.20.2625; Mouradian WE, 2007, J DENT EDUC, V71, P619; Okunseri C, 2008, J PUBLIC HEALTH DENT, V68, P149, DOI 10.1111/j.1752-7325.2007.00079.x; Patrick Donald L, 2006, BMC Oral Health, V6 Suppl 1, pS4, DOI 10.1186/1472-6831-6-S1-S4; Peltzer K, 2015, BMC ORAL HEALTH, V15, DOI 10.1186/s12903-015-0093-8; Poutanen R, 2006, ACTA ODONTOL SCAND, V64, P286, DOI 10.1080/00016350600714498; Reisine S, 1998, COMMUNITY DENT ORAL, V26, P32, DOI 10.1111/j.1600-0528.1998.tb02092.x; Roberts Kate, 2014, Community Pract, V87, P32; Shick EA, 2005, J PUBLIC HEALTH DENT, V65, P196, DOI 10.1111/j.1752-7325.2005.tb03018.x; Tomar SL, 2009, ACAD PEDIATR, V9, P388, DOI 10.1016/j.acap.2009.09.018; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Torres ME, 2013, AM J PREV MED, V44, pS225, DOI 10.1016/j.amepre.2012.11.020; Vann WF, 2010, J DENT RES, V89, P1395, DOI 10.1177/0022034510379601; Wang C, 1997, HEALTH EDUC BEHAV, V24, P369, DOI 10.1177/109019819702400309; Wang CC, 2004, MATERN CHILD HLTH J, V8, P95, DOI 10.1023/B:MACI.0000025732.32293.4f; Wang CC, 1999, J WOMENS HEALTH, V8, P185, DOI 10.1089/jwh.1999.8.185; Watt RG, 2007, COMMUNITY DENT ORAL, V35, P1, DOI 10.1111/j.1600-0528.2007.00348.x; Weintraub JA, 2010, J DENT RES, V89, P954, DOI 10.1177/0022034510372891; Weintraub JA, 1998, COMMUNITY DENT ORAL, V26, P62, DOI 10.1111/j.1600-0528.1998.tb02095.x; Willems S, 2005, FAM COMMUNITY HEALTH, V28, P168, DOI 10.1097/00003727-200504000-00008; Williams NJ, 2002, BRIT DENT J, V193, P651, DOI 10.1038/sj.bdj.4801652	63	11	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161728	10.1371/journal.pone.0161728	http://dx.doi.org/10.1371/journal.pone.0161728			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT8TP	27548714	Green Published, Green Submitted, gold			2022-12-26	WOS:000381768400080
J	Mohammed, Y; Teixido, M; Namjoshi, S; Giralt, E; Benson, H				Mohammed, Yousuf; Teixido, Meritxell; Namjoshi, Sarika; Giralt, Ernest; Benson, Heather			Cyclic Dipeptide Shuttles as a Novel Skin Penetration Enhancement Approach: Preliminary Evaluation with Diclofenac	PLOS ONE			English	Article							SOLID-PHASE SYNTHESIS; BRAIN-BARRIER BBB; H-II MESOPHASES; TRANSDERMAL DELIVERY; 5-AMINOLEVULINIC ACID; POTENTIAL USE; AMINO-ACIDS; PEPTIDES; TAT; DIKETOPIPERAZINES	This study demonstrates the effectiveness of a peptide shuttle in delivering diclofenac into and through human epidermis. Diclofenac was conjugated to a novel phenylalanyl-Nmethyl- naphthalenylalanine-derived diketopiperazine (DKP) shuttle and to TAT (a classical cell penetrating peptide), and topically applied to human epidermis in vitro. DKP and TAT effectively permeated into and through human epidermis. When conjugated to diclofenac, both DKP and TAT enhanced delivery into and through human epidermis, though DKP was significantly more effective. Penetration of diclofenac through human epidermis (to receptor) was increased by conjugation to the peptide shuttle and cell penetrating peptide with enhancement of 6x by DKP-diclofenac and 3x by TAT-diclofenac. In addition, the amount of diclofenac retained within the epidermis was significantly increased by peptide conjugation. COX-2 inhibition activity of diclofenac was retained when conjugated to DKP. Our study suggests that the peptide shuttle approach may offer a new strategy for targeted delivery of small therapeutic and diagnostic molecules to the skin.	[Mohammed, Yousuf; Benson, Heather] Curtin Univ, Curtin Hlth Innovat Res Inst, Sch Pharm, Perth, WA, Australia; [Mohammed, Yousuf; Namjoshi, Sarika] Univ Queensland, Sch Med, Therapeut Res Ctr, Translat Res Inst, Brisbane, Qld, Australia; [Teixido, Meritxell; Giralt, Ernest] Barcelona Sci & Technol Inst BIST, Inst Res Biomed IRB Barcelona, Barcelona, Spain	Curtin University; University of Queensland; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona	Benson, H (corresponding author), Curtin Univ, Curtin Hlth Innovat Res Inst, Sch Pharm, Perth, WA, Australia.; Giralt, E (corresponding author), Barcelona Sci & Technol Inst BIST, Inst Res Biomed IRB Barcelona, Barcelona, Spain.	ernest.giralt@irbbarcelona.org; h.benson@curtin.edu.au	giralt, ernest/N-1669-2014; teixido, meritxell/I-3282-2015; Namjoshi, Sarika/O-1049-2019	giralt, ernest/0000-0001-8381-1797; teixido, meritxell/0000-0002-7825-3695; Namjoshi, Sarika/0000-0002-2697-153X; Mohammed, Yousuf/0000-0002-7825-7557	Institute for Research in Biomedicine and Curtin University	Institute for Research in Biomedicine and Curtin University	Institute for Research in Biomedicine and Curtin University funded the research including materials and a scholarship to YM.	Ali M, 2014, CLIN IMMUNOL, V150, P121, DOI 10.1016/j.clim.2013.10.005; Benson Heather A. E., 2005, Current Drug Delivery, V2, P23, DOI 10.2174/1567201052772915; Biron E, 2006, J PEPT SCI, V12, P213, DOI 10.1002/psc.711; Blobaum AL, 2007, J BIOL CHEM, V282, P16379, DOI 10.1074/jbc.M609883200; Blobaum AL, 2007, J MED CHEM, V50, P1425, DOI 10.1021/jm0613166; Cevc G, 2010, J CONTROL RELEASE, V141, P277, DOI 10.1016/j.jconrel.2009.10.016; Chan LY, 2013, CHEMBIOCHEM, V14, P617, DOI 10.1002/cbic.201300034; Clark RJ, 2010, ANGEW CHEM INT EDIT, V49, P6545, DOI 10.1002/anie.201000620; Cohen-Avrahami M, 2014, COLLOID SURFACE B, V122, P231, DOI 10.1016/j.colsurfb.2014.04.026; Cohen-Avrahami M, 2014, J PHYS CHEM B, V118, P6277, DOI 10.1021/jp412739p; Cohen-Avrahami M, 2012, J CONTROL RELEASE, V159, P419, DOI 10.1016/j.jconrel.2012.01.025; Cohen-Avrahami M, 2011, J PHYS CHEM B, V115, P10189, DOI 10.1021/jp112067v; Cohen-Avrahami M, 2010, COLLOID SURFACE B, V77, P131, DOI 10.1016/j.colsurfb.2010.01.013; Craik DJ, 2006, SCIENCE, V311, P1563, DOI 10.1126/science.1125248; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Gan TJ, 2010, CURR MED RES OPIN, V26, P1715, DOI 10.1185/03007995.2010.486301; Gentilucci L, 2010, CURR PHARM DESIGN, V16, P3185, DOI 10.2174/138161210793292555; Goh CF, 2014, INT J PHARMACEUT, V473, P607, DOI 10.1016/j.ijpharm.2014.07.052; GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0; Huang RM, 2014, MAR DRUGS, V12, P6213, DOI 10.3390/md12126213; KAISER E, 1970, ANAL BIOCHEM, V34, P595, DOI 10.1016/0003-2697(70)90146-6; Krishnan G, 2011, BIOPOLYMERS, V96, P166, DOI 10.1002/bip.21520; Krishnan G, 2010, J PHARM SCI-US, V99, P2724, DOI 10.1002/jps.22024; Lopes LB, 2005, PHARM RES-DORDR, V22, P750, DOI 10.1007/s11095-005-2591-x; Lundberg P, 2003, J MOL RECOGNIT, V16, P227, DOI 10.1002/jmr.630; Madder A, 1999, EUR J ORG CHEM, V1999, P2787; Manosroi J, 2013, DRUG DEV IND PHARM, V39, P520, DOI 10.3109/03639045.2012.684388; Margus H, 2012, MOL THER, V20, P525, DOI 10.1038/mt.2011.284; Martin GM, 2012, J DRUGS DERMATOL, V11, P600; Martin I, 2013, CURR PHARM DESIGN, V19, P2924; Martins MB, 2007, TETRAHEDRON, V63, P9923, DOI 10.1016/j.tet.2007.04.105; Namjoshi S, 2008, BIOPOLYMERS, V90, P655, DOI 10.1002/bip.21033; Namjoshi S, 2007, J CHROMATOGR B, V852, P49, DOI 10.1016/j.jchromb.2006.12.040; Namjoshi S, 2010, BIOPOLYMERS, V94, P673, DOI 10.1002/bip.21476; Nelson CG, 2011, THER CLIN RISK MANAG, V7, P207, DOI 10.2147/TCRM.S12498; Nohynek GJ, 2007, CRIT REV TOXICOL, V37, P251, DOI 10.1080/10408440601177780; OECD Environment HaSP, 2011, GUID NOT DERM ASS; Oller-Salvia B, 2016, ANGEW CHEM INT EDIT, V55, P572, DOI 10.1002/anie.201508445; Rothbard JB, 2000, NAT MED, V6, P1253, DOI 10.1038/81359; Shah PP, 2012, J CONTROL RELEASE, V161, P735, DOI 10.1016/j.jconrel.2012.05.011; Teixido M, 2005, J PEPT RES, V65, P153, DOI 10.1111/j.1399-3011.2004.00213.x; Teixido M, 2007, J AM CHEM SOC, V129, P11802, DOI 10.1021/ja073522o; Teixido M, 2009, ADV EXP MED BIOL, V611, P227, DOI 10.1007/978-0-387-73657-0_105; Uchida T, 2011, J PHARMACOL EXP THER, V338, P443, DOI 10.1124/jpet.111.180042; Vasconcelos L, 2013, THER DELIV, V4, P573, DOI [10.4155/tde.13.22, 10.4155/TDE.13.22]; Wang FH, 2014, J CONTROL RELEASE, V174, P126, DOI 10.1016/j.jconrel.2013.11.020; Wang Y, 2013, INT J PHARMACEUT, V441, P748, DOI 10.1016/j.ijpharm.2012.10.019; Warner TD, 1999, P NATL ACAD SCI USA, V96, P7563, DOI 10.1073/pnas.96.13.7563; Yang LH, 1997, TETRAHEDRON LETT, V38, P7307, DOI 10.1016/S0040-4039(97)01774-7; Zane C, 2014, BRIT J DERMATOL, V170, P1143, DOI 10.1111/bjd.12844	50	8	8	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0160973	10.1371/journal.pone.0160973	http://dx.doi.org/10.1371/journal.pone.0160973			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548780	Green Published, Green Submitted, gold			2022-12-26	WOS:000381768400026
J	Tanaka, Y; Sasaki, M; Ito, F; Aoyama, T; Sato-Okamoto, M; Takahashi-Nakaguchi, A; Chibana, H; Shibata, N				Tanaka, Yutaka; Sasaki, Masato; Ito, Fumie; Aoyama, Toshio; Sato-Okamoto, Michiyo; Takahashi-Nakaguchi, Azusa; Chibana, Hiroji; Shibata, Nobuyuki			KRE5 Suppression Induces Cell Wall Stress and Alternative ER Stress Response Required for Maintaining Cell Wall Integrity in Candida glabrata	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE; GLYCOPROTEIN-GLUCOSYLTRANSFERASE; BETA-1,6-GLUCAN SYNTHESIS; FUNGAL-INFECTIONS; CALCOFLUOR WHITE; IN-VITRO; ALBICANS; CHITIN; CASPOFUNGIN	The maintenance of cell wall integrity in fungi is required for normal cell growth, division, hyphae formation, and antifungal tolerance. We observed that endoplasmic reticulum stress regulated cell wall integrity in Candida glabrata, which possesses uniquely evolved mechanisms for unfolded protein response mechanisms. Tetracycline-mediated suppression of KRE5, which encodes a predicted UDP-glucose: glycoprotein glucosyltransferase localized in the endoplasmic reticulum, significantly increased cell wall chitin content and decreased cell wall beta-1,6-glucan content. KRE5 repression induced endoplasmic reticulum stressrelated gene expression and MAP kinase pathway activation, including Slt2p and Hog1p phosphorylation, through the cell wall integrity signaling pathway. Moreover, the calcineurin pathway negatively regulated cell wall integrity, but not the reduction of beta-1,6-glucan content. These results indicate that KRE5 is required for maintaining both endoplasmic reticulum homeostasis and cell wall integrity, and that the calcineurin pathway acts as a regulator of chitin-glucan balance in the cell wall and as an alternative mediator of endoplasmic reticulum stress in C. glabrata.	[Tanaka, Yutaka; Sasaki, Masato; Ito, Fumie; Shibata, Nobuyuki] Tohoku Med & Pharmaceut Univ, Dept Infect & Host Def, Sendai, Miyagi, Japan; [Aoyama, Toshio] Suzuka Natl Coll Technol, Dept Elect & Informat Engn, Suzuka, Japan; [Sato-Okamoto, Michiyo; Takahashi-Nakaguchi, Azusa; Chibana, Hiroji] Chiba Univ, Med Mycol Res Ctr, Chiba, Japan	Tohoku Medical & Pharmaceutical University; Chiba University	Shibata, N (corresponding author), Tohoku Med & Pharmaceut Univ, Dept Infect & Host Def, Sendai, Miyagi, Japan.	nshibata@tohoku-mpu.ac.jp		tanaka, yutaka/0000-0003-2944-8485				AGATEP R, 1998, TECH TIPS ONLINE, V3, P133, DOI DOI 10.1016/S1366-2120(08)70121-1; Ahmad KM, 2014, FEMS YEAST RES, V14, P529, DOI 10.1111/1567-1364.12145; Back SH, 2005, METHODS, V35, P395, DOI 10.1016/j.ymeth.2005.03.001; Barchiesi F, 2007, ANTIMICROB AGENTS CH, V51, P941, DOI 10.1128/AAC.00880-06; Bermejo C, 2008, MOL BIOL CELL, V19, P1113, DOI 10.1091/mbc.E07-08-0742; Birkaya B, 2009, EUKARYOT CELL, V8, P1118, DOI 10.1128/EC.00006-09; Borah S, 2011, J BIOL CHEM, V286, P34311, DOI 10.1074/jbc.M111.264671; Buzzi LI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027025; Cao SS, 2012, CURR BIOL, V22, pR622, DOI 10.1016/j.cub.2012.07.004; Chamilos G, 2007, ANTIMICROB AGENTS CH, V51, P2257, DOI 10.1128/AAC.00095-07; Chavan M, 2003, P NATL ACAD SCI USA, V100, P15381, DOI 10.1073/pnas.2536561100; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Chen YL, 2012, G3-GENES GENOM GENET, V2, P675, DOI 10.1534/g3.112.002279; Cid VJ, 1998, MICROBIOL-SGM, V144, P25, DOI 10.1099/00221287-144-1-25; Clancy CJ, 2006, ANTIMICROB AGENTS CH, V50, P2569, DOI 10.1128/AAC.00291-06; Cota J, 2006, ANTIMICROB AGENTS CH, V50, P3926, DOI 10.1128/AAC.00538-06; Cota JM, 2008, ANTIMICROB AGENTS CH, V52, P1144, DOI 10.1128/AAC.01542-07; de Groot PWJ, 2008, EUKARYOT CELL, V7, P1951, DOI 10.1128/EC.00284-08; Denardi LB, 2015, BRAZ J MICROBIOL, V46, P125, DOI 10.1590/S1517-838246120120442; ELORZA MV, 1983, J GEN MICROBIOL, V129, P1577; Fanchiotti S, 1998, J CELL BIOL, V143, P625, DOI 10.1083/jcb.143.3.625; Feng XZ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002330; Francois JM, 2006, NAT PROTOC, V1, P2995, DOI 10.1038/nprot.2006.457; Frost A, 2012, CELL, V149, P1339, DOI 10.1016/j.cell.2012.04.028; Garcia R, 2009, J BIOL CHEM, V284, P10901, DOI 10.1074/jbc.M808693200; Gardner BM, 2011, SCIENCE, V333, P1891, DOI 10.1126/science.1209126; Gebbie L, 2014, METHODS MOL BIOL, V1099, P159, DOI 10.1007/978-1-62703-715-0_14; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Herrero AB, 2004, EUKARYOT CELL, V3, P1423, DOI 10.1128/EC.3.6.1423-1432.2004; Hurtado-Guerrero R, 2009, J BIOL CHEM, V284, P8461, DOI 10.1074/jbc.M807990200; Jandric Z, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00350; Jung K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089324; Jung US, 1999, MOL MICROBIOL, V34, P1049, DOI 10.1046/j.1365-2958.1999.01667.x; Katiyar S, 2006, ANTIMICROB AGENTS CH, V50, P2892, DOI 10.1128/AAC.00349-06; Kollar R, 1997, J BIOL CHEM, V272, P17762, DOI 10.1074/jbc.272.28.17762; Krysan Damian J, 2009, Commun Integr Biol, V2, P233; Kurita T, 2012, J BIOL CHEM, V287, P17415, DOI 10.1074/jbc.M111.321018; Lagorce A, 2002, EUR J BIOCHEM, V269, P1697, DOI 10.1046/j.1432-1327.2002.02814.x; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Levinson JN, 2002, YEAST, V19, P1243, DOI 10.1002/yea.908; Maesaki S, 1998, J ANTIMICROB CHEMOTH, V42, P747, DOI 10.1093/jac/42.6.747; Martin H, 2000, J BIOL CHEM, V275, P1511, DOI 10.1074/jbc.275.2.1511; MEADEN P, 1990, MOL CELL BIOL, V10, P3013, DOI 10.1128/MCB.10.6.3013; Miyazaki T, 2014, VIRULENCE, V5, P365, DOI 10.4161/viru.27373; Miyazaki T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003160; Miyazaki T, 2011, FEMS YEAST RES, V11, P621, DOI 10.1111/j.1567-1364.2011.00751.x; Miyazaki T, 2010, FEMS YEAST RES, V10, P343, DOI 10.1111/j.1567-1364.2010.00611.x; Munro CA, 2001, MOL MICROBIOL, V39, P1414, DOI 10.1046/j.1365-2958.2001.02347.x; Nakayama H, 1998, MICROBIOL-UK, V144, P2407, DOI 10.1099/00221287-144-9-2407; Neofytos D, 2010, TRANSPL INFECT DIS, V12, P220, DOI 10.1111/j.1399-3062.2010.00492.x; Nett JE, 2011, EUKARYOT CELL, V10, P1660, DOI 10.1128/EC.05126-11; Niimi K, 2012, J ANTIMICROB CHEMOTH, V67, P1666, DOI 10.1093/jac/dks112; NIKAWA JI, 1992, MOL MICROBIOL, V6, P1441, DOI 10.1111/j.1365-2958.1992.tb00864.x; Proia L, 2009, AM J TRANSPLANT, V9, pS199, DOI 10.1111/j.1600-6143.2009.02912.x; Ram R, 2009, BONE MARROW TRANSPL, V43, P643, DOI 10.1038/bmt.2008.373; Roetzer A, 2011, FEMS MICROBIOL LETT, V314, P1, DOI 10.1111/j.1574-6968.2010.02102.x; RONCERO C, 1985, J BACTERIOL, V163, P1180, DOI 10.1128/JB.163.3.1180-1185.1985; Scrimale T, 2009, MOL BIOL CELL, V20, P164, DOI 10.1091/mbc.E08-08-0809; Selvakumar D, 2006, ANTIMICROB AGENTS CH, V50, P3090, DOI 10.1128/AAC.01435-05; Shahinian S, 2000, MOL MICROBIOL, V35, P477, DOI 10.1046/j.1365-2958.2000.01713.x; Shahinian S, 1998, GENETICS, V149, P843; Skeens M, 2012, BONE MARROW TRANSPL, V47, P1415, DOI 10.1038/bmt.2012.59; Stevens DA, 2006, ANTIMICROB AGENTS CH, V50, P3160, DOI 10.1128/AAC.00563-06; Sugita T, 2005, J CLIN MICROBIOL, V43, P2824, DOI 10.1128/JCM.43.6.2824-2829.2005; Taylor SC, 2004, NAT STRUCT MOL BIOL, V11, P128, DOI 10.1038/nsmb715; Ueno K, 2007, EUKARYOT CELL, V6, P1239, DOI 10.1128/EC.00414-06; Urano F, 2000, J CELL SCI, V113, P3697; Valiante V, 2009, FUNGAL GENET BIOL, V46, P909, DOI 10.1016/j.fgb.2009.08.005; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038	69	5	5	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161371	10.1371/journal.pone.0161371	http://dx.doi.org/10.1371/journal.pone.0161371			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548283	Green Published, gold, Green Submitted			2022-12-26	WOS:000381768400048
J	Petrova, MI; Imholz, NCE; Verhoeven, TLA; Balzarini, J; Van Damme, EJM; Schols, D; Vanderleyden, J; Lebeer, S				Petrova, Mariya I.; Imholz, Nicole C. E.; Verhoeven, Tine L. A.; Balzarini, Jan; Van Damme, Els J. M.; Schols, Dominique; Vanderleyden, Jos; Lebeer, Sarah			Lectin-Like Molecules of Lactobacillus rhamnosus GG Inhibit Pathogenic Escherichia coli and Salmonella Biofilm Formation	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; FUNCTIONAL-ANALYSIS; STAPHYLOCOCCUS-AUREUS; CARBOHYDRATE-BINDING; REFERENCE COLLECTION; COMMON THEMES; GENE; TYPHIMURIUM; PLANTARUM; BACTERIA	Objectives Increased antibiotic resistance has catalyzed the research on new antibacterial molecules and alternative strategies, such as the application of beneficial bacteria. Since lectin molecules have unique sugar-recognizing capacities, and pathogens are often decorated with sugars that affect their survival and infectivity, we explored whether lectins from the probiotic strain Lactobacillus rhamnosus GG have antipathogenic properties. Methods The genome sequence of L. rhamnosus GG was screened for the presence of lectin-like proteins. Two genes, LGG_RS02780 and LGG_RS02750, encoding for polypeptides with an N-terminal conserved L-type lectin domain were detected and designated Llp1 (lectinlike protein 1) and Llp2. The capacity of Llp1 and Llp2 to inhibit biofilm formation of various pathogens was investigated. Sugar specificity was determined by Sepharose beads assays and glycan array screening. Results The isolated lectin domains of Llp1 and Llp2 possess pronounced inhibitory activity against biofilm formation by various pathogens, including clinical Salmonella species and uropathogenic E. coli, with Llp2 being more active than Llp1. In addition, sugar binding assays with Llp1 and Llp2 indicate specificity for complex glycans. Both proteins are also involved in the adhesion capacity of L. rhamnosus GG to gastrointestinal and vaginal epithelial cells. Conclusions Lectins isolated from or expressed by beneficial lactobacilli could be considered promising bio-active ingredients for improved prophylaxis of urogenital and gastrointestinal infections.	[Petrova, Mariya I.; Imholz, Nicole C. E.; Verhoeven, Tine L. A.; Vanderleyden, Jos; Lebeer, Sarah] Katholieke Univ Leuven, Ctr Microbial & Plant Genet, Kasteelpk Arenberg 20,Box 2460, B-3001 Leuven, Belgium; [Petrova, Mariya I.; Lebeer, Sarah] Univ Antwerp, Dept Biosci Engn, Groenenborgerlaan 171, B-2020 Antwerp, Belgium; [Balzarini, Jan; Schols, Dominique] Katholieke Univ Leuven, Rega Inst Med Res, Minderbroedersstr 10, B-3000 Leuven, Belgium; [Van Damme, Els J. M.] Univ Ghent, Dept Mol Biotechnol, Lab Biochem & Glycobiol, Coupure Links 653, B-9000 Ghent, Belgium	KU Leuven; University of Antwerp; KU Leuven; Ghent University	Petrova, MI; Lebeer, S (corresponding author), Katholieke Univ Leuven, Ctr Microbial & Plant Genet, Kasteelpk Arenberg 20,Box 2460, B-3001 Leuven, Belgium.; Petrova, MI; Lebeer, S (corresponding author), Univ Antwerp, Dept Biosci Engn, Groenenborgerlaan 171, B-2020 Antwerp, Belgium.	mariyapetrova3@gmail.com; sarah.lebeer@uantwerpen.be	Petrova, Mariya/U-8087-2019; Van Damme, Els J/B-4410-2015; Schols, Dominique/AAC-1309-2021; Lebeer, Sarah/S-9951-2019; Schols, Dominique/S-9057-2017; Van Damme, Els/U-3904-2019; Lebeer, Sarah/D-5156-2014	Schols, Dominique/0000-0003-3256-5850; Lebeer, Sarah/0000-0002-9400-6918; Schols, Dominique/0000-0003-3256-5850; Van Damme, Els/0000-0001-9848-766X; Lebeer, Sarah/0000-0002-9400-6918	Fund for Scientific Research (FWO Vlaanderen) [12Q0115N]; FWO Vlaanderen [1520114N]; BOF program from the KU Leuven [PF/10/018];  [R24 GM098791]	Fund for Scientific Research (FWO Vlaanderen)(FWO); FWO Vlaanderen(FWO); BOF program from the KU Leuven; 	Mariya Petrova holds a postdoctoral grant from the Fund for Scientific Research (FWO Vlaanderen, http://www.fwo.be/en/) with postdoctoral grant 12Q0115N. Sarah Lebeer was supported from the FWO Vlaanderen with a postdoctoral grant and research grant 1520114N. Work at KU Leuven was supported by BOF program financing from the KU Leuven (PF/10/018). We thank the Protein-glycan Interaction Resource of the CFG and the supporting grant R24 GM098791 for conducting the glycan array analysis. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Arndt NX, 2011, J CELL BIOCHEM, V112, P2230, DOI 10.1002/jcb.23139; Balcazar JL, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01216; BELTRAN P, 1991, J GEN MICROBIOL, V137, P601, DOI 10.1099/00221287-137-3-601; Berendonk TU, 2015, NAT REV MICROBIOL, V13, P310, DOI 10.1038/nrmicro3439; BOYD EF, 1993, J GEN MICROBIOL, V139, P1125, DOI 10.1099/00221287-139-6-1125; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Clarke SR, 2002, INFECT IMMUN, V70, P6680, DOI 10.1128/IAI.70.12.6680-6687.2002; Dias RD, 2015, MOLECULES, V20, P519, DOI 10.3390/molecules20010519; Diggle SP, 2006, ENVIRON MICROBIOL, V8, P1095, DOI 10.1111/j.1462-2920.2006.001001.x; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; FORNSTEDT N, 1975, FEBS LETT, V57, P187, DOI 10.1016/0014-5793(75)80713-7; Francois KO, 2012, MED RES REV, V32, P349, DOI 10.1002/med.20216; Gardiner GE, 2002, CLIN DIAGN LAB IMMUN, V9, P92, DOI 10.1128/CDLI.9.1.92-96.2002; GASSER F, 1970, J GEN MICROBIOL, V62, P219, DOI 10.1099/00221287-62-2-219; Hobley L, 2015, FEMS MICROBIOL REV, V39, P649, DOI 10.1093/femsre/fuv015; Hofberger JA, 2015, GENOME BIOL EVOL, V7, P720, DOI 10.1093/gbe/evv020; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Hunstad DA, 2005, INFECT IMMUN, V73, P3999, DOI 10.1128/IAI.73.7.3999-4006.2005; Imberty A, 2008, CURR OPIN STRUC BIOL, V18, P567, DOI 10.1016/j.sbi.2008.08.001; JOSSON K, 1989, PLASMID, V21, P9, DOI 10.1016/0147-619X(89)90082-6; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Lannoo N, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00397; Lasa I, 2006, RES MICROBIOL, V157, P99, DOI 10.1016/j.resmic.2005.11.003; Lebeer S, 2007, J BACTERIOL, V189, P860, DOI 10.1128/JB.01394-06; Lebeer S, 2012, APPL ENVIRON MICROB, V78, P185, DOI 10.1128/AEM.06192-11; Lebeer S, 2009, APPL ENVIRON MICROB, V75, P3554, DOI 10.1128/AEM.02919-08; Malik S, 2014, GENOME ANNOUNC, V2; Malik S, 2013, APPL ENVIRON MICROB, V79, P4576, DOI 10.1128/AEM.00926-13; MARINUS MG, 1983, MOL GEN GENET, V192, P288, DOI 10.1007/BF00327681; MOORE WEC, 1980, APPL ENVIRON MICROB, V39, P900, DOI 10.1128/AEM.39.4.900-907.1980; Nagy Z, 2004, MOL MICROBIOL, V54, P478, DOI 10.1111/j.1365-2958.2004.04279.x; Petrova MI, 2013, J ANTIMICROB CHEMOTH, V68, P2026, DOI 10.1093/jac/dkt152; Pieters RJ, 2011, ADV EXP MED BIOL, V715, P227, DOI 10.1007/978-94-007-0940-9_14; Pretzer G, 2005, J BACTERIOL, V187, P6128, DOI 10.1128/JB.187.17.6128-6136.2005; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Reid G, 1999, APPL ENVIRON MICROB, V65, P3763; Reid G, 2001, FEMS IMMUNOL MED MIC, V30, P49, DOI 10.1111/j.1574-695X.2001.tb01549.x; Robijns SCA, 2014, BIOFOULING, V30, P605, DOI 10.1080/08927014.2014.907401; Sambrook J., 1989, MOLECULAR CLONING A; Segers ME, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-S1-S7; Sharon N, 2007, LECTINS; Siezen R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-126; Steenackers H, 2012, FOOD RES INT, V45, P502, DOI 10.1016/j.foodres.2011.01.038; Steenackers HPL, 2011, J MED CHEM, V54, P472, DOI 10.1021/jm1011148; Tielker D, 2005, MICROBIOL-SGM, V151, P1313, DOI 10.1099/mic.0.27701-0; Topin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071149; Tytgat HLP, 2014, MICROBIOL MOL BIOL R, V78, P372, DOI 10.1128/MMBR.00007-14; Damme EJM, 2011, ADV EXP MED BIOL, V705, P757, DOI 10.1007/978-1-4419-7877-6_39; Van Houdt R, 2005, RES MICROBIOL, V156, P626, DOI 10.1016/j.resmic.2005.02.005; Wei Q, 2013, INT J MOL SCI, V14, P20983, DOI 10.3390/ijms141020983; Wu H, 2015, INT J ORAL SCI, V7, P1, DOI 10.1038/ijos.2014.65; Yang YH, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004169	54	47	52	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161337	10.1371/journal.pone.0161337	http://dx.doi.org/10.1371/journal.pone.0161337			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537843	Green Published, gold, Green Submitted			2022-12-26	WOS:000381577000089
J	Saggio, ML; Ritter, P; Jirsa, VK				Saggio, Maria Luisa; Ritter, Petra; Jirsa, Viktor K.			Analytical Operations Relate Structural and Functional Connectivity in the Brain	PLOS ONE			English	Article							VIRTUAL BRAIN; CEREBRAL-CORTEX; NETWORKS; DYNAMICS; MRI; ARCHITECTURE; REGIONS; MODELS; SYSTEM	Resting-state large-scale brain models vary in the amount of biological elements they incorporate and in the way they are being tested. One might expect that the more realistic the model is, the closer it should reproduce real functional data. It has been shown, instead, that when linear correlation across long BOLD fMRI time-series is used as a measure for functional connectivity (FC) to compare simulated and real data, a simple model performs just as well, or even better, than more sophisticated ones. The model in question is a simple linear model, which considers the physiological noise that is pervasively present in our brain while it diffuses across the white-matter connections, that is structural connectivity (SC). We deeply investigate this linear model, providing an analytical solution to straightforwardly compute FC from SC without the need of computationally costly simulations of time-series. We provide a few examples how this analytical solution could be used to perform a fast and detailed parameter exploration or to investigate resting-state non-stationarities. Most importantly, by inverting the analytical solution, we propose a method to retrieve information on the anatomical structure directly from functional data. This simple method can be used to complement or guide DTI/DSI and tractography results, especially for a better assessment of inter-hemispheric connections, or to provide an estimate of SC when only functional data are available.	[Saggio, Maria Luisa; Jirsa, Viktor K.] Aix Marseille Univ, Fac Med, Inst Neurosci Syst, Marseille, France; [Saggio, Maria Luisa; Jirsa, Viktor K.] Aix Marseille Univ, INSERM, UMR 1106, Marseille, France; [Ritter, Petra] Max Planck Inst Human Cognit & Brain Sci, Minerva Res Grp BrainModes, Leipzig, Germany; [Ritter, Petra] Charite, Dept Neurol, Berlin, Germany; [Ritter, Petra] Bernstein Focus State Dependencies Learning & Ber, Berlin, Germany; [Ritter, Petra] Humboldt Univ, Berlin Sch Mind & Brain & Mind, Berlin, Germany; [Ritter, Petra] Humboldt Univ, Inst Brain, Berlin, Germany	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; Humboldt University of Berlin	Jirsa, VK (corresponding author), Aix Marseille Univ, Fac Med, Inst Neurosci Syst, Marseille, France.; Jirsa, VK (corresponding author), Aix Marseille Univ, INSERM, UMR 1106, Marseille, France.	viktor.jirsa@univ-amu.fr	Jirsa, Viktor/M-4630-2016; Ritter, Petra/B-6953-2008	Jirsa, Viktor/0000-0002-8251-8860; Ritter, Petra/0000-0002-4643-4782	Brain Network Recovery Group through the James S. McDonnell Foundation; European Union Seventh Framework Programme (FP7-ICT BrainScales and Human Brain Project) [60402]; James S. McDonnell Foundation (Brain Network Recovery Group) [JSMF22002082]; German Ministry of Education and Research (Bernstein Focus State Dependencies of Learning) [01GQ0971]; Max-Planck Society (Minerva Program)	Brain Network Recovery Group through the James S. McDonnell Foundation; European Union Seventh Framework Programme (FP7-ICT BrainScales and Human Brain Project); James S. McDonnell Foundation (Brain Network Recovery Group); German Ministry of Education and Research (Bernstein Focus State Dependencies of Learning); Max-Planck Society (Minerva Program)	VJ acknowledges the support of the Brain Network Recovery Group through the James S. McDonnell Foundation and funding from the European Union Seventh Framework Programme (FP7-ICT BrainScales and Human Brain Project [grant no. 60402]). PR acknowledges the support of the James S. McDonnell Foundation (Brain Network Recovery Group JSMF22002082), the German Ministry of Education and Research (Bernstein Focus State Dependencies of Learning 01GQ0971) and the Max-Planck Society (Minerva Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelnour F, 2014, NEUROIMAGE, V90, P335, DOI 10.1016/j.neuroimage.2013.12.039; Anderson JS, 2011, AM J NEURORADIOL, V32, P548, DOI 10.3174/ajnr.A2330; Banerjee A, 2008, NEUROIMAGE, V42, P663, DOI 10.1016/j.neuroimage.2008.04.260; Barnett L, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.051914; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chang C, 2010, NEUROIMAGE, V50, P81, DOI 10.1016/j.neuroimage.2009.12.011; Daffertshofer Andreas, 2011, Front Neuroinform, V5, P6, DOI 10.3389/fninf.2011.00006; Deco G, 2014, J NEUROSCI, V34, P7910, DOI 10.1523/JNEUROSCI.4423-13.2014; Deco G, 2013, J NEUROSCI, V33, P11239, DOI 10.1523/JNEUROSCI.1091-13.2013; Deco G, 2012, J NEUROSCI, V32, P3366, DOI 10.1523/JNEUROSCI.2523-11.2012; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dhamala M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.074104; Dominguez LG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061493; Feng JF, 2006, CHAOS, V16, DOI 10.1063/1.2180690; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Galan RF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002148; Ghosh A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000196; Goni J, 2014, P NATL ACAD SCI USA, V111, P833, DOI 10.1073/pnas.1315529111; Hansen ECA, 2015, NEUROIMAGE, V105, P525, DOI 10.1016/j.neuroimage.2014.11.001; Hindriks R, 2015, NEUROIMAGE; Hlinka J, 2012, EUR J NEUROSCI, V36, P2137, DOI 10.1111/j.1460-9568.2012.08081.x; Hlinka J, 2011, NEUROIMAGE, V54, P2218, DOI 10.1016/j.neuroimage.2010.08.042; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Jirsa VK, 2010, ARCH ITAL BIOL, V148, P189; Jirsa VK, 2009, PHILOS T R SOC A, V367, P1131, DOI 10.1098/rsta.2008.0260; Jirsa VK, 2008, COGN NEURODYNAMICS, V2, P29, DOI 10.1007/s11571-007-9030-0; Jirsa VK, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.070602; Lauritzen S.L.., 1996, GRAPHICAL MODELS; Leonardi N, 2015, NEUROIMAGE, V104, P430, DOI 10.1016/j.neuroimage.2014.09.007; Li LC, 2012, NEUROIMAGE, V61, P1017, DOI 10.1016/j.neuroimage.2012.03.071; Liptrot MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096247; Marrelec G, 2009, HUM BRAIN MAPP, V30, P941, DOI 10.1002/hbm.20555; Marrelec G, 2006, NEUROIMAGE, V32, P228, DOI 10.1016/j.neuroimage.2005.12.057; Masuda H, 2004, BERNOULLI, V10, P97, DOI 10.3150/bj/1077544605; McIntosh AR, 2010, ARCH ITAL BIOL, V148, P323; Messe A, 2015, SCI REP-UK, V5, DOI 10.1038/srep07870; Messe A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003530; Mueller S, 2013, NEURON, V77, P586, DOI 10.1016/j.neuron.2012.12.028; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Park HJ, 2013, SCIENCE, V342, P579, DOI 10.1126/science.1238411; Qubbaj MR, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.238102; Rho YA, 2011, BRAIN CONNECT, V1, P73, DOI 10.1089/brain.2011.0009; Ritter P, 2006, NEUROSCI BIOBEHAV R, V30, P823, DOI 10.1016/j.neubiorev.2006.06.008; Ritter P, 2013, BRAIN CONNECT, V3, P121, DOI 10.1089/brain.2012.0120; Ritter P, 2010, EEG-FMRI: PHYSIOLOGICAL BASIS, TECHNIQUE AND APPLICATIONS, P153, DOI 10.1007/978-3-540-87919-0_9; Robinson PA, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.012707; Robinson PA, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.011912; Rosazza C, 2011, NEUROL SCI, V32, P773, DOI 10.1007/s10072-011-0636-y; Roy D, 2014, BRAIN CONNECT, V4, P791, DOI 10.1089/brain.2014.0252; Schirner M, 2015, NEUROIMAGE, V117, P343, DOI 10.1016/j.neuroimage.2015.03.055; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Stam C, 2015, INT J PSYCHOPHYSIOLO; Steinke GK, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002207; Sutera A, 2014, ARXIV14067865; TONONI G, 1994, P NATL ACAD SCI USA, V91, P5033, DOI 10.1073/pnas.91.11.5033; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; Uddin LQ, 2011, J NEUROSCI, V31, P18578, DOI 10.1523/JNEUROSCI.4465-11.2011; Uhlenbeck GE, 1930, PHYS REV, V36, P0823, DOI 10.1103/PhysRev.36.823; Watanabe T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2388	62	26	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0157292	10.1371/journal.pone.0157292	http://dx.doi.org/10.1371/journal.pone.0157292			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536987	Green Published, Green Submitted, gold			2022-12-26	WOS:000381577000003
J	Taylor, JM; Ptomey, L; Hamilton-Reeves, JM; Sullivan, DK; Creed, C; Carlson, SE; Wesson, DE; Grantham, JJ; Gibson, CA				Taylor, Jacob M.; Ptomey, Lauren; Hamilton-Reeves, Jill M.; Sullivan, Debra K.; Creed, Catherine; Carlson, Susan E.; Wesson, Donald E.; Grantham, Jared J.; Gibson, Cheryl A.			Experiences and Perspectives of Polycystic Kidney Disease Patients following a Diet of Reduced Osmoles, Protein, and Acid Precursors Supplemented with Water: A Qualitative Study	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; BLOOD-PRESSURE; PROGRESSION; AMELIORATION; ENDOTHELIN; REDUCTION; DECLINE; INJURY; LOAD; SALT	Background Salt, protein, acid precursors, and fluid intake have been identified as factors that influence cyst growth in ADPKD. Unfortunately, the feasibility of following these dietary restrictions/enhancements from a patient's point-of-view has yet to be studied. The purpose of this study is to understand better the experiences of patients following a relatively complex dietary prescription targeting these factors. Methods Twelve adults with ADPKD and kidney function >30ml/min/1.73m(2) were recruited from the University of Kansas Medical Center Polycystic Kidney Disease clinic. In a qualitative design, semi-structured interviews of participants were conducted following a four week dietary intervention (experimental diet lower in sodium, protein, and acid precursors, and supplemented with water) either face-to-face or by telephone. All interviews were recorded, transcribed verbatim, and checked for accuracy. Transcripts were analyzed thematically for emerging themes. Results Participants reported that eating less meat and more fruits and vegetables were the easiest components of the diet, whereas reaching the daily goal amount of fruits and vegetables and tracking the diet constantly were the most difficult components. Participants had little difficulty with fluid intake and reported the prescribed fluid goal as achievable. The tracking system for fruits and vegetables and protein was reported to be both helpful and intuitive, but tracking their intake on paper was tedious. Eating out was the most significant barrier to following the diet with some individuals avoiding restaurants in order to comply with the dietary prescription. Conclusion Participants on the experimental diet heightened their awareness of the consumption of dietary salt, protein, acid precursors, and fluid intake. Additionally, most participants believed adherence to the prescribed diet was feasible. However, participants wanted less cumbersome ways to track and monitor the diet, especially given that the prescribed diet is designed for lifelong adherence. Future studies should focus on targeting these specific dietary factors in larger groups of more ethnically and culturally diverse populations to help inform clinicians and how best to help diverse populations adhere to the dietary intervention.	[Taylor, Jacob M.; Hamilton-Reeves, Jill M.; Sullivan, Debra K.; Carlson, Susan E.] Univ Kansas, Med Ctr, Dept Nutr & Dietet, Sch Hlth Profess, Kansas City, KS 66103 USA; [Taylor, Jacob M.] Childrens Mercy Hosp & Clin, Dept Nutr Serv, Kansas City, MO 64108 USA; [Ptomey, Lauren] Univ Kansas, Med Ctr, Sch Med, Div Cardiovasc Dis, Kansas City, KS 66103 USA; [Creed, Catherine; Grantham, Jared J.] Univ Kansas, Med Ctr, Sch Med, Dept Med Nephrol,Kidney Inst, Kansas City, KS 66103 USA; [Wesson, Donald E.] Texas A&M Hlth Sci Ctr Coll Med, Baylor Scott & White Hlth, Dept Internal Med, Temple, TX USA; [Gibson, Cheryl A.] Univ Kansas, Med Ctr, Sch Med, Dept Internal Med,Div Gen Med, Kansas City, KS 66103 USA; [Taylor, Jacob M.] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands	University of Kansas; University of Kansas Medical Center; Children's Mercy Hospital; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; Baylor Health Care System; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Kansas; University of Kansas Medical Center; University of Groningen	Taylor, JM (corresponding author), Univ Kansas, Med Ctr, Dept Nutr & Dietet, Sch Hlth Profess, Kansas City, KS 66103 USA.; Taylor, JM (corresponding author), Childrens Mercy Hosp & Clin, Dept Nutr Serv, Kansas City, MO 64108 USA.; Taylor, JM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands.	jacobtaylor.ms_rd@yahoo.com		Ptomey, Lauren/0000-0002-1705-1643	Frontiers Pilot and Collaborative Studies Funding Program; University of Kansas Medical Center Research Institute Clinical Pilots Program; Abbott Nutrition Award through the Academy of Nutrition and Dietetics; University of Kansas Medical Center Kidney Institute's Research and Development fund; NCATS [KL2TR000119]	Frontiers Pilot and Collaborative Studies Funding Program; University of Kansas Medical Center Research Institute Clinical Pilots Program; Abbott Nutrition Award through the Academy of Nutrition and Dietetics; University of Kansas Medical Center Kidney Institute's Research and Development fund; NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the Frontiers Pilot and Collaborative Studies Funding Program and the University of Kansas Medical Center Research Institute Clinical Pilots Program (JJG, JMHR, DKS), the Abbott Nutrition Award funded through the Academy of Nutrition and Dietetics (JMT), and the University of Kansas Medical Center Kidney Institute's Research and Development fund (JJG). Support for J. Hamilton-Reeves was provided by KL2 training grant KL2TR000119 a CTSA grant from NCATS awarded to the University of Kansas Medical Center for Frontiers: The Heartland Institute for Clinical and Translational Research (JMHR). The contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH or NCATS. The sponsors were not involved in the study design, in the collection, analysis and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication.	Banerjee T, 2015, J AM SOC NEPHROL, V26, P1693, DOI 10.1681/ASN.2014040332; Banerjee T, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-137; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brindal E, 2013, J TELEMED TELECARE, V19, P166, DOI 10.1177/1357633X13479702; Cianciaruso B, 2008, NEPHROL DIAL TRANSPL, V23, P636, DOI 10.1093/ndt/gfm576; Colin-Ramirez E, 2015, J CARDIOVASC NURS, V30, P58, DOI 10.1097/JCN.0000000000000124; Cowley BD, 1996, AM J KIDNEY DIS, V27, P865, DOI 10.1016/S0272-6386(96)90525-9; Ecder T, 2000, AM J KIDNEY DIS, V36, P266, DOI 10.1053/ajkd.2000.8970; Frassetto LA, 2007, J NUTR, V137, P1491, DOI 10.1093/jn/137.6.1491; Gattone VH, 2003, NAT MED, V9, P1323, DOI 10.1038/nm935; Goraya N, 2014, AM J NEPHROL, V39, P142, DOI 10.1159/000358602; Goraya N, 2012, CURR OPIN NEPHROL HY, V21, P552, DOI 10.1097/MNH.0b013e328356233b; Goraya N, 2012, KIDNEY INT, V81, P86, DOI 10.1038/ki.2011.313; Grantham JJ, 2008, NEW ENGL J MED, V359, P1477, DOI 10.1056/NEJMcp0804458; Grantham JJ, 2015, PEDIATR NEPHROL, V30, P1053, DOI 10.1007/s00467-014-2882-8; Hadziabdic MO, 2015, J HUM NUTR DIET, V28, P24, DOI 10.1111/jhn.12270; He FJ, 2009, J HUM HYPERTENS, V23, P363, DOI 10.1038/jhh.2008.144; Mahajan A, 2010, KIDNEY INT, V78, P303, DOI 10.1038/ki.2010.129; McCauley LR, 2012, J UROLOGY, V187, P1282, DOI 10.1016/j.juro.2011.11.111; McMahon EJ, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/720429; MILAS NC, 1995, J AM DIET ASSOC, V95, P1295, DOI 10.1016/S0002-8223(95)00340-1; Miles M. B., 2019, SAGE, DOI DOI 10.1080/1034912X.2016.1228856; Nagao S, 2006, J AM SOC NEPHROL, V17, P2220, DOI 10.1681/ASN.2006030251; Ogborn MR, 1995, J AM SOC NEPHROL, V6, P1649; Phisitkul S, 2010, KIDNEY INT, V77, P617, DOI 10.1038/ki.2009.519; Ritchie J., 2013, QUALITATIVE RES PRAC; Schakel SF, 2001, J FOOD COMPOS ANAL, V14, P315, DOI 10.1006/jfca.2001.0992; Schrier RW, 2014, NEW ENGL J MED, V371, P2255, DOI 10.1056/NEJMoa1402685; Shenton A.K., 2004, ED INF, V22, P63, DOI DOI 10.3233/EFI-2004-22201; Tanner GA, 2000, KIDNEY INT, V58, P1859, DOI 10.1046/j.1523-1755.2000.00357.x; Taylor JM, 2017, CLIN NUTR, V36, P458, DOI 10.1016/j.clnu.2016.01.003; Torres VE, 2011, CLIN J AM SOC NEPHRO, V6, P640, DOI 10.2215/CJN.03250410; Wang CJ, 2011, CLIN J AM SOC NEPHRO, V6, P192, DOI 10.2215/CJN.03950510; Wang XF, 2008, J AM SOC NEPHROL, V19, P102, DOI 10.1681/ASN.2007060688; Wesson DE, 2010, KIDNEY INT, V78, P1128, DOI 10.1038/ki.2010.348	35	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161043	10.1371/journal.pone.0161043	http://dx.doi.org/10.1371/journal.pone.0161043			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537328	Green Published, gold, Green Submitted			2022-12-26	WOS:000381577000045
J	Ballhorn, DJ; Rakotoarivelo, FP; Kautz, S				Ballhorn, Daniel J.; Rakotoarivelo, Fanny Patrika; Kautz, Stefanie			Coevolution of Cyanogenic Bamboos and Bamboo Lemurs on Madagascar	PLOS ONE			English	Article							PLANT SECONDARY COMPOUNDS; GENERALIST MAMMALIAN FOLIVORE; BEAN PHASEOLUS-LUNATUS; SOUTHEASTERN MADAGASCAR; TRICHOSURUS-VULPECULA; PHYLOGENETIC ANALYSIS; HERBIVOROUS INSECTS; FEEDING PATTERNS; BETA-GLUCOSIDASE; TROPICAL FORESTS	Feeding strategies of specialist herbivores often originate from the coevolutionary arms race of plant defenses and counter-adaptations of herbivores. The interaction between bamboo lemurs and cyanogenic bamboos on Madagascar represents a unique system to study diffuse coevolutionary processes between mammalian herbivores and plant defenses. Bamboo lemurs have different degrees of dietary specialization while bamboos show different levels of chemical defense. In this study, we found variation in cyanogenic potential (HCNp) and nutritive characteristics among five sympatric bamboo species in the Ranomafana area, southeastern Madagascar. The HCNp ranged from 209 +/- 72 mu mol cyanide*g(-1) dwt in Cathariostachys madagascariensis to no cyanide in Bambusa madagascariensis. Among three sympatric bamboo lemur species, the greater bamboo lemur (Prolemur simus) has the narrowest food range as it almost exclusively feeds on the highly cyanogenic C. madagascariensis. Our data suggest that high HCNp is the derived state in bamboos. The ancestral state of lemurs is most likely "generalist" while the ancestral state of bamboo lemurs was determined as equivocal. Nevertheless, as recent bamboo lemurs comprise several "facultative specialists" and only one "obligate specialist" adaptive radiation due to increased flexibility is likely. We propose that escaping a strict food plant specialization enabled facultative specialist bamboo lemurs to inhabit diverse geographical areas.	[Ballhorn, Daniel J.; Kautz, Stefanie] Portland State Univ, Dept Biol, 1719 SW 10th Ave, Portland, OR 97201 USA; [Rakotoarivelo, Fanny Patrika] Univ La Reunion, UMR PVBMT, 15 Ave Rene Cassin, St Denis 97715, Reunion, France	Portland State University; University of La Reunion	Ballhorn, DJ (corresponding author), Portland State Univ, Dept Biol, 1719 SW 10th Ave, Portland, OR 97201 USA.	ballhorn@pdx.edu			Deutsche Forschungsgemeinschaft (DFG) [Ba 3966/1-1]; National Science Foundation (NSF) [1457369]; German Academy of Sciences Leopoldina [LPDS 2009-29]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); National Science Foundation (NSF)(National Science Foundation (NSF)); German Academy of Sciences Leopoldina	DJB gratefully acknowledges funding from the Deutsche Forschungsgemeinschaft (DFG grant Ba 3966/1-1) and the National Science Foundation (NSF grant 1457369). SK acknowledges financial support from the German Academy of Sciences Leopoldina (grant LPDS 2009-29). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali JG, 2012, TRENDS PLANT SCI, V17, P293, DOI 10.1016/j.tplants.2012.02.006; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2006, THESIS U TEXAS AUSTI; Ball JP, 2000, J APPL ECOL, V37, P247, DOI 10.1046/j.1365-2664.2000.00487.x; Ballhorn DJ, 2007, J CHEM ECOL, V33, P2195, DOI 10.1007/s10886-007-9380-4; Ballhorn DJ, 2010, ENTOMOL EXP APPL, V134, P245, DOI 10.1111/j.1570-7458.2009.00961.x; Ballhorn DJ, 2008, J ECOL, V96, P971, DOI 10.1111/j.1365-2745.2008.01404.x; Ballhorn DJ, 2006, J CHEM ECOL, V32, P1861, DOI 10.1007/s10886-006-9114-z; Ballhorn DJ, 2011, J ECOL, V99, P313, DOI 10.1111/j.1365-2745.2010.01747.x; Ballhorn DJ, 2009, AM J PRIMATOL, V71, P305, DOI 10.1002/ajp.20653; Ballhorn DJ, 2006, J CHEM ECOL, V32, P261, DOI 10.1007/s10886-005-9001-z; Ballhorn DJ, 2005, J CHEM ECOL, V31, P1445, DOI 10.1007/s10886-005-5791-2; Banea-Mayambu JP, 2000, ANN TROP PAEDIATR, V20, P34, DOI 10.1080/02724930092048; BELOVSKY GE, 1984, AM NAT, V124, P97, DOI 10.1086/284254; BELOVSKY GE, 1984, THEOR POPUL BIOL, V25, P235, DOI 10.1016/0040-5809(84)90009-1; BELOVSKY GE, 1994, J MAMMAL, V75, P816, DOI 10.2307/1382464; BERENBAUM M, 1981, SCIENCE, V212, P927, DOI 10.1126/science.212.4497.927; Berenbaum MR, 1998, P NATL ACAD SCI USA, V95, P13743, DOI 10.1073/pnas.95.23.13743; BERENBAUM MR, 1990, ANNU REV ENTOMOL, V35, P319, DOI 10.1146/annurev.en.35.010190.001535; BERNAYS E, 1988, ECOLOGY, V69, P886, DOI 10.2307/1941237; Bernays E. A., 1994, Host-plant selection by phytophagous insects.; Bernays EA, 1997, ECOLOGY, V78, P1157, DOI 10.1890/0012-9658(1997)078[1157:IHDRFB]2.0.CO;2; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Boyle R, 1999, AM ZOOL, V39, p120A; Braby MF, 2012, BIOL J LINN SOC, V107, P697, DOI 10.1111/j.1095-8312.2012.01970.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brooks D.R., 2002, NATURE DIVERSITY; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Bryant JP, 2009, AM NAT, V174, P13, DOI 10.1086/599304; BRYANT JP, 1980, ANNU REV ECOL SYST, V11, P261, DOI 10.1146/annurev.es.11.110180.001401; Carmona D, 2011, FUNCT ECOL, V25, P358, DOI 10.1111/j.1365-2435.2010.01794.x; Chatterjee HJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-259; CHUNG TK, 1991, J NUTR, V121, P979, DOI 10.1093/jn/121.7.979; Clark Lynn G., 2007, Aliso, V23, P315; Colles A, 2009, ECOL LETT, V12, P849, DOI 10.1111/j.1461-0248.2009.01336.x; COOPER SM, 1988, OECOLOGIA, V75, P336, DOI 10.1007/BF00376934; CRAWLEY MJ, 1983, STUDIES ECOLOGY, V10; Dearing MD, 2000, OECOLOGIA, V123, P397, DOI 10.1007/s004420051027; Dearing MD, 1999, J CHEM ECOL, V25, P1205, DOI 10.1023/A:1020958221803; DEARING MD, 1992, ECOLOGY, V73, P845, DOI 10.2307/1940162; Degabriel JL, 2009, ECOLOGY, V90, P711, DOI 10.1890/08-0940.1; DIRZO R, 1982, J ECOL, V70, P119, DOI 10.2307/2259868; Dolch Rainer, 2004, Lemur News, V9, P24; Dolch Rainer, 2008, Lemur News, V13, P14; Drummond A., 2011, GENEIOUS V5 5; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EDWARDS AWF, 1972, LIKELIHOOD; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Engler HS, 2000, NATURE, V406, P144, DOI 10.1038/35018159; Eppley TM, 2011, PRIMATES, V52, P7, DOI 10.1007/s10329-010-0225-3; Evans LM, 2008, EVOLUTION, V62, P3027, DOI 10.1111/j.1558-5646.2008.00497.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Feng ZL, 2009, ECOSYSTEMS, V12, P534, DOI 10.1007/s10021-009-9240-x; FREELAND WJ, 1974, AM NAT, V108, P269, DOI 10.1086/282907; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; GANZHORN JU, 1992, OECOLOGIA, V91, P540, DOI 10.1007/BF00650329; Garshelis DL, 2008, URSUS, V19, P168, DOI 10.2192/07PER011.1; GLANDER KE, 1989, AM J PRIMATOL, V19, P119, DOI 10.1002/ajp.1350190205; Gleadow RM, 2000, AUST J PLANT PHYSIOL, V27, P693, DOI 10.1071/PP00004; Godfrey LR, 1986, PRIMATE CONSERVATION, V7, P92; GOODMAN SM, 2001, INVENTAIRE BIOL PARC, P231; Guglielmo CG, 1996, ECOLOGY, V77, P1103, DOI 10.2307/2265579; Haley SL, 2007, COMP BIOCHEM PHYS C, V146, P552, DOI 10.1016/j.cbpc.2007.06.007; Handasyde, 1999, KOALA NATURAL HIST C; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Isaacson T, 2006, NAT PROTOC, V1, P769, DOI 10.1038/nprot.2006.102; JAENIKE J, 1990, ANNU REV ECOL SYST, V21, P243, DOI 10.1146/annurev.es.21.110190.001331; JAKUBAS WJ, 1993, PHYSIOL ZOOL, V66, P580, DOI 10.1086/physzool.66.4.30163809; JANZEN DH, 1980, EVOLUTION, V34, P611, DOI 10.1111/j.1558-5646.1980.tb04849.x; Johansson J, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.0301; Jordan WC, 1996, AM J BOT, V83, P430, DOI 10.2307/2446212; Julliard R, 2004, GLOBAL CHANGE BIOL, V10, P148, DOI 10.1111/j.1365-2486.2003.00723.x; Kareiva P, 1999, P NATL ACAD SCI USA, V96, P8, DOI 10.1073/pnas.96.1.8; Kautz S, 2009, EVOLUTION, V63, P839, DOI 10.1111/j.1558-5646.2008.00594.x; Kelchner SA, 1997, MOL PHYLOGENET EVOL, V8, P385, DOI 10.1006/mpev.1997.0432; LANYON SM, 1992, SCIENCE, V255, P77, DOI 10.1126/science.1553533; Lawler IR, 1998, OECOLOGIA, V116, P160, DOI 10.1007/s004420050575; LEESON S, 1991, POULTRY SCI, V70, P1739, DOI 10.3382/ps.0701739; Lehman Shawn M., 2000, Lemur News, V5, P23; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Li WM, 2003, P NATL ACAD SCI USA, V100, P14593, DOI 10.1073/pnas.1934643100; LOBEL PS, 1981, MAR BIOL, V64, P173, DOI 10.1007/BF00397106; Maddison D.R., 2007, MESQUITE 2 MODULAR S; Magalhaes CP, 2000, PHYTOCHEM ANALYSIS, V11, P57, DOI 10.1002/(SICI)1099-1565(200001/02)11:1&lt;57::AID-PCA489&gt;3.0.CO;2-E; Marsh KJ, 2006, ECOLOGY, V87, P2103, DOI 10.1890/0012-9658(2006)87[2103:CDODPI]2.0.CO;2; Marsh KJ, 2003, AUST J ZOOL, V51, P31, DOI 10.1071/ZO02055; MASON JR, 1983, PHARMACOL BIOCHEM BE, V19, P857, DOI 10.1016/0091-3057(83)90093-X; McArthur Clare, 1991, P103; McKinney ML, 1997, ANNU REV ECOL SYST, V28, P495, DOI 10.1146/annurev.ecolsys.28.1.495; MEIER B, 1987, FOLIA PRIMATOL, V48, P211, DOI 10.1159/000156299; Mittermeier RA, 1994, LEMURS PALEARCTIC AN; Mittermeier RA, 1992, LEMURS MADAGASCAR AC; Mittermeier R, 2008, INT J PRIMATOL, V29, P1607, DOI 10.1007/s10764-008-9317-y; MONTGOMERY RD, 1969, TOXIC CONSTITUENTS P; Moore BD, 2000, AUST J ZOOL, V48, P317, DOI 10.1071/ZO99034; Muller A, 1996, ECOL MONOGR, V66, P235, DOI 10.2307/2963476; NAHRSTEDT A, 1985, PLANT SYST EVOL, V150, P35, DOI 10.1007/BF00985566; Novotny V, 2007, NATURE, V448, P692, DOI 10.1038/nature06021; Novotny V, 2006, SCIENCE, V313, P1115, DOI 10.1126/science.1129237; Nylander J. A. A., 2004, MRMODELTEST V2; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Overdorff DJ, 1997, AM J PRIMATOL, V43, P211, DOI 10.1002/(SICI)1098-2345(1997)43:3<211::AID-AJP2>3.3.CO;2-V; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Palo R.T., 1991, PLANT DEFENSES MAMMA; Papachristou TG, 2007, APPL ANIM BEHAV SCI, V108, P68, DOI 10.1016/j.applanim.2006.11.015; PELLMYR O, 1992, P NATL ACAD SCI USA, V89, P2927, DOI 10.1073/pnas.89.7.2927; Pentzold S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091337; Rakotondravony Daniel, 2004, Lemur News, V9, P28; Rakotosamimanana Berthe, 2004, Lemur News, V9, P19; Rasmann S, 2011, AM NAT, V177, P728, DOI 10.1086/659948; Robbins C. T., 1993, WILDLIFE FEEDING NUT; Robinson BW, 1998, AM NAT, V151, P223, DOI 10.1086/286113; Rodriguez-Saona CR, 2010, J CHEM ECOL, V36, P1043, DOI 10.1007/s10886-010-9854-7; Schaller G.B., 1985, GIANT PANDAS WOLONG; Shipley LA, 2006, J CHEM ECOL, V32, P2455, DOI 10.1007/s10886-006-9156-2; Shipley LA, 2009, INTEGR COMP BIOL, V49, P274, DOI 10.1093/icb/icp051; Skopec MM, 2011, COMP BIOCHEM PHYS C, V154, P383, DOI 10.1016/j.cbpc.2011.07.010; Sorensen JS, 2006, J CHEM ECOL, V32, P1181, DOI 10.1007/s10886-006-9079-y; Sorensen JS, 2005, OECOLOGIA, V146, P415, DOI 10.1007/s00442-005-0236-8; Sorensen JS, 2005, ECOLOGY, V86, P125, DOI 10.1890/03-0627; Sorensen JS, 2003, OECOLOGIA, V134, P88, DOI 10.1007/s00442-002-1085-3; Stephens PR, 2003, BIOL J LINN SOC, V79, P577, DOI 10.1046/j.1095-8312.2003.00211.x; Swofford D.L., 2002, PHYLOGENETIC ANAL US; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tan CL, 1999, INT J PRIMATOL, V20, P547, DOI 10.1023/A:1020390723639; Tattersall I., 1982, PRIMATES MADAGASCAR, DOI 10.1002/ajpa.1330590417; Thompson JD., 1994, COEVOLUTIONARY PROCE; vanderMeijden E, 1996, ENTOMOL EXP APPL, V80, P307, DOI 10.1007/BF00194780; Villalba JJ, 2004, OIKOS, V107, P100, DOI 10.1111/j.0030-1299.2004.12983.x; Wiggins NL, 2006, J CHEM ECOL, V32, P1133, DOI 10.1007/s10886-006-9076-1; Wiggins NL, 2006, OECOLOGIA, V147, P650, DOI 10.1007/s00442-005-0305-z; Wiggins NL, 2003, J CHEM ECOL, V29, P1447, DOI 10.1023/A:1024221705354; Wissing F., 1981, CYANIDE BIOL; Wright Patricia C., 2008, Primate Conservation, V23, P5, DOI 10.1896/052.023.0102; WRIGHT PC, 1989, AM J PHYS ANTHROPOL, V78, P327; Xin Xia, 2007, Scientia Silvae Sinicae, V43, P26; Yamashita N, 2010, AM J PRIMATOL, V72, P56, DOI 10.1002/ajp.20751; Zentek J, 1997, DEUT TIERARZTL WOCH, V104, P153; Zhang WP, 2000, MOL PHYLOGENET EVOL, V15, P135, DOI 10.1006/mpev.1999.0729	141	12	14	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0158935	10.1371/journal.pone.0158935	http://dx.doi.org/10.1371/journal.pone.0158935			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532127	Green Published, gold, Green Submitted			2022-12-26	WOS:000381487600004
J	Gon, G; Restrepo-Mendez, MC; Campbell, OMR; Barros, AJD; Woodd, S; Benova, L; Graham, WJ				Gon, Giorgia; Restrepo-Mendez, Maria Clara; Campbell, Oona M. R.; Barros, Aluisio J. D.; Woodd, Susannah; Benova, Lenka; Graham, Wendy J.			Who Delivers without Water? A Multi Country Analysis of Water and Sanitation in the Childbirth Environment	PLOS ONE			English	Article							INFECTION	Background and Objectives Hygiene during childbirth is essential to the health of mothers and newborns, irrespective of where birth takes place. This paper investigates the status of water and sanitation in both the home and facility childbirth environments, and for whom and where this is a more significant problem. Methods We used three datasets: a global dataset, with information on the home environment from 58 countries, and two datasets for each of four countries in Eastern Africa: a healthcare facility dataset, and a dataset that incorporated information on facilities and the home environment to create a comprehensive description of birth environments in those countries. We constructed indices of improved water, and improved water and sanitation combined (WATSAN), for the home and healthcare facilities. The Joint Monitoring Program was used to construct indices for household; we tailored them to the facility context-household and facility indices include different components. We described what proportion of women delivered in an environment with improved WATSAN. For those women who delivered at home, we calculated what proportion had improved WATSAN by socio-economic status, education and rural-urban status. Results Among women delivering at home (58 countries), coverage of improved WATSAN by region varied from 9% to 53%. Fewer than 15% of women who delivered at home in Sub-Saharan Africa, had access to water and sanitation infrastructure (range 0.1% to 37%). This was worse among the poorest, the less educated and those living in rural areas. In Eastern Africa, where we looked at both the home and facility childbirth environment, a third of women delivered in an environment with improved water in Uganda and Rwanda; whereas, 18% of women in Kenya and 7% in Tanzania delivered with improved water and sanitation. Across the four countries, less than half of the facility deliveries had improved water, or improved water and sanitation in the childbirth environment. Conclusions Access to water and sanitation during childbirth is poor across low and middle-income countries. Even when women travel to health facilities for childbirth, they are not guaranteed access to basic WATSAN infrastructure. These indicators should be measured routinely in order to inform improvements.	[Gon, Giorgia; Campbell, Oona M. R.; Woodd, Susannah; Benova, Lenka; Graham, Wendy J.] London Sch Hyg & Trop Med, Infect Dis Epidemiol Dept, London, England; [Restrepo-Mendez, Maria Clara; Barros, Aluisio J. D.] Univ Fed Pelotas, Int Ctr Equ Hlth, Pelotas, Brazil	University of London; London School of Hygiene & Tropical Medicine; Universidade Federal de Pelotas	Gon, G (corresponding author), London Sch Hyg & Trop Med, Infect Dis Epidemiol Dept, London, England.	giorgia.gon@lshtm.ac.uk	Gon, Giorgia/GRJ-9198-2022; Barros, Aluisio JD/A-7417-2008	Barros, Aluisio JD/0000-0002-2022-8729; Gon, Giorgia/0000-0002-9741-7712; Campbell, Oona/0000-0002-9311-0115; Restrepo-Mendez, Maria Clara/0000-0001-7714-7340; Graham, Wendy/0000-0003-1473-5342	U.S. Fund for UNICEF under the Bill & Melinda Gates Foundation; Scottish Charity; UNICEF; Soapbox Collaborative	U.S. Fund for UNICEF under the Bill & Melinda Gates Foundation; Scottish Charity; UNICEF; Soapbox Collaborative	This work was funded through a sub-grant from the U.S. Fund for UNICEF under the Countdown to 2015 for Maternal, Newborn and Child Survival grant from the Bill & Melinda Gates Foundation; and by funding provided by a Scottish Charity, the Soapbox Collaborative.; We thank Prof Cesar Victora<SUP>1</SUP>, Dr. Sandra Virgo<SUP>2</SUP>, Dr. Clara Calvert<SUP>2</SUP>, and Oliver Cumming<SUP>2</SUP> for their technical input to this paper, and Deepthi Wickremasinghe<SUP>2</SUP> for her editorial contribution. We also thank Countdown to 2015, UNICEF and the Soapbox Collaborative for the financial contribution to the project.	Allegranzi B, 2011, LANCET, V377, P228, DOI 10.1016/S0140-6736(10)61458-4; Bain R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001644; Barros AJD, 2012, LANCET, V379, P1225, DOI 10.1016/S0140-6736(12)60113-5; Benova L, 2014, TROP MED INT HLTH; Benova L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106738; Blencowe H, 2011, BMC PUBLIC HEALTH, V11, DOI [10.1186/1471-2458-11-S3-S9, 10.1186/1471-2458-11-S3-S11]; Campbell OMR, 2014, TROP MED INT HLTH TM, DOI [10.1111/tmi.12439, DOI 10.1111/TMI.2439]; Chambers V, 2012, DELIVERING MATERNAL; Fink G, 2011, INT J EPIDEMIOL, V40, P1196, DOI 10.1093/ije/dyr102; Gon G, 2014, TROP MED INT HEALTH, V19, P1488, DOI 10.1111/tmi.12394; Gordon AA., 1795, TREATISE EPIDEMIC PU; Gould IM, 2010, LANCET INFECT DIS, V10, P275, DOI 10.1016/S1473-3099(09)70304-4; Johnson K, 2004, DHS COMP REPORTS; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; Luangasanatip N, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3728; Makaka A, 2012, LANCET S2, V380, pS7, DOI DOI 10.1016/S0140-6736(13)60293-7; Padhi BK, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001851; Restrepo-Mendez MC, 2014, PUBLIC HEALTH NUTR, V18; Rheingans R, 2014, TROP MED INT HEALTH, V19, P2, DOI 10.1111/tmi.12220; Seale AC, 2014, LANCET INFECT DIS, V14, P731, DOI 10.1016/S1473-3099(14)70804-7; Semmelweis I., 1983, ETIOLOGY CONCEPT PRO; Shamba DD, 2013, J HEALTH POPUL NUTR, V31, P110; Skiles MP, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-14; UN DESA, SUST DEV KNOWL PLATF; UNICEF and World Health Organization, 2015, 25 YEARS PROGR SAN D; Velleman Y, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001771; WHO, 2015, WATER SANITATION HYG; Wolf J, 2014, TROP MED INT HEALTH, V19, P928, DOI 10.1111/tmi.12331; Zaidi AKM, 2005, LANCET, V365, P1175, DOI 10.1016/S0140-6736(05)71881-X	29	20	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e01605720	10.1371/journal.pone.0160572	http://dx.doi.org/10.1371/journal.pone.0160572			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532291	Green Published, Green Accepted, gold			2022-12-26	WOS:000381487600037
J	Gu, L; Qu, JX; Sun, B; Yu, XM; Li, H; Cao, B				Gu, Li; Qu, Jiuxin; Sun, Bing; Yu, Xiaomin; Li, Hui; Cao, Bin			Sustained Viremia and High Viral Load in Respiratory Tract Secretions Are Predictors for Death in Immunocompetent Adults with Adenovirus Pneumonia	PLOS ONE			English	Article							DISEASE	The predictors for fatal adenovirus (AdV) pneumonia among immunocompetent adults are unclear. Laboratory-confirmed, hospitalized AdV pneumonia adults were prospectively enrolled in Beijing Chao-Yang hospital from March to June 2013. Clinical data and serial whole blood and respiratory tract secretions from such patients were collected. Quantitative real-time polymerase chain reaction was performed to quantify the viral load. A total of 14 AdV pneumonia cases were consecutively enrolled, and four of them were fatal. Ten cases were caused by AdV-55, three by AdV-7 and one by AdV-3. There were no differences in age, gender or underlying diseases between the patients in the fatal cases and surviving cases. At admission (on day 5-7 after illness onset), the patients in fatal cases presented higher initial viral loads in respiratory tract secretions (8.578 +/- 2.115 vs 6.263 +/- 1.225 Log(10) copies/ml, p = 0.023). All patients in fatal cases presented with viremia on day 12-14 (100% vs 66.7%, p = 0.017). A higher initial viral load in the respiratory tract and sustained viremia (more than 2 weeks) may be predictors for fatal clinical outcomes.	[Gu, Li; Qu, Jiuxin; Yu, Xiaomin; Li, Hui; Cao, Bin] Capital Med Univ, Beijing Chao Yang Hosp, Beijing Inst Resp Med, Dept Infect Dis & Clin Microbiol, Beijing, Peoples R China; [Sun, Bing] Capital Med Univ, Beijing Chao Yang Hosp, Beijing Inst Resp Med, Dept Pulm & Crit Care, Beijing, Peoples R China; [Cao, Bin] China Japan Friendship Hosp, Clin Microbiol & Infect Dis Lab, Dept Resp & Crit Care Med, Beijing, Peoples R China	Capital Medical University; Capital Medical University; China-Japan Friendship Hospital	Cao, B (corresponding author), Capital Med Univ, Beijing Chao Yang Hosp, Beijing Inst Resp Med, Dept Infect Dis & Clin Microbiol, Beijing, Peoples R China.; Cao, B (corresponding author), China Japan Friendship Hosp, Clin Microbiol & Infect Dis Lab, Dept Resp & Crit Care Med, Beijing, Peoples R China.	caobin_ben@163.com		Gu, Li/0000-0002-3318-3902	Beijing Science and Technology Project [D101100049810002, Z131100002613001]; Ministry of Health, P.R. China [20130217]; Beijing Municipal Administration of Hospitals' Youth Programme [20150306]; National Natural Science Foundation of China [81070005/H0104, 81030032/H19, 81271840, 81400005/H0104]	Beijing Science and Technology Project; Ministry of Health, P.R. China; Beijing Municipal Administration of Hospitals' Youth Programme; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Beijing Science and Technology Project [grant numbers D101100049810002, Z131100002613001], Ministry of Health, P.R. China [grant number 20130217], Beijing Municipal Administration of Hospitals' Youth Programme [grant number 20150306], and the National Natural Science Foundation of China [grant numbers 81070005/H0104, 81030032/H19, 81271840 and 81400005/H0104].	Cao B, 2010, EUR J CLIN MICROBIOL, V29, P1443, DOI 10.1007/s10096-010-1003-2; Cao B, 2014, CHEST, V145, P79, DOI 10.1378/chest.13-1186; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P553; Gu L, 2012, J CLIN VIROL, V54, P295, DOI 10.1016/j.jcv.2012.04.018; Hakim FA, 2008, EUR J CLIN MICROBIOL, V27, P153, DOI 10.1007/s10096-007-0416-z; Lee YJ, 2013, BIOL BLOOD MARROW TR, V19, P387, DOI 10.1016/j.bbmt.2012.10.014; Louie JK, 2008, CLIN INFECT DIS, V46, P421, DOI 10.1086/525261; Shike H, 2005, PEDIATR INFECT DIS J, V24, P29, DOI 10.1097/01.inf.0000148882.97399.79; Zhu Z, 2009, J CLIN MICROBIOL, V47, P697, DOI 10.1128/JCM.01769-08	9	24	26	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160777	10.1371/journal.pone.0160777	http://dx.doi.org/10.1371/journal.pone.0160777			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532864	Green Published, gold, Green Submitted			2022-12-26	WOS:000381487600042
J	Guan, TP; Owens, JR; Gong, MH; Liu, G; Ouyang, ZY; Song, YL				Guan, Tian-Pei; Owens, Jacob R.; Gong, Ming-Hao; Liu, Gang; Ouyang, Zhi-Yun; Song, Yan-Ling			Role of New Nature Reserve in Assisting Endangered Species Conservation - Case Study of Giant Pandas in the Northern Qionglai Mountains, China	PLOS ONE			English	Article							WOLONG NATURE-RESERVE; WENCHUAN EARTHQUAKE; HABITAT; DISPERSAL; DIVERSITY; NETWORK; MINSHAN	The creation of nature reserves is the most direct way to save endangered species populations and their habitat. Development of the giant panda (Ailuropoda melanoleuca) nature reserve network in China was initiated in the 1960s, though the effort to create new reserves boomed considerably after the year 2000. Given this rapid development of protected areas in panda habitats, and the potential conflicting interests between conservation administrations and local economic development, it is essential to assess the role of new nature reserves in the overall giant panda conservation effort and reserve network. We utilized data from national giant panda surveys conducted in 2000 and 2012 to compare the size, spatial use, and distribution of panda populations, as well as the habitat suitability and connectivity in the Northern Qionglai Mountains between the two survey years. Our results show that although the total giant panda population in the study area did not change remarkably, local changes did occur. Most notably, the population in Wolong Nature Reserve declined by 27.3% (N = 39) and the population in Caopo Nature Reserve increased by 71.4% (N = 29) over the 12-year study period. We also found habitat suitability and availability decreased in both Wolong (12.4%) and Caopo (7.4%), but that the relative density of giant pandas declined (19.2%) and increased (84.6%) at each site, respectively. The distance between centers of high IUA were more distant in 2012 (14.1 +/- 1.9km) than that in 2000 (6.1 +/- 0.9km; t = -7.4, df = 5, p = 0.001), showing a scattered spatial pattern. Habitat availability decreased by 42% within the corridor between the two reserves, however panda occurrences in the corridor increased 24.6%. Compared to the total number of encounters, the proportion of the corridor increased 45.76%. Our results show the importance and success of the newly established Caopo to the conservation of giant pandas, and how crucial it is to identify and repair reserve corridors. Furthermore, we propose criteria for future nature reserve network management and investment, which is applicable for other endangered species conservation practices.	[Guan, Tian-Pei] Mianyang Normal Univ, Ecol Secur & Protect Key Lab Sichuan Prov, Mianyang, Peoples R China; [Owens, Jacob R.] Chengdu Res Base Giant Panda Breeding, Chengdu, Peoples R China; [Gong, Ming-Hao; Liu, Gang] Chinese Acad Forestry, Res Inst Wetland, Beijing, Peoples R China; [Ouyang, Zhi-Yun] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, Beijing, Peoples R China; [Song, Yan-Ling] Chinese Acad Sci, Inst Zool, Beijing, Peoples R China	Mianyang Teachers' College; Chinese Academy of Forestry; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Chinese Academy of Sciences; Institute of Zoology, CAS	Gong, MH (corresponding author), Chinese Acad Forestry, Res Inst Wetland, Beijing, Peoples R China.	gongmh2005@hotmail.com	Liu, Gang/AAE-4197-2022; guan, tianpei/ABG-4874-2020	Liu, Gang/0000-0002-3614-0561; Owens, Jacob/0000-0003-1528-650X	Fourth National Giant Panda Survey; Chinese State Forestry Administration (SFA); National Natural Science Foundation of China [31300319]; Chinese State Forestry Administration [CM1423]; WWF-China [10002980]; Mianyang Normal University [QD2014A001, QD2012A12]	Fourth National Giant Panda Survey; Chinese State Forestry Administration (SFA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese State Forestry Administration; WWF-China; Mianyang Normal University	This study was funded by the Fourth National Giant Panda Survey initiated by the Chinese State Forestry Administration (SFA). National Natural Science Foundation of China (31300319) Chinese State Forestry Administration (No. CM1423), WWF-China (No. 10002980), Mianyang Normal University (QD2014A001, QD2012A12) also provided financial support for this study. We thank Jiansheng Jia, Director of Wildlife Conservation Department at SFA, for providing supporting during our study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by the Fourth National Giant Panda Survey initiated by the Chinese State Forestry Administration (SFA). National Natural Science Foundation of China (31300319) Chinese State Forestry Administration (No. CM1423), WWF-China (No. 10002980), Mianyang Normal University (QD2014A001, QD2012A12) also provided financial support for this study. We thank Jiansheng Jia, Director of Wildlife Conservation Department at SFA, for providing supporting during our study. We are grateful toWeihua Xu, Zhichen Wang, Baocheng Yu, Ximing Zhang, Qiang Jiu and Youde Chang for comments and assistance. Especially, we appreciate the contributions of all field survey teams. We also acknowledge comments and suggestions from anonymous reviewers and Dr. William J McShea in improving the manuscript.	Boitani L, 2008, PLOS BIOL, V6, P436, DOI 10.1371/journal.pbio.0060066; Brooks TM, 2009, CONSERV BIOL, V23, P1448, DOI 10.1111/j.1523-1739.2009.01334.x; Burgess ND, 2007, ORYX, V41, P151, DOI 10.1017/S0030605307001895; Campbell D, 2004, J APPL ECOL, V41, P1185, DOI 10.1111/j.0021-8901.2004.00964.x; Dai FC, 2011, J ASIAN EARTH SCI, V40, P883, DOI 10.1016/j.jseaes.2010.04.010; Efford MG, 2013, OIKOS, V122, P918, DOI 10.1111/j.1600-0706.2012.20440.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Forestry Department of Sichuan Province, 2016, PAND SICH 4 SURV REP; Gaston KJ, 2008, ANNU REV ECOL EVOL S, V39, P93, DOI 10.1146/annurev.ecolsys.39.110707.173529; Hu JC, 2001, RES GIANT PANDA; Li HL, 2010, ECOL MODEL, V221, P944, DOI 10.1016/j.ecolmodel.2009.12.006; Li RQ, 2015, BIOL CONSERV, V182, P93, DOI 10.1016/j.biocon.2014.11.037; Liu JG, 2001, SCIENCE, V292, P98, DOI 10.1126/science.1058104; Liu XH, 2015, ENVIRON SCI POLLUT R, V22, P1175, DOI 10.1007/s11356-014-3412-8; Liu XH, 2013, ECOL INDIC, V33, P121, DOI 10.1016/j.ecolind.2012.09.022; Matthysen E, 2005, ECOGRAPHY, V28, P403, DOI 10.1111/j.0906-7590.2005.04073.x; Morris DW, 2006, NATURE, V443, P645, DOI 10.1038/443645a; [欧阳志云 OUYANG ZhiYun], 2008, [生态学报, Acta Ecologica Sinica], V28, P5801; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Qi DW, 2015, FOLIA ZOOL, V64, P56; Qi DW, 2011, J ZOOL, V285, P205, DOI 10.1111/j.1469-7998.2011.00831.x; Rebelo H, 2010, GLOBAL CHANGE BIOL, V16, P561, DOI 10.1111/j.1365-2486.2009.02021.x; Schaller G.B., 1985, GIANT PANDAS WOLONG; Smart LS, 2012, FOREST ECOL MANAG, V281, P100, DOI 10.1016/j.foreco.2012.06.020; State Forestry Administration of Peoples Republic of China, 2006, BEIJ 3 NAT SURV REP; Teel TL, 2010, CONSERV BIOL, V24, P128, DOI 10.1111/j.1523-1739.2009.01374.x; Western D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006140; Wu RD, 2011, FRONT ECOL ENVIRON, V9, P383, DOI 10.1890/100093; Xu JL, 2012, ORYX, V46, P554, DOI 10.1017/S0030605311000810; Xu WH, 2009, FRONT ECOL ENVIRON, V7, P353, DOI 10.1890/080192; Yang B, 2015, CONSERV LETT, V8, P251, DOI 10.1111/conl.12143; Zheng W, 2012, BIOL CONSERV, V145, P241, DOI 10.1016/j.biocon.2011.11.016	32	7	8	1	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0159738	10.1371/journal.pone.0159738	http://dx.doi.org/10.1371/journal.pone.0159738			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532870	Green Published, Green Submitted, gold			2022-12-26	WOS:000381487600011
J	Yu, ZY; Huang, P; Yu, YH; Zheng, Z; Huang, ZC; Guo, CY; Lin, DH				Yu, Ziyao; Huang, Pei; Yu, Yuanhui; Zheng, Zhen; Huang, Zicheng; Guo, Chenyun; Lin, Donghai			Unique Properties of the Rabbit Prion Protein Oligomer	PLOS ONE			English	Article							PHYSICAL-PROPERTIES; SOLUBLE OLIGOMERS; AMYLOID FIBRILS; TOXICITY; DISEASE; NEURODEGENERATION; TRANSITION; STABILITY; INFECTION; NEUROTOXICITY	Prion diseases, also known as transmissible spongiform encephalopathies (TSEs), are a group of fatal neurodegenerative disorders infecting both humans and animals. Recent works have demonstrated that the soluble prion protein oligomer (PrPO), the intermediate of the conformational transformation from the host-derived cellular form (PrPC) to the disease-associated Scrapie form (PrPSc), exerts the major neurotoxicity in vitro and in vivo. Rabbits show strong resistance to TSEs, the underlying mechanism is unclear to date. It is expected that the relative TSEs-resistance of rabbits is closely associated with the unique properties of rabbit prion protein oligomer which remain to be addressed in detail. In the present work, we prepared rabbit prion protein oligomer (recRaPrP(O)) and human prion protein oligomer (recHuPrP(O)) under varied conditions, analyzed the effects of pH, NaCl concentration and incubation temperature on the oligomerization, and compared the properties of recRaPrP(O) and recHuPrP(O). We found that several factors facilitated the formation of prion protein oligomers, including low pH, high NaCl concentration, high incubation temperature and low conformational stability of monomeric prion protein. RecRaPrPO was formed more slowly than recHuPrP(O) at physiological-like conditions (< 57 degrees C, < 150 mM NaCl). Furthermore, recRaPrP(O) possessed higher susceptibility to proteinase K and lower cytotoxicity in vitro than recHuPrP(O). These unique properties of recRaPrP(O) might substantially contribute to the TSEs-resistance of rabbits. Our work sheds light on the oligomerization of prion proteins and is of benefit to mechanistic understanding of TSEs-resistance of rabbits.	[Yu, Ziyao; Huang, Pei; Yu, Yuanhui; Zheng, Zhen; Huang, Zicheng; Guo, Chenyun; Lin, Donghai] Xiamen Univ, Coll Chem & Chem Engn, Key Lab Chem Biol Fujian Prov, MOE Key Lab Spectrochem Anal & Instrumentat, Xiamen 361005, Peoples R China	Xiamen University	Lin, DH (corresponding author), Xiamen Univ, Coll Chem & Chem Engn, Key Lab Chem Biol Fujian Prov, MOE Key Lab Spectrochem Anal & Instrumentat, Xiamen 361005, Peoples R China.	dhlin@xmu.edu.cn			National Natural Science Foundation of China [31170717, 31470034]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by funds from the National Natural Science Foundation of China (Nos. 31170717, 31470034, https://isisn.nsfc.gov.cn/egrantweb/).	Apetri AC, 2003, J BIOL CHEM, V278, P22187, DOI 10.1074/jbc.M302130200; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; Baskakov IV, 2000, BIOCHEMISTRY-US, V39, P2792, DOI 10.1021/bi9923353; Baskakov IV, 2001, J BIOL CHEM, V276, P19687, DOI 10.1074/jbc.C100180200; Bitel Claudine L., 2010, BMC Physiology, V10, P18, DOI 10.1186/1472-6793-10-18; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; Carrell RW, 2008, FEBS LETT, V582, P2537, DOI 10.1016/j.febslet.2008.06.021; Carrell RW, 2005, TRENDS CELL BIOL, V15, P574, DOI 10.1016/j.tcb.2005.09.005; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Cheon M, 2007, PLOS COMPUT BIOL, V3, P1727, DOI 10.1371/journal.pcbi.0030173; Chianini F, 2012, P NATL ACAD SCI USA, V109, P5080, DOI 10.1073/pnas.1120076109; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Eghiaian F, 2007, P NATL ACAD SCI USA, V104, P7414, DOI 10.1073/pnas.0607745104; Fernandez-Borges N, 2012, PRION, V6, DOI 10.4161/pri.22057; Gerber R, 2007, J BIOL CHEM, V282, P6300, DOI 10.1074/jbc.M608926200; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Horiuchi M, 1999, STRUCTURE, V7, pR231, DOI 10.1016/S0969-2126(00)80049-0; Horwich AL, 1997, CELL, V89, P499, DOI 10.1016/S0092-8674(00)80232-9; Huang P, 2013, ACTA BIOCH BIOPH SIN, V45, P442, DOI 10.1093/abbs/gmt037; Kudo W, 2012, HUM MOL GENET, V21, P1138, DOI 10.1093/hmg/ddr542; Lansbury PT, 1997, NEURON, V19, P1151, DOI 10.1016/S0896-6273(00)80406-7; Loftus B, 1997, GENE, V184, P215, DOI 10.1016/S0378-1119(96)00598-7; Ma JY, 2002, SCIENCE, V298, P1781, DOI 10.1126/science.1073725; Ma Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036288; Martins SM, 2006, J BIOL CHEM, V281, P26121, DOI 10.1074/jbc.M605367200; MEYER RK, 1986, P NATL ACAD SCI USA, V83, P2310, DOI 10.1073/pnas.83.8.2310; Mindell JA, 2012, ANNU REV PHYSIOL, V74, P69, DOI 10.1146/annurev-physiol-012110-142317; Morillas M, 2001, BIOCHEMISTRY-US, V40, P6982, DOI 10.1021/bi010232q; Pauli Georg, 2005, Cell and Tissue Banking, V6, P191, DOI 10.1007/s10561-005-0336-z; PRUSINER SB, 1984, SCI AM, V251, P50, DOI 10.1038/scientificamerican1084-50; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rezaei H, 2005, J MOL BIOL, V347, P665, DOI 10.1016/j.jmb.2005.01.043; Rezaei H, 2002, J MOL BIOL, V322, P799, DOI 10.1016/S0022-2836(02)00856-2; Sasaki K, 2008, PRION, V2, P118, DOI 10.4161/pri.2.3.7148; Sigurdson CJ, 2006, J VIROL, V80, P12303, DOI 10.1128/JVI.01120-06; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Simoneau S, 2007, PLOS PATHOG, V3, P1175, DOI 10.1371/journal.ppat.0030125; Sokolowski F, 2003, J BIOL CHEM, V278, P40481, DOI 10.1074/jbc.M304391200; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Swietnicki W, 1997, J BIOL CHEM, V272, P27517, DOI 10.1074/jbc.272.44.27517; Vorberg I, 2003, J VIROL, V77, P2003, DOI 10.1128/JVI.77.3.2003-2009.2003; Wen Y, 2010, J BIOL CHEM, V285, P31682, DOI 10.1074/jbc.M110.118844; Wen Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013273; Yan X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113238; Yin SM, 2003, PROTEIN EXPRES PURIF, V32, P104, DOI 10.1016/S1046-5928(03)00195-5; Yuan Z, 2015, J NEUROCHEM, V133, P722, DOI 10.1111/jnc.13098; Yuan Z, 2013, ACTA BIOCH BIOPH SIN, V45, P899, DOI 10.1093/abbs/gmt093; Zhang JP, 2011, J THEOR BIOL, V269, P88, DOI 10.1016/j.jtbi.2010.10.020; Zhou Z, 2011, BIOPHYS J, V101, P1483, DOI 10.1016/j.bpj.2011.08.018	50	5	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160874	10.1371/journal.pone.0160874	http://dx.doi.org/10.1371/journal.pone.0160874			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529173	gold, Green Submitted, Green Published			2022-12-26	WOS:000381476700029
J	Zylstra, P; Bradstock, RA; Bedward, M; Penman, TD; Doherty, MD; Weber, RO; Gill, AM; Cary, GJ				Zylstra, Philip; Bradstock, Ross A.; Bedward, Michael; Penman, Trent D.; Doherty, Michael D.; Weber, Rodney O.; Gill, A. Malcolm; Cary, Geoffrey J.			Biophysical Mechanistic Modelling Quantifies the Effects of Plant Traits on Fire Severity: Species, Not Surface Fuel Loads, Determine Flame Dimensions in Eucalypt Forests	PLOS ONE			English	Article							SOUTH-EASTERN AUSTRALIA; MOISTURE-CONTENT; LITTER FLAMMABILITY; TEMPERATE FOREST; LEAF TRAITS; CROWN FIRE; BEHAVIOR; SPREAD; LIDAR; PERFORMANCE	The influence of plant traits on forest fire behaviour has evolutionary, ecological and management implications, but is poorly understood and frequently discounted. We use a process model to quantify that influence and provide validation in a diverse range of eucalypt forests burnt under varying conditions. Measured height of consumption was compared to heights predicted using a surface fuel fire behaviour model, then key aspects of our model were sequentially added to this with and without species-specific information. Our fully specified model had a mean absolute error 3.8 times smaller than the otherwise identical surface fuel model (p < 0.01), and correctly predicted the height of larger (>= 1 m) flames 12 times more often (p < 0.001). We conclude that the primary endogenous drivers of fire severity are the species of plants present rather than the surface fuel load, and demonstrate the accuracy and versatility of the model for quantifying this.	[Zylstra, Philip; Bradstock, Ross A.; Bedward, Michael] Univ Wollongong, Ctr Environm Risk Management Bushfires, Biol Sci, Wollongong, NSW, Australia; [Penman, Trent D.] Univ Melbourne, Sch Ecosyst & Forest Sci, Creswick, Vic, Australia; [Doherty, Michael D.; Gill, A. Malcolm; Cary, Geoffrey J.] Australian Natl Univ, Fenner Sch Environm & Soc, Acton, ACT, Australia; [Weber, Rodney O.] Univ NSW ADFA, Phys Environm & Math Sci, Canberra, ACT, Australia	University of Wollongong; University of Melbourne; Australian National University; University of New South Wales Sydney	Zylstra, P (corresponding author), Univ Wollongong, Ctr Environm Risk Management Bushfires, Biol Sci, Wollongong, NSW, Australia.	pzylstra@uow.edu.au	Cary, Geoffrey J./AAX-1964-2021; Zylstra, Philip/O-2587-2016; Penman, Trent D/A-7242-2012; Bedward, Michael/ABB-6905-2021; Doherty, Michael D/E-9700-2010	Zylstra, Philip/0000-0002-6946-866X; Penman, Trent D/0000-0002-5203-9818; Bedward, Michael/0000-0002-9986-1286; Doherty, Michael D/0000-0001-7671-880X; Cary, Geoffrey J./0000-0002-6386-1751	NSW Office of Environment and Heritage; University of Wollongong Centre for Environmental Risk Management of Bushfires	NSW Office of Environment and Heritage; University of Wollongong Centre for Environmental Risk Management of Bushfires	All work was funded by the NSW Office of Environment and Heritage (http://www.environment.nsw.gov.au) as part of an ongoing contract with the University of Wollongong Centre for Environmental Risk Management of Bushfires. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander ME, 2013, INT J WILDLAND FIRE, V22, P415, DOI 10.1071/WF12008; Alexander ME, 2012, INT J WILDLAND FIRE, V21, P95, DOI 10.1071/WF11001; Andersen HE, 2005, REMOTE SENS ENVIRON, V94, P441, DOI 10.1016/j.rse.2004.10.013; Anderson H. E., 1970, Fire Technology, V6, P312, DOI 10.1007/BF02588932; [Anonymous], 2021, LANG ENV STAT COMP; [Anonymous], 1996, IGNITABILITY LEAVES; Barrett TW, 2006, BUSHF C 2006 LIF FIR; Belcher CM, 2010, NAT GEOSCI, V3, P426, DOI 10.1038/NGEO871; Bowman DMJS, 2015, TRENDS ECOL EVOL, V30, P255, DOI 10.1016/j.tree.2015.03.005; Bradstock RA, 2010, LANDSCAPE ECOL, V25, P607, DOI 10.1007/s10980-009-9443-8; Burrows N. D., 1999, CALMScience, V3, P31; Burrows N. D., 1999, CALMScience, V3, P57; Butler BW, 2004, MON SCI TECHN S UN K, P595; Caccamo G, 2012, INT J WILDLAND FIRE, V21, P257, DOI 10.1071/WF11024; Cassiani M, 2008, BOUND-LAY METEOROL, V126, P433, DOI 10.1007/s10546-007-9242-1; Cheney NP, 2012, FOREST ECOL MANAG, V280, P120, DOI 10.1016/j.foreco.2012.06.012; Chuvieco E, 2004, REMOTE SENS ENVIRON, V92, P322, DOI 10.1016/j.rse.2004.01.019; CIONCO R M, 1972, Boundary-Layer Meteorology, V3, P255, DOI 10.1007/BF02033923; Collins L, 2013, INT J WILDL FIRE; Cornwell WK, 2015, NEW PHYTOL, V206, P672, DOI 10.1111/nph.13317; Cruz MG, 2005, CAN J FOREST RES, V35, P1626, DOI 10.1139/X05-085; de Magalhaes RMQ, 2012, J ECOL, V100, P1153, DOI 10.1111/j.1365-2745.2012.01987.x; DICKINSON KJM, 1985, J BIOGEOGR, V12, P121, DOI 10.2307/2844836; Doherty MD, 1998, VEGETATION SURVEY MA; Doherty MD, 1997, VEGETATION SURVEY MA; Fernandes PM, 2012, NEW PHYTOL, V194, P606, DOI 10.1111/j.1469-8137.2012.04065.x; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gill A. M., 1975, Australian Forestry, V38, P4; Gill A. M., 2005, Australian Forestry, V68, P87; Gill AM, 2012, FLAMMABLE AUSTRALIA: FIRE REGIMES, BIODIVERSITY AND ECOSYSTEMS IN A CHANGING WORLD, P235; Gill AM, 2012, FLAMMABLE AUSTR FIRE, P351; Gill AM, 1994, P 2 INT C FOR FIR RE, P63; Gould J.S., 2007, FIELD GUIDE FUEL ASS; Grootemaat S, 2015, MODELS LEAF IGNITABI, P130, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Grootemaat S, 2015, FUNCT ECOL, V29, P1486, DOI 10.1111/1365-2435.12449; Higgins SI, 2014, BIOGEOSCIENCES, V11, P4357, DOI 10.5194/bg-11-4357-2014; Hintze JL, 1998, AM STAT, V52, P181, DOI 10.2307/2685478; Jensen JLR, 2008, REMOTE SENS ENVIRON, V112, P3947, DOI 10.1016/j.rse.2008.07.001; Kattge J, 2011, GLOBAL CHANGE BIOL, V17, P2905, DOI 10.1111/j.1365-2486.2011.02451.x; Keeley J. E., 2012, FIRE MEDITERRANEAN E; Keeley JE, 2009, INT J WILDLAND FIRE, V18, P116, DOI 10.1071/WF07049; Korhonen L, 2011, REMOTE SENS ENVIRON, V115, P1065, DOI 10.1016/j.rse.2010.12.011; Lindenmayer DB, 2013, BIOL CONSERV, V167, P137, DOI 10.1016/j.biocon.2013.07.028; Little JK, 2012, AUSTRAL ECOL, V37, P915, DOI 10.1111/j.1442-9993.2011.02350.x; Lovell JL, 2003, CAN J REMOTE SENS, V29, P607, DOI 10.5589/m03-026; Madrigal J, 2012, ANN FOREST SCI, V69, P387, DOI 10.1007/s13595-011-0165-0; Matthews S, 2014, INT J WILDLAND FIRE, V23, P78, DOI 10.1071/WF13005; Mccaw WL, 2012, FOREST ECOL MANAG, V271, P170, DOI 10.1016/j.foreco.2012.02.003; NOBLE IR, 1980, AUST J ECOL, V5, P201, DOI 10.1111/j.1442-9993.1980.tb01243.x; Olsen TS, 1963, ECOLOGY, V44, P322; Onoda Y, 2011, ECOL LETT, V14, P301, DOI 10.1111/j.1461-0248.2010.01582.x; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; PHILPOT CW, 1970, FOREST SCI, V16, P461; Plucinski MP, 2010, INT J WILDLAND FIRE, V19, P512, DOI 10.1071/WF09038; Price OF, 2012, J ENVIRON MANAGE, V113, P146, DOI 10.1016/j.jenvman.2012.08.041; Rothermel RC, 1972, INT115; Scarff FR, 2006, FUNCT ECOL, V20, P745, DOI 10.1111/j.1365-2435.2006.01174.x; Scarff FR, 2012, INT J WILDLAND FIRE, V21, P1042, DOI 10.1071/WF09065; Schwilk DW, 2015, NEW PHYTOL, V206, P486, DOI 10.1111/nph.13372; Schwilk DW, 2011, J ECOL, V99, P970, DOI 10.1111/j.1365-2745.2011.01828.x; Sharples JJ, 2010, ENVIRON MODELL SOFTW, V25, P1099, DOI 10.1016/j.envsoft.2010.03.016; Simpson KJ, 2016, J ECOL, V104, P138, DOI 10.1111/1365-2745.12503; Taylor C, 2014, CONSERV LETT, V7, P355, DOI 10.1111/conl.12122; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; van Bodegom PM, 2014, P NATL ACAD SCI USA, V111, P13733, DOI 10.1073/pnas.1304551110; Van Wagner CE, 1973, CAN J FOREST RES, V3, P373, DOI DOI 10.1139/X73-055; Viegas DX, 2014, ADV FOREST FIRE RES, P326; Wagner C. E. van, 1977, Canadian Journal of Forest Research, V7, P23, DOI 10.1139/x77-004; Weber R. O., 1995, Landscape Fires '93: Proceedings of an Australian Bushfire Conference, Perth, Western Australia, 27-29 September 1993., P23; Williams RJ, 1998, INT J WILDLAND FIRE, V8, P227, DOI 10.1071/WF9980227; Willmott CJ, 2005, CLIMATE RES, V30, P79, DOI 10.3354/cr030079; Wright GT, 2004, PRELIMINARY ASSESSME; Wright GT, 2005, CONTINUING ASSESSMEN; Yebra M, 2013, REMOTE SENS ENVIRON, V136, P455, DOI 10.1016/j.rse.2013.05.029; Yebra M, 2009, REMOTE SENS ENVIRON, V113, P2403, DOI 10.1016/j.rse.2009.07.001; Zylstra P., 2006, FOREST ECOL MANAG, V234, pS81, DOI [10.1016/j.foreco.2006.08.117, DOI 10.1016/J.FORECO.2006.08.117]; Zylstra P., 2011, FOREST FLAMMABILITY, DOI DOI 10.13140/2.1.3722.0166; Zylstra P., 2014, GEOPH RES ABSTR, V16; Zylstra Philip, 2013, Victorian Naturalist (Blackburn), V130, P232	80	74	76	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160715	10.1371/journal.pone.0160715	http://dx.doi.org/10.1371/journal.pone.0160715			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529789	Green Published, gold, Green Submitted			2022-12-26	WOS:000381476700018
J	Labourel, A; Crouch, LI; Bras, JLA; Jackson, A; Rogowski, A; Gray, J; Yadav, MP; Henrissat, B; Fontes, CMGA; Gilbert, HJ; Najmudin, S; Basle, A; Cuskin, F				Labourel, Aurore; Crouch, Lucy I.; Bras, Joana L. A.; Jackson, Adam; Rogowski, Artur; Gray, Joseph; Yadav, Madhav P.; Henrissat, Bernard; Fontes, Carlos M. G. A.; Gilbert, Harry J.; Najmudin, Shabir; Basle, Arnaud; Cuskin, Fiona			The Mechanism by Which Arabinoxylanases Can Recognize Highly Decorated Xylans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cellulosome; crystallography; enzyme kinetics; enzyme mechanism; glycoside hydrolase	CARBOHYDRATE-BINDING MODULES; CLOSTRIDIUM-THERMOCELLUM; POLYSACCHARIDE RECOGNITION; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURES; DEGRADATION; DECONSTRUCTION; CELLULOSOMES; BIOCHEMISTRY; REFINEMENT	The enzymatic degradation of plant cell walls is an important biological process of increasing environmental and industrial significance. Xylan, a major component of the plant cell wall, consists of a backbone of -1,4-xylose (Xylp) units that are often decorated with arabinofuranose (Araf) side chains. A large penta-modular enzyme, CtXyl5A, was shown previously to specifically target arabinoxylans. The mechanism of substrate recognition displayed by the enzyme, however, remains unclear. Here we report the crystal structure of the arabinoxylanase and the enzyme in complex with ligands. The data showed that four of the protein modules adopt a rigid structure, which stabilizes the catalytic domain. The C-terminal non-catalytic carbohydrate binding module could not be observed in the crystal structure, suggesting positional flexibility. The structure of the enzyme in complex with Xylp--1,4-Xylp--1,4-Xylp-[-1,3-Araf]--1,4-Xylp showed that the Araf decoration linked O-3 to the xylose in the active site is located in the pocket (-2* subsite) that abuts onto the catalytic center. The -2* subsite can also bind to Xylp and Arap, explaining why the enzyme can utilize xylose and arabinose as specificity determinants. Alanine substitution of Glu(68), Tyr(92), or Asn(139), which interact with arabinose and xylose side chains at the -2* subsite, abrogates catalytic activity. Distal to the active site, the xylan backbone makes limited apolar contacts with the enzyme, and the hydroxyls are solvent-exposed. This explains why CtXyl5A is capable of hydrolyzing xylans that are extensively decorated and that are recalcitrant to classic endo-xylanase attack.	[Labourel, Aurore; Crouch, Lucy I.; Jackson, Adam; Rogowski, Artur; Gray, Joseph; Gilbert, Harry J.; Basle, Arnaud; Cuskin, Fiona] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Bras, Joana L. A.; Fontes, Carlos M. G. A.; Najmudin, Shabir] Univ Lisbon, CIISA Fac Med Vet, Polo Univ Alto Ajuda, Ave Univ Tecn, P-1300477 Lisbon, Portugal; [Bras, Joana L. A.; Fontes, Carlos M. G. A.] NZYTech Genes & Enzymes, P-1649038 Lisbon, Portugal; [Yadav, Madhav P.] ARS, Eastern Reg Res Ctr, USDA, Wyndmoor, PA 19038 USA; [Henrissat, Bernard] Aix Marseille Univ, CNRS, UMR7857, Architecture & Fonct Macromol Biol, F-13288 Marseille, France; [Henrissat, Bernard] INRA, Architecture & Fonct Macromol Biol USC1408, F-13288 Marseille, France; [Henrissat, Bernard] King Abdulaziz Univ, Dept Biol Sci, Jedda 21589, Saudi Arabia	Newcastle University - UK; Universidade de Lisboa; United States Department of Agriculture (USDA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; INRAE; King Abdulaziz University	Basle, A; Cuskin, F (corresponding author), Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.; Najmudin, S (corresponding author), Univ Lisbon, CIISA Fac Med Vet, Polo Univ Alto Ajuda, Ave Univ Tecn, P-1300477 Lisbon, Portugal.	shabir@fmv.ulosboa.pt; arnaud.basle@ncl.uk; Fiona.cuskin@newcastle.ac.uk	Henrissat, Bernard/J-2475-2012	Henrissat, Bernard/0000-0002-3434-8588; Bras, Joana/0000-0002-1141-5530; Labourel, Aurore/0000-0002-4762-5804; Fontes, Carlos/0000-0002-1219-9753; Najmudin, Shabir/0000-0002-0429-5454; Basle, Arnaud/0000-0002-4899-3086; Gray, Joseph/0000-0003-2338-0301; Cuskin, Fiona/0000-0003-4287-4921	European Research Council [322820]; Biotechnology and Biological Research Council [BB/K020358/1, BB/K001949/1]; Wellcome Trust [RES/0120/7613]; Agence Nationale de la Recherche [ANR 12-BIME-0006-01]; Fundacao para a Ciencia e Tecnologia [PTDC/BIAPRO/103980/2008, PTDC/BIAMIC/5947/2014]; BBSRC [BB/K001949/1, BB/K020358/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K020358/1, BB/K001949/1] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Biotechnology and Biological Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by European Research Council Grant 322820 (to H. J. G. and B. H.), Biotechnology and Biological Research Council Grants BB/K020358/1 and BB/K001949/1 (to H. J. G.), Wellcome Trust Grant RES/0120/7613 (to H. J. G.), Agence Nationale de la Recherche Grant ANR 12-BIME-0006-01 (to B. H.), and Fundacao para a Ciencia e Tecnologia Grants PTDC/BIAPRO/103980/2008 and PTDC/BIAMIC/5947/2014 (to C. M. G. A. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Agger J, 2010, J AGR FOOD CHEM, V58, P6141, DOI 10.1021/jf100633f; Alahuhta M, 2010, ACTA CRYSTALLOGR F, V66, P878, DOI 10.1107/S1744309110022529; Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; Beylot MH, 2001, BIOCHEM J, V358, P607, DOI 10.1042/0264-6021:3580607; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Bras JLA, 2011, ACTA CRYSTALLOGR F, V67, P833, DOI 10.1107/S1744309111020823; Brett CT, 1996, PHYSL BIOCH PLANT CE; Bui NK, 2009, J BACTERIOL, V191, P494, DOI 10.1128/JB.00608-08; Cartmell A, 2011, J BIOL CHEM, V286, P15483, DOI 10.1074/jbc.M110.215962; Charnock SJ, 1998, J BIOL CHEM, V273, P32187, DOI 10.1074/jbc.273.48.32187; Charnock SJ, 2002, P NATL ACAD SCI USA, V99, P14077, DOI 10.1073/pnas.212516199; Charnock SJ, 1997, J BIOL CHEM, V272, P2942, DOI 10.1074/jbc.272.5.2942; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Correia MAS, 2011, J BIOL CHEM, V286, P22510, DOI 10.1074/jbc.M110.217315; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cuskin F, 2015, NATURE, V517, P165, DOI 10.1038/nature13995; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Ebringerova A, 2005, ADV POLYM SCI, V186, P1, DOI 10.1007/b136816; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fontes CMGA, 2010, ANNU REV BIOCHEM, V79, P655, DOI 10.1146/annurev-biochem-091208-085603; Fujimoto Z, 2000, J MOL BIOL, V300, P575, DOI 10.1006/jmbi.2000.3877; Gilbert HJ, 2008, CURR OPIN PLANT BIOL, V11, P338, DOI 10.1016/j.pbi.2008.03.004; Gilbert HJ, 2013, CURR OPIN STRUC BIOL, V23, P669, DOI 10.1016/j.sbi.2013.05.005; Gilbert HJ, 2010, PLANT PHYSIOL, V153, P444, DOI 10.1104/pp.110.156646; Herve C, 2010, P NATL ACAD SCI USA, V107, P15293, DOI 10.1073/pnas.1005732107; Himmel ME, 2009, CURR OPIN BIOTECH, V20, P316, DOI 10.1016/j.copbio.2009.05.005; Ichinose H, 2009, J BIOL CHEM, V284, P25097, DOI 10.1074/jbc.M109.022723; Jiang DH, 2012, J STRUCT BIOL, V180, P447, DOI 10.1016/j.jsb.2012.08.005; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Laskowski RA, 2009, NUCLEIC ACIDS RES, V37, pD355, DOI 10.1093/nar/gkn860; Leslie A. G. W., 2007, EVOLVING METHODS MAC; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mewis K, 2016, APPL ENVIRON MICROB, V82, P1686, DOI 10.1128/AEM.03453-15; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Montanier CY, 2011, J BIOL CHEM, V286, P22499, DOI 10.1074/jbc.M110.217372; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Notenboom V, 2002, BIOCHEMISTRY-US, V41, P4246, DOI 10.1021/bi015865j; Pell G, 2004, J BIOL CHEM, V279, P9597, DOI 10.1074/jbc.M312278200; Poon DKY, 2007, J BIOL CHEM, V282, P2091, DOI 10.1074/jbc.M609670200; Proctor MR, 2005, P NATL ACAD SCI USA, V102, P2697, DOI 10.1073/pnas.0500051102; Stierand K, 2010, ACS MED CHEM LETT, V1, P540, DOI 10.1021/ml100164p; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vardakou M, 2008, J MOL BIOL, V375, P1293, DOI 10.1016/j.jmb.2007.11.007; Venditto I, 2015, J BIOL CHEM, V290, P10572, DOI 10.1074/jbc.M115.637827; Vrsanska M, 2007, FEBS J, V274, P1666, DOI 10.1111/j.1742-4658.2007.05710.x	49	21	21	2	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22149	22159		10.1074/jbc.M116.743948	http://dx.doi.org/10.1074/jbc.M116.743948			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27531750	Green Published, hybrid			2022-12-26	WOS:000386332600028
J	Noel, JP; De Niear, M; Van der Burg, E; Wallace, MT				Noel, Jean-Paul; De Niear, Matthew; Van der Burg, Erik; Wallace, Mark T.			Audiovisual Simultaneity Judgment and Rapid Recalibration throughout the Lifespan	PLOS ONE			English	Article							CORTICAL MULTISENSORY INTEGRATION; VISUAL SPEECH-PERCEPTION; TEMPORAL RECALIBRATION; SUPERIOR COLLICULUS; UNITY ASSUMPTION; WINDOW; BINDING; INFORMATION; STIMULI; TIME	Multisensory interactions are well established to convey an array of perceptual and behavioral benefits. One of the key features of multisensory interactions is the temporal structure of the stimuli combined. In an effort to better characterize how temporal factors influence multisensory interactions across the lifespan, we examined audiovisual simultaneity judgment and the degree of rapid recalibration to paired audiovisual stimuli (Flash-Beep and Speech) in a sample of 220 participants ranging from 7 to 86 years of age. Results demonstrate a surprisingly protracted developmental time-course for both audiovisual simultaneity judgment and rapid recalibration, with neither reaching maturity until well into adolescence. Interestingly, correlational analyses revealed that audiovisual simultaneity judgments (i. e., the size of the audiovisual temporal window of simultaneity) and rapid recalibration significantly co-varied as a function of age. Together, our results represent the most complete description of age-related changes in audiovisual simultaneity judgments to date, as well as being the first to describe changes in the degree of rapid recalibration as a function of age. We propose that the developmental time-course of rapid recalibration scaffolds the maturation of more durable audiovisual temporal representations.	[Noel, Jean-Paul] Vanderbilt Univ, Sch Med, Vanderbilt Brain Inst, Grad Program Neurosci, 221 Kirkland Hall, Nashville, TN 37235 USA; [Noel, Jean-Paul; De Niear, Matthew; Wallace, Mark T.] Vanderbilt Univ, Vanderbilt Brain Inst, Sch Med, 221 Kirkland Hall, Nashville, TN 37235 USA; [De Niear, Matthew] Vanderbilt Univ, Sch Med, Med Scientist Training Program, 221 Kirkland Hall, Nashville, TN 37235 USA; [Van der Burg, Erik] Vrije Univ Amsterdam, Dept Expt & Appl Psychol, Amsterdam, Netherlands; [Van der Burg, Erik] Univ Sydney, Sch Psychol, Sydney, NSW, Australia; [Wallace, Mark T.] Vanderbilt Univ, Med Ctr, Dept Speech & Hearing Sci, 221 Kirkland Hall, Nashville, TN 37235 USA; [Wallace, Mark T.] Vanderbilt Univ, Dept Psychol, 221 Kirkland Hall, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vrije Universiteit Amsterdam; University of Sydney; Vanderbilt University; Vanderbilt University	Wallace, MT (corresponding author), Vanderbilt Univ, Vanderbilt Brain Inst, Sch Med, 221 Kirkland Hall, Nashville, TN 37235 USA.; Wallace, MT (corresponding author), Vanderbilt Univ, Med Ctr, Dept Speech & Hearing Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.; Wallace, MT (corresponding author), Vanderbilt Univ, Dept Psychol, 221 Kirkland Hall, Nashville, TN 37235 USA.	mark.wallace@vanderbilt.edu	Noel, Jean-Paul/I-8083-2019	Noel, Jean-Paul/0000-0001-5297-3363	NIH [CA183492, HD083211]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083211] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R21CA183492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by NIH CA183492 and HD083211. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, DEV INTERSENSORY PER; Bedard G, 2016, EXP BRAIN RES, V234, P331, DOI 10.1007/s00221-015-4466-7; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bruns P, 2015, SCI REP-UK, V5, DOI 10.1038/srep12739; Carriere BN, 2007, J NEUROPHYSIOL, V98, P2858, DOI 10.1152/jn.00587.2007; Chan YM, 2014, J VISION, V14, DOI 10.1167/14.11.13; Chan YM, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00226; Cienkowski KM, 2002, EAR HEARING, V23, P439, DOI 10.1097/00003446-200210000-00006; De Niear M., IMPACT FEEDBAC UNPUB; Diederich A, 2004, PERCEPT PSYCHOPHYS, V66, P1388, DOI 10.3758/BF03195006; Diederich A, 2015, PSYCHOL REV, V122, P232, DOI 10.1037/a0038696; DIXON NF, 1980, PERCEPTION, V9, P719, DOI 10.1068/p090719; Frassinetti F, 2002, EXP BRAIN RES, V147, P332, DOI 10.1007/s00221-002-1262-y; FRENS MA, 1995, PERCEPT PSYCHOPHYS, V57, P802, DOI 10.3758/BF03206796; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; Harvey C, 2014, BRAIN RES, V1585, P120, DOI 10.1016/j.brainres.2014.08.028; Hillock AR, 2011, NEUROPSYCHOLOGIA, V49, P461, DOI 10.1016/j.neuropsychologia.2010.11.041; Hillock-Dunn A., 2016, TEMPORAL WINDOW SIMU; Hillock-Dunn A, 2012, DEVELOPMENTAL SCI, V15, P688, DOI 10.1111/j.1467-7687.2012.01171.x; James T. W., 2012, NEURAL BASEMULTISE; Lewkowicz DJ, 2014, CHILD DEV, V85, P685, DOI 10.1111/cdev.12142; Lewkowicz DJ, 2014, DEV PSYCHOBIOL, V56, P292, DOI 10.1002/dev.21197; Lewkowicz DJ, 2009, TRENDS COGN SCI, V13, P470, DOI 10.1016/j.tics.2009.08.004; Lewkowicz DJ, 1996, J EXP PSYCHOL HUMAN, V22, P1094, DOI 10.1037/0096-1523.22.5.1094; Lovelace CT, 2003, COGNITIVE BRAIN RES, V17, P447, DOI 10.1016/S0926-6410(03)00160-5; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; MEREDITH MA, 1987, J NEUROSCI, V7, P3215; MILLER J, 1982, COGNITIVE PSYCHOL, V14, P247, DOI 10.1016/0010-0285(82)90010-X; Mozolic J.L., 2012, NEURAL BASEMULTISE; Nelson WT, 1998, HUM FACTORS, V40, P452, DOI 10.1518/001872098779591304; Noel JP, 2017, AUTISM RES, V10, P121, DOI 10.1002/aur.1633; Noel JP, 2016, NEUROPSYCHOLOGIA, V82, P84, DOI 10.1016/j.neuropsychologia.2016.01.005; Noel JP, 2015, SCI REP-UK, V5, DOI 10.1038/srep17467; Noel JP, 2015, COGNITION, V144, P49, DOI 10.1016/j.cognition.2015.07.012; NOZAWA G, 1994, BIOL CYBERN, V72, P19, DOI 10.1007/BF00206235; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Poliakoff E, 2006, NEUROSCI LETT, V396, P207, DOI 10.1016/j.neulet.2005.11.034; Polley DB, 2008, J AM ACAD AUDIOL, V19, P780, DOI 10.3766/jaaa.19.10.6; Powers AR, 2009, J NEUROSCI, V29, P12265, DOI 10.1523/JNEUROSCI.3501-09.2009; Quinto L, 2010, ATTEN PERCEPT PSYCHO, V72, P1450, DOI 10.3758/APP.72.6.1450; Setti A, 2011, NEUROREPORT, V22, P554, DOI 10.1097/WNR.0b013e328348c731; Setti A, 2011, EXP BRAIN RES, V209, P375, DOI 10.1007/s00221-011-2560-z; Stein BE., 1993, MERGING SENSES; Stevenson RA, 2013, EXP BRAIN RES, V227, P249, DOI 10.1007/s00221-013-3507-3; Stevenson RA, 2012, J EXP PSYCHOL HUMAN, V38, P1517, DOI 10.1037/a0027339; Stone JV, 2001, P ROY SOC B-BIOL SCI, V268, P31, DOI 10.1098/rspb.2000.1326; Turi M, 2016, SCI REP-UK, V6, DOI 10.1038/srep21756; Van der Burg E, 2008, J EXP PSYCHOL HUMAN, V34, P1053, DOI 10.1037/0096-1523.34.5.1053; Van der Burg E, 2015, SCI REP-UK, V5, DOI 10.1038/srep14526; Van der Burg E, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.3083; Van der Burg E, 2015, EXP BRAIN RES, V233, P53, DOI 10.1007/s00221-014-4085-8; Van der Burg E, 2013, J NEUROSCI, V33, P14633, DOI 10.1523/JNEUROSCI.1182-13.2013; Van der Burg E, 2011, NEUROIMAGE, V55, P1208, DOI 10.1016/j.neuroimage.2010.12.068; van Wassenhove V, 2007, NEUROPSYCHOLOGIA, V45, P598, DOI 10.1016/j.neuropsychologia.2006.01.001; Vatakis A, 2008, ACTA PSYCHOL, V127, P12, DOI 10.1016/j.actpsy.2006.12.002; Vatakis A, 2007, PERCEPT PSYCHOPHYS, V69, P744, DOI 10.3758/BF03193776; Vroomen J, 2004, COGNITIVE BRAIN RES, V22, P32, DOI 10.1016/j.cogbrainres.2004.07.003; Wallace M. T, 2004, HDB MULTISENSORY PRO, P683; Wallace M.T., 2004, COGNIT PROCESS, V5, P69, DOI [10.1007/s10339-004-0017-z, DOI 10.1007/S10339-004-0017-Z]; Wallace MT, 2006, J NEUROSCI, V26, P11844, DOI 10.1523/JNEUROSCI.3295-06.2006; Wallace MT, 2014, NEUROPSYCHOLOGIA, V64, P105, DOI 10.1016/j.neuropsychologia.2014.08.005; Wallace MT, 1997, J NEUROSCI, V17, P2429; Wallace MT, 1997, J NEUROPHYSIOL, V78, P2732, DOI 10.1152/jn.1997.78.5.2732; Wilkinson LK, 1996, EXP BRAIN RES, V112, P1	65	47	47	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0161698	10.1371/journal.pone.0161698	http://dx.doi.org/10.1371/journal.pone.0161698			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27551918	Green Submitted, gold, Green Published			2022-12-26	WOS:000381768800072
J	Shang, Q; Lin, CY; Yang, ZS; Bing, QC; Zhou, XY				Shang, Qiang; Lin, Ciyun; Yang, Zhaosheng; Bing, Qichun; Zhou, Xiyang			A Hybrid Short-Term Traffic Flow Prediction Model Based on Singular Spectrum Analysis and Kernel Extreme Learning Machine	PLOS ONE			English	Article							EMBEDDING DIMENSION; NEURAL-NETWORK; SEARCH; INTELLIGENCE; REGRESSION; DYNAMICS; TESTS; GSA	Short-term traffic flow prediction is one of the most important issues in the field of intelligent transport system (ITS). Because of the uncertainty and nonlinearity, short-term traffic flow prediction is a challenging task. In order to improve the accuracy of short-time traffic flow prediction, a hybrid model (SSA-KELM) is proposed based on singular spectrum analysis (SSA) and kernel extreme learning machine (KELM). SSA is used to filter out the noise of traffic flow time series. Then, the filtered traffic flow data is used to train KELM model, the optimal input form of the proposed model is determined by phase space reconstruction, and parameters of the model are optimized by gravitational search algorithm (GSA). Finally, case validation is carried out using the measured data of an expressway in Xiamen, China. And the SSA-KELM model is compared with several well-known prediction models, including support vector machine, extreme learning machine, and single KLEM model. The experimental results demonstrate that performance of the proposed model is superior to that of the comparison models. Apart from accuracy improvement, the proposed model is more robust.	[Shang, Qiang; Lin, Ciyun; Yang, Zhaosheng; Bing, Qichun; Zhou, Xiyang] Jilin Univ, Coll Transportat, Changchun 130022, Peoples R China; [Lin, Ciyun; Yang, Zhaosheng] Jilin Univ, State Key Lab Automobile Simulat & Control, Changchun 130022, Peoples R China	Jilin University; Jilin University	Lin, CY (corresponding author), Jilin Univ, Coll Transportat, Changchun 130022, Peoples R China.; Lin, CY (corresponding author), Jilin Univ, State Key Lab Automobile Simulat & Control, Changchun 130022, Peoples R China.	linciyun@jlu.edu.cn	Lin, Ciyun/B-2086-2009; Bing, Qichun/HHN-2399-2022; Lin, Ciyun/AAK-6489-2020	Lin, Ciyun/0000-0001-9098-2666; Bing, Qichun/0000-0001-8180-2424; Shang, Qiang/0000-0002-0016-2232	Chinese National High Technology Research and Development Program [2014BAG03B03]; National Science Foundation of China [51408257, 51308248]	Chinese National High Technology Research and Development Program(National High Technology Research and Development Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Chinese National High Technology Research and Development Program (Grant No. 2014BAG03B03), the National Science Foundation of China (Grant No. 51408257 and No. 51308248). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahzade M, 2015, INFORM SCIENCES, V295, P107, DOI 10.1016/j.ins.2014.09.002; Afshar K, 2011, ENERGY, V36, P2620, DOI 10.1016/j.energy.2011.02.003; Bencherif MA, 2015, IEEE GEOSCI REMOTE S, V12, P527, DOI 10.1109/LGRS.2014.2349538; Brock W.A., 1991, NONLINEAR DYNAMICS C; Cao LY, 1997, PHYSICA D, V110, P43, DOI 10.1016/S0167-2789(97)00118-8; Castro-Neto M, 2009, EXPERT SYST APPL, V36, P6164, DOI 10.1016/j.eswa.2008.07.069; Chandra SR, 2009, J INTELL TRANSPORT S, V13, P53, DOI 10.1080/15472450902858368; Chen HL, 2016, NEUROCOMPUTING, V184, P131, DOI 10.1016/j.neucom.2015.07.138; Demsar J, 2006, J MACH LEARN RES, V7, P1; DENDRINOS DS, 1994, CHAOS SOLITON FRACT, V4, P605, DOI 10.1016/0960-0779(94)90069-8; Deng ZH, 2014, IEEE T CYBERNETICS, V44, P2585, DOI 10.1109/TCYB.2014.2311014; Deng ZH, 2014, IEEE T NEUR NET LEAR, V25, P664, DOI 10.1109/TNNLS.2013.2280171; Derrac J, 2011, SWARM EVOL COMPUT, V1, P3, DOI 10.1016/j.swevo.2011.02.002; FRASER AM, 1986, PHYS REV A, V33, P1134, DOI 10.1103/PhysRevA.33.1134; Frazier C, 2004, TRANSPORT RES REC, P9, DOI 10.3141/1897-02; Garavello M., 2006, TRAFFIC FLOW NETWORK; Garcia S, 2010, INFORM SCIENCES, V180, P2044, DOI 10.1016/j.ins.2009.12.010; Ghouti L, 2013, PROCEDIA COMPUT SCI, V19, P305, DOI 10.1016/j.procs.2013.06.043; GIPPS PG, 1981, TRANSPORT RES B-METH, V15, P105, DOI 10.1016/0191-2615(81)90037-0; Golyandina N., 2001, ANAL TIME SERIES STR, DOI DOI 10.1201/9781420035841; GRASSBERGER P, 1983, PHYS REV LETT, V50, P346, DOI 10.1103/PhysRevLett.50.346; Guo F, 2013, TRANSPORT PLAN TECHN, V36, P62, DOI 10.1080/03081060.2012.745721; Hassani H, 2013, INT J ENERGY STAT, V1, P55, DOI 10.1142/S2335680413500051; Hassani H, 2010, NONLINEAR ANAL-REAL, V11, P2023, DOI 10.1016/j.nonrwa.2009.05.008; He YL, 2015, ENG APPL ARTIF INTEL, V41, P65, DOI 10.1016/j.engappai.2015.02.001; Holzfuss J., 1986, APPROACH ERROR ESTIM, P114, DOI DOI 10.1007/978-3-642-71001-8_; Hu WB, 2016, NEURAL PROCESS LETT, V43, P155, DOI 10.1007/s11063-015-9409-6; Huang GB, 2006, NEUROCOMPUTING, V70, P489, DOI 10.1016/j.neucom.2005.12.126; Huang GB, 2014, COGN COMPUT, V6, P376, DOI 10.1007/s12559-014-9255-2; Huang GB, 2012, IEEE T SYST MAN CY B, V42, P513, DOI 10.1109/TSMCB.2011.2168604; Jiang XM, 2005, J TRANSP ENG, V131, P771, DOI 10.1061/(ASCE)0733-947X(2005)131:10(771); Jiang YZ, 2015, IEEE T CYBERNETICS, V45, P548, DOI 10.1109/TCYB.2014.2330844; KENNEL MB, 1992, PHYS REV A, V45, P3403, DOI 10.1103/PhysRevA.45.3403; Kim HS, 1999, PHYSICA D, V127, P48, DOI 10.1016/S0167-2789(98)00240-1; Lan L.W., 2003, THE J, V5, P1975; Laval JA, 2008, TRANSPORT RES B-METH, V42, P511, DOI 10.1016/j.trb.2007.10.004; Li CS, 2015, NEURAL COMPUT APPL, V26, P713, DOI 10.1007/s00521-014-1757-z; Ma XL, 2015, TRANSPORT RES C-EMER, V54, P187, DOI 10.1016/j.trc.2015.03.014; Meng M, 2015, J CENT SOUTH UNIV, V22, P779, DOI 10.1007/s11771-015-2582-y; Olatunji SO, 2014, INFORM FUSION, V16, P29, DOI 10.1016/j.inffus.2012.06.001; Rashedi E, 2009, INFORM SCIENCES, V179, P2232, DOI 10.1016/j.ins.2009.03.004; ROSENSTEIN MT, 1994, PHYSICA D, V73, P82, DOI 10.1016/0167-2789(94)90226-7; Sanei S, 2011, MED ENG PHYS, V33, P362, DOI 10.1016/j.medengphy.2010.11.004; Shamshirband S, 2015, J ATMOS SOL-TERR PHY, V134, P109, DOI 10.1016/j.jastp.2015.09.014; Soltani S, 2002, NEUROCOMPUTING, V48, P267, DOI 10.1016/S0925-2312(01)00648-8; Stathopoulos A, 2003, TRANSPORT RES C-EMER, V11, P121, DOI 10.1016/S0968-090X(03)00004-4; Sun HY, 2003, TRANSPORT RES REC, P143, DOI 10.3141/1836-18; Takens F, 1981, DYNAMICAL SYSTEMS TU, P366, DOI [10.1007/BFb0091924, DOI 10.1007/BFB0091924]; van Lint J.W.C., 2012, ARTIF INTELL APPL CR, V22, P22; van Lint JWC, 2002, TRANSPORT RES REC, P30, DOI 10.3141/1811-04; Vlahogianni EI, 2004, TRANSPORT REV, V24, P533, DOI 10.1080/0144164042000195072; Vlahogianni EI, 2014, TRANSPORT RES C-EMER, V43, P3, DOI 10.1016/j.trc.2014.01.005; Wang DA, 2014, NEUROCOMPUTING, V128, P258, DOI 10.1016/j.neucom.2012.12.062; Wang ST, 2015, APPL SOFT COMPUT, V37, P125, DOI 10.1016/j.asoc.2015.07.040; Wang XY, 2014, NEUROCOMPUTING, V145, P90, DOI 10.1016/j.neucom.2014.05.068; Wu CH, 2004, IEEE T INTELL TRANSP, V5, P276, DOI 10.1109/TITS.2004.837813; Yang S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141223; Yu Q, 2014, NEUROCOMPUTING, V128, P296, DOI 10.1016/j.neucom.2013.01.063; Yuan XH, 2015, ENERG CONVERS MANAGE, V101, P393, DOI 10.1016/j.enconman.2015.05.065; Zhang Q, 2011, WATER RESOUR MANAG, V25, P2683, DOI 10.1007/s11269-011-9833-y; Zhang WP, 2013, KNOWL-BASED SYST, V39, P34, DOI 10.1016/j.knosys.2012.10.004; Zhang YL, 2015, J ECONOMETRICS, V187, P95, DOI 10.1016/j.jeconom.2015.02.006	64	19	20	4	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0161259	10.1371/journal.pone.0161259	http://dx.doi.org/10.1371/journal.pone.0161259			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27551829	Green Published, gold, Green Submitted			2022-12-26	WOS:000381768800026
J	Tan, SK; Yeong, CH; Ng, KH; Aziz, YFA; Sun, ZH				Tan, Sock Keow; Yeong, Chai Hong; Ng, Kwan Hoong; Aziz, Yang Faridah Abdul; Sun, Zhonghua			Recent Update on Radiation Dose Assessment for the State-of-the-Art Coronary Computed Tomography Angiography Protocols	PLOS ONE			English	Article							2ND-GENERATION 320-DETECTOR ROW; ITERATIVE MODEL RECONSTRUCTION; CT ANGIOGRAPHY; IMAGE QUALITY; HIGH-PITCH; HEART-RATE; EXPOSURE; ACCURACY; IMPACT; RISK	Objectives This study aimed to measure the absorbed doses in selected organs for prospectively ECG-triggered coronary computed tomography angiography (CCTA) using five different generations CT scanners in a female adult anthropomorphic phantom and to estimate the effective dose (H-E). Materials and Methods Prospectively ECG-triggered CCTA was performed using five commercially available CT scanners: 64-detector-row single source CT (SSCT), 2 x 32-detector-row-dual source CT (DSCT), 2 x 64-detector-row DSCT and 320-detector-row SSCT scanners. Absorbed doses were measured in 34 organs using pre-calibrated optically stimulated luminescence dosimeters (OSLDs) placed inside a standard female adult anthropomorphic phantom. H-E was calculated from the measured organ doses and compared to the H-E derived from the air kerma-length product (P-KL) using the conversion coefficient of 0.014 mSv.mGy(-1).cm(-1) for the chest region. Results Both breasts and lungs received the highest radiation dose during CCTA examination. The highest H-E was received from 2 x 32-detector-row DSCT scanner (6.06 +/- 0.72 mSv), followed by 64-detector-row SSCT (5.60 +/- 0.68 and 5.02 +/- 0.73 mSv), 2 x 64-detector-row DSCT (1.88 +/- 0.25 mSv) and 320-detector-row SSCT (1.34 +/- 0.48 mSv) scanners. H-E calculated from the measured organ doses were about 38 to 53% higher than the H-E derived from the P-KL-to-H-E conversion factor. Conclusion The radiation doses received from a prospectively ECG-triggered CCTA are relatively small and are depending on the scanner technology and imaging protocols. H-E as low as 1.34 and 1.88 mSv can be achieved in prospectively ECG-triggered CCTA using 320-detectorrow SSCT and 2 x 64-detector-row DSCT scanners.	[Tan, Sock Keow; Yeong, Chai Hong; Ng, Kwan Hoong; Aziz, Yang Faridah Abdul] Univ Malaya, Fac Med, Dept Biomed Imaging, Kuala Lumpur 50603, Malaysia; [Sun, Zhonghua] Curtin Univ, Dept Med Radiat Sci, Perth, WA 6845, Australia	Universiti Malaya; Curtin University	Ng, KH (corresponding author), Univ Malaya, Fac Med, Dept Biomed Imaging, Kuala Lumpur 50603, Malaysia.	ngkh@ummc.edu.my	Sun, Zhonghua/B-3125-2010; HONG, YEONG CHAI/C-1083-2010; ABDUL AZIZ, YANG FARIDAH/C-1063-2010; Ng, Kwan Hoong/D-2231-2009; Aziz, Yang Faridah Abdul/C-7945-2012; Sun, Zhonghua/N-1648-2019; TAN, SOCK KEOW/N-9061-2017	Sun, Zhonghua/0000-0002-7538-4761; HONG, YEONG CHAI/0000-0003-1572-4143; Aziz, Yang Faridah Abdul/0000-0002-0869-1972; Sun, Zhonghua/0000-0002-7538-4761; 	High Impact Research Grant from the Ministry of Education, Malaysia [UM.C/625/1/HIR/MOHE/MED/36]	High Impact Research Grant from the Ministry of Education, Malaysia	This study was supported by the High Impact Research Grant UM.C/625/1/HIR/MOHE/MED/36 from the Ministry of Education, Malaysia (hir.um.edu.my).	Achenbach S, 2010, EUR HEART J, V31, P340, DOI 10.1093/eurheartj/ehp470; Alkadhi H, 2010, HEART, V96, P933, DOI 10.1136/hrt.2009.189100; [Anonymous], 1991, Ann ICRP, V21, P1; [Anonymous], 2013, DIAGN INT CARD; [Anonymous], 2007, TECHNICAL REPORT SER, V457; Benz DC, 2016, ACAD RADIOL, V23, P1008, DOI 10.1016/j.acra.2016.03.015; Chen MY, 2013, RADIOLOGY, V267, P76, DOI 10.1148/radiol.13122621; Chow BJW, 2009, CIRC-CARDIOVASC IMAG, V2, P16, DOI 10.1161/CIRCIMAGING.108.792572; Einstein AJ, 2007, JAMA-J AM MED ASSOC, V298, P317, DOI 10.1001/jama.298.3.317; Fuchs TA, 2014, ACAD RADIOL, V21, P312, DOI 10.1016/j.acra.2013.10.014; Gordic S, 2014, INT J CARDIOVAS IMAG, V30, P1173, DOI 10.1007/s10554-014-0445-5; Gosling O, 2010, CLIN RADIOL, V65, P1013, DOI 10.1016/j.crad.2010.08.001; Hou Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056295; Hsiao Edward M, 2010, Curr Cardiol Rep, V12, P68, DOI 10.1007/s11886-009-0075-z; Hurwitz LM, 2007, RADIOLOGY, V245, P742, DOI 10.1148/radiol.2453062046; LaBounty TM, 2010, AM J ROENTGENOL, V194, P933, DOI 10.2214/AJR.09.3371; Latif MA, 2016, J COMPUT ASSIST TOMO, V40, P763, DOI 10.1097/RCT.0000000000000428; Mangold S, 2016, EUR RADIOL, V26, P1871, DOI 10.1007/s00330-015-3997-4; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Oda S, 2014, EUR J RADIOL, V83, P1408, DOI 10.1016/j.ejrad.2014.04.027; Otero HJ, 2009, RADIOL CLIN N AM, V47, P79, DOI 10.1016/j.rcl.2008.11.001; Peebles C, 2006, HEART, V92, P582, DOI 10.1136/hrt.2005.082198; Sabarudin A, 2013, RADIAT PROT DOSIM, V154, P301, DOI 10.1093/rpd/ncs243; Sabarudin A, 2012, J MED IMAG RADIAT ON, V56, P5, DOI 10.1111/j.1754-9485.2011.02335.x; Scharf M, 2011, JACC-CARDIOVASC IMAG, V4, P602, DOI 10.1016/j.jcmg.2011.02.014; Shrimpton P., 2004, FIGMCT200020078CTTIP; Shrimpton P.C., 2003, NRPBW67; Sun Z, 2010, SINGAP MED J, V51, P374; Wong DTL, 2014, CARDIOVASC DIAGN THE, V4, P299, DOI 10.3978/j.issn.2223-3652.2014.08.05; Yang CC, 2011, RADIAT MEAS, V46, P2060, DOI 10.1016/j.radmeas.2011.07.003; Yuki H, 2014, J CARDIOVASC COMPUT, V8, P115, DOI 10.1016/j.jcct.2013.12.010; Zhang D, 2013, MED PHYS, V40, DOI 10.1118/1.4816299	32	11	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0161543	10.1371/journal.pone.0161543	http://dx.doi.org/10.1371/journal.pone.0161543			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27552224	Green Published, gold			2022-12-26	WOS:000381768800050
J	Ha, SJ; Kim, BG; Lee, YA; Kim, YH; Kim, BJ; Jung, SE; Pang, MG; Ryu, BY				Ha, Seung-Jung; Kim, Byung-Gak; Lee, Yong-An; Kim, Yong-Hee; Kim, Bang-Jin; Jung, Sang-Eun; Pang, Myeong-Geol; Ryu, Buom-Yong			Effect of Antioxidants and Apoptosis Inhibitors on Cryopreservation of Murine Germ Cells Enriched for Spermatogonial Stem Cells	PLOS ONE			English	Article							SILK PROTEIN SERICIN; FREE FREEZING MEDIUM; MOUSE TESTES; HEMATOPOIETIC STEM; MAMMALIAN-CELLS; TRANSPLANTATION; SERUM; TREHALOSE; PRESERVATION; EMBRYOS	Spermatogonial stem cells (SSCs) are germline stem cells that serve as the foundation of spermatogenesis to maintain fertility throughout a male's lifetime. To treat male infertility using stem cell banking systems and transplantation, it is important to be able to preserve SSCs for long periods of time. Therefore, this study was conducted to develop an optimal cryopreservation protocol for SSCs using antioxidants and apoptosis inhibitors in freezing medium. No differences were observed compared to controls when SSCs were cryopreserved in the presence of apoptosis inhibitors by themselves. However, mouse germ cells cryopreserved in basal medium containing the antioxidant hypotaurine (14 mM) resulted in significantly greater proliferation potential and mitochondrial activity. Furthermore, treatment groups with combinations containing 200 mM trehalose and 14 mM hypotaurine showed higher proliferation rates compared to controls. In addition, several serum free conditions were evaluated for SSC cryopreservation. Treatment media containing 10% or 20% knockout serum replacement resulted in similar cryopreservation results compared to media containing FBS. SSC transplantation was also performed to confirm the functionality of SSCs frozen in 14 mM hypotaurine. Donor SSCs formed normal spermatogenic colonies and sperm in the recipient testis. These data indicate that inclusion of 14 mM hypotaurine in cryopreservation media is an effective way to efficiently cryopreserve germ cells enriched for SSCs and that knockout serum replacement can replace FBS in germ cell cryopreservation media.	[Ha, Seung-Jung; Kim, Yong-Hee; Kim, Bang-Jin; Jung, Sang-Eun; Pang, Myeong-Geol; Ryu, Buom-Yong] Chung Ang Univ, Dept Anim Sci & Technol, Anseong, Gyeonggi Do, South Korea; [Kim, Byung-Gak] Chung Ang Univ, Bio Environm Technol Res Inst, Anseong, Gyeonggi Do, South Korea; [Lee, Yong-An] Agcy Sci Technol & Res, Singapore Bioimaging Consortium, Lab Bioimaging Probe Dev, Singapore, Singapore; [Kim, Bang-Jin] Univ Penn, Perelman Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA	Chung Ang University; Chung Ang University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC); University of Pennsylvania; Pennsylvania Medicine	Ryu, BY (corresponding author), Chung Ang Univ, Dept Anim Sci & Technol, Anseong, Gyeonggi Do, South Korea.	byryu@cau.ac.kr		Lee, Yong-An/0000-0001-7253-2397	Korean Health Technology R&D Project, Ministry of Health and Welfare [HI12C0055]; Next-Generation BioGreen 21 Program, Republic of Korea [PJ011347]	Korean Health Technology R&D Project, Ministry of Health and Welfare; Next-Generation BioGreen 21 Program, Republic of Korea	This work was supported by the Korean Health Technology R&D Project, Ministry of Health and Welfare (HI12C0055), and Next-Generation BioGreen 21 Program (PJ011347), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboagla EME, 2003, BIOL REPROD, V69, P1245, DOI 10.1095/biolreprod.103.017889; Brinster RL, 1998, SEMIN CELL DEV BIOL, V9, P401, DOI 10.1006/scdb.1998.0205; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; Brook PF, 2001, FERTIL STERIL, V75, P269, DOI 10.1016/S0015-0282(00)01721-0; Bucak MN, 2013, CRYOBIOLOGY, V67, P34, DOI 10.1016/j.cryobiol.2013.04.007; CHEN Y, 1993, CRYOBIOLOGY, V30, P423, DOI 10.1006/cryo.1993.1042; CROWE JH, 1984, SCIENCE, V223, P701, DOI 10.1126/science.223.4637.701; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Dalcin L, 2013, CRYOBIOLOGY, V67, P137, DOI 10.1016/j.cryobiol.2013.05.012; Desjardins C, 1993, CELL MOL BIOL TESTIS; Dobrinski I, 1999, BIOL REPROD, V61, P1331, DOI 10.1095/biolreprod61.5.1331; Dobrinski I, 2000, MOL REPROD DEV, V57, P270, DOI 10.1002/1098-2795(200011)57:3&lt;270::AID-MRD9&gt;3.0.CO;2-Z; Dohle GR, 2010, INT J UROL, V17, P327, DOI 10.1111/j.1442-2042.2010.02484.x; Duchez P, 2013, TRANSFUSION, V53, P2012, DOI 10.1111/trf.12015; Eroglu A, 2000, NAT BIOTECHNOL, V18, P163, DOI 10.1038/72608; Fellman J H, 1985, Prog Clin Biol Res, V179, P71; Gao D, 2000, ILAR J, V41, P187; GEORGE MA, 1992, HUM REPROD, V7, P408, DOI 10.1093/oxfordjournals.humrep.a137659; GRILLI G, 1980, CRYOBIOLOGY, V17, P516, DOI 10.1016/0011-2240(80)90063-2; Hagedorn M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039397; Isobe T, 2013, CRYOBIOLOGY, V67, P184, DOI 10.1016/j.cryobiol.2013.06.010; Izadyar F, 2002, J ANDROL, V23, P537; Kanatsu-Shinohara M, HUMAN REPROD; Kim GA, 2010, FERTIL STERIL, V94, P2409, DOI 10.1016/j.fertnstert.2010.01.073; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Lee YA, 2014, FERTIL STERIL, V101, P1165, DOI 10.1016/j.fertnstert.2013.12.033; Lee YA, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.111195; Lee YA, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063255, 10.1371/journal.pone.0054889]; LEIBO SP, 1971, CRYOBIOLOGY, V8, P447, DOI 10.1016/0011-2240(71)90035-6; Limaye LS, 2001, J HEMATOTH STEM CELL, V10, P709, DOI 10.1089/152581601753193931; Memon AA, 2012, ANIM REPROD SCI, V136, P55, DOI 10.1016/j.anireprosci.2012.10.020; Miyamoto Y, 2012, CELL TRANSPLANT, V21, P617, DOI 10.3727/096368911X605556; Nagano M, 1999, BIOL REPROD, V60, P1429, DOI 10.1095/biolreprod60.6.1429; Oatley JM, 2006, METHOD ENZYMOL, V419, P259, DOI 10.1016/S0076-6879(06)19011-4; Ogawa T, 1997, INT J DEV BIOL, V41, P111; Ogawa T, 1999, BIOL REPROD, V60, P515, DOI 10.1095/biolreprod60.2.515; Ohnishi K, 2012, J HEPATO-BIL-PAN SCI, V19, P354, DOI 10.1007/s00534-011-0415-4; Pegg David E, 2007, Methods Mol Biol, V368, P39; Piwkham Duangjai, 2015, Asian Pac J Cancer Prev, V16, P4727; Ryu BY, 2004, DEV BIOL, V274, P158, DOI 10.1016/j.ydbio.2004.07.004; Sasaki M, 2005, BIOTECHNOL APPL BIOC, V42, P183, DOI 10.1042/BA20050019; Seo JM, 2011, CRYOBIOLOGY, V62, P167, DOI 10.1016/j.cryobiol.2011.02.003; Siriboon C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118165; Stroh C, 2002, FASEB J, V16, P1651, DOI 10.1096/fj.02-0034fje; Thibier M, 2006, REPROD DOMEST ANIM, V41, P260, DOI 10.1111/j.1439-0531.2006.00721.x; WRIGHT CE, 1986, ANNU REV BIOCHEM, V55, P427, DOI 10.1146/annurev.bi.55.070186.002235; Wu X, 2012, HUM REPROD, V27, P1249, DOI 10.1093/humrep/des077; Zeng W, 2009, REPROD FERT DEVELOP, V21, P489, DOI 10.1071/RD08235	48	40	43	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161372	10.1371/journal.pone.0161372	http://dx.doi.org/10.1371/journal.pone.0161372			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548381	gold, Green Published, Green Submitted			2022-12-26	WOS:000381768400049
J	Montana, S; Schramm, STJ; Traglia, GM; Chiem, K; Di Noto, GP; Almuzara, M; Barberis, C; Vay, C; Quiroga, C; Tolmasky, ME; Iriarte, A; Ramirez, MS				Montana, Sabrina; Schramm, Sareda T. J.; Matias Traglia, German; Chiem, Kevin; Parmeciano Di Noto, Gisela; Almuzara, Marisa; Barberis, Claudia; Vay, Carlos; Quiroga, Cecilia; Tolmasky, Marcelo E.; Iriarte, Andres; Soledad Ramirez, Maria			The Genetic Analysis of an Acinetobacter johnsonii Clinical Strain Evidenced the Presence of Horizontal Genetic Transfer	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; BAUMANNII; IDENTIFICATION; BACTEREMIA; EXPRESSION; ANNOTATIONS; BLA(OXA-58); PHYLOGENIES; ALGORITHMS; INFECTION	Acinetobacter johnsonii rarely causes human infections. While most A. johnsonii isolates are susceptible to virtually all antibiotics, strains harboring a variety of beta-lactamases have recently been described. An A. johnsonii Aj2199 clinical strain recovered from a hospital in Buenos Aires produces PER-2 and OXA-58. We decided to delve into its genome by obtaining the whole genome sequence of the Aj2199 strain. Genome comparison studies on Aj2199 revealed 240 unique genes and a close relation to strain WJ10621, isolated from the urine of a patient in China. Genomic analysis showed evidence of horizontal genetic transfer (HGT) events. Forty-five insertion sequences and two intact prophages were found in addition to several resistance determinants such as bla(PER-2), bla(OXA-58), bla(TEM-1), strA, strB, ereA, sul1, aacC2 and a new variant of bla(OXA-211), called bla(OXA-498). In particular, bla(PER-2) and bla(TEM- 1) are present within the typical contexts previously described in the Enterobacteriaceae family. These results suggest that A. johnsonii actively acquires exogenous DNA from other bacterial species and concomitantly becomes a reservoir of resistance genes.	[Montana, Sabrina; Matias Traglia, German; Chiem, Kevin; Parmeciano Di Noto, Gisela; Quiroga, Cecilia; Soledad Ramirez, Maria] UBA CONICET, Inst Invest Microbiol & Parasitol Med IMPaM, Buenos Aires, DF, Argentina; [Schramm, Sareda T. J.; Chiem, Kevin; Tolmasky, Marcelo E.; Soledad Ramirez, Maria] Calif State Univ Fullerton, Dept Biol Sci, Fullerton, CA 92634 USA; [Almuzara, Marisa; Barberis, Claudia; Vay, Carlos] Hosp Clin Jose San Martin, Dept Bioquim Clin, Lab Bacteriol Clin, Fac Farm & Bioquim, Buenos Aires, DF, Argentina; [Iriarte, Andres] UdelaR, Fac Med, Inst Higiene, Dept Desarrollo Biotecnol, Montevideo, Uruguay	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; California State University System; California State University Fullerton; University of Buenos Aires; Hospital de Clinicas Jose de San Martin; Universidad de la Republica, Uruguay	Ramirez, MS (corresponding author), UBA CONICET, Inst Invest Microbiol & Parasitol Med IMPaM, Buenos Aires, DF, Argentina.; Ramirez, MS (corresponding author), Calif State Univ Fullerton, Dept Biol Sci, Fullerton, CA 92634 USA.	msramirez@fullerton.edu	Quiroga, Cecilia/AAK-2933-2020; Tolmasky, Marcelo/AAC-5316-2020	Tolmasky, Marcelo/0000-0002-6298-7811; Traglia, German Matias/0000-0002-4780-5311; Quiroga, Cecilia/0000-0002-5552-3349; Iriarte, Andres/0000-0002-5862-0152	"Secretaria de Ciencia y Tecnica de la Universidad de Buenos Aires" (UBACyT); Buenos Aires, Argentina [PICT 0120]; CONICET; National Institute on Minority Health and Health Disparities, National Institute of Health [MHIRT 2T37MD001368]; Science, Technology, and Productive Innovation office (Mincyt) Argentina [AECID A1/041041/11, D/024562/09]; National Institute on Minority Health and Health Disparities [T37MD001368] Funding Source: NIH RePORTER	"Secretaria de Ciencia y Tecnica de la Universidad de Buenos Aires" (UBACyT)(Secretaria de Ciencia y Tecnologia (SECYT)); Buenos Aires, Argentina; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); National Institute on Minority Health and Health Disparities, National Institute of Health; Science, Technology, and Productive Innovation office (Mincyt) Argentina; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by grants from the "Secretaria de Ciencia y Tecnica de la Universidad de Buenos Aires" (UBACyT) and PICT 0120 to MSR, Buenos Aires, Argentina. MSR and CQ is a member of the CONICET research career and SM, GMT, and GPDN have a Doctoral Fellowship from CONICET. KC was supported by grant MHIRT 2T37MD001368 from the National Institute on Minority Health and Health Disparities, National Institute of Health. AI is a researcher from the Sistema Nacional de Investigadores (ANII), Uruguay.; We want to acknowledge the Argentinian Consortium of Genomic Technology ( ACGT), which is funded by the PPL project of the Science, Technology, and Productive Innovation office (Mincyt) Argentina AECID A1/041041/11, D/024562/09, and INTA, for technical support.	Antipov D, 2016, BIORXIV, P1; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bailey JK, 2011, J ANTIMICROB CHEMOTH, V66, P745, DOI 10.1093/jac/dkq529; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Basmaci R, 2014, ANTIMICROB AGENTS CH, V58, P6258, DOI 10.1128/AAC.03562-14; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; CHIOU CS, 1993, J BACTERIOL, V175, P732, DOI 10.1128/JB.175.3.732-740.1993; Cho BK, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-4; Chusri S, 2014, ANTIMICROB AGENTS CH, V58, P4172, DOI 10.1128/AAC.02992-14; Contreras-Moreira B, 2013, APPL ENVIRON MICROB, V79, P7696, DOI 10.1128/AEM.02411-13; Fehlberg LCC, 2014, ANTIMICROB AGENTS CH, V58, P1831, DOI 10.1128/AAC.01260-13; Di Nocera PP, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-224; Endo S, 2014, J CLIN MICROBIOL, V52, P911, DOI 10.1128/JCM.03009-13; Espinal P, 2011, FUTURE MICROBIOL, V6, P495, DOI [10.2217/fmb.11.30, 10.2217/FMB.11.30]; Feng Y, 2016, J ANTIMICROB CHEMOTH, V71, P71, DOI 10.1093/jac/dkv324; Fu YQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084680; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Guardabassi L, 1999, J APPL MICROBIOL, V87, P659, DOI 10.1046/j.1365-2672.1999.00905.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gupta SK, 2014, ANTIMICROB AGENTS CH, V58, P212, DOI 10.1128/AAC.01310-13; Hare JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093861; Hare JM, 2012, MICROBIOL-SGM, V158, P601, DOI 10.1099/mic.0.054668-0; Harmer CJ, 2015, MBIO, V6, DOI 10.1128/mBio.01866-15; Huerta-Cepas J, 2016, NUCLEIC ACIDS RES, V44, pD286, DOI 10.1093/nar/gkv1248; Iacono M, 2008, ANTIMICROB AGENTS CH, V52, P2616, DOI 10.1128/AAC.01643-07; Imperi F, 2011, IUBMB LIFE, V63, P1068, DOI 10.1002/iub.531; Karah N, 2011, J ANTIMICROB CHEMOTH, V66, P738, DOI 10.1093/jac/dkq521; Krizova L, 2015, INT J SYST EVOL MICR, V65, P3905, DOI 10.1099/ijsem.0.000511; Krizova L, 2015, INT J SYST EVOL MICR, V65, P857, DOI 10.1099/ijs.0.000028; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liebert CA, 1999, MICROBIOL MOL BIOL R, V63, P507, DOI 10.1128/MMBR.63.3.507-522.1999; Liu ZR, 2015, J CHEMOTHERAPY, V27, P207, DOI 10.1179/1973947814Y.0000000190; Lopes BS, 2012, J MED MICROBIOL, V61, P1103, DOI 10.1099/jmm.0.044156-0; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mammeri H, 2003, ANTIMICROB AGENTS CH, V47, P1536, DOI 10.1128/AAC.47.5.1536-1542.2003; Traglia GM, 2014, J INFECT DEV COUNTR, V8, P666, DOI 10.3855/jidc.3747; Mazauric MH, 2008, J BIOL CHEM, V283, P20421, DOI 10.1074/jbc.M802829200; Menouni R, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnu022; Mugnier PD, 2009, J BACTERIOL, V191, P2414, DOI 10.1128/JB.01258-08; Nawrocki EP, 2013, BIOINFORMATICS, V29, P2933, DOI 10.1093/bioinformatics/btt509; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Perichon B, 2014, ANTIMICROB AGENTS CH, V58, P936, DOI 10.1128/AAC.01261-13; Poirel L, 2006, ANTIMICROB AGENTS CH, V50, P1442, DOI 10.1128/AAC.50.4.1442-1448.2006; Poirel L, 2008, ANTIMICROB AGENTS CH, V52, P1252, DOI 10.1128/AAC.01304-07; Power P, 2007, ANTIMICROB AGENTS CH, V51, P2359, DOI 10.1128/AAC.01395-06; Rapa RA, 2015, ENVIRON MICROBIOL, V17, P1090, DOI 10.1111/1462-2920.12512; Ravasi P, 2011, ANTIMICROB AGENTS CH, V55, P917, DOI 10.1128/AAC.00491-10; Renda BA, 2015, J BACTERIOL, V197, P872, DOI 10.1128/JB.02263-14; Roca I, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00148; Rodriguez CH, 2014, DIAGN MICR INFEC DIS, V80, P341, DOI 10.1016/j.diagmicrobio.2014.09.013; Schilling D, 2010, ARCH MICROBIOL, V192, P691, DOI 10.1007/s00203-010-0592-6; SEIFERT H, 1993, CLIN INFECT DIS, V17, P632, DOI 10.1093/clinids/17.4.632; Seifert H, 1997, J CLIN MICROBIOL, V35, P2819, DOI 10.1128/JCM.35.11.2819-2825.1997; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Ramirez MS, 2010, J CLIN MICROBIOL, V48, P1488, DOI 10.1128/JCM.01264-09; Sousa C, 2014, EUR J CLIN MICROBIOL, V33, P1345, DOI 10.1007/s10096-014-2078-y; Sousa C, 2014, INT J MED MICROBIOL, V304, P669, DOI 10.1016/j.ijmm.2014.04.014; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; TOLMASKY ME, 1984, J BACTERIOL, V160, P860, DOI 10.1128/JB.160.3.860-866.1984; Touchon M, 2014, GENOME BIOL EVOL, V6, P2866, DOI 10.1093/gbe/evu225; Tsai HY, 2012, EUR J CLIN MICROBIOL, V31, P2737, DOI 10.1007/s10096-012-1622-x; Turton JF, 2010, J CLIN MICROBIOL, V48, P1445, DOI 10.1128/JCM.02467-09; van den Broek PJ, 2009, J CLIN MICROBIOL, V47, P3593, DOI 10.1128/JCM.00967-09; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; Yamamoto M, 2009, ADV EXP MED BIOL, V667, P59, DOI 10.1007/978-1-4419-1603-7_6; Yildirim S, 2016, SCI REP-UK, V6, DOI 10.1038/srep22110; Zarrilli R, 2008, ANTIMICROB AGENTS CH, V52, P4115, DOI 10.1128/AAC.00366-08; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485; Zimbler DL, 2013, INFECT IMMUN, V81, P3382, DOI 10.1128/IAI.00540-13; Zong ZY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090046	75	21	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161528	10.1371/journal.pone.0161528	http://dx.doi.org/10.1371/journal.pone.0161528			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548264	gold, Green Published, Green Submitted			2022-12-26	WOS:000381768400065
J	Costello, MJ; Brennan, LA; Mohamed, A; Gilliland, KO; Johnsen, S; Kantorow, M				Costello, M. Joseph; Brennan, Lisa A.; Mohamed, Ashik; Gilliland, Kurt O.; Johnsen, Soenke; Kantorow, Marc			Identification and Ultrastructural Characterization of a Novel Nuclear Degradation Complex in Differentiating Lens Fiber Cells	PLOS ONE			English	Article							MOUSE EYE LENS; TERMINAL DIFFERENTIATION; VERTEBRATE LENS; OCULAR LENS; AUTOPHAGY; CATARACT; MECHANISMS; EXPRESSION; BREAKDOWN; DNASE	An unresolved issue in structural biology is how the encapsulated lens removes membranous organelles to carry out its role as a transparent optical element. In this ultrastructural study, we establish a mechanism for nuclear elimination in the developing chick lens during the formation of the organelle-free zone. Day 12-15 chick embryo lenses were examined by high-resolution confocal light microscopy and thin section transmission electron microscopy (TEM) following fixation in 10% formalin and 4% paraformaldehyde, and then processing for confocal or TEM as described previously. Examination of developing fiber cells revealed normal nuclei with dispersed chromatin and clear nucleoli typical of cells in active ribosome production to support protein synthesis. Early signs of nuclear degradation were observed about 300 mu m from the lens capsule in Day 15 lenses where the nuclei display irregular nuclear stain and prominent indentations that sometimes contained a previously undescribed macromolecular aggregate attached to the nuclear envelope. We have termed this novel structure the nuclear excisosome. This complex by confocal is closely adherent to the nuclear envelope and by TEM appears to degrade the outer leaflet of the nuclear envelope, then the inner leaflet up to 500 mu m depth. The images suggest that the nuclear excisosome separates nuclear membrane proteins from lipids, which then form multilamellar assemblies that stain intensely in confocal and in TEM have 5 nm spacing consistent with pure lipid bilayers. The denuded nucleoplasm then degrades by condensation and loss of structure in the range 600 to 700 mu m depth producing pyknotic nuclear remnants. None of these stages display any classic autophagic vesicles or lysosomes associated with nuclei. Uniquely, the origin of the nuclear excisosome is from filopodial-like projections of adjacent lens fiber cells that initially contact, and then appear to fuse with the outer nuclear membrane. These filopodial-like projections appear to be initiated with a clathrin-like coat and driven by an internal actin network. In summary, a specialized cellular organelle, the nuclear excisosome, generated in part by adjacent fiber cells degrades nuclei during fiber cell differentiation and maturation.	[Costello, M. Joseph; Gilliland, Kurt O.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA; [Brennan, Lisa A.; Kantorow, Marc] Florida Atlantic Univ, Dept Biomed Sci, Boca Raton, FL 33431 USA; [Mohamed, Ashik] LV Prasad Eye Inst, Ophthalm Biophys, Hyderabad, Andhra Pradesh, India; [Johnsen, Soenke] Duke Univ, Dept Biol, Durham, NC USA	University of North Carolina; University of North Carolina Chapel Hill; State University System of Florida; Florida Atlantic University; L. V. Prasad Eye Institute; Duke University	Costello, MJ (corresponding author), Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA.	mjc@med.unc.edu	Mohamed, Ashik/D-5105-2014; Core UNC, Hooker Imaging/AAE-1484-2022	Mohamed, Ashik/0000-0001-5520-4930; Gilliland, Kurt/0000-0002-9000-2119	NIH/NEI grant [R01EY008148, R01EY026478, P30EY005722]; NATIONAL EYE INSTITUTE [R01EY008148, R01EY026478] Funding Source: NIH RePORTER	NIH/NEI grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH/NEI grants R01EY008148 (MJC), R01EY026478 (MK) and P30EY005722 (Duke Core Grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassnett S, 1997, J CELL BIOL, V137, P37, DOI 10.1083/jcb.137.1.37; BASSNETT S, 1992, DEV DYNAM, V194, P85, DOI 10.1002/aja.1001940202; Bassnett S, 2011, PHILOS T R SOC B, V366, P1250, DOI 10.1098/rstb.2010.0302; Bassnett S, 2009, EXP EYE RES, V88, P133, DOI 10.1016/j.exer.2008.08.017; Basu S, 2014, AUTOPHAGY, V10, P1193, DOI 10.4161/auto.28768; Brennan LA, 2012, MOL VIS, V18, P1773; Caceres A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013331; Chaffee BR, 2014, DEVELOPMENT, V141, P3388, DOI 10.1242/dev.106005; Chen K, 2014, MOL BIOL EVOL, V31, P2194, DOI 10.1093/molbev/msu181; Costello MJ, 2013, EXP EYE RES, V116, P141, DOI 10.1016/j.exer.2013.08.017; Costello MJ, 2010, EXP EYE RES, V91, P881, DOI 10.1016/j.exer.2010.09.013; Cvekl A, 2014, DEVELOPMENT, V141, P4432, DOI 10.1242/dev.107953; De Maria A, 2007, INVEST OPHTH VIS SCI, V48, P5638, DOI 10.1167/iovs.07-0782; Girao H, 2005, INVEST OPHTH VIS SCI, V46, P1386, DOI 10.1167/iovs.04-0563; Kuszak JR, 2004, INT J DEV BIOL, V48, P889, DOI 10.1387/ijdb.041880jk; KUSZAK JR, 2004, DEV OCULAR LENS, P71; KUSZAK JR, 1994, PRINCIPLES PRACTICE, P82; KUWABARA T, 1974, INVEST OPHTH VISUAL, V13, P973; Lovicu FJ, 2005, DEV BIOL, V280, P1, DOI 10.1016/j.ydbio.2005.01.020; Mochizuki T, 2014, DEV GROWTH DIFFER, V56, P387, DOI 10.1111/dgd.12128; MODAK SP, 1970, EXP CELL RES, V59, P43, DOI 10.1016/0014-4827(70)90622-1; Mohamed A, 2013, MOL VIS, V19, P2352; Nakahara M, 2007, FEBS J, V274, P3055, DOI 10.1111/j.1742-4658.2007.05836.x; Nishimoto S, 2003, NATURE, V424, P1071, DOI 10.1038/nature01895; Rabl C., 1899, Z WISS ZOOL, V67, P1; Robinson ML, 2006, SEMIN CELL DEV BIOL, V17, P726, DOI 10.1016/j.semcdb.2006.10.002; SANWAL M, 1986, EXP CELL RES, V167, P429, DOI 10.1016/0014-4827(86)90183-7; Vrensen GFJM, 2004, EXP EYE RES, V78, P661, DOI 10.1016/j.exer.2003.07.004; VRENSEN GFJM, 1991, EXP EYE RES, V52, P647, DOI 10.1016/0014-4835(91)90017-9; Wignes JA, 2013, EXP EYE RES, V115, P263, DOI 10.1016/j.exer.2013.06.026; WILLEKENS B, 1985, TISSUE CELL, V17, P359, DOI 10.1016/0040-8166(85)90055-2; Wride MA, 2011, PHILOS T R SOC B, V366, P1219, DOI 10.1098/rstb.2010.0324; Zandy AJ, 2005, J BIOL CHEM, V280, P30263, DOI 10.1074/jbc.M504007200; Zandy AJ, 2007, INVEST OPHTH VIS SCI, V48, P293, DOI 10.1167/iovs.06-0656; Zhou CJ, 2003, EXP EYE RES, V77, P423, DOI 10.1016/S0014-4835(03)00171-4	35	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0160785	10.1371/journal.pone.0160785	http://dx.doi.org/10.1371/journal.pone.0160785			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536868	Green Submitted, Green Published, gold			2022-12-26	WOS:000381577000031
J	Han, D; Shim, H; Jeon, B; Jang, Y; Hong, Y; Jung, S; Ha, S; Chang, HJ				Han, Dongjin; Shim, Hackjoon; Jeon, Byunghwan; Jang, Yeonggul; Hong, Youngtaek; Jung, Sunghee; Ha, Seongmin; Chang, Hyuk-Jae			Automatic Coronary Artery Segmentation Using Active Search for Branches and Seemingly Disconnected Vessel Segments from Coronary CT Angiography	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; EXTRACTION; TRACKING	We propose a Bayesian tracking and segmentation method of coronary arteries on coronary computed tomographic angiography (CCTA). The geometry of coronary arteries including lumen boundary is estimated in Maximum A Posteriori (MAP) framework. Three consecutive sphere based filtering is combined with a stochastic process that is based on the similarity of the consecutive local neighborhood voxels and the geometric constraint of a vessel. It is also founded on the prior knowledge that an artery can be seen locally disconnected and consist of branches which may be seemingly disconnected due to plaque build up. For such problem, an active search method is proposed to find branches and seemingly disconnected but actually connected vessel segments. Several new measures have been developed for branch detection, disconnection check and planar vesselness measure. Using public domain Rotterdam CT dataset, the accuracy of extracted centerline is demonstrated and automatic reconstruction of coronary artery mesh is shown.	[Han, Dongjin; Shim, Hackjoon; Jeon, Byunghwan; Jang, Yeonggul; Hong, Youngtaek; Jung, Sunghee; Ha, Seongmin; Chang, Hyuk-Jae] Yonsei Univ, Coll Med, 134 Sinchon, Seoul, South Korea	Yonsei University; Yonsei University Health System	Chang, HJ (corresponding author), Yonsei Univ, Coll Med, 134 Sinchon, Seoul, South Korea.	ross.djhan@gmail.com	Shim, Hackjoon/AAA-3027-2021; Han, Dongjin/A-7554-2010; Jung, Sunghee/AAL-1636-2021	Han, Dongjin/0000-0003-1093-1741; Chang, Hyuk-Jae/0000-0002-6139-7545	ICT R&D program of MSIP/IITP (Development of Multi-modality Imaging and 3D Simulation-Based Integrative Diagnosis-Treatment Support Software System for Cardiovascular Diseases) Korea [10044910]; Institute for Information & communications Technology Promotion(IITP) grant - Korea government(MSIP) [R0101-16-0171]	ICT R&D program of MSIP/IITP (Development of Multi-modality Imaging and 3D Simulation-Based Integrative Diagnosis-Treatment Support Software System for Cardiovascular Diseases) Korea; Institute for Information & communications Technology Promotion(IITP) grant - Korea government(MSIP)	This work was supported by the ICT R&D program of MSIP/IITP (10044910, Development of Multi-modality Imaging and 3D Simulation-Based Integrative Diagnosis-Treatment Support Software System for Cardiovascular Diseases) Korea.; This work was supported by Institute for Information & communications Technology Promotion(IITP) grant funded by the Korea government(MSIP) (No. R0101-16-0171, Development of Multi-modality Imaging and 3D Simulation-Based Integrative Diagnosis-Treatment Support Software System for Cardiovascular Diseases).	Bahler, 2008, INSIGHT J, V4; Barzohar M, 1996, IEEE T PATTERN ANAL, V18, P707, DOI 10.1109/34.506793; Bauer C, 2008, INSIGHT J; Boskamp T, 2005, MEDICAL IMAGING SYSTEMS TECHNOLOGY: METHODS IN CARDIOVASCULAR AND BRAIN SYSTEMS, VOL 5, P1; Ciresan D., 2012, ADV NEURAL INF PROCE, V25, P2843; Frangi AF, 1998, LECT NOTES COMPUT SC, V1496, P130, DOI 10.1007/BFb0056195; grand-challenge org, 2009, ROTTERDAM CORONARY A; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Jiang S, 2013, JOURNAL OF COMPUTATI, V9, P9833; Kirbas C, 2004, ACM COMPUT SURV, V36, P81, DOI 10.1145/1031120.1031121; Kitamura Y, 2012, 2012 9TH IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), P234, DOI 10.1109/ISBI.2012.6235527; Kitslaar P, 2008, MIDAS J; Lesage D, 2009, LECT NOTES COMPUT SC, V5761, P222, DOI 10.1007/978-3-642-04268-3_28; Lesage D, 2009, MED IMAGE ANAL, V13, P819, DOI 10.1016/j.media.2009.07.011; Marquering HA, 2005, INT J CARDIOVAS IMAG, V21, P73, DOI 10.1007/s10554-004-5341-y; Marquering HA, 2008, MED IMAGING; Schaap M, 2009, MED IMAGE ANAL, V13, P701, DOI 10.1016/j.media.2009.06.003; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626; Shim H, 2006, COMPUT METH PROG BIO, V84, P135, DOI 10.1016/j.cmpb.2006.09.001; Strandmark P, 2013, IEEE I CONF COMP VIS, P2024, DOI 10.1109/ICCV.2013.253; Struik D. J., 1961, LECTURES ON CLASSICA; Szymczak A, 2006, MED IMAGE ANAL, V10, P548, DOI 10.1016/j.media.2006.05.002; Taylor CA, 2013, J AM COLL CARDIOL, V61, P2233, DOI 10.1016/j.jacc.2012.11.083; Tek H., 2008, THE MIDAS JOURNAL GR; Ulen J, 2015, IEEE T PATTERN ANAL, V37, P2588, DOI 10.1109/TPAMI.2015.2409869; van der Giessen AG, 2010, INT J CARDIOVAS IMAG, V26, P781, DOI 10.1007/s10554-009-9546-y; Wesarg S, 2006, J DIGIT IMAGING, V19, P249, DOI 10.1007/s10278-006-9947-6; Yang GY, 2012, INT J CARDIOVAS IMAG, V28, P921, DOI 10.1007/s10554-011-9894-2; Yang Q, 2002, INT C PATT RECOG, P282, DOI 10.1109/ICPR.2002.1048295; Zhao F, 2011, I S BIOMED IMAGING, P2066, DOI 10.1109/ISBI.2011.5872819; Zheng YF, 2013, LECT NOTES COMPUT SC, V8151, P74, DOI 10.1007/978-3-642-40760-4_10; Zhou C, 2012, COMPUT MED IMAG GRAP, V36, P1, DOI 10.1016/j.compmedimag.2011.04.001	32	15	17	8	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0156837	10.1371/journal.pone.0156837	http://dx.doi.org/10.1371/journal.pone.0156837			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536939	Green Published, Green Submitted, gold			2022-12-26	WOS:000381577000002
J	Montefusco, F; Akman, OE; Soyer, OS; Bates, DG				Montefusco, Francesco; Akman, Ozgur E.; Soyer, Orkun S.; Bates, Declan G.			Ultrasensitive Negative Feedback Control: A Natural Approach for the Design of Synthetic Controllers	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; COVALENT MODIFICATION; YEAST OSMOREGULATION; OSMOTIC-STRESS; GENE NETWORKS; ADAPTATION; NOISE; SYSTEMS; MODEL; GLYCEROL	Many of the most important potential applications of Synthetic Biology will require the ability to design and implement high performance feedback control systems that can accurately regulate the dynamics of multiple molecular species within the cell. Here, we argue that the use of design strategies based on combining ultrasensitive response dynamics with negative feedback represents a natural approach to this problem that fully exploits the strongly nonlinear nature of cellular information processing. We propose that such feedback mechanisms can explain the adaptive responses observed in one of the most widely studied biomolecular feedback systems-the yeast osmoregulatory response network. Based on our analysis of such system, we identify strong links with a well-known branch of mathematical systems theory from the field of Control Engineering, known as Sliding Mode Control. These insights allow us to develop design guidelines that can inform the construction of feedback controllers for synthetic biological systems.	[Montefusco, Francesco] Univ Padua, Dept Informat Engn, Padua, Italy; [Akman, Ozgur E.] Univ Exeter, Coll Engn Math & Phys Sci, Exeter, Devon, England; [Soyer, Orkun S.] Univ Warwick, Sch Life Sci, Coventry, W Midlands, England; [Bates, Declan G.] Univ Warwick, Sch Engn, Coventry, W Midlands, England	University of Padua; University of Exeter; University of Warwick; University of Warwick	Montefusco, F (corresponding author), Univ Padua, Dept Informat Engn, Padua, Italy.	montefusco@dei.unipd.it	MONTEFUSCO, FRANCESCO/ABI-7613-2020	MONTEFUSCO, FRANCESCO/0000-0002-3264-9686	UK Engineering and Physical Sciences Research Council (EPSRC) [EP/I017445/1]; EPSRC [EP/I017445/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I017445/1] Funding Source: researchfish	UK Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by the UK Engineering and Physical Sciences Research Council (EPSRC), grant number EP/I017445/1.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Amin M, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003890; Amin M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002949; Ang J, 2013, BIOPHYS J, V104, P505, DOI 10.1016/j.bpj.2012.12.015; Arpino JAJ, 2013, MICROBIOL-SGM, V159, P1236, DOI 10.1099/mic.0.067975-0; Bashor CJ, 2008, SCIENCE, V319, P1539, DOI 10.1126/science.1151153; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Behar M, 2007, BIOPHYS J, V93, P806, DOI 10.1529/biophysj.107.107516; Bluthgen N, 2006, FEBS J, V273, P895, DOI 10.1111/j.1742-4658.2006.05105.x; Bruggeman FJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000506; Buchler NE, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.30; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Cosentino C., 2011, FEEDBACK CONTROL SYS; Csikasz-Nagy A, 2008, J R SOC INTERFACE, V5, pS41, DOI 10.1098/rsif.2008.0099.focus; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; Del Vecchio D, 2013, ANNU REV CONTROL, V37, P333, DOI 10.1016/j.arcontrol.2013.09.011; Dorf R., 2000, MODERN CONTROL SYSTE; Drengstig T, 2012, BIOPHYS J, V103, P2000, DOI 10.1016/j.bpj.2012.09.033; Dublanche Y, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100081; Fan SS, 2014, INTERFACE FOCUS, V4, DOI 10.1098/rsfs.2014.0002; Fleming PJ, 2002, CONTROL ENG PRACT, V10, P1223, DOI 10.1016/S0967-0661(02)00081-3; Franklin GF, 1994, EMANI NAEINI FEEDBAC; Gennemark Peter, 2006, In Silico Biology, V6, P193; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Goldberg D.E., 1996, GENETIC ALGORITHMS S; GOLDBETER A, 1984, J BIOL CHEM, V259, P14441; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Gomez-Uribe C, 2007, PLOS COMPUT BIOL, V3, P2487, DOI 10.1371/journal.pcbi.0030246; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Khalil HK, 2002, NONLINEAR SYSTENS; Klipp E, 2005, NAT BIOTECHNOL, V23, P975, DOI 10.1038/nbt1114; Kothamachu VB, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003322; LEVIN RL, 1979, J MEMBRANE BIOL, V46, P91, DOI 10.1007/BF01961376; Ljung L., 1999, SYSTEM IDENTIFICATIO; Lobo FG, 1996, ILLIGAL REPORT NO 96; MATLAB, 2004, GLOB OPT TOOLB US GU; MATLAB, 1990, OPT TOOLB US GUID; Mettetal JT, 2008, SCIENCE, V319, P482, DOI 10.1126/science.1151582; Muzzey D, 2009, CELL, V138, P160, DOI 10.1016/j.cell.2009.04.047; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; O'Shaughnessy EC, 2011, CELL, V144, P119, DOI 10.1016/j.cell.2010.12.014; Oyarzun DA, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0671; Peisajovich SG, 2010, SCIENCE, V328, P368, DOI 10.1126/science.1182376; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; REED RH, 1987, APPL ENVIRON MICROB, V53, P2119, DOI 10.1128/AEM.53.9.2119-2123.1987; Schaber J, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.53; Schaber J, 2010, EUR BIOPHYS J BIOPHY, V39, P1547, DOI 10.1007/s00249-010-0612-0; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shin YJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012785; Shtessel Y., 2013, SLIDING MODE CONTROL; Singh A, 2009, BIOPHYS J, V96, P4013, DOI 10.1016/j.bpj.2009.02.064; Skogestad S, 1996, MULTIVARIABLE FEEDBA; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P123, DOI 10.1073/pnas.011589998; Sunder S, 1996, MOL CELL BIOCHEM, V158, P121; Tamas MJ, 1999, MOL MICROBIOL, V31, P1087, DOI 10.1046/j.1365-2958.1999.01248.x; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Tiwari A, 2011, MATH BIOSCI, V231, P76, DOI 10.1016/j.mbs.2011.03.004; Tsimring LS, 2014, REP PROG PHYS, V77, DOI 10.1088/0034-4885/77/2/026601; Utkin VI, 1992, SLIDING MODES IN CON, P1992; Ventura AC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000041; Zi ZK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009522	61	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161605	10.1371/journal.pone.0161605	http://dx.doi.org/10.1371/journal.pone.0161605			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537373	gold, Green Published			2022-12-26	WOS:000381577000126
J	Puce, S; Pica, D; Schiaparelli, S; Negrisolo, E				Puce, Stefania; Pica, Daniela; Schiaparelli, Stefano; Negrisolo, Enrico			Integration of Morphological Data into Molecular Phylogenetic Analysis: Toward the Identikit of the Stylasterid Ancestor	PLOS ONE			English	Article							GENERIC REVISION; HYDROZOA; CNIDARIA; EVOLUTION; COELENTERATA; TREE; NOV	Stylasteridae is a hydroid family including 29 worldwide-distributed genera, all provided with a calcareous skeleton. They are abundant in shallow and deep waters and represent an important component of marine communities. In the present paper, we studied the evolution of ten morphological characters, currently used in stylasterid taxonomy, using a phylogenetic approach. Our results indicate that stylasterid morphology is highly plastic and that many events of independent evolution and reversion have occurred. Our analysis also allows sketching a possible identikit of the stylasterid ancestor. It had calcareous skeleton, reticulate-granular coenosteal texture, polyps randomly arranged, gastrostyle, and dactylopore spines, while lacking a gastropore lip and dactylostyles. If the ancestor had single or double/multiple chambered gastropore tube is uncertain. These data suggest that the ancestor was similar to the extant genera Cyclohelia and Stellapora. Our investigation is the first attempt to integrate molecular and morphological information to clarify the stylasterid evolutionary scenario and represents the first step to infer the stylasterid ancestor morphology.	[Puce, Stefania; Pica, Daniela] Univ Politecn Marche, Dipartimento Sci Vita & Ambiente, Ancona, Italy; [Schiaparelli, Stefano] Univ Genoa, Dipartimento Sci Terra Ambiente & Vita, Genoa, Italy; [Schiaparelli, Stefano] Museo Nazl Antartide, Sede Genova, Genoa, Italy; [Negrisolo, Enrico] Univ Padua, Agripolis, Dipartimento Biomed Comparata & Alimentaz, Padua, Italy	Marche Polytechnic University; University of Genoa; University of Padua	Puce, S (corresponding author), Univ Politecn Marche, Dipartimento Sci Vita & Ambiente, Ancona, Italy.	s.puce@univpm.it	Schiaparelli, Stefano/AAI-4024-2020	Schiaparelli, Stefano/0000-0002-0137-3605; Pica, Daniela/0000-0001-7823-0488	SYNTHESYS Project; European Community Research Infrastructure Action under the FP7 Integrating Activities Programme; Universita Politecnica delle Marche - Ricerca Scientifica di Ateneo	SYNTHESYS Project; European Community Research Infrastructure Action under the FP7 Integrating Activities Programme; Universita Politecnica delle Marche - Ricerca Scientifica di Ateneo	This work was supported by a grant to SP (Universita Politecnica delle Marche - Ricerca Scientifica di Ateneo). DP visited the Natural History Museum in London and Natural History Museum in Leiden receiving support from the SYNTHESYS Project, which is financed by European Community Research Infrastructure Action under the FP7 Integrating Activities Programme (www.synthesys.info). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Broch H., 1942, SKRIFTER UTGITT N MN, V3, P1; Minh BQ, 2013, MOL BIOL EVOL, V30, P1188, DOI 10.1093/molbev/mst024; Cairns S.D., 1987, P257; Cairns S.D., 1983, Antarctic Research Series, V38, P61; Cairns S.D., 1998, Zoologische Verhandelingen (Leiden), V323, P311; Cairns S.D., 1991, New Zealand Oceanographic Institute Memoir, P1; CAIRNS S D, 1986, Smithsonian Contributions to Zoology, P1; CAIRNS S D, 1988, Records of the Western Australian Museum, V14, P105; CAIRNS SD, 1984, B MAR SCI, V35, P38; CAIRNS SD, 1983, B MAR SCI, V33, P427; Cairns SD., 1986, SMITHSONIAN CONTRIB, V426, P1, DOI [10.5479/si.00810282.426, DOI 10.5479/SI.00810282.426]; Cairns SD, 1983, P BIOL SOC WASH, V96, P158; Cairns Stephen D., 2015, V207, P5; Cairns SD, 2011, ZOOKEYS, P1, DOI 10.3897/zookeys.158.1910; Cairns SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021670; Cairns Stephen D., 2005, Pacific Science, V59, P439, DOI 10.1353/psc.2005.0034; Deng Z., 1982, P184; Felsenstein J., 2004, INFERRING PHYLOGENIE; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Kennedy M, 2005, SYST BIOL, V54, P620, DOI 10.1080/106351591007462; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Leclere L, 2007, ZOOL SCR, V36, P371, DOI 10.1111/j.1463-6409.2007.00283.x; Leclere L, 2009, SYST BIOL, V58, P509, DOI 10.1093/sysbio/syp044; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Lindner A, 2004, J MAR BIOL ASSOC UK, V84, P943, DOI 10.1017/S0025315404010239h; Lindner A, 2014, ZOOTAXA, V3900, P581, DOI 10.11646/zootaxa.3900.4.8; Lindner A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002429; Maddison WP., 2021, MESQUITE MODULAR SYS; Mendoza-Becerril MA, 2016, ZOOLOGICAL J LINNEAN; Miglietta MP, 2010, INTEGR COMP BIOL, V50, P428, DOI 10.1093/icb/icq102; Miglietta MP, 2012, EVOLUTION, V66, P3876, DOI 10.1111/j.1558-5646.2012.01717.x; Moseley HN., 1881, REPORT SCI RESULTS V, V2, P1; Moseley HN., 1881, REP SCI RES VOYAGE C, V2, P209; Puce S, 2012, CORAL REEFS, V31, P715, DOI 10.1007/s00338-012-0885-0; Puce S, 2010, J MAR BIOL ASSOC UK, V90, P1145, DOI 10.1017/S0025315409991433; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Royer-Carenzi M, 2013, MATH BIOSCI, V242, P95, DOI 10.1016/j.mbs.2012.12.003; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Stylasteridae Broch H., 1914, DAN INGOLF EXPED, V5, P1; ZIBROWIUS H, 1981, BIJDR DIERKD, V51, P268	41	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161423	10.1371/journal.pone.0161423	http://dx.doi.org/10.1371/journal.pone.0161423			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537333	Green Published, gold, Green Submitted			2022-12-26	WOS:000381577000105
J	Segre, H; DeMalach, N; Henkin, Z; Kadmon, R				Segre, Hila; DeMalach, Niv; Henkin, Zalmen; Kadmon, Ronen			Quantifying Competitive Exclusion and Competitive Release in Ecological Communities: A Conceptual Framework and a Case Study	PLOS ONE			English	Article							GRASSLAND PLANT DIVERSITY; SPECIES RICHNESS; INTERMEDIATE DISTURBANCE; INTERTIDAL COMMUNITY; BIODIVERSITY LOSS; PREDATION; PRODUCTIVITY; HERBIVORES; MAINTENANCE; MECHANISMS	A fundamental notion in community ecology is that local species diversity reflects some balance between the contrasting forces of competitive exclusion and competitive release. Quantifying this balance is not trivial, and requires data on the magnitude of both processes in the same system, as well as appropriate methodology to integrate and interpret such data. Here we present a novel framework for empirical studies of the balance between competitive exclusion and competitive release and demonstrate its applicability using data from a Mediterranean annual grassland where grazing is a major mechanism of competitive release. Empirical data on the balance between competitive exclusion and competitive release are crucial for understanding observed patterns of variation in local species diversity and the proposed approach provides a simple framework for the collection, interpretation, and synthesis of such data.	[Segre, Hila; DeMalach, Niv; Kadmon, Ronen] Hebrew Univ Jerusalem, Dept Ecol Evolut & Behav, Jerusalem, Israel; [Henkin, Zalmen] Agr Res Org, Dept Nat Resources, Beef Cattle Sect, Newe Yaar Res Ctr, Ramat Yishay, Israel	Hebrew University of Jerusalem	DeMalach, N (corresponding author), Hebrew Univ Jerusalem, Dept Ecol Evolut & Behav, Jerusalem, Israel.	Nivdemalach@gmail.com	DeMalach, niv/AAW-8339-2020; Segre, Hila/AAJ-3995-2021	DeMalach, niv/0000-0002-4509-5387; Segre, Hila/0000-0002-3354-4675	Nature and Parks Authority; Ministry of Science and Technology TASHTIOT program; Israeli Science Foundation [454/11, 1026/11]	Nature and Parks Authority; Ministry of Science and Technology TASHTIOT program; Israeli Science Foundation(Israel Science Foundation)	This work was supported by the Nature and Parks Authority, the Ministry of Science and Technology TASHTIOT program, and the Israeli Science Foundation grants no. 454/11 and 1026/11.	Bakker ES, 2006, ECOL LETT, V9, P780, DOI 10.1111/j.1461-0248.2006.00925.x; BELSKY JA, 1992, J VEG SCI, V3, P187, DOI 10.2307/3235679; Borer ET, 2014, NATURE, V508, P517, DOI 10.1038/nature13144; Chase JM, 2002, ECOL LETT, V5, P302, DOI 10.1046/j.1461-0248.2002.00315.x; Chesson P, 2008, NATURE, V456, P235, DOI 10.1038/nature07248; Cingolani AM, 2005, ECOL APPL, V15, P757, DOI 10.1890/03-5272; Collins SL, 1998, SCIENCE, V280, P745, DOI 10.1126/science.280.5364.745; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Craine JM, 2005, J ECOL, V93, P1041, DOI 10.1111/j.1365-2745.2005.01043.x; De Bello F, 2007, J VEG SCI, V18, P25, DOI 10.1111/j.1654-1103.2007.tb02512.x; DeMalach N, 2016, J ECOL, V104, P899, DOI 10.1111/1365-2745.12557; Diaz S, 2001, J APPL ECOL, V38, P497, DOI 10.1046/j.1365-2664.2001.00635.x; Fox JW, 2013, TRENDS ECOL EVOL, V28, P86, DOI 10.1016/j.tree.2012.08.014; Gallet R, 2007, AM NAT, V170, P143, DOI 10.1086/518567; GOLDBERG DE, 1995, FOLIA GEOBOT PHYTOTX, V30, P231, DOI 10.1007/BF02812101; Goldberg DE, 1999, ECOLOGY, V80, P1118, DOI 10.2307/177059; GRIME JP, 1973, NATURE, V242, P344, DOI 10.1038/242344a0; Harrison S, 2010, ECOLOGY, V91, P2141, DOI 10.1890/09-0742.1; Hautier Y, 2009, SCIENCE, V324, P636, DOI 10.1126/science.1169640; HIXON MA, 1983, SCIENCE, V220, P511, DOI 10.1126/science.220.4596.511; HUSTON M, 1979, AM NAT, V113, P81, DOI 10.1086/283366; Isbell F, 2013, P NATL ACAD SCI USA, V110, P11911, DOI 10.1073/pnas.1310880110; KADMON R, 1990, ISRAEL J BOT, V39, P403; Kadmon R, 2006, AM NAT, V167, P939, DOI 10.1086/504602; May F, 2009, OIKOS, V118, P1830, DOI 10.1111/j.1600-0706.2009.17724.x; McWethy DB, 2010, LANDSCAPE ECOL, V25, P533, DOI 10.1007/s10980-009-9437-6; MENGE BA, 1976, ECOL MONOGR, V46, P355, DOI 10.2307/1942563; MENGE BA, 1987, AM NAT, V130, P730, DOI 10.1086/284741; MILCHUNAS DG, 1988, AM NAT, V132, P87, DOI 10.1086/284839; Munson SM, 2009, J VEG SCI, V20, P224, DOI 10.1111/j.1654-1103.2009.05556.x; NEWMAN EI, 1973, NATURE, V244, P310, DOI 10.1038/244310a0; NOYMEIR I, 1989, J ECOL, V77, P290, DOI 10.2307/2260930; NOYMEIR I, 1995, J VEG SCI, V6, P701, DOI 10.2307/3236441; Osem Y, 2002, J ECOL, V90, P936, DOI 10.1046/j.1365-2745.2002.00730.x; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; PETRAITIS PS, 1989, Q REV BIOL, V64, P393, DOI 10.1086/416457; Rueda M, 2013, OECOLOGIA, V172, P449, DOI 10.1007/s00442-012-2501-y; Segre H, 2014, ECOL LETT, V17, P1400, DOI 10.1111/ele.12343; Shea K, 2004, ECOL LETT, V7, P491, DOI 10.1111/j.1461-0248.2004.00600.x; Shurin JB, 2001, AM NAT, V158, P624, DOI 10.1086/323589; SOUSA WP, 1979, ECOLOGY, V60, P1225, DOI 10.2307/1936969; Sternberg M, 2000, J APPL ECOL, V37, P224, DOI 10.1046/j.1365-2664.2000.00491.x; Sternberg M, 2001, ECOL RES, V16, P335, DOI 10.1046/j.1440-1703.2001.00393.x; Suding KN, 2001, ECOLOGY, V82, P2133, DOI 10.2307/2680221; Wilson SD, 2002, ECOLOGY, V83, P492, DOI 10.1890/0012-9658(2002)083[0492:QVIOFS]2.0.CO;2; WOOTTON JT, 1993, AM NAT, V141, P71, DOI 10.1086/285461; Yang ZL, 2015, OECOLOGIA, V179, P261, DOI 10.1007/s00442-015-3313-7	47	20	20	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0160798	10.1371/journal.pone.0160798	http://dx.doi.org/10.1371/journal.pone.0160798			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536943	Green Published, gold, Green Submitted			2022-12-26	WOS:000381577000032
J	Wong, YH; Yu, L; Zhang, G; He, LS; Qian, PY				Wong, Yue Him; Yu, Li; Zhang, Gen; He, Li-Sheng; Qian, Pei-Yuan			In Silico Prediction of Neuropeptides/Peptide Hormone Transcripts in the Cheilostome Bryozoan Bugula neritina	PLOS ONE			English	Article							LARVAL NERVOUS-SYSTEM; PEDAL PEPTIDE; BRAIN; IDENTIFICATION; METAMORPHOSIS; MECHANISMS; ORCOKININ; EVOLUTION; DISCOVERY; SITES	The bryozoan Bugula neritina has a biphasic life cycle that consists of a planktonic larval stage and a sessile juvenile/adult stage. The transition between these two stages is crucial for the development and recruitment of B. neritina. Metamorphosis in B. neritina is mediated by both the nervous system and the release of developmental signals. However, no research has been conducted to investigate the expression of neuropeptides (NP)/peptide hormones in B. neritina larvae. Here, we report a comprehensive study of the NP/peptide hormones in the marine bryozoan B. neritina based on in silico identification methods. We recovered 22 transcripts encompassing 11 NP/peptide hormone precursor transcript sequences. The transcript sequences of the 11 isolated NP precursors were validated by cDNA cloning using gene-specific primers. We also examined the expression of three peptide hormone precursor transcripts (BnFDSIG, BnILP1, BnGPB) in the coronate larvae of B. neritina, demonstrating their distinct expression patterns in the larvae. Overall, our findings serve as an important foundation for subsequent investigations of the peptidergic control of bryozoan larval behavior and settlement.	[Wong, Yue Him; Yu, Li; Zhang, Gen; He, Li-Sheng; Qian, Pei-Yuan] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China; [He, Li-Sheng; Qian, Pei-Yuan] Chinese Acad Sci, Sanya Inst Deep Sea Sci & Engn, San Ya, Hai Nan, Peoples R China; [Wong, Yue Him] Akita Prefectural Univ, Dept Biotechnol, Akita, Japan	Hong Kong University of Science & Technology; Chinese Academy of Sciences; Institute of Deep-Sea Science & Engineering, CAS; Akita Prefectural University	Qian, PY (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China.; Qian, PY (corresponding author), Chinese Acad Sci, Sanya Inst Deep Sea Sci & Engn, San Ya, Hai Nan, Peoples R China.	boqianpy@ust.hk	Zhang/L-6428-2017	Zhang/0000-0001-8619-3285; Qian, Pei-Yuan/0000-0003-4074-9078	Research Grant Council of HKSAR [662313, 16101015]	Research Grant Council of HKSAR(Hong Kong Research Grants Council)	This work was supported by the grants from Research Grant Council of HKSAR (662313 and 16101015) to PY Qian.; This work was supported by grants from the Research Grant Council of HKSAR (662313 and 16101015) to PY Qian.	Behrens HL, 2008, ANAL CHEM, V80, P6949, DOI 10.1021/ac800798h; Boonen K, 2008, J SEP SCI, V31, P427, DOI 10.1002/jssc.200700450; Brown MR, 1999, PEPTIDES, V20, P1035, DOI 10.1016/S0196-9781(99)00097-2; Burbach JPH, 2011, METHODS MOL BIOL, V789, P1, DOI 10.1007/978-1-61779-310-3_1; Chen ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022913; Christie AE, 2015, GEN COMP ENDOCR, V213, P90, DOI 10.1016/j.ygcen.2015.02.003; Christie AE, 2010, CELL MOL LIFE SCI, V67, P4135, DOI 10.1007/s00018-010-0482-8; Conzelmann M, 2011, P NATL ACAD SCI USA, V108, pE1174, DOI 10.1073/pnas.1109085108; CRUZ LJ, 1987, J BIOL CHEM, V262, P15821; DUVIGNEAUD V, 1953, J AM CHEM SOC, V75, P4880; DUVIGNEAUD V, 1953, J BIOL CHEM, V205, P949; EBBERINK RHM, 1989, BIOL BULL, V177, P176, DOI 10.2307/1541928; Ferre F, 2005, NUCLEIC ACIDS RES, V33, pW230, DOI 10.1093/nar/gki412; Fricker L.D., 2012, C SERIES NEUROPEPTID, V1, P1, DOI DOI 10.4199/C00058ED1V01Y201205NPE003; Gruhl A, 2009, ZOOMORPHOLOGY, V128, P135, DOI 10.1007/s00435-009-0084-x; HALL JD, 1990, J NEUROBIOL, V21, P858, DOI 10.1002/neu.480210604; Heyland A, 2006, INTEGR COMP BIOL, V46, P743, DOI 10.1093/icb/icl023; Hofer S, 2006, J EXP BIOL, V209, P2794, DOI 10.1242/jeb.02307; Hummon AB, 2006, MASS SPECTROM REV, V25, P77, DOI 10.1002/mas.20055; Huybrechts J, 2010, INSECT MOL BIOL, V19, P87, DOI 10.1111/j.1365-2583.2009.00951.x; Liu F, 2006, MOL CELL PROTEOMICS, V5, P510, DOI 10.1074/mcp.M400114-MCP200; LLOYD PE, 1989, J NEUROSCI, V9, P312; Ma MM, 2010, PEPTIDES, V31, P27, DOI 10.1016/j.peptides.2009.10.007; MAULE AG, 1991, PARASITOLOGY, V102, P309, DOI 10.1017/S0031182000062648; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; Monigatti F, 2002, BIOINFORMATICS, V18, P769, DOI 10.1093/bioinformatics/18.5.769; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Okajima Y, 2008, REGUL PEPTIDES, V148, P62, DOI 10.1016/j.regpep.2008.03.002; Okano K, 1996, J EXP ZOOL, V276, P138, DOI 10.1002/(SICI)1097-010X(19961001)276:2<138::AID-JEZ7>3.0.CO;2-P; Ostrovsky A, 2013, EVOLUTION OF SEXUAL REPRODUCTION IN MARINE INVERTEBRATES: EXAMPLE OF GYMNOLAEMATE BRYOZOANS, P229, DOI 10.1007/978-94-007-7146-8_3; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pettersson E, 2009, GENOMICS, V93, P105, DOI 10.1016/j.ygeno.2008.10.003; Pires A, 1997, BIOL BULL-US, V192, P399, DOI 10.2307/1542749; REED CG, 1988, J MORPHOL, V197, P127, DOI 10.1002/jmor.1051970202; REED CG, 1983, J MORPHOL, V177, P127, DOI 10.1002/jmor.1051770202; Roch GJ, 2014, GENOME BIOL EVOL, V6, P1466, DOI 10.1093/gbe/evu118; Rotwein P, 1991, Growth Factors, V5, P3, DOI 10.3109/08977199109000267; Salio C, 2011, METHODS MOL BIOL, V789, P57, DOI 10.1007/978-1-61779-310-3_3; Santagata S, 2008, BIOL BULL-US, V215, P3, DOI 10.2307/25470679; Shimizu K, 2000, MAR BIOL, V136, P1, DOI 10.1007/s002270050001; Siuzdak G, 2004, J AM SOC MASS SPECTR, V15, P625; Smit AB, 1996, NEUROSCIENCE, V70, P589, DOI 10.1016/0306-4522(95)00378-9; Soehler S, 2011, CELL TISSUE RES, V343, P559, DOI 10.1007/s00441-010-1091-4; Spittaels K, 1996, INSECT BIOCHEM MOLEC, V26, P375, DOI 10.1016/0965-1748(95)00104-2; Stafflinger E, 2008, P NATL ACAD SCI USA, V105, P3262, DOI 10.1073/pnas.0710897105; STANGIER J, 1992, PEPTIDES, V13, P859, DOI 10.1016/0196-9781(92)90041-Z; STEINER DF, 1985, ANNU REV GENET, V19, P463, DOI 10.1146/annurev.ge.19.120185.002335; Strand FL, 1999, NEUROPEPTIDES REGULA; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor PD, 1988, HIST BIOL, V1, P209; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Toullec JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071609; Veenstra JA, 2000, ARCH INSECT BIOCHEM, V43, P49, DOI 10.1002/(SICI)1520-6327(200002)43:2&lt;49::AID-ARCH1&gt;3.0.CO;2-M; Veenstra JA, 2011, GEN COMP ENDOCR, V171, P160, DOI 10.1016/j.ygcen.2011.01.005; Veenstra JA, 2010, GEN COMP ENDOCR, V167, P86, DOI 10.1016/j.ygcen.2010.02.010; Ventura T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097323; Wanninger A, 2005, ZOOMORPHOLOGY, V124, P161, DOI 10.1007/s00435-005-0004-7; Wei HY, 2011, J BIOL RHYTHM, V26, P507, DOI 10.1177/0748730411419968; WITTEN JL, 1984, BIOCHEM BIOPH RES CO, V124, P350, DOI 10.1016/0006-291X(84)91560-2; Wong YH, 2014, SCI REP-UK, V4, DOI 10.1038/srep06534; WOOLLACOTT RM, 1971, J MORPHOL, V134, P351, DOI 10.1002/jmor.1051340307; Wu Q, 2006, ANNU REV ENTOMOL, V51, P1, DOI 10.1146/annurev.ento.51.110104.151011; Yamanaka N, 2011, J COMP NEUROL, V519, P238, DOI 10.1002/cne.22517; Yan XC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046513; YANG HYT, 1985, P NATL ACAD SCI USA, V82, P7757, DOI 10.1073/pnas.82.22.7757	65	3	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0160271	10.1371/journal.pone.0160271	http://dx.doi.org/10.1371/journal.pone.0160271			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537380	gold, Green Submitted, Green Published			2022-12-26	WOS:000381577000016
J	Jarczok, MN; Koenig, J; Li, J; Mauss, D; Hoffmann, K; Schmidt, B; Fischer, JE; Thayer, JF				Jarczok, Marc N.; Koenig, Julian; Li, Jian; Mauss, Daniel; Hoffmann, Kristina; Schmidt, Burkhard; Fischer, Joachim E.; Thayer, Julian F.			The Association of Work Stress and Glycemic Status Is Partially Mediated by Autonomic Nervous System Function: Cross-Sectional Results from the Mannheim Industrial Cohort Study (MICS)	PLOS ONE			English	Article							EFFORT-REWARD IMBALANCE; HEART-RATE-VARIABILITY; PSYCHOSOCIAL FACTORS; HEALTHY POPULATIONS; DIABETES-MELLITUS; NEURAL REGULATION; HEMOGLOBIN A1C; RISK-FACTORS; VAGUS NERVE; GLUCOSE	Background Work stress is associated with an increased risk of pre-diabetes, Type 2 diabetes, and inflammation, as well as decreased autonomic nervous system function as measured, for example, via heart rate variability. We investigated the extent to which the association between work stress and glycemic status is mediated by vagally-mediated heart rate variability (vmHRV) and/or inflammation. Methods Cross-sectional data from the Mannheim Industrial Cohort Study (MICS) with 9,937 participants were analyzed. The root mean squared successive differences (RMSSD) from long-term heart rate monitoring during work and night time periods was used to index vmHRV. Fasting plasma glucose and glycosylated hemoglobin were assessed to determine glycemic status. High sensitive C-reactive protein levels were observed as a measure of systemic inflammation and the Effort-Reward-Imbalance scale was used to evaluate work stress. Mediation models were adjusted for age, sex, and occupational status, and estimations were bootstrapped (5,000 replications). Results Effort-Reward-Imbalance was significantly negatively associated with RMSSD and both glycosylated hemoglobin and fasting plasma glucose during both work and night time periods. Effort-Reward-Imbalance was observed to have a significant direct effect on glycosylated hemoglobin and significant indirect effects, through RMSSD, on both glycemic measures during both time periods. Introducing C-reactive protein as a further mediator to the model did not alter the indirect effects observed. C-reactive protein, as an exclusive mediator, was observed to have smaller direct and indirect effects on the glycemic measures as compared to when Effort-Reward-Imbalance was included in the model. Conclusions Our results suggest that the association between work stress and glycemic status is partially mediated through vmHRV independent of systemic inflammation as measured by C-reactive protein. We conclude that work stress may be an additional factor that promotes development of hyperglycemic-metabolic states. If supported by prospective evidence, these results may lead to new approaches for primary prevention of hyperglycemia in the workplace.	[Jarczok, Marc N.; Hoffmann, Kristina; Schmidt, Burkhard; Fischer, Joachim E.] Heidelberg Univ, Mannheim Inst Publ Hlth Social & Prevent Med, Mannheim Med Fac, Ludolf Krehl Str 7-11, D-68167 Mannheim, Germany; [Jarczok, Marc N.] UniversityHosp Heidelberg, Ctr Psychosocial Med, Inst Med Psychol, Bergheimer Str 20, D-69115 Heidelberg, Germany; [Koenig, Julian; Thayer, Julian F.] Ohio State Univ, Dept Psychol, 1835 Neil Ave, Columbus, OH 43210 USA; [Li, Jian] Univ Dusseldorf, Inst Occupat Social & Environm Med, Ctr Hlth & Soc, Fac Med, Univ Str 1, D-40225 Dusseldorf, Germany; [Mauss, Daniel] Allianz SE, Dept Occupat Med, Koniginstr 28, D-80802 Munich, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University System of Ohio; Ohio State University; Heinrich Heine University Dusseldorf; Allianz SE	Jarczok, MN (corresponding author), Heidelberg Univ, Mannheim Inst Publ Hlth Social & Prevent Med, Mannheim Med Fac, Ludolf Krehl Str 7-11, D-68167 Mannheim, Germany.; Jarczok, MN (corresponding author), UniversityHosp Heidelberg, Ctr Psychosocial Med, Inst Med Psychol, Bergheimer Str 20, D-69115 Heidelberg, Germany.	marc.jarczok@gmail.com	Koenig, Julian/J-8863-2017; Jarczok, Marc N/A-2383-2014; Thayer, Julian/AAA-1161-2020; Jarczok, M/GZN-2543-2022	Koenig, Julian/0000-0003-1009-9625; Jarczok, Marc N/0000-0002-6055-385X; Thayer, Julian/0000-0001-9385-3421; Schmidt, Burkhard/0000-0001-7394-2742	Mannheim Institute of Public Health; Humboldt Senior Research Award; Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg	Mannheim Institute of Public Health; Humboldt Senior Research Award; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg	This work was funded through internal funds of the Mannheim Institute of Public Health. Julian F. Thayer was supported by a Humboldt Senior Research Award. Julian Koenig, Jian Li and Daniel Mauss received no specific funding for this work. We acknowledge additional financial support by Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing.	Abadie JM, 2008, ANN CLIN LAB SCI, V38, P31; Backe EM, 2012, INT ARCH OCC ENV HEA, V85, P67, DOI 10.1007/s00420-011-0643-6; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Cameron OG, 2001, PSYCHOSOM MED, V63, P697, DOI 10.1097/00006842-200109000-00001; Camm AJ, 1996, CIRCULATION, V93, P1043; Chandola T, 2006, BMJ-BRIT MED J, V332, P521, DOI 10.1136/bmj.38693.435301.80; Chandola T, 2008, EUR HEART J, V29, P640, DOI 10.1093/eurheartj/ehm584; Chida Y, 2008, PSYCHOL BULL, V134, P829, DOI 10.1037/a0013342; Daniele G, 2014, ACTA DIABETOL, V51, P123, DOI 10.1007/s00592-013-0543-1; Darwin C., 1872, P374; Ditlevsen S, 2005, EPIDEMIOLOGY, V16, P114, DOI 10.1097/01.ede.0000147107.76079.07; Eskesen K, 2013, J INTERN MED, V273, P94, DOI 10.1111/j.1365-2796.2012.02594.x; Federici M, 2005, J CLIN INVEST, V115, P3494, DOI 10.1172/JCI26052; Fujihara K, 2012, EXP CLIN ENDOCR DIAB, V120, P560, DOI 10.1055/s-0032-1314873; Groves DA, 2005, NEUROSCI BIOBEHAV R, V29, P493, DOI 10.1016/j.neubiorev.2005.01.004; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Heraclides A, 2009, DIABETES CARE, V32, P2230, DOI 10.2337/dc09-0132; Heraclides AM, 2012, OBESITY, V20, P428, DOI 10.1038/oby.2011.95; Houtman I., 2007, RAISING AWARENESS ST; Jarczok MN, 2013, INT J CARDIOL, V168, P3025, DOI 10.1016/j.ijcard.2013.04.147; Jarczok MN, 2013, NEUROSCI BIOBEHAV R, V37, P1810, DOI 10.1016/j.neubiorev.2013.07.004; Jarczok MN, 2013, INT J CARDIOL, V167, P855, DOI 10.1016/j.ijcard.2012.02.002; Jarczok MN, 2015, PLOS ONE, P1, DOI [10.1371/journal, DOI 10.1371/JOURNAL]; JOSE AD, 1970, CARDIOVASC RES, V4, P160, DOI 10.1093/cvr/4.2.160; Juster RP, 2010, NEUROSCI BIOBEHAV R, V35, P2, DOI 10.1016/j.neubiorev.2009.10.002; Kawakami N, 2000, OCCUP ENVIRON MED, V57, P805, DOI 10.1136/oem.57.12.805; Kivimaki M, 2015, CURR CARDIOL REP, V17, DOI 10.1007/s11886-015-0630-8; Koenig J, 2014, EUR J PAIN, V18, P301, DOI 10.1002/j.1532-2149.2013.00379.x; Kogler L, 2015, NEUROIMAGE, V119, P235, DOI 10.1016/j.neuroimage.2015.06.059; Kornitzer M, 2001, EUR HEART J, V22, P109, DOI 10.1053/euhj.2000.2375; Lane RD, 2009, NEUROIMAGE, V47, P1135, DOI 10.1016/j.neuroimage.2009.06.013; Lane RD, 2009, PSYCHOSOM MED, V71, P117, DOI 10.1097/PSY.0b013e31819783be; Li J, 2013, INT J BEHAV MED, V20, P495, DOI 10.1007/s12529-012-9255-0; Li J, 2012, AM J IND MED, V55, P808, DOI 10.1002/ajim.22018; Liao DP, 1995, DIABETES RES CLIN PR, V30, P211, DOI 10.1016/0168-8227(95)01190-0; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Luft FC, 2012, J AM SOC HYPERTENS, V6, P23, DOI 10.1016/j.jash.2011.09.006; Marty N, 2007, PHYSIOLOGY, V22, P241, DOI 10.1152/physiol.00010.2007; Matteoli G, 2013, GUT, V62, P1214, DOI 10.1136/gutjnl-2012-302550; Mauss D, 2015, IND HEALTH, V53, P5, DOI 10.2486/indhealth.2014-0122; MCEWEN BS, 1993, ARCH INTERN MED, V153, P2093, DOI 10.1001/archinte.153.18.2093; Monroy A, 2009, DIABETOLOGIA, V52, P2169, DOI 10.1007/s00125-009-1451-3; Niedhammer I, 2004, SOC SCI MED, V58, P1531, DOI 10.1016/S0277-9536(03)00346-0; Page KA, 2011, J CLIN INVEST, V121, P4161, DOI 10.1172/JCI57873; Pavlov VA, 2012, NAT REV ENDOCRINOL, V8, P743, DOI 10.1038/nrendo.2012.189; Pocai A, 2005, CELL METAB, V1, P53, DOI 10.1016/j.cmet.2004.11.001; POMERANZ B, 1985, AM J PHYSIOL, V248, pH151, DOI 10.1152/ajpheart.1985.248.1.H151; Pouwer F, 2010, DISCOV MED, V9, P112; Roy M, 2012, TRENDS COGN SCI, V16, P147, DOI 10.1016/j.tics.2012.01.005; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Sun Y, 2013, CELL RES, V23, P1270, DOI 10.1038/cr.2013.116; Tamashiro KLK, 2011, ANN NY ACAD SCI, V1231, P46, DOI 10.1111/j.1749-6632.2011.06134.x; Thayer JF, 2005, PSYCHONEUROENDOCRINO, V30, P1050, DOI 10.1016/j.psyneuen.2005.04.014; Thayer JF, 2012, NEUROSCI BIOBEHAV R, V36, P747, DOI 10.1016/j.neubiorev.2011.11.009; Thayer JF, 2011, RESP PHYSIOL NEUROBI, V178, P387, DOI 10.1016/j.resp.2011.05.016; Thayer JF, 2010, BRAIN BEHAV IMMUN, V24, P1223, DOI 10.1016/j.bbi.2010.07.247; Thayer JF, 2010, INT J CARDIOL, V141, P122, DOI 10.1016/j.ijcard.2009.09.543; Thayer JF, 2009, ANN BEHAV MED, V37, P141, DOI 10.1007/s12160-009-9101-z; Thayer JF, 2009, NEUROSCI BIOBEHAV R, V33, P81, DOI 10.1016/j.neubiorev.2008.08.004; Toker S, 2012, J OCCUP HEALTH PSYCH, V17, P259, DOI 10.1037/a0028401; Toshihiro M, 2008, DIABETIC MED, V25, P1211, DOI 10.1111/j.1464-5491.2008.02566.x; Tracey KJ, 2010, NAT IMMUNOL, V11, P561, DOI 10.1038/ni0710-561; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Tripathy D, 2013, DIABETOLOGIA, V56, P2153, DOI 10.1007/s00125-013-2976-z; Tukey JW, 1977, EXPLORATORY DATA ANA; WARNER HR, 1962, J APPL PHYSIOL, V17, P349, DOI 10.1152/jappl.1962.17.2.349; Weippert M, 2010, EUR J APPL PHYSIOL, V109, P779, DOI 10.1007/s00421-010-1415-9; Wittling W., 2012, HERZSCHLAGVARIABILIT; World Health Organization (WHO), 2000, WHO TECHN REP SER, P256, DOI DOI 10.1007/978-0-387-71799-9_454; Xu WX, 2012, INT ARCH OCC ENV HEA, V85, P215, DOI 10.1007/s00420-011-0650-7	70	16	16	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160743	10.1371/journal.pone.0160743	http://dx.doi.org/10.1371/journal.pone.0160743			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT4YN	27532642	Green Published, gold, Green Submitted			2022-12-26	WOS:000381487600041
J	van Beurden, YH; Dekkers, OM; Bomers, MK; Kaiser, AM; van Houdt, R; Knetsch, CW; Girbes, ARJ; Mulder, CJJ; Vandenbroucke-Grauls, CMJE				van Beurden, Yvette H.; Dekkers, Olaf M.; Bomers, Marije K.; Kaiser, Annie M.; van Houdt, Robin; Knetsch, Cornelis W.; Girbes, Armand R. J.; Mulder, Chris J. J.; Vandenbroucke-Grauls, Christina M. J. E.			An Outbreak of Clostridium difficile Ribotype 027 Associated with Length of Stay in the Intensive Care Unit and Use of Selective Decontamination of the Digestive Tract: A Case Control Study	PLOS ONE			English	Article							INFECTION; MORTALITY; METAANALYSIS; RESISTANCE; MICROBIOTA; MORBIDITY; EXPOSURE; DIARRHEA; RISK; TIME	Background An outbreak of Clostridium difficile ribotype 027 infection (CDI) occurred at an university hospital, involving 19 departments. To determine what hospital-associated factors drove the outbreak of this particular strain we performed a case-control study. Methods Cases (n = 79), diagnosed with CDI due to C. difficile ribotype 027 were matched for age and treating medical specialty to four control patients (n = 316). Patients diagnosed with CDI due to other ribotypes were included as a second control group. A random selection of C. difficile ribotype 027 strains (n = 10) was genotyped by Whole Genome Sequencing (WGS). Findings WGS showed the outbreak was likely caused by a single strain of C. difficile (two or less single-nucleotide variants between isolates). Ninety-five percent of cases had used antibiotics, compared to 56% of controls. Previous admission to the intensive care unit (ICU) (OR: 2.4, 95% CI 1.0-5.6), longer length of stay (LOS), and recent hospital admission were associated with CDI ribotype 027. Cases were less likely to have been admitted to a ward with a known isolated CDI patient (OR: 0.2, 95% CI 0.1-0.6). Analysis of patients who stayed at the ICU (35 cases; 51 controls), indicated that the use of selective decontamination of the digestive tract (SDD) and a longer LOS in the ICU were associated with CDI risk. Interpretation In this large outbreak, any antibiotic use, including SDD use, appeared as a prerequisite for acquisition of the outbreak strain. The role of use of SDD and prolonged stay on the ICU could not be disentangled, but both factors can play a biologically plausible role in C. difficile acquisition and infection.	[van Beurden, Yvette H.; Kaiser, Annie M.; van Houdt, Robin; Vandenbroucke-Grauls, Christina M. J. E.] Vrije Univ Amsterdam, Med Ctr, Dept Med Microbiol & Infect Control, Amsterdam, Netherlands; [van Beurden, Yvette H.; Mulder, Chris J. J.] Vrije Univ Amsterdam, Med Ctr, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands; [Dekkers, Olaf M.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; [Dekkers, Olaf M.] Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, Leiden, Netherlands; [Bomers, Marije K.] Vrije Univ Amsterdam, Med Ctr, Dept Internal Med, Amsterdam, Netherlands; [Knetsch, Cornelis W.] Leiden Univ, Med Ctr, Dept Med Microbiol, Leiden, Netherlands; [Girbes, Armand R. J.] Vrije Univ Amsterdam, Med Ctr, Dept Intens Care, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam	van Beurden, YH (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Med Microbiol & Infect Control, Amsterdam, Netherlands.; van Beurden, YH (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands.	y.vanbeurden@vumc.nl	Vandenbroucke-Grauls, Christina/AAO-7953-2020	Vandenbroucke-Grauls, Christina/0000-0003-2074-1597; Bomers, Marije/0000-0003-0399-6926; Knetsch, Wilco/0000-0001-8569-3456; Dekkers, Olaf/0000-0002-1333-7580				Ananthakrishnan AN, 2011, NAT REV GASTRO HEPAT, V8, P17, DOI 10.1038/nrgastro.2010.190; Archibald LK, 2004, J INFECT DIS, V189, P1585, DOI 10.1086/383045; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bruijnesteijn van Coppenraet LES, 2009, CLIN MICROBIOL INFEC, V15, P924, DOI 10.1111/j.1469-0691.2009.02798.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Daneman N, 2013, LANCET INFECT DIS, V13, P328, DOI 10.1016/S1473-3099(12)70322-5; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Ghose C, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.62; Hensgens MPM, 2011, EUR J CLIN MICROBIOL, V30, P587, DOI 10.1007/s10096-010-1127-4; Hensgens MPM, 2012, J ANTIMICROB CHEMOTH, V67, P742, DOI 10.1093/jac/dkr508; Janarthanan S, 2012, AM J GASTROENTEROL, V107, P1001, DOI 10.1038/ajg.2012.179; Jernberg C, 2010, MICROBIOL-SGM, V156, P3216, DOI 10.1099/mic.0.040618-0; Knetsch CW, 2014, EUROSURVEILLANCE, V19, P30, DOI 10.2807/1560-7917.ES2014.19.45.20954; Lawrence SJ, 2007, INFECT CONT HOSP EP, V28, P123, DOI 10.1086/511793; Leffler DA, 2015, NEW ENGL J MED, V372, P1539, DOI 10.1056/NEJMra1403772; Lofgren ET, 2014, EPIDEMIOLOGY, V25, P570, DOI 10.1097/EDE.0000000000000119; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; Miller M, 2010, CLIN INFECT DIS, V50, P194, DOI 10.1086/649213; Oostdijk EAN, 2014, JAMA-J AM MED ASSOC, V312, P1429, DOI 10.1001/jama.2014.7247; Stevens V, 2011, CLIN INFECT DIS, V53, P42, DOI 10.1093/cid/cir301; Stevens VW, 2015, INFECT CONT HOSP EP, V36, P1024, DOI 10.1017/ice.2015.132; van Prehn J, 2015, EUR J CLIN MICROBIOL; Zimmerman JE, 2006, CRIT CARE MED, V34, P1297, DOI 10.1097/01.CCM.0000215112.84523.F0	23	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160778	10.1371/journal.pone.0160778	http://dx.doi.org/10.1371/journal.pone.0160778			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27533048	Green Submitted, Green Published, gold			2022-12-26	WOS:000381487600043
J	Korolowicz, KE; Iyer, RP; Czerwinski, S; Suresh, M; Yang, JM; Padmanabhan, S; Sheri, A; Pandey, RK; Skell, J; Marquis, JK; Kallakury, BV; Tucker, RD; Menne, S				Korolowicz, Kyle E.; Iyer, Radhakrishnan P.; Czerwinski, Stefanie; Suresh, Manasa; Yang, Junming; Padmanabhan, Seetharamaiyer; Sheri, Anjaneyulu; Pandey, Rajendra K.; Skell, Jeffrey; Marquis, Judith K.; Kallakury, Bhaskar V.; Tucker, Robin D.; Menne, Stephan			Antiviral Efficacy and Host Innate Immunity Associated with SB 9200 Treatment in the Woodchuck Model of Chronic Hepatitis B	PLOS ONE			English	Article							VIRUS-INFECTION; IFN-ALPHA; IN-VIVO; RIG-I; THERAPY; REPLICATION; PHOSPHOROTHIOATE; TRANSCRIPTION; DINUCLEOTIDE; ACTIVATION	SB 9200, an oral prodrug of the dinucleotide SB 9000, is being developed for the treatment of chronic hepatitis B virus (HBV) infection and represents a novel class of antivirals. SB 9200 is thought to activate the viral sensor proteins, retinoic acid-inducible gene 1 (RIG-I) and nucleotide-binding oligomerization domain-containing protein 2 (NOD2) resulting in interferon (IFN) mediated antiviral immune responses in virus-infected cells. Additionally, the binding of SB 9200 to these sensor proteins could also sterically block the ability of the viral polymerase to access pre-genomic RNA for nucleic acid synthesis. The immune stimulating and direct antiviral properties of SB 9200 were evaluated in woodchucks chronically infected with woodchuck hepatitis virus (WHV) by daily, oral dosing at 15 and 30 mg/kg for 12 weeks. Prolonged treatment resulted in 2.2 and 3.7 log10 reductions in serum WHV DNA and in 0.5 and 1.6 log10 declines in serum WHV surface antigen from pretreatment level with the lower or higher dose of SB 9200, respectively. SB 9200 treatment also resulted in lower hepatic levels of WHV nucleic acids and antigen and reduced liver inflammation. Following treatment cessation, recrudescence of viral replication was observed but with dose-dependent delays in viral relapse. The antiviral effects were associated with dose-dependent and long-lasting induction of IFN-alpha, IFN-beta and IFN-stimulated genes in blood and liver, which correlated with the prolonged activation of the RIG-I/NOD2 pathway and hepatic presence of elevated RIG-I protein levels. These results suggest that in addition to a direct antiviral activity, SB 9200 induces antiviral immunity during chronic hepadnaviral infection via activation of the viral sensor pathway.	[Korolowicz, Kyle E.; Czerwinski, Stefanie; Suresh, Manasa; Yang, Junming; Menne, Stephan] Georgetown Univ, Med Ctr, Dept Microbiol & Immunol, Washington, DC 20057 USA; [Iyer, Radhakrishnan P.; Padmanabhan, Seetharamaiyer; Sheri, Anjaneyulu; Pandey, Rajendra K.; Skell, Jeffrey; Marquis, Judith K.] Spring Bank Pharmaceut Inc, Suite S-7,113 Cedar St, Milford, MA 01757 USA; [Kallakury, Bhaskar V.] Georgetown Univ, Med Ctr, Dept Pathol, Washington, DC 20057 USA; [Tucker, Robin D.] Georgetown Univ, Med Ctr, Dept Comparat Med, Washington, DC 20057 USA; [Pandey, Rajendra K.] Johnson & Johnson Inc, New Brunswick, NJ 08933 USA	Georgetown University; Georgetown University; Georgetown University; Johnson & Johnson; Johnson & Johnson USA	Menne, S (corresponding author), Georgetown Univ, Med Ctr, Dept Microbiol & Immunol, Washington, DC 20057 USA.	sm923@georgetown.edu			IDIQ [HHSN272201000011I, HHSN27200002 (D06)]; Division of Microbiology and Infectious Diseases (DMID) of the National Institute of Allergy and Infectious Diseases (NIAID); NIAID [AI094469]	IDIQ; Division of Microbiology and Infectious Diseases (DMID) of the National Institute of Allergy and Infectious Diseases (NIAID); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by IDIQ Contract HHSN272201000011I, Task Order HHSN27200002 (D06) to the Department of Microbiology & Immunology, Georgetown University Medical Center (SM) from the Division of Microbiology and Infectious Diseases (DMID) of the National Institute of Allergy and Infectious Diseases (NIAID). Support by R01 grant AI094469 to Spring Bank Pharmaceuticals, Inc. (RPI) from NIAID is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belloni L, 2012, J CLIN INVEST, V122, P529, DOI 10.1172/JCI58847; ClinicalTrials.gov, 2013, MULT ASC DOS PHAS I; Cote Paul J., 1993, Viral Immunology, V6, P161, DOI 10.1089/vim.1993.6.161; Coughlin JE, 2012, DRUG METAB DISPOS, V40, P970, DOI 10.1124/dmd.111.044446; Coughlin JE, 2010, BIOORG MED CHEM LETT, V20, P1783, DOI 10.1016/j.bmcl.2010.01.010; Cunningham ME, 2013, HEPATOLOGY, V58, p928A; Dunn C, 2009, GASTROENTEROLOGY, V137, P1289, DOI 10.1053/j.gastro.2009.06.054; Fiedler M, 2004, J VIROL, V78, P10111, DOI 10.1128/JVI.78.18.10111-10121.2004; Fletcher SP, 2013, HEPATOLOGY, V57, P13, DOI 10.1002/hep.25954; Fletcher SP, 2012, HEPATOLOGY, V56, P820, DOI 10.1002/hep.25730; Fletcher SP, 2015, PLOS PATHOG IN PRESS; Iyer R.P., 2014, P 27 INT C ANTIVIRAL, P12; Iyer RP, 2005, CURR OPIN PHARMACOL, V5, P520, DOI 10.1016/j.coph.2005.04.019; Iyer RP, 2004, ANTIMICROB AGENTS CH, V48, P2318, DOI 10.1128/AAC.48.6.2318-2320.2004; Kwon H, 2011, NAT REV GASTRO HEPAT, V8, P275, DOI 10.1038/nrgastro.2011.33; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Menne S, 2008, ANTIMICROB AGENTS CH, V52, P3617, DOI 10.1128/AAC.00654-08; Menne S, 2007, WORLD J GASTROENTERO, V13, P104, DOI 10.3748/wjg.v13.i1.104; Menne S, 2015, J HEPATOL, V62, P1237, DOI 10.1016/j.jhep.2014.12.026; Moraleda G, 1997, J VIROL, V71, P9392, DOI 10.1128/JVI.71.12.9392-9399.1997; Nakagawa S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059611; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Sato S, 2015, IMMUNITY, V42, P123, DOI 10.1016/j.immuni.2014.12.016; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Wieland S, 2004, P NATL ACAD SCI USA, V101, P6669, DOI 10.1073/pnas.0401771101; Wieland SF, 2005, P NATL ACAD SCI USA, V102, P9913, DOI 10.1073/pnas.0504273102; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	30	48	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0161313	10.1371/journal.pone.0161313	http://dx.doi.org/10.1371/journal.pone.0161313			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27552102	gold, Green Submitted, Green Published			2022-12-26	WOS:000381768800029
J	Brecko, J; Mathys, A; Dekoninck, W; De Ceukelaire, M; VandenSpiegel, D; Semal, P				Brecko, Jonathan; Mathys, Aurore; Dekoninck, Wouter; De Ceukelaire, Marleen; VandenSpiegel, Didier; Semal, Patrick			Revealing Invisible Beauty, Ultra Detailed: The Influence of Low Cost UV Exposure on Natural History Specimens in 2D+Digitization	PLOS ONE			English	Article							ULTRAVIOLET REFLECTANCE; CARNIVOROUS PLANTS; PATTERNS; SPIDERS; TRAPS; LIGHT	Digitization of the natural history specimens usually occurs by taking detailed pictures from different sides or producing 3D models. Additionally this is normally limited to imaging the specimen while exposed by light of the visual spectrum. However many specimens can see in or react to other spectra as well. Fluorescence is a well known reaction to the ultraviolet (UV) spectrum by animals, plants, minerals etc. but rarely taken into account while examining natural history specimens. Our tests show that museum specimens still fluoresce when exposed to UV light of 395 nm and 365 nm, even after many years of preservation. When the UV exposure is used in the digitization of specimens using our low cost focus stacking (2D+) setup, the resulting pictures reveal more detail than the conventional 2D+ images. Differences in fluorescence using 395 nm or 365 nm UV lights were noticed, however there isn't a preferred wavelength as some specimens react more to the first, while others have better results with the latter exposure. Given the increased detail and the low cost of the system, UV exposure should be considered while digitizing natural history museum collections.	[Brecko, Jonathan; Mathys, Aurore; Dekoninck, Wouter; De Ceukelaire, Marleen; Semal, Patrick] Royal Belgian Inst Nat Sci, Sci Heritage Serv, Vautierstr 29, B-1000 Brussels, Belgium; [Brecko, Jonathan; Mathys, Aurore; VandenSpiegel, Didier] Royal Museum Cent Africa, Biol Collect & Data Management, Leuvensesteenweg 13, B-3080 Tervuren, Belgium	Royal Belgian Institute of Natural Sciences; Royal Museum for Central Africa	Brecko, J (corresponding author), Royal Belgian Inst Nat Sci, Sci Heritage Serv, Vautierstr 29, B-1000 Brussels, Belgium.; Brecko, J (corresponding author), Royal Museum Cent Africa, Biol Collect & Data Management, Leuvensesteenweg 13, B-3080 Tervuren, Belgium.	jonathan.brecko@naturalsciences.be	Mathys, Aurore/AAA-3835-2022	Semal, Patrick/0000-0002-4048-7728	Belgian Science Policy [DIGIT-03]; "Synthesys of systematic resources" (FP7-CP-CSA-INFRA) [312253]	Belgian Science Policy(Belgian Federal Science Policy Office); "Synthesys of systematic resources" (FP7-CP-CSA-INFRA)	The research is funded by the DIGIT-03 program of the Belgian Science Policy and the "Synthesys of systematic resources" (FP7-CP-CSA-INFRA, no 312253). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Alvarez C, 2004, BEHAV ECOL, V15, P805, DOI 10.1093/beheco/arh083; Altshuler DL, 2001, EVOL ECOL RES, V3, P767; Andrews K, 2007, BIOL LETTERS, V3, P265, DOI 10.1098/rsbl.2007.0016; Bok MJ, 2015, J EXP BIOL, V218, P2055, DOI 10.1242/jeb.122036; Brecko J, 2014, ZOOKEYS, P1, DOI 10.3897/zookeys.464.8615; Croft DA, 2004, PALAEONTOLOGY, V47, P795, DOI 10.1111/j.0031-0239.2004.00398.x; Eaton MD, 2003, P ROY SOC B-BIOL SCI, V270, P1721, DOI 10.1098/rspb.2003.2431; Holovachov SD, PHOTOGRAPHY ARTICLES; Honkavaara J, 2002, OIKOS, V98, P505, DOI 10.1034/j.1600-0706.2002.980315.x; Hunt S, 1998, P ROY SOC B-BIOL SCI, V265, P451, DOI 10.1098/rspb.1998.0316; JOEL DM, 1985, NEW PHYTOL, V101, P585, DOI 10.1111/j.1469-8137.1985.tb02864.x; Knuttel H, 2001, J EXP BIOL, V204, P2447; Kurup R, 2013, PLANT BIOLOGY, V15, P611, DOI 10.1111/j.1438-8677.2012.00709.x; Loria SF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112913; Mazza CA, 2010, P ROY SOC B-BIOL SCI, V277, P367, DOI 10.1098/rspb.2009.1565; Meadows MG, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1211; Molina-Borja M, 2006, J ZOOL, V268, P193, DOI 10.1111/j.1469-7998.2005.00008.x; Rorslett B., FLOWERS ULTRAVIOLET; Tischlinger Helmut, 2013, P549; Volschenk ES, 2005, J ARACHNOL, V33, P820, DOI 10.1636/S03-047.1; Welch VL, 2012, PROC SPIE, V8480, DOI 10.1117/12.929547; Wiesenborn William D., 2011, Psyche (Cambridge), V2011; Yang XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055125; Zschokke S, 2002, J ARACHNOL, V30, P246, DOI 10.1636/0161-8202(2002)030[0246:UROSAW]2.0.CO;2	24	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161572	10.1371/journal.pone.0161572	http://dx.doi.org/10.1371/journal.pone.0161572			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536993	Green Published, gold, Green Submitted			2022-12-26	WOS:000381577000123
J	Haasum, Y; Fastbom, J; Johnell, K				Haasum, Ylva; Fastbom, Johan; Johnell, Kristina			Use of Fall-Risk Inducing Drugs in Patients Using Anti-Parkinson Drugs (APD): A Swedish Register-Based Study	PLOS ONE			English	Article							POPULATION-BASED COHORT; INCREASING DRUGS; NONMOTOR SYMPTOMS; ELDERLY-PEOPLE; MEDICATION USE; HIP FRACTURE; OLDER-PEOPLE; DISEASE; PREVALENCE; METAANALYSIS	Objectives Many drugs increase the risk of falls in old age. Although persons with Parkinson's disease (PD) are at increased risk of experiencing falls and fractures, the use of fall-risk inducing drugs (FRIDs) in this population has not previously been investigated. The objective of this study was to investigate the burden of use of FRIDs in older persons treated with anti-Parkinson drugs (APD; used as a proxy for PD), compared to persons without APD. Methods We analyzed individual data on age, sex, type of housing and drug use in 1 346 709 persons aged >= 65 years in the Swedish Prescribed Drug Register on the date of 30 September 2008. Main outcome measure was the use of FRIDs. Results FRIDs were used by 79% of persons with APD and 75% of persons without APD. Persons with APD were more likely to use >= 1 FRIDs compared to persons without APD (adjusted OR: 1.09; 95% CI: 1.06-1-12). The association was stronger for concomitant use of >= 5 FRIDS (adjusted OR: 1.49; 95% CI: 1.44-1.55). Conclusions The high use of FRIDs among persons with APD indicates that these patients may be at increased risk of drug-induced falls. Further studies are needed to investigate how these drugs affect the risk of falling in persons with PD.	[Haasum, Ylva] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Aging Res Ctr, Stockholm, Sweden; Stockholm Univ, Stockholm, Sweden	Karolinska Institutet; Stockholm University	Haasum, Y (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, Aging Res Ctr, Stockholm, Sweden.	Ylva.Haasum@ki.se			Swedish Research Council; Strategic Research Program in Epidemiology at Karolinska Institutet	Swedish Research Council(Swedish Research CouncilEuropean Commission); Strategic Research Program in Epidemiology at Karolinska Institutet	This study was supported financially by grants from the Swedish Research Council and the Strategic Research Program in Epidemiology at Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 2000, J AM GERIATR SOC, V48, P938, DOI 10.1111/j.1532-5415.2000.tb06891.x; Ahlskog JE, 2014, MAYO CLIN PROC, V89, P997, DOI 10.1016/j.mayocp.2014.02.018; Allen NE, 2013, PARKINSONS DIS-US, V2013, DOI 10.1155/2013/906274; Baranzini F, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-228; Bennett A, 2014, DRUG AGING, V31, P225, DOI 10.1007/s40266-013-0151-3; BLAKE AJ, 1988, AGE AGEING, V17, P365, DOI 10.1093/ageing/17.6.365; Bloem BR, 2001, J NEUROL, V248, P950, DOI 10.1007/s004150170047; Brandt-Christensen M, 2006, MOVEMENT DISORD, V21, P1221, DOI 10.1002/mds.20907; Canning CG, 2014, NEURODEGENER DIS MAN, V4, P203, DOI [10.2217/nmt.14.22, 10.2217/NMT.14.22]; Chaudhuri KR, 2015, MOVEMENT DISORD, V30, P1623, DOI 10.1002/mds.26270; Chou KL, 2011, PARKINSONISM RELAT D, V17, P440, DOI 10.1016/j.parkreldis.2011.03.002; Comella Cynthia L, 2003, Curr Neurol Neurosci Rep, V3, P173, DOI 10.1007/s11910-003-0073-2; Crispo JAG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150621; Dissanayaka NNNW, 2014, MOVEMENT DISORD, V29, P967, DOI 10.1002/mds.25937; Ehrt U, 2010, J NEUROL NEUROSUR PS, V81, P160, DOI 10.1136/jnnp.2009.186239; Fastbom J, 2010, SWEDISH NATL BORD HL, V6; Grimbergen YAM, 2004, CURR OPIN NEUROL, V17, P405, DOI 10.1097/01.wco.0000137530.68867.93; Harris MA, 2011, PARKINSONISM RELAT D, V17, P464, DOI 10.1016/j.parkreldis.2011.04.007; Hartikainen S, 2007, J GERONTOL A-BIOL, V62, P1172, DOI 10.1093/gerona/62.10.1172; Hausdorff JM, 2003, EXP BRAIN RES, V149, P187, DOI 10.1007/s00221-002-1354-8; Huang AR, 2012, DRUG AGING, V29, P359, DOI 10.2165/11599460-000000000-00000; Johnell K, 2011, EUR J CLIN PHARMACOL, V67, P1069, DOI 10.1007/s00228-011-1051-2; Kannus P, 2005, LANCET, V366, P1885, DOI 10.1016/S0140-6736(05)67604-0; Kojima G, 2015, J AM MED DIR ASSOC, V16, P940, DOI 10.1016/j.jamda.2015.06.025; Kojima T, 2011, GERIATR GERONTOL INT, V11, P438, DOI 10.1111/j.1447-0594.2011.00703.x; Kragh A, 2011, J AM GERIATR SOC, V59, P863, DOI 10.1111/j.1532-5415.2011.03372.x; Laflamme L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123390; Leipzig RM, 1999, J AM GERIATR SOC, V47, P40, DOI 10.1111/j.1532-5415.1999.tb01899.x; Leipzig RM, 1999, J AM GERIATR SOC, V47, P30, DOI 10.1111/j.1532-5415.1999.tb01898.x; Lieberman A, 2006, ACTA NEUROL SCAND, V113, P1, DOI 10.1111/j.1600-0404.2006.00536.x; Masud T, 2001, AGE AGEING, V30, P3, DOI 10.1093/ageing/30.suppl_4.3; Milos V, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-40; Modugno N, 2013, ARCH ITAL BIOL, V151, P148; Nilson F, 2016, INT J INJ CONTROL SA, V23, P277, DOI 10.1080/17457300.2015.1032980; Payne RA, 2014, BRIT J CLIN PHARMACO, V77, P1073, DOI 10.1111/bcp.12292; Perez-Lloret S, 2012, PARKINSONISM RELAT D, V18, P501, DOI 10.1016/j.parkreldis.2012.01.012; Richardson K, 2015, J AM GERIATR SOC, V63, P1561, DOI 10.1111/jgs.13543; Rossini M, 2014, DRUG AGING, V31, P547, DOI 10.1007/s40266-014-0184-2; Seppi K, 2011, MOVEMENT DISORD, V26, pS42, DOI 10.1002/mds.23884; Stevens JA, 2006, INJURY PREV, V12, P290, DOI 10.1136/ip.2005.011015; Stolze H, 2005, MOVEMENT DISORD, V20, P89, DOI 10.1002/mds.20266; Stolze H, 2004, J NEUROL, V251, P79, DOI 10.1007/s00415-004-0276-8; TANDBERG E, 1995, MOVEMENT DISORD, V10, P541, DOI 10.1002/mds.870100503; The Swedish National Board of Health and Welfare, 2008, CAR SERV ELD PERS 30; Van der Velde N, 2007, BRIT J CLIN PHARMACO, V63, P232, DOI 10.1111/j.1365-2125.2006.02736.x; Wenning GK, 2000, J NEUROL NEUROSUR PS, V68, P434, DOI 10.1136/jnnp.68.4.434; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294; WHO Collaborating Centre for Drug Statistics Methodology, 2015, GUIDELINES ATC CLASS; Wood BH, 2002, J NEUROL NEUROSUR PS, V72, P721, DOI 10.1136/jnnp.72.6.721	49	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161246	10.1371/journal.pone.0161246	http://dx.doi.org/10.1371/journal.pone.0161246			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT6ES	27537366	Green Published, gold, Green Submitted			2022-12-26	WOS:000381577000076
J	Zitt, E; Pscheidt, C; Concin, H; Kramar, R; Lhotta, K; Nagel, G				Zitt, Emanuel; Pscheidt, Constanze; Concin, Hans; Kramar, Reinhard; Lhotta, Karl; Nagel, Gabriele			Anthropometric and Metabolic Risk Factors for ESRD Are Disease-Specific: Results from a Large Population-Based Cohort Study in Austria	PLOS ONE			English	Article							STAGE RENAL-DISEASE; CHRONIC KIDNEY-DISEASE; GAMMA-GLUTAMYL-TRANSFERASE; BODY-MASS INDEX; BLOOD-PRESSURE; MICROVASCULAR COMPLICATIONS; MULTIFACTORIAL INTERVENTION; FOLLOW-UP; PROGRESSION; MORTALITY	Background Anthropometric and metabolic risk factors for all-cause end-stage renal disease (ESRD) may vary in their impact depending on the specific primary renal disease. Methods In this Austrian population-based prospective cohort study (n = 185,341; 53.9% women) the following data were collected between 1985 and 2005: age, sex, body mass index (BMI), fasting blood glucose (FBG) from 1988, blood pressure, total cholesterol (TC), triglycerides (TG), gamma-glutamyl transferase (GGT) and smoking status. These data were merged with the Austrian Dialysis and Transplant Registry to identify ESRD patients. Cox proportional hazards models were applied to calculate hazard ratios (HR) for all-cause ESRD as well as for cause-specific ESRD due to the following primary renal diseases: autosomal dominant polycystic kidney disease (ADPKD), vascular nephropathy (VN), diabetic nephropathy (DN) and other diseases (OD). Results During a mean follow-up of 17.5 years 403 participants developed ESRD (ADPKD 36, VN 97, DN 86, and OD 184). All parameters except TG and GGT were significantly associated with all-cause ESRD risk. Particular cause-specific ESRD risk factor patterns were found: for ADPKD increased risk from hypertension (HR 11.55); for VN from smoking (HR 1.81), hypertension (HR 2.37), TG (>= 5.70 vs. <1.17 mmol/L: HR 9.27); for DN from smoking (HR 1.77), BMI (>= 30 vs. 18.5-24.9 kg/m(2): HR 7.55), FBG (>= 6.94 vs. <5.55 mmol/L: HR 7.67), hypertension (HR 1.08), TG (>= 5.70 vs. <1.17 mmol/L: HR 2.02), GGT (HR 2.14); and for OD from hypertension (HR 2.29), TG (>= 5.70 vs. <1.17 mmol/L: HR 6.99) and TC (>= 6.22 vs. <5.18 mmol/L: HR 1.56). Conclusions Particular anthropometric and metabolic ESRD risk factors differ in importance depending on the primary renal disease. This needs to be considered for future preventive and therapeutic strategies addressing cause-specific ESRD.	[Zitt, Emanuel; Lhotta, Karl] Acad Teaching Hosp Feldkirch, Dept Nephrol & Dialysis, Feldkirch, Austria; [Zitt, Emanuel; Lhotta, Karl] Acad Teaching Hosp Feldkirch, VIVIT, Feldkirch, Austria; [Pscheidt, Constanze; Concin, Hans; Nagel, Gabriele] Agcy Prevent & Social Med, Bregenz, Austria; [Pscheidt, Constanze; Nagel, Gabriele] Univ Ulm, Inst Epidemiol & Med Biometry, Ulm, Germany; [Kramar, Reinhard] Austrian Dialysis & Transplant Registry, Rohr Im Kremstal, Austria	Ulm University	Nagel, G (corresponding author), Agcy Prevent & Social Med, Bregenz, Austria.; Nagel, G (corresponding author), Univ Ulm, Inst Epidemiol & Med Biometry, Ulm, Germany.	hans.concin@aks.or.at; gabriele.nagel@uni-ulm.de	vhmpp, aks/F-9756-2012; Nagel, Gabriele/C-3635-2012; Zitt, Emanuel/ABE-1926-2020	Nagel, Gabriele/0000-0001-6185-8535; Zitt, Emanuel/0000-0001-6944-6041				Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; [Anonymous], 2013, N 1, V17, DOI DOI 10.1093/NDT/GFV100; Bangalore S, 2011, CIRCULATION, V123, P2799, DOI 10.1161/CIRCULATIONAHA.110.016337; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Carter BD, 2015, NEW ENGL J MED, V372, P631, DOI 10.1056/NEJMsa1407211; Chang TI, 2013, AM J KIDNEY DIS, V61, pS4, DOI 10.1053/j.ajkd.2012.12.016; Charlton J, 2008, DIABETES CARE, V31, P1761, DOI 10.2337/dc08-0137; Cooper CJ, 2014, NEW ENGL J MED, V370, P13, DOI 10.1056/NEJMoa1310753; Cornec-Le Gall E, 2013, J AM SOC NEPHROL, V24, P1006, DOI 10.1681/ASN.2012070650; Dialysis Austrian and Registry Transplantation (OEDTR), 2014, ANNUAL REPORT 2014; Ejerblad E, 2006, J AM SOC NEPHROL, V17, P1695, DOI 10.1681/ASN.2005060638; Eriksen BO, 2006, KIDNEY INT, V69, P375, DOI 10.1038/sj.ki.5000058; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Gregg EW, 2014, NEW ENGL J MED, V370, P1514, DOI 10.1056/NEJMoa1310799; Gross O, 2012, KIDNEY INT, V81, P494, DOI 10.1038/ki.2011.407; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hallan SI, 2011, KIDNEY INT, V80, P516, DOI 10.1038/ki.2011.157; Hecking M, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001750; Hsu CY, 2009, ARCH INTERN MED, V169, P342, DOI 10.1001/archinternmed.2008.605; Hsu CY, 2005, ARCH INTERN MED, V165, P923, DOI 10.1001/archinte.165.8.923; Iseki K, 2004, KIDNEY INT, V65, P1870, DOI 10.1111/j.1523-1755.2004.00582.x; Kastarinen M, 2010, J INTERN MED, V267, P612, DOI 10.1111/j.1365-2796.2009.02197.x; Klag MJ, 1996, NEW ENGL J MED, V334, P13, DOI 10.1056/NEJM199601043340103; Klenk J, 2009, EUR J EPIDEMIOL, V24, P83, DOI 10.1007/s10654-009-9312-4; Lee DH, 2005, CLIN CHEM, V51, P1185, DOI 10.1373/clinchem.2004.045872; McMahon GM, 2014, J AM SOC NEPHROL, V25, P2633, DOI 10.1681/ASN.2013070750; Muntner P, 2000, KIDNEY INT, V58, P293, DOI 10.1046/j.1523-1755.2000.00165.x; Nagel G, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-177; Neugarten J, 2000, J AM SOC NEPHROL, V11, P319, DOI 10.1681/ASN.V112319; Ozkok A, 2013, CLIN EXP NEPHROL, V17, P345, DOI 10.1007/s10157-012-0706-3; Panwar B, 2015, KIDNEY INT, V87, P1216, DOI 10.1038/ki.2014.384; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Prischl FC, 2015, NEPHROL DIAL TRANSPL, V30, P1920, DOI 10.1093/ndt/gfv113; Pscheidt C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135052; Rahman M, 2014, CLIN J AM SOC NEPHRO, V9, P1190, DOI 10.2215/CJN.09320913; Ruggenenti P, 2004, NEW ENGL J MED, V351, P1941, DOI 10.1056/NEJMoa042167; Ruggenenti P, 1998, LANCET, V352, P1252, DOI 10.1016/S0140-6736(98)04433-X; Schrier RW, 2014, NEW ENGL J MED, V371, P2255, DOI 10.1056/NEJMoa1402685; Schrier RW, 2014, J AM SOC NEPHROL, V25, P2399, DOI 10.1681/ASN.2013111184; SILBIGER SR, 1995, AM J KIDNEY DIS, V25, P515, DOI 10.1016/0272-6386(95)90119-1; Spithoven EM, 2014, KIDNEY INT, V86, P1244, DOI 10.1038/ki.2014.120; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Sundin PO, 2014, AM J KIDNEY DIS, V64, P723, DOI 10.1053/j.ajkd.2014.06.019; Targher G, 2010, CLIN CHEM LAB MED, V48, P147, DOI 10.1515/CCLM.2010.031; Thomas G, 2011, CLIN J AM SOC NEPHRO, V6, P2364, DOI 10.2215/CJN.02180311; Torres VE, 2014, NEW ENGL J MED, V371, P2267, DOI 10.1056/NEJMoa1402686; Tozawa M, 2003, HYPERTENSION, V41, P1341, DOI 10.1161/01.HYP.0000069699.92349.8C; Ulmer H, 2003, EUR HEART J, V24, P1004, DOI 10.1016/S0195-668X(03)00170-2; US Renal Data System, 2014, 2014 ANNUAL DATA REP; Vivante A, 2012, ARCH INTERN MED, V172, P1644, DOI 10.1001/2013.jamainternmed.85; Wimmer F, 2003, NEPHROL DIAL TRANSPL, V18, P1562, DOI 10.1093/ndt/gfg184	54	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161376	10.1371/journal.pone.0161376	http://dx.doi.org/10.1371/journal.pone.0161376			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537361	Green Published, gold, Green Submitted			2022-12-26	WOS:000381577000095
J	Gim, J; Won, S; Park, T				Gim, Jungsoo; Won, Sungho; Park, Taesung			LPEseq: Local-Pooled-Error Test for RNA Sequencing Experiments with a Small Number of Replicates	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; SEQ; NORMALIZATION	RNA-Sequencing (RNA-Seq) provides valuable information for characterizing the molecular nature of the cells, in particular, identification of differentially expressed transcripts on a genome-wide scale. Unfortunately, cost and limited specimen availability often lead to studies with small sample sizes, and hypothesis testing on differential expression between classes with a small number of samples is generally limited. The problem is especially challenging when only one sample per each class exists. In this case, only a few methods among many that have been developed are applicable for identifying differentially expressed transcripts. Thus, the aim of this study was to develop a method able to accurately test differential expression with a limited number of samples, in particular non-replicated samples. We propose a local-pooled-error method for RNA-Seq data (LPEseq) to account for non-replicated samples in the analysis of differential expression. Our LPEseq method extends the existing LPE method, which was proposed for microarray data, to allow examination of non-replicated RNA-Seq experiments. We demonstrated the validity of the LPEseq method using both real and simulated datasets. By comparing the results obtained using the LPEseq method with those obtained from other methods, we found that the LPEseq method outperformed the others for non-replicated datasets, and showed a similar performance with replicated samples; LPEseq consistently showed high true discovery rate while not increasing the rate of false positives regardless of the number of samples. Our proposed LPEseq method can be effectively used to conduct differential expression analysis as a preliminary design step or for investigation of a rare specimen, for which a limited number of samples is available.	[Gim, Jungsoo] Seoul Natl Univ, Inst Hlth & Environm, 1 Gwanak Ro, Seoul, South Korea; [Won, Sungho] Seoul Natl Univ, Grad Sch Publ Hlth, 1 Gwanak Ro, Seoul, South Korea; [Park, Taesung] Seoul Natl Univ, Dept Stat, 1 Gwanak Ro, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Park, T (corresponding author), Seoul Natl Univ, Dept Stat, 1 Gwanak Ro, Seoul, South Korea.	tspark@stats.snu.ac.kr			National Research Foundation of Korea (NRF) grants - Korea government (MSIP) [2012R1A3A2026438]; Bio-Synergy Research Project of the Ministry of Science, ICT and Future Planning through the NRF [2013M3A9C4078158]	National Research Foundation of Korea (NRF) grants - Korea government (MSIP); Bio-Synergy Research Project of the Ministry of Science, ICT and Future Planning through the NRF	This work is supported by the National Research Foundation of Korea (NRF) grants funded by the Korea government (MSIP) (no. 2012R1A3A2026438) and by the Bio-Synergy Research Project (2013M3A9C4078158) of the Ministry of Science, ICT and Future Planning through the NRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Thanks to Yoav Benjamini (Tel Aviv University) and Nancy Cox (University of Chicago) for invaluable comments and helpful discussions. This work is supported by the National Research Foundation of Korea (NRF) grants funded by the Korea government (MSIP) (No. 2012R1A3A2026438) and by the Bio-Synergy Research Project (2013M3A9C4078158) of the Ministry of Science, ICT and Future Planning through the NRF.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; CASSIE RM, 1962, J ANIM ECOL, V31, P65, DOI 10.2307/2333; Di YM, 2011, STAT APPL GENET MOL, V10, DOI 10.2202/1544-6115.1637; Frazee AC, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-449; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Hammer P, 2010, GENOME RES, V20, P847, DOI 10.1101/gr.101204.109; Henningsen A, 2011, COMPUTATION STAT, V26, P443, DOI 10.1007/s00180-010-0217-1; Hoaglin DC, 1993, HOW TO DETECT AND HA, Vix; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jain N, 2003, BIOINFORMATICS, V19, P1945, DOI 10.1093/bioinformatics/btg264; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li J, 2013, STAT METHODS MED RES, V22, P519, DOI 10.1177/0962280211428386; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Rapaport F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r95; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Robles JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-484; Seyednasrollah F, 2015, BRIEF BIOINFORM, V16, P59, DOI 10.1093/bib/bbt086; Soneson C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-91; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342	27	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0159182	10.1371/journal.pone.0159182	http://dx.doi.org/10.1371/journal.pone.0159182			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532300	Green Published, gold, Green Submitted			2022-12-26	WOS:000381487600006
J	Fani, S; Dehghan, F; Karimian, H; Lo, KM; Nigjeh, SE; Keong, YS; Soori, R; Chow, KM; Kamalidehghan, B; Ali, HM; Hashim, NM				Fani, Somayeh; Dehghan, Firouzeh; Karimian, Hamed; Lo, Kong Mun; Nigjeh, Siyamak Ebrahimi; Keong, Yeap Swee; Soori, Rahman; Chow, Kit May; Kamalidehghan, Behnam; Ali, Hapipah Mohd; Hashim, Najihah Mohd			Monobenzyltin Complex C1 Induces Apoptosis in MCF-7 Breast Cancer Cells through the Intrinsic Signaling Pathway and through the Targeting of MCF-7-Derived Breast Cancer Stem Cells via the Wnt/beta Catenin Signaling Pathway	PLOS ONE			English	Article							IN-VITRO CYTOTOXICITY; BETA-CATENIN; STRUCTURAL-CHARACTERIZATION; PROSPECTIVE IDENTIFICATION; ALDEHYDE DEHYDROGENASE; ANTITUMOR-ACTIVITY; ACTIVATION; THERAPY; DEATH; DERIVATIVES	Monobenzyltin Schiff base complex, [N-(3,5-dichloro-2-oxidobenzylidene)-4-chlorobenzyhy-drazidato](o-methylbenzyl) aquatin(IV) chloride, C1, is an organotin non-platinum metal-based agent. The present study was conducted to investigate its effects on MCF-7 cells with respect to the induction of apoptosis and its inhibitory effect against MCF-7 breast cancer stem cells. As determined in a previous study, compound C1 revealed strong antiproliferative activity on MCF-7 cells with an IC50 value of 2.5 mu g/mL. Annexin V/propidium iodide staining coupled with flow cytometry indicated the induction of apoptosis in treated cells. Compound C1 induced apoptosis in MCF-7 cells and was mediated through the intrinsic pathway with a reduction in mitochondrial membrane potential and mitochondrial cytochrome c release to cytosol. Complex C1 activated caspase 9 as a result of cytochrome c release. Subsequently, western blot and real time PCR revealed a significant increase in Bax and Bad expression and a significant decrease in the expression levels of Bcl2 and HSP70. Furthermore, a flow cytometric analysis showed that treatment with compound C1 caused a significant arrest of MCF-7 cells in G0/G1 phase. The inhibitory analysis of compound C1 against derived MCF-7 stem cells showed a significant reduction in the aldehyde dehydrogenase-positive cell population and a significant reduction in the population of MCF-7 cancer stem cells in primary, secondary, and tertiary mammospheres. Moreover, treatment with C1 down-regulated the Wnt/beta-catenin self-renewal pathway. These findings indicate that complex C1 is a suppressive agent of MCF-7 cells that functions through the induction of apoptosis, cell cycle arrest, and the targeting of MCF-7-derived cancer stem cells. This work may lead to a better treatment strategy for the reduction of breast cancer recurrence.	[Fani, Somayeh; Karimian, Hamed; Hashim, Najihah Mohd] Univ Malaya, Dept Pharm, Fac Med, Kuala Lumpur 50603, Malaysia; [Dehghan, Firouzeh; Soori, Rahman] Univ Tehran, Fac Phys Educ & Sport Sci, Dept Exercise Physiol, Tehran 14174, Iran; [Dehghan, Firouzeh] Univ Malaya, Dept Exercise Sci, Sports Ctr, Kuala Lumpur 50603, Malaysia; [Lo, Kong Mun; Chow, Kit May; Ali, Hapipah Mohd] Univ Malaya, Dept Chem, Fac Sci, Kuala Lumpur 50603, Malaysia; [Nigjeh, Siyamak Ebrahimi; Keong, Yeap Swee] Univ Putra Malaysia, Inst Biosci, Serdang 43400, Malaysia; [Kamalidehghan, Behnam] NIGEB, Dept Med Genet, Tehran Karaj Highway, Tehran, Iran; [Ali, Hapipah Mohd; Hashim, Najihah Mohd] Univ Malaya, Ctr Nat Prod & Drug Discovery CENAR, Dept Chem, Fac Sci, Kuala Lumpur, Malaysia	Universiti Malaya; University of Tehran; Universiti Malaya; Universiti Malaya; Universiti Putra Malaysia; Universiti Malaya	Fani, S; Hashim, NM (corresponding author), Univ Malaya, Dept Pharm, Fac Med, Kuala Lumpur 50603, Malaysia.; Hashim, NM (corresponding author), Univ Malaya, Ctr Nat Prod & Drug Discovery CENAR, Dept Chem, Fac Sci, Kuala Lumpur, Malaysia.	somi.fani@gmail.com; najihahmh@um.edu.my	Soori, Rahman/AAM-8873-2020; Kamalidehghan, Behnam/B-5401-2013; Hashim, Najihah Mohd/J-5508-2015; Yeap, Swee Keong/H-9285-2013	Soori, Rahman/0000-0002-4661-7204; Kamalidehghan, Behnam/0000-0001-8530-8124; Hashim, Najihah Mohd/0000-0003-1133-7998; Yeap, Swee Keong/0000-0002-4736-0674	University of Malaya Research Grant [RG084-13BIO]; IPPP grant [PG082-2013B];  [UM.0000104/HIR.C1]	University of Malaya Research Grant; IPPP grant; 	The authors would like to express their greatest appreciation to the University of Malaya Research Grant (RG084-13BIO), IPPP grant (PG082-2013B), and UM.0000104/HIR.C1 for providing partial financial support to conduct this study.	Ahmadipour F, 2015, DRUG DES DEV THER, V9, P1193, DOI 10.2147/DDDT.S72127; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alama A, 2009, DRUG DISCOV TODAY, V14, P500, DOI 10.1016/j.drudis.2009.02.002; Arbab IA, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/856029; Awang N, 2011, Pak J Biol Sci, V14, P768; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; CARUSO F, 1994, J ORGANOMET CHEM, V466, P69, DOI 10.1016/0022-328X(94)88030-1; Chan CK, 2012, MOLECULES, V17, P6633, DOI 10.3390/molecules17066633; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Chen SP, 2009, MUTAT RES-FUND MOL M, V666, P68, DOI 10.1016/j.mrfmmm.2009.04.006; Chute JP, 2006, P NATL ACAD SCI USA, V103, P11707, DOI 10.1073/pnas.0603806103; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Cragg GM, 2005, J ETHNOPHARMACOL, V100, P72, DOI 10.1016/j.jep.2005.05.011; Croker AK, 2009, J CELL MOL MED, V13, P2236, DOI 10.1111/j.1582-4934.2008.00455.x; Csuk R, 2012, EUR J MED CHEM, V56, P237, DOI 10.1016/j.ejmech.2012.08.032; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Fani S, 2015, DRUG DES DEV THER, V9, P6191, DOI 10.2147/DDDT.S87064; Fantozzi A, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1530; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fulda S, 2010, INT J BIOCHEM CELL B, V42, P31, DOI 10.1016/j.biocel.2009.06.010; Gielen M, 2000, J INORG BIOCHEM, V79, P139, DOI 10.1016/S0162-0134(99)00161-0; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gomez E, 2006, CHEM PHARM BULL, V54, P54, DOI 10.1248/cpb.54.54; Gu Q, 2005, CARCINOGENESIS, V26, P541, DOI 10.1093/carcin/bgh345; Gupta SC, 2010, CANCER METAST REV, V29, P405, DOI 10.1007/s10555-010-9235-2; Hadjikakou SK, 2009, COORDIN CHEM REV, V253, P235, DOI 10.1016/j.ccr.2007.12.026; Hajrezaie M, 2014, SCI WORLD J, DOI 10.1155/2014/540463; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; He YC, 2014, INT J MOL SCI, V15, P8335, DOI 10.3390/ijms15058335; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hunter AM, 2007, APOPTOSIS, V12, P1543, DOI 10.1007/s10495-007-0087-3; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; Joo JH, 2010, CANCER LETT, V287, P123, DOI 10.1016/j.canlet.2009.05.015; Kakarala M, 2008, J CLIN ONCOL, V26, P2813, DOI 10.1200/JCO.2008.16.3931; Kanagesan S, 2013, ADV MATER SCI ENG, V2013, DOI 10.1155/2013/710432; Karimian H, 2015, CELL PHYSIOL BIOCHEM, V36, P988, DOI 10.1159/000430273; Karimian H, 2014, DRUG DES DEV THER, V8, P1481, DOI 10.2147/DDDT.S68818; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Kim BM, 2007, BIOCHEM BIOPH RES CO, V363, P745, DOI 10.1016/j.bbrc.2007.09.024; Kizlink J, 2001, CHEM PAP, V55, P53; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Korkaya H, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000121; Lee SM, 2013, INORG CHIM ACTA, V406, P272, DOI 10.1016/j.ica.2013.04.036; Liu ZB, 2009, J CELL BIOCHEM, V108, P195, DOI 10.1002/jcb.22241; Luo W, 2007, EMBO J, V26, P1511, DOI 10.1038/sj.emboj.7601607; Ma S, 2008, ONCOGENE, V27, P1749, DOI 10.1038/sj.onc.1210811; Mohan S, 2010, J ETHNOPHARMACOL, V131, P592, DOI 10.1016/j.jep.2010.07.043; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Monica C, 1998, ANTI-CANCER DRUG, V9, P603; Morrison BJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2111; Ngai P, 2008, HEPATOLOGY, V47, P919, DOI [10.1002/hep.22082, DOI 10.1002/HEP.22082]; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ocker M, 2012, EUR SURG RES, V48, P111, DOI 10.1159/000336875; Pahlke G, 2006, J AGR FOOD CHEM, V54, P7075, DOI 10.1021/jf0612530; Pham PV, 2012, ISOLATION BREAST CAN, DOI DOI 10.5772/3071; Pham TD, 2003, AM J PHYSIOL-REG I, V285, pR962, DOI 10.1152/ajpregu.00201.2003; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Rehman W, 2008, EUR J MED CHEM, V43, P2380, DOI 10.1016/j.ejmech.2008.01.019; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Sachlos E, 2012, CELL, V149, P1284, DOI 10.1016/j.cell.2012.03.049; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Schwartz GK, 2005, J CLIN ONCOL, V23, P9408, DOI 10.1200/JCO.2005.01.5594; Shim HY, 2007, MOL CELLS, V24, P95; Shpakovsky DB, 2012, DALTON T, V41, P14568, DOI 10.1039/c2dt31527k; Siddiqi ZA, 2009, J ORGANOMET CHEM, V694, P3768, DOI 10.1016/j.jorganchem.2009.07.030; Siegel R, 2012, CA-CANCER J CLIN, V62, P220, DOI 10.3322/caac.21149; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Takahashi-Yanaga F, 2010, CLIN CANCER RES, V16, P3153, DOI 10.1158/1078-0432.CCR-09-2943; Thoonen SHL, 2004, J ORGANOMET CHEM, V689, P2145, DOI 10.1016/j.jorganchem.2004.03.027; Vakkala M, 1999, CLIN CANCER RES, V5, P319; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Weinl C, 2005, PLANT CELL, V17, P1704, DOI 10.1105/tpc.104.030486; Wu XZ, 2006, MED HYPOTHESES, V66, P883, DOI 10.1016/j.mehy.2005.11.036; Xanthopoulou MN, 2003, J INORG BIOCHEM, V96, P425, DOI 10.1016/S0162-0134(03)00178-8; Xiang JL, 1996, P NATL ACAD SCI USA, V93, P14559, DOI 10.1073/pnas.93.25.14559; Yun HR, 2009, J ACUPUNCT MERIDIAN, V2, P210, DOI 10.1016/S2005-2901(09)60057-1; Zhang H, 2013, P NATL ACAD SCI USA, V110, P5606, DOI 10.1073/pnas.1302352110; Zhou JB, 2008, BREAST CANCER RES TR, V111, P419, DOI 10.1007/s10549-007-9798-y	86	15	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160836	10.1371/journal.pone.0160836	http://dx.doi.org/10.1371/journal.pone.0160836			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529753	Green Published, gold, Green Submitted			2022-12-26	WOS:000381476700027
J	Ivleva, NB; Groat, J; Staub, JM; Stephens, M				Ivleva, Natalia B.; Groat, Jeanna; Staub, Jeffrey M.; Stephens, Michael			Expression of Active Subunit of Nitrogenase via Integration into Plant Organelle Genome	PLOS ONE			English	Article							PSBA MESSENGER-RNA; NIF-GENE-TRANSFER; AZOTOBACTER-VINELANDII; KLEBSIELLA-PNEUMONIAE; TOBACCO PLASTIDS; FIXATION; CEREALS; PROTEIN; CHLOROPLASTS; TRANSFORMATION	Nitrogen availability is crucial for crop yield with nitrogen fertilizer accounting for a large percentage of farmers' expenses. However, an untimely or excessive application of fertilizer can increase risks of negative environmental effects. These factors, along with the environmental and energy costs of synthesizing nitrogen fertilizer, led us to seek out novel biotechnology-driven approaches to supply nitrogen to plants. The strategy we focused on involves transgenic expression of nitrogenase, a bacterial multi-subunit enzyme that can capture atmospheric nitrogen. Here we report expression of the active Fe subunit of nitrogenase via integration into the tobacco plastid genome of bacterial gene sequences modified for expression in plastid. Our study suggests that it will be possible to engineer plants that are able to produce their own nitrogen fertilizer by expressing nitrogenase genes in plant plastids.	[Ivleva, Natalia B.; Groat, Jeanna; Staub, Jeffrey M.; Stephens, Michael] Monsanto Co, 700 Chesterfield Village Pkwy, Chesterfield, MO USA	Monsanto	Ivleva, NB (corresponding author), Monsanto Co, 700 Chesterfield Village Pkwy, Chesterfield, MO USA.	natalia.ivleva@monsanto.com			Monsanto Company	Monsanto Company	Monsanto Company provided support in the form of salaries for authors N.B.I., J.G., J.M.S., M.S., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aronsson H, 2002, FEBS LETT, V529, P215, DOI 10.1016/S0014-5793(02)03342-2; Beatty PH, 2011, SCIENCE, V333, P416, DOI 10.1126/science.1209467; Bock R, 2015, ANNU REV PLANT BIOL, V66, P211, DOI 10.1146/annurev-arplant-050213-040212; Bock R, 2013, PLANT MOL BIOL, V83, P21, DOI 10.1007/s11103-013-0045-0; Cazetta JO, 1999, ANN BOT-LONDON, V84, P747, DOI 10.1006/anbo.1999.0976; Charles Dan, 2013, National Geographic, V223, P96; Cheng Q, 2005, BIOCHEM BIOPH RES CO, V329, P966, DOI 10.1016/j.bbrc.2005.02.064; Curatti L, 2014, PLANT SCI, V225, P130, DOI 10.1016/j.plantsci.2014.06.003; Dixon R, 1997, PLANT SOIL, V194, P193, DOI 10.1023/A:1004296703638; DIXON RA, 1972, NATURE, V237, P102, DOI 10.1038/237102a0; Dos Santos PC, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-162; DU D, 1990, Chinese Journal of Oceanology and Limnology, V8, P378; Geddes BA, 2015, CURR OPIN BIOTECH, V32, P216, DOI 10.1016/j.copbio.2015.01.004; Hamilton TL, 2011, J BACTERIOL, V193, P4534, DOI 10.1128/JB.05100-11; Hamilton TL, 2011, J BACTERIOL, V193, P4477, DOI 10.1128/JB.05099-11; HARDY RWF, 1975, SCIENCE, V188, P633, DOI 10.1126/science.188.4188.633; HYMAN MR, 1987, APPL ENVIRON MICROB, V53, P298, DOI 10.1128/AEM.53.2.298-303.1987; Lu YH, 2013, P NATL ACAD SCI USA, V110, pE623, DOI 10.1073/pnas.1216898110; Ludden PW, ANNUAL REVIEW OF MIC, P93; Maliga P, 2011, PLANT PHYSIOL, V155, P1501, DOI 10.1104/pp.110.170969; Maliga P, 2011, METHODS MOL BIOL, V701, P37, DOI 10.1007/978-1-61737-957-4_2; Millar AH, 2007, METHOD CELL BIOL, V80, P65, DOI 10.1016/S0091-679X(06)80003-8; Mueller ND, 2012, NATURE, V490, P254, DOI 10.1038/nature11420; Oldroyd GED, 2014, CURR OPIN BIOTECH, V26, P19, DOI 10.1016/j.copbio.2013.08.006; POSTGATE J, 1992, PHILOS T ROY SOC B, V338, P409, DOI 10.1098/rstb.1992.0158; Poza-Carrion C, 2014, J BACTERIOL, V196, P595, DOI 10.1128/JB.00942-13; Preuss SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030717; Raymond J, 2004, MOL BIOL EVOL, V21, P541, DOI 10.1093/molbev/msh047; Ritchie JT., 1998, CEREAL GROWTH DEV YI, P79; Rogers C, 2014, J EXP BOT, V65, P1939, DOI 10.1093/jxb/eru098; Rubio LM, 2005, J BACTERIOL, V187, P405, DOI 10.1128/JB.187.2.405-414.2005; SHAH VK, 1973, BIOCHIM BIOPHYS ACTA, V305, P445, DOI 10.1016/0005-2728(73)90190-4; Sidorov VA, 1999, PLANT J, V19, P209, DOI 10.1046/j.1365-313X.1999.00508.x; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STAUB JM, 1994, PLANT J, V6, P547, DOI 10.1046/j.1365-313X.1994.6040547.x; Staub JM, 2000, NAT BIOTECHNOL, V18, P333, DOI 10.1038/73796; STAUB JM, 1993, EMBO J, V12, P601, DOI 10.1002/j.1460-2075.1993.tb05692.x; Sutton MA, 2011, NATURE, V472, P159, DOI 10.1038/472159a; SVAB Z, 1993, P NATL ACAD SCI USA, V90, P913, DOI 10.1073/pnas.90.3.913; Temme K, 2012, P NATL ACAD SCI USA, V109, P7085, DOI 10.1073/pnas.1120788109; Uribelarrea M, 2004, CROP SCI, V44, P1593, DOI 10.2135/cropsci2004.1593; Wang LY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003865; Wang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068677; Zhang J, 2012, PLANT J, V72, P115, DOI 10.1111/j.1365-313X.2012.05065.x	44	51	54	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160951	10.1371/journal.pone.0160951	http://dx.doi.org/10.1371/journal.pone.0160951			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529475	Green Submitted, Green Published, gold			2022-12-26	WOS:000381476700032
J	Sowa-Staszczak, A; Trofimiuk-Muldner, M; Stefanska, A; Tomaszuk, M; Buziak-Bereza, M; Gilis-Januszewska, A; Jabrocka-Hybel, A; Glowa, B; Malecki, M; Bednarczuk, T; Kaminski, G; Kowalska, A; Mikolajczak, R; Janota, B; Hubalewska-Dydejczyk, A				Sowa-Staszczak, Anna; Trofimiuk-Muldner, Malgorzata; Stefanska, Agnieszka; Tomaszuk, Monika; Buziak-Bereza, Monika; Gilis-Januszewska, Aleksandra; Jabrocka-Hybel, Agata; Glowa, Boguslaw; Malecki, Maciej; Bednarczuk, Tomasz; Kaminski, Grzegorz; Kowalska, Aldona; Mikolajczak, Renata; Janota, Barbara; Hubalewska-Dydejczyk, Alicja			Tc-99m Labeled Glucagon-Like Peptide-1-Analogue (Tc-99m-GLP1) Scintigraphy in the Management of Patients with Occult Insulinoma	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; DEPENDENT DIABETIC-PATIENTS; NEUROENDOCRINE TUMORS; HYPERINSULINEMIC HYPOGLYCEMIA; RECEPTOR; LOCALIZATION; SECRETION; RESPONSES; FORMS; AMIDE	Introduction The aim of this study was to assess the utility of [Lys(40)(Ahx-HYNIC-Tc-99m/EDDA)NH2]-exendin-4 scintigraphy in the management of patients with hypoglycemia, particularly in the detection of occult insulinoma. Materials and Methods Forty patients with hypoglycemia and increased/confusing results of serum insulin and C-peptide concentration and negative/inconclusive results of other imaging examinations were enrolled in the study. In all patients GLP-1 receptor imaging was performed to localise potential pancreatic lesions. Results Positive results of GLP-1 scintigraphy were observed in 28 patients. In 18 patients postsurgical histopathological examination confirmed diagnosis of insulinoma. Two patients had contraindications to the surgery, one patient did not want to be operated. One patient, who presented with postprandial hypoglycemia, with positive result of GLP-1 imaging was not qualified for surgery and is in the observational group. Eight patients were lost for follow up, among them 6 patients with positive GLP-1 scintigraphy result. One patient with negative scintigraphy was diagnosed with malignant insulinoma. In two patients with negative scintigraphy Munchausen syndrome was diagnosed (patients were taking insulin). Other seven patients with negative results of (99m)TcGLP-1 scintigraphy and postprandial hypoglycemia with C-peptide and insulin levels within the limits of normal ranges are in the observational group. We would like to mention that Tc-99m-GLP1-SPECT/CT was also performed in 3 pts with nesidioblastosis (revealing diffuse tracer uptake in two and a focal lesion in one case) and in two patients with malignant insulinoma (with the a focal uptake in the localization of a removed pancreatic headin one case and negative GLP-1 1 scintigraphy in the other patient). Conclusions Tc-99m-GLP1-SPECT/CT could be helpful examination in the management of patients with hypoglycemia enabling proper localization of the pancreatic lesion and effective surgical treatment. This imaging technique may eliminate the need to perform invasive procedures in case of occult insulinoma.	[Sowa-Staszczak, Anna; Trofimiuk-Muldner, Malgorzata; Stefanska, Agnieszka; Tomaszuk, Monika; Buziak-Bereza, Monika; Gilis-Januszewska, Aleksandra; Jabrocka-Hybel, Agata; Hubalewska-Dydejczyk, Alicja] Jagiellonian Univ, Dept Endocrinol, Coll Med, Krakow, Poland; [Glowa, Boguslaw] Univ Hosp, Dept Endocrinol, Krakow, Poland; [Malecki, Maciej] Jagiellonian Univ, Dept Metab Dis, Coll Med, Krakow, Poland; [Bednarczuk, Tomasz] Med Univ Warsaw, Dept Endocrinol, Warsaw, Poland; [Kaminski, Grzegorz] Mil Inst Med, Dept Endocrinol & Radioisotop Therapy, Warsaw, Poland; [Kowalska, Aldona] Holycross Canc Ctr, Dept Endocrinol & Nucl Med, Kielce, Poland; [Mikolajczak, Renata; Janota, Barbara] Natl Ctr Nucl Res, Radioisotope Ctr POLATOM, Otwock, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University; Medical University of Warsaw; Military Institute of Aviation Medicine; National Centre for Nuclear Research	Hubalewska-Dydejczyk, A (corresponding author), Jagiellonian Univ, Dept Endocrinol, Coll Med, Krakow, Poland.	alahub@cm-uj.krakow.pl	KAMINSKI, GRZEGORZ/AAH-9765-2020; Mikolajczak, Renata/S-2978-2019; Kielce, SCO/O-6702-2016; Trofimiuk-Muldner, Malgorzata/AFV-2722-2022; Bednarczuk, Tomasz/AFQ-8418-2022	KAMINSKI, GRZEGORZ/0000-0002-2357-0634; Mikolajczak, Renata/0000-0002-6882-751X; Tulik, Monika/0000-0002-6725-6575; KOWALSKA, ALDONA/0000-0001-5647-5898	Polish Ministry of Science [N402 445039]	Polish Ministry of Science(Ministry of Science and Higher Education, Poland)	This study was supported by the Polish Ministry of Science within Research Project No N402 445039. The costs of the publication of the manuscript are covered by KNOW 2012-2017 Leading National Research Center, Polish Ministry of Science and Higher Education.	Christ E, 2013, LANCET DIABETES ENDO, V1, P115, DOI 10.1016/S2213-8587(13)70049-4; Christ E, 2009, J CLIN ENDOCR METAB, V94, P4398, DOI 10.1210/jc.2009-1082; Christesen HBT, 2008, CLIN ENDOCRINOL, V68, P747, DOI 10.1111/j.1365-2265.2008.03184.x; Cryer PE., 2008, WILLIAMS TXB ENDOCRI, P1503; Cryer PE, 2009, J CLIN ENDOCR METAB, V94, P709, DOI 10.1210/jc.2008-1410; de Herder WW, 2016, BEST PRACT RES CL EN, V30, P3, DOI 10.1016/j.beem.2015.10.004; Eriksson O, 2014, J CLIN ENDOCR METAB, V99, P1519, DOI 10.1210/jc.2013-3541; Haubner R, 2010, RADIOTHER ONCOL, V96, P280, DOI 10.1016/j.radonc.2010.07.022; Kann PH, 2016, FRONT HORM RES, V45, P46, DOI 10.1159/000442277; Kauhanen S, 2007, J CLIN ENDOCR METAB, V92, P1237, DOI 10.1210/jc.2006-1479; Lerche S, 2009, CLIN ENDOCRINOL, V71, P500, DOI 10.1111/j.1365-2265.2008.03510.x; Morera J, 2016, J ENDOCRINOL INVEST, V39, P455, DOI 10.1007/s40618-015-0406-4; Nauck MA, 1997, HORM METAB RES, V29, P411, DOI 10.1055/s-2007-979067; Nauck MA, 2002, J CLIN ENDOCR METAB, V87, P1239, DOI 10.1210/jc.87.3.1239; NAUCK MA, 1993, DIABETOLOGIA, V36, P741, DOI 10.1007/BF00401145; Nauck MA, 1997, AM J PHYSIOL-ENDOC M, V273, pE981, DOI 10.1152/ajpendo.1997.273.5.E981; Noone TC, 2005, BEST PRACT RES CL EN, V19, P195, DOI 10.1016/j.beem.2004.11.013; Pach D, 2012, RADIOTHER ONCOL, V102, P45, DOI 10.1016/j.radonc.2011.08.006; Placzkowski KA, 2009, J CLIN ENDOCR METAB, V94, P1069, DOI DOI 10.1210/JC.2008-2031); Raffel A, 2007, SURGERY, V141, P179, DOI 10.1016/j.surg.2006.04.015; Reubi JC, 2003, EUR J NUCL MED MOL I, V30, P781, DOI 10.1007/s00259-003-1184-3; Reubi JC, 2008, J NUCL MED, V49, P1735, DOI 10.2967/jnumed.108.053041; Sempoux C, 2004, ENDOCR PATHOL, V15, P241, DOI 10.1385/EP:15:3:241; SERVICE FJ, 1991, MAYO CLIN PROC, V66, P711, DOI 10.1016/S0025-6196(12)62083-7; Shantavasinkul PC, 2016, CLIN ENDOCRINOL, V85, P3, DOI 10.1111/cen.13033; Siegel EG, 1999, REGUL PEPTIDES, V79, P93, DOI 10.1016/S0167-0115(98)00155-4; Sowa-Staszczak A, 2013, EUR J NUCL MED MOL I, V40, P524, DOI 10.1007/s00259-012-2299-1; Toumpanakis C, 2014, NEUROENDOCRINOLOGY, V99, P63, DOI 10.1159/000358727; Whipple AO, 1938, J INT CHIR, V3, P237; WIDMANN C, 1995, BIOCHEM J, V310, P203, DOI 10.1042/bj3100203; Wild D, 2008, NEW ENGL J MED, V359, P766, DOI 10.1056/NEJMc0802045; Wild D, 2006, J NUCL MED, V47, P2025; Wild D, 2011, J NUCL MED, V52, P1073, DOI 10.2967/jnumed.110.085142; Wild D, 2010, J NUCL MED, V51, P1059, DOI 10.2967/jnumed.110.074914; Willms B, 1996, J CLIN ENDOCR METAB, V81, P327, DOI 10.1210/jc.81.1.327	35	30	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0160714	10.1371/journal.pone.0160714	http://dx.doi.org/10.1371/journal.pone.0160714			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27526057	Green Published, gold, Green Submitted			2022-12-26	WOS:000381471100019
J	Samakai, E; Hooper, R; Martin, KA; Shmurak, M; Zhang, Y; Kappes, DJ; Tempera, I; Soboloff, J				Samakai, Elsie; Hooper, Robert; Martin, Kayla A.; Shmurak, Maya; Zhang, Yi; Kappes, Dietmar J.; Tempera, Italo; Soboloff, Jonathan			Novel STIM1-dependent control of Ca2+ clearance regulates NFAT activity during T-cell activation	FASEB JOURNAL			English	Article						calcium; EGR1; EGR4; Jurkat; PMCA4; SOCe	STIM1; AUTOPHAGY; ORAI1; ENTRY	Antigen presentation to the T-cell receptor leads to sustained cytosolic Ca2+ elevation, which is critical for T-cell activation. We previously showed that in activated T cells, Ca2+ clearance is inhibited by the endoplasmic reticulum Ca2+ sensor stromal interacting molecule 1 (STIM1) via association with the plasma membrane Ca2+/ATPase 4 (PMCA4) Ca2+ pump. Having further observed that expression of both proteins is increased in activated T cells, the current study focused on mechanisms regulating both up-regulation of STIM1 and PMCA4 and assessing how this up-regulation contributes to control of Ca2+ clearance. Using a STIM1 promoter luciferase vector, we found that the zinc finger transcription factors early growth response (EGR) 1 and EGR4, but not EGR2 or EGR3, drive luciferase activity. We further found that neither STIM1 nor PMCA4 is up-regulated when both EGR1 and EGR4 are knocked down using RNA interference. Further, under these conditions, activation-induced Ca2+ clearance inhibition was eliminated with little effect on Ca2+ entry. Finally, we found that nuclear factor of activated T-cell (NFAT) activity is profoundly attenuated if Ca2+ clearance is not inhibited by STIM1. These findings reveal a critical role for STIM1-mediated control of Ca2+ clearance in NFAT induction during T-cell activation.Samakai, E., Hooper, R., Martin, K. A., Shmurak, M., Zhang, Y., Kappes, D. J., Tempera, I., Soboloff, J. Novel STIM1-dependent control of Ca2+ clearance regulates NFAT activity during T-cell activation.	[Samakai, Elsie; Hooper, Robert; Martin, Kayla A.; Shmurak, Maya; Zhang, Yi; Tempera, Italo; Soboloff, Jonathan] Temple Univ, Fels Inst Canc Res & Mol Biol, Sch Med, 3307 North Broad St, Philadelphia, PA 19140 USA; [Samakai, Elsie; Hooper, Robert; Shmurak, Maya; Soboloff, Jonathan] Temple Univ, Sch Med, Dept Med Genet & Mol Biochem, Philadelphia, PA 19140 USA; [Kappes, Dietmar J.] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Fox Chase Cancer Center	Soboloff, J (corresponding author), Temple Univ, Fels Inst Canc Res & Mol Biol, Sch Med, 3307 North Broad St, Philadelphia, PA 19140 USA.	soboloff@temple.edu	Soboloff, Jonathan/I-6995-2012; Tempera, Italo/N-2495-2019	Soboloff, Jonathan/0000-0001-5192-1297; Tempera, Italo/0000-0001-7893-2914	National Institutes of Health, National Institute of General Medical Sciences [R01GM097335, R01GM117907, F31GM103731]; NATIONAL CANCER INSTITUTE [R01CA172106, P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097335, R01GM117907] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank J. Kedra (Temple University) for technical support with this project, M. Ritchie (Champions Oncology, New York, NY, USA) for his efforts developing the STIM1 luciferase construct, J. Pomerantz (Johns Hopkins University) for the NFAT luciferase vector and J. Huang (Temple University) for his assistance with CRISPR/Cas9. This work was supported by National Institutes of Health, National Institute of General Medical Sciences grants R01GM097335 and R01GM117907 (to J.S.), and F31GM103731 (to E.S.).	Bronietzki AW, 2015, IMMUNOL CELL BIOL, V93, P25, DOI 10.1038/icb.2014.81; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Gwack Y, 2008, MOL CELL BIOL, V28, P5209, DOI 10.1128/MCB.00360-08; Lin J, 2001, J CELL SCI, V114, P243; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Oh-hora M, 2013, IMMUNITY, V38, P881, DOI 10.1016/j.immuni.2013.02.008; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Puleston DJ, 2014, IMMUNOLOGY, V141, P1, DOI 10.1111/imm.12165; Quintana A, 2011, EMBO J, V30, P3895, DOI 10.1038/emboj.2011.289; Ritchie MF, 2012, EMBO J, V31, P1123, DOI 10.1038/emboj.2011.495; Ritchie MF, 2010, J BIOL CHEM, V285, P10591, DOI 10.1074/jbc.M109.083493; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Soboloff J, 2006, CURR BIOL, V16, P1465, DOI 10.1016/j.cub.2006.05.051; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Soboloff J, 2012, NAT REV MOL CELL BIO, V13, P549, DOI 10.1038/nrm3414; Tempera I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002180; Tempera I, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001048; Tourtellotte WG, 2000, MOL CELL BIOL, V20, P5261, DOI 10.1128/MCB.20.14.5261-5268.2000; Valdor R, 2014, NAT IMMUNOL, V15, P1046, DOI 10.1038/ni.3003	20	7	8	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2016	30	11					3878	3886		10.1096/fj.201600532R	http://dx.doi.org/10.1096/fj.201600532R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EA3BY	27528628	Green Published			2022-12-26	WOS:000386474700022
J	Kawashima, N; Nishimiya, Y; Takahata, S; Nakayama, K				Kawashima, Nagako; Nishimiya, Yoshiyuki; Takahata, Shouta; Nakayama, Ken-ichi			Induction of Glycosphingolipid GM3 Expression by Valproic Acid Suppresses Cancer Cell Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell proliferation; epidermal growth factor receptor (EGFR); ganglioside; glycolipid; histone deacetylase inhibitor (HDAC inhibitor) (HDI); GM3; glycosphingolipid; valproic acid	GANGLIOSIDE-MEDIATED MODULATION; TYROSINE KINASE-ACTIVITY; FACTOR RECEPTOR; HISTONE DEACETYLASE; INSULIN-RECEPTOR; PHOSPHORYLATION; SYNTHASE; GENE; DIFFERENTIATION; GLYCOLIPIDS	Glycosphingolipid GM3, a known suppressor of epidermal growth factor receptor (EGFR) phosphorylation, inhibits cell proliferation. Valproic acid, conversely, is known as an up-regulator of GM3 synthase gene (ST3GAL5). To test the possibility that valproic acid could inhibit EGFR phosphorylation by increasing the level of GM3 in cells, we treated A431 epidermoid carcinoma cells with valproic acid and found that valproic acid treatment caused an about 6-fold increase in the GM3 level but only a marginal increase in the GM2 level in these cells and that the observed increase in GM3 level was valproic acid dose-dependent. Consistent with this observation, valproic acid treatment induced GM3 synthase gene expression by about 8-fold. Furthermore, phosphorylation of EGFR was reduced, and cell proliferation was inhibited following valproic acid treatment. Consistent with these results, transient expression of GM3 synthase gene in A431 cells also increased cellular level of GM3, reduced phosphorylation of EGFR, and inhibited cell proliferation. Treatment with l-phenyl-2-decanoylamino-3-morpholino-l-propanol, an inhibitor of glucosylceramide synthesis, decreased the cellular level of GM3 and reduced the inhibitory effects of valproic acid on EGFR phosphorylation and cell proliferation. These results suggested that induction of GM3 synthesis was enough to inhibit proliferation of cancer cells by suppressing EGFR activity. Valproic acid treatment similarly increased the GM3 level and reduced phosphorylation of EGFR in U87MG glioma cells and inhibited their proliferation. These results suggested that up-regulators of GM3 synthase gene, such as valproic acid, are potential suppressors of cancer cell proliferation.	[Kawashima, Nagako; Nishimiya, Yoshiyuki; Takahata, Shouta; Nakayama, Ken-ichi] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Sapporo, Hokkaido 0628517, Japan; [Kawashima, Nagako] Pacific Northwest Res Inst, Div Biomembrane Res Inst, Seattle, WA 98122 USA; [Nakayama, Ken-ichi] Natl Inst Adv Ind Sci & Technol, Res Inst Sustainable Chem, Hiroshima 7390046, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST)	Nakayama, K (corresponding author), Natl Inst Adv Ind Sci & Technol, Res Inst Sustainable Chem, Hiroshima 7390046, Japan.	k-nakayama@aist.go.jp	Nishimiya, Yoshiyuki/M-4173-2018	Nishimiya, Yoshiyuki/0000-0002-0701-7775				Alvarez-Breckenridge CA, 2012, J VIROL, V86, P4566, DOI 10.1128/JVI.05545-11; BREMER EG, 1984, J BIOL CHEM, V259, P6818; BREMER EG, 1986, J BIOL CHEM, V261, P2434; Fu J, 2010, NEURO-ONCOLOGY, V12, P328, DOI 10.1093/neuonc/nop005; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; HAKOMORI SI, 1977, VIROLOGY, V76, P485, DOI 10.1016/0042-6822(77)90231-8; HAKOMORI SI, 1971, VIROLOGY, V44, P609, DOI 10.1016/0042-6822(71)90375-8; Huang HJS, 1997, J BIOL CHEM, V272, P2927, DOI 10.1074/jbc.272.5.2927; INOKUCHI JI, 1987, J LIPID RES, V28, P565; Ishii A, 1998, J BIOL CHEM, V273, P31652, DOI 10.1074/jbc.273.48.31652; Kabayama K, 2007, P NATL ACAD SCI USA, V104, P13678, DOI 10.1073/pnas.0703650104; Kawashima N, 2009, J BIOL CHEM, V284, P6147, DOI 10.1074/jbc.M808171200; Makino A, 2006, BIOCHEMISTRY-US, V45, P4530, DOI 10.1021/bi052104y; Masoudi A, 2008, ANTICANCER RES, V28, P2437; Miura Y, 2004, P NATL ACAD SCI USA, V101, P16204, DOI 10.1073/pnas.0407297101; Noguchi M, 2007, CANCER SCI, V98, P1625, DOI 10.1111/j.1349-7006.2007.00578.x; NOJIRI H, 1991, J BIOL CHEM, V266, P4531; Okuda T, 2010, GLYCOCONJUGATE J, V27, P287, DOI 10.1007/s10719-009-9277-2; Osuka S, 2012, NEUROL MED-CHIR, V52, P186, DOI 10.2176/nmc.52.186; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Rogawski MA, 2004, NAT REV NEUROSCI, V5, P553, DOI 10.1038/nrn1430; Song N, 2011, BMB REP, V44, P405, DOI 10.5483/BMBRep.2011.44.6.405; Suzuki Y, 2011, J NEUROCHEM, V116, P874, DOI 10.1111/j.1471-4159.2010.07042.x; Tsai YT, 2014, J NEUROCHEM, V128, P101, DOI 10.1111/jnc.12456; Yoon SJ, 2006, P NATL ACAD SCI USA, V103, P18987, DOI 10.1073/pnas.0609281103; ZHOU QG, 1994, J BIOL CHEM, V269, P1959	26	16	16	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21424	21433		10.1074/jbc.M116.751503	http://dx.doi.org/10.1074/jbc.M116.751503			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27539856	Green Published, hybrid			2022-12-26	WOS:000385999200011
J	Lu, H; Fagnant, PM; Krementsova, EB; Trybus, KM				Lu, Hailong; Fagnant, Patricia M.; Krementsova, Elena B.; Trybus, Kathleen M.			Severe Molecular Defects Exhibited by the R179H Mutation in Human Vascular Smooth Muscle -Actin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; cofilin; contractile protein; formin; myosin; profilin; vascular smooth muscle cells	THORACIC AORTIC-ANEURYSMS; F-ACTIN; ACTA2 MUTATIONS; DYNAMICS; CELL; POLYMERIZATION; TROPOMYOSIN; DISEASE; DEPOLYMERIZATION; DISSECTIONS	Mutations in vascular smooth muscle -actin (SM -actin), encoded by ACTA2, are the most common cause of familial thoracic aortic aneurysms that lead to dissection (TAAD). The R179H mutation has a poor patient prognosis and is unique in causing multisystemic smooth muscle dysfunction (Milewicz, D. M., Ostergaard, J. R., Ala-Kokko, L. M., Khan, N., Grange, D. K., Mendoza-Londono, R., Bradley, T. J., Olney, A. H., Ades, L., Maher, J. F., Guo, D., Buja, L. M., Kim, D., Hyland, J. C., and Regalado, E. S. (2010) Am. J. Med. Genet. A 152A, 2437-2443). Here, we characterize this mutation in expressed human SM -actin. R179H actin shows severe polymerization defects, with a 40-fold higher critical concentration for assembly than WT SM -actin, driven by a high disassembly rate. The mutant filaments are more readily severed by cofilin. Both defects are attenuated by copolymerization with WT. The R179H monomer binds more tightly to profilin, and formin binding suppresses nucleation and slows polymerization rates. Linear filaments will thus not be readily formed, and cells expressing R179H actin will likely have increased levels of monomeric G-actin. The cotranscription factor myocardin-related transcription factor-A, which affects cellular phenotype, binds R179H actin with less cooperativity than WT actin. Smooth muscle myosin moves R179H filaments more slowly than WT, even when copolymerized with equimolar amounts of WT. The marked decrease in the ability to form filaments may contribute to the poor patient prognosis and explain why R179H disrupts even visceral smooth muscle cell function where the SM -actin isoform is present in low amounts. The R179H mutation has the potential to affect actin structure and function in both the contractile domain of the cell and the more dynamic cytoskeletal pool of actin, both of which are required for contraction.	[Trybus, Kathleen M.] Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05446 USA; Univ Vermont, Burlington, VT 05446 USA	University of Vermont; University of Vermont	Trybus, KM (corresponding author), Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05446 USA.	kathleen.trybus@uvm.edu	lu, hailong/C-7754-2009		National Institutes of Health [P01 HL110869]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL110869] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant P01 HL110869. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aktories K, 2012, TOXICON, V60, P572, DOI 10.1016/j.toxicon.2012.04.338; Bartman T, 2004, PLOS BIOL, V2, P673, DOI 10.1371/journal.pbio.0020129; Barua B, 2013, J BIOL CHEM, V288, P9602, DOI 10.1074/jbc.M113.451161; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; De la Cruz EM, 2015, BIOPHYS J, V108, P2270, DOI 10.1016/j.bpj.2015.03.058; Fujii T, 2010, NATURE, V467, P724, DOI 10.1038/nature09372; Galkin VE, 2015, STRUCTURE, V23, P173, DOI 10.1016/j.str.2014.11.006; Gallant C, 2011, AM J PHYSIOL-CELL PH, V300, pC1356, DOI 10.1152/ajpcell.00450.2010; Georgescu MM, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0262-7; Gunst SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC576, DOI 10.1152/ajpcell.00253.2008; Guo DC, 2007, NAT GENET, V39, P1488, DOI 10.1038/ng.2007.6; Guo DC, 2009, AM J HUM GENET, V84, P617, DOI 10.1016/j.ajhg.2009.04.007; Lu H, 2015, P NATL ACAD SCI USA, V112, pE4168, DOI 10.1073/pnas.1507587112; Milewicz DM, 2008, ANNU REV GENOM HUM G, V9, P283, DOI 10.1146/annurev.genom.8.080706.092303; Milewicz DM, 2010, AM J MED GENET A, V152A, P2437, DOI 10.1002/ajmg.a.33657; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Morisaki H, 2009, HUM MUTAT, V30, P1406, DOI 10.1002/humu.21081; Moseley JB, 2004, MOL BIOL CELL, V15, P896, DOI 10.1091/mbc.E03-08-0621; Mouilleron S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001750; Munot P, 2012, BRAIN, V135, P2506, DOI 10.1093/brain/aws172; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; POLLARD TD, 1984, J CELL BIOL, V99, P769, DOI 10.1083/jcb.99.3.769; Regalado ES, 2015, CIRC-CARDIOVASC GENE, V8, P457, DOI 10.1161/CIRCGENETICS.114.000943; STRAUCH AR, 1984, J BIOL CHEM, V259, P7224; Tang DD, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0296-1; Torres RA, 2011, ARTERIOSCL THROM VAS, V31, P2424, DOI 10.1161/ATVBAHA.111.232769; von der Ecken J, 2015, NATURE, V519, P114, DOI 10.1038/nature14033; Wangler MF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004258; Wen KK, 2003, J BIOL CHEM, V278, P48386, DOI 10.1074/jbc.M308980200; Wriggers W, 1999, PROTEINS, V35, P262, DOI 10.1002/(SICI)1097-0134(19990501)35:2<262::AID-PROT11>3.0.CO;2-N; Yamin R, 2012, J PHYSIOL-LONDON, V590, P4145, DOI 10.1113/jphysiol.2012.232306; Zhao R, 2008, J BIOL CHEM, V283, P36522, DOI 10.1074/jbc.M805294200; Zigmond SH, 2004, CURR OPIN CELL BIOL, V16, P99, DOI 10.1016/j.ceb.2003.10.019; Zimmerman RA, 2004, J UROLOGY, V172, P1667, DOI 10.1097/01.ju.0000139874.48574.1b	36	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21729	21739		10.1074/jbc.M116.744011	http://dx.doi.org/10.1074/jbc.M116.744011			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27551047	hybrid, Green Published			2022-12-26	WOS:000385999200037
J	Mezza, T; Shirakawa, J; Martinez, R; Hu, J; Giaccari, A; Kulkarni, RN				Mezza, Teresa; Shirakawa, Jun; Martinez, Rachael; Hu, Jiang; Giaccari, Andrea; Kulkarni, Rohit N.			Nuclear Export of FoxO1 Is Associated with ERK Signaling in -Cells Lacking Insulin Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						beta cell (-cell); FOXO; insulin; insulin receptor; signal transduction	PANCREATIC BETA-CELLS; GENE-EXPRESSION; PROTEIN-KINASE; GLUCOSE-HOMEOSTASIS; ADIPOSE-TISSUE; IN-VIVO; SECRETION; MICE; ACTIVATION; GROWTH	The insulin/insulin-like growth factor (IGF) signaling pathway plays a critical role in the regulation of islet cell biology. However, the signaling pathway(s) utilized by insulin to directly modulate -cells is unclear. To interrogate whether insulin exerts endocrine effects in regulating proteins in the insulin/IGF-1 signaling cascade in vivo in physiological states via the insulin receptor, we designed two experimental approaches: 1) glucose gavage and 2) hyperinsulinemic intravenous infusion, for studies in either -cell specific insulin receptor knock-out (IRKO) or control mice. Immunostaining of sections of pancreas (collected immediately after glucose gavage or insulin infusion) from controls showed significant increases in pAKT+, p-p70S6K+, and pERK+ -cells and a significant decrease in % nuclear FoxO1+ -cells compared with corresponding vehicle-treated groups. In contrast, in IRKOs, we observed no significant changes in pAKT+ or p-p70S6K+ -cells in either experiment; however, pERK+ -cells were significantly increased, and an attenuated decrease in % nuclear FoxO1+ cells was evident in response to glucose gavage or insulin infusion. Treatment of control and IRKO -cell lines with glucose or insulin showed significantly decreased % nuclear FoxO1+ -cells suggesting direct effects. Furthermore, blocking MAPK signaling had virtually no effect on FoxO1 nuclear export in controls, in contrast to attenuated export in IRKO -cells. These data suggest insulin acts on -cells in an endocrine manner in the normal situation; and that in -cells lacking insulin receptors, insulin and glucose minimally activate the Akt pathway, while ERK phosphorylation and FoxO1 nuclear export occur independently of insulin signaling.	[Mezza, Teresa; Shirakawa, Jun; Martinez, Rachael; Hu, Jiang; Kulkarni, Rohit N.] Harvard Med Sch, Harvard Stem Cell Inst, Brigham & Womens Hosp, Islet Cell & Regenerat Biol,Joslin Diabet Ctr,Dep, Boston, MA 02215 USA; [Mezza, Teresa; Giaccari, Andrea] Univ Cattolica Sacro Cuore, Ctr Endocrine & Metab Dis, Policlin Gemelli, I-00168 Rome, Italy	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Joslin Diabetes Center, Inc.; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Kulkarni, RN (corresponding author), Joslin Diabet Ctr, Islet Cell & Regenerat Biol, 1 Joslin Pl, Boston, MA 02215 USA.	Rohit.Kulkarni@joslin.harvard.edu	Giaccari, Andrea/AAA-7824-2022	Giaccari, Andrea/0000-0002-7462-7792; Shirakawa, Jun/0000-0002-0822-8750	National Institutes of Health, Diabete Ricerca [R01 DK67536, R01 DK103215]; European Society for Clinical Nutrition and Metabolism; European Foundation for the study of Diabetes and Universita Cattolica del Sacro Cuore, Linea [D3.2 2015]; Japan Society for the Promotion of Science (JSPS); European Foundation for the Study of Diabetes [AZ CP 2014_2] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067536, P30DK036836, R01DK103215] Funding Source: NIH RePORTER	National Institutes of Health, Diabete Ricerca(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Society for Clinical Nutrition and Metabolism; European Foundation for the study of Diabetes and Universita Cattolica del Sacro Cuore, Linea; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); European Foundation for the Study of Diabetes; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Grants R01 DK67536 (to R. N. K.) and R01 DK103215 (to R. N. K.) from the National Institutes of Health, Diabete Ricerca (to A. G. and T. M.), European Society for Clinical Nutrition and Metabolism (to T. M.), European Foundation for the study of Diabetes and Universita Cattolica del Sacro Cuore, Linea D3.2 2015 (to A. G.), and the Japan Society for the Promotion of Science (JSPS) (to J. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Accili D, 2004, DIABETES, V53, P1633, DOI 10.2337/diabetes.53.7.1633; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Assmann A, 2009, PEDIATR DIABETES, V10, P14, DOI 10.1111/j.1399-5448.2008.00468.x; Assmann A, 2009, MOL CELL BIOL, V29, P3219, DOI 10.1128/MCB.01489-08; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Dickson LM, 2001, J BIOL CHEM, V276, P21110, DOI 10.1074/jbc.M101257200; Fabrizi M, 2014, DIABETES, V63, P2086, DOI 10.2337/db13-0939; Goldfine AB, 2012, DIABETES OBES METAB, V14, P152, DOI 10.1111/j.1463-1326.2012.01647.x; Goren HJ, 2004, ENDOCRINOLOGY, V145, P3307, DOI 10.1210/en.2003-1400; Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027; Halperin F, 2012, DIABETES, V61, P301, DOI 10.2337/db11-1067; Khoo S, 1997, P NATL ACAD SCI USA, V94, P5599, DOI 10.1073/pnas.94.11.5599; Kim JK, 2009, METHODS MOL BIOL, V560, P221, DOI 10.1007/978-1-59745-448-3_15; Kim JK, 2000, J CLIN INVEST, V105, P1791, DOI 10.1172/JCI8305; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Kulkarni RN, 1999, J CLIN INVEST, V104, pR69, DOI 10.1172/JCI8339; Leibiger IB, 1998, MOL CELL, V1, P933, DOI 10.1016/S1097-2765(00)80093-3; LeRoith D, 2006, INT J BIOCHEM CELL B, V38, P904, DOI 10.1016/j.biocel.2005.01.019; Liew CW, 2014, P NATL ACAD SCI USA, V111, pE2319, DOI 10.1073/pnas.1323066111; Lopez X, 2011, J CLIN ENDOCR METAB, V96, P3811, DOI 10.1210/jc.2011-0627; Mari A, 2011, DIABETES, V60, P3141, DOI 10.2337/db11-0827; Martinez SC, 2006, DIABETES, V55, P1581, DOI 10.2337/db05-0678; Mezza T, 2014, DIABETOLOGIA, V57, P1291, DOI 10.1007/s00125-014-3251-7; Muller D, 2006, DIABETES, V55, P2835, DOI 10.2337/db06-0532; Ohsugi M, 2005, J BIOL CHEM, V280, P4992, DOI 10.1074/jbc.M411727200; Perry RJ, 2016, NATURE, V534, P213, DOI 10.1038/nature18309; Stamateris RE, 2016, DIABETES, V65, P981, DOI 10.2337/db15-0529; Wrede CE, 2002, J BIOL CHEM, V277, P49676, DOI 10.1074/jbc.M208756200; Xavier GD, 2004, BIOCHEM J, V377, P149, DOI 10.1042/BJ20031260; Zhang C, 2016, AM J PHYSIOL-ENDOC M, V310, pE874, DOI 10.1152/ajpendo.00318.2015	30	16	16	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21485	21495		10.1074/jbc.M116.735738	http://dx.doi.org/10.1074/jbc.M116.735738			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27535223	Green Published, hybrid			2022-12-26	WOS:000385999200016
J	Li, T; Paudel, HK				Li, Tong; Paudel, Hemant K.			14-3-3 zeta Mediates Tau Aggregation in Human Neuroblastoma M17 Cells	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; DEPENDENT PROTEIN-KINASE; PAIRED HELICAL FILAMENTS; ALZHEIMERS-DISEASE; PHOSPHORYLATION; BETA; HYPERPHOSPHORYLATION; NEURODEGENERATION; MICROTUBULES; MECHANISM	Microtubule-associated protein tau is the major component of paired helical filaments (PHFs) associated with the neuropathology of Alzheimer's disease (AD). Tau in the normal brain binds and stabilizes microtubules. Tau isolated from PHFs is hyperphosphorylated, which prevents it from binding to microtubules. Tau phosphorylation has been suggested to be involved in the development of NFT pathology in the AD brain. Recently, we showed that 14-3-3 zeta is bound to tau in the PHFs and when incubated in vitro with 14-3-3 zeta, tau formed amorphous aggregates, single-stranded straight filaments, double stranded ribbon-like filaments and PHF-like filaments that displayed close resemblance with corresponding ultra-structures of AD brain. Surprisingly however, phosphorylated and non-phosphorylated tau aggregated in a similar manner, indicating that tau phosphorylation does not affect in vitro tau aggregation (Qureshi et al (2013) Biochemistry 52, 6445-6455). In this study, we have examined the role of tau phosphorylation in tau aggregation in cellular level. We have found that in human M17 neuroblastoma cells, tau phosphorylation by GSK3 beta or PKA does not cause tau aggregation, but promotes 14-3-3 zeta-induced tau aggregation by destabilizing microtubules. Microtubule disrupting drugs also promoted 14-3-3 zeta-induced tau aggregation without changing tau phosphorylation in M17 cell. In vitro, when incubated with 14-3-3 zeta and microtubules, nonphosphorylated tau bound to microtubules and did not aggregate. Phosphorylated tau on the other hand did not bind to microtubules and aggregated. Our data indicate that microtubule-bound tau is resistant to 14-3-3 zeta-induced tau aggregation and suggest that tau phosphorylation promotes tau aggregation in the brain by detaching tau from microtubules and thus making it accessible to 14-3-3 zeta.	[Li, Tong; Paudel, Hemant K.] Jewish Gen Hosp, Lady Davis Inst Med Res, Bloomfield Ctr Res Aging, Montreal, PQ, Canada; [Paudel, Hemant K.] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada	Lady Davis Institute; McGill University; McGill University	Paudel, HK (corresponding author), Jewish Gen Hosp, Lady Davis Inst Med Res, Bloomfield Ctr Res Aging, Montreal, PQ, Canada.; Paudel, HK (corresponding author), McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada.	hemant.paudel@mcgill.ca			Canadian Institute for Health Research; Alzheimer's Society of Canada	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Alzheimer's Society of Canada	This work was supported by grants from Canadian Institute for Health Research and Alzheimer's Society of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal-Mawal A, 2003, J BIOL CHEM, V278, P12722, DOI 10.1074/jbc.M211491200; Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Andres D, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-49; Avila J, 2004, PHYSIOL REV, V84, P361, DOI 10.1152/physrev.00024.2003; Bai B, 2013, P NATL ACAD SCI USA, V110, P16562, DOI 10.1073/pnas.1310249110; Berg D, 2003, NAT REV NEUROSCI, V4, P752, DOI 10.1038/nrn1197; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; Brunden KR, 2009, NAT REV DRUG DISCOV, V8, P783, DOI 10.1038/nrd2959; Chun J, 2004, MOL CELLS, V18, P360; CLEVELAND DW, 1977, J MOL BIOL, V116, P227, DOI 10.1016/0022-2836(77)90214-5; COLLINS CA, 1987, J CELL BIOL, V105, P2847, DOI 10.1083/jcb.105.6.2847; CROWTHER RA, 1985, EMBO J, V4, P3661, DOI 10.1002/j.1460-2075.1985.tb04132.x; Diner I, 2014, J BIOL CHEM, V289, P35296, DOI 10.1074/jbc.M114.562959; Friedhoff P, 1998, BIOCHEMISTRY-US, V37, P10223, DOI 10.1021/bi980537d; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Galvan M, 2001, J ALZHEIMERS DIS, V3, P417, DOI 10.3233/JAD-2001-3409; Gartlon J, 2006, TOXICOL IN VITRO, V20, P1569, DOI 10.1016/j.tiv.2006.07.009; Giacobini E, 2013, NAT REV NEUROL, V9, P677, DOI 10.1038/nrneurol.2013.223; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; Han D, 2009, J BIOL CHEM, V284, P13422, DOI 10.1074/jbc.M901095200; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; Hashiguchi M, 2000, J BIOL CHEM, V275, P25247, DOI 10.1074/jbc.M003738200; Hernandez F, 2004, NEUROSCI LETT, V357, P143, DOI 10.1016/j.neulet.2003.12.049; Jerome M, 2014, ARCH BIOCHEM BIOPHYS, V558, P28, DOI 10.1016/j.abb.2014.06.012; Jicha GA, 1999, J NEUROSCI, V19, P7486, DOI 10.1523/JNEUROSCI.19-17-07486.1999; Konno T, 2004, BIOCHEMISTRY-US, V43, P13613, DOI 10.1021/bi048549o; Li T, 2006, BIOCHEMISTRY-US, V45, P3125, DOI 10.1021/bi051634r; Li T, 2007, NEUROSCI LETT, V414, P203, DOI 10.1016/j.neulet.2006.11.073; Lia LJ, 2004, J BIOL CHEM, V279, P37061, DOI 10.1074/jbc.M403672200; Liu SJ, 2004, J BIOL CHEM, V279, P50078, DOI 10.1074/jbc.M406109200; Lu YF, 2011, J BIOL CHEM, V286, P20569, DOI 10.1074/jbc.M111.220962; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; MORISHIMAKAWASHIMA M, 1995, J BIOL CHEM, V270, P823, DOI 10.1074/jbc.270.2.823; Mukrasch MD, 2005, J BIOL CHEM, V280, P24978, DOI 10.1074/jbc.M501565200; Paudel HK, 1999, J BIOL CHEM, V274, P8029, DOI 10.1074/jbc.274.12.8029; Perez M, 1996, J NEUROCHEM, V67, P1183; Qureshi HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084615; Qureshi HY, 2013, BIOCHEMISTRY-US, V52, P6445, DOI 10.1021/bi400442d; Qureshi HY, 2011, J BIOL CHEM, V286, P5055, DOI 10.1074/jbc.M110.178905; Sadik G, 2009, J NEUROCHEM, V108, P33, DOI 10.1111/j.1471-4159.2008.05716.x; Schneider A, 1999, BIOCHEMISTRY-US, V38, P3549, DOI 10.1021/bi981874p; SCOTT CW, 1993, J BIOL CHEM, V268, P1166; Sluchanko NN, 2011, BIOCHEMISTRY-US, V50, P9797, DOI 10.1021/bi201374s; Sluchanko NN, 2011, ARCH BIOCHEM BIOPHYS, V506, P24, DOI 10.1016/j.abb.2010.11.003; Sluchanko NN, 2009, BIOCHEM BIOPH RES CO, V379, P990, DOI 10.1016/j.bbrc.2008.12.164; Sobue K, 2000, J BIOL CHEM, V275, P16673, DOI 10.1074/jbc.M000784200; Song W, 2009, J NEUROCHEM, V110, P719, DOI 10.1111/j.1471-4159.2009.06165.x; Soulie C, 2004, NEUROSCI LETT, V365, P1, DOI 10.1016/j.neulet.2004.03.090; Sun W, 2002, J BIOL CHEM, V277, P11933, DOI 10.1074/jbc.M107182200; Umahara T, 2004, ACTA NEUROPATHOL, V108, P279, DOI 10.1007/s00401-004-0885-4; WISCHIK CM, 1985, J CELL BIOL, V100, P1905, DOI 10.1083/jcb.100.6.1905; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; Yuan ZF, 2004, J BIOL CHEM, V279, P26105, DOI 10.1074/jbc.M308298200	54	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0160635	10.1371/journal.pone.0160635	http://dx.doi.org/10.1371/journal.pone.0160635			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548710	gold, Green Published, Green Submitted			2022-12-26	WOS:000381768400016
J	Igarashi, Y; Ohnishi, K; Irie, K; Murakami, A				Igarashi, Yoko; Ohnishi, Kohta; Irie, Kazuhiro; Murakami, Akira			Possible Contribution of Zerumbone-Induced Proteo-Stress to Its Anti-Inflammatory Functions via the Activation of Heat Shock Factor 1	PLOS ONE			English	Article							TROPICAL GINGER SESQUITERPENE; MOLECULAR CHAPERONES; IN-VITRO; TRANSCRIPTION; HSP70; SUPPRESSES; EXPRESSION; DISEASE; MICE; HSF1	Zerumbone is a sesquiterpene present in Zinger zerumbet. Many studies have demonstrated its marked anti-inflammatory and anti-carcinogenesis activities. Recently, we showed that zerumbone binds to numerous proteins with scant selectivity and induces the expression of heat shock proteins (HSPs) in hepatocytes. To dampen proteo-toxic stress, organisms have a stress-responsive molecular machinery, known as heat shock response. Heat shock factor 1 (HSF1) plays a key role in this protein quality control system by promoting activation of HSPs. In this study, we investigated whether zerumbone-induced HSF1 activation contributes to its anti-inflammatory functions in stimulated macrophages. Our findings showed that zerumbone increased cellular protein aggregates and promoted nuclear translocation of HSF1 for HSP expression. Interestingly, HSF1 down-regulation attenuated the suppressive effects of zerumbone on mRNA and protein expressions of pro-inflammatory genes, including inducible nitric oxide synthase and interlukin-1 beta. These results suggest that proteo-stress induced by zerumbone activates HSF1 for exhibiting its anti-inflammatory functions.	[Igarashi, Yoko; Ohnishi, Kohta; Irie, Kazuhiro; Murakami, Akira] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Kyoto, Japan; [Ohnishi, Kohta] Univ Tokushima, Inst Biomed Sci, Dept Food Sci, Tokushima, Japan; [Murakami, Akira] Univ Hyogo, Sch Human Sci & Environm, Dept Food Sci & Nutr, Kobe, Hyogo, Japan	Kyoto University; Tokushima University; University of Hyogo	Murakami, A (corresponding author), Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Kyoto, Japan.; Murakami, A (corresponding author), Univ Hyogo, Sch Human Sci & Environm, Dept Food Sci & Nutr, Kobe, Hyogo, Japan.	akira@shse.u-hyogo.ac.jp	Irie, Kazuhiro/A-6121-2014	Irie, Kazuhiro/0000-0001-7109-8568	Japan Society for the Promotion of Science [26450156, 22.3355]; Urakami Foundation for Food and Food Culture Promotion	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Urakami Foundation for Food and Food Culture Promotion	This study was partly supported by a Grant-in-Aid for Scientific Research (C) (No. 26450156 to AM) from the Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/index.html), the Urakami Foundation for Food and Food Culture Promotion (https://www.urakamizaidan.or.jp/) (AM), and a Grant-in-Aid for JSPS Fellows (No. 22.3355 to KO) from the Japan Society for the Promotion of Science.; This study was partly supported by a Grant-in-Aid for Scientific Research (C) (No. 26450156 to A.M.), Urakami Foundation for Food and Food Culture Promotion, and a Grant-in-Aid for JSPS Fellows (No. 22.3355 to K.O.) from the Japan Society for the Promotion of Science.	Anckar J, 2011, ANNU REV BIOCHEM, V80, P1089, DOI 10.1146/annurev-biochem-060809-095203; Camacho LH, 2007, INVEST NEW DRUG, V25, P131, DOI 10.1007/s10637-006-9017-4; Chen Y, 2006, CARDIOVASC RES, V69, P66, DOI 10.1016/j.cardiores.2005.07.004; Ciocca DR, 2013, ARCH TOXICOL, V87, P19, DOI 10.1007/s00204-012-0918-z; Cortez L, 2014, PRION, V8, P197, DOI 10.4161/pri.28938; Cuadrado-Tejedor M, 2011, CURR MED CHEM, V18, P5545, DOI 10.2174/092986711798347315; Dinkova-Kostova AT, 2005, P NATL ACAD SCI USA, V102, P4584, DOI 10.1073/pnas.0500815102; Gardian G, 2005, J BIOL CHEM, P280; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Kacimi R, 2015, GLIA, V63, P1200, DOI 10.1002/glia.22811; Kim M, 2009, INT J CANCER, V124, P264, DOI 10.1002/ijc.23923; Lee CT, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00140; McLean PJ, 2004, BIOCHEM BIOPH RES CO, V321, P665, DOI 10.1016/j.bbrc.2004.07.021; Murakami A, 2005, J NUTR, V135, p2987S, DOI 10.1093/jn/135.12.2987S; Murakami A, 2004, BIOFACTORS, V21, P95, DOI 10.1002/biof.552210118; Murakami A, 2004, INT J CANCER, V110, P481, DOI 10.1002/ijc.20175; Murakami A, 2002, CARCINOGENESIS, V23, P795, DOI 10.1093/carcin/23.5.795; Murakami A, 1999, BIOSCI BIOTECH BIOCH, V63, P1811, DOI 10.1271/bbb.63.1811; Muralidharan S, 2014, J IMMUNOL, V193, P1975, DOI 10.4049/jimmunol.1303468; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Myeku N, 2011, METHODS MOL BIOL, V793, P273, DOI 10.1007/978-1-61779-328-8_18; Nakamura Y, 2004, FEBS LETT, V572, P245, DOI 10.1016/j.febslet.2004.07.042; Ohnishi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058641; Ohnishi K, 2013, BIOCHEM BIOPH RES CO, V430, P616, DOI 10.1016/j.bbrc.2012.11.104; Ohnishi K, 2009, BIOSCI BIOTECH BIOCH, V73, P1905, DOI 10.1271/bbb.90265; Rahman HS, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/563930; Rappa F, 2012, ANTICANCER RES, V32, P5139; Salminen A, 2008, IMMUNOL LETT, V117, P9, DOI 10.1016/j.imlet.2007.12.017; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; Sha YB, 2009, MOL CELL BIOL, V29, P116, DOI 10.1128/MCB.00829-08; Shen HY, 2005, J BIOL CHEM, V280, P39962, DOI 10.1074/jbc.M505524200; Shim S, 2011, FOOD CHEM TOXICOL, V49, P2734, DOI 10.1016/j.fct.2011.08.012; Shin JW, 2011, CANCER PREV RES, V4, P860, DOI 10.1158/1940-6207.CAPR-10-0354; Singh IS, 2002, J BIOL CHEM, V277, P4981, DOI 10.1074/jbc.M108154200; Sittler A, 2001, HUM MOL GENET, V10, P1307, DOI 10.1093/hmg/10.12.1307; Takii R, 2010, J IMMUNOL, V184, P1041, DOI 10.4049/jimmunol.0902579; Teiten MH, 2009, CANCER LETT, V279, P145, DOI 10.1016/j.canlet.2009.01.031; Turturici G, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/618127; van Eden W, 2005, NAT REV IMMUNOL, V5, P318, DOI 10.1038/nri1593; Vihervaara A, 2014, J CELL SCI, V127, P261, DOI 10.1242/jcs.132605; Voellmy R, 2007, ADV EXP MED BIOL, V594, P89; Wang XJ, 2013, J MOL CELL CARDIOL, V55, P73, DOI 10.1016/j.yjmcc.2012.09.012; Westerheide SD, 2012, CURR PROTEIN PEPT SC, V13, P86; Xie Y, 2002, J BIOL CHEM, V277, P11802, DOI 10.1074/jbc.M109296200; Yao XY, 2012, INT IMMUNOPHARMACOL, V14, P138, DOI 10.1016/j.intimp.2012.06.017; Zhou WB, 2011, J BIOL CHEM, V286, P14941, DOI 10.1074/jbc.M110.211029; Zou J, 1998, CELL	48	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161282	10.1371/journal.pone.0161282	http://dx.doi.org/10.1371/journal.pone.0161282			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536885	Green Published, gold, Green Submitted			2022-12-26	WOS:000381577000081
J	Koh, J; Hogue, JA; Sosa, JA				Koh, James; Hogue, Joyce A.; Sosa, Julie A.			A Novel Ex Vivo Method for Visualizing Live-Cell Calcium Response Behavior in Intact Human Tumors	PLOS ONE			English	Article							PRIMARY HYPERPARATHYROIDISM; SENSING RECEPTOR; PARATHYROID ADENOMAS; SECONDARY HYPERPARATHYROIDISM; DECREASED EXPRESSION; COLOCALIZATION; PATHOGENESIS; PHYSIOLOGY; MUTATIONS	The functional impact of intratumoral heterogeneity has been difficult to assess in the absence of a means to interrogate dynamic, live-cell biochemical events in the native tissue context of a human tumor. Conventional histological methods can reveal morphology and static biomarker expression patterns but do not provide a means to probe and evaluate tumor functional behavior and live-cell responsiveness to experimentally controlled stimuli. Here, we describe an approach that couples vibratome-mediated viable tissue sectioning with live-cell confocal microscopy imaging to visualize human parathyroid adenoma tumor cell responsiveness to extracellular calcium challenge. Tumor sections prepared as 300 micron-thick tissue slices retain viability throughout a >24 hour observation period and retain the native architecture of the parental tumor. Live-cell observation of biochemical signaling in response to extracellular calcium challenge in the intact tissue slices reveals discrete, heterogeneous kinetic waveform categories of calcium agonist reactivity within each tumor. Plotting the proportion of maximally responsive tumor cells as a function of calcium concentration yields a sigmoid dose-response curve with a calculated calcium EC50 value significantly elevated above published reference values for wild-type calcium-sensing receptor (CASR) sensitivity. Subsequent fixation and immunofluorescence analysis of the functionally evaluated tissue specimens allows alignment and mapping of the physical characteristics of individual cells within the tumor to specific calcium response behaviors. Evaluation of the relative abundance of intracellular PTH in tissue slices challenged with variable calcium concentrations demonstrates that production of the hormone can be dynamically manipulated ex vivo. The capability of visualizing live human tumor tissue behavior in response to experimentally controlled conditions opens a wide range of possibilities for personalized ex vivo therapeutic testing. This highly adaptable system provides a unique platform for live-cell ex vivo provocative testing of human tumor responsiveness to a range of physiological agonists or candidate therapeutic compounds.	[Koh, James; Hogue, Joyce A.; Sosa, Julie A.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Sosa, Julie A.] Duke Univ, Med Ctr, Duke Canc Inst, Durham, NC USA; [Sosa, Julie A.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA	Duke University; Duke University; Duke University	Koh, J (corresponding author), Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA.	james.koh@dm.duke.edu		Hogue, Joyce A/0000-0003-0848-3484	NIH [1R21CA192004-02]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grant 1R21CA192004-02 to JK and JAS.	Arnold A, 2002, J BONE MINER RES, V17, pN30; Avlani VA, 2013, AM J PHYSIOL-ENDOC M, V304, pE1097, DOI 10.1152/ajpendo.00054.2013; Brennan SC, 2015, ENDOCRINOLOGY, V156, P1330, DOI 10.1210/en.2014-1771; Brennan SC, 2013, BBA-MOL CELL RES, V1833, P1732, DOI 10.1016/j.bbamcr.2012.12.011; Brown EM, 2013, BEST PRACT RES CL EN, V27, P333, DOI 10.1016/j.beem.2013.02.006; Brown EM, 2002, J BONE MINER RES, V17, pN24; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; Carneiro DM, 2003, SURGERY, V134, P973, DOI 10.1016/j.surg.2003.06.001; Chen RA, 2004, AM J PHYSIOL-RENAL, V286, pF1005, DOI 10.1152/ajprenal.00013.2004; Costa-Guda J, 2014, MOL CELL ENDOCRINOL, V386, P46, DOI 10.1016/j.mce.2013.09.005; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Cromer MK, 2012, J CLIN ENDOCR METAB, V97, pE1774, DOI 10.1210/jc.2012-1743; DeLellis RA, 2008, ARCH PATHOL LAB MED, V132, P1251, DOI 10.1043/1543-2165(2008)132[1251:PHACP]2.0.CO;2; Dissing-Olesen L, 2015, CURR PROTOC NEUROSCI, V71, p1 23 1, DOI 10.1002/0471142301.ns0123s71; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Farnebo F, 1998, SURGERY, V124, P1094, DOI 10.1067/msy.1998.91828; Farnebo F, 1997, J CLIN ENDOCR METAB, V82, P3481, DOI 10.1210/jc.82.10.3481; Goodman WG, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341017; Kifor O, 1996, J CLIN ENDOCR METAB, V81, P1598, DOI 10.1210/jc.81.4.1598; Koh J, 2016, J CELL MOL MED, V20, P351, DOI 10.1111/jcmm.12732; Koh J, 2011, MOL ENDOCRINOL, V25, P867, DOI 10.1210/me.2010-0277; Nemeth EF, 2004, CELL CALCIUM, V35, P283, DOI 10.1016/j.ceca.2003.10.020; Nesbit MA, 2013, NEW ENGL J MED, V368, P2476, DOI 10.1056/NEJMoa1300253; Nesbit MA, 2013, NAT GENET, V45, P93, DOI 10.1038/ng.2492; Newey PJ, 2012, J CLIN ENDOCR METAB, V97, pE1995, DOI 10.1210/jc.2012-2303; Roman SA, 2011, ANN SURG, V253, P131, DOI 10.1097/SLA.0b013e3181f66720; Shi YH, 2014, P NATL ACAD SCI USA, V111, P3092, DOI 10.1073/pnas.1319742111; Silverberg SJ, 2009, J CLIN ENDOCR METAB, V94, P351, DOI 10.1210/jc.2008-1760; Silverberg SJ, 1997, NEW ENGL J MED, V337, P1506, DOI 10.1056/NEJM199711203372104; Spohn D, 2010, MOL PHARMACOL, V78, P865, DOI 10.1124/mol.110.067637; Verma A, 2011, CELL CALCIUM, V50, P510, DOI 10.1016/j.ceca.2011.08.007; Wettschureck N, 2007, MOL ENDOCRINOL, V21, P274, DOI 10.1210/me.2006-0110	32	3	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161134	10.1371/journal.pone.0161134	http://dx.doi.org/10.1371/journal.pone.0161134			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537691	Green Published, gold, Green Submitted			2022-12-26	WOS:000381577000058
J	Kumar, V; Jha, P				Kumar, Vipan; Jha, Prashant			Differences in Germination, Growth, and Fecundity Characteristics of Dicamba-Fluroxypyr-Resistant and Susceptible Kochia scoparia	PLOS ONE			English	Article							AUXINIC HERBICIDE RESISTANCE; LOLIUM-RIGIDUM POPULATION; WILD MUSTARD; SULFONYLUREA-RESISTANT; MANAGEMENT-PRACTICES; SEEDLING EMERGENCE; ECOLOGICAL FITNESS; DOSE-RESPONSE; GLYPHOSATE; EVOLUTION	The widespread occurrence of herbicide-resistant (HR) Kochia scoparia is an increasing concern for growers in the US Great Plains and Canada. K. scoparia populations resistant to dicamba have been reported in six US states. Populations cross-resistant to dicamba and fluroxypyr have been reported from wheat fields in Montana, USA. It is unclear whether resistance to the auxinic herbicides (dicamba and/or fluroxypyr), can alter the fitness traits of K. scoparia. The objectives of this research were to compare the germination dynamics in response to thermal environment, vegetative growth and fecundity characteristics, and the relative competitive ability of dicamba-fluroxypyr-susceptible (S) vs.-resistant (R) K. scoparia selected from within a single segregating population (collected from wheat-fallow field in MT). S and R selected lines were developed after three generations of recurrent group selection. Compared to the S selected line, the R selected line had lower cumulative germination at all constant temperatures except 25 degrees C, and at all alternating temperatures except 30/35 degrees C. Also, the R selected line had delayed germination relative to the S selected line. The R had lower plant height, plant width, primary branches, total leaf area, stem diameter, and shoot dry weight compared with the S plants in the absence of competition. The reduction in seed production per plant resulted in a 39% fitness cost. The 1000-seed weight of R (1.6 g) was also less than that of S (2.6 g). When grown in an intraspecific competition at different mixture proportions, replacement series indices for the growth parameters further indicated that the R was less competitive than the S. Evident from this research, the dicamba-fluroxypyr-resistant R selected line is less likely to persist in a field population in the absence of the auxinic herbicides.	[Kumar, Vipan; Jha, Prashant] Montana State Univ Bozeman, Dept Res Ctr, Southern Agr Res Ctr, Huntley, MT 59037 USA	Montana State University System; Montana State University Bozeman	Jha, P (corresponding author), Montana State Univ Bozeman, Dept Res Ctr, Southern Agr Res Ctr, Huntley, MT 59037 USA.	pjha@montana.edu	Kumar, Vipan/N-1879-2019	Kumar, Vipan/0000-0002-8301-5878	Montana Agricultural Experiment Station [923658]	Montana Agricultural Experiment Station	The authors acknowledge Montana Agricultural Experiment Station for funding this research, Grant # 923658. The grant was obtained by PJ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded by Montana Agricultural Experiment Station- Award # 923658. We greatly appreciate extension agents and growers from Choteau County, Montana for their valuable assistance in auxinic-herbicide-resistant K. scoparia seed collection. We also thank Dr. Aruna Varanasi, Ms. Anjani, Mr. Charlemagne A. Lim, and Mr. Shane Leland for their technical assistance in conducting this research.	Bagavathiannan MV, 2011, WEED SCI, V59, P353, DOI 10.1614/WS-D-10-00151.1; Baker DV, 2010, INVAS PLANT SCI MANA, V3, P301, DOI 10.1614/IPSM-D-09-00016.1; Bourdot GW, 1996, J APPL ECOL, V33, P151, DOI 10.2307/2405024; Christoffoleti PJ, 1997, WEED SCI, V45, P691; Cranston HJ, 2001, WEED SCI, V49, P164, DOI 10.1614/0043-1745(2001)049[0164:DRIK]2.0.CO;2; Debreuil DJ, 1996, WEED SCI, V44, P871, DOI 10.1017/S0043174500094856; Delye C, 2013, ANN BOT-LONDON, V111, P681, DOI 10.1093/aob/mct018; Eberlein C. V., 1984, Weeds Today, V15, P5; EVERITT JH, 1983, J RANGE MANAGE, V36, P646, DOI 10.2307/3898360; Friesen LF, 2009, CAN J PLANT SCI, V89, P141, DOI 10.4141/CJPS08057; Giacomini D, 2014, WEED SCI, V62, P29, DOI 10.1614/WS-D-13-00066.1; Goh SS, 2016, PEST MANAG SCI, V72, P67, DOI 10.1002/ps.4005; Goss GA, 2003, WEED SCI, V51, P839, DOI 10.1614/P2002-164; HALL JC, 1995, PESTIC BIOCHEM PHYS, V52, P149, DOI 10.1006/pest.1995.1039; Hall LM, 2014, CAN J PLANT SCI, V94, P127, DOI [10.4141/CJPS2013-204, 10.4141/cjps2013-204]; Harper J. L, 1977, POPULATION BIOL PLAN; Heap I, INT SURVEY HERBICIDE; Hoffman ML, 2002, WEED SCI, V50, P466, DOI 10.1614/0043-1745(2002)050[0466:USAAFM]2.0.CO;2; JASIENIUK M, 1994, PHYTOPROTECTION, V75, P25, DOI 10.7202/706069ar; Jha P, 2015, CAN J PLANT SCI, V95, P965, DOI [10.4141/cjps-2015-019, 10.4141/CJPS-2015-019]; Kern AJ, 2005, WEED SCI, V53, P139, DOI 10.1614/WS-04-090R; Knezevic SZ, 2007, WEED TECHNOL, V21, P840, DOI 10.1614/WT-06-161.1; Kumar V, 2015, WEED TECHNOL, V29, P24, DOI 10.1614/WT-D-14-00026.1; Kumar V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142675; Kumar V, 2015, WEED SCI, V63, P758, DOI 10.1614/WS-D-15-00021.1; Kumar V, 2015, CROP PROT, V76, P39, DOI 10.1016/j.cropro.2015.06.010; Kumar V, 2014, WEED TECHNOL, V28, P122, DOI 10.1614/WT-D-13-00115.1; Legere A, 2013, WEED SCI, V61, P267, DOI 10.1614/WS-D-12-00116.1; MAXWELL BD, 1990, WEED TECHNOL, V4, P2, DOI 10.1017/S0890037X0002488X; Menalled FD, 2007, WEED BIOL MANAG, V7, P115, DOI 10.1111/j.1445-6664.2007.00244.x; Mengistu LW, 2002, WEED SCI, V50, P498, DOI 10.1614/0043-1745(2002)050[0498:GDOK]2.0.CO;2; Mithila J, 2011, WEED SCI, V59, P445, DOI 10.1614/WS-D-11-00062.1; Mithila J, 2012, PEST MANAG SCI, V68, P548, DOI 10.1002/ps.2289; Norsworthy JK, 2012, WEED SCI, V60, P31, DOI 10.1614/WS-D-11-00155.1; Sbatella GM, 2010, WEED TECHNOL, V24, P392, DOI 10.1614/WT-D-09-00023.1; Schwinghamer TD, 2008, WEED SCI, V56, P37, DOI 10.1614/WS-07-098.1; SEEFELDT SS, 1995, WEED TECHNOL, V9, P218, DOI 10.1017/S0890037X00023253; STALLINGS GP, 1995, WEED SCI, V43, P63, DOI 10.1017/S0043174500080838; STALLINGS GP, 1995, WEED SCI, V43, P95, DOI 10.1017/S0043174500080887; Steadman KJ, 2006, AUST J AGR RES, V57, P133, DOI 10.1071/AR05122; Vila-Aiub MM, 2015, J EXP BOT, V66, P4711, DOI 10.1093/jxb/erv248; Vila-Aiub MM, 2015, WEED SCI, V63, P203, DOI 10.1614/WS-D-14-00062.1; Vila-Aiub MM, 2009, NEW PHYTOL, V184, P751, DOI 10.1111/j.1469-8137.2009.03055.x; Vila-Aiub MM, 2005, NEW PHYTOL, V167, P787, DOI 10.1111/j.1469-8137.2005.01465.x; Vila-Aiub MM, 2005, J APPL ECOL, V42, P288, DOI 10.1111/j.1365-2664.2005.01017.x; Weinberg T, 2006, J AGR FOOD CHEM, V54, P9126, DOI 10.1021/jf061803u; Yanniccari M, 2016, WEED SCI, V64, P71, DOI 10.1614/WS-D-15-00065.1; YOUNG JA, 1981, AGRON J, V73, P957, DOI 10.2134/agronj1981.00021962007300060012x; Zheng HG, 2001, WEED SCI, V49, P276, DOI 10.1614/0043-1745(2001)049[0276:UAHRIW]2.0.CO;2	49	28	29	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161533	10.1371/journal.pone.0161533	http://dx.doi.org/10.1371/journal.pone.0161533			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537419	gold, Green Published, Green Submitted			2022-12-26	WOS:000381577000117
J	Polimanti, R; Yang, BZ; Zhao, HY; Gelernter, J				Polimanti, Renato; Yang, Bao Zhu; Zhao, Hongyu; Gelernter, Joel			Evidence of Polygenic Adaptation in the Systems Genetics of Anthropometric Traits	PLOS ONE			English	Article							LOW-FREQUENCY VARIANTS; NATURAL-SELECTION; SEXUAL-DIMORPHISM; ASSOCIATION; COMMON; LOCI; VARIABILITY; EVOLUTION; HEIGHT; SWEEPS	Many signals of natural selection have been identified in the human genome. However, except for some single-locus mechanisms, most molecular processes generating these adaptation signals are still unknown. We developed an approach that integrates datasets related to genome-wide association studies (GWAS) with information about systems biology and genetic signatures of natural selection to identify evidence of polygenic adaptation. Specifically, we focused on five anthropometric measurements: body mass index (BMI), height, waist-to-hip ratio adjusted for BMI (WHR), and waist circumference adjusted for BMI (WC), and sex differences for WHR and WC. We performed an enrichment analysis for signals of natural selection in protein interaction networks associated with anthropometric traits in European populations. The adaptation signals-enriched gene networks associated highlighted epistatic interactions in the context of polygenic selection for the investigated traits. These polygenic mechanisms indicated intriguing selective mechanisms related to the anthropometric traits: adult locomotory behavior for BMI, infection resistance for height, interplay between lipid transport and immune systems forWHR, and female-specific polygenic adaptation forWHR and WC. In conclusion, we observed evidence of polygenic adaptation in the context of systems genetics of anthropometric traits that indicates polygenic mechanisms related to the natural selection in European populations.	[Polimanti, Renato; Yang, Bao Zhu; Gelernter, Joel] Yale Univ, Sch Med, Dept Psychiat, West Haven, CT 06516 USA; [Polimanti, Renato; Yang, Bao Zhu; Gelernter, Joel] VA CT Healthcare Ctr, West Haven, CT USA; [Zhao, Hongyu] Yale Univ, Sch Publ Hlth, Dept Biostat, New Haven, CT USA; [Zhao, Hongyu; Gelernter, Joel] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Gelernter, Joel] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA	Yale University; Yale University; Yale University; Yale University	Polimanti, R (corresponding author), Yale Univ, Sch Med, Dept Psychiat, West Haven, CT 06516 USA.; Polimanti, R (corresponding author), VA CT Healthcare Ctr, West Haven, CT USA.	renato.polimanti@yale.edu		Gelernter, Joel/0000-0002-4067-1859; Polimanti, Renato/0000-0003-0745-6046	National Institutes of Health grants [R01 DA030976, R01 DA12690, R01 DA12849, R01 AA11330, R01 AA017535]; VA Connecticut MIRECC; NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER	National Institutes of Health grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Connecticut MIRECC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by National Institutes of Health grants [R01 DA030976, R01 DA12690, R01 DA12849, R01 AA11330, and R01 AA017535] and the VA Connecticut MIRECC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Babin PJ, 2009, PROG LIPID RES, V48, P73, DOI 10.1016/j.plipres.2008.11.002; Berg JJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004412; Berndt SI, 2013, NAT GENET, V45, P501, DOI 10.1038/ng.2606; Chan YL, 2014, AM J HUM GENET, V94, P437, DOI 10.1016/j.ajhg.2014.02.006; Choudhury A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-437; Colonna V, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r88; Courtiol A, 2013, CURR BIOL, V23, P884, DOI 10.1016/j.cub.2013.04.006; Cowley MJ, 2012, NUCLEIC ACIDS RES, V40, pD862, DOI 10.1093/nar/gkr967; Daub JT, 2013, MOL BIOL EVOL, V30, P1544, DOI 10.1093/molbev/mst080; Ding KY, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-55; Ferrer-Admetlla A, 2014, MOL BIOL EVOL, V31, P1275, DOI 10.1093/molbev/msu077; Festi D, 2014, WORLD J GASTROENTERO, V20, P16079, DOI 10.3748/wjg.v20.i43.16079; Fumagalli M, 2014, CURR OPIN IMMUNOL, V30, P9, DOI 10.1016/j.coi.2014.05.001; GOLDSTEIN MS, 1984, HUM BIOL, V56, P35; Gragnoli C, 2014, APPL CLIN GENET, V7, P43, DOI 10.2147/TACG.S39993; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Henderson GC, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00162; Hou Lin, 2013, Frontiers in Genetics, V4, P280, DOI 10.3389/fgene.2013.00280; Houser Brandy L., 2012, Yale Journal of Biology and Medicine, V85, P105; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jablonski NG, 2012, J ROY COLL PHYS EDIN, V42, P58, DOI 10.4997/JRCPE.2012.114; Janani C, 2014, DIABETES METAB SYNDR; Jeong C, 2014, CURR OPIN GENET DEV, V29, P1, DOI 10.1016/j.gde.2014.06.011; Jia PL, 2011, BIOINFORMATICS, V27, P95, DOI 10.1093/bioinformatics/btq615; Joel Dipesalema R, 2014, J Int Assoc Provid AIDS Care, V13, P529, DOI 10.1177/2325957414531621; Lachance J, 2013, ANNU REV ECOL EVOL S, V44, P123, DOI 10.1146/annurev-ecolsys-110512-135833; Legein B, 2013, CELL MOL LIFE SCI, V70, P3847, DOI 10.1007/s00018-013-1289-1; Limou S, 2009, J INFECT DIS, V199, P419, DOI 10.1086/596067; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Loria AS, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12125; Mortensen HM, 2011, PHARMACOGENOMICS, V12, P1545, DOI [10.2217/PGS.11.88, 10.2217/pgs.11.88]; Piwoz E, 2012, ADV NUTR, V3, P234, DOI 10.3945/an.111.001164; Polimanti R, 2015, ADDICT BIOL; Polimanti R, 2015, PHARMACOGENOMICS, V16, P1487, DOI [10.2217/PGS.15.91, 10.2217/pgs.15.91]; Polimanti R, 2012, PHARMACOGENOMICS, V13, P1951, DOI [10.2217/PGS.12.163, 10.2217/pgs.12.163]; Pritchard JK, 2010, NAT REV GENET, V11, P665, DOI 10.1038/nrg2880; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Randall JC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003500; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sakkou M, 2007, CELL METAB, V5, P450, DOI 10.1016/j.cmet.2007.05.007; Southam L, 2009, DIABETOLOGIA, V52, P1846, DOI 10.1007/s00125-009-1419-3; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Taal HR, 2012, NAT GENET, V44, P532, DOI 10.1038/ng.2238; Tsalik EL, 2003, J NEUROBIOL, V56, P178, DOI 10.1002/neu.10245; Turchin MC, 2012, NAT GENET, V44, P1015, DOI 10.1038/ng.2368; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wells JCK, 2012, AM J PHYS ANTHROPOL, V147, P169, DOI 10.1002/ajpa.21591; Wheeler E, 2013, NAT GENET, V45, P513, DOI 10.1038/ng.2607; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Wuren T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088252; Xing JC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003634; Yang J, 2012, NATURE, V490, P267, DOI 10.1038/nature11401; Zahra K., 2014, NEUROL SCI; Zoumakis E, 2009, CURR MED CHEM, V16, P4230, DOI 10.2174/092986709789578204; Zuloaga KL, 2014, AM J PHYSIOL-HEART C, V306, pH929, DOI 10.1152/ajpheart.00698.2013	59	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0160654	10.1371/journal.pone.0160654	http://dx.doi.org/10.1371/journal.pone.0160654			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537407	gold, Green Published, Green Submitted			2022-12-26	WOS:000381577000027
J	Zhang, CW; Tatham, AJ; Abe, RY; Hammel, N; Belghith, A; Weinreb, RN; Medeiros, FA; Liebmann, JM; Girkin, CA; Zangwill, LM				Zhang, Chunwei; Tatham, Andrew J.; Abe, Ricardo Y.; Hammel, Na'ama; Belghith, Akram; Weinreb, Robert N.; Medeiros, Felipe A.; Liebmann, Jeffrey M.; Girkin, Christopher A.; Zangwill, Linda M.			Macular Ganglion Cell Inner Plexiform Layer Thickness in Glaucomatous Eyes with Localized Retinal Nerve Fiber Layer Defects	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; AFRICAN DESCENT; DAMAGE; PARAMETERS; DIAGNOSIS; HISTOLOGY; ATROPHY; ABILITY; COUNTS; MAPS	Purpose To investigate macular ganglion cell-inner plexiform layer (mGCIPL) thickness in glaucomatous eyes with visible localized retinal nerve fiber layer (RNFL) defects on stereophotographs. Methods 112 healthy and 149 glaucomatous eyes from the Diagnostic Innovations in Glaucoma Study (DIGS) and the African Descent and Glaucoma Evaluation Study (ADAGES) subjects had standard automated perimetry (SAP), optical coherence tomography (OCT) imaging of the macula and optic nerve head, and stereoscopic optic disc photography. Masked observers identified localized RNFL defects by grading of stereophotographs. Result 47 eyes had visible localized RNFL defects on stereophotographs. Eyes with visible localized RNFL defects had significantly thinner mGCIPL thickness compared to healthy eyes (68.3 +/- 11.4 mu m versus 79.2 +/- 6.6 mu m respectively, P<0.001) and similar mGCIPL thickness to glaucomatous eyes without localized RNFL defects (68.6 +/- 11.2 mu m, P = 1.000). The average mGCIPL thickness in eyes with RNFL defects was 14% less than similarly aged healthy controls. For 29 eyes with a visible RNFL defect in just one hemiretina (superior or inferior) mGCIPL was thinnest in the same hemiretina in 26 eyes (90%). Eyes with inferior-temporal RNFL defects also had significantly thinner inferior-temporal mGCIPL (P<0.001) and inferior mGCIPL (P = 0.030) compared to glaucomatous eyes without a visible RNFL defect. Conclusion The current study indicates that presence of a localized RNFL defect is likely to indicate significant macular damage, particularly in the region of the macular that topographically corresponds to the location of the RNFL defect.	[Zhang, Chunwei] Harbin Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Harbin, Peoples R China; [Zhang, Chunwei; Tatham, Andrew J.; Abe, Ricardo Y.; Hammel, Na'ama; Belghith, Akram; Weinreb, Robert N.; Medeiros, Felipe A.; Zangwill, Linda M.] Univ Calif San Diego, Dept Ophthalmol, Hamilton Glaucoma Ctr, San Diego, CA 92103 USA; [Zhang, Chunwei; Tatham, Andrew J.; Abe, Ricardo Y.; Hammel, Na'ama; Belghith, Akram; Weinreb, Robert N.; Medeiros, Felipe A.; Zangwill, Linda M.] Univ Calif San Diego, Shiley Eye Inst, San Diego, CA 92103 USA; [Tatham, Andrew J.] Univ Edinburgh, Princess Alexandra Eye Pavil, Edinburgh, Midlothian, Scotland; [Tatham, Andrew J.] Univ Edinburgh, Dept Ophthalmol, Edinburgh, Midlothian, Scotland; [Abe, Ricardo Y.] Univ Estadual Campinas, Dept Ophthalmol, Campinas, SP, Brazil; [Liebmann, Jeffrey M.] Columbia Univ, Harkness Eye Inst, Med Ctr, New York, NY USA; [Girkin, Christopher A.] Univ Alabama Birmingham, Dept Ophthalmol, Birmingham, AL 35294 USA	Harbin Medical University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Edinburgh; University of Edinburgh; Universidade Estadual de Campinas; Columbia University; University of Alabama System; University of Alabama Birmingham	Zangwill, LM (corresponding author), Univ Calif San Diego, Dept Ophthalmol, Hamilton Glaucoma Ctr, San Diego, CA 92103 USA.; Zangwill, LM (corresponding author), Univ Calif San Diego, Shiley Eye Inst, San Diego, CA 92103 USA.	lzangwill@ucsd.edu	Abe, Ricardo Y/L-1965-2018	Abe, Ricardo Y/0000-0002-7023-2144; Girkin, Christopher/0000-0002-5781-7682; Tatham, Andrew/0000-0003-0372-3100	National Institutes of Health/National Eye Institute [EY021818, EY11008, EY14267, EY019869, P30EY022589]; NHS Scotland Career Researcher Grant; Research to Prevent Blindness (New York, NY); Alcon; Allergan; Pfizer; Merck; Santen; Natural Science Foundation of Heilongjiang Province for Returned Scholars, China [LC2012C21]; Innovation research special fund of the Science and Technology of Harbin of Heilong Jiang Province, China [2011RFLYS029]; Research fund of the First Affiliated Hospital of Harbin Medical University, China [2007021]; Scientific and technical research fund of Education Bureau of Heilongjiang Province, China [12511311]	National Institutes of Health/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHS Scotland Career Researcher Grant; Research to Prevent Blindness (New York, NY)(Research to Prevent Blindness (RPB)); Alcon(Novartis); Allergan(AbbVieAllergan); Pfizer(Pfizer); Merck(Merck & Company); Santen; Natural Science Foundation of Heilongjiang Province for Returned Scholars, China; Innovation research special fund of the Science and Technology of Harbin of Heilong Jiang Province, China; Research fund of the First Affiliated Hospital of Harbin Medical University, China; Scientific and technical research fund of Education Bureau of Heilongjiang Province, China	This work was supported in part by National Institutes of Health/National Eye Institute grants EY021818 (FAM), EY11008 (LMZ), EY14267 (LMZ), EY019869 (LMZ), core grant P30EY022589; NHS Scotland Career Researcher Grant (AJT); an unrestricted grant from Research to Prevent Blindness (New York, NY); grants for participants' glaucoma medications from Alcon, Allergan, Pfizer, Merck and Santen; Natural Science Foundation of Heilongjiang Province for Returned Scholars, China. No. LC2012C21 (CZ); Innovation research special fund of the Science and Technology of Harbin of Heilong Jiang Province, China. No. 2011RFLYS029 (CZ). Research fund of the First Affiliated Hospital of Harbin Medical University, China No. 2007021(CZ). Scientific and technical research fund of Education Bureau of Heilongjiang Province, China. No. 12511311 (CZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIRAKSINEN PJ, 1984, AM J OPHTHALMOL, V98, P566, DOI 10.1016/0002-9394(84)90242-3; Akashi A, 2013, INVEST OPHTH VIS SCI, V54, P6025, DOI 10.1167/iovs.13-12630; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; Hood DC, 2014, INVEST OPHTH VIS SCI, V55, P632, DOI 10.1167/iovs.13-13130; Hood DC, 2013, PROG RETIN EYE RES, V32, P1, DOI 10.1016/j.preteyeres.2012.08.003; Hood DC, 2011, INVEST OPHTH VIS SCI, V52, P940, DOI 10.1167/iovs.10-5803; HOYT WF, 1972, LANCET, V1, P692; JONAS JB, 1994, GRAEF ARCH CLIN EXP, V232, P759, DOI 10.1007/BF00184280; Kim KE, 2014, INVEST OPHTH VIS SCI, V55, P3501, DOI 10.1167/iovs.14-13925; Kim MJ, 2015, ACTA OPHTHALMOL, V93, pE22, DOI 10.1111/aos.12485; Kim TW, 2007, OPHTHALMOLOGY, V114, P1053, DOI 10.1016/j.ophtha.2006.09.015; Knighton RW, 2012, INVEST OPHTH VIS SCI, V53, P3653, DOI 10.1167/iovs.12-9719; Kotowski J, 2012, BRIT J OPHTHALMOL, V96, P1420, DOI 10.1136/bjophthalmol-2011-301021; Leung CKS, 2010, OPHTHALMOLOGY, V117, P2337, DOI 10.1016/j.ophtha.2010.04.002; Leung CKS, 2012, OPHTHALMOLOGY, V119, P1858, DOI 10.1016/j.ophtha.2012.03.044; Lu ATH, 2008, OPHTHALMOLOGY, V115, P1352, DOI 10.1016/j.ophtha.2008.01.011; Medeiros FA, 2005, ARCH OPHTHALMOL-CHIC, V123, P1351, DOI 10.1001/archopht.123.10.1351; Medeiros FA, 2004, ARCH OPHTHALMOL-CHIC, V122, P827, DOI 10.1001/archopht.122.6.827; Medeiros FA, 2008, OPHTHALMOLOGY, V115, P1340, DOI 10.1016/j.ophtha.2007.11.008; Medeiros FA, 2007, INVEST OPHTH VIS SCI, V48, P3146, DOI 10.1167/iovs.06-1139; Mwanza JC, 2012, OPHTHALMOLOGY, V119, P1151, DOI 10.1016/j.ophtha.2011.12.014; Mwanza JC, 2011, INVEST OPHTH VIS SCI, V52, P8323, DOI 10.1167/iovs.11-7962; Quigley H A, 1986, Trans Am Ophthalmol Soc, V84, P920; QUIGLEY HA, 1979, OPHTHALMOLOGY, V86, P1803; QUIGLEY HA, 1987, EYE, V1, P318, DOI 10.1038/eye.1987.51; Racette L, 2010, ARCH OPHTHALMOL-CHIC, V128, P551, DOI 10.1001/archophthalmol.2010.58; RADIUS RL, 1979, ARCH OPHTHALMOL-CHIC, V97, P948; Sample PA, 2009, ARCH OPHTHALMOL-CHIC, V127, P1136, DOI 10.1001/archophthalmol.2009.187; Shah NN, 2006, OPHTHALMOLOGY, V113, P1593, DOI 10.1016/j.ophtha.2006.06.004; SOMMER A, 1977, ARCH OPHTHALMOL-CHIC, V95, P2149; SOMMER A, 1991, ARCH OPHTHALMOL-CHIC, V109, P77, DOI 10.1001/archopht.1991.01080010079037; Tatham AJ, 2013, AM J OPHTHALMOL, V156, P578, DOI 10.1016/j.ajo.2013.04.015; Tham YC, 2013, BRIT J OPHTHALMOL, V97, P1592, DOI 10.1136/bjophthalmol-2013-303660; TUULONEN A, 1993, OPHTHALMOLOGY, V100, P587; Ueda K, 2016, J GLAUCOMA, V25, P383, DOI 10.1097/IJG.0000000000000216; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192; Yang ZY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125957; Yang ZY, 2015, AM J OPHTHALMOL, V159, P193, DOI 10.1016/j.ajo.2014.10.019; Zhang CW, 2014, OPHTHALMOLOGY, V121, P2371, DOI 10.1016/j.ophtha.2014.06.047	39	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0160549	10.1371/journal.pone.0160549	http://dx.doi.org/10.1371/journal.pone.0160549			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537107	Green Published, gold, Green Submitted			2022-12-26	WOS:000381577000024
J	Neyrinck, AM; Pachikian, B; Taminiau, B; Daube, G; Frederick, R; Cani, PD; Bindels, LB; Delzenne, NM				Neyrinck, Audrey M.; Pachikian, Barbara; Taminiau, Bernard; Daube, Georges; Frederick, Raphael; Cani, Patrice D.; Bindels, Laure B.; Delzenne, Nathalie M.			Intestinal Sucrase as a Novel Target Contributing to the Regulation of Glycemia by Prebiotics	PLOS ONE			English	Article							RAT LARGE-BOWEL; GUT MICROBIOTA; AKKERMANSIA-MUCINIPHILA; CELL-PROLIFERATION; PEPTIDE-1 RECEPTOR; LIPID-METABOLISM; MICE; GLUCOSE; OBESITY; FIBER	Inulin-type fructans (ITF) are known for their capacity to modulate gut microbiota, energy metabolism and to improve glycemia in several animal models of obesity, and in humans. The potential contribution of ITF as modulators of sugar digestion by host enzymes has not been evaluated yet. A sucrose challenge has been performed on naive mice fed a standard diet supplemented with or without native chicory inulin (Fibruline 5%) for 3 weeks. The area under the curve of glycemia as well as sucrase activity in the small intestine were lowered after inulin treatment. Pyrosequencing of the 16S rRNA gene confirmed important changes in gut microbiota (mostly in favor of Blautia genus) due to inulin extract supplementation. Interestingly, the suppressive effect of inulin extract on postprandial glycemia also occurred when inulin was directly added to the sucrose solution, suggesting that the effect on sucrose digestion did not require chronic inulin administration. In vitro tests confirmed a direct inhibition of sucrase enzyme by the inulin extract, thereby suggesting that native chicory inulin, in addition to its well-known prebiotic effect, is also able to decrease the digestibility of carbohydrates, a phenomenon that can contribute in the control of post prandial glycemia. We may not exclude that the sucrose escaping the digestion could also contribute to the changes in the gut microbiota after a chronic treatment with inulin.	[Neyrinck, Audrey M.; Pachikian, Barbara; Cani, Patrice D.; Bindels, Laure B.; Delzenne, Nathalie M.] Catholic Univ Louvain, Metab & Nutr Res Grp, Louvain Drug Res Inst, Brussels, Belgium; [Taminiau, Bernard; Daube, Georges] Univ Liege, Fac Vet Med, FARAH, Liege, Belgium; [Frederick, Raphael] Catholic Univ Louvain, Med Chem Res Grp, Louvain Drug Res Inst, Brussels, Belgium; [Cani, Patrice D.] UCL, Louvain Drug Res Inst, Walloon Excellence Life Sci & BIOtechnol WELBIO, B-1200 Brussels, Belgium	Universite Catholique Louvain; University of Liege; Universite Catholique Louvain; Universite Catholique Louvain; WELBIO	Delzenne, NM (corresponding author), Catholic Univ Louvain, Metab & Nutr Res Grp, Louvain Drug Res Inst, Brussels, Belgium.	nathalie.delzenne@uclouvain.be	Delzenne, Nathalie/AAC-4628-2019; D., Cani Patrice/M-8055-2016; Taminiau, Bernard/E-8008-2017; Bindels, Laure/T-7846-2019; Neyrinck, Audrey/AAE-7929-2019	Delzenne, Nathalie/0000-0003-2115-6082; D., Cani Patrice/0000-0003-2040-2448; Taminiau, Bernard/0000-0001-6456-329X; Bindels, Laure/0000-0003-3747-3234; Neyrinck, Audrey/0000-0002-9435-3338; Daube, Georges/0000-0002-9282-8408; Frederick, Raphael/0000-0001-8119-1272	FRS-FNRS grants; Wallonia (FOOD4GUT project) [1318148]; Wallonia - competitive cluster Wagralim (NUTRIGUTIOR project) [6918]; ERC Starting Grant (European Research Council) [336452-ENIGMO]; PDR (Fonds de la Recherche Scientifique, Belgium) [T0.138.14]; ARC (Concerted Research Activities-French Community of Belgium) [12/17-047]; FRS-FNRS via the FRFS-WELBIO [WELBIO-CR-2012S-02R]	FRS-FNRS grants(Fonds de la Recherche Scientifique - FNRS); Wallonia (FOOD4GUT project); Wallonia - competitive cluster Wagralim (NUTRIGUTIOR project); ERC Starting Grant (European Research Council); PDR (Fonds de la Recherche Scientifique, Belgium); ARC (Concerted Research Activities-French Community of Belgium); FRS-FNRS via the FRFS-WELBIO(Fonds de la Recherche Scientifique - FNRS)	LBB is Postdoctoral Researcher from the FRS-FNRS (Fond National de la Recherche Scientifique, Belgium). NMD is a recipient of FRS-FNRS grants and of grant from the Wallonia (FOOD4GUT project, convention 1318148). NMD and GD are recipients of grant from Wallonia supported by the competitive cluster Wagralim (NUTRIGUTIOR project, convention 6918). PDC, a research associate at the FRS-FNRS (Belgium), is a recipient of an ERC Starting Grant 2013 (European Research Council, Starting Grant 336452-ENIGMO), PDR subsidies (Projet de recherches T0.138.14; Fonds de la Recherche Scientifique, Belgium) and ARC subsidies (Concerted Research Activities-French Community of Belgium convention: 12/17-047) and is supported by the FRS-FNRS via the FRFS-WELBIO under Grant number WELBIO-CR-2012S-02R.; We thank Remi Selleslagh and Bouazza Es Saadi for skillful technical assistance and Carine Nezer, Quality Partner s.a., Herstal, Belgium, for performing metagenetic analysis. LBB is Post-doctoral Researcher from the FRS-FNRS (Fond National de la Recherche Scientifique, Belgium). NMD is a recipient of FRS-FNRS grants and of grant from the Wallonia (FOOD4GUT project, convention 1318148). NMD and GD are recipients of grant from Wallonia supported by the competitive cluster Wagralim (NUTRIGUTIOR project, convention 6918). PDC, a research associate at the FRS-FNRS (Belgium), is a recipient of an ERC Starting Grant 2013 (European Research Council, Starting Grant 336452-ENIGMO), PDR subsidies (Projet de recherches T0.138.14; Fonds de la Recherche Scientifique, Belgium) and ARC subsidies (Concerted Research Activities-French Community of Belgium convention: 12/17-047) and is supported by the FRS-FNRS via the FRFS-WELBIO under Grant number WELBIO-CR-2012S-02R.	Barlow GM, 2015, NUTR CLIN PRACT, V30, P787, DOI 10.1177/0884533615609896; Bindels LB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131009; Bindels LB, 2015, NAT REV GASTRO HEPAT, V12, P303, DOI 10.1038/nrgastro.2015.47; Brownlee IA, 2003, P NUTR SOC, V62, P245, DOI 10.1079/PNS2003206; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Cani PD, 2006, DIABETES, V55, P1484, DOI 10.2337/db05-1360; CANI PD, 2007, BR J NUTR, P1; DAHLQVIST A, 1968, ANAL BIOCHEM, V22, P99, DOI 10.1016/0003-2697(68)90263-7; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Delzenne NM, 2015, DIABETOLOGIA, V58, P2206, DOI 10.1007/s00125-015-3712-7; Delzenne NM, 2011, NAT REV ENDOCRINOL, V7, P639, DOI 10.1038/nrendo.2011.126; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Everard A, 2014, ISME J, V8, P2116, DOI 10.1038/ismej.2014.45; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Everard A, 2011, DIABETES, V60, P2775, DOI 10.2337/db11-0227; Fletcher MM, 2016, BIOCHEM SOC T, V44, P582, DOI 10.1042/BST20150244; Fukunaga T, 2003, DIGESTION, V67, P42, DOI 10.1159/000069705; Hedemann MS, 2006, J ANIM SCI, V84, P1375, DOI 10.2527/2006.8461375x; Hutkins RW, 2016, CURR OPIN BIOTECH, V37, P1, DOI 10.1016/j.copbio.2015.09.001; JACOBS LR, 1984, AM J PHYSIOL, V246, pG378, DOI 10.1152/ajpgi.1984.246.4.G378; Junicke H, 2016, BIOTECHNOL BIOENG, V113, P560, DOI 10.1002/bit.25816; KAWAI Y, 1978, INFECT IMMUN, V19, P771, DOI 10.1128/IAI.19.3.771-778.1978; Liu CX, 2008, INT J SYST EVOL MICR, V58, P1896, DOI 10.1099/ijs.0.65208-0; LUPTON JR, 1988, J NUTR, V118, P840, DOI 10.1093/jn/118.7.840; Martinez I, 2013, ISME J, V7, P269, DOI 10.1038/ismej.2012.104; Maurer AD, 2009, J PHYSIOL-LONDON, V587, P679, DOI 10.1113/jphysiol.2008.161844; Nakamura N, 2010, ANNU REV FOOD SCI T, V1, P363, DOI 10.1146/annurev.food.102308.124101; Oki T, 1999, J AGR FOOD CHEM, V47, P550, DOI 10.1021/jf980788t; Oku T, 2014, NUTR RES, V34, P961, DOI 10.1016/j.nutres.2014.09.009; Quintero M, 2011, CURR MICROBIOL, V62, P1448, DOI 10.1007/s00284-011-9882-8; Roberfroid M, 2010, BRIT J NUTR, V104, pS1, DOI 10.1017/S0007114510003363; Salonen A, 2014, ISME J, V8, P2218, DOI 10.1038/ismej.2014.63; Schneeberger M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16643; Sim L, 2010, J BIOL CHEM, V285, P17763, DOI 10.1074/jbc.M109.078980; Tannock GW, 2014, APPL ENVIRON MICROB, V80, P2240, DOI 10.1128/AEM.03799-13; Urias-Silvas JE, 2008, BRIT J NUTR, V99, P254, DOI 10.1017/S0007114507795338; WHITT DD, 1981, APPL ENVIRON MICROB, V42, P513, DOI 10.1128/AEM.42.3.513-520.1981; Williamson G, 2013, MOL NUTR FOOD RES, V57, P48, DOI 10.1002/mnfr.201200511; Yang JY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146144; Zenhom M, 2011, J NUTR, V141, P971, DOI 10.3945/jn.110.136176	40	18	20	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160488	10.1371/journal.pone.0160488	http://dx.doi.org/10.1371/journal.pone.0160488			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532866	gold, Green Published			2022-12-26	WOS:000381487600032
J	Xie, SS; Spelmink, L; Codemo, M; Subramanian, K; Putsep, K; Henriques-Normark, B; Olliver, M				Xie, Shanshan; Spelmink, Laura; Codemo, Mario; Subramanian, Karthik; Putsep, Katrin; Henriques-Normark, Birgitta; Olliver, Marie			Cinobufagin Modulates Human Innate Immune Responses and Triggers Antibacterial Activity	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE INFECTION; PLASMACYTOID DENDRITIC CELLS; GINGIVAL EPITHELIAL-CELLS; PROSTATE-CANCER CELLS; NF-KAPPA-B; HUMAN BETA-DEFENSIN-2; ANTIMICROBIAL PEPTIDES; PROTECTIVE IMMUNITY; HUMAN-NEUTROPHILS; HOST-DEFENSE	The traditional Chinese medicine Chan-Su is widely used for treatment of cancer and cardiovascular diseases, but also as a remedy for infections such as furunculosis, tonsillitis and acute pharyngitis. The clinical use of Chan-Su suggests that it has anti-infective effects, however, the mechanism of action is incompletely understood. In particular, the effect on the human immune system is poorly defined. Here, we describe previously unrecognized immunomodulatory activities of cinobufagin (CBG), a major bioactive component of ChanSu. Using human monocyte-derived dendritic cells (DCs), we show that LPS-induced maturation and production of a number of cytokines was potently inhibited by CBG, which also had a pro-apoptotic effect, associated with activation of caspase-3. Interestingly, CBG triggered caspase-1 activation and significantly enhanced IL-1 beta production in LPS-stimulated cells. Finally, we demonstrate that CBG upregulates gene expression of the antimicrobial peptides (AMPs) hBD-2 and hBD-3 in DCs, and induces secretion of HNP1-3 and hCAP-18/LL-37 from neutrophils, potentiating neutrophil antibacterial activity. Taken together, our data indicate that CBG modulates the inflammatory phenotype of DCs in response to LPS, and triggers an antibacterial innate immune response, thus proposing possible mechanisms for the clinical effects of Chan-Su in anti-infective therapy.	[Xie, Shanshan; Spelmink, Laura; Codemo, Mario; Subramanian, Karthik; Putsep, Katrin; Henriques-Normark, Birgitta; Olliver, Marie] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, SE-17177 Stockholm, Sweden; [Xie, Shanshan] Jilin Univ, Dept Clin Vet Med, Coll Vet Med, Changchun, Jilin, Peoples R China; [Henriques-Normark, Birgitta] Karolinska Univ Hosp, Dept Clin Microbiol, SE-17176 Stockholm, Sweden	Karolinska Institutet; Jilin University; Karolinska Institutet; Karolinska University Hospital	Henriques-Normark, B (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, SE-17177 Stockholm, Sweden.; Henriques-Normark, B (corresponding author), Karolinska Univ Hosp, Dept Clin Microbiol, SE-17176 Stockholm, Sweden.	birgitta.henriques@ki.se	Subramanian, Karthik/N-3587-2019; xie, shanshan/GSM-8999-2022	Subramanian, Karthik/0000-0002-4381-5037; Olliver, Marie/0000-0003-4115-2716	Swedish Research Council; Knut and Alice Wallenberg Foundation; Swedish Foundation for Strategic research; ALF-grant from Stockholm City Council; EU commission EIMID-ITN Project; China Scholarship Council	Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Foundation for Strategic research(Swedish Foundation for Strategic Research); ALF-grant from Stockholm City Council; EU commission EIMID-ITN Project; China Scholarship Council(China Scholarship Council)	Financial support was received from the Swedish Research Council www.vr.se (BHN), Knut and Alice Wallenberg Foundation www.wallenberg.com/kaw (BHN), the Swedish Foundation for Strategic research www.stratresearch.se (BHN), ALF-grant from Stockholm City Council (BHN), the EU commission EIMID-ITN Project (BHN), and by China Scholarship Council (SX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardeshna KM, 2000, BLOOD, V96, P1039, DOI 10.1182/blood.V96.3.1039.015k04_1039_1046; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Beiter K, 2006, CURR BIOL, V16, P401, DOI 10.1016/j.cub.2006.01.056; BENTWOOD BJ, 1980, J IMMUNOL, V124, P855; Bick RJ, 2002, LIFE SCI, V72, P699, DOI 10.1016/S0024-3205(02)02302-0; Biragyn A, 2002, SCIENCE, V298, P1025, DOI 10.1126/science.1075565; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; CHEN KK, 1967, J PHARM SCI-US, V56, P1535, DOI 10.1002/jps.2600561202; Chen QY, 2006, J IMMUNOL, V177, P6044, DOI 10.4049/jimmunol.177.9.6044; Clarke BT, 1997, BIOL REV, V72, P365, DOI 10.1017/S0006323197005045; Cookson BT, 2001, TRENDS MICROBIOL, V9, P113, DOI 10.1016/S0966-842X(00)01936-3; Dommisch H, 2012, J CLIN PERIODONTOL, V39, P913, DOI 10.1111/j.1600-051X.2012.01933.x; Fang RD, 2011, J IMMUNOL, V187, P4890, DOI 10.4049/jimmunol.1100381; Fernebro J, 2004, J INFECT DIS, V189, P328, DOI 10.1086/380564; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Greer A, 2013, PERIODONTOL 2000, V63, P67, DOI 10.1111/prd.12028; Han GW, 2012, INT J BIOL SCI, V8, P228, DOI 10.7150/ijbs.8.228; Harder J, 2000, AM J RESP CELL MOL, V22, P714, DOI 10.1165/ajrcmb.22.6.4023; Horowitz MA, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu076; Kafka D, 2008, INT IMMUNOL, V20, P1139, DOI 10.1093/intimm/dxn071; Kanda N, 2007, AM J PHYSIOL-CELL PH, V293, pC1916, DOI 10.1152/ajpcell.00293.2007; Kim C, 2006, TRENDS MICROBIOL, V14, P428, DOI 10.1016/j.tim.2006.08.001; Krisanaprakornkit S, 1998, INFECT IMMUN, V66, P4222; Ku CL, 2007, J EXP MED, V204, P2407, DOI 10.1084/jem.20070628; Li C, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/849054; Lu CX, 2008, ANTI-CANCER DRUG, V19, P931, DOI 10.1097/CAD.0b013e3283139100; Meyer-Hoffert U, 2008, GUT, V57, P764, DOI 10.1136/gut.2007.141481; MORISHITA S, 1992, AM J CHINESE MED, V20, P245, DOI 10.1142/S0192415X92000254; Oppenheim JJ, 2005, CURR OPIN IMMUNOL, V17, P359, DOI 10.1016/j.coi.2005.06.002; Oppenheim JJ, 2007, ADV EXP MED BIOL, V601, P185; Prassas I, 2008, NAT REV DRUG DISCOV, V7, P926, DOI 10.1038/nrd2682; Qi FH, 2011, CANCER SCI, V102, P951, DOI 10.1111/j.1349-7006.2011.01900.x; Qi FH, 2010, BIOSCI TRENDS, V4, P297; Ren K, 2009, BRAIN RES REV, V60, P57, DOI 10.1016/j.brainresrev.2008.12.020; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Ryan LK, 2011, J LEUKOCYTE BIOL, V90, P343, DOI 10.1189/jlb.0209079; Sheshachalam A, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00448; Stockinger S, 2014, J INNATE IMMUN, V6, P530, DOI 10.1159/000357644; TERRITO MC, 1989, J CLIN INVEST, V84, P2017, DOI 10.1172/JCI114394; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tewary P, 2013, J IMMUNOL, V191, P865, DOI 10.4049/jimmunol.1201648; Tsutsumi-Ishii Y, 2003, J IMMUNOL, V170, P4226, DOI 10.4049/jimmunol.170.8.4226; van de Laar L, 2010, J IMMUNOL, V185, P7252, DOI 10.4049/jimmunol.1000672; Xie XF, 2013, MED HYPOTHESES, V81, P243, DOI 10.1016/j.mehy.2013.04.038; Yamamoto-Furusho JK, 2010, INFLAMM BOWEL DIS, V16, P736, DOI 10.1002/ibd.21144; Yang D, 2009, TRENDS IMMUNOL, V30, P531, DOI 10.1016/j.it.2009.07.004; Yang H, 2013, J INFECT DIS, V207, P50, DOI 10.1093/infdis/jis651; Ye Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep11685; Yeh JY, 2003, PROSTATE, V54, P112, DOI 10.1002/pros.10172; Yin L, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-37; Yu CH, 2008, CANCER SCI, V99, P2467, DOI 10.1111/j.1349-7006.2008.00966.x; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zwijnenburg PJG, 2003, J IMMUNOL, V170, P4724, DOI 10.4049/jimmunol.170.9.4724	54	11	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160734	10.1371/journal.pone.0160734	http://dx.doi.org/10.1371/journal.pone.0160734			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529866	Green Submitted, Green Published, gold			2022-12-26	WOS:000381476700019
J	Ikeda, K; Shiraishi, K; Yoshida, A; Shinchi, Y; Sanada, M; Motooka, Y; Fujino, K; Mori, T; Suzuki, M				Ikeda, Koei; Shiraishi, Kenji; Yoshida, Ayaka; Shinchi, Yusuke; Sanada, Mune; Motooka, Yamato; Fujino, Kosuke; Mori, Takeshi; Suzuki, Makoto			Synchronous Multiple Lung Adenocarcinomas: Estrogen Concentration in Peripheral Lung	PLOS ONE			English	Article							CANCER; EXPRESSION; CARCINOMA; AROMATASE; MUTATIONS; WOMEN; RISK	Background The detection rate of synchronous multiple lung adenocarcinomas (SMLA), which display multiple ground glass opacity nodules in the peripheral lung, is increasing due to advances in high resolution computed tomography. The backgrounds of multicentric development of adenocarcinoma are unknown. In this study, we quantitated estrogen concentration in the peripheral lungs of postmenopausal female patients with SMLA. Methods The tissue concentration of estrogens (estrone [E1] and estdadiol [E2]) in the noncancerous peripheral lung were measured with liquid chromatography/electrospray tandem mass spectrometry in postmenopausal female patients with lung adenocarcinoma. The expression levels of CYP19A1 in the normal lung were also quantitated with real-time PCR. Thirty patients with SMLA and 79 cases of control patients with single lung adenocarcinoma were analyzed. Results The concentrations of E1 and E2 in the noncancerous tissue were significantly higher in SMLA cases than control cases (P = 0.004 and P = 0.02, respectively). The minor allele (A) of single nucleotide polymorphism rs3764221 were significantly associated with higher concentration of E1 and E2 (P = 0.002 and P = 0.01, respectively) and higher CYP19A1 mRNA expression (P = 0.03). Conclusion The tissue estrogen concentration of peripheral lung was significantly higher in SMLA than control cases. The high concentration of estrogen may be one of the causes of multicentric development of peripheral lung adenocarcinomas.	[Ikeda, Koei; Shiraishi, Kenji; Yoshida, Ayaka; Shinchi, Yusuke; Sanada, Mune; Motooka, Yamato; Fujino, Kosuke; Mori, Takeshi; Suzuki, Makoto] Kumamoto Univ, Grad Sch Med Sci, Dept Thorac Surg, 1-1-1 Honjo, Kumamoto 8608556, Japan	Kumamoto University	Ikeda, K (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Thorac Surg, 1-1-1 Honjo, Kumamoto 8608556, Japan.	koei@cg7.so-net.ne.jp	Suzuki, Makoto/AAE-5248-2020		Ministry of Education, Science, Sports, Culture and Technology of Japan [23592069, 24592096]; Smoking Research Foundation	Ministry of Education, Science, Sports, Culture and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Smoking Research Foundation	This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, Culture and Technology of Japan (23592069) (24592096) and by a grant from the Smoking Research Foundation (2012-2015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, Culture and Technology of Japan (23592069) (24592096) and by a grant from the Smoking Research Foundation (2012-2015). We thank ASKA Pharma Medical (Kawasaki, Japan) for the skillful technical assistance.	BARSKY SH, 1994, MODERN PATHOL, V7, P633; Bouchardy C, 2011, CANCER-AM CANCER SOC, V117, P1288, DOI 10.1002/cncr.25638; Chlebowski RT, 2009, LANCET, V374, P1243, DOI 10.1016/S0140-6736(09)61526-9; Clague J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103735; GUINEE DG, 1995, CARCINOGENESIS, V16, P993, DOI 10.1093/carcin/16.5.993; Hammoud Z, 2008, ENDOCR-RELAT CANCER, V15, P475, DOI 10.1677/ERC-08-0002; Ikeda K, 2008, J THORAC ONCOL, V3, P467, DOI 10.1097/JTO.0b013e31816b4b14; Ikeda K, 2014, ANN SURG ONCOL, V21, P939, DOI 10.1245/s10434-013-3362-2; Kim HK, 2010, J THORAC ONCOL, V5, P206, DOI 10.1097/JTO.0b013e3181c422be; Koutras A, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-109; Marquez-Garban DC, 2009, ANN NY ACAD SCI, V1155, P194, DOI 10.1111/j.1749-6632.2009.04116.x; MARTINI N, 1975, J THORAC CARDIOV SUR, V70, P606; Niikawa H, 2008, CLIN CANCER RES, V14, P4417, DOI 10.1158/1078-0432.CCR-07-1950; Omoto Y, 2001, BIOCHEM BIOPH RES CO, V285, P340, DOI 10.1006/bbrc.2001.5158; Pesatori AC, 2013, INT J CANCER, V132, P2630, DOI 10.1002/ijc.27926; Shen H, 2010, BIOMED PHARMACOTHER, V64, P88, DOI 10.1016/j.biopha.2009.06.010; Taniuchi S, 2014, MOL CELL ENDOCRINOL, V392, P136, DOI 10.1016/j.mce.2014.05.016; Toyoda Y, 2008, JPN J CLIN ONCOL, V38, P534, DOI 10.1093/jjco/hyn072; Travis WD, 2013, ARCH PATHOL LAB MED, V137, P668, DOI 10.5858/arpa.2012-0263-RA; Traynor AM, 2009, LUNG CANCER, V64, P51, DOI 10.1016/j.lungcan.2008.07.002; Wang HZ, 2009, ENDOCRINOLOGY, V150, P3301, DOI 10.1210/en.2008-1812; Zang EA, 1996, JNCI-J NATL CANCER I, V88, P183, DOI 10.1093/jnci/88.3-4.183	22	10	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0160910	10.1371/journal.pone.0160910	http://dx.doi.org/10.1371/journal.pone.0160910			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27526096	gold, Green Published, Green Submitted			2022-12-26	WOS:000381471100026
J	Veprik, A; Laufer, D; Weiss, S; Rubins, N; Walker, MD				Veprik, Anna; Laufer, Dana; Weiss, Sara; Rubins, Nir; Walker, Michael D.			GPR41 modulates insulin secretion and gene expression in pancreatic -cells and modifies metabolic homeostasis in fed and fasting states	FASEB JOURNAL			English	Article						diabetes; SCFA; glucose; islet; FFAR3; fasting	PROTEIN-COUPLED RECEPTOR; FATTY-ACID RECEPTORS; GLUCOSE-TOLERANCE; ENCODING GPR40; PROPIONATE; MICROBIOTA; TARGETS; ETHANOL; ISLETS; FFA2	Insulin secretion by pancreatic -cells is primarily regulated by glucose; however, hormones and additional nutrients, such as long-chain fatty acids, also play an important role in adjusting insulin output to physiologic needs. To examine the role of short-chain fatty acids (SCFAs) in -cell function, we analyzed mouse models of gain and loss of function of GPR41 (FFAR3), a receptor for SCFAs, vs. wild-type control mice. GPR41 gain of function [GPR41-overexpressing transgenic (41 Tg) model] and GPR41 loss of function [GPR41-knockout (KO 41) model] resulted in complementary changes in glucose tolerance, without significant effects on insulin sensitivity. KO 41 mice showed fasting hypoglycemia, which was consistent with increased basal and glucose-induced insulin secretion by islets in vitro. Mirroring this, 41 Tg islets showed impaired glucose responsiveness in vitro. Microarray analysis of islets from 41 Tg mice indicated significant alterations in gene expression patterns; several of the altered genes were chosen for further analysis and were also observed to change upon incubation of islets and cultured -cells with SCFAs in a GPR41-dependent manner. Taken together, our results indicate that GPR41 and its ligands, SCFAs, may play an important role in the fine-tuning of insulin secretion in fed and fasting states.Veprik, A., Laufer, D., Weiss, S., Rubins, N., Walker, M. D. GPR41 modulates insulin secretion and gene expression in pancreatic -cells and modifies metabolic homeostasis in fed and fasting states.	[Veprik, Anna; Laufer, Dana; Weiss, Sara; Rubins, Nir; Walker, Michael D.] Weizmann Inst Sci, Dept Biomol Sci, POB 26, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Walker, MD (corresponding author), Weizmann Inst Sci, Dept Biomol Sci, POB 26, IL-76100 Rehovot, Israel.	m.walker@weizmann.ac.il		Veprik, Anna/0000-0002-3904-7151				Ahren B, 2009, NAT REV DRUG DISCOV, V8, P369, DOI 10.1038/nrd2782; Bartoov-Shifman R, 2007, J BIOL CHEM, V282, P23561, DOI 10.1074/jbc.M702115200; Bellahcene M, 2013, BRIT J NUTR, V109, P1755, DOI 10.1017/S0007114512003923; Boni-Schnetzler M, 2009, ENDOCRINOLOGY, V150, P5218, DOI 10.1210/en.2009-0543; Brouwers B, 2014, CELL METAB, V20, P979, DOI 10.1016/j.cmet.2014.11.004; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; De Vadder F, 2014, CELL, V156, P84, DOI 10.1016/j.cell.2013.12.016; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Halpern KB, 2012, J BIOL CHEM, V287, P20154, DOI 10.1074/jbc.M112.358887; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hudson BD, 2012, J BIOL CHEM, V287, P41195, DOI 10.1074/jbc.M112.396259; Ichimura A, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00236; Kassem S, 2010, NEW ENGL J MED, V362, P1348, DOI 10.1056/NEJMc0909845; Kimura I, 2011, P NATL ACAD SCI USA, V108, P8030, DOI 10.1073/pnas.1016088108; Layden BT, 2012, DIABET METAB SYND OB, V5, P49, DOI 10.2147/DMSO.S29244; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Lin HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035240; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Newman JC, 2014, TRENDS ENDOCRIN MET, V25, P42, DOI 10.1016/j.tem.2013.09.002; PATEL DG, 1979, METABOLISM, V28, P85, DOI 10.1016/0026-0495(79)90173-2; Porat S, 2011, CELL METAB, V13, P440, DOI 10.1016/j.cmet.2011.02.012; Priyadarshini M, 2015, ISLETS, V7, DOI 10.1080/19382014.2015.1045182; Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105; SHAH JH, 1977, DIABETES, V26, P271, DOI 10.2337/diabetes.26.4.271; Tang C, 2015, NAT MED, V21, P173, DOI 10.1038/nm.3779; Teutsch CA, 2014, DIABETOLOGIA, V57, P776, DOI 10.1007/s00125-014-3161-8; Wolever TMS, 1997, METABOLISM, V46, P805, DOI 10.1016/S0026-0495(97)90127-X; Won YJ, 2013, J NEUROSCI, V33, P19314, DOI 10.1523/JNEUROSCI.3102-13.2013; Ximenes HMA, 2007, CELL BIOCHEM FUNCT, V25, P173, DOI 10.1002/cbf.1297	31	53	55	3	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2016	30	11					3860	3869		10.1096/fj.201500030R	http://dx.doi.org/10.1096/fj.201500030R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EA3BY	27550964	Green Submitted			2022-12-26	WOS:000386474700020
J	Yoshihisa, Y; Rehman, MU; Kondo, T; Shimizu, T				Yoshihisa, Yoko; Rehman, Mati Ur; Kondo, Takashi; Shimizu, Tadamichi			Role of macrophage migration inhibitory factor in heat-induced apoptosis in keratinocytes	FASEB JOURNAL			English	Article						MIF; p53; hyperthermia; JNK signaling; skin	HUMAN EPIDERMAL-KERATINOCYTES; SYSTEMIC-LUPUS-ERYTHEMATOSUS; PROGRAMMED CELL-DEATH; FACTOR MIF; DNA-DAMAGE; HUMAN SKIN; IN-VITRO; CYTOKINE; GROWTH; ANGIOGENESIS	In human skin, keratinocytes are constantly challenged by adverse influences, such as hot and cold temperatures; however, the effects of heat on apoptosis induction in keratinocytes are not well understood. Macrophage migration inhibitory factor (MIF) is a potent cytokine that overcomes p53 function by suppressing its transcriptional activity. Here, we evaluated the effects of MIF on hyperthermia (HT)-induced apoptosis in MIF-deficient [knockout (KO)] and MIF-transgenic (Tg) mouse keratinocytes. Cells were exposed to HT at 44 degrees C, and increased apoptosis was observed in MIF-KO and wild-type (WT) cells compared with MIF-Tg cells. To determine the mechanism, MIF-mediated changes in the cellular p53 level and its effects on p53-dependent death signaling (Bax and p21) and JNK signaling (p-JNK, JNK, p-Bad, and Bad) were investigated. MIF-Tg cells exhibited substantially decreased levels of p53 after HT treatment compared with WT and MIF-KO cells. In addition, HT treatment caused decreased expression of p-JNK and p-Bad in MIF-Tg cells; however, no such changes were observed in MIF-KO and WT cells. These results showed that the activation of JNK (p-JNK and p-Bad) and p53 may be involved in HT-induced apoptosis in keratinocytes and that enhanced endogenous MIF expression suppressed apoptosis.Yoshihisa, Y., Rehman, M. U., Kondo, T., Shimizu, T. Role of macrophage migration inhibitory factor in heat-induced apoptosis in keratinocytes.	[Yoshihisa, Yoko; Rehman, Mati Ur; Shimizu, Tadamichi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Dermatol, Sugitani 2630, Toyama 9300194, Japan; [Rehman, Mati Ur; Kondo, Takashi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Radiol Sci, Toyama, Japan	University of Toyama; University of Toyama	Shimizu, T (corresponding author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Dermatol, Sugitani 2630, Toyama 9300194, Japan.	shimizut@med.u-toyama.ac.jp	Rehman, Mati Ur/AAE-6885-2019	Shimizu, Tadamichi/0000-0002-3231-0279	Japan Society for the Promotion of Science [15K09761, 15K19681]; Grants-in-Aid for Scientific Research [15K09761] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research (15K09761 and 15K19681) from the Japan Society for the Promotion of Science. The authors declare no conflicts of interest.	Akagi Y, 1997, KIDNEY INT, V51, P1265, DOI 10.1038/ki.1997.172; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; Bick RJ, 2004, BURNS, V30, P329, DOI 10.1016/j.burns.2003.12.009; BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80; Boehm I, 2006, CURR MOL MED, V6, P375, DOI 10.2174/156652406777435390; Bowman PD, 1997, AM J PHYSIOL-CELL PH, V272, pC1988, DOI 10.1152/ajpcell.1997.272.6.C1988; Brock SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099795; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; Chesney J, 1999, MOL MED, V5, P181, DOI 10.1007/BF03402061; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P72, DOI 10.1073/pnas.56.1.72; Diker-Cohen T, 2006, APOPTOSIS, V11, P519, DOI 10.1007/s10495-006-5115-1; Fingerle-Rowson G, 2003, P NATL ACAD SCI USA, V100, P9354, DOI 10.1073/pnas.1533295100; Foote A, 2004, J RHEUMATOL, V31, P268; Gasparrini A, 2012, OCCUP ENVIRON MED, V69, P56, DOI 10.1136/oem.2010.059782; Hagemann T, 2007, MOL CANCER THER, V6, P1993, DOI 10.1158/1535-7163.MCT-07-0118; Hall EJ, 2012, RADIOBIOLOGY RADIOLO, P490; HARMON BV, 1990, INT J RADIAT BIOL, V58, P845, DOI 10.1080/09553009014552221; Hildebrandt B, 2002, CRIT REV ONCOL HEMAT, V43, P33, DOI 10.1016/S1040-8428(01)00179-2; Hoi AY, 2003, IMMUNOL CELL BIOL, V81, P367, DOI 10.1046/j.1440-1711.2003.01183.x; Honda A, 2009, CARCINOGENESIS, V30, P1597, DOI 10.1093/carcin/bgp160; Honma N, 2000, IMMUNOLOGY, V100, P84, DOI 10.1046/j.1365-2567.2000.00011.x; Hudson JD, 1999, J EXP MED, V190, P1375, DOI 10.1084/jem.190.10.1375; Jung HY, 2008, J BIOL CHEM, V283, P20383, DOI 10.1074/jbc.M800050200; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; LANAHAN A, 1992, MOL CELL BIOL, V12, P3919, DOI 10.1128/MCB.12.9.3919; Lippens S, 2009, APOPTOSIS, V14, P549, DOI 10.1007/s10495-009-0324-z; Martin J, 2009, FASEB J, V23, P720, DOI 10.1096/fj.08-119628; Matylevitch NP, 1998, AM J PATHOL, V153, P567, DOI 10.1016/S0002-9440(10)65599-X; MAYTIN EV, 1992, J BIOL CHEM, V267, P23189; Merk M, 2012, CYTOKINE, V59, P10, DOI 10.1016/j.cyto.2012.03.014; Metz CN, 1997, ADV IMMUNOL, V66, P197, DOI 10.1016/S0065-2776(08)60598-2; Nemajerova A, 2007, EMBO J, V26, P987, DOI 10.1038/sj.emboj.7601564; Nguyen MT, 2003, J IMMUNOL, V170, P3337, DOI 10.4049/jimmunol.170.6.3337; Qi D, 2009, J CLIN INVEST, V119, P3807, DOI 10.1172/JCI39738; Raj D, 2006, J INVEST DERMATOL, V126, P243, DOI 10.1038/sj.jid.5700008; Saegusa J, 2008, J INVEST DERMATOL, V128, P2403, DOI 10.1038/jid.2008.119; SAKAGUCHI Y, 1995, CANCER RES, V55, P5459; Schmidt-Rose T, 1999, J PHOTOCH PHOTOBIO B, V53, P144, DOI 10.1016/S1011-1344(99)00141-4; Segrelles C, 2011, BMC DERMATOL, V11, DOI 10.1186/1471-5945-11-9; Shimizu T, 1999, J INVEST DERMATOL, V112, P210, DOI 10.1046/j.1523-1747.1999.00486.x; Shimizu T, 1999, BIOCHEM BIOPH RES CO, V264, P751, DOI 10.1006/bbrc.1999.1584; Shimizu T, 1996, FEBS LETT, V381, P199, DOI 10.1016/0014-5793(96)00120-2; Sun B, 2005, CLIN CANCER RES, V11, P1050; TAMADA Y, 1994, BRIT J DERMATOL, V131, P521; Wang XQ, 2009, APOPTOSIS, V14, P721, DOI 10.1007/s10495-009-0344-8; Weisfelner Michelle Emily, 2003, J Drugs Dermatol, V2, P385; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Yoshihisa Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089569; Yoshihisa Y, 2011, J INVEST DERMATOL, V131, P925, DOI 10.1038/jid.2010.418	49	5	5	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2016	30	11					3870	3877		10.1096/fj.201600408RR	http://dx.doi.org/10.1096/fj.201600408RR			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EA3BY	27528627				2022-12-26	WOS:000386474700021
J	Dong, CJ; Cao, N; Li, L; Shang, QM				Dong, Chun-Juan; Cao, Ning; Li, Liang; Shang, Qing-Mao			Quantitative Proteomic Profiling of Early and Late Responses to Salicylic Acid in Cucumber Leaves	PLOS ONE			English	Article							2,6-DICHLOROISONICOTINIC ACID; STARCH METABOLISM; 2 INDUCERS; TOLERANCE; OXYGEN; ACCUMULATION; RESISTANCE; LIGNIN; BIOSYNTHESIS; CHLOROPLASTS	Salicylic acid (SA) is an important phytohormone that plays vital regulatory roles in plant growth, development, and stress responses. However, studies on the molecular mechanism of SA, especially during the early SA responses, are lagging behind. In this study, we initiated a comprehensive isobaric tag for relative and absolute quantitation (iTRAQ)-based proteomic analysis to explore the early and late SA-responsive proteins in leaves of cucumber (Cucumis sativus L.) seedlings. Upon SA application through the roots, endogenous SA accumulated in cucumber leaves. By assaying the changes in marker gene expression and photosynthetic rate, we collected samples at 12 h and 72 h post treatment (hpt) to profile the early and late SA responsiveness, respectively. The iTRAQ assay followed by tandem mass spectrometry revealed 135 differentially expressed proteins (DEPs) at 12 hpt and 301 DEPs at 72 hpt. The functional categories for these SA-responsive proteins included in a variety of biochemical processes, including photosynthesis, redox homeostasis, carbohydrate and energy metabolism, lipid metabolism, transport, protein folding and modification, proteolysis, cell wall organization, and the secondary phenylpropanoid pathway. Conclusively, based on the abundant changes of these DEPs, together with their putative functions, we proposed a possible SA-responsive protein network. It appears that SA could elicit reactive oxygen species (ROS) production via enhancing the photosynthetic electron transferring, and then confer some growth-promoting and stress-priming effects on cells during the late phase, including enhanced photosynthesis and ROS scavenging, altered carbon metabolic flux for the biosynthesis of amino acids and nucleotides, and cell wall reorganization. Overall, the present iTRAQ assay provides higher proteome coverage and deepened our understanding of the molecular basis of SA-responses.	[Dong, Chun-Juan; Cao, Ning; Li, Liang; Shang, Qing-Mao] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Key Lab Hort Crop Biol & Germplasm Innovat, Minist Agr, Beijing 100081, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; Ministry of Agriculture & Rural Affairs	Dong, CJ; Shang, QM (corresponding author), Chinese Acad Agr Sci, Inst Vegetables & Flowers, Key Lab Hort Crop Biol & Germplasm Innovat, Minist Agr, Beijing 100081, Peoples R China.	dongchunjuan@caas.cn; shangqingmao@caas.cn			Young Scientists Fund of the National Natural Science Foundation of China [31101548]; Special Fund for Agro-scientific Research in the Public Interest [201303014]; China Agriculture Research System [CARS-25]; Science and Technology Innovation Program of the Chinese Academy of Agricultural Sciences (CAAS-ASTIP-IVFCAAS)	Young Scientists Fund of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; China Agriculture Research System; Science and Technology Innovation Program of the Chinese Academy of Agricultural Sciences (CAAS-ASTIP-IVFCAAS)	This work was supported by grants from the Young Scientists Fund of the National Natural Science Foundation of China (No. 31101548), the Special Fund for Agro-scientific Research in the Public Interest (No. 201303014), the China Agriculture Research System (CARS-25), and the Science and Technology Innovation Program of the Chinese Academy of Agricultural Sciences (CAAS-ASTIP-IVFCAAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; Belkadhi A, 2015, ENVIRON SCI POLLUT R, V22, P1457, DOI 10.1007/s11356-014-3475-6; Bhardwaj PR, 2015, CURR PROTEIN PEPT SC, V16, P435; Blanco F, 2009, PLANT MOL BIOL, V70, P79, DOI 10.1007/s11103-009-9458-1; Bonawitz ND, 2010, ANNU REV GENET, V44, P337, DOI 10.1146/annurev-genet-102209-163508; Botte CY, 2014, TRENDS PLANT SCI, V19, P71, DOI 10.1016/j.tplants.2013.10.004; Cai H, 2014, J AGR FOOD CHEM, V62, P10118, DOI 10.1021/jf503495z; Cao HB, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0426-4; Chan ZL, 2007, J PROTEOME RES, V6, P1677, DOI 10.1021/pr060483r; Chen X, 2011, PLANT SIGNAL BEHAV, V6, P1695, DOI 10.4161/psb.6.11.17777; CONRATH U, 1995, P NATL ACAD SCI USA, V92, P7143, DOI 10.1073/pnas.92.16.7143; Deschamps P, 2008, TRENDS PLANT SCI, V13, P574, DOI 10.1016/j.tplants.2008.08.009; Dong CJ, 2014, PLANTA, V240, P687, DOI 10.1007/s00425-014-2115-1; Dong CJ, 2011, SCI HORTIC-AMSTERDAM, V129, P629, DOI 10.1016/j.scienta.2011.05.005; Donofrio NM, 2001, MOL PLANT MICROBE IN, V14, P439, DOI 10.1094/MPMI.2001.14.4.439; DURNER J, 1995, P NATL ACAD SCI USA, V92, P11312, DOI 10.1073/pnas.92.24.11312; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Eastmond PJ, 2000, J BIOL CHEM, V275, P34375, DOI 10.1074/jbc.M004945200; Evans C, 2012, ANAL BIOANAL CHEM, V404, P1011, DOI 10.1007/s00216-012-5918-6; Fan HF, 2015, J PROTEOMICS, V125, P54, DOI 10.1016/j.jprot.2015.05.001; Fu ZQ, 2012, NATURE, V486, P228, DOI 10.1038/nature11162; Gao QM, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00228; Gloerich J, 2006, FEBS LETT, V580, P2092, DOI 10.1016/j.febslet.2006.03.011; Goepfert S, 2007, CURR OPIN PLANT BIOL, V10, P245, DOI 10.1016/j.pbi.2007.04.007; Han Y, 2013, ANTIOXID REDOX SIGN, V18, P2106, DOI 10.1089/ars.2012.5052; Hao JH, 2012, PLANT SCI, V187, P69, DOI 10.1016/j.plantsci.2012.01.001; Herrera-Vasquez A, 2015, PLANT MOL BIOL REP, V33, P624, DOI 10.1007/s11105-014-0782-5; Herrera-Vasquez A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00171; Hu LP, 2011, PLANT CELL ENVIRON, V34, P1835, DOI 10.1111/j.1365-3040.2011.02380.x; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; JORGENSEN TG, 1976, SCAND J CLIN LAB INV, V36, P771, DOI 10.3109/00365517609081936; Martinez-Esteso MJ, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-167; Kang GZ, 2012, J PROTEOME RES, V11, P6066, DOI 10.1021/pr300728y; Kang GZ, 2012, BBA-PROTEINS PROTEOM, V1824, P1324, DOI 10.1016/j.bbapap.2012.07.012; Karpinski S, 1999, SCIENCE, V284, P654, DOI 10.1126/science.284.5414.654; Khan MIR, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00462; Kirch HH, 2004, TRENDS PLANT SCI, V9, P371, DOI 10.1016/j.tplants.2004.06.004; Kotting O, 2009, PLANT CELL, V21, P334, DOI 10.1105/tpc.108.064360; Kruger NJ, 2003, CURR OPIN PLANT BIOL, V6, P236, DOI 10.1016/S1369-5266(03)00039-6; Kundu S, 2011, J PROTEOMICS, V74, P337, DOI 10.1016/j.jprot.2010.11.012; Lan P, 2011, PLANT PHYSIOL, V155, P821, DOI 10.1104/pp.110.169508; Lee JY, 2011, PLANT CELL, V23, P3353, DOI 10.1105/tpc.111.087742; Li YF, 2012, PROTEOMICS, V12, P2340, DOI 10.1002/pmic.201200054; LILLEY RM, 1975, NEW PHYTOL, V75, P1, DOI 10.1111/j.1469-8137.1975.tb01365.x; Liu GT, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-110; Liu YD, 2007, PLANT J, V51, P941, DOI 10.1111/j.1365-313X.2007.03191.x; Malinovsky FG, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00178; Menden B, 2007, PHYTOCHEMISTRY, V68, P513, DOI 10.1016/j.phytochem.2006.11.011; Mittasch J, 2013, PLANT PHYSIOL, V161, P1656, DOI 10.1104/pp.113.215491; Miura K, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00004; Miura K, 2013, PLANT J, V73, P91, DOI 10.1111/tpj.12014; Munoz-Bertomeu J, 2009, PLANT PHYSIOL, V151, P541, DOI 10.1104/pp.109.143701; MURATA N, 1992, NATURE, V356, P710, DOI 10.1038/356710a0; Nagashima Y, 2014, PLANT CELL PHYSIOL, V55, P1772, DOI 10.1093/pcp/pcu108; Nair RB, 2004, PLANT CELL, V16, P544, DOI 10.1105/tpc.017509; Nie SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119853; Nogueira FCS, 2012, J PROTEOME RES, V11, P3046, DOI 10.1021/pr300192f; Norman C, 2004, PLANT PHYSIOL, V134, P492, DOI 10.1104/pp.103.031039; Pajares M, 2015, REDOX BIOL, V6, P409, DOI 10.1016/j.redox.2015.07.003; Rajjou L, 2006, PLANT PHYSIOL, V141, P910, DOI 10.1104/pp.106.082057; Ramel F, 2012, PLANT PHYSIOL, V158, P1267, DOI 10.1104/pp.111.182394; Salzman RA, 2005, PLANT PHYSIOL, V138, P352, DOI 10.1104/pp.104.058206; Sattler SE, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00070; Seyfferth C, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00697; Shi Q, 2006, PLANT GROWTH REGUL, V48, P127, DOI 10.1007/s10725-005-5482-6; Shimojima M, 2011, PROG LIPID RES, V50, P234, DOI 10.1016/j.plipres.2011.02.003; Slaymaker DH, 2002, P NATL ACAD SCI USA, V99, P11640, DOI 10.1073/pnas.182427699; Smith SJ, 2015, MOL CELL PROTEOMICS, V14, P1556, DOI 10.1074/mcp.M114.045054; Tcherkez G, 2012, CURR OPIN PLANT BIOL, V15, P308, DOI 10.1016/j.pbi.2011.12.003; Turner JG, 2002, PLANT CELL, V14, pS153, DOI 10.1105/tpc.000679; Vicente MRS, 2011, J EXP BOT, V62, P3321, DOI 10.1093/jxb/err031; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Wu WW, 2006, J PROTEOME RES, V5, P651, DOI 10.1021/pr050405o; Xie ZX, 1999, PLANT PHYSIOL, V120, P217, DOI 10.1104/pp.120.1.217; Yan SP, 2014, CURR OPIN PLANT BIOL, V20, P64, DOI 10.1016/j.pbi.2014.04.006; Zeeman SC, 2004, PLANT PHYSIOL, V135, P849, DOI 10.1104/pp.103.032631; Zhang Y, 2016, PLANT PHYSIOL BIOCH, V106, P64, DOI 10.1016/j.plaphy.2016.04.047; Zhou YH, 2006, PLANT CELL PHYSIOL, V47, P192, DOI 10.1093/pcp/pci234; Zieske LR, 2006, J EXP BOT, V57, P1501, DOI 10.1093/jxb/erj168	79	5	8	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0161395	10.1371/journal.pone.0161395	http://dx.doi.org/10.1371/journal.pone.0161395			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27551830	Green Published, gold, Green Submitted			2022-12-26	WOS:000381768800036
J	Manesso, E; Kueh, HY; Freedman, G; Rothenberg, EV; Peterson, C				Manesso, Erica; Kueh, Hao Yuan; Freedman, George; Rothenberg, Ellen V.; Peterson, Carsten			Irreversibility of T-Cell Specification: Insights from Computational Modelling of a Minimal Network Architecture	PLOS ONE			English	Article							TRANSCRIPTION FACTOR PU.1; GENE REGULATORY NETWORKS; LINEAGE SPECIFICATION; IKAROS REPRESSES; NOTCH; DIFFERENTIATION; PROGENITORS; COMMITMENT; EXPRESSION; IDENTITY	Background/Objectives A cascade of gene activations under the control of Notch signalling is required during T-cell specification, when T-cell precursors gradually lose the potential to undertake other fates and become fully committed to the T-cell lineage. We elucidate how the gene/protein dynamics for a core transcriptional module governs this important process by computational means. Methods We first assembled existing knowledge about transcription factors known to be important for T-cell specification to form a minimal core module consisting of TCF-1, GATA-3, BCL11B, and PU.1 aiming at dynamical modeling. Model architecture was based on published experimental measurements of the effects on each factor when each of the others is perturbed. While several studies provided gene expression measurements at different stages of T-cell development, pure time series are not available, thus precluding a straightforward study of the dynamical interactions among these genes. We therefore translate stage dependent data into time series. A feed-forward motif with multiple positive feedbacks can account for the observed delay between BCL11B versus TCF-1 and GATA-3 activation by Notch signalling. With a novel computational approach, all 32 possible interactions among Notch signalling, TCF-1, and GATA-3 are explored by translating combinatorial logic expressions into differential equations for BCL11B production rate. Results Our analysis reveals that only 3 of 32 possible configurations, where GATA-3 works as a dimer, are able to explain not only the time delay, but very importantly, also give rise to irreversibility. The winning models explain the data within the 95% confidence region and are consistent with regard to decay rates. Conclusions This first generation model for early T-cell specification has relatively few players. Yet it explains the gradual transition into a committed state with no return. Encoding logics in a rate equation setting allows determination of binding properties beyond what is possible in a Boolean network.	[Manesso, Erica; Peterson, Carsten] Lund Univ, Dept Astron & Theoret Phys, Computat Biol & Biol Phys, SE-22362 Lund, Sweden; [Kueh, Hao Yuan; Freedman, George; Rothenberg, Ellen V.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Kueh, Hao Yuan] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Freedman, George] Univ Calif San Francisco, San Francisco, CA 94143 USA	Lund University; California Institute of Technology; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco	Peterson, C (corresponding author), Lund Univ, Dept Astron & Theoret Phys, Computat Biol & Biol Phys, SE-22362 Lund, Sweden.; Rothenberg, EV (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	evroth@its.caltech.edu; carsten@thep.lu.se		Rothenberg, Ellen/0000-0002-3901-347X	Swedish Research Council [Vr 621-2008-3074]; Swedish Foundation for Strategic Research [A3 04 159p]; United States Public Health Service (NIH) [HL119102, AI095943]; NIH [K99/R00, HL119638-02]; Albert Billings Ruddock Professorship of Biology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL119638, R01HL119102, K99HL119638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095943] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); United States Public Health Service (NIH)(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Billings Ruddock Professorship of Biology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Swedish Research Council (Vr 621-2008-3074), the Swedish Foundation for Strategic Research (A3 04 159p), and the United States Public Health Service (NIH grants HL119102 to EVR and CP, AI095943 to EVR). HYK is supported by an NIH K99/R00 award HL119638-02 and EVR by the Albert Billings Ruddock Professorship of Biology. EM acknowledges Professor Rudiyanto Gunawan (ETH Zurich) for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates DL, 2008, J MOL BIOL, V381, P1292, DOI 10.1016/j.jmb.2008.06.072; Belyaev NN, 2012, IMMUNOGENETICS, V64, P591, DOI 10.1007/s00251-012-0620-6; Champhekar A, 2015, GENE DEV, V29, P832, DOI 10.1101/gad.259879.115; David-Fung ES, 2009, DEV BIOL, V325, P444, DOI 10.1016/j.ydbio.2008.10.021; Davidson EH, 2010, NATURE, V468, P911, DOI 10.1038/nature09645; Del Real MM, 2013, DEVELOPMENT, V140, P1207, DOI 10.1242/dev.088559; Franco CB, 2006, P NATL ACAD SCI USA, V103, P11993, DOI 10.1073/pnas.0601188103; Garcia-Ojeda ME, 2013, BLOOD, V121, P1749, DOI 10.1182/blood-2012-06-440065; Georgescu C, 2008, P NATL ACAD SCI USA, V105, P20100, DOI 10.1073/pnas.0806501105; Germar K, 2011, P NATL ACAD SCI USA, V108, P20060, DOI 10.1073/pnas.1110230108; Guo Y, 2008, BLOOD, V112, P480, DOI 10.1182/blood-2007-10-120261; Huang G, 2008, NAT GENET, V40, P51, DOI 10.1038/ng.2007.7; Ikawa T, 2010, SCIENCE, V329, P93, DOI 10.1126/science.1188995; Kalyanmoy D, 2002, IEEE T EVOLUTIONARY, V6, P181; Karlebach G, 2008, NAT REV MOL CELL BIO, V9, P770, DOI 10.1038/nrm2503; Kawazu M, 2007, J IMMUNOL, V179, P5335, DOI 10.4049/jimmunol.179.8.5335; Kleinmann E, 2008, MOL CELL BIOL, V28, P7465, DOI 10.1128/MCB.00715-08; Krangel MS, 2009, CURR OPIN IMMUNOL, V21, P133, DOI 10.1016/j.coi.2009.03.009; Kueh HY, 2012, WIRES SYST BIOL MED, V4, P79, DOI 10.1002/wsbm.162; Leddin M, 2011, BLOOD, V117, P2827, DOI 10.1182/blood-2010-08-302976; Li P, 2010, SCIENCE, V329, P85, DOI 10.1126/science.1188063; Love PE, 2011, NAT REV IMMUNOL, V11, P469, DOI 10.1038/nri2989; Lunn DJ, 2011, STAT MED, V30, P2234, DOI 10.1002/sim.4254; Manesso E, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0774; Mangan S, 2003, J MOL BIOL, V334, P197, DOI 10.1016/j.jmb.2003.09.049; Martinez MR, 2012, P NATL ACAD SCI USA, V109, P2672, DOI 10.1073/pnas.1113019109; Mingueneau M, 2013, NAT IMMUNOL, V14, P619, DOI 10.1038/ni.2590; Naldi A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000912; Oh P, 2013, CELL STEM CELL, V13, P190, DOI 10.1016/j.stem.2013.05.015; Okuno Y, 2005, MOL CELL BIOL, V25, P2832, DOI 10.1128/MCB.25.7.2832-2845.2005; Rosenbauer F, 2006, NAT GENET, V38, P27, DOI 10.1038/ng1679; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Rothenberg EV, 2012, CURR OPIN IMMUNOL, V24, P132, DOI 10.1016/j.coi.2011.12.012; Rothenberg EV, 2011, J IMMUNOL, V186, P6649, DOI 10.4049/jimmunol.1003703; Sambandam A, 2005, NAT IMMUNOL, V6, P663, DOI 10.1038/ni1216; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Sciammas R, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.25; Scripture-Adams DD, 2014, J IMMUNOL, V193, P3470, DOI 10.4049/jimmunol.1301663; SHEA MA, 1985, J MOL BIOL, V181, P211, DOI 10.1016/0022-2836(85)90086-5; Tabrizifard S, 2004, J IMMUNOL, V173, P1094, DOI 10.4049/jimmunol.173.2.1094; Taghon TN, 2005, GENE DEV, V19, P965, DOI 10.1101/gad.1298305; Taghon T, 2007, NAT IMMUNOL, V8, P845, DOI 10.1038/ni1486; Tan JB, 2005, NAT IMMUNOL, V6, P671, DOI 10.1038/ni1217; Tydell CC, 2007, J IMMUNOL, V179, P421, DOI 10.4049/jimmunol.179.1.421; Van de Walle I, 2009, BLOOD, V113, P2988, DOI 10.1182/blood-2008-06-164871; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Weerkamp F, 2006, LEUKEMIA, V20, P1967, DOI 10.1038/sj.leu.2404396; Yui MA, 2014, NAT REV IMMUNOL, V14, P529, DOI 10.1038/nri3702; Yui MA, 2010, J IMMUNOL, V185, P284, DOI 10.4049/jimmunol.1000679; Zarnegar MA, 2012, ONCOGENE, V31, P4647, DOI 10.1038/onc.2011.597; Zarnegar MA, 2010, MOL CELL BIOL, V30, P4922, DOI 10.1128/MCB.00354-10; Zhang JLA, 2012, CELL, V149, P467, DOI 10.1016/j.cell.2012.01.056	52	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0161260	10.1371/journal.pone.0161260	http://dx.doi.org/10.1371/journal.pone.0161260			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27551921	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000381768800027
J	Hoonakker, ME; Verhagen, LM; Pupo, E; de Haan, A; Metz, B; Hendriksen, CFM; Han, WGH; Sloots, A				Hoonakker, Marieke E.; Verhagen, Lisa M.; Pupo, Elder; de Haan, Alex; Metz, Bernard; Hendriksen, Coenraad F. M.; Han, Wanda G. H.; Sloots, Arjen			Vaccine-Mediated Activation of Human TLR4 Is Affected by Modulation of Culture Conditions during Whole-Cell Pertussis Vaccine Preparation	PLOS ONE			English	Article							BORDETELLA-PERTUSSIS; PHOSPHATE GROUPS; ACYL-CHAIN; LIPOPOLYSACCHARIDE BIOSYNTHESIS; HAEMOPHILUS-INFLUENZAE; IMMUNE-RESPONSES; KDO KINASE; INFECTION; GLUCOSAMINE; PROTECTION	The potency of whole-cell pertussis (wP) vaccines is still determined by an intracerebral mouse protection test. To allow development of suitable in vitro alternatives to this test, insight into relevant parameters to monitor the consistency of vaccine quality is essential. To this end, a panel of experimental wP vaccines of varying quality was prepared by sulfate- mediated suppression of the BvgASR master virulence regulatory system of Bordetella pertussis during cultivation. This system regulates the transcription of a range of virulence proteins, many of which are considered important for the induction of effective host immunity. The protein compositions and in vivo potencies of the vaccines were BvgASR dependent, with the vaccine containing the highest amount of virulence proteins having the highest in vivo potency. Here, the capacities of these vaccines to stimulate human Toll-like receptors (hTLR) 2 and 4 and the role these receptors play in wP vaccine-mediated activation of antigen-presenting cells in vitro were studied. Prolonged BvgASR suppression was associated with a decreased capacity of vaccines to activate hTLR4. In contrast, no significant differences in hTLR2 activation were observed. Similarly, vaccine-induced activation of MonoMac-6 and monocyte-derived dendritic cells was strongest with the highest potency vaccine. Blocking of TLR2 and TLR4 showed that differences in antigen-presenting cell activation could be largely attributed to vaccine-dependent variation in hTLR4 signalling. Interestingly, this BvgASR-dependent decrease in hTLR4 activation coincided with a reduction in GlcN-modified lipopolysaccharides in these vaccines. Accordingly, expression of the lgmA-C genes, required for this glucosamine modification, was significantly reduced in bacteria exposed to sulfate. Together, these findings demonstrate that the BvgASR status of bacteria during wP vaccine preparation is critical for their hTLR4 activation capacity and suggest that including such parameters to assess consistency of newly produced vaccines could bring in vitro testing of vaccine quality a step closer.	[Hoonakker, Marieke E.; Verhagen, Lisa M.; Pupo, Elder; de Haan, Alex; Metz, Bernard; Hendriksen, Coenraad F. M.; Sloots, Arjen] Inst Translat Vaccinol Intravacc, Bilthoven, Netherlands; [Hoonakker, Marieke E.; Hendriksen, Coenraad F. M.] Univ Utrecht, Dept Anim Sci & Soc, Fac Vet Med, Utrecht, Netherlands; [Verhagen, Lisa M.; Han, Wanda G. H.] Natl Inst Publ Hlth & Environm, Ctr Immunol Infect Dis & Vaccines, Bilthoven, Netherlands	Utrecht University; Netherlands National Institute for Public Health & the Environment	Hoonakker, ME (corresponding author), Inst Translat Vaccinol Intravacc, Bilthoven, Netherlands.; Hoonakker, ME (corresponding author), Univ Utrecht, Dept Anim Sci & Soc, Fac Vet Med, Utrecht, Netherlands.	Marieke.Hoonakker@intravacc.nl		Verhagen, Lisa/0000-0002-4130-580X				Allen A, 1996, MOL MICROBIOL, V19, P37, DOI 10.1046/j.1365-2958.1996.354877.x; Allen AG, 1998, J BACTERIOL, V180, P35, DOI 10.1128/JB.180.1.35-40.1998; Allen AG, 1998, MOL MICROBIOL, V29, P27, DOI 10.1046/j.1365-2958.1998.00878.x; [Anonymous], 2014, WKLY EPIDEMIOL REC, V21, P230; Baart GJE, 2008, BIOTECHNOL BIOENG, V101, P1022, DOI 10.1002/bit.22016; BELLALOU J, 1984, ANN INST PASTEUR MIC, VB135, P101, DOI 10.1016/S0769-2609(84)80047-2; Caroff M, 2000, FEBS LETT, V477, P8, DOI 10.1016/S0014-5793(00)01720-8; de Gouw D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084523; de Gouw D, 2011, FEMS MICROBIOL REV, V35, P441, DOI 10.1111/j.1574-6976.2010.00257.x; de Tejada GM, 1998, INFECT IMMUN, V66, P2762, DOI 10.1128/IAI.66.6.2762-2768.1998; Decker KB, 2012, MICROBIOL-SGM, V158, P1665, DOI 10.1099/mic.0.058941-0; Dunne A, 2015, MUCOSAL IMMUNOL, V8, P607, DOI 10.1038/mi.2014.93; Fedele G, 2008, J IMMUNOL, V181, P208, DOI 10.4049/jimmunol.181.1.208; Fedele G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008734; Flo TH, 2001, J LEUKOCYTE BIOL, V69, P474; Fransen F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015692; Geurtsen J, 2007, J BIOL CHEM, V282, P37875, DOI 10.1074/jbc.M706391200; Geurtsen J, 2009, INFECT IMMUN, V77, P2602, DOI 10.1128/IAI.00033-09; HAMSTRA HJ, 1995, VACCINE, V13, P747, DOI 10.1016/0264-410X(94)00040-T; Harvill ET, 2000, INFECT IMMUN, V68, P6720, DOI 10.1128/IAI.68.12.6720-6728.2000; Hendriksen C F, 2000, ILAR J, V41, P105; Higgins SC, 2006, J IMMUNOL, V177, P7980, DOI 10.4049/jimmunol.177.11.7980; Higgs R, 2012, MUCOSAL IMMUNOL, V5, P485, DOI 10.1038/mi.2012.54; Hoonakker ME, 2015, BIOLOGICALS, V43, P100, DOI 10.1016/j.biologicals.2014.12.002; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kondakov A, 2005, EUR J MASS SPECTROM, V11, P535, DOI 10.1255/ejms.721; LeBouder E, 2006, J IMMUNOL, V176, P3742, DOI 10.4049/jimmunol.176.6.3742; Libster R, 2012, EXPERT REV VACCINES, V11, P1331, DOI [10.1586/erv.12.118, 10.1586/ERV.12.118]; Liko J, 2013, NEW ENGL J MED, V368, P581, DOI 10.1056/NEJMc1212006; Marr N, 2008, J BACTERIOL, V190, P4281, DOI 10.1128/JB.01875-07; Marr N, 2010, INFECT IMMUN, V78, P2060, DOI 10.1128/IAI.01346-09; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; Merkel TJ, 1998, INFECT IMMUN, V66, P4367; Mills KHG, 1998, INFECT IMMUN, V66, P594, DOI 10.1128/IAI.66.2.594-602.1998; Nakamura MM, 2006, INFECT IMMUN, V74, P5537, DOI 10.1128/IAI.00781-06; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Pharmacopeia E, 2013, ASSAY PERTUSSIS VACC, P242; Preston A, 2002, MICROB PATHOGENESIS, V33, P91, DOI 10.1006/mpat.2002.0511; ROBERTS M, 1992, VACCINE, V10, P43, DOI 10.1016/0264-410X(92)90418-J; Robins LI, 2009, BIOCHEMISTRY-US, V48, P6191, DOI 10.1021/bi900629e; ROBINSON A, 1989, VACCINE, V7, P321, DOI 10.1016/0264-410X(89)90193-X; Shah NR, 2014, ANTIMICROB AGENTS CH, V58, P4931, DOI 10.1128/AAC.02590-14; Shah NR, 2013, J BIOL CHEM, V288, P11751, DOI 10.1074/jbc.M112.434365; Sheridan SL, 2012, JAMA-J AM MED ASSOC, V308, P454, DOI 10.1001/jama.2012.6364; Thalen M, 1999, J BIOTECHNOL, V75, P147, DOI 10.1016/S0168-1656(99)00155-8; Thalen M, 2006, BIOLOGICALS, V34, P213, DOI 10.1016/j.biologicals.2005.11.002; Trent MS, 2001, J BIOL CHEM, V276, P43122, DOI 10.1074/jbc.M106961200; van de Waterbeemd B, 2009, BIOTECHNOL BIOENG, V103, P900, DOI 10.1002/bit.22326; vanStraatenvandeKappelle I, 1997, BIOLOGICALS, V25, P41, DOI 10.1006/biol.1996.0059; WEISS AA, 1984, INFECT IMMUN, V43, P263, DOI 10.1128/IAI.43.1.263-269.1984; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83; Weyrich LS, 2014, J INFECT DIS, V209, P913, DOI 10.1093/infdis/jit597; White KA, 1997, J BIOL CHEM, V272, P16555, DOI 10.1074/jbc.272.26.16555; White KA, 1999, J BIOL CHEM, V274, P31391, DOI 10.1074/jbc.274.44.31391; WHO, 2007, WHO TECHN REP SER, V941, P301; WILM MS, 1994, INT J MASS SPECTROM, V136, P167, DOI 10.1016/0168-1176(94)04024-9; Witt MA, 2013, CLIN INFECT DIS, V56, P1248, DOI 10.1093/cid/cit046; Xing D, 2001, VACCINE, V20, P342, DOI 10.1016/S0264-410X(01)00372-3; ZIEGLERHEITBROCK HWL, 1988, INT J CANCER, V41, P456, DOI 10.1002/ijc.2910410324	59	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161428	10.1371/journal.pone.0161428	http://dx.doi.org/10.1371/journal.pone.0161428			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548265	Green Submitted, Green Published, gold			2022-12-26	WOS:000381768400056
J	Robertson, J; Jepson, R; Macvean, A; Gray, S				Robertson, Judy; Jepson, Ruth; Macvean, Andrew; Gray, Stuart			Understanding the Importance of Context: A Qualitative Study of a Location-Based Exergame to Enhance School Childrens Physical Activity	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; SELF-EFFICACY	Many public health interventions are less effective than expected in 'real life settings', yet little work is undertaken to understand the reasons why. The effectiveness of complex public health interventions can often be traced back to a robust programme theory (how and why an intervention brings about a change in outcome(s)) and assumptions that are made about the context in which it is implemented. Understanding whether effectiveness (or lack thereof) is due to the intervention or the context is hugely helpful in decisions about whether to a) modify the intervention; b) modify the context; c) stop providing the intervention. Exergames-also known as Active Video Games or AVGS-are video games which use the player's bodily movements as input and have potential to increase physical activity in children. However, the results of a recent pilot randomised controlled trial (RCT) of a location-based exergame (FitQuest) in a school setting were inconclusive; no significant effect was detected for any of the outcome measures. The aimof this study was to explore whether the programme theory for FitQuest was correct with respect to how and why it would change children's perceptions of physical activity (PA) and exercise self-efficacy in the school setting. A further aim was to investigate the features of the school setting (context) that may impact on FitQuest's implementation and effectiveness. Qualitative data (gathered during the RCT) were gathered from interviews with teachers and children, and observation of sessions using FitQuest. Thematic analysis indicated that whilst children enjoyed playing the game, engaged with goal setting within the game context and undertook low to vigorous physical activity, there were significant contextual factors that prevented it from being played as often as intended. These included environmental factors (e. g. size of the playground), school factors (cancellations due to other activities), school technology policy (rules relating tomobile phone usage) and teacher factors (engagement with the intervention). A revised logicmodel for the FitQuest intervention indicates how both the design of exergame technology (intervention) and features of the school environment (context) could be improved to increase chances of effectiveness in the future.	[Robertson, Judy; Gray, Stuart] Univ Edinburgh, Moray House Sch Educ, Edinburgh, Midlothian, Scotland; [Jepson, Ruth] Univ Edinburgh, Scottish Collaborat Publ Hlth Res & Policy, Edinburgh, Midlothian, Scotland; [Macvean, Andrew] Heriot Watt Univ, Comp Sci, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; Heriot Watt University	Robertson, J (corresponding author), Univ Edinburgh, Moray House Sch Educ, Edinburgh, Midlothian, Scotland.	judy.robertson@ed.ac.uk			Heriot-Watt University [F12R10074]; UK Engineering and Physical Sciences Research Council; Medical Research Council [MR/K023209/1] Funding Source: researchfish; MRC [MR/K023209/1] Funding Source: UKRI	Heriot-Watt University; UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by an Impact Acceleration Grant from the UK Engineering and Physical Sciences Research Council (http://www.epsrc.ac.uk/). This grant was held by Dr Robertson and was administered by Heriot-Watt University with grant number F12R10074. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2008, HEALTH PSYCHOL, V27, P379, DOI 10.1037/0278-6133.27.3.379; [Anonymous], 2009, INTERNET EVIDENCE BA, DOI DOI 10.1002/EBCH.461; BANDURA A, 1982, AM PSYCHOL, V37, P122, DOI 10.1037/0003-066X.37.2.122; Bandura A, 1986, PRENTICEHALL SERIES; BBC, 2014, NEWS; Bell M, 2006, P SIGCHI C HUM FACT, P417, DOI DOI 10.1145/1124772.1124835; Blair SN, 2009, BRIT J SPORT MED, V43, P1; Bonell C, 2012, SOC SCI MED, V75, P2299, DOI 10.1016/j.socscimed.2012.08.032; Broll G, 2005, LECT NOTES COMPUT SC, V3711, P155; Carson RL, 2013, AM J LIFESTYLE MED, V7, P343, DOI 10.1177/1559827613492604; Casey MM, 2009, QUAL HEALTH RES, V19, P881, DOI 10.1177/1049732309338198; Chalmers M., 2005, P 2005 ACM SIGCHI IN, P306, DOI [DOI 10.1145/1178477.1178533, 10.1145/1178477. 1178533]; Cullen KW, 2004, HEALTH EDUC BEHAV, V31, P258, DOI 10.1177/1090198103260518; Currie C., SOCIAL DETERMINANTS, V6, DOI [10.1358/dof.2005.030.10.942816, DOI 10.1358/DOF.2005.030.10.942816]; Delidou E, 2016, EUR PHYS EDUC REV, V22, P215, DOI 10.1177/1356336X15598790; Department of Health Physical Activity Health Improvement and Protection, 2011, START ACT STAY ACT R; Eiriksdottir E., 2011, ASSESSING HLTH GAMES; Ennis CD, 2013, J SPORT HEALTH SCI, V2, P152, DOI 10.1016/j.jshs.2013.02.004; Foster-Fishman PG, 2007, AM J COMMUN PSYCHOL, V39, P197, DOI 10.1007/s10464-007-9109-0; Fulton J, 2010, CIRCULATION, V125AD, pAP260; Gao QF, 2014, COMPUT HUM BEHAV, V38, P25, DOI 10.1016/j.chb.2014.05.011; Hamari J, 2014, P ANN HICSS, P3025, DOI 10.1109/HICSS.2014.377; Hawe P, 2009, AM J COMMUN PSYCHOL, V43, P267, DOI 10.1007/s10464-009-9229-9; Hayes N., 2000, DOING PSYCHOL RES GA; Hekler E.B., 2013, P SIGCHI C HUMAN FAC, P3307, DOI DOI 10.1145/2470654.2466452; Jenkinson KA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-55; Klasnja P, 2011, CHI 2011; Latif H, 2011, HEALTH EDUC BEHAV, V38, P521, DOI 10.1177/1090198110385774; Macvean A, 2013, UNDERSTANDING EXERGA; Macvean Andrew, 2013, UNDERSTANDING EXERGA, P1251, DOI [10.1145/2470654.2466163, DOI 10.1145/2470654.2466163]; Neumark-Sztainer D, 2003, ARCH PEDIAT ADOL MED, V157, P803, DOI 10.1001/archpedi.157.8.803; Ofcom, 2015, CHILDR PAR MED US AT; Pender N.J., 2002, HLTH PROMOTION NURSI, V4, P1; Peng W, 2013, HEALTH EDUC BEHAV, V40, P171, DOI 10.1177/1090198112444956; Peng W, 2011, CYBERPSYCH BEH SOC N, V14, P681, DOI 10.1089/cyber.2010.0578; Richard L, 2011, ANNU REV PUBL HEALTH, V32, P307, DOI 10.1146/annurev-publhealth-031210-101141; Robertson J, INT J CHILD COMPUT I; STRECHER VJ, 1986, HEALTH EDUC QUART, V13, P73, DOI 10.1177/109019818601300108; The Parliamentary Office of Science and Technology, 2012, POSTNOTE 405 IMP VID; The Scottish Government, 2012, SCOTT IND MULT DEPR; Wechsler H, 2000, PREV MED, V31, pS121, DOI 10.1006/pmed.2000.0649; Wells M, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-95; Wight D, 2014, EUR J PUBLIC HEALTH, V24, P96; Xu Y., 2012, P INT C FDN DIG GAM, P49, DOI DOI 10.1145/2282338.2282352; Zuckerman O, 2014, PERS UBIQUIT COMPUT, V18, P1705, DOI 10.1007/s00779-014-0783-2	45	15	17	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0160927	10.1371/journal.pone.0160927	http://dx.doi.org/10.1371/journal.pone.0160927			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT8TP	27548504	Green Published, Green Submitted, gold			2022-12-26	WOS:000381768400023
J	Walter, JM; Tschoeke, DA; Meirelles, PM; de Oliveira, L; Leomil, L; Tenorio, M; Valle, R; Salomon, PS; Thompson, CC; Thompson, FL				Walter, Juline M.; Tschoeke, Diogo A.; Meirelles, Pedro M.; de Oliveira, Louisi; Leomil, Luciana; Tenorio, Marcio; Valle, Rogerio; Salomon, Paulo S.; Thompson, Cristiane C.; Thompson, Fabiano L.			Taxonomic and Functional Metagenomic Signature of Turfs in the Abrolhos Reef System (Brazil)	PLOS ONE			English	Article							CORAL; BACTERIA; CYANOBACTERIA; ACQUISITION; ECOLOGY; DAMAGE; MATS; DMSP	Turfs are widespread assemblages (consisting of microbes and algae) that inhabit reef systems. They are the most abundant benthic component in the Abrolhos reef system (Brazil), representing greater than half the coverage of the entire benthic community. Their presence is associated with a reduction in three-dimensional coral reef complexity and decreases the habitats available for reef biodiversity. Despite their importance, the taxonomic and functional diversity of turfs remain unclear. We performed a metagenomics and pigments profile characterization of turfs from the Abrolhos reefs. Turf microbiome primarily encompassed Proteobacteria (mean 40.57% +/- s.d. 10.36, N = 1.548,192), Cyanobacteria (mean 35.04% +/- s.d. 15.5, N = 1.337,196), and Bacteroidetes (mean 11.12% +/- s.d. 4.25, N = 424,185). Oxygenic and anoxygenic phototrophs, chemolithotrophs, and aerobic anoxygenic phototrophic (AANP) bacteria showed a conserved functional trait of the turf microbiomes. Genes associated with oxygenic photosynthesis, AANP, sulfur cycle (S oxidation, and DMSP consumption), and nitrogen metabolism (N-2 fixation, ammonia assimilation, dissimilatory nitrate and nitrite ammonification) were found in the turf microbiomes. Principal component analyses of the most abundant taxa and functions showed that turf microbiomes differ from the other major Abrolhos benthic microbiomes (i.e., corals and rhodoliths) and seawater. Taken together, these features suggest that turfs have a homogeneous functional core across the Abrolhos Bank, which holds diverse microbial guilds when comparing with other benthic organisms.	[Walter, Juline M.; Tschoeke, Diogo A.; Meirelles, Pedro M.; de Oliveira, Louisi; Leomil, Luciana; Thompson, Cristiane C.; Thompson, Fabiano L.] Univ Fed Rio de Janeiro, Inst Biol, Microbiol Lab, Rio De Janeiro, Brazil; [Walter, Juline M.; Tschoeke, Diogo A.; de Oliveira, Louisi; Leomil, Luciana; Salomon, Paulo S.; Thompson, Fabiano L.] Univ Fed Rio de Janeiro, Ctr Technol CT2, SAGE COPPE, Rio De Janeiro, Brazil; [Tenorio, Marcio; Salomon, Paulo S.] Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, Brazil; [Valle, Rogerio] Univ Fed Rio de Janeiro, COPPE Prod Engn Program, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Thompson, FL (corresponding author), Univ Fed Rio de Janeiro, Inst Biol, Microbiol Lab, Rio De Janeiro, Brazil.; Thompson, FL (corresponding author), Univ Fed Rio de Janeiro, Ctr Technol CT2, SAGE COPPE, Rio De Janeiro, Brazil.	fabianothompson1@gmail.com	Salomon, Paulo Sergio/D-3310-2011; Tschoeke, Diogo A/F-9913-2019; Meirelles, Pedro/GRY-0806-2022; Meirelles, Pedro/AAK-5942-2021; Leomil, Luciana/O-4860-2019; Tschoeke, Diogo/AAB-4739-2021; Meirelles, Pedro/AAL-4542-2020	Salomon, Paulo Sergio/0000-0002-0037-6011; Tschoeke, Diogo A/0000-0001-8134-4259; Meirelles, Pedro/0000-0002-1306-0331; Walter, Juline/0000-0002-8073-2142; Thompson, Fabiano/0000-0002-7562-1683	National Counsel of Technological and Scientific Development (CNPq); Coordination for the Improvement of Higher Education Personnel (CAPES); Rio de Janeiro Research Foundation (FAPERJ)	National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Rio de Janeiro Research Foundation (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	The authors received funding from National Counsel of Technological and Scientific Development (CNPq), Coordination for the Improvement of Higher Education Personnel (CAPES), Rio de Janeiro Research Foundation (FAPERJ) for this work.	Ainsworth TD, 2015, ISME J, V9, P2261, DOI 10.1038/ismej.2015.39; Amado GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035171; Andrews S., 2010, FASTQC QUALITY CONTR; Barott KL, 2012, TRENDS MICROBIOL, V20, P621, DOI 10.1016/j.tim.2012.08.004; Barott KL, 2012, MAR ECOL PROG SER, V460, P1, DOI 10.3354/meps09874; Barott KL, 2012, P ROY SOC B-BIOL SCI, V279, P1655, DOI 10.1098/rspb.2011.2155; Barott KL, 2011, ENVIRON MICROBIOL, V13, P1192, DOI 10.1111/j.1462-2920.2010.02419.x; Behrendt L, 2011, ISME J, V5, P1072, DOI 10.1038/ismej.2010.195; BENNETT A, 1973, J CELL BIOL, V58, P419, DOI 10.1083/jcb.58.2.419; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bruce T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036687; BRYANT DA, 1979, ARCH MICROBIOL, V123, P113, DOI 10.1007/BF00446810; Casadevall A, 2015, INFECT IMMUN, V83, P2, DOI 10.1128/IAI.02627-14; Cavalcanti GS, 2013, CONT SHELF RES, V70, P126, DOI 10.1016/j.csr.2013.05.011; Cavalcanti GS, 2014, ISME J, V8, P52, DOI 10.1038/ismej.2013.133; Chen M, 2010, SCIENCE, V329, P1318, DOI 10.1126/science.1191127; Connell SD, 2014, MAR ECOL PROG SER, V495, P299, DOI 10.3354/meps10513; Cordero OX, 2012, P NATL ACAD SCI USA, V109, P20059, DOI 10.1073/pnas.1213344109; Cordero OX, 2012, SCIENCE, V337, P1228, DOI 10.1126/science.1219385; Costa TRD, 2015, NAT REV MICROBIOL, V13, P343, DOI 10.1038/nrmicro3456; Dinsdale EA, 2008, NATURE, V455, P830, DOI 10.1038/nature07346; Dinsdale EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001584; Dinsdale Elizabeth A., 2013, Frontiers in Genetics, V4, P41, DOI 10.3389/fgene.2013.00041; Echenique-Subiabre I, 2015, MICROB ECOL, V69, P234, DOI 10.1007/s00248-014-0496-0; Egan S, 2014, ENVIRON MICROBIOL, V16, P925, DOI 10.1111/1462-2920.12288; Egan S, 2013, FEMS MICROBIOL REV, V37, P462, DOI 10.1111/1574-6976.12011; Faraldo-Gomez JD, 2003, NAT REV MOL CELL BIO, V4, P105, DOI 10.1038/nrm1015; Fernandes N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027387; Fierer N, 2012, P NATL ACAD SCI USA, V109, P21390, DOI 10.1073/pnas.1215210110; Francini RB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054260; Garcia GD, 2013, MICROB ECOL, V65, P1076, DOI 10.1007/s00248-012-0161-4; Goldberg WM., 2013, BIOL REEFS REEF ORGA, DOI 10.7208/chicago/9780226925370.001.0001; Haas AF, 2013, PEERJ, V1, DOI 10.7717/peerj.108; Haas AF, 2013, PEERJ, V1, DOI 10.7717/peerj.106; Haas AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027973; Hester ER, 2016, ISME J, V10, P1157, DOI 10.1038/ismej.2015.190; Hollants J, 2013, FEMS MICROBIOL ECOL, V83, P1, DOI 10.1111/j.1574-6941.2012.01446.x; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Lesser MP, 2004, SCIENCE, V305, P997, DOI 10.1126/science.1099128; Mason OU, 2012, ISME J, V6, P1715, DOI 10.1038/ismej.2012.59; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Moran NA, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002311; Nelson CE, 2013, ISME J, V7, P962, DOI 10.1038/ismej.2012.161; NEVEUX J, 1993, DEEP-SEA RES PT I, V40, P1747, DOI 10.1016/0967-0637(93)90030-7; Oksanen J., 2005, VEGAN R FUNCTIONS VE; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; R Core Team, 2021, R LANGUAGE ENV STAT; Raina JB, 2013, NATURE, V502, P677, DOI 10.1038/nature12677; Raina JB, 2010, TRENDS MICROBIOL, V18, P101, DOI 10.1016/j.tim.2009.12.002; Richardson LL, 2009, DIS AQUAT ORGAN, V87, P79, DOI 10.3354/dao02083; Rodrigue S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011840; Roff G, 2012, TRENDS ECOL EVOL, V27, P404, DOI 10.1016/j.tree.2012.04.007; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Sheppard CRC, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198566359.001.0001; STAL LJ, 1995, NEW PHYTOL, V131, P1, DOI 10.1111/j.1469-8137.1995.tb03051.x; Steunou AS, 2006, P NATL ACAD SCI USA, V103, P2398, DOI 10.1073/pnas.0507513103; Sweet M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062580; Tenorio MMB, 2005, ESTUAR COAST SHELF S, V64, P531, DOI 10.1016/j.ecss.2005.02.030; Teske A, 1998, APPL ENVIRON MICROB, V64, P2943; Weber M, 2012, P NATL ACAD SCI USA, V109, pE1558, DOI 10.1073/pnas.1100715109; Welker M, 2006, FEMS MICROBIOL REV, V30, P530, DOI 10.1111/j.1574-6976.2006.00022.x; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickham H, 2007, J STAT SOFTW, V21, P1; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yoon S, 2015, ISME J, V9, P1093, DOI 10.1038/ismej.2014.201	67	17	17	5	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161168	10.1371/journal.pone.0161168	http://dx.doi.org/10.1371/journal.pone.0161168			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548380	gold, Green Published, Green Submitted			2022-12-26	WOS:000381768400031
J	Wrzesniak, M; Kepinska, M; Krolik, M; Milnerowicz, H				Wrzesniak, Marta; Kepinska, Marta; Krolik, Malgorzata; Milnerowicz, Halina			The Influence of Tobacco Smoke on Protein and Metal Levels in the Serum of Women during Pregnancy	PLOS ONE			English	Article							CIGARETTE-SMOKING; TRANSFERRIN MICROHETEROGENEITY; OXIDATIVE STRESS; MATERNAL SMOKING; TRACE-ELEMENTS; CADMIUM; ALPHA-1-ANTITRYPSIN; GLYCOPROTEIN; INFLAMMATION; TRANSPORT	Background Tobacco smoking by pregnant women has a negative effect on fetal development and increases pregnancy risk by changing the oxidative balance and microelements level. Smoking affects the concentration, structure and function of proteins, potentially leading to various negative effects on pregnancy outcomes. Methodology/Principal Findings The influence of tobacco smoke on key protein fractions in smoking and non-smoking healthy pregnant women was determined by capillary electrophoresis (CE). Concentrations of the proteins alpha 1-antitrypsin, alpha 1-acid glycoprotein, alpha 2-macroglobulin and transferrin were determined by ELISA tests. Total protein concentration was measured by the Biuretmethod. Smoking status was established by cotinine levels. Cadmium (Cd) and Zinc (Zn) concentrations were determined by flame atomic absorption spectrometry and the Zn/Cd ratio was calculated based on these numbers. Smoking women had a 3.7 times higher level of Cd than non-smoking women. Zn levels decreased during pregnancy for all women. The Zn/Cd ratio was three times lower in smoking women. The differences between the changes in the protein profile for smoking and non-smoking women were noted. Regarding proteins, alpha 1-antitrypsin and alpha 2-macroglobulin levels were lower in the non-smoking group than in the smoking group and correlated with Cd levels (r = -0.968, p = 0.032 for non-smokers; r = -0.835, p = 0.019 for smokers). Zn/Cd ratios correlated negatively with alpha 1-, alpha 2-and beta-globulins. Conclusions/Significance Exposure to tobacco smoke increases the concentration of Cd in the blood of pregnant women and may lead to an elevated risk of pregnancy disorders. During pregnancy alter concentrations of some proteins. The correlation of Cd with proteins suggests that it is one of the causes of protein aberrations.	[Wrzesniak, Marta; Kepinska, Marta; Milnerowicz, Halina] Wroclaw Med Univ, Dept Biomed & Environm Anal, Fac Pharm, Wroclaw, Poland; [Krolik, Malgorzata] Early Pregnancy Pathol Clin, Ctr Gynaecol Obstet & Neonatol, Opole, Poland	Wroclaw Medical University	Wrzesniak, M; Milnerowicz, H (corresponding author), Wroclaw Med Univ, Dept Biomed & Environm Anal, Fac Pharm, Wroclaw, Poland.	krolikm87@gmail.com; halina.milnerowicz@umed.wroc.pl	Kepinska, Marta/C-8354-2011	Wrzesniak, Marta/0000-0003-1388-2594; Milnerowicz, Halina/0000-0002-0772-9852; Kepinska, Marta/0000-0002-0935-5663	National Science Centre in Poland [DEC-2012/07/N/NZ7/02387]	National Science Centre in Poland(National Science Centre, Poland)	The project was financed by the National Science Centre in Poland granted on the basis of the decision DEC-2012/07/N/NZ7/02387 number (https://www.ncn.gov.pl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bizon A, 2011, REPROD TOXICOL, V32, P360, DOI 10.1016/j.reprotox.2011.08.007; Catarino C, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/684384; Cetin I, 2011, ANN NUTR METAB, V59, P55, DOI 10.1159/000332133; CHIBA M, 1992, B WORLD HEALTH ORGAN, V70, P269; CHU CYT, 1981, CLIN CHIM ACTA, V112, P235, DOI 10.1016/0009-8981(81)90382-X; Cogswell ME, 2003, J NUTR, V133, p1722S; Colombo G, 2012, ANTIOXID REDOX SIGN, V17, P1515, DOI 10.1089/ars.2012.4702; Fenzl V, 2013, ARCH GYNECOL OBSTET, V287, P19, DOI 10.1007/s00404-012-2502-4; Fournier T, 2000, BBA-PROTEIN STRUCT M, V1482, P157, DOI 10.1016/S0167-4838(00)00153-9; GOLDENBERG RL, 1991, OBSTET GYNECOL, V78, P594; Harmon AC, 2016, CLIN SCI, V130, P409, DOI 10.1042/CS20150702; Hendrick DJ, 2004, THORAX, V59, P184, DOI 10.1136/thx.2003.018432; Janciauskiene SM, 2011, RESP MED, V105, P1129, DOI 10.1016/j.rmed.2011.02.002; Jang ES, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-145; Kippler M, 2010, TOXICOL LETT, V192, P162, DOI 10.1016/j.toxlet.2009.10.018; Kowalska K, 2015, J TRACE ELEM MED BIO, V29, P99, DOI 10.1016/j.jtemb.2014.05.001; KUHNERT BR, 1988, J AM COLL NUTR, V7, P309, DOI 10.1080/07315724.1988.10720248; Kwon Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147065; LEGGE M, 1984, J CLIN PATHOL, V37, P867, DOI 10.1136/jcp.37.8.867; Lisowska-Myjak B, 2003, EUR J OBSTET GYN R B, V106, P31, DOI 10.1016/S0301-2115(02)00201-4; Mattsson K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144207; Milnerowicz H, 2000, Int J Occup Med Environ Health, V13, P185; Milnerowicz H, 2000, Ginekol Pol, V71, P311; Milnerowicz H, 1993, ACTA POLONIAE TOXICO, V1, P25; Milnerowicz-Nabzdyk E, 2015, REPROD TOXICOL, V58, P79, DOI 10.1016/j.reprotox.2015.08.003; Milnerowicz-Nabzdyk E, 2014, REPROD TOXICOL, V50, P27, DOI 10.1016/j.reprotox.2014.10.002; Nafstad P, 1996, EUR RESPIR J, V9, P2623, DOI 10.1183/09031936.96.09122623; PARVIN R, 1965, ANAL BIOCHEM, V12, P219, DOI 10.1016/0003-2697(65)90085-0; PATEL AB, 1992, IND HEALTH, V30, P97, DOI 10.2486/indhealth.30.97; RAMCHARAN S, 1976, OBSTET GYNECOL, V48, P211; Rollin HB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142455; Rogers JM, 2009, REPROD TOXICOL, V28, P152, DOI 10.1016/j.reprotox.2009.03.012; Rom O, 2013, RESP PHYSIOL NEUROBI, V187, P5, DOI 10.1016/j.resp.2013.01.013; Sciskalska M, 2014, BIOL TRACE ELEM RES, V159, P59, DOI 10.1007/s12011-014-9984-9; Shaper AG, 2004, J CLIN EPIDEMIOL, V57, P195, DOI 10.1016/j.jclinepi.2003.07.001; Shiels MS, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju294; Staff AC, 2014, J REPROD IMMUNOL, V101, P120, DOI 10.1016/j.jri.2013.09.001; Suriyaprom Kanjana, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P918; Tayade C, 2005, MOL CELL ENDOCRINOL, V245, P60, DOI 10.1016/j.mce.2005.10.004; Tekin D, 2012, J APPL TOXICOL, V32, P270, DOI 10.1002/jat.1661; Tong VT, 2013, SITES, V40, P2000; Twina G, 2012, J MATERN-FETAL NEO M, V25, P2667, DOI 10.3109/14767058.2012.705397; Wallin M, 2014, OCCUP ENVIRON MED, V71, P848, DOI 10.1136/oemed-2014-102279; Wang J, 2016, PHYS CHEM CHEM PHYS, V18, P3536, DOI 10.1039/c5cp06100h; Wen QJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065571; WINGERD J, 1977, CLIN CHEM, V23, P1310; Wrzesniak M, 2015, FETAL PEDIATR PATHOL, V34, P391, DOI 10.3109/15513815.2015.1095260; Wu Y, 2004, BIOL NEONATE, V86, P98, DOI 10.1159/000078311; Wu YH, 2003, CLIN CHIM ACTA, V332, P103, DOI 10.1016/S0009-8981(03)00134-7; Zalewska M, 2014, INT J ENVIRON AN CH, V94, P1422, DOI 10.1080/03067319.2014.962530	50	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161342	10.1371/journal.pone.0161342	http://dx.doi.org/10.1371/journal.pone.0161342			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548057	gold, Green Published, Green Submitted			2022-12-26	WOS:000381768400046
J	Chan, AW; Hamblin, MT; Jannink, JL				Chan, Ariel W.; Hamblin, Martha T.; Jannink, Jean-Luc			Evaluating Imputation Algorithms for Low-Depth Genotyping-By-Sequencing (GBS) Data	PLOS ONE			English	Article							GENOMIC SELECTION; ASSOCIATION; MODELS	Well-powered genomic studies require genome-wide marker coverage across many individuals. For non-model species with few genomic resources, high-throughput sequencing (HTS) methods, such as Genotyping-By-Sequencing (GBS), offer an inexpensive alternative to array-based genotyping. Although affordable, datasets derived from HTS methods suffer from sequencing error, alignment errors, and missing data, all of which introduce noise and uncertainty to variant discovery and genotype calling. Under such circumstances, meaningful analysis of the data is difficult. Our primary interest lies in the issue of how one can accurately infer or impute missing genotypes in HTS-derived datasets. Many of the existing genotype imputation algorithms and software packages were primarily developed by and optimized for the human genetics community, a field where a complete and accurate reference genome has been constructed and SNP arrays have, in large part, been the common genotyping platform. We set out to answer two questions: 1) can we use existing imputation methods developed by the human genetics community to impute missing genotypes in datasets derived from non-human species and 2) are these methods, which were developed and optimized to impute ascertained variants, amenable for imputation of missing genotypes at HTS-derived variants? We selected Beagle v.4, a widely used algorithm within the human genetics community with reportedly high accuracy, to serve as our imputation contender. We performed a series of cross-validation experiments, using GBS data collected from the species Manihot esculenta by the Next Generation (NEXTGEN) Cassava Breeding Project. NEXTGEN currently imputes missing genotypes in their datasets using a LASSO-penalized, linear regression method (denoted 'glmnet'). We selected glmnet to serve as a benchmark imputation method for this reason. We obtained estimates of imputation accuracy by masking a subset of observed genotypes, imputing, and calculating the sample Pearson correlation between observed and imputed genotype dosages at the site and individual level; computation time served as a second metric for comparison. We then set out to examine factors affecting imputation accuracy, such as levels of missing data, read depth, minor allele frequency (MAF), and reference panel composition.	[Chan, Ariel W.; Jannink, Jean-Luc] Cornell Univ, Sch Integrat Plant Sci, Sect Plant Breeding & Genet, Ithaca, NY 14850 USA; [Hamblin, Martha T.] Cornell Univ, Inst Genom Div, Ithaca, NY USA; [Jannink, Jean-Luc] ARS, USDA, RW Holley Ctr Agr & Hlth, Ithaca, NY USA	Cornell University; Cornell University; United States Department of Agriculture (USDA)	Chan, AW (corresponding author), Cornell Univ, Sch Integrat Plant Sci, Sect Plant Breeding & Genet, Ithaca, NY 14850 USA.	ac2278@cornell.edu		Jannink, Jean-Luc/0000-0003-4849-628X	Bill & Melinda Gates Foundation; Department for International Development of the United Kingdom; National Science Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Department for International Development of the United Kingdom; National Science Foundation(National Science Foundation (NSF))	The Next Generation (NEXTGEN) Cassava Breeding Project is supported by a grant from the Bill & Melinda Gates Foundation and the Department for International Development of the United Kingdom. JLJ and MTH received funding from the Bill & Melinda Gates Foundation and the Department for International Development of the United Kingdom. AWC received funding from the National Science Foundation. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Browning BL, 2009, AM J HUM GENET, V85, P847, DOI 10.1016/j.ajhg.2009.11.004; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Browning SR, 2006, AM J HUM GENET, V78, P903, DOI 10.1086/503876; Calus MPL, 2014, ANIMAL, V8, P1743, DOI 10.1017/S1751731114001803; Ceballos H, 2004, PLANT MOL BIOL, V56, P503, DOI 10.1007/s11103-004-5010-5; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Endelman JB, 2012, G3-GENES GENOM GENET, V2, P1405, DOI 10.1534/g3.112.004259; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; Hastie T, 2005, ELEMENTS STAT LEARNI, V27; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Li Y, 2011, GENOME RES, V21, P940, DOI 10.1101/gr.117259.110; Poland J, 2012, PLANT GENOME-US, V5, P103, DOI 10.3835/plantgenome2012.06.0006; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Rutkoski JE, 2013, G3-GENES GENOM GENET, V3, P427, DOI 10.1534/g3.112.005363; Wolf M. M., 2016, 2016 IEEE HIGH PERFO, P1, DOI [DOI 10.3835/PLANTGEN0ME2015.11.0118, 10.1109/HPEC.2016.7761649, DOI 10.1109/HPEC.2016.7761649]	20	21	21	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0160733	10.1371/journal.pone.0160733	http://dx.doi.org/10.1371/journal.pone.0160733			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537694	gold, Green Submitted, Green Published			2022-12-26	WOS:000381577000029
J	Helfenstein, J; Muller, I; Gruter, R; Bhullar, G; Mandloi, L; Papritz, A; Siegrist, M; Schulin, R; Frossard, E				Helfenstein, Julian; Mueller, Isabel; Gruter, Roman; Bhullar, Gurbir; Mandloi, Lokendra; Papritz, Andreas; Siegrist, Michael; Schulin, Rainer; Frossard, Emmanuel			Organic Wheat Farming Improves Grain Zinc Concentration	PLOS ONE			English	Article							HEAVY-METALS; SOILS; BIOFORTIFICATION; INDIA; DEFICIENCY; NUTRITION; PLAINS; ZN	Zinc (Zn) nutrition is of key relevance in India, as a large fraction of the population suffers from Zn malnutrition and many soils contain little plant available Zn. In this study we compared organic and conventional wheat cropping systems with respect to DTPA (diethylene triamine pentaacetic acid)-extractable Zn as a proxy for plant available Zn, yield, and grain Zn concentration. We analyzed soil and wheat grain samples from 30 organic and 30 conventional farms in Madhya Pradesh (central India), and conducted farmer interviews to elucidate sociological and management variables. Total and DTPA-extractable soil Zn concentrations and grain yield (3400 kg ha(-1)) did not differ between the two farming systems, but with 32 and 28 mg kg(-1) respectively, grain Zn concentrations were higher on organic than conventional farms (t = -2.2, p = 0.03). Furthermore, multiple linear regression analyses revealed that (a) total soil zinc and sulfur concentrations were the best predictors of DTPA-extractable soil Zn, (b) Olsen phosphate taken as a proxy for available soil phosphorus, exchangeable soil potassium, harvest date, training of farmers in nutrient management, and soil silt content were the best predictors of yield, and (c) yield, Olsen phosphate, grain nitrogen, farmyard manure availability, and the type of cropping system were the best predictors of grain Zn concentration. Results suggested that organic wheat contained more Zn despite same yield level due to higher nutrient efficiency. Higher nutrient efficiency was also seen in organic wheat for P, N and S. The study thus suggests that appropriate farm management can lead to competitive yield and improved Zn concentration in wheat grains on organic farms.	[Helfenstein, Julian; Mueller, Isabel; Frossard, Emmanuel] Swiss Fed Inst Technol, Inst Agr Sci, CH-8315 Lindau, Switzerland; [Gruter, Roman; Papritz, Andreas; Schulin, Rainer] Swiss Fed Inst Technol, Inst Terr Ecosyst, CH-8092 Zurich, Switzerland; [Bhullar, Gurbir] Res Inst Organ Agr FiBL, Int Cooperat Dept, CH-5070 Frick, Switzerland; [Mandloi, Lokendra] bioRe Assoc, Div Res, Kasrawad, Madhya Pradesh, India; [Siegrist, Michael] Swiss Fed Inst Technol, Inst Environm Decis, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Helfenstein, J (corresponding author), Swiss Fed Inst Technol, Inst Agr Sci, CH-8315 Lindau, Switzerland.	julian.helfenstein@usys.ethz.ch	Siegrist, Michael/A-1032-2008	Siegrist, Michael/0000-0002-6139-7190; Helfenstein, Julian/0000-0002-5012-2589; Bhullar, Gurbir S./0000-0001-7311-2562	WFSC Mercator Research Program; Biovision Foundation for Ecological Development; Coop Sustainability Fund; Liechtenstein Development Service (LED); Swiss Agency for Development and Cooperation (SDC)	WFSC Mercator Research Program; Biovision Foundation for Ecological Development; Coop Sustainability Fund; Liechtenstein Development Service (LED); Swiss Agency for Development and Cooperation (SDC)	The project was funded by WFSC Mercator Research Program (http://www.worldfoodsystem.ethz.ch/research.html) and was conducted in the framework of long-term farming systems comparison in the tropics (SysCom) program, which is financially supported by Biovision Foundation for Ecological Development, Coop Sustainability Fund, Liechtenstein Development Service (LED) and the Swiss Agency for Development and Cooperation (SDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AACC, 1999, 461901 AACC; Aghili F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101487; Andres C, 2016, FRONT ENV SCI-SWITZ, V4, DOI 10.3389/fenvs.2016.00005; [Anonymous], 2011, THE EC; BANSAL RL, 1990, FERT RES, V21, P163, DOI 10.1007/BF01087426; Bhullar GS, 2014, P FAO INT S; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bulluck LR, 2002, APPL SOIL ECOL, V19, P147, DOI 10.1016/S0929-1393(01)00187-1; Cakmak I, 2002, PLANT SOIL, V247, P3, DOI 10.1023/A:1021194511492; Cakmak I, 2008, PLANT SOIL, V302, P1, DOI 10.1007/s11104-007-9466-3; Cakmak I, 2010, CEREAL CHEM, V87, P10, DOI 10.1094/CCHEM-87-1-0010; Crowder DW, 2015, P NATL ACAD SCI USA, V112, P7611, DOI 10.1073/pnas.1423674112; de Ponti T, 2012, AGR SYST, V108, P1, DOI 10.1016/j.agsy.2011.12.004; Diesing WE, 2008, EUR J SOIL SCI, V59, P716, DOI 10.1111/j.1365-2389.2008.01032.x; Dijkstra JJ, 2009, ENVIRON SCI TECHNOL, V43, P6196, DOI 10.1021/es900555g; Eyhorn F., 2007, International Journal of Agricultural Sustainability, V5, P25; Eyhorn F., 2007, ORGANIC FARMING SUST, DOI [10.3218/3152-2, DOI 10.3218/3152-2]; FAL RAC FAW, 1996, EXTR ABF KON GESCHL, P3; FAL RAC FAW, 1996, BEST KORN MIN ANT FE; FAL RAC FAW, 1996, PH WERT WASS 1 2 5 P; FAOSTAT, 2013, FOOD AGR COMM PROD; Forster D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081039; Frossard E, 2011, HDB SOIL SCI PROPERT; Guttieri MJ, 2015, CROP SCI, V55, P1035, DOI 10.2135/cropsci2014.07.0506; HarvestPlus, 2014, BIOF PROGR BRIEFS; Helfenstein J, 2015, J PLANT NUTR SOIL SC, V178, P896, DOI 10.1002/jpln.201500146; Helmke P. A., 1996, Methods of soil analysis. Part 3 - chemical methods., P551; Joshi AK, 2010, FIELD CROP RES, V116, P268, DOI 10.1016/j.fcr.2010.01.004; Karami M, 2009, J AGR FOOD CHEM, V57, P10876, DOI 10.1021/jf902074f; KATYAL JC, 1991, GEODERMA, V49, P165, DOI 10.1016/0016-7061(91)90099-F; Lehmann A, 2014, SOIL BIOL BIOCHEM, V69, P123, DOI 10.1016/j.soilbio.2013.11.001; Mader P, 2002, SCIENCE, V296, P1694, DOI 10.1126/science.1071148; Mader P, 2007, J SCI FOOD AGR, V87, P1826, DOI 10.1002/jsfa.2866; Marschner, 1995, MINERAL NUTR HIGHER, P596, DOI DOI 10.1016/B978-012473542-2/50018-3; Nicholson FA, 2003, SCI TOTAL ENVIRON, V311, P205, DOI 10.1016/S0048-9697(03)00139-6; Ova EA, 2015, PLANT SOIL, V393, P147, DOI 10.1007/s11104-015-2483-8; Ozer M, 2010, ENVIRON ENG GEOSCI, V16, P163, DOI 10.2113/gseegeosci.16.2.163; Pace NJ, 2014, BIOMOLECULES, V4, P419, DOI 10.3390/biom4020419; Persson DP, 2016, NEW PHYTOL, V211, P1255, DOI 10.1111/nph.13989; Ram H, 2015, CURR SCI INDIA, V109, P1171, DOI 10.18520/v109/i6/1171-1176; RCoreTeam, 2015, R LANG ENV STAT COMP; Reed S. T., 1996, Methods of soil analysis. Part 3 - chemical methods., P703; Ryan MH, 2004, J SCI FOOD AGR, V84, P207, DOI 10.1002/jsfa.1634; Sakamoto Y., 1986, AKAIKE INFORM CRITER; Schoenau J.J., 2007, SOIL SAMPLING METHOD; Schulin R, 2008, DEV USE BIOFORTIFIED, P95; Stein AJ, 2007, PUBLIC HEALTH NUTR, V10, P492, DOI 10.1017/S1368980007223857; Syers J.K., 2008, FAO FERTILIZER PLANT, V18, P5; unicefIndia, 2013, WHAT WE DO STUNT; van Groenigen JW, 2015, SOIL-GERMANY, V1, P235, DOI 10.5194/soil-1-235-2015; World Health Organisation, 2010, GLOB DAT CHILD GROWT; Zou CQ, 2012, PLANT SOIL, V361, P119, DOI 10.1007/s11104-012-1369-2	52	11	11	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0160729	10.1371/journal.pone.0160729	http://dx.doi.org/10.1371/journal.pone.0160729			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537548	Green Published, gold, Green Submitted			2022-12-26	WOS:000381577000028
J	Na, HN; Hegde, V; Dubuisson, O; Dhurandhar, NV				Na, Ha-Na; Hegde, Vijay; Dubuisson, Olga; Dhurandhar, Nikhil V.			E4orf1 Enhances Glucose Uptake Independent of Proximal Insulin Signaling	PLOS ONE			English	Article							SENSITIVITY; PROTEIN; RESISTANCE; ADIPOSITY; SYSTEM; CELLS; FAT	Impaired proximal insulin signaling is often present in diabetes. Hence, approaches to enhance glucose disposal independent of proximal insulin signaling are desirable. Evidence indicates that Adenovirus-derived E4orf1 protein may offer such an approach. This study determined if E4orf1 improves insulin sensitivity and downregulates proximal insulin signaling in vivo and enhances cellular glucose uptake independent of proximal insulin signaling in vitro. High fat fed mice were injected with a retrovirus plasmid expressing E4orf1, or a null vector. E4orf1 significantly improved insulin sensitivity in response to a glucose load. Yet, their proximal insulin signaling in fat depots was impaired, as indicated by reduced tyrosine phosphorylation of insulin receptor (IR), and significantly increased abundance of ectonucleotide pyrophosphatase/phosphodiesterase- 1 (ENPP1). In 3T3-L1 pre-adipocytes E4orf1 expression impaired proximal insulin signaling. Whereas, treatment with rosiglitazone reduced ENPP1 abundance. Unaffected by IR-KD (insulin receptor knockdown) with siRNA, E4orf1 significantly up-regulated distal insulin signaling pathway and enhanced cellular glucose uptake. In vivo, E4orf1 impairs proximal insulin signaling in fat depots yet improves glycemic control. This is probably explained by the ability of E4orf1 to promote cellular glucose uptake independent of proximal insulin signaling. E4orf1 may provide a therapeutic template to enhance glucose disposal in the presence of impaired proximal insulin signaling.	[Na, Ha-Na; Hegde, Vijay; Dubuisson, Olga; Dhurandhar, Nikhil V.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Infect & Obes Lab, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Dhurandhar, NV (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, Infect & Obes Lab, Baton Rouge, LA 70803 USA.	Nikhil.Dhurandhar@TTU.EDU			Vital Health Interventions; COBRE center grant from National Institutes of Health [NIH 8 P20-GM103528]; NORC center grant from National Institutes of Health [NIH 2P30-DK072476]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103528] Funding Source: NIH RePORTER	Vital Health Interventions; COBRE center grant from National Institutes of Health; NORC center grant from National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by Vital Health Interventions. The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript.; This work utilized the facilities of the Cell Biology and Bioimaging Core that are supported in part by COBRE (NIH 8 P20-GM103528) and NORC (NIH 2P30-DK072476) center grants from the National Institutes of Health.	Anderson MS, 2005, EFFECTS ACUTE HYPERI; CHANDALIA M, 2012, J CLIN ENDOCR METAB, V97, P4663, DOI [DOI 10.1210/jc.2012-2018, DOI 10.1210/JC.2012-2018]; Czech MP, 1999, J BIOL CHEM, V274, P1865, DOI 10.1074/jbc.274.4.1865; Dhurandhar EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047813; Dhurandhar EJ, 2011, OBESITY, V19, pS86; Dhurandhar EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023394; Dhurandhar NV, 2013, J DIABETES COMPLICAT, V27, P191, DOI 10.1016/j.jdiacomp.2012.09.006; Dubuisson O, 2011, ENDOCRINOLOGY, V152, P3648, DOI 10.1210/en.2011-0225; DUNCAN MH, 1995, LANCET, V346, P120, DOI 10.1016/S0140-6736(95)92143-5; Farese RV, 2001, INSULIN SENSITIVE PH; GOODYEAR LJ, 1995, J CLIN INVEST, V95, P2195, DOI 10.1172/JCI117909; Hegde V, 2016, BIOCHIMIE, V121, P140, DOI 10.1016/j.biochi.2015.12.002; Krishnapuram R, 2013, INT J OBESITY, V37, P146, DOI 10.1038/ijo.2012.6; Krishnapuram R, 2011, AM J PHYSIOL-ENDOC M, V300, pE779, DOI 10.1152/ajpendo.00703.2010; Kusminski CM, 2015, MOL METAB, V4, P653, DOI 10.1016/j.molmet.2015.07.004; Legro RS, 1998, J CLIN ENDOCR METAB, V83, P2694, DOI 10.1210/jc.83.8.2694; Pan Wentong, 2012, J Metabonomics Metab, V1, DOI 10.4172/2325-9736.1000e103; Pasarica M, 2006, OBESITY, V14, P1905, DOI 10.1038/oby.2006.222; Pessin JE, 2000, J CLIN INVEST, V106, P165, DOI 10.1172/JCI10582; Rogers PM, 2008, INT J OBESITY, V32, P397, DOI 10.1038/sj.ijo.0803748; Sesti G, 2001, FASEB J, V15, P2099, DOI 10.1096/fj.01-0009rev; Wang ZQ, 2008, DIABETES, V57, P1805, DOI 10.2337/db07-1313; White MF, 1998, CURR TOP MICROBIOL, V228, P179; Zhou HH, 2009, EUR J PHARMACOL, V616, P346, DOI 10.1016/j.ejphar.2009.06.057	24	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161275	10.1371/journal.pone.0161275	http://dx.doi.org/10.1371/journal.pone.0161275			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537838	Green Submitted, gold, Green Published			2022-12-26	WOS:000381577000079
J	Brugnara, L; Murillo, S; Novials, A; Rojo-Martinez, G; Soriguer, F; Goday, A; Calle-Pascual, A; Castano, L; Gaztambide, S; Valdes, S; Franch, J; Castell, C; Vendrell, J; Casamitjana, R; Bosch-Comas, A; Bordiu, E; Carmena, R; Catala, M; Delgado, E; Girbes, J; Lopez-Alba, A; Martinez-Larrad, MT; Menendez, E; Mora-Peces, I; Pascual-Manich, G; Serrano-Rios, M; Gomis, R; Ortega, E				Brugnara, Laura; Murillo, Serafin; Novials, Anna; Rojo-Martinez, Gemma; Soriguer, Federico; Goday, Albert; Calle-Pascual, Alfonso; Castano, Luis; Gaztambide, Sonia; Valdes, Sergio; Franch, Josep; Castell, Conxa; Vendrell, Joan; Casamitjana, Roser; Bosch-Comas, Anna; Bordiu, Elena; Carmena, Rafael; Catala, Miguel; Delgado, Elias; Girbes, Juan; Lopez-Alba, Alfonso; Teresa Martinez-Larrad, Maria; Menendez, Edelmiro; Mora-Peces, Inmaculada; Pascual-Manich, Gemma; Serrano-Rios, Manuel; Gomis, Ramon; Ortega, Emilio			Low Physical Activity and Its Association with Diabetes and Other Cardiovascular Risk Factors: A Nationwide, Population-Based Study	PLOS ONE			English	Article							INSULIN-RESISTANCE; ADULTS; PREVENTION; PREVALENCE; OBESITY; DIET; ADHERENCE; EXERCISE	Low physical activity (PA), or sedentary lifestyle, is associated with the development of several chronic diseases. We aimed to investigate current prevalence of sedentariness and its association with diabetes and other cardiovascular risk factors. PA was evaluated in a population-based, cross-sectional, randomly sampled study conducted in 2009-2010 in Spain. International Physical Activity Questionnaire (SF-IPAQ) was used to assess PA. 4991 individuals (median age 50 years, 57% women) were studied. Prevalence of sedentariness was 32.3% for men and 39% for women (p < 0.0001). Sex differences were particularly notable (age*sex interaction, p = 0.0024) at early and older ages. Sedentary individuals had higher BMI (28 vs. 27 kg/m(2)) and obesity prevalence (37 vs. 26%). Low PA was present in 44, 43, and 38% of individuals with known diabetes (KDM), prediabetes/unknown-diabetes (PREDM/UKDM), and normal glucose regulation (p = 0.0014), respectively. No difference between KDM and PREDM/UKDM (p = 0.72) was found. Variables independently associated (p < 0.05) with sedentariness were age, sex, BMI, central obesity, Mediterranean diet adherence, smoking habit, HDL-cholesterol, triglycerides and dyslipidemia. Low PA is on the rise in Spain, especially among women. Sedentariness is associated with several cardiovascular risk factors and may be responsible for the increasing prevalence of obesity and diabetes in this country.	[Brugnara, Laura; Murillo, Serafin; Novials, Anna; Rojo-Martinez, Gemma; Soriguer, Federico; Castano, Luis; Gaztambide, Sonia; Valdes, Sergio; Vendrell, Joan; Casamitjana, Roser; Bosch-Comas, Anna; Carmena, Rafael; Catala, Miguel; Teresa Martinez-Larrad, Maria; Pascual-Manich, Gemma; Serrano-Rios, Manuel; Gomis, Ramon] CIBERDEM Spanish Biomed Res Ctr Diabet & Associat, Madrid, Spain; [Brugnara, Laura; Murillo, Serafin; Novials, Anna; Casamitjana, Roser; Bosch-Comas, Anna; Pascual-Manich, Gemma; Gomis, Ramon] Hosp Clin Barcelona, IDIBAPS August Pi & Sunyer Biomed Res Inst, Barcelona, Spain; [Rojo-Martinez, Gemma; Soriguer, Federico; Valdes, Sergio] Hosp Univ Carlos Haya, Dept Endocrinol & Nutr, Malaga, Spain; [Goday, Albert] Hosp Mar, Dept Endocrinol & Nutr, Barcelona, Spain; [Calle-Pascual, Alfonso; Bordiu, Elena] Hosp Univ San Carlos, Madrid, Spain; [Castano, Luis; Gaztambide, Sonia] Univ Basque Country, Hosp Univ Cruces, Diabet Res Grp, Baracaldo, Spain; [Franch, Josep] IDIAP, Red GEDAPS, Inst Catala Salut, EAP Raval Sud, Barcelona, Spain; [Castell, Conxa] Autonomous Govt Catalonia, Publ Hlth Div, Barcelona, Spain; [Vendrell, Joan] Hosp Univ Joan XXIII, Dept Endocrinol & Nutr, Tarragona, Spain; [Carmena, Rafael; Catala, Miguel] Hosp Clin Univ Valencia, Dept Med & Endocrinol, Valencia, Spain; [Delgado, Elias; Menendez, Edelmiro] Univ Oviedo, Hosp Univ Cent Asturias, Fac Med & Ciencias Salud, Dept Endocrinol & Nutr, Oviedo, Spain; [Girbes, Juan] Hosp Arnau Vilanova, Valencia, Spain; [Lopez-Alba, Alfonso] Fdn Hosp Jove, Gijon, Spain; [Serrano-Rios, Manuel] Hosp Clin San Carlos IdISSC, Inst Invest Sanitaria, Madrid, Spain; [Mora-Peces, Inmaculada] Canarian Hlth Serv, Tenerife, Spain; [Teresa Martinez-Larrad, Maria; Ortega, Emilio] CIBEROBN Spanish Biomed Res Ctr Physiopathol Obes, Pamplona, Spain; [Ortega, Emilio] Hosp Clin Barcelona, ICMDM, Dept Endocrinol & Nutr, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Hospital Carlos Haya; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Hospital Universitario Cruces; University of Basque Country; Hospital Clinic Universitari de Valencia; Central University Hospital Asturias; University of Oviedo; Hospital Clinico San Carlos; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University of Barcelona; Hospital Clinic de Barcelona	Ortega, E (corresponding author), CIBEROBN Spanish Biomed Res Ctr Physiopathol Obes, Pamplona, Spain.; Ortega, E (corresponding author), Hosp Clin Barcelona, ICMDM, Dept Endocrinol & Nutr, Barcelona, Spain.	eortega1@clinic.ub.es	Vendrell, Joan j/V-4034-2018; Menendez Torre, Edelmiro Luis/AFR-2604-2022; Ortega Martínez de V, Emilio/AAB-2072-2022; Torre, Edelmiro Menéndez/G-1547-2013; Franch-Nadal, Josep/AAC-1945-2019; Serrano Ríos, Manuel/E-4625-2019; Rojo-martínez, Gemma/E-3351-2010; Delgado, Elias/B-2634-2013; Stefanadis, Christodoulos/ABH-2232-2020	Vendrell, Joan j/0000-0002-6994-6115; Menendez Torre, Edelmiro Luis/0000-0002-9548-7821; Ortega Martínez de V, Emilio/0000-0002-2217-8905; Torre, Edelmiro Menéndez/0000-0002-9548-7821; Franch-Nadal, Josep/0000-0002-5175-1555; Serrano Ríos, Manuel/0000-0002-3214-1444; Rojo-martínez, Gemma/0000-0003-2179-2134; Delgado, Elias/0000-0001-6114-9712; Stefanadis, Christodoulos/0000-0001-5974-6454; GAZTAMBIDE, SONIA/0000-0003-3569-2265; Castano, Luis/0000-0003-0437-9401; Novials, Anna/0000-0003-0465-2949	Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM; ISCIII Ministerio de Ciencia e Innovacion); Ministerio de Sanidad y Consumo; Spanish Diabetes Society (SED)	Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM; ISCIII Ministerio de Ciencia e Innovacion); Ministerio de Sanidad y Consumo(Instituto de Salud Carlos III); Spanish Diabetes Society (SED)	This work was supported by the Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM; ISCIII Ministerio de Ciencia e Innovacion), Ministerio de Sanidad y Consumo and the Spanish Diabetes Society (SED). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baudrand R, 2010, REV MED CHILE, V138, P1294, DOI [10.4067/S0034-98872010001100015, /S0034-98872010001100015]; Egede LE, 2002, ARCH INTERN MED, V162, P427, DOI 10.1001/archinte.162.4.427; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Guthold R, 2008, AM J PREV MED, V34, P486, DOI 10.1016/j.amepre.2008.02.013; Felix-Redondo FJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-542; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Larsson CA, 2012, METABOLISM, V61, P590, DOI 10.1016/j.metabol.2011.09.010; Lee PH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-115; Lee PG, 2013, DIABETES CARE, V36, P3076, DOI 10.2337/dc13-0412; Lindstrom J, 2003, DIABETES CARE, V26, P3230, DOI 10.2337/diacare.26.12.3230; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Murillo S, 2008, AV DIABETOL, V24, P320; Navarro-Vidal B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061549; Nelson KM, 2002, DIABETES CARE, V25, P1722, DOI 10.2337/diacare.25.10.1722; Ortega E, 2013, ANN NUTR METAB, V62, P339, DOI 10.1159/000346553; Panagiotakos DB, 2007, PREV MED, V44, P335, DOI 10.1016/j.ypmed.2006.12.009; Paulweber B, 2010, HORM METAB RES, V42, pS3, DOI 10.1055/s-0029-1240928; Pitel L, 2010, PUBLIC HEALTH, V124, P512, DOI 10.1016/j.puhe.2010.05.005; Schneider KL, 2014, MED SCI SPORT EXER, V46, P84, DOI 10.1249/MSS.0b013e3182a33010; Sjostrom M, 2006, J PUBLIC HEALTH-HEID, V14, P291, DOI 10.1007/s10389-006-0031-y; Soriguer F, 2008, EUR J CLIN INVEST, V38, P126, DOI 10.1111/j.1365-2362.2007.01910.x; Soriguer F, 2012, DIABETOLOGIA, V55, P88, DOI 10.1007/s00125-011-2336-9; Strath SJ, 2013, CIRCULATION, V128, P2259, DOI 10.1161/01.cir.0000435708.67487.da; Varo JJ, 2003, INT J EPIDEMIOL, V32, P138, DOI 10.1093/ije/dyg116; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914; World Health Organization, 1999, WHONCDNCS992	29	33	36	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160959	10.1371/journal.pone.0160959	http://dx.doi.org/10.1371/journal.pone.0160959			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532610	Green Published, Green Submitted, gold			2022-12-26	WOS:000381487600050
J	Chen, YL; Reese, DH				Chen, Yanling; Reese, David H.			Disruption of Retinol (Vitamin A) Signaling by Phthalate Esters: SAR and Mechanism Studies	PLOS ONE			English	Article							MALE REPRODUCTIVE DEVELOPMENT; HOMOZYGOUS HOXA1 MUTATIONS; MALE-RAT; SEXUAL-DIFFERENTIATION; EXTERNAL GENITALIA; ACID BIOSYNTHESIS; AXIAL SKELETON; IN-UTERO; EXPRESSION; EXPOSURE	A spectrum of reproductive system anomalies (cryptorchidism, hypospadias, dysgenesis of Wolffian duct-derived tissues and prostate, and reduced sperm production) in male rats exposed in utero to phthalate esters (PEs) are thought to be caused by PE inhibition of fetal testosterone production. Recently, dibutyl and dipentyl phthalate (DBuP, DPnP) were shown to disrupt the retinol signaling pathway (RSP) in mouse pluripotent P19 embryonal carcinoma cells in vitro. The RSP regulates the synthesis and cellular levels of retinoic acid (RA), the active metabolite of retinol (vitamin A). In this new study, a total of 26 di- and mono-esters were screened to identify additional phthalate structures that disrupt the RSP and explore their mechanisms of action. The most potent PEs, those causing >50% inhibition, contained aryl and cycloalkane groups or C4-C6 alkyl ester chains and were the same PEs reported to cause malformations in utero. They shared similar lipid solubility; logP values were between 4 and 6 and, except for PEs with butyl and phenyl groups, were stable for prolonged periods in culture. Mono-and cognate di-esters varied in ability to disrupt the RSP; e.g., DEHP was inactive but its monoester was active while DBuP was active yet its monoester was inactive. DBuP and dibenzyl phthalate both disrupted the synthesis of RA from retinol but not the ability of RA to activate gene transcription. Both PEs also disrupted the RSP in C3H10T1/2 multipotent mesenchymal stem cells. Based on this in vitro study showing that some PEs disrupt retinol signaling and previous in vivo studies that vitamin A/RA deficiency and PEs both cause strikingly similar anomalies in the male rat reproductive system, we propose that PE-mediated inhibition of testosterone and RA synthesis in utero are both causes of malformations in male rat offspring.	[Chen, Yanling; Reese, David H.] US FDA, Div Mol Biol, Off Appl Res & Safety Assessment, Ctr Food Safety & Appl Nutr, 8301 Muirkirk Rd, Laurel, MD 20708 USA	US Food & Drug Administration (FDA)	Reese, DH (corresponding author), US FDA, Div Mol Biol, Off Appl Res & Safety Assessment, Ctr Food Safety & Appl Nutr, 8301 Muirkirk Rd, Laurel, MD 20708 USA.	dhreeseret@gmail.com	chen, yanling/GRE-8287-2022					Alexander T, 2009, ANNU REV CELL DEV BI, V25, P431, DOI 10.1146/annurev.cellbio.042308.113423; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Bay K, 2011, NAT REV UROL, V8, P187, DOI 10.1038/nrurol.2011.23; Bosley TM, 2008, AM J MED GENET A, V146A, P1235, DOI 10.1002/ajmg.a.32262; Cammas L, 2007, DEV DYNAM, V236, P2899, DOI 10.1002/dvdy.21312; Cao XL, 2010, COMPR REV FOOD SCI F, V9, P21, DOI 10.1111/j.1541-4337.2009.00093.x; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Chen YL, 2013, BIRTH DEFECTS RES B, V98, P276, DOI 10.1002/bdrb.21062; Chen YL, 2011, J CELL BIOCHEM, V112, P2865, DOI 10.1002/jcb.23200; Clagett-Dame M, 2011, NUTRIENTS, V3, P385, DOI 10.3390/nu3040385; Cobb J, 2005, DEVELOPMENT, V132, P3055, DOI 10.1242/dev.01885; Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S; Ema M, 1997, J APPL TOXICOL, V17, P223, DOI 10.1002/(SICI)1099-1263(199707)17:4<223::AID-JAT433>3.0.CO;2-H; Farjo KM, 2011, DEV BIOL, V357, P347, DOI 10.1016/j.ydbio.2011.07.011; Feng CW, 2014, MOL CELL ENDOCRINOL, V382, P488, DOI 10.1016/j.mce.2013.09.026; Foster PMD, 2006, INT J ANDROL, V29, P140, DOI 10.1111/j.1365-2605.2005.00563.x; Foster PMD, 2005, CRIT REV TOXICOL, V35, P713, DOI 10.1080/10408440591007395; Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350; Hannas BR, 2011, TOXICOL SCI, V120, P184, DOI 10.1093/toxsci/kfq386; Hernandez-Diaz S, 2013, REPROD TOXICOL, V37, P1, DOI 10.1016/j.reprotox.2013.01.001; Kaiser ME, 2003, DEV BIOL, V257, P14, DOI 10.1016/S0012-1606(03)00044-7; Kelley KE, 2012, ENVIRON HEALTH PERSP, V120, P379, DOI 10.1289/ehp.1103998; KESSEL M, 1991, CELL, V67, P89, DOI 10.1016/0092-8674(91)90574-I; Klonisch T, 2005, INT J ONCOL, V27, P307; Liu LQ, 2012, BIRTH DEFECTS RES B, V95, P79, DOI 10.1002/bdrb.20344; LUFKIN T, 1991, CELL, V66, P1105, DOI 10.1016/0092-8674(91)90034-V; MCBURNEY MW, 1993, INT J DEV BIOL, V37, P135; Millard CJ, 2013, J MOL ENDOCRINOL, V51, pT23, DOI 10.1530/JME-13-0227; Miyagawa S, 2011, ENDOCRINOLOGY, V152, P2894, DOI 10.1210/en.2011-0263; Mylchreest E, 2000, TOXICOL SCI, V55, P143, DOI 10.1093/toxsci/55.1.143; Napoli JL, 2012, BBA-MOL CELL BIOL L, V1821, P152, DOI 10.1016/j.bbalip.2011.05.004; Nicholls PK, 2013, MOL CELL ENDOCRINOL, V377, P33, DOI 10.1016/j.mce.2013.06.034; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Niederreither K, 1997, MECH DEVELOP, V62, P67, DOI 10.1016/S0925-4773(96)00653-3; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; NOY N, 1990, BIOCHEMISTRY-US, V29, P3888, DOI 10.1021/bi00468a014; Ogino Y, 2001, ANN NY ACAD SCI, V948, P13; Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339; Pierzchalski K, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.119677; Raverdeau M, 2012, P NATL ACAD SCI USA, V109, P16582, DOI 10.1073/pnas.1214936109; REESE DH, 1992, J CELL PHYSIOL, V151, P239, DOI 10.1002/jcp.1041510204; REZNIKOFF CA, 1973, CANCER RES, V33, P3231; Saillenfait AM, 2008, REPROD TOXICOL, V26, P107, DOI 10.1016/j.reprotox.2008.07.006; See AWM, 2008, DEV BIOL, V316, P171, DOI 10.1016/j.ydbio.2007.10.018; Serrano SE, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-43; Serrano T, 2013, HUM REPROD, V28, P1974, DOI 10.1093/humrep/det111; Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723; TAYLOR SM, 1979, CELL, V17, P771, DOI 10.1016/0092-8674(79)90317-9; Tischfield MA, 2005, NAT GENET, V37, P1035, DOI 10.1038/ng1636; van der Zanden LFM, 2012, HUM REPROD UPDATE, V18, P260, DOI 10.1093/humupd/dms002; Watson PJ, 2012, MOL CELL ENDOCRINOL, V348, P440, DOI 10.1016/j.mce.2011.08.033; WILSON JG, 1948, AM J ANAT, V83, P357, DOI 10.1002/aja.1000830303; WILSON JG, 1953, AM J ANAT, V92, P189, DOI 10.1002/aja.1000920202; Wolbach SB, 1925, J EXP MED, V42, P753, DOI 10.1084/jem.42.6.753; Yamasaki K, 2009, TOXICOL LETT, V189, P14, DOI 10.1016/j.toxlet.2009.04.023; Zhao XL, 2009, CURR BIOL, V19, P1050, DOI 10.1016/j.cub.2009.04.059	56	10	13	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161167	10.1371/journal.pone.0161167	http://dx.doi.org/10.1371/journal.pone.0161167			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532513	Green Published, Green Submitted, gold			2022-12-26	WOS:000381487600069
J	Costa, MD; de Paula, SO; Martins, GF; Zanuncio, JC; Santana, AEG; Serrao, JE				Costa, Marilza da Silva; de Paula, Sergio Oliveira; Martins, Gustavo Ferreira; Zanuncio, Jose Cola; Goulart Santana, Antonio Euzebio; Serrao, Jose Eduardo			Multiple Modes of Action of the Squamocin in the Midgut Cells of Aedes aegypti Larvae	PLOS ONE			English	Article							ATG1 KINASE COMPLEX; PROTEIN ATG8; FAT-BODY; AUTOPHAGY; DIPTERA; ATPASE; INSECTICIDES; ACETOGENINS; MECHANISMS	Annonaceous acetogenins are botanical compounds with good potential for use as insecticides. In the vector, Aedes aegypti (L.) (Diptera: Culicidae), squamocin (acetogenin) has been reported to be a larvicide and cytotoxic, but the modes of action of this molecule are still poorly understood. This study evaluated the changes in the cell morphology, and in the expression of genes, for autophagy (Atg1 and Atg8), for membrane ion transporter V-ATPase, and for water channel aquaporin-4 (Aqp4) in the midgut of A. aegypti larvae exposed to squamocin from Annona mucosa Jacq. (Annonaceae). Squamocin showed cytotoxic action with changes in the midgut epithelium and digestive cells of A. aegypti larvae, increase in the expression for autophagy gene Atg1 and Atg8, decrease in the expression of V-ATPase, decrease in the expression of Aqp4 gene in LC20 and inhibition of Apq4 genes in the midgut of this vector in LC50. These multiple modes of action for squamocin are described for the first time in insects, and they are important because different sites of action of squamocin from A. mucosa may reduce the possibility of resistance of A. aegypti to this molecule.	[Costa, Marilza da Silva; Zanuncio, Jose Cola] Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil; [de Paula, Sergio Oliveira; Martins, Gustavo Ferreira; Serrao, Jose Eduardo] Univ Fed Vicosa, Dept Gen Biol, Vicosa, MG, Brazil; [Goulart Santana, Antonio Euzebio] Univ Fed Alagoas, Inst Chem & Biotechnol, Maceio, Alagoas, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade Federal de Alagoas	Serrao, JE (corresponding author), Univ Fed Vicosa, Dept Gen Biol, Vicosa, MG, Brazil.	jeserrao@ufv.br	De Paula, Sergio/N-2609-2018; Sant'Ana, Antonio/AAP-6955-2021; Martins, Gustavo Ferreira/AAL-7744-2020	De Paula, Sergio/0000-0002-2275-5768; Santana, Antonio/0000-0002-3750-438X; Martins, Gustavo/0000-0003-0614-8551	Conselho Nacional de Pesquisa grants reagents; Fundacao de Amparo a Pesquisa do estado de Minas Gerais; Brazilian research agency CNPq; Brazilian research agency FAPEMIG	Conselho Nacional de Pesquisa grants reagents; Fundacao de Amparo a Pesquisa do estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Brazilian research agency CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian research agency FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	The funding from Conselho Nacional de Pesquisa grants reagents for JES. The funding from Fundacao de Amparo a Pesquisa do estado de Minas Gerais grants fellowship and reagents for MSC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by Brazilian research agencies CNPq and FAPEMIG. Authors are grateful to Nucleus of Microscopy and Microanalysis, UFV, for technical support.	AHAMMADSAHIB KI, 1993, LIFE SCI, V53, P1113, DOI 10.1016/0024-3205(93)90547-G; Almeida GD, 2014, ISJ-INVERT SURVIV J, V11, P79; Alves SN, 2010, MICRON, V41, P592, DOI 10.1016/j.micron.2010.04.004; [Anonymous], 2012, PESTICIDES ADV CHEM, DOI DOI 10.5772/46225; Arruda W, 2008, REV PATOLOGIA TROPIC, V37; Bermejo A, 2005, NAT PROD REP, V22, P269, DOI 10.1039/b500186m; BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3; BRAGA I. A., 2007, REV EPIDEMIOLOGIA SA, V16, P179, DOI DOI 10.5123/S1679-49742007000400006; Bryant B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025502; Cheong H, 2008, MOL BIOL CELL, V19, P668, DOI 10.1091/mbc.E07-08-0826; COCKE J, 1979, LIFE SCI, V24, P817, DOI 10.1016/0024-3205(79)90366-7; Cooper S, 2009, AM J POTATO RES, V86, P24, DOI 10.1007/s12230-008-9057-8; Correia AA, 2009, NEOTROP ENTOMOL, V38, P83, DOI 10.1590/S1519-566X2009000100008; Costa MS, 2012, NEOTROP ENTOMOL, V41, P311, DOI 10.1007/s13744-012-0050-z; Costa MS, 2014, TOXINS, V6, P1169, DOI 10.3390/toxins6041169; DAVIDSON EW, 1979, CAN J MICROBIOL, V25, P178, DOI 10.1139/m79-028; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Drake LL, 2015, SCI REP-UK, V5, DOI 10.1038/srep07795; Fernandes KM, 2015, MED VET ENTOMOL, V29, P245, DOI 10.1111/mve.12122; Finn RN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8814; Furtado RF, 2005, NEOTROP ENTOMOL, V34, P843, DOI 10.1590/S1519-566X2005000500018; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Halstead SB, 2008, ANNU REV ENTOMOL, V53, P273, DOI 10.1146/annurev.ento.53.103106.093326; Hariri M, 2000, MOL BIOL CELL, V11, P255, DOI 10.1091/mbc.11.1.255; He K, 1997, PESTIC SCI, V49, P372, DOI 10.1002/(SICI)1096-9063(199704)49:4&lt;372::AID-PS543&gt;3.0.CO;2-K; Hu C, 2010, ACTA CRYSTALLOGR F, V66, P787, DOI 10.1107/S1744309110018464; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Isman MB, 2006, ANNU REV ENTOMOL, V51, P45, DOI 10.1146/annurev.ento.51.110104.151146; Kamada Y, 2010, MOL CELL BIOL, V30, P1049, DOI 10.1128/MCB.01344-09; Klionsky DJ, 2014, NAT STRUCT MOL BIOL, V21, P336, DOI 10.1038/nsmb.2787; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Ligon B Lee, 2006, Semin Pediatr Infect Dis, V17, P99, DOI 10.1053/j.spid.2006.04.009; Luna JED, 2004, REV SAUDE PUBL, V38, P842, DOI 10.1590/S0034-89102004000600013; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nakatogawa H, 2012, J BIOL CHEM, V287, P28503, DOI 10.1074/jbc.C112.387514; Patramool S, 2012, PROTEOMICS, V12, P3510, DOI 10.1002/pmic.201200300; Patrick ML, 2006, J EXP BIOL, V209, P4638, DOI 10.1242/jeb.02551; Perumalsamy H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080226; Rattan RS, 2010, CROP PROT, V29, P913, DOI 10.1016/j.cropro.2010.05.008; Regis L, 2008, MEM I OSWALDO CRUZ, V103, P50, DOI 10.1590/S0074-02762008000100008; Rost-Roszkowska MM, 2012, ARTHROPOD STRUCT DEV, V41, P271, DOI 10.1016/j.asd.2012.01.001; Santos DE, 2015, PROTOPLASMA, V252, P619, DOI 10.1007/s00709-014-0707-z; Souza W, 2007, TECNICAS MICROSCOPI, P20; von Schwarzenberg K, 2013, J BIOL CHEM, V288, P1385, DOI 10.1074/jbc.M112.412007; Whalon M, 2006, DATABASE ARTHROPOD R; Wieczorek H, 1999, J BIOENERG BIOMEMBR, V31, P67, DOI 10.1023/A:1005448614450; Wink M, 2000, STUD NAT PROD CHEM, V21, P3; Zhuang ZP, 1999, J EXP BIOL, V202, P2449	48	24	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160928	10.1371/journal.pone.0160928	http://dx.doi.org/10.1371/journal.pone.0160928			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532504	Green Submitted, Green Published, gold			2022-12-26	WOS:000381487600049
J	Ortiz, F; Gelpi, R; Helantera, I; Melilli, E; Honkanen, E; Bestard, O; Grinyo, JM; Cruzado, JM				Ortiz, Fernanda; Gelpi, Rosana; Helantera, Ilkka; Melilli, Edoardo; Honkanen, Eero; Bestard, Oriol; Grinyo, Josep M.; Cruzado, Josep M.			Decreased Kidney Graft Survival in Low Immunological Risk Patients Showing Inflammation in Normal Protocol Biopsies	PLOS ONE			English	Article							EARLY SUBCLINICAL REJECTION; RENAL-ALLOGRAFT REJECTION; TUBULAR ATROPHY; TRANSPLANT RECIPIENTS; INTERSTITIAL FIBROSIS; SURVEILLANCE BIOPSIES; PROTEINURIA; CLASSIFICATION; CONSEQUENCES; MANAGEMENT	Introduction The pros and cons for implementing protocol biopsies (PB) after kidney transplantation are still a matter of debate. We aimed to address the frequency of pathological findings in PB, to analyze their impact on long-term graft survival (GS) and to analyze the risk factors predicting an abnormal histology. Methods We analyzed 946 kidney PB obtained at a median time of 6.5 (+/- 2.9) months after transplantation. Statistics included comparison between groups, Kaplan-Meier and multinomial logistic regression analysis. Results and Discussion PB diagnosis were: 53.4% normal; 46% IFTA; 12.3% borderline and 4.9% had subclinical acute rejection (SCAR). Inflammation had the strongest negative impact on GS. Therefore we split the cases into: "normal without inflammation", "normal with inflammation", "IFTA without inflammation", "IFTA with inflammation" and "rejection" (including SCAR and borderline). 15-year GS in PB diagnosed normal with inflammation was significantly decreased in a similar fashion as in rejection cases. Among normal biopsies, inflammation increased significantly the risk of 15-y graft loss (P = 0.01). Variables that predicted an abnormal biopsy were proteinuria, previous AR and DR-mismatch. Conclusion We conclude that inflammation in normal PB is associated with a significantly lower 15-y GS, comparable to rejection or IFTA with inflammation.	[Ortiz, Fernanda; Honkanen, Eero] Helsinki Univ Hosp, Nephrol, Helsinki, Finland; [Gelpi, Rosana; Melilli, Edoardo; Bestard, Oriol; Grinyo, Josep M.; Cruzado, Josep M.] Bellvitge Univ Hosp, Dept Nephrol, Barcelona, Spain; [Helantera, Ilkka] Helsinki Univ Hosp, Transplantat & Liver Surg, Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; University of Helsinki; Helsinki University Central Hospital	Ortiz, F (corresponding author), Helsinki Univ Hosp, Nephrol, Helsinki, Finland.	fernanda.ortiz@hus.fi		Melilli, Edoardo/0000-0001-6965-3745; Ortiz, Fernanda/0000-0003-0462-4833	 [TYH2015108];  [PI12/01427]	; 	The work was supported by the following: http://www.med.helsinki.fi/english/research/, Grant number TYH2015108; and http://redinren.org/, Grant Number PI12/01427.	Amer H, 2007, AM J TRANSPLANT, V7, P2748, DOI 10.1111/j.1600-6143.2007.02006.x; Buchmann TN, 2012, TRANSPLANTATION, V93, P908, DOI 10.1097/TP.0b013e318248cab0; Cosio FG, 2005, AM J TRANSPLANT, V5, P2464, DOI 10.1111/j.1600-6143.2005.01050.x; de Freitas DG, 2012, AM J TRANSPLANT, V12, P191, DOI 10.1111/j.1600-6143.2011.03784.x; de Freitas DG, 2011, AM J TRANSPLANT, V11, P56; Gago M, 2012, AM J TRANSPLANT, V12, P1199, DOI 10.1111/j.1600-6143.2011.03911.x; Halimi JM, 2007, AM J TRANSPLANT, V7, P2775, DOI 10.1111/j.1600-6143.2007.02010.x; Halimi JM, 2005, AM J TRANSPLANT, V5, P2281, DOI 10.1111/j.1600-6143.2005.01020.x; Heilman RL, 2010, AM J TRANSPLANT, V10, P563, DOI 10.1111/j.1600-6143.2009.02966.x; ISONIEMI H, 1994, TRANSPLANTATION, V58, P1195, DOI 10.1097/00007890-199412270-00010; Jenni F, 2013, KIDNEY BLOOD PRESS R, V37, P116, DOI 10.1159/000350065; Kee TYS, 2006, TRANSPLANTATION, V82, P36, DOI 10.1097/01.tp.0000225783.86950.c2; Legendre C, 2014, TRANSPL INT, V27, P19, DOI 10.1111/tri.12217; Mannon RB, 2010, AM J TRANSPLANT, V10, P2066, DOI 10.1111/j.1600-6143.2010.03240.x; Matsushita K, 2012, JAMA-J AM MED ASSOC, V307, P1941, DOI 10.1001/jama.2012.3954; Mengel M, 2007, AM J TRANSPLANT, V7, P512, DOI 10.1111/j.1600-6143.2006.01677.x; Mengel M, 2007, AM J TRANSPLANT, V7, P356, DOI 10.1111/j.1600-6143.2006.01635.x; Moreso F, 2012, TRANSPLANTATION, V93, P41, DOI 10.1097/TP.0b013e31823bb647; Nankivell BJ, 2006, AM J TRANSPLANT, V6, P2006, DOI 10.1111/j.1600-6143.2006.01436.x; Oblak M, 2013, TRANSPL P, V45, P1453, DOI 10.1016/j.transproceed.2013.02.106; Ponticelli C, 2012, TRANSPL INT, V25, P909, DOI 10.1111/j.1432-2277.2012.01500.x; Racusen LC, 2003, AM J TRANSPLANT, V3, P708, DOI 10.1034/j.1600-6143.2003.00072.x; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; Roberts ISD, 2004, TRANSPLANTATION, V77, P1194, DOI 10.1097/01.TP.0000118905.98469.91; Rush D, 2007, AM J TRANSPLANT, V7, P2538, DOI 10.1111/j.1600-6143.2007.01979.x; Rush D, 1998, J AM SOC NEPHROL, V9, P2129; Rush DN, 2015, CURR OPIN NEPHROL HY, V24, P582, DOI 10.1097/MNH.0000000000000170; RUSH DN, 1995, TRANSPLANT P, V27, P1017; RUSH DN, 1994, TRANSPLANTATION, V57, P208, DOI 10.1097/00007890-199401001-00009; Scholten EM, 2006, J AM SOC NEPHROL, V17, P2622, DOI 10.1681/ASN.2006030227; Seron D, 2009, TRANSPL P, V41, P769, DOI 10.1016/j.transproceed.2008.12.027; Shamseddin MK, 2011, CLIN J AM SOC NEPHRO, V6, P1786, DOI 10.2215/CJN.01310211; Solez K, 2007, AM J TRANSPLANT, V7, P518, DOI 10.1111/j.1600-6143.2006.01688.x; Thierry A, 2011, AM J TRANSPLANT, V11, P2153, DOI 10.1111/j.1600-6143.2011.03695.x	34	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0159717	10.1371/journal.pone.0159717	http://dx.doi.org/10.1371/journal.pone.0159717			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532630	Green Submitted, Green Published, gold			2022-12-26	WOS:000381487600009
J	Dietz, S; Schirmer, U; Merce, C; von Bubnoff, N; Dahl, E; Meister, M; Muley, T; Thomas, M; Sultmann, H				Dietz, Steffen; Schirmer, Uwe; Merce, Clementine; von Bubnoff, Nikolas; Dahl, Edgar; Meister, Michael; Muley, Thomas; Thomas, Michael; Sueltmann, Holger			Low Input Whole-Exome Sequencing to Determine the Representation of the Tumor Exome in Circulating DNA of Non-Small Cell Lung Cancer Patients	PLOS ONE			English	Article							PLASMA DNA; GENOME; MUTATIONS; BLOOD; EVOLUTION; ORIGIN; QUANTIFICATION; HETEROGENEITY; CAPTURE; FORMAT	Circulating cell-free DNA (cfDNA) released from cancerous tissues has been found to harbor tumor-associated alterations and to represent the molecular composition of the tumor. Recent advances in technologies, especially in next-generation sequencing, enable the analysis of low amounts of cfDNA from body fluids. We analyzed the exomes of tumor tissue and matched serum samples to investigate the molecular representation of the tumor exome in cfDNA. To this end, we implemented a workflow for sequencing of cfDNA from low serum volumes (200 mu l) and performed whole-exome sequencing (WES) of serum and matched tumor tissue samples from six non-small cell lung cancer (NSCLC) patients and two control sera. Exomes, including untranslated regions (UTRs) of cfDNA were sequenced with an average coverage of 68.5x. Enrichment efficiency, target coverage, and sequencing depth of cfDNA reads were comparable to those from matched tissues. Discovered variants were compared between serum and tissue as well as to the COSMIC database of known mutations. Although not all tissue variants could be confirmed in the matched serum, up to 57% of the tumor variants were reflected in matched cfDNA with mutations in PIK3CA, ALK, and PTEN as well as variants at COSMIC annotated sites in all six patients analyzed. Moreover, cfDNA revealed a mutation in MTOR, which was not detected in the matched tissue, potentially from an untested region of the heterogeneous primary tumor or from a distant metastatic clone. WES of cfDNA may provide additional complementary molecular information about clinically relevant mutations and the clonal heterogeneity of the tumors.	[Dietz, Steffen; Schirmer, Uwe; Merce, Clementine; Sueltmann, Holger] German Canc Res Ctr, Canc Genome Res Grp, Neuenheimer Feld 460, Heidelberg, Germany; [Dietz, Steffen; Schirmer, Uwe; Merce, Clementine; Sueltmann, Holger] Natl Ctr Tumor Dis NCT, Neuenheimer Feld 460, Heidelberg, Germany; [Dietz, Steffen; Schirmer, Uwe; Merce, Clementine; Meister, Michael; Muley, Thomas; Thomas, Michael; Sueltmann, Holger] German Ctr Lung Res DZL, TLRC, Heidelberg, Germany; [von Bubnoff, Nikolas] Univ Med Ctr Freiburg, Dept Hematol Oncol & Stem Cell Transplantat, Freiburg, Germany; [von Bubnoff, Nikolas; Sueltmann, Holger] German Canc Consortium DKTK, Heidelberg, Germany; [Dahl, Edgar] Rhein Westfal TH Aachen, Inst Pathol, Mol Oncol Grp, Aachen, Germany; [Meister, Michael; Muley, Thomas] Univ Heidelberg Hosp, Translat Res Unit, Thoraxklin, Heidelberg, Germany; [Thomas, Michael] Univ Heidelberg Hosp, Dept Oncol, Thoraxklin, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ); RWTH Aachen University; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Sultmann, H (corresponding author), German Canc Res Ctr, Canc Genome Res Grp, Neuenheimer Feld 460, Heidelberg, Germany.; Sultmann, H (corresponding author), Natl Ctr Tumor Dis NCT, Neuenheimer Feld 460, Heidelberg, Germany.; Sultmann, H (corresponding author), German Ctr Lung Res DZL, TLRC, Heidelberg, Germany.; Sultmann, H (corresponding author), German Canc Consortium DKTK, Heidelberg, Germany.	h.sueltmann@dkfz.de	von Bubnoff, Nikolas/F-2351-2017; Muley, Thomas/AAY-9200-2020; von Bubnoff, Nikolas/AAG-1845-2021; Sültmann, Holger/E-4534-2013	von Bubnoff, Nikolas/0000-0001-9593-8947; Sültmann, Holger/0000-0002-5257-8600				Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Alexandrov LB, 2014, CURR OPIN GENET DEV, V24, P52, DOI 10.1016/j.gde.2013.11.014; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Belkadi A, 2015, P NATL ACAD SCI USA, V112, P5473, DOI 10.1073/pnas.1418631112; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Butler TM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136407; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; De Mattos-Arruda L, 2014, ANN ONCOL, V25, P1729, DOI 10.1093/annonc/mdu239; Diaz LA, 2014, J CLIN ONCOL, V32, P579, DOI 10.1200/JCO.2012.45.2011; Diehl F, 2005, P NATL ACAD SCI USA, V102, P16368, DOI 10.1073/pnas.0507904102; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Frenel JS, 2015, CLIN CANCER RES, V21, P4586, DOI 10.1158/1078-0432.CCR-15-0584; Frumkin D, 2005, PLOS COMPUT BIOL, V1, P382, DOI 10.1371/journal.pcbi.0010050; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gomez-Ramos A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101412; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Heitzer E, 2013, INT J CANCER, V133, P346, DOI 10.1002/ijc.28030; Holstege H, 2014, GENOME RES, V24, P733, DOI 10.1101/gr.162131.113; Hummel M, 2011, BIOINFORMATICS, V27, P1316, DOI 10.1093/bioinformatics/btr122; Jahr S, 2001, CANCER RES, V61, P1659; Jiang PY, 2015, P NATL ACAD SCI USA, V112, pE1317, DOI 10.1073/pnas.1500076112; Kane MD, 2000, NUCLEIC ACIDS RES, V28, P4552, DOI 10.1093/nar/28.22.4552; Klevebring D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104417; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Leary RJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004742; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lo YMD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001720; Lupski JR, 2013, SCIENCE, V341, P358, DOI 10.1126/science.1239503; McBride DJ, 2010, GENE CHROMOSOME CANC, V49, P1062, DOI 10.1002/gcc.20815; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mohan S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004271; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Newman AM, 2014, NAT MED, V20, P552, DOI 10.1038/nm.3519; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rykalina VN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101154; Snyder MW, 2016, CELL, V164, P57, DOI 10.1016/j.cell.2015.11.050; SORENSON GD, 1994, CANCER EPIDEM BIOMAR, V3, P67; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Thierry AR, 2014, NAT MED, V20, P430, DOI 10.1038/nm.3511; Thierry AR, 2010, NUCLEIC ACIDS RES, V38, P6159, DOI 10.1093/nar/gkq421; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang ZT, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0097907, 10.1371/journal.pone.0114792, 10.1371/journal.pone.0103645, 10.1371/journal.pone.0089948, 10.1371/journal.pone.0087381, 10.1371/journal.pone.0091755, 10.1371/journal.pone.0109571, 10.1371/journal.pone.0104657]	52	30	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161012	10.1371/journal.pone.0161012	http://dx.doi.org/10.1371/journal.pone.0161012			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529345	gold, Green Submitted, Green Published			2022-12-26	WOS:000381476700039
J	Hatae, R; Hata, N; Yoshimoto, K; Kuga, D; Akagi, Y; Murata, H; Suzuki, SO; Mizoguchi, M; Iihara, K				Hatae, Ryusuke; Hata, Nobuhiro; Yoshimoto, Koji; Kuga, Daisuke; Akagi, Yojiro; Murata, Hideki; Suzuki, Satoshi O.; Mizoguchi, Masahiro; Iihara, Koji			Precise Detection of IDH1/2 and BRAF Hotspot Mutations in Clinical Glioma Tissues by a Differential Calculus Analysis of High-Resolution Melting Data	PLOS ONE			English	Article							IDH2 MUTATIONS; CURVE ANALYSIS; GLIOBLASTOMA; INHIBITOR; SUBSET; ASSAY	High resolution melting (HRM) is a simple and rapid method for screening mutations. It offers various advantages for clinical diagnostic applications. Conventional HRM analysis often yields equivocal results, especially for surgically obtained tissues. We attempted to improve HRM analyses for more effective applications to clinical diagnostics. HRM analyses were performed for IDH1R132 and IDH2R172 mutations in 192 clinical glioma samples in duplicate and these results were compared with sequencing results. BRAFV600E mutations were analyzed in 52 additional brain tumor samples. The melting profiles were used for differential calculus analyses. Negative second derivative plots revealed additional peaks derived from heteroduplexes in PCR products that contained mutations; this enabled unequivocal visual discrimination of the mutations. We further developed a numerical expression, the HRM-mutation index (MI), to quantify the heteroduplex-derived peak of the mutational curves. Using this expression, all IDH1 mutation statuses matched those ascertained by sequencing, with the exception of three samples. These discordant results were all derived from the misinterpretation of sequencing data. The effectiveness of our approach was further validated by analyses of IDH2R172 and BRAFV600E mutations. The present analytical method enabled an unequivocal and objective HRM analysis and is suitable for reliable mutation scanning in surgically obtained glioma tissues. This approach could facilitate molecular diagnostics in clinical environments.	[Hatae, Ryusuke; Hata, Nobuhiro; Yoshimoto, Koji; Kuga, Daisuke; Akagi, Yojiro; Murata, Hideki; Mizoguchi, Masahiro; Iihara, Koji] Kyushu Univ, Grad Sch Med Sci, Dept Neurosurg, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan; [Hata, Nobuhiro] Kyushu Med Ctr, Natl Hosp Org, Clin Res Inst, Dept Neurosurg, Fukuoka, Japan; [Suzuki, Satoshi O.] Kyushu Univ, Grad Sch Med Sci, Dept Neuropathol, Fukuoka, Japan; [Mizoguchi, Masahiro] Kitakyushu Municipal Med Ctr, Dept Neurosurg, Kitakyushu, Fukuoka, Japan	Kyushu University; Kyushu University	Hata, N (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Neurosurg, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.; Hata, N (corresponding author), Kyushu Med Ctr, Natl Hosp Org, Clin Res Inst, Dept Neurosurg, Fukuoka, Japan.	hatanobu@kyumed.jp	Suzuki, Satoshi O/H-8367-2019; Hata, Nobuhiro/AAF-3034-2021	Suzuki, Satoshi O/0000-0002-0742-5680; Hata, Nobuhiro/0000-0002-5523-7166; Hatae, Ryusuke/0000-0001-5636-8064	JSPS KAKENHI [26462185, 25293311, 15K15529, 16K10779]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI, https://www.jsps.go.jp/english/index.html. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Ms. Fumie Doi for technical assistance. This work was supported by JSPS KAKENHI Grant Number 26462185, 25293311, 15K15529 and 16K10779.	Adachi JI, 2014, JSM NEUROSURG SPINE, V2, P1028; Arita H, 2015, BRAIN TUMOR PATHOL, V32, P22, DOI 10.1007/s10014-014-0186-0; Carbonell P, 2011, J MOL DIAGN, V13, P467, DOI 10.1016/j.jmoldx.2011.03.009; Chi AS, 2013, J CLIN ONCOL, V31, pE233, DOI 10.1200/JCO.2012.46.0220; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dang L, 2010, NATURE, V465, P966, DOI 10.1038/nature09132; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Duncan CG, 2012, GENOME RES, V22, P2339, DOI 10.1101/gr.132738.111; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Garritano S, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-5; Gonzalez-Bosquet J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014522; Gundry CN, 2003, CLIN CHEM, V49, P396, DOI 10.1373/49.3.396; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hata N, 2006, CLIN CHEM, V52, P370, DOI 10.1373/clinchem.2005.060954; Herrmann MG, 2006, CLIN CHEM, V52, P494, DOI 10.1373/clinchem.2005.063438; Horbinski C, 2010, J MOL DIAGN, V12, P487, DOI 10.2353/jmoldx.2010.090228; Ihle MA, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-13; Kanamori M, 2014, J NEUROSURG, V120, P1288, DOI 10.3171/2014.3.JNS131505; Li M, 2014, CLIN CHEM, V60, P864, DOI 10.1373/clinchem.2013.220160; Mengel M, 2002, J PATHOL, V198, P292, DOI 10.1002/path.1218; Milbury CA, 2009, CLIN CHEM, V55, P2130, DOI 10.1373/clinchem.2009.131029; Nicolaides TP, 2011, CLIN CANCER RES, V17, P7595, DOI 10.1158/1078-0432.CCR-11-1456; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Reed GH, 2004, CLIN CHEM, V50, P1748, DOI 10.1373/clinchem.2003.029751; Rohle D, 2013, SCIENCE, V340, P626, DOI 10.1126/science.1236062; Schiffman JD, 2010, CANCER RES, V70, P512, DOI 10.1158/0008-5472.CAN-09-1851; Schindler G, 2011, ACTA NEUROPATHOL, V121, P397, DOI 10.1007/s00401-011-0802-6; Setty P, 2010, J MOL DIAGN, V12, P750, DOI 10.2353/jmoldx.2010.090237; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Tsiatis AC, 2010, J MOL DIAGN, V12, P425, DOI 10.2353/jmoldx.2010.090188; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Vossen RHAM, 2009, HUM MUTAT, V30, P860, DOI 10.1002/humu.21019; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Zhang JH, 2013, NAT GENET, V45, P602, DOI 10.1038/ng.2611; Zhou LM, 2005, CLIN CHEM, V51, P1770, DOI 10.1373/clinchem.2005.054924	38	33	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160489	10.1371/journal.pone.0160489	http://dx.doi.org/10.1371/journal.pone.0160489			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529619	Green Published, Green Submitted, gold			2022-12-26	WOS:000381476700007
J	Meertens, JH; Nienhuis, HL; Lefrandt, JD; Schalkwijk, CG; Nyyssonen, K; Ligtenberg, JJM; Smit, AJ; Zijlstra, JG; Mulder, DJ				Meertens, John H.; Nienhuis, Hans L.; Lefrandt, Joop D.; Schalkwijk, Casper G.; Nyyssonen, Kristiina; Ligtenberg, Jack J. M.; Smit, Andries J.; Zijlstra, Jan G.; Mulder, D. J.			The Course of Skin and Serum Biomarkers of Advanced Glycation Endproducts and Its Association with Oxidative Stress, Inflammation, Disease Severity, and Mortality during ICU Admission in Critically Ill Patients: Results from a Prospective Pilot Study	PLOS ONE			English	Article							IMPAIRED RENAL-FUNCTION; ACUTE LUNG INJURY; END-PRODUCTS; ORGAN FAILURE; ENDOTHELIAL DYSFUNCTION; HEMODIALYSIS-PATIENTS; N-EPSILON-(CARBOXYMETHYL)LYSINE LEVELS; PREDICTS MORTALITY; SOLUBLE RECEPTOR; PLASMA-LEVELS	Background Advanced glycation end products (AGEs) have been implicated in multiple organ failure, predominantly via their cellular receptor (RAGE) in preclinical studies. Little is known about the time course and prognostic relevance of AGEs in critically ill human patients, including those with severe sepsis. Objective 1) To explore the reliability of Skin Autofluorescence (AF) as an index of tissue AGEs in ICU patients, 2) to compare its levels to healthy controls, 3) to describe the time course of AGEs and influencing factors during ICU admission, and 4) to explore their association with disease severity, outcome, and markers of oxidative stress and inflammation. Methods Skin AF, serum N ''-(carboxyethyl) lysine (CEL), N ''-(carboxymethyl) lysine (CML), and soluble RAGE (sRAGE) were serially measured for a maximum of 7 days in critically ill ICU patients with multiple organ failure and compared to age-matched healthy controls. Correlations with (changes in) clinical parameters of disease severity, LDL dienes, and CRP were studied and survival analysis for in-hospital mortality was performed. Results Forty-five ICU patients (age: 59 +/- 15 years; 60% male), and 37 healthy controls (59 +/- 14; 68%) were included. Skin AF measurements in ICU patients were reproducible (CV right-left arm: 13%, day-to-day: 10%), with confounding effects of skin reflectance and plasma bilirubin levels. Skin AF was higher in ICU patients vs healthy controls (2.7 +/- 0.7 vs 1.8 +/- 0.3 au; p < 0.001). Serum CEL (23 +/- 10 vs, 16 +/- 3 nmol/gr protein; p < 0.001), LDL dienes (19 (15-23) vs. 9 (8-11) mu mol/mmol cholesterol; < 0.001), and sRAGE (1547 (998-2496) vs. 1042 (824-1388) pg/ml; p = 0.003) were significantly higher in ICU patients compared to healthy controls, while CML was not different (27 (20-39) vs 29 (25-33) nmol/gr protein). While CRP and LDL dienes decreased significantly, Skin AF and serum AGEs and sRAGE did not change significantly during the first 7 days of ICU admission. CML and CEL were strongly correlated with SOFA scores and CML above the median at baseline was associated with increased risk for mortality (Hazard ratio 3.3 (1.3-8.3); p = 0.01). All other markers did not correlate with disease severity and did not predict mortality. Conclusions This study demonstrates that markers for the AGE-RAGE axis are elevated in critically ill patients compared to healthy controls but remain stable for at least 7 days despite clearly fading inflammation and oxidative stress. Circulating AGEs may be associated with disease severity and outcome. Further research should be conducted to elucidate the role of the AGE-RAGE axis in the exaggerated inflammatory response leading to multiple organ failure and death, and whether or not this may be a target for treatment.	[Meertens, John H.; Zijlstra, Jan G.] Univ Groningen, Univ Med Ctr Groningen, Dept Crit Care, Groningen, Netherlands; [Nienhuis, Hans L.; Lefrandt, Joop D.; Ligtenberg, Jack J. M.; Smit, Andries J.; Mulder, D. J.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Groningen, Netherlands; [Schalkwijk, Casper G.] Maastricht Univ, Dept Internal Med, Lab Metab & Vasc Med, Med Ctr, Maastricht, Netherlands; [Nyyssonen, Kristiina] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Dept Clin Chem, Kuopio, Finland; [Nyyssonen, Kristiina] Eastern Finland Lab Ctr, Kuopio, Finland	University of Groningen; University of Groningen; Maastricht University; University of Eastern Finland	Meertens, JH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Crit Care, Groningen, Netherlands.	j.h.j.m.meertens@umcg.nl	Zijlstra, Jan/E-6782-2011	Zijlstra, Jan/0000-0001-9079-0795; Schalkwijk, Casper G/0000-0003-0190-2690; Nienhuis, Hans/0000-0003-3974-6830				Anderson MM, 1999, J CLIN INVEST, V104, P103, DOI 10.1172/JCI3042; Andrades ME, 2012, EUR J CLIN INVEST, V42, P1055, DOI 10.1111/j.1365-2362.2012.02694.x; Basta G, 2008, CORONARY ARTERY DIS, V19, P299, DOI 10.1097/MCA.0b013e3282fec058; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Bopp C, 2008, J SURG RES, V147, P79, DOI 10.1016/j.jss.2007.07.014; Brodska H, 2013, SCAND J CLIN LAB INV, V73, P650, DOI 10.3109/00365513.2013.849357; Bryland A, 2010, INTENS CARE MED, V36, P1213, DOI 10.1007/s00134-010-1873-x; Calfee CS, 2008, THORAX, V63, P1083, DOI 10.1136/thx.2008.095588; Cnossen TT, 2011, PERITON DIALYSIS INT, V31, P679, DOI 10.3747/pdi.2010.00004; Corstjens AM, 2006, CRIT CARE, V10, DOI 10.1186/cc5048; de Vega JMA, 2000, CRIT CARE MED, V28, P1812, DOI 10.1097/00003246-200006000-00021; den Hollander NC, 2007, J INHERIT METAB DIS, V30, P916, DOI 10.1007/s10545-007-0507-0; Dullaart RPF, 2012, CLIN CHIM ACTA, V414, P161, DOI 10.1016/j.cca.2012.08.029; DYER DG, 1993, J CLIN INVEST, V91, P2463, DOI 10.1172/JCI116481; DYER DG, 1991, Z ERNAHRUNGSWISS, V30, P29, DOI 10.1007/BF01910730; Ehrhardt C, 2010, RECEPTOR ADV GLYCATI, V2010, DOI [10.1155/2010/917108, DOI 10.1155/2010/917108]; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fu MX, 1996, J BIOL CHEM, V271, P9982, DOI 10.1074/jbc.271.17.9982; Gaens KHJ, 2015, ARTERIOSCL THROM VAS, V35, P2707, DOI 10.1161/ATVBAHA.115.306106; Gaens KHJ, 2012, J HEPATOL, V56, P647, DOI 10.1016/j.jhep.2011.07.028; Gerrits EG, 2009, NEPHROL DIAL TRANSPL, V24, P710, DOI 10.1093/ndt/gfn634; Graaff R, 2005, P SOC PHOTO-OPT INS, V5692, P111, DOI 10.1117/12.588984; Graaff R, 2014, ARTIF ORGANS, V38, P515, DOI 10.1111/aor.12205; Greven WL, 2010, BMC CLIN PATHOL, V10, DOI 10.1186/1472-6890-10-4; Grune T, 2007, CURR OPIN CLIN NUTR, V10, P712, DOI 10.1097/MCO.0b013e3282f0c97c; Halliwell B, 2007, BIOCHEM J, V401, P1, DOI 10.1042/BJ20061131; Hanssen NMJ, 2013, J CLIN ENDOCR METAB, V98, pE1369, DOI 10.1210/jc.2013-1068; Hartog JWL, 2007, EUR HEART J, V28, P2879, DOI 10.1093/eurheartj/ehm486; Humpert PM, 2009, J LEUKOCYTE BIOL, V86, P589, DOI 10.1189/jlb.1008646; Kalousova M, 2005, CELL MOL BIOL, V51, P387, DOI 10.1170/T642; Kalousova M, 2006, AM J KIDNEY DIS, V47, P406, DOI 10.1053/j.ajkd.2005.12.028; Karppi J, 2010, ATHEROSCLEROSIS, V209, P565, DOI 10.1016/j.atherosclerosis.2009.10.007; Lieuw-A-Fa MLM, 2004, NEPHROL DIAL TRANSPL, V19, P631, DOI 10.1093/ndt/gfg619; Liliensiek B, 2004, J CLIN INVEST, V113, P1641, DOI 10.1172/JCI200418704; Lobo SMA, 2003, CHEST, V123, P2043, DOI 10.1378/chest.123.6.2043; Meerwaldt R, 2005, ANN NY ACAD SCI, V1043, P290, DOI 10.1196/annals.1333.036; Meerwaldt R, 2005, J AM SOC NEPHROL, V16, P3687, DOI 10.1681/ASN.2005020144; Meerwaldt R, 2004, DIABETOLOGIA, V47, P1324, DOI 10.1007/s00125-004-1451-2; Meisner M, 1999, CRIT CARE, V3, P45, DOI 10.1186/cc306; Motoyama T, 2003, CRIT CARE MED, V31, P1048, DOI 10.1097/01.CCM.0000055371.27268.36; Mulder DJ, 2009, NETH HEART J, V17, P162, DOI 10.1007/BF03086239; Mulder DJ, 2004, INTENS CARE MED, V30; Mulder DJ, 2006, DIABETES TECHNOL THE, V8, P523, DOI 10.1089/dia.2006.8.523; Nakamura T, 2009, PHARMACOL RES, V60, P515, DOI 10.1016/j.phrs.2009.05.002; Price CL, 2010, J CELL MOL MED, V14, P1806, DOI 10.1111/j.1582-4934.2009.00803.x; Schalkwijk CG, 2005, ANN NY ACAD SCI, V1043, P662, DOI 10.1196/annals.1333.075; Schmidt AM, 1999, CIRC RES, V84, P489, DOI 10.1161/01.RES.84.5.489; Schwedler SB, 2002, KIDNEY INT, V62, P301, DOI 10.1046/j.1523-1755.2002.00423.x; Smit AJ, 2004, CURR MED CHEM, V11, P2767, DOI 10.2174/0929867043364342; Stam F, 2006, NEPHROL DIAL TRANSPL, V21, P677, DOI 10.1093/ndt/gfi309; Uchida T, 2006, AM J RESP CRIT CARE, V173, P1008, DOI 10.1164/rccm.200509-1477OC; van Zoelen MAD, 2008, CRIT CARE, V12, DOI 10.1186/cc6187; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wagner Z, 2006, AM J KIDNEY DIS, V47, P294, DOI 10.1053/j.ajkd.2005.10.010; Wagner Z, 2001, AM J KIDNEY DIS, V38, P785, DOI 10.1053/ajkd.2001.27695; Ware LB, 2011, SHOCK, V36, P12, DOI 10.1097/SHK.0b013e318217025a	56	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160893	10.1371/journal.pone.0160893	http://dx.doi.org/10.1371/journal.pone.0160893			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529340	Green Submitted, Green Published, gold			2022-12-26	WOS:000381476700030
J	Sakellariou, GK; Pearson, T; Lightfoot, AP; Nye, GA; Wells, N; Giakoumaki, II; Griffiths, RD; McArdle, A; Jackson, MJ				Sakellariou, Giorgos K.; Pearson, Timothy; Lightfoot, Adam P.; Nye, Gareth A.; Wells, Nicola; Giakoumaki, Ifigeneia I.; Griffiths, Richard D.; McArdle, Anne; Jackson, Malcolm J.			Long-term administration of the mitochondria-targeted antioxidant mitoquinone mesylate fails to attenuate age-related oxidative damage or rescue the loss of muscle mass and function associated with aging of skeletal muscle	FASEB JOURNAL			English	Article						heat shock protein; NF-B; NOX4; SOD; superoxide	CU,ZN SUPEROXIDE-DISMUTASE; CONTRACTILE ACTIVITY; REACTIVE OXYGEN; COMPLEX-I; LIFE-SPAN; ADAPTIVE RESPONSES; INSULIN-RESISTANCE; RESPIRATORY-CHAIN; CELL-DEATH; MICE	Age-related skeletal muscle dysfunction is the underlying cause of morbidity that affects up to half the population aged 80 and over. Considerable evidence indicates that oxidative damage and mitochondrial dysfunction contribute to the sarcopenic phenotype that occurs with aging. To examine this, we administered the mitochondria-targeted antioxidant mitoquinone mesylate {[10-(4,5-dimethoxy-2-methyl-3,6-dioxo-1,4-cyclohexadien-1-yl)decyl] triphenylphosphonium; 100 M} to wild-type C57BL/6 mice for 15 wk (from 24 to 28 mo of age) and investigated the effects on age-related loss of muscle mass and function, changes in redox homeostasis, and mitochondrial organelle integrity and function. We found that mitoquinone mesylate treatment failed to prevent age-dependent loss of skeletal muscle mass associated with myofiber atrophy or alter a variety of in situ and ex vivo muscle function analyses, including maximum isometric tetanic force, decline in force after a tetanic fatiguing protocol, and single-fiber-specific force. We also found evidence that long-term mitoquinone mesylate administration did not reduce mitochondrial reactive oxygen species or induce significant changes in muscle redox homeostasis, as assessed by changes in 4-hydroxynonenal protein adducts, protein carbonyl content, protein nitration, and DNA damage determined by the content of 8-hydroxydeoxyguanosine. Mitochondrial membrane potential, abundance, and respiration assessed in permeabilized myofibers were not significantly altered in response to mitoquinone mesylate treatment. Collectively, these findings demonstrate that long-term mitochondria-targeted mitoquinone mesylate administration failed to attenuate age-related oxidative damage in skeletal muscle of old mice or provide any protective effect in the context of muscle aging.Sakellariou, G. K., Pearson, T., Lightfoot, A. P., Nye, G. A., Wells, N., Giakoumaki, I. I., Griffiths, R. D., McArdle, A., Jackson, M. J. Long-term administration of the mitochondria-targeted antioxidant mitoquinone mesylate fails to attenuate age-related oxidative damage or rescue the loss of muscle mass and function associated with aging of skeletal muscle.	[Sakellariou, Giorgos K.; Pearson, Timothy; Lightfoot, Adam P.; Nye, Gareth A.; Wells, Nicola; Giakoumaki, Ifigeneia I.; Griffiths, Richard D.; McArdle, Anne; Jackson, Malcolm J.] Univ Liverpool, Med Res Council, Arthrit Res UK Ctr Integrated Res Musculoskeletal, Dept Musculoskeletal Biol,Inst Ageing & Chron Dis, Liverpool, Merseyside, England; [Sakellariou, Giorgos K.] GeneFirst Ltd, Culham Sci Ctr, Abingdon, Oxon, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Liverpool; Culham Science Centre; UK Atomic Energy Authority	Jackson, MJ (corresponding author), Univ Liverpool, Inst Ageing & Chron Dis, Liverpool L69 3GA, Merseyside, England.	mjj@liverpool.ac.uk	Lightfoot, Adam/H-1292-2016; nye, gareth/M-1293-2019	Lightfoot, Adam/0000-0003-1501-7879; nye, gareth/0000-0003-4508-0406; Jackson, Malcolm/0000-0003-3683-8297; Pearson, Tim/0000-0002-3653-4421	UK Medical Research Council (Moscow, Russia) [G1002120]; U.S. National Institutes of Health, National Institute on Aging [AG-20591]; MRC [MR/K006312/1, G1002120] Funding Source: UKRI; Medical Research Council [MR/K006312/1, G1002120] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [P01AG020591] Funding Source: NIH RePORTER	UK Medical Research Council (Moscow, Russia); U.S. National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank C. S. Davis and S. V. Brooks (University of Michigan, Ann Arbor, MI, USA), M. E. Walsh (University of Texas Health Science Center, Houston, TX, USA), H. Van Remmen (Oklahoma Medical Research Foundation, Oklahoma City, OK, USA), R. T. Hepple (McGill University Health Centre, Montreal, QC, Canada), M. Picard (Center for Mitochondrial and Epigenomic Medicine, Philadelphia, PA, USA), M. Brand (Buck Institute for Research on Aging, Novato, CA, USA), V. P. Skulachev (Moscow State University), S. I. Dikalov (Vanderbilt University Medical Center), and W. I. Sivitz (University of Iowa Carver College of Medicine). This work was supported by the UK Medical Research Council (Moscow, Russia; Grant G1002120) and the U.S. National Institutes of Health, National Institute on Aging (Grant AG-20591).	Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Asin-Cayuela J, 2004, FEBS LETT, V571, P9, DOI 10.1016/j.febslet.2004.06.045; Broome CS, 2006, FASEB J, V20, P1549, DOI 10.1096/fj.05-4935fje; Chabi B, 2008, AGING CELL, V7, P2, DOI 10.1111/j.1474-9726.2007.00347.x; Changou CA, 2014, P NATL ACAD SCI USA, V111, P14147, DOI 10.1073/pnas.1404171111; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Chouchani ET, 2013, NAT MED, V19, P753, DOI 10.1038/nm.3212; Degens H, 2010, PFLUG ARCH EUR J PHY, V460, P863, DOI 10.1007/s00424-010-0866-5; Dikalov S, 2002, J BIOL CHEM, V277, P25480, DOI 10.1074/jbc.M203271200; Dimauro Ivan, 2012, BMC Res Notes, V5, P513, DOI 10.1186/1756-0500-5-513; Doughan AK, 2007, ANTIOXID REDOX SIGN, V9, P1825, DOI 10.1089/ars.2007.1693; Fink BD, 2012, J PHARMACOL EXP THER, V342, P709, DOI 10.1124/jpet.112.195586; Goncalves RLS, 2015, J BIOL CHEM, V290, P209, DOI 10.1074/jbc.M114.619072; Gouspillou G, 2014, FASEB J, V28, P1621, DOI 10.1096/fj.13-242750; Gouspillou G, 2014, AGING CELL, V13, P39, DOI 10.1111/acel.12147; Houot V, 2001, J EXP BOT, V52, P1721, DOI 10.1093/jexbot/52.361.1721; Jackson MJ, 2013, ANTIOXID REDOX SIGN, V19, P804, DOI 10.1089/ars.2013.5383; James AM, 2004, ARCH BIOCHEM BIOPHYS, V423, P47, DOI 10.1016/j.abb.2003.12.025; Jang YC, 2010, FASEB J, V24, P1376, DOI 10.1096/fj.09-146308; Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873; King MS, 2009, BIOCHEMISTRY-US, V48, P2053, DOI 10.1021/bi802282h; Kirkendall DT, 1998, AM J SPORT MED, V26, P598, DOI 10.1177/03635465980260042401; Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; Lee HY, 2010, CELL METAB, V12, P668, DOI 10.1016/j.cmet.2010.11.004; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Lustgarten MS, 2009, AM J PHYSIOL-CELL PH, V297, pC1520, DOI 10.1152/ajpcell.00372.2009; McDonagh B, 2014, J PROTEOME RES, V13, P5008, DOI 10.1021/pr5006394; McDonagh B, 2014, BIOCHEM SOC T, V42, P965, DOI 10.1042/BST20140085; McManus MJ, 2011, J NEUROSCI, V31, P15703, DOI 10.1523/JNEUROSCI.0552-11.2011; Mecocci P, 1999, FREE RADICAL BIO MED, V26, P303, DOI 10.1016/S0891-5849(98)00208-1; Melov S, 2000, SCIENCE, V289, P1567, DOI 10.1126/science.289.5484.1567; Miro O, 2000, CARDIOVASC RES, V47, P624, DOI 10.1016/S0008-6363(00)00122-X; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Mukherjee TK, 2007, J IMMUNOL, V178, P1835, DOI 10.4049/jimmunol.178.3.1835; Muller FL, 2006, FREE RADICAL BIO MED, V40, P1993, DOI 10.1016/j.freeradbiomed.2006.01.036; O'Malley Y, 2006, J BIOL CHEM, V281, P39766, DOI 10.1074/jbc.M608268200; Patkova J, 2014, CELL PHYSIOL BIOCHEM, V33, P1439, DOI 10.1159/000358709; Perez VI, 2009, AGING CELL, V8, P73, DOI 10.1111/j.1474-9726.2008.00449.x; Picard Martin, 2010, Aging Cell, V9, P1032, DOI 10.1111/j.1474-9726.2010.00628.x; Plecita-Hlavata L, 2009, INT J BIOCHEM CELL B, V41, P1697, DOI 10.1016/j.biocel.2009.02.015; Pollack M, 2001, J GERONTOL A-BIOL, V56, pB475, DOI 10.1093/gerona/56.11.B475; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Rodriguez-Cuenca S, 2010, FREE RADICAL BIO MED, V48, P161, DOI 10.1016/j.freeradbiomed.2009.10.039; Sakellariou GK, 2014, FREE RADICAL RES, V48, P12, DOI 10.3109/10715762.2013.830718; Sakellariou GK, 2014, FASEB J, V28, P1666, DOI 10.1096/fj.13-240390; Sakellariou GK, 2011, AGING CELL, V10, P749, DOI 10.1111/j.1474-9726.2011.00709.x; Sakellariou GK, 2013, ANTIOXID REDOX SIGN, V18, P603, DOI 10.1089/ars.2012.4623; Sartori R, 2013, NAT GENET, V45, P1309, DOI 10.1038/ng.2772; Sataranatarajan K, 2015, REDOX BIOL, V5, P140, DOI 10.1016/j.redox.2015.04.005; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Severin FF, 2010, P NATL ACAD SCI USA, V107, P663, DOI 10.1073/pnas.0910216107; Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102; Umanskaya A, 2014, P NATL ACAD SCI USA, V111, P15250, DOI 10.1073/pnas.1412754111; Vasilaki A, 2006, MECH AGEING DEV, V127, P830, DOI 10.1016/j.mad.2006.08.004; Vasilaki A, 2006, AGING CELL, V5, P109, DOI 10.1111/j.1474-9726.2006.00198.x; Vasilaki A, 2004, FASEB J, V18, pA344; Vasilaki A, 2010, AGING CELL, V9, P979, DOI 10.1111/j.1474-9726.2010.00635.x; Wanagat J, 2015, EXP GERONTOL, V61, P15, DOI 10.1016/j.exger.2014.11.012; Wang AL, 2010, NEUROBIOL AGING, V31, P2002, DOI 10.1016/j.neurobiolaging.2008.10.019; Zhang YQ, 2013, FASEB J, V27, P3536, DOI 10.1096/fj.13-228130; Zielonka J, 2010, FREE RADICAL BIO MED, V48, P983, DOI 10.1016/j.freeradbiomed.2010.01.028	62	30	30	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2016	30	11					3771	3785		10.1096/fj.201600450R	http://dx.doi.org/10.1096/fj.201600450R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EA3BY	27550965	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000386474700012
J	Bugarski-Stanojevic, V; Stamenkovic, G; Blagojevic, J; Liehr, T; Kosyakova, N; Rajicic, M; Vujosevic, M				Bugarski-Stanojevic, Vanja; Stamenkovic, Gorana; Blagojevic, Jelena; Liehr, Thomas; Kosyakova, Nadezda; Rajicic, Marija; Vujosevic, Mladen			Exploring Supernumeraries - A New Marker for Screening of B-Chromosomes Presence in the Yellow Necked Mouse Apodemus flavicollis	PLOS ONE			English	Article							KOREAN FIELD-MOUSE; PENINSULAE RODENTIA; MOLECULAR-CLONING; DNA-SEQUENCES; SMALL MAMMALS; EVOLUTION; GENOME; MICRODISSECTION; POPULATIONS; GENES	Since the density of simple sequence repeats (SSRs) may vary between different chromosomes of the same species in eukaryotic genomes, we screened SSRs of the whole genome of the yellow necked mouse, Apodemus flavicollis, in order to reveal SSR profiles specific for animals carrying B chromosomes. We found that the 2200 bp band was amplified by primer (CAG)(4)AC to a highly increased level in samples with B chromosomes. This quantitative difference (B-marker) between animals with (+B) and without (0B) B chromosomes was used to screen 20 populations (387 animals). The presence/absence of Bs was confirmed in 96.5% of 342 non mosaic individuals, which recommends this method for noninvasive B-presence detection. A group of 45 animals with mosaic and micro B (mu B) karyotypes was considered separately and showed 55.6% of overall congruence between karyotyping and molecular screening results. Relative quantification by qPCR of two different targeted sequences from B-marker indicated that these B-specific fragments are multiplied on B chromosomes. It also confirms our assumption that different types of Bs with variable molecular composition may exist in the same individual and between individuals of this species. Our results substantiate the origin of Bs from the standard chromosomal complement. The B-marker showed 98% sequence identity with the serine/threonine protein kinase VRK1 gene, similarly to findings reported for Bs from phylogenetically highly distant mammalian species. Evolutionarily conserved protein-coding genes found in Bs, including this one in A. flavicollis, could suggest a common evolutionary pathway.	[Bugarski-Stanojevic, Vanja; Stamenkovic, Gorana; Blagojevic, Jelena; Rajicic, Marija; Vujosevic, Mladen] Univ Belgrade, Inst Biol Res Sinisa Stankovic, Dept Genet Res, Belgrade, Serbia; [Liehr, Thomas; Kosyakova, Nadezda] Univ Klinikum, Inst Humangenet & Anthropol, Mol Zytogenet, Jena, Germany	University of Belgrade; Friedrich Schiller University of Jena	Bugarski-Stanojevic, V (corresponding author), Univ Belgrade, Inst Biol Res Sinisa Stankovic, Dept Genet Res, Belgrade, Serbia.	vanjabs@ibiss.bg.ac.rs	Liehr, Thomas/H-2852-2019; Blagojević, Jelena/B-4593-2008; Vujosevic, Mladen/C-3707-2016	Liehr, Thomas/0000-0003-1672-3054; Blagojević, Jelena/0000-0001-7102-5510; /0000-0002-9365-2993; Rajicic, Marija/0000-0002-2470-9888; Vujosevic, Mladen/0000-0002-5577-4455	Ministry of Education and Science of Serbia [173003]	Ministry of Education and Science of Serbia(Ministry of Education, Science & Technological Development, Serbia)	This work was supported by the Ministry of Education and Science of Serbia (http://www.mpn.gov.rs/nauka), Contract No. 173003. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adnadevic T, 2012, POPUL ECOL, V54, P537, DOI 10.1007/s10144-012-0333-6; Axtner Jan, 2009, BMC Res Notes, V2, P264, DOI 10.1186/1756-0500-2-264; Banaei-Moghaddam AM, 2013, PLANT CELL, V25, P2536, DOI 10.1105/tpc.113.111856; Becker SED, 2011, CHROMOSOME RES, V19, P685, DOI 10.1007/s10577-011-9233-4; BEUKEBOOM LW, 1994, HEREDITY, V73, P328, DOI 10.1038/hdy.1994.140; BLAGOJEVIC J, 1995, GENOME, V38, P472, DOI 10.1139/g95-062; Bornet B, 2001, PLANT MOL BIOL REP, V19, P209, DOI 10.1007/BF02772892; Bugarski-Stanojevic V, 2013, ZOOL ANZ, V252, P579, DOI 10.1016/j.jcz.2012.11.004; Bugarski-Stanojevic V, 2011, SYST BIODIVERS, V9, P95, DOI 10.1080/14772000.2011.560970; Bugrov AG, 2003, FOLIA BIOL-KRAKOW, V51, P1; Bugrov AG, 2007, CHROMOSOME RES, V15, P315, DOI 10.1007/s10577-007-1128-z; Carchilan M, 2009, CHROMOSOMA, V118, P607, DOI 10.1007/s00412-009-0222-8; COBB BD, 1994, NUCLEIC ACIDS RES, V22, P3801, DOI 10.1093/nar/22.18.3801; de Jesus CM, 2003, GENETICA, V118, P25; Graphodatsky AS, 2005, CHROMOSOME RES, V13, P113, DOI 10.1007/s10577-005-7474-9; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Han YN, 2001, PLANT J, V25, P305, DOI 10.1046/j.1365-313x.2001.00969.x; Houben A, 1997, CHROMOSOMA, V106, P513, DOI 10.1007/s004120050273; Houben A, 2014, CELL MOL LIFE SCI, V71, P467, DOI 10.1007/s00018-013-1437-7; Jojic V, 2011, J MAMMAL, V92, P396, DOI 10.1644/10-MAMM-A-158.1; Jones N, 2003, TRENDS PLANT SCI, V8, P417, DOI 10.1016/S1360-1385(03)00187-0; Jones RN, 1982, CHROMOSOMES; Karamysheva TV, 2002, CYTOGENET GENOME RES, V96, P154, DOI 10.1159/000063027; Kartavtseva I.V., 1994, CYTOL GENET, V28, P96; Kartavtseva IV, 2004, CYTOGENET GENOME RES, V106, P271, DOI 10.1159/000079298; Kartavtseva IV, 2002, KARYOSYSTEMATICS WOO, P140; Katti MV, 2001, MOL BIOL EVOL, V18, P1161, DOI 10.1093/oxfordjournals.molbev.a003903; Klemme S, 2013, NEW PHYTOL, V199, P550, DOI 10.1111/nph.12289; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; KRAL B, 1979, FOLIA ZOOL, V28, P5; Lamatsch DK, 2011, CYTOGENET GENOME RES, V135, P135, DOI 10.1159/000331271; Leach CR, 2005, GENETICS, V171, P269, DOI 10.1534/genetics.105.043273; Liehr Thomas, 2009, P23, DOI 10.1007/978-3-540-70581-9_2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Makunin AI, 2014, MOL CYTOGENET, V7, DOI 10.1186/s13039-014-0099-y; Martis MM, 2012, P NATL ACAD SCI USA, V109, P13343, DOI 10.1073/pnas.1204237109; Matsubara K, 2004, CHROMOSOME RES, V12, P383, DOI 10.1023/B:CHRO.0000034103.05528.83; Matsubara K, 2008, CHROMOSOME RES, V16, P1013, DOI 10.1007/s10577-008-1259-x; MCCLELLAND M, 1994, PCR METH APPL, V4, pS59; MIAO VP, 1991, SCIENCE, V254, P1773, DOI 10.1126/science.1763326; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; Navin N, 2006, BIOINFORMATICS, V22, P2437, DOI 10.1093/bioinformatics/btl273; Obara Yoshitaka, 1997, Chromosome Science, V1, P1; Owczarzy R, 2008, NUCLEIC ACIDS RES, V36, pW163, DOI 10.1093/nar/gkn198; Rajicic M, 2015, GENETIKA-BELGRADE, V47, P311, DOI 10.2298/GENSR1501311R; Randolph L, 1928, ANAT REC, V41, P102; Rubtsov NB, 2015, RUSS J GENET+, V51, P278, DOI 10.1134/S1022795415030114; Rubtsov NB, 2004, CYTOGENET GENOME RES, V106, P289, DOI 10.1159/000079301; Ruiz-Estevez M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036600; Serizawa K, 2000, BIOCHEM GENET, V38, P27, DOI 10.1023/A:1001828203201; Silva DMZD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094896; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanic N, 2000, GENOME RES, V10, P55; Trifonov VA, 2002, CHROMOSOME RES, V10, P109, DOI 10.1023/A:1014940800901; Trifonov VA, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-90; Tyler KD, 1997, J CLIN MICROBIOL, V35, P339, DOI 10.1128/JCM.35.2.339-346.1997; Valente GT, 2014, MOL BIOL EVOL, V31, P2061, DOI 10.1093/molbev/msu148; Vujosevic M, 2000, Z SAUGETIERKD, V65, P313; Vujosevic M, 2004, CYTOGENET GENOME RES, V106, P247, DOI 10.1159/000079295; VUJOSEVIC M, 1987, ACTA VET-BEOGRAD, V37, P115; VUJOSEVIC M, 1991, GENETICA, V83, P167, DOI 10.1007/BF00058534; Vujosevic M, 1990, ARCH BIOL SCI, V42, P39; Vujosevic M, 2005, FOLIA BIOL, V53, P1; Wang HZ, 2009, GENETICA, V136, P391, DOI 10.1007/s10709-008-9340-0; Wiebe MS, 2010, BIOL REPROD, V82, P182, DOI 10.1095/biolreprod.109.079095; Wilson D.E., 2005, MAMMAL SPECIES WORLD, V1; Yamada K, 2004, CHROMOSOMA, V112, P277, DOI 10.1007/s00412-003-0267-z; Yang F, 1997, CHROMOSOMA, V106, P37, DOI 10.1007/s004120050222; Yoshida K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002203; Yudkin DV, 2007, CYTOGENET GENOME RES, V116, P100, DOI 10.1159/000097424; Zelko I, 1998, ARCH BIOCHEM BIOPHYS, V352, P31, DOI 10.1006/abbi.1998.0582; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; ZIETKIEWICZ E, 1994, GENOMICS, V20, P176, DOI 10.1006/geno.1994.1151; Zima J, 1995, ACTA THERIOL, P75; ZIMA J, 1984, FOLIA ZOOL, V33, P133	75	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0160946	10.1371/journal.pone.0160946	http://dx.doi.org/10.1371/journal.pone.0160946			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27551940	Green Submitted, Green Published, gold			2022-12-26	WOS:000381768800019
J	Gajewska-Wozniak, O; Grycz, K; Czarkowska-Bauch, J; Skup, M				Gajewska-Wozniak, Olga; Grycz, Kamil; Czarkowska-Bauch, Julita; Skup, Malgorzata			Electrical Stimulation of Low-Threshold Proprioceptive Fibers in the Adult Rat Increases Density of Glutamatergic and Cholinergic Terminals on Ankle Extensor alpha-Motoneurons	PLOS ONE			English	Article							MEDIAL GASTROCNEMIUS-MUSCLE; LOW-FREQUENCY ACTIVATION; SPINAL-CORD-INJURY; H-REFLEX; TRICEPS SURAE; NERVE INJURY; HORSERADISH-PEROXIDASE; PREMOTOR INTERNEURONS; SYNAPTIC CONNECTIONS; AFFERENT SYNAPSES	The effects of stimulation of low-threshold proprioceptive afferents in the tibial nerve on two types of excitatory inputs to alpha-motoneurons were tested. The first input is formed by glutamatergic Ia sensory afferents contacting monosynaptically alpha-motoneurons. The second one is the cholinergic input originating from V0(c)-interneurons, located in lamina X of the spinal cord, modulating activity of alpha-motoneurons via C-terminals. Our aim was to clarify whether enhancement of signaling to ankle extensor alpha-motoneurons, via direct electrical stimulation addressed predominantly to low-threshold proprioceptive fibers in the tibial nerve of awake rats, will affect I alpha glutamatergic and cholinergic innervation of alpha-motoneurons of lateral gastrocnemius (LG). LG motoneurons were identified with True Blue tracer injected intramuscularly. Tibial nerve was stimulated for 7 days with continuous bursts of three pulses applied in four 20 min sessions daily. The Hoffmann reflex and motor responses recorded from the soleus muscle, LG synergist, allowed controlling stimulation. I alpha terminals and C-terminals abutting on LG-labeled alpha-motoneurons were detected by immunofluorescence (IF) using input-specific anti-VGLUT1 and anti-VAChT antibodies, respectively. Quantitative analysis of confocal images revealed that the number of VGLUT1 IF and VAChT IF terminals contacting the soma of LG alpha-motoneurons increased after stimulation by 35% and by 26%, respectively, comparing to the sham-stimulated side. The aggregate volume of VGLUT1 IF and VAChT IF terminals increased by 35% and by 30%, respectively. Labeling intensity of boutons was also increased, suggesting an increase of signaling to LG alpha-motoneurons after stimulation. To conclude, one week of continuous burst stimulation of proprioceptive input to LG alpha-motoneurons is effective in enrichment of their direct glutamatergic but also indirect cholinergic inputs. The effectiveness of such and longer stimulation in models of injury is a prerequisite to propose it as a therapeutic method to improve inputs to selected group of alpha-motoneurons after damage.	[Gajewska-Wozniak, Olga; Grycz, Kamil; Czarkowska-Bauch, Julita; Skup, Malgorzata] Nencki Inst Expt Biol, Dept Neurophysiol, 3 Pasteur St, Warsaw, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Skup, M (corresponding author), Nencki Inst Expt Biol, Dept Neurophysiol, 3 Pasteur St, Warsaw, Poland.	m.skup@nencki.gov.pl	Czarkowska-Bauch, Julita/AAB-6872-2020	Grycz, Kamil/0000-0002-1821-2453; Gajewska-Wozniak, Olga/0000-0003-3529-5788; Skup, Malgorzata/0000-0002-2605-0124	National Science Centre, Poland [2013/09/B/NZ4/03306]; Statutory funds for the Nencki Institute [411, 400.1]	National Science Centre, Poland(National Science Centre, Poland); Statutory funds for the Nencki Institute	This work was supported by National Science Centre, Poland, (https://www.ncn.gov.pl) grant no. 2013/09/B/NZ4/03306, [MS] and Statutory funds for the Nencki Institute, (http://www.nencki.gov.pl/) [no 411: JCzB, no 400.1: MS].	Alstermark B, 2004, J NEUROPHYSIOL, V91, P1832, DOI 10.1152/jn.00820.2003; Alvarez FJ, 2004, J COMP NEUROL, V472, P257, DOI 10.1002/cne.20012; Alvarez FJ, 2011, J NEUROPHYSIOL, V106, P2450, DOI 10.1152/jn.01095.2010; Alvarez FJ, 2010, ANN NY ACAD SCI, V1198, P231, DOI 10.1111/j.1749-6632.2010.05459.x; Banks RW, 2006, J ANAT, V208, P753, DOI 10.1111/j.1469-7580.2006.00558.x; Bannatyne BA, 2009, J PHYSIOL-LONDON, V587, P379, DOI 10.1113/jphysiol.2008.159129; Bawa P, 2008, MUSCLE NERVE, V38, P1604, DOI 10.1002/mus.21184; Brandt J, 2015, J NEUROPHYSIOL, V113, P2390, DOI 10.1152/jn.00892.2014; BRANNSTROM T, 1993, J COMP NEUROL, V330, P439, DOI 10.1002/cne.903300311; BROWN AG, 1978, J PHYSIOL-LONDON, V274, P111, DOI 10.1113/jphysiol.1978.sp012137; Burke RE, 1996, J COMP NEUROL, V372, P465; Carp JS, 2001, NEUROSCI LETT, V312, P1, DOI 10.1016/S0304-3940(01)02183-8; Cash F, 2016, J NEUROPHYSIOL, V115, P843, DOI 10.1152/jn.01053.2015; Chakkalakal JV, 2010, DEVELOPMENT, V137, P3489, DOI 10.1242/dev.053348; Chalmers GR, 1997, EXP BRAIN RES, V116, P351, DOI 10.1007/PL00005762; Chen HH, 2002, J NEUROSCI, V22, P3512; Chen XY, 2010, ANN NY ACAD SCI, V1198, pE12, DOI 10.1111/j.1749-6632.2010.05565.x; Chen Y, 2006, J NEUROSCI, V26, P12537, DOI 10.1523/JNEUROSCI.2198-06.2006; Chen Y, 2014, J NEUROPHYSIOL, V112, P2374, DOI 10.1152/jn.00422.2014; Chen Y, 2010, J NEUROSCI, V30, P16128, DOI 10.1523/JNEUROSCI.4578-10.2010; CHIANG RG, 1986, J NEUROCYTOL, V15, P63, DOI 10.1007/BF02057905; CONRADI S, 1979, J COMP NEUROL, V184, P741, DOI 10.1002/cne.901840407; Czarkowska-Bauch J, 1997, COE INT S BRAINST CO; Daniels RW, 2006, NEURON, V49, P11, DOI 10.1016/j.neuron.2005.11.032; Daniels RW, 2004, J NEUROSCI, V24, P10466, DOI 10.1523/JNEUROSCI.3001-04.2004; de Carrizosa MADL, 2009, J NEUROSCI, V29, P575, DOI 10.1523/JNEUROSCI.5312-08.2009; Du Beau A, 2012, NEUROSCIENCE, V227, P67, DOI 10.1016/j.neuroscience.2012.09.037; ECCLES JC, 1957, J PHYSIOL-LONDON, V137, P22, DOI 10.1113/jphysiol.1957.sp005794; English AW, 2007, J NEUROPHYSIOL, V97, P1127, DOI 10.1152/jn.01035.2006; FengChen KC, 1996, P NATL ACAD SCI USA, V93, P9206, DOI 10.1073/pnas.93.17.9206; Gajewska-Wozniak O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065937; Gordon T, 1997, J NEUROPHYSIOL, V77, P2585, DOI 10.1152/jn.1997.77.5.2585; Hellstrom J, 2003, J COMP NEUROL, V460, P476, DOI 10.1002/cne.10648; Ichiyama RM, 2006, J COMP NEUROL, V499, P306, DOI 10.1002/cne.21110; ISHIZUKA N, 1979, J COMP NEUROL, V186, P189, DOI 10.1002/cne.901860206; KRARUP C, 1988, MUSCLE NERVE, V11, P922; Liu CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098633; Liu TT, 2010, J PHYSIOL-LONDON, V588, P4217, DOI 10.1113/jphysiol.2010.192211; Loeb G. E., 1986, ELECTROMYOGRAPHY EXP; Makihara Y, 2012, MUSCLE NERVE, V45, P116, DOI 10.1002/mus.22265; MAO CC, 1984, EXP BRAIN RES, V56, P341; Mendell LM, 1999, J NEUROSCI, V19, P3162; Mentis GZ, 2010, ANN NY ACAD SCI, V1198, P220, DOI 10.1111/j.1749-6632.2010.05538.x; Miles GB, 2007, P NATL ACAD SCI USA, V104, P2448, DOI 10.1073/pnas.0611134104; Munson JB, 1997, J NEUROPHYSIOL, V77, P2605, DOI 10.1152/jn.1997.77.5.2605; OAKLEY RA, 1995, DEVELOPMENT, V121, P1341; Oliveira ALR, 2003, SYNAPSE, V50, P117, DOI 10.1002/syn.10249; Patel TD, 2003, NEURON, V38, P403, DOI 10.1016/S0896-6273(03)00261-7; RIDLER TW, 1978, IEEE T SYST MAN CYB, V8, P630, DOI 10.1109/tsmc.1978.4310039; Rotterman TM, 2014, J NEUROSCI, V34, P3475, DOI 10.1523/JNEUROSCI.4768-13.2014; SCHIEPPATI M, 1987, PROG NEUROBIOL, V28, P345, DOI 10.1016/0301-0082(87)90007-4; Schinder AF, 2000, NEURON, V25, P151, DOI 10.1016/S0896-6273(00)80879-X; SCOTT JG, 1976, J NEUROPHYSIOL, V39, P679, DOI 10.1152/jn.1976.39.4.679; Skup M, 2012, EUR J NEUROSCI, V36, P2679, DOI 10.1111/j.1460-9568.2012.08182.x; STEIN RB, 1977, BRAIN RES, V128, P21, DOI 10.1016/0006-8993(77)90233-5; Stepien AE, 2010, NEURON, V68, P456, DOI 10.1016/j.neuron.2010.10.019; Todd AJ, 2003, EUR J NEUROSCI, V17, P13, DOI 10.1046/j.1460-9568.2003.02406.x; Tucker KJ, 2005, HUM MOVEMENT SCI, V24, P667, DOI 10.1016/j.humov.2005.09.010; Tucker KJ, 2004, SOMATOSENS MOT RES, V21, P189, DOI 10.1080/08990220400012489; Varoqui H, 2002, J NEUROSCI, V22, P142, DOI 10.1523/JNEUROSCI.22-01-00142.2002; Vicario-Abejon C, 2002, NAT REV NEUROSCI, V3, P965, DOI 10.1038/nrn988; Wojcik SM, 2004, P NATL ACAD SCI USA, V101, P7158, DOI 10.1073/pnas.0401764101; Zagoraiou L, 2009, NEURON, V64, P645, DOI 10.1016/j.neuron.2009.10.017	63	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0161614	10.1371/journal.pone.0161614	http://dx.doi.org/10.1371/journal.pone.0161614			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27552219	Green Submitted, Green Published, gold			2022-12-26	WOS:000381768800058
J	Maheshwari, A; Norby, FL; Soliman, EZ; Adabag, S; Whitsel, EA; Alonso, A; Chen, LY				Maheshwari, Ankit; Norby, Faye L.; Soliman, Elsayed Z.; Adabag, Selcuk; Whitsel, Eric A.; Alonso, Alvaro; Chen, Lin Y.			Low Heart Rate Variability in a 2-Minute Electrocardiogram Recording Is Associated with an Increased Risk of Sudden Cardiac Death in the General Population: The Atherosclerosis Risk in Communities Study	PLOS ONE			English	Article							PROGNOSTIC VALUE; MYOCARDIAL-INFARCTION; VAGAL-STIMULATION; FAILURE INCIDENCE; SPECTRAL-ANALYSIS; MORTALITY; DISEASE; TRIAL; ARRHYTHMIAS; PREVENTION	Low heart rate variability (HRV) has been linked to increased total mortality in the general population; however, the relationship between low HRV and sudden cardiac death (SCD) is less well-characterized. The goal of this study was to evaluate the relationship between low HRV and SCD in a community-based cohort. Our cohort consisted of 12,543 participants from the Atherosclerosis Risk in Communities (ARIC) study. HRV measures were derived from 2-minute electrocardiogram recordings obtained during the baseline exam (1987-89). Time domain measurements included the standard deviation of all normal RR intervals (SDNN) and the root mean squared successive difference (r-MSSD). Frequency domain measurements included low frequency power (LF) and high frequency (HF) power. During a median follow-up of 13 years, 215 SCDs were identified from physician adjudication of all coronary heart disease deaths through 2001. In multivariable adjusted Cox proportional hazards models, each standard deviation decrement in SDNN, LF, and HF were associated with 24%, 27% and 16% increase in SCD risk, respectively. Low HRV is independently associated with increased risk of SCD in the general population.	[Maheshwari, Ankit; Chen, Lin Y.] Univ Minnesota, Sch Med, Dept Med, Div Cardiovasc, Minneapolis, MN 55455 USA; [Norby, Faye L.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Soliman, Elsayed Z.] Wake Forest Sch Med, Epidemiol Cardiol Res Ctr EPICARE, Winston Salem, NC USA; [Adabag, Selcuk] Vet Affairs Med Ctr, Div Cardiol, Minneapolis, MN USA; [Whitsel, Eric A.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Whitsel, Eric A.] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Alonso, Alvaro] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Wake Forest University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Emory University; Rollins School Public Health	Maheshwari, A (corresponding author), Univ Minnesota, Sch Med, Dept Med, Div Cardiovasc, Minneapolis, MN 55455 USA.	mahes046@umn.edu	Alonso, Alvaro/A-4917-2010; Soliman, Elsayed Z/AAD-7135-2020; Norby, Faye/FNA-7255-2022	Alonso, Alvaro/0000-0002-2225-8323; Soliman, Elsayed Z/0000-0001-5632-8150; Norby, Faye/0000-0002-1975-0405; Chen, Lin/0000-0002-0700-814X	National Heart, Lung, and Blood Institute [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C]	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C). The authors thank the staff and participants of the ARIC study for their important contributions.	Adabag AS, 2010, AM HEART J, V159, P33, DOI 10.1016/j.ahj.2009.10.019; Albert CM, 2003, CIRCULATION, V107, P2096, DOI 10.1161/01.CIR.0000065223.21530.11; ALGRA A, 1993, CIRCULATION, V88, P180, DOI 10.1161/01.CIR.88.1.180; [Anonymous], [No title captured]; Baek HJ, 2015, TELEMED E-HEALTH, V21, P404, DOI 10.1089/tmj.2014.0104; BIGGER JT, 1993, CIRCULATION, V88, P927, DOI 10.1161/01.CIR.88.3.927; Bilchick KC, 2002, AM J CARDIOL, V90, P24, DOI 10.1016/S0002-9149(02)02380-9; Brouwer J, 1996, J AM COLL CARDIOL, V28, P1183, DOI 10.1016/S0735-1097(96)00279-3; Camm AJ, 1996, EUR HEART J, V17, P354; Camm AJ, 2004, CIRCULATION, V109, P990, DOI 10.1161/01.CIR.0000117090.01718.2A; Chen LY, 2013, JAMA INTERN MED, V173, P29, DOI 10.1001/2013.jamainternmed.744; Chugh SS, 2010, NAT REV CARDIOL, V7, P318, DOI 10.1038/nrcardio.2010.52; Crow RS, 1995, AM J CARDIOL, V25, P2377; Dekker JM, 2000, CIRCULATION, V102, P1239, DOI 10.1161/01.CIR.102.11.1239; Deo R, 2012, CIRCULATION, V125, P620, DOI 10.1161/CIRCULATIONAHA.111.023838; deVreedeSwagemakers JJM, 1997, J AM COLL CARDIOL, V30, P1500, DOI 10.1016/S0735-1097(97)00355-0; FARRELL TG, 1991, J AM COLL CARDIOL, V18, P687, DOI 10.1016/0735-1097(91)90791-7; Fishman GI, 2010, CIRCULATION, V122, P2335, DOI 10.1161/CIRCULATIONAHA.110.976092; Folsom AR, 2011, STROKE, V42, P3075, DOI 10.1161/STROKEAHA.111.623157; Folsom AR, 2009, CIRC-HEART FAIL, V2, P11, DOI 10.1161/CIRCHEARTFAILURE.108.794933; Galinier M, 2000, EUR HEART J, V21, P475, DOI 10.1053/euhj.1999.1875; Hartikainen JEK, 1996, J AM COLL CARDIOL, V28, P296, DOI 10.1016/0735-1097(96)00169-6; Hou YM, 2016, HEART RHYTHM, V13, P584, DOI 10.1016/j.hrthm.2015.10.001; Kao WHL, 2009, CIRCULATION, V119, P940, DOI 10.1161/CIRCULATIONAHA.108.791723; Kotecha D, 2011, HEART, V97, pA38, DOI 10.1136/heartjnl-2011-300198.61; La Rovere MT, 2003, CIRCULATION, V107, P565, DOI 10.1161/01.CIR.0000047275.25795.17; Liao DP, 2002, DIABETES, V51, P3524, DOI 10.2337/diabetes.51.12.3524; Liao DP, 1996, COMPUT BIOMED RES, V29, P140, DOI 10.1006/cbmr.1996.0012; LIAO DP, 1995, AM J CARDIOL, V76, P906, DOI 10.1016/S0002-9149(99)80260-4; Loehr LR, 2008, AM J CARDIOL, V101, P1016, DOI 10.1016/j.amjcard.2007.11.061; Mehta D, 1997, CIRCULATION, V96, P3215, DOI 10.1161/01.CIR.96.9.3215; Modi S, 2011, CIRCULATION, V123, P2994, DOI 10.1161/CIRCULATIONAHA.110.981381; Munoz ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138921; Myerburg RJ, 2012, CIRCULATION, V125, P1043, DOI 10.1161/CIRCULATIONAHA.111.023846; MYERS RW, 1974, CIRCULATION, V49, P943, DOI 10.1161/01.CIR.49.5.943; Nolan J, 1998, CIRCULATION, V98, P1510, DOI 10.1161/01.CIR.98.15.1510; Schroeder EB, 2004, J ELECTROCARDIOL, V37, P163, DOI 10.1016/j.jelectrocard.2004.04.004; SCHWARTZ PJ, 1985, AM HEART J, V109, P937, DOI 10.1016/0002-8703(85)90233-9; Stein PK, 2010, J ELECTROCARDIOL, V43, P251, DOI 10.1016/j.jelectrocard.2009.12.009; Szabo BM, 1997, AM J CARDIOL, V79, P978, DOI 10.1016/S0002-9149(97)00026-X; Tsuji H, 1996, CIRCULATION, V94, P2850, DOI 10.1161/01.CIR.94.11.2850; TSUJI H, 1994, CIRCULATION, V90, P878, DOI 10.1161/01.CIR.90.2.878; VANOLI E, 1991, CIRC RES, V68, P1471, DOI 10.1161/01.RES.68.5.1471; Vaseghi M, 2008, PROG CARDIOVASC DIS, V50, P404, DOI 10.1016/j.pcad.2008.01.003; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	45	35	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0161648	10.1371/journal.pone.0161648	http://dx.doi.org/10.1371/journal.pone.0161648			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27551828	gold, Green Published, Green Submitted			2022-12-26	WOS:000381768800062
J	Castillo, M; Astudillo, A; Clavero, O; Velasco, J; Ibanez, R; de Sanjose, S				Castillo, Marta; Astudillo, Aurora; Clavero, Omar; Velasco, Julio; Ibanez, Raquel; de Sanjose, Silvia			Poor Cervical Cancer Screening Attendance and False Negatives. A Call for Organized Screening	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; HISTORY; WOMEN; CARCINOMA; PROGRAM; ADENOCARCINOMA; NETHERLANDS; PREVENTION; CYTOLOGY; AUDIT	Objective The objective of this study was to describe prior negative screening history and symptoms around the time of diagnosis of incident cervical cancer (CC) cases diagnosed between 2000 and 2010 within the Asturias public health system. Methods Records from 374 women diagnosed with CC between 2000 and 2010 from all public hospitals in Asturias were retrieved. Clinical information, FIGO stage and all previous cytological data were extracted from clinical and histopathological records. Proportional differences were assessed using chi-square tests. Logistic regression analysis was used to estimate odds ratios (OR) and 95% confidence intervals (CI). Inter-observer agreement in cytology was checked by comparing concordance values using k-statistics. Results No prior screening history was recorded in 60.7% of CC cases and its absence increased with age and advanced stage. Advanced stage (e.g., >= II) at diagnosis was associated with age (> 50 years) and adenocarcinoma (ADC) compared to younger women and those with a squamous cell carcinoma (SCC). False negative smears were identified in 27.1% of women with CC (ADC 52.6% vs. SCC 16.2%, p< 0.05). Conclusions Absence of prior screening history was common among CC cases. Organized actions to reduce "under screening"and the use of highly sensitive HPV-based tests could be useful strategies in reducing the burden of CC in Asturias.	[Castillo, Marta] SESPA, Jarrio Hosp, Dept Obstet & Gynecol, Coana, Asturias, Spain; [Astudillo, Aurora] Univ Oviedo, SESPA, Asturias Cent Univ Hosp, Dept Pathol, Oviedo, Asturias, Spain; [Clavero, Omar; Ibanez, Raquel; de Sanjose, Silvia] Inst Catala Oncol IDIBELL, Canc Epidemiol Res Programme, Infect & Canc Unit, Barcelona, Spain; [Velasco, Julio] Med Ctr Asturias, Dept Pathol, Oviedo, Asturias, Spain; [de Sanjose, Silvia] CIBER Epidemiol & Publ Hlth CIBERESP, Barcelona, Spain	Central University Hospital Asturias; University of Oviedo; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Castillo, M (corresponding author), SESPA, Jarrio Hosp, Dept Obstet & Gynecol, Coana, Asturias, Spain.	mamacasnu@gmail.com		Castillo Nunez, Marta/0000-0003-1565-9652; Ibanez, Raquel/0000-0003-3324-8312; Clavero, Omar/0000-0001-9721-6382; Astudillo Gonzalez, Maria Aurora/0000-0001-8947-8809	Agencia de Gestiio d'Ajuts Universitaris i de Recerca (Catalan Government) [SGR_14_756]; Instituto de Salud Carlos III CIBERESP [36]	Agencia de Gestiio d'Ajuts Universitaris i de Recerca (Catalan Government); Instituto de Salud Carlos III CIBERESP(Instituto de Salud Carlos III)	This study has been partially supported by Agencia de Gestiio d'Ajuts Universitaris i de Recerca (Catalan Government, grants SGR_14_756) and from the Instituto de Salud Carlos III CIBERESP, group 36. Silvia de Sanjose, Omar Clavero, Raquel Ibanez.	Blade A.T., 2014, REV ESP PATOL, V57, P1, DOI [10.1016/S0304-5013(14)73068-7, DOI 10.1016/S0304-5013(14)73068-7]; Bofin AM, 2007, CANCER CYTOPATHOL, V111, P210, DOI 10.1002/cncr.22865; Bos AB, 2006, INT J CANCER, V119, P2372, DOI 10.1002/ijc.22114; Boulanger JC, 2007, GYNECOL OBSTET FERTI, V35, P764, DOI 10.1016/j.gyobfe.2007.07.019; Bruni L, 2014, PAPILLOMAVIRUS RELAT; Castanon A, 2013, BRIT J CANCER, V109, P35, DOI 10.1038/bjc.2013.322; Castanon A, 2012, CYTOPATHOLOGY, V23, P13, DOI 10.1111/j.1365-2303.2011.00948.x; Marqueta PC, 2011, MED CLIN-BARCELONA, V136, P192, DOI 10.1016/j.medcli.2010.07.010; Castro P, 2004, PROG OBSTET GINECOL, V47, P214; CIATTO S, 1993, TUMORI, V79, P311, DOI 10.1177/030089169307900505; Sanjosé Silvia de, 2006, Gac Sanit, V20, P166; Franco EL, 2012, VACCINE, V30, pF175, DOI 10.1016/j.vaccine.2012.06.092; Gispert Rosa, 2006, Gac Sanit, V20, P184, DOI 10.1157/13088849; Herbert A, 2009, BJOG-INT J OBSTET GY, V116, P854, DOI 10.1111/j.1471-0528.2008.01989.x; Herbert A, 2009, BJOG-INT J OBSTET GY, V116, P845, DOI 10.1111/j.1471-0528.2008.01990.x; Ibanez R, 2014, J CLIN MICROBIOL, V52, P1511, DOI 10.1128/JCM.00100-14; Ibanez R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/605375; Kirschner B, 2011, GYNECOL ONCOL, V120, P68, DOI 10.1016/j.ygyno.2010.09.021; LANDIS JR, 1977, BIOMETRICS, V33, P363, DOI 10.2307/2529786; Margolles M., 2009, ENCUESTA SALUD ASTUR; Mubiayi N, 2002, Gynecol Obstet Fertil, V30, P210, DOI 10.1016/S1297-9589(02)00297-7; Mulvany NJ, 2009, PATHOLOGY, V41, P411, DOI 10.1080/00313020903042604; Pirog EC, 2014, MODERN PATHOL, V27, P1559, DOI 10.1038/modpathol.2014.55; RATIMA K, 1993, NEW ZEAL MED J, V106, P519; Ronco G, 2014, LANCET, V383, P524, DOI 10.1016/S0140-6736(13)62218-7; Skaznik-Wikiel ME, 2012, ACTA CYTOL, V56, P388, DOI 10.1159/000338555; Spayne J, 2008, EUR J PUBLIC HEALTH, V18, P162, DOI 10.1093/eurpub/ckm043; Spence AR, 2007, PREV MED, V45, P93, DOI 10.1016/j.ypmed.2007.06.007; Stuart GCE, 1997, CAN MED ASSOC J, V157, P513; van der Aa MA, 2008, EUR J OBSTET GYN R B, V139, P204, DOI 10.1016/j.ejogrb.2007.10.017; Wright JD, 2005, CANCER-AM CANCER SOC, V103, P85, DOI 10.1002/cncr.20751	31	11	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161403	10.1371/journal.pone.0161403	http://dx.doi.org/10.1371/journal.pone.0161403			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27547971	Green Published, Green Submitted, gold			2022-12-26	WOS:000381768400054
J	Aunger, R; Greenland, K; Ploubidis, G; Schmidt, W; Oxford, J; Curtis, V				Aunger, Robert; Greenland, Katie; Ploubidis, George; Schmidt, Wolf; Oxford, John; Curtis, Valerie			The Determinants of Reported Personal and Household Hygiene Behaviour: A Multi-Country Study	PLOS ONE			English	Article							INFLUENZA TRANSMISSION; RESPIRATORY ILLNESS; VALIDITY; HEALTH; RISK; HOME; CONTAMINATION; INTERVENTION; SANITATION; VARIABLES	A substantial proportion of the total infectious disease burden world-wide is due to person-to-person spread of pathogens within households. A questionnaire-based survey on the determinants of hand-washing with soap and cleaning of household surfaces was conducted in at least 1000 households in each of twelve countries across the world (N = 12,239). A structural equation model of hygiene behaviour and its consequences derived from theory was then estimated on this dataset for both behaviours, using a maximum likelihood procedure. The analysis showed that the frequency of hand washing with soap is significantly related to how automatically it is performed, and whether or not someone is busy, or tired. Surface cleaning was strongly linked to possessing a cleaning routine, the perception that one is living in a dirty environment and that others are doing the behaviour, whether one has a strong sense of contamination, as well as a felt need to keep one's surroundings tidy. Being concerned with good manners is also linked to the performance of both behaviours. This study is the first to identify the role of manners, orderliness and routine on hygiene behaviours globally. Such findings should prove helpful in designing programs to improve domestic hygiene practices.	[Aunger, Robert; Greenland, Katie; Schmidt, Wolf; Curtis, Valerie] London Sch Hyg & Trop Med, Environm Hlth Grp, London, England; [Ploubidis, George] UCL, Inst Educ, London, England; [Oxford, John] Queen Mary Univ London, Sch Med, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; UCL Institute of Education; University of London; Queen Mary University London	Aunger, R (corresponding author), London Sch Hyg & Trop Med, Environm Hlth Grp, London, England.	robert.aunger@lshtm.ac.uk	Ploubidis, George B/G-9531-2011	Ploubidis, George B/0000-0002-8198-5790; Schmidt, Wolf-Peter/0000-0001-7449-4152	Hygiene Council	Hygiene Council	The Hygiene Council approached the LSHTM team to conduct a global study; they paid for some LSHTM staff time, all data collection but played no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.; We would like to thank Oliver Parsons, Lee-Ann Cameron, Ann Walters and Claire Leggott of Tonic Plc for their help in coordinating the study; Kate Norfolk and her staff from Opinion Matters for supervising the data collection, providing details about their methods, and conducting preliminary statistical analyses; and the Hygiene Council for funding the research.	AJZEN I, 1973, J PERS SOC PSYCHOL, V27, P41, DOI 10.1037/h0034440; [Anonymous], 1974, Health Education Monograph, V2, P324; Aunger R, 2014, APPL EVOLUTIONARY AN; Aunger R, 2010, SOC SCI MED, V70, P383, DOI 10.1016/j.socscimed.2009.10.038; Bandura A., 1986, SOCIAL FDN THOUGHT A; Bloomfield S.F., 2007, AM J INFECT SUPPL 1, V35, P1; Bollen KA, 1989, STRUCTURAL EQUATIONS; Buss A. R., 1979, PERSONALITY SOCIAL P, V5, P191; Cairncross S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000365; Cogan TA, 2002, J APPL MICROBIOL, V92, P885, DOI 10.1046/j.1365-2672.2002.01598.x; Cole EC, 2012, S AFR J CHILD HEALTH, V6, P109, DOI 10.7196/SAJCH.459; Costa P.T., 1992, PSYCHOL ASSESSMENT, V4, P5, DOI [https://doi.org/10.1037/1040-3590.4.1.5, DOI 10.1037/1040-3590.4.1.5, 10.1037/1040-3590.4.1.5]; Cowling BJ, 2009, ANN INTERN MED, V151, P437, DOI 10.7326/0003-4819-151-7-200910060-00142; CURTIS V, 1993, B WORLD HEALTH ORGAN, V71, P23; Curtis V, 2003, LANCET INFECT DIS, V3, P275, DOI 10.1016/S1473-3099(03)00606-6; Curtis V, 2003, SOC SCI MED, V57, P657, DOI 10.1016/S0277-9536(02)00409-4; Curtis V, 2004, P ROY SOC B-BIOL SCI, V271, pS131, DOI 10.1098/rsbl.2003.0144; Curtis V, 2000, TROP MED INT HEALTH, V5, P22, DOI 10.1046/j.1365-3156.2000.00512.x; Curtis V, 2011, LANCET INFECT DIS, V11, P312, DOI 10.1016/S1473-3099(10)70224-3; Curtis V, 2011, PHILOS T R SOC B, V366, P389, DOI 10.1098/rstb.2010.0117; Curtis VA, 2009, HEALTH EDUC RES, V24, P655, DOI 10.1093/her/cyp002; Denham S.A., 2003, J FAMILY NURSING, V9, P305, DOI DOI 10.1177/1074840703255447; Dodou D, 2014, COMPUT HUM BEHAV, V36, P487, DOI 10.1016/j.chb.2014.04.005; Douglas M., 1985, RISK ACCEPTABILITY A; Douglas Mary., 1966, PURITY DANGER ANAL C; Duncan LA, 2009, PERS INDIV DIFFER, V47, P541, DOI 10.1016/j.paid.2009.05.001; Ejemot-Nwadiaro RI, 2015, COCHRANE DATABASE SY, P9; EPSTEIN S, 1985, PSYCHOL BULL, V98, P513, DOI 10.1037/0033-2909.98.3.513; Exner M, 2004, J HOSP INFECT, V56, pS70, DOI 10.1016/j.jhin.2003.12.037; Exner M., 2007, GMS KRANKENHAUSHYGIE, V2, P1; Falsey AR, 1999, INFECT CONT HOSP EP, V20, P200, DOI 10.1086/501612; Fishbein M, 1992, FACT INFL BEH BEH CH; Fleeson W, 2008, SOC PERSONAL PSYCHOL, V2, P1667, DOI 10.1111/j.1751-9004.2008.00122.x; Foddy W., 1994, CONSTRUCTING QUESTIO; Grayson ML, 2009, CLIN INFECT DIS, V48, P285, DOI 10.1086/595845; Halder AK, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-545; Horner KL, 1996, PERS INDIV DIFFER, V21, P195, DOI 10.1016/0191-8869(96)00067-0; House T, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-117; Inglis D., 2000, SOCIOLOGICAL HIST EX; Jackson JJ, 2010, J RES PERS, V44, P501, DOI 10.1016/j.jrp.2010.06.005; Jones E. E., 1971, ACTOR OBSERVER DIVER; Judah G, 2012, BRIT J HLTH PSYCHOL; Judah G, 2009, AM J PUBLIC HEALTH, V99, pS405, DOI 10.2105/AJPH.2009.164160; Kaiser FG, 2001, EUR J PSYCHOL ASSESS, V17, P212, DOI 10.1027//1015-5759.17.3.212; Klesges LM, 2004, PREV MED, V38, pS78, DOI 10.1016/j.ypmed.2003.07.003; Kline R.B., 2005, PRINCIPLES PRACTICE, V2, DOI DOI 10.1038/156278A0; Knapp H, 2003, COMPUT HUM BEHAV, V19, P117, DOI 10.1016/S0747-5632(02)00008-0; KNIGHT GP, 1981, DEV PSYCHOL, V17, P430; Lamont Michele, 1992, MONEY MORALS MANNERS; Largo TW, 2011, PUBLIC HEALTH REP, V126, P14, DOI 10.1177/00333549111260S104; Larson E, 2001, PUBLIC HEALTH NURS, V18, P116, DOI 10.1046/j.1525-1446.2001.00116.x; Lee A, 2006, J EPIDEMIOL COMMUN H, V60, P530, DOI 10.1136/jech.2005.040121; Lewis M.A., 2002, HLTH BEHAV HLTH ED T, Vthird, P240; Lopez-Quintero C, 2009, AM J PUBLIC HEALTH, V99, P94, DOI 10.2105/AJPH.2007.129759; MacCann C, 2009, LEARN INDIVID DIFFER, V19, P451, DOI 10.1016/j.lindif.2009.03.007; Mattioli MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084939; MISCHEL W, 1995, PSYCHOL REV, V102, P246, DOI 10.1037/0033-295X.102.2.246; Nickmilder M, 2007, PEDIAT ALLERG IMM-UK, V18, P27, DOI 10.1111/j.1399-3038.2006.00487.x; Oxford JS, 2012, ENCY GLOBAL STUDIES, P838; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Rabie T, 2006, TROP MED INT HEALTH, V11, P258, DOI 10.1111/j.1365-3156.2006.01568.x; Rabie T, 2006, TROP MED INT HEALTH, V11, P1; Rose E, 2009, ARCH PEDIAT ADOL MED, V163, P61, DOI 10.1001/archpediatrics.2008.509; Sobsey M. D., 2002, MANAGING WATER HOME; Stange KC, 1998, MED CARE, V36, P851, DOI 10.1097/00005650-199806000-00009; Stauber CE, 2013, INT J ENV RES PUB HE, V10, P1586, DOI 10.3390/ijerph10041586; Sutton S., 2012, SAGE HDB HLTH PSYCHO, P94, DOI DOI 10.4135/9781848608153.N4; Viboud C, 2004, INT CONGR SER, V1263, P291, DOI 10.1016/j.ics.2004.01.013; Vickers R, 1989, PSYCHOSOCIAL RISK FA; Vujcic J, 2014, TROP MED INT HEALTH, V19, P528, DOI 10.1111/tmi.12292; WARNER LG, 1969, AM SOCIOL REV, V34, P153, DOI 10.2307/2092174	71	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2016	11	8							e0159551	10.1371/journal.pone.0159551	http://dx.doi.org/10.1371/journal.pone.0159551			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT6UQ	27541259	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000381620200002
J	Ha, JH; Doguer, C; Wang, XY; Flores, SR; Collins, JF				Ha, Jung-Heun; Doguer, Caglar; Wang, Xiaoyu; Flores, Shireen R.; Collins, James F.			High-Iron Consumption Impairs Growth and Causes Copper-Deficiency Anemia in Weanling Sprague-Dawley Rats	PLOS ONE			English	Article							TRANSFERRIN RECEPTOR 2; AIN-93 PURIFIED DIETS; ATPASE ATP7A GENE; HEREDITARY HEMOCHROMATOSIS; PHOSPHATE BINDER; FERRIC CITRATE; OVERLOAD; CERULOPLASMIN; EXPRESSION; HEPCIDIN	Iron-copper interactions were described decades ago; however, molecular mechanisms linking the two essential minerals remain largely undefined. Investigations in humans and other mammals noted that copper levels increase in the intestinal mucosa, liver and blood during iron deficiency, tissues all important for iron homeostasis. The current study was undertaken to test the hypothesis that dietary copper influences iron homeostasis during iron deficiency and iron overload. We thus fed weanling, male Sprague-Dawley rats (n = 611/group) AIN-93G-based diets containing high (similar to 8800 ppm), adequate (similar to 80) or low (similar to 11) iron in combination with high (similar to 183), adequate (similar to 8) or low (similar to 0.9) copper for 5 weeks. Subsequently, the iron-and copper-related phenotype of the rats was assessed. Rats fed the low-iron diets grew slower than controls, with changes in dietary copper not further influencing growth. Unexpectedly, however, high-iron (HFe) feeding also impaired growth. Furthermore, consumption of the HFe diet caused cardiac hypertrophy, anemia, low serum and tissue copper levels and decreased circulating ceruloplasmin activity. Intriguingly, these physiologic perturbations were prevented by adding extra copper to the HFe diet. Furthermore, higher copper levels in the HFe diet increased serum nonheme iron concentration and transferrin saturation, exacerbated hepatic nonheme iron loading and attenuated splenic nonheme iron accumulation. Moreover, serum erythropoietin levels, and splenic erythroferrone and hepatic hepcidin mRNA levels were altered by the dietary treatments in unanticipated ways, providing insight into how iron and copper influence expression of these hormones. We conclude that high-iron feeding of weanling rats causes systemic copper deficiency, and further, that copper influences the iron-overload phenotype.	[Ha, Jung-Heun; Doguer, Caglar; Wang, Xiaoyu; Flores, Shireen R.; Collins, James F.] Univ Florida, Dept Food Sci & Human Nutr, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Collins, JF (corresponding author), Univ Florida, Dept Food Sci & Human Nutr, Gainesville, FL 32611 USA.	jfcollins@ufl.edu	Doguer, Caglar/ABA-3152-2020	Doguer, Caglar/0000-0003-0059-1819	National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK074867]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074867] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by R01 DK074867 (JFC) (www.niddk.nih.gov) National Institute of Diabetes and Digestive and Kidney Diseases.	BABSON AL, 1967, CLIN CHEM, V13, P163; BACON BR, 1983, J CLIN INVEST, V71, P429, DOI 10.1172/JCI110787; Coffey R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086019; COHEN NL, 1985, J NUTR, V115, P710, DOI 10.1093/jn/115.6.710; Collins JF, 2008, AM J PHYSIOL-GASTR L, V294, pG948, DOI 10.1152/ajpgi.00274.2007; Collins JF, 2005, AM J PHYSIOL-GASTR L, V288, pG964, DOI 10.1152/ajpgi.00489.2004; DELMEZ JA, 1992, AM J KIDNEY DIS, V19, P303, DOI 10.1016/S0272-6386(12)80446-X; Dongiovanni P, 2013, AM J PATHOL, V182, P2254, DOI 10.1016/j.ajpath.2013.02.019; FIELDS M, 1995, J AM COLL NUTR, V14, P399; Floege J, 2016, J NEPHROL, V29, P329, DOI 10.1007/s40620-016-0266-9; Fox PL, 2003, BIOMETALS, V16, P9, DOI 10.1023/A:1020799512190; Gao JW, 2009, CELL METAB, V9, P217, DOI 10.1016/j.cmet.2009.01.010; Gehrke SG, 2003, BLOOD, V102, P371, DOI 10.1182/blood-2002-11-3610; Gulec S, 2014, ANNU REV NUTR, V34, P95, DOI 10.1146/annurev-nutr-071812-161215; Gulec S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066010; Jiang LL, 2013, J NUTR, V143, P1927, DOI 10.3945/jn.113.181867; Kautz L, 2014, BLOOD, V124, P2569, DOI 10.1182/blood-2014-06-584607; Kautz L, 2014, NAT GENET, V46, P678, DOI 10.1038/ng.2996; Klevay LM, 2016, NUTR RES REV, V29, P172, DOI 10.1017/S0954422416000093; Klevay LM, 2001, J TRACE ELEM MED BIO, V14, P237, DOI 10.1016/S0946-672X(01)80009-2; LINDER MC, 1979, ENZYME, V24, P23, DOI 10.1159/000458625; MACKINNON M, 1995, HEPATOLOGY, V21, P1083; Matak P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059538; Matsuo A, 2014, RENAL FAILURE, V36, P1291, DOI 10.3109/0886022X.2014.930491; Merza H, 2015, CLIN CASE REP, V3, P819, DOI 10.1002/ccr3.344; Nam H, 2012, BIOMETALS, V25, P115, DOI 10.1007/s10534-011-9487-5; Pai AB, 2016, EXPERT OPIN DRUG MET, V12, pV, DOI 10.1517/17425255.2016.1127670; PARK CH, 1987, LAB INVEST, V57, P555; Prasad Rakesh, 2015, BMJ Case Rep, V2015, DOI 10.1136/bcr-2015-211390; PROHASKA JR, 1982, J NUTR, V112, P2142; RAMSAY WNM, 1957, CLIN CHIM ACTA, V2, P221, DOI 10.1016/0009-8981(57)90106-7; Ranganathan PN, 2012, BIOMETALS, V25, P687, DOI 10.1007/s10534-012-9527-9; Ranganathan PN, 2011, BLOOD, V118, P3146, DOI 10.1182/blood-2011-05-352112; Ravia JJ, 2005, J BIOL CHEM, V280, P36221, DOI 10.1074/jbc.M506727200; REEVES PG, 1993, J NUTR, V123, P1923, DOI 10.1093/jn/123.11.1923; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; ROESER HP, 1970, J CLIN INVEST, V49, P2408, DOI 10.1172/JCI106460; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; SHERMAN AR, 1981, J NUTR, V111, P266, DOI 10.1093/jn/111.2.266; SUNDERMAN FW, 1970, CLIN CHEM, V16, P903; TORRANCE J D, 1968, South African Journal of Medical Sciences, V33, P9; Van Buren PN, 2015, AM J KIDNEY DIS, V66, P479, DOI 10.1053/j.ajkd.2015.03.013; Wallace DF, 2005, GUT, V54, P980, DOI 10.1136/gut.2004.062018; WANG GL, 1993, BLOOD, V82, P3610; Wilkins SJ, 2006, BLOOD, V107, P1659, DOI 10.1182/blood-2005-07-2614; Xie LW, 2013, J BIOL CHEM, V288, P23943, DOI 10.1074/jbc.M113.489500; Xie LW, 2011, AM J PHYSIOL-CELL PH, V300, pC1298, DOI 10.1152/ajpcell.00023.2011; YOUNG DS, 1965, J CLIN PATHOL, V18, P98, DOI 10.1136/jcp.18.1.98; Yu F, 2015, NEUROSCI LETT, V597, P183, DOI 10.1016/j.neulet.2015.04.049	49	24	25	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161033	10.1371/journal.pone.0161033	http://dx.doi.org/10.1371/journal.pone.0161033			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537180	Green Submitted, Green Published, gold			2022-12-26	WOS:000381577000044
J	Allahverdyan, AE; Galstyan, A				Allahverdyan, Armen E.; Galstyan, Aram			Emergence of Leadership in Communication	PLOS ONE			English	Article							NETWORKS; DYNAMICS; MODEL; BEHAVIOR; POPULATIONS	We study a neuro-inspired model that mimics a discussion (or information dissemination) process in a network of agents. During their interaction, agents redistribute activity and network weights, resulting in emergence of leader(s). The model is able to reproduce the basic scenarios of leadership known in nature and society: laissez-faire (irregular activity, weak leadership, sizable inter-follower interaction, autonomous sub-leaders); participative or democratic (strong leadership, but with feedback from followers); and autocratic (no feedback, one-way influence). Several pertinent aspects of these scenarios are found as well-e.g., hidden leadership (a hidden clique of agents driving the official autocratic leader), and successive leadership (two leaders influence followers by turns). We study how these scenarios emerge from inter-agent dynamics and how they depend on behavior rules of agents-in particular, on their inertia against state changes.	[Allahverdyan, Armen E.] Yerevan Phys Inst, Alikhanian Bros St 2, Yerevan 375036, Armenia; [Galstyan, Aram] USC Informat Sci Inst, 4676 Admiralty Way, Marina Del Rey, CA 90292 USA	Yerevan Physics Institute; University of Southern California	Allahverdyan, AE (corresponding author), Yerevan Phys Inst, Alikhanian Bros St 2, Yerevan 375036, Armenia.	armen.allahverdyan@gmail.com		Galstyan, Aram/0000-0003-4215-0886	Yerevan Physics Institute (Armenia); DARPA grant [W911NF-12-1-0034]	Yerevan Physics Institute (Armenia); DARPA grant(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This research was funded by Yerevan Physics Institute (Armenia) to AEA and DARPA grant No. W911NF-12-1-0034 to AG. AEA was also partially funded by the above DARPA grant.; This research was supported by DARPA grant No. W911NF-12-1-0034.	Allahverdyan AE, 2006, EUROPHYS LETT, V75, P908, DOI 10.1209/epl/i2006-10212-8; Allahverdyan AE, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.062824; Allahverdyan AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099557; Anghel M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.058701; Aronson E, 2007, SOCIAL ANIMAL; BECKMAN MD, 1967, J MARKETING, V31, P34, DOI 10.2307/1249027; Ben-Naim E, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/11/L11002; Blondel VD, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.036114; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; BONABEAU E, 1995, PHYSICA A, V217, P373, DOI 10.1016/0378-4371(95)00064-E; Borgatti SP, 1999, SOC NETWORKS, V21, P375; Bornholdt S, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.066118; Burt RS, 1999, ANN AM ACAD POLIT SS, V566, P37, DOI 10.1177/0002716299566001004; Caldarelli G, 2008, EUR PHYS J B, V64, P585, DOI 10.1140/epjb/e2008-00243-5; Caldarelli G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.258702; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Cheng J., 2016, DO CASCADES RECUR, P11; Cholvi V, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.035103; COLOMER JM, 1995, RATION SOC, V7, P225, DOI 10.1177/1043463195007002008; COREY LG, 1971, J MARKETING, V35, P48, DOI 10.2307/1250457; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; DEUTSCH KW, 1961, BEHAV SCI, V6, P72; Dodds PS, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.218701; Durlauf SN, 2001, SOCIOL METHODOL, V31, P47, DOI 10.1111/0081-1750.00089; Eguiluz VM, 2005, AM J SOCIOL, V110, P977, DOI 10.1086/428716; EMELYANOVYAROSLAVSKY LB, 1992, BIOL CYBERN, V67, P67, DOI 10.1007/BF00201803; EMELYANOVYAROSLAVSKY LB, 1992, BIOL CYBERN, V67, P73, DOI 10.1007/BF00201804; Fiedler F. E., 1967, THEORY LEADERSHIP EF; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Galster GC, 2000, HOUS POLICY DEBATE, V11, P701; Galstyan A., 2013, P 6 ACM INT C WEB SE, P3, DOI [10.1145/2433396.2433400, DOI 10.1145/2433396.2433400, /10.1145 /2433396.2433400]; Galstyan A, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.036109; Godreche S, 2010, J STAT MECH-THEORY E; Goethals G.R., 2004, ENCY LEADERSHIP; Gomez-Rodriguez M, 2012, ACM T KNOWL DISCOV D, V5, DOI 10.1145/2086737.2086741; Goncalves B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022656; GRANOVETTER M, 1978, AM J SOCIOL, V83, P1420, DOI 10.1086/226707; Granovetter M., 1988, SOCIOL METHODOL, V18, P69, DOI [10.2307/271045, DOI 10.2307/271045]; Greene MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052219; Gross T, 2008, J R SOC INTERFACE, V5, P259, DOI 10.1098/rsif.2007.1229; Guttenberg N, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046111; Hazy JK, 2007, LEADERSHIP QUART, V18, P391, DOI 10.1016/j.leaqua.2007.04.007; Hodas N., 2012, SOCIALCOM; Hogg MA, 2007, HDB BASIC PRINCIPLES; Huberman BA, 2004, LECT NOTES PHYS, V650, P371; Huberman BA, 2008, 1 MONDAY, V14, P1, DOI [DOI 10.5210/FM.V14I1.2317, 10.2139/ssrn.1313405]; Huberman BA, 2008, ADV COMPLEX SYST, V11, P487, DOI 10.1142/S0219525908001830; Jost J, 2009, PHYSICA A, V388, P1959, DOI 10.1016/j.physa.2008.12.073; Katz E., 1955, PERSONAL INFLUENCE P; Kianercy A, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.012815; Larson-Prior LJ, 2013, HDB HUMAN COMPUTATIO; Lewin K, 1939, J SOC PSYCHOL, V10, P271, DOI 10.1080/00224545.1939.9713366; Lipowski A, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.032817; MALSBURG CV, 1973, KYBERNETIK, V14, P85, DOI 10.1007/BF00288907; Morris S, 2000, REV ECON STUD, V67, P57, DOI 10.1111/1467-937X.00121; MULLEN B, 1989, J EXP SOC PSYCHOL, V25, P545, DOI 10.1016/0022-1031(89)90005-X; Nowak A., 1998, COMPUTER MODELLING S, P97; Peretto P, 1994, INTRO MODELLING NEUR; Piedrahita P, 2013, EPL-EUROPHYS LETT, V104, DOI 10.1209/0295-5075/104/48004; Pugliese F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137234; RASHEVSKY N., 1955, BULL MATH BIOPHYS, V17, P229, DOI 10.1007/BF02477860; RASHEVSKY N., 1954, BULL MATH BIOPHYS, V16, P317, DOI 10.1007/BF02484495; RASHEVSKY N., 1955, BULL MATH BIOPHYS, V17, P207, DOI 10.1007/BF02477858; Rashevsky N., 1949, B AM MATH SOC, V55, P722, DOI [10.1090/S0002-9904-1949-09260-1, DOI 10.1090/S0002-9904-1949-09260-1]; Rombach MP, 2014, SIAM J APPL MATH, V74, P167, DOI 10.1137/120881683; Shvyrkov VB, 1985, ADV PSYCH, V25, P47, DOI [10.1016/S0166-4115(08)61596-4, DOI 10.1016/S0166-4115(08)61596-4]; Simaan M, 1973, J OPTIMIZ THEORY APP, V11, P533, DOI 10.1007/BF00935665; Sole R. V., 2002, Complexity, V8, P20, DOI 10.1002/cplx.10055; SORRENTINO RM, 1975, J EXP SOC PSYCHOL, V11, P403, DOI 10.1016/0022-1031(75)90044-X; Stogdill RM, 1948, J PSYCHOL, V25, P35, DOI 10.1080/00223980.1948.9917362; SUTTON RS, 1981, PSYCHOL REV, V88, P135, DOI 10.1037/0033-295X.88.2.135; TROLDAHL VC, 1966, PUBLIC OPIN QUART, V30, P609, DOI 10.1086/267459; USHER M, 1993, NEURAL COMPUT, V5, P570, DOI 10.1162/neco.1993.5.4.570; Valente TW, 1999, ANN AM ACAD POLIT SS, V566, P55, DOI 10.1177/0002716299566001005; Van Vugt M, 2006, PERS SOC PSYCHOL REV, V10, P354, DOI 10.1207/s15327957pspr1004_5; VANVREESWIJK C, 1993, SIAM J APPL MATH, V53, P253, DOI 10.1137/0153015; Venkatasubramanian V, 2004, COMPUT CHEM ENG, V28, P1789, DOI 10.1016/j.compchemeng.2004.02.028; Ver Steeg G., 2012, P 21 INT C WORLD WID, P509, DOI DOI 10.1145/2187836.2187906; Vidal JM, 2003, HDB BRAIN THEORY NEU; Watts DJ, 2002, P NATL ACAD SCI USA, V99, P5766, DOI 10.1073/pnas.082090499; WEIMANN G, 1982, AM SOCIOL REV, V47, P764, DOI 10.2307/2095212; Winkler I., 2010, CONT LEADERSHIP THEO; Zhang LS, 2014, CHINESE PHYS B, V23, DOI 10.1088/1674-1056/23/10/108902	85	3	3	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0159301	10.1371/journal.pone.0159301	http://dx.doi.org/10.1371/journal.pone.0159301			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT4YN	27532484	Green Published, Green Submitted, gold			2022-12-26	WOS:000381487600007
J	Frilander, H; Lallukka, T; Viikari-Juntura, E; Heliovaara, M; Solovieva, S				Frilander, Heikki; Lallukka, Tea; Viikari-Juntura, Eira; Heliovaara, Markku; Solovieva, Svetlana			Health Problems during Compulsory Military Service Predict Disability Retirement: A Register-Based Study on Secular Trends during 40 Years of Follow-Up	PLOS ONE			English	Article							COMMON MENTAL-DISORDERS; POPULATION-BASED COHORT; MUSCULOSKELETAL DISORDERS; YOUNG MEN; FINLAND; PENSION; AWARDS	Disability retirement causes a significant burden on the society and affects the well-being of individuals. Early health problems as determinants of disability retirement have received little attention. The objective was to study, whether interrupting compulsory military service is an early indicator of disability retirement among Finnish men and whether seeking medical advice during military service increases the risk of all-cause disability retirement and disability retirement due to mental disorders and musculoskeletal diseases. We also looked at secular trends in these associations. We examined a nationally representative sample of 2069 men, who had entered military service during 1967-1996. We linked military service health records with cause-specific register data on disability retirement from 1968 to 2008. Secular trends were explored in three service time strata. We used the Cox regression model to estimate proportional hazard ratios and their 95% confidence intervals. During the follow-up time altogether 140 ( 6.8%) men retired due to disability, mental disorders being the most common cause. The men who interrupted service had a remarkably higher cumulative incidence of disability retirement ( 18.9%). The associations between seeking medical advice during military service and all-cause disability retirement were similar across the three service time cohorts ( overall hazard ratio 1.40 per one standard deviation of the number of visits; 95% confidence interval 1.26-1.56). Visits due to mental problems predicted disability retirement due to mental disorders in the men who served between 1987 and 1996 and a tendency for a similar cause-specific association was seen for musculoskeletal diseases in the men who served in 1967-1976. In conclusion, health problems-in particular mental problems-during late adolescence are strong determinants of disability retirement. Call-up examinations and military service provide access to the entire age cohort of men, where persons at risk for work disability can be identified and early preventive measures initiated.	[Frilander, Heikki; Lallukka, Tea; Solovieva, Svetlana] Finnish Inst Occupat Hlth, Ctr Expertise Hlth & Work Abil, Helsinki, Finland; [Frilander, Heikki; Lallukka, Tea; Viikari-Juntura, Eira; Solovieva, Svetlana] Finnish Inst Occupat Hlth, Disabil Prevent Res Ctr, Helsinki, Finland; [Heliovaara, Markku] Natl Inst Hlth & Welf, Dept Hlth, Helsinki, Finland	Finnish Institute of Occupational Health; Finnish Institute of Occupational Health; Finland National Institute for Health & Welfare	Frilander, H (corresponding author), Finnish Inst Occupat Hlth, Ctr Expertise Hlth & Work Abil, Helsinki, Finland.; Frilander, H (corresponding author), Finnish Inst Occupat Hlth, Disabil Prevent Res Ctr, Helsinki, Finland.	heikki.frilander@ttl.fi		Lallukka, Tea/0000-0003-3841-3129	Academy of Finland [129475, 287488]; Centre for Military Medicine, Helsinki, Finland	Academy of Finland(Academy of Finland); Centre for Military Medicine, Helsinki, Finland	This work was supported by the Academy of Finland (www.aka.fi/en/) grants #129475 (HF), #287488 (TL) and the Centre for Military Medicine, Helsinki, Finland (HF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, STAT DAT FINN CTR PE; Appelqvist-Schmidlechner K, 2010, SCAND J PUBLIC HEALT, V38, P168, DOI 10.1177/1403494809357103; Aromaa A., 2004, HLTH FUNCTIONAL CAPA; Brown J, 2009, J PUBLIC HEALTH-UK, V31, P74, DOI 10.1093/pubmed/fdn098; Buist-Bouwman MA, 2005, ACTA PSYCHIAT SCAND, V111, P436, DOI 10.1111/j.1600-0447.2005.00513.x; Cattrell A, 2011, OCCUP MED-OXFORD, V61, P148, DOI 10.1093/occmed/kqr008; Finnish Centre for Pensions, 2014, STAT YB PENS FINL 20; Frilander H, 2012, MIL MED, V177, P1069, DOI 10.7205/MILMED-D-11-00327; Gould R, 2003, EUROPEAN DISABILITY, V26, P165; Heistaro S., 2008, METHODOLOGY REPORT H; Jarvisalo J, 2005, SOCIAL SECURITY HLTH, P27; Kaila-Kangas L, 2014, J AFFECT DISORDERS, V165, P38, DOI 10.1016/j.jad.2014.04.036; Knudsen AK, 2010, J PSYCHOSOM RES, V69, P59, DOI 10.1016/j.jpsychores.2010.03.007; Lahelma E, 2015, OCCUP ENVIRON MED, V72, P181, DOI 10.1136/oemed-2014-102432; Leboeuf-Yde C, 1998, SPINE, V23, P228, DOI 10.1097/00007632-199801150-00015; Li RL, 2007, ANN EPIDEMIOL, V17, P227, DOI 10.1016/j.annepidem.2006.10.009; Mittendorfer-Rutz E, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-75; Murphy L, 2008, ARTHRIT RHEUM-ARTHR, V59, P1207, DOI 10.1002/art.24021; Mykletun A, 2006, AM J PSYCHIAT, V163, P1412, DOI 10.1176/appi.ajp.163.8.1412; Organisation for economic Co-operation and development, 2010, SICKN DIS WORK BREAK; Parkkola K, 1999, THESIS; Salminen JK, 1997, ACTA PSYCHIAT SCAND, V95, P242, DOI 10.1111/j.1600-0447.1997.tb09626.x; Santtila M, 2006, MED SCI SPORT EXER, V38, P1990, DOI 10.1249/01.mss.0000232023.28984.78; Suvisaari J, 2009, PSYCHOL MED, V39, P287, DOI 10.1017/S0033291708003632; Upmark M, 1999, SOC PSYCH PSYCH EPID, V34, P533, DOI 10.1007/s001270050172; van Rijn RM, 2014, OCCUP ENVIRON MED, V71, P295, DOI 10.1136/oemed-2013-101591	26	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0159786	10.1371/journal.pone.0159786	http://dx.doi.org/10.1371/journal.pone.0159786			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT4YN	27533052	gold, Green Published, Green Submitted			2022-12-26	WOS:000381487600012
J	Hoarau, M; Malbert, Y; Irague, R; Hureau, C; Faller, P; Gras, E; Andre, I; Remaud-Simeon, M				Hoarau, Marie; Malbert, Yannick; Irague, Romain; Hureau, Christelle; Faller, Peter; Gras, Emmanuel; Andre, Isabelle; Remaud-Simeon, Magali			A Robust and Efficient Production and Purification Procedure of Recombinant Alzheimers Disease Methionine-Modified Amyloid-beta Peptides	PLOS ONE			English	Article							STRUCTURAL-ANALYSIS; INCLUSION-BODIES; FACILE METHOD; EXPRESSION; N-15; AGGREGATION; A-BETA-42; COLI	An improved production and purification method for Alzheimer's disease related methionine-modified amyloid-beta 1-40 and 1-42 peptides is proposed, taking advantage of the formation of inclusion body in Escherichia coli. A Thioflavin-S assay was set-up to evaluate inclusion body formation during growth and optimize culture conditions for amyloid-beta peptides production. A simple and fast purification protocol including first the isolation of the inclusion bodies and second, two cycles of high pH denaturation/neutralization combined with an ultrafiltration step on 30-kDa cut-off membrane was established. Special attention was paid to purity monitoring based on a rational combination of UV spectrophotometry and SDS-PAGE analyses at the various stages of the process. It revealed that this chromatography-free protocol affords good yield of high quality peptides in term of purity. The resulting peptides were fully characterized and are appropriate models for highly reproducible in vitro aggregation studies.	[Hoarau, Marie; Malbert, Yannick; Irague, Romain; Andre, Isabelle; Remaud-Simeon, Magali] Univ Toulouse, CNRS, INRA, Lab Ingn Syst Biol & Proc,INSA, Toulouse, France; [Hoarau, Marie; Hureau, Christelle; Faller, Peter; Gras, Emmanuel] Univ Toulouse, CNRS, INPT, Chim Coordinat Lab, Toulouse, France; [Irague, Romain] Univ Nantes, CNRS, Unite Fonct & Ingn Prot, Nantes, France; [Faller, Peter] Univ Strasbourg, Inst Chim, UMR 7177, Strasbourg, France	INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); Nantes Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Remaud-Simeon, M (corresponding author), Univ Toulouse, CNRS, INRA, Lab Ingn Syst Biol & Proc,INSA, Toulouse, France.	remaud@insa-toulouse.fr	HUREAU, Christelle/AAM-1642-2021; Faller, Peter/B-9614-2018	HUREAU, Christelle/0000-0003-3339-0239; Faller, Peter/0000-0001-8013-0806; GRAS, Emmanuel/0000-0002-1178-3579; Hoarau, Marie/0000-0002-5758-3556	APR-PRES	APR-PRES	This work was funded within the frame of APR-PRES 2013, project EVOLCAT.	Alies B, 2012, INORG CHEM, V51, P7897, DOI 10.1021/ic300972j; ALLEN SP, 1992, J BACTERIOL, V174, P6938, DOI 10.1128/JB.174.21.6938-6947.1992; BEAVEN GH, 1952, ADV PROTEIN CHEM, V7, P319, DOI 10.1016/S0065-3233(08)60022-4; Bockhorn JJ, 2010, BIOPOLYMERS, V94, P511, DOI 10.1002/bip.21391; Chang YJ, 2014, FEBS J, V281, P2674, DOI 10.1111/febs.12813; Chhetri G, 2015, PROTEIN EXPRES PURIF, V114, P71, DOI 10.1016/j.pep.2015.05.015; Delrieu J, 2014, REV NEUROL-FRANCE, V170, P739, DOI 10.1016/j.neurol.2014.10.003; Espargaro A, 2012, MOL BIOSYST, V8, P2839, DOI 10.1039/c2mb25214g; Finder VH, 2010, J MOL BIOL, V396, P9, DOI 10.1016/j.jmb.2009.12.016; Fu Z, 2015, BIOCHEMISTRY-US, V54, P4197, DOI 10.1021/acs.biochem.5b00467; Garai K, 2009, PROTEIN EXPRES PURIF, V66, P107, DOI 10.1016/j.pep.2009.02.009; Hamley IW, 2012, CHEM REV, V112, P5147, DOI 10.1021/cr3000994; Henderson VW, 2014, J STEROID BIOCHEM, V142, P99, DOI 10.1016/j.jsbmb.2013.05.010; Kim EK, 2012, PROTEIN EXPRES PURIF, V86, P53, DOI 10.1016/j.pep.2012.08.021; Lee EK, 2005, PROTEIN EXPRES PURIF, V40, P183, DOI 10.1016/j.pep.2004.12.014; Liao YH, 2015, PROTEIN EXPRES PURIF, V113, P63, DOI 10.1016/j.pep.2015.05.002; Long F, 2011, PROTEIN EXPRES PURIF, V79, P16, DOI 10.1016/j.pep.2011.05.012; Neerathilingam M, 2014, BIOCHEM BIOPH RES CO, V448, P45, DOI 10.1016/j.bbrc.2014.04.049; SATO C, 1995, NEUROSCI LETT, V200, P105, DOI 10.1016/0304-3940(95)12089-M; Schneider LS, 2014, J INTERN MED, V275, P251, DOI 10.1111/joim.12191; Sharma SC, 2015, PROTEIN EXPRES PURIF, V116, P82, DOI 10.1016/j.pep.2015.07.012; Shen M, 2009, PROTEIN EXPRES PURIF, V63, P84, DOI 10.1016/j.pep.2008.09.015; Szczepankiewicz O, 2015, J AM CHEM SOC, V137, P14673, DOI 10.1021/jacs.5b07849; Tong LM, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.124; Villar-Pique A, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-55; Walsh DM, 2009, FEBS J, V276, P1266, DOI 10.1111/j.1742-4658.2008.06862.x; Wiesehan K, 2007, J CHROMATOGR B, V856, P229, DOI 10.1016/j.jchromb.2007.06.003; Zagorski MG, 1999, METHOD ENZYMOL, V309, P189	28	8	8	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161209	10.1371/journal.pone.0161209	http://dx.doi.org/10.1371/journal.pone.0161209			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532547	Green Published, gold, Green Submitted			2022-12-26	WOS:000381487600076
J	Kantar, MB; Anderson, JE; Lucht, SA; Mercer, K; Bernau, V; Case, KA; Le, NC; Frederiksen, MK; DeKeyser, HC; Wong, ZZ; Hastings, JC; Baumler, DJ				Kantar, Michael B.; Anderson, Justin E.; Lucht, Sarah A.; Mercer, Kristin; Bernau, Vivian; Case, Kyle A.; Le, Nina C.; Frederiksen, Matthew K.; DeKeyser, Haley C.; Wong, Zen-Zi; Hastings, Jennifer C.; Baumler, David J.			Vitamin Variation in Capsicum Spp. Provides Opportunities to Improve Nutritional Value of Human Diets	PLOS ONE			English	Article							ANNUUM L.; SWEET-PEPPERS; BELL PEPPERS; DEVELOPING-COUNTRIES; GENETIC DIVERSITY; ASCORBIC-ACID; CHILE PEPPER; C CONTENT; CAROTENOIDS; COLLECTION	Chile peppers, native to the Americas, have spread around the world and have been integrated into the diets of many cultures. Much like their heat content, nutritional content can vary dramatically between different pepper types. In this study, a diverse set of chile pepper types were examined for nutrient content. Some pepper types were found to have high levels of vitamin A, vitamin C, or folate. Correlations between nutrient content, species, cultivation status, or geographic region were limited. Varietal selection or plant breeding offer tools to augment nutrient content in peppers. Integration of nutrient rich pepper types into diets that already include peppers could help combat nutrient deficiencies by providing a significant portion of recommended daily nutrients.	[Kantar, Michael B.; Anderson, Justin E.] Univ Hawaii Manoa, Dept Trop Plant & Soil Sci, Honolulu, HI 96822 USA; [Lucht, Sarah A.] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Mercer, Kristin; Bernau, Vivian] Ohio State Univ, Dept Hort & Crop Sci, Columbus, OH 43210 USA; [Case, Kyle A.; Le, Nina C.; Frederiksen, Matthew K.; DeKeyser, Haley C.; Wong, Zen-Zi; Hastings, Jennifer C.; Baumler, David J.] Univ Minnesota Twin Cities, Dept Food Sci & Nutr, St Paul, MN 55108 USA; [Baumler, David J.] Univ Minnesota Twin Cities, Microbial & Plant Genome Inst, St Paul, MN 55108 USA; [Baumler, David J.] Univ Minnesota Twin Cities, Inst Biotechnol, St Paul, MN 55108 USA	University of Hawaii System; University of Hawaii Manoa; Harvard University; Harvard T.H. Chan School of Public Health; University System of Ohio; Ohio State University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Baumler, DJ (corresponding author), Univ Minnesota Twin Cities, Dept Food Sci & Nutr, St Paul, MN 55108 USA.; Baumler, DJ (corresponding author), Univ Minnesota Twin Cities, Microbial & Plant Genome Inst, St Paul, MN 55108 USA.; Baumler, DJ (corresponding author), Univ Minnesota Twin Cities, Inst Biotechnol, St Paul, MN 55108 USA.	dbaumler@umn.edu	Anderson, Justin/R-3007-2016	Anderson, Justin/0000-0001-7642-4641; Bernau, Vivian/0000-0002-2393-8101; Lucht, Sarah/0000-0001-5904-2844; Kantar, Michael/0000-0001-5542-0975				[Agricultural Research Service Nutrient Data Laboratory US Department of Agriculture], 2015, NUTRIENT DATA USDA N; Akhtar S, 2013, J HEALTH POPUL NUTR, V31, P413; [Anonymous], 2014, J INFECT DIS THER; Asnin L, 2015, CRIT REV FOOD SCI, V55, P254, DOI 10.1080/10408398.2011.652316; Bassett T.J., 2010, ATLAS WORLD HUNGER; Black MM, 2008, FOOD NUTR BULL, V29, pS126, DOI 10.1177/15648265080292S117; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Blancquaert D, 2014, J EXP BOT, V65, P895, DOI 10.1093/jxb/ert483; Bosland PW, 2007, HORTSCIENCE, V42, P222, DOI 10.21273/HORTSCI.42.2.222; Bosland PW, 2012, HORTTECHNOLOGY, V22, P534, DOI 10.21273/HORTTECH.22.4.534; Cichewicz RH, 1996, J ETHNOPHARMACOL, V52, P61, DOI 10.1016/0378-8741(96)01384-0; Crider KS, 2011, NUTRIENTS, V3, P370, DOI 10.3390/nu3030370; Cunningham SA, 2014, NEW ENGL J MED, V370, P403, DOI [10.1056/NEJMoa1309753, 10.1056/NEJMc1402397]; Dary O, 2002, J NUTR, V132, p2927S, DOI 10.1093/jn/132.9.2927S; Deepa N, 2007, LWT-FOOD SCI TECHNOL, V40, P121, DOI 10.1016/j.lwt.2005.09.016; Diepvens K, 2007, AM J PHYSIOL-REG I, V292, pR77, DOI 10.1152/ajpregu.00832.2005; Estrada B, 1999, SCI HORTIC-AMSTERDAM, V81, P385, DOI 10.1016/S0304-4238(99)00029-1; FDA, 2013, LAB NUTR GUID IND FO; Frank CA, 2001, HORTSCIENCE, V36, P795, DOI 10.21273/HORTSCI.36.4.795; Geleta LF, 2006, J SCI FOOD AGR, V86, P1317, DOI 10.1002/jsfa.2494; Guil-Guerrero JL, 2006, EUR FOOD RES TECHNOL, V224, P1, DOI 10.1007/s00217-006-0281-5; Hayano-Kanashiro C, 2016, CROP SCI, V56, P1, DOI 10.2135/cropsci2014.11.0789; HURTADOHERNANDEZ H, 1985, J HERED, V76, P211, DOI 10.1093/oxfordjournals.jhered.a110070; *I MED FOOD NUTR B, 2001, DIET REF INT VIT A V; Kraft KH, 2014, P NATL ACAD SCI USA, V111, P6165, DOI 10.1073/pnas.1308933111; Lejeune MP, 2009, BR J NUTR, V90, P651; Li Z, 2013, PLOS ONE, V18; Martinez S, 2005, INT J FOOD SCI NUTR, V56, P45, DOI 10.1080/09637480500081936; Martínez-Sánchez David, 2010, Rev. Chapingo Ser.Hortic, V16, P169; Martins KC, 2015, CROP BREED APPL BIOT, V15, P139, DOI 10.1590/1984-70332015v15n3a25; Naegele RP, 2015, PHYTOPATHOLOGY, V105, P110, DOI 10.1094/PHYTO-02-14-0031-R; Perez-Lopez AJ, 2007, J AGR FOOD CHEM, V55, P8158, DOI 10.1021/jf071534n; Perla V, 2016, FOOD CHEM, V202, P189, DOI 10.1016/j.foodchem.2016.01.135; Phillips KM, 2006, J AGR FOOD CHEM, V54, P9998, DOI 10.1021/jf062327a; PICKERSGILL B, 1971, EVOLUTION, V25, P683, DOI 10.1111/j.1558-5646.1971.tb01926.x; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Pugliese A, 2013, FOOD CHEM, V141, P2606, DOI 10.1016/j.foodchem.2013.05.046; Qin C, 2014, P NATL ACAD SCI USA, V111, P5135, DOI 10.1073/pnas.1400975111; R Core Team, 2013, R LANG ENV STAT COMP; Rodriguez Gustavo R, 2010, J Vis Exp, DOI 10.3791/1856; Scholl TO, 2000, AM J CLIN NUTR, V71, p1295S, DOI 10.1093/ajcn/71.5.1295s; Sherman PW, 1999, BIOSCIENCE, V49, P453, DOI 10.2307/1313553; Smith SH, 2015, J ETHNOPHARMACOL, V167, P64, DOI 10.1016/j.jep.2014.10.048; Sun T, 2007, J FOOD SCI, V72, pS98, DOI 10.1111/j.1750-3841.2006.00245.x; Topuz A, 2007, J FOOD COMPOS ANAL, V20, P596, DOI 10.1016/j.jfca.2007.03.007; van Jaarsveld PJ, 2005, AM J CLIN NUTR, V81, P1080; van Zonneveld M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134663; Varela-Silva MI, 2012, COLLEGIUM ANTROPOL, V36, P39; Wahyuni Y, 2013, J NAT PROD, V76, P783, DOI 10.1021/np300898z; Wahyuni Y, 2011, PHYTOCHEMISTRY, V72, P1358, DOI 10.1016/j.phytochem.2011.03.016; [WHO] World Health Organization, 2016, MICR DEF; Zhang DL, 2003, J FOOD AGRIC ENVIRON, V1, P22	52	60	61	4	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161464	10.1371/journal.pone.0161464	http://dx.doi.org/10.1371/journal.pone.0161464			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532495	gold, Green Submitted, Green Published			2022-12-26	WOS:000381487600097
J	Kaufman, DJ; Baker, R; Milner, LC; Devaney, S; Hudson, KL				Kaufman, David J.; Baker, Rebecca; Milner, Lauren C.; Devaney, Stephanie; Hudson, Kathy L.			A Survey of U.S Adults' Opinions about Conduct of a Nationwide Precision Medicine Initiative (R) Cohort Study of Genes and Environment	PLOS ONE			English	Article							DATABASE; BIOBANK; HEART	Objectives A survey of a population-based sample of U.S adults was conducted to measure their attitudes about, and inform the design of the Precision Medicine Initiative's planned national cohort study. Methods An online survey was conducted by GfK between May and June of 2015. The influence of different consent models on willingness to share data was examined by randomizing participants to one of eight consent scenarios. Results Of 4,777 people invited to take the survey, 2,706 responded and 2,601 (54% response rate) provided valid responses. Most respondents (79%) supported the proposed study, and 54% said they would definitely or probably participate if asked. Support for and willingness to participate in the study varied little among demographic groups; younger respondents, LGBT respondents, and those with more years of education were significantly more likely to take part if asked. The most important study incentive that the survey asked about was learning about one's own health information. Willingness to share data and samples under broad, study-by-study, menu and dynamic consent models was similar when a statement about transparency was included in the consent scenarios. Respondents were generally interested in taking part in several governance functions of the cohort study. Conclusions A large majority of the U.S. adults who responded to the survey supported a large national cohort study. Levels of support for the study and willingness to participate were both consistent across most demographic groups. The opportunity to learn health information about one's self from the study appears to be a strong motivation to participate.	[Kaufman, David J.] NHGRI, Div Genom & Soc, NIH, Rockville, MD 20852 USA; [Baker, Rebecca; Milner, Lauren C.; Devaney, Stephanie; Hudson, Kathy L.] NIH, Off Director, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA	Kaufman, DJ (corresponding author), NHGRI, Div Genom & Soc, NIH, Rockville, MD 20852 USA.	dave.kaufman@nih.gov			Foundation for the National Institutes of Health	Foundation for the National Institutes of Health	The authors wish to thank the Foundation for the National Institutes of Health, which funded this survey. The authors would also like to thank Vence Bonham, Laura Rodriguez, Alex Lee and the members of the Consent, Education, Regulation and Consultation Working Group of the eMERGE research consortium for their contributions to the survey and manuscript development.; The Foundation for National Institutes of Health directly paid for GfK to field the survey. The authors themselves received no specific funding for the work. FNIH did not participate in data collection, analysis, decisions to publish or preparation of the manuscript. They were involved in discussions about the logistics of study design but did not influence survey content.	BAKER LC, VALIDITY SURVEY HLTH; Bollinger JM, 2014, GENET MED, V16, P932, DOI 10.1038/gim.2014.50; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Collins FS, 2004, NATURE, V429, P475, DOI 10.1038/nature02628; Genomeweb.com, REG LAUNCH 100K PAT; GfK, 2015, GFK 2015; Gulcher J, 1999, NAT BIOTECHNOL, V17, P620, DOI 10.1038/10796; Hudson K., 2015, PRECISION MED INITIA; Kaufman D, 2009, GENET MED, V11, P329, DOI 10.1097/GIM.0b013e31819994f8; Kaufman D, 2008, GENET MED, V10, P331, DOI 10.1097/GIM.0b013e31818bb3ab; Mathews AW, 2015, WALL STREET J; McQuillan GM, 2003, GENET MED, V5, P35, DOI 10.1097/00125817-200301000-00006; National Human Genome Research Institute, 2005, DES CONS POT US POP; National Institutes of Health, 2015, SUMM RESP REQ INF BU; National Institutes of Health, 2015, MOB PERS TECHN PREC; National Institutes of Health, 2015, ACD PREC MED IN WORK; NIH, 2015, REQ INF NIH PREC MED; North KE, 2003, AM J EPIDEMIOL, V157, P303, DOI 10.1093/aje/kwf208; Oh SS, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001918; Palmer LJ, 2007, LANCET, V369, P1980, DOI 10.1016/S0140-6736(07)60924-6; Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89; Sanger David, 2015, NEW YORK TIMES; Splansky GL, 2007, AM J EPIDEMIOL, V165, P1328, DOI 10.1093/aje/kwm021; SPSS Inc, 2012, SPSS WIND REL 21 0; The White House, 2015, PREC MED IN PROP PRI	25	63	63	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160461	10.1371/journal.pone.0160461	http://dx.doi.org/10.1371/journal.pone.0160461			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532667	Green Published, Green Submitted, gold			2022-12-26	WOS:000381487600031
J	El-Sayed, MA				El-Sayed, Mahmoud Ahmed			The Behaviour of Bifilm Defects in Cast Al-7Si-Mg Alloy	PLOS ONE			English	Article							DOUBLE-OXIDE-FILM; MECHANICAL-PROPERTIES; ALUMINUM; HYDROGEN	Double oxide films (bifilms) are significant defects in the casting of light alloys, and have been shown to decrease tensile and fatigue properties, and also to increase their scatter, making casting properties unreproducible and unreliable. A bifilm consists of doubled-over oxide films containing a gas-filled crevice and is formed due to surface turbulence of the liquid metal during handling and/or pouring. Previous studies has shown that the nature of oxide film defects may change with time, as the atmosphere inside the bifilm could be consumed by reaction with the surrounding melt, which may enhance the mechanical properties of Al alloy castings. As a proxy for a bifilm, an air bubble was trapped within an Al-7wt.% Si-0.3wt.% Mg (2L99) alloy melt, subjected to stirring. The effect of different parameters such as the holding time, stirring velocity and melt temperature on the change in gas composition of the bubble was investigated, using a design of experiments (DoE) approach. Also, the solid species inside the bubbles solidified in the melt were examined using SEM. The results suggested that both oxygen and nitrogen inside the bifilm would be consumed by reaction with the surrounding melt producing MgAl2O4 and AlN, respectively. Also, hydrogen was suggested to consistently diffuse into the defect. The reaction rates and the rate of H diffusion were shown to increase upon increasing the holding time and temperature, and stirring velocity. Such significant effect of the process parameters studied on the gaseous content of the bubble suggesting that a careful control of such parameters might lead to the deactivation of bifilm defects, or at least elimination of their deteriorous effect in light alloy castings.	[El-Sayed, Mahmoud Ahmed] Arab Acad Sci Technol Maritime Transport Abu Qir, Dept Ind & Management Engn, Alexandria, Egypt	Egyptian Knowledge Bank (EKB); Arab Academy for Science, Technology & Maritime Transport	El-Sayed, MA (corresponding author), Arab Acad Sci Technol Maritime Transport Abu Qir, Dept Ind & Management Engn, Alexandria, Egypt.	m_elsayed@aast.edu	El-Sayed, Mahmoud Ahmed/Q-7425-2016	El-Sayed, Mahmoud Ahmed/0000-0003-3086-0872	Arab Academy for Science and Technology and Maritime Transport, Egypt	Arab Academy for Science and Technology and Maritime Transport, Egypt(Arab Academy for Science, Technology & Maritime Transport)	This work has been funded by The Arab Academy for Science and Technology and Maritime Transport, Egypt (www.aast.edu). The funder role was the financial support of the research fellowship by the author (ME) at The University of Birmingham from June 1st 2015 to September 30th 2015. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brandes E.A., 1999, SMITHELLS METALS REF; Campbell J, 2006, MATER SCI TECH-LOND, V22, P127, DOI 10.1179/174328406X74248; CAMPBELL J, 1993, J PHYS IV, V3, P861, DOI 10.1051/jp4:19937135; Chase M.W., 1985, JANAF THERMOCHEMICAL; El-Sayed, 2012, DOUBLE OXIDE FILM DE; El-Sayed M, 2013, MATER SCI FORUM, V765, P260, DOI 10.4028/www.scientific.net/MSF.765.260; El-Sayed M, 2016, INT J CAST IN PRESS; El-Sayed MA, 2014, INT J CAST METAL RES, V27, P282, DOI 10.1179/1743133614Y.0000000113; El-Sayed MA., 2015, INT REV MECH ENG, V9, P252; El-Sayed MA, 2014, METALL MATER TRANS B, V45, P1398, DOI 10.1007/s11663-014-0035-x; El-Sayed MA, 2011, METALL MATER TRANS B, V42, P1104, DOI 10.1007/s11663-011-9571-9; Griffiths W., 2013, P 2013 INT S LIQ MET, P187; Griffiths William D., 2014, Materials Science Forum, V783-786, P142, DOI 10.4028/www.scientific.net/MSF.783-786.142; Griffiths WD, 2009, J MATER SCI, V44, P3402, DOI 10.1007/s10853-009-3450-7; Griffiths WD, 2007, EFFECT HOLDING TIME; Halvaee A., 1997, AFS T, V105, P35; Nyahumwa C., 1998, J MECH BEHAV MAT, V9, P227; Raiszadeh R, 2006, METALL MATER TRANS B, V37, P865, DOI 10.1007/BF02735007; RANSLEY CE, 1948, J I MET, V74, P599; SLEPPY WC, 1961, J ELECTROCHEM SOC, V108, P1097, DOI 10.1149/1.2427963	20	13	13	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160633	10.1371/journal.pone.0160633	http://dx.doi.org/10.1371/journal.pone.0160633			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529350	Green Published, Green Submitted, gold			2022-12-26	WOS:000381476700012
J	Prevosto, C; Usmani, MF; McDonald, S; Gumienny, AM; Key, T; Goodman, RS; Gaston, JSH; Deery, MJ; Busch, R				Prevosto, Claudia; Usmani, M. Farooq; McDonald, Sarah; Gumienny, Aleksandra M.; Key, Tim; Goodman, Reyna S.; Gaston, J. S. Hill; Deery, Michael J.; Busch, Robert			Allele-Independent Turnover of Human Leukocyte Antigen (HLA) Class I alpha Molecules	PLOS ONE			English	Article							MHC CLASS-I; HUMAN DENDRITIC CELLS; DIFFERENTIAL EXPRESSION; RECOGNITION; ACTIVATION; HLA-B27; TAPASIN; GENES; TAP; MECHANISMS	Major histocompatibility complex class I (MHCI) glycoproteins present cytosolic peptides to CD8+ T cells and regulate NK cell activity. Their heavy chains (HC) are expressed from up to three MHC gene loci (human leukocyte antigen [HLA]-A, -B, and -C in humans), whose extensive polymorphism maps predominantly to the antigen-binding groove, diversifying the bound peptide repertoire. Codominant expression of MHCI alleles is thus functionally critical, but how it is regulated is not fully understood. Here, we have examined the effect of polymorphism on the turnover rates of MHCI molecules in cell lines with functional MHCI peptide loading pathways and in monocyte-derived dendritic cells (MoDCs). Proteins were labeled biosynthetically with heavy water ((H2O)-H-2), folded MHCI molecules immunoprecipitated, and tryptic digests analysed by mass spectrometry. MHCI-derived peptides were assigned to specific alleles and isotypes, and turnover rates quantified by H-2 incorporation, after correcting for cell growth. MHCI turnover half-lives ranged from undetectable to a few hours, depending on cell type, activation state, donor, and MHCI isotype. However, in all settings, the turnover half-lives of alleles of the same isotype were similar. Thus, MHCI protein turnover rates appear to be allele-independent in normal human cells. We propose that this is an important feature enabling the normal function and codominant expression of MHCI alleles.	[Prevosto, Claudia; Usmani, M. Farooq; McDonald, Sarah; Gumienny, Aleksandra M.; Gaston, J. S. Hill; Busch, Robert] Univ Cambridge, Dept Med, Cambridge, England; [Key, Tim; Goodman, Reyna S.] Addenbrookes Hosp, Tissue Typing Lab, Cambridge, England; [Deery, Michael J.] Univ Cambridge, Cambridge Ctr Prote, Cambridge, England; [Busch, Robert] Univ Roehampton, Dept Life Sci, London, England; [Key, Tim] NHS Blood & Transplant, Histocompatibil & Immunogenet Lab, Sheffield, S Yorkshire, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; Roehampton University	Busch, R (corresponding author), Univ Cambridge, Dept Med, Cambridge, England.; Busch, R (corresponding author), Univ Roehampton, Dept Life Sci, London, England.	robert.busch@roehampton.ac.uk		Busch, Robert/0000-0002-4132-0751	Arthritis Research UK [18543, 20648]; Cambridge Arthritis Research Endeavour (CARE); Cambridge Commonwealth, European and International Trust; Cancer Research UK [16491] Funding Source: researchfish; Versus Arthritis [20648] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); Cambridge Arthritis Research Endeavour (CARE); Cambridge Commonwealth, European and International Trust; Cancer Research UK(Cancer Research UK); Versus Arthritis(Versus Arthritis)	This work was funded primarily by a Senior Research Fellowship and a Research Progression Award from Arthritis Research UK (refs. 18543 and 20648; http://www.arthritisresearchuk.org/), with start-up funding from Cambridge Arthritis Research Endeavour (CARE; http://www.cambridge-arthritis.org.uk/; all to RB). MFU was supported by an International Scholarship from the Cambridge Commonwealth, European and International Trust (https://www.cambridgetrust.org/). The authors also gratefully acknowledge support for core facilities by the Cambridge Biomedical Research Centre of the National Institute for Health Research, and support from the Tissue Typing Laboratory at Addenbrooke's Hospital, Cambridge, for HLA typing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman AL, 2003, J IMMUNOL, V170, P4178, DOI 10.4049/jimmunol.170.8.4178; Andres AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001157; Apps R, 2015, J IMMUNOL, V194, P3594, DOI 10.4049/jimmunol.1403234; Barel MT, 2006, INT IMMUNOL, V18, P173, DOI 10.1093/intimm/dxh362; BARNSTABLE CJ, 1978, CELL, V14, P9, DOI 10.1016/0092-8674(78)90296-9; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; Bowness P, 2011, J IMMUNOL, V186, P2672, DOI 10.4049/jimmunol.1002653; Cano F, 2013, MOL IMMUNOL, V55, P135, DOI 10.1016/j.molimm.2012.10.015; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Chapman DC, 2010, SEMIN CELL DEV BIOL, V21, P512, DOI 10.1016/j.semcdb.2009.12.013; Chazara O, 2011, J LEUKOCYTE BIOL, V90, P703, DOI 10.1189/jlb.0511227; De Riva A, 2013, J IMMUNOL, V190, P5961, DOI 10.4049/jimmunol.1300551; De Riva A, 2010, ANAL BIOCHEM, V403, P1, DOI 10.1016/j.ab.2010.04.018; Delay ML, 2009, ARTHRITIS RHEUM-US, V60, P2633, DOI 10.1002/art.24763; DOBBE LME, 1988, IMMUNOGENETICS, V27, P203, DOI 10.1007/BF00346587; Duncan LM, 2010, J IMMUNOL, V184, P6978, DOI 10.4049/jimmunol.0904154; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Falk CS, 1997, IMMUNOL RES, V16, P203, DOI 10.1007/BF02786363; Garstka MA, 2011, FASEB J, V25, P3989, DOI 10.1096/fj.11-190249; Grandea AG, 1997, IMMUNOGENETICS, V46, P477, DOI 10.1007/s002510050308; Gras S, 2012, IMMUNOL REV, V250, P61, DOI 10.1111/j.1600-065X.2012.01159.x; Gromme M, 1999, P NATL ACAD SCI USA, V96, P10326, DOI 10.1073/pnas.96.18.10326; Hammer GE, 2007, NAT IMMUNOL, V8, P101, DOI 10.1038/ni1409; HAMMER RE, 1990, CELL, V63, P1099, DOI 10.1016/0092-8674(90)90512-D; Hellerstein MK, 1999, AM J PHYSIOL-ENDOC M, V276, pE1146, DOI 10.1152/ajpendo.1999.276.6.E1146; Hermann C, 2015, ELIFE, V4, DOI 10.7554/eLife.09617; Holmes WE, 2015, METHOD ENZYMOL, V561, P219, DOI 10.1016/bs.mie.2015.05.018; Hou Tieying, 2013, Methods Mol Biol, V960, P411, DOI 10.1007/978-1-62703-218-6_31; Johnson DR, 2000, HUM IMMUNOL, V61, P389, DOI 10.1016/S0198-8859(99)00186-X; Jones EY, 1997, CURR OPIN IMMUNOL, V9, P75, DOI 10.1016/S0952-7915(97)80162-8; Jorgensen KW, 2014, IMMUNOLOGY, V141, P18, DOI 10.1111/imm.12160; Karre K, 2002, SCAND J IMMUNOL, V55, P221, DOI 10.1046/j.1365-3083.2002.01053.x; Kim TY, 2012, MOL CELL PROTEOMICS, V11, P1586, DOI 10.1074/mcp.M112.021162; KOEFFLER HP, 1978, SCIENCE, V200, P1153, DOI 10.1126/science.306682; Kulkarni S, 2011, NATURE, V472, P495, DOI 10.1038/nature09914; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Li L, 2012, MOL CELL PROTEOMICS, V11, DOI [10.1074/mcp.M111.010025, 10.1074/mcp.M111.014209]; McLaren JE, 2009, J GEN VIROL, V90, P2239, DOI 10.1099/vir.0.011627-0; MOMBURG F, 1994, NATURE, V367, P648, DOI 10.1038/367648a0; Murphy K, 2008, JANEWAYS IMMUNOBIOLO; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; NEEFJES JJ, 1988, EUR J IMMUNOL, V18, P801, DOI 10.1002/eji.1830180522; NEEFJES JJ, 1986, IMMUNOGENETICS, V23, P164, DOI 10.1007/BF00373817; Neisig A, 1998, J IMMUNOL, V160, P171; Obst R, 2005, J EXP MED, V201, P1555, DOI 10.1084/jem.20042521; ORR HT, 1983, NATURE, V302, P534, DOI 10.1038/302534a0; Peh CA, 1998, IMMUNITY, V8, P531, DOI 10.1016/S1074-7613(00)80558-0; Prevosto C, 2012, J RHEUMATOL, V39, P1918, DOI 10.3899/jrheum.120208; Rabenstein H, 2014, J IMMUNOL, V192, P3507, DOI 10.4049/jimmunol.1302725; Rachdaoui N, 2009, MOL CELL PROTEOMICS, V8, P2653, DOI 10.1074/mcp.M900026-MCP200; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Reeves E, 2014, P NATL ACAD SCI USA, V111, P17594, DOI 10.1073/pnas.1408882111; Rene C, 2015, EUR J IMMUNOL, V45, P3454, DOI 10.1002/eji.201545927; Ridley A, 2015, ARTHRITIS RHEUM; Rivas HG, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8040102; Robinson J, 2016, HUM IMMUNOL; Rowe M, 2007, P NATL ACAD SCI USA, V104, P3366, DOI 10.1073/pnas.0611128104; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; SALTER RD, 1985, IMMUNOGENETICS, V21, P235, DOI 10.1007/BF00375376; Santos SG, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2492; Schaefer MR, 2008, J IMMUNOL, V180, P7804, DOI 10.4049/jimmunol.180.12.7804; SHIMIZU Y, 1988, P NATL ACAD SCI USA, V85, P227, DOI 10.1073/pnas.85.1.227; Spiliotis ET, 2002, MOL BIOL CELL, V13, P1566, DOI 10.1091/mbc.01-07-0322; Spurgin LG, 2010, P ROY SOC B-BIOL SCI, V277, P979, DOI 10.1098/rspb.2009.2084; Teobald I, 2008, IMMUNOBIOLOGY, V213, P75, DOI 10.1016/j.imbio.2007.06.001; Thammavongsa V, 2009, IMMUNOGENETICS, V61, P703, DOI 10.1007/s00251-009-0399-2; Thammavongsa V, 2006, J IMMUNOL, V177, P3150, DOI 10.4049/jimmunol.177.5.3150; Usmani MF, 2012, THESIS; van de Weijer ML, 2015, SEMIN IMMUNOL, V27, P125, DOI 10.1016/j.smim.2015.03.010; van den Elsen PJ, 2004, CURR OPIN IMMUNOL, V16, P67, DOI 10.1016/j.coi.2003.11.015; WEI ML, 1992, NATURE, V356, P443, DOI 10.1038/356443a0; Wilkins MR, 1997, ELECTROPHORESIS, V18, P403, DOI 10.1002/elps.1150180314	74	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161011	10.1371/journal.pone.0161011	http://dx.doi.org/10.1371/journal.pone.0161011			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529174	Green Submitted, Green Published, gold			2022-12-26	WOS:000381476700038
J	Cao, C; Zhang, T; Zhang, D; Xie, L; Zou, X; Lei, L; Wu, D; Liu, L				Cao, C.; Zhang, T.; Zhang, D.; Xie, L.; Zou, X.; Lei, L.; Wu, D.; Liu, L.			The long non-coding RNA, SNHG6-003, functions as a competing endogenous RNA to promote the progression of hepatocellular carcinoma	ONCOGENE			English	Article							METASTASIS; CELLS; TAK1; DIFFERENTIATION; IDENTIFICATION; EXPRESSION; SPONGES; GROWTH	The expression of long non-coding RNAs (lncRNAs) is dysregulated in hepatocellular carcinoma (HCC). However, the functions and contributions of lncRNAs remain largely unknown. Here, we identified a critical role of SNHG6-003 in HCC. We found that five SNHG6 transcripts were differentially expressed in HCC tissues while only the SNHG6-003 had an oncogenic function. Ectopic expression of SNHG6-003 in HCC cells promoted cell proliferation and induced drug resistance, whereas SNHG6-003 knockdown promoted apoptosis. Moreover, SNHG6-003 functioned as a competitive endogenous RNA (ceRNA), effectively becoming sponge for miR-26a/b and thereby modulating the expression of transforming growth factor-beta-activated kinase 1 (TAK1). Importantly, expression analysis revealed that both SNHG6-003 and TAK1 were upregulated in human cancers, exhibiting a co-expression pattern. In HCC patients, high expression of SNHG6-003 closely correlated with tumor progression and shorter survival. Thus, targeting the ceRNA network involving SNHG6-003 may be used as a treatment strategy against HCC.	[Cao, C.; Zhang, D.; Lei, L.; Wu, D.] Southern Med Univ, Nanfang Hosp, Dept Radiat Oncol, Guangzhou 510515, Guangdong, Peoples R China; [Zhang, T.; Zou, X.; Liu, L.] Guangdong Prov Key Lab Viral Hepatitis Res, Guangzhou 510515, Guangdong, Peoples R China; [Zhang, T.; Liu, L.] Southern Med Univ, Nanfang Hosp, Dept Infect Dis, Guangzhou, Guangdong, Peoples R China; [Xie, L.] Univ Georgia, Ctr Mol Med, Athens, GA USA	Southern Medical University - China; Southern Medical University - China; University System of Georgia; University of Georgia	Wu, D (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Radiat Oncol, Guangzhou 510515, Guangdong, Peoples R China.; Liu, L (corresponding author), Guangdong Prov Key Lab Viral Hepatitis Res, Guangzhou 510515, Guangdong, Peoples R China.	wudehua.gd@gmail.com; liuli.fimmu@gmail.com		Wu, De-Hua/0000-0003-0560-0016; Liu, Li/0000-0002-5265-4159; Zou, Xuejing/0000-0001-6360-204X	National Nature Science Foundation of China [81172586, 81401180, 81372283, 91540111]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Schem; Natural Science Funding of Guangdong Province [2014A030311013]; postdoctoral fellowship from American Heart Association [16POST26400005]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Universities and Colleges Pearl River Scholar Funded Schem; Natural Science Funding of Guangdong Province; postdoctoral fellowship from American Heart Association	This work was supported by the National Nature Science Foundation of China (Grant Nos. 81172586, 81401180, 81372283 and 91540111), Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2015), Natural Science Funding of Guangdong Province (Grant No. 2014A030311013) and postdoctoral fellowship from American Heart Association 16POST26400005 (to XL). LX thanks Dr Hang Yin (University of Georgia) for support of the studies proposed in this manuscript.	Bak RO, 2014, WIRES RNA, V5, P317, DOI 10.1002/wrna.1213; Bodzin AS, 2015, WORLD J HEPATOL, V7, P1157, DOI 10.4254/wjh.v7.i9.1157; Cai PCH, 2014, ONCOTARGET, V5, P7549, DOI 10.18632/oncotarget.2273; Cao CH, 2015, GASTROENTEROLOGY, V148, P415, DOI 10.1053/j.gastro.2014.10.012; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chen FC, 2014, EVOL BIOINFORM, V10, P219, DOI 10.4137/EBO.S20772; Chen IT, 2015, SCI REP-UK, V5, DOI 10.1038/srep12300; Fan YH, 2013, APOPTOSIS, V18, P1224, DOI 10.1007/s10495-013-0864-0; Ge D, 2014, AUTOPHAGY, V10, P957, DOI 10.4161/auto.28363; Ghosal S, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00249; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hou P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.249; Jalali S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053823; Joo JH, 2014, MOL VIS, V20, P1629; Karreth FA, 2015, CELL, V161, P319, DOI 10.1016/j.cell.2015.02.043; Kumar MS, 2014, NATURE, V505, P212, DOI 10.1038/nature12785; Li L, 2014, SCI REP-UK, V4, DOI 10.1038/srep05406; Liu BD, 2015, CANCER CELL, V27, P370, DOI 10.1016/j.ccell.2015.02.004; Liu M, 2012, HEPATOLOGY, V55, P1754, DOI 10.1002/hep.25584; Liu XH, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-92; Ma MZ, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.541; Ng SY, 2013, MOL CELL, V51, P349, DOI 10.1016/j.molcel.2013.07.017; Pilyugin M, 2014, INT J BIOCHEM CELL B, V54, P356, DOI 10.1016/j.biocel.2014.06.018; Tang J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.518; Tay FC, 2015, ADV DRUG DELIVER REV, V81, P117, DOI 10.1016/j.addr.2014.05.010; Tay Y, 2014, NATURE, V505, P344, DOI 10.1038/nature12986; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Volders PJ, 2013, NUCLEIC ACIDS RES, V41, pD246, DOI 10.1093/nar/gks915; Wang P, 2015, NUCLEIC ACIDS RES, V43, P3478, DOI 10.1093/nar/gkv233; Wu XF, 2014, P NATL ACAD SCI USA, V111, P13870, DOI 10.1073/pnas.1414358111; Yuan JH, 2014, CANCER CELL, V25, P666, DOI 10.1016/j.ccr.2014.03.010; Zhang YC, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0512-1; Zheng LF, 2015, BREAST CANCER RES TR, V150, P105, DOI 10.1007/s10549-015-3298-2; Zhou X, 2014, GYNECOL ONCOL, V133, P333, DOI 10.1016/j.ygyno.2014.02.033	34	136	138	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 23	2017	36	8					1112	1122		10.1038/onc.2016.278	http://dx.doi.org/10.1038/onc.2016.278			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EM5SA	27530352				2022-12-26	WOS:000395371500009
J	Halle, M; Christersdottir, T; Back, M				Halle, Martin; Christersdottir, Tinna; Back, Magnus			Chronic adventitial inflammation, vasa vasorum expansion, and 5-lipoxygenase up-regulation in irradiated arteries from cancer survivors	FASEB JOURNAL			English	Article						radiotherapy; cardiovascular disease; leukotrienes	RADIATION; PATHWAY; RADIOTHERAPY; RECEPTOR; ATHEROSCLEROSIS; EXPRESSION; THERAPIES; DISEASE; INJURY; COHORT	Radiation-induced cardiovascular disease is an emerging problem in a steadily increasing population of survivors of cancer. However, the underlying biology is poorly described, and the late onset, which occurs several years after exposure, precludes adequate investigations in animal and cell culture models. We investigated the role of the 5-lipoxygenase (5-LO)/leukotriene pathway in radiation-induced vascular changes. Use of paired samples of irradiated arteries and nonirradiated internal control arteries from the same patient that were harvested during surgery for cancer reconstruction 10 yr after radiotherapy provides a unique human model of chronic radiation-induced vascular changes. Immunohistochemical stainings and perioperative inspection revealed an adventitial inflammatory response, with vasa vasorum expansion and chronic infiltration of CD68(+) macrophages. These macrophages stained positive for the leukotriene-forming enzyme 5-LO. Messenger RNA levels of 5-LO and leukotriene B-4 receptor 1 were increased in irradiated arterial segments compared with control vessels. These results point to targeting the 5-LO/leukotriene pathway as a therapeutic adjunct to prevent late adverse vascular effects of radiotherapy.Halle, M., Christersdottir, T., Back, M. Chronic adventitial inflammation, vasa vasorum expansion, and 5-lipoxygenase up-regulation in irradiated arteries from cancer survivors.	[Halle, Martin; Christersdottir, Tinna] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Back, Magnus] Karolinska Inst, Dept Med, Stockholm, Sweden; [Halle, Martin] Karolinska Univ Hosp, Dept Reconstruct Plast Surg, Stockholm, Sweden; [Back, Magnus] Karolinska Univ Hosp, Dept Cardiol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Back, M (corresponding author), Karolinska Univ Hosp, Ctr Mol Med, L8 03, S-17176 Stockholm, Sweden.	magnus.back@ki.se			Funds of Radiumhemmet [111122]; Swedish Society of Medicine [SLS-408771]; Stockholm County Council [20140170, 20140222]; Swedish Research Council [2014-2312]; Swedish Heart and Lung Foundation [20150600, 20150683]	Funds of Radiumhemmet; Swedish Society of Medicine; Stockholm County Council(Stockholm County Council); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation)	The authors thank Linda Haglund (Department of Medicine, Karolinska Institutet) for excellent technical support. M.H. is supported by Funds of Radiumhemmet (Grant 111122), the Swedish Society of Medicine (Grant SLS-408771), and the Stockholm County Council (Grant 20140170). M.B. is supported by the Swedish Research Council (Grant 2014-2312), the Swedish Heart and Lung Foundation (Grants 20150600 and 20150683), and the Stockholm County Council (Grant 20140222).	Altena R, 2009, LANCET ONCOL, V10, P391, DOI 10.1016/S1470-2045(09)70042-7; Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; Back M, 2015, NAT REV CARDIOL, V12, P199, DOI 10.1038/nrcardio.2015.5; Back M, 2011, PHARMACOL REV, V63, P539, DOI 10.1124/pr.110.004184; Back M, 2009, CURR PHARM DESIGN, V15, P3116, DOI 10.2174/138161209789058020; Bjorklund TC, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-223; Busseuil D, 2003, INT J RADIAT BIOL, V79, P787, DOI 10.1080/09553000310001610970; COLE AT, 1993, GUT, V34, P1210, DOI 10.1136/gut.34.9.1210; Darby SC, 2013, NEW ENGL J MED, V368, P987, DOI 10.1056/NEJMoa1209825; Fajardo LF, 2002, INT J RADIAT ONCOL, V53, P714, DOI 10.1016/S0360-3016(02)02759-1; GROSS NJ, 1991, RADIAT RES, V127, P317, DOI 10.2307/3577947; Halle M, 2010, J AM COLL CARDIOL, V55, P1227, DOI 10.1016/j.jacc.2009.10.047; Herrmann J, 2016, CIRCULATION, V133, P1272, DOI 10.1161/CIRCULATIONAHA.115.018347; Houard X, 2009, FASEB J, V23, P1376, DOI 10.1096/fj.08-116202; Ingelsson E, 2012, J ALLERGY CLIN IMMUN, V129, P702, DOI 10.1016/j.jaci.2011.11.052; Kollum M, 2001, INT J RADIAT ONCOL, V50, P495, DOI 10.1016/S0360-3016(01)01497-3; Michel JB, 2007, ARTERIOSCL THROM VAS, V27, P1259, DOI 10.1161/ATVBAHA.106.137851; Mulligan-Kehoe MJ, 2014, CIRCULATION, V129, P2557, DOI 10.1161/CIRCULATIONAHA.113.007189; Mulrooney DA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4606; Nagy E, 2011, CIRCULATION, V123, P1316, DOI 10.1161/CIRCULATIONAHA.110.966846; Panes J, 2000, ALIMENT PHARM THERAP, V14, P841; Plummer C, 2011, STROKE, V42, P2410, DOI 10.1161/STROKEAHA.111.615203; Powers BE, 1999, INT J RADIAT ONCOL, V45, P753, DOI 10.1016/S0360-3016(99)00219-9; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Spanbroek R, 2003, P NATL ACAD SCI USA, V100, P1238, DOI 10.1073/pnas.242716099; Zhao L, 2004, NAT MED, V10, P966, DOI 10.1038/nm1099	26	12	13	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2016	30	11					3845	3852		10.1096/fj.201600620R	http://dx.doi.org/10.1096/fj.201600620R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EA3BY	27530979	Green Published, hybrid			2022-12-26	WOS:000386474700018
J	Xiao, J; Xu, QQ; Wu, CL; Gao, YX; Hua, TQ; Xu, CW				Xiao, Jing; Xu, Qiongqiong; Wu, Chuanli; Gao, Yuexia; Hua, Tianqi; Xu, Chenwu			Performance Evaluation of Missing-Value Imputation Clustering Based on a Multivariate Gaussian Mixture Model	PLOS ONE			English	Article								Background It is challenging to deal with mixture models when missing values occur in clustering datasets. Methods and Results We propose a dynamic clustering algorithm based on a multivariate Gaussian mixture model that efficiently imputes missing values to generate a "pseudo-complete" dataset. Parameters from different clusters and missing values are estimated according to the maximum likelihood implemented with an expectation-maximization algorithm, and multivariate individuals are clustered with Bayesian posterior probability. A simulation showed that our proposed method has a fast convergence speed and it accurately estimates missing values. Our proposed algorithm was further validated with Fisher's Iris dataset, the Yeast Cell-cycle Gene-expression dataset, and the CIFAR-10 images dataset. The results indicate that our algorithm offers highly accurate clustering, comparable to that using a complete dataset without missing values. Furthermore, our algorithm resulted in a lower misjudgment rate than both clustering algorithms with missing data deleted and with missing-value imputation by mean replacement. Conclusion We demonstrate that our missing-value imputation clustering algorithm is feasible and superior to both of these other clustering algorithms in certain situations.	[Xiao, Jing; Xu, Qiongqiong; Wu, Chuanli; Gao, Yuexia; Hua, Tianqi] Nantong Univ, Sch Publ Hlth, Dept Epidemiol & Med Stat, Nantong 226019, Peoples R China; [Xu, Chenwu] Yangzhou Univ, Jiangsu Key Lab Crop Genet & Physiol, Coinnovat Ctr Modern Prod Technol Grain Crops, Key Lab Plant Funct Genom,Minist Educ, Yangzhou 225009, Jiangsu, Peoples R China	Nantong University; Yangzhou University	Xu, CW (corresponding author), Yangzhou Univ, Jiangsu Key Lab Crop Genet & Physiol, Coinnovat Ctr Modern Prod Technol Grain Crops, Key Lab Plant Funct Genom,Minist Educ, Yangzhou 225009, Jiangsu, Peoples R China.	qtls@yzu.edu.cn			National Natural Science Foundation of China [31000539, 31391632, 91535103]; Priority Academic Program Development of Jiangsu Higher Education Institutions; National High-tech RAMP;D Program (863 Program) [2014AA10A601-5]; Natural Science Foundations of Jiangsu Province [BK20150010]; Natural Science Foundation of the Jiangsu Higher Education Institutions [14KJA210005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; National High-tech RAMP;D Program (863 Program); Natural Science Foundations of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Natural Science Foundation of the Jiangsu Higher Education Institutions	The research was supported by grants from the National Natural Science Foundation of China (31000539, 31391632 and 91535103), the Priority Academic Program Development of Jiangsu Higher Education Institutions, the National High-tech R&D Program (863 Program, 2014AA10A601-5), the Natural Science Foundations of Jiangsu Province (BK20150010) and the Natural Science Foundation of the Jiangsu Higher Education Institutions (14KJA210005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carpenter J., 2012, MULTIPLE IMPUTATION, DOI DOI 10.1002/9781119942283; Chen J, 2000, J OFF STAT, V16, P113; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Dasgupta A, 1998, J AM STAT ASSOC, V93, P294, DOI 10.2307/2669625; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ghahramani Z., 1994, ADV NEURAL INFORM PR, V6, P120; Green PJ, 1995, BIOMETRIKA, V82, P711, DOI 10.2307/2337340; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hathaway RJ, 2001, IEEE T SYST MAN CY B, V31, P735, DOI 10.1109/3477.956035; Hayes M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052881; Herrero J, 2001, BIOINFORMATICS, V17, P126, DOI 10.1093/bioinformatics/17.2.126; Hunt L, 2003, COMPUT STAT DATA AN, V41, P429, DOI 10.1016/S0167-9473(02)00190-1; Jiao YB, 2013, SCI WORLD J, DOI 10.1155/2013/427072; Johnoson RA, 1992, APPL MULTIVARIATE ST, P532; Krizhevsky Alex, 2009, LEARNING MULTIPLE LA; Li SY., 2004, ENGINEERING FUZZY MA; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; McLachlan G. J., 1988, MIXTURE MODELS INFER, V84; Podofillini L, 2010, RELIAB ENG SYST SAFE, V95, P534, DOI 10.1016/j.ress.2010.01.004; Qu Y, 2004, BIOINFORMATICS, V20, P1905, DOI 10.1093/bioinformatics/bth177; Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; Rubin DB., 1978, P SURV RES METH SECT, P20, DOI DOI 10.1631/JZUS.C10B0359; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sebzalli YM, 2001, ENG APPL ARTIF INTEL, V14, P607, DOI 10.1016/S0952-1976(01)00032-X; SELIM SZ, 1991, PATTERN RECOGN, V24, P1003, DOI 10.1016/0031-3203(91)90097-O; Si YQ, 2014, BIOINFORMATICS, V30, P197, DOI 10.1093/bioinformatics/btt632; Siminski K, 2013, FUND INFORM, V123, P331, DOI 10.3233/FI-2013-814; Titterington D. M., 1985, STAT ANAL FINITE MIX; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Wang SC, 2006, LECT NOTES COMPUT SC, V4304, P1145; Wylie MP, 1996, ICUPC '96 - 1996 5TH IEEE INTERNATIONAL CONFERENCE ON UNIVERSAL PERSONAL COMMUNICATIONS RECORD, VOLS 1 AND 2, P827, DOI 10.1109/ICUPC.1996.562692; [杨军 YANG Jun], 2008, [数理统计与管理, Application of Statistics and Management], V27, P821; Yang YH, 2003, INTERDISC STAT, P35; Yeung KY, 2001, BIOINFORMATICS, V17, P977, DOI 10.1093/bioinformatics/17.10.977; Zhang YT, 1983, INTRO MULTIVARIATE S, P401	37	6	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0161112	10.1371/journal.pone.0161112	http://dx.doi.org/10.1371/journal.pone.0161112			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27552203	Green Published, gold, Green Submitted			2022-12-26	WOS:000381768800022
J	Zhang, L; Ferreyros, M; Feng, WG; Hupe, M; Crumrine, DA; Chen, J; Elias, PM; Holleran, WM; Niswander, L; Hohl, D; Williams, T; Torchia, EC; Roop, DR				Zhang, Lei; Ferreyros, Michael; Feng, Weiguo; Hupe, Melanie; Crumrine, Debra A.; Chen, Jiang; Elias, Peter M.; Holleran, Walter M.; Niswander, Lee; Hohl, Daniel; Williams, Trevor; Torchia, Enrique C.; Roop, Dennis R.			Defects in Stratum Corneum Desquamation Are the Predominant Effect of Impaired ABCA12 Function in a Novel Mouse Model of Harlequin Ichthyosis	PLOS ONE			English	Article							PERMEABILITY BARRIER; LAMELLAR GRANULES; TERMINAL DIFFERENTIATION; EPIDERMAL-KERATINOCYTES; SPHINGOLIPID METABOLISM; TRANSPORTER ABCA12; GOLGI-APPARATUS; GENE; MUTATIONS; MICE	Harlequin Ichthyosis is a severe skin disease caused by mutations in the human gene encoding ABCA12. Here, we characterize a novel mutation in intron 29 of the mouse Abca12 gene that leads to the loss of a 5' splice donor site and truncation of the Abca12 RNA transcript. Homozygous mutants of this smooth skin or smsk allele die perinatally with shiny translucent skin, typical of animal models of Harlequin Ichthyosis. Characterization of smsk mutant skin showed that the delivery of glucosylceramides and CORNEODESMOSIN was defective, while ultrastructural analysis revealed abnormal lamellar bodies and the absence of lipid lamellae in smsk epidermis. Unexpectedly, mutant stratum corneum remained intact when subjected to harsh chemical dissociation procedures. Moreover, both KALLIKREIN 5 and -7 were drastically decreased, with retention of desmoplakin in mutant SC. In cultured wild type keratinocytes, both KALLIKREIN 5 and -7 colocalized with ceramide metabolites following calcium-induced differentiation. Reducing the intracellular levels of glucosylceramide with a glucosylceramide synthase inhibitor resulted in decreased secretion of KALLIKREIN proteases by wild type keratinocytes, but not by smsk mutant keratinocytes. Together, these findings suggest an essential role for ABCA12 in transferring not only lipids, which are required for the formation of multilamellar structures in the stratum corneum, but also proteolytic enzymes that are required for normal desquamation. Smsk mutant mice recapitulate many of the pathological features of HI and can be used to explore novel topical therapies against a potentially lethal and debilitating neonatal disease.	[Zhang, Lei; Ferreyros, Michael; Torchia, Enrique C.; Roop, Dennis R.] Univ Colorado, Dept Dermatol, Anschutz Med Campus, Aurora, CO 80045 USA; [Zhang, Lei; Ferreyros, Michael; Torchia, Enrique C.; Roop, Dennis R.] Univ Colorado, Charles C Gates Ctr Regenerat Med, Anschutz Med Campus, Aurora, CO 80045 USA; [Feng, Weiguo; Williams, Trevor] Univ Colorado, Dept Craniofacial Biol, Anschutz Med Campus, Aurora, CO 80045 USA; [Hupe, Melanie; Crumrine, Debra A.; Elias, Peter M.; Holleran, Walter M.] Univ Calif San Francisco, Dept Dermatol, Sch Med, San Francisco, CA 94143 USA; [Hupe, Melanie; Crumrine, Debra A.; Elias, Peter M.; Holleran, Walter M.] Vet Affairs Med Ctr, San Francisco, CA 94121 USA; [Chen, Jiang] SUNY Stony Brook, Sch Med, Dept Pathol & Dermatol, Stony Brook, NY 11794 USA; [Niswander, Lee] Univ Colorado, Dept Pediat, Anschutz Med Campus, Aurora, CO USA; [Hohl, Daniel] Univ Lausanne, Hop Beaumont, Serv Dermatol & Venereol, Lausanne, Switzerland	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Lausanne	Torchia, EC; Roop, DR (corresponding author), Univ Colorado, Dept Dermatol, Anschutz Med Campus, Aurora, CO 80045 USA.; Torchia, EC; Roop, DR (corresponding author), Univ Colorado, Charles C Gates Ctr Regenerat Med, Anschutz Med Campus, Aurora, CO 80045 USA.; Williams, T (corresponding author), Univ Colorado, Dept Craniofacial Biol, Anschutz Med Campus, Aurora, CO 80045 USA.	Trevor.Williams@ucdenver.edu; Enrique.Torchia@ucdenver.edu; Dennis.Roop@ucdenver.edu	Niswander, Lee/D-3976-2013; Hohl, Daniel M/N-7554-2016	Niswander, Lee/0000-0002-9959-0594; 	University of Colorado Cancer Center Core Grant [P30CA046934]; University of Colorado Anschutz Medical Campus Skin Diseases Research Center (UCAMC-SDRC, NIAMS) [P30 AR057212]; Dermatology Foundation Research Career Development Awards; Children's Hospital of Colorado Department of Pediatrics; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057212, R01AR061106] Funding Source: NIH RePORTER	University of Colorado Cancer Center Core Grant; University of Colorado Anschutz Medical Campus Skin Diseases Research Center (UCAMC-SDRC, NIAMS); Dermatology Foundation Research Career Development Awards; Children's Hospital of Colorado Department of Pediatrics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by a University of Colorado Cancer Center Core Grant (P30CA046934), the University of Colorado Anschutz Medical Campus Skin Diseases Research Center (UCAMC-SDRC, NIAMS (P30 AR057212)), and by Dermatology Foundation Research Career Development Awards to Lei Zhang and Enrique C. Torchia, respectively. We also acknowledge the Children's Hospital of Colorado Department of Pediatrics for financial support of the ENU mutagenesis screen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama M, 1999, J DERMATOL SCI, V21, P96, DOI 10.1016/S0923-1811(99)00024-9; Akiyama M, 2005, J CLIN INVEST, V115, P1777, DOI 10.1172/JCI24834; Akiyama M, 2011, NAGOYA J MED SCI, V73, P79; Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; Brattsand M, 2005, J INVEST DERMATOL, V124, P198, DOI 10.1111/j.0022-202X.2004.23547.x; BUXMAN MM, 1979, ARCH DERMATOL, V115, P189, DOI 10.1001/archderm.115.2.189; Caubet C, 2004, J INVEST DERMATOL, V122, P1235, DOI 10.1111/j.0022-202X.2004.22512.x; Chan A, 2015, JAMA DERMATOL, V151, P285, DOI 10.1001/jamadermatol.2014.3369; Chen J, 2008, J INVEST DERMATOL, V128, P270, DOI 10.1038/sj.jid.5701038; Doering T, 2002, J LIPID RES, V43, P1727, DOI 10.1194/jlr.M200208-JLR200; Elias PM, 2008, J LIPID RES, V49, P697, DOI 10.1194/jlr.R800002-JLR200; Elias PM, 2014, BBA-MOL CELL BIOL L, V1841, P314, DOI 10.1016/j.bbalip.2013.09.011; FLECK RM, 1989, J AM ACAD DERMATOL, V21, P999, DOI 10.1016/S0190-9622(89)70289-9; Follmann J, 2013, GENE, V531, P510, DOI 10.1016/j.gene.2013.07.046; Garrod Kym R, 2008, J Vis Exp, DOI 10.3791/634; Griner RD, 2000, J PHARMACOL EXP THER, V294, P1219; Hatzfeld M, 2007, BBA-MOL CELL RES, V1773, P69, DOI 10.1016/j.bbamcr.2006.04.009; Hentges KE, 2006, GENE EXPR PATTERNS, V6, P653, DOI 10.1016/j.modgep.2005.11.015; Hsu W Y, 1989, Zhonghua Yi Xue Za Zhi (Taipei), V43, P63; ISC van, 2000, MOL BIOL CELL, V11, P1093; Ishida-Yamamoto A, 2004, J INVEST DERMATOL, V122, P1137, DOI 10.1111/j.0022-202X.2004.22515.x; Kelsell DP, 2005, AM J HUM GENET, V76, P794; Leclerc EA, 2009, J CELL SCI, V122, P2699, DOI 10.1242/jcs.050302; Lefevre C, 2003, HUM MOL GENET, V12, P2369, DOI 10.1093/hmg/ddg235; Madison KC, 1996, J INVEST DERMATOL, V106, P1030, DOI 10.1111/1523-1747.ep12338596; MADISON KC, 1990, J INVEST DERMATOL, V95, P657, DOI 10.1111/1523-1747.ep12514333; Mallet A, 2013, BRIT J DERMATOL, V169, P1322, DOI 10.1111/bjd.12593; MILNER ME, 1992, J INVEST DERMATOL, V99, P824, DOI 10.1111/1523-1747.ep12614791; Moreau S, 1999, SURG RADIOL ANAT, V21, P215, DOI 10.1007/s00276-999-0215-6; Moskowitz DG, 2004, J PEDIATR-US, V145, P82, DOI 10.1016/j.jpeds.2004.03.052; Oram JF, 2000, BBA-MOL CELL BIOL L, V1529, P321, DOI 10.1016/S1388-1981(00)00157-8; Ovaere P, 2009, TRENDS BIOCHEM SCI, V34, P453, DOI 10.1016/j.tibs.2009.08.001; Peelman F, 2003, J MOL BIOL, V325, P259, DOI 10.1016/S0022-2836(02)01105-1; Rabionet M, 2014, BBA-MOL CELL BIOL L, V1841, P422, DOI 10.1016/j.bbalip.2013.08.011; Rassner U, 1999, TISSUE CELL, V31, P489, DOI 10.1054/tice.1999.0050; Rassner UA, 1997, HISTOCHEM J, V29, P387, DOI 10.1023/A:1026438917856; Raymond AA, 2008, MOL CELL PROTEOMICS, V7, P2151, DOI 10.1074/mcp.M700334-MCP200; ROOP DR, 1984, J BIOL CHEM, V259, P8037; ROSENWALD AG, 1993, ADV LIPID RES, V26, P101; Sakai K, 2007, EXP DERMATOL, V16, P920, DOI 10.1111/j.1600-0625.2007.00614.x; Sakai K, 2009, J INVEST DERMATOL, V129, P2306, DOI 10.1038/jid.2009.23; Sarkar R, 2000, J Dermatol, V27, P609; Sevilla LM, 2007, J CELL BIOL, V179, P1599, DOI 10.1083/jcb.200706187; Shulenin S, 2004, NEW ENGL J MED, V350, P1296, DOI 10.1056/NEJMoa032178; Singh S, 2001, INT J DERMATOL, V40, P472, DOI 10.1046/j.1365-4362.2001.01173.x; Smyth I, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000192; Takami Yoshihiro, 1998, Journal of Dermatology (Tokyo), V25, P73; Thomas AC, 2009, AM J PATHOL, V174, P970, DOI 10.2353/ajpath.2009.080860; Torchia EC, 2013, J INVEST DERMATOL, V133, P78, DOI 10.1038/jid.2012.249; Torchia EC, 2009, CANCER RES, V69, P7207, DOI 10.1158/0008-5472.CAN-09-1059; Uchida Y, 2002, J LIPID RES, V43, P1293, DOI 10.1194/jlr.M100442-JLR200; Uchida Y, 2000, J LIPID RES, V41, P2071; Victor Frank, 2005, Dermatol Online J, V11, P13; Vielhaber G, 2001, J INVEST DERMATOL, V117, P1126, DOI 10.1046/j.0022-202x.2001.01527.x; WILLIAMS ML, 1987, DERMATOL CLIN, V5, P155, DOI 10.1016/S0733-8635(18)30772-1; Wojcik SM, 2000, MOL CELL BIOL, V20, P5248, DOI 10.1128/MCB.20.14.5248-5255.2000; Yanagi T, 2008, HUM MOL GENET, V17, P3075, DOI 10.1093/hmg/ddn204; Yanagi T, 2010, AM J PATHOL, V177, P106, DOI 10.2353/ajpath.2010.091120; Yu ZQ, 2006, DEV BIOL, V299, P122, DOI 10.1016/j.ydbio.2006.07.015; Zuo Y, 2008, J BIOL CHEM, V283, P36624, DOI 10.1074/jbc.M807377200	60	21	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0161465	10.1371/journal.pone.0161465	http://dx.doi.org/10.1371/journal.pone.0161465			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27551807	gold, Green Published, Green Submitted			2022-12-26	WOS:000381768800044
J	Mingo, J; Erramuzpe, A; Luna, S; Aurtenetxe, O; Amo, L; Diez, I; Schepens, JTG; Hendriks, WJAJ; Cortes, JM; Pulido, R				Mingo, Janire; Erramuzpe, Asier; Luna, Sandra; Aurtenetxe, Olaia; Amo, Laura; Diez, Ibai; Schepens, Jan T. G.; Hendriks, Wiljan J. A. J.; Cortes, Jesus M.; Pulido, Rafael			One-Tube-Only Standardized Site-Directed Mutagenesis: An Alternative Approach to Generate Amino Acid Substitution Collections	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PTEN; SATURATION MUTAGENESIS; PROTEIN LIBRARIES; EVOLUTION; SINGLE; PCR; DNA; MUTANTS; RANDOMIZATION; CONSTRUCTION	Site-directed mutagenesis (SDM) is a powerful tool to create defined collections of protein variants for experimental and clinical purposes, but effectiveness is compromised when a large number of mutations is required. We present here a one-tube-only standardized SDM approach that generates comprehensive collections of amino acid substitution variants, including scanning-and single site-multiple mutations. The approach combines unified mutagenic primer design with the mixing of multiple distinct primer pairs and/ or plasmid templates to increase the yield of a single inverse-PCR mutagenesis reaction. Also, a userfriendly program for automatic design of standardized primers for Ala-scanning mutagenesis is made available. Experimental results were compared with a modeling approach together with stochastic simulation data. For single site-multiple mutagenesis purposes and for simultaneous mutagenesis in different plasmid backgrounds, combination of primer sets and/or plasmid templates in a single reaction tube yielded the distinct mutations in a stochastic fashion. For scanning mutagenesis, we found that a combination of overlapping primer sets in a single PCR reaction allowed the yield of different individual mutations, although this yield did not necessarily follow a stochastic trend. Double mutants were generated when the overlap of primer pairs was below 60%. Our results illustrate that one-tubeonly SDM effectively reduces the number of reactions required in large-scale mutagenesis strategies, facilitating the generation of comprehensive collections of protein variants suitable for functional analysis.	[Mingo, Janire; Luna, Sandra; Aurtenetxe, Olaia; Amo, Laura; Pulido, Rafael] Biocruces Hlth Res Inst, Biomarkers Canc Unit, Baracaldo, Spain; [Erramuzpe, Asier; Diez, Ibai; Cortes, Jesus M.] Biocruces Hlth Res Inst, Quantitat Biomed Unit, Baracaldo, Spain; [Schepens, Jan T. G.; Hendriks, Wiljan J. A. J.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Cell Biol, Nijmegen, Netherlands; [Cortes, Jesus M.; Pulido, Rafael] Basque Fdn Sci, Ikerbasque, Bilbao, Spain	Radboud University Nijmegen; Basque Foundation for Science	Pulido, R (corresponding author), Biocruces Hlth Res Inst, Biomarkers Canc Unit, Baracaldo, Spain.; Pulido, R (corresponding author), Basque Fdn Sci, Ikerbasque, Bilbao, Spain.	rpulidomurillo@gmail.com	Erramuzpe, Asier/AFX-8870-2022; Cortes, Jesus/D-9949-2012; Hendriks, Wiljan/Q-4325-2019; Hendriks, Wiljan J.A.J./A-5214-2013; Aliaga, Asier Erramuzpe/AAC-3223-2021	Erramuzpe, Asier/0000-0002-9402-2184; Cortes, Jesus/0000-0002-9059-8194; Hendriks, Wiljan/0000-0001-9481-8281; Hendriks, Wiljan J.A.J./0000-0001-9481-8281; Aliaga, Asier Erramuzpe/0000-0002-9402-2184; Pulido, Rafael/0000-0001-9100-248X; Diez, Ibai/0000-0001-5769-0178; , Laura/0000-0003-0322-0167	Ministerio de Economia y Competitividad (Spain) [SAF2013-48812-R]; Gobierno Vasco, Departamento de Salud (Basque Country, Spain) [2013111011]; BIOEF/EITB maratoia (Basque Country, Spain) [BIO13/CI/001/BC]; Ikerbasque: Basque Foundation for Science (Basque Country, Spain); Gobierno Vasco, Departamento de Educacion (Basque Country, Spain) [PRE_2014_1_252, PRE_2014_1_285]; Bilbao Bizkaia Kutxa (BBK) (Spain)	Ministerio de Economia y Competitividad (Spain); Gobierno Vasco, Departamento de Salud (Basque Country, Spain); BIOEF/EITB maratoia (Basque Country, Spain); Ikerbasque: Basque Foundation for Science (Basque Country, Spain); Gobierno Vasco, Departamento de Educacion (Basque Country, Spain); Bilbao Bizkaia Kutxa (BBK) (Spain)	This work was supported in part by grant SAF2013-48812-R from Ministerio de Economia y Competitividad (Spain), 2013111011 from Gobierno Vasco, Departamento de Salud (Basque Country, Spain), and BIO13/CI/001/BC from BIOEF/EITB maratoia (Basque Country, Spain). JMC and RP are funded by Ikerbasque: Basque Foundation for Science (Basque Country, Spain). AE and JM are the recipients of two pre-doctoral fellowships from Gobierno Vasco, Departamento de Educacion (Basque Country, Spain) (PRE_2014_1_252 to AE and PRE_2014_1_285 to JM). SL has been the recipient of a fellowship from Bilbao Bizkaia Kutxa (BBK) (Spain).	Alfoldi J, 2013, GENOME RES, V23, P1063, DOI 10.1101/gr.157503.113; Ashraf M, 2013, BIOCHEM SOC T, V41, P1189, DOI 10.1042/BST20130123; Bosley AD, 2005, BIOMOL ENG, V22, P57, DOI 10.1016/j.bioeng.2004.11.002; Burks EA, 1997, P NATL ACAD SCI USA, V94, P412, DOI 10.1073/pnas.94.2.412; Carapito R, 2006, ANAL BIOCHEM, V355, P110, DOI 10.1016/j.ab.2006.04.047; Chiu J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh172; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Edelheit O, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-61; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Hogrefe HH, 2002, BIOTECHNIQUES, V33, P1158, DOI 10.2144/02335pf01; Hughes MD, 2003, J MOL BIOL, V331, P973, DOI 10.1016/S0022-2836(03)00833-7; Hughes SR, 2006, PROTEOME SCI, V4, DOI 10.1186/1477-5956-4-10; Kille S, 2013, ACS SYNTH BIOL, V2, P83, DOI 10.1021/sb300037w; Krauss U, 2005, BIOTECHNIQUES, V39, P679, DOI 10.2144/000112013; Labrou NE, 2010, CURR PROTEIN PEPT SC, V11, P91, DOI 10.2174/138920310790274617; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Mitchell LA, 2013, ACS SYNTH BIOL, V2, P473, DOI 10.1021/sb300131w; Neylon C, 2004, NUCLEIC ACIDS RES, V32, P1448, DOI 10.1093/nar/gkh315; Nov Y, 2013, J COMPUT BIOL, V20, P990, DOI 10.1089/cmb.2013.0026; Patrick WM, 2005, BIOMOL ENG, V22, P105, DOI 10.1016/j.bioeng.2005.06.001; Patrick WM, 2003, PROTEIN ENG, V16, P451, DOI 10.1093/protein/gzg057; Qi D, 2008, J VIROL METHODS, V149, P85, DOI 10.1016/j.jviromet.2008.01.002; Rai MK, 2014, CRIT REV BIOTECHNOL; Reetz MT, 2007, NAT PROTOC, V2, P891, DOI 10.1038/nprot.2007.72; Rodriguez-Escudero I, 2011, HUM MOL GENET, V20, P4132, DOI 10.1093/hmg/ddr337; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Shen T, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00215; Steffens David L, 2007, J Biomol Tech, V18, P147; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Sun DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078878; Torres J, 2003, J BIOL CHEM, V278, P30652, DOI 10.1074/jbc.M212610200; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Tseng WC, 2008, ANAL BIOCHEM, V375, P376, DOI 10.1016/j.ab.2007.12.013; Wang HP, 2011, ANAL BIOCHEM, V418, P304, DOI 10.1016/j.ab.2011.07.008; Wei DS, 2004, ANAL BIOCHEM, V331, P401, DOI 10.1016/j.ab.2004.04.019; WEINER MP, 1994, GENE, V151, P119, DOI 10.1016/0378-1119(94)90641-6; Wong TS, 2006, J MOL BIOL, V355, P858, DOI 10.1016/j.jmb.2005.10.082; Wu W, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni115; Xia YZ, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1189; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	40	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0160972	10.1371/journal.pone.0160972	http://dx.doi.org/10.1371/journal.pone.0160972			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548698	Green Submitted, gold, Green Published			2022-12-26	WOS:000381768400025
J	Svedenkrans, J; Kowalski, J; Norman, M; Bohlin, K				Svedenkrans, Jenny; Kowalski, Jan; Norman, Mikael; Bohlin, Kajsa			Low Exercise Capacity Increases the Risk of Low Cognitive Function in Healthy Young Men Born Preterm: A Population-Based Cohort Study	PLOS ONE			English	Article							BIRTH-WEIGHT CHILDREN; HIGHER BLOOD-PRESSURE; FOR-GESTATIONAL-AGE; INTELLECTUAL-PERFORMANCE; FETAL-GROWTH; BRAIN; INFANTS; NEUROGENESIS; METAANALYSIS; ASSOCIATION	Background Preterm birth is a risk factor for decreased exercise capacity and impaired cognitive functions in later life. The objective of this study was to disentangle the associations between preterm birth, physical fitness and cognitive performance in young adulthood. Methods This population-based cohort study included 218,802 young men born in Sweden 19731983. Data on birth characteristics was obtained from the Medical Birth Register and linked to exercise capacity assessed by ergometer cycling and cognitive tests performed at conscription for military service in 1993-2001. Cognitive performance was assessed using stanine (STAndard NINE) scores. The results were adjusted for socioeconomic factors. Results Exercise capacity was positively associated with cognitive performance across all gestational ages. The sub-group of men who were born extremely preterm (gestational age < 28 weeks) and had low exercise capacity exhibited the lowest odds ratio (OR = 0.26, 95% CI: 0.09-0.82) of having a cognitive function above the mean stanine score (2.9) for men born at term with normal birth weight. Men born extremely preterm with a high exercise capacity had similar or even higher ORs for cognitive function (OR = 0.59; 95% CI: 0.350.99) than men born at term with lowWmax (OR = 0.57; 95% CI: 0.55-0.59). Conclusions Physical fitness is associated with higher cognitive function at all gestational ages, also in young men born extremely preterm. Targeting early physical exercise may be a possible intervention to enhance cognitive performance and educational achievements in populations at risk, such as childhood and adult survivors of preterm birth.	[Svedenkrans, Jenny; Kowalski, Jan; Norman, Mikael; Bohlin, Kajsa] Karolinska Inst, Dept Clin Sci Intervent & Technol, Div Pediat, Stockholm, Sweden; [Svedenkrans, Jenny; Norman, Mikael; Bohlin, Kajsa] Karolinska Univ Hosp, Dept Neonatol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Svedenkrans, J; Bohlin, K (corresponding author), Karolinska Inst, Dept Clin Sci Intervent & Technol, Div Pediat, Stockholm, Sweden.; Svedenkrans, J; Bohlin, K (corresponding author), Karolinska Univ Hosp, Dept Neonatol, Stockholm, Sweden.	jenny.svedenkrans@ki.se; kajsa.bohlin@ki.se	Svedenkrans, Jenny/AAF-4982-2021; Kowalski, Jan/HDM-3504-2022	Norman, Mikael/0000-0003-4191-3781; Svedenkrans, Jenny/0000-0002-6194-5118	Samaritan foundation; Swedish Heart and Lung Foundation; Childhood foundation of the Swedish Order of Freemasons; Stockholm County Council; Karolinska Institutet (ALF)	Samaritan foundation; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Childhood foundation of the Swedish Order of Freemasons; Stockholm County Council(Stockholm County Council); Karolinska Institutet (ALF)(Karolinska Institutet)	Support was provided by JS: The Samaritan foundation (to JS) and the Swedish Heart and Lung Foundation; Childhood foundation of the Swedish Order of Freemasons; Research grant as a regional agreement between the Stockholm County Council and Karolinska Institutet (ALF) (to MN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnoudse-Moens CSH, 2009, PEDIATRICS, V124, P717, DOI 10.1542/peds.2008-2816; Aberg MAI, 2009, P NATL ACAD SCI USA, V106, P20906, DOI 10.1073/pnas.0905307106; Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X; Ball G, 2013, P NATL ACAD SCI USA, V110, P9541, DOI 10.1073/pnas.1301652110; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Bergvall N, 2006, PEDIATRICS, V117, pE460, DOI 10.1542/peds.2005-0737; Bolton CE, 2015, THORAX, V70, P574, DOI 10.1136/thoraxjnl-2014-206590; Bonamy AKE, 2007, J INTERN MED, V262, P635, DOI 10.1111/j.1365-2796.2007.01868.x; Bonamy AKE, 2005, PEDIATR RES, V58, P845, DOI 10.1203/01.PDR.0000181373.29290.80; Cederlof M, 2015, BRIT J DERMATOL, V173, P155, DOI 10.1111/bjd.13740; Clemm HH, 2015, ACTA PAEDIATR, V104, P1174, DOI 10.1111/apa.13080; Creer DJ, 2010, P NATL ACAD SCI USA, V107, P2367, DOI 10.1073/pnas.0911725107; de Kieviet JF, 2009, JAMA-J AM MED ASSOC, V302, P2235, DOI 10.1001/jama.2009.1708; Ekeus C, 2010, PEDIATRICS, V125, pE67, DOI 10.1542/peds.2008-3329; Fletcher GF, 2001, CIRCULATION, V104, P1694, DOI 10.1161/hc3901.095960; Frisell T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041783; Goyen TA, 2009, ARCH DIS CHILD, V94, P298, DOI 10.1136/adc.2007.134692; Hassmen P, 1997, AGING-CLIN EXP RES, V9, P136, DOI 10.1007/BF03340139; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Huang CX, 2013, NEUROSCIENCE, V233, P139, DOI 10.1016/j.neuroscience.2012.12.046; Johnson S, 2009, ARCH DIS CHILD-FETAL, V94, pF283, DOI 10.1136/adc.2008.152793; Karlsson H, 2010, BRAIN BEHAV IMMUN, V24, P868, DOI 10.1016/j.bbi.2010.02.009; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Lundgren M, 2004, GROWTH HORM IGF RES, V14, pS7, DOI 10.1016/j.ghir.2004.03.004; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; Mikkola K, 2005, PEDIATRICS, V116, P1391, DOI 10.1542/peds.2005-0171; Population and Housing Census, 1992, POP HOUS CENS 1990 7; Schubert U, 2011, J DEV ORIG HLTH DIS, V2, P218, DOI 10.1017/S2040174411000274; Spittle A, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005495.pub4; Stockholm SNBoHaW, 2003, SWED MED BIRTH REG S; Strunk T, 2014, LANCET INFECT DIS, V14, P751, DOI 10.1016/S1473-3099(14)70710-8; Svedenkrans J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080869; Sweden SC, 1982, MIS 1982 4 SOC IND S, P20; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Voss MW, 2011, J APPL PHYSIOL, V111, P1505, DOI 10.1152/japplphysiol.00210.2011; Walker DM, 2008, ARCH DIS CHILD-FETAL, V93, pF322, DOI 10.1136/adc.2007.120485	39	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161314	10.1371/journal.pone.0161314	http://dx.doi.org/10.1371/journal.pone.0161314			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548612	Green Published, gold, Green Submitted			2022-12-26	WOS:000381768400042
J	Yakob, B; Ncama, BP				Yakob, Bereket; Ncama, Busisiwe Purity			Correlates of Strengthening Lessons from HIV/AIDS Treatment and Care Services in Ethiopia Perceived Access and Implications for Health System	PLOS ONE			English	Article							QUALITY-OF-LIFE; LOW-INCOME COUNTRIES; PATIENT SATISFACTION; ANTIRETROVIRAL TREATMENT; SPATIAL ACCESSIBILITY; SOUTH-AFRICA; USER FEES; HIV; PEOPLE; RESPONSIVENESS	Background Access to healthcare is an important public health concept and has been traditionally measured by using population level parameters, such as availability, distribution and proximity of the health facilities in relation to the population. However, client based factors such as their expectations, experiences and perceptions which impact their evaluations of health care access were not well studied and integrated into health policy frameworks and implementation programs. Objective This study aimed to investigate factors associated with perceived access to HIV/AIDS Treatment and care services in Wolaita Zone, Ethiopia. Methods A cross-sectional survey was conducted on 492 people living with HIV, with 411 using ART and 81 using pre-ART services accessed at six public sector health facilities from November 2014 to March 2015. Data were analyzed using the ologit function of STATA. The variables explored consisted of socio-demographic and health characteristics, type of health facility, type of care, distance, waiting time, healthcare responsiveness, transportation convenience, satisfaction with service, quality of care, financial fairness, out of pocket expenses and HIV disclosure. Results Of the 492 participants, 294 (59.8%) were females and 198 (40.2%) were males, with a mean age of 38.8 years. 23.0% and 12.2% believed they had 'good' or 'very good' access respectively, and 64.8% indicated lower ratings. In the multivariate analysis, distance from the health facility, type of care, HIV clinical stage, out of pocket expenses, employment status, type of care, HIV disclosure and perceived transportation score were not associated with the perceived access (PA). With a unit increment in satisfaction, perceived quality of care, health system responsiveness, transportation convenience and perceived financial fairness scores, the odds of providing higher rating of PA increased by 29.0% (p<0.001), 6.0%(p<0.01), 100.0% (p<0.001), 9.0% (p<0.05) and 6.0% (p<0.05) respectively. Conclusion Perceived quality of care, health system responsiveness, perceived financial fairness, transportation convenience and satisfaction with services were correlates of perceived access and affected healthcare performance. Interventions targeted at improving access to HIV/AIDS treatment and care services should address these factors. Further studies may be needed to confirm the findings.	[Yakob, Bereket; Ncama, Busisiwe Purity] Univ KwaZulu Natal, Howard Coll, Sch Nursing & Publ Hlth, Durban, South Africa; [Yakob, Bereket] Univ KwaZulu Natal, Hlth Econ & HIV AIDS Res Div HEARD, Durban, South Africa	University of Kwazulu Natal; University of Kwazulu Natal	Yakob, B (corresponding author), Univ KwaZulu Natal, Howard Coll, Sch Nursing & Publ Hlth, Durban, South Africa.; Yakob, B (corresponding author), Univ KwaZulu Natal, Hlth Econ & HIV AIDS Res Div HEARD, Durban, South Africa.	berekbot@yahoo.com	Yakob, Bereket/X-5487-2019	Yakob, Bereket/0000-0002-8383-6449	Wolaita Zone Health Department; Boditti Town Administration Health Unit; Humbo Tebela Woreda Health Office; Areka Town Administration Health Unit; Soddo Town Administration Health Unit; Ofa Woreda Health Office	Wolaita Zone Health Department; Boditti Town Administration Health Unit; Humbo Tebela Woreda Health Office; Areka Town Administration Health Unit; Soddo Town Administration Health Unit; Ofa Woreda Health Office	The authors thank all participants for offering their time and providing the information required for the study. The authors extend their acknowledegements to Wolaita Zone Health Department, Boditti Town Administration Health Unit, Humbo Tebela Woreda Health Office, Areka Town Administration Health Unit, Soddo Town Administration Health Unit, Ofa Woreda Health Office and all health facilities for providing permission and support during the study. Many thanks to the data collectors, data entry clerk and to all those contributed to this study. Finally, the authors acknowledge HEARD and the College of Health Sciences, School of Nursing and Public Health, Public Health Medicine of the University of KwaZulu-Natal for providing learning environment. All literatures used in this article are acknowledged.	Aday L A, 1974, Health Serv Res, V9, P208; Andaleeb SS, 2001, SOC SCI MED, V52, P1359, DOI 10.1016/S0277-9536(00)00235-5; [Anonymous], 2014, HSDP 4 ANN PERF REP; [Anonymous], 2014, SHEET FACT 2014; Assefa Y, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/1744-8603-10-43; Assefa Y, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-45; BABAKUS E, 1992, HEALTH SERV RES, V26, P767; Chaudhuri A, 2008, HEALTH POLICY, V88, P38, DOI 10.1016/j.healthpol.2008.02.014; Clarke TR, 2010, W INDIAN MED J, V59, P369; Cook JA, 2002, J ACQ IMMUN DEF SYND, V30, P401, DOI [10.1097/00042560-200208010-00005, 10.1097/01.QAI.0000018280.16783.FE]; Coyne JS, 2002, AM J PUBLIC HEALTH, V92, P30, DOI 10.2105/AJPH.92.1.30; CSA, 2009, 2007 POP HOUS CENS S; Dao HT, 2008, PUBLIC HEALTH, V122, P1068, DOI 10.1016/j.puhe.2008.01.002; Dionisio D, 2004, CURR HIV RES, V2, P377, DOI 10.2174/1570162043351057; Donabedian A, 2003, INTRO QUALITY ASSURA; Elashoff J, 2005, HDB EPIDEMIOLOGY; Endrias Markos, 2008, Ethiopian Journal of Health Development, V22, P174; FHAPCO, 2014, COUNTR PROGR REP HIV; FMoH, 2014, EP DISTR MAL; GESLER W, 1986, SOC SCI MED, V23, P963, DOI 10.1016/0277-9536(86)90253-4; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Goddard M, 2001, SOC SCI MED, V53, P1149, DOI 10.1016/S0277-9536(00)00415-9; Gold M, 1998, HEALTH SERV RES, V33, P625; Guagliardo Mark F, 2004, Int J Health Geogr, V3, P3; Gulliford M, 2001, ACCESS HLTH CARE; Gusdal AK, 2009, AIDS CARE, V21, P1381, DOI 10.1080/09540120902883119; HADDAD S, 1995, SOC SCI MED, V40, P743, DOI 10.1016/0277-9536(94)00134-F; Haddad S, 1998, SOC SCI MED, V47, P381, DOI 10.1016/S0277-9536(98)00075-6; Haggerty JL, 2003, BRIT MED J, V327, P1219, DOI 10.1136/bmj.327.7425.1219; Heckman TG, 2003, HEALTH PSYCHOL, V22, P140, DOI 10.1037/0278-6133.22.2.140; Hekkert KD, 2009, SOC SCI MED, V69, P68, DOI 10.1016/j.socscimed.2009.04.016; Himakalasa W, 2013, HIV AIDS-RES PALLIAT, V5, P205, DOI 10.2147/HIV.S49729; Hu RS, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-35; Iacobuta AO, 2012, PROCD SOC BEHV, V62, P896, DOI 10.1016/j.sbspro.2012.09.151; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Institute of Medicine Committee on Monitoring Access to Personal Health Care Services, 1993, AC HLTH CAR AM; Jerene D, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-136; KENDALL ALEXANDRA, 2012, US RESPONSE GLOBAL T; Kerouedan D, 2007, Med Trop (Mars), V67, P515; Kerouedan D, 2010, Bull Soc Pathol Exot, V103, P119, DOI 10.1007/s13149-010-0051-2; Lei P, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-436; Levesque JF, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-18; Liu X, 2012, J MOD APPL STAT METH, V11, P242, DOI 10.22237/jmasm/1335846000; Luo W, 2004, HEALTH PLACE, V10, P1, DOI 10.1016/S1353-8292(02)00067-9; Luo W, 2003, ENVIRON PLANN B, V30, P865, DOI 10.1068/b29120; MASUR H, 1989, ANN INTERN MED, V111, P223, DOI 10.7326/0003-4819-111-3-223; McGrail MR, 2009, APPL GEOGR, V29, P533, DOI 10.1016/j.apgeog.2008.12.003; McIntyre D, 2009, HEALTH ECON POLICY L, V4, P179, DOI 10.1017/S1744133109004836; Meessen B, 2006, LANCET, V368, P2253, DOI 10.1016/S0140-6736(06)69899-1; MOH, 2011, HLTH HLTH REL IND 20; Mossialos E, PERFORMANCE MEASUREM; Munoz UH, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-40; Negash T, 2013, J ASSOC NURSE AIDS C, V24, P530, DOI 10.1016/j.jana.2012.11.004; Ngowi BJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-341; Owoaje EE, 2013, PREV MED, V1, P11, DOI [10.12691/jpm-1-3-1, DOI 10.12691/JPM-1-3-1]; Parasuraman A., 2004, J RETAIL, V67, P114; Peltzer K, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-117; PENCHANSKY R, 1981, MED CARE, V19, P127, DOI 10.1097/00005650-198102000-00001; Piot P, 2001, B WORLD HEALTH ORGAN, V79, P1106; Porter ME, 2010, NEW ENGL J MED, V363, P2477, DOI 10.1056/NEJMp1011024; Power M, 1998, SOC SCI MED, V46, P1569, DOI 10.1016/s0277-9536(98)00009-4; Robone S, 2011, HEALTH SERV RES, V46, P2079, DOI 10.1111/j.1475-6773.2011.01291.x; Savedoff W., 2009, MOVING TARGET UNIVER; Souteyrand YP, 2008, AIDS, V22, pS161, DOI 10.1097/01.aids.0000327637.59672.02; Takahashi LM, 2002, CULT HEALTH SEX, V4, P67, DOI 10.1080/136910502753389387; TANAHASHI T, 1978, B WORLD HEALTH ORGAN, V56, P295; Timyan J, 1993, HLTH WOMEN GLOBAL PE; Tiyou A, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-39; Vachirasudlekha B, 2014, INT J HEALTH CARE Q, V27, P405, DOI 10.1108/IJHCQA-01-2013-0007; Valentine N, 2003, HLTH SYSTEMS PERFORM, P573; Valentine N, FACTORS ASS PERCEIVE; Valentine N, 2008, SOC SCI MED, V66, P1939, DOI 10.1016/j.socscimed.2007.12.002; Wagner AK, 2011, HEALTH POLICY, V100, P151, DOI 10.1016/j.healthpol.2010.08.004; Williams B, 1998, SOC SCI MED, V47, P1351, DOI 10.1016/S0277-9536(98)00213-5; WINSHIP C, 1984, AM SOCIOL REV, V49, P512, DOI 10.2307/2095465; World Health Organization Department of Reproductive Health and Research, 2003, KANG MOTH CAR PRACT, P1; Wouters E, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-210; Yakob B, 2016, INT HLTH, P1; Yakob B, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2830-6; Yakob B, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-010026	80	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161553	10.1371/journal.pone.0161553	http://dx.doi.org/10.1371/journal.pone.0161553			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT8TP	27548753	Green Published, gold			2022-12-26	WOS:000381768400071
J	Elkalaf, M; Tuma, P; Weiszenstein, M; Polak, J; Trnka, J				Elkalaf, Moustafa; Tuma, Petr; Weiszenstein, Martin; Polak, Jan; Trnka, Jan			Mitochondrial Probe Methyltriphenylphosphonium (TPMP) Inhibits the Krebs Cycle Enzyme 2-Oxoglutarate Dehydrogenase	PLOS ONE			English	Article							TRIPHENYLPHOSPHONIUM CATIONS; TARGETED ANTIOXIDANT; RESPIRATORY-CHAIN; CULTURED-CELLS; COMPLEX-I; BIOENERGETICS; ASSAY; UBIQUINONE; SAMPLES; ENERGY	Methyltriphenylphosphonium (TPMP) salts have been widely used to measure the mitochondrial membrane potential and the triphenylphosphonium (TPP+) moiety has been attached to many bioactive compounds including antioxidants to target them into mitochondria thanks to their high affinity to accumulate in the mitochondrial matrix. The adverse effects of these compounds on cellular metabolism have been insufficiently studied and are still poorly understood. Micromolar concentrations of TPMP cause a progressive inhibition of cellular respiration in adherent cells without a marked effect on mitochondrial coupling. In permeabilized cells the inhibition was limited to NADH-linked respiration. We found a mixed inhibition of the Krebs cycle enzyme 2-oxoglutarate dehydrogenase complex (OGDHC) with an estimated IC50 3.93 [3.70-4.17] mM, which is pharmacologically plausible since it corresponds to micromolar extracellular concentrations. Increasing the lipophilic character of the used TPP+ compound further potentiates the inhibition of OGDHC activity. This effect of TPMP on the Krebs cycle ought to be taken into account when interpreting observations on cells and mitochondria in the presence of TPP+ derivatives. Compounds based on or similar to TPP+ derivatives may also be used to alter OGDHC activity for experimental or therapeutic purposes.	[Elkalaf, Moustafa; Trnka, Jan] Charles Univ Prague, Fac Med 3, Lab Metab & Bioenerget, Prague, Czech Republic; [Tuma, Petr; Trnka, Jan] Charles Univ Prague, Fac Med 3, Dept Biochem Cell & Mol Biol, Prague, Czech Republic; [Weiszenstein, Martin; Polak, Jan] Charles Univ Prague, Fac Med 3, Dept Sport Med, Prague, Czech Republic; [Elkalaf, Moustafa; Tuma, Petr; Weiszenstein, Martin; Polak, Jan; Trnka, Jan] Charles Univ Prague, Fac Med 3, Ctr Res Diabet Metab & Nutr, Prague, Czech Republic	Charles University Prague; Charles University Prague; Charles University Prague; Charles University Prague	Trnka, J (corresponding author), Charles Univ Prague, Fac Med 3, Lab Metab & Bioenerget, Prague, Czech Republic.; Trnka, J (corresponding author), Charles Univ Prague, Fac Med 3, Dept Biochem Cell & Mol Biol, Prague, Czech Republic.; Trnka, J (corresponding author), Charles Univ Prague, Fac Med 3, Ctr Res Diabet Metab & Nutr, Prague, Czech Republic.	jan.trnka@lf3.cuni.cz	Tuma, Petr/B-7868-2014; Trnka, Jan/B-8951-2012; Elkalaf, Moustafa/AAL-4938-2020; Polak, Jan/J-3404-2014	Tuma, Petr/0000-0003-3489-9547; Trnka, Jan/0000-0002-1786-7562; Elkalaf, Moustafa/0000-0002-0418-2732; Polak, Jan/0000-0001-9964-652X	Charles University in Prague (Univerzita Karlova v Praze) [PRVOUK-P31, UNCE 204015/2012, 260042/SVV/2014, 260165/SVV/2015]	Charles University in Prague (Univerzita Karlova v Praze)	This work was supported by grants PRVOUK-P31, UNCE 204015/2012, 260042/SVV/2014 and 260165/SVV/2015 from Charles University in Prague (Univerzita Karlova v Praze). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonenko YN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061902; Asin-Cayuela J, 2004, FEBS LETT, V571, P9, DOI 10.1016/j.febslet.2004.06.045; Brand M. D., 1995, BIOENERGETICS, V154, P62; BROWN GC, 1985, BIOCHEM J, V225, P399, DOI 10.1042/bj2250399; CHEN FR, 1963, BIOCHEMISTRY-US, V2, P1023, DOI 10.1021/bi00905a020; Cocheme HM, 2012, NAT PROTOC, V7, P946, DOI 10.1038/nprot.2012.035; COOPERSTEIN SJ, 1951, J BIOL CHEM, V189, P665; Elkalaf M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070772; Floryk D, 1999, BIOSCIENCE REP, V19, P27, DOI 10.1023/A:1020193906974; FRICKE W, 1992, J EXP BOT, V43, P1515, DOI 10.1093/jxb/43.11.1515; Goncalves S, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-5; GRINIUS LL, 1970, BIOCHIM BIOPHYS ACTA, V216, P1, DOI 10.1016/0005-2728(70)90153-2; HECKERT LL, 1989, J GEN MICROBIOL, V135, P155; Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873; Johnson G, 2006, AM J PHYSIOL-ENDOC M, V291, pE460, DOI 10.1152/ajpendo.00258.2005; Kelso GF, 2012, CHEM BIOL, V19, P1237, DOI 10.1016/j.chembiol.2012.08.005; Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200; Lee I, 2001, BIOL CHEM, V382, P1629, DOI 10.1515/BC.2001.198; Leo S, 2008, ANN NY ACAD SCI, V1147, P264, DOI 10.1196/annals.1427.019; LIBERMAN EA, 1969, NATURE, V222, P1076, DOI 10.1038/2221076a0; Luo C, 2008, CLIN CHIM ACTA, V395, P38, DOI 10.1016/j.cca.2008.04.025; Murphy MP, 1997, TRENDS BIOTECHNOL, V15, P326, DOI 10.1016/S0167-7799(97)01068-8; Nicholls DG, 2012, METHODS MOL BIOL, V810, P119, DOI 10.1007/978-1-61779-382-0_8; O'Malley Y, 2006, J BIOL CHEM, V281, P39766, DOI 10.1074/jbc.M608268200; Ojovan SM, 2011, J BIOENERG BIOMEMBR, V43, P175, DOI 10.1007/s10863-011-9345-8; Plecita-Hlavata L, 2009, INT J BIOCHEM CELL B, V41, P1697, DOI 10.1016/j.biocel.2009.02.015; Qi F, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-53; Rasmussen UF, 2000, MOL CELL BIOCHEM, V208, P37, DOI 10.1023/A:1007046028132; Reily C, 2013, REDOX BIOL, V1, P86, DOI 10.1016/j.redox.2012.11.009; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Ross MF, 2008, BIOCHEM J, V411, P633, DOI 10.1042/BJ20080063; Ross MF, 2005, BIOCHEMISTRY-MOSCOW+, V70, P222, DOI 10.1007/s10541-005-0104-5; Salabei JK, 2014, NAT PROTOC, V9, P421, DOI 10.1038/nprot.2014.018; Sauer SW, 2005, J BIOL CHEM, V280, P21830, DOI 10.1074/jbc.M502845200; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Severin FF, 2010, P NATL ACAD SCI USA, V107, P663, DOI 10.1073/pnas.0910216107; Sheu KFR, 1999, ANN NY ACAD SCI, V893, P61; Smith RAJ, 1999, EUR J BIOCHEM, V263, P709, DOI 10.1046/j.1432-1327.1999.00543.x; Smith RAJ, 2012, TRENDS PHARMACOL SCI, V33, P341, DOI 10.1016/j.tips.2012.03.010; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Trendeleva TA, 2012, BIOCHEMISTRY-MOSCOW+, V77, P1021, DOI 10.1134/S000629791209009X; Trnka J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121837; Trnka J, 2009, FREE RADICAL RES, V43, P4, DOI 10.1080/10715760802582183; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Tuma P, 2011, ANAL CHIM ACTA, V685, P84, DOI 10.1016/j.aca.2010.11.007; Tuma P, 2010, J SEP SCI, V33, P2394, DOI 10.1002/jssc.201000137; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006	47	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161413	10.1371/journal.pone.0161413	http://dx.doi.org/10.1371/journal.pone.0161413			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537184	Green Published, Green Submitted, gold			2022-12-26	WOS:000381577000104
J	He, L; Yuan, J; Xu, QY; Chen, RX; Chen, LG; Fang, MX				He, Ling; Yuan, Jing; Xu, Qingyun; Chen, Ruixue; Chen, Liguo; Fang, Meixia			miRNA-1283 Regulates the PERK/ATF4 Pathway in Vascular Injury by Targeting ATF4	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; CIRCULATING ENDOTHELIAL-CELLS; UNFOLDED PROTEIN RESPONSE; VON-WILLEBRAND-FACTOR; INFLAMMATION; HYPERTENSION; EXPRESSION	Background In our previous study, we found significant differences in the mRNA and microRNA (miRNA) levels among hypertensive patients with different degrees of vascular endothelial cells damage. These differences were closely associated with endoplasmic reticulum stress (ERS)-related proteins. Moreover, compared to the control group, the expression of transcription factor activating factor 4 (ATF4) was also found to be significantly different in the hypertensive patients with different degrees of vascular endothelial cells damage groups. These results were confirmed using gene prediction software, which showed synergistic effects between ATF4 and miR-1283. ATF4 is a key molecule in ERS. Three ERS pathways exist: protein kinase RNA-like ER kinase (PERK), activating transcription factor 6 (ATF6) and inositol-requiring enzyme-1 (IRE-1)-induced apoptosis. The PERK pathway is the most important and also includes the phosphorylation of eukaryotic translation initiation factor 2 alpha (eIF2 alpha) and ATF4. In this report, we studied the regulatory effects of miR-1283 and ATF4 on the PERK-eIF2 alpha-ATF4 signaling pathway using human umbilical vein endothelial cells (HUVECs) and mice. Methodology/Principal Findings We verified the relationship between miR-1283 and ATF4 using a luciferase activity assay and observed the regulatory effects of miR-1283 and ATF4 on the PERK-eIF2 alpha-ATF4 signaling pathway in vivo and in vitro. Conclusions/Significance ATF4 is a target gene of miR-1283, which regulates the PERK-eIF2 alpha-ATF4 signaling pathway by inhibiting ATF4, and it plays a critical role in inducing injury in HUVECs and mouse heart tissue.	[He, Ling; Yuan, Jing; Xu, Qingyun; Chen, Ruixue; Chen, Liguo] Jinan Univ, Dept Chinese Med, Coll Med, Guangzhou 510632, Guangdong, Peoples R China; [Fang, Meixia] Jinan Univ, Inst Lab Anim, Guangzhou 510632, Guangdong, Peoples R China	Jinan University; Jinan University	Chen, LG (corresponding author), Jinan Univ, Dept Chinese Med, Coll Med, Guangzhou 510632, Guangdong, Peoples R China.; Fang, MX (corresponding author), Jinan Univ, Inst Lab Anim, Guangzhou 510632, Guangdong, Peoples R China.	tchenly@jnu.edu.cn; fangmx1979@163.com		Chen, Ruixue/0000-0003-3347-2584	National Natural Science Foundation of China [81173157]; National Natural Science Foundation of Guangdong [10151063201000045]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province)	This study was supported by the National Natural Science Foundation of China (No. 81173157), and the National Natural Science Foundation of Guangdong (No. 10151063201000045).; This study was supported by the National Natural Science Foundation of China (Nos. 81173157), and the National Natural Science Foundation of Guangdong (Nos. 10151063201000045). The fund certificates are showed in S1 File.	Behrman S, 2011, J CELL BIOL, V192, P919, DOI 10.1083/jcb.201010055; Byrd AE, 2012, J CELL BIOL, V196, P689, DOI 10.1083/jcb.201201077; Chong AY, 2006, EUR J HEART FAIL, V8, P167, DOI 10.1016/j.ejheart.2005.06.010; Dai RY, 2010, BIOL CHEM, V391, P791, DOI 10.1515/BC.2010.072; Ding J, 2010, J APPLIDCLINICAL PED, V31, P1013; Fernandez JA, 2006, J IMMUNOL METHODS, V314, P174, DOI 10.1016/j.jim.2006.05.004; Guan HS, 2010, ADV CARDIOVASCULAR D, V5, P669; He L, 2016, J TRADIT CHIN MED, V36, P173; [何铃 He Ling], 2015, [中国病理生理杂志, Chinese Journal of Pathophysiology], V31, P817; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Kang EB, 2013, APOPTOSIS, V18, P1332, DOI 10.1007/s10495-013-0884-9; Lee KW, 2006, INT J CARDIOL, V111, P302, DOI 10.1016/j.ijcard.2005.10.014; [李载权 Li Zaiquan], 2004, [中国生物化学与分子生物学报, Chinese Journal of Biochemistry and Molecular Biology], V20, P283; Liu XH, 2010, CHINESE J PATHOPHYSI, V26, P1964; Mei Y, 2013, PHARM BIOMED ANAL, V1, P1; [秦明春 Qin Mingchun], 2014, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V25, P2016; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Simioni P, 2006, THROMB RES, V117, P523, DOI 10.1016/j.thromres.2005.04.029; Wu Q, 2014, CELL BIOL INT, V38, P881, DOI 10.1002/cbin.10272; Yang SB, 2015, FEBS LETT, V589, P2087, DOI 10.1016/j.febslet.2015.06.029; Zeng W, 2014, LIFE SCI, V103, P15, DOI 10.1016/j.lfs.2014.03.007; Zhang JG, 2014, BIOMED REP, V2, P233, DOI 10.3892/br.2014.225	22	22	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0159171	10.1371/journal.pone.0159171	http://dx.doi.org/10.1371/journal.pone.0159171			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537404	Green Published, gold, Green Submitted			2022-12-26	WOS:000381577000007
J	Latasa, C; Echeverz, M; Garcia, B; Gil, C; Garcia-Ona, E; Burgui, S; Casares, N; Hervas-Stubbs, S; Lasarte, JJ; Lasa, I; Solano, C				Latasa, Cristina; Echeverz, Maite; Garcia, Begona; Gil, Carmen; Garcia-Ona, Enrique; Burgui, Saioa; Casares, Noelia; Hervas-Stubbs, Sandra; Jose Lasarte, Juan; Lasa, Inigo; Solano, Cristina			Evaluation of a Salmonella Strain Lacking the Secondary Messenger C-di-GMP and RpoS as a Live Oral Vaccine	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; ESCHERICHIA-COLI; BIOFILM FORMATION; IMMUNE-RESPONSE; CYCLIC DIGUANYLATE; MARKER VACCINE; IFN-GAMMA; VIRULENCE; BACTERIAL; CELLULOSE	Salmonellosis is one of the most important bacterial zoonotic diseases transmitted through the consumption of contaminated food, with chicken and pig related products being key reservoirs of infection. Although numerous studies on animal vaccination have been performed in order to reduce Salmonella prevalence, there is still a need for an ideal vaccine. Here, with the aim of constructing a novel live attenuated Salmonella vaccine candidate, we firstly analyzed the impact of the absence of cyclic-di-GMP (c-di-GMP) in Salmonella virulence. C-di-GMP is an intracellular second messenger that controls a wide range of bacterial processes, including biofilm formation and synthesis of virulence factors, and also modulates the host innate immune response. Our results showed that a Salmonella multiple mutant in the twelve genes encoding diguanylate cyclase proteins that, as a consequence, cannot synthesize c-di-GMP, presents a moderate attenuation in a systemic murine infection model. An additional mutation of the rpoS gene resulted in a synergic attenuating effect that led to a highly attenuated strain, referred to as Delta XIII, immunogenic enough to protect mice against a lethal oral challenge of a S. Typhimurium virulent strain. Delta XIII immunogenicity relied on activation of both antibody and cell mediated immune responses characterized by the production of opsonizing antibodies and the induction of significant levels of IFN-gamma, TNF-alpha, IL-2, IL-17 and IL-10. Delta XIII was unable to form a biofilm and did not survive under desiccation conditions, indicating that it could be easily eliminated from the environment. Moreover, Delta XIII shows DIVA features that allow differentiation of infected and vaccinated animals. Altogether, these results show Delta XIII as a safe and effective live DIVA vaccine.	[Latasa, Cristina; Echeverz, Maite; Garcia, Begona; Gil, Carmen; Garcia-Ona, Enrique; Burgui, Saioa; Lasa, Inigo; Solano, Cristina] Univ Publ Navarra CSIC Gobierno Navarra, Lab Microbial Biofilms, Inst Agrobiotecnol Idab, Pamplona, Spain; [Latasa, Cristina] Recombina SL Mutilva, Navarra, Spain; [Casares, Noelia; Hervas-Stubbs, Sandra; Jose Lasarte, Juan] Univ Navarra, Inst Invest Sanitaria Navarra IdISNA, Program Immunol & Immunotherapy, Ctr Appl Med Res CIMA, Pamplona, Spain; [Lasa, Inigo] Navarrabiomed Univ Publ Navarra, Inst Invest Sanitaria Navarra IdISNA, Pamplona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-GN-UPNA - Instituto de Agrobiotecnologia (IDAB); Universidad Publica de Navarra; University of Navarra; Navarrabiomed	Lasa, I; Solano, C (corresponding author), Univ Publ Navarra CSIC Gobierno Navarra, Lab Microbial Biofilms, Inst Agrobiotecnol Idab, Pamplona, Spain.; Lasa, I (corresponding author), Navarrabiomed Univ Publ Navarra, Inst Invest Sanitaria Navarra IdISNA, Pamplona, Spain.	ilasa@unavarra.es; cristina.solano@unavarra.es	Lasa, Iñigo/F-2947-2011; Echeverz, Maite/H-6471-2017; Solano, Cristina/ABG-8407-2020; Lasarte, Juan José/AAN-6548-2020; Garcia, Begoña/I-8051-2012; Burgui, Saioa/V-5868-2019; Solano, Cristina/F-9607-2011; Gil, Carmen/K-3759-2017; Casares, Noelia/AAA-5568-2019; Hervas-Stubbs, Sandra/C-9053-2018	Lasa, Iñigo/0000-0002-6625-9221; Echeverz, Maite/0000-0002-4153-4549; Solano, Cristina/0000-0002-6207-1766; Lasarte, Juan José/0000-0003-1641-3881; Garcia, Begoña/0000-0002-0476-4900; Burgui, Saioa/0000-0002-3601-7221; Solano, Cristina/0000-0002-6207-1766; Gil, Carmen/0000-0002-8867-4442; Casares, Noelia/0000-0003-3817-6434; Hervas-Stubbs, Sandra/0000-0003-3391-1516	Departamento de Innovacion, Empresa y Empleo, Government of Navarra [IIM 13329.RI1]; Spanish Ministry of Economy and Competitiveness [BIO2011-30503-C02-02, BIO2014-53530-R]	Departamento de Innovacion, Empresa y Empleo, Government of Navarra; Spanish Ministry of Economy and Competitiveness(Spanish Government)	SB is a predoctoral fellow from the Public University of Navarra. CG and BG are recipients of a postdoctoral contract under Grants IIM 13329.RI1 and BIO2011-30503-C02-02, respectively. This work was supported by grant IIM 13329.RI1 from the Departamento de Innovacion, Empresa y Empleo, Government of Navarra and grants BIO2011-30503-C02-02 and BIO2014-53530-R from the Spanish Ministry of Economy and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Recombina S.L. provided support in the form of salaries for author CL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Ahmad I, 2013, MOL MICROBIOL, V90, P1216, DOI 10.1111/mmi.12428; Ahmad I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028351; Allombert J, 2014, INFECT IMMUN, V82, P1222, DOI 10.1128/IAI.01077-13; Argello H, 2012, SALMONELLA - DISTRIBUTION, ADAPTATION, CONTROL MEASURES AND MOLECULAR TECHNOLOGIES, P99; Bohez L, 2008, VET MICROBIOL, V126, P216, DOI 10.1016/j.vetmic.2007.06.025; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Chaveroche MK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e97; Cyktor JC, 2011, INFECT IMMUN, V79, P2964, DOI 10.1128/IAI.00047-11; Denagamage TN, 2007, FOODBORNE PATHOG DIS, V4, P539, DOI 10.1089/fpd.2007.0013; Desin TS, 2013, EXPERT REV VACCINES, V12, P87, DOI [10.1586/ERV.12.138, 10.1586/erv.12.138]; Dougan G, 2011, IMMUNOL REV, V240, P196, DOI 10.1111/j.1600-065X.2010.00999.x; Doyle ME, 2015, FOODBORNE PATHOG DIS, V12, P261, DOI 10.1089/fpd.2014.1865; FANG FC, 1992, P NATL ACAD SCI USA, V89, P11978, DOI 10.1073/pnas.89.24.11978; Figueira R, 2013, MBIO, V4, DOI 10.1128/mBio.00065-13; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Garcia B, 2004, MOL MICROBIOL, V54, P264, DOI 10.1111/j.1365-2958.2004.04269.x; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Gonzalez-Zorn B, 2012, INT MICROBIOL, V15, P101, DOI 10.2436/20.1501.01.163; Henderson LM, 2005, BIOLOGICALS, V33, P203, DOI 10.1016/j.biologicals.2005.08.006; Jouanguy E, 1999, CURR OPIN IMMUNOL, V11, P346, DOI 10.1016/S0952-7915(99)80055-7; Karasova D, 2009, VACCINE, V27, P5265, DOI 10.1016/j.vaccine.2009.06.060; Kong W, 2012, P NATL ACAD SCI USA, V109, P19414, DOI 10.1073/pnas.1217554109; Kulesekara H, 2006, P NATL ACAD SCI USA, V103, P2839, DOI 10.1073/pnas.0511090103; Leyman B, 2012, VET J, V194, P250, DOI 10.1016/j.tvjl.2012.04.011; Leyman B, 2011, VACCINE, V29, P3679, DOI 10.1016/j.vaccine.2011.03.004; Li WH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9330; Lo WF, 2004, INFECT IMMUN, V72, P2843, DOI 10.1128/IAI.72.5.2843-2849.2004; Mastroeni P, 2003, J MED MICROBIOL, V52, P453, DOI 10.1099/jmm.0.05173-0; MASTROENI P, 1993, INFECT IMMUN, V61, P3981, DOI 10.1128/IAI.61.9.3981-3984.1993; Mastroeni P, 2000, INFECT IMMUN, V68, P46, DOI 10.1128/IAI.68.1.46-53.2000; Matulova M, 2012, VACCINE, V30, P2090, DOI 10.1016/j.vaccine.2012.01.050; MCKENNA AJ, 1995, MICROBIOL-UK, V141, P1993, DOI 10.1099/13500872-141-8-1993; Methner U, 2011, ZOONOSES PUBLIC HLTH, V58, P540, DOI 10.1111/j.1863-2378.2011.01400.x; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Moe-Behrens GG, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00005; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; MUOTIALA A, 1990, MICROB PATHOGENESIS, V8, P135, DOI 10.1016/0882-4010(90)90077-4; OCALLAGHAN D, 1990, IMMUNOLOGY, V69, P184; Parvatiyar K, 2012, NAT IMMUNOL, V13, P1155, DOI 10.1038/ni.2460; Pontes MH, 2015, P NATL ACAD SCI USA, V112, P5183, DOI 10.1073/pnas.1500989112; Povolotsky TL, 2012, J BIOTECHNOL, V160, P10, DOI 10.1016/j.jbiotec.2011.12.024; Raffatellu M, 2008, NAT MED, V14, P421, DOI 10.1038/nm1743; Romling U, 1998, J BACTERIOL, V180, P722; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Rubino SJ, 2012, TRENDS IMMUNOL, V33, P112, DOI 10.1016/j.it.2012.01.003; Schulte LN, 2011, EMBO J, V30, P1977, DOI 10.1038/emboj.2011.94; Selke M, 2007, INFECT IMMUN, V75, P2476, DOI 10.1128/IAI.01908-06; Shang F, 2009, INFECT IMMUN, V77, P2849, DOI 10.1128/IAI.01405-08; Simon R, 2011, VACCINE, V29, P5094, DOI 10.1016/j.vaccine.2011.05.022; Singh BR, 2009, OPEN VAC J, V2, P100, DOI DOI 10.2174/1875035400902010100; Solano C, 2002, MOL MICROBIOL, V43, P793, DOI 10.1046/j.1365-2958.2002.02802.x; Solano C, 1998, J CLIN MICROBIOL, V36, P674, DOI 10.1128/JCM.36.3.674-678.1998; Solano C, 2009, P NATL ACAD SCI USA, V106, P7997, DOI 10.1073/pnas.0812573106; Spurbeck RR, 2013, J BACTERIOL, V195, P3156, DOI 10.1128/JB.02254-12; Stewart MK, 2011, P NATL ACAD SCI USA, V108, P20742, DOI 10.1073/pnas.1108963108; Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426; Valle J, 2013, TRENDS MICROBIOL, V21, P364, DOI 10.1016/j.tim.2013.05.008; VanCott JL, 1998, NAT MED, V4, P1247, DOI 10.1038/3227; Voinnet O, 2011, EMBO J, V30, P1877, DOI 10.1038/emboj.2011.134; White AP, 2006, J BACTERIOL, V188, P3219, DOI 10.1128/JB.188.9.3219-3227.2006; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Yang FH, 2014, MOL PLANT MICROBE IN, V27, P578, DOI 10.1094/MPMI-12-13-0371-R; Zorraquino V, 2013, J BACTERIOL, V195, P417, DOI 10.1128/JB.01789-12	63	8	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161216	10.1371/journal.pone.0161216	http://dx.doi.org/10.1371/journal.pone.0161216			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537839	Green Published, Green Submitted, gold			2022-12-26	WOS:000381577000069
J	Dourado, PM; Bacalhau, FB; Amado, D; Carvalho, RA; Martinelli, S; Head, GP; Omoto, C				Dourado, Patrick M.; Bacalhau, Fabiana B.; Amado, Douglas; Carvalho, Renato A.; Martinelli, Samuel; Head, Graham P.; Omoto, Celso			High Susceptibility to Cry1Ac and Low Resistance Allele Frequency Reduce the Risk of Resistance of Helicoverpa armigers to Bt Soybean in Brazil	PLOS ONE			English	Article							PUNCTIGERA WALLENGREN LEPIDOPTERA; FIELD-EVOLVED RESISTANCE; BASE-LINE-SUSCEPTIBILITY; BACILLUS-THURINGIENSIS; INSECT RESISTANCE; HUBNER LEPIDOPTERA; TRANSGENIC CROPS; NOCTUIDAE; COTTON; MANAGEMENT	The Old World bollworm, Helicoverpa armigera (Hubner), was recently introduced into Brazil, where it has caused extensive damage to cotton and soybean crops. MON 87701 x MON 89788 soybean, which expresses the Bt protein Cry1Ac, was recently deployed in Brazil, providing high levels of control against H. armigera. To assess the risk of resistance to the Cry1Ac protein expressed by MON 87701 x MON 89788 soybean in Brazil, we conducted studies to evaluate the baseline susceptibility of H. armigera to Cry1Ac, in planta efficacy including the assessment of the high-dose criterion, and the initial resistance allele frequency based on an F-2 screen. The mean Cry1Ac lethal concentration (LC50) ranged from 0.11 to 1.82 mu g.mL(-1) of diet among all H. armigera field populations collected from crop seasons 2013/14 to 2014/15, which indicated about 16.5-fold variation. MON 87701 x MON 89788 soybean exhibited a high level of efficacy against H. armigera and most likely met the high dose criterion against this target species in leaf tissue dilution bioassays up to 50 times. A total of 212 F2 family lines of H. armigera were established from field collections sampled from seven locations across Brazil and were screened for the presence of MON 87701 x MON 89788 soybean resistance alleles. None of the 212 families survived on MON 87701 x MON 89788 soybean leaf tissue (estimated allele frequency = 0.0011). The responses of H. armigera to Cry1Ac protein, high susceptibility to MON 87701 x MON 89788 soybean, and low frequency of resistance alleles across the main soybean-producing regions support the assumptions of a high-dose/refuge strategy. However, maintenance of reasonable compliance with the refuge recommendation will be essential to delay the evolution of resistance in H. armigera to MON 87701 x MON 89788 soybean in Brazil.	[Dourado, Patrick M.; Amado, Douglas; Omoto, Celso] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Dept Entomol & Acarol, Sao Paulo, Brazil; [Dourado, Patrick M.; Bacalhau, Fabiana B.; Carvalho, Renato A.] Monsanto Brasil Ltda, Sao Paulo, Brazil; [Martinelli, Samuel; Head, Graham P.] Monsanto LLC, St Louis, MO USA	Universidade de Sao Paulo; Monsanto; Monsanto	Dourado, PM (corresponding author), Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Dept Entomol & Acarol, Sao Paulo, Brazil.; Dourado, PM (corresponding author), Monsanto Brasil Ltda, Sao Paulo, Brazil.	patrick.m.dourado@monsanto.com	Omoto, Celso/D-9794-2012; Amado, Douglas/U-9426-2018	Omoto, Celso/0000-0002-6432-830X; Amado, Douglas/0000-0003-2982-5404; Dourado, Patrick/0000-0001-8587-3561; Head, Graham/0000-0003-0521-0616	Monsanto	Monsanto	Monsanto provided support in the form of salaries for PMD, FBB, RAC, SM and GPH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albernaz KC, 2013, J ECON ENTOMOL, V106, P1819, DOI 10.1603/EC12222; Ali MI, 2009, J ECON ENTOMOL, V102, P1935, DOI 10.1603/029.102.0526; Andow DA, 1998, J ECON ENTOMOL, V91, P572, DOI 10.1093/jee/91.3.572; [Anonymous], 2015, OLD WORLD BOLLWORM F, V20, P18; Azambuja R, 2015, EFFECT BT SOYBEAN LA, V7; Barros Ricardo, 2012, Cientifica (Jaboticabal), V40, P117; Behere GT, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-117; Bernardi O, 2014, PEST MANAG SCI, V70, P588, DOI 10.1002/ps.3581; Bernardi O, 2012, PEST MANAG SCI, V68, P1083, DOI 10.1002/ps.3271; Bird LJ, 2007, J INVERTEBR PATHOL, V94, P84, DOI 10.1016/j.jip.2006.08.005; Blanco CA, 2009, J ECON ENTOMOL, V102, P381, DOI 10.1603/029.102.0149; Brevault T, 2009, J ECON ENTOMOL, V102, P2301, DOI 10.1603/029.102.0636; Comissao Tecnica Nacional de Biosseguranca (CTNBio), TECHN OP 2542 2010; Conte L, 2006, THESIS; Cunningham JP, 2014, J ECON ENTOMOL, V107, P881, DOI 10.1603/EC14036; Czepak Cecília, 2013, Pesqui. Agropecu. Trop., V43, P110, DOI 10.1590/S1983-40632013000100015; Dhurua S, 2011, PEST MANAG SCI, V67, P898, DOI 10.1002/ps.2127; Downes Sharon, 2012, GM Crops Food, V3, P228, DOI 10.4161/gmcr.20194; Downes S, 2012, J INVERTEBR PATHOL, V110, P281, DOI 10.1016/j.jip.2012.04.005; Farias JR, 2014, CROP PROT, V64, P150, DOI 10.1016/j.cropro.2014.06.019; Fathipour Y., 2013, SOYBEAN PEST RESISTA, P231, DOI DOI 10.5772/54522; Ffrench-Constant R.H., 1990, PESTICIDE RESISTANCE, P4, DOI [10.1007/978-1-4684-6429-0_2, DOI 10.1007/978-1-4684-6429-0_2]; FITT GP, 1989, ANNU REV ENTOMOL, V34, P17, DOI 10.1146/annurev.en.34.010189.000313; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; Greenplate JT, 2003, J APPL ENTOMOL, V127, P340, DOI 10.1046/j.1439-0418.2003.00766.x; Gujar GT, 2007, J INVERTEBR PATHOL, V95, P214, DOI 10.1016/j.jip.2007.03.011; HALLIDAY WR, 1990, J ECON ENTOMOL, V83, P1151, DOI 10.1093/jee/83.4.1151; Head G, 2010, J APPL ECOL, V47, P583, DOI 10.1111/j.1365-2664.2010.01796.x; Head Graham P, 2012, GM Crops Food, V3, P144, DOI 10.4161/gmcr.20743; Huang FN, 2011, PEST MANAG SCI, V67, P1269, DOI 10.1002/ps.2182; Huang FN, 2011, ENTOMOL EXP APPL, V140, P1, DOI 10.1111/j.1570-7458.2011.01138.x; Jalali SK, 2004, CROP PROT, V23, P53, DOI 10.1016/S0261-2194(03)00170-4; Jin L, 2015, NAT BIOTECHNOL, V33, P169, DOI 10.1038/nbt.3100; Kasten Jr P., 1978, REV AGR, V53, P69; Kranthi K. R., 2001, International Journal of Pest Management, V47, P141, DOI 10.1080/09670870151130651; Kranthi KR, 2002, CROP PROT, V21, P449, DOI 10.1016/S0261-2194(01)00131-4; Kriticos DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119618; Leite NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113286; Llewellyn DJ, 2007, AGR FOREST ENTOMOL, V9, P93, DOI 10.1111/j.1461-9563.2007.00332.x; Luttrell RG, 1999, J ECON ENTOMOL, V92, P21, DOI 10.1093/jee/92.1.21; Macrae TC, 2005, J ECON ENTOMOL, V98, P577, DOI 10.1603/0022-0493-98.2.577; Mastrangelo T, 2014, J ECON ENTOMOL, V107, P970, DOI 10.1603/EC13403; McPherson RM, 2009, J ECON ENTOMOL, V102, P1640, DOI 10.1603/029.102.0431; NAPPO. North American Plant Protection Organizations Phytosanitary Alert System, 2014, DET OLD WORLD BOLLW; Omoto C, 2016, PEST MANAG SCI; Pogue MG, 2004, ANN ENTOMOL SOC AM, V97, P1222, DOI 10.1603/0013-8746(2004)097[1222:ANSOHZ]2.0.CO;2; Producao Agriola Municipal, 2012, QUANT PROD VAL PROD; Robertson J.L., 2007, BIOASSAYS ARTHROPODS, V2nd; Roush RT, 1997, PESTIC SCI, V51, P328, DOI 10.1002/(SICI)1096-9063(199711)51:3&lt;328::AID-PS650&gt;3.0.CO;2-B; ROUSH RT, 1986, J ECON ENTOMOL, V79, P293, DOI 10.1093/jee/79.2.293; Sosa-Gomez DR, REV BRASILEIRA ENTOM; Specht A, 2013, PESQUI AGROPECU BRAS, V48, P689, DOI 10.1590/S0100-204X2013000600015; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; Tabashnik BE, 2004, J EVOLUTION BIOL, V17, P904, DOI 10.1111/j.1420-9101.2004.00695.x; Tabashnik BE, 2013, NAT BIOTECHNOL, V31, P510, DOI 10.1038/nbt.2597; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; TAY WT, 2013, PLOS ONE, V8; van Rensburg J. B. J., 2007, South African Journal of Plant and Soil, V24, P147; WILSON FD, 1992, J ECON ENTOMOL, V85, P1516, DOI 10.1093/jee/85.4.1516; Wu KM, 1999, J ECON ENTOMOL, V92, P273, DOI 10.1093/jee/92.2.273; Wu KM, 2005, ANNU REV ENTOMOL, V50, P31, DOI 10.1146/annurev.ento.50.071803.130349; Wu KM, 2002, J ECON ENTOMOL, V95, P832, DOI 10.1603/0022-0493-95.4.832; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Yang YH, 2013, J ECON ENTOMOL, V106, P375, DOI 10.1603/EC12286; Yano SA, 2015, PEST MANAG SCI; Yu HL, 2013, PEST MANAG SCI, V69, P1326, DOI 10.1002/ps.3508; ZALUCKI MP, 1986, AUST J ZOOL, V34, P779, DOI 10.1071/ZO9860779; Zalucki Myron P., 2005, Insect Science, V12, P45, DOI 10.1111/j.1672-9609.2005.00007.x; Zhang HN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022874	70	27	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161388	10.1371/journal.pone.0161388	http://dx.doi.org/10.1371/journal.pone.0161388			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532632	gold, Green Published			2022-12-26	WOS:000381487600090
J	Robert, MA; Christofferson, RC; Silva, NJB; Vasquez, C; Mores, CN; Wearing, HJ				Robert, Michael A.; Christofferson, Rebecca C.; Silva, Noah J. B.; Vasquez, Chalmers; Mores, Christopher N.; Wearing, Helen J.			Modeling Mosquito-Borne Disease Spread in US Urbanized Areas: The Case of Dengue in Miami	PLOS ONE			English	Article							AEDES-AEGYPTI DIPTERA; HUMAN MOVEMENT; HABITAT SEGREGATION; AIR-TRAVEL; VIRUS; CULICIDAE; ALBOPICTUS; DISPERSAL; TRANSMISSION; DYNAMICS	Expansion of mosquito-borne pathogens into more temperate regions of the world necessitates tools such as mathematical models for understanding the factors that contribute to the introduction and emergence of a disease in populations naive to the disease. Often, these models are not developed and analyzed until after a pathogen is detected in a population. In this study, we develop a spatially explicit stochastic model parameterized with publicly available U.S. Census data for studying the potential for disease spread in Urbanized Areas of the United States. To illustrate the utility of the model, we specifically study the potential for introductions of dengue to lead to autochthonous transmission and outbreaks in a population representative of the Miami Urbanized Area, where introductions of dengue have occurred frequently in recent years. We describe seasonal fluctuations in mosquito populations by fitting a population model to trap data provided by the Miami-Dade Mosquito Control Division. We show that the timing and location of introduced cases could play an important role in determining both the probability that local transmission occurs as well as the total number of cases throughout the entire region following introduction. We show that at low rates of clinical presentation, small outbreaks of dengue could go completely undetected during a season, which may confound mitigation efforts that rely upon detection. We discuss the sensitivity of the model to several critical parameter values that are currently poorly characterized and motivate the collection of additional data to strengthen the predictive power of this and similar models. Finally, we emphasize the utility of the general structure of this model in studying mosquito-borne diseases such as chikungunya and Zika virus in other regions.	[Robert, Michael A.; Silva, Noah J. B.; Wearing, Helen J.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Robert, Michael A.; Wearing, Helen J.] Univ New Mexico, Dept Math & Stat, Albuquerque, NM 87131 USA; [Christofferson, Rebecca C.; Mores, Christopher N.] Louisiana State Univ, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA; [Vasquez, Chalmers] Miami Dade Cty Mosquito Control Div, Miami, FL USA	University of New Mexico; University of New Mexico; Louisiana State University System; Louisiana State University	Robert, MA (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.; Robert, MA (corresponding author), Univ New Mexico, Dept Math & Stat, Albuquerque, NM 87131 USA.	marobert@unm.edu		Mores, Christopher/0000-0001-6678-9049; Wearing, Helen/0000-0002-9837-9797; Robert, Michael/0000-0003-3705-0952	National Institutes of Health/NIGMS program for Models of Infectious Disease Agent Study (MIDAS) [U01GM097661]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM097661] Funding Source: NIH RePORTER	National Institutes of Health/NIGMS program for Models of Infectious Disease Agent Study (MIDAS); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by the National Institutes of Health/NIGMS program for Models of Infectious Disease Agent Study (MIDAS) grant U01GM097661. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBEY HELEN, 1952, HUMAN BIOL, V24, P201; Adalja AA, 2012, EMERG INFECT DIS, V18, P608, DOI 10.3201/eid1804.110968; Adams B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006763; Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; ANDERSON R M, 1991; Bacaer N, 2007, B MATH BIOL, V69, P1067, DOI 10.1007/s11538-006-9166-9; Becker B, 2014, INT J ENV RES PUB HE, V11, P3256, DOI 10.3390/ijerph110303256; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bhoomiboonchoo P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003138; Braks MAH, 2003, J MED ENTOMOL, V40, P785, DOI 10.1603/0022-2585-40.6.785; Carrington LB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002190; Cauchemez S., 2004, EUROSURVEILLANCE, V19; Christofferson RC, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-282; de Jong M, 1995, EPIDEMIC MODELS THEI, P84; Dowling Z, 2013, J MED ENTOMOL, V50, P764, DOI 10.1603/ME12250; Drake JM, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002056; Erlander Sven, 1990, GRAVITY MODEL TRANSP, V3; Feldstein LR, 2015, T ROY SOC TROP MED H, P1; Florida Department of Health, 2015, WEEKL SURV INF MOSQ; Fouque F, 2006, J VECTOR ECOL, V31, P390, DOI 10.3376/1081-1710(2006)31[390:AASADT]2.0.CO;2; Guagliardo SA, 2015, J MED ENTOMOL, V52, P726, DOI 10.1093/jme/tjv048; Guagliardo SA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003648; Guagliardo SA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003033; Gubler DJ, 2009, REV SCI TECH OIE, V28, P583, DOI 10.20506/rst.28.2.1904; GUBLER DJ, 1981, B WORLD HEALTH ORGAN, V59, P623; Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326; Gubler DJ, 2011, ASIA PACIFIC J MOL B, V19, P111; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209; Heesterbeek JAP, 2007, MATH BIOSCI, V206, P3, DOI 10.1016/j.mbs.2004.10.013; Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; Johansson MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104915; Johansson MA, 2012, AM J TROP MED HYG, V86, P349, DOI 10.4269/ajtmh.2012.11-0432; Johansson MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022151; Juliano SA, 2002, OECOLOGIA, V130, P458, DOI 10.1007/s004420100811; Juliano SA, 2004, OECOLOGIA, V139, P583, DOI 10.1007/s00442-004-1532-4; Knudsen A. B., 1995, Parassitologia (Rome), V37, P91; Lourenco J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003083; MACDONALD G, 1952, Trop Dis Bull, V49, P813; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; Martinez JC., 2013, PREDICTION MUTATIONS; Messenger AM, 2014, VECTOR-BORNE ZOONOT, V14, P783, DOI 10.1089/vbz.2014.1665; Nasci RS, 2014, EMERG INFECT DIS, V20, P1394, DOI 10.3201/eid2008.140333; OMEARA GF, 1995, J MED ENTOMOL, V32, P554, DOI 10.1093/jmedent/32.4.554; Poletti P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018860; Read JM, 2003, P ROY SOC B-BIOL SCI, V270, P699, DOI 10.1098/rspb.2002.2305; Reiner RC, 2014, EPIDEMICS-NETH, V6, P30, DOI 10.1016/j.epidem.2013.12.003; Reiskind MH, 2013, MED VET ENTOMOL, V27, P421, DOI 10.1111/mve.12000; Rey JR, 2006, J MED ENTOMOL, V43, P1134, DOI 10.1603/0022-2585(2006)43[1134:HSOMAV]2.0.CO;2; Rey Jorge R, 2014, Insects, V5, P991, DOI 10.3390/insects5040991; Rezza G, 2014, PATHOG GLOB HEALTH, V108, P349, DOI 10.1179/2047773214Y.0000000163; Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874; Ross R, 1911, NATURE, V87, P466, DOI 10.1038/087466a0; Ross R., 1910, PREVENTION MALARIA; Rudolph KE, 2014, AM J TROP MED HYG, V90, P882, DOI 10.4269/ajtmh.13-0403; Ruiz-Moreno D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001918; Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89; Semenza JC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003278; Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110; Suk JE, 2014, EUR J PUBLIC HEALTH, V24, P531, DOI 10.1093/eurpub/cku041; Tatem AJ, 2012, PARASITOLOGY, V139, P1816, DOI 10.1017/S0031182012000352; The Bureau of Transportation Statistics, 2015, STATE TRANSPORTATION; Trout A., 2010, Morbidity and Mortality Weekly Report, V59, P577; TRPIS M, 1986, AM J TROP MED HYG, V35, P1263, DOI 10.4269/ajtmh.1986.35.1263; U. S. Census Bureau, 2010, 2010 CENS POP HOUS T; U. S. Census Bureau, 2010, TIG LIN SHAP TIG LIN; U. S. Centers for Disease Control and Prevention, 2016, ZIK VIR DIS US 2015; U. S. Centers for Disease Control and Prevention, 2014, CHIK VIR US 2014; U. S. Department of Transportation Bureau of Transportation Statistics, 2012, CRUIS SHIP STAT; Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215; Vazquez-Prokopec GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058802; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Wesolowski A, 2015, P NATL ACAD SCI USA, V112, P11887, DOI 10.1073/pnas.1504964112; World Health Organization (WHO), 2015, DENG SEV DENG FACT S; Xia YC, 2004, AM NAT, V164, P267, DOI 10.1086/422341	78	21	21	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161365	10.1371/journal.pone.0161365	http://dx.doi.org/10.1371/journal.pone.0161365			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532496	Green Published, Green Submitted, gold			2022-12-26	WOS:000381487600088
J	Sakwinska, O; Moine, D; Delley, M; Combremont, S; Rezzonico, E; Descombes, P; Vinyes-Pares, G; Zhang, YM; Wang, PY; Thakkar, SK				Sakwinska, Olga; Moine, Deborah; Delley, Michele; Combremont, Severine; Rezzonico, Enea; Descombes, Patrick; Vinyes-Pares, Gerard; Zhang, Yumei; Wang, Peiyu; Thakkar, Sagar K.			Microbiota in Breast Milk of Chinese Lactating Mothers	PLOS ONE			English	Article							REAL-TIME PCR; BACTERIAL DIVERSITY; MATERNAL WEIGHT; HEALTHY WOMEN; BIFIDOBACTERIA; DELIVERY; FECES; MODE; OLIGOSACCHARIDES; COLLECTION	The microbiota of breast milk from Chinese lactating mothers at different stages of lactation was examined in the framework of a Maternal Infant Nutrition Growth (MING) study investigating the dietary habits and breast milk composition in Chinese urban mothers. We used microbiota profiling based on the sequencing of fragments of 16S rRNA gene and specific qPCR for bifidobacteria, lactobacilli and total bacteria to study microbiota of the entire breast milk collected using standard protocol without aseptic cleansing (n = 60), and the microbiota of the milk collected aseptically (n = 30). We have also investigated the impact of the delivery mode and the stage of lactation on the microbiota composition. The microbiota of breast milk was dominated by streptococci and staphylococci for both collection protocols and, in the case of standard collection protocol, Acinetobacter sp. While the predominance of streptococci and staphylococci was consistently reported previously for other populations, the abundance of Acinetobacter sp. was reported only once before in a study where milk collection was done without aseptic cleansing of the breast and rejection of foremilk. Higher bacterial counts were found in the milk collected using standard protocol. Bifidobacteria and lactobacilli were present in few samples with low abundance. We observed no effect of the stage of lactation or the delivery mode on microbiota composition. Methodological and geographical differences likely explain the variability in microbiota composition reported to date.	[Sakwinska, Olga; Delley, Michele; Combremont, Severine; Rezzonico, Enea; Thakkar, Sagar K.] Nestle Res Ctr, Lausanne, Switzerland; [Moine, Deborah; Descombes, Patrick] Nestle Inst Hlth Sci, Lausanne, Switzerland; [Vinyes-Pares, Gerard] Nestle Res Ctr Beijing, Beijing, Peoples R China; [Zhang, Yumei; Wang, Peiyu] Peking Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Beijing, Peoples R China; [Rezzonico, Enea] Le Grand Chemin 58, CH-1066 Epalinges, Switzerland	Nestle SA; Nestle SA; Peking University	Sakwinska, O (corresponding author), Nestle Res Ctr, Lausanne, Switzerland.	olga.sakwinska@rdls.nestle.com		Sakwinska, Olga/0000-0002-3142-9542	Nestle Research Center; Nestle Nutrition Institute China	Nestle Research Center(Nestle SA); Nestle Nutrition Institute China(Nestle SA)	OS, GVP, MD, SC, and ST are employees of Nestec Ltd. PD and DM are employees of Nestle Institute of Health Sciences SA. Nestle Research Center and Nestle Nutrition Institute China sponsored the study. We would like to confirm that the funders of the study, Nestle Research Center and Nestle Nutrition Institute China, provided support in the form of salaries for authors (OS, GVP, MD, SC, and ST are employees of Nestec Ltd. and PD and DM are employees of Nestle Institute of Health Sciences SA), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Albesharat R, 2011, SYST APPL MICROBIOL, V34, P148, DOI 10.1016/j.syapm.2010.12.001; Austin S, 2016, NUTRIENTS, V8, DOI 10.3390/nu8060346; Biesbroek G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032942; Cabrera-Rubio R, 2016, J DEV ORIG HLTH DIS, V7, P54, DOI 10.1017/S2040174415001397; Cabrera-Rubio R, 2012, AM J CLIN NUTR, V96, P544, DOI 10.3945/ajcn.112.037382; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Collado MC, 2012, PEDIATR RES, V72, P77, DOI 10.1038/pr.2012.42; CARROLL L, 1979, LANCET, V2, P1186; Collado MC, 2009, LETT APPL MICROBIOL, V48, P523, DOI 10.1111/j.1472-765X.2009.02567.x; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; EIDELMAN AI, 1979, OBSTET GYNECOL, V53, P550; ELMOHANDES AE, 1993, AM J INFECT CONTROL, V21, P226, DOI 10.1016/0196-6553(93)90413-X; Gronlund MM, 2007, CLIN EXP ALLERGY, V37, P1764, DOI 10.1111/j.1365-2222.2007.02849.x; Gueimonde M, 2007, NEONATOLOGY, V92, P64, DOI 10.1159/000100088; Heikkila MP, 2003, J APPL MICROBIOL, V95, P471, DOI 10.1046/j.1365-2672.2003.02002.x; Hunt KM, 2012, APPL ENVIRON MICROB, V78, P4763, DOI 10.1128/AEM.00477-12; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jimenez E, 2008, RES MICROBIOL, V159, P595, DOI 10.1016/j.resmic.2008.09.001; Jimenez E, 2015, J HUM LACT, V31, P406, DOI 10.1177/0890334415585078; Jost T, 2013, BRIT J NUTR, V110, P1253, DOI 10.1017/S0007114513000597; Khodayar-Pardo P, 2014, J PERINATOL, V34, P599, DOI 10.1038/jp.2014.47; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; LIEBHABER M, 1978, J PEDIATR-US, V92, P236, DOI 10.1016/S0022-3476(78)80014-6; Makino H, 2015, BENEF MICROBES, V6, P563, DOI 10.3920/BM2014.0082; Martin R, 2009, APPL ENVIRON MICROB, V75, P965, DOI 10.1128/AEM.02063-08; Martin V, 2012, J HUM LACT, V28, P36, DOI 10.1177/0890334411424729; Matsuki T, 2002, APPL ENVIRON MICROB, V68, P5445, DOI 10.1128/AEM.68.11.5445-5451.2002; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Solis G, 2010, ANAEROBE, V16, P307, DOI 10.1016/j.anaerobe.2010.02.004; Soto A, 2014, J PEDIATR GASTR NUTR, V59, P78, DOI 10.1097/MPG.0000000000000347; Urbaniak C, 2016, MICROBIOME, V4, DOI 10.1186/s40168-015-0145-y; Urbaniak C, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-24; Ward TL, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-116; WEST PA, 1979, J APPL BACTERIOL, V46, P269, DOI 10.1111/j.1365-2672.1979.tb00820.x	37	64	68	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160856	10.1371/journal.pone.0160856	http://dx.doi.org/10.1371/journal.pone.0160856			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529821	Green Published, Green Submitted, gold			2022-12-26	WOS:000381476700028
J	Addepalli, B; Limbach, PA				Addepalli, Balasubrahmanyam; Limbach, Patrick A.			Pseudouridine in the Anticodon of Escherichia coli tRNA(Tyr(Q Psi A)) Is Catalyzed by the Dual Specificity Enzyme RluF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chemical modification; mass spectrometry (MS); RNA modification; transfer RNA (tRNA); translation; CMCT; RluF; acrylonitrile; derivatization; pseudouridine	DESORPTION/IONIZATION MASS-SPECTROMETRY; TRANSFER-RNA; RIBOSOMAL-RNA; MODIFIED NUCLEOSIDES; DIGESTION PRODUCTS; RIBONUCLEIC-ACIDS; TRANSFER RNA(TYR); CRYSTAL-STRUCTURE; SYNTHASE; IDENTIFICATION	Pseudouridine is found in almost all cellular ribonucleic acids (RNAs). Of the multiple characteristics attributed to pseudouridine, making messenger RNAs (mRNAs) highly translatable and non-immunogenic is one such feature that directly implicates this modification in protein synthesis. We report the existence of pseudouridine in the anticodon of Escherichia coli tyrosine transfer RNAs (tRNAs) at position 35. Pseudouridine was verified by multiple detection methods, which include pseudouridine-specific chemical derivatization and gas phase dissociation of RNA during liquid chromatography tandem mass spectrometry (LC-MS/MS). Analysis of total tRNA isolated from E. coli pseudouridine synthase knock-out mutants identified RluF as the enzyme responsible for this modification. Furthermore, the absence of this modification compromises the translational ability of a luciferase reporter gene coding sequence when it is preceded by multiple tyrosine codons. This effect has implications for the translation of mRNAs that are rich in tyrosine codons in bacterial expression systems.	[Addepalli, Balasubrahmanyam; Limbach, Patrick A.] Univ Cincinnati, Dept Chem, Rieveschl Labs Mass Spectrometry, Cincinnati, OH 45221 USA	University System of Ohio; University of Cincinnati	Addepalli, B; Limbach, PA (corresponding author), Univ Cincinnati, Dept Chem, POB 210172, Cincinnati, OH 45221 USA.	balasual@ucmail.uc.edu; Pat.Limbach@uc.edu	Limbach, Patrick/A-9188-2009	Limbach, Patrick/0000-0003-1526-4546; Addepalli, Balasubrahmanyam/0000-0001-6257-7700	NIGMS, National Institutes of Health [R01 GM 058843]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058843] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grant R01 GM 058843 (to P. A. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Addepalli B, 2007, NUCLEIC ACIDS RES, V35, P4453, DOI 10.1093/nar/gkm457; Addepalli B, 2011, J AM SOC MASS SPECTR, V22, P1363, DOI 10.1007/s13361-011-0137-5; Addepalli B, 2015, RNA, V21, P1746, DOI 10.1261/rna.052472.115; Alian A, 2009, J MOL BIOL, V388, P785, DOI 10.1016/j.jmb.2009.03.029; BARE LA, 1986, BIOCHEMISTRY-US, V25, P5825, DOI 10.1021/bi00367a072; Boros G, 2013, J PHOTOCH PHOTOBIO B, V129, P93, DOI 10.1016/j.jphotobiol.2013.09.010; Carlile TM, 2015, METHOD ENZYMOL, V560, P219, DOI 10.1016/bs.mie.2015.03.011; Carlile TM, 2014, NATURE, V515, P143, DOI 10.1038/nature13802; Charette M, 2000, IUBMB LIFE, V49, P341; COHN WE, 1951, NATURE, V167, P483, DOI 10.1038/167483a0; Conrad J, 1999, RNA, V5, P751, DOI 10.1017/S1355838299990167; CUNNINGHAM PR, 1991, BIOCHIMIE, V73, P789, DOI 10.1016/0300-9084(91)90058-9; Czudnochowski N, 2014, NUCLEIC ACIDS RES, V42, P2037, DOI 10.1093/nar/gkt1050; Dai Q, 2007, NUCLEIC ACIDS RES, V35, P6322, DOI 10.1093/nar/gkm657; Davis DR, 1995, NUCLEIC ACIDS RES, V23, P5020, DOI 10.1093/nar/23.24.5020; Davis DR, 1998, J BIOMOL STRUCT DYN, V15, P1121, DOI 10.1080/07391102.1998.10509006; Del Campo M, 2001, RNA, V7, P1603; Durairaj A, 2008, ANAL CHIM ACTA, V623, P117, DOI 10.1016/j.aca.2008.06.027; Durairaj A, 2008, ANAL CHIM ACTA, V612, P173, DOI 10.1016/j.aca.2008.02.026; Durairaj A, 2008, RAPID COMMUN MASS SP, V22, P3727, DOI 10.1002/rcm.3789; Friedt J, 2014, NUCLEIC ACIDS RES, V42, P3857, DOI 10.1093/nar/gkt1331; GOODMAN HM, 1970, EUR J BIOCHEM, V13, P461, DOI 10.1111/j.1432-1033.1970.tb00950.x; Grosjean H, 1997, BIOCHIMIE, V79, P293, DOI 10.1016/S0300-9084(97)83517-1; Gutgsell N, 2000, RNA, V6, P1870, DOI 10.1017/S1355838200001588; Guymon R, 2007, RNA, V13, P396, DOI 10.1261/rna.361607; Hamma T, 2010, J BIOL CHEM, V285, P805, DOI 10.1074/jbc.R109.076893; Hammal T, 2006, CHEM BIOL, V13, P1125, DOI 10.1016/j.chembiol.2006.09.009; Hoang C, 2001, CELL, V107, P929, DOI 10.1016/S0092-8674(01)00618-3; Hossain M, 2007, RNA, V13, P295, DOI 10.1261/rna.272507; Houser WM, 2015, ANAL BIOCHEM, V478, P52, DOI 10.1016/j.ab.2015.03.016; Huang LX, 1998, BIOCHEMISTRY-US, V37, P344, DOI 10.1021/bi971874+; Hur S, 2007, MOL CELL, V26, P189, DOI 10.1016/j.molcel.2007.02.027; KAMMEN HO, 1988, J BIOL CHEM, V263, P2255; Kierzek E, 2014, NUCLEIC ACIDS RES, V42, P3492, DOI 10.1093/nar/gkt1330; Koonin EV, 1996, NUCLEIC ACIDS RES, V24, P2411, DOI 10.1093/nar/24.12.2411; Kramer EB, 2007, RNA, V13, P87, DOI 10.1261/rna.294907; Krivos KL, 2011, RAPID COMMUN MASS SP, V25, P3609, DOI 10.1002/rcm.5266; Lee C, 2007, J BIOL CHEM, V282, P27744, DOI 10.1074/jbc.M704572200; Li MM, 2015, DRUG METAB DISPOS, V43, P1129, DOI 10.1124/dmd.115.064493; LIMBACH PA, 1994, NUCLEIC ACIDS RES, V22, P2183, DOI 10.1093/nar/22.12.2183; Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007; McCleverty CJ, 2007, J MOL BIOL, V373, P1243, DOI 10.1016/j.jmb.2007.08.053; McDonald MK, 2011, BIOCHEMISTRY-US, V50, P426, DOI 10.1021/bi101737z; Meeks LR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008082; Meng ZJ, 2005, ANAL CHEM, V77, P1891, DOI 10.1021/ac048801y; Mengel-Jorgensen J, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf135; Ofengand J, 2001, METHODS, V25, P365, DOI 10.1006/meth.2001.1249; Patteson KG, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.10.e49; Pomerantz SC, 2005, ANAL CHEM, V77, P4687, DOI 10.1021/ac058023p; POMERANTZ SC, 1990, METHOD ENZYMOL, V193, P796, DOI 10.1016/0076-6879(90)93452-Q; Popova AM, 2014, J AM CHEM SOC, V136, P2058, DOI 10.1021/ja412084b; Ramamurthy V, 1999, J BIOL CHEM, V274, P22225, DOI 10.1074/jbc.274.32.22225; Raychaudhuri S, 1999, J BIOL CHEM, V274, P18880, DOI 10.1074/jbc.274.27.18880; Russell SP, 2013, J CHROMATOGR B, V923, P74, DOI 10.1016/j.jchromb.2013.02.010; Spedaliere CJ, 2004, J AM CHEM SOC, V126, P12758, DOI 10.1021/ja046375s; Spenkuch F, 2014, RNA BIOL, V11, P1540, DOI 10.4161/15476286.2014.992278; SZWEYKOWSKAKULINSKA Z, 1992, EMBO J, V11, P1907, DOI 10.1002/j.1460-2075.1992.tb05243.x; Taucher M, 2011, INT J MASS SPECTROM, V304, P91, DOI 10.1016/j.ijms.2010.05.024; Wang WP, 2015, J PHARMACOL EXP THER, V354, P131, DOI 10.1124/jpet.115.225631; WRZESINSKI J, 1995, RNA, V1, P437; Yang CX, 2005, J BIOL CHEM, V280, P6655, DOI 10.1074/jbc.M413288200; ZERFASS K, 1992, NUCLEIC ACIDS RES, V20, P5911, DOI 10.1093/nar/20.22.5911; Zhao XL, 2004, RNA, V10, P996, DOI 10.1261/rna.7110804	63	18	18	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22327	22337		10.1074/jbc.M116.747865	http://dx.doi.org/10.1074/jbc.M116.747865			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27551044	Green Published, hybrid			2022-12-26	WOS:000386332600042
J	Avila-Medina, J; Calderon-Sanchez, E; Gonzalez-Rodriguez, P; Monje-Quiroga, F; Rosado, JA; Castellano, A; Ordonez, A; Smani, T				Avila-Medina, Javier; Calderon-Sanchez, Eva; Gonzalez-Rodriguez, Patricia; Monje-Quiroga, Francisco; Antonio Rosado, Juan; Castellano, Antonio; Ordonez, Antonio; Smani, Tarik			Orai1 and TRPC1 Proteins Co-localize with Ca(V)1.2 Channels to Form a Signal Complex in Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPERATED CALCIUM-ENTRY; RAT CORONARY-ARTERY; CA2+ ENTRY; STORE; STIM1; PATHWAY; INFLUX; VASOCONSTRICTION; INHIBITION; MECHANISMS	Voltage-dependent CaV1.2 L-type Ca2+ channels (LTCC) are the main route for calcium entry in vascular smooth muscle cells (VSMC). Several studies have also determined the relevant role of store-operated Ca2+ channels (SOCC) in vascular tone regulation. Nevertheless, the role of Orai1- and TRPC1-dependent SOCC in vascular tone regulation and their possible interaction with Ca(V)1.2 are still unknown. The current study sought to characterize the co-activation of SOCC and LTCC upon stimulation by agonists, and to determine the possible crosstalk between Orai1, TRPC1, and Ca(V)1.2. Aorta rings and isolated VSMCobtained from wild type or smooth muscle-selective conditional Ca(V)1.2 knock-out (Ca(V)1.2(KO)) mice were used to study vascular contractility, intracellular Ca2+ mobilization, and distribution of ion channels. We found that serotonin (5-HT) or store depletion with thapsigargin (TG) enhanced intracellular free Ca2+ concentration ([Ca2+](i)) and stimulated aorta contraction. These responses were sensitive to LTCC and SOCC inhibitors. Also, 5-HT-and TG-induced responses were significantly attenuated in Ca(V)1.2(KO) mice. Furthermore, hyperpolarization induced with cromakalim or valinomycin significantly reduced both 5-HT and TG responses, whereas these responses were enhanced with LTCC agonist Bay-K-8644. Interestingly, in situ proximity ligation assay revealed that Ca(V)1.2 interacts with Orai1 and TRPC1 in untreated VSMC. These interactions enhanced significantly after stimulation of cells with 5-HT and TG. Therefore, these data indicate for the first time a functional interaction between Orai1, TRPC1, and Ca(V)1.2 channels in VSMC, confirming that upon agonist stimulation, vessel contraction involves Ca2+ entry due to co-activation of Orai1- and TRPC1-dependent SOCC and LTCC.	[Avila-Medina, Javier; Gonzalez-Rodriguez, Patricia; Castellano, Antonio; Smani, Tarik] Univ Seville, CSIC, Hosp Univ Virgen del Rocio, Dept Fisiol Med & Biofis,Inst Biomed Sevilla IBiS, Seville 41013, Spain; [Avila-Medina, Javier; Calderon-Sanchez, Eva; Ordonez, Antonio; Smani, Tarik] Univ Seville, CSIC, Hosp Univ Virgen del Rocio, Grp Fisiopatol Cardiovasc,Inst Biomed Sevilla IBi, Seville 41013, Spain; [Monje-Quiroga, Francisco] Med Univ Vienna, Ctr Physiol & Pharmacol, Dept Neurophysiol & Neuropharmacol, A-1090 Vienna, Austria; [Antonio Rosado, Juan] Univ Extremadura, Dept Fisiol, Caceres 10071, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Medical University of Vienna; Universidad de Extremadura	Smani, T (corresponding author), Hosp Univ Virgen del Rocio, Inst Biomed Sevilla, Grp Fisiopatol Cardiovasc, Lab 113, Ave Manuel Siurot S-N, Seville 41013, Spain.	tasmani@us.es	Rosado, Juan A/H-3488-2015; IBIS, NEUROBIOLOGIA/O-9922-2015; Castellano, Antonio/AAH-8829-2021; Calderón-Sánchez, Eva María/B-5906-2016; Castellano, Antonio/E-6285-2010; Rodriguez, Patricia Gonzalez/AAV-5006-2020; IBIS, CARDIOVASCULAR/P-3910-2015; IBIS, VASCULAR/P-3934-2015; Hajami, Tarik Smani/D-5372-2016	Rosado, Juan A/0000-0002-9749-2325; Castellano, Antonio/0000-0003-3955-5137; Calderón-Sánchez, Eva María/0000-0002-9599-3513; Castellano, Antonio/0000-0003-3955-5137; Rodriguez, Patricia Gonzalez/0000-0002-2561-3984; Hajami, Tarik Smani/0000-0002-1877-7438; Ordonez, Antonio/0000-0002-4344-8660; Avila-Medina, Javier/0000-0002-4044-4840	Spanish Ministry of Economy and Competitiveness [BFU2013-45564-C2-1-P, BFU2013-45564-C2-2-P]; Institute of Carlos III; Cardiovascular Network "RIC" [RD12/0042/0041, PI12/00941]; Andalusia Government [PI-0108-2012, P12-CTS-1965]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Institute of Carlos III; Cardiovascular Network "RIC"; Andalusia Government	This work was supported by grants from the Spanish Ministry of Economy and Competitiveness (BFU2013-45564-C2-1-P; BFU2013-45564-C2-2-P); the Institute of Carlos III and Cardiovascular Network "RIC" (RD12/0042/0041; PI12/00941); and the Andalusia Government (PI-0108-2012; P12-CTS-1965). The authors declare that they have no conflicts of interest with the contents of this article.	Barrett CF, 2008, P NATL ACAD SCI USA, V105, P2157, DOI 10.1073/pnas.0710501105; Beech DJ, 2012, PFLUG ARCH EUR J PHY, V463, P635, DOI 10.1007/s00424-012-1090-2; Berna-Erro A, 2012, ADV EXP MED BIOL, V740, P349, DOI 10.1007/978-94-007-2888-2_15; Bird GS, 2008, METHODS, V46, P204, DOI 10.1016/j.ymeth.2008.09.009; Bolotina VM, 2012, ARTERIOSCL THROM VAS, V32, P1066, DOI 10.1161/ATVBAHA.112.245449; BOLTON TB, 1979, PHYSIOL REV, V59, P606, DOI 10.1152/physrev.1979.59.3.606; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Cheng KT, 2011, ADV EXP MED BIOL, V704, P435, DOI 10.1007/978-94-007-0265-3_24; Derler I, 2013, CELL CALCIUM, V53, P139, DOI 10.1016/j.ceca.2012.11.005; Desai PN, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa8323; Dionisio N, 2015, BBA-MOL CELL RES, V1853, P1145, DOI 10.1016/j.bbamcr.2015.02.014; Dominguez-Rodriguez A, 2012, ARTERIOSCL THROM VAS, V32, P1325, DOI 10.1161/ATVBAHA.111.243014; Fernandez-Tenorio M, 2010, CIRC RES, V106, P1285, DOI 10.1161/CIRCRESAHA.109.213967; Funabashi K, 2010, AM J PHYSIOL-CELL PH, V298, pC786, DOI 10.1152/ajpcell.00469.2009; Hansen P.C., 2006, DEBLURRING IMAGES MA; He XD, 2012, AM J PHYSIOL-GASTR L, V303, pG240, DOI 10.1152/ajpgi.00102.2012; Hofmann F, 2014, PHYSIOL REV, V94, P303, DOI 10.1152/physrev.00016.2013; Hogan PG, 2015, BIOCHEM BIOPH RES CO, V460, P40, DOI 10.1016/j.bbrc.2015.02.110; Kwan HY, 2009, CIRC RES, V104, P670, DOI 10.1161/CIRCRESAHA.108.188748; Mignen O, 2009, J PHYSIOL-LONDON, V587, P4181, DOI 10.1113/jphysiol.2009.174193; Moosmang S, 2003, EMBO J, V22, P6027, DOI 10.1093/emboj/cdg583; NELSON MT, 1995, AM J PHYSIOL-CELL PH, V268, pC799, DOI 10.1152/ajpcell.1995.268.4.C799; Noble D, 2014, CELL CALCIUM, V56, P188, DOI 10.1016/j.ceca.2014.07.003; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Park KM, 2008, AM J PHYSIOL-HEART C, V294, pH1183, DOI 10.1152/ajpheart.01148.2007; RAMPE D, 1992, MOL PHARMACOL, V41, P599; Rodriguez-Moyano M, 2013, CARDIOVASC RES, V100, P297, DOI 10.1093/cvr/cvt196; Saponara S, 2008, EUR J PHARMACOL, V598, P75, DOI 10.1016/j.ejphar.2008.08.016; Smani T, 2002, CARDIOVASC RES, V53, P97, DOI 10.1016/S0008-6363(01)00422-9; Smani T, 2004, NAT CELL BIOL, V6, P113, DOI 10.1038/ncb1089; Smani T, 2008, AM J PHYSIOL-CELL PH, V294, pC1499, DOI 10.1152/ajpcell.00365.2007; Smani T, 2007, CIRC RES, V101, P1194, DOI 10.1161/CIRCRESAHA.107.159053; Smani T, 2011, CLIN EXP PHARMACOL P, V38, P71, DOI 10.1111/j.1440-1681.2010.05466.x; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Song K, 2015, BIOCHEM BIOPH RES CO, V466, P456, DOI 10.1016/j.bbrc.2015.09.049; Spinelli AM, 2016, AM J PHYSIOL-CELL PH, V310, pC402, DOI 10.1152/ajpcell.00355.2015; Tanner MK, 1998, METH MOL B, V91, P85; Vaca L, 2010, CELL CALCIUM, V47, P199, DOI 10.1016/j.ceca.2010.01.002; Wang YJ, 2010, SCIENCE, V330, P105, DOI 10.1126/science.1191086	39	25	25	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					21148	21159		10.1074/jbc.M116.742171	http://dx.doi.org/10.1074/jbc.M116.742171			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27535226	Green Published, hybrid			2022-12-26	WOS:000385406200029
J	Yamazaki, W; Amano, T; Bai, H; Takahashi, M; Kawahara, M				Yamazaki, Wataru; Amano, Tomoko; Bai, Hanako; Takahashi, Masashi; Kawahara, Manabu			The Influence of Polyploidy and Genome Composition on Genomic Imprinting in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRADER-WILLI-SYNDROME; DNA METHYLATION IMPRINTS; PREIMPLANTATION DEVELOPMENT; NUCLEAR TRANSPLANTATION; UNIPARENTAL FETUSES; MOUSE EMBRYOGENESIS; MAMMALIAN-CELLS; SYNDROME REGION; NERVOUS-SYSTEM; AXON GUIDANCE	Genomic imprinting is an epigenetic mechanism that switches the expression of imprinted genes involved in normal embryonic growth and development in a parent-of-origin-specific manner. Changes inDNAmethylation statuses from polyploidization are a well characterized epigenetic modification in plants. However, how changes in ploidy affect both imprinted gene expression and methylation status in mammals remains unclear. To address this, we used quantitative real time PCR to analyze expression levels of imprinted genes in mouse tetraploid fetuses. We used bisulfite sequencing to assess the methylation statuses of differentially methylated regions (DMRs) that regulate imprinted gene expression in triploid and tetraploid fetuses. The nine imprinted genes H19, Gtl2, Dlk1, Igf2r, Grb10, Zim1, Peg3, Ndn, and Ipw were all unregulated; in particular, the expression of Zim1 was more than 10-fold higher, and the expression of Ipw was repressed in tetraploid fetuses. The methylation statuses of four DMRs H19, intergenic (IG), Igf2r, and Snrpn in tetraploid and triploid fetuses were similar to those in diploid fetuses. We also performed allele-specific RT-PCR sequencing to determine the alleles expressing the three imprinted genes Igf2, Gtl2, and Dlk1 in tetraploid fetuses. These three imprinted genes showed monoallelic expression in a parent-of-origin-specific manner. Expression of non-imprinted genes regulating neural cell development significantly decreased in tetraploid fetuses, which might have been associated with unregulated imprinted gene expression. This study provides the first detailed analysis of genomic imprinting in tetraploid fetuses, suggesting that imprinted gene expression is disrupted, but DNA methylation statuses of DMRs are stable following changes in ploidy in mammals.	[Yamazaki, Wataru; Bai, Hanako; Takahashi, Masashi; Kawahara, Manabu] Hokkaido Univ, Res Fac Agr, Lab Anim Genet & Reprod, Kita Ku, Kita 9,Nishi 9, Sapporo, Hokkaido 0608589, Japan; [Amano, Tomoko] Rakuno Gakuen Univ, Coll Agr Food & Environm Sci, Dept Sustainable Agr, Lab Anim Genet, Bunkyodai Midorimachi, Ebetsu, Hokkaido 0698501, Japan	Hokkaido University; Rakuno Gakuen University	Kawahara, M (corresponding author), Hokkaido Univ, Res Fac Agr, Lab Anim Genet & Reprod, Kita Ku, Kita 9,Nishi 9, Sapporo, Hokkaido 0608589, Japan.	k-hara@anim.agr.hokudai.ac.jp	Bai, Hanako/K-4769-2019	Bai, Hanako/0000-0001-9940-1880	Ministry of Education, Culture, Sports, Science and Technology of Japan [16K14587, 15H04579]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-aid for Research on Priority Area to Challenging Exploratory Research 16K14587 (to M. K.) and a Grant-in-aid for Scientific Research (B) 15H04579 (to M. T.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Al Adhami H, 2015, GENOME RES, V25, P353, DOI 10.1101/gr.175919.114; Andreassen PR, 2001, MOL BIOL CELL, V12, P1315, DOI 10.1091/mbc.12.5.1315; Andrieu D, 2003, GENE EXPR PATTERNS, V3, P761, DOI 10.1016/S1567-133X(03)00138-8; Arnaud P, 2006, HUM MOL GENET, V15, P589, DOI 10.1093/hmg/ddi475; Biniszkiewicz D, 2002, MOL CELL BIOL, V22, P2124, DOI 10.1128/MCB.22.7.2124-2135.2002; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; CUELLAR O, 1972, CYTOGENETICS, V11, P508, DOI 10.1159/000130217; Eakin GS, 2005, DEV BIOL, V288, P150, DOI 10.1016/j.ydbio.2005.09.028; Ferguson-Smith AC, 2011, NAT REV GENET, V12, P565, DOI 10.1038/nrg3032; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Gallardo MH, 1999, NATURE, V401, P341, DOI 10.1038/43815; Henckel A, 2012, EMBO J, V31, P606, DOI 10.1038/emboj.2011.425; Hirasawa R, 2008, GENE DEV, V22, P1607, DOI 10.1101/gad.1667008; Hiura H, 2007, FEBS LETT, V581, P1255, DOI 10.1016/j.febslet.2007.02.034; Horii T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08907; Howell CY, 2001, CELL, V104, P829, DOI 10.1016/S0092-8674(01)00280-X; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; KAUFMAN MH, 1989, DEVELOPMENT, V105, P137; KAUFMAN MH, 1990, DEVELOPMENT, V110, P1121; KAUFMAN MH, 1991, HUM REPROD, V6, P8, DOI 10.1093/oxfordjournals.humrep.a137263; Kawahara M, 2007, NAT BIOTECHNOL, V25, P1045, DOI 10.1038/nbt1331; Kono T, 2004, NATURE, V428, P860, DOI 10.1038/nature02402; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Kurihara Y, 2008, DEV BIOL, V313, P335, DOI 10.1016/j.ydbio.2007.10.033; Lee HS, 2001, P NATL ACAD SCI USA, V98, P6753, DOI 10.1073/pnas.121064698; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Li YF, 2011, CELL RES, V21, P466, DOI 10.1038/cr.2011.15; Liu XL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2562; Loebel DAF, 2004, NATURE, V428, P809, DOI 10.1038/428809a; Lutz A M, 1907, Science, V26, P151, DOI 10.1126/science.26.657.151; Mastick GS, 1997, DEVELOPMENT, V124, P1985; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; MCKINNELL RG, 1964, GENETICS, V49, P895; Meixner A, 2000, J CELL BIOL, V151, P1169, DOI 10.1083/jcb.151.6.1169; NICOLSON GL, 1975, J CELL BIOL, V66, P263, DOI 10.1083/jcb.66.2.263; Obata Y, 2014, REPRODUCTION, V147, pH1, DOI 10.1530/REP-13-0359; Obata Y, 2011, J REPROD DEVELOP, V57, P327, DOI 10.1262/jrd.10-145A; Ogawa H, 2006, FEBS LETT, V580, P5377, DOI 10.1016/j.febslet.2006.08.087; Otto SP, 2007, CELL, V131, P452, DOI 10.1016/j.cell.2007.10.022; Peters Jo, 2004, Briefings in Functional Genomics & Proteomics, V2, P320, DOI 10.1093/bfgp/2.4.320; Plasschaert RN, 2014, DEVELOPMENT, V141, P1805, DOI 10.1242/dev.101428; Quinn JC, 1996, GENE DEV, V10, P435, DOI 10.1101/gad.10.4.435; QUINN P, 1985, FERTIL STERIL, V44, P493; QUINN P, 1982, J REPROD FERTIL, V66, P161; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Song QX, 2015, CURR OPIN PLANT BIOL, V24, P101, DOI 10.1016/j.pbi.2015.02.007; Sotomaru Y, 2002, J BIOL CHEM, V277, P12474, DOI 10.1074/jbc.M109212200; Sotomaru Y, 2001, J BIOL CHEM, V276, P26694, DOI 10.1074/jbc.M101367200; Stelzer Y, 2014, NAT GENET, V46, P551, DOI 10.1038/ng.2968; SURANI MAH, 1986, CELL, V45, P127, DOI 10.1016/0092-8674(86)90544-1; Takeo T, 2011, BIOL REPROD, V85, P1066, DOI 10.1095/biolreprod.111.092536; Watrin F, 1997, EUR J HUM GENET, V5, P324, DOI 10.1159/000484784; WEVRICK R, 1994, HUM MOL GENET, V3, P1877, DOI 10.1093/hmg/3.10.1877; Whittingham D G, 1971, J Reprod Fertil Suppl, V14, P7; Yamazaki W, 2015, ZYGOTE, V23, P874, DOI 10.1017/S0967199414000550; Ye A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108596	58	3	3	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					20924	20931		10.1074/jbc.M116.744144	http://dx.doi.org/10.1074/jbc.M116.744144			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27531747	Green Published, hybrid			2022-12-26	WOS:000385406200011
J	Thibault, K; Riviere, S; Lenkei, Z; Ferezou, I; Pezet, S				Thibault, Karine; Riviere, Sebastien; Lenkei, Zsolt; Ferezou, Isabelle; Pezet, Sophie			Orofacial Neuropathic Pain Leads to a Hyporesponsive Barrel Cortex with Enhanced Structural Synaptic Plasticity	PLOS ONE			English	Article							PRIMARY SOMATOSENSORY CORTEX; CORTICAL REORGANIZATION; NEURONAL-ACTIVITY; SPINAL-CORD; PERIPHERAL MONONEUROPATHY; TRIGEMINAL NEURALGIA; CONSTRICTION INJURY; INFRAORBITAL NERVE; MOUSE MODEL; RAT MODEL	Chronic pain is a long-lasting debilitating condition that is particularly difficult to treat due to the lack of identified underlying mechanisms. Although several key contributing processes have been described at the level of the spinal cord, very few studies have investigated the supraspinal mechanisms underlying chronic pain. Using a combination of approaches (cortical intrinsic imaging, immunohistochemical and behavioural analysis), our study aimed to decipher the nature of functional and structural changes in a mouse model of orofacial neuropathic pain, focusing on cortical areas involved in various pain components. Our results show that chronic neuropathic orofacial pain is associated with decreased haemodynamic responsiveness to whisker stimulation in the barrel field cortex. This reduced functional activation is likely due to the increased basal neuronal activity (measured indirectly using cFos and phospho-ERK immunoreactivity) observed in several cortical areas, including the contralateral barrel field, motor and cingulate cortices. In the same animals, immunohistochemical analysis of markers for active pre-or postsynaptic elements (Piccolo and phosphoCofilin, respectively) revealed an increased immunofluorescence in deep cortical layers of the contralateral barrel field, motor and cingulate cortices. These results suggest that longlasting orofacial neuropathic pain is associated with exacerbated neuronal activity and synaptic plasticity at the cortical level.	[Thibault, Karine; Riviere, Sebastien; Lenkei, Zsolt; Ferezou, Isabelle; Pezet, Sophie] PSL Res Univ, ESPCI, Brain Plast Unit, 10 Rue Vauquelin, F-75005 Paris, France; [Thibault, Karine; Riviere, Sebastien; Lenkei, Zsolt; Ferezou, Isabelle; Pezet, Sophie] CNRS, UMR 8249, F-75005 Paris, France; [Riviere, Sebastien] Univ Bourgogne, UMR INRA 1324, UMR CNRS 6265, Ctr Sci Gout & Alimentat, 9E Blvd Jeanne Arc, F-21000 Dijon, France; [Ferezou, Isabelle] CNRS, FRE 3693, Unit Neurosci Informat & Complex, Gif Sur Yvette, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay	Pezet, S (corresponding author), PSL Res Univ, ESPCI, Brain Plast Unit, 10 Rue Vauquelin, F-75005 Paris, France.; Pezet, S (corresponding author), CNRS, UMR 8249, F-75005 Paris, France.	sophie.pezet@espci.fr	Lenkei, Zsolt/G-4369-2013; PEZET, sophie/AAR-1239-2021	Lenkei, Zsolt/0000-0002-1142-5931; PEZET, sophie/0000-0002-3305-3315; Ferezou, Isabelle/0000-0001-7602-1295	Centre National pour la Recherche Scientifique (CNRS); Ecole Superieure de Physique et Chimie Industrielles de la mairie de Paris, ParisTech	Centre National pour la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Ecole Superieure de Physique et Chimie Industrielles de la mairie de Paris, ParisTech	This work was supported by the Centre National pour la Recherche Scientifique (CNRS) and the Ecole Superieure de Physique et Chimie Industrielles de la mairie de Paris, ParisTech. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work has been supported by the Centre National pour la Recherche Scientifique (CNRS) and the Ecole Superieure de Physique et Chimie Industrielles de la mairie de Paris, ParisTech. The authors thank Mr. Marcel Leopoldie for animal husbandry and Brandon Loveall of Improvence for English proofreading of the manuscript.	ABBADIE C, 1992, NEUROSCIENCE, V48, P985, DOI 10.1016/0306-4522(92)90287-C; Abbadie C, 2009, BRAIN RES REV, V60, P125, DOI 10.1016/j.brainresrev.2008.12.002; Anderson EM, 2013, JOVE-J VIS EXP, DOI 10.3791/50336; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Apkarian AV, 2004, J NEUROSCI, V24, P10410, DOI 10.1523/JNEUROSCI.2541-04.2004; Baliki MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026010; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; Becerra L, 2006, J NEUROSCI, V26, P10646, DOI 10.1523/JNEUROSCI.2305-06.2006; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Bennetto L, 2007, BMJ-BRIT MED J, V334, P201, DOI 10.1136/bmj.39085.614792.BE; Benoist JM, 1999, EXP BRAIN RES, V126, P383, DOI 10.1007/s002210050745; Braz JM, 2010, PAIN, V150, P290, DOI 10.1016/j.pain.2010.05.005; Cha MH, 2009, NEUROSCI LETT, V464, P117, DOI 10.1016/j.neulet.2009.08.024; Cha M, 2012, BEHAV BRAIN RES, V234, P82, DOI 10.1016/j.bbr.2012.06.020; Chen LY, 2007, J NEUROSCI, V27, P5363, DOI 10.1523/JNEUROSCI.0164-07.2007; CLAVELOU P, 1995, PAIN, V62, P295, DOI 10.1016/0304-3959(94)00273-H; Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; DaSilva AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003396; De Gois S, 2005, J NEUROSCI, V25, P7121, DOI 10.1523/JNEUROSCI.5221-04.2005; DeSouza DD, 2014, PAIN, V155, P37, DOI 10.1016/j.pain.2013.08.029; Fenster SD, 2000, NEURON, V25, P203, DOI 10.1016/S0896-6273(00)80883-1; Flor H, 1997, NEUROSCI LETT, V224, P5, DOI 10.1016/S0304-3940(97)13441-3; FLOR H, 1995, NATURE, V375, P482, DOI 10.1038/375482a0; Frangeul L, 2014, EUR J NEUROSCI, V39, P1455, DOI 10.1111/ejn.12524; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; Gracely RH, 2004, BRAIN, V127, P835, DOI 10.1093/brain/awh098; Gu JP, 2010, NAT NEUROSCI, V13, P1208, DOI 10.1038/nn.2634; Guo D, 2014, NEUROSCIENCE, V283, P95, DOI 10.1016/j.neuroscience.2014.09.032; Gustin RM, 2010, NEUROBIOL DIS, V39, P283, DOI 10.1016/j.nbd.2010.04.012; Gustin SM, 2014, PLOS ONE, P9, DOI [10.1371/ journal.none.0109664, DOI 10.1371/J0URNAL.P0NE.0109664]; Gustin SM, 2013, J PAIN, V14, P1642, DOI 10.1016/j.jpain.2013.08.005; Gustin SM, 2012, J NEUROSCI, V32, P14874, DOI 10.1523/JNEUROSCI.1733-12.2012; Gustin SM, 2011, J NEUROSCI, V31, P5956, DOI 10.1523/JNEUROSCI.5980-10.2011; Hayes DJ, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-60; Hu HJ, 2007, J NEUROSCI, V27, P13181, DOI 10.1523/JNEUROSCI.0269-07.2007; Hubbard CS, 2015, NEUROIMAGE, V107, P333, DOI 10.1016/j.neuroimage.2014.12.024; Imamura Y, 1997, EXP BRAIN RES, V116, P97, DOI 10.1007/PL00005748; Ji RR, 1999, NAT NEUROSCI, V2, P1114, DOI 10.1038/16040; Ji RR, 2003, TRENDS NEUROSCI, V26, P696, DOI 10.1016/j.tins.2003.09.017; Jones EG, 2009, ANN NY ACAD SCI, V1157, P10, DOI 10.1111/j.1749-6632.2009.04534.x; Juottonen K, 2002, PAIN, V98, P315, DOI 10.1016/S0304-3959(02)00119-7; KAJANDER KC, 1992, J NEUROPHYSIOL, V68, P734, DOI 10.1152/jn.1992.68.3.734; Karim F, 2001, J NEUROSCI, V21, P3771, DOI 10.1523/JNEUROSCI.21-11-03771.2001; Kawai HD, 2013, SYNAPSE, V67, P455, DOI 10.1002/syn.21647; Kim SK, 2011, J NEUROSCI, V31, P5477, DOI 10.1523/JNEUROSCI.0328-11.2011; Kitagawa J, 2006, EUR J NEUROSCI, V24, P1976, DOI 10.1111/j.1460-9568.2006.05065.x; Krzyzanowska A, 2011, J NEUROSCI METH, V201, P46, DOI 10.1016/j.jneumeth.2011.07.006; Lam David K, 2005, Pain Res Manag, V10, P145; LAMOUR Y, 1983, EXP BRAIN RES, V49, P46; Lazarevic V, 2011, J NEUROSCI, V31, P10189, DOI 10.1523/JNEUROSCI.2088-11.2011; LEE SM, 2015, FRONT HUM NEUROSCI, V9, DOI DOI 10.3389/FNINS.2015.00462; Lin CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094300; Ma F, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-44; Maihofner C, 2004, NEUROLOGY, V63, P693, DOI 10.1212/01.WNL.0000134661.46658.B0; MAO JR, 1993, J NEUROSCI, V13, P2689, DOI 10.1523/JNEUROSCI.13-06-02689.1993; Marchand F, 2005, NAT REV NEUROSCI, V6, P521, DOI 10.1038/nrn1700; Moulder KL, 2004, NEURON, V42, P423, DOI 10.1016/S0896-6273(04)00184-9; Nemoto M, 2004, J NEUROSCI; Neubert JK, 2005, PAIN, V116, P386, DOI 10.1016/j.pain.2005.05.011; Nolan TA, 2011, BEHAV BRAIN RES, V217, P477, DOI 10.1016/j.bbr.2010.10.022; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Pattany PM, 2002, AM J NEURORADIOL, V23, P901; Paulson PE, 2002, PAIN, V95, P31, DOI 10.1016/S0304-3959(01)00370-0; Paxinos G, 2012, PAXINOS FRANKLINS MO; Pelissier T, 2002, PAIN, V96, P81, DOI 10.1016/S0304-3959(01)00432-8; Pezet S, 2002, MOL CELL NEUROSCI, V21, P684, DOI 10.1006/mcne.2002.1205; Pirttimaki TM, 2011, J NEUROSCI, V31, P7637, DOI 10.1523/JNEUROSCI.5783-10.2011; Pleger B, 2006, NEUROIMAGE, V32, P503, DOI 10.1016/j.neuroimage.2006.03.045; Pontrello CG, 2012, P NATL ACAD SCI USA, V109, pE442, DOI 10.1073/pnas.1118803109; Pozo K, 2010, NEURON, V66, P337, DOI 10.1016/j.neuron.2010.04.028; Rex CS, 2007, J NEUROSCI, V27, P3017, DOI 10.1523/JNEUROSCI.4037-06.2007; Rossi HL, 2012, NEUROSCIENCE, V224, P294, DOI 10.1016/j.neuroscience.2012.08.015; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Sheth S, 2003, NEUROIMAGE, V19, P884, DOI 10.1016/S1053-8119(03)00086-7; Staiger JF, 2000, NEUROSCIENCE, V99, P7, DOI 10.1016/S0306-4522(00)00166-4; Swart CMA, 2009, EUR J PAIN, V13, P902, DOI 10.1016/j.ejpain.2008.11.010; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; Thibault K, 2014, J NEUROSCI, V34, P14739, DOI 10.1523/JNEUROSCI.0860-14.2014; Tracey I, 2005, CURR OPIN NEUROBIOL, V15, P478, DOI 10.1016/j.conb.2005.06.010; Treede RD, 1999, PAIN, V79, P105, DOI 10.1016/S0304-3959(98)00184-5; Tsubota T, 2015, COFILIN1 CONTROLS TR, P1, DOI [10.1371/journal.pbio.1002070content/23/6/901.short, DOI 10.1371/JOURNAL.PBIO.1002070CONTENT/23/6/901.SHORT]; Tsujino H, 2000, MOL CELL NEUROSCI, V15, P170, DOI 10.1006/mcne.1999.0814; Vartiainen N, 2009, J PAIN, V10, P854, DOI 10.1016/j.jpain.2009.02.006; Vogt BA, CYTOARCHITECTURE MOU, DOI [10.1007/s00429-012-0493-3, DOI 10.1007/S00429-012-0493-3]; VOS BP, 1994, J NEUROSCI, V14, P2708; Wierenga CJ, 2005, J NEUROSCI, V25, P2895, DOI 10.1523/JNEUROSCI.5217-04.2005; Xu M, 2008, J PAIN, V9, P1036, DOI 10.1016/j.jpain.2008.06.006; Zakrzewska JM, 2011, POSTGRAD MED J, V87, P410, DOI 10.1136/pgmj.2009.080473; Zhang ZW, 1997, J NEUROSCI, V17, P6365	89	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0160786	10.1371/journal.pone.0160786	http://dx.doi.org/10.1371/journal.pone.0160786			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548330	Green Published, Green Submitted, gold			2022-12-26	WOS:000381768400021
J	Xiong, L; Lu, YJ; Zhang, YF; Zhang, XG; Gupta, P				Xiong, Li; Lu, Yan-Jun; Zhang, Yong-Fang; Zhang, Xin-Guo; Gupta, Parag			Design and Hardware Implementation of a New Chaotic Secure Communication Technique	PLOS ONE			English	Article							NONLINEAR-SYSTEMS; SYNCHRONIZATION; CIRCUIT; OSCILLATORS; REALIZATION; HYPERCHAOS; STATE	In this paper, a scheme for chaotic modulation secure communication is proposed based on chaotic synchronization of an improved Lorenz system. For the first time, the intensity limit and stability of the transmitted signal, the characteristics of broadband and the requirements for accuracy of electronic components are presented by Multisim simulation. In addition, some improvements are made on the measurement method and the proposed experimental circuit in order to facilitate the experiments of chaotic synchronization, chaotic non-synchronization, experiment without signal and experiment with signal. To illustrate the effectiveness of the proposed scheme, some numerical simulations are presented. Then, the proposed chaotic secure communication circuit is implemented through analog electronic circuit, which is characterized by its high accuracy and good robustness.	[Xiong, Li; Lu, Yan-Jun] Xian Univ Technol, Sch Mech & Precis Instrument Engn, Xian 710048, Peoples R China; [Xiong, Li] Hexi Univ, Sch Phys & Electromech Engn, Zhangye 734000, Peoples R China; [Zhang, Yong-Fang] Xian Univ Technol, Sch Printing Packaging Engn & Digital Media, Xian 710048, Peoples R China; [Zhang, Xin-Guo] Lanzhou Univ, Sch Informat Sci & Engn, Lanzhou 730000, Peoples R China; [Gupta, Parag] Northwestern Univ, Robert R McCormick Sch Engn & Appl Sci, Evanston, IL 60208 USA	Xi'an University of Technology; Hexi University; Xi'an University of Technology; Lanzhou University; Northwestern University	Lu, YJ (corresponding author), Xian Univ Technol, Sch Mech & Precis Instrument Engn, Xian 710048, Peoples R China.	yanjunlu@xaut.edu.cn	Gupta, Parag/P-8425-2017	Gupta, Parag/0000-0001-6618-2132	National Natural Science Foundation of China [51505375]; Open Project of State Key Laboratory of Mechanical Transmission [SKLMT-KFKT-201510]; Scientific Research Program of Shanxi Provincial Education Department of China [15JS068, 15JK1549]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Project of State Key Laboratory of Mechanical Transmission; Scientific Research Program of Shanxi Provincial Education Department of China	The authors are greatly thankful for the help and support from the National Natural Science Foundation of China (Grant No. 51505375), Open Project of State Key Laboratory of Mechanical Transmission (Grant No. SKLMT-KFKT-201510), Scientific Research Program of Shanxi Provincial Education Department of China (15JS068, 15JK1549).	Boutayeb M, 2002, IEEE T CIRCUITS-I, V49, P345, DOI 10.1109/81.989169; Carbajal-Gomez VH, 2013, APPL MATH COMPUT, V219, P8163, DOI 10.1016/j.amc.2013.01.072; Chen G., 2003, DYNAMICAL ANAL CONTR; Chen HC, 2013, SENSORS-BASEL, V13, P2494, DOI 10.3390/s130202494; CUOMO KM, 1993, PHYS REV LETT, V71, P65, DOI 10.1103/PhysRevLett.71.65; CUOMO KM, 1993, IEEE T CIRCUITS-II, V40, P626, DOI 10.1109/82.246163; El-Sayed AMA, 2014, APPL MATH COMPUT, V239, P333, DOI 10.1016/j.amc.2014.04.109; Feng CW, 2015, J COMPUT NONLIN DYN, V10, DOI 10.1115/1.4029227; Filali RL, 2014, COMMUN NONLINEAR SCI, V19, P1424, DOI 10.1016/j.cnsns.2013.09.005; Galias Z, 2001, IEEE T CIRCUITS-I, V48, P1510, DOI 10.1109/TCSI.2001.972858; Garza-Gonzalez E, 2016, REV MEX FIS, V62, P51; Ge SS, 2014, IEEE T AUTOMAT CONTR, V59, P1624, DOI 10.1109/TAC.2013.2294826; de la Fraga LG, 2014, NONLINEAR DYNAM, V76, P1503, DOI 10.1007/s11071-013-1224-x; Halimi M, 2014, APPL MATH INFORM SCI, V8, P1509, DOI 10.12785/amis/080404; Kiani-B A, 2009, COMMUN NONLINEAR SCI, V14, P863, DOI 10.1016/j.cnsns.2007.11.011; Li F, 2016, NONLINEAR DYNAM, V84, P2305, DOI 10.1007/s11071-016-2646-z; Li F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154282; Li SJ, 2005, CHAOS SOLITON FRACT, V25, P109, DOI 10.1016/j.chaos.2004.09.077; Lin TC, 2015, INT J FUZZY SYST, V17, P206, DOI 10.1007/s40815-015-0024-5; [刘玉民 LIU Yu-min], 2009, [电路与系统学报, Journal of Circuits and Systems], V14, P116; Lu JH, 2002, INT J BIFURCAT CHAOS, V12, P2917, DOI 10.1142/S021812740200631X; Mbe ESK, 2014, CHAOS SOLITON FRACT, V61, P27, DOI 10.1016/j.chaos.2014.02.004; Merah L., 2013, APPL MATH SCI, V7, P237; Milanovic V, 1996, ELECTRON LETT, V32, P11, DOI 10.1049/el:19960004; Munoz-Pacheco JM, 2014, INT J ELECTRON, V101, P1559, DOI 10.1080/00207217.2014.880999; Muthuswamy B, 2010, INT J BIFURCAT CHAOS, V20, P1567, DOI 10.1142/S0218127410027076; Ni W., 2005, COMPUTER MODERNIZATI, V64, P96; Nunez JC, 2015, IEEE LAT AM T, V13, P2865, DOI 10.1109/TLA.2015.7350032; PECORA LM, 1990, PHYS REV LETT, V64, P821, DOI 10.1103/PhysRevLett.64.821; Pehlivan I, 2014, J SOUND VIB, V333, P5077, DOI 10.1016/j.jsv.2014.05.025; Rahul Ekhande, 2014, INT J ENG RES, V3, P458; Rui WB, 2014, CHINESE PHYS B, V23, DOI 10.1088/1674-1056/23/10/107502; Sanchez-Lopez C, 2010, NONLINEAR DYNAM, V61, P331, DOI 10.1007/s11071-009-9652-3; Sira-Ramirez H, 2001, INT J BIFURCAT CHAOS, V11, P1381, DOI 10.1142/S0218127401002778; Soriano-Sanchez AG, 2016, APPL MATH COMPUT, V275, P305, DOI 10.1016/j.amc.2015.11.081; Swathy PS, 2014, NONLINEAR DYNAM, V78, P2639, DOI 10.1007/s11071-014-1615-7; Tlelo-Cuautle E, 2015, NONLINEAR DYNAM, V82, P1879, DOI 10.1007/s11071-015-2284-x; Tlelo-Cuautle E, 2015, COMMUN NONLINEAR SCI, V27, P66, DOI 10.1016/j.cnsns.2015.03.003; Trejo-Guerra R, 2013, INT J CIRC THEOR APP, V41, P831, DOI 10.1002/cta.821; Trejo-Guerra R, 2012, COMMUN NONLINEAR SCI, V17, P4328, DOI 10.1016/j.cnsns.2012.01.029; Trejo-Guerra R, 2009, INT J BIFURCAT CHAOS, V19, P4217, DOI 10.1142/S0218127409025304; Yan XG, 2002, T I MEAS CONTROL, V24, P263, DOI 10.1191/0142331202tm06loa; Yan XG, 2008, IEEE T IND ELECTRON, V55, P4029, DOI 10.1109/TIE.2008.2003367; Zapateiro M, 2014, COMMUN NONLINEAR SCI, V19, P991, DOI 10.1016/j.cnsns.2013.07.029; Zhang X., 2011, NONLINEAR CIRCUIT BA; Zhang X. G., 2014, ACTA PHYS SINICA, V63, P1	46	24	24	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0158348	10.1371/journal.pone.0158348	http://dx.doi.org/10.1371/journal.pone.0158348			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548385	Green Published, Green Submitted, gold			2022-12-26	WOS:000381768400004
J	Chen, SM; Li, YY; Tu, CH; Salazar, N; Tseng, YY; Huang, SF; Hsieh, LL; Lui, TN				Chen, Shu-Mei; Li, Ying-Ying; Tu, Chiao-Hui; Salazar, Nicole; Tseng, Yuan-Yun; Huang, Shiang-Fu; Hsieh, Ling-Ling; Lui, Tai-Ngar			Blockade of Inhibitors of Apoptosis Proteins in Combination with Conventional Chemotherapy Leads to Synergistic Antitumor Activity in Medulloblastoma and Cancer Stem-Like Cells	PLOS ONE			English	Article							MALIGNANT GLIOMA-CELLS; NERVOUS-SYSTEM TUMORS; ADJUVANT CHEMOTHERAPY; RISK MEDULLOBLASTOMA; PEDIATRIC-ONCOLOGY; RADIATION-THERAPY; RANDOMIZED-TRIAL; IN-VITRO; AUTOPHAGY; RADIOTHERAPY	Background Medulloblastoma (MB) is the most common pediatric primary malignant brain tumor. Approximately one-third of MB patients succumb to treatment failure and some survivors suffer detrimental side effects. Hence, the purpose of this study is to explore new therapeutic regimens to overcome chemotherapeutic agent resistance or reduce chemotherapy-induced toxicity. Methods We detected the expression of inhibitors of apoptosis proteins (IAPs) in MB and CD133+MB cell lines and MB tissues using immunoblotting and immunohistochemical staining. The antitumor effects of inhibitors against IAPs on MB or CD133+ MB cells were evaluated by MTT assay, Annexin V/PI analysis, and caspase-3/7 activity. Autophagy was assessed by the conversion of light chain (LC) 3-I to LC3-II and Cyto-ID autophagy detection kit. Results MB cells showed higher expression of IAPs compared to normal astrocytes and normal brain tissues. Conventional chemotherapeutic agents combined with small-molecule IAP inhibitors (LCL161 or LBW242) showed a synergistic effect in MB cells. Combined treatments triggered apoptosis in MB cells through activation of caspase-3/7 and autophagic flux simultaneously. In addition, we found that CD133+ MB cells with features of cancer stem cells displayed higher levels of X-linked inhibitor of apoptosis (XIAP) and cellular inhibitor of apoptosis 1/2 (cIAP1/2), and were hypersensitive to treatment with IAP inhibitors. Conclusions These results shed light on the biological effects of combination therapy on MB cells and illustrate that IAP inhibitors are more effective for CD133+ stem-like MB cells.	[Chen, Shu-Mei] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Chen, Shu-Mei; Tu, Chiao-Hui; Lui, Tai-Ngar] Taipei Med Univ, Wan Fang Hosp, Dept Neurosurg, Taipei, Taiwan; [Li, Ying-Ying; Salazar, Nicole] Univ Miami, Miller Sch Med, Sheila & David Fuente Grad Program Canc Biol, Miami, FL USA; [Tseng, Yuan-Yun] Taipei Med Univ, Shuang Ho Hosp, Dept Neurosurg, Taipei, Taiwan; [Tseng, Yuan-Yun; Lui, Tai-Ngar] Taipei Med Univ, Coll Med, Sch Med, Dept Surg, Taipei, Taiwan; [Huang, Shiang-Fu; Hsieh, Ling-Ling] Chang Gung Univ, Coll Med, Dept Publ Hlth, Taoyuan, Taiwan; [Huang, Shiang-Fu] Chang Gung Univ, Chang Gung Mem Hosp, Dept Otolaryngol Head & Neck Surg, Taoyuan, Taiwan	Chang Gung University; Taipei Medical University; Taipei Municipal WanFang Hospital; University of Miami; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Lui, TN (corresponding author), Taipei Med Univ, Wan Fang Hosp, Dept Neurosurg, Taipei, Taiwan.; Lui, TN (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Surg, Taipei, Taiwan.; Hsieh, LL (corresponding author), Chang Gung Univ, Coll Med, Dept Publ Hlth, Taoyuan, Taiwan.	aaanray@yahoo.com.tw; 99318@w.tmu.edu.tw	Salazar, Nicole/I-6467-2019	Salazar, Nicole/0000-0002-8658-6553; Tseng, Yuan Yun/0000-0003-4968-3298	Wan Fang Hospital, Taipei Medical University, Taiwan [100-wf-phd-02, 101-wf-phd-04]; Taipei Medical University, Taiwan [TMU99-AE1-B24]	Wan Fang Hospital, Taipei Medical University, Taiwan; Taipei Medical University, Taiwan	This work was supported by Wan Fang Hospital, Taipei Medical University, Taiwan (grant no. 100-wf-phd-02 and 101-wf-phd-04) and Taipei Medical University, Taiwan (grant no. TMU99-AE1-B24). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Blazek ER, 2007, INT J RADIAT ONCOL, V67, P1, DOI 10.1016/j.ijrobp.2006.09.037; Brown JM, 2005, NAT REV CANCER, V5, P231, DOI 10.1038/nrc1560; Chauhan D, 2007, BLOOD, V109, P1220, DOI 10.1182/blood-2006-04-015149; Chawla-Sarkar M, 2004, CELL DEATH DIFFER, V11, P915, DOI 10.1038/sj.cdd.4401416; Chen YJ, 2008, SITIS 2008: 4TH INTERNATIONAL CONFERENCE ON SIGNAL IMAGE TECHNOLOGY AND INTERNET BASED SYSTEMS, PROCEEDINGS, P3, DOI 10.1109/SITIS.2008.31; Elmore SP, 2001, FASEB J, V15, P2286, DOI 10.1096/fj.01-0206fje; Frasson C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/973912; Gaither A, 2007, CANCER RES, V67, P11493, DOI 10.1158/0008-5472.CAN-07-5173; Gidding CEM, 1999, CRIT REV ONCOL HEMAT, V29, P267, DOI 10.1016/S1040-8428(98)00023-7; Gurney JG, 2001, CURR OPIN ONCOL, V13, P160, DOI 10.1097/00001622-200105000-00005; He W, 2014, ONCOGENE, V33, P3004, DOI 10.1038/onc.2013.256; Huang X, 2013, EMBO J, V32, P2204, DOI 10.1038/emboj.2013.133; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Jozwiak J, 2007, MED RES REV, V27, P869, DOI 10.1002/med.20088; Kanzawa T, 2003, CANCER RES, V63, P2103; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Keating J, 2012, MOL CANCER THER, V11, P2654, DOI 10.1158/1535-7163.MCT-12-0352; Kortmann RD, 2000, INT J RADIAT ONCOL, V46, P269, DOI 10.1016/S0360-3016(99)00369-7; Kumar D, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-171; Lannering B, 2012, J CLIN ONCOL, V30, P3187, DOI 10.1200/JCO.2011.39.8719; LEGHA SS, 1986, MED TOXICOL ADV DRUG, V1, P421, DOI 10.1007/BF03259853; Lin F, 2015, HUM MOL GENET, V24, P2899, DOI 10.1093/hmg/ddv052; LOEHRER PJ, 1984, ANN INTERN MED, V100, P704, DOI 10.7326/0003-4819-100-5-704; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Massimino M, 2012, J NEURO-ONCOL, V108, P163, DOI 10.1007/s11060-012-0822-7; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Odagiri K, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-201; Onodera J, 2005, J BIOL CHEM, V280, P31582, DOI 10.1074/jbc.M506736200; PACKER RJ, 1994, J NEUROSURG, V81, P690, DOI 10.3171/jns.1994.81.5.0690; Packer RJ, 1999, J CLIN ONCOL, V17, P2127, DOI 10.1200/JCO.1999.17.7.2127; Packer RJ, 2013, NEURO-ONCOLOGY, V15, P97, DOI 10.1093/neuonc/nos267; Paglin S, 2001, CANCER RES, V61, P439; Pui CH, 2011, NAT REV CLIN ONCOL, V8, P540, DOI 10.1038/nrclinonc.2011.95; Raso A, 2008, NEUROPATH APPL NEURO, V34, P306, DOI 10.1111/j.1365-2990.2007.00896.x; Rood BR, 2004, SEMIN ONCOL, V31, P666, DOI 10.1053/j.seminoncol.2004.07.009; Rutkauskiene Giedre, 2005, Medicina (Kaunas), V41, P1026; Shu Q, 2008, STEM CELLS, V26, P1414, DOI 10.1634/stemcells.2007-1009; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Tarbell NJ, 2013, J CLIN ONCOL, V31, P2936, DOI 10.1200/JCO.2012.43.9984; Taylor RE, 2005, EUR J CANCER, V41, P727, DOI 10.1016/j.ejca.2004.12.017; Tian AP, 2014, CANCER LETT, V351, P232, DOI 10.1016/j.canlet.2014.06.006; Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777; Vogler M, 2008, CANCER RES, V68, P7956, DOI 10.1158/0008-5472.CAN-08-1296; Wan F, 2010, BRAIN PATHOL, V20, P877, DOI 10.1111/j.1750-3639.2010.00379.x; Weisberg E, 2007, MOL CANCER THER, V6, P1951, DOI 10.1158/1535-7163.MCT-06-0810; Yao X, 2007, AM J MED SCI, V334, P115, DOI 10.1097/MAJ.0b013e31812dfe1e; Yu CC, 2010, CHILD NERV SYST, V26, P897, DOI 10.1007/s00381-010-1087-0; Zanini C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063748; Ziegler DS, 2008, J CLIN INVEST, V118, P3109, DOI 10.1172/JCI34120; Ziegler DS, 2011, NEURO-ONCOLOGY, V13, P820, DOI 10.1093/neuonc/nor066	53	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161299	10.1371/journal.pone.0161299	http://dx.doi.org/10.1371/journal.pone.0161299			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537345	Green Submitted, Green Published, gold			2022-12-26	WOS:000381577000085
J	Eadie, LN; Hughes, TP; White, DL				Eadie, Laura N.; Hughes, Timothy P.; White, Deborah L.			ABCB1 Overexpression Is a Key Initiator of Resistance to Tyrosine Kinase Inhibitors in CML Cell Lines	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; CHRONIC MYELOGENOUS LEUKEMIA; BCR-ABL INHIBITORS; IMATINIB MESYLATE; CHRONIC-PHASE; LYN KINASE; CLINICAL RESISTANCE; TRANSPORTERS ABCB1; GENE-EXPRESSION; P-GLYCOPROTEIN	The tyrosine kinase inhibitor (TKI) imatinib has resulted in excellent responses in the majority of Chronic Myeloid Leukaemia (CML) patients; however, resistance is observed in 20-30% of patients. More recently, resistance to the second generation TKIs, nilotinib and dasatinib, has also been observed albeit at a lower incidence. ABCB1 has previously been implicated in TKI export and its overexpression linked to TKI resistance. In this study the dynamics of nilotinib resistance was studied in CML cell lines with particular focus on ABCB1 expression levels during development of resistance. Results revealed ABCB1 overexpression is likely an important initiator of nilotinib resistance in vitro. ABCB1 overexpression was also observed in cell lines as an intermediate step during development of resistance to imatinib and dasatinib in vitro. We conclude that ABCB1 overexpression may provide an initial platform to facilitate development of additional mechanisms for resistance to TKIs. This provides a rationale for investigating this phenomenon in patients undergoing TKI therapy.	[Eadie, Laura N.; Hughes, Timothy P.; White, Deborah L.] South Australian Hlth & Med Res Inst, Canc Theme, Adelaide, SA, Australia; [Eadie, Laura N.; Hughes, Timothy P.; White, Deborah L.] Univ Adelaide, Dept Med, Adelaide, SA, Australia; [White, Deborah L.] Univ Adelaide, Dept Paediat, Adelaide, SA, Australia; [Hughes, Timothy P.] SA Pathol, Div Haematol, Adelaide, SA, Australia; [Hughes, Timothy P.] Ctr Canc Biol, Adelaide, SA, Australia	South Australian Health & Medical Research Institute (SAHMRI); University of Adelaide; University of Adelaide; SA Pathology; Centre for Cancer Biology	White, DL (corresponding author), South Australian Hlth & Med Res Inst, Canc Theme, Adelaide, SA, Australia.; White, DL (corresponding author), Univ Adelaide, Dept Med, Adelaide, SA, Australia.; White, DL (corresponding author), Univ Adelaide, Dept Paediat, Adelaide, SA, Australia.	deborah.white@sahmri.com	Hughes, Tim/AAO-9975-2021; Eadie, Laura N/P-9385-2016	Eadie, Laura N/0000-0003-1912-7602; Hughes, Timothy/0000-0002-0910-3730; White, Deborah/0000-0003-4844-333X	Leukaemia Foundation of Australia	Leukaemia Foundation of Australia	This research was supported by the Leukaemia Foundation of Australia. LNE received a PhD scholarship to support these studies. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Barnes DJ, 2005, CANCER RES, V65, P8912, DOI 10.1158/0008-5472.CAN-05-0076; Branford S, 2003, BLOOD, V102, P276, DOI 10.1182/blood-2002-09-2896; Burger H, 2005, CANCER BIOL THER, V4, P747, DOI 10.4161/cbt.4.7.1826; Camgoz A, 2013, LEUKEMIA LYMPHOMA, V54, P1279, DOI 10.3109/10428194.2012.737919; Campbell LJ, 2002, CANCER GENET CYTOGEN, V139, P30, DOI 10.1016/S0165-4608(02)00615-5; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Dai Y, 2004, J BIOL CHEM, V279, P34227, DOI 10.1074/jbc.M402290200; De Braekeleer E, 2007, CANCER GENET CYTOGEN, V179, P159, DOI 10.1016/j.cancergencyto.2007.09.003; Donato NJ, 2003, BLOOD, V101, P690, DOI 10.1182/blood.V101.2.690; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Eadie LN, 2017, LEUKEMIA, V31, P75, DOI 10.1038/leu.2016.179; Eadie LN, 2014, CLIN PHARMACOL THER, V95, P294, DOI 10.1038/clpt.2013.208; Eadie LN, 2015, BLOOD, V126, DOI 10.1182/blood.V126.23.348.348; Eadie LN, 2013, LEUKEMIA LYMPHOMA, V54, P569, DOI 10.3109/10428194.2012.715345; Giles FJ, 2013, LEUKEMIA, V27, P107, DOI 10.1038/leu.2012.181; Goldman JM, 2003, NEW ENGL J MED, V349, P1451, DOI 10.1056/NEJMra020777; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Gromicho M, 2011, LEUKEMIA LYMPHOMA, V52, P1980, DOI 10.3109/10428194.2011.584005; Grosso S, 2009, MOL CANCER THER, V8, P1924, DOI 10.1158/1535-7163.MCT-09-0168; Hantschel O, 2008, LEUKEMIA LYMPHOMA, V49, P615, DOI 10.1080/10428190801896103; Hirayama C, 2008, PHARM RES, V25, P827, DOI 10.1007/s11095-007-9376-3; Hochhaus A, 2002, LEUKEMIA, V16, P2190, DOI 10.1038/sj.leu.2402741; Hochhaus A, 2013, BLOOD, V121, P3703, DOI 10.1182/blood-2012-04-423418; Hughes T, 2009, J CLIN ONCOL, V27, P4204, DOI 10.1200/JCO.2009.21.8230; Hughes TP, 2003, NEW ENGL J MED, V349, P1423, DOI 10.1056/NEJMoa030513; Illmer T, 2004, LEUKEMIA, V18, P401, DOI 10.1038/sj.leu.2403257; Kantarjian H, 2010, NEW ENGL J MED, V362, P2260, DOI 10.1056/NEJMoa1002315; Khorashad JS, 2013, BLOOD, V121, P489, DOI 10.1182/blood-2012-05-431379; le Coutre P, 2000, BLOOD, V95, P1758, DOI 10.1182/blood.V95.5.1758.005a41_1758_1766; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; Mahon FX, 2008, CANCER RES, V68, P9809, DOI 10.1158/0008-5472.CAN-08-1008; Mahon FX, 2000, BLOOD, V96, P1070, DOI 10.1182/blood.V96.3.1070.015k17_1070_1079; Mahon FX, 2003, BLOOD, V101, P2368, DOI 10.1182/blood.V101.6.2368; Manley PW, 2004, BIOORG MED CHEM LETT, V14, P5793, DOI 10.1016/j.bmcl.2004.09.042; Meyn MA, 2006, J BIOL CHEM, V281, P30907, DOI 10.1074/jbc.M605902200; Muller MC, 2009, BLOOD, V114, P4944, DOI 10.1182/blood-2009-04-214221; NICHOLS GL, 1994, BLOOD, V84, P2912; NOWELL PC, 1960, SCIENCE, V132, P1497; Okabe S, 2013, BIOCHEM BIOPH RES CO, V435, P506, DOI 10.1016/j.bbrc.2013.05.022; Okabe S, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-32; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Scappini B, 2004, CANCER-AM CANCER SOC, V100, P1459, DOI 10.1002/cncr.20131; Tanaka C, 2010, CLIN PHARMACOL THER, V87, P197, DOI 10.1038/clpt.2009.208; Tang C, 2011, LEUKEMIA LYMPHOMA, V52, P2139, DOI 10.3109/10428194.2011.591013; Warmuth M, 1997, J BIOL CHEM, V272, P33260, DOI 10.1074/jbc.272.52.33260; Weisberg E, 2000, BLOOD, V95, P3498, DOI 10.1182/blood.V95.11.3498.011k27_3498_3505; White D, 2005, BLOOD, V106, P2520, DOI 10.1182/blood-2005-03-1103; White D, 2006, BLOOD, V108, p608A, DOI 10.1182/blood.V108.11.2144.2144; Wu J, 2008, J NATL CANCER I, V100, P926, DOI 10.1093/jnci/djn188; Wu J, 2008, BLOOD, V111, P3821, DOI 10.1182/blood-2007-08-109330; Yuan HF, 2010, J BIOL CHEM, V285, P5085, DOI 10.1074/jbc.M109.039206; Zhao F, 2010, ONCOGENE, V29, P2962, DOI 10.1038/onc.2010.67	52	24	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161470	10.1371/journal.pone.0161470	http://dx.doi.org/10.1371/journal.pone.0161470			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536777	Green Submitted, Green Published, gold			2022-12-26	WOS:000381577000110
J	Kochi, M; Kohagura, K; Shiohira, Y; Iseki, K; Ohya, Y				Kochi, Masako; Kohagura, Kentaro; Shiohira, Yoshiki; Iseki, Kunitoshi; Ohya, Yusuke			Inflammation as a Risk of Developing Chronic Kidney Disease in Rheumatoid Arthritis	PLOS ONE			English	Article							C-REACTIVE PROTEIN; SUBCLINICAL RENAL DYSFUNCTION; CARDIOVASCULAR EVENTS; FOLLOW-UP; POPULATION; GLOMERULONEPHRITIS; METHOTREXATE; MARKERS; DAMAGE; METAANALYSIS	Objective The relationship between chronic inflammation and the incidence of chronic kidney disease (CKD) remained not-clear in patients with rheumatoid arthritis (RA). This study aims to examine the relationship between persistently high C-reactive protein (CRP), a marker of inflammation, and the incidence of CKD in RA. Methods We retrospectively examined the relationship between the levels of CRP and incidence of CKD in 345 RA patients. The outcome of interest was incidence of CKD, defined as an estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73 m(2) and/or positive dipstick testing for proteinuria for >= 3 months. We defined high CRP, as > 3.0 mg/L. On the basis of three measurements of CRP for 6-months period, patients were divided into three groups: group 1, including patients with no high CRP values; group 2, patients with transient high CRP values (once or twice) and group 3, patients with persistently high CRP values. Results During a median follow-up period of 89 months, 14% of all patients developed CKD. The cumulative incidence of CKD was 7% in group 1, 14% in group 2 and 22% in group 3 (P = 0.008, log-rank test). In a multivariate analysis, including classical risk factors for CKD, persistently high CRP was an independent predictor of the incidence of CKD (hazard ratio, 3.00; 95% confidence interval, 1.23-8.53; P = 0.01). Conclusions Persistently high CRP was a significant risk factor for the incidence of CKD. Results suggest that persistent inflammation is a marker for the high risk of CKD in RA.	[Kochi, Masako] Univ Ryukyus, Sch Med, Dept Cardiovasc Med Nephrol & Neurol, Nishihara, Okinawa, Japan; [Kochi, Masako; Ohya, Yusuke] Yuuaikai Nanbu Hosp, Itoman, Okinawa, Japan; [Kohagura, Kentaro] Univ Hosp Ryukyus, Dialysis Unit, Nishihara, Okinawa, Japan; [Shiohira, Yoshiki; Iseki, Kunitoshi] Yuuaikai Tomishiro Cent Hosp, Tomigusuku, Okinawa, Japan; [Iseki, Kunitoshi] Okinawa Heart & Renal Assoc, Naha, Okinawa, Japan	University of the Ryukyus; University of the Ryukyus	Kohagura, K (corresponding author), Univ Hosp Ryukyus, Dialysis Unit, Nishihara, Okinawa, Japan.	kohagura@med.u-ryukyu.ac.jp		Kohagura, Kentaro/0000-0003-1636-7889				ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Azzi JR, 2013, J IMMUNOL, V191, P5785, DOI 10.4049/jimmunol.1390055; Bash LD, 2009, AM J KIDNEY DIS, V53, P596, DOI 10.1053/j.ajkd.2008.10.044; BERTANI T, 1989, AM J PATHOL, V134, P419; BOERS M, 1990, ARTHRITIS RHEUM, V33, P95, DOI 10.1002/art.1780330113; Bulgarelli A, 2012, J CARDIOVASC PHARM, V59, P308, DOI 10.1097/FJC.0b013e318241c385; Combe B, 2001, ARTHRITIS RHEUM, V44, P1736, DOI 10.1002/1529-0131(200108)44:8<1736::AID-ART308>3.0.CO;2-I; DAWES PT, 1986, BRIT J RHEUMATOL, V25, P44; de Wit MPT, 2011, ANN RHEUM DIS, V70, P891, DOI 10.1136/ard.2010.146662; Galarraga B, 2008, RHEUMATOLOGY, V47, P1780, DOI 10.1093/rheumatology/ken386; GLENNER GG, 1980, NEW ENGL J MED, V302, P1283, DOI 10.1056/NEJM198006053022305; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hall C L, 1989, Adv Exp Med Biol, V252, P247; Haroon M, 2011, INT J RHEUM DIS, V14, P255, DOI 10.1111/j.1756-185X.2011.01594.x; HELIN HJ, 1995, ARTHRITIS RHEUM, V38, P242, DOI 10.1002/art.1780380213; Hickson LJ, 2014, AM J KIDNEY DIS, V63, P206, DOI 10.1053/j.ajkd.2013.08.010; Hiramoto JS, 2012, AM J KIDNEY DIS, V60, P225, DOI 10.1053/j.ajkd.2012.02.335; Iseki K, 2003, KIDNEY INT, V63, P1468, DOI 10.1046/j.1523-1755.2003.00868.x; Iseki K, 2011, NEPHRON CLIN PRACT, V117, pC51, DOI 10.1159/000319647; Karie S, 2008, RHEUMATOLOGY, V47, P350, DOI 10.1093/rheumatology/kem370; Karkar AM, 2001, NEPHROL DIAL TRANSPL, V16, P518, DOI 10.1093/ndt/16.3.518; Karstila K, 2007, CLIN RHEUMATOL, V26, P2089, DOI 10.1007/s10067-007-0625-y; Keith DS, 2004, ARCH INTERN MED, V164, P659, DOI 10.1001/archinte.164.6.659; Koseki Y, 2001, ANN RHEUM DIS, V60, P327, DOI 10.1136/ard.60.4.327; Lachmann HJ, 2007, NEW ENGL J MED, V356, P2361, DOI 10.1056/NEJMoa070265; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levy L, 2008, CLIN EXP RHEUMATOL, V26, P673; Li Z, 2011, LAB INVEST, V91, P837, DOI 10.1038/labinvest.2011.42; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P722, DOI 10.1002/art.20878; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Meune C, 2009, RHEUMATOLOGY, V48, P1309, DOI 10.1093/rheumatology/kep252; Micha R, 2011, AM J CARDIOL, V108, P1362, DOI 10.1016/j.amjcard.2011.06.054; Moller B, 2015, ANN RHEUM DIS, V74, P718, DOI 10.1136/annrheumdis-2013-204078; Mustonen J, 1985, Duodecim, V101, P1549; Nakahara C, 2001, CLIN NEPHROL, V55, P365; Nakano M, 1998, CLIN NEPHROL, V50, P154; Ninomiya T, 2005, KIDNEY INT, V68, P228, DOI 10.1111/j.1523-1755.2005.00397.x; Paisley KE, 2003, KIDNEY INT, V63, P624, DOI 10.1046/j.1523-1755.2003.00768.x; Perazella MA, 2009, CLIN J AM SOC NEPHRO, V4, P1275, DOI 10.2215/CJN.02050309; Peters MJL, 2010, ANN RHEUM DIS, V69, P325, DOI 10.1136/ard.2009.113696; Plant MJ, 2000, ARTHRITIS RHEUM, V43, P1473, DOI 10.1002/1529-0131(200007)43:7<1473::AID-ANR9>3.0.CO;2-N; Remuzzi G, 1998, NEW ENGL J MED, V339, P1448, DOI 10.1056/NEJM199811123392007; Roubille C, 2015, ANN RHEUM DIS, V74, P480, DOI 10.1136/annrheumdis-2014-206624; Schwedler SB, 2003, NEPHROL DIAL TRANSPL, V18, P2300, DOI 10.1093/ndt/gfg407; Shankar A, 2011, KIDNEY INT, V80, P1231, DOI 10.1038/ki.2011.283; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Stuveling EM, 2003, KIDNEY INT, V63, P654, DOI 10.1046/j.1523-1755.2003.00762.x; Tapia E, 2008, AM J PHYSIOL-RENAL, V295, pF1431, DOI 10.1152/ajprenal.90201.2008; Teramoto T, 2007, J ATHEROSCLER THROMB, V14, P155, DOI 10.5551/jat.E537; TIPPING PG, 1991, LAB INVEST, V65, P272; van Sijl AM, 2012, ANN RHEUM DIS, V71, P341, DOI 10.1136/annrheumdis-2011-200051; VANLEEUWEN MA, 1994, J RHEUMATOL, V21, P425; YOSHIDA A, 1994, CLIN THER, V16, P1000	55	30	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0160225	10.1371/journal.pone.0160225	http://dx.doi.org/10.1371/journal.pone.0160225			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537204	Green Published, Green Submitted, gold			2022-12-26	WOS:000381577000014
J	Montes, A; Regueiro, C; Perez-Pampin, E; Boveda, MD; Gomez-Reino, JJ; Gonzalez, A				Montes, Ariana; Regueiro, Cristina; Perez-Pampin, Eva; Dolores Boveda, Maria; Gomez-Reino, Juan J.; Gonzalez, Antonio			Anti-Carbamylated Protein Antibodies as a Reproducible Independent Type of Rheumatoid Arthritis Autoantibodies	PLOS ONE			English	Article							CARP ANTIBODIES; SHARED EPITOPE; SMOKING; HLA-DRB1; ASSOCIATION; SUBSETS; PREDICT; PTPN22	A large fraction of the patients with rheumatoid arthritis (RA) develop specific autoantibodies, which until recently were only of two types, rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPA). We aimed to replicate important findings about a recently described third type of specific autoantibodies, anti-carbamylated protein (anti-CarP) antibodies, because they have been described based only in the homemade ELISA from a single laboratory. Our study included 520 patients with established RA and 278 healthy controls of Spanish ancestry and it was done with an independently performed ELISA. The prevalence and pattern of environmental, clinical and genetic associations of the anti-CarP antibodies were similar to the previously described. Notably, the presence and titers of anti-CarP correlated with the presence and titers of ACPA, but the anti-CarP antibodies did not share the known genetic and exposure risk factors of the ACPA. In addition, anti-CarP antibodies were independently associated with a higher (10.5%) prevalence of bone erosions. The reproducibility of these characteristics across laboratories and European subpopulations, indicates the wide validity of the results and suggests that determination of anti-CarP antibodies could contribute to explain RA pathogenesis and identify clinically relevant patient subgroups.	[Montes, Ariana; Regueiro, Cristina; Perez-Pampin, Eva; Gomez-Reino, Juan J.; Gonzalez, Antonio] Inst Invest Sanitaria Hosp Clin Univ Santiago, Lab Invest 10, Santiago De Compostela, Spain; [Montes, Ariana; Regueiro, Cristina; Perez-Pampin, Eva; Gomez-Reino, Juan J.; Gonzalez, Antonio] Inst Invest Sanitaria Hosp Clin Univ Santiago, Rheumatol Unit, Santiago De Compostela, Spain; [Dolores Boveda, Maria] Inst Invest Sanitaria Hosp Clin Univ Santiago, Dept Pediat, Unit Diag & Treatment Congenital Metab Dis, Santiago De Compostela, Spain; [Gomez-Reino, Juan J.] Univ Santiago de Compostela, Dept Med, Santiago De Compostela, Spain	Universidade de Santiago de Compostela	Gonzalez, A (corresponding author), Inst Invest Sanitaria Hosp Clin Univ Santiago, Lab Invest 10, Santiago De Compostela, Spain.; Gonzalez, A (corresponding author), Inst Invest Sanitaria Hosp Clin Univ Santiago, Rheumatol Unit, Santiago De Compostela, Spain.	agmartinezp@ser.es	Gonzalez, Antonio/C-4444-2008; Perez-Pampin, Eva/ABF-7200-2020; Gomez-Reino, Juan/ABI-2853-2020; Expósito, Cristina Regueiro/AAC-1405-2021	Gonzalez, Antonio/0000-0002-2624-0606; Perez-Pampin, Eva/0000-0003-0319-4456; Regueiro, Cristina/0000-0002-8567-6784; Gomez-Reino, Juan/0000-0001-5229-6294	Instituto de Salud Carlos III [PI14/01651, RD12/0009/0008]; Instituto de Salud Carlos III (Spain) - European Regional Development Fund of the EU (FEDER) [PI14/01651, RD12/0009/0008]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Instituto de Salud Carlos III (Spain) - European Regional Development Fund of the EU (FEDER)	Funding was provided by the Instituto de Salud Carlos III, PI14/01651; and Instituto de Salud Carlos III, RD12/0009/0008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are indebted to the patients that generously have contributed the samples and time to this work. They also thank Camen Pena for her excellent technical support. Funding was provided by the Instituto de Salud Carlos III (Spain) through grants PI14/01651 and RD12/0009/0008, which are partially financed by the European Regional Development Fund of the EU (FEDER).	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bax M, 2014, SEMIN IMMUNOPATHOL, V36, P313, DOI 10.1007/s00281-014-0429-5; Brink M, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0536-2; Catrina AI, 2014, NAT REV RHEUMATOL, V10, P645, DOI 10.1038/nrrheum.2014.115; Gan RW, 2015, J RHEUMATOL, V42, P572, DOI 10.3899/jrheum.140767; Harre U, 2012, J CLIN INVEST, V122, P1791, DOI 10.1172/JCI60975; Hecht C, 2015, ANN RHEUM DIS, V74, P2151, DOI 10.1136/annrheumdis-2014-205428; Holoshitz J, 2010, CURR OPIN RHEUMATOL, V22, P293, DOI 10.1097/BOR.0b013e328336ba63; Jiang X, 2014, ANN RHEUM DIS, V73, P1761, DOI 10.1136/annrheumdis-2013-205109; Kallberg H, 2007, AM J HUM GENET, V80, P867, DOI 10.1086/516736; Lee HS, 2007, ARTHRITIS RHEUM-US, V56, P1745, DOI 10.1002/art.22703; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Micallef L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101717; Montes A, 2012, ARTHRITIS RHEUM-US, V64, P3102, DOI 10.1002/art.34569; Montes A, 2011, ARTHRITIS RHEUM-US, V63, P654, DOI 10.1002/art.30186; Morgan AW, 2009, ARTHRITIS RHEUM-US, V60, P2565, DOI 10.1002/art.24752; Mydel P, 2010, J IMMUNOL, V184, P6882, DOI 10.4049/jimmunol.1000075; Scinocca M, 2014, J RHEUMATOL, V41, P270, DOI 10.3899/jrheum.130742; Shi J, 2014, ANN RHEUM DIS, V73, P780, DOI 10.1136/annrheumdis-2013-204154; Shi J, 2013, ARTHRITIS RHEUM-US, V65, P911, DOI 10.1002/art.37830; Shi J, 2011, P NATL ACAD SCI USA, V108, P17372, DOI 10.1073/pnas.1114465108; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Townsend MJ, 2014, BEST PRACT RES CL RH, V28, P539, DOI 10.1016/j.berh.2014.10.024; van Heemst J, 2014, ANN MED, V46, P304, DOI 10.3109/07853890.2014.907097	24	31	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161141	10.1371/journal.pone.0161141	http://dx.doi.org/10.1371/journal.pone.0161141			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537849	Green Published, Green Submitted, gold			2022-12-26	WOS:000381577000059
J	Sun, J; Hinton, MG; Webster, DG				Sun, Jenny; Hinton, Michael G.; Webster, D. G.			Modeling the Spatial Dynamics of International Tuna Fleets	PLOS ONE			English	Article							FISHING LOCATION CHOICE; KATSUWONUS-PELAMIS; TRAWL FISHERIES; BEHAVIOR; HETEROGENEITY; GOVERNANCE; PACIFIC; SHRIMP; OCEAN	We developed an iterative sequential random utility model to investigate the social and environmental determinants of the spatiotemporal decision process of tuna purse-seine fishery fishing effort in the eastern Pacific Ocean. Operations of the fishing gear mark checkpoints in a continuous complex decision-making process. Individual fisher behavior is modeled by identifying diversified choices over decision-space for an entire fishing trip, which allows inclusion of prior and current vessel locations and conditions among the explanatory variables. Among these factors are vessel capacity; departure and arrival port; duration of the fishing trip; daily and cumulative distance travelled, which provides a proxy for operation costs; expected revenue; oceanographic conditions; and tons of fish on board. The model uses a two-step decision process to capture the probability of a vessel choosing a specific fishing region for the first set and the probability of switching to ( or staying in) a specific region to fish before returning to its landing port. The model provides a means to anticipate the success of marine resource management, and it can be used to evaluate fleet diversity in fisher behavior, the impact of climate variability, and the stability and resilience of complex coupled human and natural systems.	[Sun, Jenny] Gulf Maine Res Inst, Portland, ME 04101 USA; [Hinton, Michael G.] Interamer Trop Tuna Commiss, La Jolla, CA 92037 USA; [Webster, D. G.] Dartmouth Coll, Environm Studies, Hanover, NH 03755 USA	Gulf of Maine Research Institute; Dartmouth College	Hinton, MG (corresponding author), Interamer Trop Tuna Commiss, La Jolla, CA 92037 USA.	mghinton@uw.edu		Webster, D.G./0000-0002-8368-983X; Hinton, Michael Gene/0000-0003-4508-4335	National Science Foundation; Coupled Natural and Human systems project called Fishscape under NSF [CNH-1010280]; Directorate For Geosciences [1010280] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Coupled Natural and Human systems project called Fishscape under NSF; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This study is sponsored by the National Science Foundation and is funded through Coupled Natural and Human systems project called Fishscape under NSF Grant No. CNH-1010280 (DGW JS) (http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=13681). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen BS, 2012, ICES J MAR SCI, V69, P131, DOI 10.1093/icesjms/fsr181; Andersen BS, 2010, FISH RES, V102, P26, DOI 10.1016/j.fishres.2009.10.004; BARKLEY RA, 1978, FISH B-NOAA, V76, P653; BOCKSTAEL NE, 1983, J ENVIRON ECON MANAG, V10, P125, DOI 10.1016/0095-0696(83)90021-9; Branch TA, 2006, CAN J FISH AQUAT SCI, V63, P1647, DOI 10.1139/F06-072; Brill Richard W., 1994, Fisheries Oceanography, V3, P204, DOI 10.1111/j.1365-2419.1994.tb00098.x; Crowder LB, 2006, SCIENCE, V313, P617, DOI 10.1126/science.1129706; Cumming GS, 2013, LANDSCAPE ECOL, V28, P1139, DOI 10.1007/s10980-012-9725-4; Curtis R, 2000, AM J AGR ECON, V82, P1191, DOI 10.1111/0002-9092.00119; Davies TK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114037; Deriso, 1998, NOAA TECHNICAL REPOR, P161; Eales James, 1986, MAR RESOUR ECON, V2, P331, DOI [10.1086/mre.2.4.42628909, DOI 10.1086/MRE.2.4.42628909]; EVANS RH, 1981, MAR FISH REV, V43, P1; Hicks RL, 2008, J ENVIRON ECON MANAG, V56, P103, DOI 10.1016/j.jeem.2008.01.001; HILBORN R, 1985, CAN J FISH AQUAT SCI, V42, P2, DOI 10.1139/f85-001; Holland DS, 1999, CAN J FISH AQUAT SCI, V56, P253, DOI 10.1139/cjfas-56-2-253; Hutton T, 2004, ICES J MAR SCI, V61, P1443, DOI 10.1016/j.icesjms.2004.08.016; IATTC, 2012, IATTC CONVENTION ARE; IATTC, 2013, IATTC REPORT FOR THE; Joyner CC, 2000, OCEAN DEV INT LAW, V31, P127, DOI 10.1080/009083200276094; Larson DM, 1999, CONTEMP ECON POLICY, V17, P267, DOI 10.1111/j.1465-7287.1999.tb00681.x; Liu JG, 2007, AMBIO, V36, P639, DOI 10.1579/0044-7447(2007)36[639:CHANS]2.0.CO;2; McFadden D., 1978, MODELING THE CHOICE; McFadden D., 1974, J PUBLIC ECON, V3, P303, DOI [10.1016/0047-2727(74)90003-6, DOI 10.1016/0047-2727(74)90003-6]; NOAA, 2015, MULTIVARIATE EL NINO; Salas S, 2004, FISH FISH, V5, P153, DOI 10.1111/j.1467-2979.2004.00146.x; Schaefer KM, 2009, REV-METHODS TECHNOL, V9, P121, DOI 10.1007/978-1-4020-9640-2_8; Schnier KE, 2011, LAND ECON, V87, P382, DOI 10.3368/le.87.3.382; Smith MD, 2005, J ENVIRON ECON MANAG, V50, P319, DOI 10.1016/j.jeem.2005.04.001; Swait J, 2004, J ENVIRON ECON MANAG, V47, P94, DOI 10.1016/S0095-0696(03)00077-9; van Putten IE, 2012, FISH FISH, V13, P216, DOI 10.1111/j.1467-2979.2011.00430.x; Vermard Y, 2008, CAN J FISH AQUAT SCI, V65, P2444, DOI 10.1139/F08-147; WARD JM, 1994, AM J AGR ECON, V76, P916, DOI 10.2307/1243751; Wilson J, 2007, P NATL ACAD SCI USA, V104, P15212, DOI 10.1073/pnas.0702241104	34	20	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0159626	10.1371/journal.pone.0159626	http://dx.doi.org/10.1371/journal.pone.0159626			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT6ES	27537545	Green Published, Green Submitted, gold			2022-12-26	WOS:000381577000008
J	Yoon, HI; Koom, WS; Kim, TH; Ahn, JB; Jung, M; Kim, TI; Kim, H; Shin, SJ; Kim, NK				Yoon, Hong In; Koom, Woong Sub; Kim, Tae Hyung; Ahn, Joong Bae; Jung, Minkyu; Kim, Tae Il; Kim, Hoguen; Shin, Sang Joon; Kim, Nam Kyu			Upfront Systemic Chemotherapy and Short-Course Radiotherapy with Delayed Surgery for Locally Advanced Rectal Cancer with Distant Metastases: Outcomes, Compliance, and Favorable Prognostic Factors	PLOS ONE			English	Article							COURSE PREOPERATIVE RADIOTHERAPY; COLORECTAL LIVER METASTASES; CIRCUMFERENTIAL MARGIN; LUNG METASTASECTOMY; RANDOMIZED-TRIAL; PHASE-II; CHEMORADIOTHERAPY; CHEMORADIATION; METAANALYSIS; MULTICENTER	Purpose/Objective(s) Optimal treatment for locally advanced rectal cancer (LARC) with distant metastasis remains elusive. We aimed to evaluate upfront systemic chemotherapy and short-course radiotherapy (RT) followed by delayed surgery for such patients, and to identify favorable prognostic factors. Materials/Methods We retrospectively reviewed 50 LARC patients (cT4 or cT3, < 2 mm from the mesorectal fascia) with synchronous metastatic disease. The primary endpoint was progression-free survival (PFS). The secondary endpoints were overall survival, treatment-related toxicity, and compliance. We considered P values < 0.05 significant. Results At 22 months median follow-up, the median PFS time was 16 months and the 2-year PFS rate was 34.8%. Thirty-five patients who received radical surgery for primary and metastatic tumors were designated the curable group. Six patients with clinical complete response (ypCR) of metastases who underwent radical surgery for only the primary tumor were classified as potentially curable. Nine patients who received no radical surgery (3 received palliative surgery) were deemed the palliative group. The ypCR rate among surgery patients was 13.6%. PFS rates for the curable or potentially curable groups were significantly longer than that of the palliative group (P<0.001). On multivariate analysis, solitary organ metastasis and R0 status were independent prognostic factors for PFS. Conclusions These findings demonstrated that a strong possibility that upfront chemotherapy and short-course RT with delayed surgery are an effective alternative treatment for LARC with potentially resectable distant metastasis, owing to achievement of pathologic down-staging, R0 resection, and favorable compliance and toxicity, despite the long treatment duration.	[Yoon, Hong In; Koom, Woong Sub; Kim, Tae Hyung] Yonsei Univ Hlth Syst, Yonsei Univ, Dept Radiat Oncol, Yonsei Canc Ctr,Coll Med, Seoul, South Korea; [Ahn, Joong Bae; Jung, Minkyu; Shin, Sang Joon] Yonsei Univ Hlth Syst, Yonsei Univ, Div Med Oncol, Dept Internal Med,Yonsei Canc Ctr,Coll Med, Seoul, South Korea; [Kim, Tae Il] Yonsei Univ Hlth Syst, Yonsei Univ, Div Gastroenterol, Dept Internal Med,Coll Med, Seoul, South Korea; [Kim, Hoguen] Yonsei Univ Hlth Syst, Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Kim, Hoguen; Kim, Nam Kyu] Yonsei Univ Hlth Syst, Yonsei Univ, Dept Surg, Div Colorectal Surg,Coll Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Shin, SJ (corresponding author), Yonsei Univ Hlth Syst, Yonsei Univ, Div Med Oncol, Dept Internal Med,Yonsei Canc Ctr,Coll Med, Seoul, South Korea.; Kim, NK (corresponding author), Yonsei Univ Hlth Syst, Yonsei Univ, Dept Surg, Div Colorectal Surg,Coll Med, Seoul, South Korea.	SSJ338@yuhs.ac; NAMKYUK@yuhs.ac		Koom, Woong Sub/0000-0002-9435-7750; Shin, Sang Joon/0000-0001-5350-7241; Jung, Minkyu/0000-0001-8281-3387; Kim, Nam-Kyu/0000-0003-0639-5632; Ahn, Joong Bae/0000-0001-6787-1503; Yoon, Hong In/0000-0002-2106-6856; Kim, Tae Il/0000-0003-4807-890X	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2015R1C1A1A01053547]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2015R1C1A1A01053547).	Beppu N, 2014, INT J COLORECTAL DIS, V29, P1459, DOI 10.1007/s00384-014-1997-5; Blazer DG, 2008, J CLIN ONCOL, V26, P5344, DOI 10.1200/JCO.2008.17.5299; Bonney GK, 2015, J SURG ONCOL, V111, P716, DOI 10.1002/jso.23899; Bujko K, 2006, BRIT J SURG, V93, P1215, DOI 10.1002/bjs.5506; Ciliberto D, 2012, ONCOL REP, V27, P1849, DOI 10.3892/or.2012.1740; Glimelius B, 2003, ACTA ONCOL, V42, P476, DOI 10.1080/02841860310012301; Gonzalez M, 2013, ANN SURG ONCOL, V20, P572, DOI 10.1245/s10434-012-2726-3; Hatfield P, 2009, RADIOTHER ONCOL, V92, P210, DOI 10.1016/j.radonc.2009.04.007; He Yi-Fu, 2006, Ai Zheng, V25, P1153; Kim KH, 2016, RADIOTHER ONCOL, V118, P369, DOI 10.1016/j.radonc.2015.11.029; MANDARD AM, 1994, CANCER, V73, P2680, DOI 10.1002/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C; Marijnen CAM, 2003, INT J RADIAT ONCOL, V55, P1311, DOI 10.1016/S0360-3016(02)04291-8; Nagtegaal ID, 2002, AM J SURG PATHOL, V26, P350, DOI 10.1097/00000478-200203000-00009; Nagtegaal ID, 2008, J CLIN ONCOL, V26, P303, DOI 10.1200/JCO.2007.12.7027; Network NCC, 2015, NCCN CLIN PRACTICE G; Nordlinger B, 2008, LANCET, V371, P1007, DOI 10.1016/S0140-6736(08)60455-9; Pettersson D, 2012, BRIT J SURG, V99, P577, DOI 10.1002/bjs.7796; Poultsides GA, 2012, ANN SURG ONCOL, V19, P2797, DOI 10.1245/s10434-012-2335-1; Radu C, 2008, RADIOTHER ONCOL, V87, P343, DOI 10.1016/j.radonc.2007.11.025; Rama N, 2009, EUR J CARDIO-THORAC, V35, P444, DOI 10.1016/j.ejcts.2008.10.047; Salah S, 2012, ANN ONCOL, V23, P2649, DOI 10.1093/annonc/mds100; Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694; Shin SJ, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-99; Tyc-Szczepaniak D, 2013, ANN ONCOL, V24, P2829, DOI 10.1093/annonc/mdt363; van der Pool AE, 2010, BRIT J SURG, V97, P383, DOI 10.1002/bjs.6947; van Dijk TH, 2013, ANN ONCOL, V24, P1762, DOI 10.1093/annonc/mdt124; van Gijn W, 2011, LANCET ONCOL, V12, P575, DOI 10.1016/S1470-2045(11)70097-3; Wong RKS, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002102.pub2; Yeo SG, 2013, INT J RADIAT ONCOL, V86, P34, DOI 10.1016/j.ijrobp.2012.11.018; Zhou ZR, 2014, SURG ONCOL, V23, P211, DOI 10.1016/j.suronc.2014.10.003; Zhu DX, 2012, ANN SURG ONCOL, V19, P2860, DOI 10.1245/s10434-012-2356-9	31	34	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161475	10.1371/journal.pone.0161475	http://dx.doi.org/10.1371/journal.pone.0161475			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536871	Green Submitted, Green Published, gold			2022-12-26	WOS:000381577000111
J	Zhu, XQ; Lu, W; Chen, Y; Cheng, XF; Qiu, JY; Xu, Y; Sun, Y				Zhu, Xiang-qing; Lu, Wei; Chen, Yang; Cheng, Xiao-fan; Qiu, Jia-ying; Xu, Yan; Sun, Ying			Effects of Porphyromonas gingivalis Lipopolysaccharide Tolerized Monocytes on Inflammatory Responses in Neutrophils	PLOS ONE			English	Article							EXPRESSION; TOLERANCE; APOPTOSIS; RECEPTOR; ACTIVATION; CHEMOKINES; CELLS; IL-10; LPS; PHOSPHORYLATION	Periodontitis is a chronic inflammatory disease induced by bacteria. Exposure of the host to periodontal pathogens and their virulence factors induces a state of hyporesponsiveness to subsequent stimulations, which is termed endotoxin tolerance. The role and mechanism of lipopolysaccharide (LPS)-tolerized monocytes in inflammatory responses in neutrophils are currently unclear. Here, conditioned supernatants were collected from THP-1 cells treated with or without repeated 1 mu g/ml Porphyromonas gingivalis (P. gingivalis) LPS. The chemotactic response of freshly isolated neutrophils recruited by supernatants was determined by a transwell migration assay, which demonstrated a reduced migration of neutrophils stimulated with supernatants from tolerized THP-1 cells in comparison to non-tolerized THP-1 cells. In addition, there was a marked increase in reactive oxygen species (ROS) generation and a significant decrease in Caspase 3 activities in neutrophils treated with supernatants from THP-1 cells that were treated repeatedly with P. gingivalis LPS in comparison to single treatment. A cytokine antibody array was then used to assess cytokine expression patterns in THP-1 cells. In tolerized THP-1 cells, 43 cytokine (43/170) expression levels were decreased, including chemokine ligand 23 (CCL23) and IFN-gamma, while 11 cytokine (11/170) expression levels were increased, such as death receptor 6 (DR6). Furthermore, there was decreased production of IFN-gamma and epithelial neutrophil activating peptide-78 (ENA-78) in THP-1 cells after stimulation with repeated P. gingivalis LPS in comparison to single challenge, which was confirmed by ELISA. Therefore, P. gingivalis LPS-tolerized THP-1 cells were able to depress neutrophil chemotaxis and apoptosis, and contribute to respiratory burst, which might be related to the changes in cytokine expression patterns in THP-1 cells.	[Zhu, Xiang-qing; Lu, Wei; Chen, Yang; Cheng, Xiao-fan; Qiu, Jia-ying; Xu, Yan; Sun, Ying] Nanjing Med Univ, Jiangsu Key Lab Oral Dis, Nanjing, Jiangsu, Peoples R China; [Zhu, Xiang-qing; Lu, Wei; Chen, Yang; Cheng, Xiao-fan; Qiu, Jia-ying; Xu, Yan; Sun, Ying] Nanjing Med Univ, Affiliated Hosp Stomatol, Dept Periodontol, Nanjing, Jiangsu, Peoples R China; [Zhu, Xiang-qing] Nanjing First Hosp, Dept Stomatol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Sun, Y (corresponding author), Nanjing Med Univ, Jiangsu Key Lab Oral Dis, Nanjing, Jiangsu, Peoples R China.; Sun, Y (corresponding author), Nanjing Med Univ, Affiliated Hosp Stomatol, Dept Periodontol, Nanjing, Jiangsu, Peoples R China.	ebolasun@njmu.edu.cn			Natural Science Foundation of Jiangsu Province [BK20161565];  [81370025];  [2014-37]	Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); ; 	Grant BK20161565 (http://www.jstd.gov.cn/) from Natural Science Foundation of Jiangsu Province was received by YS. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Then, there were 3 funds (Grant 81370025, Grant 2014-37, Grant BK20161565) that subsidized this paper now.	Al-Shibani NK, 2011, J PERIODONTOL, V82, P1504, DOI 10.1902/jop.2011.100757; Bliss CM, 1998, INFECT IMMUN, V66, P5357, DOI 10.1128/IAI.66.11.5357-5363.1998; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Bosmann M, 2014, J IMMUNOL, V193, P5668, DOI 10.4049/jimmunol.1302280; Bratton DL, 2011, TRENDS IMMUNOL, V32, P350, DOI 10.1016/j.it.2011.04.009; CHENG JH, 1994, SCIENCE, V263, P1759, DOI 10.1126/science.7510905; Cole TS, 2012, IMMUNOL LETT, V144, P49, DOI 10.1016/j.imlet.2012.03.006; El-Benna J, 2008, SEMIN IMMUNOPATHOL, V30, P279, DOI 10.1007/s00281-008-0118-3; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; Golz L, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/986264; Gong J, 2015, SHOCK, V44, P371, DOI 10.1097/SHK.0000000000000434; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Grosse-Steffen T, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/720768; Haute GV, 2015, TOXICOL IN VITRO, V30, P309, DOI 10.1016/j.tiv.2015.10.005; Huang G, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.378; Jain S, 2010, PERIODONTOL 2000, V54, P53, DOI 10.1111/j.1600-0757.2009.00333.x; Kang SW, 2015, GENET MOL RES, V14, P18069, DOI 10.4238/2015.December.22.33; Kaplanski G, 2003, TRENDS IMMUNOL, V24, P25, DOI 10.1016/S1471-4906(02)00013-3; Kathariya R, 2014, J INVESTIG CLIN DENT, V5, P23, DOI 10.1111/jicd.12009; Keglowich L, 2014, J ALLERGY CAIRO, V2014; Kovacs I, 2014, FREE RADICAL RES, V48, P1190, DOI 10.3109/10715762.2014.938234; Ling MR, 2015, INNATE IMMUN-LONDON, V21, P714, DOI 10.1177/1753425915589387; Mathy-Hartert M, 2003, INFLAMM RES, V52, P111; Medvedev AE, 2006, J ENDOTOXIN RES, V12, P133, DOI 10.1179/096805106X102255; Melo ES, 2010, MOL IMMUNOL, V47, P2587, DOI 10.1016/j.molimm.2010.06.011; Morozumi T, 2016, J PERIODONTAL RES, V51, P768, DOI 10.1111/jre.12353; Muniz FWMG, 2015, ARCH ORAL BIOL, V60, P1203, DOI 10.1016/j.archoralbio.2015.05.007; Muthukuru M, 2005, INFECT IMMUN, V73, P687, DOI 10.1128/IAI.73.2.687-694.2005; Patel VP, 1997, J EXP MED, V185, P1163, DOI 10.1084/jem.185.7.1163; Poposki JA, 2011, J ALLERGY CLIN IMMUN, V128, P73, DOI 10.1016/j.jaci.2011.03.017; Searles S, 2013, J IMMUNOL, V191, P3884, DOI 10.4049/jimmunol.1301344; Shih CH, 2005, EXP HEMATOL, V33, P1101, DOI 10.1016/j.exphem.2005.06.028; Sugaya M, 2015, ARCH IMMUNOL THER EX, V63, P109, DOI 10.1007/s00005-014-0313-y; Sun Y, 2014, INFLAMMATION, V37, P268, DOI 10.1007/s10753-013-9737-5; Sun Y, 2010, J PERIODONTOL, V81, P1488, DOI 10.1902/jop.2010.100004; Ribeiro ALT, 2011, TOXICOLOGY, V288, P1, DOI 10.1016/j.tox.2011.05.009; Tonetti MS, 1997, J PERIODONTAL RES, V32, P104, DOI 10.1111/j.1600-0765.1997.tb01389.x; Varghese Sheeja S, 2015, Contemp Clin Dent, V6, pS152, DOI 10.4103/0976-237X.166816; Wall DM, 2014, CELL MICROBIOL, V16, P1746, DOI 10.1111/cmi.12368; Wang L, 2014, INT ENDOD J, V47, P271, DOI 10.1111/iej.12143; Wei SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077519; Xiong YB, 2016, J INNATE IMMUN, V8, P171, DOI 10.1159/000440838; Zeng LL, 2012, J BIOL CHEM, V287, P29125, DOI 10.1074/jbc.M112.362038; Zhou HF, 2013, J IMMUNOL, V190, P5078, DOI 10.4049/jimmunol.1203228; Zhu CL, 2010, SCAND J IMMUNOL, V72, P469, DOI 10.1111/j.1365-3083.2010.02460.x; Zhu XJ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4377; Zizzo G, 2013, J IMMUNOL, V190, P5237, DOI 10.4049/jimmunol.1203017	48	11	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161482	10.1371/journal.pone.0161482	http://dx.doi.org/10.1371/journal.pone.0161482			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536946	gold, Green Submitted, Green Published			2022-12-26	WOS:000381577000112
J	Bohn, B; Karges, B; Vogel, C; Otto, KP; Marg, W; Hofer, SE; Frohlich-Reiterer, E; Holder, M; Plamper, M; Wabitsch, M; Kerner, W; Holl, RW				Bohn, Barbara; Karges, Beate; Vogel, Christian; Otto, Klaus-Peter; Marg, Wolfgang; Hofer, Sabine E.; Froehlich-Reiterer, Elke; Holder, Martin; Plamper, Michaela; Wabitsch, Martin; Kerner, Wolfgang; Holl, Reinhard W.		DPV Initiative	20 Years of Pediatric Benchmarking in Germany and Austria: Age-Dependent Analysis of Longitudinal Follow-Up in 63,967 Children and Adolescents with Type 1 Diabetes	PLOS ONE			English	Article							CONSENSUS STATEMENT; INSULIN THERAPY; MANAGEMENT; ENDOCRINOLOGY; KETOACIDOSIS; ASSOCIATION; DISEASE; TRENDS; CARE	Background To investigate changes in diabetes treatment over the last two decades in three age-groups of children and adolescents with type 1 diabetes (T1D) from Germany and Austria. Methods 63,967 subjects (< 18yr) with T1D documented between 1995 and 2014 from the DPV-database were included and stratified according to age (0.5-<6, 6-<12, 12-<18yr). Regression models were applied for insulin regimens (< 3 and >= 4 injection time points/day, or continuous subcutaneous insulin infusion (CSII)), use of rapid-and long acting insulin analogues, NPH insulin, and frequency of self-monitoring of blood glucose (SMBG)/day. Models were adjusted for sex, diabetes duration, and migration background. P-value for trend was given. Findings The number of subjects with <3 injection time points/day decreased from 1995 to 2014 to <5% in all age-groups (p<0.0001). Proportion of patients with >= 4 injections/day increased until the early 2000s, and then declined until 2014. This trend was not found in 6-<12yr olds (p = 0.3403). CSII increased in all age-groups (p<0.0001) with the highest increase in children <6 years (from 0.4% to 79.2%), and the lowest increase in 12-<18 year olds (from 1.0% to 38.9%). NPH insulin decreased in all age-groups (p<0.0001). Insulin analogues, especially rapid-acting, became more frequent in all age-groups (p<0.0001), accounting for 78.4% in 2014 for all subjects. The highest use was found in the youngest children (in 2014: 85.6%), the lowest use in 6-<12 year olds (in 2014: 72.9%). The number of SMBG/day increased from 2.2 to 6.4 with a similar rise in all age-groups (p<0.0001). Frequency was highest in subjects <6yr. Conclusions In all age-groups, T1D treatment was intensified over the last 20 years. Age-specific differences in trends were particularly observed in the number of patients on CSII, in the number of patients with 4 or more injections/day, and in the frequency of SMBG/day.	[Bohn, Barbara; Holl, Reinhard W.] Univ Ulm, ZIBMT, Inst Epidemiol & Med Biometry, Ulm, Germany; [Bohn, Barbara; Holl, Reinhard W.] German Ctr Diabet Res DZD, Munich, Germany; [Karges, Beate] Rhein Westfal TH Aachen, German Ctr Diabet Res DZD, Fac Med, Div Endocrinol & Diabet, Aachen, Germany; [Karges, Beate] Rhein Westfal TH Aachen, German Ctr Diabet Res DZD, Fac Med, Dept Gynecol Endocrinol & Reprod Med, Aachen, Germany; [Karges, Beate] Bethlehem Hosp, Dept Pediat, Stolberg, Germany; [Vogel, Christian] Clin Chemnitz, Dept Pediat Endocrinol & Diabetol, Chemnitz, Germany; [Otto, Klaus-Peter] Clin Itzehoe, Ctr Pediat & Adolescents Med Neonatol & Pediat In, Itzehoe, Germany; [Marg, Wolfgang] Bremen Mitte Hosp, Ctr Pediat & Adolescent Med, Bremen, Germany; [Hofer, Sabine E.] Med Univ Innsbruck, Dept Paediat, Innsbruck, Austria; [Froehlich-Reiterer, Elke] Med Univ Graz, Dept Pediat, Graz, Austria; [Holder, Martin] Olgahospital, Stuttgart Clin Ctr, Dept Pediat Endocrinol & Diabetol, Stuttgart, Germany; [Plamper, Michaela] Univ Hosp Bonn, Dept Pediat Endocrinol & Diabetol, Bonn, Germany; [Wabitsch, Martin] Univ Hosp Children & Adolescents, Div Pediat Endocrinol & Diabet, Ulm, Germany; [Kerner, Wolfgang] Ctr Diabet & Metab Disorders, Karlsburg, Germany	Ulm University; RWTH Aachen University; RWTH Aachen University; Chemnitz Clinic; Klinikum Bremen-Mitte; Medical University of Innsbruck; Medical University of Graz; Klinikum Stuttgart; University of Bonn	Bohn, B (corresponding author), Univ Ulm, ZIBMT, Inst Epidemiol & Med Biometry, Ulm, Germany.; Bohn, B (corresponding author), German Ctr Diabet Res DZD, Munich, Germany.	barbara.bohn@uni-ulm.de	Plamper, Michaela/AAG-4445-2020	Holl, Reinhard/0000-0003-1395-4842	German Competence Network Diabetes mellitus - Federal Ministry of Education and Research [FKZ 01GI1106]; European Foundation for the Study of Diabetes (EFSD); German Diabetes Association (DDG); European Foundation for the Study of Diabetes [AZ Macrov 2014_2] Funding Source: researchfish	German Competence Network Diabetes mellitus - Federal Ministry of Education and Research; European Foundation for the Study of Diabetes (EFSD); German Diabetes Association (DDG); European Foundation for the Study of Diabetes	The study was supported by the German Competence Network Diabetes mellitus (diabetes meta-database) funded by the Federal Ministry of Education and Research (FKZ 01GI1106) (https://www.bmbf.de/), now integrated into the German Center for Diabetes Research (DZD) (https://www.dzd-ev.de/) as of January 2015. Further financial support was provided by the European Foundation for the Study of Diabetes (EFSD) (http://www.europeandiabetesfoundation.org/), and by the German Diabetes Association (DDG) (http://www.deutsche-diabetes-gesellschaft.de/home.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altobelli E, 2000, ACTA DIABETOL, V37, P173, DOI 10.1007/s005920070001; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Bangstad HJ, 2009, PEDIATR DIABETES, V10, P82, DOI 10.1111/j.1399-5448.2009.00578.x; Blum RW, 2002, PEDIATRICS, V110, P1304; Cameron FJ, 2015, LANCET, V385, P2096, DOI 10.1016/S0140-6736(15)60971-0; Carstensen B, 2008, DIABETOLOGIA, V51, P2187, DOI 10.1007/s00125-008-1156-z; Cengiz E, 2013, PEDIATR DIABETES, V14, P447, DOI 10.1111/pedi.12030; Danne T, 2007, ARCH DIS CHILD, V92, P1015, DOI 10.1136/adc.2006.094904; de Beaufort CE, 2007, DIABETES CARE, V30, P2245, DOI 10.2337/dc07-0475; Grabert M, 2002, COMPUT METH PROG BIO, V69, P115, DOI 10.1016/S0169-2607(02)00035-4; Grunberger G, 2014, ENDOCR PRACT, V20, P463, DOI 10.4158/EP14145.PS; Hattersley AT, 2014, LANCET DIABETES ENDO, V2, P194, DOI 10.1016/S2213-8587(13)70179-7; Hofer S, 2012, MINERVA PEDIATR, V64, P433; Hofer SE, 2014, J PEDIAT, V165, pe1; Icks A, 2013, EXP CLIN ENDOCR DIAB, V121, P58, DOI 10.1055/s-0032-1312639; Karges B, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001742; Margeirsdottir HD, 2010, PEDIATR DIABETES, V11, P88, DOI 10.1111/j.1399-5448.2009.00542.x; Miller KM, 2015, DIABETES CARE, V38, P971, DOI 10.2337/dc15-0078; Neu A, 2015, DIABETOL STOFFWECHS, V10, pS181; Otto T, 2014, GESUNDH QUAL, V19, P126, DOI 10.1055/s-0033-1355963; Phillip M, 2007, DIABETES CARE, V30, P1653, DOI 10.2337/dc07-9922; Prinz N, 2016, DIABETES TECHNOL THE, V18, P34, DOI 10.1089/dia.2015.0180; Redon I, 2014, PEDIATR DIABETES, V15, P329, DOI 10.1111/pedi.12062; Rohrer TR, 2015, DIABETES CARE, V38, P801, DOI 10.2337/dc14-0683; Rosario AS, 2010, EUR J CLIN NUTR, V64, P341, DOI 10.1038/ejcn.2010.8; Rosenbauer J, 2012, DIABETES CARE, V35, P80, DOI 10.2337/dc11-0993; Svensson J, 2009, PEDIATR DIABETES, V10, P461, DOI 10.1111/j.1399-5448.2008.00460.x; Svoren BM, 2007, J PEDIATR-US, V150, P279, DOI 10.1016/j.jpeds.2006.12.009; Waite P, 2015, J ABNORM CHILD PSYCH, V43, P1079, DOI 10.1007/s10802-015-0005-z	29	41	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160971	10.1371/journal.pone.0160971	http://dx.doi.org/10.1371/journal.pone.0160971			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532627	Green Published, gold			2022-12-26	WOS:000381487600051
J	Casonato, A; Cattini, MG; Daidone, V; Pontara, E; Bertomoro, A; Prandoni, P				Casonato, Alessandra; Cattini, Maria Grazia; Daidone, Viviana; Pontara, Elena; Bertomoro, Antonella; Prandoni, Paolo			Diagnostic Value of Measuring Platelet Von Willebrand Factor in Von Willebrand Disease	PLOS ONE			English	Article							ABO BLOOD-GROUP; BONE-MARROW-TRANSPLANTATION; VONWILLEBRAND-FACTOR; MULTIMERIC STRUCTURE; BINDING-ACTIVITY; FACTOR MUTATION; PLASMA; PROTEOLYSIS; ADAMTS13; SURVIVAL	Von Willebrand disease (VWD) may be caused by an impaired von Willebrand factor (VWF) synthesis, its increased clearance or abnormal function, or combinations of these factors. It may be difficult to recognize the different contributions of these anomalies. Here we demonstrate that VWD diagnostics gains from measuring platelet VWF, which can reveal a defective VWF synthesis. Measuring platelet VWF revealed that: severe type 1 VWD always coincided with significantly lower platelet and plasma VWF levels, whereas mild forms revealed low plasma VWF levels associated with low or normal platelet VWF levels, and the latter were associated with a slightly shorter VWF survival; type Vicenza (the archetype VWD caused by a reduced VWF survival) featured normal platelet VWF levels despite significantly reduced plasma VWF levels; type 2B patients could have either normal platelet VWF levels associated with abnormal multimer patterns, or reduced platelet VWF levels associated with normal multimer patterns; type 2A patients could have reduced or normal platelet VWF levels, the former associated mainly with type 2A-I, the latter with type 2A-II; plasma and platelet VWF levels were normal in type 2N, except when the defect was associated with a quantitative VWF mutation. Our findings show that measuring platelet VWF helps to characterize VWD, especially the ambiguous phenotypes, shedding light on the mechanisms underlying the disorder.	[Casonato, Alessandra; Bertomoro, Antonella] Univ Padua, Sch Med, Dept Med, Padua, Italy; [Cattini, Maria Grazia; Daidone, Viviana; Pontara, Elena; Prandoni, Paolo] Univ Padua, Sch Med, Dept Cardiol Thorac & Vasc Sci, Padua, Italy	University of Padua; University of Padua	Casonato, A (corresponding author), Univ Padua, Sch Med, Dept Med, Padua, Italy.	andra.casonato@unipd.it			Ministero dell'Universita e della Ricerca Scientifica e Tecnologica	Ministero dell'Universita e della Ricerca Scientifica e Tecnologica(Ministry of Education, Universities and Research (MIUR))	This work was supported by a grant from the Ministero dell'Universita e della Ricerca Scientifica e Tecnologica (60%, 2013). AC received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowen DJ, 2003, J THROMB HAEMOST, V1, P33, DOI 10.1046/j.1538-7836.2003.00007.x; BOWIE EJW, 1986, J CLIN INVEST, V78, P26, DOI 10.1172/JCI112560; Brown SA, 2002, THROMB HAEMOSTASIS, V87, P990; Casonato A, 2015, THROMB RES, V136, P682, DOI 10.1016/j.thromres.2015.07.014; Casonato A, 2002, BLOOD, V99, P180, DOI 10.1182/blood.V99.1.180; Casonato A, 1997, J LAB CLIN MED, V129, P251, DOI 10.1016/S0022-2143(97)90147-5; CASONATO A, 1989, BLOOD, V74, P2028; CASONATO A, 1992, BLOOD COAGUL FIBRIN, V3, P149, DOI 10.1097/00001721-199204000-00003; Casonato A, 1998, AM J CLIN PATHOL, V109, P347, DOI 10.1093/ajcp/109.3.347; Casonato A, 2007, THROMB HAEMOSTASIS, V98, P1182, DOI 10.1160/TH07-05-0347; Casonato A, 2010, TRANSL RES, V155, P200, DOI 10.1016/j.trsl.2009.12.003; CASTILLO R, 1991, BLOOD, V77, P1901; Eikenboom JCJ, 2002, THROMB HAEMOSTASIS, V87, P252; Eikenboom J, 2013, BLOOD, V121, P2336, DOI 10.1182/blood-2012-09-455089; FERNANDEZ MFL, 1982, BLOOD, V60, P1132; FOSTER PA, 1987, J BIOL CHEM, V262, P8443; FRESSINAUD E, 1994, BRIT J HAEMATOL, V86, P327, DOI 10.1111/j.1365-2141.1994.tb04734.x; Gallinaro L, 2008, BLOOD, V111, P3540, DOI 10.1182/blood-2007-11-122945; Gallinaro L, 2006, THROMB HAEMOSTASIS, V96, P711, DOI 10.1160/TH06-07-0417; GRALNICK HR, 1986, BLOOD, V68, P58; Kagami K, 2000, Nagoya J Med Sci, V63, P51; LYONS SE, 1992, J BIOL CHEM, V267, P4424; MANCUSO DJ, 1989, J BIOL CHEM, V264, P19514; MANNUCCI PM, 1985, BLOOD, V66, P796; Matsui T, 1999, BLOOD, V94, P2895, DOI 10.1182/blood.V94.8.2895.420a03_2895_2900; MAYADAS TN, 1991, ANN NY ACAD SCI, V614, P153, DOI 10.1111/j.1749-6632.1991.tb43700.x; McGrath RT, 2013, BLOOD, V122, P4107, DOI 10.1182/blood-2013-04-496851; NACHMAN RL, 1975, J EXP MED, V141, P1101, DOI 10.1084/jem.141.5.1101; NICHOLS TC, 1995, P NATL ACAD SCI USA, V92, P2455, DOI 10.1073/pnas.92.7.2455; Sadler JE, 2006, J THROMB HAEMOST, V4, P2103, DOI 10.1111/j.1538-7836.2006.02146.x; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Schneppenheim R, 2000, THROMB HAEMOSTASIS, V83, P136; SWEENEY JD, 1992, THROMB RES, V68, P393, DOI 10.1016/0049-3848(92)90097-T; TSAI HM, 1991, BRIT J HAEMATOL, V79, P239, DOI 10.1111/j.1365-2141.1991.tb04528.x; WEISS HJ, 1983, J LAB CLIN MED, V101, P411; WILLIAMS SB, 1994, BRIT J HAEMATOL, V88, P582, DOI 10.1111/j.1365-2141.1994.tb05077.x	36	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161310	10.1371/journal.pone.0161310	http://dx.doi.org/10.1371/journal.pone.0161310			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532107	Green Submitted, Green Published, gold			2022-12-26	WOS:000381487600084
J	Guo, WH; Chen, YY; Wei, N; Feng, XY				Guo, Weihua; Chen, Yingying; Wei, Na; Feng, Xueyang			Investigate the Metabolic Reprogramming of Saccharomyces cerevisiae for Enhanced Resistance to Mixed Fermentation Inhibitors via C-13 Metabolic Flux Analysis	PLOS ONE			English	Article							ACETIC-ACID; TOLERANCE; YEAST; STRESS; ADAPTATION; ACETATE; GENES	The fermentation inhibitors from the pretreatment of lignocellulosic materials, e.g., acetic acid and furfural, are notorious due to their negative effects on the cell growth and chemical production. However, the metabolic reprogramming of the cells under these stress conditions, especially metabolic response for resistance to mixed inhibitors, has not been systematically investigated and remains mysterious. Therefore, in this study, C-13 metabolic flux analysis (C-13-MFA), a powerful tool to elucidate the intracellular carbon flux distributions, has been applied to two Saccharomyces cerevisiae strains with different tolerances to the inhibitors under acetic acid, furfural, and mixed (i.e., acetic acid and furfural) stress conditions to unravel the key metabolic responses. By analyzing the intracellular carbon fluxes as well as the energy and cofactor utilization under different conditions, we uncovered varied metabolic responses to different inhibitors. Under acetate stress, ATP and NADH production was slightly impaired, while NADPH tended towards overproduction. Under furfural stress, ATP and cofactors (including both NADH and NADPH) tended to be overproduced. However, under dual-stress condition, production of ATP and cofactors was severely impaired due to synergistic stress caused by the simultaneous addition of two fermentation inhibitors. Such phenomenon indicated the pivotal role of the energy and cofactor utilization in resisting the mixed inhibitors of acetic acid and furfural. Based on the discoveries, valuable insights are provided to improve the tolerance of S. cerevisiae strain and further enhance lignocellulosic fermentation.	[Guo, Weihua; Feng, Xueyang] Virginia Polytech Inst & State Univ, Dept Biol Syst Engn, Blacksburg, VA 24061 USA; [Chen, Yingying; Wei, Na] Univ Notre Dame, Dept Civil & Environm Engn & Earth Sci, Notre Dame, IN 46556 USA	Virginia Polytechnic Institute & State University; University of Notre Dame	Feng, XY (corresponding author), Virginia Polytech Inst & State Univ, Dept Biol Syst Engn, Blacksburg, VA 24061 USA.; Wei, N (corresponding author), Univ Notre Dame, Dept Civil & Environm Engn & Earth Sci, Notre Dame, IN 46556 USA.	nwei@nd.edu; xueyang@vt.edu	Guo, Weihua/AGF-9090-2022; chen, ying/HHS-8254-2022	Feng, Xueyang/0000-0003-4426-5732	Institute for Critical Technology and Applied Science from Virginia Polytechnic Institute and State University [175323, J0663185]; University of Notre Dame; Institute for Critical Technology and Applied Science from Virginia Tech [175323, J0663185]	Institute for Critical Technology and Applied Science from Virginia Polytechnic Institute and State University; University of Notre Dame; Institute for Critical Technology and Applied Science from Virginia Tech	This study was supported by a start-up fund (#175323) and Junior Faculty Award of Institute for Critical Technology and Applied Science (#J0663185 to XYF) from Virginia Polytechnic Institute and State University, and a start-up fund from the University of Notre Dame.; We thank the writing center in Virginia Tech for improving the language of the paper. This study was supported by a start-up fund (#175323) and Junior Faculty Award of Institute for Critical Technology and Applied Science (#J0663185) from Virginia Tech and a start-up fund from the University of Notre Dame.	Almeida JRM, 2007, J CHEM TECHNOL BIOT, V82, P340, DOI 10.1002/jctb.1676; BANERJEE N, 1981, EUR J APPL MICROBIOL, V11, P226, DOI 10.1007/BF00505872; Bauer BE, 2003, EUR J BIOCHEM, V270, P3189, DOI 10.1046/j.1432-1033.2003.03701.x; Cakir T, 2004, BIOTECHNOL BIOENG, V86, P251, DOI 10.1002/bit.20020; Casal M, 1996, MICROBIOL-UK, V142, P1385, DOI 10.1099/13500872-142-6-1385; Chen Y, 2016, APPLIED AND ENVIRONM; Chen YY, 2016, APPL ENVIRON MICROB, V82, P2156, DOI 10.1128/AEM.03718-15; Chen YY, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-015-0418-5; Cvijovic M, 2010, NUCLEIC ACIDS RES, V38, pW144, DOI 10.1093/nar/gkq404; Feng XY, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-114; Feng Xueyang, 2012, Methods Mol Biol, V881, P309, DOI 10.1007/978-1-61779-827-6_11; Giannattasio S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00033; Gorsich SW, 2006, APPL MICROBIOL BIOT, V71, P339, DOI 10.1007/s00253-005-0142-3; Guo Weihua, 2016, Bioengineering-Basel, V3, P3, DOI 10.3390/bioengineering3010003; Hasunuma T, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-2; Heer D, 2009, APPL ENVIRON MICROB, V75, P7631, DOI 10.1128/AEM.01649-09; Heer D, 2008, MICROB BIOTECHNOL, V1, P497, DOI 10.1111/j.1751-7915.2008.00050.x; Hohmann S, 2003, YEAST STRESS RESPONS; Horvath IS, 2003, APPL ENVIRON MICROB, V69, P4076, DOI 10.1128/AEM.69.7.4076-4086.2003; Jarboe LR, 2011, CURR OPIN CHEM ENG, V1, P38, DOI 10.1016/j.coche.2011.08.003; Jonsson LJ, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-16; Keating JD, 2006, BIOTECHNOL BIOENG, V93, P1196, DOI 10.1002/bit.20838; Kim SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057048; KREBS HA, 1952, BIOCHEM J, V51, P614, DOI 10.1042/bj0510614; Lambert RJ, 1999, J APPL MICROBIOL, V86, P157, DOI 10.1046/j.1365-2672.1999.00646.x; Lee YJ, 2011, YEAST, V28, P153, DOI 10.1002/yea.1828; Li BZ, 2010, APPL MICROBIOL BIOT, V86, P1915, DOI 10.1007/s00253-010-2518-2; Lin FM, 2009, APPL ENVIRON MICROB, V75, P3765, DOI 10.1128/AEM.02594-08; Liu ZL, 2011, APPL MICROBIOL BIOT, V90, P809, DOI 10.1007/s00253-011-3167-9; MAIORELLA B, 1983, BIOTECHNOL BIOENG, V25, P103, DOI 10.1002/bit.260250109; Martin C, 2007, BIORESOURCE TECHNOL, V98, P1767, DOI 10.1016/j.biortech.2006.07.021; Mira NP, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-79; Mira NP, 2010, OMICS, V14, P525, DOI 10.1089/omi.2010.0072; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; NIKAWA J, 1991, J BIOL CHEM, V266, P11184; Palmqvist E, 1999, BIOTECHNOL BIOENG, V63, P46, DOI 10.1002/(SICI)1097-0290(19990405)63:1<46::AID-BIT5>3.0.CO;2-J; Palmqvist E, 1999, BIOTECHNOL BIOENG, V62, P447, DOI 10.1002/(SICI)1097-0290(19990220)62:4<447::AID-BIT7>3.3.CO;2-S; Palmqvist E, 2000, BIORESOURCE TECHNOL, V74, P17, DOI 10.1016/S0960-8524(99)00160-1; Semchyshyn HM, 2011, REDOX REP, V16, P15, DOI 10.1179/174329211X12968219310954; Sousa MJ, 2012, STRESS CELL DEATH YE, DOI [10.1179/174329211X12968219310954, DOI 10.1179/174329211X12968219310954]; Taherzadeh MJ, 2000, J BIOSCI BIOENG, V90, P374, DOI 10.1263/jbb.90.374; Wahl SA, 2004, BIOTECHNOL BIOENG, V85, P259, DOI 10.1002/bit.10909; Zamboni N, 2009, NAT PROTOC, V4, P878, DOI 10.1038/nprot.2009.58; Zhang JG, 2011, BIOTECHNOL LETT, V33, P277, DOI 10.1007/s10529-010-0433-3; Zheng DQ, 2011, J IND MICROBIOL BIOT, V38, P415, DOI 10.1007/s10295-010-0784-8	45	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161448	10.1371/journal.pone.0161448	http://dx.doi.org/10.1371/journal.pone.0161448			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532329	Green Published, gold, Green Submitted			2022-12-26	WOS:000381487600096
J	Kano, Y; Dudgeon, D; Nam, S; Samejima, H; Watanabe, K; Grudpan, C; Grudpan, J; Magtoon, W; Musikasinthorn, P; Nguyen, PT; Praxaysonbath, B; Sato, T; Shibukawa, K; Shimatani, Y; Suvarnaraksha, A; Tanaka, W; Thach, P; Tran, DD; Yamashita, T; Utsugi, K				Kano, Yuichi; Dudgeon, David; Nam, So; Samejima, Hiromitsu; Watanabe, Katsutoshi; Grudpan, Chaiwut; Grudpan, Jarungjit; Magtoon, Wichan; Musikasinthorn, Prachya; Phuong Thanh Nguyen; Praxaysonbath, Bounthob; Sato, Tomoyuki; Shibukawa, Koichi; Shimatani, Yukihiro; Suvarnaraksha, Apinun; Tanaka, Wataru; Thach, Phanara; Dac Dinh Tran; Yamashita, Tomomi; Utsugi, Kenzo			Impacts of Dams and Global Warming on Fish Biodiversity in the Indo-Burma Hotspot	PLOS ONE			English	Article							FRESH-WATER BIODIVERSITY; CLIMATE-CHANGE; FUTURE; FLOW; HYDROPOWER; SCENARIOS; SECURITY; PATTERNS; THREATS; WORLDS	Both hydropower dams and global warming pose threats to freshwater fish diversity. While the extent of global warming may be reduced by a shift towards energy generation by large dams in order to reduce fossil-fuel use, such dams profoundly modify riverine habitats. Furthermore, the threats posed by dams and global warming will interact: for example, dams constrain range adjustments by fishes that might compensate for warming temperatures. Evaluation of their combined or synergistic effects is thus essential for adequate assessment of the consequences of planned water-resource developments. We made projections of the responses of 363 fish species within the Indo-Burma global biodiversity hotspot to the separate and joint impacts of dams and global warming. The hotspot encompasses the Lower Mekong Basin, which is the world's largest freshwater capture fishery. Projections for 81 dam-building scenarios revealed progressive impacts upon projected species richness, habitable area, and the proportion of threatened species as generating capacity increased. Projections from 126 global-warming scenarios included a rise in species richness, a reduction in habitable area, and an increase in the proportion of threatened species; however, there was substantial variation in the extent of these changes among warming projections. Projections from scenarios that combined the effects of dams and global warming were derived either by simply adding the two threats, or by combining them in a synergistic manner that took account of the likelihood that habitat shifts under global warming would be constrained by river fragmentation. Impacts on fish diversity under the synergistic projections were 10-20% higher than those attributable to additive scenarios, and were exacerbated as generating capacity increased-particularly if CO2 emissions remained high. The impacts of dams, especially those on river mainstreams, are likely to be greater, more predictable and more immediately pressing for fishes than the consequences of global warming. Limits upon dam construction should therefore be a priority action for conserving fish biodiversity in the Indo-Burma hotspot. This would minimize synergistic impacts attributable to dams plus global warming, and help ensure the continued provision of ecosystem services represented by the Lower Mekong fishery.	[Kano, Yuichi; Shimatani, Yukihiro; Yamashita, Tomomi] Kyushu Univ, Inst Decis Sci Sustainable Soc, Fukuoka, Fukuoka, Japan; [Dudgeon, David] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Nam, So; Thach, Phanara] Inland Fisheries Res & Dev Inst Fisheries Adm, Phnom Penh, Cambodia; [Samejima, Hiromitsu] Inst Global Environm Strategies, Hayama, Kanagawa, Japan; [Samejima, Hiromitsu; Shimatani, Yukihiro] Kyushu Univ, Dept Urban & Environm Engn, Fukuoka, Fukuoka, Japan; [Watanabe, Katsutoshi] Kyoto Univ, Dept Zool, Kyoto, Kyoto, Japan; [Grudpan, Chaiwut; Grudpan, Jarungjit] Ubon Ratchathani Univ, Dept Fisheries, Ubon Ratchathani, Thailand; [Magtoon, Wichan] Mahasakham Univ, Dept Biol, Maha Sarakham, Thailand; [Musikasinthorn, Prachya] Kasetsart Univ, Fac Fisheries, Bangkok, Thailand; [Phuong Thanh Nguyen; Dac Dinh Tran] Can Tho Univ, Dept Fisheries Management & Econ, Chan Tho, Vietnam; [Praxaysonbath, Bounthob] Natl Univ Laos, Fac Sci, Viangchan, Laos; [Sato, Tomoyuki] Siem Reap Freshwater Fishes Lab, Siem Reap, Cambodia; [Shibukawa, Koichi; Utsugi, Kenzo] Nagao Nat Environm Fdn, Tokyo, Japan; [Shibukawa, Koichi] Museum Nat & Environm Hist, Shizuoka, Shizuoka, Japan; [Suvarnaraksha, Apinun] Maejo Univ, Fac Fisheries Technol & Aquat Resources, Chiang Mai, Thailand; [Tanaka, Wataru] Kyushu Univ, Grad Educ & Res Training Program Decis Sci Sustai, Fukuoka, Fukuoka, Japan	Kyushu University; University of Hong Kong; Kyushu University; Kyoto University; Ubon Ratchathani University; Kasetsart University; Can Tho University; Maejo University; Kyushu University	Kano, Y (corresponding author), Kyushu Univ, Inst Decis Sci Sustainable Soc, Fukuoka, Fukuoka, Japan.	kano@species.jp		Kano, Yuichi/0000-0001-7158-753X	Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [S9-4-7]; JSPS KAKENHI Grant [26304007]; JSPS Program for Leading Graduate Schools (Graduate Education and Research Training Program in Decision Science for a Sustainable Society)	Environment Research and Technology Development Fund of the Ministry of the Environment, Japan(Ministry of the Environment, Japan); JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS Program for Leading Graduate Schools (Graduate Education and Research Training Program in Decision Science for a Sustainable Society)	This research was financially supported, in part, by grants from the Environment Research and Technology Development Fund (S9-4-7) of the Ministry of the Environment, Japan, JSPS KAKENHI Grant Number 26304007, and JSPS Program for Leading Graduate Schools (Graduate Education and Research Training Program in Decision Science for a Sustainable Society). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study. We declare all the funding or sources of support received during this study.	Akin S, 2005, ESTUAR COAST SHELF S, V64, P671, DOI 10.1016/j.ecss.2005.03.019; Allan JD, 2005, BIOSCIENCE, V55, P1041, DOI 10.1641/0006-3568(2005)055[1041:OOIW]2.0.CO;2; Allen D.J., 2012, STATUS DISTRIBUTION; Baran E, 2009, AQUAT ECOSYST HEALTH, V12, P227, DOI 10.1080/14634980903149902; Baran E, 2010, MEKONG RIVER COMMISS, P1; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Besnard AG, 2013, DIVERS DISTRIB, V19, P955, DOI 10.1111/ddi.12047; Beven K.J., 1979, HYDROL SCI B, V24, P43, DOI [10.1080/02626667909491834, DOI 10.1080/02626667909491834]; Bezuijen MR, 2011, WETLAND BIODIVERSITY; CEPF (Critical Ecosystem Partnership Fund), 2012, EC PROF IND BIOD HOT; CGIAR Research Program on Water Land and Ecosystems, 2015, MEK DAM MAP; Comte L, 2013, DIVERS DISTRIB, V19, P996, DOI 10.1111/ddi.12078; Comte L, 2013, FRESHWATER BIOL, V58, P625, DOI 10.1111/fwb.12081; Conti L, 2015, ECOGRAPHY, V38, P510, DOI 10.1111/ecog.00753; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Dudgeon D, 2007, WA SCI TECHNOL, V7, P69, DOI 10.2166/ws.2007.042; Dudgeon D, 2000, ANNU REV ECOL SYST, V31, P239, DOI 10.1146/annurev.ecolsys.31.1.239; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Dugan PJ, 2010, AMBIO, V39, P344, DOI 10.1007/s13280-010-0036-1; Edenhofer O., 2014, CONTRIBUTION WORKING; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fitzpatrick MC, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00066.1; Fourcade Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097122; Grill G, 2014, ECOL INDIC, V45, P148, DOI 10.1016/j.ecolind.2014.03.026; Heino J, 2009, BIOL REV, V84, P39, DOI 10.1111/j.1469-185X.2008.00060.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hortle KG, 2009, AQUAT ECOL-SAN DIEGO, P197, DOI 10.1016/B978-0-12-374026-7.00009-7; Institute for Global Environmental Strategies (IGES), 2013, IGES MARK MECH COUNT; IUCN, 2012, IUCN RED LIST CATEGO, VSecond edition; Junk WJ, 2006, AQUAT SCI, V68, P400, DOI 10.1007/s00027-006-0856-z; Jutagate Tuantong, 2003, Kasetsart Journal Natural Sciences, V37, P101; Kano Y, 2013, ICHTHYOL RES, V60, P293, DOI 10.1007/s10228-013-0349-8; Kramer-Schadt S, 2013, DIVERS DISTRIB, V19, P1366, DOI 10.1111/ddi.12096; Kummu M, 2007, GEOMORPHOLOGY, V85, P275, DOI 10.1016/j.geomorph.2006.03.024; Lao PDR, 2015, INTENDED NATL DETERM; Lehner B, 2011, FRONT ECOL ENVIRON, V9, P494, DOI 10.1890/100125; Markovic D, 2014, DIVERS DISTRIB, V20, P1097, DOI 10.1111/ddi.12232; Mekong River Commission (MRC), 2009, HYDR PROJ DAT; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nagao Natural Environment Foundation (NEF), 2011, REP RES WIS US CONS; NASA Socioeconomic Data and Applications Center (SEDAC), 2011, GLOB RES DAM GRAND V; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Ormerod SJ, 2010, FRESHWATER BIOL, V55, P1, DOI 10.1111/j.1365-2427.2009.02395.x; Orr S, 2012, GLOBAL ENVIRON CHANG, V22, P925, DOI 10.1016/j.gloenvcha.2012.06.002; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Poulsen A.F., 2002, MRC TECH PAP; Roberts Tyson R., 2001, Natural History Bulletin of the Siam Society, V49, P189; Roberts Tyson R., 2002, Natural History Bulletin of the Siam Society, V50, P135; Royle JA, 2012, METHODS ECOL EVOL, V3, P545, DOI 10.1111/j.2041-210X.2011.00182.x; Strayer DL, 2010, J N AM BENTHOL SOC, V29, P344, DOI 10.1899/08-171.1; Syvitski JPM, 2009, NAT GEOSCI, V2, P681, DOI 10.1038/NGEO629; Tedesco PA, 2013, J APPL ECOL, V50, P1105, DOI 10.1111/1365-2664.12125; UNEP (United Nations Environment Programme), 2010, BLUE HARVEST INLAND; United States Geological Survey (USGS), 1997, HYDRO1K; USGS, 1996, GLOB 30 ARC 2 EL GTO; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; WCD, 2000, PAK MUN DAN MEK RIV; WCS, 2005, LAST WILD PROJ VERS; Winemiller KO, 2016, SCIENCE, V351, P128, DOI 10.1126/science.aac7082; World Commission on Dams, 2000, DAMS DEV NEW FRAMEWO; World Wide Fund for Nature (WWF), 2001, TERR EC WORLD; Xenopoulos MA, 2005, GLOBAL CHANGE BIOL, V11, P1557, DOI 10.1111/j.1365-2486.2005.001008.x; Xu JC, 2009, CONSERV BIOL, V23, P520, DOI 10.1111/j.1523-1739.2009.01237.x; Ziv G, 2012, P NATL ACAD SCI USA, V109, P5609, DOI 10.1073/pnas.1201423109	66	27	28	4	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160151	10.1371/journal.pone.0160151	http://dx.doi.org/10.1371/journal.pone.0160151			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532150	Green Published, gold, Green Submitted			2022-12-26	WOS:000381487600025
J	Li, ZY; Wang, H				Li, Zhongyi; Wang, Hao			Interactive Tooth Separation from Dental Model Using Segmentation Field	PLOS ONE			English	Article							MESH SEGMENTATION	Tooth segmentation on dental model is an essential step of computer-aided-design systems for orthodontic virtual treatment planning. However, fast and accurate identifying cutting boundary to separate teeth from dental model still remains a challenge, due to various geometrical shapes of teeth, complex tooth arrangements, different dental model qualities, and varying degrees of crowding problems. Most segmentation approaches presented before are not able to achieve a balance between fine segmentation results and simple operating procedures with less time consumption. In this article, we present a novel, effective and efficient framework that achieves tooth segmentation based on a segmentation field, which is solved by a linear system defined by a discrete Laplace-Beltrami operator with Dirichlet boundary conditions. A set of contour lines are sampled from the smooth scalar field, and candidate cutting boundaries can be detected from concave regions with large variations of field data. The sensitivity to concave seams of the segmentation field facilitates effective tooth partition, as well as avoids obtaining appropriate curvature threshold value, which is unreliable in some case. Our tooth segmentation algorithm is robust to dental models with low quality, as well as is effective to dental models with different levels of crowding problems. The experiments, including segmentation tests of varying dental models with different complexity, experiments on dental meshes with different modeling resolutions and surface noises and comparison between our method and the morphologic skeleton segmentation method are conducted, thus demonstrating the effectiveness of our method.	[Li, Zhongyi; Wang, Hao] Huazhong Univ Sci & Technol, Sch Hydropower & Informat Engn, Wuhan, Hubei Province, Peoples R China	Huazhong University of Science & Technology	Wang, H (corresponding author), Huazhong Univ Sci & Technol, Sch Hydropower & Informat Engn, Wuhan, Hubei Province, Peoples R China.	wanghao4110@hust.edu.cn		Wang, Hao/0000-0001-9355-1319				Attene M, 2006, VISUAL COMPUT, V22, P181, DOI 10.1007/s00371-006-0375-x; Au OKC, 2007, ACM T GRAPHIC, V26, DOI 10.1145/1239451.1239534; Au OKC, 2012, IEEE T VIS COMPUT GR, V18, P1125, DOI 10.1109/TVCG.2011.131; Axler Sheldon, 2001, GRAD TEXT M, V137, DOI 10.1007/978-1-4757-8137-3; Barnfather KDP, 2007, BRIT DENT J, V202, P731, DOI 10.1038/bdj.2007.534; Bell RB, 2010, ORAL MAXIL SURG CLIN, V22, P135, DOI 10.1016/j.coms.2009.10.010; Cignoni P, 2008, ERCIM NEWS, V73, P47; Grauer D, 2012, J ESTHET RESTOR DENT, V24, P3, DOI 10.1111/j.1708-8240.2011.00500.x; Grzegorzek M, 2010, LECT NOTES COMPUT SC, V6134, P521, DOI 10.1007/978-3-642-13681-8_61; Hoffman DD, 1997, COGNITION, V63, P29, DOI 10.1016/S0010-0277(96)00791-3; HOFFMAN DD, 1984, COGNITION, V18, P65, DOI 10.1016/0010-0277(84)90022-2; Katz S., 2003, HIERARCHICAL MESH DE, V22; Kihara T, 2012, AM J ORTHOD DENTOFAC, V141, P806, DOI 10.1016/j.ajodo.2011.10.027; Kobbelt L., 1998, Computer Graphics. Proceedings. SIGGRAPH 98 Conference Proceedings, P105, DOI 10.1145/280814.280831; Kondo T, 2004, IEEE T MED IMAGING, V23, P350, DOI 10.1109/TMI.2004.824235; Kronfeld T., 2010, COMPUT AIDED APPL, V7, P221, DOI [10.3722/cadaps.2010.221-233, DOI 10.3722/CADAPS.2010.221-233]; Kumar Y., 2012, COMPUT AIDED APPL, V9, P747, DOI [10.3722/cadaps.2012.747-769, DOI 10.3722/CADAPS.2012.747-769]; Kumar Y., 2011, COMPUT AIDED APPL, V8, P211, DOI [10.3722/cadaps.2011.211-224, DOI 10.3722/CADAPS.2011.211-224, DOI 10.3722/cadaps.2011.211-224]; Lai YK, 2008, SPM 2008: PROCEEDINGS OF THE ACM SOLID AND PHYSICAL MODELING SYMPOSIUM, P183; Lai YK, 2009, COMPUT AIDED GEOM D, V26, P665, DOI 10.1016/j.cagd.2008.09.007; Li ZL, 2007, 2007 IEEE/ICME INTERNATIONAL CONFERENCE ON COMPLEX MEDICAL ENGINEERING, VOLS 1-4, P163, DOI 10.1109/ICCME.2007.4381713; Meng M, 2008, INTERACTIVE MESH SEG; Meng M, 2011, COMPUT ANIMAT VIRT W, V22, P334, DOI 10.1002/cav.422; Meng Min, 2008, Journal of Computer Aided Design & Computer Graphics, V20, P1146; Mortara M., 2004, P 9 ACM S SOL MOD AP, P339; Mouritsen D. A., 2013, AUTOMATIC SEGMENTATI; Pinkall U., 1993, EXP MATH, V2, P15, DOI DOI 10.1080/10586458.1993.10504266; Reniers D, 2007, IEEE INTERNATIONAL CONFERENCE ON SHAPE MODELING AND APPLICATIONS 2007, PROCEEDINGS, P179, DOI 10.1109/SMI.2007.33; Shapira L, 2008, VISUAL COMPUT, V24, P249, DOI 10.1007/s00371-007-0197-5; Shlafman S, 2002, COMPUT GRAPH FORUM, V21, P219, DOI 10.1111/1467-8659.00581; Sorkine O, 2005, IEEE T VIS COMPUT GR, V11, P171, DOI 10.1109/TVCG.2005.33; Tai Chiew-Lan, 2005, P S GEOM PROC; Wang H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104023; Wu K, 2014, COMPUT GRAPH-UK, V38, P199, DOI 10.1016/j.cag.2013.10.028; Yamany SM, 1999, PROC SPIE, V3640, P115, DOI 10.1117/12.341053; Yuan T., 2010, J BIOMED IMAGING, V2010, P9; Zayer R, 2005, COMPUT GRAPH FORUM, V24, P601, DOI 10.1111/j.1467-8659.2005.00885.x; Zhang H., 2005, PROC VISION MODELING, P429; Zhang JY, 2010, COMPUT GRAPH FORUM, V29, P517, DOI 10.1111/j.1467-8659.2009.01621.x; Zhao MX, 2005, P ANN INT IEEE EMBS, P654; Zheng YY, 2010, COMPUT GRAPH FORUM, V29, P527, DOI 10.1111/j.1467-8659.2009.01622.x	41	13	17	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161159	10.1371/journal.pone.0161159	http://dx.doi.org/10.1371/journal.pone.0161159			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532266	Green Published, gold			2022-12-26	WOS:000381487600067
J	Chung, SJ; Lee, JJ; Ham, JH; Ye, BS; Lee, PH; Sohn, YH				Chung, Su Jin; Lee, Jae Jung; Ham, Jee Hyun; Ye, Byoung Seok; Lee, Phil Hyu; Sohn, Young H.			Striatal Dopamine Depletion Patterns and Early Non-Motor Burden in Parkinsons Disease	PLOS ONE			English	Article							SYMPTOMS SCALE; PATHOLOGY; PET	Background The mechanism underlying non-motor symptoms in Parkinson's disease has not yet been elucidated. In this study, we hypothesized that Parkinson patients with more non-motor symptoms have a different pattern of striatal dopamine depletion, particularly in areas other than the sensorimotor striatum, compared to those with fewer non-motor symptoms. Methods We conducted a prospective survey of the degree of non-motor symptoms (using the Korean version of the Non-Motor Symptoms Scale; K-NMSS) in 151 patients with early-stage Parkinson's disease who had undergone a dopamine transporter PET scan as an initial diagnostic procedure. We classified the patients into two groups; high non-motor patients (HNM-PD; K-NMSS score >= 41) and low non-motor patients (LNM-PD). Results Patients in the HNM-PD group (n = 71) were older, had longer symptom duration, exhibited more severe motor deficits, and had been prescribed higher levodopa-equivalent doses at follow-up than those in the LNM-PD group. However, dopamine transporter binding to the striatal sub-regions and inter-sub-regional binding ratios were comparable between the two groups. A general linear model showed that the HNM-PD group had significantly more severe motor deficits than the LNM-PD group after controlling for age, gender, symptom duration, and dopamine transporter binding to the sensorimotor striatum. Conclusions This study demonstrated that the pattern of striatal dopamine depletion does not contribute to early non-motor burden in Parkinson's disease. Our results suggest that LNM-PD patients may have a more benign course of motor symptom progression than HNM-PD patients.	[Chung, Su Jin; Lee, Jae Jung; Ham, Jee Hyun; Ye, Byoung Seok; Lee, Phil Hyu; Sohn, Young H.] Yonsei Univ, Dept Neurol, Coll Med, Seoul, South Korea; [Lee, Jae Jung] Inje Univ, Dept Neurol, Ilsan Paik Hosp, Goyang, South Korea; [Lee, Phil Hyu] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea	Yonsei University; Yonsei University Health System; Inje University; Yonsei University; Yonsei University Health System	Sohn, YH (corresponding author), Yonsei Univ, Dept Neurol, Coll Med, Seoul, South Korea.	yhsohn62@yuhs.ac	Chung, Su Jin/G-5382-2019	Chung, Su Jin/0000-0002-9324-3284; Lee, Phil Hyu/0000-0001-9931-8462; Sohn, Young H./0000-0001-6533-2610; Ye, Byoung Seok/0000-0003-0187-8440				Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Chaudhuri KR, 2009, LANCET NEUROL, V8, P464, DOI 10.1016/S1474-4422(09)70068-7; Chaudhuri KR, 2007, MOVEMENT DISORD, V22, P1901, DOI 10.1002/mds.21596; Chaudhuri KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057221; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; Erro R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070244; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Haber SN, 2000, J NEUROSCI, V20, P2369; Jellinger KA, 2012, MOVEMENT DISORD, V27, P8, DOI 10.1002/mds.23795; Kingsbury AE, 2010, MOVEMENT DISORD, V25, P2508, DOI 10.1002/mds.23305; Koh SB, 2012, J CLIN NEUROL, V8, P276, DOI 10.3988/jcn.2012.8.4.276; Lee DH, 2015, NEUROLOGY, V85, P1270, DOI 10.1212/WNL.0000000000001999; Oh M, 2012, J NUCL MED, V53, P399, DOI 10.2967/jnumed.111.095224; PARENT A, 1995, BRAIN RES REV, V20, P91, DOI 10.1016/0165-0173(94)00007-C; Politis M, 2008, EXP NEUROL, V214, P112, DOI 10.1016/j.expneurol.2008.07.021; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Wang J, 2007, J NEUROL, V254, P185, DOI 10.1007/s00415-006-0322-9; Wolters EC, 2006, J NEURAL TRANSM-SUPP, P309; Yoo K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125455	19	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161316	10.1371/journal.pone.0161316	http://dx.doi.org/10.1371/journal.pone.0161316			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529171	Green Published, gold, Green Submitted			2022-12-26	WOS:000381476700065
J	Hou, ZF; Sun, GX; Guo, Y				Hou, Zhifei; Sun, Guoxiang; Guo, Yong			Linear Quantitative Profiling Method Fast Monitors Alkaloids of Sophora Flavescens That Was Verified by Tri-Marker Analyses	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; UP-REGULATION; MAST-CELLS; IN-VITRO; MATRINE; RADIX; EXTRACT; MICE; OXYMATRINE; INJECTION	The present study demonstrated the use of the Linear Quantitative Profiling Method (LQPM) to evaluate the quality of Alkaloids of Sophora flavescens (ASF) based on chromatographic fingerprints in an accurate, economical and fast way. Both linear qualitative and quantitative similarities were calculated in order to monitor the consistency of the samples. The results indicate that the linear qualitative similarity (LQLS) is not sufficiently discriminating due to the predominant presence of three alkaloid compounds (matrine, sophoridine and oxymatrine) in the test samples; however, the linear quantitative similarity (LQTS) was shown to be able to obviously identify the samples based on the difference in the quantitative content of all the chemical components. In addition, the fingerprint analysis was also supported by the quantitative analysis of three marker compounds. The LQTS was found to be highly correlated to the contents of the marker compounds, indicating that quantitative analysis of the marker compounds may be substituted with the LQPM based on the chromatographic fingerprints for the purpose of quantifying all chemicals of a complex sample system. Furthermore, once reference fingerprint (RFP) developed from a standard preparation in an immediate detection way and the composition similarities calculated out, LQPM could employ the classical mathematical model to effectively quantify the multiple components of ASF samples without any chemical standard.	[Hou, Zhifei; Sun, Guoxiang] Shenyang Pharmaceut Univ, Sch Pharm, Shenyang, Peoples R China; [Hou, Zhifei] Hebei Chem & Pharmaceut Coll, Dept Pharmaceut Engn, Shijiazhuang, Peoples R China; [Guo, Yong] Fairleigh Dickinson Univ, Sch Pharm, Florham Pk, NJ USA	Shenyang Pharmaceutical University; Hebei Chemical & Pharmaceutical College; Fairleigh Dickinson University	Sun, GX (corresponding author), Shenyang Pharmaceut Univ, Sch Pharm, Shenyang, Peoples R China.	gxswmwys@163.com		Guo, Yong/0000-0003-0488-3093				Araujo-Leon JA, 2015, J SEP SCI; Guo CR, 2014, PHYTOMEDICINE, V21, P807, DOI 10.1016/j.phymed.2014.02.007; Ho-sub L, 2001, AM J CHINESE MED, V29, P129; Huang XY, 2013, PHYTOMEDICINE, V20, P202, DOI 10.1016/j.phymed.2012.10.012; Ji Rui, 2013, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V31, P275; Ji Rui, 2013, Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi, V25, P280; Kan QC, 2015, EXP MOL PATHOL, V98, P124, DOI 10.1016/j.yexmp.2015.01.001; Kan QC, 2013, IMMUNOL RES, V56, P189, DOI 10.1007/s12026-013-8393-z; Kim BJ, 2012, J PHARMACOPUNCT, V15, P31, DOI 10.3831/KPI.2012.15.003; Kim HY, 2010, ANTIVIR THER, V15, P697, DOI 10.3851/IMP1615; Kim H, 2012, J ETHNOPHARMACOL, V142, P253, DOI 10.1016/j.jep.2012.04.053; Kim MC, 2012, J PHARMACOPUNCT, V15, P15, DOI 10.3831/KPI.2012.15.2.015; Ko E, 2007, LUPUS, V16, P335, DOI 10.1177/0961203307078228; Kwon KB, 2004, CLIN CHIM ACTA, V348, P79, DOI 10.1016/j.cccn.2004.05.003; Li Yan-qun, 2005, Weishengwu Xuebao, V45, P643; Liang YZ, 2010, PLANTA MED, V76, P1997, DOI 10.1055/s-0030-1250541; Liu JP, 2003, AM J CHINESE MED, V31, P337, DOI 10.1142/S0192415X03001107; Liu N, 2014, EXP MOL PATHOL, V97, P470, DOI 10.1016/j.yexmp.2014.10.004; Liu YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118223; Long G, 2009, PLANTA MED, V75, P1293, DOI 10.1055/s-0029-1185602; Lu J, 2013, MOL MED REP, V8, P227, DOI 10.3892/mmr.2013.1491; Sun Guo-xiang, 2009, Yaoxue Xuebao, V44, P401; Sun GX, 2014, ANAL METHODS-UK, V6, P838, DOI 10.1039/c3ay41670d; The State Commission of Chinese Pharmacopoeia, 2015, PHARMACOPOEIA OF PEO, V1, P202; The State Commission of Chinese Pharmacopoeia, 2002, THE STATE DRUG STAND, P27; Wang HY, 2012, J PHARMACEUT BIOMED, V58, P146, DOI 10.1016/j.jpba.2011.09.014; Wang W, 2015, ACTA PHARMACOL SIN, V36, P676, DOI 10.1038/aps.2015.24; Wang YZ, 2013, J TRADIT CHIN MED, V33, P218; Xiao ZM, 2013, AFR J TRADIT COMPLEM, V10, P352, DOI 10.4314/ajtcam.v10i5.22; Xu GP, 2015, TUMOR BIOL, V36, P1653, DOI 10.1007/s13277-014-2764-5; Yong JP, 2015, CURR PHARM DESIGN, V21, P3673, DOI 10.2174/1381612821666150122123748; Zeng XY, 2015, BRIT J PHARMACOL, V172, P4303, DOI 10.1111/bph.13209; Zhang L, 2015, INT J CLIN EXP MED, V8, P5591; Zhang S, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/736085; Zhang X, 2003, J ASIAN NAT PROD RES, V5, P171, DOI 10.1080/1028602031000082043; Zhao Feng-chun, 2015, Zhongguo Zhong Yao Za Zhi, V40, P245; Zhao P, 2015, INT J MOL MED, V36, P633, DOI 10.3892/ijmm.2015.2260; Zhao XY, 2011, AM J CHINESE MED, V39, P933, DOI 10.1142/S0192415X11009317; Zhao Y, 2015, J PHARMACEUT BIOMED, V107, P251, DOI 10.1016/j.jpba.2014.12.035	39	6	6	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161146	10.1371/journal.pone.0161146	http://dx.doi.org/10.1371/journal.pone.0161146			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529425	gold, Green Published			2022-12-26	WOS:000381476700049
J	Augusto, I; Monteiro, D; Girard-Dias, W; dos Santos, TO; Belmonte, SLR; de Oliveira, JP; Mauad, H; Pacheco, MD; Lenz, D; Bittencourt, AS; Nogueira, BV; dos Santos, JRL; Miranda, K; Guimaraes, MCC				Augusto, Ingrid; Monteiro, Douglas; Girard-Dias, Wendell; dos Santos, Thaisa Oliveira; Rosa Belmonte, Simone Leticia; de Oliveira, Jairo Pinto; Mauad, Helder; Pacheco, Marcos da Silva; Lenz, Dominik; Bittencourt, Athelson Stefanon; Nogueira, Breno Valentim; Lopes dos Santos, Jorge Roberto; Miranda, Kildare; Cunegundes Guimaraes, Marco Cesar			Virtual Reconstruction and Three-Dimensional Printing of Blood Cells as a Tool in Cell Biology Education	PLOS ONE			English	Article							ELECTRON-MICROSCOPY; TOMOGRAPHY; ORGANIZATION	The cell biology discipline constitutes a highly dynamic field whose concepts take a long time to be incorporated into the educational system, especially in developing countries. Amongst the main obstacles to the introduction of new cell biology concepts to students is their general lack of identification with most teaching methods. The introduction of elaborated figures, movies and animations to textbooks has given a tremendous contribution to the learning process and the search for novel teaching methods has been a central goal in cell biology education. Some specialized tools, however, are usually only available in advanced research centers or in institutions that are traditionally involved with the development of novel teaching/learning processes, and are far from becoming reality in the majority of life sciences schools. When combined with the known declining interest in science among young people, a critical scenario may result. This is especially important in the field of electron microscopy and associated techniques, methods that have greatly contributed to the current knowledge on the structure and function of different cell biology models but are rarely made accessible to most students. In this work, we propose a strategy to increase the engagement of students into the world of cell and structural biology by combining 3D electron microscopy techniques and 3D prototyping technology (3D printing) to generate 3D physical models that accurately and realistically reproduce a close-to-the native structure of the cell and serve as a tool for students and teachers outside the main centers. We introduce three strategies for 3D imaging, modeling and prototyping of cells and propose the establishment of a virtual platform where different digital models can be deposited by EM groups and subsequently downloaded and printed in different schools, universities, research centers and museums, thereby modernizing teaching of cell biology and increasing the accessibility to modern approaches in basic science.	[Augusto, Ingrid; dos Santos, Thaisa Oliveira; de Oliveira, Jairo Pinto; Nogueira, Breno Valentim; Cunegundes Guimaraes, Marco Cesar] Univ Fed Espirito Santo, Lab Ultraestrutura Celular Carlos Alberto Redins, Biotecnol, Vitoria, Brazil; [Mauad, Helder] Univ Fed Espirito Santo, Dept Fisiol, Vitoria, Brazil; [Pacheco, Marcos da Silva] Univ Fed Espirito Santo, Dept Morfol, Vitoria, Brazil; [Lenz, Dominik] Univ Vila Velha, Ciencias Farmaceut, Vila Velha, Brazil; [Bittencourt, Athelson Stefanon] Museu Ciencias Vida, Vitoria, Brazil; [Rosa Belmonte, Simone Leticia; Lopes dos Santos, Jorge Roberto] Pontificia Univ Catolica Rio de Janeiro, Rio de Janeiro, Brazil; [Augusto, Ingrid; Monteiro, Douglas; Girard-Dias, Wendell; Miranda, Kildare] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil; [Augusto, Ingrid; Monteiro, Douglas; Girard-Dias, Wendell; Miranda, Kildare] Univ Fed Rio de Janeiro, Ctr Nacl Biol Estrutural & Bioimagem, Rio De Janeiro, Brazil	Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo; Centro Universitario Vila Velha; Pontificia Universidade Catolica do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Guimaraes, MCC (corresponding author), Univ Fed Espirito Santo, Lab Ultraestrutura Celular Carlos Alberto Redins, Biotecnol, Vitoria, Brazil.; Miranda, K (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil.; Miranda, K (corresponding author), Univ Fed Rio de Janeiro, Ctr Nacl Biol Estrutural & Bioimagem, Rio De Janeiro, Brazil.	kmiranda@biof.ufrj.br; marco.guimaraes@ufes.br	OLIVEIRA, JAIRO/I-7147-2019; NOGUEIRA, BRENO VALENTIM/O-7459-2016; Monteiro, Douglas/W-9011-2019; NOGUEIRA, BRENO/X-7418-2019; Monteiro, Douglas/AAZ-1859-2021; Guimarães, Marco Cesar C/O-3917-2018	OLIVEIRA, JAIRO/0000-0001-7595-1183; NOGUEIRA, BRENO VALENTIM/0000-0002-2199-0635; NOGUEIRA, BRENO/0000-0002-2199-0635; Monteiro, Douglas/0000-0002-1407-6685; Guimarães, Marco Cesar C/0000-0003-2146-0180; Lenz, Dominik/0000-0001-6932-401X; AUGUSTO, INGRID/0000-0003-0651-0899	Ministry of Science and Technology CNPq [483036/2011-0]; Ministry of Education (MEC-PROEXT Grant); CAPES; FAPERJ; FAPES [018/2012]; FINEP (MCTI/FINEP/CT-INFRA); Instituto Nacional de Ciencia e Tecnologia em Biologia Estrutural e Bioimagens (INBEB)	Ministry of Science and Technology CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministry of Education (MEC-PROEXT Grant); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); FAPES(Fundacao de Amparo a Pesquisa do Estado de Espiritu Santo (FAPES)); FINEP (MCTI/FINEP/CT-INFRA); Instituto Nacional de Ciencia e Tecnologia em Biologia Estrutural e Bioimagens (INBEB)	This work was supported by grants from the following organizations and agencies to KM and MCG: Ministry of Science and Technology CNPq (Grant 483036/2011-0), Ministry of Education (MEC-PROEXT Grant 04/2011), CAPES, FAPERJ, FAPES (Grant 018/2012), FINEP (MCTI/FINEP/CT-INFRA), and the Instituto Nacional de Ciencia e Tecnologia em Biologia Estrutural e Bioimagens (INBEB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Mr. Helio Santos and Mr. Paulo Crepaldi for their help with the figures and movies. We are also very grateful for the copyediting work of Catherine Thorpe. This work was supported by grants from the following Brazilian organization and agencies to KM and MCG: Ministry of Science and Technology CNPq (Grant 483036/2011-0), Ministry of Education (MEC-PROEXT Grant 04/2011), CAPES, FAPERJ, FAPES (Grant 018/2012) and FINEP (MCTI/FINEP/CT-INFRA). The authors also acknowledge support from Instituto Nacional de Ciencia e Tecnologia em Biologia Estrutural e Bioimagens (INBEB) and declare no conflicts of interest.	[Anonymous], 2015, ENCY BRITANNICA; Baumeister W, 2002, CURR OPIN STRUC BIOL, V12, P679, DOI 10.1016/S0959-440X(02)00378-0; Braga SDMC, 2009, NAT M RES SCI ED NOV; Buabeng-Andoh C., 2012, INT J ED DEV USING I, V8, P136; Connell JL, 2013, P NATL ACAD SCI USA, V110, P18380, DOI 10.1073/pnas.1309729110; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Dorey E., 2014, CHEM IND, V78, P7; ELLIOTT DA, 2007, MICROSCOPY TODAY, V15, P30; FAHRENBACH WH, 1984, J ELECTRON MICR TECH, V1, P387, DOI 10.1002/jemt.1060010407; Girard-Dias W, 2012, HISTOCHEM CELL BIOL, V138, P821, DOI 10.1007/s00418-012-1002-8; Hajdu SI, 2003, ANN CLIN LAB SCI, V33, P237; Hooke R, 1665, SOME PHYSL DESCRIPTI; Horstmann H., 2012, PLOS ONE, V7, P1; Irving K. E., 2006, TEACHING SCI 21 CENT, P3; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; McIntosh JR, 2001, ELECTRON MICROS, V153, P25; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Miranda K, 2015, MOL REPROD DEV, V82, P530, DOI 10.1002/mrd.22455; OECD, 2006, EV STUD INT SCI TECH; Oppenheimer DM, 2006, APPL COGNITIVE PSYCH, V20, P139, DOI 10.1002/acp.1178; PALADE GEORGE E., 1956, JOUR BIOPHYS AND BIOCHEM CYTOL, V2, P85, DOI 10.1083/jcb.2.4.85; Price TR, BRIEF HIST 3D PRINTI; RUSKA E, 1987, BIOSCIENCE REP, V7, P607, DOI 10.1007/BF01127674; SAXTON WO, 1984, ULTRAMICROSCOPY, V13, P57, DOI 10.1016/0304-3991(84)90057-3; Medeiros LCS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033445; van Leeuwenhoek A., 1677, PHILOS T, V12, P821, DOI DOI 10.1098/RSTL.1677.0003; Wendt C, 2016, J STRUCT BIOL, V194, P171, DOI 10.1016/j.jsb.2016.02.014	27	4	4	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0161184	10.1371/journal.pone.0161184	http://dx.doi.org/10.1371/journal.pone.0161184			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27526196	Green Submitted, gold, Green Published			2022-12-26	WOS:000381471100040
J	Richie, DL; Takeoka, KT; Bojkovic, J; Metzger, LE; Rath, CM; Sawyer, WS; Wei, JR; Dean, CR				Richie, Daryl L.; Takeoka, Kenneth T.; Bojkovic, Jade; Metzger, Louis E.; Rath, Christopher M.; Sawyer, William S.; Wei, Jun-Rong; Dean, Charles R.			Toxic Accumulation of LPS Pathway Intermediates Underlies the Requirement of LpxH for Growth of Acinetobacter baumannii ATCC 19606	PLOS ONE			English	Article							ZINC-DEPENDENT DEACETYLASE; ACYL-CHAIN SPECIFICITY; COLISTIN RESISTANCE; ESCHERICHIA-COLI; ANTIBIOTIC-ACTIVITY; LIPOPOLYSACCHARIDE; BIOSYNTHESIS; ACYLTRANSFERASES; INHIBITION; DEFICIENT	The lipid A moiety of lipopolysaccharide (LPS) is the main constituent of the outer leaflet of the Gram-negative bacterial outer membrane (OM) and is essential in many Gram-negative pathogens. An exception is Acinetobacter baumannii ATCC 19606, where mutants lacking enzymes occurring early in lipid A biosynthesis (LpxA, LpxC or LpxD), and correspondingly lacking LPS, can grow. In contrast, we show here that LpxH, an enzyme that occurs downstream of LpxD in the lipid A biosynthetic pathway, is essential for growth in this strain. Multiple attempts to disrupt lpxH on the genome were unsuccessful, and when LpxH expression was controlled by an isopropyl beta-D-1-thiogalactopyranoside (IPTG) inducible promoter, cell growth under typical laboratory conditions required IPTG induction. Mass spectrometry analysis of cells shifted from LpxH-induced to uninduced (and whose growth was correspondingly slowing as LpxH was depleted) showed a large cellular accumulation of UDP2,3- diacyl-GlcN (substrate of LpxH), a C14: 0(3-OH) acyl variant of the LpxD substrate (UDP-3-O-[(R)-3-OH-C-14]-GlcN), and disaccharide 1-monophosphate (DSMP). Furthermore, the viable cell counts of the LpxH depleted cultures dropped modestly, and electron microscopy revealed clear defects at the cell (inner) membrane, suggesting lipid A intermediate accumulation was toxic. Consistent with this, blocking the synthesis of these intermediates by inhibition of the upstream LpxC enzyme using CHIR-090 abrogated the requirement for IPTG induction of LpxH. Taken together, these data indicate that LpxH is essential for growth in A. baumannii ATCC19606, because, unlike earlier pathway steps like LpxA or LpxC, blockage of LpxH causes accumulation of detergent-like pathway intermediates that prevents cell growth.	[Richie, Daryl L.; Takeoka, Kenneth T.; Bojkovic, Jade; Metzger, Louis E.; Rath, Christopher M.; Sawyer, William S.; Wei, Jun-Rong; Dean, Charles R.] Novartis Inst BioMed Res, Emeryville, CA USA	Novartis	Dean, CR (corresponding author), Novartis Inst BioMed Res, Emeryville, CA USA.	charlesr.dean@novartis.com		Sawyer, William/0000-0002-7593-1972	Novartis organization; Novartis	Novartis organization; Novartis(Novartis)	Funding of this research was provided solely within the Novartis organization as per standard research activities. The Novartis funders provided support in the form of salaries for authors [DLR, KTT, JB, LEMIV, CMR, WSS, J-RW, CRD], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adams MD, 2009, ANTIMICROB AGENTS CH, V53, P3628, DOI 10.1128/AAC.00284-09; Babinski KJ, 2002, J BIOL CHEM, P277; Bainbridge BW, 2008, J BACTERIOL, V190, P4549, DOI 10.1128/JB.00234-08; Barb AW, 2008, CURR PHARM BIOTECHNO, V9, P9; Barb AW, 2007, P NATL ACAD SCI USA, V104, P18433, DOI 10.1073/pnas.0709412104; Barb AW, 2007, BIOCHEMISTRY-US, V46, P3793, DOI 10.1021/bi6025165; Bartling CM, 2008, BIOCHEMISTRY-US, V47, P5290, DOI 10.1021/bi800240r; Beceiro A, 2014, ANTIMICROB AGENTS CH, V58, P518, DOI 10.1128/AAC.01597-13; Beceiro A, 2011, ANTIMICROB AGENTS CH, V55, P3370, DOI 10.1128/AAC.00079-11; Bojkovic J, 2015, J BACTERIOLOGY; Bos MP, 2005, INFECT IMMUN, V73, P6194, DOI 10.1128/IAI.73.9.6194-6197.2005; Cai Y, 2012, J ANTIMICROB CHEMOTH, V67, P1607, DOI 10.1093/jac/dks084; Clements JM, 2002, ANTIMICROB AGENTS CH, V46, P1793, DOI 10.1128/AAC.46.6.1793-1799.2002; de Berardinis V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.10; DeLucia AM, 2011, MBIO, V2, DOI 10.1128/mBio.00142-11; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Emiola A, 2016, P NATL ACAD SCI US; Emiola A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121216; Garcia-Quintanilla M, 2016, ANTIMICROBIAL AGENTS; Garrett TA, 1997, J BIOL CHEM, V272, P21855, DOI 10.1074/jbc.272.35.21855; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Jackman JE, 1999, BIOCHEMISTRY-US, V38, P1902, DOI 10.1021/bi982339s; Jenkins RJ, 2014, J BIOL CHEM, V289, P15527, DOI 10.1074/jbc.M114.564278; Jenkins RJ, 2012, ACS CHEM BIOL, V7, P1170, DOI 10.1021/cb300094a; Klein G, 2009, J BIOL CHEM, V284, P15369, DOI 10.1074/jbc.M900490200; Lin L, 2012, MBIO, V3, DOI 10.1128/mBio.00312-12; Manchanda V, 2010, J GLOB INFECT DIS, V2, P291, DOI 10.4103/0974-777X.68538; McClerren AL, 2005, BIOCHEMISTRY-US, V44, P16574, DOI 10.1021/bi0518186; Metzger LE, 2012, NAT STRUCT MOL BIOL, V19, P1132, DOI 10.1038/nsmb.2393; Metzger LE, 2010, BIOCHEMISTRY-US, V49, P6715, DOI 10.1021/bi1008744; Moffatt JH, 2011, ANTIMICROB AGENTS CH, V55, P3022, DOI 10.1128/AAC.01732-10; Moffatt JH, 2010, ANTIMICROB AGENTS CH, V54, P4971, DOI 10.1128/AAC.00834-10; Montgomery JI, 2012, J MED CHEM, V55, P1662, DOI 10.1021/jm2014875; Nayar AS, 2015, J BACTERIOL, V197, P1726, DOI 10.1128/JB.02552-14; Peng DX, 2005, INFECT IMMUN, V73, P7569, DOI 10.1128/IAI.73.11.7569-7577.2005; Piet JR, 2014, J INFECTION, V69, P352, DOI 10.1016/j.jinf.2014.06.005; Quan JY, 2011, NAT PROTOC, V6, P242, DOI 10.1038/nprot.2010.181; RADIKA K, 1988, J BIOL CHEM, V263, P14859; Raetz CRH, 2009, J LIPID RES, V50, pS103, DOI 10.1194/jlr.R800060-JLR200; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Srinivas N, 2010, SCIENCE, V327, P1010, DOI 10.1126/science.1182749; Steeghs L, 2001, EMBO J, V20, P6937, DOI 10.1093/emboj/20.24.6937; Steeghs L, 1998, NATURE, V392, P449, DOI 10.1038/33046; Sweet CR, 2002, J BIOL CHEM, V277, P18281, DOI 10.1074/jbc.M201057200; Sweet CR, 2001, J BIOL CHEM, V276, P19565, DOI 10.1074/jbc.M101868200; Walsh AG, 2000, MOL MICROBIOL, V35, P718, DOI 10.1046/j.1365-2958.2000.01741.x; Wang XY, 2010, PROG LIPID RES, V49, P97, DOI 10.1016/j.plipres.2009.06.002; Whitfield C, 2014, ANNU REV BIOCHEM, V83, P99, DOI 10.1146/annurev-biochem-060713-035600; Young HE, 2016, MBIO, V7, DOI 10.1128/mBio.00090-16; Young HE, 2013, J BIOL CHEM, V288, P26987, DOI 10.1074/jbc.M113.497636; Zhang G, 2013, CURR OPIN MICROBIOL, V16, P779, DOI 10.1016/j.mib.2013.09.007; Zhao X, 2002, J BIOL CHEM, V277, P4722, DOI 10.1074/jbc.M107803200	52	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0160918	10.1371/journal.pone.0160918	http://dx.doi.org/10.1371/journal.pone.0160918			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27526195	Green Published, gold, Green Submitted			2022-12-26	WOS:000381471100027
J	Shah, S; King, EM; Mostafa, MM; Altonsy, MO; Newton, R				Shah, Suharsh; King, Elizabeth M.; Mostafa, Mahmoud M.; Altonsy, Mohammed O.; Newton, Robert			DUSP1 Maintains IRF1 and Leads to Increased Expression of IRF1-dependent Genes A MECHANISM PROMOTING GLUCOCORTICOID INSENSITIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glucocorticoid; inflammation; innate immunity; interferon regulatory factor (IRF); mitogen-activated protein kinase (MAPK); CXCL10; DUSP1; glucocorticoid resistance; IRF1; MKP-1	ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; AIRWAY EPITHELIAL-CELLS; UBIQUITIN-PROTEASOME PATHWAY; SPECIFICITY PHOSPHATASE 1; INNATE IMMUNE-RESPONSES; SMOOTH-MUSCLE-CELLS; REGULATORY FACTOR-I; IFN-GAMMA; TRANSCRIPTION FACTORS	Although the mitogen-activated protein kinase (MAPK) phosphatase, DUSP1, mediates dexamethasone-induced repression of MAPKs, 14 of 46 interleukin-1 (IL1B)-induced mRNAs were significantly enhanced by DUSP1 overexpression in pulmonary A549 cells. These include the interferon regulatory factor, IRF1, and the chemokine, CXCL10. Of these, DUSP1-enhanced mRNAs, 10 including CXCL10, were IRF1-dependent. MAPK inhibitors and DUSP1 overexpression prolonged IRF1 expression by elevating transcription and increasing IRF1 mRNA and protein stability. Conversely, DUSP1 silencing increased IL1B-induced MAPK phosphorylation while significantly reducing IRF1 protein expression at 4 h. This confirms a regulatory network whereby DUSP1 switches off MAPKs to maintain IRF1 expression. There was no repression of IRF1 expression by dexamethasone in primary human bronchial epithelial cells, and in A549 cells IL1B-induced IRF1 protein was only modestly and transiently repressed. Although dexamethasone did not repress IL1B-induced IRF1 protein expression at 4-6 h, silencing of IL1B plus dexamethasone-induced DUSP1 significantly reduced IRF1 expression. IL1B-induced expression of CXCL10 was largely insensitive to dexamethasone, whereas other DUSP1-enhanced, IRF1-dependent mRNAs showed various degrees of repression. With IL1B plus dexamethasone, CXCL10 expression was also IRF1-dependent, and expression was reduced by DUSP1 silencing. Thus, IL1B plus dexamethasone-induced DUSP1 maintains expression of IRF1 and the IRF1-dependent gene, CXCL10. This is supported by chromatin immunoprecipitation showing IRF1 recruitment to be essentially unaffected by dexamethasone at the CXCL10 promoter or at the promoters of more highly repressed IRF1-dependent genes. Since IRF1-dependent genes, such as CXCL10, are central to host defense, these data may help explain the reduced effectiveness of glucocorticoids during asthma exacerbations.	[Shah, Suharsh; King, Elizabeth M.; Mostafa, Mahmoud M.; Altonsy, Mohammed O.; Newton, Robert] Univ Calgary, Snyder Inst Chron Dis, Airways Inflammat Res Grp, Calgary, AB T2N 4Z6, Canada; [Altonsy, Mohammed O.] Sohag Univ, Dept Zool, Sohag 825224, Egypt	University of Calgary; Egyptian Knowledge Bank (EKB); Sohag University	Newton, R (corresponding author), Univ Calgary, Dept Cell Biol & Anat, Calgary, AB T2N 4N1, Canada.	rnewton@ucalgary.ca	; Newton, Robert/C-6814-2012	Mostafa, Mahmoud/0000-0001-6377-911X; Newton, Robert/0000-0002-4919-8498; Altonsy, Mohammed Omar/0000-0002-9086-5934	Canadian Fund of Innovation (CFI); Alberta Science and Research Authority	Canadian Fund of Innovation (CFI); Alberta Science and Research Authority	Real-time PCR was performed by virtue of an equipment and infrastructure grant from the Canadian Fund of Innovation (CFI) and the Alberta Science and Research Authority.	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Barnes PJ, 2011, BRIT J PHARMACOL, V163, P29, DOI 10.1111/j.1476-5381.2010.01199.x; Carter AB, 1999, J BIOL CHEM, V274, P30858, DOI 10.1074/jbc.274.43.30858; Carter KB, 2000, J BIOL CHEM, V275, P27858; Chapin WJ, 2015, PHARMACOGENET GENOM, V25, P126, DOI 10.1097/FPC.0000000000000116; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; Chivers JE, 2006, MOL PHARMACOL, V70, P2084, DOI 10.1124/mol.106.025841; Clark AR, 2008, J BIOL CHEM, V283, P25765, DOI 10.1074/jbc.R700053200; Colonna M, 2007, EUR J IMMUNOL, V37, P306, DOI 10.1002/eji.200637009; Darnell JE, 2013, RNA, V19, P443, DOI 10.1261/rna.038596.113; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Diamond G, 2000, IMMUNOL REV, V173, P27, DOI 10.1034/j.1600-065X.2000.917304.x; Ehrchen J, 2007, BLOOD, V109, P1265, DOI 10.1182/blood-2006-02-001115; Galon J, 2002, FASEB J, V16, P61, DOI 10.1096/fj.01-0245com; Gavrila A, 2015, AM J RESP CELL MOL, V53, P728, DOI 10.1165/rcmb.2014-0477OC; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Hammer M, 2006, J EXP MED, V203, P15, DOI 10.1084/jem.20051753; Hayashi S, 2008, RESPIROLOGY, V13, P203, DOI 10.1111/j.1440-1843.2007.01204.x; Holden NS, 2004, EUR J BIOCHEM, V271, P785, DOI 10.1111/j.1432-1033.2004.03982.x; Huang GH, 2011, IMMUNITY, V35, P45, DOI 10.1016/j.immuni.2011.05.014; Huang Y, 2002, J IMMUNOL, V169, P2627, DOI 10.4049/jimmunol.169.5.2627; Hudy MH, 2010, EUR RESPIR J, V35, P1256, DOI 10.1183/09031936.00128809; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Jatakanon A, 1999, AM J RESP CRIT CARE, V160, P1532, DOI 10.1164/ajrccm.160.5.9806170; Jeffrey KL, 2006, NAT IMMUNOL, V7, P274, DOI 10.1038/ni1310; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Kadiyala V, 2016, J BIOL CHEM, V291, P12673, DOI 10.1074/jbc.M116.721217; Kim TK, 1996, SCIENCE, V273, P1717, DOI 10.1126/science.273.5282.1717; King EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053936; King EM, 2009, J BIOL CHEM, V284, P26803, DOI 10.1074/jbc.M109.028381; King EM, 2009, J PHARMACOL EXP THER, V330, P575, DOI 10.1124/jpet.109.151423; Korhonen R, 2012, MOL IMMUNOL, V51, P219, DOI 10.1016/j.molimm.2012.03.019; Laine Aaron, 2005, Sci STKE, V2005, pre5, DOI 10.1126/stke.2812005re5; LEIGH R, 2016, PHARMACOL RES PERSPE, V4, P1; Maki CG, 1996, CANCER RES, V56, P2649; Medoff BD, 2002, J IMMUNOL, V168, P5278, DOI 10.4049/jimmunol.168.10.5278; Miyamoto NG, 2000, J NEUROIMMUNOL, V105, P78, DOI 10.1016/S0165-5728(00)00195-8; Nakagawa K, 2000, EUR J BIOCHEM, V267, P1680, DOI 10.1046/j.1432-1327.2000.01163.x; Newton R, 2000, BRIT J PHARMACOL, V130, P1353, DOI 10.1038/sj.bjp.0703431; Newton R, 2014, EUR J PHARMACOL, V724, P231, DOI 10.1016/j.ejphar.2013.05.035; Newton R, 2010, BIOCHEM J, V427, P113, DOI 10.1042/BJ20091038; Newton R, 2010, PHARMACOL THERAPEUT, V125, P286, DOI 10.1016/j.pharmthera.2009.11.003; O'Connell D, 2015, AM J PHYSIOL-LUNG C, V309, pL348, DOI 10.1152/ajplung.00099.2015; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Pawliczak R, 2005, PHYSIOL GENOMICS, V23, P28, DOI 10.1152/physiolgenomics.00011.2005; Renauld JC, 2001, J CLIN PATHOL, V54, P577, DOI 10.1136/jcp.54.8.577; Sakai A, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-2; Sasse SK, 2016, AM J PHYSIOL-LUNG C, V311, pL421, DOI 10.1152/ajplung.00179.2016; Sasse SK, 2013, MOL CELL BIOL, V33, P2104, DOI 10.1128/MCB.01474-12; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; Schleimer Robert P, 2004, Proc Am Thorac Soc, V1, P222, DOI 10.1513/pats.200402-018MS; Shah S, 2016, J BIOL CHEM, V291, P110, DOI 10.1074/jbc.M115.697599; Shah S, 2014, J BIOL CHEM, V289, P13667, DOI 10.1074/jbc.M113.540799; Shi LH, 2011, GENE, V487, P21, DOI 10.1016/j.gene.2011.07.004; Smallie T, 2015, J IMMUNOL, V195, P277, DOI 10.4049/jimmunol.1402830; Stellato C, 2007, J ALLERGY CLIN IMMUN, V120, P1247, DOI 10.1016/j.jaci.2007.10.041; Szczepankiewicz BG, 2006, J MED CHEM, V49, P3563, DOI 10.1021/jm060199b; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Tliba O, 2008, AM J RESP CELL MOL, V38, P463, DOI 10.1165/rcmb.2007-0226OC; van de Garde MDB, 2014, J IMMUNOL, V192, P1196, DOI 10.4049/jimmunol.1302138; Wang YL, 2008, RESP MED, V102, P949, DOI 10.1016/j.rmed.2008.01.017; Wark PAB, 2007, J ALLERGY CLIN IMMUN, V120, P586, DOI 10.1016/j.jaci.2007.04.046; WATANABE N, 1991, NUCLEIC ACIDS RES, V19, P4421, DOI 10.1093/nar/19.16.4421; Zaheer RS, 2010, AM J RESP CELL MOL, V43, P413, DOI 10.1165/rcmb.2009-0203OC; Zaheer RS, 2009, J IMMUNOL, V182, P4854, DOI 10.4049/jimmunol.0802401; Zhang N, 2007, J IMMUNOL, V179, P578, DOI 10.4049/jimmunol.179.1.578; Zhao BM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134984; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794; Zhou XB, 2000, P NATL ACAD SCI USA, V97, P14329, DOI 10.1073/pnas.250494697	69	14	14	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21802	21816		10.1074/jbc.M116.728964	http://dx.doi.org/10.1074/jbc.M116.728964			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27551049	Green Published, hybrid			2022-12-26	WOS:000385999200043
J	Smith, SS; Dole, NS; Franceschetti, T; Hrdlicka, HC; Delany, AM				Smith, Spenser S.; Dole, Neha S.; Franceschetti, Tiziana; Hrdlicka, Henry C.; Delany, Anne M.			MicroRNA-433 Dampens Glucocorticoid Receptor Signaling, Impacting Circadian Rhythm and Osteoblastic Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bone; circadian; circadian rhythm; glucocorticoid receptor; microRNA (miRNA); microRNA mechanism; osteoblast; post-transcriptional regulation	MESSENGER-RNA; I COLLAGEN; TISSUE SENSITIVITY; BONE-FORMATION; STEM-CELLS; ERR-GAMMA; METABOLISM; MECHANISMS; TRANSCRIPTOME; OSTEOPOROSIS	Serum glucocorticoids play a critical role in synchronizing circadian rhythm in peripheral tissues, and multiple mechanisms regulate tissue sensitivity to glucocorticoids. In the skeleton, circadian rhythm helps coordinate bone formation and resorption. Circadian rhythm is regulated through transcriptional and post-transcriptional feedback loops that include microRNAs. How microRNAs regulate circadian rhythm in bone is unexplored. We show that in mouse calvaria, miR-433 displays robust circadian rhythm, peaking just after dark. In C3H/10T1/2 cells synchronized with a pulse of dexamethasone, inhibition of miR-433 using a tough decoy altered the period and amplitude of Per2 gene expression, suggesting that miR-433 regulates rhythm. Although miR-433 does not directly target the Per2 3-UTR, it does target two rhythmically expressed genes in calvaria, Igf1 and Hif1. miR-433 can target the glucocorticoid receptor; however, glucocorticoid receptor protein abundance was unaffected in miR-433 decoy cells. Rather, miR-433 inhibition dramatically enhanced glucocorticoid signaling due to increased nuclear receptor translocation, activating glucocorticoid receptor transcriptional targets. Last, in calvaria of transgenic mice expressing a miR-433 decoy in osteoblastic cells (Col3.6 promoter), the amplitude of Per2 and Bmal1 mRNA rhythm was increased, confirming that miR-433 regulates circadian rhythm. miR-433 was previously shown to target Runx2, and mRNA for Runx2 and its downstream target, osteocalcin, were also increased in miR-433 decoy mouse calvaria. We hypothesize that miR-433 helps maintain circadian rhythm in osteoblasts by regulating sensitivity to glucocorticoid receptor signaling.	[Smith, Spenser S.; Dole, Neha S.; Franceschetti, Tiziana; Hrdlicka, Henry C.; Delany, Anne M.] UConn Hlth, Ctr Mol Med, 263 Farmington Ave, Farmington, CT 06030 USA; [Dole, Neha S.] Univ Calif San Francisco, Sch Med, Dept Orthoped Surg, San Francisco, CA 94143 USA; [Franceschetti, Tiziana] Univ Aberdeen, Inst Med Sci, Aberdeen AB25 2ZD, Scotland	University of California System; University of California San Francisco; University of Aberdeen	Delany, AM (corresponding author), UConn Hlth, Ctr Mol Med, 263 Farmington Ave, Farmington, CT 06030 USA.	adelany@uchc.edu		Franceschetti, Tiziana/0000-0002-8839-0247; Dole, Neha/0000-0003-4675-2649; Smith, Spenser/0000-0002-3984-3174; Hrdlicka, Henry/0000-0002-7014-7919	NIAMS, National Institutes of Health [AR044877]; NIDCR, National Institutes of Health [5T90DE21989]; American Society for Bone and Mineral Research; UConn Health Center Research Advisory Council; Center for Molecular Medicine at UConn Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R56AR044877, R29AR044877, R01AR044877] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE021989] Funding Source: NIH RePORTER	NIAMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); American Society for Bone and Mineral Research; UConn Health Center Research Advisory Council; Center for Molecular Medicine at UConn Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by NIAMS, National Institutes of Health, Grant AR044877; NIDCR, National Institutes of Health, Grant 5T90DE21989; a Grant-in-Aid award from the American Society for Bone and Mineral Research; the UConn Health Center Research Advisory Council; and the Center for Molecular Medicine at UConn Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; BAMBERGER CM, 1995, J CLIN INVEST, V95, P2435, DOI 10.1172/JCI117943; Bamberger CM, 1996, ENDOCR REV, V17, P245, DOI 10.1210/er.17.3.245; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Cain DW, 2015, BEST PRACT RES CL EN, V29, P545, DOI 10.1016/j.beem.2015.04.007; Canalis E, 2007, OSTEOPOROSIS INT, V18, P1319, DOI 10.1007/s00198-007-0394-0; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Chung S, 2011, BBA-MOL BASIS DIS, V1812, P581, DOI 10.1016/j.bbadis.2011.02.003; DELANY AM, 1994, J CELL BIOCHEM, V56, P295, DOI 10.1002/jcb.240560304; Dufour CR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002143; Eckel-Mahan K, 2013, PHYSIOL REV, V93, P107, DOI 10.1152/physrev.00016.2012; Gatfield D, 2009, GENE DEV, V23, P1313, DOI 10.1101/gad.1781009; Gimble JM, 2009, J CELL BIOCHEM, V107, P569, DOI 10.1002/jcb.22153; Golombek DA, 2013, J PHYSIOL-PARIS, V107, P310, DOI 10.1016/j.jphysparis.2013.03.007; Haraguchi T, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp040; HASSAGER C, 1992, J BONE MINER RES, V7, P1307; Heshmati HM, 1998, J CLIN ENDOCR METAB, V83, P751, DOI 10.1210/jc.83.3.751; Hinds TD, 2010, MOL ENDOCRINOL, V24, P1715, DOI 10.1210/me.2009-0411; Jeong BC, 2010, J BONE MINER RES, V25, P262, DOI 10.1359/jbmr.090718; Kalajzic I, 2002, J BONE MINER RES, V17, P15, DOI 10.1359/jbmr.2002.17.1.15; Kalajzic Z, 2002, BONE, V31, P654, DOI 10.1016/S8756-3282(02)00912-2; Kawai M, 2010, ENDOCRINOLOGY, V151, P4861, DOI 10.1210/en.2010-0407; Kim EJ, 2013, LIFE SCI, V92, P562, DOI 10.1016/j.lfs.2013.01.015; Kojima S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011264; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Merrill GF, 1998, METHOD CELL BIOL, V57, P229; Moller-Levet CS, 2013, P NATL ACAD SCI USA, V110, pE1132, DOI 10.1073/pnas.1217154110; Moutsatsou P, 2012, TRENDS MOL MED, V18, P348, DOI 10.1016/j.molmed.2012.04.005; Na YJ, 2009, EXP MOL MED, V41, P638, DOI 10.3858/emm.2009.41.9.070; Nader N, 2010, TRENDS ENDOCRIN MET, V21, P277, DOI 10.1016/j.tem.2009.12.011; Nader N, 2009, FASEB J, V23, P1572, DOI 10.1096/fj.08-117697; Nandi A, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-45; Nicolaides NC, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-71; Ohlsson C, 2009, ENDOCR REV, V30, P494, DOI 10.1210/er.2009-0010; Oishi Katsutaka, 2006, J Circadian Rhythms, V4, P13, DOI 10.1186/1740-3391-4-13; PIETSCHMANN P, 1990, EUR J CLIN INVEST, V20, P310, DOI 10.1111/j.1365-2362.1990.tb01861.x; Reddy TE, 2012, MOL CELL BIOL, V32, P3756, DOI 10.1128/MCB.00062-12; Regan JN, 2014, P NATL ACAD SCI USA, V111, P8673, DOI 10.1073/pnas.1324290111; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Riester A, 2012, ENDOCRINOLOGY, V153, P212, DOI 10.1210/en.2011-1285; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Segall LA, 2010, J MOL NEUROSCI, V42, P168, DOI 10.1007/s12031-010-9341-1; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; Shipp LE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013754; Shomento SH, 2010, J CELL BIOCHEM, V109, P196, DOI 10.1002/jcb.22396; Simon D, 2010, HUM MOL GENET, V19, P2015, DOI 10.1093/hmg/ddq083; So AYL, 2009, P NATL ACAD SCI USA, V106, P17582, DOI 10.1073/pnas.0909733106; Son GH, 2008, P NATL ACAD SCI USA, V105, P20970, DOI 10.1073/pnas.0806962106; Song GS, 2008, NUCLEIC ACIDS RES, V36, P5727, DOI 10.1093/nar/gkn567; Villena JA, 2008, TRENDS ENDOCRIN MET, V19, P269, DOI 10.1016/j.tem.2008.07.005; Vollmers C, 2012, CELL METAB, V16, P833, DOI 10.1016/j.cmet.2012.11.004; Witt-Enderby PA, 2012, J PINEAL RES, V53, P374, DOI 10.1111/j.1600-079X.2012.01007.x; Wu XY, 2008, BONE, V42, P861, DOI 10.1016/j.bone.2007.12.226; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200; Zvonic S, 2007, J BONE MINER RES, V22, P357, DOI 10.1359/jbmr.061114	58	32	33	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21717	21728		10.1074/jbc.M116.737890	http://dx.doi.org/10.1074/jbc.M116.737890			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27551048	hybrid, Green Published			2022-12-26	WOS:000385999200036
J	Peterson, RL; Galaleldeen, A; Villarreal, J; Taylor, AB; Cabelli, DE; Hart, PJ; Culotta, VC				Peterson, Ryan L.; Galaleldeen, Ahmad; Villarreal, Johanna; Taylor, Alexander B.; Cabelli, Diane E.; Hart, P. John; Culotta, Valeria C.			The Phylogeny and Active Site Design of Eukaryotic Copper-only Superoxide Dismutases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANDIDA-ALBICANS; ZINC; BINDING; SOD1; PH; GENE; ERYTHROCUPREIN; MECHANISM; EVOLUTION; INSIGHTS	In eukaryotes the bimetallic Cu/Zn superoxide dismutase (SOD) enzymes play important roles in the biology of reactive oxygen species by disproportionating superoxide anion. Recently, we reported that the fungal pathogen Candida albicans expresses a novel copper-only SOD, known as SOD5, that lacks the zinc cofactor and electrostatic loop (ESL) domain of Cu/Zn-SODs for substrate guidance. Despite these abnormalities, C. albicans SOD5 can disproportionate superoxide at rates limited only by diffusion. Here we demonstrate that this curious copper-only SOD occurs throughout the fungal kingdom as well as in phylogenetically distant oomycetes or "pseudofungi" species. It is the only form of extracellular SOD in fungi and oomycetes, in stark contrast to the extracellular Cu/Zn-SODs of plants and animals. Through structural biology and biochemical approaches we demonstrate that these copper-only SODs have evolved with a specialized active site consisting of two highly conserved residues equivalent to SOD5 Glu-110 and Asp-113. The equivalent positions are zinc binding ligands in Cu/ZnSODs and have evolved in copper-only SODs to control catalysis and copper binding in lieu of zinc and the ESL. Similar to the zinc ion in Cu/Zn-SODs, SOD5 Glu-110 helps orient a key copper-coordinating histidine and extends the pH range of enzyme catalysis. SOD5 Asp-113 connects to the active site in a manner similar to that of the ESL in Cu/Zn-SODs and assists in copper cofactor binding. Copper-only SODs are virulence factors for certain fungal pathogens; thus this unique active site may be a target for future anti-fungal strategies.	[Peterson, Ryan L.; Culotta, Valeria C.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA; [Galaleldeen, Ahmad; Villarreal, Johanna] St Marys Univ, Dept Biol Sci, San Antonio, TX 78228 USA; [Galaleldeen, Ahmad; Taylor, Alexander B.; Hart, P. John] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Cabelli, Diane E.] Brookhaven Natl Labs, Dept Chem, Upton, NY 11973 USA; [Hart, P. John] South Texas Vet Hlth Care Syst, Dept Vet Affairs, Geriatr Res Educ & Clin Ctr, San Antonio, TX 78229 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Texas System; University of Texas Health San Antonio; United States Department of Energy (DOE); Brookhaven National Laboratory; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Culotta, VC (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA.	vculott1@jhu.edu		Taylor, Alexander/0000-0003-3517-6033; Galaleldeen, Ahmad/0000-0003-1160-6908	National Institutes of Health [P41 GM103403, P30 CA054174]; United States Department of Energy [DE-AC02-06CH11357]; Office of the Vice President for Research; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-98-CH10886]; NATIONAL CANCER INSTITUTE [T32CA009110, P30CA054174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM112320, R01GM050016, P41GM103403] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002580] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy(United States Department of Energy (DOE)); Office of the Vice President for Research; United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	We thank Drs. Julie Gleason and Brian Learn for helpful discussions and Professor Jiou Wang for assistance with protein purification. Support for Northeastern Collaborative Access Team beamline 24-ID-E was provided by National Institutes of Health Grant P41 GM103403 and United States Department of Energy Grant DE-AC02-06CH11357. The X-Ray Crystallography Core Laboratory at the University of Texas Health Science Center at San Antonio is supported in part by the Office of the Vice President for Research and by National Institutes of Health Grant P30 CA054174 (Cancer Therapy and Research Center). Pulse radiolysis studies were carried out using the Van de Graaff facilities of the BNL Accelerator Center for Energy Research, which is supported by United States Department of Energy, Office of Science, Office of Basic Energy Sciences through Grant DE-AC02-98-CH10886.	Abreu IA, 2010, BBA-PROTEINS PROTEOM, V1804, P263, DOI 10.1016/j.bbapap.2009.11.005; Achkar JM, 2010, CLIN MICROBIOL REV, V23, P253, DOI 10.1128/CMR.00076-09; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], PYMOL MOL GRAPH SYST; Antonyuk SV, 2009, J MOL BIOL, V388, P310, DOI 10.1016/j.jmb.2009.03.026; BANCI L, 1991, EUR J BIOCHEM, V196, P123, DOI 10.1111/j.1432-1033.1991.tb15794.x; Beakes GW, 2012, PROTOPLASMA, V249, P3, DOI 10.1007/s00709-011-0269-2; BENOV L, 1995, ARCH BIOCHEM BIOPHYS, V319, P508, DOI 10.1006/abbi.1995.1324; Broxton CN, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005295; CRAPO JD, 1992, P NATL ACAD SCI USA, V89, P10405, DOI 10.1073/pnas.89.21.10405; Davis D, 2003, CURR GENET, V44, P58, DOI [10.1007/s00294-003-0415-2, 10.1007/s00294-003-0431-2]; Ellerby LM, 1996, J AM CHEM SOC, V118, P6556, DOI 10.1021/ja953845x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FISHER CL, 1994, PROTEINS, V19, P24, DOI 10.1002/prot.340190105; Fisher CL, 1997, PROTEINS, V29, P103, DOI 10.1002/(SICI)1097-0134(199709)29:1<103::AID-PROT8>3.0.CO;2-G; FORMAN HJ, 1973, ARCH BIOCHEM BIOPHYS, V158, P396, DOI 10.1016/0003-9861(73)90636-X; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Fukai T, 2011, ANTIOXID REDOX SIGN, V15, P1583, DOI 10.1089/ars.2011.3999; GETZOFF ED, 1992, NATURE, V358, P347, DOI 10.1038/358347a0; Gleason JE, 2014, P NATL ACAD SCI USA, V111, P5866, DOI 10.1073/pnas.1400137111; Goto JJ, 1998, J BIOL CHEM, V273, P30104, DOI 10.1074/jbc.273.46.30104; Goto JJ, 2000, J BIOL CHEM, V275, P1007, DOI 10.1074/jbc.275.2.1007; Hart PJ, 1999, BIOCHEMISTRY-US, V38, P2167, DOI 10.1021/bi982284u; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; Huang P, 2000, NATURE, V407, P390, DOI 10.1038/35030140; Hwang CS, 2002, MICROBIOL-SGM, V148, P3705, DOI 10.1099/00221287-148-11-3705; Juarez JC, 2008, P NATL ACAD SCI USA, V105, P7147, DOI 10.1073/pnas.0709451105; Judelson HS, 2012, EUKARYOT CELL, V11, P1304, DOI 10.1128/EC.00155-12; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Latijnhouwers M, 2003, TRENDS MICROBIOL, V11, P462, DOI 10.1016/j.tim.2003.08.002; MARKLUND SL, 1982, P NATL ACAD SCI-BIOL, V79, P7634, DOI 10.1073/pnas.79.24.7634; MARKLUND SL, 1982, CLIN CHIM ACTA, V126, P41, DOI 10.1016/0009-8981(82)90360-6; Martchenko M, 2004, MOL BIOL CELL, V15, P456, DOI 10.1091/mbc.E03-03-0179; Mason KL, 2012, INFECT IMMUN, V80, P150, DOI 10.1128/IAI.05162-11; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Miramon P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052850; Ogihara NL, 1996, BIOCHEMISTRY-US, V35, P2316, DOI 10.1021/bi951930b; PANTOLIANO MW, 1982, J INORG BIOCHEM, V17, P325, DOI 10.1016/S0162-0134(00)80093-8; Perry JJP, 2010, BBA-PROTEINS PROTEOM, V1804, P245, DOI 10.1016/j.bbapap.2009.11.004; Potter SZ, 2007, J AM CHEM SOC, V129, P4575, DOI 10.1021/ja066690+; Qin ZY, 2006, FASEB J, V20, P334, DOI 10.1096/fj.05-4564fje; Reddi AR, 2013, CELL, V152, P224, DOI 10.1016/j.cell.2012.11.046; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Richards TA, 2006, CURR BIOL, V16, P1857, DOI 10.1016/j.cub.2006.07.052; Richards TA, 2011, P NATL ACAD SCI USA, V108, P15258, DOI 10.1073/pnas.1105100108; Richards TA, 2007, PLANT SIGNAL BEHAV, V2, P112, DOI 10.4161/psb.2.2.3640; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rosenbach A, 2010, EUKARYOT CELL, V9, P1075, DOI 10.1128/EC.00034-10; Sabharwal SS, 2014, NAT REV CANCER, V14, P709, DOI 10.1038/nrc3803; Seetharaman SV, 2010, BIOCHEMISTRY-US, V49, P5714, DOI 10.1021/bi100314n; Sheng YW, 2014, CHEM REV, V114, P3854, DOI 10.1021/cr4005296; Spagnolo L, 2004, J BIOL CHEM, V279, P33447, DOI 10.1074/jbc.M404699200; STROMQVIST M, 1991, J CHROMATOGR, V548, P293, DOI 10.1016/S0021-9673(01)88611-8; Sturtz LA, 2001, J BIOL CHEM, V276, P38084; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; VALENTINE JS, 1979, P NATL ACAD SCI USA, V76, P4245, DOI 10.1073/pnas.76.9.4245; Vylkova S, 2011, MBIO, V2, DOI 10.1128/mBio.00055-11; Youseff BH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002713	58	19	19	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					20911	20923		10.1074/jbc.M116.748251	http://dx.doi.org/10.1074/jbc.M116.748251			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27535222	hybrid, Green Published			2022-12-26	WOS:000385406200010
J	Soniat, M; Cagatay, T; Chook, YM				Soniat, Michael; Cagatay, Tolga; Chook, Yuh Min			Recognition Elements in the Histone H3 and H4 Tails for Seven Different Importins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-LOCALIZATION SIGNALS; NUCLEOSOME CORE PARTICLE; STRUCTURAL BASIS; CELL-CYCLE; IN-VIVO; NUCLEOCYTOPLASMIC TRANSPORT; LINKER HISTONES; T-ANTIGEN; PROTEIN; CHROMATIN	N-terminal tails of histones H3 and H4 are known to bind several different Importins to import the histones into the cell nucleus. However, it is not known what binding elements in the histone tails are recognized by the individual Importins. Biochemical studies of H3 and H4 tails binding to seven Importins, Imp beta, Kap beta 2, Imp4, Imp5, Imp7, Imp9, and Imp beta, show the H3 tail binding more tightly than the H4 tail. The H3 tail binds Kap beta 2 and Imp5 with K-D values of 77 and 57 nM, respectively, and binds the other five Importins more weakly. Mutagenic analysis shows H3 tail residues 11-27 to be the sole binding segment for Imp beta, Kap beta 2, and Imp4. However, Imp5, Imp7, Imp9, and Imp beta bind two separate elements in the H3 tail: the segment at residues 11-27 and an isoleucine-lysine nuclear localization signal (IK-NLS) motif at residues 35-40. The H4 tail also uses either one or two basic segments to bind the same set of Importins with a similar trend of relative affinities as the H3 tail, albeit at least 10-fold weaker. Of the many lysine residues in the H3 and H4 tails, only acetylation of the H3 Lys14 substantially decreased binding to several Importins. Lastly, we show that, in addition to the N-terminal tails, the histone fold domains of H3 and H4 and/or the histone chaperone Asf1b are important for Importin-histone recognition.	[Soniat, Michael; Cagatay, Tolga; Chook, Yuh Min] Univ Texas Southwestern, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Chook, YM (corresponding author), Univ Texas Southwestern, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	yuhmin.chook@utsouthwestern.edu	Chook, Yuh Min/AAA-9549-2019	Soniat, Michael/0000-0003-3670-4344	United States Department of Energy [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [P30CA142543] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM098256, R01GM069909] Funding Source: NIH RePORTER	United States Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Bing Li for histone constructs, Chad Brautigam and Thomas Scheuermann from the Macromolecular Biophysics Resource at University of Texas Southwestern for assistance in ITC experiments, Diana Tomchick and James Chen from Structural Biology Laboratory at University of Texas Southwestern for assistance in crystallographic data collection, Ho Yee Joyce Fung and Szu-Chin Fu for comments, and Xian-Jin Xie for help with statistical analysis. The use of SBC 19ID beamline at Advanced Photon Source is supported by United States Department of Energy Contract DE-AC02-06CH11357.	Alekseev OM, 2005, J BIOL CHEM, V280, P2904, DOI 10.1074/jbc.M410397200; Alvarez F, 2011, J BIOL CHEM, V286, P17714, DOI 10.1074/jbc.M111.223453; Annunziato AT, 2012, BBA-GENE REGUL MECH, V1819, P196, DOI 10.1016/j.bbagrm.2011.07.005; Baake M, 2001, EUR J CELL BIOL, V80, P669, DOI 10.1078/0171-9335-00208; Baake M, 2001, J CELL BIOCHEM, V81, P333, DOI 10.1002/1097-4644(20010501)81:2<333::AID-JCB1048>3.3.CO;2-4; Bevington PR., 2002, DATA REDUCTION ERROR; Blackwell JS, 2007, J BIOL CHEM, V282, P20142, DOI 10.1074/jbc.M701989200; Burgess RJ, 2013, NAT STRUCT MOL BIOL, V20, P14, DOI 10.1038/nsmb.2461; Campos EI, 2010, NAT STRUCT MOL BIOL, V17, P1343, DOI 10.1038/nsmb.1911; Cansizoglu AE, 2007, NAT STRUCT MOL BIOL, V14, P452, DOI 10.1038/nsmb1229; Chook YM, 1999, NATURE, V399, P230, DOI 10.1038/20375; Chook YM, 2002, BIOCHEMISTRY-US, V41, P6955, DOI 10.1021/bi012122p; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; Chook YM, 2011, BBA-MOL CELL RES, V1813, P1593, DOI 10.1016/j.bbamcr.2010.10.014; Cingolani G, 2002, MOL CELL, V10, P1345, DOI 10.1016/S1097-2765(02)00727-X; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; DINGWALL C, 1982, CELL, V30, P449, DOI 10.1016/0092-8674(82)90242-2; EICKBUSH TH, 1978, BIOCHEMISTRY-US, V17, P4955, DOI 10.1021/bi00616a016; Ejlassi-Lassallette A, 2011, MOL BIOL CELL, V22, P245, DOI 10.1091/mbc.E10-07-0633; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Giesecke A, 2010, J BIOL CHEM, V285, P17628, DOI 10.1074/jbc.M110.102343; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Greiner M, 2004, EUR J CELL BIOL, V83, P511, DOI 10.1078/0171-9335-00418; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Jakel S, 1998, EMBO J, V17, P4491, DOI 10.1093/emboj/17.15.4491; Jasencakova Z, 2010, MOL CELL, V37, P736, DOI 10.1016/j.molcel.2010.01.033; Johnson-Saliba M, 2000, FEBS LETT, V467, P169, DOI 10.1016/S0014-5793(00)01142-X; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; Keck KM, 2012, BBA-GENE REGUL MECH, V1819, P277, DOI 10.1016/j.bbagrm.2011.09.007; Kobayashi J, 2013, J MOL BIOL, V425, P1852, DOI 10.1016/j.jmb.2013.02.035; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Lam MHC, 1999, J BIOL CHEM, V274, P7391, DOI 10.1074/jbc.274.11.7391; LANFORD RE, 1984, CELL, V37, P801, DOI 10.1016/0092-8674(84)90415-X; Lange A, 2010, TRAFFIC, V11, P311, DOI 10.1111/j.1600-0854.2009.01028.x; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Li Y, 2014, GENE DEV, V28, P1217, DOI 10.1101/gad.240531.114; Lott K, 2011, BBA-MOL CELL RES, V1813, P1578, DOI 10.1016/j.bbamcr.2010.10.012; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 1999, METH MOL B, V119, P1; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; McLane LM, 2008, NUCLEIC ACIDS RES, V36, P4317, DOI 10.1093/nar/gkn383; Mosammaparast N, 2002, J BIOL CHEM, V277, P862, DOI 10.1074/jbc.M106845200; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Mousson F, 2005, P NATL ACAD SCI USA, V102, P5975, DOI 10.1073/pnas.0500149102; Muhlhausser P, 2001, EMBO REP, V2, P690, DOI 10.1093/embo-reports/kve168; Murzina NV, 2008, STRUCTURE, V16, P1077, DOI 10.1016/j.str.2008.05.006; Nakagawa T, 2001, J BIOL CHEM, V276, P27384, DOI 10.1074/jbc.M101331200; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; SMITH S, 1991, EMBO J, V10, P971, DOI 10.1002/j.1460-2075.1991.tb08031.x; Soniat M., 2016, STRUCTURE IN PRESS; Soniat M, 2015, BIOCHEM J, V468, P353, DOI 10.1042/BJ20150368; Suel KE, 2009, J BIOL CHEM, V284, P15416, DOI 10.1074/jbc.M809384200; Suel KE, 2008, PLOS BIOL, V6, P1253, DOI 10.1371/journal.pbio.0060137; Timney BL, 2006, J CELL BIOL, V175, P579, DOI 10.1083/jcb.200608141; Verreault A, 1998, CURR BIOL, V8, P96, DOI 10.1016/S0960-9822(98)70040-5; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207; Xu DR, 2015, BIOINFORMATICS, V31, P1357, DOI 10.1093/bioinformatics/btu826; Xu DR, 2010, CURR OPIN STRUC BIOL, V20, P782, DOI 10.1016/j.sbi.2010.09.008; Zhang ZC, 2012, P NATL ACAD SCI USA, V109, P12017, DOI 10.1073/pnas.1207247109; Zhang ZC, 2011, MOL BIOL CELL, V22, P4657, DOI 10.1091/mbc.E11-03-0222	62	25	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					21171	+		10.1074/jbc.M116.730218	http://dx.doi.org/10.1074/jbc.M116.730218			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27528606	Green Published, hybrid			2022-12-26	WOS:000385406200031
J	Bischof, J; Ibrahim, SM				Bischof, Julia; Ibrahim, Saleh M.			bcRep: R Package for Comprehensive Analysis of B Cell Receptor Repertoire Data	PLOS ONE			English	Article							DIVERSITY; SOFTWARE; IMMUNITY	Immunoglobulins, as well as T cell receptors, play a key role in adaptive immune responses because of their ability to recognize antigens. Recent advances in next generation sequencing improved also the quality and quantity of individual B cell receptors repertoire sequencing. Unfortunately, appropriate software to exhaustively analyze repertoire data from NGS platforms without limitations of the number of sequences are lacking. Here we introduce a new R package, bcRep, which offers a platform for comprehensive analyses of B cell receptor repertoires, using IMGT/HighV-QUEST formatted data. Methods for gene usage statistics, clonotype classification, as well as diversity measures, are included. Furthermore, functions to filter datasets, to do summary statistics about mutations, as well as visualization methods, are available. To compare samples in respect of gene usage, diversity, amino acid proportions, similar sequences or clones, several functions including also distance measurements, as well as multidimensional scaling methods, are provided.	[Bischof, Julia; Ibrahim, Saleh M.] Univ Lubeck, Inst Expt Dermatol, Lubeck, Germany	University of Lubeck	Bischof, J (corresponding author), Univ Lubeck, Inst Expt Dermatol, Lubeck, Germany.	Julia.Bischof@uksh.de	Ibrahim, Saleh/AAO-9541-2020	Ibrahim, Saleh/0000-0001-7827-2290	German science foundations [EXC-306, GRK1743]	German science foundations	This work was supported by the German science foundations grants: EXC-306 and the GRK1743, to Saleh Ibrahim.	Amit S., 2001, IEEE DATA ENG B, V24, P35; Bard GV, 2007, P 5 AUSTR S ACSW FRO, V68, P117; Bolotin DA, 2015, NAT METHODS, V12, P380, DOI 10.1038/nmeth.3364; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Broder AZ, 1997, COMPUT NETWORKS ISDN, V29, P1157, DOI 10.1016/S0169-7552(97)00031-7; Cardenas D, 2015, CLIN EXP IMMUNOL, V182, P173, DOI 10.1111/cei.12682; Gini C., 1997, RIV POLIT ECON, V87, P769; Gupta NT, 2015, BIOINFORMATICS, V31, P3356, DOI 10.1093/bioinformatics/btv359; HAMMING RW, 1950, BELL SYST TECH J, V29, P147, DOI 10.1002/j.1538-7305.1950.tb00463.x; He J, IRAP CHARACTERIZING; Jaccard P., 1912, NEW PHYTOL, V11, P37, DOI [10.1111/j.1469-8137.1912.tb05611.x, DOI 10.1111/J.1469-8137.1912.TB05611.X, DOI 10.1371/journal.pbio.1001889]; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Kramer JM, 2016, J LEUKOCYTE BIOL, V99, P321, DOI 10.1189/jlb.2A0715-297R; Levenshtein VI, 1966, SOV PHYS DOKL, V10, P707; Li S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3333; Martin V, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0237; Meyer M, 2015, PROXY DISTANCE SIMIL; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Oksanen J, 2022, R PACKAGE VERSION; R Core Team, 2013, R LANG ENV STAT COMP; Saifi M, 2015, IMMUNOL ALLERGY CLIN, V35, P731, DOI 10.1016/j.iac.2015.07.007; Schaller S, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0687-9; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Shugay M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004503; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; van der Loo MPJ, 2014, R J, V6, P111; Weston S., 2015, DOPARALLEL FOREACH P; Winkler W.E, 1990, P SECT SURV RES ISS	28	18	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0161569	10.1371/journal.pone.0161569	http://dx.doi.org/10.1371/journal.pone.0161569			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27551775	Green Published, Green Submitted, gold			2022-12-26	WOS:000381768800052
J	Classon, E; Fallman, K; Wressle, E; Marcusson, J				Classon, Elisabet; Fallman, Katarina; Wressle, Ewa; Marcusson, Jan			Relations between Concurrent Longitudinal Changes in Cognition, Depressive Symptoms, Self-Rated Health and Everyday Function in Normally Aging Octogenarians	PLOS ONE			English	Article							ADULT AGE-DIFFERENCES; MINI-MENTAL-STATE; QUALITY-OF-LIFE; OLDER-ADULTS; INSTRUMENTAL ACTIVITIES; DIGIT SYMBOL; SCREENING INSTRUMENTS; PROCESSING-SPEED; MEMORY DECLINE; PREDICTORS	Ability to predict and prevent incipient functional decline in older adults may help prolong independence. Cognition is related to everyday function and easily administered, sensitive cognitive tests may help identify at-risk individuals. Factors like depressive symptoms and self-rated health are also associated with functional ability and may be as important as cognition. The purpose of this study was to investigate the relationship between concurrent longitudinal changes in cognition, depression, self-rated health and everyday function in a well-defined cohort of healthy 85 year olds that were followed-up at the age of 90 in the Elderly in Linkoping Screening Assessment 85 study. Regression analyses were used to determine if cognitive decline as assessed by global (the Mini-Mental State Examination) and domain specific (the Cognitive Assessment Battery, CAB) cognitive tests predicted functional decline in the context of changes in depressive symptoms and self-rated health. Results showed deterioration in most variables and as many as 83% of these community-dwelling elders experienced functional difficulties at the age of 90. Slowing-down of processing speed as assessed by the Symbol Digits Modality Test (included in the CAB) accounted for 14% of the variance in functional decline. Worsening self-rated health accounted for an additional 6%, but no other variables reached significance. These results are discussed with an eye to possible preventive interventions that may prolong independence for the steadily growing number of normally aging old-old citizens.	[Classon, Elisabet; Fallman, Katarina; Wressle, Ewa; Marcusson, Jan] Linkoping Univ, Dept Acute Internal Med & Geriatr, Linkoping, Sweden; [Classon, Elisabet; Fallman, Katarina; Wressle, Ewa; Marcusson, Jan] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden	Linkoping University; Linkoping University	Classon, E (corresponding author), Linkoping Univ, Dept Acute Internal Med & Geriatr, Linkoping, Sweden.; Classon, E (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden.	elisabet.classon@liu.se	; Fallman, Katarina/Y-4314-2018	Classon, Elisabet/0000-0003-1403-6357; Fallman, Katarina/0000-0002-5289-8831	Health Research Council of the South-East of Sweden [FORSS-8888, FORSS-11636, FORSS-31811]; County of Ostergotland [LIO-11877, LIO-31321, LIO-79951, LIO-430341]; Janne Elgqvist Family Foundation	Health Research Council of the South-East of Sweden; County of Ostergotland; Janne Elgqvist Family Foundation	This work was supported by the Health Research Council of the South-East of Sweden (Grants: FORSS-8888, FORSS-11636, FORSS-31811. http://www.fou.nu/is/forss/), the County of Ostergotland (Grants: LIO-11877, LIO-31321, LIO-79951, LIO-430341. http://www.researchweb.org/is/lio/Regler_och_information_om_anslag) to EW and EC. EW was also supported by the Janne Elgqvist Family Foundation (http://stiftelsemedel.se/familjen-janne-elgqvists-stiftelse/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguero-Torres H, 2002, J CLIN EPIDEMIOL, V55, P1007, DOI 10.1016/S0895-4356(02)00461-4; Andersson LB, 2014, HEALTH SOC CARE COMM, V22, P368, DOI 10.1111/hsc.12088; Andren E, 1997, INSTRUMENTAL ACTIVIT; Appels BA, 2010, AM J ALZHEIMERS DIS, V25, P301, DOI 10.1177/1533317510367485; Backman L, 2004, AGING NEUROPSYCHOL C, V11, P212, DOI 10.1080/13825580490511099; Ball K, 2010, NEUROPSYCHOLOGY EVER; Ball K, 2007, J GERONTOL B-PSYCHOL, V62, P19, DOI 10.1093/geronb/62.special_issue_1.19; Bennett HP, 2006, J AM GERIATR SOC, V54, P3, DOI 10.1111/j.1532-5415.2005.00532.x; Bergdahl E, 2005, INT PSYCHOGERIATR, V17, P557, DOI 10.1017/S1041610205002267; BOLLER F, 1966, BRAIN, V89, P815, DOI 10.1093/brain/89.4.815; Bunce D, 2012, J PSYCHIATR RES, V46, P1662, DOI 10.1016/j.jpsychires.2012.08.023; Byers AL, 2011, NAT REV NEUROL, V7, P323, DOI 10.1038/nrneurol.2011.60; Cahn-Weiner DA, 2007, J INT NEUROPSYCH SOC, V13, P747, DOI 10.1017/S1355617707070853; Charles ST, 2010, ANNU REV PSYCHOL, V61, P383, DOI 10.1146/annurev.psych.093008.100448; Chodosh J, 2007, AM J GERIAT PSYCHIAT, V15, P406, DOI 10.1097/01.JGP.0b013e31802c0c63; Christensen K, 2013, LANCET, V382, P1507, DOI 10.1016/S0140-6736(13)60777-1; Collie A, 2001, NEUROLOGY, V56, P1533, DOI 10.1212/WNL.56.11.1533; Crawford JR, 2000, AGING NEUROPSYCHOL C, V7, P9, DOI 10.1076/anec.7.1.9.806; Davey A, 2004, J GERONTOL B-PSYCHOL, V59, pP270, DOI 10.1093/geronb/59.6.P270; de Craen AJM, 2003, INT J GERIATR PSYCH, V18, P63, DOI 10.1002/gps.773; de Paula JJ, 2015, FRONT AGING NEUROSCI, P7; Diehr PH, 2013, J GERONTOL A-BIOL, V68, P1059, DOI 10.1093/gerona/glt038; Dixon RA, 2004, MEM COGNITION, V32, P768, DOI 10.3758/BF03195867; Farias ST, 2003, ARCH CLIN NEUROPSYCH, V18, P655, DOI 10.1016/S0887-6177(02)00159-2; Fastame MC, 2015, APPL RES QUAL LIFE, V10, P459, DOI 10.1007/s11482-014-9323-5; Fastame MC, 2015, AGING MENT HEALTH, V19, P698, DOI 10.1080/13607863.2014.962003; Finkel D, 2007, PSYCHOL AGING, V22, P558, DOI 10.1037/0882-7974.22.3.558; Fischer J.S., 2012, NEUROPSYCHOLOGICAL A, V5th; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Folstein MF, 2001, MINI MENTAL STATE EX; Forn C, 2011, J CLIN EXP NEUROPSYC, V33, P42, DOI 10.1080/13803395.2010.481620; Gerstorf D, 2015, PSYCHOL AGING, V30, P301, DOI 10.1037/pag0000016; Goodglass H., 1983, BOSTON NAMING TEST; Gross AL, 2011, J GERONTOL B-PSYCHOL, V66, P557, DOI 10.1093/geronb/gbr033; IDLER EL, 1993, J GERONTOL, V48, pS289, DOI 10.1093/geronj/48.6.S289; Ismail Z, 2010, INT J GERIATR PSYCH, V25, P111, DOI 10.1002/gps.2306; Iwarsson S, 2009, J REHABIL MED, V41, P150, DOI 10.2340/16501977-0298; Janssen B., 2014, SELF REPORTED POPULA; Johansson MM, 2012, AGING NEUROPSYCHOL C, V19, P421, DOI 10.1080/13825585.2011.629290; Jopp DS, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-015-0167-0; Joy S, 2004, ARCH CLIN NEUROPSYCH, V19, P759, DOI 10.1016/j.acn.2003.09.009; Jylha M, 2009, SOC SCI MED, V69, P307, DOI 10.1016/j.socscimed.2009.05.013; Kalldalen A, 2012, OTJR-OCCUP PART HEAL, V32, P30, DOI 10.3928/15394492-20110623-01; Kobau R, 2004, HLTH QUALITY LIFE OU, V2; Kuo HK, 2005, J AM GERIATR SOC, V53, P1154, DOI 10.1111/j.1532-5415.2005.53368.x; Leinonen R, 2002, ARCH GERONTOL GERIAT, V35, P79, DOI 10.1016/S0167-4943(02)00017-1; Leinonen R, 2001, SOC SCI MED, V52, P1329, DOI 10.1016/S0277-9536(00)00249-5; Loewenstein D, 2010, NEUROPSYCHOLOGY EVER; Lyness JM, 2007, AM J GERIAT PSYCHIAT, V15, P214, DOI 10.1097/01.JGP.0000235763.50230.83; Makizako H, 2015, INT J ENV RES PUB HE, V12, P3002, DOI 10.3390/ijerph120303002; Marshall GA, 2011, ALZHEIMERS DEMENT, V7, P300, DOI 10.1016/j.jalz.2010.04.005; Nagga K, 2012, ARCH GERONTOL GERIAT, V54, P391, DOI 10.1016/j.archger.2011.04.023; Nordlund A, 2005, J NEUROL NEUROSUR PS, V76, P1485, DOI 10.1136/jnnp.2004.050385; Nordlund A, 2011, INT PSYCHOGERIATR, V23, P1144, DOI 10.1017/S1041610210002334; O'Brien JT, 2015, LANCET, V386, P1698, DOI 10.1016/S0140-6736(15)00463-8; Panagiotakos DB, 2011, CARDIOLOGY RES PRACT; Pereira FS, 2008, INT PSYCHOGERIATR, V20, P1104, DOI 10.1017/S1041610208007631; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Rebok GW, 2014, J AM GERIATR SOC, V62, P16, DOI 10.1111/jgs.12607; Regard M., 1981, THESIS; Reitan RM, 1992, TRAIL MAKING TEST MA; Reppermund S, 2011, INT J GERIATR PSYCH, V26, P843, DOI 10.1002/gps.2612; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Rog LA, 2014, CLIN NEUROPSYCHOL, V28, P215, DOI 10.1080/13854046.2013.876101; Rosano C, 2008, J AM GERIATR SOC, V56, P1618, DOI 10.1111/j.1532-5415.2008.01856.x; Royall DR, 2007, J NEUROPSYCH CLIN N, V19, P249, DOI 10.1176/appi.neuropsych.19.3.249; Royall DR, 2004, J AM GERIATR SOC, V52, P346, DOI 10.1111/j.1532-5415.2004.52104.x; Royall DR, 1998, J NEUROL NEUROSUR PS, V64, P588, DOI 10.1136/jnnp.64.5.588; Royall DR, 2005, J INT NEUROPSYCH SOC, V11, P899, DOI 10.1017/S135561770505109X; Salthouse TA, 2005, NEUROPSYCHOLOGY, V19, P532, DOI 10.1037/0894-4105.19.4.532; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; SALTHOUSE TA, 1992, J GERONTOL, V47, pP121, DOI 10.1093/geronj/47.3.P121; Schneider G, 2004, ARCH GERONTOL GERIAT, V39, P227, DOI 10.1016/j.archger.2004.03.005; Shafto MA, 2014, SCIENCE, V346, P583, DOI 10.1126/science.1254404; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Shulman KI, 2006, INT PSYCHOGERIATR, V18, P281, DOI 10.1017/S1041610205002693; Sliwinski MJ, 2003, PSYCHOL AGING, V18, P658, DOI 10.1037/0882-7974.18.4.658; Small BJ, 2011, J GERONTOL B-PSYCHOL, V66, P153, DOI 10.1093/geronb/gbq093; Smith A., 1982, SYMBOL DIGIT MODALIT; Soubelet A, 2011, J PERS, V79, P741, DOI 10.1111/j.1467-6494.2011.00700.x; Stuck AE, 1999, SOC SCI MED, V48, P445, DOI 10.1016/S0277-9536(98)00370-0; Tomaszewski S, 2009, CLIN NEUROPSYCHOL, V23, P446, DOI 10.1080/13854040802360558; Tombaugh TN, 1996, PSYCHOL ASSESSMENT, V8, P48, DOI 10.1037/1040-3590.8.1.48; Venkatraman VK, 2011, FRONT AGING NEUROSCI, P3; Wancata J, 2006, ACTA PSYCHIAT SCAND, V114, P398, DOI 10.1111/j.1600-0447.2006.00888.x; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	88	7	7	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0160742	10.1371/journal.pone.0160742	http://dx.doi.org/10.1371/journal.pone.0160742			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT8TR	27551749	Green Published, Green Submitted, gold			2022-12-26	WOS:000381768800016
J	Nojima, H; Konishi, T; Freeman, CM; Schuster, RM; Japtok, L; Kleuser, B; Edwards, MJ; Gulbins, E; Lentsch, AB				Nojima, Hiroyuki; Konishi, Takanori; Freeman, Christopher M.; Schuster, Rebecca M.; Japtok, Lukasz; Kleuser, Burkhard; Edwards, Michael J.; Gulbins, Erich; Lentsch, Alex B.			Chemokine Receptors, CXCR1 and CXCR2, Differentially Regulate Exosome Release in Hepatocytes	PLOS ONE			English	Article							HEPATIC ISCHEMIA-REPERFUSION; LIVER-REGENERATION; ISCHEMIA/REPERFUSION; NEUTROPHIL; CERAMIDE; INJURY; MECHANISMS; RECOVERY; HOMOLOG	Exosomes are small membrane vesicles released by different cell types, including hepatocytes, that play important roles in intercellular communication. We have previously demonstrated that hepatocyte-derived exosomes contain the synthetic machinery to form sphingosine-1-phosphate (S1P) in target hepatocytes resulting in proliferation and liver regeneration after ischemia/reperfusion (I/R) injury. We also demonstrated that the chemokine receptors, CXCR1 and CXCR2, regulate liver recovery and regeneration after I/R injury. In the current study, we sought to determine if the regulatory effects of CXCR1 and CXCR2 on liver recovery and regeneration might occur via altered release of hepatocyte exosomes. We found that hepatocyte release of exosomes was dependent upon CXCR1 and CXCR2. CXCR1-deficient hepatocytes produced fewer exosomes, whereas CXCR2-deficient hepatocytes produced more exosomes compared to their wild-type controls. In CXCR2-deficient hepatocytes, there was increased activity of neutral sphingomyelinase (Nsm) and intracellular ceramide. CXCR1-deficient hepatocytes had no alterations in Nsm activity or ceramide production. Interestingly, exosomes from CXCR1-deficient hepatocytes had no effect on hepatocyte proliferation, due to a lack of neutral ceramidase and sphingosine kinase. The data demonstrate that CXCR1 and CXCR2 regulate hepatocyte exosome release. The mechanism utilized by CXCR1 remains elusive, but CXCR2 appears to modulate Nsm activity and resultant production of ceramide to control exosome release. CXCR1 is required for packaging of enzymes into exosomes that mediate their hepatocyte proliferative effect.	[Nojima, Hiroyuki; Konishi, Takanori; Freeman, Christopher M.; Schuster, Rebecca M.; Edwards, Michael J.; Gulbins, Erich; Lentsch, Alex B.] Univ Cincinnati, Dept Surg, Coll Med, Cincinnati, OH 45267 USA; [Japtok, Lukasz; Kleuser, Burkhard] Univ Potsdam, Inst Nutr Sci, Nuthetal, Germany; [Gulbins, Erich] Univ Duisburg Essen, Dept Mol Biol, Essen, Germany	University System of Ohio; University of Cincinnati; University of Potsdam; University of Duisburg Essen	Lentsch, AB (corresponding author), Univ Cincinnati, Dept Surg, Coll Med, Cincinnati, OH 45267 USA.	alex.lentsch@uc.edu	NOJIMA, HIROYUKI/E-3782-2017; Konishi, Takanori/AAY-7199-2021	Kleuser, Burkhard/0000-0002-1888-9595; NOJIMA, HIROYUKI/0000-0003-3983-2501	National Institutes of Health [DK56029, AG025881]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056029] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants DK56029 and AG025881 to ABL.	CACALANO G, 1994, SCIENCE, V265, P682, DOI 10.1126/science.8036519; Clarke C, 2011, HEPATOLOGY, V53, P261, DOI 10.1002/hep.24028; Clarke CN, 2009, AM J SURG, V198, P415, DOI 10.1016/j.amjsurg.2009.01.025; Conde-Vancells J, 2008, J PROTEOME RES, V7, P5157, DOI 10.1021/pr8004887; Denzer K, 2000, J CELL SCI, V113, P3365; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Fu WX, 2005, CYTOKINE, V31, P9, DOI 10.1016/j.cyto.2005.02.005; Gulbins E, 2003, ONCOGENE, V22, P7070, DOI 10.1038/sj.onc.1207146; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Jaeschke H, 2006, AM J PHYSIOL-GASTR L, V290, pG1083, DOI 10.1152/ajpgi.00568.2005; Kuboki S, 2008, HEPATOLOGY, V48, P1213, DOI 10.1002/hep.22471; Lasser C, 2012, JOVE-J VIS EXP, DOI 10.3791/3037; Lemasters JJ, 1997, ANNU REV PHARMACOL, V37, P327, DOI 10.1146/annurev.pharmtox.37.1.327; Lentsch AB, 1998, HEPATOLOGY, V27, P1172; Lentsch AB, 2000, HEPATOLOGY, V32, P169, DOI 10.1053/jhep.2000.9323; Liu DL, 1996, ARCH SURG-CHICAGO, V131, P442; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Michalopoulos GK, 2013, COMPR PHYSIOL, V3, P485, DOI 10.1002/cphy.c120014; Moepps B, 2006, MOL IMMUNOL, V43, P897, DOI 10.1016/j.molimm.2005.06.043; Murphy PM, 1997, SEMIN HEMATOL, V34, P311; Neel NF, 2007, J CELL SCI, V120, P1559, DOI 10.1242/jcs.03437; Nojima H, 2016, J HEPATOL, V64, P60, DOI 10.1016/j.jhep.2015.07.030; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Pewzner-Jung Y, 2014, EMBO MOL MED, V6, P1205, DOI 10.15252/emmm.201404075; Sakai N, 2012, HEPATOLOGY, V56, P1468, DOI 10.1002/hep.25768; Serracino-Inglott F, 2001, AM J SURG, V181, P160, DOI 10.1016/S0002-9610(00)00573-0; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Van Sweringen HL, 2011, HEPATOLOGY, V54, P1445, DOI 10.1002/hep.24457; Wilson GC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120092	33	18	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0161443	10.1371/journal.pone.0161443	http://dx.doi.org/10.1371/journal.pone.0161443			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27551720	Green Published, Green Submitted, gold			2022-12-26	WOS:000381768800042
J	Ruiz, C; Kustermann, S; Pietilae, E; Vlajnic, T; Baschiera, B; Arabi, L; Lorber, T; Oeggerli, M; Savic, S; Obermann, E; Singer, T; Rothschild, SI; Zippelius, A; Roth, AB; Bubendorf, L				Ruiz, Christian; Kustermann, Stefan; Pietilae, Elina; Vlajnic, Tatjana; Baschiera, Betty; Arabi, Leila; Lorber, Thomas; Oeggerli, Martin; Savic, Spasenija; Obermann, Ellen; Singer, Thomas; Rothschild, Sacha I.; Zippelius, Alfred; Roth, Adrian B.; Bubendorf, Lukas			Culture and Drug Profiling of Patient Derived Malignant Pleural Effusions for Personalized Cancer Medicine	PLOS ONE			English	Article							CELL LUNG CANCERS; KINASE INHIBITION; RESISTANCE; ALK; CRIZOTINIB; GENERATION; CHEMOSENSITIVITY; MECHANISMS; THERAPIES; DIAGNOSIS	Introduction The use of patients' own cancer cells for in vitro selection of the most promising treatment is an attractive concept in personalized medicine. Human carcinoma cells from malignant pleural effusions (MPEs) are suited for this purpose since they have already adapted to the liquid environment in the patient and do not depend on a stromal cell compartment. Aim of this study was to develop a systematic approach for the in-vitro culture of MPEs to analyze the effect of chemotherapeutic as well as targeted drugs. Methods MPEs from patients with solid tumors were selected for this study. After morphological and molecular characterization, they were cultured in medium supplemented with patientderived sterile-filtered effusion supernatant. Growth characteristics were monitored in realtime using the xCELLigence system. MPEs were treated with a targeted therapeutic (erlotinib) according to the mutational status or chemotherapeutics based on the recommendation of the oncologists. Results We have established a robust system for the ex-vivo culture of MPEs and the application of drug tests in-vitro. The use of an antibody based magnetic cell separation system for epithelial cells before culture allowed treatment of effusions with only moderate tumor cell proportion. Experiments using drugs and drug-combinations revealed dose-dependent and specific growth inhibitory effects of targeted drugs. Conclusions We developed a new approach for the ex-vivo culture of MPEs and the application of drug tests in-vitro using real-time measuring of cell growth, which precisely reproduced the effect of clinically established treatments by standard chemotherapy and targeted drugs. This sets the stage for future studies testing agents against specific targets from genomic profiling of metastatic tumor cells and multiple drug-combinations in a personalized manner.	[Ruiz, Christian; Vlajnic, Tatjana; Baschiera, Betty; Arabi, Leila; Lorber, Thomas; Oeggerli, Martin; Savic, Spasenija; Obermann, Ellen; Bubendorf, Lukas] Univ Basel Hosp, Inst Pathol, Basel, Switzerland; [Kustermann, Stefan; Pietilae, Elina; Singer, Thomas; Roth, Adrian B.] Roche Innovat Ctr Basel, Pharmaceut Sci, Basel, Switzerland; [Rothschild, Sacha I.; Zippelius, Alfred] Univ Basel Hosp, Dept Med Oncol, Basel, Switzerland; [Arabi, Leila] Mashhad Univ Med Sci, Sch Pharm, Nanotechnol Res Ctr, Mashhad, Iran	University of Basel; Roche Holding; University of Basel; Mashhad University Medical Science	Ruiz, C (corresponding author), Univ Basel Hosp, Inst Pathol, Basel, Switzerland.	christian.ruiz@unibas.ch	Bubendorf, Lukas/G-5299-2015; Bubendorfl, Lukas/H-5880-2011; Rothschild, Sacha/AAV-4003-2020; Arabi, Leila/H-2312-2018	Bubendorf, Lukas/0000-0001-5970-1803; Rothschild, Sacha/0000-0003-1304-9340; Arabi, Leila/0000-0003-1623-3346; Pietila, Elina/0000-0003-0209-9369	Basel Translational Medicine Hub and the Swiss National Science Foundation (SNF) [310030_138513]	Basel Translational Medicine Hub and the Swiss National Science Foundation (SNF)	This study was supported by the Basel Translational Medicine Hub and the Swiss National Science Foundation (SNF 310030_138513, www.snf.ch). The funders provided support in the form of salaries for authors [LA, TL and MO], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Basak SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005884; Bergethon K, 2012, J CLIN ONCOL, V30, P863, DOI 10.1200/JCO.2011.35.6345; Buttitta F, 2013, CLIN CANCER RES, V19, P691, DOI 10.1158/1078-0432.CCR-12-1958; Camidge DR, 2014, NAT REV CLIN ONCOL, V11, P473, DOI 10.1038/nrclinonc.2014.104; Camidge DR, 2012, LANCET ONCOL, V13, P1011, DOI 10.1016/S1470-2045(12)70344-3; Castellarin M, 2013, J PATHOL, V229, P515, DOI 10.1002/path.4105; Chong CR, 2013, NAT MED, V19, P1389, DOI 10.1038/nm.3388; Cree IA, 2009, CURR OPIN OBSTET GYN, V21, P39, DOI 10.1097/GCO.0b013e32832210ff; Davidson B, 2004, DIAGN CYTOPATHOL, V31, P246, DOI 10.1002/dc.20133; Dienstmann R, 2013, J CLIN ONCOL, V31, P1874, DOI 10.1200/JCO.2012.45.2268; Dinu M, 2012, ROM J MORPHOL EMBRYO, V53, P817; Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126; Katayama R, 2011, P NATL ACAD SCI USA, V108, P7535, DOI 10.1073/pnas.1019559108; Kelm JM, 2003, BIOTECHNOL BIOENG, V83, P173, DOI 10.1002/bit.10655; Kustermann S, 2013, TOXICOL IN VITRO, V27, P1589, DOI 10.1016/j.tiv.2012.08.019; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Maniwa Y, 2010, ONCOL LETT, V1, P345, DOI 10.3892/ol_00000061; Masters JR, 2007, NAT PROTOC, V2, P2276, DOI 10.1038/nprot.2007.319; McDermott U, 2011, NEW ENGL J MED, V364, P340, DOI 10.1056/NEJMra0907178; Melosky B, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00244; Niederst MJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004652; Ohara Tatsuru, 2005, Hum Cell, V18, P171; Ou SHI, 2011, J THORAC ONCOL, V6, P942, DOI 10.1097/JTO.0b013e31821528d3; Pall G, 2015, CURR OPIN ONCOL, V27, P118, DOI 10.1097/CCO.0000000000000165; Rolfo C, 2014, TRANSL LUNG CANCER R, V3, P250, DOI 10.3978/j.issn.2218-6751.2014.03.01; Rosfjord E, 2014, BIOCHEM PHARMACOL, V91, P135, DOI 10.1016/j.bcp.2014.06.008; Ruiz Christian, 2012, Swiss Med Wkly, V142, pw13587, DOI 10.4414/smw.2012.13587; Saleh HA, 2009, DIAGN CYTOPATHOL, V37, P324, DOI 10.1002/dc.21006; Samson DJ, 2004, J CLIN ONCOL, V22, P3618, DOI 10.1200/JCO.2004.04.077; Savic S, 2013, J THORAC ONCOL, V8, P1004, DOI 10.1097/JTO.0b013e3182936ca9; Tapia C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1676; Wendt D, 2006, BIORHEOLOGY, V43, P481; Wetterauer C, 2015, PROSTATE, V75, P585, DOI 10.1002/pros.22939	33	9	10	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0160807	10.1371/journal.pone.0160807	http://dx.doi.org/10.1371/journal.pone.0160807			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548442	gold, Green Published, Green Submitted			2022-12-26	WOS:000381768400022
J	Chung, HJ; Lin, ATL; Lin, CC; Chen, TJ; Chen, KK				Chung, Hsiao-Jen; Lin, Alex Tong-Long; Lin, Chih-Chieh; Chen, Tzeng-Ji; Chen, Kuang-Kuo			Patients with Urinary Incontinence Appear More Likely to Develop Upper Urinary Tract Stones: A Nationwide, Population-Based Study with 8-Year Follow-Up	PLOS ONE			English	Article							METABOLIC SYNDROME; PREVALENCE; OBESITY; RISK; NEPHROLITHIASIS; EPIDEMIOLOGY; DISORDERS; DISEASE	This study aimed to investigate associations between primary urinary incontinence and development of upper urinary tract stones in a nationwide population in Taiwan. Data of 1,777 adults with primary urinary incontinence and 26,655 controls (groups A, B, and C) without urinary incontinence at study inception were retrieved from the National Health Insurance System database in Taiwan and were analyzed retrospectively. No enrolled subjects had previous diagnosis of upper urinary tract stones or spinal cord injury. All subjects were followed through end of 2009, with a minimum follow-up of 8 years. A greater percentage of study subjects (334/1777, 18.8%) developed upper urinary tract stones than that of control groups A (865/8885, 9.7%) and B (888/8885, 10%), and C (930/8885, 10.5%) (all p-values < 0.0001). Urinary incontinence was associated with significantly increased risk of developing urinary tract stones (HR 1.99, 95% CI, 1.70-2.34, p < 0.001). Age and metabolic syndrome status were both associated with developing upper urinary tract stones (both p-values < 0.0001). After adjusting for metabolic syndrome, regression analysis showed that urinary incontinence was still associated with a significantly increased risk of developing upper urinary tract stones (HR 1.99, 95% CI = 1.76-2.26, p < 0.0001). Long-term follow-up of Taiwanese patients with primary urinary incontinence suggests that urinary incontinence is associated with a significantly increased risk of developing upper urinary tract stones. Study findings suggest that physicians treating patients with urinary incontinence should give attention to early detection of upper urinary tract stones.	[Chung, Hsiao-Jen; Lin, Alex Tong-Long; Lin, Chih-Chieh; Chen, Kuang-Kuo] Taipei Vet Gen Hosp, Dept Urol, Taipei, Taiwan; [Chen, Tzeng-Ji] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan; [Chen, Tzeng-Ji] Natl Yang Ming Univ, Div Family Med, Dept Med, Taipei, Taiwan; [Chung, Hsiao-Jen; Lin, Alex Tong-Long; Lin, Chih-Chieh; Chen, Kuang-Kuo] Natl Yang Ming Univ, Sch Med, Dept Urol, Shu Tien Urol Res Ctr, Taipei, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Chung, HJ (corresponding author), Taipei Vet Gen Hosp, Dept Urol, Taipei, Taiwan.; Chung, HJ (corresponding author), Natl Yang Ming Univ, Sch Med, Dept Urol, Shu Tien Urol Res Ctr, Taipei, Taiwan.	hjchung@vghtpe.gov.tw	Chen, TJ/AAH-8430-2021					Amarenco G, 2012, PROG UROL, V22, P207, DOI 10.1016/j.purol.2012.01.005; BORGHI L, 1990, BRIT J UROL, V65, P231, DOI 10.1111/j.1464-410X.1990.tb14716.x; Boudokhane S, 2013, PROG UROL, V23, P256, DOI 10.1016/j.purol.2012.10.009; Chiu AF, 2012, TZU CHI MED J, V24, P56, DOI 10.1016/j.tcmj.2012.03.002; Curhan GC, 2007, UROL CLIN N AM, V34, P287, DOI 10.1016/j.ucl.2007.04.003; CURHAN GC, 1994, J UROLOGY, V151, P838, DOI 10.1016/S0022-5347(17)35101-7; Gorbachinsky Ilya, 2010, Rev Urol, V12, pe157; Gustafson B, 2007, ARTERIOSCL THROM VAS, V27, P2276, DOI 10.1161/ATVBAHA.107.147835; Huang PL, 2009, DIS MODEL MECH, V2, P231, DOI 10.1242/dmm.001180; Huang WY, 2013, J UROLOGY, V189, P2158, DOI 10.1016/j.juro.2012.12.105; Janssen I, 2007, OBESITY, V15, P1827, DOI 10.1038/oby.2007.217; Lawrence JM, 2007, DIABETES CARE, V30, P2536, DOI 10.2337/dc07-0262; Lee RK, 2012, BJU INT, V110, P540, DOI 10.1111/j.1464-410X.2011.10819.x; Lee YH, 2002, UROL INT, V68, P172, DOI 10.1159/000048445; Otunctemur A, 2014, INT UROL NEPHROL, V46, P1501, DOI 10.1007/s11255-014-0680-7; ROBERTSON WG, 1990, UROL RES, V18, pS3, DOI 10.1007/BF00301521; Saigal CS, 2005, KIDNEY INT, V68, P1808, DOI 10.1111/j.1523-1755.2005.00599.x; Taylor EN, 2005, JAMA-J AM MED ASSOC, V293, P455, DOI 10.1001/jama.293.4.455; Tsai YC, 2009, INT UROL NEPHROL, V41, P795, DOI 10.1007/s11255-009-9523-3; West B, 2008, AM J KIDNEY DIS, V51, P741, DOI 10.1053/j.ajkd.2007.12.030; Zuo L, 2014, J UROLOGY, V191, P1906, DOI 10.1016/j.juro.2014.01.013	21	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161223	10.1371/journal.pone.0161223	http://dx.doi.org/10.1371/journal.pone.0161223			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536881	gold, Green Submitted, Green Published			2022-12-26	WOS:000381577000071
J	Kellom, M; Raymond, J				Kellom, Matthew; Raymond, Jason			Using Dendritic Heat Maps to Simultaneously Display Genotype Divergence with Phenotype Divergence	PLOS ONE			English	Article							KEY INNOVATION; MICROBIOME; KINGDOMS; PATTERNS; GENOMES; SEARCH; LENGTH; BLAST; TOOL	The advancement of techniques to visualize and analyze large-scale sequencing datasets is an area of active research and is rooted in traditional techniques such as heat maps and dendrograms. We introduce dendritic heat maps that display heat map results over aligned DNA sequence clusters for a range of clustering cutoffs. Dendritic heat maps aid in visualizing the effects of group differences on clustering hierarchy and relative abundance of sampled sequences. Here, we artificially generate two separate datasets with simplified mutation and population growth procedures with GC content group separation to use as example phenotypes. In this work, we use the term phenotype to represent any feature by which groups can be separated. These sequences were clustered in a fractional identity range of 0.75 to 1.0 using agglomerative minimum-, maximum-, and average-linkage algorithms, as well as a divisive centroid-based algorithm. We demonstrate that dendritic heat maps give freedom to scrutinize specific clustering levels across a range of cutoffs, track changes in phenotype inequity across multiple levels of sequence clustering specificity, and easily visualize how deeply rooted changes in phenotype inequity are in a dataset. As genotypes diverge in sample populations, clusters are shown to break apart into smaller clusters at higher identity cutoff levels, similar to a dendrogram. Phenotype divergence, which is shown as a heat map of relative abundance bin response, may or may not follow genotype divergences. This joined view highlights the relationship between genotype and phenotype divergence for treatment groups. We discuss the minimum-, maximum-, average-, and centroid-linkage algorithm approaches to building dendritic heat maps and make a case for the divisive "top-down" centroid-based clustering methodology as being the best option visualize the effects of changing factors on clustering hierarchy and relative abundance.	[Kellom, Matthew; Raymond, Jason] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85281 USA	Arizona State University; Arizona State University-Tempe	Raymond, J (corresponding author), Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85281 USA.	jason.raymond@asu.edu	Kellom, Matthew/GNP-5389-2022		National Aeronautics and Space Administration Exobiology and Evolutionary Biology Program [NNX08AP61G]; National Aeronautics and Space Administration Astrobiology Institute at Arizona State University [08-NAI5-0018]	National Aeronautics and Space Administration Exobiology and Evolutionary Biology Program; National Aeronautics and Space Administration Astrobiology Institute at Arizona State University	The authors acknowledge support from the National Aeronautics and Space Administration Exobiology and Evolutionary Biology Program (NNX08AP61G) (https://astrobiology.nasa.gov/exobiology/) as well as the National Aeronautics and Space Administration Astrobiology Institute at Arizona State University (08-NAI5-0018) (https://astrobiology.nasa.gov/nai/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blount ZD, 2012, NATURE, V489, P513, DOI 10.1038/nature11514; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Brewer C.A., 2003, CARTOGR GEOGR INF SC, V30, P159, DOI [10.1559/152304003100011126, DOI 10.1559/152304003100011126]; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Darling AE, 2014, PEERJ, V2, DOI 10.7717/peerj.243; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Elser JJ, 2014, APPL ENV MICROBIOLOG; Florek K, 1951, COLLOQ MATH-WARSAW, V2, P282, DOI 10.4064/cm-2-3-4-282-285; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Goll J, 2010, BIOINFORMATICS, V26, P2631, DOI 10.1093/bioinformatics/btq455; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Krebs JE, 2011, LEWINS GENES 10; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; MACNAUGHTONSMIT.P, 1964, NATURE, V202, P1034, DOI 10.1038/2021034a0; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Meyer JR, 2012, SCIENCE, V335, P428, DOI 10.1126/science.1214449; Mitchell-Olds T, 2007, NAT REV GENET, V8, P845, DOI 10.1038/nrg2207; Nodine MD, 2012, NATURE, V482, P94, DOI 10.1038/nature10756; Ondov BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385; Schloissnig S, 2013, NATURE, V493, P45, DOI 10.1038/nature11711; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SNEATH PHA, 1957, J GEN MICROBIOL, V17, P201, DOI 10.1099/00221287-17-1-201; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Wang DY, 2005, MOL BIOL EVOL, V22, P142, DOI 10.1093/molbev/msh263; Wilkinson L, 2009, AM STAT, V63, P179, DOI 10.1198/tas.2009.0033; WILLIAMS WT, 1966, J ECOL, V54, P427, DOI 10.2307/2257960; Williams WT, 1967, COMPUT J, V9, P373; Wooley JC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000667; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Xu L, 2006, MOL BIOL EVOL, V23, P1107, DOI 10.1093/molbev/msk019; Zhao YA, 2012, BIOINFORMATICS, V28, P125, DOI 10.1093/bioinformatics/btr595	35	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161292	10.1371/journal.pone.0161292	http://dx.doi.org/10.1371/journal.pone.0161292			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536963	Green Published, gold, Green Submitted			2022-12-26	WOS:000381577000082
J	Browne, JL; Klipstein-Grobusch, K; Koster, MPH; Ramamoorthy, D; Antwi, E; Belmouden, I; Franx, A; Grobbee, DE; Schielen, PCJI				Browne, Joyce L.; Klipstein-Grobusch, Kerstin; Koster, Maria P. H.; Ramamoorthy, Dhivya; Antwi, Edward; Belmouden, Idder; Franx, Arie; Grobbee, Diederick E.; Schielen, Peter C. J. I.			Pregnancy Associated Plasma Protein-A and Placental Growth Factor in a Sub-Saharan African Population: A Nested Cross-Sectional Study	PLOS ONE			English	Article							HUMAN CHORIONIC-GONADOTROPIN; FREE BETA-HCG; PAPP-A; 1ST-TRIMESTER; SERUM; WOMEN; TRISOMY-21; BIOMARKERS; ETHNICITY; MARKERS	Background Baseline distributions of pregnancy disorders' biomarkers PlGF and PAPP-A levels are primarily based on Western European populations of Caucasian ethnicity. Differences in PAPP-A and PlGF concentrations by ethnicity have been observed, with increased levels in Afro-Caribbean, East Asian, and South Asian women. Baseline concentrations of sub-Saharan African women have not been evaluated. Objectives To investigate PlGF and PAPP-A in a sub-Saharan African population and assess the performance of existing reference values of PAPP-A and PlGF. Methods A nested cross-sectional study was conducted in two public hospitals in Accra, Ghana. Out of the original 1010 women enrolled in the cohort, 398 participants were eligible for inclusion with a normotensive singleton gestation and serum samples taken between 56-97 days of pregnancy. PAPP-A and PlGF concentrations were measured with an automated immunoassay. Multiple of the median (MoM) values corrected for gestation and maternal weight for PAPP-A and PlGF were calculated using reference values of a Dutch perinatal screening laboratory based on over 10.000 samples, and PlGF manufacturer reference values, respectively. Results The PAPP-A median MoM was 2.34 (interquartile range (IQR) 1.24-3.97). Median PlGF MoM was 1.25 (IQR 0.95-1.80). Median MoM values for PAPP-A and PlGF tended to be slightly different for various Ghanaian ethnic subgroups. Conclusions PAPP-A and PlGF MoM values appear to be substantially higher in a sub-Saharan African population compared to the Caucasian or Afro-Caribbean MoM values previously reported. The difference suggests the need for a specific correction factor for this population to avoid underestimation of risk for fetal aneuploidies or placental disorders when using PAPP-A and PlGF MoM for screening purposes.	[Browne, Joyce L.; Klipstein-Grobusch, Kerstin; Ramamoorthy, Dhivya; Antwi, Edward; Grobbee, Diederick E.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Julius Global Hlth, Utrecht, Netherlands; [Klipstein-Grobusch, Kerstin] Univ Witwatersrand, Sch Publ Hlth, Div Obstet & Gynecol, Fac Hlth Sci, Johannesburg, South Africa; [Koster, Maria P. H.; Franx, Arie] Univ Med Ctr Utrecht, Dept Obstet & Gynecol, Utrecht, Netherlands; [Antwi, Edward] Greater Accra Reg Hlth Directorate, Ghana Hlth Serv, Accra, Ghana; [Belmouden, Idder; Schielen, Peter C. J. I.] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Res Diagnost & Screening IDS, Bilthoven, Netherlands	Utrecht University; Utrecht University Medical Center; University of Witwatersrand; Utrecht University; Utrecht University Medical Center; Ghana Health Service; Netherlands National Institute for Public Health & the Environment	Browne, JL (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Julius Global Hlth, Utrecht, Netherlands.	J.L.Browne@umcutrecht.nl	Klipstein-Grobusch, Kerstin/F-5555-2016; Franx, Arie/AAA-1739-2021; Antwi, Edward/GQH-0788-2022; Schielen, Peter/AAP-4539-2020	Klipstein-Grobusch, Kerstin/0000-0002-5462-9889; Antwi, Edward/0000-0002-4143-3254; 				Agyemang C, 2005, J EPIDEMIOL COMMUN H, V59, P1014, DOI 10.1136/jech.2005.035964; [Anonymous], 2006, OPP AFR NEWB; Ball S, 2013, ULTRASOUND OBST GYN, V41, P33, DOI 10.1002/uog.11209; Ball S, 2012, FETAL DIAGN THER, V31, P162, DOI 10.1159/000336252; Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; Bujold E, 2014, PRENATAL DIAG, V34, P642, DOI 10.1002/pd.4403; Cowans NJ, 2011, PRENATAL DIAG, V31, P1193, DOI 10.1002/pd.2894; Cowans NJ, 2013, PRENATAL DIAG, V33, P56, DOI 10.1002/pd.4010; Cowans NJ, 2010, PRENATAL DIAG, V30, P127, DOI 10.1002/pd.2423; Cox NJ, 2011, AAPLOT; Cruz J, 2010, ULTRASOUND OBST GYN, V36, P141, DOI 10.1002/uog.7688; Darling AM, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.05.032; DOMBROWSKI MP, 1994, ARCH PEDIAT ADOL MED, V148, P508, DOI 10.1001/archpedi.1994.02170050066012; Gagnon AJ, 2016, BEST PRACT RES CL OB, V32, P3, DOI 10.1016/j.bpobgyn.2016.01.005; Geerts L, 2008, INT J GYNECOL OBSTET, V103, P16, DOI 10.1016/j.ijgo.2008.05.028; Govender L, 2012, CARDIOVASC J AFR, V23, P153, DOI 10.5830/CVJA-2012-003; Govender N, 2013, CARDIOVASC J AFR, V24, P174, DOI 10.5830/CVJA-2013-029; Hofmeyr GJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001059.pub4; Inhorn MC, 2015, HUM REPROD UPDATE, V21, P411, DOI 10.1093/humupd/dmv016; JACKSON MR, 1987, J ANAT, V152, P173; Kagan KO, 2008, ULTRASOUND OBST GYN, V31, P493, DOI 10.1002/uog.5332; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; Kuc S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063546; Kuc S, 2011, OBSTET GYNECOL SURV, V66, P225, DOI 10.1097/OGX.0b013e3182227027; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Leung TY, 2006, FETAL DIAGN THER, V21, P140, DOI 10.1159/000089064; Manotaya S, 2015, PRENATAL DIAG, V35, P735, DOI 10.1002/pd.4602; Molteno C, 1997, PAEDIATR PERINAT EP, V11, P428, DOI 10.1046/j.1365-3016.1997.d01-25.x; Muy-Rivera M, 2005, PHYSIOL RES, V54, P611, DOI 10.33549/physiolres.930000.54.611; Nicolaides KH, 2005, ULTRASOUND OBST GYN, V25, P221, DOI 10.1002/uog.1860; Odibo AO, 2014, J PERINATOL, V34, P186, DOI 10.1038/jp.2013.176; Owusu-Dabo E, 2009, TOB CONTROL, V18, P365, DOI 10.1136/tc.2009.030635; Pandya P, 2012, FETAL DIAGN THER, V31, P87, DOI 10.1159/000335684; PERRY IJ, 1995, BMJ-BRIT MED J, V310, P436, DOI 10.1136/bmj.310.6977.436; Poon LC, 2014, PRENATAL DIAG, V34, P618, DOI 10.1002/pd.4397; Powis KM, 2013, JAIDS-J ACQ IMM DEF, V62, P517, DOI 10.1097/QAI.0b013e318286d77e; Sivarao S, 2002, PLACENTA, V23, P691, DOI 10.1053/plac.2002.0817; Spencer K, 2005, PRENATAL DIAG, V25, P365, DOI 10.1002/pd.1153; Spencer K, 2000, PRENATAL DIAG, V20, P491, DOI 10.1002/1097-0223(200006)20:6<491::AID-PD844>3.0.CO;2-3; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Tsiakkas A, 2015, ULTRASOUND OBST GYN, V45, P591, DOI 10.1002/uog.14811; Williams LA, 1997, BRIT MED J, V314, P1864, DOI 10.1136/bmj.314.7098.1864; Wright D, 2015, ULTRASOUND OBST GYN, V46, P42, DOI 10.1002/uog.14870; Wright D, 2010, ULTRASOUND OBST GYN, V36, P404, DOI 10.1002/uog.7755	44	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0159592	10.1371/journal.pone.0159592	http://dx.doi.org/10.1371/journal.pone.0159592			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532602	gold, Green Published, Green Submitted			2022-12-26	WOS:000381487600008
J	Hu, SB; Wong, DJL; Correa, A; Li, N; Deng, JC				Hu, Scott B.; Wong, Deborah J. L.; Correa, Aditi; Li, Ning; Deng, Jane C.			Prediction of Clinical Deterioration in Hospitalized Adult Patients with Hematologic Malignancies Using a Neural Network Model	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; EARLY WARNING SCORE; CARDIORESPIRATORY INSTABILITY; INCREASED MORTALITY; VALIDATION; ALARMS; OUTCOMES; VIEWS; ADMISSIONS; TRANSFERS	Introduction Clinical deterioration (ICU transfer and cardiac arrest) occurs during approximately 5-10% of hospital admissions. Existing prediction models have a high false positive rate, leading to multiple false alarms and alarm fatigue. We used routine vital signs and laboratory values obtained from the electronic medical record (EMR) along with a machine learning algorithm called a neural network to develop a prediction model that would increase the predictive accuracy and decrease false alarm rates. Design Retrospective cohort study. Setting The hematologic malignancy unit in an academic medical center in the United States. Patient Population Adult patients admitted to the hematologic malignancy unit from 2009 to 2010. Intervention None. Measurements and Main Results Vital signs and laboratory values were obtained from the electronic medical record system and then used as predictors (features). A neural network was used to build a model to predict clinical deterioration events (ICU transfer and cardiac arrest). The performance of the neural network model was compared to the VitalPac Early Warning Score (ViEWS). Five hundred sixty five consecutive total admissions were available with 43 admissions resulting in clinical deterioration. Using simulation, the neural network outperformed the ViEWS model with a positive predictive value of 82% compared to 24%, respectively. Conclusion We developed and tested a neural network-based prediction model for clinical deterioration in patients hospitalized in the hematologic malignancy unit. Our neural network model outperformed an existing model, substantially increasing the positive predictive value, allowing the clinician to be confident in the alarm raised. This system can be readily implemented in a real-time fashion in existing EMR systems.	[Hu, Scott B.; Deng, Jane C.] Univ Calif Los Angeles, Div Pulm Crit Care, Los Angeles, CA 90095 USA; [Wong, Deborah J. L.] Univ Calif Los Angeles, Div Hematol Oncol, Los Angeles, CA USA; [Correa, Aditi] SUNY Albany, Downstate Coll Med, Albany, NY USA; [Li, Ning] Univ Calif Los Angeles, Dept Biomath, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; State University of New York (SUNY) System; State University of New York (SUNY) Albany; University of California System; University of California Los Angeles	Hu, SB (corresponding author), Univ Calif Los Angeles, Div Pulm Crit Care, Los Angeles, CA 90095 USA.	scotthu@mednet.ucla.edu			NIH [5T32HL072752]; NIH/National Center for Advancing Translational Science (NCATS) UCLA CTSI Grant [UL1TR000124]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL072752] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Center for Advancing Translational Science (NCATS) UCLA CTSI Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The research was supported by NIH 5T32HL072752 (SBH) and NIH/National Center for Advancing Translational Science (NCATS) UCLA CTSI Grant Number UL1TR000124.; The research was supported by NIH 5T32HL072752 (S.B.H.) and NIH/National Center for Advancing Translational Science (NCATS) UCLA CTSI Grant Number UL1TR000124	Alam N, 2014, RESUSCITATION, V85, P587, DOI 10.1016/j.resuscitation.2014.01.013; [Anonymous], 2005, BIOINFORMATICS, V21, P7881; Bergmeir C, 2012, J STAT SOFTW, V46, P1; Bliss JP, 2007, APPL ERGON, V38, P191, DOI 10.1016/j.apergo.2006.03.004; Bliss JP, 2000, ERGONOMICS, V43, P1283, DOI 10.1080/001401300421743; Chambrin MC, 1999, INTENS CARE MED, V25, P1360, DOI 10.1007/s001340051082; Churpek MM, 2014, CRIT CARE MED, V42, P841, DOI 10.1097/CCM.0000000000000038; Churpek MM, 2013, CHEST, V143, P1758, DOI 10.1378/chest.12-1605; Churpek MM, 2013, RESUSCITATION, V84, P564, DOI 10.1016/j.resuscitation.2012.09.024; Cvach Maria, 2012, Biomed Instrum Technol, V46, P268, DOI 10.2345/0899-8205-46.4.268; Edworthy J, 2005, QUAL SAF HEALTH CARE, V14, P212, DOI 10.1136/qshc.2004.013052; Finlay GD, 2014, J HOSP MED, V9, P116, DOI 10.1002/jhm.2132; Hravnak M, 2008, ARCH INTERN MED, V168, P1300, DOI 10.1001/archinte.168.12.1300; Hravnak M, 2011, CRIT CARE MED, V39, P65, DOI 10.1097/CCM.0b013e3181fb7b1c; Kellett J, 2012, RESUSCITATION, V83, P297, DOI 10.1016/j.resuscitation.2011.08.022; LAWLESS ST, 1994, CRIT CARE MED, V22, P981, DOI 10.1097/00003246-199406000-00017; Lengline E, 2012, LEUKEMIA LYMPHOMA, V53, P1352, DOI 10.3109/10428194.2011.649752; Liu V, 2012, J HOSP MED, V7, P224, DOI 10.1002/jhm.964; Manning T, 2013, BIOENGINEERED, V5; Mardini L, 2012, J CRIT CARE, V27, P688, DOI 10.1016/j.jcrc.2012.04.011; Mokart D, 2013, LEUKEMIA LYMPHOMA, V54, P1724, DOI 10.3109/10428194.2012.753446; Morgan R., 1997, CLIN INTENSIVE CARE, V8, P100, DOI DOI 10.3109/TCIC.8.2.93.110; Motta S, 2013, BRIEF BIOINFORM, V14, P411, DOI 10.1093/bib/bbs061; Opio MO, 2013, RESUSCITATION, V84, P743, DOI 10.1016/j.resuscitation.2013.02.007; Pappalardo AP F., 2012, MATH MODELLING NATUR, V7; Penny W, 1996, MED DECIS MAKING, V16, P386, DOI 10.1177/0272989X9601600409; Prytherch DR, 2010, RESUSCITATION, V81, P932, DOI 10.1016/j.resuscitation.2010.04.014; Rothman MJ, 2013, J BIOMED INFORM, V46, P837, DOI 10.1016/j.jbi.2013.06.011; Sendelbach S, 2013, AACN ADV CRIT CARE, V24, P378, DOI 10.1097/NCI.0b013e3182a903f9; Siebig S, 2010, CRIT CARE MED, V38, P451, DOI 10.1097/CCM.0b013e3181cb0888; Smith GB, 2008, RESUSCITATION, V77, P170, DOI 10.1016/j.resuscitation.2007.12.004; Smith GB, 2013, RESUSCITATION, V84, P465, DOI 10.1016/j.resuscitation.2012.12.016; Subbe CP, 2001, QJM-MON J ASSOC PHYS, V94, P521, DOI 10.1093/qjmed/94.10.521; Thiel SW, 2010, J HOSP MED, V5, P19, DOI 10.1002/jhm.530; Tsien CL, 1997, CRIT CARE MED, V25, P614, DOI 10.1097/00003246-199704000-00010; Young MP, 2003, J GEN INTERN MED, V18, P77, DOI 10.1046/j.1525-1497.2003.20441.x; Yousef K, 2012, AM J CRIT CARE, V21, P344, DOI 10.4037/ajcc2012797	37	25	26	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161401	10.1371/journal.pone.0161401	http://dx.doi.org/10.1371/journal.pone.0161401			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532679	Green Published, gold, Green Submitted			2022-12-26	WOS:000381487600092
J	Wang, P; Goggins, WB; Chan, EYY				Wang, Pin; Goggins, William B.; Chan, Emily Y. Y.			Hand, Foot and Mouth Disease in Hong Kong: A Time-Series Analysis on Its Relationship with Weather	PLOS ONE			English	Article							ENTEROVIRUS 71; METEOROLOGICAL FACTORS; TEMPERATURE; GUANGZHOU; INFECTIONS; SURVIVAL; HUMIDITY; OUTBREAK; PATTERNS; CHILDREN	Background Hand, foot and mouth disease (HFMD) is an emerging enterovirus-induced infectious disease for which the environmental risk factors promoting disease circulation remain inconclusive. This study aims to quantify the association of daily weather variation with hospitalizations for HFMD in Hong Kong, a subtropical city in China. Methods A time series of daily counts of HFMD public hospital admissions from 2008 through 2011 in Hong Kong was regressed on daily mean temperature, relative humidity, wind speed, solar radiation and total rainfall, using a combination of negative binomial generalized additive models and distributed lag non-linear models, adjusting for trend, season, and day of week. Results There was a positive association between temperature and HFMD, with increasing trends from 8 to 20 degrees C and above 25 degrees C with a plateau in between. A hockey-stick relationship of relative humidity with HFMD was found, with markedly increasing risks over 80%. Moderate rainfall and stronger wind and solar radiation were also found to be associated with more admissions. Conclusions The present study provides quantitative evidence that short-term meteorological variations could be used as early indicators for potential HFMD outbreaks. Climate change is likely to lead to a substantial increase in severe HFMD cases in this subtropical city in the absence of further interventions.	[Wang, Pin; Goggins, William B.] Chinese Univ Hong Kong, Fac Med, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Chan, Emily Y. Y.] Chinese Univ Hong Kong, Fac Med, Sch Publ Hlth & Primary Care, Collaborating Ctr Oxford Univ & CUHK Disaster & M, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Goggins, WB (corresponding author), Chinese Univ Hong Kong, Fac Med, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China.	wgoggins@cuhk.edu.hk	Chan, Emily Ying Yang/H-6849-2017; Wang, Pin/S-6226-2016; Ibrahim, Essam Hassan/G-1960-2018	Wang, Pin/0000-0002-8031-8494; Ibrahim, Essam Hassan/0000-0003-0130-2257; Chan, Emily Ying Yang/0000-0002-8854-5093	Health and Medical Research Fund of the Food and Health Bureau of the government of Hong Kong SAR [08090261]	Health and Medical Research Fund of the Food and Health Bureau of the government of Hong Kong SAR	This work was supported by the Health and Medical Research Fund of the Food and Health Bureau of the government of Hong Kong SAR (ref: 08090261) (website: https://rfs1.fhb.gov.hk/english/funds/funds_hmrf/funds_hmrf_abt/funds_hmrf_abt.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; Atkinson J, 2010, NATURAL VENTILATION; Belanger M, 2009, ANN EPIDEMIOL, V19, P180, DOI 10.1016/j.annepidem.2008.12.008; Blomqvist S, 2010, J CLIN VIROL, V48, P49, DOI 10.1016/j.jcv.2010.02.002; Centre for Health Protection, 2016, EV SCAN 2016; Chan EYY, 2013, B WORLD HEALTH ORGAN, V91, P576, DOI 10.2471/BLT.12.113035; Chen C, 2014, INT J BIOMETEOROL, V58, P1605, DOI 10.1007/s00484-013-0764-6; Chen KT, 2007, PEDIATRICS, V120, pE244, DOI 10.1542/peds.2006-3331; Cheng J, 2014, SCI TOTAL ENVIRON, V497, P484, DOI 10.1016/j.scitotenv.2014.08.006; Chong KC, 2015, INT J ENV RES PUB HE, V12, P1560, DOI 10.3390/ijerph120201560; Chua Kaw Bing, 2011, Virologica Sinica, V26, P221, DOI 10.1007/s12250-011-3195-8; DUFF MF, 1968, BMJ-BRIT MED J, V2, P661, DOI 10.1136/bmj.2.5606.661; Fan J, 2014, EPIDEMIOL INFECT, V142, P634, DOI 10.1017/S0950268813001519; Fares A, 2013, INT J PREVENTIVE MED, V4, P128; Feng HF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087916; Gasparrini A, 2011, J STAT SOFTW, V43, P1, DOI 10.18637/jss.v043.i08; Guo B, 2015, EXPERT REV VACCINES, V14, P561, DOI 10.1586/14760584.2014.990387; Hii YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016796; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Kung YH, 2010, VIROLOGY, V396, P1, DOI 10.1016/j.virol.2009.10.017; Li T, 2014, EPIDEMIOL INFECT, V142, P1741, DOI 10.1017/S0950268813002938; Lin HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065585; Ma E, 2010, EPIDEMIOL INFECT, V138, P1779, DOI 10.1017/S0950268810002256; Ma E, 2010, JPN J INFECT DIS, V63, P422; Nguyen NTB, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-341; Onozuka D, 2011, SCI TOTAL ENVIRON, V410, P119, DOI 10.1016/j.scitotenv.2011.09.055; Rzezutka A, 2004, FEMS MICROBIOL REV, V28, P441, DOI 10.1016/j.femsre.2004.02.001; SATTAR SA, 1988, J MED VIROL, V25, P289, DOI 10.1002/jmv.1890250306; Ventarola D, 2015, CLIN DERMATOL, V33, P340, DOI 10.1016/j.clindermatol.2014.12.011; Wang Y, 2011, EPIDEMIOLOGY, V22, P781, DOI 10.1097/EDE.0b013e318231d67a; Wong SSY, 2010, EPIDEMIOL INFECT, V138, P1071, DOI 10.1017/S0950268809991555; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; World Health Organization Western Pacific Region, 2015, HAND FOOT MOUTH DIS; World Health Organization Western Pacific Region, 2012, GUID CLIN MAN PUBL H; World Health Organization Western Pacific Region, 2014, HAND FOOT MOUTH DIS; Wu HX, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.24664; Wu XN, 2014, JPN J INFECT DIS, V67, P95, DOI 10.7883/yoken.67.95; Wu Y, 2010, INT J INFECT DIS, V14, pE1076, DOI 10.1016/j.ijid.2010.07.006; Zhang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067157; Zou XN, 2012, BRAZ J INFECT DIS, V16, P457, DOI 10.1016/j.bjid.2012.08.001	40	54	56	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161006	10.1371/journal.pone.0161006	http://dx.doi.org/10.1371/journal.pone.0161006			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532865	Green Published, gold, Green Submitted			2022-12-26	WOS:000381487600053
J	Lin, CC; Lin, ATL; Yang, AH; Chen, KK				Lin, Chih-Chieh; Lin, Alex Tong-Long; Yang, An-Hang; Chen, Kuang-Kuo			Microvascular Injury in Ketamine-Induced Bladder Dysfunction	PLOS ONE			English	Article							TO-MESENCHYMAL TRANSITION; NMDA RECEPTOR; INTERSTITIAL CYSTITIS; PROXIMITY LIGATION; INDUCED APOPTOSIS; INDUCED UROPATHY; CLINICAL ENTITY; IN-SITU; DETRUSOR; FIBROSIS	The pathogenesis of ketamine-induced cystitis (KC) remains unclear. In this study, bladder microvascular injury was investigated as a possible contributing mechanism. A total of 36 KC patients with exposure to ketamine for more than 6 months, and 9 control subjects, were prospectively recruited. All participants completed questionnaires, including the O'Leary-Sant interstitial cystitis symptom index (ICSI) and the interstitial cystitis problem index (ICPI). All KC patients received a urodynamic study and radiological exams. Bladder tissues were obtained from cystoscopic biopsies in the control group and after hydrodistention in the KC group. Double-immunofluorescence staining of N-methyl-D-aspartate receptor subunit 1 (NMDAR1) and the endothelial marker, cluster of differentiation 31 (CD31), was performed to reveal the existence of NMDAR1 on the endothelium. Electron microscopy (EM) was applied to assess the microvascular change in the urinary bladder and to measure the thickening of the basement membrane (BM). A proximity ligation assay (PLA) was used to quantify the co-localization of the endothelial CD31 receptor and the mesenchymal marker [fibroblast-specific protein 1 (FSP-1)]. The Mann-Whitney U test and Spearman's correlation coefficient were used for statistical analysis. The mean ICSI [14.38 (+/- 4.16)] and ICPI [12.67 (+/- 3.54)] scores of the KC group were significantly higher than those (0 and 0, respectively) of the control group (both p < 0.001). The KC patients had decreasing cystometric bladder capacity (CBC) with a mean volume of 65.38 (+/- 48.67) mL. NMDAR1 was expressed on endothelial cells in both groups under immunofluorescence staining. Moreover, KC patients had significant BM duplication of microvessels in the mucosa of the urinary bladder under EM. The co-expression of the endothelial marker CD31 and mesenchymal marker FSP1 was significantly stained and calculated under PLA. In conclusion, microvascular injury and mesenchymal phenotypic alteration of endothelial cells can potentially contribute to KC-induced bladder dysfunction.	[Lin, Chih-Chieh; Yang, An-Hang] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan; [Lin, Chih-Chieh; Lin, Alex Tong-Long; Chen, Kuang-Kuo] Natl Yang Ming Univ, Sch Med, Dept Urol, Taipei, Taiwan; [Lin, Chih-Chieh; Lin, Alex Tong-Long; Chen, Kuang-Kuo] Taipei Vet Gen Hosp, Dept Urol, Taipei, Taiwan; [Yang, An-Hang] Taipei Vet Gen Hosp, Dept Pathol & Lab Med, Taipei, Taiwan; [Yang, An-Hang] Natl Yang Ming Univ, Sch Med, Dept Pathol, Taipei, Taiwan; [Yang, An-Hang] Taipei Vet Gen Hosp, Dept Pathol, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Yang, AH (corresponding author), Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan.; Yang, AH (corresponding author), Taipei Vet Gen Hosp, Dept Pathol & Lab Med, Taipei, Taiwan.; Yang, AH (corresponding author), Natl Yang Ming Univ, Sch Med, Dept Pathol, Taipei, Taiwan.; Yang, AH (corresponding author), Taipei Vet Gen Hosp, Dept Pathol, Taipei, Taiwan.	ahyang@vghtpe.gov.tw			Taipei Veterans General Hospital [V100B-024, V105C-014]; Ministry of Science and Technology [MOST-102-2320-B-075-001-MY3]	Taipei Veterans General Hospital(Taipei Veterans General Hospital); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was partially supported by Taipei Veterans General Hospital (V100B-024 and V105C-014) and Ministry of Science and Technology (MOST-102-2320-B-075-001-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asosingh K, 2013, J IMMUNOL, V190, P3458, DOI 10.4049/jimmunol.1202095; Baker SC, 2016, AM J PATHOL, V186, P1267, DOI 10.1016/j.ajpath.2015.12.014; Baker SC, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-64; Chang T, 2012, LUTS, V4, P19, DOI 10.1111/j.1757-5672.2011.00101.x; Chu PSK, 2008, BJU INT, V102, P1616, DOI 10.1111/j.1464-410X.2008.07920.x; Cristofaro V, 2012, J UROLOGY, V188, P1017, DOI 10.1016/j.juro.2012.04.100; Cryan JF, 2010, SCIENCE, V329, P913, DOI 10.1126/science.1194313; Diazgranados N, 2010, ARCH GEN PSYCHIAT, V67, P793, DOI 10.1001/archgenpsychiatry.2010.90; Gonzalez-Cadavid NF, 2000, J ANDROL, V21, P566; Homma Y, 2009, INT J UROL, V16, P597, DOI 10.1111/j.1442-2042.2009.02326.x; Huang LK, 2014, POSTGRAD MED J, V90, P185, DOI 10.1136/postgradmedj-2013-131776; Jarvius M, 2007, MOL CELL PROTEOMICS, V6, P1500, DOI 10.1074/mcp.M700166-MCP200; Jhang JF, 2014, J UROLOGY, V192, P1249, DOI 10.1016/j.juro.2014.05.084; Jiang XG, 2014, J MOL MED, V92, P797, DOI 10.1007/s00109-014-1173-y; Kushner L, 2006, J UROLOGY, V176, P587, DOI 10.1016/j.juro.2006.03.035; Lee CL, 2013, BJU INT, V112, P1156, DOI 10.1111/bju.12256; Li JH, 2009, AM J PATHOL, V175, P1380, DOI 10.2353/ajpath.2009.090096; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Miodonski AJ, 1999, ANAT REC, V254, P375, DOI 10.1002/(SICI)1097-0185(19990301)254:3<375::AID-AR8>3.3.CO;2-I; Piera-Velazquez S, 2011, AM J PATHOL, V179, P1074, DOI 10.1016/j.ajpath.2011.06.001; Reijerkerk A, 2010, J NEUROCHEM, V113, P447, DOI 10.1111/j.1471-4159.2010.06598.x; Shahani R, 2007, UROLOGY, V69, P810, DOI 10.1016/j.urology.2007.01.038; Smith KM, 2002, AM J HEALTH-SYST PH, V59, P1067, DOI 10.1093/ajhp/59.11.1067; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Takadera T, 2006, TOXICOL APPL PHARM, V210, P100, DOI 10.1016/j.taap.2005.10.005; Tang HC, 2014, INT UROL NEPHROL, V46, P1563, DOI 10.1007/s11255-014-0690-5; Tang JJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13573; Tsai TH, 2009, INT J UROL, V16, P826, DOI 10.1111/j.1442-2042.2009.02361.x; Xu-Dubois YC, 2015, J AM SOC NEPHROL; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183	32	11	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160578	10.1371/journal.pone.0160578	http://dx.doi.org/10.1371/journal.pone.0160578			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529746	Green Published, gold, Green Submitted			2022-12-26	WOS:000381476700009
J	Umeda, S; Miyagawa, S; Fukushima, S; Oda, N; Saito, A; Sakai, Y; Sawa, Y; Okuyama, H				Umeda, Satoshi; Miyagawa, Shigeru; Fukushima, Satsuki; Oda, Noriko; Saito, Atsuhiro; Sakai, Yoshiki; Sawa, Yoshiki; Okuyama, Hiroomi			Enhanced Pulmonary Vascular and Alveolar Development via Prenatal Administration of a Slow-Release Synthetic Prostacyclin Agonist in Rat Fetal Lung Hypoplasia	PLOS ONE			English	Article							CONGENITAL DIAPHRAGMATIC-HERNIA; ENDOSCOPIC TRACHEAL OCCLUSION; ARTERY STRUCTURAL-CHANGES; HYPERTENSION; MODEL; THERAPY; GROWTH; GLUCOCORTICOIDS; ANGIOGENESIS; HYPEROXIA	Lung hypoplasia and pulmonary hypertension are the major causes of mortality in neonates with congenital diaphragmatic hernia (CDH). Although the prostaglandin pathway plays a pivotal role in lung development, the reported efficacy of postnatal prostaglandin agonist treatment is suboptimal. We hypothesized that prenatal treatment with ONO-1301SR, a slow-release form of a novel synthetic prostacyclin agonist with thromboxane inhibitory activity, might enhance the development of lungs exhibiting hypoplasia in the fetal period. On embryonic day (E) 9.5, nitrofen was given to pregnant Sprague-Dawley rats to establish a CDH-related lung hypoplasia model, whereas normal rats received the vehicle only. The same day, either ONO-1301SR or a placebo was also randomly administered. On E21.5, the fetuses of the normal group and those exhibiting CDH were analyzed. Prenatal ONO-1301SR administration had no influence on the incidence of nitrofen-induced CDH. The lung-to-body weight ratio in the CDH+ONO group was greater than that in the CDH group. Histologically, the medial wall in the CDH+ONO group was two-thirds thinner than that in the CDH group. In addition, the number of Ttf-1-positive cells and the capillary density were >= 1.5 times greater in the CDH+ONO group than in the CDH group, and this increase was associated with higher expression of vascular endothelial growth factor and stromal cell-derived factor in the CDH+ONO group, suggesting enhanced development of the alveolar and capillary networks. Thus, prenatal ONO-1301SR was protective against the progression of lung hypoplasia associated with CDH in a nitrofen-induced rat model, indicating the potential of this treatment for pathologies exhibiting lung hypoplasia.	[Umeda, Satoshi; Okuyama, Hiroomi] Osaka Univ, Grad Sch Med, Dept Pediat Surg, Osaka, Japan; [Miyagawa, Shigeru; Fukushima, Satsuki; Oda, Noriko; Saito, Atsuhiro; Sakai, Yoshiki; Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Osaka, Japan	Osaka University; Osaka University	Okuyama, H (corresponding author), Osaka Univ, Grad Sch Med, Dept Pediat Surg, Osaka, Japan.	okuyama@pedsurg.med.osaka-u.ac.jp	Fukushima, Satsuki/ABE-6582-2020	Fukushima, Satsuki/0000-0002-9481-8860; Miyagawa, Shigeru/0000-0003-0015-6569	JSPS KAKENHI [16K20343]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was financially supported by JSPS KAKENHI Grant Number 16K20343 (SU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Budhiraja R, 2004, CIRCULATION, V109, P159, DOI 10.1161/01.CIR.0000102381.57477.50; Chang YT, 2012, AM J PHYSIOL-LUNG C, V302, pL1159, DOI 10.1152/ajplung.00325.2010; Garne E, 2002, ULTRASOUND OBST GYN, V19, P329, DOI 10.1046/j.1469-0705.2002.00635.x; HISLOP A, 1976, THORAX, V31, P450, DOI 10.1136/thx.31.4.450; Imanishi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069302; Ishimaru K, 2013, J THORAC CARDIOV SUR, V146, P1516, DOI 10.1016/j.jtcvs.2013.02.045; Jakkula M, 2000, AM J PHYSIOL-LUNG C, V279, pL600, DOI 10.1152/ajplung.2000.279.3.L600; Jani JC, 2009, ULTRASOUND OBST GYN, V34, P304, DOI 10.1002/uog.6450; Kamiyama M, 2005, J PEDIATR SURG, V40, P1562, DOI 10.1016/j.jpedsurg.2005.06.005; Kanai M, 2001, J PEDIATR SURG, V36, P839, DOI 10.1053/jpsu.2001.23950; Kataoka M, 2005, AM J RESP CRIT CARE, V172, P1575, DOI 10.1164/rccm.200501-102OC; Kunig AM, 2005, AM J PHYSIOL-LUNG C, V289, pL529, DOI 10.1152/ajplung.00336.2004; Kunig AM, 2006, AM J PHYSIOL-LUNG C, V291, pL1068, DOI 10.1152/ajplung.00093.2006; Langham MR, 1996, CLIN PERINATOL, V23, P671, DOI 10.1016/S0095-5108(18)30201-X; Leeuwen L, 2014, J PAEDIATR CHILD H, V50, P667, DOI 10.1111/jpc.12508; Lemus-Varela MDL, 2014, WORLD J PEDIATR, V10, P354, DOI 10.1007/s12519-014-0512-y; Luong C, 2011, CIRCULATION, V123, P2120, DOI 10.1161/CIRCULATIONAHA.108.845909; Obata H, 2008, AM J RESP CRIT CARE, V177, P195, DOI 10.1164/rccm.200703-349OC; Okoye BO, 1998, J PEDIATR SURG, V33, P76, DOI 10.1016/S0022-3468(98)90366-9; Ruano R, 2012, ULTRASOUND OBST GYN, V39, P20, DOI 10.1002/uog.10142; Sakai K, 2014, J PEDIATR SURG, V49, P1749, DOI 10.1016/j.jpedsurg.2014.09.015; Schmidt AF, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.04.025; Taira Y, 1998, J PEDIATR SURG, V33, P1052, DOI 10.1016/S0022-3468(98)90530-9; Thebaud B, 2005, CIRCULATION, V112, P2477, DOI 10.1161/CIRCULATIONAHA.105.541524; Thebaud B, 1998, BIOL NEONATE, V74, P323, DOI 10.1159/000014050; Thebaud B, 2007, AM J RESP CRIT CARE, V175, P978, DOI 10.1164/rccm.200611-1660PP; THURLBEC.WM, 1967, THORAX, V22, P483, DOI 10.1136/thx.22.6.483; Wharton J, 2000, CIRCULATION, V102, P3130; Yamataka T, 1997, J PEDIATR SURG, V32, P387, DOI 10.1016/S0022-3468(97)90587-X	29	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161334	10.1371/journal.pone.0161334	http://dx.doi.org/10.1371/journal.pone.0161334			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529478	Green Submitted, Green Published, gold			2022-12-26	WOS:000381476700068
J	Li, YP; Dillon, TJ; Takahashi, M; Earley, KT; Stork, PJS				Li, Yanping; Dillon, Tara J.; Takahashi, Maho; Earley, Keith T.; Stork, Philip J. S.			Protein Kinase A-independent Ras Protein Activation Cooperates with Rap1 Protein to Mediate Activation of the Extracellular Signal-regulated Kinases (ERK) by cAMP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclic AMP (cAMP); extracellular-signal-regulated kinase (ERK); guanine nucleotide exchange factor (GEF); Ras protein; Ras-related protein 1 (Rap1)	NUCLEOTIDE-EXCHANGE FACTOR; EARLY GENE-PRODUCTS; NERVE GROWTH-FACTOR; B-RAF; CYCLIC-AMP; DEPENDENT ACTIVATION; CELL-PROLIFERATION; MELANOMA-CELLS; MAP KINASE; PC12 CELLS	Cyclic adenosine monophosphate (cAMP) is an important mediator of hormonal stimulation of cell growth and differentiation through its activation of the extracellular signal-regulated kinase (ERK) cascade. Two small G proteins, Ras and Rap1, have been proposed to mediate this activation, with either Ras or Rap1 acting in distinct cell types. Using Hek293 cells, we show that both Ras and Rap1 are required for cAMP signaling to ERKs. The roles of Ras and Rap1 were distinguished by their mechanism of activation, dependence on the cAMP-dependent protein kinase (PKA), and the magnitude and kinetics of their effects on ERKs. Ras was required for the early portion of ERK activation by cAMP and was activated independently of PKA. Ras activation required the Ras/Rap guanine nucleotide exchange factor (GEF) PDZ-GEF1. Importantly, this action of PDZ-GEF1 was disrupted by mutation within its putative cyclic nucleotide-binding domain within PDZ-GEF1. Compared with Ras, Rap1 activation of ERKs was of longer duration. Rap1 activation was dependent on PKA and required Src family kinases and the Rap1 exchanger C3G. This is the first report of a mechanism for the cooperative actions of Ras and Rap1 in cAMP activation of ERKs. One physiological role for the sustained activation of ERKs is the transcription and stabilization of a range of transcription factors, including c-FOS. We show that the induction of c-FOS by cAMP required both the early and sustained phases of ERK activation, requiring Ras and Rap1, as well as for each of the Raf isoforms, B-Raf and C-Raf.	[Li, Yanping; Dillon, Tara J.; Takahashi, Maho; Earley, Keith T.; Stork, Philip J. S.] Oregon Hlth & Sci Univ, Vollum Inst, L474,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA	Oregon Health & Science University	Stork, PJS (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, L474,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	stork@ohsu.edu	li, yan/GTI-4638-2022		National Institutes of Health [R01 DK090309, R21 CA191392-01]; NATIONAL CANCER INSTITUTE [R21CA191392, T32CA106195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090309] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants R01 DK090309 and R21 CA191392-01. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alleaume C, 2003, NEUROPEPTIDES, V37, P98, DOI 10.1016/S0143-4179(03)00020-9; Amsen EM, 2006, J BIOL CHEM, V281, P121, DOI 10.1074/jbc.M507595200; Bhatt KV, 2007, ONCOGENE, V26, P1056, DOI 10.1038/sj.onc.1209861; Bouschet T, 2003, J BIOL CHEM, V278, P4778, DOI 10.1074/jbc.M204652200; Busca R, 2000, EMBO J, V19, P2900, DOI 10.1093/emboj/19.12.2900; Carey KD, 2003, J BIOL CHEM, V278, P3185, DOI 10.1074/jbc.M207014200; Chadee DN, 2004, NAT CELL BIOL, V6, P770, DOI 10.1038/ncb1152; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; de Rooij J, 1999, J BIOL CHEM, V274, P38125, DOI 10.1074/jbc.274.53.38125; Dumaz N, 2003, J BIOL CHEM, V278, P29819, DOI 10.1074/jbc.C300182200; Ehses JA, 2002, J BIOL CHEM, V277, P37088, DOI 10.1074/jbc.M205055200; Emery AC, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003993; Eriksson M, 2007, J CELL PHYSIOL, V210, P538, DOI 10.1002/jcp.20907; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; Fujita T, 2002, J BIOL CHEM, V277, P22191, DOI 10.1074/jbc.M110364200; Gao L, 2006, CANCER RES, V66, P7880, DOI 10.1158/0008-5472.CAN-06-0254; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Gomez E, 2002, J BIOL CHEM, V277, P48146, DOI 10.1074/jbc.M209165200; Grewal SS, 2000, J BIOL CHEM, V275, P3722, DOI 10.1074/jbc.275.5.3722; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hisata S, 2007, J CELL BIOL, V178, P843, DOI 10.1083/jcb.200610073; Iacovelli L, 2001, MOL PHARMACOL, V60, P924, DOI 10.1124/mol.60.5.924; Insel PA, 2003, CELL MOL NEUROBIOL, V23, P305, DOI 10.1023/A:1023684503883; Kovalovsky D, 2002, MOL ENDOCRINOL, V16, P1638, DOI 10.1210/me.16.7.1638; Kuiperij HB, 2003, BBA-MOL CELL RES, V1593, P141, DOI 10.1016/S0167-4889(02)00365-8; Largaespada DA, 2003, CANCER CELL, V4, P3, DOI 10.1016/S1535-6108(03)00171-5; Le Pechon-Vallee C, 2000, NEUROENDOCRINOLOGY, V72, P46, DOI 10.1159/000054570; Li YP, 2013, J BIOL CHEM, V288, P27646, DOI 10.1074/jbc.M113.463067; Liao YH, 1999, J BIOL CHEM, V274, P37815, DOI 10.1074/jbc.274.53.37815; Liao YH, 2001, J BIOL CHEM, V276, P28478, DOI 10.1074/jbc.M101737200; Liu C, 2008, MOL CELL BIOL, V28, P7109, DOI 10.1128/MCB.01060-08; Liu C, 2010, MOL CELL BIOL, V30, P3956, DOI 10.1128/MCB.00242-10; Lohse MJ, 2003, CIRC RES, V93, P896, DOI 10.1161/01.RES.0000102042.83024.CA; Lorenz K, 2009, INT J BIOCHEM CELL B, V41, P2351, DOI 10.1016/j.biocel.2009.08.002; Marshall CJ, 1996, CURR OPIN CELL BIOL, V8, P197, DOI 10.1016/S0955-0674(96)80066-4; Mason CS, 1999, EMBO J, V18, P2137, DOI 10.1093/emboj/18.8.2137; Merkel MJ, 2010, AM J PHYSIOL-HEART C, V298, pH679, DOI 10.1152/ajpheart.00533.2009; Monaghan TK, 2008, J NEUROCHEM, V104, P74, DOI 10.1111/j.1471-4159.2007.05018.x; Morozov A, 2003, NEURON, V39, P309, DOI 10.1016/S0896-6273(03)00404-5; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Murphy LO, 2004, MOL CELL BIOL, V24, P144, DOI 10.1128/MCB.24.1.144-153.2004; Nolz JC, 2008, J CELL BIOL, V182, P1231, DOI 10.1083/jcb.200801121; O'Connell Timothy D, 2007, Methods Mol Biol, V357, P271; Obara Y, 2004, J CELL SCI, V117, P6085, DOI 10.1242/jcs.01527; Ohtsuka T, 1999, BIOCHEM BIOPH RES CO, V265, P38, DOI 10.1006/bbrc.1999.1619; Pak Y, 2002, MOL CELL BIOL, V22, P7942, DOI 10.1128/MCB.22.22.7942-7952.2002; Pellegrino MJ, 2006, J NEUROCHEM, V99, P1480, DOI 10.1111/j.1471-4159.2006.04250.x; Pham N, 2000, CURR BIOL, V10, P555, DOI 10.1016/S0960-9822(00)00473-5; Rebhun JF, 2000, J BIOL CHEM, V275, P34901, DOI 10.1074/jbc.M005327200; Romano D, 2003, J BIOL CHEM, V278, P51386, DOI 10.1074/jbc.M308372200; Roskoski R, 2010, BIOCHEM BIOPH RES CO, V399, P313, DOI 10.1016/j.bbrc.2010.07.092; Schmitt JM, 2000, J BIOL CHEM, V275, P25342, DOI 10.1074/jbc.M003213200; Schmitt JM, 2002, J BIOL CHEM, V277, P43024, DOI 10.1074/jbc.M204006200; Schmitt JM, 2002, MOL CELL, V9, P85, DOI 10.1016/S1097-2765(01)00432-4; Seifert R, 2012, TRENDS PHARMACOL SCI, V33, P64, DOI 10.1016/j.tips.2011.10.006; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Stork PJS, 2003, TRENDS BIOCHEM SCI, V28, P267, DOI 10.1016/S0968-0004(03)00087-2; Takahashi M, 2013, J BIOL CHEM, V288, P27712, DOI 10.1074/jbc.M113.466904; TANAKA S, 1994, P NATL ACAD SCI USA, V91, P3443, DOI 10.1073/pnas.91.8.3443; Van Kolen K, 2010, NEUROPHARMACOLOGY, V58, P135, DOI 10.1016/j.neuropharm.2009.06.022; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Vuchak LA, 2009, MOL PHARMACOL, V76, P1123, DOI 10.1124/mol.109.060129; Wang ZP, 2006, MOL CELL BIOL, V26, P2130, DOI 10.1128/MCB.26.6.2130-2145.2006; Werlen G, 2003, SCIENCE, V299, P1859, DOI 10.1126/science.1067833; Wittchen Erika S, 2011, Small GTPases, V2, P65; Yamaguchi T, 2003, KIDNEY INT, V63, P1983, DOI 10.1046/j.1523-1755.2003.00023.x; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; Zeiller C, 2012, CELL SIGNAL, V24, P2237, DOI 10.1016/j.cellsig.2012.08.006	69	25	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21584	21595		10.1074/jbc.M116.730978	http://dx.doi.org/10.1074/jbc.M116.730978			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27531745	hybrid, Green Published			2022-12-26	WOS:000385999200025
J	Liu, L; Phua, YW; Lee, RS; Ma, XQ; Jenkins, Y; Novy, K; Humphrey, ES; Chan, H; Shearer, R; Ong, PC; Dai, WW; Saunders, DN; Lucet, IS; Daly, RJ				Liu, Ling; Phua, Yu Wei; Lee, Rachel S.; Ma, Xiuquan; Jenkins, Yiping; Novy, Karel; Humphrey, Emily S.; Chan, Howard; Shearer, Robert; Ong, Poh Chee; Dai, Weiwen; Saunders, Darren N.; Lucet, Isabelle S.; Daly, Roger J.			Homo- and Heterotypic Association Regulates Signaling by the SgK269/PEAK1 and SgK223 Pseudokinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						breast cancer; oncogene; protein kinase; scaffold protein; signal transduction	EPITHELIAL-CELLS; CARCINOMA-CELLS; PROTEIN; GROWTH; CANCER; QUANTIFICATION; REVEALS; KINASES; PRAGMIN; GENOME	SgK269/PEAK1 is a pseudokinase and scaffolding protein that plays a critical role in regulating growth factor receptor signal output and is implicated in the progression of several cancers, including those of the breast, colon, and pancreas. SgK269 is structurally related to SgK223, a human pseudokinase that also functions as a scaffold but recruits a distinct repertoire of signaling proteins compared with SgK269. Structural similarities between SgK269 and SgK223 include a predicted -helical region (designated CH) immediately preceding the conserved C-terminal pseudokinase (PK) domain. Structure-function analyses of SgK269 in MCF-10A mammary epithelial cells demonstrated a critical role for the CH and PK regions in promoting cell migration and Stat3 activation. Characterization of the SgK269 interactome by mass spectrometry-based proteomics identified SgK223 as a novel binding partner, and association of SgK269 with SgK223 in cells was dependent on the presence of the CH and PK domains of both pseudokinases. Homotypic association of SgK269 and SgK223 was also demonstrated and exhibited the same structural requirements. Further analysis using pulldowns and size-exclusion chromatography underscored the critical role of the CH region in SgK269/SgK223 association. Importantly, although SgK269 bridged SgK223 to Grb2, it was unable to activate Stat3 or efficiently enhance migration in SgK223 knock-out cells generated by CRISPR/Cas9. These results reveal previously unrecognized interplay between two oncogenic scaffolds and demonstrate a novel signaling mechanism for pseudokinases whereby homotypic and heterotypic association is used to assemble scaffolding complexes with distinct binding properties and hence qualitatively regulate signal output.	[Liu, Ling; Phua, Yu Wei; Lee, Rachel S.; Ma, Xiuquan; Jenkins, Yiping; Novy, Karel; Chan, Howard; Ong, Poh Chee; Daly, Roger J.] Monash Univ, Biomed Discovery Inst, Canc Program, Level 1,Bldg 77, Clayton, Vic 3800, Australia; [Liu, Ling; Phua, Yu Wei; Lee, Rachel S.; Ma, Xiuquan; Jenkins, Yiping; Novy, Karel; Chan, Howard; Ong, Poh Chee; Daly, Roger J.] Monash Univ, Dept Biochem & Mol Biol, Level 1,Bldg 77, Clayton, Vic 3800, Australia; [Humphrey, Emily S.; Shearer, Robert; Saunders, Darren N.] Kinghorn Canc Ctr, Garvan Inst Med Res, Canc Res Program, 384 Victoria St, Sydney, NSW 2010, Australia; [Dai, Weiwen; Lucet, Isabelle S.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Dai, Weiwen; Lucet, Isabelle S.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3050, Australia; [Saunders, Darren N.] Univ New S Wales, Sch Med Sci, Sydney, NSW 2052, Australia	Monash University; Monash University; Garvan Institute of Medical Research; Walter & Eliza Hall Institute; University of Melbourne; University of New South Wales Sydney	Daly, RJ (corresponding author), Monash Univ, Biomed Discovery Inst, Canc Program, Level 1,Bldg 77, Clayton, Vic 3800, Australia.	roger.daly@monash.edu	Ma, Hugh/S-4266-2019	Ma, Hugh/0000-0001-7227-1289; Daly, Roger/0000-0002-5739-8027; Saunders, Darren/0000-0003-0924-0513	National Health and Medical Research Council of Australia [1084621]; National Health and Medical Research Council ECR Fellowship [1054497]; Research Scholar Award from the Cancer Institute of New South Wales [10/RSA/1-28]; Australian Postgraduate Award from the University of New South Wales; Baxter Family Scholarship; Australian Cancer Research Foundation; National Health and Medical Research Council [1052963]; Walter and Eliza Hall Institute; National Health and Medical Research Council Fellowship [1058540]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council ECR Fellowship; Research Scholar Award from the Cancer Institute of New South Wales; Australian Postgraduate Award from the University of New South Wales; Baxter Family Scholarship; Australian Cancer Research Foundation; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Walter and Eliza Hall Institute; National Health and Medical Research Council Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by Project Grant 1084621 from the National Health and Medical Research Council of Australia. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by National Health and Medical Research Council ECR Fellowship 1054497.; Recipient of Research Scholar Award 10/RSA/1-28 from the Cancer Institute of New South Wales and an Australian Postgraduate Award from the University of New South Wales.; Supported by a Baxter Family Scholarship.; Supported by the Australian Cancer Research Foundation.; Supported by National Health and Medical Research Council Grant 1052963.; Supported by Australian Cancer Research Foundation and by the Walter and Eliza Hall Institute.; Supported by National Health and Medical Research Council Fellowship 1058540. To whom correspondence should be addressed. Tel.: 61-3-990-29301; Fax: 61-3-990-29500; E-mail: roger.daly@monash.edu.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brummer T, 2006, J BIOL CHEM, V281, P626, DOI 10.1074/jbc.M509567200; Choi M, 2014, BIOINFORMATICS, V30, P2524, DOI 10.1093/bioinformatics/btu305; Christie M, 2013, MOL CELL, V51, P360, DOI 10.1016/j.molcel.2013.07.011; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Croucher DR, 2013, CANCER RES, V73, P1969, DOI 10.1158/0008-5472.CAN-12-1472; Croucher DR, 2010, MOL CELL BIOL, V30, P5057, DOI 10.1128/MCB.00249-10; Kelber JA, 2012, CANCER RES, V72, P2554, DOI 10.1158/0008-5472.CAN-11-3552; Kovacs E, 2015, ANNU REV BIOCHEM, V84, P739, DOI 10.1146/annurev-biochem-060614-034402; Lavoie H, 2014, TRENDS BIOCHEM SCI, V39, P475, DOI 10.1016/j.tibs.2014.08.004; Leroy C, 2009, CANCER RES, V69, P2279, DOI 10.1158/0008-5472.CAN-08-2354; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Murphy JM, 2014, BIOCHEM J, V457, P323, DOI 10.1042/BJ20131174; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reiterer V, 2014, TRENDS CELL BIOL, V24, P489, DOI 10.1016/j.tcb.2014.03.008; Safari F, 2011, P NATL ACAD SCI USA, V108, P14938, DOI 10.1073/pnas.1107740108; Tactacan CM, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0412-3; Tanaka H, 2006, J BIOL CHEM, V281, P10355, DOI 10.1074/jbc.M511314200; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wang YC, 2010, P NATL ACAD SCI USA, V107, P10920, DOI 10.1073/pnas.0914776107; Zeqiraj E, 2010, CURR OPIN STRUC BIOL, V20, P772, DOI 10.1016/j.sbi.2010.10.001; Zheng Y, 2013, NATURE, V499, P166, DOI 10.1038/nature12308	24	22	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21571	21583		10.1074/jbc.M116.748897	http://dx.doi.org/10.1074/jbc.M116.748897			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27531744	hybrid, Green Published			2022-12-26	WOS:000385999200024
J	Smith, J; Yang, YW; Levy, S; Adelusi, OO; Hahn, MG; O'Neill, MA; Bar-Peled, M				Smith, James; Yang, Yiwen; Levy, Shahar; Adelusi, Oluwatoyin Oluwayemi; Hahn, Michael G.; O'Neill, Malcolm A.; Bar-Peled, Maor			Functional Characterization of UDP-apiose Synthases from Bryophytes and Green Algae Provides Insight into the Appearance of Apiose-containing Glycans during Plant Evolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						algae; decarboxylase; glycosyltransferase; plant cell wall; vascular	D-XYLOSE SYNTHASE; POLYSACCHARIDE RHAMNOGALACTURONAN II; BETA-D-XYLOSYLTRANSFERASE; CELL-WALL; PECTIC POLYSACCHARIDE; PHYSCOMITRELLA-PATENS; ESCHERICHIA-COLI; GLUCURONIC ACID; CROSS-LINKING; BORATE ESTER	Apiose is a branched monosaccharide that is present in the cell wall pectic polysaccharides rhamnogalacturonan II and apiogalacturonan and in numerous plant secondary metabolites. These apiose-containing glycans are synthesized using UDP-apiose as the donor. UDP-apiose (UDP-Api) together with UDP-xylose is formed from UDP-glucuronic acid (UDP-GlcA) by UDP-Api synthase (UAS). It was hypothesized that the ability to form Api distinguishes vascular plants from the avascular plants and green algae. UAS from several dicotyledonous plants has been characterized; however, it is not known if avascular plants or green algae produce this enzyme. Here we report the identification and functional characterization of UAS homologs from avascular plants (mosses, liverwort, and hornwort), from streptophyte green algae, and from a monocot (duckweed). The recombinant UAS homologs all form UDP-Api from UDP-glucuronic acid albeit in different amounts. Apiose was detected in aqueous methanolic extracts of these plants. Apiose was detected in duckweed cell walls but not in the walls of the avascular plants and algae. Overexpressing duckweed UAS in the moss Physcomitrella patens led to an increase in the amounts of aqueous methanol-acetonitrile-soluble apiose but did not result in discernible amounts of cell wall-associated apiose. Thus, bryophytes and algae likely lack the glycosyltransferase machinery required to synthesize apiose-containing cell wall glycans. Nevertheless, these plants may have the ability to form apiosylated secondary metabolites. Our data are the first to provide evidence that the ability to form apiose existed prior to the appearance of rhamnogalacturonan II and apiogalacturonan and provide new insights into the evolution of apiose-containing glycans.	[Smith, James; Hahn, Michael G.; O'Neill, Malcolm A.; Bar-Peled, Maor] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Smith, James; Levy, Shahar; Adelusi, Oluwatoyin Oluwayemi] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Yang, Yiwen; Hahn, Michael G.; Bar-Peled, Maor] Univ Georgia, Dept Plant Biol, CCRC 315 Riverbend Rd, Athens, GA 30602 USA; [Yang, Yiwen] Univ Texas Houston, MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Bar-Peled, M (corresponding author), Univ Georgia, Dept Plant Biol, CCRC 315 Riverbend Rd, Athens, GA 30602 USA.	peled@ccrc.uga.edu	Hahn, Michael/AHC-5847-2022		Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy [DE-FG02-12ER16324, DE-FG02-12ER16326]; United States Department of Energy [DE-FG02-93ER20097]	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); United States Department of Energy(United States Department of Energy (DOE))	This work was supported by Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy Grant DE-FG02-12ER16324 and Grant DE-FG02-12ER16326 (to M. A. O and M. B.-P.) for funding studies of apiose synthesis and United States Department of Energy-funded Center for Plant and Microbial Complex Carbohydrates Grant DE-FG02-93ER20097 for funding analytical equipment support. The authors declare that they have no conflicts of interest with the contents of this article.	Ahn JW, 2006, J BIOL CHEM, V281, P13708, DOI 10.1074/jbc.M512403200; Bar-Peled M, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00092; Baylson FA, 2001, J PHYCOL, V37, P796, DOI 10.1046/j.1529-8817.2001.00179.x; Beck E., 1990, Methods in Plant Biochemistry, Vol. 2: Carbohydrates., P235; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breazeale SD, 2005, J BIOL CHEM, V280, P14154, DOI 10.1074/jbc.M414265200; Broach B, 2012, FEBS J, V279, P100, DOI 10.1111/j.1742-4658.2011.08402.x; Camacho-Cristobal JJ, 2008, J INTEGR PLANT BIOL, V50, P1247, DOI 10.1111/j.1744-7909.2008.00742.x; Choi SH, 2012, J AM CHEM SOC, V134, P13946, DOI 10.1021/ja305322x; DARVILL AG, 1978, PLANT PHYSIOL, V62, P418, DOI 10.1104/pp.62.3.418; Dumont M, 2014, ANN BOT-LONDON, V114, P1177, DOI 10.1093/aob/mcu093; ECKEYKALTENBACH H, 1993, PHYTOCHEMISTRY, V34, P687, DOI 10.1016/0031-9422(93)85340-W; Fleischer A, 1999, PLANT PHYSIOL, V121, P829, DOI 10.1104/pp.121.3.829; Gloaguen V, 2010, J NAT PROD, V73, P1087, DOI 10.1021/np100092c; Golovchenko VV, 2002, PHYTOCHEMISTRY, V60, P89, DOI 10.1016/S0031-9422(02)00040-7; Gotting C, 2000, J MOL BIOL, V304, P517, DOI 10.1006/jmbi.2000.4261; Grisebach H., 1980, The biochemistry of plants. A comprehensive treatise. Volume 3. Carbohydrates: structure and function., P171; GRISEBACH H, 1964, BIOCHEM BIOPH RES CO, V17, P737, DOI 10.1016/0006-291X(64)90423-1; Gu XG, 2011, MICROBIOL-SGM, V157, P260, DOI 10.1099/mic.0.040758-0; Gu XG, 2010, J BIOL CHEM, V285, P9030, DOI 10.1074/jbc.M109.066803; Guyett P, 2009, CARBOHYD RES, V344, P1072, DOI 10.1016/j.carres.2009.03.026; Harper AD, 2002, PLANT PHYSIOL, V130, P2188, DOI 10.1104/pp.009654; HART DA, 1970, BIOCHEM J, V116, P569, DOI 10.1042/bj1160569; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Hwang S, 2014, J BIOL CHEM, V289, P35620, DOI 10.1074/jbc.M114.614917; Ishii T, 1996, CARBOHYD RES, V284, P1, DOI 10.1016/0008-6215(96)00010-9; Ishii T, 1999, J BIOL CHEM, V274, P13098, DOI 10.1074/jbc.274.19.13098; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Kobayashi M, 1996, PLANT PHYSIOL, V110, P1017, DOI 10.1104/pp.110.3.1017; Kobayashi M, 2002, PLANT CELL PHYSIOL, V43, P1259, DOI 10.1093/pcp/pcf157; Kuhn J, 2001, J BIOL CHEM, V276, P4940, DOI 10.1074/jbc.M005111200; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; LONGLAND JM, 1989, PLANT PHYSIOL, V90, P972, DOI 10.1104/pp.90.3.972; Matasci N, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-17; MATOH T, 1993, PLANT CELL PHYSIOL, V34, P639; Matoh T, 1996, PLANT CELL PHYSIOL, V37, P636, DOI 10.1093/oxfordjournals.pcp.a028992; McCarthy TW, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-79; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Molhoj M, 2003, PLANT J, V35, P693, DOI 10.1046/j.1365-313X.2003.01841.x; Neilson EH, 2013, TRENDS PLANT SCI, V18, P250, DOI 10.1016/j.tplants.2013.01.001; Nishiyama T, 2000, DNA RES, V7, P9, DOI 10.1093/dnares/7.1.9; O'Neill MA, 2001, SCIENCE, V294, P846, DOI 10.1126/science.1062319; ONeill M., 1990, METHODS PLANT BIOCH, V2, P415, DOI [DOI 10.1016/B978-0-12-461012-5.50018-5, 10.1016/b978-0-12-461012-5.50018-5]; ONeill MA, 1996, J BIOL CHEM, V271, P22923, DOI 10.1074/jbc.271.37.22923; Ortiz-Ramirez C, 2016, MOL PLANT, V9, P205, DOI 10.1016/j.molp.2015.12.002; ORTMANN R, 1972, BIOCHIM BIOPHYS ACTA, V289, P293, DOI 10.1016/0005-2744(72)90080-0; Pabst M, 2013, PLANT J, V76, P61, DOI 10.1111/tpj.12271; Picmanova M, 2016, GLYCOBIOLOGY, V26, P430, DOI 10.1093/glycob/cww012; Polizzi SJ, 2012, BIOCHEMISTRY-US, V51, P8844, DOI 10.1021/bi301135b; Popper ZA, 2003, ANN BOT-LONDON, V91, P1, DOI 10.1093/aob/mcg013; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Roberts AW, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00166; SANDERMA.H, 1968, BIOCHIM BIOPHYS ACTA, V165, P552, DOI 10.1016/0304-4165(68)90239-0; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Treutter D, 2005, PLANT BIOLOGY, V7, P581, DOI 10.1055/s-2005-873009; Vidali L, 2007, PLANT CELL, V19, P3705, DOI 10.1105/tpc.107.053413; Wakuta S, 2015, PLANT CELL PHYSIOL, V56, P852, DOI 10.1093/pcp/pcv011; Walsh RM, 2015, BIOCHEMISTRY-US, V54, P807, DOI 10.1021/bi501357c; Watson R R, 1975, Adv Carbohydr Chem Biochem, V31, P135; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Yang T, 2012, ANAL BIOCHEM, V421, P691, DOI 10.1016/j.ab.2011.12.028; Yang T, 2009, J BIOL CHEM, V284, P21526, DOI 10.1074/jbc.M109.014761; Yin YB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027995; YORK WS, 1986, METHOD ENZYMOL, V118, P3	64	10	10	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21434	21447		10.1074/jbc.M116.749069	http://dx.doi.org/10.1074/jbc.M116.749069			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27551039	Green Published, hybrid			2022-12-26	WOS:000385999200012
J	Martin-Sole, O; Rodo, J; Garcia-Aparicio, L; Blanch, J; Cusi, V; Albert, A				Martin-Sole, Oriol; Rodo, Joan; Garcia-Aparicio, Lluis; Blanch, Josep; Cusi, Victoria; Albert, Asteria			Effects of Platelet-Rich Plasma (PRP) on a Model of Renal Ischemia-Reperfusion in Rats	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; CHRONIC WOUNDS; IN-VITRO; GEL; IMPROVES; RECOVERY; FAILURE; ANASTOMOSIS; SURVIVAL; SYSTEM	Renal ischemia-reperfusion injury is a major cause of acute renal failure, causing renal cell death, a permanent decrease of renal blood flow, organ dysfunction and chronic kidney disease. Platelet-rich plasma (PRP) is an autologous product rich in growth factors, and therefore able to promote tissue regeneration and angiogenesis. This product has proven its efficacy in multiple studies, but has not yet been tested on kidney tissue. The aim of this work is to evaluate whether the application of PRP to rat kidneys undergoing ischemia-reperfusion reduces mid-term kidney damage. A total of 30 monorrenal Sprague-Dawley male rats underwent renal ischemia-reperfusion for 45 minutes. During ischemia, PRP (PRP Group, n = 15) or saline solution (SALINE Group, n = 15) was administered by subcapsular renal injection. Control kidneys were the contralateral organs removed immediately before the start of ischemia in the remaining kidneys. Survival, body weight, renal blood flow on Doppler ultrasound, kidney weight, kidney volume, blood biochemistry and histopathology were determined for all subjects and kidneys, as applicable. Correlations between these variables were searched for. The PRP Group showed significantly worse kidney blood flow (p = 0.045) and more histopathological damage (p<0.0001). Correlations were found between body weight, kidney volume, kidney weight, renal blood flow, histology, and serum levels of creatinine and urea. Our study provides the first evidence that treatment with PRP results in the deterioration of the kidney's response to ischemia-reperfusion injury.	[Martin-Sole, Oriol; Rodo, Joan; Garcia-Aparicio, Lluis] Univ Barcelona, Hosp St Joan de Deu, Dept Pediat Surg, Unit Pediat Urol, Barcelona, Spain; [Blanch, Josep] Univ Barcelona, Hosp St Joan de Deu, Dept Pediat Radiol, Barcelona, Spain; [Cusi, Victoria] Univ Barcelona, Hosp St Joan de Deu, Dept Pathol, Barcelona, Spain; [Albert, Asteria] Univ Barcelona, Hosp St Joan de Deu, Dept Pediat Surg, Barcelona, Spain	University of Barcelona; University of Barcelona; University of Barcelona; University of Barcelona	Martin-Sole, O (corresponding author), Univ Barcelona, Hosp St Joan de Deu, Dept Pediat Surg, Unit Pediat Urol, Barcelona, Spain.	orimartin@gmail.com		Martin Sole, Oriol/0000-0002-4758-9321				Abuelo JG, 2007, NEW ENGL J MED, V357, P797, DOI 10.1056/NEJMra064398; Ahmad Zafar, 2012, JRSM Short Rep, V3, P40, DOI 10.1258/shorts.2011.011148; Anjayani S, 2014, INT J DERMATOL, V53, P109, DOI 10.1111/ijd.12162; Arnoczky SP, 2013, SPORTS MED ARTHROSC, V21, P180, DOI 10.1097/JSA.0b013e3182999712; Bakacak M, 2016, GYNECOL OBSTET INVES, V81, P225, DOI 10.1159/000440617; Bielecki TM, 2007, J BONE JOINT SURG BR, V89B, P417, DOI 10.1302/0301-620X.89B3.18491; Bir SC, 2009, J VASC SURG, V50, P870, DOI 10.1016/j.jvs.2009.06.016; Cieslik-Bielecka A, 2009, TRANSFUS APHER SCI, V41, P9, DOI 10.1016/j.transci.2009.05.006; de Leon JM, 2011, ADV SKIN WOUND CARE, V24, P357, DOI 10.1097/01.ASW.0000403249.85131.6f; DeLong JM, 2012, ARTHROSCOPY, V28, P998, DOI 10.1016/j.arthro.2012.04.148; Dietrich F, 2015, WORLD J PLAST SURG, V4, P101; Dimauro I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102993; Docherty NG, 2002, RENAL FAILURE, V24, P391, DOI 10.1081/JDI-120006767; Dolkart O, 2014, ARCH ORTHOP TRAUM SU, V134, P1271, DOI 10.1007/s00402-014-2026-4; Dorai T, 2011, J UROLOGY, V186, P2448, DOI 10.1016/j.juro.2011.08.010; Ehrenfest DMD, 2009, TRENDS BIOTECHNOL, V27, P158, DOI 10.1016/j.tibtech.2008.11.009; Erdogan H, 2006, UROL RES, V34, P41, DOI 10.1007/s00240-005-0031-3; Filardo G, 2012, KNEE SURG SPORT TR A, V20, P1655, DOI 10.1007/s00167-012-2136-x; Frykberg RG, 2010, OSTOMY WOUND MANAG, V56, P36; Gomez-Caro A, 2011, INTERACT CARDIOV TH, V13, P552, DOI 10.1510/icvts.2011.273995; Guan QN, 2010, TRANSPLANTATION, V89, P1320, DOI 10.1097/TP.0b013e3181d8e9dc; Hamid MSA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090538; Harper S, 2006, BRIT J SURG, V93, P623, DOI 10.1002/bjs.5324; He S, 2013, AM J PHYSIOL-RENAL, V304, pF356, DOI 10.1152/ajprenal.00553.2012; Kim YG, 2000, KIDNEY INT, V58, P2390, DOI 10.1046/j.1523-1755.2000.00422.x; Koga H, 2012, J SURG RES, V174, P352, DOI 10.1016/j.jss.2011.01.011; Lee JW, 2013, ARCH PLAST SURG-APS, V40, P530, DOI 10.5999/aps.2013.40.5.530; Lee KS, 2011, AM J ROENTGENOL, V196, P628, DOI 10.2214/AJR.10.5975; Li WW, 2012, PLAST RECONSTR SURG, V129, P858, DOI 10.1097/PRS.0b013e3182450ac9; Liu F, 2012, KIDNEY BLOOD PRESS R, V35, P182, DOI 10.1159/000331054; Mafi A, 2016, PLATELETS, V27, P771, DOI 10.1080/09537104.2016.1184749; Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4; McCarrel Taralyn M, 2012, J Bone Joint Surg Am, V94, DOI 10.2106/JBJS.L.00019; Moojen DJF, 2008, J ORTHOP RES, V26, P404, DOI 10.1002/jor.20519; Muylle L, 1993, TRANSFUSION, V33; Nunley DC, 1999, TRANSPLANT P, V31, P1051, DOI 10.1016/S0041-1345(98)01898-3; Oz M, 2016, ARCH GYNECOL OBSTET, V294, P533, DOI 10.1007/s00404-016-4079-9; Patel AN, 2016, J CARDIOTHORAC SURG, V11, DOI 10.1186/s13019-016-0452-9; Perez AGM, 2013, BIORESEARCH OPEN ACC, V2, P307, DOI 10.1089/biores.2013.0015; Raman RN, 2011, TRANSPL P, V43, P1511, DOI 10.1016/j.transproceed.2011.01.177; Rappl LM, 2011, INT WOUND J, V8, P187, DOI 10.1111/j.1742-481X.2011.00770.x; Rosenberger C, 2006, CLIN EXP PHARMACOL P, V33, P980, DOI 10.1111/j.1440-1681.2006.04472.x; Russell RP, 2013, SPORTS MED ARTHROSC, V21, P186, DOI 10.1097/JSA.0000000000000007; Sanchez-Gonzalez Dolores Javier, 2012, Int J Pept, V2012, P532519, DOI 10.1155/2012/532519; Schick MA, 2010, INTENS CARE MED, V36, P541, DOI 10.1007/s00134-009-1704-0; Schneider R, 2003, KIDNEY INT, V64, P216, DOI 10.1046/j.1523-1755.2003.00063.x; Schrier RW, 2004, J CLIN INVEST, V114, P5, DOI 10.1172/JC1200422353; Setta HS, 2011, INT WOUND J, V8, P307, DOI 10.1111/j.1742-481X.2011.00797.x; Sheth U, 2012, J BONE JOINT SURG AM, V94A, P298, DOI 10.2106/JBJS.K.00154; Solchaga LA, 2014, J ORTHOP RES, V32, P145, DOI 10.1002/jor.22483; Sozutek A, 2016, J INVEST SURG, V29, P294, DOI 10.3109/08941939.2015.1111473; Toledo-Pereyra LH, 2011, J SURG RES, V169, P188, DOI 10.1016/j.jss.2010.09.048; Tufro A, 1999, J AM SOC NEPHROL, V10, P2125; Yamaguchi R, 2012, J SURG RES, V173, P258, DOI 10.1016/j.jss.2010.10.001; Yang B, 2010, J SURG RES, V164, pE315, DOI 10.1016/j.jss.2010.07.044; Yang Y, 2016, PHARMACOL THERAPEUT, V163, P58, DOI 10.1016/j.pharmthera.2016.03.015; Zhang Q, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054250, 10.1371/journal.pone.0059667]; Zhang Y, 2015, BRAIN RES, V1594, P267, DOI 10.1016/j.brainres.2014.10.035; Zhou B, 2014, INJURY, V45, P864, DOI 10.1016/j.injury.2014.01.018	59	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0160703	10.1371/journal.pone.0160703	http://dx.doi.org/10.1371/journal.pone.0160703			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27551718	Green Published, gold, Green Submitted			2022-12-26	WOS:000381768800015
J	Benoit, J; Manger, PR; Fernandez, V; Rubidge, BS				Benoit, Julien; Manger, Paul R.; Fernandez, Vincent; Rubidge, Bruce S.			Cranial Bosses of Choerosaurus dejageri (Therapsida, Therocephalia): Earliest Evidence of Cranial Display Structures in Eutheriodonts	PLOS ONE			English	Article							BURNETIAMORPH THERAPSIDA; TEEKLOOF FORMATION; COLLAGEN ARRAYS; SOUTH-AFRICA; EVOLUTION; BIARMOSUCHIA; MORPHOLOGY; PATTERNS; RECONSTRUCTION; ORNITHISCHIA	Choerosaurus dejageri, a non-mammalian eutheriodont therapsid from the South African late Permian (similar to 259 Ma), has conspicuous hemispheric cranial bosses on the maxilla and the mandible. These bosses, the earliest of this nature in a eutheriodont, potentially make C. dejageri a key species for understanding the evolutionary origins of sexually selective behaviours (intraspecific competition, ritualized sexual and intimidation displays) associated with cranial outgrowths at the root of the clade that eventually led to extant mammals. Comparison with the tapinocephalid dinocephalian Moschops capensis, a therapsid in which head butting is strongly supported, shows that the delicate structure of the cranial bosses and the gracile structure of the skull of Choerosaurus would be more suitable for display and low energy combat than vigorous head butting. Thus, despite the fact that Choerosaurus is represented by only one skull (which makes it impossible to address the question of sexual dimorphism), its cranial bosses are better interpreted as structures involved in intraspecific selection, i.e. low-energy fighting or display. Display structures, such as enlarged canines and cranial bosses, are widespread among basal therapsid clades and are also present in the putative basal therapsid Tetraceratops insignis. This suggests that sexual selection may have played a more important role in the distant origin and evolution of mammals earlier than previously thought. Sexual selection may explain the subsequent independent evolution of cranial outgrowths and pachyostosis in different therapsid lineages (Biarmosuchia, Dinocephalia, Gorgonopsia and Dicynodontia).	[Benoit, Julien; Rubidge, Bruce S.] Univ Witwatersrand, Sch Geosci, ESI, ZA-2050 Johannesburg, South Africa; [Benoit, Julien; Manger, Paul R.] Univ Witwatersrand, Sch Anat Sci, 7 York Rd, ZA-2193 Johannesburg, South Africa; [Fernandez, Vincent] European Synchrotron Radiat Facil, 71 Rue Martyrs, F-38000 Grenoble, France	University of Witwatersrand; University of Witwatersrand; European Synchrotron Radiation Facility (ESRF)	Benoit, J (corresponding author), Univ Witwatersrand, Sch Geosci, ESI, ZA-2050 Johannesburg, South Africa.; Benoit, J (corresponding author), Univ Witwatersrand, Sch Anat Sci, 7 York Rd, ZA-2193 Johannesburg, South Africa.	julien.benoit@wits.ac.za	Rubidge, Bruce/AAE-7021-2019	Rubidge, Bruce/0000-0003-2477-1873; Benoit, Julien/0000-0001-5378-3940; Fernandez, Vincent/0000-0002-8315-1458	Palaeontological Scientific Trust (PAST); NRF African Origins Platform; DST-NRF Centre of Excellence in Palaeosciences; European Synchrotron Radiation Facility grant	Palaeontological Scientific Trust (PAST); NRF African Origins Platform; DST-NRF Centre of Excellence in Palaeosciences; European Synchrotron Radiation Facility grant	This research was conducted with financial support from the Palaeontological Scientific Trust (PAST) and its scatterlings projects; the NRF African Origins Platform; the DST-NRF Centre of Excellence in Palaeosciences; and the European Synchrotron Radiation Facility grant.	Angielczyk KD, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1642; BARGHUSEN H R, 1975, Paleobiology, V1, P295; Benoit J, 2016, SCI REP-UK, V6, DOI 10.1038/srep25604; Benoit J, 2013, GEOBIOS-LYON, V46, P357, DOI 10.1016/j.geobios.2013.07.002; Boonstra L. D., 1968, Annals of the South African Museum, V50, P195; BOONSTRA LIEUWE D., 1934, ANN S AFRICAN MUS, V31, P215; Boucot AJ., 1990, EVOLUTIONARY PALEOBI; Brink A. S., 1958, Palaeontologia Africana, V5, P39; Broom, 1932, MAMMAL LIKE REPTILES; Camp C.L., 1956, MEM U CALIF, V13, P255; Carlson KJ, 2011, SCIENCE, V333, P1402, DOI 10.1126/science.1203922; Cisneros JC, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150090; de Margerie E, 2004, J EXP BIOL, V207, P869, DOI 10.1242/jeb.00841; Emlen DJ, 2008, ANNU REV ECOL EVOL S, V39, P387, DOI 10.1146/annurev.ecolsys.39.110707.173502; Evans DC, 2009, ANAT REC, V292, P1315, DOI 10.1002/ar.20984; Farke AA, 2008, J EXP BIOL, V211, P3085, DOI 10.1242/jeb.019042; Fernandez V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064978; Fiorelli LE, 2013, SCI REP-UK, V3, DOI 10.1038/srep03348; Gand Georges, 2000, Palaeovertebrata (Montpellier), V29, P1; GEIST V, 1972, Zeitschrift fuer Saeugetierkunde, V37, P1; GEIST V, 1966, BEHAVIOUR, V27, P175, DOI 10.1163/156853966X00155; Goodwin MB, 2004, PALEOBIOLOGY, V30, P253, DOI 10.1666/0094-8373(2004)030<0253:CHOPOM>2.0.CO;2; GOW CE, 1986, S AFR J ZOOL, V21, P136; GRINE F E, 1979, Palaeontologia Africana, V22, P35; HAUGHTON S. H., 1929, ANN SOUTH AFRICAN MUS, V28, P55; Hieronymus TL, 2009, ANAT REC, V292, P1370, DOI 10.1002/ar.20985; Hopkins SSB, 2005, P ROY SOC B-BIOL SCI, V272, P1705, DOI 10.1098/rspb.2005.3171; Hopson J.A., 1979, P39; Horner JR, 2011, CR PALEVOL, V10, P439, DOI 10.1016/j.crpv.2011.04.006; Horner JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007626; Huttenlocker AK, 2016, J VERTEBR PALEONTOL, V36, DOI 10.1080/02724634.2016.1111897; Huttenlocker AK, 2015, J VERTEBR PALEONTOL, V35, DOI 10.1080/02724634.2015.969400; Huttenlocker AK, 2014, PEERJ, V2, DOI 10.7717/peerj.325; Ivachnenko M.F., 2000, PALEONTOL J, V34, P189; Ivakhnenko M, 2008, PALEONTOL J+, V42, P859, DOI 10.1134/S0031030108090013; Jasinoski SC, ANAT REC IN PRESS; JASLOW CR, 1995, J ZOOL, V235, P193; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Kammerer CF, 2015, FOSS REC, V18, P43, DOI 10.5194/fr-18-43-2015; Kammerer CF, 2016, J VERTEBR PALEONTOL, V36, DOI 10.1080/02724634.2015.1030408; Kammerer CF, 2016, PEERJ, V4, DOI 10.7717/peerj.1608; Kammerer CF, 2011, J VERTEBR PALEONTOL, V31, P1, DOI 10.1080/02724634.2011.627074; Kammerer CF, 2011, J SYST PALAEONTOL, V9, P261, DOI 10.1080/14772019.2010.492645; Kammerer CF, 2009, ZOOTAXA, P1; KEMP TS, 2005, ORIGIN EVOLUTION MAM; Kielan-Jaworowska Z, 2004, ACTA PALAEONTOL POL, V49, P177; Krapovickas V, 2013, LETHAIA, V46, P154, DOI 10.1111/j.1502-3931.2012.00329.x; Kruger A, 2015, J VERTEBR PALEONTOL, V35, DOI 10.1080/02724634.2015.1008698; LAURIN M, 1990, NATURE, V345, P249, DOI 10.1038/345249a0; Liu J, 2013, J VERTEBR PALEONTOL, V33, P1394, DOI 10.1080/02724634.2013.781505; Liu J, 2009, ACTA PALAEONTOL POL, V54, P393, DOI 10.4202/app.2008.0071; Margerie E., 2002, CR BIOL, V325, P221, DOI DOI 10.1016/S1631-0691(02)01429-4; Mirone A, 2014, NUCL INSTRUM METH B, V324, P41, DOI 10.1016/j.nimb.2013.09.030; Nasterlack T, 2012, J VERTEBR PALEONTOL, V32, P1396, DOI 10.1080/02724634.2012.697410; Olson E. C., 1962, Transactions of the American Philosophical Society NS, V52, P1, DOI 10.2307/1005904; Paganin D, 2002, J MICROSC-OXFORD, V206, P33, DOI 10.1046/j.1365-2818.2002.01010.x; Perez-Barberia FJ, 2005, OECOLOGIA, V145, P41, DOI 10.1007/s00442-005-0067-7; Peterson JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068620; Piveteau J, 1961, TRAITE PALEONTOLOGIE, VVI; PRUM RO, 1994, J MORPHOL, V222, P61, DOI 10.1002/jmor.1052220107; Prum RO, 1999, J EXP BIOL, V202, P3507; Rehorek SJ, 2005, CHEM SIGNAL, V10, P152, DOI 10.1007/0-387-25160-X_19; Reichel M, 2009, PALAEONTOLOGY, V52, P229, DOI 10.1111/j.1475-4983.2008.00824.x; Rodrigues PG, 2014, PALAEONTOL Z, V88, P329, DOI 10.1007/s12542-013-0200-6; Romer A. S., 1940, GEOLOGICAL SOC AM SP, V28, P1, DOI DOI 10.1130/SPE28-P1; Rubidge BS, 2006, J PALEONTOL, V80, P740, DOI 10.1666/0022-3360(2006)80[740:ANBTBF]2.0.CO;2; RUBIDGE BS, 1991, PALAEONTOLOGY, V34, P547; RUBIDGE BS, 1994, PALAEONTOLOGY, V37, P579; Rubidge BS, 2003, PALAEONTOLOGY, V46, P199, DOI 10.1111/1475-4983.00294; Rubidge BS, 2002, J VERTEBR PALEONTOL, V22, P257, DOI 10.1671/0272-4634(2002)022[0257:OTCMOT]2.0.CO;2; Rubidge BS, 2001, ANNU REV ECOL SYST, V32, P449, DOI 10.1146/annurev.ecolsys.32.081501.114113; Ruta M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1865; Sidor CA, 2004, J VERTEBR PALEONTOL, V24, P938, DOI 10.1671/0272-4634(2004)024[0938:ANBTFT]2.0.CO;2; Sidor CA, 2003, J VERTEBR PALEONTOL, V23, P631, DOI 10.1671/0272-4634(2003)023[0631:ASSOLP]2.0.CO;2; Sidor CA, 2007, J VERTEBR PALEONTOL, V27, P420, DOI 10.1671/0272-4634(2007)27[420:ASBTFT]2.0.CO;2; SIGOGNEAU D, 1970, Palaeontologia Africana, V13, P25; Sigogneau D., 1970, REVISION SYSTEMATIQU; Sigurdsen T, 2012, J VERTEBR PALEONTOL, V32, P1113, DOI 10.1080/02724634.2012.688693; Simmons RE, 1996, AM NAT, V148, P771, DOI 10.1086/285955; Smith RMH, 2006, J VERTEBR PALEONTOL, V26, P331, DOI 10.1671/0272-4634(2006)26[331:ANBTBF]2.0.CO;2; STANLEY SM, 1974, EVOLUTION, V28, P447, DOI 10.1111/j.1558-5646.1974.tb00766.x; Sues H.-D., 1978, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V1978, P459; Sullivan C, 2003, P ROY SOC B-BIOL SCI, V270, P173, DOI 10.1098/rspb.2002.2189; Tatarinov LP., 1976, MORPHOLOGICAL EVOLUT; TCHUDINOV PK, 1960, PALEONTOL ZH, V4, P81; Thackeray J. F., 1998, Annals of the Transvaal Museum, V36, P413; TOLLMAN S M, 1980, Annals of the South African Museum, V81, P159; Tomkins JL, 2010, AM NAT, V176, P141, DOI 10.1086/653001; Viglietti PA, 2013, PALAEOGEOGR PALAEOCL, V392, P9, DOI 10.1016/j.palaeo.2013.08.015; Vjuschkov BP, 1964, FUNDAMENTALS PALEONT, P275	90	17	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161457	10.1371/journal.pone.0161457	http://dx.doi.org/10.1371/journal.pone.0161457			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548428	Green Published, gold, Green Submitted			2022-12-26	WOS:000381768400058
J	Heurich, M; Zeis, K; Kuchenhoff, H; Muller, J; Belotti, E; Bufka, L; Woelfing, B				Heurich, Marco; Zeis, Klara; Kuechenhoff, Helmut; Mueller, Joerg; Belotti, Elisa; Bufka, Ludek; Woelfing, Benno			Selective Predation of a Stalking Predator on Ungulate Prey	PLOS ONE			English	Article							LYNX LYNX-LYNX; DEER CAPREOLUS-CAPREOLUS; ROE DEER; EURASIAN LYNX; TEMPORAL VARIATION; RED DEER; HABITAT SELECTION; NATIONAL-PARK; RISK; POPULATION	Prey selection is a key factor shaping animal populations and evolutionary dynamics. An optimal forager should target prey that offers the highest benefits in terms of energy content at the lowest costs. Predators are therefore expected to select for prey of optimal size. Stalking predators do not pursue their prey long, which may lead to a more random choice of prey individuals. Due to difficulties in assessing the composition of available prey populations, data on prey selection of stalking carnivores are still scarce. We show how the stalking predator Eurasian lynx (Lynx lynx) selects prey individuals based on species identity, age, sex and individual behaviour. To address the difficulties in assessing prey population structure, we confirm inferred selection patterns by using two independent data sets: (1) data of 387 documented kills of radio-collared lynx were compared to the prey population structure retrieved from systematic camera trapping using Manly's standardized selection ratio alpha and (2) data on 120 radio-collared roe deer were analysed using a Cox proportional hazards model. Among the larger red deer prey, lynx selected against adult males-the largest and potentially most dangerous prey individuals. In roe deer lynx preyed selectively on males and did not select for a specific age class. Activity during high risk periods reduced the risk of falling victim to a lynx attack. Our results suggest that the stalking predator lynx actively selects for size, while prey behaviour induces selection by encounter and stalking success rates.	[Heurich, Marco; Mueller, Joerg; Woelfing, Benno] Bavarian Forest Natl Pk, Dept Conservat & Res, Freyunger Str 2, D-94481 Grafenau, Germany; [Heurich, Marco] Univ Freiburg, Chair Wildlife Ecol & Management, Tennenbacher Str 4, D-79106 Freiburg, Germany; [Zeis, Klara; Kuechenhoff, Helmut] Univ Munich, Dept Stat, Stat Consulting Unit, Ludwigstr 33, D-80539 Munich, Germany; [Belotti, Elisa] Czech Univ Life Sci Prague, Fac Forestry & Wood Sci, Kamycka 1176, CZ-16521 Prague 6, Czech Republic; [Belotti, Elisa; Bufka, Ludek] Sumava Natl Pk Adm, Dept Res & Nat Protect, Susicka 399, CZ-34192 Kasperske Hory, Czech Republic; [Mueller, Joerg] Univ Wurzburg, Bioctr, Dept Anim Ecol & Trop Biol, Field Stn Fabrikschleichach, Rauhenebrach, Germany	University of Freiburg; University of Munich; Czech University of Life Sciences Prague; University of Wurzburg	Heurich, M (corresponding author), Bavarian Forest Natl Pk, Dept Conservat & Res, Freyunger Str 2, D-94481 Grafenau, Germany.; Heurich, M (corresponding author), Univ Freiburg, Chair Wildlife Ecol & Management, Tennenbacher Str 4, D-79106 Freiburg, Germany.	Marco.heurich@npv-bw.bayern.de	Heurich, Marco/O-4653-2014	Heurich, Marco/0000-0003-0051-2930; Muller, Jorg/0000-0002-1409-1586; Kuchenhoff, Helmut/0000-0002-6372-2487	EU Programme INTERREG IV (EFREZiel 3) [18]; Bavarian Forest National Park Administration	EU Programme INTERREG IV (EFREZiel 3); Bavarian Forest National Park Administration	Financial support was provided by the EU Programme INTERREG IV (EFREZiel 3) Project Nr. 18 (http://www.stmwi.bayern.de/EFRE/Interreg_IV/) and the Bavarian Forest National Park Administration.; This study is part of a project on the predator-prey relationship of Eurasian lynx, red deer and roe deer carried out by the Bavarian Forest National Park Administration, Department of Research and Documentation. Financial support was provided by the EU Programme INTERREG IV (EFREZiel 3) and the Bavarian Forest National Park Administration. We thank Horst Burghart, Martin Gahbauer, Oldrich Vojtech, Jan Mokry, Helmut Penn, Michael Penn, Rudiger Fischer, and Lothar Ertl for technical support and Karen A. Brune for language editing.	Aanes R, 1996, CAN J ZOOL, V74, P1857, DOI 10.1139/z96-209; Abrams PA, 2000, ANNU REV ECOL SYST, V31, P79, DOI 10.1146/annurev.ecolsys.31.1.79; Andersen R., 1998, EUROPEAN ROE DEER BI; Andersen R, 2007, WILDLIFE BIOL, V13, P467, DOI 10.2981/0909-6396(2007)13[467:SOELLL]2.0.CO;2; Apollonio M., 2010, EUROPEAN UNGULATES T; Belotti E, 2014, EUR J WILDLIFE RES, V60, P441, DOI 10.1007/s10344-014-0801-8; Boon AK, 2008, OIKOS, V117, P1321, DOI 10.1111/j.0030-1299.2008.16567.x; Borkowski J, 2008, FOREST ECOL MANAG, V255, P468, DOI 10.1016/j.foreco.2007.09.013; Creel S, 2005, ANIM BEHAV, V69, P1181, DOI 10.1016/j.anbehav.2004.07.022; Creel S., 2002, AFRICAN WILD DOG BEH; Creel S, 2011, ECOLOGY, V92, P2190, DOI 10.1890/11-0327.1; Danilkin A, 1995, BEHAV ECOLOGY SIBERI; Davis ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047894; DiRienzo N, 2013, ANIM BEHAV, V86, P317, DOI 10.1016/j.anbehav.2013.05.020; Dorai-Raj S., 2014, BINOM BINOMIAL CONFI; Efron B, 2000, J AM STAT ASSOC, V95, P1293, DOI 10.2307/2669773; Ellenberg H, 1978, POPULATIONSOKOLOGIE; Ewald M, 2014, FORESTS, V5, P1374, DOI 10.3390/f5061374; Fellows I, 2012, J STAT SOFTW, V49, P1; Festa-Bianchet M, 2006, P ROY SOC B-BIOL SCI, V273, P1537, DOI 10.1098/rspb.2006.3467; Festetics A, 1980, WIEDEREINBURGERUNG L, P89; FITZGIBBON CD, 1990, ANIM BEHAV, V39, P1116, DOI 10.1016/S0003-3472(05)80784-5; FITZGIBBON CD, 1989, J ZOOL, V218, P99, DOI 10.1111/j.1469-7998.1989.tb02528.x; FITZGIBBON CD, 1990, ANIM BEHAV, V40, P837, DOI 10.1016/S0003-3472(05)80984-4; GEIGER C, 1974, Zeitschrift fuer Jagdwissenschaft, V20, P53, DOI 10.1007/BF01901849; Gervasi V, 2012, J ANIM ECOL, V81, P443, DOI 10.1111/j.1365-2656.2011.01928.x; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Griffin PC, 2005, BEHAV ECOL, V16, P938, DOI 10.1093/beheco/ari074; Hagen R, 2014, ECOL COMPLEX, V20, P43, DOI 10.1016/j.ecocom.2014.07.006; Haglund B., 1966, Viltrevy, V4, P81; Hayward MW, 2006, J ZOOL, V270, P298, DOI 10.1111/j.1469-7998.2006.00139.x; Hayward MW, 2012, J ZOOL, V286, P221, DOI 10.1111/j.1469-7998.2011.00871.x; Hayward MW, 2006, J MAMMAL, V87, P1122, DOI 10.1644/05-MAMM-A-304R2.1; Hayward MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023607; Hayward MW, 2005, J ZOOL, V267, P309, DOI 10.1017/S0952836905007508; Hebblewhite M, 2002, CAN J ZOOL, V80, P800, DOI 10.1139/Z02-059; Heurich M, 2012, EUROPEAN J WILDLIFE, P1; Heurich M, 2011, 12 INT FACHT FRAG VE, P142; Heurich M, 2012, ACTA THERIOL, P1; Heurich M, 2005, WALDER NATIONALPARKS; Heurich M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120960; Heurich M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114143; Hornocker M.G., 1970, WILDLIFE MONOGR, V21, P3; Husseman JS, 2003, OIKOS, V101, P591, DOI 10.1034/j.1600-0706.2003.12230.x; Jarnemo A, 2004, CAN J ZOOL, V82, P416, DOI 10.1139/z04-011; JEDRZEJEWSKI W, 1993, ACTA THERIOL, V38, P385; Jobin A, 2000, ACTA THERIOL, V45, P243, DOI 10.4098/AT.arch.00-26; Kamler JF, 2012, J MAMMAL, V93, P627, DOI 10.1644/11-MAMM-A-241.1; KARANTH KU, 1995, J ANIM ECOL, V64, P439, DOI 10.2307/5647; KITCHENER A., 1991, NATURAL HIST WILD CA; KLEIMAN DG, 1973, ANIM BEHAV, V21, P637, DOI 10.1016/S0003-3472(73)80088-0; Koubek P., 1996, LYNX CZECH SLOVAK RE; Krivan V, 1996, THEOR POPUL BIOL, V49, P265, DOI 10.1006/tpbi.1996.0014; Krivan V, 2003, THEOR POPUL BIOL, V63, P269, DOI 10.1016/S0040-5809(03)00012-1; Krofel M, 2014, EUR J WILDLIFE RES, V60, P11, DOI 10.1007/s10344-013-0745-4; Kunkel KE, 1999, J WILDLIFE MANAGE, V63, P901, DOI 10.2307/3802804; Lausch A, 2013, ECOL INDIC, V31, P73, DOI 10.1016/j.ecolind.2012.07.026; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; Lottker P, 2009, WILDLIFE BIOL, V15, P425, DOI 10.2981/08-014; MAGNHAGEN C, 1991, TRENDS ECOL EVOL, V6, P183, DOI 10.1016/0169-5347(91)90210-O; MANLY BFJ, 1972, AM NAT, V106, P719, DOI 10.1086/282808; MCNAMARA JM, 1992, B MATH BIOL, V54, P355; Mech L. David, 2003, P131; Mejlgaard T, 2013, J ZOOL, V289, P222, DOI 10.1111/j.1469-7998.2012.00980.x; Melis C, 2009, GLOBAL ECOL BIOGEOGR, V18, P724, DOI 10.1111/j.1466-8238.2009.00480.x; Molinari-Jobin A, 2004, ECOGRAPHY, V27, P323, DOI 10.1111/j.0906-7590.2004.03862.x; Morellet N, 2007, J APPL ECOL, V44, P634, DOI 10.1111/j.1365-2664.2007.01307.x; Muller J, 2014, BIOL CONSERV, V177, P210, DOI 10.1016/j.biocon.2014.07.007; MYSTERUD A, 1995, CAN J ZOOL, V73, P924, DOI 10.1139/z95-108; Mysterud A, 1997, WILDLIFE BIOL, V3, P27, DOI 10.2981/wlb.1997.004; Nahlik A., 2005, Wildlife Biology in Practice, V1, P47; Necas J, 1986, BEITRAGE JAGD WILDFO, VVI, P27; Nilsen EB, 2009, J ANIM ECOL, V78, P741, DOI 10.1111/j.1365-2656.2009.01547.x; Okarma H, 1997, ACTA THERIOL, V42, P203, DOI 10.4098/AT.arch.97-22; Pettorelli N, 2011, OECOLOGIA, V167, P305, DOI 10.1007/s00442-011-2069-y; Pierce BM, 2000, J MAMMAL, V81, P462, DOI 10.1644/1545-1542(2000)081<0462:SOMDBM>2.0.CO;2; Podolski I, 2013, WILDLIFE BIOL, V19, P69, DOI 10.2981/12-049; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Quinn JL, 2012, P ROY SOC B-BIOL SCI, V279, P1919, DOI 10.1098/rspb.2011.2227; R Core Team, 2021, R LANGUAGE ENV STAT; Reale D, 2003, ANIM BEHAV, V65, P463, DOI 10.1006/anbe.2003.2100; Reale D, 2010, PHILOS T R SOC B, V365, P3937, DOI 10.1098/rstb.2010.0222; Rowcliffe JM, 2008, J APPL ECOL, V45, P1228, DOI 10.1111/j.1365-2664.2008.01473.x; Ruckstuhl K.E., 2005, SEXUAL SEGREGATION V; SCHEEL D, 1991, ANIM BEHAV, V41, P697, DOI 10.1016/S0003-3472(05)80907-8; Siebert U, 2012, REHWILDZAHLUNG NP BA; Sih A, 2002, ANIM BEHAV, V63, P437, DOI 10.1006/anbe.2001.1921; Sinclair ARE, 2003, NATURE, V425, P288, DOI 10.1038/nature01934; Sokal R.R., 2012, BIOMETRY; Stache A, 2013, FOLIA ZOOL, P62; Stubbe C., 1997, REHWILD BIOL OKOLOGI, Vfourth; Sunquist ME, 1989, ECOLOGICAL CONSTRAIN, P283; Sunquist ME, 2002, WILD CATS WORLD; Therneau T. M., 2015, PACKAGE SURVIVAL ANA; Weilnbock G., 2012, CURRENT RES APPL ETH, P22; Weingarth K, 2012, ANIM BIODIV CONSERV, V35, P197; Wickham H, 2007, J STAT SOFTW, V21, P1; Winnie J, 2007, ANIM BEHAV, V73, P215, DOI 10.1016/j.anbehav.2006.07.007; Wolfl M, 2001, ACTA THERIOL, V46, P181, DOI 10.1007/BF03192427; Yearsley IM, 2005, ANIM BEHAV, V69, P257, DOI 10.1016/j.anbehav.2004.04.010	100	15	16	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0158449	10.1371/journal.pone.0158449	http://dx.doi.org/10.1371/journal.pone.0158449			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548478	gold, Green Published, Green Submitted			2022-12-26	WOS:000381768400005
J	Lee, DH; Lee, SH; Kim, AR; Quan, FS				Lee, Dong Hun; Lee, Su Hwa; Kim, Ah Ra; Quan, Fu Shi			Virus-Like Nanoparticle Vaccine Confers Protection against Toxoplasma gondii	PLOS ONE			English	Article							INFLUENZA-VIRUS; MICE; INFECTION; IMMUNITY; REPLICATION; CHALLENGE; PARTICLES; RESPONSES; MEMORY; CELLS	The inner membrane complex (IMC) of Toxoplasma gondii as a peripheral membrane system has unique and critical roles in parasite replication, motility and invasion. Disruption of IMC sub-compartment protein produces a severe defect in T. gondii endodyogeny, the form of internal cell budding. In this study, we generated T. gondii virus-like particle particles (VLPs) containing proteins derived from IMC, and investigated their efficacy as a vaccine in mice. VLP vaccination induced Toxoplasma gondii-specific total IgG, IgG1 and IgG2a antibody responses in the sera and IgA antibody responses in the feces. Upon challenge infection with a lethal dose of T. gondii (ME49), all vaccinated mice survived, whereas all naive control mice died. Vaccinated mice showed significantly reduced cyst load and cyst size in the brain. VLP vaccination also induced IgA and IgG antibody responses in feces and intestines, and antibody-secreting plasma cells, mixed Th1/Th2 cytokines and CD4(+)/CD8(+) T cells from spleen. Taken together, these results indicate that non-replicating VLPs containing inner membrane complex of T. gondii represent a promising strategy for the development of a safe and effective vaccine to control the spread of Toxoplasma gondii infection.	[Lee, Dong Hun; Lee, Su Hwa; Kim, Ah Ra] Kyung Hee Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea; [Quan, Fu Shi] Kyung Hee Univ, Sch Med, Dept Med Zool, Seoul, South Korea	Kyung Hee University; Kyung Hee University	Quan, FS (corresponding author), Kyung Hee Univ, Sch Med, Dept Med Zool, Seoul, South Korea.	fsquan@khu.ac.kr	Quan, Fu-Shi/V-1826-2019		National Research Foundation of Korea (NRF) [NRF-2014R1A2A2A01004899]; Agri-Bio Industry Technology Development Program [315030031-HD020]; IPET; MAFRA; KHIDI; Ministry of Health & Welfare, Republic of Korea [HI15C2928]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Agri-Bio Industry Technology Development Program; IPET(Institute of Planning & Evaluation for Technology in Food, Agriculture, Forestry, & Fisheries (iPET), Republic of Korea); MAFRA(Ministry of Agriculture, Food & Rural Affairs (MAFRA), Republic of Korea); KHIDI; Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by a grant from the National Research Foundation of Korea (NRF) (NRF-2014R1A2A2A01004899), a grant from the Agri-Bio Industry Technology Development Program (315030031-HD020), IPET, MAFRA, KHIDI, and a grant from the Ministry of Health & Welfare, Republic of Korea (HI15C2928). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Rodriguez JB, 2012, EXPERT OPIN THER PAT, V22, P311, DOI 10.1517/13543776.2012.668886; Beck JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001094; Bhopale GM, 2003, MICROBES INFECT, V5, P457, DOI 10.1016/S1286-4579(03)00048-0; Chu KB, 2014, PARASITE IMMUNOL, V36, P522, DOI 10.1111/pim.12125; Dubey J.P., 1988, TOXOPLASMOSIS ANIMAL; Fang R, 2010, VACCINE, V28, P1803, DOI 10.1016/j.vaccine.2009.12.005; FRENKEL JK, 1988, PARASITOL TODAY, V4, P273, DOI 10.1016/0169-4758(88)90018-X; Glor SB, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-85; Hassan IA, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-431; Johnson LL, 2002, INFECT IMMUN, V70, P185, DOI 10.1128/IAI.70.1.185-191.2002; Jongert E, 2009, MEM I OSWALDO CRUZ, V104, P252, DOI 10.1590/S0074-02762009000200019; Kang H, 2000, J IMMUNOL, V164, P2629, DOI 10.4049/jimmunol.164.5.2629; Perrone LA, 2009, J VIROL, V83, P5726, DOI 10.1128/JVI.00207-09; Pitoiset F, 2015, EXPERT REV VACCINES, P1; Quan F, 2010, VIRUS LIKE PARTICLE; Quan FS, 2008, VACCINE, V26, P3352, DOI 10.1016/j.vaccine.2008.03.055; Quan FS, 2009, J VIROL, V83, P4489, DOI 10.1128/JVI.02035-08; Quan FS, 2007, J VIROL, V81, P3514, DOI 10.1128/JVI.02052-06; Quan FS, 2011, J INFECT DIS, V204, P987, DOI 10.1093/infdis/jir474; Sanchez VR, 2015, ACTA TROP, V150, P159, DOI 10.1016/j.actatropica.2015.07.013; Slifka MK, 1996, J IMMUNOL METHODS, V199, P37, DOI 10.1016/S0022-1759(96)00146-9; Tonkin ML, 2014, J BIOL CHEM, V289, P13962, DOI 10.1074/jbc.M114.548891; Vercammen M, 1999, PARASITE IMMUNOL, V21, P555, DOI 10.1046/j.1365-3024.1999.00256.x; Weiss LM, 2009, INT J PARASITOL, V39, P895, DOI 10.1016/j.ijpara.2009.02.004; Woodland DL, 2001, IMMUNOL RES, V24, P53, DOI 10.1385/IR:24:1:53	26	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161231	10.1371/journal.pone.0161231	http://dx.doi.org/10.1371/journal.pone.0161231			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548677	Green Published, Green Submitted, gold			2022-12-26	WOS:000381768400034
J	Hollo, G				Hollo, Gabor			Intrasession and Between-Visit Variability of Sector Peripapillary Angioflow Vessel Density Values Measured with the Angiovue Optical Coherence Tomograph in Different Retinal Layers in Ocular Hypertension and Glaucoma	PLOS ONE			English	Article							OCT ANGIOGRAPHY; PERFUSION; DISC; EYES	Purpose To evaluate intrasession and between-visit reproducibility of sector peripapillary angioflow vessel-density (PAFD, %) values in the optic nerve head (ONH) and radial peripapillary capillaries (RPC) layers, respectively, and to analyze the influence of the corresponding sector retinal nerve fiber layer thickness (RNFLT) on the results. Methods High quality images acquired with the Angiovue/RTVue-XR Avanti optical coherence tomograph (Optovue Inc., Fremont, USA) on 1 eye of 18 stable glaucoma and ocular hypertension patients were analyzed using the Optovue 2015.100.0.33 software version. Three images were acquired in one visit and 1 image 3 months later. Results PAFD image quality for all images necessary to calculate reproducibility was sufficient to analysis only in 18 of the 83 participants (21.7%) who were successfully imaged for RNFLT. Intrasession coefficient of variation (CV) ranged between 2.30 and 3.89%, and 3.51 and 5.12% for the peripapillary sectors in the ONH and RPC layers, respectively. The corresponding between-visit CV values ranged between 3.05 and 4.26%, and 4.99 and 6.90%, respectively. Intrasession SD did not correlate with the corresponding RNFLT in any sector in either layer (P >= 0.170). In the ONH layer sector PAFD values did not correlate with the corresponding RNFLT values (P >= 0.100). In contrast, in the RPC layer a significant positive correlation between the corresponding sector PAFD and RNFLT values was found for all but one peripapillary sectors (Pearson-r range: 0.652 to 0.771, P <= 0.0046). Conclusion Though in several patients routine use of PAFD measurement may be limited by suboptimal image quality, in the successfully imaged cases (21.7% of the study eyes in the current investigation) reproducibility of sector PAFD values seems to be sufficient for clinical research. In stable patients intrasession variability explains most of the between-visit variability. Sector PAFD variability is independent from sector RNFLT, a marker of glaucoma severity. In the RPC layer sector PAFD and RNFLT show strong to very strong positive correlation.	[Hollo, Gabor] Semmelweis Univ, Dept Ophthalmol, Budapest, Hungary	Semmelweis University	Hollo, G (corresponding author), Semmelweis Univ, Dept Ophthalmol, Budapest, Hungary.	hollo.gabor@med.semmelweis-univ.hu						Carpineto P, 2016, BRIT J OPHTHALMOL, V100, P671, DOI 10.1136/bjophthalmol-2015-307330; Coscas F, 2016, AM J OPHTHALMOL, V161, P160, DOI 10.1016/j.ajo.2015.10.008; Garas A, 2010, OPHTHALMOLOGY, V117, P738, DOI 10.1016/j.ophtha.2009.08.039; Garway-Heath DF, 2000, OPHTHALMOLOGY, V107, P1809, DOI 10.1016/S0161-6420(00)00284-0; Hollo G, 2016, EUR J OPHTHALMOL, V26, pE42, DOI 10.5301/ejo.5000717; Kuehlewein L, 2015, EYE, V29, P932, DOI 10.1038/eye.2015.80; Liu L, 2015, JAMA OPHTHALMOL, V133, P1045, DOI 10.1001/jamaophthalmol.2015.2225; Pechauer AD, 2015, INVEST OPHTH VIS SCI, V56, P3287, DOI 10.1167/iovs.15-16655; Quaranta L, 2013, SURV OPHTHALMOL, V58, P26, DOI 10.1016/j.survophthal.2012.05.003; Wang XL, 2015, GRAEF ARCH CLIN EXP, V253, P1557, DOI 10.1007/s00417-015-3095-y	10	42	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161631	10.1371/journal.pone.0161631	http://dx.doi.org/10.1371/journal.pone.0161631			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537500	gold, Green Published, Green Submitted			2022-12-26	WOS:000381577000127
J	Tribouillois, H; Durr, C; Demilly, D; Wagner, MH; Justes, E				Tribouillois, Helene; Durr, Carolyne; Demilly, Didier; Wagner, Marie-Helene; Justes, Eric			Determination of Germination Response to Temperature and Water Potential for a Wide Range of Cover Crop Species and Related Functional Groups	PLOS ONE			English	Article							HELIANTHUS-ANNUUS L.; SEED-GERMINATION; CARDINAL TEMPERATURES; TIME-COURSE; EMERGENCE; REQUIREMENTS; MITIGATION; MODEL; PEA	A wide range of species can be sown as cover crops during fallow periods to provide various ecosystem services. Plant establishment is a key stage, especially when sowing occurs in summer with high soil temperatures and low water availability. The aim of this study was to determine the response of germination to temperature and water potential for diverse cover crop species. Based on these characteristics, we developed contrasting functional groups that group species with the same germination ability, which may be useful to adapt species choice to climatic sowing conditions. Germination of 36 different species from six botanical families was measured in the laboratory at eight temperatures ranging from 4.5-43 degrees C and at four water potentials. Final germination percentages, germination rate, cardinal temperatures, base temperature and base water potential were calculated for each species. Optimal temperatures varied from 21.3-37.2 degrees C, maximum temperatures at which the species could germinate varied from 27.7-43.0 degrees C and base water potentials varied from -0.1 to -2.6 MPa. Most cover crops were adapted to summer sowing with a relatively high mean optimal temperature for germination, but some Fabaceae species were more sensitive to high temperatures. Species mainly from Poaceae and Brassicaceae were the most resistant to water deficit and germinated under a low base water potential. Species were classified, independent of family, according to their ability to germinate under a range of temperatures and according to their base water potential in order to group species by functional germination groups. These groups may help in choosing the most adapted cover crop species to sow based on climatic conditions in order to favor plant establishment and the services provided by cover crops during fallow periods. Our data can also be useful as germination parameters in crop models to simulate the emergence of cover crops under different pedoclimatic conditions and crop management practices.	[Tribouillois, Helene; Justes, Eric] INRA, UMR AGIR 1248, 24 Chemin Borderouge Auzeville, F-31320 Castanet Tolosan, France; [Durr, Carolyne] INRA, IRHS 1345, 42 Rue George Morel, F-49071 Beaucouze, France; [Demilly, Didier; Wagner, Marie-Helene] GEVES, Stn Natl Essais Semences, 42 Rue George Morel, F-49071 Beaucouze, France	INRAE; INRAE	Justes, E (corresponding author), INRA, UMR AGIR 1248, 24 Chemin Borderouge Auzeville, F-31320 Castanet Tolosan, France.	eric.justes@toulouse.inra.fr	Justes, Eric/GLT-6299-2022	Justes, Eric/0000-0001-7390-7058; WAGNER, Marie-Helene/0000-0001-6224-5271	Arvalis-Institut du Vegetal; Midi-Pyrenees Region; CASDAR-CTPS project [C2011-2013]; ADEME project CiCC; UMR AGIR INRA	Arvalis-Institut du Vegetal; Midi-Pyrenees Region(Region Occitanie); CASDAR-CTPS project; ADEME project CiCC; UMR AGIR INRA	This study was financed by Arvalis-Institut du Vegetal, the Midi-Pyrenees Region, the CASDAR-CTPS project C2011-2013, the ADEME project CiCC and UMR AGIR INRA.; This study was financed by Arvalis-Institut du Vegetal, the Midi-Pyrenees Region, the CASDAR-CTPS project C2011-2013, the ADEME project CiCC and UMR AGIR INRA. The authors would like to thank L. Ledroit, E. Chardon and M. Labarrere for their efficient technical help. We thank M. L. and M. S. Corson for improving the English in the text.	Allen BL, 2014, AGRON J, V106, P940, DOI 10.2134/agronj13.0469; ANGUS JF, 1981, FIELD CROP RES, V3, P365; BASKIN CC, 1988, AM J BOT, V75, P286, DOI 10.2307/2443896; Bewley JD., 1994, SEEDS PHYSL DEV GERM, DOI [10.1007/978-1-4899-1002-8_1, DOI 10.1007/978-1-4899-1002-8]; Brisson N, 2003, EUR J AGRON, V18, P309, DOI 10.1016/S1161-0301(02)00110-7; Brisson N., 2008, CONCEPTUAL BASIS FOR; Constantin J, 2012, AGR ECOSYST ENVIRON, V147, P36, DOI 10.1016/j.agee.2011.06.006; Constantin J, 2015, EUR J AGRON, V69, P75, DOI 10.1016/j.eja.2015.06.002; Constantin J, 2015, FIELD CROP RES, V176, P22, DOI 10.1016/j.fcr.2015.02.017; Dahal P, 1994, SEED SCI RES, V4, P71, DOI 10.1017/S096025850000204X; Dayrell RL, 2016, ANN BOT IN PRESS; Demilly D, 2014, PLANT IMAGE IN PRESS; Demilly D, 1995, DIGITAL IMAGING SEED; Dorsainvil F, 2005, EUR J AGRON, V23, P146, DOI 10.1016/j.eja.2004.11.002; Dorsainvil F., 2002, THESIS; DRACUP M, 1993, AUST J EXP AGR, V33, P759, DOI 10.1071/EA9930759; Ducournau S, 2005, SEED SCI TECHNOL, V33, P329, DOI 10.15258/sst.2005.33.2.06; Ducournau S, 2004, COMPUT ELECTRON AGR, V44, P189, DOI 10.1016/j.compag.2004.04.005; Durr C, 2015, AGR FOREST METEOROL, V200, P222, DOI 10.1016/j.agrformet.2014.09.024; DUMUR D, 1990, J EXP BOT, V41, P1423, DOI 10.1093/jxb/41.11.1423; Durr C, 2003, BIOLOGY OF SEEDS: RECENT RESEARCH ADVANCES, P225, DOI 10.1079/9780851996530.0225; GUMMERSON RJ, 1986, J EXP BOT, V37, P729, DOI 10.1093/jxb/37.6.729; HARDEGREE SP, 1994, SEED SCI TECHNOL, V22, P1; Iannucci A, 2008, FIELD CROP RES, V106, P156, DOI 10.1016/j.fcr.2007.11.005; Jacobsen KL, 2010, AGRON J, V102, P1346, DOI 10.2134/agronj2010.0002n; Justes E, 2009, PLANT SOIL, V325, P171, DOI 10.1007/s11104-009-9966-4; Justes E., 2012, INT FERT SOC M CAMBR, P4; Kamkar B., 2006, Asian Journal of Plant Sciences, V5, P316; Lee JiHyun, 2009, Korean Journal of Crop Science / Hanguk Jakmul Hakhoe Chi, V54, P218; Marshall B, 1996, J EXP BOT, V47, P1369, DOI 10.1093/jxb/47.9.1369; MICHEL BE, 1983, PLANT PHYSIOL, V72, P66, DOI 10.1104/pp.72.1.66; Mwale SS, 2003, SEED SCI TECHNOL, V31, P199, DOI 10.15258/sst.2003.31.1.21; Olivier FC, 1998, FIELD CROP RES, V56, P301, DOI 10.1016/S0378-4290(97)00097-X; Parent B, 2012, NEW PHYTOL, V194, P760, DOI 10.1111/j.1469-8137.2012.04086.x; Raveneau MP, 2011, SEED SCI RES, V21, P205, DOI 10.1017/S0960258511000067; ROBERTS EH, 1988, SYM SOC EXP BIOL, V42, P109; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SCHOPFER P, 1979, PLANT PHYSIOL, V64, P822, DOI 10.1104/pp.64.5.822; Thorup-Kristensen K, 2003, ADV AGRON, V79, P227, DOI 10.1016/S0065-2113(02)79005-6; Tosti G, 2014, EUR J AGRON, V54, P34, DOI 10.1016/j.eja.2013.11.012; Tribouillois H, 2016, PLANT SOIL, V401, P347, DOI 10.1007/s11104-015-2734-8; Tribouillois H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122156; Uzun F., 2004, Asian Journal of Plant Sciences, V3, P714; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wilke BJ, 2008, J SCI FOOD AGR, V88, P551, DOI 10.1002/jsfa.3149; YIN XY, 1995, AGR FOREST METEOROL, V77, P1, DOI 10.1016/0168-1923(95)02236-Q; Yusoff MM, 2012, CROP PASTURE SCI, V63, P1097, DOI 10.1071/CP12305	47	47	48	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161185	10.1371/journal.pone.0161185	http://dx.doi.org/10.1371/journal.pone.0161185			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532825	Green Published, Green Submitted, gold			2022-12-26	WOS:000381487600071
J	Rivet, CA; Kniss-James, AS; Gran, MA; Potnis, A; Hill, A; Lu, H; Kemp, ML				Rivet, Catherine A.; Kniss-James, Ariel S.; Gran, Margaret A.; Potnis, Anish; Hill, Abby; Lu, Hang; Kemp, Melissa L.			Calcium Dynamics of Ex Vivo Long-Term Cultured CD8(+) T Cells Are Regulated by Changes in Redox Metabolism	PLOS ONE			English	Article							OPERATED CA2+ ENTRY; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; AGE-RELATED ALTERATIONS; GENE-EXPRESSION; KINETIC-MODEL; LYMPHOCYTE-ACTIVATION; ENDOPLASMIC-RETICULUM; MEMBRANE CA2+-ATPASE; SIGNAL-TRANSDUCTION; CARDIAC MYOCYTES	T cells reach a state of replicative senescence characterized by a decreased ability to proliferate and respond to foreign antigens. Calcium release associated with TCR engagement is widely used as a surrogate measure of T cell response. Using an ex vivo culture model that partially replicates features of organismal aging, we observe that while the amplitude of Ca2+ signaling does not change with time in culture, older T cells exhibit faster Ca2+ rise and a faster decay. Gene expression analysis of Ca2+ channels and pumps expressed in T cells by RT-qPCR identified overexpression of the plasma membrane CRAC channel subunit ORAI1 and PMCA in older T cells. To test whether overexpression of the plasma membrane Ca2+ channel is sufficient to explain the kinetic information, we adapted a previously published computational model by Maurya and Subramaniam to include additional details on the store-operated calcium entry (SOCE) process to recapitulate Ca2+ dynamics after T cell receptor stimulation. Simulations demonstrated that upregulation of ORAI1 and PMCA channels is not sufficient to explain the observed alterations in Ca2+ signaling. Instead, modeling analysis identified kinetic parameters associated with the IP3R and STIM1 channels as potential causes for alterations in Ca2+ dynamics associated with the long term ex vivo culturing protocol. Due to these proteins having known cysteine residues susceptible to oxidation, we subsequently investigated and observed transcriptional remodeling of metabolic enzymes, a shift to more oxidized redox couples, and post-translational thiol oxidation of STIM1. The model-directed findings from this study highlight changes in the cellular redox environment that may ultimately lead to altered T cell calcium dynamics during immunosenescence or organismal aging.	[Rivet, Catherine A.] Georgia Inst Technol, Sch Elect & Comp Engn, Atlanta, GA 30332 USA; [Kniss-James, Ariel S.; Gran, Margaret A.; Potnis, Anish; Hill, Abby; Lu, Hang; Kemp, Melissa L.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Kniss-James, Ariel S.; Gran, Margaret A.; Potnis, Anish; Hill, Abby; Lu, Hang; Kemp, Melissa L.] Emory Univ, Atlanta, GA 30322 USA; [Lu, Hang] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA; [Lu, Hang; Kemp, Melissa L.] Parker H Petit Inst Bioengn & Biosci, Atlanta, GA USA; [Hill, Abby] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Emory University; University System of Georgia; Georgia Institute of Technology; Massachusetts Institute of Technology (MIT)	Kemp, ML (corresponding author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.; Kemp, ML (corresponding author), Emory Univ, Atlanta, GA 30322 USA.; Kemp, ML (corresponding author), Parker H Petit Inst Bioengn & Biosci, Atlanta, GA USA.	melissa.kemp@bme.gatech.edu		Kemp, Melissa/0000-0003-3781-8802	NIAID [R01AI088023A]; NIH New Innovator award [DP2OD006483]; NSF Graduate Research Fellowship [DGE-1148903]; NIH T32 Pre-Doctoral Training Grant [32GM105490]; National Institutes of Health [R01AI088023A, DP2OD006483]; P.E.O. Scholar Award; NIH Training Grant [32GM105490]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI088023, R01AI088023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM105490] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006483] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH New Innovator award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Graduate Research Fellowship(National Science Foundation (NSF)); NIH T32 Pre-Doctoral Training Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); P.E.O. Scholar Award; NIH Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was supported by the following: NIAID, www.niaid.nih.gov, R01AI088023A (awarded to MLK and HL); NIH New Innovator award, Office of Director, www.commonfund.nih.gov/newinnovator/, DP2OD006483 (to MLK); NSF Graduate Research Fellowship, www.nsfgrfp.org, DGE-1148903 (to AK); and NIH T32 Pre-Doctoral Training Grant, www.nigms.nih.gov/Training/InstPredoc, 32GM105490 (to AK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors would like to acknowledge invaluable assistance in parameter optimization from Gaurav Dwivedi. Support for this work was provided by the National Institutes of Health awards R01AI088023A and DP2OD006483. Financial support to AK provided through NSF Graduate Research Fellowship Grant DGE-1148903, P.E.O. Scholar Award, and NIH Training Grant 32GM105490.	Abell E, 2011, P NATL ACAD SCI USA, V108, P14485, DOI 10.1073/pnas.1018266108; Ahnadi CE, 1996, CELL CALCIUM, V19, P509, DOI 10.1016/S0143-4160(96)90060-3; Arrol HP, 2008, CLIN EXP IMMUNOL, V153, P86, DOI 10.1111/j.1365-2249.2008.03677.x; ATRI A, 1993, BIOPHYS J, V65, P1727, DOI 10.1016/S0006-3495(93)81191-3; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Bogeski I, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000672; BOOTMAN MD, 1992, J BIOL CHEM, V267, P25113; Cao JN, 2010, AGING CELL, V9, P19, DOI 10.1111/j.1474-9726.2009.00534.x; Chay TR, 1996, NEURAL COMPUT, V8, P951, DOI 10.1162/neco.1996.8.5.951; Chen JL, 2010, J IMMUNOL, V184, P1829, DOI 10.4049/jimmunol.0902103; Chen XF, 2008, BIOPHYS CHEM, V136, P87, DOI 10.1016/j.bpc.2008.04.010; Chung KH, 2011, ANAL CHEM, V83, P7044, DOI 10.1021/ac2011153; Csordas G, 2009, BBA-BIOENERGETICS, V1787, P1352, DOI 10.1016/j.bbabio.2009.06.004; Cui JJ, 2009, FEMS YEAST RES, V9, P1137, DOI 10.1111/j.1567-1364.2009.00552.x; Dadsetan S, 2008, J BIOL CHEM, V283, P12512, DOI 10.1074/jbc.M709330200; DEYOUNG GW, 1992, P NATL ACAD SCI USA, V89, P9895, DOI 10.1073/pnas.89.20.9895; Esser MT, 1998, J EXP MED, V187, P1057, DOI 10.1084/jem.187.7.1057; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Fulop T, 2003, ARTHRITIS RES THER, V5, P290, DOI 10.1186/ar1019; Galan C, 2010, MOLECULES, V15, P7167, DOI 10.3390/molecules15107167; Gautam N, 2010, OXID MED CELL LONGEV, V3, P275, DOI 10.4161/oxim.3.4.12860; Groenendaal W, 2008, IET SYST BIOL, V2, P411, DOI 10.1049/iet-syb:20070050; GROSSMANN A, 1991, CELL IMMUNOL, V135, P118, DOI 10.1016/0008-8749(91)90259-E; GROSSMANN A, 1989, EXP CELL RES, V180, P367, DOI 10.1016/0014-4827(89)90064-5; Grupe M, 2010, CELL CALCIUM, V48, P1, DOI 10.1016/j.ceca.2010.05.005; GUPTA S, 1989, ANN NY ACAD SCI, V568, P277; GUSE AH, 1993, BIOCHEM J, V291, P447, DOI 10.1042/bj2910447; Hake J, 2012, J PHYSL; Hawkins BJ, 2010, J CELL BIOL, V190, P391, DOI 10.1083/jcb.201004152; He L, 2013, AUTOMATED HIGH THROU; Holcman D, 2005, SIAM J APPL MATH, V65, P1006, DOI 10.1137/S003613990342894X; Hoth M, 1997, J CELL BIOL, V137, P633, DOI 10.1083/jcb.137.3.633; Jones DP, 2008, AM J PHYSIOL-CELL PH, V295, pC849, DOI 10.1152/ajpcell.00283.2008; Jones DP, 2002, METHOD ENZYMOL, V348, P93, DOI 10.1016/S0076-6879(02)48630-2; Kang S, 2008, J BIOL CHEM, V283, P25567, DOI 10.1074/jbc.M803321200; Kaplan P, 2007, MOL CELL BIOCHEM, V301, P219, DOI 10.1007/s11010-007-9414-9; KENNES B, 1981, IMMUNOL LETT, V2, P231, DOI 10.1016/0165-2478(81)90048-1; Kim S, 2001, ANN BIOMED ENG, V29, P373, DOI 10.1114/1.1366671; Kniss A, 2013, METHOD ENZYMOL, V526, P219, DOI 10.1016/B978-0-12-405883-5.00013-2; Kowalewski JM, 2006, MATH BIOSCI, V204, P232, DOI 10.1016/j.mbs.2006.03.001; Kwon YW, 2003, BIOL CHEM, V384, P991, DOI 10.1515/BC.2003.111; LEJEMTEL TH, 1993, CIRC RES, V72, P341, DOI 10.1161/01.RES.72.2.341; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; LI YX, 1994, J THEOR BIOL, V166, P461, DOI 10.1006/jtbi.1994.1041; Liu WJ, 2010, MATH BIOSCI, V228, P110, DOI 10.1016/j.mbs.2010.08.013; Lushington GH, 2005, J MOL GRAPH MODEL, V24, P175, DOI 10.1016/j.jmgm.2005.07.003; Marhl M, 2000, BIOSYSTEMS, V57, P75, DOI 10.1016/S0303-2647(00)00090-3; Maul-Pavicic A, 2011, P NATL ACAD SCI USA, V108, P3324, DOI 10.1073/pnas.1013285108; Maurya MR, 2007, BIOPHYS J, V93, P709, DOI 10.1529/biophysj.106.097469; Maurya MR, 2007, BIOPHYS J, V93, P729, DOI 10.1529/biophysj.106.097501; Miller RA, 1996, LIFE SCI, V59, P469, DOI 10.1016/0024-3205(96)00326-8; Mirza N, 2011, AGING CELL, V10, P853, DOI 10.1111/j.1474-9726.2011.00730.x; Newrzela S, 2008, T CELL CULTURE GAMMA, P71; Nunes P, 2014, ANTIOXID REDOX SIGN, V21, P915, DOI 10.1089/ars.2013.5615; Oh-Hora M, 2008, CURR OPIN IMMUNOL, V20, P250, DOI 10.1016/j.coi.2008.04.004; PETRZILKA GE, 1979, CELL TISSUE RES, V201, P101; PHILOSOPHE B, 1989, EUR J IMMUNOL, V19, P695, DOI 10.1002/eji.1830190419; Politi A, 2006, BIOPHYS J, V90, P3120, DOI 10.1529/biophysj.105.072249; Pottorf WJ, 2001, BRAIN RES, V914, P57, DOI 10.1016/S0006-8993(01)02773-1; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Quintana A, 2011, EMBO J, V30, P3895, DOI 10.1038/emboj.2011.289; Redondo PC, 2004, BIOCHEM PHARMACOL, V67, P491, DOI 10.1016/j.bcp.2003.09.031; Remondini D, 2010, MOL BIOSYST, V6, P1983, DOI 10.1039/c004635c; Rice JJ, 2001, PHILOS T R SOC A, V359, P1143, DOI 10.1098/rsta.2001.0822; Rink L, 1998, MECH AGEING DEV, V102, P199, DOI 10.1016/S0047-6374(97)00153-X; Ritchie MF, 2012, EMBO J, V31, P1123, DOI 10.1038/emboj.2011.495; Rivet CA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003921; Roussel C, 2006, CELL CALCIUM, V39, P455, DOI 10.1016/j.ceca.2006.01.004; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sneyd J, 2002, P NATL ACAD SCI USA, V99, P2398, DOI 10.1073/pnas.032281999; Sulger J, 1999, BIOL PSYCHIAT, V45, P737, DOI 10.1016/S0006-3223(98)00218-2; Swietach P, 2010, FRONT BIOSCI-LANDMRK, V15, P661, DOI 10.2741/3639; Thakur P, 2012, BIOPHYS J, V102, p315A, DOI 10.1016/j.bpj.2011.11.1735; Thompson JA, 2003, CLIN CANCER RES, V9, P3562; Utzny C, 2005, BIOPHYS J, V88, P1, DOI 10.1529/biophysj.103.038216; Watson WH, 2003, FEBS LETT, V543, P144, DOI 10.1016/S0014-5793(03)00430-7; WONG AYK, 1993, CELL CALCIUM, V14, P227, DOI 10.1016/0143-4160(93)90070-M; Zaidi A, 1998, NEUROBIOL AGING, V19, P487, DOI 10.1016/S0197-4580(98)00078-5; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhao XL, 2008, AGING CELL, V7, P561, DOI 10.1111/j.1474-9726.2008.00408.x; Zhong F, 2006, J CELL BIOL, V172, P127, DOI 10.1083/jcb.200506189	81	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0159248	10.1371/journal.pone.0159248	http://dx.doi.org/10.1371/journal.pone.0159248			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27526200	Green Published, Green Submitted, gold			2022-12-26	WOS:000381471100006
J	van der Linden, M; Falkenhorst, G; Perniciaro, S; Fitzner, C; Imohl, M				van der Linden, Mark; Falkenhorst, Gerhard; Perniciaro, Stephanie; Fitzner, Christina; Imoehl, Matthias			Effectiveness of Pneumococcal Conjugate Vaccines (PCV7 and PCV13) against Invasive Pneumococcal Disease among Children under Two Years of Age in Germany	PLOS ONE			English	Article							LOGISTIC-REGRESSION; VACCINATION; EVENTS; IMPACT	Background In this study we calculate the effectiveness of pneumococcal conjugate vaccines (PCV) against invasive pneumococcal disease (IPD) among children under the age of two years using the indirect cohort method. We also discuss the timeliness of vaccination and the residual cases of vaccine type IPD. Methods and Findings From July 2006 until June 2015, 921 IPD cases were reported and for 618 children (67.1%), the vaccination status at the time of infection could be accurately determined. Of these, 379 (61.3%) were vaccinated and 239 (38.7%) were not vaccinated. The adjusted vaccine effectiveness (VE) of PCV7 for all included serotypes + 6A was 80% (95% CI: 63-89) for at least one dose, 97% (89-100) after three primary doses (post primary) and 95% (57-100) post booster. The adjusted overall VE of PCV13 was 86% (74-93) for at least one dose, 85% (62-94) post primary and 91% (61-99) post booster. For the additional serotypes included in PCV13, the adjusted VE was 82% (66-91), 80% (46-93) and 90% (54-98) respectively. The serotype specific VE for at least one dose was high for serotypes 1 (83%; 15-97), 3 (74%; 2-93), 7F (84%; 18-98) and 19A (77%; 47-90). Only 39.5% of children with IPD obtained their first dose of PCV7 according to schedule (2nd dose: 32.9%, 3rd dose: 22.0%, booster dose: 63.6%). For children vaccinated with PCV13 values were slightly better: 43.8%, 33.5%, 26.3% and 74.3% respectively. Among 90 residual cases with PCV7 serotypes, 73 (81.1%) were in unvaccinated children, and 15 (16.7%) in children who had not obtained the number of doses recommended for their age, and only two (2.2%) in children vaccinated according to age. Of 82 cases with PCV13 serotypes occurring after the switch from PCV7 to PCV13, 56 (68.3%) were not vaccinated, 22 (26.8%) were incompletely vaccinated, and four (4.9%) were vaccinated according to age. Conclusions Our data show a high effectiveness of pneumococcal conjugate vaccination in Germany. However, the administration of vaccine doses among children with IPD is often delayed, resulting in many vaccine type cases in non- or incompletely-vaccinated children. Whether the recently-implemented change to a 2+1 schedule will improve the timeliness of vaccination should be subject to careful monitoring.	[van der Linden, Mark; Perniciaro, Stephanie; Imoehl, Matthias] Univ Hosp RWTH, Dept Med Microbiol, Natl Reference Ctr Streptococci, Aachen, Germany; [Falkenhorst, Gerhard] Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany; [Fitzner, Christina] Univ Hosp RWTH, Dept Med Stat, Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital; Robert Koch Institute; RWTH Aachen University; RWTH Aachen University Hospital	van der Linden, M (corresponding author), Univ Hosp RWTH, Dept Med Microbiol, Natl Reference Ctr Streptococci, Aachen, Germany.	mlinden@ukaachen.de	van der Linden, Mark/B-9305-2009; Imöhl, Matthias/P-5014-2014; Perniciaro, Stephanie R/J-3669-2017; Fitzner, Christina/H-6431-2013	van der Linden, Mark/0000-0002-6574-4313; Imöhl, Matthias/0000-0002-8372-0251; Perniciaro, Stephanie R/0000-0002-3146-2182; 	investigator initiated research grant from Pfizer Pharma GmbH [IRR WI 172072]; Robert Koch Institut, Berlin, Germany	investigator initiated research grant from Pfizer Pharma GmbH; Robert Koch Institut, Berlin, Germany	This study was in part funded by investigator initiated research grant IRR WI 172072 from Pfizer Pharma GmbH. PneumoWeb is maintained and supported by the Robert Koch Institut, Berlin, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028435; Andrews NJ, 2014, LANCET INFECT DIS, V14, P839, DOI 10.1016/S1473-3099(14)70822-9; [Anonymous], EPIDEMIOL B; BROOME CV, 1980, NEW ENGL J MED, V303, P549, DOI 10.1056/NEJM198009043031003; Camilli R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076309; [Centre HaSCI Screening and Immunisations team], 2014, NHS IMM STAT 2014; De Serres G, 2012, VACCINE, V30, P4067, DOI 10.1016/j.vaccine.2012.04.017; Deceuninck G, 2015, VACCINE, V33, P2684, DOI 10.1016/j.vaccine.2015.04.005; Harboe ZB, 2014, CLIN INFECT DIS, V59, P1066, DOI 10.1093/cid/ciu524; Heinze G, 2006, STAT MED, V25, P4216, DOI 10.1002/sim.2687; Hussain M, 2005, EPIDEMIOL INFECT, V133, P891, DOI 10.1017/S0950268805004012; Kunze W, 2010, PADIATR PRAX, V75, P249; Moore MR, 2015, LANCET INFECT DIS, V15, P301, DOI 10.1016/S1473-3099(14)71081-3; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Picon T, 2013, VACCINE, V31, pC109, DOI 10.1016/j.vaccine.2013.01.059; Ruckinger S, 2010, VACCINE, V28, P5012, DOI 10.1016/j.vaccine.2010.05.021; Ruckinger S, 2009, VACCINE, V27, P4136, DOI 10.1016/j.vaccine.2009.04.057; Schmitt HJ, 2003, LANCET INFECT DIS, V3, P103, DOI 10.1016/S1473-3099(03)00519-X; Standige Impfkommission (STIKO), 2006, EPIDEMIOL B, P255; Standige Impfkommission (STIKO), 2015, EPIDEMIOL B, P339; Steens A, 2013, VACCINE, V31, P6232, DOI 10.1016/j.vaccine.2013.10.032; Theidel U, 2013, GESUNDHEITSWESEN, V75, P309, DOI 10.1055/s-0032-1321747; van der Linden M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131494; van der Linden M, 2015, EUR J PEDIATR, V174, P355, DOI 10.1007/s00431-014-2409-0; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Weiss S, 2015, EUROSURVEILLANCE, V20, DOI 10.2807/1560-7917.ES2015.20.10.21057	26	55	60	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0161257	10.1371/journal.pone.0161257	http://dx.doi.org/10.1371/journal.pone.0161257			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27526117	Green Published, gold			2022-12-26	WOS:000381471100048
J	Walker, EC; Johnson, RW; Hu, YF; Brennan, HJ; Poulton, IJ; Zhang, JG; Jenkins, BJ; Smyth, GK; Nicola, NA; Sims, NA				Walker, Emma C.; Johnson, Rachelle W.; Hu, Yifang; Brennan, Holly J.; Poulton, Ingrid J.; Zhang, Jian-Guo; Jenkins, Brendan J.; Smyth, Gordon K.; Nicola, Nicos A.; Sims, Natalie A.			Murine Oncostatin M Acts via Leukemia Inhibitory Factor Receptor to Phosphorylate Signal Transducer and Activator of Transcription 3 (STAT3) but Not STAT1, an Effect That Protects Bone Mass	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytokine; osteoblast; osteocyte; signal transducers and activators of transcription 1 (STAT1); STAT3; glycoprotein 130; leukemia inhibitory factor; oncostatin M	NF-KAPPA-B; SOLUBLE INTERLEUKIN-6; M OSM; TARGETED DISRUPTION; NEGATIVE REGULATION; GENE-EXPRESSION; STEM-CELLS; CYTOKINE; INFLAMMATION; ROLES	Oncostatin M (OSM) and leukemia inhibitory factor (LIF) are IL-6 family members with a wide range of biological functions. Human OSM (hOSM) and murine LIF (mLIF) act in mouse cells via a LIF receptor (LIFR)-glycoprotein 130 (gp130) heterodimer. In contrast, murine OSM (mOSM) signals mainly via an OSM receptor (OSMR)-gp130 heterodimer and binds with only very low affinity to mLIFR. hOSM and mLIF stimulate bone remodeling by both reducing osteocytic sclerostin and up-regulating the pro-osteoclastic factor receptor activator of NF-B ligand (RANKL) in osteoblasts. In the absence of OSMR, mOSM still strongly suppressed sclerostin and stimulated bone formation but did not induce RANKL, suggesting that intracellular signaling activated by the low affinity interaction of mOSM with mLIFR is different from the downstream effects when mLIF or hOSM interacts with the same receptor. Both STAT1 and STAT3 were activated by mOSM in wild type cells or by mLIF/hOSM in wild type and Osmr(-/-) cells. In contrast, in Osmr(-/-) primary osteocyte-like cells stimulated with mOSM (therefore acting through mLIFR), microarray expression profiling and Western blotting analysis identified preferential phosphorylation of STAT3 and induction of its target genes but not of STAT1 and its target genes; this correlated with reduced phosphorylation of both gp130 and LIFR. In a mouse model of spontaneous osteopenia caused by hyperactivation of STAT1/3 signaling downstream of gp130 (gp130(Y757F/Y757F)), STAT1 deletion rescued the osteopenic phenotype, indicating a beneficial effect of promoting STAT3 signaling over STAT1 downstream of gp130 in this low bone mass condition, and this may have therapeutic value.	[Walker, Emma C.; Johnson, Rachelle W.; Brennan, Holly J.; Poulton, Ingrid J.; Sims, Natalie A.] St Vincents Inst Med Res, 9 Princes St, Fitzroy, Vic 3065, Australia; [Hu, Yifang; Zhang, Jian-Guo; Smyth, Gordon K.; Nicola, Nicos A.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Jenkins, Brendan J.] Hudson Inst Med Res, Clayton, Vic 3168, Australia; [Jenkins, Brendan J.] Monash Univ, Fac Med Nursing & Hlth Sci, Dept Mol Translat Sci, Clayton, Vic 3168, Australia; [Smyth, Gordon K.] Univ Melbourne, St Vincents Hosp, Dept Math & Stat, Melbourne, Vic 3010, Australia; [Zhang, Jian-Guo; Nicola, Nicos A.] Univ Melbourne, St Vincents Hosp, Dept Med Biol, Melbourne, Vic 3010, Australia; [Sims, Natalie A.] Univ Melbourne, St Vincents Hosp, Dept Med, Melbourne, Vic 3010, Australia	St. Vincent's Institute of Medical Research; Walter & Eliza Hall Institute; Hudson Institute of Medical Research; Monash University; St Vincent's Hospital Melbourne; University of Melbourne; St Vincent's Hospital Melbourne; University of Melbourne; St Vincent's Hospital Melbourne; University of Melbourne	Sims, NA (corresponding author), St Vincents Inst Med Res, 9 Princes St, Fitzroy, Vic 3065, Australia.	nsims@svi.edu.au	Sims, Natalie Ann/A-7192-2012	Sims, Natalie Ann/0000-0003-1421-8468; Jenkins, Brendan/0000-0002-7552-4656	National Health and Medical Research Council (NHMRC) (Australia) [1004945, 1058625, 1054618]; NHMRC	National Health and Medical Research Council (NHMRC) (Australia)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by National Health and Medical Research Council (NHMRC) (Australia) Project Grants 1004945 (to N. A. S. and J.-G. Z.) and 1058625 (to N. A. S.) and Program Grant 1054618 (to G. K. S.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by an NHMRC senior research fellowship.	Achtman AH, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003515; Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Bancerek J, 2013, IMMUNITY, V38, P250, DOI 10.1016/j.immuni.2012.10.017; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolin Celeste, 2012, Genes Cancer, V3, P117, DOI 10.1177/1947601912458284; Bourillot PY, 2009, STEM CELLS, V27, P1760, DOI 10.1002/stem.110; Buttmann M, 2007, J VASC RES, V44, P51, DOI 10.1159/000097977; Croker BA, 2008, SEMIN CELL DEV BIOL, V19, P414, DOI 10.1016/j.semcdb.2008.07.010; Devlin RD, 1996, J CLIN ENDOCR METAB, V81, P1893, DOI 10.1210/jc.81.5.1893; Dickensheets H, 2013, J LEUKOCYTE BIOL, V93, P377, DOI 10.1189/jlb.0812395; El Kasmi KC, 2007, J IMMUNOL, V179, P7215, DOI 10.4049/jimmunol.179.11.7215; Ernst M, 2008, J CLIN INVEST, V118, P1727, DOI 10.1172/JCI34944; Fairlie WD, 2004, J BIOL CHEM, V279, P2125, DOI 10.1074/jbc.M310103200; Fernandes TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073266; Fielding CA, 2008, J IMMUNOL, V181, P2189, DOI 10.4049/jimmunol.181.3.2189; Guihard P, 2012, STEM CELLS, V30, P762, DOI 10.1002/stem.1040; Haan S, 1999, J BIOL CHEM, V274, P1342, DOI 10.1074/jbc.274.3.1342; Hermanns HM, 2015, CYTOKINE GROWTH F R, V26, P545, DOI 10.1016/j.cytogfr.2015.07.006; Hiroi M, 2003, J BIOL CHEM, V278, P651, DOI 10.1074/jbc.M204544200; Ho HH, 2006, J BIOL CHEM, V281, P14111, DOI 10.1074/jbc.M511797200; Ichihara M, 1997, BLOOD, V90, P165; JILKA RL, 1992, SCIENCE, V257, P88, DOI 10.1126/science.1621100; Johnson RW, 2015, BONE, V81, P343, DOI 10.1016/j.bone.2015.08.005; Johnson RW, 2014, J BONE MINER RES, V29, P1492, DOI 10.1002/jbmr.2159; Kang S, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001433; Kartsogiannis V, 2008, J BIOL CHEM, V283, P30850, DOI 10.1074/jbc.M801761200; King KY, 2011, BLOOD, V118, P1525, DOI 10.1182/blood-2011-01-328682; Koolpe M, 2005, J BIOL CHEM, V280, P17301, DOI 10.1074/jbc.M500363200; Kotake S, 1996, J BONE MINER RES, V11, P88; Kuwata H, 2003, BLOOD, V102, P4123, DOI 10.1182/blood-2003-04-1228; Kyrtsonis MC, 1996, BRIT J HAEMATOL, V93, P398, DOI 10.1046/j.1365-2141.1996.4721018.x; Larsen JV, 2010, MOL CELL BIOL, V30, P4175, DOI 10.1128/MCB.00274-10; Li SL, 2000, J EXP MED, V191, P985, DOI 10.1084/jem.191.6.985; Lindberg RA, 1998, MOL CELL BIOL, V18, P3357, DOI 10.1128/MCB.18.6.3357; Louro R, 2004, BIOCHEM BIOPH RES CO, V316, P618, DOI 10.1016/j.bbrc.2004.02.091; Madoux F., 2010, PROBE REPORTS NIH MO; Malilas W, 2013, CANCER GENE THER, V20, P125, DOI 10.1038/cgt.2012.96; Marques L, 2004, J IMMUNOL, V173, P1103, DOI 10.4049/jimmunol.173.2.1103; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Mitchell TJ, 2003, CANCER RES, V63, P9048; MITSUYAMA K, 1995, GUT, V36, P45, DOI 10.1136/gut.36.1.45; Mosley B, 1996, J BIOL CHEM, V271, P32635, DOI 10.1074/jbc.271.51.32635; Mozaffarian A, 2008, J IMMUNOL, V181, P7243, DOI 10.4049/jimmunol.181.10.7243; NAIR BC, 1992, SCIENCE, V255, P1430, DOI 10.1126/science.1542792; Nguyen TT, 2002, J INTERF CYTOK RES, V22, P899, DOI 10.1089/107999002760274926; Nicola NA, 2015, CYTOKINE GROWTH F R, V26, P533, DOI 10.1016/j.cytogfr.2015.07.001; Nicolaidou V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039871; Obana M, 2012, AM J PHYSIOL-HEART C, V303, pH569, DOI 10.1152/ajpheart.00060.2012; Palmqvist P, 2002, J IMMUNOL, V169, P3353, DOI 10.4049/jimmunol.169.6.3353; Piehler J, 2012, IMMUNOL REV, V250, P317, DOI 10.1111/imr.12001; Poling J, 2012, CELL CYCLE, V11, P439, DOI 10.4161/cc.11.3.19024; Pradeep AR, 2010, BIOMARKERS, V15, P277, DOI 10.3109/13547500903573209; Qin HR, 2008, CANCER RES, V68, P7736, DOI 10.1158/0008-5472.CAN-08-1125; Quach JM, 2011, J BIOL CHEM, V286, P4186, DOI 10.1074/jbc.M110.178251; Ramana CV, 2002, TRENDS IMMUNOL, V23, P96, DOI 10.1016/S1471-4906(01)02118-4; Ramsauer K, 2007, P NATL ACAD SCI USA, V104, P2849, DOI 10.1073/pnas.0610944104; Retting KN, 2009, DEVELOPMENT, V136, P1093, DOI 10.1242/dev.029926; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rogerson FM, 2010, ARTHRITIS RHEUM-US, V62, P3365, DOI 10.1002/art.27661; ROODMAN GD, 1992, J CLIN INVEST, V89, P46, DOI 10.1172/JCI115584; Saleh H, 2011, ENDOCRINOLOGY, V152, P1911, DOI 10.1210/en.2010-1268; Schmitz J, 2000, J IMMUNOL, V164, P848, DOI 10.4049/jimmunol.164.2.848; Shi W, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq871; Simpson JL, 2009, EXP LUNG RES, V35, P781, DOI 10.3109/01902140902906412; Sims NA, 1996, CALCIFIED TISSUE INT, V59, P121, DOI 10.1007/s002239900098; Sims NA, 2004, J CLIN INVEST, V113, P379, DOI 10.1172/JCI200419872; Sims NA, 2000, J CLIN INVEST, V106, P1095, DOI 10.1172/JCI10753; Sims NA, 2015, CYTOKINE GROWTH F R, V26, P517, DOI 10.1016/j.cytogfr.2015.07.014; Sims Natalie A, 2014, Bonekey Rep, V3, P527, DOI 10.1038/bonekey.2014.22; Sims NA, 2010, BMB REP, V43, P513, DOI 10.5483/BMBRep.2010.43.8.513; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Song HY, 2007, J CELL BIOCHEM, V101, P1238, DOI 10.1002/jcb.21245; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tajima K, 2010, J ORTHOP RES, V28, P937, DOI 10.1002/jor.21086; Takyar FM, 2013, J BONE MINER RES, V28, P912, DOI 10.1002/jbmr.1820; TAMURA T, 1993, P NATL ACAD SCI USA, V90, P11924, DOI 10.1073/pnas.90.24.11924; Tanaka M, 2003, BLOOD, V102, P3154, DOI 10.1182/blood-2003-02-0367; Taniya T, 2012, GENOMICS, V99, P1, DOI 10.1016/j.ygeno.2011.10.002; Thomas RJ, 1999, ENDOCRINOLOGY, V140, P4451, DOI 10.1210/en.140.10.4451; Underhill-Day N, 2006, CANCER RES, V66, P10891, DOI 10.1158/0008-5472.CAN-06-1766; Walker EC, 2012, J BONE MINER RES, V27, P902, DOI 10.1002/jbmr.1506; Walker EC, 2010, J CLIN INVEST, V120, P582, DOI 10.1172/JCI40568; Winkler IG, 2005, J EXP MED, V201, P1077, DOI 10.1084/jem.20042299; Wong PKK, 2006, ARTHRITIS RHEUM-US, V54, P158, DOI 10.1002/art.21537; Wormald S, 2006, J BIOL CHEM, V281, P11135, DOI 10.1074/jbc.M509595200; Wu M, 2009, BONE, V44, P528, DOI 10.1016/j.bone.2008.11.011; Yang E, 2003, J BIOL CHEM, V278, P15794, DOI 10.1074/jbc.M213073200; ZARLING JM, 1986, P NATL ACAD SCI USA, V83, P9739, DOI 10.1073/pnas.83.24.9739	90	30	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21703	21716		10.1074/jbc.M116.748483	http://dx.doi.org/10.1074/jbc.M116.748483			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27539849	Green Published, hybrid			2022-12-26	WOS:000385999200035
J	Donk, R; Verbeek, A; Verhagen, W; Groenewoud, H; Hosman, A; Bartels, R				Donk, Roland; Verbeek, Andre; Verhagen, Wim; Groenewoud, Hans; Hosman, Allard; Bartels, Ronald			The Qualification of Outcome after Cervical Spine Surgery by Patients Compared to the Neck Disability Index	PLOS ONE			English	Article							EXPECTATIONS	Objective The Neck Disability Index (NDI) is a patient self-assessed outcome measurement tool to assess disability, and that is frequently used to evaluate the effects of the treatment of neck-related problems. In individualized medicine it is mandatory that patients can interpret data in order to choose a treatment. A change of NDI or an absolute NDI is generally meaningless to a patient. Therefore, a correlation between the qualification of the clinical situation rated by the patient and the NDI score was evaluated. Methods Patients who completed an NDI after anterior surgery because of symptomatic single level degenerative cervical disc disease were asked one month after completion of the NDI to qualify their clinical situation of a 5-item Likert scale varying from excellent to bad. Since a clear distinction between the categories was not possible based on the total NDI score, a ROC-curve was built, and the AUC computed in order to estimate best dichotomization in qualification of the clinical situation. The best corresponding cut-off point for the NDI total score was found by studying sensitivity and specificity for all possible cut-off points. Results 102 patients were included. The highest AUC was obtained by dichotomizing the qualification into a group with good outcome and less-good outcome. The highest sensitivity and specificity for the dichotomized qualification as good outcome corresponded to a NDI <= 7. Sensitivity was 81.08% and specificity was 78.57%. Conclusion This is the first study that correlated the qualification of the situation by the patients themselves and NDI. An NDI <= 7 corresponded to a good outcome according to the patients. This is valuable information to inform patients in their decision for any treatment.	[Donk, Roland] Dept Orthoped Surg, Via Sana Clin,Hoogveldseweg 1, NL-5451 AA Mill, Netherlands; [Verbeek, Andre; Groenewoud, Hans] Radboud Univ Nijmegen, Med Ctr, Dept Hlth Evidence, Geert Groote Pl Zuid 10, NL-6525 GA Nijmegen, Netherlands; [Verhagen, Wim] Canisius Wilhelmina Hosp, Dept Neurol, Weg Door Jonkerbos 100, NL-6532 SZ Nijmegen, Netherlands; [Hosman, Allard] Radboud Univ Nijmegen, Med Ctr, Dept Orthoped Surg, Geert Groote Pl Zuid 10, NL-6525 GA Nijmegen, Netherlands; [Bartels, Ronald] Radboud Univ Nijmegen, Med Ctr, Dept Neurosurg, Geert Groote Pl Zuid 10, NL-6525 GA Nijmegen, Netherlands; [Bartels, Ronald] Canisius Wilhelmina Hosp, Dept Neurosurg, Weg Door Jonkerbos 100, NL-6532 SZ Nijmegen, Netherlands	Radboud University Nijmegen; Canisius-Wilhelmina Hospital; Radboud University Nijmegen; Radboud University Nijmegen; Canisius-Wilhelmina Hospital	Bartels, R (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Neurosurg, Geert Groote Pl Zuid 10, NL-6525 GA Nijmegen, Netherlands.; Bartels, R (corresponding author), Canisius Wilhelmina Hosp, Dept Neurosurg, Weg Door Jonkerbos 100, NL-6532 SZ Nijmegen, Netherlands.	ronald.bartels@radboudumc.nl	Hosman, A.J.F./L-4393-2015; Bartels, Ronald HMA/L-4184-2015; Groenewoud, Hans JMM/R-3588-2017; Verbeek, A.L.M./H-8103-2014	Bartels, Ronald HMA/0000-0002-8638-4660; Groenewoud, Hans JMM/0000-0002-4974-150X; Verbeek, A.L.M./0000-0002-2319-5002				Bartels RHMA, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-85; El-Daly I, 2016, CLIN ORTHOP RELAT R, V474, P246, DOI 10.1007/s11999-015-4595-0; Fincham JE, 2008, AM J PHARM EDUC, V72, DOI 10.5688/aj720243; Fuson RL, 1997, J BONE JOINT SURG AM, V79A, P1089, DOI 10.2106/00004623-199707000-00019; Godil SS, 2015, SPINE J, V15, P1203, DOI 10.1016/j.spinee.2013.07.444; Howell Emily R, 2011, J Can Chiropr Assoc, V55, P211; Jorritsma W, 2012, EUR SPINE J, V21, P93, DOI 10.1007/s00586-011-1920-5; MacDermid JC, 2009, J ORTHOP SPORT PHYS, V39, P400, DOI 10.2519/jospt.2009.2930; Mannion AF, 2009, SPINE, V34, P1590, DOI 10.1097/BRS.0b013e31819fcd52; McGregor AH, 2002, SPINE, V27, P1471, DOI 10.1097/00007632-200207010-00019; Miettinen T, 2004, SPINE, V29, pE47, DOI 10.1097/01.BRS.0000106496.23202.60; Pellise F, 2009, EUR SPINE J, V18, pS395, DOI 10.1007/s00586-009-0973-1; Soroceanu A, 2012, SPINE, V37, pE103, DOI 10.1097/BRS.0b013e3182245c1f; Sterling M, 2004, SPINE, V29, P182, DOI 10.1097/01.BRS.0000105535.12598.AE; Tam CC, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-33; Vernon H, 2000, J MUSCULOSKELET PAIN, V8, P155, DOI 10.1300/J094v08n01_13; Vernon H, 2008, J MANIP PHYSIOL THER, V31, P491, DOI 10.1016/j.jmpt.2008.08.006; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wellburn S, 2013, SPINE, V38, P1590, DOI 10.1097/BRS.0b013e31829965bc	19	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0161593	10.1371/journal.pone.0161593	http://dx.doi.org/10.1371/journal.pone.0161593			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27551964	Green Published, gold, Green Submitted			2022-12-26	WOS:000381768800055
J	Salger, SA; Cassady, KR; Reading, BJ; Noga, EJ				Salger, Scott A.; Cassady, Katherine R.; Reading, Benjamin J.; Noga, Edward J.			A Diverse Family of Host-Defense Peptides (Piscidins) Exhibit Specialized Anti-Bacterial and Anti-Protozoal Activities in Fishes	PLOS ONE			English	Article							BASS MORONE-SAXATILIS; HYBRID STRIPED BASS; COD GADUS-MORHUA; ANTIMICROBIAL PEPTIDES; BACTERIAL DIVERSITY; MAST-CELLS; SEA-BASS; EXPRESSION; SEQUENCE; PROTEIN	Conventional antibiotics and other chemical-based drugs are currently one of the most common methods used to control disease-related mortality in animal agriculture. Use of the innate immune system to decrease disease related mortalities is a novel alternative to conventional drugs. One component of the innate immune system is the host-defense peptides, also known as antimicrobial peptides. Host-defense peptides are typically small, amphipathic, alpha-helical peptides with a broad-spectrum of action against viral, bacterial, fungal, and/ or protozoal pathogens. Piscidins are host-defense peptides first discovered in the hybrid striped bass (white bass, Morone chrysops, x striped bass, M. saxatilis). In this paper we identify four new piscidin isoforms in the hybrid striped bass and describe their tissue distributions. We also determine the progenitor species of origin of each piscidin (orthology) and propose a revised nomenclature for this newly described piscidin family based on a three class system. The Class I piscidins (22 amino acids in length; striped bass and white bass piscidin 1 and piscidin 3) show broad-spectrum activity against bacteria and ciliated protozoans, while the Class III piscidins (55 amino acids in length; striped bass and white bass piscidin 6 and striped bass piscidin 7) primarily show anti-protozoal activity. The Class II piscidins (44-46 amino acids in length; striped bass and white bass piscidin 4 and white bass piscidin 5) have a level of activity against bacteria and protozoans intermediate to Classes I and III. Knowledge of piscidin function and activity may help in the future development of disease-resistant lines of striped bass and white bass that could be used to produce superior hybrids for aquaculture.	[Salger, Scott A.; Cassady, Katherine R.; Reading, Benjamin J.] North Carolina State Univ, Dept Appl Ecol, Raleigh, NC 27695 USA; [Noga, Edward J.] North Carolina State Univ, Dept Clin Sci, Coll Vet Med, Raleigh, NC USA; [Noga, Edward J.] South Eastern Aquatechnol Inc, Boca Raton, FL USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Reading, BJ (corresponding author), North Carolina State Univ, Dept Appl Ecol, Raleigh, NC 27695 USA.	bjreadin@ncsu.edu		Reading, Benjamin/0000-0002-0778-4069	National Sea Grant College Program, National Oceanic and Atmospheric Administration [NA16-RG-2251, R/AF-43, R/AF-45, R/MG-0510]; United States Department of Agriculture, Agriculture and Food Research Initiative Grant [2009-03571]; United States Department of Agriculture, National Needs Graduate Fellowship [2007-38420-17763]	National Sea Grant College Program, National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); United States Department of Agriculture, Agriculture and Food Research Initiative Grant; United States Department of Agriculture, National Needs Graduate Fellowship	This work was supported by Grant NA16-RG-2251 (R/AF-43, R/AF-45 and R/MG-0510) from the National Sea Grant College Program, National Oceanic and Atmospheric Administration, to the North Carolina Sea Grant College Program (to E.J.N.), and the United States Department of Agriculture, Agriculture and Food Research Initiative Grant #2009-03571 (to E.J.N. and Jim D. Oliver). S.A. Salger is a recipient of a United States Department of Agriculture, National Needs Graduate Fellowship (Award # 2007-38420-17763 to Craig V. Sullivan, Russell J. Borski, and E.J.N.).	Acosta J, 2013, AQUACULTURE, V372, P9, DOI 10.1016/j.aquaculture.2012.07.032; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrews M, 2010, J FISH DIS, V33, P211, DOI 10.1111/j.1365-2761.2009.01107.x; Auguet JC, 2010, ISME J, V4, P182, DOI 10.1038/ismej.2009.109; Barberan A, 2010, AQUAT MICROB ECOL, V59, P1, DOI 10.3354/ame01389; BAUMANN M A, 1991, Glycobiology, V1, P537, DOI 10.1093/glycob/1.5.537; Brown MM, 2008, MAR ENVIRON RES, V66, P127, DOI 10.1016/j.marenvres.2008.02.043; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; CAHILL MM, 1990, MICROB ECOL, V19, P21, DOI 10.1007/BF02015051; Conlon JM, 2014, PEPTIDES, V57, P67, DOI 10.1016/j.peptides.2014.04.019; Corrales J, 2009, FISH SHELLFISH IMMUN, V27, P154, DOI 10.1016/j.fsi.2009.02.023; Corrales J, 2010, DEV COMP IMMUNOL, V34, P331, DOI 10.1016/j.dci.2009.11.004; Dezfuli BS, 2010, FISH SHELLFISH IMMUN, V28, P476, DOI 10.1016/j.fsi.2009.12.012; Diamond G, 2009, CURR PHARM DESIGN, V15, P2377, DOI 10.2174/138161209788682325; DRYL S, 1976, ACTA PROTOZOOL, V15, P501; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fernandes J.M.O., 2010, PLOS ONE, V5, P1; Garber AF, 2006, AQUAC RES, V37, P319, DOI 10.1111/j.1365-2109.2005.01439.x; Garnier J, 1996, METHOD ENZYMOL, V266, P540; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gertz EM, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-41; Giuliani A, 2008, CELL MOL LIFE SCI, V65, P2450, DOI 10.1007/s00018-008-8188-x; Harrell R.M., 1990, CULTURE PROPAGATION; Heras J, 2011, MAR GENOM, V4, P93, DOI 10.1016/j.margen.2011.02.001; Hodson R. G., 1993, Aquaculture and Fisheries Management, V24, P389, DOI 10.1111/j.1365-2109.1993.tb00562.x; HORSLEY RW, 1973, J APPL BACTERIOL, V36, P377, DOI 10.1111/j.1365-2672.1973.tb04119.x; Iijima N, 2003, EUR J BIOCHEM, V270, P675, DOI 10.1046/j.1432-1033.2003.03419.x; LARRICK JW, 1995, INFECT IMMUN, V63, P1291, DOI 10.1128/IAI.63.4.1291-1297.1995; Lauth X, 2002, J BIOL CHEM, V277, P5030, DOI 10.1074/jbc.M109173200; Li C, 2014, ANIM GENET, V45, P885, DOI 10.1111/age.12211; Ligeon C, 2000, AQUACULTURE MAGAZINE, V26, P39; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Noga EJ, 2011, COMP BIOCHEM PHYS D, V6, P44, DOI 10.1016/j.cbd.2010.06.001; Noga EJ, 2009, COMP BIOCHEM PHYS B, V152, P299, DOI 10.1016/j.cbpb.2008.12.018; Ohno S., 1970, EVOLUTION GENE DUPLI; Palffy R, 2009, MOL MED, V15, P51, DOI 10.2119/molmed.2008.00087; Pan CY, 2007, DNA CELL BIOL, V26, P403, DOI 10.1089/dna.2006.0564; Park NG, 2011, BIOCHEMISTRY-US, V50, P3288, DOI 10.1021/bi101395j; Parker HS., 2001, AGR RES, V49, P2; Peng KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050263; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; Ravi V, 2008, CURR OPIN GENET DEV, V18, P544, DOI 10.1016/j.gde.2008.11.001; Reading BJ, 2015, STRIPED BASS MORONE; Rondeau EB, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-452; Ruangsri J, 2012, FISH SHELLFISH IMMUN, V32, P396, DOI 10.1016/j.fsi.2011.11.022; Salerno G, 2007, COMP BIOCHEM PHYS B, V146, P521, DOI 10.1016/j.cbpb.2006.12.007; Salger SA, 2011, FISH SHELLFISH IMMUN, V30, P420, DOI 10.1016/j.fsi.2010.10.009; Samuelsen OB, 2006, DIS AQUAT ORGAN, V71, P239, DOI 10.3354/dao071239; Sato H, 2006, BBA-BIOMEMBRANES, V1758, P1245, DOI 10.1016/j.bbamem.2006.02.021; Sauvant MP, 1999, CHEMOSPHERE, V38, P1631; Schnick R. A., 1997, Bulletin of the European Association of Fish Pathologists, V17, P251; Silphaduang U, 2006, DIS AQUAT ORGAN, V72, P241, DOI 10.3354/dao072241; Silphaduang U, 2001, NATURE, V414, P268, DOI 10.1038/35104690; Sun BJ, 2007, J FISH DIS, V30, P335, DOI 10.1111/j.1365-2761.2007.00789.x; Sun DD, 2012, J ANTIBIOT, V65, P117, DOI 10.1038/ja.2011.120; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tipsmark CK, 2008, AM J PHYSIOL-REG I, V294, pR1004, DOI 10.1152/ajpregu.00112.2007; Toranzo AE, 2005, AQUACULTURE, V246, P37, DOI 10.1016/j.aquaculture.2005.01.002; Ullal AJ, 2008, DEV COMP IMMUNOL, V32, P1301, DOI 10.1016/j.dci.2008.04.005; Venkatesh B, 2003, CURR OPIN GENET DEV, V13, P588, DOI 10.1016/j.gde.2003.09.001; Wang Y, 2012, APPL ENVIRON MICROB, V78, P8264, DOI 10.1128/AEM.01821-12; Williams VN, 2014, J EXP ZOOL PART A, V321, P301, DOI 10.1002/jez.1859; Woo P.T.K., 2006, FISH DIS DISORDERS, V1; Zahran E, 2010, J FISH DIS, V33, P995, DOI 10.1111/j.1365-2761.2010.01205.x	65	36	39	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0159423	10.1371/journal.pone.0159423	http://dx.doi.org/10.1371/journal.pone.0159423			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27552222	Green Published, gold, Green Submitted			2022-12-26	WOS:000381768800005
J	Jaaks, P; D'Alessandro, V; Grob, N; Buel, S; Hajdin, K; Schafer, BW; Bernasconi, M				Jaaks, Patricia; D'Alessandro, Valentina; Grob, Nicole; Buel, Sina; Hajdin, Katarina; Schafer, Beat W.; Bernasconi, Michele			The Proprotein Convertase Furin Contributes to Rhabdomyosarcoma Malignancy by Promoting Vascularization, Migration and Invasion	PLOS ONE			English	Article							GENE-EXPRESSION; ALVEOLAR RHABDOMYOSARCOMA; GROWTH-FACTOR; CANCER-CELLS; EMBRYONAL RHABDOMYOSARCOMA; EXTRACELLULAR-MATRIX; TUMOR PROGRESSION; BREAST-CANCER; HUMAN HEAD; VEGF-C	The proprotein convertase (PC) furin cleaves precursor proteins, an important step in the activation of many cancer-associated proteins. Substrates of furin and furin-like PCs play a role in proliferation, metastasis and invasion. Some of them are involved in the progression of the pediatric soft tissue sarcoma rhabdomyosarcoma (RMS). In this study, we show that PCs, and in particular furin, are expressed in RMS cell lines. To investigate the functional role of furin, we generated RMS cell lines with modulated furin activity. Silencing or stable inhibition of furin delayed tumor growth in Rh30 and RD xenografts in vivo, and was correlated with lower microvessel density. Reduced furin activity also decreased migration and invasion abilities in vitro, and inhibition of furin in RMS cells diminished processing of IGF1R, VEGF-C, PDGF-B and MT1-MMP, leading to lower levels of mature proteins. Furthermore, we found that furin activity is required for proper IGF signaling in RMS cells, as furin silencing resulted in reduced phosphorylation of Akt upon IGF1 stimulation. Taken together, our results suggest that furin plays an important role in the malignant phenotype of RMS cells by activating proteins involved in tumor growth and vascularization, metastasis and invasion.	[Jaaks, Patricia; D'Alessandro, Valentina; Grob, Nicole; Buel, Sina; Hajdin, Katarina; Schafer, Beat W.; Bernasconi, Michele] Univ Childrens Hosp Zurich, Dept Oncol, Zurich, Switzerland; [Jaaks, Patricia; D'Alessandro, Valentina; Grob, Nicole; Buel, Sina; Hajdin, Katarina; Schafer, Beat W.; Bernasconi, Michele] Univ Childrens Hosp Zurich, Childrens Res Ctr, Zurich, Switzerland	University Children's Hospital Zurich; University Children's Hospital Zurich	Bernasconi, M (corresponding author), Univ Childrens Hosp Zurich, Dept Oncol, Zurich, Switzerland.; Bernasconi, M (corresponding author), Univ Childrens Hosp Zurich, Childrens Res Ctr, Zurich, Switzerland.	michele.bernasconi@kispi.uzh.ch	Bernasconi, Michele/C-6734-2008; Bernasconi, Michele/GOH-1815-2022; Bernasconi, Michele/CAG-2492-2022	Bernasconi, Michele/0000-0002-5746-8806; Bernasconi, Michele/0000-0002-5746-8806; Bernasconi, Michele/0000-0002-5746-8806; Schafer, Beat/0000-0001-5988-2915	Cancer League of the Canton Zurich; Stiftung Julius Muller zur Unterstutzung der Krebsforschung; Stiftung zur Krebsbekapfung [255]	Cancer League of the Canton Zurich; Stiftung Julius Muller zur Unterstutzung der Krebsforschung; Stiftung zur Krebsbekapfung	This work was supported by the Cancer League of the Canton Zurich (www.krebsligazuerich.ch); by the Stiftung Julius Muller zur Unterstutzung der Krebsforschung; and by the Stiftung zur Krebsbekapfung (Grant 255, www.krebsbekaempfung.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON ED, 1993, J BIOL CHEM, V268, P24887; Bassi DE, 2005, MOL CARCINOGEN, V44, P151, DOI 10.1002/mc.20134; Bassi DE, 2003, AM J PATHOL, V162, P439, DOI 10.1016/S0002-9440(10)63838-2; Bassi DE, 2001, P NATL ACAD SCI USA, V98, P10326, DOI 10.1073/pnas.191199198; Bassi DE, 2001, MOL CARCINOGEN, V31, P224, DOI 10.1002/mc.1057; Bennett BD, 2000, J BIOL CHEM, V275, P37712, DOI 10.1074/jbc.M005339200; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bourne GL, 2011, J IMMUNOL METHODS, V364, P101, DOI 10.1016/j.jim.2010.11.008; Cao LA, 2010, CANCER RES, V70, P6497, DOI 10.1158/0008-5472.CAN-10-0582; Chen X, 2013, CANCER CELL, V24, P710, DOI 10.1016/j.ccr.2013.11.002; Cheng M, 1997, INT J CANCER, V71, P966, DOI 10.1002/(SICI)1097-0215(19970611)71:6<966::AID-IJC10>3.3.CO;2-A; Coppola J, 2008, NEOPLASIA, V10, P363, DOI 10.1593/neo.08166; CREEMERS JWM, 1992, FEBS LETT, V300, P82, DOI 10.1016/0014-5793(92)80169-H; CROSE LE, 2011, SARCOMA, V2011, P56982, DOI DOI 10.1155/2011/75698221253475; D'Anjou F, 2011, TRANSL ONCOL, V4, P157, DOI 10.1593/tlo.10295; Davicioni E, 2006, CANCER RES, V66, P6936, DOI 10.1158/0008-5472.CAN-05-4578; de Cicco RL, 2004, CLIN CANCER RES, V10, P4480, DOI 10.1158/1078-0432.CCR-03-0670; Epstein JA, 1998, MOL CELL BIOL, V18, P4118, DOI 10.1128/MCB.18.7.4118; Geback T, 2009, BIOTECHNIQUES, V46, P265, DOI 10.2144/000113083; Hajdin K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010445; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; Jechlinger M, 2006, J CLIN INVEST, V116, P1561, DOI 10.1172/JCI24652; Joukov V, 1997, EMBO J, V16, P3898, DOI 10.1093/emboj/16.13.3898; Kaatsch P, 2010, CANCER TREAT REV, V36, P277, DOI 10.1016/j.ctrv.2010.02.003; Khatib AM, 2002, AM J PATHOL, V160, P1921, DOI 10.1016/S0002-9440(10)61140-6; Khatib AM, 2001, J BIOL CHEM, V276, P30686, DOI 10.1074/jbc.M101725200; Kuno K, 1999, J BIOL CHEM, V274, P18821, DOI 10.1074/jbc.274.26.18821; Lapierre M, 2007, CANCER RES, V67, P9030, DOI 10.1158/0008-5472.CAN-07-0807; Liu BS, 2014, ONCOL LETT, V7, P1033, DOI 10.3892/ol.2014.1839; Loechel F, 1998, J BIOL CHEM, V273, P16993, DOI 10.1074/jbc.273.27.16993; Ma YC, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-43; Martins Ana Sofia, 2011, Sarcoma, V2011, P209736, DOI 10.1155/2011/209736; McColl BK, 2007, FASEB J, V21, P1088, DOI 10.1096/fj.06-7060com; MOLLOY SS, 1994, EMBO J, V13, P18, DOI 10.1002/j.1460-2075.1994.tb06231.x; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; Ohuchi E, 1997, J BIOL CHEM, V272, P2446, DOI 10.1074/jbc.272.4.2446; Remacle AG, 2006, ONCOGENE, V25, P5648, DOI 10.1038/sj.onc.1209572; Scamuffa N, 2008, J CLIN INVEST, V118, P352, DOI 10.1172/JCI32040; Scamuffa N, 2014, CARCINOGENESIS, V35, P528, DOI 10.1093/carcin/bgt345; SCHALKEN JA, 1987, J CLIN INVEST, V80, P1545, DOI 10.1172/JCI113240; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Shern JF, 2014, CANCER DISCOV, V4, P216, DOI 10.1158/2159-8290.CD-13-0639; Siegfried G, 2005, ONCOGENE, V24, P6925, DOI 10.1038/sj.onc.1208838; Siegfried G, 2003, J CLIN INVEST, V111, P1723, DOI 10.1172/JCI200317220; Sorensen PHB, 2002, J CLIN ONCOL, V20, P2672, DOI 10.1200/JCO.2002.03.137; Van Gaal JC, 2012, ANTICANCER RES, V32, P4485; Wachtel M, 2004, CANCER RES, V64, P5539, DOI 10.1158/0008-5472.CAN-04-0844; Weissmueller S, 2014, CELL, V157, P382, DOI 10.1016/j.cell.2014.01.066; Williamson D, 2010, J CLIN ONCOL, V28, P2151, DOI 10.1200/JCO.2009.26.3814; Xue Y, 2012, NAT MED, V18, P100, DOI 10.1038/nm.2575; Yana I, 2000, MOL BIOL CELL, V11, P2387, DOI 10.1091/mbc.11.7.2387	52	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161396	10.1371/journal.pone.0161396	http://dx.doi.org/10.1371/journal.pone.0161396			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548722	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000381768400053
J	Perez, C; Perez-Zuniga, FJ; Garrido, F; Reytor, E; Portillo, F; Pajares, MA				Perez, Claudia; Perez-Zuniga, Francisco J.; Garrido, Francisco; Reytor, Edel; Portillo, Francisco; Pajares, Maria A.			The Oncogene PDRG1 Is an Interaction Target of Methionine Adenosyltransferases	PLOS ONE			English	Article							S-ADENOSYLMETHIONINE SYNTHETASE; IMPAIRED LIVER-REGENERATION; CRYSTAL-STRUCTURES; GENE-EXPRESSION; CANCER; GROWTH; MICE; METHYLATION; INJURY; METABOLISM	Methionine adenosyltransferases MAT I and MAT III (encoded by Mat1a) catalyze S-adenosylmethionine synthesis in normal liver. Major hepatic diseases concur with reduced levels of this essential methyl donor, which are primarily due to an expression switch from Mat1a towards Mat2a. Additional changes in the association state and even in subcellular localization of these isoenzymes are also detected. All these alterations result in a reduced content of the moderate (MAT I) and high V-max] (MAT III) isoenzymes, whereas the low Vmax (MAT II) isoenzyme increases and nuclear accumulation of MAT I is observed. These changes derive in a reduced availability of cytoplasmic S-adenosylmethionine, together with an effort to meet its needs in the nucleus of damaged cells, rendering enhanced levels of certain epigenetic modifications. In this context, the putative role of protein-protein interactions in the control of S-adenosylmethionine synthesis has been scarcely studied. Using yeast two hybrid and a rat liver library we identified PDRG1 as an interaction target for MAT alpha 1 (catalytic subunit of MAT I and MAT III), further confirmation being obtained by immunoprecipitation and pull-down assays. Nuclear MAT alpha interacts physically and functionally with the PDRG1 oncogene, resulting in reduced DNA methylation levels. Increased Pdrg1 expression is detected in acute liver injury and hepatoma cells, together with decreased Mat1a expression and nuclear accumulation of MATa1. Silencing of Pdrg1 expression in hepatoma cells alters their steady-state expression profile on microarrays, downregulating genes associated with tumor progression according to GO pathway analysis. Altogether, the results unveil the role of PDRG1 in the control of the nuclear methylation status through methionine adenosyltransferase binding and its putative collaboration in the progression of hepatic diseases.	[Perez, Claudia; Perez-Zuniga, Francisco J.; Garrido, Francisco; Reytor, Edel; Portillo, Francisco; Pajares, Maria A.] CSIC UAM, Inst Invest Biomed Alberto Sols, Arturo Duperier 4, Madrid 28029, Spain; [Portillo, Francisco; Pajares, Maria A.] Inst Invest Sanitaria La Paz IdiPAZ, Paseo Castellana 261, Madrid 28046, Spain; [Portillo, Francisco] Univ Autonoma Madrid, Fac Med, Dept Bioquim, Arzobispo Morcillo 4, E-28029 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid	Pajares, MA (corresponding author), CSIC UAM, Inst Invest Biomed Alberto Sols, Arturo Duperier 4, Madrid 28029, Spain.; Pajares, MA (corresponding author), Inst Invest Sanitaria La Paz IdiPAZ, Paseo Castellana 261, Madrid 28046, Spain.	mapajares@iib.uam.es	Pajares, Maria Angeles/I-5952-2012	Pajares, Maria Angeles/0000-0002-4714-9051; Portillo Perez, Francisco/0000-0003-4922-346X	RCMN [C03/08, PI05/056]; Ministerio de Economia y Competitividad [BFU2005-00050, BFU2008-00666, BFU2009-08977]; Institute de Salud Carlos III (RCMN) [C03/08, PI05/0563]	RCMN; Ministerio de Economia y Competitividad(Spanish Government); Institute de Salud Carlos III (RCMN)(Instituto de Salud Carlos III)	CP was a postdoctoral fellow of the UNAM-CSIC program and ER was supported by RCMN C03/08 and PI05/056. This work was supported by grants of the Ministerio de Economia y Competitividad (BFU2005-00050, BFU2008-00666, BFU2009-08977), and the Institute de Salud Carlos III (RCMN C03/08 and PI05/0563). The authors declare that there are no competing interests. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ALVAREZ L, 1994, BIOCHEM J, V301, P557, DOI 10.1042/bj3010557; Ansorena E, 2002, HEPATOLOGY, V35, P274, DOI 10.1053/jhep.2002.30419; Antonov AV, 2011, NUCLEIC ACIDS RES, V39, pW323, DOI 10.1093/nar/gkr372; Avila MA, 2000, J HEPATOL, V33, P907, DOI 10.1016/S0168-8278(00)80122-1; Avila MA, 1998, BIOFACTORS, V8, P27, DOI 10.1002/biof.5520080106; Avila MA, 1997, HEPATOLOGY, V25, P391; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boulon S, 2010, MOL CELL, V39, P912, DOI 10.1016/j.molcel.2010.08.023; CABRERO C, 1988, HEPATOLOGY, V8, P1530, DOI 10.1002/hep.1840080610; CANTONI GL, 1975, ANNU REV BIOCHEM, V44, P435, DOI 10.1146/annurev.bi.44.070175.002251; Chen LX, 2004, FASEB J, V18, P914, DOI 10.1096/fj.03-1204fje; Chen NC, 2010, FASEB J, V24, P2804, DOI 10.1096/fj.09-143651; CHRISTMAN JK, 1980, J CELL BIOL, V86, P366, DOI 10.1083/jcb.86.2.366; CORRALES F, 1991, HEPATOLOGY, V14, P528, DOI 10.1002/hep.1840140320; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Delgado M, 2008, CELL MOL LIFE SCI, V65, P2080, DOI 10.1007/s00018-008-8201-4; Delgado M, 2014, ANTIOXID REDOX SIGN, V20, P2541, DOI 10.1089/ars.2013.5342; Derfoul A, 2011, CARCINOGENESIS, V32, P1607, DOI 10.1093/carcin/bgr184; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; GILLIES RJ, 1986, ANAL BIOCHEM, V159, P109, DOI 10.1016/0003-2697(86)90314-3; Gonzalez B, 2000, J MOL BIOL, V300, P363, DOI 10.1006/jmbi.2000.3858; Gonzalez B, 2003, BIOCHEM J, V370, P945, DOI 10.1042/BJ20021510; Gonzalez B, 2003, J MOL BIOL, V331, P407, DOI 10.1016/s0022-2836(03)00728-9; Gonzalez B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050329; Halim AB, 1999, J BIOL CHEM, V274, P29720, DOI 10.1074/jbc.274.42.29720; Jeronimo C, 2007, MOL CELL, V27, P262, DOI 10.1016/j.molcel.2007.06.027; Jiang LY, 2011, CANCER BIOL THER, V11, P567, DOI 10.4161/cbt.11.6.14412; Katoh Y, 2011, MOL CELL, V41, P554, DOI 10.1016/j.molcel.2011.02.018; Kebebew E, 2004, J CLIN ENDOCR METAB, V89, P6105, DOI 10.1210/jc.2004-1234; LeGros HL, 2000, J BIOL CHEM, V275, P2359, DOI 10.1074/jbc.275.4.2359; LeGros L, 2001, J BIOL CHEM, V276, P24918, DOI 10.1074/jbc.M102816200; Liu SP, 2007, HEPATOLOGY, V46, P1413, DOI 10.1002/hep.21863; Lu SC, 2001, P NATL ACAD SCI USA, V98, P5560, DOI 10.1073/pnas.091016398; Lu SC, 2012, PHYSIOL REV, V92, P1515, DOI 10.1152/physrev.00047.2011; Luo XQ, 2003, ONCOGENE, V22, P7247, DOI 10.1038/sj.onc.1207010; Markham GD, 2009, CELL MOL LIFE SCI, V66, P636, DOI 10.1007/s00018-008-8516-1; Martin-Benito J, 2002, EMBO J, V21, P6377, DOI 10.1093/emboj/cdf640; Martinez-Chantar ML, 2008, HEPATOLOGY, V47, P1191, DOI 10.1002/hep.22159; Martinez-Chantar ML, 2002, FASEB J, V16, P1292, DOI 10.1096/fj.02-0078fje; Martinez-Chantar ML, 2000, EUR J BIOCHEM, V267, P132, DOI 10.1046/j.1432-1327.2000.00974.x; Martinez-Una M, 2015, J HEPATOL, V62, P673, DOI 10.1016/j.jhep.2014.10.019; Martinez-Una M, 2013, HEPATOLOGY, V58, P1296, DOI 10.1002/hep.26399; MartinezChantar ML, 1996, FEBS LETT, V397, P293, DOI 10.1016/S0014-5793(96)01201-X; Mato JM, 1997, PHARMACOL THERAPEUT, V73, P265, DOI 10.1016/S0163-7258(96)00197-0; Mingorance J, 1996, BIOCHEM J, V315, P761, DOI 10.1042/bj3150761; Mita P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063879; Miyato H, 2012, CANCER SCI, V103, P1961, DOI 10.1111/cas.12003; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; PAJARES MA, 1992, J BIOL CHEM, V267, P17598; Pajares MA, 2013, FEBS LETT, V587, P1711, DOI 10.1016/j.febslet.2013.04.034; Pajares Maria A, 2011, Adv Enzymol Relat Areas Mol Biol, V78, P449; Peng H, 2015, AM J PATHOL, V185, P1135, DOI 10.1016/j.ajpath.2014.12.016; Peng H, 2013, HEPATOLOGY, V57, P2299, DOI 10.1002/hep.26258; Petrossian TC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000976; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reytor E, 2009, FASEB J, V23, P3347, DOI 10.1096/fj.09-130187; Saigusa S, 2012, ONCOL REP, V28, P855, DOI 10.3892/or.2012.1863; Sanchez-Perez GF, 2004, J MOL BIOL, V335, P693, DOI 10.1016/j.jmb.2003.11.022; Sanchez-Perez GF, 2003, J BIOL CHEM, V278, P7285, DOI 10.1074/jbc.M210177200; SanchezGongora E, 1996, BIOCHEM J, V319, P767, DOI 10.1042/bj3190767; Sardiu ME, 2008, P NATL ACAD SCI USA, V105, P1454, DOI 10.1073/pnas.0706983105; Schroder PC, 2011, FUNCT INTEGR GENOMIC, V11, P419, DOI 10.1007/s10142-011-0230-7; Shafqat N, 2013, BIOCHEM J, V452, P27, DOI 10.1042/BJ20121580; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Tolwani RJ, 2005, PLOS GENET, V1, P205, DOI 10.1371/journal.pgen.0010023; Torres L, 2000, INT J BIOCHEM CELL B, V32, P397, DOI 10.1016/S1357-2725(99)00140-5; Vainberg IE, 1998, CELL, V93, P863, DOI 10.1016/S0092-8674(00)81446-4; Varela-Rey M, 2009, HEPATOLOGY, V50, P443, DOI 10.1002/hep.23033; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; [王俊岭 Wang Junling], 2015, [环境工程, Environment Engineering], V33, P1; Wei ZW, 2015, CANCER LETT, V359, P335, DOI 10.1016/j.canlet.2015.01.033; Welch MD, 2013, BRIT J HAEMATOL, V162, P537, DOI 10.1111/bjh.12417; Yang HP, 2008, GASTROENTEROLOGY, V134, P281, DOI 10.1053/j.gastro.2007.10.027; Yang HP, 2013, J BIOL CHEM, V288, P23161, DOI 10.1074/jbc.M113.487157; Yang HP, 2013, J CLIN INVEST, V123, P285, DOI 10.1172/JCI63861	77	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161672	10.1371/journal.pone.0161672	http://dx.doi.org/10.1371/journal.pone.0161672			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548429	Green Published, Green Submitted, gold			2022-12-26	WOS:000381768400076
J	Mannan, T; Ahmed, S; Akhtar, E; Roy, AK; Haq, MA; Roy, A; Kippler, M; Ekstrom, EC; Wagatsuma, Y; Raqib, R				Mannan, Tania; Ahmed, Sultan; Akhtar, Evana; Roy, Anjan Kumar; Haq, Md Ahsanul; Roy, Adity; Kippler, Maria; Ekstrom, Eva-Charlotte; Wagatsuma, Yukiko; Raqib, Rubhana			Maternal Micronutrient Supplementation and Long Term Health Impact in Children in Rural Bangladesh	PLOS ONE			English	Article							UTERO ARSENIC EXPOSURE; VITAMIN-A; PREGNANCY OUTCOMES; OXIDATIVE STRESS; AGED CHILDREN; ANEMIA; DETERMINANTS; ASSOCIATION; PREVALENCE; MORTALITY	Background Limited data is available on the role of prenatal nutritional status on the health of school-age children. We aimed to determine the impact of maternal micronutrient supplementation on the health status of Bangladeshi children. Methods Children (8.6-9.6 years; n = 540) were enrolled from a longitudinal mother-child cohort, where mothers were supplemented daily with either 30mg iron and 400 mu g folic acid (Fe30F), or 60mg iron and 400 mu g folic acid (Fe60F), or Fe30F including 15 micronutrients (MM), in rural Matlab. Blood was collected from children to determine the concentration of hemoglobin (Hb) and several micronutrients. Anthropometric and Hb data from these children were also available at 4.5 years of age and mothers at gestational week (GW) 14 and 30. Results MM supplementation significantly improved (p <= 0.05) body mass index-for-age z-score (BAZ), but not Hb levels, in 9 years old children compared to the Fe30F group. MM supplementation also reduced markers of inflammation (p <= 0.05). About 28%, 35% and 23% of the women were found to be anemic at GW14, GW30 and both time points, respectively. The prevalence of anemia was 5% and 15% in 4.5 and 9 years old children, respectively. The adjusted odds of having anemia in 9 year old children was 3-fold higher if their mothers were anemic at both GW14 and GW30 [ Odds Ratio (OR) = 3.05; 95% Confidence Interval (CI) 1.42, 6.14, P = 0.002] or even higher if they were also anemic at 4.5 years of age [OR = 5.92; 95% CI 2.64, 13.25; P<0.001]. Conclusion Maternal micronutrient supplementation imparted beneficial effects on child health. Anemia during pregnancy and early childhood are important risk factors for the occurrence of anemia in school-age children.	[Mannan, Tania; Ahmed, Sultan; Akhtar, Evana; Roy, Anjan Kumar; Haq, Md Ahsanul; Roy, Adity; Raqib, Rubhana] Icddr b, Div Infect Dis, Immunobiol Nutr & Toxicol Lab, Dhaka, Bangladesh; [Mannan, Tania] Bangladesh Univ Hlth Sci, Dept Immunol, Dhaka, Bangladesh; [Kippler, Maria] Karolinska Inst, Inst Environm Med, Stockholm, Sweden; [Ekstrom, Eva-Charlotte] Uppsala Univ, Dept Womens & Childrens Hlth, IMCH, Uppsala, Sweden; [Wagatsuma, Yukiko] Univ Tsukuba, Fac Med, Dept Clin Epidemiol, Tsukuba, Ibaraki, Japan	International Centre for Diarrhoeal Disease Research (ICDDR); Bangladesh University of Health Sciences (BUHS); Karolinska Institutet; Uppsala University; University of Tsukuba	Raqib, R (corresponding author), Icddr b, Div Infect Dis, Immunobiol Nutr & Toxicol Lab, Dhaka, Bangladesh.	rubhana@icddrb.org	Wagatsuma, Yukiko/AAE-5881-2020	Wagatsuma, Yukiko/0000-0002-8056-9998; Kippler, Maria/0000-0002-9010-9821; Haq, Ahsanul/0000-0002-4408-6104	Japan Society for the Promotion of Science (JSPS) [18256005]; Karolinska Institutet [00933]; icddrb [384, SWE-2008-065]; Government of the People's Republic of Bangladesh; Global Affairs Canada (GAC); Swedish International Development Cooperation Agency (Sida); Department for International Development, (UKAid)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Karolinska Institutet(Karolinska Institutet); icddrb; Government of the People's Republic of Bangladesh; Global Affairs Canada (GAC)(CGIAR); Swedish International Development Cooperation Agency (Sida); Department for International Development, (UKAid)(CGIAR)	This work was supported by the Japan Society for the Promotion of Science (JSPS; Grant No. 18256005), Karolinska Institutet (Grant No. 00933), and icddrb (Grant 384, SWE-2008-065). icddr, b also gratefully acknowledges the following donors who provide unrestricted support: Government of the People's Republic of Bangladesh; Global Affairs Canada (GAC); Swedish International Development Cooperation Agency (Sida) and the Department for International Development, (UKAid).	Abioye AI, 2016, J NUTR, V146, P1162, DOI 10.3945/jn.115.225482; Ahmed S, 2014, TOXICOL SCI, V141, P166, DOI 10.1093/toxsci/kfu113; Ahmed S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081530; Ahmed S, 2012, TOXICOL SCI, V129, P305, DOI 10.1093/toxsci/kfs202; Ahmed S, 2011, ENVIRON HEALTH PERSP, V119, P258, DOI 10.1289/ehp.1002086; Akcam M, 2007, DIGEST DIS SCI, V52, P405, DOI 10.1007/s10620-006-9422-8; [Anonymous], 2001, WHO TECHN REP SER; [Anonymous], 2008, WORLDW PREV AN 1993; Capra L, 2013, ITAL J PEDIATR, V39, DOI 10.1186/1824-7288-39-7; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Demirchyan A, 2016, PUBLIC HEALTH NUTR, V19, P1260, DOI 10.1017/S1368980015002451; Doi M, 2011, BRIT J NUTR, V106, P1398, DOI 10.1017/S0007114511001747; Faruque ASG, 2008, J HEALTH POPUL NUTR, V26, P325; GWATKIN DR, 2000, SOCIOECONOMIC DIFFER; Haider BA, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004905.pub4; Hawlader Mohammad D H, 2014, Trop Med Health, V42, P77, DOI 10.2149/tmh.2013-19; Hawlader MDH, 2014, PUBLIC HEALTH NUTR, V17, P1570, DOI 10.1017/S1368980013001262; Henriksson H, 2015, PREVALENCE ANEMIA IT; IZiNCG, 2007, ASS POP ZINC STAT SE; Janus J, 2010, AM FAM PHYSICIAN, V81, P1462; Khan AI, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-134; Khan JR, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-015-0536-z; Khavari N, 2014, INT HEALTH, V6, P298, DOI 10.1093/inthealth/ihu061; Kolbe-Busch S, 2002, CLIN CHEM LAB MED, V40, P529, DOI 10.1515/CCLM.2002.091; Lu WP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088496; Luo RF, 2011, J HEALTH POPUL NUTR, V29, P471; NCCLS, REF SEL PROC ER SED; NMS, 2013, NAT MICR STAT SURV 2; Ozaltin E, 2010, JAMA-J AM MED ASSOC, V303, P1507, DOI 10.1001/jama.2010.450; Palmer AC, 2015, NUTRITION, V31, P813, DOI 10.1016/j.nut.2014.11.016; Pasricha SR, 2010, PEDIATRICS, V126, pE140, DOI 10.1542/peds.2009-3108; Persson LA, 2012, JAMA-J AM MED ASSOC, V307, P2050, DOI 10.1001/jama.2012.4061; Raqib R, 2009, TOXICOL LETT, V185, P197, DOI 10.1016/j.toxlet.2009.01.001; Rosales FJ, 1999, J NUTR, V129, P1223, DOI 10.1093/jn/129.6.1223; Sanou D., 2012, RISK FACTORS ANEMIA; Sdogou T, 2015, J CLIN LAB ANAL, V29, P10, DOI 10.1002/jcla.21719; Semba RD, 2002, EUR J CLIN NUTR, V56, P271, DOI 10.1038/sj.ejcn.1601320; Shamim AA, 2013, PUBLIC HEALTH NUTR, V16, P1354, DOI 10.1017/S1368980013000475; Subramanian SV, 2009, JAMA-J AM MED ASSOC, V301, P1691, DOI 10.1001/jama.2009.548; WHO, 2011, WHO GLOBAL DATABASE; WHO, 2006, WHO CHILD GROWTH STA; World Health Organization, 2011, SER FERR CONC ASS IR; Zerfu TA, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-20; Zhao A, 2012, AM J TROP MED HYG, V87, P306, DOI 10.4269/ajtmh.2012.11-0660	44	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161294	10.1371/journal.pone.0161294	http://dx.doi.org/10.1371/journal.pone.0161294			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537051	gold, Green Published, Green Submitted			2022-12-26	WOS:000381577000083
J	Ingargiola, A; Lerner, E; Chung, S; Weiss, S; Michalet, X				Ingargiola, Antonino; Lerner, Eitan; Chung, SangYoon; Weiss, Shimon; Michalet, Xavier			FRETBursts: An Open Source Toolkit for Analysis of Freely-Diffusing Single-Molecule FRET	PLOS ONE			English	Article							ALTERNATING-LASER EXCITATION; RESONANCE ENERGY-TRANSFER; STRUCTURAL HETEROGENEITIES; CORRELATION SPECTROSCOPY; CONFORMATIONAL DYNAMICS; DISTRIBUTIONS; EFFICIENCY; IDENTIFICATION; PROTEIN	Single-molecule Forster Resonance Energy Transfer (smFRET) allows probing intermolecular interactions and conformational changes in biomacromolecules, and represents an invaluable tool for studying cellular processes at the molecular scale. smFRET experiments can detect the distance between two fluorescent labels (donor and acceptor) in the 3-10 nm range. In the commonly employed confocal geometry, molecules are free to diffuse in solution. When a molecule traverses the excitation volume, it emits a burst of photons, which can be detected by single-photon avalanche diode (SPAD) detectors. The intensities of donor and acceptor fluorescence can then be related to the distance between the two fluorophores. While recent years have seen a growing number of contributions proposing improvements or new techniques in smFRET data analysis, rarely have those publications been accompanied by software implementation. In particular, despite the widespread application of smFRET, no complete software package for smFRET burst analysis is freely available to date. In this paper, we introduce FRETBursts, an open source software for analysis of freely-diffusing smFRET data. FRETBursts allows executing all the fundamental steps of smFRET bursts analysis using state-of-the-art as well as novel techniques, while providing an open, robust and well-documented implementation. Therefore, FRETBursts represents an ideal platform for comparison and development of new methods in burst analysis. We employ modern software engineering principles in order to minimize bugs and facilitate long-term maintainability. Furthermore, we place a strong focus on reproducibility by relying on Jupyter notebooks for FRETBursts execution. Notebooks are executable documents capturing all the steps of the analysis (including data files, input parameters, and results) and can be easily shared to replicate complete smFRET analyzes. Notebooks allow beginners to execute complex workflows and advanced users to customize the analysis for their own needs. By bundling analysis description, code and results in a single document, FRETBursts allows to seamless share analysis workflows and results, encourages reproducibility and facilitates collaboration among researchers in the single-molecule community.	[Ingargiola, Antonino; Lerner, Eitan; Chung, SangYoon; Weiss, Shimon; Michalet, Xavier] Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles	Ingargiola, A (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA.	ingargiola.antonino@gmail.com	Michalet, Xavier/A-9704-2009; Lerner, Eitan/S-5576-2018; weiss, shimon/B-4164-2009	Michalet, Xavier/0000-0001-6602-7693; Lerner, Eitan/0000-0002-3791-5277; weiss, shimon/0000-0002-0720-5426; Ingargiola, Antonino/0000-0002-9348-1397; Chung, SangYoon/0000-0002-0592-4099	National Institutes of Health [R01-GM95904, R01-GM069709]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095904, R01GM069709] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health (http://www.nih.gov/) grant R01-GM95904 awarded to XM and SW and grant R01-GM069709 awarded to SW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Eyal Nir and Dr. Toma Tomov for support in the implementation of the 2CDE method and Dr. Achillefs Kapanidis and Dr. Nicole Robb for providing experimental data for testing the BVA implementation. This work was supported by National Institutes of Health (NIH) grant R01-GM95904 and R01-GM069709. Dr. Weiss discloses equity in Nesher Technologies and intellectual property used in the research reported here. The work at UCLA was conducted in Dr. Weiss's Laboratory.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Antonik M, 2006, J PHYS CHEM B, V110, P6970, DOI 10.1021/jp057257+; Blischak JD, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004668; Bronson JE, 2009, BIOPHYS J, V97, P3196, DOI 10.1016/j.bpj.2009.09.031; Buckheit JB., 1995, WAVELETS STAT, P55, DOI [DOI 10.1007/978-1-4612-2544-7_5, 10.1007/978-1-4612-2544-7_5]; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Camley BA, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3230974; Dahan M, 1999, CHEM PHYS, V247, P85, DOI 10.1016/S0301-0104(99)00132-9; Deniz AA, 1999, P NATL ACAD SCI USA, V96, P3670, DOI 10.1073/pnas.96.7.3670; DeVore MS, 2012, J PHYS CHEM B, V116, P4006, DOI 10.1021/jp209861u; Droettboom M, 2016, MATPLOTLIB MATPLOTLI; Edman L, 1996, P NATL ACAD SCI USA, V93, P6710, DOI 10.1073/pnas.93.13.6710; Eggeling C, 2001, J BIOTECHNOL, V86, P163, DOI 10.1016/S0168-1656(00)00412-0; Eggeling C, 1998, P NATL ACAD SCI USA, V95, P1556, DOI 10.1073/pnas.95.4.1556; Eglen S, 2016, BIORXIV; Fries JR, 1998, J PHYS CHEM A, V102, P6601, DOI 10.1021/jp980965t; Gopich I, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1812746; Gopich IV, 2008, J PHYS CHEM B, V112, P6214, DOI 10.1021/jp0764182; Gopich IV, 2007, J PHYS CHEM B, V111, P12925, DOI 10.1021/jp075255e; Gopich IV, 2012, ADV CHEM PHYS, V146, P245; Gopich IV, 2010, J PHYS CHEM B, V114, P15221, DOI 10.1021/jp105359z; Gopich IV, 2009, J PHYS CHEM B, V113, P10965, DOI 10.1021/jp903671p; Greenfeld M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030024; Haran G, 2012, CURR OPIN STRUC BIOL, V22, P14, DOI 10.1016/j.sbi.2011.10.005; Hoffmann A, 2011, PHYS CHEM CHEM PHYS, V13, P1857, DOI 10.1039/c0cp01911a; Hohlbein J, 2014, CHEM SOC REV, V43, P1156, DOI 10.1039/c3cs60233h; Ince DC, 2012, NATURE, V482, P485, DOI 10.1038/nature10836; Ingargiola A, 2016, PROC SPIE, V9714, DOI 10.1117/12.2212085; Ingargiola A, 2016, BIOPHYS J, V110, P26, DOI 10.1016/j.bpj.2015.11.013; Ingargiola A, 2013, PROC SPIE, V8590, DOI 10.1117/12.2003704; Kalinin S, 2007, J PHYS CHEM B, V111, P10253, DOI 10.1021/jp072293p; Kalinin S, 2010, J PHYS CHEM B, V114, P6197, DOI 10.1021/jp100025v; Kapanidis AN, 2004, P NATL ACAD SCI USA, V101, P8936, DOI 10.1073/pnas.0401690101; Kapanidis AN, 2005, ACCOUNTS CHEM RES, V38, P523, DOI 10.1021/ar0401348; Konig SLB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084157; Kou SC, 2005, J R STAT SOC C-APPL, V54, P469, DOI 10.1111/j.1467-9876.2005.00509.x; Laurence TA, 2005, P NATL ACAD SCI USA, V102, P17348, DOI 10.1073/pnas.0508584102; Laurence TA, 2007, BIOPHYS J, V92, P2184, DOI 10.1529/biophysj.106.093591; Lee NK, 2005, BIOPHYS J, V88, P2939, DOI 10.1529/biophysj.104.054114; Lerner E, 2014, BIOPHYS J, V106, P667, DOI 10.1016/j.bpj.2013.11.4500; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; Merali Z, 2010, NATURE, V467, P775, DOI 10.1038/467775a; Michalet X, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0035; Muller BK, 2005, BIOPHYS J, V89, P3508, DOI 10.1529/biophysj.105.064766; Murphy RR, 2014, ANAL CHEM, V86, P8603, DOI 10.1021/ac501188r; Murphy RR, 2014, PYFRET PYTHON LIB SI; Nettels D, 2008, J PHYS CHEM B, V112, P6137, DOI 10.1021/jp076971j; Newville M, 2016, IMFIT PY RELEASE 0 9; Nir E, 2006, J PHYS CHEM B, V110, P22103, DOI 10.1021/jp063483n; Prlic A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002802; Rahamim G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143732; Robb NC, 2013, J MOL BIOL, V425, P875, DOI 10.1016/j.jmb.2012.12.015; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Santoso Y, 2010, CHEMPHYSCHEM, V11, P2209, DOI 10.1002/cphc.201000129; Santoso Y, 2009, ANAL CHEM, V81, P9561, DOI 10.1021/ac901423e; Schuler B, 2008, CURR OPIN STRUC BIOL, V18, P16, DOI 10.1016/j.sbi.2007.12.003; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Selvin PR, 2000, NAT STRUCT BIOL, V7, P730, DOI 10.1038/78948; Shen H, 2014, NATURE, V515, P151, DOI 10.1038/515151a; Sisamakis E, 2010, METHOD ENZYMOL, V475, P455, DOI 10.1016/S0076-6879(10)75018-7; Soergel DAW, 2015, RAMPANT SOFTWARE ERR; Tomov TE, 2012, BIOPHYS J, V102, P1163, DOI 10.1016/j.bpj.2011.11.4025; Torella JP, 2011, BIOPHYS J, V100, P1568, DOI 10.1016/j.bpj.2011.01.066; Torres T, 2007, J PHYS CHEM B, V111, P7392, DOI 10.1021/jp070659s; Tsukanov R, 2013, J PHYS CHEM B, V117, P11932, DOI 10.1021/jp4059214; van de Meent JW, 2014, BIOPHYS J, V106, P1327, DOI 10.1016/j.bpj.2013.12.055; Vihinen M, 2015, NATURE, V521, P261, DOI 10.1038/521261a; Weiss S, 1999, SCIENCE, V283, P1676, DOI 10.1126/science.283.5408.1676; Wilson G, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001745; Zhang K, 2005, J PHYS CHEM B, V109, P21930, DOI 10.1021/jp0546047	70	36	36	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160716	10.1371/journal.pone.0160716	http://dx.doi.org/10.1371/journal.pone.0160716			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532626	Green Published, Green Submitted, gold			2022-12-26	WOS:000381487600040
J	Montes-Torres, J; Subirats, JL; Ribelles, N; Urda, D; Franco, L; Alba, E; Jerez, JM				Montes-Torres, Julio; Luis Subirats, Jose; Ribelles, Nuria; Urda, Daniel; Franco, Leonardo; Alba, Emilio; Manuel Jerez, Jose			Advanced Online Survival Analysis Tool for Predictive Modelling in Clinical Data Science	PLOS ONE			English	Article							DISTRIBUTIONS; CANCER; TESTS	One of the prevailing applications of machine learning is the use of predictive modelling in clinical survival analysis. In this work, we present our view of the current situation of computer tools for survival analysis, stressing the need of transferring the latest results in the field of machine learning to biomedical researchers. We propose a web based software for survival analysis called OSA (Online Survival Analysis), which has been developed as an open access and user friendly option to obtain discrete time, predictive survival models at individual level using machine learning techniques, and to perform standard survival analysis. OSA employs an Artificial Neural Network (ANN) based method to produce the predictive survival models. Additionally, the software can easily generate survival and hazard curves with multiple options to personalise the plots, obtain contingency tables from the uploaded data to perform different tests, and fit a Cox regression model from a number of predictor variables. In the Materials and Methods section, we depict the general architecture of the application and introduce the mathematical background of each of the implemented methods. The study concludes with examples of use showing the results obtained with public datasets.	[Montes-Torres, Julio; Luis Subirats, Jose; Urda, Daniel; Franco, Leonardo; Manuel Jerez, Jose] Univ Malaga, Dept Comp Sci, Malaga, Spain; [Luis Subirats, Jose] Yachay Tech Univ, Urcuqui, Imbabura, Ecuador; [Ribelles, Nuria; Alba, Emilio] Virgen de la Victoria Univ Hosp, Malaga, Spain; [Montes-Torres, Julio; Luis Subirats, Jose; Ribelles, Nuria; Urda, Daniel; Franco, Leonardo; Alba, Emilio; Manuel Jerez, Jose] Malaga Biomed Res Inst IBIMA, Malaga, Spain	Universidad de Malaga; Hospital Virgen de la Victoria	Montes-Torres, J (corresponding author), Univ Malaga, Dept Comp Sci, Malaga, Spain.; Montes-Torres, J (corresponding author), Malaga Biomed Res Inst IBIMA, Malaga, Spain.	julmontor@uma.es	Franco, Leonardo/AAD-9050-2020; Jerez, José/GYV-4500-2022; Muñoz, Daniel Urda/B-2040-2017; Ribelles, Nuria/ABH-2617-2020; Alba, Emilio/S-1435-2019; Franco, Leonardo/C-3929-2008; Jerez Aragones, Jose Manuel/L-1801-2014	Franco, Leonardo/0000-0003-0012-5914; Muñoz, Daniel Urda/0000-0003-2662-798X; Ribelles, Nuria/0000-0003-3194-7398; Alba, Emilio/0000-0002-3364-2603; Franco, Leonardo/0000-0003-0012-5914; Jerez Aragones, Jose Manuel/0000-0002-7858-2966; Montes Torres, Julio/0000-0001-8708-7847	MICINN-SPAIN (Spanish Government) [TIN2010-16556]; Andalusia Regional Government, Spain [P08-TIC-4026]; MICINN-SPAIN [TIN2010-16556, TIN2014-58516-c2-1-R]; Junta de Andalucia [P08-TIC-4026]; FEDER funds (European Union); FEDER funds	MICINN-SPAIN (Spanish Government); Andalusia Regional Government, Spain; MICINN-SPAIN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia(Junta de Andalucia); FEDER funds (European Union)(European Commission); FEDER funds(European Commission)	This work was supported by grants TIN2010-16556 from MICINN-SPAIN (Spanish Government) and P08-TIC-4026 (Andalusia Regional Government, Spain). All of them include FEDER funds (European Union). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge support through grants TIN2014-58516-c2-1-R and TIN2010-16556 from MICINN-SPAIN, and P08-TIC-4026 (Junta de Andalucia), all of which include FEDER funds.	AALEN O, 1978, ANN STAT, V6, P701, DOI 10.1214/aos/1176344247; [Anonymous], 2012, CANS VERS 1 1 STAT M; Ansari D, 2013, AM J SURG, V205, P1, DOI 10.1016/j.amjsurg.2012.05.032; Arsene CTC, 2011, LECT NOTES COMPUT SC, V6692, P210, DOI 10.1007/978-3-642-21498-1_27; BRESLOW N, 1974, BIOMETRICS, V30, P89, DOI 10.2307/2529620; COX DR, 1972, J R STAT SOC B, V34, P187; Crowther MJ, 2013, J STAT SOFTW, V53, P1; EFRON B, 1977, J AM STAT ASSOC, V72, P557, DOI 10.2307/2286217; Goswami Chirayu Pankaj, 2013, J Clin Bioinforma, V3, P22, DOI 10.1186/2043-9113-3-22; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hertzberg AM, 1985, COLLECTION PROBLEMS; Hess KR, 1999, STAT MED, V18, P3075, DOI 10.1002/(SICI)1097-0258(19991130)18:22<3075::AID-SIM244>3.3.CO;2-Y; Jozwiak K, 2013, COMPUT METH PROG BIO, V111, P115, DOI 10.1016/j.cmpb.2013.02.005; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; LOPRINZI CL, 1994, J CLIN ONCOL, V12, P601, DOI 10.1200/JCO.1994.12.3.601; Mani DR, 1999, P 5 ACM SIGKDD INT C, P94; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; McNemar Q, 1947, PSYCHOMETRIKA, V12, P153, DOI 10.1007/BF02295996; MULLER HG, 1994, BIOMETRICS, V50, P61, DOI 10.2307/2533197; Muller HG, 1979, LECT NOTES MATH, V757; NELSON W, 1972, TECHNOMETRICS, V14, P945, DOI 10.2307/1267144; PETO R, 1972, J R STAT SOC SER A-G, V135, P185, DOI 10.2307/2344317; TARONE RE, 1977, BIOMETRIKA, V64, P156, DOI 10.1093/biomet/64.1.156; Venables WN., 2002, MODERN APPL STAT S 4; WEI LJ, 1989, J AM STAT ASSOC, V84, P1065, DOI 10.2307/2290084; Yang JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023525; Zhang X, 2012, COMPUT METH PROG BIO, V108, P310, DOI 10.1016/j.cmpb.2012.01.003	28	2	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161135	10.1371/journal.pone.0161135	http://dx.doi.org/10.1371/journal.pone.0161135			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532883	Green Submitted, gold, Green Published			2022-12-26	WOS:000381487600062
J	Scheepbouwer, C; Meyer, S; Burggraaf, MJ; Jose, J; Molthoff, CFM				Scheepbouwer, Chantal; Meyer, Sandra; Burggraaf, Maroeska J.; Jose, Jithin; Molthoff, Carla F. M.			A Multimodal Imaging Approach for Longitudinal Evaluation of Bladder Tumor Development in an Orthotopic Murine Model	PLOS ONE			English	Article							OVARIAN-CANCER DETECTION; IN-VIVO; MICRO-ULTRASOUND; GENE-EXPRESSION; NUDE-MICE; CARCINOMA; BCG; COMBINATION; METASTASIS; LUCIFERASE	Bladder cancer is the fourth most common malignancy amongst men in Western industrialized countries with an initial response rate of 70% for the non-muscle invasive type, and improving therapy efficacy is highly needed. For this, an appropriate, reliable animal model is essential to gain insight into mechanisms of tumor growth for use in response monitoring of (new) agents. Several animal models have been described in previous studies, but so far success has been hampered due to the absence of imaging methods to follow tumor growth non-invasively over time. Recent developments of multimodal imaging methods for use in animal research have substantially strengthened these options of in vivo visualization of tumor growth. In the present study, a multimodal imaging approach was addressed to investigate bladder tumor proliferation longitudinally. The complementary abilities of Bioluminescence, High Resolution Ultrasound and Photo-acoustic Imaging permit a better understanding of bladder tumor development. Hybrid imaging modalities allow the integration of individual strengths to enable sensitive and improved quantification and understanding of tumor biology, and ultimately, can aid in the discovery and development of new therapeutics.	[Scheepbouwer, Chantal; Burggraaf, Maroeska J.; Molthoff, Carla F. M.] Vrije Univ Amsterdam, Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands; [Meyer, Sandra; Jose, Jithin] FUJIFILM VisualSon Inc, Amsterdam, Netherlands; [Burggraaf, Maroeska J.] Dept Med Microbiol & Infect Control, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Fujifilm Corporation	Molthoff, CFM (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands.	cfm.molthoff@vumc.nl		Scheepbouwer, Chantal/0000-0003-4243-0095; Meyer, Sandra/0000-0002-1778-8768	FUJIFILM VisualSonics Inc.	FUJIFILM VisualSonics Inc.	Fujifilm VisualSonics Inc. did not play a role in the study design, decision to publish, or preparation of the manuscript. FujiFilm VisualSonics Inc. did not provide any salary to the authors CS, MJB and CFMM. FUJIFILM VisualSonics Inc. only provided access and use of their equipment and both co-author's (SM, JJ) helped with operating the system, explaining the system, how to collect the data without further interest related to the outcome of the data. The funder provided support in the form of salaries for authors SM and JJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre A, 2011, TRANSL ONCOL, V4, P29, DOI 10.1593/tlo.10187; Anastasiadis A, 2012, THER ADV UROL, V4, P13, DOI 10.1177/1756287211431976; Arnold J, 2004, J IMMUNOTHER, V27, P116, DOI 10.1097/00002371-200403000-00005; Babjuk M, 2008, EUR UROL, V54, P303, DOI 10.1016/j.eururo.2008.04.051; Benedict WF, 2004, MOL THER, V10, P525, DOI 10.1016/j.ymthe.2004.05.027; Bhaumik S, 2002, P NATL ACAD SCI USA, V99, P377, DOI 10.1073/pnas.012611099; Botteman MF, 2003, PHARMACOECONOMICS, V21, P1315, DOI 10.1007/BF03262330; Chan E, 2009, BJU INT, V104, P1286, DOI 10.1111/j.1464-410X.2009.08577.x; Chan ESY, 2009, J UROLOGY, V182, P2926, DOI 10.1016/j.juro.2009.08.020; Chen FH, 2009, J UROLOGY, V182, P2932, DOI 10.1016/j.juro.2009.08.018; Contag CH, 1997, PHOTOCHEM PHOTOBIOL, V66, P523, DOI 10.1111/j.1751-1097.1997.tb03184.x; Foster FS, 2011, INTERFACE FOCUS, V1, P576, DOI 10.1098/rsfs.2011.0037; FU XY, 1992, INT J CANCER, V51, P989; FU XY, 1991, INT J CANCER, V49, P938, DOI 10.1002/ijc.2910490623; Gerling M, 2014, THERANOSTICS, V4, P604, DOI 10.7150/thno.7996; Gunther JH, 1999, CANCER RES, V59, P2834; Hadaschik BA, 2007, BJU INT, V100, P1377, DOI 10.1111/j.1464-410X.2007.07165.x; Hoffman RM, 2005, NAT REV CANCER, V5, P796, DOI 10.1038/nrc1717; Inoue Y, 2009, EUR J NUCL MED MOL I, V36, P771, DOI 10.1007/s00259-008-1022-8; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jokerst JV, 2012, ACS NANO, V6, P10366, DOI 10.1021/nn304347g; Jose J, 2012, MED PHYS, V39, P7262, DOI 10.1118/1.4764911; Jurczok A, 2008, BJU INT, V101, P120, DOI 10.1111/j.1464-410X.2007.07193.x; Kamaya A, 2013, J ULTRAS MED, V32, P1245, DOI 10.7863/ultra.32.7.1245; Keyaerts M, 2012, TRENDS MOL MED, V18, P164, DOI 10.1016/j.molmed.2012.01.005; Kirkali Z, 2005, UROLOGY, V66, P4, DOI 10.1016/j.urology.2005.07.062; Kolkman RGM, 2008, J BIOMED OPT, V13, DOI 10.1117/1.3005421; Lerner SP, 2015, CANCER-AM CANCER SOC, V121, P169, DOI 10.1002/cncr.28905; Liu JJ, 2012, J UROLOGY, V188, P361, DOI 10.1016/j.juro.2012.03.127; Luke GP, 2012, ANN BIOMED ENG, V40, P422, DOI 10.1007/s10439-011-0449-4; Needles A, 2015, NAT METHODS, V12; Needles A, 2013, IEEE T ULTRASON FERR, V60, P888, DOI 10.1109/TUFFC.2013.2646; Newton MR, 2014, CLIN EXP IMMUNOL, V177, P261, DOI 10.1111/cei.12315; Scanga CA, 2014, PATHOG DIS, V71, P205, DOI 10.1111/2049-632X.12186; van Rijn S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01046; Wirtzfeld LA, 2005, CANCER RES, V65, P6337, DOI 10.1158/0008-5472.CAN-05-0414; Witjes JA, 2006, EUR UROL, V49, P790, DOI 10.1016/j.eururo.2006.01.017; Wurdinger T, 2008, NAT METHODS, V5, P171, DOI 10.1038/NMETH.1177; Xiao ZW, 2011, CLIN MED INSIGHTS-ON, V5, P315, DOI 10.4137/CMO.S7658; Xie ZX, 2011, OPT LETT, V36, P4815, DOI 10.1364/OL.36.004815; Yang Xi-hua, 2012, Cancer Biology Medicine, V9, P261, DOI 10.7497/j.issn.2095-3941.2012.04.007; Zhou JH, 2002, CANCER GENE THER, V9, P681, DOI 10.1038/sj.cgt.7700489	42	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161284	10.1371/journal.pone.0161284	http://dx.doi.org/10.1371/journal.pone.0161284			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27533303	Green Submitted, gold, Green Published			2022-12-26	WOS:000381487600082
J	Kim, SM; Shu, AD; Long, J; Montez-Rath, ME; Leonard, MB; Norton, JA; Chertow, GM				Kim, Sun Moon; Shu, Aimee D.; Long, Jin; Montez-Rath, Maria E.; Leonard, Mary B.; Norton, Jeffrey A.; Chertow, Glenn M.			Declining Rates of Inpatient Parathyroidectomy for Primary Hyperparathyroidism in the US	PLOS ONE			English	Article							ASYMPTOMATIC PRIMARY HYPERPARATHYROIDISM; 3RD INTERNATIONAL WORKSHOP; CLINICAL-TRIAL; POSTMENOPAUSAL WOMEN; SERUM-CALCIUM; SURGERY; MANAGEMENT; MILD; GUIDELINES; STATEMENT	Parathyroidectomy is the only curative therapy for patients with primary hyperparathyroidism. However, the incidence, correlates and consequences of parathyroidectomy for primary hyperparathyroidism across the entire US population are unknown. We evaluated temporal trends in rates of inpatient parathyroidectomy for primary hyperparathyroidism, and associated in-hospital mortality, length of stay, and costs. We used the Healthcare Cost and Utilization Project Nationwide Inpatient Sample (NIS) from 2002-2011. Parathyroidectomies for primary hyperparathyroidism were identified using International Classification of Diseases, Ninth Revision codes. Unadjusted and age-and sex-adjusted rates of inpatient parathyroidectomy for primary hyperparathyroidism were derived from the NIS and the annual US Census. We estimated 109,583 parathyroidectomies for primary hyperparathyroidism between 2002 and 2011. More than half (55.4%) of patients were younger than age 65, and more than three-quarters (76.8%) were female. The overall rate of inpatient parathyroidectomy was 32.3 cases per million person-years. The adjusted rate decreased from 2004 (48.3 cases/million person-years) to 2007 (31.7 cases/million person-years) and was sustained thereafter. Although inpatient parathyroidectomy rates declined over time across all geographic regions, a steeper decline was observed in the South compared to other regions. Overall in-hospital mortality rates were 0.08%: 0.02% in patients younger than 65 years and 0.14% in patients 65 years and older. Inpatient parathyroidectomy rates for primary hyperparathyroidism have declined in recent years.	[Kim, Sun Moon; Long, Jin; Montez-Rath, Maria E.; Leonard, Mary B.; Chertow, Glenn M.] Stanford Univ, Dept Med, Sch Med, Div Nephrol, Stanford, CA 94305 USA; [Shu, Aimee D.] Stanford Univ, Sch Med, Div Endocrinol Gerontol & Metab, Stanford, CA 94305 USA; [Leonard, Mary B.] Stanford Univ, Dept Pediat, Sch Med, Div Pediat Nephrol, Stanford, CA 94305 USA; [Norton, Jeffrey A.] Stanford Univ, Dept Surg, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Chertow, GM (corresponding author), Stanford Univ, Dept Med, Sch Med, Div Nephrol, Stanford, CA 94305 USA.	gchertow@stanford.edu		Chertow, Glenn/0000-0002-7599-0534	Amgen	Amgen(Amgen)	JL and GC have received research support from Amgen, the manufacturer of cinacalcet, an oral calcimimetic approved for the treatment of primary hyperparathyroidism. The authors did not receive any support from Amgen for this project. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrogini E, 2007, J CLIN ENDOCR METAB, V92, P3114, DOI 10.1210/jc.2007-0219; Anderson R. C., 2000, Navigation. Journal of the Institute of Navigation, V47, P1; [Anonymous], 1991, J BONE MINER RES SUP, V6, pS1; Bilezikian JP, 2014, J CLIN ENDOCR METAB, V99, P3561, DOI 10.1210/jc.2014-1413; Bilezikian JP, 2009, J CLIN ENDOCR METAB, V94, P335, DOI 10.1210/jc.2008-1763; Bilezikian JP, 2002, J CLIN ENDOCR METAB, V87, P5353, DOI 10.1210/jc.2002-021370; Bilezikian JP, 2004, NEW ENGL J MED, V350, P1746, DOI 10.1056/NEJMcp032200; Flynn MB, 2015, AM SURGEON, V81, P472; Griebeler ML, 2015, BONE, V73, P1, DOI 10.1016/j.bone.2014.12.003; Haas JS, 2004, ANN INTERN MED, V140, P184, DOI 10.7326/0003-4819-140-3-200402030-00009; HEATH H, 1980, NEW ENGL J MED, V302, P189, DOI 10.1056/NEJM198001243020402; Jha S, 2015, J BONE MINER RES; Khan A, 2009, J CLIN ENDOCR METAB, V94, P373, DOI 10.1210/jc.2008-1762; Kim SM, 2016, CLIN J AM SOC NEPHRO, V11, P1260, DOI 10.2215/CJN.10370915; Marcocci C, 2009, J CLIN ENDOCR METAB, V94, P2766, DOI 10.1210/jc.2008-2640; MARCUS R, 1984, ANN INTERN MED, V100, P633, DOI 10.7326/0003-4819-100-5-633; MCDERMOTT MT, 1994, J BONE MINER RES, V9, P509; Mollerup CL, 2002, BMJ-BRIT MED J, V325, P807, DOI 10.1136/bmj.325.7368.807; Niederle B, 2015, EUR J ENDOCRINOL, V173, pD13, DOI 10.1530/EJE-15-0277; Peacock M, 2005, J CLIN ENDOCR METAB, V90, P135, DOI 10.1210/jc.2004-0842; Rao DS, 2004, J CLIN ENDOCR METAB, V89, P5415, DOI 10.1210/jc.2004-0028; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Sattar N, 2012, LANCET, V379, P95, DOI 10.1016/S0140-6736(11)61816-3; Shoback DM, 2003, J CLIN ENDOCR METAB, V88, P5644, DOI 10.1210/jc.2002-021597; Silverberg SJ, 1997, NEW ENGL J MED, V337, P1506, DOI 10.1056/NEJM199711203372104; Silverberg SJ, 1999, NEW ENGL J MED, V341, P1249, DOI 10.1056/NEJM199910213411701; Silverberg SJ, 1996, J CLIN ENDOCR METAB, V81, P2036, DOI 10.1210/jc.81.6.2036; Stack BC, 2012, OTOLARYNG HEAD NECK, V147, P438, DOI 10.1177/0194599812445551; [The Healthcare cost and utilization project Agency for Healthcare Research and Quality], 2011, INTRODUCTION TO THE; Thomas DC, 2011, J SURG RES, V170, P240, DOI 10.1016/j.jss.2011.03.014; Udell JA, 2006, J BONE MINER RES, V21, P765, DOI 10.1359/JBMR.060119; US Census Bureau, CURR POPP SURV AG SE; Wermers RA, 2006, J BONE MINER RES, V21, P171, DOI 10.1359/JBMR.050910; Wermers RA, 1997, ANN INTERN MED, V126, P433, DOI 10.7326/0003-4819-126-6-199703150-00003; Wu BA, 2010, J CLIN ENDOCR METAB, V95, P4324, DOI 10.1210/jc.2009-2819; Yeh MW, 2013, J CLIN ENDOCR METAB, V98, P1122, DOI 10.1210/jc.2012-4022; Yeh MW, 2012, ANN SURG, V255, P1179, DOI 10.1097/SLA.0b013e31824dad7d	37	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161192	10.1371/journal.pone.0161192	http://dx.doi.org/10.1371/journal.pone.0161192			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529699	Green Published, Green Submitted, gold			2022-12-26	WOS:000381476700053
J	Torres, MA; Diaz, R; Boguen, R; Martins, SMMK; Ravagnani, GM; Leal, DF; Oliveira, MD; Muro, BBD; Parra, BM; Meirelles, FV; Papa, FO; Dell'Aqua, JA; Alvarenga, MA; Moretti, AD; Sepulveda, N; de Andrade, AFC				Torres, Mariana Andrade; Diaz, Rommy; Boguen, Rodrigo; Massami Kitamura Martins, Simone Maria; Ravagnani, Gisele Mouro; Leal, Diego Feitosa; Oliveira, Melissa de Lima; Donatelli Muro, Bruno Bracco; Parra, Beatriz Martins; Meirelles, Flavio Vieira; Papa, Frederico Ozanan; Dell'Aqua, Jose Antonio, Jr.; Alvarenga, Marco Antonio; Moretti, Anibal de Sant'Anna; Sepulveda, Nestor; Cesar de Andrade, Andre Furugen			Novel Flow Cytometry Analyses of Boar Sperm Viability: Can the Addition of Whole Sperm-Rich Fraction Seminal Plasma to Frozen-Thawed Boar Sperm Affect It?	PLOS ONE			English	Article							PORCINE LUTEINIZING-HORMONE; TYROSINE PHOSPHORYLATION; SURFACE-PROTEINS; IN-VITRO; MITOCHONDRIAL-FUNCTION; SPERMATOZOA; CAPACITATION; SEMEN; MEMBRANE; POSTTHAW	Boar semen cryopreservation remains a challenge due to the extension of cold shock damage. Thus, many alternatives have emerged to improve the quality of frozen-thawed boar sperm. Although the use of seminal plasma arising from boar sperm-rich fraction (SP-SRF) has shown good efficacy; however, the majority of actual sperm evaluation techniques include a single or dual sperm parameter analysis, which overrates the real sperm viability. Within this context, this work was performed to introduce a sperm flow cytometry fourfold stain technique for simultaneous evaluation of plasma and acrosomal membrane integrity and mitochondrial membrane potential. We then used the sperm flow cytometry fourfold stain technique to study the effect of SP-SRF on frozen-thawed boar sperm and further evaluated the effect of this treatment on sperm movement, tyrosine phosphorylation and fertility rate (FR). The sperm fourfold stain technique is accurate (R-2 = 0.9356, p > 0.01) for simultaneous evaluation of plasma and acrosomal membrane integrity and mitochondrial membrane potential (IPIAH cells). Centrifugation pre-cryopreservation was not deleterious (p > 0.05) for any analyzed variables. Addition of SP-SRF after cryopreservation was able to improve total and progressive motility (p < 0.05) when boar semen was cryopreserved without SP-SRF; however, it was not able to decrease tyrosine phosphorylation (p > 0.05) or improve IPIAH cells (p > 0.05). FR was not (p > 0.05) statistically increased by the addition of seminal plasma, though females inseminated with frozen-thawed boar semen plus SP-SRF did perform better than those inseminated with sperm lacking seminal plasma. Thus, we conclude that sperm fourfold stain can be used to simultaneously evaluate plasma and acrosomal membrane integrity and mitochondrial membrane potential, and the addition of SP-SRF at thawed boar semen cryopreserved in absence of SP-SRF improve its total and progressive motility.	[Torres, Mariana Andrade; Massami Kitamura Martins, Simone Maria; Ravagnani, Gisele Mouro; Leal, Diego Feitosa; Oliveira, Melissa de Lima; Donatelli Muro, Bruno Bracco; Parra, Beatriz Martins; Cesar de Andrade, Andre Furugen] Univ Sao Paulo, Sch Vet Med & Anim Sci, Dept Anim Reprod, Lab Androl & Technol Swine Embryos, Sao Paulo, Brazil; [Diaz, Rommy; Boguen, Rodrigo; Sepulveda, Nestor] Univ La Frontera, Ctr Excellence Biotechnol Reprod, Temuco, Araucania, Chile; [Massami Kitamura Martins, Simone Maria; Moretti, Anibal de Sant'Anna] Univ Sao Paulo, Lab Swine Res, Dept Anim Nutr & Prod, Sch Vet Med & Anim Sci, Sao Paulo, Brazil; [Meirelles, Flavio Vieira] Univ Sao Paulo, Sch Anim Sci & Food Engn, Dept Vet Med, Sao Paulo, Brazil; [Papa, Frederico Ozanan; Dell'Aqua, Jose Antonio, Jr.; Alvarenga, Marco Antonio] Sao Paulo State Univ UNESP, Sch Vet Med & Anim Sci, Dept Anim Reprod & Vet Radiol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidad de La Frontera; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual Paulista	de Andrade, AFC (corresponding author), Univ Sao Paulo, Sch Vet Med & Anim Sci, Dept Anim Reprod, Lab Androl & Technol Swine Embryos, Sao Paulo, Brazil.	andrefc@usp.br	Torres, Mariana Andrade/AAC-2471-2020; de Andrade, André Furugen Cesar/C-5092-2012; Meirelles, Flavio V/B-5048-2010; Díaz, Rommy/I-3255-2018; Sepulveda, Nestor/H-8699-2018; Torres, Mariana Andrade MAT/W-9214-2018; Martins, Simone Maria Massami Kitamura/M-7538-2013; CTC USP, CEPID 13 18/J-8951-2014	de Andrade, André Furugen Cesar/0000-0002-0148-4372; Meirelles, Flavio V/0000-0003-0372-4920; Sepulveda, Nestor/0000-0001-8321-604X; Torres, Mariana Andrade MAT/0000-0003-0222-0544; Martins, Simone Maria Massami Kitamura/0000-0002-5895-3678; Diaz, Rommy/0000-0002-6209-6728; CTC USP, CEPID 13 18/0000-0002-7123-9524; Boguen, Rodrigo/0000-0002-0325-743X; Leal, Diego/0000-0001-9205-2382; Dell'Aqua Jr., Jose Antonio/0000-0001-8758-3605	FUNDACAO DE AMPARO A PESQUISA DO ESTADO DE SAO PAULO [2011/23484-8, 2013/08070-8, 2014/22972-7]	FUNDACAO DE AMPARO A PESQUISA DO ESTADO DE SAO PAULO(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by FUNDACAO DE AMPARO A PESQUISA DO ESTADO DE SAO PAULO; grant numbers and author who received the funding: 2011/23484-8 AFCA, 2013/08070-8 MAT, 2014/22972-7 MAT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade AFC, 2008, ANIM REPROD SCI, V107, P304, DOI 10.1016/j.anireprosci.2008.05.082; [Anonymous], 1983, BIOL TRACE ELEM RES; Baker MA, 2004, J CELL SCI, V117, P211, DOI 10.1242/jcs.00842; Braundmeier AG, 2001, J DAIRY SCI, V84, P1915, DOI 10.3168/jds.S0022-0302(01)74633-4; Caballero I, 2008, THERIOGENOLOGY, V70, P1352, DOI 10.1016/j.theriogenology.2008.07.013; Caballero I, 2012, REPROD DOMEST ANIM, V47, P12, DOI 10.1111/j.1439-0531.2012.02028.x; Cai K, 2005, ARCH ANDROLOGY, V51, P371, DOI 10.1080/014850190924485; Candini P. H., 2004, Brazilian Journal of Veterinary Research and Animal Science, V41, P124; Carvajal G, 2004, J ANDROL, V25, P389; Celeghini ECC, 2007, REPROD DOMEST ANIM, V42, P479, DOI 10.1111/j.1439-0531.2006.00810.x; de Andrade AFC, 2012, THERIOGENOLOGY, V77, P1866, DOI 10.1016/j.theriogenology.2012.01.003; Cremades T, 2005, J ANDROL, V26, P610, DOI 10.2164/jandrol.05028; CROSS NL, 1989, BIOL REPROD, V41, P635, DOI 10.1095/biolreprod41.4.635; de Andrade AFC, 2007, REPROD DOMEST ANIM, V42, P190, DOI 10.1111/j.1439-0531.2006.00751.x; de Andrade AFC, 2011, REPROD DOMEST ANIM, V46, P682, DOI 10.1111/j.1439-0531.2010.01729.x; Degenstein KL, 2008, THERIOGENOLOGY, V70, P1075, DOI 10.1016/j.theriogenology.2008.06.027; DOSTALOVA Z, 1994, BIOL CHEM H-S, V375, P457, DOI 10.1515/bchm3.1994.375.7.457; EISERT WG, 1981, CYTOMETRY, V1, P254, DOI 10.1002/cyto.990010403; Ekhlasi-Hundrieser M, 2005, BIOL REPROD, V73, P536, DOI 10.1095/biolreprod.105.040824; Flesch FM, 1999, BIOCHEM BIOPH RES CO, V262, P787, DOI 10.1006/bbrc.1999.1300; Gama RD, 2005, REPROD DOMEST ANIM, V40, P433, DOI 10.1111/j.1439-0531.2005.00605.x; Garcia JC, 2010, ANIM REPROD SCI, V119, P160, DOI 10.1016/j.anireprosci.2009.11.001; Garner DL, 1997, BIOL REPROD, V57, P1401, DOI 10.1095/biolreprod57.6.1401; Garner DL, 1996, THERIOGENOLOGY, V45, P1103, DOI 10.1016/0093-691X(96)00067-2; GARNER DL, 1994, J ANDROL, V15, P620; GARNER DL, 1995, BIOL REPROD, V53, P276, DOI 10.1095/biolreprod53.2.276; Gomez-Fernandez J, 2013, REPROD DOMEST ANIM, V48, P177, DOI 10.1111/j.1439-0531.2012.02126.x; Gonzalez-Cadavid V, 2014, THERIOGENOLOGY, V82, P697, DOI [10.1016/j.theriogenology.2014.05.024, 10.1016/j.theriogen]; GRAHAM JK, 1990, BIOL REPROD, V43, P55, DOI 10.1095/biolreprod43.1.55; Hernandez M, 2007, J ANDROL, V28, P689, DOI 10.2164/jandrol.107.002725; Hossain MS, 2011, ANIM REPROD SCI, V128, P37, DOI 10.1016/j.anireprosci.2011.08.006; Hossain MS, 2011, ASIAN J ANDROL, V13, P406, DOI 10.1038/aja.2011.15; Johnson LA, 2000, ANIM REPROD SCI, V62, P143, DOI 10.1016/S0378-4320(00)00157-3; Jonakova V, 2000, MOL REPROD DEV, V56, P275, DOI 10.1002/(SICI)1098-2795(200006)56:2+&lt;275::AID-MRD13&gt;3.0.CO;2-G; Martinez-Pastor F, 2010, REPROD DOMEST ANIM, V45, P67, DOI 10.1111/j.1439-0531.2010.01622.x; Maxwell WMC, 1997, THERIOGENOLOGY, V48, P209, DOI 10.1016/S0093-691X(97)84068-X; Nagy S, 2003, BIOL REPROD, V68, P1828, DOI 10.1095/biolreprod.102.011445; Okazaki T, 2009, THERIOGENOLOGY, V71, P491, DOI 10.1016/j.theriogenology.2008.08.014; Okazaki T, 2012, J ANDROL, V33, P990, DOI 10.2164/jandrol.111.015115; Oura C., 1990, International Review of Cytology, V122, P105, DOI 10.1016/S0074-7696(08)61207-3; Petrunkina AM, 2013, REPROD DOMEST ANIM, V48, P11, DOI 10.1111/rda.12202; Petrunkina AM, 2010, THERIOGENOLOGY, V73, P995, DOI 10.1016/j.theriogenology.2009.12.006; Piehler E, 2006, CYTOM PART A, V69A, P1062, DOI 10.1002/cyto.a.20338; Rath D, 2009, Soc Reprod Fertil Suppl, V66, P51; Rieseberg M, 2001, APPL MICROBIOL BIOT, V56, P350, DOI 10.1007/s002530100673; Roca J, 2003, THERIOGENOLOGY, V60, P77, DOI 10.1016/S0093-691X(02)01330-4; Rodriguez-Martinez H, 2006, REPROD DOMEST ANIM, V41, P2, DOI 10.1111/j.1439-0531.2006.00764.x; Rodriguez-Martinez Heriberto, 2010, Vet Med Int, V2010, DOI 10.4061/2011/396181; Saravia F, 2007, INT J ANDROL, V30, P485, DOI 10.1111/j.1365-2605.2006.00741.x; Saravia F, 2010, ANIM REPROD SCI, V117, P279, DOI 10.1016/j.anireprosci.2009.04.014; Saravia F, 2009, THERIOGENOLOGY, V71, P662, DOI 10.1016/j.theriogenology.2008.09.037; Schmidt H, 2004, REPRODUCTION, V128, P171, DOI 10.1530/rep.1.00153; Sidhu KS, 2004, REPRODUCTION, V127, P95, DOI 10.1530/rep.1.00073; Siqueira AP, 2011, THERIOGENOLOGY, V75, P1175, DOI 10.1016/j.theriogenology.2010.11.024; Talevi R, 2010, THERIOGENOLOGY, V73, P796, DOI 10.1016/j.theriogenology.2009.07.005; Tartaglione CM, 2004, THERIOGENOLOGY, V62, P1245, DOI 10.1016/j.theriogenology.2004.01.012; Topfer-Petersen E, 2008, INT J DEV BIOL, V52, P717, DOI 10.1387/ijdb.072536et; Vadnais ML, 2010, REPROD FERT DEVELOP, V22, P893, DOI 10.1071/RD09274; Vadnais ML, 2005, ANIM REPROD SCI, V90, P347, DOI 10.1016/j.anireprosci.2005.02.007; Yaniz JL, 2013, REPROD DOMEST ANIM, V48, P598, DOI 10.1111/rda.12132; Zasiadczyk L, 2015, THERIOGENOLOGY, V83, P1287, DOI 10.1016/j.theriogenology.2015.01.015	61	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160988	10.1371/journal.pone.0160988	http://dx.doi.org/10.1371/journal.pone.0160988			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529819	gold, Green Published, Green Submitted			2022-12-26	WOS:000381476700037
J	Winther, JA; Brynildsen, J; Hoiseth, AD; Folling, I; Brekke, PH; Christensen, G; Hagve, TA; Verbalis, JG; Omland, T; Rosjo, H				Winther, Jacob A.; Brynildsen, Jon; Hoiseth, Arne Didrik; Folling, Ivar; Brekke, Pal H.; Christensen, Geir; Hagve, Tor-Arne; Verbalis, Joseph G.; Omland, Torbjorn; Rosjo, Helge			Prevalence and Prognostic Significance of Hyponatremia in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Data from the Akershus Cardiac Examination (ACE) 2 Study	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; SERUM SODIUM CONCENTRATION; HOSPITALIZED-PATIENTS; EMERGENCY-DEPARTMENT; NATRIURETIC PEPTIDE; PROSPECTIVE COHORT; OPTIMIZE-HF; MORTALITY; OUTCOMES; ASSOCIATION	Background Hyponatremia is prevalent and associated with mortality in patients with heart failure (HF). The prevalence and prognostic implications of hyponatremia in acute exacerbation of chronic obstructive pulmonary (AECOPD) have not been established. Method We included 313 unselected patients with acute dyspnea who were categorized by etiology of dyspnea according to established guidelines (derivation cohort). Serum Na+ was determined on hospital admission and corrected for hyperglycemia, and hyponatremia was defined as [Na+]< 137 mmol/L. Survival was ascertained after a median follow-up of 816 days and outcome was analyzed in acute HF (n = 143) and AECOPD (n = 83) separately. Results were confirmed in an independent AECOPD validation cohort (n = 99). Results In the derivation cohort, median serum Na+ was lower in AECOPD vs. acute HF (138.5 [135.9-140.5] vs. 139.2 [136.7-141.3] mmol/L, p = 0.02), while prevalence of hyponatremia (27% [22/83] vs. 20% [29/143], p = 0.28) and mortality rate (42% [35/83] vs. 46% [66/143], p = 0.56) were similar. By univariate Cox regression analysis, hyponatremia was associated with increased mortality in acute HF (HR 1.85 [95% CI 1.08, 3.16], p = 0.02), but not in AECOPD (HR 1.00 [0.47, 2.15], p = 1.00). Analogous to the results of the derivation cohort, hyponatremia was prevalent also in the AECOPD validation cohort (25% [25/99]), but not associated with mortality. The diverging effect of hyponatremia on outcome between AECOPD and acute HF was statistically significant (p = 0.04). Conclusion Hyponatremia is prevalent in patients with acute HF and AECOPD, but is associated with mortality in patients with acute HF only.	[Winther, Jacob A.; Brynildsen, Jon; Hoiseth, Arne Didrik; Folling, Ivar; Brekke, Pal H.; Omland, Torbjorn; Rosjo, Helge] Akershus Univ Hosp, Div Med, Lorenskog, Norway; [Winther, Jacob A.; Brynildsen, Jon; Hoiseth, Arne Didrik; Folling, Ivar; Brekke, Pal H.; Christensen, Geir; Hagve, Tor-Arne; Omland, Torbjorn; Rosjo, Helge] Univ Oslo, Inst Clin Med, Oslo, Norway; [Christensen, Geir] Oslo Univ Hosp, Expt Med Res Inst, Oslo, Norway; [Hagve, Tor-Arne] Akershus Univ Hosp, Div Diagnost & Technol, Lorenskog, Norway; [Verbalis, Joseph G.] Georgetown Univ, Med Ctr, Div Endocrinol & Metab, Washington, DC 20007 USA; [Brekke, Pal H.] Oslo Univ Hosp, Div Med, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; Georgetown University; University of Oslo	Winther, JA (corresponding author), Akershus Univ Hosp, Div Med, Lorenskog, Norway.; Winther, JA (corresponding author), Univ Oslo, Inst Clin Med, Oslo, Norway.	j.a.winther@medisin.uio.no		Brekke, Pal/0000-0003-4875-9633	Akershus University Hospital; Research Council of Norway	Akershus University Hospital; Research Council of Norway(Research Council of Norway)	The ACE 2 Study was funded by Akershus University Hospital (http://www.ahus.no) and the Research Council of Norway (http://www.forskningsradet.no). The sponsors had no role in any of the following: design and conduct of the study, collection, management, analysis and interpretation of the data, or preparation, review and approval of the manuscript.	Abraham WT, 2008, J AM COLL CARDIOL, V52, P347, DOI 10.1016/j.jacc.2008.04.028; Balling L, 2011, EUR J HEART FAIL, V13, P968, DOI 10.1093/eurjhf/hfr086; BAUER FK, 1965, AM J MED SCI, V250, P245, DOI 10.1097/00000441-196509000-00001; Bettari L, 2012, J CARD FAIL, V18, P74, DOI 10.1016/j.cardfail.2011.09.005; Borroni G, 2000, DIGEST LIVER DIS, V32, P605, DOI 10.1016/S1590-8658(00)80844-0; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Corona G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124105; Corona G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080451; Deubner N, 2012, EUR J HEART FAIL, V14, P1147, DOI 10.1093/eurjhf/hfs115; Filippatos TD, 2013, WORLD J CARDIOL, V5, P317, DOI [10.4330/wjc.v5.i9.317, 10.4330/wjc.v5.i7.210]; Gheorghiade M, 2007, ARCH INTERN MED, V167, P1998, DOI 10.1001/archinte.167.18.1998; Gheorghiade M, 2007, EUR HEART J, V28, P980, DOI 10.1093/eurheartj/ehl542; GOLD, GLOB STRAT DIAGN MAN; Hawkins RC, 2003, CLIN CHIM ACTA, V337, P169, DOI 10.1016/j.cccn.2003.08.001; Hillier TA, 1999, AM J MED, V106, P399, DOI 10.1016/S0002-9343(99)00055-8; Hoiseth AD, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-97; Hoiseth AD, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-22; Januzzi JL, 2005, AM J CARDIOL, V95, P948, DOI 10.1016/j.amjcard.2004.12.032; Karadag F, 2004, RESPIROLOGY, V9, P481, DOI 10.1111/j.1440-1843.2004.00614.x; Kim WR, 2008, NEW ENGL J MED, V359, P1018, DOI 10.1056/NEJMoa0801209; Lainscak M, 2011, J CACHEXIA SARCOPENI, V2, P81, DOI 10.1007/s13539-011-0023-9; Landbo C, 1999, AM J RESP CRIT CARE, V160, P1856, DOI 10.1164/ajrccm.160.6.9902115; Levine M, 2001, PHARMACOTHERAPY, V21, P405, DOI 10.1592/phco.21.5.405.34503; Lim WS, 2000, THORAX, V55, P219, DOI 10.1136/thorax.55.3.219; Madan VD, 2011, CIRC-HEART FAIL, V4, P637, DOI 10.1161/CIRCHEARTFAILURE.111.961011; McCullough PA, 2002, CIRCULATION, V106, P416, DOI 10.1161/01.CIR.0000025242.79963.4C; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Mohan S, 2013, AM J MED, V126, P1127, DOI 10.1016/j.amjmed.2013.07.021; Porcel A, 2002, ARCH INTERN MED, V162, P323, DOI 10.1001/archinte.162.3.323; Rosjo H, 2015, CLIN CHEM, V61, P1087, DOI 10.1373/clinchem.2015.239673; Rustad P, 2004, SCAND J CLIN LAB INV, V64, P271, DOI 10.1080/00365510410006324; SCHRIER RW, 1981, J LAB CLIN MED, V98, P1; SONNENBLICK M, 1993, CHEST, V103, P601, DOI 10.1378/chest.103.2.601; STEVENSON LW, 1989, JAMA-J AM MED ASSOC, V261, P884, DOI 10.1001/jama.261.6.884; TANG WW, 1993, AM J MED, V94, P169, DOI 10.1016/0002-9343(93)90179-S; Tribouilloy C, 2008, EUR HEART J, V29, P339, DOI 10.1093/eurheartj/ehm554; Upadhyay A, 2006, AM J MED, V119, pS30, DOI 10.1016/j.amjmed.2006.05.005; Vazquez R, 2009, EUR HEART J, V30, P1088, DOI 10.1093/eurheartj/ehp032; Verbalis JG, 2013, AM J MED, V126, pS5, DOI 10.1016/j.amjmed.2013.07.006; Wald R, 2010, ARCH INTERN MED, V170, P294, DOI 10.1001/archinternmed.2009.513; Wang CS, 2005, JAMA-J AM MED ASSOC, V294, P1944, DOI 10.1001/jama.294.15.1944; WOOD CE, 1989, AM J PHYSIOL, V257, pR344, DOI 10.1152/ajpregu.1989.257.2.R344	42	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161232	10.1371/journal.pone.0161232	http://dx.doi.org/10.1371/journal.pone.0161232			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529844	Green Published, gold, Green Submitted			2022-12-26	WOS:000381476700055
J	Xia, WW; Morch, CD; Andersen, OK				Xia, Weiwei; Morch, Carsten Dahl; Andersen, Ole Kaeseler			Test-Retest Reliability of 10 Hz Conditioning Electrical Stimulation Inducing Long-Term Potentiation (LTP)-Like Pain Amplification in Humans	PLOS ONE			English	Article							SPINAL DORSAL-HORN; FIBER-EVOKED POTENTIALS; PRIMARY AFFERENT-FIBERS; C-FIBER; HUMAN SKIN; SECONDARY HYPERALGESIA; CENTRAL SENSITIZATION; PERCEPTUAL CORRELATE; INFLAMMATORY PAIN; HEAT HYPERALGESIA	Background 10 Hz conditioning electrical stimulation (CES) has been shown to induce long-term potentiation (LTP)-like pain amplification similar to traditional 100 Hz CES in healthy humans. The aim of this study was to assess the test-retest reliability and to estimate sample sizes required for future crossover and parallel study designs. Methods The 10 Hz paradigm (500 rectangular pulses lasting 50 s) was repeated on two separate days with one week interval in twenty volunteers. Perceptual intensities to single electrical stimulation (SES) at the conditioned skin site and to mechanical stimuli (pinprick and light stroking) in immediate vicinity to the conditioned skin site were recorded. Superficial blood flow (SBF) was assessed as indicator of neurogenic inflammation. All outcome measures were assessed with 10 min interval three times before and six times after the CES. The coefficient of variation and intra-class correlation coefficient were calculated within session and between sessions. Sample sizes were estimated for future crossover (Ncr) and parallel (Np) drug testing studies expected to detect a 30% decrease for the individual outcome measure following 10 Hz CES. Results Perceptual intensity ratings to light stroking (Ncr = 2, Np = 33) and pinprick stimulation (491 mN) (Ncr = 6, Np = 54) increased after CES and showed better reliability in crossover than parallel design. The SBF increased after CES, and then declined until reaching a plateau 20 minutes postCES. SBF showed acceptable reliability both in crossover and parallel designs (Ncr = 3, Np = 13). Pain ratings to SES were reliable, but with large estimated sample sizes (Ncr = 634, Np = 11310) due to the minor pain amplification. Conclusions The reliability of 10 Hz CES was acceptable in inducing LTP-like effects in the assessments of superficial blood flow, heterotopic mechanical hyperalgesia, and dysesthesia in terms of sample sizes for future crossover study designs.	[Xia, Weiwei; Morch, Carsten Dahl; Andersen, Ole Kaeseler] Aalborg Univ, Dept Hlth Sci & Technol, SMI, CNAP, Fredrik Bajers Vej 7 D3, DK-9220 Aalborg, Denmark; [Xia, Weiwei] Jilin Univ, China Japan Union Hosp, Changchun, Jilin Province, Peoples R China	Aalborg University; Jilin University	Xia, WW (corresponding author), Aalborg Univ, Dept Hlth Sci & Technol, SMI, CNAP, Fredrik Bajers Vej 7 D3, DK-9220 Aalborg, Denmark.; Xia, WW (corresponding author), Jilin Univ, China Japan Union Hosp, Changchun, Jilin Province, Peoples R China.	wx@hst.aau.dk	Mørch, Carsten Dahl/J-5639-2019; Andersen, Ole Kæseler/J-7825-2013	Mørch, Carsten Dahl/0000-0001-6693-2028; Andersen, Ole Kæseler/0000-0001-6307-8786	Danish National Research Foundation [DNRF121]; China Scholarship Council [2011617176]	Danish National Research Foundation(Danmarks Grundforskningsfond); China Scholarship Council(China Scholarship Council)	This study was supported by the Danish National Research Foundation (DNRF121) (O.K.A.) URL:http://dg.dk/en/ and China Scholarship Council (FILE NO.2011617176) (W.X.) URL:http://www.csc.edu.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1989, MEASUREMENT CONCEPTS; Benrath J, 2005, BRIT J ANAESTH, V95, P518, DOI 10.1093/bja/aei215; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Chizh BA, 2007, PAIN, V132, P132, DOI 10.1016/j.pain.2007.06.006; Dawson A, 2012, J OROFAC PAIN, V26, P39; De Col R, 2008, PAIN, V138, P556, DOI 10.1016/j.pain.2008.02.005; Djouhri L, 2006, J NEUROSCI, V26, P1281, DOI 10.1523/JNEUROSCI.3388-05.2006; Drdla R, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-18; Dusch M, 2007, NEUROREPORT, V18, P1101, DOI 10.1097/WNR.0b013e3281e72cff; Gazerani P, 2006, PAIN, V122, P315, DOI 10.1016/j.pain.2006.04.014; Han HC, 2000, PAIN, V84, P253; HANDWERKER HO, 1987, EXP BRAIN RES, V65, P493; Hansen N, 2007, J NEUROPHYSIOL, V97, P2559, DOI 10.1152/jn.01125.2006; Hathway GJ, 2009, PAIN, V144, P110, DOI 10.1016/j.pain.2009.03.022; Henrich F, 2015, BRAIN, V138, P2505, DOI 10.1093/brain/awv108; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Ikeda H, 2006, SCIENCE, V312, P1659, DOI 10.1126/science.1127233; Jensen MP, 2003, J PAIN, V4, P2, DOI 10.1054/jpai.2003.1; Jurgens TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099507; Julious SA, 2004, STAT MED, V23, P1921, DOI 10.1002/sim.1783; Kim HY, 2015, PAIN, V156, P618, DOI 10.1097/01.j.pain.0000460354.09622.ec; Klein T, 2004, J NEUROSCI, V24, P964, DOI 10.1523/JNEUROSCI.1222-03.2004; Klein T, 2007, NEUROPHARMACOLOGY, V52, P655, DOI 10.1016/j.neuropharm.2006.09.008; Klein T, 2006, J NEUROPHYSIOL, V96, P3551, DOI 10.1152/jn.00755.2006; Lang S, 2007, PAIN, V128, P254, DOI 10.1016/j.pain.2006.09.026; LIU XG, 1995, NEUROSCI LETT, V191, P43, DOI 10.1016/0304-3940(95)11553-0; Liu XG, 1997, J NEUROPHYSIOL, V78, P1973, DOI 10.1152/jn.1997.78.4.1973; Lynn B, 1996, PROG BRAIN RES, V113, P361, DOI 10.1016/S0079-6123(08)61098-5; MAGERL W, 1987, NEUROSCI LETT, V82, P349, DOI 10.1016/0304-3940(87)90281-3; Magerl W, 2006, HAND CLINIC, V81, P503, DOI 10.1016/S0072-9752(06)80037-0; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Manresa JAB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100241; Manresa JAB, 2010, EUR J PAIN, V14, P822, DOI 10.1016/j.ejpain.2009.12.008; Matre D, 2006, J NEUROSCI, V26, P559, DOI 10.1523/JNEUROSCI.4218-05.2006; Matre D, 2013, BRAIN RES, V1491, P54, DOI 10.1016/j.brainres.2012.10.045; Morch Carsten Dahl, 2013, Int J Physiol Pathophysiol Pharmacol, V5, P203; Pfau DB, 2011, PAIN, V152, P1532, DOI 10.1016/j.pain.2011.02.037; Portney LG, 2009, FDN CLIN RES APPL PR, V3rd, DOI DOI 10.1016/S0039-6257(02)00362-4; Price TJ, 2015, PROG MOL BIOL TRANSL, V131, P409, DOI 10.1016/bs.pmbts.2014.11.010; Puig S, 1996, PAIN, V64, P345, DOI 10.1016/0304-3959(95)00121-2; Rankin CH, 2009, NEUROBIOL LEARN MEM, V92, P135, DOI 10.1016/j.nlm.2008.09.012; Rankin G, 1998, CLIN REHABIL, V12, P187, DOI 10.1191/026921598672178340; RAYMOND SA, 1990, BRAIN RES, V526, P318, DOI 10.1016/0006-8993(90)91239-D; Sandkuhler J, 2012, CURR OPIN PHARMACOL, V12, P18, DOI 10.1016/j.coph.2011.10.018; Sauerstein K, 2000, J PHYSIOL-LONDON, V529, P803, DOI 10.1111/j.1469-7793.2000.00803.x; Schaible H. -G., 2007, V177, P3; Schaible HG, 2005, RHEUM DIS CLIN N AM, V31, P77, DOI 10.1016/j.rdc.2004.09.004; SIMONE DA, 1991, J NEUROPHYSIOL, V66, P228, DOI 10.1152/jn.1991.66.1.228; Sumikura H, 2003, PAIN, V105, P285, DOI 10.1016/S0304-3959(03)00243-4; Sumikura H, 2003, NEUROSCI LETT, V337, P147, DOI 10.1016/S0304-3940(02)01325-3; Svendsen F, 1998, NEUROREPORT, V9, P1185, DOI 10.1097/00001756-199804200-00041; Terman GW, 2001, J NEUROPHYSIOL, V85, P485, DOI 10.1152/jn.2001.85.2.485; TREEDE RD, 1992, PROG NEUROBIOL, V38, P397, DOI 10.1016/0301-0082(92)90027-C; van den Broeke EN, 2014, J NEUROPHYSIOL, V112, P2059, DOI 10.1152/jn.00342.2014; van den Broeke EN, 2014, J NEUROPHYSIOL, V111, P1564, DOI 10.1152/jn.00651.2013; Van den Broeke EN, 2012, J NEUROPHYSIOL, V108, P2276, DOI 10.1152/jn.00391.2012; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Xia WW, 2016, EXP BRAIN RES, V234, P2479, DOI 10.1007/s00221-016-4653-1; Xiao WH, 2007, ANESTHESIOLOGY, V107, P813, DOI 10.1097/01.anes.0000286983.33184.9c; Yang HW, 2004, J NEUROPHYSIOL, V91, P1122, DOI 10.1152/jn.00735.2003; Yucel A, 2002, EUR J PAIN, V6, P357, DOI 10.1016/S1090-3801(02)00022-8	63	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161117	10.1371/journal.pone.0161117	http://dx.doi.org/10.1371/journal.pone.0161117			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529175	Green Published, gold, Green Submitted			2022-12-26	WOS:000381476700047
J	Huynh, VTT; Lim, YS; Tran, SC; Pham, TM; Nguyen, LN; Hwang, SB				Huynh, Van T. T.; Lim, Yun-Sook; Tran, Si C.; Pham, Tu M.; Nguyen, Lam N.; Hwang, Soon B.			Hepatitis C Virus Nonstructural 5A Protein Interacts with Abelson Interactor 1 and Modulates Epidermal Growth Factor-mediated MEK/ERK Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						early growth response protein 1 (EGR1); epidermal growth factor (EGF); extracellular-signal-regulated kinase (ERK); growth factor receptor-bound protein 2 (GRB2); hepatitis C virus (HCV); signal transduction	FACTOR RECEPTOR; RAS; ACTIVATION; COMPLEX; KINASE; EPS8; REPLICATION; NS5A; E3B1; ABI1	The propagation of hepatitis C virus (HCV) is highly dependent on host cellular factors. To identify the cellular factors involved in HCV propagation, we have previously performed protein microarray assays using the HCV nonstructural 5A (NS5A) protein as a probe. Of approximate to 9,000 host proteins immobilized in a microarray, approximate to 90 cellular proteins were identified as HCV NS5A interacting partners. Of these candidates, we selected Abelson interactor 1 (Abi1) for further characterization. Binding of HCV NS5A to Abi1 was verified by both in vitro pulldown and coimmunoprecipitation assays. HCV NS5A interacted with Abi1 through regions I + II of Abi1 and domain I of NS5A. We further demonstrated that Abi1 colocalized with the HCV NS5A protein in the cytoplasm. We showed that NS5A inhibited epidermal growth factor-mediated ERK and Egr1 activations and this inhibitory activity of NS5A was nullified in Abi1-knockdown cells. Moreover, silencing of Abi1 expression impaired HCV replication, whereas overexpression of Abi1 promoted HCV propagation. Collectively, these data indicate that HCV exploits host Abi1 protein via NS5A to modulate MEK/ERK signaling pathway for its own propagation.	Hallym Univ, Natl Res Lab Hepatitis Virus C, Anyang 14066, South Korea; Hallym Univ, Ilsong Inst Life Sci, Anyang 14066, South Korea	Hallym University; Hallym University	Hwang, SB (corresponding author), 1605-4 Gwanyang Dong, Anyang 431060, South Korea.	sbhwang@hallym.ac.kr	Huynh, Van/GSM-7997-2022; Nguyen, Nhat Lam/ABD-9095-2020	Nguyen, Nhat Lam/0000-0002-3461-8103	Basic Science Research Program Grant from the Ministry of Science, ICT and Future Planning, Korea [2016R010886]; Korean Health Technology RAMP;D Project Grant from the Ministry of Health and Welfare, Korea [HI13C1746]	Basic Science Research Program Grant from the Ministry of Science, ICT and Future Planning, Korea; Korean Health Technology RAMP;D Project Grant from the Ministry of Health and Welfare, Korea	This work was supported by Basic Science Research Program Grant 2016R010886 from the Ministry of Science, ICT and Future Planning, Korea and Korean Health Technology R&D Project Grant HI13C1746 from the Ministry of Health and Welfare, Korea. The authors declare that they have no conflicts of interest with the contents of this article.	Biesova Z, 1997, ONCOGENE, V14, P233, DOI 10.1038/sj.onc.1200822; Chen HJ, 2010, CANCER RES, V70, P9979, DOI 10.1158/0008-5472.CAN-10-2394; Choi SH, 2006, J BIOL CHEM, V281, P7468, DOI 10.1074/jbc.M512438200; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P15180; Cui MH, 2010, MED ONCOL, V27, P632, DOI 10.1007/s12032-009-9260-6; Fan PD, 2000, MOL CELL BIOL, V20, P7591, DOI 10.1128/MCB.20.20.7591-7601.2000; Georgopoulou U, 2003, ARCH VIROL, V148, P237, DOI 10.1007/s00705-002-0925-0; Giannini C, 2003, CELL DEATH DIFFER, V10, pS27, DOI 10.1038/sj.cdd.4401121; Gretton S, 2010, J GEN VIROL, V91, P671, DOI 10.1099/vir.0.016899-0; He YP, 2002, J VIROL, V76, P9207, DOI 10.1128/JVI.76.18.9207-9217.2002; Innocenti M, 2004, NAT CELL BIOL, V6, P319, DOI 10.1038/ncb1105; Innocenti M, 2003, J CELL BIOL, V160, P17, DOI 10.1083/jcb.200206079; Innocenti M, 2002, J CELL BIOL, V156, P125, DOI 10.1083/jcb.200108035; Jenei V, 2005, EXP CELL RES, V310, P463, DOI 10.1016/j.yexcr.2005.08.010; Kotula L, 2012, FEBS LETT, V586, P2790, DOI 10.1016/j.febslet.2012.05.015; Lanzetti L, 2000, NATURE, V408, P374, DOI 10.1038/35042605; Lim YS, 2011, J VIROL, V85, P8777, DOI 10.1128/JVI.02533-10; Macdonald A, 2005, J GEN VIROL, V86, P1027, DOI 10.1099/vir.0.80724-0; Macdonald A, 2003, J BIOL CHEM, V278, P17775, DOI 10.1074/jbc.M210900200; Mankouri J, 2008, TRAFFIC, V9, P1497, DOI 10.1111/j.1600-0854.2008.00779.x; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Ndjomou J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007498; Ngo HTT, 2013, J VIROL, V87, P5718, DOI 10.1128/JVI.03353-12; Nigg Erich A., 1993, Trends in Cell Biology, V3, P296, DOI 10.1016/0962-8924(93)90011-O; Park C, 2015, J VIROL, V89, P10073, DOI 10.1128/JVI.01707-15; Park CY, 2009, J HEPATOL, V51, P853, DOI 10.1016/j.jhep.2009.06.026; Penin F, 2004, J BIOL CHEM, V279, P40835, DOI 10.1074/jbc.M404761200; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; Tan SL, 1999, P NATL ACAD SCI USA, V96, P5533, DOI 10.1073/pnas.96.10.5533	29	8	9	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22607	22617		10.1074/jbc.M116.727081	http://dx.doi.org/10.1074/jbc.M116.727081			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27551040	hybrid, Green Published			2022-12-26	WOS:000386760600021
J	Slapsak, U; Salzano, G; Amin, L; Abskharon, RNN; Ilc, G; Zupancic, B; Biljan, I; Plavec, J; Giachin, G; Legname, G				Slapsak, Urska; Salzano, Giulia; Amin, Ladan; Abskharon, Romany N. N.; Ilc, Gregor; Zupancic, Blaz; Biljan, Ivana; Plavec, Janez; Giachin, Gabriele; Legname, Giuseppe			The N Terminus of the Prion Protein Mediates Functional Interactions with the Neuronal Cell Adhesion Molecule (NCAM) Fibronectin Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell adhesion; fibronectin; nuclear magnetic resonance (NMR); prion; protein-protein interaction; NCAM; NMR spectroscopy; prion protein; fibronectin type-3 domain; stimulated emission depletion microscopy; STED	COPPER-BINDING SITE; SYNAPTIC PLASTICITY; ALTERED FLEXIBILITY; STRUCTURAL BIOLOGY; NEURITE OUTGROWTH; SELF-RENEWAL; RECEPTOR; DIFFERENTIATION; PROLIFERATION; NEUROGENESIS	The cellular form of the prion protein (PrPC) is a highly conserved glycoprotein mostly expressed in the central and peripheral nervous systems by different cell types in mammals. A misfolded, pathogenic isoform, denoted as prion, is related to a class of neurodegenerative diseases known as transmissible spongiform encephalopathy. PrPC function has not been unequivocally clarified, and it is rather defined as a pleiotropic protein likely acting as a dynamic cell surface scaffolding protein for the assembly of different signaling modules. Among the variety of PrPC protein interactors, the neuronal cell adhesion molecule (NCAM) has been studied in vivo, but the structural basis of this functional interaction is still a matter of debate. Here we focused on the structural determinants responsible for human PrPC (HuPrP) and NCAM interaction using stimulated emission depletion (STED) nanoscopy, SPR, and NMR spectroscopy approaches. PrPC co-localizes with NCAM in mouse hippocampal neurons, and this interaction is mainly mediated by the intrinsically disordered PrPC N-terminal tail, which binds with high affinity to the NCAM fibronectin type-3 domain. NMR structural investigations revealed surface-interacting epitopes governing the interaction between HuPrP N terminus and the second module of the NCAM fibronectin type-3 domain. Our data provided molecular details about the interaction between HuPrP and the NCAM fibronectin domain, and revealed a new role of PrPC N terminus as a dynamic and functional element responsible for protein-protein interaction.	[Slapsak, Urska; Ilc, Gregor; Zupancic, Blaz; Plavec, Janez] Natl Inst Chem, Slovenian NMR Ctr, Hajdrihova 19, SI-1000 Ljubljana, Slovenia; [Salzano, Giulia; Amin, Ladan; Giachin, Gabriele; Legname, Giuseppe] SISSA, Dept Neurosci, Lab Prion Biol, Via Bonomea 265, I-34136 Trieste, Italy; [Abskharon, Romany N. N.] Vrije Univ Brussel VIB, Struct Biol Res Ctr, Pleinlaan 2, B-1050 Brussels, Belgium; [Ilc, Gregor; Plavec, Janez] EN FIST Ctr Excellence, Dunajska 156, SI-1000 Ljubljana, Slovenia; [Biljan, Ivana] Univ Zagreb, Fac Sci, Dept Chem, Horvatovac 102A, HR-10000 Zagreb, Croatia; [Plavec, Janez] Univ Ljubljana, Fac Chem & Chem Technol, Dept Chem & Biochem, Vecna Pot 113, SI-1000 Ljubljana, Slovenia; [Giachin, Gabriele] ESRF, Struct Biol Grp, 71 Ave Martyrs, F-38000 Grenoble, France; [Abskharon, Romany N. N.] NIOF, Cairo 11516, Egypt; [Abskharon, Romany N. N.] Van Andel Res Inst, Grand Rapids, MI 49503 USA	National Institute of Chemistry - Slovenia; International School for Advanced Studies (SISSA); Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; University of Zagreb; University of Ljubljana; European Synchrotron Radiation Facility (ESRF); Egyptian Knowledge Bank (EKB); National Institute of Oceanography & Fisheries (NIOF); Van Andel Institute	Plavec, J (corresponding author), Natl Inst Chem, Slovenian NMR Ctr, Hajdrihova 19, SI-1000 Ljubljana, Slovenia.; Legname, G (corresponding author), SISSA, Dept Neurosci, Lab Prion Biol, Via Bonomea 265, I-34136 Trieste, Italy.	janez.plavec@ki.si; legname@sissa.it	Salzano, Giulia/AAA-2705-2019; Giachin, Gabriele/AAE-2348-2020; Legname, Giuseppe/C-1723-2012	Giachin, Gabriele/0000-0001-7550-0307; Legname, Giuseppe/0000-0003-0716-4393; Biljan, Ivana/0000-0002-0650-1063; Salzano, Giulia/0000-0001-9770-794X	CERIC-ERIC	CERIC-ERIC	Access to NMR spectrometers was funded partially through CERIC-ERIC. We acknowledge Dr. Federico Carafoli (Imperial College London, London, UK) for providing the plasmid encoding for FNIII1,2 and Dr. Dan Cojoc (IOM-CNR, Trieste, Italy) for technical support. We are grateful to Jan Steyaert (VUB, Brussels, Belgium) for providing valuable information and suggestions.	Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; Amoureux MC, 2000, J NEUROSCI, V20, P3631, DOI 10.1523/JNEUROSCI.20-10-03631.2000; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Bodrikov V, 2005, J CELL BIOL, V168, P127, DOI 10.1083/jcb.200405073; Boutin C, 2009, EUR J NEUROSCI, V30, P1209, DOI 10.1111/j.1460-9568.2009.06928.x; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; Caiati MD, 2013, J NEUROSCI, V33, P2973, DOI 10.1523/JNEUROSCI.4149-12.2013; Carafoli F, 2008, J MOL BIOL, V377, P524, DOI 10.1016/j.jmb.2008.01.030; Cavanagh J., 1995, PROTEIN NMR SPECTROS; Colby DW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a006833; COLLINGE J, 1994, NATURE, V370, P295, DOI 10.1038/370295a0; Crossin KL, 2000, DEV DYNAM, V218, P260, DOI 10.1002/(SICI)1097-0177(200006)218:2<260::AID-DVDY3>3.0.CO;2-9; D'Angelo P, 2012, BIOCHEMISTRY-US, V51, P6068, DOI 10.1021/bi300233n; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Devanathan V, 2010, J NEUROSCI, V30, P9292, DOI 10.1523/JNEUROSCI.5657-09.2010; Doreleijers JF, 2012, J BIOMOL NMR, V54, P267, DOI 10.1007/s10858-012-9669-7; FREI T, 1992, J CELL BIOL, V118, P177, DOI 10.1083/jcb.118.1.177; Gasperini L, 2015, ANTIOXID REDOX SIGN, V22, P772, DOI 10.1089/ars.2014.6032; Gauczynski S, 2001, EMBO J, V20, P5863, DOI 10.1093/emboj/20.21.5863; Giachin G, 2015, SCI REP-UK, V5, DOI 10.1038/srep15253; Goddard D., 2008, SPARKY 3; Gottfert F, 2013, BIOPHYS J, V105, pL1, DOI 10.1016/j.bpj.2013.05.029; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hajj GNM, 2007, J CELL SCI, V120, P1915, DOI 10.1242/jcs.03459; Jacobsen J, 2008, NEUROCHEM RES, V33, P2532, DOI 10.1007/s11064-008-9680-2; Keller R., 2004, COMPUTER AIDED RESON, V1; Khosravani H, 2008, J CELL BIOL, V181, P551, DOI 10.1083/jcb.200711002; Kiselyov VV, 2005, J NEUROCHEM, V94, P1169, DOI 10.1111/j.1471-4159.2005.03284.x; Kiselyov VV, 2003, STRUCTURE, V11, P691, DOI 10.1016/S0969-2126(03)00096-0; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Kulahin N, 2011, FEBS LETT, V585, P58, DOI 10.1016/j.febslet.2010.11.043; Lee YJ, 2013, J NEUROCHEM, V124, P310, DOI 10.1111/j.1471-4159.2012.07913.x; Maglio LE, 2004, MOL BRAIN RES, V131, P58, DOI 10.1016/j.molbrainres.2004.08.004; Marianayagam NJ, 2004, TRENDS BIOCHEM SCI, V29, P618, DOI 10.1016/j.tibs.2004.09.006; McElroy C, 2002, J MOL BIOL, V323, P463, DOI 10.1016/S0022-2836(02)00940-3; Mehrabian M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133741; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Perrier V, 2004, J NEUROCHEM, V89, P454, DOI 10.1111/j.1471-4159.2004.02356.x; Prodromidou K, 2014, STEM CELLS, V32, P1674, DOI 10.1002/stem.1663; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Pushie MJ, 2011, METALLOMICS, V3, P206, DOI 10.1039/c0mt00037j; Requena JR, 2014, PRION, V8, P60, DOI 10.4161/pri.28368; Santos TG, 2011, STEM CELLS, V29, P1126, DOI 10.1002/stem.664; Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127; Schachner M, 1997, CURR OPIN CELL BIOL, V9, P627, DOI 10.1016/S0955-0674(97)80115-9; Schmitt-Ulms G, 2004, NAT BIOTECHNOL, V22, P724, DOI 10.1038/nbt969; Schmitt-Ulms G, 2001, J MOL BIOL, V314, P1209, DOI 10.1006/jmbi.2000.5183; Silva JL, 2011, METHODS, V53, P306, DOI 10.1016/j.ymeth.2010.12.002; Soroka V, 2003, STRUCTURE, V11, P1291, DOI 10.1016/j.str.2003.09.006; Soroka V, 2010, ADV EXP MED BIOL, V663, P3, DOI 10.1007/978-1-4419-1170-4_1; Steele AD, 2006, P NATL ACAD SCI USA, V103, P3416, DOI 10.1073/pnas.0511290103; Taubner LM, 2010, J MOL BIOL, V395, P475, DOI 10.1016/j.jmb.2009.10.075; Taylor DR, 2005, J CELL SCI, V118, P5141, DOI 10.1242/jcs.02627; Walmsley AR, 2003, J BIOL CHEM, V278, P37241, DOI 10.1074/jbc.M302036200; Wassenaar TA, 2012, J GRID COMPUT, V10, P743, DOI 10.1007/s10723-012-9246-z; Watts JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000608; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145	59	22	23	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					21857	21868		10.1074/jbc.M116.743435	http://dx.doi.org/10.1074/jbc.M116.743435			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27535221	Green Published, hybrid			2022-12-26	WOS:000386332600003
J	Nilsson, JA; Molokwu, MN; Olsson, O				Nilsson, Jan-Ake; Molokwu, Mary Ngozi; Olsson, Ola			Body Temperature Regulation in Hot Environments	PLOS ONE			English	Article							CLIMATE-CHANGE; ADAPTIVE THERMOREGULATION; AVIAN THERMOREGULATION; PHYSIOLOGICAL ECOLOGY; HEAT TOLERANCE; DESERT BIRDS; PATCH USE; HYPERTHERMIA; ENDOTHERMS; INCREASES	Organisms in hot environments will not be able to passively dissipate metabolically generated heat. Instead, they have to revert to evaporative cooling, a process that is energetically expensive and promotes excessive water loss. To alleviate these costs, birds in captivity let their body temperature increase, thereby entering a state of hyperthermia. Here we explore the use of hyperthermia in wild birds captured during the hot and dry season in central Nigeria. We found pronounced hyperthermia in several species with the highest body temperatures close to predicted lethal levels. Furthermore, birds let their body temperature increase in direct relation to ambient temperatures, increasing body temperature by 0.22 degrees C for each degree of increased ambient temperature. Thus to offset the costs of thermoregulation in ambient temperatures above the upper critical temperature, birds are willing to let their body temperatures increase by up to 5 degrees C above normal temperatures. This flexibility in body temperature may be an important mechanism for birds to adjust to predicted increasing ambient temperatures in the future.	[Nilsson, Jan-Ake; Olsson, Ola] Lund Univ, Dept Biol, SE-22362 Lund, Sweden; [Molokwu, Mary Ngozi] Fauna & Flora Int, Monrovia 1000 10, Liberia; [Molokwu, Mary Ngozi] AP Leventis Ornithol Res Inst, POB 13404, Jos, Nigeria	Lund University	Nilsson, JA (corresponding author), Lund Univ, Dept Biol, SE-22362 Lund, Sweden.	jan-ake.nilsson@biol.lu.se		Olsson, Ola/0000-0003-0789-1064	Swedish Research Council [621-2006-2858]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by Swedish Research Council 621-2006-2858 (JAN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams NJ, 1999, J COMP PHYSIOL B, V169, P195, DOI 10.1007/s003600050211; Araujo MB, 2013, ECOL LETT, V16, P1206, DOI 10.1111/ele.12155; BORROW N, 2004, BIRDS W AFRICA; Boyles JG, 2011, INTEGR COMP BIOL, V51, P676, DOI 10.1093/icb/icr053; Bozinovic F, 2015, ECOL EVOL, V5, P1025, DOI 10.1002/ece3.1403; Cabanac AJ, 2001, PHYSIOL BEHAV, V74, P475, DOI 10.1016/S0031-9384(01)00586-8; Cabanac M, 2000, PHYSIOL BEHAV, V69, P541, DOI 10.1016/S0031-9384(00)00227-4; Daniel RM, 2010, BIOCHEM J, V425, P353, DOI 10.1042/BJ20091254; Dawson W. R., 1964, HDB PHYSL ADAPTATION, P81; Del Vesco AP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115821; du Plessis KL, 2012, GLOBAL CHANGE BIOL, V18, P3063, DOI 10.1111/j.1365-2486.2012.02778.x; Eduardo J, 2010, ECOLOGICAL ENV PHYSL, P134; HIRTH KD, 1987, J COMP PHYSIOL B, V157, P111, DOI 10.1007/BF00702735; Khaliq I, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1097; LASIEWSKI RC, 1966, CONDOR, V68, P253, DOI 10.2307/1365559; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Hai L, 2006, COMP BIOCHEM PHYS A, V144, P11, DOI 10.1016/j.cbpa.2006.01.032; McKechnie AE, 2010, BIOL LETTERS, V6, P253, DOI 10.1098/rsbl.2009.0702; Molokwu MN, 2008, OIKOS, V117, P892, DOI 10.1111/j.2008.0030-1299.16549.x; Molokwu MN, 2010, OECOLOGIA, V164, P637, DOI 10.1007/s00442-010-1781-3; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; PRINZINGER R, 1991, COMP BIOCHEM PHYS A, V99, P499, DOI 10.1016/0300-9629(91)90122-S; Skold-Chiriac S, 2015, J EXP BIOL, V218, P2961, DOI 10.1242/jeb.122150; Smit B, 2013, ECOLOGY, V94, P1142, DOI 10.1890/12-1511.1; Smith EK, 2015, J EXP BIOL, V218, P3636, DOI 10.1242/jeb.128645; Sparks TH, 2009, CLIM RES, V39, P191, DOI 10.3354/cr00814; Speakman JR, 2010, J ANIM ECOL, V79, P726, DOI 10.1111/j.1365-2656.2010.01689.x; Thompson LJ, 2015, J EXP BIOL, V218, P1504, DOI 10.1242/jeb.116509; Tieleman BI, 1999, PHYSIOL BIOCHEM ZOOL, V72, P87, DOI 10.1086/316640; WEATHERS WW, 1981, PHYSIOL ZOOL, V54, P345, DOI 10.1086/physzool.54.3.30159949; Whitfield MC, 2015, J EXP BIOL, V218, P1705, DOI 10.1242/jeb.121749; Williams JB, 2001, CURR ORNITHOL, V16, P299	32	34	36	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161481	10.1371/journal.pone.0161481	http://dx.doi.org/10.1371/journal.pone.0161481			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548758	Green Published, Green Submitted, gold			2022-12-26	WOS:000381768400062
J	Zaman, A; Ali, N; Sajid, M; Hayat, T				Zaman, Akbar; Ali, Nasir; Sajid, M.; Hayat, Tasawar			Numerical and Analytical Study of Two-Layered Unsteady Blood Flow through Catheterized Artery	PLOS ONE			English	Article							PERIODIC BODY ACCELERATION; PULSATILE FLOW; STENOSED ARTERY; MAGNETIC-FIELD; FLUID-FLOW; MODEL; VISCOSITY; VISCOELASTICITY; RESISTANCE; TUBES	The pulsatile flow of blood in a catheterized blood vessel is analyzed. The flow of blood in vessel is modeled as the flow of two immiscible fluids. The fluid in the core region is characterized as a non-Newtonian viscoelastic fluid satisfying the constitutive equation of an Oldroyd-B fluid. The fluid in the peripheral region is treated as a Newtonian fluid. The catheter inside the vessel is modeled as a rigid tube of very small radius. The resulting differential system for velocity in each region is computed numerically by finite-difference scheme and analytically by Laplace transform. A comparison of numerical solution with Laplace transform solution is carried out. Various physical quantities of interest through the computed velocity are also analyzed.	[Zaman, Akbar; Ali, Nasir; Sajid, M.] Int Islamic Univ, Fac Basic & Appl Sci, Dept Math & Stat, Islamabad 44000, Pakistan; [Hayat, Tasawar] Quaid I Azam Univ, Dept Math, Islamabad 4400, Pakistan; [Hayat, Tasawar] King Abdulaziz Univ, Dept Math, Nonlinear Anal & Appl Math NAAM Res Grp, Fac Sci, Jeddah 21589, Saudi Arabia	International Islamic University, Pakistan; King Abdulaziz University	Zaman, A (corresponding author), Int Islamic Univ, Fac Basic & Appl Sci, Dept Math & Stat, Islamabad 44000, Pakistan.	akbarzaman75@yahoo.com	Hayat, Tasawar/Y-2524-2019; Ali, Nasir/ABB-1446-2021					Abdullah I, 2011, INT J NUMER METH FL, V67, P1624, DOI 10.1002/fld.2436; AKAY G, 1985, INT J ENG SCI, V23, P265, DOI 10.1016/0020-7225(85)90047-3; [Anonymous], [No title captured]; BACK LH, 1994, J BIOMECH, V27, P169, DOI 10.1016/0021-9290(94)90205-4; BUGLIARELLO G, 1970, Biorheology, V7, P85; Burton A. C., 1966, INTRO TEXT YB; Canic S, 2006, SIAM J APPL MATH, V67, P164, DOI 10.1137/060651562; CHATURANI P, 1990, BIORHEOLOGY, V27, P747; CHATURANI P, 1991, INT J ENG SCI, V29, P113, DOI 10.1016/0020-7225(91)90081-D; CHIEN S, 1975, BIORHEOLOGY, V12, P341; Dash RK, 1996, J BIOMECH, V29, P917, DOI 10.1016/0021-9290(95)00153-0; Dash RK, 1999, J BIOMECH, V32, P49, DOI 10.1016/S0021-9290(98)00142-0; Fung YC, 1997, BIOMECHANICS CIRCULA, P571; Hoffmann K. A., 2000, COMPUTATIONAL FLUID, V1, P67208; Ikbal MA, 2009, J COMPUT APPL MATH, V230, P243, DOI 10.1016/j.cam.2008.11.010; JAYARAMAN G, 1995, MED BIOL ENG COMPUT, V33, P720, DOI 10.1007/BF02510793; KARAHALIOS GT, 1990, MED PHYS, V17, P922, DOI 10.1118/1.596448; MACDONALD DA, 1986, J BIOMECH, V19, P239, DOI 10.1016/0021-9290(86)90156-9; MAJHI SN, 1994, INT J ENG SCI, V32, P839, DOI 10.1016/0020-7225(94)90064-7; Mandal PK, 2005, INT J NONLIN MECH, V40, P151, DOI 10.1016/j.ijnonlinmec.2004.07.007; Massoudi M, 2008, COMPUT MATH APPL, V56, P199, DOI 10.1016/j.camwa.2007.07.018; Mekheimer KS, 2008, APPL MATH MECH-ENGL, V29, P1093, DOI 10.1007/s10483-008-0813-x; Mustapha N., 2009, NUM METH PARTIAL DIF, V27, P960; Mustapha N, 2009, COMPUT BIOL MED, V39, P896, DOI 10.1016/j.compbiomed.2009.07.004; Mustapha N, 2008, J MECH MED BIOL, V8, P395, DOI 10.1142/S0219519408002723; Muthu P, 2008, J MECH MED BIOL, V8, P561, DOI 10.1142/S0219519408002541; PRALHAD RN, 1988, BIORHEOLOGY, V25, P715; Reddy JVR, 2014, EUR J MECH B-FLUID, V48, P236, DOI 10.1016/j.euromechflu.2014.07.001; Sajid M, 2015, INT J NONLIN SCI NUM, V16, P197, DOI 10.1515/ijnsns-2013-0133; Sankar DS, 2007, APPL MATH MODEL, V31, P1847, DOI 10.1016/j.apm.2006.06.009; Sankar DS, 2007, APPL MATH MODEL, V31, P1497, DOI 10.1016/j.apm.2006.04.012; Sarkar A, 1998, J BIOMECH, V31, P781, DOI 10.1016/S0021-9290(98)00053-0; Shahed SR, 2014, PROCEDIA ENGINEER, V90, P339, DOI 10.1016/j.proeng.2014.11.859; SHUKLA JB, 1980, B MATH BIOL, V42, P797, DOI 10.1016/S0092-8240(80)80003-6; Srivastava VP, 2010, COMPUT MATH APPL, V59, P1377, DOI 10.1016/j.camwa.2009.12.007; SRIVASTAVA VP, 1994, J BIOMECH, V27, P921, DOI 10.1016/0021-9290(94)90264-X; Thurston G. B., 1992, THEORETICAL APPL RHE, V112, P17; THURSTON GB, 1979, BIORHEOLOGY, V16, P149; THURSTON GB, 1972, BIOPHYS J, V12, P1205, DOI 10.1016/S0006-3495(72)86156-3; Yeleswarapu K, 1996, THESIS; Yeleswarapu KK, 1998, MECH RES COMMUN, V25, P257, DOI 10.1016/S0093-6413(98)00036-6; Yilmaz F, 2008, KOREA-AUST RHEOL J, V20, P197	42	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161377	10.1371/journal.pone.0161377	http://dx.doi.org/10.1371/journal.pone.0161377			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548476	Green Submitted, Green Published, gold			2022-12-26	WOS:000381768400050
J	Coronado, LM; Montealegre, S; Chaverra, Z; Mojica, L; Espinosa, C; Almanza, A; Correa, R; Stoute, JA; Gittens, RA; Spadafora, C				Coronado, Lorena M.; Montealegre, Stephania; Chaverra, Zumara; Mojica, Luis; Espinosa, Carlos; Almanza, Alejandro; Correa, Ricardo; Stoute, Jose A.; Gittens, Rolando A.; Spadafora, Carmenza			Blood Stage Plasmodium falciparum Exhibits Biological Responses to Direct Current Electric Fields	PLOS ONE			English	Article							CHLOROQUINE RESISTANCE; PARASITES; BONE; TRANSPORT; REVERSAL	The development of resistance to insecticides by the vector of malaria and the increasingly faster appearance of resistance to antimalarial drugs by the parasite can dangerously hamper efforts to control and eradicate the disease. Alternative ways to treat this disease are urgently needed. Here we evaluate the in vitro effect of direct current (DC) capacitive coupling electrical stimulation on the biology and viability of Plasmodium falciparum. We designed a system that exposes infected erythrocytes to different capacitively coupled electric fields in order to evaluate their effect on P. falciparum. The effect on growth of the parasite, replication of DNA, mitochondrial membrane potential and level of reactive oxygen species after exposure to electric fields demonstrate that the parasite is biologically able to respond to stimuli from DC electric fields involving calcium signaling pathways.	[Coronado, Lorena M.; Almanza, Alejandro; Correa, Ricardo; Spadafora, Carmenza] City Knowledge, Inst Invest Cient & Serv Alta Tecnol INDICASAT AI, Ctr Cellular & Mol Biol Dis CBCMe, Clayton, Ancon, Panama; [Coronado, Lorena M.; Correa, Ricardo] Acharya Nagarjuna Univ, Dept Biotechnol, Guntur 522510, Andhra Pradesh, India; [Montealegre, Stephania; Chaverra, Zumara] Univ Latina, Sch Biotechnol, Fac Ciencias Salud William C Gorgas, Panama City, Panama; [Mojica, Luis; Espinosa, Carlos] City Knowledge, Natl Ctr Metrol Panama CENAMEP AIP, Clayton, Ancon, Panama; [Stoute, Jose A.] Penn State Univ, Dept Med, Div Infect Dis & Epidemiol, Coll Med, Hershey, PA USA; [Gittens, Rolando A.] City Knowledge, INDICASAT AIP, CBDD, Clayton, Ancon, Panama	Instituto de Investigacion Cientificas y Servicios de Alta Tecnologia (INDICASAT-AIP); Acharya Nagarjuna University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Instituto de Investigacion Cientificas y Servicios de Alta Tecnologia (INDICASAT-AIP)	Spadafora, C (corresponding author), City Knowledge, Inst Invest Cient & Serv Alta Tecnol INDICASAT AI, Ctr Cellular & Mol Biol Dis CBCMe, Clayton, Ancon, Panama.	cspadafora@indicasat.org.pa	Spadafora, Carmenza/ABE-8973-2020	Spadafora, Carmenza/0000-0002-3002-9467; Mojica Ovalle, Luis/0000-0001-5594-9166; Gittens, Rolando A./0000-0002-0286-3956; Correa, Ricardo/0000-0001-5475-5407; Coronado, Lorena/0000-0001-6755-3118	Bill & Melinda Gates Foundation, Seattle, WA [51797]; Secretaria Nacional de Ciencia, Tecnologia e Innovacion, Panama; National System of Investigators, Panama [38-2014, 91-2015]	Bill & Melinda Gates Foundation, Seattle, WA(Bill & Melinda Gates Foundation); Secretaria Nacional de Ciencia, Tecnologia e Innovacion, Panama; National System of Investigators, Panama	This work was supported by the Bill & Melinda Gates Foundation, Seattle, WA, www.gatesfoundation.org [grant number 51797] to CS and JAS; the Secretaria Nacional de Ciencia, Tecnologia e Innovacion, Panama, www.senacyt.gob.pa [Ph.D. scholarships] to LMC and RC; and National System of Investigators, Panama, www.senacyt.gob.pa [grant numbers 38-2014, 91-2015] to CS and RG.	Almanza A., 2011, Current Trends in Biotechnology and Pharmacy, V5, P1130; [Anonymous], 2008, MOL MECH PARASITE IN; Asadi MR, 2014, ADV WOUND CARE, V3, P91, DOI 10.1089/wound.2012.0410; ATAMNA H, 1993, MOL BIOCHEM PARASIT, V61, P231, DOI 10.1016/0166-6851(93)90069-A; Bacarin CC, 2015, CNS NEUROL DISORD-DR, V14, P400, DOI 10.2174/1871527314666150225125232; BASSETT CAL, 1962, SCIENCE, V137, P1063, DOI 10.1126/science.137.3535.1063; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Brighton CT, 2001, J BONE JOINT SURG AM, V83A, P1514, DOI 10.2106/00004623-200110000-00009; Cakmak AS, 2016, TURK J BIOL, V40, P462, DOI 10.3906/biy-1505-114; Corbett Y, 2004, AM J TROP MED HYG, V70, P119, DOI 10.4269/ajtmh.2004.70.119; Draz EI, 2015, PHARMACOL REP, V67, P317, DOI 10.1016/j.pharep.2014.10.007; FUKADA E, 1957, J PHYS SOC JPN, V12, P1158, DOI 10.1143/JPSJ.12.1158; Gan JC, 2006, EUR SPINE J, V15, P1301, DOI 10.1007/s00586-006-0087-y; Gittens RA, 2011, J DENT RES, V90, P1389, DOI 10.1177/0022034511408428; Gittens RA, 2013, BIOELECTROMAGNETICS, V34, P599, DOI 10.1002/bem.21810; Golberg A, 2013, BIOTECHNOL BIOENG, V110, P1759, DOI 10.1002/bit.24831; Gopalakrishnan AM, 2015, ANTIMICROB AGENTS CH, V59, P317, DOI 10.1128/AAC.03663-14; HAYNES JD, 1976, NATURE, V263, P767, DOI 10.1038/263767a0; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Jakubowski W, 2000, CELL BIOL INT, V24, P757, DOI 10.1006/cbir.2000.0556; Keitany GJ, 2014, HUM VACC IMMUNOTHER, V10, P2903, DOI 10.4161/21645515.2014.972764; Khan SI, 2016, BIOTECHNOL BIOENG, V113, P643, DOI 10.1002/bit.25818; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; MARTIN SK, 1987, SCIENCE, V235, P899, DOI 10.1126/science.3544220; MARTINEY JA, 1995, J BIOL CHEM, V270, P22393, DOI 10.1074/jbc.270.38.22393; McCaig CD, 2005, PHYSIOL REV, V85, P943, DOI 10.1152/physrev.00020.2004; Nelson FRT, J AM ACAD ORTHOP SUR, V11, P344; Nuccitelli R, 2003, CURR TOP DEV BIOL, V58, P1, DOI 10.1016/S0070-2153(03)58001-2; Pak O, 2013, AM J RESP CELL MOL, V49, P358, DOI 10.1165/rcmb.2012-0361OC; Prole DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026218; Rotmann A, 2010, MOL MICROBIOL, V76, P1591, DOI 10.1111/j.1365-2958.2010.07187.x; Shanks GD, 2015, T ROY SOC TROP MED H, V109, P182, DOI 10.1093/trstmh/tru199; TANABE K, 1982, J CELL BIOL, V93, P680, DOI 10.1083/jcb.93.3.680; Titushkin IA, 2009, IEEE ENG MED BIO, P2090, DOI 10.1109/IEMBS.2009.5333949; van Schalkwyk DA, 2016, J INFECT DIS, V213, P800, DOI 10.1093/infdis/jiv509; *WHO, 2013, WORLD MAL REP 2014 W; Williams GSB, 2013, P NATL ACAD SCI USA, V110, P10479, DOI 10.1073/pnas.1300410110; Zangeneh M, 2015, RADIAT ENVIRON BIOPH, V54, P175, DOI 10.1007/s00411-015-0586-5; Zhao HP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129625	39	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161207	10.1371/journal.pone.0161207	http://dx.doi.org/10.1371/journal.pone.0161207			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537497	Green Published, Green Submitted, gold			2022-12-26	WOS:000381577000067
J	Maina, AN; Fogarty, C; Krueger, L; Macaluso, KR; Odhiambo, A; Nguyen, K; Farris, CM; Luce-Fedrow, A; Bennett, S; Jiang, J; Sun, S; Cummings, RF; Richards, AL				Maina, Alice N.; Fogarty, Carrie; Krueger, Laura; Macaluso, Kevin R.; Odhiambo, Antony; Kiet Nguyen; Farris, Christina M.; Luce-Fedrow, Alison; Bennett, Stephen; Jiang, Ju; Sun, Sokanary; Cummings, Robert F.; Richards, Allen L.			Rickettsial Infections among Ctenocephalides felis and Host Animals during a Flea-Borne Rickettsioses Outbreak in Orange County, California	PLOS ONE			English	Article							LOS-ANGELES-COUNTY; MURINE TYPHUS; XENOPSYLLA-CHEOPIS; CAT FLEAS; ENDEMIC TYPHUS; IDENTIFICATION; BARTONELLA; TRANSMISSION; SIPHONAPTERA; ASSOCIATION	Due to a resurgence of flea-borne rickettsioses in Orange County, California, we investigated the etiologies of rickettsial infections of Ctenocephalides felis, the predominant fleas species obtained from opossums (Didelphis virginiana) and domestic cats (Felis catus), collected from case exposure sites and other areas in Orange County. In addition, we assessed the prevalence of IgG antibodies against spotted fever group (SFGR) and typhus group (TGR) rickettsiae in opossum sera. Of the 597 flea specimens collected from opossums and cats, 37.2% tested positive for Rickettsia. PCR and sequencing of rickettsial genes obtained from C. felis flea DNA preparations revealed the presence of R. typhi (1.3%), R. felis (28.0%) and R. felislike organisms (7.5%). Sera from opossums contained TGR-specific (40.84%), but not SFGR-specific antibodies. The detection of R. felis and R. typhi in the C. felis fleas in Orange County highlights the potential risk for human infection with either of these pathogens, and underscores the need for further investigations incorporating specimens from humans, animal hosts, and invertebrate vectors in endemic areas. Such studies will be essential for establishing a link in the ongoing flea-borne rickettsioses outbreaks.	[Maina, Alice N.; Odhiambo, Antony; Farris, Christina M.; Luce-Fedrow, Alison; Jiang, Ju; Richards, Allen L.] Naval Med Res Ctr, Silver Spring, MD 20910 USA; [Fogarty, Carrie; Krueger, Laura; Kiet Nguyen; Bennett, Stephen; Cummings, Robert F.] Orange Cty Mosquito & Vector Control Dist, Garden Grove, CA USA; [Macaluso, Kevin R.] Louisiana State Univ, Baton Rouge, LA 70803 USA; [Luce-Fedrow, Alison] Shippensburg Univ, Shippensburg, PA 17257 USA; [Sun, Sokanary] West Valley Mosquito & Vector Control Dist, Ontario, CA USA	Naval Medical Research Center (NMRC); Louisiana State University System; Louisiana State University; Pennsylvania State System of Higher Education (PASSHE); Shippensburg University of Pennsylvania	Maina, AN (corresponding author), Naval Med Res Ctr, Silver Spring, MD 20910 USA.	alice.n.maina.ctr@mail.mil		Farris, Christina/0000-0002-4004-410X	Global Emerging Infections Surveillance and Response System, a Division of the Armed Forces Health Surveillance Center [847705.82000.25GB.A0074]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI122672] Funding Source: NIH RePORTER	Global Emerging Infections Surveillance and Response System, a Division of the Armed Forces Health Surveillance Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Global Emerging Infections Surveillance and Response System, a Division of the Armed Forces Health Surveillance Center, work unit number 847705.82000.25GB.A0074 (https://www.afhsc.mil/Home/Sections/GEIS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdad Mohammad Yazid, 2011, Emerg Health Threats J, V4, P7168, DOI 10.3402/ehtj.v4i0.7168; Abramowicz KF, 2012, MED VET ENTOMOL, V26, P458, DOI 10.1111/j.1365-2915.2012.01017.x; Abramowicz KF, 2011, VECTOR-BORNE ZOONOT, V11, P979, DOI 10.1089/vbz.2010.0117; ADAMS JR, 1990, AM J TROP MED HYG, V43, P400, DOI 10.4269/ajtmh.1990.43.400; ADAMS WH, 1970, AM J TROP MED HYG, V19, P311, DOI 10.4269/ajtmh.1970.19.311; Adjemian J, 2010, EMERG INFECT DIS, V16, P412, DOI 10.3201/eid1603.091028; American Veterinary Medical Association (AVMA), 2013, AVMA GUID EUTH AN 20; Azad AF, 1997, EMERG INFECT DIS, V3, P319, DOI 10.3201/eid0303.970308; Billeter SA, 2016, VECTOR-BORNE ZOONOT, V16, P151, DOI 10.1089/vbz.2015.1869; Boostrom A, 2002, EMERG INFECT DIS, V8, P549, DOI 10.3201/eid0806.010350; Borchert JN, 2012, J MED ENTOMOL, V49, P210, DOI 10.1603/ME11045; CDPH, 1950, TYPH FEV CAL 1916 19; CDPH-VBDS, 2008, CDPH VBDS 2007 ANN R; CDPH-VBDS, 2014, CDPH VBDS 2013 ANN R; Christou C, 2010, AM J TROP MED HYG, V83, P1301, DOI 10.4269/ajtmh.2010.10-0118; Civen R, 2008, CLIN INFECT DIS, V46, P913, DOI 10.1086/527443; Eremeeva ME, 2008, EMERG INFECT DIS, V14, P1613, DOI 10.3201/eid1410.080571; Eremeeva ME, 2012, J MED ENTOMOL, V49, P1485, DOI 10.1603/ME11291; Fang R, 2003, CLIN DIAGN LAB IMMUN, V10, P221, DOI 10.1128/CDLI.10.2.221-228.2003; Graf PCF, 2008, CLIN INFECT DIS, V46, P70, DOI 10.1086/524018; Green JS, 2011, PEDIATR INFECT DIS J, V30, P163, DOI 10.1097/INF.0b013e3181f4cc25; Henry KM, 2007, MOL CELL PROBE, V21, P17, DOI 10.1016/j.mcp.2006.06.002; Hirunkanokpun S, 2011, MOL ECOL, V20, P4577, DOI 10.1111/j.1365-294X.2011.05289.x; Horta MC, 2010, VECTOR-BORNE ZOONOT, V10, P959, DOI 10.1089/vbz.2009.0149; Houhamdi L, 2003, ANN NY ACAD SCI, V990, P617, DOI 10.1111/j.1749-6632.2003.tb07436.x; Irons J. V., 1944, AMER JOUR TROP MED, V24, P359; Jiang J, 2006, EMERG INFECT DIS, V12, P1281, DOI 10.3201/eid1708.060327; Jiang J, 2013, VECTOR-BORNE ZOONOT, V13, P550, DOI 10.1089/vbz.2012.1123; Jiang J, 2012, VECTOR-BORNE ZOONOT, V12, P175, DOI 10.1089/vbz.2011.0614; Jima DD, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00018-15; Karpathy SE, 2009, CLIN MICROBIOL INFEC, V15, P218, DOI 10.1111/j.1469-0691.2008.02140.x; Leulmi H, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003152; Mediannikov O., 2015, New Microbes and New Infections, V3, P24, DOI 10.1016/j.nmni.2014.10.005; Meleney H E, 1945, Cal West Med, V62, P116; Nogueras MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071386; Noden BH, 1998, J MED ENTOMOL, V35, P410, DOI 10.1093/jmedent/35.4.410; Odhiambo AM, 2014, VECTOR-BORNE ZOONOT, V14, P476, DOI 10.1089/vbz.2013.1518; Oteo JA, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0455-0; Parola P, 2011, CLIN MICROBIOL INFEC, V17, P996, DOI 10.1111/j.1469-0691.2011.03516.x; Parola P, 2003, ANN NY ACAD SCI, V990, P173, DOI 10.1111/j.1749-6632.2003.tb07359.x; Reeves WK, 2005, J VECTOR ECOL, V30, P310; Reif KE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002805; SCHRIEFER ME, 1994, J CLIN MICROBIOL, V32, P949, DOI 10.1128/JCM.32.4.949-954.1994; SORVILLO FJ, 1993, AM J TROP MED HYG, V48, P269, DOI 10.4269/ajtmh.1993.48.269; Sunyakumthorn P, 2008, APPL ENVIRON MICROB, V74, P3151, DOI 10.1128/AEM.00025-08; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tay ST, 2015, EMERG INFECT DIS, V21, P545, DOI 10.3201/eid2103.141457; WILLIAMS SG, 1992, J CLIN MICROBIOL, V30, P1758, DOI 10.1128/JCM.30.7.1758-1762.1992; Znazen A, 2006, EMERG INFECT DIS, V12, P138, DOI 10.3201/eid1201.050876	49	47	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0160604	10.1371/journal.pone.0160604	http://dx.doi.org/10.1371/journal.pone.0160604			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537367	Green Published, gold, Green Submitted			2022-12-26	WOS:000381577000026
J	Salem, J; Borgmann, H; Bultitude, M; Fritsche, HM; Haferkamp, A; Heidenreich, A; Miernik, A; Neisius, A; Knoll, T; Thomas, C; Tsaur, I				Salem, Johannes; Borgmann, Hendrik; Bultitude, Matthew; Fritsche, Hans-Martin; Haferkamp, Axel; Heidenreich, Axel; Miernik, Arkadiusz; Neisius, Andreas; Knoll, Thomas; Thomas, Christian; Tsaur, Igor			Online Discussion on #KidneyStones: A Longitudinal Assessment of Activity, Users and Content	PLOS ONE			English	Article							SOCIAL MEDIA; CALCIUM NEPHROLITHIASIS; RECURRENCE RATE; RISK-FACTORS; STONE; UROLITHIASIS; PROPHYLAXIS; PREVALENCE; OBESITY; CALCULI	Introduction Twitter is a popular microblogging platform for the rapid dissemination of information and reciprocal exchange in the urological field. We aimed to assess the activity, users and content of the online discussion, #KidneyStones, on Twitter. Methods We investigated the Symplur Signals analytics tool for Twitter data distributed via the #KidneyStones hashtag over a one year period. Activity analysis reflected overall activity and tweet enhancements. We assessed users' geolocations and performed an influencer analysis. Content analysis included the most frequently used words, tweet sentiment and shares for top tweets. Results 3,426 users generated over 10,333 tweets, which were frequently accompanied by links (49%), mentions (30%) and photos (13%). Users came from 106 countries across the globe and were most frequently from North America (63%) and Europe (16%). Individual and organisational healthcare professionals made up 56% of the influencers of the Twitter discussion on #KidneyStones. Besides the words 'kidney' (used 4,045 times) and 'stones' (3,335), 'pain' (1,233), 'urine' (1,158), and 'risk' (1,023) were the most frequently used words. 56% of tweets had a positive sentiment. The median (range) number of shares was 85 (62-587) for the top 10 links, 45.5 (17-94) for the top 10 photos, and 44 (22-95) for the top 10 retweets. Conclusion The rapidly growing Twitter discussion on #KidneyStones engaged multiple stakeholders in the healthcare sector on a global scale and reached both professionals and laypeople. When used effectively and responsibly, the Twitter platform could improve prevention and medical care of kidney stone patients.	[Salem, Johannes; Heidenreich, Axel] Univ Hosp, Dept Urol, Cologne, Germany; [Borgmann, Hendrik; Haferkamp, Axel; Neisius, Andreas; Thomas, Christian; Tsaur, Igor] Univ Med, Dept Urol, Mainz, Germany; [Bultitude, Matthew] Guys & St Thomas NHS Fdn Trust, Stone Unit, London, England; [Fritsche, Hans-Martin] Univ Regensburg, Caritas St Josef Hosp, Dept Urol, Regensburg, Germany; [Miernik, Arkadiusz] Univ Med Ctr, Dept Urol, Freiburg, Germany; [Knoll, Thomas] Klinikum Sindelfingen Boblingen, Dept Urol, Sindelfingen, Germany	University of Cologne; Guy's & St Thomas' NHS Foundation Trust; University of Regensburg; University of Freiburg	Salem, J (corresponding author), Univ Hosp, Dept Urol, Cologne, Germany.	j.salem@gesru.de	Miernik, Arkadiusz/AAF-1226-2020; Tsaur, Igor/ACG-6445-2022; Borgmann, Hendrik/F-4658-2015	Tsaur, Igor/0000-0001-5107-3523; Borgmann, Hendrik/0000-0002-3955-564X; Salem, Johannes/0000-0002-0528-9291				Antonelli JA, 2014, EUR UROL, V66, P724, DOI 10.1016/j.eururo.2014.06.036; Attai DJ, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4721; BARCELO P, 1993, J UROLOGY, V150, P1761, DOI 10.1016/S0022-5347(17)35888-3; Borghi L, 1996, J UROLOGY, V155, P839, DOI 10.1016/S0022-5347(01)66321-3; Borgmann HD, 2015, CUAJ, V9; Borgmann H, 2016, UROL ONCOL-SEMIN ORI, V34, P377, DOI 10.1016/j.urolonc.2016.02.021; Canvasser NE, 2015, J ENDOUROL, V29, P615, DOI 10.1089/end.2014.0329; Cardona-Grau D SI, 2016, EUR UROL FO IN PRESS, P138; Chung A, 2016, ANZ J SURG, V86, P224, DOI 10.1111/ans.13393; Dauw CA, 2016, J UROLOGY, V195, P648, DOI 10.1016/j.juro.2015.10.082; Dauw CA, 2015, J UROLOGY, V193, P885, DOI 10.1016/j.juro.2014.09.111; Davies N, 2015, BJU INT, V116, P984, DOI 10.1111/bju.13159; ETTINGER B, 1986, NEW ENGL J MED, V315, P1386, DOI 10.1056/NEJM198611273152204; Kocvara R, 1999, BJU INT, V84, P393; Kutikov A, 2016, EUR UROL, V69, P183, DOI 10.1016/j.eururo.2015.09.034; LAERUM E, 1984, ACTA MED SCAND, V215, P383; Leveridge MJ, 2016, WORLD J UROL, V34, P57, DOI 10.1007/s00345-015-1725-y; Loeb S, 2014, BJU INT, V113, P993, DOI 10.1111/bju.12586; Lotan Y, 2012, BJU INT, V110, pE1060, DOI 10.1111/j.1464-410X.2012.11212.x; Robillard JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069861; Scales CD, 2012, EUR UROL, V62, P160, DOI 10.1016/j.eururo.2012.03.052; Siener R, 2004, OBES RES, V12, P106, DOI 10.1038/oby.2004.14; Signals S., HEALTHC CAT DEF; Sun BYC, 1996, J UROLOGY, V156, P903, DOI 10.1016/S0022-5347(01)65657-X; Symplur, HEALTHC HASHT PROJ; Tasian GE, 2016, CLIN J AM SOC NEPHRO, V11, P488, DOI 10.2215/CJN.07610715; Thackeray R, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.3002; Thangasamy IA, 2014, EUR UROL, V66, P112, DOI 10.1016/j.eururo.2014.01.034; Trinchieri A, 1999, J UROLOGY, V162, P27, DOI 10.1097/00005392-199907000-00007; Weeg Christopher, 2015, JMIR Public Health Surveill, V1, pe6, DOI 10.2196/publichealth.3953	30	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0160863	10.1371/journal.pone.0160863	http://dx.doi.org/10.1371/journal.pone.0160863			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537406	Green Submitted, Green Published, gold			2022-12-26	WOS:000381577000037
J	Venkatesh, J; Jahn, M; Kang, BC				Venkatesh, Jelli; Jahn, Molly; Kang, Byoung-Cheorl			Genome-Wide Analysis and Evolution of the Pto-Like Protein Kinase (PLPK) Gene Family in Pepper	PLOS ONE			English	Article							DISEASE RESISTANCE GENE; BACTERIAL SPECK DISEASE; AVIRULENCE GENE; SUBCELLULAR-LOCALIZATION; RECOGNITION SPECIFICITY; PHYLOGENETIC ANALYSIS; FUNCTIONAL-ANALYSIS; TOMATO CULTIVARS; MOLECULAR-BASIS; AVRPTO	The tomato Pto gene, which encodes a serine/threonine kinase (STK) domain-containing protein, confers resistance to bacterial speck disease caused by Pseudomonas syringae pv. tomato (Pst). In this study, in vivo recognition assays using PVX constructs showed that AvrPto was specifically recognized in the pepper genotypes. This AvrPto recognition caused a nonhost hypersensitive response (HR) and localization of the PVX::AvrPto fusion protein to inoculated pepper leaf tissues, which indicates the presence of a similar Pto recognition mechanism in pepper as in tomato. However, genome-wide analysis in pepper revealed no Pto clade corresponding to that in tomato, suggesting an alternative system for Pto recognition in pepper. Nevertheless, 25 Pto-like protein kinases (PLPKs) with a highly conserved STK domain have been identified in the pepper genome. For the majority of the amino acid sites in the STK domain of Ptos and PLPKs, nonsynonymous (dN) to synonymous (dS) nucleotide substitution ratios (omega) were less than one, suggesting that purifying selection played a predominant role in the evolutionary process. However, some amino acid sites were found to be subjected to episodic positive selection in the course of evolution of Pto homologs, and, thus, different evolutionary processes might have shaped the Pto gene family in plants. Based on RNA-seq data, PLPK genes and other Pto pathway genes, such as Prf, Pti1, Pti5, and Pti6 were expressed in all tested pepper genotypes. Therefore, the nonhost HR against Pst in pepper may be due to the recognition of the AvrPto effector by a PLPK homolog, and subsequent action of downstream components of the Pto signaling pathway. However, the possibility remains that the recognition of AvrPto in pepper plants may involve activities of other receptor like kinases (RLKs). The identification of the PLPKs in this study will serve as a foundation for further efforts to understand the roles of PLPKs in nonhost resistance.	[Venkatesh, Jelli; Kang, Byoung-Cheorl] Seoul Natl Univ, Dept Plant Sci, Vegetable Breeding Res Ctr, Seoul 151921, South Korea; [Venkatesh, Jelli; Kang, Byoung-Cheorl] Seoul Natl Univ, Plant Genom & Breeding Inst, Vegetable Breeding Res Ctr, Seoul 151921, South Korea; [Jahn, Molly] Univ Wisconsin, Madison, WI 53706 USA	Seoul National University (SNU); Seoul National University (SNU); University of Wisconsin System; University of Wisconsin Madison	Kang, BC (corresponding author), Seoul Natl Univ, Dept Plant Sci, Vegetable Breeding Res Ctr, Seoul 151921, South Korea.; Kang, BC (corresponding author), Seoul Natl Univ, Plant Genom & Breeding Inst, Vegetable Breeding Res Ctr, Seoul 151921, South Korea.	bk54@snu.ac.kr	Kang, Byoung-Cheorl/Q-6174-2019; Venkatesh, Jelli/O-8942-2019; Venkatesh, Jelli/E-7887-2018	Venkatesh, Jelli/0000-0002-8896-0385; Venkatesh, Jelli/0000-0002-8896-0385; Jahn, Molly/0000-0003-0181-0374	Vegetable Breeding Research Center through the R&D Convergence Center Support Program, Ministry for Food, Agriculture, Forestry and Fisheries [710001-03]; Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center), Rural Development Administration [PJ00906501]	Vegetable Breeding Research Center through the R&D Convergence Center Support Program, Ministry for Food, Agriculture, Forestry and Fisheries; Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center), Rural Development Administration	This research was funded by a grant (Project No. 710001-03) from the Vegetable Breeding Research Center through the R&D Convergence Center Support Program, Ministry for Food, Agriculture, Forestry and Fisheries. This work was also supported by a grant from the Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center No. PJ00906501), Rural Development Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded by a grant (Project No. 710001-03) from the Vegetable Breeding Research Center through the R&D Convergence Center Support Program, Ministry for Food, Agriculture, Forestry and Fisheries. This work was also supported by a grant from the Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center No. PJ00906501), Rural Development Administration. We would like to thank Dr. Marco van Schriek at KeyGene for microarray analysis. We thank G.B. Martin, D. Baulcombe, A.R. Collmer, Y.-J. Kim, B. Riely, R. Stall, X. Tang, and S.D. Tanksley for providing experimental materials.	Abramovitch RB, 2003, EMBO J, V22, P60, DOI 10.1093/emboj/cdg006; Balmuth A, 2007, PLANT J, V51, P978, DOI 10.1111/j.1365-313X.2007.03199.x; BAULCOMBE DC, 1995, PLANT J, V7, P1045, DOI 10.1046/j.1365-313X.1995.07061045.x; Belkhadir Y, 2004, CURR OPIN PLANT BIOL, V7, P391, DOI 10.1016/j.pbi.2004.05.009; Bogdanove AJ, 2000, P NATL ACAD SCI USA, V97, P8836, DOI 10.1073/pnas.97.16.8836; Chang JH, 2002, MOL PLANT MICROBE IN, V15, P281, DOI 10.1094/MPMI.2002.15.3.281; Chang JH, 2001, MOL PLANT MICROBE IN, V14, P451, DOI 10.1094/MPMI.2001.14.4.451; Chang TH, 2013, J COMPUT AID MOL DES, V27, P91, DOI 10.1007/s10822-012-9628-0; Chen QH, 2010, J MOL EVOL, V70, P137, DOI 10.1007/s00239-009-9316-4; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Collier SM, 2009, TRENDS PLANT SCI, V14, P521, DOI 10.1016/j.tplants.2009.08.001; Collmer A, 2000, P NATL ACAD SCI USA, V97, P8770, DOI 10.1073/pnas.97.16.8770; Cui HT, 2015, ANNU REV PLANT BIOL, V66, P487, DOI 10.1146/annurev-arplant-050213-040012; Cui HT, 2009, CELL MICROBIOL, V11, P1453, DOI 10.1111/j.1462-5822.2009.01359.x; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Deng Z, 2003, THEOR APPL GENET, V108, P53, DOI 10.1007/s00122-003-1410-1; Di Gaspero G, 2003, MOL GENET GENOMICS, V269, P612, DOI 10.1007/s00438-003-0884-5; Frederick RD, 1998, MOL CELL, V2, P241, DOI 10.1016/S1097-2765(00)80134-3; Gilardi P, 1998, MOL PLANT MICROBE IN, V11, P1253, DOI 10.1094/MPMI.1998.11.12.1253; Gimenez-Ibanez S, 2009, CURR BIOL, V19, P423, DOI 10.1016/j.cub.2009.01.054; Gohre V, 2008, ANNU REV PHYTOPATHOL, V46, P189, DOI 10.1146/annurev.phyto.46.120407.110050; Grube RC, 2000, PLANT DIS, V84, P885, DOI 10.1094/PDIS.2000.84.8.885; Gu YQ, 2002, PLANT CELL, V14, P817, DOI 10.1105/tpc.000794; Gururani MA, 2012, PHYSIOL MOL PLANT P, V78, P51, DOI 10.1016/j.pmpp.2012.01.002; Gutierrez JR, 2010, PLANT J, V61, P507, DOI 10.1111/j.1365-313X.2009.04078.x; Hammond-Kosack KE, 2003, CURR OPIN BIOTECH, V14, P177, DOI 10.1016/S0958-1669(03)00035-1; Hardie DG, 1999, ANNU REV PLANT PHYS, V50, P97, DOI 10.1146/annurev.arplant.50.1.97; He P, 2001, MOL PLANT MICROBE IN, V14, P1453, DOI 10.1094/MPMI.2001.14.12.1453; Hok S, 2011, PLANT CELL ENVIRON, V34, P1944, DOI 10.1111/j.1365-3040.2011.02390.x; Hulbert SH, 2001, ANNU REV PHYTOPATHOL, V39, P285, DOI 10.1146/annurev.phyto.39.1.285; Jia YL, 1997, PLANT CELL, V9, P61, DOI 10.1105/tpc.9.1.61; Kang JH, 2014, KOREAN J HORTIC SCI, V32, P535, DOI 10.7235/hort.2014.14109; Kang L, 2004, MOL PLANT MICROBE IN, V17, P1328, DOI 10.1094/MPMI.2004.17.12.1328; Kim YJ, 2002, CELL, V109, P589, DOI 10.1016/S0092-8674(02)00743-2; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Lin NC, 2007, MOL PLANT MICROBE IN, V20, P806, DOI 10.1094/MPMI-20-7-0806; Livingstone KD, 1999, GENETICS, V152, P1183; LOH YT, 1995, PLANT PHYSIOL, V108, P1735, DOI 10.1104/pp.108.4.1735; MARTIN GB, 1993, SCIENCE, V262, P1432, DOI 10.1126/science.7902614; MARTIN GB, 1994, PLANT CELL, V6, P1543, DOI 10.1105/tpc.6.11.1543; Martin GB, 1999, CURR OPIN PLANT BIOL, V2, P273, DOI 10.1016/S1369-5266(99)80049-1; Zamora MGM, 2008, J MOL EVOL, V67, P211, DOI 10.1007/s00239-008-9134-0; Mathieu J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004227; Michelmore RW, 1998, GENOME RES, V8, P1113, DOI 10.1101/gr.8.11.1113; Oh CS, 2011, TRENDS PLANT SCI, V16, P132, DOI 10.1016/j.tplants.2010.11.001; Pan QL, 2000, J MOL EVOL, V50, P203, DOI 10.1007/s002399910023; Pedley KF, 2003, ANNU REV PHYTOPATHOL, V41, P215, DOI 10.1146/annurev.phyto.41.121602.143032; Peraza-Echeverria S, 2007, MOL GENET GENOMICS, V278, P443, DOI 10.1007/s00438-007-0262-9; Pflieger S, 1999, GENOME, V42, P1100, DOI 10.1139/gen-42-6-1100; Pond SLK, 2011, MOL BIOL EVOL; Rathjen JP, 1999, EMBO J, V18, P3232, DOI 10.1093/emboj/18.12.3232; Richter TE, 2000, PLANT MOL BIOL, V42, P195, DOI 10.1023/A:1006388223475; Riely BK, 2001, P NATL ACAD SCI USA, V98, P2059, DOI 10.1073/pnas.98.4.2059; RONALD PC, 1992, J BACTERIOL, V174, P1604, DOI 10.1128/jb.174.5.1604-1611.1992; Rose LE, 2007, GENETICS, V175, P1307, DOI 10.1534/genetics.106.063602; Saur IML, 2015, J BIOL CHEM, V290, P11258, DOI 10.1074/jbc.M114.616532; Scofield SR, 1996, SCIENCE, V274, P2063, DOI 10.1126/science.274.5295.2063; Sessa G, 2000, EMBO J, V19, P2257, DOI 10.1093/emboj/19.10.2257; Shan LB, 2000, PLANT CELL, V12, P2323, DOI 10.1105/tpc.12.12.2323; Shan LB, 2008, CELL HOST MICROBE, V4, P17, DOI 10.1016/j.chom.2008.05.017; Speth EB, 2009, PLANT PHYSIOL, V149, P1824, DOI 10.1104/pp.108.132092; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanksley SD, 1997, REPT TOMATO GENET CO, V47, P35; Tobias CM, 1999, PLANT J, V17, P41, DOI 10.1046/j.1365-313X.1999.00350.x; Vallad G, 2001, THEOR APPL GENET, V103, P1046, DOI 10.1007/s001220100705; van der Hoorn RAL, 2008, PLANT CELL, V20, P2009, DOI 10.1105/tpc.108.060194; Vleeshouwers VGAA, 2001, MOL PLANT MICROBE IN, V14, P996, DOI 10.1094/MPMI.2001.14.8.996; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wan HJ, 2013, PLANT MOL BIOL REP, V31, P901, DOI 10.1007/s11105-013-0564-5; Wan HJ, 2010, FUNCT PLANT BIOL, V37, P513, DOI 10.1071/FP09205; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; White FF, 2000, CURR OPIN PLANT BIOL, V3, P291, DOI 10.1016/S1369-5266(00)00082-0; Xiang TT, 2008, CURR BIOL, V18, P74, DOI 10.1016/j.cub.2007.12.020; Yeam I, 2010, PLANT J, V61, P16, DOI 10.1111/j.1365-313X.2009.04028.x; Yuan M, 2009, PLANT CELL PHYSIOL, V50, P947, DOI 10.1093/pcp/pcp046	75	4	5	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161545	10.1371/journal.pone.0161545	http://dx.doi.org/10.1371/journal.pone.0161545			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536870	gold, Green Published, Green Submitted			2022-12-26	WOS:000381577000121
J	Hasche, D; Stephan, S; Savelyeva, L; Westermann, F; Rosl, F; Vinzon, SE				Hasche, Daniel; Stephan, Sonja; Savelyeva, Larissa; Westermann, Frank; Roesl, Frank; Vinzon, Sabrina E.			Establishment of an Immortalized Skin Keratinocyte Cell Line Derived from the Animal Model Mastomys coucha	PLOS ONE			English	Article							NATALENSIS; CANCER; P53; DIFFERENTIATION; VACCINATION; DOXORUBICIN; EXPRESSION; PREVENTION; MUTATIONS; BINDING	In the present report we describe the establishment of a spontaneous immortalized skin keratinocyte cell line derived from the skin of the multimammate rodent Mastomys coucha. These animals are used in preclinical studies for a variety of human diseases such as infections with nematodes, bacteria and papillomaviruses, especially regarding cutaneous manifestations such as non-melanoma skin cancer. Here we characterize the cells in terms of their origin and cytogenetic features. Searching for genomic signatures, a spontaneous mutation in the splicing donor sequence of Trp53 (G to A transition at the first position of intron 7) could be detected. This point mutation leads to alternative splicing and to a premature stop codon, resulting in a truncated and, in turn, undetectable form of p53, probably contributing to the process of immortalization. Mastomys coucha-derived skin keratinocytes can be used as an in vitro system to investigate molecular and immunological aspects of infectious agent interactions with their host cells.	[Hasche, Daniel; Stephan, Sonja; Roesl, Frank; Vinzon, Sabrina E.] German Canc Res Ctr, Div Viral Transformat Mech F030, Heidelberg, Germany; [Savelyeva, Larissa; Westermann, Frank] German Canc Res Ctr, Div Neuroblastoma Genom B087, Heidelberg, Germany; [Vinzon, Sabrina E.] IIBBA CONICET, Fdn Inst Leloir, Lab Mol & Cellular Therapy, Buenos Aires, DF, Argentina	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute	Rosl, F; Vinzon, SE (corresponding author), German Canc Res Ctr, Div Viral Transformat Mech F030, Heidelberg, Germany.; Vinzon, SE (corresponding author), IIBBA CONICET, Fdn Inst Leloir, Lab Mol & Cellular Therapy, Buenos Aires, DF, Argentina.	f.roesl@dkfz.de; s.vinzon@dkfz.de	Vinzon, Sabrina/HFZ-9144-2022; Westermann, Frank/F-7509-2013; Vinzón, Sabrina/Q-1631-2019; Hasche, Daniel/ABC-3206-2020	Vinzón, Sabrina/0000-0002-1330-9125; Hasche, Daniel/0000-0001-9306-3059	Eurostars Project [E! 6872 TOSCA, 01QE1203C]	Eurostars Project	This study was supported by the "Eurostars Project" E! 6872 TOSCA (01QE1203C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ast G, 2004, NAT REV GENET, V5, P773, DOI 10.1038/nrg1451; Boccellino M, 2010, TOXICOL LETT, V197, P61, DOI 10.1016/j.toxlet.2010.04.026; Borowiec AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077507; Caldelari R, 2010, METHODS MOL BIOL, V633, P125, DOI 10.1007/978-1-59745-019-5_10; Cavallo F, 2006, ADV IMMUNOL, V90, P175, DOI 10.1016/S0065-2776(06)90005-4; Chapman S, 2010, J CLIN INVEST, V120, P2619, DOI 10.1172/JCI42297; Diederichs S, 2016, EMBO MOL MED, V8, P442, DOI 10.15252/emmm.201506055; Doorbar J, 2016, J PATHOL, V238, P166, DOI 10.1002/path.4656; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Golunski G, 2016, BIOCHIMIE, V123, P95, DOI 10.1016/j.biochi.2016.02.003; Goodpaster T, 2008, J HISTOCHEM CYTOCHEM, V56, P347, DOI 10.1369/jhc.7A7287.2007; Hanel W, 2012, J CELL BIOCHEM, V113, P433, DOI 10.1002/jcb.23400; Hodivala-Dilke Kairbaan, 2002, Methods Mol Biol, V188, P139; Khoury MP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000927; Koga T, 2002, J MED MICROBIOL, V51, P777, DOI 10.1099/0022-1317-51-9-777; KRUPPA TF, 1990, TROP MED PARASITOL, V41, P219; Kushwaha S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072585; Kvac M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147090; Larmour LI, 2015, INT J GYNECOL CANCER, V25, P1345, DOI 10.1097/IGC.0000000000000525; Le Hir H, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.7; LEHMAN TA, 1993, CARCINOGENESIS, V14, P833, DOI 10.1093/carcin/14.5.833; Leibiger C, 2013, J HISTOCHEM CYTOCHEM, V61, P306, DOI 10.1369/0022155413476868; Lutzner N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032590; Macville M, 1999, CANCER RES, V59, P141; Matt S, 2016, CELL MOL LIFE SCI, V73, P2829, DOI 10.1007/s00018-016-2130-4; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; MOMPARLER RL, 1976, CANCER RES, V36, P2891; MULLER H, 1978, J GEN VIROL, V41, P315, DOI 10.1099/0022-1317-41-2-315; MURPHY GF, 1984, J INVEST DERMATOL, V82, P453, DOI 10.1111/1523-1747.ep12260945; Nafz J, 2008, VIROLOGY, V374, P186, DOI 10.1016/j.virol.2007.12.012; Ng G, 2006, J MOL DIAGN, V8, P449, DOI 10.2353/jmoldx.2006.060033; Niebler M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003536; Ojok L, 2002, VET PARASITOL, V105, P327, DOI 10.1016/S0304-4017(02)00017-1; Olayemi A, 2016, SCI REP-UK, V6, DOI 10.1038/srep25280; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; Pandit SK, 2013, TRENDS CELL BIOL, V23, P556, DOI 10.1016/j.tcb.2013.06.002; Reizner W, 2014, EUR CELLS MATER, V27, P196, DOI 10.22203/eCM.v027a15; Salvermoser M, 2016, J GEN VIROL, V97, P1658, DOI 10.1099/jgv.0.000471; Schoenfelder KP, 2015, J CELL BIOL, V209, P485, DOI 10.1083/jcb.201502016; STRICKLAND JE, 1988, CANCER RES, V48, P165; Verma SK, 2015, VACCINE, V33, P527, DOI 10.1016/j.vaccine.2014.11.041; Vinzon SE, 2015, HUM VACC IMMUNOTHER, V11, P353, DOI 10.4161/21645515.2014.983858; Vinzon SE, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003924; Weiss J., 2008, TIERPFLEGE FORSCHUNG; YUSPA SH, 1989, J CELL BIOL, V109, P1207, DOI 10.1083/jcb.109.3.1207	45	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161283	10.1371/journal.pone.0161283	http://dx.doi.org/10.1371/journal.pone.0161283			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27533138	gold, Green Published, Green Submitted			2022-12-26	WOS:000381487600081
J	Tokushima, Y; Uehara, T; Yamaguchi, T; Arikawa, K; Kainoh, Y; Shimoda, M				Tokushima, Yoshiaki; Uehara, Takuya; Yamaguchi, Terumi; Arikawa, Kentaro; Kainoh, Yooichi; Shimoda, Masami			Broadband Photoreceptors Are Involved in Violet Light Preference in the Parasitoid Fly Exorista Japonica	PLOS ONE			English	Article							COLOR-VISION; PHOTOTACTIC BEHAVIOR; SPECTRAL PREFERENCE; DROSOPHILA-MELANOGASTER; TSETSE-FLY; HOST; TACHINIDAE; GREEN; ORIENTATION; SENSITIVITY	Phototaxis has been described in many insects, which are often attracted to specific wavelengths of light. However, little is known about phototaxis in parasitoid insect species that are potentially useful for integrated pest management. In this study, we investigated the wavelength dependency of the phototactic behavior of the parasitoid fly Exorista japonica and its possible mechanism. Multiple-choice tests with six monochromatic stimuli revealed that the flies were specifically attracted to violet light peaking at 405 nm, which was unexpected because insects are generally attracted to ultraviolet or green light. We measured the spectral sensitivity of the compound eye, and found that the sensitivity peaked at 340 nm, as in other brachyceran flies. We used statistical modeling and optimization of the process parameters to predict the type of photoreceptor contributing to the violet preference. The analysis revealed that the wavelength preference could be explained by linear models of the quanta received by photoreceptors, including the R1-6 broadband receptors. The broadband receptors appear to contribute positively, whereas the R7-8 narrowband receptors contribute negatively to achieve the violet preference; i.e., spectral opponency might be involved.	[Tokushima, Yoshiaki; Uehara, Takuya; Yamaguchi, Terumi; Shimoda, Masami] NARO, Inst Agrobil Sci, Tsukuba, Ibaraki, Japan; [Tokushima, Yoshiaki] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 305, Japan; [Arikawa, Kentaro] SOKENDAI, Lab Neuroethol, Hayama, Japan; [Kainoh, Yooichi] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 305, Japan	National Agriculture & Food Research Organization - Japan; University of Tsukuba; Graduate University for Advanced Studies - Japan; University of Tsukuba	Shimoda, M (corresponding author), NARO, Inst Agrobil Sci, Tsukuba, Ibaraki, Japan.; Kainoh, Y (corresponding author), Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 305, Japan.	kainoh.yooichi.gf@u.tsukuba.ac.jp; shimoda1@affrc.go.jp	Uehara, Takuya/I-4880-2019; Kainoh, Yooichi/AAF-5717-2020	Uehara, Takuya/0000-0002-4871-0197; Kainoh, Yooichi/0000-0002-7183-2483; Arikawa, Kentaro/0000-0002-4365-0762	Cross-ministerial Strategic Innovation Promotion Program (SIP), "Technologies for creating next-generation agriculture, forestry, and fisheries" (funding agency: Bio-oriented Technology Research Advancement Institution, NARO); JSPS KAKENHI grant [25660268, 16K14868]	Cross-ministerial Strategic Innovation Promotion Program (SIP), "Technologies for creating next-generation agriculture, forestry, and fisheries" (funding agency: Bio-oriented Technology Research Advancement Institution, NARO); JSPS KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was partially supported by the Cross-ministerial Strategic Innovation Promotion Program (SIP), "Technologies for creating next-generation agriculture, forestry, and fisheries" (funding agency: Bio-oriented Technology Research Advancement Institution, NARO) and by JSPS KAKENHI grant numbers 25660268 and 16K14868 to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auguie B, 2017, GRIDEXTRA MISCELLANE; BUCHSBAUM G, 1983, PROC R SOC SER B-BIO, V220, P89, DOI 10.1098/rspb.1983.0090; COOMBE PE, 1982, PHYSIOL ENTOMOL, V7, P243, DOI 10.1111/j.1365-3032.1982.tb00297.x; Crawley MJ, 2005, STAT INTRO USING R; Dobson AJ., 2008, INTRO GEN LINEAR MOD, DOI 10.1201/9780367807849; GREEN CH, 1983, J INSECT PHYSIOL, V29, P795, DOI 10.1016/0022-1910(83)90009-4; Ichiki RT, 2008, J CHEM ECOL, V34, P614, DOI 10.1007/s10886-008-9459-6; Ichiki RT, 2011, ENTOMOL EXP APPL, V138, P175, DOI 10.1111/j.1570-7458.2010.01091.x; JACOB KG, 1977, J COMP PHYSIOL, V116, P209, DOI 10.1007/BF00605403; JANDER R, 1963, ANNU REV ENTOMOL, V8, P95, DOI 10.1146/annurev.en.08.010163.000523; Kanda K., 1991, REARING METHOD INSEC, P206; Karuppudurai T, 2014, NEURON, V81, P603, DOI 10.1016/j.neuron.2013.12.010; Kelber A, 2003, BIOL REV, V78, P81, DOI 10.1017/S1464793102005985; Kelber A, 2001, ENTOMOL EXP APPL, V99, P231, DOI 10.1023/A:1019244619503; Kelber A, 1999, J EXP BIOL, V202, P2619; Kinoshita M, 1999, J EXP BIOL, V202, P95; Kinoshita M, 2014, J COMP PHYSIOL A, V200, P513, DOI 10.1007/s00359-014-0903-5; Kishi M, 2014, JPN J APPL ENTOMOL Z, V58, P13, DOI 10.1303/jjaez.2014.13; Lunau K, 2014, J COMP PHYSIOL A, V200, P497, DOI 10.1007/s00359-014-0895-1; Menzel R., 1979, COMP PHYSL EVOLUTION, P503; Moller R, 2002, J THEOR BIOL, V214, P619, DOI 10.1006/jtbi.2001.2484; Nakamura S, 1997, APPL ENTOMOL ZOOL, V32, P189, DOI 10.1303/aez.32.189; Ogino T, 2015, JPN J APPL ENTOMOL Z, V59, P10, DOI 10.1303/jjaez.2015.10; Ohashi K, 2015, FUNCT ECOL, V29, P1144, DOI 10.1111/1365-2435.12420; Otalora-Luna F, 2011, ENTOMOL EXP APPL, V138, P93, DOI 10.1111/j.1570-7458.2010.01081.x; Otani Y, 2014, JPN J APPL ENTOMOL Z, V58, P177, DOI 10.1303/jjaez.2014.177; Otsuna H, 2015, NEURAL CIRCUITS JPN, V99; Ottoson D, 1985, PROGR SENSORY PHYSL, P1; PROKOPY RJ, 1983, ANNU REV ENTOMOL, V28, P337, DOI 10.1146/annurev.en.28.010183.002005; ROBERTS AE, 1992, ENTOMOL EXP APPL, V64, P259, DOI 10.1007/BF00341089; Santer RD, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004121; Santer RD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003360; Schnaitmann C, 2013, CURR BIOL, V23, P2375, DOI 10.1016/j.cub.2013.10.037; SCHUMPERLI RA, 1973, J COMP PHYSIOL, V86, P77, DOI 10.1007/BF00694480; Shimoda M, 2013, APPL ENTOMOL ZOOL, V48, P413, DOI 10.1007/s13355-013-0219-x; Stireman JO, 2006, ANNU REV ENTOMOL, V51, P525, DOI 10.1146/annurev.ento.51.110104.151133; Tanaka C, 1999, APPL ENTOMOL ZOOL, V34, P91, DOI 10.1303/aez.34.91; Uehara T, 2014, JPN J APPL ENTOMOL Z, V58, P36, DOI 10.1303/jjaez.2014.36; Wakakuwa M, 2014, J COMP PHYSIOL A, V200, P527, DOI 10.1007/s00359-014-0892-4; Yamaguchi S, 2010, P NATL ACAD SCI USA, V107, P5634, DOI 10.1073/pnas.0809398107; Yamawaki Y, 2002, J EXP BIOL, V205, P485; Yamawaki Y, 2005, ZOOL SCI, V22, P563, DOI 10.2108/zsj.22.563	42	15	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160441	10.1371/journal.pone.0160441	http://dx.doi.org/10.1371/journal.pone.0160441			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532635	Green Published, gold, Green Submitted			2022-12-26	WOS:000381487600030
J	Vanselow, J; Vernunft, A; Koczan, D; Spitschak, M; Kuhla, B				Vanselow, Jens; Vernunft, Andreas; Koczan, Dirk; Spitschak, Marion; Kuhla, Bjoern			Exposure of Lactating Dairy Cows to Acute Pre-Ovulatory Heat Stress Affects Granulosa Cell-Specific Gene Expression Profiles in Dominant Follicles	PLOS ONE			English	Article							HUMAN CHORIONIC-GONADOTROPIN; ACTIVIN-BINDING PROTEIN; DEVELOPMENTAL COMPETENCE; FOLLICULAR DEVELOPMENT; HYALURONAN SYNTHESIS; OOCYTE COMPETENCE; CORPUS-LUTEUM; HOLSTEIN COWS; RAT OVARY; FOLLISTATIN	High environmental temperatures induce detrimental effects on various reproductive processes in cattle. According to the predicted global warming the number of days with unfavorable ambient temperatures will further increase. The objective of this study was to investigate effects of acute heat stress during the late pre-ovulatory phase on morphological, physiological and molecular parameters of dominant follicles in cycling cows during lactation. Eight German Holstein cows in established lactation were exposed to heat stress (28 degrees C) or thermoneutral conditions (15 degrees C) with pair-feeding for four days. After hormonal heat induction growth of the respective dominant follicles was monitored by ultrasonography for two days, then an ovulatory GnRH dose was given and follicular steroid hormones and granulosa cell-specific gene expression profiles were determined 23 hrs thereafter. The data showed that the pre-ovulatory growth of dominant follicles and the estradiol, but not the progesterone concentrations tended to be slightly affected. mRNA microarray and hierarchical cluster analysis revealed distinct expression profiles in granulosa cells derived from heat stressed compared to pair-fed animals. Among the 255 affected genes heatstress-, stress- or apoptosis associated genes were not present. But instead, we found upregulation of genes essentially involved in G-protein coupled signaling pathways, extracellular matrix composition, and several members of the solute carrier family as well as up-regulation of FST encoding follistatin. In summary, the data of the present study show that acute pre-ovulatory heat stress can specifically alter gene expression profiles in granulosa cells, however without inducing stress related genes and pathways and suggestively can impair follicular growth due to affecting the activin-inhibin-follistatin system.	[Vanselow, Jens; Vernunft, Andreas] Leibniz Inst Farm Anim Biol FBN, Inst Reprod Biol, D-18196 Dummerstorf, Germany; [Kuhla, Bjoern] Leibniz Inst Farm Anim Biol FBN, Inst Nutr Physiol, D-18196 Dummerstorf, Germany; [Spitschak, Marion] Leibniz Inst Farm Anim Biol FBN, Inst Genome Biol, D-18196 Dummerstorf, Germany; [Koczan, Dirk] Univ Rostock, Inst Immunol, D-18055 Rostock, Germany	Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN); University of Rostock	Vanselow, J (corresponding author), Leibniz Inst Farm Anim Biol FBN, Inst Reprod Biol, D-18196 Dummerstorf, Germany.; Kuhla, B (corresponding author), Leibniz Inst Farm Anim Biol FBN, Inst Nutr Physiol, D-18196 Dummerstorf, Germany.	vanselow@fbn-dummerstorf.de; b.kuhla@fbn-dummerstorf.de	Vanselow, Jens/ABU-1095-2022		core budget of the Leibniz Institute for Farm Animals (FBN); Open Access fund of the Leibniz Association; core budget of the FBN	core budget of the Leibniz Institute for Farm Animals (FBN); Open Access fund of the Leibniz Association; core budget of the FBN	This study was supported by the core budget of the Leibniz Institute for Farm Animals (FBN) and the publication of this article was funded by the Open Access fund of the Leibniz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We express our gratitude to the staff of the Tiertechnikum at the FBN and we thank M. Anders and V. Schreiter (all Leibniz Institute for Farm Animal Biology) for excellent technical assistance with sampling and analysis. This study was supported by the core budget of the FBN.	Abdoon AS, 2014, THERIOGENOLOGY, V82, P1055, DOI 10.1016/j.theriogenology.2014.07.008; Al-Katanani YM, 1999, J DAIRY SCI, V82, P2611, DOI 10.3168/jds.S0022-0302(99)75516-5; Aroyo A, 2007, THERIOGENOLOGY, V67, P1013, DOI 10.1016/j.theriogenology.2006.12.001; Baddela VS, 2014, REPROD BIOL ENDOCRIN, V12, P1, DOI 10.1186/1477-7827-12-118; BADINGA L, 1993, THERIOGENOLOGY, V39, P797, DOI 10.1016/0093-691X(93)90419-6; Baufeld A, 2013, CELL TISSUE RES, V354, P869, DOI 10.1007/s00441-013-1712-9; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bharadwaj AG, 2009, AM J PATHOL, V174, P1027, DOI 10.2353/ajpath.2009.080501; Chebel RC, 2004, ANIM REPROD SCI, V84, P239, DOI 10.1016/j.anireprosci.2003.12.012; Chong ZL, 2015, ANIM REPROD SCI, V155, P80, DOI 10.1016/j.anireprosci.2015.02.003; Christenson LK, 2013, MOL ENDOCRINOL, V27, P1153, DOI 10.1210/me.2013-1093; De Rensis F, 2003, THERIOGENOLOGY, V60, P1139, DOI 10.1016/S0093-691X(03)00126-2; ESCH FS, 1987, MOL ENDOCRINOL, V1, P849, DOI 10.1210/mend-1-11-849; Eslamizad M, 2015, PHYSIOL BEHAV, V145, P64, DOI 10.1016/j.physbeh.2015.03.044; Fu Y, 2014, INT J MOL SCI, V15, P21090, DOI 10.3390/ijms151121090; Gendelman M, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.092882; Glister C, 2011, REPRODUCTION, V142, P581, DOI 10.1530/REP-11-0150; Gregory SJ, 2004, SEMIN REPROD MED, V 22, P253, DOI 10.1055/s-2004-831901; Guzeloglu A, 2001, ANIM REPROD SCI, V66, P15, DOI 10.1016/S0378-4320(01)00082-3; Hansen PJ, 1999, J ANIM SCI, V77, P36; Hunter RHF, 2005, J ANIM PHYSIOL AN N, V89, P240, DOI 10.1111/j.1439-0396.2005.00509.x; Hunter RHF, 2000, HUM REPROD, V15, P273, DOI 10.1093/humrep/15.2.273; Itano N, 2002, IUBMB LIFE, V54, P195, DOI 10.1080/15216540214929; Kussano NR, 2016, THERIOGENOLOGY, V85, P1167, DOI 10.1016/j.theriogenology.2015.11.033; Lamp O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125264; Li L, 2016, CELL STRESS CHAPERON, V21, P467, DOI 10.1007/s12192-016-0673-9; Lin CC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4551; Miro F, 1996, ENDOCRINOLOGY, V137, P464, DOI 10.1210/en.137.2.464; NAKAMURA T, 1990, SCIENCE, V247, P836, DOI 10.1126/science.2106159; Nimz M, 2009, DOMEST ANIM ENDOCRIN, V37, P45, DOI 10.1016/j.domaniend.2009.02.002; Pennarossa G, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.104018; Phillips DJ, 1998, FRONT NEUROENDOCRIN, V19, P287, DOI 10.1006/frne.1998.0169; Ploutarchou P, 2015, REPRODUCTION, V149, P533, DOI 10.1530/REP-14-0503; PUTNEY DJ, 1988, BIOL REPROD, V39, P717, DOI 10.1095/biolreprod39.3.717; Rhoads ML, 2009, J DAIRY SCI, V92, P1986, DOI 10.3168/jds.2008-1641; Rodgers RJ, 2010, BIOL REPROD, V82, P1021, DOI 10.1095/biolreprod.109.082941; Rodgers RJ, 2003, REPRODUCTION, V126, P415, DOI 10.1530/rep.0.1260415; Romero JJ, 2013, PHYSIOL GENOMICS, V45, P1095, DOI 10.1152/physiolgenomics.00082.2013; Roth Z, 2000, J REPROD FERTIL, V120, P83, DOI 10.1530/reprod/120.1.83; Schmahl J, 2008, GENE DEV, V22, P3255, DOI 10.1101/gad.1723908; Schoenfelder M, 2003, BIOL REPROD, V69, P269, DOI 10.1095/biolreprod.102.011577; Shehab-El-Deen MAMM, 2010, ANIM REPROD SCI, V117, P189, DOI 10.1016/j.anireprosci.2009.04.013; Sirois J, 2004, HUM REPROD UPDATE, V10, P373, DOI 10.1093/humupd/dmh032; SIROIS J, 1994, ENDOCRINOLOGY, V135, P841, DOI 10.1210/en.135.3.841; Sirotkin AV, 2011, CELL STRESS CHAPERON, V16, P379, DOI 10.1007/s12192-010-0252-4; Sirotkin AV, 2010, J EXP BIOL, V213, P2125, DOI 10.1242/jeb.040626; Soto P, 2009, MOL REPROD DEV, V76, P637, DOI 10.1002/mrd.20986; Spitschak M, 2012, GEN COMP ENDOCR, V178, P37, DOI 10.1016/j.ygcen.2012.04.001; Stangaferro ML, 2014, ANIM REPROD SCI, V148, P97, DOI 10.1016/j.anireprosci.2014.06.005; Stock AE, 2002, ENDOCRINOLOGY, V143, P4375, DOI 10.1210/en.2002-220563; Takahashi N, 2014, REPRODUCTION, V147, P189, DOI 10.1530/REP-13-0464; Torres-Junior JRD, 2008, THERIOGENOLOGY, V69, P155, DOI 10.1016/j.theriogenology.2007.06.023; Vernunft A, 2013, VET MED-CZECH, V58, P221, DOI 10.17221/6760-VETMED; Vitoratos N, 2006, ANN NY ACAD SCI, V1092, P310, DOI 10.1196/annals.1365.029; Wang SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125816; Wolfenson D, 1997, ANIM REPROD SCI, V47, P9, DOI 10.1016/S0378-4320(96)01638-7; Xu J, 2006, J CLIN ENDOCR METAB, V91, P1544, DOI 10.1210/jc.2005-2776; Xu J, 2007, ENDOCRINOLOGY, V148, P5385, DOI 10.1210/en.2007-0541; Yamada K, 2004, BIOL REPROD, V70, P76, DOI 10.1095/biolreprod.103.020107; Yan KQ, 2013, MOL CELL ENDOCRINOL, V372, P73, DOI 10.1016/j.mce.2013.03.027; Yenuganti VR, 2016, GEN COMP ENDOCR, V232, P134, DOI 10.1016/j.ygcen.2016.04.020	61	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160600	10.1371/journal.pone.0160600	http://dx.doi.org/10.1371/journal.pone.0160600			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532452	Green Submitted, Green Published, gold			2022-12-26	WOS:000381487600038
J	Wang, K; Langevin, S; O'Hern, CS; Shattuck, MD; Ogle, S; Forero, A; Morrison, J; Slayden, R; Katze, MG; Kirby, M				Wang, Kun; Langevin, Stanley; O'Hern, Corey S.; Shattuck, Mark D.; Ogle, Serenity; Forero, Adriana; Morrison, Juliet; Slayden, Richard; Katze, Michael G.; Kirby, Michael			Anomaly Detection in Host Signaling Pathways for the Early Prognosis of Acute Infection	PLOS ONE			English	Article							ACUTE INFLAMMATORY RESPONSE; REDUCED MATHEMATICAL-MODEL; GENE-EXPRESSION; INFLUENZA-VIRUS; TNF-ALPHA; LPS; LIPOPOLYSACCHARIDE; CELLS; INTERLEUKIN-10; INDUCTION	Clinical diagnosis of acute infectious diseases during the early stages of infection is critical to administering the appropriate treatment to improve the disease outcome. We present a data driven analysis of the human cellular response to respiratory viruses including influenza, respiratory syncytia virus, and human rhinovirus, and compared this with the response to the bacterial endotoxin, Lipopolysaccharides (LPS). Using an anomaly detection framework we identified pathways that clearly distinguish between asymptomatic and symptomatic patients infected with the four different respiratory viruses and that accurately diagnosed patients exposed to a bacterial infection. Connectivity pathway analysis comparing the viral and bacterial diagnostic signatures identified host cellular pathways that were unique to patients exposed to LPS endotoxin indicating this type of analysis could be used to identify host biomarkers that can differentiate clinical etiologies of acute infection. We applied the Multivariate State Estimation Technique (MSET) on two human influenza (H1N1 and H3N2) gene expression data sets to define host networks perturbed in the asymptomatic phase of infection. Our analysis identified pathways in the respiratory virus diagnostic signature as prognostic biomarkers that triggered prior to clinical presentation of acute symptoms. These early warning pathways correctly predicted that almost half of the subjects would become symptomatic in less than forty hours post-infection and that three of the 18 subjects would become symptomatic after only 8 hours. These results provide a proof-of-concept for utility of anomaly detection algorithms to classify host pathway signatures that can identify presymptomatic signatures of acute diseases and differentiate between etiologies of infection. On a global scale, acute respiratory infections cause a significant proportion of human co-morbidities and account for 4.25 million deaths annually. The development of clinical diagnostic tools to distinguish between acute viral and bacterial respiratory infections is critical to improve patient care and limit the overuse of antibiotics in the medical community. The identification of prognostic respiratory virus biomarkers provides an early warning system that is capable of predicting which subjects will become symptomatic to expand our medical diagnostic capabilities and treatment options for acute infectious diseases. The host response to acute infection may be viewed as a deterministic signaling network responsible for maintaining the health of the host organism. We identify pathway signatures that reflect the very earliest perturbations in the host response to acute infection. These pathways provide a monitor the health state of the host using anomaly detection to quantify and predict health outcomes to pathogens.	[Wang, Kun; Kirby, Michael] Colorado State Univ, Dept Math, Ft Collins, CO 80523 USA; [Wang, Kun; O'Hern, Corey S.; Shattuck, Mark D.] Yale Univ, Dept Mech Engn & Mat Sci, New Haven, CT USA; [Langevin, Stanley; Forero, Adriana; Morrison, Juliet; Katze, Michael G.] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA; [O'Hern, Corey S.] Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA; [O'Hern, Corey S.] Yale Univ, Dept Phys, New Haven, CT USA; [O'Hern, Corey S.] Yale Univ, Grad Program Computat Biol & Bioinformat, New Haven, CT USA; [Shattuck, Mark D.] CUNY City Coll, Dept Phys, New York, NY 10031 USA; [Shattuck, Mark D.] CUNY City Coll, Benjamin Levich Inst, New York, NY 10031 USA; [Slayden, Richard] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Ogle, Serenity] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA; [Kirby, Michael] Colorado State Univ, Dept Comp Sci, Ft Collins, CO 80523 USA	Colorado State University; Yale University; University of Washington; University of Washington Seattle; Yale University; Yale University; Yale University; City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System; City College of New York (CUNY); Colorado State University; Colorado State University; Colorado State University	Kirby, M (corresponding author), Colorado State Univ, Dept Math, Ft Collins, CO 80523 USA.; Kirby, M (corresponding author), Colorado State Univ, Dept Comp Sci, Ft Collins, CO 80523 USA.	Michael.Kirby@Colostate.edu	Slayden, Richard/O-8626-2016; Slayden, Richard/AAV-2582-2021; Shattuck, Mark D/F-5680-2015; O'Hern, Corey/I-3459-2014	Slayden, Richard/0000-0001-6857-7277; Slayden, Richard/0000-0001-6857-7277; Shattuck, Mark D/0000-0001-8473-2505; Morrison, Juliet/0000-0001-7387-6351; O'Hern, Corey/0000-0002-8272-5640	National Science Foundation [DMS-1513633]; Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health; National Institutes of Health [P51OD010425]; Department of Health and Human Services, under CEIRS Contract [HHSN272201400005C]	National Science Foundation(National Science Foundation (NSF)); Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services, under CEIRS Contract	This research was partially supported by the National Science Foundation under award DMS-1513633. Any opinions, findings and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. This project has been funded in whole or in part with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under CEIRS Contract No. HHSN272201400005C, and the National Institutes of Health, Office of the Director under grant No. P51OD010425.	Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; BERG DJ, 1995, J CLIN INVEST, V96, P2339, DOI 10.1172/JCI118290; BLANCHARD DK, 1986, J IMMUNOL, V136, P963; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Cheng Shunfeng, 2007, PARAMETERS, V1, px2; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Curtis RK, 2005, TRENDS BIOTECHNOL, V23, P429, DOI 10.1016/j.tibtech.2005.05.011; Day J, 2006, J THEOR BIOL, V242, P237, DOI 10.1016/j.jtbi.2006.02.015; Day J, 2010, MATH BIOSCI ENG, V7, P739, DOI 10.3934/mbe.2010.7.739; Derlindati E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119751; Gee K, 2002, J IMMUNOL, V169, P5660, DOI 10.4049/jimmunol.169.10.5660; Ghosh M, 2014, J IMMUNOL S, V192, P180; Ginsburg GS, 2012, CRIT CARE, V16, DOI 10.1186/cc11685; GOTSCH U, 1994, CELL ADHES COMMUN, V2, P7, DOI 10.3109/15419069409014198; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Guo HL, 2010, J VIROL, V84, P7750, DOI 10.1128/JVI.00187-10; Gutzeit C, 2014, IMMUNOL REV, V260, P76, DOI 10.1111/imr.12189; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; HUANG K, 1995, INFLAMMATION, V19, P389, DOI 10.1007/BF01534395; Huschak G, 2003, CLIN EXP IMMUNOL, V134, P491, DOI 10.1111/j.1365-2249.2003.02302.x; Iyer SS, 2010, J IMMUNOL, V185, P6599, DOI 10.4049/jimmunol.1002041; Jaai R, 2009, P REL MAINT S, P100; Jin SQ, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-105; KAMADA T, 1989, INFORM PROCESS LETT, V31, P7, DOI 10.1016/0020-0190(89)90102-6; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Kim ID, 2010, ARCH PHARM RES, V33, P959, DOI 10.1007/s12272-010-0620-8; Kirby M., 2000, GEOMETRIC DATA ANAL, V1st ed.; Lettau M, 2011, EUR J CELL BIOL, V90, P456, DOI 10.1016/j.ejcb.2010.10.006; Liu G, 2009, J IMMUNOL, V182, P5063, DOI 10.4049/jimmunol.0803526; Lunardi Andrea, 2011, Genes Cancer, V2, P10, DOI 10.1177/1947601911402682; Mei B, 2014, GENE, V551, P255, DOI 10.1016/j.gene.2014.08.062; Mejias A, 2014, CURR OPIN INFECT DIS, V27, P228, DOI [10.1097/QCO.0000000000000065, 10.1097/QCO.0000000000000063]; Morrison J, 2014, J VIROL, V88, P10556, DOI 10.1128/JVI.00570-14; Negishi M, 2011, AM J REPROD IMMUNOL, V65, P20, DOI 10.1111/j.1600-0897.2010.00856.x; Nikoopour E, 2014, CYTOKINE; O'Hara S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-832; Oh JZ, 2014, IMMUNITY, V41, P478, DOI 10.1016/j.immuni.2014.08.009; Openshaw PJ, 2009, MUCOSAL IMMUNOL, V2, P100, DOI 10.1038/mi.2008.79; Parnell GP, 2012, CRIT CARE, V16, DOI 10.1186/cc11477; Pociask DA, 2013, AM J PATHOL, V182, P1286, DOI 10.1016/j.ajpath.2012.12.007; Reynolds A, 2006, J THEOR BIOL, V242, P220, DOI 10.1016/j.jtbi.2006.02.016; Rui YX, 2007, J IMMUNOL, V179, P7344, DOI 10.4049/jimmunol.179.11.7344; Sawa Y, 2008, J HISTOCHEM CYTOCHEM, V56, P97, DOI 10.1369/jhc.7A7299.2007; Scholz G, 2000, J BIOL CHEM, V275, P14615, DOI 10.1074/jbc.275.19.14615; Shi YZ, 2006, SHOCK, V26, P277, DOI 10.1097/01.shk.0000223134.17877.ad; Shouval DS, 2014, ADV IMMUNOL, V122, P177, DOI 10.1016/B978-0-12-800267-4.00005-5; Storey JD, 2005, P NATL ACAD SCI USA, V102, P12837, DOI 10.1073/pnas.0504609102; Sun K, 2010, J VIROL, V84, P5007, DOI 10.1128/JVI.02408-09; Sun YJ, 2007, IEEE T PATTERN ANAL, V29, P1035, DOI 10.1109/TPAMI.2007.1093; Thompson J., 2010, 2010 International Conference on Dependable Systems and Networks Workshops (DSN-W), P8, DOI 10.1109/DSNW.2010.5542626; Tuyt LML, 1996, BRIT J HAEMATOL, V92, P521, DOI 10.1046/j.1365-2141.1996.00378.x; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YH, 2005, BIOINFORMATICS, V21, P1530, DOI 10.1093/bioinformatics/bti192; Wang Y, 2011, CELL BIOL INT, V35, P677, DOI 10.1042/CBI20100625; Weber GF, 2007, INFECT IMMUN, V75, P1690, DOI 10.1128/IAI.01564-06; Whisnant K, 2005, CDES '05: Proceedings of the 2005 International Conference on Computer Design, P3; Woods CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052198; Wu CX, 2012, J SURG RES, V175, P88, DOI 10.1016/j.jss.2011.02.026; Xaus J, 2000, BLOOD, V95, P3823; Xing E.P., 2001, ICML CITESEER, V1, P601; Yao ZY, 2014, J BIOL CHEM, V289, P9372, DOI 10.1074/jbc.M113.533992; Yeung KY, 2005, BIOINFORMATICS, V21, P2394, DOI 10.1093/bioinformatics/bti319; Yu L., 2004, P 10 ACM SIGKDD INT, P737, DOI DOI 10.1145/1014052.1014149; Zaas AK, 2014, TRENDS MOL MED, V20, P579, DOI 10.1016/j.molmed.2014.08.001; Zaas AK, 2009, CELL HOST MICROBE, V6, P207, DOI 10.1016/j.chom.2009.07.006; Zavaljevski N, 1999, P MC, V99; Zavaljevski N, 2001, P YUG NUCL SOC I NUC; Zhong J, 2009, J IMMUNOL, V182, P91	68	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160919	10.1371/journal.pone.0160919	http://dx.doi.org/10.1371/journal.pone.0160919			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532264	Green Published, gold			2022-12-26	WOS:000381487600047
J	Tominaga, K; Shimamura, T; Kimura, N; Murayama, T; Matsubara, D; Kanauchi, H; Niida, A; Shimizu, S; Nishioka, K; Tsuji, EI; Yano, M; Sugano, S; Shimono, Y; Ishii, H; Saya, H; Mori, M; Akashi, K; Tada, KI; Ogawa, T; Tojo, A; Miyano, S; Gotoh, N				Tominaga, K.; Shimamura, T.; Kimura, N.; Murayama, T.; Matsubara, D.; Kanauchi, H.; Niida, A.; Shimizu, S.; Nishioka, K.; Tsuji, E-I; Yano, M.; Sugano, S.; Shimono, Y.; Ishii, H.; Saya, H.; Mori, M.; Akashi, K.; Tada, K-I; Ogawa, T.; Tojo, A.; Miyano, S.; Gotoh, N.			Addiction to the IGF2-ID1-IGF2 circuit for maintenance of the breast cancer stem-like cells	ONCOGENE			English	Article							NF-KAPPA-B; SIGNALING PATHWAYS; HUMAN MAMMARY; ID PROTEINS; EXPRESSION; INSULIN; INFLAMMATION; POPULATIONS; METASTASIS; REGULATORS	The transcription factor nuclear factor-kappa B (NF-kappa B) has important roles for tumorigenesis, but how it regulates cancer stem cells (CSCs) remains largely unclear. We identified insulin-like growth factor 2 (IGF2) is a key target of NF-kappa B activated by HER2/HER3 signaling to form tumor spheres in breast cancer cells. The IGF2 receptor, IGF1 R, was expressed at high levels in CSC-enriched populations in primary breast cancer cells. Moreover, IGF2-PI3K (IGF2-phosphatidyl inositol 3 kinase) signaling induced expression of a stemness transcription factor, inhibitor of DNA-binding 1 (ID1), and IGF2 itself. ID1 knockdown greatly reduced IGF2 expression, and tumor sphere formation. Finally, treatment with anti-IGF1/2 antibodies blocked tumorigenesis derived from the IGF1R(high) CSC-enriched population in a patient-derived xenograft model. Thus, NF-kappa B may trigger IGF2-ID1-IGF2-positive feedback circuits that allow cancer stem-like cells to appear. Then, they may become addicted to the circuits. As the circuits are the Achilles' heels of CSCs, it will be critical to break them for eradication of CSCs.	[Tominaga, K.; Kimura, N.; Murayama, T.; Tojo, A.; Gotoh, N.] Univ Tokyo, Inst Med Sci, Div Mol Therapy, Minato Ku, 4-6-1 Shirokanedai, Tokyo, Japan; [Tominaga, K.] Japan Soc Promot Sci, Tokyo, Japan; [Shimamura, T.; Niida, A.; Miyano, S.] Univ Tokyo, Inst Med Sci, Lab DNA informat Anal, Minato Ku, Tokyo, Japan; [Murayama, T.; Gotoh, N.] Kanazawa Univ, Canc Res Inst, Div Canc Cell Biol, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan; [Murayama, T.; Sugano, S.] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Lab Funct Genom,Minato Ku, Tokyo, Japan; [Matsubara, D.] Univ Tokyo, Inst Med Sci, Div Mol Pathol, Minato Ku, Tokyo, Japan; [Kanauchi, H.] Showa Gen Hosp, Dept Breast & Endocrine Surg, Kodaira, Tokyo, Japan; [Shimizu, S.] Showa Gen Hosp, Dept Pathol Diag, Kodaira, Tokyo, Japan; [Nishioka, K.; Tsuji, E-I; Tada, K-I; Ogawa, T.] Univ Tokyo, Grad Sch Med, Dept Breast & Endocrine Surg, Bunkyo Ku, Tokyo, Japan; [Yano, M.] Minami Machida Hosp, Dept Surg, Machida, Tokyo, Japan; [Shimono, Y.] Kobe Univ, Grad Sch Med, Div Mol & Cellular Biol, Kobe, Hyogo, Japan; [Ishii, H.] Osaka Univ, Grad Sch Med, Dept Frontier Sci Canc & Chemotherapy, Suita, Osaka, Japan; [Saya, H.] Keio Univ, Grad Sch Med, Inst Adv Med Res, Div Gene Regulat,Shinjuku Ku, Tokyo, Japan; [Mori, M.] Osaka Univ, Grad Sch Med, Dept Gastroenterol Surg, Suita, Osaka, Japan; [Akashi, K.] Kyushu Univ, Grad Sch Med, Dept Med & Biosyst Sci, Fukuoka, Japan	University of Tokyo; Japan Society for the Promotion of Science; University of Tokyo; Kanazawa University; University of Tokyo; University of Tokyo; University of Tokyo; Kobe University; Osaka University; Keio University; Osaka University; Kyushu University	Gotoh, N (corresponding author), Univ Tokyo, Inst Med Sci, Div Mol Therapy, Minato Ku, 4-6-1 Shirokanedai, Tokyo, Japan.; Gotoh, N (corresponding author), Kanazawa Univ, Canc Res Inst, Div Canc Cell Biol, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	ngotoh@ims.u-tokyo.ac.jp	Ishii, Hideshi/AAV-5317-2020; GOTOH, Noriko/D-8430-2015; Saya, Hideyuki/J-4325-2013	Shimono, Yohei/0000-0002-6256-4704; Shimamura, Teppei/0000-0003-2994-872X; Saya, Hideyuki/0000-0001-6610-1902; Gotoh, Noriko/0000-0003-3733-260X; Murayama, Takahiko/0000-0003-0764-8646; Miyano, Satoru/0000-0002-1753-6616; Tominaga, Kana/0000-0001-5136-5091	MEXT [22130009]; JSPS [15H04294]; Ministry of Health, Labor and Welfare of Japan for the Third term Comprehensive 10-year Strategy for Cancer Control; JSPS; Grants-in-Aid for Scientific Research [15K14381] Funding Source: KAKEN	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor and Welfare of Japan for the Third term Comprehensive 10-year Strategy for Cancer Control(Ministry of Health, Labour and Welfare, Japan); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank H Nakauchi, Y Ishii and A Fujita for their help with flow cytometry. We are grateful to A Umezawa for his kind gift of DHMEQ. We are grateful to S Akinaga and N Shiraishi in Kyowa Hakko Kirin Co. Ltd for their kind gift of KM1468. This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas from MEXT (22130009), a Grant-in-Aid for Scientific Research (B) from JSPS (15H04294) and a research grant from the Ministry of Health, Labor and Welfare of Japan for the Third term Comprehensive 10-year Strategy for Cancer Control (to NG). This work was supported by Grant-in-Aid for JSPS Fellows (to KT).	Ablett MP, 2012, EUR J CANCER, V48, P2104, DOI 10.1016/j.ejca.2012.03.019; AJCC, 2010, CANC STAGING MANUAL; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Anido J, 2010, CANCER CELL, V18, P655, DOI 10.1016/j.ccr.2010.10.023; Badve S, 2012, LANCET ONCOL, V13, pE43, DOI 10.1016/S1470-2045(11)70191-7; Bair E, 2006, J AM STAT ASSOC, V101, P119, DOI 10.1198/016214505000000628; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Gale NW, 1999, GENE DEV, V13, P1055, DOI 10.1101/gad.13.9.1055; Gombos A, 2012, INVEST NEW DRUG, V30, P2433, DOI 10.1007/s10637-012-9811-0; Gotoh N, 2011, CANC STEM CELLS THEO, P261; Goya M, 2004, CANCER RES, V64, P6252, DOI 10.1158/0008-5472.CAN-04-0919; Heldin CH, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-97; Hinohara K, 2012, P NATL ACAD SCI USA, V109, P6584, DOI 10.1073/pnas.1113271109; Hinohara K, 2010, CURR OPIN PHARMACOL, V10, P650, DOI 10.1016/j.coph.2010.08.003; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Korkaya H, 2011, J CLIN INVEST, V121, P3804, DOI 10.1172/JCI57099; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Lasorella A, 2014, NAT REV CANCER, V14, P77, DOI 10.1038/nrc3638; Lewitzky M, 2007, CURR OPIN BIOTECH, V18, P467, DOI 10.1016/j.copbio.2007.09.007; Loi S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-239; Miyamoto S, 2005, CLIN CANCER RES, V11, P3494, DOI 10.1158/1078-0432.CCR-04-1701; Miyoshi H, 1999, SCIENCE, V283, P682, DOI 10.1126/science.283.5402.682; Mukherjee D, 2013, AM J CANCER RES, V3, P46; Murayama T, 2016, CANCER RES, V76, P974, DOI 10.1158/0008-5472.CAN-15-2135; Murohashi M, 2010, BRIT J CANCER, V102, P206, DOI 10.1038/sj.bjc.6605468; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; O'Brien CA, 2012, CANCER CELL, V21, P777, DOI 10.1016/j.ccr.2012.04.036; Osuka S, 2013, STEM CELLS, V31, P627, DOI 10.1002/stem.1328; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Perk J, 2006, CANCER RES, V66, P10870, DOI 10.1158/0008-5472.CAN-06-2643; Perry SS, 2007, BLOOD, V110, P2351, DOI 10.1182/blood-2007-01-069914; Plaks V, 2015, CELL STEM CELL, V16, P225, DOI 10.1016/j.stem.2015.02.015; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Sansone P, 2011, CURR OPIN GENET DEV, V21, P80, DOI 10.1016/j.gde.2010.11.001; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Sottoriva A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001132; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; SUN XH, 1991, MOL CELL BIOL, V11, P5603, DOI 10.1128/MCB.11.11.5603; Valent P, 2012, NAT REV CANCER, V12, P767, DOI 10.1038/nrc3368; Wee ZN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9746; Yamamoto M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3299; Yamauchi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043923; Yarden Y, 2012, NAT REV CANCER, V12, P553, DOI 10.1038/nrc3309; Yi TF, 2014, P NATL ACAD SCI USA, V111, pE2182, DOI 10.1073/pnas.1404943111; Zardavas D, 2013, NAT REV CLIN ONCOL, V10, P191, DOI 10.1038/nrclinonc.2013.29	51	44	45	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2017	36	9					1276	1286		10.1038/onc.2016.293	http://dx.doi.org/10.1038/onc.2016.293			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EN2SV	27546618	Green Published, hybrid			2022-12-26	WOS:000395861300011
J	ElRamlawy, KG; Fujimura, T; Baba, K; Kim, JW; Kawamoto, C; Isobe, T; Abe, T; Hodge-Hanson, K; Downs, DM; Refaat, IH; Al-Azhary, DB; Aki, T; Asaoku, Y; Hayashi, T; Katsutani, T; Tsuboi, S; Ono, K; Kawamoto, S				ElRamlawy, Kareem Gamal; Fujimura, Takashi; Baba, Koji; Kim, Ji Won; Kawamoto, Chika; Isobe, Toshihide; Abe, Takuya; Hodge-Hanson, Kelsey; Downs, Diana M.; Refaat, Inas Hussein; Al-Azhary, Diaa Beshr; Aki, Tsunehiro; Asaoku, Yoshiko; Hayashi, Takaharu; Katsutani, Takashi; Tsuboi, Shinji; Ono, Kazuhisa; Kawamoto, Seiji			Der f 34, a Novel Major House Dust Mite Allergen Belonging to a Highly Conserved Rid/YjgF/YER057c/UK114 Family of Imine Deaminases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allergen; allergy; Aspergillus; asthma; fungi; immunoglobulin E (IgE); Rid; YjgF; YER057c; UK114 family; house dust mite; imine deaminase	CRYPTOMERIA-JAPONICA POLLEN; SERINE-PROTEASE ALLERGEN; OF-THE-ART; DERMATOPHAGOIDES-FARINAE; INTERNATIONAL CONSENSUS; GENOME SEQUENCE; CLONING; IMMUNOTHERAPY; PTERONYSSINUS; BINDING	The high prevalence of house dust mite (HDM) allergy is a growing health problem worldwide, and the characterization of clinically important HDM allergens is a prerequisite for the development of diagnostic and therapeutic strategies. Here, we report a novel HDM allergen that belongs structurally to the highly conserved Rid/YjgF/YER057c/UK114 family (Rid family) with imine deaminase activity. Isolated HDM cDNA, named der f 34, encodes 128 amino acids homologous to Rid-like proteins. This new protein belongs to the Rid family and has seven conserved residues involved in enamine/imine deaminase activity. Indeed, we demonstrated that purified Der f 34 had imine deaminase activity that preferentially acted on leucine and methionine. Native Der f 34 showed a high IgE binding frequency as revealed by two-dimensional immunoblotting (62.5%) or ELISA (68%), which was comparable with those of a major HDM allergen Der f 2 (77.5 and 79%, respectively). We also found that Der f 34 showed cross-reactivity with another prominent indoor allergen source, Aspergillus fumigatus. This is the first report showing that the Rid family imine deaminase represents an additional important pan-allergen that is conserved across organisms.	[ElRamlawy, Kareem Gamal; Fujimura, Takashi; Baba, Koji; Kim, Ji Won; Kawamoto, Chika; Isobe, Toshihide; Abe, Takuya; Aki, Tsunehiro; Ono, Kazuhisa; Kawamoto, Seiji] Hiroshima Univ, Grad Sch Adv Sci Matter, Dept Mol Biotechnol, Hiroshima Res Ctr Healthy Aging HiHA, 1-3-1 Kagamiyama, Hiroshima 7398530, Japan; [ElRamlawy, Kareem Gamal; Refaat, Inas Hussein; Al-Azhary, Diaa Beshr] Menia Univ, Fac Sci, Dept Zool, Al Minya 61519, Egypt; [Hodge-Hanson, Kelsey; Downs, Diana M.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Asaoku, Yoshiko; Hayashi, Takaharu] Takanobashi Cent Hosp, Hiroshima, Hiroshima 7300042, Japan; [Katsutani, Takashi] Katsutani Ogasawara Clin, Hiroshima 7380042, Japan; [Tsuboi, Shinji] Tsuboi Clin, Hiroshima 7390613, Japan; [Ono, Kazuhisa] Hiroshima Inst Technol, Fac Life Sci, Dept Food Sci & Biotechnol, Hiroshima, Hiroshima 7315193, Japan	Hiroshima University; Egyptian Knowledge Bank (EKB); Minia University; University System of Georgia; University of Georgia; Hiroshima Institute of Technology	Fujimura, T; Kawamoto, S (corresponding author), Hiroshima Univ, Grad Sch Adv Sci Matter, Dept Mol Biotechnol, 1-3-1 Kagamiyama, Hiroshima 7398530, Japan.	fmuratks@hiroshima-u.ac.jp; skawa@hiroshima-u.ac.jp	Aki, Tsunehiro/B-6719-2012; Kawamoto, Seiji/F-3423-2015; Fujimura, Takashi/V-5310-2017	Aki, Tsunehiro/0000-0001-9753-2043; Kawamoto, Seiji/0000-0002-2056-4802; Fujimura, Takashi/0000-0001-7442-5974; refaat, inas/0000-0002-5432-062X	JSPS KAKENHI [14360209]; National Institutes of Health [GMO95837]; Ministry of higher education (MoHE), Egypt; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095837] Funding Source: NIH RePORTER	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of higher education (MoHE), Egypt(Ministry of Higher Education & Scientific Research (MHESR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Grant-in-Aid for Scientific Research (B), JSPS KAKENHI Grant 14360209 (to K. O. and S. K.), and National Institutes of Health Grant GMO95837 (to D. M. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the Ministry of higher education (MoHE), Egypt.	AKI T, 1995, J ALLERGY CLIN IMMUN, V96, P74, DOI 10.1016/S0091-6749(95)70035-8; AKI T, 1994, INT ARCH ALLERGY IMM, V103, P349, DOI 10.1159/000236653; AKI T, 1994, J BIOCHEM, V115, P435, DOI 10.1093/oxfordjournals.jbchem.a124356; ARRUDA LK, 1990, J EXP MED, V172, P1529, DOI 10.1084/jem.172.5.1529; Asaoku Y, 1995, Arerugi, V44, P692; Baldacci S, 2015, RESP MED, V109, P1089, DOI 10.1016/j.rmed.2015.05.017; Bennett BJ, 1996, CLIN EXP ALLERGY, V26, P1150, DOI 10.1111/j.1365-2222.1996.tb00501.x; Boden R, 2011, J BACTERIOL, V193, P7001, DOI 10.1128/JB.06267-11; Ceciliani F, 1996, FEBS LETT, V393, P147, DOI 10.1016/0014-5793(96)00850-2; Chruszcz M, 2009, J MOL BIOL, V386, P520, DOI 10.1016/j.jmb.2008.12.049; Colabroy KL, 2005, J BACTERIOL, V187, P7866, DOI 10.1128/JB.187.22.7866-7869.2005; DAVIS L, 1965, ANAL BIOCHEM, V12, P36, DOI 10.1016/0003-2697(65)90139-9; Farkas A, 2004, BIOCHEM J, V383, P165, DOI 10.1042/BJ20040668; Fujii S, 1996, IMMUNOL LETT, V49, P37, DOI 10.1016/0165-2478(95)02475-1; Fujikawa A, 1998, CLIN EXP ALLERGY, V28, P1549, DOI 10.1046/j.1365-2222.1998.00433.x; Fujikawa A, 1996, MOL IMMUNOL, V33, P311, DOI 10.1016/0161-5890(95)00127-1; Fujimura T, 2005, CLIN EXP ALLERGY, V35, P234, DOI 10.1111/j.1365-2222.2005.02167.x; Fujimura T, 2004, INT ARCH ALLERGY IMM, V133, P125, DOI 10.1159/000076438; Fujimura T, 2015, ALLERGOL INT, V64, P312, DOI 10.1016/j.alit.2015.05.008; Fujimura Takashi, 2010, Allergology International, V59, P21, DOI 10.2332/allergolint.09-RAI-0151; Funaro A, 1999, EXP CELL RES, V247, P441, DOI 10.1006/excr.1998.4384; Hauser Michael, 2010, Allergy Asthma Clin Immunol, V6, P1, DOI 10.1186/1710-1492-6-1; Ichikawa S, 2009, GENES CELLS, V14, P1055, DOI 10.1111/j.1365-2443.2009.01334.x; Jutel M, 2016, J ALLERGY CLIN IMMUN, V137, P358, DOI 10.1016/j.jaci.2015.12.1300; Jutel M, 2015, J ALLERGY CLIN IMMUN, V136, P556, DOI 10.1016/j.jaci.2015.04.047; Kamijo S, 2013, J IMMUNOL, V190, P4489, DOI 10.4049/jimmunol.1201212; Kawamoto S, 2002, J BIOSCI BIOENG, V94, P285, DOI 10.1016/S1389-1723(02)80166-9; Kawamoto S, 2002, FEBS LETT, V516, P234, DOI 10.1016/S0014-5793(02)02540-1; Kawamoto S, 1999, BBA-MOL BASIS DIS, V1454, P201, DOI 10.1016/S0925-4439(99)00041-1; King C, 1996, J ALLERGY CLIN IMMUN, V98, P739, DOI 10.1016/S0091-6749(96)70121-5; Lambrecht JA, 2012, J BIOL CHEM, V287, P3454, DOI 10.1074/jbc.M111.304477; Lambrecht JA, 2010, J BIOL CHEM, V285, P34401, DOI 10.1074/jbc.M110.160515; Morishita R, 1999, J BIOL CHEM, V274, P20688, DOI 10.1074/jbc.274.29.20688; Niehaus TD, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1584-3; Niehaus TD, 2014, PLANT CELL, V26, P3010, DOI 10.1105/tpc.114.126854; Nishiyama C, 1995, FEBS LETT, V377, P62, DOI 10.1016/0014-5793(95)01291-5; Oh HM, 2010, J BACTERIOL, V192, P4530, DOI 10.1128/JB.00683-10; Panerai AE, 1999, ANN NY ACAD SCI, V876, P229, DOI 10.1111/j.1749-6632.1999.tb07643.x; Racca S, 1997, VIRCHOWS ARCH, V431, P323, DOI 10.1007/s004280050106; Rittmeyer D, 2012, INT ARCH ALLERGY IMM, V159, P216, DOI 10.1159/000338994; Shigeta S, 1995, Arerugi, V44, P170; Singh Kumar Saurabh, 2014, J Genomics, V2, P118, DOI 10.7150/jgen.9123; SMITH WA, 1994, CLIN EXP ALLERGY, V24, P220, DOI 10.1111/j.1365-2222.1994.tb00223.x; Takenaka S, 2000, ARCH MICROBIOL, V174, P265, DOI 10.1007/s002030000203; Thomas WR, 2015, ALLERGOL INT, V64, P304, DOI 10.1016/j.alit.2015.05.004; To T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-204; Weghofer M, 2013, J IMMUNOL, V190, P3059, DOI 10.4049/jimmunol.1202288; YASUEDA H, 1993, CLIN EXP ALLERGY, V23, P384, DOI 10.1111/j.1365-2222.1993.tb00343.x; Zhou L, 2013, MOL MICROBIOL, V87, P80, DOI 10.1111/mmi.12084	49	15	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21607	21615		10.1074/jbc.M116.728006	http://dx.doi.org/10.1074/jbc.M116.728006			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27539850	Green Published, hybrid			2022-12-26	WOS:000385999200027
J	Martiniuk, JT; Pacheco, B; Russell, G; Tong, S; Backstrom, I; Measday, V				Martiniuk, Jonathan T.; Pacheco, Braydon; Russell, Gordon; Tong, Stephanie; Backstrom, Ian; Measday, Vivien			Impact of Commercial Strain Use on Saccharomyces cerevisiae Population Structure and Dynamics in Pinot Noir Vineyards and Spontaneous Fermentations of a Canadian Winery	PLOS ONE			English	Article							ALCOHOLIC FERMENTATION; YEAST POPULATIONS; GENETIC-ANALYSIS; R PACKAGE; DIVERSITY; GRAPE; DISSEMINATION; SURVIVAL; ECOLOGY; REGION	Wine is produced by one of two methods: inoculated fermentation, where a commercially-produced, single Saccharomyces cerevisiae (S. cerevisiae) yeast strain is used; or the traditional spontaneous fermentation, where yeast present on grape and winery surfaces carry out the fermentative process. Spontaneous fermentations are characterized by a diverse succession of yeast, ending with one or multiple strains of S. cerevisiae dominating the fermentation. In wineries using both fermentation methods, commercial strains may dominate spontaneous fermentations. We elucidate the impact of the winery environment and commercial strain use on S. cerevisiae population structure in spontaneous fermentations over two vintages by comparing S. cerevisiae populations in aseptically fermented grapes from a Canadian Pinot Noir vineyard to S. cerevisiae populations in winery-conducted fermentations of grapes from the same vineyard. We also characterize the vineyard-associated S. cerevisiae populations in two other geographically separate Pinot Noir vineyards farmed by the same winery. Winery fermentations were not dominated by commercial strains, but by a diverse number of strains with genotypes similar to commercial strains, suggesting that a population of S. cerevisiae derived from commercial strains is resident in the winery. Commercial and commercial-related yeast were also identified in the three vineyards examined, although at a lower frequency. There is low genetic differentiation and S. cerevisiae population structure between vineyards and between the vineyard and winery that persisted over both vintages, indicating commercial yeast are a driver of S. cerevisiae population structure. We also have evidence of distinct and persistent populations of winery and vineyard-associated S. cerevisiae populations unrelated to commercial strains. This study is the first to characterize S. cerevisiae populations in Canadian vineyards.	[Martiniuk, Jonathan T.; Pacheco, Braydon; Russell, Gordon; Tong, Stephanie; Backstrom, Ian; Measday, Vivien] Univ British Columbia, Wine Res Ctr, Vancouver, BC, Canada	University of British Columbia	Measday, V (corresponding author), Univ British Columbia, Wine Res Ctr, Vancouver, BC, Canada.	vmeasday@mail.ubc.ca		Backstrom, Ian/0000-0003-2203-540X	Natural Sciences and Engineering Research Council of Canada [EGP 461955-13, RGPIN 326924-11]; Genome British Columbia (GBC); Stoneboat Vineyards (SBV) under the GBC User Partnership Program [UPP015]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Genome British Columbia (GBC); Stoneboat Vineyards (SBV) under the GBC User Partnership Program	This study was funded by Engage and Discovery Grants from the Natural Sciences and Engineering Research Council of Canada (EGP 461955-13, RGPIN 326924-11) and by Genome British Columbia (GBC) including a financial contribution from Stoneboat Vineyards (SBV) under the GBC User Partnership Program (UPP015). SBV conducted winery fermentations according to the authors' plans. Lallemand and Cellar-Tek donated some commercial yeast strains used in this manuscript. The donation of strains by Cellar-Tek was made without any conditions. The authors have a Material Transfer Agreement (MTA) with Lallemand for certain commercial yeast strains. Under the terms of the authors' MTA, Lallemand has the right to review the manuscript prior to publication. The funders had no additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberto F, 2009, J HERED, V100, P394, DOI 10.1093/jhered/esn110; Bardou P, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-293; Beltran G, 2002, SYST APPL MICROBIOL, V25, P287, DOI 10.1078/072320202320386479; Bisson LF, 2012, AM J ENOL VITICULT, V63, P165, DOI 10.5344/ajev.2012.11083; Blanco P, 2011, J IND MICROBIOL BIOT, V38, P235, DOI 10.1007/s10295-010-0818-2; Borlin M, 2016, APPL ENVIRON MICROB, V82, P2909, DOI 10.1128/AEM.03627-15; Bradbury JE, 2006, ANTON LEEUW INT J G, V89, P27, DOI 10.1007/s10482-005-9006-1; Bruvo R, 2004, MOL ECOL, V13, P2101, DOI 10.1111/j.1365-294X.2004.02209.x; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Ciani M, 2004, ANTON LEEUW INT J G, V85, P159, DOI 10.1023/B:ANTO.0000020284.05802.d7; Clemente-Jimenez JM, 2004, FOOD MICROBIOL, V21, P149, DOI 10.1016/S0740-0020(03)00063-7; Constanti M, 1997, AM J ENOL VITICULT, V48, P339; Cromie GA, 2013, G3-GENES GENOM GENET, V3, P2163, DOI 10.1534/g3.113.007492; Fay JC, 2005, PLOS GENET, V1, P66, DOI 10.1371/journal.pgen.0010005; Fleet GH, 2003, INT J FOOD MICROBIOL, V86, P11, DOI 10.1016/S0168-1605(03)00245-9; Fleet GH, 2008, FEMS YEAST RES, V8, P979, DOI 10.1111/j.1567-1364.2008.00427.x; Francesca N, 2012, ENV MICROBIOL REP, V4, P105, DOI 10.1111/j.1758-2229.2011.00310.x; Franco-Duarte R, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov063; FREZIER V, 1992, AM J ENOL VITICULT, V43, P375; FUGELSANG KC, 2007, WIN MICR PRACT APPL, pR15; Gao H, 2007, GENETICS, V176, P1635, DOI 10.1534/genetics.107.072371; Gao H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021014; Gayevskiy V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085196; Gayevskiy V, 2012, ISME J, V6, P1281, DOI 10.1038/ismej.2011.195; Goddard MR, 2008, ECOLOGY, V89, P2077, DOI 10.1890/07-2060.1; Goddard MR, 2010, ENVIRON MICROBIOL, V12, P63, DOI 10.1111/j.1462-2920.2009.02035.x; Hall B, 2011, AM J ENOL VITICULT, V62, P66, DOI 10.5344/ajev.2010.10054; HEARD GM, 1986, J APPL BACTERIOL, V60, P477, DOI 10.1111/j.1365-2672.1986.tb01086.x; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Hyma KE, 2013, MOL ECOL, V22, P2917, DOI 10.1111/mec.12155; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; Knight S, 2015, SCI REP-UK, V5, DOI 10.1038/srep14233; Knight S, 2015, ISME J, V9, P361, DOI 10.1038/ismej.2014.132; Knop M, 2006, BIOESSAYS, V28, P696, DOI 10.1002/bies.20435; Legras JL, 2007, MOL ECOL, V16, P2091, DOI 10.1111/j.1365-294X.2007.03266.x; Ling MF, 1995, NUCLEIC ACIDS RES, V23, P4924, DOI 10.1093/nar/23.23.4924; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Mercado L, 2007, FOOD MICROBIOL, V24, P403, DOI 10.1016/j.fm.2006.06.005; OIV, 2010, MICR AN WIN MUSTS ME, P1; Oksanen J., 2019, VEGAN COMMUNITY ECOL; Pallmann CL, 2001, AM J ENOL VITICULT, V52, P198; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pretorius IS, 2000, YEAST, V16, P675, DOI 10.1002/1097-0061(20000615)16:8<675::AID-YEA585>3.0.CO;2-B; QUEROL A, 1990, J FOOD SCI, V55, P1603, DOI 10.1111/j.1365-2621.1990.tb03580.x; R Core Team, 2016, R FDN STAT COMP; Richards KD, 2009, ANTON LEEUW INT J G, V96, P355, DOI 10.1007/s10482-009-9346-3; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Santamaria P, 2005, INT J FOOD MICROBIOL, V103, P49, DOI 10.1016/j.ijfoodmicro.2004.11.024; Schacherer J, 2009, NATURE, V458, P342, DOI 10.1038/nature07670; Scholl CM, 2016, AUST J GRAPE WINE R, DOI [10.1111/ajgw.122211016/j.femsec.2004.08.003, DOI 10.1111/AJGW.122211016/J.FEMSEC.2004.08.003]; Schuller D, 2005, FEMS MICROBIOL ECOL, V51, P167, DOI 10.1016/j.femsec.2004.08.003; Schuller D, 2004, FEMS MICROBIOL LETT, V231, P19, DOI 10.1016/S0378-1097(03)00928-5; Schuller D, 2007, YEAST, V24, P625, DOI 10.1002/yea.1496; Schuller D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032507; Sipiczki M, 2011, ANN MICROBIOL, V61, P85, DOI 10.1007/s13213-010-0086-4; SPSS Inc, 2015, SPSS WINDOWS; Stefanini I, 2012, P NATL ACAD SCI USA, V109, P13398, DOI 10.1073/pnas.1208362109; Tello J, 2012, J APPL MICROBIOL, V112, P302, DOI 10.1111/j.1365-2672.2011.05202.x; Toonen RJ, 2001, BIOTECHNIQUES, V31, P1320; Torija MJ, 2001, ANTON LEEUW INT J G, V79, P345, DOI 10.1023/A:1012027718701; Valero E, 2005, FEMS YEAST RES, V5, P959, DOI 10.1016/j.femsyr.2005.04.007; Valero E, 2007, FEMS YEAST RES, V7, P317, DOI 10.1111/j.1567-1364.2006.00161.x	65	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0160259	10.1371/journal.pone.0160259	http://dx.doi.org/10.1371/journal.pone.0160259			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27551920	Green Submitted, Green Published, gold			2022-12-26	WOS:000381768800010
J	Adhikari, P; Feigl, B; Zele, AJ				Adhikari, Prakash; Feigl, Beatrix; Zele, Andrew J.			Rhodopsin and Melanopsin Contributions to the Early Redilation Phase of the Post-Illumination Pupil Response (PIPR)	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; LIGHT REFLEX; PRIMATE RETINA; ASSESSING ROD; CONE; GLAUCOMA; DISEASE; HUMANS; AGE; PUPILLOMETRY	Melanopsin expressing intrinsically photosensitive Retinal Ganglion Cells (ipRGCs) entirely control the post-illumination pupil response (PIPR) from 6 s post-stimulus to the plateau during redilation after light offset. However, the photoreceptor contributions to the early redilation phase of the PIPR (< 6 s post-stimulus) have not been reported. Here, we evaluated the photoreceptor contributions to the early phase PIPR (0.6 s to 5.0 s) by measuring the spectral sensitivity of the criterion PIPR amplitude in response to 1 s light pulses at five narrow-band stimulus wavelengths (409, 464, 508, 531 and 592 nm). The retinal irradiance producing a criterion PIPR was normalised to the peak and fitted by either a single photopigment nomogram or the combined melanopsin and rhodopsin spectral nomograms with the +L+M cone photopic luminous efficiency (V lambda) function. We show that the PIPR spectral sensitivity at times >= 1.7 s after light offset is best described by the melanopsin nomogram. At times < 1.7 s, the peak PIPR sensitivity shifts to longer wavelengths (range: 482 to 498 nm) and is best described by the combined photoreceptor nomogram, with major contributions from melanopsin and rhodopsin. This first report of melanopsin and rhodopsin contributions to the early phase PIPR is in line with the electrophysiological findings of ipRGC and rod signalling after the cessation of light stimuli and provides a cut-off time for isolating photoreceptor specific function in healthy and diseased eyes.	[Adhikari, Prakash; Feigl, Beatrix; Zele, Andrew J.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Visual Sci Lab, Brisbane, Qld, Australia; [Adhikari, Prakash; Feigl, Beatrix; Zele, Andrew J.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Med Retina Lab, Brisbane, Qld, Australia; [Adhikari, Prakash; Zele, Andrew J.] Queensland Univ Technol, Sch Optometry & Vis Sci, Brisbane, Qld, Australia; [Feigl, Beatrix] Queensland Univ Technol, Sch Biomed Sci, Brisbane, Qld, Australia; [Feigl, Beatrix] Queensland Eye Inst, Brisbane, Qld, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT); Queensland University of Technology (QUT); Queensland University of Technology (QUT); Queensland Eye Institute	Zele, AJ (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Visual Sci Lab, Brisbane, Qld, Australia.; Zele, AJ (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Med Retina Lab, Brisbane, Qld, Australia.; Zele, AJ (corresponding author), Queensland Univ Technol, Sch Optometry & Vis Sci, Brisbane, Qld, Australia.	andrew.zele@qut.edu.au	Adhikari, Prakash/AFO-8162-2022	Adhikari, Prakash/0000-0003-4834-8500; Zele, Andrew/0000-0003-0291-9929; Feigl, Beatrix/0000-0001-7198-7373	Australian Research Council [ARC-DP140100333]; Institute of Health and Biomedical Innovation Vision and Eye Program Grant	Australian Research Council(Australian Research Council); Institute of Health and Biomedical Innovation Vision and Eye Program Grant	This work was supported by Australian Research Council Discovery Projects ARC-DP140100333 (AJZ, BF) (URL: http://www.arc.gov.au/discovery-projects) and an Institute of Health and Biomedical Innovation Vision and Eye Program Grant (AJZ, BF) (URL: http://www.qut.edu.au/institute-of-health-and-biomedical-innovation). None of the authors received a salary from any of the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari P, 2016, QUADRANT FI IN PRESS; Adhikari P, 2015, SCI REP-UK, V5, DOI 10.1038/srep17610; Adhikari P, 2015, INVEST OPHTH VIS SCI, V56, P3838, DOI 10.1167/iovs.14-16233; Barrionuevo PA, 2014, INVEST OPHTH VIS SCI, V55, P719, DOI 10.1167/iovs.13-13252; Beer RD, 2005, BEHAV RES METHODS, V37, P513, DOI 10.3758/BF03192722; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BONE RA, 1988, INVEST OPHTH VIS SCI, V29, P843; Braggio S, 1996, J PHARMACEUT BIOMED, V14, P375, DOI 10.1016/0731-7085(95)01644-9; Cao DC, 2015, J VISION, V15, DOI 10.1167/15.1.27; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; *CIE, 1988, CIE PUBL; COLLINS FD, 1950, BIOCHEM J, V47, P3, DOI 10.1042/bj0470003; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; DARTNALL HJA, 1953, BRIT MED BULL, V9, P24, DOI 10.1093/oxfordjournals.bmb.a074302; Feigl B, 2014, OPTOMETRY VISION SCI, V91, P894, DOI 10.1097/OPX.0000000000000284; Feigl B, 2012, ACTA OPHTHALMOL, V90, pe230, DOI 10.1111/j.1755-3768.2011.02226.x; Feigl B, 2011, INVEST OPHTH VIS SCI, V52, P4362, DOI 10.1167/iovs.10-7069; Gamlin PDR, 2007, VISION RES, V47, P946, DOI 10.1016/j.visres.2006.12.015; Gooley JJ, 2012, J NEUROSCI, V32, P14242, DOI 10.1523/JNEUROSCI.1321-12.2012; Gracitelli CPB, 2014, INVEST OPHTH VIS SCI, V55, P7997, DOI 10.1167/iovs.14-15146; Graham N.V.S, 1989, VISUAL PATTERN ANAL; Hansen RM, 2003, INVEST OPHTH VIS SCI, V44, pU60; Heikkinen H, 2008, VISION RES, V48, P264, DOI 10.1016/j.visres.2007.11.005; Herbst K., 2011, FRONT NEUROL, V2, P1; Joyce DS, 2015, VISION RES, V107, P58, DOI 10.1016/j.visres.2014.12.001; Jusuf PR, 2007, EUR J NEUROSCI, V26, P2906, DOI 10.1111/j.1460-9568.2007.05924.x; Kankipati L, 2010, INVEST OPHTH VIS SCI, V51, P2764, DOI 10.1167/iovs.09-4717; Kardon R, 2009, OPHTHALMOLOGY, V116, P1564, DOI 10.1016/j.ophtha.2009.02.007; Kuhne Wilhelm, 1878, PHOTOCHEMISTRY RETIN; Lei SB, 2014, INVEST OPHTH VIS SCI, V55, P4496, DOI 10.1167/iovs.14-14103; Liao HW, 2016, J COMP NEUROL IN PRE; Markwell EL, 2010, CLIN EXP OPTOM, V93, P137, DOI 10.1111/j.1444-0938.2010.00479.x; Maynard ML, 2015, INVEST OPHTH VIS SCI, V56, P6906, DOI 10.1167/iovs.15-17357; McDougal DH, 2010, VISION RES, V50, P72, DOI 10.1016/j.visres.2009.10.012; Mendez A, 2000, NEURON, V28, P153, DOI 10.1016/S0896-6273(00)00093-3; Munch M, 2015, SCI REP-UK, V5, DOI 10.1038/srep15185; Munch M, 2012, INVEST OPHTH VIS SCI, V53, P4546, DOI 10.1167/iovs.12-9494; Neitz M, 1998, MOL GENETICS BIOL BA, P101; Nissen C, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00015; NYGAARD RW, 1982, VISION RES, V22, P433, DOI 10.1016/0042-6989(82)90189-4; Park JC, 2011, INVEST OPHTH VIS SCI, V52, P6624, DOI 10.1167/iovs.11-7586; POKORNY J, 1993, J OPT SOC AM A, V10, P1304, DOI 10.1364/JOSAA.10.001304; QUICK RF, 1974, KYBERNETIK, V16, P65, DOI 10.1007/BF00271628; Roecklein K, 2013, PSYCHIAT RES, V210, P150, DOI 10.1016/j.psychres.2013.05.023; Spitschan M, 2014, P NATL ACAD SCI USA, V111, P15568, DOI 10.1073/pnas.1400942111; Stockman A, 2000, VISION RES, V40, P1711, DOI 10.1016/S0042-6989(00)00021-3; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P6481, DOI 10.1073/pnas.88.15.6481; Troland LT, 1915, PSYCHOL REV, V22, P167, DOI 10.1037/h0073849; Tsika C, 2015, SCI REP-UK, V5, DOI 10.1038/srep10780; Tsujimura S, 2011, OPHTHAL PHYSL OPT, V31, P469, DOI 10.1111/j.1475-1313.2011.00846.x; van de Kraats J, 2007, J OPT SOC AM A, V24, P1842, DOI 10.1364/JOSAA.24.001842; Vinberg F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013025; WEBSTER JG, 1968, J OPT SOC AM, V58, P419, DOI 10.1364/JOSA.58.000419; Wyszecki G, 1982, COLOR SCI, Vsecond; Young RSL, 2008, VISION RES, V48, P862, DOI 10.1016/j.visres.2007.12.016; Zele AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017860	56	40	40	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161175	10.1371/journal.pone.0161175	http://dx.doi.org/10.1371/journal.pone.0161175			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548480	Green Published, gold, Green Submitted			2022-12-26	WOS:000381768400032
J	Baghirov, H; Karaman, D; Viitala, T; Duchanoy, A; Lou, YR; Mamaeva, V; Pryazhnikov, E; Khiroug, L; Davies, CD; Sahlgren, C; Rosenholm, JM				Baghirov, Habib; Karaman, Didem; Viitala, Tapani; Duchanoy, Alain; Lou, Yan-Ru; Mamaeva, Veronika; Pryazhnikov, Evgeny; Khiroug, Leonard; Davies, Catharina de Lange; Sahlgren, Cecilia; Rosenholm, Jessica M.			Feasibility Study of the Permeability and Uptake of Mesoporous Silica Nanoparticles across the Blood-Brain Barrier	PLOS ONE			English	Article							BIOMEDICAL APPLICATIONS; IN-VITRO; CELLS; EXOCYTOSIS; NANOCARRIERS; ENDOCYTOSIS; DETERMINES; ABSORPTION; MECHANISM; TRANSPORT	Drug delivery into the brain is impeded by the blood-brain-barrier (BBB) that filters out the vast majority of drugs after systemic administration. In this work, we assessed the transport, uptake and cytotoxicity of promising drug nanocarriers, mesoporous silica nanoparticles (MSNs), in in vitro models of the BBB. RBE4 rat brain endothelial cells and Madin-Darby canine kidney epithelial cells, strain II, were used as BBB models. We studied spherical and rod-shaped MSNs with the following modifications: bare MSNs and MSNs coated with a poly (ethylene glycol)-poly(ethylene imine) (PEG-PEI) block copolymer. In transport studies, MSNs showed low permeability, whereas the results of the cellular uptake studies suggest robust uptake of PEG-PEI-coated MSNs. None of the MSNs showed significant toxic effects in the cell viability studies. While the shape effect was detectable but small, especially in the real-time surface plasmon resonance measurements, coating with PEG-PEI copolymers clearly facilitated the uptake of MSNs. Finally, we evaluated the in vivo detectability of one of the best candidates, i.e. the copolymer-coated rod-shaped MSNs, by two-photon in vivo imaging in the brain vasculature. The particles were clearly detectable after intravenous injection and caused no damage to the BBB. Thus, when properly designed, the uptake of MSNs could potentially be utilized for the delivery of drugs into the brain via transcellular transport.	[Baghirov, Habib; Mamaeva, Veronika; Sahlgren, Cecilia] Univ Turku, Turku Ctr Biotechnol, Turku, Finland; [Baghirov, Habib; Mamaeva, Veronika; Sahlgren, Cecilia] Abo Akad Univ, Turku, Finland; [Baghirov, Habib; Karaman, Didem; Duchanoy, Alain; Rosenholm, Jessica M.] Abo Akad Univ, Fac Sci & Engn, Phys Chem Lab, Turku, Finland; [Baghirov, Habib; Sahlgren, Cecilia] Abo Akad Univ, Fac Sci & Engn, Cell Biol, Turku, Finland; [Baghirov, Habib; Davies, Catharina de Lange] Norwegian Univ Sci & Technol, Dept Phys, Trondheim, Norway; [Karaman, Didem; Rosenholm, Jessica M.] Abo Akad Univ, Fac Sci & Engn, Pharmaceut Sci Lab, Turku, Finland; [Viitala, Tapani; Lou, Yan-Ru] Univ Helsinki, Div Pharmaceut Biosci, Ctr Drug Res, Helsinki, Finland; [Pryazhnikov, Evgeny; Khiroug, Leonard] Neurotar LtD, Helsinki, Finland; [Sahlgren, Cecilia] Eindhoven Univ Technol, Eindhoven, Netherlands	University of Turku; Abo Akademi University; Abo Akademi University; Abo Akademi University; Norwegian University of Science & Technology (NTNU); Abo Akademi University; University of Helsinki; Eindhoven University of Technology	Sahlgren, C (corresponding author), Univ Turku, Turku Ctr Biotechnol, Turku, Finland.; Sahlgren, C (corresponding author), Abo Akad Univ, Turku, Finland.; Rosenholm, JM (corresponding author), Abo Akad Univ, Fac Sci & Engn, Phys Chem Lab, Turku, Finland.; Sahlgren, C (corresponding author), Abo Akad Univ, Fac Sci & Engn, Cell Biol, Turku, Finland.; Rosenholm, JM (corresponding author), Abo Akad Univ, Fac Sci & Engn, Pharmaceut Sci Lab, Turku, Finland.; Sahlgren, C (corresponding author), Eindhoven Univ Technol, Eindhoven, Netherlands.	csahlgre@btk.fi; jerosenh@abo.fi	Karaman, Didem Sen/AAA-4738-2020; Lou, Yan-Ru/K-4348-2012; Viitala, Tapani/N-1434-2014; Rosenholm, Jessica Marianne/H-2542-2012; Lou, Yan-Ru/AAX-4008-2020	Karaman, Didem Sen/0000-0002-2368-9598; Lou, Yan-Ru/0000-0001-7717-6010; Viitala, Tapani/0000-0001-9074-9450; Rosenholm, Jessica Marianne/0000-0001-6085-1112; Lou, Yan-Ru/0000-0001-7717-6010; Baghirov, Habib/0000-0002-3441-9825; Sahlgren, Cecilia/0000-0003-3350-4937	Academy of Finland [140193, 137101, 260599, 137053, 263861]; Norwegian Research Council [Biotek2021 226159, Nano2021 220005]; Center for Functional Materials; Graduate School of Materials Research; Neurotar LtD	Academy of Finland(Academy of Finland); Norwegian Research Council(Research Council of NorwayEuropean Commission); Center for Functional Materials; Graduate School of Materials Research; Neurotar LtD	Funding for this research work was provided by the Academy of Finland project #140193: "Targeting of cancer cells by design - Nanoparticles as theranostic agents" (JR). Other supporting funding sources the authors acknowledge are Norwegian Research Council projects (Biotek2021 226159 and Nano2021 220005), Academy of Finland projects (#137101, #260599, #137053 and #263861) (CD), Center for Functional Materials (DSK) and Graduate School of Materials Research (AD). Neurotar LtD provided support in the form of salaries for authors EP and LK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; ARTURSSON P, 1991, BIOCHEM BIOPH RES CO, V175, P880, DOI 10.1016/0006-291X(91)91647-U; Barandeh F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029424; Chabot V, 2009, BIOSENS BIOELECTRON, V24, P1667, DOI 10.1016/j.bios.2008.08.025; Chen Y, 2014, EXPERT OPIN DRUG DEL, V11, P917, DOI 10.1517/17425247.2014.908181; Chithrani BD, 2007, NANO LETT, V7, P1542, DOI 10.1021/nl070363y; Desai D, 2014, MESOPOROUS BIOMATERI, V1, P28; Fazlollahi F, 2011, NANOMED-NANOTECHNOL, V7, P588, DOI 10.1016/j.nano.2011.01.008; Gratton SEA, 2008, P NATL ACAD SCI USA, V105, P11613, DOI 10.1073/pnas.0801763105; Gu J, 2007, SMALL, V3, P1740, DOI 10.1002/smll.200700311; Hanada S, 2014, INT J MOL SCI, V15, P1812, DOI 10.3390/ijms15021812; Harush-Frenkel O, 2008, BIOMACROMOLECULES, V9, P435, DOI 10.1021/bm700535p; He QJ, 2009, SMALL, V5, P2722, DOI 10.1002/smll.200900923; Huang XL, 2010, BIOMATERIALS, V31, P438, DOI 10.1016/j.biomaterials.2009.09.060; Jain KK, 2012, NANOMEDICINE-UK, V7, P1225, DOI 10.2217/nnm.12.86; Jiang XE, 2010, ACS NANO, V4, P6787, DOI 10.1021/nn101277w; Jin H, 2008, NANO LETT, V8, P1577, DOI 10.1021/nl072969s; Kim JS, 2006, TOXICOL SCI, V89, P338, DOI 10.1093/toxsci/kfj027; Koch AM, 2005, CHEMBIOCHEM, V6, P337, DOI 10.1002/cbic.200400174; Ku ST, 2010, BIOCHEM BIOPH RES CO, V394, P871, DOI 10.1016/j.bbrc.2010.03.006; Kumar R, 2010, ACS NANO, V4, P699, DOI 10.1021/nn901146y; Lee CM, 2014, INT J NANOMED, V9, P243, DOI 10.2147/IJN.S57938; Limnell T., 2011, MESOPOROUS SILICA SI; Liu D, 2014, ACS APPL MATER INTER, V6, P2131, DOI 10.1021/am405219u; Meng H, 2011, ACS NANO, V5, P4434, DOI 10.1021/nn103344k; Panyam J, 2003, PHARM RES-DORDR, V20, P212, DOI 10.1023/A:1022219003551; Pardridge WM, 2002, DRUG DISCOV TODAY, V7, P5, DOI 10.1016/S1359-6446(01)02082-7; Ragnaill MN, 2011, EUR J PHARM BIOPHARM, V77, P360, DOI 10.1016/j.ejpb.2010.12.024; Rosenholm JM, 2011, CURR DRUG TARGETS, V12, P1166; Salvati A, 2011, NANOMED-NANOTECHNOL, V7, P818, DOI 10.1016/j.nano.2011.03.005; Santra S, 2004, CHEM COMMUN, P2810, DOI 10.1039/b411916a; Schulze C, 2011, EURO NANOTOX LETT, V1, P0001; Sen Karaman D, 2014, J COLLOID INTERF SCI, V418, P300, DOI 10.1016/j.jcis.2013.11.080; Sen Karaman D, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-358; Shim KH, 2014, INT J NANOMED, V9, P225, DOI 10.2147/IJN.S58205; Veiseh O, 2005, NANO LETT, V5, P1003, DOI 10.1021/nl0502569; Viitala T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072192; Wang Y, 2015, NANOMED-NANOTECHNOL, V11, P313, DOI 10.1016/j.nano.2014.09.014; Wong HL, 2012, ADV DRUG DELIVER REV, V64, P686, DOI 10.1016/j.addr.2011.10.007; Wu SH, 2011, CHEM COMMUN, V47, P9972, DOI 10.1039/c1cc11760b; Xia TA, 2009, ACS NANO, V3, P3273, DOI 10.1021/nn900918w; Yashunsky V, 2010, BIOPHYS J, V99, P4028, DOI 10.1016/j.bpj.2010.10.017	42	55	55	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0160705	10.1371/journal.pone.0160705	http://dx.doi.org/10.1371/journal.pone.0160705			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27547955	Green Published, Green Submitted, gold			2022-12-26	WOS:000381768400018
J	Gunay, M; Celik, G; Tuten, A; Karatekin, G; Bardak, H; Ovali, F				Gunay, Murat; Celik, Gokhan; Tuten, Abdulhamit; Karatekin, Guner; Bardak, Handan; Ovali, Fahri			Characteristics of Severe Retinopathy of Prematurity in Infants with Birth Weight above 1500 Grams at a Referral Center in Turkey	PLOS ONE			English	Article							AGGRESSIVE POSTERIOR RETINOPATHY; INTENSIVE-CARE-UNIT; RISK-FACTORS; OUTCOMES; BEVACIZUMAB; FREQUENCY	Purpose To demonstrate the clinical characteristics and treatment outcomes of severe retinopathy of prematurity (ROP) in preterm infants with birth weight (BW) above 1500 g in Turkey. Methods A retrospective review of 5920 ROP records was performed in Zeynep Kamil Maternity and Children's Diseases Training and Research Hospital. The records were obtained from ROP treatment center of the same institute between 2011 and 2016. The data comprised the demographic and clinical characteristics including, gestational age, BW, systemic risk factors, zone and stage of ROP, ROP type, treatment modality, treatment outcomes and inborn/outborn status of the babies. Results A total of 36 infants (71 eyes) with severe ROP and BW> 1500 g were retrieved. There were 30 infants (83.3%) with type 1 ROP and 6 infants (16.7%) with aggressive posterior ROP (APROP). 3 infants (8.3%) were born at our hospital whereas 33 (91.7%) were referred from outer private neonatal intensive care unit (NICU) centers. Zone I APROP was detected during the initial screening. 21 infants (58.3%) underwent laser treatment while 15 (41.7%) received intravitreal bevacizumab (IVB) injections. No unfavorable structural outcome was observed following either treatment modality. Conclusion Severe ROP may occur in heavier preterm infants. Laser treatment and IVB injections were useful in selected cases. Presence of APROP at first examination suggests an earlier screening in heavier babies. Standardization of private NICU centers as well as establishing a national ROP protocol is necessary in Turkey.	[Gunay, Murat; Celik, Gokhan] Zeynep Kamil Matern & Childrens Dis Training & Re, Dept Ophthalmol, Istanbul, Turkey; [Tuten, Abdulhamit; Karatekin, Guner] Zeynep Kamil Matern & Childrens Dis Training & Re, Dept Neonatol, Istanbul, Turkey; [Bardak, Handan] Haydarpasa Numune Training & Res Hosp, Dept Ophthalmol, Istanbul, Turkey; [Ovali, Fahri] Istanbul Medeniyet Univ, Fac Med, Div Neonatol, Dept Pediat, Istanbul, Turkey	Istanbul Zeynep Kamil Maternity & Children's Diseases Training & Research Hospital; Istanbul Zeynep Kamil Maternity & Children's Diseases Training & Research Hospital; Istanbul Haydarpasa Numune Training & Research Hospital; Istanbul Haydarpasa Sultan Abdulhamid Training & Research Hospital; Istanbul Medeniyet University	Gunay, M (corresponding author), Zeynep Kamil Matern & Childrens Dis Training & Re, Dept Ophthalmol, Istanbul, Turkey.	drmurat301@yahoo.com.tr	Gunay, Murat/AAK-1697-2020; Tüten, Abdullah/E-2856-2019; çelik, gökhan/AAE-1248-2021	Gunay, Murat/0000-0002-8874-1473; Karatekin, Guner/0000-0001-7112-0323				Akcakaya AA, 2012, J PEDIAT OPHTH STRAB, V49, P21, DOI 10.3928/01913913-20110208-01; Bas AY, 2015, BRIT J OPHTHALMOL, V99, P1311, DOI 10.1136/bjophthalmol-2014-306286; Calo LA, 2009, J ENDOCRINOL INVEST, V32, P832, DOI [10.3275/6430, 10.1007/BF03345754]; Cerman E, 2014, OSLI RETINA, V45, P550, DOI 10.3928/23258160-20141118-10; Chawla D, 2012, INDIAN J PEDIATR, V79, P501, DOI 10.1007/s12098-010-0279-7; Chen Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116669; Chen Yi-Hsing, 2013, Biomed J, V36, P84, DOI 10.4103/2319-4170.110399; Gebesce A, 2016, TURK J MED SCI, V46, P315, DOI 10.3906/sag-1407-127; Gilbert C, 2005, PEDIATRICS, V115, pE518, DOI 10.1542/peds.2004-1180; Gole GA, 2005, ARCH OPHTHALMOL-CHIC, V123, P991, DOI 10.1001/archopht.123.7.991; Good WV, 2003, ARCH OPHTHALMOL-CHIC, V121, P1684; Haines L, 2005, ARCH DIS CHILD-FETAL, V90, P240, DOI 10.1136/adc.2004.057570; Hungi B, 2012, INDIAN J PEDIATR, V79, P911, DOI 10.1007/s12098-012-0707-y; Hussain S, 2016, J PAK MED ASSOC, V66, P612; Jalali S, 2014, INDIAN J OPHTHALMOL, V62, P610, DOI 10.4103/0301-4738.118449; Jalali S, 2011, AM J OPHTHALMOL, V151, P719, DOI 10.1016/j.ajo.2010.10.007; Jensen Anne K, 2011, J AAPOS, V15, pe3; Kola M, 2016, TURK J MED SCI, V46, P381, DOI 10.3906/sag-1410-97; Kucukevcilioglu M, 2013, TURKISH J PEDIATR, V55, P467; Kumar P, 2011, INDIAN J PEDIATR, V78, P812, DOI 10.1007/s12098-011-0363-7; Lichtenstein SJ, 2006, PEDIATRICS, V117, P572, DOI 10.1542/peds.2005-2749; Mintz-Hittner HA, 2011, NEW ENGL J MED, V364, P603, DOI 10.1056/NEJMoa1007374; Mutlu FM, 2013, INT J OPHTHALMOL-CHI, V6, P228, DOI 10.3980/j.issn.2222-3959.2013.02.23; Sanghi G, 2014, INDIAN J OPHTHALMOL, V62, DOI 10.4103/0301-4738.128639; Sanghi G, 2013, AM J OPHTHALMOL, V155, P159, DOI 10.1016/j.ajo.2012.07.012; Sarikabadayi YU, 2011, OPHTHAL EPIDEMIOL, V18, P269, DOI 10.3109/09286586.2011.615449; Sarlos S, 2003, AM J PATHOL, V163, P879, DOI 10.1016/S0002-9440(10)63448-7; Shah PK, 2012, ARCH DIS CHILD-FETAL, V97, pF371, DOI 10.1136/fetalneonatal-2011-301121; Shan HD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144313; Thomas K, 2015, J Neonatal Perinatal Med, V8, P207, DOI 10.3233/NPM-15814128; Wu WC, 2013, AM J OPHTHALMOL, V155, P150, DOI 10.1016/j.ajo.2012.06.010; Xu Y, 2013, INVEST OPHTH VIS SCI, V54, P8229, DOI 10.1167/iovs.13-12297; Yang CY, 2011, PEDIATR NEONATOL, V52, P321, DOI 10.1016/j.pedneo.2011.08.004	33	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161692	10.1371/journal.pone.0161692	http://dx.doi.org/10.1371/journal.pone.0161692			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548628	Green Published, gold, Green Submitted			2022-12-26	WOS:000381768400078
J	Orfei, CP; Lovati, AB; Vigano, M; Stanco, D; Bottagisio, M; Di Giancamillo, A; Setti, S; de Girolamo, L				Orfei, Carlotta Perucca; Lovati, Arianna B.; Vigano, Marco; Stanco, Deborah; Bottagisio, Marta; Di Giancamillo, Alessia; Setti, Stefania; de Girolamo, Laura			Dose-Related and Time-Dependent Development of Collagenase-Induced Tendinopathy in Rats	PLOS ONE			English	Article							LEVEL LASER THERAPY; INDUCED ACHILLES TENDINITIS; INDUCED TENDON INJURY; PLATELET-RICH PLASMA; ANIMAL-MODELS; CELLS; EXPRESSION; DEGENERATION; INFLAMMATION; CYTOKINES	Tendinopathy is a big burden in clinics and it represents 45% of musculoskeletal lesions. Despite the relevant social impact, both pathogenesis and development of the tendinopathy are still under-investigated, thus limiting the therapeutic advancement in this field. The purpose of this study was to evaluate the dose-dependent and time-related tissue-level changes occurring in a collagenase-induced tendinopathy in rat Achilles tendons, in order to establish a standardized model for future pre-clinical studies. With this purpose, 40 Sprague Dawley rats were randomly divided into two groups, treated by injecting collagenase type I within the Achilles tendon at 1 mg/mL (low dose) or 3 mg/mL (high dose). Tendon explants were histologically evaluated at 3, 7, 15, 30 and 45 days. Our results revealed that both the collagenase doses induced a disorganization of collagen fibers and increased the number of rounded resident cells. In particular, the high dose treatment determined a greater neovascularization and fatty degeneration with respect to the lower dose. These changes were found to be time-dependent and to resemble the features of human tendinopathy. Indeed, in our series, the acute phase occurred from day 3 to day 15, and then progressed towards the proliferative phase from day 30 to day 45 displaying a degenerative appearance associated with a very precocious and mild remodeling process. The model represents a good balance between similarity with histological features of human tendinopathy and feasibility, in terms of tendon size to create lesions and costs when compared to other animal models. Moreover, this model could contribute to improve the knowledge in this field, and it could be useful to properly design further pre-clinical studies to test innovative treatments for tendinopathy.	[Orfei, Carlotta Perucca; Vigano, Marco; Stanco, Deborah; de Girolamo, Laura] IRCCS Galeazzi Orthopaed Inst, Orthopaed Biotechnol Lab, Milan, Italy; [Orfei, Carlotta Perucca] Univ Pavia, Dept Drug Sci, Pavia, Italy; [Lovati, Arianna B.; Bottagisio, Marta] IRCCS Galeazzi Orthopaed Inst, Cell & Tissue Engn Lab, Milan, Italy; [Vigano, Marco] Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy; [Bottagisio, Marta] Univ Milan, Dept Vet Med DiMeVet, Milan, Italy; [Di Giancamillo, Alessia] Univ Milan, Dept Hlth Anim Sci & Food Safety, Milan, Italy; [Setti, Stefania] IGEA SpA Clin Biophys, Carpi, MO, Italy	IRCCS Istituto Ortopedico Galeazzi; University of Pavia; IRCCS Istituto Ortopedico Galeazzi; University of Milano-Bicocca; University of Milan; University of Milan	Lovati, AB (corresponding author), IRCCS Galeazzi Orthopaed Inst, Cell & Tissue Engn Lab, Milan, Italy.	arianna.lovati@grupposadonato.it	Di Giancamillo, Alessia/Z-1477-2019; Orfei, Carlotta Perucca/B-1436-2017; Orfei, Carlotta Perucca/N-4262-2019; Bottagisio, Marta/J-8212-2016; Stanco, Deborah/AAV-6387-2021; Lovati, Arianna Barbara/J-8213-2016; Viganò, Marco/H-2559-2013; DE GIROLAMO, LAURA/C-6274-2011	Di Giancamillo, Alessia/0000-0003-1674-3020; Orfei, Carlotta Perucca/0000-0001-6162-8668; Bottagisio, Marta/0000-0001-8105-5959; Lovati, Arianna Barbara/0000-0002-5230-9718; Viganò, Marco/0000-0002-6463-6564; STANCO, DEBORAH/0000-0001-6973-1555; DE GIROLAMO, LAURA/0000-0002-9979-3092	IGEA Clinical Biophysics SpA	IGEA Clinical Biophysics SpA	This work was funded by IGEA Clinical Biophysics SpA, and the authors have no competing financial interests to declare. The funder provided support in the form of salaries for the author SS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the "author contributions."	Abbott A, 2004, NATURE, V428, P464, DOI 10.1038/428464a; [Anonymous], 2005, BASIC ORTHOPAEDIC BI; Bagnaninchi PO, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2006.030643; Battery L, 2011, SPORTS MED ARTHROSC, V19, P213, DOI 10.1097/JSA.0b013e31820e6a92; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Burssens A, 2013, KNEE SURG SPORT TR A, V21, P1459, DOI 10.1007/s00167-012-2203-3; Casalechi HL, 2013, LASER MED SCI, V28, P989, DOI 10.1007/s10103-012-1189-x; CHARD MD, 1994, ANN RHEUM DIS, V53, P30, DOI 10.1136/ard.53.1.30; Chen L, 2014, CELL PHYSIOL BIOCHEM, V34, P2153, DOI 10.1159/000369659; Cook JL, 2009, BRIT J SPORT MED, V43, P409, DOI 10.1136/bjsm.2008.051193; de Girolamo L, 2013, CELL BIOCHEM BIOPHYS, V66, P697, DOI 10.1007/s12013-013-9514-y; De Girolamo L, 2014, ULTRASOUND MED BIOL, V40, P1204, DOI 10.1016/j.ultrasmedbio.2013.12.003; Dirks RC, 2011, J MUSCULOSKEL NEURON, V11, P141; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Hast MW, 2014, BONE JOINT RES, V3, P193, DOI 10.1302/2046-3758.36.2000281; Hildebrand KA, 2002, MICROSC RES TECHNIQ, V58, P34, DOI 10.1002/jemt.10114; Kamineni S, 2015, J ORTHOP SURG RES, V10, DOI 10.1186/s13018-015-0207-7; Lake SP, 2008, DISABIL REHABIL, V30, P1530, DOI 10.1080/09638280701785460; Lovati AB, 2011, J BIOL REGUL HOMEOST, V25, P75; Lui PPY, 2011, SCAND J MED SCI SPOR, V21, P3, DOI 10.1111/j.1600-0838.2010.01164.x; Lui PPY, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-248; Lui PPY, 2010, AM J SPORT MED, V38, P757, DOI 10.1177/0363546509355402; Lui PPY, 2009, J HISTOCHEM CYTOCHEM, V57, P91, DOI 10.1369/jhc.2008.952143; Maffulli N, 1998, ARTHROSCOPY, V14, P840, DOI 10.1016/S0749-8063(98)70021-0; Maffulli N, 2003, CLIN SPORT MED, V22, P675, DOI 10.1016/S0278-5919(03)00004-8; Maffulli N, 2002, J BONE JOINT SURG BR, V84B, P1, DOI 10.1302/0301-620X.84B1.12792; Maffulli N, 2006, CLIN J SPORT MED, V16, P329, DOI 10.1097/00042752-200607000-00008; Marcos RL, 2012, J ORTHOP RES, V30, P1945, DOI 10.1002/jor.22156; Pires D, 2011, LASER MED SCI, V26, P85, DOI 10.1007/s10103-010-0811-z; Rees JD, 2014, BRIT J SPORT MED, V48, P1553, DOI 10.1136/bjsports-2012-091957; Rui YF, 2012, KNEE SURG SPORT TR A, V20, P1409, DOI 10.1007/s00167-011-1685-8; Scott AM, 2015, J MOL MODEL, V21, DOI 10.1007/s00894-015-2577-5; Sharma P., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P181; Shepherd JH, 2013, INT J EXP PATHOL, V94, P260, DOI 10.1111/iep.12037; Solchaga LA, 2014, J ORTHOP RES, V32, P145, DOI 10.1002/jor.22483; Soslowsky L J, 1996, J Shoulder Elbow Surg, V5, P383; Stanco D, 2015, REGEN MED, V10, P729, DOI 10.2217/rme.14.92; Tsai YP, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/402692; Urdzikova LM, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-42; Warden SJ, 2007, BRIT J SPORT MED, V41, P232, DOI 10.1136/bjsm.2006.032342; WILLIAMS IF, 1984, RES VET SCI, V36, P326, DOI 10.1016/S0034-5288(18)31954-4; Yoo SD, 2012, LASER MED SCI, V27, P1195, DOI 10.1007/s10103-011-1049-0; Yuan T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148557	43	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161590	10.1371/journal.pone.0161590	http://dx.doi.org/10.1371/journal.pone.0161590			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548063	Green Published, gold, Green Submitted			2022-12-26	WOS:000381768400073
J	Kamisugi, Y; Whitaker, JW; Cuming, AC				Kamisugi, Yasuko; Whitaker, John W.; Cuming, Andrew C.			The Transcriptional Response to DNA-Double-Strand Breaks in Physcomitrella patens	PLOS ONE			English	Article							HOMOLOGOUS RECOMBINATION; SEQUENCE-ANALYSIS; EARLY EVOLUTION; ARABIDOPSIS; MOSS; END; ACTIVATION; MECHANISM; HELICASE; STRESS	The model bryophyte Physcomitrella patens is unique among plants in supporting the generation of mutant alleles by facile homologous recombination-mediated gene targeting (GT). Reasoning that targeted transgene integration occurs through the capture of transforming DNA by the homology-dependent pathway for DNA double-strand break (DNA-DSB) repair, we analysed the genome-wide transcriptomic response to bleomycin-induced DNA damage and generated mutants in candidate DNA repair genes. Massively parallel (Illumina) cDNA sequencing identified potential participants in gene targeting. Transcripts encoding DNA repair proteins active in multiple repair pathways were significantly up-regulated. These included Rad51, CtIP, DNA ligase 1, Replication protein A and ATR in homology-dependent repair, Xrcc4, DNA ligase 4, Ku70 and Ku80 in non-homologous end-joining and Rad1, Tebichi/polymerase theta, PARP in microhomology-mediated end-joining. Differentially regulated cell-cycle components included up-regulated Rad9 and Hus1 DNA-damage-related checkpoint proteins and down-regulated D-type cyclins and B-type CDKs, commensurate with the imposition of a checkpoint at G2 of the cell cycle characteristic of homology-dependent DNA-DSB repair. Candidate genes, including ATP-dependent chromatin remodelling helicases associated with repair and recombination, were knocked out and analysed for growth defects, hypersensitivity to DNA damage and reduced GT efficiency. Targeted knockout of PpCtIP, a cell-cycle activated mediator of homology-dependent DSB resection, resulted in bleomycin-hypersensitivity and greatly reduced GT efficiency.	[Kamisugi, Yasuko; Cuming, Andrew C.] Univ Leeds, Fac Biol Sci, Ctr Plant Sci, Leeds LS2 9JT, W Yorkshire, England; [Whitaker, John W.] Univ Leeds, Sch Mol & Cellular Biol, Bioinformat Res Grp, Leeds LS2 9JT, W Yorkshire, England; [Whitaker, John W.] Janssen R&D Johnson & Johnson, Discovery Sci, San Diego, CA USA	University of Leeds; University of Leeds	Cuming, AC (corresponding author), Univ Leeds, Fac Biol Sci, Ctr Plant Sci, Leeds LS2 9JT, W Yorkshire, England.	a.c.cuming@leeds.ac.uk		Whitaker, John W./0000-0002-0585-9119; Cuming, Andrew/0000-0003-2562-2052	UK Biotechnology and Biological Sciences Research Council [BB/I006710/1]; BBSRC [BB/I006710/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I006710/1] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors are grateful to the UK Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk) for its support through BBSRC Research Grant BB/I006710/1. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to the UK Biotechnology and Biological Sciences Research Council for its support through BBSRC Research Grant BB/I006710/1. We are grateful to Dr. Fabien Nogue (INRA, Versailles) and Dr. Didier Schaefer (Univ. Neuchatel) for providing us with the mismatched PpAPT targeting vectors. We also thank Stefan Rensing, Daniel Lang and Andreas Zimmer (Freiburg University) for integrating the sequence reads into the Cosmoss Physcomitrella genome browser.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Antony E, 2009, MOL CELL, V35, P105, DOI 10.1016/j.molcel.2009.05.026; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Britt AB, 2003, TRENDS PLANT SCI, V8, P90, DOI 10.1016/S1360-1385(03)00002-5; Charlot F, 2014, NUCLEIC ACIDS RES, V42, P11965, DOI 10.1093/nar/gku890; Chen IP, 2003, PLANT J, V35, P771, DOI 10.1046/j.1365-313X.2003.01847.x; Clerici M, 2005, J BIOL CHEM, V280, P38631, DOI 10.1074/jbc.M508339200; Colaiacovo MP, 1999, GENETICS, V151, P1409; Colavito S, 2009, NUCLEIC ACIDS RES, V37, P6754, DOI 10.1093/nar/gkp748; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Culligan KM, 2006, PLANT J, V48, P947, DOI 10.1111/j.1365-313X.2006.02931.x; Cuming AC, 2007, NEW PHYTOL, V176, P275, DOI 10.1111/j.1469-8137.2007.02187.x; DIXON RA, 1995, PLANT CELL, V7, P1085, DOI 10.1105/tpc.7.7.1085; Dubest S, 2002, EMBO REP, V3, P1049, DOI 10.1093/embo-reports/kvf211; Feng JX, 2005, PLANT MOL BIOL, V59, P853, DOI 10.1007/s11103-005-1511-0; Frank W, 2005, PLANTA, V220, P384, DOI 10.1007/s00425-004-1351-1; FUTERS TS, 1993, PLANT MOL BIOL, V23, P1067, DOI 10.1007/BF00021821; Gottschalk AJ, 2012, J BIOL CHEM, V287, P43527, DOI 10.1074/jbc.M112.401141; Hartmann U, 2005, PLANT MOL BIOL, V57, P155, DOI 10.1007/s11103-004-6910-0; Hu ZB, 2015, PLANT CELL, V27, P149, DOI 10.1105/tpc.114.134312; Huertas P, 2009, J BIOL CHEM, V284, P9558, DOI 10.1074/jbc.M808906200; Inagaki S, 2006, PLANT CELL, V18, P879, DOI 10.1105/tpc.105.036798; Inagaki S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000613; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Jin HL, 1999, PLANT MOL BIOL, V41, P577, DOI 10.1023/A:1006319732410; Kai M, 2013, BIOMOLECULES, V3, P75, DOI 10.3390/biom3010075; Kamisugi Y, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni172; Kamisugi Y, 2008, PLANT J, V56, P855, DOI 10.1111/j.1365-313X.2008.03637.x; Kamisugi Y, 2009, ANNU PLANT REV, V36, P76, DOI 10.1111/b.9781405181891.2009.00004.x; Kamisugi Y, 2012, NUCLEIC ACIDS RES, V40, P3496, DOI 10.1093/nar/gkr1272; Kamisugi Y, 2006, NUCLEIC ACIDS RES, V34, P6205, DOI 10.1093/nar/gkl832; Kenrick P, 1997, NATURE, V389, P33, DOI 10.1038/37918; Kim DG, 2005, J PLANT BIOL, V48, P298, DOI 10.1007/BF03030526; Knight CD, 2002, PRACT APPROACH SER, V259, P285; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mannuss A, 2010, PLANT CELL, V22, P3318, DOI 10.1105/tpc.110.078568; Markmann-Mulisch U, 2007, PLANT CELL, V19, P3080, DOI 10.1105/tpc.107.054049; Ogas J, 1999, P NATL ACAD SCI USA, V96, P13839, DOI 10.1073/pnas.96.24.13839; ORRWEAVER TL, 1981, P NATL ACAD SCI-BIOL, V78, P6354, DOI 10.1073/pnas.78.10.6354; Peterson SE, 2013, MOL CELL, V49, P657, DOI 10.1016/j.molcel.2012.11.020; PLESSIS A, 1993, GENE, V134, P41, DOI 10.1016/0378-1119(93)90172-Y; Recker J, 2014, PLANT CELL, V26, P4889, DOI 10.1105/tpc.114.132472; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Roerink SF, 2014, GENOME RES, V24, P954, DOI 10.1101/gr.170431.113; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Schaefer DG, 2010, DNA REPAIR, V9, P526, DOI 10.1016/j.dnarep.2010.02.001; Schaefer DG, 2002, ANNU REV PLANT BIOL, V53, P477, DOI 10.1146/annurev.arplant.53.100301.135202; Schaefer DG, 1997, PLANT J, V11, P1195, DOI 10.1046/j.1365-313X.1997.11061195.x; Schiml S, 2016, PLANT METHODS, V12, DOI 10.1186/s13007-016-0103-0; Sfeir A, 2015, TRENDS BIOCHEM SCI, V40, P701, DOI 10.1016/j.tibs.2015.08.006; Shaked H, 2006, GENETICS, V173, P985, DOI 10.1534/genetics.105.051664; TAYLOR RM, 1993, FEBS LETT, V331, P71, DOI 10.1016/0014-5793(93)80299-A; Terada R, 2007, PLANT PHYSIOL, V144, P846, DOI 10.1104/pp.107.095992; Thompson JE, 2001, PLANT J, V26, P23, DOI 10.1046/j.1365-313x.2001.01005.x; Townsend JA, 2009, NATURE, V459, P442, DOI 10.1038/nature07845; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Trouiller B, 2006, NUCLEIC ACIDS RES, V34, P232, DOI 10.1093/nar/gkj423; von Stackelberg M, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-9; West CE, 2004, BIOCHEM SOC T, V32, P964, DOI 10.1042/BST0320964; Woodhouse BC, 2008, DNA REPAIR, V7, P1077, DOI 10.1016/j.dnarep.2008.03.009; Yun MH, 2009, NATURE, V459, P460, DOI 10.1038/nature07955; Zimmer A, 2007, MOL GENET GENOMICS, V278, P393, DOI 10.1007/s00438-007-0257-6	66	22	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161204	10.1371/journal.pone.0161204	http://dx.doi.org/10.1371/journal.pone.0161204			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537368	Green Published, gold			2022-12-26	WOS:000381577000066
J	Sukseree, S; Chen, YT; Laggner, M; Gruber, F; Petit, V; Nagelreiter, IM; Mlitz, V; Rossiter, H; Pollreisz, A; Schmidt-Erfurth, U; Larue, L; Tschachler, E; Eckhart, L				Sukseree, Supawadee; Chen, Ying-Ting; Laggner, Maria; Gruber, Florian; Petit, Valerie; Nagelreiter, Ionela-Mariana; Mlitz, Veronika; Rossiter, Heidemarie; Pollreisz, Andreas; Schmidt-Erfurth, Ursula; Larue, Lionel; Tschachler, Erwin; Eckhart, Leopold			Tyrosinase-Cre-Mediated Deletion of the Autophagy Gene Atg7 Leads to Accumulation of the RPE65 Variant M450 in the Retinal Pigment Epithelium of C57BL/6 Mice	PLOS ONE			English	Article							VISUAL CYCLE; OXIDATIVE STRESS; EPIDERMAL-KERATINOCYTES; MACULAR DEGENERATION; STEM-CELLS; EXPRESSION; A2E; DIFFERENTIATION; AGGREGATION; INHIBITION	Targeted gene knockout mouse models have helped to identify roles of autophagy in many tissues. Here, we investigated the retinal pigment epithelium (RPE) of Atg7(f/f) Tyr-Cre mice (on a C57BL/6 background), in which Cre recombinase is expressed under the control of the tyrosinase promoter to delete the autophagy gene Atg7. In line with pigment cell-directed blockade of autophagy, the RPE and the melanocytes of the choroid showed strong accumulation of the autophagy adaptor and substrate, sequestosome 1 (Sqstm1)/p62, relative to the levels in control mice. Immunofluorescence and Western blot analysis demonstrated that the RPE, but not the choroid melanocytes, of Atg7(f/f) Tyr-Cre mice also had strongly increased levels of retinoid isomerohydrolase RPE65, a pivotal enzyme for the maintenance of visual perception. In contrast to Sqstm1, genes involved in retinal regeneration, i.e. Lrat, Rdh5, Rgr, and Rpe65, were expressed at higher mRNA levels. Sequencing of the Rpe65 gene showed that Atg7(f/f) and Atg7(f/f) Tyr-Cre mice carry a point mutation (L450M) that is characteristic for the C57BL/6 mouse strain and reportedly causes enhanced degradation of the RPE65 protein by an as-yet unknown mechanism. These results suggest that the increased abundance of RPE65 M450 in the RPE of Atg7(f/f) Tyr-Cre mice is, at least partly, mediated by upregulation of Rpe65 transcription; however, our data are also compatible with the hypothesis that the RPE65 M450 protein is degraded by Atg7-dependent autophagy in Atg7(f/f) mice. Further studies in mice of different genetic backgrounds are necessary to determine the relative contributions of these mechanisms.	[Sukseree, Supawadee; Gruber, Florian; Nagelreiter, Ionela-Mariana; Mlitz, Veronika; Rossiter, Heidemarie; Tschachler, Erwin; Eckhart, Leopold] Med Univ Vienna, Dept Dermatol, Res Div Biol & Pathobiol Skin, Vienna, Austria; [Chen, Ying-Ting; Laggner, Maria; Pollreisz, Andreas; Schmidt-Erfurth, Ursula] Med Univ Vienna, Dept Ophthalmol, Vienna, Austria; [Gruber, Florian; Nagelreiter, Ionela-Mariana] Christian Doppler Lab Biotechnol Skin Aging, Vienna, Austria; [Petit, Valerie; Larue, Lionel] PSL Res Univ, Inst Curie, CNRS UMR3347, INSERM U1021,Normal & Pathol Dev Melanocytes, Orsay, France; [Petit, Valerie; Larue, Lionel] INSERM, Orsay, France; [Petit, Valerie; Larue, Lionel] Univ Paris 11, Equipe Labellisee Ligue Natl Canc, Orsay, France	Medical University of Vienna; Medical University of Vienna; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Eckhart, L (corresponding author), Med Univ Vienna, Dept Dermatol, Res Div Biol & Pathobiol Skin, Vienna, Austria.	leopold.eckhart@meduniwien.ac.at	Pollreisz, Andreas/AAJ-1538-2021; Sukseree, Supawadee/AAT-6545-2020; Larue, Lionel/I-6532-2016	PETIT, Valerie/0000-0003-1645-9396; Sukseree, Supawadee/0000-0002-7011-9352; Eckhart, Leopold/0000-0002-5645-2036; Gruber, Florian/0000-0003-1094-5641; Chen, Ying-Ting/0000-0002-8606-2418; Nagelreiter, Ionela Mariana/0000-0003-4684-7947; Schmidt-Erfurth, Ursula/0000-0002-7788-7311; Tschachler, Erwin/0000-0002-0248-1798				Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]; Choi SW, 2015, STEM CELL REV REP, V11, P376, DOI 10.1007/s12015-014-9568-2; Colombo S, 2007, PIGM CELL RES, V20, P305, DOI 10.1111/j.1600-0749.2007.00387.x; Danciger M, 2000, MAMM GENOME, V11, P422, DOI 10.1007/s003350010081; Delmas V, 2003, GENESIS, V36, P73, DOI 10.1002/gene.10197; Eckhart L, 2008, J DERMATOL SCI, V50, P209, DOI 10.1016/j.jdermsci.2007.12.009; Ferrington DA, 2016, PROG RETIN EYE RES, V51, P69, DOI 10.1016/j.preteyeres.2015.09.002; Fischer H, 2014, J INVEST DERMATOL, V134, P2579, DOI 10.1038/jid.2014.197; Frost LS, 2015, MOL NEUROBIOL, V52, P1135, DOI 10.1007/s12035-014-8920-5; Galluzzi L, 2014, CELL, V159, P1263, DOI 10.1016/j.cell.2014.11.006; Garcia TY, 2015, INVEST OPHTH VIS SCI, V56, P7480, DOI 10.1167/iovs.15-17251; Ildefonso CJ, 2016, INVEST OPHTH VIS SCI, V57, P372, DOI 10.1167/iovs.15-17703; Jacobson SG, 2015, NEW ENGL J MED, V372, P1920, DOI 10.1056/NEJMoa1412965; Kaarniranta K, 2013, AUTOPHAGY, V9, P973, DOI 10.4161/auto.24546; Katsuragi Y, 2015, FEBS J, V282, P4672, DOI 10.1111/febs.13540; Kim JY, 2013, CELL, V154, P365, DOI 10.1016/j.cell.2013.06.012; Kim SR, 2004, P NATL ACAD SCI USA, V101, P11668, DOI 10.1073/pnas.0403499101; Kole C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150758; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Lorenz B, 2008, INVEST OPHTH VIS SCI, V49, P5235, DOI 10.1167/iovs.07-1671; Maeda T, 2009, INVEST OPHTH VIS SCI, V50, P322, DOI 10.1167/iovs.08-2301; Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139; Masuda T, 2014, J BIOL CHEM, V289, P12908, DOI 10.1074/jbc.M114.556738; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Mehalow AK, 2003, HUM MOL GENET, V12, P2179, DOI 10.1093/hmg/ddg232; Mitter SK, 2014, AUTOPHAGY, V10, P1989, DOI 10.4161/auto.36184; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Perusek L, 2015, J BIOL CHEM, V290, P29035, DOI 10.1074/jbc.M115.682310; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Radu RA, 2008, J BIOL CHEM, V283, P19730, DOI 10.1074/jbc.M801288200; Redmond TM, 2007, MOL VIS, V13, P1813; Rossiter H, 2013, J DERMATOL SCI, V71, P67, DOI 10.1016/j.jdermsci.2013.04.015; Saadat KASM, 2014, FEBS OPEN BIO, V4, P1007, DOI 10.1016/j.fob.2014.11.003; Sachdeva MM, 2014, EXP EYE RES, V119, P111, DOI 10.1016/j.exer.2013.10.024; Sukseree Supawadee, 2013, Front Biosci (Elite Ed), V5, P1000; Sukseree S, 2013, BIOCHEM BIOPH RES CO, V430, P689, DOI 10.1016/j.bbrc.2012.11.090; Sukseree S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038933; Tang PH, 2013, PROG RETIN EYE RES, V32, P48, DOI 10.1016/j.preteyeres.2012.09.002; Valapala M, 2014, AUTOPHAGY, V10, P480, DOI 10.4161/auto.27292; Viiri J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069563; Wang AL, 2009, AUTOPHAGY, V5, P1190, DOI 10.4161/auto.5.8.10087; Wang L, 2014, BBA-MOL CELL RES, V1843, P1248, DOI 10.1016/j.bbamcr.2014.03.016; Wavre-Shapton ST, 2015, HUM MOL GENET, V24, P7060, DOI 10.1093/hmg/ddv406; Wavre-Shapton ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057769; Wenzel A, 2001, J NEUROSCI, V21, P53, DOI 10.1523/JNEUROSCI.21-01-00053.2001; Yao JY, 2015, AUTOPHAGY, V11, P939, DOI 10.1080/15548627.2015.1041699; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6; Zhang CF, 2015, J INVEST DERMATOL, V135, P1348, DOI 10.1038/jid.2014.439; Zhang J, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.330; Zhao ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019456	51	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161640	10.1371/journal.pone.0161640	http://dx.doi.org/10.1371/journal.pone.0161640			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537685	Green Submitted, gold, Green Published			2022-12-26	WOS:000381577000128
J	Vassilev, I; Rogers, A; Kennedy, A; Wensing, M; Koetsenruijter, J; Orlando, R; Portillo, MC; Culliford, D				Vassilev, Ivaylo; Rogers, Anne; Kennedy, Anne; Wensing, Michel; Koetsenruijter, Jan; Orlando, Rosanna; Portillo, Maria Carmen; Culliford, David			Social Network Type and Long-Term Condition Management Support: A Cross-Sectional Study in Six European Countries	PLOS ONE			English	Article							SELF-MANAGEMENT; WELL; ILLNESS; PEOPLE; HEALTH; LAY	Background Network types and characteristics have been linked to the capacity of inter-personal environments to mobilise and share resources. The aim of this paper is to examine personal network types in relation to long-term condition management in order to identify the properties of network types most likely to provide support for those with a long-term condition. Method A cross-sectional observational survey of people with type 2 diabetes using interviews and questionnaires was conducted between April and October 2013 in six European countries: Greece, Spain, Bulgaria, Norway, United Kingdom, and Netherlands. 1862 people with predominantly lower socio-economic status were recruited from each country. We used k-means clustering analysis to derive the network types, and one-way analysis of variance and multivariate logistic regression analysis to explore the relationship between network type socio-economic characteristics, self-management monitoring and skills, well-being, and network member work. Results Five network types of people with long-term conditions were identified: restricted, minimal family, family, weak ties, and diverse. Restricted network types represented those with the poorest self-management skills and were associated with limited support from social network members. Restricted networks were associated with poor indicators across self-management capacity, network support, and well-being. Diverse networks were associated with more enhanced self-management skills amongst those with a long-term condition and high level of emotional support. It was the three network types which had a large number of network members (diverse, weak ties, and family) where healthcare utilisation was most likely to correspond to existing health needs. Discussion Our findings suggest that type of increased social involvement is linked to greater self-management capacity and potentially lower formal health care costs indicating that diverse networks constitute the optimal network type as a policy in terms of the design of LTCM interventions and building support for people with LTCs.	[Vassilev, Ivaylo; Rogers, Anne; Kennedy, Anne; Orlando, Rosanna; Portillo, Maria Carmen; Culliford, David] Univ Southampton, NIHR Collaborat Leadership Appl Hlth Res CLAHRC W, Hlth Sci, Highfield Campus, Southampton, Hants, England; [Wensing, Michel] Univ Heidelberg Hosp, Dept Gen Practice & Hlth Serv Res, Heidelberg, Germany; [Koetsenruijter, Jan] Aarhus Univ, Dept Publ Hlth, Bartholins Alee 2, DK-8000 Aarhus C, Denmark	University of Southampton; Ruprecht Karls University Heidelberg; Aarhus University	Vassilev, I (corresponding author), Univ Southampton, NIHR Collaborat Leadership Appl Hlth Res CLAHRC W, Hlth Sci, Highfield Campus, Southampton, Hants, England.	I.I.Vassilev@soton.ac.uk	Wensing, Michel/H-8113-2014	Wensing, Michel/0000-0001-6569-8137; Koetsenruijter, Jan/0000-0003-4632-5129; Vassilev, Ivaylo/0000-0002-2206-8247; Orlando, Rosa/0000-0002-7097-5431	NIHR Collaboration for Leadership in Applied Health Research and Care (CLAHRC) Wessex; EU FP7 Collaborative Research Grant-EU-WISE; National Institute for Health Research [NF-SI-0513-10103] Funding Source: researchfish	NIHR Collaboration for Leadership in Applied Health Research and Care (CLAHRC) Wessex; EU FP7 Collaborative Research Grant-EU-WISE; National Institute for Health Research(National Institute for Health Research (NIHR))	This research has been funded by the NIHR Collaboration for Leadership in Applied Health Research and Care (CLAHRC) Wessex and EU FP7 Collaborative Research Grant-EU-WISE. CLAHRC Wessex is a partnership between Wessex NHS organisations and partners and the University of Southampton and is part of the National Institute for Health Research. EU-WISE is an integrated project under the 7th Framework Programme of the European Commission. The views expressed in this article are those of the authors and not necessarily those of the NIHR.	ADAMS RG, 1995, AM BEHAV SCI, V39, P209, DOI 10.1177/0002764295039002008; Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4; Bossy D, 2016, HEALTH SOC CARE COMM, V24, pE191, DOI 10.1111/hsc.12277; Carstensen L.L., 2001, FAMILIES LATER LIFE, P265; Christakis NA., 2010, CONNECTED AMAZING PO; Fiori KL, 2007, J GERONTOL B-PSYCHOL, V62, pP322, DOI 10.1093/geronb/62.6.P322; Gallant MP, 2003, HEALTH EDUC BEHAV, V30, P170, DOI 10.1177/1090198102251030; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Jeffries M, 2015, HEALTH SOC CARE COMM, V23, P252, DOI 10.1111/hsc.12138; Kalmijn M, 2001, SOC FORCES, V79, P1289, DOI 10.1353/sof.2001.0044; Kennedy A., 2015, IMPLEMENT SCI, V11, P1; Kennedy A, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-7; Knutsen IR, 2017, QUAL HEALTH RES, V27, P299, DOI 10.1177/1049732315610318; Koetsenruijter J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135079; Koetsenruijter J, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-29; Laumann E.O., 1966, PRESTIGE ASS URBAN C; Li T, 2015, SOC SCI MED, V130, P59, DOI 10.1016/j.socscimed.2015.02.007; Litwin H, 1997, J Cross Cult Gerontol, V12, P45, DOI 10.1023/A:1006593025061; Litwin H, 2001, GERONTOLOGIST, V41, P516, DOI 10.1093/geront/41.4.516; Litwin H, 2011, GERONTOLOGIST, V51, P379, DOI 10.1093/geront/gnq094; Litwin H, 2010, J GERONTOL B-PSYCHOL, V65, P599, DOI 10.1093/geronb/gbp104; Miller RJ, 2002, J COMMUNITY PSYCHOL, V30, P461, DOI 10.1002/jcop.10023; Osborne Richard H., W KATHRYN HLTH ED IM; Pahl R., 2004, CURR SOCIOL, V52, P199, DOI DOI 10.1177/0011392104041808; Portillo MC, 2015, DIABETES EDUCATOR, V41, P550, DOI 10.1177/0145721715594026; Reeves D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098340; Rogers A, 1998, BRIT MED J, V316, P1816, DOI 10.1136/bmj.316.7147.1816; Rogers A., 2014, IMPLEMENTATION SCI; Rogers A, 2011, IMPLEMENTATION SCI, V6; Scott A., 1995, CONNECTING GENDER AG, P158; Steinhaus H., 1956, B ACAD POLONAISE SCI; Stoller EP, 2003, J AGING HEALTH, V15, P482, DOI 10.1177/0898264303253504; Vassilev I, 2014, CHRONIC ILLNESS; Vassilev I, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-719; Vassilev I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059723; Ware J.E., 2009, USERS MANUAL SF 12V2; WELLMAN B, 1990, AM J SOCIOL, V96, P558, DOI 10.1086/229572; Wenger GC, 1997, AGING MENT HEALTH, V1, P311, DOI 10.1080/13607869757001	39	30	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161027	10.1371/journal.pone.0161027	http://dx.doi.org/10.1371/journal.pone.0161027			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT6ES	27536988	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000381577000043
J	Audet, JN; Ducatez, S; Lefebvre, L				Audet, Jean-Nicolas; Ducatez, Simon; Lefebvre, Louis			Bajan Birds Pull Strings: Two Wild Antillean Species Enter the Select Club of String-Pullers	PLOS ONE			English	Article							CALEDONIAN CROWS; END; PERFORMANCE; RADIATION; COGNITION; INSIGHT; RAVENS	String-pulling is one of the most popular tests in animal cognition because of its apparent complexity, and of its potential to be applied to very different taxa. In birds, the basic procedure involves a food reward, suspended from a perch by a string, which can be reached by a series of coordinated pulling actions with the beak and holding actions of the pulled lengths of string with the foot. The taxonomic distribution of species that pass the test includes several corvids, parrots and parids, but in other families, data are much spottier and the number of individuals per species that succeed is often low. To date, the association between string-pulling ability and other cognitive traits was never tested. It is generally assumed that string-pulling is a complex form of problem-solving, suggesting that performance on string-pulling and other problem-solving tasks should be correlated. Here, we show that individuals of two innovative species from Barbados, the bullfinch Loxigilla barbadensis and the Carib grackle Quiscalus lugubris fortirostris, pass the string-pulling test. Eighteen of the 42 bullfinches tested succeeded, allowing us to correlate performance on this test to that on several other behavioral measurements. Surprisingly, string-pulling in bullfinches was unrelated to shyness, neophobia, problem-solving, discrimination and reversal learning performance. Only two of 31 grackles tested succeeded, precluding correlational analyses with other measures but still, the two successful birds largely differed in their other behavioral traits.	[Audet, Jean-Nicolas; Ducatez, Simon; Lefebvre, Louis] McGill Univ, Dept Biol, Montreal, PQ, Canada	McGill University	Audet, JN (corresponding author), McGill Univ, Dept Biol, Montreal, PQ, Canada.	jean-nicolas.audet@mail.mcgill.ca	Audet, Jean-Nicolas/P-2535-2014; Ducatez, Simon/AAA-5378-2020	Audet, Jean-Nicolas/0000-0002-0511-183X; Ducatez, Simon/0000-0003-2865-4674	Fond de Recherche du Quebec Nature et Technologies; Fondation Fyssen; Natural Sciences and Engineering Research Council of Canada	Fond de Recherche du Quebec Nature et Technologies; Fondation Fyssen; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by a Fond de Recherche du Quebec Nature et Technologies doctoral scholarship to JNA, a post-doctoral fellowship from the Fondation Fyssen to SD and a Natural Sciences and Engineering Research Council of Canada Discovery grant to LL.	Audet JN, 2016, BEHAV ECOL, V27, P637, DOI 10.1093/beheco/arv201; Bagotskaya M.S., 2012, NEUROSCI BEHAV PHYSL, V42, P36, DOI DOI 10.1007/S11055-011-9529-Z; Bird CD, 2009, CURR BIOL, V19, P1410, DOI 10.1016/j.cub.2009.07.033; Burns KJ, 2014, MOL PHYLOGENET EVOL, V75, P41, DOI 10.1016/j.ympev.2014.02.006; Ducatez S, 2015, ANIM COGN, V18, P485, DOI 10.1007/s10071-014-0817-1; DUCKER G, 1977, BEHAVIOUR, V62, P164, DOI 10.1163/156853977X00081; Ellison AM, 2015, ANIM COGN, V18, P111, DOI 10.1007/s10071-014-0782-8; Emery NJ, 2004, SCIENCE, V306, P1903, DOI 10.1126/science.1098410; Graves GR, 2006, J CARIB ORNITHOL, V19, P56; Griffin AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084907; Heinrich B, 2005, ETHOLOGY, V111, P962, DOI 10.1111/j.1439-0310.2005.01133.x; Heinrich B, 1995, AUK, V112, P994, DOI 10.2307/4089030; Isden J, 2013, ANIM BEHAV, V86, P829, DOI 10.1016/j.anbehav.2013.07.024; Jacobs IF, 2015, J COMP PSYCHOL, V129, P89, DOI 10.1037/a0038746; Kayello L., 2013, OPPORTUNISM COGNITIO; Krasheninnikova A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085499; Lefebvre L, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0188; MILLIKAN GEORGE C., 1967, LIVING BIRD, V6, P23; Osthaus B, 2005, ANIM COGN, V8, P37, DOI 10.1007/s10071-004-0230-2; Pepperberg IM, 2004, ANIM COGN, V7, P263, DOI 10.1007/s10071-004-0218-y; Schuck-Paim C, 2009, ANIM COGN, V12, P287, DOI 10.1007/s10071-008-0190-z; Seed AM, 2013, CURR BIOL, V23, pR67, DOI 10.1016/j.cub.2012.11.043; Seibt U, 2006, ETHOLOGY, V112, P493, DOI 10.1111/j.1439-0310.2005.01172.x; Shaw RC, 2015, ANIM BEHAV, V109, P101, DOI 10.1016/j.anbehav.2015.08.001; Taylor AH, 2009, P R SOC B, V276, P247, DOI 10.1098/rspb.2008.1107; Taylor AH, 2012, P ROY SOC B-BIOL SCI, V279, P4977, DOI 10.1098/rspb.2012.1998; Taylor AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009345; Tebbich S, 2010, PHILOS T R SOC B, V365, P1099, DOI 10.1098/rstb.2009.0291; Teschke I, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0418; Teschke I, 2011, ANIM BEHAV, V82, P945, DOI 10.1016/j.anbehav.2011.07.032; VINCE M. A., 1961, BEHAVIOUR, V17, P103, DOI 10.1163/156853961X00033; Volter CJ, 2012, ANIM COGN, V15, P923, DOI 10.1007/s10071-012-0519-5; Werdenich D, 2006, ANIM BEHAV, V71, P855, DOI 10.1016/j.anbehav.2005.06.018; West-Eberhard Mary Jane, 2003, pi; Whitt E, 2009, ANIM COGN, V12, P739, DOI 10.1007/s10071-009-0228-x	35	6	6	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0156112	10.1371/journal.pone.0156112	http://dx.doi.org/10.1371/journal.pone.0156112			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27533282	Green Published, Green Submitted, gold			2022-12-26	WOS:000381487600001
J	Descamps, S; Tarroux, A; Cherel, Y; Delord, K; Godo, OR; Kato, A; Krafft, BA; Lorentsen, SH; Ropert-Coudert, Y; Skaret, G; Varpe, O				Descamps, Sebastien; Tarroux, Arnaud; Cherel, Yves; Delord, Karine; Godo, Olaf Rune; Kato, Akiko; Krafft, Bjorn A.; Lorentsen, Svein-Hakon; Ropert-Coudert, Yan; Skaret, Georg; Varpe, Oystein			At-Sea Distribution and Prey Selection of Antarctic Petrels and Commercial Krill Fisheries	PLOS ONE			English	Article							SOUTH-SHETLAND-ISLANDS; DRONNING-MAUD LAND; EUPHAUSIA-SUPERBA; THALASSOICA-ANTARCTICA; FUR SEALS; SEABIRD COMMUNITIES; CHINSTRAP PENGUINS; FOOD SECURITY; MINKE WHALES; INDIAN-OCEAN	Commercial fisheries may impact marine ecosystems and affect populations of predators like seabirds. In the Southern Ocean, there is an extensive fishery for Antarctic krill Euphausia superba that is projected to increase further. Comparing distribution and prey selection of fishing operations versus predators is needed to predict fishery-related impacts on krill-dependent predators. In this context, it is important to consider not only predators breeding near the fishing grounds but also the ones breeding far away and that disperse during the non-breeding season where they may interact with fisheries. In this study, we first quantified the overlap between the distribution of the Antarctic krill fisheries and the distribution of a krill dependent seabird, the Antarctic petrel Thalassoica antarctica, during both the breeding and non-breeding season. We tracked birds from the world biggest Antarctic petrel colony (Svarthamaren, Dronning Maud Land), located >1000 km from the main fishing areas, during three consecutive seasons. The overall spatial overlap between krill fisheries and Antarctic petrels was limited but varied greatly among and within years, and was high in some periods during the non-breeding season. In a second step, we described the length frequency distribution of Antarctic krill consumed by Antarctic petrels, and compared this with results from fisheries, as well as from diet studies in other krill predators. Krill taken by Antarctic petrels did not differ in size from that taken by trawls or from krill taken by most Antarctic krill predators. Selectivity for specific Antarctic krill stages seems generally low in Antarctic predators. Overall, our results show that competition between Antarctic petrels and krill fisheries is currently likely negligible. However, if krill fisheries are to increase in the future, competition with the Antarctic petrel may occur, even with birds breeding thousands of kilometers away.	[Descamps, Sebastien; Tarroux, Arnaud] Norwegian Polar Res Inst, Fram Ctr, N-9296 Tromso, Norway; [Cherel, Yves; Delord, Karine; Kato, Akiko; Ropert-Coudert, Yan] Univ La Rochelle, CNRS, UMR 7372, Ctr Etud Biol Chize, F-79360 Villiers En Bois, France; [Godo, Olaf Rune; Krafft, Bjorn A.; Skaret, Georg] Inst Marine Res, POB 1870 Nordnes, N-5817 Bergen, Norway; [Lorentsen, Svein-Hakon] Norwegian Inst Nat Res, N-7485 Trondheim, Norway; [Kato, Akiko; Ropert-Coudert, Yan] CNRS, UMR7178, F-67037 Strasbourg, France; [Kato, Akiko; Ropert-Coudert, Yan] Univ Strasbourg, IPHC, 23 Rue Becquerel, F-67087 Strasbourg, France; [Varpe, Oystein] Univ Ctr Svalbard, N-9171 Longyearbyen, Norway; [Varpe, Oystein] Akvaplan Niva, Fram Ctr, N-9296 Tromso, Norway	Norwegian Polar Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); La Rochelle Universite; Institute of Marine Research - Norway; Norwegian Institute Nature Research; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University Centre Svalbard (UNIS); Akvaplan-niva	Descamps, S (corresponding author), Norwegian Polar Res Inst, Fram Ctr, N-9296 Tromso, Norway.	Sebastien.descamps@npolar.no	Tarroux, Arnaud/AAE-5173-2021; Kato, Akiko/W-2447-2019; Varpe, Øystein/B-9693-2008	Tarroux, Arnaud/0000-0001-8306-6694; Varpe, Øystein/0000-0002-5895-6983; Kato, Akiko/0000-0002-8947-3634; Godo, Olav Rune/0000-0001-8826-8068	Norwegian Research Council (program NARE-Norwegian Antarctic Research Expedition); Norwegian Research Council (Norwegian Antarctic Research Expedition program)	Norwegian Research Council (program NARE-Norwegian Antarctic Research Expedition); Norwegian Research Council (Norwegian Antarctic Research Expedition program)	The study was funded by a grant from the Norwegian Research Council (program NARE-Norwegian Antarctic Research Expedition).; This study was funded by the Norwegian Research Council (Norwegian Antarctic Research Expedition program). We are very grateful to H. Weimerskirch, T. Nordstad, S. Haaland, E. Soininen, G. Mabille and J. Sward for their help in the field, to all the personnel from the logistics department at the Norwegian Polar Institute and the Troll summer and overwintering teams. We also extend our gratitude to CCAMLR Secretariat and Members for providing the krill fishery data, to C. Trouve for her help in the analysis of food samples from Antarctic petrels, and to F. Crenner and N. Chatelain who customized the GPS units at the IPHC-CNRS UMR7178.	Afanasyev Vsevolod, 2004, Memoirs of National Institute of Polar Research Special Issue, V58, P227; Ainley D.G., 1984, MARINE ECOLOGY BIRDS; AINLEY DG, 1992, MAR ECOL PROG SER, V90, P207, DOI 10.3354/meps090207; AINLEY DG, 1994, J ANIM ECOL, V63, P347, DOI 10.2307/5553; ARNOULD JPY, 1991, ANTARCT SCI, V3, P19, DOI 10.1017/S0954102091000056; Atkinson A, 2008, MAR ECOL PROG SER, V362, P1, DOI 10.3354/meps07498; Atkinson A, 2004, NATURE, V432, P100, DOI 10.1038/nature02996; Baker AC, 1990, PRACTICAL GUIDE EUPH; Belda EJ, 2001, BIOL CONSERV, V98, P357, DOI 10.1016/S0006-3207(00)00178-6; Bocher P, 2001, MAR ECOL PROG SER, V223, P261, DOI 10.3354/meps223261; Boyd IL, 2001, J ANIM ECOL, V70, P747, DOI 10.1046/j.0021-8790.2001.00534.x; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; CHEREL Y, 1992, IBIS, V134, P118, DOI 10.1111/j.1474-919X.1992.tb08388.x; Cherel Y, 2002, MAR ECOL PROG SER, V228, P263, DOI 10.3354/meps228263; Constable AJ, 2002, CCAMLR SCI, V9, P117; Cornejo-Donoso J, 2008, ECOL MODEL, V218, P1, DOI 10.1016/j.ecolmodel.2008.06.011; Croll DA, 2006, J ZOOL, V269, P506, DOI 10.1111/j.1469-7998.2006.00090.x; Croll DA, 1998, POLAR BIOL, V19, P365, DOI 10.1007/s003000050261; Croxall J.P., 1985, P516; Descamps S, 2016, ECOGRAPHY, V39, P496, DOI 10.1111/ecog.01659; Duffy DC, 1994, SEABIRD FISHERY INTE; EVERSON I, 1996, CCAMLR SCI, V3, P1; Fauchald P, 2006, OECOLOGIA, V149, P383, DOI 10.1007/s00442-006-0463-7; Fraser WR, 2003, MAR ECOL PROG SER, V265, P1, DOI 10.3354/meps265001; Freeman AND, 1998, EMU, V98, P36, DOI 10.1071/MU98005; Friedlaender AS, 2009, MAR MAMMAL SCI, V25, P402, DOI 10.1111/j.1748-7692.2008.00263.x; Furness RW, 2003, SCI MAR, V67, P33, DOI 10.3989/scimar.2003.67s233; Garcia SM, 2010, PHILOS T R SOC B, V365, P2869, DOI 10.1098/rstb.2010.0171; Garthe S, 1996, MAR ECOL PROG SER, V136, P1, DOI 10.3354/meps136001; Gremillet D, 2008, P R SOC B, V275, P1149, DOI 10.1098/rspb.2007.1763; Hill HJ, 1996, MAR ECOL PROG SER, V140, P1, DOI 10.3354/meps140001; Hinke JT, 2007, OECOLOGIA, V153, P845, DOI 10.1007/s00442-007-0781-4; Hjermann DO, 2004, P NATL ACAD SCI USA, V101, P11679, DOI 10.1073/pnas.0402904101; Ichii T, 1996, POLAR BIOL, V16, P63, DOI 10.1007/BF02388736; ICHII T, 1991, POLAR BIOL, V11, P479; JOIRIS CR, 1991, POLAR BIOL, V11, P415; Krafft BA, 2013, 8 I MAR RES; Krafft BA, 2014, 8 I MAR RES; LORENTSEN SH, 1995, IBIS, V137, P345, DOI 10.1111/j.1474-919X.1995.tb08031.x; Lorentsen SH, 1998, POLAR BIOL, V19, P414, DOI 10.1007/s003000050267; Lynnes AS, 2004, POLAR BIOL, V27, P544, DOI 10.1007/s00300-004-0617-1; Marchant S., 1990, HDB AUSTR NZ ANTARCT, V1; MEHLUM F, 1988, Polar Research, V6, P1, DOI 10.1111/j.1751-8369.1988.tb00576.x; Miller AK, 2007, POLAR BIOL, V30, P1615, DOI 10.1007/s00300-007-0326-7; MONTAGUE TL, 1984, EMU, V84, P244, DOI 10.1071/MU9840244; Morris D. J., 1988, BR ANTARCT SURV B, V79, P27; Murphy EJ, 2007, PHILOS T R SOC B, V362, P113, DOI 10.1098/rstb.2006.1957; Myers RA, 2007, CURR BIOL, V17, pR10, DOI 10.1016/j.cub.2006.11.045; Nicol S, 2006, BIOSCIENCE, V56, P111, DOI 10.1641/0006-3568(2006)056[0111:KCASIE]2.0.CO;2; NICOL S, 1993, POLAR BIOL, V13, P399, DOI 10.1007/BF01681981; Nicol S, 2012, FISH FISH, V13, P30, DOI 10.1111/j.1467-2979.2011.00406.x; Olsen EM, 2004, NATURE, V428, P932, DOI 10.1038/nature02430; Pauly D, 2005, PHILOS T R SOC B, V360, P5, DOI 10.1098/rstb.2004.1574; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; Phillips RA, 2006, EMU, V106, P305, DOI 10.1071/MU06035; Pichegru L, 2010, BIOL LETTERS, V6, P498, DOI 10.1098/rsbl.2009.0913; Quetin LB, 2003, MAR ECOL PROG SER, V259, P185, DOI 10.3354/meps259185; R Development Core Team, 2014, R LANG ENV STAT COMP; Ratcliffe N, 2015, DIVERS DISTRIB, V21, P1339, DOI 10.1111/ddi.12366; Reid K, 2004, DEEP-SEA RES PT II, V51, P1383, DOI 10.1016/j.dsr2.2004.06.007; Reid K, 1996, POLAR BIOL, V16, P105, DOI 10.1007/BF02390431; Reid K, 1996, MAR ECOL PROG SER, V140, P13, DOI 10.3354/meps140013; Santora JA, 2014, POLAR BIOL, V37, P1083, DOI 10.1007/s00300-014-1502-1; Santora JA, 2010, MAR ECOL PROG SER, V405, P255, DOI 10.3354/meps08513; Schmidt K, 2014, LIMNOL OCEANOGR, V59, P17, DOI 10.4319/lo.2014.59.1.0017; Shelton AO, 2013, MAR ECOL PROG SER, V481, P53, DOI 10.3354/meps10245; SIEGEL V, 1995, MAR ECOL PROG SER, V123, P45, DOI 10.3354/meps123045; Skaret G, 2013, 9 I MAR RES; Smith WO, 2007, PHILOS T R SOC B, V362, P95, DOI 10.1098/rstb.2006.1956; Tarroux A, 2016, ANIM BEHAV, V113, P99, DOI 10.1016/j.anbehav.2015.12.021; Tierney M, 2009, MAR BIOL; Torres LG, 2013, MAR ECOL PROG SER, V473, P275, DOI 10.3354/meps10071; Tuck GN, 2003, BIOL CONSERV, V114, P1, DOI 10.1016/S0006-3207(02)00378-6; Urbanek S., PROJ4 SIMPLE INTERFA; van Franeker JA, 1999, WATERBIRDS, V22, P14, DOI 10.2307/1521989; vanFraneker JA, 1996, POLAR BIOL, V16, P565, DOI 10.1007/s003000050090; VEIT RR, 1993, J ANIM ECOL, V62, P551, DOI 10.2307/5204; Verity PG, 2002, ENVIRON CONSERV, V29, P207, DOI 10.1017/S0376892902000139; Votier SC, 2004, NATURE, V427, P727, DOI 10.1038/nature02315; WATKINS JL, 1986, MAR ECOL PROG SER, V31, P67, DOI 10.3354/meps031067; WHITEHOUSE MJ, 1994, POLAR BIOL, V14, P325; Williams R., 1990, ANARE RES NOTES, V75, P1; WILSON RP, 1984, J FIELD ORNITHOL, V55, P109; Wilson RP, 1992, WILDLIFE TELEMETRY R; Wing SR, 2014, MAR ECOL PROG SER, V510, P1, DOI 10.3354/meps10923; Winship AJ, 2012, METHODS ECOL EVOL, V3, P291, DOI 10.1111/j.2041-210X.2011.00161.x; Xavier J. C, 2009, CEPHALOPOD BEAK GUID	87	19	20	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0156968	10.1371/journal.pone.0156968	http://dx.doi.org/10.1371/journal.pone.0156968			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27533327	Green Submitted, gold, Green Published			2022-12-26	WOS:000381487600002
J	Emmert, K; Zoller, D; Preti, MG; Van De Ville, D; Giannakopoulos, P; Haller, S				Emmert, Kirsten; Zoller, Daniela; Preti, Maria Giulia; Van De Ville, Dimitri; Giannakopoulos, Panteleimon; Haller, Sven			Influence of Vascular Variant of the Posterior Cerebral Artery (PCA) on Cerebral Blood Flow, Vascular Response to CO2 and Static Functional Connectivity	PLOS ONE			English	Article							BRAIN; FMRI; ACTIVATION; REACTIVITY; MRI	Introduction The fetal origin of the posterior cerebral artery (fPCA) is a frequent vascular variant in 11-29% of the population. For the fPCA, blood flow in the PCA originates from the anterior instead of the posterior circulation. We tested whether this blood supply variant impacts the cerebral blood flow assessed by arterial spin labeling (ASL), cerebrovascular reserve as well as resting-state static functional connectivity (sFC) in the sense of a systematic confound. Methods The study included 385 healthy, elderly subjects (mean age: 74.18 years [range: 68.9-90.4]; 243 female). Participants were classified into normal vascular supply (n = 296, 76.88%), right fetal origin (n = 23, 5.97%), left fetal origin (n = 16, 4.16%), bilateral fetal origin (n = 4, 1.04%), and intermediate (n = 46, 11.95%, excluded from further analysis) groups. ASL-derived relative cerebral blood flow (relCBF) maps and cerebrovascular reserve (CVR) maps derived from a CO2 challenge with blocks of 7% CO2 were compared. Additionally, sFC between 90 regions of interest (ROIs) was compared between the groups. Results CVR was significantly reduced in subjects with ipsilateral fPCA, most prominently in the temporal lobe. ASL yielded a non-significant trend towards reduced relCBF in bilateral posterior watershed areas. In contrast, conventional atlas-based sFC did not differ between groups. Conclusions In conclusion, fPCA presence may bias the assessment of cerebrovascular reserve by reducing the response to CO2. In contrast, its effect on ASL-assessed baseline perfusion was marginal. Moreover, fPCA presence did not systematically impact resting-state sFC. Taken together, this data implies that perfusion variables should take into account the vascularization patterns.	[Emmert, Kirsten; Preti, Maria Giulia; Van De Ville, Dimitri; Haller, Sven] Univ Geneva, Fac Med, Geneva, Switzerland; [Emmert, Kirsten; Zoller, Daniela; Preti, Maria Giulia; Van De Ville, Dimitri] Ecole Polytech Fed Lausanne, Inst Bioengn, Med Image Proc Lab, Geneva, Switzerland; [Zoller, Daniela] Univ Geneva, Dept Psychiat, Off Medicopedag, Geneva, Switzerland; [Giannakopoulos, Panteleimon] Univ Geneva, Dept Psychiat, Geneva, Switzerland; [Haller, Sven] Affidea Ctr Diagnost Radiol Carouge CDRC, Carouge, Switzerland; [Haller, Sven] Uppsala Univ, Dept Surg Sci, Radiol, Uppsala, Sweden	University of Geneva; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva; University of Geneva; Uppsala University	Haller, S (corresponding author), Univ Geneva, Fac Med, Geneva, Switzerland.; Haller, S (corresponding author), Affidea Ctr Diagnost Radiol Carouge CDRC, Carouge, Switzerland.; Haller, S (corresponding author), Uppsala Univ, Dept Surg Sci, Radiol, Uppsala, Sweden.	sven.haller@me.com	Haller, Sven/AAY-2564-2020; Zöller, Daniela/D-7452-2019; Van De Ville, Dimitri/A-5364-2008; Preti, Maria Giulia/X-9430-2019	Haller, Sven/0000-0001-7433-0203; Zöller, Daniela/0000-0002-7049-0696; Van De Ville, Dimitri/0000-0002-2879-3861; Preti, Maria Giulia/0000-0002-5323-5327	Swiss National Science Foundation [SNF 320030-147126, 3200B0-1161193, SPUM 33CM30-124111]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation (Grant SNF 320030-147126, 3200B0-1161193 and SPUM 33CM30-124111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman-Gomez Y., 2006, 12 ANN M ORG HUM BRA; Bartynski WS, 2007, AM J NEURORADIOL, V28, P1320, DOI 10.3174/ajnr.A0549; Caplan LR, 1998, ARCH NEUROL-CHICAGO, V55, P1475, DOI 10.1001/archneur.55.11.1475; Haller S, 2008, RADIOLOGY, V249, P251, DOI 10.1148/radiol.2491071644; Haller S, 2006, EUR J NEUROSCI, V24, P2672, DOI 10.1111/j.1460-9568.2006.05147.x; Hinchey J, 1996, NEW ENGL J MED, V334, P494, DOI 10.1056/NEJM199602223340803; Jiang Z, 2010, NEUROIMAGE, V52, P538, DOI 10.1016/j.neuroimage.2010.04.194; Khalili-Mahani N, 2014, HUM BRAIN MAPP, V35, P929, DOI 10.1002/hbm.22224; Kohn JC, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00112; Krainik A, 2013, Diagn Interv Imaging, V94, P1259, DOI 10.1016/j.diii.2013.08.004; Park SY, 2015, AM J PHYSL HEART CIR; Richiardi J, 2015, NEUROBIOL AGING, V36, P33, DOI 10.1016/j.neurobiolaging.2014.07.020; Richiardi J, 2012, NEUROIMAGE, V62, P2021, DOI 10.1016/j.neuroimage.2012.05.078; Richiardi J, 2011, NEUROIMAGE, V56, P616, DOI 10.1016/j.neuroimage.2010.05.081; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Tak S, 2014, NEUROIMAGE, V84, P672, DOI 10.1016/j.neuroimage.2013.09.057; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Raamt AF, 2006, CEREBROVASC DIS, V22, P217, DOI 10.1159/000094007; VILLRINGER A, 1995, CEREBROVAS BRAIN MET, V7, P240; Wentland AL, 2010, AM J NEURORADIOL, V31, P448, DOI 10.3174/ajnr.A1858; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Ziyeh S, 2005, STROKE, V36, P751, DOI 10.1161/01.STR.0000157593.03470.3d	22	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161121	10.1371/journal.pone.0161121	http://dx.doi.org/10.1371/journal.pone.0161121			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532633	Green Published, gold, Green Submitted			2022-12-26	WOS:000381487600061
J	Martin, C; Bideau, B; Delamarche, P; Kulpa, R				Martin, Caroline; Bideau, Benoit; Delamarche, Paul; Kulpa, Richard			Influence of a Prolonged Tennis Match Play on Serve Biomechanics	PLOS ONE			English	Article							FATIGUE; MUSCLE; PERFORMANCE; KINEMATICS; STRENGTH; INERTIA	The aim of this study was to quantify kinematic, kinetic and performance changes that occur in the serve throughout a prolonged tennis match play. Serves of eight male advanced tennis players were recorded with a motion capture system before, at mid-match, and after a 3-hour tennis match. Before and after each match, electromyographic data of 8 upper limb muscles obtained during isometric maximal voluntary contraction were compared to determine the presence of muscular fatigue. Vertical ground reaction forces, rating of perceived exertion, ball speed, and ball impact height were measured. Kinematic and upper limb kinetic variables were computed. The results show decrease in mean power frequency values for several upper limb muscles that is an indicator of local muscular fatigue. Decreases in serve ball speed, ball impact height, maximal angular velocities and an increase in rating of perceived exertion were also observed between the beginning and the end of the match. With fatigue, the majority of the upper limb joint kinetics decreases at the end of the match. No change in timing of maximal angular velocities was observed between the beginning and the end of the match. A prolonged tennis match play may induce fatigue in upper limb muscles, which decrease performance and cause changes in serve maximal angular velocities and joint kinetics. The consistency in timing of maximal angular velocities suggests that advanced tennis players are able to maintain the temporal pattern of their serve technique, in spite of the muscular fatigue development.	[Martin, Caroline; Bideau, Benoit; Delamarche, Paul; Kulpa, Richard] Univ Rennes 2, Lab M2S, UFR APS, ENS Rennes, Campus Ker Lann,Ave Robert Schuman, F-35170 Bruz, France	Ecole Normale Superieure de Rennes (ENS Rennes); Universite Rennes 2	Martin, C (corresponding author), Univ Rennes 2, Lab M2S, UFR APS, ENS Rennes, Campus Ker Lann,Ave Robert Schuman, F-35170 Bruz, France.	caromartin@numericable.fr	Martin, Caroline/J-6385-2019; Bideau, Benoit/AAD-2052-2020	MARTIN, CAROLINE/0000-0002-4114-8947	Society of Tennis Medicine and Science (STMS); Sport Court Tennis	Society of Tennis Medicine and Science (STMS); Sport Court Tennis	The Society of Tennis Medicine and Science (STMS) and Sport Court Tennis have supported our work with an STMS Tennis Medicine Research Grant 2013 (2500 $); http://www.stms-web.org/additional_info.html; http://www.sportcourt.com. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, ARCH SEX BEHAV, DOI DOI 10.1007/s10508-008-9314-4; Apriantono T, 2006, J SPORT SCI, V24, P951, DOI 10.1080/02640410500386050; Aune TK, 2008, PERCEPT MOTOR SKILL, V106, P371, DOI 10.2466/PMS.106.2.371-386; Bahamonde RE, 2000, J SPORT SCI, V18, P579, DOI 10.1080/02640410050082297; Borg G., 1985, INTRO BORGS RPE SCAL; Brody H, 2006, BRIT J SPORT MED, V40, P397, DOI 10.1136/bjsm.2005.023432; BRODY H, 1985, PHYS TEACH, V23, P213, DOI 10.1119/1.2341781; Brotherhood J.R., 2005, MED SCI TENNIS, V10, P12; Cairns SP, 2005, EXERC SPORT SCI REV, V33, P9; Chow John W, 2009, Sports Med Arthrosc Rehabil Ther Technol, V1, P24, DOI 10.1186/1758-2555-1-24; Cifrek M, 2009, CLIN BIOMECH, V24, P327, DOI 10.1016/j.clinbiomech.2009.01.010; Davey PR, 2002, J SPORT SCI, V20, P311, DOI 10.1080/026404102753576080; de Leva P, 1996, J BIOMECH, V29, P1223, DOI 10.1016/0021-9290(95)00178-6; Donatelli R, 2000, J ORTHOP SPORT PHYS, V30, P544, DOI 10.2519/jospt.2000.30.9.544; Ebaugh DD, 2006, J ELECTROMYOGR KINES, V16, P224, DOI 10.1016/j.jelekin.2005.06.015; Elliott B, 2003, J SCI MED SPORT, V6, P76, DOI 10.1016/S1440-2440(03)80011-7; Elliott B., 2009, TECHNIQUE DEV TENNIS; Escamilla RF, 2007, AM J SPORT MED, V35, P23, DOI 10.1177/0363546506293025; Escamilla RF, 2009, SPORTS MED, V39, P569, DOI 10.2165/00007256-200939070-00004; FELTNER M, 1986, INT J SPORT BIOMECH, V2, P235, DOI 10.1123/ijsb.2.4.235; Fleisig Glenn, 2003, Sports Biomech, V2, P51, DOI 10.1080/14763140308522807; Gescheit DT, 2015, INT J SPORT PHYSIOL, V10, P913, DOI 10.1123/ijspp.2014-0329; Girard O, 2006, BRIT J SPORT MED, V40, P521, DOI 10.1136/bjsm.2005.023754; Girard O, 2011, SCAND J MED SCI SPOR, V21, P455, DOI 10.1111/j.1600-0838.2009.01032.x; Girard O, 2012, ITF COACH SPORT SCI, V20, P18; Girard O, 2007, J STRENGTH COND RES, V21, P950; Gordon BJ, 2006, J SPORT SCI, V24, P31, DOI 10.1080/02640410400022045; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Hornery DJ, 2007, BRIT J SPORT MED, V41, P531, DOI 10.1136/bjsm.2006.031351; Hornery DJ, 2007, SPORTS MED, V37, P199, DOI 10.2165/00007256-200737030-00002; Kendall F, 1993, MUSCLE TESTING FUNCT; Kovacs MS, 2006, BRIT J SPORT MED, V40, P381, DOI 10.1136/bjsm.2005.023309; Manary, 1999, SAE T J PASSENGERS C, V108, P1; Martin C, 2014, SCAND J MED SCI SPOR, V24, P700, DOI 10.1111/sms.12043; Martin C, 2013, SPORT BIOMECH, V12, P2, DOI 10.1080/14763141.2012.734321; Martin C, 2011, J STRENGTH COND RES, V25, P163, DOI 10.1519/JSC.0b013e3181fb459b; Murray TA, 2001, AM J SPORT MED, V29, P137, DOI 10.1177/03635465010290020501; OBERG T, 1990, EUR J APPL PHYSIOL, V61, P362, DOI 10.1007/BF00236054; Reid M, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2013-093196; Reid M, 2011, SPORT BIOMECH, V10, P407, DOI 10.1080/14763141.2011.629206; RODOSKY MW, 1994, AM J SPORT MED, V22, P121, DOI 10.1177/036354659402200119; Rota S, 2014, J ELECTROMYOGR KINES, V24, P90, DOI 10.1016/j.jelekin.2013.10.007; RYU RKN, 1988, AM J SPORT MED, V16, P481, DOI 10.1177/036354658801600509; USRSA, 2010, RACQUET SPORTS IND M, V38, P29; Vergauwen L, 1998, MED SCI SPORT EXER, V30, P1289, DOI 10.1097/00005768-199808000-00017; Winter D. A., 2009, BIOMECHANICS MOTOR C, DOI DOI 10.1002/9780470549148; Zatsiorsky VM, 1990, CONT PROBLEMS BIOMEC, P272; ZIPP P, 1982, EUR J APPL PHYSIOL O, V50, P41, DOI 10.1007/BF00952243	49	9	9	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0159979	10.1371/journal.pone.0159979	http://dx.doi.org/10.1371/journal.pone.0159979			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532421	Green Published, Green Submitted, gold			2022-12-26	WOS:000381487600018
J	Sharabi, S; Drori, Y; Micheli, M; Friedman, N; Orzitzer, S; Bassal, R; Glatman-Freedman, A; Shohat, T; Mendelson, E; Hindiyeh, M; Mandelboim, M				Sharabi, Sivan; Drori, Yaron; Micheli, Michal; Friedman, Nehemya; Orzitzer, Sara; Bassal, Ravit; Glatman-Freedman, Aharona; Shohat, Tamar; Mendelson, Ella; Hindiyeh, Musa; Mandelboim, Michal			Epidemiological and Virological Characterization of Influenza B Virus Infections	PLOS ONE			English	Article							CHILDREN; LINEAGES; VACCINE; DYNAMICS; SEASON; DIFFERENTIATION; YAMAGATA; VICTORIA; EFFICACY; ISRAEL	While influenza A viruses comprise a heterogeneous group of clinically relevant influenza viruses, influenza B viruses form a more homogeneous cluster, divided mainly into two lineages: Victoria and Yamagata. This divergence has complicated seasonal influenza vaccine design, which traditionally contained two seasonal influenza A virus strains and one influenza B virus strain. We examined the distribution of the two influenza B virus lineages in Israel, between 2011-2014, in hospitalized and in non-hospitalized (community) influenza B virus-infected patients. We showed that influenza B virus infections can lead to hospitalization and demonstrated that during some winter seasons, both influenza B virus lineages circulated simultaneously in Israel. We further show that the influenza B virus Yamagata lineage was dominant, circulating in the county in the last few years of the study period, consistent with the anti-Yamagata influenza B virus antibodies detected in the serum samples of affected individuals residing in Israel in the year 2014. Interestingly, we found that elderly people were particularly vulnerable to Yamagata lineage influenza B virus infections.	[Sharabi, Sivan; Drori, Yaron; Micheli, Michal; Friedman, Nehemya; Orzitzer, Sara; Mendelson, Ella; Hindiyeh, Musa; Mandelboim, Michal] Chaim Sheba Med Ctr, Minist Hlth, Cent Virol Lab, IL-52621 Ramat Gan, Israel; [Sharabi, Sivan; Drori, Yaron; Friedman, Nehemya; Shohat, Tamar; Mendelson, Ella; Hindiyeh, Musa; Mandelboim, Michal] Tel Aviv Univ, Sackler Fac Med, Sch Publ Hlth, Dept Epidemiol & Prevent Med, Tel Aviv, Israel; [Bassal, Ravit; Glatman-Freedman, Aharona; Shohat, Tamar] Israel Minist Hlth, Israel Ctr Dis Control, IL-52621 Tel Hashomer, Israel; [Glatman-Freedman, Aharona] New York Med Coll, Dept Family & Community Med, Valhalla, NY 10595 USA	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; New York Medical College	Mandelboim, M (corresponding author), Chaim Sheba Med Ctr, Minist Hlth, Cent Virol Lab, IL-52621 Ramat Gan, Israel.; Mandelboim, M (corresponding author), Tel Aviv Univ, Sackler Fac Med, Sch Publ Hlth, Dept Epidemiol & Prevent Med, Tel Aviv, Israel.	michalman@sheba.health.gov.il						Ambrose CS, 2012, HUM VACC IMMUNOTHER, V8, P81, DOI 10.4161/hv.8.1.17623; Belshe RB, 2010, VACCINE, V28, P2149, DOI 10.1016/j.vaccine.2009.11.068; Beran J, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-2; Biere B, 2010, J CLIN MICROBIOL, V48, P1425, DOI 10.1128/JCM.02116-09; Chen RB, 2008, J MOL EVOL, V66, P655, DOI 10.1007/s00239-008-9119-z; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Heikkinen T, 2014, CLIN INFECT DIS, V59, P1519, DOI 10.1093/cid/ciu664; Hindiyeh M, 2005, J CLIN MICROBIOL, V43, P589, DOI 10.1128/JCM.43.2.589-595.2005; KANEGAE Y, 1990, J VIROL, V64, P2860, DOI 10.1128/JVI.64.6.2860-2865.1990; Kim YH, 2009, VIRAL IMMUNOL, V22, P423, DOI 10.1089/vim.2009.0045; Langley JM, 2013, J INFECT DIS, V208, P544, DOI 10.1093/infdis/jit263; Mandelboim M, 2016, ONCOTARGET, V7, P1185, DOI 10.18632/oncotarget.6746; Meningher T, 2014, INFLUENZA OTHER RESP, V8, P422, DOI 10.1111/irv.12249; Nelson MI, 2006, PLOS PATHOG, V2, P1144, DOI 10.1371/journal.ppat.0020125; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; Osterhaus ADME, 2000, SCIENCE, V288, P1051, DOI 10.1126/science.288.5468.1051; ROTA PA, 1990, VIROLOGY, V175, P59, DOI 10.1016/0042-6822(90)90186-U; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Skowronski DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038929; Skowronski DM, 2011, PEDIATR INFECT DIS J, V30, P833, DOI 10.1097/INF.0b013e31822db4dc; Socan M, 2014, J CLIN VIROL, V61, P156, DOI 10.1016/j.jcv.2014.06.018; Tan Y, 2013, J VIROL, V87, P12447, DOI 10.1128/JVI.01039-13; Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316; Weil M, 2013, INFLUENZA OTHER RESP, V7, P838, DOI 10.1111/irv.12071; WRIGHT PF, 1980, J INFECT DIS, V141, P430, DOI 10.1093/infdis/141.4.430; WRIGHT PF, 2006, FIELDS VIROLOGY, P1691; Wu CT, 2010, ACTA PAEDIATR, V99, P1701, DOI 10.1111/j.1651-2227.2009.01595.x	28	21	23	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161195	10.1371/journal.pone.0161195	http://dx.doi.org/10.1371/journal.pone.0161195			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27533045	Green Published, Green Submitted, gold			2022-12-26	WOS:000381487600072
J	Sugihara, T; Nagata, T; Mason, B; Koyanagi, M; Terakita, A				Sugihara, Tomohiro; Nagata, Takashi; Mason, Benjamin; Koyanagi, Mitsumasa; Terakita, Akihisa			Absorption Characteristics of Vertebrate Non-Visual Opsin, Opn3	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; VISUAL CELLS; PHOTORECEPTOR-MEMBRANES; SPECTRAL SENSITIVITY; BINDING PROTEIN; RHODOPSIN; PIGMENT; GENE; MELANOPSIN; TISSUE	Most animals possess multiple opsins which sense light for visual and non-visual functions. Here, we show spectral characteristics of non-visual opsins, vertebrate Opn3s, which are widely distributed among vertebrates. We successfully expressed zebrafish Opn3 in mammalian cultured cells and measured its absorption spectrumspectroscopically. When incubated with 11-cis retinal, zebrafish Opn3 formed a blue-sensitive photopigment with an absorption maximum around 465 nm. The Opn3 converts to an all-trans retinal-bearing photoproduct with an absorption spectrum similar to the dark state following brief blue-light irradiation. The photoproduct experienced a remarkable blue-shift, with changes in position of the isosbestic point, during further irradiation. We then used a cAMP-dependent luciferase reporter assay to investigate light-dependent cAMP responses in cultured cells expressing zebrafish, pufferfish, anole and chicken Opn3. The wild type opsins did not produce responses, but cells expressing chimera mutants (WT Opn3s in which the third intracellular loops were replaced with the third intracellular loop of a Gs-coupled jellyfish opsin) displayed light-dependent changes in cAMP. The results suggest that Opn3 is capable of activating G protein(s) in a light-dependent manner. Finally, we used this assay to measure the relative wavelength-dependent response of cells expressing Opn3 chimeras to multiple quantally-matched stimuli. The inferred spectral sensitivity curve of zebrafish Opn3 accurately matched the measured absorption spectrum. We were unable to estimate the spectral sensitivity curve ofmouse or anole Opn3, but, like zebrafish Opn3, the chicken and pufferfish Opn3-JiL3 chimeras also formed blue-sensitive pigments. These findings suggest that vertebrate Opn3s may form blue-sensitive G protein-coupled pigments. Further, we suggest that the method described here, combining a cAMPdependent luciferase reporter assay with chimeric opsins possessing the third intracellular loop of jellyfish opsin, is a versatile approach for estimating absorption spectra of opsins with unknown signaling cascades or for which absorption spectra are difficult to obtain.	[Sugihara, Tomohiro; Nagata, Takashi; Koyanagi, Mitsumasa; Terakita, Akihisa] Osaka City Univ, Grad Sch Sci, Dept Biol & Geosci, Sumiyoshi Ku, Osaka, Japan; [Mason, Benjamin] Stanford Univ, Dept Genet, Stanford Sch Med, Stanford, CA 94305 USA; [Koyanagi, Mitsumasa] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama, Japan	Osaka Metropolitan University; Stanford University; Japan Science & Technology Agency (JST)	Koyanagi, M; Terakita, A (corresponding author), Osaka City Univ, Grad Sch Sci, Dept Biol & Geosci, Sumiyoshi Ku, Osaka, Japan.; Koyanagi, M (corresponding author), Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama, Japan.	koyanagi@sci.osaka-cu.ac.jp; terakita@sci.osaka-cu.ac.jp	Nagata, Takashi/ABB-1780-2020	Nagata, Takashi/0000-0001-5379-2951; Terakita, Akihisa/0000-0002-8379-8913; Koyanagi, Mitsumasa/0000-0002-7741-918X	Japanese Ministry of Education, Culture, Sports, Science and Technology [23247011, 15H05777, 20770057, 22687005, 15K14568]; Human Frontier Science Program; PRESTO from the Japan Science and Technology Agency (JST); National Science Foundation [1158967]; Grants-in-Aid for Scientific Research [26291070, 16K14778, 15H05777] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Human Frontier Science Program(Human Frontier Science Program); PRESTO from the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); National Science Foundation(National Science Foundation (NSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology (nos 23247011, 15H05777 to AT and nos 20770057, 22687005, 15K14568 to MK), http://www.jsps.go.jp/english/e-grants/, Human Frontier Science Program (to AT), http://www.hfsp.org/, PRESTO from the Japan Science and Technology Agency (JST) (to MK), http://www.jst.go.jp/kisoken/en/, and the National Science Foundation (no 1158967 to BM), http://www.nsf.gov/.	Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; Arendt D, 2004, SCIENCE, V306, P869, DOI 10.1126/science.1099955; Arikawa K, 2003, J NEUROSCI, V23, P4527; Bailes HJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2987; Blackshaw S, 1999, J NEUROSCI, V19, P3681; Davies WIL, 2015, GENOME RES, V25, P1666, DOI 10.1101/gr.189886.115; Fischer RM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001585; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; Halford S, 2001, GENOMICS, V72, P203, DOI 10.1006/geno.2001.6469; Hao WS, 1999, J BIOL CHEM, V274, P6085, DOI 10.1074/jbc.274.10.6085; HARA T, 1968, NATURE, V219, P450, DOI 10.1038/219450a0; Kasper G, 2002, GENE, V295, P27, DOI 10.1016/S0378-1119(02)00799-0; Kikkawa S, 1996, BIOCHEMISTRY-US, V35, P15857, DOI 10.1021/bi961360v; Kojima D, 1997, J BIOL CHEM, V272, P22979, DOI 10.1074/jbc.272.37.22979; Kojima D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026388; Koyanagi M, 2005, CURR BIOL, V15, P1065, DOI 10.1016/j.cub.2005.04.063; Koyanagi M, 2004, P NATL ACAD SCI USA, V101, P6687, DOI 10.1073/pnas.0400819101; Koyanagi M, 2002, FEBS LETT, V531, P525, DOI 10.1016/S0014-5793(02)03616-5; Koyanagi M, 2008, P NATL ACAD SCI USA, V105, P15576, DOI 10.1073/pnas.0806215105; Koyanagi M, 2008, PHOTOCHEM PHOTOBIOL, V84, P1024, DOI 10.1111/j.1751-1097.2008.00369.x; Koyanagi M, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0174-9; Koyanagi M, 2014, BBA-BIOENERGETICS, V1837, P710, DOI 10.1016/j.bbabio.2013.09.003; Koyanagi M, 2013, P NATL ACAD SCI USA, V110, P4998, DOI 10.1073/pnas.1219416110; KUHN H, 1980, NATURE, V283, P587, DOI 10.1038/283587a0; LEE YJ, 1994, NEURON, V13, P1143, DOI 10.1016/0896-6273(94)90052-3; MOLDAY RS, 1983, BIOCHEMISTRY-US, V22, P653, DOI 10.1021/bi00272a020; Moutsaki P, 2003, MOL BRAIN RES, V112, P135, DOI 10.1016/S0169-328X(03)00059-7; Nagata T, 2012, SCIENCE, V335, P469, DOI 10.1126/science.1211667; Nagata T, 2010, J COMP PHYSIOL A, V196, P51, DOI 10.1007/s00359-009-0493-9; Sakai K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141238; Sun L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108209; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; Terakita A, 2002, J BIOL CHEM, V277, P40, DOI 10.1074/jbc.M104960200; TERAKITA A, 1993, FEBS LETT, V330, P197, DOI 10.1016/0014-5793(93)80272-V; TERAKITA A, 1989, VISION RES, V29, P639, DOI 10.1016/0042-6989(89)90026-6; Terakita A, 2008, J NEUROCHEM, V105, P883, DOI 10.1111/j.1471-4159.2007.05184.x; Terakita A, 2014, ZOOL SCI, V31, P653, DOI 10.2108/zs140094; Tsukamoto H, 2013, J BIOL CHEM, V288, P28207, DOI 10.1074/jbc.M113.472464; White JH, 2008, HUM MOL GENET, V17, P1890, DOI 10.1093/hmg/ddn087; Yamashita T, 2010, P NATL ACAD SCI USA, V107, P22084, DOI 10.1073/pnas.1012498107	40	40	41	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161215	10.1371/journal.pone.0161215	http://dx.doi.org/10.1371/journal.pone.0161215			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532629	gold, Green Published, Green Submitted			2022-12-26	WOS:000381487600077
J	Penailillo, J; Olivares, G; Moncada, X; Payacan, C; Chang, CS; Chung, KF; Matthews, PJ; Seelenfreund, A; Seelenfreund, D				Penailillo, Johany; Olivares, Gabriela; Moncada, Ximena; Payacan, Claudia; Chang, Chi-Shan; Chung, Kuo-Fang; Matthews, Peter J.; Seelenfreund, Andrea; Seelenfreund, Daniela			Sex Distribution of Paper Mulberry (Broussonetia papyrifera) in the Pacific	PLOS ONE			English	Article							AIRBORNE POLLEN; ANCIENT DNA; NEW-ZEALAND; L. VENT.; IDENTIFICATION; MIGRATIONS; SETTLEMENT; MORACEAE; MARKERS; REGION	Background Paper mulberry (Broussonetia papyrifera (L.) L'Her. ex Vent) is a dioecious tree native to East Asia and mainland Southeast-Asia, introduced prehistorically to Polynesia as a source of bark fiber by Austronesian-speaking voyagers. In Oceania, trees are coppiced and harvested for production of bark-cloth, so flowering is generally unknown. A survey of botanical records of paper mulberry revealed a distributional disjunction: the tree is apparently absent in Borneo and the Philippines. A subsequent study of chloroplast haplotypes linked paper mulberry of Remote Oceania directly to a population in southern Taiwan, distinct from known populations in mainland Southeast-Asia. Methodology We describe the optimization and use of a DNA marker designed to identify sex in paper mulberry. We used this marker to determine the sex distribution in selected localities across Asia, Near and Remote Oceania. We also characterized all samples using the ribosomal internal transcribed spacer sequence (ITS) in order to relate results to a previous survey of ITS diversity. Results In Near and Remote Oceania, contemporary paper mulberry plants are all female with the exception of Hawaii, where plants of both sexes are found. In its natural range in Asia, male and female plants are found, as expected. Male plants in Hawaii display an East Asian ITS genotype, consistent with modern introduction, while females in Remote Oceania share a distinctive variant. Conclusions Most paper mulberry plants now present in the Pacific appear to be descended from female clones introduced prehistorically. In Hawaii, the presence of male and female plants is thought to reflect a dual origin, one a prehistoric female introduction and the other a modern male introduction by Japanese/Chinese immigrants. If only female clones were dispersed from a source-region in Taiwan, this may explain the absence of botanical records and breeding populations in the Philippines and Borneo, and Remote Oceania.	[Penailillo, Johany; Olivares, Gabriela; Payacan, Claudia; Seelenfreund, Daniela] Univ Chile, Fac Ciencias Quim & Farmaceut, Dept Bioquim & Biol Mol, Santiago, Chile; [Moncada, Ximena] CEAZA, La Serena, Chile; [Chang, Chi-Shan] Natl Museum Prehist, Taitung 95060, Taiwan; [Chung, Kuo-Fang] Acad Sinica, Biodivers Res Ctr, Taipei 11529, Taiwan; [Matthews, Peter J.] Natl Museum Ethnol, Osaka, Japan; [Seelenfreund, Andrea] Univ Acad Humanismo Cristiano, Escuela Antropol, Santiago, Chile	Universidad de Chile; Academia Sinica - Taiwan; Universidad Academia de Humanismo Cristiano	Seelenfreund, D (corresponding author), Univ Chile, Fac Ciencias Quim & Farmaceut, Dept Bioquim & Biol Mol, Santiago, Chile.	dseelen@ciq.uchile.cl	Matthews, Peter J./AID-1290-2022	Matthews, Peter/0000-0003-2563-0976	Fondo Nacional de Desarrollo Cientifico y Tecnologico from the Government of Chile [1080061, 1120175]; National Science Council, Taiwan [NSC-102-2621-B-002-007]	Fondo Nacional de Desarrollo Cientifico y Tecnologico from the Government of Chile; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This project was funded by the Fondo Nacional de Desarrollo Cientifico y Tecnologico (www.conicyt.cl/fondecyt/) grants 1080061 and 1120175 from the Government of Chile to AS, and National Science Council, Taiwan (www.most.gov.tw/) Grant NSC-102-2621-B-002-007 to KFC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2012, WORLD ALLERGY ORGAN, V5, P103, DOI 10.1097/WOX.0b013e31826421c8; Adhikari Sinchan, 2014, ScientificWorldJournal, V2014, P216896, DOI 10.1155/2014/216896; Anderson E., 1952, PLANTS MAN AND LIFE; Bachtrog D, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001899; Barker Christine, 2002, Curtis's Botanical Magazine, V19, P8, DOI 10.1111/1467-8748.00324; Bellwood P, 1993, ASIAN PERSPECT, V32, P37; Blattner FR, 1999, BIOTECHNIQUES, V27, P1180, DOI 10.2144/99276st04; Brown, 1996, OCEANIC CULTURE HIST, P117; Chang CS, 2015, P NATL ACAD SCI USA, V112, P13537, DOI 10.1073/pnas.1503205112; de Witte LC, 2010, ANN BOT-LONDON, V106, P859, DOI 10.1093/aob/mcq191; Deputy JC, 2002, THEOR APPL GENET, V106, P107, DOI 10.1007/s00122-002-0995-0; Dubois A., 2013, PLANTAS RAPA NUI GUI; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elevitch CR, 2006, TRADITIONAL TREES PA; FLENLEY JR, 1991, J QUATERNARY SCI, V6, P85, DOI 10.1002/jqs.3390060202; Florece LM, 2006, JESAM, V9, P54; Florence J, 1997, FLORE POLYNESIE FRAN, V1; Ghersa CM, 2002, AGR ECOSYST ENVIRON, V88, P271, DOI 10.1016/S0167-8809(01)00209-2; Gonzalez-Lorca J, 2015, NEW ZEAL J BOT, V53, P75, DOI 10.1080/0028825X.2015.1010546; Horrocks M, 2008, J ARCHAEOL SCI, V35, P2446, DOI 10.1016/j.jas.2008.03.011; Howard M, 2006, STUDIES MAT CULTURES, V10; Howe KR, 2007, VAKA MOANA VOYAGES A, P94; Jacomb C, 2014, J ARCHAEOL SCI, V50, P24, DOI 10.1016/j.jas.2014.05.023; Kafkas S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1326-6; Kahn JG, 2014, ECON BOT, V68, P246, DOI 10.1007/s12231-014-9274-7; KIRCH PV, 2000, ROAD WINDS ARCHAEOLO; Lebot V, 2002, J SOC OCEANISTES, V114-115, P46; Lepofsky D, 2003, ECON BOT, V57, P73, DOI 10.1663/0013-0001(2003)057[0073:TEOCPO]2.0.CO;2; Ling SS, 1962, 2 BIENN C INT ASS HI; Lodhi M. A., 1994, Plant Molecular Biology Reporter, V12, P6, DOI 10.1007/BF02668658; Malik RN, 2007, PAK J BOT, V39, P1045; Matisoo-Smith E, 2015, J HUM EVOL, V79, P93, DOI 10.1016/j.jhevol.2014.10.017; Matthews PJ, 2002, VEGECULTURE E ASIA O; McKey D, 2010, NEW PHYTOL, V186, P318, DOI 10.1111/j.1469-8137.2010.03210.x; Merrill ED, 1954, BOT COOKS VOYAGES IT, P384; Moncada X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056549; Orliac C, 1998, J SOC OCEANISTES, V107, P135, DOI DOI 10.3406/JSO.1998.2053; Orliac C, 2000, EASTER ISLAND ARCHAE, P199; Overholt WA, 2013, ONE SERIES ENTOMOLOG; Prebble M, 2008, TERRA AUSTRALIS, V29, P227; Primack RB, 1987, PEOPLE TROPICAL FORE, P45; Rodriguez W., 2000, Agronomia Mesoamericana, V11, P133; Seelenfreund D, 2011, NEW ZEAL J BOT, V49, P413, DOI 10.1080/0028825X.2011.579135; Seelenfreund D, 2010, NEW ZEAL J BOT, V48, P1; Sieveking G de G, 1956, J MALAYAN BRANCH ROY, V29, P78; Singh AB, 2003, GRANA, V42, P168, DOI 10.1080/00173130310016149; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wang DW, 2011, INT J MOL SCI, V12, P857, DOI 10.3390/ijms12010857; Wang L, 2012, CHINESE HLTH EC, V11, P11; Whistler W, 2009, PLANTS CANOE PEOPLE; Wilmshurst JM, 2011, P NATL ACAD SCI USA, V108, P1815, DOI 10.1073/pnas.1015876108; Yang YL, 1998, J PLANT RES, V111, P501, DOI 10.1007/BF02507785; Zerega NJC, 2005, MOL PHYLOGENET EVOL, V37, P402, DOI 10.1016/j.ympev.2005.07.004; Zerega NJC, 2004, AM J BOT, V91, P760, DOI 10.3732/ajb.91.5.760; Zizka G, 1991, FLOWERING PLANTS E I	55	24	25	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161148	10.1371/journal.pone.0161148	http://dx.doi.org/10.1371/journal.pone.0161148			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529483	Green Published, gold, Green Submitted			2022-12-26	WOS:000381476700050
J	Lahiri, P; Schmidt, V; Smole, C; Kufferath, I; Denk, H; Strnad, P; Rulicke, T; Frohlich, LF; Zatloukal, K				Lahiri, Pooja; Schmidt, Volker; Smole, Claudia; Kufferath, Iris; Denk, Helmut; Strnad, Pavel; Ruelicke, Thomas; Froehlich, Leopold F.; Zatloukal, Kurt			p62/Sequestosome-1 Is Indispensable for Maturation and Stabilization of Mallory-Denk Bodies	PLOS ONE			English	Article							INTRACELLULAR HYALINE BODIES; TRANSCRIPTION FACTOR NRF2; CUL3-BASED E3 LIGASE; OXIDATIVE STRESS; BODY FORMATION; PROTEIN; P62; AUTOPHAGY; MOUSE; LIVER	Mallory-Denk bodies (MDBs) are hepatocytic protein aggregates found in steatohepatitis and several other chronic liver diseases as well as hepatocellular carcinoma. MDBs are mainly composed of phosphorylated keratins and stress protein p62/Sequestosome-1 (p62), which is a common component of cytoplasmic aggregates in a variety of protein aggregation diseases. In contrast to the well-established role of keratins, the role of p62 in MDB pathogenesis is still elusive. We have generated total and hepatocyte-specific p62 knockout mice, fed them with 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) to induce MDBs and allowed the mice to recover from DDC intoxication on a standard diet to investigate the role of p62 in MDB formation and elimination. In the absence of p62, smaller, granular and less distinct MDBs appeared, which failed to mature to larger and compact inclusions. Moreover, p62 deficiency impaired the binding of other proteins such as NBR1 and Hsp25 to MDBs and altered the cellular defense mechanism by downregulation of Nrf2 target genes. Upon recovery from DDC intoxication on a standard diet, there was an enhanced reduction of p62-deficient MDBs, which was accompanied by a pronounced decrease in ubiquitinated proteins. Our data provide strong evidence that keratin aggregation is the initial step in MDB formation in steatohepatitis-related mouse models. Interaction of p62 with keratin aggregates then leads to maturation i.e., enlargement and stabilization of the MDBs as well as recruitment of other MDB-associated proteins.	[Lahiri, Pooja; Smole, Claudia; Kufferath, Iris; Denk, Helmut; Froehlich, Leopold F.; Zatloukal, Kurt] Med Univ Graz, Inst Pathol, Graz, Austria; [Schmidt, Volker; Ruelicke, Thomas] Univ Vet Med Vienna, Inst Lab Anim Sci, Vienna, Austria; [Strnad, Pavel] IZKF, Aachen, Germany; [Strnad, Pavel] Dept Internal Med 3, Aachen, Germany	Medical University of Graz; University of Veterinary Medicine Vienna	Zatloukal, K (corresponding author), Med Univ Graz, Inst Pathol, Graz, Austria.	kurt.zatloukal@medunigraz.at	Lahiri, Pooja/AAE-6663-2019	Lahiri, Pooja/0000-0002-6305-9451	Doctoral College of Metabolic and Cardiovascular Diseases, Medical University of Graz; FWF Austrian Science Fund [DK-MCD W1226]; Emmy Noether program of the German Research Foundation [STR 1095/2-1]; Interdisciplinary Center for Clinical Research (IZKF) within the faculty of medicine at the RWTH Aachen University; GEN-AU programme Austromouse	Doctoral College of Metabolic and Cardiovascular Diseases, Medical University of Graz; FWF Austrian Science Fund(Austrian Science Fund (FWF)); Emmy Noether program of the German Research Foundation(German Research Foundation (DFG)); Interdisciplinary Center for Clinical Research (IZKF) within the faculty of medicine at the RWTH Aachen University; GEN-AU programme Austromouse	This project was supported by the Doctoral College of Metabolic and Cardiovascular Diseases, Medical University of Graz and FWF Austrian Science Fund DK-MCD W1226 (to KZ), the Emmy Noether program of the German Research Foundation STR 1095/2-1 and the Interdisciplinary Center for Clinical Research (IZKF) within the faculty of medicine at the RWTH Aachen University (to PS) and the GEN-AU programme Austromouse (to TR).	Aguzzi A, 2010, NAT REV DRUG DISCOV, V9, P237, DOI 10.1038/nrd3050; Copple IM, 2010, J BIOL CHEM, V285, P16782, DOI 10.1074/jbc.M109.096545; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; DENK H, 1979, P NATL ACAD SCI USA, V76, P4112, DOI 10.1073/pnas.76.8.4112; DENK H, 1981, EUR J CELL BIOL, V23, P241; Denk H, 2006, J PATHOL, V208, P653, DOI 10.1002/path.1946; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; FRANKE WW, 1979, LAB INVEST, V40, P207; Harada M, 2008, HEPATOLOGY, V47, P2026, DOI 10.1002/hep.22294; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Janig E, 2005, EUR J CELL BIOL, V84, P329, DOI 10.1016/j.ejcb.2004.12.018; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; Kim J, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2746457; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836; Ku NO, 2004, METHOD CELL BIOL, V78, P489; Leneuve P, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng021; Mahajan V, 2011, GASTROENTEROLOGY, V141, P1080, DOI 10.1053/j.gastro.2011.05.039; Moscat J, 2007, TRENDS BIOCHEM SCI, V32, P95, DOI 10.1016/j.tibs.2006.12.002; Moscat J, 2009, EMBO REP, V10, P804, DOI 10.1038/embor.2009.172; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Muller TD, 2013, J CLIN INVEST, V123, P469, DOI 10.1172/JCI64209; Muller T, 2004, HEPATOLOGY, V39, P963, DOI 10.1002/hep.20108; Naeem A, 2011, CELL BIOCHEM BIOPHYS, V61, P237, DOI 10.1007/s12013-011-9200-x; Nezis IP, 2008, J CELL BIOL, V180, P1065, DOI 10.1083/jcb.200711108; Nikam A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066094; Odagiri S, 2012, ACTA NEUROPATHOL, V124, P173, DOI 10.1007/s00401-012-0975-7; Osburn WO, 2008, MUTAT RES-REV MUTAT, V659, P31, DOI 10.1016/j.mrrev.2007.11.006; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; PREISEGGER KH, 1992, LAB INVEST, V66, P193; Reynaud E., 2010, NAT ED, V3, P28; Richter-Landsberg C, 2003, CELL MOL LIFE SCI, V60, P337, DOI 10.1007/s000180300028; Singla A, 2012, HEPATOLOGY, V56, P322, DOI 10.1002/hep.25664; Strnad P, 2007, GASTROENTEROLOGY, V132, P1515, DOI 10.1053/j.gastro.2007.02.020; Stumptner C, 2002, HEPATOLOGY, V35, P1053, DOI 10.1053/jhep.2002.32674; Stumptner C, 2001, J HEPATOL, V34, P665, DOI 10.1016/S0168-8278(00)00099-4; Stumptner C, 2007, HEPATOLOGY, V46, P851, DOI 10.1002/hep.21744; Umemura A, 2016, CANCER CELL, V29, P935, DOI 10.1016/j.ccell.2016.04.006; Yao Tso-Pang, 2010, Genes Cancer, V1, P779; YOKOO H, 1982, GASTROENTEROLOGY, V83, P109; Yuan QX, 1995, EXP MOL PATHOL, V63, P63, DOI 10.1006/exmp.1995.1031; Zatloukal B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096690; ZATLOUKAL K, 1990, HEPATOLOGY, V11, P652, DOI 10.1002/hep.1840110419; ZATLOUKAL K, 1990, LAB INVEST, V62, P427; ZATLOUKAL K, 1992, LAB INVEST, V66, P774; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6; Zatloukal K, 2007, EXP CELL RES, V313, P2033, DOI 10.1016/j.yexcr.2007.04.024	51	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0161083	10.1371/journal.pone.0161083	http://dx.doi.org/10.1371/journal.pone.0161083			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27526095	gold, Green Published, Green Submitted			2022-12-26	WOS:000381471100033
J	Pressman, PS; Noniyeva, Y; Bott, N; Dutt, S; Sturm, V; Miller, BL; Kramer, JH				Pressman, Peter S.; Noniyeva, Yuliana; Bott, Nick; Dutt, Shubir; Sturm, Virginia; Miller, Bruce L.; Kramer, Joel H.			Comparing Volume Loss in Neuroanatomical Regions of Emotion versus Regions of Cognition in Healthy Aging	PLOS ONE			English	Article							ANTERIOR TEMPORAL-LOBE; WHITE-MATTER LESION; BRAIN ATROPHY; OLD-AGE; ALZHEIMERS-DISEASE; NEGATIVE IMAGES; LATE-LIFE; CORTEX; MEMORY; AMYGDALA	Many emotional functions are relatively preserved in aging despite declines in several cognitive domains and physical health. High levels of happiness exist even among centenarians. To address the hypothesis of whether preservation of emotional function in healthy aging may relate to different rates of age-related volume loss across brain structures, we performed two volumetric analyses on structural magnetic resonance neuroimaging of a group of healthy aging research participants using Freesurfer version 5.1. Volumes selected as supporting cognition included bilateral midfrontal and lateral frontal gyri, lateral parietal and temporal cortex, and medial temporal lobes. Volumes supporting emotion included bilateral amygdala, rostral anterior cingulate, insula, orbitofrontal cortex, and nucleus accumbens. A cross-sectional analysis was performed using structural MRI scans from 258 subjects. We found no difference in proportional change between groups. A longitudinal mixed effects model was used to compare regional changes over time in a subset of 84 subjects. Again, there was no difference in proportional change over time. While our results suggest that aging does not collectively target cognitive brain regions more than emotional regions, subgroup analysis suggests relative preservation of the anterior cingulate cortex, with greater volume loss in the nucleus accumbens. Implications of these relative rates of age-related volume loss in healthy aging are discussed and merit further research.	[Pressman, Peter S.; Noniyeva, Yuliana; Bott, Nick; Dutt, Shubir; Sturm, Virginia; Miller, Bruce L.; Kramer, Joel H.] Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, 675 Nelson Rising Lane,Suite 190, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Pressman, PS (corresponding author), Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, 675 Nelson Rising Lane,Suite 190, San Francisco, CA 94158 USA.	ppressman@memory.ucsf.edu			National Institutional of Health (NIH) through the Larry L. Hillblom Foundation [P50AG023501, P01AG019724, P0502788]; NIH [P0504774]; Clinical Research Training Fellowship of the American Brain Foundation; NATIONAL INSTITUTE ON AGING [P50AG023501, P01AG019724, R01AG048234] Funding Source: NIH RePORTER	National Institutional of Health (NIH) through the Larry L. Hillblom Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical Research Training Fellowship of the American Brain Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding for this study was made available to the Memory and Aging Center at the University of California, San Francisco (National Institutional of Health (NIH) P50AG023501 and P01AG019724) through the Larry L. Hillblom Foundation (P0502788) and NIH (P0504774). Dr. Pressman is funded through a Clinical Research Training Fellowship of the American Brain Foundation (https://www.americanbrainfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett DA, 2012, ANN NEUROL, V72, P599, DOI 10.1002/ana.23654; Berridge KC, 2013, CURR OPIN NEUROBIOL, V23, P294, DOI 10.1016/j.conb.2013.01.017; Bilello M, 2015, J ALZHEIMERS DIS, V48, P987, DOI 10.3233/JAD-150400; Binney RJ, 2010, CEREB CORTEX, V20, P2728, DOI 10.1093/cercor/bhq019; Brassen S, 2011, BIOL PSYCHIAT, V70, P131, DOI 10.1016/j.biopsych.2010.10.013; Buckner RL, 2004, NEURON, V44, P195, DOI 10.1016/j.neuron.2004.09.006; Cabeza R, 2012, TRENDS COGN SCI, V16, P338, DOI 10.1016/j.tics.2012.04.008; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Charles ST, 2003, J EXP PSYCHOL GEN, V132, P310, DOI 10.1037/0096-3445.132.2.310; Charles ST, 2010, ANNU REV PSYCHOL, V61, P383, DOI 10.1146/annurev.psych.093008.100448; Charles ST, 2010, PSYCHOL BULL, V136, P1068, DOI 10.1037/a0021232; Cherbuin N, 2011, BRAIN BEHAV, V1, P125, DOI 10.1002/brb3.24; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dong C, 2015, NEUROLOGY, V85, P441, DOI 10.1212/WNL.0000000000001716; Duerden EG, 2013, NEUROIMAGE, V78, P159, DOI 10.1016/j.neuroimage.2013.04.014; Duncan J, 2013, NEURON, V80, P35, DOI 10.1016/j.neuron.2013.09.015; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fjell AM, 2013, J NEUROSCI, V33, P8237, DOI 10.1523/JNEUROSCI.5506-12.2013; Fjell AM, 2009, CEREB CORTEX, V19, P2001, DOI 10.1093/cercor/bhn232; GoldmanRakic PS, 1996, PHILOS T ROY SOC B, V351, P1445, DOI 10.1098/rstb.1996.0129; Goodkind MS, 2012, HUM BRAIN MAPP, V33, P753, DOI 10.1002/hbm.21251; Gross Rachel G, 2010, Continuum (Minneap Minn), V16, P140, DOI 10.1212/01.CON.0000368266.46038.0e; Gyurak A, 2011, COGNITION EMOTION, V25, P400, DOI 10.1080/02699931.2010.544160; Hedman AM, 2012, HUM BRAIN MAPP, V33, P1987, DOI 10.1002/hbm.21334; Isaacowitz DM, 2006, PSYCHOL AGING, V21, P40, DOI 10.1037/0882-7974.21.1.40; Jefferies E, 2013, CORTEX, V49, P611, DOI 10.1016/j.cortex.2012.10.008; Jeste DV, 2014, INDIVIDUAL SOCIETAL; John YJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00101; Johnsrude IS, 2000, J NEUROSCI, V20, P2649; Jopp D, 2006, PSYCHOL AGING, V21, P266, DOI 10.1037/0882-7974.21.2.266; Kennedy Q, 2004, PSYCHOL SCI, V15, P208, DOI 10.1111/j.0956-7976.2004.01503011.x; Labouvie-Vief G., 2010, HDB LIFE SPAN DEV SO, V2, P79; Levenson R.W., 2000, PSYCHOL AGING REVOLU, V9, P123, DOI [10.1037/10363-007, DOI 10.1037/10363-007]; Long XJ, 2012, ACAD RADIOL, V19, P785, DOI 10.1016/j.acra.2012.03.006; Mann SL, 2011, BRAIN RES, V1401, P18, DOI 10.1016/j.brainres.2011.05.050; Mather M, 2003, PSYCHOL SCI, V14, P409, DOI 10.1111/1467-9280.01455; Mather M, 2012, ANN NY ACAD SCI, V1251, P33, DOI 10.1111/j.1749-6632.2012.06471.x; Medford N, 2010, BRAIN STRUCT FUNCT, V214, P535, DOI 10.1007/s00429-010-0265-x; Meeks TW, 2009, ARCH GEN PSYCHIAT, V66, P355, DOI 10.1001/archgenpsychiatry.2009.8; Moran C, 2013, DIABETES CARE, V36, P4036, DOI 10.2337/dc13-0143; Morey RA, 2010, HUM BRAIN MAPP, V31, P1751, DOI 10.1002/hbm.20973; Piguet O, 2008, PSYCHOL AGING, V23, P307, DOI 10.1037/0882-7974.23.2.307; Quirk GJ, 1997, NEURON, V19, P613, DOI 10.1016/S0896-6273(00)80375-X; Reuter-Lorenz PA, 2005, CURR OPIN NEUROBIOL, V15, P245, DOI 10.1016/j.conb.2005.03.016; Ritchey M, 2011, NEUROPSYCHOLOGIA, V49, P640, DOI 10.1016/j.neuropsychologia.2010.09.009; Samanez-Larkin GR, 2010, J NEUROSCI, V30, P1426, DOI 10.1523/JNEUROSCI.4902-09.2010; Schlagman S, 2006, MEMORY, V14, P161, DOI 10.1080/09658210544000024; Schoenbaum G, 2003, J NEUROSCI, V23, P9833; Seider BH, 2011, SOC COGN AFFECT NEUR, V6, P186, DOI 10.1093/scan/nsq069; Shiota MN, 2009, PSYCHOL AGING, V24, P890, DOI 10.1037/a0017896; StataCorp, 2013, STATA STAT SOFTW REL; Stemmler M, 2013, GESUNDHEITSWESEN, V75, P761, DOI 10.1055/s-0033-1357164; Straube T, 2011, NEUROIMAGE, V54, P2534, DOI 10.1016/j.neuroimage.2010.10.010; Sturm VE, 2013, SOC COGN AFFECT NEUR, V8, P468, DOI 10.1093/scan/nss023; Sze JA, 2012, EMOTION, V12, P1129, DOI 10.1037/a0025011; Wilensky AE, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-24-j0006.1999	56	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0158187	10.1371/journal.pone.0158187	http://dx.doi.org/10.1371/journal.pone.0158187			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27552103	Green Published, gold			2022-12-26	WOS:000381768800003
J	Strano, E; Sood, V				Strano, Emanuele; Sood, Vishal			Rich and Poor Cities in Europe. An Urban Scaling Approach to Mapping the European Economic Transition	PLOS ONE			English	Article								Recent advances in the urban science make broad use of the notion of scaling. We focus here on the important scaling relationship between the gross metropolitan product (GMP) of a city and its population (pop). It has been demonstrated that GMP alpha Y Ypop(beta) with beta always greater than 1 and close to 1.2. This fundamental finding highlights a universal rule that holds across countries and cultures and might explain the very nature of cities. However, in an increasingly connected world, the hypothesis that the economy of a city solely depends on its population might be questionable. Using data for 248 cities in the European Union between 2005 and 2010, we found a double GMP/pop scaling regime. For West EU cities, beta = 1 over the whole the period, while for post-communist cities beta > 1 and increases from similar to 1.2 to similar to 1.4. The evolution of the scaling exponent describes the convergence of postcommunist European cities to open and liberal economies. We propose a simple model of economic convergence in which, under stable political conditions, a linear GMP/pop scaling is expected for all cities. The results suggest that the GMP/pop super-linear scaling represents a phase of economic growth rather than a steady, universal urban feature. The results also suggest that relationships between cities are embedded in their political and economic context and cannot be neglected in explanations of cities, urbanization and urban economics.	[Strano, Emanuele] MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Strano, Emanuele; Sood, Vishal] Polytech Sch Lausanne EPFL, Dept Civil & Environm Engn, Lausanne, Switzerland	Massachusetts Institute of Technology (MIT)	Strano, E (corresponding author), MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Strano, E (corresponding author), Polytech Sch Lausanne EPFL, Dept Civil & Environm Engn, Lausanne, Switzerland.	emanuele.strano@epfl.ch		Strano, Emanuele/0000-0002-2339-6824				Arcaute E., 2013, ARXIV13011674; Batty M, 2008, SCIENCE, V319, P769, DOI 10.1126/science.1151419; Batty M, 2011, ENVIRON PLANN B, V38, P753, DOI 10.1068/b3805ed; Bettencourt LMA, 2013, HYPOTHESIS URBAN SCA; Bettencourt L, 2010, NATURE, V467, P912, DOI 10.1038/467912a; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bettencourt LMA, 2013, SCIENCE, V340, P1438, DOI 10.1126/science.1235823; Bureau UC, 2008, METROPOLITAN MICROPO; Duranton G, 2014, GROWING CITIES DEV C; Glaeser E. L., 1991, GROWTH CITIES; Glaeser EL, 2014, J EUR ECON ASSOC, V12, P1154, DOI 10.1111/jeea.12100; Gollin D, 2013, URBANIZATION U UNPUB; Heyns B, 2005, ANNU REV SOCIOL, V31, P163, DOI 10.1146/annurev.soc.30.012703.110637; Jacobs J, 1961, LIFE DEATH GREAT AM; Jacobs J., 1970, EC CITIES, VFirst; KLEIBER M, 1947, PHYSIOL REV, V27, P511, DOI 10.1152/physrev.1947.27.4.511; Oliveira EA, 2014, SCI REP-UK, V4, DOI 10.1038/srep04235; ROMER PM, 1986, J POLIT ECON, V94, P1002, DOI 10.1086/261420; Spence Michael, 2009, URBANIZATION GROWTH; Svejnar J, 2002, J ECON PERSPECT, V16, P3, DOI 10.1257/0895330027058; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122	21	28	30	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0159465	10.1371/journal.pone.0159465	http://dx.doi.org/10.1371/journal.pone.0159465			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT8TR	27551719	Green Published, Green Submitted, gold			2022-12-26	WOS:000381768800006
J	Resch, Y; Blatt, K; Malkus, U; Fercher, C; Swoboda, I; Focke-Tejkl, M; Chen, KW; Seiberler, S; Mittermann, I; Lupinek, C; Rodriguez-Dominguez, A; Zieglmayer, P; Zieglmayer, R; Keller, W; Krzyzanek, V; Valent, P; Valenta, R; Vrtala, S				Resch, Yvonne; Blatt, Katharina; Malkus, Ursula; Fercher, Christian; Swoboda, Ines; Focke-Tejkl, Margit; Chen, Kuan-Wei; Seiberler, Susanne; Mittermann, Irene; Lupinek, Christian; Rodriguez-Dominguez, Azahara; Zieglmayer, Petra; Zieglmayer, Rene; Keller, Walter; Krzyzanek, Vladislav; Valent, Peter; Valenta, Rudolf; Vrtala, Susanne			Molecular, Structural and Immunological Characterization of Der p 18, a Chitinase-Like House Dust Mite Allergen	PLOS ONE			English	Article							DERMATOPHAGOIDES-PTERONYSSINUS; PERITROPHIC MATRIX; IGE-BINDING; PROTEIN; IDENTIFICATION; SENSITIZATION; INFLAMMATION; RECOMBINANT; CLONING; ASTHMA	Background The house dust mite (HDM) allergen Der p 18 belongs to the glycoside hydrolase family 18 chitinases. The relevance of Der p 18 for house dust mite allergic patients has only been partly investigated. Objective To perform a detailed characterization of Der p 18 on a molecular, structural and immunological level. Methods Der p 18 was expressed in E. coli, purified to homogeneity, tested for chitin-binding activity and its secondary structure was analyzed by circular dichroism. Der p 18-specific IgG antibodies were produced in rabbits to localize the allergen in mites using immunogold electron microscopy and to search for cross-reactive allergens in other allergen sources (i.e. mites, crustacea, mollusca and insects). IgE reactivity of rDer p 18 was tested with sera from clinically well characterized HDM-allergic patients (n = 98) and its allergenic activity was analyzed in basophil activation experiments. Results Recombinant Der p 18 was expressed and purified as a folded, biologically active protein. It shows weak chitin-binding activity and partial cross-reactivity with Der f 18 from D. farinae but not with proteins from the other tested allergen sources. The allergen was mainly localized in the peritrophic matrix of the HDM gut and to a lower extent in fecal pellets. Der p 18 reacted with IgE from 10% of mite allergic patients from Austria and showed allergenic activity when tested for basophil activation in Der p 18-sensitized patients. Conclusion Der p 18 is a rather genus-specific minor allergen with weak chitin-binding activity but exhibits allergenic activity and therefore should be included in diagnostic test panels for HDM allergy.	[Resch, Yvonne; Swoboda, Ines; Focke-Tejkl, Margit; Chen, Kuan-Wei; Seiberler, Susanne; Mittermann, Irene; Lupinek, Christian; Valenta, Rudolf; Vrtala, Susanne] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Dept Pathophysiol & Allergy Res, Div Immunopathol, Vienna, Austria; [Blatt, Katharina; Valent, Peter] Med Univ Vienna, Dept Internal Med 1, Div Hematol & Hemostaseol, Vienna, Austria; [Malkus, Ursula] Univ Munster, Inst Med Phys & Biophys, Munster, Germany; [Fercher, Christian; Keller, Walter] Graz Univ, Inst Mol Biosci, Div Struct Biol, Graz, Austria; [Zieglmayer, Petra; Zieglmayer, Rene] Vienna Challenge Chamber, Vienna, Austria; [Krzyzanek, Vladislav] Acad Sci Czech Republic, ASCR, Inst Sci Instruments, Brno, Czech Republic; [Vrtala, Susanne] Med Univ Vienna, Christian Doppler Lab Dev Allergen Chips, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; University of Munster; University of Graz; Czech Academy of Sciences; Institute of Scientific Instruments of the Czech Academy of Sciences; Medical University of Vienna	Vrtala, S (corresponding author), Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Dept Pathophysiol & Allergy Res, Div Immunopathol, Vienna, Austria.; Vrtala, S (corresponding author), Med Univ Vienna, Christian Doppler Lab Dev Allergen Chips, Vienna, Austria.	susanne.vrtala@meduniwien.ac.at	Keller, Walter/AAW-1501-2021; Test, PV/U-9451-2019; Valent, Peter/B-8533-2016; Lupinek, Christian/I-3311-2019; Krzyzanek, Vladislav/C-6275-2008; Zieglmayer, Petra/AAG-1006-2020; Gamperl, Susi/V-2715-2019; Test, Test/Y-7921-2019; Fercher, Christian/AAN-1445-2020	Keller, Walter/0000-0002-2261-958X; Valent, Peter/0000-0003-0456-5095; Lupinek, Christian/0000-0002-8612-8245; Krzyzanek, Vladislav/0000-0002-7996-2979; Gamperl, Susi/0000-0003-0456-5095; Fercher, Christian/0000-0002-3693-9357; Resch, Yvonne/0000-0002-7933-2547; Chen, Kuan-Wei/0000-0001-5899-5766; Vrtala, Susanne/0000-0003-4250-8243; Swoboda, Ines/0000-0002-9164-1721; Valenta, Rudolf/0000-0001-5944-3365; Mittermann, Irene/0000-0002-6240-6730	Austrian Science Fund (FWF) [F4602, F4604, F4605, F4611]; Christian Doppler Association, Vienna, Austria	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Christian Doppler Association, Vienna, Austria	This work was supported by grants F4602, F4604, F4605 and F4611 of the Austrian Science Fund (FWF, www.fwf.ac.at) and by the Christian Doppler Association, Vienna, Austria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants F4602, F4604, F4605 and F4611 of the Austrian Science Fund (FWF) and by the Christian Doppler Association, Vienna, Austria.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Banerjee S, 2015, J INVEST DERMATOL, V135, P102, DOI 10.1038/jid.2014.271; Blanco C, 2003, CURR ALLERGY ASTHM R, V3, P47, DOI 10.1007/s11882-003-0012-y; Blomme K, 2013, INT ARCH ALLERGY IMM, V160, P200, DOI 10.1159/000339853; Boulet LP, 1997, CLIN EXP ALLERGY, V27, P52, DOI 10.1111/j.1365-2222.1997.tb00672.x; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Casu R, 1997, P NATL ACAD SCI USA, V94, P8939, DOI 10.1073/pnas.94.17.8939; Chen KW, 2008, MOL IMMUNOL, V45, P2486, DOI 10.1016/j.molimm.2008.01.006; Chupp GL, 2007, NEW ENGL J MED, V357, P2016, DOI 10.1056/NEJMoa073600; COULSON AFW, 1994, FEBS LETT, V354, P41, DOI 10.1016/0014-5793(94)01084-6; Dahiya N, 2006, APPL MICROBIOL BIOT, V71, P773, DOI 10.1007/s00253-005-0183-7; Diaz-Perales A, 2003, J ALLERGY CLIN IMMUN, V112, P1002, DOI 10.1016/j.jaci.2003.07.006; Elias JA, 2005, J ALLERGY CLIN IMMUN, V116, P497, DOI 10.1016/j.jaci.2005.06.028; Elvin CM, 1996, J BIOL CHEM, V271, P8925, DOI 10.1074/jbc.271.15.8925; FLING SP, 1986, ANAL BIOCHEM, V155, P83, DOI 10.1016/0003-2697(86)90228-9; Hales BJ, 2013, INT ARCH ALLERGY IMM, V160, P233, DOI 10.1159/000339760; Hauswirth AW, 2002, J ALLERGY CLIN IMMUN, V110, P102, DOI 10.1067/mai.2002.125257; Heinzerling LM, 2009, ALLERGY, V64, P1498, DOI 10.1111/j.1398-9995.2009.02093.x; Hemmer W, 2010, CLIN EXP ALLERGY, V40, P679, DOI 10.1111/j.1365-2222.2010.03486.x; Hervas D, 2013, INT ARCH ALLERGY IMM, V160, P383, DOI 10.1159/000342444; HEYMANN PW, 1986, J IMMUNOL, V137, P2841; Jacquet A, 2013, ISRN ALLERGY, V2013, DOI [10.1155/2013/735031, DOI 10.1155/2013/735031]; Johansen JS, 2006, DAN MED BULL, V53, P172; Lupinek C, 2014, METHODS, V66, P106, DOI 10.1016/j.ymeth.2013.10.008; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; McCall C, 2001, VET IMMUNOL IMMUNOP, V78, P231, DOI 10.1016/S0165-2427(00)00258-0; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Nandy Andreas, 2013, Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess, V97, P140; Niespodziana K, 2011, J ALLERGY CLIN IMMUN, V127, P1562, DOI 10.1016/j.jaci.2011.02.004; Nolte H, 2015, J ALLERGY CLIN IMMUN, V135, P1494, DOI 10.1016/j.jaci.2014.12.1911; O'Neil SE, 2006, CLIN EXP ALLERGY, V36, P831, DOI 10.1111/j.1365-2222.2006.02497.x; Radauer C, 2014, ALLERGY, V69, P413, DOI 10.1111/all.12348; Rao FV, 2005, CHEM BIOL, V12, P65, DOI 10.1016/j.chembiol.2004.10.013; Resch Y, 2011, CLIN EXP ALLERGY, V41, P1468, DOI 10.1111/j.1365-2222.2011.03798.x; Shen ZC, 1998, J BIOL CHEM, V273, P17665, DOI 10.1074/jbc.273.28.17665; Thomas WR, 2010, ASIAN PAC J ALLERGY, V28, P211; Thomas WR, 2007, PROTEIN PEPTIDE LETT, V14, P943, DOI 10.2174/092986607782541169; VALENTA R, 1992, J EXP MED, V175, P377, DOI 10.1084/jem.175.2.377; Vrtala S, 2014, METHODS, V66, P67, DOI 10.1016/j.ymeth.2013.07.034; Wang HY, 2015, INT ARCH ALLERGY IMM, V167, P203, DOI 10.1159/000438724; Weber E, 2003, J ALLERGY CLIN IMMUN, V112, P79, DOI 10.1067/mai.2003.1602; Weghofer M, 2008, INT ARCH ALLERGY IMM, V147, P101, DOI 10.1159/000135696; Weghofer M, 2013, J IMMUNOL, V190, P3059, DOI 10.4049/jimmunol.1202288; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; YASUEDA H, 1993, CLIN EXP ALLERGY, V23, P384, DOI 10.1111/j.1365-2222.1993.tb00343.x; Zakzuk J, 2014, INT ARCH ALLERGY IMM, V163, P119, DOI 10.1159/000356482; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336	47	21	23	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0160641	10.1371/journal.pone.0160641	http://dx.doi.org/10.1371/journal.pone.0160641			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548813	Green Published, Green Submitted, gold			2022-12-26	WOS:000381768400017
J	Welter, M; Fredrich, T; Rinneberg, H; Rieger, H				Welter, Michael; Fredrich, Thierry; Rinneberg, Herbert; Rieger, Heiko			Computational Model for Tumor Oxygenation Applied to Clinical Data on Breast Tumor Hemoglobin Concentrations Suggests Vascular Dilatation and Compression	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; INTERSTITIAL FLUID PRESSURE; SCANNING OPTICAL MAMMOGRAPHY; BLOOD-FLOW; MICROVASCULAR NETWORKS; CAPILLARY NETWORKS; SOLID STRESS; VESSEL COOPTION; TRANSPORT; TISSUE	We present a computational model for trans-vascular oxygen transport in synthetic tumor and host tissue blood vessel networks, aiming at qualitatively explaining published data of optical mammography, which were obtained from 87 breast cancer patients. The data generally show average hemoglobin concentration to be higher in tumors versus host tissue whereas average oxy-to total hemoglobin concentration (vascular segment RBC-volume-weighted blood oxygenation) can be above or below normal. Starting from a synthetic arterio-venous initial network the tumor vasculature was generated by processes involving cooption, angiogenesis, and vessel regression. Calculations of spatially resolved blood flow, hematocrit, oxy- and total hemoglobin concentrations, blood and tissue oxygenation were carried out for ninety tumor and associated normal vessel networks starting from various assumed geometries of feeding arteries and draining veins. Spatial heterogeneity in the extra-vascular partial oxygen pressure distribution can be related to various tumor compartments characterized by varying capillary densities and blood flow characteristics. The reported higher average hemoglobin concentration of tumors is explained by growth and dilatation of tumor blood vessels. Even assuming sixfold metabolic rate of oxygen consumption in tumorous versus host tissue, the predicted oxygen hemoglobin concentrations are above normal. Such tumors are likely associated with high tumor blood flow caused by high-caliber blood vessels crossing the tumor volume and hence oxygen supply exceeding oxygen demand. Tumor oxy- to total hemoglobin concentration below normal could only be achieved by reducing tumor vessel radii during growth by a randomly selected factor, simulating compression caused by intra-tumoral solid stress due to proliferation of cells and extracellular matrix. Since compression of blood vessels will impede chemotherapy we conclude that tumors with oxy- to total hemoglobin concentration below normal are less likely to respond to chemotherapy. Such behavior was recently reported for neo-adjuvant chemotherapy of locally advanced breast tumors.	[Welter, Michael; Fredrich, Thierry; Rieger, Heiko] Univ Saarland, Theoret Phys, Saarbrucken, Germany; [Rinneberg, Herbert] Phys Tech Bundesanstalt PTB Berlin, Div Med Phys & Metrol Informat Technol, Berlin, Germany	Saarland University; Physikalisch-Technische Bundesanstalt (PTB)	Rieger, H (corresponding author), Univ Saarland, Theoret Phys, Saarbrucken, Germany.	h.rieger@mx.uni-saarland.de	Rieger, Heiko/C-3298-2012	Fredrich, Thierry/0000-0001-7030-3048; Rieger, Heiko/0000-0003-0205-3678	German Research Foundation (DFG) within the Collaborative Research Center [SFB 1027]	German Research Foundation (DFG) within the Collaborative Research Center(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG) within the Collaborative Research Center SFB 1027. The funders had no influence on this work.	An Hongyu, 2011, Open Neuroimag J, V5, P120, DOI 10.2174/1874440001105010120; Anderson PG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117322; Bartha K, 2006, J THEOR BIOL, V241, P903, DOI 10.1016/j.jtbi.2006.01.022; BEANEY RP, 1984, SEMIN NUCL MED, V14, P324, DOI 10.1016/S0001-2998(84)80006-9; Beard DA, 2001, ANN BIOMED ENG, V29, P837, DOI 10.1114/1.1408920; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Carp SA, 2008, OPT EXPRESS, V16, P16064, DOI 10.1364/OE.16.016064; CHARY SR, 1989, P NATL ACAD SCI USA, V86, P5385, DOI 10.1073/pnas.86.14.5385; Chauhan VP, 2014, CANCER CELL, V26, P14, DOI 10.1016/j.ccr.2014.06.003; Chauhan VP, 2011, ANNU REV CHEM BIOMOL, V2, P281, DOI 10.1146/annurev-chembioeng-061010-114300; Choe R, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3103325; Christen T, 2013, AM J NEURORADIOL, V34, P1113, DOI 10.3174/ajnr.A3070; Coppola G, 2008, J R SOC INTERFACE, V5, P1067, DOI 10.1098/rsif.2007.1338; D'Angelo C, 2012, SIAM J NUMER ANAL, V50, P194, DOI 10.1137/100813853; Dafni H, 2002, CANCER RES, V62, P6731; Dasu A, 2003, PHYS MED BIOL, V48, P2829, DOI 10.1088/0031-9155/48/17/307; DelGiorno KE, 2014, CANCER CELL, V26, P16, DOI 10.1016/j.ccr.2014.06.004; Dewhirst MW, 2008, NAT REV CANCER, V8, P425, DOI 10.1038/nrc2397; Dhakal HP, 2009, HISTOL HISTOPATHOL, V24, P1049, DOI 10.14670/HH-24.1049; Dome B, 2002, J PATHOL, V197, P355, DOI 10.1002/path.1124; Espinoza I, 2013, MED PHYS, V40, DOI 10.1118/1.4812431; Fernandez-Guinea O, 2013, INT J CLIN ONCOL, V18, P629, DOI 10.1007/s10147-012-0428-2; Fleming IN, 2015, BRIT J CANCER, V112, P238, DOI 10.1038/bjc.2014.610; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Fraser GM, 2013, MICROCIRCULATION, V20, P748, DOI 10.1111/micc.12075; Godde R, 2001, DEV DYNAM, V220, P387, DOI 10.1002/dvdy.1118; Goldman D, 1999, ADV EXP MED BIOL, V471, P555; Goldman D, 2008, MICROCIRCULATION, V15, P795, DOI 10.1080/10739680801938289; Griffon-Etienne G, 1999, CANCER RES, V59, P3776; Grimes DR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153692; Grimes DR, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1124; Grosenick D, 2005, PHYS MED BIOL, V50, P2429, DOI 10.1088/0031-9155/50/11/001; Grosenick D, 2005, PHYS MED BIOL, V50, P2451, DOI 10.1088/0031-9155/50/11/002; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hartmann P, 2006, MELANOMA RES, V16, P479, DOI 10.1097/01.cmr.0000222605.03675.1d; Hellums JD, 1996, ANN BIOMED ENG, V24, P1, DOI 10.1007/BF02770991; Heroux MA, 2005, ACM T MATH SOFTWARE, V31, P397, DOI 10.1145/1089014.1089021; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; HSU R, 1989, MATH BIOSCI, V96, P61, DOI 10.1016/0025-5564(89)90083-7; Ito H, 2004, EUR J NUCL MED MOL I, V31, P635, DOI 10.1007/s00259-003-1430-8; Ito M, 2006, ACAD RADIOL, V13, P598, DOI 10.1016/j.acra.2006.01.007; Jain RK, 1999, ANNU REV BIOMED ENG, V1, P241, DOI 10.1146/annurev.bioeng.1.1.241; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; KALLINOWSKI F, 1989, INT J CANCER, V44, P266, DOI 10.1002/ijc.2910440214; KALLINOWSKI F, 1989, CANCER RES, V49, P3759; Kelly CJ, 2006, PHYS MED BIOL, V51, P5859, DOI 10.1088/0031-9155/51/22/009; Kesmarky G, 2008, CLIN HEMORHEOL MICRO, V39, P243, DOI 10.3233/CH-2008-1088; Kim E, 2013, MAGN RESON MED, V70, P1106, DOI 10.1002/mrm.24530; Kim E, 2012, ANN BIOMED ENG, V40, P2425, DOI 10.1007/s10439-012-0585-5; Kirkpatrick JP, 2003, RADIAT RES, V159, P336, DOI 10.1667/0033-7587(2003)159[0336:AMMOTO]2.0.CO;2; Knabner P., 2000, NUMERIK PARTIELLER D; Krogh A, 1919, J PHYSIOL-LONDON, V52, P409, DOI 10.1113/jphysiol.1919.sp001839; Lagerlof JH, 2014, MED PHYS, V41, DOI 10.1118/1.4866887; Lee DS, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.058104; Less J R, 1992, EXS, V61, P74; LEU AJ, 1994, AM J PHYSIOL-HEART C, V267, pH1507, DOI 10.1152/ajpheart.1994.267.4.H1507; LeVeque RJ, 2007, OTHER TITL APPL MATH, V98, P1, DOI 10.1137/1.9780898717839; Mankoff DA, 2002, J NUCL MED, V43, P500; Marieb E.N., 2013, HUMAN ANATOMY PHYSL; Monnich D, 2011, PHYS MED BIOL, V56, P2045, DOI 10.1088/0031-9155/56/7/009; Moschandreou TE, 2011, MATH BIOSCI, V232, P1, DOI 10.1016/j.mbs.2011.03.010; Nagy JA, 2009, BRIT J CANCER, V100, P865, DOI 10.1038/sj.bjc.6604929; NAIR PK, 1990, MICROVASC RES, V39, P203, DOI 10.1016/0026-2862(90)90070-8; Neri D, 2005, NAT REV CANCER, V5, P436, DOI 10.1038/nrc1627; Ntziachristos V, 2002, NEOPLASIA, V4, P347, DOI 10.1038/sj.neo.7900244; Padera TP, 2004, NATURE, V427, P695, DOI 10.1038/427695a; PRIES AR, 1990, CIRC RES, V67, P826, DOI 10.1161/01.RES.67.4.826; PRIES AR, 1994, CIRC RES, V75, P904, DOI 10.1161/01.RES.75.5.904; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Quarto G, 2014, BIOMED OPT EXPRESS, V5, P3684, DOI 10.1364/BOE.5.003684; Rieger H, 2015, WIRES SYST BIOL MED, V7, P113, DOI 10.1002/wsbm.1295; Safaeian N, 2012, COMPUTATIONAL MODELL; Safaeian N, 2013, J CEREBR BLOOD F MET, V33, P1633, DOI 10.1038/jcbfm.2013.119; Safaeian N, 2011, J THEOR BIOL, V271, P145, DOI 10.1016/j.jtbi.2010.11.038; Secomb TW, 2004, ANN BIOMED ENG, V32, P1519, DOI 10.1114/B:ABME.0000049036.08817.44; Sharan M, 2008, J CEREBR BLOOD F MET, V28, P1597, DOI 10.1038/jcbfm.2008.51; Skeldon AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038597; Sourbron SP, 2012, PHYS MED BIOL, V57, pR1, DOI 10.1088/0031-9155/57/2/R1; Spinelli L, 2005, PHYS MED BIOL, V50, P2489, DOI 10.1088/0031-9155/50/11/004; Stamatelos SK, 2014, MICROVASC RES, V91, P8, DOI 10.1016/j.mvr.2013.12.003; Stylianopoulos T, 2013, CANCER RES, V73, P3833, DOI 10.1158/0008-5472.CAN-12-4521; Stylianopoulos T, 2012, P NATL ACAD SCI USA, V109, P15101, DOI 10.1073/pnas.1213353109; Taroni P, 2005, PHYS MED BIOL, V50, P2469, DOI 10.1088/0031-9155/50/11/003; Taroni Paola, 2012, Photochem Photobiol Sci, V11, P241, DOI 10.1039/c1pp05230f; Thomas H, 2009, INTRODUCTION TO ALGO; Ueda S, 2012, CANCER RES, V72, P4318, DOI 10.1158/0008-5472.CAN-12-0056; VAUPEL P, 1991, CANCER RES, V51, P3316; Viacava P, 2004, J PATHOL, V204, P140, DOI 10.1002/path.1626; Walocha JA, 2003, HUM REPROD, V18, P1088, DOI 10.1093/humrep/deg213; Wang Y, C SERIES INTEGRATED, P1; Welter M, 2008, J THEOR BIOL, V250, P257, DOI 10.1016/j.jtbi.2007.09.031; Welter M, 2010, EUR PHYS J E, V33, P149, DOI 10.1140/epje/i2010-10611-6; Welter M, 2009, J THEOR BIOL, V259, P405, DOI 10.1016/j.jtbi.2009.04.005; Welter M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070395; WILSON CBJH, 1992, CANCER RES, V52, P1592; Yaseen MA, 2011, J CEREBR BLOOD F MET, V31, P1051, DOI 10.1038/jcbfm.2010.227; Zubieta-Calleja G, 2015, NEW HUMAN PHYSL	98	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161267	10.1371/journal.pone.0161267	http://dx.doi.org/10.1371/journal.pone.0161267			42	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27547939	gold, Green Submitted, Green Published			2022-12-26	WOS:000381768400036
J	Xu, Y; Buss, EA; Boucias, DG				Xu, Yao; Buss, Eileen A.; Boucias, Drion G.			Environmental Transmission of the Gut Symbiont Burkholderia to Phloem-Feeding Blissus insularis	PLOS ONE			English	Article							SOUTHERN CHINCH BUG; VERTICAL TRANSMISSION; BACTERIAL SYMBIONTS; HEMIPTERA; HETEROPTERA; WOLBACHIA; DIVERSITY; IDENTIFICATION; ENDOSYMBIONTS; ASSOCIATION	The plant-phloem-feeding Blissus insularis possesses specialized midgut crypts, which harbor a dense population of the exocellular bacterial symbiont Burkholderia. Most individual B. insularis harbor a single Burkholderia ribotype in their midgut crypts; however, a diverse Burkholderia community exists within a host population. To understand the mechanism underlying the consistent occurrence of various Burkholderia in B. insularis and their specific association, we investigated potential gut symbiont transmission routes. PCR amplification detected a low titer of Burkholderia in adult reproductive tracts; however, fluorescence in situ hybridization assays failed to produce detectable signals in these tracts. Furthermore, no Burkholderia-specific PCR signals were detected in eggs and neonates, suggesting that it is unlikely that B. insularis prenatally transmits gut symbionts via ovarioles. In rearing experiments, most nymphs reared on St. Augustinegrass treated with cultured Burkholderia harbored the cultured Burkholderia strains. Burkholderia was detected in the untreated host grass of B. insularis, and most nymphs reared on untreated grass harbored a Burkholderia ribotype that was closely related to a plant-associated Burkholderia strain. These findings revealed that B. insularis neonates acquired Burkholderia primarily from the environment (i.e., plants and soils), even though the possibility of acquisition via egg surface cannot be excluded. In addition, our study explains how the diverse Burkholderia symbiont community in B. insularis populations can be maintained.	[Xu, Yao; Buss, Eileen A.; Boucias, Drion G.] Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Xu, Y (corresponding author), Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA.	bigantbrl@hotmail.com			Insecticide Resistance Action Committee	Insecticide Resistance Action Committee	This work was supported by Insecticide Resistance Action Committee, www.irac-online.org. EB received the funding. The funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge C. Verhoeven (U. Florida) for providing invaluable laboratory assistance, Dr. P. Linser (Whitney Laboratory for Marine Bioscience, U. Florida) for technical guidance on confocal microscopy, and Dr. S. Shanker (ICBR Sequencing Core, U. Florida) for sequencing. D. Dye (Florida Pest Control and Chemical Company, FL) and R. Levin (Environmental Pest and Lawn Services, FL) provided some of the insects used in this research. This study was partially supported by the Insecticide Resistance Action Committee.	Addesso KM, 2012, ENVIRON ENTOMOL, V41, P887, DOI 10.1603/EN11145; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Baines S., 1956, Journal of exp Ecol Cambridge, V33, P533; Bansal R, 2014, ENVIRON ENTOMOL, V43, P617, DOI 10.1603/EN13341; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; Ben Beard C, 2002, ANNU REV ENTOMOL, V47, P123, DOI 10.1146/annurev.ento.47.091201.145144; Bistolas KSI, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00349; Boucias DG, 2012, FEMS MICROBIOL ECOL, V82, P629, DOI 10.1111/j.1574-6941.2012.01433.x; Bright M, 2010, NAT REV MICROBIOL, V8, P218, DOI 10.1038/nrmicro2262; BUSEY P, 1987, J ECON ENTOMOL, V80, P608, DOI 10.1093/jee/80.3.608; Coenye T, 2001, J CLIN MICROBIOL, V39, P3427, DOI 10.1128/JCM.39.10.3427-3436.2001; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Compant S, 2008, FEMS MICROBIOL REV, V32, P607, DOI 10.1111/j.1574-6976.2008.00113.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fukatsu T, 2002, APPL ENVIRON MICROB, V68, P389, DOI 10.1128/AEM.68.1.389-396.2002; Gonella E, 2015, SCI REP-UK, V5, DOI 10.1038/srep15811; Hosokawa T, 2006, PLOS BIOL, V4, P1841, DOI 10.1371/journal.pbio.0040337; Hosokawa T, 2012, ANIM BEHAV, V83, P293, DOI 10.1016/j.anbehav.2011.11.006; Hosokawa T, 2010, P NATL ACAD SCI USA, V107, P769, DOI 10.1073/pnas.0911476107; Itoh H, 2014, APPL ENVIRON MICROB, V80, P5974, DOI 10.1128/AEM.01087-14; Kaiwa N, 2010, APPL ENVIRON MICROB, V76, P3486, DOI 10.1128/AEM.00421-10; Kaltenpoth M, 2009, FEMS MICROBIOL ECOL, V69, P373, DOI 10.1111/j.1574-6941.2009.00722.x; KERR S. H., 1966, FLORIDA ENTOMOL, V49, P9, DOI 10.2307/3493308; Kikuchi Y, 2005, APPL ENVIRON MICROB, V71, P4035, DOI 10.1128/AEM.71.7.4035-4043.2005; Kikuchi Y, 2007, APPL ENVIRON MICROB, V73, P4308, DOI 10.1128/AEM.00067-07; Kikuchi Y, 2011, ISME J, V5, P446, DOI 10.1038/ismej.2010.150; Kikuchi Y, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-2; Kim JK, 2015, ARCH INSECT BIOCHEM, V88, P4, DOI 10.1002/arch.21218; Kuechler SM, 2012, APPL ENVIRON MICROB, V78, P2648, DOI 10.1128/AEM.07191-11; Matsuura Y, 2012, ISME J, V6, P397, DOI 10.1038/ismej.2011.103; Minard G, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-146; Moriya Shigeharu, 2007, Methods Mol Biol, V353, P105; Olivier-Espejel S, 2011, ENVIRON ENTOMOL, V40, P1102, DOI 10.1603/EN10309; Prado SS, 2006, ANN ENTOMOL SOC AM, V99, P577, DOI 10.1603/0013-8746(2006)99[577:VTOAPC]2.0.CO;2; Rangasamy M, 2009, J ECON ENTOMOL, V102, P432, DOI 10.1603/029.102.0156; REINERT J A, 1973, Bulletin of the Entomological Society of America, V19, P91; Salem H, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2957; Sandstrom JP, 2001, MOL ECOL, V10, P217, DOI 10.1046/j.1365-294X.2001.01189.x; Schneider DI, 2013, J INVERTEBR PATHOL, V112, pS104, DOI 10.1016/j.jip.2012.03.024; Segata N, 2016, SCI REP-UK, V6, DOI 10.1038/srep24207; Shibata TF, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00441-13; Suarez-Moreno ZR, 2012, MICROB ECOL, V63, P249, DOI 10.1007/s00248-011-9929-1; Takeshita K, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00556-14; Vazquez JC, 2010, J ECON ENTOMOL, V103, P726, DOI 10.1603/EC09254; Wang AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106988; Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Xu Y, 2016, APPL ENVIRON MICROB, V82, P3319, DOI 10.1128/AEM.00367-16; Xu Yong, 2015, THESIS	49	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161699	10.1371/journal.pone.0161699	http://dx.doi.org/10.1371/journal.pone.0161699			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548682	Green Published, Green Submitted, gold			2022-12-26	WOS:000381768400079
J	Capoor, MN; Ruzicka, F; Machackova, T; Jancalek, R; Smrcka, M; Schmitz, JE; Hermanova, M; Sana, J; Michu, E; Baird, JC; Ahmed, FS; Maca, K; Lipina, R; Alamin, TF; Coscia, MF; Stonemetz, JL; Witham, T; Ehrlich, GD; Gokaslan, ZL; Mavrommatis, K; Birkenmaier, C; Fischetti, VA; Slaby, O				Capoor, Manu N.; Ruzicka, Filip; Machackova, Tana; Jancalek, Radim; Smrcka, Martin; Schmitz, Jonathan E.; Hermanova, Marketa; Sana, Jiri; Michu, Elleni; Baird, John C.; Ahmed, Fahad S.; Maca, Karel; Lipina, Radim; Alamin, Todd F.; Coscia, Michael F.; Stonemetz, Jerry L.; Witham, Timothy; Ehrlich, Garth D.; Gokaslan, Ziya L.; Mavrommatis, Konstantinos; Birkenmaier, Christof; Fischetti, Vincent A.; Slaby, Ondrej			Prevalence of Propionibacterium acnes in Intervertebral Discs of Patients Undergoing Lumbar Microdiscectomy: A Prospective Cross-Sectional Study	PLOS ONE			English	Article							BACTERIAL-INFECTION; BIOFILM FORMATION; ASSOCIATION; SCIATICA; SAMPLES; SKIN; DNA	Background The relationship between intervertebral disc degeneration and chronic infection by Propionibacterium acnes is controversial with contradictory evidence available in the literature. Previous studies investigating these relationships were under-powered and fraught with methodical differences; moreover, they have not taken into consideration P. acnes' ability to form biofilms or attempted to quantitate the bioburden with regard to determining bacterial counts/genome equivalents as criteria to differentiate true infection from contamination. The aim of this prospective cross-sectional study was to determine the prevalence of P. acnes in patients undergoing lumbar disc microdiscectomy. Methods and Findings The sample consisted of 290 adult patients undergoing lumbar microdiscectomy for symptomatic lumbar disc herniation. An intraoperative biopsy and pre-operative clinical data were taken in all cases. One biopsy fragment was homogenized and used for quantitative anaerobic culture and a second was frozen and used for real-time PCR-based quantification of P. acnes genomes. P. acnes was identified in 115 cases (40%), coagulase-negative staphylococci in 31 cases (11%) and alpha-hemolytic streptococci in 8 cases (3%). P. acnes counts ranged from 100 to 9000 CFU/ml with a median of 400 CFU/ml. The prevalence of intervertebral discs with abundant P. acnes (>= 1x10(3) CFU/ml) was 11% (39 cases). There was significant correlation between the bacterial counts obtained by culture and the number of P. acnes genomes detected by real-time PCR (r = 0.4363, p<0.0001). Conclusions In a large series of patients, the prevalence of discs with abundant P. acnes was 11%. We believe, disc tissue homogenization releases P. acnes from the biofilm so that they can then potentially be cultured, reducing the rate of false-negative cultures. Further, quantification study revealing significant bioburden based on both culture and real-time PCR minimize the likelihood that observed findings are due to contamination and supports the hypothesis P. acnes acts as a pathogen in these cases of degenerative disc disease.	[Capoor, Manu N.; Fischetti, Vincent A.] Rockefeller Univ, Lab Bacterial Pathogenesis & Immunol, 1230 York Ave, New York, NY 10021 USA; [Ruzicka, Filip] Masaryk Univ, St Annes Fac Hosp, Dept Microbiol, Fac Med, Brno, Czech Republic; [Capoor, Manu N.; Machackova, Tana; Sana, Jiri; Michu, Elleni; Baird, John C.; Ahmed, Fahad S.; Slaby, Ondrej] Masaryk Univ, Dept Mol Oncol, Cent European Inst Technol CEITEC, Brno, Czech Republic; [Jancalek, Radim] Masaryk Univ, St Annes Univ Hosp, Dept Neurosurg, Brno, Czech Republic; [Smrcka, Martin; Maca, Karel] Masaryk Univ, Univ Hosp Brno, Dept Neurosurg, Brno, Czech Republic; [Schmitz, Jonathan E.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [Hermanova, Marketa] Masaryk Univ, St Annes Univ Hosp, Dept Pathol Anat 1, Brno, Czech Republic; [Lipina, Radim] Univ Ostrava, Univ Hosp Ostrava, Dept Neurosurg, Ostrava, Czech Republic; [Alamin, Todd F.] Stanford Univ, Dept Orthoped Surg, Stanford Univ Med Ctr, Stanford, CA 94305 USA; [Coscia, Michael F.] OrthoIndy Hosp, Dept Orthoped Surg, Indianapolis, IN USA; [Stonemetz, Jerry L.] Johns Hopkins Univ Hosp, Dept Anesthesia, Baltimore, MD 21287 USA; [Witham, Timothy] Johns Hopkins Univ Hosp, Dept Neurosurg, Baltimore, MD 21287 USA; [Ehrlich, Garth D.] Drexel Univ, Ctr Genom Sci, Coll Med, Philadelphia, PA 19104 USA; [Ehrlich, Garth D.] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA; [Ehrlich, Garth D.] Drexel Univ, Dept Otolaryngol Head & Neck Surg, Coll Med, Philadelphia, PA 19104 USA; [Ehrlich, Garth D.] Drexel Univ, Inst Mol Med & Infect Dis, Coll Med, Philadelphia, PA 19104 USA; [Gokaslan, Ziya L.] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Dept Neurosurg, Providence, RI 02903 USA; [Mavrommatis, Konstantinos] Celgene Corp, Informat Knowledge & Utilizat, San Francisco, CA USA; [Birkenmaier, Christof] Univ Munich LMU, Dept Orthoped Phys Med & Rehabil, Munich, Germany	Rockefeller University; Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC); Masaryk University Brno; Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC); Masaryk University Brno; University Hospital Brno; Vanderbilt University; Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC); University Hospital Ostrava; University of Ostrava; Stanford University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Drexel University; Drexel University; Drexel University; Drexel University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Bristol-Myers Squibb; Celgene Corporation; University of Munich	Capoor, MN (corresponding author), Rockefeller Univ, Lab Bacterial Pathogenesis & Immunol, 1230 York Ave, New York, NY 10021 USA.; Capoor, MN; Slaby, O (corresponding author), Masaryk Univ, Dept Mol Oncol, Cent European Inst Technol CEITEC, Brno, Czech Republic.	mcapoor@mail.rockefeller.edu; ondrej.slaby@ceitec.muni.cz	Jancalek, Radim/AAP-9193-2020; Smrčka, Martin/AAM-8872-2021; Růžička, Filip/K-6360-2015; capoor, manu/AAI-2709-2021	Jancalek, Radim/0000-0001-6834-6567; Smrčka, Martin/0000-0002-9191-8700; Hermanova, Marketa/0000-0002-3889-0905; Capoor, Manu/0000-0002-0861-4993; Mavrommatis, Konstantinos/0000-0003-4549-385X; Ehrlich, Garth/0000-0003-1140-6594; Witham, Timothy/0000-0002-9397-8344; Ruzicka, Filip/0000-0001-5679-0513; Machackova, Tana/0000-0001-5055-7147	DiscitisDx	DiscitisDx	DiscitisDx provided support in the form of a research grant which was used to pay for culturing and PCR reagents and materials. Neither DiscitiDX, Inc. nor any other commercial organization provided any support in the form of salaries for authors and did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Achermann Y, 2014, CLIN MICROBIOL REV, V27, P419, DOI 10.1128/CMR.00092-13; Adams MA, 2006, SPINE, V31, P2151, DOI 10.1097/01.brs.0000231761.73859.2c; Agarwal V, 2011, J SPINAL DISORD TECH, V24, P397, DOI 10.1097/BSD.0b013e3182019f3a; Albert HB, 2013, EUR SPINE J, V22, P690, DOI 10.1007/s00586-013-2674-z; Arndt J, 2012, J SPINAL DISORD TECH, V25, pE211, DOI 10.1097/BSD.0b013e318269851a; Bae Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090324; Bayston R, 2007, J BIOMED MATER RES A, V81A, P705, DOI 10.1002/jbm.a.31145; Ben-Galim P, 2006, SPINE, V31, P2507, DOI 10.1097/01.brs.0000238657.13263.b2; Brzuszkiewicz E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021581; Carricajo A, 2007, J HOSP INFECT, V66, P275, DOI 10.1016/j.jhin.2007.04.007; Chen Z, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9612437; Coenye T, 2007, RES MICROBIOL, V158, P386, DOI 10.1016/j.resmic.2007.02.001; Colina M, 2007, CLIN EXP RHEUMATOL, V25, P457; Coscia M, 2003, SCOL RES SOC SRS ANN; Eishi Y, 2002, J CLIN MICROBIOL, V40, P198, DOI 10.1128/JCM.40.1.198-204.2002; Portillo ME, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/804391; Ganko R, 2015, SPINE, V40, pE587, DOI 10.1097/BRS.0000000000000832; Iulia L, 2013, ROM BIOTECH LETT, V18, P8007; Jahns AC, 2014, EXP DERMATOL, V23, P687, DOI 10.1111/exd.12482; Kadler BK, 2015, INT J SHOULDER SURG, V9, P139, DOI 10.4103/0973-6042.167957; Kassis C, 2009, J CLIN MICROBIOL, V47, P3255, DOI 10.1128/JCM.01045-09; Lee MJ, 2014, J BONE JOINT SURG AM, V96A, P1447, DOI 10.2106/JBJS.M.01474; Liu PF, 2015, CURR DRUG METAB, V16, P245, DOI 10.2174/1389200216666150812124801; MARSHALL BJ, 1988, SCAND J GASTROENTERO, V23, P58, DOI 10.3109/00365528809099131; Matsen FA, 2013, J BONE JOINT SURG AM, V95A, P1126, DOI [10.2106/JBJS.L.01104, 10.2106/JBJS.L.01733]; Miura Yuriko, 2010, Journal of Medical and Dental Sciences, V57, P65; Mollerup S, 2016, J CLIN MICROBIOL, V54, P980, DOI 10.1128/JCM.02723-15; Perry A, 2011, EXPERT REV ANTI-INFE, V9, P1149, DOI [10.1586/ERI.11.137, 10.1586/eri.11.137]; Rigal J, 2016, EUR SPINE J, V25, P1000, DOI 10.1007/s00586-016-4396-5; Scholz CFP, 2016, SCI REP-UK, V6, DOI 10.1038/srep20662; Stirling A, 2001, LANCET, V357, P2024, DOI 10.1016/S0140-6736(00)05109-6; Urquhart DM, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0267-x; Zhou Y, 2013, SARCOIDOSIS VASC DIF, V30, P262; Zhou ZZ, 2015, EUR SPINE J, V24, P2496, DOI 10.1007/s00586-015-4180-y	34	48	49	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161676	10.1371/journal.pone.0161676	http://dx.doi.org/10.1371/journal.pone.0161676			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536784	Green Published, gold, Green Submitted			2022-12-26	WOS:000381577000130
J	Fournier, J; Mueller, CM; Shein-Idelson, M; Hemberger, M; Laurent, G				Fournier, Julien; Mueller, Christian M.; Shein-Idelson, Mark; Hemberger, Mike; Laurent, Gilles			Consensus-Based Sorting of Neuronal Spike Waveforms	PLOS ONE			English	Article							RECORDINGS	Optimizing spike-sorting algorithms is difficult because sorted clusters can rarely be checked against independently obtained "ground truth" data. In most spike-sorting algorithms in use today, the optimality of a clustering solution is assessed relative to some assumption on the distribution of the spike shapes associated with a particular single unit (e.g., Gaussianity) and by visual inspection of the clustering solution followed by manual validation. When the spatiotemporal waveforms of spikes from different cells overlap, the decision as to whether two spikes should be assigned to the same source can be quite subjective, if it is not based on reliable quantitative measures. We propose a new approach, whereby spike clusters are identified from the most consensual partition across an ensemble of clustering solutions. Using the variability of the clustering solutions across successive iterations of the same clustering algorithm (template matching based on K-means clusters), we estimate the probability of spikes being clustered together and identify groups of spikes that are not statistically distinguishable from one another. Thus, we identify spikes that are most likely to be clustered together and therefore correspond to consistent spike clusters. This method has the potential advantage that it does not rely on any model of the spike shapes. It also provides estimates of the proportion of misclassified spikes for each of the identified clusters. We tested our algorithm on several datasets for which there exists a ground truth (simultaneous intracellular data), and show that it performs close to the optimum reached by a support vector machine trained on the ground truth. We also show that the estimated rate of misclassification matches the proportion of misclassified spikes measured from the ground truth data.	[Fournier, Julien; Mueller, Christian M.; Shein-Idelson, Mark; Hemberger, Mike; Laurent, Gilles] Max Planck Inst Brain Res, Dept Neural Syst, Max von Laue Str 4, D-60438 Frankfurt, Germany	Max Planck Society	Fournier, J; Laurent, G (corresponding author), Max Planck Inst Brain Res, Dept Neural Syst, Max von Laue Str 4, D-60438 Frankfurt, Germany.	julien.fournier@brain.mpg.de; gilles.laurent@brain.mpg.de	Shein, Mark/M-9170-2018	Shein, Mark/0000-0001-8132-2826	Max Planck Society; European Research Council; Human Frontiers Science Program; HFSP	Max Planck Society(Max Planck SocietyFoundation CELLEX); European Research Council(European Research Council (ERC)European Commission); Human Frontiers Science Program(Human Frontier Science Program); HFSP(Human Frontier Science Program)	This work was funded by the Max Planck Society, the European Research Council, and the Human Frontiers Science Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Max Planck Society paid the salaries of GL and CMM. The HFSP and the Max Planck Society paid the salary of JF.	Achtert E, 2006, P ADV KNOWL DISC DAT; Ankerst M, 1999, P SIGMOD; Ayad HG, 2008, IEEE T PATTERN ANAL, V30, P160, DOI 10.1109/TPAMI.2007.1138; Barnett AH, 2016, J NEUROSCI METH, V264, P65, DOI 10.1016/j.jneumeth.2016.02.022; Buzsaki G, 2015, NEURON, V86, P92, DOI 10.1016/j.neuron.2015.01.028; Connors BW, 1984, CELLULAR PHYSL TURTL, V6, P164; Einevoll GT, 2012, CURR OPIN NEUROBIOL, V22, P11, DOI 10.1016/j.conb.2011.10.001; Fee S, 1996, VARIABILITY EXTRACEL, V76; Franke F, 2010, J COMPUT NEUROSCI, V29, P127, DOI 10.1007/s10827-009-0163-5; Fred A, 2001, P 3 INT WORK MULT CL; Fred ALN, 2005, IEEE T PATTERN ANAL, V27, P835, DOI 10.1109/TPAMI.2005.113; Gibson S, 2012, IEEE SIGNAL PROC MAG, V29, P124, DOI 10.1109/MSP.2011.941880; Gold C, 2006, J NEUROPHYSIOL, V95, P3113, DOI 10.1152/jn.00979.2005; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Hill DN, 2011, J NEUROSCI, V31, P8699, DOI 10.1523/JNEUROSCI.0971-11.2011; Jain AK., 1988, TECHNOMETRICS; Kadir SN, 2014, NEURAL COMPUT, V26, P2379, DOI 10.1162/NECO_a_00661; Khodagholy D, 2015, NAT NEUROSCI, V18, P310, DOI 10.1038/nn.3905; Lewicki MS, 1999, NETW COMPUT NEURAL S, V9; Marre O, 2012, J NEUROSCI, V32, P14859, DOI 10.1523/JNEUROSCI.0723-12.2012; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Pillow JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062123; Pouzat C, 2002, J NEUROSCI METH, V122, P43, DOI 10.1016/S0165-0270(02)00276-5; Prentice JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019884; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Raftery AE, 2006, J AM STAT ASS; Segev R, 2004, NAT NEUROSCI, V7, P1155, DOI 10.1038/nn1323; Senbabaoglu Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06207	29	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0160494	10.1371/journal.pone.0160494	http://dx.doi.org/10.1371/journal.pone.0160494			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536990	Green Submitted, Green Published, gold			2022-12-26	WOS:000381577000023
J	Halmai, M; Frittmann, O; Szabo, Z; Daraba, A; Gali, VK; Balint, E; Unk, I				Halmai, Miklos; Frittmann, Orsolya; Szabo, Zoltan; Daraba, Andreea; Gali, Vamsi K.; Balint, Eva; Unk, Ildiko			Mutations at the Subunit Interface of Yeast Proliferating Cell Nuclear Antigen Reveal a Versatile Regulatory Domain	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; DNA-POLYMERASE-DELTA; REPLICATION FACTOR-C; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; IN-VITRO; FUNCTIONAL INTERACTIONS; ERROR-PRONE; PCNA; UBIQUITIN	Proliferating cell nuclear antigen (PCNA) plays a key role in many cellular processes and due to that it interacts with a plethora of proteins. The main interacting surfaces of Saccharomyces cerevisiae PCNA have been mapped to the interdomain connecting loop and to the carboxy-terminal domain. Here we report that the subunit interface of yeast PCNA also has regulatory roles in the function of several DNA damage response pathways. Using sitedirected mutagenesis we engineered mutations at both sides of the interface and investigated the effect of these alleles on DNA damage response. Genetic experiments with strains bearing the mutant alleles revealed that mutagenic translesion synthesis, nucleotide excision repair, and homologous recombination are all regulated through residues at the subunit interface. Moreover, genetic characterization of one of our mutants identifies a new sub-branch of nucleotide excision repair. Based on these results we conclude that residues at the subunit boundary of PCNA are not only important for the formation of the trimer structure of PCNA, but they constitute a regulatory protein domain that mediates different DNA damage response pathways, as well.	[Halmai, Miklos; Frittmann, Orsolya; Szabo, Zoltan; Daraba, Andreea; Gali, Vamsi K.; Balint, Eva; Unk, Ildiko] Hungarian Acad Sci, Biol Res Ctr, Inst Genet, Szeged, Hungary; [Gali, Vamsi K.] Univ Aberdeen, Inst Med Sci Foresterhill, Aberdeen, Scotland	Hungarian Academy of Sciences; Hungarian Biological Research Center; University of Aberdeen	Unk, I (corresponding author), Hungarian Acad Sci, Biol Res Ctr, Inst Genet, Szeged, Hungary.	unk.ildiko@brc.mta.hu	Balint, Eva/B-8695-2008	Balint, Eva/0000-0002-1258-6892; Gali, Vamsi Krishna/0000-0001-7048-4133	Hungarian Science Foundation [OTKA 109521]; National Research Development and Innovation Office [GINOP-2.3.2-15-2016-00001]	Hungarian Science Foundation(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Research Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary)	This work was supported by Hungarian Science Foundation Grant OTKA 109521 and National Research Development and Innovation Office GINOP-2.3.2-15-2016-00001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Szilvia Minorits for technical assistance. I.U. conceived and designed the project and wrote the manuscript. All authors participated in designing and performing the experiments, and analyzing the results. The authors declare no competing financial interests. This work was also supported by a grant from the National Research, Development and Innovation Office GINOP-2.3.2-15-2016-00001.	Amin NS, 1996, GENETICS, V144, P479; AYYAGARI R, 1995, MOL CELL BIOL, V15, P4420; BAILLY V, 1994, GENE DEV, V8, P811, DOI 10.1101/gad.8.7.811; BAUER GA, 1990, NUCLEIC ACIDS RES, V18, P261, DOI 10.1093/nar/18.2.261; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; BOHR VA, 1985, CELL, V40, P359, DOI 10.1016/0092-8674(85)90150-3; BRAVO R, 1987, NATURE, V326, P515, DOI 10.1038/326515a0; BURGERS PMJ, 1991, J BIOL CHEM, V266, P22698; Burgess RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082630; Carlile CM, 2009, J BIOL CHEM, V284, P29326, DOI 10.1074/jbc.M109.043885; Clark AB, 2000, J BIOL CHEM, V275, P36498, DOI 10.1074/jbc.C000513200; Daraba A, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001771; Dovrat D, 2014, P NATL ACAD SCI USA, V111, P14118, DOI 10.1073/pnas.1321349111; Eissenberg JC, 1997, MOL CELL BIOL, V17, P6367, DOI 10.1128/MCB.17.11.6367; FIEN K, 1992, MOL CELL BIOL, V12, P155, DOI 10.1128/MCB.12.1.155; Flores-Rozas H, 2000, NAT GENET, V26, P375, DOI 10.1038/81708; Fridman Y, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000507; Gomes XV, 2000, EMBO J, V19, P3811, DOI 10.1093/emboj/19.14.3811; Guzder SN, 1997, J BIOL CHEM, V272, P21665, DOI 10.1074/jbc.272.35.21665; Haracska L, 2004, MOL CELL BIOL, V24, P4267, DOI 10.1128/MCB.24.10.4267-4274.2004; Haracska L, 2001, P NATL ACAD SCI USA, V98, P14256, DOI 10.1073/pnas.261560798; Haracska L, 2001, MOL CELL BIOL, V21, P7199, DOI 10.1128/MCB.21.21.7199-7206.2001; Haracska L, 2001, MOL CELL, V8, P407, DOI 10.1016/S1097-2765(01)00319-7; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Johnson RE, 2006, METHOD ENZYMOL, V408, P390, DOI 10.1016/S0076-6879(06)08024-4; Kang MS, 2010, YEAST, V27, P399, DOI 10.1002/yea.1764; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; LEE SH, 1991, J BIOL CHEM, V266, P22707; Li SS, 2002, EMBO J, V21, P5921, DOI 10.1093/emboj/cdf589; LI XY, 1995, J BIOL CHEM, V270, P22109, DOI 10.1074/jbc.270.38.22109; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; MIYACHI K, 1978, J IMMUNOL, V121, P2228; Nair DT, 2004, NATURE, V430, P377, DOI 10.1038/nature02692; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; PRELICH G, 1987, NATURE, V326, P517, DOI 10.1038/326517a0; Reed SH, 1998, J BIOL CHEM, V273, P29481, DOI 10.1074/jbc.273.45.29481; Sharma NM, 2011, J BIOL CHEM, V286, P33557, DOI 10.1074/jbc.M110.206680; Silvian LF, 2001, NAT STRUCT BIOL, V8, P984, DOI 10.1038/nsb1101-984; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Torres-Ramos CA, 2002, MOL CELL BIOL, V22, P2419, DOI 10.1128/MCB.22.7.2419-2426.2002; Trincao J, 2001, MOL CELL, V8, P417, DOI 10.1016/S1097-2765(01)00306-9; TSURIMOTO T, 1991, J BIOL CHEM, V266, P1950; Uijon SN, 2004, STRUCTURE, V12, P1395, DOI 10.1016/j.str.2004.05.011; Umar A, 1996, CELL, V87, P65, DOI 10.1016/S0092-8674(00)81323-9; Unk I, 2002, MOL CELL BIOL, V22, P6480, DOI 10.1128/MCB.22.18.6480-6486.2002; VANGOOL AJ, 1994, EMBO J, V13, P5361, DOI 10.1002/j.1460-2075.1994.tb06871.x; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Vijayakumar S, 2007, NUCLEIC ACIDS RES, V35, P1624, DOI 10.1093/nar/gkm006; Wang ZG, 1997, MOL CELL BIOL, V17, P635, DOI 10.1128/MCB.17.2.635; Zhang HS, 2005, P NATL ACAD SCI USA, V102, P15954, DOI 10.1073/pnas.0504586102; Zhang XP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082184; Zhou BL, 2001, MOL CELL, V8, P427, DOI 10.1016/S1097-2765(01)00310-0	55	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161307	10.1371/journal.pone.0161307	http://dx.doi.org/10.1371/journal.pone.0161307			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537501	Green Submitted, Green Published, gold			2022-12-26	WOS:000381577000087
J	Qin, Y; Liu, CZ; Jiang, SS; Cao, JM; Xiong, L; Sun, QJ				Qin, Yang; Liu, Chengzhen; Jiang, Suisui; Cao, Jinmiao; Xiong, Liu; Sun, Qingjie			Functional Properties of Glutinous Rice Flour by Dry-Heat Treatment	PLOS ONE			English	Article							MOISTURE TREATMENT; PHYSICOCHEMICAL PROPERTIES; RHEOLOGICAL PROPERTIES; STRUCTURAL-PROPERTIES; THERMAL-PROPERTIES; AMYLOSE CONTENT; IONIC GUMS; STARCH; XANTHAN; CORN	Glutinous rice flour (GRF) and glutinous rice starch (GRS) were modified by dry-heat treatment and their rheological, thermal properties and freeze-thaw stability were evaluated. Compared with the native GRF and GRS, the water-holding ability of modified GRF and GRS were enhanced. Both the onset and peak temperatures of the modified samples increased while the endothermic enthalpy change decreased significantly (p < 0.05). Meanwhile, dry heating remarkably increased the apparent viscosities of both GRF and GRS. Importantly, compared with GRS samples, the storage modulus (G') and loss modulus (G") values of modified GRF increased more greatly and the tan delta values decreased more remarkably, indicating that the dry-heat treatment showed more impact on the GRF and a higher viscoelasticity compared with GRS. Our results suggest the dry-heat treatment of GRF is a more effective method than that of GRS, which omits the complex and tedious process for purifying GRS, and thereby has more practical applications in the food industry.	[Qin, Yang; Liu, Chengzhen; Jiang, Suisui; Cao, Jinmiao; Xiong, Liu; Sun, Qingjie] Qingdao Agr Univ, Coll Food Sci & Engn, Qingdao 266109, Shandong, Peoples R China	Qingdao Agricultural University	Sun, QJ (corresponding author), Qingdao Agr Univ, Coll Food Sci & Engn, Qingdao 266109, Shandong, Peoples R China.	phdsun@163.com						Achayuthakan P, 2008, CARBOHYD POLYM, V71, P9, DOI 10.1016/j.carbpol.2007.05.006; Ahmed J, 2014, J FOOD ENG, V124, P43, DOI 10.1016/j.jfoodeng.2013.09.030; Akesowan A., 2009, J APPL SCI RES, V5, P2477; [Anonymous], 2000, OFFICIAL METHODS ANA, DOI DOI 10.1007/978-3-642-31241-0; Arns B, 2014, INT J FOOD SCI TECH, V49, P1939, DOI 10.1111/ijfs.12580; Arunyanart T, 2008, CARBOHYD POLYM, V74, P514, DOI 10.1016/j.carbpol.2008.04.002; Chen X, 2015, J CEREAL SCI, V63, P109, DOI 10.1016/j.jcs.2015.03.003; Chung HJ, 2007, J APPL POLYM SCI, V105, P2280, DOI 10.1002/app.26237; Falade KO, 2015, FOOD HYDROCOLLOID, V44, P478, DOI 10.1016/j.foodhyd.2014.10.005; Falade KO, 2012, FOOD BIOPROCESS TECH, V5, P879, DOI 10.1007/s11947-010-0383-8; Gonzalez-Tomas L, 2008, INT DAIRY J, V18, P858, DOI 10.1016/j.idairyj.2007.09.010; Dias ARG, 2010, FOOD CHEM, V123, P711, DOI 10.1016/j.foodchem.2010.05.040; Gujral HS, 2003, J AGR FOOD CHEM, V51, P3814, DOI 10.1021/jf034112w; Hasjim J, 2013, CARBOHYD POLYM, V92, P682, DOI 10.1016/j.carbpol.2012.09.023; Ji Y, 2007, FOOD CHEM, V104, P53, DOI 10.1016/j.foodchem.2006.10.072; Ju ZY, 2001, J FOOD SCI, V66, P229, DOI 10.1111/j.1365-2621.2001.tb11322.x; Khunae P, 2007, STARCH-STARKE, V59, P593, DOI 10.1002/star.200700618; Kim WW, 2009, INT J FOOD SCI TECH, V44, P503, DOI 10.1111/j.1365-2621.2008.01760.x; Kim YL, 2013, INT J BIOL MACROMOL, V60, P422, DOI 10.1016/j.ijbiomac.2013.04.032; Lai HM, 2001, FOOD CHEM, V72, P455, DOI 10.1016/S0308-8146(00)00261-2; Lawal OS, 2011, FOOD HYDROCOLLOID, V25, P1785, DOI 10.1016/j.foodhyd.2011.04.010; Lee MH, 2002, FOOD HYDROCOLLOID, V16, P345, DOI 10.1016/S0268-005X(01)00107-2; Li Y, 2013, CARBOHYD POLYM, V92, P1647, DOI 10.1016/j.carbpol.2012.11.002; Lim ST, 2002, CEREAL CHEM, V79, P601, DOI 10.1094/CCHEM.2002.79.5.601; Lopez ACB, 2004, BRAZ ARCH BIOL TECHN, V47, P63, DOI 10.1590/S1516-89132004000100009; Loubes MA, 2014, LWT-FOOD SCI TECHNOL, V57, P320, DOI 10.1016/j.lwt.2013.12.048; Noriko O, 2003, J COOKERY SCI JAPAN, V36, P210; Pramodrao KS, 2014, FOOD HYDROCOLLOID, V35, P613, DOI 10.1016/j.foodhyd.2013.08.006; Puncha-arnon S, 2013, CARBOHYD POLYM, V91, P85, DOI 10.1016/j.carbpol.2012.08.006; Qiu C, 2015, STARCH-STARKE, V67, P756, DOI 10.1002/star.201500016; Qiu C, 2015, FOOD HYDROCOLLOID, V48, P1, DOI 10.1016/j.foodhyd.2015.01.030; Salgado S. M., 2005, Ciencia e Tecnologia de Alimentos, V25, P525, DOI 10.1590/S0101-20612005000300022; Satmalee P, 2011, INT J FOOD SCI TECH, V46, P2628, DOI 10.1111/j.1365-2621.2011.02793.x; Singh N, 2006, FOOD HYDROCOLLOID, V20, P532, DOI 10.1016/j.foodhyd.2005.05.003; Sopade PA, 2008, J FOOD ENG, V84, P553, DOI 10.1016/j.jfoodeng.2007.06.024; Sun D, 2015, LWT-FOOD SCI TECHNOL, V64, P205, DOI 10.1016/j.lwt.2015.05.062; Sun QJ, 2014, INT J BIOL MACROMOL, V68, P86, DOI 10.1016/j.ijbiomac.2014.04.032; Sun QJ, 2014, CARBOHYD POLYM, V110, P128, DOI 10.1016/j.carbpol.2014.03.090; Sun QJ, 2013, FOOD CHEM, V136, P1421, DOI 10.1016/j.foodchem.2012.09.061; Zavareze ED, 2010, FOOD CHEM, V121, P358, DOI 10.1016/j.foodchem.2009.12.036; Zhang L, 2015, COLLOID POLYM SCI, V293, P229, DOI 10.1007/s00396-014-3407-5; Zhang YY, 2011, STARCH-STARKE, V63, P11, DOI 10.1002/star.200900255; Zhu LJ, 2010, FOOD CHEM, V120, P94, DOI 10.1016/j.foodchem.2009.09.076; Zieba T, 2014, CARBOHYD POLYM, V99, P687, DOI 10.1016/j.carbpol.2013.08.064; 이기정, 2004, [Korean Journal of Food Science and Technology, 한국식품과학회지], V36, P568	45	15	15	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0160371	10.1371/journal.pone.0160371	http://dx.doi.org/10.1371/journal.pone.0160371			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537844	Green Submitted, Green Published, gold			2022-12-26	WOS:000381577000019
J	Tominaga, K; Lee, A; Altenmuller, E; Miyazaki, F; Furuya, S				Tominaga, Kenta; Lee, Andre; Altenmueller, Eckart; Miyazaki, Fumio; Furuya, Shinichi			Kinematic Origins of Motor Inconsistency in Expert Pianists	PLOS ONE			English	Article							HUMAN FINGER MOVEMENTS; TASK-SPECIFIC TREMOR; INDEPENDENT CONTROL; COMMON INPUT; MUSICIANS; COORDINATION; ACQUISITION; PERFORMANCE; MODULATION	For top performers, including athletes and musicians, even subtle inconsistencies in rhythm and force during movement production decrease the quality of performance. However, extensive training over many years beginning in childhood is unable to perfect dexterous motor performance so that it is without any error. To gain insight into the biological mechanisms underlying the subtle defects of motor actions, the present study sought to identify the kinematic origins of inconsistency of dexterous finger movements in musical performance. Seven highly-skilled pianists who have won prizes at international piano competitions played a short sequence of tones with the right hand at a predetermined tempo. Time-varying joint angles of the fingers were recorded using a custom-made data glove, and the timing and velocity of the individual keystrokes were recorded from a digital piano. Both ridge and stepwise multiple regression analyses demonstrated an association of the inter-trial variability of the inter-keystroke interval (i.e., rhythmic inconsistency) with both the rotational velocity of joints of the finger used for a keystroke (i.e., striking finger) and the movement independence between the striking and non-striking fingers. This indicates a relationship between rhythmic inconsistency in musical performance and the dynamic features of movements in not only the striking finger but also the non-striking fingers. In contrast, the inter-trial variability of the key-descending velocity (i.e., loudness inconsistency) was associated mostly with the kinematic features of the striking finger at the moment of the keystroke. Furthermore, there was no correlation between the rhythmic and loudness inconsistencies. The results suggest distinct kinematic origins of inconsistencies in rhythm and loudness in expert musical performance.	[Tominaga, Kenta; Miyazaki, Fumio] Osaka Univ, Dept Engn Sci, 1-3 Machikaneyama, Toyonaka, Osaka 5608531, Japan; [Lee, Andre] Tech Univ Munich, Klinikum Rechts Isar, Neurol Klin & Poliklin, Munich, Germany; [Lee, Andre; Altenmueller, Eckart; Furuya, Shinichi] Hannover Univ Mus Drama & Media, Inst Mus Physiol & Musicians Med, Emmichpl 1, D-30175 Hannover, Germany; [Furuya, Shinichi] Sophia Univ, Mus Skill & Injury Ctr MuSIC, Tokyo, Japan	Osaka University; Technical University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; Sophia University	Furuya, S (corresponding author), Hannover Univ Mus Drama & Media, Inst Mus Physiol & Musicians Med, Emmichpl 1, D-30175 Hannover, Germany.; Furuya, S (corresponding author), Sophia Univ, Mus Skill & Injury Ctr MuSIC, Tokyo, Japan.	sfuruya@sophia.ac.jp	Altenmuller, Eckart/AAB-9948-2021	Furuya, Shinichi/0000-0003-1387-6645	YAMAHA music foundation	YAMAHA music foundation	The study was supported by YAMAHA music foundation to SF (http://www.yamaha-mf.or.jp/english/index.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The present study was partly supported by the YAMAHA Music Foundation.	Bella SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020518; Brown RM, 2015, PROG BRAIN RES, V217, P57, DOI 10.1016/bs.pbr.2014.11.021; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Furuya S, 2008, NEUROSCIENCE, V156, P390, DOI 10.1016/j.neuroscience.2008.07.028; Furuya S, 2014, NEUROSCIENCE, V275, P444, DOI 10.1016/j.neuroscience.2014.06.031; Furuya S, 2013, NEUROSCIENCE, V247, P152, DOI 10.1016/j.neuroscience.2013.05.025; Furuya S, 2015, SCI REP-UK, V5, DOI 10.1038/srep13360; Furuya S, 2015, ANN NY ACAD SCI, V1337, P118, DOI 10.1111/nyas.12659; Furuya S, 2012, J NEUROPHYSIOL, V108, P2060, DOI 10.1152/jn.00378.2012; Furuya S, 2011, J NEUROPHYSIOL, V106, P2849, DOI 10.1152/jn.00378.2011; Furuya S, 2010, EXP BRAIN RES, V204, P223, DOI 10.1007/s00221-010-2307-2; Gentner R, 2009, J NEUROSCI METH, V178, P138, DOI 10.1016/j.jneumeth.2008.11.005; Goebl W, 2008, EXP BRAIN RES, V186, P471, DOI 10.1007/s00221-007-1252-1; Goebl W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050901; Gordon AM, 1995, EXP BRAIN RES, V107, P281; Hager-Ross C, 2000, J NEUROSCI, V20, P8542, DOI 10.1523/JNEUROSCI.20-22-08542.2000; Hore J, 1996, J NEUROPHYSIOL, V75, P1013, DOI 10.1152/jn.1996.75.3.1013; Jabusch HC, 2009, HUM MOVEMENT SCI, V28, P74, DOI 10.1016/j.humov.2008.08.001; Konczak J, 2009, J MOTOR BEHAV, V41, P243, DOI 10.3200/JMBR.41.3.243-252; LACQUANITI F, 1992, J NEUROSCI, V12, P1750; Lang CE, 2004, J NEUROPHYSIOL, V92, P2802, DOI 10.1152/jn.00480.2004; Lee A, 2015, J NEURAL TRANSM, V122, P393, DOI 10.1007/s00702-014-1275-2; Lee A, 2013, MOVEMENT DISORD, V28, P1890, DOI 10.1002/mds.25569; Leijnse JNAL, 1997, J BIOMECH, V30, P659, DOI 10.1016/S0021-9290(97)00008-0; Osborne LC, 2005, NATURE, V437, P412, DOI 10.1038/nature03961; Repp BH, 1999, PERCEPT PSYCHOPHYS, V61, P529, DOI 10.3758/BF03211971; SCHIEBER MH, 1993, SCIENCE, V261, P489, DOI 10.1126/science.8332915; Schoonderwaldt E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106615; Sims SEG, 2015, J HAND SURG-AM, V40, P1996, DOI 10.1016/j.jhsa.2015.06.009; van Beers RJ, 2007, J NEUROSCI, V27, P8757, DOI 10.1523/JNEUROSCI.2311-07.2007; Van der Steen MCM, 2014, NEUROSCIENCE, V269, P290, DOI 10.1016/j.neuroscience.2014.03.058; van Duinen H, 2011, J PHYSIOL-LONDON, V589, P5583, DOI 10.1113/jphysiol.2011.217810; van Vugt FT, 2014, EXP BRAIN RES, V232, P3555, DOI 10.1007/s00221-014-4036-4; van Vugt FT, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00495; Venkadesan M, 2008, J NEUROSCI, V28, P1366, DOI 10.1523/JNEUROSCI.4993-07.2008; Verrel J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00157; Verrel J, 2013, EXP BRAIN RES, V224, P323, DOI 10.1007/s00221-012-3314-2; WING AM, 1973, PERCEPT PSYCHOPHYS, V13, P455, DOI 10.3758/BF03205802; Winges SA, 2008, J NEUROPHYSIOL, V99, P1119, DOI 10.1152/jn.01059.2007; Winges SA, 2006, J NEUROPHYSIOL, V96, P1258, DOI 10.1152/jn.00327.2006; Zatsiorsky VM, 2000, EXP BRAIN RES, V131, P187, DOI 10.1007/s002219900261	41	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161324	10.1371/journal.pone.0161324	http://dx.doi.org/10.1371/journal.pone.0161324			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537686	gold, Green Submitted, Green Published			2022-12-26	WOS:000381577000088
J	Katayama, K; Narimatsu, H				Katayama, Kayoko; Narimatsu, Hiroto			Prediction of Female Breast Cancer Incidence among the Aging Society in Kanagawa, Japan	PLOS ONE			English	Article							UNITED-KINGDOM PROJECTIONS; PASSIVE SMOKING; FUTURE BURDEN; RISK; POPULATION; COHORT; TRENDS; RATES	Owing to the increasing number of elderly "baby boomers" in Japan, the number of cancer patients is also expected to increase. Approximately 2 million baby boomers from nearby local areas are residing in metropolitan areas; hence, the geographical distribution of cancer patients will probably markedly change. We assessed the expected number of breast cancer (BC) patients in different regions (urban, outer city, town, rural) using estimates of the nation's population and Kanagawa Cancer Registry data. To estimate future BC incidence for each region, we multiplied the 2010 rate by the predicted female population for each region according to age group. The incidence cases of BC in those aged >= 65 years is expected to increase in all areas; in particular, compared to rates in 2010, the BC incidence in urban areas was predicted to increase by 82.6% in 2035 and 102.2% in 2040. Although the incidence in all BC cases in urban areas showed an increasing trend, until peaking in 2040 (increasing 31.2% from 2010), the number of BC patients would continue to decrease in other areas. The number of BC patients per capita BC specialist was 64.3 patients in 2010; this value would increase from 59.3 in 2010 to 77.7 in 2040 in urban areas, but would decrease in other areas. Our findings suggest that the number of elderly BC patients is expected to increase rapidly in urban areas and that the demand for BC treatment would increase in the elderly population in urban areas.	[Katayama, Kayoko; Narimatsu, Hiroto] Kanagawa Canc Ctr Res Inst, Canc Prevent & Control Div, Yokohama, Kanagawa, Japan	Kanagawa Prefectural Cancer Center	Narimatsu, H (corresponding author), Kanagawa Canc Ctr Res Inst, Canc Prevent & Control Div, Yokohama, Kanagawa, Japan.	hiroto-narimatsu@umin.org	片山, 佳代子/HGA-9604-2022; Narimatsu, Hiroto/ABC-9150-2021	Narimatsu, Hiroto/0000-0002-5302-5872; Narimatsu, Hiroto/0000-0002-0383-4911				[Anonymous], 2006, ANN REP INT MIGR JAP; [Anonymous], 2015, ANN REP KAN CANC REG, P114; [Anonymous], 2014, ANN REP AG SOC IMPL; [Anonymous], 2015, ANN REP AG SOC CURR; [Anonymous], 2007, SURV RES HOUS DANK J; [Anonymous], 2006, WHITE PAPER NATL CAP, P1; [Anonymous], 2015, CANC STAT JAP 2014; [Anonymous], 2013, WORLD POP PROSP 2012; ARMSTRONG BK, 1992, CANCER CAUSE CONTROL, V3, P569, DOI 10.1007/BF00052754; Bray F, 2006, NAT REV CANCER, V6, P63, DOI 10.1038/nrc1781; CLAYTON D, 1987, STAT MED, V6, P449, DOI 10.1002/sim.4780060405; Cooper RA, 2002, HEALTH AFFAIR, V21, P140, DOI 10.1377/hlthaff.21.1.140; Extermann Martine, 2004, Curr Treat Options Oncol, V5, P161, DOI 10.1007/s11864-004-0048-9; Ferlay J, GLOBOCAN 2012 V1 0; FIELD NA, 1992, INT J EPIDEMIOL, V21, P842, DOI 10.1093/ije/21.5.842; Foundation High Life Insutitute, RET SEN RES SER FY20; Hanaoka T, 2005, INT J CANCER, V114, P317, DOI 10.1002/ijc.20709; Hori M, 2015, JPN J CLIN ONCOL, V45, P884, DOI 10.1093/jjco/hyv088; Institute of Population Based Cancer Research, NORDPRED SOFTW PACK; Keyes KM, 2010, SOC SCI MED, V70, P1100, DOI 10.1016/j.socscimed.2009.12.018; Kohno K, 2014, J BLOOD MED, V5, P31, DOI 10.2147/JBM.S57944; Lin Y, 2008, J EPIDEMIOL, V18, P77, DOI 10.2188/jea.18.77; Matsuda A, 2014, JPN J CLIN ONCOL, V44, P388, DOI 10.1093/jjco/hyu003; Mistry M, 2011, BRIT J CANCER, V105, P1795, DOI 10.1038/bjc.2011.430; Moller B, 2005, EUR J CANCER PREV, V14, P117, DOI 10.1097/00008469-200504000-00007; Moller B, 2002, EUR J CANCER PREV, V11, pS1; Moller H, 2007, BRIT J CANCER, V96, P1484, DOI 10.1038/sj.bjc.6603746; Nagata C, 2006, JPN J CLIN ONCOL, V36, P387, DOI 10.1093/jjco/hyl031; National Institute of Population and Social Security Research, 2013, EST NAT POP TRENDS R; Olsen AH, 2008, BRIT J CANCER, V99, P1549, DOI 10.1038/sj.bjc.6604710; Ross JS, 2002, EINSTEIN Q, V19, P129; TANGO T, 1995, STAT MED, V14, P2323, DOI 10.1002/sim.4780142105; Virani S, 2014, CANCER EPIDEMIOL, V38, P235, DOI 10.1016/j.canep.2014.03.003; Wada K, 2014, ANN ONCOL, V25, P519, DOI 10.1093/annonc/mdt542	34	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0159913	10.1371/journal.pone.0159913	http://dx.doi.org/10.1371/journal.pone.0159913			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532126	gold, Green Published, Green Submitted			2022-12-26	WOS:000381487600015
J	Pinto, P; Peixoto, A; Santos, C; Rocha, P; Pinto, C; Pinheiro, M; Leca, L; Martins, AT; Ferreira, V; Bartosch, C; Teixeira, MR				Pinto, Pedro; Peixoto, Ana; Santos, Catarina; Rocha, Patricia; Pinto, Carla; Pinheiro, Manuela; Leca, Luis; Martins, Ana Teresa; Ferreira, Veronica; Bartosch, Carla; Teixeira, Manuel R.			Analysis of Founder Mutations in Rare Tumors Associated With Hereditary Breast/Ovarian Cancer Reveals a Novel Association of BRCA2 Mutations with Ampulla of Vater Carcinomas	PLOS ONE			English	Article							BREAST-CANCER; PANCREATIC ADENOCARCINOMA; INHERITED PREDISPOSITION; GERMLINE MUTATIONS; PROSTATE-CANCER; GENE-MUTATIONS; OVARIAN-CANCER; FAMILIES; FREQUENCY; REPAIR	BRCA1 and BRCA2 mutations are responsible for hereditary breast and ovarian cancer, but they also confer an increased risk for the development of rarer cancers associated with this syndrome, namely, cancer of the pancreas, male breast, peritoneum, and fallopian tube. The objective of this work was to quantify the contribution of the founder mutations BRCA2 c.156_157insAlu and BRCA1 c.3331_3334del for cancer etiology in unselected hospital-based cohorts of Portuguese patients diagnosed with these rarer cancers, by using a strategy that included testing of archival tumor tissue. A total of 102 male breast, 68 pancreatic and 33 peritoneal/fallopian tube carcinoma cases were included in the study. The BRCA2 c.156_157insAlu mutation was observed with a frequency of 7.8% in male breast cancers, 3.0% in peritoneal/fallopian tube cancers, and 1.6% in pancreatic cancers, with estimated total contributions of germline BRCA2 mutations of 14.3%, 5.5%, and 2.8%, respectively. No carriers of the BRCA1 c.3331_3334del mutation were identified. During our study, a patient with an ampulla of Vater carcinoma was incidentally found to carry the BRCA2 c.156_157insAlu mutation, so we decided to test a consecutive series of additional 15 ampullary carcinomas for BRCA1/BRCA2 mutations using a combination of direct founder mutation testing and full gene analysis with next generation sequencing. BRCA2 mutations were observed with a frequency of 14.3% in ampulla of Vater carcinomas. In conclusion, taking into account the implications for both the individuals and their family members, we recommend that patients with these neoplasias should be offered BRCA1/BRCA2 genetic testing and we here show that it is feasible to test for founder mutations in archival tumor tissue. Furthermore, we identified for the first time a high frequency of germline BRCA2 mutations in ampullary cancers.	[Pinto, Pedro; Peixoto, Ana; Santos, Catarina; Rocha, Patricia; Pinto, Carla; Pinheiro, Manuela; Teixeira, Manuel R.] Portuguese Oncol Inst Porto IPO Porto, Dept Genet, Porto, Portugal; [Leca, Luis; Martins, Ana Teresa; Ferreira, Veronica; Bartosch, Carla] Portuguese Oncol Inst Porto IPO Porto, Dept Pathol, Porto, Portugal; [Teixeira, Manuel R.] Univ Porto, Inst Biomed Sci Abel Salazar ICBAS, Porto, Portugal	Portuguese Institute of Oncology; Portuguese Institute of Oncology; Universidade do Porto	Teixeira, MR (corresponding author), Portuguese Oncol Inst Porto IPO Porto, Dept Genet, Porto, Portugal.; Teixeira, MR (corresponding author), Univ Porto, Inst Biomed Sci Abel Salazar ICBAS, Porto, Portugal.	manuel.teixeira@ipoporto.min-saude.pt	Pinheiro, Manuela/AAG-2543-2021; Teixeira, Manuel António Rodrigues/E-4885-2011; Teixeira, Manuel AC/AAZ-7251-2020; Pinheiro, Manuela/AAV-4114-2020	Teixeira, Manuel António Rodrigues/0000-0002-4896-5982; Teixeira, Manuel AC/0000-0002-1959-0624; Pinheiro, Manuela/0000-0001-8228-3435; Bartosch, Carla/0000-0003-0646-7667; Pinto, Carla/0000-0001-8689-3388; Santos, Catarina/0000-0002-9102-757X; Peixoto, Ana/0000-0002-1404-5897; Rocha, Patricia/0000-0001-6275-026X; Pinto, Pedro/0000-0001-6289-5792	Fundacao para a Ciencia e a Tecnologia [SFRH/BD/73719/2010]	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	PP was awarded a PhD grant (SFRH/BD/73719/2010) by the Fundacao para a Ciencia e a Tecnologia (http://www.fct.pt/). PP and MP are research fellows of the Nucleo Regional do Norte da Liga Portuguesa Contra o Cancro (http://www.ligacontracancro.pt/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburjania Nana, 2014, J Gastrointest Cancer, V45, P87, DOI 10.1007/s12029-013-9479-5; Albores-Saavedra J, 2009, J SURG ONCOL, V100, P598, DOI 10.1002/jso.21374; Alsop K, 2012, J CLIN ONCOL, V30, P2654, DOI 10.1200/JCO.2011.39.8545; Ashworth A, 2008, J CLIN ONCOL, V26, P3785, DOI 10.1200/JCO.2008.16.0812; Besic N, 2008, GENET TEST, V12, P203, DOI 10.1089/gte.2007.0071; Bjork J, 2001, GASTROENTEROLOGY, V121, P1127, DOI 10.1053/gast.2001.28707; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Chodick G, 2008, EUR J MED GENET, V51, P141, DOI 10.1016/j.ejmg.2007.11.001; Ding YC, 2011, BREAST CANCER RES TR, V126, P771, DOI 10.1007/s10549-010-1195-2; Durocher F, 1996, J MED GENET, V33, P814, DOI 10.1136/jmg.33.10.814; Evans DGR, 2010, J MED GENET, V47, P710, DOI 10.1136/jmg.2009.075176; Ferla R, 2007, ANN ONCOL, V18, P93, DOI 10.1093/annonc/mdm234; Hahn SA, 2003, JNCI-J NATL CANCER I, V95, P214, DOI 10.1093/jnci/95.3.214; Holter S, 2015, J CLIN ONCOL, V33, P3124, DOI 10.1200/JCO.2014.59.7401; Lal G, 2000, CANCER RES, V60, P409; Ledermann J, 2014, LANCET ONCOL, V15, P852, DOI 10.1016/S1470-2045(14)70228-1; Machado PM, 2007, J CLIN ONCOL, V25, P2027, DOI 10.1200/JCO.2006.06.9443; Maia S, 2016, FAM CANCER, V15, P111, DOI 10.1007/s10689-015-9832-x; Mateo J, 2015, NEW ENGL J MED, V373, P1697, DOI 10.1056/NEJMoa1506859; Mavaddat N, 2013, JNCI-J NATL CANCER I, V105, P812, DOI 10.1093/jnci/djt095; Mersch J, 2015, CANCER-AM CANCER SOC, V121, P269, DOI 10.1002/cncr.29041; Moreira MAM, 2012, FAM CANCER, V11, P657, DOI 10.1007/s10689-012-9551-5; Murphy KM, 2002, CANCER RES, V62, P3789; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; National Comprehensive Cancer Network, 2015, GENETIC FAMILIAL HIG; Ottini L, 2009, BREAST CANCER RES TR, V116, P577, DOI 10.1007/s10549-008-0194-z; Peixoto A, 2015, CLIN GENET, V88, P41, DOI 10.1111/cge.12441; Peixoto A, 2011, BREAST CANCER RES TR, V127, P671, DOI 10.1007/s10549-010-1036-3; Peixoto A, 2009, BREAST CANCER RES TR, V114, P31, DOI 10.1007/s10549-008-9978-4; Blesa JR, 2000, HUM MUTAT, V15, P381, DOI 10.1002/(SICI)1098-1004(200004)15:4<381::AID-HUMU14>3.0.CO;2-H; Robson M, 2007, NEW ENGL J MED, V357, P154, DOI 10.1056/NEJMcp071286; Stadler ZK, 2012, CANCER-AM CANCER SOC, V118, P493, DOI 10.1002/cncr.26191; Teugels E, 2005, HUM MUTAT, V26, DOI 10.1002/humu.9366; Thorlacius S, 1997, AM J HUM GENET, V60, P1079; Torres D, 2007, BREAST CANCER RES TR, V103, P225, DOI 10.1007/s10549-006-9370-1; Vicus D, 2010, GYNECOL ONCOL, V118, P299, DOI 10.1016/j.ygyno.2010.05.011; Walsh T, 2011, P NATL ACAD SCI USA, V108, P18032, DOI 10.1073/pnas.1115052108	37	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161438	10.1371/journal.pone.0161438	http://dx.doi.org/10.1371/journal.pone.0161438			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532258	gold, Green Published, Green Submitted			2022-12-26	WOS:000381487600095
J	Tjiurutue, MC; Palmer-Young, EC; Adler, LS				Tjiurutue, Muvari Connie; Palmer-Young, Evan C.; Adler, Lynn S.			Parasite Removal, but Not Herbivory, Deters Future Parasite Attachment on Tomato	PLOS ONE			English	Article							HOST-PLANT GENOTYPE; HEMIPARASITIC PLANT; INSECT HERBIVORES; LYCOPERSICON-ESCULENTUM; DEFENSE; POLLINATION; COMMUNITIES; MECHANISMS; RESISTANCE; RESPONSES	Plants face many antagonistic interactions that occur sequentially. Often, plants employ defense strategies in response to the initial damage that are highly specific and can affect interactions with subsequent antagonists. In addition to herbivores and pathogens, plants face attacks by parasitic plants, but we know little about how prior herbivory compared to prior parasite attachment affects subsequent host interactions. If host plants can respond adaptively to these different damage types, we predict that prior parasitism would have a greater deterrent effect on subsequent parasites than would prior herbivory. To test the effects of prior parasitism and prior herbivory on subsequent parasitic dodder (Cuscuta spp.) preference, we conducted two separate greenhouse studies with tomato hosts (Solanum lycopersicum). In the first experiment, we tested the effects of previous dodder attachment on subsequent dodder preference on tomato hosts using three treatments: control plants that had no previous dodder attachment; dodder-removed plants that had an initial dodder seedling attached, removed and left in the same pot to simulate parasite death; and dodder-continuous plants with an initial dodder seedling that remained attached. In the second experiment, we tested the effects of previous caterpillar damage (Spodoptera exigua) and mechanical damage on future dodder attachment on tomato hosts. Dodder attached most slowly to tomato hosts that had dodder plants previously attached and then removed, compared to control plants or plants with continuous dodder attachment. In contrast, herbivory did not affect subsequent dodder attachment rate. These results indicate that dodder preference depended on the identity and the outcome of the initial attack, suggesting that early-season interactions have the potential for profound impacts on subsequent community dynamics.	[Tjiurutue, Muvari Connie; Palmer-Young, Evan C.; Adler, Lynn S.] Univ Massachusetts, Dept Biol, Morrill Sci Ctr South 221, 611 North Pleasant St, Amherst, MA 01003 USA; [Tjiurutue, Muvari Connie] Univ Namibia, Dept Chem & Biochem, Windhoek, Namibia	University of Massachusetts System; University of Massachusetts Amherst; University of Namibia	Tjiurutue, MC (corresponding author), Univ Massachusetts, Dept Biol, Morrill Sci Ctr South 221, 611 North Pleasant St, Amherst, MA 01003 USA.; Tjiurutue, MC (corresponding author), Univ Namibia, Dept Chem & Biochem, Windhoek, Namibia.	connie.muv@gmail.com	Palmer-Young, Evan/AFL-1225-2022	Palmer-Young, Evan/0000-0002-9258-2073	Fulbright Fellowship [15101429]; Schlumberger Faculty for the Future Fellowship; Plant Biology Graduate program; USDA NIFA predoctoral fellowship [2016-67011-24698]; USDA/CSREES (Hatch) [MAS000411]; USDA [NRI 2008-02346]	Fulbright Fellowship; Schlumberger Faculty for the Future Fellowship(Schlumberger); Plant Biology Graduate program; USDA NIFA predoctoral fellowship; USDA/CSREES (Hatch)(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); USDA(United States Department of Agriculture (USDA))	This work is supported by: MCT: Fulbright Fellowship (15101429), Schlumberger Faculty for the Future Fellowship and the Plant Biology Graduate program; EPY: USDA NIFA predoctoral fellowship, Award number 2016-67011-24698; LSA: USDA/CSREES (Hatch) MAS000411 and USDA NRI 2008-02346. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler LS, 2000, AM NAT, V156, P92, DOI 10.1086/303374; Agrawal AA, 2011, FUNCT ECOL, V25, P420, DOI 10.1111/j.1365-2435.2010.01796.x; Ali JG, 2012, TRENDS PLANT SCI, V17, P293, DOI 10.1016/j.tplants.2012.02.006; [Anonymous], 2014, A LANGUAGE AND ENVIR; BELL RA, 1976, ANN ENTOMOL SOC AM, V69, P365, DOI 10.1093/aesa/69.2.365; Cronin JT, 1999, OECOLOGIA, V121, P392, DOI 10.1007/s004420050944; Dawson JH, 1984, WEED SCI, V6, P265; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; Dicke M, 2010, TRENDS PLANT SCI, V15, P167, DOI 10.1016/j.tplants.2009.12.002; Ghantous KM, 2012, WEED TECHNOL, V26, P485, DOI 10.1614/WT-D-11-00077.1; Ghantous KM, 2012, PROC NORTHEAST WEED; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Goldwasser Y, 2001, WEED SCI, V49, P520, DOI 10.1614/0043-1745(2001)049[0520:TOTVTL]2.0.CO;2; Hartley SE, 2015, ECOLOGY, V96, P2408, DOI 10.1890/14-1244.1; Hopkins RJ, 1998, J CHEM ECOL, V24, P2003, DOI 10.1023/A:1020729524818; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; IHL B, 1988, FLORA, V181, P383; Irving LJ, ADVANCES IN BOTANICA, V50, P87; Johnson MTJ, 2007, OIKOS, V116, P941, DOI 10.1111/j.0030-1299.2007.15773.x; Kahl J, 2000, PLANTA, V210, P336, DOI 10.1007/PL00008142; Kant MR, 2015, ANN BOT-LONDON, V115, P1015, DOI 10.1093/aob/mcv054; KARBAN R, 1997, INDUCED RESPONSES TO; Korth KL, 1997, PLANT PHYSIOL, V115, P1299, DOI 10.1104/pp.115.4.1299; Matthies D, 1996, OIKOS, V75, P118, DOI 10.2307/3546328; McCall AC, 2006, ECOL LETT, V9, P1351, DOI 10.1111/j.1461-0248.2006.00975.x; Moraes MCB, 2005, ENTOMOL EXP APPL, V115, P227, DOI 10.1111/j.1570-7458.2005.00290.x; Morandin LA, 2001, J ECON ENTOMOL, V94, P172, DOI 10.1603/0022-0493-94.1.172; Niemela M, 2008, BASIC APPL ECOL, V9, P117, DOI 10.1016/j.baae.2007.01.001; Pennings SC, 1996, ECOLOGY, V77, P1410, DOI 10.2307/2265538; Pennings SC, 2002, OECOLOGIA, V131, P479, DOI 10.1007/s00442-002-0923-7; Press M.C., 1995, PARASITIC PLANTS; Press MC, 2005, NEW PHYTOL, V166, P737, DOI 10.1111/j.1469-8137.2005.01358.x; Prider JN, 2011, AUSTRAL ECOL, V36, P167, DOI 10.1111/j.1442-9993.2010.02132.x; Puustinen S, 1999, CAN J BOT, V77, P523, DOI 10.1139/cjb-77-4-523; Runyon JB, 2008, PLANT PHYSIOL, V146, P987, DOI 10.1104/pp.107.112219; Runyon JB, 2006, SCIENCE, V313, P1964, DOI 10.1126/science.1131371; Runyon JB, 2010, PLANT CELL ENVIRON, V33, P290, DOI 10.1111/j.1365-3040.2009.02082.x; Runyon JB, 2009, SUSTAIN AGR REV, V1, P123, DOI 10.1007/978-1-4020-9654-9_8; Sandler Hilary A., 2010, Sustainability, V2, P660, DOI 10.3390/su2020660; Sandler HA, 2008, CRANBERRY PRODUCTION, P11; Schadler M, 2010, ENTOMOL EXP APPL, V135, P162, DOI 10.1111/j.1570-7458.2010.00976.x; Schwartzberg EG, 2014, FUNCT ECOL, V28, P386, DOI 10.1111/1365-2435.12182; Schwartzberg EG, 2011, J CHEM ECOL, V37, P1055, DOI 10.1007/s10886-011-0006-5; Siemens DH, 1996, ENVIRON ENTOMOL, V25, P1344, DOI 10.1093/ee/25.6.1344; Stam JM, 2014, ANNU REV PLANT BIOL, V65, P689, DOI 10.1146/annurev-arplant-050213-035937; Sui XL, 2015, J PLANT RES, V128, P563, DOI 10.1007/s10265-015-0727-6; Tedeschi P, 2011, J FOOD COMPOS ANAL, V24, P131, DOI 10.1016/j.jfca.2010.06.008; Thaler JS, 2012, TRENDS PLANT SCI, V17, P260, DOI 10.1016/j.tplants.2012.02.010; Thaler JS, 2010, ECOLOGY, V91, P1075, DOI 10.1890/08-2347.1; Thaler JS, 1996, J CHEM ECOL, V22, P1767, DOI 10.1007/BF02028503; Thaler JS, 2001, ECOL ENTOMOL, V26, P312, DOI 10.1046/j.1365-2311.2001.00324.x; Therneau T.M., 2015, R PACKAGE COXME MIXE; Tjiurutue MC, 2016, J CHEM ECOL, V42, P95, DOI 10.1007/s10886-016-0671-5; Uesugi A, 2013, OECOLOGIA, V173, P1387, DOI 10.1007/s00442-013-2717-5; Underwood N, 2009, J ANIM ECOL, V78, P839, DOI 10.1111/j.1365-2656.2009.01540.x; Van Zandt PA, 2004, OIKOS, V104, P401, DOI 10.1111/j.0030-1299.2004.12964.x	56	0	0	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161076	10.1371/journal.pone.0161076	http://dx.doi.org/10.1371/journal.pone.0161076			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529694	gold, Green Submitted, Green Published			2022-12-26	WOS:000381476700044
J	Perla-Kajan, J; Utyro, O; Rusek, M; Malinowska, A; Sitkiewicz, E; Jakubowski, H				Perla-Kajan, Joanna; Utyro, Olga; Rusek, Marta; Malinowska, Agata; Sitkiewicz, Ewa; Jakubowski, Hieronim			N-Homocysteinylation impairs collagen cross-linking in cystathionine -synthase-deficient mice: a novel mechanism of connective tissue abnormalities	FASEB JOURNAL			English	Article						hyperhomocysteinemia; homocysteine thiolactone; collagen modification; pyridinoline cross-links; Col1A1	BETA-SYNTHASE; LYSYL OXIDASE; METHYLENETETRAHYDROFOLATE-REDUCTASE; PROTEIN HOMOCYSTEINYLATION; HUMAN SERUM; PATHOLOGICAL CONSEQUENCES; ENDOTHELIAL-CELLS; THIOLACTONE; HUMANS; PLASMA	Cystathionine -synthase (CBS) deficiency, a genetic disorder in homocysteine (Hcy) metabolism in humans, elevates plasma Hcy-thiolactone and leads to connective tissue abnormalities that affect the cardiovascular and skeletal systems. However, the underlying mechanism of these abnormalities is not understood. Hcy-thiolactone has the ability to form isopeptide bonds with protein lysine residues, which generates N-homocysteinylated protein. Because lysine residues are involved in collagen cross-linking, N-homocysteinylation of these lysines should impair cross-linking. Using a Tg-I278T Cbs(-/-) mouse model of hyperhomocysteinemia (HHcy) which replicates the connective tissue abnormalities observed in CBS-deficient patients, we found that N-Hcy-collagen was elevated in bone, tail, and heart of Cbs(-/-) mice, whereas pyridinoline cross-links were significantly reduced. Plasma deoxypyridinoline cross-link and cross-linked carboxyterminal telopeptide of type I collagen were also significantly reduced in the Cbs(-/-) mice. Lysine oxidase activity and mRNA level were not reduced by the Cbs(-/-) genotype. We also showed that collagen carries S-linked Hcy bound to the thiol of N-linked Hcy. In vitro experiments showed that Hcy-thiolactone modifies lysine residues in collagen type I -1 chain. Residue K-160, located in the nonhelical N-telopeptide region and involved in pyridinoline cross-link formation, was also N-homocysteinylated in vivo. Taken together, our findings showed that N-homocysteinylation of collagen in Cbs(-/-) mice impairs its cross-linking. These findings explain, at least in part, connective tissue abnormalities observed in HHcy.Pera-Kajan, J., Utyro, O., Rusek, M., Malinowska, A., Sitkiewicz, E., Jakubowski, H. N-Homocysteinylation impairs collagen cross-linking in cystathionine -synthase-deficient mice: a novel mechanism of connective tissue abnormalities.	[Perla-Kajan, Joanna; Jakubowski, Hieronim] Univ Life Sci, Dept Biochem & Biotechnol, Pozna, Poland; [Utyro, Olga; Jakubowski, Hieronim] Inst Bioorgan Chem, Poznan, Poland; [Rusek, Marta; Jakubowski, Hieronim] Rutgers State Univ, Rutgers New Jersey Med Sch, Dept Microbiol Biochem & Mol Genet, Int Ctr Publ Hlth, Newark, NJ USA; [Malinowska, Agata; Sitkiewicz, Ewa] Inst Biochem & Biophys, Dept Biophys, Prote Lab, Warsaw, Poland; [Rusek, Marta] Med Univ, Dept Pathophysiol, Lublin, Poland	Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Medical University of Lublin	Jakubowski, H (corresponding author), Rutgers New Jersey Med Sch, Int Ctr Publ Hlth, Dept Microbiol Biochem & Mol Genet, 225 Warren St, Newark, NJ 07103 USA.	jakubows@rutgers.edu	Perla-Kajan, Joanna/F-2965-2010; Jakubowski, Hieronim/AAA-6834-2019; Rusek, Marta/H-2321-2018; Jakubowski, Hieronim/A-2510-2017	Perla-Kajan, Joanna/0000-0002-0791-5057; Rusek, Marta/0000-0001-9592-2478; Jakubowski, Hieronim/0000-0001-5845-4409; Malinowska, Agata/0000-0001-6599-901X; Utyro, Olga/0000-0002-9571-6057; Sitkiewicz, Ewa/0000-0002-9511-8575	National Science Center (Krakow, Poland) [2011/02/A/NZ1/00010, 2012/07/B/NZ7/01178, 2013/09/B/NZ5/02794, 2013/11/B/NZ1/00091, 2014/15/B/NZ2/01079]; American Heart Association [0855919D, 12GRNT9420014]	National Science Center (Krakow, Poland); American Heart Association(American Heart Association)	The authors thank Warren Kruger (Fox Chase Cancer Center, Philadelphia, PA, USA) for the breeding pair of Tg-I278T Cbs<SUP>+/-</SUP> mice. This study was supported in part by National Science Center (Krakow, Poland) (Grants 2011/02/A/NZ1/00010, 2012/07/B/NZ7/01178, 2013/09/B/NZ5/02794, 2013/11/B/NZ1/00091, and 2014/15/B/NZ2/01079), and American Heart Association (Grants 0855919D and 12GRNT9420014). The authors declare no conflicts of interest.	Abrahamsen B, 2006, BONE, V38, P215, DOI 10.1016/j.bone.2005.08.005; Bakun Magda, 2012, Clin Proteomics, V9, P13, DOI 10.1186/1559-0275-9-13; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chwatko G, 2005, CLIN CHEM, V51, P408, DOI 10.1373/clinchem.2004.042531; Chwatko G, 2005, ANAL BIOCHEM, V337, P271, DOI 10.1016/j.ab.2004.11.035; Chwatko G, 2007, FASEB J, V21, P1707, DOI 10.1096/fj.06-7435com; EDWARDS CA, 1980, CLIN CHIM ACTA, V104, P161, DOI 10.1016/0009-8981(80)90192-8; Eyre DR, 2008, METHODS, V45, P65, DOI 10.1016/j.ymeth.2008.01.002; Fledelius C, 1997, J BIOL CHEM, V272, P9755; FUJIMOTO D, 1978, BIOCHEM BIOPH RES CO, V84, P52, DOI 10.1016/0006-291X(78)90261-9; Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002; Glowacki R, 2004, J BIOL CHEM, V279, P10864, DOI 10.1074/jbc.M313268200; GRIFFITHS R, 1976, CONNECT TISSUE RES, V4, P101, DOI 10.3109/03008207609152205; Gupta S, 2009, FASEB J, V23, P883, DOI 10.1096/fj.08-120584; Hornstra IK, 2003, J BIOL CHEM, V278, P14387, DOI 10.1074/jbc.M210144200; JAKUBOWSKI H, 1993, FEBS LETT, V317, P237, DOI 10.1016/0014-5793(93)81283-6; Jakubowski H, 2000, CIRC RES, V87, P45, DOI 10.1161/01.RES.87.1.45; Jakubowski H, 1997, J BIOL CHEM, V272, P1935; Jakubowski H, 2002, J BIOL CHEM, V277, P30425, DOI 10.1074/jbc.C200267200; Jakubowski H, 2002, ANAL BIOCHEM, V308, P112, DOI 10.1016/S0003-2697(02)00224-5; Jakubowski H, 1999, FASEB J, V13, P2277, DOI 10.1096/fasebj.13.15.2277; Jakubowski H, 2000, J NUTR, V130, p377S, DOI 10.1093/jn/130.2.377S; Jakubowski H, 2015, CIRCULATION, V132, DOI [10.1161/circ.132.suppl_3.19250, DOI 10.1161/CIRC.132.SUPPL_3.19250]; Jakubowski H., 2013, HOMOCYSTEINE PROTEIN; Jakubowski H, 2008, ANAL BIOCHEM, V380, P257, DOI 10.1016/j.ab.2008.05.049; Jakubowski H, 2006, CHEM-EUR J, V12, P8039, DOI 10.1002/chem.200600785; Jakubowski H, 2008, FASEB J, V22, P4071, DOI 10.1096/fj.08-112086; Jakubowski H, 2009, FASEB J, V23, P1721, DOI 10.1096/fj.08-127548; KANG AH, 1973, J CLIN INVEST, V52, P2571, DOI 10.1172/JCI107449; Lei WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130421; Liu GM, 1997, J BIOL CHEM, V272, P32370, DOI 10.1074/jbc.272.51.32370; Lubec B, 1996, BBA-MOL BASIS DIS, V1315, P159, DOI 10.1016/0925-4439(95)00119-0; Majors A, 1997, ARTERIOSCL THROM VAS, V17, P2074, DOI 10.1161/01.ATV.17.10.2074; Maki JM, 2002, CIRCULATION, V106, P2503, DOI 10.1161/01.CIR.0000038109.84500.1E; Marczak L, 2011, J PROTEOMICS, V74, P967, DOI 10.1016/j.jprot.2011.01.021; McKusick V. A., 1966, HERITABLE DISORDERS, P155; McLean RR, 2004, J BONE MINER RES, V19, P410, DOI 10.1359/JBMR.0301261; MUDD SH, 2001, METABOLIC MOL BASES, V2, P2007; Paoli P, 2010, J MOL BIOL, V400, P889, DOI 10.1016/j.jmb.2010.05.039; Pera-Kajan J, 2011, ANAL BIOANAL CHEM, V401, P2473, DOI 10.1007/s00216-011-5346-z; Perla-Kajan J, 2008, BIOMED PHARMACOTHER, V62, P473, DOI 10.1016/j.biopha.2008.04.001; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Raposo B, 2004, ATHEROSCLEROSIS, V177, P1, DOI 10.1016/j.atherosclerosis.2004.06.015; Robert K, 2005, ANAT REC PART A, V282A, P1, DOI 10.1002/ar.a.20145; Saito M, 2010, OSTEOPOROSIS INT, V21, P655, DOI 10.1007/s00198-009-0980-4; Sauls DL, 2006, BIOCHEMISTRY-US, V45, P2480, DOI 10.1021/bi052076j; Sikora M, 2014, AMINO ACIDS, V46, P235, DOI 10.1007/s00726-013-1617-7; Sikora M, 2010, ANAL BIOCHEM, V405, P132, DOI 10.1016/j.ab.2010.04.034; Takaluoma K, 2007, J BIOL CHEM, V282, P6588, DOI 10.1074/jbc.M608830200; TANZER ML, 1968, J BIOL CHEM, V243, P4045; TELSER A, 1980, BIOCHIM BIOPHYS ACTA, V624, P363, DOI 10.1016/0005-2795(80)90077-X; Thaler R, 2011, J BIOL CHEM, V286, P5578, DOI 10.1074/jbc.M110.166181; Undas A, 2005, THROMB HAEMOSTASIS, V93, P346, DOI 10.1160/TH04-08-0493; Undas A, 2004, STROKE, V35, P1299, DOI 10.1161/01.STR.0000128412.59768.6e; WATANABE M, 1995, P NATL ACAD SCI USA, V92, P1585, DOI 10.1073/pnas.92.5.1585; Yang X, 2006, CLIN CHIM ACTA, V364, P230, DOI 10.1016/j.cccn.2005.07.007	56	26	26	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2016	30	11					3810	3821		10.1096/fj.201600539	http://dx.doi.org/10.1096/fj.201600539			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EA3BY	27530978	Green Submitted			2022-12-26	WOS:000386474700015
J	Singh, SK; Hasan, SS; Zakharov, SD; Naurin, S; Cohn, W; Ma, J; Whitelegge, JP; Cramer, WA				Singh, Sandeep K.; Hasan, S. Saif; Zakharov, Stanislav D.; Naurin, Sejuti; Cohn, Whitaker; Ma, Jia; Whitelegge, Julian P.; Cramer, William A.			Trans-membrane Signaling in Photosynthetic State Transitions: REDOX- AND STRUCTURE-DEPENDENT INTERACTION IN VITRO BETWEEN STT7 KINASE AND THE CYTOCHROME b(6)f COMPLEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome; light-harvesting complex (antenna complex); redox signaling; serine; threonine protein kinase; signal transduction; state transitions; Stt7; cytochrome b6f	THYLAKOID PROTEIN-KINASE; CIRCULAR-DICHROISM SPECTRA; CHLAMYDOMONAS-REINHARDTII; TRANSMEMBRANE HELICES; PROLYL ISOMERIZATION; DISULFIDE-ISOMERASE; SECONDARY STRUCTURE; LIPID FUNCTIONS; PHOSPHORYLATION; DYNAMICS	Trans-membrane signaling involving a serine/threonine kinase (Stt7 in Chlamydomonas reinhardtii) directs light energy distribution between the two photosystems of oxygenic photosynthesis. Oxidation of plastoquinol mediated by the cytochrome b(6)f complex on the electrochemically positive side of the thylakoid membrane activates the kinase domain of Stt7 on the trans (negative) side, leading to phosphorylation and redistribution (state transition) of the light-harvesting chlorophyll proteins between the two photosystems. The molecular description of the Stt7 kinase and its interaction with the cytochrome b(6)f complex are unknown or unclear. In this study, Stt7 kinase has been cloned, expressed, and purified in a heterologous host. Stt7 kinase is shown to be active in vitro in the presence of reductant and purified as a tetramer, as determined by analytical ultracentrifugation, electron microscopy, and electrospray ionization mass spectrometry, with a molecular weight of 332 kDa, consisting of an 83.41-kDa monomer. Far-UV circular dichroism spectra show Stt7 to be mostly -helical and document a physical interaction with the b(6)f complex through increased thermal stability of Stt7 secondary structure. The activity of wild-type Stt7 and its Cys-Ser mutant at positions 68 and 73 in the presence of a reductant suggest that the enzyme does not require a disulfide bridge for its activity as suggested elsewhere. Kinase activation in vivo could result from direct interaction between Stt7 and the b(6)f complex or long-range reduction of Stt7 by superoxide, known to be generated in the b(6)f complex by quinol oxidation.	[Singh, Sandeep K.; Hasan, S. Saif; Zakharov, Stanislav D.; Naurin, Sejuti; Cramer, William A.] Purdue Univ, Bindley Biosci Ctr, Dept Biol Sci, W Lafayette, IN 47907 USA; [Ma, Jia] Purdue Univ, Bindley Biosci Ctr, Biophys Anal Lab, W Lafayette, IN 47907 USA; [Whitelegge, Julian P.; Cramer, William A.] Univ Calif Los Angeles, David Geffen Sch Med, NPI Semel Inst, Pasarow Mass Spectrometry Lab, Los Angeles, CA 90024 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Cramer, WA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, NPI Semel Inst, Pasarow Mass Spectrometry Lab, Los Angeles, CA 90024 USA.; Cramer, WA (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	waclab@purdue.edu		Cohn, Whitaker/0000-0001-9198-8904; Singh, Sandeep/0000-0001-9322-2929	National Institutes of Health [GMS-038323]; Purdue University Center for Cancer Research [P30 CA23168]; University of California, San Diego/Los Angeles NIDDK, National Institutes of Health Diabetes Research Center [P30 DK063491]; NATIONAL CANCER INSTITUTE [P30CA023168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038323] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Purdue University Center for Cancer Research; University of California, San Diego/Los Angeles NIDDK, National Institutes of Health Diabetes Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GMS-038323 (to W. A. C.), Purdue University Center for Cancer Research Grant P30 CA23168 (to W. A. C.), and University of California, San Diego/Los Angeles NIDDK, National Institutes of Health Diabetes Research Center Grant P30 DK063491 (to J. P. W.). A preliminary account was presented at the meeting of the Biophysical Society, February 27-March 2, 2016, Los Angeles, CA ((2016) Biophys. J. 110, 91a). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALLEN JF, 1981, NATURE, V291, P25, DOI 10.1038/291025a0; Alric J, 2005, P NATL ACAD SCI USA, V102, P15860, DOI 10.1073/pnas.0508102102; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Baniulis D, 2013, BIOCHEMISTRY-US, V52, P8975, DOI 10.1021/bi4013534; Baniulis D, 2009, J BIOL CHEM, V284, P9861, DOI 10.1074/jbc.M809196200; BARBER J, 1982, BIOSCIENCE REP, V2, P1, DOI 10.1007/BF01142194; BARBER J, 1982, ANNU REV PLANT PHYS, V33, P261, DOI 10.1146/annurev.pp.33.060182.001401; Bellafiore S, 2005, NATURE, V433, P892, DOI 10.1038/nature03286; Brazin KN, 2002, P NATL ACAD SCI USA, V99, P1899, DOI 10.1073/pnas.042529199; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Chen JM, 2013, PROTEIN SCI, V22, P510, DOI 10.1002/pro.2230; Depege N, 2003, SCIENCE, V299, P1572, DOI 10.1126/science.1081397; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Eberhard S, 2008, ANNU REV GENET, V42, P463, DOI 10.1146/annurev.genet.42.110807.091452; GILBERT HF, 1990, ADV ENZYMOL RAMB, V63, P69; Guo JT, 2013, PROTEIN CELL, V4, P607, DOI 10.1007/s13238-013-3034-9; Hari SB, 2013, CHEM BIOL, V20, P806, DOI 10.1016/j.chembiol.2013.05.005; Hasan SS, 2014, BIOPHYS J, V107, P1620, DOI 10.1016/j.bpj.2014.08.003; Hasan SS, 2014, STRUCTURE, V22, P1008, DOI 10.1016/j.str.2014.05.004; Hasan SS, 2013, BBA-BIOENERGETICS, V1827, P1295, DOI 10.1016/j.bbabio.2013.03.002; Hasan SS, 2013, P NATL ACAD SCI USA, V110, P4297, DOI 10.1073/pnas.1222248110; Hasan SS, 2012, PHILOS T R SOC B, V367, P3406, DOI 10.1098/rstb.2012.0058; Hasan SS, 2011, J MOL BIOL, V414, P145, DOI 10.1016/j.jmb.2011.09.023; HORTON P, 1981, FEBS LETT, V125, P193, DOI 10.1016/0014-5793(81)80716-8; Huber-Wunderlich M, 1998, FOLD DES, V3, P161, DOI 10.1016/S1359-0278(98)00024-8; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Jones DT, 2015, BIOINFORMATICS, V31, P857, DOI 10.1093/bioinformatics/btu744; Kannan N, 2005, J MOL BIOL, V351, P956, DOI 10.1016/j.jmb.2005.06.057; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; Kruse O, 1999, PHOTOSYNTH RES, V61, P43, DOI 10.1023/A:1006229308606; Lemeille S, 2009, PLOS BIOL, V7, P664, DOI 10.1371/journal.pbio.1000045; LIN TY, 1989, BIOCHEMISTRY-US, V28, P5282, DOI 10.1021/bi00438a054; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Lummis SCR, 2005, NATURE, V438, P248, DOI 10.1038/nature04130; Manglik A, 2014, CURR OPIN CELL BIOL, V27, P136, DOI 10.1016/j.ceb.2014.01.008; MILLNER PA, 1982, J BIOL CHEM, V257, P1736; Minagawa J, 2015, PLANT J, V82, P413, DOI 10.1111/tpj.12805; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Patananan AN, 2014, J BIOL CHEM, V289, P16936, DOI 10.1074/jbc.M114.564385; PETERSON DA, 1994, BIOCHEM BIOPH RES CO, V200, P1586, DOI 10.1006/bbrc.1994.1632; Petlicki J, 1998, J CHEM SOC FARADAY T, V94, P2763, DOI 10.1039/a804551h; Puthiyaveetil S, 2011, FEBS LETT, V585, P1717, DOI 10.1016/j.febslet.2011.04.076; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rochaix JD, 2007, FEBS LETT, V581, P2768, DOI 10.1016/j.febslet.2007.04.038; Sansom MSP, 2000, TRENDS PHARMACOL SCI, V21, P445; Sarkar P, 2007, MOL CELL, V25, P413, DOI 10.1016/j.molcel.2007.01.004; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Shapiguzov A, 2016, PLANT PHYSIOL, V171, P82, DOI 10.1104/pp.15.01893; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stroebel D, 2003, NATURE, V426, P413, DOI 10.1038/nature02155; Tieleman DP, 2001, PROTEINS, V44, P63, DOI 10.1002/prot.1073; Vener AV, 1997, P NATL ACAD SCI USA, V94, P1585, DOI 10.1073/pnas.94.4.1585; Wedemeyer WJ, 2002, BIOCHEMISTRY-US, V41, P14637, DOI 10.1021/bi020574b; Whitelegge JP, 2002, MOL CELL PROTEOMICS, V1, P816, DOI 10.1074/mcp.M200045-MCP200; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wollman FA, 2001, EMBO J, V20, P3623, DOI 10.1093/emboj/20.14.3623; Wulf G, 2005, NAT CELL BIOL, V7, P435, DOI 10.1038/ncb0505-435; WUNDERLICH M, 1993, PROTEIN SCI, V2, P717, DOI 10.1002/pro.5560020503; Zhang L, 2015, SCI REP-UK, V5, DOI 10.1038/srep10115; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X; Zito F, 1999, EMBO J, V18, P2961, DOI 10.1093/emboj/18.11.2961; Zito F, 2002, J BIOL CHEM, V277, P12446, DOI 10.1074/jbc.M110914200	65	12	12	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21740	21750		10.1074/jbc.M116.732545	http://dx.doi.org/10.1074/jbc.M116.732545			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27539852	Green Published, hybrid			2022-12-26	WOS:000385999200038
J	Hrapcak, S; Kuper, H; Bartlett, P; Devendra, A; Makawa, A; Kim, M; Kazembe, P; Ahmed, S				Hrapcak, Susan; Kuper, Hannah; Bartlett, Peter; Devendra, Akash; Makawa, Atupele; Kim, Maria; Kazembe, Peter; Ahmed, Saeed			Hearing Loss in HIV-Infected Children in Lilongwe, Malawi	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; UNINFECTED CHILDREN; PREVALENCE; AFRICA; IMPAIRMENT; COUNTRIES; HIV/AIDS; PEOPLE	Introduction With improved access to antiretroviral therapy (ART), HIV infection is becoming a chronic illness. Preliminary data suggest that HIV-infected children have a higher risk of disabilities, including hearing impairment, although data are sparse. This study aimed to estimate the prevalence and types of hearing loss in HIV-infected children in Lilongwe, Malawi. Methods This was a cross-sectional survey of 380 HIV-infected children aged 4-14 years attending ART clinic in Lilongwe between December 2013-March 2014. Data was collected through pediatric quality of life and sociodemographic questionnaires, electronic medical record review, and detailed audiologic testing. Hearing loss was defined as > 20 decibels hearing level (dBHL) in either ear. Predictors of hearing loss were explored by regression analysis generating age-and sex-adjusted odds ratios. Children with significant hearing loss were fitted with hearing aids. Results Of 380 patients, 24% had hearing loss: 82% conductive, 14% sensorineural, and 4% mixed. Twenty-one patients (23% of those with hearing loss) were referred for hearing aid fitting. There was a higher prevalence of hearing loss in children with history of frequent ear infections (OR 7.4, 4.2-13.0) and ear drainage (OR 6.4, 3.6-11.6). Hearing loss was linked to history of WHO Stage 3 (OR 2.4, 1.2-4.5) or Stage 4 (OR 6.4, 2.7-15.2) and history of malnutrition (OR 2.1, 1.3-3.5), but not to duration of ART or CD4. Only 40% of caregivers accurately perceived their child's hearing loss. Children with hearing impairment were less likely to attend school and had poorer emotional (p = 0.02) and school functioning (p = 0.04). Conclusions There is an urgent need for improved screening tools, identification and treatment of hearing problems in HIV-infected children, as hearing loss was common in this group and affected school functioning and quality of life. Clear strategies were identified for prevention and treatment, since most hearing loss was conductive in nature, likely due to frequent ear infections, and many children with hearing loss qualified for hearing aids. Screening strategies need to be developed and tested since caregivers were not reliable at identifying hearing loss, and often mis-identified children with normal hearing as having hearing loss. Children with frequent ear infections, ear drainage, TB, severe HIV disease, or low BMI should receive more frequent ear assessments and hearing evaluations.	[Hrapcak, Susan; Devendra, Akash; Makawa, Atupele; Kim, Maria; Kazembe, Peter; Ahmed, Saeed] Baylor Coll Med, Abbott Fund, Childrens Clin Ctr Excellence Malawi, Lilongwe, Malawi; [Hrapcak, Susan; Kim, Maria; Kazembe, Peter; Ahmed, Saeed] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Hrapcak, Susan; Kim, Maria; Kazembe, Peter; Ahmed, Saeed] Texas Childrens Hosp, Baylor Int Pediat AIDS Initiat, Houston, TX 77030 USA; [Kuper, Hannah] London Sch Hyg & Trop Med, Int Ctr Evidence Disabil, London, England; [Bartlett, Peter] African Bible Coll ABC Hearing Clin & Training Ct, Lilongwe, Malawi	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of London; London School of Hygiene & Tropical Medicine	Hrapcak, S (corresponding author), Baylor Coll Med, Abbott Fund, Childrens Clin Ctr Excellence Malawi, Lilongwe, Malawi.; Hrapcak, S (corresponding author), Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.; Hrapcak, S (corresponding author), Texas Childrens Hosp, Baylor Int Pediat AIDS Initiat, Houston, TX 77030 USA.	Susan.Hrapcak@gmail.com			United States Agency For International Development (USAID) [674-A-00-10-00093-00]; Fogarty International Center of the National Institutes of Health [K01 TW009644]; FOGARTY INTERNATIONAL CENTER [K01TW009644] Funding Source: NIH RePORTER	United States Agency For International Development (USAID)(United States Agency for International Development (USAID)); Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported by the United States Agency For International Development (USAID) Cooperative Agreement number 674-A-00-10-00093-00. MHK was supported by the Fogarty International Center of the National Institutes of Health under Award Number K01 TW009644. The contents are the responsibility of the authors and do not necessarily reflect the views of the funders, including the National Institutes of Health, USAID and the United States Government.	Akileswaran C, 2005, CLIN INFECT DIS, V41, P376, DOI 10.1086/431482; Banks LM, 2015, TROP MED INT HEALTH, V20, P411, DOI 10.1111/tmi.12449; Assuiti LFC, 2013, BRAZ J OTORHINOLAR, V79, P248, DOI 10.5935/1808-8694.20130042; Chao CK, 2012, OTOLARYNG HEAD NECK, V146, P259, DOI 10.1177/0194599811429271; Christopher N, 2013, INT J PEDIATR OTORHI, V77, P262, DOI 10.1016/j.ijporl.2012.11.013; Devendra A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084024; Gelfand S., 2009, ESSENTIALS AUDIOLOGY, P161; Govender R, 2011, J CHILD NEUROL, V26, P1355, DOI 10.1177/0883073811405203; Jeremy RJ, 2005, PEDIATRICS, V115, P380, DOI 10.1542/peds.2004-1108; Kakuda TN, 2000, CLIN THER, V22, P685, DOI 10.1016/S0149-2918(00)90004-3; Buriti AKL, 2013, CODAS, V25, P513, DOI 10.1590/S2317-17822013.05000013; Malawi Ministry of Health, 2014, HIV PROGR REP; Malawi Ministry of Health, 2007, WEIGHT FOR HEIGHT TA; Matas CG, 2008, BRAZ J INFECT DIS, V12, P10, DOI 10.1590/S1413-86702008000100004; Matas Carla Gentile, 2010, Pró-Fono R. Atual. Cient., V22, P269, DOI 10.1590/S0104-56872010000300019; Mills EJ, 2011, ANN INTERN MED, V155, P209, DOI 10.7326/0003-4819-155-4-201108160-00358; Palacios GC, 2008, INT J PEDIATR OTORHI, V72, P1671, DOI 10.1016/j.ijporl.2008.08.002; Puthanakit T, 2010, AIDS PATIENT CARE ST, V24, P141, DOI 10.1089/apc.2009.0314; Russell S, 2007, HEALTH POLICY PLANN, V22, P344, DOI 10.1093/heapol/czm023; Schouten JT, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-28; Sow PS, 2007, JAIDS-J ACQ IMM DEF, V44, P262, DOI 10.1097/QAI.0b013e31802bf109; Stevens G, 2013, EUR J PUBLIC HEALTH, V23, P146, DOI 10.1093/eurpub/ckr176; Taipale A, 2011, EUR ARCH OTO-RHINO-L, V268, P1527, DOI 10.1007/s00405-011-1579-x; Torre P, 2015, AIDS CARE, V27, P1037, DOI 10.1080/09540121.2015.1021746; Torre P, 2012, PEDIATR INFECT DIS J, V31, P835, DOI 10.1097/INF.0b013e31825b9524	25	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0161421	10.1371/journal.pone.0161421	http://dx.doi.org/10.1371/journal.pone.0161421			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27551970	Green Accepted, Green Submitted, gold, Green Published			2022-12-26	WOS:000381768800038
J	Wendell, DL; Vaziri, A; Shergill, G				Wendell, Douglas L.; Vaziri, Anoumid; Shergill, Gurbaksh			The Gene Encoding Dihydroflavonol 4-Reductase Is a Candidate for the anthocyaninless Locus of Rapid Cycling Brassica rapa (Fast Plants Type)	PLOS ONE			English	Article							MUTANT; BIOCHEMISTRY; MUTATIONS; L.	Rapid cycling Brassica rapa, also known as Wisconsin Fast Plants, are a widely used organism in both K-12 and college science education. They are an excellent system for genetics laboratory instruction because it is very easy to conduct genetic crosses with this organism, there are numerous seed stocks with variation in both Mendelian and quantitative traits, they have a short generation time, and there is a wealth of educational materials for instructors using them. Their main deficiency for genetics education is that none of the genetic variation in RCBr has yet been characterized at the molecular level. Here we present the first molecular characterization of a gene responsible for a trait in Fast Plants. The trait under study is purple/nonpurple variation due to the anthocyaninless locus, which is one of the Mendelian traits most frequently used for genetics education with this organism. We present evidence that the DFR gene, which encodes dihyroflavonol 4-reductase, is the candidate gene for the anthocyaninless (ANL) locus in RCBr. DFR shows complete linkage with ANL in genetic crosses with a total of 948 informative chromosomes, and strains with the recessive nonpurple phenotype have a transposon-related insertion in the DFR which is predicted to disrupt gene function.	[Wendell, Douglas L.; Vaziri, Anoumid; Shergill, Gurbaksh] Oakland Univ, Dept Biol Sci, Rochester, MI 48309 USA	Oakland University	Wendell, DL (corresponding author), Oakland Univ, Dept Biol Sci, Rochester, MI 48309 USA.	wendell@oakland.edu		Vaziri, Anoumid/0000-0002-3406-0656	American Recovery and Reinvestment Act grant from the National Institutes of Health, National Center for Research Resources, USA [5 RC1 RR030293-02]; Research Excellence Fund of Oakland University; NATIONAL CENTER FOR RESEARCH RESOURCES [RC1RR030293] Funding Source: NIH RePORTER	American Recovery and Reinvestment Act grant from the National Institutes of Health, National Center for Research Resources, USA; Research Excellence Fund of Oakland University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was funded by an American Recovery and Reinvestment Act grant 5 RC1 RR030293-02 from the National Institutes of Health (https://www.nih.gov/), National Center for Research Resources, USA, and the Research Excellence Fund of Oakland University (https://wwwp.oakland.edu/cbr/research-excellence-program/). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Michael Hagen, Ph.D. of the Applied Genomics Technology Center for valuable advice on sequencing a difficult template. This work was funded by an American Recovery and Reinvestment Act grant 5 RC1 RR030293-02 from the National Institutes of Health, National Center for Research Resources, USA, and the Research Excellence Fund of Oakland University.	Batzli JM, 2014, CBE-LIFE SCI EDUC, V13, P410, DOI 10.1187/cbe.13-12-0232; BELD M, 1989, PLANT MOL BIOL, V13, P491, DOI 10.1007/BF00027309; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Burdzinski C, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-64; Cheng F, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-136; Coburn RA, 2015, AM J BOT, V102, P264, DOI 10.3732/ajb.1400395; Goldman I. L., 1999, HortTechnology, V9, P579; GOLDSBROUGH A, 1994, PLANT PHYSIOL, V105, P491, DOI 10.1104/pp.105.2.491; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Gould K, 2014, ANTHOCYANINS BIOSYNT; Grotewold E, 2006, ANNU REV PLANT BIOL, V57, P761, DOI 10.1146/annurev.arplant.57.032905.105248; HOLTON TA, 1995, PLANT CELL, V7, P1071, DOI 10.1105/tpc.7.7.1071; Kazama Y, 2013, PLANT CELL REP, V32, P11, DOI 10.1007/s00299-012-1336-7; Lauffer HB, 2012, WISCONSIN FAST PLANT; Loreiux M, 2012, MAPDISTO FAST EFFICI, V30, P1231; REDDY AR, 1987, PLANT SCI, V52, P7, DOI 10.1016/0168-9452(87)90098-7; SHIRLEY BW, 1992, PLANT CELL, V4, P333, DOI 10.1105/tpc.4.3.333; Slankster EE, 2012, DNA BASED GENETIC MA, V3, P118; Song S, 2014, MOL BREEDING, V33, P173, DOI 10.1007/s11032-013-9942-9; Suzuki K, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0389-z; TOMKINS SP, 1990, J BIOL EDUC, V24, P239, DOI 10.1080/00219266.1990.9655152; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; WISCONSIN FAST PLANTS PROGRAM, 2016, WISC FAST PLANTS MAN; Woody S., 2016, FPSC NEW PLANT BASED, pW800; Wu CA, 2013, GENETIC BASIS RARE F, V8; Xu M, 2010, GENETICS, V184, P53, DOI 10.1534/genetics.109.107904; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	27	1	4	2	199	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161394	10.1371/journal.pone.0161394	http://dx.doi.org/10.1371/journal.pone.0161394			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548675	Green Published, gold, Green Submitted			2022-12-26	WOS:000381768400052
J	Curran, AM; Ryan, MF; Drummond, E; Gibney, ER; Gibney, MJ; Roche, HM; Brennan, L				Curran, Aoife M.; Ryan, Miriam F.; Drummond, Elaine; Gibney, Eileen R.; Gibney, Michael J.; Roche, Helen M.; Brennan, Lorraine			Uncovering Factors Related to Pancreatic Beta-Cell Function	PLOS ONE			English	Article							BODY-MASS INDEX; INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; AMPLIFYING PATHWAYS; ADIPONECTIN RECEPTORS; METABOLIC SYNDROME; SECRETION; RISK; SENSITIVITY; DYSFUNCTION	Aim The incidence of type 2 diabetes has increased rapidly on a global scale. Beta-cell dysfunction contributes to the overall pathogenesis of type 2 diabetes. However, factors contributing to beta-cell function are not clear. The aims of this study were (i) to identify factors related to pancreatic beta-cell function and (ii) to perform mechanistic studies in vitro. Methods Three specific measures of beta-cell function were assessed for 110 participants who completed an oral glucose tolerance test as part of the Metabolic Challenge Study. Anthropometric and biochemical parameters were assessed as potential modulators of beta-cell function. Subsequent in vitro experiments were performed using the BRIN-BD11 pancreatic beta-cell line. Validation of findings were performed in a second human cohort. Results Waist-to-hip ratio was the strongest anthropometric modulator of beta-cell function, with beta-coefficients of -0.33 (p = 0.001) and -0.30 (p = 0.002) for beta-cell function/homeostatic model assessment of insulin resistance (HOMA-IR), and disposition index respectively. Additionally, the resistin-to-adiponectin ratio (RA index) emerged as being strongly associated with beta-cell function, with beta-coefficients of -0.24 (p = 0.038) and -0.25 (p = 0.028) for beta-cell function/HOMA-IR, and disposition index respectively. Similar results were obtained using a third measure for beta-cell function. In vitro experiments revealed that the RA index was a potent regulator of acute insulin secretion where a high RA index (20ng ml(-1) resistin, 5nmol l(-1) g-adiponectin) significantly decreased insulin secretion whereas a low RA index (10ng ml(-1) resistin, 10nmol l(-1) g-adiponectin) significantly increased insulin secretion. The RA index was successfully validated in a second human cohort with beta-coefficients of -0.40 (p = 0.006) and -0.38 (p = 0.008) for beta-cell function/HOMA-IR, and disposition index respectively. Conclusions Waist-to- hip ratio and RA index were identified as significant modulators of beta-cell function. The ability of the RA index to modulate insulin secretion was confirmed in mechanistic studies. Future work should identify strategies to alter the RA index.	[Curran, Aoife M.; Ryan, Miriam F.; Drummond, Elaine; Gibney, Eileen R.; Gibney, Michael J.; Roche, Helen M.; Brennan, Lorraine] Univ Coll Dublin, Sch Agr & Food Sci, Inst Food & Hlth, Dublin, Ireland; [Roche, Helen M.] Univ Coll Dublin, UCD Conway Inst Biomol & Biomed Res, Nutrigen Res Grp, Dublin 4, Ireland; [Roche, Helen M.] Univ Coll Dublin, UCD Inst Food & Hlth, Sch Publ Hlth Physiotherapy & Sports Sci, Dublin 4, Ireland	University College Dublin; University College Dublin; University College Dublin	Brennan, L (corresponding author), Univ Coll Dublin, Sch Agr & Food Sci, Inst Food & Hlth, Dublin, Ireland.	lorraine.brennan@ucd.ie	Roche, Helen M/AAF-4164-2019	Roche, Helen M/0000-0002-0628-3318; Brennan, Lorraine/0000-0002-7711-7499	Food for Health Ireland, through Enterprise Ireland [TC20130001]; Irish department of Agriculture, Food and the Marine [07FHRIUCD1, 13F407-ENPADASI]; Science Foundation Ireland Principal Investigator Award (SFI PI) [11/PI/1119]; SFI [14/JP-HDHL/B3075]; ERC Consolidator grants [647783]	Food for Health Ireland, through Enterprise Ireland; Irish department of Agriculture, Food and the Marine; Science Foundation Ireland Principal Investigator Award (SFI PI)(Science Foundation Ireland); SFI(Science Foundation Ireland); ERC Consolidator grants	This work was supported by Food for Health Ireland, through Enterprise Ireland Grant No. TC20130001. This work was conducted as part of a clinical trial (NCT01172951), funded by the Irish department of Agriculture, Food and the Marine through the grants 07FHRIUCD1 and 13F407-ENPADASI www.ucd.ie/jingo. H.M.R is supported by the Science Foundation Ireland Principal Investigator Award (SFI PI 11/PI/1119). L.B was supported by SFI (14/JP-HDHL/B3075) and ERC Consolidator grants 647783). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Arnlov J, 2011, DIABETES CARE, V34, P61, DOI 10.2337/dc10-0955; Bardini G, 2011, DIABETIC MED, V28, P1229, DOI 10.1111/j.1464-5491.2011.03332.x; Bardini G, 2013, ACTA DIABETOL, V50, P277, DOI 10.1007/s00592-011-0339-0; Benomar Y, 2013, DIABETES, V62, P102, DOI 10.2337/db12-0237; Boslem E, 2012, ISLETS, V4, P177, DOI 10.4161/isl.20102; Breda E, 2001, DIABETES, V50, P150, DOI 10.2337/diabetes.50.1.150; Brown JEP, 2007, FEBS LETT, V581, P3273, DOI 10.1016/j.febslet.2007.06.031; Brown JEP, 2010, PEPTIDES, V31, P944, DOI 10.1016/j.peptides.2010.02.004; Carr DB, 2004, DIABETES, V53, P2087, DOI 10.2337/diabetes.53.8.2087; Cheng CH, 2010, NUTR RES, V30, P585, DOI 10.1016/j.nutres.2010.08.007; Donin AS, 2014, DIABETES CARE, V37, P116, DOI 10.2337/dc13-1263; Elbein SC, 2000, DIABETES CARE, V23, P221, DOI 10.2337/diacare.23.2.221; Flehmig G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099785; Heidemann C, 2008, ANN INTERN MED, V149, P307, DOI 10.7326/0003-4819-149-5-200809020-00005; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Hermans MP, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-132; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Jamaluddin MS, 2012, BRIT J PHARMACOL, V165, P622, DOI 10.1111/j.1476-5381.2011.01369.x; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Khaldi MZ, 2004, AM J PHYSIOL-ENDOC M, V287, pE207, DOI 10.1152/ajpendo.00426.2003; Kharroubi I, 2003, BIOCHEM BIOPH RES CO, V312, P1118, DOI 10.1016/j.bbrc.2003.11.042; Kruit JK, 2010, CURR OPIN LIPIDOL, V21, P178, DOI 10.1097/MOL.0b013e328339387b; Kuo TY, 2016, J BIOL CHEM, V291, P9648, DOI 10.1074/jbc.M115.702183; Lau CH, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-8; Lim EL, 2011, DIABETOLOGIA, V54, P2506, DOI 10.1007/s00125-011-2204-7; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; McClenaghan NH, 1996, DIABETES, V45, P1132, DOI 10.2337/diabetes.45.8.1132; Morris C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072890; Nakata M, 2007, BIOCHEM BIOPH RES CO, V353, P1046, DOI 10.1016/j.bbrc.2006.12.134; Narayan KMV, 2007, DIABETES CARE, V30, P1562, DOI 10.2337/dc06-2544; Nenquin M, 2004, J BIOL CHEM, V279, P32316, DOI 10.1074/jbc.M402076200; O'Gorman A, 2014, J CHROMATOGR B, V966, P140, DOI [10.1016/j.jchromb.2014.01.032, 10.1016/]; Okamoto M, 2008, DIABETOLOGIA, V51, P827, DOI 10.1007/s00125-008-0944-9; Park HK, 2013, DIABETES METAB J, V37, P404, DOI [10.4093/dmj.2013.37.6.404, 10.4093/dmj.2013.37.2.113]; Ryan MF, 2013, AM J CLIN NUTR, V97, P261, DOI 10.3945/ajcn.112.047936; Schienkiewitz A, 2006, AM J CLIN NUTR, V84, P427; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Tao C, 2014, BEST PRACT RES CL EN, V28, P43, DOI 10.1016/j.beem.2013.11.003; Utzschneider KM, 2009, DIABETES CARE, V32, P335, DOI 10.2337/dc08-1478; Wallace M, 2014, MOL BIOSYST, V10, P1586, DOI 10.1039/c3mb70529c; Wallace M, 2013, BBA-GEN SUBJECTS, V1830, P2583, DOI 10.1016/j.bbagen.2012.10.025; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Wen JP, 2008, BIOCHEM BIOPH RES CO, V371, P756, DOI 10.1016/j.bbrc.2008.04.146; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Winzell MS, 2004, BIOCHEM BIOPH RES CO, V321, P154, DOI 10.1016/j.bbrc.2004.06.130; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705	47	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161350	10.1371/journal.pone.0161350	http://dx.doi.org/10.1371/journal.pone.0161350			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536890	Green Published, Green Submitted, gold			2022-12-26	WOS:000381577000091
J	Rochford, K; Chen, F; Waguespack, Y; Figliozzi, RW; Kharel, MK; Zhang, QJ; Martin-Caraballo, M; Hsia, SV				Rochford, Kevin; Chen, Feng; Waguespack, Yan; Figliozzi, Robert W.; Kharel, Madan K.; Zhang, Qiaojuan; Martin-Caraballo, Miguel; Hsia, S. Victor			Volatile Organic Compound Gamma-Butyrolactone Released upon Herpes Simplex Virus Type-1 Acute Infection Modulated Membrane Potential and Repressed Viral Infection in Human Neuron-Like Cells	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; HYDROXYBUTYRIC ACID; NEUROENDOCRINE DIFFERENTIATION; AMINOBUTYRIC-ACID; CHANNEL ACTIVITY; LNCAP CELLS; IN-VITRO; REPLICATION; METABOLISM; EXPRESSION	Herpes Simplex Virus Type-1 (HSV-1) infections can cause serious complications such as keratitis and encephalitis. The goal of this study was to identify any changes in the concentrations of volatile organic compounds (VOCs) produced during HSV-1 infection of epithelial cells that could potentially be used as an indicator of a response to stress. An additional objective was to study if any VOCs released from acute epithelial infection may influence subsequent neuronal infection to facilitate latency. To investigate these hypotheses, Vero cells were infected with HSV-1 and the emission of VOCs was analyzed using two-dimensional gas chromatograph/mass spectrometry (2D GC/MS). It was observed that the concentrations of gamma-butyrolactone (GBL) in particular changed significantly after a 24-hour infection. Since HSV-1 may establish latency in neurons after the acute infection, GBL was tested to determine if it exerts neuronal regulation of infection. The results indicated that GBL altered the resting membrane potential of differentiated LNCaP cells and promoted a non-permissive state of HSV-1 infection by repressing viral replication. These observations may provide useful clues towards understanding the complex signaling pathways that occur during the HSV-1 primary infection and establishment of viral latency.	[Rochford, Kevin; Chen, Feng; Figliozzi, Robert W.; Kharel, Madan K.; Zhang, Qiaojuan; Martin-Caraballo, Miguel; Hsia, S. Victor] Univ Maryland, Sch Pharm & Hlth Profess, Dept Pharmaceut Sci, Princess Anne, MD 21853 USA; [Rochford, Kevin; Waguespack, Yan; Figliozzi, Robert W.] Univ Maryland, Sch Agr & Nat Sci, Dept Nat Sci, Princess Anne, MD 21853 USA	University System of Maryland; University of Maryland Eastern Shore; University System of Maryland; University of Maryland Eastern Shore	Hsia, SV (corresponding author), Univ Maryland, Sch Pharm & Hlth Profess, Dept Pharmaceut Sci, Princess Anne, MD 21853 USA.	vhsia@umes.edu		Hsia, Victor/0000-0001-7623-2842	NINDS/NIH [R01NS081109]; NIH [R01NS081109]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081109] Funding Source: NIH RePORTER	NINDS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This project is in part supported by R01NS081109 to SVH from NINDS/NIH and the content is solely the responsibility of the authors and does not necessarily represent the official views of the NINDS/NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful for the support in part from NIH grant R01NS081109 to SVH. We thank Dr. Peter Wang from the University of Maryland Eastern Shore for his assistance in statistical analyses. The authors appreciate the editorial assistance from UMES staff.	Aghi MK, 2009, MOL THER, V17, P51, DOI 10.1038/mt.2008.232; [Anonymous], 2016, J NEUROVIROL; [Anonymous], 2016, VIROL SIN; Berard AR, 2015, J PROTEOME RES, V14, P2121, DOI 10.1021/pr5012284; Biarnes-Carrera M, 2015, CURR OPIN CHEM BIOL, V28, P91, DOI 10.1016/j.cbpa.2015.06.024; Biswas A, 2014, J PHYS CHEM B, V118, P10035, DOI 10.1021/jp503589h; Bony G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2820; Dahlen J, 2011, FORENSIC SCI INT, V210, P247, DOI 10.1016/j.forsciint.2011.03.016; Derouiche S, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-54; Dizeyi N, 2011, UROL ONCOL-SEMIN ORI, V29, P436, DOI 10.1016/j.urolonc.2009.09.013; Dodson AW, 2007, VIROLOGY, V366, P340, DOI 10.1016/j.virol.2007.05.001; Du YL, 2011, APPL ENVIRON MICROB, V77, P8415, DOI 10.1128/AEM.05898-11; Figliozzi RW, 2014, J NEUROL SCI, V346, P164, DOI 10.1016/j.jns.2014.08.017; Foster TP, 1998, J VIROL METHODS, V75, P151, DOI 10.1016/S0166-0934(98)00107-4; Friedman GK, 2012, TRANSL ONCOL, V5, P200, DOI 10.1593/tlo.12115; HOLLAND KD, 1995, MOL PHARMACOL, V47, P1217; Hsia SC, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-24; Knipe D.M.H., 2013, PETER FIELDS VIROLOG, V6th; Laniado ME, 2001, PROSTATE, V46, P262, DOI 10.1002/1097-0045(20010301)46:4<262::AID-PROS1032>3.0.CO;2-F; Laviv T, 2011, J NEUROSCI, V31, P12523, DOI 10.1523/JNEUROSCI.1527-11.2011; Moritz T, 2016, TUMOUR BIOL; Munshi T, 2013, DRUG TEST ANAL, V5, P678, DOI 10.1002/dta.1438; Murmu MS, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-105; Ottani A, 2003, BRAIN RES, V986, P181, DOI 10.1016/S0006-8993(03)03252-9; Pawliszyn J, 2000, J CHROMATOGR SCI, V38, P270, DOI 10.1093/chromsci/38.7.270; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; SCHOLZ D, 1983, HEPATO-GASTROENTEROL, V30, P102; Scorey N, 2006, PROSTATE CANCER P D, V9, P399, DOI 10.1038/sj.pcan.4500894; Skryma RN, 1997, PROSTATE, V33, P112, DOI 10.1002/(SICI)1097-0045(19971001)33:2<112::AID-PROS5>3.0.CO;2-M; SNEAD OC, 1989, BIOCHEM PHARMACOL, V38, P4375, DOI 10.1016/0006-2952(89)90645-X; Wang L, 2003, MICROBIOL-SGM, V149, P1991, DOI 10.1099/mic.0.26209-0; Watson S, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-130; Weaver EM, 2015, EUR J PHARMACOL, V749, P20, DOI 10.1016/j.ejphar.2014.12.021; Yuan TC, 2006, ENDOCR-RELAT CANCER, V13, P151, DOI 10.1677/erc.1.01043; Zhang CX, 2005, J NEUROVIROL, V11, P256, DOI 10.1080/13550280590952781; Zhu YZ, 2014, PROSTATE, V74, P1086, DOI 10.1002/pros.22819	37	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161119	10.1371/journal.pone.0161119	http://dx.doi.org/10.1371/journal.pone.0161119			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537375	gold, Green Submitted, Green Published			2022-12-26	WOS:000381577000056
J	Sasaki, T; Hashimoto, K; Oda, Y; Ishima, T; Yakita, M; Kurata, T; Kunou, M; Takahashi, J; Kamata, Y; Kimura, A; Niitsu, T; Komatsu, H; Hasegawa, T; Shiina, A; Hashimoto, T; Kanahara, N; Shimizu, E; Iyo, M				Sasaki, Tsuyoshi; Hashimoto, Kenji; Oda, Yasunori; Ishima, Tamaki; Yakita, Madoka; Kurata, Tsutomu; Kunou, Masaru; Takahashi, Jumpei; Kamata, Yu; Kimura, Atsushi; Niitsu, Tomihisa; Komatsu, Hideki; Hasegawa, Tadashi; Shiina, Akihiro; Hashimoto, Tasuku; Kanahara, Nobuhisa; Shimizu, Eiji; Iyo, Masaomi			Increased Serum Levels of Oxytocin in 'Treatment Resistant Depression in Adolescents (TRDIA)' Group	PLOS ONE			English	Article							BIPOLAR DISORDER; RATING-SCALE; VALIDITY; OUTCOMES; CHILDREN; TORDIA; RELIABILITY; VASOPRESSIN; BEHAVIOR	Objective 'Treatment-resistant depression' is depression that does not respond to an adequate regimen of evidence-based treatment. Treatment-resistant depression frequently becomes chronic. Children with treatment-resistant depression might also develop bipolar disorder (BD). The objective of this study was to determine whether serum levels of oxytocin (OXT) in treatment-resistant depression in adolescents (TRDIA) differ from non-treatment-resistant depression in adolescents (non-TRDIA) or controls. We also investigated the relationships between serum OXT levels and the clinical symptoms, severity, and familial histories of adolescent depressive patients. Methods We measured serum OXT levels: TRDIA (n = 10), non-TRDIA (n = 27), and age-and sex-matched, neurotypical controls (n = 25). Patients were evaluated using the Children's Depression Rating Scale-Revised (CDRS-R) and the Depression Self-Rating Scale for Children-Japanese Version (DSRS-C-J). The patients were also assessed retrospectively using the following variables: familial history of major depressive disorder and BD (1st degree or 2nd degree), history of disruptive mood dysregulation disorder, recurrent depressive disorder (RDD), history of antidepressant activation. Results Serum levels of OXT among the TRDIA and non-TRDIA patients and controls differed significantly. Interestingly, the rates of a family history of BD (1st or 2nd degree), RDD and a history of antidepressant activation in our TRDIA group were significantly higher than those of the non-TRDIA group. Conclusions Serum levels of OXT may play a role in the pathophysiology of TRDIA.	[Sasaki, Tsuyoshi; Yakita, Madoka; Kurata, Tsutomu; Kunou, Masaru; Takahashi, Jumpei; Iyo, Masaomi] Chiba Univ Hosp, Dept Child Psychiat, Chiba, Japan; [Sasaki, Tsuyoshi; Oda, Yasunori; Kamata, Yu; Kimura, Atsushi; Niitsu, Tomihisa; Komatsu, Hideki; Hasegawa, Tadashi; Shiina, Akihiro; Hashimoto, Tasuku; Iyo, Masaomi] Chiba Univ, Grad Sch Med, Dept Psychiat, Chiba, Japan; [Hashimoto, Kenji; Ishima, Tamaki; Iyo, Masaomi] Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba, Japan; [Kanahara, Nobuhisa; Iyo, Masaomi] Chiba Univ, Ctr Forens Mental Hlth, Div Med Treatment & Rehabil, Chiba, Japan; [Kunou, Masaru; Shimizu, Eiji] Chiba Univ, Grad Sch Med, Dept Cognit Behav Physiol, Chiba, Japan	Chiba University; Chiba University; Chiba University; Chiba University; Chiba University	Sasaki, T (corresponding author), Chiba Univ Hosp, Dept Child Psychiat, Chiba, Japan.; Sasaki, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Psychiat, Chiba, Japan.	sasaki@faculty.chiba-u.jp	Shimizu, Eiji/K-4637-2017; Hashimoto, Kenji/I-5800-2015	Shimizu, Eiji/0000-0002-6741-9338; Hashimoto, Kenji/0000-0002-8892-0439; KUNO, Masaru/0000-0002-4153-280X; Sasaki, Tsuyoshi/0000-0001-8502-6469	Health Labour Sciences Research Grant [KAKENHI 201419072A]; Astellas; Dainippon Sumitomo; Eli Lilly; Janssen; Mochida; Otsuka; Shionogi; Taisho; Yoshitomi; Novartis; Abbvie; Ministry of Health, Labour and Welfare; Non-Profit Organization of dependence research; General Association for Justice; Sumitomo Dainippon Phama; Chiba-ken Bengoshi-kai (Chiba Lawyers Association); Chugai; Pfizer; Daiichi-Sankyo; Eizai; Glaxosmithkline; MSD; Takeda; Asahi Kasei; Sanofi	Health Labour Sciences Research Grant(Ministry of Health, Labour and Welfare, Japan); Astellas(Astellas Pharmaceuticals); Dainippon Sumitomo(Dainippon Sumitomo Pharma Co., Ltd.); Eli Lilly(Eli Lilly); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Mochida; Otsuka(Otsuka Pharmaceutical); Shionogi; Taisho; Yoshitomi(Mitsubishi Tanabe Pharma Corporation); Novartis(Novartis); Abbvie(AbbVie); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Non-Profit Organization of dependence research; General Association for Justice; Sumitomo Dainippon Phama; Chiba-ken Bengoshi-kai (Chiba Lawyers Association); Chugai; Pfizer(Pfizer); Daiichi-Sankyo(Daiichi Sankyo Company Limited); Eizai; Glaxosmithkline(GlaxoSmithKline); MSD; Takeda(Takeda Pharmaceutical Company Ltd); Asahi Kasei(Asahi Kasei Corporation); Sanofi	This study was supported in part by a Health Labour Sciences Research Grant [KAKENHI 201419072A] (https://mhlw-grants.niph.go.jp/niph/search/NIDD00.do?resrchNum=201419072A). TS has received research support or speakers' honoraria from Astellas, Dainippon Sumitomo, Eli Lilly, Janssen, Mochida, Otsuka, Shionogi, Taisho, and Yoshitomi and he has also received research support from Novartis, Otsuka, and Taisho. KH has served as a scientific consultant to Taisho, and he has also received research support from Abbvie, Dainippon Sumitomo, Mochida, Otsuka, and Taisho. TK has received speakers' honoraria from Astellas, Eli Lilly, Janssen, Takeda, and Otsuka. MK has received speakers' honoraria from Eli Lilly. YK has received speakers' honoraria from Dainippon Sumitomo and Otsuka. TN has received honoraria from Eli Lilly and Dainippon Sumitomo. HK has received research support or speakers' honoraria from Dainippon Sumitomo, Eli Lilly, and Novartis. T. Hasegawa has received speakers' honoraria from Astellas, Dainippon Sumitomo, Eli Lilly, Mochida, Otsuka, and Shionogi. AS has received research support from Ministry of Health, Labour and Welfare, Non-Profit Organization of dependence research and General Association for Justice, a lecture fee from Sumitomo Dainippon Phama and Chiba-ken Bengoshi-kai (Chiba Lawyers Association). T. Hashimoto has received honoraria as speaker/consultant from Astellas, Glaxosmithkline, Meiji Seika, Mochida, Otsuka, Tanabe Mitsubishi, Yoshitomiyakuhin, and received research/grant support from Astellas, Chugai, Otsuka, Pfizer, and Shionogi. NK has received honoraria from Eli Lilly, Janssen, and Otsuka. ES has received speaking honoraria from MSD, Meiji Seika, Mochida, Eli Lilly, Janssen, and Yoshitomi. MI has received research support and honoraria from Astellas, Daiichi-Sankyo, Dainippon Sumitomo, Eizai, Glaxosmithkline, Janssen, Mochida, MSD, Novartis, Otsuka, Takeda, and Yoshitomi, and received research support from Asahi Kasei, Pfizer, Sanofi, Shionogi, Taisho, and received honoraria from Chugai-Nissin Pharmaceutical, Eli Lilly, Hisamitsu, Kyowa-Hakko Kirin, Meiji, Ono, and Tsumura. YO, TI, MY, JT, and AK, report no biomedical financial interests or potential conflicts of interest. The funders along with any other relevant declarations relating to employment, consultancy, patents, products in development, marketed products had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	American Psychiatric Association, 2013, DIAGNOSTIC AND STATI; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; [Anonymous], 2011, OPEN CLIN CHEM J, DOI DOI 10.2174/1874241601104010028; BIRLESON P, 1981, J CHILD PSYCHOL PSYC, V22, P73, DOI 10.1111/j.1469-7610.1981.tb00533.x; Birmaher B, 2007, J AM ACAD CHILD PSY, V46, P1503, DOI 10.1097/chi.0b013e318145ae1c; Brent D., TREATMENT RESISTANT; Brent DA, 2009, J CHILD PSYCHOL PSYC, V50, P143, DOI 10.1111/j.1469-7610.2008.02037.x; Emslie GJ, 2010, AM J PSYCHIAT, V167, P782, DOI 10.1176/appi.ajp.2010.09040552; Green LA, 2001, BIOL PSYCHIAT, V50, P609, DOI 10.1016/S0006-3223(01)01139-8; Kennard BD, 2009, J AM ACAD CHILD PSY, V48, P186, DOI 10.1097/CHI.0b013e31819176f9; Lee HJ, 2009, PROG NEUROBIOL, V88, P127, DOI 10.1016/j.pneurobio.2009.04.001; Maalouf FT, 2012, J AFFECT DISORDERS, V138, P86, DOI 10.1016/j.jad.2011.12.021; MacDonald K, 2012, ACTA NEUROPSYCHIATR, V24, P130, DOI 10.1111/j.1601-5215.2011.00634.x; March J, 2004, JAMA-J AM MED ASSOC, V292, P807; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Modahl C, 1998, BIOL PSYCHIAT, V43, P270, DOI 10.1016/S0006-3223(97)00439-3; Murata T., 1996, SAISHIN SEISHIN IGAK, V1, P131; Pitchot W, 2008, J PSYCHIATR RES, V42, P684, DOI 10.1016/j.jpsychires.2007.07.007; POZNANSKI EO, 1984, J AM ACAD CHILD PSY, V23, P191, DOI 10.1097/00004583-198403000-00011; Reid JM, 2010, CHILD YOUTH CARE FOR, V39, P113, DOI 10.1007/s10566-010-9095-5; Sakolsky DJ, 2011, J CLIN PSYCHOPHARM, V31, P92, DOI 10.1097/JCP.0b013e318204b117; Sasaki T, 2015, PSYCHIAT RES, V228, P746, DOI 10.1016/j.psychres.2015.05.029; Sheehan DV, 2010, J CLIN PSYCHIAT, V71, P313, DOI 10.4088/JCP.09m05305whi; Smith Donald F, 2013, Front Psychiatry, V4, P57, DOI 10.3389/fpsyt.2013.00057; Stavropoulos KKM, 2013, J CHILD PSYCHOL PSYC, V54, P603, DOI 10.1111/jcpp.12061; Striepens N, 2011, FRONT NEUROENDOCRIN, V32, P426, DOI 10.1016/j.yfrne.2011.07.001; Turan T, 2013, PSYCHONEUROENDOCRINO, V38, P2890, DOI 10.1016/j.psyneuen.2013.07.017; World Health Organization, ICD 10 CLASS MENT BE; Yamasue H, 2012, J NEUROSCI, V32, P14109, DOI 10.1523/JNEUROSCI.3327-12.2012; Youngstrom EA, 2012, ISR J PSYCHIATR REL, V49, P15	30	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0160767	10.1371/journal.pone.0160767	http://dx.doi.org/10.1371/journal.pone.0160767			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT6ES	27536785	Green Published, Green Submitted, gold			2022-12-26	WOS:000381577000030
J	Sozanski, K; Wisniewska, A; Kalwarczyk, T; Sznajder, A; Holyst, R				Sozanski, Krzysztof; Wisniewska, Agnieszka; Kalwarczyk, Tomasz; Sznajder, Anna; Holyst, Robert			Motion of Molecular Probes and Viscosity Scaling in Polyelectrolyte Solutions at Physiological Ionic Strength	PLOS ONE			English	Article							POLYMER-SOLUTIONS; COMPLEX LIQUIDS; DIFFUSION; MOBILITY; DYNAMICS; MACROMOLECULES; CYTOPLASM; CHAIN; VISCOELASTICITY; NANOPARTICLES	We investigate transport properties of model polyelectrolyte systems at physiological ionic strength (0.154 M). Covering a broad range of flow length scales-from diffusion of molecular probes to macroscopic viscous flow-we establish a single, continuous function describing the scale dependent viscosity of high-salt polyelectrolyte solutions. The data are consistent with the model developed previously for electrically neutral polymers in a good solvent. The presented approach merges the power-law scaling concepts of de Gennes with the idea of exponential length scale dependence of effective viscosity in complex liquids. The result is a simple and applicable description of transport properties of high-salt polyelectrolyte solutions at all length scales, valid for motion of single molecules as well as macroscopic flow of the complex liquid.	[Sozanski, Krzysztof; Wisniewska, Agnieszka; Kalwarczyk, Tomasz; Sznajder, Anna; Holyst, Robert] Polish Acad Sci, Inst Phys Chem, Kasprzaka 44-52, PL-01224 Warsaw, Poland	Polish Academy of Sciences; Institute of Physical Chemistry of the Polish Academy of Sciences	Holyst, R (corresponding author), Polish Acad Sci, Inst Phys Chem, Kasprzaka 44-52, PL-01224 Warsaw, Poland.	rholyst@ichf.edu.pl	Kalwarczyk, Tomasz/V-5262-2018; Wiśniewska, Agnieszka/HCI-1785-2022	Kalwarczyk, Tomasz/0000-0003-1136-9789; Wiśniewska, Agnieszka/0000-0001-5317-757X; Holyst, Robert/0000-0002-3211-4286; Sozanski, Krzysztof/0000-0002-4514-3836	National Science Centre [2011/02/A/ST3/00143]	National Science Centre(National Science Centre, Poland)	The authors acknowledge the National Science Centre (https://www.ncn.gov.pl/) for funding the project from the funds granted on the basis of the decision number 2011/02/A/ST3/00143 (Maestro grant).	Amsden B, 2002, POLYMER, V43, P1623, DOI 10.1016/S0032-3861(01)00749-2; Bielejewska A, 2010, ANAL CHEM, V82, P5463, DOI 10.1021/ac1008207; Boris DC, 1998, MACROMOLECULES, V31, P5746, DOI 10.1021/ma971884i; Cai LH, 2011, MACROMOLECULES, V44, P7853, DOI 10.1021/ma201583q; Carrillo JMY, 2010, J PHYS CHEM B, V114, P9391, DOI 10.1021/jp101978k; COHEN J, 1988, J CHEM PHYS, V88, P7111, DOI 10.1063/1.454361; Colby RH, 2010, RHEOL ACTA, V49, P425, DOI 10.1007/s00397-009-0413-5; COLBY RH, 1991, MACROMOLECULES, V24, P3873, DOI 10.1021/ma00013a021; COOPER EC, 1991, POLYMER, V32, P2815, DOI 10.1016/0032-3861(91)90114-X; CUKIER RI, 1984, MACROMOLECULES, V17, P252, DOI 10.1021/ma00132a023; de Gennes PG, 1979, SCALING CONCEPTS IN; de Kort DW, 2015, MACROMOLECULES, V48, P7585, DOI 10.1021/acs.macromol.5b01530; DEGENNES PG, 1976, J PHYS-PARIS, V37, P1461, DOI 10.1051/jphys:0197600370120146100; Dobrynin AV, 2005, PROG POLYM SCI, V30, P1049, DOI 10.1016/j.progpolymsci.2005.07.006; DOBRYNIN AV, 1995, MACROMOLECULES, V28, P1859, DOI 10.1021/ma00110a021; Doi M, 1986, THE THEORY OF POLYME; Dou SC, 2006, J POLYM SCI POL PHYS, V44, P2001, DOI 10.1002/polb.20853; Elowitz MB, 1999, J BACTERIOL, V181, P197, DOI 10.1128/JB.181.1.197-203.1999; Gelbart WM, 2000, PHYS TODAY, V53, P38, DOI 10.1063/1.1325230; Heo Y, 2005, J RHEOL, V49, P1117, DOI 10.1122/1.1993595; Holyst R, 2009, PHYS CHEM CHEM PHYS, V11, P9025, DOI 10.1039/b908386c; Izzo D, 2014, SOFT MATTER, V10, P1714, DOI 10.1039/c3sm52630e; Janmey PA, 2014, SOFT MATTER, V10, P1439, DOI 10.1039/c3sm50854d; Jonsson B, 2003, LANGMUIR, V19, P9914, DOI 10.1021/la034850e; Kalwarczyk T, 2014, NANOSCALE, V6, P10340, DOI 10.1039/c4nr00647j; Kalwarczyk T, 2015, ADV COLLOID INTERFAC, V223, P55, DOI 10.1016/j.cis.2015.06.007; Kalwarczyk T, 2011, NANO LETT, V11, P2157, DOI 10.1021/nl2008218; Khorasani FB, 2014, MACROMOLECULES, V47, P5328, DOI 10.1021/ma501248u; KIRKWOOD JG, 1948, J CHEM PHYS, V16, P565, DOI 10.1063/1.1746947; Konop AJ, 1999, MACROMOLECULES, V32, P2803, DOI 10.1021/ma9818174; Lakowicz JR, 2007, PRINCIPLES OF FLUORE; LANGEVIN D, 1978, POLYMER, V19, P875, DOI 10.1016/0032-3861(78)90191-X; Liu J, 2008, J PHYS CHEM C, V112, P6653, DOI 10.1021/jp800474t; Lukacs GL, 2000, J BIOL CHEM, V275, P1625, DOI 10.1074/jbc.275.3.1625; Majcher A, 2015, ANAL CHIM ACTA, V855, P51, DOI 10.1016/j.aca.2014.12.008; MANNING GS, 1969, J CHEM PHYS, V51, P924, DOI 10.1063/1.1672157; Miyazaki K, 2004, J CHEM PHYS, V121, P8120, DOI 10.1063/1.1797193; Moulay S, 2006, J APPL POLYM SCI, V100, P954, DOI 10.1002/app.23002; Nishida K, 2002, POLYMER, V43, P1295, DOI 10.1016/S0032-3861(01)00682-6; Nystrom B, 1982, PROG POLYM SCI, V8, P333, DOI [10.1016/0079-6700(82)90003-X, DOI 10.1016/0079-6700(82)90003-X]; ODIJK T, 1979, MACROMOLECULES, V12, P688, DOI 10.1021/ma60070a028; Odijk T, 2000, BIOPHYS J, V79, P2314, DOI 10.1016/S0006-3495(00)76477-0; Pecora R, 2005, MACROMOL SYMP, V229, P18, DOI 10.1002/masy.200551103; PHILLIES GDJ, 1987, MACROMOLECULES, V20, P2280, DOI 10.1021/ma00175a037; PHILLIES GDJ, 1985, J CHEM PHYS, V82, P5242, DOI 10.1063/1.448969; PHILLIES GDJ, 1992, MACROMOLECULES, V25, P4948, DOI 10.1021/ma00045a021; PHILLIES GDJ, 1989, MACROMOLECULES, V22, P4068, DOI 10.1021/ma00200a044; PHILLIES GDJ, 1986, MACROMOLECULES, V19, P2367, DOI 10.1021/ma00163a006; PHILLIES GDJ, 1988, MACROMOLECULES, V21, P214, DOI 10.1021/ma00179a041; PHILLIES GDJ, 1995, MACROMOLECULES, V28, P8198, DOI 10.1021/ma00128a033; RABIN Y, 1988, J POLYM SCI POL LETT, V26, P397, DOI 10.1002/pol.1988.140260904; Rapoport DH, 2007, J PHYS CHEM C, V111, P5726, DOI 10.1021/jp066735t; RUBINSTEIN M, 1994, PHYS REV LETT, V73, P2776, DOI 10.1103/PhysRevLett.73.2776; Rubinstein M, 2012, SOFT MATTER, V8, P9265, DOI 10.1039/c2sm90104h; Saenger W., 1984, PRINCILPES OF NUCLEI; SCHACHMAN HK, 1952, J AM CHEM SOC, V74, P3965, DOI 10.1021/ja01135a533; Sozanski K, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.228301; STONEMASUI J, 1968, J COLLOID INTERF SCI, V28, P187, DOI 10.1016/0021-9797(68)90120-3; Szymanski J, 2006, J PHYS CHEM B, V110, P25593, DOI 10.1021/jp0666784; TAKAHASHI Y, 1985, MACROMOLECULES, V18, P1002, DOI 10.1021/ma00147a033; Teraoka I., 2002, POLYMER SOLUTIONS AN; Tuteja A, 2007, NANO LETT, V7, P1276, DOI 10.1021/nl070192x; Uzum C, 2011, MACROMOLECULES, V44, P7782, DOI 10.1021/ma201466a; UTRACKI LA, 1981, J RHEOL, V25, P329, DOI 10.1122/1.549646; Weiller GF, 2004, PROTEOMICS, V4, P943, DOI 10.1002/pmic.200200648; Wisniewska A, 2014, POLYMER, V55, P4651, DOI 10.1016/j.polymer.2014.07.029; Wyart FB, 2000, EUR PHYS J E, V1, P93, DOI 10.1007/s101890050011; YING QC, 1987, MACROMOLECULES, V20, P362, DOI 10.1021/ma00168a023; Zustiak SP, 2011, BIOPHYS J, V101, P255, DOI 10.1016/j.bpj.2011.05.035	69	6	6	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161409	10.1371/journal.pone.0161409	http://dx.doi.org/10.1371/journal.pone.0161409			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536866	Green Submitted, gold, Green Published			2022-12-26	WOS:000381577000101
J	Staines, K; Batra, A; Mwangi, W; Maier, HJ; Van Borm, S; Young, JR; Fife, M; Butter, C				Staines, Karen; Batra, Ambalika; Mwangi, William; Maier, Helena J.; Van Borm, Steven; Young, John R.; Fife, Mark; Butter, Colin			A Versatile Panel of Reference Gene Assays for the Measurement of Chicken mRNA by Quantitative PCR	PLOS ONE			English	Article							RT-PCR; IDENTIFICATION; PUBLICATION; MODEL; MIQE	Quantitative real-time PCR assays are widely used for the quantification of mRNA within avian experimental samples. Multiple stably-expressed reference genes, selected for the lowest variation in representative samples, can be used to control random technical variation. Reference gene assays must be reliable, have high amplification specificity and efficiency, and not produce signals from contaminating DNA. Whilst recent research papers identify specific genes that are stable in particular tissues and experimental treatments, here we describe a panel of ten avian gene primer and probe sets that can be used to identify suitable reference genes in many experimental contexts. The panel was tested with TaqMan and SYBR Green systems in two experimental scenarios: a tissue collection and virus infection of cultured fibroblasts. GeNorm and NormFinder algorithms were able to select appropriate reference gene sets in each case. We show the effects of using the selected genes on the detection of statistically significant differences in expression. The results are compared with those obtained using 28s ribosomal RNA, the present most widely accepted reference gene in chicken work, identifying circumstances where its use might provide misleading results. Methods for eliminating DNA contamination of RNA reduced, but did not completely remove, detectable DNA. We therefore attached special importance to testing each qPCR assay for absence of signal using DNA template. The assays and analyses developed here provide a useful resource for selecting reference genes for investigations of avian biology.	[Staines, Karen; Batra, Ambalika; Mwangi, William; Maier, Helena J.; Young, John R.; Fife, Mark; Butter, Colin] Pirbright Inst, Pirbright, Surrey, England; [Van Borm, Steven] CODA CERVA Vet & Agrochem Res Ctr, Brussels, Belgium; [Staines, Karen; Butter, Colin] Lincoln Univ, Sch Life Sci, Joseph Banks Labs, Lincoln, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of Lincoln	Butter, C (corresponding author), Pirbright Inst, Pirbright, Surrey, England.; Butter, C (corresponding author), Lincoln Univ, Sch Life Sci, Joseph Banks Labs, Lincoln, England.	colin.butter@avianimmunology.org	Maier, Helena J/D-6517-2012	batra, ambalika/0000-0001-6798-6714	BBSRC (Biotechnology and Biological Sciences Research Council), Institute Strategic Programme Grant [BBS/E/I/00001423, BB/J016837/1]; BBSRC [BBS/E/I/00002535, BB/J016837/1, BBS/E/I/00001423, BBS/E/I/00001712, BBS/E/I/00001758, BB/L003996/1, BBS/E/I/00001707] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001712, BBS/E/I/00001707, BBS/E/I/00002535, BB/J016837/1, BBS/E/I/00001758, 1524044, BBS/E/I/00001423, BB/L003996/1] Funding Source: researchfish	BBSRC (Biotechnology and Biological Sciences Research Council), Institute Strategic Programme Grant; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the BBSRC (Biotechnology and Biological Sciences Research Council) under grant number BBS/E/I/00001423 as part of the Institute Strategic Programme Grant to the Avian Viral Diseases Programme at the Pirbright Institute (KAS, CB, MF, WM, JRY) and grant number BB/J016837/1 (MF, AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Boggy GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012355; Borowska D, 2016, VET IMMUNOL IMMUNOP, V170, P20, DOI 10.1016/j.vetimm.2016.01.001; Bustin SA, 2013, NAT METHODS, V10, P1063, DOI 10.1038/nmeth.2697; Bustin SA, 2010, METHODS, V50, P217, DOI 10.1016/j.ymeth.2009.12.006; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; De Boever S, 2008, VET IMMUNOL IMMUNOP, V122, P312, DOI 10.1016/j.vetimm.2007.12.002; Edmunds Richard C, 2014, J Biomol Tech, V25, P54, DOI 10.7171/jbt.14-2502-003; Fan WQ, 2012, BIOSCI BIOTECH BIOCH, V76, P2255, DOI 10.1271/bbb.120521; Khaperskyy DA, 2015, J VIROL, V89, P6528, DOI 10.1128/JVI.00386-15; Moody A, 2000, J VIROL METHODS, V85, P55, DOI 10.1016/S0166-0934(99)00156-1; Olias P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099678; Perkins JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-296; Reddy SK, 2008, DEV COMP IMMUNOL, V32, P1076, DOI 10.1016/j.dci.2008.02.004; Rutledge RG, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-96; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034	16	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0160173	10.1371/journal.pone.0160173	http://dx.doi.org/10.1371/journal.pone.0160173			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537060	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000381577000013
J	Franzini, PZN; Ramond, JB; Scholtz, CH; Sole, CL; Ronca, S; Cowan, DA				Franzini, Philippa Z. N.; Ramond, Jean-Baptiste; Scholtz, Clarke H.; Sole, Catherine L.; Ronca, Sandra; Cowan, Don A.			The Gut Microbiomes of Two Pachysoma MacLeay Desert Dung Beetle Species (Coleoptera: Scarabaeidae: Scarabaeinae) Feeding on Different Diets	PLOS ONE			English	Article							BACTERIAL COMMUNITY; RETICULITERMES-FLAVIPES; FUNCTIONAL-ANALYSIS; SYMBIOTIC BACTERIA; HIGHER TERMITES; DIVERSITY; HINDGUT; INSECTS; LARVAE; HOST	Micro-organisms inhabiting animal guts benefit from a protected and nutrient-rich environment while assisting the host with digestion and nutrition. In this study we compare, for the first time, the bacterial and fungal gut communities of two species of the small desert dung beetle genus Pachysoma feeding on different diets: the detritivorous P. endroedyi and the dry-dung-feeding P. striatum. Whole-gut microbial communities from 5 individuals of each species were assessed using 454 pyrosequencing of the bacterial 16S rRNA gene and fungal ITS gene regions. The two bacterial communities were significantly different, with only 3.7% of operational taxonomic units shared, and displayed intra-specific variation. The number of bacterial phyla present within the guts of P. endroedyi and P. striatum individuals ranged from 6-11 and 4-7, respectively. Fungal phylotypes could only be detected within the gut of P. striatum. Although the role of host phylogeny in Pachysoma microbiome assembly remains unknown, evidence presented in this study suggests that host diet may be a deterministic factor.	[Franzini, Philippa Z. N.; Ramond, Jean-Baptiste; Ronca, Sandra; Cowan, Don A.] Univ Pretoria, Dept Genet, Genom Res Inst, Ctr Microbial Ecol & Genom, Pretoria, South Africa; [Scholtz, Clarke H.; Sole, Catherine L.] Univ Pretoria, Dept Zool & Entomol, Scarab Res Grp, Pretoria, South Africa	University of Pretoria; University of Pretoria	Cowan, DA (corresponding author), Univ Pretoria, Dept Genet, Genom Res Inst, Ctr Microbial Ecol & Genom, Pretoria, South Africa.	don.cowan@up.ac.za	Sole, Catherine/AAB-3095-2020; Sole, Catherine L/A-9200-2012; Ramond, Jean-Baptiste/AAI-8087-2020; Cowan, Don/E-3991-2012	Sole, Catherine/0000-0002-1578-0973; Sole, Catherine L/0000-0002-1578-0973; Ramond, Jean-Baptiste/0000-0003-4790-6232; Cowan, Don/0000-0001-8059-861X				Ahn JH, 2012, J MICROBIOL, V50, P735, DOI 10.1007/s12275-012-2188-0; Anderson KE, 2012, MOL ECOL, V21, P2282, DOI 10.1111/j.1365-294X.2011.05464.x; Andert J, 2010, FEMS MICROBIOL ECOL, V74, P439, DOI 10.1111/j.1574-6941.2010.00950.x; Andongma AA, 2015, SCI REP-UK, V5, DOI 10.1038/srep09470; Arias-Cordero E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051557; Bell TH, 2014, ISME J, V8, P331, DOI 10.1038/ismej.2013.149; Bertino-Grimaldi D, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-609; Billiet A, 2015, INSECT SCI; Boissiere Anne, 2012, PLoS Pathog, V8, pe1002742, DOI 10.1371/journal.ppat.1002742; Boucias DG, 2013, MOL ECOL, V22, P1836, DOI 10.1111/mec.12230; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Broderick NA, 2012, GUT MICROBES, V3, P307, DOI 10.4161/gmic.19896; Brune A, 2000, CURR OPIN MICROBIOL, V3, P263, DOI 10.1016/S1369-5274(00)00087-4; Brune A., 2013, PROKARYOTES, P545; Calderon-Cortes N, 2012, ANNU REV ECOL EVOL S, V43, P45, DOI 10.1146/annurev-ecolsys-110411-160312; Calderon-Cortes N, 2010, INT J MOL SCI, V11, P5057, DOI 10.3390/ijms11125056; Chandler JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002272; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Colman DR, 2012, MOL ECOL, V21, P5124, DOI 10.1111/j.1365-294X.2012.05752.x; Coon KL, 2014, MOL ECOL, V23, P2727, DOI 10.1111/mec.12771; Correa VR, 2012, APPL ENVIRON MICROB, V78, P6327, DOI 10.1128/AEM.00892-12; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Dillon RJ, 2002, J APPL MICROBIOL, V92, P759, DOI 10.1046/j.1365-2672.2002.01581.x; Diouf M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140014; Douglas AE, 2009, FUNCT ECOL, V23, P38, DOI 10.1111/j.1365-2435.2008.01442.x; Douglas AE, 2015, ANNU REV ENTOMOL, V60, P17, DOI 10.1146/annurev-ento-010814-020822; Douglas AE, 2013, J CHEM ECOL, V39, P952, DOI 10.1007/s10886-013-0308-x; Douglas AE, 2011, CELL HOST MICROBE, V10, P359, DOI 10.1016/j.chom.2011.09.001; Engel P, 2013, FEMS MICROBIOL REV, V37, P699, DOI 10.1111/1574-6976.12025; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gibson CM, 2010, ECOL LETT, V13, P223, DOI 10.1111/j.1461-0248.2009.01416.x; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Hamdi C, 2011, J APPL ENTOMOL, V135, P524, DOI 10.1111/j.1439-0418.2010.01609.x; Harrison JDG, 2003, J NAT HIST, V37, P305, DOI 10.1080/713834683; He SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061126; Holter P, 2013, J MORPHOL, V274, P657, DOI 10.1002/jmor.20123; Holter P, 2011, J MORPHOL, V272, P1007, DOI 10.1002/jmor.10968; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Huang SW, 2010, INSECT SCI, V17, P175, DOI 10.1111/j.1744-7917.2010.01320.x; Huang XF, 2013, MICROB ECOL, V65, P531, DOI 10.1007/s00248-013-0219-y; Husseneder C, 2010, ENVIRON ENTOMOL, V39, P378, DOI 10.1603/EN09006; Ihrmark K, 2012, FEMS MICROBIOL ECOL, V82, P666, DOI 10.1111/j.1574-6941.2012.01437.x; Jones RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061218; Karasov WH, 2011, ANNU REV PHYSIOL, V73, P69, DOI 10.1146/annurev-physiol-012110-142152; KAUFMAN MG, 1991, COMP BIOCHEM PHYS A, V98, P117, DOI 10.1016/0300-9629(91)90588-4; Koch H, 2011, P NATL ACAD SCI USA, V108, P19288, DOI 10.1073/pnas.1110474108; Kohler T, 2012, APPL ENVIRON MICROB, V78, P4691, DOI 10.1128/AEM.00683-12; Lagisz M, 2010, INSECT SCI, V17, P465, DOI 10.1111/j.1744-7917.2010.01318.x; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Lim YW, 2010, J MICROBIOL, V48, P284, DOI 10.1007/s12275-010-9369-5; Loy A, 2007, NUCLEIC ACIDS RES, V35, pD800, DOI 10.1093/nar/gkl856; Meeus I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125152; Meriweather M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061465; Miyata R, 2007, BIOSCI BIOTECH BIOCH, V71, P1244, DOI 10.1271/bbb.60672; Montagna M, 2015, INSECT SCI, V22, P340, DOI 10.1111/1744-7917.12143; Montagna M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117439; Moran NA, 2015, CURR OPIN INSECT SCI, V10, P22, DOI 10.1016/j.cois.2015.04.003; Nardi JB, 2002, J INSECT PHYSIOL, V48, P751, DOI 10.1016/S0022-1910(02)00105-1; Nguyen NH, 2007, MYCOLOGIA, V99, P842, DOI 10.3852/mycologia.99.6.842; Nichols E, 2008, BIOL CONSERV, V141, P1461, DOI 10.1016/j.biocon.2008.04.011; Ohkuma M, 2003, APPL MICROBIOL BIOT, V61, P1, DOI 10.1007/s00253-002-1189-z; Osei-Poku J, 2012, MOL ECOL, V21, P5138, DOI 10.1111/j.1365-294X.2012.05759.x; Pandey N, 2016, INSECT SCI, V23, P704, DOI 10.1111/1744-7917.12220; Park DS, 2007, J MICROBIOL, V45, P394; Petti S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0078999, 10.1371/journal.pone.0073827]; Poulsen M, 2015, ENVIRON MICROBIOL, V17, P2562, DOI 10.1111/1462-2920.12765; Pramono AK, 2015, INT J SYST EVOL MICR, V65, P681, DOI 10.1099/ijs.0.070391-0; Priya NG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030768; Reid NM, 2011, APPL ENVIRON MICROB, V77, P7000, DOI 10.1128/AEM.05609-11; Sabree ZL, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-138; Santana RH, 2015, MICROB ECOL, V70, P545, DOI 10.1007/s00248-015-0581-z; Santo Domingo JW, 1998, MOL ECOL, V7, P761, DOI 10.1046/j.1365-294x.1998.00390.x; Schauer C, 2014, PYROTAG SEQUENCING G; Schauer C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085861; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SCHOLTZ CH, 1989, J ARID ENVIRON, V16, P305, DOI 10.1016/S0140-1963(18)30946-7; Shao MW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134542; Shi ZH, 2012, INT J MOL SCI, V13, P6266, DOI 10.3390/ijms13056266; Soininen EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115335; Sole CL, 2005, J BIOGEOGR, V32, P75, DOI 10.1111/j.1365-2699.2004.01124.x; Suh SO, 2005, MYCOL RES, V109, P261, DOI 10.1017/S0953756205002388; Suh SO, 2004, INT J SYST EVOL MICR, V54, P2409, DOI 10.1099/ijs.0.63246-0; Suh SO, 2008, FEMS YEAST RES, V8, P88, DOI 10.1111/j.1567-1364.2007.00320.x; Tagliavia M, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-136; Tsuchida T, 2010, SCIENCE, V330, P1102, DOI 10.1126/science.1195463; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vasanthakumar A, 2008, ENVIRON ENTOMOL, V37, P1344, DOI 10.1603/0046-225X(2008)37[1344:GMOAIS]2.0.CO;2; Waite DW, 2015, ARCH MICROBIOL, V197, P603, DOI 10.1007/s00203-015-1094-3; Wang AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106988; Wang SB, 2012, P NATL ACAD SCI USA, V109, P12734, DOI 10.1073/pnas.1204158109; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024767; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Wong ACN, 2013, ISME J, V7, P1922, DOI 10.1038/ismej.2013.86; Yang YJ, 2014, INT J SYST EVOL MICR, V64, P2956, DOI 10.1099/ijs.0.061739-0; Yun JH, 2014, APPL ENVIRON MICROB, V80, P5254, DOI 10.1128/AEM.01226-14; Zhang ML, 2014, MICROB ECOL, V68, P416, DOI 10.1007/s00248-014-0388-3; Zhang N, 2003, J INVERTEBR PATHOL, V84, P226, DOI 10.1016/j.jip.2003.10.002; Zouache K, 2012, MOL ECOL, V21, P2297, DOI 10.1111/j.1365-294X.2012.05526.x	100	26	28	4	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161118	10.1371/journal.pone.0161118	http://dx.doi.org/10.1371/journal.pone.0161118			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532606	Green Submitted, gold, Green Published			2022-12-26	WOS:000381487600060
J	Hoffmann, J; Thomassen, K; Stumpp, P; Grothoff, M; Engel, C; Kahn, T; Stepan, H				Hoffmann, Janine; Thomassen, Katrin; Stumpp, Patrick; Grothoff, Matthias; Engel, Christoph; Kahn, Thomas; Stepan, Holger			New MRI Criteria for Successful Vaginal Breech Delivery in Primiparae	PLOS ONE			English	Article							PLANNED CESAREAN-SECTION; TERM BREECH; PELVIMETRY; MANAGEMENT; TRIAL; BIRTH; NETHERLANDS; OUTCOMES; WOMEN; STILL	Background Even if lower vaginal delivery success rates and impaired neonatal short-term outcomes have been reported for primiparous women with breech presentation, vaginal breech delivery remains an option for carefully selected patients. Because Magnetic resonance imaging (MRI) pelvimetry can provide additional information on maternal pelvic morphology, we sought to identify new MRI parameters that predict successful vaginal breech delivery. Methods In this retrospective unicentre study, 240 primiparous women with breech presentation at term underwent MRI pelvimetry. For all patients vaginal delivery was planned, according to German guidelines and if the conjugata vera (CV) was >= 12 cm. The patients with uneventful vaginal deliveries and the patients who underwent a secondary caesarean section were compared according to pelvimetric parameters and outcomes. Regression analyses were performed. Results In the vaginal delivery group (n = 162, (67.5%)), the distance between the spinae ischiadicae (interspinous diameter, ISD) was significantly enlarged. The ISD significantly influenced the mode of delivery in the regression analyses. The CV did not significantly differ between the groups. The patients with successful vaginal deliveries were significantly younger than the patients who underwent caesarean section. In the receiver operating characteristic (ROC) analysis, the area under the curve (AUC) for ISD was 67.7% (p<0.001, 95% CI [0.303-0.642]) and was higher considering the mother's age (AUC = 73.1%, p<0.001, 95% CI [0.662-0.800]). The neonatal short-term outcomes were comparable in both groups. Conclusion The additional use of ISD may predict successful vaginal breech delivery and may be superior to the CV, which is more commonly used.	[Hoffmann, Janine; Thomassen, Katrin; Stepan, Holger] Univ Leipzig, Dept Obstet, Liebigstr 20a, D-04103 Leipzig, Germany; [Stumpp, Patrick; Kahn, Thomas] Univ Leipzig, Dept Radiol, Liebigstr 20, D-04103 Leipzig, Germany; [Grothoff, Matthias] Univ Leipzig, Ctr Heart, Dept Radiol, Struempellstr 39, D-04289 Leipzig, Germany; [Engel, Christoph] Univ Leipzig, Inst Med Informat Stat & Epidemiol, Haertelstr 16-18, D-04107 Leipzig, Germany	Leipzig University; Leipzig University; Heart Center Leipzig GMBH; Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Leipzig University	Hoffmann, J (corresponding author), Univ Leipzig, Dept Obstet, Liebigstr 20a, D-04103 Leipzig, Germany.	janine.hoffmann@medizin.uni-leipzig.de	Hoffmann, Janine/AAZ-1828-2020	Engel, Christoph/0000-0002-7247-282X				ACOG Committee on Obstetric Practice, 2006, Obstet Gynecol, V108, P235; Alarab M, 2004, OBSTET GYNECOL, V103, P407, DOI 10.1097/01.AOG.0000113625.29073.4c; Azria E, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.08.027; BERGER R, 1994, EUR J OBSTET GYN R B, V55, P97, DOI 10.1016/0028-2243(94)90061-2; BINGHAM P, 1987, OBSTET GYNECOL, V69, P965; Burgos J, 2015, J PERINATOL, V35, P803, DOI 10.1038/jp.2015.75; Burke G, 2006, BJOG-INT J OBSTET GY, V113, P969, DOI 10.1111/j.1471-0528.2006.00997.x; DIEHL J, 1968, ACTA OBSTET GYN SCAN, VS 47, P5, DOI 10.3109/00016346809156614; Diro M, 1999, AM J OBSTET GYNECOL, V181, P247, DOI 10.1016/S0002-9378(99)70543-0; Ghosh MK, 2005, J REPROD MED, V50, P108; Gilbert WM, 2003, OBSTET GYNECOL, V102, P911, DOI 10.1016/S0029-7844(03)00809-3; GIMOVSKY ML, 1994, J REPROD MED, V39, P489; Glezerman M, 2006, AM J OBSTET GYNECOL, V194, P20, DOI 10.1016/j.ajog.2005.08.039; Goffinet F, 2006, AM J OBSTET GYNECOL, V194, P1002, DOI 10.1016/j.ajog.2005.10.817; Hannah ME, 2004, AM J OBSTET GYNECOL, V191, P917, DOI 10.1016/j.ajog.2004.08.004; Hannah ME, 2000, LANCET, V356, P1375, DOI 10.1016/S0140-6736(00)02840-3; Huerta-Enochian GS, 2006, AM J OBSTET GYNECOL, V194, P1689, DOI 10.1016/j.ajog.2006.03.008; Impey LWM, 2006, MANAGEMENT BREECH PR; JOYCE DN, 1975, BMJ-BRIT MED J, V4, P505, DOI 10.1136/bmj.4.5995.505; Keller TM, 2003, RADIOLOGY, V227, P37, DOI 10.1148/radiol.2271011658; Korhonen U, 2010, EUR J RADIOL, V75, pE56, DOI 10.1016/j.ejrad.2009.11.018; MERZ E, 1988, ULTRASCHALL MED, V9, P15, DOI 10.1055/s-2007-1011588; Michel SCA, 2002, AM J ROENTGENOL, V179, DOI 10.2214/ajr.179.4.1791063; OLEARY JA, 1979, OBSTET GYNECOL, V53, P341; PFAMMATTER T, 1990, ROFO FORTSCHR RONTG, V153, P706, DOI 10.1055/s-2008-1033469; Reitter A, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.06.029; Rietberg CCT, 2005, BJOG-INT J OBSTET GY, V112, P205, DOI 10.1111/j.1471-0528.2004.00317.x; Sporri S, 2002, AM J ROENTGENOL, V179, P137; STARK DD, 1985, AM J ROENTGENOL, V144, P947, DOI 10.2214/ajr.144.5.947; van Loon AJ, 1997, LANCET, V350, P1799, DOI 10.1016/S0140-6736(97)05431-7; van Roosmalen J, 2014, LANCET, V383, P1863, DOI 10.1016/S0140-6736(14)60618-8; Vlemmix F, 2014, ACTA OBSTET GYN SCAN, V93, P888, DOI 10.1111/aogs.12449; WATSON WJ, 1984, OBSTET GYNECOL, V64, P638; WENTZ KU, 1994, GEBURTSH FRAUENHEILK, V54, P204, DOI 10.1055/s-2007-1023583; Whyte H, 2004, AM J OBSTET GYNECOL, V191, P864, DOI 10.1016/j.ajog.2004.06.056	35	12	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161028	10.1371/journal.pone.0161028	http://dx.doi.org/10.1371/journal.pone.0161028			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532122	gold, Green Submitted, Green Published			2022-12-26	WOS:000381487600055
J	Kim, M; Song, KH; Kim, CJ; Song, M; Choe, PG; Park, WB; Bang, JH; Hwang, H; Kim, ES; Park, SW; Kim, NJ; Oh, MD; Kim, HB				Kim, Moonsuk; Song, Kyoung-Ho; Kim, Chung-Jong; Song, Minkyo; Choe, Pyoeng Gyun; Park, Wan Beom; Bang, Ji Hwan; Hwang, Hee; Kim, Eu Suk; Park, Sang-Won; Kim, Nam Joong; Oh, Myoung-don; Kim, Hong Bin			Electronic Alerts with Automated Consultations Promote Appropriate Antimicrobial Prescriptions	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; STEWARDSHIP PROGRAMS; STAPHYLOCOCCUS-AUREUS; ANTIBIOTIC-THERAPY; IMPACT; BACTEREMIA; MORTALITY; TRIAL; INTERVENTION; SPECIALISTS	Background To promote appropriate antimicrobial use in bloodstream infections (BSIs), we initiated an intervention program consisting of electronic alerts and automated infectious diseases consultations in which the identification and antimicrobial susceptibility test (ID/AST) results were reported. Methods We compared the appropriateness of antimicrobial prescriptions and clinical outcomes in BSIs before and after initiation of the program. Appropriateness was assessed in terms of effective therapy, optimal therapy, de-escalation therapy, and intravenous to oral switch therapy. Results There were 648 BSI episodes in the pre-program period and 678 in the program period. The proportion of effective, optimal, and de-escalation therapies assessed 24 hours after the reporting of the ID/AST results increased from 87.8% (95% confidence interval [CI] 85.590.5), 64.4% (95% CI 60.8-68.1), and 10.0% (95% CI 7.5-12.6) in the pre-program period, respectively, to 94.4% (95% CI 92.7-96.1), 81.4% (95% CI 78.4-84.3), and 18.6% (95% CI 15.3-21.9) in the program period, respectively. Kaplan-Meier analyses and log-rank tests revealed that the time to effective (p<0.001), optimal (p<0.001), and de-escalation (p = 0.017) therapies were significantly different in the two periods. Segmented linear regression analysis showed the increase in the proportion of effective (p = 0.015), optimal (p<0.001), and de-escalation (p = 0.010) therapies at 24 hours after reporting, immediately after program initiation. No significant baseline trends or changes in trends were identified. There were no significant differences in time to intravenous to oral switch therapy, length of stay, and 30-day mortality rate. Conclusion This novel form of stewardship program based on intervention by infectious disease specialists and information technology improved antimicrobial prescriptions in BSIs.	[Kim, Moonsuk; Song, Kyoung-Ho; Kim, Chung-Jong; Kim, Eu Suk; Kim, Hong Bin] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam, South Korea; [Song, Kyoung-Ho; Choe, Pyoeng Gyun; Park, Wan Beom; Bang, Ji Hwan; Kim, Eu Suk; Park, Sang-Won; Kim, Nam Joong; Oh, Myoung-don; Kim, Hong Bin] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Song, Minkyo] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Hwang, Hee] Seoul Natl Univ, Bundang Hosp, Med Informat Ctr, Songnam, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Song, KH (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam, South Korea.; Song, KH (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	khsongmd@gmail.com	Park, Wan Beom/GLU-9886-2022; Park, Wan Beom/AGO-0374-2022; Song, Minkyo/AAE-9095-2020; Kim, Hong Bin/J-5452-2012	Park, Wan Beom/0000-0003-0022-9625; Song, Minkyo/0000-0002-9412-2871; Kim, Hong Bin/0000-0001-6262-372X; Song, Kyoung-Ho/0000-0002-4517-3840; Kim, Moonsuk/0000-0001-8640-939X				[Anonymous], 2015, HLTH GLANCE 2015; ARBO MDJ, 1994, ARCH INTERN MED, V154, P2641, DOI 10.1001/archinte.1994.00420230024004; Avdic E, 2014, INFECT DIS CLIN N AM, V28, P215, DOI 10.1016/j.idc.2014.01.002; Bauer KA, 2014, CLIN INFECT DIS, V59, pS134, DOI 10.1093/cid/ciu547; Bouza E, 2004, CLIN INFECT DIS, V39, P1161, DOI 10.1086/424520; Byl B, 1999, CLIN INFECT DIS, V29, P60, DOI 10.1086/520182; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Forrest GN, 2014, CLIN INFECT DIS, V59, pS122, DOI 10.1093/cid/ciu565; Friedman ND, 2002, ANN INTERN MED, V137, P791, DOI 10.7326/0003-4819-137-10-200211190-00007; Hamilton-Miller J. M. T., 1996, Clin Microbiol Infect, V2, P12, DOI 10.1111/j.1469-0691.1996.tb00194.x; Harbarth S, 1998, ARCH INTERN MED, V158, P182, DOI 10.1001/archinte.158.2.182; Harbarth S, 2003, AM J MED, V115, P529, DOI 10.1016/j.amjmed.2003.07.005; Jenkins TC, 2008, CLIN INFECT DIS, V46, P1000, DOI 10.1086/529190; Kullar R, 2014, INFECT DIS CLIN N AM, V28, P291, DOI 10.1016/j.idc.2014.01.009; Lesprit P, 2013, CLIN MICROBIOL INFEC, V19, pE91, DOI 10.1111/1469-0691.12062; McGregor JC, 2007, CLIN INFECT DIS, V45, P329, DOI 10.1086/519283; Paul M, 2010, ANTIMICROB AGENTS CH, V54, P4851, DOI 10.1128/AAC.00627-10; Pogue JM, 2014, INFECT CONT HOSP EP, V35, P132, DOI 10.1086/674849; Pollack LA, 2014, CLIN INFECT DIS, V59, pS97, DOI 10.1093/cid/ciu542; Pulcini C, 2014, CLIN MICROBIOL INFEC, V20, P963, DOI 10.1111/1469-0691.12751; Retamar P, 2012, ANTIMICROB AGENTS CH, V56, P472, DOI 10.1128/AAC.00462-11; RINTALA E, 1991, SCAND J INFECT DIS, V23, P341, DOI 10.3109/00365549109024321; Shardell M, 2007, CLIN INFECT DIS, V45, P901, DOI 10.1086/521255; Tissot F, 2014, J INFECTION, V69, P226, DOI 10.1016/j.jinf.2014.05.004	24	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160551	10.1371/journal.pone.0160551	http://dx.doi.org/10.1371/journal.pone.0160551			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532125	Green Published, gold			2022-12-26	WOS:000381487600035
J	Liu, M; Jing, HJ; Zhang, JJ; Che, G; Zhou, M; Gao, Z; Li, SS; Ren, ZZ; Hao, L; Liu, Y; Jia, L				Liu, Min; Jing, Huijuan; Zhang, Jianjun; Che, Gen; Zhou, Meng; Gao, Zheng; Li, Shangshang; Ren, Zhenzhen; Hao, Long; Liu, Yu; Jia, Le			Optimization of Mycelia Selenium Polysaccharide Extraction from Agrocybe cylindracea SL-02 and Assessment of their Antioxidant and Anti-Ageing Activities	PLOS ONE			English	Article							IN-VITRO; PLEUROTUS-OSTREATUS; D-GALACTOSE; MUSHROOMS; PURIFICATION; SENESCENCE; HEALTH; ZINC; RATS; MICE	The aim of the present study was to optimize the purification of mycelia selenium polysaccharides (MSPS) from Agrocybe cylindracea SL-02 and characterize their in vitro antioxidant and in vivo anti-ageing activities. The Box-Behnken experimental design (BBD) was evaluated, which showed that the optimum conditions included an extraction temperature of 94.99 degrees C, a pH of 9 and a precipitation temperature of 12 degrees C, and the predicted yield was 11.036 +/- 0.31%. The in vitro antioxidant assay demonstrated that MSPS had potential effects on scavenging and enhanced the reducing power of reactive oxygen species. The in vivo anti-ageing evaluation showed that MSPS significantly reduced the malonaldehyde (MDA) contents and total cholesterol (CHOL) levels, and remarkably improved the activities of superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), and total antioxidant capacity (T-AOC) in mice in response to D-galactose-induced ageing. Furthermore, the characteristic analysis of MSPS indicated a selenium content of 1.76 +/- 0.10 mg/g at a concentration of 6 mu g/mL in liquid media and a monosaccharide composition of rhamnose, arabinose, mannose, glucose and galactose at a molar ratio of 29:3:1:18.8:2.7. These results suggest that MSPS might be suitable for functional foods and natural drugs on preventing the ageing progress induced by toxic chemicals.	[Liu, Min; Liu, Yu] Beijing Acad Agr & Forestry Sci, Beijing Engn Res Ctr Edible Mushroom, Key Lab Urban Agr North, Inst Plant & Environm Protect,Minist Agr, Beijing, Peoples R China; [Liu, Min; Jing, Huijuan; Zhang, Jianjun; Gao, Zheng; Li, Shangshang; Ren, Zhenzhen; Hao, Long; Jia, Le] Shandong Agr Univ, Coll Life Sci, Tai An, Shandong, Peoples R China; [Che, Gen] Shandong Acad Agr Sci, Jinan, Peoples R China; [Zhou, Meng] Qual & Safety Monitoring Ctr Anim Prod, Jinan, Peoples R China	Beijing Academy of Agriculture & Forestry; Ministry of Agriculture & Rural Affairs; Shandong Agricultural University; Shandong Academy of Agricultural Sciences	Liu, Y (corresponding author), Beijing Acad Agr & Forestry Sci, Beijing Engn Res Ctr Edible Mushroom, Key Lab Urban Agr North, Inst Plant & Environm Protect,Minist Agr, Beijing, Peoples R China.; Jia, L (corresponding author), Shandong Agr Univ, Coll Life Sci, Tai An, Shandong, Peoples R China.	ly6828@sina.com; jiale0525@163.com			Mushroom Technology System of Shandong Province [SDAIT-07-05]	Mushroom Technology System of Shandong Province	This work was funded by Mushroom Technology System of Shandong Province (SDAIT-07-05), Le Jia, Presenter.	[Anonymous], 1994, CARBOHYDRATE ANAL PR; Balaban H, 2017, MOL NEUROBIOL, V54, P2852, DOI 10.1007/s12035-016-9835-0; Capek P, 2009, INT J BIOL MACROMOL, V44, P75, DOI 10.1016/j.ijbiomac.2008.10.007; da Silva MCS, 2012, FOOD CHEM, V131, P558, DOI 10.1016/j.foodchem.2011.09.023; Dong CH, 2008, LWT-FOOD SCI TECHNOL, V41, P669, DOI 10.1016/j.lwt.2007.05.002; Falandysz J, 2013, APPL MICROBIOL BIOT, V97, P477, DOI 10.1007/s00253-012-4552-8; Falandysz J, 2013, FOOD CHEM, V138, P242, DOI 10.1016/j.foodchem.2012.10.046; Farage MA, 2008, AGING CLIN EXP RES, V20, P195; Figlas D, 2010, J MED FOOD, V13, P469, DOI 10.1089/jmf.2008.0284; Gan D, 2011, CARBOHYD POLYM, V84, P997, DOI 10.1016/j.carbpol.2010.12.058; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hifney AF, 2016, FOOD HYDROCOLLOID, V54, P77, DOI 10.1016/j.foodhyd.2015.09.022; Hsieh HM, 2009, FOOD CHEM TOXICOL, V47, P625, DOI 10.1016/j.fct.2008.12.026; Huang SJ, 2006, LWT-FOOD SCI TECHNOL, V39, P379, DOI 10.1016/j.lwt.2005.02.012; Jain RB, 2015, J TRACE ELEM MED BIO, V30, P142, DOI 10.1016/j.jtemb.2014.12.004; Jayakumar T, 2011, FOOD RES INT, V44, P851, DOI 10.1016/j.foodres.2011.03.015; Johnson FB, 1999, CELL, V96, P291, DOI 10.1016/S0092-8674(00)80567-X; Kacurakova M, 2000, CARBOHYD POLYM, V43, P195, DOI 10.1016/S0144-8617(00)00151-X; Kim HO, 2005, BIORESOURCE TECHNOL, V96, P1175, DOI 10.1016/j.biortech.2004.09.021; Kumar A, 2011, J ASIAN NAT PROD RES, V13, P42, DOI 10.1080/10286020.2010.544253; Li B, 2013, CARBOHYD POLYM, V92, P1991, DOI 10.1016/j.carbpol.2012.11.088; Luo AX, 2010, CARBOHYD POLYM, V79, P1014, DOI 10.1016/j.carbpol.2009.10.033; Maseko T, 2013, FOOD CHEM, V141, P3681, DOI 10.1016/j.foodchem.2013.06.027; Naziroglu M, 2004, TOXICOLOGY, V195, P221, DOI 10.1016/j.tox.2003.10.012; NOHL H, 1993, BRIT MED BULL, V49, P653, DOI 10.1093/oxfordjournals.bmb.a072638; OYAIZU M, 1986, Japanese Journal of Nutrition, V44, P307; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Sheng JC, 2007, FOOD CHEM, V105, P533, DOI 10.1016/j.foodchem.2007.04.018; SMIRNOFF N, 1989, PHYTOCHEMISTRY, V28, P1057, DOI 10.1016/0031-9422(89)80182-7; Soares JR, 1997, FREE RADICAL RES, V26, P469, DOI 10.3109/10715769709084484; Sun T, 2005, FOOD CHEM, V90, P743, DOI 10.1016/j.foodchem.2004.04.035; Thomet U, 1999, EUR FOOD RES TECHNOL, V209, P317, DOI 10.1007/s002170050502; Tsai SY, 2007, LWT-FOOD SCI TECHNOL, V40, P1392, DOI 10.1016/j.lwt.2006.10.001; Tsai SY, 2006, FOOD CHEM, V98, P670, DOI 10.1016/j.foodchem.2005.07.003; Wu Z, 2015, INT J BIOL MACROMOL, V74, P224, DOI 10.1016/j.ijbiomac.2014.12.010; Xiao N, 2004, SHOCK, V21, P276; Ye CL, 2012, CARBOHYD POLYM, V89, P1131, DOI 10.1016/j.carbpol.2012.03.084; Ye M, 2012, FOOD CHEM, V132, P338, DOI 10.1016/j.foodchem.2011.10.087; You QH, 2014, CARBOHYD POLYM, V99, P1, DOI 10.1016/j.carbpol.2013.07.088; Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X; Zhang P, 2014, J BASIC MICROB, V54, P866, DOI 10.1002/jobm.201200757; Zheng L, 2015, J SCI FOOD AGR, V95, P3117, DOI 10.1002/jsfa.7048; Zhong WQ, 2013, INT J BIOL MACROMOL, V60, P355, DOI 10.1016/j.ijbiomac.2013.06.018; ZHOU YC, 1991, BIOCHEM PHARMACOL, V42, P1177	44	29	32	3	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160799	10.1371/journal.pone.0160799	http://dx.doi.org/10.1371/journal.pone.0160799			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532123	Green Published, gold, Green Submitted			2022-12-26	WOS:000381487600045
J	Matanda, DJ; Urke, HB; Mittelmark, MB				Matanda, Dennis Juma; Urke, Helga Bjornoy; Mittelmark, Maurice B.			Changes in Optimal Childcare Practices in Kenya: Insights from the 2003, 2008-9 and 2014 Demographic and Health Surveys	PLOS ONE			English	Article							ORAL REHYDRATION THERAPY; INFLUENZAE TYPE-B; NET USE; DEVELOPING-COUNTRIES; COVERAGE; URBAN; IMMUNIZATION; SERVICES; DIARRHEA; EQUITY	Objective(s) Using nationally representative surveys conducted in Kenya, this study examined optimal health promoting childcare practices in 2003, 2008-9 and 2014. This was undertaken in the context of continuous child health promotion activities conducted by government and non-government organizations throughout Kenya. It was the aim of such activities to increase the prevalence of health promoting childcare practices; to what extent have there been changes in optimal childcare practices in Kenya during the 11-year period under study? Methods Cross-sectional data were obtained from the Kenya Demographic and Health Surveys conducted in 2003, 2008-9 and 2014. Women 15-49 years old with children 0-59 months were interviewed about a range of childcare practices. Logistic regression analysis was used to examine changes in, and correlates of, optimal childcare practices using the 2003, 2008-9 and 2014 data. Samples of 5949, 6079 and 20964 women interviewed in 2003, 2008-9 and 2014 respectively were used in the analysis. Results Between 2003 and 2014, there were increases in all health facility-based childcare practices with major increases observed in seeking medical treatment for diarrhoea and complete child vaccination. Mixed results were observed in home-based care where increases were noted in the use of insecticide treated bed nets, sanitary stool disposal and use of oral rehydration solutions, while decreases were observed in the prevalence of urging more fluid/food during diarrhoea and consumption of a minimum acceptable diet. Logit models showed that area of residence (region), household wealth, maternal education, parity, mother's age, child's age and pregnancy history were significant determinants of optimal childcare practices across the three surveys. Conclusions The study observed variation in the uptake of the recommended optimal childcare practices in Kenya. National, regional and local child health promotion activities, coupled with changes in society and in living conditions between 2003 and 2014, could have influenced uptake of certain recommended childcare practices in Kenya. Decreases in the prevalence of children who were offered same/more fluid/food when they had diarrhea and children who consumed the minimum acceptable diet is alarming and perhaps a red flag to stakeholders who may have focused more on health facility-based care at the expense of homebased care. Concerted efforts are needed to address the consistent inequities in the uptake of the recommended childcare practices. Such efforts should be cognizant of the underlying factors that affect childcare in Kenya, herein defined as region, household wealth, maternal education, parity, mother's age, child's age and pregnancy history.	[Matanda, Dennis Juma] Populat Council, Nairobi, Kenya; [Matanda, Dennis Juma; Urke, Helga Bjornoy; Mittelmark, Maurice B.] Univ Bergen, Multicultural Venues Hlth Gender & Social Justice, Bergen, Norway; [Urke, Helga Bjornoy; Mittelmark, Maurice B.] Univ Bergen, Fac Psychol, Dept Hlth Promot & Dev, Bergen, Norway	University of Bergen; University of Bergen	Urke, HB (corresponding author), Univ Bergen, Multicultural Venues Hlth Gender & Social Justice, Bergen, Norway.; Urke, HB (corresponding author), Univ Bergen, Fac Psychol, Dept Hlth Promot & Dev, Bergen, Norway.	helga.urke@uib.no						Abou-Zahr CL, 2003, ANTENATAL CARE DEV C; Abuya BA, 2011, MATERN CHILD HLTH J, V15, P1389, DOI 10.1007/s10995-010-0670-z; Akumu AO, 2007, B WORLD HEALTH ORGAN, V85, P511, DOI 10.2471/BLT.06.034686; [Anonymous], 2015, ANN EVALUATION ABOLI; Arimond M, 2004, J NUTR, V134, P2579, DOI 10.1093/jn/134.10.2579; Baume CA, 2007, AM J TROP MED HYG, V77, P963, DOI 10.4269/ajtmh.2007.77.963; Bell A, 2013, SOC SCI MED, V93, P163, DOI 10.1016/j.socscimed.2013.04.029; Blum LS, 2011, AM J TROP MED HYG, V85, P1126, DOI 10.4269/ajtmh.2011.11-0171; Boerma J T, 1993, World Health Stat Q, V46, P222; Boerma JT, 2008, LANCET, V371, P1259, DOI 10.1016/S0140-6736(08)60560-7; Bwibo NO, 2003, J NUTR, V133, p3936S, DOI 10.1093/jn/133.11.3936S; Cho HY, 2007, J COMMUN, V57, P293, DOI 10.1111/j.1460-2466.2007.00344.x; Chuma J, 2013, FREE MATERNAL CARE R; Chuma J, 2007, TROP MED INT HEALTH, V12, P673, DOI 10.1111/j.1365-3156.2007.01825.x; Clarke PM, 2008, J HEALTH ECON, V27, P1275, DOI 10.1016/j.jhealeco.2008.05.012; Clasen TF, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007180.pub2; COUGHLIN SS, 1990, J CLIN EPIDEMIOL, V43, P87, DOI 10.1016/0895-4356(90)90060-3; Engle P.L., 1997, CARE NUTR CONCEPTS M; Engle PL, 1997, ENVIRON URBAN, V9, P253, DOI 10.1177/095624789700900213; Fotso JC, 2007, HEALTH PLACE, V13, P205, DOI 10.1016/j.healthplace.2006.01.004; Government of Kenya, 2011, RAPID QUALITATIVE AS; Graft-Johnson J, 2006, CONTINUUM CARE MATER; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Hawley WA, 2003, AM J TROP MED HYG, V68, P121, DOI 10.4269/ajtmh.2003.68.121; HILL Z, 2004, FAMILY COMMUNITY PRA; [ICF International KNBS], 2014, KEN DEM HLT SURV 201; Kenya national Bureau of statistics (KNBS) and ICF macro, 2010, KEN DEM HLTH SURV 20; Kenya National Bureau of Statistics; Ministry of Health; National AIDS Control Council; The DHS Program ICF International KDHS, 2003, KEN DEM HLTH SURV 20; Kerber KJ, 2007, LANCET, V370, P1358, DOI 10.1016/S0140-6736(07)61578-5; Kreps GL, 2015, J NATURE SCI, V1, P35; Magadi MA, 2000, SOC SCI MED, V51, P551, DOI 10.1016/S0277-9536(99)00495-5; Magadi MA, 2007, SOC SCI MED, V64, P1311, DOI 10.1016/j.socscimed.2006.11.004; Marston C, 2003, POP STUD-J DEMOG, V57, P77, DOI 10.1080/0032472032000061749; Masmalai A., 2010, Journal of Population and Social Studies, V19, P123; Matanda DJ, 2014, NUTR RES, V34, P507, DOI 10.1016/j.nutres.2014.05.004; Matanda DJ, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-5; Matanda DJ, 2015, CHILD PHYS GROWTH CA; Menon Purnima, 2000, Food and Nutrition Bulletin, V21, P282; Ministry of Health, 2001, NAT MAL STRAT 2001 2; Ministry of Planning and National Development, 2003, KEN EC REC STRAT WEA; Ministry of Public Health and Sanitation, 2010, POL GUID CONTR MAN D; Ministry of Public Health and Sanitation, 2007, NAT STRAT INF YOUNG; Moisi JC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-142; Munos MK, 2010, INT J EPIDEMIOL, V39, P75, DOI 10.1093/ije/dyq025; Ndiritu M, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-132; Noor AM, 2007, PLOS MED, V4, P1341, DOI 10.1371/journal.pmed.0040255; Noor AM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-5; Okeke TA, 2010, HEALTH POLICY, V95, P62, DOI 10.1016/j.healthpol.2009.11.005; Olson CK, 2011, AM J TROP MED HYG, V85, P1134, DOI 10.4269/ajtmh.2011.11-0178; Pagnini DL, 2000, FAM PLANN PERSPECT, V32, P56, DOI 10.2307/2648213; Rutstein S. O., 2004, DHS COMP REPORTS; Say L, 2007, B WORLD HEALTH ORGAN, V85, P812, DOI 10.2471/BLT.06.035659; Smith L.C., 2000, EXPLAINING CHILD MAL; Smith LC, 2005, WORLD DEV, V33, P1285, DOI 10.1016/j.worlddev.2005.03.002; Stephenson K, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-9; Taffa N, 2005, TROP MED INT HEALTH, V10, P240, DOI 10.1111/j.1365-3156.2004.01381.x; UNICEF, 2008, STAT WORLDS CHILDR 2, V9; Van de Poel E, 2007, SOC SCI MED, V65, P1986, DOI 10.1016/j.socscimed.2007.06.032; van Eijk Anna M, 2006, Reprod Health, V3, P2, DOI 10.1186/1742-4755-3-2; Vijayaraghavan M, 2007, HEALTH POLICY, V83, P27, DOI 10.1016/j.healthpol.2006.11.008; Wamae A, 2009, KENYA WORKING PAPERS; World Health Organization, 2010, IND ASS INF YOUNG CH; Yawn BP, 1998, J CLIN EPIDEMIOL, V51, P399, DOI 10.1016/S0895-4356(97)00304-1; Yeager BAC, 1999, SOC SCI MED, V49, P531, DOI 10.1016/S0277-9536(99)00119-7; Yesuf EA, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-131	66	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161221	10.1371/journal.pone.0161221	http://dx.doi.org/10.1371/journal.pone.0161221			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT4YN	27532665	Green Published, gold, Green Submitted			2022-12-26	WOS:000381487600078
J	Yasmin, S; Zaka, A; Imran, A; Zahid, MA; Yousaf, S; Rasul, G; Arif, M; Mirza, MS				Yasmin, Sumera; Zaka, Abha; Imran, Asma; Zahid, Muhammad Awais; Yousaf, Sumaira; Rasul, Ghulam; Arif, Muhammad; Mirza, Muhammad Sajjad			Plant Growth Promotion and Suppression of Bacterial Leaf Blight in Rice by Inoculated Bacteria	PLOS ONE			English	Article							SYSTEMIC RESISTANCE; XANTHOMONAS-ORYZAE; FLUORESCENT PSEUDOMONADS; BIOCONTROL AGENTS; INDUCTION; STRAIN; RHIZOBACTERIA; PEROXIDASE; RHIZOSPHERE; DIVERSITY	The present study was conducted to evaluate the potential of rice rhizosphere associated antagonistic bacteria for growth promotion and disease suppression of bacterial leaf blight (BLB). A total of 811 rhizospheric bacteria were isolated and screened against 3 prevalent strains of BLB pathogen Xanthomonas oryzae pv. oryzae (Xoo) of which five antagonistic bacteria, i.e., Pseudomonas spp. E227, E233, Rh323, Serratia sp. Rh269 and Bacillus sp. Rh219 showed antagonistic potential (zone of inhibition 1-19 mm). Production of siderophores was found to be the common biocontrol determinant and all the strains solubilized inorganic phosphate (82-116 mu g mL(-1)) and produced indole acetic acid (0.48-1.85 mg L-1) in vitro. All antagonistic bacteria were non-pathogenic to rice, and their co-inoculation significantly improved plant health in terms of reduced diseased leaf area (80%), improved shoot length (31%), root length (41%) and plant dry weight (60%) as compared to infected control plants. Furthermore, under pathogen pressure, bacterial inoculation resulted in increased activity of defense related enzymes including phenylalanine ammonia-lyase and polyphenol oxidase, along with 86% increase in peroxidase and 53% increase in catalase enzyme activities in plants inoculated with Pseudomonas sp. Rh323 as well as co-inoculated plants. Bacterial strains showed good colonization potential in the rice rhizosphere up to 21 days after seed inoculation. Application of bacterial consortia in the field resulted in an increase of 31% in grain yield and 10% in straw yield over non-inoculated plots. Although, yield increase was statistically non-significant but was accomplished with overall saving of 20% chemical fertilizers. The study showed that Pseudomonas sp. Rh323 can be used to develop dual-purpose inoculum which can serve not only to suppress BLB but also to promote plant growth in rice.	[Yasmin, Sumera; Zaka, Abha; Imran, Asma; Zahid, Muhammad Awais; Rasul, Ghulam; Arif, Muhammad; Mirza, Muhammad Sajjad] NIBGE, Faisalabad, Pakistan; [Zahid, Muhammad Awais] Univ Sargodha, Univ Coll Agr, Dept Plant Pathol, Sargodha, Pakistan; [Yousaf, Sumaira] NIAB, Faisalabad, Pakistan; [Zahid, Muhammad Awais] Univ Hohenheim, Inst Phytomed, Stuttgart, Germany	Pakistan Institute of Engineering & Applied Science; Bahauddin Zakariya University; University of Sargodha; Nuclear Institute for Agriculture & Biology - Pakistan; University Hohenheim	Yasmin, S (corresponding author), NIBGE, Faisalabad, Pakistan.	sumeraimran2012@gmail.com	Arif, Dr Muhammad/HGB-3451-2022	Zahid, Muhammad Awais/0000-0001-7065-5369; Yasmin, Sumera/0000-0002-9744-6257	grant of PSF	grant of PSF	The research work (few chemicals, sequencing charges) was only partially supported by the grant of PSF funded project. There was no additional external funding received for this study.	Adesemoye AO, 2009, MICROB ECOL, V58, P921, DOI 10.1007/s00248-009-9531-y; Adhikari TB, 1999, PHYTOPATHOLOGY, V89, P687, DOI 10.1094/PHYTO.1999.89.8.687; Ahirwar N, 2015, J MICROBIOL BIOTECHN, V7, P96; Ali S, 2014, MICROB CELL FACT, V13, DOI 10.1186/s12934-014-0144-x; Arshad HMI, 2015, ADVAN LIFE SCI, V2, P125; Cappuccino J.G., 2004, MICROBIOLOGY LAB MAN; Chen L, 2013, J EXP BOT, V64, P1565, DOI 10.1093/jxb/ert031; Choodamani MS, 2009, INT J PEST MANAGE, V55, P121, DOI 10.1080/09670870802601076; Copping LG, 2000, PEST MANAG SCI, V56, P651, DOI 10.1002/1526-4998(200008)56:8<651::AID-PS201>3.0.CO;2-U; Couillerot O, 2009, LETT APPL MICROBIOL, V48, P505, DOI 10.1111/j.1472-765X.2009.02566.x; Das B, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-82; Denizci AA, 2004, J APPL MICROBIOL, V96, P320, DOI 10.1046/j.1365-2672.2003.02153.x; EDWARDS A, 1991, AM J HUM GENET, V49, P746; Fravel DR, 2005, ANNU REV PHYTOPATHOL, V43, P337, DOI 10.1146/annurev.phyto.43.032904.092924; GLICK BR, 1995, CAN J MICROBIOL, V41, P109, DOI 10.1139/m95-015; Cabanas CGL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00427; Gustavo S.M., 2012, BIOCONTROL SCI TECHN, V22, P8558; Hafeez FY, 2004, AUST J EXP AGR, V44, P617, DOI 10.1071/EA03074; Hafeez FY., 2009, P INT S MICR TECHN S, P279; Hallmann J, 1997, CAN J MICROBIOL, V43, P895, DOI 10.1139/m97-131; Hameed A, 2014, CEREAL RES COMMUN, V42, P450, DOI 10.1556/CRC.2013.0066; HAMMERSCHMIDT R, 1982, PHYSIOL PLANT PATHOL, V20, P73, DOI 10.1016/0048-4059(82)90025-X; HammondKosack KE, 1996, PLANT CELL, V8, P1773, DOI 10.1105/tpc.8.10.1773; Hanif MK, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00583; Hassan TU, 2015, J SOIL SCI PLANT NUT, V15, P190, DOI 10.4067/S0718-95162015005000016; Hemm MR, 2004, PLANT J, V38, P765, DOI 10.1111/j.1365-313X.2004.02089.x; Hewitt W, 1989, THEORY APPL MICROBIO, P39; Hiddink GA, 2005, PHYTOPATHOLOGY, V95, P1325, DOI 10.1094/PHYTO-95-1325; Hoagland DR, 1950, CAL AGR EXP STN CIRC, V347, DOI [DOI 10.1016/S0140-6736(00)73482-9, 10.1016/S0140-6736(00)73482-9]; Jabeen R, 2011, PAK J BOT, V43, P111; Jayaraj J, 2004, Z PFLANZENK PFLANZEN, V111, P115; Jetiyanon K, 2002, BIOL CONTROL, V24, P285, DOI 10.1016/S1049-9644(02)00022-1; Ji GH, 2008, BIOL CONTROL, V45, P288, DOI 10.1016/j.biocontrol.2008.01.004; JOCKUSCH H., 1966, Phytopathologische Zeitschrift, V55, P185, DOI 10.1111/j.1439-0434.1966.tb02222.x; KAUFFMAN HE, 1973, PLANT DIS REP, V57, P537; Khan M S, PHOSPHATE SOLUBILIZI, P297; Lavania M, 2006, CURR MICROBIOL, V52, P363, DOI 10.1007/s00284-005-5578-2; Liang JG, 2011, AFR J BIOTECHNOL, V10, P6920; Maksimov IV, 2014, APPL BIOCHEM MICRO+, V50, P82, DOI 10.1134/S0003683813060124; Marten P, 2000, J APPL MICROBIOL, V89, P463, DOI 10.1046/j.1365-2672.2000.01136.x; Mathivanan S, 2014, INT J CURRENT RES AC, V2, P187; Mehmood MA, 2009, WORLD J MICROB BIOT, V25, P1955, DOI 10.1007/s11274-009-0094-3; Molina J, 2011, P NATL ACAD SCI USA, V108, P8351, DOI 10.1073/pnas.1104686108; Muhammad Tahir, 2013, Australian Journal of Crop Science, V7, P1284; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Nascimento FX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099168; Naureen Z, 2009, CROP PROT, V28, P1052, DOI 10.1016/j.cropro.2009.08.007; Oke O L, 1969, World Rev Nutr Diet, V11, P170; Ou SH, 1985, RICE DIS; Panhwar QA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097241; Patten CL, 2002, APPL ENVIRON MICROB, V68, P3795, DOI 10.1128/AEM.68.8.3795-3801.2002; Perez-Montano F, 2014, MICROBIOL RES, V169, P325, DOI 10.1016/j.micres.2013.09.011; PIKOVSKAIA R. I., 1948, Mikrobiologiya, V17, P362; Qing F., 2002, CHINESE SCI BULL, V47, P292, DOI [10.1360/02tb9070, DOI 10.1360/02TB9070]; Ramette A, 2003, MOL PLANT MICROBE IN, V16, P525, DOI 10.1094/MPMI.2003.16.6.525; Rasul G, 1998, DEV PLANT SOIL SCI, V79, P25; Saikia Ratul, 2006, The Plant Pathology Journal, V22, P339; Schiliro E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048646; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Shanti R., 2014, INT J CURR RES ACTA, V2, P74; Shoebitz M, 2009, SOIL BIOL BIOCHEM, V41, P1768, DOI 10.1016/j.soilbio.2007.12.031; Sofo A, 2015, INT J MOL SCI, V16, P13561, DOI 10.3390/ijms160613561; Tahir M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130030; Tahsili J, 2014, J PLANT INTERACT, V9, P412, DOI 10.1080/17429145.2013.846419; Tariq M, 2007, PAK J BOT, V39, P245; TIEN TM, 1979, APPL ENVIRON MICROB, V37, P1016, DOI 10.1128/AEM.37.5.1016-1024.1979; Vanitha SC, 2011, BIOL PLANTARUM, V55, P317, DOI 10.1007/s10535-011-0045-3; Velusamy P, 2013, RICE SCI, V20, P356, DOI 10.1016/S1672-6308(13)60143-2; Vincent JM, 1970, IBP HDB; Wang ChunLian, 2001, Chinese Journal of Rice Science, V15, P131; Wartiainen I, 2008, APPL SOIL ECOL, V39, P65, DOI 10.1016/j.apsoil.2007.11.008; Weisany W, 2012, PLANT OMICS, V5, P60; Wimberly JE., 1983, TECHNICAL HDB PADDY, P147; Worthington C.C., 1988, WORTHINGTON ENZYME M; Xie JJ, 2007, J MICROBIOL, V45, P219; Yang JH, 2008, J APPL MICROBIOL, V104, P91, DOI 10.1111/j.1365-2672.2007.03534.x; Yao T, 2008, J AGR SCI-CAMBRIDGE, V146, P49, DOI 10.1017/S0021859607007356; Yoshida K, 2003, APPL MICROBIOL BIOT, V60, P665, DOI 10.1007/s00253-002-1157-7; Zhang Y, 2006, CAN J MICROBIOL, V52, P476, DOI 10.1139/W05-152; ZUCKER M, 1965, PLANT PHYSIOL, V40, P779, DOI 10.1104/pp.40.5.779	80	51	53	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160688	10.1371/journal.pone.0160688	http://dx.doi.org/10.1371/journal.pone.0160688			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532545	gold, Green Published, Green Submitted			2022-12-26	WOS:000381487600039
J	Hong, L; Sharp, T; Khorsand, B; Fischer, C; Eliason, S; Salem, A; Akkouch, A; Brogden, K; Amendt, BA				Hong, Liu; Sharp, Thad; Khorsand, Behnoush; Fischer, Carol; Eliason, Steven; Salem, Ali; Akkouch, Adil; Brogden, Kim; Amendt, Brad A.			MicroRNA-200c Represses IL-6, IL-8, and CCL-5 Expression and Enhances Osteogenic Differentiation	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; BONE-FORMATION; SUPPRESSION; MIR-200C; NOGGIN; MIRNA	MicroRNAs (miRs) regulate inflammation and BMP antagonists, thus they have potential uses as therapeutic reagents. However, the molecular function of miR-200c in modulating proinflammatory and bone metabolic mediators and osteogenic differentiation is not known. After miR-200c was transduced into a human embryonic palatal mesenchyme (HEPM) (a cell line of preosteoblasts), using lentiviral vectors, the resulting miR-200c overexpression increased osteogenic differentiation biomarkers, including osteocalcin (OCN) transcripts and calcium content. miR-200c expression also down-regulated interleukin (IL)-6, IL-8, and chemokine (C-C motif) ligand (CCL)-5 under lipopolysaccharide (LPS) stimulation and increased osteoprotegerin (OPG) in these cells. miR-200c directly regulates the expression of IL-6, IL-8 and CCL-5 transcripts by binding to their 3' UTRs. A plasmid-based miR-200c inhibitor effectively reduces their binding activities. Additionally, miR-200c delivered using polyethylenimine (PEI) nanoparticles effectively inhibits IL-6, IL-8 and CCL-5 in primary human periodontal ligament fibroblasts and increases the biomarkers of osteogenic differentiation in human bone marrow mesenchymal stem cells (MSCs), including calcium content, ALP, and Runx2. These data demonstrate that miR-200c represses IL-6, IL-8 and CCL-5 and improves osteogenic differentiation. miR-200c may potentially be used as an effective means to prevent periodontitis-associated bone loss by arresting inflammation and osteoclastogenesis and enhancing bone regeneration.	[Hong, Liu; Fischer, Carol; Akkouch, Adil; Brogden, Kim; Amendt, Brad A.] Univ Iowa, Coll Dent, Dows Inst Dent Res, Iowa City, IA 52242 USA; [Hong, Liu; Eliason, Steven; Amendt, Brad A.] Univ Iowa, Carver Coll Med, Ctr Craniofacial Anomalies Res, Iowa City, IA USA; [Sharp, Thad; Eliason, Steven; Amendt, Brad A.] Univ Iowa, Carver Coll Med, Dept Anat & Cell Biol, Iowa City, IA USA; [Khorsand, Behnoush; Salem, Ali] Univ Iowa, Coll Pharm, Dept Pharmaceut Sci & Expt Therapeut, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa	Hong, L; Amendt, BA (corresponding author), Univ Iowa, Coll Dent, Dows Inst Dent Res, Iowa City, IA 52242 USA.; Hong, L; Amendt, BA (corresponding author), Univ Iowa, Carver Coll Med, Ctr Craniofacial Anomalies Res, Iowa City, IA USA.; Amendt, BA (corresponding author), Univ Iowa, Carver Coll Med, Dept Anat & Cell Biol, Iowa City, IA USA.	liu-hong@uiowa.edu; brad-amendt@uiowa.edu	Akkouch, Adil/AAW-1531-2020	Akkouch, Adil/0000-0001-8816-1885; Amendt, Brad A./0000-0001-6524-1006; hong, liu/0000-0003-0308-5049; Fischer, Carol/0000-0002-9050-5170	NIDCR NIH HHS [R21 DE024799] Funding Source: Medline; NIEHS NIH HHS [P30 ES005605] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE024799] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Armas Joshe, 2013, Dent Update, V40, P472; Borgwardt DS, 2014, SCI REP-UK, V4, DOI 10.1038/srep03904; Cao H, 2016, GENE THER, V23, P527, DOI 10.1038/gt.2016.22; Cao HJ, 2013, DEVELOPMENT, V140, P3348, DOI 10.1242/dev.089193; Chang J, 2013, P NATL ACAD SCI USA, V110, P9469, DOI 10.1073/pnas.1300532110; Chang J, 2009, NAT MED, V15, P682, DOI 10.1038/nm.1954; Chuang TD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095370; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Di Benedetto A, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/503754; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; Elangovan S, 2014, BIOMATERIALS, V35, P737, DOI 10.1016/j.biomaterials.2013.10.021; Graves Dana T, 2011, J Oral Microbiol, V3, DOI 10.3402/jom.v3i0.5304; Hajishengallis G, 2012, ADV EXP MED BIOL, V946, P69, DOI 10.1007/978-1-4614-0106-3_5; Heliotis M, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2467; Herath TDK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058496; Hikiji H, 2000, AM J PHYSIOL-ENDOC M, V278, pE1031, DOI 10.1152/ajpendo.2000.278.6.E1031; Holpuch AS, 2010, PHARM RES-DORDR, V27, P1224, DOI 10.1007/s11095-010-0121-y; Howe EN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049987; Huang HN, 2014, STEM CELL RES, V12, P338, DOI 10.1016/j.scr.2013.11.009; Jeffcoat M K, 1998, Ann Periodontol, V3, P312, DOI 10.1902/annals.1998.3.1.312; Katoh Y, 2008, INT J MOL MED, V22, P271, DOI 10.3892/ijmm_00000019; Khosla S, 2012, J CLIN ENDOCR METAB, V97, P2272, DOI 10.1210/jc.2012-1027; Lacey DC, 2009, OSTEOARTHR CARTILAGE, V17, P735, DOI 10.1016/j.joca.2008.11.011; Lian JB, 2012, NAT REV ENDOCRINOL, V8, P212, DOI 10.1038/nrendo.2011.234; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Muller HP, 2005, CLIN ORAL INVEST, V9, P98, DOI 10.1007/s00784-005-0303-x; Papapanou PN, 2000, PERIODONTOL 2000, V22, P8, DOI 10.1034/j.1600-0757.2000.2220102.x; Plank M, 2013, CLIN EXP ALLERGY, V43, P981, DOI [10.1111/cea.12135, 10.1111/cea.12170]; Rokavec M, 2012, MOL CELL, V45, P777, DOI 10.1016/j.molcel.2012.01.015; Sidiropoulou-Chatzigiannis Sossani, 2007, J Int Acad Periodontol, V9, P77; Singh RP, 2013, AUTOIMMUN REV, V12, P1160, DOI 10.1016/j.autrev.2013.07.003; Stoecklin-Wasmer C, 2012, J DENT RES, V91, P934, DOI 10.1177/0022034512456551; Stottmann RW, 2001, DEV BIOL, V240, P457, DOI 10.1006/dbio.2001.0479; Wang L, 2012, J DENT RES, V91, P1003, DOI 10.1177/0022034512460404; Wendlandt EB, 2012, INNATE IMMUN-LONDON, V18, P846, DOI 10.1177/1753425912443903; Yang N, 2013, J BONE MINER RES, V28, P559, DOI 10.1002/jbmr.1798	36	43	46	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160915	10.1371/journal.pone.0160915	http://dx.doi.org/10.1371/journal.pone.0160915			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529418	Green Published, gold, Green Submitted			2022-12-26	WOS:000381476700031
J	Ying, GX; Gerstner, CD; Frederick, JM; Boye, SL; Hauswirth, WW; Baehr, W				Ying, Guoxin; Gerstner, Cecilia D.; Frederick, Jeanne M.; Boye, Sanford L.; Hauswirth, William W.; Baehr, Wolfgang			Small GTPases Rab8a and Rab11a Are Dispensable for Rhodopsin Transport in Mouse Photoreceptors	PLOS ONE			English	Article							ROD OUTER SEGMENTS; DROSOPHILA PHOTORECEPTORS; PRIMARY CILIOGENESIS; MEMBRANE-TRANSPORT; CRE RECOMBINASE; TRANSGENIC MICE; EXCHANGE FACTOR; MYOSIN-VB; IN-VIVO; CELLS	Rab11a and Rab8a are ubiquitous small GTPases shown as required for rhodopsin transport in Xenopus laevis and zebrafish photoreceptors by dominant negative (dn) disruption of function. Here, we generated retina-specific Rab11a ((ret)Rab11a) and Rab8a ((ret)Rab8a) single and double knockout mice to explore the consequences in mouse photoreceptors. Rhodopsin and other outer segment (OS) membrane proteins targeted correctly to OS and electroretinogram (ERG) responses in all three mutant mouse lines were indistinguishable from wild-type (WT). Further, AAV (adeno-associated virus)-mediated expression of dnRab11b in (ret)Rab11a(-/-) retina, or expression of dnRab8b in (ret)Rab8a(-/-) retina did not cause OS protein mislocalization. Finally, a (ret)Rab8a(-/-) retina injected at one month of age with AAVs expressing dnRab11a, dnRab11b, dnRab8b, and dnRab10 (four dn viruses on Rab8a(-/-) background) and harvested three months later exhibited normal OS protein localization. In contrast to results obtained with dnRab GTPases in Xenopus and zebrafish, mouse Rab11a and Rab8a are dispensable for proper rhodopsin and outer segment membrane protein targeting. Absence of phenotype after expression of four dn Rab GTPases in a Rab8a(-/-) retina suggests that Rab8b and Rab11b paralogsmaybe dispensable as well. Our data thus demonstrate significant interspecies variation in photoreceptor membrane protein and rhodopsin trafficking.	[Ying, Guoxin; Gerstner, Cecilia D.; Frederick, Jeanne M.; Baehr, Wolfgang] Univ Utah, Hlth Sci Ctr, Dept Ophthalmol & Visual Sci, Salt Lake City, UT 84132 USA; [Boye, Sanford L.; Hauswirth, William W.] Univ Florida, Dept Ophthalmol, 1600 SW Archer Rd, Gainesville, FL 32610 USA; [Baehr, Wolfgang] Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA; [Baehr, Wolfgang] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; State University System of Florida; University of Florida; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Ying, GX; Baehr, W (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Ophthalmol & Visual Sci, Salt Lake City, UT 84132 USA.; Baehr, W (corresponding author), Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA.; Baehr, W (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	g.ying@utah.edu; wbaehr@hsc.utah.edu		hauswirth, william/0000-0002-3244-4947	NIH [EY08123, EY019298]; NEI core grants [EY014800, 039003, 021721]; Research to Prevent Blindness, Inc. (RPB; New York); RPB Senior Investigator award; RPB Nelson Trust Award	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI core grants; Research to Prevent Blindness, Inc. (RPB; New York)(Research to Prevent Blindness (RPB)); RPB Senior Investigator award; RPB Nelson Trust Award	work was supported by NIH grants EY08123, EY019298 (WB); by NEI core grants EY014800 (Utah), 039003 and 021721 (UF); by an unrestricted grant to the University of Utah Department of Ophthalmology and to the University of Florida Department of Ophthalmology from Research to Prevent Blindness, Inc. (RPB; New York). WB is the recipient of an RPB Senior Investigator award and an RPB Nelson Trust Award.	Babbey CM, 2006, MOL BIOL CELL, V17, P3156, DOI 10.1091/mbc.E05-08-0799; Bachmann-Gagescu R, 2011, HUM MOL GENET, V20, P4041, DOI 10.1093/hmg/ddr332; Best JM, 2011, AM J PHYSIOL-CELL PH, V300, pC1023, DOI 10.1152/ajpcell.00288.2010; BOK D, 1971, J CELL BIOL, V49, P664, DOI 10.1083/jcb.49.3.664; Butterworth MB, 2012, AM J PHYSIOL-RENAL, V302, pF581, DOI 10.1152/ajprenal.00304.2011; Chen S, 2001, J BIOL CHEM, V276, P13209, DOI 10.1074/jbc.M010798200; DERETIC D, 1995, J CELL SCI, V108, P215; Deretic D, 1996, J BIOL CHEM, V271, P2279, DOI 10.1074/jbc.271.4.2279; FARNSWORTH CC, 1994, P NATL ACAD SCI USA, V91, P11963, DOI 10.1073/pnas.91.25.11963; Feng SS, 2012, J BIOL CHEM, V287, P15602, DOI 10.1074/jbc.M111.333245; Furuta Y, 2000, GENESIS, V26, P130, DOI 10.1002/(SICI)1526-968X(200002)26:2<130::AID-GENE9>3.0.CO;2-I; Guo W, 1999, EMBO J, V18, P1071, DOI 10.1093/emboj/18.4.1071; Hattula K, 2002, MOL BIOL CELL, V13, P3268, DOI 10.1091/mbc.E02-03-0143; Jiang L, 2011, P NATL ACAD SCI USA, V108, P18476, DOI 10.1073/pnas.1112758108; Kelly EE, 2012, BIOCHEM SOC T, V40, P1360, DOI 10.1042/BST20120157; Knodler A, 2010, P NATL ACAD SCI USA, V107, P6346, DOI 10.1073/pnas.1002401107; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lapierre LA, 2001, MOL BIOL CELL, V12, P1843, DOI 10.1091/mbc.12.6.1843; Le YZ, 2004, MOL VIS, V10, P1011; Li BX, 2007, J CELL BIOL, V177, P659, DOI 10.1083/jcb.200610157; Li S, 2005, GENESIS, V41, P73, DOI 10.1002/gene.20097; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Mazelova J, 2009, J CELL SCI, V122, P2003, DOI 10.1242/jcs.039982; Mazelova J, 2009, EMBO J, V28, P183, DOI 10.1038/emboj.2008.267; Moritz OL, 2001, MOL BIOL CELL, V12, P2341, DOI 10.1091/mbc.12.8.2341; Mukhopadhyay S, 2008, DEV CELL, V14, P762, DOI 10.1016/j.devcel.2008.03.002; Murga-Zamalloa CA, 2010, MOL VIS, V16, P1373; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nickell S, 2007, J CELL BIOL, V177, P917, DOI 10.1083/jcb.200612010; Omori Y, 2008, NAT CELL BIOL, V10, P437, DOI 10.1038/ncb1706; Pearring JN, 2013, PROG RETIN EYE RES, V36, P24, DOI 10.1016/j.preteyeres.2013.03.002; Peranen J, 2011, CYTOSKELETON, V68, P527, DOI 10.1002/cm.20529; Reish NJ, 2014, J NEUROSCI, V34, P14854, DOI 10.1523/JNEUROSCI.1943-14.2014; Riveiro-Alvarez R, 2015, JAMA OPHTHALMOL, V133, P133, DOI 10.1001/jamaophthalmol.2014.4266; Roland JT, 2007, MOL BIOL CELL, V18, P2828, DOI 10.1091/mbc.E07-02-0169; Roosing S, 2013, AM J HUM GENET, V93, P110, DOI 10.1016/j.ajhg.2013.05.005; Sato T, 2007, NATURE, V448, P366, DOI 10.1038/nature05929; Sato T, 2014, J CELL SCI, V127, P422, DOI 10.1242/jcs.136903; Satoh AK, 2005, DEVELOPMENT, V132, P1487, DOI 10.1242/dev.01704; SEABRA MC, 1995, J BIOL CHEM, V270, P24420, DOI 10.1074/jbc.270.41.24420; Silvis MR, 2009, MOL BIOL CELL, V20, P2337, DOI 10.1091/mbc.E08-01-0084; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; TROUTT LL, 1988, J NEUROSCI, V8, P2371; Wang J, 2015, J CELL SCI, V128, P1375, DOI 10.1242/jcs.162925; Wang J, 2014, PROG RETIN EYE RES, V38, P1, DOI 10.1016/j.preteyeres.2013.08.004; Wang J, 2012, EMBO J, V31, P4057, DOI 10.1038/emboj.2012.253; Welz T, 2014, TRENDS CELL BIOL, V24, P407, DOI 10.1016/j.tcb.2014.02.004; Westfall JE, 2010, J NEUROSCI, V30, P8759, DOI 10.1523/JNEUROSCI.5229-09.2010; Westlake CJ, 2011, P NATL ACAD SCI USA, V108, P2759, DOI 10.1073/pnas.1018823108; Wu SY, 2005, NAT STRUCT MOL BIOL, V12, P879, DOI 10.1038/nsmb987; Yoshimura S, 2007, J CELL BIOL, V178, P363, DOI 10.1083/jcb.200703047; Yoshimura S, 2010, J CELL BIOL, V191, P367, DOI 10.1083/jcb.201008051; YOUNG RW, 1967, J CELL BIOL, V33, P61, DOI 10.1083/jcb.33.1.61; Yu SY, 2014, J BIOL CHEM, V289, P32030, DOI 10.1074/jbc.M113.538223; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	56	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161236	10.1371/journal.pone.0161236	http://dx.doi.org/10.1371/journal.pone.0161236			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529348	Green Published, gold, Green Submitted			2022-12-26	WOS:000381476700057
J	Hain, EG; Klein, C; Munder, T; Braun, J; Riek, K; Mueller, S; Sack, I; Steiner, B				Hain, Elisabeth G.; Klein, Charlotte; Munder, Tonia; Braun, Juergen; Riek, Kerstin; Mueller, Susanne; Sack, Ingolf; Steiner, Barbara			Dopaminergic Neurodegeneration in the Mouse Is Associated with Decrease of Viscoelasticity of Substantia Nigra Tissue	PLOS ONE			English	Article							MAGNETIC-RESONANCE ELASTOGRAPHY; PRECURSOR CELL-PROLIFERATION; PARKINSONS-DISEASE; MR ELASTOGRAPHY; BRAIN VISCOELASTICITY; MODEL; 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; STIFFNESS	The biomechanical properties of brain tissue are altered by histopathological changes due to neurodegenerative diseases like Parkinson's disease (PD). Such alterations can be measured by magnetic resonance elastography (MRE) as a non-invasive technique to determine viscoelastic parameters of the brain. Until now, the correlation between histopathological mechanisms and observed alterations in tissue viscoelasticity in neurodegenerative diseases is still not completely understood. Thus, the objective of this study was to evaluate (1) the validity of MRE to detect viscoelastic changes in small and specific brain regions: the substantia nigra (SN), midbrain and hippocampus in a mouse model of PD, and (2) if the induced dopaminergic neurodegeneration and inflammation in the SN is reflected by local changes in viscoelasticity. Therefore, MRE measurements of the SN, midbrain and hippocampus were performed in adult female mice before and at five time points after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridin hydrochloride (MPTP) treatment specifically lesioning dopaminergic neurons in the SN. At each time point, additional mice were utilized for histological analysis of the SN. After treatment cessation, we observed opposed viscoelastic changes in the midbrain, hippocampus and SN with the midbrain showing a gradual rise and the hippocampus a distinct transient increase of viscous and elastic parameters, while viscosity and-to a lesser extent-elasticity in the SN decreased over time. The decrease in viscosity and elasticity in the SN was paralleled by a reduced number of neurons due to the MPTP-induced neurodegeneration. In conclusion, MRE is highly sensitive to detect local viscoelastic changes in specific and even small brain regions. Moreover, we confirmed that neuronal cells likely constitute the backbone of the adult brain mainly accounting for its viscoelasticity. Therefore, MRE could be established as a new potential instrument for clinical evaluation and diagnostics of neurodegenerative diseases.	[Hain, Elisabeth G.; Klein, Charlotte; Munder, Tonia; Steiner, Barbara] Charite, Dept Neurol, Berlin, Germany; [Braun, Juergen] Charite, Inst Med Informat, Berlin, Germany; [Riek, Kerstin; Sack, Ingolf] Charite, Dept Radiol, Berlin, Germany; [Mueller, Susanne] Ctr Stroke Res Berlin, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Steiner, B (corresponding author), Charite, Dept Neurol, Berlin, Germany.	barbara.steiner@charite.de		Hain, Elisabeth G./0000-0001-5755-5339; Mueller, Susanne/0000-0002-5053-2211; Steiner, Barbara/0000-0003-2106-4532; Munder, Tonia/0000-0001-5995-6275; Braun, Jurgen/0000-0001-5183-7546	German Research Foundation [STE 1450/8, SA901/17]	German Research Foundation(German Research Foundation (DFG))	This study was funded by the German Research Foundation (www.dfg.de) to Barbara Steiner: STE 1450/8, and Ingolf Sack: SA901/17. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annese V, 2015, BRAIN STRUCT FUNCT, V220, P703, DOI 10.1007/s00429-014-0718-8; Araki T, 2001, EUR J PHARM SCI, V12, P231, DOI 10.1016/S0928-0987(00)00170-6; Arani A, 2015, NEUROIMAGE, V111, P59, DOI 10.1016/j.neuroimage.2015.02.016; Clayton EH, 2011, PHYS MED BIOL, V56, P2391, DOI 10.1088/0031-9155/56/8/005; Freimann FB, 2013, NMR BIOMED, V26, P1534, DOI 10.1002/nbm.2987; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; Hoglinger GU, 2004, NAT NEUROSCI, V7, P726, DOI 10.1038/nn1265; Huston J, 2016, J MAGN RESON IMAGING, V43, P474, DOI 10.1002/jmri.24977; Jackson-Lewis V, 2007, NAT PROTOC, V2, P141, DOI 10.1038/nprot.2006.342; JACKSONLEWIS V, 1995, NEURODEGENERATION, V4, P257, DOI 10.1016/1055-8330(95)90015-2; Klaissle P, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-132; Klein C, 2016, BEHAV BRAIN RES, V307, P227, DOI 10.1016/j.bbr.2016.02.040; Klein C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092582; Kruse SA, 2008, NEUROIMAGE, V39, P231, DOI 10.1016/j.neuroimage.2007.08.030; Lesemann A, 2012, BRAIN RES, V1457, P51, DOI 10.1016/j.brainres.2012.03.046; Lipp A, 2013, NEUROIMAGE-CLIN, V3, P381, DOI 10.1016/j.nicl.2013.09.006; Lu YB, 2011, FASEB J, V25, P624, DOI 10.1096/fj.10-163790; Mariappan YK, 2010, CLIN ANAT, V23, P497, DOI 10.1002/ca.21006; McCracken PJ, 2005, MAGN RESON MED, V53, P628, DOI 10.1002/mrm.20388; McGeer PL, 2008, MOVEMENT DISORD, V23, P474, DOI 10.1002/mds.21751; Millward JM, 2015, NMR BIOMED, V28, P831, DOI 10.1002/nbm.3319; Murphy MC, 2012, MAGN RESON IMAGING, V30, P535, DOI 10.1016/j.mri.2011.12.019; Murphy MC, 2011, J MAGN RESON IMAGING, V34, P494, DOI 10.1002/jmri.22707; MUTHUPILLAI R, 1995, SCIENCE, V269, P1854, DOI 10.1126/science.7569924; Papazoglou S, 2008, PHYS MED BIOL, V53, P3147, DOI 10.1088/0031-9155/53/12/005; Phani S, 2010, BRAIN RES, V1343, P1, DOI 10.1016/j.brainres.2010.04.061; Przedborski S, 2003, ANN NY ACAD SCI, V991, P189; Riek K, 2012, NEUROIMAGE-CLIN, V1, P81, DOI 10.1016/j.nicl.2012.09.003; Sack I, 2009, NEUROIMAGE, V46, P652, DOI 10.1016/j.neuroimage.2009.02.040; Schregel K, 2012, P NATL ACAD SCI USA, V109, P6650, DOI 10.1073/pnas.1200151109; Streitberger KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110588; Streitberger KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029888; Streitberger KJ, 2011, NMR BIOMED, V24, P385, DOI 10.1002/nbm.1602; Wuerfel J, 2010, NEUROIMAGE, V49, P2520, DOI 10.1016/j.neuroimage.2009.06.018	34	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0161179	10.1371/journal.pone.0161179	http://dx.doi.org/10.1371/journal.pone.0161179			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27526042	Green Submitted, Green Published, gold			2022-12-26	WOS:000381471100039
J	Maughan-Brown, B; Evans, M; George, G				Maughan-Brown, Brendan; Evans, Meredith; George, Gavin			Sexual Behaviour of Men and Women within Age-Disparate Partnerships in South Africa: Implications for Young Women's HIV Risk	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; TRANSACTIONAL SEX; CONCURRENT PARTNERSHIPS; ECONOMIC ASYMMETRIES; REPRODUCTIVE HEALTH; ADOLESCENT GIRLS; ALCOHOL-USE; CONDOM USE; URBAN; PREVALENCE	Background Age-disparate partnerships are hypothesized to increase HIV-risk for young women. However, the evidence base remains mixed. Most studies have focused only on unprotected sex among women in the partnership. Consequently, little is known about other risky behaviours, such as transactional sex, alcohol use, and concurrency, as well as the behaviours of the men who partner with young women. We therefore examined differences in various sexual behaviours of both young women and their male partners by partnership age difference. Methods We used nationally representative data from South Africa (2012) on partnerships reported by 16-24 year old black African women (n = 818) and by black African men in partnerships with 16-24 year old women (n = 985). We compared sexual behaviours in age-disparate partnerships and age-similar partnerships, using multiple logistic regression to control for potential confounders and to assess rural/urban differences. Results Young women in age-disparate partnerships were more likely to report unprotected sex than young women in similar-aged partnerships (aOR: 1.51; p = 0.014; 95% CI: 1.09-2.11). Men in partnerships with young women were more likely to report unprotected sex (aOR: 1.92; p<0.01; 95% CI: 1.31-2.81), transactional sex (aOR: 2.73; p< 0.01; 95% CI: 1.64-4.56), drinking alcohol before sex (aOR:1.60; p = 0.062; 95%CI:0.98-2.61), and concurrency (aOR: 1.39; p = 0.097; 95%CI:0.94-2.07) when their partners were five or more years younger. The association between age-disparate partnerships and transactional sex (aOR: 4.14; p< 0.01; 95% CI: 2.03-8.46) and alcohol use (aOR:2.24; p< 0.013; 95% CI:1.20-4.19) was only found in urban areas. Conclusions Results provide evidence that young women's age-disparate partnerships involve greater sexual risk, particularly through the risky behaviours of their male partners, with the risk amplified for young women in urban areas.	[Maughan-Brown, Brendan] Univ Cape Town, Southern Africa Labour & Dev Res Unit, Dept Econ, Cape Town, South Africa; [Evans, Meredith] Univ Cape Town, Dept Sociol, Inst Humanities Africa HUMA, Cape Town, South Africa; [George, Gavin] Univ KwaZulu Natal, Hlth Econ & HIV & AIDS Res Div HEARD, Durban, South Africa	University of Cape Town; University of Cape Town; University of Kwazulu Natal	Maughan-Brown, B (corresponding author), Univ Cape Town, Southern Africa Labour & Dev Res Unit, Dept Econ, Cape Town, South Africa.	brendan.maughanbrown@gmail.com	George, Gavin L/N-5756-2013; Evans, Meredith/HHN-7716-2022; Maughan-Brown, Brendan/AAH-4254-2019	George, Gavin L/0000-0001-7258-8470; Evans, Meredith/0000-0002-9986-3185; 	National Research Foundation, South Africa, through the Research Career Advancement Fellowship; Department of Health, the United States Agency for International Development (USAID) through the President's Emergency Plan for AIDS Relief (PEPFAR); Global Fund	National Research Foundation, South Africa, through the Research Career Advancement Fellowship; Department of Health, the United States Agency for International Development (USAID) through the President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Global Fund	Brendan Maughan-Brown acknowledges support from the National Research Foundation, South Africa, through the Research Career Advancement Fellowship. The National Research Foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors thank Atheendar Venkataramani and David Maughan Brown for helpful comments and suggestions on previous versions of this manuscript. The data used in this paper are from the Third National HIV Communication Survey (NCS). The NCS is a collaborative survey undertaken by Johns Hopkins Health and Education in South Africa (JHHESA), loveLife and Soul City. The survey was managed by Health and Development Africa (HDA). The Johns Hopkins Bloomberg School of Public Health Center for Communication Programs (JHUCCP) provided technical support and oversight at all stages of the study. Data were gathered by Freshly Ground Insights (FGI). The NCS was funded by the Department of Health, the United States Agency for International Development (USAID) through the President's Emergency Plan for AIDS Relief (PEPFAR) and the Global Fund.	Baird SJ, 2012, LANCET, V379, P1320, DOI 10.1016/S0140-6736(11)61709-1; Balkus JE, 2015, JAIDS-J ACQ IMM DEF, V70, P212, DOI 10.1097/QAI.0000000000000715; Bankole Akinrinola, 2007, Afr J Reprod Health, V11, P197, DOI 10.2307/25549740; Bauman LJ, 2005, AIDS BEHAV, V9, P211, DOI 10.1007/s10461-005-3902-2; Beauclair R, 2012, EUR J CONTRACEP REPR, V17, P30, DOI 10.3109/13625187.2011.644841; Britton A, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0273-z; Cameron AC, 2015, J HUM RESOUR, V50, P317, DOI 10.3368/jhr.50.2.317; Chapman R, 2010, TROP MED INT HEALTH, V15, P554, DOI 10.1111/j.1365-3156.2010.02483.x; Choudhry V, 2014, GLOBAL HEALTH ACTION, V8, P27249; Darj E, 2010, SEX REPROD HEALTHC, V1, P111, DOI 10.1016/j.srhc.2010.03.001; Dodoo FNA, 2007, SOC SCI MED, V64, P1019, DOI 10.1016/j.socscimed.2006.10.007; Dunkle KL, 2004, SOC SCI MED, V59, P1581, DOI 10.1016/j.socscimed.2004.02.003; Dunkle KL, 2010, PUBLIC HEALTH REP, V125, P90, DOI 10.1177/00333549101250S413; Dupas P, 2009, AM ECON J-APPL ECON; Dupas P., 2009, BOTSWANA J EC, V3, P1; Fisher JC, 2008, SEX TRANSM DIS, V35, P537, DOI 10.1097/OLQ.0b013e3181677547; Gregson S, 2002, LANCET, V359, P1896, DOI 10.1016/S0140-6736(02)08780-9; Harling G, 2014, J ACQ IMMUN DEF SYND, V66, P433; Harling G, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-005638; Hope Ruth, 2007, ADDRESSING CROSS GEN; Hunter Mark., 2002, AFR STUD-UK, V61, P99, DOI [DOI 10.1080/00020180220140091, 10.1080/00020180220140091]; Jewkes R., 2012, Journal of AIDS and Clinical Research, V3, P158; Jewkes R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-325; Jewkes R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040821; Jewkes R, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-6; Johnson S, 2013, 3 NATL HIV COMMUNICA; Kalichman SC, 2007, PREV SCI, V8, P141, DOI 10.1007/s11121-006-0061-2; Karlyn AS, 2005, CULT HEALTH SEX, V7, P279, DOI 10.1080/13691050412331334362; Katz I, 2008, SEX TRANSM DIS, V35, P837, DOI 10.1097/OLQ.0b013e31817c0be5; Kaufman CE, 2004, CULT HEALTH SEX, V6, P377, DOI 10.1080/13691050410001680492; Kelly RJ, 2003, JAIDS-J ACQ IMM DEF, V32, P446, DOI 10.1097/00126334-200304010-00016; Kenyon C, 2013, INT J STD AIDS, V24, P211, DOI 10.1177/0956462412472455; KNAUB JR, 1987, AM STAT, V41, P246; KwaZulu-Natal Department of Health, 2012, SUG DADD CAMP; Lamb MR, 2014, AIDS, V28, P559, DOI 10.1097/QAD.0000000000000054; Langeni T, 2007, AJAR-AFR J AIDS RES, V6, P261, DOI 10.2989/16085900709490422; Leclerc-Madlala S, 2003, SOC DYNAMICS, V29, P213, DOI 10.1080/02533950308628681; Leclerc-Madlala S, 2008, AIDS, V22, pS17, DOI 10.1097/01.aids.0000341774.86500.53; Longfield K, 2004, STUD FAMILY PLANN, V35, P125, DOI 10.1111/j.1728-4465.2004.00014.x; Luke N, 2005, INT FAM PLAN PERSPEC, V31, P6, DOI 10.1363/3100605; Luke N, 2003, STUD FAMILY PLANN, V34, P67, DOI 10.1111/j.1728-4465.2003.00067.x; Lurie M, 2008, JAIDS-J ACQ IMM DEF, V47, P484, DOI 10.1097/QAI.0b013e3181648de8; MacPhail C, 2001, SOC SCI MED, V52, P1613, DOI 10.1016/S0277-9536(00)00272-0; Mantell JE, 2015, GLOB PUBLIC HEALTH, V10, P947, DOI 10.1080/17441692.2015.1045918; Masvawure T, 2010, CULT HEALTH SEX, V12, P857, DOI 10.1080/13691050903471441; Maughan-Brown B, 2014, AIDS BEHAV, V18, P2469, DOI 10.1007/s10461-014-0828-6; Maughan-Brown B, 2011, AIDS, V25, P1549, DOI 10.1097/QAD.0b013e32834905c4; Mavhandu-Mudzusi AH, 2014, MEDITERRANEAN J SOCI, V5, DOI [10.5901/mjss.2014.v5n20p2876, DOI 10.5901/MJSS.2014.V5N20P2876]; Miller KS, 1997, FAM PLANN PERSPECT, V29, P212, DOI 10.2307/2953397; Morris M, 2010, AIDS BEHAV, V14, P31, DOI 10.1007/s10461-009-9639-6; Nyanzi S, 2001, AIDS CARE, V13, P83, DOI 10.1080/09540120020018206; Ott MQ, 2011, AIDS, V25, P861, DOI 10.1097/QAD.0b013e32834344c9; Papo JK, 2011, AIDS, V25, P247, DOI 10.1097/QAD.0b013e328341b9b8; Pettifor AE, 2005, AIDS, V19, P1525, DOI 10.1097/01.aids.0000183129.16830.06; Pettifor AE, 2005, TROP MED INT HEALTH, V10, P971, DOI 10.1111/j.1365-3156.2005.01483.x; PSI, 2014, CROSS GEN SEX; Robinson J, 2011, AM ECON J-APPL ECON, V3, P35, DOI 10.1257/app.3.1.35; Schroder KEE, 2003, ANN BEHAV MED, V26, P76, DOI 10.1207/S15324796ABM2602_02; Shisana O, 2009, S AFRICAN NATL PREVA; Shisana O, 2014, S AFRICAN NATL HIV P; Silberschmidt M, 2001, SOC SCI MED, V52, P1815, DOI 10.1016/S0277-9536(00)00299-9; Stephenson R, 2013, AIDS CARE, V25, P784, DOI 10.1080/09540121.2012.748161; Tumwesigye NM, 2013, AFR HEALTH SCI, V13, P407, DOI 10.4314/ahs.v13i2.30; UNAIDS, 2020, UNAIDS 2020 GLOB REP; Voeten HACM, 2007, TROP MED INT HEALTH, V12, P174, DOI 10.1111/j.1365-3156.2006.01776.x; Voeten HACM, 2004, SEX TRANSM DIS, V31, P481, DOI 10.1097/01.olq.0000135989.14131.9d; Volpe EM, 2013, J INTERPERS VIOLENCE, V28, P2068, DOI 10.1177/0886260512471082; Wamoyi J, 2011, ARCH SEX BEHAV, V40, P5, DOI 10.1007/s10508-010-9646-8; Wood K, 1998, SOC SCI MED, V47, P233, DOI 10.1016/S0277-9536(98)00057-4; Zembe YZ, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-28	70	47	47	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0159162	10.1371/journal.pone.0159162	http://dx.doi.org/10.1371/journal.pone.0159162			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT4SL	27526116	Green Published, gold			2022-12-26	WOS:000381471100005
J	Madeira, MFM; Queiroz-Junior, CM; Montero-Melendez, T; Werneck, SMC; Correa, JD; Soriani, FM; Garlet, GP; Souza, DG; Teixeira, MM; Silva, TA; Perretti, M				Madeira, Mila F. M.; Queiroz-Junior, Celso M.; Montero-Melendez, Trinidad; Werneck, Silvia M. C.; Correa, Joice D.; Soriani, Frederico M.; Garlet, Gustavo P.; Souza, Daniele G.; Teixeira, Mauro M.; Silva, Tarcilia A.; Perretti, Mauro			Melanocortin agonism as a viable strategy to control alveolar bone loss induced by oral infection	FASEB JOURNAL			English	Article						osteoclasts; periodontitis; Aggregatibacter actinomycetemcomitans; inflammation; DTrp(8)-gamma MSH	MELANOCYTE-STIMULATING HORMONE; PERIODONTAL-DISEASE; RHEUMATOID-ARTHRITIS; RECEPTOR; INFLAMMATION; DESTRUCTION; CYTOKINES; SYSTEM; PROOPIOMELANOCORTIN; CHONDROCYTES	Alveolar bone loss is a result of an aggressive form of periodontal disease (PD) associated with Aggre-gatibacter actinomycetemcomitans (Aa) infection. PD is often observed with other systemic inflammatory conditions, including arthritis. Melanocortin peptides activate specific receptors to exert antiarthritic properties, avoiding excessing inflammation and modulating macrophage function. Recent work has indicated that melanocortin can control osteoclast development and function, butwhether such protection takes place in infection-induced alveolar bone loss has not been investigated. The purpose of this study was to evaluate the role of melanocortin in Aainduced PD. Mice were orally infected with Aa and treated with the melanocortin analog DTrp(8)-gamma MSH or vehicle daily for 30 d. Then, periodontal tissue was collected and analyzed. Aa-infected mice treated with DTrp(8)-gamma MSH presented decreased alveolar bone loss and a lower degree of neutrophil infiltration in the periodontium than vehicle-treated animals; these actionswere associated with reducedperiodontal levels ofTNF-alpha, IFN-gamma, and IL-17A. In vitro experiments with cells differentiated into osteoclasts showed that osteoclast formation and resorptive activity were attenuated after treatment with DTrp(8)-gamma MSH. Thus, melanocortin agonism could represent an innovativeway to tame overexuberant inflammation and, at the same time, preserve bone physiology, as seen afterAa infection.-Madeira, M. F. M., Queiroz-Junior, C. M., Montero-Melendez, T., Werneck, S. M. C., Correa, J. D., Soriani, F. M., Garlet, G. P., Souza, D. G., Teixeira, M. M., Silva, T. A., Perretti, M. Melanocortin agonismas a viable strategy to control alveolar bone loss induced by oral infection.	[Madeira, Mila F. M.; Werneck, Silvia M. C.; Souza, Daniele G.] Univ Fed Minas Gerais, Sch Dent, Inst Biol Sci, Dept Microbiol, Belo Horizonte, MG, Brazil; [Queiroz-Junior, Celso M.] Univ Fed Minas Gerais, Sch Dent, Inst Biol Sci, Dept Morphol, Belo Horizonte, MG, Brazil; [Soriani, Frederico M.] Univ Fed Minas Gerais, Sch Dent, Inst Biol Sci, Dept Gen Biol, Belo Horizonte, MG, Brazil; [Teixeira, Mauro M.] Univ Fed Minas Gerais, Sch Dent, Inst Biol Sci, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil; [Madeira, Mila F. M.; Correa, Joice D.; Silva, Tarcilia A.] Univ Fed Minas Gerais, Sch Dent, Dept Oral Pathol, Belo Horizonte, MG, Brazil; [Montero-Melendez, Trinidad; Perretti, Mauro] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England; [Garlet, Gustavo P.] Univ Sao Paulo, Sch Dent Bauru, Dept Biol Sci, Bauru, SP, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; University of London; Queen Mary University London; Universidade de Sao Paulo	Madeira, MFM (corresponding author), Univ Fed Minas Gerais, Inst Biol Sci, Dept Microbiol, Ave Antonio Carlos 6627, Belo Horizonte, MG, Brazil.	madeiramila@gmail.com	Montero-Melendez, Trinidad/AAF-6345-2020; Garlet, Gustavo Pompermaier/E-6762-2012; da Silva, Tarcília Aparecida/O-7530-2015; Teixeira, Mauro M/A-4587-2008; Soriani, Frederico M/A-8896-2013; Corrêa, Jôice Dias/H-6868-2012; Queiroz-Junior, Celso/L-5438-2013; Madeira, Mila F M/A-9041-2015; Silva, Tarcilia/AAP-3760-2021	Garlet, Gustavo Pompermaier/0000-0002-5071-8382; da Silva, Tarcília Aparecida/0000-0001-9623-7835; Teixeira, Mauro M/0000-0002-6944-3008; Soriani, Frederico M/0000-0003-4720-6746; Corrêa, Jôice Dias/0000-0003-0170-6163; Queiroz-Junior, Celso/0000-0002-7884-7709; Madeira, Mila F M/0000-0002-1770-9978; Silva, Tarcilia/0000-0001-9623-7835; Montero-Melendez, Trinidad/0000-0002-3563-376X	Brazilian Ministry of Education (CAPES); Ministry of Science Technology and Innovation (CNPq); Minas Gerais Research Foundation (FAPEMIG; Belo Horizonte, Brazil); Instituto Nacional de Ciencia e Tecnologia (INCT; Dengue, Brazil); UK Medical Research Council [MR/K013068/1]	Brazilian Ministry of Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Ministry of Science Technology and Innovation (CNPq); Minas Gerais Research Foundation (FAPEMIG; Belo Horizonte, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Instituto Nacional de Ciencia e Tecnologia (INCT; Dengue, Brazil); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank Dr. Osamu Fujise (Faculty of Dental Science, Kyushu University, Fukuoka, Japan) for providing the LPS from Aa. This work was supported by grants from the Brazilian Ministry of Education (CAPES), the Ministry of Science Technology and Innovation (CNPq), and the Minas Gerais Research Foundation (FAPEMIG; Belo Horizonte, Brazil); by financial support from the Instituto Nacional de Ciencia e Tecnologia (INCT; Dengue, Brazil); and by Grant MR/K013068/1 from The UK Medical Research Council. The authors declare no conflicts of interest.	Baehni P, 2010, EUR J DENT EDUC, V14, P2, DOI 10.1111/j.1600-0579.2010.00619.x; BLALOCK JE, 1985, J NEUROIMMUNOL, V10, P31, DOI 10.1016/0165-5728(85)90032-3; Bohm M, 2012, ENDOCR REV, V33, P623, DOI 10.1210/er.2011-1016; Chakravarti A, 2009, BLOOD, V114, P1633, DOI 10.1182/blood-2008-09-178301; Chen HH, 2013, ANN RHEUM DIS, V72, P1206, DOI 10.1136/annrheumdis-2012-201593; Chiang N, 2012, NATURE, V484, P524, DOI 10.1038/nature11042; Cochran DL, 2008, J PERIODONTOL, V79, P1569, DOI 10.1902/jop.2008.080233; Cornish J, 2003, AM J PHYSIOL-ENDOC M, V284, pE1181, DOI 10.1152/ajpendo.00412.2002; Dennison DK, 1997, PERIODONTOL 2000, V14, P54, DOI 10.1111/j.1600-0757.1997.tb00192.x; Di Benedetto A, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/503754; Erciyas K, 2013, ORAL DIS, V19, P394, DOI 10.1111/odi.12017; Garlet GP, 2010, J DENT RES, V89, P1349, DOI 10.1177/0022034510376402; Getting SJ, 2002, ARTHRITIS RHEUM, V46, P2765, DOI 10.1002/art.10526; Gonzalez SM, 2015, J PERIODONTOL, V86, P222, DOI 10.1902/jop.2014.140425; Grassel S, 2009, ARTHRITIS RHEUM-US, V60, P3017, DOI 10.1002/art.24846; Graves D, 2008, J PERIODONTOL, V79, P1585, DOI 10.1902/jop.2008.080183; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; Hasturk H, 2006, FASEB J, V20, P401, DOI 10.1096/fj.05-4724fje; Holloway PM, 2015, ARTERIOSCL THROM VAS, V35, P1936, DOI 10.1161/ATVBAHA.115.305348; Kalsi Rupali, 2011, J Indian Soc Periodontol, V15, P304, DOI 10.4103/0972-124X.92559; Kaneva MK, 2014, BIOCHEM PHARMACOL, V92, P336, DOI 10.1016/j.bcp.2014.08.019; Kassebaum NJ, 2014, J DENT RES, V93, P1045, DOI 10.1177/0022034514552491; Kaur S, 2013, J DENT RES, V92, P399, DOI 10.1177/0022034513483142; Kobayashi Y, 2008, FRONT BIOSCI-LANDMRK, V13, P2400, DOI 10.2741/2853; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenz J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105858; Madeira MFM, 2013, MOL ORAL MICROBIOL, V28, P415, DOI 10.1111/omi.12034; Malle E, 2007, BRIT J PHARMACOL, V152, P838, DOI 10.1038/sj.bjp.0707358; Montero-Melendez T, 2015, SEMIN IMMUNOL, V27, P216, DOI 10.1016/j.smim.2015.02.003; Montero-Melendez T, 2014, AM J PATHOL, V184, P2333, DOI 10.1016/j.ajpath.2014.04.009; Montero-Melendez T, 2011, AM J PATHOL, V179, P259, DOI 10.1016/j.ajpath.2011.03.042; Montero-Melendez T, 2011, CURR RHEUMATOL REP, V13, P138, DOI 10.1007/s11926-011-0163-0; Madeira MFM, 2013, INFECT IMMUN, V81, P4244, DOI 10.1128/IAI.01046-13; Madeira MFM, 2012, MICROBES INFECT, V14, P198, DOI 10.1016/j.micinf.2011.09.005; Morita M, 2013, CELL, V153, P112, DOI 10.1016/j.cell.2013.02.027; Okada M, 2013, J PERIODONTOL, V84, pE74, DOI 10.1902/jop.2013.130079; Page RC, 1997, PERIODONTOL 2000, V14, P9, DOI 10.1111/j.1600-0757.1997.tb00189.x; PAGE RC, 1991, J PERIODONTAL RES, V26, P230, DOI 10.1111/j.1600-0765.1991.tb01649.x; Patel HB, 2010, FASEB J, V24, P4835, DOI 10.1096/fj.10-167759; Scher JU, 2012, ARTHRITIS RHEUM-US, V64, P3083, DOI 10.1002/art.34539; Schioth HB, 2001, VITAM HORM, V63, P195, DOI 10.1016/S0083-6729(01)63007-3; Socransky SS, 2005, PERIODONTOL 2000, V38, P135, DOI 10.1111/j.1600-0757.2005.00107.x; SUDA T, 1992, ENDOCR REV, V13, P66, DOI 10.1210/er.13.1.66; Teng YTA, 2003, CRIT REV ORAL BIOL M, V14, P237, DOI 10.1177/154411130301400402; Yu JJ, 2007, BLOOD, V109, P3794, DOI 10.1182/blood-2005-09-010116	45	2	2	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4033	4041		10.1096/fj.201600790R	http://dx.doi.org/10.1096/fj.201600790R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27535487				2022-12-26	WOS:000388201500011
J	Murray, AJ; Knight, NS; Cole, MA; Cochlin, LE; Carter, E; Tchabanenko, K; Pichulik, T; Gulston, MK; Atherton, HJ; Schroeder, MA; Deacon, RMJ; Kashiwaya, Y; King, MT; Pawlosky, R; Rawlins, JNP; Tyler, DJ; Griffin, JL; Robertson, J; Veech, RL; Clarke, K				Murray, Andrew J.; Knight, Nicholas S.; Cole, Mark A.; Cochlin, Lowri E.; Carter, Emma; Tchabanenko, Kirill; Pichulik, Tica; Gulston, Melanie K.; Atherton, Helen J.; Schroeder, Marie A.; Deacon, Robert M. J.; Kashiwaya, Yoshihiro; King, M. Todd; Pawlosky, Robert; Rawlins, J. Nicholas P.; Tyler, Damian J.; Griffin, Julian L.; Robertson, Jeremy; Veech, Richard L.; Clarke, Kieran			Novel ketone diet enhances physical and cognitive performance	FASEB JOURNAL			English	Article						metabolism; muscle; energetics; exercise; heart	BETA-HYDROXYBUTYRATE; EXERCISE PERFORMANCE; UNCOUPLING PROTEINS; KETOGENIC DIET; MITOCHONDRIAL BIOGENESIS; ENERGY-METABOLISM; FAILING HEART; ESTER; ALZHEIMERS; KETOSIS	Ketone bodies are the most energy-efficient fuel and yield more ATP per mole of substrate than pyruvate and increase the free energy released from ATP hydrolysis. Elevation of circulating ketones via high-fat, low carbohydrate diets has been used for the treatment of drug-refractory epilepsy and for neurodegenerative diseases, such as Parkinson's disease. Ketones may also be beneficial for muscle and brain in times of stress, such as endurance exercise. The challenge has been to raise circulating ketone levels by using a palatable diet without altering lipid levels. We found that blood ketone levels can be increased and cholesterol and triglycerides decreased by feeding rats a novel ketone ester diet: chow that is supplemented with (R)-3-hydroxybutyl (R)-3-hydroxybutyrate as 30% of calories. For 5 d, rats on the ketone diet ran 32% further on a treadmill than did control rats that ate an isocaloric diet that was supplemented with either corn starch or palm oil (P < 0.05). Ketone-fed rats completed an 8-arm radial maze test 38% faster than did those on the other diets, making more correct decisions before making a mistake (P < 0.05). Isolated, perfused hearts from rats that were fed the ketone diet had greater free energy available from ATP hydrolysis during increased work than did hearts from rats on the other diets as shown by using [P-31]-NMR spectroscopy. The novel ketone diet, therefore, improved physical performance and cognitive function in rats, and its energy-sparing properties suggest that it may help to treat a range of human conditions with metabolic abnormalities.-Murray, A. J., Knight, N. S., Cole, M. A., Cochlin, L. E., Carter, E., Tchabanenko, K., Pichulik, T., Gulston, M. K., Atherton, H. J., Schroeder, M. A., Deacon, R. M. J., Kashiwaya, Y., King, M. T., Pawlosky, R., Rawlins, J. N. P., Tyler, D. J., Griffin, J. L., Robertson, J., Veech, R. L., Clarke, K. Novel ketone diet enhances physical and cognitive performance.	[Murray, Andrew J.; Knight, Nicholas S.; Cochlin, Lowri E.; Carter, Emma; Pichulik, Tica; Atherton, Helen J.; Schroeder, Marie A.; Tyler, Damian J.; Clarke, Kieran] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Cole, Mark A.; Tchabanenko, Kirill; Robertson, Jeremy] Univ Oxford, Dept Chem, Oxford, England; [Deacon, Robert M. J.; Rawlins, J. Nicholas P.] Univ Oxford, Dept Expt Psychol, Oxford, England; [Murray, Andrew J.] Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge CB2 3EG, England; [Gulston, Melanie K.; Griffin, Julian L.] Univ Cambridge, Dept Biochem, Cambridge, England; [Gulston, Melanie K.; Griffin, Julian L.] Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge, England; [Kashiwaya, Yoshihiro; King, M. Todd; Pawlosky, Robert; Veech, Richard L.] NIAAA, Lab Metab Control, NIH, Rockville, MD 20852 USA; [Cole, Mark A.] Univ Nottingham, Fac Med & Hlth Sci, Nottingham, England; [Tchabanenko, Kirill] Queens Univ Belfast, Sch Chem & Chem Engn, Belfast, Antrim, North Ireland	University of Oxford; University of Oxford; University of Oxford; University of Cambridge; University of Cambridge; University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of Nottingham; Queens University Belfast	Murray, AJ (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge CB2 3EG, England.	ajm267@cam.ac.uk		Cole, Mark/0000-0002-0727-7833; Murray, Andrew/0000-0002-0929-9315; Tyler, Damian/0000-0002-0780-8905	Defense Advanced Research Projects Agency; Research Councils UK; Biotechnology and Biological Sciences Research Council [BB/H013539/1] Funding Source: researchfish; British Heart Foundation [FS/10/002/28078, FS/14/17/30634] Funding Source: researchfish; Medical Research Council [MC_UP_A090_1006, G0601490, MR/P011705/1] Funding Source: researchfish; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000110] Funding Source: NIH RePORTER; BBSRC [BB/H013539/1] Funding Source: UKRI; MRC [MC_UP_A090_1006, G0601490, MR/P011705/1] Funding Source: UKRI	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Research Councils UK(UK Research & Innovation (UKRI)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank Dr. Joseph Bielitsky, the late Dr. Catherine Golden, Dr. Brett Giroir, and Dr. Kerrie DeMarco (Defense Advanced Research Projects Agency, Arlington, VA, USA), whose constant support and advice made this study possible. A.J.M. thanks the Research Councils UK for supporting his Academic Fellowship. This work was supported by the Defense Advanced Research Projects Agency. The intellectual property covering the uses of ketone bodies and esters are owned by BTG, Ltd., the University of Oxford, and the U.S. National Institutes of Health. Should royalties ever accrue from these patents, A.J.M., R.L.V., M.T.K., and K.C., as named inventors, may receive a share of royalties as determined by the terms of the respective institutions. K.C. is director of T Delta S, Ltd., a company spun out of the University of Oxford to develop products on the basis of ketone ester nutrition.	Ashrafian H, 2007, CIRCULATION, V116, P434, DOI 10.1161/CIRCULATIONAHA.107.702795; Atherton HJ, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.18; Aubert G, 2016, CIRCULATION, V133, P698, DOI 10.1161/CIRCULATIONAHA.115.017355; Bedi KC, 2016, CIRCULATION, V133, P706, DOI 10.1161/CIRCULATIONAHA.115.017545; Bergqvist AGC, 2005, EPILEPSIA, V46, P1810, DOI 10.1111/j.1528-1167.2005.00282.x; BERGSTROM J, 1967, ACTA PHYSIOL SCAND, V71, P140, DOI 10.1111/j.1748-1716.1967.tb03720.x; Brand-Miller JC, 2002, AM J CLIN NUTR, V76, p281S, DOI 10.1093/ajcn/76.1.281S; Burgess SC, 2008, J BIOL CHEM, V283, P1670, DOI 10.1074/jbc.M706540200; Burke LM, 2006, J APPL PHYSIOL, V100, P7, DOI 10.1152/japplphysiol.01238.2005; Burke LM, 2015, SPORTS MED, V45, pS33, DOI 10.1007/s40279-015-0393-9; Cahill G., 1980, CEREBRAL METABOLISM, P234; Cahill G F Jr, 1970, N Engl J Med, V282, P668, DOI 10.1056/NEJM197003052821026; Cahill George F Jr, 2003, Trans Am Clin Climatol Assoc, V114, P149; Clarke K, 2012, REGUL TOXICOL PHARM, V63, P401, DOI 10.1016/j.yrtph.2012.04.008; Clarke K, 2012, REGUL TOXICOL PHARM, V63, P196, DOI 10.1016/j.yrtph.2012.04.001; Cole MA, 2011, BASIC RES CARDIOL, V106, P447, DOI 10.1007/s00395-011-0156-1; Cox PJ, 2014, EXTREME PHYSIOL MED, V3, DOI 10.1186/2046-7648-3-17; Deng CH, 2004, J CHROMATOGR B, V805, P235, DOI 10.1016/j.jchromb.2004.03.001; Desrois M, 2014, NMR BIOMED, V27, P529, DOI 10.1002/nbm.3088; Dodd MS, 2015, EMAGRES, V4, P811, DOI 10.1002/9780470034590.emrstm1460; Dorn GW, 2015, GENE DEV, V29, P1981, DOI 10.1101/gad.269894.115; Edwards LM, 2011, FASEB J, V25, P1088, DOI 10.1096/fj.10-171983; Holloway CJ, 2011, AM J CLIN NUTR, V93, P748, DOI 10.3945/ajcn.110.002758; Kashiwaya Y, 1997, AM J CARDIOL, V80, pA50, DOI 10.1016/S0002-9149(97)00458-X; Kashiwaya Y, 2000, P NATL ACAD SCI USA, V97, P5440, DOI 10.1073/pnas.97.10.5440; Kashiwaya Y, 2013, NEUROBIOL AGING, V34, P1530, DOI 10.1016/j.neurobiolaging.2012.11.023; Kashiwaya Y, 2010, J BIOL CHEM, V285, P25950, DOI 10.1074/jbc.M110.138198; Kemper MF, 2015, LIPIDS, V50, P1185, DOI 10.1007/s11745-015-4085-x; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Kiens B, 2015, EXERC SPORT SCI REV, V43, P109, DOI 10.1249/JES.0000000000000053; Knapp DR, 1979, HDB ANAL DERIVATIZAT; Korbonits M, 2005, NEW ENGL J MED, V353, P2306, DOI 10.1056/NEJM200511243532124; KREBS H. A., 1937, Enzymologia, V4, P148; Kwiterovich PO, 2003, JAMA-J AM MED ASSOC, V290, P912, DOI 10.1001/jama.290.7.912; Lommi J, 1998, AM J CARDIOL, V81, P45, DOI 10.1016/S0002-9149(97)00804-7; MITCHELL P, 1967, NATURE, V213, P137, DOI 10.1038/213137a0; Murray AJ, 2005, DIABETES, V54, P3496, DOI 10.2337/diabetes.54.12.3496; Murray AJ, 2004, LANCET, V364, P1786, DOI 10.1016/S0140-6736(04)17402-3; Murray AJ, 2008, J MOL CELL CARDIOL, V44, P694, DOI 10.1016/j.yjmcc.2008.01.008; Murray AJ, 2006, CARDIOVASC RES, V71, P149, DOI 10.1016/j.cardiores.2006.02.031; Murray AJ, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-55; Murray AJ, 2009, FASEB J, V23, P4353, DOI 10.1096/fj.09-139691; Naressi A, 2001, COMPUT BIOL MED, V31, P269, DOI 10.1016/S0010-4825(01)00006-3; Neubauer S, 1997, CIRCULATION, V96, P2190; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Newport MT, 2015, ALZHEIMERS DEMENT, V11, P99, DOI 10.1016/j.jalz.2014.01.006; OLTON DS, 1976, J EXP PSYCHOL-ANIM B, V2, P97, DOI 10.1037/0097-7403.2.2.97; OWEN OE, 1967, J CLIN INVEST, V46, P1589, DOI 10.1172/JCI105650; Pan JW, 1999, EPILEPSIA, V40, P703, DOI 10.1111/j.1528-1157.1999.tb00766.x; Paoli A, 2015, EXERC SPORT SCI REV, V43, P153, DOI 10.1249/JES.0000000000000050; PHINNEY SD, 1983, METABOLISM, V32, P757, DOI 10.1016/0026-0495(83)90105-1; Rajabi M, 2007, HEART FAIL REV, V12, P331, DOI 10.1007/s10741-007-9034-1; Rapoport BI, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000960; Reger MA, 2004, NEUROBIOL AGING, V25, P311, DOI 10.1016/S0197-4580(03)00087-3; SATO K, 1995, FASEB J, V9, P651, DOI 10.1096/fasebj.9.8.7768357; Schroeder MA, 2008, P NATL ACAD SCI USA, V105, P12051, DOI 10.1073/pnas.0805953105; Seymour AML, 1997, J MOL CELL CARDIOL, V29, P2771, DOI 10.1006/jmcc.1997.0512; Sharma S, 2004, FASEB J, V18, P1692, DOI 10.1096/fj.04-2263com; Srivastava S, 2012, FASEB J, V26, P2351, DOI 10.1096/fj.11-200410; Swink T D, 1997, Adv Pediatr, V44, P297; Tieu K, 2003, J CLIN INVEST, V112, P892, DOI 10.1172/JCI200318797; VanItallie TB, 2005, NEUROLOGY, V64, P728, DOI 10.1212/01.WNL.0000152046.11390.45; Veech RL, 2014, J LIPID RES, V55, P2004, DOI 10.1194/jlr.R046292; Veech RL, 2012, IUBMB LIFE, V64, P203, DOI 10.1002/iub.590; VEECH RL, 1979, J BIOL CHEM, V254, P6538; VEECH RL, 1974, TOXICOL APPL PHARM, V29, P196, DOI 10.1016/0041-008X(74)90056-8; Volek JS, 2016, METABOLISM, V65, P100, DOI 10.1016/j.metabol.2015.10.028	67	105	106	6	70	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4021	4032		10.1096/fj.201600773R	http://dx.doi.org/10.1096/fj.201600773R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27528626	hybrid, Green Accepted, Green Submitted, Green Published			2022-12-26	WOS:000388201500010
J	Zhang, H; Zhou, MX; Yang, TD; Haslam, SM; Dell, A; Wu, H				Zhang, Hua; Zhou, Meixian; Yang, Tiandi; Haslam, Stuart M.; Dell, Anne; Wu, Hui			New Helical Binding Domain Mediates a Glycosyltransferase Activity of a Bifunctional Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adhesin; crystal structure; glycoprotein biosynthesis; glycosylation; glycosyltransferase; Streptococcus	FIMBRIAE-ASSOCIATED ADHESIN; STREPTOCOCCUS-PARASANGUIS; MOLECULAR CHAPERONE; FUNCTIONAL-ANALYSIS; BIOFILM FORMATION; UNKNOWN FUNCTION; SURFACE PROTEIN; FAP1; GLYCOSYLATION; GLYCOPROTEIN	Serine-rich repeat glycoproteins (SRRPs) conserved in streptococci and staphylococci are important for bacterial colonization and pathogenesis. Fap1, a well studied SRRP is a major surface constituent of Streptococcus parasanguinis and is required for bacterial adhesion and biofilm formation. Biogenesis of Fap1 is a multistep process that involves both glycosylation and secretion. A series of glycosyltransferases catalyze sequential glycosylation of Fap1. We have identified a unique hybrid protein dGT1 (dual glycosyltransferase 1) that contains two distinct domains. N-terminal DUF1792 is a novel GT-D-type glycosyltransferase, transferring Glc residues to Glc-GlcNAc-modified Fap1. C-terminal dGT1 (CgT) is predicted to possess a typical GT-A-type glycosyltransferase, however, the activity remains unknown. In this study, we determine that CgT is a distinct glycosyltransferase, transferring GlcNAc residues to Glc-Glc-GlcNAc-modified Fap1. A 2.4- x-ray crystal structure reveals that CgT has a unique binding domain consisting of three helices in addition to a typical GT-A-type glycosyltransferase domain. The helical domain is crucial for the oligomerization of CgT. Structural and biochemical studies revealed that the helix domain is required for the protein-protein interaction and crucial for the glycosyltransferase activity of CgT in vitro and in vivo. As the helix domain presents a novel structural fold, we conclude that CgT represents a new member of GT-A-type glycosyltransferases.	[Zhang, Hua; Zhou, Meixian; Wu, Hui] Univ Alabama Birmingham, Sch Dent, Dept Pediat Dent, Birmingham, AL 35294 USA; [Zhang, Hua; Zhou, Meixian; Wu, Hui] Univ Alabama Birmingham, Sch Dent, Dept Microbiol, Birmingham, AL 35294 USA; [Zhang, Hua; Zhou, Meixian; Wu, Hui] Univ Alabama Birmingham, Sch Med, Dept Pediat Dent, Birmingham, AL 35294 USA; [Zhang, Hua; Zhou, Meixian; Wu, Hui] Univ Alabama Birmingham, Sch Med, Dept Microbiol, Birmingham, AL 35294 USA; [Yang, Tiandi; Haslam, Stuart M.; Dell, Anne] Imperial Coll London, Dept Life Sci, London SW7 2AZ, England	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Imperial College London	Wu, H (corresponding author), 1919 7th Ave South, Birmingham, AL 35294 USA.	hwu@uab.edu		Dell, Anne/0000-0003-1380-2347	National Institutes of Health Shared Instrumentation Grant [1S10RR026478]; Shared Facility Program of the UAB Comprehensive Cancer Center Grant [316851]; BBSRC [BB/K016164/1] Funding Source: UKRI; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026478] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [F33DE022215, R01DE017954] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/K016164/1] Funding Source: researchfish	National Institutes of Health Shared Instrumentation Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shared Facility Program of the UAB Comprehensive Cancer Center Grant; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank Zhengrong Yang for helping to access the Auto-iTC200 in the Biocalorimetry Laboratory supported by National Institutes of Health Shared Instrumentation Grant 1S10RR026478 and Shared Facility Program of the UAB Comprehensive Cancer Center Grant 316851. X-ray data were collected at Southeast Regional Collaborative Access Team (SER-CAT) 22-ID beamline at the Advanced Photon Source, Argonne National Laboratory.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bensing BA, 2002, MOL MICROBIOL, V44, P1081, DOI 10.1046/j.1365-2958.2002.02949.x; Brown K, 1999, EMBO J, V18, P4096, DOI 10.1093/emboj/18.15.4096; Charnock SJ, 1999, BIOCHEMISTRY-US, V38, P6380, DOI 10.1021/bi990270y; Chen Q, 2004, MOL MICROBIOL, V53, P843, DOI 10.1111/j.1365-2958.2004.04116.x; Drickamer K, 1998, TRENDS BIOCHEM SCI, V23, P321, DOI 10.1016/S0968-0004(98)01246-8; Echlin H, 2013, J BACTERIOL, V195, P2166, DOI 10.1128/JB.02255-12; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Froeliger EH, 2001, INFECT IMMUN, V69, P2512, DOI 10.1128/IAI.69.4.2512-2519.2001; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Holzl G, 2005, GLYCOBIOLOGY, V15, P874, DOI 10.1093/glycob/cwi066; Izquierdo L, 2015, GLYCOBIOLOGY, V25, P438, DOI 10.1093/glycob/cwu131; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Nakanishi M, 2014, PARASITOL INT, V63, P513, DOI 10.1016/j.parint.2014.01.007; North SJ, 2010, METHOD ENZYMOL, V478, P27, DOI 10.1016/S0076-6879(10)78002-2; O'Reilly MK, 2006, BIOCHEMISTRY-US, V45, P9593, DOI 10.1021/bi060878o; Otwinowski Z., 2001, INT TABLES CRYSTALLO, V276, P226; Peng Z, 2008, ORAL MICROBIOL IMMUN, V23, P70, DOI 10.1111/j.1399-302X.2007.00401.x; Peng Z., 2008, BMC MICROBIOL, V8, P52; Plummer C, 2005, BRIT J HAEMATOL, V129, P101, DOI 10.1111/j.1365-2141.2005.05421.x; Romanow A, 2013, J BIOL CHEM, V288, P11718, DOI 10.1074/jbc.M113.452276; Sanchez CJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001044; Seifert KN, 2006, MICROBIOL-SGM, V152, P1029, DOI 10.1099/mic.0.28516-0; Shivshankar P, 2009, MOL MICROBIOL, V73, P663, DOI 10.1111/j.1365-2958.2009.06796.x; Siboo IR, 2005, INFECT IMMUN, V73, P2273, DOI 10.1128/IAI.73.4.2273-2280.2005; Sobhany M, 2005, J BIOL CHEM, V280, P23441, DOI 10.1074/jbc.M413379200; Sobhany M, 2008, J BIOL CHEM, V283, P32328, DOI 10.1074/jbc.M804332200; Stephenson AE, 2002, MOL MICROBIOL, V43, P147, DOI 10.1046/j.1365-2958.2002.02725.x; Takahashi Y, 2006, INFECT IMMUN, V74, P740, DOI 10.1128/IAI.74.1.740-743.2006; Takahashi Y, 2004, INFECT IMMUN, V72, P3876, DOI 10.1128/IAI.72.7.3876-3882.2004; Tarbouriech N, 2001, J MOL BIOL, V314, P655, DOI 10.1006/jmbi.2001.5159; van der Wel H, 2002, J BIOL CHEM, V277, P46527, DOI 10.1074/jbc.M208824200; Wang ZA, 2009, J BIOL CHEM, V284, P28896, DOI 10.1074/jbc.M109.022574; Williams KJ, 2006, J BIOL CHEM, V281, P5391, DOI 10.1074/jbc.M510439200; Wu H, 1999, MOL MICROBIOL, V34, P1070, DOI 10.1046/j.1365-2958.1999.01670.x; Wu H, 1998, MOL MICROBIOL, V28, P487, DOI 10.1046/j.1365-2958.1998.00805.x; Wu H, 2007, INFECT IMMUN, V75, P2181, DOI 10.1128/IAI.01544-06; Wu H, 2007, J BACTERIOL, V189, P1390, DOI 10.1128/JB.00836-06; Wu R, 2011, J BIOL CHEM, V286, P34923, DOI 10.1074/jbc.M111.239350; Yang Yong Ryoul, 2014, Advances in Biological Regulation, V54, P68, DOI 10.1016/j.jbior.2013.09.007; Zegzouti H., 2013, GLYCOBIOLOGY, P2001; Zhang H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5339; Zhang H, 2013, ACTA CRYSTALLOGR F, V69, P520, DOI 10.1107/S1744309113007161; Zhang YQ, 2003, MOL MICROBIOL, V49, P1577, DOI 10.1046/j.1365-2958.2003.03671.x; Zhou M, 2008, J MICROBIOL METH, V72, P249, DOI 10.1016/j.mimet.2007.12.002; Zhou MX, 2012, MOL MICROBIOL, V83, P866, DOI 10.1111/j.1365-2958.2012.07970.x; Zhou MX, 2011, J BACTERIOL, V193, P6560, DOI 10.1128/JB.05668-11; Zhou MX, 2010, J BIOL CHEM, V285, P12140, DOI 10.1074/jbc.M109.066928; Zhu F, 2015, J DENT RES, V94, P659, DOI 10.1177/0022034515574865; Zhu Fan, 2013, Methods Mol Biol, V1022, P29, DOI 10.1007/978-1-62703-465-4_3; Zhu F, 2011, J BIOL CHEM, V286, P27048, DOI 10.1074/jbc.M110.208629	51	13	13	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22106	22117		10.1074/jbc.M116.731695	http://dx.doi.org/10.1074/jbc.M116.731695			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27539847	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000386332600025
J	Bandara, M; Corey, RA; Martin, R; Skehel, JM; Blocker, AJ; Jenkinson, HF; Collinson, I				Bandara, Mikaila; Corey, Robin A.; Martin, Remy; Skehel, J. Mark; Blocker, Ariel J.; Jenkinson, Howard F.; Collinson, Ian			Composition and Activity of the Non-canonical Gram-positive SecY2 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPase; complex; membrane; secretion; transport; SecY2; Streptococcus gordonii; accessory Sec system; translocon	BINDING-PROTEIN-GSPB; MOLECULAR-DYNAMICS SIMULATIONS; GROUP-A STREPTOCOCCI; ANTIGEN-I/II FAMILY; ESCHERICHIA-COLI; CELL-SURFACE; PREPROTEIN TRANSLOCASE; BIOFILM FORMATION; GORDONII; EXPORT	The accessory Sec system in Streptococcus gordonii DL1 is a specialized export system that transports a large serine-rich repeat protein, Hsa, to the bacterial surface. The system is composed of core proteins SecA2 and SecY2 and accessory Sec proteins Asp1-Asp5. Similar to canonical SecYEG, SecY2 forms a channel for translocation of the Hsa adhesin across the cytoplasmic membrane. Accessory Sec proteins Asp4 and Asp5 have been suggested to work alongside SecY2 to form the translocon, similar to the associated SecY, SecE, and SecG of the canonical system (SecYEG). To test this theory, S. gordonii secY2, asp4, and asp5 were co-expressed in Escherichia coli. The resultant complex was subsequently purified, and its composition was confirmed by mass spectrometry to be SecY2-Asp4-Asp5. Like SecYEG, the non-canonical complex activates the ATPase activity of the SecA motor (SecA2). This study also shows that Asp4 and Asp5 are necessary for optimal adhesion of S. gordonii to glycoproteins gp340 and fibronectin, known Hsa binding partners, as well as for early stage biofilm formation. This work opens new avenues for understanding the structure and function of the accessory Sec system.	[Bandara, Mikaila; Jenkinson, Howard F.] Sch Oral & Dent Sci, Lower Maudlin St, Bristol BS1 2LY, Avon, England; [Bandara, Mikaila; Corey, Robin A.; Martin, Remy; Blocker, Ariel J.; Collinson, Ian] Univ Bristol, Sch Biochem, Univ Walk, Bristol BS8 1TD, Avon, England; [Bandara, Mikaila; Blocker, Ariel J.] Univ Bristol, Sch Cellular & Mol Med, Univ Walk, Bristol BS8 1TD, Avon, England; [Skehel, J. Mark] MRC, Mol Biol Lab, Biol Mass Spectrometry & Prote, Francis Crick Ave, Cambridge CB2 0QH, England	University of Bristol; University of Bristol; University of Bristol; MRC Laboratory Molecular Biology	Collinson, I (corresponding author), Univ Bristol, Sch Biochem, Univ Walk, Bristol BS8 1TD, Avon, England.	ian.collinson@bristol.ac.uk	Jenkinson, Howard/ABI-1842-2020; Jenkinson, Howard/AAD-9282-2022; Corey, Robin A/AAI-7251-2020	Corey, Robin A/0000-0003-1820-7993; Jayaweera Bandara, Mikaila/0000-0002-6195-6116; Collinson, Ian/0000-0002-3931-0503; Jenkinson, Howard/0000-0002-9195-7945; Martin, Remy/0000-0001-7924-6254	Biotechnology and Biological Sciences Research Council [BB/I008675/1]; Medical Research Council Doctoral Training Grant [2011-G1001606]; Biotechnology and Biological Sciences Research Council South West Bioscience Doctoral Training Partnership; University of Bristol postgraduate scholarship; BBSRC [BB/I008675/1] Funding Source: UKRI; MRC [MC_U105178788] Funding Source: UKRI; Medical Research Council [1168597, MC_U105178788] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council Doctoral Training Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council South West Bioscience Doctoral Training Partnership(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Bristol postgraduate scholarship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work supported by Biotechnology and Biological Sciences Research Council Project Grant BB/I008675/1 (to I. C.), Medical Research Council Doctoral Training Grant 2011-G1001606 (to M. B.), Biotechnology and Biological Sciences Research Council South West Bioscience Doctoral Training Partnership (to R. A. C.), and University of Bristol postgraduate scholarship (to R. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Allen WJ, 2016, ELIFE, V5, DOI 10.7554/eLife.15598; Bensing B. A., 2013, BIOCHIM BIOPHYS ACTA, V1843, P1674; Bensing BA, 2005, MOL MICROBIOL, V58, P1468, DOI 10.1111/j.1365-2958.2005.04919.x; Bensing BA, 2004, J BACTERIOL, V186, P638, DOI 10.1128/JB.186.3.638-645.2004; Bensing BA, 2002, MOL MICROBIOL, V44, P1081, DOI 10.1046/j.1365-2958.2002.02949.x; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; BRUNDAGE L, 1990, CELL, V62, P649, DOI 10.1016/0092-8674(90)90111-Q; Collinson I, 2001, EMBO J, V20, P2462, DOI 10.1093/emboj/20.10.2462; Collinson I, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0025; Corey RA, 2016, STRUCTURE, V24, P518, DOI 10.1016/j.str.2016.02.001; DOUGLAS CWI, 1993, J MED MICROBIOL, V39, P179, DOI 10.1099/00222615-39-3-179; DOUVILLE K, 1995, J BIOL CHEM, V270, P20106, DOI 10.1074/jbc.270.34.20106; Duong F, 1997, EMBO J, V16, P2756, DOI 10.1093/emboj/16.10.2756; Feltcher ME, 2012, NAT REV MICROBIOL, V10, P779, DOI 10.1038/nrmicro2874; Garnier F, 1997, J CLIN MICROBIOL, V35, P2337, DOI 10.1128/JCM.35.9.2337-2341.1997; Gold VAM, 2007, J BIOL CHEM, V282, P17424, DOI 10.1074/jbc.M702066200; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hartford O, 2001, MICROBIOL-SGM, V147, P2545, DOI 10.1099/00221287-147-9-2545; ITO K, 1984, MOL GEN GENET, V197, P204, DOI 10.1007/BF00330964; Jack AA, 2015, MICROBIOL-SGM, V161, P411, DOI 10.1099/mic.0.000010; Jakubovics NS, 2009, MICROBIOL-SGM, V155, P3572, DOI 10.1099/mic.0.032078-0; Jakubovics NS, 2005, INFECT IMMUN, V73, P6629, DOI 10.1128/IAI.73.10.6629-6638.2005; Jakubovics NS, 2005, MOL MICROBIOL, V55, P1591, DOI 10.1111/j.1365-2958.2005.04495.x; Jang A., 2014, J BACTERIOL VIROL, V44, P317; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Lembke C, 2006, APPL ENVIRON MICROB, V72, P2864, DOI 10.1128/AEM.72.4.2864-2875.2006; LILL R, 1989, EMBO J, V8, P961, DOI 10.1002/j.1460-2075.1989.tb03458.x; Lizcano A, 2012, MOL ORAL MICROBIOL, V27, P257, DOI 10.1111/j.2041-1014.2012.00653.x; Loimaranta V, 2005, INFECT IMMUN, V73, P2245, DOI 10.1128/IAI.73.4.2245-2252.2005; MCNAB R, 1994, MOL MICROBIOL, V14, P743, DOI 10.1111/j.1365-2958.1994.tb01311.x; Mori H, 2001, TRENDS MICROBIOL, V9, P494, DOI 10.1016/S0966-842X(01)02174-6; Nijeholt JALA, 2013, FEBS LETT, V587, P3083, DOI 10.1016/j.febslet.2013.07.046; NISHIYAMA K, 1994, EMBO J, V13, P3272, DOI 10.1002/j.1460-2075.1994.tb06628.x; Nobbs AH, 2007, J BACTERIOL, V189, P3106, DOI 10.1128/JB.01535-06; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; NYVAD B, 1990, CARIES RES, V24, P267, DOI 10.1159/000261281; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; PAKULA R, 1963, J GEN MICROBIOL, V31, P125, DOI 10.1099/00221287-31-1-125; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Podbielski A, 1996, GENE, V177, P137, DOI 10.1016/0378-1119(96)84178-3; Rigel NW, 2008, MOL MICROBIOL, V69, P291, DOI 10.1111/j.1365-2958.2008.06294.x; Robson A, 2009, P NATL ACAD SCI USA, V106, P5111, DOI 10.1073/pnas.0809592106; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Seepersaud R, 2010, MOL MICROBIOL, V78, P490, DOI 10.1111/j.1365-2958.2010.07346.x; Takahashi Y, 2002, INFECT IMMUN, V70, P1209, DOI 10.1128/IAI.70.3.1209-1218.2002; Takamatsu D, 2006, INFECT IMMUN, V74, P1933, DOI 10.1128/IAI.74.3.1933-1940.2006; Takamatsu D, 2005, J BACTERIOL, V187, P3878, DOI 10.1128/JB.187.11.3878-3883.2005; Takamatsu D, 2004, J BACTERIOL, V186, P7100, DOI 10.1128/JB.186.21.7100-7111.2004; Takamatsu D, 2004, MOL MICROBIOL, V52, P189, DOI 10.1111/j.1365-2958.2004.03978.x; Tanaka Y, 2015, CELL REP, V13, P1561, DOI 10.1016/j.celrep.2015.10.025; Tieleman DP, 1999, BIOPHYS J, V76, P40, DOI 10.1016/S0006-3495(99)77176-6; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Whittaker CJ, 1996, ANNU REV MICROBIOL, V50, P513, DOI 10.1146/annurev.micro.50.1.513; Wolf MG, 2010, J COMPUT CHEM, V31, P2169, DOI 10.1002/jcc.21507; Yen YT, 2013, J BACTERIOL, V195, P682, DOI 10.1128/JB.01742-12; Yen YT, 2011, J BACTERIOL, V193, P3165, DOI 10.1128/JB.00057-11; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	58	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21474	21484		10.1074/jbc.M116.729806	http://dx.doi.org/10.1074/jbc.M116.729806			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27551046	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000385999200015
J	Franco, ML; Melero, C; Sarasola, E; Acebo, P; Luque, A; Calatayud-Baselga, I; Garcia-Barcina, M; Vilar, M				Luisa Franco, Maria; Melero, Cristina; Sarasola, Esther; Acebo, Paloma; Luque, Alfonso; Calatayud-Baselga, Isabel; Garcia-Barcina, Maria; Vilar, Marcal			Mutations in TrkA Causing Congenital Insensitivity to Pain with Anhidrosis (CIPA) Induce Misfolding, Aggregation, and Mutation-dependent Neurodegeneration by Dysfunction of the Autophagic Flux	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; ER quality control; neurodegeneration; protein aggregation; TRK1-transforming tyrosine kinase protein (Trk-A); autophagic flux; congenital insensitivity to pain with anhidrosis	NERVE GROWTH-FACTOR; PROTEIN-QUALITY CONTROL; RECEPTOR TYROSINE KINASE; CELL-DEATH; NTRK1 GENE; ACTIVATION; SURVIVAL; STRESS; ROLES; ER	Congenital insensitivity to pain with anhidrosis (CIPA) is a rare autosomal recessive disorder characterized by insensitivity to noxious stimuli and variable intellectual disability (ID) due to mutations in the NTRK1 gene encoding the NGF receptor TrkA. To get an insight in the effect of NTRK1 mutations in the cognitive phenotype we biochemically characterized three TrkA mutations identified in children diagnosed of CIPA with variable ID. These mutations are located in different domains of the protein; L213P in the extracellular domain, 736 in the kinase domain, and C300stop in the extracellular domain, a new mutation causing CIPA diagnosed in a Spanish teenager. We found that TrkA mutations induce misfolding, retention in the endoplasmic reticulum (ER), and aggregation in a mutation-dependent manner. The distinct mutations are degraded with a different kinetics by different ER quality control mechanisms; although C300stop is rapidly disposed by autophagy, 736 degradation is sensitive to the proteasome and to autophagy inhibitors, and L213P is a long-lived protein refractory to degradation. In addition L213P enhances the formation of autophagic vesicles triggering an increase in the autophagic flux with deleterious consequences. Mouse cortical neurons expressing L213P showed the accumulation of LC3-GFP positive puncta and dystrophic neurites. Our data suggest that TrkA misfolding and aggregation induced by some CIPA mutations disrupt the autophagy homeostasis causing neurodegeneration. We propose that distinct disease-causing mutations of TrkA generate different levels of cell toxicity, which may provide an explanation of the variable intellectual disability observed in CIPA patients.	[Luisa Franco, Maria; Melero, Cristina; Calatayud-Baselga, Isabel; Vilar, Marcal] IBV CSIC, Inst Biomed Valencia, Mol Basis Neurodegenerat Unit, C-O Jaume Roig 11, Valencia 46010, Spain; [Sarasola, Esther; Garcia-Barcina, Maria] Basurto Univ Hosp, Dept Genet, Serv Vasco Salud, Bilbao, Spain; [Acebo, Paloma] ISCIII, Chron, Madrid 28220, Spain; [Luque, Alfonso] ISCIII, Rare Dis Ctr, Crta Majadahonda Pozuelo Km 2 Majadahonda, Madrid 28220, Spain; [Melero, Cristina] Univ Manchester, Fac Life Sci, Oxford Rd, Manchester M13 9PT, Lancs, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); Basurto Hospital; Instituto de Salud Carlos III; Instituto de Salud Carlos III; University of Manchester	Vilar, M (corresponding author), IBV CSIC, Inst Biomed Valencia, Mol Basis Neurodegenerat Unit, C-O Jaume Roig 11, Valencia 46010, Spain.	mvilar@ibv.csic.es	Vilar, Marçal/B-4581-2016; Luque, Alfonso/C-5846-2018	Vilar, Marçal/0000-0002-9376-6544; Calatayud-Baselga, Isabel/0000-0001-8653-2662	Spanish Minister of Economy and Competitiveness [BFU2013/42746-P, TPY-M-1068/13]	Spanish Minister of Economy and Competitiveness(Spanish Government)	This work was supported in part by the Spanish Minister of Economy and Competitiveness Grants BFU2013/42746-P (to M. V.) and TPY-M-1068/13 (to A. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Araki K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a007526; Arevalo JC, 2006, NEURON, V50, P549, DOI 10.1016/j.neuron.2006.03.044; Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Bodnarchuk TW, 2012, J NEURO-ONCOL, V109, P485, DOI 10.1007/s11060-012-0927-z; Bonkowsky JL, 2003, PEDIATRICS, V112, pE237, DOI 10.1542/peds.112.3.e237; Brodsky JL, 2012, CELL, V151, P1163, DOI 10.1016/j.cell.2012.11.012; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; Cuervo AM, 2014, CELL RES, V24, P92, DOI 10.1038/cr.2013.153; Dadakhujaev S, 2009, AUTOPHAGY, V5, P103, DOI 10.4161/auto.5.1.7276; Doyle KM, 2011, J CELL MOL MED, V15, P2025, DOI 10.1111/j.1582-4934.2011.01374.x; Erez DL, 2010, DEV MED CHILD NEUROL, V52, P559, DOI 10.1111/j.1469-8749.2009.03567.x; Frake RA, 2015, J CLIN INVEST, V125, P65, DOI 10.1172/JCI73944; Geetha T, 2005, MOL CELL, V20, P301, DOI 10.1016/j.molcel.2005.09.014; Geetha T, 2008, BIOCHEM BIOPH RES CO, V374, P33, DOI 10.1016/j.bbrc.2008.06.082; Gestwicki JE, 2012, PROG MOL BIOL TRANSL, V107, P327, DOI 10.1016/B978-0-12-385883-2.00003-5; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Hansen K, 2007, J NEUROCHEM, V103, P259, DOI 10.1111/j.1471-4159.2007.04753.x; Houck SA, 2014, MOL CELL, V54, P166, DOI 10.1016/j.molcel.2014.02.025; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Indo Y, 1996, NAT GENET, V13, P485, DOI 10.1038/ng0896-485; Indo Y, 2001, HUM MUTAT, V18, P462, DOI 10.1002/humu.1224; Indo Y, 2001, HUM MUTAT, V18, P308, DOI 10.1002/humu.1192; Indo Y, 2010, EXPERT REV NEUROTHER, V10, P1707, DOI [10.1586/ern.10.154, 10.1586/ERN.10.154]; Indo Yasuhiro, 2002, Clin Auton Res, V12 Suppl 1, pI20, DOI 10.1007/s102860200016; Jung EJ, 2008, MOL CELLS, V26, P12; Jung EJ, 2011, BIOCHEM BIOPH RES CO, V404, P841, DOI 10.1016/j.bbrc.2010.12.072; Jung EJ, 2010, MOL CELLS, V30, P121, DOI 10.1007/s10059-010-0096-x; Kaasinen SK, 2008, INT J DEV NEUROSCI, V26, P625, DOI 10.1016/j.ijdevneu.2008.03.011; Lallemend F, 2012, TRENDS NEUROSCI, V35, P373, DOI 10.1016/j.tins.2012.03.006; Li CH, 2010, J NEUROCHEM, V112, P882, DOI 10.1111/j.1471-4159.2009.06507.x; Liu YF, 2012, CURR PROTEIN PEPT SC, V13, P436, DOI 10.2174/138920312802430608; Liu Y, 2011, CURR OPIN NEUROBIOL, V21, P52, DOI 10.1016/j.conb.2010.09.003; LOEB DM, 1991, CELL, V66, P961, DOI 10.1016/0092-8674(91)90441-Z; Maattanen P, 2010, SEMIN CELL DEV BIOL, V21, P500, DOI 10.1016/j.semcdb.2010.03.006; Mardy S, 1999, AM J HUM GENET, V64, P1570, DOI 10.1086/302422; Mardy S, 2001, HUM MOL GENET, V10, P179, DOI 10.1093/hmg/10.3.179; Marmigere F, 2006, NAT NEUROSCI, V9, P180, DOI 10.1038/nn1631; Matus S, 2008, CURR MOL MED, V8, P157, DOI 10.2174/156652408784221324; Merulla J, 2013, TRAFFIC, V14, P767, DOI 10.1111/tra.12068; Miranda C, 2002, J BIOL CHEM, V277, P6455, DOI 10.1074/jbc.M110016200; Mnich K, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.173; Morimoto RI, 2014, J GERONTOL A-BIOL, V69, pS33, DOI 10.1093/gerona/glu049; Nixon RA, 2014, BIOESSAYS, V36, P547, DOI 10.1002/bies.201400064; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Petruska JC, 2004, NEUROSCI LETT, V361, P168, DOI 10.1016/j.neulet.2003.12.012; Sarasola E, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-86; Schecterson LC, 2010, MOL CELL NEUROSCI, V43, P403, DOI 10.1016/j.mcn.2010.01.007; Schneider JL, 2014, CURR OPIN GENET DEV, V26, P16, DOI 10.1016/j.gde.2014.04.003; Senft D, 2015, TRENDS BIOCHEM SCI, V40, P141, DOI 10.1016/j.tibs.2015.01.002; Shaid S, 2013, CELL DEATH DIFFER, V20, P21, DOI 10.1038/cdd.2012.72; Sztriha L, 2001, PEDIATR NEUROL, V25, P63, DOI 10.1016/S0887-8994(01)00278-8; Tanaka K, 2014, BBA-MOL CELL RES, V1843, P197, DOI 10.1016/j.bbamcr.2013.03.012; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Watson FL, 1999, J NEUROBIOL, V39, P323, DOI 10.1002/(SICI)1097-4695(199905)39:2<323::AID-NEU15>3.0.CO;2-4; Wooten MW, 2008, J BIOL CHEM, V283, P6783, DOI 10.1074/jbc.M709496200; Wooten MW, 2001, J BIOL CHEM, V276, P7709, DOI 10.1074/jbc.C000869200; Yan CH, 2002, CANCER RES, V62, P4867	57	21	22	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21363	21374		10.1074/jbc.M116.722587	http://dx.doi.org/10.1074/jbc.M116.722587			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27551041	Green Published, hybrid			2022-12-26	WOS:000385999200003
J	Kim, GD; Das, R; Goduni, L; McClellan, S; Hazlett, LD; Mahabeleshwar, GH				Kim, Gun-Dong; Das, Riku; Goduni, Lediana; McClellan, Sharon; Hazlett, Linda D.; Mahabeleshwar, Ganapati H.			Kruppel-like Factor 6 Promotes Macrophage-mediated Inflammation by Suppressing B Cell Leukemia/Lymphoma 6 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; IN-VIVO; POLARIZATION; PLASTICITY; GENE; DIFFERENTIATION; DYNAMICS; BCL-6; TRANSCRIPTION; HOMEOSTASIS	Macrophages are the predominant innate immune cells recruited to tissues following injury or infection. These early-responding, pro-inflammatory macrophages play an essential role in the amplification of inflammation. However, macrophage pro-inflammatory gene expression should be tightly regulated to avert host tissue damage. In this study, we identify the Kruppel-like transcription factor 6 (KLF6)-B cell leukemia/lymphoma 6 (BCL6) signaling axis as a novel regulator of macrophage inflammatory gene expression and function. Utilizing complementary gain-and loss-of-function studies, we observed that KLF6 is essential for macrophage motility under ex vivo and in vivo conditions. Concordant with these observations, myeloid-specific deficiency of KLF6 significantly attenuates macrophage pro-inflammatory gene expression, recruitment, and progression of inflammation. At the molecular level, KLF6 suppresses BCL6 mRNA and protein expression by elevating PR domain-containing 1 with ZNF domain (PRDM1) levels in macrophages. Interestingly, pharmacological or genetic inhibition of BCL6 in KLF6-deficient macrophages completely abrogated the attenuation of pro-inflammatory cytokine/chemokine expression and cellular motility. Collectively, our observations reveal that KLF6 repress BCL6 to enhance macrophage inflammatory gene expression and function.	[Kim, Gun-Dong; Goduni, Lediana; Mahabeleshwar, Ganapati H.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Mahabeleshwar, Ganapati H.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Das, Riku] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA; [McClellan, Sharon; Hazlett, Linda D.] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA	Case Western Reserve University; Case Western Reserve University; Cleveland Clinic Foundation; Wayne State University	Mahabeleshwar, GH (corresponding author), Case Cardiovasc Res Inst, Harrington Heart & Vasc Inst, Dept Med, Wolstein Res Bldg,Rm 4524,2103 Cornell Rd, Cleveland, OH 44106 USA.	ghm4@case.edu			National Institutes of Health [HL126626]; Cleveland Digestive Diseases Research Core Center Pilot/Feasibility Award [P30DK097948]; Crohn's and Colitis Foundation of America Senior Research Award [421904]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK097948] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cleveland Digestive Diseases Research Core Center Pilot/Feasibility Award; Crohn's and Colitis Foundation of America Senior Research Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant HL126626, Cleveland Digestive Diseases Research Core Center Pilot/Feasibility Award P30DK097948, and Crohn's and Colitis Foundation of America Senior Research Award 421904 (to G. H. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Barish GD, 2012, CELL METAB, V15, P554, DOI 10.1016/j.cmet.2012.02.012; Barish GD, 2010, GENE DEV, V24, P2760, DOI 10.1101/gad.1998010; Basso K, 2010, ADV IMMUNOL, V105, P193, DOI 10.1016/S0065-2776(10)05007-8; Cerchietti LC, 2010, CANCER CELL, V17, P400, DOI 10.1016/j.ccr.2009.12.050; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Date D, 2014, J BIOL CHEM, V289, P10318, DOI 10.1074/jbc.M113.526749; Davis Beckley K, 2013, Methods Mol Biol, V1031, P27, DOI 10.1007/978-1-62703-481-4_3; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Diehl SA, 2008, J IMMUNOL, V180, P4805, DOI 10.4049/jimmunol.180.7.4805; Goodman WA, 2016, MUCOSAL IMMUNOL, V9, P1250, DOI 10.1038/mi.2016.1; Koritschoner NP, 1997, J BIOL CHEM, V272, P9573; Laskin DL, 2011, ANNU REV PHARMACOL, V51, P267, DOI 10.1146/annurev.pharmtox.010909.105812; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Miyauchi Y, 2010, J EXP MED, V207, P751, DOI 10.1084/jem.20091957; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nayak L, 2013, AM J PATHOL, V182, P1696, DOI 10.1016/j.ajpath.2013.01.029; Nilsson R, 2006, GENOMICS, V88, P133, DOI 10.1016/j.ygeno.2006.03.022; Nykter M, 2008, P NATL ACAD SCI USA, V105, P1897, DOI 10.1073/pnas.0711525105; Palau N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-825; Pasqualucci L, 2003, BLOOD, V101, P2914, DOI 10.1182/blood-2002-11-3387; SCHALL TJ, 1994, CURR OPIN IMMUNOL, V6, P865, DOI 10.1016/0952-7915(94)90006-X; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Smale ST, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016261; Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342; Stout RD, 2004, J LEUKOCYTE BIOL, V76, P509, DOI 10.1189/jlb.0504272; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; YE BHH, 1993, CANCER RES, V53, P2732; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zhang Y, 2014, J BIOL CHEM, V289, P12876, DOI 10.1074/jbc.M113.535831	35	23	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					21271	21282		10.1074/jbc.M116.738617	http://dx.doi.org/10.1074/jbc.M116.738617			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27539853	Green Published, hybrid			2022-12-26	WOS:000385406200039
J	He, JG; Wang, TL; Wang, T; Xu, H; Zhang, Y; Dong, JS				He, Jin-Guang; Wang, Ting-Liang; Wang, Tao; Xu, Hua; Zhang, Yi; Dong, Jia-Sheng			The Immunologic Properties of Bone Morphogenic Protein Receptor IB Positive Subpopulation before and after Osteogenic Differentiation in Mouse Dermis	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; T-LYMPHOCYTE PROLIFERATION; FIBROBLASTS; CAPACITY	We have previously reported that human dermal bone morphogenic protein receptor (BMPR) IB positive subpopulation had a high osteogenic differentiation potential and may be a promising cell source for allogeneic bone tissue engineering. In this study, the immunologic properties of dermal BMPR-IB+ subpopulation before and after osteogenic differentiation were reported. The results confirmed that dermal BMPR-IB+ cells possessed a similar osteogenic differentiation potential with bone marrow mesenchymal stromal cells in a mouse model. Furthermore, the expression of immune rejection-related surface antigens such as major histocompatibility class II and co-stimulatory proteins (CD40, CD80, and CD86) were absent on dermal BMPRIB+ cells. Dermal BMPRIB+ cells elicited no proliferation of allogeneic splenocytes and suppressed the proliferation of stimulated immune cells. Interestingly, osteogenic differentiation in vitro had no adverse effect on the immunological features of these cells. Most importantly, inducible NO synthase (iNOS) was involved in immunoregulatory effects by undifferentiated BMPRIB+ fibroblasts, whereas indoleamine 2,3-dioxygenase (IDO) activity was related to mediating immunomodulatory function by osteogenic differentiated BMPRIB+ fibroblasts. In conclusion, dermal BMPRIB+ cells have a low immunogenicity and possess immunosuppressive capacity before and after osteogenic differentiation in vitro, which would facilitate the allotransplantation in the future. However, mechanisms mediating immunoregulatory property between undifferentiated and osteogenic differentiated BMPRIB+ fibroblasts may be different and need further investigation.	[He, Jin-Guang; Wang, Ting-Liang; Wang, Tao; Xu, Hua; Zhang, Yi; Dong, Jia-Sheng] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Dept Plast & Reconstruct Surg, Sch Med, Shanghai, Peoples R China	Shanghai Jiao Tong University	Dong, JS (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Dept Plast & Reconstruct Surg, Sch Med, Shanghai, Peoples R China.	jsdong2011@hotmail.com		Wang, Tingliang/0000-0001-7440-7119	National Natural Scientific Foundation of China [81301337]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Scientific Foundation of China (http://www.nsfc.gov.cn/) 81301337. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X; Brown PT, 2014, CELL TISSUE RES, V358, P149, DOI 10.1007/s00441-014-1926-5; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chen FG, 2007, J CELL SCI, V120, P2875, DOI 10.1242/jcs.03478; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Fu X, 2015, TISSUE ENG PT A, V21, P616, DOI [10.1089/ten.tea.2013.0651, 10.1089/ten.TEA.2013.0651]; Haniffa MA, 2007, J IMMUNOL, V179, P1595, DOI 10.4049/jimmunol.179.3.1595; He JG, 2011, ARCH DERMATOL RES, V303, P581, DOI 10.1007/s00403-011-1156-6; Junker JPE, 2010, CELLS TISSUES ORGANS, V191, P105, DOI 10.1159/000232157; Liu H, 2006, J IMMUNOL, V176, P2864, DOI 10.4049/jimmunol.176.5.2864; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Mukonoweshuro B, 2014, J TISSUE ENG, V5, DOI 10.1177/2041731414534255; Nasef A, 2007, GENE EXPRESSION, V13, P217; Niemeyer P, 2007, TISSUE ENG, V13, P111, DOI 10.1089/ten.2006.0114; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Ren GW, 2009, STEM CELLS, V27, P1954, DOI 10.1002/stem.118; Ryan JM, 2007, CLIN EXP IMMUNOL, V149, P353, DOI 10.1111/j.1365-2249.2007.03422.x; Sato K, 2007, BLOOD, V109, P228, DOI 10.1182/blood-2006-02-002246; Thompson EM, 2016, TISSUE ENG PT A, V22, P556, DOI [10.1089/ten.tea.2015.0457, 10.1089/ten.TEA.2015.0457]; Thompson EM, 2015, J TISSUE ENG REGEN M, V9, P889, DOI 10.1002/term.1918; Wada N, 2011, STEM CELLS DEV, V20, P647, DOI 10.1089/scd.2010.0246	23	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0161785	10.1371/journal.pone.0161785	http://dx.doi.org/10.1371/journal.pone.0161785			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27552226	Green Published, Green Submitted, gold			2022-12-26	WOS:000381768800077
J	Kruk, ME; Riley, PL; Palma, AM; Adhikari, S; Ahoua, L; Arnaldo, C; Belo, DF; Brusamento, S; Cumba, LIG; Dziuban, EJ; El-Sadr, WM; Gutema, Y; Habtamu, Z; Heller, T; Kidanu, A; Langa, J; Mahagaja, E; McCarthy, CF; Melaku, Z; Shodell, D; Tsiouris, F; Young, PR; Rabkin, M				Kruk, Margaret E.; Riley, Patricia L.; Palma, Anton M.; Adhikari, Sweta; Ahoua, Laurence; Arnaldo, Carlos; Belo, Dercio F.; Brusamento, Serena; Cumba, Luisa I. G.; Dziuban, Eric J.; El-Sadr, Wafaa M.; Gutema, Yoseph; Habtamu, Zelalem; Heller, Thomas; Kidanu, Aklilu; Langa, Judite; Mahagaja, Epifanio; McCarthy, Carey F.; Melaku, Zenebe; Shodell, Daniel; Tsiouris, Fatima; Young, Paul R.; Rabkin, Miriam			How Can the Health System Retain Women in HIV Treatment for a Lifetime? A Discrete Choice Experiment in Ethiopia and Mozambique	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; CARE; PREFERENCES; RETENTION; SERVICES; COMMUNICATION; HETEROGENEITY; INITIATION; DELIVERY; QUALITY	Introduction Option B+, an approach that involves provision of antiretroviral therapy (ART) to all HIV-infected pregnant women for life, is the preferred strategy for prevention of mother to child transmission of HIV. Lifelong retention in care is essential to its success. We conducted a discrete choice experiment in Ethiopia and Mozambique to identify health system characteristics preferred by HIV-infected women to promote continuity of care. Methods Women living with HIV and receiving care at hospitals in Oromia Region, Ethiopia and Zambezia Province, Mozambique were shown nine choice cards and asked to select one of two hypothetical health facilities, each with six varying characteristics related to the delivery of HIV services for long term treatment. Mixed logit models were used to estimate the influence of six health service attributes on choice of clinics. Results 2,033 women participated in the study (response rate 97.8% in Ethiopia and 94.7% in Mozambique). Among the various attributes of structure and content of lifelong ART services, the most important attributes identified in both countries were respectful provider attitude and ability to obtain non-HIV health services during HIV-related visits. Availability of counseling support services was also a driver of choice. Facility type, i.e., hospital versus health center, was substantially less important. Conclusions Efforts to enhance retention in HIV care and treatment for pregnant women should focus on promoting respectful care by providers and integrating access to non-HIV health services in the same visit, as well as continuing to strengthen counseling.	[Kruk, Margaret E.] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Riley, Patricia L.; Dziuban, Eric J.; McCarthy, Carey F.; Young, Paul R.] US Ctr Dis Control & Prevent, Div Global HIV AIDS, Atlanta, GA USA; [Palma, Anton M.; Adhikari, Sweta] Columbia Univ, Mailman Sch Publ Hlth, Dept Hlth Policy & Management, New York, NY USA; [Ahoua, Laurence; Brusamento, Serena; El-Sadr, Wafaa M.; Gutema, Yoseph; Melaku, Zenebe; Tsiouris, Fatima; Rabkin, Miriam] Columbia Univ, Mailman Sch Publ Hlth, ICAP, New York, NY USA; [Arnaldo, Carlos] Ctr Populat & Hlth Res, Maputo, Mozambique; [Belo, Dercio F.; Cumba, Luisa I. G.; Mahagaja, Epifanio] Mozamb Minist Hlth, Maputo, Mozambique; [Habtamu, Zelalem] Ethiopia Minist Hlth, Oromio Reg Hlth Bur, Addis Ababa, Ethiopia; [Heller, Thomas] Ctr Dis Control & Prevent, Addis Ababa, Ethiopia; [Kidanu, Aklilu] Miz Hasab Res Ctr, Addis Ababa, Ethiopia; [Langa, Judite; Shodell, Daniel] Ctr Dis Control & Prevent, Maputo, Mozambique	Harvard University; Harvard T.H. Chan School of Public Health; Centers for Disease Control & Prevention - USA; Columbia University; Columbia University	Kruk, ME (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA.	mkruk@hsph.harvard.edu	Kruk, Margaret E/E-3058-2010	Kruk, Margaret E/0000-0002-9549-8432	U.S. Centers for Disease Control and Prevention (CDC), Division of Global HIV/AIDS (DGHA) [5U2GPS001537]; NIH's National Institute for Allergy & Infectious Diseases [T32AI114398]; national ministries of health in Ethiopia; national ministries of health in Mozambique; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI114398] Funding Source: NIH RePORTER	U.S. Centers for Disease Control and Prevention (CDC), Division of Global HIV/AIDS (DGHA); NIH's National Institute for Allergy & Infectious Diseases; national ministries of health in Ethiopia; national ministries of health in Mozambique; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this research was provided by the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through cooperative agreement 5U2GPS001537 from the U.S. Centers for Disease Control and Prevention (CDC), Division of Global HIV/AIDS (DGHA) and by the NIH's National Institute for Allergy & Infectious Diseases under award number T32AI114398. The findings and conclusions in this paper are those of the author(s) and do not necessarily represent the official position of the U.S. Centers for Disease Control and Prevention, the NIH or the Governments of Ethiopia and Mozambique.; The authors are indebted to the women in Ethiopia and Mozambique who participated in the study. We wish to thank Boaventura Cau, Hawi Fita, Estevao Manhice, and Semret Zenebe for their capable supervision of the fieldwork for the study as well as the interviewers who collected the data. We appreciate the input and support of health authorities and health workers at the participating health facilities in Oromia region and Zambezia province as well as the support of national ministries of health in Ethiopia and Mozambique.	Anglewicz P, 2011, AIDS CARE, V23, P998, DOI 10.1080/09540121.2010.542130; [Anonymous], 2013, WHO GLOBAL HLTH OBSE; [Anonymous], 2014, 3 GLOB S HLTH SYST R, DOI 1017/S1744133109004836; Assefa Y, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/1744-8603-10-43; Audet CM, 2016, QUAL HEALTH RES, V26, P1721, DOI 10.1177/1049732315580302; Avortri GS, 2011, INT J HEALTH CARE Q, V24, P223, DOI 10.1108/09526861111116660; Business Leadership Council UNICEF Clinton Global Health Initiative, 2012, BUS CAS OPT B B; Callaghan M, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-8; Clouse K, 2014, JAIDS-J ACQ IMM DEF, V67, pE12, DOI 10.1097/QAI.0000000000000263; Curran K, 2014, AIDS, V28, P227, DOI 10.1097/QAD.0000000000000025; da Silva M, 2015, AIDS BEHAV, V19, P666, DOI 10.1007/s10461-014-0874-0; Decroo T, 2014, TROP MED INT HEALTH, V19, P514, DOI 10.1111/tmi.12278; Feyissa TR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113008; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Freedman LP, 2014, LANCET, V384, pE42, DOI 10.1016/S0140-6736(14)60859-X; Haddad S, 1998, SOC SCI MED, V47, P381, DOI 10.1016/S0277-9536(98)00075-6; Hole AR, 2008, J HEALTH ECON, V27, P1078, DOI 10.1016/j.jhealeco.2007.11.006; Howard A, 2015, CLIN INFECT DIS S3, p[50, S238]; ICAP, 2013, ICAP SUPP CLIN INV D; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Kjae T, 2008, HEALTH POLICY, V85, P124, DOI 10.1016/j.healthpol.2007.07.002; Kruk ME, 2010, J EPIDEMIOL COMMUN H, V64, DOI 10.1136/jech.2009.087973; Kruk ME, 2009, AM J PUBLIC HEALTH, V99, P1666, DOI 10.2105/AJPH.2008.146209; Lancsar E, 2006, HEALTH ECON, V15, P797, DOI 10.1002/hec.1104; Lettenmaier C, 2014, JAIDS-J ACQ IMM DEF, V66, pS300, DOI 10.1097/QAI.0000000000000238; McIntyre D, 2009, HEALTH ECON POLICY L, V4, P179, DOI 10.1017/S1744133109004836; MEASURE DHS, 2011, MOZ DEM HLTH SURV 20; Melaku Z, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1776-4; Office of the US Global AIDS Coordinator, 2014, PEPFAR 3 0 CONTR EP; Paulin HN, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1388-z; Revelt D, 1998, REV ECON STAT, V80, P647, DOI 10.1162/003465398557735; Ryan M, 2000, BMJ-BRIT MED J, V320, P1530, DOI 10.1136/bmj.320.7248.1530; Ryan M, 2001, Health Technol Assess, V5, P1; Schneider H, 2006, REPROD HEALTH MATTER, V14, P12, DOI 10.1016/S0968-8080(06)27232-X; Seid Mohammed, 2012, Afr J Reprod Health, V16, P97; Tenthani L, 2014, AIDS, V28, P589, DOI 10.1097/QAD.0000000000000143; Thomas JC, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-22; Tomori C, 2014, JAIDS-J ACQ IMM DEF, V66, pS306, DOI 10.1097/QAI.0000000000000239; UNAIDS, 2013, GLOBAL REPORT UNAIDS; UNAIDS, 2012, TOG WE WILL END AIDS; UNAIDS, 2011, COUNTD ZER GLOB PLAN; UNAIDS, 2013, UNAIDS 2013 WORLD AD; WHO, 2013, GLOB UPD HIV TREATM; Wiegert K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098236; World Health Organization, 2010, PMTCT STRAT VIS 2010	45	34	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0160764	10.1371/journal.pone.0160764	http://dx.doi.org/10.1371/journal.pone.0160764			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT8TR	27551785	gold, Green Published, Green Submitted			2022-12-26	WOS:000381768800017
J	Sands, RJ; Rowntree, JK				Sands, Richard J.; Rowntree, Jennifer K.			Interactions between the Bumblebee Bombus pascuorum and Red Clover (Trifolium pratense) Are Mediated by Plant Genetic Background	PLOS ONE			English	Article							EVOLUTION; FLIES; THERMOREGULATION; COMMUNITY; DIVERSITY; DIPTERA	Wildflower mixes are often planted around field margins to provide forage for pollinators. Although seed for these mixtures is often wild-sourced, for species where agricultural cultivars are available, for example red clover (Trifolium pratense), cultivars can also be included. Previous evidence suggests that plant genetic background can have a strong influence on plant-arthropod interactions and therefore the provenance and genetic background of the plants included in wildflower mixes could impact plant-pollinator interactions. We tested the performance of five individual T. pratense cultivars against two commercially available wild-sourced T. pratense populations in terms of their ability to attract potential pollinator species (focusing on bumblebees) and their floral traits using greenhouse and garden experiments. The main bumblebee observed interacting with T. pratense was Bombus pascuorum and we found no difference in the absolute number of B. pascuorum visiting the cultivars or wild populations. However, we found variation among cultivars and between wild populations in their ability to attract bumblebees, which seems to be related to their relative investment in different floral traits. There was a positive relationship between biomass and number of inflorescences produced by the wild populations of T. pratense, which was not apparent for the cultivars. This suggests that artificial selection on the cultivars has changed the G-matrix of correlated traits. We show that agricultural cultivars of T. pratense can be as effective as wild populations at attracting pollinators such as bumblebees, but that the genetic background of both cultivars and wild populations can have a significant impact on the attractiveness of the plant to pollinators. We also show divergence in the correlated traits of T. pratense cultivars and wild populations that could lead to outbreeding depression if the plants interbreed.	[Sands, Richard J.; Rowntree, Jennifer K.] Univ Manchester, Fac Life Sci, Ctr Genet Ecosyst Serv, Michael Smith Bldg, Manchester, Lancs, England; [Sands, Richard J.] Univ Southampton, Ctr Biol Sci, Highfield Campus, Southampton, Hants, England; [Sands, Richard J.] Forest Res, Ctr Ecosyst Soc & Biosecur, Farnham, Surrey, England	University of Manchester; University of Southampton	Rowntree, JK (corresponding author), Univ Manchester, Fac Life Sci, Ctr Genet Ecosyst Serv, Michael Smith Bldg, Manchester, Lancs, England.	Jennifer.Rowntree@manchester.ac.uk	Rowntree, Jennifer/AAW-8041-2020	Rowntree, Jennifer/0000-0001-8249-8057	University of Manchester; UK Natural Environmental Research Council (NERC) [NE/H016821/3]; Oliver seeds through the provision of cultivar seeds; Natural Environment Research Council [NE/H016821/3] Funding Source: researchfish; NERC [NE/H016821/3] Funding Source: UKRI	University of Manchester; UK Natural Environmental Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Oliver seeds through the provision of cultivar seeds; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	RS received funding for an MPhil from The University of Manchester. JKR received funding through a fellowship from from the UK Natural Environmental Research Council (NERC http://www.nerc.ac.uk); grant number: NE/H016821/3 and two Impact Acceleration Awards. JKR and RS received funding in kind from Oliver seeds (http://www.oliverseeds.co.uk) through the provision of cultivar seeds. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abberton MT, 2005, IGER INNOVATIONS, V9, P24; Barton K., MUMIN MULTIMODEL INF; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Carvell C, 2007, J APPL ECOL, V44, P29, DOI 10.1111/j.1365-2664.2006.01249.x; Dias PMB, 2008, EUPHYTICA, V160, P189, DOI 10.1007/s10681-007-9534-z; Etterson JR, 2001, SCIENCE, V294, P151, DOI 10.1126/science.1063656; Fox J., 2018, R COMPANION APPL REG, VThird; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Genung MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008711; Goulson D, 2005, BIOL CONSERV, V122, P1, DOI 10.1016/j.biocon.2004.06.017; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; Goulson D, 2004, APIDOLOGIE, V35, P55, DOI 10.1051/apido:2003062; Goulson Dave, 2010, P415; HEINRICH B, 1975, J EXP BIOL, V62, P599; Heinrich B., 2004, BUMBLEBEE EC; Ishii HS, 2016, BEHAV ECOL SOCIOBIOL, V70, P377, DOI 10.1007/s00265-016-2057-7; Isobe S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-57; Kearns A, 1993, TECHNIQUES POLLINATI; KREBS C J, 1972, P694; Ludecke D., **DATA OBJECT**; LYNCH M, 1991, EVOLUTION, V45, P622, DOI [10.1111/j.1558-5646.1991.tb04333.x, 10.2307/2409915]; Natural England, 2010, HIGH LEV STEW ENV ST; Natural England, 2012, ENTR LEV STEW ENV ST; ONEILL KM, 1990, ANIM BEHAV, V39, P181, DOI 10.1016/S0003-3472(05)80738-9; Orford KA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2934; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Prys-Jones OE, 2011, BUMBLEBEES; Pugnaire F.I., 2007, FUNCTIONAL PLANT ECO; Pywell RF, 2005, BIOL CONSERV, V121, P479, DOI 10.1016/j.biocon.2004.05.020; R Core Team, 2021, R LANGUAGE ENV STAT; RATHCKE B, 1985, ANNU REV ECOL SYST, V16, P179, DOI 10.1146/annurev.es.16.110185.001143; ROACH DA, 1987, ANNU REV ECOL SYST, V18, P209, DOI 10.1146/annurev.ecolsys.18.1.209; Roff DA, 1996, EVOLUTION, V50, P1392, DOI [10.2307/2410877, 10.1111/j.1558-5646.1996.tb03913.x]; Rowntree JK, 2010, OECOLOGIA, V163, P675, DOI 10.1007/s00442-010-1609-1; Rowntree JK, 2011, PHILOS T R SOC B, V366, P1322, DOI 10.1098/rstb.2010.0357; Sakamoto Y, 1986, AKAIKE INFORM CRITER; Schemske DW, 1999, P NATL ACAD SCI USA, V96, P11910, DOI 10.1073/pnas.96.21.11910; Scheper J, 2013, ECOL LETT, V16, P912, DOI 10.1111/ele.12128; SHUEL RW, 1952, PLANT PHYSIOL, V27, P95, DOI 10.1104/pp.27.1.95; Steppan SJ, 2002, TRENDS ECOL EVOL, V17, P320, DOI 10.1016/S0169-5347(02)02505-3; Taylor N. L., 1979, Advances in Agronomy, V31, P125; Whitham TG, 2003, ECOLOGY, V84, P559, DOI 10.1890/0012-9658(2003)084[0559:CAEGAC]2.0.CO;2; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zuur A, 2009, MIXED EFFECTS MODELS; Zytynska SE, 2011, PHILOS T R SOC B, V366, P1329, DOI 10.1098/rstb.2010.0183; Zytynska SE, 2010, ECOLOGY, V91, P1563, DOI 10.1890/09-2070.1	46	2	2	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0161327	10.1371/journal.pone.0161327	http://dx.doi.org/10.1371/journal.pone.0161327			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27552193	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000381768800030
J	Seo, EK; Choi, JY; Jeong, JH; Kim, YG; Park, HH				Seo, Eun Kyung; Choi, Jae Young; Jeong, Jae-Hee; Kim, Yeon-Gil; Park, Hyun Ho			Crystal Structure of C-Terminal Coiled-Coil Domain of SYCP1 Reveals Non-Canonical Anti-Parallel Dimeric Structure of Transverse Filament at the Synaptonemal Complex	PLOS ONE			English	Article							PROTEIN; ORGANIZATION; MOLECULES; GENETICS; SCP1	The synaptonemal complex protein 1 (SYCP1) is the main structural element of transverse filaments (TFs) of the synaptonemal complex (SC), which is a meiosis-specific complex structure formed at the synapse of homologue chromosomes to hold them together. The Nterminal domain of SYCP1 is known to be located within the central elements (CEs), whereas the C-terminal domain is located toward lateral elements (LEs). SYCP1 is a wellknown meiosis marker that is also known to be a prognostic marker in the early stage of several cancers including breast, gliomas, and ovarian cancers. The structure of SC, especially the TF structure formed mainly by SYCP1, remains unclear without any structural information. To elucidate a molecular basis of SC formation and function, we first solved the crystal structure of C-terminal coiled-coil domain of SYCP1. The coiled-coil domain of SYCP1 forms asymmetric, anti-parallel dimers in solution.	[Seo, Eun Kyung; Choi, Jae Young; Park, Hyun Ho] Yeungnam Univ, Sch Chem & Biochem, Gyongsan, South Korea; [Seo, Eun Kyung; Choi, Jae Young; Park, Hyun Ho] Yeungnam Univ, Grad Sch Biochem, Gyongsan, South Korea; [Jeong, Jae-Hee; Kim, Yeon-Gil] Pohang Univ Sci & Technol, Pohang Accelerator Lab, Pohang, South Korea	Yeungnam University; Yeungnam University; Pohang University of Science & Technology (POSTECH)	Park, HH (corresponding author), Yeungnam Univ, Sch Chem & Biochem, Gyongsan, South Korea.; Park, HH (corresponding author), Yeungnam Univ, Grad Sch Biochem, Gyongsan, South Korea.	hyunho@ynu.ac.kr		park, hyun ho/0000-0001-9928-0847	Korea Healthcare Technology Research & Development project, Ministry of Health & Welfare, Republic of Korea [HI13C1449]; Yeungnam University	Korea Healthcare Technology Research & Development project, Ministry of Health & Welfare, Republic of Korea; Yeungnam University	This study was supported by the Korea Healthcare Technology Research & Development project, Ministry of Health & Welfare, Republic of Korea (HI13C1449). This study was supported by Yeungnam University research grants in 2014.; We would like to thank the staff at the BL-5C and BL-7A of the Pohang Accelerator Laboratory (Pohang, Korea) for their kind help with data collection. This study was supported by Yeungnam University research grants in 2014.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bisig CG, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002701; Bolor H, 2009, AM J HUM GENET, V84, P14, DOI 10.1016/j.ajhg.2008.12.002; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Davies OR, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120099; de Vries FAT, 2005, GENE DEV, V19, P1376, DOI 10.1101/gad.329705; Dong HJ, 2000, J CELL BIOL, V148, P417, DOI 10.1083/jcb.148.3.417; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fraune J, 2012, EXP CELL RES, V318, P1340, DOI 10.1016/j.yexcr.2012.02.018; Gurkan H, 2013, ANDROLOGIA, V45, P92, DOI 10.1111/j.1439-0272.2012.01317.x; Handel MA, 2010, NAT REV GENET, V11, P124, DOI 10.1038/nrg2723; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Kleckner N, 2006, CHROMOSOMA, V115, P175, DOI 10.1007/s00412-006-0055-7; Lee HH, 2008, SCIENCE, V322, P576, DOI 10.1126/science.1162042; Li XH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1648; Liu JG, 1996, EXP CELL RES, V226, P11, DOI 10.1006/excr.1996.0197; MEUWISSEN RLJ, 1992, EMBO J, V11, P5091, DOI 10.1002/j.1460-2075.1992.tb05616.x; Otwinowski Z., 1990, DENZO DATA PROCESSIN; Page SL, 2004, ANNU REV CELL DEV BI, V20, P525, DOI 10.1146/annurev.cellbio.19.111301.155141; Qiao HY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002790; Roos A, 2013, ARCH GYNECOL OBSTET, V288, P1153, DOI 10.1007/s00404-013-2861-5; Schmekel K, 1996, EXP CELL RES, V226, P20, DOI 10.1006/excr.1996.0198; Syrjanen JL, 2014, ELIFE CAMBRIDGE; Tu DQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018080; Tureci O, 1998, P NATL ACAD SCI USA, V95, P5211, DOI 10.1073/pnas.95.9.5211; Walshaw J, 2001, J MOL BIOL, V307, P1427, DOI 10.1006/jmbi.2001.4545; WESTERGAARD M, 1972, ANNU REV GENET, V6, P71, DOI 10.1146/annurev.ge.06.120172.000443; Yuan L, 1998, J CELL BIOL, V142, P331, DOI 10.1083/jcb.142.2.331; Zickler D, 2006, CHROMOSOMA, V115, P158, DOI 10.1007/s00412-006-0048-6	30	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161379	10.1371/journal.pone.0161379	http://dx.doi.org/10.1371/journal.pone.0161379			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548613	Green Published, gold, Green Submitted			2022-12-26	WOS:000381768400051
J	Yagi-Yaguchi, Y; Yamaguchi, T; Okuyama, Y; Satake, Y; Tsubota, K; Shimazaki, J				Yagi-Yaguchi, Yukari; Yamaguchi, Takefumi; Okuyama, Yumi; Satake, Yoshiyuki; Tsubota, Kazuo; Shimazaki, Jun			Corneal Higher Order Aberrations in Granular, Lattice and Macular Corneal Dystrophies	PLOS ONE			English	Article							LASER PHOTOTHERAPEUTIC KERATECTOMY; AUTOMATED ENDOTHELIAL KERATOPLASTY; OPTICAL COHERENCE TOMOGRAPHY; EXCIMER-LASER; SURFACE IRREGULARITY; CATARACT-SURGERY; VISUAL-ACUITY; ANTERIOR; EYES; AGE	Purpose To evaluate the corneal higher-order aberrations (HOAs) in granular, lattice and macular corneal dystrophies. Methods This retrospective study includes consecutive patients who were diagnosed as granular corneal dystrophy type2 (GCD2; 121 eyes), lattice corneal dystrophies type 1, type 3A (LCDI; 20 eyes, LCDIIIA; 32 eyes) and macular corneal dystrophies (MCD; 13 eyes), and 18 healthy control eyes. Corneal HOAs were calculated using anterior segment optical coherence tomography, and the correlations between HOAs and visual acuity were analyzed. Results HOAs of the total cornea within 4 mm diameter were significantly larger in GCD2 (0.17 +/- 0.35 mu m), in LCDI (0.33 +/- 0.27), LCDIIIA (0.61 +/- 1.56) and in MCD (0.23 +/- 0.18), compared with healthy controls (0.09 +/- 0.02 mu m, all P < 0.01). HOAs of the total cornea within 6 mm diameter were significantly larger in GCD2 (0.32 +/- 0.48), in LCDI (0.60 +/- 0.46), LCDIIIA (0.83 +/- 2.29) and in MCD (0.44 +/- 0.24), compared with healthy controls (0.19 +/- 0.06, all P < 0.001). In GCD2, there was no significant correlation between logMAR and HOAs (r = 0.113, P = 0.227). In MCD, LCDI and LCDIIIA, logMAR was positively significantly correlated with HOAs (r = 0.620 and P = 0.028, r = 0.587 and P = 0.007, r = 0.614 and P < 0.001, respectively). Conclusions Increased HOAs occur in eyes with corneal dystrophies, especially in eye with LCD and MCD. Larger amount corneal HOAs are associated with poorer visual acuity in patients with LCD and MCD.	[Yagi-Yaguchi, Yukari; Yamaguchi, Takefumi; Okuyama, Yumi; Satake, Yoshiyuki; Shimazaki, Jun] Tokyo Dent Coll, Ichikawa Gen Hosp, Dept Ophthalmol, Chiba, Japan; [Tsubota, Kazuo] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan	Tokyo Dental College; Keio University	Yamaguchi, T (corresponding author), Tokyo Dent Coll, Ichikawa Gen Hosp, Dept Ophthalmol, Chiba, Japan.	tym.i.eye.i@gmail.com	Yamaguchi, Takefumi/AEV-4169-2022; YAMAGUCHI, Takefumi/AAY-6964-2020; Jun, Shimazaki/K-5976-2019	Yamaguchi, Takefumi/0000-0002-2546-2813				Applegate RA, 2003, J CATARACT REFR SURG, V29, P1487, DOI 10.1016/S0886-3350(03)00334-1; Applegate RA, 2003, OPTOMETRY VISION SCI, V80, P97, DOI 10.1097/00006324-200302000-00005; Dang XH, 2009, MOL VIS, V15, P700; Das S, 2005, J REFRACT SURG, V21, P727; Dighiero P, 2000, OPHTHALMOLOGY, V107, P1353, DOI 10.1016/S0161-6420(00)00149-4; Dinh R, 1999, OPHTHALMOLOGY, V106, P1490, DOI 10.1016/S0161-6420(99)90441-4; FANTES FE, 1990, ARCH OPHTHALMOL-CHIC, V108, P665, DOI 10.1001/archopht.1990.01070070051034; Fukuda S, 2010, J CATARACT REFR SURG, V36, P1867, DOI 10.1016/j.jcrs.2010.05.024; Hafner A, 2005, AM J OPHTHALMOL, V140, P392, DOI 10.1016/j.ajo.2005.03.052; Hayashi K, 2015, AM J OPHTHALMOL, V160, P171, DOI 10.1016/j.ajo.2015.04.015; Lakshminarayanan R, 2014, OCUL SURF, V12, P234, DOI 10.1016/j.jtos.2013.12.002; Maeda N, 2010, EYE CONTACT LENS, V36, P254, DOI 10.1097/ICL.0b013e3181ef0dbb; McLellan JS, 2001, INVEST OPHTH VIS SCI, V42, P1390; Montes-Mico R, 2005, INVEST OPHTH VIS SCI, V46, P1615, DOI 10.1167/iovs.05-0017; Musch DC, 2011, INVEST OPHTH VIS SCI, V52, P6959, DOI 10.1167/iovs.11-7771; Nassaralla BA, 1996, J REFRACT SURG, V12, P795; Nowinska AK, 2014, BRIT J OPHTHALMOL, V98, P1514, DOI 10.1136/bjophthalmol-2014-305098; Okamoto F, 2008, OPHTHALMOLOGY, V115, P1216, DOI 10.1016/j.ophtha.2007.09.016; Oshika T, 2006, OPHTHALMOLOGY, V113, P1807, DOI 10.1016/j.ophtha.2006.03.061; Pepose JS, 2005, AM J OPHTHALMOL, V139, P335, DOI 10.1016/j.ajo.2004.11.010; Radhakrishnan S, 2014, CURR OPIN OPHTHALMOL, V25, P98, DOI 10.1097/ICU.0000000000000026; Rudolph M, 2012, OPHTHALMOLOGY, V119, P528, DOI 10.1016/j.ophtha.2011.08.034; Seitz B, 2004, CORNEA, V23, P380, DOI 10.1097/00003226-200405000-00013; Seitz B, 2011, DEV OPHTHALMOL, V48, P116, DOI 10.1159/000324081; Thibos LN, 2002, J REFRACT SURG, V18, pS652; Tomida D, 2015, JPN J OPHTHALMOL, V59, P216, DOI 10.1007/s10384-015-0388-y; Wang L, 2007, J CATARACT REFR SURG, V33, P1713, DOI 10.1016/j.jcrs.2007.07.010; Weiss JS, 2015, CORNEA, V34, P117, DOI 10.1097/ICO.0000000000000307; Yamaguchi T, 2011, INVEST OPHTH VIS SCI, V52, P6222, DOI 10.1167/iovs.11-7647; Yamaguchi T, 2010, CORNEA, V29, P1086, DOI 10.1097/ICO.0b013e3181d0092c; Yamaguchi TD, 2009, J CATARACT REFR SURG, V35, P688, DOI 10.1016/j.jcrs.2008.11.062; Yamaguchi T, 2009, J CATARACT REFR SURG, V35, P57, DOI 10.1016/j.jcrs.2008.09.012	32	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161075	10.1371/journal.pone.0161075	http://dx.doi.org/10.1371/journal.pone.0161075			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536778	Green Published, gold, Green Submitted			2022-12-26	WOS:000381577000050
J	Ahn, JJ; Son, Y; He, Y; Lee, E; Park, YL				Ahn, Jeong Joon; Son, Youngsoo; He, Yaqian; Lee, Eungul; Park, Yong-Lak			Effects of Temperature on Development and Voltinism of Chaetodactylus krombeini (Acari: Chaetodactylidae): Implications for Climate Change Impacts	PLOS ONE			English	Article							VAPOR-PRESSURE DEFICIT; MITE NEOSEIULUS-CALIFORNICUS; HIGH RELATIVE-HUMIDITY; PREDATORY MITE; AIR-TEMPERATURE; DEPENDENT DEVELOPMENT; AMBLYSEIUS-CUCUMERIS; DEVELOPMENT RATES; FALLACIS ACARINA; COLD-STORAGE	Temperature plays an important role in the growth and development of arthropods, and thus the current trend of climate change will alter their biology and species distribution. We used Chaetodactylus krombeini (Acari: Chaetodactylidae), a cleptoparasitic mite associated with Osmia bees (Hymenoptera: Megachilidae), as a model organism to investigate how temperature affects the development and voltinism of C. krombeini in the eastern United States. The effects of temperature on the stage-specific development of C. krombeini were determined at seven constant temperatures (16.1, 20.2, 24.1, 27.5, 30.0, 32.4 and 37.8 degrees C). Parameters for stage-specific development, such as threshold temperatures and thermal constant, were determined by using empirical models. Results of this study showed that C. krombeini eggs developed successfully to adult at all temperatures tested except 37.8 degrees C. The nonlinear and linear empirical models were applied to describe quantitatively the relationship between temperature and development of each C. krombeini stage. The nonlinear Lactin model estimated optimal temperatures as 31.4, 32.9, 32.6 and 32.5 degrees C for egg, larva, nymph, and egg to adult, respectively. In the linear model, the lower threshold temperatures were estimated to be 9.9, 14.7, 13.0 and 12.4 degrees C for egg, larva, nymph, and egg to adult, respectively. The thermal constant for each stage completion were 61.5, 28.1, 64.8 and 171.1 degree days for egg, larva, nymph, and egg to adult, respectively. Under the future climate scenarios, the number of generations (i.e., voltinism) would increase more likely by 1.5 to 2.0 times by the year of 2100 according to simulation. The findings herein firstly provided comprehensive data on thermal development of C. krombeini and implications for the management of C. krombeini populations under global warming were discussed.	[Ahn, Jeong Joon; Park, Yong-Lak] West Virginia Univ, Div Plant & Soil Sci, Entomol Program, Morgantown, WV 26506 USA; [Ahn, Jeong Joon] RDA, NIHHS, Res Inst Climate Change & Agr, 281 Ayeonno, Jeju 63240, South Korea; [Son, Youngsoo] Calif Dept Food & Agr, Pierces Dis Control Program, Arvin, CA 93203 USA; [He, Yaqian; Lee, Eungul] West Virginia Univ, Dept Geol & Geog, Morgantown, WV 26506 USA	West Virginia University; National Institute of Horticultural & Herbal Science (NIHHS), Republic of Korea; Rural Development Administration (RDA), Republic of Korea; California Department of Food & Agriculture; West Virginia University	Park, YL (corresponding author), West Virginia Univ, Div Plant & Soil Sci, Entomol Program, Morgantown, WV 26506 USA.	yopark@mail.wvu.edu	He, Yaqian/AAB-6147-2021; Lee, Eungul/AAJ-2993-2020; Park, Yong-Lak/ABH-2225-2020	Park, Yong-Lak/0000-0002-6995-8212; Lee, Eungul/0000-0002-1887-1870	USDA National Institute of Food & Agriculture (NIFA) Grant NIFA Award [2014-67004-21631]	USDA National Institute of Food & Agriculture (NIFA) Grant NIFA Award	The study was supported by the USDA National Institute of Food & Agriculture (NIFA) Grant NIFA Award: 2014-67004-21631 (http://nifa.usda.gov/program/agriculture-and-food-research-initiative-afri). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are very grateful to Dr. Pavel Klimov (University of Michigan) for confirming that Chaetodactylus krombeini used in this study was correctly identified. The study was supported by the USDA National Institute of Food & Agriculture (NIFA) Grant (NIFA Award: 2014-67004-21631). We acknowledge the World Climate Research Programme's Working Group on Coupled Modelling, which is responsible for CMIP, and we thank the climate modeling groups, especially the CESM groups, for producing and making available their model output. For CMIP the United States Department of Energy's Program for Climate Model Diagnosis and Intercomparison provides coordinating support and led development of software infrastructure in partnership with the Global Organization for Earth System Science Portals.	ALLEN JC, 1995, ENVIRON ENTOMOL, V24, P996, DOI 10.1093/ee/24.5.996; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; Batra SWT, 1998, AM BEE J, V138, P361; Boina DR, 2009, J ECON ENTOMOL, V102, P685, DOI 10.1603/029.102.0229; BOSCH J, 2001, SUSTAINABLE AGR NETW, V5; Bosch J, 2010, J INSECT PHYSIOL, V56, P1949, DOI 10.1016/j.jinsphys.2010.08.017; Briere JF, 1999, ENVIRON ENTOMOL, V28, P22, DOI 10.1093/ee/28.1.22; CAMPBELL A, 1974, J APPL ECOL, V11, P431, DOI 10.2307/2402197; Cook BI, 2014, CLIM DYNAM, V43, P2607, DOI 10.1007/s00382-014-2075-y; Danilevskii A.S., 1965, PHOTOPERIODISM SEASO; Eaton M, 2009, EXP APPL ACAROL, V47, P201, DOI 10.1007/s10493-008-9206-2; Field CB, 2007, ANNU REV ENV RESOUR, V32, P1, DOI 10.1146/annurev.energy.32.053006.141119; Gadino AN, 2012, EXP APPL ACAROL, V58, P1, DOI 10.1007/s10493-012-9562-9; Ghazy NA, 2014, PEST MANAG SCI, V70, P483, DOI 10.1002/ps.3599; Ghazy NA, 2012, BIOCONTROL, V57, P635, DOI 10.1007/s10526-012-9441-7; Ghazy NA, 2012, EXP APPL ACAROL, V58, P111, DOI 10.1007/s10493-012-9556-7; Ghazy NA, 2012, BIOL CONTROL, V60, P241, DOI 10.1016/j.biocontrol.2011.12.006; Gotoh T, 2014, EXP APPL ACAROL, V64, P465, DOI 10.1007/s10493-014-9841-8; Gutierrez AP, 2008, CLIMATIC CHANGE, V87, pS167, DOI 10.1007/s10584-007-9379-4; Hance T, 2007, ANNU REV ENTOMOL, V52, P107, DOI 10.1146/annurev.ento.52.110405.091333; Hart AJ, 2002, PHYSIOL ENTOMOL, V27, P112, DOI 10.1046/j.1365-3032.2002.00276.x; Hatherly IS, 2005, BIOCONTROL, V50, P687, DOI 10.1007/s10526-005-6758-5; IMS RA, 1990, TRENDS ECOL EVOL, V5, P135, DOI 10.1016/0169-5347(90)90218-3; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Johnson RM, 2010, APIDOLOGIE, V41, P312, DOI 10.1051/apido/2010018; Klimov PB, 2007, EVOLUTION, V61, P1368, DOI 10.1111/j.1558-5646.2007.00119.x; KLIMOV PB, 2008, MISCELLANEOUS PUBLIC, V199; KRAMER DA, 1989, ENVIRON ENTOMOL, V18, P741, DOI 10.1093/ee/18.5.743; KROMBEIN KARL V., 1962, PROC BIOL SOC WASHINGTON, V75, P237; Krunic Miloje, 2005, Bulletin of Insectology, V58, P141; LACTIN DJ, 1995, ENVIRON ENTOMOL, V24, P68, DOI 10.1093/ee/24.1.68; LOGAN JA, 1976, ENVIRON ENTOMOL, V5, P1133, DOI 10.1093/ee/5.6.1133; Lutterschmidt WI, 1997, CAN J ZOOL, V75, P1561, DOI 10.1139/z97-783; MANGINI AC, 1991, ENVIRON ENTOMOL, V20, P823, DOI 10.1093/ee/20.3.823; McKinney MI, 2013, EXP APPL ACAROL, V60, P153, DOI 10.1007/s10493-012-9629-7; Meehl GA, 2013, J CLIMATE, V26, P6287, DOI 10.1175/JCLI-D-12-00572.1; Mills N, 2005, BIOL CONTROL, V34, P274, DOI 10.1016/j.biocontrol.2005.02.012; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Park HH, 2011, J ASIA-PAC ENTOMOL, V14, P497, DOI 10.1016/j.aspen.2011.07.010; Park YL, 2009, J APPL ENTOMOL, V133, P174, DOI 10.1111/j.1439-0418.2008.01351.x; Pautasso M, 2010, BIOL REV, V85, P729, DOI 10.1111/j.1469-185X.2010.00123.x; Qu Da-cai, 2002, Japanese Journal of Entomology (New Series), V5, P121; Radmacher S, 2011, APIDOLOGIE, V42, P711, DOI 10.1007/s13592-011-0078-9; REGNIERE J, 1984, CAN ENTOMOL, V116, P1367, DOI 10.4039/Ent1161367-10; SAS Institute, 1995, SAS US GUID STAT VER; Schweiger O, 2008, ECOLOGY, V89, P3472, DOI 10.1890/07-1748.1; Scientific Jandel, 1996, TABLECURVE US MAN SA; Shi PJ, 2011, J ASIA-PAC ENTOMOL, V14, P15, DOI 10.1016/j.aspen.2010.11.008; Shipp JL, 1996, ENTOMOL EXP APPL, V78, P31, DOI 10.1007/BF00304454; Shipp JL, 1997, ENVIRON ENTOMOL, V26, P106, DOI 10.1093/ee/26.1.106; Son Y, 2012, BIOL CONTROL, V60, P233, DOI 10.1016/j.biocontrol.2011.04.008; SUGIURA N, 1989, Japanese Journal of Entomology, V57, P861; UCIPM, 2014, UC IPM STAT INT PEST; WAGNER TL, 1984, ANN ENTOMOL SOC AM, V77, P208, DOI 10.1093/aesa/77.2.208; WEIBULL W, 1951, J APPL MECH-T ASME, V18, P293; White J, 2009, J ECON ENTOMOL, V102, P2026, DOI 10.1603/029.102.0602; White JB, 2009, J ECON ENTOMOL, V102, P2090, DOI 10.1603/029.102.0611; YAMAGUCHI M, 1990, BIOENERGETICS, P39	58	9	10	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161319	10.1371/journal.pone.0161319	http://dx.doi.org/10.1371/journal.pone.0161319			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532151	gold, Green Published, Green Submitted			2022-12-26	WOS:000381487600085
J	Gusscott, S; Jenkins, CE; Lam, SH; Giambra, V; Pollak, M; Weng, AP				Gusscott, Samuel; Jenkins, Catherine E.; Lam, Sonya H.; Giambra, Vincenzo; Pollak, Michael; Weng, Andrew P.			IGF1R Derived PI3K/AKT Signaling Maintains Growth in a Subset of Human T-Cell Acute Lymphoblastic Leukemias	PLOS ONE			English	Article							OF-FUNCTION MUTATIONS; FACTOR-I RECEPTOR; FOLLICULAR LYMPHOMA; INSULIN; INHIBITION; NOTCH1; ACTIVATION; PATHWAYS; THERAPY; PTEN	Insulin-like growth factor 1 receptor (IGF1R) is a prevalent signaling pathway in human cancer that supports cell growth/survival and thus contributes to aggressive biological behavior. Much work has gone into development of IGF1R inhibitors; however, candidate agents including small molecule tyrosine kinase inhibitors and blocking antibodies have yet to fulfill their promise clinically. Understanding cellular features that define sensitivity versus resistance are important for effective patient selection and anticipation of outgrowth of a resistant clone. We previously identified an important role for IGF signaling in T-cell acute lymphoblastic leukemia (T-ALL) relying primarily upon genetically defined mouse models. We present here an assessment of IGF1R dependence in human T-ALL using a broad panel of 27 established cell lines that capture a spectrum of the genetic variation that might be encountered in clinical practice. We observed that a subset of cell lines are sensitive to IGF1R inhibition and are characterized by high levels of surface IGF1R expression and PTEN positivity. Interestingly, lentiviral expression or knock-down of PTEN in PTEN-negative/positive cell lines, respectively, had limited effects on their response to IGF1R inhibition, suggesting that PTEN contributes to, but does not define IGF dependence. Additionally, we characterize downstream PI3K/AKT signaling as dominant over RAS/RAF/MEK/ERK in mediating growth and/or survival in this context. Finally, we demonstrate that IGF and interleukin-7 (IL-7) fulfill non-overlapping roles in supporting T-ALL growth. These findings are significant in that they reveal cellular features and downstream mechanisms that may determine the response of an individual patient's tumor to IGF1R inhibitor therapy.	[Gusscott, Samuel; Jenkins, Catherine E.; Lam, Sonya H.; Giambra, Vincenzo; Weng, Andrew P.] BC Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Pollak, Michael] McGill Univ, Dept Oncol, Montreal, PQ, Canada	British Columbia Cancer Agency; McGill University	Weng, AP (corresponding author), BC Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada.	aweng@bccrc.ca	Giambra, Vincenzo/ABG-8306-2021	Giambra, Vincenzo/0000-0003-2607-2080; Pollak, Michael/0000-0003-3047-0604	Canadian Institutes of Health Research; Terry Fox Foundation; Leukemia and Lymphoma Society of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Terry Fox Foundation; Leukemia and Lymphoma Society of Canada	This work was supported by Canadian Institutes of Health Research, http://cihr-irsc.gc.ca/e/193.html, APW; Terry Fox Foundation, http://www.terryfox.org/TerryFox/The_Terry_Fox_Foundation.html, APW; and Leukemia and Lymphoma Society of Canada, http://www.llscanada.org/, APW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandapalli OR, 2014, THE ACTIVATING STAT5, pe188; Barata JT, 2004, HAEMATOLOGICA, V89, P1459; Barata JT, 2004, J EXP MED, V200, P659, DOI 10.1084/jem.20040789; Britten CD, 2013, CANCER CHEMOTH PHARM, V71, P1395, DOI 10.1007/s00280-013-2121-1; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Carboni JM, 2005, CANCER RES, V65, P3781, DOI 10.1158/0008-5472.CAN-04-4602; Carboni JM, 2009, MOL CANCER THER, V8, P3341, DOI 10.1158/1535-7163.MCT-09-0499; Castillo JJ, 2014, ONCOTARGETS THER, V7, P333, DOI 10.2147/OTT.S34641; Chapuis N, 2010, HAEMATOL-HEMATOL J, V95, P415, DOI 10.3324/haematol.2009.010785; Chiang MY, 2008, J CLIN INVEST, V118, P3181, DOI 10.1172/JCI35090; Clappier E, 2007, BLOOD, V110, P1251, DOI 10.1182/blood-2006-12-064683; Cohen BD, 2005, CLIN CANCER RES, V11, P2063, DOI 10.1158/1078-0432.CCR-04-1070; Doepfner KT, 2007, LEUKEMIA, V21, P1921, DOI 10.1038/sj.leu.2404813; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Giambra V, 2012, NAT MED, V18, P1693, DOI 10.1038/nm.2960; Gombos A, 2012, INVEST NEW DRUG, V30, P2433, DOI 10.1007/s10637-012-9811-0; Gusscott S, 2012, LEUKEMIA RES, V36, P905, DOI 10.1016/j.leukres.2012.02.013; Gutierrez A, 2009, BLOOD, V114, P647, DOI 10.1182/blood-2009-02-206722; Haluska P, 2011, J CLIN ONCOL S, V29; Holmfeldt L, 2013, NAT GENET, V45, P242, DOI 10.1038/ng.2532; Jin MZ, 2013, ONCOL REV, V7, P12, DOI 10.4081/oncol.2013.e3; Kawamura M, 1999, LEUKEMIA RES, V23, P115, DOI 10.1016/S0145-2126(98)00146-5; Lahortiga I, 2007, NAT GENET, V39, P593, DOI 10.1038/ng2025; Maser RS, 2007, NATURE, V447, P966, DOI 10.1038/nature05886; McCubrey JA, 2012, ONCOTARGET, V3, P1068, DOI 10.18632/oncotarget.659; Medyouf H, 2011, J EXP MED, V208, P1809, DOI 10.1084/jem.20110121; Meier F, 2007, BRIT J DERMATOL, V156, P1204, DOI 10.1111/j.1365-2133.2007.07821.x; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Miller WT, 2012, J SIGNAL TRANSDUCTIO, V2012, P7; Mitsiades CS, 2004, CANCER CELL, V5, P221, DOI 10.1016/S1535-6108(04)00050-9; MYAL Y, 1984, CANCER RES, V44, P5486; Palomero T, 2006, LEUKEMIA, V20, P1279, DOI 10.1038/sj.leu.2404258; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Pavlicek A, 2013, MOL CANCER THER, V12, P2929, DOI 10.1158/1535-7163.MCT-13-0442-T; Perentesis JP, 2004, LEUKEMIA, V18, P685, DOI 10.1038/sj.leu.2403272; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Porcu M, 2012, BLOOD, V119, P4476, DOI 10.1182/blood-2011-09-379958; Renshaw J, 2013, CLIN CANCER RES, V19, P5940, DOI 10.1158/1078-0432.CCR-13-0850; Sabnis AJ, 2009, PLOS BIOL, V7, P537, DOI 10.1371/journal.pbio.1000059; SELL C, 1993, P NATL ACAD SCI USA, V90, P11217, DOI 10.1073/pnas.90.23.11217; Shochat C, 2011, J EXP MED, V208, P901, DOI 10.1084/jem.20110580; Silva A, 2008, J CLIN INVEST, V118, P3762, DOI 10.1172/JCI34616; Silva A, 2011, CANCER RES, V71, P4780, DOI 10.1158/0008-5472.CAN-10-3606; Solal-Celigny P, 2004, BLOOD, V104, P1258, DOI 10.1182/blood-2003-12-4434; Staffas A, 2015, LEUKEMIA, V29, P1032, DOI 10.1038/leu.2014.315; Stengel C, 2013, BRIT J HAEMATOL, V162, P285, DOI 10.1111/bjh.12353; Subramaniam PS, 2012, CANCER CELL, V21, P459, DOI 10.1016/j.ccr.2012.02.029; Tamiya T, 2011, ARTERIOSCL THROM VAS, V31, P980, DOI 10.1161/ATVBAHA.110.207464; Thorpe LM, 2015, NAT REV CANCER, V15, P7, DOI 10.1038/nrc3860; Treanor LM, 2014, J EXP MED, V211, P701, DOI 10.1084/jem.20122727; Trimarchi T, 2014, CELL, V158, P593, DOI 10.1016/j.cell.2014.05.049; Vanhaesebroeck B, 2012, NAT REV MOL CELL BIO, V13, P195, DOI 10.1038/nrm3290; von Lintig FC, 2000, CLIN CANCER RES, V6, P1804; Wagner-Johnston ND, 2015, BLOOD, V126, P851, DOI 10.1182/blood-2015-01-621375; Wan XL, 2015, NEOPLASIA, V17, P358, DOI 10.1016/j.neo.2015.03.001; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Yaktapour N, 2013, BLOOD, V122, P1621, DOI 10.1182/blood-2013-02-484386; Yamada H, 2013, INT J HEMATOL, V97, P73, DOI 10.1007/s12185-012-1234-3; Yang XF, 1996, CANCER RES, V56, P1509; Yee D, 2012, JOURNAL OF THE NATIO, V104, P982; Yokoyama K, 2013, BLOOD, V122, P4259, DOI 10.1182/blood-2012-08-451278; Yost AJ, 2013, LEUKEMIA, V27, P1437, DOI 10.1038/leu.2012.337; Zenatti PP, 2011, NAT GENET, V43, P932, DOI 10.1038/ng.924; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhao JJ, 2006, P NATL ACAD SCI USA, V103, P16296, DOI 10.1073/pnas.0607899103; Zhao L, 2008, ONCOGENE, V27, P5486, DOI 10.1038/onc.2008.244	67	30	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161158	10.1371/journal.pone.0161158	http://dx.doi.org/10.1371/journal.pone.0161158			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532210	gold, Green Published			2022-12-26	WOS:000381487600066
J	Peffers, MJ; Goljanek-Whysall, K; Collins, J; Fang, YX; Rushton, M; Loughlin, J; Proctor, C; Clegg, PD				Peffers, Mandy Jayne; Goljanek-Whysall, Katarzyna; Collins, John; Fang, Yongxiang; Rushton, Michael; Loughlin, John; Proctor, Carole; Clegg, Peter David			Decoding the Regulatory Landscape of Ageing in Musculoskeletal Engineered Tissues Using Genome-Wide DNA Methylation and RNASeq	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; AGE-RELATED-CHANGES; NERVE GROWTH-FACTOR; GENE-EXPRESSION; NONCODING RNAS; STROMAL CELLS; ARTICULAR CHONDROCYTES; TENDON; DIFFERENTIATION; SENESCENCE	Mesenchymal stem cells (MSC) are capable of multipotent differentiation into connective tissues and as such are an attractive source for autologous cell-based regenerative medicine and tissue engineering. Epigenetic mechanisms, like DNA methylation, contribute to the changes in gene expression in ageing. However there was a lack of sufficient knowledge of the role that differential methylation plays during chondrogenic, osteogenic and tenogenic differentiation from ageing MSCs. This study undertook genome level determination of the effects of DNA methylation on expression in engineered tissues from chronologically aged MSCs. We compiled unique DNA methylation signatures from chondrogenic, osteogenic, and tenogenic engineered tissues derived from young; n = 4 (21.8 years +/- 2.4 SD) and old; n = 4 (65.5 years +/- 8.3SD) human MSCs donors using the Illumina Human-Methylation 450 Beadchip arrays and compared these to gene expression by RNA sequencing. Unique and common signatures of global DNA methylation were identified. There were 201, 67 and 32 chondrogenic, osteogenic and tenogenic age-related DE protein-coding genes respectively. Findings inferred the nature of the transcript networks was predominantly for 'cell death and survival', 'cell morphology', and 'cell growth and proliferation'. Further studies are required to validate if this gene expression effect translates to cell events. Alternative splicing (AS) was dysregulated in ageing with 119, 21 and 9 differential splicing events identified in chondrogenic, osteogenic and tenogenic respectively, and enrichment in genes associated principally with metabolic processes. Gene ontology analysis of differentially methylated loci indicated age-related enrichment for all engineered tissue types in 'skeletal system morphogenesis', 'regulation of cell proliferation' and 'regulation of transcription' suggesting that dynamic epigenetic modifications may occur in genes associated with shared and distinct pathways dependent upon engineered tissue type. An altered phenotype in engineered tissues was observed with ageing at numerous levels. These changes represent novel insights into the ageing process, with implications for stem cell therapies in older patients. In addition we have identified a number of tissue-dependant pathways, which warrant further studies.	[Peffers, Mandy Jayne; Goljanek-Whysall, Katarzyna; Clegg, Peter David] Univ Liverpool, Inst Ageing & Chron Dis, Chester High Rd, Wirral CH64 7TE, Merseyside, England; [Collins, John] Univ N Carolina, Sch Med, Thurston Arthrit Res Ctr, Chapel Hill, NC 27599 USA; [Fang, Yongxiang] Univ Liverpool, Ctr Genom Res, Inst Integrat Biol, Biosci Bldg,Crown St, Liverpool L69 7ZB, Merseyside, England; [Rushton, Michael; Loughlin, John; Proctor, Carole] Newcastle Univ, Inst Cellular Med, Musculoskeletal Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Proctor, Carole] Newcastle Univ, Inst Ageing, Campus Ageing & Vital, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England	University of Liverpool; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Liverpool; Newcastle University - UK; Newcastle University - UK	Peffers, MJ (corresponding author), Univ Liverpool, Inst Ageing & Chron Dis, Chester High Rd, Wirral CH64 7TE, Merseyside, England.	peffs@liv.ac.uk	Whysall, Kasia/P-2070-2019; Peffers, Mandy Jayne/AAV-9411-2020	Whysall, Kasia/0000-0001-8166-8800; Peffers, Mandy Jayne/0000-0001-6979-0440; Clegg, Peter/0000-0003-0632-0032; Loughlin, John/0000-0003-2018-3361	Wellcome Trust [WT088557MA]; Medical Research Council (MRC); Arthritis Research UK as part of the MRC-Arthritis Research UK Centre for Integrated research into Musculoskeletal Ageing (CIMA); BBSRC [BB/L021668/1] Funding Source: UKRI; MRC [MR/K006312/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L021668/1] Funding Source: researchfish; Medical Research Council [MR/K006312/1] Funding Source: researchfish; Versus Arthritis [20771, 20028] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research UK as part of the MRC-Arthritis Research UK Centre for Integrated research into Musculoskeletal Ageing (CIMA)(Versus Arthritis); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis)	This work was supported by the Wellcome Trust www.welccometrust.ac.uk (WT088557MA) to MJP, Medical Research Council (MRC) and Arthritis Research UK as part of the MRC-Arthritis Research UK Centre for Integrated research into Musculoskeletal Ageing (CIMA) www.cimauk.org to MJP, JC, KW, CP, JL, MR, PDC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2013, AGING CELL, V12, P890, DOI 10.1111/acel.12115; Ackema KB, 2008, STEM CELLS DEV, V17, P979, DOI 10.1089/scd.2007.0220; ALOE L, 1992, ARTHRITIS RHEUM, V35, P351, DOI 10.1002/art.1780350315; Alt EU, 2012, STEM CELL RES, V8, P215, DOI 10.1016/j.scr.2011.11.002; Bancroft JD, 2008, HEORY PRACTICE HISTO, DOI DOI 10.1186/GM444; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergman RJ, 1996, J BONE MINER RES, V11, P568; Blakeley P, 2015, DEVELOPMENT, V142, P3613, DOI 10.1242/dev.131235; Bork S, 2010, AGING CELL, V9, P54, DOI 10.1111/j.1474-9726.2009.00535.x; Brady K, 2014, STEM CELLS DEV, V23, P541, DOI 10.1089/scd.2013.0301; Buitrago DH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121521; Calvanese V, 2009, AGEING RES REV, V8, P268, DOI 10.1016/j.arr.2009.03.004; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chang JW, 2012, J CELL MOL MED, V16, P2935, DOI 10.1111/j.1582-4934.2012.01610.x; Chen L, 2015, BONE, V71, P210, DOI 10.1016/j.bone.2014.11.001; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Collins JA, 2016, J BIOL CHEM, V291, P6641, DOI 10.1074/jbc.M115.693523; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; Delgado-Calle Jesus, 2012, Biology (Basel), V1, P698, DOI 10.3390/biology1030698; Dexheimer V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022980; Ding W, 2015, CARDIOVASC RES, V106, P131, DOI 10.1093/cvr/cvv030; Docheva D, 2015, ADV DRUG DELIVER REV, V84, P222, DOI 10.1016/j.addr.2014.11.015; Duque G, 2002, BIOCHEM BIOPH RES CO, V299, P446, DOI 10.1016/S0006-291X(02)02657-8; Fickert S, 2011, J BONE MINER METAB, V29, P224, DOI 10.1007/s00774-010-0215-y; Gang HY, 2015, J CELL BIOL, V210, P1101, DOI 10.1083/jcb.201504047; Gerstenfeld LC, 1996, ENDOCRINOLOGY, V137, P3957, DOI 10.1210/en.137.9.3957; Giorda K, 2014, J FEDERATION AM SO S, V28, pLB211, DOI DOI 10.1002/ART.38713; Goltzman D, 2002, NAT REV DRUG DISCOV, V1, P784, DOI 10.1038/nrd916; Gomez-Barrena E, 2015, BONE, V70, P93, DOI 10.1016/j.bone.2014.07.033; Grammatikakis I, 2014, AGING-US, V6, P992, DOI 10.18632/aging.100710; Grimsholm O, 2008, CELLS TISSUES ORGANS, V188, P299, DOI 10.1159/000121432; Guan YF, 2002, DRUG NEWS PERSPECT, V15, P147, DOI 10.1358/dnp.2002.15.3.840011; Hanzelmann S, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0057-5; Harries LW, 2011, AGING CELL, V10, P868, DOI 10.1111/j.1474-9726.2011.00726.x; Haussler MR, 1998, J BONE MINER RES, V13, P325, DOI 10.1359/jbmr.1998.13.3.325; Henrotin YE, 2003, OSTEOARTHR CARTILAGE, V11, P747, DOI 10.1016/S1063-4584(03)00150-X; HORST RL, 1990, ENDOCRINOLOGY, V126, P1053, DOI 10.1210/endo-126-2-1053; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iannone F, 2002, RHEUMATOLOGY, V41, P1413, DOI 10.1093/rheumatology/41.12.1413; Jjingo D, 2012, ONCOTARGET, V3, P462, DOI 10.18632/oncotarget.497; Kanawa M, 2013, CYTOTHERAPY, V15, P1062, DOI 10.1016/j.jcyt.2013.03.015; Kapacee Z, 2010, MATRIX BIOL, V29, P668, DOI 10.1016/j.matbio.2010.08.005; Katoh-Semba R, 1998, NEUROSCI RES, V31, P227, DOI 10.1016/S0168-0102(98)00040-6; Kawase Y, 2003, J BONE MINER RES, V18, P975, DOI 10.1359/jbmr.2003.18.6.975; Kharaz YA, 2016, PROTEOMICS, V16, P1547, DOI 10.1002/pmic.201500459; Knuth CA, 2013, STEM CELL REV REP, V9, P599, DOI 10.1007/s12015-013-9446-3; Kohler J, 2013, AGING CELL, V12, P988, DOI 10.1111/acel.12124; Kretlow JD, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-60; Laine SK, 2012, J CELL BIOCHEM, V113, P2687, DOI 10.1002/jcb.24144; Le LTT, 2016, J MOL MED, V94, P583, DOI 10.1007/s00109-015-1374-z; Leskela HV, 2003, BIOCHEM BIOPH RES CO, V311, P1008, DOI 10.1016/j.bbrc.2003.10.095; Li CR, 2015, J APPL REMOTE SENS, V8, DOI 10.1117/1.JRS.8.083498; Liu-Bryan R, 2015, NAT REV RHEUMATOL, V11, P35, DOI 10.1038/nrrheum.2014.162; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loeser RF, 2014, ARTHRITIS RHEUMATOL, V66, P2201, DOI 10.1002/art.38641; Martin I, 2001, OSTEOARTHR CARTILAGE, V9, P112, DOI 10.1053/joca.2000.0366; McAlinden A, 2014, CONNECT TISSUE RES, V55, P165, DOI 10.3109/03008207.2014.908860; McCauley BS, 2014, BBA-GENE REGUL MECH, V1839, P1454, DOI 10.1016/j.bbagrm.2014.05.008; Mendias CL, 2012, J APPL PHYSIOL, V113, P56, DOI 10.1152/japplphysiol.00301.2012; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Millar NL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7774; Mueller AM, 2015, A SYSTEMS BIOLOGY AP; Nakamura Y, 2011, MOL CELL BIOL, V31, P3019, DOI 10.1128/MCB.05178-11; Natsu K, 2004, TISSUE ENG, V10, P1093, DOI 10.1089/1076327041887754; Nockher WA, 2005, CLIN CHIM ACTA, V352, P49, DOI 10.1016/j.cccn.2004.10.002; O'Loughlin A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-250; Oh J, 2014, NAT MED, V20, P870, DOI 10.1038/nm.3651; Orth P, 2014, STEM CELLS CLONING, V7, P1, DOI 10.2147/SCCAA.S42880; PAUL H, 1983, ARTHRITIS RHEUM, V26, P191, DOI 10.1002/art.1780260211; Paxton JZ, 2012, TISSUE ENG PT A, V18, P277, DOI [10.1089/ten.tea.2011.0336, 10.1089/ten.TEA.2011.0336]; Payne KA, 2010, OSTEOARTHR CARTILAGE, V18, P705, DOI 10.1016/j.joca.2010.01.011; Peffers MJ, 2016, EUR CELLS MATER, V31, P136, DOI 10.22203/eCM.v031a10; Peffers MJ, 2016, J ORTHOP RES, V34, P106, DOI 10.1002/jor.22963; Peffers MJ, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0544-2; Peffers MJ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4278; Pidsley R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-293; Pivetta E, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3047; Poulsen RC, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.52; Prinos P, 2011, NAT STRUCT MOL BIOL, V18, P673, DOI 10.1038/nsmb.2040; Robertson KD, 2000, CARCINOGENESIS, V21, P461, DOI 10.1093/carcin/21.3.461; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Roura S, 2006, EUR J HEART FAIL, V8, P555, DOI 10.1016/j.ejheart.2005.11.006; Rushton MD, 2014, ARTHRITIS RHEUMATOL, V66, P2450, DOI 10.1002/art.38713; Scharstuhl A, 2007, STEM CELLS, V25, P3244, DOI 10.1634/stemcells.2007-0300; Sethe S, 2006, AGEING RES REV, V5, P91, DOI 10.1016/j.arr.2005.10.001; Shargunov AV, 2014, J PROTEOME RES, V13, P173, DOI 10.1021/pr400808u; Sheng JJ, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00165; Stelnicki EJ, 1998, J INVEST DERMATOL, V110, P110, DOI 10.1046/j.1523-1747.1998.00092.x; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Stolzing A, 2008, MECH AGEING DEV, V129, P163, DOI 10.1016/j.mad.2007.12.002; Sun HJ, 2006, J ORTHOP RES, V24, P2059, DOI 10.1002/jor.20273; Tan JL, 2015, BONE RES, V3, DOI 10.1038/boneres.2015.3; Tazi J, 2009, BBA-MOL BASIS DIS, V1792, P14, DOI 10.1016/j.bbadis.2008.09.017; Tollervey JR, 2011, GENOME RES, V21, P1572, DOI 10.1101/gr.122226.111; Venkataraman K, 2002, FEBS LETT, V528, P3, DOI 10.1016/S0014-5793(02)03248-9; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang HJ, 2012, J VIROL, V86, P6286, DOI 10.1128/JVI.00205-12; Wang JM, 2014, ARTERIOSCL THROM VAS, V34, P99, DOI 10.1161/ATVBAHA.113.302104; Wang Y, 2015, ARTHRITIS RHEUMATOL, V67, P2141, DOI 10.1002/art.39182; Wei JF, 2014, STEM CELLS DEV, V23, P1452, DOI 10.1089/scd.2013.0600; Whitaker JW, 2013, GENOME MED, V5, DOI 10.1186/gm444; Wu TT, 2015, STEM CELLS, V33, P3281, DOI 10.1002/stem.2081; Yang KC, 2014, CIRCULATION, V129, P1009, DOI 10.1161/CIRCULATIONAHA.113.003863; Zaim M, 2012, ANN HEMATOL, V91, P1175, DOI 10.1007/s00277-012-1438-x; Zhang YP, 2012, BIOMED ENVIRON SCI, V25, P311, DOI 10.3967/0895-3988.2012.03.009; Zhao YS, 2015, HAEMATOLOGICA, V100, P194, DOI 10.3324/haematol.2014.109769; Zimmermann P, 2008, ARTHRITIS RHEUM, V58, P2743, DOI 10.1002/art.23736	108	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160517	10.1371/journal.pone.0160517	http://dx.doi.org/10.1371/journal.pone.0160517			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27533049	Green Submitted, Green Published, gold			2022-12-26	WOS:000381487600033
J	Soller, KJ; Yang, J; Veglia, G; Bowser, MT				Soller, Kailey J.; Yang, Jing; Veglia, Gianluigi; Bowser, Michael T.			Reversal of Phospholamban Inhibition of the Sarco(endo)plasmic Reticulum Ca2+-ATPase (SERCA) Using Short, Protein-interacting RNAs and Oligonucleotide Analogs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiomyopathy; fluorescence anisotropy; microRNA (miRNA); protein complex; RNA-protein interaction; Phospholamban (PLN); calcium ATPase (SERCA); oligonucleotide analogs; structure-function; protein-nucleic acid interaction	SARCOPLASMIC-RETICULUM; THERAPEUTIC TARGET; THERMUS-AQUATICUS; GENE-THERAPY; MICRORNAS; HEART; DNA; PHOSPHORYLATION; MUTATION; ATPASE	The sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) and phospholamban (PLN) complex regulates heart relaxation through its removal of cytosolic Ca2+ during diastole. Dysfunction of this complex has been related to many heart disorders and is therefore a key pharmacological target. There are currently no therapeutics that directly target either SERCA or PLN. It has been previously reported that single-stranded DNA binds PLN with strong affinity and relieves inhibition of SERCA in a length-dependent manner. In the current article, we demonstrate that RNAs and single-stranded oligonucleotide analogs, or xeno nucleic acids (XNAs), also bind PLN strongly (K-d <10 nm) and relieve inhibition of SERCA. Affinity for PLN is sequence-independent. Relief of PLN inhibition is length-dependent, allowing SERCA activity to be restored incrementally. The improved in vivo stability of XNAs offers more realistic pharmacological potential than DNA or RNA. We also found that microRNAs (miRNAs) 1 and 21 bind PLN strongly and relieve PLN inhibition of SERCA to a greater extent than a similar length random sequence RNA mixture. This may suggest that miR-1 and miR-21 have evolved to contain distinct sequence elements that are more effective at relieving PLN inhibition than random sequences.	[Soller, Kailey J.; Yang, Jing; Veglia, Gianluigi; Bowser, Michael T.] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA; [Veglia, Gianluigi] Univ Minnesota, Dept Biochem, Minneapolis, MN 55455 USA; [Veglia, Gianluigi] Univ Minnesota, Dept Mol Biol, Minneapolis, MN 55455 USA; [Veglia, Gianluigi] Univ Minnesota, Dept Biophys, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Veglia, G (corresponding author), Dept Chem & Biochem, 321 Church St SE, Minneapolis, MN 55455 USA.; Veglia, G (corresponding author), Depts Mol Biol & Biophys, 321 Church St SE, Minneapolis, MN 55455 USA.; Bowser, MT (corresponding author), Dept Chem, 207 Pleasant St SE, Minneapolis, MN 55455 USA.	vegli001@umn.edu; bowser@umn.edu	Yang, Jing/B-8964-2017; Bowser, Michael/HCI-4724-2022	Yang, Jing/0000-0003-3363-5515; 	National Institutes of Health [GM063533, GM072701]; AHA [13PRE16950023]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072701, R01GM063533] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM063533 (to M. B.) and GM072701 (to G. V.) and the AHA (13PRE16950023 to K. S). G. V. and M. B. have filed a U. S. Patent (application no. 15, 056, 761, February 29, 2016) for the use of XNAs as therapeutics for heart failure. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bai YL, 2013, CIRC RES, V113, P517, DOI 10.1161/CIRCRESAHA.113.301678; Bao MH, 2013, INT J MOL SCI, V14, P23086, DOI 10.3390/ijms141123086; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2000, CIRC RES, V87, P275, DOI 10.1161/01.RES.87.4.275; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Buck B, 2003, PROTEIN EXPRES PURIF, V30, P253, DOI 10.1016/S1046-5928(03)00127-X; Ceholski DK, 2012, J BIOL CHEM, V287, P16521, DOI 10.1074/jbc.M112.360859; Cheng YH, 2007, AM J PATHOL, V170, P1831, DOI 10.2353/ajpath.2007.061170; Cornea RL, 2013, J BIOMOL SCREEN, V18, P97, DOI 10.1177/1087057112456878; Cornea RL, 1997, BIOCHEMISTRY-US, V36, P2960, DOI 10.1021/bi961955q; Datta K, 2003, NUCLEIC ACIDS RES, V31, P5590, DOI 10.1093/nar/gkg774; Datta K, 2003, J BIOL CHEM, V278, P5694, DOI 10.1074/jbc.M208133200; Eom SH, 1996, NATURE, V382, P278, DOI 10.1038/382278a0; Eulalio A, 2012, NATURE, V492, P376, DOI 10.1038/nature11739; Gottesfeld JM, 2001, BIOCHEMISTRY-US, V40, P10927, DOI 10.1021/bi0109966; Grol T., 2014, PLOS ONE, V9; Gruber SJ, 2014, J BIOMOL SCREEN, V19, P215, DOI 10.1177/1087057113510740; Gustavsson M, 2011, BIOCHEMISTRY-US, V50, P10367, DOI 10.1021/bi200759y; Gwathmey JK, 2013, HUM GENE THER, V24, P937, DOI 10.1089/hum.2013.2512; Ha KN, 2007, J BIOL CHEM, V282, P37205, DOI 10.1074/jbc.M704056200; Ha KN, 2012, J MUSCLE RES CELL M, V33, P485, DOI 10.1007/s10974-012-9319-4; Ha KN, 2011, P NATL ACAD SCI USA, V108, P2735, DOI 10.1073/pnas.1013987108; Haghighi K, 2006, P NATL ACAD SCI USA, V103, P1388, DOI 10.1073/pnas.0510519103; Halkein J, 2013, J CLIN INVEST, V123, P2143, DOI 10.1172/JCI64365; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Jessup M, 2011, CIRCULATION, V124, P304, DOI 10.1161/CIRCULATIONAHA.111.022889; Jing M, 2011, ANAL CHIM ACTA, V686, P9, DOI 10.1016/j.aca.2010.10.032; Kairouz V, 2012, ANN NY ACAD SCI, V1254, P42, DOI 10.1111/j.1749-6632.2012.06520.x; Keklikoglou I, 2015, ONCOGENE, V34, P4867, DOI 10.1038/onc.2014.408; Kranias E. G., 2007, V45, P523; Li L, 1998, AM J PHYSIOL-HEART C, V274, pH1335, DOI 10.1152/ajpheart.1998.274.4.H1335; Li Q, 2010, J CELL SCI, V123, P2444, DOI 10.1242/jcs.067165; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MADDEN TD, 1979, NATURE, V279, P538, DOI 10.1038/279538a0; Mishra PK, 2013, BBA-MOL BASIS DIS, V1832, P2271, DOI 10.1016/j.bbadis.2013.09.004; Mishra PK, 2009, J CELL MOL MED, V13, P778, DOI 10.1111/j.1582-4934.2009.00744.x; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Shackman JG, 2004, J CHROMATOGR A, V1040, P273, DOI 10.1016/j.chroma.2004.04.004; Simmerman HKB, 1998, PHYSIOL REV, V78, P921, DOI 10.1152/physrev.1998.78.4.921; SIMMERMAN HKB, 1986, J BIOL CHEM, V261, P3333; Soller KJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13000; STOKES DL, 1990, BIOPHYS J, V57, P1, DOI 10.1016/S0006-3495(90)82501-7; TADA M, 1975, J BIOL CHEM, V250, P2640; Tatsuguchi M, 2007, J MOL CELL CARDIOL, V42, P1137, DOI 10.1016/j.yjmcc.2007.04.004; Tijsen AJ, 2012, CARDIOVASC RES, V93, P573, DOI 10.1093/cvr/cvr344; van der Zwaag PA, 2012, EUR J HEART FAIL, V14, P1199, DOI 10.1093/eurjhf/hfs119; van Rooij E, 2012, NAT REV DRUG DISCOV, V11, P860, DOI 10.1038/nrd3864; Vostrikov VV, 2015, BBA-BIOMEMBRANES, V1848, P315, DOI 10.1016/j.bbamem.2014.09.007; Wijnen WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096290; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030; Zhou Qiulian, 2014, Front Genet, V5, P185, DOI 10.3389/fgene.2014.00185	53	13	17	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21510	21518		10.1074/jbc.M116.738807	http://dx.doi.org/10.1074/jbc.M116.738807			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27531746	Green Published, hybrid			2022-12-26	WOS:000385999200018
J	Vrentas, CE; Moayeri, M; Keefer, AB; Greaney, AJ; Tremblay, J; O'Mard, D; Leppla, SH; Shoemaker, CB				Vrentas, Catherine E.; Moayeri, Mahtab; Keefer, Andrea B.; Greaney, Allison J.; Tremblay, Jacqueline; O'Mard, Danielle; Leppla, Stephen H.; Shoemaker, Charles B.			A Diverse Set of Single-domain Antibodies (VHHs) against the Anthrax Toxin Lethal and Edema Factors Provides a Basis for Construction of a Bispecific Agent That Protects against Anthrax Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						anthrax toxin; antibody; epitope mapping; microbial pathogenesis; phage display; toxin; EF; LF; VHH; VNA	MONOCLONAL-ANTIBODIES; NEUTRALIZING AGENT; VARIABLE DOMAINS; RICIN TOXIN; CHALLENGE; MICE; INHIBITORS; NANOBODIES	Infection with Bacillus anthracis, the causative agent of anthrax, can lead to persistence of lethal secreted toxins in the bloodstream, even after antibiotic treatment. VHH single-domain antibodies have been demonstrated to neutralize diverse bacterial toxins both in vitro and in vivo, with protein properties such as small size and high stability that make them attractive therapeutic candidates. Recently, we reported on VHHs with in vivo activity against the protective antigen component of the anthrax toxins. Here, we characterized a new set of 15 VHHs against the anthrax toxins that act by binding to the edema factor (EF) and/or lethal factor (LF) components. Six of these VHHs are cross-reactive against both EF and LF and recognize the N-terminal domain (LFN, EFN) of their target(s) with subnanomolar affinity. The cross-reactive VHHs block binding of EF/LF to the protective antigen C-terminal binding interface, preventing toxin entry into the cell. Another VHH appears to recognize the LF C-terminal domain and exhibits a kinetic effect on substrate cleavage by LF. A subset of the VHHs neutralized against EF and/or LF in murine macrophage assays, and the neutralizing VHHs that were tested improved survival of mice in a spore model of anthrax infection. Finally, a bispecific VNA (VHH-based neutralizing agent) consisting of two linked toxin-neutralizing VHHs, JMN-D10 and JMO-G1, was fully protective against lethal anthrax spore infection in mice as a single dose. This set of VHHs should facilitate development of new therapeutic VNAs and/or diagnostic agents for anthrax.	[Vrentas, Catherine E.] Frostburg State Univ, Dept Biol, Frostburg, MD 21532 USA; [Vrentas, Catherine E.; Moayeri, Mahtab; Keefer, Andrea B.; Greaney, Allison J.; O'Mard, Danielle; Leppla, Stephen H.] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Tremblay, Jacqueline; Shoemaker, Charles B.] Tufts Univ, Cummings Sch Vet Med, Dept Infect Dis & Global Hlth, North Grafton, MA 01536 USA	University System of Maryland; Frostburg State University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Tufts University	Shoemaker, CB (corresponding author), Tufts Univ, Cummings Sch Vet Med, Dept Infect Dis & Global Hlth, 200 Westboro Rd, North Grafton, MA 01536 USA.	charles.shoemaker@tufts.edu	Greaney, Allison/HDM-8896-2022	Greaney, Allison/0000-0001-7202-3349; Moayeri, Mahtab/0000-0002-4448-8883	National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health [U54 AI057159]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159, ZIAAI000929] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID) and by National Institutes of Health Grant U54 AI057159 (to C.B.S). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams R, 2016, MABS-AUSTIN, V8, P1336, DOI 10.1080/19420862.2016.1185581; Chen ZC, 2011, TOXINS, V3, P1004, DOI 10.3390/toxins3081004; Chen ZC, 2009, INFECT IMMUN, V77, P3902, DOI 10.1128/IAI.00200-09; Feld GK, 2010, NAT STRUCT MOL BIOL, V17, P1383, DOI 10.1038/nsmb.1923; Hassanzadeh-Ghassabeh G, 2013, NANOMEDICINE-UK, V8, P1013, DOI [10.2217/nnm.13.86, 10.2217/NNM.13.86]; Herrera C, 2015, J BIOL CHEM, V290, P27880, DOI 10.1074/jbc.M115.658070; Hultberg A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017665; Kaliberov SA, 2014, LAB INVEST, V94, P893, DOI 10.1038/labinvest.2014.82; Leysath CE, 2011, INFECT IMMUN, V79, P4609, DOI 10.1128/IAI.05314-11; Lim NK, 2005, INFECT IMMUN, V73, P6547, DOI 10.1128/IAI.73.10.6547-6551.2005; LITTLE SF, 1988, INFECT IMMUN, V56, P1807, DOI 10.1128/IAI.56.7.1807-1813.1988; Lopez-Requena A, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00159; Lui SH, 2010, CELL HOST MICROBE, V8, P455, DOI 10.1016/j.chom.2010.10.004; Maass DR, 2007, INT J PARASITOL, V37, P953, DOI 10.1016/j.ijpara.2007.02.005; Moayeri M, 2016, CLIN VACCINE IMMUNOL, V23, P213, DOI 10.1128/CVI.00611-15; Moayeri M, 2015, ANNU REV MICROBIOL, V69, P185, DOI 10.1146/annurev-micro-091014-104523; Moayeri M, 2015, J BIOL CHEM, V290, P6584, DOI 10.1074/jbc.M114.627943; Moayeri M, 2013, ANTIMICROB AGENTS CH, V57, P4139, DOI 10.1128/AAC.00941-13; Mukherjee J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106422; Mukherjee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029941; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Pannifer AD, 2001, NATURE, V414, P229, DOI 10.1038/n35101998; Pant N, 2011, FUTURE MICROBIOL, V6, P583, DOI [10.2217/fmb.11.32, 10.2217/FMB.11.32]; Park S, 2000, PROTEIN EXPRES PURIF, V18, P293, DOI 10.1006/prep.2000.1208; Pomerantsev AP, 2006, INFECT IMMUN, V74, P682, DOI 10.1128/IAI.74.1.682-693.2006; Thullier P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065855; Tremblay JM, 2013, INFECT IMMUN, V81, P4592, DOI 10.1128/IAI.01033-13; Tremblay JM, 2010, TOXICON, V56, P990, DOI 10.1016/j.toxicon.2010.07.003; Vance DJ, 2013, J BIOL CHEM, V288, P36538, DOI 10.1074/jbc.M113.519207	29	17	18	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21596	21606		10.1074/jbc.M116.749184	http://dx.doi.org/10.1074/jbc.M116.749184			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27539858	hybrid, Green Published			2022-12-26	WOS:000385999200026
J	Feinberg, H; Rambaruth, NDS; Jegouzo, SAF; Jacobsen, KM; Djurhuus, R; Poulsen, TB; Weis, WI; Taylor, ME; Drickamer, K				Feinberg, Hadar; Rambaruth, Neela D. S.; Jegouzo, Sabine A. F.; Jacobsen, Kristian M.; Djurhuus, Rasmus; Poulsen, Thomas B.; Weis, William I.; Taylor, Maureen E.; Drickamer, Kurt			Binding Sites for Acylated Trehalose Analogs of Glycolipid Ligands on an Extended Carbohydrate Recognition Domain of the Macrophage Receptor Mincle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TYPE LECTINS; ASIALOGLYCOPROTEIN RECEPTOR; TRIMERIC STRUCTURE; CRYSTAL-STRUCTURE; STRUCTURAL-BASIS; DENDRITIC-CELL; MECHANISM; PROTEIN; MODEL	The macrophage receptor mincle binds to trehalose dimycolate on the surface of Mycobacterium tuberculosis. Signaling initiated by this interaction leads to cytokine production, which underlies the ability of mycobacteria to evade the immune system and also to function as adjuvants. In previous work the mechanism for binding of the sugar headgroup of trehalose dimycolate to mincle has been elucidated, but the basis for enhanced binding to glycolipid ligands, in which hydrophobic substituents are attached to the 6-hydroxyl groups, has been the subject of speculation. In the work reported here, the interaction of trehalose derivatives with bovine mincle has been probed with a series of synthetic mimics of trehalose dimycolate in binding assays, in structural studies by x-ray crystallography, and by site-directed mutagenesis. Binding studies reveal that, rather than reflecting specific structural preference, the apparent affinity of mincle for ligands with hydrophobic substituents correlates with their overall size. Structural and mutagenesis analysis provides evidence for interaction of the hydrophobic substituents with multiple different portions of the surface of mincle and confirms the presence of three Ca2+-binding sites. The structure of an extended portion of the extracellular domain of mincle, beyond the minimal C-type carbohydrate recognition domain, also constrains the way the binding domains may interact on the surface of macrophages.	[Feinberg, Hadar; Weis, William I.] Stanford Univ, Sch Med, Dept Struct Biol, Stanford, CA 94305 USA; [Rambaruth, Neela D. S.; Jegouzo, Sabine A. F.; Taylor, Maureen E.; Drickamer, Kurt] Imperial Coll, Dept Life Sci, Sir Ernst Chain Bldg, London SW7 2AZ, England; [Jacobsen, Kristian M.; Djurhuus, Rasmus; Poulsen, Thomas B.] Aarhus Univ, Dept Chem, Biol Chem Lab, DK-8000 Aarhus, Denmark	Stanford University; Imperial College London; Aarhus University	Drickamer, K (corresponding author), Imperial Coll, Dept Life Sci, Sir Ernst Chain Bldg, London SW7 2AZ, England.	k.drickamer@imperial.ac.uk	Weis, William I/G-1437-2011; Jacobsen, Kristian Mark/AAQ-4526-2020; Poulsen, Thomas/C-5953-2017	Weis, William I/0000-0002-5583-6150; Poulsen, Thomas/0000-0002-0763-9996; Taylor, Maureen/0000-0001-8300-4987; Jegouzo, Sabine/0000-0001-7768-0102; Jacobsen, Kristian Mark/0000-0002-3450-0850	United States DOE [DE-AC02-06CH11357]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; NIGMS, National Institutes of Health [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER; BBSRC [BB/K007718/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K007718/1] Funding Source: researchfish; Lundbeck Foundation [R105-2011-9308] Funding Source: researchfish	United States DOE(United States Department of Energy (DOE)); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Lundbeck Foundation(Lundbeckfonden)	We thank Paul Hitchen for obtaining mass spectrometry data, the NMR facility of the Department of Chemistry, Imperial College London, for access to the NMR instruments, and Thomas Rowntree and David Staunton in the Department of Biochemistry, University of Oxford, for providing assistance with the dynamic light scattering measurements. Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the United States DOE under Contract DE-AC02-06CH11357. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by DOE Office of Biological and Environmental Research and by the NIGMS, National Institutes of Health (including P41GM103393).	Adams PD, 2004, J SYNCHROTRON RADIAT, V11, P53, DOI 10.1107/S0909049503024130; Cormack B, 2001, Curr Protoc Neurosci, VChapter 4, DOI 10.1002/0471142301.ns0411s03; Drickamer K, 2015, CURR OPIN STRUC BIOL, V34, P26, DOI 10.1016/j.sbi.2015.06.003; EISENBERG SP, 1990, NATURE, V343, P341, DOI 10.1038/343341a0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Feinberg H, 2000, J BIOL CHEM, V275, P35176, DOI 10.1074/jbc.M005557200; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Feinberg H, 2007, J BIOL CHEM, V282, P17250, DOI 10.1074/jbc.M701624200; Feinberg H, 2013, J BIOL CHEM, V288, P28457, DOI 10.1074/jbc.M113.497149; Feinberg H, 2010, J BIOL CHEM, V285, P13285, DOI 10.1074/jbc.M109.086058; Furukawa A, 2013, P NATL ACAD SCI USA, V110, P17438, DOI 10.1073/pnas.1312649110; Hakansson K, 1999, STRUCTURE, V7, P255, DOI 10.1016/S0969-2126(99)80036-7; Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; Jacobsen KM, 2015, MEDCHEMCOMM, V6, P647, DOI 10.1039/c4md00512k; Jegouzo SAF, 2015, J BIOL CHEM, V290, P16759, DOI 10.1074/jbc.M115.660613; Jegouzo SAF, 2014, GLYCOBIOLOGY, V24, P1291, DOI 10.1093/glycob/cwu072; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Lang R, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00005; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Levitzki A., 1997, PROTEIN FUNCTION PRA, P101; Masumoto M, 1999, J IMMUNOL, V163, P5039; Matsunaga I, 2009, J EXP MED, V206, P2865, DOI 10.1084/jem.20092533; Meier M, 2000, J MOL BIOL, V300, P857, DOI 10.1006/jmbi.2000.3853; Nagae M, 2013, J BIOL CHEM, V288, P33598, DOI 10.1074/jbc.M113.513572; Ng KKS, 1998, BIOCHEMISTRY-US, V37, P17965, DOI 10.1021/bi981972a; Petrescu AJ, 1999, GLYCOBIOLOGY, V9, P343, DOI 10.1093/glycob/9.4.343; Rambaruth NDS, 2015, MOLECULES, V20, P6670, DOI 10.3390/molecules20046670; Shang FF, 2011, J BIOL CHEM, V286, P757, DOI 10.1074/jbc.M110.175265; Stocker BL, 2014, CHEMBIOCHEM, V15, P382, DOI 10.1002/cbic.201300674; WEIS WI, 1991, SCIENCE, V254, P1608, DOI 10.1126/science.1721241; WEIS WI, 1994, STRUCTURE, V2, P1227, DOI 10.1016/S0969-2126(94)00124-3; Wells CA, 2008, J IMMUNOL, V180, P7404, DOI 10.4049/jimmunol.180.11.7404; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651	35	47	47	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					21222	+		10.1074/jbc.M116.749515	http://dx.doi.org/10.1074/jbc.M116.749515			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27542410	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000385406200035
J	Li, L; Li, D; Tian, F; Cen, J; Chen, XT; Ji, Y; Hui, LJ				Li, Lu; Li, Dan; Tian, Feng; Cen, Jin; Chen, Xiaotao; Ji, Yuan; Hui, Lijian			Hepatic Loss of Borealin Impairs Postnatal Liver Development, Regeneration, and Hepatocarcinogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGENITOR CELLS; MATURE HEPATOCYTES; PROMOTES EXPANSION; CANCER-CELLS; STEM-CELLS; SURVIVIN; PROTEIN; AURORA; PROLIFERATION; TUMORIGENESIS	Borealin, a member of the chromosomal passenger complex, plays a key regulatory role at centromeres and the central spindle during mitosis. Loss of Borealin leads to defective cell proliferation and early embryonic lethality. The in vivo functions of Borealin in mammalian postnatal development, tissue homeostasis, and tumorigenesis remain elusive. We specifically analyzed the role of Borealin in regulating postnatal liver development, damage-induced liver regeneration, and liver carcinogenesis using mice carrying conditional Borealin alleles. Perinatal loss of Borealin caused increased genome ploidy and enlarged cell size in hepatocytes, likely due to the impaired function of the chromosomal passenger complex in mitosis. Borealin deletion also showed attenuated expansion of Sox9(+)HNF4 alpha(+) progenitor-like cells in liver regeneration during 3,5-diethoxycarbonyl-1,4-dihydrocollidine diet-inducedliverinjury. Moreover, Delta N90-beta-Catenin and c-Met-induced hepatocarcinogenesis development was largely impeded by Borealin deletion. These findings indicate that Borealin plays a key role in liver development, regeneration, and tumorigenesis and suggests that Borealin could be a potential target for related liver diseases.	[Li, Lu; Li, Dan; Cen, Jin; Chen, Xiaotao; Hui, Lijian] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai, Peoples R China; [Li, Lu] Univ Chinese Acad Sci, Shanghai, Peoples R China; [Tian, Feng; Ji, Yuan] Fudan Univ, Zhongshan Hosp, Dept Pathol, Fenglin Rd 180, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Fudan University	Li, D; Hui, LJ (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai, Peoples R China.	lidan@sibcb.ac.cn; ljhui@sibcb.ac.cn		Li, Dan/0000-0002-8777-4580	Ministry of Science and Technology (MOST) of China [2014CB910601, 2012CB945001]; National Science Foundation of China (NSFC) [31225016, 81471948, 31501111]; Shanghai Science and Technology Committee [12JC1409500, 14XD1404200]; Postdoctor Research Program of Shanghai Institutes for Biological Sciences; Chinese Academy of Sciences [2014KIP302]; China Postdoctoral Science Foundation [2015M580361]	Ministry of Science and Technology (MOST) of China(Ministry of Science and Technology, China); National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); Postdoctor Research Program of Shanghai Institutes for Biological Sciences; Chinese Academy of Sciences(Chinese Academy of Sciences); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported in part by Ministry of Science and Technology (MOST) of China Grants 2014CB910601 and 2012CB945001, National Science Foundation of China (NSFC) Grants 31225016, 81471948, and 31501111, and Shanghai Science and Technology Committee Grants 12JC1409500 and 14XD1404200. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Postdoctor Research Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences Grant 2014KIP302, and China Postdoctoral Science Foundation Grant 2015M580361. To whom correspondence may be addressed. E-mail: lidan@sibcb.ac.cn.	Benhamouche S, 2010, GENE DEV, V24, P1718, DOI 10.1101/gad.1938710; Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; Chang JL, 2006, EXP CELL RES, V312, P962, DOI 10.1016/j.yexcr.2005.12.015; Chen X, 2014, AM J PATHOL, V184, P912, DOI 10.1016/j.ajpath.2013.12.002; Duncan AW, 2009, GASTROENTEROLOGY, V137, P466, DOI 10.1053/j.gastro.2009.05.044; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Font-Burgada J, 2015, CELL, V162, P766, DOI 10.1016/j.cell.2015.07.026; Gassmann R, 2004, J CELL BIOL, V166, P179, DOI 10.1083/jcb.200404001; Hagemann S, 2013, CELL DEATH DIFFER, V20, P834, DOI 10.1038/cdd.2013.20; Hanson KK, 2005, DEVELOPMENT, V132, P4777, DOI 10.1242/dev.02057; Hayama S, 2007, CANCER RES, V67, P4113, DOI 10.1158/0008-5472.CAN-06-4705; Jeyaprakash AA, 2007, CELL, V131, P271, DOI 10.1016/j.cell.2007.07.045; Li D, 2016, HEPATOLOGY, V64, P1105, DOI [10.1002/hep.28637, 10.1002/hep.28837]; Li D, 2013, HEPATOLOGY, V58, P2109, DOI 10.1002/hep.26601; Lu WY, 2015, NAT CELL BIOL, V17, P971, DOI 10.1038/ncb3203; Michalopoulos GK, 2015, GASTROENTEROLOGY, V149, P876, DOI 10.1053/j.gastro.2015.08.004; Min LH, 2012, NAT CELL BIOL, V14, P1203, DOI 10.1038/ncb2590; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Tarlow BD, 2014, CELL STEM CELL, V15, P605, DOI 10.1016/j.stem.2014.09.008; Tatsuka M, 1998, CANCER RES, V58, P4811; Tward AD, 2007, P NATL ACAD SCI USA, V104, P14771, DOI 10.1073/pnas.0706578104; Uren AG, 2000, CURR BIOL, V10, P1319, DOI 10.1016/S0960-9822(00)00769-7; Wang EY, 2011, P NATL ACAD SCI USA, V108, P18384, DOI 10.1073/pnas.1116386108; Wang Y, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0248-5; Yamaji S, 2010, P NATL ACAD SCI USA, V107, P22237, DOI 10.1073/pnas.1015793108; Yamanaka Y, 2008, MECH DEVELOP, V125, P441, DOI 10.1016/j.mod.2008.01.011	26	6	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					21137	+		10.1074/jbc.M116.736173	http://dx.doi.org/10.1074/jbc.M116.736173			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27542413	Green Published, hybrid			2022-12-26	WOS:000385406200028
J	Petrie, M; Esquibel, J; Kabachinski, G; Maciuba, S; Takahashi, H; Edwardson, JM; Martin, TFJ				Petrie, Matt; Esquibel, Joseph; Kabachinski, Greg; Maciuba, Stephanie; Takahashi, Hirohide; Edwardson, J. Michael; Martin, Thomas F. J.			The Vesicle Priming Factor CAPS Functions as a Homodimer via C2 Domain Interactions to Promote Regulated Vesicle Exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSE-CORE VESICLES; CA2+-DEPENDENT ACTIVATOR PROTEIN; C. ELEGANS NEURONS; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; TETHERING FACTORS; CRYSTAL-STRUCTURE; PLASMA-MEMBRANE; SINGLE-MOLECULE; MUN DOMAIN; FUSION	Neurotransmitters and peptide hormones are secreted by regulated vesicle exocytosis. CAPS (also known as CADPS) is a 145-kDa cytosolic and peripheral membrane protein required for vesicle docking and priming steps that precede Ca2+-triggered vesicle exocytosis. CAPS binds phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2) and SNARE proteins and is proposed to promote SNARE protein complex assembly for vesicle docking and priming. We characterized purified soluble CAPS as mainly monomer in equilibrium with small amounts of dimer. However, the active form of CAPS bound to PC12 cell membranes or to liposomes containing PI(4,5)P-2 and Q-SNARE proteins was mainly dimer. CAPS dimer formation required its C2 domain based on mutation or deletion studies. Moreover, C2 domain mutations or deletions resulted in a loss of CAPS function in regulated vesicle exocytosis, indicating that dimerization is essential for CAPS function. Comparison of the CAPS C2 domain to a structurally defined Munc13-1 C2A domain dimer revealed conserved residues involved in CAPS dimerization. We conclude that CAPS functions as a C2 domain-mediated dimer in regulated vesicle exocytosis. The unique tandem C2-PH domain of CAPS may serve as a PI(4,5)P-2-triggered switch for dimerization. CAPS dimerization may be coupled to oligomeric SNARE complex assembly for vesicle docking and priming.	[Petrie, Matt; Esquibel, Joseph; Kabachinski, Greg; Maciuba, Stephanie; Martin, Thomas F. J.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Esquibel, Joseph; Martin, Thomas F. J.] Univ Wisconsin, Program Mol & Cellular Pharmacol, Madison, WI 53706 USA; [Petrie, Matt; Kabachinski, Greg; Maciuba, Stephanie; Martin, Thomas F. J.] Univ Wisconsin, Integrated Program Biochem, Madison, WI 53706 USA; [Takahashi, Hirohide; Edwardson, J. Michael] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Cambridge	Martin, TFJ (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	tfmartin@wisc.edu	Martin, Thomas F/A-6962-2009	Martin, Thomas F/0000-0002-5204-0202; Takahashi, Hirohide/0000-0002-2553-8806	University of Wisconsin-Madison; National Science Foundation (NSF) [BIR-95212577]; National Institutes of Health [S10RR13790]; University of Wisconsin Carbone Center Support Grant [P30 CA014520]; NSF summer research program [DBI-1063085]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR013790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040428, R01DK025861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM119158, T32GM008688] Funding Source: NIH RePORTER	University of Wisconsin-Madison; National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Wisconsin Carbone Center Support Grant; NSF summer research program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge the help provided by D. McCaslin with the analytic ultracentrifugation conducted at the University of Wisconsin-Madison Biophysics Instrumentation Facility established with support from the University of Wisconsin-Madison, National Science Foundation (NSF) Grant BIR-95212577, and National Institutes of Health Grant S10RR13790. FACS sorting was assisted by the University of Wisconsin Carbone Center Support Grant P30 CA014520. We acknowledge the help of M. Reddick in single molecule studies in an NSF summer research program (Grant DBI-1063085).	Ann K, 1997, J BIOL CHEM, V272, P19637, DOI 10.1074/jbc.272.32.19637; Bai JH, 2004, NEURON, V41, P929, DOI 10.1016/S0896-6273(04)00117-5; Barrera NP, 2008, MOL PHARMACOL, V73, P960, DOI 10.1124/mol.107.042481; Berwin B, 1998, NEURON, V21, P137, DOI 10.1016/S0896-6273(00)80521-8; Chia Pei Zhi Cheryl, 2014, F1000Prime Rep, V6, P74, DOI 10.12703/P6-74; Coppola T, 2001, J BIOL CHEM, V276, P32756, DOI 10.1074/jbc.M100929200; Daily NJ, 2010, J BIOL CHEM, V285, P35320, DOI 10.1074/jbc.M110.145169; Deak F, 2006, EMBO J, V25, P2856, DOI 10.1038/sj.emboj.7601165; Deng LB, 2011, NEURON, V69, P317, DOI 10.1016/j.neuron.2011.01.005; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Farina M, 2015, ELIFE, V4, DOI [10.7554/eLife.05438, 10.7554/eLife.12968]; Fong JH, 2009, BIOINFORMATICS, V25, P1862, DOI 10.1093/bioinformatics/btp334; Friedrich R, 2008, J NEUROSCI, V28, P6794, DOI 10.1523/JNEUROSCI.0538-08.2008; Fujita Y, 2007, J BIOL CHEM, V282, P21392, DOI 10.1074/jbc.M703699200; Garcia J, 2004, NAT STRUCT MOL BIOL, V11, P45, DOI 10.1038/nsmb707; Grishanin RN, 2004, NEURON, V43, P551, DOI 10.1016/j.neuron.2004.07.028; Grishanin RN, 2002, J BIOL CHEM, V277, P22025, DOI 10.1074/jbc.M201614200; Guan R, 2007, BIOCHEMISTRY-US, V46, P8988, DOI 10.1021/bi700698a; Hammarlund M, 2008, J CELL BIOL, V180, P483, DOI 10.1083/jcb.200708018; Imig C, 2014, NEURON, V84, P416, DOI 10.1016/j.neuron.2014.10.009; Jain A, 2012, NAT PROTOC, V7, P445, DOI 10.1038/nprot.2011.452; James DJ, 2008, J CELL BIOL, V182, P355, DOI 10.1083/jcb.200801056; James Declan J, 2013, Front Endocrinol (Lausanne), V4, P187, DOI 10.3389/fendo.2013.00187; James DJ, 2009, P NATL ACAD SCI USA, V106, P17308, DOI 10.1073/pnas.0900755106; Jockusch WJ, 2007, CELL, V131, P796, DOI 10.1016/j.cell.2007.11.002; Kabachinski G, 2016, MOL BIOL CELL, V27, P654, DOI 10.1091/mbc.E15-07-0509; Kabachinski G, 2014, MOL BIOL CELL, V25, P508, DOI 10.1091/mbc.E12-11-0829; Khodthong C, 2011, CELL METAB, V14, P254, DOI 10.1016/j.cmet.2011.07.002; Koch H, 2000, BIOCHEM J, V349, P247, DOI 10.1042/0264-6021:3490247; Kulkarni Aditya, 2012, Bioarchitecture, V2, P59; Li W, 2011, STRUCTURE, V19, P1443, DOI 10.1016/j.str.2011.07.012; Lin XG, 2010, BIOCHEM BIOPH RES CO, V397, P526, DOI 10.1016/j.bbrc.2010.05.148; Liu YY, 2008, J NEUROSCI, V28, P5594, DOI 10.1523/JNEUROSCI.5672-07.2008; Liu YY, 2010, J CELL BIOL, V190, P1067, DOI 10.1083/jcb.201001164; Loyet KM, 1998, J BIOL CHEM, V273, P8337, DOI 10.1074/jbc.273.14.8337; Lu J, 2006, PLOS BIOL, V4, P1159, DOI 10.1371/journal.pbio.0040192; MARTIN TFJ, 1989, J BIOL CHEM, V264, P10299; Martin TFJ, 2015, BBA-MOL CELL BIOL L, V1851, P785, DOI 10.1016/j.bbalip.2014.09.017; Masumoto T, 2012, MOL CELL NEUROSCI, V49, P1, DOI 10.1016/j.mcn.2011.09.007; Nojiri M, 2009, J BIOL CHEM, V284, P18707, DOI 10.1074/jbc.M109.017483; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Parsaud L, 2013, J BIOL CHEM, V288, P23050, DOI 10.1074/jbc.M113.494088; Pei JM, 2009, J MOL BIOL, V391, P509, DOI 10.1016/j.jmb.2009.06.054; Sadakata T, 2013, J NEUROSCI, V33, P17326, DOI 10.1523/JNEUROSCI.2777-13.2013; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Speese S, 2007, J NEUROSCI, V27, P6150, DOI 10.1523/JNEUROSCI.1466-07.2007; Stieglitz B, 2012, J BIOL CHEM, V287, P20823, DOI 10.1074/jbc.M112.359547; Tsuboi T, 2005, J BIOL CHEM, V280, P39253, DOI 10.1074/jbc.M507173200; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; Viaud Julien, 2012, Advances in Biological Regulation, V52, P303, DOI 10.1016/j.jbior.2012.04.001; vonPoser C, 1997, J BIOL CHEM, V272, P14314, DOI 10.1074/jbc.272.22.14314; WALENT JH, 1992, CELL, V70, P765, DOI 10.1016/0092-8674(92)90310-9; Xu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027884; Yang XY, 2015, NAT STRUCT MOL BIOL, V22, P547, DOI 10.1038/nsmb.3038; Yu IM, 2010, ANNU REV CELL DEV BI, V26, P137, DOI 10.1146/annurev.cellbio.042308.113327; Zhang Z, 2013, J BIOL CHEM, V288, P7769, DOI 10.1074/jbc.M112.419317; Zhou KM, 2007, NEURON, V56, P657, DOI 10.1016/j.neuron.2007.09.015; Ziemba BP, 2013, BIOCHEMISTRY-US, V52, P4820, DOI 10.1021/bi400488f	58	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					21257	21270		10.1074/jbc.M116.728097	http://dx.doi.org/10.1074/jbc.M116.728097			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27528604	Green Published, hybrid			2022-12-26	WOS:000385406200038
J	Olive, S; Clement, G; Daeschler, EB; Dupret, V				Olive, Sebastien; Clement, Gael; Daeschler, Edward B.; Dupret, Vincent			Placoderm Assemblage from the Tetrapod-Bearing Locality of Strud (Belgium, Upper Famennian) Provides Evidence for a Fish Nursery	PLOS ONE			English	Article							INTERNAL FERTILIZATION; DEVONIAN PERIOD; SHARK NURSERY; SOUTH-AFRICA; ONTOGENY; INSECT; GNATHOSTOMES; CRUSTACEANS; ARTHRODIRES; AUSTRALIA	The placoderm fauna of the upper Famennian tetrapod- bearing locality of Strud, Belgium, includes the antiarch Grossilepis rikiki, the arthrodire groenlandaspidid Turrisaspis strudensis and the phyllolepidid Phyllolepis undulata. Based on morphological and morphometric evidence, the placoderm specimens from Strud are predominantly recognised as immature specimens and this locality as representing a placoderm nursery. The Strud depositional environment corresponds to a channel in an alluvial plain, and the presence of a nursery in such environment could have provided nutrients and protection to the placoderm offspring. This represents one of the earliest pieces of evidence for this sort of habitat partitioning in vertebrate history, with adults living more distantly from the nursery and using the nursery only to spawn or give live birth.	[Olive, Sebastien] Royal Belgian Inst Nat Sci, OD Earth & Life Hist, Brussels, Belgium; [Olive, Sebastien] Univ Liege, Dept Geol, Evolut & Divers Dynam Lab, Liege, Belgium; [Clement, Gael] Univ Paris 06, Sorbonne Univ, Ctr Rech Paleobiodiversite & Paleoenvironm, Museum Natl Hist Nat,CNRS,MNHN,UMR CR2P 7207, Paris, France; [Daeschler, Edward B.] Drexel Univ, Acad Nat Sci, Philadelphia, PA 19104 USA; [Dupret, Vincent] Uppsala Univ, Dept Organismal Biol, Subdept Evolut & Dev, Uppsala, Sweden; [Dupret, Vincent] Australian Natl Univ, Coll Phys & Math Sci, Res Sch Phys & Engn, Acton, Australia	Royal Belgian Institute of Natural Sciences; University of Liege; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Drexel University; Uppsala University; Australian National University	Olive, S (corresponding author), Royal Belgian Inst Nat Sci, OD Earth & Life Hist, Brussels, Belgium.; Olive, S (corresponding author), Univ Liege, Dept Geol, Evolut & Divers Dynam Lab, Liege, Belgium.; Dupret, V (corresponding author), Uppsala Univ, Dept Organismal Biol, Subdept Evolut & Dev, Uppsala, Sweden.; Dupret, V (corresponding author), Australian Natl Univ, Coll Phys & Math Sci, Res Sch Phys & Engn, Acton, Australia.	sebastien.olive@naturalsciences.be; vincent.dupret@anu.edu.au	; Dupret, Vincent/L-2306-2015	olive, sebastien/0000-0001-9690-7464; Dupret, Vincent/0000-0002-6859-1041	Belgian Federal Science Policy Office; Jessup Fund (ANSP, Philadelphia, USA); P.E. Ahlberg's European Research Council Advanced Investigator Grant [233111]; Wallenberg Scholarship from the Knut and Alice Wallenberg Foundation; Agence Nationale pour la Recherche TERRES project [2010-BLAN-607-03]	Belgian Federal Science Policy Office(Belgian Federal Science Policy Office); Jessup Fund (ANSP, Philadelphia, USA); P.E. Ahlberg's European Research Council Advanced Investigator Grant; Wallenberg Scholarship from the Knut and Alice Wallenberg Foundation; Agence Nationale pour la Recherche TERRES project(French National Research Agency (ANR))	The authors gratefully acknowledge the Belgian Federal Science Policy Office (https://www.belspo.be/) for the research financial support (Doctoral Fellow to S.O.) and the Jessup Fund (ANSP, Philadelphia, USA, http://www.ansp.org/research/fellowships-endowments/jessup-mchenry/) for the funding provided to S.O. for the ANSP collection visit. V.D. was supported by P.E. Ahlberg's European Research Council Advanced Investigator Grant 233111 (https://erc.europa.eu) and a Wallenberg Scholarship from the Knut and Alice Wallenberg Foundation (https://www.wallenberg.com/kaw/en). This paper is a contribution to the Agence Nationale pour la Recherche TERRES 2010-BLAN-607-03 project (http://www.agence-nationale-recherche.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlberg P, 2009, NATURE, V460, P888, DOI 10.1038/nature08176; BALON EK, 1981, AM ZOOL, V21, P573; Carpenter DK, 2014, PALAEONTOLOGY, V57, P1215, DOI 10.1111/pala.12112; Carr RK., 2010, J VERTEBR PALEONTO A, P70; Clement G, 2006, J VERTEBR PALEONTOL, V26, P276, DOI 10.1671/0272-4634(2006)26[276:LTAFDA]2.0.CO;2; Clement G, 2004, NATURE, V427, P412, DOI 10.1038/427412a; Cloutier R, 2010, SEMIN CELL DEV BIOL, V21, P400, DOI 10.1016/j.semcdb.2009.11.004; Cloutier Richard, 2009, Naturaliste Canadien (Quebec), V133, P84; Daeschler Edward B., 2003, Records of the Australian Museum, V55, P45; Daeschler T, 2011, GEOLOGICAL SOC AM FI, V20, P1, DOI DOI 10.1130/2011.0020(01); Denayer J, 2016, GEOL MAG, V153, P112, DOI 10.1017/S001675681500031X; Downs JP, 2011, P ACAD NAT SCI PHILA, V161, P191, DOI 10.1635/053.161.0111; Fischer J, 2011, J VERTEBR PALEONTOL, V31, P937, DOI 10.1080/02724634.2011.601729; Garrouste R, 2013, NATURE, V494, pE4, DOI 10.1038/nature11888; Garrouste R, 2012, NATURE, V488, P82, DOI 10.1038/nature11281; Gess RW, 2015, ZOOL J LINN SOC-LOND, V175, P360, DOI 10.1111/zoj.12276; Groot C., 1991, PACIFIC SALMON LIFE; Gueriau P, 2016, CURR BIOL, V26, P383, DOI 10.1016/j.cub.2015.12.039; Gueriau P, 2014, PALAEONTOLOGY, V57, P1203, DOI 10.1111/pala.12111; Gueriau P, 2014, NEUES JAHRB GEOL P-A, V273, P327, DOI 10.1127/0077-7749/2014/0434; Heupel MR, 2007, MAR ECOL PROG SER, V337, P287, DOI 10.3354/meps337287; Hornschemeyer T, 2013, NATURE, V494, pE3, DOI 10.1038/nature11887; Johanson Z, 2014, PALAEONTOLOGY, V57, P505, DOI 10.1111/pala.12093; Lagebro L, 2015, PALAEONTOLOGY, V58, P497, DOI 10.1111/pala.12155; Leriche M., 1931, MEMOIRES ACAD ROYALE, V10, P1; Lohest M., 1888, ANN SOC GEOL BELG, V15, P112; Long JA, 1997, J VERTEBR PALEONTOL, V17, P253, DOI 10.1080/02724634.1997.10010973; Long JA, 2008, NATURE, V453, P650, DOI 10.1038/nature06966; Long JA, 2015, NATURE, V517, P196, DOI 10.1038/nature13825; Long JA, 2009, NATURE, V457, P1124, DOI 10.1038/nature07732; Olive S, 2015, PALAEONTOLOGY, V58, P981, DOI 10.1111/pala.12190; Olive S, 2015, ACTA PALAEONTOL POL, V60, P711, DOI 10.4202/app.00015.2013; Prestianni Cyrille, 2007, Carnets de Geologie, P43; Ritchie A, 2005, P LINN SOC N S W, V126, P215; Sallan LC, 2014, J VERTEBR PALEONTOL, V34, P22, DOI 10.1080/02724634.2013.782875; Schultze Hans-Peter, 1999, P373, DOI 10.1016/B978-012356040-7/50018-4; Stensio EA., 1948, PALAEOZOOLOGICA GROE, V2, P1; Trinajstic K, 2009, ACTA ZOOL-STOCKHOLM, V90, P83, DOI 10.1111/j.1463-6395.2008.00363.x; Trinajstic K, 2007, J VERTEBR PALEONTOL, V27, P571, DOI 10.1671/0272-4634(2007)27[571:OPVAPI]2.0.CO;2; Trinajstic K, 2015, BIOL REV, V90, P467, DOI 10.1111/brv.12118; Upeniece I, 1992, FOSSIL FISHES LIVING, P167; Upeniece I., 2011, THESIS; Urho L, 2002, FOLIA ZOOL, V51, P161; WERDELIN L, 1986, LETHAIA, V19, P161, DOI 10.1111/j.1502-3931.1986.tb00727.x; Zhu Min, 1996, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V18, P233	45	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0161540	10.1371/journal.pone.0161540	http://dx.doi.org/10.1371/journal.pone.0161540			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27552196	Green Published, gold, Green Submitted			2022-12-26	WOS:000381768800049
J	Pelkonen, L; Reinisalo, M; Morin-Picardat, E; Kidron, H; Urtti, A				Pelkonen, Laura; Reinisalo, Mika; Morin-Picardat, Emmanuelle; Kidron, Heidi; Urtti, Arto			Isolation of Intact and Functional Melanosomes from the Retinal Pigment Epithelium	PLOS ONE			English	Article							RPE MELANOSOMES; OCULAR MELANIN; ORGANELLES; BINDING; CELLS; LOCALIZATION; BIOGENESIS; GRANULES; ATPASES; INVITRO	Melanosomes of retinal pigment epithelium (RPE) have many vision supporting functions. Melanosome research would benefit from a method to isolate pure and characterized melanosomes. Sucrose gradient centrifugation is the most commonly used method for isolation of RPE melanosomes, but the isolated products are insufficiently characterized and their quality is unclear. Here we introduce a new gentle method for fractionation of porcine RPE that produces intact functional melanosomes with minimal cross-contamination from other cell organelles. The characterization of isolated organelles was conducted with several methods confirming the purity of the isolated melanosomal fraction (transmission electron microscopy, immunoblotting) and presence of the melanosomal membrane (fluorescence staining of melanosomal membrane, zeta potential measurement). We demonstrate that our isolation method produces RPE melanosomes with the ability to generate free phosphate (Pi) from ATP thereby proving that many membrane proteins remain functional after isolation. The isolated porcine RPE melanosomes represented V-type H(+)ATPase activity that was demonstrated with bafilomycin A1, a specific V-ATPase inhibitor. We anticipate that the isolation method described here can easily be optimized for the isolation of stage IV melanosomes from other pigmented cell types and tissues.	[Pelkonen, Laura; Reinisalo, Mika; Morin-Picardat, Emmanuelle; Urtti, Arto] Univ Eastern Finland, Sch Pharm, Kuopio, Finland; [Kidron, Heidi; Urtti, Arto] Univ Helsinki, Ctr Drug Res, Div Pharmaceut Biosci, Helsinki, Finland	University of Eastern Finland; University of Helsinki	Urtti, A (corresponding author), Univ Eastern Finland, Sch Pharm, Kuopio, Finland.; Urtti, A (corresponding author), Univ Helsinki, Ctr Drug Res, Div Pharmaceut Biosci, Helsinki, Finland.	arto.urtti@uef.fi	Morin-Picardat, Emmanuelle/I-1232-2012; Kidron, Heidi/A-5826-2015	Morin-Picardat, Emmanuelle/0000-0001-9740-9504; Hellinen, Laura/0000-0002-6090-1156; Kidron, Heidi/0000-0001-6427-8042	Academy of Finland [283721, 28868]; Doctoral Programme in Drug Research, University of Eastern Finland; Sigrid Huselius Foundation	Academy of Finland(Academy of Finland); Doctoral Programme in Drug Research, University of Eastern Finland; Sigrid Huselius Foundation	This work was supported by the Academy of Finland (283721 and 28868) (http://www.aka.fi/en/), Sigrid Huselius Foundation (http://www.sigridjuselius.fi/foundation), and Doctoral Programme in Drug Research, University of Eastern Finland (http://www2.uef.fi/en/dpdrugresearch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMSSON T, 1988, EXP EYE RES, V47, P565, DOI 10.1016/0014-4835(88)90095-4; Azarian SM, 2006, J PROTEOME RES, V5, P521, DOI 10.1021/pr0502323; Bernsmann F, 2010, J COLLOID INTERF SCI, V344, P54, DOI 10.1016/j.jcis.2009.12.052; Bhatnagar V, 1998, MOL CELL BIOCHEM, V189, P99, DOI 10.1023/A:1006876411202; Bhattacharjee S, 2016, J CONTROL RELEASE, V235, P337, DOI 10.1016/j.jconrel.2016.06.017; Borovansky J, 2011, MELANINS AND MELANOSOMES: BIOSYNTHESIS, BIOGENESIS, PHYSIOLOGICAL, AND PATHOLOGICAL FUNCTIONS, P1; Burke JM, 2011, MOL VIS, V17, P2864; Colombo S, 2011, MELANINS AND MELANOSOMES: BIOSYNTHESIS, BIOGENESIS, PHYSIOLOGICAL, AND PATHOLOGICAL FUNCTIONS, P21; d'Ischia M, 2013, PIGM CELL MELANOMA R, V26, P616, DOI 10.1111/pcmr.12121; DEBING I, 1988, MOL PHARMACOL, V33, P470; Futter CE, 2004, MOL BIOL CELL, V15, P2264, DOI 10.1091/mbc.E03-10-0772; Gibbs D, 2004, J CELL SCI, V117, P6473, DOI 10.1242/jcs.01580; GRAHAM J, 1994, ANAL BIOCHEM, V220, P367, DOI 10.1006/abio.1994.1351; Graham J., 2006, CELL BIOL PROTOCOLS, P87; Guo SL, 2008, PHOTOCHEM PHOTOBIOL, V84, P671, DOI 10.1111/j.1751-1097.2008.00331.x; Huss M, 2009, J EXP BIOL, V212, P341, DOI 10.1242/jeb.024067; ITO S, 1986, BIOCHIM BIOPHYS ACTA, V883, P155, DOI 10.1016/0304-4165(86)90146-7; Kaczara P, 2012, PIGM CELL MELANOMA R, V25, P804, DOI 10.1111/pcmr.12008; Kushimoto T, 2001, P NATL ACAD SCI USA, V98, P10698, DOI 10.1073/pnas.191184798; Liu Y, 2005, PHOTOCHEM PHOTOBIOL, V81, P510, DOI 10.1562/2004-10-19-RA-345.1; Liu Y, 2003, PIGM CELL RES, V16, P606, DOI 10.1046/j.1600-0749.2003.00098.x; Mani I, 2001, PIGM CELL RES, V14, P170, DOI 10.1034/j.1600-0749.2001.140306.x; Maxson ME, 2014, J CELL SCI, V127, P4987, DOI 10.1242/jcs.158550; Nuckels RJ, 2009, INVEST OPHTH VIS SCI, V50, P893, DOI 10.1167/iovs.08-2743; ORLOW SJ, 1995, J INVEST DERMATOL, V105, P3, DOI 10.1111/1523-1747.ep12312291; Peles DN, 2011, J PHYS CHEM B, V115, P12624, DOI 10.1021/jp2060624; Pitkanen L, 2007, PHARM RES-DORDR, V24, P2063, DOI 10.1007/s11095-007-9342-0; POTTS AM, 1964, INVEST OPHTH VISUAL, V3, P405; Raposo G, 2002, TRAFFIC, V3, P237, DOI 10.1034/j.1600-0854.2002.030401.x; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; Rimpela A. I., 2016, MOL PHARM; Rozanowska M, 2011, MELANINS AND MELANOSOMES: BIOSYNTHESIS, BIOGENESIS, PHYSIOLOGICAL, AND PATHOLOGICAL FUNCTIONS, P187; Schutt F, 2002, GRAEF ARCH CLIN EXP, V240, P983, DOI 10.1007/s00417-002-0558-8; SEIJI M, 1963, ANN NY ACAD SCI, V100, P497, DOI 10.1111/j.1749-6632.1963.tb42911.x; SEIJI M, 1961, J BIOCHEM-TOKYO, V49, P700, DOI 10.1093/oxfordjournals.jbchem.a127360; Shine L, 2014, ADV EXP MED BIOL, V801, P97, DOI 10.1007/978-1-4614-3209-8_13; Simon JD, 2008, J PHYS CHEM B, V112, P13201, DOI 10.1021/jp804248h; Simpson RJ, 2010, COLD SPRING HARB PRO, V2010; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Tribl F, 2005, MOL CELL PROTEOMICS, V4, P945, DOI 10.1074/mcp.M400117-MCP200; WILCZOK T, 1990, BIOPHYS CHEM, V35, P265, DOI 10.1016/0301-4622(90)80014-X; Zareba M, 2006, PHOTOCHEM PHOTOBIOL, V82, P1024, DOI 10.1562/2006-03-08-RA-836	42	12	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0160352	10.1371/journal.pone.0160352	http://dx.doi.org/10.1371/journal.pone.0160352			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27551967	Green Published, Green Submitted, gold			2022-12-26	WOS:000381768800011
J	Lee, CH; Lee, SH; Lee, S; Cho, H; Kim, KH; Lee, JE; Jung, EJ; Lee, SJ; Kim, EJ; Kim, KH; Moon, E; Cho, HJ				Lee, Chang Hun; Lee, Sun Hee; Lee, Shinwon; Cho, Heerim; Kim, Kye-Hyung; Lee, Jung Eun; Jung, Eun Ju; Lee, Su Jin; Kim, Eun Jung; Kim, Ki Hyung; Moon, Eunsoo; Cho, Hong Je			Anal Human Papillomavirus Infection among HIV-Infected Men in Korea	PLOS ONE			English	Article							HPV INFECTION; RISK-FACTORS; NATURAL-HISTORY; CYTOLOGICAL ABNORMALITIES; PREVALENCE; SEX; CANCER; CLEARANCE; SPECIMENS; PENILE	Background Little is known about the epidemiology on human papillomavirus (HPV) infection among HIV-infected men in Korea. The objective of this study was to determine the prevalence, genotype distribution and risk factors associated with anal HPV infection among HIVinfected men in Korea. Methods A single-center cross-sectional study was conducted with HIV-infected men in Korea. Participants completed a detailed sexual behavior risk factor questionnaire. Anal samples were collected for cytology and HPV genotyping. Factors associated with anal HPV infection were assessed using multivariable logistic regression, stratifying by sexual behaviour. Results A total of 201 HIV-infected men were included in the study: 133 were from men who have sex with men (MSM) and 68 from men who have sex with women (MSW). Any anal HPV infection was detected in 82.7% of HIV-infected MSM and in 51.5% of HIV-infected MSW (P < 0.001). High-risk HPV (HR-HPV) prevalence was higher among MSM (47.4%) than MSW (25.0%; P = 0.002). The HR-HPV types identified most frequently were HPV 16 (11%), HPV 18 (9.9%), and HPV 58 (5%) in MSM, and HPV 58(11%) and HPV 16 (8.9%) in MSW. Prevalence of any HPV types in 9-valent vaccine types was higher among MSM than MSW (47.4% vs 22.1%. P = 0.001). Abnormal anal cytology was more commonly detected in MSM than MSW (42.9% vs. 19.1%, P < 0.001). In HIV-infected MSM, higher number of lifetime male sex partners was significantly associated with any anal HPV infection, but age was a significant risk factor associated with anal HR-HPV infection. Conclusion Anal HPV infection was highly prevalent in HIV-infected MSM in Korea, and also commonly found in HIV-infected MSW. In HIV-infected MSM, the significant risk factor for being infected with any HPV infection was lifetime number of male sexual partners, and with anal oncogenic HPV infection was age.	[Lee, Chang Hun] Pusan Natl Univ, Pusan Natl Univ Hosp, Sch Med, Dept Pathol,Med Res Inst, Busan, South Korea; [Lee, Sun Hee; Lee, Shinwon; Cho, Heerim; Kim, Kye-Hyung; Lee, Jung Eun; Jung, Eun Ju] Pusan Natl Univ, Pusan Natl Univ Hosp, Sch Med, Dept Internal Med,Med Res Inst, Busan, South Korea; [Lee, Su Jin; Kim, Eun Jung] Pusan Natl Univ, Yangsan Pusan Natl Univ Hosp, Sch Med, Dept Internal Med, Geongsangnam Do, South Korea; [Kim, Ki Hyung] Pusan Natl Univ, Pusan Natl Univ Hosp, Sch Med, Dept Obstet & Gynecol, Busan, South Korea; [Moon, Eunsoo] Pusan Natl Univ, Pusan Natl Univ Hosp, Dept Psychiat, Sch Med, Busan, South Korea; [Cho, Hong Je] Pusan Natl Univ, Pusan Natl Univ Hosp, Dept Surg, Sch Med, Busan, South Korea	Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital	Lee, SH (corresponding author), Pusan Natl Univ, Pusan Natl Univ Hosp, Sch Med, Dept Internal Med,Med Res Inst, Busan, South Korea.	zzanmery@gmail.com	LEE, SUN HEE/AAB-5714-2022	LEE, SUN HEE/0000-0003-2093-3628; Moon, Eunsoo/0000-0002-8863-3413	Biomedical Research Institute Grant, Pusan National University Hospital	Biomedical Research Institute Grant, Pusan National University Hospital	This study was supported by Biomedical Research Institute Grant (2013-19), Pusan National University Hospital.	Beachler DC, 2013, J INFECT DIS, V208, P330, DOI 10.1093/infdis/jit170; Chan PKS, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-17; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Critchlow CW, 1998, AIDS, V12, P1177, DOI 10.1097/00002030-199810000-00010; Crum-Cianflone NF, 2010, AIDS, V24, P535, DOI 10.1097/QAD.0b013e328331f6e2; 최평균, 2006, Infection and Chemotherapy, V38, P367; Damay A, 2010, J MED VIROL, V82, P592, DOI 10.1002/jmv.21732; Darwich L, 2012, HIV MED, V13, P549, DOI 10.1111/j.1468-1293.2012.01013.x; Darwich L, 2013, DIS COLON RECTUM, V56, P1043, DOI 10.1097/DCR.0b013e31829c654f; Darwich L, 2013, SEX TRANSM DIS, V40, P611, DOI 10.1097/01.OLQ.0000430798.61475.08; de Pokomandy A, 2009, J INFECT DIS, V199, P965, DOI 10.1086/597207; Diamond C, 2005, SEX TRANSM DIS, V32, P314, DOI 10.1097/01.olq.0000162366.60245.02; Dona MG, 2014, FUTURE MICROBIOL, V9, P837, DOI [10.2217/FMB.14.44, 10.2217/fmb.14.44]; Dunne EF, 2006, J INFECT DIS, V194, P1044, DOI 10.1086/507432; Gandra S, 2015, HIV AIDS-RES PALLIAT, V7, P29, DOI 10.2147/HIV.S73880; Gao L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015256; Geskus RB, 2016, AIDS, V30, P37, DOI 10.1097/QAD.0000000000000874; 설영미, 2009, [The Korean Journal of Medicine, 대한내과학회지], V76, P554; Hernandez AL, 2014, AIDS, V28, P1341, DOI 10.1097/QAD.0000000000000254; Hu YF, 2013, JAIDS-J ACQ IMM DEF, V64, P103, DOI 10.1097/QAI.0b013e31829b6298; Jung KW, 2015, CANCER RES TREAT, V47, P127, DOI 10.4143/crt.2015.060; King EM, 2015, BRIT J CANCER, V112, P1585, DOI 10.1038/bjc.2015.90; Li Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125120; Nagata N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137434; Parisi SG, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-150; Park Ina U, 2010, Curr Infect Dis Rep, V12, P126, DOI 10.1007/s11908-010-0090-7; Patel P, 2013, IDWEEK 2013; Phanuphak N, 2013, JAIDS-J ACQ IMM DEF, V63, P472, DOI 10.1097/QAI.0b013e3182918a5a; Piketty C, 2003, ANN INTERN MED, V138, P453, DOI 10.7326/0003-4819-138-6-200303180-00008; Piketty C, 2008, AIDS, V22, P1203, DOI 10.1097/QAD.0b013e3283023f78; Piketty C, 2012, J CLIN ONCOL, V30, P4360, DOI 10.1200/JCO.2012.44.5486; Schwartz LM, 2013, J INFECT DIS, V208, P1768, DOI 10.1093/infdis/jit374; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Supindham T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124499; Torres-Ibarra L, 2014, PREV MED, V69, P157, DOI 10.1016/j.ypmed.2014.09.011; van Aar F, 2013, AIDS, V27, P2921, DOI 10.1097/01.aids.0000432541.67409.3c; van Rijn VM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092208; Videla S, 2013, SEX TRANSM DIS, V40, P3, DOI 10.1097/OLQ.0b013e31827e87bd; Yang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035983; Yu CT, 2013, AIDS BEHAV, V17, P1211, DOI 10.1007/s10461-012-0173-6	40	17	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161460	10.1371/journal.pone.0161460	http://dx.doi.org/10.1371/journal.pone.0161460			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548632	gold, Green Published, Green Submitted			2022-12-26	WOS:000381768400060
J	Pyter, LM; Husain, Y; Calero, H; Mckim, DB; Lin, HY; Godbout, JP; Sheridan, JF; Engeland, CG; Marucha, PT				Pyter, Leah M.; Husain, Yasmin; Calero, Humberto; McKim, Daniel B.; Lin, Hsin-Yun; Godbout, Jonathan P.; Sheridan, John F.; Engeland, Christopher G.; Marucha, Phillip T.			Tumors Alter Inflammation and Impair Dermal Wound Healing in Female Mice	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; ANXIETY-LIKE BEHAVIOR; OF-THE-LITERATURE; PERIPHERAL-BLOOD; TISSUE-REPAIR; MURINE MODEL; BONE-MARROW; T-CELLS; CANCER; HEAD	Tissue repair is an integral component of cancer treatment (e.g., due to surgery, chemotherapy, radiation). Previous work has emphasized the immunosuppressive effects of tumors on adaptive immunity and has shown that surgery incites cancer metastases. However, the extent to which and how tumors may alter the clinically-relevant innate immune process of wound healing remains an untapped potential area of improvement for treatment, quality of life, and ultimately, mortality of cancer patients. In this study, 3.5 mm full-thickness dermal excisional wounds were placed on the dorsum of immunocompetent female mice with and without non-malignant flank AT-84 murine oral squamous cell carcinomas. Wound closure rate, inflammatory cell number and inflammatory signaling in wounds, and circulating myeloid cell concentrations were compared between tumor-bearing and tumor-free mice. Tumors delayed wound closure, suppressed inflammatory signaling, and altered myeloid cell trafficking in wounds. An in vitro scratch " wounding" assay of adult dermal fibroblasts treated with tumor cell-conditioned media supported the in vivo findings. This study demonstrates that tumors are sufficient to disrupt fundamental and clinically-relevant innate immune functions. The understanding of these underlying mechanisms provides potential for therapeutic interventions capable of improving the treatment of cancer while reducing morbidities and mortality.	[Pyter, Leah M.; McKim, Daniel B.; Lin, Hsin-Yun; Godbout, Jonathan P.; Sheridan, John F.] Ohio State Univ, Wexner Med Ctr, Inst Behav Med Res, Columbus, OH 43210 USA; [Pyter, Leah M.; Lin, Hsin-Yun] Ohio State Univ, Dept Psychiat & Behav Hlth, Columbus, OH 43210 USA; [Pyter, Leah M.; Godbout, Jonathan P.] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; [Pyter, Leah M.; Husain, Yasmin; Calero, Humberto; Engeland, Christopher G.; Marucha, Phillip T.] Univ Illinois, Coll Dent, Ctr Wound Healing & Tissue Regenerat, Chicago, IL 60607 USA; [Sheridan, John F.] Ohio State Univ, Coll Dent, Dept Biosci, Columbus, OH 43210 USA; [Engeland, Christopher G.] Penn State Univ, Dept Biobehav Hlth, University Pk, PA 16802 USA; [Engeland, Christopher G.] Penn State Univ, Coll Nursing, University Pk, PA 16802 USA; [Marucha, Phillip T.] Oregon Hlth & Sci Univ, Coll Dent, Portland, OR 97201 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University System of Ohio; Ohio State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Oregon Health & Science University	Pyter, LM (corresponding author), Ohio State Univ, Wexner Med Ctr, Inst Behav Med Res, Columbus, OH 43210 USA.; Pyter, LM (corresponding author), Ohio State Univ, Dept Psychiat & Behav Hlth, Columbus, OH 43210 USA.; Pyter, LM (corresponding author), Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA.; Pyter, LM (corresponding author), Univ Illinois, Coll Dent, Ctr Wound Healing & Tissue Regenerat, Chicago, IL 60607 USA.	leah.pyter@osumc.edu	Sheridan, John F/E-4081-2011; Pyter, Leah/AFR-8698-2022	Pyter, Leah/0000-0001-8189-0663	UIC Center for Clinical and Translational Science award [UL1RR029879]; Ohio State University Medical Center [DE017686]; UIC Department of Periodontics; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH109234] Funding Source: NIH RePORTER	UIC Center for Clinical and Translational Science award; Ohio State University Medical Center; UIC Department of Periodontics; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by UIC Center for Clinical and Translational Science award UL1RR029879 and Ohio State University Medical Center (L.P.), DE017686 (P.M.), and UIC Department of Periodontics (C.E.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allareddy V, 2013, OR SURG OR MED OR PA, V115, P710, DOI 10.1016/j.oooo.2012.09.004; Andrews N, 2001, AUST DENT J, V46, P174, DOI 10.1111/j.1834-7819.2001.tb00278.x; Beury DW, 2014, J LEUKOCYTE BIOL, V96, P1109, DOI 10.1189/jlb.3A0414-210R; Chakravortty D, 1999, BBA-MOL BASIS DIS, V1453, P261, DOI 10.1016/S0925-4439(98)00106-9; Chen L, 2014, EXP DERMATOL, V23, P436, DOI 10.1111/exd.12411; Chen L, 2013, J INVEST DERMATOL, V133, P258, DOI 10.1038/jid.2012.267; Chen L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-471; Coskun H, 2000, OTOLARYNG HEAD NECK, V123, P328, DOI 10.1067/mhn.2000.105253; CRAWFORD DT, 1965, J SURG RES, V5, P265, DOI 10.1016/S0022-4804(65)80016-6; de Araujo T, 2003, ANN INTERN MED, V138, P326, DOI 10.7326/0003-4819-138-4-200302180-00012; DEVEREUX DF, 1979, J SURG RES, V27, P233, DOI 10.1016/0022-4804(79)90135-5; Dhabhar FS, 1999, P NATL ACAD SCI USA, V96, P1059, DOI 10.1073/pnas.96.3.1059; DiPietro LA, 1998, J CLIN INVEST, V101, P1693, DOI 10.1172/JCI1020; Dovi JV, 2003, J LEUKOCYTE BIOL, V73, P448, DOI 10.1189/jlb.0802406; Duray A, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/701657; Engler H, 2004, J NEUROIMMUNOL, V148, P106, DOI 10.1016/j.jneuroim.2003.11.011; Franz MG, 2007, CURR PROB SURG, V44, P691, DOI 10.1067/j.cpsurg.2007.07.001; Funk GF, 2002, HEAD NECK-J SCI SPEC, V24, P165, DOI 10.1002/hed.10004; Gerlach MA, 2005, NURS CLIN N AM, V40, P295, DOI 10.1016/j.cnur.2004.09.008; Goren I, 2007, J INVEST DERMATOL, V127, P2259, DOI 10.1038/sj.jid.5700842; Harreus U, 2013, GMS CURR TOP OTORHIN, V12, pDoc04, DOI DOI 10.3205/CTO000096; Haubner F, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-162; HIER MP, 1995, LARYNGOSCOPE, V105, P1077, DOI 10.1288/00005537-199510000-00013; Horan MP, 2005, BRAIN BEHAV IMMUN, V19, P207, DOI 10.1016/j.bbi.2004.09.004; Jewett A, 2006, J DENT RES, V85, P1061, DOI 10.1177/154405910608501201; Kim JW, 2004, CLIN CANCER RES, V10, P5101, DOI 10.1158/1078-0432.CCR-04-0309; Koh TJ, 2013, METHODS MOL BIOL, V1037, P507, DOI 10.1007/978-1-62703-505-7_30; Kolokythas Antonia, 2010, J Oral Maxillofac Res, V1, pe1, DOI 10.5037/jomr.2010.1301; Kolokythas Antonia, 2010, J Oral Maxillofac Res, V1, pe2, DOI 10.5037/jomr.2010.1302; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; LAWRENCE WT, 1987, J SURG ONCOL, V35, P7, DOI 10.1002/jso.2930350103; LAWRENCE WT, 1986, SURGERY, V100, P9; LEIBOVICH SJ, 1975, AM J PATHOL, V78, P71; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lou E, 2003, ORAL DIS, V9, P305, DOI 10.1034/j.1601-0825.2003.00968.x; Maida V, 2012, INT WOUND J, V9, P683, DOI 10.1111/j.1742-481X.2012.00939.x; Mandruzzato S, 2009, J IMMUNOL, V182, P6562, DOI 10.4049/jimmunol.0803831; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; Martin P, 2003, CURR BIOL, V13, P1122, DOI 10.1016/S0960-9822(03)00396-8; McNees Patrick, 2006, Semin Oncol Nurs, V22, P130, DOI 10.1016/j.soncn.2006.04.003; McNees P, 2007, OSTOMY WOUND MANAG, V53, P70; Mercado AM, 2002, BRAIN BEHAV IMMUN, V16, P150, DOI 10.1006/brbi.2001.0623; Mirza R, 2009, AM J PATHOL, V175, P2454, DOI 10.2353/ajpath.2009.090248; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Neeman E, 2013, BRAIN BEHAV IMMUN, V30, pS32, DOI 10.1016/j.bbi.2012.03.006; Neves J, 2015, DEV CELL, V32, P9, DOI 10.1016/j.devcel.2014.11.028; Ogihara H, 2009, AURIS NASUS LARYNX, V36, P457, DOI 10.1016/j.anl.2008.10.005; Olsen MA, 2008, J AM COLL SURGEONS, V207, P326, DOI 10.1016/j.jamcollsurg.2008.04.021; Park JE, 2004, AM J SURG, V187, p11S, DOI 10.1016/S0002-9610(03)00296-4; Payne Wyatt G, 2008, Eplasty, V8, pe9; Sahai SK, 2013, BEST PRACT RES-CLIN, V27, P465, DOI 10.1016/j.bpa.2013.10.001; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Simon A, 2006, SUPPORT CARE CANCER, V14, P91, DOI 10.1007/s00520-005-0874-8; Strauss L, 2007, CLIN CANCER RES, V13, P6301, DOI 10.1158/1078-0432.CCR-07-1403; Tymen SD, 2013, BRAIN BEHAV IMMUN, V28, P207, DOI 10.1016/j.bbi.2012.07.013; Vahle AK, 2012, CANCER LETT, V317, P199, DOI 10.1016/j.canlet.2011.11.027; Vasquez-Dunddel D, 2013, J CLIN INVEST, V123, P1580, DOI 10.1172/JCI60083; WEBER RS, 1992, ANN OTO RHINOL LARYN, V101, P16, DOI 10.1177/00034894921010S104; Weissflog D, 1999, CHEST, V115, P1604, DOI 10.1378/chest.115.6.1604; Wilgus TA, 2008, PHARMACOL RES, V58, P112, DOI 10.1016/j.phrs.2008.07.009; Wilgus TA, 2007, OSTOMY WOUND MANAG, V53, P16; Wohleb ES, 2013, J NEUROSCI, V33, P13820, DOI 10.1523/JNEUROSCI.1671-13.2013; Wohleb ES, 2011, J NEUROSCI, V31, P6277, DOI 10.1523/JNEUROSCI.0450-11.2011	63	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161537	10.1371/journal.pone.0161537	http://dx.doi.org/10.1371/journal.pone.0161537			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548621	Green Submitted, Green Published, gold			2022-12-26	WOS:000381768400069
J	Iversen, MM; Nefs, G; Tell, GS; Espehaug, B; Midthjell, K; Graue, M; Pouwer, F				Iversen, Marjolein M.; Nefs, Giesje; Tell, Grethe S.; Espehaug, Birgitte; Midthjell, Kristian; Graue, Marit; Pouwer, Frans			Anxiety and Depressive Symptoms as Predictors of All-Cause Mortality among People with Insulin-Naive Type 2 Diabetes: 17-Year Follow-Up of the Second Nord-Trondelag Health Survey (HUNT2), Norway	PLOS ONE			English	Article							POOR GLYCEMIC CONTROL; HOSPITAL ANXIETY; SCALE; METAANALYSIS; PREVALENCE; RISK; HYPOGLYCEMIA; POPULATION; RESISTANCE; COHORT	Aim To examine whether elevated anxiety and/or depressive symptoms are related to all-cause mortality in people with Type 2 diabetes, not using insulin. Methods 948 participants in the community-wide Nord-Trondelag Health Survey conducted during 1995-97 completed the Hospital Anxiety and Depression Scale with subscales of anxiety (HADS-A) and depression (HADS-D). Elevated symptoms were defined as HADS-A or HADS-D >= 8. Participants with type 2 diabetes, not using insulin, were followed until November 21, 2012 or death. Cox regression analyses were used to estimate associations between baseline elevated anxiety symptoms, elevated depressive symptoms and mortality, adjusting for sociodemographic factors, HbA(1c), cardiovascular disease and microvascular complications. Results At baseline, 8% (n = 77/948) reported elevated anxiety symptoms, 9% (n = 87/948) elevated depressive symptoms and 10% (n = 93/948) reported both. After a mean follow-up of 12 years (SD 5.1, range 0-17), 541 participants (57%) had died. Participants with elevated anxiety symptoms only had a decreased mortality risk (unadjusted HR 0.66, 95% CI 0.46-0.96). Adjustment for HbA(1c) attenuated this relation (HR 0.73, 95% CI 0.50-1.07). Those with elevated depression symptoms alone had an increased mortality risk (fully adjusted model HR 1.39, 95% CI 1.05-1.84). Having both elevated anxiety and depressive symptoms was not associated with increased mortality risk (adjusted HR 1.30, 95% CI 0.96-1.74). Conclusions Elevated depressive symptoms were associated with excess mortality risk in people with Type 2 diabetes not using insulin. No significant association with mortality was found among people with elevated anxiety symptoms. Having both elevated anxiety and depressive symptoms was not associated with mortality. The hypothesis that elevated levels of anxiety symptoms leads to behavior that counteracts the adverse health effects of Type 2 diabetes needs further investigation.	[Iversen, Marjolein M.; Espehaug, Birgitte; Graue, Marit] Bergen Univ Coll, Dept Hlth & Social Sci, Ctr Evidence Based Practice, Bergen, Norway; [Iversen, Marjolein M.] Stavanger Univ Hosp, Endocrinol Sect, Dept Med, Stavanger, Norway; [Nefs, Giesje; Pouwer, Frans] Tilburg Univ, Dept Med & Clin Psychol, Ctr Res Psychol & Somat Disorders CoRPS, Tilburg, Netherlands; [Tell, Grethe S.] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Midthjell, Kristian] Norwegian Univ Sci & Technol, Dept Community Med & Gen Practice, HUNT Res Ctr, Levanger, Norway	Western Norway University of Applied Sciences; Stavanger University Hospital; Tilburg University; University of Bergen; Norwegian University of Science & Technology (NTNU)	Iversen, MM (corresponding author), Bergen Univ Coll, Dept Hlth & Social Sci, Ctr Evidence Based Practice, Bergen, Norway.; Iversen, MM (corresponding author), Stavanger Univ Hosp, Endocrinol Sect, Dept Med, Stavanger, Norway.	marjolein.iversen@hib.no	Nefs, Giesje/C-9992-2018; Tell, Grethe/G-5639-2015	Tell, Grethe/0000-0003-1386-1638; Espehaug, Birgitte/0000-0002-7287-8643; Pouwer, Frans/0000-0002-8172-9818; Iversen, Marjolein Memelink/0000-0001-9954-171X				Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x; Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS13, DOI 10.2337/dc09-S013; Anderbro T, 2015, ACTA DIABETOL, V52, P581, DOI 10.1007/s00592-014-0694-8; Anderson RJ, 2002, INT J PSYCHIAT MED, V32, P235, DOI 10.2190/KLGD-4H8D-4RYL-TWQ8; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Coyne JC, 2012, J PSYCHOSOM RES, V72, P173, DOI 10.1016/j.jpsychores.2011.12.003; Cuijpers P, 2014, AM J PSYCHIAT, V171, P453, DOI 10.1176/appi.ajp.2013.13030325; Damak R., 2013, DEPRESS RES TREAT, V2013; Doering LV, 2010, INT J CARDIOL, V145, P188, DOI 10.1016/j.ijcard.2009.05.025; Drivsholm T, 2006, SCAND J PUBLIC HEALT, V34, P623, DOI 10.1080/14034940600607616; Grigsby AB, 2002, J PSYCHOSOM RES, V53, P1053, DOI 10.1016/S0022-3999(02)00417-8; Hermanns N, 2005, DIABETIC MED, V22, P293, DOI 10.1111/j.1464-5491.2005.01414.x; Holmen J, 2003, NORSK EPIDEMIOLOGI, V13, P19, DOI DOI 10.1093/eurheartj/eht019; Iversen MM, 2015, J PSYCHOSOM RES, V79, P309, DOI 10.1016/j.jpsychores.2015.07.004; Lin EHB, 2010, DIABETES CARE, V33, P264, DOI 10.2337/dc09-1068; Lou PA, 2014, COPD, V11, P444, DOI 10.3109/15412555.2013.822856; Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934; Mykletun A, 2001, BRIT J PSYCHIAT, V179, P540, DOI 10.1192/bjp.179.6.540; Nam S, 2010, DIABETES CARE, V33, P1747, DOI 10.2337/dc10-0099; Nefs G, 2012, DIABETOLOGIA, V55, P608, DOI 10.1007/s00125-011-2411-2; Nefs G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078865; Norton S, 2012, J PSYCHOSOM RES, V73, P75, DOI 10.1016/j.jpsychores.2012.04.005; Nouwen A, 2010, DIABETOLOGIA, V53, P2480, DOI 10.1007/s00125-010-1874-x; Park JH, 2015, J CARDIOVASC NURS, V30, P351, DOI 10.1097/JCN.0000000000000143; Polonsky WH, 2005, DIABETES CARE, V28, P2543, DOI 10.2337/diacare.28.10.2543; Pouwer F, 2013, ENDOCRIN METAB CLIN, V42, P529, DOI 10.1016/j.ecl.2013.05.002; Rutledge T, 2009, PSYCHOSOM MED, V71, P958, DOI 10.1097/PSY.0b013e3181bd6062; Saleh N, 2012, DIABETOLOGIA, V55, P2109, DOI 10.1007/s00125-012-2565-6; Smith KJ, 2013, J PSYCHOSOM RES, V74, P89, DOI 10.1016/j.jpsychores.2012.11.013; Strandberg RB, 2014, J PSYCHOSOM RES, V77, P174, DOI 10.1016/j.jpsychores.2014.06.015; Tovilla-Zarate C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036887; Vallis M, 2014, CURR DIABETES REV, V10, P364, DOI 10.2174/1573399810666141113115026; van Dooren FEP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057058; Watkins LL, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.000068; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	35	11	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0160861	10.1371/journal.pone.0160861	http://dx.doi.org/10.1371/journal.pone.0160861			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT6ES	27537359	Green Published, gold, Green Submitted			2022-12-26	WOS:000381577000036
J	Metwally, DM; Al-Olayan, EM; El-Khadragy, MF; Alkathiri, B				Metwally, Dina M.; Al-Olayan, Ebtesam M.; El-Khadragy, Manal F.; Alkathiri, Badriah			Anti-Leishmanial Activity (In Vitro and In Vivo) of Allicin and Allicin Cream Using Leishmania major (Sub-strain Zymowme LON4) and Balb/c Mice	PLOS ONE			English	Article							CUTANEOUS LEISHMANIASIS; L. INFANTUM; DONOVANI; INTERLEUKIN-12; PROMASTIGOTES; APOPTOSIS; PROTEINS; ASSAY	Background Leishmania is a unicellular protozoan parasite that produces several human diseases, ranging from localized self-healing cutaneous lesions to deadly visceral infections. Objective The effect of allicin on the growth of Leishmania major (L. major) promastigotes was evaluated under in vitro conditions. Moreover, the efficacy of a topical allicin cream was examined in BALB/c (Bagg albino, laboratory-bred strain of the House Mouse) mice with cutaneous leishmanial lesions compared to the currently used drug, sodiumstibogluconate (pentostam). Methods Cytotoxiciy and promastigote proliferation were measured. Different concentrations (50, 100, 150, and 200 mu M) of liquid allicin were tested on L. major promastigotes twice: after 24 and 48 hours using an MTT colorimetric assay. In the in vivo condition, the efficacies of allicin cream and liquid allicin at two concentrations (0.15 mu M/mouse and 0.30 mu M/mouse) were evaluated. Serum factors of the control and treated groups were tested to evaluate the toxic effects of allicin on the liver and kidney. Results Allicin at a concentration of 50 mu M inhibited the growth of Leishmania promastigotes. Topical application of allicin cream reduced lesion sizes in mice. No significant differences in biochemical analysis were observed between the control and treated groups. Conclusions Allicin has antileishmanial effects under in vitro and in vivo conditions and may be used in clinical applications.	[Metwally, Dina M.; Al-Olayan, Ebtesam M.; El-Khadragy, Manal F.; Alkathiri, Badriah] King Saud Univ, Fac Sci, Dept Zool, Riyadh, Saudi Arabia; [Metwally, Dina M.] Zagazig Univ, Fac Vet Med, Dept Parasitol, Zagazig, Egypt; [El-Khadragy, Manal F.] Helwan Univ, Fac Sci, Dept Zool & Entomol, Cairo, Egypt	King Saud University; Egyptian Knowledge Bank (EKB); Zagazig University; Egyptian Knowledge Bank (EKB); Helwan University	Metwally, DM (corresponding author), King Saud Univ, Fac Sci, Dept Zool, Riyadh, Saudi Arabia.; Metwally, DM (corresponding author), Zagazig Univ, Fac Vet Med, Dept Parasitol, Zagazig, Egypt.	mdbody7@yahoo.com		Metwally, Dina M./0000-0001-6042-4137	research center of the Center for Female Scientific and Medical Colleges in King Saud University	research center of the Center for Female Scientific and Medical Colleges in King Saud University	This research project was supported by a grant from the research center of the Center for Female Scientific and Medical Colleges in King Saud University.	Acardi SA, 2010, MEM I OSWALDO CRUZ, V105, P796, DOI 10.1590/S0074-02762010000600011; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Ankri S, 1999, MICROBES INFECT, V1, P125, DOI 10.1016/S1286-4579(99)80003-3; [Anonymous], 2016, FACT SHEET WHO STAND; Anthony JP, 2005, TRENDS PARASITOL, V21, P462, DOI 10.1016/j.pt.2005.08.004; City B, 2014, J COASTAL LIFE MED, V2, P319; Corral MJ, 2014, ANTIMICROB AGENTS CH, V58, P1596, DOI 10.1128/AAC.00710-13; Fuertes MA, 2008, CURR MED CHEM, V15, P433; Gharavi MJ, 2011, IRAN J PUBLIC HEALTH, V40, P105; Hepburn NC, 2000, CLIN EXP DERMATOL, V25, P363, DOI 10.1046/j.1365-2230.2000.00664.x; Corral-Caridad MJ, 2012, EXP PARASITOL, V132, P475, DOI 10.1016/j.exppara.2012.08.016; Marfurt J, 2003, J CLIN MICROBIOL, V41, P3147, DOI 10.1128/JCM.41.7.3147-3153.2003; Markle WH, 2004, AM FAM PHYSICIAN, V69, P1455; Miron T, 2010, EUR J MED CHEM, V45, P1912, DOI 10.1016/j.ejmech.2010.01.031; Mohammadzadeh M, 2013, J INFECT PUBLIC HEAL, V6, P120, DOI 10.1016/j.jiph.2012.11.003; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NABORS GS, 1995, P NATL ACAD SCI USA, V92, P3142, DOI 10.1073/pnas.92.8.3142; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Oommen S, 2004, EUR J PHARMACOL, V485, P97, DOI 10.1016/j.ejphar.2003.11.059; Rabinkov A, 1998, BBA-GEN SUBJECTS, V1379, P233, DOI 10.1016/S0304-4165(97)00104-9; Sambrook J., 2001, MOL CLONING LAB MANU; Verma NK, 2007, EXP PARASITOL, V116, P1, DOI 10.1016/j.exppara.2006.10.007; Zaghloul IY, 2004, ANN TROP MED PARASIT, V98, P793, DOI 10.1179/000349804X3171	23	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161296	10.1371/journal.pone.0161296	http://dx.doi.org/10.1371/journal.pone.0161296			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537199	Green Published, gold, Green Submitted			2022-12-26	WOS:000381577000084
J	Rubbenstroth, D; Schmidt, V; Rinder, M; Legler, M; Twietmeyer, S; Schwemmer, P; Corman, VM				Rubbenstroth, Dennis; Schmidt, Volker; Rinder, Monika; Legler, Marko; Twietmeyer, Soenke; Schwemmer, Phillip; Corman, Victor M.			Phylogenetic Analysis Supports Horizontal Transmission as a Driving Force of the Spread of Avian Bornaviruses	PLOS ONE			English	Article							PROVENTRICULAR DILATATION DISEASE; COCKATIELS NYMPHICUS-HOLLANDICUS; EXPERIMENTALLY INFECTED COCKATIELS; GEESE BRANTA-CANADENSIS; PSITTACINE BIRDS; BORNA-DISEASE; VERTICAL TRANSMISSION; MUTE SWANS; VIRUS; RESERVOIR	Background Avian bornaviruses are a genetically diverse group of viruses initially discovered in 2008. They are known to infect several avian orders. Bornaviruses of parrots and related species (Psittaciformes) are causative agents of proventricular dilatation disease, a chronic and often fatal neurologic disease widely distributed in captive psittacine populations. Although knowledge has considerably increased in the past years, many aspects of the biology of avian bornaviruses are still undiscovered. In particular, the precise way of transmission remains unknown. Aims and Methods In order to collect further information on the epidemiology of bornavirus infections in birds we collected samples from captive and free-ranging aquatic birds (n = 738) and Passeriformes (n = 145) in Germany and tested them for the presence of bornaviruses by PCR assays covering a broad range of known bornaviruses. We detected aquatic bird bornavirus 1 (ABBV-1) in three out of 73 sampled free-ranging mute swans (Cygnus olor) and one out of 282 free-ranging Eurasian oystercatchers (Haematopus ostralegus). Canary bornavirus 1 (CnBV-1), CnBV-2 and CnBV-3 were detected in four, six and one out of 48 captive common canaries (Serinus canaria forma domestica), respectively. In addition, samples originating from 49 bornavirus-positive captive Psittaciformes were used for determination of parrot bornavirus 2 (PaBV-2) and PaBV-4 sequences. Bornavirus sequences compiled during this study were used for phylogenetic analysis together with all related sequences available in GenBank. Results of the Study Within ABBV-1, PaBV-2 and PaBV-4, identical or genetically closely related bornavirus sequences were found in parallel in various different avian species, suggesting that interspecies transmission is frequent relative to the overall transmission of these viruses. Our results argue for an important role of horizontal transmission, but do not exclude the additional possibility of vertical transmission. Furthermore we defined clearly separated sequence clusters within several avian bornaviruses, providing a basis for an improved interpretation of transmission events within and between wild bird populations and captive bird collections.	[Rubbenstroth, Dennis] Univ Freiburg, Med Ctr, Inst Virol, Fac Med, Herrmann Herder Str 11, D-79104 Freiburg, Germany; [Schmidt, Volker] Univ Leipzig, Clin Birds & Reptiles, Tierkliniken 17, D-04103 Leipzig, Germany; [Rinder, Monika] Univ Ludwig Maximilian Munich, Ctr Clin Vet Med, Clin Birds Reptiles Amphibians & Ornamental Fish, Sonnenstr 18, D-85764 Oberschleissheim, Germany; [Legler, Marko] Univ Vet Med Hannover, Clin Pets Reptiles & Pet & Feral Birds, Bunteweg 9, D-30559 Hannover, Germany; [Twietmeyer, Soenke] Eifel Natl Pk, Dept Res & Documentat, Urftseestr 34, D-53937 Schleiden Gemund, Germany; [Schwemmer, Phillip] Univ Kiel, Res & Technol Ctr Busum, Hafentorn 1, D-25761 Busum, Germany; [Corman, Victor M.] Univ Bonn, Inst Virol, Sigmund Freud Str 25, D-53127 Bonn, Germany; [Corman, Victor M.] German Ctr Infect Res DZIF, Partner Site Bonn Cologne, Bonn, Germany	University of Freiburg; Leipzig University; University of Munich; University of Veterinary Medicine Hannover, Foundation; University of Kiel; University of Bonn; German Center for Infection Research	Rubbenstroth, D (corresponding author), Univ Freiburg, Med Ctr, Inst Virol, Fac Med, Herrmann Herder Str 11, D-79104 Freiburg, Germany.	Dennis.Rubbenstroth@uniklinik-freiburg.de	Corman, Victor M/K-1319-2019; Schmidt, Volker/I-7708-2019	Corman, Victor M/0000-0002-3605-0136; Schmidt, Volker/0000-0002-6001-9542	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [RU-1923/2-1]	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG))	DR obtained funding from the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG; grant RU-1923/2-1), http://www.dfg.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors like to thank Rebecca Eberhardt, Sabine Muller, Andreas Narr, Felix Rottele, Solveig Runge, Lukas Walther and Stefan Weiel for excellent technical assistance. Dennis Rubbenstroth obtained funding from the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG; grant RU-1923/2-1).	Berg M, 2001, EPIDEMIOL INFECT, V127, P173, DOI 10.1017/S0950268801005702; Bourg M, 2013, EMERG INFECT DIS, V19, P2064, DOI 10.3201/eid1912.131076; Delnatte P, 2014, AVIAN PATHOL, V43, P301, DOI 10.1080/03079457.2014.921279; Delnatte P, 2014, J VET DIAGN INVEST, V26, P266, DOI 10.1177/1040638713519641; Delnatte P, 2013, AVIAN PATHOL, V42, P114, DOI 10.1080/03079457.2013.769669; Durrwald R, 2006, MICROBES INFECT, V8, P917, DOI 10.1016/j.micinf.2005.08.013; Durrwald R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093659; Encinas-Nagel N, 2014, EMERG INFECT DIS, V20, P2103, DOI 10.3201/eid2012.140920; Gray P, 2010, EMERG INFECT DIS, V16, P473, DOI 10.3201/eid1603.091257; Gregory Christopher R., 1994, Journal of the Association of Avian Veterinarians, V8, P69; Guo JH, 2015, J WILDLIFE DIS, V51, P754, DOI 10.7589/2015-01-001; Guo JH, 2014, VIROL J, V11, DOI 10.1186/s12985-014-0197-9; Guo J, 2012, VET MED-RES REP, V3, P49, DOI 10.2147/VMRR.S33353; Heatley JJ, 2012, VET MED-RES REP, V3, P19, DOI 10.2147/VMRR.S31336; Heffels-Redmann U, 2012, AVIAN DIS, V56, P153, DOI 10.1637/9844-062811-Reg.1; Heffels-Redmann U, 2011, AVIAN PATHOL, V40, P419, DOI 10.1080/03079457.2011.589825; Hilbe M, 2006, EMERG INFECT DIS, V12, P675, DOI 10.3201/eid1204.051418; Hoffmann B, 2015, NEW ENGL J MED, V373, P154, DOI 10.1056/NEJMoa1415627; Honkavuori KS, 2008, EMERG INFECT DIS, V14, P1883, DOI 10.3201/eid1412.080984; Kerski A, 2012, AVIAN DIS, V56, P471, DOI 10.1637/9879-080511-Reg.1; Kistler AL, 2010, J VIROL, V84, P2176, DOI 10.1128/JVI.02191-09; Kistler AL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-88; Kolodziejek J, 2005, J GEN VIROL, V86, P385, DOI 10.1099/vir.0.80587-0; Kuhn JH, 2015, ARCH VIROL, V160, P621, DOI 10.1007/s00705-014-2276-z; Lierz M, 2011, EMERG INFECT DIS, V17, P2390, DOI 10.3201/eid1712.111317; Mirhosseini N, 2011, J AVIAN MED SURG, V25, P199, DOI 10.1647/2010-030.1; Monaco E, 2012, J AVIAN MED SURG, V26, P144, DOI 10.1647/2011-049R1.1; Nobach D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137018; Payne S, 2011, AVIAN PATHOL, V40, P15, DOI 10.1080/03079457.2010.536978; Payne S, 2011, J VIROL, V85, P12053, DOI 10.1128/JVI.05700-11; Philadelpho NA, 2014, VET MICROBIOL, V174, P584, DOI 10.1016/j.vetmic.2014.10.020; Piepenbring AK, 2012, EMERG INFECT DIS, V18, P234, DOI 10.3201/eid1802.111525; Puorger ME, 2010, VET PATHOL, V47, P236, DOI 10.1177/0300985809351849; Raghav R, 2010, J VET DIAGN INVEST, V22, P495, DOI 10.1177/104063871002200402; Rinder M, 2009, J VIROL, V83, P5401, DOI 10.1128/JVI.00133-09; Rubbenstroth D, 2012, VET MICROBIOL, V161, P36, DOI 10.1016/j.vetmic.2012.07.004; Rubbenstroth D, 2015, 2 NEW SPECIES FAMILY; Rubbenstroth D, 2014, VET MICROBIOL, V172, P146, DOI 10.1016/j.vetmic.2014.05.011; Rubbenstroth D, 2014, VET MICROBIOL, V168, P318, DOI 10.1016/j.vetmic.2013.11.032; Rubbenstroth D, 2013, VET MICROBIOL, V165, P287, DOI 10.1016/j.vetmic.2013.03.024; Sassa Y, 2015, VIRUS GENES, V51, P234, DOI 10.1007/s11262-015-1240-7; Schwemmer P, 2014, WATERBIRDS, V37, P319, DOI 10.1675/063.037.0310; Staeheli P, 2010, J VIROL, V84, P6269, DOI 10.1128/JVI.02567-09; Thomsen AF, 2015, EMERG INFECT DIS, V21, P2201, DOI 10.3201/eid2112.150650; Weissenbock H, 2009, J VIROL, V83, P11367, DOI 10.1128/JVI.01343-09; Weissenbock H, 2009, EMERG INFECT DIS, V15, P1453, DOI 10.3201/eid1509.090353	46	21	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0160936	10.1371/journal.pone.0160936	http://dx.doi.org/10.1371/journal.pone.0160936			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537693	Green Submitted, gold, Green Published			2022-12-26	WOS:000381577000039
J	Yan, I; Bendavid, E; Korenromp, EL				Yan, Isabel; Bendavid, Eran; Korenromp, Eline L.			Antiretroviral Treatment Scale-Up and Tuberculosis Mortality in High TB/HIV Burden Countries: An Econometric Analysis	PLOS ONE			English	Article							ISONIAZID PREVENTIVE THERAPY; RIO-DE-JANEIRO; SOUTH-AFRICA; COTRIMOXAZOLE PROPHYLAXIS; POSITIVE ADULTS; HIV; SURVIVAL; TARGETS; DEATHS; TRENDS	Introduction Antiretroviral therapy (ART) reduces mortality in patients with active tuberculosis (TB), but the population-level relationship between ART coverage and TB mortality is untested. We estimated the reduction in population-level TB mortality that can be attributed to increasing ART coverage across 41 high HIV-TB burden countries. Methods We compiled TB mortality trends between 1996 and 2011 from two sources: (1) national program-reported TB death notifications, adjusted for annual TB case detection rates, and (2) WHO TB mortality estimates. National coverage with ART, as proportion of HIV-infected people in need, was obtained from UNAIDS. We applied panel linear regressions controlling for HIV prevalence (5-year lagged), coverage of TB interventions (estimated by WHO and UNAIDS), gross domestic product per capita, health spending from domestic sources, urbanization, and country fixed effects. Results Models suggest that that increasing ART coverage was followed by reduced TB mortality, across multiple specifications. For death notifications at 2 to 5 years following a given ART scale-up, a 1% increase in ART coverage predicted 0.95% faster mortality rate decline (p = 0.002); resulting in 27% fewer TB deaths in 2011 alone than would have occurred without ART. Based on WHO death estimates, a 1% increase in ART predicted a 1.0% reduced TB death rate (p<0.001), and 31% fewer deaths in 2011. TB mortality was higher at higher HIV prevalence (p<0.001), but not related to coverage of isoniazid preventive therapy, cotrimoxazole preventive therapy, or other covariates. Conclusion This econometric analysis supports a substantial impact of ART on population-level TB mortality realized already within the first decade of ART scale-up, that is apparent despite variable-quality mortality data.	[Yan, Isabel] City Univ Hong Kong, Dept Econ & Finance, Kowloon, Hong Kong, Peoples R China; [Bendavid, Eran] Stanford Univ, Div Gen Med Disciplines, Stanford, CA 94305 USA; [Bendavid, Eran] Stanford Univ, Ctr Hlth Policy, Stanford, CA 94305 USA; [Bendavid, Eran] Stanford Univ, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA; [Korenromp, Eline L.] Univ Med Ctr, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Korenromp, Eline L.] Avenir Hlth, Geneva, Switzerland	City University of Hong Kong; Stanford University; Stanford University; Stanford University; Erasmus University Rotterdam; Erasmus MC	Korenromp, EL (corresponding author), Univ Med Ctr, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands.; Korenromp, EL (corresponding author), Avenir Hlth, Geneva, Switzerland.	ekorenromp@AvenirHealth.org			National Institute for Drug Abuse [DA015612]; Doris Duke Charitable Foundation; National Natural Science Foundation [71403061]; Global Research Unit (GRU) at the City University of Hong Kong; NATIONAL INSTITUTE ON AGING [P30AG017253] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015612, R37DA015612] Funding Source: NIH RePORTER	National Institute for Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Global Research Unit (GRU) at the City University of Hong Kong; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	EB was supported by the National Institute for Drug Abuse (DA015612) and by the Doris Duke Charitable Foundation. IY acknowledges support by the National Natural Science Foundation (project no. 71403061) and by the Global Research Unit (GRU) at the City University of Hong Kong. The funders of the study had no role in study design, data collection and analysis, data interpretation, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, GLOBAL TUBERCULOSIS; [Anonymous], 2011, INDICATOR AND MEASUR; Au-Yeung Christopher, 2011, Clin Epidemiol, V3, P21, DOI 10.2147/CLEP.S15574; Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; Bendavid E, 2012, JAMA-J AM MED ASSOC, V307, P2060, DOI 10.1001/jama.2012.2001; Bendavid E, 2009, ANN INTERN MED, V150, P688, DOI 10.7326/0003-4819-150-10-200905190-00117; Blok L, 2014, INT HEALTH, V6, P181, DOI 10.1093/inthealth/ihu055; Bor J, 2013, SCIENCE, V339, P961, DOI 10.1126/science.1230413; Charalambous S, 2010, AIDS, V24, pS5, DOI 10.1097/01.aids.0000391010.02774.6f; Cohen T, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000296; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Creswell J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094465; Dieleman JL, 2013, JOURNAL OF DEVELOPME, P1; Dowdy DW, 2014, JAIDS-J ACQ IMM DEF, V66, P552, DOI 10.1097/QAI.0000000000000219; Duber HC, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-21; Durovni B, 2013, LANCET INFECT DIS, V13, P852, DOI 10.1016/S1473-3099(13)70187-7; Fazito E, 2012, SEX TRANSM INFECT, V88, pI86, DOI 10.1136/sextrans-2012-050632; Floyd S, 2012, TROP MED INT HEALTH, V17, pe84, DOI 10.1111/j.1365-3156.2012.03032.x; Floyd S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013499; Glaziou P, 2011, B WORLD HEALTH ORGAN, V89, P573, DOI [10.2471/BLT.11.087510, DOI 10.2471/BLT.11.O87510]; Glaziou P, 2016, EPRINT ARXIV 2016 16; Glaziou P, 2011, B WORLD HEALTH ORGAN, V89, P573, DOI 10.2471/BLT.11.087510; Harries AD, 2015, LANCET INFECT DIS, V15, P1492, DOI 10.1016/S1473-3099(15)00242-X; Kabali C, 2011, INT J TUBERC LUNG D, V15, P1515, DOI 10.5588/ijtld.10.0788; Kasamba I, 2012, TROP MED INT HEALTH, V17, pe66, DOI 10.1111/j.1365-3156.2012.02841.x; Korenromp EL, 2009, INT J TUBERC LUNG D, V13, P283; Korenromp EL, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-18; Korenromp EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038816; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Maher D, 2005, INT J TUBERC LUNG D, V9, P123; Manosuthi W, 2006, JAIDS-J ACQ IMM DEF, V43, P42, DOI 10.1097/01.qai.0000230521.86964.86; Nunn AJ, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a257; Organisation for Economic Co-operation and Development, 2014, DEVELOPMENT ASSISTAN; Pretorius C, 2014, AIDS, V28, pS25, DOI 10.1097/QAD.0000000000000085; Samandari T, 2011, LANCET, V377, P1588, DOI 10.1016/S0140-6736(11)60204-3; Stoneburner R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100431; Suthar AB, 2015, LANCET HIV, V2, pE137, DOI 10.1016/S2352-3018(15)00005-3; The Global Fund to Fight AIDS Tuberculosis and Malaria, 2011, THE GLOBAL FUND RESU; UNAIDS, 2014, FAST TRACK ENDING TH; UNAIDS, 2013, REPORT ON THE GLOBAL; Uyei J, 2011, LANCET INFECT DIS, V11, P855, DOI 10.1016/S1473-3099(11)70145-1; van der Werf MJ, 2007, B WORLD HEALTH ORGAN, V85, P370, DOI 10.2471/BLT.06.039941; Vapattanawong P, 2011, B WORLD HEALTH ORGAN, V89, P806, DOI 10.2471/BLT.10.083931; Watera C, 2006, JAIDS-J ACQ IMM DEF, V42, P373, DOI 10.1097/01.qai.0000221679.14445.1b; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2013, CONSOLIDATED GUIDELI; Williams BG, 2010, P NATL ACAD SCI USA, V107, P19485, DOI [10.1073.pnas.1005660107, DOI 10.1073/PANS.1005660107]; Williams BG, 2011, TUBERCULOSIS AMONG P; World Health Organization, 2013, CARTOGRAPHER GLOBAL, P104; World Health Organization, 2011, STOP TB PARTNERSHIP; Yan I, 2014, TUBERCULOSIS AND MAL; Yassin MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063174	52	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0160481	10.1371/journal.pone.0160481	http://dx.doi.org/10.1371/journal.pone.0160481			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536864	Green Published, Green Submitted, gold			2022-12-26	WOS:000381577000021
J	Chunga, RM; Ensink, JHJ; Jenkins, MW; Brown, J				Chunga, Richard M.; Ensink, Jeroen H. J.; Jenkins, Marion W.; Brown, Joe			Adopt or Adapt: Sanitation Technology Choices in Urbanizing Malawi	PLOS ONE			English	Article							SUSTAINABLE SANITATION; ECOLOGICAL SANITATION; ENVIRONMENTAL-CHANGE; PERCEIVED EASE; CLIMATE-CHANGE; VULNERABILITY; STRATEGIES; ACCEPTANCE	This paper presents the results of a mixed-methods study examining adaptation strategies that property owners in low-income, rapidly urbanizing areas in Malawi adopt to address the limitations of pit latrines, the most common method of disposing human excreta. A particular challenge is lack of space for constructing new latrines as population density increases: traditional practice has been to cap full pits and simply move to a new site, but increasing demands on space require new approaches to extend the service life of latrines. In this context, we collected data on sanitation technology choices from January to September 2013 through 48 in-depth interviews and a stated preference survey targeting 1,300 property owners from 27 low-income urban areas. Results showed that property owners with concern about space for replacing pit latrines were 1.8 times more likely to select pit emptying service over the construction of new pit latrines with a slab floor (p = 0.02) but there was no significant association between concern about space for replacing pit latrines and intention to adopt locally promoted, novel sanitation technology known as ecological sanitation (ecosan). Property owners preferred to adapt existing, known technology by constructing replacement pit latrines on old pit latrine locations, reducing the frequency of replacing pit latrines, or via emptying pit latrines when full. This study highlights potential challenges to adoption of wholly new sanitation technologies, even when they present clear advantages to end users. To scale, alternative sanitation technologies for rapidly urbanising cities should offer clear advantages, be affordable, be easy to use when shared among multiple households, and their design should be informed by existing adaptation strategies and local knowledge.	[Chunga, Richard M.; Ensink, Jeroen H. J.; Jenkins, Marion W.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London, England; [Jenkins, Marion W.] Univ Calif Davis, Dept Civil & Environm Engn, Davis, CA 95616 USA; [Brown, Joe] Georgia Inst Technol, Sch Civil & Environm Engn, Atlanta, GA 30332 USA	University of London; London School of Hygiene & Tropical Medicine; University of California System; University of California Davis; University System of Georgia; Georgia Institute of Technology	Chunga, RM (corresponding author), London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London, England.	Richard.Chunga@btinternet.com						Abraham B., 2011, ALTERNATIVE SOLUTION; [Anonymous], 2014, STAT AFR CIT REIM SU; Blackett I., 2014, MISSING LINK SANITAT; Bostoen K, 2006, INT J EPIDEMIOL, V35, P751, DOI 10.1093/ije/dyl019; Collender G, 2011, WATERLINES, V30, P289; DAVIS FD, 1989, MIS QUART, V13, P319, DOI 10.2307/249008; Eriksen SH, 2005, GEOGR J, V171, P287, DOI 10.1111/j.1475-4959.2005.00174.x; Esrey SA, 2001, WATER SCI TECHNOL, V43, P177; Fazey I, 2010, FRONT ECOL ENVIRON, V8, P414, DOI 10.1890/080215; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Isunju JB, 2011, PUBLIC HEALTH, V125, P368, DOI 10.1016/j.puhe.2011.03.008; Jenkins MW, 2015, INT J ENV RES PUB HE, V12, P2588, DOI 10.3390/ijerph120302588; Jenkins MW, 2005, SOC SCI MED, V61, P2446, DOI 10.1016/j.socscimed.2005.04.036; Kates RW, 2012, P NATL ACAD SCI USA, V109, P7156, DOI 10.1073/pnas.1115521109; Katukiza AY, 2012, BIOTECHNOL ADV, V30, P964, DOI 10.1016/j.biotechadv.2012.02.007; Kelly PM, 2000, CLIMATIC CHANGE, V47, P325, DOI 10.1023/A:1005627828199; Matsebe G., 2011, REV ECOSAN TOILETS M; Morgan P., 2013, PAVING WAY SCALING F; Nelson DR, 2007, ANNU REV ENV RESOUR, V32, P395, DOI 10.1146/annurev.energy.32.051807.090348; NSO, 2011, 3 INT HOUS SURV; NSO, 2008, POP HOUS CENS PREL R; NSO, 2011, SOC WELF MON SURV; Nyong A., 2007, Mitigation and Adaptation Strategies for Global Change, V12, P787, DOI 10.1007/s11027-007-9099-0; Peal A, 2014, J WATER SANITATION H, V4; Ritchie J., 2003, GUIDE SOCIAL SCI STU, P77; Rogers E.M., 1995, DIFFUSION INNOVATION; Roma E, 2013, WATER SA, V39, P305, DOI 10.4314/wsa.v39i2.15; Silverman D., 2010, DOING QUALITATIVE RE, V3; Smit B, 2006, GLOBAL ENVIRON CHANG, V16, P282, DOI 10.1016/j.gloenvcha.2006.03.008; Thye YP, 2011, CRIT REV ENV SCI TEC, V41, P1793, DOI 10.1080/10643389.2010.481593; Tsinda A, 2013, INT J ENV RES PUB HE, V10, P6939, DOI 10.3390/ijerph10126939; Tumwebaze IK, 2011, ECOLOGICAL SANITATIO; UN-Habitat, 2003, CHALL SLUMS GLOB REP; UNICEF and WHO, 2010, PROGR SAN DRINK WAT; Venkatesh V, 2000, INFORM SYST RES, V11, P342, DOI 10.1287/isre.11.4.342.11872; Werner C, 2009, DESALINATION, V248, P392, DOI 10.1016/j.desal.2008.05.080; WHO/UNICEF(WHO/UnitedNationsInternationalChildren's Fund), 2014, PROGR DRINK WAT SAN; Wilson A., 2012, MARKETING RES INTEGR	38	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161262	10.1371/journal.pone.0161262	http://dx.doi.org/10.1371/journal.pone.0161262			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT4YN	27532871	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000381487600079
J	Song, B; An, LX; Han, YJ; Gao, HX; Ren, HB; Zhao, X; Wei, XS; Krishnan, HB; Liu, SS				Song, Bo; An, Lixin; Han, Yanjing; Gao, Hongxiu; Ren, Hongbo; Zhao, Xue; Wei, Xiaoshuang; Krishnan, Hari B.; Liu, Shanshan			Transcriptome Profile of Near-Isogenic Soybean Lines for beta-Conglycinin alpha-Subunit Deficiency during Seed Maturation	PLOS ONE			English	Article							STORAGE-PROTEIN GENES; GLYCINE-MAX L; ATOPIC-DERMATITIS; 7S GLOBULIN; RNA-SEQ; SUPERFAMILY; INHERITANCE; EXPRESSION; IDENTIFICATION; ALLERGENS	Crossing, backcrossing, and molecular marker-assisted background selection produced a soybean (Glycine max) near-isogenic line (cgy-2-NIL) containing the cgy-2 allele, which is responsible for the absence of the allergenic alpha-subunit of beta-conglycinin. To identify alpha-null-related transcriptional changes, the gene expressions of cgy-2-NIL and its recurrent parent DN47 were compared using Illumina high-throughput RNA-sequencing of samples at 25, 35, 50, and 55 days after flowering (DAF). Seeds at 18 DAF served as the control. Comparison of the transcript profiles identified 3,543 differentially expressed genes (DEGs) between the two genotypes, with 2,193 genes downregulated and 1,350 genes upregulated. The largest numbers of DEGs were identified at 55 DAF. The DEGs identified at 25 DAF represented a unique pattern of GO category distributions. KEGG pathway analyses identified 541 altered metabolic pathways in cgy-2-NIL. At 18DAF, 12 DEGs were involved in arginine and proline metabolism. The cgy-2 allele in the homozygous form modified the expression of several Cupin allergen genes. The cgy-2 allele is an alteration of a functional allele that is closely related to soybean protein amino acid quality, and is useful for hypoallergenic soybean breeding programs that aim to improve seed protein quality.	[Song, Bo; Han, Yanjing; Gao, Hongxiu; Zhao, Xue; Wei, Xiaoshuang; Liu, Shanshan] Northeast Agr Univ, Chinese Agr Minist, Key Lab Soybean Biol & Breeding Genet, Key Lab Soybean Biol, Harbin 150030, Peoples R China; [Ren, Hongbo] Minist Agr China, Inspect & Testing Ctr Qual Cereals & Their Prod, Harbin 150030, Peoples R China; [Krishnan, Hari B.] Univ Missouri, USDA ARS, Plant Genet Res Unit, Columbia, MO USA; [An, Lixin] Harbin Med Univ, Affiliated Hosp 1, Dept Allergy, Harbin, Peoples R China	Northeast Agricultural University - China; Ministry of Agriculture & Rural Affairs; United States Department of Agriculture (USDA); University of Missouri System; University of Missouri Columbia; Harbin Medical University	Liu, SS (corresponding author), Northeast Agr Univ, Chinese Agr Minist, Key Lab Soybean Biol & Breeding Genet, Key Lab Soybean Biol, Harbin 150030, Peoples R China.	ars336699@aliyun.com		SHANSHAN, LIU/0000-0001-7273-735X	National Natural Science Foundation of China [31071440, 31371650]; Northeast Agricultural University Innovation Foundation [yjscx14042]; ARS [ARS-0424526] Funding Source: Federal RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Northeast Agricultural University Innovation Foundation; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The work was supported by the National Natural Science Foundation of China (31071440 and 31371650) and Northeast Agricultural University Innovation Foundation for Postgraduates (yjscx14042). The study is part of the PhD research of the first author.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Asakura T, 2012, PLANT PHYSIOL BIOCH, V52, P147, DOI 10.1016/j.plaphy.2011.12.007; Beilinson V, 2002, THEOR APPL GENET, V104, P1132, DOI 10.1007/s00122-002-0884-6; BURKS AW, 1988, J ALLERGY CLIN IMMUN, V81, P1135, DOI 10.1016/0091-6749(88)90881-0; Cho YB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076954; DAVIES CS, 1985, THEOR APPL GENET, V71, P351, DOI 10.1007/BF00252079; Dunwell JM, 2004, PHYTOCHEMISTRY, V65, P7, DOI 10.1016/j.phytochem.2003.08.016; Dunwell JM, 2001, TRENDS BIOCHEM SCI, V26, P740, DOI 10.1016/S0968-0004(01)01981-8; Dunwell JM, 1998, BIOTECHNOL GENET ENG, V15, P1; Dunwell JM, 1998, J MOL EVOL, V46, P147, DOI 10.1007/PL00006289; FAO/WHO, 1991, PROT QUAL EV, P51; Fu CJJ, 2007, J AGR FOOD CHEM, V55, P4014, DOI 10.1021/jf070211o; Guo QQ, 2013, CROPS, V5, P80; Hajika M., 2009, Bulletin of the National Institute of Crop Science, P1; Hajika M, 1998, BREEDING SCI, V48, P383; Hajika M, 1996, BREEDING SCI, V46, P385; HARADA K, 1983, JPN J BREED, V33, P23; Harada K., 2013, AGR RES, V5, P101; Hidvegi M., 1984, P INT ASS CER CHEM S, P205; Holzhauser T, 2009, J ALLERGY CLIN IMMUN, V123, P452, DOI 10.1016/j.jaci.2008.09.034; Jones SI, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-136; Kita Y, 2010, PLANT CELL REP, V29, P87, DOI 10.1007/s00299-009-0800-5; KITAMURA K, 1981, JPN J BREED, V31, P353; KITAMURA K, 1984, THEOR APPL GENET, V68, P253, DOI 10.1007/BF00266899; KOSHIYAMA I, 1968, CEREAL CHEM, V45, P394; Krishnan HB, 2009, J AGR FOOD CHEM, V57, P938, DOI 10.1021/jf802451g; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leitner A, 1998, ALLERGY, V53, P36, DOI 10.1111/j.1398-9995.1998.tb03771.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MEINKE DW, 1981, PLANTA, V153, P130, DOI 10.1007/BF00384094; Mitchell HH, 1964, WASTAGE NUTR METABOL, P567; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; MUEHLBAUER GJ, 1988, CROP SCI, V28, P729, DOI 10.2135/cropsci1988.0011183X002800050002x; Narikawa T, 2010, BIOSCI BIOTECH BIOCH, V74, P1976, DOI 10.1271/bbb.100479; NIELSEN NC, 1989, PLANT CELL, V1, P313, DOI 10.1105/tpc.1.3.313; Niselsen NC, 1997, CELLULAR MOL BIOL PL, P151; ODANAKA H, 1989, JPN J BREED S1, V39, P430; OGAWA T, 1989, JPN J BREED, V39, P137; OGAWA T, 1995, BIOSCI BIOTECH BIOCH, V59, P831, DOI 10.1271/bbb.59.831; Ogawa T, 2000, J NUTR SCI VITAMINOL, V46, P271, DOI 10.3177/jnsv.46.271; Oser B.L., 1959, PROTEIN AMINO ACID N, P281, DOI DOI 10.1016/B978-0-12-395683-5.50014-6; Rabjohn P, 1999, J CLIN INVEST, V103, P535, DOI 10.1172/JCI5349; SCALLON B, 1985, THEOR APPL GENET, V70, P510, DOI 10.1007/BF00305984; Song B, 2014, PLANT BREEDING, V133, P638, DOI 10.1111/pbr.12203; TAKAHASHI K, 1994, BREEDING SCI, V44, P65; Takahashi K., 2004, Bulletin of the National Agricultural Research Center for Tohoku Region, P23; Takahashi K, 1996, BREEDING SCI, V46, P251; Takahashi M, 2003, PLANTA, V217, P577, DOI 10.1007/s00425-003-1026-3; THANH VH, 1978, J AGR FOOD CHEM, V26, P692, DOI 10.1021/jf60217a026; TSUKADA Y, 1986, JPN J BREED, V36, P390; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14	51	11	11	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0159723	10.1371/journal.pone.0159723	http://dx.doi.org/10.1371/journal.pone.0159723			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532666	Green Published, Green Submitted, gold			2022-12-26	WOS:000381487600010
J	Svalbring, E; Fredriksson, A; Eriksson, J; Dyverfeldt, P; Ebbers, T; Bolger, AF; Engvall, J; Carlhall, CJ				Svalbring, Emil; Fredriksson, Alexandru; Eriksson, Jonatan; Dyverfeldt, Petter; Ebbers, Tino; Bolger, Ann F.; Engvall, Jan; Carlhall, Carl-Johan			Altered Diastolic Flow Patterns and Kinetic Energy in Subtle Left Ventricular Remodeling and Dysfunction Detected by 4D Flow MRI	PLOS ONE			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; MAIN PULMONARY-ARTERY; BLOOD-FLOW; QUANTIFICATION; PRESSURE; DISEASE; HEART	Aims 4D flow magnetic resonance imaging (MRI) allows quantitative assessment of left ventricular (LV) function according to characteristics of the dynamic flow in the chamber. Marked abnormalities in flow components' volume and kinetic energy (KE) have previously been demonstrated in moderately dilated and depressed LV's compared to healthy subjects. We hypothesized that these 4D flow-based measures would detect even subtle LV dysfunction and remodeling. Methods and Results We acquired 4D flow and morphological MRI data from 26 patients with chronic ischemic heart disease with New York Heart Association (NYHA) class I and II and with no to mild LV systolic dysfunction and remodeling, and from 10 healthy controls. A previously validated method was used to separate the LV end-diastolic volume (LVEDV) into functional components: direct flow, which passes directly to ejection, and non-ejecting flow, which remains in the LV for at least 1 cycle. The direct flow and non-ejecting flow proportions of end-diastolic volume and KE were assessed. The proportions of direct flow volume and KE fell with increasing LVEDV-index (LVEDVI) and LVESV-index (LVESVI) (direct flow volume r = -0.64 and r = -0.74, both P<0.001; direct flow KE r = -0.48, P = 0.013, and r = -0.56, P = 0.003). The proportions of non-ejecting flow volume and KE rose with increasing LVEDVI and LVESVI (non-ejecting flow volume: r = 0.67 and r = 0.76, both P<0.001; non-ejecting flow KE: r = 0.53, P = 0.005 and r = 0.52, P = 0.006). The proportion of direct flow volume correlated moderately to LVEF (r = 0.68, P < 0.001) and was higher in a sub-group of patients with LVEDVI > 74 ml/m(2) compared to patients with LVEDVI < 74 ml/m(2) and controls (both P<0.05). Conclusion Direct flow volume and KE proportions diminish with increased LV volumes, while non-ejecting flow proportions increase. A decrease in direct flow volume and KE at end-diastole proposes that alterations in these novel 4D flow-specific markers may detect LV dysfunction even in subtle or subclinical LV remodeling.	[Svalbring, Emil; Fredriksson, Alexandru; Eriksson, Jonatan; Dyverfeldt, Petter; Ebbers, Tino; Bolger, Ann F.; Engvall, Jan; Carlhall, Carl-Johan] Linkoping Univ, Div Cardiovasc Med, Dept Med & Hlth Sci, Linkoping, Sweden; [Eriksson, Jonatan; Dyverfeldt, Petter; Ebbers, Tino; Engvall, Jan; Carlhall, Carl-Johan] Linkoping Univ, Ctr Med Image Sci & Visualizat CMIV, Linkoping, Sweden; [Bolger, Ann F.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Engvall, Jan; Carlhall, Carl-Johan] Linkoping Univ, Dept Med & Hlth Sci, Dept Clin Physiol, Linkoping, Sweden	Linkoping University; Linkoping University; University of California System; University of California San Francisco; Linkoping University	Carlhall, CJ (corresponding author), Linkoping Univ, Div Cardiovasc Med, Dept Med & Hlth Sci, Linkoping, Sweden.; Carlhall, CJ (corresponding author), Linkoping Univ, Ctr Med Image Sci & Visualizat CMIV, Linkoping, Sweden.; Carlhall, CJ (corresponding author), Linkoping Univ, Dept Med & Hlth Sci, Dept Clin Physiol, Linkoping, Sweden.	carljohan.carlhall@liu.se	Engvall, Jan Edvin/I-5019-2019; Dyverfeldt, Petter/AAO-4923-2021; Ebbers, Tino/ABB-8488-2021	Engvall, Jan Edvin/0000-0002-5716-5098; Dyverfeldt, Petter/0000-0002-3051-661X; Ebbers, Tino/0000-0003-1395-8296; Carlhall, Carl-Johan/0000-0003-2198-9690	Swedish Heart Lung foundation [20140398]; Swedish Research Council [2014-6191]; European Union FP7 [223615]; Medical Research Council of Southeast Sweden [FORSS-35141, FORSS-88731, FORSS-157921]; County Council of Ostergotland/Heart and Medicine Center [20090120]	Swedish Heart Lung foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); European Union FP7(European Commission); Medical Research Council of Southeast Sweden(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); County Council of Ostergotland/Heart and Medicine Center	This work was funded by Swedish Heart Lung foundation (grant number: 20140398) [https://www.hjart-lungfonden.se/HLF/Om-Hjart-lungfonden/About-HLF/], Receiver: CJC; Swedish Research Council (grant number: 2014-6191) [http://www.vr.se], Receiver: TE; European Union FP7 (grant number: 223615) [https://ec.europa.eu/research/fp7/index_en.cfm], Receiver: TE; Medical Research Council of Southeast Sweden (grant number: FORSS-35141, FORSS-88731, FORSS-157921) [http://www.fou.nu/is/forss/], Receiver: JE; County Council of Ostergotland/Heart and Medicine Center (grant number: 20090120) [http://www.regionostergotland.se/hmc/], Receiver: JE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvidsson PM, 2013, J APPL PHYSIOL, V114, P1472, DOI 10.1152/japplphysiol.00932.2012; Bolger AF, 2007, J CARDIOVASC MAGN R, V9, P741, DOI 10.1080/10976640701544530; Carlhall CJ, 2010, CIRC-HEART FAIL, V3, P326, DOI 10.1161/CIRCHEARTFAILURE.109.911867; Carlsson M, 2012, AM J PHYSIOL-HEART C, V302, pH893, DOI 10.1152/ajpheart.00942.2011; Dyverfeldt P, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0174-5; Elbaz MSM, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/s12968-014-0078-9; Eriksson J, 2013, EUR HEART J-CARD IMG, V14, P417, DOI 10.1093/ehjci/jes159; Eriksson J, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-9; Foll D, 2013, EUR HEART J-CARD IMG, V14, P366, DOI 10.1093/ehjci/jes196; FRANCIS GS, 2001, AM J MED, V110, P37; Francois CJ, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-16; Fredriksson AG, 2016, J MAGN RESON IMAGING, V43, P558, DOI 10.1002/jmri.25015; Fyrenius A, 2001, HEART, V86, P448, DOI 10.1136/heart.86.4.448; Geiger J, 2011, EUR RADIOL, V21, P1651, DOI 10.1007/s00330-011-2108-4; Han QJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138365; Harloff A, 2009, MAGN RESON MED, V61, P65, DOI 10.1002/mrm.21774; Heiberg Einar, 2010, BMC Med Imaging, V10, P1, DOI 10.1186/1471-2342-10-1; Hope MD, 2011, JACC-CARDIOVASC IMAG, V4, P781, DOI 10.1016/j.jcmg.2011.05.004; Maceira AM, 2006, J CARDIOVASC MAGN R, V8, P417, DOI 10.1080/10976640600572889; Rademakers F, 2013, SCAND CARDIOVASC J, V47, P329, DOI 10.3109/14017431.2013.857039; Reiter G, 2008, CIRC-CARDIOVASC IMAG, V1, P23, DOI 10.1161/CIRCIMAGING.108.780247; Stoll V, 2015, J CARDIOVASC MAGN S1, V17, pP7; Yiallourou TI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052284	23	46	46	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161391	10.1371/journal.pone.0161391	http://dx.doi.org/10.1371/journal.pone.0161391			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532640	gold, Green Published, Green Submitted			2022-12-26	WOS:000381487600091
J	Vedelek, V; Laurinyecz, B; Kovacs, AL; Juhasz, G; Sinka, R				Vedelek, Viktor; Laurinyecz, Barbara; Kovacs, Attila L.; Juhasz, Gabor; Sinka, Rita			Testis-Specific Bb8 Is Essential in the Development of Spermatid Mitochondria	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; GLUTAMATE-DEHYDROGENASE; POSTMEIOTIC TRANSCRIPTION; MALE-FERTILITY; GENE; INDIVIDUALIZATION; PROTEIN; ELONGATION; CONFLICT; DYNAMICS	Mitochondria are essential organelles of developing spermatids in Drosophila, which undergo dramatic changes in size and shape after meiotic division, where mitochondria localized in the cytoplasm, migrate near the nucleus, aggregate, fuse and create the Nebenkern. During spermatid elongation the two similar mitochondrial derivatives of the Nebenkern start to elongate parallel to the axoneme. One of the elongated mitochondrial derivatives starts to lose volume and becomes the minor mitochondrial derivative, while the other one accumulates paracrystalline and becomes the major mitochondrial derivative. Proteins and intracellular environment that are responsible for cyst elongation and paracrystalline formation in the major mitochondrial derivative need to be identified. In this work we investigate the function of the testis specific big bubble 8 (bb8) gene during spermatogenesis. We show that a Minos element insertion in bb8 gene, a predicted glutamate dehydrogenase, causes recessive male sterility. We demonstrate bb8 mRNA enrichment in spermatids and the mitochondrial localisation of Bb8 protein during spermatogenesis. We report that megamitochondria develop in the homozygous mutant testes, in elongating spermatids. Ultrastructural analysis of the cross section of elongated spermatids shows enlarged mitochondria and the production of paracrystalline in both major and minor mitochondrial derivatives. Our results suggest that the Bb8 protein and presumably glutamate metabolism has a crucial role in the normal development and establishment of the identity of the mitochondrial derivatives during spermatid elongation.	[Vedelek, Viktor; Laurinyecz, Barbara; Sinka, Rita] Univ Szeged, Dept Genet, Szeged, Hungary; [Kovacs, Attila L.; Juhasz, Gabor] Eotvos Lorand Univ, Dept Anat Cell & Dev Biol, Budapest, Hungary	Szeged University; Eotvos Lorand University	Sinka, R (corresponding author), Univ Szeged, Dept Genet, Szeged, Hungary.	rsinka@bio.u-szeged.hu	Sinka, Rita/ABA-8767-2021; Laurinyecz, Barbara/L-8322-2018; Juhasz, Gabor/G-5622-2013	Laurinyecz, Barbara/0000-0003-0620-2239; Juhasz, Gabor/0000-0001-8548-8874; Sinka, Rita/0000-0003-4040-4184	European Molecular Biology Organization (EMBO) [1825]; Hungarian Scientific Research funds [OTKA: NF101001]; Hungarian Academy of Science's Bolyai Scholarship	European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Hungarian Scientific Research funds(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Academy of Science's Bolyai Scholarship	This work was supported by grants from the European Molecular Biology Organization (EMBO)(Installation Grant (No1825)(http://www.embo.org) to RS and the Hungarian Scientific Research funds (OTKA: NF101001)(http://nkfih.gov.hu/) to RS. RS also thanks the Hungarian Academy of Science's Bolyai Scholarship for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Ferenc Jankovics, and Tibor Kalmar for discussion and critical reading of the manuscript. We are indebted to Attila Gacser for helping to carry out Q-RT-PCR experiments. This work was supported by grants from EMBO (Installation Grant (No1825)), the Hungarian Scientific Research funds (OTKA: NF101001). RS also thanks the Hungarian Academy of Science's Bolyai Scholarship for funding.	Aldridge AC, 2007, FLY, V1, P38, DOI 10.4161/fly.3913; Aram L, 2016, DEV CELL, V37, P15, DOI 10.1016/j.devcel.2016.02.025; Arama E, 2006, EMBO J, V25, P232, DOI 10.1038/sj.emboj.7600920; Barreau C, 2008, DEVELOPMENT, V135, P1897, DOI 10.1242/dev.021949; Bre MH, 1996, J CELL SCI, V109, P727; Brosnan JT, 2013, AMINO ACIDS, V45, P413, DOI 10.1007/s00726-012-1280-4; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Chintapalli VR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078066; Dorogova NV, 2013, PROTOPLASMA, V250, P515, DOI 10.1007/s00709-012-0434-2; Fabrizio JJ, 1998, DEVELOPMENT, V125, P1833; Gallach M, 2011, TRENDS ECOL EVOL, V26, P222, DOI 10.1016/j.tree.2011.02.004; Gallach M, 2010, GENOME BIOL EVOL, V2, P835, DOI 10.1093/gbe/evq069; Hales KG, 1997, CELL, V90, P121, DOI 10.1016/S0092-8674(00)80319-0; Kriventseva EV, 2015, NUCLEIC ACIDS RES, V43, pD250, DOI 10.1093/nar/gku1220; Larkin EK, 2007, BMC P, V6, P1; Laurinyecz B, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.150169; LEVINE RL, 1983, J BIOL CHEM, V258, P1823; Mastorodemos V, 2005, J NEUROSCI RES, V79, P65, DOI 10.1002/jnr.20353; Mastorodemos V, 2009, BIOCHEM CELL BIOL, V87, P505, DOI [10.1139/O09-008, 10.1139/o09-008]; Metaxakis A, 2005, GENETICS, V171, P571, DOI 10.1534/genetics.105.041848; Metzendorf C, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-68; Morris CA, 2009, NAT PROTOC, V4, P1807, DOI 10.1038/nprot.2009.192; NEWSHOLME EA, 1985, BIOSCIENCE REP, V5, P393, DOI 10.1007/BF01116556; Noguchi T, 2008, MOL BIOL CELL, V19, P2363, DOI 10.1091/mbc.E07-08-0840; Noguchi T, 2011, CURR BIOL, V21, P805, DOI 10.1016/j.cub.2011.04.016; OLSON GE, 1990, J STRUCT BIOL, V103, P13, DOI 10.1016/1047-8477(90)90081-M; Rathke C, 2010, EUR J CELL BIOL, V89, P326, DOI 10.1016/j.ejcb.2009.09.001; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; Riparbelli MG, 2007, DEV BIOL, V303, P108, DOI 10.1016/j.ydbio.2006.10.038; Santel A, 1997, MECH DEVELOP, V64, P19, DOI 10.1016/S0925-4773(97)00031-2; Santel A, 1998, J CELL SCI, V111, P3299; Shim MS, 2011, BIOCHEM J, V439, P277, DOI 10.1042/BJ20110582; Shim MS, 2009, J BIOL CHEM, V284, P32881, DOI 10.1074/jbc.M109.026492; Spanaki C, 2014, NEUROCHEM RES, V39, P500, DOI 10.1007/s11064-013-1235-5; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Timakov B, 2001, CELL STRESS CHAPERON, V6, P71, DOI 10.1379/1466-1268(2001)006<0071:THGODM>2.0.CO;2; Tiwari AK, 2014, ACTA HISTOCHEM, V116, P297, DOI 10.1016/j.acthis.2013.08.007; TOKUYASU KT, 1972, Z ZELLFORSCH MIK ANA, V124, P479, DOI 10.1007/BF00335253; Vibranovski MD, 2010, GENETICS, V186, P431, DOI 10.1534/genetics.110.118919; Vibranovski MD, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000731; Wakimoto BT, 2004, GENETICS, V167, P207, DOI 10.1534/genetics.167.1.207; White-Cooper H, 2004, METH MOL B, V247, P45; White-Cooper H, 2010, PHILOS T R SOC B, V365, P1465, DOI 10.1098/rstb.2009.0323; Wilson KL, 2006, DEVELOPMENT, V133, P4871, DOI 10.1242/dev.02671	44	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161289	10.1371/journal.pone.0161289	http://dx.doi.org/10.1371/journal.pone.0161289			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529784	Green Accepted, Green Published, gold			2022-12-26	WOS:000381476700063
J	Kim, M; Park, KY; Lee, MK; Jin, T; Seo, SJ				Kim, MinJeong; Park, Kui Young; Lee, Mi-Kyung; Jin, Taewon; Seo, Seong Jun			Adiponectin Suppresses UVB-Induced Premature Senescence and hBD2 Overexpression in Human Keratinocytes	PLOS ONE			English	Article							BETA-DEFENSIN 2; ANTIMICROBIAL PEPTIDES; HUMAN SKIN; IN-VIVO; CELLS; EXPRESSION; ACTIVATION; GROWTH; LIPOPOLYSACCHARIDE; BETA-DEFENSIN-2	Recent studies have revealed that adiponectin can suppress cellular inflammatory signaling pathways. This study aimed to elucidate the effect of adiponectin on the unregulated production of hBD2 in UVB-induced premature senescent keratinocytes. We constructed an in vitro model of premature senescent keratinocytes through repeated exposure to low energy UVB. After repeated low energy UVB exposure, there was significant generation of reactive oxygen species (ROS) and induction of senescence-associated markers, including senescence associated beta-galactosidase activity and expression of p16(INK4a) and histone H2AX. In addition, the present clinical study showed higher expression of hBD2 in sun-exposed skin of elderly group, and the overexpression of hBD2 was observed by c-Fos activation in vitro. Adiponectin has the ability to scavenge ROS and consequently inhibit MAPKs and SA-markers in UVB-exposed keratinocytes. An inhibitor study demonstrated that adiponectin downregulated hBD2 mRNA expression through suppression of the AP-1 transcription factor components c-Fos via inactivation of p38 MAPK. Collectively, the dysregulated production of hBD2 by the induction of oxidative stress was attenuated by adiponectin through the suppression of p38 and JNK/SAPK MAPK signaling in UVB-mediated premature senescent inducible conditions. These results suggest the feasibility of adiponectin as an anti-photoaging and anti-inflammatory agent in the skin.	[Kim, MinJeong; Park, Kui Young; Jin, Taewon; Seo, Seong Jun] Chung Ang Univ, Coll Med, Chung Ang Univ Hosp, Dept Dermatol, Seoul, South Korea; [Lee, Mi-Kyung] Chung Ang Univ, Coll Med, Chung Ang Univ Hosp, Dept Lab Med, Seoul, South Korea	Chung Ang University; Chung Ang University Hospital; Chung Ang University; Chung Ang University Hospital	Seo, SJ (corresponding author), Chung Ang Univ, Coll Med, Chung Ang Univ Hosp, Dept Dermatol, Seoul, South Korea.	drseo@hanafos.com		Kim, MinJeong/0000-0002-0524-9281	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI14C1379]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea. (Grant No. HI14C1379), https://www.htdream.kr/.; This study was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea. (Grant No. HI14C1379)	Ali RS, 2001, J INVEST DERMATOL, V117, P106; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Bakkenist CJ, 2004, CANCER RES, V64, P3748, DOI 10.1158/0008-5472.CAN-04-0453; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Barnes L, 2010, PHOTOCHEM PHOTOBIOL, V86, P933, DOI 10.1111/j.1751-1097.2010.00744.x; Bertrand-Vallery V, 2010, BIOGERONTOLOGY, V11, P167, DOI 10.1007/s10522-009-9238-y; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Castaneda-Delgado JE, 2013, CLIN IMMUNOL, V148, P198, DOI 10.1016/j.clim.2013.05.015; CERIMELE D, 1990, BRIT J DERMATOL, V122, P13, DOI 10.1111/j.1365-2133.1990.tb16120.x; Chen WX, 1999, ONCOGENE, V18, P7469, DOI 10.1038/sj.onc.1203210; Chertov O, 1996, J BIOL CHEM, V271, P2935, DOI 10.1074/jbc.271.6.2935; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Fahlgren A, 2003, CLIN EXP IMMUNOL, V131, P90, DOI 10.1046/j.1365-2249.2003.02035.x; Gambichler T, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-163; Gandarillas A, 2000, EXP GERONTOL, V35, P53, DOI 10.1016/S0531-5565(99)00088-1; Garcia JRC, 2001, CELL TISSUE RES, V306, P257, DOI 10.1007/s004410100433; Glasser R, 2009, J ALLERGY CLIN IMMUN, V123, P1117, DOI 10.1016/j.jaci.2009.01.043; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hibbert SA, POTENTIAL ROLE ENDOG, P2213; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kang S, 2003, J INVEST DERMATOL, V120, P835, DOI 10.1046/j.1523-1747.2003.12122.x; Kim EJ, 2015, J INVEST DERMATOL, V135, P2331, DOI 10.1038/jid.2015.150; Krtolica A, 2002, INT J BIOCHEM CELL B, V34, P1401, DOI 10.1016/S1357-2725(02)00053-5; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; Lewis DA, 2008, MOL BIOL CELL, V19, P1346, DOI 10.1091/mbc.E07-10-1041; Li RC, 2014, CLIN EXP DERMATOL, V39, P19, DOI 10.1111/ced.12250; Masaki H, 2009, J INVEST DERM SYMP P, V14, P50, DOI 10.1038/jidsymp.2009.12; Mineshiba J, 2005, FEMS IMMUNOL MED MIC, V45, P37, DOI 10.1016/j.femsim.2005.01.008; Niyonsaba F, 2007, J INVEST DERMATOL, V127, P594, DOI 10.1038/sj.jid.5700599; Rajapakse N, 2008, IMMUNOLOGY, V123, P348, DOI 10.1111/j.1365-2567.2007.02683.x; Ressler S, 2006, AGING CELL, V5, P379, DOI 10.1111/j.1474-9726.2006.00231.x; Rohrl J, 2010, J IMMUNOL, V184, P6688, DOI 10.4049/jimmunol.0903984; Seo SJ, 2001, J DERMATOL SCI, V27, P183, DOI 10.1016/S0923-1811(01)00135-9; Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296; Shi N, 2014, ONCOTARGET, V5, P11333, DOI 10.18632/oncotarget.2416; Shibata S, 2012, J IMMUNOL, V189, P3231, DOI 10.4049/jimmunol.1101739; Soroka Y, 2008, EXP GERONTOL, V43, P947, DOI 10.1016/j.exger.2008.08.003; Syed DN, 2012, PHOTOCHEM PHOTOBIOL, V88, P1184, DOI 10.1111/j.1751-1097.2012.01115.x; Takahashi A, 2005, CANCER LETT, V229, P171, DOI 10.1016/j.canlet.2005.07.016; Tomizawa A, 2008, DIABETES VASC DIS RE, V5, P123, DOI 10.3132/dvdr.2008.020; Villarreal-Molina MT, 2012, BIOCHIMIE, V94, P2143, DOI 10.1016/j.biochi.2012.06.030; Whitehead JP, 2006, DIABETES OBES METAB, V8, P264, DOI 10.1111/j.1463-1326.2005.00510.x; Wittersheim M, 2013, EXP DERMATOL, V22, P364, DOI 10.1111/exd.12133; Yamaguchi N, 2005, FEBS LETT, V579, P6821, DOI 10.1016/j.febslet.2005.11.019; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525	47	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0161247	10.1371/journal.pone.0161247	http://dx.doi.org/10.1371/journal.pone.0161247			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27526049	Green Published, gold			2022-12-26	WOS:000381471100047
J	Zhang, TM; Xue, L; Li, L; Tang, CY; Wan, ZQ; Wang, RX; Tan, JQ; Tan, Y; Han, HL; Tian, RY; Billiar, TR; Tao, WA; Zhang, ZH				Zhang, Tongmei; Xue, Liang; Li, Li; Tang, Chengyuan; Wan, Zhengqing; Wang, Ruoxi; Tan, Jieqiong; Tan, Ya; Han, Hailong; Tian, Runyi; Billiar, Timothy R.; Tao, W. Andy; Zhang, Zhuohua			BNIP3 Protein Suppresses PINK1 Kinase Proteolytic Cleavage to Promote Mitophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hypoxia; mitochondria; parkin; Parkinson's disease; ubiquitin	CELL-DEATH; MITOCHONDRIAL DYSFUNCTION; PARKINSON-DISEASE; OXIDATIVE STRESS; AUTOPHAGY; MUTATIONS; INDUCTION; LIGASE; DROSOPHILA-PINK1; DESTABILIZATION	Mutations in PINK1 (PTEN-induced putative kinase 1) cause early onset familial Parkinson's disease (PD). PINK1 accumulates on the outer membrane of damaged mitochondria followed by recruiting parkin to promote mitophagy. Here, we demonstrate that BCL2/adenovirus E1B 19-kDa interacting protein 3 (BNIP3), a mitochondrial BH3-only protein, interacts with PINK1 to promote the accumulation of full-length PINK1 on the outer membrane of mitochondria, which facilitates parkin recruitment and PINK1/parkin-mediated mitophagy. Inactivation of BNIP3 in mammalian cells promotes PINK1 proteolytic processing and suppresses PINK1/parkin-mediated mitophagy. Hypoxia-induced BNIP3 expression results in increased expression of full-length PINK1 and mitophagy. Consistently, expression of BNIP3 in Drosophila suppresses muscle degeneration and the mitochondrial abnormality caused by PINK1 inactivation. Together, the results suggest that BNIP3 plays a vital role in regulating PINK1 mitochondrial outer membrane localization, the proteolytic process of PINK1 and PINK1/parkin-mediated mitophagy under physiological conditions. Functional up-regulation of BNIP3 may represent a novel therapeutic strategy to suppress the progression of PD.	[Zhang, Tongmei; Li, Li; Tang, Chengyuan; Wan, Zhengqing; Wang, Ruoxi; Tan, Jieqiong; Tan, Ya; Han, Hailong; Tian, Runyi; Billiar, Timothy R.; Zhang, Zhuohua] Cent South Univ, Xiangya Hosp, Inst Precis Med, Changsha 410078, Hunan, Peoples R China; [Zhang, Tongmei; Li, Li; Tang, Chengyuan; Wan, Zhengqing; Wang, Ruoxi; Tan, Jieqiong; Tan, Ya; Han, Hailong; Tian, Runyi; Billiar, Timothy R.; Zhang, Zhuohua] Cent South Univ, Xiangya Med Sch, State Key Lab Med Genet, Changsha 410078, Hunan, Peoples R China; [Xue, Liang; Tao, W. Andy] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Billiar, Timothy R.] Univ Pittsburgh, Dept Surg, Sch Med, Pittsburgh, PA 15213 USA; [Zhang, Zhuohua] Fudan Univ, Collaborat Innovat Ctr Brain Sci, Shanghai 200032, Peoples R China	Central South University; Central South University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Fudan University	Zhang, ZH (corresponding author), Cent South Univ, Xiangya Med Sch, State Key Lab Med Genet, Changsha 410078, Hunan, Peoples R China.	zhangzhuohua@sklmg.edu.cn	Tao, Andy/N-1290-2019; Tao, Weiguo/AAL-2777-2020	Tao, Weiguo/0000-0002-5535-5517	Chinese National 973 Projects [2011CB510000]; Natural Science Foundation of China [313300257, 81429002, 81161120498]; Discipline Innovative Engineering Plan (111 Program) of China	Chinese National 973 Projects(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Discipline Innovative Engineering Plan (111 Program) of China	This work was supported by Chinese National 973 Projects 2011CB510000 (to Z. Z.), Natural Science Foundation of China Grants 313300257, 81429002, and 81161120498 (to Z. Z.), and the Discipline Innovative Engineering Plan (111 Program) of China (to Z. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Awan MUF, 2014, MOL BIOL REP, V41, P5729, DOI 10.1007/s11033-014-3444-7; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Bruick RK, 2000, P NATL ACAD SCI USA, V97, P9082, DOI 10.1073/pnas.97.16.9082; Chen Y, 2010, P NATL ACAD SCI USA, V107, P9035, DOI 10.1073/pnas.0914013107; Choo YS, 2012, HUM MOL GENET, V21, P2514, DOI 10.1093/hmg/dds070; Choo YS, 2004, HUM MOL GENET, V13, P1407, DOI 10.1093/hmg/ddh162; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deas E, 2011, HUM MOL GENET, V20, P867, DOI 10.1093/hmg/ddq526; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119; Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537; Dorn GW, 2010, J CARDIOVASC TRANSL, V3, P374, DOI 10.1007/s12265-010-9174-x; Farrer MJ, 2006, NAT REV GENET, V7, P306, DOI 10.1038/nrg1831; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Geisler S, 2010, AUTOPHAGY, V6, P871, DOI 10.4161/auto.6.7.13286; Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14; Hanna RA, 2012, J BIOL CHEM, V287, P19094, DOI 10.1074/jbc.M111.322933; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kubl DA, 2007, BIOCHEM J, V405, P407, DOI 10.1042/BJ20070319; Kubli DA, 2008, AM J PHYSIOL-HEART C, V295, pH2025, DOI 10.1152/ajpheart.00552.2008; Lee Y, 2011, AM J PHYSIOL-HEART C, V301, pH1924, DOI 10.1152/ajpheart.00368.2011; Lin W, 2008, J NEUROCHEM, V106, P464, DOI 10.1111/j.1471-4159.2008.05398.x; Liu WC, 2011, P NATL ACAD SCI USA, V108, P12920, DOI 10.1073/pnas.1107332108; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Muqit MMK, 2006, J NEUROCHEM, V98, P156, DOI 10.1111/j.1471-4159.2006.03845.x; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Poole AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010054; Ray R, 2000, J BIOL CHEM, V275, P1439, DOI 10.1074/jbc.275.2.1439; Regula KM, 2002, CIRC RES, V91, P226, DOI 10.1161/01.RES.0000029232.42227.16; Rikka S, 2011, CELL DEATH DIFFER, V18, P721, DOI 10.1038/cdd.2010.146; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Sulistijo ES, 2006, J MOL BIOL, V364, P974, DOI 10.1016/j.jmb.2006.09.065; Tan JQ, 2011, J BIOL CHEM, V286, P29654, DOI 10.1074/jbc.M111.233874; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Vande Velde C, 2000, MOL CELL BIOL, V20, P5454, DOI 10.1128/MCB.20.15.5454-5468.2000; Vasagiri N, 2014, MOL BIOL REP, V41, P7705, DOI 10.1007/s11033-014-3664-x; Venegas V., 2011, CURR PROTOC HUM GENE, V68, DOI [DOI 10.1002/0471142905.HG1907S68, 10.1002/0471142905.hg1907s68]; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wei HF, 2015, BBA-MOL CELL RES, V1853, P2784, DOI 10.1016/j.bbamcr.2015.03.013; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Whitworth AJ, 2005, P NATL ACAD SCI USA, V102, P8024, DOI 10.1073/pnas.0501078102; Xiong H, 2009, J CLIN INVEST, V119, P650, DOI 10.1172/JCI37617; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Yun JN, 2014, ELIFE, V3, DOI 10.7554/eLife.01958; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797; Zhang ZH, 1998, NATURE, V395, P698, DOI 10.1038/27208; Zhu YY, 2013, J BIOL CHEM, V288, P1099, DOI 10.1074/jbc.M112.399345	55	145	150	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21616	21629		10.1074/jbc.M116.733410	http://dx.doi.org/10.1074/jbc.M116.733410			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27528605	Green Published, hybrid			2022-12-26	WOS:000385999200028
J	Feigl, AB; Bloom, DE; Danaei, G; Pillay, D; Salomon, JA; Tanser, F; Barnighausen, TW				Feigl, Andrea B.; Bloom, David E.; Danaei, Goodarz; Pillay, Deenan; Salomon, Joshua A.; Tanser, Frank; Baernighausen, Till W.			The Effect of HIV and the Modifying Effect of Anti-Retroviral Therapy (ART) on Body Mass Index (BMI) and Blood Pressure Levels in Rural South Africa	PLOS ONE			English	Article							MARGINAL STRUCTURAL MODELS; SUB-SAHARAN AFRICA; RISK-FACTORS; WAIST CIRCUMFERENCE; CAUSAL INFERENCE; ASSOCIATION; POPULATION; PREVALENCE; OUTCOMES; OBESITY	Background High BMI and blood pressure are leading chronic disease risk factors in South Africa. Long-term effects of HIV and ART on adiposity and blood pressure are poorly understood, and direct comparisons of risk factor trajectories in HIV- versus HIV+ populations are rare. Methods In 2003 and 2010, height, weight, and blood pressure were recorded in a study population (n = 505) in KwaZulu-Natal, South Africa (30% adult HIV prevalence). We modeled change in BMI and BP longitudinally in HIV- individuals (n = 315), seroconverters (n = 32), HIV+ patients not on ART (HIV(+)ART(-); n = 52), HIV+ patients on ART for 0-<2 years as of 2010 (HIV(+)ART(0-<2 yrs); n = 18), patients on ART for 2-5 years (HIV(+)ART(2-5yrs); n = 44), and a sub-group with unknown HIV status (n = 44). Difference-in-differences were assessed in reference to the HIV- population. Results Between 2003 and 2010, BMI increased significantly in the HIV- group, by 0.874 (95% CI 0.339, 1.41; p = 0.001), to 30.4. BMI drop was significantly greater in HIV(+)ART(0-<2yrs) than in HIV(+)ART(2-5yrs) (p = 0.005). DID in BMI in HIV(+)ART(0-<2yrs) versus the reference was -5.21 (95% CI -7.53, -2.90; p = 0.001), and DID in HIV(+)ART(2-5yrs) versus reference was -1.35 (95% CI -2.89, 0.189; p = 0.086). DID in SBP in HIV(+)ART(-) vs HIV-DID was -7.55 mmHg (95% CI -13.2 to -1.90; p = 0.009). Conclusion Short-term ART (0-<2 years) was associated with larger weight loss than either no ART or long-term ART. Once on ART for 2+ years, individuals 'caught up' on weight gain with the HIV-population. Our results showcase the importance of health system readiness to address the burgeoning double burden of disease in South Africa.	[Feigl, Andrea B.] Harvard Med Sch, Dept Global Hlth & Social Med, 641 Huntington Ave, Boston, MA 02115 USA; [Bloom, David E.; Danaei, Goodarz; Salomon, Joshua A.; Baernighausen, Till W.] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, 677 Huntington Ave, Boston, MA 02115 USA; [Feigl, Andrea B.; Pillay, Deenan; Tanser, Frank; Baernighausen, Till W.] Africa Hlth Res Inst, Somkhele, South Africa; [Pillay, Deenan; Tanser, Frank] UCL, Div Infect & Immunol, London, England; [Baernighausen, Till W.] Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Durban, South Africa; [Baernighausen, Till W.] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany	Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Africa Health Research Institute; University of London; University College London; University of Kwazulu Natal; Ruprecht Karls University Heidelberg	Feigl, AB (corresponding author), Harvard Med Sch, Dept Global Hlth & Social Med, 641 Huntington Ave, Boston, MA 02115 USA.; Feigl, AB (corresponding author), Africa Hlth Res Inst, Somkhele, South Africa.	abfeigl@mail.harvard.edu	Salomon, Joshua/S-1929-2019; Tanser, Frank/ABE-8326-2021; Bärnighausen, Till/Y-2388-2019; Salomon, Joshua A/D-3898-2009	Salomon, Joshua/0000-0003-3929-5515; Salomon, Joshua A/0000-0003-3929-5515; Tanser, Frank/0000-0001-9797-0000	Wellcome Trust [097410/Z/11/Z]; Harvard University Center for African studies; Gamble Award in Social Sciences; National Institutes of Health (NIH) [NIAID R01-AI124389, NICHD R01-HD084233, NICHD R01-HD058482]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD084233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI124389] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Harvard University Center for African studies; Gamble Award in Social Sciences; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The data for this study was collected by the Africa Centre for Population Health, which is one of the Wellcome Trust's major overseas programmes and supported by core funding through Wellcome Trust grant 097410/Z/11/Z. ABF is thankful for the generous travel grant from the Harvard University Center for African studies as well as the Gamble Award in Social Sciences to support this research. TB and FT were supported by the National Institutes of Health (NIH, NIAID R01-AI124389, NICHD R01-HD084233, NICHD R01-HD058482). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Barnighausen T, 2008, J HUM HYPERTENS, V22, P236, DOI 10.1038/sj.jhh.1002308; Barnighausen T, 2011, EPIDEMIOLOGY, V22, P27, DOI 10.1097/EDE.0b013e3181ffa201; Bor J, 2012, HEALTH AFFAIR, V31, P1459, DOI 10.1377/hlthaff.2012.0407; Brown TT, 2007, AIDS, V21, P1731, DOI 10.1097/QAD.0b013e328270356a; Chiba Y, 2011, AM J EPIDEMIOL, V173, P745, DOI 10.1093/aje/kwq418; Cole SR, 2010, INT J EPIDEMIOL, V39, P417, DOI 10.1093/ije/dyp334; Czernichow S, 2011, OBES REV, V12, P680, DOI 10.1111/j.1467-789X.2011.00879.x; Dalal S, 2011, INT J EPIDEMIOL, V40, P885, DOI 10.1093/ije/dyr050; Dillon DG, 2013, INT J EPIDEMIOL, V42, P1754, DOI 10.1093/ije/dyt198; Dudley L, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003318.pub3; Goedecke JH, 2013, AIDS RES HUM RETROV, V29, P557, DOI 10.1089/aid.2012.0252; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Houlihan CF, 2011, INT J EPIDEMIOL, V40, P318, DOI 10.1093/ije/dyp402; HSRC, 2013, 2012 S AFR HOUS SURV; IHME, 2013, GLOB BURD DIS INJ RI; Lee CMY, 2008, J CLIN EPIDEMIOL, V61, P646, DOI 10.1016/j.jclinepi.2007.08.012; Maher D, 2010, B WORLD HEALTH ORGAN, V88, P943, DOI 10.2471/BLT.10.077891; Malaza A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047761; Mangili A, 2006, CLIN INFECT DIS, V42, P836, DOI 10.1086/500398; Mayosi BM, 2012, LANCET, V380, P2029, DOI 10.1016/S0140-6736(12)61814-5; Mayosi BM, 2009, LANCET, V374, P934, DOI 10.1016/S0140-6736(09)61087-4; Moyo D, 2014, SAMJ S AFR MED J, V104, P37, DOI [10.7196/SAMJ.6792, 10.7196/samj.6792]; Mutevedzi PC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077379; Mutevedzi PC, 2010, B WORLD HEALTH ORGAN, V88, P593, DOI 10.2471/BLT.09.069419; Ovbiagele B, 2011, JAMA-J AM MED ASSOC, V306, P2137, DOI 10.1001/jama.2011.1650; Polsky B, 2001, AIDS PATIENT CARE ST, V15, P411, DOI 10.1089/108729101316914412; Robins J.M., 2000, STAT MODELS EPIDEMIO, P95, DOI DOI 10.1007/978-1-4612-1284-3_2; ROBINS JM, 1995, J AM STAT ASSOC, V90, P122, DOI 10.2307/2291135; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Rubin DB, 2006, STAT SCI, V21, P299, DOI 10.1214/088342306000000114; Shisana O, 2014, S AFRICAN NATL HIV P; Statistics South Africa, 2014, MORT CAUS DEATH S AF; STEPS W., 2003, FRAMEWORK SURVEILLAN; van Dijk SB, 2012, NETH HEART J, V20, P208, DOI 10.1007/s12471-011-0237-7; Zaidi J, 2013, AIDS, V27, P2301, DOI 10.1097/QAD.0b013e328362e832	36	13	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0158264	10.1371/journal.pone.0158264	http://dx.doi.org/10.1371/journal.pone.0158264			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27552195	gold, Green Published, Green Submitted			2022-12-26	WOS:000381768800004
J	Indurthi, DC; Lewis, TM; Ahring, PK; Balle, T; Chebib, M; Absalom, NL				Indurthi, Dinesh C.; Lewis, Trevor M.; Ahring, Philip K.; Balle, Thomas; Chebib, Mary; Absalom, Nathan L.			Ligand Binding at the 4-4 Agonist-Binding Site of the 42 nAChR Triggers Receptor Activation through a Pre-Activated Conformational State	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; POSITIVE ALLOSTERIC MODULATOR; CYS-LOOP RECEPTORS; ALPHA-4-ALPHA-4 INTERFACE; ALTERNATE STOICHIOMETRIES; GABA(A) RECEPTORS; DESENSITIZATION; NS9283; SENSITIVITY; MECHANISM	The alpha 4 beta 2 nicotinic acetylcholine receptor (nAChR) is the most abundant subtype in the brain and exists in two functional stoichiometries: (alpha 4)(3)(beta 2)(2) and (alpha 4)(2)(beta 2)(3). A distinct feature of the (alpha 4)(3)(beta 2)(2) receptor is the biphasic activation response to the endogenous agonist acetylcholine, where it is activated with high potency and low efficacy when two alpha 4-beta 2 binding sites are occupied and with low potency/high efficacy when a third alpha 4-alpha 4 binding site is occupied. Further, exogenous ligands can bind to the third alpha 4-alpha 4 binding site and potentiate the activation of the receptor by ACh that is bound at the two alpha 4-beta 2 sites. We propose that perturbations of the recently described pre-activation step when a third binding site is occupied are a key driver of these distinct activation properties. To investigate this, we used a combination of simple linear kinetic models and voltage clamp electrophysiology to determine whether transitions into the pre-activated state were increased when three binding sites were occupied. We separated the binding at the two different sites with ligands selective for the alpha 4-beta 2 site (Sazetidine-A and TC-2559) and the alpha 4-alpha 4 site (NS9283) and identified that when a third binding site was occupied, changes in the concentration-response curves were best explained by an increase in transitions into a pre-activated state. We propose that perturbations of transitions into a pre-activated state are essential to explain the activation properties of the (alpha 4)(3)(beta 2)(2) receptor by acetylcholine and other ligands. Considering the widespread clinical use of benzodiazepines, this discovery of a conserved mechanism that benzodiazepines and ACh potentiate receptor activation via a third binding site can be exploited to develop therapeutics with similar properties at other cys-loop receptors.	[Indurthi, Dinesh C.; Ahring, Philip K.; Balle, Thomas; Chebib, Mary; Absalom, Nathan L.] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Lewis, Trevor M.] Univ NSW, Sch Med Sci, Kensington, NSW 2052, Australia	University of Sydney; University of New South Wales Sydney	Chebib, M; Absalom, NL (corresponding author), Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia.	mary.collins@sydney.edu.au; nathan.absalom@sydney.edu.au	Lewis, Trevor/A-2939-2011; Indurthi, Dinesh C C/AAW-8119-2021	Lewis, Trevor/0000-0003-1864-6806; Ahring, Joergen Philip Kiaer/0000-0003-1807-3331; Balle, Thomas/0000-0002-0233-8350	National Health and Medical Research Council of Australia (NHMRC) [1069417]; International Postgraduate Research Scholarship by the University of Sydney; John Lamberton Scholarship; Imk Almene Fond, Denmark; Saniona A/S	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); International Postgraduate Research Scholarship by the University of Sydney; John Lamberton Scholarship; Imk Almene Fond, Denmark; Saniona A/S	This work was funded by the National Health and Medical Research Council of Australia (NHMRC) Project Grant 1069417 (https://www.nhmrc.gov.au/grants-funding/apply-funding/project-grants). DCI is funded by an International Postgraduate Research Scholarship by the University of Sydney (http://sydney.edu.au/scholarships/prospective/international_postgraduate_scholarships.shtml#iprs) and received support of a John Lamberton Scholarship (http://agile2.ucc.usyd.edu.au/ro/opportunities/scholarships/1260). This work was co-funded by Imk Almene Fond, Denmark and Saniona A/S (http://saniona.com/EN/).	Absalom NL, 2013, J BIOL CHEM, V288, P26521, DOI 10.1074/jbc.M113.475053; Ahring PK, 2015, NEUROPHARMACOLOGY, V92, P135, DOI 10.1016/j.neuropharm.2014.12.035; AKASU T, 1984, BRAIN RES, V290, P342, DOI 10.1016/0006-8993(84)90953-3; Andersen N, 2011, J NEUROSCI, V31, P3662, DOI 10.1523/JNEUROSCI.5940-10.2011; Bain EE, 2013, NEUROPSYCHOPHARMACOL, V38, P405, DOI 10.1038/npp.2012.194; Benallegue N, 2013, BRIT J PHARMACOL, V170, P304, DOI 10.1111/bph.12268; Carbone AL, 2009, BRIT J PHARMACOL, V156, P970, DOI 10.1111/j.1476-5381.2008.00104.x; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Colquhoun D, 2012, J GEN PHYSIOL, V140, P599, DOI 10.1085/jgp.201210844; Corradi J, 2014, J NEUROSCI, V34, P16865, DOI 10.1523/JNEUROSCI.1970-14.2014; DELCASTILLO J, 1957, PROC R SOC SER B-BIO, V146, P369; Eaton MM, 2014, MOL PHARMACOL, V86, P647, DOI 10.1124/mol.114.094813; Engelman HS, 2004, NAT REV NEUROSCI, V5, P135, DOI 10.1038/nrn1297; Gielen MC, 2012, J NEUROSCI, V32, P5707, DOI 10.1523/JNEUROSCI.5663-11.2012; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; Grupe M, 2013, BRIT J PHARMACOL, V168, P2000, DOI 10.1111/bph.12095; Harpsoe K, 2011, J NEUROSCI, V31, P10759, DOI 10.1523/JNEUROSCI.1509-11.2011; Jones MV, 1996, TRENDS NEUROSCI, V19, P96, DOI 10.1016/S0166-2236(96)80037-3; Jorenby DE, 2006, JAMA-J AM MED ASSOC, V296, P56, DOI 10.1001/jama.296.1.56; Kuryatov A, 2005, MOL PHARMACOL, V68, P1839, DOI 10.1124/mol.105.012419; Lape R, 2008, NATURE, V454, P722, DOI 10.1038/nature07139; Leonard S, 2007, SCHIZOPHRENIA BULL, V33, P262; Li P, 2010, BRIT J PHARMACOL, V160, P1906, DOI 10.1111/j.1476-5381.2010.00761.x; Mazzaferro S, 2014, J BIOL CHEM, V289, P21795, DOI 10.1074/jbc.M114.555136; Mazzaferro S, 2011, J BIOL CHEM, V286, P31043, DOI 10.1074/jbc.M111.262014; Mike A, 2000, BRAIN RES, V882, P155, DOI 10.1016/S0006-8993(00)02863-8; Moroni M, 2008, J NEUROSCI, V28, P6884, DOI 10.1523/JNEUROSCI.1228-08.2008; Moroni M, 2006, MOL PHARMACOL, V70, P755, DOI 10.1124/mol.106.023044; Mukhtasimova N, 2009, NATURE, V459, P451, DOI 10.1038/nature07923; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; Olsen JA, 2014, J BIOL CHEM, V289, P24911, DOI 10.1074/jbc.M114.568097; Olsen JA, 2013, J BIOL CHEM, V288, P35997, DOI 10.1074/jbc.M113.498618; Papke RL, 2010, J MOL NEUROSCI, V40, P77, DOI 10.1007/s12031-009-9261-0; Paterson D, 2000, PROG NEUROBIOL, V61, P75, DOI 10.1016/S0301-0082(99)00045-3; Purohit P, 2009, P NATL ACAD SCI USA, V106, P115, DOI 10.1073/pnas.0809272106; Rezvani AH, 2001, BIOL PSYCHIAT, V49, P258, DOI 10.1016/S0006-3223(00)01094-5; Rusch D, 2004, J BIOL CHEM, V279, P20982, DOI 10.1074/jbc.M400472200; Shahsavar A, 2015, MOL PHARMACOL, V88, P697, DOI 10.1124/mol.115.098061; Tapia L, 2007, MOL PHARMACOL, V71, P769, DOI 10.1124/mol.106.030445; Timmermann DB, 2012, BRIT J PHARMACOL, V167, P164, DOI 10.1111/j.1476-5381.2012.01989.x; Timmermann DB, 2007, J PHARMACOL EXP THER, V323, P294, DOI 10.1124/jpet.107.120436; Wang JY, 2015, J BIOL CHEM, V290, P28834, DOI 10.1074/jbc.M115.676551; Wang JY, 2015, J BIOL CHEM, V290, P13907, DOI 10.1074/jbc.M115.646786; Williams DK, 2011, MOL PHARMACOL, V80, P1013, DOI 10.1124/mol.111.074302; Williams DK, 2011, BIOCHEM PHARMACOL, V82, P915, DOI 10.1016/j.bcp.2011.05.001; Zwart R, 2008, MOL PHARMACOL, V73, P1838, DOI 10.1124/mol.108.045104	46	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0161154	10.1371/journal.pone.0161154	http://dx.doi.org/10.1371/journal.pone.0161154			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27552221	Green Submitted, Green Published, gold			2022-12-26	WOS:000381768800023
J	Seppala, O; Langeloh, L				Seppala, Otto; Langeloh, Laura			Estimating Genetic and Maternal Effects Determining Variation in Immune Function of a Mixed-Mating Snail	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; FRESH-WATER SNAIL; PHENOLOXIDASE ACTIVITY; LYMNAEA-STAGNALIS; EXPERIMENTAL BOTTLENECK; ANTIMICROBIAL PEPTIDES; TREMATODE PARASITISM; NATURAL-SELECTION; SOCIAL INSECT; TRADE-OFFS	Evolution of host defenses such as immune function requires heritable genetic variation in them. However, also non-genetic maternal effects can contribute to phenotypic variation, thus being an alternative target for natural selection. We investigated the role of individuals' genetic background and maternal effects in determining immune defense traits (phenoloxidase and antibacterial activity of hemolymph), as well as in survival and growth, in the simultaneously hermaphroditic snail Lymnaea stagnalis. We utilized the mixed mating system of this species by producing full-sib families in which each parental snail had produced offspring as both a dam and as a sire, and tested whether genetic background (family) and non-genetic maternal effects (dam nested within family) explain trait variation. Immune defense traits and growth were affected solely by individuals' genetic background. Survival of snails did not show family-level variation. Additionally, some snails were produced through self-fertilization. They showed reduced growth and survival suggesting recessive load or overdominance. Immune defense traits did not respond to inbreeding. Our results suggest that the variation in snail immune function and growth was due to genetic differences. Since immune traits did not respond to inbreeding, this variation is most likely due to additive or epistatic genetic variance.	[Seppala, Otto; Langeloh, Laura] Swiss Fed Inst Technol, Inst Integrat Biol, Zurich, Switzerland; [Seppala, Otto; Langeloh, Laura] Swiss Fed Inst Aquat Sci & Technol, Dubendorf, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG)	Seppala, O (corresponding author), Swiss Fed Inst Technol, Inst Integrat Biol, Zurich, Switzerland.; Seppala, O (corresponding author), Swiss Fed Inst Aquat Sci & Technol, Dubendorf, Switzerland.	otto.seppaelae@eawag.ch		Seppala, Otto/0000-0001-7902-3069	Emil Aaltonen Foundation; Swiss National Science Foundation [31003A 140876, 31003A 163318]	Emil Aaltonen Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by the Emil Aaltonen Foundation and the Swiss National Science Foundation (grants 31003A 140876 and 31003A 163318) to OS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allam B, 2006, FISH SHELLFISH IMMUN, V20, P384, DOI 10.1016/j.fsi.2005.05.013; Bahgat M, 2002, PARASITOL RES, V88, P489, DOI 10.1007/s00436-002-0595-6; Baron OL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003792; Bernardo J, 1996, AM ZOOL, V36, P83; BRYANT EH, 1988, EVOLUTION, V42, P698, DOI 10.1111/j.1558-5646.1988.tb02488.x; BRYANT EH, 1986, GENETICS, V114, P1191; Butt D, 2008, DEV COMP IMMUNOL, V32, P299, DOI 10.1016/j.dci.2007.06.006; CAIN GL, 1956, BIOL BULL, V111, P45, DOI 10.2307/1539182; Calleri DV, 2006, P ROY SOC B-BIOL SCI, V273, P2633, DOI 10.1098/rspb.2006.3622; CARSON HL, 1989, AM NAT, V134, P668, DOI 10.1086/285004; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.es.18.110187.001321; Cotter SC, 2004, J EVOLUTION BIOL, V17, P421, DOI 10.1046/j.1420-9101.2003.00655.x; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; Endler J.A., 1986, Monographs in Population Biology, pviii; Falconer D. S., 1989, Introduction to quantitative genetics.; Faltynkova A, 2007, PARASITE, V14, P39, DOI 10.1051/parasite/2007141039; Fox CW, 2013, J EVOLUTION BIOL, V26, P88, DOI 10.1111/jeb.12027; GEBHARDT MD, 1992, GENET RES, V60, P87, DOI 10.1017/S0016672300030780; Gerloff CU, 2003, FUNCT ECOL, V17, P582, DOI 10.1046/j.1365-2435.2003.00769.x; Grindstaff JL, 2003, P ROY SOC B-BIOL SCI, V270, P2309, DOI 10.1098/rspb.2003.2485; GROSHOLZ ED, 1994, EVOLUTION, V48, P1514, DOI 10.1111/j.1558-5646.1994.tb02193.x; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; Heath DD, 1999, EVOLUTION, V53, P1605, DOI 10.1111/j.1558-5646.1999.tb05424.x; Hellio C, 2007, FISH SHELLFISH IMMUN, V22, P433, DOI 10.1016/j.fsi.2006.06.014; Hernroth B, 2003, FISH SHELLFISH IMMUN, V14, P25, DOI 10.1006/fsim.2002.0415; Imler Jean-Luc, 2005, V86, P1, DOI 10.1159/000086648; Janeway C., 2005, IMMUNOBIOLOGY IMMUNE; KAUFMANN KW, 1981, OECOLOGIA, V49, P293, DOI 10.1007/BF00347588; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kellner RLL, 2002, CHEMOECOLOGY OF INSECT EGGS AND EGG DEPOSITION, P149; Klemola N, 2007, ENTOMOL EXP APPL, V123, P167, DOI 10.1111/j.1570-7458.2007.00533.x; Knott KE, 2003, MOL ECOL NOTES, V3, P333, DOI 10.1046/j.1471-8286.2003.00444.x; Koskela T, 2002, EVOLUTION, V56, P899; Kurtz J, 1999, P ROY SOC B-BIOL SCI, V266, P2515, DOI 10.1098/rspb.1999.0954; Le Clec'h W, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1319-6; Leicht K, 2013, ECOL EVOL, V3, P4861, DOI 10.1002/ece3.874; Little TJ, 2003, CURR BIOL, V13, P489, DOI 10.1016/S0960-9822(03)00163-5; LOPEZFANJUL C, 1989, EVOLUTION, V43, P1800, DOI 10.1111/j.1558-5646.1989.tb02628.x; Lynch M., 1998, GENETICS ANAL QUANTI; Mitta G, 2000, FEBS LETT, V486, P185, DOI 10.1016/S0014-5793(00)02192-X; Mousseau T.A., 1998, MATERNAL EFFECTS ADA; Munoz P, 2006, FISH SHELLFISH IMMUN, V20, P12, DOI 10.1016/j.fsi.2005.02.002; Nakadera Y, 2014, J MOLLUS STUD, V80, P1, DOI 10.1093/mollus/eyt049; Pettay JE, 2008, EVOLUTION, V62, P2297, DOI 10.1111/j.1558-5646.2008.00452.x; Pray LA, 1997, EVOLUTION, V51, P308, DOI 10.1111/j.1558-5646.1997.tb02414.x; Puurtinen M, 2004, EVOLUTION, V58, P2747, DOI 10.1111/j.0014-3820.2004.tb01626.x; Puurtinen M, 2004, EVOLUTION, V58, P749, DOI 10.1111/j.0014-3820.2004.tb00408.x; Rasanen K, 2007, FUNCT ECOL, V21, P408, DOI 10.1111/j.1365-2435.2007.01246.x; Rantala MJ, 2007, HEREDITY, V98, P329, DOI 10.1038/sj.hdy.6800945; Rigby MC, 2000, P ROY SOC B-BIOL SCI, V267, P171, DOI 10.1098/rspb.2000.0983; Rolff J, 2005, EVOLUTION, V59, P1844, DOI 10.1111/j.0014-3820.2005.tb01831.x; Ryder JJ, 2001, J EVOLUTION BIOL, V14, P646, DOI 10.1046/j.1420-9101.2001.00302.x; Sadd BM, 2007, CURR BIOL, V17, pR1046, DOI 10.1016/j.cub.2007.11.007; Sadd BM, 2011, EVOLUTION, V65, P2995, DOI 10.1111/j.1558-5646.2011.01345.x; Schwarzenbach GA, 2005, J EVOLUTION BIOL, V18, P455, DOI 10.1111/j.1420-9101.2004.00820.x; Seppala O, 2015, J EVOLUTION BIOL, V28, P1, DOI 10.1111/jeb.12528; Seppala O, 2011, EVOLUTION, V65, P1367, DOI 10.1111/j.1558-5646.2010.01205.x; Seppala O, 2011, BIOL LETTERS, V7, P119, DOI 10.1098/rsbl.2010.0459; Seppala O, 2010, EVOLUTION, V64, P2397, DOI 10.1111/j.1558-5646.2010.00995.x; Seppala O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079366; Seppala O, 2013, J EXP BIOL, V216, P2902, DOI 10.1242/jeb.084947; Sminia T., 1981, INVERTEBRATE BLOOD C, P191; Vayrynen T, 2000, ANN ZOOL FENN, V37, P189; Wiehn J, 2002, EVOLUTION, V56, P1454, DOI 10.1111/j.0014-3820.2002.tb01457.x; Young RL, 2004, J EVOLUTION BIOL, V17, P1355, DOI 10.1111/j.1420-9101.2004.00762.x	66	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0161584	10.1371/journal.pone.0161584	http://dx.doi.org/10.1371/journal.pone.0161584			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27551822	Green Published, gold			2022-12-26	WOS:000381768800053
J	Lin, MC; Chen, PJ; Shih, YL; Huang, HH; Chang, WK; Hsieh, TY; Huang, TY				Lin, Meng-Chiung; Chen, Peng-Jen; Shih, Yu-Lueng; Huang, Hsin-Hung; Chang, Wei-Kuo; Hsieh, Tsai-Yuan; Huang, Tien-Yu			Outcome and Safety of Anterograde and Retrograde Single-Balloon Enteroscopy: Clinical Experience at a Tertiary Medical Center in Taiwan	PLOS ONE			English	Article							CAPSULE ENDOSCOPY; COMPLICATIONS; METAANALYSIS; MANAGEMENT; DIAGNOSIS; YIELD	Single-balloon enteroscopy (SBE) is designed for identifying possible small bowel lesions with balloon-assisted enteroscopy that allows deep intubation of the intestine. However, data regarding the outcome and safety of SBE remain limited. We conducted this study to evaluate the outcome and safety of anterograde and retrograde SBE approaches. This retrospective review from a tertiary medical center in Taiwan included endoscopic reports and chart data from 128 patients with 200 anterograde and retrograde procedures from September 2009 to November 2014. In this study, the most common indication for both anterograde and retrograde SBE was obscure gastrointestinal bleeding (64.4% vs. 60.6%). There were no significant differences between anterograde and retrograde approaches in terms of the diagnostic yield (69.3% vs. 52.5%) and intervention rate (23.8% vs. 17.2%). The procedure time was shorter for anterograde SBE than for retrograde SBE (68.1 +/- 23.9 vs. 76.8 +/- 27.7 min, P = 0.018). In addition, among the subgroup of patients with obscure gastrointestinal bleeding, the most common etiologies for those in different age-groups were angiodysplasia (>= 65 years), non-specific ulcers (30-64 years), and Meckel's diverticulum (< 30 years). The major complication rate during the study was 1.5%; the rate of asymptomatic hyperamylasemia was higher for patients who underwent anterograde SBE than for those who underwent retrograde SBE (13.9% vs. 2%, P = 0.005). The outcome and safety of anterograde and retrograde SBE are similar. However, anterograde SBE has a shorter procedural time and a higher rate of asymptomatic hyperamylasemia.	[Lin, Meng-Chiung; Chen, Peng-Jen; Shih, Yu-Lueng; Huang, Hsin-Hung; Chang, Wei-Kuo; Hsieh, Tsai-Yuan; Huang, Tien-Yu] Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Div Gastroenterol, Taipei, Taiwan; [Lin, Meng-Chiung] Taichiung Armed Forces Gen Hosp, Dept Internal Med, Taichung, Taiwan; [Huang, Tien-Yu] Taiwan Assoc Study Small Intestinal Dis, Taoyuan, Taiwan	National Defense Medical Center; Tri-Service General Hospital	Huang, TY (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Div Gastroenterol, Taipei, Taiwan.; Huang, TY (corresponding author), Taiwan Assoc Study Small Intestinal Dis, Taoyuan, Taiwan.	tienyu27@gmail.com						Aktas H, 2010, ENDOSCOPY, V42, P365, DOI 10.1055/s-0029-1243931; Hong SN, 2016, DIGEST ENDOSC, V28, P443, DOI 10.1111/den.12593; Iddan G, 2000, NATURE, V405, P417, DOI 10.1038/35013140; Kawamura T, 2015, WORLD J GASTRO ENDOS, V7, P59, DOI 10.4253/wjge.v7.i1.59; Lenz P, 2014, ENDOSCOPY, V46, P53, DOI 10.1055/s-0033-1359041; Lipka S, 2015, J CLIN GASTROENTEROL, V49, P177, DOI 10.1097/MCG.0000000000000274; Moeschler O, 2015, WORLD J GASTROENTERO, V21, P1385, DOI 10.3748/wjg.v21.i5.1385; Pech O, 2009, GASTROINTEST ENDOSC, V69, pAB347, DOI 10.1016/j.giec.2009.04.003; Prachayakul V, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-103; Sanaka MR, 2012, CLIN GASTROENTEROL H, V10, P910, DOI 10.1016/j.cgh.2012.04.020; Sethi S, 2014, DIGEST DIS SCI, V59, P2497, DOI 10.1007/s10620-014-3178-3; Teshima CW, 2011, J GASTROEN HEPATOL, V26, P796, DOI 10.1111/j.1440-1746.2010.06530.x; Tsujikawa T, 2008, ENDOSCOPY, V40, P11, DOI 10.1055/s-2007-966976; Upchurch BR, 2010, GASTROINTEST ENDOSC, V71, P1218, DOI 10.1016/j.gie.2010.01.012; Wadhwa V, 2015, GASTROENTEROL REP, V3, P148, DOI 10.1093/gastro/gov003; Yamamoto H, 2001, GASTROINTEST ENDOSC, V53, P216, DOI 10.1067/mge.2001.112181; Zepeda-Gomez S, 2011, ENDOSCOPY, V43, P766, DOI 10.1055/s-0030-1256473	17	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161188	10.1371/journal.pone.0161188	http://dx.doi.org/10.1371/journal.pone.0161188			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548619	Green Published, gold, Green Submitted			2022-12-26	WOS:000381768400033
J	Augustinos, AA; Rajamohan, A; Kyritsis, GA; Zacharopoulou, A; ul Haq, I; Targovska, A; Caceres, C; Bourtzis, K; Abd-Alla, AMM				Augustinos, Antonios A.; Rajamohan, Arun; Kyritsis, Georgios A.; Zacharopoulou, Antigone; ul Haq, Ihsan; Targovska, Asya; Caceres, Carlos; Bourtzis, Kostas; Abd-Alla, Adly M. M.			Cryopreservation of Embryos of the Mediterranean Fruit Fly Ceratitis capitata Vienna 8 Genetic Sexing Strain	PLOS ONE			English	Article							DIPTERA-TEPHRITIDAE; STERILE; DOMESTICATION; LEPIDOPTERA; ERADICATION; SUPPRESSION; MUTATIONS; POLYTENE; QUALITY; FLIES	The Mediterranean fruit fly, Ceratitis capitata, is one of the most serious pests of fruit crops world-wide. During the last decades, area-wide pest management (AW-IPM) approaches with a sterile insect technique (SIT) component have been used to control populations of this pest in an effective and environment-friendly manner. The development of genetic sexing strains (GSS), such as the Vienna 8 strain, has been played a major role in increasing the efficacy and reducing the cost of SIT programs. However, mass rearing, extensive inbreeding, possible bottleneck phenomena and hitch-hiking effects might pose major risks for deterioration and loss of important genetic characteristics of domesticated insect. In the present study, we present a modified procedure to cryopreserve the embryos of the medfly Vienna 8 GSS based on vitrification and used this strain as insect model to assess the impact of the cryopreservation process on the genetic structure of the cryopreserved insects. Forty-eight hours old embryos, incubated at 24 degrees C, were found to be the most suitable developmental stage for cryopreservation treatment for high production of acceptable hatch rate (38%). Our data suggest the absence of any negative impact of the cryopreservation process on egg hatch rate, pupation rates, adult emergence rates and stability of the temperature sensitive lethal (tsl) character on two established cryopreserved lines (flies emerged from cryopreserved embryos), named V8-118 and V8-228. Taken together, our study provides an optimized procedure to cryopreserve the medfly Vienna 8 GSS and documents the absence of any negative impact on the genetic structure and quality of the strain. Benefits and sceneries for utilization of this technology to support operational SIT projects are discussed in this paper.	[Augustinos, Antonios A.; Kyritsis, Georgios A.; ul Haq, Ihsan; Targovska, Asya; Caceres, Carlos; Bourtzis, Kostas; Abd-Alla, Adly M. M.] Joint FAO IAEA Div Nucl Tech Food & Agr, Insect Pest Control Lab, Vienna, Austria; [Rajamohan, Arun] USDA, Insect Genet & Biochem Unit, Biosci Res Lab, Fargo, ND 58105 USA; [Zacharopoulou, Antigone] Univ Patras, Dept Biol, Patras, Greece	Food & Agriculture Organization of the United Nations (FAO); International Atomic Energy Agency; United States Department of Agriculture (USDA); University of Patras	Abd-Alla, AMM (corresponding author), Joint FAO IAEA Div Nucl Tech Food & Agr, Insect Pest Control Lab, Vienna, Austria.	a.m.m.abd-alla@iaea.org	Augustinos, Antonios/C-1318-2019	Augustinos, Antonios/0000-0003-3682-6077; ABD-ALLA, Adly/0000-0001-7540-4462; Rajamohan, Arun/0000-0003-1587-2891	ARS [ARS-0428476] Funding Source: Federal RePORTER	ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)		[Anonymous], 1979, BASIC PRINCIPLES INS; BEDO DG, 1987, GENOME, V29, P598, DOI 10.1139/g87-101; BEDO DG, 1986, CAN J GENET CYTOL, V28, P180, DOI 10.1139/g86-025; Cayol J.P., 2000, P657; Cayol JP, 2000, FRUIT FLIES (TEPHRITIDAE): PHYLOGENY AND EVOLUTION OF BEHAVIOR, P843; CHRISTENSON LD, 1960, ANNU REV ENTOMOL, V5, P171, DOI 10.1146/annurev.en.05.010160.001131; COX BD, 1975, MUTAT RES, V28, P421, DOI 10.1016/0027-5107(75)90236-5; Enkerlin W, 2015, FLA ENTOMOL, V98, P665, DOI 10.1653/024.098.0242; Franz G, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P427, DOI 10.1007/1-4020-4051-2_16; FRANZ G, 1995, MACROMOL SYMP, V99, P187, DOI 10.1002/masy.19950990120; Franz G, 2011, GENETICA, V139, P1, DOI 10.1007/s10709-010-9543-z; Gilchrist AS, 2012, J ECON ENTOMOL, V105, P1051, DOI 10.1603/EC11421; Hendrichs J, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P563, DOI 10.1007/1-4020-4051-2_22; Hendrichs J, 2002, FLA ENTOMOL, V85, P1, DOI 10.1653/0015-4040(2002)085[0001:MASITP]2.0.CO;2; IAEA, 2001, ENTOMOLOGY; Isasawin S, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-S2-S2; Juan-Blasco M, 2014, B ENTOMOL RES, V104, P233, DOI 10.1017/S0007485313000692; Klassen W, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P3, DOI 10.1007/1-4020-4051-2_1; Lance DR, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P69, DOI 10.1007/1-4020-4051-2_3; Lance DR, 2000, ANN ENTOMOL SOC AM, V93, P1179, DOI 10.1603/0013-8746(2000)093[1179:CASAWC]2.0.CO;2; Leopold R. A., 2007, P149, DOI 10.1007/978-1-4020-6059-5_13; Leopold RA, 1999, CRYO-LETT, V20, P37; Leopold RA, 2000, ANN ENTOMOL SOC AM, V93, P884, DOI 10.1603/0013-8746(2000)093[0884:STCSOH]2.0.CO;2; Leopold RA, 2001, ANN ENTOMOL SOC AM, V94, P695, DOI 10.1603/0013-8746(2001)094[0695:COEOTN]2.0.CO;2; Leopold RA, 1993, MANAGEMENT INSECT PE, P63; Leopold RA, 2010, ANN ENTOMOL SOC AM, V103, P264, DOI 10.1603/AN09094; Mavragani-Tsipidou P, 2014, PROTOCOLS CYTOGENETI, P1; MAZUR P, 1992, SCIENCE, V258, P1932, DOI 10.1126/science.1470915; MCINNIS DO, 1994, ANN ENTOMOL SOC AM, V87, P231, DOI 10.1093/aesa/87.2.231; McInnis DO, 1993, EVALUATION IAEAS TSL, P1; NUNAMAKER RA, 1993, J MED ENTOMOL, V30, P913, DOI 10.1093/jmedent/30.5.913; Paranhos B. J., 2008, Fruit Flies of Economic Importance to Applied Knowledge. Proceedings of the 7th International Symposium on Fruit Flies of Economic Importance, 10-15 September 2006, Salvador, Brazil, P313; Parreno MA, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-S2-S14; Rajamohan A, 2007, CRYOBIOLOGY, V54, P44, DOI 10.1016/j.cryobiol.2006.10.192; Rajamohan A, 2003, CRYOLETTERS, V24, P125; Rajamohan A, 2014, J MED ENTOMOL, V51, P360, DOI 10.1603/ME13188; Rajamohan A, 2013, J ECON ENTOMOL, V106, P855, DOI 10.1603/EC12485; Rempoulakis P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157679; Rendon P, 2004, J ECON ENTOMOL, V97, P1547, DOI 10.1603/0022-0493-97.5.1547; Rendon P., 2000, Area-wide control of fruit flies and other insect pests. Joint proceedings of the international conference on area-wide control of insect pests, 28 May-2 June, 1998 and the Fifth International Symposium on Fruit Flies of Economic Importance, Penang, Malaysia, 1-5 June, 1998, P517; Rendon P.A, 1996, DEV EVALUATION TEMPE; RHODE RH, 1971, J ECON ENTOMOL, V64, P708, DOI 10.1093/jee/64.3.708; Robinson AS, 2002, MUTAT RES-REV MUTAT, V511, P113, DOI 10.1016/S1383-5742(02)00006-6; Robinson AS, 2002, GENETICA, V116, P1, DOI 10.1023/A:1020943122999; Robinson DE, 2000, USE STERILE INSECT T, P213; Roversi PF, 2008, CRYOBIOLOGY, V56, P1, DOI 10.1016/j.cryobiol.2007.09.002; Zepeda-Cisneros CS, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-S2-S1; Tanaka N, 1970, P PANEL STERILE MALE, P19, DOI DOI 10.1007/978-1-4615-9585-4_12; Vargas R., 1989, WORLD CROP PESTS FRU, V3, P141; Vreysen M., 2005, Bulletin OILB/SROP, V28, P65; Wang WB, 2000, CRYOBIOLOGY, V41, P153, DOI 10.1006/cryo.2000.2278; Wyss JH, 2000, ANN NY ACAD SCI, V916, P186, DOI 10.1111/j.1749-6632.2000.tb05289.x; Zacharopoulou A, 2013, J ECON ENTOMOL, V106, P995, DOI 10.1603/EC12379; Zygouridis NE, 2014, J APPL ENTOMOL, V138, P423, DOI 10.1111/jen.12042	54	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0160232	10.1371/journal.pone.0160232	http://dx.doi.org/10.1371/journal.pone.0160232			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537351	Green Published, Green Submitted, gold			2022-12-26	WOS:000381577000015
J	Choi, SJ; Lee, SI; Joo, EY				Choi, Su Jung; Lee, Sung Ik; Joo, Eun Yeon			Habitual Alcohol Consumption and Metabolic Syndrome in Patients with Sleep Disordered Breathing	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; KOREAN NATIONAL-HEALTH; MODERATE ALCOHOL; INSPIRATORY RESISTANCE; OXYGEN DESATURATION; RESPIRATORY DRIVE; BEDTIME ETHANOL; NONSNORING MEN; RISK-FACTORS; APNEA	To investigate the associations between amount of habitual alcohol consumption (HAC) and prevalence of metabolic syndrome (MetS), sleep, and sleep-disordered breathing (SDB). We enrolled 683 untreated SDB male patients (age: 54.4 +/- 7.80 y, apnea-hypopnea index (AHI): 29.0 +/- 21.53/h). HAC was assessed as the average number of drinks consumed per week during the past 12 months. Anthropometric and biochemical markers were used to diagnose MetS. Clinical data and MetS components were compared according to the reported amounts of HAC (no drinking, light drinking <13, heavy drinking >= 13 drinks/week). As reported, 78.9% of the participants (n = 539) were regular drinkers; 33.7% (n = 230) were habitually heavy drinkers (mean: 30.7 drinks/week), and 45.2% (n = 309) were light drinkers (5.1 drinks/week). The overall prevalence of MetS was 36.9% (n = 252) and was most common in heavy drinkers (40.5%). Compared to non-drinkers and light drinkers, heavy drinkers had the greatest body mass index (BMI) and waist circumference. Central obesity, hypertension, and hyperglycemia were most prevalent in heavy drinkers. Sleep quality and severity of SDB were the worst in heavy drinkers. After adjusting for age, AHI, and BMI, heavy drinkers had a 1.71 times greater risk of MetS when compared with nondrinkers, and light and heavy drinkers had a 2.06 and 2.11 times higher risk of severe SDB than non-drinkers. HAC may increase the prevalence of MetS and deteriorate sleep in relation to amount of alcohol intake. Even light drinkers had more than twice higher risk of severe SDB than non-drinkers.	[Choi, Su Jung; Joo, Eun Yeon] Sungkyunkwan Univ, Dept Neurol, Neurosci Ctr, Samsung Med Ctr,Sch Med, Seoul, South Korea; [Choi, Su Jung] Sungkyunkwan Univ, Grad Sch Clin Nursing Sci, Dept Clin Nursing Sci, Dept Nursing,Samsung Med Ctr, Seoul, South Korea; [Joo, Eun Yeon] Sungkyunkwan Univ, SAIHST, Dept Hlth Sci & Technol, Seoul, South Korea; [Lee, Sung Ik] Wonkwang Univ, Sch Med, Sanbon Hosp, Dept Neurol,Inam NeuroSci Res Ctr, Gunpo Si, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Wonkwang University	Joo, EY (corresponding author), Sungkyunkwan Univ, Dept Neurol, Neurosci Ctr, Samsung Med Ctr,Sch Med, Seoul, South Korea.; Joo, EY (corresponding author), Sungkyunkwan Univ, SAIHST, Dept Hlth Sci & Technol, Seoul, South Korea.	ejoo@skku.edu		Choi, Su Jung/0000-0003-2171-7441				Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alkerwi A, 2009, ATHEROSCLEROSIS, V204, P624, DOI 10.1016/j.atherosclerosis.2008.10.036; Baik I, 2008, AM J CLIN NUTR, V87, P1455, DOI 10.1093/ajcn/87.5.1455; Barreiro Bienvenido, 2013, Open Respir Med J, V7, P71, DOI 10.2174/1874306401307010071; BEARPARK H, 1995, AM J RESP CRIT CARE, V151, P1459, DOI 10.1164/ajrccm.151.5.7735600; BERRY RB, 1992, AM REV RESPIR DIS, V145, P445, DOI 10.1164/ajrccm/145.2_Pt_1.445; Bixler EO, 1998, AM J RESP CRIT CARE, V157, P144, DOI 10.1164/ajrccm.157.1.9706079; CHAN AWK, 1986, ALCOHOL ALCOHOLISM, V21, P93; Dawson A, 1997, ALCOHOL CLIN EXP RES, V21, P183, DOI 10.1111/j.1530-0277.1997.tb03747.x; DAWSON A, 1993, ALCOHOL CLIN EXP RES, V17, P256, DOI 10.1111/j.1530-0277.1993.tb00759.x; Djousse L, 2004, OBES RES, V12, P1375, DOI 10.1038/oby.2004.174; DOLLY FR, 1983, CHEST, V83, P469, DOI 10.1378/chest.83.3.469; Freiberg MS, 2004, DIABETES CARE, V27, P2954, DOI 10.2337/diacare.27.12.2954; Gastaldelli A, 2010, CURR PHARM DESIGN, V16, P2526, DOI 10.2174/138161210792062858; Iber C., 2007, AASM MANUAL SCORING; ISSA FG, 1982, J NEUROL NEUROSUR PS, V45, P353, DOI 10.1136/jnnp.45.4.353; Joe KH, 2009, J KOREAN ACAD ADDICT, V13, P34; Kato I, 2003, J CLIN EPIDEMIOL, V56, P196, DOI 10.1016/S0895-4356(02)00578-4; Keyes KM, 2012, EPIDEMIOL REV, V34, P89, DOI 10.1093/epirev/mxr018; Kim BJ, 2012, CIRC J, V76, P2363, DOI 10.1253/circj.CJ-12-0315; Kim J, 2004, AM J RESP CRIT CARE, V170, P1108, DOI 10.1164/rccm.200404-519OC; Koppes LLJ, 2005, DIABETES CARE, V28, P719, DOI 10.2337/diacare.28.3.719; Lee K, 2012, PUBLIC HEALTH NUTR, V15, P1917, DOI 10.1017/S136898001100365X; Lee SJ, 2015, NEUROLOGY, V85, P1950, DOI 10.1212/WNL.0000000000002165; Lim S, 2011, DIABETES CARE, V34, P1323, DOI 10.2337/dc10-2109; MITLER MM, 1988, ALCOHOL CLIN EXP RES, V12, P801, DOI 10.1111/j.1530-0277.1988.tb01349.x; Nolen-Hoeksema S, 2004, CLIN PSYCHOL REV, V24, P981, DOI 10.1016/j.cpr.2004.08.003; OLSON LG, 1995, AM J RESP CRIT CARE, V152, P711, DOI 10.1164/ajrccm.152.2.7633731; Pan Yue, 2014, Int J High Risk Behav Addict, V3, pe19088, DOI 10.5812/ijhrba.19088; Peppard PE, 2007, J CLIN SLEEP MED, V3, P265; Redline S, 2004, ARCH INTERN MED, V164, P406, DOI 10.1001/archinte.164.4.406; Reid MC, 1999, ARCH INTERN MED, V159, P1681, DOI 10.1001/archinte.159.15.1681; Rosell M, 2003, EUR J CLIN NUTR, V57, P227, DOI 10.1038/sj.ejcn.1601548; Scanlan MF, 2000, EUR RESPIR J, V16, P909, DOI 10.1183/09031936.00.16590900; SCHMIDTNOWARA WW, 1990, ARCH INTERN MED, V150, P597, DOI 10.1001/archinte.150.3.597; Seo S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007914; TAASAN VC, 1981, AM J MED, V71, P240; Tanigawa T, 2004, JAMA-J AM MED ASSOC, V292, P923, DOI 10.1001/jama.292.8.923-b; TCHAI BS, 1993, ANN NY ACAD SCI, V676, P279, DOI 10.1111/j.1749-6632.1993.tb38741.x; THOMASSON HR, 1991, AM J HUM GENET, V48, P677; Vgontzas AN, 2005, SLEEP MED REV, V9, P211, DOI 10.1016/j.smrv.2005.01.006; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Wu WT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130279; Xin X, 2001, HYPERTENSION, V38, P1112, DOI 10.1161/hy1101.093424; Yoon YS, 2004, AM J CLIN NUTR, V80, P217; Young T, 2005, J APPL PHYSIOL, V99, P1592, DOI 10.1152/japplphysiol.00587.2005; Zito A, 2011, EUR RESPIR J, V37, P717, DOI 10.1183/09031936.00120510	47	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161276	10.1371/journal.pone.0161276	http://dx.doi.org/10.1371/journal.pone.0161276			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536782	Green Published, Green Submitted, gold			2022-12-26	WOS:000381577000080
J	Jamal, WY; Rotimi, VO				Jamal, Wafaa Y.; Rotimi, Vincent O.			Surveillance of Antibiotic Resistance among Hospital- and Community-Acquired Toxigenic Clostridium difficile Isolates over 5-Year Period in Kuwait	PLOS ONE			English	Article							PCR RIBOTYPE; ANTIMICROBIAL SUSCEPTIBILITY; INFECTION; EMERGENCE; METRONIDAZOLE; EPIDEMIOLOGY; TUBERCULOSIS; GUIDELINES; OUTBREAK; AMERICA	Clostridium difficile infection (CDI) is a leading and an important cause of diarrhea in a healthcare setting especially in industrialized countries. Community-associated CDI appears to add to the burden on healthcare setting problems. The aim of the study was to investigate the antimicrobial resistance of healthcare-associated and community-acquired C. difficile infection over 5 years (2008-2012) in Kuwait. A total of 111 hospital-acquired (HA-CD) and 35 community-acquired Clostridium difficile (CA-CD) clinical isolates from stool of patients with diarrhoea were studied. Antimicrobial susceptibility testing of 15 antimicrobial agents against these pathogens was performed using E test method. There was no evidence of resistance to amoxicillin-clavulanic acid, daptomycin, linezolid, piperacillin-tazobactam, teicoplanin and vancomycin by both HA-CD and CA-CD isolates. Metronidazole had excellent activity against CA-CD but there was a 2.9% resistance rate against HA-CD isolates. Ampicillin, clindamycin, levofloxacin and imipenem resistance rates among the HC-CD vs. CA-CD isolates were 100 vs. 47.4%; 43 vs. 47.4%; 100 vs. 100% and 100 vs. 89%, respectively. An unexpected high rifampicin resistance rate of 15.7% emerged amongst the HA-CD isolates. In conclusion, vancomycin resistance amongst the HA-CD and CA-CD isolates was not encountered in this series but few metronidazole resistant hospital isolates were isolated. High resistance rates of ampicillin, clindamycin, levofloxacin, and imipenem resistance were evident among both CA-CD and HA-CD isolates. Rifampicin resistance is emerging among the HA-CD isolates.	[Jamal, Wafaa Y.] Kuwait Univ, Fac Med, Anaerobe Reference Lab, Jabriya, Kuwait; Kuwait Univ, Fac Med, Dept Microbiol, Jabriya, Kuwait	Kuwait University; Kuwait University	Jamal, WY (corresponding author), Kuwait Univ, Fac Med, Anaerobe Reference Lab, Jabriya, Kuwait.	wjamal@hsc.edu.kw			Kuwait University Research Grant [MI 05/10]	Kuwait University Research Grant	This work was supported by Kuwait University Research Grant no. MI 05/10. The funder had no role in study design, data collection, and analysis, decision to publish or preparation of the manuscript.	Areeshi MY, 2014, J INFECT DEV COUNTR, V8, P1137, DOI 10.3855/jidc.4053; Baines SD, 2008, J ANTIMICROB CHEMOTH, V62, P1046, DOI 10.1093/jac/dkn313; Barbut F, 1999, ANTIMICROB AGENTS CH, V43, P2607, DOI 10.1128/AAC.43.11.2607; CLSI Clinical Laboratory and Standards Institute, 2014, MI00S24 CLSI; CLSI Clinical Laboratory and Standards Institute, 2007, MI00S17 CLSI; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Debast SB, 2014, CLIN MICROBIOL INFEC, V20, P1, DOI 10.1111/1469-0691.12418; Freeman J, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2014.09.017; Freeman J, 2010, CLIN MICROBIOL REV, V23, P529, DOI 10.1128/CMR.00082-09; Gonzales M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-363; Goorhuis Abraham, 2008, Infection Control and Hospital Epidemiology, V29, P1162, DOI 10.1086/592257; Jamal WY, 2002, INT J ANTIMICROB AG, V20, P270, DOI 10.1016/S0924-8579(02)00180-2; Knight DR, 2015, J ANTIMICROB CHEMOTH, V70, P2992, DOI 10.1093/jac/dkv220; Kuijper EJ, 2006, CLIN MICROBIOL INFEC, V12, P2, DOI 10.1111/j.1469-0691.2006.01580.x; Kuijper EJ, 2008, CAN MED ASSOC J, V179, P747, DOI 10.1503/cmaj.081211; Lachowicz D, 2015, ANAEROBE, V31, P37, DOI 10.1016/j.anaerobe.2014.09.004; Lee JH, 2014, J MED MICROBIOL, V63, P819, DOI 10.1099/jmm.0.072082-0; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; Muto CA, 2005, INFECT CONT HOSP EP, V26, P273, DOI 10.1086/502539; Norman KN, 2014, FOODBORNE PATHOG DIS, V11, P257, DOI 10.1089/fpd.2013.1648; O'Connor JR, 2009, GASTROENTEROLOGY, V136, P1913, DOI 10.1053/j.gastro.2009.02.073; Obuch-Woszczatynski P, 2013, EUR J CLIN MICROBIOL, V32, P1027, DOI 10.1007/s10096-013-1845-5; ONeill GL, 1996, ANAEROBE, V2, P205, DOI 10.1006/anae.1996.0028; Owens RC, 2008, CLIN INFECT DIS, V46, pS19, DOI 10.1086/521859; Pelaez T, 2008, J CLIN MICROBIOL, V46, P3028, DOI 10.1128/JCM.00524-08; Pelaez T, 2002, ANTIMICROB AGENTS CH, V46, P1647, DOI 10.1128/AAC.46.6.1647-1650.2002; Riley TV, 2009, MED J AUSTRALIA, V190, P706, DOI 10.5694/j.1326-5377.2009.tb02644.x; Rouphael NG, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2008.01.062; Spigaglia P, 2011, J ANTIMICROB CHEMOTH, V66, P2227, DOI 10.1093/jac/dkr292; Surawicz CM, 2013, AM J GASTROENTEROL, V108, P478, DOI 10.1038/ajg.2013.4; Udo EE, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-168	31	16	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161411	10.1371/journal.pone.0161411	http://dx.doi.org/10.1371/journal.pone.0161411			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536994	Green Published, Green Submitted, gold			2022-12-26	WOS:000381577000103
J	Martinez-Hervas, S; Navarro, I; Real, JT; Artero, A; Peiro, M; Gonzalez-Navarro, H; Carmena, R; Ascaso, JF				Martinez-Hervas, Sergio; Navarro, Inmaculada; Real, Jose T.; Artero, Ana; Peiro, Marta; Gonzalez-Navarro, Herminia; Carmena, Rafael; Ascaso, Juan F.			Unsaturated Oral Fat Load Test Improves Glycemia, Insulinemia and Oxidative Stress Status in Nondiabetic Subjects with Abdominal Obesity	PLOS ONE			English	Article							MITOCHONDRIAL BIOENERGETICS; PROTEIN CARBONYLATION; POSTPRANDIAL LIPEMIA; ENDOTHELIAL FUNCTION; RESISTANCE; ACIDS; GLUCOSE; HUMANS; INFLAMMATION; SENSITIVITY	Aims To evaluate the changes in glycemia, insulinemia, and oxidative stress markers during an oral fat load test in nondiabetic subjects with abdominal obesity and to analyze the association between postprandial oxidative stress markers and postprandial glucose and insulin responses. Methods We included 20 subjects with abdominal obesity (waist circumference > 102 cm for men and > 88 cm for women) and 20 healthy lean controls (waist circumference < 102 cm for men and < 88 cm for women). After 12 hours of fasting we performed a standardized fat load test (0-8 hours) with supracal (R) (50 g/m(2)). We determined metabolic parameters, oxidized and reduced glutathione, and malondialdehyde. Results In both groups, insulin, HOMA, oxidized/reduced glutathione ratio, and malondialdehyde significantly decreased in the postprandial state after the OFLT. All these parameters were significantly higher in the abdominal obesity group at baseline and during all the postprandial points, but the reduction from the baseline levels was significantly higher in the abdominal obesity group. Conclusion Unsaturated fat improves insulin resistance and oxidative stress status. It is possible that a consumption of unsaturated fat could be beneficial even in subjects with abdominal obesity in postprandial state.	[Martinez-Hervas, Sergio; Navarro, Inmaculada; Real, Jose T.; Artero, Ana; Ascaso, Juan F.] Hosp Clin Univ Valencia, Serv Endocrinol & Nutr Hosp, Valencia, Spain; [Martinez-Hervas, Sergio; Real, Jose T.; Carmena, Rafael; Ascaso, Juan F.] Univ Valencia, Dept Med, Valencia, Spain; [Martinez-Hervas, Sergio; Real, Jose T.; Peiro, Marta; Gonzalez-Navarro, Herminia; Carmena, Rafael; Ascaso, Juan F.] ISCIII, CIBER Diabet & Associated Metab Dis CIBERDEM, Madrid, Spain; [Peiro, Marta; Gonzalez-Navarro, Herminia; Carmena, Rafael] Hosp Clin Res Fdn INCLIVA, Valencia, Spain	University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III	Real, JT (corresponding author), Hosp Clin Univ Valencia, Serv Endocrinol & Nutr Hosp, Valencia, Spain.; Real, JT (corresponding author), Univ Valencia, Dept Med, Valencia, Spain.; Real, JT (corresponding author), ISCIII, CIBER Diabet & Associated Metab Dis CIBERDEM, Madrid, Spain.	jtreal@uv.es	Martinez-Hervas, Sergio/K-2829-2014	Martinez-Hervas, Sergio/0000-0002-6775-2034; Gonzalez-Navarro, Herminia/0000-0001-6883-3808	Fondo de Investigaciones Sanitarias [FIS 10/0051, FIS 05/0348, FIS 12/01978]; Valencian Government [GE-010/09]	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Valencian Government	This work has been supported by grants from Fondo de Investigaciones Sanitarias to Juan F. Ascaso T (FIS 10/0051), Jose T. Real (FIS 05/0348, FIS 12/01978) and CIBER de Diabetes y Enfermedades Metabolicas Asociadas, and from the Valencian Government to Sergio Martinez-Hervas (GE-010/09).	Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Belfort R, 2005, DIABETES, V54, P1640, DOI 10.2337/diabetes.54.6.1640; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; BORKMAN M, 1993, NEW ENGL J MED, V328, P238, DOI 10.1056/NEJM199301283280404; CABEZAS MC, 1993, J CLIN INVEST, V92, P160, DOI 10.1172/JCI116544; Capurso C, 2012, VASC PHARMACOL, V57, P91, DOI 10.1016/j.vph.2012.05.003; Ceriello A, 2004, ARTERIOSCL THROM VAS, V24, P816, DOI 10.1161/01.ATV.0000122852.22604.78; Chen LJ, 2008, AGING CELL, V7, P866, DOI 10.1111/j.1474-9726.2008.00432.x; Cocco T, 1999, FREE RADICAL BIO MED, V27, P51, DOI 10.1016/S0891-5849(99)00034-9; Cortes B, 2006, J AM COLL CARDIOL, V48, P1666, DOI 10.1016/j.jacc.2006.06.057; Curtis JM, 2010, DIABETES, V59, P1132, DOI 10.2337/db09-1105; Delarue J, 1996, AM J PHYSIOL-ENDOC M, V270, pE353, DOI 10.1152/ajpendo.1996.270.2.E353; Eckel RH, 2005, CIRCULATION, V111, pE257, DOI 10.1161/01.CIR.0000163653.38992.E5; El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410; Espinosa A, 2009, J BIOL CHEM, V284, P2568, DOI 10.1074/jbc.M804249200; Fernandez-Sanchez A, 2011, INT J MOL SCI, V12, P3117, DOI 10.3390/ijms12053117; Fisher-Wellman KH, 2012, TRENDS ENDOCRIN MET, V23, P142, DOI 10.1016/j.tem.2011.12.008; Frohnert BI, 2011, OBESITY, V19, P1735, DOI 10.1038/oby.2011.115; Iggman D, 2010, DIABETOLOGIA, V53, P850, DOI 10.1007/s00125-010-1669-0; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Le KA, 2006, CURR OPIN CLIN NUTR, V9, P469, DOI 10.1097/01.mco.0000232910.61612.4d; Lozano A, 2013, NUTR RES, V33, P1012, DOI 10.1016/j.nutres.2013.08.010; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MayerDavis EJ, 1997, AM J CLIN NUTR, V65, P79, DOI 10.1093/ajcn/65.1.79; Navarro J, 1997, FREE RADICAL BIO MED, V22, P1203, DOI 10.1016/S0891-5849(96)00554-0; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Oltra AM, 2001, FREE RADICAL BIO MED, V30, P1286, DOI 10.1016/S0891-5849(01)00521-4; Paglialunga S, 2007, APPL PHYSIOL NUTR ME, V32, P61, DOI 10.1139/h06-100; Pedro T, 2013, TRANSL RES, V161, P50, DOI 10.1016/j.trsl.2012.09.002; Pou KM, 2007, CIRCULATION, V116, P1234, DOI 10.1161/CIRCULATIONAHA.107.710509; Ruggiero C, 2011, AM J PHYSIOL-ENDOC M, V300, pE1047, DOI 10.1152/ajpendo.00666.2010; Salas-Salvado J, 2011, DIABETES CARE, V34, P14, DOI 10.2337/dc10-1288; Stein DT, 1997, J CLIN INVEST, V100, P398, DOI 10.1172/JCI119546; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; Thomsen C, 1999, AM J CLIN NUTR, V69, P1135; Tsai WC, 2004, CLIN SCI, V106, P315, DOI 10.1042/CS20030227; Vessby B, 2001, DIABETOLOGIA, V44, P312, DOI 10.1007/s001250051620; Vincent HK, 2006, INT J OBESITY, V30, P400, DOI 10.1038/sj.ijo.0803177; Wang XF, 2015, J ENDOCRINOL, V224, pR97, DOI 10.1530/JOE-14-0581; Wassmann S, 2004, HYPERTENSION, V44, P381, DOI 10.1161/01.HYP.0000142232.29764.a7; Weinbrenner T, 2004, J NUTR, V134, P2314, DOI 10.1093/jn/134.9.2314	42	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161400	10.1371/journal.pone.0161400	http://dx.doi.org/10.1371/journal.pone.0161400			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537847	gold, Green Submitted, Green Published			2022-12-26	WOS:000381577000099
J	Tawfik, S; El Koofy, N; Moawad, EMI				Tawfik, Safaa; El Koofy, Nehal; Moawad, Eman Mohamed Ibraheim			Patterns of Nutrition and Dietary Supplements Use in Young Egyptian Athletes: A Community-Based Cross-Sectional Survey	PLOS ONE			English	Article							CREATINE USE; TEAM SPORTS; KNOWLEDGE; ADOLESCENTS; STRENGTH; CHILDREN; COACHES; PLAYERS; DRINKS; NEEDS	The aim of this study was to investigate the pattern of basic and sport nutrition as well as perspectives of young Egyptian athletes. Structured interview survey measuring knowledge, attitudes, beliefs and behaviors about basic and sport nutrition was administered to adolescent athletes recruited from 4 sport clubs and 2 fitness centers in Greater Cairo governorate. A total of 358 participants aged 13-18 years completed questionnaires. Basic nutrition knowledge was reasonable in almost all domains except fast food. Fixed breakfast (78.5%), home meals (lunch, 70.7%), and healthy snacks (55.8%) were the most positive features of the basic dietary pattern. More than 70% perceived themselves as knowledgeable about sport nutrition. The prevalence rate of sport supplement intake was (48.9%, n = 175), predominantly sport drinks (66.9%) and creatine (54.3%). Coaches were the primary source of sport nutrition information. Forty-four percent of participants (n = 77/175) reported supplement consumption during competition seasons only. Better physical appearance and enhancement of athletic performance were the major motivations for supplement intake. These findings indicate the necessity of a comprehensive nutrition education program targeting not only athletes and parents, but also coaching staff, health trainers and all sport team officials.	[Tawfik, Safaa] Minist Hlth Cairo, Natl Inst Nutr, Cairo, Egypt; [El Koofy, Nehal; Moawad, Eman Mohamed Ibraheim] Cairo Univ, Dept Pediat, Fac Med, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Ministry of Health & Population - Egypt; Egyptian Knowledge Bank (EKB); Cairo University	Moawad, EMI (corresponding author), Cairo Univ, Dept Pediat, Fac Med, Cairo, Egypt.	eimanmoawad@yahoo.com						Aljaloud SO, 2013, J NUTR METAB, V2013, DOI 10.1155/2013/245349; [Anonymous], [No title captured]; Braun H, 2009, INT J SPORT NUTR EXE, V19, P97, DOI 10.1123/ijsnem.19.1.97; Buergel NS, 2002, J AM DIET ASSOC, V102, P1283, DOI 10.1016/S0002-8223(02)90282-8; Burkhart SJ, 2009, ANN C NUTR SOC NZ, P45; Calfee R, 2006, PEDIATRICS, V117, pE577, DOI 10.1542/peds.2005-1429; Corrigan B, 2003, CLIN J SPORT MED, V13, P33, DOI 10.1097/00042752-200301000-00007; Croll JK, 2006, J AM DIET ASSOC, V106, P709, DOI 10.1016/j.jada.2006.02.010; Dawson WJ, 2002, MED PROBL PERFORM AR, V17, P50; de Silva A, 2010, INT J SPORT NUTR EXE, V20, P15, DOI 10.1123/ijsnem.20.1.15; Dunford, 2018, NUTR SPORT EXERCISE; Erdman KA, 2007, CLIN J SPORT MED, V17, P458, DOI 10.1097/JSM.0b013e31815aed33; Etchison WC, 2011, SPORTS HEALTH, V3, P249, DOI 10.1177/1941738111404655; Galanti G, 2015, TRANSL MED UNISA, V11, P44; Giannopoulou I, 2013, J SPORT SCI MED, V12, P190; Golshanraz A., 2012, INT J SPORT HLTH SCI, V6, P2480; Grete R.H., 2011, FOOD NUTR SCI, V2011; Hassan-Wassef H, 2004, E MEDITERR HEALTH J, V10, P899; Herbold NH, 2004, INT J SPORT NUTR EXE, V14, P586, DOI 10.1123/ijsnem.14.5.586; HICKSON JF, 1987, J AM DIET ASSOC, V87, P1656; Jacobson BH, 2001, J STRENGTH COND RES, V15, P63; Lachheb M, IDENTITY NATION AFRI, P99; Lazic JS, 2011, SCAND J MED SCI SPOR, V21, P260, DOI 10.1111/j.1600-0838.2009.01026.x; LOOSLI AR, 1990, PEDIATR CLIN N AM, V37, P1143; Metzl JD, 2001, PEDIATRICS, V108, P421, DOI 10.1542/peds.108.2.421; Nazni Peerkhan, 2010, Asian J Sports Med, V1, P93; Nemet Dan, 2007, Harefuah, V146, P794; Nieper A, 2005, BRIT J SPORT MED, V39, P645, DOI 10.1136/bjsm.2004.015842; Parmenter K, 1999, EUR J CLIN NUTR, V53, P298, DOI 10.1038/sj.ejcn.1600726; Petrie HJ, 2004, NUTRITION, V20, P620, DOI 10.1016/j.nut.2004.04.002; Purcell LK, 2013, PAED CHILD HEALT-CAN, V18, P200, DOI 10.1093/pch/18.4.200; Rash C, 2008, SPORT J, V11, P48; Rosenbloom CA, 2002, J AM DIET ASSOC, V102, P418, DOI 10.1016/S0002-8223(02)90098-2; Salamon Lester M, 1998, NONPROFIT SECTOR DEV, V5; Sartorius N., 1994, QUALITY LIFE ASSESSM, P3, DOI [10.1007/978-3-642-79123-9_1, DOI 10.1007/978-3-642-79123-9_1]; Sawka MN, 2007, MED SCI SPORT EXER, V39, P377, DOI 10.1249/mss.0b013e31802ca597; Seifert SM, 2011, PEDIATRICS, V127, P511, DOI 10.1542/peds.2009-3592; Shifflett B, 2002, RES Q EXERCISE SPORT, V73, P357, DOI 10.1080/02701367.2002.10609032; Singhal V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100218; Slater G, 2011, J SPORT SCI, V29, pS67, DOI 10.1080/02640414.2011.574722; Smith JW, 2015, J SPORTS MED, V2015, P1, DOI 10.1155/2015/734649; SOBAL J, 1994, INT J SPORT NUTR, V4, P320, DOI 10.1123/ijsn.4.4.320; Stafford I., 2005, COACHWISE BUSINESS S; Sundgot-Borgen J, 2004, CLIN J SPORT MED, V14, P25, DOI 10.1097/00042752-200401000-00005; Sundgot-Borgen J, 2003, SCAND J MED SCI SPOR, V13, P138, DOI 10.1034/j.1600-0838.2003.10288.x; Torres-McGehee TM, 2012, J ATHL TRAINING, V47, P205; Unnithan VB, 2001, J STRENGTH COND RES, V15, P524; Viell B, 1996, Z ERNAHRUNGSWISS, V35, P378, DOI 10.1007/BF01610556; Walsh M, 2011, INT J SPORT NUTR EXE, V21, P365, DOI 10.1123/ijsnem.21.5.365; Zinn C, 2005, J SCI MED SPORT, V8, P346, DOI 10.1016/S1440-2440(05)80045-3	50	25	26	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161252	10.1371/journal.pone.0161252	http://dx.doi.org/10.1371/journal.pone.0161252			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529492	Green Published, gold, Green Submitted			2022-12-26	WOS:000381476700059
J	Wei, Y; Xu, J; Zhou, GQ; Chen, SW; Ouyang, P; Liu, SW				Wei, Yong; Xu, Juan; Zhou, Genqing; Chen, Songwen; Ouyang, Ping; Liu, Shaowen			Renal Denervation Suppresses the Inducibility of Atrial Fibrillation in a Rabbit Model for Atrial Fibrosis	PLOS ONE			English	Article							SYMPATHETIC DENERVATION; NERVE ACTIVITY; MECHANISMS; SYSTEM; IMPACT	Renal denervation (RD) was reported to reduce the susceptibility of atrial fibrillation (AF), but the underlying mechanism has not been well understood. This study was performed to investigate the effect of RD on the inducibility of AF in a rabbit model for atrial fibrosis and to explore the potential mechanisms. Thirty-five rabbits were randomly assigned into sham-operated group (n = 12), abdominal aortic constriction (AAC) group (n = 12) and AAC with RD (AAC-RD) group (n = 11). The incidence of AF induced by burst pacing in atriums was determined. Blood was collected to measure the levels of rennin, angiotensin II and aldosterone. Atrial samples were preserved to evaluate protein and gene expression of collagen, connective tissue growth factor (CTGF) and transforming growth factor-beta 1 (TGF-beta 1). Our data suggested cardiac structure remodeling and atrial fibrosis were successfully induced by AAC. Compared with the AAC group, the AAC-RD rabbits had smaller ascending aortic diameter and left ventricular end-systolic diameter. For burst pacing at the left atrium (LA), AF was induced in two of the 12 rabbits in the sham-operated group, 10 of the 12 rabbits in the AAC group, and 2 of the 11 rabbits in the AAC-RD group, with great difference among the three groups (P = 0.001). The percentage of LA burst stimulations with induced AF achieved 47.2% in the AAC group, which was higher than those in both the AAC-RD (12.1%) and the Sham-operated (5.6%) groups. Significantly increasing intercellular space in the AAC group (P<0.001) compared with the sham-operated rabbits. RD clearly decreased the volume fraction of collagen in LA and right atrium compared with that of the AAC group (P<0.01). AAC-induced elevation of collagen I, CTGF and TGF-beta 1 was suppressed by RD. In conclusion, RD suppressed the inducibility of AF in a rabbit model for pressure associated atrial fibrosis, potentially by modulating renin-angiotensin-aldosterone system and decreasing pro-fibrotic factors.	[Wei, Yong; Ouyang, Ping] Shanghai Songjiang Cent Hosp, Dept Cardiol, Shanghai 201600, Peoples R China; [Wei, Yong; Xu, Juan; Zhou, Genqing; Chen, Songwen; Liu, Shaowen] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Cardiol, Shanghai 200800, Peoples R China	Shanghai Jiao Tong University	Liu, SW (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Cardiol, Shanghai 200800, Peoples R China.	shaowen.liu@hotmail.com	Liu, Shaowen/AAJ-4121-2020; Chen, Songwen/AAI-4389-2020	Chen, Songwen/0000-0002-6492-5702; Zhou, Genqing/0000-0003-4506-7658	Youth Project of the National Natural Science Fund of China [81300137, 81400245]; Shanghai Municipal Commission of Health and Family Planning [20134Y182]	Youth Project of the National Natural Science Fund of China; Shanghai Municipal Commission of Health and Family Planning	This work was supported by Youth Project of the National Natural Science Fund of China (grant number 81300137 and 81400245) and a grant from Shanghai Municipal Commission of Health and Family Planning (grant number: 20134Y182).	Anand K, 2006, AM HEART J, V152, P217, DOI 10.1016/j.ahj.2006.01.007; Bakris GL, 2014, J AM COLL CARDIOL, V64, P1071, DOI 10.1016/j.jacc.2014.05.012; Bhatt DL, 2014, NEW ENGL J MED, V370, P1393, DOI 10.1056/NEJMoa1402670; Booth LC, 2012, AM J PHYSIOL-REG I, V303, pR30, DOI 10.1152/ajpregu.00063.2012; de Vos CB, 2008, EUR HEART J, V29, P632, DOI 10.1093/eurheartj/ehn025; Dias LD, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-33; Doltra A, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001353; Ducharme A, 2006, AM HEART J, V152, P86, DOI 10.1016/j.ahj.2005.06.036; Dzeshka MS, 2015, J AM COLL CARDIOL, V66, P943, DOI 10.1016/j.jacc.2015.06.1313; Esler MD, 2012, CIRCULATION, V126, P2976, DOI 10.1161/CIRCULATIONAHA.112.130880; Krum H, 2014, LANCET, V383, P622, DOI 10.1016/S0140-6736(13)62192-3; Krum H, 2009, LANCET, V373, P1275, DOI 10.1016/S0140-6736(09)60566-3; Levy S, 2006, NAT CLIN PRACT CARD, V3, P220, DOI 10.1038/ncpcardio0480; Liang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105974; Linz D, 2015, CIRC-ARRHYTHMIA ELEC, V8, P466, DOI 10.1161/CIRCEP.114.002453; Linz D, 2012, HYPERTENSION, V60, P172, DOI 10.1161/HYPERTENSIONAHA.112.191965; Ogawa M, 2007, J AM COLL CARDIOL, V50, P335, DOI 10.1016/j.jacc.2007.03.045; Patel BM, 2012, EUR J PHARMACOL, V697, P1, DOI 10.1016/j.ejphar.2012.09.034; Pokushalov E, 2012, J AM COLL CARDIOL, V60, P1163, DOI 10.1016/j.jacc.2012.05.036; Redpath CJ, 2006, J MOL CELL CARDIOL, V40, P717, DOI 10.1016/j.yjmcc.2006.01.012; Sadowski J, 2011, HYPERTENSION, V57, P911, DOI 10.1161/HYPERTENSIONAHA.110.163014; Schotten U, 2011, PHYSIOL REV, V91, P265, DOI 10.1152/physrev.00031.2009; Sobotka PA, 2011, CLIN RES CARDIOL, V100, P1049, DOI 10.1007/s00392-011-0335-y; Takahashi N, 2012, CIRC J, V76, P2318, DOI 10.1253/circj.CJ-12-1099; Tan AY, 2008, CIRCULATION, V118, P916, DOI 10.1161/CIRCULATIONAHA.108.776203; Wang XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064611; Watanabe H, 2016, HYPERTENS RES, V39, P217, DOI 10.1038/hr.2015.133; Witkowski A, 2011, HYPERTENSION, V58, P559, DOI 10.1161/HYPERTENSIONAHA.111.173799; Zhao QY, 2012, J INTERV CARD ELECTR, V35, P119, DOI 10.1007/s10840-012-9717-y	29	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160634	10.1371/journal.pone.0160634	http://dx.doi.org/10.1371/journal.pone.0160634			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529427	Green Submitted, Green Published, gold			2022-12-26	WOS:000381476700013
J	Kalbitz, M; Fattahi, F; Grailer, JJ; Jajou, L; Malan, EA; Zetoune, FS; Huber-Lang, M; Russell, MW; Ward, PA				Kalbitz, Miriam; Fattahi, Fatemeh; Grailer, Jamison J.; Jajou, Lawrence; Malan, Elizabeth A.; Zetoune, Firas S.; Huber-Lang, Markus; Russell, Mark W.; Ward, Peter A.			Complement-induced activation of the cardiac NLRP3 inflammasome in sepsis	FASEB JOURNAL			English	Article						C5a; C5a receptors; IL-1 beta; CLP	ACUTE MYOCARDIAL-INFARCTION; NADPH OXIDASE; CECAL LIGATION; TNF-ALPHA; C5A; IL-1-BETA; INTERLEUKIN-1-BETA; PROMOTES; RELEASE; PROTEIN	Cardiac dysfunction develops during sepsis in humans and rodents. In the model of polymicrobial sepsis induced by cecal ligation and puncture (CLP), we investigated the role of the NLRP3 inflammasome in the heart. Mouse heart homogenates from sham-procedure mice contained high mRNA levels of NLRP3 and IL-1 beta. Using the inflammasome protocol, exposure of cardiomyocytes (CMs) to LPS followed by ATP or nigericin caused release of mature IL-1b. Immunostaining of left ventricular frozen sections before and 8 h after CLP revealed the presence of NLRP3 and IL-1b proteins in CMs. CLP caused substantial increases in mRNAs for IL-1 beta and NLRP3 in CMs which are reduced in the absence of either C5aR1 or C5aR2. After CLP, NLRP3(-/-) mice showed reduced plasma levels of IL-1 beta and IL-6. In vitro exposure of wild-type CMs to recombinant C5a (rC5a) caused elevations in both cytosolic and nuclear/mitochondrial reactive oxygen species (ROS), which were C5a-receptor dependent. Use of a selective NOX2 inhibitor prevented increased cytosolic and nuclear/mitochondrial ROS levels and release of IL-1 beta. Finally, NLRP3(-/-) mice had reduced defects in echo/Doppler parameters in heart after CLP. These studies establish that the NLRP3 inflammasome contributes to the cardiomyopathy of polymicrobial sepsis.-Kalbitz, M., Fattahi, F., Grailer, J. J., Jajou, L., Malan, E. A., Zetoune, F. S., Huber-Lang, M., Russell, M. W., Ward, P. A. Complement-induced activation of the cardiac NLRP3 inflammasome in sepsis.	[Kalbitz, Miriam; Fattahi, Fatemeh; Grailer, Jamison J.; Jajou, Lawrence; Malan, Elizabeth A.; Zetoune, Firas S.; Ward, Peter A.] Univ Michigan, Sch Med, Dept Pathol, 1301 Catherine Rd,7520 MSRB 1,Box 5602, Ann Arbor, MI 48109 USA; [Russell, Mark W.] Univ Michigan, Sch Med, Dept Pediat Cardiol, Ann Arbor, MI USA; [Kalbitz, Miriam; Huber-Lang, Markus] Univ Hosp Ulm, Dept Orthopaed Trauma Hand Plast & Reconstruct Su, Ulm, Germany	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Ulm University	Ward, PA (corresponding author), Univ Michigan, Sch Med, Dept Pathol, 1301 Catherine Rd,7520 MSRB 1,Box 5602, Ann Arbor, MI 48109 USA.	pward@umich.edu	Huber-Lang, Markus/AAJ-2209-2020		U.S. National Institutes of Health (NIH), Institute of General Medical Sciences [GM-29507, GM-61656]; NIH National Heart, Lung and Blood Institute Grant [T32-HL007517]; Deutsche Forschungsgemeinschaft Fellowship Project [KA 3740]; Endowment for the Basic Sciences; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029507, R01GM061656, R37GM029507] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH), Institute of General Medical Sciences; NIH National Heart, Lung and Blood Institute Grant; Deutsche Forschungsgemeinschaft Fellowship Project(German Research Foundation (DFG)); Endowment for the Basic Sciences; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Sue Scott and Michelle Possley (University of Michigan) for excellent assistance in the preparation of the manuscript; Peter Radermacher and Enrico Calcia (University of Ulm) for helpful suggestions; Kimber Converso-Baran, research sonographer and echocardiographic specialist (University of Michigan), for excellent services; and the Microscopy and Image-Analysis Laboratory, the Department of Pathology Flow Cytometry Core Facility, and the Department of Cell and Developmental Biology (University of Michigan Medical School) for the use of their facilities. Funding was received from The Endowment for the Basic Sciences. This study was supported by grants from the U.S. National Institutes of Health (NIH), Institute of General Medical Sciences Grants GM-29507 and GM-61656 (to P.A.W.), NIH National Heart, Lung and Blood Institute Grant T32-HL007517 (to J.J.G.), and Deutsche Forschungsgemeinschaft Fellowship Project KA 3740. The authors are responsible for the contents of this publication. The authors declare no conflicts of interest.	Abbate A, 2010, EUR J HEART FAIL, V12, P319, DOI 10.1093/eurjhf/hfq017; Asgari E, 2013, BLOOD, V122, P3473, DOI 10.1182/blood-2013-05-502229; Atefi G, 2011, FASEB J, V25, P2500, DOI 10.1096/fj.11-183236; Bae JY, 2011, J BIOL CHEM, V286, P39528, DOI 10.1074/jbc.M111.278812; BAKER CC, 1983, SURGERY, V94, P331; Boluyt MO, 2004, J APPL PHYSIOL, V96, P822, DOI 10.1152/japplphysiol.01026.2003; Boyd JH, 2006, CARDIOVASC RES, V72, P384, DOI 10.1016/j.cardiores.2006.09.011; Bracey NA, 2014, J BIOL CHEM, V289, P19571, DOI 10.1074/jbc.M114.550624; Bracey NA, 2013, EXP PHYSIOL, V98, P462, DOI 10.1113/expphysiol.2012.068338; Brandstetter C, 2015, J BIOL CHEM, V290, P31189, DOI 10.1074/jbc.M115.671180; Bulua AC, 2011, J EXP MED, V208, P519, DOI 10.1084/jem.20102049; Cave A, 2005, PHILOS T R SOC B, V360, P2327, DOI 10.1098/rstb.2005.1772; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Dikalov S, 2011, FREE RADICAL BIO MED, V51, P1289, DOI 10.1016/j.freeradbiomed.2011.06.033; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Fato R, 2009, BBA-BIOENERGETICS, V1787, P384, DOI 10.1016/j.bbabio.2008.11.003; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Gerard NP, 2005, J BIOL CHEM, V280, P39677, DOI 10.1074/jbc.C500287200; Goldhaber JI, 1996, AM J PHYSIOL-HEART C, V271, pH1449, DOI 10.1152/ajpheart.1996.271.4.H1449; Hingtgen SD, 2006, PHYSIOL GENOMICS, V26, P180, DOI 10.1152/physiolgenomics.00029.2005; Hoesel LM, 2007, J IMMUNOL, V178, P7902, DOI 10.4049/jimmunol.178.12.7902; Hopken UE, 1996, NATURE, V383, P86, DOI 10.1038/383086a0; Huber-Lang M, 2001, J IMMUNOL, V166, P1193, DOI 10.4049/jimmunol.166.2.1193; Hwang MW, 2001, J AM COLL CARDIOL, V38, P1546, DOI 10.1016/S0735-1097(01)01591-1; Kaestner L, 2009, JOVE-J VIS EXP, V31, P1433; Kalbitz M, 2016, J IMMUNOL, V197, P2353, DOI 10.4049/jimmunol.1600091; Kalbitz M, 2015, FASEB J, V29, P2185, DOI 10.1096/fj.14-268730; Kawaguchi M, 2011, CIRCULATION, V123, P594, DOI 10.1161/CIRCULATIONAHA.110.982777; Khan SA, 2011, ANTIOXID REDOX SIGN, V14, P533, DOI 10.1089/ars.2010.3213; Kim S, 2010, EUR J IMMUNOL, V40, P1545, DOI 10.1002/eji.201040425; Lacroix-Lamande S, 2012, J IMMUNOL, V188, P2805, DOI 10.4049/jimmunol.1101987; Laudisi F, 2013, J IMMUNOL, V191, P1006, DOI 10.4049/jimmunol.1300489; Louch WE, 2011, J MOL CELL CARDIOL, V51, P288, DOI 10.1016/j.yjmcc.2011.06.012; Maass DL, 2002, SHOCK, V18, P360, DOI 10.1097/00024382-200210000-00012; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Mezzaroma E, 2011, P NATL ACAD SCI USA, V108, P19725, DOI 10.1073/pnas.1108586108; Munoz-Planillo R, 2009, J IMMUNOL, V183, P3942, DOI 10.4049/jimmunol.0900729; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Niederbichler AD, 2006, J EXP MED, V203, P53, DOI 10.1084/jem.20051207; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Pomerantz BJ, 2001, P NATL ACAD SCI USA, V98, P2871, DOI 10.1073/pnas.041611398; Rittirsch D, 2008, NAT MED, V14, P551, DOI 10.1038/nm1753; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Sadek HA, 2004, BIOCHEMISTRY-US, V43, P8494, DOI 10.1021/bi049803f; Samstad EO, 2014, J IMMUNOL, V192, P2837, DOI 10.4049/jimmunol.1302484; Sandanger O, 2013, CARDIOVASC RES, V99, P164, DOI 10.1093/cvr/cvt091; Stutz A, 2009, J CLIN INVEST, V119, P3502, DOI 10.1172/JCI40599; Suzuki K, 2001, CIRCULATION, V104, pI308; Triantafilou K, 2013, J CELL SCI, V126, P2903, DOI 10.1242/jcs.124388; Wang Y, 2014, AM J PHYSIOL-HEART C, V307, pH1438, DOI 10.1152/ajpheart.00441.2014; Ward PA, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/427607; Witzenrath M, 2011, J IMMUNOL, V187, P434, DOI 10.4049/jimmunol.1003143; Xiang M, 2011, J IMMUNOL, V187, P4809, DOI 10.4049/jimmunol.1102093; Zhang WB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107639; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	56	71	75	2	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					3997	4006		10.1096/fj.201600728R	http://dx.doi.org/10.1096/fj.201600728R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27543123	Green Published, Green Submitted			2022-12-26	WOS:000388201500008
J	Walliser, C; Hermkes, E; Schade, A; Wiese, S; Deinzer, J; Zapatka, M; Desire, L; Mertens, D; Stilgenbauer, S; Gierschik, P				Walliser, Claudia; Hermkes, Elisabeth; Schade, Anja; Wiese, Sebastian; Deinzer, Julia; Zapatka, Marc; Desire, Laurent; Mertens, Daniel; Stilgenbauer, Stephan; Gierschik, Peter			The Phospholipase C gamma(2) Mutants R665W and L845F Identified in Ibrutinib-resistant Chronic Lymphocytic Leukemia Patients Are Hypersensitive to the Rho GTPase Rac2 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						leukemia; lymphoma; phosphatidylinositol signaling; phospholipase C; Rac (Rac GTPase); chronic lymphocytic leukemia; ibrutinib resistance; leukemia	BRUTONS TYROSINE KINASE; SMALL-MOLECULE INHIBITOR; FAMILY SMALL GTPASES; B-CELL ACTIVATION; ANTIGEN RECEPTOR; IN-VITRO; VAV; STIMULATION; DISEASE; BTK	Mutations in the gene encoding phospholipase C-(2) (PLC2) have been shown to be associated with resistance to targeted therapy of chronic lymphocytic leukemia (CLL) with the Bruton's tyrosine kinase inhibitor ibrutinib. The fact that two of these mutations, R665W and L845F, imparted upon PLC2 an approximate to 2-3-fold ibrutinib-insensitive increase in the concentration of cytosolic Ca2+ following ligation of the B cell antigen receptor (BCR) led to the assumption that the two mutants exhibit constitutively enhanced intrinsic activity. Here, we show that the two PLC2 mutants are strikingly hypersensitive to activation by Rac2 such that even wild-type Rac2 suffices to activate the mutant enzymes upon its introduction into intact cells. Enhanced basal activity of PLC2 in intact cells is shown using the pharmacologic Rac inhibitor EHT 1864 and the PLC2F897Q mutation mediating Rac resistance to be caused by Rac-stimulated rather than by constitutively enhanced PLC2 activity. We suggest that R665W and L845F be referred to as allomorphic rather than hypermorphic mutations of PLCG2. Rerouting of the transmembrane signals emanating from BCR and converging on PLC2 through Rac in ibrutinib-resistant CLL cells may provide novel drug treatment strategies to overcome ibrutinib resistance mediated by PLCG2 mutations or to prevent its development in ibrutinib-treated CLL patients.	[Walliser, Claudia; Hermkes, Elisabeth; Schade, Anja; Deinzer, Julia; Gierschik, Peter] Univ Ulm, Med Ctr, Inst Pharmacol & Toxicol, D-89070 Ulm, Germany; [Mertens, Daniel; Stilgenbauer, Stephan] Univ Ulm, Med Ctr, Dept Internal Med 3, D-89070 Ulm, Germany; [Wiese, Sebastian] Univ Ulm, Fac Med, Core Unit Mass Spectrometry & Prote, D-89081 Ulm, Germany; [Zapatka, Marc] German Canc Res Ctr, Div Mol Genet, D-69121 Heidelberg, Germany; [Desire, Laurent] Diaxonhit, 63-65 Blvd Massena, F-75013 Paris, France	Ulm University; Ulm University; Ulm University; Helmholtz Association; German Cancer Research Center (DKFZ)	Gierschik, P (corresponding author), Univ Ulm, Med Ctr, Inst Pharmacol & Toxicol, Albert Einstein Allee 11, D-89081 Ulm, Germany.	peter.gierschik@uni-ulm.de	Mertens, Daniel/F-4681-2011; Zapatka, Marc/G-9896-2013; Stilgenbauer, Stephan/ABE-6609-2020	Mertens, Daniel/0000-0003-0227-7188; Zapatka, Marc/0000-0001-8287-5967; 	Deutsche Forschungsgemeinschaft [SFB 1074]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Grant SFB 1074, TP A8 from the Deutsche Forschungsgemeinschaft. The authors declare that they have no conflicts of interest with the contents of this article.	Arana E, 2008, IMMUNITY, V28, P88, DOI 10.1016/j.immuni.2007.12.003; Bertrand L., 2004, Patent No. [WO2004076445A2, 2004076445]; Bunney TD, 2012, STRUCTURE, V20, P2062, DOI 10.1016/j.str.2012.09.005; Burger JA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11589; CAMPS M, 1990, BIOCHEM J, V271, P743, DOI 10.1042/bj2710743; Chakraborty R, 2015, EXPERT REV HEMATOL, V8, P569, DOI 10.1586/17474086.2015.1061427; Chrencik JE, 2008, J MOL BIOL, V380, P828, DOI 10.1016/j.jmb.2008.05.024; Cook DR, 2014, ONCOGENE, V33, P4021, DOI 10.1038/onc.2013.362; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cramer P, 2016, EUR J HAEMATOL, V96, P9, DOI 10.1111/ejh.12678; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; de Claro RA, 2015, CLIN CANCER RES, V21, P3586, DOI 10.1158/1078-0432.CCR-14-2225; de Gorter DJJ, 2007, IMMUNITY, V26, P93, DOI 10.1016/j.immuni.2006.11.012; Deckert M, 1996, IMMUNITY, V5, P591, DOI 10.1016/S1074-7613(00)80273-3; Desire L, 2005, J BIOL CHEM, V280, P37516, DOI 10.1074/jbc.M507913200; Duhren-von Minden M, 2012, NATURE, V489, P309, DOI 10.1038/nature11309; Everett KL, 2011, MOL CELL BIOL, V31, P1240, DOI 10.1128/MCB.01408-10; Everett KL, 2009, J BIOL CHEM, V284, P23083, DOI 10.1074/jbc.M109.019265; Fu C, 1998, IMMUNITY, V9, P93, DOI 10.1016/S1074-7613(00)80591-9; Fujikawa K, 2003, J EXP MED, V198, P1595, DOI 10.1084/jem.20030874; Ghia P, 2008, J INTERN MED, V264, P549, DOI 10.1111/j.1365-2796.2008.02030.x; Guinamard R, 1997, SCAND J IMMUNOL, V45, P587, DOI 10.1046/j.1365-3083.1997.d01-447.x; GUTIERREZ L, 1989, EMBO J, V8, P1093, DOI 10.1002/j.1460-2075.1989.tb03478.x; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Hendriks RW, 2006, SEMIN IMMUNOL, V18, P67, DOI 10.1016/j.smim.2005.10.002; Hewamana S, 2008, BLOOD, V111, P4681, DOI 10.1182/blood-2007-11-125278; Hicks SN, 2008, MOL CELL, V31, P383, DOI 10.1016/j.molcel.2008.06.018; Hikida M, 2005, ADV IMMUNOL, V88, P73, DOI 10.1016/S0065-2776(05)88003-4; Honigberg LA, 2010, P NATL ACAD SCI USA, V107, P13075, DOI 10.1073/pnas.1004594107; Illenberger D, 2000, METHOD ENZYMOL, V325, P167; Ito M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8360; Jumaa H, 2005, ANNU REV IMMUNOL, V23, P415, DOI 10.1146/annurev.immunol.23.021704.115606; Kadamur G, 2013, ANNU REV PHYSIOL, V75, P127, DOI 10.1146/annurev-physiol-030212-183750; Kokhaei P, 2016, J DRUG TARGET, V24, P373, DOI 10.3109/1061186X.2015.1086357; Komarova NL, 2014, P NATL ACAD SCI USA, V111, P13906, DOI 10.1073/pnas.1409362111; Kulathu Y, 2009, IMMUNOL REV, V232, P286, DOI 10.1111/j.1600-065X.2009.00837.x; Liu TM, 2015, BLOOD, V126, P61, DOI 10.1182/blood-2015-02-626846; Maddocks KJ, 2015, JAMA ONCOL, V1, P80, DOI 10.1001/jamaoncol.2014.218; Mancini M, 2016, SEMIN CELL DEV BIOL, V50, P164, DOI 10.1016/j.semcdb.2015.09.018; Matsuda M, 2001, J CELL BIOL, V153, P599, DOI 10.1083/jcb.153.3.599; Meyer S. L., 1975, DATA ANAL SCI ENG, P39; Montresor A, 2015, ONCOTARGET, V6, P34245, DOI 10.18632/oncotarget.5196; Muzio M, 2008, BLOOD, V112, P188, DOI 10.1182/blood-2007-09-111344; O'Rourke LM, 1998, IMMUNITY, V8, P635, DOI 10.1016/S1074-7613(00)80568-3; Onesto C, 2008, METHOD ENZYMOL, V439, P111, DOI 10.1016/S0076-6879(07)00409-0; Packard Thomas A, 2013, F1000Prime Rep, V5, P40, DOI 10.12703/P5-40; Piechulek T, 2005, J BIOL CHEM, V280, P38923, DOI 10.1074/jbc.M509396200; Rawlings DJ, 2012, NAT REV IMMUNOL, V12, P282, DOI 10.1038/nri3190; Shinohara M, 2014, BONE, V60, P8, DOI 10.1016/j.bone.2013.11.025; Shirakawa AK, 2010, CELL MOL IMMUNOL, V7, P428, DOI 10.1038/cmi.2010.46; Shutes A, 2007, J BIOL CHEM, V282, P35666, DOI 10.1074/jbc.M703571200; Stamatopoulos B, 2012, HAEMATOL-HEMATOL J, V97, P608, DOI 10.3324/haematol.2011.052779; Stamatopoulos K, 2007, BLOOD, V109, P259, DOI 10.1182/blood-2006-03-012948; Stevenson FK, 2011, BLOOD, V118, P4313, DOI 10.1182/blood-2011-06-338855; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; Takata M, 1996, J EXP MED, V184, P31, DOI 10.1084/jem.184.1.31; Tedder TF, 2010, J IMMUNOL, V184, P2231, DOI 10.4049/jimmunol.1090001; ten Hacken E, 2016, BBA-MOL CELL RES, V1863, P401, DOI 10.1016/j.bbamcr.2015.07.009; Walliser C, 2008, J BIOL CHEM, V283, P30351, DOI 10.1074/jbc.M803316200; Walliser C, 2015, J BIOL CHEM, V290, P17056, DOI 10.1074/jbc.M115.645739; Weber M, 2008, J EXP MED, V205, P853, DOI 10.1084/jem.20072619; Wienands J, 1998, J EXP MED, V188, P791, DOI 10.1084/jem.188.4.791; WILKIE AOM, 1994, J MED GENET, V31, P89, DOI 10.1136/jmg.31.2.89; Wilson WH, 2015, NAT MED, V21, P922, DOI 10.1038/nm.3884; Woyach JA, 2014, NEW ENGL J MED, V370, P2286, DOI 10.1056/NEJMoa1400029; Zheng H, 2009, AM J PHYSIOL-CELL PH, V297, pC188, DOI 10.1152/ajpcell.00052.2009; Zhou Q, 2012, AM J HUM GENET, V91, P713, DOI 10.1016/j.ajhg.2012.08.006	68	31	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22136	22148		10.1074/jbc.M116.746842	http://dx.doi.org/10.1074/jbc.M116.746842			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27542411	Green Published, hybrid			2022-12-26	WOS:000386332600027
J	Luo, RB; Chen, PW; Wagenbach, M; Jian, XY; Jenkins, L; Wordeman, L; Randazzo, PA				Luo, Ruibai; Chen, Pei-Wen; Wagenbach, Michael; Jian, Xiaoying; Jenkins, Lisa; Wordeman, Linda; Randazzo, Paul A.			Direct Functional Interaction of the Kinesin-13 Family Membrane Kinesin-like Protein 2A (Kif2A) and Arf GAP with GTP-binding Protein-like, Ankyrin Repeats and PH Domains1 (AGAP1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADP ribosylation factor (ARF); cell biology; enzyme; GTPase activating protein (GAP); kinesin; protein complex; small GTPase; AGAP1; Kif2A; kinesin-13; Arf GTPase-activating protein; PH domain	ADP-RIBOSYLATION FACTOR; FOCAL ADHESION KINASE; ACTIVATING PROTEIN; ACTIN CYTOSKELETON; MCAK; NOMENCLATURE; HYDROLYSIS; REGULATORS; TRANSPORT; DYNAMICS	The molecular basis for control of the cytoskeleton by the Arf GTPase-activating protein AGAP1 has not been characterized. AGAP1 is composed of G-protein-like (GLD), pleckstrin homology (PH), Arf GAP, and ankyrin repeat domains. Kif2A was identified in screens for proteins that bind to AGAP1. The GLD and PH domains of AGAP1 bound the motor domain of Kif2A. Kif2A increased GAP activity of AGAP1, and a protein composed of the GLD and PH domains of AGAP1 increased ATPase activity of Kif2A. Knockdown (KD) of Kif2A or AGAP1 slowed cell migration and accelerated cell spreading. The effect of Kif2A KD on spreading could be rescued by expression of Kif2A-GFP or FLAG-AGAP1, but not by Kif2C-GFP. The effect of AGAP1 KD could be rescued by FLAG-AGAP1, but not by an AGAP1 mutant that did not bind Kif2A efficiently, ArfGAP1-HA or Kif2A-GFP. Taken together, the results support the hypothesis that the Kif2AAGAP1 complex contributes to control of cytoskeleton remodeling involved in cell movement.	[Luo, Ruibai; Chen, Pei-Wen; Jian, Xiaoying; Randazzo, Paul A.] NCI, Lab Cellular & Mol Biol, NIH, Bethesda, MD 20892 USA; [Jenkins, Lisa] NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; [Chen, Pei-Wen] Grinnell Coll, Dept Biol, Grinnell, IA 50112 USA; [Wagenbach, Michael; Wordeman, Linda] Univ Washington, Dept Physiol & Biophys, Sch Med, Seattle, WA 98195 USA; [Chen, Pei-Wen] Williams Coll, Williamstown, MA 01267 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Washington; University of Washington Seattle; Williams College	Randazzo, PA (corresponding author), NCI, Lab Cellular & Mol Biol, NIH, Bethesda, MD 20892 USA.	randazzp@mail.nih.gov	Jenkins, Lisa/AAI-2490-2021	Wordeman, Linda/0000-0002-9444-0650	intramural program of the National Cancer Institute [BC007365]; National Institute of General Medical Sciences [GM069429]; NATIONAL CANCER INSTITUTE [Z01BC007365, ZICBC011430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069429] Funding Source: NIH RePORTER	intramural program of the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the intramural program of the National Cancer Institute (Project BC007365) and by the National Institute of General Medical Sciences (Grant GM069429) (to L. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; Bendor J, 2010, EMBO J, V29, P2813, DOI 10.1038/emboj.2010.154; Bornens M, 2008, NAT REV MOL CELL BIO, V9, P874, DOI 10.1038/nrm2524; Brown MT, 1998, MOL CELL BIOL, V18, P7038, DOI 10.1128/MCB.18.12.7038; Domnitz SB, 2012, J CELL BIOL, V197, P231, DOI 10.1083/jcb.201108147; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Drum BML, 2016, J MOL CELL CARDIOL, V93, P32, DOI 10.1016/j.yjmcc.2016.02.012; East MP, 2011, SEMIN CELL DEV BIOL, V22, P3, DOI 10.1016/j.semcdb.2010.07.002; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Ginkel LM, 2000, MOL BIOL CELL, V11, P4143, DOI 10.1091/mbc.11.12.4143; Gouveia SM, 2010, CURR BIOL, V20, P1717, DOI 10.1016/j.cub.2010.08.020; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Hirokawa N, 2004, EXP CELL RES, V301, P50, DOI 10.1016/j.yexcr.2004.08.010; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Homma N, 2003, CELL, V114, P229, DOI 10.1016/S0092-8674(03)00522-1; Hood EA, 2012, MOL BIOL CELL, V23, P2264, DOI 10.1091/mbc.E11-12-1013; Inoue H, 2007, TRAFFIC, V8, P1465, DOI 10.1111/j.1600-0854.2007.00624.x; Jackson TR, 2000, J CELL BIOL, V151, P627, DOI 10.1083/jcb.151.3.627; James P, 1996, GENETICS, V144, P1425; Jian XY, 2009, J BIOL CHEM, V284, P1652, DOI 10.1074/jbc.M804218200; Kahn RA, 2006, J CELL BIOL, V172, P645, DOI 10.1083/jcb.200512057; Kahn RA, 2008, J CELL BIOL, V182, P1039, DOI 10.1083/jcb.200806041; Knowlton AL, 2009, CURR BIOL, V19, P758, DOI 10.1016/j.cub.2009.03.018; Luo RB, 2007, BIOCHEM J, V402, P439, DOI 10.1042/BJ20061217; Luo RB, 2012, J BIOL CHEM, V287, P17176, DOI 10.1074/jbc.M111.334458; Mennella V, 2005, NAT CELL BIOL, V7, P235, DOI 10.1038/ncb1222; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Miura K, 2002, MOL CELL, V9, P109, DOI 10.1016/S1097-2765(02)00428-8; Moore AT, 2005, J CELL BIOL, V169, P391, DOI 10.1083/jcb.200411089; Nie ZZ, 2006, CURR BIOL, V16, P130, DOI 10.1016/j.cub.2005.11.069; Nie ZZ, 2003, DEV CELL, V5, P513, DOI 10.1016/S1534-5807(03)00234-X; Nie ZZ, 2002, J BIOL CHEM, V277, P48965, DOI 10.1074/jbc.M202969200; RANDAZZO PA, 1994, J BIOL CHEM, V269, P10758; Randazzo PA, 2007, BIOL CELL, V99, P583, DOI 10.1042/BC20070034; Santama N, 1998, EMBO J, V17, P5855, DOI 10.1093/emboj/17.20.5855; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Walczak CE, 2013, ANNU REV CELL DEV BI, V29, P417, DOI 10.1146/annurev-cellbio-101512-122345; Wang CQ, 2010, ORAL ONCOL, V46, P65, DOI 10.1016/j.oraloncology.2009.11.003; Wang JL, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-461; Wu YJ, 2013, BIOCHEM J, V452, P411, DOI 10.1042/BJ20121004; Zaganjor E, 2014, ONCOGENE, V33, P5457, DOI 10.1038/onc.2013.486; Zhu YJ, 2009, J BIOL CHEM, V284, P13489, DOI 10.1074/jbc.M900469200	43	4	5	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21350	21362		10.1074/jbc.M116.732479	http://dx.doi.org/10.1074/jbc.M116.732479			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27531749	Green Published, hybrid			2022-12-26	WOS:000385999200002
J	Ovchinnikova, OG; Doyle, L; Huang, BS; Kimber, MS; Lowary, TL; Whitfield, C				Ovchinnikova, Olga G.; Doyle, Liam; Huang, Bo-Shun; Kimber, Matthew S.; Lowary, Todd L.; Whitfield, Chris			Biochemical Characterization of Bifunctional 3-Deoxy--d-manno-oct-2-ulosonic Acid (-Kdo) Transferase KpsC from Escherichia coli Involved in Capsule Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell surface; Escherichia coli (E; coli); glycoconjugate; glycolipid structure; glycosyltransferase; gram-negative bacteria; oligosaccharide; Kdo; capsular polysaccharide	TRANSPORTER-DEPENDENT PATHWAYS; POLYSACCHARIDES; GLYCOSYLTRANSFERASES; LIPOPOLYSACCHARIDE	3-Deoxy-d-manno-oct-2-ulosonic acid (Kdo) is an essential component of bacterial lipopolysaccharides, where it provides the linkage between lipid and carbohydrate moieties. In all known LPS structures, Kdo residues possess -anomeric configurations, and the corresponding inverting -Kdo transferases are well characterized. Recently, it has been shown that a large group of capsular polysaccharides from Gram-negative bacteria, produced by ATP-binding cassette transporter-dependent pathways, are also attached to a lipid anchor through a conserved Kdo oligosaccharide. In the study reported here, the structure of this Kdo linker was determined by NMR spectroscopy, revealing alternating -(24)- and -(27)-linked Kdo residues. KpsC contains two retaining -Kdo glycosyltransferase domains belonging to family GT99 that are responsible for polymerizing the -Kdo linker on its glycolipid acceptor. Full-length Escherichia coli KpsC was expressed and purified, together with the isolated N-terminal domain and a mutant protein (KpsC D160A) containing a catalytically inactivated N-terminal domain. The Kdo transferase activities of these proteins were determined in vitro using synthetic acceptors, and the reaction products were characterized using TLC, mass spectrometry, and NMR spectroscopy. The N- and C-terminal domains were found to catalyze formation of -(24) and -(27) linkages, respectively. Based on phylogenetic analyses, we propose the linkage specificities of the glycosyltransferase domains are conserved in KpsC homologs from other bacterial species.	[Ovchinnikova, Olga G.; Doyle, Liam; Kimber, Matthew S.; Whitfield, Chris] Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd East, Guelph, ON N1G 2W1, Canada; [Huang, Bo-Shun; Lowary, Todd L.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada; [Huang, Bo-Shun; Lowary, Todd L.] Univ Alberta, Alberta Glyc Ctr, Edmonton, AB T6G 2G2, Canada	University of Guelph; University of Alberta; University of Alberta	Whitfield, C (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd East, Guelph, ON N1G 2W1, Canada.	cwhitfie@uoguelph.ca	Lowary, Todd L/F-9608-2019; Kimber, Matthew/Q-8144-2019	Lowary, Todd L/0000-0002-8331-8211; Whitfield, Chris/0000-0002-5267-7027	Canadian Institutes of Health Research; Discovery Grants from the National Science and Engineering Research Council of Canada; Canadian Glycomics Network (GlycoNEt, National Centres of Excellence Program)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Discovery Grants from the National Science and Engineering Research Council of Canada; Canadian Glycomics Network (GlycoNEt, National Centres of Excellence Program)	This work was supported by operating funding from the Canadian Institutes of Health Research (to C. W.), Discovery Grants from the National Science and Engineering Research Council of Canada (to M. S. K., T. L. L., and C. W.), and the Canadian Glycomics Network (GlycoNEt, National Centres of Excellence Program) (to M. S. K, T. L. L., and C. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Alqasim A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-830; Frirdich E, 2004, J BIOL CHEM, V279, P27928, DOI 10.1074/jbc.M402549200; Gronow S, 2000, EUR J BIOCHEM, V267, P6602, DOI 10.1046/j.1432-1327.2000.01754.x; Klonis N, 1996, J Fluoresc, V6, P147, DOI 10.1007/BF00732054; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; LENTER M, 1990, CARBOHYD RES, V197, P197, DOI 10.1016/0008-6215(90)84142-H; Lin CH, 1997, BIOCHEMISTRY-US, V36, P780, DOI 10.1021/bi962055c; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Mannerstedt K, 2007, CARBOHYD RES, V342, P631, DOI 10.1016/j.carres.2006.08.021; Ovchinnikova OG, 2016, P NATL ACAD SCI USA, V113, pE3120, DOI 10.1073/pnas.1603146113; Schmidt H, 2012, P NATL ACAD SCI USA, V109, P6253, DOI 10.1073/pnas.1119894109; Starr KF, 2016, INFECT IMMUN, V84, P1775, DOI 10.1128/IAI.00128-16; UNGER FM, 1980, CARBOHYD RES, V80, P191, DOI 10.1016/S0008-6215(00)85325-2; VIMR ER, 1985, J BACTERIOL, V164, P845, DOI 10.1128/JB.164.2.845-853.1985; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Willis LM, 2013, P NATL ACAD SCI USA, V110, P20753, DOI 10.1073/pnas.1312637110; Willis LM, 2013, CARBOHYD RES, V378, P35, DOI 10.1016/j.carres.2013.05.007; Willis LM, 2013, P NATL ACAD SCI USA, V110, P7868, DOI 10.1073/pnas.1222317110	18	16	16	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21519	21530		10.1074/jbc.M116.751115	http://dx.doi.org/10.1074/jbc.M116.751115			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27535220	Green Published, hybrid			2022-12-26	WOS:000385999200019
J	Beber, ARC; Polina, ER; Biolo, A; Santos, BL; Gomes, DC; La Porta, VL; Olsen, V; Clausell, N; Rohde, LE; Santos, KG				Beber, Ana Rubia C.; Polina, Evelise R.; Biolo, Andrela; Santos, Bruna L.; Gomes, Daiane C.; La Porta, Vanessa L.; Olsen, Virg-Lio; Clausell, Nadine; Rohde, Luis E.; Santos, Katia G.			Matrix Metalloproteinase-2 Polymorphisms in Chronic Heart Failure: Relationship with Susceptibility and Long-Term Survival	PLOS ONE			English	Article							GENE POLYMORPHISMS; RISK; DISEASE; MMP-2; ESTROGEN; PROMOTER; ETIOLOGY; MARKERS; IMPACT	Circulating levels of matrix metalloproteinase-2 (MMP-2) predict mortality and hospital admission in heart failure (HF) patients. However, the role of MMP-2 gene polymorphisms in the susceptibility and prognosis of HF remains elusive. In this study, 308 HF outpatients (216 Caucasian-and 92 African-Brazilians) and 333 healthy subjects (256 Caucasian-and 77 African- Brazilians) were genotyped for the -1575G>A (rs243866), -1059G>A (rs17859821), and -790G>T (rs243864) polymorphisms in the MMP-2 gene. Polymorphisms were analyzed individually and in combination (haplotype), and positive associations were adjusted for clinical covariates. Although allele frequencies were similar in HF patients and controls in both ethnic groups, homozygotes for the minor alleles were not found among African-Brazilian patients. After a median follow-up of 5.3 years, 124 patients (40.3%) died (54.8% of them for HF). In Caucasian-Brazilians, the TT genotype of the -790G>T polymorphism was associated with a decreased risk of HF-related death as compared with GT genotype (hazard ratio [HR] = 0.512, 95% confidence interval [CI] 0.285-0.920). However, this association was lost after adjusting for clinical covariates (HR = 0.703, 95% CI 0.365-1.353). Haplotype analysis revealed similar findings, as patients homozygous for the -1575G/-1059G/-790T haplotype had a lower rate of HF-related death than those with any other haplotype combination (12.9% versus 28.5%, respectively; P = 0.010). Again, this association did not remain after adjusting for clinical covariates (HR = 0.521, 95% CI 0.248-1.093). Our study does not exclude the possibility that polymorphisms inMMP-2 gene, particularly the -790G>T polymorphism, might be related to HF prognosis. However, due to the limitations of the study, our findings need to be confirmed in further larger studies.	[Beber, Ana Rubia C.; Polina, Evelise R.; Santos, Bruna L.; Gomes, Daiane C.; Santos, Katia G.] Univ Luterana Brasil, Lab Human Mol Genet, Canoas, RS, Brazil; [Biolo, Andrela; La Porta, Vanessa L.; Olsen, Virg-Lio; Clausell, Nadine; Rohde, Luis E.; Santos, Katia G.] Hosp Clin Porto Alegre, Div Cardiol, Expt & Mol Cardiovasc Lab & Heart Failure, Porto Alegre, RS, Brazil; [Biolo, Andrela; La Porta, Vanessa L.; Olsen, Virg-Lio; Clausell, Nadine; Rohde, Luis E.; Santos, Katia G.] Hosp Clin Porto Alegre, Div Cardiol, Cardiac Transplant Unit, Porto Alegre, RS, Brazil	Universidade Luterana do Brasil	Santos, KG (corresponding author), Univ Luterana Brasil, Lab Human Mol Genet, Canoas, RS, Brazil.; Santos, KG (corresponding author), Hosp Clin Porto Alegre, Div Cardiol, Expt & Mol Cardiovasc Lab & Heart Failure, Porto Alegre, RS, Brazil.; Santos, KG (corresponding author), Hosp Clin Porto Alegre, Div Cardiol, Cardiac Transplant Unit, Porto Alegre, RS, Brazil.	kgsantos2010@gmail.com	dos Santos, Kátia Gonçalves/D-2683-2014; Clausell, Nadine Oliveira/C-7813-2016; Rohde, Luis Eduardo/I-4216-2013; Gonçalves dos Santos, Kátia/GPT-4900-2022	dos Santos, Kátia Gonçalves/0000-0001-5231-2071; Clausell, Nadine Oliveira/0000-0003-4207-3809; Biolo, Andreia/0000-0002-8579-4158	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [306032/2009-0]; Fundo de Incentivo a Pesquisa do Hospital de Clinicas de Porto Alegre (FIPE-HCPA) [03-237]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundo de Incentivo a Pesquisa do Hospital de Clinicas de Porto Alegre (FIPE-HCPA)	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) -http://www.cnpq.br/ - NC received the grant #306032/2009-0; and Fundo de Incentivo a Pesquisa do Hospital de Clinicas de Porto Alegre (FIPE-HCPA) - http://www.hcpa.edu.br/content/view/1591/1112/ - LER received the grant #03-237. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson Joseph H, 2011, Epidemiol Perspect Innov, V8, P1, DOI 10.1186/1742-5573-8-1; Biolo A, 2010, CIRC-HEART FAIL, V3, P44, DOI 10.1161/CIRCHEARTFAILURE.108.844324; Braunwald E, 2013, JACC-HEART FAIL, V1, P1, DOI 10.1016/j.jchf.2012.10.002; Bui AL, 2011, NAT REV CARDIOL, V8, P30, DOI 10.1038/nrcardio.2010.165; Cardena MMSG, 2016, J HUM HYPERTENS, V30, P120, DOI 10.1038/jhh.2015.39; Chang YY, 2014, INT J MED SCI, V11, P1098, DOI 10.7150/ijms.8083; Cogni AL, 2013, ARQ BRAS CARDIOL, V100, P315, DOI 10.5935/abc.20130049; Ramos BRD, 2016, GENETICA, V144, P259, DOI 10.1007/s10709-016-9894-1; Manta FSD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075145; Deardorff R, 2009, BIOMARK MED, V3, P513, DOI 10.2217/BMM.09.60; DeCoux A, 2014, J MOL CELL CARDIOL, V77, P64, DOI 10.1016/j.yjmcc.2014.09.016; Dorn GW, 2011, CIRC RES, V108, P1270, DOI 10.1161/CIRCRESAHA.110.229260; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; George J, 2005, AM HEART J, V150, P484, DOI 10.1016/j.ahj.2004.11.016; Harendza S, 2003, J BIOL CHEM, V278, P20490, DOI 10.1074/jbc.M211536200; Ho YL, 2009, CLIN BIOCHEM, V42, P1407, DOI 10.1016/j.clinbiochem.2009.06.013; Hua YH, 2009, CLIN CHIM ACTA, V404, P119, DOI 10.1016/j.cca.2009.03.030; Hua YH, 2009, AM J MED SCI, V337, P344, DOI 10.1097/MAJ.0b013e31818eb2a2; Hughes BG, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0424-y; Jessup M, 2009, J AM COLL CARDIOL, V53, P1343, DOI 10.1016/j.jacc.2008.11.009; Kandasamy AD, 2010, CARDIOVASC RES, V85, P413, DOI 10.1093/cvr/cvp268; Kim CX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009065; Kitaoka H, 2010, CIRC J, V74, P1191, DOI 10.1253/circj.CJ-09-1013; Ky B, 2013, J AM COLL CARDIOL, V62, P1165, DOI 10.1016/j.jacc.2013.03.085; Lacchini R, 2012, J HUM HYPERTENS, V26, P171, DOI 10.1038/jhh.2011.8; Lacchini R, 2010, DNA CELL BIOL, V29, P649, DOI 10.1089/dna.2010.1056; LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444; LEWONTIN RC, 1988, GENETICS, V120, P849; Lin PI, 2007, AM J HUM GENET, V80, P531, DOI 10.1086/512133; Little J, 2009, PLOS MED, V6, P151, DOI 10.1371/journal.pmed.1000022; Lovett DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068154; Luo T, 2016, CAN J CARDIOL, V32, P1017, DOI 10.1016/j.cjca.2015.10.021; Mizon-Gerard F, 2004, EUR HEART J, V25, P688, DOI 10.1016/j.ehj.2004.01.015; Morishita T, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001359; Niu WQ, 2012, HEART, V98, P1483, DOI 10.1136/heartjnl-2012-302085; Olsen V, 2014, CAN J CARDIOL, V30, P345, DOI 10.1016/j.cjca.2013.11.014; Pena SDJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017063; Price SJ, 2001, J BIOL CHEM, V276, P7549, DOI 10.1074/jbc.M010242200; Spinale FG, 2013, CIRC RES, V112, P195, DOI 10.1161/CIRCRESAHA.112.266882; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tang LJ, 2007, CLIN BIOCHEM, V40, P1427, DOI 10.1016/j.clinbiochem.2007.09.013; Taylor MR, 2014, JACC-HEART FAIL, V2, P561, DOI 10.1016/j.jchf.2014.06.010; Vasku A, 2003, CLIN CHEM LAB MED, V41, P1299, DOI 10.1515/CCLM.2003.197; Velho FM, 2011, J CARD FAIL, V17, P115, DOI 10.1016/j.cardfail.2010.09.017; Wang JH, 2011, HEART, V97, P1542, DOI 10.1136/heartjnl-2011-300342	46	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0161666	10.1371/journal.pone.0161666	http://dx.doi.org/10.1371/journal.pone.0161666			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27551966	gold, Green Published, Green Submitted			2022-12-26	WOS:000381768800064
J	Louis, BP; Maron, PA; Menasseri-Aubry, S; Sarr, A; Leveque, J; Mathieu, O; Jolivet, C; Leterme, P; Viaud, V				Louis, Benjamin P.; Maron, Pierre-Alain; Menasseri-Aubry, Safya; Sarr, Amadou; Leveque, Jean; Mathieu, Olivier; Jolivet, Claudy; Leterme, Philippe; Viaud, Valerie			Microbial Diversity Indexes Can Explain Soil Carbon Dynamics as a Function of Carbon Source	PLOS ONE			English	Article							LAND-USE; NITROGEN MINERALIZATION; COMMUNITY STRUCTURE; FUNGAL COMMUNITIES; BACTERIAL; DECOMPOSITION; MODELS; MANAGEMENT; LITTER; PH	Mathematical models do not explicitly represent the influence of soil microbial diversity on soil organic carbon (SOC) dynamics despite recent evidence of relationships between them. The objective of the present study was to statistically investigate relationships between bacterial and fungal diversity indexes (richness, evenness, Shannon index, inverse Simpson index) and decomposition of different pools of soil organic carbon by measuring dynamics of CO2 emissions under controlled conditions. To this end, 20 soils from two different land uses (cropland and grassland) were incubated with or without incorporation of C-13-labelled wheat-straw residue. C-13-labelling allowed us to study residue mineralisation, basal respiration and the priming effect independently. An innovative data-mining approach was applied, based on generalized additive models and a predictive criterion. Results showed that microbial diversity indexes can be good covariates to integrate in SOC dynamics models, depending on the C source and the processes considered (native soil organic carbon vs. fresh wheat residue). Specifically, microbial diversity indexes were good candidates to help explain mineralisation of native soil organic carbon, while priming effect processes seemed to be explained much more by microbial composition, and no microbial diversity indexes were found associated with residue mineralisation. Investigation of relationships between diversity and mineralisation showed that higher diversity, as measured by the microbial diversity indexes, seemed to be related to decreased CO2 emissions in the control soil. We suggest that this relationship can be explained by an increase in carbon yield assimilation as microbial diversity increases. Thus, the parameter for carbon yield assimilation in mathematical models could be calculated as a function of microbial diversity indexes. Nonetheless, given limitations of the methods used, these observations should be considered with caution and confirmed with more experimental studies. Overall, along with other studies on relationships between microbial community composition and SOM dynamics, this study suggests that overall measures of microbial diversity may constitute relevant ways to include microbial diversity in models of SOM dynamics.	[Louis, Benjamin P.; Menasseri-Aubry, Safya; Leterme, Philippe] AGROCAMPUS OUEST, UMR SAS 1069, Rennes, France; [Louis, Benjamin P.; Menasseri-Aubry, Safya; Leterme, Philippe; Viaud, Valerie] INRA, UMR SAS 1069, Rennes, France; [Maron, Pierre-Alain; Sarr, Amadou] INRA, UMR Agroecol 1347, Dijon, France; [Leveque, Jean; Mathieu, Olivier] Univ Bourgogne Franche Comte, Biogeosci, CNRS, Dijon, France; [Jolivet, Claudy] INRA, US Infosol 1106, Ardon, France	Institut Agro; Agrocampus Ouest; INRAE; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; INRAE	Louis, BP (corresponding author), AGROCAMPUS OUEST, UMR SAS 1069, Rennes, France.; Louis, BP (corresponding author), INRA, UMR SAS 1069, Rennes, France.	benjaminlouis.pro@gmail.com	viaud, valerie/B-3126-2016; SAS, MOsol UMR/M-5051-2013; MATHIEU, Olivier/J-6317-2014; SAS, ASAE UMR/M-4978-2013	viaud, valerie/0000-0002-6434-369X; MATHIEU, Olivier/0000-0002-6387-6996; SAS, ASAE UMR/0000-0001-6346-7845; Jolivet, Claudy/0000-0001-5871-6413; Louis, Benjamin/0000-0002-3838-6661	French National Agency for Research [ANR-08-STRA-06]; Chair of "Ecologically Intensive Agriculture" (Agrocampus-Ouest, Oniris, Groupe ESA, Agrial, Terrena, Triskalia) [8206-R2013229]; Brittany Regional Council [0461/COH13000/00001042ared-cohorte2013-dynamod]; French National Research Agency within the Systerra DIMIMOS project [ANR-08-STRA-06]	French National Agency for Research(French National Research Agency (ANR)); Chair of "Ecologically Intensive Agriculture" (Agrocampus-Ouest, Oniris, Groupe ESA, Agrial, Terrena, Triskalia); Brittany Regional Council(Region Bretagne); French National Research Agency within the Systerra DIMIMOS project(French National Research Agency (ANR))	This work was supported by: 1. French National Agency for Research, grant number ANR-08-STRA-06, http://www.agence-nationale-recherche.fr/en/project-based-funding-to-advance-frenchresearch/; 2. Chair of "Ecologically Intensive Agriculture" (Agrocampus-Ouest, Oniris, Groupe ESA, Agrial, Terrena, Triskalia), grant number 8206-R2013229, http://www.chaire-aei.fr/; 3. Brittany Regional Council, grant number 0461/COH13000/00001042ared-cohorte2013-dynamod, http://www.bretagne.bzh/jcms/JB080225_11542/fr/english. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Financial support for this research was provided by the Chair of "Ecologically Intensive Agriculture" (Agrocampus Ouest, Oniris, Groupe ESA, Agrial, Terrena, Triskalia) and the Brittany Regional Council. This project was also funded by the French National Research Agency within the Systerra DIMIMOS project (ANR-08-STRA-06).	Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Allison SD, 2012, ECOL LETT, V15, P1058, DOI 10.1111/j.1461-0248.2012.01807.x; Allison SD, 2005, ECOL LETT, V8, P626, DOI 10.1111/j.1461-0248.2005.00756.x; Allison SD, 2010, NAT GEOSCI, V3, P336, DOI 10.1038/NGEO846; [Anonymous], [No title captured]; Arrouays Dominique, 2002, Comptes Rendus de l'Academie d'Agriculture de France, V88, P93; Baumann K, 2013, BIOGEOCHEMISTRY, V114, P201, DOI 10.1007/s10533-012-9800-6; Bellon-Maurel V, 2010, TRAC-TREND ANAL CHEM, V29, P1073, DOI 10.1016/j.trac.2010.05.006; Blagodatskaya E, 2008, BIOL FERT SOILS, V45, P115, DOI 10.1007/s00374-008-0334-y; Burnham K P, 2003, MODEL SELECT MULTIMO; Burns RG, 2013, SOIL BIOL BIOCHEM, V58, P216, DOI 10.1016/j.soilbio.2012.11.009; Chen RR, 2014, GLOBAL CHANGE BIOL, V20, P2356, DOI 10.1111/gcb.12475; de Boer W, 2005, FEMS MICROBIOL REV, V29, P795, DOI 10.1016/j.femsre.2004.11.005; Dequiedt S, 2011, GLOBAL ECOL BIOGEOGR, V20, P641, DOI 10.1111/j.1466-8238.2010.00628.x; Fang C, 2005, GEODERMA, V129, P139, DOI 10.1016/j.geoderma.2004.12.038; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Fontaine S, 2005, ECOL LETT, V8, P1075, DOI 10.1111/j.1461-0248.2005.00813.x; Fontaine S, 2011, SOIL BIOL BIOCHEM, V43, P86, DOI 10.1016/j.soilbio.2010.09.017; GRIFFITH MB, 1995, OECOLOGIA, V102, P460, DOI 10.1007/BF00341358; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; Hastie T., 1986, STAT SCI, V1, P297; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Jangid K, 2008, SOIL BIOL BIOCHEM, V40, P2843, DOI 10.1016/j.soilbio.2008.07.030; Jangid K, 2011, SOIL BIOL BIOCHEM, V43, P2184, DOI 10.1016/j.soilbio.2011.06.022; Jolivet C., 2006, ETUDE ET GESTION DES, V13, P149; Juarez S, 2013, BIOL FERT SOILS, V49, P939, DOI 10.1007/s00374-013-0784-8; Kader MA, 2013, EUR J SOIL SCI, V64, P47, DOI 10.1111/ejss.12005; Kaisermann A, 2015, APPL SOIL ECOL, V86, P158, DOI 10.1016/j.apsoil.2014.10.009; Kemmitt SJ, 2006, SOIL BIOL BIOCHEM, V38, P898, DOI 10.1016/j.soilbio.2005.08.006; Kutsch W.L., 2009, SOIL CARBON DYNAMICS, DOI [10.1017/CBO9780511711794, DOI 10.1017/CBO9780511711794]; Lundquist EJ, 1999, SOIL BIOL BIOCHEM, V31, P221, DOI 10.1016/S0038-0717(98)00093-5; MANSFIELD ER, 1982, AM STAT, V36, P158, DOI 10.2307/2683167; Manzoni S, 2009, SOIL BIOL BIOCHEM, V41, P1355, DOI 10.1016/j.soilbio.2009.02.031; Meersmans J, 2012, AGRON SUSTAIN DEV, V32, P873, DOI 10.1007/s13593-012-0085-x; Moorhead DL, 2006, ECOL MONOGR, V76, P151, DOI 10.1890/0012-9615(2006)076[0151:ATMOLD]2.0.CO;2; Nannipieri P, 2003, EUR J SOIL SCI, V54, P655, DOI 10.1046/j.1351-0754.2003.0556.x; Nicolardot B, 2001, PLANT SOIL, V228, P83, DOI 10.1023/A:1004813801728; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Parton WJ, 1996, GLOBAL BIOGEOCHEM CY, V10, P401, DOI 10.1029/96GB01455; Pascault N, 2013, ECOSYSTEMS, V16, P810, DOI 10.1007/s10021-013-9650-7; Perveen N, 2014, GLOBAL CHANGE BIOL, V20, P1174, DOI 10.1111/gcb.12493; Philippot L, 2013, ISME J, V7, P1609, DOI 10.1038/ismej.2013.34; Plassart P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044279; R Core Team, 2021, R LANGUAGE ENV STAT; Rampelotto PH, 2013, MICROB ECOL, V66, P593, DOI 10.1007/s00248-013-0235-y; Ratie C, 2010, CONSERVATOIRE SOLS M, V17, P263; Robson A., 2012, SOIL ACIDITY PLANT G; Romani AM, 2006, ECOLOGY, V87, P2559, DOI 10.1890/0012-9658(2006)87[2559:IOBAFO]2.0.CO;2; Rousk J, 2011, APPL ENVIRON MICROB, V77, P2791, DOI 10.1128/AEM.02870-10; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Scharlemann JPW, 2014, CARBON MANAG, V5, P81, DOI 10.4155/CMT.13.77; Schimel JP, 2015, MICROBIAL CONTROL CA, P155; Six J, 2006, SOIL SCI SOC AM J, V70, P555, DOI 10.2136/sssaj2004.0347; Smith P, 1997, GEODERMA, V81, P153, DOI 10.1016/S0016-7061(97)00087-6; Tardy V, 2015, SOIL BIOL BIOCHEM, V90, P204, DOI 10.1016/j.soilbio.2015.08.010; Tardy V, 2014, ENV MICROBIOL REP, V6, P173, DOI 10.1111/1758-2229.12126; TUKEY JW, 1949, BIOMETRICS, V5, P99, DOI 10.2307/3001913; Waldrop MP, 2004, OECOLOGIA, V138, P275, DOI 10.1007/s00442-003-1419-9; Walse Charlotta, 1998, Environmental Reviews, V6, P25, DOI 10.1139/a98-001; Waring BG, 2013, ECOL LETT, V16, P887, DOI 10.1111/ele.12125; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd ed., DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Wutzler T, 2008, BIOGEOSCIENCES, V5, P749, DOI 10.5194/bg-5-749-2008	63	10	11	8	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0161251	10.1371/journal.pone.0161251	http://dx.doi.org/10.1371/journal.pone.0161251			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27551779	Green Published, gold, Green Submitted			2022-12-26	WOS:000381768800025
J	Wu, JR; Liu, HJ; Zhang, G; Gu, L; Zhang, YL; Gao, J; Wei, YQ; Ma, ZG				Wu, Jianrong; Liu, Huajun; Zhang, Ge; Gu, Ling; Zhang, Yanle; Gao, Ju; Wei, Yuquan; Ma, Zhigui			Antileukemia Effect of Ciclopirox Olamine Is Mediated by Downregulation of Intracellular Ferritin and Inhibition beta-Catenin-c-Myc Signaling Pathway in Glucocorticoid Resistant T-ALL Cell Lines	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; CHILDHOOD; MECHANISMS; AGENT; MOUSE; RISK	Ciclopirox olamine (CPX) is an antifungal drug that has been reported to have antitumor effects. In this study we investigated the antileukemia effects and the possible mechanisms of CPX on glucocorticoid (GC)-resistant T-cell acute lymphoblastic leukemia (T-ALL) cell lines. The results indicated that CPX inhibited the growth of GC-resistant T-ALL cells in a time-and dose-dependent manner, and this effect was closely correlated with the downregulation of intracellular ferritin. CPX induced cell cycle arrest at G1 phase by upregulation of cyclin-dependent kinase (CDK) inhibitor of p21 and downregulation of the expressions of cyclin D, retinoblastoma protein (Rb), and phosphorylated Rb (pRb). CPX also enhanced apoptotic cell death by downregulation of anti-apoptotic proteins such as Bcl-2, Bcl-xL, and Mcl-1. More importantly, CPX demonstrated a strong synergistic antileukemia effect with GC and this effect was mediated, at least in part, by inhibition of the beta-catenin-c-Myc signaling pathway. These findings suggest that CPX could be a promising antileukemia drug, and modulation of the intracellular ferritin expression might be an effective method in the treatment of ALL. Therefore, integrating CPX into the current GC-containing ALL protocols could lead to the improvement of the outcome of ALL, especially GC-resistant ALL.	[Wu, Jianrong; Liu, Huajun; Zhang, Ge; Gu, Ling; Zhang, Yanle; Gao, Ju; Ma, Zhigui] Sichuan Univ, West China Univ Hosp 2, Key Lab Birth Defects & Related Dis Women & Child, Dept Pediat, Chengdu 60041, Peoples R China; [Wei, Yuquan; Ma, Zhigui] Sichuan Univ, State Key Lab Biotherapy, Chengdu 610041, Peoples R China; [Wei, Yuquan; Ma, Zhigui] Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, Ctr Canc, Chengdu 610041, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Ma, ZG (corresponding author), Sichuan Univ, West China Univ Hosp 2, Key Lab Birth Defects & Related Dis Women & Child, Dept Pediat, Chengdu 60041, Peoples R China.; Wei, YQ; Ma, ZG (corresponding author), Sichuan Univ, State Key Lab Biotherapy, Chengdu 610041, Peoples R China.; Wei, YQ; Ma, ZG (corresponding author), Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, Ctr Canc, Chengdu 610041, Peoples R China.	yuquanwei@scu.edu.cn; zhiguima@scu.edu.cn		Gu, Ling/0000-0002-2410-1696	National Natural Science Foundation of China [81071639]; Program for Changjiang Scholars and Innovative Research Team in University [IRT0935]; Applied and Basic Research Project of Sichuan Province, China [2015JY0044]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Applied and Basic Research Project of Sichuan Province, China	This work was supported by the National Natural Science Foundation of China (81071639) and the Program for Changjiang Scholars and Innovative Research Team in University (IRT0935), and also by the Applied and Basic Research Project of Sichuan Province, China (2015JY0044). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhateeb AA, 2013, BBA-REV CANCER, V1836, P245, DOI 10.1016/j.bbcan.2013.07.002; ARICO M, 1995, CANCER, V75, P1684, DOI 10.1002/1097-0142(19950401)75:7<1684::AID-CNCR2820750720>3.0.CO;2-2; Baldi A, 2005, CLIN CANCER RES, V11, P3175, DOI 10.1158/1078-0432.CCR-04-0631; Bhadri VA, 2012, J PAEDIATR CHILD H, V48, P634, DOI 10.1111/j.1440-1754.2011.02212.x; Cooper SL, 2015, PEDIATR CLIN N AM, V62, P61, DOI 10.1016/j.pcl.2014.09.006; Durinck K, 2015, EXP HEMATOL, V43, P625, DOI 10.1016/j.exphem.2015.05.017; Eberhard Y, 2009, BLOOD, V114, P3064, DOI 10.1182/blood-2009-03-209965; GAYNON PS, 1995, J PEDIAT HEMATOL ONC, V17, P1, DOI 10.1097/00043426-199502000-00001; Goldberg JM, 2003, J CLIN ONCOL, V21, P3616, DOI 10.1200/JCO.2003.10.116; Greenstein S, 2002, CLIN CANCER RES, V8, P1681; Griffin TC, 2000, LEUKEMIA, V14, P792, DOI 10.1038/sj.leu.2401768; Gu L, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-150; Hunger SP, 2015, BLOOD, V125, P3977, DOI 10.1182/blood-2015-02-580043; KASPERS GJL, 1994, LEUKEMIA LYMPHOMA, V13, P187, DOI 10.3109/10428199409056282; Marino S, 2009, PEDIATR BLOOD CANCER, V53, P984, DOI 10.1002/pbc.22163; Minden MD, 2014, AM J HEMATOL, V89, P363, DOI 10.1002/ajh.23640; Moricke A, 2008, BLOOD, V111, P4477, DOI 10.1182/blood-2007-09-112920; Ng OH, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2014.12; Niewerth M, 2003, ANTIMICROB AGENTS CH, V47, P1805, DOI 10.1128/AAC.47.6.1805-1817.2003; Orino K, 2001, BIOCHEM J, V357, P241, DOI 10.1042/0264-6021:3570241; Pui CH, 2014, LEUKEMIA, V28, P2336, DOI 10.1038/leu.2014.142; REITER A, 1994, BLOOD, V84, P3122, DOI 10.1182/blood.V84.9.3122.3122; Rucker P, 1996, J BIOL CHEM, V271, P33352, DOI 10.1074/jbc.271.52.33352; Schmeel LC, 2013, ANTICANCER RES, V33, P4719; Schrappe M., 2004, Annals of Hematology, V83, pS121; SEHGAL VN, 1976, BRIT J DERMATOL, V95, P83, DOI 10.1111/j.1365-2133.1976.tb15537.x; Sen S, 2013, EXP HEMATOL, V41, P799, DOI 10.1016/j.exphem.2013.04.012; Tauber A, 2015, INT J PHARMACEUT, V494, P304, DOI 10.1016/j.ijpharm.2015.08.023; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Uckun FM, 1998, BLOOD, V91, P735; van Grotel M, 2008, LEUKEMIA, V22, P124, DOI 10.1038/sj.leu.2404957; Wall I, 2014, ANTICANCER RES, V34, P5375; Weir SJ, 2011, J CLIN PHARM THER, V36, P128, DOI 10.1111/j.1365-2710.2010.01172.x; Witkowski MT, 2015, LEUKEMIA, V29, P1301, DOI 10.1038/leu.2015.27; You MJ, 2015, AM J CLIN PATHOL, V144, P411, DOI 10.1309/AJCPMF03LVSBLHPJ; Zhou HY, 2010, INT J CANCER, V127, P2467, DOI 10.1002/ijc.25255	36	12	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0161509	10.1371/journal.pone.0161509	http://dx.doi.org/10.1371/journal.pone.0161509			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27551974	Green Submitted, Green Published, gold			2022-12-26	WOS:000381768800047
J	Zhang, XH; Wang, CC; Pang, CY; Wei, HL; Wang, HT; Song, MZ; Fan, SL; Yu, SX				Zhang, Xiaohong; Wang, Congcong; Pang, Chaoyou; Wei, Hengling; Wang, Hantao; Song, Meizhen; Fan, Shuli; Yu, Shuxun			Characterization and Functional Analysis of PEBP Family Genes in Upland Cotton (Gossypium hirsutum L.)	PLOS ONE			English	Article							PHOSPHATIDYLETHANOLAMINE-BINDING PROTEIN; MOLECULAR-CLONING; FLORAL INDUCTION; TERMINAL FLOWER1; FT; ARABIDOPSIS; EXPRESSION; SIGNAL; ACTIVATION; HOMOLOGS	Upland cotton (Gossypium hirsutum L.) is a naturally occurring photoperiod-sensitive perennial plant species. However, sensitivity to the day length was lost during domestication. The phosphatidylethanolamine-binding protein (PEBP) gene family, of which three subclades have been identified in angiosperms, functions to promote and suppress flowering in photoperiod pathway. Recent evidence indicates that PEBP family genes play an important role in generating mobile flowering signals. We isolated homologues of the PEBP gene family in upland cotton and examined their regulation and function. Nine PEBP-like genes were cloned and phylogenetic analysis indicated the genes belonged to four subclades (FT, MFT, TFL1 and PEBP). Cotton PEBP-like genes showed distinct expression patterns in relation to different cotton genotypes, photoperiod responsive and cultivar maturity. The GhFT gene expression of a semi-wild race of upland cotton were strongly induced under short day condition, whereas the GhPEBP2 gene expression was induced under long days. We also elucidated that GhFT but not GhPEBP2 interacted with FD-like bZIP transcription factor GhFD and promote flowering under both long-and short-day conditions. The present result indicated that GhPEBP-like genes may perform different functions. This work corroborates the involvement of PEBP-like genes in photoperiod response and regulation of flowering time in different cotton genotypes, and contributes to an improved understanding of the function of PEBP-like genes in cotton.	[Zhang, Xiaohong; Wang, Congcong; Pang, Chaoyou; Wei, Hengling; Wang, Hantao; Song, Meizhen; Fan, Shuli; Yu, Shuxun] Inst Cotton Res CAAS, State Key Lab Cotton Biol, Anyang 455000, Henan, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Song, MZ; Fan, SL; Yu, SX (corresponding author), Inst Cotton Res CAAS, State Key Lab Cotton Biol, Anyang 455000, Henan, Peoples R China.	songmzccri@163.com; fasl@cricaas.com.cn; ysx195311@163.com	Wang, Han/GPW-9809-2022		National Key Technology RD Program [2014BAD03B01]	National Key Technology RD Program(National Key Technology R&D Program)	This work was funded by the National Key Technology R&D Program (2014BAD03B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdurakhmonov IY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4062; Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Ahn JH, 2006, EMBO J, V25, P605, DOI 10.1038/sj.emboj.7600950; Argiriou A, 2008, J PLANT PHYSIOL, V165, P1636, DOI 10.1016/j.jplph.2007.10.013; Banfield MJ, 1998, STRUCTURE, V6, P1245, DOI 10.1016/S0969-2126(98)00125-7; Bradley D, 1996, NATURE, V379, P791, DOI 10.1038/379791a0; Bradley D, 1997, SCIENCE, V275, P80, DOI 10.1126/science.275.5296.80; BRUBAKER CL, 1994, AM J BOT, V81, P1309, DOI 10.2307/2445407; Carmel-Goren L, 2003, PLANT MOL BIOL, V52, P1215, DOI 10.1023/B:PLAN.0000004333.96451.11; Chautard H, 2004, EUKARYOT CELL, V3, P459, DOI 10.1128/EC.3.2.459-470.2004; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Conti L, 2007, PLANT CELL, V19, P767, DOI 10.1105/tpc.106.049767; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; D'Aloia M, 2011, PLANT J, V65, P972, DOI 10.1111/j.1365-313X.2011.04482.x; Danilevskaya ON, 2008, PLANT PHYSIOL, V146, P250, DOI 10.1104/pp.107.109538; Faure S, 2007, GENETICS, V176, P599, DOI 10.1534/genetics.106.069500; Golembeski Greg S, 2015, Arabidopsis Book, V13, pe0178, DOI 10.1199/tab.0178; Grover CE, 2015, PLANT GENOME-US, V8, DOI 10.3835/plantgenome2014.12.0098; Guo DL, 2015, J INTEGR PLANT BIOL, V57, P522, DOI 10.1111/jipb.12316; Guo Y, 2007, EUPHYTICA, V163; Hanano S, 2011, PLANT CELL, V23, P3172, DOI 10.1105/tpc.111.088641; Hecht V, 2011, PLANT CELL, V23, P147, DOI 10.1105/tpc.110.081042; Hedman H, 2009, PLANT MOL BIOL, V70, P359, DOI 10.1007/s11103-009-9478-x; Hengst U, 2001, J BIOL CHEM, V276, P535, DOI 10.1074/jbc.M002524200; Hu GJ, 2013, NEW PHYTOL, V200, P570, DOI 10.1111/nph.12381; Igasaki T, 2008, PLANT CELL PHYSIOL, V49, P291, DOI 10.1093/pcp/pcn010; Imaizumi T, 2003, NATURE, V426, P302, DOI 10.1038/nature02090; Ishikawa M, 2006, PLANT J, V46, P736, DOI 10.1111/j.1365-313X.2006.02737.x; Jang S, 2009, PLANT J, V60, P614, DOI 10.1111/j.1365-313X.2009.03986.x; Jefferson R A, 1987, EMBO J, V6, P3901; Carmona MJ, 2007, PLANT MOL BIOL, V63, P637, DOI 10.1007/s11103-006-9113-z; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Klintenas M, 2012, NEW PHYTOL, V196, P1260, DOI 10.1111/j.1469-8137.2012.04332.x; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Lacape JM, 2013, FIELD CROP RES, V144, P256, DOI 10.1016/j.fcr.2013.01.001; Lai DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028676; Li C, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00454; Li CQ, 2013, BREEDING SCI, V63, P154, DOI 10.1270/jsbbs.63.154; Li CQ, 2012, EUPHYTICA, V188, P441, DOI 10.1007/s10681-012-0720-2; Li CY, 2009, J VIROL, V83, P3540, DOI 10.1128/JVI.02346-08; Li F, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/728307; Li FG, 2014, NAT GENET, V46, P567, DOI 10.1038/ng.2987; Li J, 2013, PLANT CELL REP, V32, P1675, DOI 10.1007/s00299-013-1479-1; Lifschitz E, 2006, P NATL ACAD SCI USA, V103, P6398, DOI 10.1073/pnas.0601620103; Liu NA, 2014, PLANT J, V80, P331, DOI 10.1111/tpj.12636; Mouhu K, 2013, PLANT CELL, V25, P3296, DOI 10.1105/tpc.113.115055; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Ratcliffe OJ, 1999, DEVELOPMENT, V126, P1109; Ryu JY, 2014, MOL PLANT, V7, P377, DOI 10.1093/mp/sst114; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schuetze Katia, 2009, V479, P189, DOI 10.1007/978-1-59745-289-2_12; Serre L, 2001, J MOL BIOL, V310, P617, DOI 10.1006/jmbi.2001.4784; Shah ST, 2013, GENE, V531, P220, DOI 10.1016/j.gene.2013.09.007; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang WX, 2014, NEW PHYTOL, V202, P509, DOI 10.1111/nph.12676; Tao YB, 2014, J PLANT RES, V127, P513, DOI 10.1007/s10265-014-0639-x; Taoka K, 2011, NATURE, V476, P332, DOI 10.1038/nature10272; Toth R, 2001, PLANT PHYSIOL, V127, P1607, DOI 10.1104/pp.010467; Tsuji H, 2012, GENES GENETIC SYSTEM, V87, P3184, DOI [10.1105/tpc.111.088641, DOI 10.1105/TPC.111.088641]; Tsuji H, 2013, PLANT CELL PHYSIOL, V54, P385, DOI 10.1093/pcp/pct005; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wang X, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0096299, 10.1371/journal.pone.0085760]; Wendel JF, 2010, PHYSIOLOGY OF COTTON, P1, DOI 10.1007/978-90-481-3195-2_1; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Xi WY, 2010, PLANT CELL, V22, P1733, DOI 10.1105/tpc.109.073072; Yamaguchi A, 2005, PLANT CELL PHYSIOL, V46, P1175, DOI 10.1093/pcp/pci151; Yeung K, 1999, NATURE, V401, P173, DOI 10.1038/43686; Zeevaart JAD, 2008, CURR OPIN PLANT BIOL, V11, P541, DOI 10.1016/j.pbi.2008.06.009; Zhang BL, 2015, GENE DEV, V29, P975, DOI 10.1101/gad.251520.114; Zhang HL, 2010, J EXP BOT, V61, P2549, DOI 10.1093/jxb/erq092; Zhang Jinjie, 2014, INT J COMADEM, V17, P17, DOI DOI 10.1371/J0URNAL.P0NE.0095642; Zhang TZ, 2015, NAT BIOTECHNOL, V33, P531, DOI 10.1038/nbt.3207; Zhang WX, 2013, J INTEGR PLANT BIOL, V55, P597, DOI 10.1111/jipb.12075; Zhang XH, 2016, PLANT SCI, V242, P178, DOI 10.1016/j.plantsci.2015.05.001; Zhang XH, 2015, MOL GENET GENOMICS, V290, P115, DOI 10.1007/s00438-014-0901-x	78	18	22	6	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0161080	10.1371/journal.pone.0161080	http://dx.doi.org/10.1371/journal.pone.0161080			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27552108	Green Published, Green Submitted, gold			2022-12-26	WOS:000381768800021
J	Saeed, I; Bachir, DG; Chen, L; Hu, YG				Saeed, Iqbal; Bachir, Daoura Goudia; Chen, Liang; Hu, Yin-Gang			The Expression of TaRca2-alpha Gene Associated with Net Photosynthesis Rate, Biomass and Grain Yield in Bread Wheat (Triticum aestivum L.) under Field Conditions	PLOS ONE			English	Article							RUBISCO ACTIVASE; GROWTH; MAIZE; PRODUCTIVITY; CAPACITY; ISOFORMS; PROTEIN	Improvement in activation of Rubisco by Rubisco activase can potentially enhance CO2 assimilation and photosynthetic efficiency in plants. The three homoeologous copies of TaRca2-alpha were identified on chromosomes 4AL, 4BS and 4DS (TaRca2-alpha-4AL, TaRca2-alpha-4BS, and TaRca2-alpha-4DS) in bread wheat. Expression patterns of the three copies at heading (Z55), anthesis (Z67) and grain-filling (Z73) stages were investigated through qRT-PCR analyses in a panel of 59 bread wheat genotypes and their effects on net photosynthesis rate (Pn), biomass plant(-1) (BMPP) and grain yield plant(-1) (GYPP) were further explored. Different but similar expression patterns were observed for the three copies of TaRca2-alpha at the three growth stages with highest expression at grain-filling stage. TaRca2-alpha-4BS expressed higher at the three stages than TaRca2-alpha-4AL and TaRca2-alpha-4DS. The 59 genotypes could be clustered into three groups as high (7 genotypes), intermediate (41 genotypes) and low (11 genotypes) expression based on the expression of the three copies of TaRca2-alpha at three growth stages. Significant variations (P<0.01) were observed among the three groups of bread wheat genotypes for Pn, BMPP and GYPP. Generally, the genotypes with higher TaRca2-alpha expression also showed higher values for Pn, BMPP and GYPP. The expressions of the three copies of TaRca2-alpha at heading, anthesis and grain-filling stages were positively correlated with Pn, BMPP and GYPP (P<0.01) with stronger association for TaRca2 alpha- 4BS at grain-filling stage. These results revealed that the expression of TaRca2-alpha contribute substantially to Pn, BMPP and GYPP, and suggested that manipulating TaRca-alpha expression may efficiently improve Pn, BMPP and GYPP in bread wheat and detecting TaRca-a expression levels with emphasis on TaRca2-alpha-4BS may be a positive strategy for selection in improving photosynthetic efficiency and grain yield of bread wheat.	[Saeed, Iqbal; Bachir, Daoura Goudia; Chen, Liang; Hu, Yin-Gang] Northwest A&F Univ, Coll Agron, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Saeed, Iqbal] NIFA, POB 446, Peshawar, KP, Pakistan; [Hu, Yin-Gang] Inst Water Saving Agr Arid Reg China, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China; Nuclear Institute for Food & Agriculture - Pakistan	Hu, YG (corresponding author), Northwest A&F Univ, Coll Agron, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.; Hu, YG (corresponding author), Inst Water Saving Agr Arid Reg China, Yangling 712100, Shaanxi, Peoples R China.	huyingang@nwsuaf.edu.cn			863 Program of the Ministry of Science and Technology [2013AA102902]; China 111 Project, P. R. China [B12007]	863 Program of the Ministry of Science and Technology; China 111 Project, P. R. China	This work is supported by sub-project of the 863 Program (2013AA102902) of the Ministry of Science and Technology, and the China 111 Project (B12007), P. R. China. YGH received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carmo-Silva E, 2013, PLANT PHYSIOL, V161, P1645, DOI [10. 1104/pp.112.213348, DOI 10.1104/PP9112.213348]; Carmo-Silva E, 2015, PLANT CELL ENVIRON, V38, P1817, DOI 10.1111/pce.12425; Chao M, 2013, J EXP BOT, V65, P47, DOI [10.1093/ jeb/e9346, DOI 10.1093/JEB/E9346]; Chen Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140934; Edae EA, 2013, PLANT GEN, V6, P2, DOI DOI 10.3835/PLANTGEN0ME2013.04.0010; Evenson RE, 2003, SCIENCE, V300, P758, DOI 10.1126/science.1078710; Fischer RA, 1998, CROP SCI, V38, P1467, DOI 10.2135/cropsci1998.0011183X003800060011x; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Huang Xiu-Qiang, 2010, BMC Res Notes, V3, P140, DOI 10.1186/1756-0500-3-140; Kruger EL, 2006, FUNCT PLANT BIOL, V33, P421, DOI 10.1071/FP05310; Kumar A, 2009, PHOTOSYNTH RES, V100, P143, DOI 10.1007/s11120-009-9438-y; Kurek I, 2007, PLANT CELL, V19, P3230, DOI 10.1105/tpc.107.054171; MartinezBarajas E, 1997, J AGR SCI-CAMBRIDGE, V128, P155, DOI 10.1017/S002185969600408X; McNevin D, 2006, J EXP BOT, V57, P3883, DOI 10.1093/jxb/erl156; Morales A, 1999, J EXP BOT, V50, P823; Neuwald AF, 1999, GENOME RES, V9, P27; PORTIS AR, 1995, J EXP BOT, V46, P1285, DOI 10.1093/jxb/46.special_issue.1285; Portis AR, 2003, PHOTOSYNTH RES, V75, P11, DOI 10.1023/A:1022458108678; Portis AR, 2008, J EXP BOT, V59, P1597, DOI 10.1093/jxb/erm240; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Raven JA, 2013, NEW PHYTOL, V198, P1, DOI 10.1111/nph.12197; Reynolds M, 2011, J EXP BOT, V62, P439, DOI 10.1093/jxb/erq311; Rieu I, 2009, PLANT CELL, V21, P1031, DOI 10.1105/tpc.109.066001; Ristic Z, 2009, J EXP BOT, V60, P4003, DOI 10.1093/jxb/erp241; Rosegrant MW., 2010, GLOBAL FOOD DEMAND S; Salvucci ME, 1996, PHOTOSYNTH RES, V47, P1, DOI 10.1007/BF00017748; SHEN JB, 1991, J BIOL CHEM, V266, P8963; Shinmachi F, 2010, PLANT PHYSIOL, V153, P327, DOI 10.1104/pp.110.153759; Spreitzer RJ, 2002, ANNU REV PLANT BIOL, V53, P449, DOI 10.1146/annurev.arplant.53.100301.135233; VERWOERD TC, 1989, NUCLEIC ACIDS RES, V17, P2362, DOI 10.1093/nar/17.6.2362; Wang D, 2010, PHYSIOL PLANTARUM, V139, P55, DOI 10.1111/j.1399-3054.2009.01344.x; Whitney SM, 2011, PLANT PHYSIOL, V155, P27, DOI 10.1104/pp.110.164814; Yin ZT, 2014, PLANT PHYSIOL, V164, P2096, DOI 10.1104/pp.113.230854; Yin ZT, 2010, PLANT PHYSIOL, V152, P1625, DOI 10.1104/pp.109.148312; Zhang N, 2002, P NATL ACAD SCI USA, V99, P3330, DOI 10.1073/pnas.042529999; Zheng JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128415	36	8	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161308	10.1371/journal.pone.0161308	http://dx.doi.org/10.1371/journal.pone.0161308			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548477	Green Published, Green Submitted, gold			2022-12-26	WOS:000381768400041
J	Busche, T; Winkler, A; Wedderhoff, I; Ruckert, C; Kalinowski, J; Lucana, DOD				Busche, Tobias; Winkler, Anika; Wedderhoff, Ina; Rueckert, Christian; Kalinowski, Joern; Lucana, Dario Ortiz de Orue			Deciphering the Transcriptional Response Mediated by the Redox-Sensing System HbpS-SenS-SenR from Streptomycetes	PLOS ONE			English	Article							HEME-BINDING PROTEIN; CATALASE-PEROXIDASE CPEB; MOLECULAR-WEIGHT THIOLS; ESCHERICHIA-COLI; DNA-BINDING; CORYNEBACTERIUM-GLUTAMICUM; CONFORMATIONAL-CHANGES; ANTIOXIDANT DEFENSE; HYDROGEN-PEROXIDE; COELICOLOR A3(2)	The secreted protein HbpS, the membrane-embedded sensor kinase SenS and the cytoplasmic response regulator SenR from streptomycetes have been shown to form a novel type of signaling pathway. Based on structural biology as well as different biochemical and biophysical approaches, redox stress-based post-translational modifications in the three proteins were shown to modulate the activity of this signaling pathway. In this study, we show that the homologous system, named here HbpSc-SenSc-SenRc, from the model species Streptomyces coelicolor A3(2) provides this bacterium with an efficient defense mechanism under conditions of oxidative stress. Comparative analyses of the transcriptomes of the Streptomyces coelicolor A3(2) wild-type and the generated hbpSc-senSc-senRc mutant under native and oxidative-stressing conditions allowed to identify differentially expressed genes, whose products may enhance the anti-oxidative defense of the bacterium. Amongst others, the results show an up-regulated transcription of genes for biosynthesis of cysteine and vitamin B-12, transport of methionine and vitamin B-12, and DNA synthesis and repair. Simultaneously, transcription of genes for degradation of an anti-oxidant compound is down-regulated in a HbpSc-SenSc-SenRc-dependent manner. It appears that HbpSc-SenSc-SenRc controls the non-enzymatic response of Streptomyces coelicolor A3(2) to counteract the hazardous effects of oxidative stress. Binding of the response regulator SenRc to regulatory regions of some of the studied genes indicates that the regulation is direct. The results additionally suggest that HbpSc-SenSc-SenRc may act in concert with other regulatory modules such as a transcriptional regulator, a two-component system and the Streptomyces B-12 riboswitch. The transcriptomics data, together with our previous in vitro results, enable a profound characterization of the HbpS-SenS-SenR system from streptomycetes. Since homologues to HbpS-SenS-SenR are widespread in different actinobacteria with ecological and medical relevance, the data presented here will serve as a basis to elucidate the biological role of these homologues.	[Busche, Tobias; Winkler, Anika; Rueckert, Christian; Kalinowski, Joern] Univ Bielefeld, Ctr Biotechnol, Microbial Genom & Biotechnol, Univ Str 27, D-33615 Bielefeld, Germany; [Wedderhoff, Ina; Lucana, Dario Ortiz de Orue] Univ Osnabruck, Dept Biol & Chem, Appl Genet Microorganisms, Barbarastr 13, D-49076 Osnabruck, Germany	University of Bielefeld; University Osnabruck	Lucana, DOD (corresponding author), Univ Osnabruck, Dept Biol & Chem, Appl Genet Microorganisms, Barbarastr 13, D-49076 Osnabruck, Germany.	ortiz@biologie.uni-osnabrueck.de		Ruckert-Reed, Christian/0000-0002-9722-4435	Deutsche Forschungsgemeinschaft (DFG) [OR 224/2-1, OR 224/4-1]; European Union Seventh Programme for Research, Technological Development and Demonstration under the grant agreement STREPSYNTH [613877]; DFG; Open Access Publishing Fund of the University of Osnabrueck	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Union Seventh Programme for Research, Technological Development and Demonstration under the grant agreement STREPSYNTH; DFG(German Research Foundation (DFG)); Open Access Publishing Fund of the University of Osnabrueck	DOOL acknowledges support of the Deutsche Forschungsgemeinschaft (DFG), grants OR 224/2-1 and OR 224/4-1. TB, CR and JK acknowledge support by the European Union Seventh Programme for Research, Technological Development and Demonstration under the grant agreement STREPSYNTH (project No. 613877). The authors acknowledge support by DFG and Open Access Publishing Fund of the University of Osnabrueck.; We are very grateful to Prof. Dr. A. Torda (Hamburg University, Germany) and Prof. Dr. H. Schrempf (University of Osnabrueck, Germany) for comments. DOOL acknowledges support of the Deutsche Forschungsgemeinschaft (DFG), grants OR 224/2-1 and OR 224/4-1. TB, CR and JK acknowledge support by the European Union Seventh Programme for Research, Technological Development and Demonstration under the grant agreement STREPSYNTH (project No. 613877). We acknowledge support by DFG and Open Access Publishing Fund of the University of Osnabrueck.	AHARONOWITZ Y, 1977, ARCH MICROBIOL, V115, P169, DOI 10.1007/BF00406371; Allen KD, 2014, ARCH BIOCHEM BIOPHYS, V543, P67, DOI 10.1016/j.abb.2013.12.004; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; Barka EA, 2016, MICROBIOL MOL BIOL R, V80, P1, DOI 10.1128/MMBR.00019-15; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Birch CS, 2009, FREE RADICAL BIO MED, V47, P184, DOI 10.1016/j.freeradbiomed.2009.04.023; Blom J, 2011, BIOINFORMATICS, V27, P1351, DOI 10.1093/bioinformatics/btr151; BlondeletRouault MH, 1997, GENE, V190, P315, DOI 10.1016/S0378-1119(97)00014-0; Bogel G, 2007, FEBS J, V274, P3900, DOI 10.1111/j.1742-4658.2007.05923.x; Bogel G, 2009, AMINO ACIDS, V37, P681, DOI 10.1007/s00726-008-0188-5; Borovok I, 2006, J BACTERIOL, V188, P2512, DOI 10.1128/JB.188.7.2512-2520.2006; Borovok I, 2002, MICROBIOL-SGM, V148, P391, DOI 10.1099/00221287-148-2-391; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buelow DR, 2010, MOL MICROBIOL, V75, P547, DOI 10.1111/j.1365-2958.2009.06982.x; Carrondo MA, 2003, EMBO J, V22, P1959, DOI 10.1093/emboj/cdg215; Casino P, 2010, CURR OPIN STRUC BIOL, V20, P763, DOI 10.1016/j.sbi.2010.09.010; Chater KF, 2010, FEMS MICROBIOL REV, V34, P171, DOI 10.1111/j.1574-6976.2009.00206.x; Chekabab SM, 2014, VIRULENCE, V5, P786, DOI 10.4161/viru.29307; Cheng Z, 2014, MOL MICROBIOL, V91, P649, DOI 10.1111/mmi.12491; Chiancone E, 2010, BBA-GEN SUBJECTS, V1800, P798, DOI 10.1016/j.bbagen.2010.01.013; Cho HY, 2009, J BIOL CHEM, V284, P13057, DOI 10.1074/jbc.M808905200; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Crawford MA, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00444; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Darbon E, 2012, APPL MICROBIOL BIOT, V95, P1553, DOI 10.1007/s00253-012-3995-2; de la Riva L, 2008, J BACTERIOL, V190, P7892, DOI 10.1128/JB.01022-08; DebRoy S, 2014, SCIENCE, V345, P937, DOI 10.1126/science.1255091; Fischer M, 2012, RES MICROBIOL, V163, P340, DOI 10.1016/j.resmic.2012.05.004; Flardh K, 2009, NAT REV MICROBIOL, V7, P36, DOI 10.1038/nrmicro1968; Flinspach K, 2010, BIOPOLYMERS, V93, P823, DOI 10.1002/bip.21493; HALL HH, 1953, APPL MICROBIOL, V1, P124, DOI 10.1128/AEM.1.3.124-129.1953; Harrison J, 2014, MICROB BIOTECHNOL, V7, P373, DOI 10.1111/1751-7915.12143; Hilker R, 2014, BIOINFORMATICS, V30, P2247, DOI 10.1093/bioinformatics/btu205; Hopwood D. A., 1985, GENETIC MANIPULATION; Hullo MF, 2007, J BACTERIOL, V189, P187, DOI 10.1128/JB.01273-06; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Jacques S, 2013, PROTEOMICS, V13, P932, DOI 10.1002/pmic.201200237; Jothivasan VK, 2008, NAT PROD REP, V25, P1091, DOI 10.1039/b616489g; Kim JN, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1311-0; Klare JP, 2012, ANTIOXID REDOX SIGN, V16, P639, DOI 10.1089/ars.2011.4080; Krautler B, 2005, BIOCHEM SOC T, V33, P806; Krell T, 2010, ANNU REV MICROBIOL, V64, P539, DOI 10.1146/annurev.micro.112408.134054; Lee EJ, 2005, MOL MICROBIOL, V57, P1252, DOI 10.1111/j.1365-2958.2005.04761.x; Levine RL, 2000, IUBMB LIFE, V50, P301, DOI 10.1080/15216540051081056; Lu M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109660; Lucana DOD, 2014, J BIOL CHEM, V289, P34214, DOI 10.1074/jbc.M114.585489; Lucana DOD, 2010, J BIOL CHEM, V285, P28086, DOI 10.1074/jbc.M110.127506; Lucana DOD, 2009, AMINO ACIDS, V37, P479, DOI 10.1007/s00726-009-0260-9; Lucana DODO, 2009, J MOL BIOL, V386, P1108, DOI 10.1016/j.jmb.2009.01.017; Lucana DOD, 2000, MOL GEN GENET, V264, P341; Lucana DOD, 2005, MICROBIOL-SGM, V151, P3603, DOI 10.1099/mic.0.28298-0; Lucana DOD, 2004, MICROBIOL-SGM, V150, P2575, DOI 10.1099/mic.0.27091-0; Ortiz-Guerrero JM, 2011, P NATL ACAD SCI USA, V108, P7565, DOI 10.1073/pnas.1018972108; Martin JF, 2012, APPL MICROBIOL BIOT, V95, P61, DOI 10.1007/s00253-012-4129-6; Mellin JR, 2014, SCIENCE, V345, P940, DOI 10.1126/science.1255083; Merlin C, 2002, J BACTERIOL, V184, P5513, DOI 10.1128/JB.184.19.5513-5517.2002; Merrick BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061768; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; MUTH G, 1989, MOL GEN GENET, V219, P341, DOI 10.1007/BF00259605; NEWTON GL, 1993, J BACTERIOL, V175, P2734, DOI 10.1128/JB.175.9.2734-2742.1993; Ortiz de Orue Lucana Dario, 2012, J Signal Transduct, V2012, P605905, DOI 10.1155/2012/605905; Park JH, 2008, MOL MICROBIOL, V68, P861, DOI 10.1111/j.1365-2958.2008.06191.x; Pfeifer-Sancar K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-888; Podust LM, 2008, BIOCHEMISTRY-US, V47, P12523, DOI 10.1021/bi8012356; Rodriguez H, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-127; Rodriguez-Garcia A, 2007, PROTEOMICS, V7, P2410, DOI 10.1002/pmic.200600883; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Santos-Beneit F, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00402; Savige W E, 1977, Methods Enzymol, V47, P453; Schneider TD, 1996, METHOD ENZYMOL, V274, P445; Schrempf H, 1995, INT J BIOL MACROMOL, V17, P353, DOI 10.1016/0141-8130(96)81845-9; Sevvana M, 2008, J MOL BIOL, V377, P512, DOI 10.1016/j.jmb.2008.01.024; Si MR, 2014, APPL ENVIRON MICROB, V80, P1750, DOI 10.1128/AEM.03654-13; Siedenburg G, 2012, ANTIOXID REDOX SIGN, V16, P668, DOI 10.1089/ars.2011.4290; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sola-Landa A, 2005, MOL MICROBIOL, V56, P1373, DOI 10.1111/j.1365-2958.2005.04631.x; Sola-Landa A, 2008, NUCLEIC ACIDS RES, V36, P1358, DOI 10.1093/nar/gkm1150; Solomon LR, 2007, BLOOD REV, V21, P113, DOI 10.1016/j.blre.2006.05.001; Song SG, 1997, J BACTERIOL, V179, P7025, DOI 10.1128/jb.179.22.7025-7032.1997; STAUDENMAIER H, 1989, J BACTERIOL, V171, P2626, DOI 10.1128/jb.171.5.2626-2633.1989; Suarez-Moreira E, 2009, J AM CHEM SOC, V131, P15078, DOI 10.1021/ja904670x; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Torda AE, 2013, FEMS MICROBIOL LETT, V342, P106, DOI 10.1111/1574-6968.12093; TRZEBIATOWSKI JR, 1994, J BACTERIOL, V176, P3568, DOI 10.1128/JB.176.12.3568-3575.1994; Van Laer K, 2013, ANTIOXID REDOX SIGN, V18, P1642, DOI 10.1089/ars.2012.4964; Vermeulen AJ, 2015, J BACTERIOL, V197, P2694, DOI 10.1128/JB.00374-15; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; WARREN MJ, 1990, BIOCHEM J, V265, P725, DOI 10.1042/bj2650725; Wedderhoff I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071579; Winterbourn CC, 1995, TOXICOL LETT, V82-3, P969, DOI 10.1016/0378-4274(95)03532-X; Zhou Z, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S10-S8; Zou P, 2008, ACTA CRYSTALLOGR F, V64, P386, DOI 10.1107/S1744309108008348; Zou PJ, 1999, MICROBIOL-SGM, V145, P549, DOI 10.1099/13500872-145-3-549	93	4	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2016	11	8							e0159873	10.1371/journal.pone.0159873	http://dx.doi.org/10.1371/journal.pone.0159873			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6UQ	27541358	Green Published, Green Submitted, gold			2022-12-26	WOS:000381620200003
J	Jiang, H; Liu, W; Zhan, SK; Pan, YX; Bian, LG; Sun, BM; Sun, QF; Pan, SJ				Jiang, Hong; Liu, Wei; Zhan, Shi-Kun; Pan, Yi-Xin; Bian, Liu-Guan; Sun, Bomin; Sun, Qing-Fang; Pan, Si-Jian			GSK621 Targets Glioma Cells via Activating AMP-Activated Protein Kinase Signalings	PLOS ONE			English	Article							CANCER CELLS; APOPTOSIS; GROWTH; CYTOTOXICITY; INHIBITION; EXPRESSION; METFORMIN	Here, we studied the anti-glioma cell activity by a novel AMP-activated protein kinase (AMPK) activator GSK621. We showed that GSK621 was cytotoxic to human glioma cells (U87MG and U251MG lines), possibly via provoking caspase-dependent apoptotic cell death. Its cytotoxicity was alleviated by caspase inhibitors. GSK621 activated AMPK to inhibit mammalian target of rapamycin (mTOR) and downregulate Tetraspanin 8 (Tspan8) in glioma cells. AMPK inhibition, through shRNA knockdown of AMPK alpha or introduction of a dominant negative (T172A) AMPK alpha, almost reversed GSK621-induced AMPK activation, mTOR inhibition and Tspan8 degradation. Consequently, GSK621's cytotoxicity in glioma cells was also significantly attenuated by AMPKa knockdown or mutation. Further studies showed that GSK621, at a relatively low concentration, significantly potentiated temozolomide (TMZ)'s sensitivity and lethality against glioma cells. We summarized that GSK621 inhibits human glioma cells possibly via activating AMPK signaling. This novel AMPK activator could be a novel and promising anti-glioma cell agent.	[Jiang, Hong; Bian, Liu-Guan; Sun, Qing-Fang; Pan, Si-Jian] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Neurosurg, Shanghai 200025, Peoples R China; [Liu, Wei; Zhan, Shi-Kun; Pan, Yi-Xin; Sun, Bomin] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Stereotact & Funct Neurosurg, Shanghai 200025, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Sun, QF; Pan, SJ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Neurosurg, Shanghai 200025, Peoples R China.	sunqingfang11@163.com; swordspan163@163.com	Pan, Yi/AAJ-2341-2021		National Natural Science Foundation of China [81441072, 81502140]; Fund of Shanghai Municipal Health Bureau [20124295]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fund of Shanghai Municipal Health Bureau	This project was supported by the National Natural Science Foundation of China (81441072) to S.P., the Fund of Shanghai Municipal Health Bureau (20124295) to S.P., and the National Natural Science Foundation of China (81502140) to W.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailane N, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00364; Averous J, 2008, ONCOGENE, V27, P1106, DOI 10.1038/sj.onc.1210715; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Chen MB, 2011, J CELL PHYSIOL, V226, P1915, DOI 10.1002/jcp.22522; Chen MB, 2011, CELL BIOCHEM BIOPHYS, V60, P311, DOI 10.1007/s12013-011-9153-0; Choi YK, 2013, MOL CELLS, V36, P279, DOI 10.1007/s10059-013-0169-8; Cui Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156915; Faubert B, 2015, CANCER LETT, V356, P165, DOI 10.1016/j.canlet.2014.01.018; Hardie DG, 2012, CHEM BIOL, V19, P1222, DOI 10.1016/j.chembiol.2012.08.019; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; He XY, 2013, BIOCHEM BIOPH RES CO, V435, P397, DOI 10.1016/j.bbrc.2013.04.099; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Ji C, 2010, ONCOGENE, V29, P6557, DOI 10.1038/onc.2010.379; Jiang G, 2011, BIOCHEM BIOPH RES CO, V406, P311, DOI 10.1016/j.bbrc.2011.02.042; Khasraw M, 2009, NAT REV NEUROL, V5, P646, DOI 10.1038/nrneurol.2009.194; Kim IY, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00175; Lefranc F, 2009, ADV TECH STAND NEURO, V34, P3, DOI 10.1007/978-3-211-78741-0_1; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; Lo Hui-Wen, 2010, Curr Mol Pharmacol, V3, P37; Luo ZJ, 2005, TRENDS PHARMACOL SCI, V26, P69, DOI 10.1016/j.tips.2004.12.011; Pan SJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11066; Pan SJ, 2015, BIOCHEM BIOPH RES CO, V458, P476, DOI 10.1016/j.bbrc.2015.01.128; Rocha GZ, 2011, CLIN CANCER RES, V17, P3993, DOI 10.1158/1078-0432.CCR-10-2243; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Su RY, 2007, MOL CANCER THER, V6, P1562, DOI 10.1158/1535-7163.MCT-06-0800; Sujobert P, 2015, CELL REP, V11, P1446, DOI 10.1016/j.celrep.2015.04.063; Sun H, 2011, CANCER LETT, V310, P118, DOI 10.1016/j.canlet.2011.06.010; Wang YZ, 2013, CANCER LETT, V331, P139, DOI 10.1016/j.canlet.2012.12.024; Westphal M, 2011, NAT REV NEUROSCI, V12, P495, DOI 10.1038/nrn3060; Yue SJ, 2013, EUR J CANCER, V49, P2934, DOI 10.1016/j.ejca.2013.03.032; Zhang WB, 2010, J BIOL CHEM, V285, P40461, DOI 10.1074/jbc.M110.164046	34	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161017	10.1371/journal.pone.0161017	http://dx.doi.org/10.1371/journal.pone.0161017			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532105	gold, Green Submitted, Green Published			2022-12-26	WOS:000381487600054
J	Pathak, A; Chauhan, A; Blom, J; Indest, KJ; Jung, CM; Stothard, P; Bera, G; Green, SJ; Ogram, A				Pathak, Ashish; Chauhan, Ashvini; Blom, Jochen; Indest, Karl J.; Jung, Carina M.; Stothard, Paul; Bera, Gopal; Green, Stefan J.; Ogram, Andrew			Comparative Genomics and Metabolic Analysis Reveals Peculiar Characteristics of Rhodococcus opacus Strain M213 Particularly for Naphthalene Degradation	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; HORIZONTAL GENE-TRANSFER; DEGRADING BACTERIUM; PSEUDOMONAS; SEQUENCE; ISLAND; SOIL; EVOLUTION; BIODEGRADATION; CATABOLISM	The genome of Rhodococcus opacus strain M213, isolated from a fuel-oil contaminated soil, was sequenced and annotated which revealed a genome size of 9,194,165 bp encoding 8680 putative genes and a G+ C content of 66.72%. Among the protein coding genes, 71.77% were annotated as clusters of orthologous groups of proteins (COGs); 55% of the COGs were present as paralog clusters. Pulsed field gel electrophoresis (PFGE) analysis of M213 revealed the presence of three different sized replicons-a circular chromosome and two megaplasmids (pNUO1 and pNUO2) estimated to be of 750Kb 350Kb in size, respectively. Conversely, using an alternative approach of optical mapping, the plasmid replicons appeared as a circular similar to 1.2 Mb megaplasmid and a linear, similar to 0.7 Mb megaplasmid. Genome-wide comparative analysis of M213 with a cohort of sequenced Rhodococcus species revealed low syntenic affiliation with other R. opacus species including strains B4 and PD630. Conversely, a closer affiliation of M213, at the functional (COG) level, was observed with the catabolically versatile R. jostii strain RHA1 and other Rhodococcii such as R. wratislaviensis strain IFP 2016, R. imtechensis strain RKJ300, Rhodococcus sp. strain JVH1, and Rhodococcus sp. strain DK17, respectively. An in-depth, genome-wide comparison between these functional relatives revealed 971 unique genes in M213 representing 11% of its total genome; many associating with catabolic functions. Of major interest was the identification of as many as 154 genomic islands (GEIs), many with duplicated catabolic genes, in particular for PAHs; a trait that was confirmed by PCR-based identification of naphthalene dioxygenase (NDO) as a representative gene, across PFGE-resolved replicons of strain M213. Interestingly, several plasmid/ GEI-encoded genes, that likely participate in degrading naphthalene (NAP) via a peculiar pathway, were also identified in strain M213 using a combination of bioinformatics, metabolic analysis and gene expression measurements of selected catabolic genes by RT-PCR. Taken together, this study provides a comprehensive understanding of the genome plasticity and ecological competitiveness of strain M213 likely facilitated by horizontal gene transfer (HGT), bacteriophage attacks and genomic reshuffling-aspects that continue to be understudied and thus poorly understood, in particular for the soil-borne Rhodococcii.	[Pathak, Ashish; Chauhan, Ashvini] Florida A&M Univ, Sch Environm, Tallahassee, FL 32307 USA; [Blom, Jochen] Univ Giessen, Bioinformat & Syst Biol, Giessen, Germany; [Indest, Karl J.; Jung, Carina M.] US Army Engn Res & Dev Ctr, Environm Proc Branch, Vicksburg, MS USA; [Stothard, Paul] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Bera, Gopal] Texas A&M Univ, Geochem & Environm Res Grp, College Stn, TX USA; [Green, Stefan J.] Univ Illinois, DNA Serv Facil, Chicago, IL USA; [Ogram, Andrew] Univ Florida, Soil & Water Sci Dept, Gainesville, FL USA	State University System of Florida; Florida A&M University; Justus Liebig University Giessen; United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC); University of Alberta; Texas A&M University System; Texas A&M University College Station; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; State University System of Florida; University of Florida	Chauhan, A (corresponding author), Florida A&M Univ, Sch Environm, Tallahassee, FL 32307 USA.	ashvini.chauhan@famu.edu	Pathak, Ashish/N-2303-2019; Chauhan, Ashvini/AAU-3285-2020; Bera, Gopal/J-1201-2018	Bera, Gopal/0000-0002-9426-3148; Jung, Carina/0000-0002-3171-7341; Green, Stefan/0000-0003-2781-359X	School of Graduate Studies, Florida AM University; Department of Defense (DoD) [W911NF-10-1-0146, W911NF-10-R-0006]; Savannah River Nuclear Solutions [0000217620]	School of Graduate Studies, Florida AM University; Department of Defense (DoD)(United States Department of Defense); Savannah River Nuclear Solutions	The authors acknowledge the support provide by the School of Graduate Studies, Florida A&M University and funding obtained from two grants funded by the Department of Defense (DoD)-W911NF-10-1-0146 and W911NF-10-R-0006. This study was also funded partly by the Savannah River Nuclear Solutions under subcontract #0000217620.	Alvarez HM, 2010, MICROBIOL MONOGR, V16, P263, DOI 10.1007/978-3-642-12937-7_10; Andreoni V, 2000, ENVIRON MICROBIOL, V2, P572, DOI 10.1046/j.1462-2920.2000.00134.x; Annweiler E, 2000, APPL ENVIRON MICROB, V66, P518, DOI 10.1128/AEM.66.2.518-523.2000; [Anonymous], [No title captured]; Auffret M, 2009, APPL ENVIRON MICROB, V75, P7774, DOI 10.1128/AEM.01117-09; Barcellos FG, 2007, APPL ENVIRON MICROB, V73, P2635, DOI 10.1128/AEM.01823-06; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Basu A, 2008, BIODEGRADATION, V19, P83, DOI 10.1007/s10532-007-9117-7; Bell KS, 1999, J APPL MICROBIOL, V87, P472, DOI 10.1046/j.1365-2672.1999.00824.x; Blom J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-154; Bostrom CE, 2002, ENVIRON HEALTH PERSP, V110, P451, DOI 10.1289/ehp.02110s3451; Bubinas A, 2008, CENT EUR J BIOL, V3, P61, DOI 10.2478/s11535-007-0042-x; Chao L, 2015, ANN MICROBIOL, P1, DOI [10.1007/s13213-015-1132-z, DOI 10.1007/S13213-015-1132-Z]; Choi KY, 2007, BIOCHEM BIOPH RES CO, V357, P766, DOI 10.1016/j.bbrc.2007.04.009; Creason Allison L, 2014, Front Plant Sci, V5, P406, DOI 10.3389/fpls.2014.00406; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Dhillon BK, 2015, NUCLEIC ACIDS RES, V43, pW104, DOI 10.1093/nar/gkv401; Di Gennaro P, 2001, RES MICROBIOL, V152, P641, DOI 10.1016/S0923-2508(01)01243-8; Dobrindt U, 2001, CURR OPIN MICROBIOL, V4, P550, DOI 10.1016/S1369-5274(00)00250-2; Duarte M, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau118; Ferrero M, 2002, APPL ENVIRON MICROB, V68, P957, DOI 10.1128/AEM.68.2.957-962.2002; Filonov AE, 2006, J CHEM TECHNOL BIOT, V81, P216, DOI 10.1002/jctb.1391; Fonger GC, 2014, TOXICOLOGY, V325, P209, DOI 10.1016/j.tox.2014.09.003; Gaillard M, 2006, J BACTERIOL, V188, P1999, DOI 10.1128/JB.188.5.1999-2013.2006; Gibson D.T., 1984, MICROBIAL DEGRADATIO, P182; Grant JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-202; GRUND E, 1992, APPL ENVIRON MICROB, V58, P1874, DOI 10.1128/AEM.58.6.1874-1877.1992; Gurtler V, 2004, FEMS MICROBIOL REV, V28, P377, DOI 10.1016/j.femsre.2004.01.001; Hacker J, 2001, EMBO REP, V2, P376, DOI 10.1093/embo-reports/kve097; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hickey WJ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00125; Husemann P, 2010, BIOINFORMATICS, V26, P570, DOI 10.1093/bioinformatics/btp690; Jin HM, 2011, J BACTERIOL, V193, P4292, DOI 10.1128/JB.05252-11; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Kapustka LA, 2004, HUM ECOL RISK ASSESS, V10, P185, DOI 10.1080/10807030490438166; Kim D, 2002, APPL ENVIRON MICROB, V68, P3270, DOI 10.1128/AEM.68.7.3270-3278.2002; Kimura N, 2006, APPL MICROBIOL BIOT, V73, P474, DOI 10.1007/s00253-006-0481-8; Krizova L, 2010, J ANTIMICROB CHEMOTH, V65, P1915, DOI 10.1093/jac/dkq223; Kulakov LA, 2005, APPL ENVIRON MICROB, V71, P1754, DOI 10.1128/AEM.71.4.1754-1764.2005; Kulakova AN, 1996, FEMS MICROBIOL LETT, V145, P227, DOI 10.1111/j.1574-6968.1996.tb08582.x; Kuyukina MS, 2010, MICROBIOL MONOGR, V16, P231, DOI 10.1007/978-3-642-12937-7_9; Laemmli CM, 2000, J BACTERIOL, V182, P4165, DOI 10.1128/JB.182.15.4165-4172.2000; Lalucat J, 2006, MICROBIOL MOL BIOL R, V70, P510, DOI 10.1128/MMBR.00047-05; Lane DJ, 1991, NUCL ACID TECHNIQUES, P115; Larkin MJ, 2006, ADV APPL MICROBIOL, V59, P1, DOI 10.1016/S0065-2164(06)59001-X; Larkin MJ, 2005, CURR OPIN BIOTECH, V16, P282, DOI 10.1016/j.copbio.2005.04.007; Larkin MJ, 1999, J BACTERIOL, V181, P6200, DOI 10.1128/JB.181.19.6200-6204.1999; Lin CL, 2012, MICROBIOL RES, V167, P395, DOI 10.1016/j.micres.2011.12.002; Liu TT, 2011, APPL MICROBIOL BIOT, V90, P671, DOI 10.1007/s00253-010-3033-1; Markowitz VM, 2014, NUCLEIC ACIDS RES, V42, pD560, DOI 10.1093/nar/gkt963; MASAI E, 1995, APPL ENVIRON MICROB, V61, P2079, DOI 10.1128/AEM.61.6.2079-2085.1995; McLeod MP, 2006, P NATL ACAD SCI USA, V103, P15582, DOI 10.1073/pnas.0607048103; Nishi A, 2000, J BACTERIOL, V182, P1949, DOI 10.1128/JB.182.7.1949-1955.2000; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Pathak A., 2012, THESIS; Pathak A, 2011, STRAT ENV RES DEV PR; Pathak A, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00144-12; Phale PS, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00234-12; Pierre B, 1999, ENV PHOTOCHEMISTRY; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Salinero KK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-351; Schuhle K, 2001, J BACTERIOL, V183, P5268, DOI 10.1128/JB.183.18.5268-5278.2001; SETO M, 1995, APPL ENVIRON MICROB, V61, P3353, DOI 10.1128/AEM.61.9.3353-3358.1995; Soares SC, 2015, J BIOTECHNOL; Suzuki K, 2002, J BACTERIOL, V184, P5714, DOI 10.1128/JB.184.20.5714-5722.2002; Tian L, 2003, PROCESS BIOCHEM, V38, P1125, DOI 10.1016/S0032-9592(02)00245-5; Tomas-Gallardo L, 2014, MICROB BIOTECHNOL, V7, P100, DOI 10.1111/1751-7915.12096; Toussaint A, 2003, APPL ENVIRON MICROB, V69, P4837, DOI 10.1128/AEM.69.8.4837-4845.2003; Tumapa S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-190; Uz I, 2000, FEMS MICROBIOL LETT, V185, P231, DOI 10.1111/j.1574-6968.2000.tb09067.x; van der Geize R, 2004, CURR OPIN MICROBIOL, V7, P255, DOI 10.1016/j.mib.2004.04.001; van Herwijnen R, 2006, FEMS MICROBIOL ECOL, V55, P122, DOI 10.1111/j.1574-6941.2005.00001.x; van Herwijnen R, 2003, APPL ENVIRON MICROB, V69, P186, DOI 10.1128/AEM.69.1.186-190.2003; Vikram S, 2012, J BACTERIOL, V194, P3543, DOI 10.1128/JB.00532-12; Yagi JM, 2009, ENVIRON MICROBIOL, V11, P2253, DOI 10.1111/j.1462-2920.2009.01947.x; Yoo M, 2012, J BACTERIOL, V194, P4440, DOI 10.1128/JB.00844-12	76	13	15	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161032	10.1371/journal.pone.0161032	http://dx.doi.org/10.1371/journal.pone.0161032			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532207	Green Published, Green Submitted, gold			2022-12-26	WOS:000381487600056
J	Sasic, L; Acanski, J; Vujic, A; Stahls, G; Radenkovic, S; Milic, D; Vidakovic, DO; Dan, M				Sasic, Ljiljana; Acanski, Jelena; Vujic, Ante; Stahls, Gunilla; Radenkovic, Snezana; Milic, Dubravka; Vidakovic, Dragana Obreht; Dan, Mihajla			Molecular and Morphological Inference of Three Cryptic Species within the Merodon aureus Species Group (Diptera: Syrphidae)	PLOS ONE			English	Article							ENVIRONMENTAL NICHE; TAXONOMY; COMPLEX; DELIMITATION; DIVERGENCE; MEIGEN; CONSERVATION; SYSTEMATICS; POPULATIONS; EXTENSIONS	The Merodon aureus species group (Diptera: Syrphidae: Eristalinae) comprises a number of different sub-groups and species complexes. In this study we focus on resolving the taxonomic status of the entity previously identified as M. cinereus B, here identified as M. atratus species complex. We used an integrative approach based on morphological descriptions, combined with supporting characters that were obtained from molecular analyses of the mitochondrial cytochrome c oxidase I gene as well as from geometric morphometry of wing and surstylus shapes and environmental niche comparisons. All applied data and methods distinguished and supported three morphologically cryptic species: M. atratus stat. nov., M. virgatus sp. nov. and M. balkanicus sp. nov., which constitute the M. atratus species complex. We present an identification key for the sub-groups and species complexes of the M. aureus species group occurring in Europe, describe the taxa and discuss the utility of the applied methods for species delimitation. The estimated divergence times for the species splits of these taxa coincide with the Pleistocene Gunz-Mindel interglaciation and the Great interglaciation (between the Ris and Mindel glacial periods).	[Sasic, Ljiljana; Vujic, Ante; Radenkovic, Snezana; Milic, Dubravka; Vidakovic, Dragana Obreht; Dan, Mihajla] Univ Novi Sad, Dept Biol & Ecol, Fac Sci, Novi Sad, Serbia; [Acanski, Jelena] Univ Novi Sad, BioSense Inst, Lab Biosyst Res, Res Inst Informat Technol Biosyst, Novi Sad, Serbia; [Stahls, Gunilla] Univ Helsinki, Zool Unit, Finnish Museum Nat Hist, Helsinki, Finland	University of Novi Sad; University of Novi Sad; University of Helsinki	Sasic, L (corresponding author), Univ Novi Sad, Dept Biol & Ecol, Fac Sci, Novi Sad, Serbia.	ljiljana.sasic@dbe.uns.ac.rs	Ačanski, Jelena/S-5383-2017; Vujic, Ante/AAG-2996-2020	Ačanski, Jelena/0000-0003-1745-6410; Sasic Zoric, Ljiljana/0000-0003-1616-2701; Stahls, Gunilla/0000-0003-0505-0691; Milic, Dubravka/0000-0002-8828-1489; Vujic, Ante/0000-0002-8819-8079	Ministry of Education, Science and Technological Development of Serbia [173002]	Ministry of Education, Science and Technological Development of Serbia(Ministry of Education, Science & Technological Development, Serbia)	This work was supported by the Ministry of Education, Science and Technological Development of Serbia (http://www.mpn.gov.rs/), Grant Number 173002 (Conservation strategies for the preservation of protected and strictly protected species in Serbia-hoverflies (Insecta: Diptera: Syrphidae) as model organisms); AV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acanski J, 2016, ARCH BIOL S IN PRESS; Acanski J, 2016, EUR J TAXON IN PRESS; Aguirre-Gutierrez J, 2015, DIVERS DISTRIB, V21, P245, DOI 10.1111/ddi.12268; Andric A, 2014, ACTA ENT MUS NAT PRA, V54, P741; Marcos-Garcia MA, 2011, CAN ENTOMOL, V143, P332, DOI 10.4039/n11-013; [Anonymous], 2014, TRACER V1 6; Avise JC, 2000, PHYLOGEOGRAPHY HIST, DOI 10.2307/j.ctv1nzfgj7; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bookstein FL, 1997, MED IMAGE ANAL, V1, P225, DOI DOI 10.1016/S1361-8415(97)85012-8; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Burns John M., 2007, Journal of the Lepidopterists' Society, V61, P138; Chen H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011963; Cognato AI, 2006, J ECON ENTOMOL, V99, P1037, DOI 10.1603/0022-0493-99.4.1037; Debandi G, 2012, AUSTRAL ECOL, V37, P392, DOI 10.1111/j.1442-9993.2011.02295.x; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Francuski L, 2011, J INSECT CONSERV, V15, P379, DOI 10.1007/s10841-010-9311-5; Goloboff P. A, 1999, NONA COMPUTER PROGRA; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hasson Esteban, 2009, P89; Hawlitschek O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016662; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Hippa Heikki, 2005, Acta Zoologica Fennica, V215, P1; House CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063807; Kambhampati S, 2007, BIOL J LINN SOC, V90, P457, DOI 10.1111/j.1095-8312.2006.00734.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Knowles LL, 2000, EVOLUTION, V54, P1337, DOI 10.1111/j.0014-3820.2000.tb00566.x; Kukla G, 2005, QUATERNARY SCI REV, V24, P1573, DOI 10.1016/j.quascirev.2004.08.023; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MANTEL N, 1967, CANCER RES, V27, P209; Marcos-Garcia MA, 2007, EUR J ENTOMOL, V104, P531, DOI 10.14411/eje.2007.073; Masetti A, 2006, EUR J ENTOMOL, V103, P459, DOI 10.14411/eje.2006.059; Mengual Ximo, 2006, Zootaxa, V1377, P1; Milankov V, 2008, CONSERV GENET, V9, P1125, DOI 10.1007/s10592-007-9426-8; Milankov V, 2013, BIOL J LINN SOC, V110, P257, DOI 10.1111/bij.12127; Milankovitch M., 1941, CANON INSOLATION ICE, V133, P633; Miller M.A., 2010, P GAT COMP ENV WORKS; Montgomery D. C., 1992, INTRO LINEAR REGRESS; Mutanen M, 2007, SYST ENTOMOL, V32, P371, DOI 10.1111/j.1365-3113.2006.00372.x; Naimi B., 2015, R PACKAGE VERSION, P1; Nedeljkovic Z, 2015, CONTRIB ZOOL, V84, P285, DOI 10.1163/18759866-08404002; Nedeljkovic Z, 2013, ZOOL J LINN SOC-LOND, V169, P84, DOI 10.1111/zoj.12052; Nixon K.C., 2002, WINCLADA VER 1 00 08; Oldenberg L., 1919, DTSCH ENTOMOL Z, P387; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Penman TD, 2005, J BIOGEOGR, V32, P397, DOI 10.1111/j.1365-2699.2005.01205.x; Perez-Banon C, 2003, EUR J ENTOMOL, V100, P417, DOI 10.14411/eje.2003.064; Petersen MJ, 2013, BIOL INVASIONS, V15, P885, DOI 10.1007/s10530-012-0337-3; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Popovic D, 2015, EUR J ENTOMOL, V112, P790, DOI 10.14411/eje.2015.100; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; R Core Team, 2021, R LANGUAGE ENV STAT; Radenkovic S, 2011, ZOOTAXA, P35, DOI 10.11646/zootaxa.2735.1.5; RAMBAUT A., 2014, FIGTREE 1 4 4 SOFTWA; Rissler LJ, 2007, SYST BIOL, V56, P924, DOI 10.1080/10635150701703063; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Rohlf FJ., 2006, TPSDIG DIGITIZE LAND; Rosenberg MS, 2011, METHODS ECOL EVOL, V2, P229, DOI 10.1111/j.2041-210X.2010.00081.x; Rutschmann F, 2006, DIVERS DISTRIB, V12, P35, DOI 10.1111/j.1366-9516.2006.00210.x; Schmitt T, 2009, VYVOJ PRIRODY SLOVEN, P143; Schmitt T, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-9; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; Sheets HD, 2012, IMP SOFTW SER; Sheffield CS, 2009, MOL ECOL RESOUR, V9, P196, DOI 10.1111/j.1755-0998.2009.02645.x; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Speight MCD., 2014, SYRPH NET DATABASE E, V78; Stahls G, 2009, MOL ECOL RESOUR, V9, P1431, DOI 10.1111/j.1755-0998.2009.02592.x; Stahls G, 2008, ANN ZOOL FENN, V45, P149, DOI 10.5735/086.045.0206; Stamatakis A., 2014, BIOINFORMATICS, V21; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vujic A, 2007, ANN SOC ENTOMOL FR, V43, P319, DOI 10.1080/00379271.2007.10697527; Vujic A, 2015, ZOOTAXA, V4006, P439, DOI 10.11646/zootaxa.4006.3.2; Vujic A, 2013, ZOOL SCR, V42, P288, DOI 10.1111/zsc.12005; Vujic A, 2012, SYST ENTOMOL, V37, P578, DOI 10.1111/j.1365-3113.2012.00631.x; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Zelditch ML, 2004, GEOMETRIC MORPHOMETR; Zhu GP, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.10201	86	37	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160001	10.1371/journal.pone.0160001	http://dx.doi.org/10.1371/journal.pone.0160001			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532618	Green Published, Green Submitted, gold			2022-12-26	WOS:000381487600020
J	Wu, YH; Lee, WJ; Chen, YH; Chang, MH; Lin, CH				Wu, Yu-Hsuan; Lee, Wei-Ju; Chen, Yi-Huei; Chang, Ming-Hong; Lin, Ching-Heng			Premotor Symptoms as Predictors of Outcome in Parkinsons Disease: A Case-Control Study	PLOS ONE			English	Article							SLEEP BEHAVIOR DISORDER; SUBTHALAMIC NUCLEUS; STIMULATION; PREVALENCE; TAIWAN; RISK	Background To evaluate the association between the premotor symptoms and the prognosis of PD. Methods A total of 1213 patients who were diagnosed of PD from January 2001 to December 2008 were selected from the Taiwan's National Health Insurance Research Database. Patients were traced back to determine the presence of premotor symptoms, including rapid eye movement sleep behavior disorder (RBD), depression, and constipation. Cox's regression analysis was used to detect the risks between the occurrence of premotor symptoms and the outcome (including death, psychosis, accidental injury, dementia and aspiration pneumonia). In addition, the association between premotor symptoms and levodopa equivalent dosage (LED) was examined. Results Higher occurrence of death, dementia and aspiration pneumonia were identified in PD patients with premotor symptoms than without premotor symptoms (HR 1.69, 95% CI 1.342 .14, p < 0.001 for death; HR 1.63, 95% CI 1.20-2.22, p = 0.002 for dementia; HR 2.45, 95% CI 1.42-4.21, p = 0.001 for aspiration pneumonia). In a comorbidities-stratified analysis, PD patients with premotor symptoms showed significantly high risks of mortality and morbidity (dementia and aspiration pneumonia), especially in the absence of comorbidities. Independent predictors of mortality in PD were found to be higher age, male sex, constipation, RBD, RBD with constipation and depression, and diabetes. Furthermore, no significant differences of LED and subsequent accidental injury were noted between PD patient with or without premotor symptoms. Conclusion Premotor symptoms seem to be not merely risk factors, but also prognostic factors of PD.	[Wu, Yu-Hsuan; Lee, Wei-Ju; Chang, Ming-Hong] Taichung Vet Gen Hosp, Neurol Sect, Taichung, Taiwan; [Lee, Wei-Ju; Chang, Ming-Hong] Natl Yang Ming Univ, Sch Med, Dept Neurol, Taipei, Taiwan; [Chen, Yi-Huei; Lin, Ching-Heng] Taichung Vet Gen Hosp, Dept Med Educ & Res, Taichung, Taiwan	Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital	Chang, MH (corresponding author), Taichung Vet Gen Hosp, Neurol Sect, Taichung, Taiwan.; Chang, MH (corresponding author), Natl Yang Ming Univ, Sch Med, Dept Neurol, Taipei, Taiwan.; Lin, CH (corresponding author), Taichung Vet Gen Hosp, Dept Med Educ & Res, Taichung, Taiwan.	cmh50@ms10.hinet.net; joelin99@gmail.com		Lee, Wei-Ju/0000-0002-3720-4539	Taichung Veterans General Hospital [TCVGH-1053402C, TCVGH-1053404D]	Taichung Veterans General Hospital	Full financial support for all authors came from the Taichung Veterans General Hospital (TCVGH-1053402C and TCVGH-1053404D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhidayasiri R, 2012, PARKINSONISM RELAT D, V18, P694, DOI 10.1016/j.parkreldis.2012.01.010; Chen RC, 2001, NEUROLOGY, V57, P1679, DOI 10.1212/WNL.57.9.1679; de Lau LML, 2014, PARKINSONISM RELAT D, V20, P613, DOI 10.1016/j.parkreldis.2014.02.030; Guo YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107465; Hely MA, 2005, MOVEMENT DISORD, V20, P190, DOI 10.1002/mds.20324; Hsieh LP, 2011, EPILEPSY RES, V96, P81, DOI 10.1016/j.eplepsyres.2011.05.003; Jennum P, 2013, SLEEP MED, V14, P782, DOI 10.1016/j.sleep.2012.11.002; Kang SH, 2013, SLEEP, V36, P1147, DOI 10.5665/sleep.2874; Krack P, 2003, NEW ENGL J MED, V349, P1925, DOI 10.1056/NEJMoa035275; Lang AE, 2011, MOVEMENT DISORD, V26, P775, DOI 10.1002/mds.23609; Lebouvier T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012728; Lin CH, 2014, PARKINSONISM RELAT D, V20, P1371, DOI 10.1016/j.parkreldis.2014.09.026; Morgan JC, 2014, PARKINSONS DIS-US, V2014, DOI 10.1155/2014/426976; O'Sullivan SS, 2008, MOVEMENT DISORD, V23, P101, DOI 10.1002/mds.21813; Romenets Silvia Rios, 2012, Mov Disord, V27, P996, DOI 10.1002/mds.25086; Shen CC, 2013, NEUROLOGY, V81, P1538, DOI 10.1212/WNL.0b013e3182a956ad; Wu YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130282; Yamada K, 2008, ACTA NEUROCHIR, V150, P15, DOI 10.1007/s00701-007-1451-3	18	8	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161271	10.1371/journal.pone.0161271	http://dx.doi.org/10.1371/journal.pone.0161271			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27533053	Green Published, gold, Green Submitted			2022-12-26	WOS:000381487600080
J	Mahamoud, YS; Aite, M; Martin, C; Zhadobov, M; Sauleau, R; Le Drean, Y; Habauzit, D				Mahamoud, Yonis Soubere; Aite, Meziane; Martin, Catherine; Zhadobov, Maxim; Sauleau, Ronan; Le Drean, Yves; Habauzit, Denis			Additive Effects of Millimeter Waves and 2-Deoxyglucose Co-Exposure on the Human Keratinocyte Transcriptome	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; CHEMICAL GENOMICS; GENE-EXPRESSION; B-CELL; T-CELL; 2-DEOXY-D-GLUCOSE; DOSIMETRY; STRESS; CYCLOPHOSPHAMIDE; APOPTOSIS	Millimeter Waves (MMW) will be used in the next-generation of high-speed wireless technologies, especially in future Ultra-Broadband small cells in 5G cellular networks. Therefore, their biocompatibilities must be evaluated prior to their massive deployment. Using a micro-array-based approach, we analyzed modifications to the whole genome of a human keratinocyte model that was exposed at 60.4 GHz-MMW at an incident power density (IPD) of 20 mW/cm(2) for 3 hours in athermic conditions. No keratinocyte transcriptome modifications were observed. We tested the effects of MMWs on cell metabolism by co-treating MMW-exposed cells with a glycolysis inhibitor, 2-deoxyglucose (2dG, 20 mM for 3 hours), and whole genome expression was evaluated along with the ATP content. We found that the 2dG treatment decreased the cellular ATP content and induced a high modification in the transcriptome (632 coding genes). The affected genes were associated with transcriptional repression, cellular communication and endoplasmic reticulum homeostasis. The MMW/2dG co-treatment did not alter the keratinocyte ATP content, but it did slightly alter the transcriptome, which reflected the capacity of MMWto interfere with the bioenergetic stress response. The RT-PCR-based validation confirmed 6 MMW-sensitive genes (SOCS3, SPRY2, TRIB1, FAM46A, CSRNP1 and PPP1R15A) during the 2dG treatment. These 6 genes encoded transcription factors or inhibitors of cytokine pathways, which raised questions regarding the potential impact of long-term or chronic MMW exposure on metabolically stressed cells.	[Mahamoud, Yonis Soubere; Aite, Meziane; Martin, Catherine; Le Drean, Yves; Habauzit, Denis] INSERM, UMR 1085, Irset, Transcript Environm & Canc Grp TREC, Rennes, France; [Mahamoud, Yonis Soubere; Aite, Meziane; Martin, Catherine; Zhadobov, Maxim; Sauleau, Ronan; Le Drean, Yves; Habauzit, Denis] Univ Rennes 1, Rennes, France; [Zhadobov, Maxim; Sauleau, Ronan] CNRS, UMR 6164, IETR, Rennes, France; [Mahamoud, Yonis Soubere] Univ Djibouti, Djibouti City, Djibouti	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); University Djibouti	Habauzit, D (corresponding author), INSERM, UMR 1085, Irset, Transcript Environm & Canc Grp TREC, Rennes, France.; Habauzit, D (corresponding author), Univ Rennes 1, Rennes, France.	denis.habauzit@univ-rennes1.fr	Habauzit, Denis/K-1779-2015; Zhadobov, Maxim/P-6492-2016	Habauzit, Denis/0000-0001-8101-3839; Zhadobov, Maxim/0000-0002-3809-110X; Sauleau, Ronan/0000-0001-7510-9762	French National Research Agency (Agence Nationale de la Recherche, ANR) [10-CESA-017-01]; French Agency for Food, Environmental and Occupational Health Safety (ANSES) [EST-2014/2 RF/012]	French National Research Agency (Agence Nationale de la Recherche, ANR)(French National Research Agency (ANR)); French Agency for Food, Environmental and Occupational Health Safety (ANSES)	This work was supported by the French National Research Agency (Agence Nationale de la Recherche, ANR), under grant number 10-CESA-017-01 (BioREF project) and by the French Agency for Food, Environmental and Occupational Health & Safety (ANSES), under grant number EST-2014/2 RF/012 (BEMAM project). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseev SI, 2008, BIOELECTROMAGNETICS, V29, P65, DOI 10.1002/bem.20363; [Anonymous], 1998, HEALTH PHYS, V74, P494; Caraglia M, 2005, J CELL PHYSIOL, V204, P539, DOI 10.1002/jcp.20327; Cojocari D, 2013, RADIOTHER ONCOL, V108, P541, DOI 10.1016/j.radonc.2013.06.005; FORNACE AJ, 1988, P NATL ACAD SCI USA, V85, P8800, DOI 10.1073/pnas.85.23.8800; Frank MJ, 2009, BLOOD, V113, P2478, DOI 10.1182/blood-2008-05-156943; Gapeyev AB, 2009, BIOELECTROMAGNETICS, V30, P454, DOI 10.1002/bem.20499; Ha YT, 2010, INT J RADIAT BIOL, V86, P27, DOI 10.3109/09553000903264507; Habauzit D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109435; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2013, IARC Monogr Eval Carcinog Risks Hum, V102, P1; Ikeda J, 1997, BIOCHEM BIOPH RES CO, V230, P94, DOI 10.1006/bbrc.1996.5890; Jing W, WEB BASED GENE SET A; Joshi MB, 2013, FEBS LETT, V587, P2241, DOI 10.1016/j.febslet.2013.05.053; Ke XQ, 2008, INT J RADIAT BIOL, V84, P413, DOI 10.1080/09553000801998875; Kunz S, 2006, EXP DERMATOL, V15, P991, DOI 10.1111/j.1600-0625.2006.00516.x; Le Drean Y, 2013, CR PHYS, V14, P402, DOI 10.1016/j.crhy.2013.02.005; Le Quement C, 2014, BIOELECTROMAGNETICS, V35, P444, DOI 10.1002/bem.21864; Li YM, 2014, ACTA BIOCH BIOPH SIN, V46, P629, DOI 10.1093/abbs/gmu048; Logani MK, 2012, IMMUNOPHARM IMMUNOT, V34, P107, DOI 10.3109/08923973.2011.583252; Lu YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108318; Makar VR, 2006, BIOELECTROMAGNETICS, V27, P458, DOI 10.1002/bem.20230; Maschek G, 2004, CANCER RES, V64, P31, DOI 10.1158/0008-5472.CAN-03-3294; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Puigdecanet E, 2008, LEUKEMIA, V22, P1368, DOI 10.1038/leu.2008.112; Radzievsky AA, 2008, BIOELECTROMAGNETICS, V29, P284, DOI 10.1002/bem.20389; Rainard P, 2008, MOL IMMUNOL, V45, P4020, DOI 10.1016/j.molimm.2008.06.010; Rojavin MA, 1998, QJM-MON J ASSOC PHYS, V91, P57, DOI 10.1093/qjmed/91.1.57; Saito S, 2011, METHOD ENZYMOL, V491, P327, DOI 10.1016/B978-0-12-385928-0.00018-3; Saito S, 2009, CANCER RES, V69, P4225, DOI 10.1158/0008-5472.CAN-08-2689; Shefler I, 2014, J ALLERGY CLIN IMMUN, V133, P217, DOI 10.1016/j.jaci.2013.04.035; Simons AL, 2007, INT J RADIAT ONCOL, V69, P1222, DOI 10.1016/j.ijrobp.2007.07.2343; Simons AL, 2009, J CANCER RES THER, V5, P2, DOI 10.4103/0973-1482.55133; Skobowiat C, 2011, AM J PHYSIOL-ENDOC M, V301, pE484, DOI [10.1152/ajpendo.00217.2011, 10.1152/ajpendo.00217.2011.]; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; SLOMINSKI A, 2013, J STEROID BIOCHEM, V137, P107, DOI [10.1016/.jsbmb.2013.02.006, DOI 10.1016/J.JSBMB.2013.02.006]; Usichenko TI, 2006, EVID-BASED COMPL ALT, V3, P201, DOI 10.1093/ecam/nel012; van Galen P, 2014, NATURE, V510, P268, DOI 10.1038/nature13228; WARBURG O, 1956, SCIENCE, V124, P269; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yang XS, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-54; Zhadobov M, 2012, BIOELECTROMAGNETICS, V33, P55, DOI 10.1002/bem.20685; Zhadobov M, 2008, IEEE T MICROW THEORY, V56, P2998, DOI 10.1109/TMTT.2008.2006797; Zhang Hua, 2008, Zhonghua Fu Chan Ke Za Zhi, V43, P356; Zhang XD, 2006, ANTICANCER RES, V26, P3561; Zheng YZ, 2014, BREAST CANCER RES TR, V145, P349, DOI 10.1007/s10549-014-2967-x; Zhong DS, 2009, J BIOL CHEM, V284, P23225, DOI 10.1074/jbc.M109.005280	49	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160810	10.1371/journal.pone.0160810	http://dx.doi.org/10.1371/journal.pone.0160810			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529420	gold, Green Published, Green Submitted			2022-12-26	WOS:000381476700022
J	Martin, BR; Lambert, NA				Martin, Brent R.; Lambert, Nevin A.			Activated G Protein G alpha(s) Samples Multiple Endomembrane Compartments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endosome; G protein-coupled receptor (GPCR); heterotrimeric G protein; intracellular trafficking; lipase; protein acylation; protein palmitoylation; endosomes	HETEROTRIMERIC G-PROTEINS; INDUCED SUBCELLULAR REDISTRIBUTION; BETA-ADRENERGIC-RECEPTOR; PLASMA-MEMBRANE; ALPHA-SUBUNITS; CHOLERA-TOXIN; PALMITOYLATION; RAS; TRANSLOCATION; LOCALIZATION	Heterotrimeric G proteins are localized to the plasma membrane where they transduce extracellular signals to intracellular effectors. G proteins also act at intracellular locations, and can translocate between cellular compartments. For example, G(s) can leave the plasma membrane and move to the cell interior after activation. However, the mechanism of G(s) translocation and its intracellular destination are not known. Here we use bioluminescence resonance energy transfer (BRET) to show that after activation, G(s) rapidly associates with the endoplasmic reticulum, mitochondria, and endosomes, consistent with indiscriminate sampling of intracellular membranes from the cytosol rather than transport via a specific vesicular pathway. The primary source of G(s) for endosomal compartments is constitutive endocytosis rather than activity-dependent internalization. Recycling of G(s) to the plasma membrane is complete 25 min after stimulation is discontinued. We also show that an acylation-deacylation cycle is important for the steady-state localization of G(s) at the plasma membrane, but our results do not support a role for deacylation in activity-dependent G(s) internalization.	[Martin, Brent R.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Lambert, Nevin A.] Augusta Univ, Dept Pharmacol & Toxicol, Med Coll Georgia, CB3522,1120 15th St, Augusta, GA 30912 USA	University of Michigan System; University of Michigan; University System of Georgia; Augusta University	Lambert, NA (corresponding author), Augusta Univ, Dept Pharmacol & Toxicol, Med Coll Georgia, CB3522,1120 15th St, Augusta, GA 30912 USA.	nelambert@augusta.edu	Martin, Brent/B-4370-2012	Martin, Brent/0000-0002-7136-2397	National Institutes of Health [GM078319, GM109879, GM114848]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP2GM114848, R01GM078319, R01GM109879] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants GM078319 and GM109879 (to N. A. L.) and GM114848 (to B. R. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allen JA, 2005, MOL PHARMACOL, V67, P1493, DOI 10.1124/mol.104.008342; Balla A, 2012, J BIOL CHEM, V287, P9090, DOI 10.1074/jbc.M111.293944; DEGTYAREV MY, 1993, J BIOL CHEM, V268, P23769; DEGTYAREV MY, 1993, BIOCHEMISTRY-US, V32, P8057, DOI 10.1021/bi00083a001; Duncan JA, 1998, J BIOL CHEM, V273, P15830, DOI 10.1074/jbc.273.25.15830; Evanko DS, 2000, J BIOL CHEM, V275, P1327, DOI 10.1074/jbc.275.2.1327; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Goodwin JS, 2005, J CELL BIOL, V170, P261, DOI 10.1083/jcb.200502063; Hein P, 2006, J BIOL CHEM, V281, P33345, DOI 10.1074/jbc.M606713200; Hewavitharana T, 2012, CELL SIGNAL, V24, P25, DOI 10.1016/j.cellsig.2011.08.014; Hynes TR, 2004, J BIOL CHEM, V279, P44101, DOI 10.1074/jbc.M405151200; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Jalink K, 2010, BIOESSAYS, V32, P13, DOI 10.1002/bies.200900153; Jones TLZ, 1997, BIOCHEMISTRY-US, V36, P7185, DOI 10.1021/bi9628376; KUISMANEN E, 1989, METHOD CELL BIOL, V32, P257; Lan TH, 2012, TRAFFIC, V13, P1450, DOI 10.1111/j.1600-0854.2012.01401.x; Lan TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017361; LINDER ME, 1993, P NATL ACAD SCI USA, V90, P3675, DOI 10.1073/pnas.90.8.3675; Loening AM, 2006, PROTEIN ENG DES SEL, V19, P391, DOI 10.1093/protein/gzl023; LYNCH CJ, 1986, FEBS LETT, V200, P333, DOI 10.1016/0014-5793(86)81163-2; Marrari Y, 2007, BIOCHEMISTRY-US, V46, P7665, DOI 10.1021/bi700338m; Martin BR, 2012, NAT METHODS, V9, P84, DOI [10.1038/NMETH.1769, 10.1038/nmeth.1769]; MUMBY SM, 1994, P NATL ACAD SCI USA, V91, P2800, DOI 10.1073/pnas.91.7.2800; O'Neill PR, 2012, P NATL ACAD SCI USA, V109, pE3568, DOI 10.1073/pnas.1205345109; RANSNAS LA, 1989, P NATL ACAD SCI USA, V86, P7900, DOI 10.1073/pnas.86.20.7900; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Saini DK, 2009, TRENDS PHARMACOL SCI, V30, P278, DOI 10.1016/j.tips.2009.04.001; Scarselli M, 2009, J BIOL CHEM, V284, P3577, DOI 10.1074/jbc.M806819200; Slepak VZ, 2008, IUBMB LIFE, V60, P2, DOI 10.1002/iub.7; Takida S, 2004, FEBS LETT, V567, P209, DOI 10.1016/j.febslet.2004.04.062; Thiyagarajan MM, 2002, BIOCHEMISTRY-US, V41, P9470, DOI 10.1021/bi025533u; Tsvetanova NG, 2015, J BIOL CHEM, V290, P6689, DOI 10.1074/jbc.R114.617951; Vilardaga JP, 2014, NAT CHEM BIOL, V10, P700, DOI [10.1038/nchembio.1611, 10.1038/NCHEMBIO.1611]; Wedegaertner PB, 1996, MOL BIOL CELL, V7, P1225, DOI 10.1091/mbc.7.8.1225; WEDEGAERTNER PB, 1994, CELL, V77, P1063, DOI 10.1016/0092-8674(94)90445-6; Wedegaertner Philip B, 2012, Subcell Biochem, V63, P193, DOI 10.1007/978-94-007-4765-4_11; Yu JZ, 2002, MOL PHARMACOL, V61, P352, DOI 10.1124/mol.61.2.352; Zheng H, 2007, J BIOL CHEM, V282, P25760, DOI 10.1074/jbc.M700437200	38	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20295	20302		10.1074/jbc.M116.729731	http://dx.doi.org/10.1074/jbc.M116.729731			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27528603	hybrid, Green Published			2022-12-26	WOS:000384574800002
J	Librero, J; Sanfelix-Gimeno, G; Peiro, S				Librero, Julian; Sanfelix-Gimeno, Gabriel; Peiro, Salvador			Medication Adherence Patterns after Hospitalization for Coronary Heart Disease. A Population-Based Study Using Electronic Records and Group-Based Trajectory Models	PLOS ONE			English	Article							GROWTH MIXTURE-MODELS; DRUG-THERAPY; LATENT; OUTCOMES; OVEREXTRACTION; NONADHERENCE; PREDICTORS; VALIDITY; NUMBER	Objective To identify adherence patterns over time and their predictors for evidence-based medications used after hospitalization for coronary heart disease (CHD). Patients and Methods We built a population-based retrospective cohort of all patients discharged after hospitalization for CHD from public hospitals in the Valencia region (Spain) during 2008 (n = 7462). From this initial cohort, we created 4 subcohorts with at least one prescription (filled or not) from each therapeutic group (antiplatelet, beta-blockers, ACEI/ARB, statins) within the first 3 months after discharge. Monthly adherence was defined as having >= 24 days covered out of 30, leading to a repeated binary outcome measure. We assessed the membership to trajectory groups of adherence using group-based trajectory models. We also analyzed predictors of the different adherence patterns using multinomial logistic regression. Results We identified a maximum of 5 different adherence patterns: 1) Nearly-always adherent patients; 2) An early gap in adherence with a later recovery; 3) Brief gaps in medication use or occasional users; 4) A slow decline in adherence; and 5) A fast decline. These patterns represented variable proportions of patients, the descending trajectories being more frequent for the beta-blocker and ACEI/ARB cohorts (16% and 17%, respectively) than the antiplatelet and statin cohorts (10% and 8%, respectively). Predictors of poor or intermediate adherence patterns were having a main diagnosis of unstable angina or other forms of CHD vs. AMI in the index hospitalization, being born outside Spain, requiring copayment or being older. Conclusion Distinct adherence patterns over time and their predictors were identified. This may be a useful approach for targeting improvement interventions in patients with poor adherence patterns.	[Librero, Julian; Sanfelix-Gimeno, Gabriel; Peiro, Salvador] Ctr Publ Hlth Res CSISP FISABIO, Hlth Serv Res Unit, Valencia, Spain; [Librero, Julian; Sanfelix-Gimeno, Gabriel; Peiro, Salvador] Red Invest Serv Salud Enfermedades Cron REDISSEC, Valencia, Spain		Sanfelix-Gimeno, G (corresponding author), Ctr Publ Hlth Res CSISP FISABIO, Hlth Serv Res Unit, Valencia, Spain.; Sanfelix-Gimeno, G (corresponding author), Red Invest Serv Salud Enfermedades Cron REDISSEC, Valencia, Spain.	sanfelix_gab@gva.es	Peiro, Salvador/H-5778-2017; Librero, Julian/F-4947-2017; Sanfélix-Gimeno, Gabriel/E-9140-2012	Peiro, Salvador/0000-0002-3902-569X; Librero, Julian/0000-0002-4859-9054; Sanfélix-Gimeno, Gabriel/0000-0001-7098-4576	Department of Health of the Valencia Government [678/2007, 011/2011, PCC-3/1]; Spanish Health Economics Association (the Research grant in Health Economics and Health Services)	Department of Health of the Valencia Government; Spanish Health Economics Association (the Research grant in Health Economics and Health Services)	This work was supported by the Department of Health of the Valencia Government [grant numbers 678/2007, 011/2011 and PCC-3/1] and the Spanish Health Economics Association (the 2012 Research grant in Health Economics and Health Services). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bastard M, 2011, JAIDS-J ACQ IMM DEF, V57, P55, DOI 10.1097/QAI.0b013e318211b43b; Bauer DJ, 2007, MULTIVAR BEHAV RES, V42, P757, DOI 10.1080/00273170701710338; Bauer DJ, 2004, PSYCHOL METHODS, V9, P3, DOI 10.1037/1082-989X.9.1.3; Bauer DJ, 2003, PSYCHOL METHODS, V8, P384, DOI 10.1037/1082-989X.8.3.384; Bauer DJ, 2003, PSYCHOL METHODS, V8, P338, DOI 10.1037/1082-989X.8.3.338; Bitton A, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2012.09.004; Bogner HR, 2006, INT J PSYCHIAT MED, V36, P103, DOI 10.2190/DJH3-Y4R0-R3KG-JYCC; Chan DC, 2010, MED CARE, V48, P196, DOI 10.1097/MLR.0b013e3181c132ad; Chen HY, 2015, HEART LUNG, V44, P299, DOI 10.1016/j.hrtlng.2015.02.004; Crystal S, 2007, MED CARE, V45, pS58, DOI 10.1097/MLR.0b013e31805371bf; Franklin JM, 2013, MED CARE, V51, P789, DOI 10.1097/MLR.0b013e3182984c1f; Grymonpre R, 2006, MED CARE, V44, P471, DOI 10.1097/01.mlr.0000207817.32496.cb; Ho PM, 2008, AM HEART J, V155, P772, DOI 10.1016/j.ahj.2007.12.011; Hoeksma JB, 2006, INFANT CHILD DEV, V15, P627, DOI 10.1002/icd.483; Hoekstra T, 2013, THESIS; Li YF, 2014, CLINICOECONOMIC OUTC, V6, P197, DOI 10.2147/CEOR.S59339; Lo YT, 2001, BIOMETRIKA, V88, P767, DOI 10.1093/biomet/88.3.767; Modi AC, 2011, JAMA-J AM MED ASSOC, V305, P1669, DOI 10.1001/jama.2011.506; Modi AC, 2010, J PEDIATR PSYCHOL, V35, P1028, DOI 10.1093/jpepsy/jsq015; Muthen B, 2000, ALCOHOL CLIN EXP RES, V24, P882, DOI 10.1111/j.1530-0277.2000.tb02070.x; Muthen L. K., 2007, MPLUS USERS GUIDE 19; Nagin DS, 2010, ANNU REV CLIN PSYCHO, V6, P109, DOI 10.1146/annurev.clinpsy.121208.131413; Nagin DS, 2001, PSYCHOL METHODS, V6, P18, DOI 10.1037/1082-989X.6.1.18; Newman-Casey PA, 2015, OPHTHALMOLOGY, V122, P2010, DOI 10.1016/j.ophtha.2015.06.039; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; R Development Core Team, 2012, R LANG ENV STAT COMP; Riegel B, 2012, CIRC-HEART FAIL, V5, P430, DOI 10.1161/CIRCHEARTFAILURE.111.965152; Roebuck MC, 2011, HEALTH AFFAIR, V30, P91, DOI 10.1377/hlthaff.2009.1087; Sanfelix-Gimeno G, 2014, MED CARE, V52, P669, DOI 10.1097/MLR.0000000000000148; Sanfelix-Gimeno G, 2013, J MANAGE CARE PHARM, V19, P247, DOI 10.18553/jmcp.2013.19.3.247; Schneeweiss S, 2005, J CLIN EPIDEMIOL, V58, P323, DOI 10.1016/j.jclinepi.2004.10.012; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Simpson SH, 2006, BMJ-BRIT MED J, V333, P15, DOI 10.1136/bmj.38875.675486.55; Stanger C, 2006, INFANT CHILD DEV, V15, P635, DOI 10.1002/icd.484; Steiner JF, 1997, J CLIN EPIDEMIOL, V50, P105, DOI 10.1016/S0895-4356(96)00268-5; Steiner JF, 2009, CIRC-CARDIOVASC QUAL, V2, P451, DOI 10.1161/CIRCOUTCOMES.108.841635; Twisk J, 2012, J CLIN EPIDEMIOL, V65, P1078, DOI 10.1016/j.jclinepi.2012.04.010	39	25	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0161381	10.1371/journal.pone.0161381	http://dx.doi.org/10.1371/journal.pone.0161381			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT8TR	27551748	Green Submitted, gold, Green Published			2022-12-26	WOS:000381768800034
J	Michel, M; Aliee, M; Rudolf, K; Bialas, L; Julicher, F; Dahmann, C				Michel, Marcus; Aliee, Maryam; Rudolf, Katrin; Bialas, Lisa; Juelicher, Frank; Dahmann, Christian			The Selector Gene apterous and Notch Are Required to Locally Increase Mechanical Cell Bond Tension at the Drosophila Dorsoventral Compartment Boundary	PLOS ONE			English	Article							LINEAGE RESTRICTION; DEVELOPMENTAL COMPARTMENTALIZATION; IMAGINAL DISC; VENTRAL CELLS; WING DISK; DORSAL; EXPRESSION; HEDGEHOG; COMPETITION; FRINGE	The separation of cells with distinct fates and functions is important for tissue and organ formation during animal development. Regions of different fates within tissues are often separated from another along straight boundaries. These compartment boundaries play a crucial role in tissue patterning and growth by stably positioning organizers. In Drosophila, the wing imaginal disc is subdivided into a dorsal and a ventral compartment. Cells of the dorsal, but not ventral, compartment express the selector gene apterous. Apterous expression sets in motion a gene regulatory cascade that leads to the activation of Notch signaling in a few cell rows on either side of the dorsoventral compartment boundary. Both Notch and apterous mutant clones disturb the separation of dorsal and ventral cells. Maintenance of the straight shape of the dorsoventral boundary involves a local increase in mechanical tension at cell bonds along the boundary. The mechanisms by which cell bond tension is locally increased however remain unknown. Here we use a combination of laser ablation of cell bonds, quantitative image analysis, and genetic mutants to show that Notch and Apterous are required to increase cell bond tension along the dorsoventral compartment boundary. Moreover, clonal expression of the Apterous target gene capricious results in cell separation and increased cell bond tension at the clone borders. Finally, using a vertex model to simulate tissue growth, we find that an increase in cell bond tension at the borders of cell clones, but not throughout the cell clone, can lead to cell separation. We conclude that Apterous and Notch maintain the characteristic straight shape of the dorsoventral compartment boundary by locally increasing cell bond tension.	[Michel, Marcus; Rudolf, Katrin; Bialas, Lisa; Dahmann, Christian] Tech Univ Dresden, Inst Genet, D-01062 Dresden, Germany; [Aliee, Maryam; Juelicher, Frank] Max Planck Inst Phys Komplexer Syst, Nothnitzer Str 38, D-01187 Dresden, Germany	Technische Universitat Dresden; Max Planck Society	Dahmann, C (corresponding author), Tech Univ Dresden, Inst Genet, D-01062 Dresden, Germany.; Julicher, F (corresponding author), Max Planck Inst Phys Komplexer Syst, Nothnitzer Str 38, D-01187 Dresden, Germany.	julicher@pks.mpg.de; christian.dahmann@tu-dresden.de	Dahmann, Christian/B-5841-2017; Julicher, Frank/B-1828-2009	Julicher, Frank/0000-0003-4731-9185	Deutsche Forschungsgemeinschaft dfg.de [DA586/12-1]	Deutsche Forschungsgemeinschaft dfg.de	This work has been funded by the Deutsche Forschungsgemeinschaft dfg.de (DA586/12-1 to CD). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigouy B, 2010, CELL, V142, P773, DOI 10.1016/j.cell.2010.07.042; Aliee M, 2012, CURR BIOL, V22, P967, DOI 10.1016/j.cub.2012.03.070; Batlle E, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008227; Becam I, 2011, DEVELOPMENT, V138, P3781, DOI 10.1242/dev.064774; Bielmeier C, 2016, CURR BIOL, V26, P563, DOI 10.1016/j.cub.2015.12.063; BLAIR SS, 1993, DEVELOPMENT, V119, P339; BLAIR SS, 1994, DEVELOPMENT, V120, P1805; Blair SS, 1997, DEVELOPMENT, V124, P4053; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; BRYANT PJ, 1970, DEV BIOL, V22, P389, DOI 10.1016/0012-1606(70)90160-0; Calleja M, 1996, SCIENCE, V274, P252, DOI 10.1126/science.274.5285.252; COHEN B, 1992, GENE DEV, V6, P715, DOI 10.1101/gad.6.5.715; Dahmann C, 1999, TRENDS GENET, V15, P320, DOI 10.1016/S0168-9525(99)01774-6; Dahmann C, 2000, CELL, V100, P411, DOI 10.1016/S0092-8674(00)80677-7; Dahmann C, 2011, NAT REV GENET, V12, P43, DOI 10.1038/nrg2902; DIAZBENJUMEA FJ, 1993, CELL, V75, P741, DOI 10.1016/0092-8674(93)90494-B; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; GARCIABELLIDO A, 1976, DEV BIOL, V48, P132, DOI 10.1016/0012-1606(76)90052-X; GARCIABELLIDO A, 1973, NATURE-NEW BIOL, V245, P251, DOI 10.1038/newbio245251a0; Gogna R, 2015, ANNU REV GENET, V49, P697, DOI 10.1146/annurev-genet-112414-055214; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; Koelzer S, 2006, DEV BIOL, V289, P77, DOI 10.1016/j.ydbio.2005.10.008; Landsberg KP, 2009, CURR BIOL, V19, P1950, DOI 10.1016/j.cub.2009.10.021; Lawrence PA, 1997, NATURE, V389, P546, DOI 10.1038/39188; Levayer R, 2015, NATURE, V524, P476, DOI 10.1038/nature14684; Levayer R, 2013, J CELL BIOL, V200, P689, DOI 10.1083/jcb.201301051; Major RJ, 2005, DEVELOPMENT, V132, P3823, DOI 10.1242/dev.01957; Major RJ, 2006, DEV DYNAM, V235, P3051, DOI 10.1002/dvdy.20966; Marinari E, 2012, NATURE, V484, P542, DOI 10.1038/nature10984; Martin AC, 2010, NAT CELL BIOL, V12, P5, DOI 10.1038/ncb0110-5; Mayer M, 2010, NATURE, V467, P617, DOI 10.1038/nature09376; Micchelli CA, 1999, NATURE, V401, P473, DOI 10.1038/46779; Milan M, 2002, DEV CELL, V2, P797, DOI 10.1016/S1534-5807(02)00169-7; Milan M, 2001, CELL, V106, P785, DOI 10.1016/S0092-8674(01)00489-5; Milan M, 1999, MOL CELL, V4, P1073, DOI 10.1016/S1097-2765(00)80235-X; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Monier B, 2011, CELL MOL LIFE SCI, V68, P1897, DOI 10.1007/s00018-011-0668-8; Monier B, 2010, NAT CELL BIOL, V12, P60, DOI 10.1038/ncb2005; MORATA G, 1975, NATURE, V255, P614, DOI 10.1038/255614a0; Oda H, 2001, J CELL SCI, V114, P493; Pignoni F, 1997, DEVELOPMENT, V124, P271; Rauskolb C, 1999, NATURE, V401, P476, DOI 10.1038/46786; Rodriguez I, 1997, NATURE, V389, P614, DOI 10.1038/39343; Rudolf K, 2015, DEVELOPMENT, V142, P3845, DOI 10.1242/dev.125542; Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI 10.1016/j.cub.2004.01.023; Shen J, 2005, DEV BIOL, V279, P31, DOI 10.1016/j.ydbio.2004.11.033; Shishido E, 1998, SCIENCE, V280, P2118, DOI 10.1126/science.280.5372.2118; SIMPSON P, 1979, DEV BIOL, V69, P182, DOI 10.1016/0012-1606(79)90284-7; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Umetsu D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114340; Umetsu D, 2014, CURR BIOL, V24, P1798, DOI 10.1016/j.cub.2014.06.052; Vincent JP, 2009, CURR BIOL, V19, pR1028, DOI 10.1016/j.cub.2009.10.030; WILLIAMS JA, 1993, DEVELOPMENT, V117, P571; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096; Zaffran S, 2000, DEVELOPMENT, V127, P1115; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1	57	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0161668	10.1371/journal.pone.0161668	http://dx.doi.org/10.1371/journal.pone.0161668			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27552097	Green Published, gold, Green Submitted			2022-12-26	WOS:000381768800065
J	Stiasny, MH; Mittermayer, FH; Sswat, M; Voss, R; Jutfelt, F; Chierici, M; Puvanendran, V; Mortensen, A; Reusch, TBH; Clemmesen, C				Stiasny, Martina H.; Mittermayer, Felix H.; Sswat, Michael; Voss, Ruediger; Jutfelt, Fredrik; Chierici, Melissa; Puvanendran, Velmurugu; Mortensen, Atle; Reusch, Thorsten B. H.; Clemmesen, Catriona			Ocean Acidification Effects on Atlantic Cod Larval Survival and Recruitment to the Fished Population	PLOS ONE			English	Article							EARLY-LIFE HISTORY; CLIMATE-CHANGE; ELEVATED CO2; GROWTH; IMPACTS; OTOLITHS; CARBON; DAMAGE; PREY	How fisheries will be impacted by climate change is far from understood. While some fish populations may be able to escape global warming via range shifts, they cannot escape ocean acidification (OA), an inevitable consequence of the dissolution of anthropogenic carbon dioxide (CO2) emissions in marine waters. How ocean acidification affects population dynamics of commercially important fish species is critical for adapting management practices of exploited fish populations. Ocean acidification has been shown to impair fish larvae's sensory abilities, affect the morphology of otoliths, cause tissue damage and cause behavioural changes. Here, we obtain first experimental mortality estimates for Atlantic cod larvae under OA and incorporate these effects into recruitment models. End-of-century levels of ocean acidification (similar to 1100 mu atm according to the IPCC RCP 8.5) resulted in a doubling of daily mortality rates compared to present-day CO2 concentrations during the first 25 days post hatching (dph), a critical phase for population recruitment. These results were consistent under different feeding regimes, stocking densities and in two cod populations (Western Baltic and Barents Sea stock). When mortality data were included into Ricker-type stock-recruitment models, recruitment was reduced to an average of 8 and 24% of current recruitment for the two populations, respectively. Our results highlight the importance of including vulnerable early life stages when addressing effects of climate change on fish stocks.	[Stiasny, Martina H.; Mittermayer, Felix H.; Reusch, Thorsten B. H.; Clemmesen, Catriona] GEOMAR Helmholtz Ctr Ocean Res, Evolutionary Ecol Marine Fishes, Kiel, Germany; [Stiasny, Martina H.; Voss, Ruediger] Univ Kiel, Dept Econ, Sustainable Fisheries, Kiel, Germany; [Sswat, Michael] GEOMAR Helmholtz Ctr Ocean Res, Biol Oceanog, Kiel, Germany; [Jutfelt, Fredrik] Norwegian Univ Sci & Technol, Dept Biol, Trondheim, Norway; [Chierici, Melissa] Inst Marine Res, Tromso, Norway; [Puvanendran, Velmurugu; Mortensen, Atle] Nofima AS, Tromso, Norway	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Kiel; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Norwegian University of Science & Technology (NTNU); Institute of Marine Research - Norway; Nofima	Clemmesen, C (corresponding author), GEOMAR Helmholtz Ctr Ocean Res, Evolutionary Ecol Marine Fishes, Kiel, Germany.	cclemmesen@geomar.de	Sswat, Michael/B-7944-2019; Puvanendran, Velmurugu/AAN-7205-2020; Reusch, Thorsten B.H./G-4141-2011; Voss, Rudi/A-6113-2011; Clemmesen, Catriona/B-1480-2014; Jutfelt, Fredrik/B-6988-2014; Reusch, Thorsten B. H./B-9311-2019; Stiasny, Martina/O-4988-2018	Sswat, Michael/0000-0002-5957-4792; Clemmesen, Catriona/0000-0003-4102-7341; Jutfelt, Fredrik/0000-0001-9838-3991; Stiasny, Martina/0000-0001-6365-2610; Voss, Rudi/0000-0002-4299-8791; Reusch, Thorsten B. H./0000-0002-8961-4337	BIOACID project (BIOlogical Impacts of Ocean ACIDification) - German Ministry for Education and Research (BMBF); AquaExcel transnational access grant for aquaculture infrastructures; EU [03F0682A]; BMBF [03F0682A]	BIOACID project (BIOlogical Impacts of Ocean ACIDification) - German Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); AquaExcel transnational access grant for aquaculture infrastructures; EU(European Commission); BMBF(Federal Ministry of Education & Research (BMBF))	Funding was provided through the BIOACID project (BIOlogical Impacts of Ocean ACIDification) funded by the German Ministry for Education and Research (BMBF), http://www.bioacid.de/; the AquaExcel transnational access grant for aquaculture infrastructures, http://www.aquaexcel.eu/; and the Bonus Baltic Sea research and development programme (Art 185) BIO-C3 project, funded jointly by the EU and the BMBF (Grant No. 03F0682A), https://www.bio-c3.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding was provided through the BIOACID project (BIOlogical Impacts of Ocean ACIDification) funded by the German Ministry for Education and Research (BMBF), the AquaExcel transnational access grant for aquaculture infrastructures and the Bonus Baltic Sea research and development programme (Art 185) BIO-C3 project, funded jointly by the EU and the BMBF (Grant No. 03F0682A). The Western Baltic cod experiment was conducted at the Sven Loven Centre, Kristineberg, Sweden. The Barents Sea cod experiment was conducted at the Norwegian Cod Breeding Centre, NOFIMA, Tromso, Norway. The authors are grateful to all scientists and staff at both research stations.	Baumann H, 2012, NAT CLIM CHANGE, V2, P38, DOI 10.1038/NCLIMATE1291; Bignami S, 2013, P NATL ACAD SCI USA, V110, P7366, DOI 10.1073/pnas.1301365110; Bromhead D, 2015, DEEP-SEA RES PT II, V113, P268, DOI 10.1016/j.dsr2.2014.03.019; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Chambers R.C., 2013, BIOGEOSCI DISCUSS, V10, P13897, DOI DOI 10.5194/BGD-10-13897-2013; Checkley DM, 2009, SCIENCE, V324, P1683, DOI 10.1126/science.1169806; Cheung WWL, 2012, AQUAT CONSERV, V22, P368, DOI 10.1002/aqc.2248; Denman K, 2011, ICES J MAR SCI, V68, P1019, DOI 10.1093/icesjms/fsr074; Dixson DL, 2012, ANIM BEHAV, V84, P45, DOI 10.1016/j.anbehav.2012.04.001; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Falk-Petersen IB, 2005, FISH SHELLFISH IMMUN, V19, P397, DOI 10.1016/j.fsi.2005.03.006; Franke A, 2011, BIOGEOSCIENCES, V8, P3697, DOI 10.5194/bg-8-3697-2011; Frommel AY, 2014, ECOL APPL, V24, P1131, DOI 10.1890/13-0297.1; Frommel AY, 2013, MAR BIOL, V160, P1825, DOI 10.1007/s00227-011-1876-3; Frommel AY, 2012, NAT CLIM CHANGE, V2, P42, DOI 10.1038/nclimate1324; Haigh R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117533; Houde Edward D., 2009, Journal of Northwest Atlantic Fishery Science, V41, P53; Hurst TP, 2013, ICES J MAR SCI, V70, P812, DOI 10.1093/icesjms/fst053; Hurst TP, 2015, ICES J MAR SCI, V71, P982; Ishimatsu A, 2008, MAR ECOL PROG SER, V373, P295, DOI 10.3354/meps07823; Kroeker KJ, 2013, GLOBAL CHANGE BIOL, V19, P1884, DOI 10.1111/gcb.12179; Lam V.W.Y., 2014, FISH FISH; Llopiz JK, 2014, OCEANOGRAPHY, V27, P26, DOI 10.5670/oceanog.2014.84; MacNeil MA, 2010, PHILOS T R SOC B, V365, P3753, DOI 10.1098/rstb.2010.0289; Maneja RH, 2013, MAR ECOL PROG SER, V477, P251, DOI 10.3354/meps10146; Miller GM, 2012, NAT CLIM CHANGE, V2, P858, DOI 10.1038/NCLIMATE1599; Munday PL, 2016, ICES J MAR SCI, V73, P641, DOI 10.1093/icesjms/fsv210; Munday PL, 2011, MAR ECOL PROG SER, V423, P211, DOI 10.3354/meps08990; Munday PL, 2010, P NATL ACAD SCI USA, V107, P12930, DOI 10.1073/pnas.1004519107; Munday PL, 2009, P ROY SOC B-BIOL SCI, V276, P3275, DOI 10.1098/rspb.2009.0784; Munday PL, 2009, P NATL ACAD SCI USA, V106, P1848, DOI 10.1073/pnas.0809996106; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Pinsky ML, 2011, P NATL ACAD SCI USA, V108, P8317, DOI 10.1073/pnas.1015313108; Portner HO, 2010, J EXP BIOL, V213, P881, DOI 10.1242/jeb.037523; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/nclimate1958, 10.1038/NCLIMATE1958]; Puvanendran V, 1999, AQUACULTURE, V175, P77, DOI 10.1016/S0044-8486(99)00023-X; Riebesell U., 2010, GUIDE BEST PRACTICES, DOI 10.2777/58454; Solomon S., 2007, PHYS SCI BASIS WORKI; van der Meeren T, 2007, AQUACULTURE, V265, P206, DOI [10.1016/j.aquaculture.2007.01.042, 10.1016/j.aquaculture.2007.06.038]	41	81	81	1	153	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0155448	10.1371/journal.pone.0155448	http://dx.doi.org/10.1371/journal.pone.0155448			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27551924	gold, Green Published, Green Accepted			2022-12-26	WOS:000381768800001
J	Dennison, TJ; Smith, J; Hofmann, MP; Bland, CE; Badhan, RK; Al-Khattawi, A; Mohammed, AR				Dennison, Thomas J.; Smith, Julian; Hofmann, Michael P.; Bland, Charlotte E.; Badhan, Raj K.; Al-Khattawi, Ali; Mohammed, Afzal R.			Design of Experiments to Study the Impact of Process Parameters on Droplet Size and Development of Non-Invasive Imaging Techniques in Tablet Coating	PLOS ONE			English	Article							NON-NEWTONIAN LIQUIDS; ROUND WATER-JET; ANNULAR AIR-JET; AIRBLAST ATOMIZATION; COATED TABLETS; SPRAY DRYER; SCALE-UP; THICKNESS; COMPRESSION; MICROSCOPY	Atomisation of an aqueous solution for tablet film coating is a complex process with multiple factors determining droplet formation and properties. The importance of droplet size for an efficient process and a high quality final product has been noted in the literature, with smaller droplets reported to produce smoother, more homogenous coatings whilst simultaneously avoiding the risk of damage through over-wetting of the tablet core. In this work the effect of droplet size on tablet film coat characteristics was investigated using X-ray microcomputed tomography (X mu CT) and confocal laser scanning microscopy (CLSM). A quality by design approach utilising design of experiments (DOE) was used to optimise the conditions necessary for production of droplets at a small (20 mu m) and large (70 mu m) droplet size. Droplet size distribution was measured using real-time laser diffraction and the volume median diameter taken as a response. DOE yielded information on the relationship three critical process parameters: pump rate, atomisation pressure and coating-polymer concentration, had upon droplet size. The model generated was robust, scoring highly for model fit (R-2 = 0.977), predictability (Q(2) = 0.837), validity and reproducibility. Modelling confirmed that all parameters had either a linear or quadratic effect on droplet size and revealed an interaction between pump rate and atomisation pressure. Fluidised bed coating of tablet cores was performed with either small or large droplets followed by CLSM and X mu CT imaging. Addition of commonly used contrast materials to the coating solution improved visualisation of the coating by X mu CT, showing the coat as a discrete section of the overall tablet. Imaging provided qualitative and quantitative evidence revealing that smaller droplets formed thinner, more uniform and less porous film coats.	[Dennison, Thomas J.; Badhan, Raj K.; Al-Khattawi, Ali; Mohammed, Afzal R.] Aston Univ, Aston Sch Pharm, Birmingham, W Midlands, England; [Smith, Julian] Viridian Pharma Ltd, Newport, Shrops, England; [Hofmann, Michael P.] Univ Birmingham, Sch Dent, Biomat Unit, Birmingham, W Midlands, England; [Bland, Charlotte E.] Aston Univ, Aston Res Ctr Hlth Ageing, Birmingham, W Midlands, England; [Al-Khattawi, Ali] De Montfort Univ, Leicester Sch Pharm, Leicester, Leics, England	Aston University; University of Birmingham; Aston University; De Montfort University	Mohammed, AR (corresponding author), Aston Univ, Aston Sch Pharm, Birmingham, W Midlands, England.	a.u.r.mohammed@aston.ac.uk	Hofmann, Michael P/B-8636-2008	Al-khattawi, Ali/0000-0002-2498-2817; Badhan, Raj/0000-0002-0904-9324; Mohammed, Afzal-Ur-Rahman/0000-0002-5212-3040	MRC CASE award [MR/J01236X/1]; Viridian Pharma Ltd.; Viridian Pharma Ltd; Medical Research Council [1264674] Funding Source: researchfish	MRC CASE award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Viridian Pharma Ltd.; Viridian Pharma Ltd; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Financial support was provided by a joint funded MRC CASE award (Grant No. MR/J01236X/1) with Viridian Pharma Ltd. The kind use of equipment and expertise provided by Malvern Instruments and Michelle Holder of the University of Birmingham School of Dentistry is very much appreciated. Malvern Instruments had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Author Julian Smith is employed by Viridian Pharma Ltd. Viridian Pharma Ltd provided support in the form of salary for author JS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.; Financial support was provided by a joint funded MRC CASE award (Grant No. MR/J01236X/1) with Viridian Pharma Ltd. The kind use of equipment and expertise provided by Malvern Instruments and Michelle Holder of the University of Birmingham School of Dentistry is very much appreciated. Julian Smith (Viridian Pharma Ltd.) was involved in study design, decision to publish and preparation of the manuscript and this contribution is also greatly acknowledged.	Aguilar G, 2001, INT J HEAT MASS TRAN, V44, P3201, DOI 10.1016/S0017-9310(00)00363-X; Aliseda A, 2008, INT J MULTIPHAS FLOW, V34, P161, DOI 10.1016/j.ijmultiphaseflow.2007.09.003; Aulton ME, 1995, PHARM COATING TECHNO, P65; Beaulieu LY, 2002, MICROSC MICROANAL, V8, P422, DOI 10.1017/S1431927602010309; Christensen FN, 1997, DRUG DEV IND PHARM, V23, P451, DOI 10.3109/03639049709148494; Coomaraswamy KS, 2007, J ENDODONT, V33, P295, DOI 10.1016/j.joen.2006.11.018; Depypere F, 2009, EUR J PHARM BIOPHARM, V73, P179, DOI 10.1016/j.ejpb.2009.04.007; Dumouchel C, 2008, EXP FLUIDS, V45, P371, DOI 10.1007/s00348-008-0526-0; Felton LA, 2013, EXPERT OPIN DRUG DEL, V10, P421, DOI 10.1517/17425247.2013.763792; FRASER RP, 1963, CHEM ENG SCI, V18, P339, DOI 10.1016/0009-2509(63)80027-5; Funada T, 2004, INT J MULTIPHAS FLOW, V30, P1279, DOI 10.1016/j.ijmultiphaseflow.2004.07.001; Gauno MH, 2013, PHARM DEV TECHNOL, V18, P926, DOI 10.3109/10837450.2011.619542; Ginebra MP, 2002, BIOMATERIALS, V23, P1873, DOI 10.1016/S0142-9612(01)00314-3; Hede PD, 2008, CHEM ENG SCI, V63, P3821, DOI 10.1016/j.ces.2008.04.014; Hemati A, 2003, POWDER TECHNOL, V130, P18; Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x; Jiang DJ, 2012, CHEM ENG RES DES, V90, P185, DOI 10.1016/j.cherd.2011.07.006; Kemp IC, 2013, DRY TECHNOL, V31, P930, DOI 10.1080/07373937.2012.710693; Lasheras JC, 1998, J FLUID MECH, V357, P351, DOI 10.1017/S0022112097008070; Lecomte F, 2004, PHARM RES-DORDR, V21, P882, DOI 10.1023/B:PHAM.0000026443.71935.cb; LEFEBVRE AH, 1980, PROG ENERG COMBUST, V6, P233, DOI 10.1016/0360-1285(80)90017-9; LEWIS HC, 1948, IND ENG CHEM, V40, P67, DOI 10.1021/ie50457a020; Lorck CA, 1997, EUR J PHARM BIOPHARM, V43, P149, DOI 10.1016/S0939-6411(96)00035-5; MANSOUR A, 1995, J NON-NEWTON FLUID, V58, P161, DOI 10.1016/0377-0257(95)01356-Z; MANSOUR A, 1990, PHYS FLUIDS A-FLUID, V2, P706, DOI 10.1063/1.857724; Marmottant PH, 2004, J FLUID MECH, V498, P73, DOI 10.1017/S0022112003006529; Missaghi S, 2004, AAPS PHARMSCITECH, V5, DOI 10.1208/pt050229; Ozeki Y, 2003, INT J PHARM, V259, P69, DOI 10.1016/S0378-5173(03)00208-4; Pandey P, 2014, AAPS PHARMSCITECH, V15, P296, DOI 10.1208/s12249-013-0060-0; Perfetti G, 2010, ADV POWDER TECHNOL, V21, P663, DOI 10.1016/j.apt.2010.08.002; Prpich A, 2010, COMPUT CHEM ENG, V34, P1092, DOI 10.1016/j.compchemeng.2010.03.006; Rambali B, 2001, INT J PHARMACEUT, V220, P149, DOI 10.1016/S0378-5173(01)00658-5; RANZ WE, 1952, CHEM ENG PROG, V48, P141; RIZKALLA AA, 1975, J FLUID ENG-T ASME, V97, P316, DOI 10.1115/1.3447309; Roy S., 2012, INT J PHARM BIOMEDIC, V3, P100; Ruotsalainen M, 2003, EUR J PHARM BIOPHARM, V56, P381, DOI 10.1016/S0939-6411(03)00118-8; Russe IS, 2012, MOL PHARMACEUT, V9, P3551, DOI 10.1021/mp300383y; Saleh K, 1999, ADV POWDER TECHNOL, V10, P255, DOI 10.1163/156855299X00334; Sander A, 2014, CHEM ENG TECHNOL, V37, P2073, DOI 10.1002/ceat.201400185; Schmidt D.P., 1999, SAE TECHNICAL PAPER; SCHMIDT PC, 1994, DRUG DEV IND PHARM, V20, P2899, DOI 10.3109/03639049409042687; Suyari M, 1986, DROP SIZE MEASUREMEN; Thybo P, 2008, PHARM DEV TECHNOL, V13, P93, DOI [10.1080/10837450701830957, 10.1080/10837450701830957 ]; Wang J, 2012, INT J PHARMACEUT, V427, P163, DOI 10.1016/j.ijpharm.2012.01.033	44	8	9	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0157267	10.1371/journal.pone.0157267	http://dx.doi.org/10.1371/journal.pone.0157267			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548263	Green Accepted, Green Published, gold			2022-12-26	WOS:000381768400002
J	Dione, I; Deteix, J; Briffard, T; Chamberland, E; Doyon, N				Dione, Ibrahima; Deteix, Jean; Briffard, Thomas; Chamberland, Eric; Doyon, Nicolas			Improved Simulation of Electrodiffusion in the Node of Ranvier by Mesh Adaptation	PLOS ONE			English	Article							DIELECTRIC-CONSTANT; MODEL; MICROSCOPY; ERROR; AXONS	In neural structures with complex geometries, numerical resolution of the Poisson-NernstPlanck (PNP) equations is necessary to accurately model electrodiffusion. This formalism allows one to describe ionic concentrations and the electric field (even away from the membrane) with arbitrary spatial and temporal resolution which is impossible to achieve with models relying on cable theory. However, solving the PNP equations on complex geometries involves handling intricate numerical difficulties related either to the spatial discretization, temporal discretization or the resolution of the linearized systems, often requiring large computational resources which have limited the use of this approach. In the present paper, we investigate the best ways to use the finite elements method (FEM) to solve the PNP equations on domains with discontinuous properties (such as occur at the membrane-cytoplasm interface). 1) Using a simple 2D geometry to allow comparison with analytical solution, we show that mesh adaptation is a very (if not the most) efficient way to obtain accurate solutions while limiting the computational efforts, 2) We use mesh adaptation in a 3D model of a node of Ranvier to reveal details of the solution which are nearly impossible to resolve with other modelling techniques. For instance, we exhibit a non linear distribution of the electric potential within the membrane due to the non uniform width of the myelin and investigate its impact on the spatial profile of the electric field in the Debye layer.	[Dione, Ibrahima; Deteix, Jean; Briffard, Thomas; Chamberland, Eric; Doyon, Nicolas] Univ Laval, GIREF, Dept Math & Stat, Quebec City, PQ, Canada; [Dione, Ibrahima; Doyon, Nicolas] Univ Laval, Neurosci Cellulaires & Mol Inst Univ Sante Mental, Quebec City, PQ, Canada	Laval University; Laval University	Doyon, N (corresponding author), Univ Laval, GIREF, Dept Math & Stat, Quebec City, PQ, Canada.; Doyon, N (corresponding author), Univ Laval, Neurosci Cellulaires & Mol Inst Univ Sante Mental, Quebec City, PQ, Canada.	nicolas.doyon@mat.ulaval.ca		Deteix, Jean/0000-0001-9463-2057	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Jean Deteix and Nicolas Doyon are supported by the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/).	Auroux PA, 2002, ANAL CHEM, V74, P2637, DOI 10.1021/ac020239t; Bois R, 2012, EUR J COMPUT MECH, V21, P72, DOI 10.1080/17797179.2012.702431; Bois R, 2012, COMPUT METHOD APPL M, V209, P12, DOI 10.1016/j.cma.2011.10.001; Carnevale NT, 2004, NEURON BOOK; Ciarlet P. G., 1986, FINITE ELEMENT METHO; COURANT R, 1967, IBM J RES DEV, V11, P215, DOI 10.1147/rd.112.0215; Dailey ME, 1996, J NEUROSCI, V16, P2983; DAZEVEDO EF, 1991, NUMER MATH, V59, P321, DOI 10.1007/BF01385784; Doyon N, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002149; Fortin A, 2012, INT J NUMER ANAL MOD, V3, P408; Gramse G, 2013, BIOPHYS J, V104, P1257, DOI 10.1016/j.bpj.2013.02.011; Hille B., 1992, IONIC CHANNELS EXCIT; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Holcman D, 2015, NAT REV NEUROSCI, V16, P685, DOI 10.1038/nrn4022; Krishnan GP, 2011, J NEUROSCI, V31, P8870, DOI 10.1523/JNEUROSCI.6200-10.2011; Lachance M, 2014, J COMPUT NEUROSCI, V37, P523, DOI 10.1007/s10827-014-0521-9; Leger S, 2016, COMPUT METHOD APPL M, V309, P1, DOI 10.1016/j.cma.2016.05.036; Lopreore CL, 2008, BIOPHYS J, V95, P2624, DOI 10.1529/biophysj.108.132167; MALMBERG CG, 1956, J RES NAT BUR STAND, V56, P1, DOI 10.6028/jres.056.001; Pods J, 2013, BIOPHYS J, V105, P242, DOI 10.1016/j.bpj.2013.05.041; QIAN N, 1989, BIOL CYBERN, V62, P1, DOI 10.1007/BF00217656; Rappaz B, 2005, OPT EXPRESS, V13, P9361, DOI 10.1364/OPEX.13.009361; Reutskiy S, 2003, BIOL CYBERN, V89, P439, DOI 10.1007/s00422-003-0430-x; Sosinsky GE, 2005, NEUROINFORMATICS, V3, P133, DOI 10.1385/NI:3:2:133; Tora AS, 2015, FASEB J, V29, P4174, DOI 10.1096/fj.14-269746; Xu S., 2014, MOL BASED MATH BIOL, V2, P34, DOI [DOI 10.2478/MLBMB-2014-0003, 10.2478/mlbmb-2014-0003]; Yang Y, 2013, ADV APPL MATH MECH, V5, P113, DOI 10.4208/aamm.11-m11184; Zhang ZM, 2005, SIAM J SCI COMPUT, V26, P1192, DOI 10.1137/S1064827503402837	29	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161318	10.1371/journal.pone.0161318	http://dx.doi.org/10.1371/journal.pone.0161318			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548674	Green Published, Green Submitted, gold			2022-12-26	WOS:000381768400043
J	Ortiz-Fernandez, L; Carmona, FD; Montes-Cano, MA; Garcia-Lozano, JR; Conde-Jaldon, M; Ortego-Centeno, N; Castillo, MJ; Espinosa, G; Grana-Gil, G; Sanchez-Burson, J; Julia, MR; Solans, R; Blanco, R; Barnosi-Marin, AC; de la Torre, RG; Fanlo, P; Rodriguez-Carballeira, M; Rodriguez-Rodriguez, L; Camps, T; Castaneda, S; Alegre-Sancho, JJ; Martin, J; Gonzalez-Escribano, MF				Ortiz-Fernandez, Lourdes; Carmona, Francisco-David; Montes-Cano, Marco-Antonio; Garcia-Lozano, Jose-Raul; Conde-Jaldon, Marta; Ortego-Centeno, Norberto; Jesus Castillo, Maria; Espinosa, Gerard; Grana-Gil, Genaro; Sanchez-Burson, Juan; Rosa Julia, Maria; Solans, Roser; Blanco, Ricardo; Barnosi-Marin, Ana-Celia; Gomez de la Torre, Ricardo; Fanlo, Patricia; Rodriguez-Carballeira, Monica; Rodriguez-Rodriguez, Luis; Camps, Teresa; Castaneda, Santos; Alegre-Sancho, Juan-Jose; Martin, Javier; Francisca Gonzalez-Escribano, Maria			Genetic Analysis with the Immunochip Platform in Behcet Disease. Identification of Residues Associated in the HLA Class I Region and New Susceptibility Loci	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MHC CLASS-I; RHEUMATOID-ARTHRITIS; POPULATION; PEPTIDE; BINDING; RISK; IL23R-IL12RB2; IMPUTATION; SCLEROSIS	Behcet's disease (BD) is an immuno-mediated vasculitis in which knowledge of its etiology and genetic basis is limited. To improve the current knowledge, a genetic analysis performed with the Immunochip platform was carried out in a population from Spain. A discovery cohort comprising 278 BD cases and 1,517 unaffected controls were genotyped using the Immunochip platform. The validation step was performed on an independent replication cohort composed of 130 BD cases and 600 additional controls. The strongest association signals were observed in the HLA class I region, being HLA-B*51 the highest peak (overall P = 6.82E-32, OR = 3.82). A step-wise conditional logistic regression with classical alleles identified HLA-B*57 and HLA-A*03 as additional independent markers. The amino acid model that best explained the association, includes the position 97 of the HLA-B molecule and the position 66 of the HLA-A. Among the non-HLA loci, the most significant in the discovery analysis were: IL23R (rs10889664: P = 3.81E-12, OR = 2.00), the JRKL/CNTN5 region (rs2848479: P = 5.00E-08, OR = 1.68) and IL12A (rs1874886: P = 6.67E-08, OR = 1.72), which were confirmed in the validation phase (JRKL/CNTN5 rs2848479: P = 3.29E10, OR = 1.66; IL12A rs1874886: P = 1.62E-08, OR = 1.61). Our results confirm HLA-B*51 as a primary-association marker in predisposition to BD and suggest additional independent signals within the class I region, specifically in the genes HLA-A and HLA-B. Regarding the non-HLA genes, in addition to IL-23R, previously reported in our population; IL12A, described in other populations, was found to be a BD susceptibility factor also in Spaniards; finally, a new associated locus was found in the JRKL/CNTN5 region.	[Ortiz-Fernandez, Lourdes; Montes-Cano, Marco-Antonio; Garcia-Lozano, Jose-Raul; Conde-Jaldon, Marta; Francisca Gonzalez-Escribano, Maria] Hosp Univ Virgen Rocio IBiS CSIC US, Dept Immunol, Seville 41013, Spain; [Carmona, Francisco-David; Martin, Javier] PTS Granada, CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada 18016, Spain; [Ortego-Centeno, Norberto] Hosp Clin San Cecilio, Dept Internal Med, Granada 18003, Spain; [Jesus Castillo, Maria] Hosp Univ Virgen Rocio, Dept Internal Med, Seville 41003, Spain; [Espinosa, Gerard] Hosp Univ Clin, Dept Autoimmune Dis, Barcelona 08036, Spain; [Grana-Gil, Genaro] Dept Rheumatol, Complejo Hosp Univ A Coruna, La Coruna 15006, Spain; [Sanchez-Burson, Juan] Hosp Univ Valme, Dept Rheumatol, Seville 41014, Spain; [Rosa Julia, Maria] Hosp Univ Son Espases, Dept Immunol, Palma de Mallorca 07120, Spain; [Solans, Roser] Univ Autonoma Barcelona, Hosp Vall Hebron, Autoimmune Syst Dis Unit, Dept Internal Med, Barcelona 08035, Spain; [Blanco, Ricardo] Hosp Univ Marques Valdecilla, Dept Rheumatol, Santander 39008, Spain; [Barnosi-Marin, Ana-Celia] Dept Internal Med, Complejo Hosp Torrecardenas, Almeria 04009, Spain; [Gomez de la Torre, Ricardo] Hosp Univ Cent Asturias, Dept Internal Med, Asturias 33011, Spain; [Fanlo, Patricia] Hosp Virgen Camino, Dept Internal Med, Pamplona 31008, Spain; [Rodriguez-Carballeira, Monica] Hosp Univ Mutua Terrassa, Dept Internal Med, Terrassa 08221, Spain; [Rodriguez-Rodriguez, Luis] Hosp Clin San Carlos, Dept Rheumatol, Madrid 28040, Spain; [Camps, Teresa] Hosp Reg Univ Malaga, Dept Internal Med, Malaga 29010, Spain; [Castaneda, Santos] IIS Princesa, Hosp Princesa, Dept Rheumatol, Madrid 28006, Spain; [Alegre-Sancho, Juan-Jose] Hosp Univ Doctor Peset, Dept Rheumatol, Valencia 46017, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Hospital Universitario San Cecilio; Virgen del Rocio University Hospital; Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Hospital Valme; Hospital Universitari Son Espases; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Hospital Universitario Marques de Valdecilla (HUMV); Hospital Torrecardenas; Central University Hospital Asturias; Hospital Virgen del Camino; Servicio Navarro de Salud - Osasunbidea; Hospital Universitario Mutua Terrassa; Hospital Clinico San Carlos	Gonzalez-Escribano, MF (corresponding author), Hosp Univ Virgen Rocio IBiS CSIC US, Dept Immunol, Seville 41013, Spain.	mariaf.gonzalez.sspa@juntadeandalucia.es	Martin, Javier/B-8141-2008; Martín, Javier/AAV-5209-2021; Ortiz-Fernández, Lourdes/GOJ-7451-2022; Martín, María/HDL-9512-2022; Carballeir, Monica Rodriguez/AAQ-8337-2021; Carmona, F. David/F-9953-2016; Rodriguez-Rodriguez, Luis/H-5880-2013; Julia, Rosa/AAG-6185-2021; González-Escribano, María Francisca/X-5554-2019; blanco, ricardo/AAA-1248-2020; Espinosa, Gerard/J-2603-2016; Centeno, Norberto Ortego/C-4793-2019; Ortiz-Fernández, Lourdes/AAA-6647-2020; Espinosa, Gerard/AAV-2751-2020	Martin, Javier/0000-0002-2202-0622; Carballeir, Monica Rodriguez/0000-0002-8802-0238; Carmona, F. David/0000-0002-1427-7639; Rodriguez-Rodriguez, Luis/0000-0002-2869-7861; blanco, ricardo/0000-0003-2344-2285; Espinosa, Gerard/0000-0003-1336-0163; Centeno, Norberto Ortego/0000-0003-2325-0937; Ortiz-Fernández, Lourdes/0000-0002-0247-4280; Espinosa, Gerard/0000-0003-1336-0163; Grana, Jenaro/0000-0001-9041-8117; Alegre Sancho, Juan Jose/0000-0003-1641-0875	Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III (ISCIII) [13/01118]; Fondos FEDER; Plan Andaluz de Investigacion [CTS-0197]; ISCIII [FI11/00547]; RETICS Program (RIER, ISCIII) [RD12/0009/0013]	Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III (ISCIII); Fondos FEDER(European Commission); Plan Andaluz de Investigacion; ISCIII(Instituto de Salud Carlos III); RETICS Program (RIER, ISCIII)	This work was supported by Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III (ISCIII, 13/01118), Fondos FEDER and Plan Andaluz de Investigacion (CTS-0197). LOF is the recipient of a fellowship (ISCIII, FI11/00547) and FDC was funded by the RETICS Program (RIER, ISCIII, RD12/0009/0013). All these are public institutions from Spain and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III (ISCIII, 13/01118), Fondos FEDER and Plan Andaluz de Investigacion (CTS-0197). LOF is the recipient of a fellowship (ISCIII, FI11/00547) and FDC was funded by the RETICS Program (RIER, ISCIII, RD12/0009/0013).	Montes-Cano MA, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4328; Brombacher F, 2003, TRENDS IMMUNOL, V24, P207, DOI 10.1016/S1471-4906(03)00067-X; Brown WM, 2009, DIABETES OBES METAB, V11, P2, DOI 10.1111/j.1463-1326.2008.00997.x; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Conde-Jaldon M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102100; Cortes A, 2013, NAT GENET, V45, P730, DOI 10.1038/ng.2667; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; Croxford AL, 2012, EUR J IMMUNOL, V42, P2263, DOI 10.1002/eji.201242598; Carmona FD, 2015, AM J HUM GENET, V96, P565, DOI 10.1016/j.ajhg.2015.02.009; Carmona FD, 2015, CURR OPIN RHEUMATOL, V27, P10, DOI 10.1097/BOR.0000000000000124; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; de Bakker PIW, 2012, HUM MOL GENET, V21, pR29, DOI 10.1093/hmg/dds384; de Menthon M, 2009, ARTHRIT CARE RES, V61, P1287, DOI 10.1002/art.24642; Dopazo J, 2014, DRUG DISCOV TODAY, V19, P126, DOI 10.1016/j.drudis.2013.06.003; Eyre S, 2012, NAT GENET, V44, P1336, DOI 10.1038/ng.2462; Fei YP, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2695; Hou SP, 2012, ARTHRITIS RHEUM-US, V64, P4104, DOI 10.1002/art.37708; Hughes T, 2013, NAT GENET, V45, P319, DOI 10.1038/ng.2551; Jia XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064683; Kappen JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119085; Kirino Y, 2013, NAT GENET, V45, P202, DOI 10.1038/ng.2520; Kone-Paut I, 1999, J PEDIATR-US, V135, P89, DOI 10.1016/S0022-3476(99)70333-1; Le Clerc S, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.97; Lee YJ, 2013, ANN RHEUM DIS, V72, P1510, DOI 10.1136/annrheumdis-2011-200288; Lenz TL, 2015, NAT GENET, V47, P1085, DOI 10.1038/ng.3379; Li MX, 2012, HUM GENET, V131, P747, DOI 10.1007/s00439-011-1118-2; Maenaka K, 2000, J IMMUNOL, V165, P3260, DOI 10.4049/jimmunol.165.6.3260; Mayes MD, 2014, AM J HUM GENET, V94, P47, DOI 10.1016/j.ajhg.2013.12.002; McMahon RM, 2011, ACTA CRYSTALLOGR D, V67, P447, DOI 10.1107/S0907444911007888; Mendes D, 2009, J AUTOIMMUN, V32, P178, DOI 10.1016/j.jaut.2009.02.011; Mizuki N, 2010, NAT GENET, V42, P703, DOI 10.1038/ng.624; Ombrello MJ, 2014, P NATL ACAD SCI USA, V111, P8867, DOI 10.1073/pnas.1406575111; Ortiz-Fernandez L, 2014, ANN RHEUM DIS, V73, P1433, DOI 10.1136/annrheumdis-2013-205156; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Remmers EF, 2010, NAT GENET, V42, P698, DOI 10.1038/ng.625; Sakane T, 1999, NEW ENGL J MED, V341, P1284, DOI 10.1056/NEJM199910213411707; Sanjanwala B, 2008, J IMMUNOL, V181, P6293, DOI 10.4049/jimmunol.181.9.6293; Saruhan-Direskeneli G, 2013, AM J HUM GENET, V93, P298, DOI 10.1016/j.ajhg.2013.05.026; Shimoda Y, 2009, CELL ADHES MIGR, V3, P64, DOI 10.4161/cam.3.1.7764; SILMAN AJ, 1990, LANCET, V335, P1078; Takeuchi M, 2015, J AUTOIMMUN, V64, P137, DOI 10.1016/j.jaut.2015.08.013; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467	46	30	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161305	10.1371/journal.pone.0161305	http://dx.doi.org/10.1371/journal.pone.0161305			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548383	gold, Green Published, Green Submitted			2022-12-26	WOS:000381768400040
J	Siede, J; Frohlich, A; Datsi, A; Hegazy, AN; Varga, DV; Holecska, V; Saito, H; Nakae, S; Lohning, M				Siede, Julia; Froehlich, Anja; Datsi, Angeliki; Hegazy, Ahmed N.; Varga, Domonkos V.; Holecska, Vivien; Saito, Hirohisa; Nakae, Susumu; Loehning, Max			IL-33 Receptor-Expressing Regulatory T Cells Are Highly Activated, Th2 Biased and Suppress CD4 T Cell Proliferation through IL-10 and TGF beta Release	PLOS ONE			English	Article							VISCERAL ADIPOSE-TISSUE; ACCUMULATION; INFLAMMATION; CYTOKINE; SUBSETS; CD25(+); GENE; INTERLEUKIN-10; MAINTENANCE; MECHANISMS	Immunomodulatory Foxp3(+) regulatory T cells (Tregs) form a heterogeneous population consisting of subsets with different activation states, migratory properties and suppressive functions. Recently, expression of the IL-33 receptor ST2 was shown on Tregs in inflammatory settings. Here we report that ST2 expression identifies highly activated Tregs in mice even under homeostatic conditions. ST2(+) Tregs preferentially accumulate at non-lymphoid sites, likely mediated by their high expression of several chemokine receptors facilitating tissue homing. ST2(+) Tregs exhibit a Th2-biased character, expressing GATA-3 and producing the Th2 cytokines IL-5 and IL-13 -especially in response to IL-33. Yet, IL-33 is dispensable for the generation and maintenance of these cells in vivo. Furthermore, ST2(+) Tregs are superior to ST2(-) Tregs in suppressing CD4(+) T cell proliferation in vitro independent of IL-33. This higher suppressive capacity is partially mediated by enhanced production and activation of the anti-inflammatory cytokines IL-10 and TGF beta. Thus, ST2 expression identifies a highly activated, strongly suppressive Treg subset preferentially located in non-lymphoid tissues. Here ST2(+) Tregs may be well positioned to immediately react to IL-33 alarm signals. Their specific properties may render ST2(+) Tregs useful targets for immunomodulatory therapies.	[Siede, Julia; Froehlich, Anja; Datsi, Angeliki; Varga, Domonkos V.; Holecska, Vivien; Loehning, Max] Charite Univ Med Berlin, Dept Rheumatol & Clin Immunol, Expt Immunol & Osteoarthrit Res, Berlin, Germany; [Siede, Julia; Froehlich, Anja; Datsi, Angeliki; Varga, Domonkos V.; Holecska, Vivien; Loehning, Max] German Rheumatism Res Ctr DRFZ, Leibniz Inst, Pitzer Lab Osteoarthrit Res, Berlin, Germany; [Hegazy, Ahmed N.] Univ Oxford, John Radcliffe Hosp, Div Expt Med, Translat Gastroenterol Unit,Nuffield Dept Clin Me, Oxford, England; [Hegazy, Ahmed N.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Kennedy Inst Rheumatol, Oxford, England; [Saito, Hirohisa] Natl Res Inst Child Hlth & Dev, Dept Allergy & Immunol, Tokyo, Japan; [Nakae, Susumu] Univ Tokyo, Inst Med Sci, Ctr Expt Med & Syst Biol, Lab Syst Biol, Tokyo, Japan; [Nakae, Susumu] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Saitama, Japan	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deutsches Rheuma-Forschungszentrum (DRFZ); University of Oxford; University of Oxford; National Center for Child Health & Development - Japan; University of Tokyo; Japan Science & Technology Agency (JST)	Lohning, M (corresponding author), Charite Univ Med Berlin, Dept Rheumatol & Clin Immunol, Expt Immunol & Osteoarthrit Res, Berlin, Germany.; Lohning, M (corresponding author), German Rheumatism Res Ctr DRFZ, Leibniz Inst, Pitzer Lab Osteoarthrit Res, Berlin, Germany.	loehning@drfz.de	Datsi, Angeliki/N-1778-2016; Löhning, Max/AAL-2967-2021	Datsi, Angeliki/0000-0001-5022-8087; Löhning, Max/0000-0001-6382-7281; Hegazy, Ahmed N./0000-0002-2946-8251; Saito, Hirohisa/0000-0002-6630-8337	German Research Foundation [SFB650, TP28, GRK1121, TPB1, LO1542/3-1]; German Federal Ministry of Education and Research (e:Bio/T-Sys) [0316164G]; Swiss National Science Foundation (Sinergia) [CRSII3 160772/1]; Volkswagen Foundation (Lichtenberg Program); Willy Robert Pitzer Foundation (Osteoarthritis Research Program); International Max Planck Research School for Infectious Diseases and Immunology; European Molecular Biology Organization (EMBO) long-term fellowship [ALTF 116-2012, ALTF 314-2012];  [330621]	German Research Foundation(German Research Foundation (DFG)); German Federal Ministry of Education and Research (e:Bio/T-Sys); Swiss National Science Foundation (Sinergia)(Swiss National Science Foundation (SNSF)); Volkswagen Foundation (Lichtenberg Program); Willy Robert Pitzer Foundation (Osteoarthritis Research Program); International Max Planck Research School for Infectious Diseases and Immunology; European Molecular Biology Organization (EMBO) long-term fellowship(European Molecular Biology Organization (EMBO)); 	This work was supported by the German Research Foundation (www.dfg.de) (SFB650, grant TP28; GRK1121, grant TPB1; and grant LO1542/3-1), the German Federal Ministry of Education and Research (www.bmbf.de) (e:Bio/T-Sys, grant 0316164G), the Swiss National Science Foundation (http://www.snf.ch) (Sinergia, grant CRSII3 160772/1), Volkswagen Foundation (www.volkswagenstiftung.de) (Lichtenberg Program) (to M.L.) and Willy Robert Pitzer Foundation (www.wrp-stiftung.de) (Osteoarthritis Research Program) (to M.L.), in part by the International Max Planck Research School for Infectious Diseases and Immunology (https://www.zibi-graduateschool-berlin.de) (to J.S., A.D. and D.V.V.), a European Molecular Biology Organization (EMBO) (http://www.embo.org) long-term fellowship (ALTF 116-2012 and ALTF 314-2012) (to A.N.H.) and a Marie Sklodowska-Curie Research Fellow (http://ec.europa.eu/research/mariecurieactions) (proposal 330621) (to A.N.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpaia N, 2015, CELL, V162, P1078, DOI 10.1016/j.cell.2015.08.021; Beyersdorf N, 2007, EUR J IMMUNOL, V37, P3445, DOI 10.1002/eji.200737126; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Burzyn D, 2013, NAT IMMUNOL, V14, P1007, DOI 10.1038/ni.2683; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chen Y, 2012, J IMMUNOL, V188, P1698, DOI 10.4049/jimmunol.1102448; Cheng GY, 2012, J IMMUNOL, V189, P1780, DOI 10.4049/jimmunol.1103768; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Collison LW, 2009, J IMMUNOL, V182, P6121, DOI 10.4049/jimmunol.0803646; Cretney E, 2011, NAT IMMUNOL, V12, P304, DOI 10.1038/ni.2006; Duan LH, 2012, MOL MED, V18, P753, DOI 10.2119/molmed.2011.00428; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Fu S, 2004, AM J TRANSPLANT, V4, P65, DOI 10.1046/j.1600-6143.2003.00293.x; Guo LY, 2009, P NATL ACAD SCI USA, V106, P13463, DOI 10.1073/pnas.0906988106; Han JM, 2015, J IMMUNOL, V194, P4777, DOI 10.4049/jimmunol.1500020; Hasegawa H, 2008, GENE THER, V15, P171, DOI 10.1038/sj.gt.3303051; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Huehn J, 2005, CURR TOP MICROBIOL, V293, P89, DOI 10.1007/3-540-27702-1_5; Kamanaka M, 2006, IMMUNITY, V25, P941, DOI 10.1016/j.immuni.2006.09.013; Kendal AR, 2011, J EXP MED, V208, P2043, DOI 10.1084/jem.20110767; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Kolodin D, 2015, CELL METAB, V21, P543, DOI 10.1016/j.cmet.2015.03.005; Kuniyasu Y, 2000, INT IMMUNOL, V12, P1145, DOI 10.1093/intimm/12.8.1145; Kuswanto W, 2016, IMMUNITY, V44, P355, DOI 10.1016/j.immuni.2016.01.009; Lavenu-Bombled C, 2002, J BIOL CHEM, V277, P18313, DOI 10.1074/jbc.M110013200; Lehmann J, 2002, P NATL ACAD SCI USA, V99, P13031, DOI 10.1073/pnas.192162899; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Liston A, 2014, NAT REV IMMUNOL, V14, P154, DOI 10.1038/nri3605; Liu T, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-40; Matta BM, 2014, J IMMUNOL, V193, P4010, DOI 10.4049/jimmunol.1400481; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Ohkura N, 2013, IMMUNITY, V38, P414, DOI 10.1016/j.immuni.2013.03.002; Oida T, 2006, J IMMUNOL, V177, P2331, DOI 10.4049/jimmunol.177.4.2331; Pabst O, 2013, INT IMMUNOL, V25, P139, DOI 10.1093/intimm/dxs113; Piccirillo CA, 2002, J EXP MED, V196, P237, DOI 10.1084/jem.20020590; Pichery M, 2012, J IMMUNOL, V188, P3488, DOI 10.4049/jimmunol.1101977; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sakaguchi S, 2009, INT IMMUNOL, V21, P1105, DOI 10.1093/intimm/dxp095; Sather BD, 2007, J EXP MED, V204, P1335, DOI 10.1084/jem.20070081; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Schneider MA, 2007, J EXP MED, V204, P735, DOI 10.1084/jem.20061405; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Thornton AM, 2000, J IMMUNOL, V164, P183, DOI 10.4049/jimmunol.164.1.183; Tiemessen MM, 2007, P NATL ACAD SCI USA, V104, P19446, DOI 10.1073/pnas.0706832104; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Turnquist HR, 2011, J IMMUNOL, V187, P4598, DOI 10.4049/jimmunol.1100519; Vasanthakumar A, 2015, NAT IMMUNOL, V16, P276, DOI 10.1038/ni.3085; Vignali DAAA, 2008, EUR J IMMUNOL, V38, P908, DOI 10.1002/eji.200738114; Wang YQ, 2011, IMMUNITY, V35, P337, DOI 10.1016/j.immuni.2011.08.012; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wohlfert EA, 2011, J CLIN INVEST, V121, P4503, DOI 10.1172/JCI57456; Worthington JJ, 2015, IMMUNITY, V42, P903, DOI 10.1016/j.immuni.2015.04.012; Zhang DH, 1998, J IMMUNOL, V161, P3817; Zhang J, 1997, J IMMUNOL, V159, P5412	61	74	76	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161507	10.1371/journal.pone.0161507	http://dx.doi.org/10.1371/journal.pone.0161507			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548066	Green Published, Green Submitted, gold			2022-12-26	WOS:000381768400064
J	Callesen, MM; Berthelsen, MF; Lund, S; Fuchtbauer, AC; Fuchtbauer, EM; Jakobsen, JE				Callesen, Morten M.; Berthelsen, Martin F.; Lund, Sira; Fuchtbauer, Annette C.; Fuchtbauer, Ernst-Martin; Jakobsen, Jannik E.			Recombinase-Mediated Cassette Exchange (RMCE)-in Reporter Cell Lines as an Alternative to the Flp-in System	PLOS ONE			English	Article							TRANSGENE EXPRESSION; SLEEPING-BEAUTY; FLUORESCENT PROTEIN; ES CELLS; RMCE; TRANSPOSON; VIVO	Recombinase mediated cassette exchange (RMCE) is a powerful tool for targeted insertion of transgenes. Here we describe non-proprietary 'RMCE-in' cell lines as an alternative to the 'Flp-in' system and cell lines. RMCE-in cell lines offer a number of advantages including increased efficiency of integration of the genetic element of interest (GEI) at a single docking site, lack of bacterial backbone at the docking site both before and after GEI integration, removal of selection and visual markers initially present at the docking site upon GEI integration and the possibility to validate GEI integration by loss of a red fluorescence reporter. Moreover, the RMCE-in cell lines are compatible with GEI donors used for the Flp-in system. We demonstrate a three-step procedure for generating RMCE-in cell lines, (I) RMCE-in transposon and SB10 transposase transfection, (II) clone isolation, and (III) selecting single integrated clones with highest RFP level, which could in principle be used to turn any cell line into an RMCE-in cell line. The RMCE-in system was used as a proof of concept to produce three new RMCE-in cell lines using HEK293, HeLa, and murine embryonic stem (mES) cells. The established RMCE-in cell lines and vector are freely available from the ATCC cell bank and Addgene respectively.	[Callesen, Morten M.; Berthelsen, Martin F.; Lund, Sira; Jakobsen, Jannik E.] Aarhus Univ, Fac Hlth, Dept Biomed, Aarhus C, Denmark; [Callesen, Morten M.; Berthelsen, Martin F.; Jakobsen, Jannik E.] Aarhus Univ, Fac Hlth, Dept Clin Med, Aarhus N, Denmark; [Fuchtbauer, Annette C.; Fuchtbauer, Ernst-Martin] Aarhus Univ, Dept Mol Biol & Genet, Aarhus C, Denmark	Aarhus University; Aarhus University; Aarhus University	Fuchtbauer, EM (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Aarhus C, Denmark.	emf@mbg.au.dk		Callesen, Morten/0000-0001-6258-2171	Danish Agency for Science, Technology and Innovation [11-105224]	Danish Agency for Science, Technology and Innovation	JEJ was supported by the Danish Agency for Science, Technology and Innovation, no. 11-105224.	Ai HW, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-13; Anastassiadis K, 2013, METHOD ENZYMOL, V533, P133, DOI 10.1016/B978-0-12-420067-8.00009-X; Chen ZY, 2004, GENE THER, V11, P856, DOI 10.1038/sj.gt.3302231; Chen ZY, 2003, MOL THER, V8, P495, DOI 10.1016/S1525-0016(03)00168-0; Dalle B, 2005, MOL THER, V11, P591, DOI 10.1016/j.ymthe.2004.11.012; Geurts AM, 2003, MOL THER, V8, P108, DOI 10.1016/S1525-0016(03)00099-6; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Jakobsen JE, 2011, TRANSGENIC RES, V20, P533, DOI 10.1007/s11248-010-9438-x; Jakobsen JE, 2010, BIOTECHNIQUES, V48, P313, DOI 10.2144/000113386; Jakobsen JE, 2013, TRANSGENIC RES, V22, P709, DOI 10.1007/s11248-012-9671-6; Liu GY, 2005, J MOL BIOL, V346, P161, DOI 10.1016/j.jmb.2004.09.086; Louwerse JD, 2007, PLANT PHYSIOL, V145, P1282, DOI 10.1104/pp.107.108092; Meaux S, 2006, RNA, V12, P1323, DOI 10.1261/rna.46306; Mulholland CB, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv550; OGORMAN S, 1991, SCIENCE, V251, P1351, DOI 10.1126/science.1900642; Proudfoot NJ, 2011, GENE DEV, V25, P1770, DOI 10.1101/gad.17268411; Sandhu U, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq868; SCHLAKE T, 1994, BIOCHEMISTRY-US, V33, P12746, DOI 10.1021/bi00209a003; Schnutgen F, 2011, METHODS, V53, P347, DOI 10.1016/j.ymeth.2010.12.037; Shcherbo D, 2007, NAT METHODS, V4, P741, DOI 10.1038/NMETH1083; SWIATEK PJ, 1993, GENE DEV, V7, P2071, DOI 10.1101/gad.7.11.2071; Turan S, 2013, GENE, V515, P1, DOI 10.1016/j.gene.2012.11.016; Turan S, 2010, J MOL BIOL, V402, P52, DOI 10.1016/j.jmb.2010.07.015	23	2	2	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2016	11	8							e0161471	10.1371/journal.pone.0161471	http://dx.doi.org/10.1371/journal.pone.0161471			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6UQ	27541869	Green Published, Green Submitted, gold			2022-12-26	WOS:000381620200006
J	Casas, E; Cai, G; Kuehn, LA; Register, KB; McDaneld, TG; Neill, JD				Casas, Eduardo; Cai, Guohong; Kuehn, Larry A.; Register, Karen B.; McDaneld, Tara G.; Neill, John D.			Association of MicroRNAs with Antibody Response to Mycoplasma bovis in Beef Cattle	PLOS ONE			English	Article							RESPIRATORY-DISEASE; HEME OXYGENASE-1; EXPRESSION; TRANSCRIPTOME; BIOMARKERS; INFECTION; MUSCLE; VIRUS; CELLS	The objective of this study was to identify microRNAs associated with a serum antibody response to Mycoplasma bovis in beef cattle. Serum from sixteen beef calves was collected at three points: in summer after calves were born, in fall at weaning, and in the following spring. All sera collected in the summer were ELISA-negative for anti-M. bovis. By the fall, eight animals were seropositive for IgG (positive group), while eight remained negative (negative group). By spring, all animals in both groups were seropositive. MicroRNAs were extracted from sera and sequenced on the Illumina HiSeq next-generation sequencer. A total of 1,374,697 sequences mapped to microRNAs in the bovine genome. Of these, 82% of the sequences corresponded to 27 microRNAs, each represented by a minimum of 10,000 sequences. There was a statistically significant interaction between ELISA response and season for bta-miR-24-3p (P = 0.0268). All sera collected at the initial summer had a similar number of copies of this microRNA (P = 0.773). In the fall, the positive group had an increased number of copies when compared to the negative group (P = 0.021), and this grew more significant by the following spring (P = 0.0001). There were 21 microRNAs associated (P< 0.05) with season. These microRNAs could be evaluated further as candidates to potentially improve productivity in cattle. The microRNAs bta-let-7b, bta-miR- 24-3p, bta-miR- 92a, and bta-miR-423-5p, were significatly associated with ELISA status (P< 0.05). These microRNAs have been recognized as playing a role in the host defense against bacteria in humans, mice, and dairy cattle. Further studies are needed to establish if these microRNAs could be used as diagnostic marker or indicator of exposure, or whether intervention strategies could be developed as an alternative to antibiotics for controlling disease due to M. bovis.	[Casas, Eduardo; Cai, Guohong; Register, Karen B.; Neill, John D.] ARS, USDA, Natl Anim Dis Ctr, Ames, IA 50010 USA; [Kuehn, Larry A.; McDaneld, Tara G.] ARS, USDA, US Meat Anim Res Ctr, Clay Ctr, NE 68933 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Casas, E (corresponding author), ARS, USDA, Natl Anim Dis Ctr, Ames, IA 50010 USA.	eduardo.casas@ars.usda.gov	Cai, Guohong/N-1274-2013	Cai, Guohong/0000-0002-7700-6019; Casas, Eduardo/0000-0003-3773-4035; Kuehn, Larry/0000-0002-7573-5365	USDA	USDA(United States Department of Agriculture (USDA))	This research was conducted at a USDA research facility and all funding was provided through internal USDA research dollars. This project is an intramural project of the USDA/ARS National Animal Disease Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Angelini TG, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00240; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Berschneider B, 2014, INT J BIOCHEM CELL B, V53, P432, DOI 10.1016/j.biocel.2014.06.011; Boese AS, 2016, MOL CELL NEUROSCI, V71, P13, DOI 10.1016/j.mcn.2015.12.001; Britton LE, 2016, VET J, V209, P32, DOI 10.1016/j.tvjl.2015.10.033; Bush TJV, 2003, VET IMMUNOL IMMUNOP, V94, P23, DOI 10.1016/S0165-2427(03)00056-4; Caswell JL, 2010, VET CLIN N AM-FOOD A, V26, P365, DOI 10.1016/j.cvfa.2010.03.003; Chen X, 2012, TRENDS CELL BIOL, V22, P125, DOI 10.1016/j.tcb.2011.12.001; Chung SW, 2008, J CLIN INVEST, V118, P239, DOI 10.1172/JCI32730; Chung SW, 2009, CELL MICROBIOL, V11, P199, DOI 10.1111/j.1462-5822.2008.01261.x; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Edmonds MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101802; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Griffin D, 1997, VET CLIN N AM-FOOD A, V13, P367, DOI 10.1016/S0749-0720(15)30302-9; Huang YZ, 2014, SCI REP-UK, V4, P1, DOI 10.1038/srep06546; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Jin WW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-181; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kozakowska M, 2014, ANTIOXID REDOX SIGN, V20, P1827, DOI 10.1089/ars.2013.5341; Lai LH, 2013, J BIOL CHEM, V288, P7956, DOI 10.1074/jbc.M112.445429; Lawless N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00611; Lawless N, 2014, G3-GENES GENOM GENET, V4, P957, DOI 10.1534/g3.113.009936; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; MARTIN SW, 1990, CAN J VET RES, V54, P337; Maunsell FP, 2011, J VET INTERN MED, V25, P772, DOI 10.1111/j.1939-1676.2011.0750.x; McDaneld TG, 2009, J ANIM SCI, V87, pE21, DOI 10.2527/jas.2008-1303; Miles Delbert G., 2009, Animal Health Research Reviews, V10, P101, DOI 10.1017/S1466252309990090; Oksuz Z, 2015, MOL BIOL REP, V42, P713, DOI 10.1007/s11033-014-3819-9; Punga T, 2016, J NEUROIMMUNOL, V292, P21, DOI 10.1016/j.jneuroim.2016.01.003; Register KB, 2013, CLIN VACCINE IMMUNOL, V20, P1405, DOI 10.1128/CVI.00409-13; Shahriar FM, 2002, CAN VET J, V43, P863; Sun J, 2015, ANIM GENET, V46, P227, DOI 10.1111/age.12272; Thornburg NJ, 2012, MBIO, V3, DOI 10.1128/mBio.00220-12; Wang J, 2016, J CELL PHYSIOL, V231, P25, DOI 10.1002/jcp.25056; Wang X, 2013, ANIMAL, V7, P1567, DOI 10.1017/S1751731113001183; Xiao SQ, 2015, J VIROL, V89, P4494, DOI 10.1128/JVI.02810-14	37	14	14	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161651	10.1371/journal.pone.0161651	http://dx.doi.org/10.1371/journal.pone.0161651			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537842	gold, Green Published, Green Submitted			2022-12-26	WOS:000381577000129
J	Gazmuri, RJ; Kaufman, CL; Baetiong, A; Radhakrishnan, J				Gazmuri, Raul J.; Kaufman, Christopher L.; Baetiong, Alvin; Radhakrishnan, Jeejabai			Ventricular Fibrillation Waveform Changes during Controlled Coronary Perfusion Using Extracorporeal Circulation in a Swine Model	PLOS ONE			English	Article							CARDIAC-ARREST; RESUSCITATION; DEFIBRILLATION; ELECTROCARDIOGRAM	Background Several characteristics of the ventricular fibrillation (VF) waveform have been found predictive of successful defibrillation and hypothesized to reflect the myocardial energy state. In an open-chest swine model of VF, we modeled "average CPR" using extracorporeal circulation (ECC) and assessed the time course of coronary blood flow, myocardial metabolism, and myocardial structure in relation to the amplitude spectral area (AMSA) of the VF waveform without artifacts related to chest compression. Methods VF was induced and left untreated for 8 minutes in 16 swine. ECC was then started adjusting its flow to maintain a coronary perfusion pressure of 10 mmHg for 10 minutes. AMSA was calculated in the frequency domain and analyzed continuously with a 2.1 s timeframe and a Tukey window that moved ahead every 0.5 s. Results AMSA progressively declined during untreated VF. With ECC, AMSA increased from 7.0 +/- 1.9 mV.Hz (at minute 8) to 12.8 +/- 3.3 mV.Hz (at minute 14) (p < 0.05) without subsequent increase and showing a modest correlation with coronary blood flow of borderline statistical significance (r = 0.489, p = 0.0547). Myocardial energy measurements showed marked reduction in phosphocreatine and moderate reduction in ATP with increases in ADP, AMP, and adenosine along with myocardial lactate, all indicative of ischemia. Yet, ischemia did not resolve during ECC despite a coronary blood flow of similar to 30% of baseline. Conclusion AMSA increased upon return of coronary blood flow during ECC. However, the maximal level was reached after similar to 6 minutes without further change. The significance of the findings for determining the optimal timing for delivering an electrical shock during resuscitation from VF remains to be further explored.	[Gazmuri, Raul J.; Baetiong, Alvin; Radhakrishnan, Jeejabai] Rosalind Franklin Univ Med & Sci, Resuscitat Inst, N Chicago, IL 60088 USA; [Gazmuri, Raul J.] CAPT James A Lovell Fed Hlth Care Ctr, Sect Crit Care Med, N Chicago, IL 60064 USA; [Kaufman, Christopher L.] ZOLL Med Corp, Chelmsford, MA USA	Rosalind Franklin University Medical & Science	Gazmuri, RJ (corresponding author), Rosalind Franklin Univ Med & Sci, Resuscitat Inst, N Chicago, IL 60088 USA.; Gazmuri, RJ (corresponding author), CAPT James A Lovell Fed Hlth Care Ctr, Sect Crit Care Med, N Chicago, IL 60064 USA.	raul.gazmuri@rosalindfranklin.edu		Gazmuri, Raul J./0000-0002-3848-7227	VA Merit Review Grant entitled Myocardial Effects of Erythropoietin during Resuscitation from Cardiac Arrest [5I01BX000233]; ZOLL Medical Corporation	VA Merit Review Grant entitled Myocardial Effects of Erythropoietin during Resuscitation from Cardiac Arrest(US Department of Veterans Affairs); ZOLL Medical Corporation	This work was funded by a VA Merit Review Grant entitled Myocardial Effects of Erythropoietin during Resuscitation from Cardiac Arrest (#5I01BX000233) for which RJG served as Principal Investigator. The funder provided support in the form of salaries for authors AB, JR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. It was also supported by unrestricted Funds to Support Educational and Research Activities from ZOLL Medical Corporation, for which RJG served as Principal Investigator. The funder provided partial support in the form of salaries for author AB and research materials but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. CLK is employed by ZOLL Medical Corporation and contributed to portions of the data analysis and the Methods section of the manuscript.	ANGELOS MG, 1994, RESUSCITATION, V27, P245, DOI 10.1016/0300-9572(94)90038-8; Ayoub IM, 2003, CIRCULATION, V107, P1804, DOI 10.1161/01.CIR.0000058704.45646.0D; Ayoub IM, 2007, CRIT CARE MED, V35, P2329, DOI 10.1097/01.CCM.0000280569.87413.74; Borovnik-Lesjak V, 2013, TRANSL RES, V162, P110, DOI 10.1016/j.trsl.2013.06.002; Cobb LA, 1999, JAMA-J AM MED ASSOC, V281, P1182, DOI 10.1001/jama.281.13.1182; Gazmuri RJ, 2000, CRIT CARE MED, V28, P2690, DOI 10.1097/00003246-200008000-00002; Indik JH, 2009, CIRC-ARRHYTHMIA ELEC, V2, P179, DOI 10.1161/CIRCEP.108.824862; Kolarova J, 2003, CRIT CARE MED, V31, P2022, DOI 10.1097/01.CCM.0000070446.84095.F4; Marn-Pernat A, 2001, CRIT CARE MED, V29, P2360, DOI 10.1097/00003246-200112000-00019; NIEMANN JT, 1992, CIRCULATION, V85, P281, DOI 10.1161/01.CIR.85.1.281; NOC M, 1994, J LAB CLIN MED, V124, P421; Olivecrona Goran K, 2004, Purinergic Signal, V1, P59, DOI 10.1007/s11302-004-4742-7; Reynolds JC, 2012, RESUSCITATION, V83, P1497, DOI 10.1016/j.resuscitation.2012.04.013; Ristagno G, 2008, CRIT CARE MED, V36, pS422, DOI 10.1097/CCM.0b013e31818a84c5; Salcido DD, 2012, RESUSCITATION, V83, P505, DOI 10.1016/j.resuscitation.2011.09.018; Salcido DD, 2009, RESUSCITATION, V80, P946, DOI 10.1016/j.resuscitation.2009.05.002; Sun Shijie, 2011, Resuscitation, V82 Suppl 2, pS3, DOI 10.1016/S0300-9572(11)70144-7; Tsai MS, 2009, CRIT CARE MED, V37, P2394, DOI 10.1097/CCM.0b013e3181a02ea1; Wang SF, 2007, J APPL PHYSIOL, V103, P55, DOI 10.1152/japplphysiol.01167.2006; Weisfeldt ML, 2002, JAMA-J AM MED ASSOC, V288, P3035, DOI 10.1001/jama.288.23.3035; Xie JL, 1997, CIRCULATION, V96, P683	21	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161166	10.1371/journal.pone.0161166	http://dx.doi.org/10.1371/journal.pone.0161166			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536996	Green Published, Green Submitted, gold			2022-12-26	WOS:000381577000063
J	Chaabane, A; Neifar, L; Gey, D; Justine, JL				Chaabane, Amira; Neifar, Lassad; Gey, Delphine; Justine, Jean-Lou			Species of Pseudorhabdosynochus (Monogenea, Diplectanidae) from Groupers (Mycteroperca spp., Epinephelidae) in the Mediterranean and Eastern Atlantic Ocean, with Special Reference to the 'Beverleyburtonae Group' and Description of Two New Species	PLOS ONE			English	Article							E-MERRA PERCIFORMES; CORAL-REEF FISH; NEW-CALEDONIA; NEMATODA PHILOMETRIDAE; PARASITE BIODIVERSITY; CYCLOPLECTANUM OLIVER; N. SP; SERRANIDAE; GILLS; PLATYHELMINTHES	Pseudorhabdosynochus Yamaguti, 1958 is a species-rich diplectanid genus, mainly restricted to the gills of groupers (Epinephelidae) and especially abundant in warm seas. Species from the Mediterranean are not fully documented. Two new and two previously known species from the gills of Mycteroperca spp. (M. costae, M. rubra, and M. marginata) in the Mediterranean and Eastern Atlantic Ocean are described here from new material and slides kept in collections. Identifications of newly collected fish were ascertained by barcoding of cytochrome c oxidase subunit I (COI) sequences. Pseudorhabdosynochus beverley-burtonae (Oliver, 1984) Kritsky & Beverley-Burton, 1986 and P. sosia Neifar & Euzet 2007 are redescribed from type-specimens and new specimens collected off Tunisia and Libya from M. marginata and M. costae, respectively. Pseudorhabdosynochus oliveri n. sp., from M. marginata (type-host) off the Mediterranean coast of France (type-locality), is described from specimens found among voucher specimens of P. beverleyburtonae deposited by Guy Oliver in the collection of the Museum National d'Histoire Naturelle, Paris. Pseudorhabdosynochus oliveri is distinguished by the shape of its sclerotised vagina; it was not found in the other localities investigated. Pseudorhabdosynochus hayet n. sp. is described from M. rubra (type host) off Senegal (type-locality) and Tunisia. Pseudorhabdosynochus hayet is morphologically similar to P. sosia (type-host: M. costae) but was distinguished by differences in measurements of the vagina and male copulatory organ, different host, and divergent COI sequences. The four species (P. beverleyburtonae, P. sosia, P. oliveri, and P. hayet) share common characteristics such as squamodiscs with 2 innermost circular rows of rodlets and a similar general structure of the sclerotised vagina; we propose to group them into a 'beverleyburtonae group' within Pseudorhabdosynochus.	[Chaabane, Amira; Neifar, Lassad] Univ Sfax, Fac Sci Sfax, Lab Biodiversite & Ecosyst Aquat, Sfax, Tunisia; [Gey, Delphine] Univ Paris 04, Museum Natl Hist Nat, UMS Serv Systemat Mol 2700, Paris, France; [Justine, Jean-Lou] Univ Paris 04, Museum Natl Hist Nat, ISYEB,CNRS,EPHE,MNHN,UPMC, Inst Systemat Evolut Biodiversite,UMR7205, Paris, France	Universite de Sfax; Faculty of Sciences Sfax; Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite	Chaabane, A (corresponding author), Univ Sfax, Fac Sci Sfax, Lab Biodiversite & Ecosyst Aquat, Sfax, Tunisia.	amirachaabene@hotmail.fr	Chaabane, Amira/AAQ-3021-2021; Justine, Jean-Lou/B-1298-2010	Chaabane, Amira/0000-0002-2931-4113; Justine, Jean-Lou/0000-0002-7155-4540; Gey, Delphine/0000-0002-5656-1793	Ministere des Affaires Etrangeres, France; Museum National d'Histoire Naturelle, France	Ministere des Affaires Etrangeres, France; Museum National d'Histoire Naturelle, France	This work was supported by Ministere des Affaires Etrangeres, France: grant BIOPARMED-ENVIMED, http://www.mistrals-home.org/spip.php?rubrique82; and Museum National d'Histoire Naturelle, France: Grant ATM Barcode, Grant PARSUDMED, https://www.mnhn.fr/fr. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Presas M, 2012, MOL PHYLOGENET EVOL, V64, P491, DOI 10.1016/j.ympev.2012.05.001; Chaabane A, 2016, PEERJ, V4, DOI 10.7717/peerj.2233; Chaabane A, 2015, PARASITE, V22, DOI 10.1051/parasite/2015005; Craig M. T., 2012, GROUPERS WORLD FIELD; Craig MT, 2007, ICHTHYOL RES, V54, P1, DOI 10.1007/s10228-006-0367-x; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; EUZET LOUIS, 1965, ANN PARASITOL HUM COMP, V40, P517; Gibson DI, 2016, MONOGENEA; Heemstra P.C., 1993, FAO SPECIES CATALOGU, V125; Hinsinger DD, 2006, SYST PARASITOL, V64, P69, DOI 10.1007/s11230-005-9018-2; Justine JL, 2007, SYST PARASITOL, V68, P195, DOI 10.1007/s11230-007-9096-4; Justine JL, 2007, SYST PARASITOL, V66, P81, DOI 10.1007/s11230-006-9057-3; Justine JL, 2015, PEERJ, V3, DOI 10.7717/peerj.1037; Justine JL, 2010, FOLIA PARASIT, V57, P237, DOI 10.14411/fp.2010.032; Justine JL, 2010, BELG J ZOOL, V140, P155; Justine JL, 2010, SYST PARASITOL, V77, P81, DOI 10.1007/s11230-010-9263-x; Justine Jean-Lou, 2007, Zootaxa, V1543, P1; Justine JL, 2009, SYST PARASITOL, V72, P113, DOI 10.1007/s11230-008-9159-1; Justine JL, 2009, SYST PARASITOL, V72, P27, DOI 10.1007/s11230-008-9171-5; Justine JL, 2006, SYST PARASITOL, V64, P147, DOI 10.1007/s11230-006-9028-8; Justine JL, 2005, SYST PARASITOL, V62, P1, DOI 10.1007/s11230-005-5480-0; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Knoff M, 2015, PARASITE, V22, DOI 10.1051/parasite/2015011; KRITSKY DC, 1986, P BIOL SOC WASH, V99, P17; Kritsky DC, 2015, PARASITE, V22, DOI 10.1051/parasite/2015024; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Littlewood DTJ, 1997, INT J PARASITOL, V27, P1289, DOI 10.1016/S0020-7519(97)00086-6; MALMBERG G., 1957, Skrifter utgivna av Sodra Sveriges Fiskeriforening, P19; Mendoza-Franco EF, 2011, J PARASITOL, V97, P20, DOI 10.1645/GE-2716.1; Moravec F, 2016, PARASITE, V23, DOI 10.1051/parasite/2016008; Moravec F, 2016, SYST PARASITOL, V93, P115, DOI 10.1007/s11230-015-9610-z; Neifar L, 2007, FOLIA PARASIT, V54, P117, DOI 10.14411/fp.2007.017; OLIVER G, 1984, ANN PARASIT HUM COMP, V59, P31, DOI 10.1051/parasite/1984591031; OLIVER G, 1968, Vie et Milieu, V19, P95; Oliver G, 1987, THESIS; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Roumbedakis K, 2013, Braz J Biol, V73, P871, DOI 10.1590/S1519-69842013000400025; Santos CP, 2000, SYST PARASITOL, V45, P145, DOI 10.1023/A:1006232029426; Schoelinck C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098198; Schoelinck C, 2012, PARASITOL INT, V61, P356, DOI 10.1016/j.parint.2012.01.009; Schoelinck C, 2011, SYST PARASITOL, V79, P41, DOI 10.1007/s11230-010-9289-0; Sigura A, 2008, ZOOTAXA, P1; Sluys R, 2013, BIODIVERS CONSERV, V22, P1095, DOI 10.1007/s10531-013-0472-x; ULMER MJ, 1981, T AM MICROSC SOC, V100, P392, DOI 10.2307/3226153; Vanhove MPM, 2013, ZOOKEYS, P355, DOI 10.3897/zookeys.365.5776; VidalMartinez VM, 1997, FOLIA PARASIT, V44, P274; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716	47	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0159886	10.1371/journal.pone.0159886	http://dx.doi.org/10.1371/journal.pone.0159886			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532108	Green Published, Green Submitted, gold			2022-12-26	WOS:000381487600014
J	Khatat, SE; Sahibi, H; Hing, M; Moustain, IA; El Amri, H; Benajiba, M; Kachani, M; Duchateau, L; Daminet, S				Khatat, Sarah Elhamiani; Sahibi, Hamid; Hing, Mony; Moustain, Ismail Alaoui; El Amri, Hamid; Benajiba, Mohammed; Kachani, Malika; Duchateau, Luc; Daminet, Sylvie			Human Exposure to Anaplasma phagocytophilum in Two Cities of Northwestern Morocco	PLOS ONE			English	Article							HUMAN GRANULOCYTIC EHRLICHIOSIS; SEROLOGICAL EVIDENCE; LYME BORRELIOSIS; FORESTRY RANGERS; SEROPREVALENCE; RISK; ANTIBODIES; WORKERS; TICKS; INFECTIONS	Anaplasma phagocytophilum is an emerging tick-borne zoonosis with extensive increased interest. Epidemiological data are available in several regions of the USA, Europe and Asia in contrast to other parts of the world such as North Africa. Blood samples of 261 healthy individuals divided in two groups i.e., dog handlers and blood donors were analysed. Indirect immunofluorescent assay using a commercial kit was performed to detect specific A. phagocytophilum IgG. Two dilutions were used to assess the prevalence of seroreactive samples. Demographic variables were assessed as potential risk factors using exact logistic regression. Seropositivity rates reached 37% and 27% in dog handlers and 36% and 22% in blood donors. No statistically significant differences were found in the prevalence rates between the two groups. Analysis of risk factors such as gender, age groups, outdoor activities, self-reported previous exposure to ticks, or contact with domestic animals (dogs, cats, ruminants and horses) did not shown any significant difference. A. phagocytophilum exposure was common in both high-risk population and blood donors in Morocco.	[Khatat, Sarah Elhamiani; Sahibi, Hamid] Inst Agron & Vet Hassan II, Dept Pathol & Vet Publ Heath, Rabat, Morocco; [Khatat, Sarah Elhamiani; Daminet, Sylvie] Univ Ghent, Dept Compan Anim, Fac Vet Med, Merelbeke, Belgium; [Hing, Mony] Queen Astrid Mil Hosp, Lab Clin Biol, Natl Reference Lab Anaplasma phagocytophilum, Brussels, Belgium; [Moustain, Ismail Alaoui] Royal Gendarmery, Cent Hlth Serv, Rabat, Morocco; [El Amri, Hamid] Royal Gendarmery, Rabat, Morocco; [Benajiba, Mohammed] Reg Transfus Ctr, Rabat, Morocco; [Kachani, Malika] Western Univ Hlth Sci, Coll Vet Med, Pomona, CA USA; [Duchateau, Luc] Univ Ghent, Fac Vet Med, Dept Comparat Physiol & Biometr, Merelbeke, Belgium	Ghent University; Queen Astrid Military Hospital; Western University of Health Sciences; Ghent University	Khatat, SE (corresponding author), Inst Agron & Vet Hassan II, Dept Pathol & Vet Publ Heath, Rabat, Morocco.; Khatat, SE (corresponding author), Univ Ghent, Dept Compan Anim, Fac Vet Med, Merelbeke, Belgium.	elhamianis@yahoo.fr		Daminet, Sylvie/0000-0001-6733-7925				Adjemian J, 2012, VECTOR-BORNE ZOONOT, V12, P922, DOI 10.1089/vbz.2011.0917; Aguero-Rosenfeld ME, 2002, J CLIN MICROBIOL, V40, P2612, DOI 10.1128/JCM.40.7.2612-2615.2002; Annen K, 2012, AM J CLIN PATHOL, V137, P562, DOI 10.1309/AJCP4E4VQQQOZIAQ; Anonymous, 2008, Morbidity and Mortality Weekly Report, V57, P1145; Bakken JS, 2006, ANN NY ACAD SCI, V1078, P236, DOI 10.1196/annals.1374.042; Bakken JS, 2015, INFECT DIS CLIN N AM, V29, P341, DOI 10.1016/j.idc.2015.02.007; BROUQUI P, 1995, LANCET, V346, P782, DOI 10.1016/S0140-6736(95)91544-3; Chmielewska-Badora J, 2012, ANN AGR ENV MED, V19, P271; Chochlakis D, 2008, EUR J CLIN MICROBIOL, V27, P473, DOI 10.1007/s10096-007-0457-3; Chochlakis D, 2009, J INFECTION, V58, P87, DOI 10.1016/j.jinf.2008.11.005; Cinco M, 2004, CLIN MICROBIOL INFEC, V10, P1056, DOI 10.1111/j.1469-0691.2004.01026.x; Cisak E, 2005, ANN AGR ENV MED, V12, P127; Dumler JS, 2005, EMERG INFECT DIS, V11, P1828, DOI 10.3201/eid1112.050898; Fingerle V, 1997, J CLIN MICROBIOL, V35, P3244, DOI 10.1128/JCM.35.12.3244-3247.1997; Graf PCF, 2008, CLIN INFECT DIS, V46, P70, DOI 10.1086/524018; Groen J, 2002, EUR J CLIN MICROBIOL, V21, P46, DOI 10.1007/s10096-001-0659-z; Grzeszczuk A, 2002, EUR J CLIN MICROBIOL, V21, P6, DOI 10.1007/s10096-001-0649-1; Hao Q, 2013, BIOMED ENVIRON SCI, V26, P185, DOI 10.3967/0895-3988.2013.03.005; Henningsson AJ, 2015, TICKS TICK-BORNE DIS, V6, P787, DOI 10.1016/j.ttbdis.2015.07.005; Heyman P, 2003, J INFECTION, V47, P129, DOI 10.1016/S0163-4453(03)00056-2; Heyman P, 2010, EXPERT REV ANTI-INFE, V8, P33, DOI 10.1586/ERI.09.118; Hjetland R, 2015, INFECT DIS-NOR, V47, P52, DOI 10.3109/00365548.2014.959044; Leiby DA, 2002, TRANSFUSION, V42, P1585, DOI 10.1046/j.1537-2995.2002.00251.x; Maczka Ilona, 2013, Przegl Epidemiol, V67, P633; Oteo JA, 2001, EPIDEMIOL INFECT, V127, P353, DOI 10.1017/S0950268801005878; Otranto D, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-328; Pusterla N, 1998, EUR J CLIN MICROBIOL, V17, P207, DOI 10.1007/BF01691120; Santos AS, 2006, ANN NY ACAD SCI, V1078, P100, DOI 10.1196/annals.1374.014; Seng P, 2009, CLIN MICROBIOL INFEC, V15, P86, DOI 10.1111/j.1469-0691.2008.02251.x; Stanczak J, 2006, ANN NY ACAD SCI, V1078, P89, DOI 10.1196/annals.1374.011; Thomas DR, 1998, EPIDEMIOL INFECT, V121, P609, DOI 10.1017/S0950268898001514; von Wissmann B, 2015, INT J MED MICROBIOL, V305, P736, DOI 10.1016/j.ijmm.2015.08.026; Walder G, 2003, EUR J CLIN MICROBIOL, V22, P543, DOI 10.1007/s10096-003-0986-3; Zhang L., 2014, BIOMED RES INT, V2014, P313867, DOI [10.1155/2014/313867, DOI 10.1155/2014/313867]; Zhang LJ, 2008, EMERG INFECT DIS, V14, P938, DOI 10.3201/eid1406.071502; Zhang LJ, 2011, ASIAN PAC J TROP MED, V4, P568, DOI 10.1016/S1995-7645(11)60148-X; Zhang SY, 2009, AM J TROP MED HYG, V81, P293, DOI 10.4269/ajtmh.2009.81.293; Zhang XC, 2012, VECTOR-BORNE ZOONOT, V12, P932, DOI 10.1089/vbz.2012.0961; Zhang YongGen, 2012, Asian Pacific Journal of Tropical Disease, V2, P27; Zukiewicz-Sobczak W, 2014, ANN AGR ENV MED, V21, P767, DOI 10.5604/12321966.1129930	40	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160880	10.1371/journal.pone.0160880	http://dx.doi.org/10.1371/journal.pone.0160880			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532208	gold, Green Published, Green Submitted			2022-12-26	WOS:000381487600046
J	Iliodromiti, S; Ghouri, N; Celis-Morales, CA; Sattar, N; Lumsden, MA; Gill, JMR				Iliodromiti, Stamatina; Ghouri, Nazim; Celis-Morales, Carlos A.; Sattar, Naveed; Lumsden, Mary Ann; Gill, Jason M. R.			Should Physical Activity Recommendations for South Asian Adults Be Ethnicity-Specific? Evidence from a Cross-Sectional Study of South Asian and White European Men and Women	PLOS ONE			English	Article							ACTIVITY GUIDELINES; INSULIN-RESISTANCE; METABOLIC SYNDROME; OBESITY; RISK; ASSOCIATION; PREVALENCE; MORTALITY	International public health guidelines recommend that adults undertake at least 150 min. week(-1) of moderate-intensity physical activity. However, the underpinning evidence has largely been obtained from studies of populations of white European descent. It is unclear whether these recommendations are appropriate for other ethnic groups, particularly South Asians, who have greater cardio-metabolic risk than white Europeans. The objective of our study was to determine the level of moderate-intensity physical activity required in South Asians adults to confer a similar cardio-metabolic risk profile to that observed in Europeans of similar age and body mass index (BMI) undertaking the currently recommended levels of 150 min. week(-1). 148 South Asians and 163 white Europeans aged 18 to 70 years were recruited. Physical activity was measured objectively via vertical axis accelerations from hip-worn accelerometers. Factor analysis was used to summarize the measured risk biomarkers into a single underlying latent "factor" describing overall cardio-metabolic risk. Sex did not modify the association between physical activity and the cardio-metabolic risk factor, so data for both sexes were combined and models adjusted for age, sex, BMI and accelerometer wear time. We estimated that South Asian adults needed to undertake 232 (95% Confidence interval: 200 to 268) min. week(-1) in order to obtain the same cardio-metabolic risk factor score as a white European undertaking 150 minutes of moderate-equivalent physical activity per week. The present findings suggest that South Asian men and women need to undertake similar to 230 minutes of moderate intensity physical activity per week. This equates to South Asians undertaking an extra 10-15 minutes of moderate intensity physical activity per day on top of existing recommendations.	[Iliodromiti, Stamatina; Lumsden, Mary Ann; Gill, Jason M. R.] Univ Glasgow, Sch Med, Dept Obstet & Gynaecol, Glasgow, Lanark, Scotland; [Ghouri, Nazim; Celis-Morales, Carlos A.; Sattar, Naveed] Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland	University of Glasgow; University of Glasgow	Iliodromiti, S (corresponding author), Univ Glasgow, Sch Med, Dept Obstet & Gynaecol, Glasgow, Lanark, Scotland.	Stamatina.iliodromiti@glasgow.ac.uk	Celis-Morales, Carlos/AAJ-5103-2020	Ghouri, Noushima/0000-0002-8202-3913; Iliodromiti, Stamatina/0000-0001-6453-6654				Agyemang C, 2012, DIABETIC MED, V29, P1159, DOI 10.1111/j.1464-5491.2012.03616.x; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; American Diabetes Association, 2017, Diabetes Care, V40, pS11, DOI 10.2337/dc15-S005; Babakus WS, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-150; British Heart Foundation, 2000, S AS HEART DIS; Celis-Morales CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082568; Celis-Morales CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036345; Deanfield J, 2014, HEART, V100, P1, DOI 10.1136/heartjnl-2014-305693; Department of Health, 2011, START ACT STAY ACT R; Fischbacher CM, 2004, J PUBLIC HEALTH-UK, V26, P250, DOI 10.1093/pubmed/fdh158; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Ghouri N, 2013, DIABETOLOGIA, V56, P2238, DOI 10.1007/s00125-013-2969-y; Gill JMR, 2008, SPORTS MED, V38, P807, DOI 10.2165/00007256-200838100-00002; Gill JMR, 2014, ATHEROSCLEROSIS, V232, P319, DOI 10.1016/j.atherosclerosis.2013.11.039; Glazer NL, 2013, MED SCI SPORT EXER, V45, P109, DOI 10.1249/MSS.0b013e31826beae5; Gray LJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026464; Gregg EW, 2003, JAMA-J AM MED ASSOC, V289, P2379, DOI 10.1001/jama.289.18.2379; Hall LML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014197; Hansen BH, 2012, MED SCI SPORT EXER, V44, P266, DOI 10.1249/MSS.0b013e31822cb354; Jeon CY, 2007, DIABETES CARE, V30, P744, DOI 10.2337/dc06-1842; MATHER HM, 1985, BRIT MED J, V291, P1081, DOI 10.1136/bmj.291.6502.1081; MCKEIGUE PM, 1993, CIRCULATION, V87, P152, DOI 10.1161/01.CIR.87.1.152; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; Misra A, 2009, J Assoc Physicians India, V57, P163; Misra A, 2012, DIABETES TECHNOL THE, V14, P83, DOI 10.1089/dia.2011.0111; NICE, 2013, ASSESSING BODY MASS; Nocon M, 2008, EUR J CARDIOV PREV R, V15, P239, DOI 10.1097/HJR.0b013e3282f55e09; Razak F, 2007, CIRCULATION, V115, P2111, DOI 10.1161/CIRCULATIONAHA.106.635011; Sproston K., 2006, HLTH MINORITY ETHNIC; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Tuomilehto J, 2003, DIABETES CARE, V26, P1770; U.S. Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A; Waidyatilaka I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058328; Warburton DER, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-39; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Yates T, 2010, PREV MED, V51, P290, DOI 10.1016/j.ypmed.2010.06.011; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	39	32	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160024	10.1371/journal.pone.0160024	http://dx.doi.org/10.1371/journal.pone.0160024			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529339	gold, Green Accepted, Green Submitted, Green Published			2022-12-26	WOS:000381476700003
J	Molano, M; Tabrizi, SN; Garland, SM; Roberts, JM; Machalek, DA; Phillips, S; Chandler, D; Hillman, RJ; Grulich, AE; Jin, FY; Poynten, IM; Templeton, DJ; Cornall, AM				Molano, Monica; Tabrizi, Sepehr N.; Garland, Suzanne M.; Roberts, Jennifer M.; Machalek, Dorothy A.; Phillips, Samuel; Chandler, David; Hillman, Richard J.; Grulich, Andrew E.; Jin, Fengyi; Poynten, I. Mary; Templeton, David J.; Cornall, Alyssa M.		SPANC Study Team	CpG Methylation Analysis of HPV16 in Laser Capture Microdissected Archival Tissue and Whole Tissue Sections from High Grade Anal Squamous Intraepithelial Lesions: A Potential Disease Biomarker	PLOS ONE			English	Article							PAPILLOMAVIRUS TYPE-16 DNA; E2 BINDING-SITES; HIV-INFECTED MEN; 16 E6 GENE; CERVICAL-CANCER; NEOPLASIA; PROGRESSION; PRECANCER; PATTERNS; GENOMES	Incidence and mortality rates of anal cancer are increasing globally. More than 90% of anal squamous cell carcinomas (ASCC) are associated with human papillomavirus (HPV). Studies on HPV-related anogenital lesions have shown that patterns of methylation of viral and cellular DNA targets could potentially be developed as disease biomarkers. Lesion-specific DNA isolated from formalin-fixed paraffin-embedded (FFPE) tissues from existing or prospective patient cohorts may constitute a valuable resource for methylation analysis. However, low concentrations of DNA make these samples technically challenging to analyse using existing methods. We therefore set out to develop a sensitive and reproducible nested PCR-pyrosequencing based method to accurately quantify methylation at 10 CpG sites within the E2BS1, E2BS2,3,4 and Sp1 binding sites in the viral upstream regulatory region of HPV16 genome. Methylation analyses using primary and nested PCR-pyrosequencing on 52 FFPE tissue [26 paired whole tissue sections (WTS) and laser capture microdissected (LCM) tissues] from patients with anal squamous intraepithelial lesions was performed. Using nested PCR, methylation results were obtained for the E2BS1, E2BS2,3,4 and Sp1 binding sites in 86.4% of the WTS and 81.8% of the LCM samples. Methylation patterns were strongly correlated within median values of matched pairs of WTS and LCM sections, but overall methylation was higher in LCM samples at different CpG sites. High gradelesions showed low methylation levels in the E2BS1 and E2BS2 regions, with increased methylation detected in the E2BS, 3,4/Sp1 regions, showing the highest methylation at CpG site 37. The method developed is highly sensitive in samples with low amounts of DNA and demonstrated to be suitable for archival samples. Our data shows a possible role of specific methylation in the HPV16 URR for detection of HSIL.	[Molano, Monica; Tabrizi, Sepehr N.; Garland, Suzanne M.; Machalek, Dorothy A.; Phillips, Samuel; Cornall, Alyssa M.] Royal Womens Hosp, Dept Microbiol & Infect Dis, Reg HPV Labnet Reference Lab, Parkville, Vic, Australia; [Tabrizi, Sepehr N.; Garland, Suzanne M.; Machalek, Dorothy A.; Phillips, Samuel; Cornall, Alyssa M.] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Tabrizi, Sepehr N.; Garland, Suzanne M.] Univ Melbourne, Dept Obstet & Gynaecol, Parkville, Vic, Australia; [Tabrizi, Sepehr N.; Garland, Suzanne M.] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Roberts, Jennifer M.] GynaePath, Douglass Hanly Moir Pathol, Macquarie Pk, Sydney, NSW, Australia; [Chandler, David] Australian Genome Res Facil, Perth, WA, Australia; [Hillman, Richard J.] Western Sydney Local Hlth Dist, Western Sydney Sexual Hlth Ctr, Parramatta, NSW, Australia; [Hillman, Richard J.] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia; [Grulich, Andrew E.; Jin, Fengyi; Poynten, I. Mary; Templeton, David J.] Univ New South Wales, Kirby Inst, Sydney, NSW, Australia; [Templeton, David J.] Royal Prince Alfred Hosp, RPA Sexual Hlth, Camperdown, NSW, Australia	Murdoch Children's Research Institute; University of Melbourne; Murdoch Children's Research Institute; University of Sydney; University of New South Wales Sydney; Kirby Institute; University of Sydney	Cornall, AM (corresponding author), Royal Womens Hosp, Dept Microbiol & Infect Dis, Reg HPV Labnet Reference Lab, Parkville, Vic, Australia.; Cornall, AM (corresponding author), Murdoch Childrens Res Inst, Parkville, Vic, Australia.	alyssa.cornall@mcri.edu.au	McCaffery, Kirsten/K-7945-2019; Segelov, Eva/Q-7611-2019; Hillman, Richard/AAM-1177-2020; Tong, Winnie Wing Yin/H-6785-2013	McCaffery, Kirsten/0000-0003-2696-5006; Segelov, Eva/0000-0002-4410-6144; Hillman, Richard/0000-0002-1859-0761; Tong, Winnie Wing Yin/0000-0003-2235-8452; Phillips, Samuel/0000-0002-2549-8111; Templeton, David/0000-0003-2157-9587; Machalek, Dorothy/0000-0002-4101-8085; Prestage, Garrett/0000-0003-3917-8992; Howard, Kirsten/0000-0002-0918-7540; Jin, Fengyi/0000-0002-8573-637X; Law, Matthew/0000-0002-3540-8837; Christopher, Fairley/0000-0001-9081-1664	Australian National Health and Medical Research Council Program [568971, 1071269]; Cancer Council NSW, Australia;  [13-11]	Australian National Health and Medical Research Council Program(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council NSW, Australia(Cancer Council New South Wales); 	This work is funded by Australian National Health and Medical Research Council (www.nhmrc.gov.au) Program Grants (#568971 and #1071269) and a Cancer Council NSW, Australia (www.cancercouncil.com.au), Strategic Research Partnership Program grant (#13-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz L, 2007, AIDS, V21, P1457, DOI 10.1097/QAD.0b013e3281c61201; Badal V, 2003, J VIROL, V77, P6227, DOI 10.1128/JVI.77.11.6227-6234.2003; Berry JM, 2014, INT J CANCER, V134, P1147, DOI 10.1002/ijc.28431; Bhattacharjee B, 2006, VIROLOGY, V354, P280, DOI 10.1016/j.virol.2006.06.018; Brandsma JL, 2009, VIROLOGY, V389, P100, DOI 10.1016/j.virol.2009.03.029; Chaiwongkot A, 2013, INT J CANCER, V132, P2087, DOI 10.1002/ijc.27906; Cheung JLK, 2013, GYNECOL ONCOL, V131, P374, DOI 10.1016/j.ygyno.2013.08.026; Clarke MA, 2012, CANCER EPIDEM BIOMAR, V21, P2125, DOI 10.1158/1055-9965.EPI-12-0905; Cornall AM, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008439; de Ruijter TC, 2015, LAB INVEST, V95, P833, DOI 10.1038/labinvest.2015.53; Dietrich D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077771; Ding DC, 2009, EUR J OBSTET GYN R B, V147, P215, DOI 10.1016/j.ejogrb.2009.08.023; Hoots BE, 2009, INT J CANCER, V124, P2375, DOI 10.1002/ijc.24215; Hublarova P, 2009, INT J GYNECOL CANCER, V19, P321, DOI 10.1111/IGC.0b013e31819d8a5c; Jacobs MV, 1999, BRIT J CANCER, V81, P114, DOI 10.1038/sj.bjc.6690659; Jacquin E, 2013, J CLIN MICROBIOL, V51, P3207, DOI 10.1128/JCM.01106-13; Jin FY, 2011, VACCINE, V29, P2322, DOI 10.1016/j.vaccine.2011.01.015; Johannsen E, 2013, VIROLOGY, V445, P205, DOI 10.1016/j.virol.2013.07.016; Kalantari M, 2004, J VIROL, V78, P12762, DOI 10.1128/JVI.78.23.12762-12772.2004; Kalantari M, 2009, VIROLOGY, V390, P261, DOI 10.1016/j.virol.2009.05.006; Leung TW, 2015, J MED VIROL, V87, P1022, DOI 10.1002/jmv.24129; Li QL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104481; LILLSUNDE L, 2014, PLOS ONE, V0009; Macedo MP, 2015, EXP MOL PATHOL, V98, P563, DOI [10.1016/j.yexmp.2015.03.038, DOI 10.1016/J.YEXMP.2015.03.038]; Machalek DA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-946; Machalek DA, 2012, LANCET ONCOL, V13, P487, DOI 10.1016/S1470-2045(12)70080-3; Mazumder D, 2011, GYNECOL ONCOL, V123, P597, DOI 10.1016/j.ygyno.2011.08.004; Mirabello L, 2015, INT J CANCER, V136, pE146, DOI 10.1002/ijc.29119; Mirabello L, 2012, JNCI-J NATL CANCER I, V104, P556, DOI 10.1093/jnci/djs135; Narasimhan Supraja, 2009, BMC Res Notes, V2, P104, DOI 10.1186/1756-0500-2-104; Patel DA, 2012, J VIROL METHODS, V184, P84, DOI 10.1016/j.jviromet.2012.05.022; Piyathilake CJ, 2011, CANCER-AM CANCER SOC, V117, P957, DOI 10.1002/cncr.25511; Rajeevan MS, 2006, J VIROL METHODS, V138, P170, DOI 10.1016/j.jviromet.2006.08.012; Richel O, 2014, J INFECT DIS, V210, P111, DOI 10.1093/infdis/jiu052; Siegel EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122495; Snellenberg S, 2012, VIROLOGY, V422, P357, DOI 10.1016/j.virol.2011.11.006; Sobhani I, 2004, AIDS, V18, P1561, DOI 10.1097/01.aids.0000131335.15301.dd; Sun C, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00150; Sun C, 2011, GYNECOL ONCOL, V121, P59, DOI 10.1016/j.ygyno.2011.01.013; Thierry F, 2009, VIROLOGY, V384, P375, DOI 10.1016/j.virol.2008.11.014; Turan T, 2006, VIROLOGY, V349, P175, DOI 10.1016/j.virol.2005.12.033; Vinokurova S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024451; Wang Z, 2011, CANCER BIOL THER, V11, P490, DOI 10.4161/cbt.11.5.14550; Wiley DJ, 2005, JAIDS-J ACQ IMM DEF, V39, P143	44	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160673	10.1371/journal.pone.0160673	http://dx.doi.org/10.1371/journal.pone.0160673			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529629	Green Published, Green Submitted, gold			2022-12-26	WOS:000381476700016
J	Ralston, ME; Myatt, MA				Ralston, Mark E.; Myatt, Mark A.			Weight Estimation Tool for Children Aged 6 to 59 Months in Limited-Resource Settings	PLOS ONE			English	Article							BROSELOW TAPE; BODY-WEIGHT; PEDIATRIC CARE; TUBE SIZE; ACCURACY; LENGTH; RESUSCITATION; AGREEMENT; FORMULAS; STANDARD	Importance A simple, reliable anthropometric tool for rapid estimation of weight in children would be useful in limited-resource settings where current weight estimation tools are not uniformly reliable, nearly all global under-five mortality occurs, severe acute malnutrition is a significant contributor in approximately one-third of under-five mortality, and a weight scale may not be immediately available in emergencies to first-response providers. Objective To determine the accuracy and precision of mid-upper arm circumference (MUAC) and height as weight estimation tools in children under five years of age in low-to-middle income countries. Design This was a retrospective observational study. Data were collected in 560 nutritional surveys during 1992-2006 using a modified Expanded Program of Immunization two-stage cluster sample design. Setting Locations with high prevalence of acute and chronic malnutrition. Participants A total of 453,990 children met inclusion criteria (age 6-59 months; weight <= 25 kg; MUAC 80-200 mm) and exclusion criteria (bilateral pitting edema; biologically implausible weight-for-height z-score (WHZ), weight-for-age z-score (WAZ), and height-for-age z-score (HAZ) values). Exposures Weight was estimated using Broselow Tape, Hong Kong formula, and database MUAC alone, height alone, and height and MUAC combined. Main Outcomes and Measures Mean percentage difference between true and estimated weight, proportion of estimates accurate to within +/- 25% and +/- 10% of true weight, weighted Kappa statistic, and Bland-Altman bias were reported as measures of tool accuracy. Standard deviation of mean percentage difference and Bland-Altman 95% limits of agreement were reported as measures of tool precision. Results Database height was a more accurate and precise predictor of weight compared to Brose-low Tape 2007 [B], Broselow Tape 2011 [A], and MUAC. Mean percentage difference between true and estimated weight was +0.49%(SD = 10.33%); proportion of estimates accurate to within +/- 25% of true weight was 97.36% (95% CI 97.40%, 97.46%); and Bland-Altman bias and 95% limits of agreement were 0.05 kg and (-2.15 kg; 2.24 kg). The height model fitted for MUAC classes was accurate and precise. For MUAC < 115 mm, the proportion of estimates accurate to within +/- 25% of true weight was 97.15% (95% CI 96.90%, 97.42%) and the Bland-Altman bias and 95% limits of agreement were 0.08 kg and (-1.21 kg; 1.37 kg). For MUAC between 115 and 125 mm, the proportion of estimates accurate to within +/- 25% of true weight was 98.93% (95% CI 98.82%, 99.03%) and Bland-Altman bias and 95% limits of agreement were 0.05 kg and (-1.15 kg; 1.24 kg). For MUAC > 125 mm, the proportion of estimates accurate to within +/- 25% of true weight was 98.33% (95% CI 98.29%, 98.37%) and Bland-Altman bias and 95% limits of agreement were 0.05 kg and (-2.08 kg; 2.19 kg). Conclusions and Relevance Models estimating weight from height alone and height with MUAC class in children aged 6-59 months in a database from low-to-middle income countries were more accurate and precise than previous weight estimation tools. A height-based weight estimation tape stratified according to MUAC classes is proposed for children aged 6-59 months in limited-resource settings.	[Ralston, Mark E.] Uniformed Serv Univ Hlth Sci, Dept Pediat, Bethesda, MD 20814 USA; [Myatt, Mark A.] Brixton Hlth, Llawryglyn, Powys, Wales	Uniformed Services University of the Health Sciences - USA	Ralston, ME (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Pediat, Bethesda, MD 20814 USA.	mark.e.ralston.civ@mail.mil						Abdel-Rahman SM, 2012, OPEN MED DEV J, V4, P87, DOI [10.2174/1875181401204010087, DOI 10.2174/1875181401204010087]; Abdel-Rahman SM, 2014, ARCH DIS CHILD, V99, P570, DOI 10.1136/archdischild-2013-305211; Abdel-Rahman SM, 2013, ANN EMERG MED, V62, P332, DOI 10.1016/j.annemergmed.2013.02.021; Argall JAW, 2003, ARCH DIS CHILD, V88, P789, DOI 10.1136/adc.88.9.789; Asskaryar F, 2015, INT J EMERG MED, V8, DOI 10.1186/s12245-015-0078-z; Batmanabane Gitanjali, 2015, Glob Pediatr Health, V2, p2333794X14566625, DOI 10.1177/2333794X14566625; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boelaert M, 1995, NUTR GUIDELINES FACI; Bourdeau S, 2011, CAN J RURAL MED, V16, P123; Carroll W, 2001, ARCH DIS CHILD S, V84, pA12; Cattermole GN, 2010, RESUSCITATION, V81, P1105, DOI 10.1016/j.resuscitation.2010.05.015; Clark MC, 2016, ACAD EMERG MED, V23, P21, DOI 10.1111/acem.12854; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Department of Maternal and Child Health and Community Health Ministry of Health PRC, 2009, CHILD GROWTH STAND I; Dicko A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-270; DuBois D, 2007, PEDIATR EMERG CARE, V23, P227, DOI 10.1097/PEC.0b013e31803f5aca; English M, 2004, LANCET, V364, P1622, DOI 10.1016/S0140-6736(04)17318-2; English M, 2004, LANCET, V363, P1948, DOI 10.1016/S0140-6736(04)16408-8; EVERITT BS, 1968, BRIT J MATH STAT PSY, V21, P97, DOI 10.1111/j.2044-8317.1968.tb00400.x; FLEISS JL, 1969, PSYCHOL BULL, V72, P323, DOI 10.1037/h0028106; GARLAND JS, 1986, AM J EMERG MED, V4, P390, DOI 10.1016/0735-6757(86)90184-1; Geduld H, 2011, EMERG MED J, V28, P856, DOI 10.1136/emj.2010.098640; Golden M, 2006, MEASURING MORTALITY; Graves L, 2014, RESUSCITATION, V85, P392, DOI 10.1016/j.resuscitation.2013.11.024; HABICHT JP, 1974, B OFIC SANIT PANAM, V75, P375; Hofer CK, 2002, BRIT J ANAESTH, V88, P283, DOI 10.1093/bja/88.2.283; HOFVANDER Y., 1969, Journal of Tropical Pediatrics, V15, P251; House DR, 2013, ANN EMERG MED, V61, P1, DOI 10.1016/j.annemergmed.2012.07.110; Huber PJ, 2009, WILEY SERIES PROBABI; Jang HY, 2007, ACAD EMERG MED, V14, P489, DOI 10.1197/j.aem.2006.12.014; JELLIFFE D. B., 1966, The assessment of the nutritional status of the community (with special reference to field surveys in developing regions of the world)., P271; Khouli M, 2015, J EMERG MED, V48, P660, DOI 10.1016/j.jemermed.2014.12.082; Lack JA, 1997, BRIT J ANAESTH, V78, P601, DOI 10.1093/bja/78.5.601; Larson L L, 1985, J Emerg Nurs, V11, P246; Loo PY, 2013, J PAEDIATR CHILD H, V49, pE311, DOI 10.1111/jpc.12141; LUBITZ DS, 1988, ANN EMERG MED, V17, P576, DOI 10.1016/S0196-0644(88)80396-2; McKAY D. A., 1969, Journal of Tropical Pediatrics, V15, P213; Milne WK, 2012, CAN J EMERG MED, V14, P25, DOI 10.2310/8000.2011.110523; Molyneux E, 1999, LANCET, V354, P1616, DOI 10.1016/S0140-6736(99)04552-3; Myatt M, 2006, FOOD NUTR BULL, V27, pS7, DOI 10.1177/15648265060273S302; Nieman CT, 2006, ACAD EMERG MED, V13, P1011, DOI 10.1197/j.aem.2006.06.042; Park J, 2012, RESUSCITATION, V83, P1129, DOI 10.1016/j.resuscitation.2012.01.023; R Core Team, 2021, R LANGUAGE ENV STAT; Ramarajan N, 2008, ACAD EMERG MED, V15, P431, DOI 10.1111/j.1553-2712.2008.00081.x; Rosenberg M, 2011, AM J EMERG MED, V29, P482, DOI 10.1016/j.ajem.2009.12.002; RUTISHAUSER I. H. E., 1969, Journal of Tropical Pediatrics, V15, P196; Simoes EAF, 2003, B WORLD HEALTH ORGAN, V81, P522; Sinha M, 2012, PEDIATR EMERG CARE, V28, P544, DOI 10.1097/PEC.0b013e318258ac2e; So TY, 2009, PEDIATRICS, V123, pE1045, DOI 10.1542/peds.2008-1968; The World Bank, 2020, GNI PER CAP ATL METH; Theron Lynn, 2005, Emerg Med Australas, V17, P238; Thompson A, 2008, NIST SPECIAL PUBLICA, V811; Trakulsrichai Satariya, 2012, Journal of the Medical Association of Thailand, V95, P1194; Utley R, 1990, Dimens Crit Care Nurs, V9, P75, DOI 10.1097/00003465-199003000-00003; Wang HD, 2014, LANCET, V384, P957, DOI 10.1016/S0140-6736(14)60497-9; Wells M, 2013, RESUSCITATION, V84, P227, DOI 10.1016/j.resuscitation.2012.05.028; WHO, 2006, WHO CHILD GROWTH STA; World Health Organization, 2013, GUID UPD MAN SEV AC; Yamamoto LG, 2009, AM J EMERG MED, V27, P810, DOI 10.1016/j.ajem.2008.06.023; Young KD, 2016, ANN EMERG MED, V68, P441, DOI 10.1016/j.annemergmed.2016.02.043	60	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0159260	10.1371/journal.pone.0159260	http://dx.doi.org/10.1371/journal.pone.0159260			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529816	Green Published, gold, Green Submitted			2022-12-26	WOS:000381476700001
J	Zhang, WS; Ning, N; Li, XJ; Niu, G; Bai, LJ; Guo, YM; Yang, J				Zhang, Weishan; Ning, Ning; Li, Xianjun; Niu, Gang; Bai, Lijun; Guo, Youmin; Yang, Jian			Changes of Brain Glucose Metabolism in the Pretreatment Patients with Non-Small Cell Lung Cancer: A Retrospective PET/CT Study	PLOS ONE			English	Article							DORSAL ATTENTION NETWORK; BREAST-CANCER; WHITE-MATTER; CHEMOTHERAPY; SYSTEM; IMPAIRMENT; DISORDER; WOMEN	Objective The tumor-to-brain communication has been emphasized by recent converging evidences. This study aimed to compare the difference of brain glucose metabolism between patients with non-small cell lung cancer (NSCLC) and control subjects. Methods NSCLC patients prior to oncotherapy and control subjects without malignancy confirmed by 6 months follow-up were collected and underwent the resting state 18F-fluoro-D-glucose (FDG) PET/CT. Normalized FDG metabolism was calculated by a signal intensity ratio of each brain region to whole brain. Brain glucose metabolism was compared between NSCLC patients and control group using two samples t-test and multivariate test by statistical parametric maps (SPM) software. Results Compared with the control subjects (n = 76), both brain glucose hyper- and hypometabolism regions with significant statistical differences (P<0.01) were found in the NSCLC patients (n = 83). The hypermetabolism regions (bilateral insula, putamen, pallidum, thalamus, hippocampus and amygdala, the right side of cerebellum, orbital part of right inferior frontal gyrus and vermis) were component parts of visceral to brain signal transduction pathways, and the hypometabolism regions (the left superior parietal lobule, bilateral inferior parietal lobule and left fusiform gyrus) lied in dorsal attention network and visuospatial function areas. Conclusions The changes of brain glucose metabolism exist in NSCLC patients prior to oncotherapy, which might be attributed to lung-cancer related visceral sympathetic activation and decrease of dorsal attention network function.	[Zhang, Weishan; Ning, Ning; Li, Xianjun; Niu, Gang; Guo, Youmin; Yang, Jian] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Radiol, Xian, Shaanxi, Peoples R China; [Ning, Ning] Xi An Jiao Tong Univ, Dept Nucl Med, Affiliated Hosp 2, Xian, Shaanxi, Peoples R China; [Li, Xianjun; Bai, Lijun; Yang, Jian] Xi An Jiao Tong Univ, Dept Biomed Engn, Key Lab Biomed Informat Engn, Minist Educ,Sch Life Sci & Technol, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Yang, J (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Radiol, Xian, Shaanxi, Peoples R China.; Yang, J (corresponding author), Xi An Jiao Tong Univ, Dept Biomed Engn, Key Lab Biomed Informat Engn, Minist Educ,Sch Life Sci & Technol, Xian, Shaanxi, Peoples R China.	cjr.yangjian@vip.163.com	Li, Xianjun/G-4472-2018	Li, Xianjun/0000-0001-7690-9155	National Natural Science Foundation of China [81171317, 81471631]; New Century Excellent Talent Support Plan from Ministry of Education of China [NCET-11-0438]; Fund of the First Affiliated Hospital of Xi'an Jiaotong University [2014YK22]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellent Talent Support Plan from Ministry of Education of China; Fund of the First Affiliated Hospital of Xi'an Jiaotong University	This study has received funding by the National Natural Science Foundation of China (No. 81171317, 81471631), New Century Excellent Talent Support Plan from Ministry of Education of China (NCET-11-0438), and Fund of the First Affiliated Hospital of Xi'an Jiaotong University (2014YK22). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2008, CURR OPIN NEUROBIOL, V18, P166, DOI 10.1016/j.conb.2008.06.006; Akechi T, 2004, J CLIN ONCOL, V22, P1957, DOI 10.1200/JCO.2004.08.149; Armaiz-Pena GN, 2009, BRAIN BEHAV IMMUN, V23, P10, DOI 10.1016/j.bbi.2008.06.007; Benveniste H, 2012, INT J CLIN EXP MED, V5, P154; Blessing W, 1997, LOWER BRAINSTEM BODI; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Critchley HD, 2013, NEURON, V77, P624, DOI 10.1016/j.neuron.2013.02.008; D'Agata F, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-22; de Ruiter MB, 2012, HUM BRAIN MAPP, V33, P2971, DOI 10.1002/hbm.21422; de Ruiter MB, 2011, HUM BRAIN MAPP, V32, P1206, DOI 10.1002/hbm.21102; Deprez S, 2012, J CLIN ONCOL, V30, P274, DOI 10.1200/JCO.2011.36.8571; Dumas JA, 2013, BRAIN IMAGING BEHAV, V7, P524, DOI 10.1007/s11682-013-9244-1; Golan H, 2009, J NUCL MED, V50, P1072, DOI 10.2967/jnumed.108.061085; Halpern BS, 2005, J NUCL MED, V46, P603; Hanaoka K, 2010, ANN NUCL MED, V24, P707, DOI 10.1007/s12149-010-0415-5; Hegel MT, 2006, CANCER-AM CANCER SOC, V107, P2924, DOI 10.1002/cncr.22335; Husted DS, 2006, PROG NEURO-PSYCHOPH, V30, P389, DOI 10.1016/j.pnpbp.2005.11.024; Kiebel SJ, 1997, NEUROIMAGE, V5, P271, DOI 10.1006/nimg.1997.0265; Li WL, 2015, CHINESE MED J-PEKING, V128, P301, DOI 10.4103/0366-6999.150089; Mravec B, 2008, SEMIN CANCER BIOL, V18, P150, DOI 10.1016/j.semcancer.2007.12.002; Nonokuma M, 2014, J NUCL MED, V55; Ondicova K, 2010, LANCET ONCOL, V11, P596, DOI 10.1016/S1470-2045(09)70337-7; Ptak R, 2010, J NEUROSCI, V30, P12557, DOI 10.1523/JNEUROSCI.2722-10.2010; Reddick WE, 2006, CANCER-AM CANCER SOC, V106, P941, DOI 10.1002/cncr.21679; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Tashiro M, 1999, PSYCHO-ONCOL, V8, P283, DOI 10.1002/(SICI)1099-1611(199907/08)8:4<283::AID-PON384>3.3.CO;2-1; Tashiro M, 2001, PSYCHO-ONCOL, V10, P541, DOI 10.1002/pon.548; Turrin NP, 2001, BRAIN RES BULL, V54, P443, DOI 10.1016/S0361-9230(01)00445-2; Vardy J, 2008, ANN ONCOL, V19, P623, DOI 10.1093/annonc/mdm500; Walker MS, 2006, PSYCHO-ONCOLOGY, V15, P684, DOI 10.1002/pon.997; Zhu JN, 2006, BRAIN RES REV, V52, P93, DOI 10.1016/j.brainresrev.2006.01.003	31	6	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161325	10.1371/journal.pone.0161325	http://dx.doi.org/10.1371/journal.pone.0161325			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529342	Green Published, gold, Green Submitted			2022-12-26	WOS:000381476700066
J	Miyazaki, S; Tashiro, F; Miyazaki, J				Miyazaki, Satsuki; Tashiro, Fumi; Miyazaki, Jun-ichi			Transgenic Expression of a Single Transcription Factor Pdx1 Induces Transdifferentiation of Pancreatic Acinar Cells to Endocrine Cells in Adult Mice	PLOS ONE			English	Article							BETA-CELL; EXOCRINE PANCREAS; RAT PANCREAS; ALPHA-CELLS; IN-VITRO; GLUCOSE-TOLERANCE; MOUSE PANCREAS; NEOGENESIS; REGENERATION; DIFFERENTIATION	A promising approach to new diabetes therapies is to generate beta cells from other differentiated pancreatic cells in vivo. Because the acinar cells represent the most abundant cell type in the pancreas, an attractive possibility is to reprogram acinar cells into beta cells. The transcription factor Pdx1 (Pancreas/duodenum homeobox protein 1) is essential for pancreatic development and cell lineage determination. Our objective is to examine whether exogenous expression of Pdx1 in acinar cells of adult mice might induce reprogramming of acinar cells into beta cells. We established a transgenic mouse line in which Pdx1 and EGFP (enhanced green fluorescent protein) could be inducibly expressed in the acinar cells. After induction of Pdx1, we followed the acinar cells for their expression of exocrine and endocrine markers using cell-lineage tracing with EGFP. The acinar cell-specific expression of Pdx1 in adult mice reprogrammed the acinar cells as endocrine precursor cells, which migrated into the pancreatic islets and differentiated into insulin-,somatostatin-, or PP (pancreatic polypeptide)-producing endocrine cells, but not into glucagon-producing cells. When the mice undergoing such pancreatic reprogramming were treated with streptozotocin (STZ), the newly generated insulin-producing cells were able to ameliorate STZ-induced diabetes. This paradigm of in vivo reprogramming indicates that acinar cells hold promise as a source for new islet cells in regenerative therapies for diabetes.	[Miyazaki, Satsuki; Tashiro, Fumi; Miyazaki, Jun-ichi] Osaka Univ, Grad Sch Med, Div Stem Cell Regulat Res, Suita, Osaka 5650871, Japan	Osaka University	Miyazaki, J (corresponding author), Osaka Univ, Grad Sch Med, Div Stem Cell Regulat Res, Suita, Osaka 5650871, Japan.	jimiyaza@nutri.med.osaka-u.ac.jp	Miyazaki, Jun-ichi/N-1976-2015	Miyazaki, Jun-ichi/0000-0003-2475-589X; Miyazaki, Satsuki/0000-0003-1781-1590	Ministry of Education, Culture, Sports, Science and Technology of Japan [20790647, 25860213]; 21st Century COE "CICET" Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan; NICHD; University of Iowa, Department of Biological Sciences (Iowa City, IA 52242)	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 21st Century COE "CICET" Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); University of Iowa, Department of Biological Sciences (Iowa City, IA 52242)	This research was supported by Grants-in-Aid (20790647 and 25860213 to SM) and in part by the 21st Century COE "CICET" Program (to JM) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www-shinsei.jsps.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Rat anti-CK19 monoclonal antibody (TROMA III) and mouse anti-Nkx6.1 monoclonal antibody (N55A10) were obtained from the Developmental Studies Hybridoma Bank (DSHB) developed under the auspices of the NICHD and maintained by the University of Iowa, Department of Biological Sciences (Iowa City, IA 52242). We are grateful to Dr. Eiji Yamato and Mr. Masafumi Ashida for helpful discussion and excellent technical assistance, respectively. We acknowledge the editorial assistance of Drs. Leslie A. Miglietta and Grace E. Gray of Clarity Editing.	Artner I, 2010, DIABETES, V59, P2530, DOI 10.2337/db10-0190; Baeyens L, 2005, DIABETOLOGIA, V48, P49, DOI 10.1007/s00125-004-1606-1; Baeyens L, 2014, NAT BIOTECHNOL, V32, P76, DOI 10.1038/nbt.2747; Bertelli E, 1997, AM J PHYSIOL-CELL PH, V273, pC1641, DOI 10.1152/ajpcell.1997.273.5.C1641; Bonner-Weir S, 2000, ENDOCRINOLOGY, V141, P1926, DOI 10.1210/en.141.6.1926; BONNERWEIR S, 1993, DIABETES, V42, P1715, DOI 10.2337/diabetes.42.12.1715; Bouwens L, 2005, PHYSIOL REV, V85, P1255, DOI 10.1152/physrev.00025.2004; Chung CH, 2010, STEM CELLS, V28, P1630, DOI 10.1002/stem.482; DELISLE RC, 1990, EUR J CELL BIOL, V51, P64; Desai BM, 2007, J CLIN INVEST, V117, P971, DOI 10.1172/JCI29988; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Goodyer WR, 2012, DEV CELL, V23, P21, DOI 10.1016/j.devcel.2012.05.014; Grippo PJ, 2002, GENESIS, V32, P277, DOI 10.1002/gene.10080; Gu DL, 1997, PANCREAS, V15, P246, DOI 10.1097/00006676-199710000-00005; GU DL, 1993, DEVELOPMENT, V118, P33; Guz Y, 2001, ENDOCRINOLOGY, V142, P4956, DOI 10.1210/en.142.11.4956; Habener JF, 2005, ENDOCRINOLOGY, V146, P1025, DOI 10.1210/en.2004-1576; HALL PA, 1992, J PATHOL, V166, P97, DOI 10.1002/path.1711660203; Heller RS, 2001, DIABETES, V50, P1553, DOI 10.2337/diabetes.50.7.1553; Inada A, 2008, P NATL ACAD SCI USA, V105, P19915, DOI 10.1073/pnas.0805803105; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Lardon J, 2004, VIRCHOWS ARCH, V444, P61, DOI 10.1007/s00428-003-0930-z; LAVINE RL, 1971, DIABETES, V20, P134, DOI 10.2337/diab.20.3.134; Li WD, 2014, NAT BIOTECHNOL, V32, P1223, DOI 10.1038/nbt.3082; Minami K, 2005, P NATL ACAD SCI USA, V102, P15116, DOI 10.1073/pnas.0507567102; Miyatsuka T, 2006, GENE DEV, V20, P1435, DOI 10.1101/gad.1412806; Miyazaki S, 2004, DIABETES, V53, P1030, DOI 10.2337/diabetes.53.4.1030; Miyazaki S, 2005, BIOCHEM BIOPH RES CO, V338, P1083, DOI 10.1016/j.bbrc.2005.10.054; Miyazaki S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047536; Montanya E, 2000, DIABETES, V49, P1341, DOI 10.2337/diabetes.49.8.1341; Offield MF, 1996, DEVELOPMENT, V122, P983; Pan FC, 2013, DEVELOPMENT, V140, P751, DOI 10.1242/dev.090159; Pedersen IL, 2006, J HISTOCHEM CYTOCHEM, V54, P567, DOI 10.1369/jhc.5A6827.2006; Rankin MM, 2013, DIABETES, V62, P1634, DOI 10.2337/db12-0848; Ritz-Laser B, 2003, DIABETOLOGIA, V46, P810, DOI 10.1007/s00125-003-1115-7; Rooman I, 2000, DIABETOLOGIA, V43, P907, DOI 10.1007/s001250051468; Rooman I, 2001, GASTROENTEROLOGY, V121, P940, DOI 10.1053/gast.2001.27998; ROSENBERG L, 1995, CELL TRANSPLANT, V4, P371, DOI 10.1016/0963-6897(95)00020-X; Rosenberg L, 1998, MICROSC RES TECHNIQ, V43, P337, DOI 10.1002/(SICI)1097-0029(19981115)43:4<337::AID-JEMT8>3.0.CO;2-U; Sander M, 2000, DEVELOPMENT, V127, P5533; Sangan CB, 2010, BIOESSAYS, V32, P881, DOI 10.1002/bies.201000074; Schaffer AE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003274; Sharma A, 1999, DIABETES, V48, P507, DOI 10.2337/diabetes.48.3.507; Strobel O, 2007, GASTROENTEROLOGY, V133, P1999, DOI 10.1053/j.gastro.2007.09.009; Suzuki T, 2003, ARCH HISTOL CYTOL, V66, P347, DOI 10.1679/aohc.66.347; Taniguchi H, 2003, GENE THER, V10, P15, DOI 10.1038/sj.gt.3301846; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Waguri M, 1997, DIABETES, V46, P1281, DOI 10.2337/diabetes.46.8.1281; Xiao XW, 2013, J CLIN INVEST, V123, P2207, DOI 10.1172/JCI66323; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Yang YP, 2011, GENE DEV, V25, P1680, DOI 10.1101/gad.16875711; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	52	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0161190	10.1371/journal.pone.0161190	http://dx.doi.org/10.1371/journal.pone.0161190			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27526291	gold, Green Submitted, Green Published			2022-12-26	WOS:000381471100041
J	Nikolaienko, RM; Hammel, M; Dubreuil, V; Zalmai, R; Hall, DR; Mehzabeen, N; Karuppan, SJ; Harroch, S; Stella, SL; Bouyain, S				Nikolaienko, Roman M.; Hammel, Michal; Dubreuil, Veronique; Zalmai, Rana; Hall, David R.; Mehzabeen, Nurjahan; Karuppan, Sebastian J.; Harroch, Sheila; Stella, Salvatore L.; Bouyain, Samuel			Structural Basis for Interactions Between Contactin Family Members and Protein-tyrosine Phosphatase Receptor Type G in Neural Tissues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell adhesion; cell surface; crystal structure; protein phosphatase; retina; contactin; immunoglobulin|L-like domain	NUCLEOTIDE-GATED CHANNELS; EXTRACELLULAR REGION; CRYSTAL-STRUCTURE; RPTP-GAMMA; COMPLEX; SYSTEM; CELLS; CIS; SPECIFICITY; SUPERFAMILY	Protein-tyrosine phosphatase receptor type G (RPTP/PTPRG) interacts in vitro with contactin-3-6 (CNTN3-6), a group of glycophosphatidylinositol-anchored cell adhesion molecules involved in the wiring of the nervous system. In addition to PTPRG, CNTNs associate with multiple transmembrane proteins and signal inside the cell via cis-binding partners to alleviate the absence of an intracellular region. Here, we use comprehensive biochemical and structural analyses to demonstrate that PTPRGCNTN3-6 complexes share similar binding affinities and a conserved arrangement. Furthermore, as a first step to identifying PTPRGCNTN complexes in vivo, we found that PTPRG and CNTN3 associate in the outer segments of mouse rod photoreceptor cells. In particular, PTPRG and CNTN3 form cis-complexes at the surface of photoreceptors yet interact in trans when expressed on the surfaces of apposing cells. Further structural analyses suggest that all CNTN ectodomains adopt a bent conformation and might lie parallel to the cell surface to accommodate these cis and trans binding modes. Taken together, these studies identify a PTPRGCNTN complex in vivo and provide novel insights into PTPRG- and CNTN-mediated signaling.	[Nikolaienko, Roman M.; Zalmai, Rana; Hall, David R.; Mehzabeen, Nurjahan; Karuppan, Sebastian J.; Bouyain, Samuel] Univ Missouri, Sch Biol Sci, Div Mol Biol & Biochem, 5100 Rockhill Rd, Kansas City, MO 64110 USA; [Hammel, Michal] Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Dubreuil, Veronique] Inst Pasteur Paris, Dept Neurosci, 25-28 Rue Dr Roux, F-75624 Paris, France; [Dubreuil, Veronique; Harroch, Sheila] Univ Paris Diderot, CNRS, Sorbonne Paris Cite, Epigenet & Cell Fate,UMR 7216, Paris, France; [Stella, Salvatore L.] Univ Missouri, Dept Basic Med Sci, Sch Med, Kansas City, MO 64108 USA; [Harroch, Sheila] NYU, Sch Med, Dept Psychiat, 550 First Ave, New York, NY 10016 USA; [Stella, Salvatore L.] Penn State Univ, Coll Med, Dept Neural & Behav Sci, 500 Univ Dr, Hershey, PA 17033 USA	University of Missouri System; University of Missouri Kansas City; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; University of Missouri System; University of Missouri Kansas City; New York University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Bouyain, S (corresponding author), Univ Missouri, Sch Biol Sci, Div Mol Biol & Biochem, 5100 Rockhill Rd, Kansas City, MO 64110 USA.	bouyains@umkc.edu		Dubreuil, Veronique/0000-0001-8060-3597; Hammel, Michal/0000-0002-5610-9289; Bouyain, Samuel/0000-0002-7499-738X	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; United States Department of Energy Program Integrated Diffraction Analysis Technologies (IDAT); National Institutes of Health [MINOS GM105404]; NIGMS, National Institutes of Health [P41-GM103311]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105404, P41GM103311, R01GM088806] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); United States Department of Energy Program Integrated Diffraction Analysis Technologies (IDAT); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Prof. Brian Geisbrecht for helpful comments on the manuscript and assistance with circular dichroism. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract W-31-109-Eng-38. Data were collected at Southeast Regional Collaborative Access Team beamlines at the Advanced Photon Source, Argonne National Laboratory. Supporting institutions may be found at www.ser-cat.org/members.html. X-ray scattering technologies at the Lawrence Berkeley National Laboratory SIBYLS beamline of the Advanced Light Source are supported in part by the United States Department of Energy Program Integrated Diffraction Analysis Technologies (IDAT) and National Institutes of Health Grant MINOS GM105404. Chimera was developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by NIGMS, National Institutes of Health, Grant P41-GM103311).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Ashrafi S, 2014, NEURON, V81, P120, DOI 10.1016/j.neuron.2013.10.060; BARNEA G, 1993, MOL CELL BIOL, V13, P1497, DOI 10.1128/MCB.13.3.1497; Bouyain S, 2007, PROTEIN SCI, V16, P654, DOI 10.1110/ps.062700307; Bouyain S, 2010, P NATL ACAD SCI USA, V107, P2443, DOI 10.1073/pnas.0911235107; Charles P, 2002, CURR BIOL, V12, P217, DOI 10.1016/S0960-9822(01)00680-7; Chen F, 2011, STRUCTURE, V19, P779, DOI 10.1016/j.str.2011.03.012; Coles CH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6209; Coles CH, 2011, SCIENCE, V332, P484, DOI 10.1126/science.1200840; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ensslen-Craig SE, 2004, DEV BIOL, V275, P12, DOI 10.1016/j.ydbio.2004.08.009; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Guinier A., 1955, SMALL ANGLE SCATTERI; Hamaoka BY, 2004, P NATL ACAD SCI USA, V101, P11673, DOI 10.1073/pnas.0402559101; Harroch S, 2000, MOL CELL BIOL, V20, P7706, DOI 10.1128/MCB.20.20.7706-7715.2000; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; Hayashi M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2683; Held W, 2011, CELL MOL LIFE SCI, V68, P3469, DOI 10.1007/s00018-011-0798-z; Horvat-Broecker A, 2008, NEUROSCIENCE, V152, P618, DOI 10.1016/j.neuroscience.2008.01.016; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Janssen BJC, 2012, NAT STRUCT MOL BIOL, V19, P1293, DOI 10.1038/nsmb.2416; Johnson KG, 2006, NEURON, V49, P517, DOI 10.1016/j.neuron.2006.01.026; Kaneko-Goto T, 2008, NEURON, V57, P834, DOI 10.1016/j.neuron.2008.01.023; Kao TJ, 2011, NEURON, V71, P76, DOI 10.1016/j.neuron.2011.05.031; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kulahin N, 2011, STRUCTURE, V19, P203, DOI 10.1016/j.str.2010.12.014; Lamprianou S, 2006, MOL CELL BIOL, V26, P5106, DOI 10.1128/MCB.00101-06; Lamprianou S, 2011, P NATL ACAD SCI USA, V108, P17498, DOI 10.1073/pnas.1108774108; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Longo PA, 2013, METHOD ENZYMOL, V529, P227, DOI 10.1016/B978-0-12-418687-3.00018-5; Lorenzetto E, 2014, BRAIN STRUCT FUNCT, V219, P875, DOI 10.1007/s00429-013-0541-7; Luca VC, 2015, SCIENCE, V347, P847, DOI 10.1126/science.1261093; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller MT, 2011, STRUCTURE, V19, P767, DOI 10.1016/j.str.2011.03.011; Molokanova E, 1999, J NEUROSCI, V19, P4786; Molokanova E, 1997, J NEUROSCI, V17, P9068; Nans A, 2011, J NEUROSCI RES, V89, P310, DOI 10.1002/jnr.22561; Osterfield M, 2008, DEVELOPMENT, V135, P1189, DOI 10.1242/dev.007401; Osterhout JA, 2015, NEURON, V86, P985, DOI 10.1016/j.neuron.2015.04.005; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parent AS, 2007, J NEUROENDOCRINOL, V19, P847, DOI 10.1111/j.1365-2826.2007.01597.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sakurai K, 2010, NEUROSCI LETT, V473, P102, DOI 10.1016/j.neulet.2010.02.027; Savchenko A, 2001, P NATL ACAD SCI USA, V98, P5880, DOI 10.1073/pnas.101524998; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneidman-Duhovny D, 2013, BIOPHYS J, V105, P962, DOI 10.1016/j.bpj.2013.07.020; Shimoda Y, 2012, NEUROSCI LETT, V510, P148, DOI 10.1016/j.neulet.2012.01.026; Shimoda Y, 2009, CELL ADHES MIGR, V3, P64, DOI 10.4161/cam.3.1.7764; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Stella SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043463; Tolbert WD, 2007, P NATL ACAD SCI USA, V104, P14592, DOI 10.1073/pnas.0704290104; Toyoshima M, 2009, DEV BIOL, V336, P192, DOI 10.1016/j.ydbio.2009.09.043; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Williams ME, 2010, NEURON, V68, P9, DOI 10.1016/j.neuron.2010.09.007; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamagata M, 2012, J NEUROSCI, V32, P14402, DOI 10.1523/JNEUROSCI.3193-12.2012; Ye H, 2008, EMBO J, V27, P188, DOI 10.1038/sj.emboj.7601939; YOSHIHARA Y, 1994, NEURON, V13, P415, DOI 10.1016/0896-6273(94)90357-3; Zayas-Santiago A, 2009, MOL VIS, V15, P1; Zuko A, 2011, ADV PROTEIN CHEM STR, V84, P143, DOI 10.1016/B978-0-12-386483-3.00001-X	61	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21335	21349		10.1074/jbc.M116.742163	http://dx.doi.org/10.1074/jbc.M116.742163			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27539848	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000385999200001
J	Sathianathan, A; Ravichandran, P; Lippi, JM; Cohen, L; Messina, A; Shaju, S; Swede, MJ; Ginsburg, DS				Sathianathan, Anish; Ravichandran, Priyadarshini; Lippi, Jake M.; Cohen, Leah; Messina, Angelo; Shaju, Sherwin; Swede, Marci J.; Ginsburg, Daniel S.			The Eaf3/5/7 Subcomplex Stimulates NuA4 Interaction with Methylated Histone H3 Lys-36 and RNA Polymerase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; IN-VIVO; ACETYLTRANSFERASE COMPLEX; TARGETED RECRUITMENT; MOLECULAR-BASIS; CODING REGIONS; CHROMO DOMAIN; YEAST NUA4; ACETYLATION; TRANSCRIPTION	NuA4 is the only essential lysine acetyltransferase complex in Saccharomyces cerevisiae, where it has been shown to stimulate transcription initiation and elongation. Interaction with nucleosomes is stimulated by histone H3 Lys-4 and Lys-36 methylation, but the mechanism of this interaction is unknown. Eaf3, Eaf5, and Eaf7 form a subcomplex within NuA4 that may also function independently of the lysine acetyltransferase complex. The Eaf3/5/7 complex and the Rpd3C(S) histone deacetylase complex have both been shown to bind di- and trimethylated histone H3 Lys-36 stimulated by Eaf3. Weinvestigated the role of the Eaf3/5/7 subcomplex in NuA4 binding to nucleosomes. Different phenotypes of eaf3/5/7 Delta mutants support functions for the complex as both part of and independent of NuA4. Further evidence for Eaf3/5/7 within NuA4 came from mutations in the subcomplex leading to similar to 40% reductions in H4 acetylation in bulk histones, probably caused by binding defects to both nucleosomes and RNA polymerase II. In vitro binding assays showed that Eaf3/5/7 specifically stimulates NuA4 binding to di- and trimethylated histone H3 Lys-36 and that this binding is important for NuA4 occupancy in transcribed ORFs. Consistent with the role of NuA4 in stimulating transcription elongation, loss of EAF5 or EAF7 resulted in a processivity defect. Overall, these results reveal the function of Eaf3/5/7 within NuA4 to be important for both NuA4 and RNA polymerase II binding.	[Sathianathan, Anish; Ravichandran, Priyadarshini; Lippi, Jake M.; Cohen, Leah; Messina, Angelo; Shaju, Sherwin; Ginsburg, Daniel S.] LIU Post, Dept Biomed Sci, Brookville, NY 11548 USA; [Swede, Marci J.] LIU Post, Dept Hlth Sci, Brookville, NY 11548 USA		Ginsburg, DS (corresponding author), Dept Biomed Sci, 720 Northern Blvd, Brookville, NY 11548 USA.	daniel.ginsburg@liu.edu	Swede, Marci/AAD-3921-2021	Swede, Marci/0000-0002-3003-4258	LIU Post Research Committee	LIU Post Research Committee	This work was funded by intramural grants from the LIU Post Research Committee. The authors declare that they have no conflicts of interest with the contents of this article.	Allard S, 1999, EMBO J, V18, P5108, DOI 10.1093/emboj/18.18.5108; Auger A, 2008, MOL CELL BIOL, V28, P2257, DOI 10.1128/MCB.01755-07; Bird AW, 2002, NATURE, V419, P411, DOI 10.1038/nature01035; Biswas D, 2008, MOL CELL BIOL, V28, P4445, DOI 10.1128/MCB.00164-08; Boudreault AA, 2003, GENE DEV, V17, P1415, DOI 10.1101/gad.1056603; Brower-Toland B, 2005, J MOL BIOL, V346, P135, DOI 10.1016/j.jmb.2004.11.056; Brown CE, 2001, SCIENCE, V292, P2333, DOI 10.1126/science.1060214; Carey M, 2006, MOL CELL, V24, P481, DOI 10.1016/j.molcel.2006.09.012; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Cheng X, 2014, TRANSCR-AUSTIN, V5, DOI 10.1080/21541264.2014.995571; Chittuluru JR, 2011, NAT STRUCT MOL BIOL, V18, P1196, DOI 10.1038/nsmb.2128; Choy JS, 2001, J BIOL CHEM, V276, P43653, DOI 10.1074/jbc.M102531200; Clarke AS, 1999, MOL CELL BIOL, V19, P2515; Dong JS, 2004, J BIOL CHEM, V279, P42157, DOI 10.1074/jbc.M404502200; Downs JA, 2004, MOL CELL, V16, P979, DOI 10.1016/j.molcel.2004.12.003; Doyon Y, 2004, CURR OPIN GENET DEV, V14, P147, DOI 10.1016/j.gde.2004.02.009; Doyon Y, 2004, MOL CELL BIOL, V24, P1884, DOI 10.1128/MCB.24.5.1884-1896.2004; Eisen A, 2001, J BIOL CHEM, V276, P3484, DOI 10.1074/jbc.M008159200; Eissenberg JC, 2012, GENE, V496, P69, DOI 10.1016/j.gene.2012.01.003; Galarneau L, 2000, MOL CELL, V5, P927, DOI 10.1016/S1097-2765(00)80258-0; Geng FQ, 2004, EMBO J, V23, P127, DOI 10.1038/sj.emboj.7600035; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Ginsburg DS, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.585588; Ginsburg DS, 2009, MOL CELL BIOL, V29, P6473, DOI 10.1128/MCB.01033-09; Govind CK, 2007, MOL CELL, V25, P31, DOI 10.1016/j.molcel.2006.11.020; Govind CK, 2010, MOL CELL, V39, P234, DOI 10.1016/j.molcel.2010.07.003; Jacobs SA, 2001, EMBO J, V20, P5232, DOI 10.1093/emboj/20.18.5232; Kapitzky L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.107; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim T, 2009, CELL, V137, P259, DOI 10.1016/j.cell.2009.02.045; Lee JS, 2007, MUTAT RES-FUND MOL M, V618, P130, DOI 10.1016/j.mrfmmm.2006.08.014; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Li YY, 2014, CELL, V159, P558, DOI 10.1016/j.cell.2014.09.049; Lin YY, 2008, GENE DEV, V22, P2062, DOI 10.1101/gad.1679508; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; Mitchell L, 2008, MOL CELL BIOL, V28, P2244, DOI 10.1128/MCB.01653-07; Morillo-Huesca M, 2006, FEBS J, V273, P756, DOI 10.1111/j.1742-4658.2005.05108.x; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Nourani A, 2004, EMBO J, V23, P2597, DOI 10.1038/sj.emboj.7600230; Pinskaya M, 2009, EMBO J, V28, P1697, DOI 10.1038/emboj.2009.108; Prelich G, 2002, EUKARYOT CELL, V1, P153, DOI 10.1128/EC.1.2.153-162.2002; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Qiu HF, 2009, MOL CELL, V33, P752, DOI 10.1016/j.molcel.2009.02.018; Rasband W, 2014, IMAGEJ 1 48V; REID GA, 1982, J BIOL CHEM, V257, P3056; Reid JL, 2004, MOL CELL BIOL, V24, P757, DOI 10.1128/MCB.24.2.757-764.2004; Reid JL, 2000, MOL CELL, V6, P1297, DOI 10.1016/S1097-2765(00)00128-3; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Rossetto D, 2014, EMBO J, V33, P1397, DOI 10.15252/embj.201386433; Ruan C, 2015, CELL REP, V10, P204, DOI 10.1016/j.celrep.2014.12.027; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X; Sun BF, 2008, J BIOL CHEM, V283, P36504, DOI 10.1074/jbc.M806564200; Swanson MJ, 2003, MOL CELL BIOL, V23, P2800, DOI 10.1128/MCB.23.8.2800-2820.2003; Voth WP, 2003, YEAST, V20, P985, DOI 10.1002/yea.1018; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Youdell ML, 2008, MOL CELL BIOL, V28, P4915, DOI 10.1128/MCB.00001-08; Zhang F, 2004, MOL CELL BIOL, V24, P6871, DOI 10.1128/mcb.24.15.6871-6886.2004	62	10	10	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					21195	21207		10.1074/jbc.M116.718742	http://dx.doi.org/10.1074/jbc.M116.718742			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27535225	Green Published, hybrid			2022-12-26	WOS:000385406200033
J	Fattahi, F; Brandsma, CA; Lodewijk, M; Reinders-Luinge, M; Postma, DS; Timens, W; Hylkema, MN; Ten Hacken, NHT				Fattahi, Fatemeh; Brandsma, Corry-Anke; Lodewijk, Monique; Reinders-Luinge, Marjan; Postma, Dirkje S.; Timens, Wim; Hylkema, Machteld N.; Ten Hacken, Nick H. T.			Atopy and Inhaled Corticosteroid Use Associate with Fewer IL-17(+) Cells in Asthmatic Airways	PLOS ONE			English	Article							T(H)17 CELLS; TH17 CELLS; INFLAMMATION; NEUTROPHILIA; EXPRESSION; INTERLEUKIN-17; DISTINCT; MODERATE; LINEAGE; SPUTUM	Background Interleukin (IL)-17 plays a critical role in numerous immune and inflammatory responses and was recently suggested to contribute to the pathogenesis of nonatopic (non-eosinophil/neutrophil-dominant) asthma. We aimed to compare expression of IL-17 in bronchial airways between atopic and nonatopic asthmatics, with/without inhaled corticosteroid (ICS) use and to identify its major cellular source. Methods Bronchial biopsies from 114 patients with mild-to-moderate asthma were investigated: 33 nonatopic, 63 non-corticosteroid users, 90 nonsmokers. IL-17 expression was correlated with atopy and inflammatory cell counts (EPX, NP57, CD3, CD4, CD8, CD20, CD68), taking ICS use and smoking into account. Multiple linear regression analyses were used to determine the independent factors as well as the most relevant inflammatory cells contributing to IL-17 expression. Double immunostainings were performed to confirm the major cellular source of IL-17. Results In non-ICS users, nonatopic asthmatics had more IL-17(+) cells in the airway wall than atopic asthmatics. In both atopic and nonatopic asthmatics, ICS use was associated with lower numbers of IL-17(+) cells, independent of smoking. The number of IL-17(+) cells was associated with the number of neutrophils (B: 0.26, 95% CI: 0.17-0.35) and eosinophils (B: 0.18, 95% CI: 0.07-0.29). The majority of IL-17(+) cells were neutrophils, as confirmed by double immunostaining. Conclusions We show for the first time that atopy and ICS use are associated with lower numbers of IL-17(+) cells in asthmatic airways. Importantly, IL-17(+) cells were mostly neutrophils which conflicts with the paradigm that lymphocytes (Th17) are the main source of IL-17.	[Fattahi, Fatemeh; Postma, Dirkje S.; Ten Hacken, Nick H. T.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, Groningen, Netherlands; [Fattahi, Fatemeh; Brandsma, Corry-Anke; Lodewijk, Monique; Reinders-Luinge, Marjan; Timens, Wim; Hylkema, Machteld N.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Fattahi, Fatemeh; Brandsma, Corry-Anke; Lodewijk, Monique; Reinders-Luinge, Marjan; Postma, Dirkje S.; Timens, Wim; Hylkema, Machteld N.; Ten Hacken, Nick H. T.] Univ Groningen, Univ Med Ctr Groningen, Res Inst Asthma & COPD GRIAC, Groningen, Netherlands; [Fattahi, Fatemeh] Univ Tehran Med Sci, Immunol Asthma & Allergy Res Inst, Tehran, Iran	University of Groningen; University of Groningen; University of Groningen; Immunology Asthma & Allergy Research Institute - Iran; Tehran University of Medical Sciences	Ten Hacken, NHT (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, Groningen, Netherlands.; Ten Hacken, NHT (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Res Inst Asthma & COPD GRIAC, Groningen, Netherlands.	n.h.t.ten.hacken@umcg.nl	Timens, Wim/K-5570-2013	Timens, Wim/0000-0002-4146-6363				Alcorn JF, 2010, ANNU REV PHYSIOL, V72, P495, DOI 10.1146/annurev-physiol-021909-135926; Amin K, 2000, AM J RESP CRIT CARE, V162, P2295, DOI 10.1164/ajrccm.162.6.9912001; Bajoriuniene I, 2012, LUNG, V190, P487, DOI 10.1007/s00408-012-9411-y; Brandt EB, 2013, J ALLERGY CLIN IMMUN, V132, P1194, DOI 10.1016/j.jaci.2013.06.048; Broekema M, 2009, AM J RESP CRIT CARE, V180, P1170, DOI 10.1164/rccm.200906-0828OC; Bullens DMA, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-135; Busse WW, 2013, AM J RESP CRIT CARE, V188, P1294, DOI 10.1164/rccm.201212-2318OC; Chakir J, 2003, J ALLERGY CLIN IMMUN, V111, P1293, DOI 10.1067/mai.2003.1557; Chesne J, 2015, J ALLERGY CLIN IMMUN, V135, P1643, DOI 10.1016/j.jaci.2014.12.1872; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Di Stefano A, 2009, CLIN EXP IMMUNOL, V157, P316, DOI 10.1111/j.1365-2249.2009.03965.x; Doe C, 2010, CHEST, V138, P1140, DOI 10.1378/chest.09-3058; Eustace A, 2011, CHEST, V139, P1089, DOI 10.1378/chest.10-0779; Ferretti S, 2003, J IMMUNOL, V170, P2106, DOI 10.4049/jimmunol.170.4.2106; Handoyo S, 2009, CURR ALLERGY ASTHM R, V9, P439, DOI 10.1007/s11882-009-0065-7; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Irvin C, 2014, J ALLERGY CLIN IMMUN, V134, P1175, DOI 10.1016/j.jaci.2014.05.038; Iwakura Y, 2008, IMMUNOL REV, V226, P57, DOI 10.1111/j.1600-065X.2008.00699.x; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Katayama M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062231; Lemanske RF, 2010, J ALLERGY CLIN IMMUN, V125, pS95, DOI 10.1016/j.jaci.2009.10.047; Li L, 2010, J CLIN INVEST, V120, P331, DOI 10.1172/JCI38702; McKinley L, 2008, J IMMUNOL, V181, P4089, DOI 10.4049/jimmunol.181.6.4089; Molet S, 2001, J ALLERGY CLIN IMMUN, V108, P430, DOI 10.1067/mai.2001.117929; Nanzer AM, 2013, J ALLERGY CLIN IMMUN, V132, P297, DOI 10.1016/j.jaci.2013.03.037; Oboki Keisuke, 2008, Allergol Int, V57, P121, DOI 10.2332/allergolint.R-07-160; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Ramirez-Velazquez C, 2013, ALLERGY ASTHMA CL IM, V9, DOI 10.1186/1710-1492-9-23; Sorbello V, 2015, ALLERGY, V70, P236, DOI 10.1111/all.12547; Sun YC, 2005, CHINESE MED J-PEKING, V118, P953; Tan HL, 2011, AM J RESP CRIT CARE, V184, P252, DOI 10.1164/rccm.201102-0236OC; Taylor PR, 2014, NAT IMMUNOL, V15, P143, DOI 10.1038/ni.2797; Wakashin H, 2008, AM J RESP CRIT CARE, V178, P1023, DOI 10.1164/rccm.200801-086OC; Werner JL, 2011, INFECT IMMUN, V79, P3966, DOI 10.1128/IAI.05493-11; YOO ZB, 1995, J IMMUNOL, V155, P5483; Zijlstra GJ, 2012, EUR RESPIR J, V39, P439, DOI 10.1183/09031936.00017911	36	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0161433	10.1371/journal.pone.0161433	http://dx.doi.org/10.1371/journal.pone.0161433			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27552197	Green Submitted, Green Published, gold			2022-12-26	WOS:000381768800040
J	Jing, H; Li, C; Ma, F; Ma, JH; Khan, A; Wang, X; Zhao, LY; Gong, ZH; Chen, RG				Jing, Hua; Li, Chao; Ma, Fang; Ma, Ji-Hui; Khan, Abid; Wang, Xiao; Zhao, Li-Yang; Gong, Zhen-Hui; Chen, Ru-Gang			Genome-Wide Identification, Expression Diversication of Dehydrin Gene Family and Characterization of CaDHN3 in Pepper (Capsicum annuum L.)	PLOS ONE			English	Article							EMBRYOGENESIS ABUNDANT PROTEINS; INDUCED LEAF SENESCENCE; PHYSCOMITRELLA-PATENS; PROVIDES INSIGHTS; PLANT DEHYDRINS; DROUGHT STRESS; ION-BINDING; SALT; DEHYDRATION; TOLERANCE	Dehydrins (DHNs) play a crucial role in enhancing abiotic stress tolerance in plants. Although DHNs have been identified and characterized in many plants, there is little known about Capsicum annuum L., one of the economically important vegetable crops. In this study, seven CaDHNs in the pepper genome were identified, which could be divided into two classes: YnSKn- and SKn-type, based on their highly conserved domains. Quantitative real-time PCR (qRT-PCR) results showed that the seven DHN genes were expressed in all tissues and might be involved in the growth and development of pepper. The gene expression profiles analysis suggested that most of the CaDHN genes were induced by various stresses (low temperature, salt and mannitol) and signaling molecules (ABA, SA and MeJA). Furthermore, the CaDHN3 (YSK2)-silenced pepper plants showed obvious lower resistance to abiotic stresses (cold, salt and mannitol) than the control plants (TRV2:00). So the CaDHN3 might act as a positive role in resisting abiotic stresses. This study lays the foundation for further studies into the regulation of their expression under various conditions.	[Jing, Hua; Li, Chao; Ma, Fang; Ma, Ji-Hui; Khan, Abid; Wang, Xiao; Zhao, Li-Yang; Gong, Zhen-Hui; Chen, Ru-Gang] Northwest A&F Univ, Coll Hort, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Gong, ZH; Chen, RG (corresponding author), Northwest A&F Univ, Coll Hort, Yangling, Shaanxi, Peoples R China.	zhgong@nwsuaf.edu.cn; rugangchen@126.com	Khan, Abid/AAG-6856-2021	Khan, Abid/0000-0002-5937-1549	National Key Research and Development Project [2016YFD0101900]; National Natural Science Foundation of China [31201615, 31272163]; Shaanxi Provincial Science and Technology Coordinating Innovative Engineering Project [2012KTCL02-09]; Northwest A&F University Cyrus Tang Seed Development Fund	National Key Research and Development Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shaanxi Provincial Science and Technology Coordinating Innovative Engineering Project; Northwest A&F University Cyrus Tang Seed Development Fund	This work was supported through funding from the National Key Research and Development Project (grant no. 2016YFD0101900), the National Natural Science Foundation of China (#31201615, #31272163), the Shaanxi Provincial Science and Technology Coordinating Innovative Engineering Project (#2012KTCL02-09), and the Northwest A&F University Cyrus Tang Seed Development Fund.	Allagulova CR, 2003, BIOCHEMISTRY-MOSCOW+, V68, P945, DOI 10.1023/A:1026077825584; Alsheikh MK, 2005, PLANT CELL ENVIRON, V28, P1114, DOI 10.1111/j.1365-3040.2005.01348.x; Alsheikh MK, 2003, J BIOL CHEM, V278, P40882, DOI 10.1074/jbc.M307151200; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bin WS, 2012, MOL BREEDING, V30, P1393, DOI 10.1007/s11032-012-9726-7; Cao J, 2015, PLANTA, V241, P757, DOI 10.1007/s00425-014-2215-y; Chen RG, 2015, PLANT CELL REP, V34, P2189, DOI 10.1007/s00299-015-1862-1; Choi DW, 2000, THEOR APPL GENET, V100, P1274, DOI 10.1007/s001220051434; Choi DW, 1999, THEOR APPL GENET, V98, P1234, DOI 10.1007/s001220051189; Choudhury Shuvasish, 2013, Plant Signal Behav, V8, pe23681, DOI 10.4161/psb.23681; Chung E, 2003, MOL CELLS, V15, P327; Close TJ, 1997, PHYSIOL PLANTARUM, V100, P291, DOI 10.1034/j.1399-3054.1997.1000210.x; Close TJ, 1996, PHYSIOL PLANTARUM, V97, P795, DOI 10.1111/j.1399-3054.1996.tb00546.x; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Dionisio-Sese ML, 1998, PLANT SCI, V135, P1, DOI 10.1016/S0168-9452(98)00025-9; Eddy Sean R, 2009, Genome Inform, V23, P205; Eriksson SK, 2011, PLANT CELL, V23, P2391, DOI 10.1105/tpc.111.085183; GODAY A, 1994, PLANT CELL, V6, P351, DOI 10.1105/tpc.6.3.351; GODOY JA, 1994, PLANT MOL BIOL, V26, P1921, DOI 10.1007/BF00019503; Graether SP, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00576; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Guo M, 2014, GENET MOL RES, V13, P1865, DOI 10.4238/2014.March.17.14; Guo WL, 2012, GENET MOL RES, V11, P4063, DOI 10.4238/2012.September.10.5; Guo WL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066667; Ha YI, 2006, J PLANT BIOL, V49, P205, DOI 10.1007/BF03030534; Hundertmark M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-118; Ingram J, 1996, ANNU REV PLANT PHYS, V47, P377, DOI 10.1146/annurev.arplant.47.1.377; Kim Seungill, 2014, Nat Genet, V46, P270, DOI 10.1038/ng.2877; Koag MC, 2009, PLANT PHYSIOL, V150, P1503, DOI 10.1104/pp.109.136697; Kosova K, 2007, BIOL PLANTARUM, V51, P601, DOI 10.1007/s10535-007-0133-6; Lee DH, 2000, PLANT SCI, V159, P75, DOI 10.1016/S0168-9452(00)00326-5; Li W, 2009, J INTEGR PLANT BIOL, V51, P279, DOI 10.1111/j.1744-7909.2008.00790.x; Li ZG, 2004, PLANT PHYSIOL BIOCH, V42, P789, DOI 10.1016/j.plaphy.2004.09.001; Liang D, 2012, MOL BIOL REP, V39, P10759, DOI 10.1007/s11033-012-1968-2; Lim CW, 2015, PHYSIOL PLANTARUM, V154, P526, DOI 10.1111/ppl.12298; Liu CC, 2012, PLANT MOL BIOL REP, V30, P848, DOI 10.1007/s11105-011-0395-1; Liu R H, 2003, HEREDITAS BEIJING, V25, P317; Nylander M, 2001, PLANT MOL BIOL, V45, P263, DOI 10.1023/A:1006469128280; Qin C, 2014, P NATL ACAD SCI USA, V111, P5135, DOI 10.1073/pnas.1400975111; Rodriguez EM, 2005, THEOR APPL GENET, V110, P852, DOI 10.1007/s00122-004-1877-4; Rorat T, 2006, CELL MOL BIOL LETT, V11, P536, DOI 10.2478/s11658-006-0044-0; Ruibal C, 2012, PLANT SCI, V190, P89, DOI 10.1016/j.plantsci.2012.03.009; Saavedra L, 2006, PLANT J, V45, P237, DOI 10.1111/j.1365-313X.2005.02603.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sarhan F, 1997, PHYSIOL PLANTARUM, V101, P439, DOI 10.1034/j.1399-3054.1997.1010226.x; Szabala BM, 2014, PLANTA, V239, P847, DOI 10.1007/s00425-013-2018-6; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vlad F, 2008, PLANT J, V55, P104, DOI 10.1111/j.1365-313X.2008.03488.x; Wan HJ, 2011, BIOCHEM BIOPH RES CO, V416, P24, DOI 10.1016/j.bbrc.2011.10.105; Wang JE, 2013, GENET MOL RES, V12, P2492, DOI 10.4238/2013.July.24.4; Wang JE, 2013, INT J MOL SCI, V14, P3158, DOI 10.3390/ijms14023158; Wang XS, 2007, PLANT SCI, V172, P414, DOI 10.1016/j.plantsci.2006.10.004; Wei CJ, 2014, PLANT PHYSIOL BIOCH, V77, P108, DOI 10.1016/j.plaphy.2014.02.002; WELIN BV, 1994, PLANT MOL BIOL, V26, P131, DOI 10.1007/BF00039526; Xiao HJ, 2014, INT J MOL SCI, V15, P8316, DOI 10.3390/ijms15058316; Yang Y, 2012, BMC PLANT BIOL, V12, P25; Yao K, 2005, PLANT PHYSIOL BIOCH, V43, P83, DOI 10.1016/j.plaphy.2004.12.006; Yue HY, 2012, J EXP BOT, V63, P4463, DOI 10.1093/jxb/ers122; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	60	27	30	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0161073	10.1371/journal.pone.0161073	http://dx.doi.org/10.1371/journal.pone.0161073			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27551973	Green Published, gold, Green Submitted			2022-12-26	WOS:000381768800020
J	Kulesza, A; Burdzinska, A; Szczepanska, I; Zarychta-Wisniewska, W; Pajak, B; Bojarczuk, K; Dybowski, B; Paczek, L				Kulesza, Agnieszka; Burdzinska, Anna; Szczepanska, Izabela; Zarychta-Wisniewska, Weronika; Pajak, Beata; Bojarczuk, Kamil; Dybowski, Bartosz; Paczek, Leszek			The Mutual Interactions between Mesenchymal Stem Cells and Myoblasts in an Autologous Co-Culture Model	PLOS ONE			English	Article							ADULT BONE-MARROW; MUSCLE REGENERATION; SKELETAL-MUSCLE; STROMAL CELLS; INTRAMUSCULAR TRANSPLANTATION; ISCHEMIC CARDIOMYOPATHY; SATELLITE CELLS; MIGRATION; DIFFERENTIATION; FUSION	Both myoblasts and mesenchymal stem cells (MSC) take part in the muscle tissue regeneration and have been used as experimental cellular therapy in muscular disorders treatment. It is possible that co-transplantation approach could improve the efficacy of this treatment. However, the relations between those two cell types are not clearly defined. The aim of this study was to determine the reciprocal interactions between myoblasts and MSC in vitro in terms of the features important for the muscle regeneration process. Primary caprine muscle- derived cells (MDC) and bone marrow-derived MSC were analysed in autologous settings. We found that MSC contribute to myotubes formation by fusion with MDC when co-cultured directly, but do not acquire myogenic phenotype if exposed to MDC-derived soluble factors only. Experiments with exposure to hydrogen peroxide showed that MSC are significantly more resistant to oxidative stress than MDC, but a direct co-culture with MSC does not diminish the cytotoxic effect of H2O2 on MDC. Cell migration assay demonstrated that MSC possess significantly greater migration ability than MDC which is further enhanced by MDC-derived soluble factors, whereas the opposite effect was not found. MSC-derived soluble factors significantly enhanced the proliferation of MDC, whereas MDC inhibited the division rate of MSC. To conclude, presented results suggest that myogenic precursors and MSC support each other during muscle regeneration and therefore myoblasts-MSC co-transplantation could be an attractive approach in the treatment of muscular disorders.	[Kulesza, Agnieszka; Burdzinska, Anna; Szczepanska, Izabela; Zarychta-Wisniewska, Weronika; Paczek, Leszek] Med Univ Warsaw, Inst Transplantat, Dept Immunol Transplant Med & Internal Dis, Warsaw, Poland; [Zarychta-Wisniewska, Weronika] Polish Acad Sci, Electron Microscopy Platform, Mossakowski Med Res Ctr, 5 Pawinskiego St, Warsaw, Poland; [Bojarczuk, Kamil] Med Univ Warsaw, Dept Immunol, Ctr Biostruct Res, Warsaw, Poland; [Dybowski, Bartosz] Med Univ Warsaw, Dept Urol, Warsaw, Poland; [Pajak, Beata] Warsaw Univ Life Sci SGGW, Dept Physiol Sci, Fac Vet Med, 159 Nowoursynowska St, Warsaw, Poland; [Bojarczuk, Kamil] Med Univ Warsaw, Postgrad Sch Mol Med, 61 Zwirki & Wigury St, Warsaw, Poland; [Paczek, Leszek] Polish Acad Sci, Inst Biochem & Biophys, Dept Bioinformat, 5a Pawinskiego St, Warsaw, Poland	Medical University of Warsaw; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Medical University of Warsaw; Medical University of Warsaw; Warsaw University of Life Sciences; Medical University of Warsaw; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Burdzinska, A (corresponding author), Med Univ Warsaw, Inst Transplantat, Dept Immunol Transplant Med & Internal Dis, Warsaw, Poland.; Dybowski, B (corresponding author), Med Univ Warsaw, Dept Urol, Warsaw, Poland.	anna.burdzinska@wum.edu.pl; bartosz.dybowski@wum.edu.pl	Zarychta-Wiśniewska, Weronika/A-7389-2019; Bojarczuk, Kamil/AAC-4824-2020; Burdzinska, Anna/Q-2402-2016	Zarychta-Wiśniewska, Weronika/0000-0002-1383-2151; Bojarczuk, Kamil/0000-0002-6110-4060; Pajak, Beata/0000-0002-3565-8860; Kulesza, Agnieszka/0000-0001-7575-2475; Burdzinska, Anna/0000-0001-7148-5971; Paczek, Leszek/0000-0003-0160-3009	Parent Bridge program of the Foundation for Polish Science; European Union under the European Regional Development Fund	Parent Bridge program of the Foundation for Polish Science; European Union under the European Regional Development Fund	This study was supported within Parent Bridge program of the Foundation for Polish Science, co-financed by the European Union under the European Regional Development Fund. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajaj P, 2011, INTEGR BIOL-UK, V3, P897, DOI 10.1039/c1ib00058f; Bartoszuk-Bruzzone U, 2012, MUSCLE NERVE, V45, P32, DOI 10.1002/mus.22248; Bedada FB, 2005, MOL CELL BIOL, V25, P9509, DOI 10.1128/MCB.25.21.9509-9519.2005; Beitnes JO, 2012, CELL TRANSPLANT, V21, P1697, DOI 10.3727/096368911X627462; Berardi E, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00119; Burdzinska A, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/482352; Burdzinska A, 2008, FOLIA HISTOCHEM CYTO, V46, P401, DOI 10.2478/v10042-008-0060-1; Collins RA, 2001, J HISTOCHEM CYTOCHEM, V49, P989, DOI 10.1177/002215540104900807; Cornelissen AS, 2015, IMMUNOL LETT, V168, P159, DOI 10.1016/j.imlet.2015.06.019; de la Garza-Rodea AS, 2012, CELL TRANSPLANT, V21, P153, DOI 10.3727/096368911X580554; Dezawa M, 2005, SCIENCE, V309, P314, DOI 10.1126/science.1110364; Dreyfus PA, 2004, AM J PATHOL, V164, P773, DOI 10.1016/S0002-9440(10)63165-3; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Fukada S, 2002, J CELL SCI, V115, P1285; Hauerslev S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100594; Holzer N, 2005, NEUROMUSCULAR DISORD, V15, P237, DOI 10.1016/j.nmd.2004.11.001; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; Lesault PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046698; Ponte AL, 2007, STEM CELLS, V25, P1737, DOI 10.1634/stemcells.2007-0054; Ma S, 2014, CELL DEATH DIFFER, V21, P216, DOI 10.1038/cdd.2013.158; Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002; Memon IA, 2005, J THORAC CARDIOV SUR, V130, P646, DOI 10.1016/j.jtcvs.2005.02.024; Moens PDJ, 1996, J MUSCLE RES CELL M, V17, P37, DOI 10.1007/BF00140322; Murphy JM, 2003, ARTHRITIS RHEUM-US, V48, P3464, DOI 10.1002/art.11365; Negroni E, 2015, NEUROPATH APPL NEURO, V41, P270, DOI 10.1111/nan.12198; Ott HC, 2004, EUR J CARDIO-THORAC, V25, P627, DOI 10.1016/j.ejcts.2003.12.031; Rochlin K, 2010, DEV BIOL, V341, P66, DOI 10.1016/j.ydbio.2009.10.024; Sassoli C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037512; Schulze M, 2005, GENE DEV, V19, P1787, DOI 10.1101/gad.339305; Shi DQ, 2004, BLOOD, V104, P290, DOI 10.1182/blood-2003-03-0688; Shudo Y, 2014, TISSUE ENG PT A, V20, P728, DOI 10.1089/ten.TEA.2012.0534; Skuk D, 2014, CELL TRANSPLANT, V23, P13, DOI 10.3727/096368912X661337; Smythe GM, 2001, EXP CELL RES, V267, P267, DOI 10.1006/excr.2001.5257; Stern-Straeter J, 2014, INT J MOL MED, V33, P160, DOI 10.3892/ijmm.2013.1555; Takehara Y, 2013, LAB INVEST, V93, P181, DOI 10.1038/labinvest.2012.167; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; Torrente Y, 2000, CELL TRANSPLANT, V9, P539, DOI 10.1177/096368970000900410; Urish KL, 2009, MOL BIOL CELL, V20, P509, DOI 10.1091/mbc.E08-03-0274; Vella JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029226; Yamanouchi K, 2009, J REPROD DEVELOP, V55, P252, DOI 10.1262/jrd.20175; Yang Z, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-55; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007; Zammit PS, 2002, EXP CELL RES, V281, P39, DOI 10.1006/excr.2002.5653	43	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0161693	10.1371/journal.pone.0161693	http://dx.doi.org/10.1371/journal.pone.0161693			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27551730	Green Published, gold, Green Submitted			2022-12-26	WOS:000381768800069
J	Lai, XL; Soler-Lopez, M; Wichers, HJ; Dijkstra, BW				Lai, Xuelei; Soler-Lopez, Montserrat; Wichers, Harry J.; Dijkstra, Bauke W.			Large-Scale Recombinant Expression and Purification of Human Tyrosinase Suitable for Structural Studies	PLOS ONE			English	Article							OCULOCUTANEOUS ALBINISM TYPE-1; RAY CRYSTALLOGRAPHIC ANALYSIS; N-GLYCOSYLATION SITES; MUSHROOM TYROSINASE; POLYPHENOL OXIDASE; INSECT CELLS; AURONE SYNTHASE; GENE-MUTATIONS; CRYSTALLIZATION; PROTEIN	Human tyrosinase (TYR) is a glycoprotein that initiates the first two reactions in the melanin biosynthesis pathway. Mutations in its encoding gene cause Oculocutaneous Albinism type I (OCA1), the most severe form of albinism, which is a group of autosomal recessive disorders characterized by reduced or absent production of melanin in skin, hair and eyes. Despite extensive structural and characterization studies of its homologues in lower eukaryotic organisms, the catalytic mechanism of human TYR and the molecular basis of OCA1 are largely unknown. In this work, we have carried out a large-scale recombinant expression of TYR that has enabled us to obtain high yields of pure and active protein, required for crystallization trials and screening of skin whitening agents, which is highly demanded in the cosmetic industry. Addition of an N-terminal honeybee melittin signal peptide for secretion of the produced protein into the (protein-free) medium, as well as a cleavable His-tag at the C-terminus, was crucial for increasing the yield of pure protein. We have successfully crystallized two TYR variants, in both glycosylated and deglycosylated forms, showing preliminary X-ray diffraction patterns at 3.5 angstrom resolution. Hence, we have established an expression and purification protocol suitable for the crystal structure determination of human TYR, which will give unique atomic insight into the nature and conformation of the residues that shape the substrate binding pocket that will ultimately lead to efficient compound design.	[Lai, Xuelei; Dijkstra, Bauke W.] Univ Groningen, Biophys Chem Lab, Groningen, Netherlands; [Lai, Xuelei; Soler-Lopez, Montserrat] ESRF, Grenoble, France; [Wichers, Harry J.] Wageningen Univ, Food Chem Lab, Wageningen, Netherlands	University of Groningen; European Synchrotron Radiation Facility (ESRF); Wageningen University & Research	Dijkstra, BW (corresponding author), Univ Groningen, Biophys Chem Lab, Groningen, Netherlands.	b.w.dijkstra@rug.nl	Dijkstra, Bauke W./H-4308-2019	Dijkstra, Bauke W./0000-0001-9731-6586; Wichers, HJ/0000-0002-8030-7090	ESRF; Groningen Biomolecular Sciences and Biotechnology Institute (GBB) of the University of Groningen	ESRF; Groningen Biomolecular Sciences and Biotechnology Institute (GBB) of the University of Groningen	This research was funded by the ESRF and the Groningen Biomolecular Sciences and Biotechnology Institute (GBB) of the University of Groningen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann F, 1999, GLYCOCONJUGATE J, V16, P109, DOI 10.1023/A:1026488408951; BAKER HM, 1994, ACTA CRYSTALLOGR D, V50, P380, DOI 10.1107/S0907444993013435; Bergfors T, 2003, J STRUCT BIOL, V142, P66, DOI 10.1016/S1047-8477(03)00039-X; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Berson JF, 2000, J BIOL CHEM, V275, P12281, DOI 10.1074/jbc.275.16.12281; Bijelic A, 2015, ANGEW CHEM INT EDIT, V54, P14677, DOI 10.1002/anie.201506994; BOISSY RE, 1988, DERMATOL CLIN, V6, P161, DOI 10.1016/S0733-8635(18)30663-6; Boissy RE, 2005, EXP DERMATOL, V14, P601, DOI 10.1111/j.0906-6705.2005.00337.x; Bowler MW, 2006, ACTA CRYSTALLOGR D, V62, P991, DOI 10.1107/S0907444906020877; Branza-Nichita N, 2000, J BIOL CHEM, V275, P8169, DOI 10.1074/jbc.275.11.8169; Branza-Nichita N, 2000, CHEM REV, V100, P4697, DOI 10.1021/cr990291y; Chang TS, 2012, MATERIALS, V5, P1661, DOI 10.3390/ma5091661; Chang TS, 2009, INT J MOL SCI, V10, P2440, DOI 10.3390/ijms10062440; Chayen NE, 2008, NAT METHODS, V5, P147, DOI 10.1038/NMETH.F.203; Chen GH, 2012, J AGR FOOD CHEM, V60, P2838, DOI 10.1021/jf205021g; Cooper DN, 1998, NUCLEIC ACIDS RES, V26, P285, DOI 10.1093/nar/26.1.285; Dolinska MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084494; Dupeux F, 2011, ACTA CRYSTALLOGR D, V67, P915, DOI 10.1107/S0907444911036225; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Espin JC, 1997, J AGR FOOD CHEM, V45, P1084, DOI 10.1021/jf960428a; Fogal S, 2015, MOL BIOTECHNOL, V57, P45, DOI 10.1007/s12033-014-9800-y; Fujieda N, 2013, J BIOL CHEM, V288, P22128, DOI 10.1074/jbc.M113.477612; FUKAI K, 1995, NAT GENET, V9, P92, DOI 10.1038/ng0195-92; GIEBEL LB, 1991, J CLIN INVEST, V87, P1119, DOI 10.1172/JCI115075; GIEBEL LB, 1991, AM J HUM GENET, V48, P1159; GrueningerLeitch F, 1996, PROTEIN SCI, V5, P2617, DOI 10.1002/pro.5560051224; Gupta G, 2009, GLYCOCONJUGATE J, V26, P691, DOI 10.1007/s10719-008-9213-x; Hanson B Leif, 2007, Methods Mol Biol, V364, P31; HEARING VJ, 1991, FASEB J, V5, P2902, DOI 10.1096/fasebj.5.14.1752358; Ismaya WT, 2011, BIOCHEMISTRY-US, V50, P5477, DOI 10.1021/bi200395t; Ito S, 2015, J DERMATOL SCI, V80, P18, DOI 10.1016/j.jdermsci.2015.07.007; Kim M, 2012, INT J COSMETIC SCI, V34, P202, DOI 10.1111/j.1468-2494.2012.00704.x; KING RA, 1991, J CLIN INVEST, V87, P1046, DOI 10.1172/JCI115064; King RA, 2003, HUM GENET, V113, P502, DOI 10.1007/s00439-003-0998-1; Kong JN, 2010, PROTEIN PEPTIDE LETT, V17, P1026, DOI 10.2174/092986610791498957; Kong KH, 2000, COMP BIOCHEM PHYS B, V125, P563, DOI 10.1016/S0305-0491(00)00163-2; KORNER A, 1982, SCIENCE, V217, P1163, DOI 10.1126/science.6810464; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Marusek CM, 2006, J INORG BIOCHEM, V100, P108, DOI 10.1016/j.jinorgbio.2005.10.008; Mauracher SG, 2014, ACTA CRYSTALLOGR D, V70, P2301, DOI 10.1107/S1399004714013777; Mauracher SG, 2014, ACTA CRYSTALLOGR F, V70, P263, DOI 10.1107/S2053230X14000582; Mesters JR, 2007, CRYST GROWTH DES, V7, P2251, DOI 10.1021/cg7006843; Molitor C, 2016, P NATL ACAD SCI USA, V113, pE1806, DOI 10.1073/pnas.1523575113; Molitor C, 2015, ACTA CRYSTALLOGR F, V71, P746, DOI 10.1107/S2053230X15007542; Oetting WS, 2000, PIGM CELL RES, V13, P320, DOI 10.1034/j.1600-0749.2000.130503.x; Oetting WS, 2003, PIGM CELL RES, V16, P307, DOI 10.1034/j.1600-0749.2003.00045.x; Prota G, 2000, PIGM CELL RES, V13, P283, DOI 10.1034/j.1600-0749.2000.130412.x; Sanchez-Weatherby J, 2009, ACTA CRYSTALLOGR D, V65, P1237, DOI 10.1107/S0907444909037822; SANCHEZFERRER A, 1995, BBA-PROTEIN STRUCT M, V1247, P1; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; STURA E A, 1990, Methods (Orlando), V1, P38, DOI 10.1016/S1046-2023(05)80145-8; TESSIER DC, 1991, GENE, V98, P177, DOI 10.1016/0378-1119(91)90171-7; Ujvari A, 2001, J BIOL CHEM, V276, P5924, DOI 10.1074/jbc.M009203200; Wang N, 2006, PIGM CELL RES, V19, P3, DOI 10.1111/j.1600-0749.2005.00288.x; Wang T, 2005, BRIT J OPHTHALMOL, V89, P1383, DOI 10.1136/bjo.2005.070243; WINDER AJ, 1991, EUR J BIOCHEM, V198, P317, DOI 10.1111/j.1432-1033.1991.tb16018.x; Xing R, 2016, FOOD CHEM, V197, P205, DOI 10.1016/j.foodchem.2015.10.119; Yoshimori A, 2014, BIOORGAN MED CHEM, V22, P6193, DOI 10.1016/j.bmc.2014.08.027; Zander U, 2015, ACTA CRYSTALLOGR D, V71, P2328, DOI 10.1107/S1399004715017927; Zekiri F, 2014, ACTA CRYSTALLOGR F, V70, P832, DOI 10.1107/S2053230X1400884X	60	26	27	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0161697	10.1371/journal.pone.0161697	http://dx.doi.org/10.1371/journal.pone.0161697			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27551823	Green Published, Green Submitted, gold			2022-12-26	WOS:000381768800071
J	Liu, JJ; Sieuwerts, AM; Look, MP; van der Vlugt-Daane, M; Meijer-van Gelder, ME; Foekens, JA; Hollestelle, A; Martens, JWM				Liu, Jingjing; Sieuwerts, Anieta M.; Look, Maxime P.; van der Vlugt-Daane, Michelle; Meijer-van Gelder, Marion E.; Foekens, John A.; Hollestelle, Antoinette; Martens, John W. M.			The 29.5 kb APOBEC3B Deletion Polymorphism Is Not Associated with Clinical Outcome of Breast Cancer	PLOS ONE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; MUTATIONAL PROCESSES; EXPRESSION; ESTROGEN; RISK; RETROTRANSPOSITION; POPULATION; SUBTYPES; THERAPY; TRIAL	Increased APOBEC3B mRNA levels are associated with a hypermutator phenotype and poor prognosis in ER-positive breast cancer patients. In addition, a 29.5 kb deletion polymorphism of APOBEC3B, resulting in an APOBEC3A-B hybrid transcript, has been associated with an increased breast cancer risk and the hypermutator phenotype. Here we evaluated whether the APOBEC3B deletion polymorphism also associates with clinical outcome of breast cancer. Copy number analysis was performed by quantitative PCR (qPCR) in primary tumors of 1,756 Dutch breast cancer patients. The APOBEC3B deletion was found in 187 patients of whom 16 carried a two-copy deletion and 171 carried a one-copy deletion. The prognostic value of the APOBEC3B deletion for the natural course of the disease was evaluated among 1,076 lymph-node negative (LNN) patients who did not receive adjuvant systemic treatment. No association was found between APOBEC3B copy number values and the length of metastasis-free survival (MFS; hazard ratio (HR) = 1.00, 95% confidence interval (CI) = 0.90-1.11, P = 0.96). Subgroup analysis by ER status also did not reveal an association between APOBEC3B copy number values and the length of MFS. The predictive value of the APOBEC3B deletion was assessed among 329 ER-positive breast cancer patients who received tamoxifen as the first-line therapy for recurrent disease and 226 breast cancer patients who received first-line chemotherapy for recurrent disease. No association between APOBEC3B copy number values and the overall response rate (ORR) to either tamoxifen (odds ratio (OR) = 0.88, 95% CI = 0.69-1.13, P = 0.31) or chemotherapy (OR = 0.97, 95% CI = 0.71-1.33, P = 0.87) was found. Thus, in contrast to APOBEC3B mRNA levels, the APOBEC3B deletion polymorphism has neither a prognostic nor a predictive value for breast cancer patients. Although a correlation exists between APOBEC3B copy number and mRNA expression, it is relatively weak. This suggests that other mechanisms exist that may affect and therefore determine the prognostic value of APOBEC3B mRNA levels.	[Liu, Jingjing; Sieuwerts, Anieta M.; Look, Maxime P.; van der Vlugt-Daane, Michelle; Meijer-van Gelder, Marion E.; Foekens, John A.; Hollestelle, Antoinette; Martens, John W. M.] Erasmus Univ, Med Ctr, Erasmus MC Canc Inst, Dept Med Oncol, Rotterdam, Netherlands; [Sieuwerts, Anieta M.] Canc Genom Netherlands, Utrecht, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute	Hollestelle, A (corresponding author), Erasmus Univ, Med Ctr, Erasmus MC Canc Inst, Dept Med Oncol, Rotterdam, Netherlands.	a.hollestelle@erasmusmc.nl			Cancer Genomics Netherlands (CGC.nl); grant for the Netherlands Organization of Scientific Research (NWO); China Scholarship Council (Beijing, China)	Cancer Genomics Netherlands (CGC.nl); grant for the Netherlands Organization of Scientific Research (NWO); China Scholarship Council (Beijing, China)(China Scholarship Council)	This study was funded by Cancer Genomics Netherlands (CGC.nl) and a grant for the Netherlands Organization of Scientific Research (NWO). JL received a scholarship from the China Scholarship Council (Beijing, China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Bogerd HP, 2006, P NATL ACAD SCI USA, V103, P8780, DOI 10.1073/pnas.0603313103; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Caval V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6129; Cescon DW, 2015, P NATL ACAD SCI USA, V112, P2841, DOI 10.1073/pnas.1424869112; Conticello SG, 2005, MOL BIOL EVOL, V22, P367, DOI 10.1093/molbev/msi026; European Organization for Research and Treatment of Cancer BCCG, 2000, MAN CLIN RES TREATM, P116; FOEKENS JA, 1989, CANCER RES, V49, P5823; FOEKENS JA, 1994, BRIT J CANCER, V70, P1217, DOI 10.1038/bjc.1994.476; Gohler S, 2015, J CANC RES CLIN ONCO; Harris RS, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-014-0498-3; HAYWARD JL, 1977, CANCER, V39, P1289, DOI 10.1002/1097-0142(197703)39:3<1289::AID-CNCR2820390340>3.0.CO;2-F; Kidd JM, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030063; Loi S, 2014, ANN ONCOL, V25, P1544, DOI 10.1093/annonc/mdu112; Loi S, 2013, J CLIN ONCOL, V31, P860, DOI 10.1200/JCO.2011.41.0902; Long JR, 2013, JNCI-J NATL CANCER I, V105, P573, DOI 10.1093/jnci/djt018; McShane LM, 2005, JNCI-J NATL CANCER I, V97, P1180, DOI 10.1093/jnci/dji237; Muckenfuss H, 2006, J BIOL CHEM, V281, P22161, DOI 10.1074/jbc.M601716200; Nik-Zainal S, 2016, NATURE, V534, P47, DOI 10.1038/nature17676; Nik-Zainal S, 2014, NAT GENET, V46, P487, DOI 10.1038/ng.2955; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Periyasamy M, 2015, CELL REP, V13, P108, DOI 10.1016/j.celrep.2015.08.066; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Prat A, 2015, BREAST; Rezaei M, 2015, INT J MOL CELL MED, V4, P103; Sieuwerts AM, 2005, CLIN CANCER RES, V11, P7311, DOI 10.1158/1078-0432.CCR-05-0560; Sieuwerts AM, 2014, HORM CANCER-US, V5, P405, DOI 10.1007/s12672-014-0196-8; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Taylor BJM, 2013, ELIFE, V2, DOI 10.7554/eLife.00534; Tsuboi M, 2015, BREAST CANC; van Agthoven T, 2009, J CLIN ONCOL, V27, P542, DOI 10.1200/JCO.2008.17.1462; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Xuan D, 2013, CARCINOGENESIS, V34, P2240, DOI 10.1093/carcin/bgt185	36	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0161731	10.1371/journal.pone.0161731	http://dx.doi.org/10.1371/journal.pone.0161731			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27552096	Green Submitted, Green Published, gold			2022-12-26	WOS:000381768800074
J	Keppel, AG; Breitburg, DL; Burrell, RB				Keppel, Andrew G.; Breitburg, Denise L.; Burrell, Rebecca B.			Effects of Co-Varying Diel-Cycling Hypoxia and pH on Growth in the Juvenile Eastern Oyster, Crassostrea virginica	PLOS ONE			English	Article							MYTILUS-EDULIS; OCEAN ACIDIFICATION; FRESH-WATER; HABITAT DEGRADATION; FOOD AVAILABILITY; DISSOLVED-OXYGEN; PATUXENT RIVER; PACIFIC OYSTER; CHESAPEAKE BAY; TEMPERATURE	Shallow water provides important habitat for many species, but also exposes these organisms to daily fluctuations in dissolved oxygen (DO) and pH caused by cycles in the balance between photosynthesis and respiration that can contribute to repeated, brief periods of hypoxia and low pH (caused by elevated pCO(2)). The amplitude of these cycles, and the severity and duration of hypoxia and hypercapnia that result, can be increased by eutrophication, and are predicted to worsen with climate change. We conducted laboratory experiments to test the effects of both diel-cycling and constant low DO and pH (elevated pCO(2)) on growth of the juvenile eastern oyster (Crassostrea virginica), an economically and ecologically important estuarine species. Severe diel-cycling hypoxia (to 0.5 mg O-2 L-1) reduced shell growth in juvenile oysters, as did constant hypoxia (1.2 and 2.0 mg O-2 L-1), although effects varied among experiments, oyster ages, and exposure durations. Dielcycling pH reduced growth only in experiments in which calcite saturation state cycled to <= 0.10 and only during the initial weeks of these experiments. In other cases, cycling pH sometimes led to increased growth rates. Comparisons of treatment effects across multiple weeks of exposure, and during a longer post-experiment field deployment, indicated that juvenile oysters can acclimate to, and in some cases compensate for initial reductions in growth. As a result, some ecosystem services dependent on juvenile oyster growth rates may be preserved even under severe cycling hypoxia and pH.	[Keppel, Andrew G.] US Naval Acad, Dept Oceanog, Annapolis, MD 21402 USA; [Keppel, Andrew G.; Breitburg, Denise L.; Burrell, Rebecca B.] Smithsonian Environm Res Ctr, Edgewater, MD USA	United States Department of Defense; United States Navy; United States Naval Academy; Smithsonian Institution; Smithsonian Environmental Research Center	Keppel, AG (corresponding author), US Naval Acad, Dept Oceanog, Annapolis, MD 21402 USA.; Keppel, AG (corresponding author), Smithsonian Environm Res Ctr, Edgewater, MD USA.	Keppel@usna.edu			NOAA Center for Sponsored Coastal Ocean Research [NA10NOS4780138]; Smithsonian Hunterdon and Johnson Endowments; NSF REU program	NOAA Center for Sponsored Coastal Ocean Research; Smithsonian Hunterdon and Johnson Endowments; NSF REU program(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was funded by a grant to Denise Breitburg from the NOAA Center for Sponsored Coastal Ocean Research (NA10NOS4780138). In addition, the Smithsonian Hunterdon and Johnson Endowments provided funding for technical staff and the NSF REU program supported some interns who worked on the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri AH, 2014, CLIMATE CHANGE DEAD; American Public Health Association American Water Works Association Water Pollution Control Federation, 1992, STANDARD METHODS EXA; [Anonymous], 2007, CO2SYS XLS CALCULATO; BAKER SM, 1992, BIOL BULL, V182, P265, DOI 10.2307/1542120; Bartol IK, 1999, J EXP MAR BIOL ECOL, V237, P157, DOI 10.1016/S0022-0981(98)00175-0; Barton A, 2012, LIMNOL OCEANOGR, V57, P698, DOI 10.4319/lo.2012.57.3.0698; Bayne BL, 2002, MAR ECOL PROG SER, V232, P163, DOI 10.3354/meps232163; Bell GW, 2005, MAR BIOL, V146, P761, DOI 10.1007/s00227-004-1483-7; Beniash E, 2010, MAR ECOL PROG SER, V419, P95, DOI 10.3354/meps08841; BENSON BB, 1984, LIMNOL OCEANOGR, V29, P620, DOI 10.4319/lo.1984.29.3.0620; Bockmon EE, 2013, BIOGEOSCIENCES, V10, P5967, DOI 10.5194/bg-10-5967-2013; Bogue K, 2013, INTERACTIVE EFFECTS; Boleza KA, 2001, FISH SHELLFISH IMMUN, V11, P593, DOI 10.1006/fsim.2001.0339; Breitburg DL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116223; Breitburg DL, 1998, SUCCESSES, LIMITATIONS, AND FRONTIERS IN ECOSYSTEM SCIENCE, P416; Breitburg DL, 2003, ESTUARIES, V26, P280, DOI 10.1007/BF02695967; BREITBURG DL, 1992, ECOL MONOGR, V62, P525, DOI 10.2307/2937315; Brouwer M, 2007, J EXP MAR BIOL ECOL, V341, P16, DOI 10.1016/j.jembe.2006.10.049; BROWN JR, 1988, AQUACULTURE, V70, P253, DOI 10.1016/0044-8486(88)90100-7; Burnett LE, 1997, AM ZOOL, V37, P633; Burrell RB, 2015, LIMNOLOGY OCEANOGRAP; Carter JG, 1998, J PALEONTOL, V72, P991, DOI 10.1017/S0022336000027359; Clark V, 2014, EFFECTS DIEL CYCLING; DAVIS HC, 1956, BIOL BULL, V110, P117, DOI 10.2307/1538972; DEVOOYS CGN, 1978, COMP BIOCHEM PHYS A, V60, P343, DOI 10.1016/0300-9629(78)90259-1; Diaz RJ, 1995, OCEANOGR MAR BIOL, V33, P245; Dickson A.G., 2007, GUIDE BEST PRACTICES; Eby LA, 2005, MAR ECOL PROG SER, V291, P249, DOI 10.3354/meps291249; Eby LA, 2002, CAN J FISH AQUAT SCI, V59, P952, DOI 10.1139/F02-067; Ekstrom JA, 2015, NAT CLIM CHANGE, V5, P207, DOI 10.1038/NCLIMATE2508; Folt CL, 1999, LIMNOL OCEANOGR, V44, P864, DOI 10.4319/lo.1999.44.3_part_2.0864; Ford SE, 1996, J SHELLFISH RES, V15, P45; GABBOTT PA, 1973, J MAR BIOL ASSOC UK, V53, P269, DOI 10.1017/S0025315400022268; Gazeau F, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028554; Gobler CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083648; Grabowski JH, 2007, THEOR ECOL SER, P281; Hargis William J. Jr, 1999, P329; Heugens EHW, 2001, CRIT REV TOXICOL, V31, P247, DOI 10.1080/20014091111695; Ivanina AV, 2009, AQUAT TOXICOL, V91, P245, DOI 10.1016/j.aquatox.2008.11.016; Ivanina AV, 2011, CHEMOSPHERE, V82, P377, DOI 10.1016/j.chemosphere.2010.09.075; JOKELA J, 1995, OECOLOGIA, V104, P122, DOI 10.1007/BF00365570; Jokela J., 1997, EXS, V82, P179; Jokela J, 1997, ECOLOGY, V78, P452; Keister JE, 2000, MAR ECOL PROG SER, V205, P43, DOI 10.3354/meps205043; KEMP WM, 1980, ESTUAR COAST MAR SCI, V11, P407, DOI 10.1016/S0302-3524(80)80065-X; Keppel A, 2014, EFFECTS COVARYING DI; Keppel AG, 2015, MAR ECOL PROG SER, V538, P169, DOI 10.3354/meps11479; Keppel G, 1991, DESIGN ANAL RES HDB; Kim TW, 2013, BIOGEOSCIENCES, V10, P7255, DOI 10.5194/bg-10-7255-2013; Lannig G, 2006, AQUAT TOXICOL, V79, P278, DOI 10.1016/j.aquatox.2006.06.017; Lee K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027207; Lenihan HS, 1998, ECOL APPL, V8, P128, DOI 10.2307/2641316; MALONE PG, 1967, LIMNOL OCEANOGR, V12, P432, DOI 10.4319/lo.1967.12.3.0432; Mann R, 2004, J SHELLFISH RES, V23, P41; McNatt RA, 2004, J EXP MAR BIOL ECOL, V311, P147, DOI 10.1016/j.jembe.2004.05.006; MDNR, 2013, EYES ON THE BAY; Melzner F, 2013, MAR BIOL, V160, P1875, DOI 10.1007/s00227-012-1954-1; Miller AW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005661; MILLERO FJ, 1979, GEOCHIM COSMOCHIM AC, V43, P1651, DOI 10.1016/0016-7037(79)90184-4; Mukherjee J, 2013, J EXP BIOL, V216, P4580, DOI 10.1242/jeb.094516; Najjar RG, 2010, ESTUAR COAST SHELF S, V86, P1, DOI 10.1016/j.ecss.2009.09.026; Newell RIE, 1988, ADV CHESAP BAY RES, V129, P536; NIXON SW, 1973, ECOL MONOGR, V43, P463, DOI 10.2307/1942303; Norkko J, 2005, MAR ECOL PROG SER, V298, P205, DOI 10.3354/meps298205; OSMAN RW, 1994, CHANGES IN FLUXES IN ESTUARIES: IMPLICATIONS FROM SCIENCE TO MANAGEMENT, P335; Portner HO, 2012, J THERM BIOL, V37, P547, DOI 10.1016/j.jtherbio.2012.06.009; Portner HO, 2004, J OCEANOGR, V60, P705, DOI 10.1007/s10872-004-5763-0; Portner HO, 2005, J GEOPHYS RES, P110; Rabalais NN, 2010, BIOGEOSCIENCES, V7, P585, DOI 10.5194/bg-7-585-2010; Rabalais NN, 2002, ANNU REV ECOL SYST, V33, P235, DOI 10.1146/annurev.ecolsys.33.010802.150513; Sanford E, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2681; Tanner CA, 2006, COMP BIOCHEM PHYS A, V144, P218, DOI 10.1016/j.cbpa.2006.02.042; Taylor JC, 2001, J EXP MAR BIOL ECOL, V258, P195, DOI 10.1016/S0022-0981(01)00215-5; Thomsen J, 2013, GLOBAL CHANGE BIOL, V19, P1017, DOI 10.1111/gcb.12109; Tseng YC, 2013, COMP BIOCHEM PHYS A, V165, P119, DOI 10.1016/j.cbpa.2013.02.005; Tyler RM, 2009, ESTUAR COAST, V32, P123, DOI 10.1007/s12237-008-9108-x; Vaquer-Sunyer R, 2010, LIMNOL OCEANOGR, V55, P1075, DOI 10.4319/lo.2010.55.3.1075; Volstad JH, 2008, J SHELLFISH RES, V27, P525, DOI 10.2983/0730-8000(2008)27[525:EOAMRF]2.0.CO;2; Waldbusser GG, 2011, ESTUAR COAST, V34, P221, DOI 10.1007/s12237-010-9307-0; WIDDOWS J, 1989, BIOL BULL, V177, P154, DOI 10.2307/1541843; Wilberg MJ, 2011, MAR ECOL PROG SER, V436, P131, DOI 10.3354/meps09161	81	25	27	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161088	10.1371/journal.pone.0161088	http://dx.doi.org/10.1371/journal.pone.0161088			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548256	gold, Green Published, Green Submitted			2022-12-26	WOS:000381768400029
J	Orme, JJ; Du, Y; Vanarsa, K; Wu, T; Satterthwaite, AB; Mohan, C				Orme, Jacob J.; Du, Yong; Vanarsa, Kamala; Wu, Tianfu; Satterthwaite, Anne B.; Mohan, Chandra			Leukocyte Beta-Catenin Expression Is Disturbed in Systemic Lupus Erythematosus	PLOS ONE			English	Article							NF-KAPPA-B; COLORECTAL-CANCER; DENDRITIC CELLS; E-CADHERIN; WNT; PATHWAY; GENE; MUTATIONS; MICE; ADHESION	Wnt/beta-catenin signaling is relatively understudied in immunity and autoimmunity. beta-catenin blocks inflammatory mediators and favors tolerogenic dendritic cell (DC) phenotypes. We show here that leukocytes from lupus-prone mice and SLE patients express diminished beta-catenin transcriptional activity, particularly in myeloid cells, although other leukocytes revealed similar trends. Serum levels of DKK-1, an inhibitor under transcriptional control of Wnt/beta-catenin, were also decreased in lupus-prone mice. Surprisingly, however, preemptive deletion of beta-catenin from macrophages appears to have no effect on lupus development, even in mice with varying genetic loads for lupus. Although myeloid-specific loss of beta-catenin does not seem to be important for lupus development, the potential role of this transcription factor in other leukocytes and renal cells remain to be elucidated.	[Orme, Jacob J.; Du, Yong; Vanarsa, Kamala; Wu, Tianfu; Satterthwaite, Anne B.; Mohan, Chandra] Univ Texas Southwestern Med Ctr, Dept Internal Med, Div Rheumat Dis, Dallas, TX 75235 USA; [Du, Yong; Vanarsa, Kamala; Wu, Tianfu; Mohan, Chandra] Univ Houston, Dept Biomed Engn, Houston, TX 77004 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Houston System; University of Houston	Mohan, C (corresponding author), Univ Texas Southwestern Med Ctr, Dept Internal Med, Div Rheumat Dis, Dallas, TX 75235 USA.; Mohan, C (corresponding author), Univ Houston, Dept Biomed Engn, Houston, TX 77004 USA.	cmohan@Central.UH.EDU	Wu, Tianfu/G-6672-2019; Mohan, Chandra/GPX-8233-2022; DU, YONG/B-9964-2011; Orme, Jacob/AAG-2653-2020	Orme, Jacob/0000-0002-0319-0239; DU, YONG/0000-0003-1687-9024; Wu, Tianfu/0000-0003-4406-1449	National Institute of Health [NIH R01 DK81872]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding support was provided by NIH R01 DK81872 from the National Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006098; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Brault V, 2001, DEVELOPMENT, V128, P1253; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Deng JO, 2002, CANCER CELL, V2, P323, DOI 10.1016/S1535-6108(02)00154-X; Diarra D, 2007, NAT MED, V13, P156, DOI 10.1038/nm1538; Ding Y, 2008, NAT MED, V14, P162, DOI 10.1038/nm1707; Enzler T, 2006, IMMUNITY, V25, P403, DOI 10.1016/j.immuni.2006.07.010; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; HELYER BJ, 1963, NATURE, V197, P197, DOI 10.1038/197197a0; Huang ZF, 2008, J IMMUNOL, V180, P6586, DOI 10.4049/jimmunol.180.10.6586; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Jiang A, 2007, IMMUNITY, V27, P610, DOI 10.1016/j.immuni.2007.08.015; KEMLER R, 1993, TRENDS GENET, V9, P317, DOI 10.1016/0168-9525(93)90250-L; Kim JH, 2005, NATURE, V434, P921, DOI 10.1038/nature03452; Laken SJ, 1997, NAT GENET, V17, P79, DOI 10.1038/ng0997-79; Liu JJ, 2003, J IMMUNOL, V170, P4489, DOI 10.4049/jimmunol.170.9.4489; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; MCCREA PD, 1991, SCIENCE, V254, P1359, DOI 10.1126/science.1962194; Morel L, 2000, P NATL ACAD SCI USA, V97, P6670, DOI 10.1073/pnas.97.12.6670; Morel L, 2001, P NATL ACAD SCI USA, V98, P1787, DOI 10.1073/pnas.031336098; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; Orme J, 2012, AUTOIMMUN REV, V11, P365, DOI 10.1016/j.autrev.2011.10.010; OZAWA M, 1990, P NATL ACAD SCI USA, V87, P4246, DOI 10.1073/pnas.87.11.4246; Pascual V, 2003, CURR OPIN RHEUMATOL, V15, P548, DOI 10.1097/00002281-200309000-00005; Pazdera TM, 1998, DEVELOPMENT, V125, P3427; Ranheim EA, 2005, BLOOD, V105, P2487, DOI 10.1182/blood-2004-06-2334; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Rivera MN, 2007, SCIENCE, V315, P642, DOI 10.1126/science.1137509; Satoh S, 2000, NAT GENET, V24, P245, DOI 10.1038/73448; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Staal FJT, 2001, EUR J IMMUNOL, V31, P285, DOI 10.1002/1521-4141(200101)31:1<285::AID-IMMU285>3.3.CO;2-4; Subramanian S, 2006, P NATL ACAD SCI USA, V103, P9970, DOI 10.1073/pnas.0603912103; Thompson MD, 2011, J HEPATOL, V54, P506, DOI 10.1016/j.jhep.2010.07.020; Tveita AA, 2011, ARTHRITIS RHEUM-US, V63, P513, DOI 10.1002/art.30116; Wakui M, 2004, J IMMUNOL, V173, P7368, DOI 10.4049/jimmunol.173.12.7368; Wang XD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084852; Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876; Yu Q, 2011, J IMMUNOL, V186, P3946, DOI 10.4049/jimmunol.1003497	42	13	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161682	10.1371/journal.pone.0161682	http://dx.doi.org/10.1371/journal.pone.0161682			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548498	gold, Green Published, Green Submitted			2022-12-26	WOS:000381768400077
J	Rubio-Codina, M; Araujo, MC; Attanasio, O; Munoz, P; Grantham-McGregor, S				Rubio-Codina, Marta; Araujo, M. Caridad; Attanasio, Orazio; Munoz, Pablo; Grantham-McGregor, Sally			Concurrent Validity and Feasibility of Short Tests Currently Used to Measure Early Childhood Development in Large Scale Studies	PLOS ONE			English	Article							CASH TRANSFER PROGRAM; PSYCHOSOCIAL STIMULATION; DEVELOPING-COUNTRIES; CHILDREN; NUTRITION	In low-and middle-income countries (LIMCs), measuring early childhood development (ECD) with standard tests in large scale surveys and evaluations of interventions is difficult and expensive. Multi-dimensional screeners and single-domain tests ('short tests') are frequently used as alternatives. However, their validity in these circumstances is unknown. We examined the feasibility, reliability, and concurrent validity of three multi-dimensional screeners (Ages and Stages Questionnaires (ASQ-3), Denver Developmental Screening Test (Denver-II), Battelle Developmental Inventory screener (BDI-2)) and two single-domain tests (MacArthur-Bates Short-Forms (SFI and SFII), WHO Motor Milestones (WHO-Motor)) in 1,311 children 6-42 months in Bogota, Colombia. The scores were compared with those on the Bayley Scales of Infant and Toddler Development (Bayley-III), taken as the ` gold standard'. The Bayley-III was given at a center by psychologists; whereas the short tests were administered in the home by interviewers, as in a survey setting. Findings indicated good internal validity of all short tests except the ASQ-3. The BDI-2 took long to administer and was expensive, while the single-domain tests were quickest and cheapest and the Denver- II and ASQ-3 were intermediate. Concurrent validity of the multi-dimensional tests' cognitive, language, and fine motor scales with the corresponding Bayley-III scale was low below 19 months. However, it increased with age, becoming moderate-to-high over 30 months. In contrast, gross motor scales' concurrence was high under 19 months and then decreased. Of the single-domain tests, the WHO-Motor had high validity with gross motor under 16 months, and the SFI and SFII expressive scales showed moderate correlations with language under 30 months. Overall, the Denver-II was the most feasible and valid multi-dimensional test and the ASQ-3 performed poorly under 31 months. By domain, gross motor development had the highest concurrence below 19 months, and language above.	[Rubio-Codina, Marta; Araujo, M. Caridad] Interamer Dev Bank, Social Protect & Hlth Div, Washington, DC USA; [Rubio-Codina, Marta; Attanasio, Orazio] Inst Fiscal Studies, Ctr Evaluat Dev Policies, London, England; [Attanasio, Orazio] UCL, Dept Econ, London, England; [Munoz, Pablo] Univ Laval, Ecole Psychol, Quebec City, PQ G1K 7P4, Canada; [Grantham-McGregor, Sally] UCL, Inst Child Hlth, Fac Populat Hlth Sci, London, England	Inter-American Development Bank; University of London; London School Economics & Political Science; University of London; University College London; Laval University; University of London; University College London	Rubio-Codina, M (corresponding author), Interamer Dev Bank, Social Protect & Hlth Div, Washington, DC USA.; Rubio-Codina, M (corresponding author), Inst Fiscal Studies, Ctr Evaluat Dev Policies, London, England.	martarubio@iadb.org		Araujo, M. Caridad/0000-0002-6564-3088	Inter-American Development Bank (IDB) [RGT1907]; Leverhulme Trust Early Career Fellowship [ECF/2008/0170]; European Research Council (ERC) Advanced Grants [249612]; Economic and Social Research Council (ESRC) Professorial Fellowship [ES/K010700/1]; ESRC [ES/G015953/1, ES/K010700/1] Funding Source: UKRI; Economic and Social Research Council [ES/M010147/1, ES/K010700/1] Funding Source: researchfish	Inter-American Development Bank (IDB); Leverhulme Trust Early Career Fellowship(Leverhulme Trust); European Research Council (ERC) Advanced Grants(European Research Council (ERC)); Economic and Social Research Council (ESRC) Professorial Fellowship; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	Data collection was funded by Fund RGT1907 from the Inter-American Development Bank (IDB). Rubio-Codina's research time was partly financed by the Leverhulme Trust Early Career Fellowship ECF/2008/0170. Attanasio's research time was partially financed by the European Research Council (ERC) Advanced Grants 249612 and the Economic and Social Research Council (ESRC) Professorial Fellowship ES/K010700/1. The funder (IDB) provided support in the form of salaries for authors (MRC, MCA), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The opinions expressed in this publication are those of the authors and do not necessarily reflect the views of the IDB, its Board of Directors, or the countries they represent.	[Anonymous], EXAMINING CHILD DEV; [Anonymous], 1990, DENVER 2 TECHNICAL M; Attanasio OP, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5785; Bayley N., 1993, BAYLEY SCALES INFANT, Vsecond; Bayley N., 2019, BAYLEY SCALES INFANT; Campbell F, 2014, SCIENCE, V343, P1478, DOI 10.1126/science.1248429; Efron B., 1982, CBMS NSF REGIONAL C; Engle PL, 2007, LANCET, V369, P229, DOI 10.1016/S0140-6736(07)60112-3; Evans JD., 1996, STRAIGHTFORWARD STAT; Fenson L, 2002, MACARTHUR COMMUNICAT; Fernald LCH, 2012, P NATL ACAD SCI USA, V109, P17273, DOI 10.1073/pnas.1121241109; Fernald LCH, 2011, SOC SCI MED, V72, P1437, DOI 10.1016/j.socscimed.2011.03.005; Fernandes M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113360; FRANKENBURG WK, 1992, PEDIATRICS, V89, P91; Frongillo E., 2003, UNICEF PSYCHOSOCIAL; Frongillo EA, 2014, ANN NY ACAD SCI, V1308, P68, DOI 10.1111/nyas.12319; Gertler P, 2014, SCIENCE, V344, P998, DOI 10.1126/science.1251178; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Greenspan S.I., 2004, GREENSPAN SOCIAL EMO; Hamadani JD, 2006, J NUTR, V136, P2645, DOI 10.1093/jn/136.10.2645; Hamadani JD, 2010, FOOD NUTR BULL, V31, pS198, DOI 10.1177/15648265100312S212; Hamadani JD, 2013, MATERN CHILD NUTR, V9, P89, DOI 10.1111/mcn.12020; Harrison P., 2003, ADAPTIVE BEHAV ASSES; Heckman JJ, 2007, P NATL ACAD SCI USA, V104, P13250, DOI 10.1073/pnas.0701362104; Jackson-Maldonado D, 2012, APPL PSYCHOLINGUIST, P1; Jackson-Maldonado D., 2003, MACARTHUR INVENTARIO; Luby JL, 2015, JAMA PEDIAT, P1; Macours K, 2012, AM ECON J-APPL ECON, V4, P247, DOI 10.1257/app.4.2.247; Martinez S., 2012, PROMISE PRESCHOOL AF, DOI DOI 10.1002/cad.20072; Martorell R, 2006, ACTA PAEDIATR, V95, P86, DOI 10.1080/08035320500495563; Nahar B, 2009, EUR J CLIN NUTR, V63, P725, DOI 10.1038/ejcn.2008.44; Newborg J., 2005, BATTELLE DEV INVENTO, V2nd; Rubio-Codina M, 2016, INT J BEHAV DEV; Rubio-Codina M, 2015, J HUM RESOUR, V50, P464, DOI 10.3368/jhr.50.2.464; Squires J., 2009, AGES STAGES ENGLISH; Verdisco A., 2009, URGENCY POSSIBILITY; Walker SP, 2011, LANCET, V378, P1325, DOI 10.1016/S0140-6736(11)60555-2; Walker SP, 2011, PEDIATRICS, V127, P849, DOI 10.1542/peds.2010-2231; Wijnhoven TMA, 2004, FOOD NUTR B, V25	39	55	56	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0160962	10.1371/journal.pone.0160962	http://dx.doi.org/10.1371/journal.pone.0160962			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT8TP	27548634	Green Submitted, Green Published, gold			2022-12-26	WOS:000381768400024
J	Mowry, AV; Kavazis, AN; Sirman, AE; Potts, WK; Hood, WR				Mowry, Annelise V.; Kavazis, Andreas N.; Sirman, Aubrey E.; Potts, Wayne K.; Hood, Wendy R.			Reproduction Does Not Adversely Affect Liver Mitochondrial Respiratory Function but Results in Lipid Peroxidation and Increased Antioxidants in House Mice	PLOS ONE			English	Article							OXIDOREDUCTASE COMPLEX-I; OXIDATIVE STRESS; RAT-LIVER; GLUTATHIONE-PEROXIDASE; SUPEROXIDE-PRODUCTION; DNA MUTATIONS; LIFE-SPAN; DYSFUNCTION; MECHANISMS; DAMAGE	Reproduction is thought to come at a cost to longevity. Based on the assumption that increased energy expenditure during reproduction is associated with increased free-radical production by mitochondria, oxidative damage has been suggested to drive this trade-off. We examined the impact of reproduction on liver mitochondrial function by utilizing post-reproductive and non-reproductive house mice (Mus musculus) living under semi-natural conditions. The age-matched post-reproductive and non-reproductive groups were compared after the reproductive females returned to a non-reproductive state, so that both groups were in the same physiological state at the time the liver was collected. Despite increased oxidative damage (p = 0.05) and elevated CuZnSOD (p = 0.002) and catalase (p = 0.04) protein levels, reproduction had no negative impacts on the respiratory function of liver mitochondria. Specifically, in a post-reproductive, maintenance state the mitochondrial coupling (i.e., respiratory control ratio) of mouse livers show no negative impacts of reproduction. In fact, there was a trend (p = 0.059) to suggest increased maximal oxygen consumption by liver mitochondria during the ADP stimulated state (i.e., state 3) in post-reproduction. These findings suggest that oxidative damage may not impair mitochondrial respiratory function and question the role of mitochondria in the trade-off between reproduction and longevity. In addition, the findings highlight the importance of quantifying the respiratory function of mitochondria in addition to measuring oxidative damage.	[Mowry, Annelise V.; Sirman, Aubrey E.; Hood, Wendy R.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA; [Kavazis, Andreas N.] Auburn Univ, Sch Kinesiol, Auburn, AL 36849 USA; [Potts, Wayne K.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Mowry, Annelise V.] Stimlabs, Prod Dev, Roswell, GA USA; [Sirman, Aubrey E.] North Dakota State Univ, Dept Biol Sci, Fargo, ND USA	Auburn University System; Auburn University; Auburn University System; Auburn University; Utah System of Higher Education; University of Utah; North Dakota State University Fargo	Hood, WR (corresponding author), Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA.	wrhood@auburn.edu	Sirman, Aubrey/AAS-3982-2021	Hood, Wendy/0000-0002-8398-3908	Auburn University, Department of Biological Sciences; Auburn University, School of Kinesiology; American Society of Mammalogist; Alabama Academy of Sciences; National Science Foundation [DBI-1453784]; Auburn University, College of Science and Mathematics; Auburn University, College of Education; Department of Biological Sciences, School of Kinesiology, College of Science and Mathematics at Auburn University; Department of Biological Sciences, School of Kinesiology College of Education at Auburn University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109500] Funding Source: NIH RePORTER	Auburn University, Department of Biological Sciences; Auburn University, School of Kinesiology; American Society of Mammalogist; Alabama Academy of Sciences; National Science Foundation(National Science Foundation (NSF)); Auburn University, College of Science and Mathematics; Auburn University, College of Education; Department of Biological Sciences, School of Kinesiology, College of Science and Mathematics at Auburn University; Department of Biological Sciences, School of Kinesiology College of Education at Auburn University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by Auburn University, Department of Biological Sciences and College of Science and Mathematics to WRH (http://www.auburn.edu/cosam/departments/biology/index.htm); Auburn University, School of Kinesiology and College of Education to ANK (http://www.education.auburn.edu/kinesiology); American Society of Mammalogist Grant-in-Aid to AVM (http://www.mammalsociety.org/grants); Alabama Academy of Sciences Research Grant to AVM (http://www.alabamaacademyofscience.org/students.php); and National Science Foundation DBI-1453784 to WRH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the Hood lab undergraduates for assistance with husbandry and the Hood, Hill, and Wada labs and two anonymous reviewers for valuable comments that improved the manuscript. The authors acknowledge the Department of Biological Sciences, School of Kinesiology, College of Science and Mathematics and College of Education at Auburn University, American Society of Mammalogists, Alabama Academy of Sciences and National Science Foundation DBI-1453784 provided funding for this project.	BAST A, 1991, AM J MED, V91, pS2, DOI 10.1016/0002-9343(91)90278-6; Blount JD, 2016, BIOL REV, V91, P483, DOI 10.1111/brv.12179; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Carre M, 2002, J BIOL CHEM, V277, P33664, DOI 10.1074/jbc.M203834200; Costantini D, 2008, ECOL LETT, V11, P1238, DOI 10.1111/j.1461-0248.2008.01246.x; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; deHaan JB, 1996, HUM MOL GENET, V5, P283, DOI 10.1093/hmg/5.2.283; Dowling DK, 2009, P ROY SOC B-BIOL SCI, V276, P1737, DOI 10.1098/rspb.2008.1791; Dumas JF, 2003, BRIT J NUTR, V90, P969, DOI 10.1079/BJN2003980; Esworthy RS, 1997, ARCH BIOCHEM BIOPHYS, V340, P59, DOI 10.1006/abbi.1997.9901; Galloway CA, 2012, J GEN PHYSIOL, V139, P455, DOI 10.1085/jgp.201210771; Garratt M, 2011, P ROY SOC B-BIOL SCI, V278, P1098, DOI 10.1098/rspb.2010.1818; Hammond KA, 1997, J MAMMARY GLAND BIOL, V2, P243, DOI 10.1023/A:1026332304435; Hansford RG, 1997, J BIOENERG BIOMEMBR, V29, P89, DOI 10.1023/A:1022420007908; HIGASHI T, 1963, J BIOL CHEM, V238, P3945; Itsara LS, 2014, OXIDATIVE STRESS IS; Kavazis AN, 2009, FREE RADICAL BIO MED, V46, P842, DOI 10.1016/j.freeradbiomed.2009.01.002; KIRKWOOD TBL, 1979, PROC R SOC SER B-BIO, V205, P531, DOI 10.1098/rspb.1979.0083; Klein J, 1975, NATURAL HIST MOUSE H; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; Lambert AJ, 2004, BIOCHEM J, V382, P511, DOI 10.1042/BJ20040485; Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701; LIPSKY NG, 1981, J BIOL CHEM, V256, P8652; Loeb LA, 2005, P NATL ACAD SCI USA, V102, P18769, DOI 10.1073/pnas.0509776102; MAKINEN MW, 1968, ARCH BIOCHEM BIOPHYS, V126, P75, DOI 10.1016/0003-9861(68)90561-4; Meagher S, 2000, P NATL ACAD SCI USA, V97, P3324, DOI 10.1073/pnas.060284797; Messer JI, 2004, AM J PHYSIOL-CELL PH, V286, pC565, DOI 10.1152/ajpcell.00146.2003; MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Muller FL, 2007, FREE RADICAL BIO MED, V43, P477, DOI 10.1016/j.freeradbiomed.2007.03.034; Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200; Pichaud N, 2013, J EXP BIOL, V216, P2889, DOI 10.1242/jeb.082685; Pinto M, 2015, FREE RADICAL BIO MED, V85, P250, DOI 10.1016/j.freeradbiomed.2015.05.005; Powers SK, 2010, INT J SPORT NUTR EXE, V20, P2, DOI 10.1123/ijsnem.20.1.2; Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1; RCoreTeam, 2012, R LANG ENV STAT COMP; Ristow M, 2014, DOSE-RESPONSE, V12, P288, DOI 10.2203/dose-response.13-035.Ristow; Ristow M, 2011, FREE RADICAL BIO MED, V51, P327, DOI 10.1016/j.freeradbiomed.2011.05.010; Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594; Salin K, 2015, P ROY SOC B-BIOL SCI, V282, P14, DOI 10.1098/rspb.2015.1028; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490; SEWELL DL, 1975, AM J PHYSIOL, V228, P526, DOI 10.1152/ajplegacy.1975.228.2.526; Speakman JR, 2014, BIOESSAYS, V36, P93, DOI 10.1002/bies.201300108; Speakman JR, 1996, PHYSIOL ZOOL, V69, P746, DOI 10.1086/physzool.69.4.30164228	46	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0160883	10.1371/journal.pone.0160883	http://dx.doi.org/10.1371/journal.pone.0160883			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537547	Green Published, Green Submitted, gold			2022-12-26	WOS:000381577000038
J	Shukla, A; Yang, YH; Madanikia, S; Ho, Y; Li, MM; Sanchez, V; Cataisson, C; Huang, J; Yuspa, SH				Shukla, Anjali; Yang, Yihan; Madanikia, Sara; Ho, Yan; Li, Mangmang; Sanchez, Vanesa; Cataisson, Christophe; Huang, Jing; Yuspa, Stuart H.			Elevating CLIC4 in Multiple Cell Types Reveals a TGF-Dependent Induction of a Dominant Negative Smad7 Splice Variant	PLOS ONE			English	Article							BETA SUPERFAMILY; GROWTH; SKIN; INHIBITION; KERATINOCYTES; NUCLEUS; DOMAIN; ROLES; FORM	CLIC4 (Chloride intracellular channel 4) belongs to a family of putative intracellular chloride channel proteins expressed ubiquitously in multiple tissues. CLIC4 is predominantly soluble and traffics between the cytoplasm and nucleus and participates in cell cycle control and differentiation. Transforming growth factor beta (TGF-beta) elevates CLIC4, which enhances TGF-beta signaling through CLIC4 mediated stabilization of phospho-Smad2/3. CLIC4 is essential for TGF-beta induced conversion of fibroblasts to myofibroblasts and expression of matrix proteins, signaling via the p38MAPK pathway. Therefore, regulation of TGF-beta signaling is a major mechanism by which CLIC4 modifies normal growth and differentiation. We now report that elevated CLIC4 alters Smad7 function, a feedback inhibitor of the TGF-beta pathway. Overexpression of CLIC4 in keratinocytes, mouse embryonic fibroblasts and other mouse and human cell types increases the expression of Smad7 Delta, a novel truncated form of Smad7. The alternatively spliced Smad7 Delta variant is missing 94bp in exon 4 of Smad 7 and is conserved between mouse and human cells. The deletion is predicted to lack the TGF-beta signaling inhibitory MH2 domain of Smad7. Treatment with exogenous TGF-beta 1 also enhances expression of Smad7 Delta that is amplified in the presence of CLIC4. While Smad7 expression inhibits TGF-beta signaling, exogenously expressed Smad7 Delta does not inhibit TGF-beta signaling as determined by TGF-beta dependent proliferation, reporter assays and phosphorylation of Smad proteins. Instead, exogenous Smad7 Delta acts as a dominant negative inhibitor of Smad7, thus increasing TGF-beta signaling. This discovery adds another dimension to the myriad ways by which CLIC4 modifies TGF-beta signaling.	[Shukla, Anjali; Yang, Yihan; Madanikia, Sara; Ho, Yan; Li, Mangmang; Sanchez, Vanesa; Cataisson, Christophe; Huang, Jing; Yuspa, Stuart H.] NCI, Lab Canc Biol & Genet, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Yuspa, SH (corresponding author), NCI, Lab Canc Biol & Genet, Ctr Canc Res, Bethesda, MD 20892 USA.	yuspas@mail.nih.gov		, Yan/0000-0003-4980-9663	NCI, CCR intramural program [BC005445-30]; NATIONAL CANCER INSTITUTE [ZIABC005445] Funding Source: NIH RePORTER	NCI, CCR intramural program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was conducted with funding to SHY from the NCI, CCR intramural program under project BC005445-30.	Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Bai ST, 2000, J BIOL CHEM, V275, P8267, DOI 10.1074/jbc.275.12.8267; Bornstein S, 2007, MOL CARCINOGEN, V46, P660, DOI 10.1002/mc.20336; Casellas R, 1998, DEV BIOL, V198, P1; Hallgren O, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-6; Hanyu A, 2001, J CELL BIOL, V155, P1017, DOI 10.1083/jcb.200106023; Hata A, 1998, GENE DEV, V12, P186, DOI 10.1101/gad.12.2.186; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; He W, 2001, ONCOGENE, V20, P471, DOI 10.1038/sj.onc.1204117; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Jiang YF, 2000, BLOOD, V95, P3945; Konrad L, 2008, ANDROLOGIA, V40, P358, DOI 10.1111/j.1439-0272.2008.00869.x; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; Littler DR, 2008, PROTEINS, V71, P364, DOI 10.1002/prot.21704; Littler DR, 2010, FEBS LETT, V584, P2093, DOI 10.1016/j.febslet.2010.01.027; Littler DR, 2005, FEBS J, V272, P4996, DOI 10.1111/j.1742-4658.2005.04909.x; Liu X, 2003, CANCER RES, V63, P7760; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Mochizuki T, 2004, J BIOL CHEM, V279, P31568, DOI 10.1074/jbc.M313977200; MOSES HL, 1992, MOL REPROD DEV, V32, P179, DOI 10.1002/mrd.1080320215; Nishita M, 1999, GENES CELLS, V4, P583, DOI 10.1046/j.1365-2443.1999.00285.x; Padmakumar VC, 2012, AM J PATHOL, V181, P74, DOI 10.1016/j.ajpath.2012.03.025; Schilling Stephen H., 2008, P45; SHIPLEY GD, 1986, CANCER RES, V46, P2068; Shukla A, 2014, ONCOGENE, V33, P842, DOI 10.1038/onc.2013.18; Shukla A, 2010, NUCLEUS-PHILA, V1, P144; Shukla A, 2009, NAT CELL BIOL, V11, P777, DOI 10.1038/ncb1885; Stolfi C, 2013, INT J MOL SCI, V14, P23774, DOI 10.3390/ijms141223774; Suh KS, 2012, CARCINOGENESIS, V33, P986, DOI 10.1093/carcin/bgs115; Suh KS, 2004, J BIOL CHEM, V279, P4632, DOI 10.1074/jbc.M311632200; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Ueberham U, 2009, INT J DEV NEUROSCI, V27, P501, DOI 10.1016/j.ijdevneu.2009.04.001; Wang XJ, 2001, MICROSC RES TECHNIQ, V52, P420, DOI 10.1002/1097-0029(20010215)52:4<420::AID-JEMT1027>3.3.CO;2-Z; Wendt MK, 2014, BREAST CANCER RES, V16, P1; Zhang SP, 2007, MOL CELL BIOL, V27, P4488, DOI 10.1128/MCB.01636-06; Zhang XY, 2013, CELL CYCLE, V12, P1279, DOI 10.4161/cc.24364	36	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161410	10.1371/journal.pone.0161410	http://dx.doi.org/10.1371/journal.pone.0161410			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536941	gold, Green Published			2022-12-26	WOS:000381577000102
J	Abd-Elrahman, I; Kosuge, H; Sadan, TW; Ben-Nun, Y; Meir, K; Rubinstein, C; Bogyo, M; McConnell, MV; Blum, G				Abd-Elrahman, Ihab; Kosuge, Hisanori; Sadan, Tommy Wises; Ben-Nun, Yael; Meir, Karen; Rubinstein, Chen; Bogyo, Matthew; McConnell, Michael V.; Blum, Galia			Cathepsin Activity-Based Probes and Inhibitor for Preclinical Atherosclerosis Imaging and Macrophage Depletion	PLOS ONE			English	Article							PROTEASE ACTIVITY	Background and Purpose Cardiovascular disease is the leading cause of death worldwide, mainly due to an increasing prevalence of atherosclerosis characterized by inflammatory plaques. Plaques with high levels of macrophage infiltration are considered "vulnerable" while those that do not have significant inflammation are considered stable; cathepsin protease activity is highly elevated in macrophages of vulnerable plaques and contributes to plaque instability. Establishing novel tools for non-invasive molecular imaging of macrophages in plaques could aid in preclinical studies and evaluation of therapeutics. Furthermore, compounds that reduce the macrophage content within plaques should ultimately impact care for this disease. Methods We have applied quenched fluorescent cathepsin activity-based probes (ABPs) to a murine atherosclerosis model and evaluated their use for in vivo imaging using fluorescent molecular tomography (FMT), as well as ex vivo fluorescence imaging and fluorescent microscopy. Additionally, freshly dissected human carotid plaques were treated with our potent cathepsin inhibitor and macrophage apoptosis was evaluated by fluorescent microscopy. Results We demonstrate that our ABPs accurately detect murine atherosclerotic plaques non-invasively, identifying cathepsin activity within plaque macrophages. In addition, our cathepsin inhibitor selectively induced cell apoptosis of 55%+/- 10% of the macrophage within excised human atherosclerotic plaques. Conclusions Cathepsin ABPs present a rapid diagnostic tool for macrophage detection in atherosclerotic plaque. Our inhibitor confirms cathepsin-targeting as a promising approach to treat atherosclerotic plaque inflammation.	[Abd-Elrahman, Ihab; Sadan, Tommy Wises; Ben-Nun, Yael; Blum, Galia] Hebrew Univ Jerusalem, Fac Med, Sch Pharm, Inst Drug Res, IL-9112001 Jerusalem, Israel; [Kosuge, Hisanori; McConnell, Michael V.] Stanford Univ, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA; [Meir, Karen] Hadassah Med Ctr, Dept Pathol, IL-9112001 Jerusalem, Israel; [Rubinstein, Chen] Hadassah Med Ctr, Dept Vasc Surg, IL-9112001 Jerusalem, Israel; [Bogyo, Matthew] Stanford Univ, Sch Med, Dept Pathol & Microbiol & Immunol, Stanford, CA 94305 USA; [Kosuge, Hisanori] Tokyo Med & Dent Univ, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138519, Japan	Hebrew University of Jerusalem; Stanford University; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Stanford University; Tokyo Medical & Dental University (TMDU)	Blum, G (corresponding author), Hebrew Univ Jerusalem, Fac Med, Sch Pharm, Inst Drug Res, IL-9112001 Jerusalem, Israel.	galiabl@ekmd.huji.ac.il		Bogyo, Matthew/0000-0003-3753-4412; abd-elrahman, ihab/0000-0003-2012-2024; Ben-Nun, Yael/0000-0002-5123-649X; Blum, Galia/0000-0002-9374-2489; McConnell, Michael/0000-0001-8743-0932	United States -Israel Binational Science Foundation (BSF) [2009010, 2011480]; Israel Ministry of Health Chief Scientist [3-00000-7035]	United States -Israel Binational Science Foundation (BSF)(US-Israel Binational Science Foundation); Israel Ministry of Health Chief Scientist	The sources of funding for this work are: United States -Israel Binational Science Foundation (BSF) (2009010 and 2011480 to G.B., M.V.M. and M.B.), URL: BSF.org.il; The Israel Ministry of Health Chief Scientist, 3-00000-7035 to G.B., URL: https://www.old.health.gov.il.	Abd-Elrahman I, 2016, STROKE, V47, P1101, DOI 10.1161/STROKEAHA.115.011573; Ben-Aderet L, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0586-5; Blum G, 2005, NAT CHEM BIOL, V1, P203, DOI 10.1038/nchembio728; Blum G, 2007, NAT CHEM BIOL, V3, P668, DOI 10.1038/nchembio.2007.26; Calfon MA, 2010, J BIOMEDICAL OPTICS, V15; Croons V, 2010, CURR VASC PHARMACOL, V8, P495, DOI 10.2174/157016110791330816; Jaffer FA, 2008, CIRCULATION, V118, P1802, DOI 10.1161/CIRCULATIONAHA.108.785881; Kitagawa T, 2012, MOL IMAGING BIOL, V14, P315, DOI 10.1007/s11307-011-0495-1; Li W, 2009, ATHEROSCLEROSIS, V202, P92, DOI 10.1016/j.atherosclerosis.2008.03.027; MORENO PR, 1994, CIRCULATION, V90, P775, DOI 10.1161/01.CIR.90.2.775; Salpeter SJ, 2015, ONCOGENE, V34, P6066, DOI 10.1038/onc.2015.51; Sanman LE, 2016, ELIFE, V5, DOI 10.7554/eLife.13663; Skjot-Arkil H, 2010, ASSAY DRUG DEV TECHN, V8, P542, DOI 10.1089/adt.2009.0258; Terashima M, 2011, MOL IMAGING BIOL, V13, P1061, DOI 10.1007/s11307-010-0451-5; Weissleder R, 1999, NAT BIOTECHNOL, V17, P375, DOI 10.1038/7933	15	27	28	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160522	10.1371/journal.pone.0160522	http://dx.doi.org/10.1371/journal.pone.0160522			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532109	gold, Green Submitted, Green Published			2022-12-26	WOS:000381487600034
J	Diniz, WJD; Coutinho, LL; Tizioto, PC; Cesar, ASM; Gromboni, CF; Nogueira, ARA; de Oliveira, PSN; de Souza, MM; Regitano, LCD				da Silva Diniz, Wellison Jarles; Coutinho, Luiz Lehmann; Tizioto, Polyana Cristine; Mello Cesar, Aline Silva; Gromboni, Caio Fernando; Araujo Nogueira, Ana Rita; Neubern de Oliveira, Priscila Silva; de Souza, Marcela Maria; de Almeida Regitano, Luciana Correia			Iron Content Affects Lipogenic Gene Expression in the Muscle of Nelore Beef Cattle	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; QUANTITATIVE TRAIT LOCI; FATTY-ACID-COMPOSITION; COMPLEMENT FACTOR C3; LONGISSIMUS MUSCLE; LIPID-METABOLISM; SKELETAL-MUSCLE; MINERAL-CONTENT; PROTEIN; MEAT	Iron (Fe) is an essential mineral for metabolism and plays a central role in a range of biochemical processes. Therefore, this study aimed to identify differentially expressed (DE) genes and metabolic pathways in Longissimus dorsi (LD) muscle from cattle with divergent iron content, as well as to investigate the likely role of these DE genes in biological processes underlying beef quality parameters. Samples for RNA extraction for sequencing and iron, copper, manganese, and zinc determination were collected from LD muscles at slaughter. Eight Nelore steers, with extreme genomic estimated breeding values for iron content (Fe-GEBV), were selected from a reference population of 373 animals. From the 49 annotated DE genes (FDR<0.05) found between the two groups, 18 were up-regulated and 31 down-regulated for the animals in the low Fe-GEBV group. The functional enrichment analyses identified several biological processes, such as lipid transport and metabolism, and cell growth. Lipid metabolism was the main pathway observed in the analysis of metabolic and canonical signaling pathways for the genes identified as DE, including the genes FASN, FABP4, and THRSP, which are functional candidates for beef quality, suggesting reduced lipogenic activities with lower iron content. Our results indicate metabolic pathways that are partially influenced by iron, contributing to a better understanding of its participation in skeletal muscle physiology.	[da Silva Diniz, Wellison Jarles; de Souza, Marcela Maria] Univ Fed Sao Carlos, Dept Genet & Evolut, Sao Carlos, SP, Brazil; [Coutinho, Luiz Lehmann; Mello Cesar, Aline Silva] Univ Sao Paulo, ESALQ, Dept Anim Sci, Piracicaba, Brazil; [Tizioto, Polyana Cristine; Araujo Nogueira, Ana Rita; Neubern de Oliveira, Priscila Silva; de Almeida Regitano, Luciana Correia] Embrapa Pecuaria Sudeste, Sao Carlos, SP, Brazil; [Gromboni, Caio Fernando] Bahia Fed Inst Educ Sci & Technol, Ilheus, Brazil	Universidade Federal de Sao Carlos; Universidade de Sao Paulo; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Instituto Federal da Bahia (IFBA)	Regitano, LCD (corresponding author), Embrapa Pecuaria Sudeste, Sao Carlos, SP, Brazil.	luciana.regitano@embrapa.br	da Silva WJSD Diniz, Wellison J./G-6593-2014; Cesar, Aline Silva Mello/E-6887-2014; Coutinho, Luiz/P-5233-2019; de Almeida Regitano, Luciana Correia/C-7002-2012; Diniz, Wellison J. S./AAF-4556-2020; Nogueira, Ana Rita/D-9319-2012; Coutinho, Luiz L/C-8455-2012	da Silva WJSD Diniz, Wellison J./0000-0003-1082-5535; Cesar, Aline Silva Mello/0000-0001-9921-214X; Coutinho, Luiz/0000-0002-7266-8881; de Almeida Regitano, Luciana Correia/0000-0001-9242-8351; Diniz, Wellison J. S./0000-0003-1082-5535; Nogueira, Ana Rita/0000-0003-3648-2956; Coutinho, Luiz L/0000-0002-7266-8881; de Souza, Marcela Maria/0000-0001-7512-5893	Sao Paulo Research Foundation (FAPESP) [2014/12652-5]; National Council of Technological and Scientific Development (CNPq) fellowships; FAPESP [2012/23638-8]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council of Technological and Scientific Development (CNPq) fellowships(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	WJSD received a scholarship from Sao Paulo Research Foundation (FAPESP, grant numbers: 2014/12652-5 <http://www.bv.fapesp.br/pt/bolsas/154947/expressao-genica-diferencial-associada-ao-conteudo-de-ferro-no-musculo-emanimais-nelore/>. LAR and LC were granted by National Council of Technological and Scientific Development (CNPq) fellowships. The thematic FAPESP grant number is 2012/23638-8.	Ahlberg CM, 2014, MEAT SCI, V98, P804, DOI 10.1016/j.meatsci.2014.07.030; Barbu A, 2015, MOL IMMUNOL, V67, P101, DOI 10.1016/j.molimm.2015.02.027; Beard JL, 2001, J NUTR, V131, p568S, DOI 10.1093/jn/131.2.568S; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bosma M, 2012, HISTOCHEM CELL BIOL, V137, P205, DOI 10.1007/s00418-011-0888-x; Casas E, 2014, ANIM GENET, V45, P283, DOI 10.1111/age.12108; Cesar ASM, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-39; Choi YM, 2009, LIVEST SCI, V122, P105, DOI 10.1016/j.livsci.2008.08.015; Collins JF, 2005, AM J PHYSIOL-GASTR L, V288, pG964, DOI 10.1152/ajpgi.00489.2004; Corominas J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-843; Cunningham BA, 1998, THYROID, V8, P815, DOI 10.1089/thy.1998.8.815; Damon M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033763; Dauncey M. J., 2004, Muscle development of livestock animals: physiology, genetics and meat quality, P103, DOI 10.1079/9780851998114.0103; Davis M, 2013, NUTRIENTS, V5, P2611, DOI 10.3390/nu5072611; Davis MR, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-95; Davis MR, 2012, GENES NUTR, V7, P415, DOI 10.1007/s12263-011-0278-y; De Jager N, 2013, J ANIM SCI, V91, P1112, DOI 10.2527/jas.2012-5409; Duan Q, 2012, ANIM GENET, V43, P115, DOI 10.1111/j.1365-2052.2011.02224.x; Fang L, 2013, FASEB J, V27, P907, DOI 10.1096/fj.12-220905; Gardi C, 2002, BIOCHEM PHARMACOL, V64, P1139, DOI 10.1016/S0006-2952(02)01257-1; Garmyn AJ, 2011, J ANIM SCI, V89, P2849, DOI 10.2527/jas.2010-3497; Garrick DJ, 2009, GENSEL USER MANUAL P, P23; Goff LA, 2012, CUMMERBUND VISUALIZA, P42; Griffin MJ, 2004, IUBMB LIFE, V56, P595, DOI 10.1080/15216540400022474; Hamara K, 2013, MOL BIOL REP, V40, P5573, DOI 10.1007/s11033-013-2659-3; Hansen SL, 2010, J ANIM SCI, V88, P275, DOI 10.2527/jas.2009-1846; He H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064356; Hocquette Jean-Francois, 2006, Animal Science Papers and Reports, V24, P173; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jiang ZH, 2009, INT J BIOL SCI, V5, P528; Kamei A, 2010, PHYSIOL GENOMICS, V42, P149, DOI 10.1152/physiolgenomics.00150.2009; Kayan A, 2011, MEAT SCI, V89, P76, DOI 10.1016/j.meatsci.2011.04.001; Lee SH, 2002, J ANIM SCI, V80, P1999; Li YF, 2015, J BIOL CHEM, V290, P11918, DOI 10.1074/jbc.M115.645903; Lieu Pauline T., 2001, Molecular Aspects of Medicine, V22, P1, DOI 10.1016/S0098-2997(00)00006-6; Loor J. J., 2010, Energy and protein metabolism and nutrition. 3rd EAAP International Symposium on Energy and Protein Metabolism and Nutrition, Parma, Italy, 6-10 September, 2010, P59; Maier T, 2008, SCIENCE, V321, P1315, DOI 10.1126/science.1161269; Mateescu R, 2014, P BEEF IMPR FED RES, P87; Mateescu RG, 2013, J ANIM SCI, V91, P3593, DOI 10.2527/jas.2012-6079; Mateescu RG, 2013, J ANIM SCI, V91, P1067, DOI 10.2527/jas.2012-5744; Mitchelson Keith Richard, 2015, World J Biol Chem, V6, P162, DOI 10.4331/wjbc.v6.i3.162; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Morris CA, 2013, ANIM GENET, V44, P361, DOI 10.1111/age.12012; Oexle H, 1999, BBA-BIOENERGETICS, V1413, P99, DOI 10.1016/S0005-2728(99)00088-2; Oh DY, 2014, ASIAN AUSTRAL J ANIM, V27, P1373, DOI 10.5713/ajas.2014.14101; Peiris H, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/520316; Persson L, 2004, ARTERIOSCL THROM VAS, V24, P1062, DOI 10.1161/01.ATV.0000127302.24266.40; Pritchard M., 2013, SYNDROME, P173, DOI [10.5772/52977, DOI 10.5772/52977]; Purohit A, 2015, J FOOD MEAS CHARACT, V9, P175, DOI 10.1007/s11694-015-9222-y; Rhee SY, 2008, NAT REV GENET, V9, P509, DOI 10.1038/nrg2363; Rodriguez A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-379; Ruttkay-Nedecky B, 2013, INT J MOL SCI, V14, P6044, DOI 10.3390/ijms14036044; Sakuma K, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/721219; Sammarco MC, 2008, J BIOL CHEM, V283, P4578, DOI 10.1074/jbc.M703456200; Sharp P, 2004, P NUTR SOC, V63, P563, DOI 10.1079/PNS2004386; Shi H, 2010, COMP BIOCHEM PHYS B, V157, P357, DOI 10.1016/j.cbpb.2010.08.005; Stangl GI, 1998, LIPIDS, V33, P889, DOI 10.1007/s11745-998-0285-8; Su HS, 2000, J NUTR, V130, p315S, DOI 10.1093/jn/130.2.315S; Sun J, 2015, ANIM GENET, V46, P227, DOI 10.1111/age.12272; Tizioto PC, 2013, PHYSIOL GENOMICS, V45, P1012, DOI 10.1152/physiolgenomics.00066.2013; Tizioto PC, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-014-0083-3; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Velleman SG, 2012, J ANIM SCI, V90, P936, DOI 10.2527/jas.2011-4497; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang H, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.207779; Wang YH, 2009, J ANIM SCI, V87, P119, DOI 10.2527/jas.2008-1082; Wight TN, 2002, CURR OPIN CELL BIOL, V14, P617, DOI 10.1016/S0955-0674(02)00375-7; Wu YJ, 2005, CELL RES, V15, P483, DOI 10.1038/sj.cr.7290318; Yujing Li ZS., 2013, INT J GENOMIC MED, V1, P34, DOI [10.4172/2332-0672.1000112, DOI 10.4172/2332-0672.1000112]; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zimmermann MB, 2002, THYROID, V12, P867, DOI 10.1089/105072502761016494	74	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161160	10.1371/journal.pone.0161160	http://dx.doi.org/10.1371/journal.pone.0161160			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532424	Green Submitted, Green Published, gold			2022-12-26	WOS:000381487600068
J	Yan, HY; Hu, KS; Wu, WJ; Li, Y; Tian, H; Chu, ZH; Koeffler, HP; Yin, D				Yan, Haiyan; Hu, Kaishun; Wu, Wenjing; Li, Yu; Tian, Huan; Chu, Zhonghua; Koeffler, H. Phillip; Yin, Dong			Low Expression of DYRK2 (Dual Specificity Tyrosine Phosphorylation Regulated Kinase 2) Correlates with Poor Prognosis in Colorectal Cancer	PLOS ONE			English	Article							PROTEIN-KINASES; INHIBITS PROLIFERATION; COLON-CANCER; C-MYC; CELLS; OVEREXPRESSION; SURVIVAL; FAMILY; GENE; ADENOCARCINOMAS	Dual-specificity tyrosine-phosphorylation-regulated kinase 2 (DYRK2) is a member of dual-specificity kinase family, which could phosphorylate both Ser/Thr and Tyr substrates. The role of DYRK2 in human cancer remains controversial. For example, overexpression of DYRK2 predicts a better survival in human non-small cell lung cancer. In contrast, amplification of DYRK2 gene occurs in esophageal/lung adenocarcinoma, implying the role of DYRK2 as a potential oncogene. However, its clinical role in colorectal cancer (CRC) has not been explored. In this study, we analyzed the expression of DYRK2 from Oncomine database and found that DYRK2 level is lower in primary or metastatic CRC compared to adjacent normal colon tissue or non-metastatic CRC, respectively, in 6 colorectal carcinoma data sets. The correlation between DYRK2 expression and clinical outcome in 181 CRC patients was also investigated by real-time PCR and IHC. DYRK2 expression was significantly down-regulated in colorectal cancer tissues compared with adjacent non-tumorous tissues. Functional studies confirmed that DYRK2 inhibited cell invasion and migration in both HCT116 and SW480 cells and functioned as a tumor suppressor in CRC cells. Furthermore, the lower DYRK2 levels were correlated with tumor sites (P = 0.023), advanced clinical stages (P = 0.006) and shorter survival in the advanced clinical stages. Univariate and multivariate analyses indicated that DYRK2 expression was an independent prognostic factor (P < 0.001). Taking all, we concluded that DYRK2 a novel prognostic biomarker of human colorectal cancer.	[Yan, Haiyan; Hu, Kaishun; Wu, Wenjing; Li, Yu; Yin, Dong] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Med Res Ctr, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou 510120, Guangdong, Peoples R China; [Yan, Haiyan] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Clin Lab, Guangzhou 510120, Guangdong, Peoples R China; [Wu, Wenjing] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Breast Oncol, Guangzhou 510120, Guangdong, Peoples R China; [Tian, Huan] Tradit Chinese Med Univ Guangzhou, Guangdong Hosp Tradit Chinese Med, Dept Breast Oncol, Guangzhou 510120, Guangdong, Peoples R China; [Chu, Zhonghua] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Gastrointestinal Surg, Guangzhou, Guangdong, Peoples R China; [Koeffler, H. Phillip] Univ Calif Los Angeles, Sch Med, Div Hematol Oncol, Cedars Sinai Med Ctr, Los Angeles, CA 90024 USA; [Koeffler, H. Phillip] Natl Univ Singapore, CSI, NCIS, Singapore, Singapore	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Guangzhou University of Chinese Medicine; Sun Yat Sen University; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; National University of Singapore	Yin, D (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Med Res Ctr, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou 510120, Guangdong, Peoples R China.	yin.dong@ymail.com			Natural Science Foundation of China [81572484, 81420108026, 81272956, 81301732, 81402199]; Guangdong Science and Technology Department [2014A050503026, 2015B050501004, S2012030006287]; Guangzhou Bureau of Science and Information Technology [201400000004-2, [2013]163]; Guangdong Natural Science Foundation [S2013040016404]; Sun Yat-sen University Training Project [13ykpy25]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Science and Technology Department; Guangzhou Bureau of Science and Information Technology; Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Sun Yat-sen University Training Project	This study was supported by grants from the Natural Science Foundation of China (81572484, 81420108026, 81272956 to D.Y.); Guangdong Science and Technology Department (2014A050503026 to D.Y., 2015B050501004, S2012030006287); Guangzhou Bureau of Science and Information Technology (201400000004-2 to D.Y.; [2013]163); Natural Science Foundation of China (81301732 to K.S.H., 81402199 to W.J.W.); Guangdong Natural Science Foundation (Grant No. S2013040016404, to K.S.H.), Sun Yat-sen University Training Project (13ykpy25 to K.S.H.).; This study was supported by grants from the Natural Science Foundation of China (81572484, 81420108026, 81272956 to D.Y.); Guangdong Science and Technology Department (2014A050503026 to D.Y., 2015B050501004, S2012030006287); Guangzhou Bureau of Science and Information Technology (201400000004-2 to D.Y.; [2013]163). Natural Science Foundation of China (81301732 to K.S.H, 81402199 to W.J.W); Guangdong Natural Science Foundation (Grant No. S2013040016404, to K.S.H), Sun Yat-sen University Training Project (13ykpy25 to K.S.H). We thank the members of the laboratory for their helpful comments on the manuscript. We appreciate professor Rui-Hua Xu from Sun-yat Sen University Cancer Center for supplying the tumor specimens and patient data for the IHC study.	Aranda S, 2011, FASEB J, V25, P449, DOI 10.1096/fj.10-165837; Becker W, 1998, J BIOL CHEM, V273, P25893, DOI 10.1074/jbc.273.40.25893; DEredita G, 1996, AUST NZ J SURG, V66, P445, DOI 10.1111/j.1445-2197.1996.tb00780.x; Friedman E, 2007, J CELL BIOCHEM, V102, P274, DOI 10.1002/jcb.21451; Gaedcke J, 2010, GENE CHROMOSOME CANC, V49, P1024, DOI 10.1002/gcc.20811; Guo XM, 2010, J BIOL CHEM, V285, P13223, DOI 10.1074/jbc.M110.102574; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Kaiser S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r131; Kekelidze M, 2013, WORLD J GASTROENTERO, V19, P8502, DOI 10.3748/wjg.v19.i46.8502; Ki DH, 2007, INT J CANCER, V121, P2005, DOI 10.1002/ijc.22975; Koon N, 2004, GUT, V53, P235, DOI 10.1136/gut.2003.021238; Lagautriere F., 1998, Annali Italiani di Chirurgia, V69, P491; Lagautriere F, 1998, ANN ITAL CHIR, V69, P6; Laguna A, 2008, DEV CELL, V15, P841, DOI 10.1016/j.devcel.2008.10.014; Leiszter K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074140; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Miller CT, 2003, CLIN CANCER RES, V9, P4819; Miller CT, 2003, CANCER RES, V63, P4136; Mimoto R, 2013, CANCER LETT, V339, P214, DOI 10.1016/j.canlet.2013.06.005; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Park J, 2010, J BIOL CHEM, V285, P31895, DOI 10.1074/jbc.M110.147520; Park J, 2009, CELL MOL LIFE SCI, V66, P3235, DOI 10.1007/s00018-009-0123-2; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Pino MS, 2010, GASTROENTEROLOGY, V138, P2059, DOI 10.1053/j.gastro.2009.12.065; Seifert A, 2008, FEBS J, V275, P6268, DOI 10.1111/j.1742-4658.2008.06751.x; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Sitz JH, 2004, MOL CELL BIOL, V24, P5821, DOI 10.1128/MCB.24.13.5821-5834.2004; Skrzypczak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013091; Taira N, 2007, MOL CELL, V25, P725, DOI 10.1016/j.molcel.2007.02.007; Taira N, 2012, J CLIN INVEST, V122, P859, DOI 10.1172/JCI60818; TEJEDOR F, 1995, NEURON, V14, P287, DOI 10.1016/0896-6273(95)90286-4; Teng KY, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-126; Yabut O, 2010, J NEUROSCI, V30, P4004, DOI 10.1523/JNEUROSCI.4711-09.2010; Yamashita S, 2009, J THORAC CARDIOV SUR, V138, P1303, DOI 10.1016/j.jtcvs.2009.08.003; Yamashita SI, 2009, ANTICANCER RES, V29, P2753; Zeng ZL, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-181; Zou YL, 2004, J BIOL CHEM, V279, P27790, DOI 10.1074/jbc.M403042200	37	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0159954	10.1371/journal.pone.0159954	http://dx.doi.org/10.1371/journal.pone.0159954			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532268	gold, Green Published, Green Submitted			2022-12-26	WOS:000381487600017
J	Hou, J; Deng, Q; Zhou, J; Zou, J; Zhang, Y; Tan, P; Zhang, W; Cui, H				Hou, J.; Deng, Q.; Zhou, J.; Zou, J.; Zhang, Y.; Tan, P.; Zhang, W.; Cui, H.			CSN6 controls the proliferation and metastasis of glioblastoma by CHIP-mediated degradation of EGFR	ONCOGENE			English	Article							PHASE-II TRIAL; COP9 SIGNALOSOME; MALIGNANT GLIOMAS; BREAST-CANCER; GROWTH; PHOSPHORYLATION; CLASSIFICATION; SUBUNIT-6; ERLOTINIB; CHAPERONE	CSN6, a critical subunit of the constitutive photomorphogenesis 9 (COP9) signalosome (CSN), has received attention as a regulator of the degradation of cancer-related proteins such as p53, c-myc and c-Jun, through the ubiquitin-proteasome system, suggesting its importance in cancerogenesis. However, the biological functions and molecular mechanisms of CSN6 in glioblastoma (GBM) remain poorly understood. Here, we report that GBM tumors overexpressed CSN6 compared with normal brain tissues and that CSN6 promoted GBM cell proliferation, migration, invasion and tumorigenesis. Erlotinib, a small-molecule epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, was used to reveal that the proliferative and metastatic effects of CSN6 on GBM cells were EGFR dependent. We also found that CSN6 positively regulated EGFR stability via reduced levels of EGFR ubiquitination, thereby elevating steady expression of EGFR. In addition, this study is the first description of a novel role for the CSN6-interacting E3 ligase, CHIP (carboxyl terminus of heat-shock protein 70-interacting protein), regulating EGFR ubiquitination in cancer cells. We showed that CSN6 associated with CHIP and led to CHIP destabilization by increasing CHIP self-ubiquitination. Moreover, CSN6 decreased CHIP expression and increased EGFR expression in the tumor samples. Deregulation of this axis promoted GBM cell's proliferation and metastasis. Thus, our study provides insights into the applicability of using the CSN6-CHIP-EGFR axis as a potential therapeutic target in cancer.	[Hou, J.; Deng, Q.; Zou, J.; Zhang, Y.; Tan, P.; Zhang, W.; Cui, H.] Southwest Univ, Cell Biol Lab, State Key Lab Silkworm Genome Biol, Chongqing 400716, Peoples R China; [Zhou, J.] Chinese Peoples Liberat Army, Rocket Force Gen Hosp, Dept Neurosurg, Beijing, Peoples R China	Southwest University - China	Cui, H (corresponding author), Southwest Univ, Cell Biol Lab, State Key Lab Silkworm Genome Biol, Chongqing 400716, Peoples R China.	hongjuan.cui@gmail.com			Research Fund for the Doctoral Program of Higher Education of China [20130182110003]; National Basic Research Program of China [2012cb114603]; National Natural Science Foundation of China [81502574, 31501100]	Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Research Fund for the Doctoral Program of Higher Education of China (20130182110003), the National Basic Research Program of China (No. 2012cb114603) and the National Natural Science Foundation of China (81502574 and 31501100).	Ahmed SF, 2012, J BIOL CHEM, V287, P15996, DOI 10.1074/jbc.M111.321083; Cao Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116934; Chen J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6384; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; DOWNWARD J, 1984, NATURE, V311, P483, DOI 10.1038/311483a0; Fang LK, 2015, CANCER CELL, V28, P183, DOI 10.1016/j.ccell.2015.07.004; Forozan F, 2000, CANCER RES, V60, P4519; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gao SJ, 2015, ONCOTARGET, V6, P28026, DOI 10.18632/oncotarget.4731; Gusmaroli G, 2007, PLANT CELL, V19, P564, DOI 10.1105/tpc.106.047571; HSUAN JJ, 1993, ANTICANCER RES, V13, P2521; Kajiro M, 2009, NAT CELL BIOL, V11, P312, DOI 10.1038/ncb1839; Kleihues P, 2002, J NEUROPATH EXP NEUR, V61, P215, DOI 10.1093/jnen/61.3.215; Lee M. H., 2011, CELL CYCLE, V10, P3057, DOI [DOI 10.4161/CC.10.18, 10.4161/cc.10.18.17320, DOI 10.4161/CC.10.18.17320]; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Li L, 2003, TRENDS CELL BIOL, V13, P507, DOI 10.1016/j.tcb.2003.08.002; LIBERMANN TA, 1985, NATURE, V313, P144, DOI 10.1038/313144a0; Lin DC, 2015, CANCER RES, V75, P1815, DOI 10.1158/0008-5472.CAN-14-1433; Lipkowitz S, 2003, BREAST CANCER RES, V5, P8, DOI 10.1186/bcr541; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Maytal-Kivity V, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-28; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Olar A, 2014, J PATHOL, V232, P165, DOI 10.1002/path.4282; Peng ZH, 2001, PLANT CELL, V13, P2393, DOI 10.1105/tpc.13.11.2393; Raizer JJ, 2010, NEURO-ONCOLOGY, V12, P95, DOI 10.1093/neuonc/nop015; Riddick G, 2011, NAT REV NEUROL, V7, P439, DOI 10.1038/nrneurol.2011.100; Ronnebaum SM, 2013, MOL CELL BIOL, V33, P4461, DOI 10.1128/MCB.00480-13; van den Bent MJ, 2009, J CLIN ONCOL, V27, P1268, DOI 10.1200/JCO.2008.17.5984; Wang TX, 2014, ONCOTARGET, V5, P1969, DOI 10.18632/oncotarget.1890; Wei N, 2003, ANNU REV CELL DEV BI, V19, P261, DOI 10.1146/annurev.cellbio.19.111301.112449; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Xuan F, 2016, NEURO-ONCOLOGY, V18, P819, DOI 10.1093/neuonc/nov281; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	34	53	54	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 23	2017	36	8					1134	1144		10.1038/onc.2016.280	http://dx.doi.org/10.1038/onc.2016.280			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EM5SA	27546621				2022-12-26	WOS:000395371500011
J	Iyer, A; Roeters, SJ; Schilderink, N; Hommersom, B; Heeren, RMA; Woutersen, S; Claessens, MMAE; Subramaniam, V				Iyer, Aditya; Roeters, Steven J.; Schilderink, Nathalie; Hommersom, Bob; Heeren, Ron M. A.; Woutersen, Sander; Claessens, Mireille M. A. E.; Subramaniam, Vinod			The Impact of N-terminal Acetylation of alpha-Synuclein on Phospholipid Membrane Binding and Fibril Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFRARED-SPECTROSCOPY; AMYLOID FIBRILS; VIBRATIONAL SPECTROSCOPY; PARKINSONS-DISEASE; LIPID VESICLES; IN-VITRO; AGGREGATION; PROTEIN; CELLS; CONFORMATION	Human alpha-synuclein (alpha S) has been shown to be N terminally acetylated in its physiological state. This modification is proposed to modulate the function and aggregation of alpha S into amyloid fibrils. Using bacterially expressed acetylated-alpha S (NTAc-alpha S) and endogenous alpha S (Endo-alpha S) from human erythrocytes, we show that N-terminal acetylation has little impact on alpha S binding to anionic membranes and thus likely not relevant for regulating membrane affinity. N-terminal acetylation does have an effect on alpha S aggregation, resulting in a narrower distribution of the aggregation lag times and rates. 2D-IR spectra show that acetylation changes the secondary structure of alpha S in fibrils. This difference may arise from the slightly higher helical propensity of acetylated-alpha S in solution leading to a more homogenous fibril population with different fibril structure than non-acetylated alpha S. We speculate that N-terminal acetylation imposes conformational restraints on N-terminal residues in alpha S, thus predisposing alpha S toward specific interactions with other binding partners or alternatively decrease nonspecific interactions.	[Iyer, Aditya; Subramaniam, Vinod] FOM Inst AMOLF, Nanoscale Biophys Grp, Amsterdam, Netherlands; [Iyer, Aditya; Schilderink, Nathalie; Claessens, Mireille M. A. E.; Subramaniam, Vinod] Univ Twente, MESA Inst Nanotechnol, Nanobiophys Grp, Enschede, Netherlands; [Roeters, Steven J.; Woutersen, Sander] Univ Amsterdam, Vant Hoff Inst Mol Sci, Sci Pk 904, NL-1098 XH Amsterdam, Netherlands; [Hommersom, Bob; Heeren, Ron M. A.] FOM Inst AMOLF, BioImaging MS Grp, Amsterdam, Netherlands; [Heeren, Ron M. A.] Maastricht Univ, Maastricht MultiModal Mol Imaging Inst, M4I, NL-6200 MD Maastricht, Netherlands; [Subramaniam, Vinod] Vrije Univ Amsterdam, De Boelelaan 1105, NL-1081 HV Amsterdam, Netherlands	AMOLF; University of Twente; University of Amsterdam; AMOLF; Maastricht University; Vrije Universiteit Amsterdam	Woutersen, S (corresponding author), Univ Amsterdam, Vant Hoff Inst Mol Sci, Sci Pk 904, NL-1098 XH Amsterdam, Netherlands.; Subramaniam, V (corresponding author), Vrije Univ Amsterdam, De Boelelaan 1105, NL-1081 HV Amsterdam, Netherlands.; Claessens, MMAE (corresponding author), Univ Twente, Nanobiophys, Drienerlolaan 5, NL-7522 NB Enschede, Netherlands.	s.woutersen@uva.nl; m.m.a.e.claessens@utwente.nl; v.subramaniam@vu.nl	Heeren, Ron/ABA-4858-2020; Subramaniam, Vinod/B-4197-2010; Iyer, Aditya/G-4839-2014; Roeters, Steven/Q-7088-2017	Heeren, Ron/0000-0002-6533-7179; Subramaniam, Vinod/0000-0001-6712-7266; Iyer, Aditya/0000-0002-3144-6385; Roeters, Steven/0000-0003-3238-2181	Stichting voor Fundamenteel Onderzoek der Materie (FOM) [127]; European Research Council (ERC) [210999]; Netherlands Organization for Scientific Research (NWO)	Stichting voor Fundamenteel Onderzoek der Materie (FOM)(FOM (The Netherlands)); European Research Council (ERC)(European Research Council (ERC)); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was part of a project titled "A Single Molecule View on Protein Aggregation" (number 127) supported by the Stichting voor Fundamenteel Onderzoek der Materie (FOM), European Research Council (ERC) Grant 210999, and the Netherlands Organization for Scientific Research (NWO). The authors declare that they have no conflicts of interest with the contents of this article.	Alim MA, 2004, J ALZHEIMERS DIS, V6, P435; Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Arnesen T, 2009, P NATL ACAD SCI USA, V106, P8157, DOI 10.1073/pnas.0901931106; Baiz C., 2013, INTRO PROTEIN 2D IR; Bartels T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103727; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bartels T, 2010, BIOPHYS J, V99, P2116, DOI 10.1016/j.bpj.2010.06.035; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; Baum J, 2012, PROTEIN SCI, V21, P61; Bellani Serena, 2010, Commun Integr Biol, V3, P106; Bodner CR, 2009, J MOL BIOL, V390, P775, DOI 10.1016/j.jmb.2009.05.066; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Breydo L, 2012, BBA-MOL BASIS DIS, V1822, P261, DOI 10.1016/j.bbadis.2011.10.002; Buchanan L. E., 2011, EXAMINING AMYLOID ST; Buell AK, 2014, P NATL ACAD SCI USA, V111, P7671, DOI 10.1073/pnas.1315346111; Celej MS, 2009, BIOCHEMISTRY-US, V48, P7465, DOI 10.1021/bi9003843; CHAKRABARTTY A, 1993, P NATL ACAD SCI USA, V90, P11332, DOI 10.1073/pnas.90.23.11332; Cho M, 2012, NAT CHEM, V4, P339, DOI 10.1038/nchem.1336; de Almeida RFM, 2003, BIOPHYS J, V85, P2406, DOI 10.1016/S0006-3495(03)74664-5; Dearborn AD, 2016, J BIOL CHEM, V291, P2310, DOI 10.1074/jbc.M115.698787; Dikiy I, 2014, J BIOL CHEM, V289, P3652, DOI 10.1074/jbc.M113.512459; Drescher M, 2008, J AM CHEM SOC, V130, P7796, DOI 10.1021/ja801594s; Faas FGA, 2009, BIOPHYS J, V97, P1148, DOI 10.1016/j.bpj.2009.06.015; Fantini J, 2013, ADV EXP MED BIOL, V991, P15, DOI 10.1007/978-94-007-6331-9_2; Fauvet B, 2012, J BIOL CHEM, V287, P28243, DOI 10.1074/jbc.M112.383711; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Ferreira TM, 2013, PHYS CHEM CHEM PHYS, V15, P1976, DOI 10.1039/c2cp42738a; Fusco G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4827; Gath J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090659; Hellstrand E, 2013, ACS CHEM NEUROSCI, V4, P1339, DOI 10.1021/cn400066t; Huerta-Viga A, 2010, J PHYS CHEM B, V114, P15212, DOI 10.1021/jp105133r; Gallea JI, 2016, BBA-PROTEINS PROTEOM, V1864, P501, DOI 10.1016/j.bbapap.2016.01.011; JARVIS JA, 1995, J BIOL CHEM, V270, P1323, DOI 10.1074/jbc.270.3.1323; Jiang ZP, 2015, J PHYS CHEM B, V119, P4812, DOI 10.1021/jp512499r; Johnson M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015801; Kang LJ, 2012, PROTEIN SCI, V21, P911, DOI 10.1002/pro.2088; Karjalainen EL, 2011, J PHYS CHEM B, V115, P749, DOI 10.1021/jp109918c; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; Lindblom G, 2009, BBA-BIOMEMBRANES, V1788, P234, DOI 10.1016/j.bbamem.2008.08.016; Longair MH, 2011, BIOINFORMATICS, V27, P2453, DOI 10.1093/bioinformatics/btr390; Lorenzen N, 2014, FEBS LETT, V588, P497, DOI 10.1016/j.febslet.2013.12.015; Maltsev AS, 2012, BIOCHEMISTRY-US, V51, P5004, DOI 10.1021/bi300642h; Manas ES, 2000, J AM CHEM SOC, V122, P9883, DOI 10.1021/ja001782z; Marsh D, 2009, BBA-BIOMEMBRANES, V1788, P2114, DOI 10.1016/j.bbamem.2009.08.004; Middleton CT, 2012, NAT CHEM, V4, P355, DOI [10.1038/nchem.1293, 10.1038/NCHEM.1293]; Middleton ER, 2010, BIOPHYS J, V99, P2279, DOI 10.1016/j.bpj.2010.07.056; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Nuscher B, 2004, J BIOL CHEM, V279, P21966, DOI 10.1074/jbc.M401076200; Peelaerts W, 2015, NATURE, V522, P340, DOI 10.1038/nature14547; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Rabe M, 2013, ACS CHEM NEUROSCI, V4, P408, DOI 10.1021/cn3001312; Rhoades E, 2006, BIOPHYS J, V90, P4692, DOI 10.1529/biophysj.105.079251; Robotta M, 2011, CHEMPHYSCHEM, V12, P267, DOI 10.1002/cphc.201000815; Rodriguez JA, 2015, NATURE, V525, P486, DOI 10.1038/nature15368; Rossetti G, 2016, PHYS CHEM CHEM PHYS, V18, P5702, DOI 10.1039/c5cp04549e; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shvadchak VV, 2015, J PHYS CHEM B, V119, P1912, DOI 10.1021/jp5111604; Shvadchak VV, 2011, FEBS LETT, V585, P3513, DOI 10.1016/j.febslet.2011.10.006; Shvadchak VV, 2011, J BIOL CHEM, V286, P13023, DOI 10.1074/jbc.M110.204776; Sidhu A, 2014, BBA-PROTEINS PROTEOM, V1844, P2127, DOI 10.1016/j.bbapap.2014.09.007; Smith B J, 1984, Methods Mol Biol, V1, P63, DOI 10.1385/0-89603-062-8:63; Sousa Alioscka A, 2013, Methods Mol Biol, V950, P195, DOI 10.1007/978-1-62703-137-0_12; Stockl M, 2008, J MOL BIOL, V375, P1394, DOI 10.1016/j.jmb.2007.11.051; SUREWICZ WK, 1988, BIOCHIM BIOPHYS ACTA, V952, P115, DOI 10.1016/0167-4838(88)90107-0; SUSI H, 1987, ARCH BIOCHEM BIOPHYS, V258, P465, DOI 10.1016/0003-9861(87)90367-5; Theillet FX, 2016, NATURE, V530, P45, DOI 10.1038/nature16531; Trexler AJ, 2012, PROTEIN SCI, V21, P601, DOI 10.1002/pro.2056; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; van Raaij ME, 2006, BIOPHYS J, V91, pL96, DOI 10.1529/biophysj.106.090449; Wang WJ, 2011, APPL CATAL B-ENVIRON, V108, P108, DOI 10.1016/j.apcatb.2011.08.015; ZANNI M, 2011, CONCEPTS METHODS 2D; Zhou RM, 2010, MOL BIOL REP, V37, P3183, DOI 10.1007/s11033-009-9899-2	72	59	59	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					21110	21122		10.1074/jbc.M116.726612	http://dx.doi.org/10.1074/jbc.M116.726612			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27531743	Green Published, hybrid			2022-12-26	WOS:000385406200026
J	Jasinska, KK; Molfese, PJ; Kornilov, SA; Mencl, WE; Frost, SJ; Lee, M; Pugh, KR; Grigorenko, EL; Landi, N				Jasinska, Kaja K.; Molfese, Peter J.; Kornilov, Sergey A.; Mencl, W. Einar; Frost, Stephen J.; Lee, Maria; Pugh, Kenneth R.; Grigorenko, Elena L.; Landi, Nicole			The BDNF Val(66)Met Polymorphism Influences Reading Ability and Patterns of Neural Activation in Children	PLOS ONE			English	Article							DEFICIT-HYPERACTIVITY DISORDER; MESSENGER-RNA EXPRESSION; TYPICALLY DEVELOPING-CHILDREN; NEUROTROPHIC FACTOR BDNF; WORD FORM AREA; WORKING-MEMORY; VAL66MET POLYMORPHISM; EXECUTIVE FUNCTION; DEVELOPMENTAL DYSLEXIA; INDIVIDUAL-DIFFERENCES	Understanding how genes impact the brain's functional activation for learning and cognition during development remains limited. We asked whether a common genetic variant in the BDNF gene (the Val(66)Met polymorphism) modulates neural activation in the young brain during a critical period for the emergence and maturation of the neural circuitry for reading. In animal models, the bdnf variation has been shown to be associated with the structure and function of the developing brain and in humans it has been associated with multiple aspects of cognition, particularly memory, which are relevant for the development of skilled reading. Yet, little is known about the impact of the Val66Met polymorphism on functional brain activation in development, either in animal models or in humans. Here, we examined whether the BDNF Val66Met polymorphism (dbSNP rs6265) is associated with children's (age 6-10) neural activation patterns during a reading task (n = 81) using functional magnetic resonance imaging (fMRI), genotyping, and standardized behavioral assessments of cognitive and reading development. Children homozygous for the Val allele at the SNP rs6265 of the BDNF gene outperformed Met allele carriers on reading comprehension and phonological memory, tasks that have a strong memory component. Consistent with these behavioral findings, Met allele carriers showed greater activation in reading-related brain regions including the fusiform gyrus, the left inferior frontal gyrus and left superior temporal gyrus as well as greater activation in the hippocampus during a word and pseudoword reading task. Increased engagement of memory and spoken language regions for Met allele carriers relative to Val/Val homozygotes during reading suggests that Met carriers have to exert greater effort required to retrieve phonological codes.	[Jasinska, Kaja K.; Molfese, Peter J.; Kornilov, Sergey A.; Mencl, W. Einar; Frost, Stephen J.; Pugh, Kenneth R.; Grigorenko, Elena L.; Landi, Nicole] Haskins Labs Inc, 270 Crown St, New Haven, CT 06511 USA; [Molfese, Peter J.; Pugh, Kenneth R.; Landi, Nicole] Univ Connecticut, Storrs, CT USA; [Mencl, W. Einar; Lee, Maria; Pugh, Kenneth R.; Grigorenko, Elena L.; Landi, Nicole] Yale Univ, New Haven, CT USA; [Kornilov, Sergey A.; Grigorenko, Elena L.] Univ Houston, Houston, TX USA; [Kornilov, Sergey A.; Grigorenko, Elena L.] Baylor Coll Med, Houston, TX 77030 USA; [Kornilov, Sergey A.] Moscow MV Lomonosov State Univ, Moscow, Russia; [Kornilov, Sergey A.; Grigorenko, Elena L.] St Petersburg State Univ, St Petersburg, Russia; [Grigorenko, Elena L.] Moscow City Univ Psychol & Educ, Moscow, Russia	Yale University; Haskins Laboratories; University of Connecticut; Yale University; University of Houston System; University of Houston; Baylor College of Medicine; Lomonosov Moscow State University; Saint Petersburg State University; Moscow State University of Psychology & Education	Jasinska, KK (corresponding author), Haskins Labs Inc, 270 Crown St, New Haven, CT 06511 USA.	kaja.jasinska@yale.edu	Kornilov, Sergey/F-1234-2010; landi, nicole/ABG-5374-2020; Grigorenko, Elena/V-2418-2019; Jasińska, Kaja/D-3344-2019; Landi, Nicole/P-2954-2014	Kornilov, Sergey/0000-0002-8378-110X; Jasińska, Kaja/0000-0002-8851-1627; Landi, Nicole/0000-0003-2890-2519	National Institutes of Health [R01 HD 048830, P01 HD052120, P01 HD 001994, R03 HD053409]; Government of the Russian Federation [14.Z50.31.0027]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD001994, P50HD052120] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD048830, R03HD053409] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Government of the Russian Federation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by National Institutes of Health grants R01 HD 048830 (K. Pugh, PI); P01 HD052120, (R. Wagner, PI); P01 HD 001994 Project 4: Examinations of skilled and impaired spoken and written comprehension, (Project Leader: Nicole Landi; P01 PI: Jay G. Rueckl); R03 HD053409 (N. Landi, PI); and Grant no. 14.Z50.31.0027 from the Government of the Russian Federation (PI: Elena L. Grigorenko). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by National Institutes of Health grants R01 HD 048830 (K. Pugh, PI); P01 HD052120, (R. Wagner, PI); P01 HD 001994 Project 4: Examinations of skilled and impaired spoken and written comprehension, (Project Leader: Nicole Landi; P01 PI: Jay G. Rueckl); R03 HD053409 (N. Landi, PI); and Grant no. 14.Z50.31.0027 from the Government of the Russian Federation (PI: Elena L. Grigorenko). We also want to thank Beth Eaton and Annie Stutzman for behavioral assessment of children, as well as Teri Hickey, Hedy Serofin and Cheryl McMurray for imaging participants, and Cheryl Lacadie for fMRI preprocessing. We are exceptionally grateful to the families and children who participated in this study, and extend a special thanks to the Windward School for their collaboration. Note that grantees undertaking such projects are encouraged to express freely their professional judgment. This article, therefore, does not necessarily reflect the position or policies of the National Institutes of Health and no official endorsement should be inferred.	Alfimova MV, 2012, B EXP BIOL MED+, V152, P606, DOI 10.1007/s10517-012-1587-x; Alloway TP, 2004, J EXP CHILD PSYCHOL, V87, P85, DOI 10.1016/j.jecp.2003.10.002; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Axmacher N, 2010, P NATL ACAD SCI USA, V107, P3228, DOI 10.1073/pnas.0911531107; Baddeley A., 1987, WORKING MEMORY; Baddeley A, 2011, J COGNITIVE NEUROSCI, V23, P3855, DOI 10.1162/jocn_a_00066; Baj G, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00188; Bath KG, 2006, COGN AFFECT BEHAV NE, V6, P79, DOI 10.3758/CABN.6.1.79; BENES FM, 1994, ARCH GEN PSYCHIAT, V51, P477; Beneventi H, 2010, INT J NEUROSCI, V120, P51, DOI 10.3109/00207450903275129; Berninger VW, 2008, DEV NEUROPSYCHOL, V33, P707, DOI 10.1080/87565640802418662; Beste C, 2011, NEUROPHARMACOLOGY, V60, P467, DOI 10.1016/j.neuropharm.2010.10.028; Bookheimer S, 2002, ANNU REV NEUROSCI, V25, P151, DOI 10.1146/annurev.neuro.25.112701.142946; Brooks SJ, 2014, PLOS ONE, V9, DOI 10. 1371/journal.pone.0082707; Brouwer RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032316; Brunswick N, 1999, BRAIN, V122, P1901, DOI 10.1093/brain/122.10.1901; Bucci DJ, 2014, NEUROBIOL LEARN MEM, V116, P197, DOI 10.1016/j.nlm.2014.05.007; Bussing R, 2008, ASSESSMENT, V15, P317, DOI 10.1177/1073191107313888; Cain K, 2004, J EDUC PSYCHOL, V96, P31, DOI 10.1037/0022-0663.96.1.31; Caplan D, 2000, HUM BRAIN MAPP, V9, P65; Chein JM, 2010, PSYCHON B REV, V17, P193, DOI 10.3758/PBR.17.2.193; Chein JM, 2005, COGNITIVE BRAIN RES, V25, P607, DOI 10.1016/j.cogbrainres.2005.08.013; Chen G, 2013, NEUROIMAGE, V73, P176, DOI 10.1016/j.neuroimage.2013.01.047; Chiang MC, 2011, NEUROIMAGE, V55, P448, DOI 10.1016/j.neuroimage.2010.12.053; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; Davis MH, 2009, PHILOS T R SOC B, V364, P3773, DOI 10.1098/rstb.2009.0111; Davis MH, 2009, J COGNITIVE NEUROSCI, V21, P803, DOI 10.1162/jocn.2009.21059; Dehaene S, 2011, TRENDS COGN SCI, V15, P254, DOI 10.1016/j.tics.2011.04.003; Dennis MY, 2009, PLOS GENET, V5, P1, DOI DOI 10.1371/J0URNAL.PGEN.1000436; Dincheva I, 2012, NEUROSCIENTIST, V18, P439, DOI 10.1177/1073858411431646; DUGICHDJORDJEVIC MM, 1992, NEURON, V8, P1127, DOI 10.1016/0896-6273(92)90133-X; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Fiebach CJ, 2002, J COGNITIVE NEUROSCI, V14, P11, DOI 10.1162/089892902317205285; Frielingsdorf H, 2010, ANN NY ACAD SCI, V1208, P150, DOI 10.1111/j.1749-6632.2010.05722.x; Frost SJ, 2008, NEW DIRECTIONS COMMU, P355; Frost SJ, 2009, ANN DYSLEXIA, V59, P78, DOI 10.1007/s11881-009-0024-y; Galloway EM, 2008, PROG BRAIN RES, V169, P251, DOI 10.1016/S0079-6123(07)00015-5; Galvan A, 2010, HUM BRAIN MAPP, V31, P879, DOI 10.1002/hbm.21029; Gathercole SE, 2004, DEV PSYCHOL, V40, P177, DOI 10.1037/0012-1649.40.2.177; Gathercole SE, 2005, J CHILD PSYCHOL PSYC, V46, P598, DOI 10.1111/j.1469-7610.2004.00379.x; Gerritsen L, 2012, MOL PSYCHIATR, V17, P597, DOI 10.1038/mp.2011.51; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Giedd JN, 2009, J AM ACAD CHILD PSY, V48, P465, DOI 10.1097/CHI.0b013e31819f2715; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Goldberg TE, 2008, BIOL PSYCHOL, V77, P20, DOI 10.1016/j.biopsycho.2007.08.009; Gong PY, 2009, J MOL NEUROSCI, V38, P250, DOI 10.1007/s12031-009-9205-8; Goswami U, 2008, EDUC RES-UK, V50, P135, DOI 10.1080/00131880802082625; Hansell NK, 2007, GENES BRAIN BEHAV, V6, P260, DOI 10.1111/j.1601-183X.2006.00254.x; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Henderson L, 2013, J EXP CHILD PSYCHOL, V116, P572, DOI 10.1016/j.jecp.2013.07.004; Hoeft F, 2011, P NATL ACAD SCI USA, V108, P361, DOI 10.1073/pnas.1008950108; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; Huey E, 2012, DEMENT GERIATR COGN, V33, P81; HUNTLEY GW, 1992, DEV BRAIN RES, V70, P53, DOI 10.1016/0165-3806(92)90103-4; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Kambeitz JP, 2012, NEUROSCI BIOBEHAV R, V36, P2165, DOI 10.1016/j.neubiorev.2012.07.002; Karege F, 2002, NEUROSCI LETT, V328, P261, DOI 10.1016/S0304-3940(02)00529-3; Kharitonova M, 2013, DEV COGN NEUROS-NETH, V6, P61, DOI 10.1016/j.dcn.2013.07.002; KNUSEL B, 1994, J NEUROSCI, V14, P1542, DOI 10.1523/JNEUROSCI.14-03-01542.1994; Kovas Y, 2007, CURR DIR PSYCHOL SCI, V16, P284, DOI 10.1111/j.1467-8721.2007.00521.x; Landi N, 2013, READ WRIT Q, V29, P145, DOI 10.1080/10573569.2013.758566; Landi N, 2010, ANN DYSLEXIA, V60, P102, DOI 10.1007/s11881-009-0029-6; Lee J, 2007, AM J MED GENET B, V144B, P976, DOI 10.1002/ajmg.b.30437; Li BJ, 2010, EUR J PHARMACOL, V628, P104, DOI 10.1016/j.ejphar.2009.11.036; Loosli Sandra V, 2012, Child Neuropsychol, V18, P62, DOI 10.1080/09297049.2011.575772; Mandelman SD, 2012, GENES BRAIN BEHAV, V11, P127, DOI 10.1111/j.1601-183X.2011.00738.x; McCallum RS, 2006, J PSYCHOEDUC ASSESS, V24, P243, DOI 10.1177/0734282906287938; McCandliss BD, 2003, TRENDS COGN SCI, V7, P293, DOI 10.1016/S1364-6613(03)00134-7; McGrath LM, 2006, TRENDS MOL MED, V12, P333, DOI 10.1016/j.molmed.2006.05.007; Milner B., 1966, AMNESIA, P109; Montag C, 2009, PSYCHOL MED, V39, P1831, DOI 10.1017/S0033291709005509; Mowla SJ, 2001, J BIOL CHEM, V276, P12660, DOI 10.1074/jbc.M008104200; Nakajo Y, 2008, BRAIN RES, V1241, P103, DOI 10.1016/j.brainres.2008.08.080; Padmanabhan A, 2008, BIOL PSYCHIAT, V63, p76S; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; PERFETTI CA, 1976, J VERB LEARN VERB BE, V15, P33, DOI 10.1016/S0022-5371(76)90004-9; Petitto LA, 2000, P NATL ACAD SCI USA, V97, P13961, DOI 10.1073/pnas.97.25.13961; Philipose LE, 2007, ANN NEUROL, V62, P481, DOI 10.1002/ana.21182; Plomin R, 2005, PSYCHOL BULL, V131, P592, DOI 10.1037/0033-2909.131.4.592; Plomin R, 2007, MIND BRAIN EDUC, V1, P11, DOI 10.1111/j.1751-228X.2007.00002.x; Preston JL, 2012, J SPEECH LANG HEAR R, V55, P1068, DOI 10.1044/1092-4388(2011/11-0056); Preston JL, 2010, BRAIN, V133, P2185, DOI 10.1093/brain/awq163; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Pugh KR, 2014, J NEUROSCI, V34, P4082, DOI 10.1523/JNEUROSCI.3907-13.2014; Pugh KR, 2013, BRAIN LANG, V125, P173, DOI 10.1016/j.bandl.2012.04.004; Pugh KR, 2000, MENT RETARD DEV D R, V6, P207, DOI 10.1002/1098-2779(2000)6:3<207::AID-MRDD8>3.0.CO;2-P; Raskind WH, 2013, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00601; Reiss AL, 1996, BRAIN, V119, P1763, DOI 10.1093/brain/119.5.1763; Richter-Schmidinger T, 2011, J NEURAL TRANSM, V118, P249, DOI 10.1007/s00702-010-0539-8; Roskies AL, 2001, J COGNITIVE NEUROSCI, V13, P829, DOI 10.1162/08989290152541485; Scassellati C, 2014, EUR CHILD ADOLES PSY, V23, P173, DOI 10.1007/s00787-013-0447-1; Schlaggar BL, 2007, ANNU REV NEUROSCI, V30, P475, DOI 10.1146/annurev.neuro.28.061604.135645; Schumacher J, 2006, AM J HUM GENET, V78, P52, DOI 10.1086/498992; Shaywitz BA, 2002, BIOL PSYCHIAT, V52, P101, DOI 10.1016/S0006-3223(02)01365-3; Shaywitz BA, 1996, NEUROSCIENTIST, V2, P245, DOI 10.1177/107385849600200413; Shim SH, 2008, PROG NEURO-PSYCHOPH, V32, P1824, DOI 10.1016/j.pnpbp.2008.08.005; Silhol M, 2005, NEUROSCIENCE, V132, P613, DOI 10.1016/j.neuroscience.2005.01.008; Simmons TR, 2010, HUM HERED, V70, P232, DOI 10.1159/000320367; Skiba T, 2011, BEHAV GENET, V41, P6, DOI 10.1007/s10519-011-9444-7; Smith DJ, 2004, J PSYCHOPHARMACOL, V18, pA18; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; STANOVICH KE, 1986, READ RES QUART, V21, P360, DOI 10.1598/RRQ.21.4.1; Sterner KN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037714; Swanson HL, 2007, J EXP CHILD PSYCHOL, V96, P249, DOI 10.1016/j.jecp.2006.12.004; Swanson HL, 2003, J EXP CHILD PSYCHOL, V85, P1, DOI 10.1016/S0022-0965(03)00043-2; SWANSON HL, 1995, INTELLIGENCE, V21, P83, DOI 10.1016/0160-2896(95)90040-3; Swanson J., 1982, SNAP RATING SCALE; Tamminen J, 2012, COGNITION, V125, P107, DOI 10.1016/j.cognition.2012.06.014; Tamnes CK, 2013, J COGNITIVE NEUROSCI, V25, P1611, DOI 10.1162/jocn_a_00434; The R Core Team, 2013, R LANG ENV STAT COMP, DOI [10.1016/j.neuroimage.2007.07.007, DOI 10.1016/J.NEUROIMAGE.2007.07.007]; Tost H, 2013, NEUROPSYCHOPHARMACOL, V38, P525, DOI 10.1038/npp.2012.214; Tsai CL, 2014, PSYCHONEUROENDOCRINO, V41, P121, DOI 10.1016/j.psyneuen.2013.12.014; TURNER ML, 1989, J MEM LANG, V28, P127, DOI 10.1016/0749-596X(89)90040-5; Ursini G, 2012, BIOL PSYCHIAT, V71, p90S; Varvara P, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00120; Waber DP, 2007, J INT NEUROPSYCH SOC, V13, P729, DOI 10.1017/S1355617707070841; Wagner RK, 2009, USING COMPREHENSIVE, P585; Wang L, 2012, GENES BRAIN BEHAV, V11, P352, DOI 10.1111/j.1601-183X.2012.00764.x; Webster MJ, 2006, GENE EXPR PATTERNS, V6, P941, DOI 10.1016/j.modgep.2006.03.009; Webster MJ, 2002, DEV BRAIN RES, V139, P139, DOI 10.1016/S0165-3806(02)00540-0; Wechsler D, 2011, WECHSLER ABBREVIATED; Yang XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037777; Yogeetha BS, 2013, MOL BIOL REP, V40, P5483, DOI 10.1007/s11033-013-2648-6; Yonelinas AP, 2013, BEHAV BRAIN RES, V254, P34, DOI 10.1016/j.bbr.2013.05.030; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946; Zeni CP, 2012, BIPOLAR DISORD, V14, P48; Ziegler E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069290; Ziegler G, 2013, NEUROIMAGE, V82, P284, DOI 10.1016/j.neuroimage.2013.05.088	130	22	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0157449	10.1371/journal.pone.0157449	http://dx.doi.org/10.1371/journal.pone.0157449			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27551971	Green Published, Green Submitted, gold			2022-12-26	WOS:000381768800002
J	Takele, Y; Adem, E; Getahun, M; Tajebe, F; Kiflie, A; Hailu, A; Raynes, J; Mengesha, B; Ayele, TA; Shkedy, Z; Lemma, M; Diro, E; Toulza, F; Modolell, M; Munder, M; Muller, I; Kropf, P				Takele, Y.; Adem, E.; Getahun, M.; Tajebe, F.; Kiflie, A.; Hailu, A.; Raynes, J.; Mengesha, B.; Ayele, T. A.; Shkedy, Z.; Lemma, M.; Diro, E.; Toulza, F.; Modolell, M.; Munder, M.; Mueller, I.; Kropf, P.			Malnutrition in Healthy Individuals Results in Increased Mixed Cytokine Profiles, Altered Neutrophil Subsets and Function	PLOS ONE			English	Article							PROTEIN-ENERGY MALNUTRITION; VISCERAL LEISHMANIASIS; ARGINASE ACTIVITY; IMMUNE-SYSTEM; DEVELOPING-COUNTRIES; NUTRITIONAL-STATUS; ANOREXIA-NERVOSA; CHILDREN; MACROPHAGES; MORBIDITY	Malnutrition is commonly associated with increased infectious disease susceptibility and severity. Whereas malnutrition might enhance the incidence of disease as well as its severity, active infection can in turn exacerbate malnutrition. Therefore, in a malnourished individual suffering from a severe infection, it is not possible to determine the contribution of the pre-existing malnutrition and/or the infection itself to increased disease severity. In the current study we focussed on two groups of malnourished, but otherwise healthy individuals: moderately malnourished (BMI: 18.4-16.5) and severely malnourished (BMI < 16.5) and compared several immune parameters with those of individuals with a normal BMI (>= 18.5). Our results show a similar haematological profile in all three groups, as well as a similar ratio of CD4(+) and CD8(+) T cells. We found significant correlations between low BMI and increased levels of T helper (Th) 1 (Interferon (IFN)-gamma, (interleukin (IL)-2, IL-12), Th2 (IL-4, IL-5, IL-13), as well as IL-10, IL-33 and tumor necrosis factor-alpha, but not IL-8 or C reactive protein. The activities of arginase, an enzyme associated with immunosuppression, were similar in plasma, peripheral blood mononuclear cells (PBMC) and neutrophils from all groups and no differences in the expression levels of CD3 zeta, a marker of T cell activation, were observed in CD4(+) and CD8(+) T cells. Furthermore, whereas the capacity of neutrophils from the malnourished groups to phagocytose particles was not impaired, their capacity to produce reactive oxygen species was impaired. Finally we evaluated the frequency of a subpopulation of low-density neutrophils and show that they are significantly increased in the malnourished individuals. These differences were more pronounced in the severely malnourished group. In summary, our results show that even in the absence of apparent infections, healthy malnourished individuals display dysfunctional immune responses that might contribute to increased susceptibility and severity to infectious diseases.	[Takele, Y.; Mueller, I.; Kropf, P.] Imperial Coll London, Dept Med, London, England; [Takele, Y.; Mengesha, B.] Gondar Univ, Leishmaniasis Res & Treatment Ctr, Gondar, Ethiopia; [Adem, E.; Getahun, M.; Tajebe, F.; Kiflie, A.; Lemma, M.] Univ Gondar, Dept Immunol, Gondar, Ethiopia; [Hailu, A.] Univ Addis Ababa, Dept Microbiol Immunol & Parasitol, Addis Ababa, Ethiopia; [Raynes, J.; Toulza, F.] London Sch Hyg & Trop Med, Dept Immunol & Infect, London, England; [Ayele, T. A.] Univ Gondar, Dept Epidemiol & Biostat, Gondar, Ethiopia; [Shkedy, Z.] Univ Hasselt, Dept Math & Stat, Hasselt, Belgium; [Diro, E.] Univ Gondar, Dept Internal Med, Gondar, Ethiopia; [Modolell, M.] Max Planck Inst Immunobiol & Epigenet, Dept Cellular Immunol, Freiburg, Germany; [Munder, M.] Univ Med Ctr Mainz, Dept Med Hematol Oncol & Pneumol 3, Mainz, Germany	Imperial College London; University of Gondar; University of Gondar; Addis Ababa University; University of London; London School of Hygiene & Tropical Medicine; University of Gondar; Hasselt University; University of Gondar; Max Planck Society; Johannes Gutenberg University of Mainz	Kropf, P (corresponding author), Imperial Coll London, Dept Med, London, England.	p.kropf@imperial.ac.uk	Raynes, John G/G-7932-2011; Hailu, Asrat/AAM-6982-2020; Shkedy, Ziv/AAQ-3096-2020; Munder, Markus/K-6737-2013	Raynes, John G/0000-0002-8536-1328; Shkedy, Ziv/0000-0002-6306-0823; Takele, Yegnasew/0000-0003-1070-7459; Alemayehu, Amare/0000-0002-2205-7767; Toulza, Frederic/0000-0002-1104-5795	Wellcome Trust [104028/B/14/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	The authors would like to also thank DNDi for their in-kind support in funding the staff of Gondar University Leishmaniasis Research and Treatment Centre. Yegnasew Takele is supported by a fellowship from The Wellcome Trust (104028/B/14/Z).	Abebe T, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002134; ADAMS EB, 1969, AM J CLIN NUTR, V22, P1634; Alcoba G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053184; Altman BJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008763; Bain LE, 2013, PAN AFR MED J, V15, DOI 10.11604/pamj.2013.15.120.2535; Bhutta ZA, 2012, ANN NUTR METAB, V61, P19, DOI 10.1159/000345167; Bowers NL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003993; BRANCA F, 1993, EUR J CLIN NUTR, V47, P840; CHANDRA R K, 1991, Nutrition Research Reviews, V4, P83, DOI 10.1079/NRR19910009; Chandra RK, 1999, P NUTR SOC, V58, P681, DOI 10.1017/S0029665199000890; Chandra RK, 2002, EUR J CLIN NUTR, V56, pS73, DOI 10.1038/sj.ejcn.1601492; Cloke TE, 2010, J INFECT DIS, V202, P374, DOI 10.1086/653736; Corware K, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-51; DELAFUENTE M, 1992, ANN NUTR METAB, V36, P41, DOI 10.1159/000177697; Dubois B, 1997, BADKEY J NAME LOST, P26988, DOI [10.1186/1743-7075-11-51, DOI 10.1186/1743-7075-11-51]; Fock RA, 2010, INFLAMMATION, V33, P101, DOI 10.1007/s10753-009-9163-x; Goto H, 2009, REV I MED TROP, V51, P241, DOI 10.1590/S0036-46652009000500002; Hutter G, 2009, INT J EAT DISORDER, V42, P293, DOI 10.1002/eat.20610; Kheloufi M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/701064; Kropf P, 2005, FASEB J, V19, P1000, DOI 10.1096/fj.04-3416fje; Kropf P, 2007, EUR J IMMUNOL, V37, P935, DOI 10.1002/eji.200636542; KUIJPERS TW, 1991, BLOOD, V78, P1105; Ma YT, 2013, IMMUNITY, V39, P211, DOI 10.1016/j.immuni.2013.07.017; MARCOS A, 1993, EUR J CLIN NUTR, V47, P787; Marcos A, 2003, EUR J CLIN NUTR, V57, pS66, DOI 10.1038/sj.ejcn.1601819; MOLOFSKY AB, 2015, IMMUNITY, V42, P1005, DOI [DOI 10.1016/j.immuni.2015.06.006, DOI 10.1016/J.IMMUNI.2015.06.006]; Muller I, 2009, TRENDS IMMUNOL, V30, P522, DOI 10.1016/j.it.2009.07.007; Muller O, 2005, CAN MED ASSOC J, V173, P279, DOI 10.1503/cmaj.050342; Munder M, 2009, BRIT J PHARMACOL, V158, P638, DOI 10.1111/j.1476-5381.2009.00291.x; Najera O, 2001, CLIN EXP IMMUNOL, V126, P461, DOI 10.1046/j.1365-2249.2001.01694.x; Nylen S, 2007, TRENDS IMMUNOL, V28, P378, DOI 10.1016/j.it.2007.07.004; Organization WH, 1995, TROP DIS RES PROGR 1, P135; Perez-Mazliah D, 2015, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00671; Qadri F, 2013, VACCINE, V31, P452, DOI 10.1016/j.vaccine.2012.11.012; REDMOND HP, 1991, ARCH SURG-CHICAGO, V126, P192, DOI 10.1001/archsurg.1991.01410260080011; Rodriguez L, 2005, CLIN DIAGN LAB IMMUN, V12, P502, DOI 10.1128/CDLI.12.4.502-507.2005; Rodriguez L, 2011, INT J ENV RES PUB HE, V8, P1174, DOI 10.3390/ijerph8041174; Schaffer MR, 1997, J AM COLL SURGEONS, V184, P37; Schaible UE, 2007, PLOS MED, V4, P806, DOI 10.1371/journal.pmed.0040115; Shankar AH, 2000, J INFECT DIS, V182, pS37, DOI 10.1086/315906; Solmi M, 2015, PSYCHONEUROENDOCRINO, V51, P237, DOI 10.1016/j.psyneuen.2014.09.031; Takele Y, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001977; Thakur N, 2014, NUTRITION, V30, P440, DOI 10.1016/j.nut.2013.09.011; TOMKINS AM, 1989, T ROY SOC TROP MED H, V83, P282, DOI 10.1016/0035-9203(89)90681-0; Wasunna KM, 1995, T ROY SOC TROP MED H, V89, P678, DOI 10.1016/0035-9203(95)90442-5; White JV, 2012, JPEN-PARENTER ENTER, V36, P275, DOI 10.1177/0148607112440285; Woodward B, 1998, NUTR REV, V56, pS84; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765	48	25	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0157919	10.1371/journal.pone.0157919	http://dx.doi.org/10.1371/journal.pone.0157919			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548305	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000381768400003
J	Elhenawy, W; Davis, RM; Fero, J; Salama, NR; Felman, MF; Ruiz, N				Elhenawy, Wael; Davis, Rebecca M.; Fero, Jutta; Salama, Nina R.; Felman, Mario F.; Ruiz, Natividad			The O-Antigen Flippase Wzk Can Substitute for MurJ in Peptidoglycan Synthesis in Helicobacter pylori and Escherichia coli	PLOS ONE			English	Article							LIPID II FLIPPASE; GLYCOPROTEIN-BIOSYNTHESIS; GENE DISRUPTION; IDENTIFICATION; MVIN; PRECURSORS; RESISTANCE; SYSTEM; LIPOPOLYSACCHARIDE; RECOMBINATION	The peptidoglycan (PG) cell wall is an essential component of the cell envelope of most bacteria. Biogenesis of PG involves a lipid-linked disaccharide-pentapeptide intermediate called lipid II, which must be translocated across the cytoplasmic membrane after it is synthesized in the inner leaflet of this bilayer. Accordingly, it has been demonstrated that MurJ, the proposed lipid II flippase in Escherichia coli, is required for PG biogenesis, and thereby viability. In contrast, MurJ is not essential in Bacillus subtilis because this bacterium produces AmJ, an unrelated protein that is functionally redundant with MurJ. In this study, we investigated why MurJ is not essential in the prominent gastric pathogen, Helicobacter pylori. We found that in this bacterium, Wzk, the ABC (ATP-binding cassette) transporter that flips the lipid-linked O- or Lewis- antigen precursors across the inner membrane, is redundant with MurJ for cell viability. Heterologous expression of wzk in E. coli also suppresses the lethality caused by the loss of murJ. Furthermore, we show that this cross-species complementation is abolished when Wzk is inactivated by mutations that target a domain predicted to be required for ATPase activity. Our results suggest that Wzk can flip lipid II, implying that Wzk is the flippase with the most relaxed specificity for lipid-linked saccharides ever identified.	[Elhenawy, Wael; Felman, Mario F.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Davis, Rebecca M.; Ruiz, Natividad] Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA; [Fero, Jutta; Salama, Nina R.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; [Felman, Mario F.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	University of Alberta; University System of Ohio; Ohio State University; Fred Hutchinson Cancer Center; Washington University (WUSTL)	Ruiz, N (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA.	ruiz.82@osu.edu	Salama, Nina Reda/AAG-2437-2019	Salama, Nina Reda/0000-0003-2762-1424; Elhenawy, Wael/0000-0002-4599-8500; Ruiz, Natividad/0000-0002-6369-2206	Natural Sciences and Engineering Research Council of Canada; National Institute of General Medical Sciences [R01GM100951]; National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01AI094839]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI094839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100951] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Natural Sciences and Engineering Research Council of Canada (to MFF; http://www.nserc-crsng.gc.ca/index_eng.asp), and the National Institute of General Medical Sciences (award number R01GM100951 to NR) and the National Institute of Allergy and Infectious Diseases (award number R01AI094839 to NRS) of the National Institutes of Health (https://www.nih.gov/).	Alaimo C, 2006, EMBO J, V25, P967, DOI 10.1038/sj.emboj.7601024; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barreteau H, 2008, FEMS MICROBIOL REV, V32, P168, DOI 10.1111/j.1574-6976.2008.00104.x; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bouhss A, 2008, FEMS MICROBIOL REV, V32, P208, DOI 10.1111/j.1574-6976.2007.00089.x; Bugg TDH, 2011, TRENDS BIOTECHNOL, V29, P167, DOI 10.1016/j.tibtech.2010.12.006; Butler EK, 2014, J BACTERIOL, V196, P4111, DOI 10.1128/JB.02172-14; Butler EK, 2013, J BACTERIOL, V195, P4639, DOI 10.1128/JB.00731-13; CHATTERJEE AN, 1964, P NATL ACAD SCI USA, V51, P9, DOI 10.1073/pnas.51.1.9; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Cuthbertson L, 2010, MICROBIOL MOL BIOL R, V74, P341, DOI 10.1128/MMBR.00009-10; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; DEBOER PAJ, 1989, CELL, V56, P641, DOI 10.1016/0092-8674(89)90586-2; Dykxhoorn DM, 1996, GENE, V177, P133, DOI 10.1016/0378-1119(96)00289-2; Fay A, 2009, J BACTERIOL, V191, P6020, DOI 10.1128/JB.00605-09; Feldman MF, 1999, J BIOL CHEM, V274, P35129, DOI 10.1074/jbc.274.49.35129; Helenius J, 2002, NATURE, V415, P447, DOI 10.1038/415447a; Hong YQ, 2014, J BACTERIOL, V196, P1713, DOI 10.1128/JB.01323-13; Hong YQ, 2012, MOL MICROBIOL, V84, P620, DOI 10.1111/j.1365-2958.2012.08048.x; HORTON RM, 1995, MOL BIOTECHNOL, V3, P93, DOI 10.1007/BF02789105; Huber J, 2009, CHEM BIOL, V16, P837, DOI 10.1016/j.chembiol.2009.05.012; Hug I, 2011, GLYCOBIOLOGY, V21, P138, DOI 10.1093/glycob/cwq148; Hug I, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000819; Humbert O, 2008, NUCLEIC ACIDS RES, V36, P6893, DOI 10.1093/nar/gkn718; Hvorup RN, 2003, EUR J BIOCHEM, V270, P799, DOI 10.1046/j.1432-1033.2003.03418.x; Inoue A, 2008, J BACTERIOL, V190, P7298, DOI 10.1128/JB.00551-08; Islam ST, 2014, CAN J MICROBIOL, V60, P697, DOI 10.1139/cjm-2014-0595; Islam ST, 2013, ENVIRON MICROBIOL, V15, P1001, DOI 10.1111/j.1462-2920.2012.02890.x; Jelk J, 2013, J BIOL CHEM, V288, P20616, DOI 10.1074/jbc.M113.479642; Jorgenson MA, 2016, MOL MICROBIOL, V100, P1, DOI 10.1111/mmi.13284; Linton D, 2005, MOL MICROBIOL, V55, P1695, DOI 10.1111/j.1365-2958.2005.04519.x; LIU D, 1994, MICROBIOL-UK, V140, P49, DOI 10.1099/13500872-140-1-49; Marolda CL, 2004, MICROBIOL-SGM, V150, P4095, DOI 10.1099/mic.0.27456-0; MEADOW PM, 1964, BIOCHEM BIOPH RES CO, V14, P382, DOI 10.1016/S0006-291X(64)80014-0; Meeske AJ, 2015, P NATL ACAD SCI USA, V112, P6437, DOI 10.1073/pnas.1504967112; MENARD R, 1993, ANTIMICROB AGENTS CH, V37, P78, DOI 10.1128/AAC.37.1.78; MENGINLECREULX D, 1991, J BACTERIOL, V173, P4625, DOI 10.1128/jb.173.15.4625-4636.1991; Mohamed YF, 2014, GLYCOBIOLOGY, V24, P564, DOI 10.1093/glycob/cwu025; Mohammadi T, 2011, EMBO J, V30, P1425, DOI 10.1038/emboj.2011.61; Musumeci MA, 2014, GLYCOBIOLOGY, V24, P39, DOI 10.1093/glycob/cwt087; Perez C, 2015, NATURE, V524, P433, DOI 10.1038/nature14953; Ranjit DK, 2016, J BACTERIOL, V198, P1230, DOI 10.1128/JB.01034-15; Rudnick PA, 2001, J BACTERIOL, V183, P2682, DOI 10.1128/JB.183.8.2682-2685.2001; Ruiz N, 2008, P NATL ACAD SCI USA, V105, P15553, DOI 10.1073/pnas.0808352105; Ruiz Natividad, 2015, Lipid Insights, V8, P21, DOI 10.4137/LPI.S31783; Ruiz N, 2009, ANTIMICROB AGENTS CH, V53, P3604, DOI 10.1128/AAC.00578-09; Salama NR, 2004, J BACTERIOL, V186, P7926, DOI 10.1128/JB.186.23.7926-7935.2004; Sanabria-Valentin E, 2007, MICROBES INFECT, V9, P1553, DOI 10.1016/j.micinf.2007.08.011; Sham LT, 2014, SCIENCE, V345, P220, DOI 10.1126/science.1254522; Silhavy T.J., 1984, EXPT GENE FUSIONS; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Sycuro LK, 2013, MOL MICROBIOL, V90, P869, DOI 10.1111/mmi.12405; Taylor VL, 2017, CURR TOP MICROBIOL, V404, P95, DOI 10.1007/82_2015_5014; Thanassi JA, 2002, NUCLEIC ACIDS RES, V30, P3152, DOI 10.1093/nar/gkf418; Turner RD, 2014, MOL MICROBIOL, V91, P862, DOI 10.1111/mmi.12513; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; Typas A, 2010, CELL, V143, P1097, DOI 10.1016/j.cell.2010.11.038; Vasudevan P, 2009, J BACTERIOL, V191, P6012, DOI 10.1128/JB.00604-09; Vollmer W, 2008, BBA-BIOMEMBRANES, V1778, P1714, DOI 10.1016/j.bbamem.2007.06.007; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Vollmer W, 2010, TRENDS MICROBIOL, V18, P59, DOI 10.1016/j.tim.2009.12.004; Wang G, 2000, MOL MICROBIOL, V36, P1187, DOI 10.1046/j.1365-2958.2000.01934.x; Yan AX, 2007, J BIOL CHEM, V282, P36077, DOI 10.1074/jbc.M706172200; Young KD, 2014, SCIENCE, V345, P139, DOI 10.1126/science.1256585; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597	67	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161587	10.1371/journal.pone.0161587	http://dx.doi.org/10.1371/journal.pone.0161587			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537185	Green Published, gold, Green Submitted			2022-12-26	WOS:000381577000124
J	Guo, J; Wang, M; Wang, ZS; Liu, XH				Guo, Jia; Wang, Min; Wang, Zhishun; Liu, Xiuheng			Overexpression of Pleomorphic Adenoma Gene-Like 2 Is a Novel Poor Prognostic Marker of Prostate Cancer	PLOS ONE			English	Article							ZINC-FINGER PROTEIN; FAMILY-MEMBERS; EXPRESSION; PLAGL2; CELLS; RISK	Pleomorphic adenoma gene like-2 (PLAGL2) is a member of the PLAG gene family. Previous studies have revealed that overexpression of PLAGL2 is associated with many human cancers. However, it has been reported that PLAGL2 also plays as a tumor suppressor. The precise role of PLAGL2 in prostate cancer (PCa) is still unknown. The aim of this study was to investigate the expression and prognostic value of PLAGL2 in PCa. Data from microarray datasets demonstrated that the DNA copy number and mRNA level of PLAGL2 were significantly increased in PCa compared with normal prostate. qRT-PCR and western blot analysis from paired PCa samples and prostate cell lines confirmed upregulated mRNA and protein expression levels in PCa. Immunohistochemistry analysis showed that staining of PLAGL2 in PCa tissues was significantly higher than that in benign prostatic hyperplasia (BPH) tissues. In addition, the high expression of PLAGL2 was only involved in preoperative PSA, but was not related to age, Gleason score, seminal vesicle invasion, surgical margin status, clinical stage and positive lymph node metastasis. Moreover, our results showed that PLAGL2 was an independent prognostic factor for biochemical recurrence (BCR)-free survival and overall survival (OS) of PCa patients, and overexpressed PLAGL2 was related to early development of BCR and poor OS. In conclusion, our findings suggest that PLAGL2 is overexpressed in PCa. The increased expression of PLAGL2 correlates to PCa progression following radical prostatectomy and may serve as a novel poor prognostic marker for PCa.	[Guo, Jia; Wang, Min; Wang, Zhishun; Liu, Xiuheng] Wuhan Univ, Renmin Hosp, Dept Urol, Wuhan, Hubei, Peoples R China	Wuhan University	Liu, XH (corresponding author), Wuhan Univ, Renmin Hosp, Dept Urol, Wuhan, Hubei, Peoples R China.	doctlxh@163.com			National Natural Science Foundation of China [2013RMFH012]; Province Natural Science Foundation of Hubei [2012FFA096]; Science Foundation of Wuhan [2015060101010049]; Fundamental Research Funds for the Central Universities [2042014kf0115]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Province Natural Science Foundation of Hubei(Natural Science Foundation of Hubei Province); Science Foundation of Wuhan; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study is supported by the grants from the National Natural Science Foundation of China (No. 2013RMFH012), the Province Natural Science Foundation of Hubei (No. 2012FFA096), the Science Foundation of Wuhan (NO. 2015060101010049) and supported by the Fundamental Research Funds for the Central Universities (NO. 2042014kf0115).; This study was supported by the grants from the National Natural Science Foundation of China (No. 2013RMFH012), the Province Natural Science Foundation of Hubei (No. 2012FFA096), the Science Foundation of Wuhan (NO. 2015060101010049) and supported by the Fundamental Research Funds for the Central Universities (NO. 2042014kf0115). We are appreciative to Key laboratory of Hubei Province for Digestive System Disease and all the authors who contributed to this study.	Abdollahi A, 2007, J CELL PHYSIOL, V210, P16, DOI 10.1002/jcp.20835; Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Briganti A, 2014, CANCER TREAT REV, V40, P3, DOI 10.1016/j.ctrv.2013.07.001; Carroll PR, 2005, J UROLOGY, V173, P1061, DOI 10.1097/01.ju.0000156838.67623.10; DAUGHADAY WH, 1990, ENDOCRINOLOGY, V127, P1; Dearnaley D., 2006, PROSTATE CANC 6 INT, P277; Furukawa T, 2001, ONCOGENE, V20, P4718, DOI 10.1038/sj.onc.1204647; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Garnick MB, 1998, SCI AM, V279, P74, DOI 10.1038/scientificamerican1298-74; Hanks TS, 2012, APOPTOSIS, V17, P236, DOI 10.1007/s10495-011-0672-3; Hensen K, 2002, CANCER RES, V62, P1510; Hess KR, 2006, CANCER, V106, P1624, DOI 10.1002/cncr.21778; Kas K, 1997, NAT GENET, V15, P170, DOI 10.1038/ng0297-170; Landrette SF, 2005, BLOOD, V105, P2900, DOI 10.1182/blood-2004-09-3630; Lin DW, 2009, CANCER-AM CANCER SOC, V115, P2863, DOI 10.1002/cncr.24324; Liu B, 2014, INT J CLIN EXP PATHO, V7, P3089; Martin ES, 2007, CANCER RES, V67, P10736, DOI 10.1158/0008-5472.CAN-07-2742; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Simmons MN, 2007, EUR UROL, V51, P1175, DOI 10.1016/j.eururo.2007.01.015; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Thompson Ian M, 2012, Am Soc Clin Oncol Educ Book, pe35, DOI 10.14694/EdBook_AM.2012.32.e35; Van Dyck F, 2007, INT J ONCOL, V30, P765; Yang MCW, 2005, AM J RESP CELL MOL, V32, P35, DOI 10.1165/rcmb.2003-0422OC; Yang YS, 2011, LUNG CANCER, V74, P12, DOI 10.1016/j.lungcan.2011.02.006; Zhang HT, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-77; Zheng HW, 2010, CANCER CELL, V17, P497, DOI 10.1016/j.ccr.2010.03.020	28	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0158667	10.1371/journal.pone.0158667	http://dx.doi.org/10.1371/journal.pone.0158667			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537362	Green Published, Green Submitted, gold			2022-12-26	WOS:000381577000006
J	Jiang, F; He, JY; Navarro-Alvarez, N; Xu, J; Li, X; Li, P; Wu, WX				Jiang, Fei; He, Jinyan; Navarro-Alvarez, Nalu; Xu, Jian; Li, Xia; Li, Peng; Wu, Wenxue			Elongation Factor Tu and Heat Shock Protein 70 Are Membrane-Associated Proteins from Mycoplasma ovipneumoniae Capable of Inducing Strong Immune Response in Mice	PLOS ONE			English	Article							BIGHORN SHEEP; RECOMBINANT PROTEIN; HYOPNEUMONIAE; PNEUMONIA; FIBRONECTIN; ANTIGENS; ADHESIN; SUBUNIT; DISEASE; INNATE	Chronic non-progressive pneumonia, a disease that has become a worldwide epidemic has caused considerable loss to sheep industry. Mycoplasma ovipneumoniae (M. ovipneumoniae) is the causative agent of interstitial pneumonia in sheep, goat and bighorn. We here have identified by immunogold and immunoblotting that elongation factor Tu (EF-Tu) and heat shock protein 70 (HSP 70) are membrane-associated proteins on M. ovipneumonaiea. We have evaluated the humoral and cellular immune responses in vivo by immunizing BALB/c mice with both purified recombinant proteins rEF-Tu and rHSP70. The sera of both rEF-Tu and rHSP70 treated BALB/c mice demonstrated increased levels of IgG, IFN-gamma, TNF-alpha, IL-12(p70), IL-4, IL-5 and IL-6. In addition, ELISPOT assay showed significant increase in IFN-gamma(+) secreting lymphocytes in the rHSP70 group when compared to other groups. Collectively our study reveals that rHSP70 induces a significantly better cellular immune response in mice, and may act as a Th1 cytokine-like adjuvant in immune response induction. Finally, growth inhibition test (GIT) of M. ovipneumoniae strain Y98 showed that sera from rHSP70 or rEF-Tu-immunized mice inhibited in vitro growth of M. ovipneumoniae. Our data strongly suggest that EF-Tu and HSP70 of M. ovipneumoniae are membrane-associated proteins capable of inducing antibody production, and cytokine secretion. Therefore, these two proteins may be potential candidates for vaccine development against M. ovipneumoniae infection in sheep.	[Jiang, Fei; He, Jinyan; Xu, Jian; Li, Xia; Li, Peng; Wu, Wenxue] China Agr Univ, Coll Vet Med, Lab Rapid Diagnost Technol Anim Dis, Beijing 100193, Peoples R China; [Jiang, Fei; He, Jinyan; Xu, Jian; Li, Xia; Li, Peng; Wu, Wenxue] China Agr Univ, Coll Vet Med, Minist Agr, Key Lab Anim Epidemiol & Zoonosis, Beijing 100193, Peoples R China; [Navarro-Alvarez, Nalu] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Transplantat Sci, Charlestown, MA 02129 USA	China Agricultural University; China Agricultural University; Ministry of Agriculture & Rural Affairs; Harvard University; Massachusetts General Hospital	Wu, WX (corresponding author), China Agr Univ, Coll Vet Med, Lab Rapid Diagnost Technol Anim Dis, Beijing 100193, Peoples R China.; Wu, WX (corresponding author), China Agr Univ, Coll Vet Med, Minist Agr, Key Lab Anim Epidemiol & Zoonosis, Beijing 100193, Peoples R China.	wuwenxue@cau.edu.cn	Navarro-Alvarez, Nalu/AAI-1034-2019	Navarro-Alvarez, Nalu/0000-0003-0118-4676	Special Fund for Agro-scientific Research in the Public Interest of China [201203056]	Special Fund for Agro-scientific Research in the Public Interest of China	This research was supported by Special Fund for Agro-scientific Research in the Public Interest of China, No. 201203056. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alley MR, 1999, NEW ZEAL VET J, V47, P155, DOI 10.1080/00480169.1999.36135; Alonso JMM, 2002, VET MICROBIOL, V89, P277, DOI 10.1016/S0378-1135(02)00258-4; Balasubramanian S, 2008, INFECT IMMUN, V76, P3116, DOI 10.1128/IAI.00173-08; Barbier M, 2013, MBIO, V4, DOI 10.1128/mBio.00207-13; Besser TE, 2008, J CLIN MICROBIOL, V46, P423, DOI 10.1128/JCM.01931-07; Besser TE, 2013, PREV VET MED, V108, P85, DOI 10.1016/j.prevetmed.2012.11.018; Besser TE, 2012, EMERG INFECT DIS, V18, P406, DOI 10.3201/eid1803.111554; Chen AY, 2008, VACCINE, V26, P4372, DOI 10.1016/j.vaccine.2008.06.005; Chen C, 2015, TROP ANIM HEALTH PRO, V47, P1641, DOI 10.1007/s11250-015-0908-2; Chen YL, 2003, INFECT IMMUN, V71, P1155, DOI 10.1128/IAI.71.3.1155-1160.2003; Cloward JM, 2009, MOL MICROBIOL, V71, P1296, DOI 10.1111/j.1365-2958.2009.06602.x; Dallo SF, 2002, MOL MICROBIOL, V46, P1041, DOI 10.1046/j.1365-2958.2002.03207.x; Dassanayake RP, 2010, VET MICROBIOL, V145, P354, DOI 10.1016/j.vetmic.2010.04.011; Deutscher AT, 2010, MOL MICROBIOL, V78, P444, DOI 10.1111/j.1365-2958.2010.07345.x; Floto RA, 2006, SCIENCE, V314, P454, DOI 10.1126/science.1133515; Galli V, 2012, VACCINE, V31, P135, DOI 10.1016/j.vaccine.2012.10.088; Giangaspero M, 2012, TROP ANIM HEALTH PRO, V44, P395, DOI 10.1007/s11250-011-9952-8; Guidotti LG, 2001, ANNU REV IMMUNOL, V19, P65, DOI 10.1146/annurev.immunol.19.1.65; Harvey ME, 2007, SMALL RUMINANT RES, V73, P287, DOI 10.1016/j.smallrumres.2007.01.013; Hausner M, 2013, MICROB PATHOGENESIS, V64, P23, DOI 10.1016/j.micpath.2013.07.004; Hsu T, 1997, J BACTERIOL, V179, P1317, DOI 10.1128/jb.179.4.1317-1323.1997; Jonak J, 2007, J CHROMATOGR B, V849, P141, DOI 10.1016/j.jchromb.2006.11.053; KOROLEV EV, 1994, MICROBIOL-UK, V140, P671, DOI 10.1099/00221287-140-3-671; Kunert A, 2007, J IMMUNOL, V179, P2979, DOI 10.4049/jimmunol.179.5.2979; Li M, 2011, GENET MOL RES, V10, P834, DOI 10.4238/vol10-2gmr1193; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Murphy ME, 2013, CARCINOGENESIS, V34, P1181, DOI 10.1093/carcin/bgt111; Nicholas RAJ, 2002, SMALL RUMINANT RES, V45, P145, DOI 10.1016/S0921-4488(02)00095-0; Nieves W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014361; Okamba FR, 2010, VACCINE, V28, P4802, DOI 10.1016/j.vaccine.2010.04.089; Parham K, 2006, VET MICROBIOL, V118, P83, DOI 10.1016/j.vetmic.2006.07.005; Patel H, 2008, VET MICROBIOL, V127, P309, DOI 10.1016/j.vetmic.2007.08.030; Pettersson B, 1996, INT J SYST BACTERIOL, V46, P1093, DOI 10.1099/00207713-46-4-1093; RAZIN S, 1992, J GEN MICROBIOL, V138, P407, DOI 10.1099/00221287-138-3-407; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Conceicao FR, 2006, VACCINE, V24, P5734, DOI 10.1016/j.vaccine.2006.04.036; Schurwanz N, 2009, INFECT IMMUN, V77, P5007, DOI 10.1128/IAI.00268-09; Shahzad W, 2010, VET IMMUNOL IMMUNOP, V136, P116, DOI 10.1016/j.vetimm.2010.02.001; Srivastava P, 2002, NAT REV IMMUNOL, V2, P185, DOI 10.1038/nri749; Sun ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088328; Suzue K, 1996, J IMMUNOL, V156, P873; Uto T, 2011, FEMS IMMUNOL MED MIC, V61, P189, DOI 10.1111/j.1574-695X.2010.00762.x; Virginio VG, 2014, VACCINE, V32, P5832, DOI 10.1016/j.vaccine.2014.08.008; Wang XH, 2014, J INTEGR AGR, V13, P2562, DOI 10.1016/S2095-3119(14)60825-X; Xin JQ, 2012, VET J, V191, P166, DOI 10.1016/j.tvjl.2011.02.011; Yang FL, 2011, J BACTERIOL, V193, P5018, DOI 10.1128/JB.05363-11; Yoshida S, 2000, INFECT IMMUN, V68, P3186, DOI 10.1128/IAI.68.6.3186-3192.2000	48	16	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161170	10.1371/journal.pone.0161170	http://dx.doi.org/10.1371/journal.pone.0161170			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537186	Green Published, Green Submitted, gold			2022-12-26	WOS:000381577000064
J	Shakib, S; Dundon, BK; Maddison, J; Thomas, J; Stanners, M; Caughey, GE; Clark, RA				Shakib, Sepehr; Dundon, Benjamin K.; Maddison, John; Thomas, Josephine; Stanners, Melinda; Caughey, Gillian E.; Clark, Robyn A.			Effect of a Multidisciplinary Outpatient Model of Care on Health Outcomes in Older Patients with Multimorbidity: A Retrospective Case Control Study	PLOS ONE			English	Article							HEART-FAILURE PATIENTS; CHRONIC DISEASES; RISK; THERAPY; METAANALYSIS; TRANSITIONS; MANAGEMENT; PROGRAMS; ADULTS; DEATH	Objective To evaluate a holistic multidisciplinary outpatient model of care on hospital readmission, length of stay and mortality in older patients with multimorbidity following discharge from hospital. Design and Participants A pilot case-control study between March 2006 and June 2009 of patients referred on discharge to a multidisciplinary, integrated outpatient model of care that includes outpatient follow-up, timely GP communication and dial-in service compared with .1 ratio with cases for age, gender, index admission diagnosis and length of stay. Main outcome measures Non-elective readmission rates, total readmission length of stay and overall survival. Results A total of 252 cases and 1008 control patients were included in the study. Despite the patients referred to the multidisciplinary model of care had slightly more comorbid conditions, significantly higher total length of hospital stay in the previous 12 months and increased prevalence of diabetes and heart failure by comparison to those who received they had significantly improved survival (adjusted hazard ratio 0.70 95% CI 0.51-0.96, p = 0.029) and no excess in the number of hospitalisations observed. Conclusion Following discharge from hospital, holistic multidisciplinary outpatient management is associated with improved survival in older patients with multimorbidity. The findings of this study warrant further examination in randomised and cost-effectiveness trials.	[Shakib, Sepehr; Maddison, John; Stanners, Melinda; Caughey, Gillian E.] Royal Adelaide Hosp, Dept Clin Pharmacol, North Terrace, Adelaide, SA 5000, Australia; [Shakib, Sepehr] Univ Adelaide, Sch Med, Discipline Pharmacol, North Terrace, Adelaide, SA 5000, Australia; [Dundon, Benjamin K.] Monash Hlth, Monash Cardiovasc Res Ctr, Clayton, Vic, Australia; [Thomas, Josephine] Univ Adelaide, Sch Med, Clin Educ, Adelaide, SA 5000, Australia; [Caughey, Gillian E.] Univ South Australia, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia; [Clark, Robyn A.] Flinders Univ South Australia, Dept Nursing Acute Care & Cardiovasc Res, Adelaide, SA 5001, Australia	Royal Adelaide Hospital; University of Adelaide; Monash University; University of Adelaide; University of South Australia; Flinders University South Australia	Shakib, S (corresponding author), Royal Adelaide Hosp, Dept Clin Pharmacol, North Terrace, Adelaide, SA 5000, Australia.; Shakib, S (corresponding author), Univ Adelaide, Sch Med, Discipline Pharmacol, North Terrace, Adelaide, SA 5000, Australia.	Sepehr.shakib@sa.gov.au	Stanners, Melinda/AAC-9235-2020; Clark, Robyn A/D-1604-2009	Stanners, Melinda/0000-0002-9480-9438; Clark, Robyn A/0000-0002-5063-2618; Caughey, Gillian/0000-0003-1192-4121; Thomas, Josephine/0000-0001-8124-5920	South Australian Health National Institute of Clinical Studies Fellowship	South Australian Health National Institute of Clinical Studies Fellowship	This study was supported by a South Australian Health National Institute of Clinical Studies Fellowship to Dr. Sepehr Shakib. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarasingham R, 2010, MED CARE, V48, P981, DOI 10.1097/MLR.0b013e3181ef60d9; Boult C, 2011, ARCH INTERN MED, V171, P460, DOI 10.1001/archinternmed.2010.540; Boult C, 2009, J AM GERIATR SOC, V57, P2328, DOI 10.1111/j.1532-5415.2009.02571.x; Caughey GE, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-221; Clarke DM, 2009, MED J AUSTRALIA, V190, pS54; Coleman EA, 2004, HEALTH SERV RES, V39, P1449, DOI 10.1111/j.1475-6773.2004.00298.x; Effing T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002990.pub2; Ellis SE, 2004, PATIENT EDUC COUNS, V52, P97, DOI 10.1016/S0738-3991(03)00016-8; Flather MD, 2000, LANCET, V355, P1575, DOI 10.1016/S0140-6736(00)02212-1; Gilbert A., 2013, AGEING WELL AGEING P; Gitlin LN, 2006, J AM GERIATR SOC, V54, P950, DOI 10.1111/j.1532-5415.2006.00733.x; Ho TH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093129; Inglis SC, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007228.pub2; Institute of Medicine, 2015, MEASURING IMPACT INT; Kwan JL, 2013, ANN INTERN MED, V158, P397, DOI 10.7326/0003-4819-158-5-201303051-00006; Lacasse Y, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003793.pub2; Lawlor DA, 2003, BRIT MED J, V327, P712, DOI 10.1136/bmj.327.7417.712; McAlister FA, 2004, J AM COLL CARDIOL, V44, P810, DOI 10.1016/j.jacc.2004.05.055; McAlister FA, 2009, ANN INTERN MED, V150, P784, DOI 10.7326/0003-4819-150-11-200906020-00006; Mosher HJ, 2015, JAMA INTERN MED, V175, P1298, DOI 10.1001/jamainternmed.2015.2430; Ouwens M, 2005, INT J QUAL HEALTH C, V17, P141, DOI 10.1093/intqhc/mzi016; Pannick S, 2015, JAMA INTERN MED, V175, P1288, DOI 10.1001/jamainternmed.2015.2421; Peytremann-Bridevaux I, 2008, AM J MED, V121, P433, DOI 10.1016/j.amjmed.2008.02.009; Renders CM, 2000, COCHRANE DATABASE SY; Reuben DB, 2012, NEW ENGL J MED, V366, P777, DOI 10.1056/NEJMp1113631; Seiler WO, 2001, NUTRITION, V17, P496, DOI 10.1016/S0899-9007(01)00558-5; Smith SM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5205; Sommers LS, 2000, ARCH INTERN MED, V160, P1825, DOI 10.1001/archinte.160.12.1825; Wang SM, 2015, EUR J INTERN MED, V94, pe1437; Wilt TJ, 2004, ARCH INTERN MED, V164, P1427, DOI 10.1001/archinte.164.13.1427	30	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161382	10.1371/journal.pone.0161382	http://dx.doi.org/10.1371/journal.pone.0161382			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT6ES	27537395	Green Published, gold, Green Accepted			2022-12-26	WOS:000381577000096
J	Timucin, AC; Basaga, H				Timucin, Ahmet Can; Basaga, Huveyda			SIRT6 Is a Positive Regulator of Aldose Reductase Expression in U937 and HeLa cells under Osmotic Stress: In Vitro and In Silico Insights	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; DEACETYLASE SIRT6; BINDING-SITES; PROTEIN; NFAT5; ATHEROSCLEROSIS; SUBSTRATE	SIRT6 is a protein deacetylase, involved in various intracellular processes including suppression of glycolysis and DNA repair. Aldose Reductase (AR), first enzyme of polyol pathway, was proposed to be indirectly associated to these SIRT6 linked processes. Despite these associations, presence of SIRT6 based regulation of AR still remains ambiguous. Thus, regulation of AR expression by SIRT6 was investigated under hyperosmotic stress. A unique model of osmotic stress in U937 cells was used to demonstrate the presence of a potential link between SIRT6 and AR expression. By overexpressing SIRT6 in HeLa cells under hyperosmotic stress, its role on upregulation of AR was revealed. In parallel, increased SIRT6 activity was shown to upregulate AR in U937 cells under hyperosmotic milieu by using pharmacological modulators. Since these modulators also target SIRT1, binding of the inhibitor, Ex-527, specifically to SIRT6 was analyzed in silico. Computational observations indicated that Ex-527 may also target SIRT6 active site residues under high salt concentration, thus, validating in vitro findings. Based on these evidences, a novel regulatory step by SIRT6, modifying AR expression under hyperosmotic stress was presented and its possible interactions with intracellular machinery was discussed.	[Timucin, Ahmet Can; Basaga, Huveyda] Sabanci Univ, Fac Engn & Nat Sci, Mol Biol Genet & Bioengn Program, Istanbul, Turkey	Sabanci University	Basaga, H (corresponding author), Sabanci Univ, Fac Engn & Nat Sci, Mol Biol Genet & Bioengn Program, Istanbul, Turkey.	huveyda@sabanciuniv.edu	Timucin, Ahmet Can/ABI-6250-2020	Timucin, Ahmet Can/0000-0002-9483-3593	Sabanci University internal research fund	Sabanci University internal research fund(Sabanci University)	This material is based upon work supported by Sabanci University internal research fund (https://www.sabanciuniv.edu/en/) to HB (No grant number available). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Buxade M, 2012, J EXP MED, V209, P379, DOI 10.1084/jem.20111569; Chen Y, 2007, AM J PHYSIOL-RENAL, V292, pP981, DOI 10.1152/ajprenal.00493.2005; Dmitrieva NI, 2011, P NATL ACAD SCI USA, V108, P20796, DOI 10.1073/pnas.1114677108; Eisenhaber B, 2011, CELL CYCLE, V10, P3897, DOI 10.4161/cc.10.22.18043; Feig M, 2003, J PHYS CHEM B, V107, P2831, DOI 10.1021/jp027293y; Feldman JL, 2013, J BIOL CHEM, V288, P31350, DOI 10.1074/jbc.C113.511261; Gertz M, 2013, P NATL ACAD SCI USA, V110, pE2772, DOI 10.1073/pnas.1303628110; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jin L, 2009, J BIOL CHEM, V284, P24394, DOI 10.1074/jbc.M109.014928; JORGENSEN WL, 1983, J AM CHEM SOC, V105, P1407, DOI 10.1021/ja00344a001; Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009; Kim SJ, 2014, INT J OPHTHALMOL-CHI, V7, P935, DOI 10.3980/j.issn.2222-3959.2014.06.04; Kokkonen P, 2014, EUR J PHARM SCI, V63, P71, DOI 10.1016/j.ejps.2014.06.015; Kwon HS, 2008, TRENDS BIOCHEM SCI, V33, P517, DOI 10.1016/j.tibs.2008.08.001; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lopez-Rodriguez C, 1999, P NATL ACAD SCI USA, V96, P7214, DOI 10.1073/pnas.96.13.7214; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723; Neuhofer W, 2010, CURR GENOMICS, V11, P584, DOI 10.2174/138920210793360961; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Oates PJ, 2008, CURR DRUG TARGETS, V9, P14, DOI 10.2174/138945008783431781; Pan PW, 2011, J BIOL CHEM, V286, P14575, DOI 10.1074/jbc.M111.218990; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Ramana KV, 2010, INT J BIOCHEM CELL B, V42, P17, DOI 10.1016/j.biocel.2009.09.009; Remo A, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0492-2; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Schymkowitz JWH, 2005, P NATL ACAD SCI USA, V102, P10147, DOI 10.1073/pnas.0501980102; Sebastian C, 2012, CELL, V151, P1185, DOI 10.1016/j.cell.2012.10.047; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Srivastava SK, 2005, ENDOCR REV, V26, P380, DOI 10.1210/er.2004-0028; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Timucin AC, 2015, CELL SIGNAL, V27, P2160, DOI 10.1016/j.cellsig.2015.08.013; Tong EHY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008435; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vance DT, 2016, ANAL BIOCHEM, V500, P24, DOI 10.1016/j.ab.2016.01.007; Vedantham Srinivasan, 2012, Cardiovascular & Hematological Agents in Medicinal Chemistry, V10, P234; Vedantham S, 2011, ARTERIOSCL THROM VAS, V31, P1805, DOI 10.1161/ATVBAHA.111.226902; Vikramadithyan RK, 2005, J CLIN INVEST, V115, P2434, DOI 10.1172/JCI24819; Wang Y, 2011, BIOCHEM BIOPH RES CO, V411, P543, DOI 10.1016/j.bbrc.2011.06.177; Wei J, 2014, FREE RADICAL BIO MED, V67, P91, DOI 10.1016/j.freeradbiomed.2013.10.811; Zhao X, 2013, J MED CHEM, V56, P963, DOI 10.1021/jm301431y; Zoete V, 2011, J COMPUT CHEM, V32, P2359, DOI 10.1002/jcc.21816	49	2	2	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161494	10.1371/journal.pone.0161494	http://dx.doi.org/10.1371/journal.pone.0161494			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536992	gold, Green Published, Green Submitted			2022-12-26	WOS:000381577000113
J	Sun, F; Zeng, SY; Huang, YQ; He, M				Sun, Fu; Zeng, Siyu; Huang, Yunqing; He, Miao			Parameter Identification of an Ultrafiltration Model for Organics Removal in a Full-Scale Wastewater Reclamation Plant with Sparse and Incomplete Monitoring Data	PLOS ONE			English	Article							GROUNDWATER POLLUTION SOURCES; ARTIFICIAL NEURAL-NETWORK; BATCH ULTRAFILTRATION; SIMULATION; REJECTION; PERFORMANCE; MEMBRANES; FLUX; UNCERTAINTY; PREDICTION	Ultrafiltration (UF) has become one of the dominant treatment processes for wastewater reclamation in China. Modeling is an effective instrument to understand and optimize UF systems. To this end, a previously developed UF model for organics removal was applied to the UF process in a typical, full-scale wastewater reclamation plant (WRP) in China. However, the sparse and incomplete field monitoring data from the studied WRP made the traditional model analysis approaches hardly work in this case. Therefore, two strategies, namely Strategy 1 and Strategy 2, were proposed, following a regional sensitivity analysis approach, for model parameter identification. Strategy 1 aimed to identify the model parameters and the missing model input, i.e. sampling times, simultaneously, while Strategy 2 tried to separate these two processes to reduce the dimension of the identification problem through an iteration procedure. With these two strategies, the model performed well in the Qinghe WRP with the absolute relative errors between the simulated and observed total organic carbon (TOC) generally below 10%. The four model parameters were all sensitive and identifiable, and even the sampling times could be roughly identified. Given the incomplete model input, these results were encouraging and added to the trustworthiness of model when it was applied to the Qinghe WRP.	[Sun, Fu; Zeng, Siyu; Huang, Yunqing; He, Miao] Tsinghua Univ, State Key Joint Lab Environm Simulat & Pollut Con, Sch Environm, Beijing 100084, Peoples R China	Tsinghua University	Zeng, SY (corresponding author), Tsinghua Univ, State Key Joint Lab Environm Simulat & Pollut Con, Sch Environm, Beijing 100084, Peoples R China.	szeng@tsinghua.edu.cn						BECK MB, 1987, WATER RESOUR RES, V23, P1393, DOI 10.1029/WR023i008p01393; Bhattacharjee C, 2001, SEP PURIF TECHNOL, V24, P13, DOI 10.1016/S1383-5866(00)00204-5; Bhattacharjee C, 1997, J MEMBRANE SCI, V125, P303, DOI 10.1016/S0376-7388(96)00247-5; Cheryan M, 1998, ULTRAFILTRATION MICR; Chiu KP, 2005, DEV MICROFILTRATION; Cho JW, 2002, DESALINATION, V142, P245, DOI 10.1016/S0011-9164(02)00206-0; Datta B, 2009, J HYDROL, V376, P48, DOI 10.1016/j.jhydrol.2009.07.014; Dudley J, 2002, WATER SCI TECHNOL, V45, P177, DOI 10.2166/wst.2002.0105; Ghose S, 2000, J MEMBRANE SCI, V169, P29, DOI 10.1016/S0376-7388(99)00329-4; Herrnegger M, 2015, HYDROL EARTH SYST SC, V19, P4619, DOI 10.5194/hess-19-4619-2015; Hormann G, 2007, ECOL MODEL, V209, P21, DOI 10.1016/j.ecolmodel.2007.07.019; Huang Yun-qing, 2015, China Environmental Science, V35, P420; Jun KS, 2007, WATER SCI TECHNOL, V56, P155, DOI 10.2166/wst.2007.447; Lin SH, 2008, DESALINATION, V234, P116, DOI 10.1016/j.desal.2007.09.077; Mahar PS, 2001, J WATER RES PL-ASCE, V127, P20, DOI 10.1061/(ASCE)0733-9496(2001)127:1(20); Morao A, 2008, J MEMBRANE SCI, V319, P64, DOI 10.1016/j.memsci.2008.03.019; Morao A, 2009, J MEMBRANE SCI, V336, P61, DOI 10.1016/j.memsci.2009.03.007; Muthukumaran S, 2011, DESALINATION, V279, P383, DOI 10.1016/j.desal.2011.06.040; Nyeko M, 2015, WATER RESOUR MANAG, V29, P81, DOI 10.1007/s11269-014-0828-3; Pluntke T, 2014, ENVIRON EARTH SCI, V72, P4801, DOI 10.1007/s12665-014-3252-3; Polyakoy YS, 2013, J MEMBRANE SCI, V434, P106, DOI 10.1016/j.memsci.2013.01.052; Rai P, 2005, J FOOD ENG, V71, P273, DOI 10.1016/j.jfoodeng.2005.02.003; Razavi MA, 2003, J MEMBRANE SCI, V220, P47, DOI 10.1016/S0376-7388(03)00211-4; Sun F, 2010, SCI TOTAL ENVIRON, V408, P1992, DOI 10.1016/j.scitotenv.2010.01.037; Nguyen TA, 2012, J MEMBRANE SCI, V403, P84, DOI 10.1016/j.memsci.2012.02.026; VANOERS CW, 1995, J MEMBRANE SCI, V107, P173, DOI 10.1016/0376-7388(95)00116-T; Vela MCV, 2005, DESALINATION, V184, P347, DOI 10.1016/j.desal.2005.03.052; WAGNER BJ, 1992, J HYDROL, V135, P275, DOI 10.1016/0022-1694(92)90092-A	28	7	7	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161300	10.1371/journal.pone.0161300	http://dx.doi.org/10.1371/journal.pone.0161300			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529845	Green Submitted, Green Published, gold			2022-12-26	WOS:000381476700064
J	Luczak, SET; Smits, SHJ; Decker, C; Nagel-Steger, L; Schmitt, L; Hegemann, JH				Luczak, Soeren E. T.; Smits, Sander H. J.; Decker, Christina; Nagel-Steger, Luitgard; Schmitt, Lutz; Hegemann, Johannes H.			The Chlamydia pneumoniae Adhesin Pmp21 Forms Oligomers with Adhesive Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adhesin; amyloid; bacterial adhesion; Chlamydia; oligomerization; Pmp	PROTEIN SECONDARY STRUCTURE; AMYLOID BETA-PROTEIN; POLYMORPHIC MEMBRANE-PROTEINS; ESCHERICHIA-COLI O157-H7; CURLI FIMBRIAE; BIOFILM FORMATION; SURFACE-PROTEINS; THIOFLAVIN T; BALB/C MICE; HOST-CELLS	Chlamydiae sp. are obligate intracellular pathogens that cause a variety of diseases in humans. The adhesion of Chlamydiae to the eukaryotic host cell is a pivotal step in pathogenesis. The adhesin family of polymorphic membrane proteins (Pmp) in Chlamydia pneumoniae consists of 21 members. Pmp21 binds to the epidermal growth factor receptor (EGFR). Pmps contain large numbers of FXXN (where X is any amino acid) and GGA(I/L/V) motifs. At least two of these motifs are crucial for adhesion by certain Pmp21 fragments. Here we describe how the two FXXN motifs in Pmp21-D (D-Wt), a domain of Pmp21, influence its self-interaction, folding, and adhesive capacities. Refolded D-Wt molecules form oligomers with high sedimentation values (8-85 S). These oligomers take the form of elongated protofibrils, which exhibit Thioflavin T fluorescence, like the amyloid protein fragment 42. A mutant version of Pmp21-D (D-Mt), with FXXN motifs replaced by SXXV, shows a markedly reduced capacity to form oligomers. Secondary-structure assays revealed that monomers of both variants exist predominantly as random coils, whereas the oligomers form predominantly -sheets. Adhesion studies revealed that oligomers of D-Wt (D-Wt-O) mediate significantly enhanced binding to human epithelial cells relative to D-Mt-O and monomeric protein species. Moreover, D-Wt-O binds EGFR more efficiently than D-Wt monomers. Importantly, pretreatment of human cells with D-Wt-O reduces infectivity upon subsequent challenge with C. pneumoniae more effectively than all other protein species. Hence, the FXXN motif in D-Wt induces the formation of -sheet-rich oligomeric protofibrils, which are important for adhesion to, and subsequent infection of human cells.	[Luczak, Soeren E. T.; Hegemann, Johannes H.] Univ Dusseldorf, Inst Funct Microbial Genom, Univ Str 1, D-40225 Dusseldorf, Germany; [Smits, Sander H. J.; Schmitt, Lutz] Univ Dusseldorf, Inst Biochem, Univ Str 1, D-40225 Dusseldorf, Germany; [Decker, Christina; Nagel-Steger, Luitgard] Univ Dusseldorf, Inst Phys Biol, Univ Str 1, D-40225 Dusseldorf, Germany; [Nagel-Steger, Luitgard] ICS 6 Res Ctr Juelich, D-52425 Julich, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Hegemann, JH (corresponding author), Univ Dusseldorf, Inst Funct Microbial Genom, Univ Str 1, D-40225 Dusseldorf, Germany.	Johannes.hegemann@hhu.de	Nagel-Steger, Luitgard/H-6415-2013	Nagel-Steger, Luitgard/0000-0001-5232-2149	NRW Graduate School BioStruct-Biological Structures in Molecular Medicine and Biotechnology	NRW Graduate School BioStruct-Biological Structures in Molecular Medicine and Biotechnology	This work was supported in part by a Ph.D. fellowship from the NRW Graduate School BioStruct-Biological Structures in Molecular Medicine and Biotechnology (to S. E. T. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Becker E, 2014, MICROBIOLOGYOPEN, V3, P544, DOI 10.1002/mbo3.186; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Blasi F, 2009, CLIN MICROBIOL INFEC, V15, P29, DOI 10.1111/j.1469-0691.2008.02130.x; Boelen E, 2007, ACTA NEUROPATHOL, V114, P255, DOI 10.1007/s00401-007-0252-3; Bokranz W, 2005, J MED MICROBIOL, V54, P1171, DOI 10.1099/jmm.0.46064-0; Bradley P, 2001, P NATL ACAD SCI USA, V98, P14819, DOI 10.1073/pnas.251267298; Brunham RC, 2005, NAT REV IMMUNOL, V5, P149, DOI 10.1038/nri1551; Campbell L. A., 2006, INTERACTIONS CHLAMYD, P505; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Crane DD, 2006, P NATL ACAD SCI USA, V103, P1894, DOI 10.1073/pnas.0508983103; D'Amico M, 2012, J PHYS CHEM LETT, V3, P1596, DOI 10.1021/jz300412v; Epstein EA, 2008, CELL MICROBIOL, V10, P1413, DOI 10.1111/j.1462-5822.2008.01148.x; Epstein EA, 2009, J BACTERIOL, V191, P608, DOI 10.1128/JB.01244-08; Fernandez LA, 2000, FEMS MICROBIOL REV, V24, P21, DOI 10.1111/j.1574-6976.2000.tb00531.x; Gophna U, 2001, INFECT IMMUN, V69, P2659, DOI 10.1128/IAI.69.4.2659-2665.2001; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Grimwood J, 2001, INFECT IMMUN, V69, P2383, DOI 10.1128/IAI.69.4.2383-2389.2001; Grimwood J, 1999, Microb Comp Genomics, V4, P187, DOI 10.1089/omi.1.1999.4.187; Harris SA, 2015, J ALZHEIMERS DIS, V48, P319, DOI 10.3233/JAD-142853; Hatch TP, 1999, CHLAMYDIA, P29; Hegemann JH, 2012, INTERCELLULAR PATHOGENS I: CHLAMYDIALES, P97, DOI 10.1128/9781555817329.ch5; Henderson IR, 2001, TRENDS MICROBIOL, V9, P573, DOI 10.1016/S0966-842X(01)02234-X; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Jantos CA, 1997, J CLIN MICROBIOL, V35, P620, DOI 10.1128/JCM.35.3.620-623.1997; Jonson Ann-Beth, 2005, V12, P67, DOI 10.1159/000081690; Junker M, 2006, P NATL ACAD SCI USA, V103, P4918, DOI 10.1073/pnas.0507923103; Kalman S, 1999, NAT GENET, V21, P385, DOI 10.1038/7716; Kiselev AO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005191; Kline KA, 2009, CELL HOST MICROBE, V5, P580, DOI 10.1016/j.chom.2009.05.011; KUO CC, 1995, CLIN MICROBIOL REV, V8, P451, DOI 10.1128/CMR.8.4.451; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lipke PN, 2012, TRENDS MICROBIOL, V20, P59, DOI 10.1016/j.tim.2011.10.002; Little CS, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00304; Little CS, 2004, NEUROBIOL AGING, V25, P419, DOI 10.1016/S0197-4580(03)00127-1; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Longbottom D, 1998, INFECT IMMUN, V66, P1317, DOI 10.1128/IAI.66.4.1317-1324.1998; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; Moelleken K, 2008, MOL MICROBIOL, V67, P403, DOI 10.1111/j.1365-2958.2007.06050.x; Molleken K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003325; Molleken K, 2010, MOL MICROBIOL, V78, P1004, DOI 10.1111/j.1365-2958.2010.07386.x; Montigiani S, 2002, INFECT IMMUN, V70, P368, DOI 10.1128/IAI.70.1.368-379.2002; MOULDER JW, 1991, MICROBIOL REV, V55, P143, DOI 10.1128/MMBR.55.1.143-190.1991; Nybo M, 1999, SCAND J IMMUNOL, V49, P219; Olsen A, 1998, INFECT IMMUN, V66, P944; Otoo HN, 2008, EUKARYOT CELL, V7, P776, DOI 10.1128/EC.00309-07; Pawar DM, 2005, J APPL MICROBIOL, V99, P418, DOI 10.1111/j.1365-2672.2005.02499.x; PODLISNY MB, 1995, J BIOL CHEM, V270, P9564, DOI 10.1074/jbc.270.16.9564; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Pujol-Pina R, 2015, SCI REP-UK, V5, DOI 10.1038/srep14809; Puolakkainen M, 2009, FEMS IMMUNOL MED MIC, V55, P167, DOI 10.1111/j.1574-695X.2008.00519.x; Rockey DD, 2000, INFECT IMMUN, V68, P5473, DOI 10.1128/IAI.68.10.5473-5479.2000; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Ryu JH, 2004, J FOOD PROTECT, V67, P2123, DOI 10.4315/0362-028X-67.10.2123; Saka HA, 2011, MOL MICROBIOL, V82, P1185, DOI 10.1111/j.1365-2958.2011.07877.x; Schachter J, 1999, CHLAMYDIA, P139; Serpell LC, 2000, BBA-MOL BASIS DIS, V1502, P16, DOI 10.1016/S0925-4439(00)00029-6; Smirnovas V, 2011, NAT STRUCT MOL BIOL, V18, P504, DOI 10.1038/nsmb.2035; Stallmann S, 2016, CELL MICROBIOL, V18, P761, DOI 10.1111/cmi.12549; Sulatskaya A, 2012, FEBS J, V279, P416; Sulatskaya AI, 2012, J PHYS CHEM B, V116, P2538, DOI 10.1021/jp2083055; Swanson KA, 2009, INFECT IMMUN, V77, P508, DOI 10.1128/IAI.01173-08; Tan C, 2010, CELL MICROBIOL, V12, P174, DOI 10.1111/j.1462-5822.2009.01389.x; Tanford C., 1961, PHYSICAL CHEMISTRY M, P381; Tanzer RJ, 2001, INFECT IMMUN, V69, P2428, DOI 10.1128/IAI.69.4.2428-2434.2001; Tsai HH, 2006, STRUCTURE, V14, P1059, DOI 10.1016/j.str.2006.03.015; Tycko R, 2013, ACCOUNTS CHEM RES, V46, P1487, DOI 10.1021/ar300282r; Uhlich GA, 2006, APPL ENVIRON MICROB, V72, P2564, DOI 10.1128/AEM.72.4.2564-2572.2006; Van Melckebeke H, 2010, J AM CHEM SOC, V132, P13765, DOI [10.1021/ja104213J, 10.1021/ja104213j]; Vandahl BB, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-36; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552; Wang X, 2007, J BIOL CHEM, V282, P3713, DOI 10.1074/jbc.M609228200; Wehrl W, 2004, MOL MICROBIOL, V51, P319, DOI 10.1046/j.1365-2958.2003.03838.x; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wright HR, 2008, LANCET, V371, P1945, DOI 10.1016/S0140-6736(08)60836-3; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zogaj X, 2003, INFECT IMMUN, V71, P4151, DOI 10.1128/IAI.71.7.4151-4158.2003	82	11	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22806	22818		10.1074/jbc.M116.728915	http://dx.doi.org/10.1074/jbc.M116.728915			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27551038	hybrid, Green Published			2022-12-26	WOS:000386760600037
J	Tikoo, K; Sharma, E; Amara, VR; Pamulapati, H; Dhawale, VS				Tikoo, Kulbhushan; Sharma, Ekta; Amara, Venkateswara Rao; Pamulapati, Himani; Dhawale, Vaibhav Shrirang			Metformin Improves Metabolic Memory in High Fat Diet (HFD)-induced Renal Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated kinase (AMPK); fibronectin; insulin resistance; kidney; metformin; Metabolic memory; diet reversal; high fat diet (HFD)	ACTIVATED PROTEIN-KINASE; INSULIN-RESISTANCE; ACID; EXPRESSION; NEPHROPATHY; MECHANISMS; PATHWAY; DISEASE; OBESITY; INJURY	Recently, we have shown that high fat diet (HFD) in vivo and in vitro generates metabolic memory by altering H3K36me2 and H3K27me3 on the promoter of FOXO1 (transcription factor of gluconeogenic genes) (Kumar, S., Pamulapati, H., and Tikoo, K. (2016) Mol. Cell. Endocrinol. 422, 233-242). Here we checked the hypothesis whether concomitant diet reversal and metformin could overcome HFD-induced metabolic memory and renal damage. Male adult Sprague-Dawley rats were rendered insulin-resistant by feeding high fat diet for 16 weeks. Then the rats were subjected to diet reversal alone and along with metformin for 8 weeks. Biochemical and histological markers of insulin resistance and kidney function were measured. Blood pressure and in vivo vascular reactivity to angiotensin II (200 mg kg(-1)) were also checked. Diet reversal could improve lipid profile but could not prevent renal complications induced by HFD. Interestingly, metformin along with diet reversal restored the levels of blood glucose, triglycerides, cholesterol, blood urea nitrogen, and creatinine. In kidney, metformin increased the activation of AMP-activated protein kinase (AMPK) and decreased inflammatory markers (COX-2 and IL-1) and apoptotic markers (poly(ADP-ribose) polymerase (PARP) and caspase 3). Metformin was effective in lowering elevated basal blood pressure and acute change in mean arterial pressure in response to angiotensin II (Ang II). It also attenuated tubulointerstitial fibrosis and glomerulosclerosis induced by HFD feeding in kidney. Here we report, for the first time, that metformin treatment overcomes metabolic memory and prevents HFD-induced renal damage.	[Tikoo, Kulbhushan; Sharma, Ekta; Amara, Venkateswara Rao; Pamulapati, Himani; Dhawale, Vaibhav Shrirang] Natl Inst Pharmaceut Educ & Res, Lab Epigenet & Dis, Dept Pharmacol & Toxicol, Sas Nagar Mohali 160062, Punjab, India	National Institute of Pharmaceutical Education & Research (NIPER); National Institute of Pharmaceutical Education & Research, S.A.S. Nagar (Mohali)	Tikoo, K (corresponding author), Natl Inst Pharmaceut Educ & Res, Lab Epigenet & Dis, Dept Pharmacol & Toxicol, Sect 67, Sas Nagar 160062, Punjab, India.	tikoo.k@gmail.com	Amara, Venkateswara Rao/AGJ-6417-2022; Amara, Venkateswara Rao/AGP-0388-2022; Amara, Venkateswara Rao/U-1081-2019	Amara, Venkateswara Rao/0000-0002-3061-0120; Tikoo, Kulbhushan/0000-0003-3061-9739	National Institute of Pharmaceutical Education and Research, S.A.S. Nagar, India; Department of Science & Technology, Government of India	National Institute of Pharmaceutical Education and Research, S.A.S. Nagar, India; Department of Science & Technology, Government of India(Department of Science & Technology (India))	This work was supported by grants from the National Institute of Pharmaceutical Education and Research, S.A.S. Nagar, India and the Department of Science & Technology, Government of India. The authors declare that they have no conflicts of interest with the contents of this article.	Bendale DS, 2013, BRIT J PHARMACOL, V170, P779, DOI 10.1111/bph.12290; Crinigan C, 2015, J NUTR METAB, V2015, DOI 10.1155/2015/157520; Decleves AE, 2011, J AM SOC NEPHROL, V22, P1846, DOI 10.1681/ASN.2011010026; Deegens JKJ, 2008, KIDNEY INT, V74, P1568, DOI 10.1038/ki.2008.413; Deji N, 2009, AM J PHYSIOL-RENAL, V296, pF118, DOI 10.1152/ajprenal.00110.2008; Drzewoski J, 2009, POL ARCH MED WEWN, V119, P493, DOI 10.20452/pamw.747; El-Atat FA, 2004, J AM SOC NEPHROL, V15, P2816, DOI 10.1097/01.ASN.0000133698.80390.37; Grande MT, 2009, NAT REV NEPHROL, V5, P319, DOI 10.1038/nrneph.2009.74; Karpe PA, 2014, DIABETES, V63, P1124, DOI 10.2337/db13-1267; Karpe PA, 2012, J HYPERTENS, V30, P132, DOI 10.1097/HJH.0b013e32834d9efe; Kim D, 2013, INT J MOL MED, V32, P1293, DOI 10.3892/ijmm.2013.1508; Kumar S, 2016, MOL CELL ENDOCRINOL, V422, P233, DOI 10.1016/j.mce.2015.12.019; Kumar S, 2015, BIOCHIMIE, V112, P73, DOI 10.1016/j.biochi.2015.02.009; Kume S, 2007, J AM SOC NEPHROL, V18, P2715, DOI 10.1681/ASN.2007010089; Lennon R, 2009, NEPHROL DIAL TRANSPL, V24, P3288, DOI 10.1093/ndt/gfp302; Majithiya JB, 2006, LIFE SCI, V78, P2615, DOI 10.1016/j.lfs.2005.10.020; Meng SM, 2015, J BIOL CHEM, V290, P3793, DOI 10.1074/jbc.M114.604421; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Nayak BK, 2016, DIABETES, V65, P1387, DOI 10.2337/db15-0519; Peairs A, 2009, CLIN EXP IMMUNOL, V156, P542, DOI 10.1111/j.1365-2249.2009.03924.x; Peng JH, 2013, EXP BIOL MED, V238, P668, DOI 10.1177/1535370213480741; Piwkowska A, 2010, BIOCHEM BIOPH RES CO, V393, P268, DOI 10.1016/j.bbrc.2010.01.119; RANDLE PJ, 1965, ANN NY ACAD SCI, V131, P324, DOI 10.1111/j.1749-6632.1965.tb34800.x; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; Sawicka KM, 2015, ADV WOUND CARE, V4, P469, DOI 10.1089/wound.2014.0616; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Srinivasan K, 2004, METHOD FIND EXP CLIN, V26, P327, DOI 10.1358/mf.2004.26.5.831322; Tallapragada DSP, 2015, BRIT J PHARMACOL, V172, P4012, DOI 10.1111/bph.13145; Tikoo K, 2007, FEBS LETT, V581, P2027, DOI 10.1016/j.febslet.2007.04.036; Tonna S, 2010, NAT REV NEPHROL, V6, P332, DOI 10.1038/nrneph.2010.55; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Villeneuve LM, 2010, AM J PHYSIOL-RENAL, V299, pF14, DOI 10.1152/ajprenal.00200.2010; Wang Wei, 2006, Beijing Da Xue Xue Bao Yi Xue Ban, V38, P170; Wu YC, 2006, ENDOCRINOLOGY, V147, P44, DOI 10.1210/en.2005-0641; Yang JYO, 2009, AM J PHYSIOL-HEART C, V296, pH1850, DOI 10.1152/ajpheart.01199.2008; YIN FCP, 1982, AM J PHYSIOL, V243, pH941, DOI 10.1152/ajpheart.1982.243.6.H941; Zhang LW, 2012, DIABETES RES CLIN PR, V96, P286, DOI 10.1016/j.diabres.2011.12.006; Zick Y, 2004, BIOCHEM SOC T, V32, P812, DOI 10.1042/BST0320812; Zick Y, 2003, INT J OBESITY, V27, pS56, DOI 10.1038/sj.ijo.0802503	41	23	26	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					21848	21856		10.1074/jbc.C116.732990	http://dx.doi.org/10.1074/jbc.C116.732990			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27551045	hybrid, Green Published			2022-12-26	WOS:000386332600002
J	Wang, D; Li, XR; Dong, DJ; Huang, H; Wang, JX; Zhao, XF				Wang, Di; Li, Xiang-Ru; Dong, Du-Juan; Huang, Hua; Wang, Jin-Xing; Zhao, Xiao-Fan			The Steroid Hormone 20-Hydroxyecdysone Promotes the Cytoplasmic Localization of Yorkie to Suppress Cell Proliferation and Induce Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; cell proliferation; Hippo pathway; insect; steroid hormone; 20-hydroxyecdysone; Yorkie; cytoplasmic localization	HIPPO-YAP PATHWAY; DROSOPHILA-MELANOGASTER; SIZE-CONTROL; DEATH; METAMORPHOSIS; FAMILY; GENES; PHOSPHORYLATION; BIOSYNTHESIS; EXPRESSION	The transcriptional co-activator Yki (Yorkie), a member of the Hippo pathway, regulates cell proliferation or apoptosis, depending on its nuclear or cytoplasmic location. However, the upstream factors regulating the subcellular localization of Yki are unclear. We found that the steroid hormone 20-hydroxyecdysone (20E) induces phosphorylation of Yki, causing it to remain in the cytoplasm, where it promotes apoptosis in the midgut of the lepidopteran insect Helicoverpa armigera. Yki is expressed in various tissues, with an increase in the epidermis and midgut during early metamorphic molting. Yki is localized mainly in the nucleus of feeding larval midgut cells but is mainly localized in the cytoplasm of metamorphic molting larval midgut cells. The knockdown of Yki in the feeding larvae promotes larval-pupal transition, midgut programmed cell death, and repressed IAP1 (inhibitor of apoptosis 1) expression. Knockdown of Yki in the epidermal cell line (HaEpi) induced increased activation of Caspase3/7. Overexpressed Yki in HaEpi cells was mainly localized in the nucleus and induced cell proliferation. 20E promotes the cytoplasmic localization of Yki, reducing the expression of the IAP1, resulting in apoptosis. 20E promotes cytoplasmic retention of Yki by increasing Yki phosphorylation levels and promoting the interaction between Yki and the adaptor protein 14-3-3-E. This regulation of Yki suppresses cell proliferation and induces cell apoptosis.	[Wang, Di; Li, Xiang-Ru; Dong, Du-Juan; Huang, Hua; Wang, Jin-Xing; Zhao, Xiao-Fan] Shandong Univ, Sch Life Sci, Shandong Prov Key Lab Anim Cells & Dev Biol, Jinan 250100, Shandong, Peoples R China	Shandong University	Zhao, XF (corresponding author), Shandong Univ, Sch Life Sci, Jinan 250100, Shandong, Peoples R China.	xfzhao@sdu.edu.cn	Wang, Jin-Xing/AAU-1514-2021; Zhao, Xiao-Fan/AGW-9886-2022	Dong, Dujuan/0000-0003-3416-5017; Wang, Jin-Xing/0000-0003-0283-3930; Zhao, Xiao-Fan/0000-0003-1809-4730	National Natural Science Foundation of China [31230067, 31372261]; Ph.D. Programs Foundation of the Ministry of Education of China [20120131110025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of the Ministry of Education of China(Ministry of Education, China)	This work was supported by the National Natural Science Foundation of China Grants 31230067 and 31372261 and Ph.D. Programs Foundation of the Ministry of Education of China Grant 20120131110025. The authors declare that they have no conflicts of interest with the contents of this article.	Boo KH, 2010, BIOSCI BIOTECH BIOCH, V74, P2226, DOI 10.1271/bbb.100410; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cai MJ, 2012, APOPTOSIS, V17, P1327, DOI 10.1007/s10495-012-0761-y; Chehrehasa F, 2009, J NEUROSCI METH, V177, P122, DOI 10.1016/j.jneumeth.2008.10.006; Dong DJ, 2015, J BIOL CHEM, V290, P24738, DOI 10.1074/jbc.M115.643783; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Fraenkel G, 1935, PROC R SOC SER B-BIO, V118, P1, DOI 10.1098/rspb.1935.0044; Gilbert LI, 2004, MOL CELL ENDOCRINOL, V215, P1, DOI 10.1016/j.mce.2003.11.003; Hsueh YJ, 2015, MOL THER-METH CLIN D, V2, DOI 10.1038/mtm.2015.14; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Jiang CG, 1997, DEVELOPMENT, V124, P4673; Levy D, 2008, MOL CELL, V29, P350, DOI 10.1016/j.molcel.2007.12.022; Liu CY, 2015, CELL CYCLE, V14, P3045, DOI 10.1080/15384101.2015.1053664; Liu CY, 2013, APOPTOSIS, V18, P171, DOI 10.1007/s10495-012-0784-4; Liu W, 2014, J BIOL CHEM, V289, P13026, DOI 10.1074/jbc.M113.547018; Martin SJ, 2002, CELL, V109, P793, DOI 10.1016/S0092-8674(02)00802-4; Miller E, 2012, CHEM BIOL, V19, P955, DOI 10.1016/j.chembiol.2012.07.005; Mo JS, 2012, GENE DEV, V26, P2138, DOI 10.1101/gad.197582.112; Moroishi T, 2015, NAT REV CANCER, V15, P73, DOI 10.1038/nrc3876; Muslin AJ, 2000, CELL SIGNAL, V12, P703, DOI 10.1016/S0898-6568(00)00131-5; Nagashima S., 2016, CURR DRUG T IN PRESS; Ogawa S, 1967, Yakugaku Zasshi, V87, P325; Oh H, 2008, DEVELOPMENT, V135, P1081, DOI 10.1242/dev.015255; Orme M, 2009, APOPTOSIS, V14, P950, DOI 10.1007/s10495-009-0358-2; Riddiford LM, 2003, INSECT BIOCHEM MOLEC, V33, P1327, DOI 10.1016/j.ibmb.2003.06.001; Santinon G, 2016, TRENDS CELL BIOL, V26, P289, DOI 10.1016/j.tcb.2015.11.004; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shao HL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003127; Strassburger K, 2012, DEV BIOL, V367, P187, DOI 10.1016/j.ydbio.2012.05.008; Sui YP, 2009, INSECT MOL BIOL, V18, P443, DOI 10.1111/j.1365-2583.2009.00884.x; Sun GP, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004324; Tettamanti G, 2007, CELL TISSUE RES, V330, P345, DOI 10.1007/s00441-007-0449-8; Wennmann DO, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.476; Yin VP, 2007, J CELL BIOL, V178, P85, DOI 10.1083/jcb.200703206; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao XF, 2005, ARCH INSECT BIOCHEM, V58, P39, DOI 10.1002/arch.20030	38	8	10	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21761	21770		10.1074/jbc.M116.719856	http://dx.doi.org/10.1074/jbc.M116.719856			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27551043	Green Published, hybrid			2022-12-26	WOS:000385999200040
J	Hacker, KE; Fahey, CC; Shinsky, SA; Chiang, YCJ; DiFiore, JV; Jha, DK; Vo, AH; Shavit, JA; Davis, IJ; Strahl, BD; Rathmell, WK				Hacker, Kathryn E.; Fahey, Catherine C.; Shinsky, Stephen A.; Chiang, Yun-Chen J.; DiFiore, Julia V.; Jha, Deepak Kumar; Vo, Andy H.; Shavit, Jordan A.; Davis, Ian J.; Strahl, Brian D.; Rathmell, W. Kimryn			Structure/Function Analysis of Recurrent Mutations in SETD2 Protein Reveals a Critical and Conserved Role for a SET Domain Residue in Maintaining Protein Stability and Histone H3 Lys-36 Trimethylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; LYSINE 36 TRIMETHYLATION; DNA MISMATCH REPAIR; I-TASSER SERVER; H3K36 METHYLATION; HOMOLOGOUS RECOMBINATION; TRANSCRIPTION ELONGATION; SACCHAROMYCES-CEREVISIAE; METHYLTRANSFERASE SETD2; BRANCHED EVOLUTION	The yeast Set2 histone methyltransferase is a critical enzyme that plays a number of key roles in gene transcription and DNA repair. Recently, the human homologue, SETD2, was found to be recurrently mutated in a significant percentage of renal cell carcinomas, raising the possibility that the activity of SETD2 is tumor-suppressive. Using budding yeast and human cell line model systems, we examined the functional significance of two evolutionarily conserved residues in SETD2 that are recurrently mutated in human cancers. Whereas one of these mutations (R2510H), located in the Set2 Rpb1 interaction domain, did not result in an observable defect in SETD2 enzymatic function, a second mutation in the catalytic domain of this enzyme (R1625C) resulted in a complete loss of histone H3 Lys-36 trimethylation (H3K36me3). This mutant showed unchanged thermal stability as compared with the wild type protein but diminished binding to the histone H3 tail. Surprisingly, mutation of the conserved residue in Set2 (R195C) similarly resulted in a complete loss of H3K36me3 but did not affect dimethylated histone H3 Lys-36 (H3K36me2) or functions associated with H3K36me2 in yeast. Collectively, these data imply a critical role for Arg-1625 in maintaining the protein interaction with H3 and specific H3K36me3 function of this enzyme, which is conserved from yeast to humans. They also may provide a refined biochemical explanation for how H3K36me3 loss leads to genomic instability and cancer.	[Hacker, Kathryn E.; Fahey, Catherine C.; DiFiore, Julia V.; Davis, Ian J.; Strahl, Brian D.; Rathmell, W. Kimryn] Univ N Carolina, Dept Genet, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Hacker, Kathryn E.; Fahey, Catherine C.; Shinsky, Stephen A.; Chiang, Yun-Chen J.; Jha, Deepak Kumar; Davis, Ian J.; Strahl, Brian D.; Rathmell, W. Kimryn] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Shinsky, Stephen A.; DiFiore, Julia V.; Jha, Deepak Kumar; Strahl, Brian D.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Vo, Andy H.; Shavit, Jordan A.] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Davis, Ian J.] Univ N Carolina, Dept Pediat, Chapel Hill, NC 27514 USA; [Rathmell, W. Kimryn] Vanderbilt Ingram Canc Ctr, Dept Canc Biol, Div Hematol & Oncol, Nashville, TN 37232 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Michigan System; University of Michigan; University of North Carolina; University of North Carolina Chapel Hill; Vanderbilt University	Strahl, BD; Rathmell, WK (corresponding author), Univ N Carolina, Dept Genet, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA.; Strahl, BD; Rathmell, WK (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.; Strahl, BD (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.; Rathmell, WK (corresponding author), Vanderbilt Ingram Canc Ctr, Dept Canc Biol, Div Hematol & Oncol, Nashville, TN 37232 USA.	brian_strahl@med.unc.edu; kimryn.rathmell@vanderbilt.edu	Chiang, Yun/GRJ-5251-2022; Ariel, Pablo/AGJ-4118-2022; Jha, Deepak/AAK-2279-2020; Strahl, Brian D/C-7601-2012	Jha, Deepak/0000-0002-6657-5662; Davis, Ian/0000-0002-1552-0960; Strahl, Brian D/0000-0002-4947-6259; Fahey, Catherine/0000-0003-4347-361X	V Foundation Translational Research Grant; National Institutes of Health (NIH) [R01 CA198482, K24 CA172355]; UNC Medical Scientist Training Program [T32 GM008719-12]; National Research Service Award (NRSA) [TR000085-05]; NRSA [F30 CA192643-02]; UNC Lineberger Cancer Center Postdoctoral Fellowship Award; NIGMS; NIH [5T32 GM007092, R01 HL124232]; NATIONAL CANCER INSTITUTE [K24CA172355, R01CA166447, T32CA009156, F30CA192643, R01CA198482] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000085] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL124232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008719, T32GM007092] Funding Source: NIH RePORTER	V Foundation Translational Research Grant; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNC Medical Scientist Training Program; National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNC Lineberger Cancer Center Postdoctoral Fellowship Award; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the V Foundation Translational Research Grant (to B. D. S., I. J. D., and W. K. R.), National Institutes of Health (NIH) Grants R01 CA198482 (to B. D. S., I. J. D., and W. K. R.) and K24 CA172355 (to W. K. R.), UNC Medical Scientist Training Program Grant T32 GM008719-12 (to K. E. H. and C. C. F.), National Research Service Award (NRSA) Training Grant TR000085-05 (to C. C. F.), NRSA Award F30 CA192643-02 (to C. C. F.), a UNC Lineberger Cancer Center Postdoctoral Fellowship Award (to S. A. S.), NIGMS, NIH, award 5T32 GM007092 (to J. V. D.), and NIH Grant R01 HL124232 (to J. A. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al Sarakbi W, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-290; [Anonymous], 2013, NATURE, V499, P43, DOI [10.1038/nature12222, DOI 10.1038/NATURE12222, DOI 10.1038/nature12222]; Awwad SW, 2015, BIOL OPEN, V4, P498, DOI 10.1242/bio.201410991; Aymard F, 2014, NAT STRUCT MOL BIOL, V21, P366, DOI 10.1038/nsmb.2796; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Carvalho S, 2014, ELIFE, V3, DOI 10.7554/eLife.02482; Carvalho S, 2013, NUCLEIC ACIDS RES, V41, P2881, DOI 10.1093/nar/gks1472; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Daugaard M, 2012, NAT STRUCT MOL BIOL, V19, P803, DOI 10.1038/nsmb.2314; DeLano W. L, 2016, PYMOL MOL GRAPHICS S; Dhayalan A, 2010, J BIOL CHEM, V285, P26114, DOI 10.1074/jbc.M109.089433; Duns G, 2010, CANCER RES, V70, P4287, DOI 10.1158/0008-5472.CAN-10-0120; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; Fnu S, 2011, P NATL ACAD SCI USA, V108, P540, DOI 10.1073/pnas.1013571108; Fontebasso AM, 2013, ACTA NEUROPATHOL, V125, P659, DOI 10.1007/s00401-013-1095-8; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Guo R, 2014, MOL CELL, V56, P298, DOI 10.1016/j.molcel.2014.08.022; Jha DK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4965; Kanu N, 2015, ONCOGENE, V34, P5699, DOI 10.1038/onc.2015.24; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Li B, 2009, J BIOL CHEM, V284, P7970, DOI 10.1074/jbc.M808220200; Li F, 2013, CELL, V153, P590, DOI 10.1016/j.cell.2013.03.025; Li M, 2005, P NATL ACAD SCI USA, V102, P17636, DOI 10.1073/pnas.0506350102; Lickwar CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004886; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Mar BG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4469; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Pai CC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5091; Pfister SX, 2014, CELL REP, V7, P2006, DOI 10.1016/j.celrep.2014.05.026; Pradeepa MM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002717; Quan TK, 2010, GENETICS, V184, P321, DOI 10.1534/genetics.109.111526; Racusen LC, 1997, J LAB CLIN MED, V129, P318, DOI 10.1016/S0022-2143(97)90180-3; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Simon JM, 2014, GENOME RES, V24, P241, DOI 10.1101/gr.158253.113; Sorenson MR, 2016, RNA BIOL, V13, P412, DOI 10.1080/15476286.2016.1144009; Sun S, 2016, GENOME RES, V26, P670, DOI 10.1101/gr.192526.115; Sun XJ, 2005, J BIOL CHEM, V280, P35261, DOI 10.1074/jbc.M504012200; Venkatesh S, 2012, NATURE, V489, P452, DOI 10.1038/nature11326; Vojnic E, 2006, J BIOL CHEM, V281, P13, DOI 10.1074/jbc.C500423200; Wagner EJ, 2012, NAT REV MOL CELL BIO, V13, P115, DOI 10.1038/nrm3274; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Wen H, 2014, NATURE, V508, P263, DOI 10.1038/nature13045; Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yoh SM, 2008, GENE DEV, V22, P3422, DOI 10.1101/gad.1720008; Youdell ML, 2008, MOL CELL BIOL, V28, P4915, DOI 10.1128/MCB.00001-08; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zheng WH, 2012, J AM CHEM SOC, V134, P18004, DOI 10.1021/ja307060p; Zhu XF, 2014, NAT GENET, V46, P287, DOI 10.1038/ng.2894; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	58	39	41	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					21283	21295		10.1074/jbc.M116.739375	http://dx.doi.org/10.1074/jbc.M116.739375			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27528607	Green Published, hybrid			2022-12-26	WOS:000385406200040
J	Lee, DG; Yang, KE; Hwang, JW; Kang, HS; Lee, SY; Choi, S; Shin, J; Jang, IS; An, HJ; Chung, H; Jung, HI; Choi, JS				Lee, Dong-Gi; Yang, Kyeong Eun; Hwang, Jeong Won; Kang, Hwan-Soo; Lee, Seung-Yeul; Choi, Seoyeon; Shin, Joonchul; Jang, Ik-Soon; An, Hyun Joo; Chung, Heesun; Jung, Hyo-Il; Choi, Jong-Soon			Degradation of Kidney and Psoas Muscle Proteins as Indicators of Post-Mortem Interval in a Rat Model, with Use of Lateral Flow Technology	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; GENE-EXPRESSION; MESSENGER-RNA; TIME; STABILITY; DISEASE; TISSUE; DEATH; BLOOD	We investigated potential protein markers of post-mortem interval (PMI) using rat kidney and psoas muscle. Tissue samples were taken at 12 h intervals for up to 96 h after death by suffocation. Expression levels of eight soluble proteins were analyzed by Western blotting. Degradation patterns of selected proteins were clearly divided into three groups: short-term, mid-term, and long-term PMI markers based on the half maximum intensity of intact protein expression. In kidney, glycogen synthase (GS) and glycogen synthase kinase-3 beta were degraded completely within 48 h making them short-term PMI markers. AMP-activated protein kinase alpha, caspase 3 and GS were short-term PMI markers in psoas muscle. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was a mid-term PMI marker in both tissues. Expression levels of the typical long-term PMI markers, p53 and beta-catenin, were constant for at least 96 h post-mortem in both tissues. The degradation patterns of GS and caspase-3 were verified by immunohistochemistry in both tissues. GAPDH was chosen as a test PMI protein to perform a lateral flow assay (LFA). The presence of recombinant GAPDH was clearly detected in LFA and quantified in a concentration-dependent manner. These results suggest that LFA might be used to estimate PMI at a crime scene.	[Lee, Dong-Gi; Yang, Kyeong Eun; Hwang, Jeong Won; Kang, Hwan-Soo; Lee, Seung-Yeul; Jang, Ik-Soon; Choi, Jong-Soon] Korea Basic Sci Inst, Biol Disaster Anal Grp, Daejeon, South Korea; [Choi, Seoyeon; Jung, Hyo-Il] Yonsei Univ, Natl Core Res Ctr Nanomed Technol, Seoul, South Korea; [An, Hyun Joo; Chung, Heesun; Choi, Jong-Soon] Chungnam Natl Univ, Grad Sch Analyt Sci & Technol, Daejeon, South Korea; [Shin, Joonchul; Jung, Hyo-Il] Yonsei Univ, Sch Mech Engn, Seoul, South Korea	Korea Basic Science Institute (KBSI); Yonsei University; Chungnam National University; Yonsei University	Choi, JS (corresponding author), Korea Basic Sci Inst, Biol Disaster Anal Grp, Daejeon, South Korea.; Jung, HI (corresponding author), Yonsei Univ, Natl Core Res Ctr Nanomed Technol, Seoul, South Korea.; Choi, JS (corresponding author), Chungnam Natl Univ, Grad Sch Analyt Sci & Technol, Daejeon, South Korea.; Jung, HI (corresponding author), Yonsei Univ, Sch Mech Engn, Seoul, South Korea.	uridle7@yonsei.ac.kr; jschoi@kbsi.re.kr		Chung, Heesun/0000-0001-8900-091X; An, Hyun Joo/0000-0001-5847-7483; Chung, Heesun/0000-0003-1298-2358; Lee, Dong-Gi/0000-0002-6767-9543	Korea Basic Science Institute NAP project [T35780]; Infrastructure and transportation technology promotion research Program - Ministry of Land, Infrastructure and Transport of Korean government [14CTAP-C077516-01]	Korea Basic Science Institute NAP project; Infrastructure and transportation technology promotion research Program - Ministry of Land, Infrastructure and Transport of Korean government	This study was supported by the Korea Basic Science Institute NAP project (T35780). This research was supported by a grant (14CTAP-C077516-01) from Infrastructure and transportation technology promotion research Program funded by Ministry of Land, Infrastructure and Transport of Korean government.	Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Anderson L, 1997, ELECTROPHORESIS, V18, P533, DOI 10.1002/elps.1150180333; ANSARI KA, 1976, J NEUROPATH EXP NEUR, V35, P180, DOI 10.1097/00005072-197603000-00005; Bauer Martin, 2003, Leg Med (Tokyo), V5, P220, DOI 10.1016/j.legalmed.2003.08.001; Birdsill AC, 2011, CELL TISSUE BANK, V12, P311, DOI 10.1007/s10561-010-9210-8; BURGER FJ, 1978, CLIN CHIM ACTA, V84, P199, DOI 10.1016/0009-8981(78)90494-1; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Chandana R, 2009, INDIAN J MED RES, V129, P189; Choi S, 2015, ANAL METHODS-UK, V7, P1834, DOI 10.1039/c4ay02940b; FARMER JG, 1985, FORENSIC SCI INT, V27, P1, DOI 10.1016/0379-0738(85)90099-4; GEDDES JW, 1995, NEUROBIOL AGING, V16, P651, DOI 10.1016/0197-4580(95)00062-J; Goggins M, 1998, CLIN SCI, V94, P677, DOI 10.1042/cs0940677; Gonzalez-Herrera L, 2013, FORENSIC SCI INT, V232, P218, DOI 10.1016/j.forsciint.2013.08.001; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Haas C, 2009, FORENSIC SCI INT-GEN, V3, P80, DOI 10.1016/j.fsigen.2008.11.003; Hanson EK, 2009, ANAL BIOCHEM, V387, P303, DOI 10.1016/j.ab.2009.01.037; Henssge C, 2007, FORENSIC SCI INT, V165, P182, DOI 10.1016/j.forsciint.2006.05.017; Kemp CM, 2006, J ANIM SCI, V84, P2841, DOI 10.2527/jas.2006-163; Kumar S, 2016, J FORENSIC SCI, V61, pS241, DOI 10.1111/1556-4029.12928; Li XH, 1996, NEUROBIOL AGING, V17, P115, DOI 10.1016/0197-4580(95)02023-3; Li XH, 2010, NEUROPSYCHOPHARMACOL, V35, P2143, DOI 10.1038/npp.2010.105; Liang JF, 2013, MEAT SCI, V95, P536, DOI 10.1016/j.meatsci.2013.05.025; Lim NKH, 2014, HUM MOL GENET, V23, P4051, DOI 10.1093/hmg/ddu119; Madea B, 2005, FORENSIC SCI INT, V151, P139, DOI 10.1016/j.forsciint.2005.01.013; McDonagh L, 2009, FORENSIC SCI INT-GEN, V3, P162, DOI 10.1016/j.fsigen.2009.01.013; Nam JuHyun, 2013, Journal of Agricultural Science (Toronto), V5, P168; Patel S, 2008, MOL CELL BIOL, V28, P6314, DOI 10.1128/MCB.00763-08; Poloz YO, 2009, INT J LEGAL MED, V123, P305, DOI 10.1007/s00414-009-0343-x; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Rastogi SK, 2012, CHEM COMMUN, V48, P7714, DOI 10.1039/c2cc33430e; Rohrman BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045611; Rong-Hwa S, 2010, FOOD CHEM, V118, P462, DOI 10.1016/j.foodchem.2009.04.106; ROSS B, 1993, BRAIN RES, V629, P225, DOI 10.1016/0006-8993(93)91324-L; Sabucedo AJ, 2003, FORENSIC SCI INT, V134, P11, DOI 10.1016/S0379-0738(03)00080-X; Sampaio-Silva F, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056507, 10.1371/annotation/cb8b37ac-cbe2-45e3-b9fe-d62e7ced4b25]; Sanoudou D, 2004, PHYSIOL GENOMICS, V16, P222, DOI 10.1152/physiolgenomics.00137.2003; Setzer M, 2008, J FORENSIC SCI, V53, P296, DOI 10.1111/j.1556-4029.2007.00652.x; Smith K.G.V., 1986, BRIT MUSEUM NATURAL; Symonowicz K, 2014, EXP THER MED, V8, P1039, DOI 10.3892/etm.2014.1847; Tanic N, 2007, J MOL NEUROSCI, V32, P38, DOI 10.1007/s12031-007-0006-7; Tian Q, 2004, MOL CELL PROTEOMICS, V3, P960, DOI 10.1074/mcp.M400055-MCP200	41	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0160557	10.1371/journal.pone.0160557	http://dx.doi.org/10.1371/journal.pone.0160557			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27552165	gold, Green Published, Green Submitted			2022-12-26	WOS:000381768800013
J	Colin, D; Micheyl, C; Girod, A; Truy, E; Gallego, S				Colin, David; Micheyl, Christophe; Girod, Anneline; Truy, Eric; Gallego, Stephane			Binaural Diplacusis and Its Relationship with Hearing-Threshold Asymmetry	PLOS ONE			English	Article							AUDITORY-NERVE FIBERS; LONG-TERM MEASUREMENT; TONE PITCH ANOMALIES; COMPLEX TONES; FREQUENCY DISCRIMINATION; INTENSITY; CORTEX; REPRESENTATION; PERCEPTION; MATCHES	Binaural pitch diplacusis refers to a perceptual anomaly whereby the same sound is perceived as having a different pitch depending on whether it is presented in the left or the right ear. Results in the literature suggest that this phenomenon is more prevalent, and larger, in individuals with asymmetric hearing loss than in individuals with symmetric hearing. However, because studies devoted to this effect have thus far involved small samples, the prevalence of the effect, and its relationship with interaural asymmetries in hearing thresholds, remain unclear. In this study, psychometric functions for interaural pitch comparisons were measured in 55 subjects, including 12 normal-hearing and 43 hearing-impaired participants. Statistically significant pitch differences between the left and right ears were observed in normal-hearing participants, but the effect was usually small (less than 1.5/16 octave, or about 7%). For the hearing-impaired participants, statistically significant interaural pitch differences were found in about three-quarters of the cases. Moreover, for about half of these participants, the difference exceeded 1.5/16 octaves and, in some participants, was as large as or larger than 1/4 octave. This was the case even for the lowest frequency tested, 500 Hz. The pitch differences were weakly, but significantly, correlated with the difference in hearing thresholds between the two ears, such that larger threshold asymmetries were statistically associated with larger pitch differences. For the vast majority of the hearing-impaired participants, the direction of the pitch differences was such that pitch was perceived as higher on the side with the higher (i.e., 'worse') hearing thresholds than on the opposite side. These findings are difficult to reconcile with purely temporal models of pitch perception, but may be accounted for by place-based or spectrotemporal models.	[Colin, David; Truy, Eric] CNRS, Lyon Neurosci Res Ctr, INSERM, IMPACT Team,CRNL,U1028,UMR5292, Lyon, France; [Colin, David; Girod, Anneline; Gallego, Stephane] Inst Sci & Tech Readaptat, Lyon, France; [Micheyl, Christophe] Starkey France, Creteil, France; [Truy, Eric] Ctr Hosp & Univ, Hop Edouard Herriot, Dept ORL, Lyon, France; [Colin, David; Truy, Eric; Gallego, Stephane] Univ Lyon 1, Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Colin, D (corresponding author), CNRS, Lyon Neurosci Res Ctr, INSERM, IMPACT Team,CRNL,U1028,UMR5292, Lyon, France.; Colin, D (corresponding author), Inst Sci & Tech Readaptat, Lyon, France.; Colin, D (corresponding author), Univ Lyon 1, Lyon, France.	david.colin@univ-lyon1.fr	truy, eric/J-9097-2017	truy, eric/0000-0002-1769-8623	Audition Conseil, Starkey France, Hospices Civils de Lyon	Audition Conseil, Starkey France, Hospices Civils de Lyon	This study was funded by Audition Conseil, Starkey France, Hospices Civils de Lyon. The funders provided support in the form of salaries for authors DC (Audition Conseil), SG (Audition Conseil), CM (Starkey France), and ET (Hospices Civils de Lyon), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Albers GD, 1968, ARCH OTOLARYNGOL, V87, P600; Bekesy G., 1960, EXPERIMENTS IN HEARI; Brannstrom KJ, 2008, INT J AUDIOL, V47, P412, DOI 10.1080/14992020801991729; Brannstrom KJ, 2008, INT J AUDIOL, V47, P59, DOI 10.1080/14992020701643826; Brannstrom KJ, 2008, INT J AUDIOL, V47, P675, DOI 10.1080/14992020802215870; BURNS EM, 1982, J ACOUST SOC AM, V72, P1394, DOI 10.1121/1.388445; BURNS EM, 1986, J ACOUST SOC AM, V79, P1530, DOI 10.1121/1.393679; CARHART R, 1959, J SPEECH HEAR DISORD, V24, P330, DOI 10.1044/jshd.2404.330; Cariani PA, 1996, J NEUROPHYSIOL, V76, P1717, DOI 10.1152/jn.1996.76.3.1717; Cariani PA, 1996, J NEUROPHYSIOL, V76, P1698, DOI 10.1152/jn.1996.76.3.1698; Cedolin L, 2010, J NEUROSCI, V30, P12712, DOI 10.1523/JNEUROSCI.6365-09.2010; de Mare G., 1948, ACTA OTO-LARYNGOL, V74, P107; FLORENTINE M, 1983, J ACOUST SOC AM, V73, P961, DOI 10.1121/1.389021; GAETH JH, 1965, J SPEECH HEAR RES, V8, P63, DOI 10.1044/jshr.0801.63; GEISLER CD, 1974, J NEUROPHYSIOL, V37, P1156, DOI 10.1152/jn.1974.37.6.1156; GOLDSTEIN JL, 1978, J ACOUST SOC AM, V63, P486, DOI 10.1121/1.381749; HARRISON RV, 1979, ARCH OTO-RHINO-LARYN, V224, P71, DOI 10.1007/BF00455226; Henry KS, 2016, J NEUROSCI, V36, P2227, DOI 10.1523/JNEUROSCI.3944-15.2016; Henry KS, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00020; Henry KS, 2013, HEARING RES, V303, P39, DOI 10.1016/j.heares.2013.01.014; Huss M, 2005, J ACOUST SOC AM, V117, P3841, DOI 10.1121/1.1920167; Kale S, 2010, JARO-J ASSOC RES OTO, V11, P657, DOI 10.1007/s10162-010-0223-6; Kral Andrej, 2006, Adv Otorhinolaryngol, V64, P89, DOI 10.1159/000094647; LOEB GE, 1983, BIOL CYBERN, V47, P149, DOI 10.1007/BF00337005; Miller RL, 1997, J ACOUST SOC AM, V101, P3602, DOI 10.1121/1.418321; Moore B C, 2001, Trends Amplif, V5, P1, DOI 10.1177/108471380100500102; Muller M, 2010, HEARING RES, V268, P184, DOI 10.1016/j.heares.2010.05.021; Ogura M, 2003, INT J AUDIOL, V42, P297, DOI 10.3109/14992020309101321; Oxenham AJ, 2012, J NEUROSCI, V32, P13335, DOI 10.1523/JNEUROSCI.3815-12.2012; RAJAN R, 1993, J COMP NEUROL, V338, P17, DOI 10.1002/cne.903380104; ROBERTSON D, 1989, J COMP NEUROL, V282, P456, DOI 10.1002/cne.902820311; ROBINSON DO, 1975, J SPEECH HEAR RES, V18, P5, DOI 10.1044/jshr.1801.05; ROSE JE, 1971, J NEUROPHYSIOL, V34, P685, DOI 10.1152/jn.1971.34.4.685; Schouten JF, 1940, P K NED AKAD WETENSC, V43, P356; SCHWABER MK, 1993, AM J OTOL, V14, P252; SHAMMA SA, 1985, J ACOUST SOC AM, V78, P1622, DOI 10.1121/1.392800; SIEBERT WM, 1970, PR INST ELECTR ELECT, V58, P723, DOI 10.1109/PROC.1970.7727; Stevens SS, 1935, J ACOUST SOC AM, V6, P150, DOI 10.1121/1.1915715; Stevens SS, 1941, PSYCHOL BULL, V38, P548; Thomas A., 2006, R NEWS, V6, P12, DOI DOI 10.1159/000323281; TURNER CW, 1982, J SPEECH HEAR RES, V25, P34, DOI 10.1044/jshr.2501.34; VERSCHUURE J, 1975, ACUSTICA, V32, P33; WEBSTER JC, 1954, J ACOUST SOC AM, V26, P754, DOI 10.1121/1.1907412; Wever EG., 1949, THEORY HEARING; WILLOTT JF, 1993, J COMP NEUROL, V329, P402, DOI 10.1002/cne.903290310; WOOLF NK, 1981, HEARING RES, V4, P335, DOI 10.1016/0378-5955(81)90017-4; Zurmuhl G., 1930, Z SINNESPHYSIOL, V61, P40; Zwicker E., 1970, FREQUENCY ANAL PERIO, P376; ZWISLOCKI J, 1956, J ACOUST SOC AM, V28, P860, DOI 10.1121/1.1908495	49	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0159975	10.1371/journal.pone.0159975	http://dx.doi.org/10.1371/journal.pone.0159975			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536884	Green Published, Green Submitted, gold			2022-12-26	WOS:000381577000011
J	Dickinson, MB; Hutchinson, TF; Dietenberger, M; Matt, F; Peters, MP				Dickinson, Matthew B.; Hutchinson, Todd F.; Dietenberger, Mark; Matt, Frederick; Peters, Matthew P.			Litter Species Composition and Topographic Effects on Fuels and Modeled Fire Behavior in an Oak-Hickory Forest in the Eastern USA	PLOS ONE			English	Article							SOUTHERN APPALACHIAN MOUNTAINS; HARDWOOD LEAF-LITTER; PRESCRIBED FIRES; LIGNIN CONTROL; DECOMPOSITION; FLAMMABILITY; DYNAMICS; PLANT; REGENERATION; VEGETATION	Mesophytic species (esp. Acer rubrum) are increasingly replacing oaks (Quercus spp.) in fire-suppressed, deciduous oak-hickory forests of the eastern US. A pivotal hypothesis is that fuel beds derived from mesophytic litter are less likely than beds derived from oak litter to carry a fire and, if they do, are more likely to burn at lower intensities. Species effects, however, are confounded by topographic gradients that affect overstory composition and fuel bed decomposition. To examine the separate and combined effects of litter species composition and topography on surface fuel beds, we conducted a common garden experiment in oak-hickory forests of the Ohio Hills. Each common garden included beds composed of mostly oak and mostly maple litter, representative of oak-and maple-dominated stands, respectively, and a mixture of the two. Beds were replenished each fall for four years. Common gardens (N = 16) were established at four topographic positions (ridges, benches on south-and northeast-facing slopes, and stream terraces) at each of four sites. Litter source and topographic position had largely independent effects on fuel beds and modeled fire dynamics after four years of development. Loading (kg m(-2)) of the upper litter layer (L), the layer that primarily supports flaming spread, was least in more mesic landscape positions and for maple beds, implying greater decomposition rates for those situations. Bulk density in the L layer (kg m(-3)) was least for oak beds which, along with higher loading, would promote fire spread and fireline intensity. Loading and bulk density of the combined fermentation and humic (FH) layers were least on stream terrace positions but were not related to species. Litter-and FH-layer moistures during a 5-day dry-down period after a rain event were affected by time and topographic effects while litter source effects were not evident. Characteristics of flaming combustion determined with a cone calorimeter pointed to greater fireline intensity for oak fuel beds and unexpected interactions between litter source and topography. A spread index, which synthesizes a suite of fuel bed, particle, and combustion characteristics to indicate spread (vs extinction) potential, was primarily affected by litter source and, secondarily, by the low spread potentials on mesic landscape positions early in the 5-day dry-down period. A similar result was obtained for modeled fireline intensity. Our results suggest that the continuing transition from oaks to mesophytic species in the Ohio Hills will reduce fire spread potentials and fire intensities.	[Dickinson, Matthew B.; Hutchinson, Todd F.; Peters, Matthew P.] US Forest Serv, Northern Res Stn, Delaware, OH 43015 USA; [Dietenberger, Mark; Matt, Frederick] US Forest Serv, Forest Prod Lab, Madison, WI 53726 USA	United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service	Dickinson, MB (corresponding author), US Forest Serv, Northern Res Stn, Delaware, OH 43015 USA.	mbdickinson@fs.fed.us		Peters, Matthew/0000-0002-4793-0075	Northern Research Station; National Fire Plan	Northern Research Station(United States Department of Agriculture (USDA)United States Forest Service); National Fire Plan	This project was funded by the Northern Research Station and National Fire Plan.; The Common Garden experiment could not have been conducted without the coordination and work in the field by the Vinton Furnace State Experimental Forest crew, especially Bill Borovicka, Levi Miller, and David Hosack. Tony Bova helped with dry-down sampling. John Stanovick, Northern Research Station Statistician, provided indispensable assistance with statistical analyses. Antoine Randolph, Mike Stambaugh, Tom Waldrop, and Joe O'Brien and one anonymous reviewer provided helpful reviews of earlier drafts. This project was funded by the Northern Research Station and National Fire Plan.	ABER JD, 1982, CAN J BOT, V60, P2263, DOI 10.1139/b82-277; Abrams MD, 2001, OAK FOREST ECOSYSTEMS, P34; Abrams MD, 1998, BIOSCIENCE, V48, P355, DOI 10.2307/1313374; BLAIR JM, 1990, ECOLOGY, V71, P1976, DOI 10.2307/1937606; Boerner REJ, 1989, LANDSCAPE ECOL, V2, P82; BOERNER REJ, 1984, CAN J FOREST RES, V14, P794, DOI 10.1139/x84-141; Brose PH, 2013, FOREST SCI, V59, P322, DOI 10.5849/forsci.12-039; Brose PH, 1998, CAN J FOREST RES, V28, P331, DOI 10.1139/cjfr-28-3-331; Byram G.M., 1959, FOREST FIRE CONTROL, P61; Chapman SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062671; Clinton BD, 1998, SRS12 US FOR SERV; Crosby JS, 1974, NC162 US FOR SERV; Cruz MG, 2010, INT J WILDLAND FIRE, V19, P377, DOI 10.1071/WF08132; Davis MW, 1998, J WOOD CHEM TECHNOL, V18, P235, DOI 10.1080/02773819809349579; Dibble AC, 2007, INT J WILDLAND FIRE, V16, P426, DOI 10.1071/WF05103; Dickinson MB, 2013, CAN J FOREST RES, V43, P321, DOI 10.1139/cjfr-2012-0291; Dickinson MB, 2010, CAN J FOREST RES, V40, P2187, DOI 10.1139/X10-148; Dickinson M.B., 2001, FOREST FIRES, P477, DOI [10.1016/b978-012386660-8/50016-7, DOI 10.1016/B978-012386660-8/50016-7]; Dickinson MB, 2009, GTRNRSP46 USFS; Dilworth JR, 1971, VARIABLE PROBABILITY; Dyer JM, 2009, LANDSCAPE ECOL, V24, P391, DOI 10.1007/s10980-008-9316-6; Engber EA, 2012, CAN J FOREST RES, V42, P1965, DOI 10.1139/x2012-138; Fei SL, 2007, FOREST SCI, V53, P473; Fernandes PM, 2012, NEW PHYTOL, V194, P606, DOI 10.1111/j.1469-8137.2012.04065.x; Fushimi C, 2003, IND ENG CHEM RES, V42, P3929, DOI 10.1021/ie0300575; Gartner TB, 2004, OIKOS, V104, P230, DOI 10.1111/j.0030-1299.2004.12738.x; Haines DA, 1975, NC16 US FOR SERV N C; Hobbie SE, 2006, ECOLOGY, V87, P2288, DOI 10.1890/0012-9658(2006)87[2288:TSEODA]2.0.CO;2; Hutchinson TF, 2008, CAN J FOREST RES, V38, P1184, DOI 10.1139/X07-216; Hutchinson TF, 2012, CAN J FOREST RES, V42, P303, DOI [10.1139/X11-184, 10.1139/x11-184]; Iverson LR, 2008, FOREST ECOL MANAG, V255, P3035, DOI 10.1016/j.foreco.2007.09.088; Iverson LR, 1997, LANDSCAPE ECOL, V12, P331, DOI 10.1023/A:1007989813501; Kane JM, 2008, FOREST ECOL MANAG, V256, P2039, DOI 10.1016/j.foreco.2008.07.039; Keane RE, 2008, CAN J FOREST RES, V38, P1431, DOI 10.1139/X08-003; Kolaks J.J., 2004, P 14 CENTRAL HARDWOO, P168; Kreye JK, 2013, ECOL APPL, V23, P1976, DOI 10.1890/13-0503.1; Linn RR, 2013, AGR FOREST METEOROL, V173, P139, DOI 10.1016/j.agrformet.2012.11.007; LOFTIS D. L., 1993, OAK REG SER PROBL PR; Loomis RM, 1975, NC184 US FOR SERV N; Loucks E, 2008, SOUTH J APPL FOR, V32, P80, DOI 10.1093/sjaf/32.2.80; MEENTEMEYER V, 1978, ECOLOGY, V59, P465, DOI 10.2307/1936576; MELILLO JM, 1982, ECOLOGY, V63, P621, DOI 10.2307/1936780; Mell W, 2007, INT J WILDLAND FIRE, V16, P1, DOI 10.1071/WF06002; Mitchell RJ, 2009, J FOREST, V107, P391; Miyanishi K., 2001, FOREST FIRES BEHAV E, P437, DOI DOI 10.1016/B978-012386660-8/50015-5; MOORE AM, 1986, SOIL BIOL BIOCHEM, V18, P427, DOI 10.1016/0038-0717(86)90049-0; NOAA, CLIM WIND DAT US; Nowacki GJ, 2008, BIOSCIENCE, V58, P123, DOI 10.1641/B580207; QUINN PF, 1995, HYDROL PROCESS, V9, P161, DOI 10.1002/hyp.3360090204; Rothermel R. C., 1986, INT359 USDA FOR SERV; Rothermel R.C., 1972, MATH MODEL PREDICTIN; Ruefenacht B, 2008, PHOTOGRAMM ENG REM S, V74, P1379, DOI 10.14358/PERS.74.11.1379; SAS Institute Inc, 2013, SAS ACCESS 9 4 INT A; Scarff FR, 2006, FUNCT ECOL, V20, P745, DOI 10.1111/j.1365-2435.2006.01174.x; Schwilk DW, 2015, NEW PHYTOL, V206, P486, DOI 10.1111/nph.13372; SINSABAUGH RL, 1993, ECOLOGY, V74, P1594, DOI 10.2307/1940087; Sorensen R, 2005, HYDROL EARTH SYST SC, V2, P1807, DOI DOI 10.5194/HESSD-2-1807-2005; Stambaugh MC, 2008, FOREST ECOL MANAG, V254, P463, DOI 10.1016/j.foreco.2007.08.029; Stottlemyer AD, 2009, INT J WILDLAND FIRE, V18, P423, DOI 10.1071/WF08017; Suarez ER, 2006, BIOL INVASIONS, V8, P553, DOI 10.1007/s10530-005-1196-y; Tang W., 1967, FPL82 USDA FOR SERV; Tarboton DG, 1997, WATER RESOUR RES, V33, P309, DOI 10.1029/96WR03137; USDA, 2003, KEYS SOIL TAXONOMY; Varner JM, 2015, CURR FOR REP, V1, P91, DOI 10.1007/s40725-015-0012-x; Vivanco L, 2008, J ECOL, V96, P727, DOI 10.1111/j.1365-2745.2008.01393.x; Waldrop TA, 2007, CAN J FOREST RES, V37, P1134, DOI 10.1139/X06-302; Weir JR, 2013, FIRE ECOLOGY, V9; White RH, 2010, INT J WILDLAND FIRE, V19, P213, DOI 10.1071/WF07128; WHITTAKER RH, 1956, ECOL MONOGR, V26, P1, DOI 10.2307/1943577; Wilson R., 1980, INT292 DEP AGR FOR S; WILSON RA, 1985, COMBUST SCI TECHNOL, V44, P179, DOI 10.1080/00102208508960302; [No title captured]	72	18	18	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0159997	10.1371/journal.pone.0159997	http://dx.doi.org/10.1371/journal.pone.0159997			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536964	gold, Green Published, Green Submitted			2022-12-26	WOS:000381577000012
J	Edwards, H; Rubenstein, M; Dombkowski, AA; Caldwell, JT; Chu, R; Xavier, AC; Thummel, R; Neely, M; Matherly, LH; Ge, YB; Taub, JW				Edwards, Holly; Rubenstein, Mara; Dombkowski, Alan A.; Caldwell, J. Timothy; Chu, Roland; Xavier, Ana C.; Thummel, Ryan; Neely, Melody; Matherly, Larry H.; Ge, Yubin; Taub, Jeffrey W.			Gene Signature of High White Blood Cell Count in B-Precursor Acute Lymphoblastic Leukemia	PLOS ONE			English	Article							EXPRESSION; CHILDHOOD; CHANNELS; RISK	In this study we sought to identify genetic factors associated with the presenting white blood cell (WBC) count in B-precursor acute lymphoblastic leukemia (BP-ALL). Using ETV6-RUNX1-positive BP-ALL patient samples, a homogeneous subtype, we identified 16 differentially expressed genes based on the presenting WBC count (< 50,000/cumm vs > 50,000). We further confirmed that IL1R1, BCAR3, KCNH2, PIR, and ZDHHC23 were differentially expressed in a larger cohort of ETV6-RUNX1-negative BP-ALL patient samples. Statistical analysis demonstrated that expression levels of these genes could accurately categorize high and low WBC count subjects using two independent patient sets, representing positive and negative ETV6-RUNX1 cases. Further studies in leukemia cell line models will better delineate the role of these genes in regulating the white blood cell count and potentially identify new therapeutic targets.	[Edwards, Holly; Matherly, Larry H.; Ge, Yubin] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI USA; [Edwards, Holly; Matherly, Larry H.; Ge, Yubin; Taub, Jeffrey W.] Wayne State Univ, Barbara Ann Karmanos Canc Inst, Mol Therapeut Program, Sch Med, Detroit, MI USA; [Rubenstein, Mara; Chu, Roland; Taub, Jeffrey W.] Childrens Hosp Michigan, Div Pediat Hematol Oncol, Detroit, MI 48201 USA; [Dombkowski, Alan A.] Childrens Hosp Michigan, Div Clin Pharmacol & Toxicol, Detroit, MI 48201 USA; [Dombkowski, Alan A.; Chu, Roland; Taub, Jeffrey W.] Wayne State Univ, Sch Med, Dept Pediat, Detroit, MI 48201 USA; [Caldwell, J. Timothy] Wayne State Univ, MD PhD Program, Sch Med, Detroit, MI USA; [Caldwell, J. Timothy] Wayne State Univ, Canc Biol Program, Sch Med, Detroit, MI USA; [Xavier, Ana C.] Univ Alabama Birmingham, Childrens Hosp Alabama, Div Pediat Hematol Oncol, Birmingham, AL USA; [Thummel, Ryan] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA; [Neely, Melody] Wayne State Univ, Sch Med, Dept Immunol & Microbiol, Detroit, MI 48201 USA; [Matherly, Larry H.] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA	Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Children's Hospital of Michigan; Children's Hospital of Michigan; Wayne State University; Wayne State University; Wayne State University; University of Alabama System; University of Alabama Birmingham; Wayne State University; Wayne State University; Wayne State University	Taub, JW (corresponding author), Wayne State Univ, Barbara Ann Karmanos Canc Inst, Mol Therapeut Program, Sch Med, Detroit, MI USA.; Taub, JW (corresponding author), Childrens Hosp Michigan, Div Pediat Hematol Oncol, Detroit, MI 48201 USA.; Taub, JW (corresponding author), Wayne State Univ, Sch Med, Dept Pediat, Detroit, MI 48201 USA.	jtaub@med.wayne.edu	Neely, Melody N/AAX-1130-2021	Neely, Melody N/0000-0003-2125-7836; Dombkowski, Alan/0000-0002-0312-8750; Ge, Yubin/0000-0002-8748-716X	National Cancer Institute [R01 CA120772, T32 CA009531]; Center for Urban Responses to Environmental Stressors [CURES: Wayne State University] P30 Center grant [P30 ES020957]; Karmanos Cancer Institute; Kids Without Cancer; Elana Fund; Herrick Foundation; Justin's Gift Charity; Buric Family; Sehn Family Foundation; Dale Meyer Memorial Endowment for Leukemia Research; Children's Hospital of Michigan Foundation; Ginopolis-Karmanos Endowment; Decerchio/Guisewite Family; Ring Screw Textron Endowed Chair for Pediatric Cancer Research	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Urban Responses to Environmental Stressors [CURES: Wayne State University] P30 Center grant; Karmanos Cancer Institute; Kids Without Cancer; Elana Fund; Herrick Foundation; Justin's Gift Charity; Buric Family; Sehn Family Foundation; Dale Meyer Memorial Endowment for Leukemia Research; Children's Hospital of Michigan Foundation; Ginopolis-Karmanos Endowment; Decerchio/Guisewite Family; Ring Screw Textron Endowed Chair for Pediatric Cancer Research	This study was supported by grants from the National Cancer Institute (R01 CA120772), Center for Urban Responses to Environmental Stressors [CURES: Wayne State University] P30 Center grant (P30 ES020957), Karmanos Cancer Institute, Kids Without Cancer, Elana Fund, the Herrick Foundation, Justin's Gift Charity, The Buric Family, Sehn Family Foundation, Dale Meyer Memorial Endowment for Leukemia Research, Children's Hospital of Michigan Foundation, Ginopolis-Karmanos Endowment, Decerchio/Guisewite Family, and the Ring Screw Textron Endowed Chair for Pediatric Cancer Research. JTC is a predoctoral trainee supported by T32 CA009531 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcangeli A., 2005, NOVART FDN SYMP, V266, P32; Arcangeli Annarosa, 2005, V266, P225; Cherubini A, 2005, MOL BIOL CELL, V16, P2972, DOI 10.1091/mbc.E04-10-0940; Licciulli S, 2010, LEUKEMIA, V24, P429, DOI 10.1038/leu.2009.247; Liu F, 2013, P NATL ACAD SCI USA, V110, P9722, DOI 10.1073/pnas.1221743110; Schrecengost RS, 2007, CANCER RES, V67, P6174, DOI 10.1158/0008-5472.CAN-06-3455; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Smith M, 1996, J CLIN ONCOL, V14, P18, DOI 10.1200/JCO.1996.14.1.18; Teachey DT, 2013, BRIT J HAEMATOL, V162, P606, DOI 10.1111/bjh.12442; Tian LJ, 2012, J BIOL CHEM, V287, P14718, DOI 10.1074/jbc.M111.335547; Ward E, 2014, CA-CANCER J CLIN, V64, P83, DOI 10.3322/caac.21219; Xie CZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079106	12	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161539	10.1371/journal.pone.0161539	http://dx.doi.org/10.1371/journal.pone.0161539			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536776	Green Submitted, Green Published, gold			2022-12-26	WOS:000381577000120
J	Hughesman, CB; Lu, XJD; Liu, KYP; Zhu, YQ; Poh, CF; Haynes, C				Hughesman, Curtis B.; Lu, X. J. David; Liu, Kelly Y. P.; Zhu, Yuqi; Poh, Catherine F.; Haynes, Charles			A Robust Protocol for Using Multiplexed Droplet Digital PCR to Quantify Somatic Copy Number Alterations in Clinical Tissue Specimens	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; INITIAL DIAGNOSIS; NUCLEIC-ACIDS; DNA INTEGRITY; CANCER; QUANTIFICATION; QUANTITATION; PROGRESSION; RESOLUTION; STRATEGIES	The ability of droplet digital PCR (ddPCR) to accurately determine the concentrations of amplifiable targets makes it a promising platform for measuring copy number alterations (CNAs) in genomic biomarkers. However, its application to clinical samples, particularly formalin-fixed paraffin-embedded specimens, will require strategies to reliably determine CNAs in DNA of limited quantity and quality. When applied to cancerous tissue, those methods must also account for global genetic instability and the associated probability that the abundance(s) of one or more chosen reference loci do not represent the average ploidy of cells comprising the specimen. Here we present an experimental design strategy and associated data analysis tool that enables accurate determination of CNAs in a panel of biomarkers using multiplexed ddPCR. The method includes strategies to optimize primer and probes design to cleanly segregate droplets in the data output from reaction wells amplifying multiple independent templates, and to correct for bias from artifacts such as DNA fragmentation. We demonstrate how a panel of reference loci can be used to determine a stable CNA-neutral benchmark. These innovations, when taken together, provide a comprehensive strategy that can be used to reliably detect biomarker CNAs in DNA extracted from either frozen or FFPE tissue biopsies.	[Hughesman, Curtis B.; Lu, X. J. David; Liu, Kelly Y. P.; Zhu, Yuqi; Poh, Catherine F.] Univ British Columbia, Dept Oral Med Biol Sci, Fac Dent, Vancouver, BC V6T 1Z3, Canada; [Hughesman, Curtis B.; Haynes, Charles] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; [Poh, Catherine F.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 2B5, Canada; [Poh, Catherine F.] British Columbia Canc Res Ctr, Dept Integrat Oncol, Vancouver, BC V5Z 1L3, Canada; [Haynes, Charles] Univ British Columbia, Dept Chem & Biol Engn, RESEAU NSERC Res Network, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia; University of British Columbia; British Columbia Cancer Agency; University of British Columbia	Poh, CF (corresponding author), Univ British Columbia, Dept Oral Med Biol Sci, Fac Dent, Vancouver, BC V6T 1Z3, Canada.; Haynes, C (corresponding author), Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada.; Poh, CF (corresponding author), Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 2B5, Canada.; Poh, CF (corresponding author), British Columbia Canc Res Ctr, Dept Integrat Oncol, Vancouver, BC V5Z 1L3, Canada.; Haynes, C (corresponding author), Univ British Columbia, Dept Chem & Biol Engn, RESEAU NSERC Res Network, Vancouver, BC V6T 1Z3, Canada.	cpoh@dentistry.ubc.ca; israels@mail.ubc.ca			Genome British Columbia [SOF-7-2015]	Genome British Columbia	This work was funded by Genome British Columbia (http://www.genomebc.ca/): Grant SOF-7-2015 awarded to CFP and CH.	Abbas T, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012914; Andor N, 2016, NAT MED, V22, P105, DOI 10.1038/nm.3984; Belgrader P, 2013, CLIN CHEM, V59, P991, DOI 10.1373/clinchem.2012.197855; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bidshahri R, 2016, J MOL DIAGN, V18, P190, DOI 10.1016/j.jmoldx.2015.09.003; Brisco MJ, 2010, BIOTECHNIQUES, V49, P893, DOI 10.2144/000113567; D'haene B, 2010, METHODS, V50, P262, DOI 10.1016/j.ymeth.2009.12.007; Day E, 2013, METHODS, V59, P101, DOI 10.1016/j.ymeth.2012.08.001; Despierre E, 2014, GYNECOL ONCOL, V135, P415, DOI 10.1016/j.ygyno.2014.09.014; Didelot A, 2013, CLIN CHEM, V59, P815, DOI 10.1373/clinchem.2012.193409; Do HD, 2015, CLIN CHEM, V61, P64, DOI 10.1373/clinchem.2014.223040; Dorazio RM, 2015, ANAL CHEM, V87, P10886, DOI 10.1021/acs.analchem.5b02429; Dube S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002876; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; Garcia-Murillas I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083409; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hedegaard J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098187; Heyries KA, 2011, NAT METHODS, V8, P649, DOI [10.1038/NMETH.1640, 10.1038/nmeth.1640]; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Hu LP, 2014, BIOMARK RES, V2, DOI 10.1186/2050-7771-2-3; Hughesman C, 2015, BIOCHEMISTRY-US, V54, P1338, DOI 10.1021/bi500905b; Hurvitz SA, 2013, CANCER TREAT REV, V39, P219, DOI 10.1016/j.ctrv.2012.04.008; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim MJ, 2016, J MOL DIAGN, V18, P253, DOI 10.1016/j.jmoldx.2015.11.002; Kinugasa H, 2015, BRIT J CANCER, V112, P1652, DOI 10.1038/bjc.2015.129; Li WL, 2013, PHYSIOL GENOMICS, V45, P1, DOI 10.1152/physiolgenomics.00082.2012; Liu BA, 2013, ONCOTARGET, V4, P1868, DOI 10.18632/oncotarget.1537; Lund HL, 2016, ANAL CHEM, V88, P4879, DOI 10.1021/acs.analchem.6b00707; Lund HL, 2016, ANAL BIOANAL CHEM, V408, P1079, DOI 10.1007/s00216-015-9204-2; McDermott GP, 2013, ANAL CHEM, V85, P11619, DOI 10.1021/ac403061n; Miotke L, 2014, ANAL CHEM, V86, P2618, DOI 10.1021/ac403843j; Mizoguchi M, 2011, BRAIN TUMOR PATHOL, V28, P191, DOI 10.1007/s10014-011-0038-0; Nadauld L, 2012, TRANSLATIONAL MED, V2; Okello JBA, 2010, ANAL BIOCHEM, V400, P110, DOI 10.1016/j.ab.2010.01.014; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Poh CF, 2012, J DENT RES, V91, P52, DOI 10.1177/0022034511425676; Salahshourifar I, 2014, ORAL ONCOL, V50, P404, DOI 10.1016/j.oraloncology.2014.02.005; Scheinin I, 2014, GENOME RES, V24, P2022, DOI 10.1101/gr.175141.114; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Shen ZY, 2011, J MOL CELL BIOL, V3, P1, DOI 10.1093/jmcb/mjq057; Snijders AM, 2001, NAT GENET, V29, P263, DOI 10.1038/ng754; Trypsteen W, 2015, ANAL BIOANAL CHEM, V407, P5827, DOI 10.1007/s00216-015-8773-4; Tsui IFL, 2010, HEAD NECK-J SCI SPEC, V32, P1143, DOI 10.1002/hed.21311; Tsui IFL, 2009, AM J SURG PATHOL, V33, P1732, DOI 10.1097/PAS.0b013e3181b669c2; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Whale AS, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks203; Ylstra B, 2006, NUCLEIC ACIDS RES, V34, P445, DOI 10.1093/nar/gkj456; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zhang LW, 2012, CANCER PREV RES, V5, P1081, DOI 10.1158/1940-6207.CAPR-12-0173; Zhong Q, 2011, LAB CHIP, V11, P2167, DOI 10.1039/c1lc20126c	51	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161274	10.1371/journal.pone.0161274	http://dx.doi.org/10.1371/journal.pone.0161274			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537682	Green Published, Green Submitted, gold			2022-12-26	WOS:000381577000078
J	Pandey, AK; Penny, WF; Bhargava, V; Lai, NC; Xu, RH; Hammond, HK				Pandey, Amit K.; Penny, William F.; Bhargava, Valmik; Lai, N. Chin; Xu, Ronghui; Hammond, H. Kirk			Clinical Evaluation of Heart Failure: Agreement among Tests	PLOS ONE			English	Article							EXERCISE CAPACITY; VENTRICULAR CONTRACTILITY; PRESSURE; CARDIOMYOPATHY; VALIDATION; INDEXES; DP/DT; RISE	Methods commonly used clinically to assess cardiac function in patients with heart failure include ejection fraction (EF), exercise treadmill testing (ETT), and symptom evaluation. Although these approaches are useful in evaluating patients with heart failure, there are at times substantial mismatches between individual assessments. For example, ETT results are often discordant with EF, and patients with minimal symptoms sometimes have surprisingly low EFs. To better define the relationship of these methods of assessment, we studied 56 patients with heart failure with reduced EF (HFrEF) who underwent measurement of ETT duration, EF by echocardiography, quantitative symptom evaluation, and LV peak dP/dt (rate of left ventricular pressure development and decline, measured invasively). Correlations were determined among these four tests in order to assess the relationship of EF, ETT, and symptoms against LV peak dP/dt. In addition, we sought to determine whether EF, ETT, and symptoms correlated with each other. Overall, correlations were poor. Only 15 of 63 total correlations (24%) were significant (p < 0.05). EF correlated most closely with LV peak -dP/dt. Linear regression analysis indicated that EF, ETT, and symptoms taken together predicted LV peak dP/dt better than any one measure alone. We conclude that clinical tests used to assess LV function in patients with HFrEF may not be as accurate or correlate as well as expected. All three clinical measures considered together may be the best representation of cardiac function in HFrEF patients currently available.	[Pandey, Amit K.; Penny, William F.; Bhargava, Valmik; Lai, N. Chin; Hammond, H. Kirk] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Pandey, Amit K.; Penny, William F.; Bhargava, Valmik; Lai, N. Chin; Hammond, H. Kirk] VA San Diego Healthcare Syst, Dept Med, San Diego, CA USA; [Xu, Ronghui] Univ Calif San Diego, Dept Family Med & Publ Hlth, San Diego, CA 92103 USA; [Xu, Ronghui] Univ Calif San Diego, Dept Math, San Diego, CA 92103 USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; University of California System; University of California San Diego	Hammond, HK (corresponding author), Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA.; Hammond, HK (corresponding author), VA San Diego Healthcare Syst, Dept Med, San Diego, CA USA.	khammond@ucsd.edu			National Institutes of Health [P01HL66941]; NHLBI Gene Therapy Resource Program [HHSN2682012000021]; Renova Therapeutics, Inc. (San Diego, CA) via an NIH Public Private Partnership; Merit grant from the Department of Veteran's Affairs [1101BX001515]; National Institute of Health [P01HL66941]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL066941] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001515] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI Gene Therapy Resource Program; Renova Therapeutics, Inc. (San Diego, CA) via an NIH Public Private Partnership; Merit grant from the Department of Veteran's Affairs; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	The clinical trial from which the data of the current study is based was funded by National Institutes of Health grants (P01HL66941; https://grants.nih.gov/grants/oer.htm), NHLBI Gene Therapy Resource Program (HHSN2682012000021; www.gtrp.org), Renova Therapeutics, Inc. (San Diego, CA; http://renovatherapeutics.com/) via an NIH Public Private Partnership, and a Merit grant from the Department of Veteran's Affairs (1101BX001515). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by National Institute of Health grant (P01HL66941,) NHLBI Gene Therapy Resource Program (HHSN2682012000021), and a Merit grant from the Department of Veteran's Affairs (1101BX001515).	BARGIGGIA GS, 1989, CIRCULATION, V80, P1287, DOI 10.1161/01.CIR.80.5.1287; BENGE W, 1980, CIRCULATION, V61, P955, DOI 10.1161/01.CIR.61.5.955; Bhargava V, 1998, AM J CARDIOL, V81, P1130, DOI 10.1016/S0002-9149(98)00133-7; Bhargava V, 1996, CATHETER CARDIO DIAG, V37, P105, DOI 10.1002/(SICI)1097-0304(199601)37:1<105::AID-CCD26>3.0.CO;2-J; BRISTOW MR, 1993, J CLIN INVEST, V92, P2737, DOI 10.1172/JCI116891; Butler J, 1999, J AM COLL CARDIOL, V34, P1802, DOI 10.1016/S0735-1097(99)00408-8; Chung N, 1992, J Am Soc Echocardiogr, V5, P147; COLUCCI WS, 1990, CIRCULATION, V82, P44; FRANCIOSA JA, 1981, AM J CARDIOL, V47, P33, DOI 10.1016/0002-9149(81)90286-1; Gemignani V, 2010, PACE, V33, P795, DOI 10.1111/j.1540-8159.2009.02684.x; GLEASON WL, 1962, J CLIN INVEST, V41, P80, DOI 10.1172/JCI104469; Green CP, 2000, J AM COLL CARDIOL, V35, P1245, DOI 10.1016/S0735-1097(00)00531-3; Guglin M, 2012, INT J CLIN PRACT, V66, P1224, DOI 10.1111/j.1742-1241.2012.03003.x; GUNDERSEN T, 1994, EUR HEART J, V15, P1659; Hammond HK, 2016, JAMA CARDIO IN PRESS; Hare JM, 1998, CIRCULATION, V97, P161, DOI 10.1161/01.CIR.97.2.161; Harrington D, 1997, J AM COLL CARDIOL, V30, P1758, DOI 10.1016/S0735-1097(97)00381-1; KASS DA, 1987, CIRCULATION, V76, P1422, DOI 10.1161/01.CIR.76.6.1422; MASON DT, 1971, CIRCULATION, V44, P47, DOI 10.1161/01.CIR.44.1.47; MASON DT, 1969, AM J CARDIOL, V23, P516, DOI 10.1016/0002-9149(69)90005-8; Olsson LG, 2005, EUR HEART J, V26, P778, DOI 10.1093/eurheartj/ehi162; Parekh R, 2013, ECHOCARDIOGR-J CARD, V30, P267, DOI 10.1111/echo.12042; Roger VL, 2012, CIRCULATION, V125, P188, DOI 10.1161/CIR.0b013e3182456d46; SULLIVAN MJ, 1992, CHEST, V101, pS340, DOI 10.1378/chest.101.5.340S; Zhang B, 2015, JOVE-J VIS EXP, DOI 10.3791/52618	25	1	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161536	10.1371/journal.pone.0161536	http://dx.doi.org/10.1371/journal.pone.0161536			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537778	gold, Green Published			2022-12-26	WOS:000381577000119
J	Wang, GS; Tong, DM; Chen, XD; Yang, TH; Zhou, YT; Ma, XB				Wang, Guang-Sheng; Tong, Dao-Ming; Chen, Xiao-Dong; Yang, Tong-Hui; Zhou, Ye-Ting; Ma, Xiao-Bo			Metabolic Syndrome Is a Strong Risk Factor for Minor Ischemic Stroke and Subsequent Vascular Events	PLOS ONE			English	Article							COMPONENTS; PREVALENCE; HEALTH; ATTACK	Background Minor ischemic stroke (MIS) represents a major global public health problem worldwide due to high incidence. The aim of this study was to investigate whether metabolic syndrome (MetS) is a strong risk for MIS and subsequent vascular events (SVE). Methods A retrospective cohort study was performed examining symptomatic MIS in a Chinese neurologic outpatient population aged over 25 years without history of stroke. MetS was defined using the International Diabetes Federation criteria. MIS was diagnosed by magnetic resonance imaging-diffusion weighted images or fluid-attenuated inversion recovery. Results Of 1361 outpatients, a total of 753 (55.3%) patients were diagnosed with MIS; of them, 80% had a score of 0 using the MIS had a 0 score on the National Institutes of Health Stroke Scale. Among these, 303 (40.2%) individuals with MIS were diagnosed with MetS. Diagnosed of MIS with MetS significantly correlated with abdominal obesity (30.7% v.s 18.0%), hypertension (91.1% v.s 81.6%), increased blood glucose (6.9 +/- 2.4 v.s 5.0 +/- 0.4), dyslipidemia (78.2% v.s 48.2%), and SVE (50.5% v.s 11.3%) when compared with the controls group. On adjusted analysis, the risk of SVE was also significantly associated with three additional MetS criterion (RR, 9.0; 95% CI, 5.677-14.46). Using Cox proportional analysis, risk of SVE in patient with MIS was significantly associated with MetS (RR, 3.3; 95% CI, 1.799-6.210), older age (RR, 1.0; 95% CI, 1.001-1.048), and high blood glucose (RR, 1.1; 95% CI, 1.007-1.187). Conclusions The MetS is a strong risk factor for MIS, and patients presenting with MIS and MetS are at a high risk of SVE. Further studies are required to determine the improvement of Mets prevention in the reduction of MIS and SVE.	[Wang, Guang-Sheng; Tong, Dao-Ming; Chen, Xiao-Dong; Yang, Tong-Hui] XuZhou Med Univ, Affiliated Shu Yang Peoples Hosp, Dept Neurol, Xuzhou, Peoples R China; [Zhou, Ye-Ting] XuZhou Med Univ, Affiliated Shu Yang Peoples Hosp, Dept Clin Res, Xuzhou, Peoples R China; [Ma, Xiao-Bo] XuZhou Med Univ, Affiliated Shu Yang Peoples Hosp, Dept Sci & Educ, Xuzhou, Peoples R China	Xuzhou Medical University; Xuzhou Medical University; Xuzhou Medical University	Tong, DM (corresponding author), XuZhou Med Univ, Affiliated Shu Yang Peoples Hosp, Dept Neurol, Xuzhou, Peoples R China.	tongdaoming@163.com			Medical Research Council	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work is supported by a grant from the Medical Research Council, affiliated Shu Yang People's Hospital, XuZhou Medical University, China.; This work is supported by a grant from the Medical Research Council, affiliated Shu Yang People's Hospital, XuZhou Medical University, China.	Abboud H, 2013, INT J STROKE, V8, P4, DOI 10.1111/j.1747-4949.2012.00893.x; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Bang OY, 2005, NEUROLOGY, V65, P296, DOI 10.1212/01.wnl.0000168862.09764.9f; Bos MJ, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001634; Brisset M, 2013, NEUROLOGY, V80, P662, DOI 10.1212/WNL.0b013e318281ccc2; Chandratheva A, 2010, STROKE, V41, P1108, DOI 10.1161/STROKEAHA.109.576611; Chen YC, 2014, J HUM HYPERTENS, V28, P689, DOI 10.1038/jhh.2013.152; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Fang XH, 2016, J STROKE CEREBROVASC, V25, P626, DOI 10.1016/j.jstrokecerebrovasdis.2015.11.017; Fischer U, 2010, STROKE, V41, P661, DOI 10.1161/STROKEAHA.109.572883; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Kono Y, 2011, CEREBROVASC DIS, V31, P365, DOI 10.1159/000323233; Koren-Morag N, 2005, STROKE, V36, P1366, DOI 10.1161/01.STR.0000169945.75911.33; Li Wei, 2009, Zhonghua Yi Xue Za Zhi, V89, P2759; Lim S, 2011, DIABETES CARE, V34, P1323, DOI 10.2337/dc10-2109; Liu L, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0080-8; Lucke-Wold Brandon P., 2012, Yale Journal of Biology and Medicine, V85, P523; Mahmood SS, 2014, LANCET, V383, P999, DOI 10.1016/S0140-6736(13)61752-3; Mallmann AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035680; Mi DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051421; Milionis HJ, 2005, STROKE, V36, P1372, DOI 10.1161/01.STR.0000169935.35394.38; Osborn MF, 2014, J STROKE CEREBROVASC, V23, P1477, DOI 10.1016/j.jstrokecerebrovasdis.2013.12.017; Peters SAE, 2014, LANCET, V383, P1973, DOI 10.1016/S0140-6736(14)60040-4; Potter GM, 2011, STROKE, V42, P359, DOI 10.1161/STROKEAHA.110.594754; Purroy F, 2004, STROKE, V35, P2313, DOI 10.1161/01.STR.0000141703.21173.91; Suh S, 2014, ENDOCRINOL METAB, V29, P522, DOI 10.3803/EnM.2014.29.4.522; Toni D, 2014, INT J STROKE, V9, P873, DOI 10.1111/ijs.12150; Tuttolomondo A, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-28; Tuttolomondo A, 2012, ATHEROSCLEROSIS, V225, P216, DOI 10.1016/j.atherosclerosis.2012.08.027; Wang AX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113205; Wang LY, 2013, NEUROL RES, V35, P517, DOI 10.1179/1743132813Y.0000000204; Wang X, 2006, J NEUROIMAGING, V16, P266, DOI 10.1111/j.1552-6569.2006.00027.x	32	12	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0156243	10.1371/journal.pone.0156243	http://dx.doi.org/10.1371/journal.pone.0156243			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536865	Green Published, gold, Green Submitted			2022-12-26	WOS:000381577000001
J	Wang, XH; Karau, MJ; Greenwood-Quaintance, KE; Block, DR; Mandrekar, JN; Cunningham, SA; Patel, R				Wang, Xiaohui; Karau, Melissa J.; Greenwood-Quaintance, Kerryl E.; Block, Darci R.; Mandrekar, Jayawant N.; Cunningham, Scott A.; Patel, Robin			Ureaplasma urealyticum Causes Hyperammonemia in an Experimental Immunocompromised Murine Model	PLOS ONE			English	Article							FATAL HYPERAMMONEMIA; RISK	Hyperammonemia syndrome is an often fatal complication of lung transplantation which has been recently associated with Ureaplasma infection. It has not been definitely established that Ureaplasma species can cause hyperammonemia. We established a novel immunocompromised murine model of Ureaplasma urealyticum infection and used it to confirm that U. urealyticum can cause hyperammonemia. Male C3H mice were pharmacologically immunosuppressed with mycophenolate mofetil, tacrolimus and oral prednisone for seven days, and then challenged intratracheally (IT) and/or intraperitoneally (IP) with 10(7) CFU U. urealyticum over six days, while continuing immunosuppression. Spent U. urealyticum-free U9 broth was used as a negative control, with uninfected immunocompetent mice, uninfected immunosuppressed mice, and infected immunocompetent mice serving as additional controls. Plasma ammonia concentrations were compared using Wilcoxon ranks sum tests. Plasma ammonia concentrations of immunosuppressed mice challenged IT/IP with spent U9 broth (n = 14) (range 155-330 mu mol/L) were similar to those of normal mice (n = 5), uninfected immunosuppressed mice (n = 5), and U. urealyticum IT/IP challenged immunocompetent mice (n = 5) [ range 99-340 mu mol/L, p = 0.60]. However, immunosuppressed mice challenged with U. urealyticum IT/IP (n = 20) or IP (n = 15) had higher plasma ammonia concentrations (range 225-945 mu mol/L and 276-687 mu mol/L, respectively) than those challenged IT/IP with spent U9 broth (p<0.001). U. urealyticum administered IT/IP or IP causes hyperammonemia in mice pharmacologically immunosuppressed with a regimen similar to that administered to lung transplant recipients.	[Wang, Xiaohui; Karau, Melissa J.; Greenwood-Quaintance, Kerryl E.; Cunningham, Scott A.; Patel, Robin] Mayo Clin, Dept Lab Med & Pathol, Div Clin Microbiol, Rochester, MN 55905 USA; [Block, Darci R.] Mayo Clin, Div Clin Core Lab, Dept Lab Med & Pathol, Rochester, MN USA; [Mandrekar, Jayawant N.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Patel, Robin] Mayo Clin, Dept Med, Div Infect Dis, Rochester, MN 55905 USA; [Wang, Xiaohui] Sichuan Univ, West China Hosp, Ctr Infect Dis, Chengdu, Sichuan, Peoples R China; [Wang, Xiaohui] Div Infect Dis, State Key Lab Biotherapy, Chengdu, Sichuan, Peoples R China	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Sichuan University	Patel, R (corresponding author), Mayo Clin, Dept Lab Med & Pathol, Div Clin Microbiol, Rochester, MN 55905 USA.; Patel, R (corresponding author), Mayo Clin, Dept Med, Div Infect Dis, Rochester, MN 55905 USA.	patel.robin@mayo.edu	Wang, Xiaohui/X-3814-2019; Cunningham, Scott A/ABC-6171-2020	Cunningham, Scott/0000-0002-7589-1712; Patel, Robin/0000-0001-6344-4141; , Xiaohui/0000-0003-2780-2823	Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN; National Institutes of Health [R01AR056647, R01 AI91594]; State Scholarship Fund from the China Scholarship Council	Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State Scholarship Fund from the China Scholarship Council(China Scholarship Council)	This work was supported by the Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN. R.P. is supported by the National Institutes of Health [grant numbers R01AR056647 and R01 AI91594]. X.W. is supported by the State Scholarship Fund from the China Scholarship Council as a Visiting Scientist at Mayo Clinic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anwar S, 2014, HEMODIAL INT, V18, P185, DOI 10.1111/hdi.12088; BALLARD RA, 1978, NEW ENGL J MED, V299, P920, DOI 10.1056/NEJM197810262991704; Beeton ML, 2012, IMMUNOBIOLOGY, V217, P187, DOI 10.1016/j.imbio.2011.07.009; Bharat A, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa8419; Cunningham Scott A, 2013, Int J Bacteriol, V2013, P168742, DOI 10.1155/2013/168742; Dando SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029856; Gwee A, 2014, J INFECTION, V68, pS19, DOI 10.1016/j.jinf.2013.09.027; Lichtenstein GR, 1997, GASTROENTEROLOGY, V112, P236, DOI 10.1016/S0016-5085(97)70240-3; Lichtenstein GR, 2000, ANN INTERN MED, V132, P283, DOI 10.7326/0003-4819-132-4-200002150-00006; Moffatt-Bruce SD, 2008, J HEART LUNG TRANSPL, V27, P801, DOI 10.1016/j.healun.2008.03.019; Okogbule-Wonodi AC, 2011, INNATE IMMUN-LONDON, V17, P145, DOI 10.1177/1753425909360552; Payne MS, 2012, J CLIN MICROBIOL, V50, P909, DOI 10.1128/JCM.06625-11; Rueda JF, 1998, ANN INTERN MED, V128, P956, DOI 10.7326/0003-4819-128-11-199806010-00022; Tuchman M, 1997, ANN INTERN MED, V127, P446, DOI 10.7326/0003-4819-127-6-199709150-00005; Waites KB, 2005, CLIN MICROBIOL REV, V18, P757, DOI 10.1128/CMR.18.4.757-789.2005; Weisman LE, 2012, PEDIATR RES, V72, P502, DOI 10.1038/pr.2012.115; Winters AH, 2013, PEDIATR INFECT DIS J, V32, P898, DOI 10.1097/INF.0b013e31828fc693; Wylam ME, 2013, LANCET, V382, P1956, DOI 10.1016/S0140-6736(13)62115-7	18	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161214	10.1371/journal.pone.0161214	http://dx.doi.org/10.1371/journal.pone.0161214			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537683	gold, Green Published, Green Submitted			2022-12-26	WOS:000381577000068
J	Zhang, B; Li, BZ; Chen, D; Zong, J; Sun, F; Qu, HX; Liang, CY				Zhang, Biao; Li, Baizhi; Chen, Dai; Zong, Jie; Sun, Fei; Qu, Huixin; Liang, Chongyang			Transcriptional Regulation of Aerobic Metabolism in Pichia pastoris Fermentation	PLOS ONE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; TRANSFER-RNA MODIFICATIONS; ISOCITRATE DEHYDROGENASE; RECOMBINANT PROTEIN; CITRATE SYNTHASE; MITOCHONDRIAL; DNA	In this study, we investigated the classical fermentation process in Pichia pastoris based on transcriptomics. We utilized methanol in pichia yeast cell as the focus of our study, based on two key steps: limiting carbon source replacement (from glycerol to methonal) and fermentative production of exogenous proteins. In the former, the core differential genes in coexpression net point to initiation of aerobic metabolism and generation of peroxisome. The transmission electron microscope (TEM) results showed that yeast gradually adapted methanol induction to increased cell volume, and decreased density, via large number of peroxisomes. In the fermentative production of exogenous proteins, the Gene Ontology (GO) mapping results show that PAS_chr2-1_0582 played a vital role in regulating aerobic metabolic drift. In order to confirm the above results, we disrupted PAS_chr2-1_0582 by homologous recombination. Alcohol consumption was equivalent to one fifth of the normal control, and fewer peroxisomes were observed in.0582 strain following methanol induction. In this study we determined the important core genes and GO terms regulating aerobic metabolic drift in Pichia, as well as developing new perspectives for the continued development within this field.	[Zhang, Biao; Li, Baizhi; Sun, Fei; Qu, Huixin; Liang, Chongyang] Jilin Univ, Inst Frontier Med Sci, Changchun 130021, Peoples R China; [Chen, Dai; Zong, Jie] NovelBio Biopharm Technol Co Ltd, Shanghai 200000, Peoples R China	Jilin University	Liang, CY (corresponding author), Jilin Univ, Inst Frontier Med Sci, Changchun 130021, Peoples R China.	liang@jlu.edu.cn			National Natural Science Foundation of China [81202446, 31271478]; Jilin Provincial Science & Technology Department [20150311065YY]; NovelBio Bio-Pharm Technology Co., Ltd	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jilin Provincial Science & Technology Department; NovelBio Bio-Pharm Technology Co., Ltd	This work was supported by the National Natural Science Foundation of China (Grant No. 81202446, 31271478) and the Jilin Provincial Science & Technology Department (Grant No. 20150311065YY). The funder provided support in the form of research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The NovelBio Bio-Pharm Technology Co., Ltd provided support in the form of salaries for authors [DC, JZ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; We thank He Zhang, Xin Guang, Yunong Liu, Changchun zuanzhi Biotech Co., Ltd., for carrying out the fermentation. This work was supported by the National Natural Science Foundation of China (Grant No. 81202446, 31271478) and the Jilin Provincial Science & Technology Department (Grant No. 20150311065YY).	Anderson SL, 2002, BIOCHEMISTRY-US, V41, P7065, DOI 10.1021/bi0200662; Baumann K, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-93; Begley U, 2007, MOL CELL, V28, P860, DOI 10.1016/j.molcel.2007.09.021; Carbone A, 2005, J MOL EVOL, V61, P456, DOI 10.1007/s00239-004-0317-z; Celton M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-317; Charoenrat T, 2005, BIOPROC BIOSYST ENG, V27, P399, DOI 10.1007/s00449-005-0005-4; Chen CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020783; CHEN SL, 1976, BIOTECHNOL BIOENG, V18, P1455, DOI 10.1002/bit.260181012; Chen XJ, 2007, P NATL ACAD SCI USA, V104, P13738, DOI 10.1073/pnas.0703078104; Grandier-Vazeille X, 2001, BIOCHEMISTRY-US, V40, P9758, DOI 10.1021/bi010277r; Guan B, 2012, FEMS YEAST RES, V12, P969, DOI 10.1111/1567-1364.12002; Guo Meijin, 2001, Weishengwu Xuebao, V41, P617; Jablonowski D, 2006, MOL MICROBIOL, V59, P677, DOI 10.1111/j.1365-2958.2005.04972.x; Lee YJ, 2007, MOL BIOL CELL, V18, P3556, DOI 10.1091/mbc.E07-02-0118; Leihne V, 2011, NUCLEIC ACIDS RES, V39, P7688, DOI 10.1093/nar/gkr406; Nagamori E, 2013, J BIOSCI BIOENG, V115, P193, DOI 10.1016/j.jbiosc.2012.08.021; Patil A, 2012, RNA BIOL, V9, P990, DOI 10.4161/rna.20531; Prieto C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003911; Ratnakumar S, 2011, MOL BIOSYST, V7, P139, DOI 10.1039/c0mb00114g; Reid RJD, 2002, YEAST, V19, P319, DOI 10.1002/yea.817; Rossouw D, 2009, APPL ENVIRON MICROB, V75, P6600, DOI 10.1128/AEM.01251-09; SANDOR A, 1994, J BIOL CHEM, V269, P29609; Sauer M, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-17; Syriopoulos C, 2008, MOL BIOSYST, V4, P937, DOI 10.1039/b718732g; Tolner B, 2006, NAT PROTOC, V1, P1006, DOI 10.1038/nprot.2006.126; Toyotome Takahito, 2008, Nihon Rinsho, V66, P2255; Velot C, 1999, BIOCHEMISTRY-US, V38, P16195, DOI 10.1021/bi991695n; Wang TY, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-24; Wu G, 2008, CURR MICROBIOL, V57, P18, DOI 10.1007/s00284-008-9145-5; Wu SX, 2004, BIOTECHNIQUES, V36, P152, DOI 10.2144/04361DD02; Zhang Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep27854; Zhang Z, 2013, ARCH TOXICOL, V87, P1557, DOI 10.1007/s00204-013-1059-8; Zhao WN, 1996, J BIOL CHEM, V271, P10347, DOI 10.1074/jbc.271.17.10347; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276; Zhu J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001301; Zimmer E, 1997, APPL ENVIRON MICROB, V63, P2779, DOI 10.1128/AEM.63.7.2779-2784.1997	36	4	4	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161502	10.1371/journal.pone.0161502	http://dx.doi.org/10.1371/journal.pone.0161502			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537181	Green Published, Green Submitted, gold			2022-12-26	WOS:000381577000114
J	Zhang, BH; Salam, N; Cheng, J; Li, HQ; Yang, JY; Zha, DM; Zhang, YQ; Ai, MJ; Hozzein, WN; Li, WJ				Zhang, Bing-Huo; Salam, Nimaichand; Cheng, Juan; Li, Han-Quan; Yang, Jian-Yuan; Zha, Dai-Ming; Zhang, Yu-Qin; Ai, Meng-Jie; Hozzein, Wael N.; Li, Wen-Jun			Modestobacter lacusdianchii sp nov., a Phosphate-Solubilizing Actinobacterium with Ability to Promote Microcystis Growth	PLOS ONE			English	Article							DEOXYRIBONUCLEIC-ACID; EMENDED DESCRIPTION; FRESH-WATER; GEN. NOV.; BACTERIA; STREPTOMYCES; CLASSIFICATION; PHYTOPLANKTON; AERUGINOSA; IDENTIFICATION	A novel actinobacterium, designated strain JXJ CY 19(T), was isolated from a culture mat of Microcystis aeruginosa FACHB-905 collected from Dianchi Lake, South-west China. 16S rRNA gene sequences comparison of strain JXJ CY 19(T) and the available sequences in the GenBank database showed that the strain was closely related to Modestobacter marinus 42H12-1(T) (99.1% similarity) and Modestobacter roseus KLBMP 1279(T) (99.0%). The isolate had meso-diaminopimelic in the cell wall with whole-cell sugars of mannose, rhamnose, ribose, glucose, galactose, and arabinose. The menaquinone detected was MK-9(H-4), while the major cellular fatty acids include C-17:1 omega 8c, C-15:0 iso, C-15:1 iso G and C-16:0 iso. The polar lipids were diphosphatidylglycerol, phosphatidylethanolamine, phosphatidylinositol, phosphatidylinositol mannoside and an unidentified phospholipid. The DNA-DNA hybridization values between strains JXJ CY 19(T) and the closely related type strains Modestobacter marinus CGMCC 4.5581(T) and Modestobacter roseus NBRC 108673(T) were determined to be 50.8 +/- 0.8% and 44.1 +/- 1.7%, respectively. The DNA G+C content was 71.9 mol%. On the basis of the above taxonomic data and differences in physiological characters from the closely related type strains, strain JXJ CY 19(T) was recognized as a novel species of the genus Modestobacter, for which the name Modestobacter lacusdianchii sp. nov. (JXJ CY 19(T) = KCTC 39600(T) = CPCC 204352(T)) is proposed. The type strain JXJ CY 19T can solubilize calcium phosphate tribasic (Ca-3(PO4)(2)), phytin and L-alpha-phosphatidylcholine. The phosphate-solubilizing property of the novel actinobacterium could be a possible factor for the increase in growth of Microcystis aeruginosa FACHB-905 in ecosystem where the amount of available soluble phosphate is limited such as Dianchi Lake.	[Zhang, Bing-Huo; Cheng, Juan; Li, Han-Quan; Yang, Jian-Yuan; Zha, Dai-Ming] Jiujiang Univ, Coll Life Sci, Jiujiang, Peoples R China; [Zhang, Bing-Huo; Salam, Nimaichand; Cheng, Juan; Li, Wen-Jun] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou, Guangdong, Peoples R China; [Zhang, Bing-Huo; Salam, Nimaichand; Cheng, Juan; Li, Wen-Jun] Sun Yat Sen Univ, Sch Life Sci, Guangdong Prov Key Lab Plant Resources, Guangzhou, Guangdong, Peoples R China; [Zhang, Yu-Qin; Ai, Meng-Jie] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing, Peoples R China; [Zhang, Yu-Qin; Ai, Meng-Jie] Peking Union Med Coll, Beijing, Peoples R China; [Hozzein, Wael N.] King Saud Univ, Coll Sci, Dept Zool, BRC, Riyadh, Saudi Arabia; [Hozzein, Wael N.] Beni Suef Univ, Fac Sci, Dept Bot & Microbiol, Bani Suwayf, Egypt	Jiujiang University; Sun Yat Sen University; Sun Yat Sen University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; King Saud University; Egyptian Knowledge Bank (EKB); Beni Suef University	Li, WJ (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou, Guangdong, Peoples R China.; Li, WJ (corresponding author), Sun Yat Sen Univ, Sch Life Sci, Guangdong Prov Key Lab Plant Resources, Guangzhou, Guangdong, Peoples R China.	liwenjun3@mail.sysu.edu.cn	Zhang, Yu-Qin/AEH-7339-2022	Zhang, Yu-Qin/0000-0002-1739-6705	National Natural Science Foundation of China [31060010]; Deanship of Scientific Research at King Saud University [1436-27]; Environmental Conservation Department of Jiangxi Province of China [JXHBKJ2013-14]; Program of JiuJiang University [201511]; Guangdong Province Higher Vocational Colleges & Schools Pearl River Scholar Funded Scheme	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Deanship of Scientific Research at King Saud University(King Saud University); Environmental Conservation Department of Jiangxi Province of China; Program of JiuJiang University; Guangdong Province Higher Vocational Colleges & Schools Pearl River Scholar Funded Scheme	This research was supported by the funding from National Natural Science Foundation of China (No. 31060010), the Deanship of Scientific Research at King Saud University (through the research group no. 1436-27), Environmental Conservation Department of Jiangxi Province of China (No. JXHBKJ2013-14), and Program of JiuJiang University (No. 201511). W-J Li was also supported by Project Supported by Guangdong Province Higher Vocational Colleges & Schools Pearl River Scholar Funded Scheme (2014).	[Anonymous], 2010, 18472010 NYT MIN AGR, P4; Casamatta DA, 2000, MICROB ECOL, V40, P64, DOI 10.1007/s002480000035; COLLINS MD, 1980, J APPL BACTERIOL, V48, P459, DOI 10.1111/j.1365-2672.1980.tb01036.x; COLLINS MD, 1977, J GEN MICROBIOL, V100, P221, DOI 10.1099/00221287-100-2-221; de-Bashan LE, 2008, J PHYCOL, V44, P938, DOI 10.1111/j.1529-8817.2008.00533.x; Deng Jie, 2012, Hupo Kexue, V24, P429; Dziallas C, 2011, ENVIRON MICROBIOL, V13, P1632, DOI 10.1111/j.1462-2920.2011.02479.x; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; EZAKI T, 1989, INT J SYST BACTERIOL, V39, P224, DOI 10.1099/00207713-39-3-224; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; GOODFELLOW M, 1971, J GEN MICROBIOL, V69, P33, DOI 10.1099/00221287-69-1-33; Gumbo JR, 2014, PHYS CHEM EARTH, V72-75, P24, DOI 10.1016/j.pce.2014.09.004; HALEMEJKO GZ, 1984, ARCH HYDROBIOL, V101, P489; HASEGAWA T, 1983, J GEN APPL MICROBIOL, V29, P319, DOI 10.2323/jgam.29.319; HECKY RE, 1988, LIMNOL OCEANOGR, V33, P796, DOI 10.4319/lo.1988.33.4_part_2.0796; JURGENS K, 1994, MAR ECOL PROG SER, V112, P169, DOI 10.3354/meps112169; KOVACS N, 1956, NATURE, V178, P703, DOI 10.1038/178703a0; KROPPENSTEDT RM, 1982, J LIQ CHROMATOGR, V5, P2359, DOI 10.1080/01483918208067640; Liu LL, 2000, J LAKE SCI, V12, P373, DOI DOI 10.18307/2000.0412.[; Liu YM, 2006, ENVIRON TOXICOL, V21, P289, DOI 10.1002/tox.20182; MESBAH M, 1989, INT J SYST BACTERIOL, V39, P159, DOI 10.1099/00207713-39-2-159; Mevs U, 2000, INT J SYST EVOL MICR, V50, P337, DOI 10.1099/00207713-50-1-337; MINNIKIN DE, 1979, J APPL BACTERIOL, V47, P87, DOI 10.1111/j.1365-2672.1979.tb01172.x; Nautiyal CS, 1999, FEMS MICROBIOL LETT, V170, P265, DOI 10.1111/j.1574-6968.1999.tb13383.x; Niu Y, 2011, WATER RES, V45, P4169, DOI 10.1016/j.watres.2011.05.022; Normand P, 2012, BERGEYS MANUAL SYS A, V5, P528; Normand P, 2006, INT J SYST EVOL MICR, V56, P2277, DOI 10.1099/ijs.0.64298-0; Park MH, 2009, AQUAT BOT, V90, P309, DOI 10.1016/j.aquabot.2008.11.007; Parveen B, 2013, ENV MICROBIOL REP, V5, P716, DOI 10.1111/1758-2229.12071; Qin S, 2013, INT J SYST EVOL MICR, V61, P1710; Reddy GSN, 2007, INT J SYST EVOL MICR, V57, P2014, DOI 10.1099/ijs.0.64932-0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sasser M, 1990, IDENTIFICATION BACTE; Sen A, 2014, INT J SYST EVOL MICR, V64, P3821, DOI 10.1099/ijs.0.063966-0; Shi LM, 2012, ENV MICROBIOL REP, V4, P669, DOI 10.1111/1758-2229.12001; Shi LM, 2009, J ENVIRON SCI, V21, P1581, DOI 10.1016/S1001-0742(08)62459-6; SHIRLING E. B., 1966, INT J SYST BACTERIOL, V16, P313; Stackebrandt E, 2006, MICROBIOLOGY TODAY, V06, P152, DOI DOI 10.1038/MSB.2013.22; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang SK, 2009, INT J SYST EVOL MICR, V59, P2025, DOI 10.1099/ijs.0.007344-0; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Trujillo ME, 2015, ANTON LEEUW INT J G, V108, P311, DOI 10.1007/s10482-015-0482-7; WILLIAMS ST, 1983, J GEN MICROBIOL, V129, P1743; Xiao J, 2011, INT J SYST EVOL MICR, V61, P1710, DOI 10.1099/ijs.0.023085-0; Xu P, 2005, INT J SYST EVOL MICR, V55, P1149, DOI 10.1099/ijs.0.63407-0; Yang LY, 2010, OUTBRUST JEOPARDIZE, P212; Yuan Li-na, 2006, Journal of Ecology and Rural Environment, V22, P85; Zhang BH, 2016, APPL MICROBIOL BIOT, V100, P4627, DOI 10.1007/s00253-015-7150-8; Zhang BH, 2015, APPL MICROBIOL BIOT, V99, P7673, DOI 10.1007/s00253-015-6584-3; Zhang BH, 2014, ANTON LEEUW INT J G, V105, P763, DOI 10.1007/s10482-014-0132-5; Zhao GY, 2012, ECOL ENG, V42, P107, DOI 10.1016/j.ecoleng.2012.02.007; Zhao Jie, 2011, Hupo Kexue, V23, P49	54	12	13	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161069	10.1371/journal.pone.0161069	http://dx.doi.org/10.1371/journal.pone.0161069			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537546	Green Published, Green Submitted, gold			2022-12-26	WOS:000381577000048
J	Wachter, J; Hill, S				Wachter, Jenny; Hill, Stuart			Positive Selection Pressure Drives Variation on the Surface-Exposed Variable Proteins of the Pathogenic Neisseria	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; AMINO-ACID SITES; OPA GENE FAMILY; ANTIGENIC VARIATION; MAXIMUM-LIKELIHOOD; EPITHELIAL-CELLS; EVOLUTIONARY CONSERVATION; SUBSTITUTION RATES; DNA POLYMORPHISM; PILUS GENES	Pathogenic species of Neisseria utilize variable outer membrane proteins to facilitate infection and proliferation within the human host. However, the mechanisms behind the evolution of these variable alleles remain largely unknown due to analysis of previously limited datasets. In this study, we have expanded upon the previous analyses to substantially increase the number of analyzed sequences by including multiple diverse strains, from various geographic locations, to determine whether positive selective pressure is exerted on the evolution of these variable genes. Although Neisseria are naturally competent, this analysis indicates that only intrastrain horizontal gene transfer among the pathogenic Neisseria principally account for these genes exhibiting linkage equilibrium which drives the polymorphisms evidenced within these alleles. As the majority of polymorphisms occur across species, the divergence of these variable genes is dependent upon the species and is independent of geographical location, disease severity, or serogroup. Tests of neutrality were able to detect strong selection pressures acting upon both the opa and pil gene families, and were able to locate the majority of these sites within the exposed variable regions of the encoded proteins. Evidence of positive selection acting upon the hypervariable domains of Opa contradicts previous beliefs and provides evidence for selection of receptor binding. As the pathogenic Neisseria reside exclusively within the human host, the strong selection pressures acting upon both the opa and pil gene families provide support for host immune system pressure driving sequence polymorphisms within these variable genes.	[Wachter, Jenny; Hill, Stuart] Northern Illinois Univ, Dept Biol Sci, De Kalb, IL 60115 USA	Northern Illinois University	Wachter, J (corresponding author), Northern Illinois Univ, Dept Biol Sci, De Kalb, IL 60115 USA.	jmcconoughey@niu.edu		Wachter, Jenny/0000-0003-2175-5595				AHO EL, 1991, MOL MICROBIOL, V5, P1429, DOI 10.1111/j.1365-2958.1991.tb00789.x; AKASHI H, 1995, GENETICS, V139, P1067; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrews TD, 2004, GENETICS, V166, P25, DOI 10.1534/genetics.166.1.25; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BESSEN D, 1986, INFECT IMMUN, V54, P154, DOI 10.1128/IAI.54.1.154-160.1986; BHAT KS, 1992, MOL MICROBIOL, V6, P1073, DOI 10.1111/j.1365-2958.1992.tb02172.x; BHAT KS, 1991, MOL MICROBIOL, V5, P1889, DOI 10.1111/j.1365-2958.1991.tb00813.x; BIHLMAIER A, 1991, MOL MICROBIOL, V5, P2529, DOI 10.1111/j.1365-2958.1991.tb02099.x; Bilek N, 2009, J BACTERIOL, V191, P1878, DOI 10.1128/JB.01518-08; Biswas S, 2006, TRENDS GENET, V22, P437, DOI 10.1016/j.tig.2006.06.005; Bos MP, 1999, J EXP MED, V190, P331, DOI 10.1084/jem.190.3.331; Callaghan MJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000020; Celniker G, 2013, ISR J CHEM, V53, P199, DOI 10.1002/ijch.201200096; CHEN T, 1995, J EXP MED, V182, P511, DOI 10.1084/jem.182.2.511; CONNELL TD, 1990, MOL MICROBIOL, V4, P439, DOI 10.1111/j.1365-2958.1990.tb00610.x; Craig L, 2006, MOL CELL, V23, P651, DOI 10.1016/j.molcel.2006.07.004; Davies JK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086704; DEMPSEY JAF, 1991, J BACTERIOL, V173, P5476, DOI 10.1128/jb.173.17.5476-5486.1991; Fox DA, 2014, J AM CHEM SOC, V136, P9938, DOI 10.1021/ja503093y; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HAAS R, 1992, MOL MICROBIOL, V6, P197, DOI 10.1111/j.1365-2958.1992.tb02001.x; HAAS R, 1986, CELL, V44, P107, DOI 10.1016/0092-8674(86)90489-7; HAGBLOM P, 1985, NATURE, V315, P156, DOI 10.1038/315156a0; HARTL DL, 1994, GENETICS, V138, P227; HARTL DL, 1991, J EVOLUTION BIOL, V4, P519, DOI 10.1046/j.1420-9101.1991.4040519.x; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hobbs MM, 1998, MICROBIOL-UK, V144, P157, DOI 10.1099/00221287-144-1-157; HOBBS MM, 1994, MOL MICROBIOL, V12, P171, DOI 10.1111/j.1365-2958.1994.tb01006.x; INA Y, 1995, J MOL EVOL, V40, P190, DOI 10.1007/BF00167113; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; KELLOGG DS, 1963, J BACTERIOL, V85, P1274, DOI 10.1128/JB.85.6.1274-1279.1963; KELLOGG DS, 1968, J BACTERIOL, V96, P596, DOI 10.1128/JB.96.3.596-605.1968; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; KUPSCH EM, 1993, EMBO J, V12, P641, DOI 10.1002/j.1460-2075.1993.tb05697.x; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; LEWONTIN RC, 1964, GENETICS, V49, P49; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Low DHW, 2013, J PROTEOMICS, V89, P95, DOI 10.1016/j.jprot.2013.05.034; Malorny B, 1998, J BACTERIOL, V180, P1323, DOI 10.1128/JB.180.5.1323-1330.1998; Masters TL, 2016, MICROBIOL-SGM, V162, P177, DOI 10.1099/mic.0.000199; Meyer T. F., 2003, ANTIGENIC VARIATION, P142; MEYER TF, 1984, P NATL ACAD SCI-BIOL, V81, P6110, DOI 10.1073/pnas.81.19.6110; Morelli G, 1997, MOL MICROBIOL, V25, P1047, DOI 10.1046/j.1365-2958.1997.5211882.x; Muenzner P, 2000, INFECT IMMUN, V68, P3601, DOI 10.1128/IAI.68.6.3601-3607.2000; MURPHY GL, 1989, CELL, V56, P539, DOI 10.1016/0092-8674(89)90577-1; Nassif X, 1999, Int Microbiol, V2, P133; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nielsen R, 1998, GENETICS, V148, P929; OOI T, 1987, P NATL ACAD SCI USA, V84, P3086, DOI 10.1073/pnas.84.10.3086; PARGE HE, 1995, NATURE, V378, P32, DOI 10.1038/378032a0; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; POOLMAN JT, 1983, INFECT IMMUN, V40, P398, DOI 10.1128/IAI.40.1.398-406.1983; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rich SM, 2001, P NATL ACAD SCI USA, V98, P15038, DOI 10.1073/pnas.071042098; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; SAWYER SA, 1992, GENETICS, V132, P1161; Sawyer Stanley A., 1994, P77; SCHERP HW, 1955, ANNU REV MICROBIOL, V9, P319, DOI 10.1146/annurev.mi.09.100155.001535; Sethupathy Praveen, 2008, Advances in Bioinformatics, V2008, P257864, DOI 10.1155/2008/257864; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Sintsova A, 2015, INFECT IMMUN, V83, P1372, DOI 10.1128/IAI.03123-14; SMITH NH, 1995, MOL BIOL EVOL, V12, P363; STERN A, 1986, CELL, V47, P61, DOI 10.1016/0092-8674(86)90366-1; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; SWANSON J, 1987, J EXP MED, V165, P1344, DOI 10.1084/jem.165.5.1344; TAJIMA F, 1989, GENETICS, V123, P585; VANDERLEY P, 1988, MOL MICROBIOL, V2, P797; VANPUTTEN JPM, 1995, EMBO J, V14, P2144, DOI 10.1002/j.1460-2075.1995.tb07208.x; Virji M, 1999, MOL MICROBIOL, V34, P538, DOI 10.1046/j.1365-2958.1999.01620.x; Virji M, 1996, MOL MICROBIOL, V22, P941, DOI 10.1046/j.1365-2958.1996.01551.x; Wachter J, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnu059; Wachter J, 2015, MICROBIOL-SGM, V161, P1124, DOI 10.1099/mic.0.000061; Wang IN, 1999, GENETICS, V151, P15; Watkins ER, 2014, SCI REP-UK, V4, DOI 10.1038/srep06554; Watt SM, 2001, BLOOD, V98, P1469, DOI 10.1182/blood.V98.5.1469; WESSON L, 1992, PROTEIN SCI, V1, P227; Wiertz EJHJ, 1996, INFECT IMMUN, V64, P298, DOI 10.1128/IAI.64.1.298-304.1996; Wong WSW, 2004, GENETICS, V168, P1041, DOI 10.1534/genetics.104.031153; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064; Xia XH, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P615; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2000, GENETICS, V155, P431; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; ZAK K, 1984, J INFECT DIS, V149, P166, DOI 10.1093/infdis/149.2.166	93	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161348	10.1371/journal.pone.0161348	http://dx.doi.org/10.1371/journal.pone.0161348			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532335	gold, Green Published, Green Submitted			2022-12-26	WOS:000381487600087
J	Sachse, D; Solevag, AL; Berg, JP; Nakstad, B				Sachse, Daniel; Solevag, Anne Lee; Berg, Jens Petter; Nakstad, Britt			The Role of Plasma and Urine Metabolomics in Identifying New Biomarkers in Severe Newborn Asphyxia: A Study of Asphyxiated Newborn Pigs following Cardiopulmonary Resuscitation	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; CARDIAC-ARREST; PERINATAL ASPHYXIA; ASPHYCTIC NEWBORN; MODEL; COMPRESSIONS; REGRESSION; TRANSPORT; HYPOXIA; PACKAGE	Background Optimizing resuscitation is important to prevent morbidity and mortality from perinatal asphyxia. The metabolism of cells and tissues is severely disturbed during asphyxia and resuscitation, and metabolomic analyses provide a snapshot of many small molecular weight metabolites in body fluids or tissues. In this study metabolomics profiles were studied in newborn pigs that were asphyxiated and resuscitated using different protocols to identify biomarkers for subject characterization, intervention effects and possibly prognosis. Methods A total of 125 newborn Noroc pigs were anesthetized, mechanically ventilated and inflicted progressive asphyxia until asystole. Pigs were randomized to resuscitation with a FiO(2) 0.21 or 1.0, different duration of ventilation before initiation of chest compressions (CC), and different CC to ventilation ratios. Plasma and urine samples were obtained at baseline, and 2 h and 4 h after return of spontaneous circulation (ROSC, heart rate > = 100 bpm). Metabolomics profiles of the samples were analyzed by nuclear magnetic resonance spectroscopy. Results Plasma and urine showed severe metabolic alterations consistent with hypoxia and acidosis 2 h and 4 h after ROSC. Baseline plasma hypoxanthine and lipoprotein concentrations were inversely correlated to the duration of hypoxia sustained before asystole occurred, but there was no evidence for a differential metabolic response to the different resuscitation protocols or in terms of survival. Conclusions Metabolic profiles of asphyxiated newborn pigs showed severe metabolic alterations. Consistent with previously published reports, we found no evidence of differences between established and alternative resuscitation protocols. Lactate and pyruvate may have a prognostic value, but have to be independently confirmed.	[Sachse, Daniel; Berg, Jens Petter] Univ Oslo, Inst Clin Med, Dept Med Biochem, Oslo, Norway; [Sachse, Daniel] Univ Oslo, Dept Chem, Oslo, Norway; [Solevag, Anne Lee; Nakstad, Britt] Akershus Univ Hosp, Dept Paediat & Adolescent Med, N-1478 Oslo, Norway; [Berg, Jens Petter] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway; [Nakstad, Britt] Univ Oslo, Campus Akershus Univ Hosp, Inst Clin Med, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Nakstad, B (corresponding author), Akershus Univ Hosp, Dept Paediat & Adolescent Med, N-1478 Oslo, Norway.; Nakstad, B (corresponding author), Univ Oslo, Campus Akershus Univ Hosp, Inst Clin Med, Oslo, Norway.	britt.nakstad@medisin.uio.no	Solevåg, Anne Lee/AAH-9734-2021; Berg, Jens P/G-1455-2012	Solevåg, Anne Lee/0000-0002-8009-7169; Berg, Jens P/0000-0003-0157-5888				[Anonymous], 2010, R LANG ENV STAT COMP; Atzori L, 2010, J MATERN-FETAL NEO M, V23, P134, DOI 10.3109/14767058.2010.517033; Barkauskas DA, 2009, FTICRMS PROGR ANAL F; Barkauskas DA, 2010, ANAL CHIM ACTA, V657, P191, DOI 10.1016/j.aca.2009.10.043; BELL JD, 1988, CHEM BRIT, V24, P1021; Chalkias A, 2014, RESUSCITATION, V85, P595, DOI 10.1016/j.resuscitation.2014.01.025; Cloarec O, 2005, ANAL CHEM, V77, P517, DOI 10.1021/ac048803i; Dannevig I, 2013, PEDIATR RES, V73, P163, DOI 10.1038/pr.2012.167; Dannevig Ingrid, 2012, Open Respir Med J, V6, P89, DOI 10.2174/1874306401206010089; Dannevig I, 2011, NEONATOLOGY, V99, P153, DOI 10.1159/000302718; Fanos V, 2014, BIOMED RES INT; Fanos V, 2014, J MATERN-FETAL NEO M, V27, P39, DOI 10.3109/14767058.2014.955966; Fanos V, 2014, CLIN BIOCHEM, V47, P708, DOI 10.1016/j.clinbiochem.2014.05.020; Fanos V, 2014, EARLY HUM DEV, V90, pS78, DOI 10.1016/S0378-3782(14)70024-6; Feingold KR, 2011, J LIPID RES, V52, P1, DOI 10.1194/jlr.E012138; Hering-Smith KS, 2000, AM J PHYSIOL-RENAL, V278, pF492, DOI 10.1152/ajprenal.2000.278.3.F492; HOHMANN B, 1974, KIDNEY INT, V5, P261, DOI 10.1038/ki.1974.35; IWAMOTO HS, 1985, AM J PHYSIOL, V249, pF836, DOI 10.1152/ajprenal.1985.249.6.F836; Jun JC, 2013, AM J PHYSIOL-ENDOC M, V304, pE424, DOI 10.1152/ajpendo.00515.2012; KRIAT M, 1992, NMR BIOMED, V5, P179, DOI 10.1002/nbm.1940050404; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Longini M, 2015, CLIN CHIM ACTA, V444, P250, DOI 10.1016/j.cca.2015.02.004; Mevik BH, 2007, J STAT SOFTW, V18, P1, DOI 10.18637/jss.v018.i02; Ponnusamy V, 2016, PEDIATR RES, V79, P799, DOI 10.1038/pr.2015.276; Reinke SN, 2013, J PROTEOME RES, V12, P4230, DOI 10.1021/pr400617m; Sachse D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052399; Savman K, 2013, TRANSL STROKE RES, V4, P228, DOI 10.1007/s12975-012-0216-3; Skappak C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065035; Solberg R, 2010, PLOS ONE, V5; Solevag AL, 2011, ARCH DIS CHILD-FETAL, V96, pF417, DOI 10.1136/adc.2010.200386; Solevag AL, 2010, RESUSCITATION, V81, P1571, DOI 10.1016/j.resuscitation.2010.06.007; Solevag AL, 2010, NEONATOLOGY, V98, P64, DOI 10.1159/000275560; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; Walsh BH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050520; Westerhuis JA, 2008, METABOLOMICS, V4, P81, DOI 10.1007/s11306-007-0099-6; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1	36	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161123	10.1371/journal.pone.0161123	http://dx.doi.org/10.1371/journal.pone.0161123			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529347	Green Published, gold, Green Submitted			2022-12-26	WOS:000381476700048
J	Zhang, XC; Brown, JC; Schmitz, KH				Zhang, Xiaochen; Brown, Justin C.; Schmitz, Kathryn H.			Association between Body Mass Index and Physical Function among Endometrial Cancer Survivors	PLOS ONE			English	Article							QUALITY-OF-LIFE; LOWER-EXTREMITY LYMPHEDEMA; LOWER-LIMB LYMPHEDEMA; EXERCISE; MORTALITY; DISABILITY; VALIDATION; COUNTRIES; STRENGTH; MOBILITY	Objectives We sought to quantify the relationship between body mass index (BMI) and physical function among endometrial cancer survivors. Understanding this relationship would help healthcare providers target efforts to refer obese endometrial cancer survivors to weight loss and exercise interventions. Methods We conducted a survey of 213 endometrial cancer survivors who received cancer care at an academic l health system between 2006 and 2010. Physical function subscale was quantified using physical functional component score from the SF-12 questionnaire. We compared physical function of endometrial cancer survivors to population-based age-standardized normative values. Results Among the 213 patients, 16% were normal weight (BMI <= 25 kg/m(2)), and 52% were obese (>= 30 kg/m(2)). Higher BMI categories were associated with lower physical function (P-trend = 0.003), as a continuous variable each 5kg/m(2) higher BMI, physical function score was lower by 0.15 points (beta = -0.15; P = 0.045). Compared to population-based age-standardized normative values, patients < 75yrs reported lower physical function, whereas patients >= 75yrs reported better physical function. BMI was the only covariate associated with differences in physical function between survivors and age-standardized normative values (P = 0.039). Conclusions Among endometrial cancer survivors, higher BMI is associated with lower physical function. Younger endometrial cancer survivors report lower physical function compared to age-standardized normative values. Healthcare providers should be aware that younger, obese endometrial cancer survivors may particularly benefit from interventions such as exercise and weight loss to increase or preserve physical function.	[Zhang, Xiaochen; Schmitz, Kathryn H.] Penn State Coll Med, Publ Hlth Sci, Hershey, PA USA; [Brown, Justin C.] Dana Farber Canc Inst, Dept Med Oncol, Div Populat Sci, Boston, MA 02115 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Harvard University; Dana-Farber Cancer Institute	Schmitz, KH (corresponding author), Penn State Coll Med, Publ Hlth Sci, Hershey, PA USA.	kschmitz@phs.psu.edu		Zhang, Xiaochen/0000-0003-3086-1285; Schmitz, Kathryn/0000-0003-2400-2935	NIH NCI [1U54CA155850-01]	NIH NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH NCI 1U54CA155850-01.	Alonso J, 2004, QUAL LIFE RES, V13, P283, DOI 10.1023/B:QURE.0000018472.46236.05; [Anonymous], 2015, SEER CANC STAT FACTS; Arem H, 2013, JNCI-J NATL CANCER I, V105, P342, DOI 10.1093/jnci/djs530; Bjorner JB, 2007, CURR MED RES OPIN, V23, P731, DOI 10.1185/030079907X178757; Brown JC, 2015, BRIT J CANCER, V112, P194, DOI 10.1038/bjc.2014.568; Brown JC, 2015, J CLIN ONCOL; Brown JC, 2016, J GERIATR ONCOL, V7, P108, DOI 10.1016/j.jgo.2016.01.009; Brown JC, 2014, SUPPORT CARE CANCER, V22, P3017, DOI 10.1007/s00520-014-2306-0; Brown JC, 2013, MED SCI SPORT EXER, V45, P2091, DOI 10.1249/MSS.0b013e318299afd4; Carter J, 2010, GYNECOL ONCOL, V117, P317, DOI 10.1016/j.ygyno.2010.01.022; Cesari M, 2008, BMC GERIATR, V8, P1, DOI DOI 10.1186/1471-2318-8-34; Cesari M, 2013, J GERONTOL A-BIOL, V68, P1129, DOI 10.1093/gerona/glt073; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Courneya KS, 2003, MED SCI SPORT EXER, V35, P1846, DOI 10.1249/01.MSS.0000093622.41587.B6; Ferraro KF, 2002, AM J PUBLIC HEALTH, V92, P834, DOI 10.2105/AJPH.92.5.834; Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7; Hall SA, 2011, AGING MALE, V14, P119, DOI 10.3109/13685538.2010.502267; Hammer SM, 2014, MED SCI SPORT EXER, V46, P2195, DOI 10.1249/MSS.0000000000000360; Hardy R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056483; Inouye SK, 1998, JAMA-J AM MED ASSOC, V279, P1187, DOI 10.1001/jama.279.15.1187; Johnson C, 2014, BMJ OPEN, V4, DOI [10.1136/bmjopen-2014-005561, 10.1136/bmjopen-2014-006629]; Jones LW, 2004, ANN BEHAV MED, V28, P105, DOI 10.1207/s15324796abm2802_5; Katz E, 2010, ARCH PHYS MED REHAB, V91, P1070, DOI 10.1016/j.apmr.2010.03.021; Li CR, 1999, MATURITAS, V31, P227, DOI 10.1016/S0378-5122(98)00106-6; Lin LL, 2014, INT J GYNECOL CANCER, V24, P1027, DOI 10.1097/IGC.0000000000000166; Pahor M, 2014, JAMA-J AM MED ASSOC, V311, P2387, DOI 10.1001/jama.2014.5616; Painter P, 1999, ADV RENAL REPLACE TH, V6, P110, DOI 10.1016/S1073-4449(99)70028-2; Park JH, 2015, CANCER; Petrick JL, 2014, J GERIATR ONCOL, V5, P359, DOI 10.1016/j.jgo.2014.06.002; Schmitz KH, 2005, CANCER EPIDEM BIOMAR, V14, P1588, DOI 10.1158/1055-9965.EPI-04-0703; Shin H, 2011, J AGING RES, DOI DOI 10.4061/2011/191896; Stafford RS, 1997, CANCER, V80, P1973, DOI 10.1002/(SICI)1097-0142(19971115)80:10<1973::AID-CNCR15>3.0.CO;2-V; Stenholm S, 2009, INT J OBESITY, V33, P635, DOI 10.1038/ijo.2009.62; Sutcliffe CG, 2015, CANCER CAUSE CONTROL, V26, P91, DOI 10.1007/s10552-014-0487-y; Sweeney C, 2006, JNCI-J NATL CANCER I, V98, P521, DOI 10.1093/jnci/djj130; US Cancer Statistics Working Group, 2014, US CANC STAT 1999 20; Villareal DT, 2011, NEW ENGL J MED, V364, P1218, DOI 10.1056/NEJMoa1008234; von Gruenigen V, 2012, GYNECOL ONCOL, V125, P699, DOI 10.1016/j.ygyno.2012.03.042; von Gruenigen VE, 2008, GYNECOL ONCOL, V109, P19, DOI 10.1016/j.ygyno.2007.12.026; Ware J, 1998, SF 12 SCORE SF 12 PH, P3; Woo J, 2007, OBESITY, V15, P1886, DOI 10.1038/oby.2007.223; Yabroff KR, 2004, JNCI-J NATL CANCER I, V96, P1322, DOI 10.1093/jnci/djh255; Zhang XC, 2015, GYNECOL ONCOL, V139, P155, DOI 10.1016/j.ygyno.2015.08.007; Zoico E, 2004, INT J OBESITY, V28, P234, DOI 10.1038/sj.ijo.0802552	44	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160954	10.1371/journal.pone.0160954	http://dx.doi.org/10.1371/journal.pone.0160954			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529546	gold, Green Submitted, Green Published			2022-12-26	WOS:000381476700033
J	Watanabe, K; Hirata, M; Tominari, T; Matsumoto, C; Fujita, H; Yonekura, K; Murphy, G; Nagase, H; Miyaura, C; Inada, M				Watanabe, Kenta; Hirata, Michiko; Tominari, Tsukasa; Matsumoto, Chiho; Fujita, Hidenori; Yonekura, Kazuhiko; Murphy, Gillian; Nagase, Hideaki; Miyaura, Chisato; Inada, Masaki			The MET/Vascular Endothelial Growth Factor Receptor (VEGFR)-targeted Tyrosine Kinase Inhibitor Also Attenuates FMS-dependent Osteoclast Differentiation and Bone Destruction Induced by Prostate Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR RECEPTOR; BREAST-CANCER; LIGAND; COMBINATION; MOUSE; MICROENVIRONMENT; INFLAMMATION; METASTASIS; ACTIVATION; PATHWAYS	The tyrosine kinase inhibitor TAS-115 that blocks VEGF receptor and hepatocyte growth factor receptor MET signaling exhibits antitumor properties in xenografts of human gastric carcinoma. In this study, we have evaluated the efficacy of TAS-115 in preventing prostate cancer metastasis to the bone and bone destruction using the PC3 cell line. When PC3 cells were injected into proximal tibiae in nude mouse, severe trabecular and cortical bone destruction and subsequent tumor growths were detected. Oral administration of TAS-115 almost completely inhibited both PC3-induced bone loss and PC3 cell proliferation by suppressing osteoclastic bone resorption. In an ex vivo bone organ culture, PC3 cells induced osteoclastic bone resorption when co-cultured with calvarial bone, but TAS-115 effectively suppressed the PC3-induced bone destruction. We found that macrophage colony-stimulating factor-dependent macrophage differentiation and subsequent receptor activator of NF-kappa B ligand-induced osteoclast formation were largely suppressed by adding TAS-115. The phosphorylation of the macrophage colony-stimulating factor receptor FMS and osteoclast related kinases such as ERK and Akt were also suppressed by the presence of TAS-115. Gene expression profiling showed that FMS expression was only seen in macrophage and in the osteoclast cell lineage. Our study indicates that tyrosine kinase signaling in host pre-osteoclasts/osteoclasts is critical for bone destruction induced by tumor cells and that targeting of MET/VEGF receptor/FMS activity makes it a promising therapeutic candidate for the treatment of prostate cancer patients with bone metastasis.	[Watanabe, Kenta; Hirata, Michiko; Matsumoto, Chiho; Miyaura, Chisato; Inada, Masaki] Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, 2-24-16 Naka Cho, Koganei, Tokyo 1848588, Japan; [Tominari, Tsukasa; Nagase, Hideaki; Miyaura, Chisato; Inada, Masaki] Tokyo Univ Agr & Technol, Global Innovat Res Org, Koganei, Tokyo 1848588, Japan; [Fujita, Hidenori; Yonekura, Kazuhiko] Taiho Pharmaceut Co Ltd, Tsukuba Res Ctr, Ibaraki 3002611, Japan; [Murphy, Gillian] Univ Cambridge, Dept Oncol, Canc Res UK, Cambridge Inst,Li Ka Shing Ctr, Cambridge CB2 0RE, England; [Nagase, Hideaki] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Kennedy Inst Rheumatol, Oxford OX3 7FY, England	Tokyo University of Agriculture & Technology; Tokyo University of Agriculture & Technology; Taiho Pharmaceutical; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Oxford	Inada, M (corresponding author), Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, 2-24-16 Naka Cho, Koganei, Tokyo 1848588, Japan.	m-inada@cc.tuat.ac.jp	Tominari, Tsukasa/B-6054-2015; Hirata, Michiko/D-2351-2013; miyaura, chisato/D-1864-2013; inada, masaki/D-1581-2013	Hirata, Michiko/0000-0002-5291-6112; miyaura, chisato/0000-0002-2548-8191; inada, masaki/0000-0002-5066-8506; Tominari, Tsukasa/0000-0001-5683-8951	National Institute of Health [AR40994]; Global Innovation Research Organization in Tokyo University of Agriculture and Technology; Japan Society for the Promotion of Science Bilateral Joint Research Projects;  [23590069];  [25460062]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040994] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Global Innovation Research Organization in Tokyo University of Agriculture and Technology; Japan Society for the Promotion of Science Bilateral Joint Research Projects(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work is partly supported by Grants-in-Aid for Scientific Research 25460062 (to C. M.) and 23590069 (to M. I.), National Institute of Health Grant AR40994 (to H. N.), and Global Innovation Research Organization in Tokyo University of Agriculture and Technology (to M. I. and H. N.). This project was also supported by Open Partnership Joint Projects of Japan Society for the Promotion of Science Bilateral Joint Research Projects. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arai A, 2012, J CELL SCI, V125, P2910, DOI 10.1242/jcs.099986; Bergh J, 2012, J CLIN ONCOL, V30, P921, DOI 10.1200/JCO.2011.35.7376; Bhatia V, 2013, EXP CELL RES, V319, P1419, DOI 10.1016/j.yexcr.2013.03.003; Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018; Dai JL, 2014, CLIN CANCER RES, V20, P617, DOI 10.1158/1078-0432.CCR-13-0839; Danks L, 2013, J BIOCHEM, V154, P29, DOI 10.1093/jb/mvt049; Eswaraka J, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-742; Feng X, 2013, BONE RES, V1, DOI 10.4248/BR201301003; Fujita H, 2013, MOL CANCER THER, V12, P2685, DOI 10.1158/1535-7163.MCT-13-0459; Gartrell BA, 2014, NAT REV CLIN ONCOL, V11, P335, DOI 10.1038/nrclinonc.2014.70; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Inada M, 2006, J IMMUNOL, V177, P1879, DOI 10.4049/jimmunol.177.3.1879; Inada M, 2015, J BIOL CHEM, V290, P29781, DOI 10.1074/jbc.M115.669481; Israeli Ron S, 2008, Rev Urol, V10, P99; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Li XT, 2003, ENDOCRINOLOGY, V144, P4999, DOI 10.1210/en.2003-0166; Miyaura C, 2003, J EXP MED, V197, P1303, DOI 10.1084/jem.20030015; Morony S, 2001, CANCER RES, V61, P4432; Negishi-Koga T, 2009, IMMUNOL REV, V231, P241, DOI 10.1111/j.1600-065X.2009.00821.x; Ohshiba T, 2003, BRIT J CANCER, V88, P1318, DOI 10.1038/sj.bjc.6600858; Olechnowicz SWZ, 2014, CANCER RES, V74, P1625, DOI 10.1158/0008-5472.CAN-13-2645; Ongkeko WM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085803; Sato K, 2006, NAT MED, V12, P1410, DOI 10.1038/nm1515; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Sulpice E, 2009, BIOL CELL, V101, P525, DOI 10.1042/BC20080221; Suzu S, 2007, J CELL PHYSIOL, V212, P519, DOI 10.1002/jcp.21045; Teoh D, 2012, INT J GYNECOL CANCER, V22, P348, DOI 10.1097/IGC.0b013e31823c6efd; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; Wong BR, 1997, J BIOL CHEM, V272, P25190, DOI 10.1074/jbc.272.40.25190; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Zhang J, 2001, J CLIN INVEST, V107, P1235, DOI 10.1172/JCI11685	32	19	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					20891	20899		10.1074/jbc.M116.727875	http://dx.doi.org/10.1074/jbc.M116.727875			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27539855	Green Published, hybrid			2022-12-26	WOS:000385406200008
J	Vidal-Martinez, G; Vargas-Medrano, J; Gil-Tommee, C; Medina, D; Garza, NT; Yang, B; Segura-Ulate, I; Dominguez, SJ; Perez, RG				Vidal-Martinez, Guadalupe; Vargas-Medrano, Javier; Gil-Tommee, Carolina; Medina, David; Garza, Nathan T.; Yang, Barbara; Segura-Ulate, Ismael; Dominguez, Samantha J.; Perez, Ruth G.			FTY720/Fingolimod Reduces Synucleinopathy and Improves Gut Motility in A53T Mice: CONTRIBUTIONS OF PRO-BRAIN-DERIVED NEUROTROPHIC FACTOR (PRO-BDNF) AND MATURE BDNF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alpha-synuclein (aSyn); neurodegenerative disease; neuroprotection; Parkinson disease; pathology; gut; preclinical assessment; synucleinopathy	TYROSINE-HYDROXYLASE PHOSPHORYLATION; ENTERIC DOPAMINERGIC-NEURONS; ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; UP-REGULATION; SUBSTANTIA-NIGRA; NERVOUS-SYSTEM; RAT MODEL; IN-VITRO; FINGOLIMOD	Patients with Parkinson's disease (PD) often have aggregated -synuclein (aSyn) in enteric nervous system (ENS) neurons, which may be associated with the development of constipation. This occurs well before the onset of classic PD motor symptoms. We previously found that aging A53T transgenic (Tg) mice closely model PD-like ENS aSyn pathology, making them appropriate for testing potential PD therapies. Here we show that Tg mice overexpressing mutant human aSyn develop ENS pathology by 4 months. We then evaluated the responses of Tg mice and their WT littermates to the Food and Drug Administration-approved drug FTY720 (fingolimod, Gilenya) or vehicle control solution from 5 months of age. Long term oral FTY720 in Tg mice reduced ENS aSyn aggregation and constipation, enhanced gut motility, and increased levels of brain-derived neurotrophic factor (BDNF) but produced no significant change in WT littermates. A role for BDNF was directly assessed in a cohort of young A53T mice given vehicle, FTY720, the Trk-B receptor inhibitor ANA-12, or FTY720 + ANA-12 from 1 to 4 months of age. ANA-12-treated Tg mice developed more gut aSyn aggregation as well as constipation, whereas FTY720-treated Tg mice had reduced aSyn aggregation and less constipation, occurring in part by increasing both pro-BDNF and mature BDNF levels. The data from young and old Tg mice revealed FTY720-associated neuroprotection and reduced aSyn pathology, suggesting that FTY720 may also benefit PD patients and others with synucleinopathy. Another finding was a loss of tyrosine hydroxylase immunoreactivity in gut neurons with aggregated aSyn, comparable with our prior findings in the CNS.	[Vidal-Martinez, Guadalupe; Vargas-Medrano, Javier; Gil-Tommee, Carolina; Medina, David; Garza, Nathan T.; Yang, Barbara; Segura-Ulate, Ismael; Dominguez, Samantha J.; Perez, Ruth G.] Texas Tech Univ, Grad Sch Biomed Sci, Paul L Foster Sch Med, Ctr Emphasis Neurosci,Hlth Sci Ctr El Paso, 5001 El Paso Dr,MSB 1,Suite 4002, El Paso, TX 79905 USA	Texas Tech University System; Texas Tech University	Perez, RG (corresponding author), Texas Tech Univ, Grad Sch Biomed Sci, Paul L Foster Sch Med, Ctr Emphasis Neurosci,Hlth Sci Ctr El Paso, 5001 El Paso Dr,MSB 1,Suite 4002, El Paso, TX 79905 USA.	ruth.g.perez@ttuhsc.edu	Vargas Medrano, Javier/AAW-4666-2021; Perez, Ruth G./AAK-9844-2020	Vargas Medrano, Javier/0000-0002-5424-4225; 	NINDS, National Institutes of Health [NS42094]; Texas Tech University Health Sciences Center El Paso; Lizanell and Colbert Coldwell Foundation; Multiple System Atrophy Coalition; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042094] Funding Source: NIH RePORTER	NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Texas Tech University Health Sciences Center El Paso; Lizanell and Colbert Coldwell Foundation; Multiple System Atrophy Coalition; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NINDS, National Institutes of Health, Grant NS42094; the Texas Tech University Health Sciences Center El Paso (startup funds); the Lizanell and Colbert Coldwell Foundation; the Multiple System Atrophy Coalition; and gifts from Anna Mae Doyle and Hoy Family Research. R. P. filed a patent for FTY720 and FTY720-based compounds (US 14/435,346). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahn M, 2006, BIOCHEM BIOPH RES CO, V346, P1142, DOI 10.1016/j.bbrc.2006.05.213; Alerte TNM, 2008, NEUROSCI LETT, V435, P24, DOI 10.1016/j.neulet.2008.02.014; Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Appel-Cresswell S, 2013, MOVEMENT DISORD, V28, P811, DOI 10.1002/mds.25421; Aranda PS, 2012, ELECTROPHORESIS, V33, P366, DOI 10.1002/elps.201100335; Ashraf W, 1997, MOVEMENT DISORD, V12, P946, DOI 10.1002/mds.870120617; Baba M, 1998, AM J PATHOL, V152, P879; Beach TG, 2013, J NEUROPATH EXP NEUR, V72, P130, DOI 10.1097/NEN.0b013e3182805c72; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; Braak H, 2000, J NEUROL, V247, P3; Braak H, 2006, NEUROSCI LETT, V396, P67, DOI 10.1016/j.neulet.2005.11.012; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Cazorla M, 2011, J CLIN INVEST, V121, P1846, DOI 10.1172/JCI43992; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chauhan A, 2015, NEUROL RES INT, V2015, DOI 10.1155/2015/345285; Chen F, 2014, ACTA PHYSIOL, V212, P226, DOI 10.1111/apha.12374; Chun HS, 2000, NEUROREPORT, V11, P511, DOI 10.1097/00001756-200002280-00017; Cipriani R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0308-6; Coulie B, 2000, GASTROENTEROLOGY, V119, P41, DOI 10.1053/gast.2000.8553; Cronin KD, 2009, HUM MOL GENET, V18, P3274, DOI 10.1093/hmg/ddp265; Deogracias R, 2012, P NATL ACAD SCI USA, V109, P14230, DOI 10.1073/pnas.1206093109; Di Menna L, 2013, PHARMACOL RES, V67, P1, DOI 10.1016/j.phrs.2012.10.004; Di Pardo A, 2014, HUM MOL GENET, V23, P2251, DOI 10.1093/hmg/ddt615; Doi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061988; Farrell KF, 2014, J NEUROCHEM, V128, P536, DOI 10.1111/jnc.12481; Fredriksson A, 2011, J NEURAL TRANSM, V118, P407, DOI 10.1007/s00702-010-0474-8; Fukumoto K, 2014, BEHAV BRAIN RES, V268, P88, DOI 10.1016/j.bbr.2014.03.046; Gao HM, 2008, J NEUROSCI, V28, P7687, DOI 10.1523/JNEUROSCI.0143-07.2008; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Goedert M, 2013, NAT REV NEUROL, V9, P13, DOI 10.1038/nrneurol.2012.242; Hait NC, 2014, NAT NEUROSCI, V17, P971, DOI 10.1038/nn.3728; Hoglinger GU, 2001, EXP NEUROL, V167, P148, DOI 10.1006/exnr.2000.7546; Howells DW, 2000, EXP NEUROL, V166, P127, DOI 10.1006/exnr.2000.7483; HYMAN C, 1991, NATURE, V350, P230, DOI 10.1038/350230a0; Iwatsubo T, 2003, J NEUROL, V250, P11, DOI 10.1007/s00415-003-1303-x; Junn E, 2012, PHARMACOL THERAPEUT, V133, P142, DOI 10.1016/j.pharmthera.2011.10.002; Karamohamed S, 2005, NEUROLOGY, V65, P1823, DOI 10.1212/01.wnl.0000187075.81589.fd; Kim TD, 2000, PROTEIN SCI, V9, P2489, DOI 10.1110/ps.9.12.2489; Krismer F, 2014, PARKINSONISM RELAT D, V20, P793, DOI 10.1016/j.parkreldis.2014.05.005; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kuo YM, 2010, HUM MOL GENET, V19, P1633, DOI 10.1093/hmg/ddq038; Lesage S, 2013, ANN NEUROL, V73, P459, DOI 10.1002/ana.23894; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; Li ZS, 2011, J NEUROSCI, V31, P8998, DOI 10.1523/JNEUROSCI.6684-10.2011; Li ZS, 2006, J NEUROSCI, V26, P2798, DOI 10.1523/JNEUROSCI.4720-05.2006; Li ZS, 2004, J NEUROSCI, V24, P1330, DOI 10.1523/JNEUROSCI.3982-03.2004; Lommatzsch M, 1999, AM J PATHOL, V155, P1183, DOI 10.1016/S0002-9440(10)65221-2; Lou HY, 2010, J BIOL CHEM, V285, P17648, DOI 10.1074/jbc.M110.100867; Manning-Bog AB, 2002, J BIOL CHEM, V277, P1641, DOI 10.1074/jbc.C100560200; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Miguez A, 2015, HUM MOL GENET, V24, P4958, DOI 10.1093/hmg/ddv218; Mogi M, 1999, NEUROSCI LETT, V270, P45, DOI 10.1016/S0304-3940(99)00463-2; Nagahara AH, 2011, NAT REV DRUG DISCOV, V10, P209, DOI 10.1038/nrd3366; Nakamura K, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0208-0; Neumann M, 2002, J CLIN INVEST, V110, P1429, DOI 10.1172/JC1200215777; Nishimura H, 2010, J HISTOCHEM CYTOCHEM, V58, P847, DOI 10.1369/jhc.2010.956409; Norris EH, 2007, AM J PATHOL, V170, P658, DOI 10.2353/ajpath.2007.060359; Pasanen P, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.03.024; Pellicano Clelia, 2007, Neuropsychiatr Dis Treat, V3, P145, DOI 10.2147/nedt.2007.3.1.145; Peng XMM, 2005, J CELL SCI, V118, P3523, DOI 10.1242/jcs.02481; Perez RG, 2004, J NEUROCHEM, V89, P1318, DOI 10.1111/j.1471-4159.2004.02423.x; Perez RG, 2002, J NEUROSCI, V22, P3090, DOI 10.1523/JNEUROSCI.22-08-03090.2002; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Salawu F K, 2010, Niger J Med, V19, P126; Savica R, 2009, NEUROLOGY, V73, P1752, DOI 10.1212/WNL.0b013e3181c34af5; Schapira AHV, 2003, ANN NEUROL, V53, pS149, DOI 10.1002/ana.10514; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shannon KM, 2012, MOVEMENT DISORD, V27, P716, DOI 10.1002/mds.25020; Shannon KM, 2012, MOVEMENT DISORD, V27, P709, DOI 10.1002/mds.23838; SINGARAM C, 1995, LANCET, V346, P861, DOI 10.1016/S0140-6736(95)92707-7; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Sun M, 2005, BRAIN RES, V1052, P119, DOI 10.1016/j.brainres.2005.05.072; Taylor TN, 2009, J NEUROSCI, V29, P8103, DOI 10.1523/JNEUROSCI.1495-09.2009; Tehranian R, 2006, J NEUROCHEM, V99, P1188, DOI 10.1111/j.1471-4159.2006.04146.x; Tome CML, 2013, MOL NEUROBIOL, V47, P561, DOI 10.1007/s12035-012-8267-8; Varendi K, 2015, CELL MOL LIFE SCI, V72, P1779, DOI 10.1007/s00018-015-1836-z; Vargas-Medrano J, 2014, ACS MED CHEM LETT, V5, P782, DOI 10.1021/ml500128g; Vila M, 2000, J NEUROCHEM, V74, P721, DOI 10.1046/j.1471-4159.2000.740721.x; Visanji Naomi P, 2013, Acta Neuropathol Commun, V1, P2, DOI 10.1186/2051-5960-1-2; Waxman EA, 2008, J NEUROPATH EXP NEUR, V67, P402, DOI 10.1097/NEN.0b013e31816fc995; Weinreb O, 2007, ANN NY ACAD SCI, V1122, P155, DOI 10.1196/annals.1403.011; Wolters EC, 2009, PARKINSONISM RELAT D, V15, pS6, DOI 10.1016/S1353-8020(09)70770-9; Wu J, 2012, NEUROSCIENCE, V207, P288, DOI 10.1016/j.neuroscience.2012.01.028; Yang JM, 2009, NAT NEUROSCI, V12, P113, DOI 10.1038/nn.2244; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang L., 2011, PROTOC EXCH, DOI [10.1038/protex.2011.236, DOI 10.1038/PROTEX.2011.236]	87	50	50	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20811	20821		10.1074/jbc.M116.744029	http://dx.doi.org/10.1074/jbc.M116.744029			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27528608	Green Published, hybrid			2022-12-26	WOS:000384574800041
J	Chen, ZT; Mu, LX; Wang, JR; Du, YZ				Chen, Zhi-Teng; Mu, Li-Xia; Wang, Ji-Rui; Du, Yu-Zhou			Complete Mitochondrial Genome of the Citrus Spiny Whitefly Aleurocanthus spiniferus (Quaintance) (Hemiptera: Aleyrodidae): Implications for the Phylogeny of Whiteflies	PLOS ONE			English	Article							BEMISIA-TABACI HEMIPTERA; RIBOSOMAL-RNA GENES; A+T-RICH REGION; MAXIMUM-LIKELIHOOD; COMPLETE SEQUENCE; BIOLOGICAL-CONTROL; APIS-MELLIFERA; DNA-SEQUENCES; STERNORRHYNCHA; ORGANIZATION	In this study, we sequenced the complete mitochondrial genome (15,220 bp) of the citrus spiny whitefly, Aleurocanthus spiniferus (Quaintance), a well-known pest from the superfamily Aleyrodidae. The A. spiniferus mitogenome contains 36 genes, including 13 protein-coding genes (PCGs), 21 transfer RNAs (tRNA), two ribosomal RNAs (rRNA) and a large non-coding region (control region, CR). Like most whiteflies, the A. spiniferus mitogenome had a large degree of rearrangement due to translocation of the nad3-trnG-cox3 gene cluster. The 13 PCGs initiated with ATN and generally terminated with TAA, although some used TAG or T as stop codons; atp6 showed the highest evolutionary rate, whereas cox2 appeared to have the lowest rate. The A. spiniferus mitogenome had 21 tRNAs with a typical cloverleaf secondary structure composed of four arms. Modeling of the two rRNA genes indicated that their secondary structure was similar to that of other insects. The CR of A. spiniferus was 920 bp and mapped between the nad3-trnG-cox3 and trnI-trnM gene clusters. One potential stem-loop structure and five tandem repeats were identified in the CR. Phylogenetic relationships of 11 species from the Aleyrodidae were analyzed based on the deduced amino acid sequences of the 13 PCGs and evolutionary characteristics were explored. Species with more genetic rearrangements were generally more evolved within the Aleyrodidae.	[Chen, Zhi-Teng; Mu, Li-Xia; Wang, Ji-Rui; Du, Yu-Zhou] Yangzhou Univ, Sch Hort Plant Protect, Yangzhou 225009, Jiangsu, Peoples R China; [Chen, Zhi-Teng; Mu, Li-Xia; Wang, Ji-Rui; Du, Yu-Zhou] Yangzhou Univ, Inst Appl Entomol, Yangzhou 225009, Jiangsu, Peoples R China; [Wang, Ji-Rui] Zhejiang Agr & Forestry Univ, Sch Agr & Food Sci, Linan 311300, Peoples R China	Yangzhou University; Yangzhou University; Zhejiang A&F University	Du, YZ (corresponding author), Yangzhou Univ, Sch Hort Plant Protect, Yangzhou 225009, Jiangsu, Peoples R China.; Du, YZ (corresponding author), Yangzhou Univ, Inst Appl Entomol, Yangzhou 225009, Jiangsu, Peoples R China.	yzdu@yzu.edu.cn			Special Fund for Agro-scientific Research in the Public Interest of China [201303019]; China Postdoctoral Science Foundation [2016M592017]; Ministry of Agriculture of the People's Republic of China	Special Fund for Agro-scientific Research in the Public Interest of China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Ministry of Agriculture of the People's Republic of China(Ministry of Agriculture & Rural Affairs)	This work was supported by the Special Fund for Agro-scientific Research in the Public Interest of China, 201303019, to Professor Yu-Zhou Du; and the China Postdoctoral Science Foundation, 2016M592017, to Dr. Ji-Rui Wang. Funding institution: Ministry of Agriculture of the People's Republic of China; China Postdoctoral Science Foundation. URLs: http://www.moa.gov.cn/;http://jj.chinapostdoctor.org.cn/.	AVISE JC, 1989, EVOLUTION, V43, P1192, DOI [10.1111/j.1558-5646.1989.tb02568.x, 10.2307/2409356]; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Boore JL, 2005, METHOD ENZYMOL, V395, P311, DOI 10.1016/S0076-6879(05)95019-2; Boykin LM, 2007, MOL PHYLOGENET EVOL, V44, P1306, DOI 10.1016/j.ympev.2007.04.020; Boykin LM, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-228; BYRNE DN, 1991, ANNU REV ENTOMOL, V36, P431, DOI 10.1146/annurev.en.36.010191.002243; Cameron SL, 2008, GENE, V408, P112, DOI 10.1016/j.gene.2007.10.023; Cameron Stephen L., 2006, Arthropod Systematics & Phylogeny, V64, P27; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-15; Chai HN, 2012, INT J BIOL SCI, V8, P561, DOI 10.7150/ijbs.3540; CLARY DO, 1985, NUCLEIC ACIDS RES, V13, P4029, DOI 10.1093/nar/13.11.4029; Clausen C, 1978, AGR HDB, V480, P480; Crease TJ, 1999, GENE, V233, P89, DOI 10.1016/S0378-1119(99)00151-1; CROZIER RH, 1993, GENETICS, V133, P97; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Evans GA., 2008, WHITEFLIES HEMIPTERA; Flook PK, 1995, J MOL EVOL, V41, P928, DOI 10.1007/BF00173173; [付建玉 FU JianYu], 2007, [生态学报, Acta Ecologica Sinica], V27, P1887; Gillespie JJ, 2006, INSECT MOL BIOL, V15, P657, DOI 10.1111/j.1365-2583.2006.00689.x; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guo L, 2006, GUANGDONG AGR SCI, V2; Gyeltshen J, 2005, ORANGE SPINY WHITEFL; Han B., 2002, ACTA ECOL SINICA, V23, P1781; Kanmiya K, 2011, ZOOTAXA, P25, DOI 10.11646/zootaxa.2797.1.3; Kuwana I., 1928, ALEYRODIDAE WHITEFLI; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lavrov DV, 2000, P NATL ACAD SCI USA, V97, P13738, DOI 10.1073/pnas.250402997; Lee W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063817; Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029419; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lin CH, 2010, BIOINFORMATICS, V26, P408, DOI 10.1093/bioinformatics/btp689; Lin CP, 2004, MOL PHYLOGENET EVOL, V30, P686, DOI 10.1016/S1055-7903(03)00241-0; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Ma C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-156; Manzari S, 2006, J NAT HIST, V40, P2423, DOI 10.1080/00222930601121890; Muniappan R., 2006, Proceedings of the Hawaiian Entomological Society, V38, P21; Nardi F, 2003, SCIENCE, V299, P1887, DOI 10.1126/science.1078607; NGUYEN M, 1993, J BIOL CHEM, V268, P25265; Niu JZ, 2014, BIOL CONTROL, V68, P15, DOI 10.1016/j.biocontrol.2013.06.005; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Peng Ping, 2010, Southwest China Journal of Agricultural Sciences, V23, P87; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Salvato P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-331; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Song N, 2009, ZOOL SCI, V26, P851, DOI 10.2108/zsj.26.851; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang ZX, 2002, PLANT PROTECTION TEC, V05, P23; Tay WT, 2014, MITOCHONDR DNA, P1; Thao ML, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-25; van den Berg MA, 2000, BIOCONTROL SCI TECHN, V10, P27, DOI 10.1080/09583150029350; Wang H., 2015, MOL NEUROBIOL, P1, DOI DOI 10.1007/S12035-014-9073-2; Wang H, 2014, MITOCHONDRIAL DNA; Wang HL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-401; Wilson K, 2000, MOL BIOL EVOL, V17, P863, DOI 10.1093/oxfordjournals.molbev.a026366; Xu W, 2006, J MOL EVOL, V63, P375, DOI 10.1007/s00239-005-0246-5; Yang F, 2011, GENE, V485, P7, DOI 10.1016/j.gene.2011.05.030; Zhou ZJ, 2007, GENOME, V50, P855, DOI 10.1139/G07-057	62	13	15	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0161385	10.1371/journal.pone.0161385	http://dx.doi.org/10.1371/journal.pone.0161385			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27551782	Green Submitted, gold, Green Published			2022-12-26	WOS:000381768800035
J	McArdle, AJ; Webbe, J; Sim, K; Parrish, G; Hoggart, C; Wang, YF; Kroll, JS; Godambe, S; Cunnington, AJ				McArdle, Andrew J.; Webbe, James; Sim, Kathleen; Parrish, Graham; Hoggart, Clive; Wang, Yifei; Kroll, J. Simon; Godambe, Sunit; Cunnington, Aubrey J.			Determinants of Carboxyhemoglobin Levels and Relationship with Sepsis in a Retrospective Cohort of Preterm Neonates	PLOS ONE			English	Article							CARBON-MONOXIDE PRODUCTION; HEME OXYGENASE-1 EXPRESSION; HEMOGLOBIN; DIAGNOSIS; PROTECTION; HEMOLYSIS; CHILDREN; AFFINITY; FORMS	Carboxyhemoglobin levels in blood reflect endogenous carbon monoxide production and are often measured during routine blood gas analysis. Endogenous carbon monoxide production has been reported to be increased during sepsis, but carboxyhemoglobin levels have not been thoroughly evaluated as a biomarker of sepsis. We sought to determine whether carboxyhemoglobin levels were elevated during sepsis in a high risk population of premature neonates. We conducted a retrospective cohort study of 30 infants in two neonatal intensive care units using electronic medical and laboratory records. The majority of infants were extremely premature and extremely low birth weight, and 25 had at least one episode of sepsis. We collected all carboxyhemoglobin measurements during their inpatient stay and examined the relationship between carboxyhemoglobin and a variety of clinical and laboratory parameters, in addition to the presence or absence of sepsis, using linear mixed-effect models. We found that postnatal age had the most significant effect on carboxyhemoglobin levels, and other significant associations were identified with gestational age, hemoglobin concentration, oxyhemoglobin saturation, and blood pH. Accounting for these covariates, there was no significant relationship between the onset of sepsis and carboxyhemoglobin levels. Our results show that carboxyhemoglobin is unlikely to be a clinically useful biomarker of sepsis in premature infants, and raise a note of caution about factors which may confound the use of carbon monoxide as a clinical biomarker for other disease processes such as hemolysis.	[McArdle, Andrew J.; Webbe, James; Kroll, J. Simon; Cunnington, Aubrey J.] Imperial Coll Healthcare NHS Trust, Paediat Infect Dis, London, England; [Webbe, James; Parrish, Graham; Godambe, Sunit] Imperial Coll Healthcare NHS Trust, Neonatal Med, London, England; [Sim, Kathleen; Hoggart, Clive; Kroll, J. Simon; Godambe, Sunit; Cunnington, Aubrey J.] Imperial Coll, Dept Med, Paediat Sect, London, England; [Wang, Yifei] Imperial Coll, Imperial Coll Sch Med, South Kensington Campus, London, England	Imperial College London; Imperial College London; Imperial College London; Imperial College London	Cunnington, AJ (corresponding author), Imperial Coll Healthcare NHS Trust, Paediat Infect Dis, London, England.; Cunnington, AJ (corresponding author), Imperial Coll, Dept Med, Paediat Sect, London, England.	a.cunnington@imperial.ac.uk		Cunnington, Aubrey/0000-0002-1305-3529; Webbe, James/0000-0001-8546-3212; McArdle, Andrew/0000-0001-7448-0869	MRC Clinician Scientist Fellowship [MR/L006529/1]; Medical Research Council [MR/L006529/1] Funding Source: researchfish; MRC [MR/L006529/1] Funding Source: UKRI	MRC Clinician Scientist Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors received no specific funding for this work. AJC is supported by a MRC Clinician Scientist Fellowship (MR/L006529/1, www.mrc.ac.uk). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam J, 2007, AM J RESP CELL MOL, V36, P166, DOI 10.1165/rcmb.2006-0340TR; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Benitz WE, 2010, CLIN PERINATOL, V37, P421, DOI 10.1016/j.clp.2009.12.001; Caboot JB, 2012, PEDIATR PULM, V47, P808, DOI 10.1002/ppul.22504; Christou H, 2005, AM J PHYSIOL-HEART C, V288, pH2647, DOI 10.1152/ajpheart.00937.2004; COBURN RF, 1964, J CLIN INVEST, V43, P1098, DOI 10.1172/JCI104994; COBURN RF, 1966, J CLIN INVEST, V45, P460, DOI 10.1172/JCI105360; Coburn RF, 2012, J APPL PHYSIOL, V112, P1949, DOI 10.1152/japplphysiol.00174.2012; Colombatti R, 2016, SEMIN FETAL NEONAT M, V21, P2, DOI 10.1016/j.siny.2015.12.001; Cunnington AJ, 2004, AM J TROP MED HYG, V71, P43, DOI 10.4269/ajtmh.2004.71.43; Douglas CG, 1912, J PHYSIOL-LONDON, V44, P275; ENGEL RR, 1969, BLOOD-J HEMATOL, V33, P37, DOI 10.1182/blood.V33.1.37.37; ENGEL RR, 1971, PEDIATRICS, V47, P723; ENGSTEDT L, 1957, Acta Med Scand Suppl, V332, P1; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Henry E, 2015, CLIN PERINATOL, V42, P483, DOI 10.1016/j.clp.2015.04.005; Igarashi K, 2006, ANTIOXID REDOX SIGN, V8, P107, DOI 10.1089/ars.2006.8.107; KUTTY RK, 1994, GENOMICS, V20, P513, DOI 10.1006/geno.1994.1213; Lal A, 2015, PEDIATR BLOOD CANCER, V62, P912, DOI 10.1002/pbc.25447; Langeroudi AG, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu085; Larsen R, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001118; Lozar-Krivec J, 2016, J MATERN-FETAL NEO M, V29, P452, DOI 10.3109/14767058.2015.1004050; MAINES MD, 1986, J BIOL CHEM, V261, P411; Maroti Z, 2007, EUR J PEDIATR, V166, P1033, DOI 10.1007/s00431-006-0375-x; Meyer J, 1998, BIOCHEM BIOPH RES CO, V244, P230, DOI 10.1006/bbrc.1998.8244; Moncure M, 1999, J TRAUMA, V46, P424, DOI 10.1097/00005373-199903000-00012; Morimatsu H, 2010, J BREATH RES, V4, DOI 10.1088/1752-7155/4/4/047103; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Mueller NT, 2015, TRENDS MOL MED, V21, P109, DOI 10.1016/j.molmed.2014.12.002; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Ng PC, 2015, ARCH DIS CHILD-FETAL, V100, pF448, DOI 10.1136/archdischild-2014-307656; Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586; Ryter SW, 2013, J BREATH RES, V7, DOI 10.1088/1752-7155/7/1/017111; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Schaer DJ, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00415; Schaer DJ, 2013, BLOOD, V121, P1276, DOI 10.1182/blood-2012-11-451229; Seixas E, 2009, P NATL ACAD SCI USA, V106, P15837, DOI 10.1073/pnas.0903419106; Shane AL, 2013, AM J PERINAT, V30, P131, DOI 10.1055/s-0032-1333413; SHARMA VS, 1976, J BIOL CHEM, V251, P4267; Shi Y, 2003, ARCH DIS CHILD, V88, P889, DOI 10.1136/adc.88.10.889; Simonsen KA, 2014, CLIN MICROBIOL REV, V27, P21, DOI 10.1128/CMR.00031-13; SJOSTRAND T, 1949, NATURE, V164, P580, DOI 10.1038/164580a0; Stark MJ, 2009, PEDIATRICS, V124, P277, DOI 10.1542/peds.2008-0877; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; Tan RNGB, 2015, FRONT PEDIATR, V3, DOI 10.3389/fped.2015.00094; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; Tidmarsh GF, 2014, J PERINATOL, V34, P577, DOI 10.1038/jp.2014.66; Westphal M, 2002, BIOCHEM BIOPH RES CO, V295, P975, DOI 10.1016/S0006-291X(02)00781-7; Widdop B, 2002, ANN CLIN BIOCHEM, V39, P378, DOI 10.1258/000456302760042146; Wu LY, 2005, PHARMACOL REV, V57, P585, DOI 10.1124/pr.57.4.3; Yasuda H, 2005, AM J RESP CRIT CARE, V171, P1246, DOI 10.1164/rccm.200407-914OC; Zuckerbraun BS, 2005, AM J PHYSIOL-GASTR L, V289, pG607, DOI 10.1152/ajpgi.00055.2005	52	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0161784	10.1371/journal.pone.0161784	http://dx.doi.org/10.1371/journal.pone.0161784			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27552216	gold, Green Published, Green Submitted			2022-12-26	WOS:000381768800076
J	Mufazalov, IA; Regen, T; Schelmbauer, C; Kuschmann, J; Muratova, AM; Nikolaev, A; Muller, W; Pinteaux, E; Waisman, A				Mufazalov, Ilgiz A.; Regen, Tommy; Schelmbauer, Carsten; Kuschmann, Janina; Muratova, Alisa M.; Nikolaev, Alexei; Mueller, Werner; Pinteaux, Emmanuel; Waisman, Ari			Generation of a Novel T Cell Specific Interleukin-1 Receptor Type 1 Conditional Knock Out Mouse Reveals Intrinsic Defects in Survival, Expansion and Cytokine Production of CD4 T Cells	PLOS ONE			English	Article							AUTOIMMUNE ENCEPHALOMYELITIS; I RECEPTOR; IL-1; MICE; ACTIVATION; SECRETION; SYSTEM; IL-1-BETA; DEFICIENT; INDUCTION	Interleukin-1 (IL-1) plays a crucial role in numerous inflammatory diseases via action on its only known signaling IL-1 receptor type 1 (IL-1R1). To investigate the role of IL-1 signaling in selected cell types, we generated a new mouse strain in which exon 5 of the Il1r1 gene is flanked by loxP sites. Crossing of these mice with CD4-Cre transgenic mice resulted in IL1R1 loss of function specifically in T cells. These mice, termed IL-1R1(Delta T), displayed normal development under steady state conditions. Importantly, isolated CD4 positive T cells retained their capacity to differentiate toward Th1 or Th17 cell lineages in vitro, and strongly proliferated in cultures supplemented with either anti-CD3/CD28 or Concanavalin A, but, as predicted, were completely unresponsive to IL-1 beta administration. Furthermore, IL-1R1(Delta T) mice were protected from gut inflammation in the anti-CD3 treatment model, due to dramatically reduced frequencies and absolute numbers of IL-17A and interferon (IFN)-gamma producing cells. Taken together, our data shows the necessity of intact IL-1 signaling for survival and expansion of CD4 T cells that were developed in an otherwise IL-1 sufficient environment.	[Mufazalov, Ilgiz A.; Regen, Tommy; Schelmbauer, Carsten; Kuschmann, Janina; Muratova, Alisa M.; Nikolaev, Alexei; Waisman, Ari] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Mol Med, Mainz, Germany; [Muratova, Alisa M.] Lomonosov Moscow State Univ, Fac Biol, Dept Immunol, Moscow, Russia; [Mueller, Werner; Pinteaux, Emmanuel] Univ Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England	Johannes Gutenberg University of Mainz; Lomonosov Moscow State University; University of Manchester	Mufazalov, IA; Waisman, A (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Mol Med, Mainz, Germany.	ilgiz.mufazalov@uni-mainz.de; waisman@uni-mainz.de	Müller, W. E. G./AAR-8651-2020; Waisman, Ari/C-7383-2015; Mufazalov, Ilgiz/GLN-4021-2022; Regen, Tommy/GQH-6929-2022; Muller, Werner/B-9044-2008	Müller, W. E. G./0000-0002-8223-3689; Waisman, Ari/0000-0003-4304-8234; Mufazalov, Ilgiz/0000-0001-9332-0131; Muller, Werner/0000-0002-1297-9725; Regen, Tommy/0000-0002-7275-3330; Pinteaux, Emmanuel/0000-0002-9986-4401	Deutsche Forschungsgemeinschaft (DFG) [WA 1600/8-1]; Gemeinnutzige Hertie-Stiftung; Sixth Research Framework Programme of the European Union, Project MUGEN [MUGEN LSHG-CT-2005-005203]; MRC research grant [G0801296]; EU (FP7) [305564]; DAAD fellowship;  [SFB/TRR128 TP A07]; MRC [G0801296] Funding Source: UKRI; Medical Research Council [G0801296] Funding Source: researchfish	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Gemeinnutzige Hertie-Stiftung; Sixth Research Framework Programme of the European Union, Project MUGEN; MRC research grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU (FP7); DAAD fellowship(Deutscher Akademischer Austausch Dienst (DAAD)); ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) grant WA 1600/8-1 to A.W., by the SFB/TRR128 TP A07 to A.W., and by the Gemeinnutzige Hertie-Stiftung to A.W. The generation of the Il1r1fl/fl mice was funded by the Sixth Research Framework Programme of the European Union, Project MUGEN (MUGEN LSHG-CT-2005-005203) to W.M. and the 2009-2012 MRC research grant (G0801296) "Mechanisms of the Interleukin action in neuronal injury" to Nancy Rothwell, Stuart Allan and, E.P. W.M. received funding from EU (FP7/2012-2017) under grant agreement no 305564, SysmedIBD. I.A.M. was supported by a DAAD fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulaal WH, 2016, EUR J IMMUNOL, V46, P912, DOI 10.1002/eji.201546075; Ben-Sasson SZ, 2009, P NATL ACAD SCI USA, V106, P7119, DOI 10.1073/pnas.0902745106; Bruttger J, 2015, IMMUNITY, V43, P92, DOI 10.1016/j.immuni.2015.06.012; Eriksson U, 2003, J EXP MED, V197, P323, DOI 10.1084/jem.20021788; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Glaccum MB, 1997, J IMMUNOL, V159, P3364; Guo LY, 2009, P NATL ACAD SCI USA, V106, P13463, DOI 10.1073/pnas.0906988106; Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463; Humphreys NE, 2009, EUR J IMMUNOL, V39, P1036, DOI 10.1002/eji.200838938; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Labow M, 1997, J IMMUNOL, V159, P2452; Lebeis SL, 2009, INFECT IMMUN, V77, P604, DOI 10.1128/IAI.00907-08; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lopez-Castejon G, 2011, CYTOKINE GROWTH F R, V22, P189, DOI 10.1016/j.cytogfr.2011.10.001; Matsuki T, 2006, INT IMMUNOL, V18, P399, DOI 10.1093/intimm/dxh379; Merger M, 2002, GUT, V51, P155, DOI 10.1136/gut.51.2.155; Qian J, 2012, P NATL ACAD SCI USA, V109, P12189, DOI 10.1073/pnas.1205207109; Reissig S, 2014, METHODS MOL BIOL, V1193, P21, DOI 10.1007/978-1-4939-1212-4_3; Robson MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150068; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Subramaniam S, 2004, DEV COMP IMMUNOL, V28, P415, DOI 10.1016/j.dci.2003.09.016; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Yazdi AS, 2013, ANN RHEUM DIS, V72, P96, DOI 10.1136/annrheumdis-2012-202252; Zheng Y, 2013, IMMUNITY, V38, P285, DOI 10.1016/j.immuni.2013.01.008	24	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0161505	10.1371/journal.pone.0161505	http://dx.doi.org/10.1371/journal.pone.0161505			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27551932	gold, Green Published, Green Submitted			2022-12-26	WOS:000381768800046
J	de Fabritus, L; Nougairede, A; Aubry, F; Gould, EA; de Lamballerie, X				de Fabritus, Lauriane; Nougairede, Antoine; Aubry, Fabien; Gould, Ernest A.; de lamballerie, Xavier			Utilisation of ISA Reverse Genetics and Large-Scale Random Codon Re-Encoding to Produce Attenuated Strains of Tick-Borne Encephalitis Virus within Days	PLOS ONE			English	Article							FLAVIVIRUS VACCINES; CAPSID REGION; PAIR BIAS; DEOPTIMIZATION; INFECTION; MEASLES; ERADICATION; VACCINATION; INFLUENZA; IMMUNITY	Large-scale codon re-encoding is a new method of attenuating RNA viruses. However, the use of infectious clones to generate attenuated viruses has inherent technical problems. We previously developed a bacterium-free reverse genetics protocol, designated ISA, and now combined it with large-scale random codon-re-encoding method to produce attenuated tick-borne encephalitis virus (TBEV), a pathogenic flavivirus which causes febrile illness and encephalitis in humans. We produced wild-type (WT) and two re-encoded TBEVs, containing 273 or 273+284 synonymous mutations in the NS5 and NS5+NS3 coding regions respectively. Both re-encoded viruses were attenuated when compared with WT virus using a laboratory mouse model and the relative level of attenuation increased with the degree of re-encoding. Moreover, all infected animals produced neutralizing antibodies. This novel, rapid and efficient approach to engineering attenuated viruses could potentially expedite the development of safe and effective new-generation live attenuated vaccines.	[de Fabritus, Lauriane; Nougairede, Antoine; Aubry, Fabien; Gould, Ernest A.; de lamballerie, Xavier] EPV Aix Marseille Univ, UMR Emergence Pathol Virales, IRD 190, EHESP,Inserm 1207, Marseille, France; [Nougairede, Antoine; de lamballerie, Xavier] Inst Hosp Univ Mediterranee Infect, Marseille, France	Ecole des Hautes Etudes en Sante Publique (EHESP); Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Nougairede, A (corresponding author), EPV Aix Marseille Univ, UMR Emergence Pathol Virales, IRD 190, EHESP,Inserm 1207, Marseille, France.; Nougairede, A (corresponding author), Inst Hosp Univ Mediterranee Infect, Marseille, France.	antoine.nougairede@univ-amu.fr		de Fabritus, Lauriane/0000-0003-0668-4629; Aubry, Fabien/0000-0002-7733-7694	French "Agence Nationale de la Recherche" [ANR-14-CE14-0001]; PREDEMICS (European Union Seventh Framework Programme) [278433]; European Virus Archive goes global programme (EVAg; European Union - Horizon programme) [653316]	French "Agence Nationale de la Recherche"(French National Research Agency (ANR)); PREDEMICS (European Union Seventh Framework Programme); European Virus Archive goes global programme (EVAg; European Union - Horizon programme)	This work was supported by the French "Agence Nationale de la Recherche" (grant agreement no. ANR-14-CE14-0001), PREDEMICS (European Union Seventh Framework Programme under grant agreement no. 278433) and European Virus Archive goes global programme (EVAg; European Union - Horizon 2020 programme under grant agreement no. 653316; http://www.european-virus-archive.com/).	Aubry F, 2014, J GEN VIROL, V95, P2462, DOI 10.1099/vir.0.068023-0; Barrett ADT, 2001, ANN NY ACAD SCI, V951, P262; Burns CC, 2009, J VIROL, V83, P9957, DOI 10.1128/JVI.00508-09; Burns CC, 2006, J VIROL, V80, P3259, DOI 10.1128/JVI.80.7.3259-3272.2006; CHRISTENSON B, 1994, VACCINE, V12, P129, DOI 10.1016/0264-410X(94)90049-3; Coffin JM, 2008, NEW ENGL J MED, V359, P2283, DOI 10.1056/NEJMcibr0805820; Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761; Cutts FT, 1999, VACCINE, V17, pS47, DOI 10.1016/S0264-410X(99)00309-6; de Fabritus L, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004738; Ding SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012191; Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X; Gritsun TS, 2003, ANTIVIR RES, V57, P129, DOI 10.1016/S0166-3542(02)00206-1; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Hayasaka D, 2004, J GEN VIROL, V85, P1007, DOI 10.1099/vir.0.19668-0; Hayasaka D, 2009, VIROLOGY, V390, P139, DOI 10.1016/j.virol.2009.04.026; Heinz FX, 2012, VACCINE, V30, P4301, DOI 10.1016/j.vaccine.2011.09.114; HENDERSON DA, 1987, B WORLD HEALTH ORGAN, V65, P535; Kimura T, 2010, VET PATHOL, V47, P806, DOI 10.1177/0300985810372507; Kitchener S, 2004, VACCINE, V22, P2103, DOI 10.1016/j.vaccine.2004.01.026; Kretsinger K, 2014, J INFECT DIS, V210, pS23, DOI 10.1093/infdis/jiu408; Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333; Le Nouen C, 2014, P NATL ACAD SCI USA, V111, P13169, DOI 10.1073/pnas.1411290111; Martrus G, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-78; Meng J, 2014, MBIO, V5, DOI 10.1128/mBio.01704-14; Mueller S, 2006, J VIROL, V80, P9687, DOI 10.1128/JVI.00738-06; Mueller S, 2010, NAT BIOTECHNOL, V28, P723, DOI 10.1038/nbt.1636; Ni YY, 2014, VIROLOGY, V450, P132, DOI 10.1016/j.virol.2013.12.009; Ninove L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016142; Nougairede A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003172; Peden J, 1997, CODONW V1 3; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reichert TA, 2001, NEW ENGL J MED, V344, P889, DOI 10.1056/NEJM200103223441204; Takashima I, 1997, J CLIN MICROBIOL, V35, P1943, DOI 10.1128/JCM.35.8.1943-1947.1997; Tigabu B, 2009, J MED VIROL, V81, P1261, DOI 10.1002/jmv.21524; ZHANG SP, 1991, GENE, V105, P61, DOI 10.1016/0378-1119(91)90514-C; Zhou JH, 2010, VET RES COMMUN, V34, P393, DOI 10.1007/s11259-010-9359-4; Zhu YD, 1997, VIROLOGY, V233, P85, DOI 10.1006/viro.1997.8575	37	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0159564	10.1371/journal.pone.0159564	http://dx.doi.org/10.1371/journal.pone.0159564			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548676	gold, Green Published, Green Submitted			2022-12-26	WOS:000381768400007
J	Thokala, R; Olivares, S; Mi, TJ; Maiti, S; Deniger, D; Huls, H; Torikai, H; Singh, H; Champlin, RE; Laskowski, T; McNamara, G; Cooper, LJN				Thokala, Radhika; Olivares, Simon; Mi, Tiejuan; Maiti, Sourindra; Deniger, Drew; Huls, Helen; Torikai, Hiroki; Singh, Harjeet; Champlin, Richard E.; Laskowski, Tamara; McNamara, George; Cooper, Laurence J. N.			Redirecting Specificity of T cells Using the Sleeping Beauty System to Express Chimeric Antigen Receptors by Mix-and-Matching of V-L and V-H Domains Targeting CD123(+) Tumors	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; TOXIN-INTERLEUKIN-3 FUSION PROTEIN; ACUTE MYELOGENOUS LEUKEMIA; ADOPTIVE IMMUNOTHERAPY; INTERLEUKIN-3 RECEPTOR; CD28 COSTIMULATION; PHASE-I; VENOOCCLUSIVE DISEASE; CYTOTOXIC LYMPHOCYTES; ANTITUMOR EFFICACY	Adoptive immunotherapy infusing T cells with engineered specificity for CD19 expressed on B-cell malignancies is generating enthusiasm to extend this approach to other hematological malignancies, such as acute myelogenous leukemia (AML). CD123, or interleukin 3 receptor alpha, is overexpressed on most AML and some lymphoid malignancies, such as acute lymphocytic leukemia (ALL), and has been an effective target for T cells expressing chimeric antigen receptors (CARs). The prototypical CAR encodes a V-H and V-L from one monoclonal antibody (mAb), coupled to a transmembrane domain and one or more cytoplasmic signaling domains. Previous studies showed that treatment of an experimental AML model with CD123-specific CAR T cells was therapeutic, but at the cost of impaired myelopoiesis, highlighting the need for systems to define the antigen threshold for CAR recognition. Here, we show that CARs can be engineered using V-H and V-L chains derived from different CD123-specific mAbs to generate a panel of CAR(+) T cells. While all CARs exhibited specificity to CD123, one V-H and V-L combination had reduced lysis of normal hematopoietic stem cells. This CAR's in vivo anti-tumor activity was similar whether signaling occurred via chimeric CD28 or CD137, prolonging survival in both AML and ALL models. Co-expression of inducible caspase 9 eliminated CAR(+) T cells. These data help support the use of CD123-specific CARs for treatment of CD123(+) hematologic malignancies.	[Thokala, Radhika; Olivares, Simon; Mi, Tiejuan; Maiti, Sourindra; Deniger, Drew; Torikai, Hiroki; Singh, Harjeet; Laskowski, Tamara; McNamara, George; Cooper, Laurence J. N.] Univ Texas MD Anderson Canc Ctr, Div Pediat, Houston, TX 77030 USA; [Thokala, Radhika] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX USA; [Champlin, Richard E.] Univ Texas MD Anderson Canc Ctr, Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA; [Cooper, Laurence J. N.] Ziopharm Oncol Inc, Boston, MA 02129 USA; [Huls, Helen] Intrexon Corp, Germantown, MD USA; [Deniger, Drew] NCI, Surg Branch, Ctr Canc Res, NIH, Bldg 10, Bethesda, MD 20892 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Cooper, LJN (corresponding author), Univ Texas MD Anderson Canc Ctr, Div Pediat, Houston, TX 77030 USA.; Cooper, LJN (corresponding author), Ziopharm Oncol Inc, Boston, MA 02129 USA.	ljncooper@ziopharm.com	Radhika Thokala Perelman school of Medicine, University of Pennsylvania/AAP-1753-2020	THOKALA, RADHIKA/0000-0002-4279-4115	Cancer Center Core Grant [CA16672]; SPORES [CA100632, CA136411, CA00632]; Albert J Ward Foundation; Alex's Lemonade Stand Foundation; Burroughs Wellcome Fund; Cancer Prevention and Research Institute of Texas; Charles B. Goddard Foundation of Texas; CLL Global Research Foundation; Energy Transfer Partners; Estate of Noelan L. Bibler; Gillson Longenbaugh Foundation; Harry T. Mangurian, Jr., Fund for Leukemia Immunotherapy; Khalifa Bin Zayed Al Nahyan Foundation; Kleberg Foundation; Leukemia and Lymphoma Society; Lymphoma Research Foundation; Miller Foundation; National Foundation for Cancer Research; Pediatric Cancer Research Foundation; Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy; University of Texas MD Anderson Cancer Center Sister Institution Network Fund; University of Texas MD Anderson Cancer Center Moon Shot Fund; William Lawrence and Blanche Hughes Children's Foundation;  [CA124782];  [CA120956];  [CA141303];  [CA148600]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Cancer Center Core Grant; SPORES; Albert J Ward Foundation; Alex's Lemonade Stand Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Cancer Prevention and Research Institute of Texas; Charles B. Goddard Foundation of Texas; CLL Global Research Foundation; Energy Transfer Partners; Estate of Noelan L. Bibler; Gillson Longenbaugh Foundation; Harry T. Mangurian, Jr., Fund for Leukemia Immunotherapy; Khalifa Bin Zayed Al Nahyan Foundation; Kleberg Foundation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Lymphoma Research Foundation; Miller Foundation; National Foundation for Cancer Research; Pediatric Cancer Research Foundation; Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy; University of Texas MD Anderson Cancer Center Sister Institution Network Fund; University of Texas MD Anderson Cancer Center Moon Shot Fund; William Lawrence and Blanche Hughes Children's Foundation; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by: Cancer Center Core Grant (CA16672); RO1 (CA124782, CA120956, CA141303; CA141303); P01 (CA148600); SPORES (CA100632, CA136411, CA00632); Albert J Ward Foundation; Alex's Lemonade Stand Foundation; Burroughs Wellcome Fund; Cancer Prevention and Research Institute of Texas; Charles B. Goddard Foundation of Texas; CLL Global Research Foundation; Energy Transfer Partners; Estate of Noelan L. Bibler; Gillson Longenbaugh Foundation; Harry T. Mangurian, Jr., Fund for Leukemia Immunotherapy; Khalifa Bin Zayed Al Nahyan Foundation; Kleberg Foundation; Leukemia and Lymphoma Society; Lymphoma Research Foundation; Miller Foundation; Mr. Herb Simons; Mr. and Mrs. Joe H. Scales; Mr. Thomas Scott; National Foundation for Cancer Research; Pediatric Cancer Research Foundation; Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy; University of Texas MD Anderson Cancer Center Sister Institution Network Fund and Moon Shot Fund; William Lawrence and Blanche Hughes Children's Foundation. Dr. Cooper receives a salary as CEO of Ziopharm. The specific roles of the authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae J, 2004, CLIN CANCER RES, V10, P7043, DOI 10.1158/1078-0432.CCR-04-0322; Berger C, 2008, J CLIN INVEST, V118, P294, DOI 10.1172/JCI32103; Brentjens R, 2010, MOL THER, V18, P666, DOI 10.1038/mt.2010.31; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Brentjens RJ, 2011, BLOOD, V118, P4817, DOI 10.1182/blood-2011-04-348540; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Caruso HG TH, 2015, ONCOIMMUNOLOGY UNPUB; Cieri N, 2013, BLOOD, V121, P573, DOI 10.1182/blood-2012-05-431718; Davila ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008226; Deniger DC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128151; Deniger DC, 2014, CLIN CANCER RES, V20, P5708, DOI 10.1158/1078-0432.CCR-13-3451; Deniger DC, 2013, MOL THER, V21, P638, DOI 10.1038/mt.2012.267; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Du X, 2007, J IMMUNOTHER, V30, P607, DOI 10.1097/CJI.0b013e318053ed8e; Eggermont LJ, 2014, TRENDS BIOTECHNOL, V32, P456, DOI 10.1016/j.tibtech.2014.06.007; ESHHAR Z, 1993, P NATL ACAD SCI USA, V90, P720, DOI 10.1073/pnas.90.2.720; Feuring-Buske M, 2002, CANCER RES, V62, P1730; Frankel A, 2008, LEUKEMIA LYMPHOMA, V49, P543, DOI 10.1080/10428190701799035; Frankel AE, 2014, BLOOD, V124, P385, DOI 10.1182/blood-2014-04-566737; Garfall AL, 2015, NEW ENGL J MED, V373, P1040, DOI 10.1056/NEJMoa1504542; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Giles FJ, 2001, CANCER-AM CANCER SOC, V92, P406, DOI 10.1002/1097-0142(20010715)92:2<406::AID-CNCR1336>3.0.CO;2-U; Gill S, 2014, BLOOD, V123, P2343, DOI 10.1182/blood-2013-09-529537; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Hinrichs CS, 2011, BLOOD, V117, P808, DOI 10.1182/blood-2010-05-286286; Hudecek M, 2013, CLIN CANCER RES, V19, P3153, DOI 10.1158/1078-0432.CCR-13-0330; Huls MH, 2013, JOVE-J VIS EXP, DOI 10.3791/50070; James ST, 2008, J IMMUNOL, V180, P7028, DOI 10.4049/jimmunol.180.10.7028; Jena B, 2010, BLOOD, V116, P1035, DOI 10.1182/blood-2010-01-043737; Jin Z, 2011, GENE THER, V18, P849, DOI 10.1038/gt.2011.40; Jonnalagadda M, 2015, MOL THER, V23, P757, DOI 10.1038/mt.2014.208; Jordan CT, 2000, LEUKEMIA, V14, P1777, DOI 10.1038/sj.leu.2401903; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Kochenderfer JN, 2010, BLOOD, V116, P4099, DOI 10.1182/blood-2010-04-281931; Kowolik CM, 2006, CANCER RES, V66, P10995, DOI 10.1158/0008-5472.CAN-06-0160; Kumaresan PR, 2014, P NATL ACAD SCI USA, V111, P10660, DOI 10.1073/pnas.1312789111; Lee DW, 2015, LANCET, V385, P517, DOI 10.1016/S0140-6736(14)61403-3; Mardiros A, 2013, BLOOD, V122, P3138, DOI 10.1182/blood-2012-12-474056; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Milone MC, 2009, MOL THER, V17, P1453, DOI 10.1038/mt.2009.83; Minagawa K, 2015, PHARMACEUTICALS, V8, P230, DOI 10.3390/ph8020230; Morgan RA, 2010, MOL THER, V18, P843, DOI 10.1038/mt.2010.24; Munoz L, 2001, HAEMATOLOGICA, V86, P1261; Orio J, 2015, CYTOTHERAPY, V17, P496, DOI 10.1016/j.jcyt.2014.12.009; Porter DL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5415; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Rabinovich BA, 2008, P NATL ACAD SCI USA, V105, P14342, DOI 10.1073/pnas.0804105105; Rassi FE, 2013, CLINICAL MEDICINE IN, V7, DOI 10.4137/CMO.S8528; Roberts AW, 2008, ANN M AM SOC HEM SAN, DOI [10.1111/imr.12137, DOI 10.1111/IMR.12137]; Rosenberg SA, 2015, SCIENCE, V348, P62, DOI 10.1126/science.aaa4967; Ruella M., 2014, BLOOD, V966; Savoldo B, 2011, J CLIN INVEST, V121, P1822, DOI 10.1172/JCI46110; Sievers EL, 1999, BLOOD, V93, P3678, DOI 10.1182/blood.V93.11.3678; Singh H, 2015, CANCER GENE THER, V22, P95, DOI 10.1038/cgt.2014.69; Singh H, 2008, CANCER RES, V68, P2961, DOI 10.1158/0008-5472.CAN-07-5600; Singh H, 2014, IMMUNOL REV, V257, P181, DOI 10.1111/imr.12137; Singh H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064138; Singh H, 2011, CANCER RES, V71, P3516, DOI 10.1158/0008-5472.CAN-10-3843; Suhoski MM, 2007, MOL THER, V15, P981, DOI 10.1038/mt.sj.6300134; Testa U, 2002, BLOOD, V100, P2980, DOI 10.1182/blood-2002-03-0852; Testa U, 2014, BIOMARK RES, V2, DOI 10.1186/2050-7771-2-4; Turkman N, 2011, BIOORGAN MED CHEM, V19, P5698, DOI 10.1016/j.bmc.2011.07.062; Wadleigh M, 2003, BLOOD, V102, P1578, DOI 10.1182/blood-2003-01-0255; Wargo JA, 2014, CANCER DISCOV, V4, P1377, DOI 10.1158/2159-8290.CD-14-0477; Wu CF, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.53; Zhang H, 2007, J IMMUNOL, V179, P4910, DOI 10.4049/jimmunol.179.7.4910; Zhong XS, 2010, MOL THER, V18, P413, DOI 10.1038/mt.2009.210; Zhou XO, 2015, BLOOD, V125, P4103, DOI 10.1182/blood-2015-02-628354; Zhou XO, 2015, METHODS MOL BIOL, V1317, P87, DOI 10.1007/978-1-4939-2727-2_6	70	39	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0159477	10.1371/journal.pone.0159477	http://dx.doi.org/10.1371/journal.pone.0159477			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548616	gold, Green Submitted, Green Published			2022-12-26	WOS:000381768400006
J	Porciello, G; Daum, MM; Menghini, C; Brugger, P; Lenggenhager, B				Porciello, Giuseppina; Daum, Moritz M.; Menghini, Cristina; Brugger, Peter; Lenggenhager, Bigna			Not That Heart-Stopping After All: Visuo-Cardiac Synchrony Does Not Boost Self-Face Attribution	PLOS ONE			English	Article							MULTISENSORY STIMULATION; BODY OWNERSHIP; HAND; SKIN; SENSE; POWER; FEEL; PART	Recent experimental evidence and theoretical models suggest that an integration of exteroceptive and interoceptive signals underlies several key aspects of the bodily self. While it has been shown that self-attribution of both the hand and the full-body are altered by conflicting extero-exteroceptive (e.g. visuo-tactile) and extero-interoceptive (e.g. visuo-cardiac) information, no study has thus far investigated whether self-attribution of the face might be altered by visuo-cardiac stimulation similarly to visuo-tactile stimulation. In three independent groups of participants we presented ambiguous (i.e. morphed with a stranger's face) self-faces flashing synchronously or asynchronously with the participants' heartbeat. We then measured the subjective percentages of self-face attribution of morphed stimuli. To control for a potential effect of visuo-cardiac synchrony on familiarity, a task assessing the attribution of a familiar face was introduced. Moreover, different durations of visuo-cardiac flashing and different degrees of asynchronicity were used. Based on previous studies showing that synchronous visuo-cardiac stimulation generally increases self-attribution of the full-body and the hand, and that synchronous visuo-tactile stimulation increases self-face attribution, we predicted higher self-face attribution during the synchronous visuo-cardiac flashing of the morphed stimuli. In contrast to this hypothesis, the results showed no difference between synchronous and asynchronous stimulation on self-face attribution in any of the three studies. We thus conclude that visuo-cardiac synchrony does not boost self-attribution of the face as it does that of hand and full-body.	[Porciello, Giuseppina] Sapienza Univ Rome, Dept Psychol, Rome, Italy; [Porciello, Giuseppina] Santa Lucia Fdn, IRCCS, Social & Cognit Neurosci Lab, Rome, Italy; [Daum, Moritz M.] Univ Zurich, Dept Psychol, Zurich, Switzerland; [Porciello, Giuseppina; Menghini, Cristina; Brugger, Peter; Lenggenhager, Bigna] Univ Zurich Hosp, Dept Neurol, Zurich, Switzerland; [Brugger, Peter; Lenggenhager, Bigna] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Brugger, Peter; Lenggenhager, Bigna] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland	Sapienza University Rome; IRCCS Santa Lucia; University of Zurich; University of Zurich; University Zurich Hospital; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Porciello, G (corresponding author), Sapienza Univ Rome, Dept Psychol, Rome, Italy.; Porciello, G (corresponding author), Santa Lucia Fdn, IRCCS, Social & Cognit Neurosci Lab, Rome, Italy.; Porciello, G; Lenggenhager, B (corresponding author), Univ Zurich Hosp, Dept Neurol, Zurich, Switzerland.; Lenggenhager, B (corresponding author), Univ Zurich, Inst Physiol, Zurich, Switzerland.; Lenggenhager, B (corresponding author), Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland.	giuseppina.porciello@uniroma1.it; bigna.lenggenhager@gmail.com	Daum, Moritz/A-1441-2013; Porciello, Giuseppina/K-3460-2018	Daum, Moritz/0000-0002-4032-4574; Lenggenhager, Bigna/0000-0003-0418-9931; Porciello, Giuseppina/0000-0001-8374-5320	Swiss National Science Foundation [142601]; FENS (NENS Exchange Grant); Progetto di Avvio alla Ricerca, 'Sapienza' University of Rome [C26N148WH2]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); FENS (NENS Exchange Grant); Progetto di Avvio alla Ricerca, 'Sapienza' University of Rome	BL was funded by the Swiss National Science Foundation (grant # 142601). GP was funded by FENS (NENS Exchange Grant) and by Progetto di Avvio alla Ricerca 2014, 'Sapienza' University of Rome (Prot. Num. C26N148WH2).	Apps MAJ, 2013, CEREB CORTEX, V1; Armel K, 2003, P R SOC L B, V270; Aspell JE, 2013, PSYCHOL SCI, V24, P2445, DOI 10.1177/0956797613498395; Barnsley N, 2011, CURR BIOL, V21, pR945, DOI 10.1016/j.cub.2011.10.039; Barton JJS, 2008, J NEUROPSYCHOL, V2, P197, DOI 10.1348/174866407X214172; Blanke O, 2015, NEURON, V88, P145, DOI 10.1016/j.neuron.2015.09.029; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Brugger P, 2014, CURR OPIN NEUROL, V27, P644, DOI 10.1097/WCO.0000000000000151; Bufalari I, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00102; Cardini F, 2013, J EXP PSYCHOL HUMAN, V44, DOI [10.1037/a0031049.It, DOI 10.1037/A0031049.IT]; Cohen J.E., 1988, STAT POWER ANAL BEHA; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Damasio Antonio, 2010, SELF COMES MIND CONS; Dienes Z, 2015, J MATH PSYCHOL ELSEV, P1, DOI [10.1007/s13398-014-0173-7.2, DOI 10.1007/S13398-014-0173-7.2]; Dienes Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00781; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Estudillo AJ, 2016, CONSCIOUS COGN, V42, P325, DOI 10.1016/j.concog.2016.04.006; Farmer H, 2012, CONSCIOUS COGN, V21, P1242, DOI 10.1016/j.concog.2012.04.011; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Feinberg T, 2005, LOST SELF PATHOLOGIE; Garfinkel SN, 2016, TRENDS COGN SCI, V20, P34, DOI 10.1016/j.tics.2015.10.005; Garfinkel SN, 2015, BIOL PSYCHOL, V104, P65, DOI 10.1016/j.biopsycho.2014.11.004; Ionta S, 2011, NEURON, V70, P363, DOI 10.1016/j.neuron.2011.03.009; Jeffreys H., 1961, THEORY PROBABILITY; Kanwisher N, 2011, OXFORD HDB FACE PERC, P111, DOI DOI 10.1093/OXFORDHB/9780199559053.013.0007; Lenggenhager B, 2007, SCIENCE, V317, P1096, DOI 10.1126/science.1143439; Lenggenhager B, 2015, NEUROPSYCHOLOGY, V29, P205, DOI 10.1037/neu0000143; Limanowski J., 2011, PSYCHOLOGY, V2, P312, DOI DOI 10.4236/PSYCH.2011.24049; Love J, 2015, JASP VERSION 0 6 6 C; Mehling WE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048230; Michel C, 2014, PERCEPTION, V43, P818, DOI 10.1068/p7733; Moseley GL, 2008, P NATL ACAD SCI USA, V105, P13169, DOI 10.1073/pnas.0803768105; Paladino MP, 2010, PSYCHOL SCI, V21, P1202, DOI 10.1177/0956797610379234; Peck TC, 2013, CONSCIOUS COGN, V22, P779, DOI 10.1016/j.concog.2013.04.016; Petkova VI, 2011, CURR BIOL, V21, P1118, DOI 10.1016/j.cub.2011.05.022; Porciello G, 2014, SCI REP-UK, V4, DOI 10.1038/srep06669; Ronchi R, 2015, NEUROPSYCHOLOGIA, V70, P11, DOI 10.1016/j.neuropsychologia.2015.02.010; SCHANDRY R, 1981, PSYCHOPHYSIOLOGY, V18, P483, DOI 10.1111/j.1469-8986.1981.tb02486.x; Seth AK, 2013, TRENDS COGN SCI, V17, P565, DOI 10.1016/j.tics.2013.09.007; Sforza A, 2010, SOC NEUROSCI-UK, V5, P148, DOI 10.1080/17470910903205503; Suzuki K, 2013, NEUROPSYCHOLOGIA, V51, P2909, DOI 10.1016/j.neuropsychologia.2013.08.014; Tajadura-Jimenez A, 2014, J EXP PSYCHOL GEN, V143, P736, DOI 10.1037/a0033171; Tajadura-Jimenez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040682; Tieri G, 2015, SCI REP-UK, V5, DOI 10.1038/srep17139; Tsakiris M, 2007, CEREB CORTEX, V17, P2235, DOI 10.1093/cercor/bhl131; Tsakiris M, 2011, P ROY SOC B-BIOL SCI, V278, P2470, DOI 10.1098/rspb.2010.2547; Tsakiris M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004040	47	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2016	11	8							e0160498	10.1371/journal.pone.0160498	http://dx.doi.org/10.1371/journal.pone.0160498			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT6UQ	27541587	Green Published, gold, Green Accepted			2022-12-26	WOS:000381620200004
J	Ben-Shachar, S; Yanai, H; Horev, HS; Elad, H; Baram, L; Issakov, O; Tulchinsky, H; Pasmanik-Chor, M; Shomron, N; Dotan, I				Ben-Shachar, Shay; Yanai, Henit; Horev, Hadas Sherman; Elad, Hofit; Baram, Liran; Issakov, Ofer; Tulchinsky, Hagit; Pasmanik-Chor, Metsada; Shomron, Noam; Dotan, Iris			MicroRNAs Expression in the Ileal Pouch of Patients with Ulcerative Colitis Is Robustly Up-Regulated and Correlates with Disease Phenotypes	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; QUALITY-OF-LIFE; RESTORATIVE PROCTOCOLECTOMY; ANAL ANASTOMOSIS; CROHNS-DISEASE; BIOMARKERS; EXPERIENCE; RESERVOIR; TARGETS; CELLS	Background Gene expression alterations are associated with disease behavior in inflammatory bowel disease (IBD). microRNAs (miRNAs) are dominant in the regulation of gene expression, and may affect IBD phenotype. Our aim was to assess mucosal miRNA expression in IBD and the correlation with intestinal inflammation. Methods We performed a large-scale analysis of ileal mucosal miRNA. Biopsies were retrieved from patients with ileal Crohn's disease (CD), unoperated ulcerative colitis (UC) patients, UC patients after pouch surgery, and normal controls (NC). Pouch UC patients were classified as having a normal pouch (NP), chronic pouchitis (CP), and Crohn's-like disease of the pouch (CLDP). miRNA expression was analyzed by parallel massive (next-generation) sequencing (NGS). Bioinformatics tools were applied for clustering and the detection of potential targets. Results Sixty-one subjects were recruited. The ileum of unoperated UC patients was comparable with NC. There were significant miRNA expression alterations (fold change >= 2, corrected P <=.05) in NP (n = 6), CP (n = 40) and CLDP (n = 139), but only two expression alterations were noted in CD. More than 90% of the altered miRNAs were up-regulated, and many were predicted to be associated with significantly decreased transcripts. miRNAs alterations were generally clustered with disease phenotypes. Conclusions Ileal inflammation causes increased miRNA expression. miRNA alterations correlate with IBD phenotype, apparently by controlling the down-regulation of specific mRNAs.	[Ben-Shachar, Shay] Tel Aviv Med Ctr & Sch Med, Genet Inst, Tel Aviv, Israel; [Yanai, Henit; Horev, Hadas Sherman; Elad, Hofit; Baram, Liran; Dotan, Iris] Tel Aviv Med Ctr & Sch Med, Dept Gastroenterol & Liver Dis, IBD Ctr, Tel Aviv, Israel; [Ben-Shachar, Shay; Yanai, Henit; Baram, Liran; Issakov, Ofer; Tulchinsky, Hagit; Shomron, Noam; Dotan, Iris] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Tulchinsky, Hagit] Tel Aviv Med Ctr & Sch Med, Div Surg, Colorectal Unit, Tel Aviv, Israel; [Pasmanik-Chor, Metsada] Tel Aviv Univ, GSW Fac Life Sci, Bioinformat Unit, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University	Dotan, I (corresponding author), Tel Aviv Med Ctr & Sch Med, Dept Gastroenterol & Liver Dis, IBD Ctr, Tel Aviv, Israel.; Dotan, I (corresponding author), Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel.	irisd@tlvmc.gov.il			Leona M. and Harry B. Helmsley Charitable Trust [2015PG-ISL020]	Leona M. and Harry B. Helmsley Charitable Trust	This study was supported by a generous grant from the Leona M. and Harry B. Helmsley Charitable Trust, under Iris Dotan (PI) fund #2015PG-ISL020. No additional funding sources of support (either external or internal) were used.	Allison J, 2008, CLIN GASTROENTEROL H, V6, P999, DOI 10.1016/j.cgh.2008.05.022; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Ben-Shachar S, 2013, INFLAMM BOWEL DIS, V19, P2509, DOI 10.1097/01.MIB.0000437045.26036.00; Brain O, 2013, IMMUNITY, V39, P521, DOI 10.1016/j.immuni.2013.08.035; Chapman CG, 2015, THER ADV GASTROENTER, V8, P4, DOI 10.1177/1756283X14547360; Chuang AY, 2014, INFLAMM BOWEL DIS, V20, P126, DOI 10.1097/01.MIB.0000436954.70596.9b; Coskun M, 2013, WORLD J GASTROENTERO, V19, P4289, DOI 10.3748/wjg.v19.i27.4289; DOZOIS RR, 1986, INT J COLORECTAL DIS, V1, P2, DOI 10.1007/BF01648830; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Fasseu M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013160; Fazio VW, 1999, ANN SURG, V230, P575, DOI 10.1097/00000658-199910000-00013; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Hubenthal M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140155; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Hurst RD, 1996, ARCH SURG-CHICAGO, V131, P497; Lin JM, 2014, MODERN PATHOL, V27, P602, DOI 10.1038/modpathol.2013.152; Lin JM, 2013, MODERN PATHOL, V26, P148, DOI 10.1038/modpathol.2012.131; Mahadevan U, 2003, GASTROENTEROLOGY, V124, P1636, DOI 10.1016/S0016-5085(03)00325-1; Maselli V, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-457; Meagher AP, 1998, BRIT J SURG, V85, P800; MELVILLE DM, 1994, GUT, V35, P1076, DOI 10.1136/gut.35.8.1076; Michelassi F, 2003, ANN SURG, V238, P433, DOI 10.1097/01.sla.0000086658.60555.ea; Peck BCE, 2015, INFLAMM BOWEL DIS, V21, P2178, DOI 10.1097/MIB.0000000000000478; Penna C, 1996, GUT, V38, P234, DOI 10.1136/gut.38.2.234; SANDBORN WJ, 1994, MAYO CLIN PROC, V69, P409, DOI 10.1016/S0025-6196(12)61634-6; Schaefer JS, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0069-0; Shen B, 2005, AM J GASTROENTEROL, V100, P2796, DOI 10.1111/j.1572-0241.2005.00278.x; Stahlberg D, 1996, DIS COLON RECTUM, V39, P1012, DOI 10.1007/BF02054692; Stocchi L, 2001, GASTROENTEROL CLIN N, V30, P223, DOI 10.1016/S0889-8553(05)70175-8; Tulchinsky H, 2003, ANN SURG, V238, P229, DOI 10.1097/01.sla.0000082121.84763.4c; Tulchinsky H, 2008, INFLAMM BOWEL DIS, V14, P1125, DOI 10.1002/ibd.20430; Tulchinsky H, 2010, DIS COLON RECTUM, V53, P866, DOI 10.1007/DCR.0b013e3181d98d66; WEXNER SD, 1990, AM J SURG, V159, P178, DOI 10.1016/S0002-9610(05)80625-7; Wheeler JMD, 2005, DIS COLON RECTUM, V48, P946, DOI 10.1007/s10350-004-0885-4; Wu F, 2008, GASTROENTEROLOGY, V135, P1624, DOI 10.1053/j.gastro.2008.07.068; Wu F, 2010, INFLAMM BOWEL DIS, V16, P1729, DOI 10.1002/ibd.21267; Xue XC, 2011, J IMMUNOL, V187, P5879, DOI 10.4049/jimmunol.1100535; Yanai H, 2015, GUT, V64, P756, DOI 10.1136/gutjnl-2014-307387	39	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0159956	10.1371/journal.pone.0159956	http://dx.doi.org/10.1371/journal.pone.0159956			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536783	Green Published, Green Submitted, gold			2022-12-26	WOS:000381577000010
J	Rasmussen, JJ; Selmer, C; Ostergren, PB; Pedersen, KB; Schou, M; Gustafsson, F; Faber, J; Juul, A; Kistorp, C				Rasmussen, Jon Jarlov; Selmer, Christian; Ostergren, Peter Busch; Pedersen, Karen Boje; Schou, Morten; Gustafsson, Finn; Faber, Jens; Juul, Anders; Kistorp, Caroline			Former Abusers of Anabolic Androgenic Steroids Exhibit Decreased Testosterone Levels and Hypogonadal Symptoms Years after Cessation: A Case-Control Study	PLOS ONE			English	Article							SERUM INHIBIN-B; HORMONE-BINDING GLOBULIN; YOUNG MEN; SEMEN PARAMETERS; SENSITIVITY TEST; REFERENCE RANGES; BLOOD; REVERSIBILITY; CONSEQUENCES; BODYBUILDERS	Aims Abuse of anabolic androgenic steroids (AAS) is highly prevalent among male recreational athletes. The objective of this study was to investigate the impact of AAS abuse on reproductive hormone levels and symptoms suggestive of hypogonadism in current and former AAS abusers. Methods This study had a cross-sectional case-control design and involved 37 current AAS abusers, 33 former AAS abusers (mean (95% CI) elapsed duration since AAS cessation: 2.5 (1.7; 3.7) years) and 30 healthy control participants. All participants were aged 18-50 years and were involved in recreational strength training. Reproductive hormones (FSH, LH, testosterone, inhibin B and anti-Mullerian hormone (AMH)) were measured using morning blood samples. Symptoms of hypogonadism (depressive symptoms, fatigue, decreased libido and erectile dysfunction) were recorded systematically. Results Former AAS abusers exhibited significantly lower median (25th - 75th percentiles) total and free testosterone levels than control participants (total testosterone: 14.4 (11.9-17.7) nmol/l vs. 18.8 (16.6-22.0) nmol/l) (P < 0.01). Overall, 27.2%(13.3; 45.5) of former AAS abusers exhibited plasma total testosterone levels below the lower reference limit (12.1 nmol/l) whereas no control participants exhibited testosterone below this limit (P < 0.01). Gonadotropins were significantly suppressed, and inhibin B and AMH were significantly decreased in current AAS abusers compared with former AAS abusers and control participants (P < 0.01). The group of former AAS abusers had higher proportions of participants with depressive symptoms ((24.2%) (11.1; 42.2)), erectile dysfunction ((27.3%) (13.3; 45.6)) and decreased libido ((40.1%) (23.2; 57.0)) than the other two groups (trend analyses: P < 0.05). Conclusions Former AAS abusers exhibited significantly lower plasma testosterone levels and higher frequencies of symptoms suggestive of hypogonadism than healthy control participants years after AAS cessation. Current AAS abusers exhibited severely decreased AMH and inhibin B indicative of impaired spermatogenesis.	[Rasmussen, Jon Jarlov; Selmer, Christian; Faber, Jens; Kistorp, Caroline] Copenhagen Univ Hosp, Dept Internal Med, Herlev, Denmark; [Ostergren, Peter Busch] Copenhagen Univ Hosp, Dept Urol, Herlev, Denmark; [Pedersen, Karen Boje] Copenhagen Univ Hosp, Dept Internal Med, Slagelse, Denmark; [Schou, Morten] Copenhagen Univ Hosp, Dept Cardiol, Herlev, Denmark; [Schou, Morten] Copenhagen Univ Hosp, Dept Cardiol, Gentofte, Denmark; [Gustafsson, Finn] Rigshosp, Dept Cardiol, Ctr Heart, Copenhagen, Denmark; [Juul, Anders] Univ Copenhagen, Rigshosp, Dept Growth & Reprod, DK-1168 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Rasmussen, JJ (corresponding author), Copenhagen Univ Hosp, Dept Internal Med, Herlev, Denmark.	jon.ras@dadlnet.dk	Østergren, Peter/AAR-2794-2020; Selmer, Christian/H-3314-2019; Rasmussen, Jon/H-6357-2019; Juul, Anders/F-5864-2013	Selmer, Christian/0000-0002-0534-3163; Rasmussen, Jon/0000-0003-2898-1771; Juul, Anders/0000-0002-0534-4350; Gustafsson, Finn/0000-0003-2144-341X; Ostergren, Peter Busch/0000-0003-4762-039X; Kistorp, Caroline/0000-0002-3019-6775	AntiDoping Denmark; Research Foundation of Herlev Hospital; Danish Heart Foundation [15-R99-A5797-22952]; University of Copenhagen	AntiDoping Denmark; Research Foundation of Herlev Hospital; Danish Heart Foundation; University of Copenhagen	Funded by AntiDoping Denmark (no specific grant number, URL: http://www.antidoping.dk/), Research Foundation of Herlev Hospital (no specific grant number, URL: https://www.herlevhospital.dk/), Danish Heart Foundation (grant number: 15-R99-A5797-22952, URL: https://www.hjerteforeningen.dk/), and Faculty Scholarship from University of Copenhagen to JJR (no specific grant number, URL: http://sund.ku.dk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksglaede L, 2010, J CLIN ENDOCR METAB, V95, P5357, DOI 10.1210/jc.2010-1207; Allison PD, 2012, HANDLING MISSING DAT, DOI [10.1016/j.drugalcdep.2010.01.011, DOI 10.1016/J.DRUGALCDEP.2010.01.011]; Barbotin AL, 2015, EUR J ENDOCRINOL, V172, P669, DOI 10.1530/EJE-14-0932; Barthel A, 2010, CLIN J SPORT MED, V20, P117, DOI 10.1097/JSM.0b013e3181d235ae; BARTSCH W, 1980, MATURITAS, V2, P109, DOI 10.1016/0378-5122(80)90044-4; Beck AT, 1996, MANUAL FOR THE BECK; Bhasin S, 2011, J CLIN ENDOCR METAB, V96, P2430, DOI 10.1210/jc.2010-3012; Bjorner JB, 1998, J CLIN EPIDEMIOL, V51, P1001, DOI 10.1016/S0895-4356(98)00092-4; Boregowda K, 2011, FERTIL STERIL, V96, pE7, DOI 10.1016/j.fertnstert.2011.04.029; Coward RM, 2013, J UROLOGY, V190, P2200, DOI 10.1016/j.juro.2013.06.010; Gazvani MR, 1997, HUM REPROD, V12, P1706, DOI 10.1093/humrep/12.8.1706; Hart RJ, 2015, HUM REPROD, V30, P2713, DOI 10.1093/humrep/dev244; Hengevoss J, 2015, J STEROID BIOCHEM, V150, P86, DOI 10.1016/j.jsbmb.2015.03.003; JAROW JP, 1990, AM J SPORT MED, V18, P429, DOI 10.1177/036354659001800417; Jorgensen N, 2010, FERTIL STERIL, V94, P2128, DOI 10.1016/j.fertnstert.2009.12.051; Kanayama G, 2015, ADDICTION, V110, P823, DOI 10.1111/add.12850; Kanayama G, 2010, DRUG ALCOHOL DEPEN, V109, P6, DOI 10.1016/j.drugalcdep.2010.01.011; Kelsey TW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109346; KNUTH UA, 1989, FERTIL STERIL, V52, P1041; Krause A, 2004, EXP CLIN ENDOCR DIAB, V112, P236, DOI 10.1055/s-2004-817969; Lloyd F H, 1996, BMJ, V313, P100; Nieschlag E, 2015, EUR J ENDOCRINOL, V173, pR47, DOI 10.1530/EJE-15-0080; Parkinson AB, 2006, MED SCI SPORT EXER, V38, P644, DOI 10.1249/01.mss.0000210194.56834.5d; Pope HG, 2014, ENDOCR REV, V35, P341, DOI 10.1210/er.2013-1058; Pope HG, 2000, ARCH GEN PSYCHIAT, V57, P133, DOI 10.1001/archpsyc.57.2.133; Rahnema CD, 2014, FERTIL STERIL, V101, P1271, DOI 10.1016/j.fertnstert.2014.02.002; Rosen RC, 1999, INT J IMPOT RES, V11, P319, DOI 10.1038/sj.ijir.3900472; Sagoe D, 2014, ANN EPIDEMIOL, V24, P383, DOI 10.1016/j.annepidem.2014.01.009; Sakamoto H, 2007, UROLOGY, V69, P152, DOI 10.1016/j.urology.2006.09.012; Schmidt PJ, 2004, ARCH GEN PSYCHIAT, V61, P997, DOI 10.1001/archpsyc.61.10.997; Sikaris K, 2005, J CLIN ENDOCR METAB, V90, P5928, DOI 10.1210/jc.2005-0962; SINNECKER G, 1989, J CLIN ENDOCR METAB, V68, P1195, DOI 10.1210/jcem-68-6-1195; Tan RS, 2009, MED HYPOTHESES, V72, P723, DOI 10.1016/j.mehy.2008.12.042; Torres-Calleja J, 2000, FERTIL STERIL, V74, P1055, DOI 10.1016/S0015-0282(00)01557-0; TUREK PJ, 1995, J UROLOGY, V153, P1628, DOI 10.1016/S0022-5347(01)67482-2; Urhausen A, 2003, J STEROID BIOCHEM, V84, P369, DOI 10.1016/S0960-0760(03)00105-5; van Breda E, 2003, INT J SPORTS MED, V24, P195, DOI 10.1055/s-2003-39089; Wikberg Carl, 2015, Prim Care Companion CNS Disord, V17, DOI 10.4088/PCC.14m01758	38	73	74	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161208	10.1371/journal.pone.0161208	http://dx.doi.org/10.1371/journal.pone.0161208			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532478	Green Published, gold, Green Submitted			2022-12-26	WOS:000381487600075
J	Dong, H; Liu, WM; Liu, MX; Xu, LQ; Li, Q; Zhang, R; Zhang, X; Liu, SG				Dong, He; Liu, Wenmiao; Liu, Meixin; Xu, Longqiang; Li, Qiang; Zhang, Ru; Zhang, Xin; Liu, Shiguo			Investigation of a Possible Role for the Histidine Decarboxylase Gene in Tourette Syndrome in the Chinese Han Population: A Family-Based Study	PLOS ONE			English	Article							EXPRESSION; ASSOCIATION	Tourette syndrome (TS) is a polygenic neuropsychiatric disease. Previous studies have indicated that dysregulation in the histaminergic system may play a crucial role in disease onset. In this study, we investigated the role of the histidine decarboxylase gene (HDC) in TS susceptibility in the Chinese Han population. After genotyping 241 TS nuclear families trios, we analyzed three tag HDC single nucleotide polymorphisms (rs854150, rs854151, and rs854157) in a family-based study using the transmission disequilibrium test (TDT) and haplotype relative risk (HRR). TDT showed no over-transmission in these SNPs across the HDC region (for rs854150: chi(2) = 0.472, P = 0.537, OR = 1.097, 95% CI = 0.738-1.630; for rs854151: chi(2) = 0.043, P = 0.889, OR = 1.145, 95% CI = 0.767-1.709; for rs854157: chi(2) = 0.984, P = 0.367, OR = 1.020, 95% CI = 0.508-2.049). HRR also showed the same tendency (for rs854150: chi(2) = 0.211, P = 0.646, OR = 1.088, 95% CI = 0.7591.559; for rs854151: chi(2) = 0.134, P = 0.714, OR = 0.935, 95% CI = 0.653-1.339; for rs854157: chi(2) = 0.841, P = 0.359, OR = 1.206, 95% CI = 0.808-1.799). Additionally, the haplo-type-based haplotype relative risk showed a negative association. Although these findings indicate an unlikely association between HDC and TS in the Chinese Han population, a potential role for HDC cannot be ruled out in TS etiology. Future research should investigate this more thoroughly using different populations and larger samples.	[Dong, He] Qingdao Univ, Affiliated Hosp, Dept Anesthesiol, Qingdao, Peoples R China; [Liu, Wenmiao; Zhang, Ru; Liu, Shiguo] Qingdao Univ, Affiliated Hosp, Prenatal Diag Ctr, Qingdao, Peoples R China; [Liu, Meixin] Qingdao Univ, Affiliated Hosp, Dept Cardiac Ultrasound, Qingdao, Peoples R China; [Xu, Longqiang] Qingdao Univ, Affiliated Hosp, Dept Clin Lab, Qingdao, Peoples R China; [Li, Qiang] Qingdao Univ, Affiliated Hosp, Dept Androl, Qingdao, Peoples R China; [Zhang, Xin] Qingdao Univ, Affiliated Hosp, Dept Resp Med, Qingdao, Peoples R China; [Liu, Shiguo] Qingdao Univ, Affiliated Hosp, Genet Lab, Qingdao, Peoples R China	Qingdao University; Qingdao University; Qingdao University; Qingdao University; Qingdao University; Qingdao University; Qingdao University	Liu, SG (corresponding author), Qingdao Univ, Affiliated Hosp, Prenatal Diag Ctr, Qingdao, Peoples R China.; Zhang, X (corresponding author), Qingdao Univ, Affiliated Hosp, Dept Resp Med, Qingdao, Peoples R China.; Liu, SG (corresponding author), Qingdao Univ, Affiliated Hosp, Genet Lab, Qingdao, Peoples R China.	zxshj@126.com; liushiguo2002@126.com			National Natural Science Foundation of China [81371499, 30971586]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81371499 and 30971586). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all participants for their involvement in our study. This work was supported by the National Natural Science Foundation of China (81371499 and 30971586).	Baldan LC, 2014, NEURON, V81, P77, DOI 10.1016/j.neuron.2013.10.052; Bloch M, 2011, CURR OPIN NEUROL, V24, P119, DOI 10.1097/WCO.0b013e328344648c; Conelea CA, 2008, J PSYCHOSOM RES, V65, P487, DOI 10.1016/j.jpsychores.2008.04.010; Dere E, 2003, LEARN MEMORY, V10, P510, DOI 10.1101/lm.67603; Ercan-Sencicek AG, 2010, NEW ENGL J MED, V362, P1901, DOI 10.1056/NEJMoa0907006; Felling RJ, 2011, J NEUROSCI, V31, P12387, DOI 10.1523/JNEUROSCI.0150-11.2011; Fernandez TV, 2012, BIOL PSYCHIAT, V71, P392, DOI 10.1016/j.biopsych.2011.09.034; Huertas-Fernandez I, 2015, MOVEMENT DISORD, V30, P1115, DOI 10.1002/mds.26279; HYDE TM, 1992, NEUROLOGY, V42, P652, DOI 10.1212/WNL.42.3.652; Karagiannidis I, 2013, J MED GENET, V50, P760, DOI 10.1136/jmedgenet-2013-101637; Leckman JF, 2006, J CHILD NEUROL, V21, P642, DOI 10.1177/08830738060210081001; Lei J, 2012, AM J MED GENET B, V159B, P72, DOI 10.1002/ajmg.b.32003; Liao IH, 2010, PHARMACOGENOMICS, V11, P1733, DOI 10.2217/PGS.10.160; Martino D, 2009, MOVEMENT DISORD, V24, P1267, DOI 10.1002/mds.22504; Ohtsu H, 2001, FEBS LETT, V502, P53, DOI 10.1016/S0014-5793(01)02663-1; Passani MB, 2011, TRENDS PHARMACOL SCI, V32, P242, DOI 10.1016/j.tips.2011.01.003; Rapanelli M, 2015, NEUROPHARMACOLOGY; Robertson MM, 2000, BRAIN, V123, P425, DOI 10.1093/brain/123.3.425; Shan L, 2015, TRENDS NEUROSCI, V38, P167, DOI 10.1016/j.tins.2014.12.008; Shprecher DR, 2014, CURR OPIN NEUROL, V27, P484, DOI 10.1097/WCO.0000000000000119; Sowell ER, 2008, NAT NEUROSCI, V11, P637, DOI 10.1038/nn.2121; Suzuki-Ishigaki S, 2000, NUCLEIC ACIDS RES, V28, P2627, DOI 10.1093/nar/28.14.2627; Wang LL, 2011, GENOMICS, V98, P1, DOI 10.1016/j.ygeno.2011.04.006	23	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160265	10.1371/journal.pone.0160265	http://dx.doi.org/10.1371/journal.pone.0160265			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529419	Green Submitted, gold, Green Published			2022-12-26	WOS:000381476700004
J	Haralambieva, IH; Zimmermann, MT; Ovsyannikova, IG; Grill, DE; Oberg, AL; Kennedy, RB; Poland, GA				Haralambieva, Iana H.; Zimmermann, Michael T.; Ovsyannikova, Inna G.; Grill, Diane E.; Oberg, Ann L.; Kennedy, Richard B.; Poland, Gregory A.			Whole Transcriptome Profiling Identifies CD93 and Other Plasma Cell Survival Factor Genes Associated with Measles-Specific Antibody Response after Vaccination	PLOS ONE			English	Article							SYSTEMS BIOLOGY APPROACH; RNA-SEQ; INTERACTION NETWORKS; SEASONAL INFLUENZA; IMMUNE-RESPONSE; POLYMORPHISMS; RECEPTOR; PERSISTENCE; INDIVIDUALS; VACCINOMICS	Background There are insufficient system-wide transcriptomic (or other) data that help explain the observed inter-individual variability in antibody titers after measles vaccination in otherwise healthy individuals. Methods We performed a transcriptome(mRNA-Seq)-profiling study after in vitro viral stimulation of PBMCs from 30 measles vaccine recipients, selected from a cohort of 764 schoolchildren, based on the highest and lowest antibody titers. We used regression and network biology modeling to define markers associated with neutralizing antibody response. Results We identified 39 differentially expressed genes that demonstrate significant differences between the high and low antibody responder groups (p-value <= 0.0002, q-value <= 0.092), including the top gene CD93 (p<1.0E(-13), q<1.0E(-09)), encoding a receptor required for antigen-driven B-cell differentiation, maintenance of immunoglobulin production and preservation of plasma cells in the bone marrow. Network biology modeling highlighted plasma cell survival (CD93, IL6, CXCL12), chemokine/cytokine activity and cell-cell communication/adhesion/ migration as biological processes associated with the observed differential response in the two responder groups. Conclusion We identified genes and pathways that explain in part, and are associated with, neutralizing antibody titers after measles vaccination. This new knowledge could assist in the identification of biomarkers and predictive signatures of protective immunity that may be useful in the design of new vaccine candidates and in clinical studies.	[Haralambieva, Iana H.; Ovsyannikova, Inna G.; Kennedy, Richard B.; Poland, Gregory A.] Mayo Clin & Mayo Fdn, Mayo Clin, Vaccine Res Grp, Dept Med, Rochester, MN USA; [Zimmermann, Michael T.; Grill, Diane E.; Oberg, Ann L.] Mayo Clin & Mayo Fdn, Div Biomed Stat & Informat, Dept Hlth Sci Res, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Poland, GA (corresponding author), Mayo Clin & Mayo Fdn, Mayo Clin, Vaccine Res Grp, Dept Med, Rochester, MN USA.	poland.gregory@mayo.edu		Zimmermann, Michael/0000-0001-7073-0525; Kennedy, Rick/0000-0001-6164-4967	NIH [R37AI048793-11, R01AI033144]; National Institute of Aging [R01 AG034676]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI048793, R01AI033144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034676] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH grants R37AI048793-11, R01AI033144 and was made possible by the Rochester Epidemiology Project (Grant Number R01 AG034676 from the National Institute of Aging). Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NCRR or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Mayo Clinic Vaccine Research Group staff and the study participants. We thank Caroline L. Vitse for her editorial assistance with this manuscript and Nathaniel D. Warner for his programming assistance and contribution to statistical analysis. This work was supported by NIH grants R37AI048793-11, R01AI033144 and was made possible by the Rochester Epidemiology Project (Grant Number R01 AG034676 from the National Institute of Aging). Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NCRR or NIH.	Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P1605; Chevrier S, 2009, P NATL ACAD SCI USA, V106, P3895, DOI 10.1073/pnas.0809736106; Dhiman N, 2005, HUM IMMUNOL, V66, P1125, DOI 10.1016/j.humimm.2005.10.002; Fiebelkorn AP, 2010, J INFECT DIS, V202, P1520, DOI 10.1086/656914; Fridley BL, 2013, SCI REP-UK, V3, DOI 10.1038/srep02898; Getahun A, 2012, J IMMUNOL, V189, P2965, DOI 10.4049/jimmunol.1201407; Hansen KD, 2012, BIOSTATISTICS, V13, P204, DOI 10.1093/biostatistics/kxr054; Haralambieva IH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062149; Haralambieva IH, 2011, VACCINE, V29, P8988, DOI 10.1016/j.vaccine.2011.09.043; Haralambieva IH, 2011, VACCINE, V29, P7883, DOI 10.1016/j.vaccine.2011.08.083; Haralambieva IH, 2011, VACCINE, V29, P4485, DOI 10.1016/j.vaccine.2011.04.037; Haralambieva IH, 2010, FUTURE MICROBIOL, V5, P1757, DOI [10.2217/fmb.10.146, 10.2217/FMB.10.146]; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Karsten CM, 2010, NAT IMMUNOL, V11, P775, DOI 10.1038/ni0910-775; Kennedy RB, 2013, GENES IMMUN, V14, P277, DOI 10.1038/gene.2013.14; Kennedy RB, 2012, VACCINE, V30, P2159, DOI 10.1016/j.vaccine.2012.01.025; Lambert ND, 2012, EXPERT REV VACCINES, V11, P985, DOI [10.1586/erv.12.61, 10.1586/ERV.12.61]; Lee I, 2011, GENOME RES, V21, P1109, DOI 10.1101/gr.118992.110; Maarof G, 2010, BLOOD, V115, P1718, DOI 10.1182/blood-2009-05-220251; Mocellin S, 2003, TRENDS IMMUNOL, V24, P36, DOI 10.1016/S1471-4906(02)00009-1; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Nelder McCullagh, 1989, GEN LINEAR MODELS; Oberg AL, 2012, BMC GENOMICS, V13, P2, DOI 10.1186/1471-2164-13-304; Oberg AL, 2011, CURR OPIN IMMUNOL, V23, P436, DOI 10.1016/j.coi.2011.04.005; Obermoser G, 2013, IMMUNITY, V38, P831, DOI 10.1016/j.immuni.2012.12.008; Ovsyannikova IG, 2011, HUM HERED, V72, P206, DOI 10.1159/000331585; Painter SD, 2015, VACCINE, V33, P4422, DOI 10.1016/j.vaccine.2015.06.101; Poland GA, 2011, OMICS, V15, P625, DOI 10.1089/omi.2011.0032; Prasad TSK, 2009, METHODS MOL BIOL, V577, P67, DOI 10.1007/978-1-60761-232-2_6; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Radbruch A, 2006, NAT REV IMMUNOL, V6, P741, DOI 10.1038/nri1886; Rhee SY, 2008, NAT REV GENET, V9, P509, DOI 10.1038/nrg2363; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Team RDC, 2019, R LANG ENV STAT COMP; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Whitaker JA, 2014, VACCINE, V32, P4703, DOI 10.1016/j.vaccine.2014.06.088; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zhang MY, 2005, IMMUNOLOGY, V115, P63, DOI 10.1111/j.1365-2567.2005.02120.x; Zilliox MJ, 2007, CLIN VACCINE IMMUNOL, V14, P918, DOI 10.1128/CVI.00031-07; Zilliox MJ, 2006, P NATL ACAD SCI USA, V103, P3363, DOI 10.1073/pnas.0511345103	48	16	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160970	10.1371/journal.pone.0160970	http://dx.doi.org/10.1371/journal.pone.0160970			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529750	gold, Green Published, Green Submitted			2022-12-26	WOS:000381476700036
J	Murakami, S; Shahbazian, D; Surana, R; Zhang, W; Chen, H; Graham, GT; White, SM; Weiner, LM; Yi, C				Murakami, S.; Shahbazian, D.; Surana, R.; Zhang, W.; Chen, H.; Graham, G. T.; White, S. M.; Weiner, L. M.; Yi, C.			Yes-associated protein mediates immune reprogramming in pancreatic ductal adenocarcinoma	ONCOGENE			English	Article							COLONY-STIMULATING FACTOR; SUPPRESSOR-CELLS; GM-CSF; BONE-MARROW; PROMOTES RESISTANCE; LUNG-CANCER; MUTANT KRAS; PROGRESSION; INFILTRATION; MACROPHAGES	Pancreatic ductal adenocarcinoma (PDAC) is characterized by a high degree of inflammation and profound immune suppression. Here we identify Yes-associated protein (Yap) as a critical regulator of the immunosuppressive microenvironment in both mouse and human PDAC. Within Kras: p53 mutant pancreatic ductal cells, Yap drives the expression and secretion of multiple cytokines/chemokines, which in turn promote the differentiation and accumulation of myeloid-derived suppressor cells (MDSCs) both in vitro and in vivo. Pancreas-specific knockout of Yap or antibody-mediated depletion of MDSCs promoted macrophage reprogramming, reactivation of T cells, apoptosis of Kras mutant neoplastic ductal cells and pancreatic regeneration after acute pancreatitis. In primary human PDAC, YAP expression levels strongly correlate with an MDSC gene signature, and high expression of YAP or MDSC-related genes predicts decreased survival in PDAC patients. These results reveal multifaceted roles of YAP in PDAC pathogenesis and underscore its promise as a therapeutic target for this deadly disease.	[Murakami, S.; Shahbazian, D.; Surana, R.; Zhang, W.; Chen, H.; Graham, G. T.; White, S. M.; Weiner, L. M.; Yi, C.] Georgetown Univ Med Ctr, Lombardi Comprehens Canc Ctr, 3970 Reservoir Rd NW, Washington, DC 20057 USA; [Zhang, W.] Nankai Univ, Coll Life Sci, Dept Canc Res, Tianjin, Peoples R China	Georgetown University; Nankai University	Yi, C (corresponding author), Georgetown Univ Med Ctr, Lombardi Comprehens Canc Ctr, 3970 Reservoir Rd NW, Washington, DC 20057 USA.	cy232@georgetown.edu		Graham, Garrett/0000-0002-1097-0962	NIH [R01CA187090, R01CA50633]; V Foundation and the Advocure foundation; Cancer Center [CA051008]; Lombardi Cancer Center Shared Resources; NATIONAL CANCER INSTITUTE [T32CA009686, P30CA051008, R01CA187090, R01CA050633] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); V Foundation and the Advocure foundation; Cancer Center; Lombardi Cancer Center Shared Resources; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs T Jacks (MIT), DJ Pan ( Johns Hopkins) and CV Wright (Vanderbilt) for producing and sharing the original mouse strains used in this study. We are grateful for the helpful suggestions and critical comments of our manuscript from Dr S Ostrand-Rosenberg (UMBC). We would also like to thank Dr Karen Creswell from the Flow Cytometry and Cell Sorting Shared Resource (FCSR) for her technical guidance. We appreciate the technical assistance from FCSR, Microscopy & Imaging Shared Resource (MISR), Histopathology & Tissue Shared Resource (HTSR) and Genomics & Epigenomics Shared Resource (GESR) at Lombardi Cancer Center Shared Resources. We thank the husbandry staff and technicians of the Division of Comparative Medicine (DCM) at Georgetown University for support in our animal studies. CY is supported by NIH (R01CA187090), the V Foundation and the Advocure foundation. LMW is the PI of NIH (R01CA50633), and Cancer Center Support Grant (CA051008) that also supports the Lombardi Cancer Center Shared Resources.	Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; ALDERSON MR, 1991, J EXP MED, V173, P923, DOI 10.1084/jem.173.4.923; Bardeesy N, 2001, SEMIN CANCER BIOL, V11, P201, DOI 10.1006/scbi.2000.0371; Bayne LJ, 2012, CANCER CELL, V21, P822, DOI 10.1016/j.ccr.2012.04.025; Bhatia M, 2004, AM J PHYSIOL-GASTR L, V286, pG189, DOI 10.1152/ajpgi.00304.2003; Brembeck FH, 2003, CANCER RES, V63, P2005; Calabro L, 2013, LANCET ONCOL, V14, P1104, DOI 10.1016/S1470-2045(13)70381-4; Carriere C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027725; Carriere C, 2009, BIOCHEM BIOPH RES CO, V382, P561, DOI 10.1016/j.bbrc.2009.03.068; Clark CE, 2007, CANCER RES, V67, P9518, DOI 10.1158/0008-5472.CAN-07-0175; FAHEY TJ, 1992, J IMMUNOL, V148, P2764; FALK LA, 1988, J LEUKOCYTE BIOL, V43, P148, DOI 10.1002/jlb.43.2.148; Feig C, 2012, CLIN CANCER RES, V18, P4266, DOI 10.1158/1078-0432.CCR-11-3114; Gabitass RF, 2011, CANCER IMMUNOL IMMUN, V60, P1419, DOI 10.1007/s00262-011-1028-0; Grippo PJ, 2003, CANCER RES, V63, P2016; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hruban RH, 2001, AM J SURG PATHOL, V25, P579, DOI 10.1097/00000478-200105000-00003; Hugo W, 2015, CELL, V162, P1271, DOI 10.1016/j.cell.2015.07.061; Jaffee EM, 2002, CANCER CELL, V2, P25, DOI 10.1016/S1535-6108(02)00093-4; Jensen JN, 2005, GASTROENTEROLOGY, V128, P728, DOI 10.1053/j.gastro.2004.12.008; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Kalluri R, 2020, SCIENCE, V367, P640, DOI 10.1126/science.aau6977; Kapoor A, 2014, CELL, V158, P185, DOI 10.1016/j.cell.2014.06.003; Katoh H, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/159269; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Khaled YS, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/879897; Kim MH, 2016, EMBO J, V35, P462, DOI 10.15252/embj.201592081; Kitamura T, 2015, J EXP MED, V212, P1043, DOI 10.1084/jem.20141836; Kurahara H, 2013, PANCREAS, V42, P155, DOI 10.1097/MPA.0b013e318254f2d1; Lacey DC, 2012, J IMMUNOL, V188, P5752, DOI 10.4049/jimmunol.1103426; Le DT, 2013, J IMMUNOTHER, V36, P382, DOI 10.1097/CJI.0b013e31829fb7a2; Lechner MG, 2010, J IMMUNOL, V185, P2273, DOI 10.4049/jimmunol.1000901; Li XG, 2017, GUT, V66, P157, DOI 10.1136/gutjnl-2015-310514; Lin LP, 2015, NAT GENET, V47, P250, DOI 10.1038/ng.3218; Lindell DM, 2001, INFECT IMMUN, V69, P6364, DOI 10.1128/IAI.69.10.6364-6369.2001; LOWENFELS AB, 1993, NEW ENGL J MED, V328, P1433, DOI 10.1056/NEJM199305203282001; Lu TY, 2011, J CLIN INVEST, V121, P4015, DOI 10.1172/JCI45862; Mace TA, 2013, CANCER RES, V73, P3007, DOI 10.1158/0008-5472.CAN-12-4601; Marigo I, 2010, IMMUNITY, V32, P790, DOI 10.1016/j.immuni.2010.05.010; Markowitz J, 2015, CANCER IMMUNOL IMMUN, V64, P149, DOI 10.1007/s00262-014-1618-8; Mok S, 2014, CANCER RES, V74, P153, DOI 10.1158/0008-5472.CAN-13-1816; Morris JP, 2010, J CLIN INVEST, V120, P508, DOI 10.1172/JCI40045; Munigala S, 2014, CLIN GASTROENTEROL H, V12, P1143, DOI 10.1016/j.cgh.2013.12.033; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Obermajer N, 2012, IMMUNOL INVEST, V41, P635, DOI 10.3109/08820139.2012.695417; Obermajer N, 2011, CANCER RES, V71, P7463, DOI 10.1158/0008-5472.CAN-11-2449; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Parker KH, 2015, ADV CANCER RES, V128, P95, DOI 10.1016/bs.acr.2015.04.002; Phan VT, 2013, P NATL ACAD SCI USA, V110, P6079, DOI 10.1073/pnas.1303302110; Plouffe SW, 2015, TRENDS MOL MED, V21, P212, DOI 10.1016/j.molmed.2015.01.003; Porembka MR, 2012, CANCER IMMUNOL IMMUN, V61, P1373, DOI 10.1007/s00262-011-1178-0; Pylayeva-Gupta Y, 2012, CANCER CELL, V21, P836, DOI 10.1016/j.ccr.2012.04.024; Roca H, 2009, J BIOL CHEM, V284, P34342, DOI 10.1074/jbc.M109.042671; Royal RE, 2010, J IMMUNOTHER, V33, P828, DOI 10.1097/CJI.0b013e3181eec14c; Ryan DP, 2014, NEW ENGL J MED, V371, P1039, DOI 10.1056/NEJMra1404198; Schutte M, 1997, CANCER RES, V57, P3126; Shao DD, 2014, CELL, V158, P171, DOI 10.1016/j.cell.2014.06.004; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sierra-Filardi E, 2014, J IMMUNOL, V192, P3858, DOI 10.4049/jimmunol.1302821; Sinha P, 2007, CANCER RES, V67, P4507, DOI 10.1158/0008-5472.CAN-06-4174; Strauss L, 2015, CANCER CELL, V28, P253, DOI 10.1016/j.ccell.2015.07.006; Stromnes IM, 2014, GUT, V63, P1769, DOI 10.1136/gutjnl-2013-306271; Surana R, 2014, CANCER IMMUNOL RES, V2, P1103, DOI 10.1158/2326-6066.CIR-14-0103; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Tuveson DA, 2006, CANCER RES, V66, P242, DOI 10.1158/0008-5472.CAN-05-2305; Wang GC, 2016, CANCER DISCOV, V6, P80, DOI 10.1158/2159-8290.CD-15-0224; Xue J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8158; Zeng LJ, 2014, J CANCER, V5, P754, DOI 10.7150/jca.10238; Zhang WY, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005049; Zhang YL, 2009, J IMMUNOL, V182, P3801, DOI 10.4049/jimmunol.0801548; Zhao F, 2009, IMMUNOLOGY, V128, P141, DOI 10.1111/j.1365-2567.2009.03105.x; Zhao XQ, 2012, J CLIN INVEST, V122, P4094, DOI 10.1172/JCI64115; Zhu Y, 2014, CANCER RES, V74, P5057, DOI 10.1158/0008-5472.CAN-13-3723	76	127	129	1	23	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2017	36	9					1232	1244		10.1038/onc.2016.288	http://dx.doi.org/10.1038/onc.2016.288			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EN2SV	27546622	Green Accepted			2022-12-26	WOS:000395861300007
J	Craine, JM; Angerer, JP; Elmore, A; Fierer, N				Craine, Joseph M.; Angerer, Jay P.; Elmore, Andrew; Fierer, Noah			Continental-Scale Patterns Reveal Potential for Warming-Induced Shifts in Cattle Diet	PLOS ONE			English	Article							CLIMATE-CHANGE; BOTANICAL COMPOSITION; FUNCTIONAL TRAITS; HERBIVORE DIETS; LIVESTOCK; NITROGEN; ECOSYSTEM; QUALITY; SYSTEMS; MODELS	In North America, it has been shown that cattle in warmer, drier grasslands have lower quality diets than those cattle grazing cooler, wetter grasslands, which suggests warming will increase nutritional stress and reduce weight gain. Yet, little is known about how the plant species that comprise cattle diets change across these gradients and whether these shifts in dietary quality coincide with shifts in dietary composition, i. e. the relative abundance of different plant species consumed by cattle. To quantify geographic patterns in dietary composition, we analyzed the dietary composition and dietary quality of unsupplemented cattle from 289 sites across the central US by sequence- based analyses of plant DNA isolated from cattle fecal samples. Overall, assuming that the percentage of reads for a species in a sample corresponds to the percentage of protein derived from the species, only 45% of the protein intake for cattle was derived from grasses. Within the Great Plains, northern cattle relied more on grasses than southern cattle, which derived a greater proportion of their protein from herbaceous and woody eudicots. Eastern cattle were also more likely to consume a unique assemblage of plant species than western cattle. High dietary protein was not strongly tied to consumption of any specific plant species, which suggests that efforts to promote individual plant species may not easily remedy protein deficiencies. A few plant species were consistently associated with lower quality diets. For example, the diets of cattle with high amounts of Elymus or Hesperostipa were more likely to have lower crude protein concentrations than diets with less of these grasses. Overall, our analyses suggest that climatic warming will increase the reliance of cattle on eudicots as protein concentrations of grasses decline. Monitoring cattle diet with this DNA- based sequencing approach can be an effective tool for quantifying cattle diet to better increase animal performance and guide mitigation strategies to changing climates.	[Craine, Joseph M.; Fierer, Noah] Jonah Ventures, Manhattan, KS 66502 USA; [Angerer, Jay P.] Blackland Res & Extens Ctr, Texas A&M Agrilife Res, Temple, TX USA; [Elmore, Andrew] Univ Maryland, Appalachian Lab, Ctr Environm Sci, Frostburg, MD USA; [Fierer, Noah] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Fierer, Noah] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research; University System of Maryland; University of Maryland Center for Environmental Science; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Craine, JM (corresponding author), Jonah Ventures, Manhattan, KS 66502 USA.	josephmcraine@gmail.com	Elmore, Andrew James/D-4341-2012; Craine, Joseph/D-4569-2009; Angerer, Jay/AAA-9592-2019	Elmore, Andrew James/0000-0002-9697-9457; Craine, Joseph/0000-0001-6561-3244; Angerer, Jay/0000-0003-0988-7181	USDA National Institute of Food and Agriculture, Hatch/Evans-Allen/McIntire Stennis project [1009337]	USDA National Institute of Food and Agriculture, Hatch/Evans-Allen/McIntire Stennis project	Funding was provided by USDA National Institute of Food and Agriculture, Hatch/Evans-Allen/McIntire Stennis project 1009337, received by JPA. Texas AM provided funding for sample analyses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALIPAYO D, 1992, J RANGE MANAGE, V45, P148, DOI 10.2307/4002773; An YA, 2005, GLOBAL CHANGE BIOL, V11, P1733, DOI 10.1111/j.1365-2486.2005.01030.x; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; BARTOLOME J, 1995, J RANGE MANAGE, V48, P267, DOI 10.2307/4002432; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Craine JM, 2002, FUNCT ECOL, V16, P563, DOI 10.1046/j.1365-2435.2002.00660.x; Craine JM, 2015, SCI REP-UK, V5, DOI 10.1038/srep16738; Craine JM, 2010, GLOBAL CHANGE BIOL, V16, P2901, DOI 10.1111/j.1365-2486.2009.02060.x; Czernik M, 2013, ACTA THERIOL, V58, P379, DOI 10.1007/s13364-013-0146-9; Easterling W, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P273; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Estell R. E., 2014, Rangelands, V36, P25, DOI 10.2111/RANGELANDS-D-13-00066.1; Estell RE, 2012, RANGELAND ECOL MANAG, V65, P553, DOI 10.2111/REM-D-11-00124.1; EVERITT JH, 1981, J RANGE MANAGE, V34, P384, DOI 10.2307/3897910; Fukami T, 2005, P ROY SOC B-BIOL SCI, V272, P2105, DOI 10.1098/rspb.2005.3277; HOLECHEK JL, 1982, J RANGE MANAGE, V35, P309, DOI 10.2307/3898308; Ibanez S, 2013, OECOLOGIA, V173, P1459, DOI 10.1007/s00442-013-2738-0; Jefferson PG, 2004, CAN J PLANT SCI, V84, P503, DOI 10.4141/P03-145; Kartzinel TR, 2015, P NATL ACAD SCI USA, V112, P8019, DOI 10.1073/pnas.1503283112; Kowalczyk R, 2011, FOREST ECOL MANAG, V261, P821, DOI 10.1016/j.foreco.2010.11.026; Limb RF, 2011, RANGELAND ECOL MANAG, V64, P659, DOI 10.2111/REM-D-10-00192.1; Link SO, 2003, GLOBAL CHANGE BIOL, V9, P1097, DOI 10.1046/j.1365-2486.2003.00647.x; LYONS RK, 1992, J RANGE MANAGE, V45, P238, DOI 10.2307/4002970; McLauchlan KK, 2010, NEW PHYTOL, V187, P1135, DOI 10.1111/j.1469-8137.2010.03322.x; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Oltjen JW, 1996, J ANIM SCI, V74, P1406; Pegard A, 2009, J AGR FOOD CHEM, V57, P5700, DOI 10.1021/jf803680c; POPPI DP, 1995, J ANIM SCI, V73, P278; Rastetter EB, 1996, BIOSCIENCE, V46, P190, DOI 10.2307/1312740; Scasta JD, 2016, RANGELAND ECOL MANAG, V69, P310, DOI 10.1016/j.rama.2016.01.001; Shipley LA., 1999, P GRAZING BEHAV LIVE, P20; Steinfeld H., 2006, LIV LONG SHAD; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Valentini A, 2009, MOL ECOL RESOUR, V9, P51, DOI 10.1111/j.1755-0998.2008.02352.x; VAVRA M, 1976, J RANGE MANAGE, V29, P449, DOI 10.2307/3897246; Vermeire L. T., 2001, Rangelands, V23, P19; Wheeler R.O., 1981, WORLD LIVESTOCK PROD; Willerslev E, 2014, NATURE, V506, P47, DOI 10.1038/nature12921	39	14	15	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0161511	10.1371/journal.pone.0161511	http://dx.doi.org/10.1371/journal.pone.0161511			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27552104	Green Published, gold, Green Submitted			2022-12-26	WOS:000381768800048
J	Ling, X; Peng, LL; Du, WX; Hong, W				Ling, Xiang; Peng Linglong; Du Weixia; Hong, Wei			Protective Effects of Bifidobacterium on Intestinal Barrier Function in LPS-Induced Enterocyte Barrier Injury of Caco-2 Monolayers and in a Rat NEC Model	PLOS ONE			English	Article							EXPERIMENTAL NECROTIZING ENTEROCOLITIS; TIGHT JUNCTIONS; EPITHELIAL-CELLS; PERMEABILITY; ZONULIN; MICE; INTERLEUKIN-6; PATHOGENESIS; PATHOPHYSIOLOGY; DYSFUNCTION	Zonulin protein is a newly discovered modulator which modulates the permeability of the intestinal epithelial barrier by disassembling intercellular tight junctions (TJ). Disruption of TJ is associated with neonatal necrotizing enterocolitis (NEC). It has been shown bifidobacterium could protect the intestinal barrier function and prophylactical administration of bifidobacterium has beneficial effects in NEC patients and animals. However, it is still unknown whether the zonulin is involved in the gut barrier dysfunction of NEC, and the protective mechanisms of bifidobacterium on intestinal barrier function are also not well understood. The present study aims to investigate the effects of bifidobacterium on intestinal barrier function, zonulin regulation, and TJ integrity both in LPS-induced enterocyte barrier injury of Caco-2 monolayers and in a rat NEC model. Our results showed bifidobacterium markedly attenuated the decrease in transepithelial electrical resistance and the increase in paracellular permeability in the Caco-2 monolayers treated with LPS (P < 0.01). Compared with the LPS group, bifidobacterium significantly decreased the production of IL-6 and TNF-alpha (P < 0.01) and suppressed zonulin release (P < 0.05). In addition, bifidobacterium pretreatment up-regulated occludin, claudin-3 and ZO-1 expression (P < 0.01) and also preserved these proteins localization at TJ compared with the LPS group. In the in vivo study, bifidobacterium decreased the incidence of NEC from 88 to 47% (P < 0.05) and reduced the severity in the NEC model. Increased levels of IL-6 and TNF-alpha in the ileum of NEC rats were normalized in bifidobacterium treated rats (P < 0.05). Moreover, administration of bifidobacterium attenuated the increase in intestinal permeability (P < 0.01), decreased the levels of serum zonulin (P < 0.05), normalized the expression and localization of TJ proteins in the ileum compared with animals with NEC. We concluded that bifidobacterium may protect against intestinal barrier dysfunction both in vitro and in NEC. This protective effect is associated with inhibition of proinflammatory cytokine secretion, suppression of zonulin protein release and improvement of intestinal TJ integrity.	[Ling, Xiang; Hong, Wei] Chongqing Med Univ, China Int Sci & Technol Cooperat Base Child Dev &, Dept Neonatol,Childrens Hosp,Minist Educ, Key Lab Child Dev & Disorders,Chongqing Key Lab P, Chongqing, Peoples R China; [Peng Linglong] Chongqing Med Univ, Affiliated Hosp 1, Dept Gastrointestinal Surg, Chongqing, Peoples R China; [Du Weixia] Chongqing Med Univ, Childrens Hosp, Dept Kidney Immunol, Chongqing, Peoples R China; [Ling, Xiang] Second Peoples Hosp Chengdu, Dept Pediat, Chengdu, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Hong, W (corresponding author), Chongqing Med Univ, China Int Sci & Technol Cooperat Base Child Dev &, Dept Neonatol,Childrens Hosp,Minist Educ, Key Lab Child Dev & Disorders,Chongqing Key Lab P, Chongqing, Peoples R China.	waehong@163.com		Peng, Linglong/0000-0002-2876-7073	National Natural Science Foundation of China [30200300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research project was supported by the National Natural Science Foundation of China (Grant No. 30200300; Project recipient: Wei Hong). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand RJ, 2007, SHOCK, V27, P124, DOI 10.1097/01.shk.0000239774.02904.65; Arrieta MC, 2006, GUT, V55, DOI 10.1136/gut.2005.085373; Bergmann KR, 2013, AM J PATHOL, V182, P1595, DOI 10.1016/j.ajpath.2013.01.013; Berman L, 2011, SEMIN FETAL NEONAT M, V16, P145, DOI 10.1016/j.siny.2011.02.002; BUCK C, 1994, PEDIATRICS, V93, P54; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Chen J, 2015, CAN J PHYSIOL PHARM, V93, P233, DOI 10.1139/cjpp-2014-0262; Clark JA, 2006, AM J PHYSIOL-GASTR L, V291, pG938, DOI 10.1152/ajpgi.00090.2006; DEBONT ESJM, 1994, ACTA PAEDIATR, V83, P696; Duffy LC, 1997, DIGEST DIS SCI, V42, P359, DOI 10.1023/A:1018826204819; El Asmar R, 2002, GASTROENTEROLOGY, V123, P1607, DOI 10.1053/gast.2002.36578; Ewaschuk JB, 2008, AM J PHYSIOL-GASTR L, V295, pG1025, DOI 10.1152/ajpgi.90227.2008; Fanning AS, 1999, J AM SOC NEPHROL, V10, P1337; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Fasano A, 2000, LANCET, V355, P1518, DOI 10.1016/S0140-6736(00)02169-3; Fasano A, 1997, J CLIN INVEST, V99, P1158, DOI 10.1172/JCI119271; FASANO A, 1995, J CLIN INVEST, V96, P710, DOI 10.1172/JCI118114; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Groschwitz KR, 2009, J ALLERGY CLIN IMMUN, V124, P3, DOI 10.1016/j.jaci.2009.05.038; Hackam David J, 2005, Semin Pediatr Surg, V14, P49, DOI 10.1053/j.sempedsurg.2004.10.025; Halpern MD, 2015, TISSUE BARRIERS, V3, DOI 10.1080/21688370.2014.1000707; Hammerman C, 2004, CLIN PERINATOL, V31, P489, DOI 10.1016/j.clp.2004.04.015; Han XN, 2004, SHOCK, V21, P261, DOI 10.1097/01.shk.0000112346.38599.10; Ivanov Andrei I, 2004, Novartis Found Symp, V263, P115; Khailova L, 2009, AM J PHYSIOL-GASTR L, V297, pG940, DOI 10.1152/ajpgi.00141.2009; Klaus DA, 2013, BIOCHEM MEDICA, V23, P107, DOI 10.11613/BM.2013.013; Lin HC, 2008, PEDIATRICS, V122, P693, DOI 10.1542/peds.2007-3007; Martin CR, 2008, SEMIN PERINATOL, V32, P127, DOI 10.1053/j.semperi.2008.01.006; Muto S, 2010, P NATL ACAD SCI USA, V107, P8011, DOI 10.1073/pnas.0912901107; Nadler EP, 2000, J SURG RES, V92, P71, DOI 10.1006/jsre.2000.5877; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Noerr Barbara, 2003, Adv Neonatal Care, V3, P107; Nusrat A, 2000, AM J PHYSIOL-GASTR L, V279, pG851, DOI 10.1152/ajpgi.2000.279.5.G851; Piena-Spoel M, 2001, J PEDIATR SURG, V36, P587, DOI 10.1053/jpsu.2001.22288; Prasad S, 2005, LAB INVEST, V85, P1139, DOI 10.1038/labinvest.3700316; Saitoh R, 2004, PHARM RES-DORDR, V21, P749, DOI 10.1023/B:PHAM.0000026423.48583.e2; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Sharma R, 2010, PEDIATR SURG INT, V26, P11, DOI 10.1007/s00383-009-2536-2; Shiou SR, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.154625; Watts T, 2005, P NATL ACAD SCI USA, V102, P2916, DOI 10.1073/pnas.0500178102; Yoshioka N, 2009, ANTICANCER RES, V29, P4861	41	102	109	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0161635	10.1371/journal.pone.0161635	http://dx.doi.org/10.1371/journal.pone.0161635			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27551722	gold, Green Published, Green Submitted			2022-12-26	WOS:000381768800060
J	Moyo, S; Vandormael, A; Wilkinson, E; Engelbrecht, S; Gaseitsiwe, S; Kotokwe, KP; Musonda, R; Tanser, F; Essex, M; Novitsky, V; de Oliveira, T				Moyo, Sikhulile; Vandormael, Alain; Wilkinson, Eduan; Engelbrecht, Susan; Gaseitsiwe, Simani; Kotokwe, Kenanao P.; Musonda, Rosemary; Tanser, Frank; Essex, Max; Novitsky, Vladimir; de Oliveira, Tulio			Analysis of Viral Diversity in Relation to the Recency of HIV-1C Infection in Botswana	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ENZYME-IMMUNOASSAY; SOUTH-AFRICA; SEROLOGICAL ASSAYS; POPULATION; TRANSMISSION; RATES; SPECIFICITY; DYNAMICS; COHORT	Background Cross-sectional, biomarker methods to determine HIV infection recency present a promising and cost-effective alternative to the repeated testing of uninfected individuals. We evaluate a viral-based assay that uses a measure of pairwise distances (PwD) to identify HIV infection recency, and compare its performance with two serologic incidence assays, BED and LAg. In addition, we assess whether combination BED plus PwD or LAg plus PwD screening can improve predictive accuracy by reducing the likelihood of a false-recent result. Methods The data comes from 854 time-points and 42 participants enrolled in a primary HIV-1C infection study in Botswana. Time points after treatment initiation or with evidence of multiplicity of infection were excluded from the final analysis. PwD was calculated from quasispecies generated using single genome amplification and sequencing. We evaluated the ability of PwD to correctly classify HIV infection recency within <130, <180 and <360 days post-seroconversion using Receiver Operator Characteristics (ROC) methods. Following a secondary PwD screening, we quantified the reduction in the relative false-recency rate (rFRR) of the BED and LAg assays while maintaining a sensitivity of either 75, 80, 85 or 90%. Results The final analytic sample consisted of 758 time-points from 40 participants. The PwD assay was more accurate in classifying infection recency for the 130 and 180-day cut-offs when compared with the recommended LAg and BED thresholds. A higher AUC statistic confirmed the superior predictive performance of the PwD assay for the three cut-offs. When used for combination screening, the PwD assay reduced the rFRR of the LAg assay by 52% and the BED assay by 57.8% while maintaining a 90% sensitivity for the 130 and 180-day cut-offs respectively. Conclusion PwD can accurately determine HIV infection recency. A secondary PwD screening reduces misclassification and increases the accuracy of serologic-based assays.	[Moyo, Sikhulile; Engelbrecht, Susan] Univ Stellenbosch, Div Med Virol, Tygerberg, South Africa; [Moyo, Sikhulile; Gaseitsiwe, Simani; Kotokwe, Kenanao P.; Musonda, Rosemary; Essex, Max; Novitsky, Vladimir] Botswana Harvard AIDS Inst Partnership, Gaborone, Botswana; [Vandormael, Alain; Wilkinson, Eduan; Tanser, Frank; de Oliveira, Tulio] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Dorris Duke Med Res Ctr, Wellcome Trust Africa Ctr Hlth & Populat Studies, Durban, South Africa; [Engelbrecht, Susan] Natl Hlth Lab Serv, Tygerberg Coastal, South Africa; [Gaseitsiwe, Simani; Musonda, Rosemary; Essex, Max; Novitsky, Vladimir] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA; [de Oliveira, Tulio] UCL, Res Dept Infect, London, England; [de Oliveira, Tulio] Univ KwaZulu Natal, Coll Hlth Sci, Durban, South Africa	Stellenbosch University; Botswana-Harvard AIDS Institute Partnership; University of Kwazulu Natal; Harvard University; Harvard T.H. Chan School of Public Health; University of London; University College London; University of Kwazulu Natal	Moyo, S (corresponding author), Univ Stellenbosch, Div Med Virol, Tygerberg, South Africa.; Moyo, S (corresponding author), Botswana Harvard AIDS Inst Partnership, Gaborone, Botswana.	sikhulilemoyo@gmail.com	Tanser, Frank/ABE-8326-2021; Moyo, Sikhulile/E-1464-2015; Engelbrecht, Susan/G-7286-2011	Moyo, Sikhulile/0000-0003-3821-4592; Engelbrecht, Susan/0000-0002-1318-5994; de Oliveira, Tulio/0000-0002-3027-5254; Tanser, Frank/0000-0001-9797-0000; Vandormael, Alain/0000-0002-5742-0511	National Institutes of Health (NIH) Fogarty International Center [5D43TW009610]; OAK Foundation Fellowship [OUSA-12-025]; NIH [R01 AI057027]; South African MRC Flagship grant [MRC-RFA-UFSP-01-2013/UKZN HIVEPI]; Academy of Medical Sciences-Newton Advanced Fellowship; Royal Society-Newton Advanced Fellowship; HIV Research Trust Scholarship program; Academy of Medical Sciences (AMS) [AMS-NAF2-Tanser] Funding Source: researchfish; FOGARTY INTERNATIONAL CENTER [D43TW009610] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); OAK Foundation Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South African MRC Flagship grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Medical Sciences-Newton Advanced Fellowship; Royal Society-Newton Advanced Fellowship; HIV Research Trust Scholarship program; Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported was supported from the National Institutes of Health (NIH) Fogarty International Center (Grant # 5D43TW009610) and the OAK Foundation Fellowship (Grant # OUSA-12-025). The primary HIV-1C infection study in Botswana ("Tshedimoso Study") was supported and funded by the NIH R01 AI057027. FT, AV, TdO were supported by a South African MRC Flagship grant (MRC-RFA-UFSP-01-2013/UKZN HIVEPI). FT was partially supported by an Academy of Medical Sciences-Newton Advanced Fellowship. TdO is partially supported by an Royal Society-Newton Advanced Fellowship. The funders had no role in the study design, data collection and decision to publish, or in the preparation of the manuscript.; We are grateful to all participants in the Tshedimoso study in Botswana. We acknowledge the support from the staff of the Botswana-Harvard HIV Reference Laboratory and the HIV Research Trust Scholarship program. We are grateful to Alex Welte and Eduard Grebe South African Centre for Epidemiological Modeling and Analysis (SACEMA) for technical assistance and guidance with use incidence assays tools package (inctools) and calculations of the MDRI.	Abrahams MR, 2009, J VIROL, V83, P3556, DOI 10.1128/JVI.02132-08; Allam O, 2011, AIDS, V25, P2047, DOI 10.1097/QAD.0b013e32834bac66; Andersson E, 2013, INFECT GENET EVOL, V18, P125, DOI 10.1016/j.meegid.2013.03.050; Atun R, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001045; Bar KJ, 2010, J VIROL, V84, P6241, DOI 10.1128/JVI.00077-10; Barnighausen T, 2008, AIDS, V22, P139, DOI 10.1097/QAD.0b013e3282f2ef43; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Brookmeyer R, 2013, AM J EPIDEMIOL, V177, P264, DOI 10.1093/aje/kws436; Chaillon A, 2012, CLIN VACCINE IMMUNOL, V19, P1248, DOI 10.1128/CVI.00120-12; Cousins MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101043; Cousins MM, 2014, J CLIN MICROBIOL, V52, P115, DOI 10.1128/JCM.02040-13; Cousins MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027211; Dandona L, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-31; Dandona L, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-327; de Lima KO, 2015, CAD SAUDE PUBLICA, V31, P1327, DOI 10.1590/0102-311X00186813; Dobbs T, 2004, J CLIN MICROBIOL, V42, P2623, DOI 10.1128/JCM.42.6.2623-2628.2004; Duong YT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114947; Duong YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033328; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emerson B, 2013, J CLIN VIROL, V58, pE48, DOI 10.1016/j.jcv.2013.08.005; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Feldblum PJ, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000626; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Geis S, 2011, JAIDS-J ACQ IMM DEF, V56, P453, DOI 10.1097/QAI.0b013e3182118fa3; Giorgi EE, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-532; Gray GE, 2014, AIDS RES HUM RETROV, V30, pA33, DOI 10.1089/aid.2014.5052a.abstract; Guy R, 2009, LANCET INFECT DIS, V9, P747, DOI 10.1016/S1473-3099(09)70300-7; Hall N, 2007, J EXP BIOL, V210, P1518, DOI 10.1242/jeb.001370; Hallett TB, 2011, CURR OPIN HIV AIDS, V6, P102, DOI 10.1097/COH.0b013e328343bfdb; Huber P. J., 1967, P 5 BERK S MATH STAT, V1, P221; Janes H, 2015, NAT MED, V21, P1139, DOI 10.1038/nm.3932; Janes H, 2009, STATA J, V9, P17, DOI 10.1177/1536867X0900900102; Joseph SB, 2015, NAT REV MICROBIOL, V13, P414, DOI 10.1038/nrmicro3471; Kassanjee R, 2014, AIDS, V28, P2439, DOI 10.1097/QAD.0000000000000429; Kassanjee R, 2012, EPIDEMIOLOGY, V23, P721, DOI 10.1097/EDE.0b013e3182576c07; Kearney M, 2009, J VIROL, V83, P2715, DOI 10.1128/JVI.01960-08; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kim Andrea A, 2011, PLoS One, V6, pe17535, DOI 10.1371/journal.pone.0017535; Kim J., 2014, J ELECT MAT, V2014, P1, DOI DOI 10.1167/14.7.1.[; Kiwelu IE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047605; Konikoff J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082772; Kouyos RD, 2011, CLIN INFECT DIS; Kumwenda N, 2006, SEX TRANSM DIS, V33, P646, DOI 10.1097/01.olq.0000223283.27142.9f; Le Vu S, 2008, EUROSURVEILLANCE, V13, P537; Li H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000890; Lopman B, 2008, INT J EPIDEMIOL, V37, P88, DOI 10.1093/ije/dym255; Lu XL, 2015, AIDS RES HUM RETROV, V31, P1038, DOI [10.1089/aid.2015.0160, 10.1089/AID.2015.0160]; Lunar MM, 2015, J MED VIROL, V87, P1510, DOI 10.1002/jmv.24209; Marinda ET, 2010, JAIDS-J ACQ IMM DEF, V53, P496, DOI 10.1097/QAI.0b013e3181b61938; Moyo S, 2015, VIRUSES-BASEL, V7, P5508, DOI 10.3390/v7102887; Moyo S, 2014, AIDS RES HUM RETROV, V30, P29, DOI [10.1089/aid.2013.0055, 10.1089/AID.2013.0055]; Murphy G, 2008, EURO SURVEILL, V13; Noguchi LM, 2015, LANCET HIV, V2, pE279, DOI 10.1016/S2352-3018(15)00058-2; Novitsky V, 2008, AIDS CARE, V20, P806, DOI 10.1080/09540120701694055; Novitsky V, 2013, INFECT GENET EVOL S, Vs1567-1348, P77; Novitsky V, 2009, JAIDS-J ACQ IMM DEF, V50, P65, DOI 10.1097/QAI.0b013e3181900141; Novitsky V, 2009, VIROLOGY, V383, P47, DOI 10.1016/j.virol.2008.09.017; Novitsky V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016714; Novitsky V, 2010, VIROLOGY, V403, P37, DOI 10.1016/j.virol.2010.04.001; Novitsky V, 2009, JAIDS-J ACQ IMM DEF, V52, P265, DOI 10.1097/QAI.0b013e3181ab6ef0; Park SY, 2014, J VIROL, V88, P2977, DOI 10.1128/JVI.03128-13; Parker ZF, 2013, J VIROL, V87, P2401, DOI 10.1128/JVI.02964-12; Parrish NF, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002686; Pepe MS, 2009, STATA J, V9, P1; Pilcher CD, 2004, J CLIN INVEST, V113, P937, DOI [10.1172/JCI200421540, 10.1172/JCI21540]; Pope M, 2003, NAT MED, V9, P847, DOI 10.1038/nm0703-847; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Ragonnet-Cronin M, 2012, J INFECT DIS; Rawal BD, 2003, JAIDS-J ACQ IMM DEF, V33, P349, DOI 10.1097/00126334-200307010-00009; Redd AD, 2014, J CLIN MICROBIOL, V52, P844, DOI 10.1128/JCM.03143-13; Redd AD, 2012, J INFECT DIS, V206, P267, DOI 10.1093/infdis/jis325; Rosenberg NE, 2015, CURR OPIN HIV AIDS, V10, P61, DOI 10.1097/COH.0000000000000121; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Sharma Usha K, 2012, AIDS Res Hum Retroviruses, V28, P532, DOI 10.1089/AID.2011.0332; Shaw PA, 2009, STAT BIOPHARM RES, V1, P18, DOI 10.1198/sbr.2009.0002; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanser F, 2015, CURR OPIN HIV AIDS, V10, P430, DOI 10.1097/COH.0000000000000192; UNAIDS, 2013, WHO UN TECHN UPD HIV; van Loggerenberg F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001954; Vandormael A, 2014, LANCET GLOB HEALTH, V2, pE209, DOI 10.1016/S2214-109X(14)70018-X; Visser MJ, 2009, AIDS CARE, V21, P197, DOI 10.1080/09540120801932157; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; WHITE H, 1982, ECONOMETRICA, V50, P1, DOI 10.2307/1912526; Xia XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100081; Yu L, 2015, AIDS RES HUM RETROV, V31, P1247, DOI 10.1089/aid.2015.0097	86	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0160649	10.1371/journal.pone.0160649	http://dx.doi.org/10.1371/journal.pone.0160649			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27552218	gold, Green Published			2022-12-26	WOS:000381768800014
J	Jia, YZ; Chang, HC; Schipma, MJ; Liu, J; Shete, V; Liu, N; Sato, T; Thorp, EB; Barger, PM; Zhu, YJ; Viswakarma, N; Kanwar, YS; Ardehali, H; Thimmapaya, B; Reddy, JK				Jia, Yuzhi; Chang, Hsiang-Chun; Schipma, Matthew J.; Liu, Jing; Shete, Varsha; Liu, Ning; Sato, Tatsuya; Thorp, Edward B.; Barger, Philip M.; Zhu, Yi-Jun; Viswakarma, Navin; Kanwar, Yashpal S.; Ardehali, Hossein; Thimmapaya, Bayar; Reddy, Janardan K.			Cardiomyocyte-Specific Ablation of Med1 Subunit of the Mediator Complex Causes Lethal Dilated Cardiomyopathy in Mice	PLOS ONE			English	Article							RECEPTOR-BINDING PROTEIN; FATTY-ACID-METABOLISM; DIABETIC CARDIOMYOPATHY; MYOCARDIAL-INFARCTION; COACTIVATOR COMPLEX; EXPRESSION ANALYSIS; ENERGY-METABOLISM; GENE-EXPRESSION; HEART-FAILURE; TRANSCRIPTION	Mediator, an evolutionarily conserved multi-protein complex consisting of about 30 subunits, is a key component of the polymerase II mediated gene transcription. Germline deletion of the Mediator subunit 1 (Med1) of the Mediator in mice results in mid-gestational embryonic lethality with developmental impairment of multiple organs including heart. Here we show that cardiomyocyte-specific deletion of Med1 in mice (csMed1(-/-)) during late gestational and early postnatal development by intercrossing Med1(fl/fl) mice to alpha-MyHC-Cre transgenic mice results in lethality within 10 days after weaning due to dilated cardiomyopathy-related ventricular dilation and heart failure. The csMed1(-/-) mouse heart manifests mitochondrial damage, increased apoptosis and interstitial fibrosis. Global gene expression analysis revealed that loss of Med1 in heart down-regulates more than 200 genes including Acadm, Cacna1s, Atp2a2, Ryr2, Pde1c, Pln, PGC1 alpha, and PGC1 beta that are critical for calcium signaling, cardiac muscle contraction, arrhythmogenic right ventricular cardiomyopathy, dilated cardiomyopathy and peroxisome proliferator-activated receptor regulated energy metabolism. Many genes essential for oxidative phosphorylation and proper mitochondrial function such as genes coding for the succinate dehydrogenase subunits of the mitochondrial complex II are also down-regulated in csMed1(-/-) heart contributing to myocardial injury. Data also showed up-regulation of about 180 genes including Tgfb2, Ace, Atf3, Ctgf, Angpt14, Col9a2, Wisp2, Nppa, Nppb, and Actn1 that are linked to cardiac muscle contraction, cardiac hypertrophy, cardiac fibrosis and myocardial injury. Furthermore, we demonstrate that cardiac specific deletion of Med1 in adult mice using tamoxifen-inducible Cre approach (TmcsMed1(-/-)), results in rapid development of cardiomyopathy and death within 4 weeks. We found that the key findings of the csMed1(-/-) studies described above are highly reproducible in TmcsMed1(-/-) mouse heart. Collectively, these observations suggest that Med1 plays a critical role in the maintenance of heart function impacting on multiple metabolic, compensatory and reparative pathways with a likely therapeutic potential in the management of heart failure.	[Jia, Yuzhi; Liu, Jing; Shete, Varsha; Liu, Ning; Thorp, Edward B.; Zhu, Yi-Jun; Kanwar, Yashpal S.; Reddy, Janardan K.] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA; [Chang, Hsiang-Chun; Sato, Tatsuya; Ardehali, Hossein] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Schipma, Matthew J.] Northwestern Univ, Feinberg Sch Med, Next Generat Sequencing Core Facil, Chicago, IL 60611 USA; [Barger, Philip M.] Washington Univ, Sch Med, Ctr Cardiovasc Res, St Louis, MO USA; [Viswakarma, Navin] Univ Illinois, Dept Surg, Chicago, IL 60680 USA; [Thimmapaya, Bayar] Northwestern Univ, Feinberg Sch Med, Dept Microbiol & Immunol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Washington University (WUSTL); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Northwestern University; Feinberg School of Medicine	Reddy, JK (corresponding author), Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA.; Thimmapaya, B (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Microbiol & Immunol, Chicago, IL 60611 USA.	b-thimmapaya@northwestern.edu; jkreddy@northwestern.edu	Shete, Varsha/L-8762-2019	Chang, Hsiang-Chun/0000-0002-9201-4500; Thorp, Edward/0000-0003-1387-7058	National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (US) (NIH NIDDK) [RO1 DK097240, RO1 DK083163]; National Institutes of Health, National Institutes of Health (US), National Institute of Allergy and Infectious Diseases (NIH) [R21AI1094296]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097249, R01DK060635] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (US) (NIH NIDDK); National Institutes of Health, National Institutes of Health (US), National Institute of Allergy and Infectious Diseases (NIH); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the following sources of funding: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (US) (NIH NIDDK) RO1 DK097240, Recipient: Janardan K. Reddy; National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (US) (NIH NIDDK) RO1 DK083163, Recipient: Janardan K. Reddy; and National Institutes of Health, National Institutes of Health (US), National Institute of Allergy and Infectious Diseases (NIH) (AI) R21AI1094296, Recipient: Bayar Thimmapaya.	Agah R, 1997, J CLIN INVEST, V100, P169, DOI 10.1172/JCI119509; Allen BL, 2015, NAT REV MOL CELL BIO, V16, P155, DOI 10.1038/nrm3951; Amoasii L, 2016, GENE DEV, V30, P434, DOI 10.1101/gad.273128.115; Asadollahi R, 2013, EUR J HUM GENET, V21, P1100, DOI 10.1038/ejhg.2013.17; Austin S, 2012, J CELL SCI, V125, P4963, DOI 10.1242/jcs.113662; Azhar M, 2003, CYTOKINE GROWTH F R, V14, P391, DOI 10.1016/S1359-6101(03)00044-3; Bai LA, 2011, HEPATOLOGY, V53, P1164, DOI 10.1002/hep.24155; Bergmann O, 2012, JOVE-J VIS EXP, DOI 10.3791/4205; Bidaud I, 2011, BIOCHIMIE, V93, P2080, DOI 10.1016/j.biochi.2011.05.015; Borik S, 2011, INTENS CARE MED, V37, P1664, DOI 10.1007/s00134-011-2296-z; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; Burrell LM, 2013, CLIN SCI, V124, P65, DOI 10.1042/CS20120269; Campbell CT, 2012, BBA-GENE REGUL MECH, V1819, P921, DOI 10.1016/j.bbagrm.2012.03.002; Carlsten JOP, 2013, TRENDS BIOCHEM SCI, V38, P531, DOI 10.1016/j.tibs.2013.08.007; Chen W, 2011, SEMIN CELL DEV BIOL, V22, P749, DOI 10.1016/j.semcdb.2011.07.026; Chen W, 2010, P NATL ACAD SCI USA, V107, P10196, DOI 10.1073/pnas.1005626107; Cheng LH, 2004, NAT MED, V10, P1245, DOI 10.1038/nm1116; Chu YJ, 2014, CELL RES, V24, P1250, DOI 10.1038/cr.2014.120; COLLIN T, 1993, CIRC RES, V72, P1337, DOI 10.1161/01.RES.72.6.1337; Crawford SE, 2002, J BIOL CHEM, V277, P3585, DOI 10.1074/jbc.M107995200; Digilio Mc, 2005, Images Paediatr Cardiol, V7, P23; Dobaczewski M, 2011, J MOL CELL CARDIOL, V51, P600, DOI 10.1016/j.yjmcc.2010.10.033; Fillmore N, 2014, BRIT J PHARMACOL, V171, P2080, DOI 10.1111/bph.12475; Fondell JD, 2013, BBA-GEN SUBJECTS, V1830, P3867, DOI 10.1016/j.bbagen.2012.02.012; Galaup A, 2012, CIRCULATION, V125, P140, DOI 10.1161/CIRCULATIONAHA.111.049072; Graham JM, 2013, AM J MED GENET A, V161, P2734, DOI 10.1002/ajmg.a.36183; Grueter Chad E., 2013, Genomics Proteomics & Bioinformatics, V11, P151, DOI 10.1016/j.gpb.2013.05.002; Haddad F, 2008, AM J PHYSIOL-HEART C, V294, pH29, DOI 10.1152/ajpheart.01125.2007; Hai T, 2010, GENE EXPRESSION, V15, P1, DOI 10.3727/105221610X12819686555015; Israeli-Rosenberg S, 2014, CIRC RES, V114, P572, DOI 10.1161/CIRCRESAHA.114.301275; Ito M, 2000, MOL CELL, V5, P683, DOI 10.1016/S1097-2765(00)80247-6; Jia Y, 2014, GENE EXPRESSION, V16, P63, DOI 10.3727/105221614X13919976902219; Jia YZ, 2004, J BIOL CHEM, V279, P24427, DOI 10.1074/jbc.M402391200; Jin F, 2013, MOL CANCER RES, V11, P736, DOI 10.1158/1541-7786.MCR-12-0618; Kim YK, 2006, CIRCULATION, V113, P2589, DOI 10.1161/CIRCULATIONAHA.105.598409; Koren L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068396; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Koshman YE, 2015, J MOL CELL CARDIOL, V89, P214, DOI 10.1016/j.yjmcc.2015.11.003; Krebs P, 2011, P NATL ACAD SCI USA, V108, P19678, DOI 10.1073/pnas.1117835108; Kushnir A, 2010, ADV PHARMACOL, V59, P1, DOI 10.1016/S1054-3589(10)59001-X; Kuwahara K, 2010, ENDOCR J, V57, P555, DOI 10.1507/endocrj.K10E-150; Landles C, 2003, MOL ENDOCRINOL, V17, P2418, DOI 10.1210/me.2003-0097; Lee TI, 2013, DIABETES RES CLIN PR, V100, P330, DOI 10.1016/j.diabres.2013.01.008; Liepinsh E, 2014, METABOLISM, V63, P127, DOI 10.1016/j.metabol.2013.09.014; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Luiken JJ, 2015, TRENDS ENDOCRINOL ME; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Marin-Garcia J, 2002, CARDIOVASC RES, V54, P516, DOI 10.1016/S0008-6363(01)00552-1; Marks AR, 2013, J CLIN INVEST, V123, P46, DOI 10.1172/JCI62834; Matsumoto K, 2010, CARCINOGENESIS, V31, P318, DOI 10.1093/carcin/bgp306; McNally EM, 2013, J CLIN INVEST, V123, P19, DOI 10.1172/JCI62862; Pyper Sean R, 2010, Nucl Recept Signal, V8, pe002, DOI 10.1621/nrs.08002; Roh JI, 2014, CELL REP, V8, P991, DOI 10.1016/j.celrep.2014.07.027; Russell LK, 2004, CIRC RES, V94, P525, DOI 10.1161/01.RES.0000117088.36577.EB; Schiano C, 2014, BBA-REV CANCER, V1845, P66, DOI 10.1016/j.bbcan.2013.12.001; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Spaeth JM, 2011, SEMIN CELL DEV BIOL, V22, P776, DOI 10.1016/j.semcdb.2011.07.024; Spiegelman Bruce M, 2007, Novartis Found Symp, V287, P60; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; Teekakirikul P, 2010, J CLIN INVEST, V120, P3520, DOI 10.1172/JCI42028; Traister A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5533; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Valencik ML, 2006, CIRC RES, V99, P1403, DOI 10.1161/01.RES.0000252291.88540.ac; Venetucci L, 2012, NAT REV CARDIOL, V9, P561, DOI 10.1038/nrcardio.2012.93; Viswakarma N, 2013, J BIOL CHEM, V288, P27898, DOI 10.1074/jbc.M113.486696; Watanabe K, 2000, J BIOL CHEM, V275, P22293, DOI 10.1074/jbc.M000248200; Wu RX, 2014, J CLIN INVEST, V124, P4795, DOI 10.1172/JCI76737; Wu RX, 2011, CIRC RES, V108, P60, DOI 10.1161/CIRCRESAHA.110.223115; Wyatt E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013823; Xiaoli, 2013, TRENDS CARDIOVAS MED, V23, P269, DOI 10.1016/j.tcm.2013.03.002; Zhou H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026744; Zhu YJ, 2000, J BIOL CHEM, V275, P14779, DOI 10.1074/jbc.C000121200; Zhu YJ, 1999, P NATL ACAD SCI USA, V96, P10848, DOI 10.1073/pnas.96.19.10848	74	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0160755	10.1371/journal.pone.0160755	http://dx.doi.org/10.1371/journal.pone.0160755			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548259	Green Published, gold			2022-12-26	WOS:000381768400020
J	Xu, Q; Wang, K; Wang, LN; Zhu, YT; Zhou, GY; Xie, D; Yang, QK				Xu, Qiang; Wang, Kai; Wang, Lina; Zhu, Yuting; Zhou, Guangyu; Xie, Dan; Yang, Qingkai			IDH1/2 Mutants Inhibit TET-Promoted Oxidation of RNA 5mC to 5hmC	PLOS ONE			English	Article							CELL SELF-RENEWAL; MEDIATED FORMATION; IDH2 MUTATIONS; MAMMALIAN DNA; STEM-CELLS; 5-HYDROXYMETHYLCYTOSINE; LEUKEMIA; 5-CARBOXYLCYTOSINE; 5-METHYLCYTOSINE; DIFFERENTIATION	TETs (TET1/2/3) play critical roles in multi cellular processes through DNA demethylation driven by oxidation of DNA 5mdC to 5hmdC. Interestingly, recent studies indicated that TETs also oxidate RNA 5mC to 5hmC. However, little is known about the distribution of RNA 5hmC and the regulatory mechanism of RNA 5hmC in human. Here, we show that 5hmC is enriched in mRNA, and IDH1/2 mutants inhibit TET-promoted oxidation of RNA 5mC to 5hmC. Since IDH1/2 mutations have been described to block the DNA oxidative activity of TETs, we hypothesized that IDH1/2 mutations might also inhibit the RNA oxidative activity of TETs. To evaluate the role of IDH1/2 mutations in RNA 5hmC, TETs with/without IDH1/2 mutants were overexpressed in human HEK293 cells. Resultant DNA and RNA were digested and analyzed by triple-quadrupole LC mass spectrometer. DNA 5hmdC and RNA 5hmC modifications were quantified with external calibration curves of appropriate standards. It was found that compared with total RNA (5hmC/C: less than 2 X 10(-7)), mRNA showed much higher 5hmC level (5hmC/C:similar to 7 X 10(-6)). Further study indicated that IDH1/2 mutants showed significant ability to inhibit TET-promoted RNA5hmC. Consistent with this result, overexpression of IDH1/2 mutants also inhibited TET catalytic domain-promoted oxidation of RNA. In this study, we show not only the enrichment of 5hmC in mRNA, but also a regulatory mechanism of RNA 5hmC-IDH1/2 mutations inhibit TET-promoted RNA 5hmC, which suggests an involvement of IDH1/2 mutations in tumorigenesis through the deregulation of RNA biology.	[Xu, Qiang; Wang, Kai; Wang, Lina; Zhu, Yuting; Zhou, Guangyu; Xie, Dan; Yang, Qingkai] DaLian Med Univ, Inst Canc Stem Cell, Affiliated Hosp 2, Dept Oncol, 9 Western Lvshun South Rd, Dalian 116044, Liaoning, Peoples R China	Dalian Medical University	Yang, QK (corresponding author), DaLian Med Univ, Inst Canc Stem Cell, Affiliated Hosp 2, Dept Oncol, 9 Western Lvshun South Rd, Dalian 116044, Liaoning, Peoples R China.	Yangqingkai@dmu.edu.cn			National Natural Science Foundation of China (NSFC) [31471328, 81302193, 81502622]; Department of Education of Liaoning Province [LR2015020]; Department of Science & Technology of Liaoning Province [2015020255]; National Natural Science Foundation of China [31471328, 81302193, 81502622]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Department of Education of Liaoning Province; Department of Science & Technology of Liaoning Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	1 Grant number: 31471328 to Qingkai Yang; Funding organization: the National Natural Science Foundation of China; URL of funder: isisn.nsfc.gov.cn. 2 Grant number: 81302193 to Qingkai Yang; Funding organization: the National Natural Science Foundation of China; URL of funder: isisn.nsfc.gov.cn. 3 Grant number: 81502622 to Lina Wang; Funding organization: the National Natural Science Foundation of China; URL of funder: isisn.nsfc.gov.cn. 4 Grant number: LR2015020 to Qingkai Yang; Funding organization: Department of Education of Liaoning Province; URL of funder: www.lnen.cn. 5 Grant number: 2015020255 to Qingkai Yang; Funding organization: Department of Science & Technology of Liaoning Province; URL of funder: www.lninfo.gov.cn.; This study was supported by grants from the National Natural Science Foundation of China (NSFC Nos. 31471328 and 81302193 to Qingkai Yang), Department of Education of Liaoning Province (LR2015020 to Qingkai Yang), and Department of Science & Technology of Liaoning Province (2015020255 to Qingkai Yang). This study was also supported by grants from the National Natural Science Foundation of China (NSFC Nos. 81502622 to Lina Wang).	Alderton GK, 2011, NAT REV CANCER, V11, P535, DOI 10.1038/nrc3115; Chen Q, 2013, NATURE, V493, P561, DOI 10.1038/nature11742; Costa Y, 2013, NATURE, V495, P370, DOI 10.1038/nature11925; Dang L, 2010, NATURE, V465, P966, DOI 10.1038/nature09132; Delatte B, 2016, SCIENCE, V351, P282, DOI 10.1126/science.aac5253; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Doege CA, 2012, NATURE, V488, P652, DOI 10.1038/nature11333; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Fu LJ, 2014, J AM CHEM SOC, V136, P11582, DOI 10.1021/ja505305z; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Huber SM, 2015, CHEMBIOCHEM, V16, P752, DOI 10.1002/cbic.201500013; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Ko M, 2011, P NATL ACAD SCI USA, V108, P14566, DOI 10.1073/pnas.1112317108; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Lian CG, 2012, CELL, V150, P1135, DOI 10.1016/j.cell.2012.07.033; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Song CL, 2015, ONCOTARGET, V6, P33279, DOI 10.18632/oncotarget.5337; Song SJ, 2013, CELL, V154, P311, DOI 10.1016/j.cell.2013.06.026; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yang H, 2013, ONCOGENE, V32, P663, DOI 10.1038/onc.2012.67; Yang QK, 2010, CANCER CELL, V18, P258, DOI 10.1016/j.ccr.2010.08.008	28	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161261	10.1371/journal.pone.0161261	http://dx.doi.org/10.1371/journal.pone.0161261			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548812	gold, Green Published, Green Submitted			2022-12-26	WOS:000381768400035
J	Zheng, XL; Fang, B; Han, DF; Yang, WX; Qi, FF; Chen, H; Li, SY				Zheng, Xianliang; Fang, Bo; Han, Dongfei; Yang, Wenxia; Qi, Feifei; Chen, Hui; Li, Shengying			Improving the Secretory Expression of an - Galactosidase from Aspergillus niger in Pichia pastoris	PLOS ONE			English	Article							HIGH-LEVEL EXPRESSION; HUMAN ALPHA-GALACTOSIDASE; ALCOHOL OXIDASE; METHYLOTROPHIC YEAST; GENE; CLONING; PURIFICATION; PRECURSOR; PROTEINS; STRAIN	alpha-Galactosidases are broadly used in feed, food, chemical, pulp, and pharmaceutical industries. However, there lacks a satisfactory microbial cell factory that is able to produce alpha-galactosidases efficiently and cost-effectively to date, which prevents these important enzymes from greater application. In this study, the secretory expression of an Aspergillus niger alpha-galactosidase (AGA) in Pichia pastoris was systematically investigated. Through codon optimization, signal peptide replacement, comparative selection of host strain, and saturation mutagenesis of the P1' residue of Kex2 protease cleavage site for efficient signal peptide removal, a mutant P. pastoris KM71H (Mut(s)) strain of AGA-I with the specific P1' site substitution (Glu to Ile) demonstrated remarkable extracellular a-galactosidase activity of 1299 U/ ml upon a 72 h methanol induction in 2.0 L fermenter. The engineered yeast strain AGA-I demonstrated approximately 12-fold higher extracellular activity compared to the initial P. pastoris strain. To the best of our knowledge, this represents the highest yield and productivity of a secreted alpha-galactosidase in P. pastoris, thus holding great potential for industrial application.	[Zheng, Xianliang; Fang, Bo; Han, Dongfei; Yang, Wenxia; Qi, Feifei; Chen, Hui; Li, Shengying] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Shandong Prov Key Lab Synthet Biol, 189 Songling Rd, Qingdao 266101, Shandong, Peoples R China; [Zheng, Xianliang; Fang, Bo; Han, Dongfei; Yang, Wenxia; Qi, Feifei; Chen, Hui; Li, Shengying] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, CAS Key Lab Biofuels, 189 Songling Rd, Qingdao 266101, Shandong, Peoples R China; [Zheng, Xianliang; Fang, Bo] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Zheng, Xianliang] Sinodanish Ctr Educ & Res, Beijing 100190, Peoples R China	Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, SY (corresponding author), Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Shandong Prov Key Lab Synthet Biol, 189 Songling Rd, Qingdao 266101, Shandong, Peoples R China.; Li, SY (corresponding author), Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, CAS Key Lab Biofuels, 189 Songling Rd, Qingdao 266101, Shandong, Peoples R China.	lishengying@qibebt.ac.cn	Han, Dongfei/ABB-3352-2020	Han, Dongfei/0000-0003-4007-8454	National Natural Science Foundation of China [NSFC 21406250, NSFC 31300663]; Applied Basic Research Programs of Science and Technology of Qingdao [15-9-1-106-jch]; Opening Fund of Key Laboratory of Protein Chemistry and Developmental Biology of the Ministry of Education at Hunan Normal University [2015DF05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Applied Basic Research Programs of Science and Technology of Qingdao; Opening Fund of Key Laboratory of Protein Chemistry and Developmental Biology of the Ministry of Education at Hunan Normal University	This work was financially supported by funding from the National Natural Science Foundation of China under grant numbers NSFC 21406250 (HC) and NSFC 31300663 (DH), the Applied Basic Research Programs of Science and Technology of Qingdao, 15-9-1-106-jch (HC), and the Opening Fund of Key Laboratory of Protein Chemistry and Developmental Biology of the Ministry of Education at Hunan Normal University, 2015DF05 (SL).	Aleksieva P, 2010, BIOTECHNOL BIOTEC EQ, V24, P1620, DOI 10.2478/V10133-010-0015-5; Basco RD, 1996, BBA-MOL CELL RES, V1310, P110, DOI 10.1016/0167-4889(95)00156-5; BRAKE AJ, 1984, P NATL ACAD SCI-BIOL, V81, P4642, DOI 10.1073/pnas.81.15.4642; Cereghino JL, 2000, FEMS MICROBIOL REV, V24, P45, DOI 10.1111/j.1574-6976.2000.tb00532.x; Chen YQ, 2012, APPL BIOCHEM BIOTECH, V168, P638, DOI 10.1007/s12010-012-9806-5; Chen YS, 2000, PROTEIN EXPRES PURIF, V20, P472, DOI 10.1006/prep.2000.1325; Chen Z, 2015, PROTEIN EXPRES PURIF, V110, P107, DOI 10.1016/j.pep.2015.02.015; Chiruvolu V, 1997, ENZYME MICROB TECH, V21, P277, DOI 10.1016/S0141-0229(97)00042-2; CREGG JM, 1989, MOL CELL BIOL, V9, P1316, DOI 10.1128/MCB.9.3.1316; CREGG JM, 1987, BIO-TECHNOL, V5, P479, DOI 10.1038/nbt0587-479; DELCAMPILLO E, 1982, PLANT PHYSIOL, V69, P628, DOI 10.1104/pp.69.3.628; DENHERDER IF, 1992, MOL GEN GENET, V233, P404, DOI 10.1007/BF00265437; EDMAN P, 1950, ACTA CHEM SCAND, V4, P283, DOI 10.3891/acta.chem.scand.04-0283; ELLIS SB, 1985, MOL CELL BIOL, V5, P1111, DOI 10.1128/MCB.5.5.1111; GERMAIN D, 1993, FEBS LETT, V323, P129, DOI 10.1016/0014-5793(93)81463-A; Ghazi S, 2003, BRIT POULTRY SCI, V44, P410, DOI 10.1080/00071660310001598283; Guerfal M, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-49; KATO K, 1982, AGR BIOL CHEM TOKYO, V46, P1089, DOI 10.1080/00021369.1982.10865204; Lee J., 2012, AFR J BIOTECHNOL, V11, P12396, DOI [10.5897/ajb12.1219, DOI 10.5897/AJB12.1219]; Manzanares P, 1998, ENZYME MICROB TECH, V22, P383, DOI 10.1016/S0141-0229(97)00207-X; Mi SJ, 2007, ENZYME MICROB TECH, V40, P1373, DOI 10.1016/j.enzmictec.2006.10.017; Patil AGG, 2010, J MICROBIOL BIOTECHN, V20, P1546, DOI 10.4014/jmb.0912.12012; Puchart V, 2000, BBA-GEN SUBJECTS, V1524, P27, DOI 10.1016/S0304-4165(00)00138-0; RHOLAM M, 1995, EUR J BIOCHEM, V227, P707, DOI 10.1111/j.1432-1033.1995.tb20192.x; Schechter I, 2012, BIOCHEM BIOPH RES CO, V425, P497, DOI 10.1016/j.bbrc.2012.08.015; Shibuya H, 1998, APPL ENVIRON MICROB, V64, P4489; Tashiro K, 1999, METHOD ENZYMOL, V303, P479; TSCHOPP JF, 1987, BIO-TECHNOL, V5, P1305, DOI 10.1038/nbt1287-1305; Tsuboi K, 2012, GENET MED, V14, P779, DOI [10.1038/gim.2012.39, 10.1038/gim.2012.81]; Unzueta U, 2015, APPL MICROBIOL BIOT, V99, P5863, DOI 10.1007/s00253-014-6328-9; Viana PA, 2006, J AGR FOOD CHEM, V54, P2385, DOI 10.1021/jf0526442; Wang H, 2010, BIORESOURCE TECHNOL, V101, P8376, DOI 10.1016/j.biortech.2010.06.045; Xiong AS, 2005, J APPL MICROBIOL, V98, P418, DOI 10.1111/j.1365-2672.2004.02476.x; Yan JY, 2014, BIORESOURCE TECHNOL, V151, P43, DOI 10.1016/j.biortech.2013.10.037; Yang S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075347; Zeyland J, 2013, J APPL GENET, V54, P293, DOI 10.1007/s13353-013-0156-y; Zhang YP, 2007, CHINESE MED J-PEKING, V120, P1145, DOI 10.1097/00029330-200707010-00006	37	13	14	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161529	10.1371/journal.pone.0161529	http://dx.doi.org/10.1371/journal.pone.0161529			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548309	gold, Green Published, Green Submitted			2022-12-26	WOS:000381768400066
J	Lloyd, ML; Hod, N; Jayaraman, J; Marchant, EA; Christen, L; Chiang, P; Hartmann, P; Shellam, GR; Simmer, K				Lloyd, Megan L.; Hod, Nurul; Jayaraman, Jothsna; Marchant, Elizabeth A.; Christen, Lukas; Chiang, Peter; Hartmann, Peter; Shellam, Geoffrey R.; Simmer, Karen			Inactivation of Cytomegalovirus in Breast Milk Using Ultraviolet-C Irradiation: Opportunities for a New Treatment Option in Breast Milk Banking	PLOS ONE			English	Article							PRETERM INFANTS; INFECTION; TRANSMISSION; PASTEURIZATION	Pasteurized donor human milk is provided by milk banks to very preterm babies where their maternal supply is insufficient or unavailable. Donor milk is currently processed by Holder pasteurization, producing a microbiologically safe product but significantly reducing immunoprotective components. Ultraviolet-C (UV-C) irradiation at 254 nm is being investigated as an alternative treatment method and has been shown to preserve components such as lactoferrin, lysozyme and secretory IgA considerably better than Holder pasteurization. We describe the inactivation of cytomegalovirus, a virus commonly excreted into breast milk, using UV-C irradiation. Full replication was ablated by various treatment doses. However, evidence of viral immediate early proteins within the cells was never completely eliminated indicating that some viral gene transcription was still occurring. In conclusion, UV-C may be a safe alternative to pasteurisation for the treatment of human donor milk that preserves the bioactivity. However, our data suggests that CMV inactivation will have to be carefully evaluated for each device designed to treat breast milk using UV-C irradiation.	[Lloyd, Megan L.; Hod, Nurul; Jayaraman, Jothsna; Marchant, Elizabeth A.; Chiang, Peter; Shellam, Geoffrey R.] Univ Western Australia, Sch Pathol & Lab Med, Crawley, WA, Australia; [Lloyd, Megan L.; Shellam, Geoffrey R.] Univ Western Australia, Marshall Ctr Infect Dis Res & Training, Crawley, WA, Australia; [Lloyd, Megan L.] Edith Cowan Univ, Sch Med & Hlth Sci, Joondalup, WA, Australia; [Marchant, Elizabeth A.] Univ British Columbia, Fac Med, Dept Expt Med, Vancouver, BC, Canada; [Marchant, Elizabeth A.] Child & Family Res Inst, Vancouver, BC, Canada; [Christen, Lukas; Hartmann, Peter] Univ Western Australia, Sch Chem & Biochem, Crawley, WA, Australia; [Christen, Lukas] Carag AG, Baar, Switzerland; [Simmer, Karen] Univ Western Australia, Sch Paediat & Child Hlth, Crawley, WA, Australia; [Simmer, Karen] Univ Western Australia, Ctr Neonatal Res & Educ, Perth, WA, Australia; [Simmer, Karen] King Edward Mem Hosp Women, Neonatal Clin Care Unit, Perth, WA, Australia	University of Western Australia; University of Western Australia; Edith Cowan University; University of British Columbia; Child & Family Research Institute; University of Western Australia; University of Western Australia; University of Western Australia; King Edward Memorial Hospital; University of Western Australia	Lloyd, ML (corresponding author), Univ Western Australia, Sch Pathol & Lab Med, Crawley, WA, Australia.; Lloyd, ML (corresponding author), Univ Western Australia, Marshall Ctr Infect Dis Res & Training, Crawley, WA, Australia.; Lloyd, ML (corresponding author), Edith Cowan Univ, Sch Med & Hlth Sci, Joondalup, WA, Australia.	m.lloyd@ecu.edu.au	Lloyd, Megan/B-5690-2008	Lloyd, Megan/0000-0002-0140-1215; Hartmann, Peter/0000-0002-7709-0740; Simmer, Karen/0000-0003-4777-9069	Princess Margaret Hospital Foundation [9396]	Princess Margaret Hospital Foundation	Funding for this study was received from the Princess Margaret Hospital Foundation, Grant ID 9396, [https://pmhfoundation.com]. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bevot A, 2012, ACTA PAEDIATR, V101, pE167, DOI 10.1111/j.1651-2227.2011.02538.x; Brecht KF, 2015, J PEDIATR-US, V166, P834, DOI 10.1016/j.jpeds.2014.11.002; Capretti MG, 2009, J PEDIATR-US, V154, P842, DOI 10.1016/j.jpeds.2008.12.046; Chiavarini M, 2011, ITAL J PEDIATR, V37, DOI 10.1186/1824-7288-37-6; Christen L., 2013, PLOS ONE, V8; Christen L., 2014, Patent No. [WO Patent App. PCT/ CH2013/ 000,224, 2014094189]; Christen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085867; Cristofalo EA, 2013, J PEDIATR-US, V163, P1592, DOI 10.1016/j.jpeds.2013.07.011; Ewaschuk JB, 2011, J PERINATOL, V31, P593, DOI 10.1038/jp.2010.209; Fischer C, 2010, NEONATOLOGY, V97, P339, DOI 10.1159/000260137; Franklin J.G., 1965, INT J DAIRY TECHNOL, V18, P115, DOI 10.1111/j.1471-0307.1965.tb00185.x; Guerrero-Beltran JA, 2004, FOOD SCI TECHNOL INT, V10, P137, DOI 10.1177/1082013204044359; Hamele M, 2010, PEDIATR INFECT DIS J, V29, P84, DOI 10.1097/INF.0b013e3181b6dbb5; Hamprecht K, 2004, PEDIATR RES, V56, P529, DOI 10.1203/01.PDR.0000139483.35087.BE; Hamprecht K, 2003, J CLIN VIROL, V28, P303, DOI 10.1016/S1386-6532(03)00074-X; Hamprecht K, 2001, LANCET, V357, P513, DOI 10.1016/S0140-6736(00)04043-5; Hartmann BT, 2007, EARLY HUM DEV, V83, P667, DOI 10.1016/j.earlhumdev.2007.07.012; Jim WT, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001835; Kelly MS, 2015, JAMA PEDIATR, V169, DOI 10.1001/jamapediatrics.2015.3785; Kurath S, 2010, CLIN MICROBIOL INFEC, V16, P1172, DOI 10.1111/j.1469-0691.2010.03140.x; Kurz SK, 1999, J VIROL, V73, P482, DOI 10.1128/JVI.73.1.482-494.1999; Lawrence RM, 2006, BREASTFEED MED, V1, P99, DOI 10.1089/bfm.2006.1.99; Maschmann J, 2006, ARCH DIS CHILD-FETAL, V91, pF288, DOI 10.1136/adc.2004.050625; Numazaki K, 1997, FEMS IMMUNOL MED MIC, V18, P91, DOI 10.1111/j.1574-695X.1997.tb01032.x; Okulu E, 2012, J PERINATOL, V32, P72, DOI 10.1038/jp.2011.58; Omarsdottir S, 2015, PEDIATR INFECT DIS J, V34, P482, DOI 10.1097/INF.0000000000000619; Rastogi RP, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/592980; REED L. J., 1938, AMER JOUR HYG, V27, P493; ROWE WP, 1958, AM J HYG, V67, P57, DOI 10.1093/oxfordjournals.aje.a119919; Seale H, 2006, CLIN VACCINE IMMUNOL, V13, P1181, DOI 10.1128/CVI.00203-06; Stock K, 2015, BREASTFEED MED, V10, P113, DOI 10.1089/bfm.2014.0108; 김지혜, 2009, Clinical and Experimental Pediatrics, V52, P1053	32	23	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161116	10.1371/journal.pone.0161116	http://dx.doi.org/10.1371/journal.pone.0161116			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537346	Green Published, gold, Green Submitted			2022-12-26	WOS:000381577000055
J	Sathyanarayana, BK; Li, P; Lin, JX; Leonard, WJ; Lee, B				Sathyanarayana, Bangalore K.; Li, Peng; Lin, Jian-Xin; Leonard, Warren J.; Lee, Byungkook			Molecular Models of STAT5A Tetramers Complexed to DNA Predict Relative GenomeWide Frequencies of the Spacing between the Two Dimer Binding Motifs of the Tetramer Binding Sites	PLOS ONE			English	Article							TRANSACTIVATION DOMAINS; GENE; TRANSCRIPTION; RECRUITMENT; ACTIVATION; INDUCTION; GROWTH; CELLS	STAT proteins bind DNA as dimers and tetramers to control cellular development, differentiation, survival, and expansion. The tetramer binding sites are comprised of two dimer-binding sites repeated in tandem. The genome-wide distribution of the spacings between the dimer binding sites shows a distinctive, non-random pattern. Here, we report on estimating the feasibility of building possible molecular models of STAT5A tetramers bound to a DNA double helix with all possible spacings between the dimer binding sites. We found that the calculated feasibility estimates correlated well with the experimentally measured frequency of tetramer-binding sites. This suggests that the feasibility of forming the tetramer complex was a major factor in the evolution of this DNA sequence variation.	[Sathyanarayana, Bangalore K.; Lee, Byungkook] NCI, Mol Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Li, Peng; Lin, Jian-Xin; Leonard, Warren J.] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Li, Peng; Lin, Jian-Xin; Leonard, Warren J.] NHLBI, Ctr Immunol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Lee, B (corresponding author), NCI, Mol Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.; Leonard, WJ (corresponding author), NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA.; Leonard, WJ (corresponding author), NHLBI, Ctr Immunol, NIH, Bethesda, MD 20892 USA.	leonardw@nhlbi.nih.gov; BKLee@mail.nih.gov	Leonard, Warren/AAA-1397-2022; Lee, Byungkook/E-4564-2011	Lee, Byungkook/0000-0002-3339-4582	Intramural Research Program of the NIH; National Cancer Institute; Center for Cancer Research; Division of Intramural Research, National Heart, Lung, and Blood Institute; National Institutes of Health (National Center for Research Resources) [2P41RR001081]; National Institutes of Health (National Institute of General Medical Sciences) [9P41GM103311]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005402, ZIAHL005401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103311] Funding Source: NIH RePORTER	Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Division of Intramural Research, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health (National Center for Research Resources)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health (National Institute of General Medical Sciences)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research and the Division of Intramural Research, National Heart, Lung, and Blood Institute. The Chimera software we used was developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco, with support from the National Institutes of Health (National Center for Research Resources grant 2P41RR001081, National Institute of General Medical Sciences grant 9P41GM103311). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Begitt A, 2014, NAT IMMUNOL, V15, P168, DOI 10.1038/ni.2794; BERGAD PL, 1995, J BIOL CHEM, V270, P24903, DOI 10.1074/jbc.270.42.24903; Chen XM, 2003, PROTEIN SCI, V12, P361, DOI 10.1110/ps.0218903; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; Dajee M, 1996, MOL ENDOCRINOL, V10, P171, DOI 10.1210/me.10.2.171; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; John S, 1999, MOL CELL BIOL, V19, P1910; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Lin JX, 2012, IMMUNITY, V36, P586, DOI 10.1016/j.immuni.2012.02.017; Moriggl R, 2005, CANCER CELL, V7, P87, DOI 10.1016/j.ccr.2004.12.010; Neculai D, 2005, J BIOL CHEM, V280, P40782, DOI 10.1074/jbc.M507682200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Shen Y, 2001, J VIROL, V75, P2627, DOI 10.1128/JVI.75.6.2627-2633.2001; Soldaini E, 2000, MOL CELL BIOL, V20, P389, DOI 10.1128/MCB.20.1.389-401.2000; Staab J, 2015, MOL IMMUNOL, V67, P596, DOI 10.1016/j.molimm.2015.07.015; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Timofeeva Olga A, 2012, JAKSTAT, V1, P274, DOI 10.4161/jkst.22313; Vinkemeier U, 1998, SCIENCE, V279, P1048, DOI 10.1126/science.279.5353.1048; Vinkemeier U, 1996, EMBO J, V15, P5616, DOI 10.1002/j.1460-2075.1996.tb00946.x; Wojciak JM, 2009, EMBO J, V28, P948, DOI 10.1038/emboj.2009.30; Xu XA, 1996, SCIENCE, V273, P794, DOI 10.1126/science.273.5276.794; Zhang XK, 2001, J BIOL CHEM, V276, P33576, DOI 10.1074/jbc.M104978200	24	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0160339	10.1371/journal.pone.0160339	http://dx.doi.org/10.1371/journal.pone.0160339			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537504	Green Published, gold, Green Submitted			2022-12-26	WOS:000381577000017
J	Beck, KK; Medeiros, AS; Finkelstein, SA				Beck, Kristen K.; Medeiros, Andrew S.; Finkelstein, Sarah A.			Drivers of Change in a 7300-Year Holocene Diatom Record from the Hemi-Boreal Region of Ontario, Canada	PLOS ONE			English	Article							EXPERIMENTAL LAKES AREA; OLD CROW FLATS; NORTHWESTERN ONTARIO; WATER DEPTH; CATCHMENT CHARACTERISTICS; LIMNOLOGICAL CONDITIONS; SOIL DEVELOPMENT; COASTAL WETLAND; NORTH-AMERICAN; FOREST FLOOR	A Holocene lake sediment record spanning the past 7300 years from Wishart Lake in the Turkey Lakes Watershed in the Hemi-Boreal of central Ontario, Canada, was used to evaluate the potential drivers of long-term change in diatom assemblages at this site. An analysis of diatom assemblages found that benthic and epiphytic taxa dominated the mid-Holocene (7300-4000 cal yr BP), indicating shallow, oligotrophic, circum-neutral conditions, with macrophytes present. A significant shift in diatom assemblages towards more planktonic species (mainly Cyclotella sensu lato, but also several species of Aulacoseira, and Tabellaria flocculosa) occurred similar to 4000 cal yr BP. This change likely reflects an increase in lake level, coincident with the onset of a more strongly positive moisture balance following the drier climates of the middle Holocene, established by numerous regional paleoclimate records. Pollen-inferred regional changes in vegetation around 4000 yrs BP, including an increase in Betula and other mesic taxa, may have also promoted changes in diatom assemblages through watershed processes mediated by the chemistry of runoff. A more recent significant change in limnological conditions is marked by further increases in Cyclotella sensu lato beginning in the late 19th century, synchronous with the Ambrosia pollen rise and increases in sediment bulk density, signaling regional and local land clearance at the time of Euro-Canadian settlement (1880 AD). In contrast to the mid-Holocene increase in planktonic diatoms, the modern increase in Cyclotella sensu lato likely indicates a response to land use and vegetation change, and erosion from the watershed, rather than a further increase in water level. The results from Wishart Lake illustrate the close connection between paleoclimate change, regional vegetation, watershed processes, and diatom assemblages and also provides insight into the controls on abundance of Cyclotella sensu lato, a diatom taxonomic group which has shown significant increases and complex dynamics in the postindustrial era in lakes spanning temperate to Arctic regions.	[Beck, Kristen K.] Univ Toronto, Dept Geog, Toronto, ON, Canada; [Medeiros, Andrew S.] York Univ, Dept Geog, Toronto, ON, Canada; [Finkelstein, Sarah A.] Univ Toronto, Dept Earth Sci, Toronto, ON, Canada; [Beck, Kristen K.] Univ Melbourne, Sch Geog, Melbourne, Vic, Australia	University of Toronto; York University - Canada; University of Toronto; University of Melbourne	Finkelstein, SA (corresponding author), Univ Toronto, Dept Earth Sci, Toronto, ON, Canada.	finkelstein@es.utoronto.ca	Beck, Kristen/Y-6561-2019; Medeiros, Andrew S./I-1947-2019; Finkelstein, Sarah/K-8202-2012	Beck, Kristen/0000-0002-8257-9639; Medeiros, Andrew S./0000-0002-7743-2560; Finkelstein, Sarah/0000-0002-8239-399X	Natural Sciences and Engineering Research Council of Canada [RGPIN 327197-11]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This study was funded by the Natural Sciences and Engineering Research Council of Canada (Discovery Grant RGPIN 327197-11 to SAF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almquist H, 2001, HOLOCENE, V11, P189, DOI 10.1191/095968301677768783; Antoniades D., 2008, ICONOGRAPHIA DIATOMO, V17, P1; Appleby PG, 2002, DEV PALEOENVIRON RES, V1, P171; Balasubramaniam AM, 2015, CAN J FISH AQUAT SCI, V72, P1058, DOI 10.1139/cjfas-2014-0340; Battarbee R. W., 2001, TRACKING ENV CHANGE, P155, DOI DOI 10.1007/0-306-47668-1_8; Beall FD, 2001, ECOSYSTEMS, V4, P514, DOI 10.1007/s10021-001-0025-0; Blaauw M, 2010, QUAT GEOCHRONOL, V5, P512, DOI 10.1016/j.quageo.2010.01.002; BRAIS S, 1995, FOREST ECOL MANAG, V76, P181, DOI 10.1016/0378-1127(95)03541-H; Brandt JP, 2009, ENVIRON REV, V17, P101, DOI 10.1139/A09-004; Brugam RB, 1998, J PALEOLIMNOL, V20, P267, DOI 10.1023/A:1007948616511; Bryant GA, 1975, THESIS; Catalan J, 2013, J PALEOLIMNOL, V49, P513, DOI 10.1007/s10933-013-9681-2; CROCKER RL, 1955, J ECOL, V43, P427, DOI 10.2307/2257005; Davis M, 2000, CONSERV BIOL, V14, P968, DOI 10.1046/j.1523-1739.2000.99219.x; Davis M.B., 1981, FOREST SUCCESSION CO, P132, DOI DOI 10.1007/978-1-4612-5950-3_10; DELORME LD, 1986, ARCH HYDROBIOL, V108, P1; Desellas AM, 2011, J LIMNOL, V70, P41, DOI 10.4081/jlimnol.2011.41; Duthie HC, 1996, J PALEOLIMNOL, V15, P79; Environment Canada, 1980, TURK LAK WAT MET DAT; Faegri K., 1975, Textbook of pollen analysis.; Fallu M.-A., 2000, FRESHWATER DIATOMS N, V45, P200; Finkelstein SA, 2006, QUATERNARY RES, V65, P33, DOI 10.1016/j.yqres.2005.08.021; Finkelstein SA, 2005, J PALEOLIMNOL, V33, P1, DOI 10.1007/s10933-004-0423-3; Fritz SC, 2013, J PALEOLIMNOL, V49, P349, DOI 10.1007/s10933-013-9684-z; Glew J, 1991, J PALEOLIMNOL, V5, P285, DOI DOI 10.1007/BF00200351; Harper NS, 1982, UNPUB; HARRISON SP, 1989, CLIM DYNAM, V3, P157; Heiri O, 2001, J PALEOLIMNOL, V25, P101, DOI 10.1023/A:1008119611481; Houk V, 2004, DIATOM RES, V19, P203; Huvane JK, 1996, J PALEOLIMNOL, V16, P323; JACOBSON GL, 1980, QUATERNARY RES, V14, P87, DOI 10.1016/0033-5894(80)90008-3; JEFFRIES DS, 1988, CAN J FISH AQUAT SCI, V45, P3; Juggins S., RIOJA R PACKAGE ANAL; Juggins S., 2003, C2 SOFTWARE FOR ECOL; Karmakar M, 2015, HOLOCENE, V25, P166, DOI 10.1177/0959683614556376; KELSO JRM, 1988, CAN J FISH AQUAT SCI, V45, P115; Kingston John C., 2003, P595, DOI 10.1016/B978-012741550-5/50017-9; KNUDSON BM, 1957, J ECOL, V45, P93, DOI 10.2307/2257078; Laird KR, 2008, QUATERNARY RES, V69, P292, DOI 10.1016/j.yqres.2007.11.003; Laird KR, 2011, QUATERNARY SCI REV, V30, P1201, DOI 10.1016/j.quascirev.2011.02.009; Lange-Beralot H, 1986, BACILLARIOPHYCEAE SU; Lavoie I., 2008, GUIDE IDENTIFICATION; LIU KB, 1990, ECOL MONOGR, V60, P179, DOI 10.2307/1943044; Mann ME, 2008, P NATL ACAD SCI USA, V105, P13252, DOI 10.1073/pnas.0805721105; McAndrews JH, 1993, PROXY CLIMATE DATA M, P22; McDowall D, 1984, STEEL AT THE SAULT; Medeiros AS, 2014, HOLOCENE, V24, P1308, DOI 10.1177/0959683614540955; Moos MT, 2011, QUATERNARY SCI REV, V30, P1232, DOI 10.1016/j.quascirev.2011.02.013; Moos MT, 2009, HOLOCENE, V19, P359, DOI 10.1177/0959683608101387; Moos MT, 2005, J PALEOLIMNOL, V34, P217, DOI 10.1007/s10933-005-2382-8; Moser K., 2004, ECOLOGY DISTRIBUTION; PARE D, 1993, J VEG SCI, V4, P811, DOI 10.2307/3235619; Patrick R.M., 1966, FRAGILARIACEAE EUNOT, V13, P1, DOI 10.2307/1351135; Pomeroy JW, 2006, HYDROL PROCESS, V20, P923, DOI 10.1002/hyp.6124; Prescott CE, 2000, CAN J FOREST RES, V30, P1742, DOI 10.1139/cjfr-30-11-1742; R Core Team, 2021, R LANGUAGE ENV STAT; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Ruhland KM, 2015, J PALEOLIMNOL, V54, P1, DOI 10.1007/s10933-015-9837-3; Ruhland K, 2008, GLOBAL CHANGE BIOL, V14, P2740, DOI 10.1111/j.1365-2486.2008.01670.x; SAARNISTO M, 1974, QUATERNARY RES, V4, P316, DOI 10.1016/0033-5894(74)90019-2; Saros JE, 2015, BIOL REV, V90, P522, DOI 10.1111/brv.12120; Shuman B, 2006, QUATERNARY RES, V65, P44, DOI 10.1016/j.yqres.2005.09.001; Shuman B, 2004, ECOLOGY, V85, P1297, DOI 10.1890/02-0286; Shuman B, 2001, QUATERNARY RES, V56, P401, DOI 10.1006/qres.2001.2273; Sirois A, 2001, ECOSYSTEMS, V4, P503, DOI 10.1007/s10021-001-0024-1; Smol JP, 2010, FRESHWATER BIOL, V55, P43, DOI 10.1111/j.1365-2427.2009.02373.x; Smol JP, 2005, P NATL ACAD SCI USA, V102, P4397, DOI 10.1073/pnas.0500245102; Sorvari S, 1998, J PALEOLIMNOL, V20, P205, DOI 10.1023/A:1007953515620; SREENIVASA MR, 1973, CAN J BOT, V51, P1599, DOI 10.1139/b73-204; St Jacques JM, 2008, J BIOGEOGR, V35, P306, DOI 10.1111/j.1365-2699.2007.01785.x; St Jacques JM, 2000, J PALEOLIMNOL, V23, P385, DOI 10.1023/A:1008178002326; Stewart KA, 2011, ARCTIC, V64, P169; Stuiver MP, 2013, CALIB 6 0; Turner KW, 2014, GLOBAL CHANGE BIOL, V20, P1585, DOI 10.1111/gcb.12465; Viau AE, 2009, J CLIMATE, V22, P316, DOI 10.1175/2008JCLI2342.1; Viau AE, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006031; Viau AE, 2001, J GEOPHYS RES-ATMOS, V106, P31703, DOI 10.1029/2000JD000237; Werner P, 2006, NOVA HEDWIGIA, P373; White MS, 2008, HYDROBIOLOGIA, V613, P21, DOI 10.1007/s10750-008-9469-y; WHITEHEAD D R, 1989, Journal of Paleolimnology, V2, P185; Wolfe AP, 2006, J PALEOLIMNOL, V36, P91, DOI 10.1007/s10933-006-0006-6; Wolin J. A., 2010, The diatoms: applications for the environmental and earth sciences, P174; Wolin JA, 2005, J PALEOLIMNOL, V33, P73, DOI 10.1007/s10933-004-1688-2; Woodside T, 1963, MARIE FOREST DISTRIC; WRIGHT HE, 1967, J SEDIMENT PETROL, V37, P975, DOI 10.1306/74D71807-2B21-11D7-8648000102C1865D; YANG JR, 1995, J GREAT LAKES RES, V21, P84, DOI 10.1016/S0380-1330(95)71023-1; Yu ZC, 1997, GEOLOGY, V25, P251, DOI 10.1130/0091-7613(1997)025<0251:MHDCCB>2.3.CO;2	87	5	5	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0159937	10.1371/journal.pone.0159937	http://dx.doi.org/10.1371/journal.pone.0159937			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532216	Green Published, Green Accepted, gold			2022-12-26	WOS:000381487600016
J	Tran, L; Hanavan, PD; Campbell, LE; De Filippis, E; Lake, DF; Coletta, DK; Roust, LR; Mandarino, LJ; Carroll, CC; Katsanos, CS				Tran, Lee; Hanavan, Paul D.; Campbell, Latoya E.; De Filippis, Elena; Lake, Douglas F.; Coletta, Dawn K.; Roust, Lori R.; Mandarino, Lawrence J.; Carroll, Chad C.; Katsanos, Christos S.			Prolonged Exposure of Primary Human Muscle Cells to Plasma Fatty Acids Associated with Obese Phenotype Induces Persistent Suppression of Muscle Mitochondrial ATP Synthase beta Subunit	PLOS ONE			English	Article							SKELETAL-MUSCLE; MESSENGER-RNA; INSULIN-RESISTANCE; PROTEIN-SYNTHESIS; 3'-UNTRANSLATED REGION; ARACHIDONIC-ACID; METABOLISM; HYPERAMINOACIDEMIA; HYPERINSULINEMIA; HYPERGLYCEMIA	Our previous studies show reduced abundance of the beta-subunit of mitochondrial H+-ATP synthase (beta-F1-ATPase) in skeletal muscle of obese individuals. The beta-F1-ATPase forms the catalytic core of the ATP synthase, and it is critical for ATP production in muscle. The mechanism(s) impairing beta-F1-ATPase metabolism in obesity, however, are not completely understood. First, we studied total muscle protein synthesis and the translation efficiency of beta-F1-ATPase in obese (BMI, 36 +/- 1 kg/m(2)) and lean (BMI, 22 +/- 1 kg/m(2)) subjects. Both total protein synthesis (0.044 +/- 0.006 vs 0.066 +/- 0.006%.h(-1)) and translation efficiency of beta-F1-ATPase (0.0031 +/- 0.0007 vs 0.0073 +/- 0.0004) were lower in muscle from the obese subjects when compared to the lean controls (P<0.05). We then evaluated these same responses in a primary cell culture model, and tested the specific hypothesis that circulating non-esterified fatty acids (NEFA) in obesity play a role in the responses observed in humans. The findings on total protein synthesis and translation efficiency of beta-F1-ATPase in primary myotubes cultured from a lean subject, and after exposure to NEFA extracted from serum of an obese subject, were similar to those obtained in humans. Among candidate microRNAs (i.e., non-coding RNAs regulating gene expression), we identified miR-127-5p in preventing the production of beta-F1-ATPase. Muscle expression of miR-127-5p negatively correlated with beta-F1-ATPase protein translation efficiency in humans (r = -0.6744; P<0.01), and could be modeled in vitro by prolonged exposure of primary myotubes derived from the lean subject to NEFA extracted from the obese subject. On the other hand, locked nucleic acid inhibitor synthesized to target miR-127-5p significantly increased beta-F1-ATPase translation efficiency in myotubes (0.6 +/- 0.1 vs 1.3 +/- 0.3, in control vs exposure to 50 nM inhibitor; P<0.05). Our experiments implicate circulating NEFA in obesity in suppressing muscle protein metabolism, and establish impaired beta-F1-ATPase translation as an important consequence of obesity.	[Tran, Lee; Hanavan, Paul D.; Campbell, Latoya E.; Lake, Douglas F.; Coletta, Dawn K.; Mandarino, Lawrence J.; Katsanos, Christos S.] Arizona State Univ, Ctr Metab & Vasc Biol, Scottsdale, AZ USA; [Tran, Lee; Hanavan, Paul D.; Campbell, Latoya E.; Lake, Douglas F.; Coletta, Dawn K.; Mandarino, Lawrence J.; Katsanos, Christos S.] Mayo Clin Arizona, Scottsdale, AZ USA; [Coletta, Dawn K.; Mandarino, Lawrence J.] Arizona State Univ, Coll Hlth Solut, Phoenix, AZ USA; [Tran, Lee; Hanavan, Paul D.; Campbell, Latoya E.; Lake, Douglas F.; Katsanos, Christos S.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [De Filippis, Elena; Roust, Lori R.; Mandarino, Lawrence J.] Mayo Clin, Dept Med, Scottsdale, AZ USA; [Carroll, Chad C.] Midwestern Univ, Dept Physiol, Glendale, AZ USA	Arizona State University; Mayo Clinic; Mayo Clinic Phoenix; Arizona State University; Arizona State University-Downtown Phoenix; Arizona State University; Arizona State University-Tempe; Mayo Clinic; Mayo Clinic Phoenix; Midwestern University	Katsanos, CS (corresponding author), Arizona State Univ, Ctr Metab & Vasc Biol, Scottsdale, AZ USA.; Katsanos, CS (corresponding author), Mayo Clin Arizona, Scottsdale, AZ USA.; Katsanos, CS (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ USA.	christos.katsanos@asu.edu	Tran, Lee/AAZ-7340-2020	Tran, Lee/0000-0001-9074-6495	NIH/National Institute of Diabetes and Digestive and Kidney Diseases [DK094062]; Mayo Clinic Metabolomics Core grants [U24DK100469, UL1TR000135]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094062, R01DK094013] Funding Source: NIH RePORTER	NIH/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Mayo Clinic Metabolomics Core grants; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the NIH/National Institute of Diabetes and Digestive and Kidney Diseases grant DK094062 to CSK. Also, Mayo Clinic Metabolomics Core grants U24DK100469 and UL1TR000135.	Antwi K, 2009, MOL IMMUNOL, V46, P2931, DOI 10.1016/j.molimm.2009.06.021; Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; Cardel M, 2015, J NUTR, V145, P2146, DOI 10.3945/jn.115.212365; Carroll CC, 2005, AM J PHYSIOL-ENDOC M, V288, pE479, DOI 10.1152/ajpendo.00393.2004; Chevalier S, 2015, OBESITY, V23, P351, DOI 10.1002/oby.20943; Corcoran MP, 2007, AM J CLIN NUTR, V85, P662; Delarue J, 2007, CURR OPIN CLIN NUTR, V10, P142, DOI 10.1097/MCO.0b013e328042ba90; Fabian MR, 2012, NAT STRUCT MOL BIOL, V19, P586, DOI 10.1038/nsmb.2296; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Gayoso-Diz P, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-47; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Guillet C, 2011, CURR OPIN CLIN NUTR, V14, P89, DOI 10.1097/MCO.0b013e328341389e; Guillet C, 2009, J CLIN ENDOCR METAB, V94, P3044, DOI 10.1210/jc.2008-2216; Hojlund K, 2010, DIABETOLOGIA, V53, P541, DOI 10.1007/s00125-009-1624-0; HUGHES SM, 1993, DEVELOPMENT, V118, P1137; Hussey SE, 2013, MED SCI SPORT EXER, V45, P1069, DOI 10.1249/MSS.0b013e3182814917; Hwang H, 2010, DIABETES, V59, P33, DOI 10.2337/db09-0214; Izquierdo JM, 2000, BIOCHEM J, V346, P849, DOI 10.1042/0264-6021:3460849; Katchman BA, 2011, MOL CANCER RES, V9, P1621, DOI 10.1158/1541-7786.MCR-11-0018; Katsanos CS, 2008, NUTR RES, V28, P651, DOI 10.1016/j.nutres.2008.06.007; Katsanos CS, 2011, OBESITY, V19, P469, DOI 10.1038/oby.2010.290; Katsanos CS, 2009, J CLIN ENDOCR METAB, V94, P2984, DOI 10.1210/jc.2008-2686; KOISHI K, 1995, DEV DYNAM, V202, P244, DOI 10.1002/aja.1002020304; Krarnarova TV, 2008, BBA-BIOENERGETICS, V1777, P747, DOI 10.1016/j.bbabio.2008.05.446; Kristensen AR, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.47; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lang CH, 2006, AM J PHYSIOL-ENDOC M, V291, pE666, DOI 10.1152/ajpendo.00065.2006; Tran L, 2013, J GERONTOL A-BIOL, V68, P1045, DOI 10.1093/gerona/glt106; Markworth JF, 2013, AM J PHYSIOL-CELL PH, V304, pC56, DOI 10.1152/ajpcell.00038.2012; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI [10.1001/jama.289.1.76, DOI 10.1001/JAMA.289.1.76]; Newcomer B, 2001, INT J OBESITY, V25, P1309, DOI 10.1038/sj.ijo.0801673; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Persson XMT, 2010, J LIPID RES, V51, P2761, DOI 10.1194/jlr.M008011; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Reyes R, 2007, BIOCHEM BIOPH RES CO, V357, P1107, DOI 10.1016/j.bbrc.2007.04.088; RODEMANN HP, 1982, J BIOL CHEM, V257, P1632; Simoes AES, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-181; Smith GI, 2011, CLIN SCI, V121, P267, DOI 10.1042/CS20100597; Szendroedi J, 2007, PLOS MED, V4, P858, DOI 10.1371/journal.pmed.0040154; Tanner CJ, 2002, AM J PHYSIOL-ENDOC M, V282, pE1191, DOI 10.1152/ajpendo.00416.2001; Tardif N, 2014, AGING CELL, V13, P1001, DOI 10.1111/acel.12263; Tran L, 2015, MOL PSYCHIATR, V20, P1219, DOI 10.1038/mp.2014.122; Tran L, 2013, PSYCHONEUROENDOCRINO, V38, P898, DOI 10.1016/j.psyneuen.2012.09.016; Tran L, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12479; Velica P, 2011, MUSCLE NERVE, V44, P366, DOI 10.1002/mus.22056; VOYTIK SL, 1993, DEV DYNAM, V198, P214, DOI 10.1002/aja.1001980307; Wang CJ, 2014, DIABETES, V63, P947, DOI 10.2337/db13-1096; Willers IM, 2012, BBA-BIOENERGETICS, V1817, P838, DOI 10.1016/j.bbabio.2012.03.005; Willers IM, 2011, BBA-BIOENERGETICS, V1807, P543, DOI 10.1016/j.bbabio.2010.10.016; Zabielski P, 2013, J MASS SPECTROM, V48, P269, DOI 10.1002/jms.3120; Zheng SQ, 2011, ANTIVIR RES, V89, P219, DOI 10.1016/j.antiviral.2011.01.008	51	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160057	10.1371/journal.pone.0160057	http://dx.doi.org/10.1371/journal.pone.0160057			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532680	Green Submitted, Green Published, gold			2022-12-26	WOS:000381487600022
J	Wang, XF; Liu, DX; Liang, Y; Xing, LL; Zhao, WH; Qin, XX; Shang, DS; Li, B; Fang, WG; Cao, L; Zhao, WD; Chen, YH				Wang, Xia-Fei; Liu, Dong-Xin; Liang, Yue; Xing, Li-Li; Zhao, Wen-Hui; Qin, Xiao-Xue; Shang, De-Shu; Li, Bo; Fang, Wen-Gang; Cao, Liu; Zhao, Wei-Dong; Chen, Yu-Hua			Cystatin C Shifts APP Processing from Amyloid-beta Production towards Non-Amyloidgenic Pathway in Brain Endothelial Cells	PLOS ONE			English	Article							PRECURSOR PROTEIN PROTECT; ALZHEIMERS-DISEASE; SECRETED FORMS; UP-REGULATION; MACULAR DEGENERATION; GENE-EXPRESSION; GAMMA-SECRETASE; MOUSE MODELS; PEPTIDE; NEURONS	Amyloid-beta (A beta), the major component of neuritic plaques in Alzheimer's disease (AD), is derived from sequential proteolytic cleavage of amyloid protein precursor (APP) by secretases. In this study, we found that cystatin C (CysC), a natural cysteine protease inhibitor, is able to reduce A beta 40 secretion in human brain microvascular endothelial cells (HBMEC). The CysC-induced A beta 40 reduction was caused by degradation of beta-secretase BACE1 through the ubiquitin/proteasome pathway. In contrast, we found that CysC promoted secretion of soluble APP alpha indicating the activated non-amyloidogenic processing of APP in HBMEC. Further results revealed that a-secretase ADAM10, which was transcriptionally upregulated in response to CysC, was required for the CysC-induced sAPP alpha secretion. Knockdown of SIRT1 abolished CysC-triggered ADAM10 upregulation and sAPP alpha production. Taken together, our results demonstrated that exogenously applied CysC can direct amyloidogenic APP processing to non-amyloidgenic pathway in brain endothelial cells, mediated by proteasomal degradation of BACE1 and SIRT1-mediated ADAM10 upregulation. Our study unveils previously unrecognized protective role of CysC in APP processing.	[Zhao, Wei-Dong; Chen, Yu-Hua] China Med Univ, Minist Publ Hlth, Key Lab Cell Biol, Dept Dev Cell Biol, 77 Puhe Rd, Shenyang 110122, Peoples R China; China Med Univ, Minist Educ, Key Lab Med Cell Biol, 77 Puhe Rd, Shenyang 110122, Peoples R China	China Medical University; China Medical University	Zhao, WD; Chen, YH (corresponding author), China Med Univ, Minist Publ Hlth, Key Lab Cell Biol, Dept Dev Cell Biol, 77 Puhe Rd, Shenyang 110122, Peoples R China.	wdzhao@163.com; yhchen@mail.cmu.edu.cn			National Natural Science Foundation of China [30970120, 31171291, 31571057, 81171537, 81201255]; Innovation Team Program Foundation of Ministry of Education of China [IRT13101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Team Program Foundation of Ministry of Education of China(Ministry of Education, China)	This work was supported by National Natural Science Foundation of China (30970120, 31171291, 31571057, 81171537, 81201255) and the Innovation Team Program Foundation of Ministry of Education of China (IRT13101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attems J, 2010, J NEUROL SCI, V299, P155, DOI 10.1016/j.jns.2010.08.030; Austin SA, 2010, CIRC RES, V107, P1498, DOI 10.1161/CIRCRESAHA.110.233080; Bai Y, 2008, MOL CELL PROTEOMICS, V7, P15, DOI 10.1074/mcp.M700077-MCP200; Butler JM, 2015, HUM GENET, V134, P705, DOI 10.1007/s00439-015-1552-7; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; Deane R, 2004, NEURON, V43, P333, DOI 10.1016/j.neuron.2004.07.017; Deng A, 2001, AM J PATHOL, V159, P1061, DOI 10.1016/S0002-9440(10)61781-6; Farzan M, 2000, P NATL ACAD SCI USA, V97, P9712, DOI 10.1073/pnas.160115697; Gauthier Sebastien, 2011, Front Biosci (Schol Ed), V3, P541, DOI 10.2741/s170; Gong B, 2013, NEUROBIOL AGING, V34, P1581, DOI 10.1016/j.neurobiolaging.2012.12.005; GOODMAN Y, 1994, EXP NEUROL, V128, P1, DOI 10.1006/exnr.1994.1107; Greenberg SA, 2004, STROKE, V35, P2616, DOI 10.1161/01.str.0000143224.36527.44; Hansson SF, 2009, J ALZHEIMERS DIS, V16, P389, DOI 10.3233/JAD-2009-0966; Jorissen E, 2010, J NEUROSCI, V30, P4833, DOI 10.1523/JNEUROSCI.5221-09.2010; Kaeser SA, 2007, NAT GENET, V39, P1437, DOI 10.1038/ng.2007.23; Kitazume S, 2010, J BIOL CHEM, V285, P40097, DOI 10.1074/jbc.M110.144626; Koh YH, 2005, J BIOL CHEM, V280, P32499, DOI 10.1074/jbc.M506199200; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Lee HR, 2014, J NEUROSCI RES, V92, P1581, DOI 10.1002/jnr.23421; Liu YB, 2010, NUCLEIC ACIDS RES, V38, P6857, DOI 10.1093/nar/gkq585; Lukasiuk K, 2002, EPILEPSIA, V43, P137, DOI 10.1046/j.1528-1157.43.s.5.20.x; Martinez-Vargas M, 2014, INT J MOL SCI, V15, P5807, DOI 10.3390/ijms15045807; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; Mi W, 2007, NAT GENET, V39, P1440, DOI 10.1038/ng.2007.29; Palsdottir A, 2006, BRAIN PATHOL, V16, P55; Pawlik M, 2004, J MOL NEUROSCI, V22, P13, DOI 10.1385/JMN:22:1-2:13; Peng Y, 2011, NEUROSCI LETT, V487, P211, DOI 10.1016/j.neulet.2010.10.025; Qing H, 2004, FASEB J, V18, P1571, DOI 10.1096/fj.04-1994fje; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; Sant'Anna R, 2016, FEBS LETT, V590, P644, DOI 10.1002/1873-3468.12093; Sastre M, 2004, NEUROBIOL AGING, V25, P1033, DOI 10.1016/j.neurobiolaging.2003.11.006; Scheltens P., 2016, LANCET; Selenica ML, 2007, SCAND J CLIN LAB INV, V67, P179, DOI 10.1080/00365510601009738; Shen CY, 2008, J BIOL CHEM, V283, P17721, DOI 10.1074/jbc.M800013200; Singh AK, 2015, AGING CELL, V14, P595, DOI 10.1111/acel.12335; SMITHSWINTOSKY VL, 1994, J NEUROCHEM, V63, P781, DOI 10.1046/j.1471-4159.1994.63020781.x; Sun BG, 2008, NEURON, V60, P247, DOI 10.1016/j.neuron.2008.10.001; Tamagno E, 2012, IUBMB LIFE, V64, P943, DOI 10.1002/iub.1099; Tarasoff-Conway JM, 2015, NAT REV NEUROL, V11, P457, DOI 10.1038/nrneurol.2015.119; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Tizon B, 2010, J ALZHEIMERS DIS, V19, P885, DOI 10.3233/JAD-2010-1291; Tong Y, 2005, J NEURAL TRANSM, V112, P455, DOI 10.1007/s00702-004-0255-3; Turk V, 2008, FRONT BIOSCI-LANDMRK, V13, P5406, DOI 10.2741/3089; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; WOLF BA, 1995, J BIOL CHEM, V270, P4916, DOI 10.1074/jbc.270.9.4916; Yamada Toshiyuki, 2002, Rinsho Byori, V50, P613; Yan RQ, 2014, LANCET NEUROL, V13, P319, DOI 10.1016/S1474-4422(13)70276-X; Zhang YW, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-3; Zhao YH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015816, 10.1371/journal.pone.0016470]	51	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161093	10.1371/journal.pone.0161093	http://dx.doi.org/10.1371/journal.pone.0161093			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532339	gold, Green Published, Green Submitted			2022-12-26	WOS:000381487600058
J	Diaz-Garcia, L; Covarrubias-Pazaran, G; Schlautman, B; Zalapa, J				Diaz-Garcia, Luis; Covarrubias-Pazaran, Giovanny; Schlautman, Brandon; Zalapa, Juan			GiNA, an Efficient and High-Throughput Software for Horticultural Phenotyping	PLOS ONE			English	Article							IMAGE-ANALYSIS; PHENOMICS; RESPONSES; CRANBERRY; DEFECTS; GROWTH; RICE	Traditional methods for trait phenotyping have been a bottleneck for research in many crop species due to their intensive labor, high cost, complex implementation, lack of reproducibility and propensity to subjective bias. Recently, multiple high-throughput phenotyping platforms have been developed, but most of them are expensive, species-dependent, complex to use, and available only for major crops. To overcome such limitations, we present the open-source software GiNA, which is a simple and free tool for measuring horticultural traits such as shape-and color-related parameters of fruits, vegetables, and seeds. GiNA is multi-platform software available in both R and MATLAB (R) programming languages and uses conventional images from digital cameras with minimal requirements. It can process up to 11 different horticultural morphological traits such as length, width, two-dimensional area, volume, projected skin, surface area, RGB color, among other parameters. Different validation tests produced highly consistent results under different lighting conditions and camera setups making GiNA a very reliable platform for high-throughput phenotyping. In addition, fivefold cross validation between manually generated and GiNA measurements for length and width in cranberry fruits were 0.97 and 0.92. In addition, the same strategy yielded prediction accuracies above 0.83 for color estimates produced from images of cranberries analyzed with GiNA compared to total anthocyanin content (TAcy) of the same fruits measured with the standard methodology of the industry. Our platform provides a scalable, easy-to-use and affordable tool for massive acquisition of phenotypic data of fruits, seeds, and vegetables.	[Diaz-Garcia, Luis; Covarrubias-Pazaran, Giovanny; Schlautman, Brandon; Zalapa, Juan] Univ Wisconsin, Dept Hort, 1575 Linden Dr, Madison, WI 53706 USA; [Diaz-Garcia, Luis] Inst Nacl Invest Forest & Agr & Pecuarias, Aguascalientes, Mexico; [Zalapa, Juan] Univ Wisconsin, USDA ARS, Vegetable Crops Res Unit, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of Agriculture (USDA); University of Wisconsin System; University of Wisconsin Madison	Diaz-Garcia, L; Zalapa, J (corresponding author), Univ Wisconsin, Dept Hort, 1575 Linden Dr, Madison, WI 53706 USA.; Diaz-Garcia, L (corresponding author), Inst Nacl Invest Forest & Agr & Pecuarias, Aguascalientes, Mexico.; Zalapa, J (corresponding author), Univ Wisconsin, USDA ARS, Vegetable Crops Res Unit, Madison, WI 53706 USA.	diaz.antonio@inifap.gob.mx; jezalapa@wisc.edu		Schlautman, Brandon/0000-0002-9983-259X; COVARRUBIAS-PAZARAN, GIOVANNY/0000-0002-7194-3837	USDA-ARS [3655-21220-001-00]; WI-DATCP (SCBG Project) [14-002]; National Science Foundation [DBI-1228280]; Ocean Spray Cranberries, Inc.; Wisconsin Cranberry Growers Association; Cranberry Institute; Frank B. Koller Cranberry Fellowship for Graduate Students; Consejo Nacional de Ciencia y Tecnologia (CONACYT, Mexico)	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); WI-DATCP (SCBG Project); National Science Foundation(National Science Foundation (NSF)); Ocean Spray Cranberries, Inc.; Wisconsin Cranberry Growers Association; Cranberry Institute; Frank B. Koller Cranberry Fellowship for Graduate Students; Consejo Nacional de Ciencia y Tecnologia (CONACYT, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This project was supported by USDA-ARS (project no. 3655-21220-001-00 provided to JZ); WI-DATCP (SCBG Project #14-002); National Science Foundation (DBI-1228280); Ocean Spray Cranberries, Inc.; Wisconsin Cranberry Growers Association; Cranberry Institute. BS was supported by the Frank B. Koller Cranberry Fellowship for Graduate Students. GCP and LDG were supported by the Consejo Nacional de Ciencia y Tecnologia (CONACYT, Mexico). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; J.Z. and B.S. wish to express their gratitude through Mt 10:32. We wish to thank Bill Hatch, Nicole Hansen, and Leah Hyatt from Cranberry Creek Cranberries Inc. for allowing us to harvest the cranberry samples used to validate GiNA. Also, thank Eric Wiesman, Walter Salazar, Yiwen Ge and Sarah Hodapp for their help in taking pictures and processing fruit samples. This project was supported by USDA-ARS (project no. 3655-21220-001-00 provided to J.Z.); WI-DATCP (SCBG Project #14-002); National Science Foundation (DBI-1228280); Ocean Spray Cranberries, Inc.; Wisconsin Cranberry Growers Association; Cranberry Institute. B.S. was supported by the Frank B. Koller Cranberry Fellowship for Graduate Students. GCP and LDG were supported by the Consejo Nacional de Ciencia y Tecnologia (CONACYT, Mexico). We thank to the anonymous reviewers who helped to enhance the quality of this paper.	Aggelopoulou AD, 2011, PRECIS AGRIC, V12, P448, DOI 10.1007/s11119-010-9187-0; Bac-Molenaar JA, 2015, J EXP BOT, V66, P5567, DOI 10.1093/jxb/erv176; Berge TW, 2012, COMPUT ELECTRON AGR, V81, P79, DOI 10.1016/j.compag.2011.11.004; Busemeyer L, 2013, SCI REP-UK, V3, DOI 10.1038/srep02442; Campbell MT, 2015, PLANT PHYSIOL, V168, P1476, DOI 10.1104/pp.15.00450; Chen DJ, 2014, PLANT CELL, V26, P4636, DOI 10.1105/tpc.114.129601; Chern CG, 2011, METHODS MOL BIOL, V678, P129, DOI 10.1007/978-1-60761-682-5_10; ElMasry G, 2007, J FOOD ENG, V81, P98, DOI 10.1016/j.jfoodeng.2006.10.016; Gonzalo MJ, 2008, THEOR APPL GENET, V116, P647, DOI 10.1007/s00122-007-0698-7; Houle D, 2010, NAT REV GENET, V11, P855, DOI 10.1038/nrg2897; Kleynen O, 2005, J FOOD ENG, V69, P41, DOI 10.1016/j.jfoodeng.2004.07.008; Li L, 2014, SENSORS-BASEL, V14, P20078, DOI 10.3390/s141120078; Lopez-Garcia F, 2010, COMPUT ELECTRON AGR, V71, P189, DOI 10.1016/j.compag.2010.02.001; Omasa K, 2007, J EXP BOT, V58, P881, DOI 10.1093/jxb/erl142; Rakun J, 2011, COMPUT ELECTRON AGR, V76, P80, DOI 10.1016/j.compag.2011.01.007; Taghadomi-Saberi S, 2015, J AGR SCI TECH-IRAN, V17, P589; Vorsa N, 2003, J AM SOC HORTIC SCI, V128, P691, DOI 10.21273/JASHS.128.5.0691; Walter A, 2015, PLANT METHODS, V11, DOI 10.1186/s13007-015-0056-8; White JW, 2012, FIELD CROP RES, V133, P101, DOI 10.1016/j.fcr.2012.04.003; Zhou Y, 2002, PLANT GROWTH REGUL, V38, P165, DOI 10.1023/A:1021322418740	20	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160439	10.1371/journal.pone.0160439	http://dx.doi.org/10.1371/journal.pone.0160439			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529547	Green Submitted, Green Published, gold			2022-12-26	WOS:000381476700006
J	Juffe-Bignoli, D; Brooks, TM; Butchart, SHM; Jenkins, RB; Boe, K; Hoffmann, M; Angulo, A; Bachman, S; Bohm, M; Brummitt, N; Carpenter, KE; Comer, PJ; Cox, N; Cuttelod, A; Darwall, WRT; Di Marco, M; Fishpool, LDC; Goettsch, B; Heath, M; Hilton-Taylor, C; Hutton, J; Johnson, T; Joolia, A; Keith, DA; Langhammer, PF; Luedtke, J; Lughadha, EN; Lutz, M; May, I; Miller, RM; Oliveira-Mrinda, MA; Parr, M; Pollock, CM; Ralph, G; Rodriguez, JP; Rondinini, C; Smart, J; Stuart, S; Symes, A; Tordoff, AW; Woodley, S; Young, B; Kingston, N				Juffe-Bignoli, Diego; Brooks, Thomas M.; Butchart, Stuart H. M.; Jenkins, Richard B.; Boe, Kaia; Hoffmann, Michael; Angulo, Ariadne; Bachman, Steve; Bohm, Monika; Brummitt, Neil; Carpenter, Kent E.; Comer, Pat J.; Cox, Neil; Cuttelod, Annabelle; Darwall, William R. T.; Di Marco, Moreno; Fishpool, Lincoln D. C.; Goettsch, Barbara; Heath, Melanie; Hilton-Taylor, Craig; Hutton, Jon; Johnson, Tim; Joolia, Ackbar; Keith, David A.; Langhammer, Penny F.; Luedtke, Jennifer; Lughadha, Eimear Nic; Lutz, Maiko; May, Ian; Miller, Rebecca M.; Oliveira-Mrinda, Maria A.; Parr, Mike; Pollock, Caroline M.; Ralph, Gina; Rodriguez, Jon Paul; Rondinini, Carlo; Smart, Jane; Stuart, Simon; Symes, Andy; Tordoff, Andrew W.; Woodley, Stephen; Young, Bruce; Kingston, Naomi			Assessing the Cost of Global Biodiversity and Conservation Knowledge	PLOS ONE			English	Article							BAROMETER; PROGRESS; TARGETS; SCIENCE; SITES	Knowledge products comprise assessments of authoritative information supported by standards, governance, quality control, data, tools, and capacity building mechanisms. Considerable resources are dedicated to developing and maintaining knowledge products for biodiversity conservation, and they are widely used to inform policy and advise decision makers and practitioners. However, the financial cost of delivering this information is largely undocumented. We evaluated the costs and funding sources for developing and maintaining four global biodiversity and conservation knowledge products: The IUCN Red List of Threatened Species, the IUCN Red List of Ecosystems, Protected Planet, and the World Database of Key Biodiversity Areas. These are secondary data sets, built on primary data collected by extensive networks of expert contributors worldwide. We estimate that US$160 million (range: US$116-204 million), plus 293 person-years of volunteer time (range: 278308 person-years) valued at US$14 million (range US$12-16 million), were invested in these four knowledge products between 1979 and 2013. More than half of this financing was provided through philanthropy, and nearly three-quarters was spent on personnel costs. The estimated annual cost of maintaining data and platforms for three of these knowledge products (excluding the IUCN Red List of Ecosystems for which annual costs were not possible to estimate for 2013) is US$6.5 million in total (range: US$6.2-6.7 million). We estimated that an additional US$114 million will be needed to reach pre-defined baselines of data coverage for all the four knowledge products, and that once achieved, annual maintenance costs will be approximately US$12 million. These costs are much lower than those to maintain many other, similarly important, global knowledge products. Ensuring that biodiversity and conservation knowledge products are sufficiently up to date, comprehensive and accurate is fundamental to inform decision-making for biodiversity conservation and sustainable development. Thus, the development and implementation of plans for sustainable long-term financing for them is critical.	[Juffe-Bignoli, Diego; Hoffmann, Michael; Hutton, Jon; Johnson, Tim; Stuart, Simon; Kingston, Naomi] UNESP WCMC, United Nations Environm Programme, 219 Huntingdon Rd, Cambridge CB3 0DL, England; [Brooks, Thomas M.; Butchart, Stuart H. M.; Hoffmann, Michael; Smart, Jane; Stuart, Simon] IUCN, 28 Rue Mauverney, CH-1196 Gland, Switzerland; [Brooks, Thomas M.] Univ Philippines Banos, World Agroforestry Ctr ICRAF, Laguna 4031, Philippines; [Brooks, Thomas M.] Univ Tasmania, Inst Marine & Antarct Studies, Hobart, Tas 7001, Australia; [Butchart, Stuart H. M.; Fishpool, Lincoln D. C.; Heath, Melanie; May, Ian; Symes, Andy] BirdLife Int, David Attenborough Bldg,Pembroke St, Cambridge CB2 3QZ, England; [Butchart, Stuart H. M.] Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England; [Jenkins, Richard B.; Cuttelod, Annabelle; Darwall, William R. T.; Goettsch, Barbara; Hilton-Taylor, Craig; Joolia, Ackbar; Pollock, Caroline M.] IUCN Global Species Programme, David Attenborough Bldg,Pembroke St, Cambridge CB2 3QZ, England; [Boe, Kaia; Miller, Rebecca M.] IUCN, Nature Based Solut Grp, 28 Rue Mauverney, CH-1196 Gland, Switzerland; [Angulo, Ariadne; Luedtke, Jennifer] IUCN Species Survival Commiss, Amphibian Specialist Grp, Toronto, ON M8W 1R2, Canada; [Bachman, Steve; Lughadha, Eimear Nic; Lutz, Maiko] Royal Bot Gardens, Richmond TW9 3AB, Surrey, England; [Bohm, Monika] Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England; [Brummitt, Neil] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England; [Carpenter, Kent E.; Ralph, Gina] Old Domin Univ, IUCN Marine Biodivers Unit, Global Species Programme Biol Sci, Norfolk, VA USA; [Cox, Neil] Conservat Int, IUCN Global Species Programme, IUCN CI Biodivers Assessment, 2011 Crystal Dr,Suite 500, Arlington, VA 22202 USA; [Di Marco, Moreno] Univ Queensland, Ctr Biodivers & Conservat Sci, ARC Ctr Excellence Environm Decis, Brisbane, Qld 4072, Australia; [Di Marco, Moreno] Univ Queensland, Sch Geog Planning & Environm Management, Brisbane, Qld 4072, Australia; [Hutton, Jon] WWF Int, Luc Hoffmann Inst, CH-1196 Gland, Switzerland; [Keith, David A.] Univ New S Wales, Ctr Ecosyst Sci, Sydney, NSW 2052, Australia; [Langhammer, Penny F.] Arizona State Univ, Sch Life Sci, POB 874501, Tempe, AZ 85287 USA; [Miller, Rebecca M.] IUCN Global Ecosyst Management Programme, David Attenborough Bldg,Pembroke St, Cambridge CB2 3QZ, England; [Oliveira-Mrinda, Maria A.; Rodriguez, Jon Paul] Provita, Apdo 47552, Caracas 1041A, Venezuela; [Rodriguez, Jon Paul] Inst Venezolano Invest Cient, Ctr Ecol, Apdo 20632, Caracas 1020A, Venezuela; [Rondinini, Carlo] Sapienza Univ Rome, Dept Biol & Biotechnol, Global Mammal Assessment Program, Viale Univ 32, I-00185 Rome, Italy; [Smart, Jane] IUCN, Biodivers Conservat Grp, 28 Rue Mauverney, CH-1196 Gland, Switzerland; [Tordoff, Andrew W.] Crit Ecosyst Partnership Fund, 2011 Crystal Dr,Suite 500, Arlington, VA 22202 USA; [Woodley, Stephen] World Commiss Protected Areas IUCN, 64 Juniper Rd, Chelsea, PQ J9B 1T3, Canada; [Comer, Pat J.; Young, Bruce] NatureServe, 4600 N Fairfax Dr, Arlington, VA 22203 USA; [Parr, Mike] Amer Bird Conservancy, 1731 Connecticut Ave, Washington, DC 20009 USA; [Keith, David A.] New South Wales Off Environm & Heritage, Hurstville, NSW 2220, Australia	CGIAR; World Agroforestry (ICRAF); University of the Philippines System; University of the Philippines Los Banos; University of Tasmania; BirdLife International; University of Cambridge; Royal Botanic Gardens, Kew; Zoological Society of London; Natural History Museum London; Old Dominion University; Conservation International; University of Queensland; University of Queensland; World Wildlife Fund; University of New South Wales Sydney; Arizona State University; Arizona State University-Tempe; Venezuelan Institute Science Research; Sapienza University Rome; Nature Conservancy; Office of Environment & Heritage - New South Wales	Juffe-Bignoli, D (corresponding author), UNESP WCMC, United Nations Environm Programme, 219 Huntingdon Rd, Cambridge CB3 0DL, England.	diego.juffe-bignoli@unep-wcmc.org	Butchart, Stuart/AAJ-1852-2021; Di Marco, Moreno/J-4285-2012; Hoffmann, Michael/E-6419-2010; Böhm, Monika/E-1153-2018; Rodriguez, Jon P/A-1491-2009; Rondinini, Carlo/E-9027-2011; Butchart, Stuart HM/Y-2711-2018; Woodley, Stephen/AAA-1985-2021; Rodriguez, Jon P/G-7224-2012; Nic Lughadha, Eimear/N-4560-2014	Butchart, Stuart/0000-0002-1140-4049; Di Marco, Moreno/0000-0002-8902-4193; Hoffmann, Michael/0000-0003-4785-2254; Böhm, Monika/0000-0003-0585-0832; Rodriguez, Jon P/0000-0001-5019-2870; Woodley, Stephen/0000-0003-3074-6578; Nic Lughadha, Eimear/0000-0002-8806-4345; Lutz, Maiko/0000-0002-6695-8380; Bachman, Steven/0000-0003-1085-6075; Comer, Patrick/0000-0002-5869-2105; Rondinini, Carlo/0000-0002-6617-018X; Keith, David/0000-0002-7627-4150	MAVA foundation; Integrated Biodiversity Assessment Tool (IBAT); National Science Foundation's Dimensions of Biodiversity program [1136586]; Rufford Foundation; Integrated Biodiversity Assessment Tool (IBAT) Partnership; Direct For Biological Sciences [1136586] Funding Source: National Science Foundation	MAVA foundation; Integrated Biodiversity Assessment Tool (IBAT); National Science Foundation's Dimensions of Biodiversity program(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Rufford Foundation; Integrated Biodiversity Assessment Tool (IBAT) Partnership; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the MAVA foundation: http://en.mava-foundation.org/ (TMB), Integrated Biodiversity Assessment Tool (IBAT): https://www.ibatforbusiness.org/ (DJ), National Science Foundation's Dimensions of Biodiversity program: http://www.nsf.gov/; award 1136586 (BY), the Rufford Foundation: http://www.rufford.org/ (MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the funders of this study, the MAVA Foundation and the Integrated Biodiversity Assessment Tool (IBAT) Partnership. NatureServe acknowledges support from the National Science Foundation's Dimensions of Biodiversity program (award 1136586). MB received continued funding from the Rufford Foundation. The Red List Unit would like to thank the MAVA Foundation, the Rufford Foundation, the Environment Agency Abu Dhabi, the European Commission and the Critical Ecosystem Partnership Fund. We are also grateful to: John Pilgrim, Trevor Sandwith, Pedro Rosabal, Kathy MacKinnon, Sarah Wyatt, Jerry Harrison, Brian MacSharry, Yichuan Shi, Mat Jones, Soyoung Park, Sylvia Wicander, Florent Latil, Enrique Lahmann and all the many thousands of individuals and organisations who contribute to the creation and maintenance of the four knowledge products assessed.	[Anonymous], 2010, 10 M C PART CONV BIO; [Anonymous], 2011, ECONOMIST; [Anonymous], 2014, PARKS, DOI DOI 10.1111/1365-2664.13060; Armsworth PR, 2014, ANN NY ACAD SCI, V1322, P61, DOI 10.1111/nyas.12455; Balmford A, 1999, NATURE, V398, P204, DOI 10.1038/18339; Berendsohn WG, 2011, ZOOKEYS, P71, DOI 10.3897/zookeys.150.2166; Birdlife, 2014, IMPORTANT BIRD BIODI; Bland LM, 2015, J APPL ECOL, V52, P861, DOI 10.1111/1365-2664.12459; Bohm M, 2015, CONSERV BIOL, V29, P1290, DOI 10.1111/cobi.12529; Bowles-Newark N. J., 2014, INCORPORATING UTILIS; Brooks TM, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.7; Brooks Thomas M., 2015, BIODIVERSITY-OTTAWA, V16, P157, DOI 10.1080/14888386.2015.1075903; Butchart Stuart H M, 2012, PLoS One, V7, pe32529, DOI 10.1371/journal.pone.0032529; Collen B, 2010, SCIENCE, V329, P140, DOI 10.1126/science.329.5988.140-a; Conservation International, 2006, 5 YEARS KEY BIOD AR; Costello MJ, 2014, BIOL CONSERV, V173, P155, DOI 10.1016/j.biocon.2013.07.042; Critical Ecosystem Partnership Fund, 2007, STRAT FRAM FY 2008 2; Di Marco M, 2016, CONSERV BIOL, V30, P392, DOI 10.1111/cobi.12609; Di Minin E, 2015, FRONT ENV SCI-SWITZ, V3, DOI 10.3389/fenvs.2015.00063; Dudley N., 2008, GUIDELINES APPL PROT, DOI [10.2305/IUCN.CH.2008.PAPS.2.en, DOI 10.2305/IUCN.CH.2008.PAPS.2.EN]; Dudley N., 2014, APPL KEY BIODIVERSIT; Edgar GJ, 2008, AQUAT CONSERV, V18, P969, DOI 10.1002/aqc.902; Foster Matthew N., 2012, Journal of Threatened Taxa, V4, P2733; Gardenfors U, 2010, SCIENCE, V329, P140, DOI 10.1126/science.329.5988.140-b; GCOS, 2010, IMPLEMENTATION PLAN; Goettsch B, 2015, NAT PLANTS, V1, DOI [10.1038/nplants.2015.142, 10.1038/NPLANTS.2015.142]; Griggs D, 2013, NATURE, V495, P305, DOI 10.1038/495305a; Hoffmann M., 2008, Endangered Species Research, V6, P113, DOI 10.3354/esr00087; Holland RA, 2012, BIOL CONSERV, V148, P167, DOI 10.1016/j.biocon.2012.01.016; Independent Sector, 2014, EST VAL VOL TIM; International Finance Corporation, 2012, 6 INT FIN CORP; International Union for Conservation of Nature, 2014, CONS DOC IUCN STAND; International Union for Conservation of Nature, 2013, 2013 IUCN ANN REP; International Union for Conservation of Nature, 2015, GUID APPL IUCN RED L; International Union for Conservation of Nature, 1994, IUCN RED LIST CAT CR; International Union for Conservation of Nature Natural Resources Iucn Species Survival Commission International Union for Conservation of Nature Natural Resources. Species Survival Commission, 2001, IUCN RED LIST CAT CR; International Union of Conservation of Nature, 2014, BIOD BUS GUID US KNO; James A, 2001, BIOSCIENCE, V51, P43, DOI 10.1641/0006-3568(2001)051[0043:CWATCB]2.0.CO;2; Juffe-Bignoli D, 2014, PROTECTED PLANET REP; Keith DA, 2015, CONSERV LETT, V8, P214, DOI 10.1111/conl.12167; Keith DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062111; Knight AT, 2010, CONSERV BIOL, V24, P1348, DOI 10.1111/j.1523-1739.2010.01494.x; Lacher TE, 2012, CONSERV LETT, V5, P327, DOI 10.1111/j.1755-263X.2012.00249.x; Langhammer P. F., 2007, IUCN WORLD COMMISSIO, V15; Leadley Paul W, 2014, CBD TECHNICAL SERIES, V78; Leverington F, 2010, ENVIRON MANAGE, V46, P685, DOI 10.1007/s00267-010-9564-5; Lindgaard A., 2011, 2011 NORWEGIAN RED L; Maxwell SL, 2015, J APPL ECOL, V52, P12, DOI 10.1111/1365-2664.12373; McCarthy DP, 2012, SCIENCE, V338, P946, DOI 10.1126/science.1229803; McCrea-Strub A, 2011, MAR POLICY, V35, P1, DOI 10.1016/j.marpol.2010.07.001; Mittermeier, 2014, IUCN RED LIST 50 YEA, P9; Mwangi MAK, 2010, BIRD CONSERV INT, V20, P215, DOI 10.1017/S0959270910000456; Newton A, 2015, GLOBAL TREE ASESSMEN; Rodriguez JP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0003; Ricketts TH, 2005, P NATL ACAD SCI USA, V102, P18497, DOI 10.1073/pnas.0509060102; Rodrigues ASL, 2006, TRENDS ECOL EVOL, V21, P71, DOI 10.1016/j.tree.2005.10.010; Rodriguez Jon Paul, 2008, Endangered Species Research, V6, P193, DOI 10.3354/esr006193; Rondinini C, 2014, CONSERV LETT, V7, P126, DOI 10.1111/conl.12040; Salamon LM, 2011, ANN PUBLIC COOP ECON, V82, P217, DOI 10.1111/j.1467-8292.2011.00437.x; Siebert SJ, 2005, TAXON, V54, P1051, DOI 10.2307/25065492; Soberon J, 2004, PHILOS T R SOC B, V359, P689, DOI 10.1098/rstb.2003.1439; Stuart SN, 2010, SCIENCE, V328, P177, DOI 10.1126/science.1188606; Theobald EJ, 2015, BIOL CONSERV, V181, P236, DOI 10.1016/j.biocon.2014.10.021; Tittensor DP, 2014, SCIENCE, V346, P241, DOI 10.1126/science.1257484; UNDP, 2009, HDB PLANN MON EV DEV; UNEP-WCMC, 2015, WORLD DAT PROT AR US; United Nations, 2012, MILLENNIUM DEV GOALS; United Nations, 2013, MILL DEV GOALS REP; United Nations, 2016, SUSTAINABLE CONSUMPT; United Nations, 2014, MILL DEV GOALS REP 2; Venter O, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001891	71	45	47	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160640	10.1371/journal.pone.0160640	http://dx.doi.org/10.1371/journal.pone.0160640			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529491	Green Published, Green Submitted, gold			2022-12-26	WOS:000381476700014
J	Sanchez, G; Berrios, D; Olmedo, I; Pezoa, J; Riquelme, JA; Montecinos, L; Pedrozo, Z; Donoso, P				Sanchez, Gina; Berrios, Daniela; Olmedo, Ivonne; Pezoa, Javier; Riquelme, Jaime A.; Montecinos, Luis; Pedrozo, Zully; Donoso, Paulina			Activation of Chymotrypsin-Like Activity of the Proteasome during Ischemia Induces Myocardial Dysfunction and Death	PLOS ONE			English	Article							20 S PROTEASOME; REPERFUSION INJURY; SARCOPLASMIC-RETICULUM; MULTIPLE-MYELOMA; CELL-DEATH; ATP CONCENTRATIONS; OXIDIZED PROTEINS; INHIBITOR MLN9708; CARDIAC-FUNCTION; 26S PROTEASOME	Inhibitors of the ubiquitin-proteasome system improve hemodynamic parameters and decrease the infarct size after ischemia reperfusion. The molecular basis of this protection is not fully understood since most available data report inhibition of the 26 proteasome after ischemia reperfusion. The decrease in cellular ATP levels during ischemia leads to the dissociation of the 26S proteasome into the 19S regulatory complex and the 20S catalytic core, which results in protein degradation independently of ubiquitination. There is scarce information on the activity of the 20S proteasome during cardiac ischemia. Accordingly, the aim of this work was to determine the effects of 30 minutes of ischemia, or 30 min of ischemia followed by 60 minutes of reperfusion on the three main peptidase activities of the 20S proteasome in Langendorff perfused rat hearts. We found that 30 min of ischemia produced a significant increase in the chymotrypsin-like activity of the proteasome, without changes in its caspase-like or trypsin-like activities. In contrast, all three activities were decreased upon reperfusion. Ixazomib, perfused before ischemia at a concentration that reduced the chymotrypsin-like activity to 50% of the control values, without affecting the other proteasomal activities, improved the hemodynamic parameters upon reperfusion and decreased the infarct size. Ixazomib also prevented the 50% reduction in RyR2 content observed after ischemia. The protection was lost, however, when simultaneous inhibition of chymotrypsin-like and caspase-like activities of the proteasome was achieved at higher concentration of ixazomib. Our results suggest that selective inhibition of chymotrypsin-like activity of the proteasome during ischemia preserves key proteins for cardiomyocyte function and exerts a positive impact on cardiac performance after reperfusion.	[Sanchez, Gina; Berrios, Daniela; Olmedo, Ivonne] Univ Chile, Inst Ciencias Biomed, Fac Med, Programa Fisiopatol, Santiago, Chile; [Sanchez, Gina; Donoso, Paulina] Univ Chile, Fac Med, Ctr Estudios Mol Celula, Santiago, Chile; [Pezoa, Javier; Montecinos, Luis; Pedrozo, Zully; Donoso, Paulina] Univ Chile, Fac Med, Programa Fisiol & Biofis, Inst Ciencias Biomed, Santiago, Chile; [Riquelme, Jaime A.; Pedrozo, Zully] Univ Chile, Adv Ctr Chron Dis, Fac Ciencias Quim & Farmaceut, Santiago, Chile	Universidad de Chile; Universidad de Chile; Universidad de Chile; Universidad de Chile	Sanchez, G (corresponding author), Univ Chile, Inst Ciencias Biomed, Fac Med, Programa Fisiopatol, Santiago, Chile.; Sanchez, G; Donoso, P (corresponding author), Univ Chile, Fac Med, Ctr Estudios Mol Celula, Santiago, Chile.; Donoso, P (corresponding author), Univ Chile, Fac Med, Programa Fisiol & Biofis, Inst Ciencias Biomed, Santiago, Chile.	gisanchez@med.uchile.cl; pdonoso@med.uchile.cl	Pedrozo, Zully/I-1069-2013; Riquelme, Jaime A/ABG-7889-2020; Pedrozo, Zully/AAN-5350-2021; Olmedo, Ivonne/N-7985-2018	Riquelme, Jaime A/0000-0003-0517-5697; Olmedo, Ivonne/0000-0003-0117-3045	Fondo Nacional de Desarrollo Cientifico y Tecnologico, FONDECYT grant [1110257, 1130407, 1150887, 3140449, 3160298]	Fondo Nacional de Desarrollo Cientifico y Tecnologico, FONDECYT grant(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by Fondo Nacional de Desarrollo Cientifico y Tecnologico, FONDECYT grants 1110257 to PD, 1130407 to GS, 1150887 to ZP and Post-doctoral Fellowships 3140449 to IO and 3160298 to JAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams B, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0258-4; Asai A, 2002, J CEREBR BLOOD F MET, V22, P705, DOI 10.1097/00004647-200206000-00009; Baker TA, 2010, BIOCHEM BIOPH RES CO, V401, P548, DOI 10.1016/j.bbrc.2010.09.093; BULL R, 1989, BIOPHYS J, V56, P749, DOI 10.1016/S0006-3495(89)82722-5; Bulteau AL, 2001, J BIOL CHEM, V276, P30057, DOI 10.1074/jbc.M100142200; Campbell B, 1999, J MOL CELL CARDIOL, V31, P467, DOI 10.1006/jmcc.1998.0880; Chauhan D, 2005, ANNU REV PHARMACOL, V45, P465, DOI 10.1146/annurev.pharmtox.45.120403.100037; Chauhan D, 2011, CLIN CANCER RES, V17, P5311, DOI 10.1158/1078-0432.CCR-11-0476; Cui ZY, 2014, J MOL CELL CARDIOL, V71, P32, DOI 10.1016/j.yjmcc.2013.10.008; Davies KJA, 2001, BIOCHIMIE, V83, P301, DOI 10.1016/S0300-9084(01)01250-0; Divald A, 2010, CIRC RES, V106, P1829, DOI 10.1161/CIRCRESAHA.110.219485; Domenech RJ, 2003, J MOL CELL CARDIOL, V35, P1429, DOI 10.1016/j.yjmcc.2003.09.006; Eaton P, 2001, CARDIOVASC RES, V51, P294, DOI 10.1016/S0008-6363(01)00303-0; Garcia-Dorado D, 2012, CARDIOVASC RES, V94, P168, DOI 10.1093/cvr/cvs116; Geng Q, 2009, BIOCHEM BIOPH RES CO, V390, P1136, DOI 10.1016/j.bbrc.2009.10.067; Gomes AV, 2006, CIRC RES, V99, P362, DOI 10.1161/01.RES.0000237386.98506.f7; Gomes AV, 2009, MOL CELL PROTEOMICS, V8, P302, DOI 10.1074/mcp.M800058-MCP200; HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; Henderson CJ, 2005, CELL DEATH DIFFER, V12, P1240, DOI 10.1038/sj.cdd.4401729; Jung T, 2014, REDOX BIOL, V2, P388, DOI 10.1016/j.redox.2013.12.029; Kupperman E, 2010, CANCER RES, V70, P1970, DOI 10.1158/0008-5472.CAN-09-2766; Lima CF, 2010, METHODS MOL BIOL, V648, P183, DOI 10.1007/978-1-60761-756-3_12; Majetschak M, 2013, AM J PHYSIOL-HEART C, V305, pH267, DOI 10.1152/ajpheart.00206.2012; Muz B, 2016, DRUG DES DEV THER, V10, P217, DOI 10.2147/DDDT.S93602; Pedrozo Z, 2013, CARDIOVASC RES, V98, P277, DOI 10.1093/cvr/cvt029; Pedrozo Z, 2010, BBA-MOL BASIS DIS, V1802, P356, DOI 10.1016/j.bbadis.2009.12.005; Powell SR, 2007, J MOL CELL CARDIOL, V42, P265, DOI 10.1016/j.yjmcc.2006.10.010; Powell SR, 2005, ANTIOXID REDOX SIGN, V7, P538, DOI 10.1089/ars.2005.7.538; Pye J, 2003, AM J PHYSIOL-HEART C, V284, pH919, DOI 10.1152/ajpheart.00851.2002; Rastogi N, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-26; Robin E, 2007, J BIOL CHEM, V282, P19133, DOI 10.1074/jbc.M701917200; Schmidtke G, 2000, J BIOL CHEM, V275, P22056, DOI 10.1074/jbc.M002513200; Silva GM, 2012, ANTIOXID REDOX SIGN, V16, P1183, DOI 10.1089/ars.2011.4210; Soriano GP, 2014, ANTIOXID REDOX SIGN, V21, P2419, DOI 10.1089/ars.2013.5794; Stansfield WE, 2007, ANN THORAC SURG, V84, P120, DOI 10.1016/j.athoracsur.2007.02.049; Temsah RM, 1999, AM J PHYSIOL-HEART C, V277, pH584, DOI 10.1152/ajpheart.1999.277.2.H584; Vanden Hoek TL, 1998, J BIOL CHEM, V273, P18092, DOI 10.1074/jbc.273.29.18092; Vila-Petroff M, 2007, CARDIOVASC RES, V73, P689, DOI 10.1016/j.cardiores.2006.12.003; Whelan RS, 2010, ANNU REV PHYSIOL, V72, P19, DOI 10.1146/annurev.physiol.010908.163111; Wong E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a006734; Yu XC, 2010, CARDIOVASC RES, V85, P312, DOI 10.1093/cvr/cvp309; Zhu X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.313	43	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161068	10.1371/journal.pone.0161068	http://dx.doi.org/10.1371/journal.pone.0161068			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529620	Green Submitted, gold, Green Published			2022-12-26	WOS:000381476700043
J	Yen, YC; Chu, PH; Lu, PL; Lin, YC; Shi, YY; Chou, LC; Wang, CF; Lin, YY; Su, HJ; Lin, CC; Zeng, JY; Tyan, YC; Ke, GM; Chu, PY				Yen, Yung-Chang; Chu, Pei-Huan; Lu, Po-Liang; Lin, Yung-Cheng; Shi, Yong-Ying; Chou, Li-Chiu; Wang, Chu-Feng; Lin, Yi-Ying; Su, Hui-Ju; Lin, Chien-Ching; Zeng, Jing-Yun; Tyan, Yu-Chang; Ke, Guan-Ming; Chu, Pei-Yu			Phylodynamic Characterization of an Ocular-Tropism Coxsackievirus A24 Variant	PLOS ONE			English	Article							ACUTE HEMORRHAGIC CONJUNCTIVITIS; MOLECULAR EPIDEMIOLOGY; TAIWAN; VP1	Recent phylodynamic studies have focused on using tree topology patterns to elucidate interactions among the epidemiological, evolutionary, and demographic characteristics of infectious agents. However, because studies of viral phylodynamics tend to focus on epidemic outbreaks, tree topology signatures of tissue-tropism pathogens might not be clearly identified. Therefore, this study used a novel Bayesian evolutionary approach to analyze the A24 variant of coxsackievirus (CV-A24v), an ocular-tropism agent of acute hemorrhagic conjunctivitis. Analyses of the 915-nucleotide VP1 and 690-nt 3D(pol) regions of 21 strains isolated in Taiwan and worldwide during 1985-2010 revealed a clear chronological trend in both the VP1 and 3D(pol) phylogenetic trees: the emergence of a single dominant cluster in each outbreak. The VP1 sequences included three genotypes: GI (prototype), GIII (isolated 1985-1999), and GIV (isolated after 2000); no VP1 sequences from GII strains have been deposited in GenBank. Another five genotypes identified in the 3D(pol) region had support values >0.9. Geographic and demographic transitions among CV-A24v clusters were clearly identified by Bayes algorithm. The transmission route was mapped from India to China and then to Taiwan, and each prevalent viral population declined before new clusters emerged. Notably, the VP1 and 3D(pol) genes had high nucleotide sequence similarities (94.1% and 95.2%, respectively). The lack of co-circulating lineages and narrow tissue tropism affected the CV-A24v gene pool.	[Yen, Yung-Chang] Chi Mei Med Ctr, Dept Ophthalmol, Tainan, Taiwan; [Yen, Yung-Chang] Min Hwei Coll Hlth Care Management, Dept Nursing, Tainan, Taiwan; [Chu, Pei-Huan] Wei Gong Mem Hosp, Dept Med, Div Cardiol, Miaoli, Taiwan; [Lu, Po-Liang] Kaohsiung Med Univ, Sch Med, Coll Med, Kaohsiung, Taiwan; [Lu, Po-Liang; Chou, Li-Chiu; Wang, Chu-Feng; Lin, Yi-Ying; Su, Hui-Ju; Chu, Pei-Yu] Kaohsiung Med Univ Hosp, Dept Lab Med, Kaohsiung, Taiwan; [Lin, Yung-Cheng] Natl Taiwan Ocean Univ, Inst Biosci & Biotechnol, Keelung, Taiwan; [Shi, Yong-Ying; Lin, Chien-Ching; Zeng, Jing-Yun; Chu, Pei-Yu] Kaohsiung Med Univ, Coll Hlth Sci, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan; [Tyan, Yu-Chang] Kaohsiung Med Univ, Dept Med Imaging & Radiol Sci, Kaohsiung, Taiwan; [Tyan, Yu-Chang] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Tyan, Yu-Chang] Natl Sun Yat Sen Univ, Inst Med Sci & Technol, Kaohsiung, Taiwan; [Tyan, Yu-Chang] Kaohsiung Med Univ, Ctr Infect Dis & Canc Res, Kaohsiung, Taiwan; [Ke, Guan-Ming] Natl Pingtung Univ Sci & Technol, Coll Vet Med, Grad Inst Anim Vaccine Technol, Pingtung, Taiwan	Chi Mei Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Taiwan Ocean University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; National Sun Yat Sen University; Kaohsiung Medical University; National Pingtung University Science & Technology	Chu, PY (corresponding author), Kaohsiung Med Univ Hosp, Dept Lab Med, Kaohsiung, Taiwan.; Chu, PY (corresponding author), Kaohsiung Med Univ, Coll Hlth Sci, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan.; Ke, GM (corresponding author), Natl Pingtung Univ Sci & Technol, Coll Vet Med, Grad Inst Anim Vaccine Technol, Pingtung, Taiwan.	mirage-ke@yahoo.com.tw; peiyuchu@kmu.edu.tw	Lu, Po-Liang/D-4499-2009; YEN, YUNG CHANG/AAH-9922-2021	Lu, Po-Liang/0000-0002-7423-6783; YEN, YUNG CHANG/0000-0002-6931-4409	Ministry of Science and Technology, Taiwan [MOST104-2320-B-037-018]; Chi-Mei Medical Center; Kaohsiung Medical University Research Foundation [103CM-KMU-06]; Center for Infectious Disease and Cancer Research, Kaohsiung Medical University [KMU-TP104E12]; Wei Gong Memorial Hospital [105-1-001]; Chi-Mei Foundation Medical Center [CLFHR10127]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Chi-Mei Medical Center; Kaohsiung Medical University Research Foundation; Center for Infectious Disease and Cancer Research, Kaohsiung Medical University; Wei Gong Memorial Hospital; Chi-Mei Foundation Medical Center	This study was supported by Ministry of Science and Technology, Taiwan grant no. MOST104-2320-B-037-018 (url: http://www.most.gov.tw/) to PYC; Chi-Mei Medical Center and Kaohsiung Medical University Research Foundation grant no. 103CM-KMU-06 (URL: http://devel.kmu.edu.tw/index.php/en-GB/) to PYC; Center for Infectious Disease and Cancer Research, Kaohsiung Medical University grant no. KMU-TP104E12 (URL: http://devel.kmu.edu.tw/index.php/en-GB/) to YCT; Wei Gong Memorial Hospital grant no. 105-1-001 (URL: http://www.weigong.org.tw/eng-index.html) to PHC, and Chi-Mei Foundation Medical Center grant no. CLFHR10127 (URL: http://www.chimei.org.tw/main/clh_department/79052/index.htm) to YCY. The funders had no role in the design of the study, the collection and analysis of data, the decision to publish, or the preparation of the manuscript.	Adams MJ, 2013, ARCH VIROL, V158, P2023, DOI 10.1007/s00705-013-1688-5; Airaksinen A, 1999, J GEN VIROL, V80, P1919, DOI 10.1099/0022-1317-80-8-1919; Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; Chansaenroj J, 2015, EPIDEMIOL INFECT, V143, P3087, DOI 10.1017/S0950268815000643; Chu PY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129272; Chu PY, 2011, INFECT GENET EVOL, V11, P1426, DOI 10.1016/j.meegid.2011.05.010; Chu PY, 2009, J CLIN VIROL, V45, P285, DOI 10.1016/j.jcv.2009.04.013; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Hansen JL, 1997, STRUCTURE, V5, P1109, DOI 10.1016/S0969-2126(97)00261-X; Hicks AL, 2011, J VIROL, V85, P7942, DOI 10.1128/JVI.02535-10; Huang HW, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0738-2; ISHIKO H, 1992, ARCH VIROL, V126, P179, DOI 10.1007/BF01309694; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Khetsuriani Nino, 2006, Morbidity and Mortality Weekly Report, V55, P18; Kim Hong Hwan, 2004, J Prev Med Public Health, V37, P312; Leitch ECM, 2012, J VIROL, V86, P2676, DOI 10.1128/JVI.06065-11; Lin KH, 2001, J MED VIROL, V64, P269, DOI 10.1002/jmv.1046; LIN KH, 1993, J CLIN MICROBIOL, V31, P1160, DOI 10.1128/JCM.31.5.1160-1166.1993; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Nidaira M, 2014, MICROBIOL IMMUNOL, V58, P227, DOI 10.1111/1348-0421.12141; Nilsson EC, 2008, J VIROL, V82, P3061, DOI 10.1128/JVI.02470-07; Oberste MS, 2003, J CLIN VIROL, V26, P375, DOI 10.1016/S1386-6532(03)00004-0; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; RICOHESSE R, 1987, VIROLOGY, V160, P311, DOI 10.1016/0042-6822(87)90001-8; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Smura Teemu, 2014, PLoS One, V9, pe94579, DOI 10.1371/journal.pone.0094579; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tavares FN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023206; Wu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086883; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064	34	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160672	10.1371/journal.pone.0160672	http://dx.doi.org/10.1371/journal.pone.0160672			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529556	Green Submitted, gold, Green Published			2022-12-26	WOS:000381476700015
J	Meneguette, RI; Filho, GPR; Guidoni, DL; Pessin, G; Villas, LA; Ueyama, J				Meneguette, Rodolfo I.; Filho, Geraldo P. R.; Guidoni, Daniel L.; Pessin, Gustavo; Villas, Leandro A.; Ueyama, Jo			Increasing Intelligence in Inter-Vehicle Communications to Reduce Traffic Congestions: Experiments in Urban and Highway Environments	PLOS ONE			English	Article							DATA DISSEMINATION; PROTOCOLS	Intelligent Transportation Systems (ITS) rely on Inter-Vehicle Communication (IVC) to streamline the operation of vehicles by managing vehicle traffic, assisting drivers with safety and sharing information, as well as providing appropriate services for passengers. Traffic congestion is an urban mobility problem, which causes stress to drivers and economic losses. In this context, this work proposes a solution for the detection, dissemination and control of congested roads based on inter-vehicle communication, called INCIDEnT. The main goal of the proposed solution is to reduce the average trip time, CO emissions and fuel consumption by allowing motorists to avoid congested roads. The simulation results show that our proposed solution leads to short delays and a low overhead. Moreover, it is efficient with regard to the coverage of the event and the distance to which the information can be propagated. The findings of the investigation show that the proposed solution leads to (i) high hit rate in the classification of the level of congestion, (ii) a reduction in average trip time, (iii) a reduction in fuel consumption, and (iv) reduced CO emissions	[Meneguette, Rodolfo I.] Univ Ottawa, Ottawa, ON, Canada; [Meneguette, Rodolfo I.] Fed Inst Sao Paulo IFSP, Catanduva, SP, Brazil; [Filho, Geraldo P. R.] Univ Sao Paulo, Inst Math & Comp Sci ICMC, Sao Carlos, SP, Brazil; [Guidoni, Daniel L.] Univ Fed Sao Joao del Rei, Dept Comp Sci, Sao Joao Del Rei, Brazil; [Pessin, Gustavo] Vale Inst Technol, Appl Comp Lab, Belem, Para, Brazil; [Villas, Leandro A.] Univ Estadual Campinas, UNICAMP, Inst Comp, Campinas, SP, Brazil; [Ueyama, Jo] Univ Southern Calif, Ming Hsieh Dept Elect Engn, Los Angeles, CA USA	University of Ottawa; Instituto Federal de Sao Paulo (IFSP); Universidade de Sao Paulo; Universidade Federal de Sao Joao del-Rei; Instituto Tecnologico Vale Desenvolvimento Sustentavel; Universidade Estadual de Campinas; University of Southern California	Meneguette, RI (corresponding author), Univ Ottawa, Ottawa, ON, Canada.; Meneguette, RI (corresponding author), Fed Inst Sao Paulo IFSP, Catanduva, SP, Brazil.	meneguette@ifsp.edu.br	Ueyama, Jo/HHN-1418-2022; Filho, Geraldo Pereira Rocha/Q-6497-2016; Meneguette, Rodolfo/B-2565-2014; Pessin, Gustavo/A-8524-2013	Ueyama, Jo/0000-0002-5591-3750; Filho, Geraldo Pereira Rocha/0000-0001-6795-2768; Meneguette, Rodolfo/0000-0003-2982-4006; Pessin, Gustavo/0000-0002-7411-9229	Sao Paulo Research Foundation (FAPESP) [2015/11536-4, 2015/18898-9]; FAPESP [2014/06330-5]; Office of Naval Research Global; CNPq; FAPEMIG	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Office of Naval Research Global(Office of Naval Research); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was funded by the grants #2015/11536-4 and # 2015/18898-9, Sao Paulo Research Foundation (FAPESP). Geraldo P. R. Filho would like to acknowledge the financial support granted by FAPESP (process 2014/06330-5) in his doctoral research. Jo Ueyama would like to thank FAPESP and Office of Naval Research Global for funding part of his research project. Daniel L. Guidoni would like to thank CNPq and FAPEMIG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by the grants #2015/11536-4 and #2015/18898-9, Sao Paulo Research Foundation (FAPESP). Geraldo P. R. Filho would like to acknowledge the financial support granted by FAPESP (process 2014/06330-5) in his doctoral research. Jo Ueyama would like to thank FAPESP and Office of Naval Research Global for funding part of his research project. Daniel L. Guidoni would like to thank CNPq and FAPEMIG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sultan S, 2014, J NETW COMPUT APPL, V37, P380, DOI 10.1016/j.jnca.2013.02.036; Behrisch M., 2011, P 3 INT C ADV SYST S, P1; Boukerche A, 2008, COMPUT COMMUN, V31, P2838, DOI 10.1016/j.comcom.2007.12.004; Caulfield B, 2007, IEEE T INTELL TRANSP, V8, P21, DOI 10.1109/TITS.2006.888620; Cesana Matteo, 2010, 2010 European Wireless Conference (EW), P689, DOI 10.1109/EW.2010.5483535; Daraghmi YA, 2013, IEEE NETWORK, V27, P74, DOI 10.1109/MNET.2013.6678930; Doolan R., 2013, VEH TECHN C VTC SPRI, P1, DOI DOI 10.1109/VTCSPRING.2013.6692807; Fahmy MF, 2008, 2008 8TH INTERNATIONAL CONFERENCE ON ITS TELECOMMUNICATIONS, PROCEEDINGS, P367, DOI 10.1109/ITST.2008.4740288; Filho GPR, 2015, 2015 IEEE 14TH INTERNATIONAL SYMPOSIUM ON NETWORK COMPUTING AND APPLICATIONS (NCA), P9, DOI 10.1109/NCA.2015.30; Fiore M, 2013, IEEE J SEL AREA COMM, V31, P480, DOI 10.1109/JSAC.2013.SUP.0513043; Fukumoto J, 2007, 2007 7TH INTERNATIONAL CONFERENCE ON ITS TELECOMMUNICATIONS, PROCEEDINGS, P40; Hartenstein H, 2008, IEEE COMMUN MAG, V46, P164, DOI 10.1109/MCOM.2008.4539481; Karagiannis G, 2011, IEEE COMMUN SURV TUT, V13, P584, DOI 10.1109/SURV.2011.061411.00019; Kim TH, 2008, LECT NOTES COMPUT SC, V5200, P295; Lee U, 2010, COMPUT NETW, V54, P527, DOI 10.1016/j.comnet.2009.07.011; Loureiro A. A. F., 2014, COMP COMM ISCC 2014, P1; Lu H., 2011, P 8 ACM INT WORKSH V, P67, DOI DOI 10.1145/2030698.2030709; Maia Guilherme, 2012, P 2 ACM INT S DESIGN, P115, DOI DOI 10.1145/2386958.2386976; Marfia G, 2013, IEEE T VEH TECHNOL, V62, P522, DOI 10.1109/TVT.2012.2226484; Meneguette RI, 2015, 20 IEEE S COMP COMM; Mitchell T. M, 2006, DISCIPLINE MACHINE L, V9; Pan J, 2012, 2012 IEEE 8TH INTERNATIONAL CONFERENCE ON DISTRIBUTED COMPUTING IN SENSOR SYSTEMS (DCOSS), P265, DOI 10.1109/DCOSS.2012.29; Pessin G, 2014, J INTELL FUZZY SYST, V27, P3047, DOI 10.3233/IFS-141262; Schwartz RS, 2011, COMPUT COMMUN, V34, P2057, DOI 10.1016/j.comcom.2011.03.007; Silva F.A., 2013, 31 S BRAS RED COM SI, P615; Sommer C., 2014, VEHICULAR NETWORKING; Tonguz OK, 2010, IEEE WIREL COMMUN, V17, P47, DOI 10.1109/MWC.2010.5450660; Varga A., 2008, P 1 INT C SIM TOOLS, P1, DOI DOI 10.1109/ITSC.2002.1041322; Villas LA, 2012, P 15 ACM INT C MOD A, P39, DOI DOI 10.1145/2387027.2387035; Villas LA, 2013, IEEE ICC, P1439, DOI 10.1109/ICC.2013.6654713; Wei-Hsun Lee, 2012, 2012 12th International Conference on ITS Telecommunications (ITST 2012), P486, DOI 10.1109/ITST.2012.6425226; Willke TL, 2009, IEEE COMMUN SURV TUT, V11, P3, DOI 10.1109/SURV.2009.090202; Ye F, 2012, IEEE J SEL AREA COMM, V30, P769, DOI 10.1109/JSAC.2012.120511	33	33	33	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0159110	10.1371/journal.pone.0159110	http://dx.doi.org/10.1371/journal.pone.0159110			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27526048	Green Submitted, gold, Green Published			2022-12-26	WOS:000381471100004
J	Topalovski, M; Hagopian, M; Wang, M; Brekken, RA				Topalovski, Mary; Hagopian, Michelle; Wang, Miao; Brekken, Rolf A.			Hypoxia and Transforming Growth Factor beta Cooperate to Induce Fibulin-5 Expression in Pancreatic Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt PKB; extracellular matrix; hypoxia; pancreatic cancer; TGF-beta; fibulin-5	TGF-BETA; TUMOR MICROENVIRONMENT; MATRICELLULAR PROTEINS; CELL-PROLIFERATION; IMMUNE CELLS; ANGIOGENESIS; ELASTIN; INVASION; BINDING; FIBRONECTIN	The deposition of extracellular matrix (ECM) is a defining feature of pancreatic ductal adenocarcinoma (PDA), where ECM signaling can promote cancer cell survival and epithelial plasticity programs. However, ECM signaling can also limit PDA tumor growth by producing cytotoxic levels of reactive oxygen species. For example, excess fibronectin stimulation of 51 integrin on stromal cells in PDA results in reduced angiogenesis and increased tumor cell apoptosis because of oxidative stress. Fibulin-5 (Fbln5) is a matricellular protein that blocks fibronectin-integrin interaction and thus directly limits ECM-driven reactive oxygen species production and supports PDA progression. Compared with normal pancreatic tissue, Fbln5 is expressed abundantly in the stroma of PDA; however, the mechanisms underlying the stimulation of Fbln5 expression in PDA are undefined. Using in vitro and in vivo approaches, we report that hypoxia triggers Fbln5 expression in a TGF-- and PI3K-dependent manner. Pharmacologic inhibition of TGF- receptor, PI3K, or protein kinase B (AKT) was found to block hypoxia-induced Fbln5 expression in mouse embryonic fibroblasts and 3T3 fibroblasts. Moreover, tumor-associated fibroblasts from mouse PDA were also responsive to TGF- receptor and PI3K/AKT inhibition with regard to suppression of Fbln5. In genetically engineered mouse models of PDA, therapy-induced hypoxia elevated Fbln5 expression, whereas pharmacologic inhibition of TGF- signaling reduced Fbln5 expression. These findings offer insight into the signaling axis that induces Fbln5 expression in PDA and a potential strategy to block its production.	[Topalovski, Mary; Wang, Miao; Brekken, Rolf A.] Univ Texas Southwestern Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, 6000 Harry Hines Blvd, Dallas, TX 75390 USA; [Topalovski, Mary; Brekken, Rolf A.] Univ Texas Southwestern Med Ctr Dallas, Canc Biol Grad Program, Dallas, TX 75390 USA; [Hagopian, Michelle; Brekken, Rolf A.] Univ Texas Southwestern Med Ctr Dallas, Div Surg Oncol, Dept Surg, Dallas, TX 75390 USA; [Brekken, Rolf A.] Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Brekken, RA (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.	rolf.brekken@utsouthwestern.edu			American Cancer Society [RSG-10-244-01-CSM]; Joe and Jessie Crump Medical Research Foundation; National Institutes of Health [R01 CA118240, T32 GM008203]; Effie Marie Cain Scholarship in Angiogenesis Research; NATIONAL CANCER INSTITUTE [R01CA118240] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008203] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Joe and Jessie Crump Medical Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Effie Marie Cain Scholarship in Angiogenesis Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by American Cancer Society Grant RSG-10-244-01-CSM (to R. A. B.), the Joe and Jessie Crump Medical Research Foundation (to R. A. B.), National Institutes of Health Grants R01 CA118240 (to R. A. B.) and T32 GM008203 (to M. T.), and the Effie Marie Cain Scholarship in Angiogenesis Research (to R. A. B.). R. A. B. is a co-founder of Tuevol Therapeutics, a company that is developing therapeutics that target the tumor microenvironment. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguilera KY, 2014, CANCER RES, V74, P1032, DOI 10.1158/0008-5472.CAN-13-2800; Albig Allan R, 2005, Future Oncol, V1, P23, DOI 10.1517/14796694.1.1.23; Albig AR, 2004, DNA CELL BIOL, V23, P367, DOI 10.1089/104454904323145254; Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7; Buchler P, 2004, J SURG RES, V120, P295, DOI 10.1016/j.jss.2004.02.014; Chan DA, 2002, J BIOL CHEM, V277, P40112, DOI 10.1074/jbc.M206922200; Chapman SL, 2010, ARTERIOSCL THROM VAS, V30, P68, DOI 10.1161/ATVBAHA.109.196725; Danen EHJ, 2001, J CELL PHYSIOL, V189, P1, DOI 10.1002/jcp.1137; Dineen SP, 2010, CANCER RES, V70, P2852, DOI 10.1158/0008-5472.CAN-09-3892; Eliceiri BP, 2001, CIRC RES, V89, P1104, DOI 10.1161/hh2401.101084; FRIESS H, 1993, GASTROENTEROLOGY, V105, P1846, DOI 10.1016/0016-5085(93)91084-U; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Guadall A, 2011, J BIOL CHEM, V286, P7093, DOI 10.1074/jbc.M110.162917; Horbelt D, 2012, INT J BIOCHEM CELL B, V44, P469, DOI 10.1016/j.biocel.2011.12.013; Horowitz JC, 2004, J BIOL CHEM, V279, P1359, DOI 10.1074/jbc.M306248200; Hwang CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084218; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; Kowal RC, 1999, CIRC RES, V84, P1166, DOI 10.1161/01.RES.84.10.1166; Kuang PP, 2007, AM J PHYSIOL-LUNG C, V292, pL944, DOI 10.1152/ajplung.00184.2006; Kuang PP, 2006, AM J PHYSIOL-CELL PH, V291, pC1412, DOI 10.1152/ajpcell.00087.2006; Kuang PP, 2003, AM J PHYSIOL-LUNG C, V285, pL1147, DOI 10.1152/ajplung.00098.2003; Lee YH, 2008, CARCINOGENESIS, V29, P2243, DOI 10.1093/carcin/bgn199; Levy L, 2006, CYTOKINE GROWTH F R, V17, P41, DOI 10.1016/j.cytogfr.2005.09.009; Lomas AC, 2007, BIOCHEM J, V405, P417, DOI 10.1042/BJ20070400; Mao Y, 2013, CANCER METAST REV, V32, P303, DOI 10.1007/s10555-012-9415-3; Melisi D, 2008, MOL CANCER THER, V7, P829, DOI 10.1158/1535-7163.MCT-07-0337; Miyazaki S, 2014, INT J CANCER, V135, P295, DOI 10.1002/ijc.28686; Nakamura T, 2002, NATURE, V415, P171, DOI 10.1038/415171a; Nakamura T, 1999, J BIOL CHEM, V274, P22476, DOI 10.1074/jbc.274.32.22476; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Ostapoff KT, 2014, CANCER RES, V74, P4996, DOI 10.1158/0008-5472.CAN-13-1807; Ostapoff KT, 2013, MOL CANCER THER, V12, P1190, DOI 10.1158/1535-7163.MCT-12-1123; Phillips P., 2012, PANCREATIC CANC TUMO, P1; Piret JP, 2002, ANN NY ACAD SCI, V973, P443, DOI 10.1111/j.1749-6632.2002.tb04680.x; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.021; Schiemann WP, 2002, J BIOL CHEM, V277, P27367, DOI 10.1074/jbc.M200148200; Schluterman MK, 2010, DIS MODEL MECH, V3, P333, DOI 10.1242/dmm.003707; Sharon Y, 2013, JOVE-J VIS EXP, DOI 10.3791/4425; Shi XY, 2014, ASIAN PAC J TROP MED, V7, P787, DOI 10.1016/S1995-7645(14)60137-1; Shibaji T, 2003, ANTICANCER RES, V23, P4721; Sullivan KM, 2007, LAB INVEST, V87, P818, DOI 10.1038/labinvest.3700594; Sullivan LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012031; Truty MJ, 2007, PANCREATOLOGY, V7, P423, DOI 10.1159/000108959; Wang M, 2015, CANCER RES, V75, P5058, DOI 10.1158/0008-5472.CAN-15-0744; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Wong GS, 2013, BRIT J CANCER, V108, P755, DOI 10.1038/bjc.2012.592; Xie L, 2008, EXP BIOL MED, V233, P155, DOI 10.3181/0706-RM-167; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a; Yanagisawa H, 2009, J CELL COMMUN SIGNAL, V3, P337, DOI 10.1007/s12079-009-0065-3; Yang L, 2010, TRENDS IMMUNOL, V31, P220, DOI 10.1016/j.it.2010.04.002; Yue W, 2009, CANCER RES, V69, P6339, DOI 10.1158/0008-5472.CAN-09-0398; Zheng Q, 2006, J INVEST DERMATOL, V126, P2707, DOI 10.1038/sj.jid.5700501	52	28	29	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22244	22252		10.1074/jbc.M116.730945	http://dx.doi.org/10.1074/jbc.M116.730945			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27531748	Green Published, hybrid			2022-12-26	WOS:000386332600035
J	Syson, K; Stevenson, CEM; Miah, F; Barclay, JE; Tang, MH; Gorelik, A; Rashid, AM; Lawson, DM; Bornemann, S				Syson, Karl; Stevenson, Clare E. M.; Miah, Farzana; Barclay, J. Elaine; Tang, Minhong; Gorelik, Andrii; Rashid, Abdul M.; Lawson, David M.; Bornemann, Stephen			Ligand-bound Structures and Site-directed Mutagenesis Identify the Acceptor and Secondary Binding Sites of Streptomyces coelicolor Maltosyltransferase GlgE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate-binding protein; crystal structure; glycosyltransferase; oligosaccharide; site-directed mutagenesis	MYCOBACTERIUM-TUBERCULOSIS GLGE; VALIDATED ANTITUBERCULOSIS TARGET; ALPHA-MALTOSE 1-PHOSPHATE; MOLECULAR-GRAPHICS; AMYLASE FAMILY; PATHWAY; GLUCAN; TRANSFERASE; INHIBITORS; TREHALOSE	GlgE is a maltosyltransferase involved in -glucan biosynthesis in bacteria that has been genetically validated as a target for tuberculosis therapies. Crystals of the Mycobacterium tuberculosis enzyme diffract at low resolution so most structural studies have been with the very similar Streptomyces coelicolor GlgE isoform 1. Although the donor binding site for -maltose 1-phosphate had been previously structurally defined, the acceptor site had not. Using mutagenesis, kinetics, and protein crystallography of the S. coelicolor enzyme, we have now identified the +1 to +6 subsites of the acceptor/product, which overlap with the known cyclodextrin binding site. The sugar residues in the acceptor subsites +1 to +5 are oriented such that they disfavor the binding of malto-oligosaccharides that bear branches at their 6-positions, consistent with the known acceptor chain specificity of GlgE. A secondary binding site remote from the catalytic center was identified that is distinct from one reported for the M. tuberculosis enzyme. This new site is capable of binding a branched -glucan and is most likely involved in guiding acceptors toward the donor site because its disruption kinetically compromises the ability of GlgE to extend polymeric substrates. However, disruption of this site, which is conserved in the Streptomyces venezuelae GlgE enzyme, did not affect the growth of S. venezuelae or the structure of the polymeric product. The acceptor subsites +1 to +4 in the S. coelicolor enzyme are well conserved in the M. tuberculosis enzyme so their identification could help inform the design of inhibitors with therapeutic potential.	[Syson, Karl; Stevenson, Clare E. M.; Miah, Farzana; Barclay, J. Elaine; Tang, Minhong; Gorelik, Andrii; Rashid, Abdul M.; Lawson, David M.; Bornemann, Stephen] John Innes Ctr, Dept Biol Chem, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Bornemann, S (corresponding author), John Innes Ctr, Dept Biol Chem, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	stephen.bornemann@jic.ac.uk	Bornemann, Stephen/K-2938-2012	Bornemann, Stephen/0000-0001-5930-9473; Gorelik, Andrii/0000-0001-5354-4042	United Kingdom Biotechnology and Biological Sciences Research Council Responsive Mode Grant [BB/I012850/1]; United Kingdom Biotechnology and Biological Sciences Research Council Institute Strategic Programme Grant [BB/J004561/1]; John Innes Foundation; Biotechnology and Biological Sciences Research Council [BB/I012850/1, BBS/E/J/000C0647] Funding Source: researchfish; BBSRC [BBS/E/J/000C0647, BB/I012850/1] Funding Source: UKRI	United Kingdom Biotechnology and Biological Sciences Research Council Responsive Mode Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); United Kingdom Biotechnology and Biological Sciences Research Council Institute Strategic Programme Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); John Innes Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by United Kingdom Biotechnology and Biological Sciences Research Council Responsive Mode Grant BB/I012850/1 and Institute Strategic Programme Grant BB/J004561/1 and by the John Innes Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Billones J.B., 2014, ORIENT J CHEM, V30, P1137; Chandra G, 2011, MICROBIOL-SGM, V157, P1565, DOI 10.1099/mic.0.044263-0; Cuyvers S, 2012, CRIT REV BIOTECHNOL, V32, P93, DOI 10.3109/07388551.2011.561537; Damager I, 2010, CHEM REV, V110, P2049, DOI 10.1021/cr900227t; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Elbein AD, 2010, J BIOL CHEM, V285, P9803, DOI 10.1074/jbc.M109.033944; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fraga J, 2015, SCI REP-UK, V5, DOI 10.1038/srep08026; Gregory MA, 2003, J BACTERIOL, V185, P5320, DOI 10.1128/JB.185.17.5320-5323.2003; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Kalscheuer R, 2010, DRUG NEWS PERSPECT, V23, P619, DOI 10.1358/dnp.2010.23.10.1534855; Kalscheuer R, 2010, NAT CHEM BIOL, V6, P376, DOI 10.1038/nchembio.340; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Koliwer-Brandl H, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005768; Leiba J, 2013, J BIOL CHEM, V288, P16546, DOI 10.1074/jbc.M112.398503; Lindenberger JJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep12830; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; MacGregor EA, 2001, BBA-PROTEIN STRUCT M, V1546, P1, DOI 10.1016/S0167-4838(00)00302-2; MANNERS DJ, 1991, CARBOHYD POLYM, V16, P37, DOI 10.1016/0144-8617(91)90071-J; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Mendes V, 2015, SCI REP-UK, V5, DOI 10.1038/srep17144; Miah F, 2016, MICROBIOL-SGM, V162, P1208, DOI 10.1099/mic.0.000296; Miah F, 2013, CHEM BIOL, V20, P487, DOI 10.1016/j.chembiol.2013.02.014; Mizuno M, 2004, EUR J BIOCHEM, V271, P2530, DOI 10.1111/j.1432-1033.2004.04183.x; Moller MS, 2015, J MOL BIOL, V427, P1263, DOI 10.1016/j.jmb.2014.12.019; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; O'Sullivan AC, 1999, BIOPOLYMERS, V50, P381, DOI 10.1002/(SICI)1097-0282(19991005)50:4<381::AID-BIP4>3.0.CO;2-W; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Rashid AM, 2016, BIOCHEMISTRY-US, V55, P3270, DOI 10.1021/acs.biochem.6b00209; Sengupta S, 2015, J BIOMOL STRUCT DYN, V33, P2655, DOI 10.1080/07391102.2014.1003602; Sengupta S, 2014, MOL BIOL REP, V41, P3549, DOI 10.1007/s11033-014-3068-y; Sheng F, 2009, BIOCHEMISTRY-US, V48, P10089, DOI 10.1021/bi900916t; SOGAARD M, 1993, CARBOHYD POLYM, V21, P137, DOI 10.1016/0144-8617(93)90008-R; Syson K, 2014, BIOCHEMISTRY-US, V53, P2494, DOI 10.1021/bi500183c; Syson K, 2011, J BIOL CHEM, V286, P38298, DOI 10.1074/jbc.M111.279315; TAKUSAGAWA F, 1978, ACTA CRYSTALLOGR B, V34, P213, DOI 10.1107/S0567740878002630; Thanna S, 2015, ORG BIOMOL CHEM, V13, P7542, DOI 10.1039/c5ob00867k; Uitdehaag JCM, 1999, NAT STRUCT BIOL, V6, P432, DOI 10.1038/8235; Veleti SK, 2014, J ORG CHEM, V79, P9444, DOI 10.1021/jo501481r; Veleti SK, 2014, BIOORGAN MED CHEM, V22, P1404, DOI 10.1016/j.bmc.2013.12.058; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701	44	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21531	21540		10.1074/jbc.M116.748160	http://dx.doi.org/10.1074/jbc.M116.748160			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27531751	hybrid, Green Accepted, Green Published			2022-12-26	WOS:000385999200020
J	Bader, CA; Shandala, T; Carter, EA; Ivask, A; Guinan, T; Hickey, SM; Werrett, MV; Wright, PJ; Simpson, PV; Stagni, S; Voelcker, NH; Lay, PA; Massi, M; Plush, SE; Brooks, DA				Bader, Christie A.; Shandala, Tetyana; Carter, Elizabeth A.; Ivask, Angela; Guinan, Taryn; Hickey, Shane M.; Werrett, Melissa V.; Wright, Phillip J.; Simpson, Peter V.; Stagni, Stefano; Voelcker, Nicolas H.; Lay, Peter A.; Massi, Massimiliano; Plush, Sally E.; Brooks, Douglas A.			A Molecular Probe for the Detection of Polar Lipids in Live Cells	PLOS ONE			English	Article							DROSOPHILA FAT-BODY; QUANTITATIVE-ANALYSIS; AUTOPHAGY REGULATION; MEMBRANE RAFTS; PALMITIC ACID; CHOLESTEROL; DROPLET; METABOLISM; PATHWAY; ATG9	Lipids have an important role in many aspects of cell biology, including membrane architecture/compartment formation, intracellular traffic, signalling, hormone regulation, inflammation, energy storage and metabolism. Lipid biology is therefore integrally involved in major human diseases, including metabolic disorders, neurodegenerative diseases, obesity, heart disease, immune disorders and cancers, which commonly display altered lipid transport and metabolism. However, the investigation of these important cellular processes has been limited by the availability of specific tools to visualise lipids in live cells. Here we describe the potential for ReZolve-L1 (TM) to localise to intracellular compartments containing polar lipids, such as for example sphingomyelin and phosphatidylethanolamine. In live Drosophila fat body tissue from third instar larvae, ReZolve-L1 (TM) interacted mainly with lipid droplets, including the core region of these organelles. The presence of polar lipids in the core of these lipid droplets was confirmed by Raman mapping and while this was consistent with the distribution of ReZolve-L1 (TM) it did not exclude that the molecular probe might be detecting other lipid species. In response to complete starvation conditions, ReZolve-L1 (TM) was detected mainly in Atg8-GFP autophagic compartments, and showed reduced staining in the lipid droplets of fat body cells. The induction of autophagy by Tor inhibition also increased ReZolve-L1 (TM) detection in autophagic compartments, whereas Atg9 knock down impaired autophagosome formation and altered the distribution of ReZolve-L1 (TM). Finally, during Drosophila metamorphosis fat body tissues showed increased ReZolve-L1 (TM) staining in autophagic compartments at two hours post puparium formation, when compared to earlier developmental time points. We concluded that ReZolve-L1 (TM) is a new live cell imaging tool, which can be used as an imaging reagent for the detection of polar lipids in different intracellular compartments.	[Bader, Christie A.; Shandala, Tetyana; Hickey, Shane M.; Plush, Sally E.; Brooks, Douglas A.] Univ South Australia, Sch Pharm & Med Sci, Adelaide, SA, Australia; [Carter, Elizabeth A.; Lay, Peter A.] Univ Sydney, Vibrat Spect Core Facil, Sydney, NSW, Australia; [Ivask, Angela; Guinan, Taryn; Voelcker, Nicolas H.] Univ South Australia, Future Ind Inst, Mawson Lakes, SA, Australia; [Werrett, Melissa V.; Wright, Phillip J.; Simpson, Peter V.; Massi, Massimiliano] Curtin Univ, Dept Chem, Bentley, WA, Australia; [Werrett, Melissa V.; Wright, Phillip J.; Simpson, Peter V.; Massi, Massimiliano] Curtin Univ, Nanochem Res Inst, Bentley, WA, Australia; [Stagni, Stefano] Univ Bologna, Dept Ind Chem Toso Montanari, Bologna, Italy	University of South Australia; University of Sydney; University of South Australia; Curtin University; Curtin University; University of Bologna	Brooks, DA (corresponding author), Univ South Australia, Sch Pharm & Med Sci, Adelaide, SA, Australia.	doug.brooks@unisa.edu.au	Stagni, Stefano/J-4969-2012; Hickey, Shane/AAE-8549-2019; Plush, Sally/E-8280-2012; Ivask, Angela/AAH-5777-2021; Carter, Elizabeth/J-7365-2019; Lay, Peter A/B-4698-2014; Massi, Massimiliano/G-1709-2011; Voelcker, Nicolas H/D-6199-2012; Ivask, Angela/G-5180-2011	Stagni, Stefano/0000-0002-7260-4845; Hickey, Shane/0000-0002-3063-531X; Plush, Sally/0000-0002-9999-9154; Carter, Elizabeth/0000-0001-6318-7771; Lay, Peter A/0000-0002-3232-2720; Voelcker, Nicolas H/0000-0002-1536-7804; Ivask, Angela/0000-0003-3451-7211; Simpson, Peter/0000-0002-5701-3203; Werrett, Melissa/0000-0001-6811-4504; Bader, Christie/0000-0002-4653-912X; Brooks, Doug/0000-0001-9098-3626	University of South Australia, an ITEK catalyst grant; BioSA Innovation grant; NHMRC development grant [APP1092904]; ARC [FT1301000033, DP130103566, DP140100176]; ARC LIEF [LE0560680]; University of Sydney NHMRC; Ramaciotti Foundation	University of South Australia, an ITEK catalyst grant; BioSA Innovation grant; NHMRC development grant(National Health and Medical Research Council (NHMRC) of Australia); ARC(Australian Research Council); ARC LIEF(Australian Research Council); University of Sydney NHMRC; Ramaciotti Foundation	This work was supported by funding from the University of South Australia, an ITEK catalyst grant and a BioSA Innovation grant awarded to DAB, SP and MM. This work was co-funded by an NHMRC development grant (APP1092904) and the ARC (FT1301000033 to MM) and (DP130103566 and DP140100176 to PAL). We are also grateful for an ARC LIEF grant (LE0560680) and University of Sydney NHMRC equipment grants for the Raman Spectrometer. Ramaciotti Foundation is thanked for financing the use of AMNIS imaging flow cytometer at University of South Australia. We confirm that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguila JR, 2007, J EXP BIOL, V210, P956, DOI 10.1242/jeb.001586; Alexaki A, 2014, J LIPID RES, V55, P2521, DOI 10.1194/jlr.M051862; Andersson L, 2006, J CELL SCI, V119, P2246, DOI 10.1242/jcs.02941; ANDRES AJ, 1994, METHOD CELL BIOL, V44, P565, DOI 10.1016/S0091-679X(08)60932-2; Arthur JR, 2011, J LIPID RES, V52, P1345, DOI 10.1194/jlr.M012633; Asha H, 2003, GENETICS, V163, P203; Bader CA, 2015, BIOL OPEN, V4, P1345, DOI 10.1242/bio.013979; Bader CA, 2014, RSC ADV, V4, P16345, DOI 10.1039/c4ra00050a; Baenke F, 2013, DIS MODEL MECH, V6, P1353, DOI 10.1242/dmm.011338; BRAND AH, 1993, DEVELOPMENT, V118, P401; BUTTERWORTH FM, 1988, TISSUE CELL, V20, P255, DOI 10.1016/0040-8166(88)90047-X; Cai N, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-28; Carter EA, 2010, MOL BIOSYST, V6, P1316, DOI 10.1039/c001499k; Carter Elizabeth A, 2009, Biophys Rev, V1, P95, DOI 10.1007/s12551-009-0012-9; Chiantia Salvatore, 2013, Handb Exp Pharmacol, P33, DOI 10.1007/978-3-7091-1368-4_2; Czamara K, 2015, J RAMAN SPECTROSC, V46, P4, DOI 10.1002/jrs.4607; Digel M, 2010, FEBS LETT, V584, P2168, DOI 10.1016/j.febslet.2010.03.035; Dirkx R, 2012, J DIABETES INVEST, V3, P339, DOI 10.1111/j.2040-1124.2012.00200.x; Dupont N, 2014, CURR BIOL, V24, P609, DOI 10.1016/j.cub.2014.02.008; Fujimoto T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004838; Fukumoto S, 2002, HISTOCHEM CELL BIOL, V118, P423, DOI 10.1007/s00418-002-0462-7; Gimpl G, 2010, SUBCELL BIOCHEM, V51, P1, DOI 10.1007/978-90-481-8622-8_1; GOCZE PM, 1994, CYTOMETRY, V17, P151, DOI 10.1002/cyto.990170207; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Gronke S, 2007, PLOS BIOL, V5, P1248, DOI 10.1371/journal.pbio.0050137; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Haberkant P, 2014, BBA-MOL CELL BIOL L, V1841, P1022, DOI 10.1016/j.bbalip.2014.01.003; Hackett MJ, 2011, ANALYST, V136, P2941, DOI 10.1039/c0an00269k; Hannich JT, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004762; Hossain MS, 2013, INSECT BIOCHEM MOLEC, V43, P829, DOI 10.1016/j.ibmb.2013.06.007; Inokuchi-Shimizu S, 2014, J CLIN INVEST, V124, P3566, DOI 10.1172/JCI74068; Juhasz Gabor, 2008, V445, P125, DOI 10.1007/978-1-59745-157-4_8; KATZ S S, 1976, Journal of Clinical Investigation, V58, P200; Kaushik S, 2015, NAT CELL BIOL, V17, P759, DOI 10.1038/ncb3166; Kaushik S, 2011, CELL METAB, V14, P173, DOI 10.1016/j.cmet.2011.06.008; Kelso RJ, 2004, NUCLEIC ACIDS RES, V32, pD418, DOI 10.1093/nar/gkh014; Khaldoun SA, 2014, MOL BIOL CELL, V25, P118, DOI 10.1091/mbc.E13-06-0324; KIRBY C, 1980, BIOCHEM J, V186, P591, DOI 10.1042/bj1860591; Koga H, 2010, FASEB J, V24, P3052, DOI 10.1096/fj.09-144519; Kuhnlein RP, 2012, J LIPID RES, V53, P1430, DOI 10.1194/jlr.R024299; Kuhnlein RP, 2011, PROG LIPID RES, V50, P348, DOI 10.1016/j.plipres.2011.04.001; Lang T, 2007, J PHYSIOL-LONDON, V585, P693, DOI 10.1113/jphysiol.2007.134346; Li ST, 2014, BBA-MOL CELL BIOL L, V1841, P22, DOI 10.1016/j.bbalip.2013.09.004; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Liu HH, 2013, INSECT BIOCHEM MOLEC, V43, P1068, DOI 10.1016/j.ibmb.2013.09.001; Liu K, 2013, CELL DEATH DIFFER, V20, P3, DOI 10.1038/cdd.2012.63; Low P, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-29; Maxfield FR, 2012, METHOD CELL BIOL, V108, P367, DOI 10.1016/B978-0-12-386487-1.00017-1; McIntosh AL, 2010, LIPIDS, V45, P465, DOI 10.1007/s11745-010-3424-1; Melo RCN, 2011, J HISTOCHEM CYTOCHEM, V59, P540, DOI 10.1369/0022155411404073; Mori M, 2001, J LIPID RES, V42, P1771; Nagy P, 2014, FEBS LETT, V588, P408, DOI 10.1016/j.febslet.2013.12.012; Neufeld TP, 2008, METHOD ENZYMOL, V451, P653, DOI 10.1016/S0076-6879(08)03236-9; Nezis Ioannis P, 2012, Cells, V1, P248, DOI 10.3390/cells1030248; Niemann A, 2001, J HISTOCHEM CYTOCHEM, V49, P177, DOI 10.1177/002215540104900205; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Ouimet M, 2013, BBA-MOL CELL BIOL L, V1831, P1124, DOI 10.1016/j.bbalip.2013.03.007; Ouimet M, 2011, CELL METAB, V13, P655, DOI 10.1016/j.cmet.2011.03.023; Pan MH, 2008, P NATL ACAD SCI USA, V105, P5862, DOI 10.1073/pnas.0707460104; Park M, 2015, J CELL PHYSIOL, V230, P630, DOI 10.1002/jcp.24781; Reggiori F, 2012, J CELL BIOL, V198, P151, DOI 10.1083/jcb.201206119; Robenek H, 2005, J LIPID RES, V46, P1331, DOI 10.1194/jlr.M400323-JLR200; Rothstein EC, 2006, J MICROSC-OXFORD, V222, P58, DOI 10.1111/j.1365-2818.2006.01570.x; Rudolf M, 2009, J HISTOCHEM CYTOCHEM, V57, P731, DOI 10.1369/jhc.2009.953448; Ruggles KV, 2013, ANNU REV NUTR, V33, P413, DOI 10.1146/annurev-nutr-071812-161254; Russell RC, 2014, CELL RES, V24, P42, DOI 10.1038/cr.2013.166; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Sahoo SK, 2003, DRUG DISCOV TODAY, V8, P1112, DOI 10.1016/S1359-6446(03)02903-9; Schnell U, 2012, NAT METHODS, V9, P152, DOI [10.1038/nmeth.1855, 10.1038/NMETH.1855]; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Singh R., 2012, INT J CELL BIOL, V2012, DOI DOI 10.1155/2012/282041; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Small D, 1970, ADV EXP MED BIOL, V7, P55, DOI [DOI 10.1091/MBC.E13-06-0324, 10.1091/mbc.E13-06-0324]; Spandl J, 2009, TRAFFIC, V10, P1579, DOI 10.1111/j.1600-0854.2009.00980.x; Spangenburg EE, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/598358; Tan SH, 2012, J BIOL CHEM, V287, P14364, DOI 10.1074/jbc.M111.294157; Tang HW, 2013, DEV CELL, V27, P489, DOI 10.1016/j.devcel.2013.10.017; Tauchi-Sato K, 2002, J BIOL CHEM, V277, P44507, DOI 10.1074/jbc.M207712200; Thiam AR, 2013, NAT REV MOL CELL BIO, V14, P775, DOI 10.1038/nrm3699; Tracy K, 2013, CURR TOP DEV BIOL, V103, P101, DOI 10.1016/B978-0-12-385979-2.00004-6; van Zutphen T, 2014, MOL BIOL CELL, V25, P290, DOI 10.1091/mbc.E13-08-0448; Vaughan JG, 2013, DALTON T, V42, P14100, DOI 10.1039/c3dt51614h; Wang JD, 2012, ANN BIOMED ENG, V40, P1862, DOI 10.1007/s10439-012-0562-z; Wang S, 2010, J MOL CELL BIOL, V2, P128, DOI 10.1093/jmcb/mjq006; Webber JL, 2010, FEBS LETT, V584, P1319, DOI 10.1016/j.febslet.2010.01.020; Xin W, 2015, BIOCHEM BIOPH RES CO, V463, P364, DOI 10.1016/j.bbrc.2015.05.070; Yang DS, 2014, BRAIN, V137, P3300, DOI 10.1093/brain/awu278; Yang HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032693; Zehmer JK, 2009, PROTEOMICS, V9, P914, DOI 10.1002/pmic.200800584; Zhou Weixin, 2002, Chinese Medical Sciences Journal, V17, P95; Zirin J, 2010, SEMIN IMMUNOPATHOL, V32, P363, DOI 10.1007/s00281-010-0223-y	92	26	26	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0161557	10.1371/journal.pone.0161557	http://dx.doi.org/10.1371/journal.pone.0161557			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27551717	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000381768800051
J	Wilke, ABB; Christe, RD; Multini, LC; Vidal, PO; Wilk-da-Silva, R; de Carvalho, GC; Marrelli, MT				Bruno Wilke, Andre Barretto; Christe, Rafael de Oliveira; Multini, Laura Cristina; Vidal, Paloma Oliveira; Wilk-da-Silva, Ramon; de Carvalho, Gabriela Cristina; Marrelli, Mauro Toledo			Morphometric Wing Characters as a Tool for Mosquito Identification	PLOS ONE			English	Article							CULEX DIPTERA-CULICIDAE; SAO-PAULO; COMPLEX MOSQUITOS; QUINQUEFASCIATUS; VECTOR; PHYLOGENY; PIPIENS; DIPTERACULICIDAE; CLASSIFICATION; DIVERSITY	Mosquitoes are responsible for the transmission of important infectious diseases, causing millions of deaths every year and endangering approximately 3 billion people around the world. As such, precise identification of mosquito species is crucial for an understanding of epidemiological patterns of disease transmission. Currently, the most common method of mosquito identification relies on morphological taxonomic keys, which do not always distinguish cryptic species. However, wing geometric morphometrics is a promising tool for the identification of vector mosquitoes, sibling and cryptic species included. This study therefore sought to accurately identify mosquito species from the three most epidemiologically important mosquito genera using wing morphometrics. Twelve mosquito species from three epidemiologically important genera (Aedes, Anopheles and Culex) were collected and identified by taxonomic keys. Next, the right wing of each adult female mosquito was removed and photographed, and the coordinates of eighteen digitized landmarks at the intersections of wing veins were collected. The allometric influence was assessed, and canonical variate analysis and thin-plate splines were used for species identification. Cross-validated reclassification tests were performed for each individual, and a Neighbor Joining tree was constructed to illustrate species segregation patterns. The analyses were carried out and the graphs plotted with TpsUtil 1.29, TpsRelw 1.39, MorphoJ 1.02 and Past 2.17c. Canonical variate analysis for Aedes, Anopheles and Culex genera showed three clear clusters in morphospace, correctly distinguishing the three mosquito genera, and pairwise cross-validated reclassification resulted in at least 99% accuracy; subgenera were also identified correctly with a mean accuracy of 96%, and in 88 of the 132 possible comparisons, species were identified with 100% accuracy after the data was subjected to reclassification. Our results showed that Aedes, Culex and Anopheles were correctly distinguished by wing shape. For the lower hierarchical levels (subgenera and species), wing geometric morphometrics was also efficient, resulting in high reclassification scores.	[Bruno Wilke, Andre Barretto; Wilk-da-Silva, Ramon; de Carvalho, Gabriela Cristina; Marrelli, Mauro Toledo] Univ Sao Paulo, Fac Saude Publ, Dept Epidemiol, Sao Paulo, Brazil; [Christe, Rafael de Oliveira; Multini, Laura Cristina] Univ Sao Paulo, Inst Med Trop Sao Paulo, Sao Paulo, Brazil; [Vidal, Paloma Oliveira] Inst Butantan, Dept Parasitol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Instituto Butantan	Wilke, ABB (corresponding author), Univ Sao Paulo, Fac Saude Publ, Dept Epidemiol, Sao Paulo, Brazil.	andrewilke@usp.br	Wilke, Andre B B/J-9973-2014; Marrelli, Mauro/H-2568-2013	Wilke, Andre B B/0000-0002-6629-7666; Marrelli, Mauro/0000-0002-0312-8777; Multini, Laura Cristina/0000-0002-1322-9889	State of Sao Paulo Research Foundation (FAPESP) [2013/15313-4]; FAPESP [2012/19117-2]	State of Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the State of Sao Paulo Research Foundation (FAPESP) for providing financial support (Grant 2013/15313-4, www.fapesp.br). ABBW is the recipient of a postdoctoral fellowship from FAPESP (2012/19117-2, www.fapesp.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borstler J, 2014, J VECTOR ECOL, V39, P204, DOI 10.1111/j.1948-7134.2014.12088.x; Wilke ABB, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0468-8; Calle DA, 2002, MEM I OSWALDO CRUZ, V97, P1191, DOI 10.1590/S0074-02762002000800021; Cartaxo MFS, 2011, T ROY SOC TROP MED H, V105, P491, DOI 10.1016/j.trstmh.2011.05.004; Ceretti W, 2015, J AM MOSQUITO CONTR, V31, P172, DOI 10.2987/14-6457R; Chaves LF, 2012, GLOBAL CHANGE BIOL, V18, P457, DOI 10.1111/j.1365-2486.2011.02522.x; Chaves LF, 2010, Q REV BIOL, V85, P27, DOI 10.1086/650284; Consoli R. A. G. B., 1994, PRINCIPAIS MOSQUITOS; Cornel A, 2012, J AM MOSQUITO CONTR, V28, P113, DOI 10.2987/8756-971X-28.4s.113; de Morais SA, 2010, MEM I OSWALDO CRUZ, V105, P672, DOI 10.1590/S0074-02762010000500012; Descloux E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001470; Dibo MR, 2011, REV SOC BRAS MED TRO, V44, P496, DOI 10.1590/S0037-86822011000400019; Dujardin JP, 2008, INFECT GENET EVOL, V8, P875, DOI 10.1016/j.meegid.2008.07.011; Dujardin Jean-Pierre Al, 2010, BMC Res Notes, V3, P266, DOI 10.1186/1756-0500-3-266; Dujardin JP., 2006, ENCY INFECT DIS MODE, P433; Eastwood G, 2011, AM J TROP MED HYG, V85, P426, DOI 10.4269/ajtmh.2011.10-0739; Farajollahi A, 2011, INFECT GENET EVOL, V11, P1577, DOI 10.1016/j.meegid.2011.08.013; Forattini O.P., 2002, CULICIDOLOGIA MED ID; Fruciano C, 2016, DEV GENES EVOL, V226, P139, DOI 10.1007/s00427-016-0537-4; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harbach R. E., 2013, MOSQUITO TAXONOMIC I; Harbach RE, 2012, ZOOL SCR, V41, P499, DOI 10.1111/j.1463-6409.2012.00546.x; Harbach RE, 2011, ACTA TROP, V120, P1, DOI 10.1016/j.actatropica.2011.06.005; Harbach RE, 1998, SYST ENTOMOL, V23, P327, DOI 10.1046/j.1365-3113.1998.00072.x; Harbach RE, 2005, SYST BIODIVERS, V3, P345, DOI 10.1017/S147720000500174X; Henry A, 2010, INFECT GENET EVOL, V10, P207, DOI 10.1016/j.meegid.2009.12.001; Honorio NA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000545; Jaramillo N, 2015, MED VET ENTOMOL, V29, P26, DOI 10.1111/mve.12091; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Laurito M, 2015, ZOOMORPHOLOGY, V134, P447, DOI 10.1007/s00435-015-0271-x; Laurito M, 2013, MEM I OSWALDO CRUZ, V108, P110, DOI 10.1590/0074-0276130457; Lorenz C, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-257; Louise C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137851; Mayagaya VS, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0661-4; Medeiros-Sousa AR, 2015, ACTA TROP, V150, P200, DOI 10.1016/j.actatropica.2015.08.002; Medeiros-Sousa AR, 2013, J AM MOSQUITO CONTR, V29, P275, DOI 10.2987/12-6304R.1; Motoki MT, 2012, INFECT GENET EVOL, V12, P1246, DOI 10.1016/j.meegid.2012.04.002; Multini LC, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1256-9; Reinert JF, 2009, EUROPEAN MOSQUITO B, P68; Restrepo AC, 2014, TROP MED INT HEALTH, V19, P863, DOI 10.1111/tmi.12325; Rohlf FJ, 2008, TPSDIG DIGITIZE LAND; Sang SW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003808; Do TTT, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1078; Tipayamongkholgul M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-422; Vidal PO, 2011, REV BRAS ENTOMOL, V55, P134, DOI 10.1590/S0085-56262011000100022; VIDAL PO, 2012, INFECT GENET EVOL, V12, P591, DOI DOI 10.1016/j.meegid.2011.11.013; Virginio F, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0769-6; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2007, GLOB PROGR EL LYMPH; Wilkerson RC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133602; World Health Organization, 2015, NATURE; World Health Organization, 2012, DENG SEV DENG WHO FA	52	41	43	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0161643	10.1371/journal.pone.0161643	http://dx.doi.org/10.1371/journal.pone.0161643			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27551777	Green Published, Green Submitted, gold			2022-12-26	WOS:000381768800061
J	Goktas, S; Uslu, FE; Kowalski, WJ; Ermek, E; Keller, BB; Pekkan, K				Goktas, Selda; Uslu, Fazil E.; Kowalski, William J.; Ermek, Erhan; Keller, Bradley B.; Pekkan, Kerem			Time-Series Interactions of Gene Expression, Vascular Growth and Hemodynamics during Early Embryonic Arterial Development	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; EARLY CHICK-EMBRYO; SHEAR-STRESS; ENDOTHELIAL-CELLS; IN-VIVO; MU-PIV; FLOW; HEART; BLOOD; KLF2	The role of hemodynamic forces within the embryo as biomechanical regulators for cardiovascular morphogenesis, growth, and remodeling is well supported through the experimental studies. Furthermore, clinical experience suggests that perturbed flow disrupts the normal vascular growth process as one etiology for congenital heart diseases (CHD) and for fetal adaptation to CHD. However, the relationships between hemodynamics, gene expression and embryonic vascular growth are poorly defined due to the lack of concurrent, sequential in vivo data. In this study, a long-term, time-lapse optical coherence tomography (OCT) imaging campaign was conducted to acquire simultaneous blood velocity, pulsatile micro-pressure and morphometric data for 3 consecutive early embryonic stages in the chick embryo. In conjunction with the in vivo growth and hemodynamics data, in vitro reverse transcription polymerase chain reaction (RT-PCR) analysis was performed to track changes in transcript expression relevant to histogenesis and remodeling of the embryonic arterial wall. Our non-invasive extended OCT imaging technique for the microstructural data showed continuous vessel growth. OCT data coupled with the PIV technique revealed significant but intermitted increases in wall shear stress (WSS) between first and second assigned stages and a noticeable decrease afterwards. Growth rate, however, did not vary significantly throughout the embryonic period. Among all the genes studied, only the MMP2 and CASP-3 expression levels remained unchanged during the time course. Concurrent relationships were obtained among the transcriptional modulation of the genes, vascular growth and hemodynamics-related changes. Further studies are indicated to determine cause and effect relationships and reversibility between mechanical and molecular regulation of vasculogenesis.	[Goktas, Selda; Uslu, Fazil E.; Ermek, Erhan; Pekkan, Kerem] Koc Univ, Dept Mech Engn, Istanbul, Turkey; [Kowalski, William J.; Keller, Bradley B.] Univ Louisville, Cardiovasc Innovat Inst, Kosair Char Pediat Heart Res Program, Louisville, KY 40292 USA	Koc University; University of Louisville	Pekkan, K (corresponding author), Koc Univ, Dept Mech Engn, Istanbul, Turkey.	kpekkan@ku.edu.tr	Kowalski, William/D-1298-2017; Pekkan, Kerem/P-5038-2019	Kowalski, William/0000-0003-2343-2706; Pekkan, Kerem/0000-0001-7637-4445; Uslu, Fazil Emre/0000-0002-2620-4314	European Research Council (ERC) Starting Grant - Vascular Growth project [307460]; European Molecular Biology Organization (EMBO) YIP	European Research Council (ERC) Starting Grant - Vascular Growth project; European Molecular Biology Organization (EMBO) YIP	European Research Council (ERC) Starting Grant - Vascular Growth project #307460 and European Molecular Biology Organization (EMBO) YIP funded this study.	Al Naieb S, 2013, ANN ANAT, V195, P324, DOI 10.1016/j.aanat.2012.10.011; Al-Roubaie S, 2011, AM J PHYSIOL-HEART C, V301, pH2473, DOI 10.1152/ajpheart.00475.2011; Alexander SM, 1997, DEV DYNAM, V209, P261, DOI 10.1002/(SICI)1097-0177(199707)209:3<261::AID-AJA2>3.0.CO;2-G; Amaya R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129952; Anwar MA, 2012, J VASC RES, V49, P463, DOI 10.1159/000339151; Banjo T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2978; Berard X, 2013, J VASC SURG, V57, P1371, DOI 10.1016/j.jvs.2012.09.041; Burridge KA, 2010, AM J PHYSIOL-HEART C, V299, pH837, DOI 10.1152/ajpheart.00002.2010; Buschmann I, 2010, DEVELOPMENT, V137, P2187, DOI 10.1242/dev.045351; Carmeliet P, 1998, KIDNEY INT, V53, P1519, DOI 10.1046/j.1523-1755.1998.00936.x; Chen CY, 2013, EXP FLUIDS, V54, DOI 10.1007/s00348-012-1426-x; Conway EM, 2001, CARDIOVASC RES, V49, P507, DOI 10.1016/S0008-6363(00)00281-9; Cooley JR, 2014, DEV DYNAM, V243, P497, DOI 10.1002/dvdy.24085; Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; Dekker RJ, 2005, AM J PATHOL, V167, P609, DOI 10.1016/S0002-9440(10)63002-7; dela Paz NG, 2012, J CELL SCI, V125, P831, DOI 10.1242/jcs.084301; Filas BA, 2007, ANAT REC, V290, P1057, DOI 10.1002/ar.20575; Fujimoto JG, 2003, NAT BIOTECHNOL, V21, P1361, DOI 10.1038/nbt892; Garcia MD, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00308; Goktas S, 2015, METHODS MOL BIOL, V1189, P17, DOI 10.1007/978-1-4939-1164-6_2; Groenendijk BCW, 2005, CIRC RES, V96, P1291, DOI 10.1161/01.RES.0000171901.40952.0d; Groenendijk BCW, 2007, PHYSIOLOGY, V22, P380, DOI 10.1152/physiol.00023.2007; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hierck BP, 2008, DEV DYNAM, V237, P725, DOI 10.1002/dvdy.21472; Hove JR, 2003, NATURE, V421, P172, DOI 10.1038/nature01282; HU N, 1995, AM J PHYSIOL-HEART C, V269, pH1359, DOI 10.1152/ajpheart.1995.269.4.H1359; HU N, 1989, CIRC RES, V65, P1665, DOI 10.1161/01.RES.65.6.1665; Kowalski WJ, 2014, PROC SPIE, V8953, DOI 10.1117/12.2044932; Kowalski WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060271; le Noble F, 2005, CARDIOVASC RES, V65, P619, DOI 10.1016/j.cardiores.2004.09.018; Lee SJ, 2011, MICROVASC RES, V82, P296, DOI 10.1016/j.mvr.2011.09.005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Midgett M, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0643; MURPHY ME, 1978, AM J ANAT, V151, P345, DOI 10.1002/aja.1001510304; Nayak L, 2011, ANTIOXID REDOX SIGN, V15, P1449, DOI 10.1089/ars.2010.3647; Rochais F, 2009, CIRC RES, V104, P933, DOI 10.1161/CIRCRESAHA.109.194464; Roman BL, 2012, BIOMECH MODEL MECHAN, V11, P1149, DOI 10.1007/s10237-012-0412-9; SenBanerjee S, 2004, J EXP MED, V199, P1305, DOI 10.1084/jem.20031132; Stekelenburg-de Vos S, 2003, J EXP BIOL, V206, P1051, DOI 10.1242/jeb.00216; Ursem NTC, 2001, ULTRASOUND MED BIOL, V27, P919, DOI 10.1016/S0301-5629(01)00393-3; Yap CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086878; Yelbuz TM, 2002, CIRCULATION, V106, P2771, DOI 10.1161/01.CIR.0000042672.51054.7B	42	6	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0161611	10.1371/journal.pone.0161611	http://dx.doi.org/10.1371/journal.pone.0161611			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27552150	Green Published, gold			2022-12-26	WOS:000381768800057
J	John, G; Platon, A; Poletti, PA; Perrier, A; Bendjelid, K				John, Gregor; Platon, Alexandra; Poletti, Pierre-Alexandre; Perrier, Arnaud; Bendjelid, Karim			Contrast Circulation Time to Assess Right Ventricular Dysfunction in Pulmonary Embolism: A Retrospective Pilot Study	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; RISK STRATIFICATION; MEDIUM ENHANCEMENT; PROGNOSTIC VALUE; CT; METAANALYSIS; ANGIOGRAPHY; HYPERTENSION; PREDICTION; MANAGEMENT	Objective To optimize enhancement of pulmonary arteries and facilitate diagnosis of pulmonary embolism (PE), modern computed tomography angiography (CTA) contains a contrast bolus tracking system. We explored the diagnostic accuracy of the time-intensity curves given by this automated system to identify right ventricular dysfunction (RVD) in acute PE. Methods 114 CTAs with a diagnosis of PE were reviewed. RVD was defined as right-to-left ventricular diameter ratio of 1 or greater. Four parameters on time-intensity curves were identified. Parameters between CTAs with and those without RVD were compared with the Wilcoxon rank-sum test. The ability of the four parameters to discriminate patients with RVD was explored by compiling the area under the operating curves (AUC). Results The time needed by the contrast media to reach the pulmonary artery [8 seconds (IQR: 7-9) versus 7 seconds (IQR: 6-8), p<0.01], the time needed to reach 40 Hounsfield units (HU) [11 seconds (IQR: 8.5-14) versus 9.5 seconds (IQR: 8-10.5), p<0.01], and the contrast intensity reached after 10 seconds [19 HU (IQR: 4-67) versus 53 HU (IQR: 32-80), p<0.05] were all statistically different between CTA with and CTA without RVD. Those three parameters changed gradually across severity categories of RVD (p<0.05 for trend). Their AUC to identify RVD ranged from 0.63 to 0.66. The slope of contrast intensity over time was not informative: [31 HU/s (IQR: 20-57) in CTA with, compared to 36 HU/s (IQR: 22.5-53) in CTA without RVD, p = 0.60]. Conclusion Several parameters of the time-intensity curve obtained by the bolus tracking system are associated with RVD assessed on CTA images. Of those, the time needed to reach a predefined threshold seems to be the easiest to obtain in any CTA without additional processing time or contrast injection. However, the performance of those parameters is globally low.	[John, Gregor] Hop Neuchatelois, Dept Internal Med, Chasseral 20, CH-2300 La Chaux de Fonds, Switzerland; [John, Gregor; Perrier, Arnaud] Geneva Univ Hosp HUG, Dept Internal Med Rehabil & Geriatr, Gabrielle Perret Gentil 4, CH-1205 Geneva, Switzerland; [Platon, Alexandra; Poletti, Pierre-Alexandre] Geneva Univ Hosp HUG, Emergency Room Radiol Unit, Dept Radiol, Gabrielle Perret Gentil 4, CH-1205 Geneva, Switzerland; [Perrier, Arnaud] Geneva Fac Med, Michel Servet 1, CH-1206 Geneva, Switzerland; [Bendjelid, Karim] Univ Hosp Geneva, Intens Care Serv, Gabrielle Perret Gentil 4, CH-1211 Geneva, Switzerland; [Bendjelid, Karim] Geneva Fac Med, Gabrielle Perret Gentil 4, CH-1211 Geneva, Switzerland; [Bendjelid, Karim] Geneva Fac Med, Geneva Hemodynam Res Grp, Michel Servet 1, CH-1206 Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Geneva	John, G (corresponding author), Hop Neuchatelois, Dept Internal Med, Chasseral 20, CH-2300 La Chaux de Fonds, Switzerland.; John, G (corresponding author), Geneva Univ Hosp HUG, Dept Internal Med Rehabil & Geriatr, Gabrielle Perret Gentil 4, CH-1205 Geneva, Switzerland.	gregor.john@h-ne.ch	John, Gregor/AAJ-6424-2021; Bendjelid, Karim/A-5056-2018	John, Gregor/0000-0002-1548-7339; 				Aribas A, 2014, JPN J RADIOL, V32, P451, DOI 10.1007/s11604-014-0327-8; Aujesky D, 2011, LANCET, V378, P41, DOI 10.1016/S0140-6736(11)60824-6; Aviram G, 2008, J THROMB HAEMOST, V6, P1488, DOI 10.1111/j.1538-7836.2008.03079.x; Azzalini L, 2016, CAN J CARDIOL, V32, P247, DOI 10.1016/j.cjca.2015.05.013; Bae KT, 1998, RADIOLOGY, V207, P657, DOI 10.1148/radiology.207.3.9609887; Bae KT, 1998, RADIOLOGY, V207, P647, DOI 10.1148/radiology.207.3.9609886; Becattini C, 2014, EUR RESPIR J, V43, P1678, DOI 10.1183/09031936.00147813; Cademartiri F, 2002, J COMPUT ASSIST TOMO, V26, P598, DOI 10.1097/00004728-200207000-00022; Chong E, 2012, SINGAP MED J, V53, P164; Coutance G, 2011, CRIT CARE, V15, DOI 10.1186/cc10119; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Davarpanah AH, 2011, AM J ROENTGENOL, V197, P1064, DOI 10.2214/AJR.10.5420; George E, 2014, J THORAC IMAG, V29, pW7, DOI 10.1097/RTI.0000000000000048; Ghaye B, 2006, RADIOLOGY, V239, P884, DOI 10.1148/radiol.2392050075; Ghuysen A, 2005, THORAX, V60, P956, DOI 10.1136/thx.2005.040873; Goldhaber SZ, 2002, ANN INTERN MED, V136, P691, DOI 10.7326/0003-4819-136-9-200205070-00012; Goldhaber SZ, 1999, LANCET, V353, P1386, DOI 10.1016/S0140-6736(98)07534-5; Gosselin MV, 1997, AM J ROENTGENOL, V169, P1597, DOI 10.2214/ajr.169.6.9393173; In E, 2015, JPN J RADIOL, V33, P471, DOI 10.1007/s11604-015-0447-9; Jaff MR, 2011, CIRCULATION, V123, P1788, DOI 10.1161/CIR.0b013e318214914f; John G, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/363756; Kang DK, 2010, AM J ROENTGENOL, V194, P1500, DOI 10.2214/AJR.09.3717; Konstantinides S, 1998, CIRCULATION, V97, P1946, DOI 10.1161/01.CIR.97.19.1946; Konstantinides SV, 2014, EUR HEART J, V35, P3033, DOI 10.1093/eurheartj/ehu283; Le Gal G, 2006, ANN INTERN MED, V144, P165, DOI 10.7326/0003-4819-144-3-200602070-00004; Li CR, 2015, J APPL REMOTE SENS, V8, DOI 10.1117/1.JRS.8.083498; MANSKE CL, 1990, AM J MED, V89, P615, DOI 10.1016/0002-9343(90)90180-L; Marti C, 2015, EUR HEART J, V36, P605, DOI 10.1093/eurheartj/ehu218; MCINTYRE KM, 1971, AM J CARDIOL, V28, P288, DOI 10.1016/0002-9149(71)90116-0; Meinel FG, 2015, AM J MED, V128, P747, DOI 10.1016/j.amjmed.2015.01.023; Meyer G, 2014, NEW ENGL J MED, V370, P1402, DOI 10.1056/NEJMoa1302097; Pienn M, 2014, EUR RADIOL, V24, P668, DOI 10.1007/s00330-013-3067-8; Platt JF, 1999, AM J ROENTGENOL, V172, P53, DOI 10.2214/ajr.172.1.9888738; Ramos-Duran LR, 2010, J THORAC IMAG, V25, P270, DOI 10.1097/RTI.0b013e3181efe8b0; Reid JH, 1998, CLIN RADIOL, V53, P694, DOI 10.1016/S0009-9260(98)80297-3; Sanchez O, 2008, EUR HEART J, V29, P1569, DOI 10.1093/eurheartj/ehn208; Seon HJ, 2011, CIRC J, V75, P428, DOI 10.1253/circj.CJ-10-0361; Tillich M, 2005, EUR RADIOL, V15, pE66, DOI 10.1007/s10406-005-0167-9; Trujillo-Santos J, 2013, J THROMB HAEMOST, V11, P1823, DOI 10.1111/jth.12393; Weekes AJ, 2016, ANN EMERGENCY MED, DOI 10.1016a. annemergmed.2016.01.027; Wicki J, 2001, ARCH INTERN MED, V161, P92, DOI 10.1001/archinte.161.1.92	41	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0159674	10.1371/journal.pone.0159674	http://dx.doi.org/10.1371/journal.pone.0159674			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27551831	Green Submitted, Green Published, gold			2022-12-26	WOS:000381768800009
J	Nielsen, ML; Isbrandt, T; Petersen, LM; Mortensen, UH; Andersen, MR; Hoof, JB; Larsen, TO				Nielsen, Maria Lund; Isbrandt, Thomas; Petersen, Lene Maj; Mortensen, Uffe Hasbro; Andersen, Mikael Rordam; Hoof, Jakob Blaesbjerg; Larsen, Thomas Ostenfeld			Linker Flexibility Facilitates Module Exchange in Fungal Hybrid PKS-NRPS Engineering	PLOS ONE			English	Article							SYNTHASE-PEPTIDE SYNTHETASE; AVIRULENCE GENE ACE1; ADENYLATION DOMAINS; NATURAL-PRODUCTS; BIOSYNTHESIS; CLUSTER; ACID; METABOLITE; EXPRESSION	Polyketide synthases (PKSs) and nonribosomal peptide synthetases (NRPSs) each give rise to a vast array of complex bioactive molecules with further complexity added by the existence of natural PKS-NRPS fusions. Rational genetic engineering for the production of natural product derivatives is desirable for the purpose of incorporating new functionalities into pre-existing molecules, or for optimization of known bioactivities. We sought to expand the range of natural product diversity by combining modules of PKS-NRPS hybrids from different hosts, hereby producing novel synthetic natural products. We succeeded in the construction of a functional cross-species chimeric PKS-NRPS expressed in Aspergillus nidulans. Module swapping of the two PKS-NRPS natural hybrids CcsA from Aspergillus clavatus involved in the biosynthesis of cytochalasin E and related Syn2 from rice plant pathogen Magnaporthe oryzae lead to production of novel hybrid products, demonstrating that the rational re-design of these fungal natural product enzymes is feasible. We also report the structure of four novel pseudo pre-cytochalasin intermediates, niduclavin and niduporthin along with the chimeric compounds niduchimaeralin A and B, all indicating that PKS-NRPS activity alone is insufficient for proper assembly of the cytochalasin core structure. Future success in the field of biocombinatorial synthesis of hybrid polyketide-nonribosomal peptides relies on the understanding of the fundamental mechanisms of inter-modular polyketide chain transfer. Therefore, we expressed several PKS-NRPS linker-modified variants. Intriguingly, the linker anatomy is less complex than expected, as these variants displayed great tolerance with regards to content and length, showing a hitherto unreported flexibility in PKS-NRPS hybrids, with great potential for synthetic biology-driven biocombinatorial chemistry.	[Nielsen, Maria Lund; Isbrandt, Thomas; Petersen, Lene Maj; Mortensen, Uffe Hasbro; Andersen, Mikael Rordam; Hoof, Jakob Blaesbjerg; Larsen, Thomas Ostenfeld] Tech Univ Denmark, Dept Syst Biol, Lyngby, Denmark; [Petersen, Lene Maj] Lundbeck AS, Ottiliavej 9, Valby, Denmark	Technical University of Denmark; Lundbeck Corporation	Larsen, TO (corresponding author), Tech Univ Denmark, Dept Syst Biol, Lyngby, Denmark.	tol@bio.dtu.dk	Andersen, Mikael R/F-9377-2013; Mortensen, Uffe/AAQ-1150-2021; Hoof, Jakob Blæsbjerg/L-6019-2015; Andersen, Mikael Rørdam/P-6743-2019	Andersen, Mikael R/0000-0003-4794-6808; Hoof, Jakob Blæsbjerg/0000-0002-7650-9300; Andersen, Mikael Rørdam/0000-0003-4794-6808; Larsen, Thomas Ostenfeld/0000-0002-3362-5707; Nielsen, Maria Lund/0000-0002-9068-8210	Novo Nordisk Foundation; Novo Nordisk Fonden [NNF12OC0000796] Funding Source: researchfish; Villum Fonden [00007361] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Fonden(Novo Nordisk Foundation); Villum Fonden(Villum Fonden)	This work was supported by the Novo Nordisk Foundation (http://www.novonordiskfonden.dk/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boettger D, 2013, CHEMBIOCHEM, V14, P28, DOI 10.1002/cbic.201200624; Boettger D, 2012, CHEMBIOCHEM, V13, P2363, DOI 10.1002/cbic.201200449; Bohnert HU, 2004, PLANT CELL, V16, P2499, DOI 10.1105/tpc.104.022715; Campbell CD, 2010, BIOPOLYMERS, V93, P755, DOI 10.1002/bip.21428; Challis GL, 2000, CHEM BIOL, V7, P211, DOI 10.1016/S1074-5521(00)00091-0; Chooi YH, 2012, J ORG CHEM, V77, P9933, DOI 10.1021/jo301592k; Collemare J, 2008, NEW PHYTOL, V179, P196, DOI 10.1111/j.1469-8137.2008.02459.x; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Fisch KM, 2011, J AM CHEM SOC, V133, P16635, DOI 10.1021/ja206914q; Fisch KM, 2013, RSC ADV, V3, P18228, DOI 10.1039/c3ra42661k; Fujii R, 2016, BIOSCI BIOTECH BIOCH, V80, P426, DOI 10.1080/09168451.2015.1104234; Fujii R, 2013, TETRAHEDRON LETT, V54, P2999, DOI 10.1016/j.tetlet.2013.03.120; Geu-Flores F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm106; Hansen BG, 2011, APPL ENVIRON MICROB, V77, P3044, DOI 10.1128/AEM.01768-10; Heneghan MN, 2011, CHEM SCI, V2, P972, DOI 10.1039/c1sc00023c; Heneghan MN, 2010, CHEMBIOCHEM, V11, P1508, DOI 10.1002/cbic.201000259; Hertweck C, 2015, TRENDS BIOCHEM SCI, V40, P189, DOI 10.1016/j.tibs.2015.02.001; Hertweck C, 2009, ANGEW CHEM INT EDIT, V48, P4688, DOI 10.1002/anie.200806121; Holm DK, 2014, CHEM BIOL, V21, P519, DOI 10.1016/j.chembiol.2014.01.013; Ishikawa N, 2014, ANGEW CHEM INT EDIT, V53, P12880, DOI 10.1002/anie.201407920; Kakule TB, 2014, J AM CHEM SOC, V136, P17882, DOI 10.1021/ja511087p; Kakule TB, 2013, ACS CHEM BIOL, V8, P1549, DOI 10.1021/cb400159f; Kasahara K, 2010, CHEMBIOCHEM, V11, P1245, DOI 10.1002/cbic.201000173; Khaldi N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r18; Klas K, 2015, J ORG CHEM, V80, P11672, DOI 10.1021/acs.joc.5b01951; Kontnik R, 2008, ORG LETT, V10, P4149, DOI 10.1021/ol801726k; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Martinez-Luis S, 2012, NAT PROD COMMUN, V7, P165; Newman DJ, 2016, J NAT PROD, V79, P629, DOI 10.1021/acs.jnatprod.5b01055; Nodvig CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133085; Norholm MHH, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-21; Ostermeier M, 2001, ADV PROTEIN CHEM, V55, P29, DOI 10.1016/S0065-3233(01)55002-0; Qiao KJ, 2011, METAB ENG, V13, P723, DOI 10.1016/j.ymben.2011.09.008; Rausch C, 2005, NUCLEIC ACIDS RES, V33, P5799, DOI 10.1093/nar/gki885; Rottig M, 2011, NUCLEIC ACIDS RES, V39, pW362, DOI 10.1093/nar/gkr323; Scherlach K, 2010, NAT PROD REP, V27, P869, DOI 10.1039/b903913a; SEIDLER NW, 1989, J BIOL CHEM, V264, P17816; Sims JW, 2005, CHEM COMMUN, P186, DOI 10.1039/b413523g; Smedsgaard J, 1997, J CHROMATOGR A, V760, P264, DOI 10.1016/S0021-9673(96)00803-5; Sondergaard TE, 2011, TOXICOL LETT, V205, P116, DOI 10.1016/j.toxlet.2011.05.1029; Song ZS, 2015, CHEM SCI, V6, P4837, DOI 10.1039/c4sc03707c; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Suzuki S, 2000, J NAT PROD, V63, P768, DOI 10.1021/np990371x; Udagawa T, 2000, J PHARMACOL EXP THER, V294, P421; Wriggers W, 2005, BIOPOLYMERS, V80, P736, DOI 10.1002/bip.20291; Xu W, 2010, J AM CHEM SOC, V132, P13604, DOI 10.1021/ja107084d; Xue MF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002869; Yang YL, 2007, CHEM-EUR J, V13, P6985, DOI 10.1002/chem.200700038	49	25	26	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0161199	10.1371/journal.pone.0161199	http://dx.doi.org/10.1371/journal.pone.0161199			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27551732	Green Submitted, Green Published, gold			2022-12-26	WOS:000381768800024
J	Huang, DX; Lin, C; Wen, XJ; Gu, SY; Zhao, P				Huang, Daoxiang; Lin, Chao; Wen, Xuejun; Gu, Shuying; Zhao, Peng			A Potential Nanofiber Membrane Device for Filling Surgical Residual Cavity to Prevent Glioma Recurrence and Improve Local Neural Tissue Reconstruction	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; VASCULOGENIC MIMICRY; CANCER RECURRENCE; GLIOBLASTOMA; TEMOZOLOMIDE; CELLS; CHEMOTHERAPY; COMBINATION	This study aims to develop a novel device with nanofiber membrane capable of sustained release of temozolomide (TMZ) and neuron growth factor (NGF). An improved bio-availability of TMZ and NGF in surroundings proximal to the device was expected to be attained for a prolonged period of time. The device was developed by integrating TMZ-doped polycaprolactone (PCL) nanofiber (TP) membrane and NGF-coated PCL (NGFP) membrane using sodium alginate hydrogel. TP was prepared by direct electrospinning of TMZ/ PCL. NGFP membrane was developed by layer-by-layer assembling technology. The incorporation of TMZ-doped nanofiber and NGFP nanofiber in the device was confirmed by scanning electron microscopy. The number of NGF layer in NGF-coated PCL membrane could be readily measured with energy spectrum analysis. The in vitro release study showed that TP-NGFP-TP membrane could efficiently liberate TMZ to inhibit the growth of C6 glioma cells, and sufficient NGF to induce the differentiation of PC12 neuron cells over four weeks. Such TP-NGFP-TP membrane device can be employed as a tampon to fill up surgical residual cavity and afford residual glioma removal, structural support, hemostasis, and local neural tissue reconstruction in the surgical treatment of glioma. The study opens a horizon to develop multifunctional biomaterial device for maximized glioma treatment efficacy.	[Huang, Daoxiang; Lin, Chao; Wen, Xuejun; Zhao, Peng] Tongji Univ, Sch Med, Shanghai East Hosp, Inst Biomed Engn & Nanosci,Inst Translat Nanomed, Shanghai, Peoples R China; [Gu, Shuying] Tongji Univ, Sch Mat Sci & Engn, Minist Educ, Key Lab Adv Civil Engn Mat, Shanghai, Peoples R China; [Huang, Daoxiang; Gu, Shuying] Tongji Univ, Sch Mat Sci & Engn, Inst Nano & Biopolymer Mat, Shanghai, Peoples R China	Tongji University; Tongji University; Tongji University	Zhao, P (corresponding author), Tongji Univ, Sch Med, Shanghai East Hosp, Inst Biomed Engn & Nanosci,Inst Translat Nanomed, Shanghai, Peoples R China.; Gu, SY (corresponding author), Tongji Univ, Sch Mat Sci & Engn, Minist Educ, Key Lab Adv Civil Engn Mat, Shanghai, Peoples R China.; Gu, SY (corresponding author), Tongji Univ, Sch Mat Sci & Engn, Inst Nano & Biopolymer Mat, Shanghai, Peoples R China.	gushuying@tongji.edu.cn; zp@tongji.edu.cn	Zhao, Peng/HDO-7507-2022		Ministry of Science and Technology of the People's Republic of China [2014CB964600, 2012CB966300]; National Natural Science Funds of China [81271369]; Fundamental Research Funds for the Central Universities	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Natural Science Funds of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the Ministry of Science and Technology of the People's Republic of China (2014CB964600 to Dr. Peng Zhao); Ministry of Science and Technology of the People's Republic of China (2012CB966300 to Dr. Xuejun Wen); National Natural Science Funds of China (81271369 to Dr. Xuejun Wen); and Fundamental Research Funds for the Central Universities (Dr. Peng Zhao).	Aloe L, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-239; Falsini B, 2016, BRAIN, V139, P404, DOI 10.1093/brain/awv366; Feng XY, 2015, ACS APPL MATER INTER, V7, P27885, DOI 10.1021/acsami.5b09934; Gonzalez-Astorga B, 2013, EUR J CANCER, V49, pS794; Goodenberger ML, 2012, CANCER GENET-NY, V205, P613, DOI 10.1016/j.cancergen.2012.10.009; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Ju RJ, 2016, INT J NANOMED, V11, P1131, DOI 10.2147/IJN.S94467; Kaplan JA, 2016, BIOMATERIALS, V76, P273, DOI 10.1016/j.biomaterials.2015.10.060; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Liu S, 2015, NANOMED-NANOTECHNOL, V11, P1047, DOI 10.1016/j.nano.2015.03.001; Liu YP, 2015, WORLD J SURG ONCOL, V13, DOI 10.1186/s12957-015-0558-x; Middleton MR, 2002, INT J CANCER, V100, P615, DOI 10.1002/ijc.10532; Mustafa AM, 2016, FOOD CHEM, V192, P782, DOI 10.1016/j.foodchem.2015.07.079; Naito E, 2015, IN VITRO CELL DEV-AN, V51, P1012, DOI 10.1007/s11626-015-9935-6; Narin S, 2013, FEBS J, V280, P418; Ni SL, 2014, ANN BIOMED ENG, V42, P214, DOI 10.1007/s10439-013-0903-6; Okonogi N, 2015, ANTICANCER RES, V35, P1229; Paw I, 2015, CANCER LETT, V362, P1, DOI 10.1016/j.canlet.2015.03.015; Reardon DA, 2006, ONCOLOGIST, V11, P152, DOI 10.1634/theoncologist.11-2-152; Zhu TH, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.41982; Zong S, 2015, EUR J PHARM BIOPHARM, V93, P127, DOI 10.1016/j.ejpb.2015.03.029	22	13	14	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161435	10.1371/journal.pone.0161435	http://dx.doi.org/10.1371/journal.pone.0161435			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548322	Green Published, gold, Green Submitted			2022-12-26	WOS:000381768400057
J	Papaioannou, A; Kuyucak, S; Kuncic, Z				Papaioannou, Anastasios; Kuyucak, Serdar; Kuncic, Zdenka			Elucidating the Activation Mechanism of the Insulin-Family Proteins with Molecular Dynamics Simulations	PLOS ONE			English	Article							GROWTH-FACTOR-II; HORMONE-RECEPTOR INTERFACE; HIGH-AFFINITY BINDING; IGF-II; BIOLOGICAL-ACTIVITY; ISOFORM-A; SITE; ANALOGS; CANCER; B26	The insulin-family proteins bind to their own receptors, but insulin-like growth factor II (IGFII) can also bind to the A isoform of the insulin receptor (IR-A), activating unique and alternative signaling pathways from those of insulin. Although extensive studies of insulin have revealed that its activation is associated with the opening of the B chain-C terminal (BCCT), the activation mechanism of the insulin-like growth factors (IGFs) still remains unknown. Here, we present the first comprehensive study of the insulin-family proteins comparing their activation process and mechanism using molecular dynamics simulations to reveal new insights into their specificity to the insulin receptor. We have found that all the proteins appear to exhibit similar stochastic dynamics in their conformational change to an active state. For the IGFs, our simulations show that activation involves two opening locations: the opening of the BC-CT section away from the core, similar to insulin; and the additional opening of the BC-CT section away from the C domain. Furthermore, we have found that these two openings occur simultaneously in IGF-I, but not in IGF-II, where they can occur independently. This suggests that the BC-CT section and the C domain behave as a unified domain in IGF-I, but as two independent domains in IGF-II during the activation process, implying that the IGFs undergo different activation mechanisms for receptor binding. The probabilities of the active and inactive states of the proteins suggest that IGF-II is hyperactive compared to IGF-I. The hinge residue and the hydrophobic interactions in the core are found to play a critical role in the stability and activity of IGFs. Overall, our simulations have elucidated the crucial differences and similarities in the activation mechanisms of the insulin-family proteins, providing new insights into the molecular mechanisms responsible for the observed differences between IGF-I and IGF-II in receptor binding.	[Papaioannou, Anastasios; Kuncic, Zdenka] Univ Sydney, Charles Perkins Ctr, Sydney, NSW, Australia; [Papaioannou, Anastasios; Kuyucak, Serdar; Kuncic, Zdenka] Univ Sydney, Sch Phys, Sydney, NSW, Australia	University of Sydney; University of Sydney	Papaioannou, A; Kuncic, Z (corresponding author), Univ Sydney, Charles Perkins Ctr, Sydney, NSW, Australia.; Papaioannou, A; Kuncic, Z (corresponding author), Univ Sydney, Sch Phys, Sydney, NSW, Australia.	anastasios.papaioannou@sydney.edu.au; zdenka.kuncic@sydney.edu.au	Kuyucak, Serdar/AAH-8417-2021	Kuyucak, Serdar/0000-0003-4315-9532; Papaioannou, Anastasios/0000-0002-8959-4559; Kuncic, Zdenka/0000-0001-6765-3215	University of Sydney International Scholarship (USydIS)	University of Sydney International Scholarship (USydIS)	AP acknowledges a University of Sydney International Scholarship (USydIS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Michael C. Lawrence is thanked for his invaluable advice and discussions. AP acknowledges a University of Sydney International Scholarship (USydIS). All the MD simulations were performed using the Avoca cluster at the Victorian Life Sciences Computation Initiative (VLSCI, Melbourne, Australia) and the Raijin cluster at the National Computational Infrastructure (NCI, Canberra, Australia).	BAYNE ML, 1989, J BIOL CHEM, V264, P11004; Belfiore A, 2011, ENDOCR-RELAT CANCER, V18, pR125, DOI 10.1530/ERC-11-0074; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Brown J, 2008, EMBO J, V27, P265, DOI 10.1038/sj.emboj.7601938; Brzozowski AM, 2002, BIOCHEMISTRY-US, V41, P9389, DOI 10.1021/bi020084j; De Meyts P, 2015, BIOESSAYS, V37, P389, DOI 10.1002/bies.201400190; Denley A, 2004, MOL ENDOCRINOL, V18, P2502, DOI 10.1210/me.2004-0183; DiMarchi RD, 2006, UNDERSTANDING BIOLOGY USING PEPTIDES, P229, DOI 10.1007/978-0-387-26575-9_97; Frasca F, 1999, MOL CELL BIOL, V19, P3278, DOI 10.1128/mcb.19.5.3278; Frasca Francesco, 2008, Archives of Physiology and Biochemistry, V114, P23, DOI [10.1080/13813450801969715, 10.1080/13813450801969715 ]; Gauguin L, 2008, J BIOL CHEM, V283, P2604, DOI 10.1074/jbc.M709220200; GICQUEL C, 1994, J CLIN ENDOCR METAB, V78, P1444, DOI 10.1210/jc.78.6.1444; Henderson ST, 2015, GROWTH HORM IGF RES, V25, P20, DOI 10.1016/j.ghir.2014.09.004; HU SQ, 1993, J PROTEIN CHEM, V12, P741, DOI 10.1007/BF01024932; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jiang LY, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-131; Jiracek J, 2010, P NATL ACAD SCI USA, V107, P1966, DOI 10.1073/pnas.0911785107; Louvi A, 1997, DEV BIOL, V189, P33, DOI 10.1006/dbio.1997.8666; MacKerell A. D., 1998, ENCY COMPUTATIONAL C, V1, P271; Menting JG, 2015, STRUCTURE, V23, P1271, DOI 10.1016/j.str.2015.04.016; Menting JG, 2014, P NATL ACAD SCI USA, V111, pE3395, DOI 10.1073/pnas.1412897111; Menting JG, 2013, NATURE, V493, P241, DOI 10.1038/nature11781; Morcavallo A, 2011, MOL ENDOCRINOL, V25, P1456, DOI 10.1210/me.2010-0484; Pandini G, 2003, J BIOL CHEM, V278, P42178, DOI 10.1074/jbc.M304980200; Pandyarajan V, 2016, J BIOL CHEM, V291, P12978, DOI 10.1074/jbc.M115.708347; Pandyarajan V, 2014, J BIOL CHEM, V289, P34709, DOI 10.1074/jbc.M114.608562; Papaioannou A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144058; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Quinn KA, 1996, J BIOL CHEM, V271, P11477, DOI 10.1074/jbc.271.19.11477; Renehan AG, 2000, BRIT J CANCER, V83, P1344, DOI 10.1054/bjoc.2000.1462; Sacco A, 2009, ENDOCRINOLOGY, V150, P3594, DOI 10.1210/en.2009-0377; Sorensen H, 2004, FEBS LETT, V565, P19, DOI 10.1016/j.febslet.2004.03.077; TORRES AM, 1995, J MOL BIOL, V248, P385, DOI 10.1006/jmbi.1995.0229; Vella V, 2002, J CLIN ENDOCR METAB, V87, P245, DOI 10.1210/jc.87.1.245; Ward CW, 2013, BIOESSAYS, V35, P945, DOI 10.1002/bies.201300065; Ward CW, 2009, BIOESSAYS, V31, P422, DOI 10.1002/bies.200800210; Williams C, 2012, SCIENCE, V338, P1209, DOI 10.1126/science.1228633; Zakova L, 2004, BIOCHEMISTRY-US, V43, P2323, DOI 10.1021/bi036001w; Zakova L, 2008, BIOCHEMISTRY-US, V47, P5858, DOI 10.1021/bi702086w; Zakova L, 2014, ACTA CRYSTALLOGR D, V70, P2765, DOI 10.1107/S1399004714017775; Zakova L, 2013, J BIOL CHEM, V288, P10230, DOI 10.1074/jbc.M112.448050; ZHANG WG, 1994, J BIOL CHEM, V269, P10609	44	4	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161459	10.1371/journal.pone.0161459	http://dx.doi.org/10.1371/journal.pone.0161459			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548502	Green Published, gold, Green Submitted			2022-12-26	WOS:000381768400059
J	Sluik, D; Jankovic, N; O'Doherty, MG; Geelen, A; Schottker, B; Rolandsson, O; Kiefte-de Jong, JC; Ferrieres, J; Bamia, C; Fransen, HP; Boer, JMA; Eriksson, S; Martinez, B; Huerta, JM; Kromhout, D; de Groot, LCPGM; Franco, OH; Trichopoulou, A; Boffetta, P; Kee, F; Feskens, EJM				Sluik, Diewertje; Jankovic, Nicole; O'Doherty, Mark G.; Geelen, Anouk; Schoettker, Ben; Rolandsson, Olov; Kiefte-de Jong, Jessica C.; Ferrieres, Jean; Bamia, Christina; Fransen, Heidi P.; Boer, Jolanda M. A.; Eriksson, Sture; Martinez, Begona; Maria Huerta, Jose; Kromhout, Daan; de Groot, Lisette C. P. G. M.; Franco, Oscar H.; Trichopoulou, Antonia; Boffetta, Paolo; Kee, Frank; Feskens, Edith J. M.			Alcoholic Beverage Preference and Dietary Habits in Elderly across Europe: Analyses within the Consortium on Health and Ageing: Network of Cohorts in Europe and the United States (CHANCES) Project	PLOS ONE			English	Article							CONSUMPTION PATTERNS; DRINKING PATTERNS; LIFE-STYLE; WINE; MORTALITY; BEER; DETERMINANTS; POPULATION; GUIDELINES; SPIRITS	Introduction The differential associations of beer, wine, and spirit consumption on cardiovascular risk found in observational studies may be confounded by diet. We described and compared dietary intake and diet quality according to alcoholic beverage preference in European elderly. Methods From the Consortium on Health and Ageing: Network of Cohorts in Europe and the United States (CHANCES), seven European cohorts were included, i.e. four sub-cohorts from EPIC-Elderly, the SENECA Study, the Zutphen Elderly Study, and the Rotterdam Study. armonized data of 29,423 elderly participants from 14 European countries were analyzed. Baseline data on consumption of beer, wine, and spirits, and dietary intake were collected with questionnaires. Diet quality was assessed using the Healthy Diet Indicator (HDI). Intakes and scores across categories of alcoholic beverage preference (beer, wine, spirit, no preference, non-consumers) were adjusted for age, sex, socio-economic status, self reported prevalent diseases, and lifestyle factors. Cohort-specific mean intakes and scores were calculated as well as weighted means combining all cohorts. Results In 5 of 7 cohorts, persons with a wine preference formed the largest group. After multivariate adjustment, persons with a wine preference tended to have a higher HDI score and intake of healthy foods in most cohorts, but differences were small. The weighted estimates of all cohorts combined revealed that non-consumers had the highest fruit and vegetable intake, followed by wine consumers. Non-consumers and persons with no specific preference had a higher HDI score, spirit consumers the lowest. However, overall diet quality as measured by HDI did not differ greatly across alcoholic beverage preference categories. Discussion This study using harmonized data from similar to 30,000 elderly from 14 European countries showed that, after multivariate adjustment, dietary habits and diet quality did not differ greatly according to alcoholic beverage preference.	[Sluik, Diewertje; Jankovic, Nicole; Geelen, Anouk; Kromhout, Daan; de Groot, Lisette C. P. G. M.; Feskens, Edith J. M.] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands; [Jankovic, Nicole] Univ Duisburg Essen, Fac Med, Ctr Clin Epidemiol, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [O'Doherty, Mark G.; Kee, Frank] Queens Univ Belfast, UKCRC Ctr Excellence Publ Hlth, Belfast, Antrim, North Ireland; [Schoettker, Ben] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Schoettker, Ben] FOM Univ, Inst Hlth Care & Social Sci, Essen, Germany; [Rolandsson, Olov; Eriksson, Sture] Umea Univ, Dept Publ Hlth & Clin Med, Family Med, Umea, Sweden; [Kiefte-de Jong, Jessica C.] Leiden Univ Coll, Global Publ Hlth, The Hague, Netherlands; [Kiefte-de Jong, Jessica C.; Franco, Oscar H.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Ferrieres, Jean] Toulouse Univ, Sch Med, Dept Cardiol, Toulouse, France; [Bamia, Christina; Trichopoulou, Antonia; Boffetta, Paolo] Hellen Hlth Fdn, Athens, Greece; [Bamia, Christina; Trichopoulou, Antonia] Univ Athens, Unit Nutr Epidemiol & Nutr Publ Hlth, Dept Hyg Epidemiol & Med Stat, WHO Collaborating Ctr Nutr & Hlth,Sch Med, Athens, Greece; [Fransen, Heidi P.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Boer, Jolanda M. A.] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Martinez, Begona] Univ Granada, Hosp Univ Granada, Escuela Andaluza Salud Publ, Inst Invest Biosanitaria Ibs Granada, Granada, Spain; [Martinez, Begona; Maria Huerta, Jose] CIBER Epidemiol Salud Publ CIBERESP, Madrid, Spain; [Maria Huerta, Jose] IMIB Arrixaca, Murcia Reg Hlth Council, Dept Epidemiol, Murcia, Spain; [Boffetta, Paolo] Mt Sinai Sch Med, Icahn Sch Med, New York, NY USA	Wageningen University & Research; University of Duisburg Essen; Queens University Belfast; Helmholtz Association; German Cancer Research Center (DKFZ); Umea University; Erasmus University Rotterdam; Erasmus MC; Universite de Franche-Comte; Universite Federale Toulouse Midi-Pyrenees (ComUE); Athens Medical School; National & Kapodistrian University of Athens; Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment; Escuela Andaluza de Salud Publica; Instituto de Investigacion Biosanitaria IBS Granada; University of Granada; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Hospital Clinico Universitario Virgen de la Arrixaca; Murcia Regional Health Council; Icahn School of Medicine at Mount Sinai	Sluik, D (corresponding author), Wageningen Univ, Div Human Nutr, Wageningen, Netherlands.	Diewertje.Sluik@wur.nl	Schöttker, Ben/F-8183-2014; TRICHOPOULOU, ANTONIA/ABF-8727-2021; Huerta, José María/N-8654-2015; Boffetta, Paolo/AAI-7767-2021; Franco, Óscar H/ABE-2305-2020; Kiefte-de Jong, Jessica/GLV-3216-2022; Eriksson, Sture/AAF-8435-2021; Feskens, Edith/ABI-1446-2020; Ferrieres, Jean/S-7993-2016	Schöttker, Ben/0000-0002-1217-4521; TRICHOPOULOU, ANTONIA/0000-0002-7204-6396; Huerta, José María/0000-0002-9637-3869; Boffetta, Paolo/0000-0002-3811-2791; Franco, Óscar H/0000-0002-4606-4929; Kiefte-de Jong, Jessica/0000-0002-8136-0918; Eriksson, Sture/0000-0002-3098-3787; Feskens, Edith/0000-0001-5819-2488; de Groot, Lisette/0000-0003-2778-2789; Ferrieres, Jean/0000-0001-6144-1297; Sluik, Diewertje/0000-0001-6304-0913	European Foundation for Alcohol Research (ERAB); Dutch Beer Institute; FP7 framework programme of the Directorate General for Research & Innovation in the European Commission [242244]; Health Research Fund (FIS) of the Spanish Ministry of Health (Spain); CIBER de Epidemiologia y Salud Publica (CIBERESP); Spanish Regional Governments of Andalucia, Asturias, Basque Country, Murcia [6236]; Navarra (Spain); Medical Research Council [MC_CF023241] Funding Source: researchfish	European Foundation for Alcohol Research (ERAB); Dutch Beer Institute; FP7 framework programme of the Directorate General for Research & Innovation in the European Commission; Health Research Fund (FIS) of the Spanish Ministry of Health (Spain); CIBER de Epidemiologia y Salud Publica (CIBERESP); Spanish Regional Governments of Andalucia, Asturias, Basque Country, Murcia; Navarra (Spain); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work of DS was supported by the European Foundation for Alcohol Research (ERAB) and the Dutch Beer Institute. The sponsor did not have any role in the design and conduct of the study; collection, management, analysis and interpretation of the data; and preparation, review or approval of the manuscript. This analysis was part of the Consortium on Health and Ageing (CHANCES) project funded in the FP7 framework programme of the Directorate General for Research & Innovation in the European Commission (grant 242244). The CHANCES project is coordinated by the Hellenic Health Foundation, Greece. The EPIC-Elderly Study was partially supported by the Health Research Fund (FIS) of the Spanish Ministry of Health (Spain); the CIBER de Epidemiologia y Salud Publica (CIBERESP), and the Spanish Regional Governments of Andalucia, Asturias, Basque Country, Murcia (no. 6236) and Navarra (Spain).	Alcacera MA, 2008, EUR J CLIN NUTR, V62, P1178, DOI 10.1038/sj.ejcn.1602833; Barefoot JC, 2002, AM J CLIN NUTR, V76, P466, DOI 10.1093/ajcn/76.2.466; Boffetta P, 2014, EUR J EPIDEMIOL, V29, P929, DOI 10.1007/s10654-014-9977-1; Breslow RA, 2006, AM J EPIDEMIOL, V163, P359, DOI 10.1093/aje/kwj050; Buijsse B, 2006, ARCH INTERN MED, V166, P411, DOI 10.1001/.411; Chatenoud L, 2000, EUR J CLIN NUTR, V54, P177, DOI 10.1038/sj.ejcn.1600913; Costanzo S, 2011, EUR J EPIDEMIOL, V26, P833, DOI 10.1007/s10654-011-9631-0; Carmona-Torre FD, 2008, AM J HEALTH PROMOT, V23, P27, DOI 10.4278/ajhp.07050143; DEGROOT LCPGM, 1991, EUR J CLIN NUTR, V45, P23; Evans A, 2005, INT J EPIDEMIOL, V34, P21, DOI 10.1093/ije/dyh327; FESKENS EJM, 1994, AM J EPIDEMIOL, V140, P350, DOI 10.1093/oxfordjournals.aje.a117257; Forshee RA, 2006, INT J FOOD SCI NUTR, V57, P494, DOI 10.1080/09637480600991240; Gronbaek M, 2001, J INTERN MED, V250, P291, DOI 10.1046/j.1365-2796.2001.00885.x; GRONBAEK M, 1995, BRIT MED J, V310, P1165, DOI 10.1136/bmj.310.6988.1165; Gronbaek M, 2007, ANN EPIDEMIOL, V17, pS13, DOI 10.1016/j.annepidem.2007.01.004; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; Huijbregts P, 1997, BRIT MED J, V315, P13, DOI 10.1136/bmj.315.7099.13; I. Foods. EPIC Group of Spain, 1997, INT J EPIDEMIOL S1, V26, pS91, DOI [10.1016/j.ehj.2003.12.022, DOI 10.1016/J.EHJ.2003.12.022]; Jankovic N, 2014, AM J EPIDEMIOL, V180, P978, DOI 10.1093/aje/kwu229; Klatsky AL, 2003, AM J EPIDEMIOL, V158, P585, DOI 10.1093/aje/kwg184; Kuulasmaa K, 2015, CHANCES COHORT DESCR; Mannisto S, 1997, EUR J CLIN NUTR, V51, P326, DOI 10.1038/sj.ejcn.1600406; McCann SE, 2003, NUTR METAB CARDIOVAS, V13, P2, DOI 10.1016/S0939-4753(03)80162-X; Mullie P, 2015, MILITARY MED RES, V2, DOI 10.1186/s40779-015-0066-x; NES M, 1991, EUR J CLIN NUTR, V45, P97; Paschall M, 2005, DRUG ALCOHOL DEPEN, V78, P339, DOI 10.1016/j.drugalcdep.2004.12.004; Rehm J, 2010, ADDICTION, V105, P817, DOI 10.1111/j.1360-0443.2010.02899.x; Riboli E, 1997, INT J EPIDEMIOL, V26, pS6, DOI 10.1093/ije/26.suppl_1.S6; Rimm EB, 2002, CIRCULATION, V105, P2806, DOI 10.1161/01.CIR.0000022344.79651.CC; Rouillier P, 2004, EUR J NUTR, V43, P69, DOI 10.1007/s00394-004-0442-x; Ruidavets JB, 2004, EUR HEART J, V25, P1153, DOI 10.1016/j.ehj.2003.12.022; Sanchez-Villegas A, 2009, PUBLIC HEALTH NUTR, V12, P351, DOI 10.1017/S1368980008002127; Satija A, 2015, ADV NUTR, V6, P5, DOI 10.3945/an.114.007492; Sluik D, 2014, EUR J CLIN NUTR, V68, P287, DOI 10.1038/ejcn.2013.279; Sluik D, 2016, CRIT REV FOOD SCI, V56, P2370, DOI 10.1080/10408398.2013.841118; Tjonneland A, 1999, AM J CLIN NUTR, V69, P49; Trichopoulou A, 2005, BMJ-BRIT MED J, V330, P991, DOI 10.1136/bmj.38415.644155.8F; Truelsen T, 1998, STROKE, V29, P2467, DOI 10.1161/01.STR.29.12.2467; Valencia-Martin JL, 2011, ALCOHOL CLIN EXP RES, V35, P2075, DOI 10.1111/j.1530-0277.2011.01559.x; Willett WC, 2008, ASIA PAC J CLIN NUTR, V17, P75	40	10	10	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161603	10.1371/journal.pone.0161603	http://dx.doi.org/10.1371/journal.pone.0161603			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548323	Green Published, gold, Green Submitted			2022-12-26	WOS:000381768400075
J	Beleut, M; Soeldner, R; Egorov, M; Guenther, R; Dehler, S; Morys-Wortmann, C; Moch, H; Henco, K; Schraml, P				Beleut, Manfred; Soeldner, Robert; Egorov, Mark; Guenther, Rolf; Dehler, Silvia; Morys-Wortmann, Corinna; Moch, Holger; Henco, Karsten; Schraml, Peter			Discretization of Gene Expression Data Unmasks Molecular Subgroups Recurring in Different Human Cancer Types	PLOS ONE			English	Article							DRIVER MUTATIONS; HUMAN BREAST; CLASSIFICATION	Despite the individually different molecular alterations in tumors, the malignancy associated biological traits are strikingly similar. Results of a previous study using renal cell carcinoma (RCC) as a model pointed towards cancer-related features, which could be visualized as three groups by microarray based gene expression analysis. In this study, we used a mathematic model to verify the presence of these groups in RCC as well as in other cancer types. We developed an algorithm for gene-expression deviation profiling for analyzing gene expression data of a total of 8397 patients with 13 different cancer types and normal tissues. We revealed three common Cancer Transcriptomic Profiles (CTPs) which recurred in all investigated tumors. Additionally, CTPs remained robust regardless of the functions or numbers of genes analyzed. CTPs may represent common genetic fingerprints, which potentially reflect the closely related biological traits of human cancers.	[Beleut, Manfred; Soeldner, Robert; Egorov, Mark; Guenther, Rolf; Morys-Wortmann, Corinna; Henco, Karsten] Qlaym Healthcare AG, Hans Adolf Krebs Weg 1, D-37077 Gottingen, Germany; [Dehler, Silvia] Univ Zurich Hosp, Canc Registry Zurich & Zug, Zurich, Switzerland; [Moch, Holger; Schraml, Peter] Univ Zurich Hosp, Inst Surg Pathol, Schmelzbergstr 12, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Beleut, M (corresponding author), Qlaym Healthcare AG, Hans Adolf Krebs Weg 1, D-37077 Gottingen, Germany.; Schraml, P (corresponding author), Univ Zurich Hosp, Inst Surg Pathol, Schmelzbergstr 12, CH-8091 Zurich, Switzerland.	AnManfred@gmx.de; Peter.Schraml@usz.ch	Beleut, Manfred/E-8427-2011	Beleut, Manfred/0000-0002-5610-156X	Swiss National Science Foundation [3238BO-10314]; HS Lifesciences GmbH	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); HS Lifesciences GmbH	Authors MB, RS, ME, RG, CM, KH are employed by the Qlaym Healthcare AG. The specific roles of individual authors are articulated in the "author contributions" section. The funders provided support in the form of salaries but did not have any additional role in study design, data collection and analysis, decision to publish or preparation of the manuscript. This project was also sponsored by a grant of the Swiss National Science Foundation (grant number: 3238BO-10314) to HM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank HS Lifesciences GmbH for supporting this project, Andreas Brede-Buchenau, Martin Wiesenfeldt and Ruediger Goetz for critical proofreading and valuable comments.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Hirata BKB, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/513158; Beleut M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-310; Bollag G, 2012, NAT REV DRUG DISCOV, V11, P873, DOI 10.1038/nrd3847; Burgess DJ, 2013, NAT REV CANCER, V13, P380, DOI 10.1038/nrc3529; CANNINGS C, 1968, ANN HUM GENET, V31, P421, DOI 10.1111/j.1469-1809.1968.tb00575.x; Cao QY, 2011, NUCLEIC ACIDS RES, V39, pD968, DOI 10.1093/nar/gkq997; Chittenden TW, 2008, GENOMICS, V91, P508, DOI 10.1016/j.ygeno.2008.03.002; de Finetti B., 1937, ANN I HENRI POINCARE, V7, P1; Fawdar S, 2013, ONCOTARGET, V4, P1334, DOI 10.18632/oncotarget.1223; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hartigan J., 1975, CLUSTERING ALGORITHM; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Huret JL, 2013, NUCLEIC ACIDS RES, V41, pD920, DOI 10.1093/nar/gks1082; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; Liu YJ, 2014, BRIT J CANCER, V110, P1169, DOI 10.1038/bjc.2014.61; McCall MN, 2014, NUCLEIC ACIDS RES, V42, pD938, DOI 10.1093/nar/gkt1204; Ogino S, 2012, EXPERT REV MOL DIAGN, V12, P621, DOI [10.1586/ERM.12.46, 10.1586/erm.12.46]; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Rhodes DR, 2005, NAT GENET, V37, pS31, DOI 10.1038/ng1570; Sohn KA, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-S6-S9; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; West D., 2013, TERNARY EQUILIBRIUM, V2; West L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031906; Zhou JX, 2013, ANN ONCOL, V24, P1319, DOI 10.1093/annonc/mds626; Zilliox MJ, 2007, NAT METHODS, V4, P911, DOI 10.1038/NMETH1102	32	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161514	10.1371/journal.pone.0161514	http://dx.doi.org/10.1371/journal.pone.0161514			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537329	Green Submitted, gold, Green Accepted, Green Published			2022-12-26	WOS:000381577000115
J	Chen, Q; Zhang, Y; Ding, D; Xia, M; Li, D; Yang, YN; Li, Q; Liu, JX; Chen, XC; Hu, G; Ling, WH				Chen, Qian; Zhang, Yuan; Ding, Ding; Xia, Min; Li, Dan; Yang, Yunou; Li, Qing; Liu, Jiaxing; Chen, Xuechen; Hu, Gang; Ling, Wenhua			Estimated Glomerular Filtration Rate and Mortality among Patients with Coronary Heart Disease	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; ALL-CAUSE MORTALITY; PRACTICE GUIDELINES COMMITTEE; ASSOCIATION TASK-FORCE; RISK-FACTOR; COLLABORATIVE METAANALYSIS; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; HIGHER ALBUMINURIA; AMERICAN-COLLEGE	Objective The association between estimated glomerular filtration rate (eGFR) and the risk of mortality among patients with coronary heart disease (CHD) is complex and still unclear. The aim of this study was to evaluate the effect of eGFR on the risk prediction of all-cause and cardiovascular disease (CVD) mortality with a long follow-up period among patients with CHD in China. Methods We conducted a prospective cohort study of 3276 Chinese patients with CHD. Cox proportional hazards regression models were used to estimate the association of different levels of eGFR with the risks of mortality. Results During a mean follow-up period of 4.9 years, 293 deaths were identified. The multivariable-adjusted hazard ratios associated with different levels of eGFR (>= 90 [reference group], 60-89, 30-59, 15-29 ml/min per 1.73m(2)) at baseline were 1.00, 1.28 (95% confidence interval [CI], 0.87-1.88), 1.96 (95% CI, 1.31-2.94), and 3.91 (95% CI, 2.15-7.13) (P <0.001) for all-cause mortality, and 1.00, 1.26 (95% CI, 0.78-2.04), 1.94 (95% CI, 1.17-3.20), and 3.77 (95% CI, 1.80-7.89) (P <0.001) for CVD mortality, respectively. After excluding subjects who died during the first 2 years of follow-up (n = 113), the graded associations of eGFR with the risks of all-cause and CVD morality were still present. The addition of eGFR to a model including traditional cardiovascular risk factors resulted in significant improvement in the prediction of all-cause and CVD mortality. Conclusions Reduced eGFR (< 60 ml/min per 1.73 m(2)) at baseline is associated with increased risks of all-cause and CVD mortality among Chinese patients with CHD.	[Chen, Qian; Ding, Ding; Xia, Min; Li, Dan; Yang, Yunou; Li, Qing; Liu, Jiaxing; Chen, Xuechen; Ling, Wenhua] Sun Yat Sen Univ, Sch Publ Hlth, Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou, Guangdong, Peoples R China; [Chen, Qian; Hu, Gang] Pennington Biomed Res Ctr, Chron Dis Epidemiol Lab, 6400 Perkins Rd, Baton Rouge, LA 70808 USA; [Zhang, Yuan] Guangzhou Mil Command Peoples Liberat Army, Dept Cardiol, Gen Hosp, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Ling, WH (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou, Guangdong, Peoples R China.; Hu, G (corresponding author), Pennington Biomed Res Ctr, Chron Dis Epidemiol Lab, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	gang.hu@pbrc.edu; lingwh@mail.sysu.edu.cn	Hu, Gang/N-1971-2017; Hu, Gang/V-7947-2019	Hu, Gang/0000-0002-6172-8017; Hu, Gang/0000-0002-6172-8017	Key Project of National Natural Science Fund [81130052]; International Program for Ph.D. Candidates, Sun Yat-Sen University	Key Project of National Natural Science Fund; International Program for Ph.D. Candidates, Sun Yat-Sen University	This study was supported and funded by the Key Project of National Natural Science Fund (grant number 81130052). Qian Chen is supported by International Program for Ph.D. Candidates, Sun Yat-Sen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1988, J CLIN EPIDEMIOL, V41, P105, DOI 10.1016/0895-4356(88)90084-4; Antolini L, 2004, COMMUN STAT-THEOR M, V33, P2117, DOI 10.1081/STA-200026579; Astor BC, 2008, AM J EPIDEMIOL, V167, P1226, DOI 10.1093/aje/kwn033; Astor BC, 2011, KIDNEY INT, V79, P1331, DOI 10.1038/ki.2010.550; Bittencourt MS, 2015, KIDNEY INT, V88, P152, DOI 10.1038/ki.2014.426; Braunwald E, 2000, CIRCULATION, V102, P1193, DOI 10.1161/01.CIR.102.10.1193; Bruetto RG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035496; de Boer IH, 2009, DIABETES CARE, V32, P1833, DOI 10.2337/dc09-0191; Ding D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120633; Ding D, 2014, DIABETES CARE, V37, P546, DOI 10.2337/dc13-1387; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fu S, 2013, CLIN INTERV AGING, V8, P229, DOI 10.2147/CIA.S40438; Gibbons RJ, 1999, CIRCULATION, V99, P2829, DOI 10.1161/01.CIR.99.21.2829; Go AS, 2006, CIRCULATION, V113, P2713, DOI 10.1161/CIRCULATIONAHA.105.577577; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Heagerty PJ, 2005, BIOMETRICS, V61, P92, DOI 10.1111/j.0006-341X.2005.030814.x; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P423, DOI 10.1001/jama.2010.39; Kestenbaum BR, 2009, KIDNEY INT, V76, P991, DOI 10.1038/ki.2009.298; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Manjunath G, 2003, J AM COLL CARDIOL, V41, P47, DOI 10.1016/S0735-1097(02)02663-3; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Nakamura M, 2009, HYPERTENS RES, V32, P920, DOI 10.1038/hr.2009.114; Navaneethan SD, 2015, J AM SOC NEPHROL, V26, P2512, DOI 10.1681/ASN.2014101034; Rodrigues FB, 2010, CLIN J AM SOC NEPHRO, V5, P1530, DOI 10.2215/CJN.01260210; Ronco C, 2008, J AM COLL CARDIOL, V52, P1527, DOI 10.1016/j.jacc.2008.07.051; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Schiffrin EL, 2007, CIRCULATION, V116, P85, DOI 10.1161/CIRCULATIONAHA.106.678342; Smith GL, 2008, J AM SOC NEPHROL, V19, P141, DOI 10.1681/ASN.2007050554; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; van der Velde M, 2011, KIDNEY INT, V79, P1341, DOI 10.1038/ki.2010.536; Vasaiwala S, 2012, CLIN CARDIOL, V35, P541, DOI 10.1002/clc.22021; Wang YJ, 2014, KIDNEY INT, V85, P1192, DOI 10.1038/ki.2013.396; Weiner DE, 2008, AM J KIDNEY DIS, V51, P212, DOI 10.1053/j.ajkd.2007.10.035; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Yang JG, 2010, J ATHEROSCLER THROMB, V17, P395, DOI 10.5551/jat.3061; Yang ZJ, 2012, EUR HEART J, V33, P213, DOI 10.1093/eurheartj/ehr205; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zhang R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027359; Zhang XH, 2008, HEART, V94, P1126, DOI 10.1136/hrt.2007.132423; Zhao WH, 2014, CIRCULATION, V130, P2143, DOI 10.1161/CIRCULATIONAHA.114.009098	41	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161599	10.1371/journal.pone.0161599	http://dx.doi.org/10.1371/journal.pone.0161599			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537335	Green Submitted, Green Published, gold			2022-12-26	WOS:000381577000125
J	Gao, D; Zhan, Y; Di, W; Moore, AR; Sher, JJ; Guan, YX; Wang, SQ; Zhang, ZD; Murphy, DA; Sawyers, CL; Chi, P; Chen, Y				Gao, Dong; Zhan, Yu; Di, Wei; Moore, Amanda R.; Sher, Jessica J.; Guan, Youxin; Wang, Shangqian; Zhang, Zeda; Murphy, Devan A.; Sawyers, Charles L.; Chi, Ping; Chen, Yu			A Tmprss2-CreER(T2) Knock-In Mouse Model for Cancer Genetic Studies on Prostate and Colon	PLOS ONE			English	Article							INTRAEPITHELIAL NEOPLASIA; ORGANOID CULTURES; LUMINAL CELLS; PTEN; MICE; EXPRESSION; PROTEASE; TMPRSS2; ORIGIN; IDENTIFICATION	Fusion between TMPRSS2 and ERG, placing ERG under the control of the TMPRSS2 promoter, is the most frequent genetic alteration in prostate cancer, present in 40-50% of cases. The fusion event is an early, if not initiating, event in prostate cancer, implicating the TMPRSS2-positive prostate epithelial cell as the cancer cell of origin in fusion-positive prostate cancer. To introduce genetic alterations into Tmprss2-positive cells in mice in a temporal-specific manner, we generated a Tmprss2-CreER(T2) knock-in mouse. We found robust tamoxifen-dependent Cre activation in the prostate luminal cells but not basal epithelial cells, as well as epithelial cells of the bladder and gastrointestinal (GI) tract. The knock-in allele on the Tmprss2 locus does not noticeably impact prostate, bladder, or gastrointestinal function. Deletion of Pten in Tmprss2-positive cells of adult mice generated neoplasia only in the prostate, while deletion of Apc in these cells generated neoplasia only in the GI tract. These results suggest that this new Tmprss2-CreER(T2) mouse model will be a useful resource for genetic studies on prostate and colon.	[Gao, Dong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Key Lab Syst Biol, Shanghai 200031, Peoples R China; [Gao, Dong; Zhan, Yu; Di, Wei; Moore, Amanda R.; Sher, Jessica J.; Guan, Youxin; Wang, Shangqian; Zhang, Zeda; Murphy, Devan A.; Sawyers, Charles L.; Chi, Ping; Chen, Yu] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Moore, Amanda R.] Cornell Univ, Weill Cornell Grad Sch Med Sci, New York, NY 10021 USA; [Chi, Ping; Chen, Yu] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Chi, Ping; Chen, Yu] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Chi, Ping; Chen, Yu] New York Presbyterian Hosp, New York, NY 10065 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Memorial Sloan Kettering Cancer Center; Cornell University; NewYork-Presbyterian Hospital	Gao, D (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Key Lab Syst Biol, Shanghai 200031, Peoples R China.; Gao, D; Chen, Y (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA.; Chen, Y (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA.; Chen, Y (corresponding author), Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA.; Chen, Y (corresponding author), New York Presbyterian Hosp, New York, NY 10065 USA.	dong.gao@sibcb.ac.cn; cheny1@mskcc.org	Zhang, Zeda/AAV-8644-2021	Zhang, Zeda/0000-0002-7225-534X; Gao, Dong/0000-0003-1821-2741	NYSTEM Stipend [C026879]; Howard Hughes Medical Institute; NCI [K08CA140946, R01CA193837, P50CA092629, K08CA151660, DP2 CA174499, U01 CA141502]; US DOD [W81XWH-10-1-0197]; Prostate Cancer Foundation; Starr Cancer Consortium; Geoffrey Beene Cancer Research Center; Gerstner Family Foundation; Bressler Scholars Fund; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA193837, R01CA155169] Funding Source: NIH RePORTER	NYSTEM Stipend; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US DOD(United States Department of Defense); Prostate Cancer Foundation; Starr Cancer Consortium; Geoffrey Beene Cancer Research Center; Gerstner Family Foundation; Bressler Scholars Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported in part by NYSTEM Stipend (C026879) to DG, the Howard Hughes Medical Institute (CLS), NCI (K08CA140946, YC; R01CA193837, CLS, YC; P50CA092629, CLS, YC; K08CA151660, PC; DP2 CA174499, PC; U01 CA141502, CLS), US DOD (W81XWH-10-1-0197), Prostate Cancer Foundation (YC), Starr Cancer Consortium (YC, PC, CLS), Geoffrey Beene Cancer Research Center (YC, PC), Gerstner Family Foundation (YC), Bressler Scholars Fund (YC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulkadir SA, 2002, MOL CELL BIOL, V22, P1495, DOI 10.1128/MCB.22.5.1495-1503.2002; Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Casey OM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041668; Chen YW, 2010, AM J PATHOL, V176, P2986, DOI 10.2353/ajpath.2010.090665; Chen Y, 2013, NAT MED, V19, P1023, DOI 10.1038/nm.3216; Choi N, 2012, CANCER CELL, V21, P253, DOI 10.1016/j.ccr.2012.01.005; Gao D, 2014, CELL, V159, P176, DOI 10.1016/j.cell.2014.08.016; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; Karthaus WR, 2014, CELL, V159, P163, DOI 10.1016/j.cell.2014.08.017; Kim TS, 2006, MOL CELL BIOL, V26, P965, DOI 10.1128/MCB.26.3.965-975.2006; Kuraguchi M, 2006, PLOS GENET, V2, P1362, DOI 10.1371/journal.pgen.0020146; Lin BY, 1999, CANCER RES, V59, P4180; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Luchman HA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003940; Ma XQ, 2005, CANCER RES, V65, P5730, DOI 10.1158/0008-5472.CAN-04-4519; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Parisotto M, 2013, MOL ONCOL, V7, P190, DOI 10.1016/j.molonc.2013.02.005; Ratnacaram CK, 2008, P NATL ACAD SCI USA, V105, P2521, DOI 10.1073/pnas.0712021105; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Wagner KU, 2001, TRANSGENIC RES, V10, P545, DOI 10.1023/A:1013063514007; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Wang ZA, 2014, CELL REP, V8, P1339, DOI 10.1016/j.celrep.2014.08.002; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Xin L, 2005, P NATL ACAD SCI USA, V102, P6942, DOI 10.1073/pnas.0502320102	32	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161084	10.1371/journal.pone.0161084	http://dx.doi.org/10.1371/journal.pone.0161084			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536883	Green Submitted, gold, Green Published			2022-12-26	WOS:000381577000051
J	Kim, EY; Kim, YS; Seo, JY; Park, I; Ahn, HK; Jeong, YM; Kim, JH; Kim, N				Kim, Eun Young; Kim, Young Saing; Seo, Ja-Young; Park, Inkeun; Ahn, Hee Kyung; Jeong, Yu Mi; Kim, Jeong Ho; Kim, Nambeom			The Relationship between Sarcopenia and Systemic Inflammatory Response for Cancer Cachexia in Small Cell Lung Cancer	PLOS ONE			English	Article							PROGNOSTIC SCORES; NUTRITIONAL-STATUS; SKELETAL-MUSCLE; MGPS PREDICTS; SURVIVAL; OBESITY; INDEX	Background The prognostic significance of sarcopenia, an important component of cancer cachexia, has been demonstrated in oncologic patients. Catabolic drivers have been suggested to be key features of cancer cachexia. Objective To determine the relationship between systemic inflammatory markers and CT-determined muscle mass in patients with SCLC. Methods Cross-sectional muscle areas were evaluated at the level of the third lumbar vertebra (L3) using baseline CT images in 186 SCLC patients. Sarcopenia was defined as a L3 muscle index (L3MI, muscle area at L3/height(2)) of < 55 cm(2)/m(2) for men and of < 39 cm(2)/m(2) for women. Systemic inflammatory markers investigated included serum white blood cell count (WBC), neutrophil: lymphocyte ratio (NLR), C-reactive protein (CRP), and albumin. Results Mean L3MI was 47.9 +/- 9.7 cm(2)/m(2) for men and 41.6 +/- 7.0 cm(2)/m(2) for women. Sarcopenia was present in 128 patients (68.8%), and sarcopenic patients had significant serum lymphocyte counts and albumin levels (p = 0.002 and 0.041, respectively), and higher NLRs and CRP levels (p = 0.011 and 0.026) than non-sarcopenic patients. Multivariable analysis revealed that CRP independently predicted L3MI (beta = -0.208; 95% CI, -0.415 to -0.002; p = 0.048), along with gender and BMI (p values < 0.001) and performance status (p = 0.010). Conclusion The present study confirms a significant linear relationship exists between CT-determined muscle mass and CRP in SCLC patients. This association might provide a better understanding of the mechanism of cancer cachexia.	[Kim, Eun Young; Jeong, Yu Mi; Kim, Jeong Ho] Gachon Univ, Gil Med Ctr, Dept Radiol, Inchon, South Korea; [Kim, Young Saing; Park, Inkeun; Ahn, Hee Kyung] Gachon Univ, Gil Med Ctr, Dept Internal Med, Div Hematol & Oncol, Inchon, South Korea; [Seo, Ja-Young] Gachon Univ, Gil Med Ctr, Dept Lab Med, Inchon, South Korea; [Kim, Nambeom] Gachon Univ, Neurosci Res Inst, Inchon, South Korea	Gachon University; Gachon University; Gachon University; Gachon University	Kim, YS (corresponding author), Gachon Univ, Gil Med Ctr, Dept Internal Med, Div Hematol & Oncol, Inchon, South Korea.	zoomboom@hanmail.net	Kim, Jeong Ho/AAA-7538-2022; Kim, Nambeom/AAR-8047-2021	Kim, Nambeom/0000-0003-4960-1256; Kim, Young Saing/0000-0003-0207-2617				Argiles JM, 2005, INT J BIOCHEM CELL B, V37, P1609, DOI 10.1016/j.biocel.2005.03.007; Azad N, 2008, J TOXICOL ENV HEAL B, V11, P1, DOI 10.1080/10937400701436460; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Collins J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003697; Fearon KC, 2006, AM J CLIN NUTR, V83, P1345, DOI 10.1093/ajcn/83.6.1345; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Forrest LM, 2003, BRIT J CANCER, V89, P1028, DOI 10.1038/sj.bjc.6601242; Fruh M, 2013, ANN ONCOL, V24, P99, DOI 10.1093/annonc/mdt178; He XB, 2015, CLIN LUNG CANCER, V16, pE165, DOI 10.1016/j.cllc.2015.03.005; Kalemkerian GP, 2013, J NATL COMPR CANC NE, V11, P99, DOI 10.6004/jnccn.2013.0012; Kim EY, 2015, J THORAC ONCOL, V10, P1795, DOI 10.1097/JTO.0000000000000690; Lu HT, 2006, MOL CANCER RES, V4, P221, DOI 10.1158/1541-7786.MCR-05-0261; Martin L, 2013, J CLIN ONCOL, V31, P1539, DOI 10.1200/JCO.2012.45.2722; McMillan DC, 2009, CURR OPIN CLIN NUTR, V12, P223, DOI 10.1097/MCO.0b013e32832a7902; Morley JE, 2006, AM J CLIN NUTR, V83, P735, DOI 10.1093/ajcn/83.4.735; Prado CMM, 2008, LANCET ONCOL, V9, P629, DOI 10.1016/S1470-2045(08)70153-0; Proctor MJ, 2011, BRIT J CANCER, V104, P726, DOI 10.1038/sj.bjc.6606087; Proctor MJ, 2011, EUR J CANCER, V47, P2633, DOI 10.1016/j.ejca.2011.03.028; Richards CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041883; Sarhill N, 2003, SUPPORT CARE CANCER, V11, P652, DOI 10.1007/s00520-003-0486-0; Schaap LA, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.10.049; Shafique K, 2012, PROSTATE CANCER P D, V15, P195, DOI 10.1038/pcan.2011.60; Shen W, 2004, J APPL PHYSIOL, V97, P2333, DOI 10.1152/japplphysiol.00744.2004; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Yang CW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132908; Zhou T, 2015, TUMOR BIOL, V36, P337, DOI 10.1007/s13277-014-2623-4	26	47	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161125	10.1371/journal.pone.0161125	http://dx.doi.org/10.1371/journal.pone.0161125			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537502	gold, Green Published, Green Submitted			2022-12-26	WOS:000381577000057
J	Kussner, MB; de Groot, AMB; Hofman, WF; Hillen, MA				Kuessner, Mats B.; de Groot, Annette M. B.; Hofman, Winni F.; Hillen, Marij A.			EEG Beta Power but Not Background Music Predicts the Recall Scores in a Foreign-Vocabulary Learning Task	PLOS ONE			English	Article							COGNITIVE TEST-PERFORMANCE; DIFFERENTIAL DISTRACTION; INSTRUMENTAL MUSIC; INTROVERTS; AROUSAL; EXTROVERSION; PERSONALITY; NOISE; MOOD	As tantalizing as the idea that background music beneficially affects foreign vocabulary learning may seem, there is-partly due to a lack of theory-driven research-no consistent evidence to support this notion. We investigated inter-individual differences in the effects of background music on foreign vocabulary learning. Based on Eysenck's theory of personality we predicted that individuals with a high level of cortical arousal should perform worse when learning with background music compared to silence, whereas individuals with a low level of cortical arousal should be unaffected by background music or benefit from it. Participants were tested in a paired-associate learning paradigm consisting of three immediate word recall tasks, as well as a delayed recall task one week later. Baseline cortical arousal assessed with spontaneous EEG measurement in silence prior to the learning rounds was used for the analyses. Results revealed no interaction between cortical arousal and the learning condition (background music vs. silence). Instead, we found an unexpected main effect of cortical arousal in the beta band on recall, indicating that individuals with high beta power learned more vocabulary than those with low beta power. To substantiate this finding we conducted an exact replication of the experiment. Whereas the main effect of cortical arousal was only present in a subsample of participants, a beneficial main effect of background music appeared. A combined analysis of both experiments suggests that beta power predicts the performance in the word recall task, but that there is no effect of background music on foreign vocabulary learning. In light of these findings, we discuss whether searching for effects of background music on foreign vocabulary learning, independent of factors such as inter-individual differences and task complexity, might be a red herring. Importantly, our findings emphasize the need for sufficiently powered research designs and exact replications of theory-driven experiments when investigating effects of background music and inter-individual variation on task performance.	[Kuessner, Mats B.] Humboldt Univ, Inst Musikwissensch & Med Wissensch, Berlin, Germany; [de Groot, Annette M. B.; Hofman, Winni F.] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Hillen, Marij A.] Univ Amsterdam, Acad Med Ctr, Dept Med Psychol, Amsterdam, Netherlands	Humboldt University of Berlin; University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Kussner, MB (corresponding author), Humboldt Univ, Inst Musikwissensch & Med Wissensch, Berlin, Germany.	mats.kussner@gmail.com		Kussner, Mats/0000-0002-4056-0702; Hillen, Marij/0000-0001-5724-7934				Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Avila C, 2012, PSYCHOL MUSIC, V40, P84, DOI 10.1177/0305735611422672; Beauducel A, 2006, INT J PSYCHOPHYSIOL, V62, P212, DOI 10.1016/j.ijpsycho.2005.12.001; Cardenas VA, 1997, BIOL PSYCHIAT, V41, P891, DOI 10.1016/S0006-3223(96)00186-2; Cassidy G., 2007, PSYCHOL MUSIC, V35, P517, DOI [10.1177/0305735607076444, DOI 10.1177/0305735607076444]; Chamorro-Premuzic T, 2009, INT J PSYCHOL STUD, V1, P2, DOI DOI 10.5539/IJPS.V1N2P2; Cohen R.A., 2011, ENCY CLIN NEUROPSYCH, P2737, DOI [DOI 10.1007/978-0-387-79948-3_1340, 10.1007/978-0-387-79948-3_1340]; CRAWFORD HJ, 1994, PERS INDIV DIFFER, V16, P237, DOI 10.1016/0191-8869(94)90162-7; DAOUSSIS L, 1986, PERCEPT MOTOR SKILL, V62, P283, DOI 10.2466/pms.1986.62.1.283; de Groot AMB, 2006, LANG LEARN, V56, P463, DOI 10.1111/j.1467-9922.2006.00374.x; de Groot AMB, 2014, STUD SECOND LANG ACQ, V36, P681, DOI 10.1017/S0272263114000059; Dobbs S, 2011, APPL COGNITIVE PSYCH, V25, P307, DOI 10.1002/acp.1692; Elshout JJ, 1973, ARBEIDS ORGANISATIEP, P49; Elshout JJ, 1975, VIJF PERSOONLIJKNEID; Eysenck H.J., 1967, BIOL BASIS PERSONALI; Felix U, 1993, J SOC ACCELERATIVE L, V18, P277; Ferreri L, 2015, MUSIC SCI, V19, P402, DOI 10.1177/1029864915604684; Fitzgibbon SP, 2004, CLIN NEUROPHYSIOL, V115, P1802, DOI 10.1016/j.clinph.2004.03.009; Furnham A, 1999, PERS INDIV DIFFER, V27, P381, DOI 10.1016/S0191-8869(98)00249-9; Furnham A, 1999, EUR J PERSONALITY, V13, P27, DOI 10.1002/(SICI)1099-0984(199901/02)13:1<27::AID-PER318>3.0.CO;2-R; Furnham A, 2002, ERGONOMICS, V45, P203, DOI 10.1080/00140130210121932; Furnham A, 1997, APPL COGNITIVE PSYCH, V11, P445; GALE A, 1969, BRIT J PSYCHOL, V60, P209, DOI 10.1111/j.2044-8295.1969.tb01194.x; Gram PC, 2005, J PSYCHOL TYPE, V65, P33; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Hagemann D, 1999, PERS INDIV DIFFER, V27, P541, DOI 10.1016/S0191-8869(98)00263-3; Hagemann D, 2009, PERS INDIV DIFFER, V47, P717, DOI 10.1016/j.paid.2009.06.009; Hallam S., 2016, OXFORD HDB MUSIC PSY; Jancke L, 2014, BEHAV BRAIN FUNCT, V10, DOI 10.1186/1744-9081-10-10; Jancke L, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-3; Jones MH, 2006, PSYCHOL AESTHET CREA, P26, DOI DOI 10.1037/1931-3896.S.1.26; Kampfe J, 2011, PSYCHOL MUSIC, V39, P424, DOI 10.1177/0305735610376261; Kang HJ, 2014, PSYCHOL MUSIC, V42, P728, DOI 10.1177/0305735613485152; Matthews G, 1999, PERS INDIV DIFFER, V26, P583, DOI 10.1016/S0191-8869(98)00158-5; Molteni E, 2007, P ANN INT IEEE EMBS, P1298, DOI 10.1109/IEMBS.2007.4352535; Patston LLM, 2011, MUSIC PERCEPT, V29, P173, DOI 10.1525/MP.2011.29.2.173; Rangaswamy M, 2002, BIOL PSYCHIAT, V52, P831, DOI 10.1016/S0006-3223(02)01362-8; RAY WJ, 1985, SCIENCE, V228, P750, DOI 10.1126/science.3992243; rnec R., 2006, EDUC PSYCHOL-US, V26, P579, DOI [DOI 10.1080/01443410500342542, 10.1080/01443410500342542]; Savan A., 1999, PSYCHOL MUSIC, V27, P138, DOI DOI 10.1177/0305735699272005; Schellenberg E.G., 2007, PSYCHOL MUSIC, V35, P5, DOI [10.1177/0305735607068885, DOI 10.1177/0305735607068885]; Schellenberg EG, 2013, PSYCHOLOGY OF MUSIC, THIRD EDITION, P499, DOI 10.1016/B978-0-12-381460-9.00012-2; Schmidtke JI, 2004, PERS INDIV DIFFER, V36, P717, DOI 10.1016/S0191-8869(03)00129-6; Schuster DH, 1982, J SOC ACCELERATIVE L, V7, P82; Thompson WF, 2001, PSYCHOL SCI, V12, P248, DOI 10.1111/1467-9280.00345	45	13	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161387	10.1371/journal.pone.0161387	http://dx.doi.org/10.1371/journal.pone.0161387			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537520	Green Published, gold, Green Submitted			2022-12-26	WOS:000381577000097
J	Lievers, R; Groot, AT				Lievers, Rik; Groot, Astrid T.			Disposable Polydimethylsiloxane (PDMS)-Coated Fused Silica Optical Fibers for Sampling Pheromones of Moths	PLOS ONE			English	Article							SOLID-PHASE MICROEXTRACTION; EUROPEAN CORN-BORER; OSTRINIA-NUBILALIS HUBNER; TOBACCO BUDWORM MOTH; SEX-PHEROMONE; HELIOTHIS-VIRESCENS; SESAMIA-NONAGRIOIDES; MASS-SPECTROMETRY; INSECT PHEROMONES; IDENTIFICATION	In the past decades, the sex pheromone composition in female moths has been analyzed by different methods, ranging from volatile collections to gland extractions, which all have some disadvantage: volatile collections can generally only be conducted on (small) groups of females to detect the minor pheromone compounds, whereas gland extractions are destructive. Direct-contact SPME overcomes some of these disadvantages, but is expensive, the SPME fiber coating can be damaged due to repeated usage, and samples need to be analyzed relatively quickly after sampling. In this study, we assessed the suitability of cheap and disposable fused silica optical fibers coated with 100 mu m polydimethylsiloxane (PDMS) by sampling the pheromone of two noctuid moths, Heliothis virescens and Heliothis subflexa. By rubbing the disposable PDMS fibers over the pheromone glands of females that had called for at least 15 minutes and subsequently extracting the PDMS fibers in hexane, we collected all known pheromone compounds, and we found a strong positive correlation for most pheromone compounds between the disposable PDMS fiber rubs and the corresponding gland extracts of the same females. When comparing this method to volatile collections and the corresponding gland extracts, we generally found comparable percentages between the three techniques, with some differences that likely stem from the chemical properties of the individual pheromone compounds. Hexane extraction of cheap, disposable, PDMS coated fused silica optical fibers allows for sampling large quantities of individual females in a short time, eliminates the need for immediate sample analysis, and enables to use the same sample for multiple chemical analyses.	[Lievers, Rik; Groot, Astrid T.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Sci Pk 904, Amsterdam, Netherlands; [Groot, Astrid T.] Max Planck Inst Chem Ecol, Hans Knoll Str 8, Jena, Germany	University of Amsterdam; Max Planck Society	Lievers, R (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Sci Pk 904, Amsterdam, Netherlands.	r.lievers@uva.nl			Netherlands Organization for Scientific Research NWO-ALW [822.01.012]; National Science Foundation [IOS-1052238, IOS-1456973]; Division Of Integrative Organismal Systems [1456973] Funding Source: National Science Foundation	Netherlands Organization for Scientific Research NWO-ALW(Netherlands Organization for Scientific Research (NWO)); National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This project is funded by the Netherlands Organization for Scientific Research NWO-ALW (www.nwo.nl/alw) under award no. 822.01.012, and the National Science Foundation (www.nsf.gov) under award no. IOS-1052238 and IOS-1456973. The grants were awarded to ATG. The funders did not play any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Joke Westerveld for helping with thermally conditioning the PDMS fibers and Joris Haftka for helping to obtain the disposable PDMS fibers. We thank Daniel Veit for constructing the volatile collection setup. We also thank Goran Birgersson, Andres Gonzalez and Bjorn Bohman for their valuable comments, and Steph Menken for correcting the text. This project is funded by the Netherlands Organisation for Scientific Research (NWO-ALW, award no. 822.01.012) and the National Science Foundation (award no. IOS-1052238 and IOS-1456973).	ARTHUR CL, 1990, ANAL CHEM, V62, P2145, DOI 10.1021/ac00218a019; Avand-Faghih A, 2008, J CHEM ECOL, V34, P103, DOI 10.1007/s10886-007-9403-1; BAKER TC, 1981, J CHEM ECOL, V7, P961, DOI 10.1007/BF00987620; BJOSTAD LB, 1980, J INSECT PHYSIOL, V26, P493, DOI 10.1016/0022-1910(80)90122-5; BorgKarlson AK, 1996, Z NATURFORSCH C, V51, P599; CARDE AM, 1979, J CHEM ECOL, V5, P423, DOI 10.1007/BF00987927; Carde RT, 2004, ADVANCES IN INSECT CHEMICAL ECOLOGY, P283, DOI 10.1017/CBO9780511542664.009; CHARLTON RE, 1982, J INSECT PHYSIOL, V28, P423, DOI 10.1016/0022-1910(82)90069-5; Crewe RM, 2004, CHEMOECOLOGY, V14, P77, DOI 10.1007/s00049-003-0263-z; Eizaguirre M, 2009, J CHEM ECOL, V35, P779, DOI 10.1007/s10886-009-9662-0; Felix AE, 2011, CHEMOECOLOGY, V21, P107, DOI 10.1007/s00049-011-0069-3; Felix AE, 2009, J CHEM ECOL, V35, P618, DOI 10.1007/s10886-009-9638-0; Ferreira-Caliman MJ, 2014, ANAL METHODS-UK, V6, P8823, DOI 10.1039/c4ay01909a; Foster SP, 2011, J CHEM ECOL, V37, P717, DOI 10.1007/s10886-011-9982-8; Frerot B, 1997, HRC-J HIGH RES CHROM, V20, P340, DOI 10.1002/jhrc.1240200609; Gago R, 2013, J CHEM ECOL, V39, P1263, DOI 10.1007/s10886-013-0349-1; Gerhardt H, 2015, J CHROMATOGR A, V1388, P24, DOI 10.1016/j.chroma.2015.02.027; Glaser N, 2014, J CHEM ECOL, V40, P923, DOI 10.1007/s10886-014-0485-2; Groot AT, 2013, MOL ECOL, V22, P1065, DOI 10.1111/mec.12171; Groot AT, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3054; Groot AT, 2009, EVOLUTION, V63, P1987, DOI 10.1111/j.1558-5646.2009.00702.x; Groot AT, 2006, P NATL ACAD SCI USA, V103, P5858, DOI 10.1073/pnas.0508609103; Groot AT, 2004, J CHEM ECOL, V30, P2495, DOI 10.1007/s10886-004-7946-y; Haftka JJH, 2010, ENVIRON SCI POLLUT R, V17, P1070, DOI 10.1007/s11356-009-0263-9; HEATH RR, 1991, ANN ENTOMOL SOC AM, V84, P182, DOI 10.1093/aesa/84.2.182; Hummel HE, 1984, TECHNIQUES PHEROMONE; James DG, 2001, ENVIRON ENTOMOL, V30, P663, DOI 10.1603/0046-225X-30.4.663; Judd GJR, 2012, CAN ENTOMOL, V144, P798, DOI 10.4039/tce.2012.75; KLUN JA, 1982, ENVIRON ENTOMOL, V11, P1084, DOI 10.1093/ee/11.5.1084; KLUN JA, 1980, J CHEM ECOL, V6, P177, DOI 10.1007/BF00987536; Krokos FD, 2002, J CHEM ECOL, V28, P1463, DOI 10.1023/A:1016256804745; Kuenen LPS, 2015, ENTOMOL EXP APPL, V154, P35, DOI 10.1111/eea.12253; Leniaud L, 2006, ENTOMOL EXP APPL, V120, P51, DOI 10.1111/j.1570-7458.2006.00427.x; Leppik E, 2012, CHEMOECOLOGY, V22, P119, DOI 10.1007/s00049-012-0104-z; MALOSSE C, 1995, HRC-J HIGH RES CHROM, V18, P669; Marques FD, 2000, J BRAZIL CHEM SOC, V11, P592; Mayer P, 2000, ENVIRON SCI TECHNOL, V34, P5177, DOI 10.1021/es001179g; Millar JG, 2010, J CHEM ECOL, V36, P923, DOI 10.1007/s10886-010-9831-1; Ouyang GF, 2011, CHEM REV, V111, P2784, DOI 10.1021/cr100203t; Pelozuelo L, 2006, J APPL ENTOMOL, V130, P230, DOI 10.1111/j.1439-0418.2006.01058.x; Pelozuelo L, 2004, J CHEM ECOL, V30, P335, DOI 10.1023/B:JOEC.0000017981.03762.ed; POPE MM, 1982, J CHEM ECOL, V8, P1043, DOI 10.1007/BF00987885; POTTER DW, 1992, J CHROMATOGR, V625, P247, DOI 10.1016/0021-9673(92)85209-C; ROELOFS WL, 1974, LIFE SCI, V14, P1555, DOI 10.1016/0024-3205(74)90166-0; Svensson MGE, 1997, J CHEM ECOL, V23, P1833, DOI 10.1023/B:JOEC.0000006454.84415.5f; TEAL PEA, 1987, ARCH INSECT BIOCHEM, V4, P261, DOI 10.1002/arch.940040404; TEAL PEA, 1981, J CHEM ECOL, V7, P1011, DOI 10.1007/BF00987623; Teal PEA, 1997, INSECT PHEROMONE RESEARCH, P535; TEAL PEA, 1988, J CHEM ECOL, V14, P2131, DOI 10.1007/BF01014254; TEAL PEA, 1986, J CHEM ECOL, V12, P353, DOI 10.1007/BF01020561; Thomas Y, 2003, EVOLUTION, V57, P261; Tillman JA, 1999, INSECT BIOCHEM MOLEC, V29, P481, DOI 10.1016/S0965-1748(99)00016-8; Tumlinson J, 1982, ANALYSIS OF CHEMICAL; Tumlinson JH, 1975, J CHEM ECOL, V1, P203, DOI 10.1007/BF00987869; Wang HL, 2015, J CHEM ECOL, V41, P724, DOI 10.1007/s10886-015-0611-9; WITZGALL P, 1989, J CHEM ECOL, V15, P707, DOI 10.1007/BF01014713; Zhu JW, 1996, GENETICS, V144, P757	58	7	7	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161138	10.1371/journal.pone.0161138	http://dx.doi.org/10.1371/journal.pone.0161138			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27533064	Green Submitted, Green Published, gold			2022-12-26	WOS:000381487600063
J	Ramsook, SN; Ni, J; Shahangian, S; Vakiloroayaei, A; Khan, N; Kwan, JJ; Donaldson, LW				Ramsook, Sarah N.; Ni, Joyce; Shahangian, Shokofeh; Vakiloroayaei, Ana; Khan, Naveen; Kwan, Jamie J.; Donaldson, Logan W.			A Model for Dimerization of the SOX Group E Transcription Factor Family	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; CAMPOMELIC DYSPLASIA; COOPERATIVE BINDING; COMPLEX SUGGESTS; TERNARY COMPLEX; MOUSE SOX-5; DNA MOTIFS; CELL FATE; HMG BOX; PROTEIN	Group Emembers of the SOX transcription factor family include SOX8, SOX9, and SOX10. Preceding the high mobility group (HMG) domain in each of these proteins is a thirty-eight amino acid region that supports the formation of dimers on promoters containing tandemly inverted sites. The purpose of this study was to obtain new structural insights into how the dimerization region functions with the HMG domain. From a mutagenic scan of the dimerization region, the most essential amino acids of the dimerization region were clustered on the hydrophobic face of a single, predicted amphipathic helix. Consistent with our hypothesis that the dimerization region directly contacts the HMG domain, a peptide corresponding to the dimerization region bound a preassembled HMG-DNA complex. Sequence conservation among Group Emembers served as a basis to identify two surface exposed amino acids in the HMG domain of SOX9 that were necessary for dimerization. These data were combined to make a molecular model that places the dimerization region of one SOX9 protein onto the HMG domain of another SOX9 protein situated at the opposing site of a tandem promoter. The model provides a detailed foundation for assessing the impact of mutations on SOX Group E transcription factors.	[Ramsook, Sarah N.; Ni, Joyce; Shahangian, Shokofeh; Vakiloroayaei, Ana; Khan, Naveen; Kwan, Jamie J.; Donaldson, Logan W.] York Univ, Dept Biol, Toronto, ON, Canada; [Ni, Joyce] Sanofi Pasteur Pharmaceut, Toronto, ON, Canada; [Kwan, Jamie J.] Ontario Canc Inst, McEwen Ctr Regenerat Med, Toronto, ON, Canada	York University - Canada; Sanofi-Aventis; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Donaldson, LW (corresponding author), York Univ, Dept Biol, Toronto, ON, Canada.	logand@yorku.ca		Donaldson, Logan/0000-0001-5034-2699	Natural Sciences and Engineering Research Council of Canada [238934]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Natural Sciences and Engineering Research Council of Canada, #238934, to LWD. The funder provided support in the form of salaries for authors [JN SS NK JJK SR], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The funder of this study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard P, 2003, HUM MOL GENET, V12, P1755, DOI 10.1093/hmg/ddg182; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cary PD, 2001, PROTEIN SCI, V10, P83, DOI 10.1110/ps.32801; Crane-Robinson C, 1998, J MOL BIOL, V281, P705, DOI 10.1006/jmbi.1998.1895; Deo RC, 2001, P NATL ACAD SCI USA, V98, P4414, DOI 10.1073/pnas.071552198; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Gao NN, 2013, PROTEIN PEPTIDE LETT, V20, P481, DOI 10.2174/092986613805290336; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, DOI DOI 10.1385/1592598900; Genzer MA, 2007, NUCLEIC ACIDS RES, V35, P1178, DOI 10.1093/nar/gkm014; Han AD, 2003, NATURE, V422, P730, DOI 10.1038/nature01555; HARLEY VR, 1994, NUCLEIC ACIDS RES, V22, P1500, DOI 10.1093/nar/22.8.1500; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Huang YH, 2015, SCI REP-UK, V5, DOI 10.1038/srep10398; Jauch R, 2012, BIOCHEM J, V443, P39, DOI 10.1042/BJ20111768; Kamachi Y, 2013, DEVELOPMENT, V140, P4129, DOI 10.1242/dev.091793; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lu XJ, 2008, NAT PROTOC, V3, P1213, DOI 10.1038/nprot.2008.104; McDowall S, 1999, J BIOL CHEM, V274, P24023, DOI 10.1074/jbc.274.34.24023; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Palasingam P, 2009, J MOL BIOL, V388, P619, DOI 10.1016/j.jmb.2009.03.055; Peirano RI, 2000, NUCLEIC ACIDS RES, V28, P3047, DOI 10.1093/nar/28.16.3047; Polach KJ, 1996, J MOL BIOL, V258, P800, DOI 10.1006/jmbi.1996.0288; Remenyi A, 2003, GENE DEV, V17, P2048, DOI 10.1101/gad.269303; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Schlierf B, 2002, NUCLEIC ACIDS RES, V30, P5509, DOI 10.1093/nar/gkf690; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sock E, 2003, HUM MOL GENET, V12, P1439, DOI 10.1093/hmg/ddg158; Soufi A, 2015, CELL, V161, P555, DOI 10.1016/j.cell.2015.03.017; Szymczyna BR, 2009, STRUCTURE, V17, P499, DOI 10.1016/j.str.2009.03.001; TAKAMATSU N, 1995, MOL CELL BIOL, V15, P3759; Tan S, 1998, NATURE, V391, P660, DOI 10.1038/35563; van de WM, 1993, EMBO J, V12, P3847; vanHoute LPA, 1995, J BIOL CHEM, V270, P30516, DOI 10.1074/jbc.270.51.30516; Wegner M, 2010, INT J BIOCHEM CELL B, V42, P381, DOI 10.1016/j.biocel.2009.07.006; Williams DC, 2004, J BIOL CHEM, V279, P1449, DOI 10.1074/jbc.M309790200; Yamashita S, 2012, J BIOL CHEM, V287, P22206, DOI 10.1074/jbc.M112.343194	36	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161432	10.1371/journal.pone.0161432	http://dx.doi.org/10.1371/journal.pone.0161432			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532129	gold, Green Submitted, Green Published			2022-12-26	WOS:000381487600094
J	Tan, X; Fujiu, K; Manabe, I; Nishida, J; Yamagishi, R; Terashima, Y; Matsushima, K; Kaburaki, T; Nagai, R; Yanagi, Y				Tan, Xue; Fujiu, Katsuhito; Manabe, Ichiro; Nishida, Junko; Yamagishi, Reiko; Terashima, Yuya; Matsushima, Kouji; Kaburaki, Toshikatsu; Nagai, Ryozo; Yanagi, Yasuo			Choroidal Neovascularization Is Inhibited in Splenic-Denervated or Splenectomized Mice with a Concomitant Decrease in Intraocular Macrophage	PLOS ONE			English	Article							MACULAR DEGENERATION AMD; HEMATOPOIETIC STEM-CELLS; BONE-MARROW; MONONUCLEAR PHAGOCYTES; MYOCARDIAL-INFARCTION; INFLAMMATORY SITES; ADOPTIVE TRANSFER; BLOOD MONOCYTES; TISSUE-INJURY; ANIMAL-MODEL	Purpose To determine the involvement of sympathetic activity in choroidal neovascularization (CNV) using laser-induced CNV in a mouse model. Methods We investigated changes in the proportions of intraocular lymphocytes, granulocytes, and three macrophage subtypes (Ly6C(hi), Ly6C(int), and Ly6C(lo)) after laser injury in mice using flow cytometry,and evaluated CNV lesion size in mice lacking inflammatory cells. Further, we evaluated the lesion size in mice administered the beta 3 receptor antagonist, splenic-denervated and splenectomized mice. We also assessed changes in the proportions of intraocular macrophages and peripheral blood monocytes in splenic-denervated and splenectomized mice. Lastly, lesion size was compared between splenic-denervated mice with or without adoptive transfer of macrophages following laser injury. After Ly5.1 mice spleen-derived Ly6C(hi) cells were transferred into Ly5.2mice, the proportions of intraocular Ly5.1(+)Ly6C(hi) cells were compared. Results In WT mice, the proportion of CD4(+) T cells recruited into the eye increased progressively from day 3 to day 7 after laser injury, whereas, intraocular CD8(+) T cells did not change significantly. Proportions of B220(+) cells, granulocytes, and two subtypes of intraocular macrophages (Ly6C(hi) and Ly6C(lo)) peaked at day 3 following laser injury. In contrast, Ly6C(int/lo)CD64(+) subtype showed a significantly higher percentage at day 7 after laser injury. There were no differences in lesion size between CD4(-/-) or Rag2(-/)-mice and controls, whereas lesion size was significantly reduced in CCR2(-/-) mice and clodronate liposome-treated mice. CNV lesion area was significantly reduced in mice with beta 3 blocker treatment, splenic-denervated and splenectomized mice compared with controls. Intraocular Ly6C(hi) macrophages were also reduced by splenic denervation or splenectomy. Adoptive transfer of spleen-derived Ly6C(hi) cells increased the lesion size in splenic-denervated mice. Compared with controls, intraocular donor-derived Ly6C(hi) cells recruited into the eye were reduced in splenic-denervated and splenectomized mice. Conclusions Although lymphocytes had little effect on CNV formation, Ly6C(hi) macrophages/monocytes exacerbated CNV in mice. Sympathetic activity might contribute to CNV via the recruitment of macrophages to the eye.	[Tan, Xue; Nishida, Junko; Yamagishi, Reiko; Kaburaki, Toshikatsu; Yanagi, Yasuo] Univ Tokyo, Grad Sch Med, Dept Ophthalmol, Tokyo, Japan; [Tan, Xue; Fujiu, Katsuhito; Nishida, Junko; Yamagishi, Reiko; Kaburaki, Toshikatsu; Yanagi, Yasuo] Univ Tokyo, Fac Med, Tokyo, Japan; [Fujiu, Katsuhito] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan; [Fujiu, Katsuhito] Univ Tokyo, Sch Med, Dept Ubiquitous Hlth Informat, Tokyo, Japan; [Fujiu, Katsuhito] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Tokyo, Japan; [Manabe, Ichiro] Chiba Univ, Grad Sch Med, Dept Aging Res, Chiba, Japan; [Terashima, Yuya; Matsushima, Kouji] Univ Tokyo, Grad Sch Med, Dept Mol Prevent Med, Tokyo, Japan; [Nagai, Ryozo] Jichi Med Univ, Shimotsuke, Tochigi, Japan; [Yanagi, Yasuo] Singapore Eye Res Inst, Singapore, Singapore; [Yanagi, Yasuo] Singapore Natl Eye Ctr, Med Retina Dept, Singapore, Singapore; [Yanagi, Yasuo] Duke NUS Natl Univ Singapore, Grad Sch Med, Singapore, Singapore	University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); Chiba University; University of Tokyo; Jichi Medical University; National University of Singapore; Singapore National Eye Center; Singapore National Eye Center	Yanagi, Y (corresponding author), Univ Tokyo, Grad Sch Med, Dept Ophthalmol, Tokyo, Japan.; Yanagi, Y (corresponding author), Univ Tokyo, Fac Med, Tokyo, Japan.; Yanagi, Y (corresponding author), Singapore Eye Res Inst, Singapore, Singapore.; Yanagi, Y (corresponding author), Singapore Natl Eye Ctr, Med Retina Dept, Singapore, Singapore.; Yanagi, Y (corresponding author), Duke NUS Natl Univ Singapore, Grad Sch Med, Singapore, Singapore.	yanagi-tky@umin.ac.jp	Yanagi, Yasuo/AAF-2670-2020; Kaburaki, Toshikatsu/AAH-7091-2020; Yanagi, Yasuo/AAA-5441-2022; Manabe, Ichiro/E-1529-2014; Manabe, Ichiro/AAE-5105-2021	Yanagi, Yasuo/0000-0002-0362-7285	Grants-in-Aid for Scientific Research [15H04824] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; ANDREESEN R, 1990, CANCER RES, V50, P7450; Apte RS, 2006, PLOS MED, V3, P1371, DOI 10.1371/journal.pmed.0030310; Cruz-Guilloty F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088201; Davis A, 2012, ACTA OPHTHALMOL, V90, pe162, DOI 10.1111/j.1755-3768.2011.02117.x; Dutta P, 2012, NATURE, V487, P325, DOI 10.1038/nature11260; Espinosa-Heidmann DG, 2003, INVEST OPHTH VIS SCI, V44, P3586, DOI 10.1167/iovs.03-0038; Fujimura S, 2012, INVEST OPHTH VIS SCI, V53, P1999, DOI 10.1167/iovs.11-8232; Fujiu K, 2011, J CLIN INVEST, V121, P3425, DOI 10.1172/JCI57582; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hasegawa E, 2013, J IMMUNOL, V190, P1778, DOI 10.4049/jimmunol.1202495; Heidt T, 2014, NAT MED, V20, P754, DOI 10.1038/nm.3589; Hristov M, 2011, THROMB HAEMOSTASIS, V106, P757, DOI 10.1160/TH11-07-0500; Ideta R, 2004, FEBS LETT, V557, P21, DOI 10.1016/S0014-5793(03)01315-2; Jo YJ, 2011, INVEST OPHTH VIS SCI, V52, P6089, DOI 10.1167/iovs.10-5189; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kelly J, 2007, J CLIN INVEST, V117, P3421, DOI 10.1172/JCI32430; Kim SJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11872; Lech M, 2013, BBA-MOL BASIS DIS, V1832, P989, DOI 10.1016/j.bbadis.2012.12.001; Liu BY, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-111; Liu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057473, 10.1371/journal.pone.0050719, 10.1371/journal.pone.0064143]; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Montero JA, 2013, RETINA-J RET VIT DIS, V33, P508, DOI 10.1097/IAE.0b013e3182695ba0; Nishida M, 2005, BIOCHEM BIOPH RES CO, V332, P11, DOI 10.1016/j.bbrc.2005.04.083; Nowak JZ, 2006, PHARMACOL REP, V58, P353; Penfold PL, 2001, PROG RETIN EYE RES, V20, P385, DOI 10.1016/S1350-9462(00)00025-2; Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P3578, DOI 10.1167/iovs.03-0097; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Shivshankar P, 2014, J MOL CELL CARDIOL, V76, P84, DOI 10.1016/j.yjmcc.2014.07.020; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Steinle JJ, 2006, EXP EYE RES, V83, P16, DOI 10.1016/j.exer.2005.11.006; Steinle JJ, 2002, EXP EYE RES, V74, P761, DOI 10.1006/exer.2002.1182; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Takahashi H, 2008, CURR EYE RES, V33, P1002, DOI 10.1080/02713680802492440; Telander DG, 2011, SEMIN OPHTHALMOL, V26, P192, DOI 10.3109/08820538.2011.570849; Thaker PH, 2006, NAT MED, V12, P939, DOI 10.1038/nm1447; Toomey CB, 2015, P NATL ACAD SCI USA, V112, pE3040, DOI 10.1073/pnas.1424391112; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Tsutsumi C, 2003, J LEUKOCYTE BIOL, V74, P25, DOI 10.1189/jlb.0902436; Tsutsumi-Miyahara C, 2004, BRIT J OPHTHALMOL, V88, P1217, DOI 10.1136/bjo.2003.036392; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; Yanagi Y, 2002, INVEST OPHTH VIS SCI, V43, P3495; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Yuda K, 2012, AM J PATHOL, V181, P1464, DOI 10.1016/j.ajpath.2012.06.028; Zhou JH, 2005, MOL VIS, V11, P414; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	49	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160985	10.1371/journal.pone.0160985	http://dx.doi.org/10.1371/journal.pone.0160985			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532664	Green Submitted, Green Published, gold			2022-12-26	WOS:000381487600052
J	Valencia-Gattas, M; Conner, GE; Fregien, NL				Valencia-Gattas, Monica; Conner, Gregory E.; Fregien, Nevis L.			Gefitinib, an EGFR Tyrosine Kinase inhibitor, Prevents Smoke-Mediated Ciliated Airway Epithelial Cell Loss and Promotes Their Recovery	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; ALPHA-CONVERTING ENZYME; CIGARETTE-SMOKE; LUNG-CANCER; DIFFERENTIATION; EXPOSURE; CILIOGENESIS; CLEARANCE; PHENOTYPE	Cigarette smoke exposure is a major health hazard. Ciliated cells in the epithelium of the airway play a critical role in protection against the noxious effects of inhaled cigarette smoke. Ciliated cell numbers are reduced in smokers which weakens host defense and leads to disease. The mechanisms for the loss of ciliated cells are not well understood. The effects of whole cigarette smoke exposure on human airway ciliated ciliated cells were examined using in vitro cultures of normal human bronchial epithelial cells and a Vitrocell (R) VC 10 (R) Smoking Robot. These experiments showed that whole cigarette smoke causes the loss of differentiated ciliated cells and inhibits differentiation of ciliated cells from undifferentiated basal cells. Furthermore, treatment with the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, Gefitinib, during smoke exposure prevents ciliated cell loss and promotes ciliated cell differentiation from basal cells. Finally, restoration of ciliated cells was inhibited after smoke exposure was ceased but was enhanced by Gefitinib treatment. These data suggest that inhibition of EGFR activity may provide therapeutic benefit for treating smoke related diseases.	[Valencia-Gattas, Monica; Conner, Gregory E.; Fregien, Nevis L.] Univ Miami, Miller Sch Med, Dept Cell Biol, Miami, FL 33136 USA	University of Miami	Fregien, NL (corresponding author), Univ Miami, Miller Sch Med, Dept Cell Biol, Miami, FL 33136 USA.	Nevis@miami.edu	Conner, Gregory/AAI-1285-2021	Conner, Gregory/0000-0003-2217-2252	Flight Attendants Medical Research Institute FAMRI [CIA 123060, CIA 082442]; FAMRI [CIA 082442, CIA 09206]	Flight Attendants Medical Research Institute FAMRI; FAMRI	This work was supported in part by Flight Attendants Medical Research Institute FAMRI Grants CIA 123060 to GEC and CIA 082442 to NLF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Matthias Salathe for helpful discussion and comments on this project. This work was supported in part by FAMRI Grants CIA 09206 to GEC and CIA 082442 to NF.	AUERBACH O, 1961, NEW ENGL J MED, V265, P253, DOI 10.1056/NEJM196108102650601; Aufderheide M, 2015, EXP TOXICOL PATHOL; Bernacki SH, 1999, AM J RESP CELL MOL, V20, P595, DOI 10.1165/ajrcmb.20.4.3442; Brekman A, 2014, AM J RESP CELL MOL B; Gerovac BJ, 2014, AM J RESP CELL MOL B; Goldkorn T, 2014, ANTIOXID REDOX SIGN, V21, P2149, DOI 10.1089/ars.2013.5469; Khan EM, 2008, FASEB J, V22, P910, DOI 10.1096/fj.06-7729com; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Lee SY, 2006, RESP MED, V100, P503, DOI 10.1016/j.rmed.2005.06.006; Lemjabbar H, 2003, J BIOL CHEM, V278, P26202, DOI 10.1074/jbc.M207018200; Leopold PL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008157; Mehta H, 2008, INFLAMM RES, V57, P497, DOI 10.1007/s00011-008-8078-6; Milara J, 2012, BRIT J PHARM; Muhsin M, 2003, NAT REV DRUG DISCOV, V2, P515, DOI 10.1038/nrd1136; Nlend MC, 2002, AM J RESP CELL MOL, V27, P436, DOI 10.1165/rcmb.2002-0012OC; Petecchia L, 2009, CHEST, V135, P1502, DOI 10.1378/chest.08-1780; Randell SH, 2001, IN VITRO CELL DEV-AN, V37, P480; Richter A, 2002, AM J RESP CELL MOL, V27, P85, DOI 10.1165/ajrcmb.27.1.4789; Schamberger AC, 2015, SCI REP-UK, V5, DOI 10.1038/srep08163; Services U.S.D.o.H.a.H, 2014, HLTH CONSMOK 50 YE; Shao MXG, 2004, AM J PHYSIOL-LUNG C, V287, pL420, DOI 10.1152/ajplung.00019.2004; Shaykhiev R, 2013, P NATL ACAD SCI USA, V110, P12102, DOI 10.1073/pnas.1303058110; Simet SM, 2010, AM J RESP CELL MOL, V43, P635, DOI 10.1165/rcmb.2009-0297OC; Stubbs JL, 2012, NAT CELL BIOL, V14, P140, DOI 10.1038/ncb2406; Takeyama K, 2001, AM J PHYSIOL-LUNG C, V280, pL165, DOI 10.1152/ajplung.2001.280.1.L165; Tamashiro E, 2009, AM J RHINOL ALLERGY, V23, P117, DOI 10.2500/ajra.2009.23.3280; Turetz ML, 2009, CTS-CLIN TRANSL SCI, V2, P260, DOI 10.1111/j.1752-8062.2009.00129.x; Wanner A, 1996, AM J RESP CRIT CARE, V154, P1868, DOI 10.1164/ajrccm.154.6.8970383; You YJ, 2004, AM J PHYSIOL-LUNG C, V286, pL650, DOI 10.1152/ajplung.00170.2003; Zhang LL, 2013, J PATHOL, V229, P74, DOI 10.1002/path.4070	30	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160216	10.1371/journal.pone.0160216	http://dx.doi.org/10.1371/journal.pone.0160216			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532261	gold, Green Submitted, Green Published			2022-12-26	WOS:000381487600026
J	Braeye, T; Verheagen, J; Mignon, A; Flipse, W; Pierard, D; Huygen, K; Schirvel, C; Hens, N				Braeye, Toon; Verheagen, Jan; Mignon, Annick; Flipse, Wim; Pierard, Denis; Huygen, Kris; Schirvel, Carole; Hens, Niel			Capture-Recapture Estimators in Epidemiology with Applications to Pertussis and Pneumococcal Invasive Disease Surveillance	PLOS ONE			English	Article							ESTIMATING ANIMAL ABUNDANCE; CLOSED POPULATION; SAMPLE COVERAGE; MODELS; BURDEN; SIZE; CENSUS; HETEROGENEITY; PROBABILITIES; MIXTURES	Introduction Surveillance networks are often not exhaustive nor completely complementary. In such situations, capture-recapture methods can be used for incidence estimation. The choice of estimator and their robustness with respect to the homogeneity and independence assumptions are however not well documented. Methods We investigated the performance of five different capture-recapture estimators in a simulation study. Eight different scenarios were used to detect and combine case-information. The scenarios increasingly violated assumptions of independence of samples and homogeneity of detection probabilities. Belgian datasets on invasive pneumococcal disease (IPD) and pertussis provided motivating examples. Results No estimator was unbiased in all scenarios. Performance of the parametric estimators depended on how much of the dependency and heterogeneity were correctly modelled. Model building was limited by parameter estimability, availability of additional information (e.g. covariates) and the possibilities inherent to the method. In the most complex scenario, methods that allowed for detection probabilities conditional on previous detections estimated the total population size within a 20-30% error-range. Parametric estimators remained stable if individual data sources lost up to 50% of their data. The investigated nonparametric methods were more susceptible to data loss and their performance was linked to the dependence between samples; overestimating in scenarios with little dependence, underestimating in others. Issues with parameter estimability made it impossible to model all suggested relations between samples for the IPD and pertussis datasets. For IPD, the estimates for the Belgian incidence for cases aged 50 years and older ranged from 44 to 58/100,000 in 2010. The estimates for pertussis (all ages, Belgium, 2014) ranged from 24.2 to30.8/100,000. Conclusion We encourage the use of capture-recapture methods, but epidemiologists should preferably include datasets for which the underlying dependency structure is not too complex, a priori investigate this structure, compensate for it within the model and interpret the results with the remaining unmodelled heterogeneity in mind.	[Braeye, Toon] Sci Inst Publ Hlth, Epidemiol, Dept Epidemiol Infect Dis, Brussels, Belgium; [Verheagen, Jan] Univ Clin Leuven, Dept Clin Microbiol, Leuven, Belgium; [Mignon, Annick] Pfizer Vaccines, Med Affairs, Brussels, Belgium; [Flipse, Wim] Flemish Agcy Care & Hlth, Infect Dis Control, Brussels, Belgium; [Pierard, Denis] Univ Hosp Brussels, Inst Med Microbiol, Brussels, Belgium; [Huygen, Kris] Sci Inst Publ Hlth, Dept Immunol Communicable & Infect Dis, Brussels, Belgium; [Schirvel, Carole] Direct Gen Sante, Cellule Surveillance Malad Infect, Brussels, Belgium; [Hens, Niel] Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat, Hasselt, Belgium; [Hens, Niel] Univ Antwerp, WHO Collaborating Ctr, Vaccine & Infect Dis Inst, CHERMID, Antwerp, Belgium; [Hens, Niel] Univ Antwerp, Epidemiol & Social Med ESOC, Antwerp, Belgium	KU Leuven; University Hospital Leuven; Pfizer; University Hospital Brussels; Hasselt University; University of Antwerp; World Health Organization; University of Antwerp	Braeye, T (corresponding author), Sci Inst Publ Hlth, Epidemiol, Dept Epidemiol Infect Dis, Brussels, Belgium.	Toon.Braeye@wiv-isp.be	Hens, Niel/M-4445-2017	Hens, Niel/0000-0003-1881-0637; Pierard, DEnis/0000-0002-7756-3691; Huygen, Kris/0000-0001-7808-0512				Amstrup S.C., 2010, HDB CAPTURE RECAPTUR; ANDERSON DR, 1994, ECOLOGY, V75, P1780, DOI 10.2307/1939637; [Anonymous], 1951, U CALIFORNIA PUBLICA; Blasi F, 2012, CLIN MICROBIOL INFEC, V18, P7, DOI 10.1111/j.1469-0691.2012.03937.x; Borchers DL, 2008, BIOMETRICS, V64, P377, DOI 10.1111/j.1541-0420.2007.00927.x; Brittain S, 2009, ASTA-ADV STAT ANAL, V93, P23, DOI 10.1007/s10182-008-0085-y; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; BURNHAM KP, 1978, BIOMETRIKA, V65, P625, DOI 10.2307/2335915; Chao A, 2001, STAT MED, V20, P3123, DOI 10.1002/sim.996.abs; Chao A, 1998, J AM STAT ASSOC, V93, P283, DOI 10.2307/2669624; CHAPMAN DG, 1956, ANN MATH STAT, V27, P375, DOI 10.1214/aoms/1177728264; Cormack RM, 1999, J CLIN EPIDEMIOL, V52, P909, DOI 10.1016/S0895-4356(99)00058-X; Coull BA, 1999, BIOMETRICS, V55, P294, DOI 10.1111/j.0006-341X.1999.00294.x; Davies MLH, 2011, J STAT SOFTW, V39; Drijkoningen JJC, 2014, CLIN MICROBIOL INFEC, V20, P45, DOI 10.1111/1469-0691.12461; eCDC, 2010, SURV INV PNEUM DIS E; European Centre for Disease Prevention and Control (ECDC), 2013, ANN EP REP REP 2012; FIENBERG SE, 1972, BIOMETRIKA, V59, P591, DOI 10.1093/biomet/59.3.591; Gaetan M, 2012, ARCH PUBLIC HEALTH, V70, DOI 10.1186/0778-7367-70-16; Grimm A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098840; Holzmann H, 2006, BIOMETRICS, V62, P934, DOI 10.1111/j.1541-0420.2006.00637_1.x; Hook E.B., 2012, EPIDEMIOL METHODS, V1, P1, DOI DOI 10.1515/2161-962X.1000; Hook EB, 2000, AM J EPIDEMIOL, V152, P771, DOI 10.1093/aje/152.8.771; Hook EB, 1995, EPIDEMIOL REV, V17, P243, DOI 10.1093/oxfordjournals.epirev.a036192; Hubbard BA, 2014, STAT METHODOL, V17, P17, DOI 10.1016/j.stamet.2012.11.005; HUGGINS RM, 1989, BIOMETRIKA, V76, P133, DOI 10.1093/biomet/76.1.133; Ivan JS, 2013, ECOLOGY, V94, P817, DOI 10.1890/12-0102.1; Jones HE, 2014, AM J EPIDEMIOL, V179, P1383, DOI 10.1093/aje/kwu056; Laake JL, 2011, J AGR BIOL ENVIR ST, V16, P389, DOI 10.1007/s13253-011-0059-5; Le Pacheco M, 2013, ZOOLOGIA-CURITIBA, V30, P182, DOI 10.1590/S1984-46702013000200008; LEE SM, 1994, BIOMETRICS, V50, P88, DOI 10.2307/2533199; Link WA, 2003, BIOMETRICS, V59, P1123, DOI 10.1111/j.0006-341X.2003.00129.x; Ludwig E, 2012, CENT EUR J PUBL HEAL, V20, P121, DOI 10.21101/cejph.a3744; Moberley S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000422.pub3; OTIS DL, 1978, WILDLIFE MONOGR, P1; Pledger S, 2005, BIOMETRICS, V61, P868, DOI 10.1111/j.1541-020X.2005.00411_1.x; Pledger S, 2008, BIOMETRICAL J, V50, P1022, DOI 10.1002/bimj.200810446; Rivest LP, 2001, CAN J STAT, V29, P555, DOI 10.2307/3316007; Royle JA, 2008, ECOLOGY, V89, P2281, DOI 10.1890/07-0601.1; Sabbe Martine, INFECTIEZIEKTEN BIJ; Salasar LEB, 2014, STATISTICS, V0, P1; Schwarz CJ, 1999, STAT SCI, V14, P427; SEBER GAF, 1986, BIOMETRICS, V42, P267, DOI 10.2307/2531049; Seber GAF, 2000, BIOMETRICS, V56, P1227, DOI 10.1111/j.0006-341X.2000.01227.x; Stoklosa J, 2011, BIOMETRICS, V67, P1659, DOI 10.1111/j.1541-0420.2011.01596.x; van Hest NAH, 2007, EPIDEMIOL INFECT, V135, P1021, DOI 10.1017/S0950268806007540; Vergne T, 2015, PREV VET MED, V120, P253, DOI 10.1016/j.prevetmed.2015.04.003; Verhaegen J, 2014, EUROSURVEILLANCE, V19, P14, DOI 10.2807/1560-7917.ES2014.19.31.20869; WALCKIERS D, 1991, EPIDEMIOL INFECT, V106, P297, DOI 10.1017/S0950268800048445; WITTES JT, 1974, J AM STAT ASSOC, V69, P93, DOI 10.2307/2285505; Wroe PC, 2012, J INFECT DIS, V205, P1589, DOI 10.1093/infdis/jis240; YIP PSF, 1995, AM J EPIDEMIOL, V142, P1047; Zhang LJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001478.pub6	57	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0159832	10.1371/journal.pone.0159832	http://dx.doi.org/10.1371/journal.pone.0159832			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529167	Green Published, Green Submitted, gold			2022-12-26	WOS:000381476700002
J	Grimberg-Peters, D; Buren, C; Windolf, J; Wahlers, T; Paunel-Gorgulu, A				Grimberg-Peters, Deborah; Bueren, Carina; Windolf, Joachim; Wahlers, Thorsten; Paunel-Goerguelue, Adnana			Hyperbaric Oxygen Reduces Production of Reactive Oxygen Species in Neutrophils from Polytraumatized Patients Yielding in the Inhibition of p38 MAP Kinase and Downstream Pathways	PLOS ONE			English	Article							EXTRACELLULAR TRAPS; ACTIVATION; APOPTOSIS; CELLS; MCL-1; REPERFUSION; RECRUITMENT; RESISTANCE; EXPRESSION; NETOSIS	Trauma represents the leading cause of death among young people in western countries. Among the beneficial role of neutrophils in host defence, excessive priming and activation of neutrophils after major trauma lead to an overwhelming inflammatory response and secondary host tissue injury due to the release of toxic metabolites and enzymes. Hyperbaric oxygen (HBO) therapy has been proposed to possess antiinflammatory effects and might represent an appropriate therapeutic option to lower inflammation in a broad range of patients. Here, we studied the effects of HBO on the activity of neutrophils isolated from severely injured patients (days 1-2 after trauma), in fact on the production of reactive oxygen species (ROS) and release of neutrophil extracellular traps (NETs). We found exposure to HBO therapy to significantly diminish phorbol-12-myristate-13-acetate (PMA)-induced ROS production in neutrophils isolated from patients and healthy volunteers. At the same time, marked decrease in NETs release was found in control cells and a less pronounced reduction in patient neutrophils. Impaired ability to produce ROS following exposure to HBO was demonstrated to be linked to a strong downregulation of the activity of p38 MAPK. Only slight suppression of ERK activity could be found. In addition, HBO did not influence neutrophil chemotaxis or apoptosis, respectively. Collectively, this study shows for the first time that HBO therapy suppresses ROS production in inflammatory human neutrophils, and thus might impair ROS-dependent pathways, e.g. kinases activation and NETs release. Thus, HBO might represent a feasible therapy for patients suffering from systemic inflammation, including those with multiple trauma.	[Grimberg-Peters, Deborah; Bueren, Carina; Windolf, Joachim] Univ Hosp Dusseldorf, Dept Trauma & Hand Surg, Moorenstr 5, D-40225 Dusseldorf, Germany; [Wahlers, Thorsten; Paunel-Goerguelue, Adnana] Univ Cologne, Ctr Heart, Dept Cardiothorac Surg, Kerpener Str 62, D-50937 Cologne, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; University of Cologne; University of Hamburg; University Medical Center Hamburg-Eppendorf	Paunel-Gorgulu, A (corresponding author), Univ Cologne, Ctr Heart, Dept Cardiothorac Surg, Kerpener Str 62, D-50937 Cologne, Germany.	adnana.paunel-goerguelue@uk-koeln.de						Almzaiel AJ, 2015, BIOCHEM CELL BIOL, V93, P405, DOI 10.1139/bcb-2014-0157; Benson RM, 2003, CLIN EXP IMMUNOL, V134, P57, DOI 10.1046/j.1365-2249.2003.02248.x; Blanc A, 2003, INT J MOL MED, V11, P229; BOTHA AJ, 1995, SURGERY, V118, P358, DOI 10.1016/S0039-6060(05)80345-9; Calandra T, 2005, CRIT CARE MED, V33, P1538, DOI 10.1097/01.CCM.0000168253.91200.83; Chen MF, 1998, LIVER, V18, P110; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Conde de la Rosa L, 2006, J HEPATOL, V44, P918, DOI 10.1016/j.jhep.2005.07.034; Dekker LV, 2000, BIOCHEM J, V347, P285, DOI 10.1042/0264-6021:3470285; Domina AM, 2004, ONCOGENE, V23, P5301, DOI 10.1038/sj.onc.1207692; Dzhagalov I, 2007, BLOOD, V109, P1620, DOI 10.1182/blood-2006-03-013771; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Ganguly BJ, 2002, APOPTOSIS, V7, P499, DOI 10.1023/A:1020686908831; Gray RD, 2013, J INFLAMM-LOND, V10, DOI 10.1186/1476-9255-10-12; GREENSPAN L, 1985, J TRAUMA, V25, P60, DOI 10.1097/00005373-198501000-00010; Gupta AK, 2010, FEBS LETT, V584, P3193, DOI 10.1016/j.febslet.2010.06.006; Hakkim A, 2011, NAT CHEM BIOL, V7, P75, DOI 10.1038/NCHEMBIO.496; Hattori H, 2010, P NATL ACAD SCI USA, V107, P3546, DOI 10.1073/pnas.0914351107; Hornstein T, 2016, J LEUKOCYTE BIOL, V99, P163, DOI 10.1189/jlb.3A1114-537RR; Jones MR, 2005, J IMMUNOL, V175, P7530, DOI 10.4049/jimmunol.175.11.7530; Kalns J, 2002, IMMUNOL LETT, V83, P125, DOI 10.1016/S0165-2478(02)00068-8; Kannan S, 2002, MED HYPOTHESES, V59, P266, DOI 10.1016/S0306-9877(02)00214-1; Kendall AC, 2013, WOUND REPAIR REGEN, V21, P860, DOI 10.1111/wrr.12108; Keshari RS, 2013, J CELL BIOCHEM, V114, P532, DOI 10.1002/jcb.24391; Leach RM, 1998, BRIT MED J, V317, P1140; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; Li ZS, 2010, FEBS LETT, V584, P2291, DOI 10.1016/j.febslet.2010.03.040; Lord JM, 2014, LANCET, V384, P1455, DOI 10.1016/S0140-6736(14)60687-5; Lustenberger T, 2016, IMMUNOBIOLOGY, V221, P427, DOI 10.1016/j.imbio.2015.11.011; Maianski NA, 2002, BLOOD, V99, P672, DOI 10.1182/blood.V99.2.672; Margraf S, 2008, SHOCK, V30, P352, DOI 10.1097/SHK.0b013e31816a6bb1; Masuoka HC, 2009, J BIOL CHEM, V284, P30039, DOI 10.1074/jbc.M109.039545; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Meng W, 2012, CRIT CARE, V16, DOI 10.1186/cc11442; Meng W, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/149560; Milot E, 2011, THESCIENTIFICWORLDJO, V11, P1948, DOI 10.1100/2011/131539; Min KJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.35; Moulding DA, 2001, J LEUKOCYTE BIOL, V70, P783; Oehmcke S, 2009, J INNATE IMMUN, V1, P225, DOI 10.1159/000203700; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Pashevin DO, 2015, PATHOBIOLOGY, V82, P290, DOI 10.1159/000440982; Paunel-Gorgulu A, 2009, J IMMUNOL, V183, P6198, DOI 10.4049/jimmunol.0901264; Peng HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100814; Probst C, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/136020; Rajalingam K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003102; Remijsen Q, 2011, CELL RES, V21, P290, DOI 10.1038/cr.2010.150; Saffarzadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032366; SIMMS HH, 1991, J SURG RES, V50, P362, DOI 10.1016/0022-4804(91)90204-Y; Singer M, 2004, J IMMUNOL, V173, P4197, DOI 10.4049/jimmunol.173.6.4197; STERLING DL, 1993, CIRCULATION, V88, P1931, DOI 10.1161/01.CIR.88.4.1931; THOM SR, 1990, TOXICOL APPL PHARM, V105, P340, DOI 10.1016/0041-008X(90)90195-Z; Thom SR, 2008, J BIOL CHEM, V283, P10822, DOI 10.1074/jbc.M709200200; Tjarnstrom J, 1999, EUR SURG RES, V31, P147, DOI 10.1159/000008633; Usatyuk PV, 2003, ANTIOXID REDOX SIGN, V5, P723, DOI 10.1089/152308603770380025; Vantaggiato Chiara, 2006, J Biol, V5, P14, DOI 10.1186/jbiol38; Wolters PJ, 2009, J IMMUNOL, V182, P8056, DOI 10.4049/jimmunol.0801323; Yipp BG, 2013, BLOOD, V122, P2784, DOI 10.1182/blood-2013-04-457671; Zhang QX, 2008, J INVEST DERMATOL, V128, P2102, DOI 10.1038/jid.2008.53	58	12	14	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161343	10.1371/journal.pone.0161343	http://dx.doi.org/10.1371/journal.pone.0161343			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529549	Green Published, gold, Green Submitted			2022-12-26	WOS:000381476700069
J	VanDam, M; Silbert, NH				VanDam, Mark; Silbert, Noah H.			Fidelity of Automatic Speech Processing for Adult and Child Talker Classifications	PLOS ONE			English	Article							VOCAL ANALYSIS; LANGUAGE; COMMUNICATION; RECOGNITION; ENVIRONMENT; OUTCOMES	Automatic speech processing (ASP) has recently been applied to very large datasets of naturalistically collected, daylong recordings of child speech via an audio recorder worn by young children. The system developed by the LENA Research Foundation analyzes children's speech for research and clinical purposes, with special focus on of identifying and tagging family speech dynamics and the at-home acoustic environment from the auditory perspective of the child. A primary issue for researchers, clinicians, and families using the Language ENvironment Analysis (LENA) system is to what degree the segment labels are valid. This classification study evaluates the performance of the computer ASP output against 23 trained human judges who made about 53,000 judgements of classification of segments tagged by the LENA ASP. Results indicate performance consistent with modern ASP such as those using HMM methods, with acoustic characteristics of fundamental frequency and segment duration most important for both human and machine classifications. Results are likely to be important for interpreting and improving ASP output.	[VanDam, Mark] Washington State Univ, Elson S Floyd Coll Med, Dept Speech & Hearing Sci, Spokane, WA 99202 USA; [VanDam, Mark] Spokane Hearing Oral Program Excellence HOPE, Spokane, WA USA; [Silbert, Noah H.] Univ Cincinnati, Dept Commun Sci & Disorders, Cincinnati, OH USA	Washington State University; University System of Ohio; University of Cincinnati	VanDam, M (corresponding author), Washington State Univ, Elson S Floyd Coll Med, Dept Speech & Hearing Sci, Spokane, WA 99202 USA.; VanDam, M (corresponding author), Spokane Hearing Oral Program Excellence HOPE, Spokane, WA USA.	mark.vanDam@wsu.edu		VanDam, Mark/0000-0002-1906-5774	Washington State University Spokane Seed Grant Program; Hearing Oral Program of Excellence (HOPE) School of Spokane; National Institutes of Health Grants/National Institute on Deafness and Communicative Disorders (NIDCD) [R01-DC009560, R01-DC009560-01S1]; National Science Foundation, Directorate for Social, Behavioral and Economic Sciences [1539129]; Washington Research Foundation; WSU Spokane Seed Grant Program; Hearing Oral Program of Excellence (HOPE) of Spokane; National Institute on Deafness and Other Communication Disorders [R01-DC009560-01S1, NIH R01-DC009560]; National Science Foundation [SBE RIDIR 1539129]; Direct For Social, Behav & Economic Scie [1539133] Funding Source: National Science Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009560] Funding Source: NIH RePORTER	Washington State University Spokane Seed Grant Program; Hearing Oral Program of Excellence (HOPE) School of Spokane; National Institutes of Health Grants/National Institute on Deafness and Communicative Disorders (NIDCD); National Science Foundation, Directorate for Social, Behavioral and Economic Sciences(National Science Foundation (NSF)); Washington Research Foundation; WSU Spokane Seed Grant Program; Hearing Oral Program of Excellence (HOPE) of Spokane; National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Science Foundation(National Science Foundation (NSF)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This project was supported by Washington State University Spokane Seed Grant Program and the Hearing Oral Program of Excellence (HOPE) School of Spokane. This work was supported by National Institutes of Health Grants/National Institute on Deafness and Communicative Disorders (NIDCD) (R01-DC009560 and R01-DC009560-01S1). The content of this project is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute on Deafness and Other Communication Disorders or the National Institutes of Health. This work was supported by the National Science Foundation, Directorate for Social, Behavioral and Economic Sciences (1539129, principal investigator M. VanDam). This work was supported by the Washington Research Foundation (principal investigator M. VanDam). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the many families and children and the volunteer judges who contributed to this project. This project was supported by WSU Spokane Seed Grant Program, the Hearing Oral Program of Excellence (HOPE) of Spokane, the National Institute on Deafness and Other Communication Disorders (NIH R01-DC009560 & R01-DC009560-01S1), the Washington Research Foundation, and the National Science Foundation (SBE RIDIR 1539129).	Ambrose SE, 2014, EAR HEARING, V35, P139, DOI 10.1097/AUD.0b013e3182a76768; [Anonymous], 2014, R LANG ENV STAT COMP; Aragon M, 2012, SEMIN SPEECH LANG, V33, P340, DOI 10.1055/s-0032-1326918; Boril H, 2014, 4 WORKSH CHILD COMP; Canault M, 2015, BEHAV RES, DOI [10.3758/s13428-015-0634-8, DOI 10.3758/s13428-015-0634-8.]; Caskey M, 2011, PEDIATRICS, V128, P910, DOI 10.1542/peds.2011-0609; Cheng J, 2015, SPEECH COMMUN, V73, P14, DOI 10.1016/j.specom.2015.07.006; Christakis DA, 2009, ARCH PEDIAT ADOL MED, V163, P554, DOI 10.1001/archpediatrics.2009.61; Das S, 1998, INT CONF ACOUST SPEE, P433, DOI 10.1109/ICASSP.1998.674460; Dykstra JR, 2013, AUTISM, V17, P582, DOI 10.1177/1362361312446206; Eskenazi M, 2009, SPEECH COMMUN, V51, P832, DOI 10.1016/j.specom.2009.04.005; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Gerosa M., 2009, P 2 WORKSHOP CHILD C, P1, DOI DOI 10.1145/1640377.1640384; Gerosa M, 2007, SPEECH COMMUN, V49, P847, DOI 10.1016/j.specom.2007.01.002; Gilkerson J., 2009, POWER TALK, V2nd ed.; Giuliani D, 2003, INT CONF ACOUST SPEE, P137; Gray SS, 2014, 5 WORKSH CHILD COMP; Johnson K, 2014, PEDIATRICS, V134, pE1603, DOI 10.1542/peds.2013-4289; LEVITT H, 1995, P NATL ACAD SCI USA, V92, P9999, DOI 10.1073/pnas.92.22.9999; Meilleur AAS, 2009, J INTELL DISABIL RES, V53, P115, DOI 10.1111/j.1365-2788.2008.01134.x; Milborrow S., 2020, RPART PLOT PLOT RPAR; Oller DK, 2010, P NATL ACAD SCI USA, V107, P13354, DOI 10.1073/pnas.1003882107; Oller D.K, 2000, EMERGENCE SPEECH CAP, DOI [10.4324/9781410602565, DOI 10.4324/9781410602565]; Paul T., 2014, Patent Number, Patent No. [US 8844847 B2, 8844847]; Potamianos A., 1997, P EUR; Russell M, 1996, ICSLP 96 - FOURTH INTERNATIONAL CONFERENCE ON SPOKEN LANGUAGE PROCESSING, PROCEEDINGS, VOLS 1-4, P176, DOI 10.1109/ICSLP.1996.607069; Soderstrom M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080646; Stevens KN, 2002, J ACOUST SOC AM, V111, P1872, DOI 10.1121/1.1458026; Therneau T., 2014, RPART RECURSIVE PART; Thiemann-Bourque KS, 2014, AM J SPEECH-LANG PAT, V23, P474, DOI 10.1044/2014_AJSLP-12-0010; VanDam M, 2010, J ACOUST SOC AM, V128, P2459; VanDam M, 2016, SEMIN SPEECH LANG, V37, P128, DOI 10.1055/s-0036-1580745; VanDam M, 2015, EAR HEARING, V36, pe146, DOI [10.1097/AUD.0000000000000138, 10.1097/AUD.0000000000000209]; VanDam M, 2014, J ACOUST SOC AM, V136, pEL263, DOI 10.1121/1.4895015; VanDam M, 2012, J DEAF STUD DEAF EDU, V17, P402, DOI 10.1093/deafed/ens025; Wang ZW, 2014, COMPUT EDUC, V78, P115, DOI 10.1016/j.compedu.2014.05.010; Warlaumont AS, 2014, PSYCHOL SCI, V25, P1314, DOI 10.1177/0956797614531023; Warren SF, 2010, J AUTISM DEV DISORD, V40, P555, DOI 10.1007/s10803-009-0902-5; Weisleder A, 2013, PSYCHOL SCI, V24, P2143, DOI 10.1177/0956797613488145; Xu D, 2008, 1 WORKSH CHILD COMP; Xu D., 2009, LTR052 LENA FDN; Xu DX, 2014, J SPEECH LANG HEAR R, V57, P1638, DOI 10.1044/2014_JSLHR-S-13-0037; Yapanel U, 2008, LTR042 LENA FDN; Zimmerman FJ, 2009, PEDIATRICS, V124, P342, DOI 10.1542/peds.2008-2267	44	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160588	10.1371/journal.pone.0160588	http://dx.doi.org/10.1371/journal.pone.0160588			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT4UN	27529813	Green Published, Green Submitted, gold			2022-12-26	WOS:000381476700010
J	Vielma, AZ; Leon, L; Fernandez, IC; Gonzalez, DR; Boric, MP				Vielma, Alejandra Z.; Leon, Luisa; Fernandez, Ignacio C.; Gonzalez, Daniel R.; Boric, Mauricio P.			Nitric Oxide Synthase 1 Modulates Basal and beta-Adrenergic-Stimulated Contractility by Rapid and Reversible Redox-Dependent S-Nitrosylation of the Heart	PLOS ONE			English	Article							LEFT-VENTRICULAR MYOCYTES; RYANODINE RECEPTOR; CARDIAC MYOCYTES; IN-VIVO; SARCOPLASMIC-RETICULUM; MYOCARDIAL RELAXATION; SELECTIVE-INHIBITION; CALCIUM LEAK; CA2+ CURRENT; NO	S-nitrosylation of several Ca2+ regulating proteins in response to beta-adrenergic stimulation was recently described in the heart; however the specific nitric oxide synthase (NOS) isoform and signaling pathways responsible for this modification have not been elucidated. NOS-1 activity increases inotropism, therefore, we tested whether beta-adrenergic stimulation induces NOS-1-dependent S-nitrosylation of total proteins, the ryanodine receptor (RyR2), SERCA2 and the L-Type Ca2+ channel (LTCC). In the isolated rat heart, isoproterenol (10 nM, 3-min) increased S-nitrosylation of total cardiac proteins (+46 +/- 14%) and RyR2 (+146 +/- 77%), without affecting S-nitrosylation of SERCA2 and LTCC. Selective NOS-1 blockade with S-methyl-L-thiocitrulline (SMTC) and N.-propyl-l-arginine decreased basal contractility and relaxation (-25-30%) and basal S-nitrosylation of total proteins (-25-60%), RyR2, SERCA2 and LTCC (-60-75%). NOS-1 inhibition reduced (-25-40%) the inotropic response and protein S-nitrosylation induced by isoproterenol, particularly that of RyR2 (-85 +/-%). Tempol, a superoxide scavenger, mimicked the effects of NOS-1 inhibition on inotropism and protein S-nitrosylation; whereas selective NOS-3 inhibitor L-N-5-(1-Iminoethyl) ornithine had no effect. Inhibition of NOS-1 did not affect phospholamban phosphorylation, but reduced its oligomerization. Attenuation of contractility was abolished by PKA blockade and unaffected by guanylate cyclase inhibition. Additionally, in isolated mouse cardiomyocytes, NOS-1 inhibition or removal reduced the Ca2+-transient amplitude and sarcomere shortening induced by isoproterenol or by direct PKA activation. We conclude that 1) normal cardiac performance requires basal NOS-1 activity and S-nitrosylation of the calcium-cycling machinery; 2) beta-adrenergic stimulation induces rapid and reversible NOS-1 dependent, PKA and ROS-dependent, S-nitrosylation of RyR2 and other proteins, accounting for about one third of its inotropic effect.	[Vielma, Alejandra Z.; Leon, Luisa; Fernandez, Ignacio C.; Boric, Mauricio P.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Fisiol, POB 114-D, Santiago, Chile; [Gonzalez, Daniel R.] Univ Talca, Dept Ciencias Basicas Biomed, Fac Ciencias Salud, Ave Lircay SN, Talca, Chile	Pontificia Universidad Catolica de Chile; Universidad de Talca	Boric, MP (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Fisiol, POB 114-D, Santiago, Chile.	mboric@bio.puc.cl	Boric, Mauricio P/G-1574-2013	Boric, Mauricio P/0000-0001-6735-6675; GONZALEZ, DANIEL/0000-0002-3437-8998; Fernandez, Ignacio/0000-0002-3631-9932	Fondecyt (Chilean National Fund for Science and Technology);  [1090757];  [1120595];  [1150662]	Fondecyt (Chilean National Fund for Science and Technology); ; ; 	Supported in part by Grants 1090757 (M.P. Boric), 1120595 and 1150662 (D.R. Gonzalez) and Anillos Act71 from Fondecyt (Chilean National Fund for Science and Technology).; Supported in part by Grants 1090757 (MP Boric), 1120595 and 1150662 (DR Gonzalez) and Anillos Act71 from Fondecyt (Chilean National Fund for Science and Technology). The authors thank Dr. Walter N. Duran for critical reviewing of the manuscript.	Andersson DC, 2011, J PHYSIOL-LONDON, V589, P1791, DOI 10.1113/jphysiol.2010.202838; Ashley EA, 2002, CIRCULATION, V105, P3011, DOI 10.1161/01.CIR.0000019516.31040.2D; Barouch LA, 2002, NATURE, V416, P337, DOI 10.1038/416337a; Beigi F, 2012, P NATL ACAD SCI USA, V109, P4314, DOI 10.1073/pnas.1113319109; Bencsik P, 2008, BRIT J PHARMACOL, V153, P488, DOI 10.1038/sj.bjp.0707599; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2001, EXCITATION CONTRACTI; Bovo E, 2012, J PHYSIOL-LONDON, V590, P3291, DOI 10.1113/jphysiol.2012.230748; Brahmajothi MV, 1999, CIRC RES, V85, P575, DOI 10.1161/01.RES.85.7.575; Burger DE, 2009, CIRCULATION, V120, P1345, DOI 10.1161/CIRCULATIONAHA.108.846402; Campbell DL, 1996, J GEN PHYSIOL, V108, P277, DOI 10.1085/jgp.108.4.277; Carnicer R, 2012, CIRC RES, V111, P718, DOI 10.1161/CIRCRESAHA.112.274464; Curran J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087495; Cutler MJ, 2012, P NATL ACAD SCI USA, V109, P18186, DOI 10.1073/pnas.1210565109; Dedkova EN, 2009, J PHYSIOL-LONDON, V587, P851, DOI 10.1113/jphysiol.2008.165423; Fauconnier J, 2010, P NATL ACAD SCI USA, V107, P1559, DOI 10.1073/pnas.0908540107; Feron O, 1998, J BIOL CHEM, V273, P30249, DOI 10.1074/jbc.273.46.30249; FURFINE ES, 1994, J BIOL CHEM, V269, P26677; Gallo MP, 2001, PFLUG ARCH EUR J PHY, V441, P621, DOI 10.1007/s004240000475; Gonzalez DR, 2008, NITRIC OXIDE-BIOL CH, V18, P157, DOI 10.1016/j.niox.2007.09.086; Gonzalez DR, 2007, P NATL ACAD SCI USA, V104, P20612, DOI 10.1073/pnas.0706796104; Gonzalez DR, 2010, J BIOL CHEM, V285, P28938, DOI 10.1074/jbc.M110.154948; Gonzalez DR, 2009, J CARDIOVASC PHARM, V54, P188, DOI 10.1097/FJC.0b013e3181b72c9f; Hare JM, 2004, NEW ENGL J MED, V351, P2112, DOI 10.1056/NEJMe048269; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hintz KK, 2002, COMP BIOCHEM PHYS A, V133, P191, DOI 10.1016/S1095-6433(02)00177-0; Hsieh HY, 2010, J NEUROSCI RES, V88, P1285, DOI 10.1002/jnr.22291; Hurt KJ, 2012, P NATL ACAD SCI USA, V109, P16624, DOI 10.1073/pnas.1213790109; Irie T, 2015, CIRC RES, V117, P793, DOI 10.1161/CIRCRESAHA.115.307157; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jian Z, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005046; Jin CZ, 2013, J MOL CELL CARDIOL, V60, P107, DOI 10.1016/j.yjmcc.2013.04.017; Jin CZ, 2012, J MOL CELL CARDIOL, V52, P1274, DOI 10.1016/j.yjmcc.2012.03.013; Koshiishi I, 2007, NITRIC OXIDE-BIOL CH, V16, P356, DOI 10.1016/j.niox.2006.12.002; Lima B, 2010, CIRC RES, V106, P633, DOI 10.1161/CIRCRESAHA.109.207381; Maier LS, 2007, CARDIOVASC RES, V73, P629, DOI 10.1016/j.cardiores.2007.01.005; Maier LS, 2009, FRONT BIOSCI-LANDMRK, V14, P486, DOI 10.2741/3257; Martin SR, 2006, CARDIOVASC RES, V70, P97, DOI 10.1016/j.cardiores.2006.02.002; Martinez-Ruiz A, 2013, ANTIOXID REDOX SIGN, V19, P1220, DOI 10.1089/ars.2012.5066; MOORE WM, 1994, J MED CHEM, V37, P3886, DOI 10.1021/jm00049a007; Murphy E, 2012, J MOL CELL CARDIOL, V52, P568, DOI 10.1016/j.yjmcc.2011.08.021; NARAYANAN K, 1995, J BIOL CHEM, V270, P11103, DOI 10.1074/jbc.270.19.11103; Ozawa K, 2008, MOL CELL, V31, P395, DOI 10.1016/j.molcel.2008.05.024; Polakova E, 2015, J PHYSIOL-LONDON, V593, P1495, DOI 10.1113/jphysiol.2014.278051; Prosser BL, 2011, SCIENCE, V333, P1440, DOI 10.1126/science.1202768; REES DD, 1990, BRIT J PHARMACOL, V101, P746, DOI 10.1111/j.1476-5381.1990.tb14151.x; Roof SR, 2015, J MOL CELL CARDIOL, V81, P54, DOI 10.1016/j.yjmcc.2015.01.003; Roof SR, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0332-6; Roof SR, 2012, NITRIC OXIDE-BIOL CH, V27, P242, DOI 10.1016/j.niox.2012.08.077; Sears CE, 2003, CIRC RES, V92, pE52, DOI 10.1161/01.RES.0000064585.95749.6D; Seddon M, 2009, CIRCULATION, V119, P2656, DOI 10.1161/CIRCULATIONAHA.108.822205; Shan J, 2010, J CLIN INVEST, V120, P4388, DOI 10.1172/JCI32726; Sun JH, 2006, CIRC RES, V98, P403, DOI 10.1161/01.RES.0000202707.79018.0a; Sun JH, 2007, CIRC RES, V101, P1155, DOI 10.1161/CIRCRESAHA.107.155879; Tamargo J, 2010, CARDIOVASC RES, V87, P593, DOI 10.1093/cvr/cvq214; Tang LF, 2014, PHARMACOL THERAPEUT, V142, P306, DOI 10.1016/j.pharmthera.2013.12.013; Wang H, 2008, AM J PHYSIOL-CELL PH, V294, pC1566, DOI 10.1152/ajpcell.00367.2007; Wang H, 2008, AM J PHYSIOL-HEART C, V294, pH1473, DOI 10.1152/ajpheart.01249.2007; Wang HL, 2010, J PHYSIOL-LONDON, V588, P2905, DOI 10.1113/jphysiol.2010.192617; Wang HL, 2009, J MOL CELL CARDIOL, V47, P304, DOI 10.1016/j.yjmcc.2009.03.021; Whalen EJ, 2007, CELL, V129, P511, DOI 10.1016/j.cell.2007.02.046; Wilcox CS, 2008, PHARMACOL REV, V60, P418, DOI 10.1124/pr.108.000240; Xu KY, 1999, P NATL ACAD SCI USA, V96, P657, DOI 10.1073/pnas.96.2.657; Xu L, 1998, SCIENCE, V279, P234, DOI 10.1126/science.279.5348.234; Zhang HQ, 1997, J MED CHEM, V40, P3869, DOI 10.1021/jm970550g; Zhang YH, 2008, CIRC RES, V102, P242, DOI 10.1161/CIRCRESAHA.107.164798; Zhang YH, 2014, J PHYSIOL-LONDON, V592, P3189, DOI 10.1113/jphysiol.2013.270306; Zhang YH, 2012, J MOL CELL CARDIOL, V52, P341, DOI 10.1016/j.yjmcc.2011.09.006	69	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160813	10.1371/journal.pone.0160813	http://dx.doi.org/10.1371/journal.pone.0160813			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529477	Green Submitted, Green Published, gold			2022-12-26	WOS:000381476700023
J	Li, YX; Erickson, JW; Stalnecker, CA; Katt, WP; Huang, QQ; Cerione, RA; Ramachandran, S				Li, Yunxing; Erickson, Jon W.; Stalnecker, Clint A.; Katt, William P.; Huang, Qingqiu; Cerione, Richard A.; Ramachandran, Sekar			Mechanistic Basis of Glutaminase Activation A KEY ENZYME THAT PROMOTES GLUTAMINE METABOLISM IN CANCER CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KIDNEY-TYPE GLUTAMINASE; PHOSPHATE ACTIVATION; INHIBITION; EXPRESSION; BIOLOGY; PROTEIN; GROWTH; LYSINE	Glutamine-derived carbon becomes available for anabolic biosynthesis in cancer cells via the hydrolysis of glutamine to glutamate, as catalyzed by GAC, a splice variant of kidney-type glutaminase (GLS). Thus, there is significant interest in understanding the regulation of GAC activity, with the suggestion being that higher order oligomerization is required for its activation. We used x-ray crystallography, together with site-directed mutagenesis, to determine the minimal enzymatic unit capable of robust catalytic activity. Mutagenesis of the helical interface between the two pairs of dimers comprising a GAC tetramer yielded a non-active, GAC dimer whose x-ray structure displays a stationary loop ("activation loop") essential for coupling the binding of allosteric activators like inorganic phosphate to catalytic activity. Further mutagenesis that removed constraints on the activation loop yielded a constitutively active dimer, providing clues regarding how the activation loop communicates with the active site, as well as with a peptide segment that serves as a "lid" to close off the active site following substrate binding. Our studies show that the formation of large GAC oligomers is not a pre-requisite for full enzymatic activity. They also offer a mechanism by which the binding of activators like inorganic phosphate enables the activation loop to communicate with the active site to ensure maximal rates of catalysis, and promotes the opening of the lid to achieve optimal product release. Moreover, these findings provide new insights into how other regulatory events might induce GAC activation within cancer cells.	[Li, Yunxing; Erickson, Jon W.; Stalnecker, Clint A.; Cerione, Richard A.; Ramachandran, Sekar] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Katt, William P.; Cerione, Richard A.] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA; [Huang, Qingqiu] Cornell Univ, Cornell Lab Accelerator Based Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University	Cerione, RA (corresponding author), Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA.	rac1@cornell.edu	Ramachandran, Sekar/AAP-2287-2020	Ramachandran, Sekar/0000-0002-2243-1368; Stalnecker, Clint/0000-0002-0570-4416; Katt, William/0000-0001-5104-7667	MacCHESS (National Institutes of Health) [P41 GM103485]; NATIONAL CANCER INSTITUTE [R01CA163255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008500, R35GM122575, R01GM040654, P41GM103485] Funding Source: NIH RePORTER	MacCHESS (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Cindy Westmiller for excellent secretarial assistance and David J. Schuller and MacCHESS (National Institutes of Health Grant P41 GM103485) for help with x-ray data analysis.	Cantor JR, 2012, CANCER DISCOV, V2, P881, DOI 10.1158/2159-8290.CD-12-0345; Cassago A, 2012, P NATL ACAD SCI USA, V109, P1092, DOI 10.1073/pnas.1112495109; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; DeLaBarre B, 2011, BIOCHEMISTRY-US, V50, P10764, DOI 10.1021/bi201613d; Erickson JW, 2010, ONCOTARGET, V1, P734, DOI 10.18632/oncotarget.208; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; GODFREY S, 1977, J BIOL CHEM, V252, P1927; Gross MI, 2014, MOL CANCER THER, V13, P890, DOI 10.1158/1535-7163.MCT-13-0870; HART MJ, 1994, J BIOL CHEM, V269, P62; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hensley CT, 2013, J CLIN INVEST, V123, P3678, DOI 10.1172/JCI69600; Hirschey MD, 2015, MOL CELL PROTEOMICS, V14, P2308, DOI 10.1074/mcp.R114.046664; Kim CU, 2006, ACTA CRYSTALLOGR D, V62, P687, DOI 10.1107/S0907444906014727; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Lukey MJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11321; Lukey MJ, 2013, FUTURE MED CHEM, V5, P1685, DOI 10.4155/fmc.13.130; McDonald CJ, 2015, NEUROCHEM INT, V88, P10, DOI 10.1016/j.neuint.2014.12.003; Moller M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074783; Pieter A, 2012, CANCER BIOL THER, V13, P1185, DOI 10.4161/cbt.21348; Robinson MM, 2007, BIOCHEM J, V406, P407, DOI 10.1042/BJ20070039; Ferreira APS, 2013, J BIOL CHEM, V288, P28009, DOI 10.1074/jbc.M113.501346; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Stalnecker CA, 2015, P NATL ACAD SCI USA, V112, P394, DOI 10.1073/pnas.1414056112; Thangavelu K, 2012, P NATL ACAD SCI USA, V109, P7705, DOI 10.1073/pnas.1116573109; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Xiang Y, 2015, J CLIN INVEST, V125, P2293, DOI 10.1172/JCI75836; Xiong Y, 2012, J CELL BIOL, V198, P155, DOI 10.1083/jcb.201202056	31	19	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					20900	20910		10.1074/jbc.M116.720268	http://dx.doi.org/10.1074/jbc.M116.720268			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27542409	hybrid, Green Published			2022-12-26	WOS:000385406200009
J	Zhou, XL; Chen, Y; Fang, ZP; Ruan, ZR; Wang, Y; Liu, RJ; Xue, MQ; Wang, ED				Zhou, Xiao-Long; Chen, Yun; Fang, Zhi-Peng; Ruan, Zhi-Rong; Wang, Yong; Liu, Ru-Juan; Xue, Mei-Qin; Wang, En-Duo			Translational Quality Control by Bacterial Threonyl-tRNA Synthetases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENETIC-CODE; PROTEIN-BIOSYNTHESIS; AMINOACYLATION; DOMAIN; MISTRANSLATION; TRNA(LEU); COMPLEX; YEAST; DISCRIMINATION; RECOGNITION	Translational fidelity mediated by aminoacyl-tRNA synthetases ensures the generation of the correct aminoacyl-tRNAs, which is critical for most species. Threonyl-tRNA synthetase (ThrRS) contains multiple domains, including an N2 editing domain. Of the ThrRS domains, N1 is the last to be assigned a function. Here, we found that ThrRSs from Mycoplasma species exhibit differences in their domain composition and editing active sites compared with the canonical ThrRSs. The Mycoplasma mobile ThrRS, the first example of a ThrRS naturally lacking the N1 domain, displays efficient post-transfer editing activity. In contrast, the Mycoplasma capricolum ThrRS, which harbors an N1 domain and a degenerate N2 domain, is editing-defective. Only editing-capable ThrRSs were able to support the growth of a yeast thrS deletion strain (Sc Delta thrS), thus suggesting that Sc Delta thrS is an excellent tool for studying the in vivo editing of introduced bacterial ThrRSs. On the basis of the presence or absence of an N1 domain, we further revealed the crucial importance of the only absolutely conserved residue within the N1 domain in regulating editing by mediating an N1-N2 domain interaction in Escherichia coli ThrRS. Our results reveal the translational quality control of various ThrRSs and the role of the N1 domain in translational fidelity.	[Zhou, Xiao-Long; Chen, Yun; Fang, Zhi-Peng; Ruan, Zhi-Rong; Liu, Ru-Juan; Xue, Mei-Qin; Wang, En-Duo] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol,Ctr Excellence Mol Cell Sc, Shanghai 200031, Peoples R China; [Wang, Yong; Wang, En-Duo] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; ShanghaiTech University	Wang, ED (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol,Ctr Excellence Mol Cell Sc, Shanghai 200031, Peoples R China.; Wang, ED (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 200031, Peoples R China.	edwang@sibcb.ac.cn	Ruan, Zhi-Rong/GYI-8935-2022	Fang, Zhipeng/0000-0001-5720-1709; Ruan, Zhi-Rong/0000-0002-1806-2942; , Yong/0000-0002-3698-123X; Liu, Ru-Juan/0000-0001-7459-3126	National Key Basic Research Foundation of China [2012CB911000]; Natural Science Foundation of China [31130064, 91440204]; Committee of Science and Technology in Shanghai [12JC1409700, 15ZR1446500]; Shanghai Rising-Star Program Grant [16QA1404400]; Youth Innovation Promotion Association of the Chinese Academy of Sciences	National Key Basic Research Foundation of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Committee of Science and Technology in Shanghai(Shanghai Science & Technology Committee); Shanghai Rising-Star Program Grant; Youth Innovation Promotion Association of the Chinese Academy of Sciences	This work was supported by Grant 2012CB911000 from the National Key Basic Research Foundation of China, Grants 31130064 and 91440204 from the Natural Science Foundation of China, and Grants 12JC1409700, 15ZR1446500 from the Committee of Science and Technology in Shanghai. This work was also sponsored by Shanghai Rising-Star Program Grant 16QA1404400 and funds from the Youth Innovation Promotion Association of the Chinese Academy of Sciences (to X.-L. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Bezerra AR, 2013, P NATL ACAD SCI USA, V110, P11079, DOI 10.1073/pnas.1302094110; Cusack S, 1997, CURR OPIN STRUC BIOL, V7, P881, DOI 10.1016/S0959-440X(97)80161-3; Dock-Bregeon AC, 2000, CELL, V103, P877, DOI 10.1016/S0092-8674(00)00191-4; Dock-Bregeon AC, 2004, MOL CELL, V16, P375, DOI 10.1016/S1097-2765(04)00591-X; Dwivedi S, 2005, NAT STRUCT MOL BIOL, V12, P556, DOI 10.1038/nsmb943; Fukai S, 2000, CELL, V103, P793, DOI 10.1016/S0092-8674(00)00182-3; Fukunaga R, 2005, NAT STRUCT MOL BIOL, V12, P915, DOI 10.1038/nsmb985; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Gruic-Sovulj I, 2005, J BIOL CHEM, V280, P23978, DOI 10.1074/jbc.M414260200; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Ji QQ, 2016, J BIOL CHEM, V291, P3613, DOI 10.1074/jbc.M115.699777; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Li L, 2011, P NATL ACAD SCI USA, V108, P9378, DOI 10.1073/pnas.1016460108; Li Y, 1998, SCI CHINA SER C, V41, P225, DOI 10.1007/BF02895095; Ling JQ, 2012, P NATL ACAD SCI USA, V109, P3281, DOI 10.1073/pnas.1200109109; Ling JQ, 2009, ANNU REV MICROBIOL, V63, P61, DOI 10.1146/annurev.micro.091208.073210; LOFTFIELD RB, 1972, BIOCHEM J, V128, P1353, DOI 10.1042/bj1281353; Lue SW, 2005, BIOCHEMISTRY-US, V44, P3010, DOI 10.1021/bi047901v; Nangle LA, 2006, CHEM BIOL, V13, P1091, DOI 10.1016/j.chembiol.2006.08.011; Palencia A, 2012, NAT STRUCT MOL BIOL, V19, P677, DOI 10.1038/nsmb.2317; Roy H, 2005, J BIOL CHEM, V280, P38186, DOI 10.1074/jbc.M508281200; Ruan ZR, 2015, J BIOL CHEM, V290, P1664, DOI 10.1074/jbc.M114.599886; Sankaranarayanan R, 1999, CELL, V97, P371, DOI 10.1016/S0092-8674(00)80746-1; SCHIMMEL P, 1987, ANNU REV BIOCHEM, V56, P125, DOI 10.1146/annurev.bi.56.070187.001013; Tan M, 2012, BIOCHEM J, V443, P477, DOI 10.1042/BJ20111925; Tan M, 2010, J BIOL CHEM, V285, P3235, DOI 10.1074/jbc.M109.060616; Wang Y, 2016, J BIOL CHEM, V291, P6507, DOI 10.1074/jbc.M115.700849; Yadavalli SS, 2013, NUCLEIC ACIDS RES, V41, P1104, DOI 10.1093/nar/gks1240; YARUS M, 1970, ANAL BIOCHEM, V35, P450, DOI 10.1016/0003-2697(70)90207-1; Zhou XL, 2014, NUCLEIC ACIDS RES, V42, P13873, DOI 10.1093/nar/gku1218; Zhou XL, 2013, NUCLEIC ACIDS RES, V41, P9825, DOI 10.1093/nar/gkt741; Zhou XL, 2013, NUCLEIC ACIDS RES, V41, P302, DOI 10.1093/nar/gks982; Zhou XL, 2008, J BIOL CHEM, V283, P36608, DOI 10.1074/jbc.M806745200; Zhou XL, 2013, SCI CHINA LIFE SCI, V56, P921, DOI 10.1007/s11427-013-4542-9; Zhu B, 2009, J BIOL CHEM, V284, P3418, DOI 10.1074/jbc.M806717200	36	12	14	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					21208	21221		10.1074/jbc.M116.740472	http://dx.doi.org/10.1074/jbc.M116.740472			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27542414	hybrid, Green Published			2022-12-26	WOS:000385406200034
J	Laurencet, ME; Girardin, F; Rigamonti, F; Bevand, A; Meyer, P; Carballo, D; Roffi, M; Noble, S; Mach, F; Gencer, B				Laurencet, Marie-Eva; Girardin, Francois; Rigamonti, Fabio; Bevand, Anne; Meyer, Philippe; Carballo, David; Roffi, Marco; Noble, Stephane; Mach, Francois; Gencer, Baris			Early Discharge in Low-Risk Patients Hospitalized for Acute Coronary Syndromes: Feasibility, Safety and Reasons for Prolonged Length of Stay	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; PRIMARY ANGIOPLASTY; RANDOMIZED-TRIAL; PRIMARY PCI; INTERVENTION; GUIDELINES; MANAGEMENT	Introduction Length of hospital stay (LHS) is an indicator of clinical effectiveness. Early hospital discharge (<= 72 hours) is recommended in patients with acute coronary syndromes (ACS) at low risk of complications, but reasons for prolonged LHS poorly reported. Methods We collected data of ACS patients hospitalized at the Geneva University Hospitals from 1st July 2013 to 30th June 2015 and used the Zwolle index score to identify patients at low risk (<= 3 points). We assessed the proportion of eligible patients who were successfully discharged within 72 hours and the reasons for prolonged LHS. Outcomes were defined as adherence to recommended therapies, major adverse events at 30 days and patients' satisfaction using a Likert-scale patient-reported questionnaire. Results Among 370 patients with ACS, 255 (68.9%) were at low-risk of complications but only 128 (50.2%) were eligible for early discharge, because of other clinical reasons for prolonged LHS (e. g. staged coronary revascularization, cardiac monitoring) in 127 patients (49.8%). Of the latter, only 45 (35.2%) benefitted from an early discharge. Reasons for delay in discharge in the remaining 83 patients (51.2%) were mainly due to delays in additional investigations, titration of medical therapy, admission or discharge during weekends. In the early discharge group, at 30 days, only one patient (2.2%) had an adverse event (minor bleeding), 97% of patients were satisfied by the medical care. Conclusion Early discharge was successfully achieved in one third of eligible ACS patients at low risk of complications and appeared sufficiently safe while being overall appreciated by the patients.	[Laurencet, Marie-Eva] Univ Hosp Geneva, Dept Med, Div Internal Med, Geneva, Switzerland; [Girardin, Francois] Univ Hosp Geneva, Dept Anesthesiol Clin Pharmacol & Toxicol Intens, Div Clin Pharmacol & Toxicol, Geneva, Switzerland; [Girardin, Francois] Univ Geneva, Geneva, Switzerland; [Girardin, Francois] Univ Hosp Geneva, Med Direct, Geneva, Switzerland; [Rigamonti, Fabio; Bevand, Anne; Meyer, Philippe; Carballo, David; Roffi, Marco; Noble, Stephane; Mach, Francois; Gencer, Baris] Univ Hosp Geneva, Dept Med, Div Cardiol, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Geneva	Gencer, B (corresponding author), Univ Hosp Geneva, Dept Med, Div Cardiol, Geneva, Switzerland.	baris.gencer@hcuge.ch	Girardin, Francois/F-5443-2017; Gencer, Baris/AAO-2305-2020; Meyer, Philippe/HHC-0770-2022	Girardin, Francois/0000-0002-0842-927X; Gencer, Baris/0000-0002-8954-9694	Geneva University Hospitals [RD 12-II-2012]; Swiss National Science Foundation [SPUM 33CM30124112, SPUM 33CM30-140 336]; de Reuter Foundation; Gerbex-Bourget Foundation; Swiss Heart Foundation; Schmidheiny Foundation	Geneva University Hospitals; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); de Reuter Foundation; Gerbex-Bourget Foundation; Swiss Heart Foundation; Schmidheiny Foundation	The work was supported by the Geneva University Hospitals, (P, RD 12-II-2012) Swiss National Science Foundation (SPUM 33CM30124112 and SPUM 33CM30-140 336, Inflammation and acute coronary syndromes (ACS) - Novel strategies for prevention and clinical management), de Reuter Foundation, Gerbex-Bourget Foundation. B.G.'s research is supported by grants from the Geneva University Hospitals, Swiss Heart Foundation, de Reuter Foundation, Gerbex-Bourget Foundation and Schmidheiny Foundation. The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.	Auer R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093147; Aujesky D, 2011, LANCET, V378, P41, DOI 10.1016/S0140-6736(11)60824-6; Azzalini L, 2015, CARDIOLOGY, V130, P120, DOI 10.1159/000368890; Barchielli A, 2007, INT J CARDIOL, V114, P57, DOI 10.1016/j.ijcard.2006.01.006; Busato A, 2010, HEALTH RES POLICY SY, V8, DOI 10.1186/1478-4505-8-31; De Luca G, 2004, CIRCULATION, V109, P2737, DOI 10.1161/01.CIR.0000131765.73959.87; Di Mario Carlo, 2004, Int J Cardiovasc Intervent, V6, P128; Gaudenzi Baris G F, 2013, J CLIN TRIALS, V3; Gencer B, 2015, ATHEROSCLEROSIS, V239, P118, DOI 10.1016/j.atherosclerosis.2014.12.049; Gencer B, 2015, EUR J INTERN MED, V26, P56, DOI 10.1016/j.ejim.2014.12.014; Jirmar R, 2008, INT HEART J, V49, P653, DOI 10.1536/ihj.49.653; Jones DA, 2012, HEART, V98, P1722, DOI 10.1136/heartjnl-2012-302414; Kelly DJ, 2013, EUROINTERVENTION, V8, P1190, DOI 10.4244/EIJV8I10A183; Kociol RD, 2012, JAMA-J AM MED ASSOC, V307, P66, DOI 10.1001/jama.2011.1926; Kotowycz MA, 2010, AM HEART J, V159, P117, DOI 10.1016/j.ahj.2009.10.024; Laarman GJ, 2010, HEART, V96, P584, DOI 10.1136/hrt.2009.171363; Melberg T, 2015, EUR J PREV CARDIOL, V22, P1427, DOI 10.1177/2047487314559276; Politi L, 2010, HEART, V96, P662, DOI 10.1136/hrt.2009.177162; Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Spencer FA, 2004, ARCH INTERN MED, V164, P733, DOI 10.1001/archinte.164.7.733; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Wald DS, 2013, NEW ENGL J MED, V369, P1115, DOI 10.1056/NEJMoa1305520	23	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0161493	10.1371/journal.pone.0161493	http://dx.doi.org/10.1371/journal.pone.0161493			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27551861	Green Published, gold, Green Submitted			2022-12-26	WOS:000381768800045
J	Perkiomaki, N; Auvinen, J; Tulppo, MP; Hautala, AJ; Perkiomaki, J; Karhunen, V; Keinanen-Kiukaanniemi, S; Puukka, K; Ruokonen, A; Jarvelin, MR; Huikuri, HV; Kiviniemi, AM				Perkiomaki, Nelli; Auvinen, Juha; Tulppo, Mikko P.; Hautala, Arto J.; Perkiomaki, Juha; Karhunen, Ville; Keinanen-Kiukaanniemi, Sirkka; Puukka, Katri; Ruokonen, Aimo; Jarvelin, Marjo-Riitta; Huikuri, Heikki V.; Kiviniemi, Antti M.			Association between Birth Characteristics and Cardiovascular Autonomic Function at Mid-Life	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; GESTATIONAL WEIGHT-GAIN; SPONTANEOUS BAROREFLEX SENSITIVITY; BODY-MASS INDEX; SYMPATHETIC-NERVE ACTIVITY; YOUNG-ADULTS; BLOOD-PRESSURE; RISK-FACTORS; IMPACT; GROWTH	Background Low birth weight is associated with an increased risk of cardiovascular diseases in adulthood. As abnormal cardiac autonomic function is a common feature in cardiovascular diseases, we tested the hypothesis that low birth weight may also be associated with poorer cardiac autonomic function in middle-aged subjects. Methods At the age of 46, the subjects of the Northern Finland Birth Cohort 1966 were invited to examinations including questionnaires about health status and life style and measurement of vagally-mediated heart rate variability (rMSSD) from R-R intervals (RRi) and spontaneous baroreflex sensitivity (BRS) in both seated and standing positions. Maternal parameters had been collected in 1965-1966 since the 16th gestational week and birth variables immediately after delivery. For rMSSD, 1,799 men and 2,279 women without cardiorespiratory diseases and diabetes were included and 902 men and 1,020 women for BRS. The analyses were adjusted for maternal (age, anthropometry, socioeconomics, parity, gestational smoking) and adult variables (life style, anthropometry, blood pressure, glycemic and lipid status) potentially confounding the relationship between birth weight and autonomic function. Results In men, birth weight correlated negatively with seated (r = -0.058, p = 0.014) and standing rMSSD (r = -0.090, p < 0.001), as well as with standing BRS (r = -0.092, p = 0.006). These observations were verified using relevant birth weight categories (< 2,500 g; 2,500-3,999 g; >= 4,000 g). In women, birth weight was positively correlated with seated BRS (r = 0.081, p = 0.010), but none of the other measures of cardiovascular autonomic function. These correlations remained significant after adjustment for potential confounders (p < 0.05 for all). Conclusions In men, higher birth weight was independently associated with poorer cardiac autonomic function at mid-life. Same association was not observed in women. Our findings suggest that higher, not lower, birth weight in males may contribute to less favourable cardiovascular autonomic regulation and potentially to an elevated cardiovascular risk in later life.	[Perkiomaki, Nelli; Tulppo, Mikko P.; Perkiomaki, Juha; Huikuri, Heikki V.; Kiviniemi, Antti M.] Oulu Univ Hosp, Med Res Ctr Oulu, Res Unit Internal Med, Oulu, Finland; [Perkiomaki, Nelli; Tulppo, Mikko P.; Perkiomaki, Juha; Huikuri, Heikki V.; Kiviniemi, Antti M.] Univ Oulu, Oulu, Finland; [Auvinen, Juha; Karhunen, Ville; Keinanen-Kiukaanniemi, Sirkka; Jarvelin, Marjo-Riitta] Univ Oulu, Ctr Life Course Hlth Res, Oulu, Finland; [Auvinen, Juha; Keinanen-Kiukaanniemi, Sirkka; Jarvelin, Marjo-Riitta] Oulu Univ Hosp, Unit Primary Hlth Care, Oulu, Finland; [Hautala, Arto J.] Univ Oulu, Ctr Machine Vis & Signal Anal, Physiol Signal Anal Team, Oulu, Finland; [Puukka, Katri; Ruokonen, Aimo] Oulu Univ Hosp, Med Res Ctr Oulu, NordLab Oulu, Oulu, Finland; [Puukka, Katri; Ruokonen, Aimo] Univ Oulu, Dept Clin Chem, Oulu, Finland; [Jarvelin, Marjo-Riitta] Imperial Coll London, Sch Publ Hlth, MRC PHE Ctr Environm & Hlth, Dept Epidemiol & Biostat, London, England; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland	University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; Imperial College London; University of Oulu	Kiviniemi, AM (corresponding author), Oulu Univ Hosp, Med Res Ctr Oulu, Res Unit Internal Med, Oulu, Finland.; Kiviniemi, AM (corresponding author), Univ Oulu, Oulu, Finland.	antti.m.kiviniemi@oulu.fi	Hautala, Arto/AAX-6146-2020; Hautala, Arto/AAF-4669-2021; Kiviniemi, Antti M/D-5288-2015	Hautala, Arto/0000-0002-7648-0130; Kiviniemi, Antti M/0000-0002-1160-493X; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Karhunen, Ville/0000-0001-6064-1588; Tulppo, Mikko/0000-0001-5598-9109	University of Oulu [24000692]; Oulu University Hospital [24301140]; European Regional Development Fund [539/2010 A31592]; Academy of Finland [267435, 285547]; Sigrid Juselius Foundation; Finnish Foundation for Cardiovascular Research; European Union's Horizon research and innovation programme [633595]; Yrjo Jahnsson Foundation	University of Oulu; Oulu University Hospital; European Regional Development Fund(European Commission); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Foundation for Cardiovascular Research; European Union's Horizon research and innovation programme; Yrjo Jahnsson Foundation	This work was supported by the University of Oulu, 24000692, (http://www.oulu.fi) to MRJ, Oulu University Hospital, 24301140, (https://www.ppshp.fi/Oulu_university_hospital) to MRJ, European Regional Development Fund, 539/2010 A31592, (http://ec.europa.eu/regional_policy/en/funding/erdf/) to MRJ, Academy of Finland, 267435, 285547, (http://www.aka.fi) to HVH and MRJ, Sigrid Juselius Foundation, (http://www.sigridjuselius.fi) to HVH, Finnish Foundation for Cardiovascular Research, (http://www.sydantutkimussaatio.fi) to HVH and MPT, European Union's Horizon 2020 research and innovation programme, 633595, (https://ec.europa.eu/programmes/horizon2020/) to MRJ and Yrjo Jahnsson Foundation, (http://www.yjs.fi) to NP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Auwerx J, 1998, LANCET, V351, P737, DOI 10.1016/S0140-6736(97)06348-4; Aziz W, 2012, CLIN AUTON RES, V22, P91, DOI 10.1007/s10286-011-0149-z; BARKER DJP, 1989, LANCET, V2, P577; Boguszewski MCS, 2004, J HYPERTENS, V22, P1157, DOI 10.1097/00004872-200406000-00017; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; BRISTOW JD, 1969, CIRCULATION, V39, P48, DOI 10.1161/01.CIR.39.1.48; Camm AJ, 1996, EUR HEART J, V17, P354; Conen D, 2010, CIRCULATION, V122, P764, DOI 10.1161/CIRCULATIONAHA.110.947978; Ehrenberg HM, 2004, AM J OBSTET GYNECOL, V191, P964, DOI 10.1016/j.ajog.2004.05.052; Elhddad AS, 2014, ACTA OBSTET GYN SCAN, V93, P771, DOI 10.1111/aogs.12427; Eriksson JG, 2001, BRIT MED J, V322, P949, DOI 10.1136/bmj.322.7292.949; Espineira AR, 2011, CLIN ENDOCRINOL, V75, P335, DOI 10.1111/j.1365-2265.2011.04054.x; EWING DJ, 1982, BRIT MED J, V285, P916, DOI 10.1136/bmj.285.6346.916; Frankel S, 1996, LANCET, V348, P1478, DOI 10.1016/S0140-6736(96)03482-4; Galland BC, 2006, J APPL PHYSIOL, V100, P933, DOI 10.1152/japplphysiol.01275.2005; Gianaros PJ, 2002, AM J HYPERTENS, V15, P486, DOI 10.1016/S0895-7061(02)02923-0; Hair J.F., 2010, MULTIVARIATE DATA AN, V7th ed; Harder T, 2007, AM J EPIDEMIOL, V165, P849, DOI 10.1093/aje/kwk071; Hillier TA, 2008, OBSTET GYNECOL, V112, P1007, DOI 10.1097/AOG.0b013e31818a9779; Hochner H, 2012, CIRCULATION, V125, P1381, DOI 10.1161/CIRCULATIONAHA.111.070060; Huxley R, 2007, AM J CLIN NUTR, V85, P1244, DOI 10.1093/ajcn/85.5.1244; Iellamo F, 1996, J HYPERTENS, V14, P1099; IJzerman RG, 2003, CIRCULATION, V108, P566, DOI 10.1161/01.CIR.0000081778.35370.1B; Jarvelin MR, 2004, HYPERTENSION, V44, P838, DOI 10.1161/01.HYP.0000148304.33869.ee; Jones A, 2007, HYPERTENSION, V49, P548, DOI 10.1161/01.HYP.0000257196.13485.9b; Kardos A, 2001, HYPERTENSION, V37, P911, DOI 10.1161/01.HYP.37.3.911; Kiviniemi AM, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00473; Kiviniemi AM, 2014, AM J CARDIOL, V114, P571, DOI 10.1016/j.amjcard.2014.05.032; Kiviniemi AM, 2013, AUTON NEUROSCI-BASIC, V179, P142, DOI 10.1016/j.autneu.2013.08.068; Kupper NHM, 2004, CIRCULATION, V110, P2792, DOI 10.1161/01.CIR.0000146334.96820.6E; La Rovere MT, 1998, LANCET, V351, P478; Langer O, 2005, AM J OBSTET GYNECOL, V192, P989, DOI 10.1016/j.ajog.2004.11.039; Leotta G, 2007, NUTR METAB CARDIOVAS, V17, P303, DOI 10.1016/j.numecd.2005.09.008; Mamun AA, 2009, CIRCULATION, V119, P1720, DOI 10.1161/CIRCULATIONAHA.108.813436; Norman M, 2008, ACTA PAEDIATR, V97, P1165, DOI 10.1111/j.1651-2227.2008.00904.x; OSCULATI G, 1990, CIRCULATION, V81, P939, DOI 10.1161/01.CIR.81.3.939; Osmond C, 2007, STROKE, V38, P264, DOI 10.1161/01.STR.0000254471.72186.03; Ouzounian JG, 2011, J PERINATOL, V31, P717, DOI 10.1038/jp.2011.15; Penttila J, 2001, CLIN PHYSIOL, V21, P365, DOI 10.1046/j.1365-2281.2001.00337.x; Phillips DIW, 1997, DIABETIC MED, V14, P673, DOI 10.1002/(SICI)1096-9136(199708)14:8<673::AID-DIA458>3.0.CO;2-9; Rakow A, 2013, PEDIATR RES, V74, P339, DOI 10.1038/pr.2013.97; Sacha J, 2013, INT J CARDIOL, V168, P4257, DOI 10.1016/j.ijcard.2013.04.160; SCHWARTZ PJ, 1988, CIRCULATION, V78, P969, DOI 10.1161/01.CIR.78.4.969; Skilton MR, 2014, ARTERIOSCL THROM VAS, V34, P1064, DOI 10.1161/ATVBAHA.113.302934; Taylor JA, 1996, CIRCULATION, V93, P1527, DOI 10.1161/01.CIR.93.8.1527; Tsuji H, 1996, CIRCULATION, V94, P2850, DOI 10.1161/01.CIR.94.11.2850; Tsuji H, 1996, J AM COLL CARDIOL, V28, P1539, DOI 10.1016/S0735-1097(96)00342-7; Tuvemo T, 1999, PEDIATR RES, V46, P491, DOI 10.1203/00006450-199911000-00001; Weitz G, 2003, J HYPERTENS, V21, P943, DOI 10.1097/00004872-200305000-00019; Weitz G, 2013, AM J CARDIOVASC DIS, V3, P239	51	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0161604	10.1371/journal.pone.0161604	http://dx.doi.org/10.1371/journal.pone.0161604			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27552091	gold, Green Published, Green Submitted			2022-12-26	WOS:000381768800056
J	Slade, RL; Pisaneschi, F; Nguyen, QD; Smith, G; Carroll, L; Beckley, A; Kaliszczak, MA; Aboagye, EO				Slade, Rozanna L.; Pisaneschi, Federica; Quang-De Nguyen; Smith, Graham; Carroll, Laurence; Beckley, Alice; Kaliszczak, Maciej A.; Aboagye, Eric O.			Identification of ABC Transporter Interaction of a Novel Cyanoquinoline Radiotracer and Implications for Tumour Imaging by Positron Emission Tomography	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; CELL LUNG-CANCER; TYROSINE KINASE INHIBITORS; PHASE-III TRIAL; P-GLYCOPROTEIN; MULTIDRUG-RESISTANCE; DRUG-RESISTANCE; PASSIVE PERMEABILITY; CONFERS RESISTANCE; SUPPORTIVE CARE	Background The epidermal growth factor receptor (EGFR) is overexpressed in many cancers including lung, ovarian, breast, head and neck and brain. Mutation of this receptor has been shown to play a crucial role in the response of non-small cell lung carcinoma (NSCLC) to EGFR-targeted therapies. It is envisaged that imaging of EGFR using positron emission tomography (PET) could aid in selection of patients for treatment with novel inhibitors. We recognised multi-drug resistant phenotype as a threat to development of successful imaging agents. In this report, we describe discovery of a novel cyanoquinoline radiotracer that lacks ABC transporter activity. Methods Cellular retention of the prototype cyanoquinoline [F-18](2E)-N-{4-[(3-chloro-4-fluorophenyl) amino]-3-cyano-7-ethoxyquinolin-6-yl}-4-({[1-(2-fluoroethyl)-1H-1,2,3-triazol-4-yl] methyl} amino)-but-2-enamide ([F-18] FED6) and [F-18](2E)-N-{4-[(3-chloro-4-fluorophenyl) amino]-3-cyano- 7-ethoxyquinolin-6-yl}-4-[({1-[(2R,5S)-3-fluoro-4,5-dihydroxy-6-(hydroxymethyl) oxan-2-yl]-1H-1,2,3-triazol-4-yl} methyl) amino] but-2-enamide ([F-18] FED20) were evaluated to establish potential for imaging specificity. The substrate specificity of a number of cyanoquinolines towards ABC transporters was investigated in cell lines proficient or deficient in ABCB1 or ABCG2. Results FED6 demonstrated substrate specificity for both ABCG2 and ABCB1, a property that was not observed for all cyanoquinolines tested, suggesting scope for designing novel probes. ABC transporter activity was confirmed by attenuating the activity of transporters with drug inhibitors or siRNA. We synthesized a more hydrophilic compound [F-18] FED20 to overcome ABC transporter activity. FED20 lacked substrate specificity for both ABCB1 and ABCG2, and maintained a strong affinity for EGFR. Furthermore, FED20 showed higher inhibitory affinity for active mutant EGFR versus wild-type or resistant mutant EGFR; this property resulted in higher [F-18] FED20 cellular retention in active mutant EGFR expressing NSCLC. Conclusion [F-18] FED20 binds EGFR but is devoid of ABC transporter activity, thus, has potential for EGFR imaging.	[Slade, Rozanna L.; Pisaneschi, Federica; Quang-De Nguyen; Smith, Graham; Carroll, Laurence; Beckley, Alice; Kaliszczak, Maciej A.; Aboagye, Eric O.] Imperial Coll London, Comprehens Canc Imaging Ctr, Fac Med, Hammersmith Hosp Campus,Du Cane Rd, London W12 0NN, England	Imperial College London	Aboagye, EO (corresponding author), Imperial Coll London, Comprehens Canc Imaging Ctr, Fac Med, Hammersmith Hosp Campus,Du Cane Rd, London W12 0NN, England.	eric.aboagye@imperial.ac.uk	Pisaneschi, Federica/GYU-7584-2022; Pisaneschi, Federica/GYU-7470-2022; Carroll, Laurence/ABA-7542-2020	Pisaneschi, Federica/0000-0002-1989-4417; Pisaneschi, Federica/0000-0002-1989-4417; ABOAGYE, Eric/0000-0003-2276-6771; Smith, Graham/0000-0002-0762-3812	Cancer Research UK - Engineering and Physical Sciences Research Council grant [C2536/A10337]; Cancer Research UK [C2536/A16584]; UK Medical Research Council [MC_US_A652_0030]; Cancer Research UK [10337, 16584, 12011] Funding Source: researchfish; Medical Research Council [MR/J007986/1] Funding Source: researchfish; National Institute for Health Research [NIHR/CS/009/009] Funding Source: researchfish; MRC [MR/J007986/1] Funding Source: UKRI	Cancer Research UK - Engineering and Physical Sciences Research Council grant(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Cancer Research UK(Cancer Research UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by Cancer Research UK (www.cancerresearchuk.org) - Engineering and Physical Sciences Research Council grant (in association with the Medical Research Council and Department of Health (England)) grant C2536/A10337 and Cancer Research UK grant C2536/A16584. E.O.A.'s laboratory receives core funding from the UK Medical Research Council (MC_US_A652_0030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abourbeh G, 2007, NUCL MED BIOL, V34, P55, DOI 10.1016/j.nucmedbio.2006.10.012; ARTURSSON P, 1991, BIOCHEM BIOPH RES CO, V175, P880, DOI 10.1016/0006-291X(91)91647-U; Bahce I, 2013, CLIN CANCER RES, V19, P183, DOI 10.1158/1078-0432.CCR-12-0289; Chen YT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017876, 10.1371/journal.pone.0021428, 10.1371/journal.pone.0017844, 10.1371/journal.pone.0024144, 10.1371/journal.pone.0027163, 10.1371/journal.pone.0027333]; Cobo M, 2007, J CLIN ONCOL, V25, P2747, DOI 10.1200/JCO.2006.09.7915; Dahabreh IJ, 2010, CLIN CANCER RES, V16, P291, DOI 10.1158/1078-0432.CCR-09-1660; de Bruin EC, 2014, CANCER DISCOV, V4, P606, DOI 10.1158/2159-8290.CD-13-0741; DELLINGER M, 1992, CANCER RES, V52, P6385; Didziapetris R, 2003, J DRUG TARGET, V11, P391, DOI 10.1080/10611860310001648248; Fletcher JI, 2010, NAT REV CANCER, V10, P147, DOI 10.1038/nrc2789; Hegedus C, 2012, BIOCHEM PHARMACOL, V84, P260, DOI 10.1016/j.bcp.2012.04.010; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Lentz KA, 2000, PHARM RES-DORDR, V17, P1456, DOI 10.1023/A:1007692622216; Lindeman NI, 2013, J MOL DIAGN; Litman T, 2001, CELL MOL LIFE SCI, V58, P931, DOI 10.1007/PL00000912; Loe DW, 2000, J PHARMACOL EXP THER, V293, P530; Lopez JP, 2007, ARCH OTOLARYNGOL, V133, P1022, DOI 10.1001/archotol.133.10.1022; Marchetti S, 2008, MOL CANCER THER, V7, P2280, DOI 10.1158/1535-7163.MCT-07-2250; Memon AA, 2009, CANCER RES, V69, P873, DOI 10.1158/0008-5472.CAN-08-3118; Mendelsohn J, 2006, SEMIN ONCOL, V33, P369, DOI 10.1053/j.seminoncol.2006.04.003; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; NAKAGAWA M, 1992, CANCER RES, V52, P6175; Nakamura Y, 2005, CANCER RES, V65, P1541, DOI 10.1158/0008-5472.CAN-03-2417; NICE, 2010, GEF 1 LIN TREATM LOC; Pao W, 2005, J CLIN ONCOL, V23, P2556, DOI 10.1200/JCO.2005.07.799; Perrotton T, 2007, J BIOL CHEM, V282, P31542, DOI 10.1074/jbc.M703964200; Pisaneschi F, 2014, J LABELLED COMPD RAD, V57, P92, DOI 10.1002/jlcr.3170; Pisaneschi F, 2010, BIOORGAN MED CHEM, V18, P6634, DOI 10.1016/j.bmc.2010.08.004; Riely GJ, 2006, CLIN CANCER RES, V12, P839, DOI 10.1158/1078-0432.CCR-05-1846; SALOMON DS, 1995, CRIT REV ONCOL HEMAT, V19, P183, DOI 10.1016/1040-8428(94)00144-I; Sebastian S, 2006, BBA-REV CANCER, V1766, P120, DOI 10.1016/j.bbcan.2006.06.001; Shepard RL, 2003, INT J CANCER, V103, P121, DOI 10.1002/ijc.10792; Shi Z, 2007, CANCER RES, V67, P11012, DOI 10.1158/0008-5472.CAN-07-2686; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Slobbe P, 2015, EJNMMI RES, V5, DOI 10.1186/s13550-015-0088-0; Sos ML, 2009, CANCER RES, V69, P3256, DOI 10.1158/0008-5472.CAN-08-4055; Su H, 2008, EUR J NUCL MED MOL I, V35, P1089, DOI 10.1007/s00259-007-0636-6; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Szakacs G, 2008, DRUG DISCOV TODAY, V13, P379, DOI 10.1016/j.drudis.2007.12.010; Tanaka T, 2010, INT J CANCER, V126, P651, DOI 10.1002/ijc.24746; Thatcher N, 2005, LANCET, V366, P1527, DOI 10.1016/S0140-6736(05)67625-8; Thress KS, 2015, NAT MED, V21, P560, DOI 10.1038/nm.3854; UEDA K, 1987, P NATL ACAD SCI USA, V84, P3004, DOI 10.1073/pnas.84.9.3004; Van Cutsem E, 2007, J CLIN ONCOL, V25, P1658, DOI 10.1200/JCO.2006.08.1620; Varma MVS, 2005, MOL PHARMACEUT, V2, P12, DOI 10.1021/mp0499196; Yanase K, 2004, MOL CANCER THER, V3, P1119; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yeh HH, 2011, P NATL ACAD SCI US; Yeh HH, 2011, P NATL ACAD SCI USA, V108, P1603, DOI 10.1073/pnas.1010744108; Yu HA, 2013, CLIN CANCER RES, V19, P2240, DOI 10.1158/1078-0432.CCR-12-2246; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105	51	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0161427	10.1371/journal.pone.0161427	http://dx.doi.org/10.1371/journal.pone.0161427			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27552105	Green Published, Green Submitted, gold			2022-12-26	WOS:000381768800039
J	Yu, XL; Shahriari, S; Li, HM; Ghildyal, R				Yu, Xuelian; Shahriari, Shadi; Li, Hong-Mei; Ghildyal, Reena			Measles Virus Matrix Protein Inhibits Host Cell Transcription	PLOS ONE			English	Article							SUBACUTE SCLEROSING-PANENCEPHALITIS; INFECTED-CELLS; 3C PROTEASE; M-GENES; NUCLEUS; BINDING; LOCALIZATION; REPLICATION; FUSION; INTERFERES	Measles virus (MeV) is a highly contagious virus that still causes annual epidemics in developing countries despite the availability of a safe and effective vaccine. Additionally, importation from endemic countries causes frequent outbreaks in countries where it has been eliminated. The M protein of MeV plays a key role in virus assembly and cytopathogenesis; interestingly, M is localised in nucleus, cytoplasm and membranes of infected cells. We have used transient expression of M in transfected cells and in-cell transcription assays to show that only some MeV M localizes to the nucleus, in addition to cell membranes and the cytoplasm as previously described, and can inhibit cellular transcription via binding to nuclear factors. Additionally, MeV M was able to inhibit in vitro transcription in a dose-dependent manner. Importantly, a proportion of M is also localized to nucleus of MeV infected cells at early times in infection, correlating with inhibition of cellular transcription. Our data show, for the first time, that MeV M may play a role early in infection by inhibiting host cell transcription.	[Yu, Xuelian] Xinjiang Med Univ, Dept Publ Hlth, Sect Epidemiol & Stat, 393 XinYi Rd, Urumqi, Peoples R China; [Li, Hong-Mei] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3800, Australia; [Shahriari, Shadi; Ghildyal, Reena] Univ Canberra, Fac ESTeM, Ctr Res Therapeut Solut, Resp Virol Grp, Canberra, ACT 2617, Australia	Xinjiang Medical University; Monash University; University of Canberra	Ghildyal, R (corresponding author), Univ Canberra, Fac ESTeM, Ctr Res Therapeut Solut, Resp Virol Grp, Canberra, ACT 2617, Australia.	Reena.Ghildyal@canberra.edu.au		Ghildyal, Reena/0000-0002-3147-4976; Shahriari, Shadi/0000-0001-9571-3035	Shanghai Municipal Health Bureau Talents Development Foundation [GWDTR201201]	Shanghai Municipal Health Bureau Talents Development Foundation	X.L.Y. was supported by The Shanghai Municipal Health Bureau Talents Development Foundation Grant No.: GWDTR201201.	Ahmed M, 1998, J VIROL, V72, P8413, DOI 10.1128/JVI.72.10.8413-8419.1998; Alvisi G, 2009, J VIROL, V83, P9567, DOI 10.1128/JVI.00669-09; Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Banerjee R, 2005, J GEN VIROL, V86, P2315, DOI 10.1099/vir.0.80817-0; Battaglia S, 2010, INT J CANCER, V126, P2511, DOI 10.1002/ijc.25181; BELLINI WJ, 1985, J VIROL, V53, P908, DOI 10.1128/JVI.53.3.908-919.1985; Cathomen T, 1998, J VIROL, V72, P1224, DOI 10.1128/JVI.72.2.1224-1234.1998; Cathomen T, 1998, EMBO J, V17, P3899, DOI 10.1093/emboj/17.14.3899; CATTANEO R, 1989, CELL, V56, P759, DOI 10.1016/0092-8674(89)90679-X; Dingwall C, 1986, NUCLEOCYTOPLASMIC TR, P159; Forcic D, 2004, VIRUS RES, V99, P51, DOI 10.1016/j.virusres.2003.10.003; Garcia-Dominguez M, 2009, BBA-GENE REGUL MECH, V1789, P451, DOI 10.1016/j.bbagrm.2009.07.001; Ghildyal R, 2005, BIOCHEMISTRY-US, V44, P12887, DOI 10.1021/bi050701e; Ghildyal R, 2003, ARCH VIROL, V148, P1419, DOI 10.1007/s00705-003-0112-y; Ghildyal R, 2009, J VIROL, V83, P7349, DOI 10.1128/JVI.01748-08; Ghildyal R, 2009, J VIROL, V83, P5353, DOI 10.1128/JVI.02374-08; GRIFFIN DE, 2007, FIELDS VIROLOGY; Groner AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000869; HE DC, 1990, J CELL BIOL, V110, P569, DOI 10.1083/jcb.110.3.569; HIRANO A, 1992, P NATL ACAD SCI USA, V89, P8745, DOI 10.1073/pnas.89.18.8745; Iwasaki M, 2009, J VIROL, V83, P10374, DOI 10.1128/JVI.01056-09; Jiang DP, 2009, MICROBES INFECT, V11, P467, DOI 10.1016/j.micinf.2009.01.009; Karasek E, 2013, PRZEGL EPIDEMIOL, V67, P181, DOI [10.1111/1469-0691.12584, DOI 10.1111/1469-0691.12584]; Kundu P, 2005, J VIROL, V79, P9702, DOI 10.1128/JVI.79.15.9702-9713.2005; Muscat M, 2014, CLIN MICROBIOL INFEC, V20, P12, DOI 10.1111/1469-0691.12584; PEEPLES ME, 1988, VIROLOGY, V162, P255, DOI 10.1016/0042-6822(88)90418-7; PEEPLES ME, 1992, J VIROL, V66, P3263, DOI 10.1128/JVI.66.5.3263-3269.1992; Pentecost M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004739; Quan BL, 2014, P NATL ACAD SCI USA, V111, P9127, DOI 10.1073/pnas.1409076111; Rajani KR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002929; Rarnachandran A, 2008, J VIROL, V82, P8330, DOI 10.1128/JVI.00831-08; Sparrer KMJ, 2012, J VIROL, V86, P796, DOI 10.1128/JVI.05899-11; Stielow B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001203; SURYANARAYANA K, 1994, J VIROL, V68, P1532, DOI 10.1128/JVI.68.3.1532-1543.1994; Tahara M, 2007, J VIROL, V81, P6827, DOI 10.1128/JVI.00248-07; Takeda M, 2005, J VIROL, V79, P14346, DOI 10.1128/JVI.79.22.14346-14354.2005; Taylor KE, 2013, IMMUNOLOGY, V138, P190, DOI 10.1111/imm.12038; von Kobbe C, 2000, MOL CELL, V6, P1243, DOI 10.1016/S1097-2765(00)00120-9; Wang YE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001186; YOSHIDA T, 1976, VIROLOGY, V71, P143, DOI 10.1016/0042-6822(76)90101-X; YOUNG KKY, 1985, VIROLOGY, V143, P536, DOI 10.1016/0042-6822(85)90392-7; Zipprich J, 2014, MMWR-MORBID MORTAL W, V63, P362	42	9	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2016	11	8							e0161360	10.1371/journal.pone.0161360	http://dx.doi.org/10.1371/journal.pone.0161360			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TR	27551716	gold, Green Submitted, Green Published			2022-12-26	WOS:000381768800033
J	Mao, YP; Wang, ZP; Li, LG; Jiang, XT; Zhang, XX; Ren, HQ; Zhang, T				Mao, Yanping; Wang, Zhiping; Li, Liguan; Jiang, Xiaotao; Zhang, Xuxiang; Ren, Hongqiang; Zhang, Tong			Exploring the Shift in Structure and Function of Microbial Communities Performing Biological Phosphorus Removal	PLOS ONE			English	Article							GLYCOGEN-ACCUMULATING ORGANISMS; CANDIDATUS-ACCUMULIBACTER; WASTE-WATER; METABOLIC MODEL; PHOSPHATE REMOVAL; SLUDGE; PH; POLYPHOSPHATE; SCALE; BACTERIA	A sequencing batch reactor fed mainly by acetate was operated to perform enhanced biological phosphorus removal (EBPR). A short-term pH shock from 7.0 to 6.0 led to a complete loss of phosphate-removing capability and a drastic change of microbial communities. 16S rRNA gene pyrosequencing showed that large proportions of glycogen accumulating organisms (GAOs) (accounted for 16% of bacteria) bloomed, including Candidatus Competibacter phosphatis and Defluviicoccus-related tetrad-forming organism, causing deteriorated EBPR performance. The EBPR performance recovered with time and the dominant Candidatus Accumulibacter (Accumulibacter) clades shifted from Clade IIC to IIA while GAOs populations shrank significantly. The Accumulibacter population variation provided a good opportunity for genome binning using a bi-dimensional coverage method, and a genome of Accumulibacter Clade IIC was well retrieved with over 90% completeness. Comparative genomic analysis demonstrated that Accumulibacter clades had different abilities in nitrogen metabolism and carbon fixation, which shed light on enriching different Accumulibacter populations selectively.	[Mao, Yanping] Shenzhen Univ, Coll Chem & Environm Engn, Shenzhen, Peoples R China; [Mao, Yanping; Wang, Zhiping; Li, Liguan; Jiang, Xiaotao; Zhang, Tong] Univ Hong Kong, Dept Civil Engn, Environm Biotechnol Lab, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China; [Zhang, Xuxiang; Ren, Hongqiang] Nanjing Univ, Sch Environm, Nanjing, Jiangsu, Peoples R China	Shenzhen University; University of Hong Kong; Nanjing University	Zhang, T (corresponding author), Univ Hong Kong, Dept Civil Engn, Environm Biotechnol Lab, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	zhangt@hku.hk	hq, ren/AGA-1128-2022; Zhang, xiaoyu/GXA-3206-2022; Mao, Yanping/AAI-6386-2020; 張彤, Tong Zhang/C-6786-2008; zhang, xian/GYA-0290-2022; zhang, xu/GRX-9733-2022; Zhang, Tong/HGC-1090-2022; zhang, xu/GYE-3558-2022	Ren, Hong-qiang/0000-0001-6136-800X	Hong Kong General Research Fund (HKU) [172057/15E]; Shenzhen University R/D Fund [2016008]; University of Hong Kong; Hong Kong Scholar Program [XJ2012030]	Hong Kong General Research Fund (HKU); Shenzhen University R/D Fund; University of Hong Kong(University of Hong Kong); Hong Kong Scholar Program	This research was financially supported by Hong Kong General Research Fund (HKU 172057/15E) and Project supported by Shenzhen University R/D Fund (2016008). YM and LL received postdoctoral fellowships from the University of Hong Kong. XJ received postgraduate scholarship from the University of Hong Kong. ZW was financially supported by the Hong Kong Scholar Program (XJ2012030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was financially supported by Hong Kong General Research Fund (HKU 172057/15E) and Project supported by Shenzhen University R/D Fund (2016008). YM and LL received postdoctoral fellowships from the University of Hong Kong. XJ received postgraduate scholarship from the University of Hong Kong. ZW was financially supported by the Hong Kong Scholar Program (XJ2012030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsen M, 2013, NAT BIOTECHNOL, V31, P533, DOI 10.1038/nbt.2579; Albertsen M, 2012, ISME J, V6, P1094, DOI 10.1038/ismej.2011.176; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carvalho G, 2007, WATER RES, V41, P4383, DOI 10.1016/j.watres.2007.06.065; Chen YG, 2005, BIOCHEM ENG J, V27, P24, DOI 10.1016/j.bej.2005.06.003; Chen YG, 2004, WATER RES, V38, P27, DOI 10.1016/j.watres.2003.08.025; Crocetti GR, 2002, MICROBIOL-SGM, V148, P3353, DOI 10.1099/00221287-148-11-3353; Dupont CL, 2012, ISME J, V6, P1186, DOI 10.1038/ismej.2011.189; Filipe CDM, 2001, BIOTECHNOL BIOENG, V76, P17, DOI 10.1002/bit.1022; Filipe CDM, 2001, WATER ENVIRON RES, V73, P213, DOI 10.2175/106143001X139191; Filipe CDM, 2001, WATER ENVIRON RES, V73, P223, DOI 10.2175/106143001X139209; Flowers JJ, 2013, ISME J, V7, P2301, DOI 10.1038/ismej.2013.117; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; He S, 2006, WATER SCI TECHNOL, V54, P111, DOI 10.2166/wst.2006.378; He S, 2007, APPL ENVIRON MICROB, V73, P5865, DOI 10.1128/AEM.01207-07; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Hesselmann RPX, 1999, SYST APPL MICROBIOL, V22, P454, DOI 10.1016/S0723-2020(99)80055-1; Hien TTN, 2012, ENVIRON MICROBIOL, V14, P2826, DOI 10.1111/j.1462-2920.2012.02826.x; Hien TTN, 2011, FEMS MICROBIOL ECOL, V76, P256, DOI 10.1111/j.1574-6941.2011.01049.x; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Kong YH, 2006, ENVIRON MICROBIOL, V8, P479, DOI 10.1111/j.1462-2920.2005.00914.x; Kong YH, 2002, ENVIRON MICROBIOL, V4, P753, DOI 10.1046/j.1462-2920.2002.00357.x; Kristiansen R, 2013, ISME J, V7, P543, DOI 10.1038/ismej.2012.136; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Liu WT, 1996, WATER SCI TECHNOL, V34, P25, DOI 10.1016/0273-1223(96)00491-X; Liu WT, 2001, ENVIRON MICROBIOL, V3, P110, DOI 10.1046/j.1462-2920.2001.00164.x; Lopez-Vazquez CM, 2007, BIOTECHNOL BIOENG, V97, P483, DOI 10.1002/bit.21302; Lopez-Vazquez CM, 2009, WATER RES, V43, P450, DOI 10.1016/j.watres.2008.10.032; Mao YP, 2014, ENVIRON SCI TECHNOL, V48, P10363, DOI 10.1021/es502642b; Martin HG, 2006, NAT BIOTECHNOL, V24, P1263, DOI 10.1038/nbt1247; McIlroy S, 2009, ENV MICROBIOL REP, V1, P563, DOI 10.1111/j.1758-2229.2009.00082.x; McIlroy SJ, 2014, ISME J, V8, P613, DOI 10.1038/ismej.2013.162; McMahon KD, 2007, APPL MICROBIOL BIOT, V77, P167, DOI 10.1007/s00253-007-1122-6; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; Meyer RL, 2006, MICROBIOL-SGM, V152, P419, DOI 10.1099/mic.0.28445-0; Mielczarek AT, 2013, WATER RES, V47, P1529, DOI 10.1016/j.watres.2012.12.003; Miller CS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056018, 10.1371/journal.pone.0081692]; Miller CS, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r44; Nielsen AT, 1999, APPL ENVIRON MICROB, V65, P1251; Nobu MK, 2014, ENVIRON MICROBIOL, V16, P2739, DOI 10.1111/1462-2920.12383; Oehmen A, 2005, WATER RES, V39, P3727, DOI 10.1016/j.watres.2005.06.031; Oehmen A, 2007, WATER RES, V41, P2271, DOI 10.1016/j.watres.2007.02.030; Ong YH, 2013, WATER SCI TECHNOL, V67, P340, DOI 10.2166/wst.2012.552; Panswad T, 2003, WATER RES, V37, P409, DOI 10.1016/S0043-1354(02)00286-5; Peterson SB, 2008, ENVIRON MICROBIOL, V10, P2692, DOI 10.1111/j.1462-2920.2008.01690.x; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Skennerton CT, 2015, ENVIRON MICROBIOL, V17, P1574, DOI 10.1111/1462-2920.12582; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tavares P, 2006, J INORG BIOCHEM, V100, P2087, DOI 10.1016/j.jinorgbio.2006.09.003; Uygur A, 2004, ENZYME MICROB TECH, V34, P313, DOI 10.1016/j.enzmictec.2003.11.010; Wang YY, 2010, BIORESOURCE TECHNOL, V101, P98, DOI 10.1016/j.biortech.2009.07.085; Wang ZP, 2014, MICROB ECOL, V68, P716, DOI 10.1007/s00248-014-0440-3; Wong MT, 2004, MICROBIOL-SGM, V150, P3741, DOI 10.1099/mic.0.27291-0; Zeng RJ, 2003, BIOTECHNOL BIOENG, V81, P92, DOI 10.1002/bit.10455; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang H, 2003, INT J SYST EVOL MICR, V53, P1155, DOI 10.1099/ijs.0.02520-0; Zhang T, 2005, BIOTECHNOL BIOENG, V92, P173, DOI 10.1002/bit.20589	60	51	53	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161506	10.1371/journal.pone.0161506	http://dx.doi.org/10.1371/journal.pone.0161506			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27547976	Green Published, Green Submitted, gold			2022-12-26	WOS:000381768400063
J	Suzuki, H; Kanchiku, T; Imajo, Y; Yoshida, Y; Nishida, N; Taguchi, T				Suzuki, Hidenori; Kanchiku, Tsukasa; Imajo, Yasuaki; Yoshida, Yuichiro; Nishida, Norihiro; Taguchi, Toshihiko			Diagnosis and Characters of Non-Specific Low Back Pain in Japan: The Yamaguchi Low Back Pain Study	PLOS ONE			English	Article							PRIMARY-CARE; POPULATION; PREVALENCE; DISABILITY; HEALTH; US	Study Design Cross sectional data from the Yamaguchi low back pain study conducted in Yamaguchi prefecture, Japan, was used for this analysis. Methods A total of 320 patients were recruited from walk-in orthopedic clinics in Yamaguchi Prefecture, Japan. Patients visited the clinics primarily for low back pain (LBP) and sought treatment between April and May 2015. A self-questionnaire was completed by patients, while radiographic testing and neurological and physical examination was performed by the orthopedist in each hospital. The cause and characters of LBP was determined following examination of the data, regional anesthesia and block injection. Results 'Specific LBP' was diagnosed in 250 (78%) patients and non-diagnosable, 'non-specific LBP' in 70 (22%) patients. The VAS scores of patients were: LBP, 5.8 +/- 0.18; leg pain, 2.9 +/- 0.18 and the intensity of leg numbness was 1.9 +/- 0.16. Item scores for SF-8 were: general health, 46.6 +/- 0.40; physical function, 43.5 +/- 0.51; physical limitations, 42.8 +/- 0.53; body pain, 42.1 +/- 0.52; vitality, 48.4 +/- 0.37; social function, 46.9 +/- 0.53; emotional problems, 48.9 +/- 0.43; mental health, 46.9 +/- 0.43. Conclusions The incidence of non-specific LBP in Japan was lower than previous reports from western countries, presumably because of variation in the diagnosis of LBP between different health care systems. In Japan, 78% of cases were classified as 'specific LBP' by orthopedists. Identification of the definitive cause of LBP should help to improve the quality of LBP treatment.	[Suzuki, Hidenori; Kanchiku, Tsukasa; Imajo, Yasuaki; Yoshida, Yuichiro; Nishida, Norihiro; Taguchi, Toshihiko] Yamaguchi Univ, Grad Sch Med, Dept Orthoped Surg, Yamaguchi, Japan	Yamaguchi University	Suzuki, H (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Orthoped Surg, Yamaguchi, Japan.	hsuzuki@yamaguchi-u.ac.jp		Suzuki, Hidenori/0000-0002-3156-0591				Adhia DB, 2016, MANUAL THER, V21, P191, DOI 10.1016/j.math.2015.08.002; [Anonymous], 1996, JAP ORTH ASS ASS CRI, P46; Brandt J, 2004, J RHEUMATOL, V31, P531; DePalma MJ, 2011, PAIN MED, V12, P224, DOI 10.1111/j.1526-4637.2010.01045.x; DEYO RA, 1991, ANNU REV PUBL HEALTH, V12, P141, DOI 10.1146/annurev.pu.12.050191.001041; DEYO RA, 1992, JAMA-J AM MED ASSOC, V268, P760, DOI 10.1001/jama.268.6.760; Deyo RA, 2001, NEW ENGL J MED, V344, P363, DOI 10.1056/NEJM200102013440508; Domholdt E., 2005, REHABILITATION RES P; FRYMOYER JW, 1988, NEW ENGL J MED, V318, P291, DOI 10.1056/NEJM198802043180506; HART LG, 1995, SPINE, V20, P11, DOI 10.1097/00007632-199501000-00003; Hashizume H, 2015, J ORTHOP SCI, V20, P264, DOI 10.1007/s00776-014-0693-1; Kanchiku T, 2014, J SPINAL DISORD TECH, V27, pE262, DOI 10.1097/BSD.0000000000000107; KELLER RB, 1990, J BONE JOINT SURG AM, V72A, P1286, DOI 10.2106/00004623-199072090-00002; Koes BW, 2010, EUR SPINE J, V19, P2075, DOI 10.1007/s00586-010-1502-y; Krismer M, 2007, BEST PRACT RES CL RH, V21, P77, DOI 10.1016/j.berh.2006.08.004; Kuniya H, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/s13018-014-0139-7; Licciardone JC, 2012, J AM OSTEOPATH ASSOC, V112, P783; Matsudaira K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093924; Ministry of Health Labour and Welfare, SURV LIV COND; Muraki S, 2011, SPINE, V36, P1312, DOI 10.1097/BRS.0b013e3181fa60d1; Potier Tara, 2015, BMJ Qual Improv Rep, V4, DOI 10.1136/bmjquality.u205903.w2411; Schmidt CO, 2007, SPINE, V32, P2005, DOI 10.1097/BRS.0b013e318133fad8; VOLINN E, 1992, SPINE, V17, P575, DOI 10.1097/00007632-199205000-00017; Wahl EC, 2013, J MAN MANIP THER, V21, P81, DOI 10.1179/2042618612Y.0000000023; Walker BF, 2004, J MANIP PHYSIOL THER, V27, P238, DOI 10.1016/j.jmpt.2004.02.002	25	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0160454	10.1371/journal.pone.0160454	http://dx.doi.org/10.1371/journal.pone.0160454			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548658	Green Submitted, Green Published, gold			2022-12-26	WOS:000381768400015
J	Pham, TM; Ekwaru, JP; Mastroeni, SS; Mastroeni, MF; Loehr, SA; Veugelers, PJ				Truong-Minh Pham; Ekwaru, John Paul; Mastroeni, Silmara S.; Mastroeni, Marco F.; Loehr, Sarah A.; Veugelers, Paul J.			The Effect of Serum 25-Hydroxyvitamin D on Elevated Homocysteine Concentrations in Participants of a Preventive Health Program	PLOS ONE			English	Article							PLASMA HOMOCYSTEINE; VITAMIN-D; CARDIOVASCULAR-DISEASE; PATHOGENESIS; POPULATION	Both lower serum 25-hydroxyvitamin D [25(OH) D] and elevated homocysteine concentrations are potential risk factors for cardiovascular disease (CVD). A recent analysis of the National Health and Nutrition Examination Survey reported an inverse association of serum 25(OH) D with homocysteine, however, the longitudinal relationship has yet to be investigated. We hypothesized and examined whether a temporal increase in 25(OH) D concentrations is paralleled by a reduction in the risk for elevated homocysteine. We analyzed data of 4475 participants with repeated assessments of serum 25(OH) D and homocysteine concentrations who enrolled in a preventive health program that encourages vitamin D supplementation and monitors serum 25(OH) D and homocysteine concentrations. We defined elevated homocysteine as concentrations greater than 13 micromoles per liter. Logistic regression was applied to assess the association of temporal changes in serum 25(OH) D with the risk of elevated homocysteine. We observed an inverse gradient whereby greater increases in 25(OH) D concentrations were associated with a lower prevalence of elevated homocysteine. Relative to those without temporal increases in 25(OH) D, participants who showed improvements in their serum 25(OH) D concentrations of "< 25", "25-50", "50-75", and ">= 75" nanomoles per liter at follow up were 0.92 (95% confidence interval: 0.62-1.37), 0.52 (0.33-0.80), 0.34 (0.20-0.58), and 0.32 (0.19-0.54) times as likely to have elevated homocysteine, respectively. These observations suggest that temporal improvements in vitamin D status reduce serum homocysteine concentrations, and therefore may potentially contribute to the primary prevention of CVD.	[Truong-Minh Pham; Ekwaru, John Paul; Mastroeni, Silmara S.; Mastroeni, Marco F.; Loehr, Sarah A.; Veugelers, Paul J.] Univ Alberta, Sch Publ Hlth, Populat Hlth Intervent Res Unit, Edmonton, AB, Canada	University of Alberta	Veugelers, PJ (corresponding author), Univ Alberta, Sch Publ Hlth, Populat Hlth Intervent Res Unit, Edmonton, AB, Canada.	Paul.Veugelers@ualberta.ca	MF, Mastroeni/M-5472-2014	MF, Mastroeni/0000-0001-9276-8866; Pham, Truong-Minh/0000-0001-9442-2930; Veugelers, Paul/0000-0001-8996-0822; Mastroeni, Silmara/0000-0003-0559-1797	Canada Research Chair in Population Health, an Alberta Research Chair in Nutrition and Disease Prevention; Canada Research Chair in Population Health, an Alberta Innovates Health Scholarship; Canadian Institutes for Health Research; School of Public Health at the University of Alberta; Pure North S'Energy Foundation; Alberta provincial government through Alberta Innovates Health Solutions; National Council for Scientific and Technological Development (CNPq), Brazil	Canada Research Chair in Population Health, an Alberta Research Chair in Nutrition and Disease Prevention; Canada Research Chair in Population Health, an Alberta Innovates Health Scholarship; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); School of Public Health at the University of Alberta; Pure North S'Energy Foundation; Alberta provincial government through Alberta Innovates Health Solutions; National Council for Scientific and Technological Development (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This is an analysis of secondary data. The data had been collected for the purpose of lifestyle counseling of participants by a preventive health program. None of the authors were involved in the execution of this program; neither did they provide financial support. PJV holds a Canada Research Chair in Population Health, an Alberta Research Chair in Nutrition and Disease Prevention, and an Alberta Innovates Health Scholarship. The funding for the Canada Research Chair is provided through the Canadian Institutes for Health Research to the University of Alberta. The Alberta Research Chair is awarded by the School of Public Health at the University of Alberta through a thematic research contract with the Pure North S'Energy Foundation. The Health Scholarship is funded by the Alberta provincial government through Alberta Innovates Health Solutions. The funders had no role in analytic design, data analysis, decision to publish, or preparation of this manuscript.; The authors wish to thank the Pure North S'Energy Foundation for allowing their data to be analyzed for the purpose of this article. They especially wish to thank Peter Tran and Ken Fyie for management and validation of the Foundation's data. M.F.M thanks the National Council for Scientific and Technological Development (CNPq), Brazil, for granting a scholarship.	Amer M, 2014, J CLIN ENDOCR METAB, V99, P633, DOI 10.1210/jc.2013-3262; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; Canada Statistics, VIT D LEV CAN 2012 2; Colapinto CK, 2011, CAN MED ASSOC J, V183, pE100, DOI 10.1503/cmaj.100568; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Eikelboom JW, 1999, ANN INTERN MED, V131, P363, DOI 10.7326/0003-4819-131-5-199909070-00008; Garcia AA, 2008, CAN J PUBLIC HEALTH, V99, P428, DOI 10.1007/BF03405255; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2009, ANN EPIDEMIOL, V19, P73, DOI 10.1016/j.annepidem.2007.12.001; Kriebitzsch C, 2011, J BONE MINER RES, V26, P2991, DOI 10.1002/jbmr.493; MacFarlane AJ, 2011, AM J CLIN NUTR, V94, P1079, DOI 10.3945/ajcn.111.020230; Manson JE, 2015, JAMA-J AM MED ASSOC, V313, P1311, DOI 10.1001/jama.2015.1353; Marti-Carvajal AJ, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006612.pub4; MCCULLY KS, 1969, AM J PATHOL, V56, P111; Norman PE, 2014, CIRC RES, V114, P379, DOI 10.1161/CIRCRESAHA.113.301241; Nygard O, 1997, NEW ENGL J MED, V337, P230, DOI 10.1056/NEJM199707243370403; Ray JG, 2002, CAN J PUBLIC HEALTH, V93, P249, DOI 10.1007/BF03405010; Selhub J, 1999, ANNU REV NUTR, V19, P217, DOI 10.1146/annurev.nutr.19.1.217; SELHUB J, 1995, NEW ENGL J MED, V332, P286, DOI 10.1056/NEJM199502023320502; Sheng L, 2015, J GERIATR CARDIOL, V12, P251, DOI 10.11909/j.issn.1671-5411.2015.03.006; Pham TM, 2015, NUTRIENTS, V7, P7271, DOI 10.3390/nu7095338; Wald DS, 2002, BMJ-BRIT MED J, V325, P1202, DOI 10.1136/bmj.325.7374.1202; WILCKEN DEL, 1976, J CLIN INVEST, V57, P1079, DOI 10.1172/JCI108350	25	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2016	11	8							e0161368	10.1371/journal.pone.0161368	http://dx.doi.org/10.1371/journal.pone.0161368			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT8TP	27548258	Green Published, gold, Green Submitted			2022-12-26	WOS:000381768400047
J	Brautigam, CA; Deka, RK; Liu, WZ; Norgard, MV				Brautigam, Chad A.; Deka, Ranjit K.; Liu, Wei Z.; Norgard, Michael V.			The Tp0684 (MglB-2) Lipoprotein of Treponema pallidum: A Glucose-Binding Protein with Divergent Topology	PLOS ONE			English	Article							SIZE-DISTRIBUTION ANALYSIS; OUTER-MEMBRANE PROTEINS; CONFORMATIONAL-CHANGES; ANALYTICAL ULTRACENTRIFUGATION; SEDIMENTATION ANALYSIS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; TRAP TRANSPORTER; GENOME SEQUENCE; SYPHILIS	Treponema pallidum, the bacterium that causes syphilis, is an obligate human parasite. As such, it must acquire energy, in the form of carbon sources, from the host. There is ample evidence that the principal source of energy for this spirochete is D-glucose acquired from its environment, likely via an ABC transporter. Further, there is genetic evidence of a D-glucose chemotaxis system in T. pallidum. Both of these processes may be dependent on a single lipidated chemoreceptor: Tp0684, also called TpMglB-2 for its sequence homology to MglB of Escherichia coli. To broaden our understanding of this potentially vital protein, we determined a 2.05-angstrom X-ray crystal structure of a soluble form of the recombinant protein. Like its namesake, TpMglB-2 adopts a bilobed fold that is similar to that of the ligand-binding proteins (LBPs) of other ABC transporters. However, the protein has an unusual, circularly permuted topology. This feature prompted a series of biophysical studies that examined whether the protein's topological distinctiveness affected its putative chemoreceptor functions. Differential scanning fluorimetry and isothermal titration calorimetry were used to confirm that the protein bound D-glucose in a cleft between its two lobes. Additionally, analytical ultracentrifugation was employed to reveal that D-glucose binding is accompanied by a significant conformational change. TpMglB-2 thus appears to be fully functional in vitro, and given the probable central importance of the protein to T. pallidum's physiology, our results have implications for the viability and pathogenicity of this obligate human pathogen.	[Brautigam, Chad A.] Univ Texas Southwestern Med Ctr, Dept Biophys, Dallas, TX 75390 USA; [Deka, Ranjit K.; Liu, Wei Z.; Norgard, Michael V.] Univ Texas Southwestern Med Ctr, Dept Microbiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Norgard, MV (corresponding author), Univ Texas Southwestern Med Ctr, Dept Microbiol, Dallas, TX 75390 USA.	Michael.Norgard@UTSouthwestern.edu		Brautigam, Chad/0000-0001-6563-1338	National Institutes of Health [AI056305]; U.S. Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056305] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (grant AI056305, www.nih.gov) to MVN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by a grant (AI056305) to M.V.N. from the National Institutes of Health. Some results shown in this report are derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne is operated by UChicago Argonne, LLC, for the U.S. Department of Energy, Office of Biological and Environmental Research under contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BARBIERI JT, 1979, INFECT IMMUN, V24, P291, DOI 10.1128/IAI.24.1.291-293.1979; BARBIERI JT, 1981, INFECT IMMUN, V31, P1071, DOI 10.1128/IAI.31.3.1071-1077.1981; BECKER PS, 1994, INFECT IMMUN, V62, P1381, DOI 10.1128/IAI.62.4.1381-1391.1994; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Bevington PR, 1992, DATA REDUCTION AND E; Borrok MJ, 2007, PROTEIN SCI, V16, P1032, DOI 10.1110/ps.062707807; Borrok MJ, 2009, ACS CHEM BIOL, V4, P447, DOI 10.1021/cb900021q; Brautigam CA, 2016, NAT PROTOC, V11, P882, DOI 10.1038/nprot.2016.044; Brautigam CA, 2015, METHOD ENZYMOL, V562, P109, DOI 10.1016/bs.mie.2015.05.001; Brautigam CA, 2015, PROTEIN SCI, V24, P11, DOI 10.1002/pro.2576; Brautigam CA, 2012, J BACTERIOL, V194, P6771, DOI 10.1128/JB.01494-12; Brautigam CA, 2012, J MOL BIOL, V420, P70, DOI 10.1016/j.jmb.2012.04.001; Bremer V, 2012, SEX TRANSM DIS, P7; Charon NW, 2002, ANNU REV GENET, V36, P47, DOI 10.1146/annurev.genet.36.041602.134359; Cohen MS, 2006, SEX TRANSM DIS, V33, P724, DOI 10.1097/01.olq.0000245917.47692.b7; COVER WH, 1982, SEX TRANSM DIS, V9, P1, DOI 10.1097/00007435-198201000-00001; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; Cox DL, 2010, INFECT IMMUN, V78, P5178, DOI 10.1128/IAI.00834-10; COX DL, 1992, INFECT IMMUN, V60, P1076, DOI 10.1128/IAI.60.3.1076-1083.1992; Cullen PA, 2004, FEMS MICROBIOL REV, V28, P291, DOI 10.1016/j.femsre.2003.10.004; Cuneo MJ, 2008, J BIOL CHEM, V283, P32812, DOI 10.1074/jbc.M803595200; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Deka RK, 2007, J BIOL CHEM, V282, P5944, DOI 10.1074/jbc.M610215200; Deka RK, 2016, MICROBIOLOGYOPEN, V5, P21, DOI 10.1002/mbo3.306; Deka RK, 2015, MBIO, V6, DOI 10.1128/mBio.00519-15; Deka RK, 2013, J BIOL CHEM, V288, P11106, DOI 10.1074/jbc.M113.449975; Deka RK, 2013, MBIO, V4, DOI 10.1128/mBio.00615-12; Deka RK, 2012, J MOL BIOL, V416, P678, DOI 10.1016/j.jmb.2012.01.015; Deka RK, 2006, J BIOL CHEM, V281, P8072, DOI 10.1074/jbc.M511405200; Deka RK, 2004, J BIOL CHEM, V279, P55644, DOI 10.1074/jbc.M409263200; Deka RK, 2004, J BACTERIOL, V186, P2303, DOI 10.1128/JB.186.8.2303-2308.2004; Deka RK, 2002, J BIOL CHEM, V277, P41857, DOI 10.1074/jbc.M207402200; Desrosiers DC, 2007, MOL MICROBIOL, V65, P137, DOI 10.1111/j.1365-2958.2007.05771.x; Desrosiers DC, 2011, MOL MICROBIOL, V80, P1496, DOI 10.1111/j.1365-2958.2011.07662.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Errington N, 2003, EUR BIOPHYS J BIOPHY, V32, P511, DOI 10.1007/s00249-003-0315-x; Felder CB, 1999, AAPS PHARMSCI, V1; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; Fukami-Kobayashi K, 1999, J MOL BIOL, V286, P279, DOI 10.1006/jmbi.1998.2454; Ghirlando R, 2013, ANAL BIOCHEM, V440, P81, DOI 10.1016/j.ab.2013.05.011; Golden MR, 2003, JAMA-J AM MED ASSOC, V290, P1510, DOI 10.1001/jama.290.11.1510; Gonin S, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-11; Greene SR, 1998, INFECT IMMUN, V66, P2999, DOI 10.1128/IAI.66.6.2999-3002.1998; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Haake DA, 2000, MICROBIOL-SGM, V146, P1491, DOI 10.1099/00221287-146-7-1491; Hagman KE, 1997, INFECT IMMUN, V65, P1701, DOI 10.1128/IAI.65.5.1701-1709.1997; HAZELBAUER GL, 1971, NATURE-NEW BIOL, V230, P101, DOI 10.1038/newbio230101a0; HODEL A, 1992, ACTA CRYSTALLOGR A, V48, P851, DOI 10.1107/S0108767392006044; Hook E. W., 2009, Morbidity and Mortality Weekly Report, V58, P463; Huerta-Cepas J, 2016, MOL BIOL EV IN PRESS; Keller S, 2012, ANAL CHEM, V84, P5066, DOI 10.1021/ac3007522; Kerani RP, 2007, SEX TRANSM DIS, V34, P154, DOI 10.1097/01.olq.0000233709.93891.e5; KIRSCHNER MW, 1971, BIOCHEMISTRY-US, V10, P1900, DOI 10.1021/bi00786a027; Klock HE, 2008, PROTEINS, V71, P982, DOI 10.1002/prot.21786; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lee YH, 1999, NAT STRUCT BIOL, V6, P628; Machius M, 2007, J MOL BIOL, V373, P681, DOI 10.1016/j.jmb.2007.08.018; Mattei PL, 2012, AM FAM PHYSICIAN, V86, P433; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; NICHOLS JC, 1975, INFECT IMMUN, V12, P1044, DOI 10.1128/IAI.12.5.1044-1050.1975; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Ning C, 2000, METABOLISM, V49, P1460, DOI 10.1053/meta.2000.9512; Norris SJ, 2001, J MOL MICROB BIOTECH, V3, P37; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM, P80; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; RADOLF JD, 1995, INFECT IMMUN, V63, P4244, DOI 10.1128/IAI.63.11.4244-4252.1995; Riley M, 2006, NUCLEIC ACIDS RES, V34, P1, DOI 10.1093/nar/gkj405; Scheuermann TH, 2015, METHODS, V76, P87, DOI 10.1016/j.ymeth.2014.11.024; SCHILLER NL, 1977, INFECT IMMUN, V16, P60, DOI 10.1128/IAI.16.1.60-68.1977; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schuck P, 1999, BIOPHYS J, V76, P2288, DOI 10.1016/S0006-3495(99)77384-4; Schuck P, 1998, BIOPHYS J, V75, P1503, DOI 10.1016/S0006-3495(98)74069-X; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shilton BH, 1996, J MOL BIOL, V264, P350, DOI 10.1006/jmbi.1996.0645; Simms I, 2005, SEX TRANSM DIS, V32, P220, DOI 10.1097/01.olq.0000149848.03733.c1; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Velicko I, 2012, CONTROL, P1; VYAS MN, 1989, J BIOL CHEM, V264, P20817; VYAS NK, 1987, NATURE, V327, P635, DOI 10.1038/327635a0; Zhao HY, 2015, METHODS, V76, P137, DOI 10.1016/j.ymeth.2014.11.012	87	10	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161022	10.1371/journal.pone.0161022	http://dx.doi.org/10.1371/journal.pone.0161022			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536942	Green Published, gold, Green Submitted			2022-12-26	WOS:000381577000042
J	Coca, SG; Nadkarni, GN; Garg, AX; Koyner, J; Thiessen-Philbrook, H; McArthur, E; Shlipak, MG; Parikh, CR				Coca, Steven G.; Nadkarni, Girish N.; Garg, Amit X.; Koyner, Jay; Thiessen-Philbrook, Heather; McArthur, Eric; Shlipak, Michael G.; Parikh, Chirag R.		TRIBE-AKI Consortium	First Post-Operative Urinary Kidney Injury Biomarkers and Association with the Duration of AKI in the TRIBE-AKI Cohort	PLOS ONE			English	Article							LONG-TERM SURVIVAL; CARDIAC-SURGERY; PREVENTION TRIALS; POOR OUTCOMES; IMPACT	Background We previously demonstrated that assessment of the duration of AKI, in addition to magnitude of rise in creatinine alone, adds prognostic information for long-term survival. We evaluated whether post-operative kidney injury biomarkers in urine collected immediately after cardiac surgery associate with duration of serum creatinine elevation. Methods We studied 1199 adults undergoing cardiac surgery in a prospective cohort study (TRIBE-AKI) and examined the association between the levels of five urinary biomarkers individually at 0-6 hours after surgery: interleukin-18 (IL-18), neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1 (KIM-1), liver fatty acid binding protein (L-FABP) and albumin with duration of serum creatinine-based AKIN criteria for AKI (0 (no AKI), 1-2, 3-6, >= 7 days). Results Overall, 407 (34%) patients had at least stage 1 AKI, of whom 251 (61.7%) had duration of 1-2 days, 118 (28.9%) had duration 3-6 days, and 38 (9.3%) had duration of >= 7 days. Higher concentrations of all biomarkers (per log increase) were independently associated with a greater odds of a longer duration of AKI; odds ratios and 95% confidence intervals using ordinal logistic regression were the following: IL-18: 1.22, 1.13-1.32; KIM-1: 1.36, 1.21-1.52; albumin 1.20, 1.09-1.32; L-FABP 1.11, 1.04-1.19; NGAL 1.06, 1.00-1.14). AKI duration of 7 days or longer was associated with a 5-fold adjusted risk of mortality at 3 years. Conclusions There was an independent dose-response association between urinary levels of injury biomarkers immediately after cardiac surgery and longer duration of AKI. Duration of AKI was also associated with long term mortality. Future studies should explore the potential utility of these urinary kidney injury biomarkers to enrich enrollment of patients at risk for longer duration of AKI into trials of interventions to prevent or treat post-operative AKI.	[Coca, Steven G.; Nadkarni, Girish N.] Icahn Sch Med Mt Sinai, Dept Med, Div Nephrol, New York, NY 10029 USA; [Garg, Amit X.; Thiessen-Philbrook, Heather; McArthur, Eric] Western Univ, Dept Med, Div Nephrol, London, ON, Canada; [Koyner, Jay] Univ Chicago, Pritzker Sch Med, Dept Med, Nephrol Sect, Chicago, IL 60637 USA; [Shlipak, Michael G.] Univ Calif San Francisco, Div Gen Internal Med, San Francisco VA Med Ctr, San Francisco, CA 94143 USA; [Parikh, Chirag R.] Yale Univ, Sch Med, Dept Internal Med, Program Appl Translat Res, New Haven, CT 06510 USA	Icahn School of Medicine at Mount Sinai; Western University (University of Western Ontario); University of Chicago; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; Yale University	Parikh, CR (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Program Appl Translat Res, New Haven, CT 06510 USA.	chirag.parikh@yale.edu	Garg, Amit X/G-3295-2011; Coca, Steven/L-7801-2019	Coca, Steven/0000-0002-0928-9168; Thiessen Philbrook, Heather/0000-0003-2067-0514; Swaminathan, Madhav/0000-0001-9136-8609; Chu, Michael/0000-0002-9872-399X; Parikh, Chirag/0000-0001-9051-7385	Institute for Clinical Evaluative Sciences (ICES) - Ontario Ministry of Health and Long-Term Care (MOHLTC); National Institutes of Health (NIH) [R01HL085757]; NIH [K23DK080132, T32-DK007757, K24DK090203, P30 DK079310-07, U01DK082185]; Dr. Adam Linton Chair in Kidney Health Analytics;  [K23 DK081616]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK081616, K23DK080132, T32DK007757, U01DK082185, P30DK079310, K24DK090203] Funding Source: NIH RePORTER	Institute for Clinical Evaluative Sciences (ICES) - Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr. Adam Linton Chair in Kidney Health Analytics; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES or the MOHLTC is intended or should be inferred. This study was supported by the National Institutes of Health (NIH) (R01HL085757 to CRP) to fund the TRIBE-AKI Consortium to study novel biomarkers of AKI in cardiac surgery. SGC has been supported by an NIH Career Development Award (K23DK080132). GNN is supported in part by the NIH (T32-DK007757). JLK has been supported by K23 DK081616. C.R.P. is supported by the NIH (K24DK090203) and P30 DK079310-07 O'Brien Center Grant. SGC, AXG, and CRP are also members of the NIH-sponsored Assess, Serial Evaluation, and Subsequent Sequelae in Acute Kidney Injury Consortium (U01DK082185). AXG is supported by the Dr. Adam Linton Chair in Kidney Health Analytics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Lead Author of the TRIBE AKI consortium: Chirag R. Parikh. Email: chirag.parikh@yale.edu. Section of Nephrology, Department of Medicine, Yale University School of Medicine, VA CT Healthcare System, and the Program of Applied Translational Research, New Haven, CT, USA. Members of TRIBE-AKI consortium: U of Chicago: Dr. Jai Raman, Dr. Valluvan Jeevanandam, Dr. Shahab Akhter. U of Colorado: Dr. Charles Edelstein. Danbury Hospital: Dr. Cary Passik, Ms. Judy Nagy. Duke University: Dr. Madhav Swaminathan. London, Ontario: Dr. Michael Chu, Dr. Martin Goldbach, Dr. Lin Ruo Guo, Dr. Neil McKenzie, Dr. Mary Lee Myers, Dr. Richard Novick, Dr. Mac Quantz. Montreal Children's: Dr. Michael Zappitelli, Dr. Ana Palijan. Yale-New Haven: Dr. Michael Dewar, Dr. Umer Darr, Dr. Sabet Hashim, Dr. John Elefteriades, Dr. Arnar Geirsson, Dr. Susan Garwood, Dr. Isabel Butrymowicz, Dr. Harlan Krumholz. Additional Contributions: We thank Dr. Stephanie Dixon for her analytic support. This study was supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES or the MOHLTC is intended or should be inferred. This study was supported by the National Institutes of Health (NIH) (R01HL085757 to C.R.P.) to fund the TRIBE-AKI Consortium to study novel biomarkers of AKI in cardiac surgery. S.G.C. has been supported by an NIH Career Development Award (K23DK080132). G.N.N is supported in part by the NIH (T32-DK007757). JLK has been supported by K23 DK081616. C.R.P. is supported by the NIH (K24DK090203) and P30 DK079310-07 O'Brien Center Grant. S.G.C., A.X.G., and C.R.P. are also members of the NIH-sponsored Assess, Serial Evaluation, and Subsequent Sequelae in Acute Kidney Injury Consortium (U01DK082185). AXG is supported by the Dr. Adam Linton Chair in Kidney Health Analytics.	Bagshaw SM, 2007, CRIT CARE, V11, DOI 10.1186/cc5949; Brown JR, 2010, ANN THORAC SURG, V90, P1142, DOI 10.1016/j.athoracsur.2010.04.039; Coca SG, 2010, KIDNEY INT, V78, P926, DOI 10.1038/ki.2010.259; Devarajan P, 2011, CURR OPIN PEDIATR, V23, P194, DOI 10.1097/MOP.0b013e328343f4dd; Endre ZH, 2010, NEPHROL DIAL TRANSPL, V25, P107, DOI 10.1093/ndt/gfp501; Lok CE, 2004, AM HEART J, V148, P430, DOI 10.1016/j.ahj.2003.12.042; Lopes JA, 2008, CRIT CARE, V12, DOI 10.1186/cc6997; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Okusa MD, 2012, CLIN J AM SOC NEPHRO, V7, P851, DOI 10.2215/CJN.12811211; Parikh CR, 2013, CLIN J AM SOC NEPHRO, V8, P1079, DOI 10.2215/CJN.10971012; Parikh CR, 2011, J AM SOC NEPHROL, V22, P1748, DOI 10.1681/ASN.2010121302; Parikh CR, 2011, J AM SOC NEPHROL, V22, P1737, DOI 10.1681/ASN.2010111163; Rosner MH, 2006, CLIN J AM SOC NEPHRO, V1, P19, DOI 10.2215/CJN.00240605; Schmitt R, 2008, AM J KIDNEY DIS, V52, P262, DOI 10.1053/j.ajkd.2008.03.005; Schmitt R, 2008, AM J PHYSIOL-RENAL, V294, pF1265, DOI 10.1152/ajprenal.00543.2007	15	31	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161098	10.1371/journal.pone.0161098	http://dx.doi.org/10.1371/journal.pone.0161098			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537050	gold, Green Submitted, Green Published			2022-12-26	WOS:000381577000053
J	David, N; Skoruppa, S; Gulberti, A; Schultz, J; Engel, AK				David, Nicole; Skoruppa, Stefan; Gulberti, Alessandro; Schultz, Johannes; Engel, Andreas K.			The Sense of Agency Is More Sensitive to Manipulations of Outcome than Movement-Related Feedback Irrespective of Sensory Modality	PLOS ONE			English	Article							RUBBER HAND ILLUSION; VICARIOUS AGENCY; BODY-OWNERSHIP; PROPRIOCEPTION; CONSEQUENCES; RECOGNITION; EMBODIMENT; EXPERIENCE; AWARENESS; TOUCH	The sense of agency describes the ability to experience oneself as the agent of one's own actions. Previous studies of the sense of agency manipulated the predicted sensory feedback related either to movement execution or to the movement's outcome, for example by delaying the movement of a virtual hand or the onset of a tone that resulted from a button press. Such temporal sensorimotor discrepancies reduce the sense of agency. It remains unclear whether movement-related feedback is processed differently than outcome-related feedback in terms of agency experience, especially if these types of feedback differ with respect to sensory modality. We employed a mixed-reality setup, in which participants tracked their finger movements by means of a virtual hand. They performed a single tap, which elicited a sound. The temporal contingency between the participants' finger movements and (i) the movement of the virtual hand or (ii) the expected auditory outcome was systematically varied. In a visual control experiment, the tap elicited a visual outcome. For each feedback type and participant, changes in the sense of agency were quantified using a forced-choice paradigm and the Method of Constant Stimuli. Participants were more sensitive to delays of outcome than to delays of movement execution. This effect was very similar for visual or auditory outcome delays. Our results indicate different contributions of movement-versus outcome-related sensory feedback to the sense of agency, irrespective of the modality of the outcome. We propose that this differential sensitivity reflects the behavioral importance of assessing authorship of the outcome of an action.	[David, Nicole; Skoruppa, Stefan; Gulberti, Alessandro; Engel, Andreas K.] Univ Med Ctr Hamburg Eppendorf, Dept Neurophysiol & Pathophysiol, Hamburg, Germany; [Schultz, Johannes] Univ Bonn, Dept Psychiat, Div Med Psychol, Bonn, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Bonn	David, N (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Neurophysiol & Pathophysiol, Hamburg, Germany.	ndavid@uke.de	Schultz, Johannes/B-8613-2012; Engel, Andreas K/C-7781-2012; Engel, Andreas K./AAH-6384-2019; David, Nicole/H-1682-2012	Schultz, Johannes/0000-0003-4117-232X; Engel, Andreas K/0000-0003-4899-8466; Engel, Andreas K./0000-0003-4899-8466; David, Nicole/0000-0001-5233-1977; Gulberti, Alessandro/0000-0003-0538-5109	European Union [FP7-ICT-270212, ERC-2010-AdG-269716]	European Union(European Commission)	This work was supported by the European Union (project "eSMCs", grant no. FP7-ICT-270212; project "Multisense", grant no. ERC-2010-AdG-269716). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balslev D, 2007, J COGNITIVE NEUROSCI, V19, P1535, DOI 10.1162/jocn.2007.19.9.1535; Banakou D, 2014, P NATL ACAD SCI USA, V111, P17678, DOI 10.1073/pnas.1414936111; Blakemore SJ, 1998, NEUROPSYCHOLOGIA, V36, P521, DOI 10.1016/S0028-3932(97)00145-0; Blakemore SJ, 2002, TRENDS COGN SCI, V6, P237, DOI 10.1016/S1364-6613(02)01907-1; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Corradi-Dell'Acqua C, 2010, NEUROPSYCHOLOGIA, V48, P689, DOI 10.1016/j.neuropsychologia.2009.11.029; David N, 2010, NEUROPSYCHOLOGY OF THE SENSE OF AGENCY: FROM CONSCIOUSNESS TO ACTION, P69, DOI 10.1007/978-88-470-1587-6_4; David N, 2013, COGN AFFECT BEHAV NE; David N, 2008, CONSCIOUS COGN, V17, P523, DOI 10.1016/j.concog.2008.03.004; David N, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00149; Dummer T, 2009, PERCEPTION, V38, P271, DOI 10.1068/p5921; Farrer, 1991, CEREB CORTEX N Y N 1, V18, P254; Farrer C, 2008, BEHAV NEUROL, V19, P53, DOI 10.1155/2008/425267; Farrer C, 2003, CONSCIOUS COGN, V12, P609, DOI 10.1016/S1053-8100(03)00047-3; Fiori F, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00734; Franck N, 2001, AM J PSYCHIAT, V158, P454, DOI 10.1176/appi.ajp.158.3.454; Fuchs X, 2016, SCI REP-UK, V6, DOI 10.1038/srep24362; Gallagher S, 2000, TRENDS COGN SCI, V4, P14, DOI 10.1016/S1364-6613(99)01417-5; Haering C, 2015, COGNITION, V136, P38, DOI 10.1016/j.cognition.2014.11.012; Haggard P, 2003, CONSCIOUS COGN, V12, P695, DOI 10.1016/S1053-8100(03)00052-7; Kalckert A, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00040; Kammers MPM, 2009, NEUROPSYCHOLOGIA, V47, P204, DOI 10.1016/j.neuropsychologia.2008.07.028; Kawabe T, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00610; Kilteni K, 2012, PRESENCE-TELEOP VIRT, V21, P373, DOI 10.1162/PRES_a_00124; Knoblich G, 2004, J EXP PSYCHOL HUMAN, V30, P657, DOI 10.1037/0096-1523.30.4.657; LEFCOURT HM, 1973, AM PSYCHOL, V28, P417, DOI 10.1037/h0034639; Lenggenhager B, 2007, SCIENCE, V317, P1096, DOI 10.1126/science.1143439; Leube DT, 2003, NEUROIMAGE, V20, P2084, DOI 10.1016/j.neuroimage.2003.07.033; Longo MR, 2008, COGNITION, V107, P978, DOI 10.1016/j.cognition.2007.12.004; Longo MR, 2012, CURR DIR PSYCHOL SCI, V21, P140, DOI 10.1177/0963721411434982; Maravita A, 2004, TRENDS COGN SCI, V8, P79, DOI 10.1016/j.tics.2003.12.008; Metcalfe J, 2013, EXP BRAIN RES, V229, P485, DOI 10.1007/s00221-012-3371-6; Michotte A. E, 1963, PERCEPTION CAUSALITY; Newport R, 2010, EXP BRAIN RES, V204, P385, DOI 10.1007/s00221-009-2104-y; Pavani F, 2000, PSYCHOL SCI, V11, P353, DOI 10.1111/1467-9280.00270; Prodoehl J, 2008, J NEUROPHYSIOL, V99, P3042, DOI 10.1152/jn.01108.2007; Roseboom W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018309; Sato A, 2005, COGNITION, V94, P241, DOI 10.1016/j.cognition.2004.04.003; Slater M, 2009, FRONT NEUROSCI-SWITZ, V3, P214, DOI 10.3389/neuro.01.029.2009; Spengler S, 2009, NEUROIMAGE, V46, P290, DOI 10.1016/j.neuroimage.2009.01.047; Synofzik M, 2008, CONSCIOUS COGN, V17, P219, DOI 10.1016/j.concog.2007.03.010; Tieri G, 2015, EXP BRAIN RES, V233, P1247, DOI 10.1007/s00221-015-4202-3; Tieri G, 2015, SCI REP-UK, V5, DOI 10.1038/srep17139; Tsakiris M, 2006, CONSCIOUS COGN, V15, P423, DOI 10.1016/j.concog.2005.09.004; Vinken PM, 2013, MULTISENS RES, V26, P533, DOI 10.1163/22134808-00002435; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; Wegner DM, 2004, J PERS SOC PSYCHOL, V86, P838, DOI 10.1037/0022-3514.86.6.838; Zopf R, 2015, EXP BRAIN RES, V233, P2311, DOI 10.1007/s00221-015-4300-2	48	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161156	10.1371/journal.pone.0161156	http://dx.doi.org/10.1371/journal.pone.0161156			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT6ES	27536948	gold, Green Published, Green Submitted			2022-12-26	WOS:000381577000062
J	Kochanek, J; Long, RL; Lisle, AT; Flematti, GR				Kochanek, Jitka; Long, Rowena L.; Lisle, Allan T.; Flematti, Gavin R.			Karrikins Identified in Biochars Indicate Post-Fire Chemical Cues Can Influence Community Diversity and Plant Development	PLOS ONE			English	Article							SEED-GERMINATION; GROWTH REGULATORS; SMOKE; SOIL; PRODUCTIVITY; RESTORATION; BUTENOLIDES; AMENDMENT; COMPOUND; VINEGAR	Background Karrikins are smoke-derived compounds that provide strong chemical cues to stimulate seed germination and seedling growth. The recent discovery in Arabidopsis that the karrikin perception system may be present throughout angiosperms implies a fundamental plant function. Here, we identify the most potent karrikin, karrikinolide (KAR(1)), in biochars and determine its role in species unique plant responses. Methods Biochars were prepared by three distinct commercial-scale pyrolysis technologies using systematically selected sourcematerial and their chemical properties, including karrikinolide, were quantified. Dose-response assays determined the effects of biochar on seed germination for two model species that require karrikinolide to break dormancy (Solanum orbiculatum, Brassica tourneforttii) and on seedling growth using two species that display plasticity to karrikins, biochar and phytotoxins (Lactuca sativa, Lycopersicon esculentum). Multivariate analysis examined relationships between biochar properties and the plant phenotype. Findings and Conclusions Results showed that karrikin abundant biochars stimulated dormant seed germination and seedling growth via mechanisms analogous to post-fire chemical cues. The individual species response was associated with its sensitivity to karrikinolide and inhibitory compounds within the biochars. These findings are critical for understanding why biochar influences community composition and plant physiology uniquely for different species and reaffirms that future pyrolysis technologies promise by-products that concomitantly sequester carbon and enhance plant growth for ecological and broader plant related applications.	[Kochanek, Jitka] Univ Queensland, Sch Agr & Food Sci, Brisbane, Qld, Australia; [Long, Rowena L.; Flematti, Gavin R.] Univ Western Australia, Sch Chem & Biochem, Crawley, WA, Australia; [Lisle, Allan T.] Univ Queensland, Sch Agr & Food Sci, Gatton, Qld, Australia	University of Queensland; University of Western Australia; University of Queensland	Kochanek, J (corresponding author), Univ Queensland, Sch Agr & Food Sci, Brisbane, Qld, Australia.	j.kochanek@uq.edu.au	Kochanek, Jitka/AAQ-8598-2020; Flematti, Gavin R/J-2018-2012	Kochanek, Jitka/0000-0002-6727-751X; Flematti, Gavin/0000-0003-2545-6939; Long, Rowena/0000-0003-4539-1319	Horticulture Innovation Australia Ltd; Australian Government [HG10025, MT13042]; University of Queensland ECR Grant; Australian Research Council [FT110100304]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R43HG010025] Funding Source: NIH RePORTER	Horticulture Innovation Australia Ltd(Horticulture Australia Limited); Australian Government(Australian GovernmentCGIAR); University of Queensland ECR Grant; Australian Research Council(Australian Research Council); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research and a Fellowship for JK was financially supported by Horticulture Innovation Australia Ltd using voluntary contributions from Brisbane City Council and matched funds from the Australian Government (HG10025, MT13042, http://horticulture.com.au/) and a University of Queensland ECR Grant (https://www.uq.edu.au/). An ARC Future Fellowship for GRF was financially supported by the Australian Research Council (FT110100304, http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research and a Fellowship for J.K. was financially supported by Horticulture Innovation Australia Ltd using voluntary contributions from Brisbane City Council and matched funds from the Australian Government (HG10025, MT13042) and a University of Queensland ECR Grant. An ARC Future Fellowship for G.R.F. was financially supported by the Australian Research Council (FT110100304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We gratefully acknowledge three Australian biochar manufacturers for study participation, Adrian Scaffidi for preparation of the <SUP>13</SUP>C<INF>5</INF>-labeled karrikinolide, Mark Kochanek for assistance with data interpretation and Christopher George for technical assistance. We also thank three anonymous colleagues for comments on this manuscript.	Bargmann I, 2013, J AGRON CROP SCI, V199, P360, DOI 10.1111/jac.12024; Beesley L, 2011, ENVIRON POLLUT, V159, P3269, DOI 10.1016/j.envpol.2011.07.023; Biederman LA, 2013, GCB BIOENERGY, V5, P202, DOI 10.1111/gcbb.12037; Buss W, 2014, J ENVIRON MANAGE, V137, P111, DOI 10.1016/j.jenvman.2014.01.045; Cernansky R, 2015, NATURE, V517, P258, DOI 10.1038/517258a; Chiwocha SDS, 2009, PLANT SCI, V177, P252, DOI 10.1016/j.plantsci.2009.06.007; Commander LE, 2008, AUST J BOT, V56, P333, DOI 10.1071/BT07209; Crane-Droesch A, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/4/044049; Di Salvatore M, 2008, CHEMOSPHERE, V73, P1461, DOI 10.1016/j.chemosphere.2008.07.061; DIXON KW, 1995, OECOLOGIA, V101, P185, DOI 10.1007/BF00317282; Flematti GR, 2007, J AGR FOOD CHEM, V55, P2189, DOI 10.1021/jf0633241; Flematti GR, 2013, MOL PLANT, V6, P29, DOI 10.1093/mp/sss132; Flematti GR, 2011, J AGR FOOD CHEM, V59, P1195, DOI 10.1021/jf1041728; Flematti GR, 2009, J AGR FOOD CHEM, V57, P9475, DOI 10.1021/jf9028128; Flematti GR, 2004, SCIENCE, V305, P977, DOI 10.1126/science.1099944; GILLMAN GP, 1986, AUST J SOIL RES, V24, P61, DOI 10.1071/SR9860061; Graber ER, 2010, PLANT SOIL, V337, P481, DOI 10.1007/s11104-010-0544-6; Gurwick NP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075932; International Biochar Initiative, 2014, IBISTD20; Jain N, 2007, SEED SCI RES, V17, P175, DOI 10.1017/S0960258507785896; Jain N, 2006, PLANT GROWTH REGUL, V49, P263, DOI 10.1007/s10725-006-9136-0; Jeffery S, 2015, GCB BIOENERGY, V7, P1, DOI 10.1111/gcbb.12132; Kochanek J, 2016, ACTA HORTIC, V1112, P327, DOI 10.17660/ActaHortic.2016.1112.44; Kochanek J, 2012, 2012 AUSTR FRONTIERS; Kochanek J, 2011, NEW PHYTOL, V191, P223, DOI 10.1111/j.1469-8137.2011.03681.x; Lehmann J, 2007, NATURE, V447, P143, DOI 10.1038/447143a; Li WQ, 2015, TRENDS PLANT SCI, V20, P535, DOI 10.1016/j.tplants.2015.07.006; Liao SH, 2014, ENVIRON SCI TECHNOL, V48, P8581, DOI 10.1021/es404250a; Light ME, 2010, J NAT PROD, V73, P267, DOI 10.1021/np900630w; Long RL, 2011, ANN BOT-LONDON, V108, P933, DOI 10.1093/aob/mcr198; Matlwa Kopano, 2010, SPILT MILK; Mu J, 2004, J WOOD SCI, V50, P470, DOI 10.1007/s10086-003-0586-y; Mukherjee A, 2014, SOIL RES, V52, P217, DOI 10.1071/SR13359; Mungkunkamchao T, 2013, SCI HORTIC-AMSTERDAM, V154, P66, DOI 10.1016/j.scienta.2013.02.020; National Environment Protection Council Schedule B (I), 1999, GUID INV LEV SOIL GR; Oh TK, 2012, J FAC AGR KYUSHU U, V57, P55; Prithiviraj B, 2007, NEW PHYTOL, V173, P852, DOI 10.1111/j.1469-8137.2006.01964.x; Quilliam RS, 2012, AGR ECOSYST ENVIRON, V158, P192, DOI 10.1016/j.agee.2012.06.011; Rayment G.E., 2011, SOIL CHEM METHODS AU; Roorda van Eysinga JPNL, 1981, NUTR DISORDERS GLASS; Scaffidi A, 2013, PLANT J, V76, P1, DOI 10.1111/tpj.12265; Scaffidi A, 2011, TETRAHEDRON, V67, P152, DOI 10.1016/j.tet.2010.11.006; Singh N, 2012, BIOGEOSCIENCES, V9, P2847, DOI 10.5194/bg-9-2847-2012; Solaiman ZM, 2012, PLANT SOIL, V353, P273, DOI 10.1007/s11104-011-1031-4; Soos V, 2012, NEW PHYTOL, V196, P1060, DOI 10.1111/j.1469-8137.2012.04358.x; Spokas KA, 2012, J ENVIRON QUAL, V41, P973, DOI 10.2134/jeq2011.0069; Spokas KA, 2010, PLANT SOIL, V333, P443, DOI 10.1007/s11104-010-0359-5; Standards Australia, 2003, 44542003 AS; van de Voorde TFJ, 2014, ECOL APPL, V24, P1167, DOI 10.1890/13-0578.1; Vanstraelen M, 2012, ANNU REV CELL DEV BI, V28, P463, DOI 10.1146/annurev-cellbio-101011-155741; Viger M, 2015, GCB BIOENERGY, V7, P658, DOI 10.1111/gcbb.12182; Warnock DD, 2007, PLANT SOIL, V300, P9, DOI 10.1007/s11104-007-9391-5; Waters MT, 2014, PLANT J, V79, P623, DOI 10.1111/tpj.12430; Waters MT, 2013, CURR OPIN PLANT BIOL, V16, P667, DOI 10.1016/j.pbi.2013.07.005	55	36	39	4	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161234	10.1371/journal.pone.0161234	http://dx.doi.org/10.1371/journal.pone.0161234			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536995	Green Submitted, gold, Green Published			2022-12-26	WOS:000381577000073
J	Kurkewich, JL; Klopfenstein, N; Hallas, WM; Wood, C; Sattler, RA; Das, C; Tucker, H; Dahl, R; Dahl, KDC				Kurkewich, Jeffrey L.; Klopfenstein, Nathan; Hallas, William M.; Wood, Christian; Sattler, Rachel A.; Das, Chhaya; Tucker, Haley; Dahl, Richard; Dahl, Karen D. Cowden			Arid3b Is Critical for B Lymphocyte Development	PLOS ONE			English	Article							MOUSE BONE-MARROW; IN-VITRO; CELL; TRANSCRIPTION; EXPRESSION; BRIGHT; RESPONSES; DEFECTS; FAMILY; CANCER	Arid3a and Arid3b belong to a subfamily of ARID (AT-rich interaction domain) transcription factors. The Arid family is involved in regulating chromatin accessibility, proliferation, and differentiation. Arid3a and Arid3b are closely related and share a unique REKLES domain that mediates their homo- and hetero-multimerization. Arid3a was originally isolated as a B cell transcription factor binding to the AT rich matrix attachment regions (MARS) of the immunoglobulin heavy chain intronic enhancer. Deletion of Arid3a results in a highly penetrant embryonic lethality with severe defects in erythropoiesis and hematopoietic stem cells (HSCs). The few surviving Arid3a(-/-) (<1%) animals have decreased HSCs and early progenitors in the bone marrow, but all mature lineages are normally represented in the bone marrow and periphery except for B cells. Arid3b(-/-) animals die around E7.5 precluding examination of hematopoietic development. So it is unclear whether the phenotype of Arid3a loss on hematopoiesis is dependent or independent of Arid3b. In this study we circumvented this limitation by also examining hematopoiesis in mice with a conditional allele of Arid3b. Bone marrow lacking Arid3b shows decreased common lymphoid progenitors (CLPs) and downstream B cell populations while the T cell and myeloid lineages are unchanged, reminiscent of the adult hematopoietic defect in Arid3a mice. Unlike Arid3a(-/-) mice, HSC populations are unperturbed in Arid3b(-/-) mice. This study demonstrates that HSC development is independent of Arid3b, whereas B cell development requires both Arid3a and Arid3b transcription factors.	[Kurkewich, Jeffrey L.; Wood, Christian; Dahl, Richard] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Kurkewich, Jeffrey L.; Klopfenstein, Nathan; Hallas, William M.; Wood, Christian; Sattler, Rachel A.; Dahl, Richard; Dahl, Karen D. Cowden] Harper Canc Res Inst, South Bend, IN 46617 USA; [Das, Chhaya] Univ Texas Austin, Dept Mol Biosci, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Klopfenstein, Nathan; Dahl, Richard] Indiana Univ Sch Med, Dept Microbiol & Immunol, South Bend, IN 46617 USA; [Hallas, William M.; Dahl, Karen D. Cowden] Indiana Univ Sch Med, Dept Biochem & Mol Biol, South Bend, IN 46617 USA; [Sattler, Rachel A.; Dahl, Karen D. Cowden] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	University of Notre Dame; University of Texas System; University of Texas Austin; Indiana University System; Indiana University South Bend; Indiana University System; Indiana University South Bend; University of Notre Dame	Dahl, R; Dahl, KDC (corresponding author), Harper Canc Res Inst, South Bend, IN 46617 USA.; Dahl, R (corresponding author), Indiana Univ Sch Med, Dept Microbiol & Immunol, South Bend, IN 46617 USA.; Dahl, KDC (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, South Bend, IN 46617 USA.; Dahl, KDC (corresponding author), Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA.	richdahl@iupui.edu; kcowdend@iupui.edu		Dahl, Richard/0000-0002-6341-5604	Indiana Clinical Translational Sciences Institute; National Institute of Health (NIH.gov); Cancer Prevention Research Institute of Texas	Indiana Clinical Translational Sciences Institute; National Institute of Health (NIH.gov); Cancer Prevention Research Institute of Texas	This work was supported by the Indiana Clinical Translational Sciences Institute (https://www. indianactsi.org/funding/all-ctsi-funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was also supported by the National Institute of Health (NIH.gov) and Cancer Prevention Research Institute of Texas (http://www.cprit.state.tx.us/).	Bobbs A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131961; Casanova JC, 2011, DEVELOPMENT, V138, P1195, DOI 10.1242/dev.057570; Cho SK, 1999, P NATL ACAD SCI USA, V96, P9797, DOI 10.1073/pnas.96.17.9797; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Feng Biao, 2004, Med Immunol, V3, P1, DOI 10.1186/1476-9433-3-1; GRONOWICZ ES, 1980, J IMMUNOL, V125, P976; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Herrscher RF, 1995, GENE DEV, V9, P3067, DOI 10.1101/gad.9.24.3067; Inlay MA, 2009, GENE DEV, V23, P2376, DOI 10.1101/gad.1836009; Jackson JT, 2015, BLOOD, V125, P803, DOI 10.1182/blood-2014-06-579813; Joseph S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042159; Kim D, 2006, MOL CELL BIOL, V26, P2187, DOI 10.1128/MCB.26.6.2187-2201.2006; Kim D, 2007, J BIOL CHEM, V282, P15768, DOI 10.1074/jbc.M700397200; Kim U, 2000, J IMMUNOL, V165, P6825, DOI 10.4049/jimmunol.165.12.6825; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Lin C, 2014, ONCOTARGETS THER, V7, P315, DOI 10.2147/OTT.S57023; Lin DJ, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-23; Oldham AL, 2011, MOL IMMUNOL, V49, P367, DOI 10.1016/j.molimm.2011.09.008; Ratliff ML, 2015, J IMMUNOL, V194, P940, DOI 10.4049/jimmunol.1401941; Roy L, 2014, ONCOTARGET, V5, P8355, DOI 10.18632/oncotarget.2247; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Srivastava B, 2005, J EXP MED, V202, P1225, DOI 10.1084/jem.20051038; Takebe A, 2006, DEV BIOL, V293, P25, DOI 10.1016/j.ydbio.2005.12.016; Uribe V, 2014, DEVELOPMENT, V141, P4168, DOI 10.1242/dev.109918; Webb CF, 2011, MOL CELL BIOL, V31, P1041, DOI 10.1128/MCB.01448-10; Webb CF, 1998, J IMMUNOL, V160, P4747; Wheat JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105557; Witt CM, 2003, J IMMUNOL, V171, P2783, DOI 10.4049/jimmunol.171.6.2783; Zong RT, 2000, EMBO J, V19, P4123, DOI 10.1093/emboj/19.15.4123	30	7	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0161468	10.1371/journal.pone.0161468	http://dx.doi.org/10.1371/journal.pone.0161468			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27537840	Green Published, gold			2022-12-26	WOS:000381577000109
J	Luo, FQ; Hu, Y; Zhao, WL; Zuo, ZY; Yu, Q; Liu, ZY; Lin, JM; Feng, YL; Li, BD; Wu, LQ; Xu, L				Luo, Foquan; Hu, Yan; Zhao, Weilu; Zuo, Zhiyi; Yu, Qi; Liu, Zhiyi; Lin, Jiamei; Feng, Yunlin; Li, Binda; Wu, Liuqin; Xu, Lin			Maternal Exposure of Rats to Isoflurane during Late Pregnancy Impairs Spatial Learning and Memory in the Offspring by Up-Regulating the Expression of Histone Deacetylase 2	PLOS ONE			English	Article							INDUCED CASPASE-3 ACTIVATION; LONG-TERM-MEMORY; SYNAPTIC PLASTICITY; LAPAROSCOPIC CHOLECYSTECTOMY; ANESTHETIC ISOFLURANE; POSTNATAL MEMORY; FEAR EXTINCTION; 3RD TRIMESTER; NITROUS-OXIDE; NEURONS	Increasing evidence indicates that most general anesthetics can harm developing neurons and induce cognitive dysfunction in a dose-and time-dependent manner. Histone deacetylase 2 (HDAC2) has been implicated in synaptic plasticity and learning and memory. Our previous results showed that maternal exposure to general anesthetics during late pregnancy impaired the offspring's learning and memory, but the role of HDAC2 in it is not known yet. In the present study, pregnant rats were exposed to 1.5% isoflurane in 100% oxygen for 2, 4 or 8 hours or to 100% oxygen only for 8 hours on gestation day 18 (E18). The offspring born to each rat were randomly subdivided into 2 subgroups. Thirty days after birth, the Morris water maze (MWM) was used to assess learning and memory in the offspring. Two hours before each MWM trial, an HDAC inhibitor (SAHA) was given to the offspring in one subgroup, whereas a control solvent was given to those in the other subgroup. The results showed that maternal exposure to isoflurane impaired learning and memory of the offspring, impaired the structure of the hippocampus, increased HDAC2 mRNA and downregulated cyclic adenosine monophosphate (cAMP) response element binding protein (CREB) mRNA, N-methyl-D-aspartate receptor 2 subunit B (NR2B) mRNA and NR2B protein in the hippocampus. These changes were proportional to the duration of the maternal exposure to isoflurane and were reversed by SAHA. These results suggest that exposure to isoflurane during late pregnancy can damage the learning and memory of the offspring rats via the HDAC2-CREB -NR2B pathway. This effect can be reversed by HDAC2 inhibition.	[Luo, Foquan; Hu, Yan; Zhao, Weilu; Yu, Qi; Liu, Zhiyi; Lin, Jiamei; Feng, Yunlin; Xu, Lin] Nanchang Univ, Affiliated Hosp 1, Dept Anesthesiol, Nanchang 33006, Peoples R China; [Hu, Yan] Jiangxi Prov Tradit Chinese Med Hosp, Dept Anesthesiol, Nanchang 33006, Peoples R China; [Zuo, Zhiyi] Univ Virginia, Dept Anesthesiol, Charlottesville, VA 22908 USA; [Li, Binda; Wu, Liuqin] Jiangxi Prov Tumor Hosp, Dept Anesthesiol, Nanchang 330006, Peoples R China	Nanchang University; Jiangxi University of Traditional Chinese Medicine; Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine; University of Virginia	Luo, FQ (corresponding author), Nanchang Univ, Affiliated Hosp 1, Dept Anesthesiol, Nanchang 33006, Peoples R China.	lfqjxmc@outlook.com	Zuo, Zhiyi/F-3950-2010	Zuo, Zhiyi/0000-0002-3542-5047; Luo, Foquan/0000-0003-0106-0710	national natural science foundation of China [81460175, 81060093]; natural science foundation of Jiangxi province of China [20122BAB205012, 20132BAB205022]	national natural science foundation of China(National Natural Science Foundation of China (NSFC)); natural science foundation of Jiangxi province of China(Natural Science Foundation of Jiangxi Province)	FL received the funding from the national natural science foundation of China (NO. 81460175, NO. 81060093), http://www.nsfc.gov.cn/; from the natural science foundation of Jiangxi province of China (NO. 20122BAB205012, NO. 20132BAB205022), http://www.jxstc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affleck DG, 1999, AM J SURG, V178, P523, DOI 10.1016/S0002-9610(99)00244-5; Almeida S, 2010, NEUROTOX RES, V17, P399, DOI 10.1007/s12640-009-9116-z; Baldwin EA, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.09.001; Bambah-Mukku D, 2014, J NEUROSCI, V34, P12547, DOI 10.1523/JNEUROSCI.0324-14.2014; Barraco RD, 2010, J TRAUMA, V69, P211, DOI 10.1097/TA.0b013e3181dbe1ea; Bliss TVP, 1999, NATURE, V401, P25, DOI 10.1038/43333; Bowers ME, 2015, LEARN MEMORY, V22, P225, DOI 10.1101/lm.036699.114; BRODSKY JB, 1980, AM J OBSTET GYNECOL, V138, P1165, DOI 10.1016/S0002-9378(16)32785-5; Buser KB, 2009, JSLS-J SOC LAPAROEND, V13, P32; Choi JJ, 2011, J AM COLL SURGEONS, V213, P627, DOI 10.1016/j.jamcollsurg.2011.07.016; De Velde MV, 2007, MINERVA ANESTESIOL, V73, P235; Fass DM, 2013, NEUROPHARMACOLOGY, V64, P81, DOI 10.1016/j.neuropharm.2012.06.043; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Fujita Y, 2012, J PSYCHIATR RES, V46, P635, DOI 10.1016/j.jpsychires.2012.01.026; Gandal MJ, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.69; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Guan ZH, 2002, CELL, V111, P483, DOI 10.1016/S0092-8674(02)01074-7; Haettig J, 2011, LEARN MEMORY, V18, P71, DOI 10.1101/lm.1986911; Hofacer RD, 2013, ANN NEUROL, V73, P695, DOI 10.1002/ana.23892; Holthausen UH, 1999, WORLD J SURG, V23, P856, DOI 10.1007/s002689900589; Jevtovic-Todorovic V, 2003, NEUROSCIENCE, V122, P609, DOI 10.1016/j.neuroscience.2003.07.012; Kong FJ, 2011, EUR J PHARMACOL, V670, P168, DOI 10.1016/j.ejphar.2011.08.050; KORT B, 1993, SURG GYNECOL OBSTET, V177, P371; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; [李兵达 Li Bingda], 2012, [中华麻醉学杂志, Chinese Journal of Anesthesiology], V32, P1334; Li YJ, 2007, NEUROPHARMACOLOGY, V53, P942, DOI 10.1016/j.neuropharm.2007.09.005; Machado NO, 2009, SURG LAPARO ENDO PER, V19, P439, DOI 10.1097/SLE.0b013e3181c30fed; Maddox SA, 2011, LEARN MEMORY, V18, P579, DOI 10.1101/lm.2243411; Mahgoub M, 2014, LEARN MEMORY, V21, P564, DOI 10.1101/lm.036012.114; MAZZE RI, 1986, ANESTHESIOLOGY, V64, P339, DOI 10.1097/00000542-198603000-00007; MAZZE RI, 1985, ANESTHESIOLOGY, V62, P339, DOI 10.1097/00000542-198503000-00021; MAZZE RI, 1989, AM J OBSTET GYNECOL, V161, P1178, DOI 10.1016/0002-9378(89)90659-5; Meshikhes AWN, 2008, SAUDI MED J, V29, P291; Morris MJ, 2013, J NEUROSCI, V33, P6401, DOI 10.1523/JNEUROSCI.1001-12.2013; Palanisamy A, 2011, ANESTHESIOLOGY, V114, P521, DOI 10.1097/ALN.0b013e318209aa71; Pan CX, 2011, ANESTH ANALG, V113, P145, DOI 10.1213/ANE.0b013e3182185fee; Penney J, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.aaa0069; Plattner F, 2014, NEURON, V81, P1070, DOI 10.1016/j.neuron.2014.01.022; Qaiser R, 2007, SEMIN NEUROL, V27, P476, DOI 10.1055/s-2007-991129; RODIER PM, 1980, DEV MED CHILD NEUROL, V22, P525; Rohan D, 2005, CAN J ANAESTH, V52, P137, DOI 10.1007/BF03027718; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Sun YX, 2014, ANESTH ANALG, V119, P1373, DOI 10.1213/ANE.0000000000000383; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Upadhyay A, 2007, SURG ENDOSC, V21, P1344, DOI 10.1007/s00464-006-9104-9; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Wagner FF, 2015, CHEM SCI, V6, P804, DOI 10.1039/c4sc02130d; Wang C, 2004, NEUROSCIENCE, V125, P473, DOI 10.1016/j.neuroscience.2004.02.003; Wang SP, 2009, PEDIATR RES, V66, P435, DOI 10.1203/PDR.0b013e3181b3381b; Wei HF, 2005, BRAIN RES, V1037, P139, DOI 10.1016/j.brainres.2005.01.009; Wei HF, 2008, ANESTHESIOLOGY, V108, P251, DOI 10.1097/01.anes.0000299435.59242.0e; Wei HF, 2011, ANESTH ANALG, V113, P972, DOI 10.1213/ANE.0b013e3182323261; [张勤 Zhang Qin], 2014, [中华麻醉学杂志, Chinese Journal of Anesthesiology], V34, P1051; Zhao TY, 2014, NEUROBIOL DIS, V68, P145, DOI 10.1016/j.nbd.2014.02.009; Zhao XL, 2013, ANESTHESIOLOGY, V118, P537, DOI 10.1097/ALN.0b013e3182833fae; Zhong T, 2014, BRIT J ANAESTH, V113, P634, DOI 10.1093/bja/aeu184; Zhong T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125815	58	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2016	11	8							e0160826	10.1371/journal.pone.0160826	http://dx.doi.org/10.1371/journal.pone.0160826			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT6ES	27536989	gold, Green Submitted, Green Published			2022-12-26	WOS:000381577000033
J	Vattimo, MDF; Watanabe, M; da Fonseca, CD; Neiva, LBDM; Pessoa, EA; Borges, FT				Fernandes Vattimo, Maria de Fatima; Watanabe, Mirian; da Fonseca, Cassiane Dezoti; de Moura Neiva, Luciana Barros; Pessoa, Edson Andrade; Borges, Fernanda Teixeira			Polymyxin B Nephrotoxicity: From Organ to Cell Damage	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; CYTOCHROME-C; APOPTOSIS; COLISTIN; MITOCHONDRIA; OLD; ISCHEMIA/REPERFUSION; PHARMACOKINETICS; TOXICITY; STRESS	Polymyxins have a long history of dose-limiting toxicity, but the underlying mechanism of polymyxin B-induced nephrotoxicity is unclear. This study investigated the link between the nephrotoxic effects of polymyxin B on renal metabolic functions and mitochondrial morphology in rats and on the structural integrity of LLC-PK1 cells. Fifteen Wistar rats were divided into two groups: Saline group, rats received 3 mL/kg of 0.9% NaCl intraperitoneally (i.p.) once a day for 5 days; Polymyxin B group, rats received 4 mg/kg/day of polymyxin B i.p. once a day for 5 days. Renal function, renal hemodynamics, oxidative stress, mitochondrial injury and histological characteristics were assessed. Cell membrane damage was evaluated via lactate dehydrogenase and nitric oxide levels, cell viability, and apoptosis in cells exposed to 12.5 mu M, 75 mu M and 375 mu M polymyxin B. Polymyxin B was immunolocated using Lissamine rhodamine-polymyxin B in LLC-PK1 cells. Polymyxin B administration in rats reduced creatinine clearance and increased renal vascular resistance and oxidative damage. Mitochondrial damage was confirmed by electron microscopy and cytosolic localization of cytochrome c. Histological analysis revealed tubular dilatation and necrosis in the renal cortex. The reduction in cell viability and the increase in apoptosis, lactate dehydrogenase levels and nitric oxide levels confirmed the cytotoxicity of polymyxin B. The incubation of LLC-PK1 cells resulted in mitochondrial localization of polymyxin B. This study demonstrates that polymyxin B nephrotoxicity is characterized by mitochondrial dysfunction and free radical generation in both LLC-PK1 cells and rat kidneys. These data also provide support for clinical studies on the side effects of polymyxin B.	[Fernandes Vattimo, Maria de Fatima; Watanabe, Mirian; da Fonseca, Cassiane Dezoti; de Moura Neiva, Luciana Barros] Univ Sao Paulo, Sch Nursing, LEMA, Sao Paulo, Brazil; [Pessoa, Edson Andrade; Borges, Fernanda Teixeira] Univ Fed Sao Paulo, Div Nephrol, Sao Paulo, Brazil; [de Moura Neiva, Luciana Barros] Eneas Carvalho de Aguiar Ave 419, BR-05403000 Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	da Fonseca, CD (corresponding author), Univ Sao Paulo, Sch Nursing, LEMA, Sao Paulo, Brazil.	cassianedezoti@usp.br	Borges, Fernanda Teixeira/Y-3439-2018; fonseca, cassiane/ABB-2703-2021; Watanabe, Mirian/J-2384-2012; da Fonseca, Cassiane Dezoti/I-5648-2013; Vattimo, MariaFatima/D-7716-2012	Borges, Fernanda Teixeira/0000-0002-9790-0915; fonseca, cassiane/0000-0002-2118-8562; Watanabe, Mirian/0000-0003-4264-3744; da Fonseca, Cassiane Dezoti/0000-0002-2118-8562; Vattimo, MariaFatima/0000-0002-7036-5676	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo;  [2013/26560-2];  [2011/24028-6]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); ; 	Financial support for this study was provided by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo. MFFV is a recipient of a grant (2013/26560-2 and 2011/24028-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelraouf K, 2014, ANTIMICROB AGENTS CH, V58, P4200, DOI 10.1128/AAC.02557-14; Abdelraouf K, 2012, ANTIMICROB AGENTS CH, V56, P5724, DOI 10.1128/AAC.01333-12; Abdelraouf K, 2012, ANTIMICROB AGENTS CH, V56, P4625, DOI 10.1128/AAC.00280-12; AEBI H, 1984, METHOD ENZYMOL, V105, P121; Agarwal A, 2016, J AM SOC NEPHROL, V27, P1288, DOI 10.1681/ASN.2015070740; Akajagbor DS, 2013, CLIN INFECT DIS, V57, P1300, DOI 10.1093/cid/cit453; Akerboom T P, 1981, Methods Enzymol, V77, P373; American Veterinary Medical Association, AVMA GUID EUTH 2013; Andrades ME, 2011, CRIT CARE, V15, DOI 10.1186/cc10334; Arnold TM, 2007, AM J HEALTH-SYST PH, V64, P819, DOI 10.2146/ajhp060473; Azad MAK, 2015, ANTIMICROB AGENTS CH, V59, P2136, DOI 10.1128/AAC.04869-14; Azad MAK, 2013, ANTIMICROB AGENTS CH, V57, P4329, DOI 10.1128/AAC.02587-12; Bergen PJ, 2012, DIAGN MICR INFEC DIS, V74, P213, DOI 10.1016/j.diagmicrobio.2012.07.010; Beuge JA, 1978, METHOD ENZYMOL, V52, P306; Borges AA, 2015, NUTR NEUROSCI, V18, P265, DOI 10.1179/1476830514Y.0000000125; Borutaite V, 2001, BBA-MOL BASIS DIS, V1537, P101, DOI 10.1016/S0925-4439(01)00062-X; DANNER RL, 1989, ANTIMICROB AGENTS CH, V33, P1428, DOI 10.1128/AAC.33.9.1428; Dorea EL, 1997, J AM SOC NEPHROL, V8, P1415; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Falagas ME, 2006, CRIT CARE, V10, DOI 10.1186/cc3995; Fernandes SM, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/3019410; FILATOV MV, 1995, MUTAT RES-FUND MOL M, V327, P209, DOI 10.1016/0027-5107(94)00189-C; Fonseca CD, 2012, ANTIMICROB AGENTS CH, V56, P5082, DOI 10.1128/AAC.00925-12; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Hall AM, 2013, KIDNEY INT, V83, P72, DOI 10.1038/ki.2012.328; Halliwell B, 2004, CURR MED CHEM, V11, P1085, DOI 10.2174/0929867043365404; Havasi A, 2011, KIDNEY INT, V80, P29, DOI 10.1038/ki.2011.120; Jassem W, 2004, KIDNEY INT, V66, P514, DOI 10.1111/j.1523-1755.2004.761_9.x; Johnson-Lyles DN, 2010, TOXICOL APPL PHARM, V248, P249, DOI 10.1016/j.taap.2010.08.008; Kasiakou SK, 2005, ANTIMICROB AGENTS CH, V49, P3136, DOI 10.1128/AAC.49.8.3136-3146.2005; Kubin CJ, 2012, J INFECTION, V65, P80, DOI 10.1016/j.jinf.2012.01.015; Kvitko CH, 2011, J ANTIMICROB CHEMOTH, V66, P175, DOI 10.1093/jac/dkq390; Markowitz GS, 2005, CLIN CHIM ACTA, V351, P31, DOI 10.1016/j.cccn.2004.09.005; Molitoris BA, 2006, ADV DRUG DELIVER REV, V58, P809, DOI 10.1016/j.addr.2006.07.017; Moncada S, 2002, NAT REV MOL CELL BIO, V3, P214, DOI 10.1038/nrm762; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nielsen R, 1998, J AM SOC NEPHROL, V9, P1767; Ozyilmaz E, 2011, INTENS CARE MED, V37, P141, DOI 10.1007/s00134-010-2038-7; Perazella MA, 2009, CLIN J AM SOC NEPHRO, V4, P1275, DOI 10.2215/CJN.02050309; Plotnikov EY, 2007, KIDNEY INT, V72, P1493, DOI 10.1038/sj.ki.5002568; Pogue JM, 2011, CLIN INFECT DIS, V53, P879, DOI 10.1093/cid/cir611; Schetz M, 2005, CURR OPIN CRIT CARE, V11, P555, DOI 10.1097/01.ccx.0000184300.68383.95; SHIH W, 1988, KIDNEY INT, V33, P1113, DOI 10.1038/ki.1988.119; Small DM, 2012, EXPERT OPIN DRUG MET, V8, P655, DOI 10.1517/17425255.2012.679657; Velkov T, 2013, FUTURE MICROBIOL, V8, P711, DOI [10.2217/FMB.13.39, 10.2217/fmb.13.39]; Velkov T, 2010, J MED CHEM, V53, P1898, DOI 10.1021/jm900999h; Yousef JM, 2012, J ANTIMICROB CHEMOTH, V67, P452, DOI 10.1093/jac/dkr483; Yousef JM, 2011, ANTIMICROB AGENTS CH, V55, P4044, DOI 10.1128/AAC.00328-11; Yu WM, 2007, AM J PHYSIOL-RENAL, V292, pF1873, DOI 10.1152/ajprenal.00218.2006; Yun B, 2015, J ANTIMICROB CHEMOTH, V70, P827, DOI 10.1093/jac/dku441; Zavascki AP, 2007, J ANTIMICROB CHEMOTH, V60, P1206, DOI 10.1093/jac/dkm357	51	37	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0161057	10.1371/journal.pone.0161057	http://dx.doi.org/10.1371/journal.pone.0161057			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532263	Green Submitted, gold, Green Published			2022-12-26	WOS:000381487600057
J	Li, XK; Liao, HF; Fan, CF; Hu, HZ; Li, Y; Li, J; Yi, ZL; Cai, XW; Peng, LC; Tu, YY				Li, Xukai; Liao, Haofeng; Fan, Chunfen; Hu, Huizhen; Li, Ying; Li, Jing; Yi, Zili; Cai, Xiwen; Peng, Liangcai; Tu, Yuanyuan			Distinct Geographical Distribution of the Miscanthus Accessions with Varied Biomass Enzymatic Saccharification	PLOS ONE			English	Article							ENERGY CROPS; LIGNIN; PRETREATMENTS; DIGESTIBILITY; GRASSES	Miscanthus is a leading bioenergy candidate for biofuels, and it thus becomes essential to characterize the desire natural Miscanthus germplasm accessions with high biomass saccharification. In this study, total 171 natural Miscanthus accessions were geographically mapped using public database. According to the equation [P(H/L vertical bar East) = P(H/L boolean AND East)/P (East)], the probability (P) parameters were calculated on relationships between geographical distributions of Miscanthus accessions in the East of China, and related factors with high(H) or low(L) values including biomass saccahrification under 1% NaOH and 1% H2SO4 pretreatments, lignocellulose features and climate conditions. Based on the maximum P value, a golden cutting line was generated from 42 degrees 25'N, 108 degrees 22'E to 22 degrees 58'N, 116 inverted perpendicular 28'E on the original locations of Miscanthus accessions with high P(H vertical bar East) values (0.800-0.813), indicating that more than 90% Miscanthus accessions were originally located in the East with high biomass saccharification. Furthermore, the averaged insolation showed high P (H broken vertical bar East) and P(East vertical bar H) values at 0.782 and 0.754, whereas other climate factors had low P(East vertical bar H) values, suggesting that the averaged insolation is unique factor on Miscanthus distributions for biomass saccharification. In terms of cell wall compositions and wall polymer features, both hemicelluloses level and cellulose crystallinity (CrI) of Miscanthus accessions exhibited relative high P values, suggesting that they should be the major factors accounting for geographic distributions of Miscanthus accessions with high biomass digestibility.	[Li, Xukai; Liao, Haofeng; Fan, Chunfen; Hu, Huizhen; Li, Ying; Peng, Liangcai; Tu, Yuanyuan] Huazhong Agr Univ, Biomass & Bioenergy Res Ctr, Wuhan, Peoples R China; [Li, Xukai; Liao, Haofeng; Fan, Chunfen; Hu, Huizhen; Li, Ying; Peng, Liangcai; Tu, Yuanyuan] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Li, Xukai; Liao, Haofeng; Fan, Chunfen; Hu, Huizhen; Li, Ying; Li, Jing; Peng, Liangcai; Tu, Yuanyuan] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China; [Yi, Zili] Hunan Agr Univ, Dept Biotechnol, Changsha, Hunan, Peoples R China; [Cai, Xiwen] North Dakota State Univ, Dept Plant Sci, Fargo, ND 58105 USA	Huazhong Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University; Hunan Agricultural University; North Dakota State University Fargo	Tu, YY (corresponding author), Huazhong Agr Univ, Biomass & Bioenergy Res Ctr, Wuhan, Peoples R China.; Tu, YY (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.; Tu, YY (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China.	yuant@mail.hzau.edu.cn	李, 旭凯/AAJ-5266-2020	李, 旭凯/0000-0001-7248-1331; Cai, Xiwen/0000-0002-3937-1074	Fundamental Research Funds for the Central Universities of China [2662015PY018]; National 111 Project [B08032]; National 973 Pre-project [2010CB134401]	Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); National 111 Project; National 973 Pre-project(National Basic Research Program of China)	This work was supported in part by grants from the Fundamental Research Funds for the Central Universities of China (Program No. 2662015PY018), the National 111 Project (B08032) and the National 973 Pre-project (2010CB134401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Kai Guo, Qingchun Pan and Guosheng Xie for very helpful comments and discussion on the manuscript. This work was supported in part by grants from the Fundamental Research Funds for the Central Universities of China (Program No. 2662015PY018), the National 111 Project (B08032) and the National 973 Pre-project (2010CB134401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini LG, 2009, BIOMASS BIOENERG, V33, P635, DOI 10.1016/j.biombioe.2008.10.005; Chang VS, 2000, APPL BIOCHEM BIOTECH, V84-6, P5, DOI 10.1385/ABAB:84-86:1-9:5; Chen F, 2007, NAT BIOTECHNOL, V25, P759, DOI 10.1038/nbt1316; Clark LV, 2014, ANN BOT-LONDON, V114, P97, DOI 10.1093/aob/mcu084; Clifton-Brown JC, 2001, AGRON J, V93, P1013, DOI 10.2134/agronj2001.9351013x; Fry S. C, 1988, GROWING PLANT CELL W, DOI DOI 10.1016/0031-9422(88)83079-6; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Huang JF, 2012, BIORESOURCE TECHNOL, V121, P274, DOI 10.1016/j.biortech.2012.06.015; Jakob K, 2009, IN VITRO CELL DEV-PL, V45, P291, DOI 10.1007/s11627-009-9214-x; Jin WX, 2016, APPL ENERG, V175, P82, DOI 10.1016/j.apenergy.2016.04.104; Lewandowski I, 2000, BIOMASS BIOENERG, V19, P209, DOI 10.1016/S0961-9534(00)00032-5; Lewandowski I, 2003, BIOMASS BIOENERG, V25, P335, DOI 10.1016/S0961-9534(03)00030-8; Li FC, 2013, BIORESOURCE TECHNOL, V130, P629, DOI 10.1016/j.biortech.2012.12.107; Li ZL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103633; Melligan F, CHARACTERISATION PRO, P258; NASA, 2014, SURF MET SOL EN REN; Peng LC, 2000, PLANTA, V211, P406, DOI 10.1007/s004250000301; PURI VP, 1984, BIOTECHNOL BIOENG, V26, P1219, DOI 10.1002/bit.260261010; Sang T, 2011, GCB BIOENERGY, V3, P79, DOI 10.1111/j.1757-1707.2010.01064.x; Si SL, 2015, BIORESOURCE TECHNOL, V183, P248, DOI 10.1016/j.biortech.2015.02.031; Simmons BA, 2010, CURR OPIN PLANT BIOL, V13, P313, DOI 10.1016/j.pbi.2010.03.001; 정지훈, 2012, Journal of Crop Science and Biotechnology, V15, P65, DOI 10.1007/s12892-012-0023-0; Sun HY, 2013, BIOCHEM BIOPH RES CO, V430, P1151, DOI 10.1016/j.bbrc.2012.12.019; Xie GS, 2011, J INTEGR PLANT BIOL, V53, P143, DOI 10.1111/j.1744-7909.2010.01022.x; Xu N, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-58; Zhang W, 2013, BIORESOURCE TECHNOL, V130, P30, DOI 10.1016/j.biortech.2012.12.029; Zhao H, 2014, GCB BIOENERGY, V6, P768, DOI 10.1111/gcbb.12115	27	152	158	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160026	10.1371/journal.pone.0160026	http://dx.doi.org/10.1371/journal.pone.0160026			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532636	Green Published, gold, Green Submitted			2022-12-26	WOS:000381487600021
J	Liao, XL; Zhao, JJ; Jiao, C; Lei, L; Qiang, Y; Cui, Q				Liao, Xiaolei; Zhao, Juanjuan; Jiao, Cheng; Lei, Lei; Qiang, Yan; Cui, Qiang			A Segmentation Method for Lung Parenchyma Image Sequences Based on Superpixels and a Self-Generating Neural Forest	PLOS ONE			English	Article							CT; ALGORITHM; NETWORKS; NODULES	Background Lung parenchyma segmentation is often performed as an important pre-processing step in the computer-aided diagnosis of lung nodules based on CT image sequences. However, existing lung parenchyma image segmentation methods cannot fully segment all lung parenchyma images and have a slow processing speed, particularly for images in the top and bottom of the lung and the images that contain lung nodules. Method Our proposed method first uses the position of the lung parenchyma image features to obtain lung parenchyma ROI image sequences. A gradient and sequential linear iterative clustering algorithm (GSLIC) for sequence image segmentation is then proposed to segment the ROI image sequences and obtain superpixel samples. The SGNF, which is optimized by a genetic algorithm (GA), is then utilized for superpixel clustering. Finally, the grey and geometric features of the superpixel samples are used to identify and segment all of the lung parenchyma image sequences. Results Our proposed method achieves higher segmentation precision and greater accuracy in less time. It has an average processing time of 42.21 seconds for each dataset and an average volume pixel overlap ratio of 92.22 +/- 4.02% for four types of lung parenchyma image sequences.	[Liao, Xiaolei; Zhao, Juanjuan; Lei, Lei; Qiang, Yan; Cui, Qiang] Taiyuan Univ Technol, Coll Comp Sci & Technol, Taiyuan 030024, Peoples R China; [Jiao, Cheng] Shanxi Coal Cent Hosp, PET CT Ctr, Taiyuan 030024, Shanxi, Peoples R China	Taiyuan University of Technology	Qiang, Y (corresponding author), Taiyuan Univ Technol, Coll Comp Sci & Technol, Taiyuan 030024, Peoples R China.	2304700796@qq.com			National Natural Science Foundation of China [61373100, 61540007]; National Key Laboratory Open Foundation of China [BUAA-VR-15KF02, BUAA-VR-16KF13]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Laboratory Open Foundation of China	The work is supported by the National Natural Science Foundation of China (61373100, 61540007) and the National Key Laboratory Open Foundation of China (BUAA-VR-15KF02, BUAA-VR-16KF13).	Bellotti R, 2007, MED PHYS, V34, P4901, DOI 10.1118/1.2804720; Dehmeshi J, 2008, IEEE T MED IMAGING, V27, P467, DOI 10.1109/TMI.2007.907555; Dehmeshki J, 2007, COMPUT MED IMAG GRAP, V31, P408, DOI 10.1016/j.compmedimag.2007.03.002; Feng S, 2010, NEUR NETW IJCNN 2010, P1; Geng H, 2014, INT CONTR AUT WCICA, P5626; Hammoudi AA, 2011, LECT NOTES COMPUT SC, V7009, P317, DOI 10.1007/978-3-642-24319-6_39; Hsieh Jiang, 2009, COMPUTED TOMOGRAPHY; Inoue H, 2003, MATH COMPUT MODEL, V38, P1225, DOI 10.1016/S0895-7177(03)00335-2; Inoue H., 2003, J SYSTEMIC CYBERNETI, V1, P72; Khan A, 2015, APPL SOFT COMPUT, V32, P300, DOI 10.1016/j.asoc.2015.03.029; Law TY, 2000, PROC SPIE, V3979, P906, DOI 10.1117/12.387756; Li CM, 2011, IEEE T IMAGE PROCESS, V20, P2007, DOI 10.1109/TIP.2011.2146190; Liming D, 2011, 2011 INT C CONS EL C, P976; Lucchi A, 2010, LECT NOTES COMPUT SC, V6362, P463; Mansoor A, 2014, IEEE ENG MED BIO, P6032, DOI 10.1109/EMBC.2014.6945004; Masoumi H, 2012, BIOMED SIGNAL PROCES, V7, P429, DOI 10.1016/j.bspc.2012.01.002; Meila M, 2003, LECT NOTES ARTIF INT, V2777, P173, DOI 10.1007/978-3-540-45167-9_14; Prastawa M, 2004, MED IMAGE ANAL, V8, P275, DOI 10.1016/j.media.2004.06.007; Ren XF, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P10; Saghir Z, 2012, THORAX, V67, P296, DOI 10.1136/thoraxjnl-2011-200736; Shojaii R, 2007, INT CONF ACOUST SPEE, P1217; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Song YY, 2014, J MED IMAG HEALTH IN, V4, P781, DOI 10.1166/jmihi.2014.1320; Unnikrishnan R, 2005, WACV 2005: SEVENTH IEEE WORKSHOP ON APPLICATIONS OF COMPUTER VISION, PROCEEDINGS, P394; Wang J, 2012, IEEE T PATTERN ANAL, V34, P1241, DOI 10.1109/TPAMI.2012.47; Wen W. X., 1992, IJCNN International Joint Conference on Neural Networks (Cat. No.92CH3114-6), P850, DOI 10.1109/IJCNN.1992.227211; Xi-ping Luo, 2002, Journal of Software, V13, P1050; Yan-hua R, 2010, INF NETW AUT ICINA 2, V2, pV2; Yu N, 2015, SPIE MED IMAGING; Zhao JJ, 2015, INT J BIO-INSPIR COM, V7, P62, DOI 10.1504/IJBIC.2015.067999; Zhao JJ, 2016, FRONT COMPUT SCI-CHI, V10, P189, DOI 10.1007/s11704-015-4543-x; Zhao JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123694	32	13	16	5	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2016	11	8							e0160556	10.1371/journal.pone.0160556	http://dx.doi.org/10.1371/journal.pone.0160556			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YN	27532214	Green Published, gold, Green Submitted			2022-12-26	WOS:000381487600036
J	Neuville, M; Hustinx, R; Jacques, J; Krzesinski, JM; Jouret, F				Neuville, Marie; Hustinx, Roland; Jacques, Jessica; Krzesinski, Jean-Marie; Jouret, Francois			Diagnostic Algorithm in the Management of Acute Febrile Abdomen in Patients with Autosomal Dominant Polycystic Kidney Disease	PLOS ONE			English	Article							HEPATIC CYST INFECTION; RENAL CYSTS; PET-CT; ADPKD; TOMOGRAPHY; CRITERIA	Background Acute febrile abdomen represents a diagnostic challenge in patients with autosomal dominant polycystic kidney disease (ADPKD). Although criteria have been proposed for cyst infection (CyI) and hemorrhage (CyH), there is a lack of comparative assessments. Furthermore, distinguishing cystic from non-cystic complications remains problematic. Design ADPKD patients presenting with abdominal pain and/or fever between 01/2005 and 06/2015 were retrospectively identified in a systematic computerized billing database. CyH was defined as spontaneous intracystic density above 50 Hounsfield units on computed tomography (CT). CyI was definite if confirmed by cyst puncture, and probable if 4 criteria were met: 3-day fever, loin/liver tenderness, C-reactive protein (CRP) plasma levels > 50mg/L and no CT evidence for CyH. Other episodes were grouped as inflammation of unknown origin (IUO). Results Among a cohort of 173 ADPKD patients, 101 presented with 205 episodes of abdominal pain (n = 172) and/or fever (n = 33). 20 patients experienced 30 CyH, whereas 16 presented 23 episodes of definite (n = 11) or probable (n = 12) CyI. 35 IUO were observed in 31 patients. Clinically, fever was observed in 7% vs. 100% vs. 66% of CyH, CyI and IUO, respectively. Biologically, CRP cut-off at 70 mg/dl showed 92% sensitivity and 81% specificity in CyI diagnosis. Urine or blood cultures remained sterile in > 90% of CyH, but were contributive in 53.4% of CyI and IUO, with a 74.2% prevalence for E. coli. Radiologically, ultrasounds, CT and magnetic resonance diagnosed CyI in 2.6%, 20% and 16.7% of cases, respectively. 18F-FDG positron-emission tomography (PET)/CT was done within a median period of 7 days post antibiotics, and significantly changed patient management in 71.4%. Conclusions This retrospective single-center series underscores the usefulness of clinical-fever-and biological-CRP-parameters, but emphasizes the limitations of bacteriological and radiological investigations in cases of acute febrile abdomen in ADPKD patients. F-18-FDG-PET/CT imaging may be helpful in such condition.	[Neuville, Marie; Krzesinski, Jean-Marie; Jouret, Francois] Univ Liege Hosp ULg CHU, Dept Nephrol, Liege, Belgium; [Hustinx, Roland] Univ Liege Hosp ULg CHU, Dept Nucl Med, Liege, Belgium; [Jacques, Jessica] Univ Liege Hosp ULg CHU, Dept Medicoecon Informat, Liege, Belgium; [Krzesinski, Jean-Marie; Jouret, Francois] Univ Liege, GIGA, Cardiovasc Sci, Liege, Belgium	University of Liege; University of Liege; University of Liege; University of Liege	Jouret, F (corresponding author), Univ Liege Hosp ULg CHU, Dept Nephrol, Liege, Belgium.; Jouret, F (corresponding author), Univ Liege, GIGA, Cardiovasc Sci, Liege, Belgium.	francois.jouret@chu.ulg.ac.be		Neuville, Marie F./0000-0002-9012-5047				Akoh Jacob A, 2015, World J Nephrol, V4, P468, DOI 10.5527/wjn.v4.i4.468; Balbo BEP, 2014, BRAZ J MED BIOL RES, V47, P584, DOI 10.1590/1414-431X20143584; Bleeker-Rovers CP, 2003, AM J KIDNEY DIS, V41, DOI 10.1016/S0272-6386(03)00368-8; Bobot M, 2016, CLIN MICROBIOL INFEC, V22, P71, DOI 10.1016/j.cmi.2015.09.024; Chapman AB, 2015, KIDNEY INT, V88, P17, DOI 10.1038/ki.2015.59; Cornec-Le Gall E, 2016, J AM SOC NEPHROL, V27, P942, DOI 10.1681/ASN.2015010016; deSouza RM, 2009, TRANSPL P, V41, P1942, DOI 10.1016/j.transproceed.2008.10.102; ELZINGA LW, 1988, ANTIMICROB AGENTS CH, V32, P844, DOI 10.1128/AAC.32.6.844; FICK GM, 1995, J AM SOC NEPHROL, V5, P2048; Gans SL, 2015, DIGEST SURG, V32, P23, DOI 10.1159/000371583; Ichioka K, 2007, UROLOGY, V70, P1219, DOI 10.1016/j.urology.2007.09.040; Jouret F, 2012, NEPHROL DIAL TRANSPL, V27, P3746, DOI 10.1093/ndt/gfs352; Jouret F, 2011, CLIN J AM SOC NEPHRO, V6, P1644, DOI 10.2215/CJN.06900810; Kaim AH, 2001, RADIOLOGY, V221, P818, DOI 10.1148/radiol.2213010445; Kanaan N, 2010, AM J KIDNEY DIS, V55, P916, DOI 10.1053/j.ajkd.2009.12.023; Lantinga MA, 2015, ALIMENT PHARM THER, V41, P253, DOI 10.1111/apt.13047; Lantinga MA, 2015, CLIN NEPHROL, V84, P61, DOI 10.5414/CN108495; Lantinga MA, 2015, NEPHROL DIAL TRANSPL, V30, P744, DOI 10.1093/ndt/gfu227; Lovinfosse P, 2016, AM J TRANSPLANT, V16, P310, DOI 10.1111/ajt.13429; Meller J, 2007, J NUCL MED, V48, P35; Pei Y, 2009, J AM SOC NEPHROL, V20, P205, DOI 10.1681/ASN.2008050507; Piccoli GB, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-48; Pirson Y, 2010, ADV CHRONIC KIDNEY D, V17, P173, DOI 10.1053/j.ackd.2010.01.003; Rule AD, 2006, J AM SOC NEPHROL, V17, P854, DOI 10.1681/ASN.2005070697; Sallee M, 2009, CLIN J AM SOC NEPHRO, V4, P1183, DOI 10.2215/CJN.01870309; Schrier RW, 2014, J AM SOC NEPHROL, V25, P2399, DOI 10.1681/ASN.2013111184; Soussan M, 2008, ANN NUCL MED, V22, P529, DOI 10.1007/s12149-008-0150-3; Suwabe T, 2012, CLIN EXP NEPHROL, V16, P892, DOI 10.1007/s10157-012-0650-2; Suwabe T, 2009, NEPHRON CLIN PRACT, V112, pC157, DOI 10.1159/000214211; TELENTI A, 1990, MAYO CLIN PROC, V65, P933, DOI 10.1016/S0025-6196(12)65154-4; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Torres VE, 2011, CLIN J AM SOC NEPHRO, V6, P640, DOI 10.2215/CJN.03250410; Vaidyanathan S, 2015, CLIN RADIOL, V70, P787, DOI 10.1016/j.crad.2015.03.010	33	20	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161277	10.1371/journal.pone.0161277	http://dx.doi.org/10.1371/journal.pone.0161277			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529555	Green Published, Green Submitted, gold			2022-12-26	WOS:000381476700060
J	Otowa, T; Kawamura, Y; Tsutsumi, A; Kawakami, N; Kan, C; Shimada, T; Umekage, T; Kasai, K; Tokunaga, K; Sasaki, T				Otowa, Takeshi; Kawamura, Yoshiya; Tsutsumi, Akizumi; Kawakami, Norito; Kan, Chiemi; Shimada, Takafumi; Umekage, Tadashi; Kasai, Kiyoto; Tokunaga, Katsushi; Sasaki, Tsukasa			The First Pilot Genome-Wide Gene-Environment Study of Depression in the Japanese Population	PLOS ONE			English	Article							NATIONAL COMORBIDITY SURVEY; PROTEIN SIGNALING RGS; STRESSFUL LIFE EVENTS; MAJOR DEPRESSION; SURVEY REPLICATION; DSM-IV; ASSOCIATION; DISORDERS; ONSET; POLYMORPHISM	Stressful events have been identified as a risk factor for depression. Although gene-environment (G x E) interaction in a limited number of candidate genes has been explored, no genome-wide search has been reported. The aim of the present study is to identify genes that influence the association of stressful events with depression. Therefore, we performed a genome-wide G x E interaction analysis in the Japanese population. A genome-wide screen with 320 subjects was performed using the Affymetrix Genome-Wide Human Array 6.0. Stressful life events were assessed using the Social Readjustment Rating Scale (SRRS) and depression symptoms were assessed with self-rating questionnaires using the Center for Epidemiologic Studies Depression (CES-D) scale. The p values for interactions between single nucleotide polymorphisms (SNPs) and stressful events were calculated using the linear regression model adjusted for sex and age. After quality control of genotype data, a total of 534,848 SNPs on autosomal chromosomes were further analyzed. Although none surpassed the level of the genome-wide significance, a marginal significant association of interaction between SRRS and rs10510057 with depression were found (p = 4.5 x 10 -8). The SNP is located on 10q26 near Regulators of G-protein signaling 10 (RGS10), which encodes a regulatory molecule involved in stress response. When we investigated a similar G x E interaction between depression (K6 scale) and work-related stress in an independent sample (n = 439), a significant G x E effect on depression was observed (p = 0.015). Our findings suggest that rs10510057, interacting with stressors, may be involved in depression risk. Incorporating G x E interaction into GWAS can contribute to find susceptibility locus that are potentially missed by conventional GWAS.	[Otowa, Takeshi] Teikyo Heisei Univ Major Profess Clin Psychol, Grad Sch Clin Psychol, Tokyo, Japan; [Otowa, Takeshi; Shimada, Takafumi; Umekage, Tadashi; Kasai, Kiyoto] Univ Tokyo, Grad Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Kawamura, Yoshiya] Shonan Kamakura Gen Hosp, Dept Psychiat, Kamakura, Kanagawa, Japan; [Tsutsumi, Akizumi] Kitasato Univ, Sch Med, Dept Publ Hlth, Sagamihara, Kanagawa, Japan; [Kawakami, Norito; Kan, Chiemi] Univ Tokyo, Grad Sch Med, Dept Mental Hlth, Tokyo, Japan; [Tokunaga, Katsushi] Univ Tokyo, Grad Sch Med, Dept Human Genet, Tokyo, Japan; [Sasaki, Tsukasa] Univ Tokyo, Grad Sch Educ, Lab Hlth Educ, Tokyo, Japan	University of Tokyo; Kitasato University; University of Tokyo; University of Tokyo; University of Tokyo	Otowa, T (corresponding author), Teikyo Heisei Univ Major Profess Clin Psychol, Grad Sch Clin Psychol, Tokyo, Japan.; Otowa, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Neuropsychiat, Tokyo, Japan.	totowa-psy@umin.org		Kasai, Kiyoto/0000-0002-4443-4535	Ministry of Education, Science, Sports and Culture of Japan [17019029, 21300242, 25461723, 21119002]	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Grants-in-Aid for Scientific Research on Priority Areas "Comprehensive Genomics" and "Applied Genomics" (T. Sasaki received No. 17019029 and No. 21300242; TO received No. 25461723) and for Scientific Research on Innovative Areas; "Elucidation of social stratification mechanism and control over health inequality in contemporary Japan: New interdisciplinary area of social and health sciences" (The Project "Social Stratification and Health": AT and NK received No. 21119002) from the Ministry of Education, Science, Sports and Culture of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEBBINGTON P, 1993, BRIT J PSYCHIAT, V162, P358, DOI 10.1192/bjp.162.3.358; Berman DM, 1996, J BIOL CHEM, V271, P27209, DOI 10.1074/jbc.271.44.27209; Brown GW, 2008, J AFFECT DISORDERS, V111, P1, DOI 10.1016/j.jad.2008.04.009; BROWN GW, 1995, PSYCHOL MED, V25, P7, DOI 10.1017/S003329170002804X; BRUGHA TS, 1985, BRIT J PSYCHIAT, V147, P641, DOI 10.1192/bjp.147.6.641; Burgon PG, 2001, J BIOL CHEM, V276, P32828, DOI 10.1074/jbc.M100960200; Cantor RM, 2010, AM J HUM GENET, V86, P6, DOI 10.1016/j.ajhg.2009.11.017; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452; Dunn EC, 2015, HARVARD REV PSYCHIAT, V23, P1, DOI 10.1097/HRP.0000000000000054; Eaves LJ, 2006, TWIN RES HUM GENET, V9, P1, DOI 10.1375/183242706776403073; Ensel WM, 1996, J AGING HEALTH, V8, P389, DOI 10.1177/089826439600800305; Flint J, 2014, NEURON, V81, P484, DOI [10.1016/j.neuron.2014.02.033, 10.1016/j.neuron.2014.01.027]; Gold SJ, 1997, J NEUROSCI, V17, P8024; Green JG, 2010, ARCH GEN PSYCHIAT, V67, P113, DOI 10.1001/archgenpsychiatry.2009.186; Hek K, 2013, BIOL PSYCHIAT, V73, P667, DOI 10.1016/j.biopsych.2012.09.033; Hishimoto A, 2004, PSYCHIAT CLIN NEUROS, V58, P579, DOI 10.1111/j.1440-1819.2004.01303.x; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; Kawakami N, 2005, PSYCHIAT CLIN NEUROS, V59, P441, DOI 10.1111/j.1440-1819.2005.01397.x; Kawamura Y, 2010, J AFFECT DISORDERS, V127, P31, DOI 10.1016/j.jad.2010.04.014; Kendler KS, 1998, J NERV MENT DIS, V186, P661, DOI 10.1097/00005053-199811000-00001; Kendler KS, 2003, ARCH GEN PSYCHIAT, V60, P789, DOI 10.1001/archpsyc.60.8.789; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Kessler RC, 1997, PSYCHOL MED, V27, P1101, DOI 10.1017/S0033291797005588; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kraft P, 2007, HUM HERED, V63, P111, DOI 10.1159/000099183; Lee JK, 2012, J NEUROCHEM, V122, P333, DOI 10.1111/j.1471-4159.2012.07780.x; Lewis CM, 2010, AM J PSYCHIAT, V167, P949, DOI 10.1176/appi.ajp.2010.09091380; Lopez-Leon S, 2008, MOL PSYCHIATR, V13, P772, DOI 10.1038/sj.mp.4002088; Menke A, 2014, DIALOGUES CLIN NEURO, V16, P395; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Narahara M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100924; Nugent NR, 2011, PSYCHOPHARMACOLOGY, V214, P175, DOI 10.1007/s00213-010-2151-x; Pinheiro AP, 2010, AM J MED GENET B, V153B, P1070, DOI 10.1002/ajmg.b.31082; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Renzaho AMN, 2014, EUR J PUBLIC HEALTH, V24, P57, DOI 10.1093/eurpub/ckt007; Rivero G, 2012, NEUROPHARMACOLOGY, V62, P1044, DOI 10.1016/j.neuropharm.2011.10.015; Rojo-Moreno L, 2002, SOC PSYCH PSYCH EPID, V37, P592, DOI 10.1007/s00127-002-0595-y; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Rudolph KD, 2009, DEV PSYCHOPATHOL, V21, P1155, DOI 10.1017/S0954579409990095; Sakurai K, 2011, PSYCHIAT CLIN NEUROS, V65, P434, DOI 10.1111/j.1440-1819.2011.02236.x; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Shi J, 2011, MOL PSYCHIATR, V16, P193, DOI 10.1038/mp.2009.124; Shima S., 1985, PSYCHIATRY, V27, P717, DOI DOI 10.11477/MF.1405203967; Sullivan PF, 2009, MOL PSYCHIATR, V14, P359, DOI 10.1038/mp.2008.125; Sullivan PF, 2013, MOL PSYCHIATR, V18, P497, DOI 10.1038/mp.2012.21; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; Suzuki T, 2013, J AFFECT DISORDERS, V150, P490, DOI 10.1016/j.jad.2013.04.044; Tennant C, 2002, AUST NZ J PSYCHIAT, V36, P173, DOI 10.1046/j.1440-1614.2002.01007.x; van der Sluis S, 2013, MOL PSYCHIATR, V18, P2, DOI 10.1038/mp.2012.65; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019; ZICH JM, 1990, INT J PSYCHIAT MED, V20, P259, DOI 10.2190/LYKR-7VHP-YJEM-MKM2	54	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160823	10.1371/journal.pone.0160823	http://dx.doi.org/10.1371/journal.pone.0160823			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529621	Green Published, gold, Green Submitted			2022-12-26	WOS:000381476700025
J	Petersen, SO; Olsen, AB; Elsgaard, L; Triolo, JM; Sommer, SG				Petersen, Soren O.; Olsen, Anne B.; Elsgaard, Lars; Triolo, Jin Mi; Sommer, Sven G.			Estimation of Methane Emissions from Slurry Pits below Pig and Cattle Confinements	PLOS ONE			English	Article							NITROUS-OXIDE; CARBON-DIOXIDE; POTENTIAL BMP; MANURE; STORAGE; MANAGEMENT; FRACTIONS; DIGESTION; AMMONIA; HOUSES	Quantifying in-house emissions of methane (CH4) from liquid manure (slurry) is difficult due to high background emissions from enteric processes, yet of great importance for correct estimation of CH4 emissions from manure management and effects of treatment technologies such as anaerobic digestion. In this study CH4 production rates were determined in 20 pig slurry and 11 cattle slurry samples collected beneath slatted floors on six representative farms; rates were determined within 24 h at temperatures close to the temperature in slurry pits at the time of collection. Methane production rates in pig and cattle slurry differed significantly at 0.030 and 0.011 kg CH4 kg(-1) VS (volatile solids). Current estimates of CH4 emissions from pig and cattle manure management correspond to 0.032 and 0.015 kg CH4 kg(-1), respectively, indicating that slurry pits under animal confinements are a significant source. Fractions of degradable volatile solids (VSd, kg kg(-1) VS) were estimated using an aerobic biodegradability assay and total organic C analyses. The VSd in pig and cattle slurry averaged 0.51 and 0.33 kg kg(-1) VS, and it was estimated that on average 43 and 28% of VSd in fresh excreta from pigs and cattle, respectively, had been lost at the time of sampling. An empirical model of CH4 emissions from slurry was reparameterised based on experimental results. A sensitivity analysis indicated that predicted CH4 emissions were highly sensitive to uncertainties in the value of lnA of the Arrhenius equation, but much less sensitive to uncertainties in VSd or slurry temperature. A model application indicated that losses of carbon in VS as CO2 may be much greater than losses as CH4. Implications of these results for the correct estimation of CH4 emissions from manure management, and for the mitigation potential of treatments such as anaerobic digestion, are discussed.	[Petersen, Soren O.; Olsen, Anne B.; Elsgaard, Lars] Aarhus Univ, Dept Agroecol, Tjele, Denmark; [Triolo, Jin Mi; Sommer, Sven G.] Univ Southern Denmark, Inst Chem Engn Biotechnol & Environm Technol, Odense, Denmark	Aarhus University; University of Southern Denmark	Petersen, SO (corresponding author), Aarhus Univ, Dept Agroecol, Tjele, Denmark.	sop@agro.au.dk	Petersen, Soren O./E-9714-2016; Sommer, Sven Gjedde/AAH-6211-2020; Elsgaard, Lars/A-7698-2013	Sommer, Sven Gjedde/0000-0002-2673-0162; Elsgaard, Lars/0000-0003-0058-7609; Park Triolo, Jin Mi/0000-0002-1960-9823	Innovation Fund Denmark [12-132631]; Danish Department of Climate and Energy [Agr-2014-4734]	Innovation Fund Denmark; Danish Department of Climate and Energy	This work was supported by Innovation Fund Denmark (http://innovationsfonden.dk/en; formerly Danish Research Council for Strategic Research) through the project "Optimisation of value chains for biogas production in Denmark" coordinated by SGS (Grant No. 12-132631), and by the Danish Department of Climate and Energy (http://www.ens.dk/) through the project "Biogas Taskforce - Methane emissions from slurry pits and pretanks" coordinated by SOP (Grant No. Agr-2014-4734).	Aarnink AJA, 2007, ASABE PUBLICATION; Alstrup L, 2015, ANIM FEED SCI TECH, V207, P10, DOI 10.1016/j.anifeedsci.2015.05.017; Angelidaki I, 2009, WATER SCI TECHNOL, V59, P927, DOI 10.2166/wst.2009.040; [Anonymous], 2013, CONTRIBUTION WORKING, P1535; Board on Nutrient Requirements of Swine, 2012, NUTR REQ SWIN; Bouwman L, 2013, P NATL ACAD SCI USA, V110, P20882, DOI 10.1073/pnas.1012878108; Clavreul J, 2012, WASTE MANAGE, V32, P2482, DOI 10.1016/j.wasman.2012.07.008; DERIKX PJL, 1994, BIORESOURCE TECHNOL, V49, P41, DOI 10.1016/0960-8524(94)90171-6; Dinuccio E, 2008, AUST J EXP AGR, V48, P93, DOI 10.1071/EA07239; Elsgaard L, 2002, J MICROBIOL METH, V49, P19, DOI 10.1016/S0167-7012(01)00361-X; Elsgaard L, 2016, SCI TOTAL ENVIRON, V539, P78, DOI 10.1016/j.scitotenv.2015.07.145; Food and Agriculture Organization of the United Nations (FAO), 2010, GREENH GAS EM DAIR S; Ge JY, 2015, CHEM ENG J, V276, P29, DOI 10.1016/j.cej.2015.04.067; Haeussermann A, 2006, AGR ECOSYST ENVIRON, V112, P115, DOI 10.1016/j.agee.2005.08.011; IPCC. Intergovernmental Panel on Climate Change, 2006, GUID NAT GREENH GAS, V4; Lesteur M, 2010, PROCESS BIOCHEM, V45, P431, DOI 10.1016/j.procbio.2009.11.018; Leytem AB, 2011, J ENVIRON QUAL, V40, P1383, DOI 10.2134/jeq2009.0515; Li CS, 2012, NUTR CYCL AGROECOSYS, V93, P163, DOI 10.1007/s10705-012-9507-z; MACY JM, 1972, AM J CLIN NUTR, V25, P1318; Mangino J., 2001, US EPAS 17 ANN EM IN; Menzi H., 2010, Livestock in a changing landscape, Volume 1: drivers, consequences and responses, P139; Moller HB, 2004, BIOMASS BIOENERG, V26, P485, DOI 10.1016/j.biombioe.2003.08.008; Monteny GJ, 2001, NUTR CYCL AGROECOSYS, V60, P123, DOI 10.1023/A:1012602911339; Nielsen O-K, 2011, EMISSION INVENTORIES; PATNI NK, 1987, BIOL WASTE, V20, P11, DOI 10.1016/0269-7483(87)90081-4; Petersen SO, 2016, AGR ECOSYST ENVIRON, V216, P258, DOI 10.1016/j.agee.2015.09.042; Petersen SO, 2013, NUTR CYCL AGROECOSYS, V95, P103, DOI 10.1007/s10705-013-9551-3; Philippe FX, 2015, AGR ECOSYST ENVIRON, V199, P10, DOI 10.1016/j.agee.2014.08.015; Ponsa S, 2008, WASTE MANAGE, V28, P2735, DOI 10.1016/j.wasman.2007.12.002; SAFLEY LM, 1990, BIOL WASTE, V34, P133, DOI 10.1016/0269-7483(90)90014-J; Sebola MR, 2015, LECT NOTES ENG COMP, P592; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Sommer SG, 2004, NUTR CYCL AGROECOSYS, V69, P143, DOI 10.1023/B:FRES.0000029678.25083.fa; Sommer SG, 2007, NUTR CYCL AGROECOSYS, V78, P27, DOI 10.1007/s10705-006-9072-4; Stromberg S, 2014, WASTE MANAGE, V34, P1939, DOI 10.1016/j.wasman.2014.07.018; Van den Weghe HFA, 2005, PRECISION LIVESTOCK FARMING '05, P73; Viguria M, 2015, AGR ECOSYST ENVIRON, V199, P261, DOI 10.1016/j.agee.2014.09.016; Yvon-Durocher G, 2014, NATURE, V507, P488, DOI 10.1038/nature13164	38	23	23	5	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0160968	10.1371/journal.pone.0160968	http://dx.doi.org/10.1371/journal.pone.0160968			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529692	gold, Green Submitted, Green Published			2022-12-26	WOS:000381476700035
J	van der Aa, E; Buschow, SI; Biesta, PJ; Janssen, HLA; Woltman, AM				van der Aa, Evelyn; Buschow, Sonja I.; Biesta, Paula J.; Janssen, Harry L. A.; Woltman, Andrea M.			The Effect of Chronic Hepatitis B Virus Infection on BDCA3+Dendritic Cell Frequency and Function	PLOS ONE			English	Article							MYELOID DENDRITIC CELLS; INTERFERON-LAMBDA; IFN-LAMBDA; IMMUNE-RESPONSE; RECEPTOR 1; IN-VIVO; ALPHA; EXPRESSION; INNATE; DCS	Chronic hepatitis B virus (HBV) infection results from inadequate HBV-specific immunity. BDCA3(+) dendritic cells (DCs) are professional antigen presenting cells considered to be important for antiviral responses because of specific characteristics, including high interferon-lambda production. BDCA3+ DCs may thus also have a role in the immune response against HBV, and immunotherapeutic strategies aiming to activate DCs, including BDCA3(+) DCs, in patient livers may represent an interesting treatment option for chronic HBV. However, neither the effect of chronic hepatitis B (CHB) infection on the frequency and function of BDCA3(+) DCs in liver and blood, nor the effect of the viral surface protein (HBsAg) that is abundantly present in blood of infected individuals are known. Here, we provide an overview of BDCA3(+) DC frequency and functional capacity in CHB patients. We find that intrahepatic BDCA3(+) DC numbers are increased in CHB patients. BDCA3(+) DCs from patient blood are not more mature at steady state, but display an impaired capacity to mature and to produce interferon-lambda upon polyI: C stimulation. Furthermore, in vitro experiments exposing blood and intrahepatic BDCA3(+) DCs to the viral envelope protein HBsAg demonstrate that HBsAg does not directly induce phenotypical maturation of BDCA3(+) DCs, but may reduce IFN-lambda production via an indirect unknown mechanism. These results suggest that BDCA3(+) DCs are available in the blood and on site in HBV infected livers, but measures may need to be taken to revive their function for DC-targeted therapy.	[van der Aa, Evelyn; Buschow, Sonja I.; Biesta, Paula J.; Janssen, Harry L. A.; Woltman, Andrea M.] Erasmus MC Univ Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [Janssen, Harry L. A.] Univ Toronto, Univ Hlth Network, Toronto Ctr Liver Dis, Toronto, ON, Canada	Erasmus University Rotterdam; Erasmus MC; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Woltman, AM (corresponding author), Erasmus MC Univ Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands.	a.woltman@erasmusmc.nl	Buschow, Sonja/AAD-3567-2020; Woltman, Andrea/GYV-2656-2022	Woltman, Andrea/0000-0001-9904-6751; Buschow, Sonja/0000-0002-7907-8315	Netherlands Organization for Scientific Research (NWO VIDI grant) [91712329]	Netherlands Organization for Scientific Research (NWO VIDI grant)(Netherlands Organization for Scientific Research (NWO))	This work was supported by The Netherlands Organization for Scientific Research (NWO VIDI grant 91712329 to A.M.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachem A, 2010, J EXP MED, V207, P1273, DOI 10.1084/jem.20100348; Bertoletti A, 2006, J GEN VIROL, V87, P1439, DOI 10.1099/vir.0.81920-0; Boltjes A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097006; Boonstra A, 2008, BEST PRACT RES CL GA, V22, P1049, DOI 10.1016/j.bpg.2008.11.015; Chan HLY, 2016, J HEPATOL, V64, P1011, DOI 10.1016/j.jhep.2015.12.018; Crozat K, 2010, J EXP MED, V207, P1283, DOI 10.1084/jem.20100223; Dandri M, 2012, GUT, V61, P6, DOI 10.1136/gutjnl-2012-302056; de Groen RA, 2014, J INTERF CYTOK RES, V34, P552, DOI 10.1089/jir.2013.0068; Duong FHT, 2014, J EXP MED, V211, P857, DOI 10.1084/jem.20131557; Egli A, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.51; Poulin LF, 2010, J EXP MED, V207, P1261, DOI 10.1084/jem.20092618; Gehring AJ, 2015, CELL MOL IMMUNOL, V12, P283, DOI 10.1038/cmi.2014.95; Haniffa M, 2012, IMMUNITY, V37, P60, DOI 10.1016/j.immuni.2012.04.012; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140; Kelly A, 2014, J HEPATOL, V60, P135, DOI 10.1016/j.jhep.2013.08.007; Lauterbach H, 2010, J EXP MED, V207, P2703, DOI 10.1084/jem.20092720; Luangsay S, 2015, J HEPATOL, V63, P1314, DOI 10.1016/j.jhep.2015.07.014; Mihm S, 2004, LAB INVEST, V84, P1148, DOI 10.1038/labinvest.3700135; Nattermann J, 2006, HEPATOLOGY, V44, P945, DOI 10.1002/hep.21350; Nizzoli G, 2013, BLOOD, V122, P932, DOI 10.1182/blood-2013-04-495424; Pagliaccetti NE, 2010, VIROLOGY, V401, P197, DOI 10.1016/j.virol.2010.02.022; Park H, 2012, HEPATOLOGY, V56, P2060, DOI 10.1002/hep.25897; Reynolds G, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00330; Robek MD, 2005, J VIROL, V79, P3851, DOI 10.1128/JVI.79.6.3851-3854.2005; Sato S, 2015, IMMUNITY, V42, P123, DOI 10.1016/j.immuni.2014.12.016; Schulte BM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121670; Steinman RM, 2008, IMMUNITY, V29, P319, DOI 10.1016/j.immuni.2008.08.001; Manh TPV, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00260; van der Aa E, 2015, SEMIN CELL DEV BIOL, V41, P39, DOI 10.1016/j.semcdb.2014.05.016; van der Molen RG, 2004, HEPATOLOGY, V40, P738, DOI 10.1002/hep.20366; van Montfoort N, 2016, J VIROL, V90, P6187, DOI 10.1128/JVI.02903-15; van Montfoort N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00182; Wack A, 2015, NAT IMMUNOL, V16, P802, DOI 10.1038/ni.3212; Waithman J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066136; Woltman AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015324; Xu Y, 2009, MOL IMMUNOL, V46, P2640, DOI 10.1016/j.molimm.2009.04.031; Yoshio S, 2013, HEPATOLOGY, V57, P1705, DOI 10.1002/hep.26182; Zhang SY, 2013, GASTROENTEROLOGY, V144, P414, DOI 10.1053/j.gastro.2012.10.034	39	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2016	11	8							e0161235	10.1371/journal.pone.0161235	http://dx.doi.org/10.1371/journal.pone.0161235			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4UN	27529176	gold, Green Published, Green Submitted			2022-12-26	WOS:000381476700056
